PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Li, H; Zhao, X; Yan, X; Jessen, WJ; Kim, MO; Dombi, E; Liu, PP; Huang, G; Wu, J				Li, H.; Zhao, X.; Yan, X.; Jessen, W. J.; Kim, M-O; Dombi, E.; Liu, P. P.; Huang, G.; Wu, J.			Runx1 contributes to neurofibromatosis type 1 neurofibroma formation	ONCOGENE			English	Article							SCHWANN-CELLS; NF1; DIFFERENTIATION; PROLIFERATION; MICROENVIRONMENT; EXPRESSION; MATURATION; PROGENITOR; INHIBITOR; ORIGIN	Neurofibromatosis type 1 (NF1) patients are predisposed to neurofibromas but the driver(s) that contribute to neurofibroma formation are not fully understood. By cross comparison of microarray gene lists on human neurofibroma-initiating cells and developed neurofibroma Schwann cells (SCs) we identified RUNX1 overexpression in human neurofibroma initiation cells, suggesting RUNX1 might relate to neurofibroma formation. Immunostaining confirmed RUNX1 protein overexpression in human plexiform neurofibromas. Runx1 overexpression was confirmed in mouse Schwann cell progenitors (SCPs) and mouse neurofibromas at the messenger RNA and protein levels. Genetic inhibition of Runx1 expression by small hairpin RNA or pharmacological inhibition of Runx1 function by a Runx1/Cbf beta interaction inhibitor, Ro5-3335, decreased mouse neurofibroma sphere number in vitro. Targeted genetic deletion of Runx1 in SCs and SCPs delayed mouse neurofibroma formation in vivo. Mechanistically, loss of Nf1 increased embryonic day 12.5 Runx1(+)/Blbp(+) progenitors that enable tumor formation. These results suggest that Runx1 has an important role in Nf1 neurofibroma initiation, and inhibition of RUNX1 function might provide a novel potential therapeutic treatment strategy for neurofibroma patients.	[Li, H.; Zhao, X.; Yan, X.; Jessen, W. J.; Huang, G.; Wu, J.] Univ Cincinnati, Cincinnati Childrens Hosp, Cincinnati Childrens Hosp Res Fdn, Div Expt Hematol & Canc Biol,Canc & Blood Dis Ins, Cincinnati, OH 45229 USA; [Kim, M-O] Univ Cincinnati, Cincinnati Childrens Hosp, Cincinnati Childrens Hosp Res Fdn, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Dombi, E.] NCI, Pediat Oncol Branch, Bethesda, MD 20892 USA; [Liu, P. P.] NHGRI, NIH, Bethesda, MD 20892 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Wu, J (corresponding author), Univ Cincinnati, Cincinnati Childrens Hosp, Cincinnati Childrens Hosp Res Fdn, Div Expt Hematol & Canc Biol,Canc & Blood Dis Ins, Cincinnati, OH 45229 USA.	Jianqiang.wu@cchmc.org		Jessen, Walter/0000-0003-3840-4337; Kim, Mi-Ok/0000-0002-7712-3653	Cincinnati Children's Hospital Trustee Grant;  [NS28840]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000030, ZIAHG000102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028840] Funding Source: NIH RePORTER	Cincinnati Children's Hospital Trustee Grant; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr Nancy Ratner for providing the microarray data (supported by NS28840 to NR) and critical review and helpful discussions of the manuscript. This work was supported by a Cincinnati Children's Hospital Trustee Grant to JW.	Aldskogius H, 2009, STEM CELLS, V27, P1592, DOI 10.1002/stem.77; BLATT J, 1986, CANCER, V57, P1225, DOI 10.1002/1097-0142(19860315)57:6<1225::AID-CNCR2820570627>3.0.CO;2-P; Bushweller JH, 2000, SEMIN CELL DEV BIOL, V11, P377, DOI 10.1006/scdb.2000.0182; Chimge NO, 2013, ONCOGENE, V32, P2121, DOI 10.1038/onc.2012.328; Cichowski K, 1999, SCIENCE, V286, P2172, DOI 10.1126/science.286.5447.2172; Cunningham L, 2012, P NATL ACAD SCI USA, V109, P14592, DOI 10.1073/pnas.1200037109; Friedman JM, 1999, AM J MED GENET, V89, P1; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Inoue KI, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-20; Jaegle M, 2003, GENE DEV, V17, P1380, DOI 10.1101/gad.258203; Jouhilahti EM, 2011, AM J PATHOL, V178, P500, DOI 10.1016/j.ajpath.2010.10.041; Kim HA, 1997, MOL CELL BIOL, V17, P862, DOI 10.1128/MCB.17.2.862; Le LQ, 2007, ONCOGENE, V26, P4609, DOI 10.1038/sj.onc.1210261; Le LQ, 2009, CELL STEM CELL, V4, P453, DOI 10.1016/j.stem.2009.03.017; Logan TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059250; Mayes DA, 2011, CANCER RES, V71, P4675, DOI 10.1158/0008-5472.CAN-10-4558; MCCORMICK F, 1995, CURR OPIN GENET DEV, V5, P51, DOI 10.1016/S0959-437X(95)90053-5; Miller SJ, 2009, EMBO MOL MED, V1, P236, DOI 10.1002/emmm.200900027; Motoda L, 2007, STEM CELLS, V25, P2976, DOI 10.1634/stemcells.2007-0061; Murthy M, 2014, GENE, V540, P191, DOI 10.1016/j.gene.2014.02.038; Nagamachi A, 2010, DEV BIOL, V345, P226, DOI 10.1016/j.ydbio.2010.07.015; Planaguma J, 2004, CANCER RES, V64, P8846, DOI 10.1158/0008-5472.CAN-04-2066; Scheitz CJF, 2013, J CELL BIOCHEM, V114, P985, DOI 10.1002/jcb.24453; Scheitz CJF, 2012, EMBO J, V31, P4124, DOI 10.1038/emboj.2012.270; SIMEONE A, 1995, DEV DYNAM, V203, P61, DOI 10.1002/aja.1002030107; Theriault FM, 2005, J NEUROSCI, V25, P2050, DOI 10.1523/JNEUROSCI.5108-04.2005; Williams JP, 2008, CELL STEM CELL, V3, P658, DOI 10.1016/j.stem.2008.10.003; Wu JQ, 2008, CANCER CELL, V13, P105, DOI 10.1016/j.ccr.2007.12.027; Zheng H, 2008, CANCER CELL, V13, P117, DOI 10.1016/j.ccr.2008.01.002; Zhu Y, 2002, SCIENCE, V296, P920, DOI 10.1126/science.1068452	30	14	14	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 17	2016	35	11					1468	1474		10.1038/onc.2015.207	http://dx.doi.org/10.1038/onc.2015.207			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DG6LQ	26073082	Green Accepted			2022-12-26	WOS:000372196400013
J	Li, J; Newhall, J; Ishiyama, N; Gottardi, C; Ikura, M; Leckband, DE; Tajkhorshid, E				Li, Jing; Newhall, Jillian; Ishiyama, Noboru; Gottardi, Cara; Ikura, Mitsuhiko; Leckband, Deborah E.; Tajkhorshid, Emad			Structural Determinants of the Mechanical Stability of alpha-Catenin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLON-CANCER CELLS; MOLECULAR-DYNAMICS; VINCULIN ACTIVATION; ADHERENS JUNCTIONS; CRYSTAL-STRUCTURE; BINDING-SITES; CADHERIN; ADHESION; FORCE; MECHANOTRANSDUCTION	alpha-Catenin plays a crucial role in cadherin-mediated adhesion by binding to beta-catenin, F-actin, and vinculin, and its dysfunction is linked to a variety of cancers and developmental disorders. As a mechanotransducer in the cadherin complex at intercellular adhesions, mechanical and force-sensing properties of alpha-catenin are critical to its proper function. Biochemical data suggest that alpha-catenin adopts an autoinhibitory conformation, in the absence of junctional tension, and biophysical studies have shown that alpha-catenin is activated in a tension-dependent manner that in turn results in the recruitment of vinculin to strengthen the cadherin complex/F-actin linkage. However, the molecular switch mechanism from autoinhibited to the activated state remains unknown for alpha-catenin. Here, based on the results of an aggregate of 3 mu s of molecular dynamics simulations, we have identified a dynamic salt-bridge network within the core M region of alpha-catenin that may be the structural determinant of the stability of the autoinhibitory conformation. According to our constant-force steered molecular dynamics simulations, the reorientation of the MII/MIII subdomains under force may constitute an initial step along the transition pathway. The simulations also suggest that the vinculin-binding domain (subdomain MI) is intrinsically much less stable than the other two subdomains in the M region (MII and MIII). Our findings reveal several key insights toward a complete understanding of the multistaged, force-induced conformational transition of alpha-catenin to the activated conformation.	[Li, Jing; Leckband, Deborah E.; Tajkhorshid, Emad] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Li, Jing; Leckband, Deborah E.; Tajkhorshid, Emad] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Li, Jing; Leckband, Deborah E.; Tajkhorshid, Emad] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Newhall, Jillian; Leckband, Deborah E.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Ishiyama, Noboru; Ikura, Mitsuhiko] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada; [Ikura, Mitsuhiko] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Gottardi, Cara] Northwestern Univ, Feinberg Coll Med, Dept Acute Pulm Care, Chicago, IL 60611 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Northwestern University; Feinberg School of Medicine	Leckband, DE (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.	leckband@illinois.edu; emad@life.illinois.edu	Tajkhorshid, Emad/AAN-8323-2021; Gottardi, Cara J./AAU-4691-2021; Regan, Clinton/E-6250-2012	Gottardi, Cara J./0000-0003-0912-7617; Ikura, Mitsuhiko/0000-0002-9524-1303; Tajkhorshid, Emad/0000-0001-8434-1010; LI, Jing/0000-0003-3277-6818	National Institutes of Health [P41-GM104601]; National Science Foundation [1029871]; Canadian Institutes of Health Research [MOP-130297]; Xsede [MCA06N060]; Illinois Campus Cluster Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM104601, R01GM076561] Funding Source: NIH RePORTER; Division Of Chemistry [1213755] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Xsede; Illinois Campus Cluster Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported, in whole or in part, by National Institutes of Health Grant P41-GM104601, National Science Foundation Grant 1029871, and the Canadian Institutes of Health Research grant (MOP-130297). This work was also supported by a supercomputing allocation through Xsede Grant MCA06N060 and the Illinois Campus Cluster Program. The authors declare that they have no conflicts of interest with the contents of this article.	Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; Barry AK, 2014, J CELL SCI, V127, P1779, DOI 10.1242/jcs.139014; Bays JL, 2014, J CELL BIOL, V205, P251, DOI 10.1083/jcb.201309092; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Borgon RA, 2004, STRUCTURE, V12, P1189, DOI 10.1016/j.str.2004.05.009; Buckley CD, 2014, SCIENCE, V346, P600, DOI 10.1126/science.1254211; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen ZM, 2009, ARTERIOSCL THROM VAS, V29, P1067, DOI 10.1161/ATVBAHA.109.186692; Choi HJ, 2012, P NATL ACAD SCI USA, V109, P8576, DOI 10.1073/pnas.1203906109; Collins C, 2012, CURR BIOL, V22, P2087, DOI 10.1016/j.cub.2012.08.051; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Desai R, 2013, NAT CELL BIOL, V15, P261, DOI 10.1038/ncb2685; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Golji J, 2011, BIOPHYS J, V100, P332, DOI 10.1016/j.bpj.2010.11.024; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Grubmuller H., 1996, SOLVATE VERSION 1 0; GUMBINER BM, 1993, J CELL SCI, P155; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huveneers S, 2013, J CELL SCI, V126, P403, DOI 10.1242/jcs.109447; Huveneers S, 2012, J CELL BIOL, V196, P641, DOI 10.1083/jcb.201108120; Hytonen VP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040024; Imamura Y, 1999, J CELL BIOL, V144, P1311, DOI 10.1083/jcb.144.6.1311; Ishiyama N, 2013, J BIOL CHEM, V288, P15913, DOI 10.1074/jbc.M113.453928; Isralewitz B, 2001, CURR OPIN STRUC BIOL, V11, P224, DOI 10.1016/S0959-440X(00)00194-9; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim TJ, 2015, CURR BIOL, V25, P218, DOI 10.1016/j.cub.2014.11.017; Kuttel M, 2002, J COMPUT CHEM, V23, P1236, DOI 10.1002/jcc.10119; Ladoux B, 2010, BIOPHYS J, V98, P534, DOI 10.1016/j.bpj.2009.10.044; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Leckband DE, 2014, ANNU REV CELL DEV BI, V30, P291, DOI 10.1146/annurev-cellbio-100913-013212; Lecuit T, 2011, ANNU REV CELL DEV BI, V27, P157, DOI 10.1146/annurev-cellbio-100109-104027; Lee SE, 2007, J BIOMECH, V40, P2096, DOI 10.1016/j.jbiomech.2007.04.006; Leerberg JM, 2014, CURR BIOL, V24, P1689, DOI 10.1016/j.cub.2014.06.028; Liu ZJ, 2010, P NATL ACAD SCI USA, V107, P9944, DOI 10.1073/pnas.0914547107; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; NAGAFUCHI A, 1994, J CELL BIOL, V127, P235, DOI 10.1083/jcb.127.1.235; Peng X, 2012, J BIOL CHEM, V287, P7728, DOI 10.1074/jbc.M111.297481; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Pokutta S, 2008, BIOCHEM SOC T, V36, P141, DOI 10.1042/BST0360141; Pokutta S, 2014, J BIOL CHEM, V289, P13589, DOI 10.1074/jbc.M114.554709; Rangarajan ES, 2013, NAT STRUCT MOL BIOL, V20, P188, DOI 10.1038/nsmb.2479; Rangarajan ES, 2012, J BIOL CHEM, V287, P18492, DOI 10.1074/jbc.M112.351023; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sarpal R, 2012, J CELL SCI, V125, P233, DOI 10.1242/jcs.096644; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Schreiner E, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-190; Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066; Seong J, 2013, P NATL ACAD SCI USA, V110, P19372, DOI 10.1073/pnas.1307405110; Smith ML, 2007, PLOS BIOL, V5, P2243, DOI 10.1371/journal.pbio.0050268; Tamada M, 2004, DEV CELL, V7, P709, DOI 10.1016/j.devcel.2004.08.021; Thomas WA, 2013, J BIOL CHEM, V288, P4957, DOI 10.1074/jbc.M112.403774; Twiss F, 2012, BIOL OPEN, V1, P1128, DOI 10.1242/bio.20122428; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; VERMEULEN SJ, 1995, CANCER RES, V55, P4722; Vermeulen SJ, 1997, ANN NY ACAD SCI, V833, P186, DOI 10.1111/j.1749-6632.1997.tb48607.x; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Yang J, 2001, EMBO J, V20, P3645, DOI 10.1093/emboj/20.14.3645; Yao MX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5525; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Zhang ZY, 2004, MOL BIOL CELL, V15, P4234, DOI 10.1091/mbc.E04-03-0264; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	68	17	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					18890	18903		10.1074/jbc.M115.647941	http://dx.doi.org/10.1074/jbc.M115.647941			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26070562	Green Published, hybrid			2022-12-26	WOS:000358781100002
J	Georgiadis, V; Stephanou, A; Townsend, PA; Jackson, TR				Georgiadis, Vassilis; Stephanou, Anastasis; Townsend, Paul A.; Jackson, Thomas R.			MultiElec: A MATLAB Based Application for MEA Data Analysis	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; MICROELECTRODE ARRAYS; BRAIN-SLICES; CARDIOMYOCYTES; STIMULATION; PROPAGATION; GENERATION; CONDUCTION; MYOCYTES; PLATFORM	We present MultiElec, an open source MATLAB based application for data analysis of microelectrode array (MEA) recordings. MultiElec displays an extremely user-friendly graphic user interface (GUI) that allows the simultaneous display and analysis of voltage traces for 60 electrodes and includes functions for activation-time determination, the production of activation-time heat maps with activation time and isoline display. Furthermore, local conduction velocities are semi-automatically calculated along with their corresponding vector plots. MultiElec allows ad hoc signal suppression, enabling the user to easily and efficiently handle signal artefacts and for incomplete data sets to be analysed. Voltage traces and heat maps can be simply exported for figure production and presentation. In addition, our platform is able to produce 3D videos of signal progression over all 60 electrodes. Functions are controlled entirely by a single GUI with no need for command line input or any understanding of MATLAB code. MultiElec is open source under the terms of the GNU General Public License as published by the Free Software Foundation, version 3. Both the program and source code are available to download from http://www.cancer.manchester.ac.uk/MultiElec/.	[Georgiadis, Vassilis; Stephanou, Anastasis] UCL, Inst Child Hlth, London, England; [Townsend, Paul A.; Jackson, Thomas R.] Univ Manchester, Inst Canc Sci, Manchester, Lancs, England; [Townsend, Paul A.; Jackson, Thomas R.] Univ Manchester, Fac Med & Human Sci, Manchester Canc Res Ctr, Manchester Ctr Cellular Metab, Manchester, Lancs, England	University of London; University College London; University of Manchester; University of Manchester	Jackson, TR (corresponding author), Univ Manchester, Inst Canc Sci, Manchester, Lancs, England.	tom.jackson-2@manchester.ac.uk	Townsend, Paul/AAF-8234-2020; Georgiadis, Vassilis/D-9434-2013	Townsend, Paul/0000-0001-8956-9508; Georgiadis, Vassilis/0000-0002-2530-2377	New Horizons Research Grant Program of the British Heart Foundation [NH/11/3/29033]; University of Manchester	New Horizons Research Grant Program of the British Heart Foundation; University of Manchester	VG and AS gratefully acknowledge funding provided by the New Horizons Research Grant Program of the British Heart Foundation (NH/11/3/29033, https://www.bhf.org.uk/). TJ and PT gratefully acknowledge funding provided by the University of Manchester (Project Diamond, http://www.manchester.ac.uk/).	Bayly PV, 1998, IEEE T BIO-MED ENG, V45, P563, DOI 10.1109/10.668746; Bayly PV, 1998, CHAOS, V8, P103, DOI 10.1063/1.166291; Besl B, 2002, EUR J NEUROSCI, V15, P999, DOI 10.1046/j.1460-9568.2002.01943.x; BROMBA MUA, 1981, ANAL CHEM, V53, P1583, DOI 10.1021/ac00234a011; Cho S, 2007, CURR NEUROPHARMACOL, V5, P19, DOI 10.2174/157015907780077105; Dunlop J, 2008, NAT REV DRUG DISCOV, V7, P358, DOI 10.1038/nrd2552; Egashira T, 2012, CARDIOVASC RES, V95, P419, DOI 10.1093/cvr/cvs206; Egert U, 1998, BRAIN RES PROTOC, V2, P229, DOI 10.1016/S1385-299X(98)00013-0; Egert U, 2002, J NEUROSCI METH, V117, P33, DOI 10.1016/S0165-0270(02)00045-6; Feld Y, 2002, CIRCULATION, V105, P522, DOI 10.1161/hc0402.102661; Grumet AE, 2000, J NEUROSCI METH, V101, P31, DOI 10.1016/S0165-0270(00)00246-6; Heuschkel MO, 2002, J NEUROSCI METH, V114, P135, DOI 10.1016/S0165-0270(01)00514-3; Johnstone AFM, 2010, NEUROTOXICOLOGY, V31, P331, DOI 10.1016/j.neuro.2010.04.001; Kehat I, 2002, CIRC RES, V91, P659, DOI 10.1161/01.RES.0000039084.30342.9B; Kujala VJ, 2011, COMPUT METH PROG BIO, V104, P199, DOI 10.1016/j.cmpb.2011.04.001; Lahti AL, 2012, DIS MODEL MECH, V5, P220, DOI 10.1242/dmm.008409; Matsa E, 2011, EUR HEART J, V32, P952, DOI 10.1093/eurheartj/ehr073; Matsuura K, 2012, BIOCHEM BIOPH RES CO, V425, P321, DOI 10.1016/j.bbrc.2012.07.089; Mauritz C, 2008, CIRCULATION, V118, P507, DOI 10.1161/CIRCULATIONAHA.108.778795; Meiry G, 2001, J CARDIOVASC ELECTR, V12, P1269, DOI 10.1046/j.1540-8167.2001.01269.x; Morefield SI, 2000, BIOSENS BIOELECTRON, V15, P383, DOI 10.1016/S0956-5663(00)00095-6; Natarajan A, 2011, BIOMATERIALS, V32, P4267, DOI 10.1016/j.biomaterials.2010.12.022; Pradhapan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073637; Rajala K, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/383709; Reppel M, 2007, CELL PHYSIOL BIOCHEM, V19, P213, DOI 10.1159/000100628; Ronn LCB, 1999, NAT BIOTECHNOL, V17, P1000, DOI 10.1038/13697; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schafer RW, 2011, IEEE SIGNAL PROC MAG, V28, P111, DOI 10.1109/MSP.2011.941097; Stett A, 2003, ANAL BIOANAL CHEM, V377, P486, DOI 10.1007/s00216-003-2149-x; Tanaka T, 2009, BIOCHEM BIOPH RES CO, V385, P497, DOI 10.1016/j.bbrc.2009.05.073; Teukolsky S.A., 1990, COMPUT PHYS, V4, P669, DOI [10.1063/1.4822961, DOI 10.1063/1.4822961]; Wagenaar DA, 2005, J NEUROSCI, V25, P680, DOI 10.1523/JNEUROSCI.4209-04.2005; Wagenaar DA, 2004, J NEUROSCI METH, V138, P27, DOI 10.1016/j.jneumeth.2004.03.005; Zwi L, 2009, CIRCULATION, V120, P1513, DOI 10.1161/CIRCULATIONAHA.109.868885	34	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129389	10.1371/journal.pone.0129389	http://dx.doi.org/10.1371/journal.pone.0129389			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076010	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900067
J	Kusakina, J; Rutterford, Z; Cotter, S; Marti, MC; Laurie, DA; Greenland, AJ; Hall, A; Webb, AAR				Kusakina, Jelena; Rutterford, Zoe; Cotter, Sean; Marti, Maria C.; Laurie, David A.; Greenland, Andy J.; Hall, Anthony; Webb, Alex A. R.			Barley Hv CIRCADIAN CLOCK ASSOCIATED 1 and Hv PHOTOPERIOD H1 Are Circadian Regulators That Can Affect Circadian Rhythms in Arabidopsis	PLOS ONE			English	Article							PSEUDO-RESPONSE REGULATORS; CLOCK; TIME; EXPRESSION; GENES; TRANSCRIPTION; CONSERVATION	Circadian clocks regulate many aspects of plant physiology and development that contribute to essential agronomic traits. Circadian clocks contain transcriptional feedback loops that are thought to generate circadian timing. There is considerable similarity in the genes that comprise the transcriptional and translational feedback loops of the circadian clock in the plant Kingdom. Functional characterisation of circadian clock genes has been restricted to a few model species. Here we provide a functional characterisation of the Hordeum vulgare (barley) circadian clock genes Hv CIRCADIAN CLOCK ASSOCIATED 1(HvCCA1) and Hv PHOTOPERIODH1, which are respectively most similar to Arabidopsis thaliana CIRCADIAN CLOCK ASSOCIATED 1 (AtCCA1) and PSEUDO RESPONSE REGULATOR 7 (AtPRR7). This provides insight into the circadian regulation of one of the major crop species of Northern Europe. Through a combination of physiological assays of circadian rhythms in barley and heterologous expression in wild type and mutant strains of A. thaliana we demonstrate that HvCCA1 has a conserved function to AtCCA1. We find that Hv PHOTOPERIOD H1 has AtPRR7-like functionality in A. thaliana and that the effects of the Hv photoperiod h1 mutation on photoperiodism and circadian rhythms are genetically separable.	[Kusakina, Jelena; Cotter, Sean; Hall, Anthony] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Rutterford, Zoe; Marti, Maria C.; Webb, Alex A. R.] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Rutterford, Zoe; Greenland, Andy J.] Natl Inst Agr Bot, Cambridge, England; [Laurie, David A.] John Innes Ctr, Norwich, Norfolk, England	University of Liverpool; University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Webb, AAR (corresponding author), Univ Cambridge, Dept Plant Sci, Downing St, Cambridge, England.	alex.webb@plantsci.cam.ac.uk	Ruiz, María Carmen Martí/AAB-2564-2019; Marti, Carmen/ABD-8806-2020; Hall, Anthony/D-2844-2009	Hall, Anthony/0000-0002-1806-020X; Marti Ruiz, Maria Carmen/0000-0003-1698-1168	National Institute of Agricultural Botany; Marie Curie Early Stage Training project [MEST-CT-2005-020526]; Biology and the Biological Sciences Research Council Doctoral Training Programme; BBSRC [BB/M006212/1]; BBSRC [BB/K018078/1, BB/H022333/1, BB/L011786/1, BB/H006826/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M006212/1, BB/K018078/1, BB/H006826/1, BB/H022333/1, BB/L011786/1] Funding Source: researchfish	National Institute of Agricultural Botany; Marie Curie Early Stage Training project; Biology and the Biological Sciences Research Council Doctoral Training Programme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	ZR is grateful to the National Institute of Agricultural Botany for the award of a Scholarship. The authors acknowledge funding from a Marie Curie Early Stage Training project MEST-CT-2005-020526 for JK, and the Biology and the Biological Sciences Research Council Doctoral Training Programme for SC. AARW and MCM are grateful to the BBSRC for the award of BBSRC Grant BB/M006212/1, which supported aspects of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campoli C, 2013, NEW PHYTOL, V199, P1045, DOI 10.1111/nph.12346; Campoli C, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-97; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Dodd AN, 2004, NEW PHYTOL, V162, P63, DOI 10.1111/j.1469-8137.2004.01005.x; Dodd AN, 2006, PLANT J, V48, P962, DOI 10.1111/j.1365-313X.2006.02933.x; Farre EM, 2005, CURR BIOL, V15, P47, DOI 10.1016/j.cub.2004.12.067; Faure S, 2012, P NATL ACAD SCI USA, V109, P8328, DOI 10.1073/pnas.1120496109; Gendron JM, 2012, P NATL ACAD SCI USA, V109, P3167, DOI 10.1073/pnas.1200355109; Gould PD, 2009, PLANT J, V58, P893, DOI 10.1111/j.1365-313X.2009.03819.x; Green RM, 2002, PLANT PHYSIOL, V129, P576, DOI 10.1104/pp.004374; Harmer SL, 2009, ANNU REV PLANT BIOL, V60, P357, DOI 10.1146/annurev.arplant.043008.092054; Herrero E, 2012, PLANT CELL, V24, P428, DOI 10.1105/tpc.111.093807; Huang W, 2012, SCIENCE, V336, P75, DOI 10.1126/science.1219075; Johnson CH, 2007, ANN PLANT REV, V21, P237; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; LeClere S, 2001, PLANT MOL BIOL, V46, P695, DOI 10.1023/A:1011699722052; Locke JCW, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100102; Matsushika A, 2000, PLANT CELL PHYSIOL, V41, P1002, DOI 10.1093/pcp/pcd043; Murakami M, 2007, BIOSCI BIOTECH BIOCH, V71, P1107, DOI 10.1271/bbb.70048; Ogiso E, 2010, PLANT PHYSIOL, V152, P808, DOI 10.1104/pp.109.148908; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Schultz TF, 2001, PLANT CELL, V13, P2659, DOI 10.1105/tpc.13.12.2659; Serikawa M, 2008, PLANT PHYSIOL, V146, P1952, DOI 10.1104/pp.107.114611; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6	28	6	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0127449	10.1371/journal.pone.0127449	http://dx.doi.org/10.1371/journal.pone.0127449			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076005	Green Published, gold			2022-12-26	WOS:000356329900013
J	Rozanov, D; Cheltsov, A; Sergienko, E; Vasile, S; Golubkov, V; Aleshin, AE; Levin, T; Traer, E; Hann, B; Freimuth, J; Alexeev, N; Alekseyev, MA; Budko, SP; Bachinger, HP; Spellman, P				Rozanov, Dmitri; Cheltsov, Anton; Sergienko, Eduard; Vasile, Stefan; Golubkov, Vladislav; Aleshin, Alexander E.; Levin, Trevor; Traer, Elie; Hann, Byron; Freimuth, Julia; Alexeev, Nikita; Alekseyev, Max A.; Budko, Sergey P.; Baechinger, Hans Peter; Spellman, Paul			TRAIL-Based High Throughput Screening Reveals a Link between TRAIL-Mediated Apoptosis and Glutathione Reductase, a Key Component of Oxidative Stress Response	PLOS ONE			English	Article							PERINUCLEOLAR COMPARTMENT PREVALENCE; PROSTATE-CANCER CELLS; IN-VIVO; CHEMOTHERAPEUTIC DRUGS; THIOREDOXIN REDUCTASE; RESISTANT MELANOMA; DOWN-REGULATION; UP-REGULATION; LIGAND; BREAST	A high throughput screen for compounds that induce TRAIL-mediated apoptosis identified ML100 as an active chemical probe, which potentiated TRAIL activity in prostate carcinoma PPC-1 and melanoma MDA-MB-435 cells. Follow-up in silico modeling and profiling in cell-based assays allowed us to identify NSC130362, pharmacophore analog of ML100 that induced 65-95% cytotoxicity in cancer cells and did not affect the viability of human primary hepatocytes. In agreement with the activation of the apoptotic pathway, both ML100 and NSC130362 synergistically with TRAIL induced caspase-3/7 activity in MDA-MB-435 cells. Subsequent affinity chromatography and inhibition studies convincingly demonstrated that glutathione reductase (GSR), a key component of the oxidative stress response, is a target of NSC130362. In accordance with the role of GSR in the TRAIL pathway, GSR gene silencing potentiated TRAIL activity in MDA-MB-435 cells but not in human hepatocytes. Inhibition of GSR activity resulted in the induction of oxidative stress, as was evidenced by an increase in intracellular reactive oxygen species (ROS) and peroxidation of mitochondrial membrane after NSC130362 treatment in MDA-MB-435 cells but not in human hepatocytes. The antioxidant reduced glutathione (GSH) fully protected MDA-MB-435 cells from cell lysis induced by NSC130362 and TRAIL, thereby further confirming the interplay between GSR and TRAIL. As a consequence of activation of oxidative stress, combined treatment of different oxidativestress inducers and NSC130362 promoted cell death in a variety of cancer cells but not in hepatocytes in cell-based assays and in in vivo, in a mouse tumor xenograft model.	[Rozanov, Dmitri; Spellman, Paul] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; [Cheltsov, Anton; Sergienko, Eduard] Q MOL LLC, San Diego, CA USA; [Vasile, Stefan] Sanford Burnham Med Res Inst, Conrad Prebys Ctr Chem Genom, Orlando, FL USA; [Golubkov, Vladislav; Aleshin, Alexander E.] Sanford Burnham Med Res Inst, Inflammatory & Infect Dis Ctr, La Jolla, CA USA; [Levin, Trevor] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Traer, Elie] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Hann, Byron; Freimuth, Julia] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Alexeev, Nikita; Alekseyev, Max A.] George Washington Univ, Computat Biol Inst, Ashburn, VA USA; [Alexeev, Nikita] St Petersburg State Univ, Dept Math & Mech, St Petersburg 199034, Russia; [Budko, Sergey P.; Baechinger, Hans Peter] Shriners Hosp Children, Res Dept, Portland, OR 97201 USA; [Budko, Sergey P.; Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA	Oregon Health & Science University; Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; Oregon Health & Science University; Oregon Health & Science University; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; George Washington University; Saint Petersburg State University; Oregon Health & Science University	Rozanov, D (corresponding author), Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA.	rozanov@ohsu.edu	Golubkov, Vladislav/L-6828-2017; Alekseyev, Max/D-9362-2016; Alexeev, Nikita/K-4106-2014	Alekseyev, Max/0000-0002-5140-8095; Alexeev, Nikita/0000-0003-3415-9565	NIH Roadmap Initiatives [U54HG003916, U54HG005033]; NIH [RO3 MH081232-01]; Department of Defense [W81XWH-09-1-0601]; National Science Foundation [IIS-1462107]; Oregon Health & Science University (OHSU) strategic investment fund; OHSU School of Medicine faculty innovation fund; Q-MOL LLC; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG005033, U54HG003916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH081232] Funding Source: NIH RePORTER; Direct For Computer & Info Scie & Enginr [1462107] Funding Source: National Science Foundation	NIH Roadmap Initiatives(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); National Science Foundation(National Science Foundation (NSF)); Oregon Health & Science University (OHSU) strategic investment fund; OHSU School of Medicine faculty innovation fund; Q-MOL LLC; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by NIH Roadmap Initiatives grants U54HG003916 and U54HG005033, NIH screening grant RO3 MH081232-01, Department of Defense grant W81XWH-09-1-0601, National Science Foundation grant IIS-1462107, Oregon Health & Science University (OHSU) strategic investment fund, and OHSU School of Medicine faculty innovation fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We also state that Q-MOL LLC provided support in the form of salary for author AC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Barnhart BC, 2003, SEMIN IMMUNOL, V15, P185, DOI 10.1016/S1044-5323(03)00031-9; Bodmer JL, 2000, J BIOL CHEM, V275, P20632, DOI 10.1074/jbc.M909721199; Chen WS, 2007, CARCINOGENESIS, V28, P2114, DOI 10.1093/carcin/bgm133; Cullingford TE, 2006, J MOL CELL CARDIOL, V40, P157, DOI 10.1016/j.yjmcc.2005.10.004; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Fawcett H, 2005, INT J ONCOL, V27, P1717; Garber K, 2006, J NATL CANCER I, V98, P512, DOI 10.1093/jnci/djj174; Gessner PK, 1995, TOXICOLOGY, V105, P161, DOI 10.1016/0300-483X(95)03210-7; Gibellini Lara, 2010, Cancers (Basel), V2, P1288, DOI 10.3390/cancers2021288; GRIFFITH OW, 1982, J BIOL CHEM, V257, P13704; Inoue T, 2013, FREE RADICAL BIO MED, V61, P273, DOI 10.1016/j.freeradbiomed.2013.04.020; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kamath RV, 2005, CANCER RES, V65, P246; KARPLUS PA, 1989, J MOL BIOL, V210, P163, DOI 10.1016/0022-2836(89)90298-2; Kelley SK, 2001, J PHARMACOL EXP THER, V299, P31; Kim JY, 2008, J CELL BIOCHEM, V105, P1386, DOI 10.1002/jcb.21958; Kim J, 2010, P NATL ACAD SCI USA, V107, P13432, DOI 10.1073/pnas.1006822107; Kim YH, 2007, J CELL BIOCHEM, V100, P998, DOI 10.1002/jcb.21098; Kleeff J, 2000, INT J CANCER, V86, P399, DOI 10.1002/(SICI)1097-0215(20000501)86:3<399::AID-IJC15>3.0.CO;2-G; Lemke J, 2014, CELL DEATH DIFFER, V21, P1350, DOI 10.1038/cdd.2014.81; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li TWH, 2006, MOL CELL BIOL, V26, P5284, DOI 10.1128/MCB.00105-06; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Lu J, 2006, CANCER RES, V66, P4410, DOI 10.1158/0008-5472.CAN-05-3310; Lu J, 2007, P NATL ACAD SCI USA, V104, P12288, DOI 10.1073/pnas.0701549104; Luu HH, 2004, CURR CANCER DRUG TAR, V4, P653, DOI 10.2174/1568009043332709; Medema JP, 1999, J EXP MED, V190, P1033, DOI 10.1084/jem.190.7.1033; Naka T, 2002, CANCER RES, V62, P5800; Nakahara T, 2007, CANCER RES, V67, P8014, DOI 10.1158/0008-5472.CAN-07-1343; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nomura K, 2000, BIOCHEM J, V351, P183, DOI 10.1042/0264-6021:3510183; NORDHOFF A, 1993, BIOCHEMISTRY-US, V32, P4060, DOI 10.1021/bi00066a029; Norton JT, 2008, CANCER-AM CANCER SOC, V113, P861, DOI 10.1002/cncr.23632; PURI RN, 1983, P NATL ACAD SCI-BIOL, V80, P5258, DOI 10.1073/pnas.80.17.5258; Ramadori G, 2010, ANN HEPATOL, V9, P133, DOI 10.1016/S1665-2681(19)31651-5; Ray S, 2003, CANCER RES, V63, P4713; Remacle AG, 2012, CANCER RES, V72, P2339, DOI 10.1158/0008-5472.CAN-11-4149; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Rodriguez-Antona C, 2006, ONCOGENE, V25, P1679, DOI 10.1038/sj.onc.1209377; Rozanov DV, 2009, MOL CANCER THER, V8, P1515, DOI 10.1158/1535-7163.MCT-09-0202; Shankar S, 2005, PROSTATE, V62, P165, DOI 10.1002/pros.20126; Singh TR, 2003, CANCER RES, V63, P5390; Srivastava RK, 2001, NEOPLASIA, V3, P535, DOI 10.1038/sj.neo.7900203; Sulis ML, 2003, TRENDS CELL BIOL, V13, P478, DOI 10.1016/S0962-8924(03)00175-2; Suzuki-Karasaki M, 2014, INT J ONCOL, V44, P616, DOI 10.3892/ijo.2013.2215; Suzuki-Karasaki Y, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00128; Tochigi M, 2013, INT J ONCOL, V42, P863, DOI 10.3892/ijo.2013.1769; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Traverso N, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/972913; Tse AKW, 2014, J INVEST DERMATOL, V134, P1397, DOI 10.1038/jid.2013.471; Voelkel-Johnson C, 2002, CANCER GENE THER, V9, P164, DOI 10.1038/sj.cgt.7700420; Wang G, 2009, ANAL CHEM, V81, P146, DOI 10.1021/ac801664q; Wenger T, 2006, CELL DEATH DIFFER, V13, P1740, DOI 10.1038/sj.cdd.4401867; White-Gilbertson SJ, 2009, J UROLOGY, V182, P1178, DOI 10.1016/j.juro.2009.05.005; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wilmarth Phillip A, 2009, J Ocul Biol Dis Infor, V2, P223; Yagita H, 2004, CANCER SCI, V95, P777, DOI 10.1111/j.1349-7006.2004.tb02181.x; Yang L, 2013, APOPTOSIS, V18, P618, DOI 10.1007/s10495-013-0808-8; Zhang HQ, 2005, METHOD ENZYMOL, V401, P468, DOI 10.1016/S0076-6879(05)01028-1; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792; Zhang R, 2008, APOPTOSIS, V13, P1465, DOI 10.1007/s10495-008-0278-6; Zhang YQ, 2008, MOL CANCER RES, V6, P1861, DOI 10.1158/1541-7786.MCR-08-0313	63	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129566	10.1371/journal.pone.0129566	http://dx.doi.org/10.1371/journal.pone.0129566			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075913	gold, Green Published, Green Submitted			2022-12-26	WOS:000356329900084
J	van Kampen, SC; Susanto, NH; Simon, S; Astiti, SD; Chandra, R; Burhan, E; Farid, MN; Chittenden, K; Mustikawati, DE; Alisjahbana, B				van Kampen, Sanne C.; Susanto, Nugroho H.; Simon, Sumanto; Astiti, Shinta D.; Chandra, Roni; Burhan, Erlina; Farid, Muhammad N.; Chittenden, Kendra; Mustikawati, Dyah E.; Alisjahbana, Bachti			Effects of Introducing Xpert MTB/RIF on Diagnosis and Treatment of Drug-Resistant Tuberculosis Patients in Indonesia: A Pre-Post Intervention Study	PLOS ONE			English	Article							POSITIVE RIFAMPICIN RESISTANCE; MYCOBACTERIUM-TUBERCULOSIS; IMPLEMENTATION; ASSAY	Background In March 2012, the Xpert MTB/RIF assay (Xpert) was introduced in three provincial public hospitals in Indonesia as a novel diagnostic to detect tuberculosis and rifampicin resistance among high risk individuals. Objective This study assessed the effects of using Xpert in place of conventional solid and liquid culture and drug-susceptibility testing on case detection rates, treatment initiation rates, and health system delays among drug-resistant tuberculosis (TB) patients. Methods Cohort data on registration, test results and treatment initiation were collected from routine presumptive patient registers one year before and one year after Xpert was introduced. Proportions of case detection and treatment initiation were compared using the Pearson Chi square test and median time delays using the Mood's Median test. Results A total of 975 individuals at risk of drug-resistant TB were registered in the pre-intervention year and 1,442 in the post-intervention year. After Xpert introduction, TB positivity rate increased by 15%, while rifampicin resistance rate reduced by 23% among TB positive cases and by 9% among all tested. Second-line TB treatment initiation rate among rifampicin resistant patients increased by 19%. Time from client registration to diagnosis was reduced by 74 days to a median of a single day (IQR 0-4) and time from diagnosis to treatment start was reduced by 27 days to a median of 15 days (IQR 7-51). All findings were significant with p<0.001. Conclusion Compared to solid and liquid culture and drug-susceptibility testing, Xpert detected more TB and less rifampicin resistance, increased second-line treatment initiation rates and shortened time to diagnosis and treatment. This test holds promise to improve rapid case finding and management of drug-resistant TB patients in Indonesia.	[van Kampen, Sanne C.] KNCV TB Fdn, Access Lab Serv Team, The Hague, Netherlands; [Susanto, Nugroho H.; Alisjahbana, Bachti] Padjadjaran State Univ, Fac Med, Bandung, Indonesia; [Susanto, Nugroho H.; Simon, Sumanto; Astiti, Shinta D.; Farid, Muhammad N.; Alisjahbana, Bachti] Minist Hlth, TB Operat Res Grp, Jakarta, Indonesia; [Simon, Sumanto] Univ Atmadjaja, Fac Med, Jakarta, Indonesia; [Chandra, Roni] KNCV TB Fdn, Lab Team TB CARE 1, Jakarta, Indonesia; [Burhan, Erlina] Persahabatan Hosp, Dept Lung & Resp Hlth, Jakarta, Indonesia; [Farid, Muhammad N.] Cent Bur Stat, Subdirectorate Stat & Design, Jakarta, Indonesia; [Chittenden, Kendra] US Agcy Int Dev, Hlth Div, Jakarta, Indonesia; [Mustikawati, Dyah E.] Minist Hlth, Natl TB Control Program, Jakarta, Indonesia	KNCV Tuberculosis Foundation; Universitas Padjadjaran; Ministry of Health - Indonesia; KNCV Tuberculosis Foundation; Persahabatan Hospital; United States Agency for International Development (USAID); Ministry of Health - Indonesia	van Kampen, SC (corresponding author), KNCV TB Fdn, Access Lab Serv Team, The Hague, Netherlands.	sanne.vankampen@kncvtbc.org	Burhan, Erlina/AAR-6425-2021; Mustikawati, Dyah Erti/K-2437-2019	Burhan, Erlina/0000-0002-6617-499X; van Kampen, Sanne/0000-0002-1519-5248	United States Agency for International Development under the USAID Tuberculosis CARE I [AID-OAA-A-10-000020]	United States Agency for International Development under the USAID Tuberculosis CARE I(United States Agency for International Development (USAID))	This study was funded by the United States Agency for International Development under the USAID Tuberculosis CARE I, Cooperative Agreement No. AID-OAA-A-10-000020. As author on this paper, KC was involved in conception of the study design and preparation of the manuscript.	Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boyles TH, 2014, INT J TUBERC LUNG D, V18, P876, DOI 10.5588/ijtld.13.0853; Chang K, 2012, J INFECTION, V64, P580, DOI 10.1016/j.jinf.2012.02.012; Clouse K, 2012, SAMJ S AFR MED J, V102, P805, DOI [10.7196/SAMJ.5851, 10.7196/samj.5851]; Creswell J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-2; Hanrahan CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065421; National Tuberculosis Control Program, 2011, NAT ACT PLAN PROGR M; Rigouts L, 2013, J CLIN MICROBIOL, V51, P2641, DOI 10.1128/JCM.02741-12; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Van Deun A, 2013, J CLIN MICROBIOL, V51, P2633, DOI 10.1128/JCM.00553-13; Van Rie A, 2013, INT J TUBERC LUNG D, V17, P368, DOI 10.5588/ijtld.12.0392; Van Rie A, 2012, INT J TUBERC LUNG D, V16, P206, DOI 10.5588/ijtld.11.0395; WHO, 2011, POL STAT AUT REAL TI; Williamson DA, 2012, DIAGN MICR INFEC DIS, V74, P207, DOI 10.1016/j.diagmicrobio.2012.06.013; World Health Organization, 2014, XPERT MTB RIF IMPL M; WorldHealthOrganization, 2013, AUT REAL TIM NUCL AM; Yoon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048599	18	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0123536	10.1371/journal.pone.0123536	http://dx.doi.org/10.1371/journal.pone.0123536			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075722	Green Submitted, Green Published, gold			2022-12-26	WOS:000356329900002
J	Solca, F; Poletti, B; Zago, S; Crespi, C; Sassone, F; Lafronza, A; Maraschi, AM; Sassone, J; Silani, V; Ciammola, A				Solca, Federica; Poletti, Barbara; Zago, Stefano; Crespi, Chiara; Sassone, Francesca; Lafronza, Annalisa; Maraschi, Anna Maria; Sassone, Jenny; Silani, Vincenzo; Ciammola, Andrea			Counterfactual Thinking Deficit in Huntington's Disease	PLOS ONE			English	Article							PREFRONTAL CORTEX; ATROPHY; PROGRESSION	Background and Objective Counterfactual thinking (CFT) refers to the generation of mental simulations of alternatives to past events, actions and outcomes. CFT is a pervasive cognitive feature in every-day life and is closely related to decision-making, planning and problem-solving - all of which are cognitive processes linked to unimpaired frontal lobe functioning. Huntington's Disease (HD) is a neurodegenerative disorder characterised by motor, behavioral and cognitive dysfunctions. Because an impairment in frontal and executive functions has been described in HD, we hypothesised that HD patients may have a CFT impairment. Methods Tests of spontaneous counterfactual thoughts and counterfactual-derived inferences were administered to 24 symptomatic HD patients and 24 age- and sex-matched healthy subjects. Results Our results show a significant impairment in the spontaneous generation of CFT and low performance on the Counterfactual Inference Test (CIT) in HD patients. Low performance on the spontaneous CFT test significantly correlates with impaired attention abilities, verbal fluency and frontal lobe efficiency, as measured by Trail Making Test - Part A, Phonemic Verbal Fluency Test and FAB. Conclusions Spontaneous CFT and the use of this type of reasoning are impaired in HD patients. This deficit may be related to frontal lobe dysfunction, which is a hallmark of HD. Because CFT has a pervasive role in patients' daily lives regarding their planning, decision making and problem solving skills, cognitive rehabilitation may improve HD patients' ability to analyse current behaviors and future actions.	[Solca, Federica; Poletti, Barbara; Sassone, Francesca; Lafronza, Annalisa; Maraschi, Anna Maria; Sassone, Jenny; Silani, Vincenzo; Ciammola, Andrea] IRCCS Ist Auxol Italiano, Dept Neurol & Lab Neurosci, Milan, Italy; [Zago, Stefano] Univ Milan, Dept Neurosci & Mental Hlth, IRCCS Fdn Ca Granda Osped Maggiore Policlin, Milan, Italy; [Crespi, Chiara] Univ Vita Salute San Raffaele, Milan, Italy; [Crespi, Chiara] Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy; [Silani, Vincenzo] Univ Milan, Dept Pathophysiol & Transplantat, Dino Ferrari Ctr, Milan, Italy	IRCCS Istituto Auxologico Italiano; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan	Poletti, B (corresponding author), IRCCS Ist Auxol Italiano, Dept Neurol & Lab Neurosci, Milan, Italy.	b.poletti@auxologico.it	Crespi, Chiara/M-9039-2019; Silani, Vincenzo/P-4421-2017; Zago, Stefano/I-5838-2015; Zago, Stefano/AAW-8595-2021; Crespi, Chiara/K-6484-2016; Poletti, Barbara/W-6917-2019; Crespi, Chiara/H-5251-2018	Crespi, Chiara/0000-0002-7851-9887; Silani, Vincenzo/0000-0002-7698-3854; Zago, Stefano/0000-0001-6578-4385; Zago, Stefano/0000-0001-6578-4385; Crespi, Chiara/0000-0002-7851-9887; Poletti, Barbara/0000-0003-4398-2051; Crespi, Chiara/0000-0002-7851-9887; Maraschi, Anna Maria/0000-0002-0766-1384				Backman L, 1997, BRAIN, V120, P2207, DOI 10.1093/brain/120.12.2207; Barbarotto R, 1998, ITAL J NEUROL SCI, V19, P161, DOI 10.1007/BF00831566; Barbey AK, 2009, PHILOS T R SOC B, V364, P1291, DOI 10.1098/rstb.2008.0315; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beldarrain MG, 2005, COGNITIVE BRAIN RES, V24, P723, DOI 10.1016/j.cogbrainres.2005.03.013; Bruyn GW, 1968, HDB CLIN NEUROLOGY, V16, P298; Bullinger M, 1998, J CLIN EPIDEMIOL, V51, P913, DOI 10.1016/S0895-4356(98)00082-1; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; CAPRARA G.V., 1993, BFQ BIG 5 QUESTIONNA; Damasio A.R., 2005, DESCARTES ERROR EMOT; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Derogatis LR., 1983, SCL90 ADM SCORING PR; Dierks T, 1999, PSYCHIAT RES-NEUROIM, V90, P65; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galer S, 2015, BRAIN TOPOGR, V28, P95, DOI 10.1007/s10548-014-0367-5; Gomez-Beldarrain M, 2004, J COGNITIVE NEUROSCI, V16, P74, DOI 10.1162/089892904322755575; Hetts JJ, 2000, PSYCHOL MARKET, V17, P345, DOI 10.1002/(SICI)1520-6793(200004)17:4<345::AID-MAR5>3.0.CO;2-M; Hobbs NZ, 2010, J NEUROL NEUROSUR PS, V81, P756, DOI 10.1136/jnnp.2009.190702; Hooker C, 2000, PSYCHIATRY, V63, P326, DOI 10.1080/00332747.2000.11024925; Kahneman D., 1982, JUDGMENT UNCERTAINTY, DOI [10.1017/CBO9780511809477, DOI 10.1017/CBO9780511809477]; Kassubek J, 2004, J NEUROL NEUROSUR PS, V75, P213; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Knight Robert T., 1995, P1357; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; McNamara P, 2003, J NEUROL NEUROSUR PS, V74, P1065, DOI 10.1136/jnnp.74.8.1065; MONDINI S, 2003, ESAME NEUROPSICOLOGI; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P477; Rahm C, 2013, SCAND J PSYCHOL, V54, P66, DOI 10.1111/sjop.12023; Raven J. C., 1986, MANUAL RAVENS PROGR; Rey A, 1964, LEXAMEN CLINIQUE PSY; Roese NJ, 1997, PSYCHOL BULL, V121, P133, DOI 10.1037/0033-2909.121.1.133; Roese NJ, 1997, ADV EXP SOC PSYCHOL, V29, P1, DOI 10.1016/S0065-2601(08)60015-5; Roese NJ, 1997, SOC COGNITION, V15, P274, DOI 10.1521/soco.1997.15.4.274; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; ROTTER JB, 1966, PSYCHOL MONOGR, V80, P1, DOI 10.1037/h0092976; Smith A., 1982, SYMBOL DIGIT MODALIT; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Squitieri F, 2009, CNS NEUROSCI THER, V15, P1, DOI 10.1111/j.1755-5949.2008.00068.x; van Duijn E, 2014, NEURODEGENER DIS, V13, P9, DOI 10.1159/000343210; Van Hoeck N, 2013, SOC COGN AFFECT NEUR, V8, P556, DOI 10.1093/scan/nss031; White RF, 1992, CLIN SYNDROMES ADULT, P213; Zago S, 2014, BEHAV NEUROL, V2014, DOI 10.1155/2014/256089	44	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0126773	10.1371/journal.pone.0126773	http://dx.doi.org/10.1371/journal.pone.0126773			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070155	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000003
J	Malyavantham, K; Weinstock-Guttman, B; Suresh, L; Zivadinov, R; Shanahan, T; Badgett, D; Ramanathan, M				Malyavantham, Kishore; Weinstock-Guttman, Bianca; Suresh, Lakshmanan; Zivadinov, Robert; Shanahan, Thomas; Badgett, Darlene; Ramanathan, Murali			Humoral Responses to Diverse Autoimmune Disease-Associated Antigens in Multiple Sclerosis	PLOS ONE			English	Article							POTASSIUM CHANNEL; ANTIBODIES; AUTOANTIBODIES; KIR4.1; RISK; DISABILITY; COMORBIDITY; DISCOVERY; DIAGNOSIS; RELATIVES	To compare frequencies of autoreactive antibody responses to endogenous disease-associated antigens in healthy controls (HC), relapsing and progressive MS and to assess their associations with clinical and MRI measures of MS disease progression. Methods The study analyzed 969 serum samples from 315 HC, 411 relapsing remitting MS (RR-MS), 128 secondary progressive MS (SP-MS), 33 primary progressive MS (PP-MS) and 82 patients with other neurological diseases for autoantibodies against two putative MS antigens CSF114(Glc) and KIR4.1a and KIR4.1b and against 24 key endogenous antigens linked to diseases such as vasculitis, systemic sclerosis, rheumatoid arthritis, Sjogren's syndrome, systemic lupus erythematosus, polymyositis, scleroderma, polymyositis, dermatomyositis, mixed connective tissue disease and primary biliary cirrhosis. Associations with disability and MRI measures of lesional injury and neurodegeneration were assessed. Results The frequencies of anti-KIR4.1a and anti-KIR4.1b peptide IgG positivity were 9.8% and 11.4% in HC compared to 4.9% and 7.5% in RR-MS, 8.6% for both peptides in SP-MS and 6.1% for both peptides in PP-MS (p = 0.13 for KIR4.1a and p = 0.34 for KIR4.1b), respectively. Antibodies against CSF114(Glc), KIR4.1a and KIR4.1b peptides were not associated with MS compared to HC, or with MS disease progression. HLA DRB1*15:01 positivity and anti-Epstein Barr virus antibodies, which are MS risk factors, were not associated with these putative MS antibodies. Conclusions Antibody responses to KIR4.1a and KIR4.1b peptides are not increased in MS compared to HC nor associated with MS disease progression. The frequencies of the diverse autoreactive antibodies investigated are similar in MS and HC.	[Malyavantham, Kishore; Suresh, Lakshmanan; Shanahan, Thomas] Immco Diagnost, Buffalo, NY USA; [Weinstock-Guttman, Bianca; Ramanathan, Murali] SUNY Buffalo, Dept Neurol, Buffalo, NY 14260 USA; [Zivadinov, Robert] SUNY Buffalo, Dept Neurol, Buffalo Neuroimaging Anal Ctr, Buffalo, NY 14260 USA; [Zivadinov, Robert; Badgett, Darlene; Ramanathan, Murali] SUNY Buffalo, Dept Pharmaceut Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Ramanathan, M (corresponding author), SUNY Buffalo, Dept Neurol, Buffalo, NY 14260 USA.	Murali@Buffalo.Edu	Weinstock-Guttman, Bianca/AAI-4694-2021; Zivadinov, Robert/Q-2054-2019	Weinstock-Guttman, Bianca/0000-0001-6732-151X; Zivadinov, Robert/0000-0002-7799-1485	National Multiple Sclerosis Society [RG4836-A-5]; Immco Diagnostics	National Multiple Sclerosis Society(National Multiple Sclerosis Society); Immco Diagnostics	Support for this study came from the National Multiple Sclerosis Society (RG4836-A-5). Immco Diagnostics provided support in the form of salaries for authors (TS, KM, LS). The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Awad A, 2010, DRUG AGING, V27, P283, DOI 10.2165/11532120-000000000-00000; Barcellos LF, 2006, LANCET NEUROL, V5, P924, DOI 10.1016/S1474-4422(06)70552-X; Beltran E, 2014, BRAIN, V137, P2703, DOI 10.1093/brain/awu205; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brickshawana A, 2014, LANCET NEUROL, V13, P795, DOI 10.1016/S1474-4422(14)70141-3; Brill L, 2015, MULT SCLER J, V21, P572, DOI 10.1177/1352458514551779; Eaton WW, 2010, IMMUNOL RES, V47, P228, DOI 10.1007/s12026-009-8153-2; Filippi M, 2014, LANCET NEUROL, V13, P753, DOI 10.1016/S1474-4422(14)70149-8; Ganapathy V, 2004, ARTHRITIS RHEUM-US, V50, P684, DOI 10.1002/art.20095; Hedstrom AK, 2014, MULT SCLER J, V20, P445, DOI 10.1177/1352458513498635; Hemmer B, 2015, MULT SCLER J, V21, P537, DOI 10.1177/1352458514564493; Hemminki K, 2009, NEUROGENETICS, V10, P5, DOI 10.1007/s10048-008-0156-y; Holmoy T, 2009, EUR NEUROL, V62, P311, DOI 10.1159/000235944; Horakova D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053996; Kraus V, 2014, NEUROLOGY, V82, P470, DOI 10.1212/WNL.0000000000000097; Langer-Gould A, 2010, MULT SCLER J, V16, P855, DOI 10.1177/1352458510369146; Lolli F, 2005, J NEUROIMMUNOL, V167, P131, DOI 10.1016/j.jneuroim.2005.05.016; Lolli F, 2005, P NATL ACAD SCI USA, V102, P10273, DOI 10.1073/pnas.0503178102; Mahler M, 2010, LUPUS, V19, P1527, DOI 10.1177/0961203310375265; Marrie RA, 2010, NEUROLOGY, V74, P1041, DOI 10.1212/WNL.0b013e3181d6b125; Marrie RA, 2009, NEUROLOGY, V72, P117, DOI 10.1212/01.wnl.0000333252.78173.5f; Mattalia A, 1998, HEPATOLOGY, V27, P656, DOI 10.1002/hep.510270303; Nerrant E, 2014, MULT SCLER J, V20, P1699, DOI 10.1177/1352458514531086; Nielsen NM, 2008, MULT SCLER J, V14, P823, DOI 10.1177/1352458508088936; Nielsen NM, 2006, ARCH NEUROL-CHICAGO, V63, P1001, DOI 10.1001/archneur.63.7.1001; Ochs RL, 2000, J ALLERGY CLIN IMMUN, V105, P1211, DOI 10.1067/mai.2000.107039; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Ramagopolan SV, 2007, LANCET NEUROL, V6, P604, DOI 10.1016/S1474-4422(07)70132-1; Roshanisefat H, 2012, MULT SCLER J, V18, P1430, DOI 10.1177/1352458512438240; Schirmer L, 2014, ANN NEUROL, V75, P810, DOI 10.1002/ana.24168; Sena A, 2010, J NEUROL, V257, P1703, DOI 10.1007/s00415-010-5606-4; SHMERLING RH, 1991, AM J MED, V91, P528, DOI 10.1016/0002-9343(91)90190-9; Solomon A, 2013, NY TIMES BK REV, P8; Srivastava R, 2014, J NEUROIMMUNOL, V275, P25, DOI 10.1016/j.jneuroim.2014.08.068; Srivastava R, 2012, NEW ENGL J MED, V367, P115, DOI 10.1056/NEJMoa1110740; Swets BP, 2001, CLIN EXP IMMUNOL, V124, P163, DOI 10.1046/j.1365-2249.2001.01488.x; Szmyrka-Kaczmarek M, 2012, LUPUS, V21, P412, DOI 10.1177/0961203311427550; Uribe L, 2013, CLIN RHEUMATOL, V32, P715, DOI 10.1007/s10067-013-2207-5; Weber MS, 2011, BBA-MOL BASIS DIS, V1812, P239, DOI 10.1016/j.bbadis.2010.06.009; Weinstock-Guttman B, 2013, J NEUROL NEUROSUR PS, V84, P1186, DOI 10.1136/jnnp-2012-304740; Weinstock-Guttman B, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-127; Wingerchuk DM, 2014, HAND CLINIC, V122, P581, DOI 10.1016/B978-0-444-52001-2.00025-X; Wu JT, 1997, CLIN LAB MED, V17, P595; Zivadinov R, 2009, J NEUROL NEUROSUR PS, V80, P620, DOI 10.1136/jnnp.2008.154906; Zivadinov R, 2014, J NEUROIMMUNOL, V273, P58, DOI 10.1016/j.jneuroim.2014.04.012; Zivadinov R, 2009, J NEUROIMMUNOL, V209, P123, DOI 10.1016/j.jneuroim.2009.01.023	46	7	7	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129503	10.1371/journal.pone.0129503	http://dx.doi.org/10.1371/journal.pone.0129503			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26065913	Green Submitted, Green Published, gold			2022-12-26	WOS:000356100900057
J	Thiyagarajan, D; Rekvig, OP; Seredkina, N				Thiyagarajan, Dhivya; Rekvig, Ole Petter; Seredkina, Natalya			TNF alpha Amplifies DNaseI Expression in Renal Tubular Cells while IL-1 beta Promotes Nuclear DNaseI Translocation in an Endonuclease-Inactive Form	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; EPITHELIAL-CELLS; ANTI-DSDNA; TRANSCRIPTIONAL INTERFERENCE; NEPHRITOGENIC ANTIBODIES; DEOXYRIBONUCLEASE-I; GLOMERULAR BINDING; MESANGIAL CELLS; NEPHRITIS; APOPTOSIS	We have demonstrated that the renal endonuclease DNaseI is up-regulated in mesangial nephritis while down-regulated during progression of the disease. To determine the basis for these reciprocal DNaseI expression profiles we analyse processes accounting for an early increase in renal DNaseI expression. Main hypotheses were that i. the mesangial inflammation and secreted pro-inflammatory cytokines directly increase DNaseI protein expression in tubular cells, ii. the anti-apoptotic protein tumor necrosis factor receptor-associated protein 1 (Trap 1) is down-regulated by increased expression of DNaseI due to transcriptional interference, and iii. pro-inflammatory cytokines promote nuclear translocation of a variant of DNaseI. The latter hypothesis emerges from the fact that anti-DNaseI antibodies stained tubular cell nuclei in murine and human lupus nephritis. The present study was performed on human tubular epithelial cells stimulated with pro-inflammatory cytokines. Expression of the DNaseI and Trap 1 genes was determined by qPCR, confocal microscopy, gel zymography, western blot and by immune electron microscopy. Results from in vitro cell culture experiments were analysed for biological relevance in kidneys from (NZBxNZW) F1 mice and human patients with lupus nephritis. Central data indicate that stimulating the tubular cells with TNF alpha promoted increased DNaseI and reduced Trap 1 expression, while TNF alpha and IL-1 beta stimulation induced nuclear translocation of the DNaseI. TNF alpha-stimulation resulted in 3 distinct effects; increased DNaseI and IL-1 beta gene expression, and nuclear translocation of DNaseI. IL-1 beta-stimulation solely induced nuclear DNaseI translocation. Tubular cells stimulated with TNF alpha and simultaneously transfected with IL-1 beta siRNA resulted in increased DNaseI expression but no nuclear translocation. This demonstrates that IL-1 beta promotes nuclear translocation of a cytoplasmic variant of DNaseI since translocation clearly was not dependent on DNaseI gene activation. Nuclear translocated DNaseI is shown to be enzymatically inactive, which may point at a new, yet unknown function of renal DNaseI.	[Thiyagarajan, Dhivya; Rekvig, Ole Petter; Seredkina, Natalya] UiT Arctic Univ Norway, Dept Med Biol, RNA & Mol Pathol Res Grp, Fac Hlth Sci, Tromso, Norway; [Rekvig, Ole Petter] Univ Hosp North Norway, Dept Radiol, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway	Seredkina, N (corresponding author), UiT Arctic Univ Norway, Dept Med Biol, RNA & Mol Pathol Res Grp, Fac Hlth Sci, Tromso, Norway.	natalya.seredkina@uit.no	Rekvig, Ole Petter/V-7113-2019		Northern Norway Regional Health Authority Medical Research Program; University of Tromso as Milieu	Northern Norway Regional Health Authority Medical Research Program; University of Tromso as Milieu	This study was supported by grants from Northern Norway Regional Health Authority Medical Research Program, and from University of Tromso as Milieu support given to OPR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT F, 1991, KIDNEY INT, V40, P597, DOI 10.1038/ki.1991.250; Alba P, 2003, ANN RHEUM DIS, V62, P556, DOI 10.1136/ard.62.6.556; Balow JE, 1999, SYSTEMIC LUPUS ERYTH, P657; Basnakian AG, 2005, J AM SOC NEPHROL, V16, P697, DOI 10.1681/ASN.2004060494; Berden JHM, 1999, CURR OPIN NEPHROL HY, V8, P299, DOI 10.1097/00041552-199905000-00005; Berden JHM, 1997, KIDNEY INT, V52, P538, DOI 10.1038/ki.1997.365; Berden JHM, 2002, J NEPHROL, V15, pS1; Berden JHM, 2003, NETH J MED, V61, P233; Chen B, 2005, GENOMICS, V86, P627, DOI 10.1016/j.ygeno.2005.08.012; Cohen M, 2006, MOL HUM REPROD, V12, P225, DOI 10.1093/molehr/gal023; Costantino E, 2009, CANCER LETT, V279, P39, DOI 10.1016/j.canlet.2009.01.018; Dodd IB, 2007, J MOL BIOL, V369, P1200, DOI 10.1016/j.jmb.2007.04.041; Felts SJ, 2000, J BIOL CHEM, V275, P3305, DOI 10.1074/jbc.275.5.3305; Fenton K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008474; Fismen S, 2013, AM J PATHOL, V182, P688, DOI 10.1016/j.ajpath.2012.11.013; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gao JY, 2012, WORLD J GASTROENTERO, V18, P5965, DOI 10.3748/wjg.v18.i41.5965; Gesualdi NM, 2007, STRESS, V10, P342, DOI 10.1080/10253890701314863; Hahn BH, 1998, NEW ENGL J MED, V338, P1359, DOI 10.1056/NEJM199805073381906; He KL, 2002, MOL CELL BIOL, V22, P6034, DOI 10.1128/MCB.22.17.6034-6045.2002; Hobson DJ, 2012, MOL CELL, V48, P365, DOI 10.1016/j.molcel.2012.08.027; Hua GQ, 2007, J BIOL CHEM, V282, P20553, DOI 10.1074/jbc.M703196200; Kalaaji M, 2007, KIDNEY INT, V71, P664, DOI 10.1038/sj.ki.5002133; Kalaaji M, 2006, AM J PATHOL, V168, P1779, DOI 10.2353/ajpath.2006.051329; Kawane K, 2008, METHOD ENZYMOL, V442, P271, DOI 10.1016/S0076-6879(08)01414-6; Kunter U, 2005, KIDNEY INT, V68, P1520, DOI 10.1111/j.1523-1755.2005.00564.x; La Flamme AC, 2000, J IMMUNOL, V164, P2419, DOI 10.4049/jimmunol.164.5.2419; Leav I, 2010, AM J PATHOL, V176, P393, DOI 10.2353/ajpath.2010.090521; Leonard M, 1999, KIDNEY INT, V56, P1366, DOI 10.1046/j.1523-1755.1999.00664.x; Liu DX, 2010, CANCER LETT, V296, P194, DOI 10.1016/j.canlet.2010.04.017; Machuca C, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-9; Masuda Y, 2004, J BIOL CHEM, V279, P42503, DOI 10.1074/jbc.M404256200; Matassa DS, 2012, AM J CANCER RES, V2, P235; MCCARTY M, 1946, J GEN PHYSIOL, V29, P123, DOI 10.1085/jgp.29.3.123; Mjelle JE, 2007, ANN RHEUM DIS, V66, P1661, DOI 10.1136/ard.2007.070482; Moos V, 2001, CLIN RHEUMATOL, V20, P353, DOI 10.1007/s100670170025; Nephritis L, 2008, AM J PATHOL, V172, P275, DOI 10.2353/ajpath.2008.070563; Mortensen ES, 2009, J AM SOC NEPHROL, V20, P696, DOI 10.1681/ASN.2008010112; Nee L, 2007, NEPHRON EXP NEPHROL, V107, pE73, DOI 10.1159/000108645; PEITSCH MC, 1993, EMBO J, V12, P371, DOI 10.1002/j.1460-2075.1993.tb05666.x; Raju R, 2003, J NEUROIMMUNOL, V141, P125, DOI 10.1016/S0165-5728(03)00218-2; Rauch F, 1997, J CELL BIOL, V137, P909, DOI 10.1083/jcb.137.4.909; Samejima K, 2005, NAT REV MOL CELL BIO, V6, P677, DOI 10.1038/nrm1715; Schlatter R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018646; Seredkina N, 2013, MOL MED, V19, P161, DOI 10.2119/molmed.2013.00010; Seredkina N, 2009, AM J PATHOL, V175, P97, DOI 10.2353/ajpath.2009.080943; Seredkina S, 2011, AM J PATHOL; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Svejstrup JQ, 2013, BBA-GENE REGUL MECH, V1829, P1, DOI 10.1016/j.bbagrm.2012.12.008; Turner NA, 2007, CARDIOVASC RES, V76, P81, DOI 10.1016/j.cardiores.2007.06.003; Van Bavel CC, 2007, KIDNEY INT, V71, P600, DOI 10.1038/sj.ki.5002126; van Bavel CC, 2008, ARTHRITIS RHEUM, V58, P1892, DOI 10.1002/art.23626; VanBruggen MCJ, 1996, ANN MED INTERNE, V147, P485; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Zucchi I, 2004, P NATL ACAD SCI USA, V101, P18147, DOI 10.1073/pnas.0408260101; Zykova SN, 2008, ARTHRITIS RHEUM-US, V58, P813, DOI 10.1002/art.23276; Zykova SN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012096	58	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129485	10.1371/journal.pone.0129485	http://dx.doi.org/10.1371/journal.pone.0129485			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26065428	Green Published, gold, Green Submitted			2022-12-26	WOS:000356100900056
J	Zhou, AB; Jiang, YF; Chen, JM; Wei, JL; Dang, BB; Li, SF; Xu, QY				Zhou, Aibao; Jiang, Yanfei; Chen, Jianming; Wei, Jianlan; Dang, Baobao; Li, Shifeng; Xu, Qiongying			Neural Mechanisms of Selective Attention in Children with Amblyopia	PLOS ONE			English	Article							TOP-DOWN MODULATION; CONFLICT ADAPTATION; STROOP INTERFERENCE; RESPONSE CONFLICT; STIMULUS-STIMULUS; POTENTIAL N270; INHIBITION; CORTEX; ADULTS; TIME	Previous studies have indicated that amblyopia might affect children's attention. We recruited amblyopic children and normal children aged 9-11 years as study subjects and compared selective attention between the two groups of children. Chinese characters denoting colors were used in the Stroop task, and the event-related potential (ERP) was analyzed. The results show that the accuracy of both groups in the congruent condition was higher than the incongruent condition, and the reaction time (RT) of amblyopic children was longer. The latency of the occipital P1 in the incongruent condition was shorter than the neutral condition for both groups; the peak of the occipital P1 elicited by the incongruent stimuli in amblyopic children was higher. In both groups, the N1 peak was higher in the occipital region than frontal and central regions. The N1 latency of normal children was shorter in the congruent and neutral conditions and longer in the incongruent condition; the N1 peak of normal children was higher. The N270 latencies of normal children in the congruent and neutral conditions were shorter; the N270 peak was higher in parietal and occipital regions than frontal and central regions for both groups. The N450 latency of normal children was shorter; in both groups, the N450 average amplitude was significantly higher in the parietal region than central and frontal regions. The accuracy was the same for both groups, but the response of amblyopic children was significantly slower. The two groups showed differences in both stages of the Stroop task. Normal children showed advantages in processing speed on both stimulus and response conflict stages. Brain regions activated during the Stroop task were consistent between groups, in line with their age characteristics.	[Zhou, Aibao; Jiang, Yanfei; Dang, Baobao; Xu, Qiongying] Northwest Normal Univ, Sch Psychol, Lanzhou, Gansu, Peoples R China; [Chen, Jianming; Wei, Jianlan] Rehabil Hosp Ctr Gansu, Lanzhou, Gansu, Peoples R China; [Li, Shifeng] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	Northwest Normal University - China; Beijing Normal University	Jiang, YF (corresponding author), Northwest Normal Univ, Sch Psychol, Lanzhou, Gansu, Peoples R China.	jiangyanfei_2006@126.com; ersi@163.com	Li, Shifeng/AAH-3055-2021		National Natural Science Foundation of Gansu province [1010RJZA166]	National Natural Science Foundation of Gansu province	This work was supported by The National Natural Science Foundation of Gansu province (1010RJZA166).	Adleman NE, 2002, NEUROIMAGE, V16, P61, DOI 10.1006/nimg.2001.1046; Akshoomoff N, 2002, DEV NEUROPSYCHOL, V22, P625, DOI 10.1207/S15326942DN2203_4; Akyurek EG, 2013, BIOL PSYCHOL, V93, P269, DOI 10.1016/j.biopsycho.2013.02.009; Bonhomme GR, 2006, J AAPOS, V10, P540, DOI 10.1016/j.jaapos.2006.07.008; Branch of Chinese Medical Association Ophthalmology Pediatric Ophthalmology and Strabismus group, 2011, CHINESE J OPHTHALMOL, V8, P768; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Brodeur DA, 2004, COGNITIVE DEV, V19, P241, DOI 10.1016/j.cogdev.2004.01.002; Brown M, 2001, MEM COGNITION, V29, P903, DOI 10.3758/BF03196419; Brown TL, 2002, J EXP PSYCHOL GEN, V131, P220, DOI 10.1037//0096-3445.131.2.220; Chen AT, 2011, INT J PSYCHOPHYSIOL, V80, P129, DOI 10.1016/j.ijpsycho.2011.02.012; Clark V.P., 1994, HUMAN BRAIN MAPPING, V2, P170, DOI [10.1002/hbm.460020306, DOI 10.1002/HBM.460020306]; Clayson PE, 2011, NEUROPSYCHOLOGIA, V49, P1953, DOI 10.1016/j.neuropsychologia.2011.03.023; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; COHEN JD, 1992, AM J PSYCHOL, V105, P239, DOI 10.2307/1423029; De Houwer J, 2003, MEM COGNITION, V31, P353, DOI 10.3758/BF03194393; [杜寒剑 DU Hanjian], 2008, [中国医学影像技术, Chinese Journal of Medical Imaging Technology], V24, P201; Esposito AG, 2013, COGNITIVE DEV, V28, P354, DOI 10.1016/j.cogdev.2013.09.002; Gazzaley A, 2012, TRENDS COGN SCI, V16, P129, DOI 10.1016/j.tics.2011.11.014; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Hanslmayr S, 2008, J COGNITIVE NEUROSCI, V20, P215, DOI 10.1162/jocn.2008.20020; Hess Robert F, 2001, Clin Exp Optom, V84, P321; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; Hopf JM, 2002, J NEUROPHYSIOL, V88, P2088, DOI 10.1152/jn.2002.88.4.2088; Hsieh YH, 2008, KAOHSIUNG J MED SCI, V24, P197, DOI 10.1016/S1607-551X(08)70117-7; Ibanez A, 2012, SOC NEUROSCI-UK, V7, P632, DOI 10.1080/17470919.2012.691078; Killikelly C, 2013, CORTEX, V49, P2888, DOI 10.1016/j.cortex.2013.08.017; Lange K, 2014, BRAIN COGNITION, V84, P153, DOI 10.1016/j.bandc.2013.12.001; Larson MJ, 2009, NEUROPSYCHOLOGIA, V47, P663, DOI 10.1016/j.neuropsychologia.2008.11.013; Lee JK, 2014, J BEHAV THER EXP PSY, V45, P208, DOI 10.1016/j.jbtep.2013.10.008; Levi DM, 2011, VISION RES, V51, P48, DOI 10.1016/j.visres.2010.09.029; Li FM, 2005, CHINESE OPHTHALOMOLO; Li HR, 2013, CHINESE J STRABISMUS, V03, P38; Li LP, 2003, BRAIN DEV-JPN, V25, P507, DOI 10.1016/S0387-7604(03)00059-7; Lin B, 2012, CHINESE J OPHTHALMOL, V12, P263; Liu HC, 2007, PSYCHOL SCI, V2, P365; Liu HY, 2010, PSYCHOL RES, V5, P42; LIU Z, 2007, PSYCHOL EXPLOR, V27, P48; LOGAN GD, 1980, COGNITIVE PSYCHOL, V12, P523, DOI 10.1016/0010-0285(80)90019-5; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; MacLeod CM, 1998, MEM COGNITION, V26, P201, DOI 10.3758/BF03201133; Mao W, 2008, INT J PSYCHOPHYSIOL, V67, P47, DOI 10.1016/j.ijpsycho.2007.10.003; [毛薇 Mao Wei], 2011, [中国心理卫生杂志, Chinese Mental Health Journal], V25, P150; Melara RD, 2003, PSYCHOL REV, V110, P422, DOI 10.1037/0033-295X.110.3.422; Melcher T, 2009, CORTEX, V45, P189, DOI 10.1016/j.cortex.2007.06.004; Mendola JD, 2005, HUM BRAIN MAPP, V25, P222, DOI 10.1002/hbm.20109; Merikle PM, 1997, CONSCIOUS COGN, V6, P219, DOI 10.1006/ccog.1997.0310; Nixon E, 2013, INT J PSYCHOPHYSIOL, V87, P313, DOI 10.1016/j.ijpsycho.2012.11.014; PENG DL, 2004, SCI TECH ENG, V4, P84; Protopapas A, 2014, ACTA PSYCHOL, V148, P204, DOI 10.1016/j.actpsy.2014.02.006; Qi L, 2013, INT J OPHTHALMOLOGY, V09, P1931; Schmidt JR, 2005, CAN J EXP PSYCHOL, V59, P132, DOI 10.1037/h0087468; Soltesz F, 2011, LEARN INDIVID DIFFER, V21, P662, DOI 10.1016/j.lindif.2010.10.004; Sternberg RJ, 2006, COGNITIVE PSYCHOL; Szucs D, 2010, BRAIN RES, V1325, P63, DOI 10.1016/j.brainres.2010.02.011; Taylor MJ, 2000, INT J PSYCHOPHYSIOL, V37, P135, DOI 10.1016/S0167-8760(00)00084-2; [王海燕 Wang Haiyan], 2003, [中国心理卫生杂志, Chinese Mental Health Journal], V17, P273; Wang K, 2010, NEUROSCIENCE, V165, P101, DOI 10.1016/j.neuroscience.2009.09.070; Wang YP, 2000, NEUROSCI LETT, V293, P17, DOI 10.1016/S0304-3940(00)01480-4; Wang YP, 2002, NEUROSCI LETT, V332, P25, DOI 10.1016/S0304-3940(02)00906-0; Wei RJ, 2013, INT EYE SCI, V7, P1432, DOI [10.1016/j.ophtha.2012.12.040, DOI 10.1016/J.OPHTHA.2012.12.040]; West R, 1999, COGNITIVE BRAIN RES, V8, P157, DOI 10.1016/S0926-6410(99)00017-8; West R, 2004, PSYCHOPHYSIOLOGY, V41, P739, DOI 10.1111/j.1469-8986.2004.00205.x; Yan H, 2008, AMBLYOPIA; Yang L, 2013, RECENT ADV OPHTHALMO, V5, P443; Yang L, 2012, RECENTADVANCES OPHTH, V09, P893; Yasumura A, 2014, BRAIN DEV-JPN, V36, P97, DOI 10.1016/j.braindev.2013.01.005; Zang L, 2009, J JILIN I PHYSICALED, V5, P92; Zhao BY, 2012, INT EYE SCI, V12, P2302; Zhao L, 2010, ERPS EXPT COURSE; [朱晓明 Zhu Xiaoming], 2004, [眼视光学杂志, Chinese Journal of Optometry & Ophthalmology], V6, P261	70	3	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0125370	10.1371/journal.pone.0125370	http://dx.doi.org/10.1371/journal.pone.0125370			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067259	Green Published, Green Submitted, gold			2022-12-26	WOS:000356100900006
J	Han, W; Zou, JM; Wang, KH; Su, YJ; Zhu, YF; Song, C; Li, GH; Qu, L; Zhang, HY; Liu, HL				Han, Wei; Zou, Jianmin; Wang, Kehua; Su, Yijun; Zhu, Yunfen; Song, Chi; Li, Guohui; Qu, Liang; Zhang, Huiyong; Liu, Honglin			High-Throughput Sequencing Reveals Hypothalamic MicroRNAs as Novel Partners Involved in Timing the Rapid Development of Chicken (Gallus gallus) Gonads	PLOS ONE			English	Article							REPRODUCTIVE-PERFORMANCE; LUTEINIZING-HORMONE; GROWTH-HORMONE; PUBERTY; EXPRESSION; LEPTIN; SECRETION; PATTERNS; GENE; RATS	Onset of the rapid gonad growth is a milestone in sexual development that comprises many genes and regulatory factors. The observations in model organisms and mammals including humans have shown a potential link between miRNAs and development timing. To determine whether miRNAs play roles in this process in the chicken (Gallus gallus), the Solexa deep sequencing was performed to analyze the profiles of miRNA expression in the hypothalamus of hens from two different pubertal stages, before onset of the rapid gonad development (BO) and after onset of the rapid gonad development (AO). 374 conserved and 46 novel miRNAs were identified as hypothalamus-expressed miRNAs in the chicken. 144 conserved miRNAs were showed to be differentially expressed (reads > 10, P < 0.05) during the transition from BO to AO. Five differentially expressed miRNAs were validated by realtime quantitative RT-PCR (qRT-PCR) method. 2013 putative genes were predicted as the targets of the 15 most differentially expressed miRNAs (fold-change > 4.0, P < 0.01). Of these genes, 7 putative circadian clock genes, Per2, Bmal1/2, Clock, Cry1/2, and Star were found to be targeted multiple times by the miRNAs. qRT-PCR revealed the basic transcription levels of these clock genes were much higher (P < 0.01) in AO than in BO. Further functional analysis suggested that these 15 miRNAs play important roles in transcriptional regulation and signal transduction pathways. The results provide new insights into miRNAs functions in timing the rapid development of chicken gonads. Considering the characteristics of miRNA functional conservation, the results will contribute to the research on puberty onset in humans.	[Han, Wei; Liu, Honglin] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Han, Wei; Zou, Jianmin; Wang, Kehua; Su, Yijun; Zhu, Yunfen; Song, Chi; Li, Guohui; Qu, Liang; Zhang, Huiyong] Chinese Acad Agr Sci, Poultry Inst, Natl Chickens Genet Resources, Yangzhou, Jiangsu, Peoples R China	Nanjing Agricultural University; Chinese Academy of Agricultural Sciences	Liu, HL (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	liuhonglin@njau.edu.cn	liu, honglin/HDN-0409-2022	liu, honglin/0000-0002-1254-3163	National Natural Science Foundation of China [31201799]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/), grant number 31201799, received by HW. The funders play complete role in in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Amar L, 2012, J NEUROSCI METH, V209, P134, DOI 10.1016/j.jneumeth.2012.05.033; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Benoit C, 2013, J ENDOCRINOL, V218, P35, DOI 10.1530/JOE-12-0561; Boden MJ., 2004, REPROD FERT DEVELOP, V16, P280; Boden MJ., 2005, REPROD FERT DEVELOP, V17, P126, DOI [10.1071/SRB05Abs297, DOI 10.1071/SRB05ABS297]; Boulan L, 2013, CURR BIOL, V23, P473, DOI 10.1016/j.cub.2013.01.072; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Cheryl LS, 2004, NAT NEUROSCI, V7, P1014; Choi JW, 2013, J NEUROCHEM, V126, P331, DOI 10.1111/jnc.12308; Clarke IJ, 2011, FRONT NEUROENDOCRIN, V32, P367, DOI 10.1016/j.yfrne.2011.01.001; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Davis CJ, 2011, J APPL PHYSIOL, V111, P665, DOI 10.1152/japplphysiol.00517.2011; Dolatshad H, 2006, HUM REPROD, V21, P68, DOI 10.1093/humrep/dei313; Dorn L. D., 2006, APPL DEV SCI, V10, P30, DOI [10.1207/s1532480xads1001_3, DOI 10.1207/S1532480XADS1001_3]; Dorn LD, 2011, J RES ADOLESCENCE, V21, P180, DOI 10.1111/j.1532-7795.2010.00722.x; Dunn IC, 2003, REPRODUCTION, V126, P217, DOI 10.1530/reprod/126.2.217; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Fortes MRS, 2011, J ANIM SCI, V89, P1669, DOI 10.2527/jas.2010-3681; Garcia-Galiano D, 2010, J MOL ENDOCRINOL, V45, P281, DOI 10.1677/JME-10-0059; Hasuwa H, 2013, SCIENCE, V341, P71, DOI 10.1126/science.1237999; Hickok JR, 2010, NEUROENDOCRINOLOGY, V91, P110, DOI 10.1159/000243163; Inukai S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040028; Kang L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-352; Kasa-Vubu JZ, 2002, J CLIN ENDOCR METAB, V87, P1885, DOI 10.1210/jc.87.4.1885; Kemirembe K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044429; Kennaway DJ, 2004, REPROD FERT DEVELOP, V16, P801, DOI 10.1071/RD04023; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lomniczi A, 2013, HORM BEHAV, V64, P175, DOI 10.1016/j.yhbeh.2012.09.013; Meister B, 2013, NEUROENDOCRINOLOGY, V98, P243, DOI 10.1159/000355619; Miller BH, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2013.00195; Ojeda SR, 2010, BRAIN RES, V1364, P164, DOI 10.1016/j.brainres.2010.09.039; Olsen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007225; Onagbesan OM, 2006, POULTRY SCI, V85, P1245, DOI 10.1093/ps/85.7.1245; Ong KK, 2009, NAT GENET, V41, P729, DOI 10.1038/ng.382; Paczoska-Eliasiewicz HE, 2006, DOMEST ANIM ENDOCRIN, V31, P211, DOI 10.1016/j.domaniend.2005.10.005; Porcu E, 1997, FERTIL STERIL, V67, P842, DOI 10.1016/S0015-0282(97)81395-7; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Roa JA, 2010, TRENDS ENDOCRIN MET, V21, P519, DOI 10.1016/j.tem.2010.05.003; Roth CL, 2007, ENDOCRINOLOGY, V148, P5147, DOI 10.1210/en.2007-0634; Sangiao-Alvarellos S, 2013, ENDOCRINOLOGY, V154, P942, DOI 10.1210/en.2012-2006; Scheer FAJL, 2010, DIABETOLOGIA, V53, P2401, DOI 10.1007/s00125-010-1869-7; Sellix Michael T, 2013, Front Endocrinol (Lausanne), V4, P91, DOI 10.3389/fendo.2013.00091; Sellix MT, 2010, TRENDS ENDOCRIN MET, V21, P628, DOI 10.1016/j.tem.2010.06.002; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Shirtcliff EA, 2009, CHILD DEV, V80, P327, DOI 10.1111/j.1467-8624.2009.01263.x; Sokol NS, 2012, CURR OPIN GENET DEV, V22, P368, DOI 10.1016/j.gde.2012.04.001; Sun GR, 2012, GENET MOL RES, V11, P4682, DOI 10.4238/2012.October.2.2; Suter KJ, 2000, J CLIN ENDOCR METAB, V85, P808, DOI 10.1210/jc.85.2.808; Tena-Sempere M, 2007, NEUROENDOCRINOLOGY, V86, P229, DOI 10.1159/000108410; Tena-Sempere M, 2012, EUR J ENDOCRINOL, V167, P733, DOI 10.1530/EJE-12-0669; Tessmar-Raible K, 2007, CELL, V129, P1389, DOI 10.1016/j.cell.2007.04.041; Tolson Kristen P, 2012, Front Endocrinol (Lausanne), V3, P45, DOI 10.3389/fendo.2012.00045; Topaloglu AK, 2009, NAT GENET, V41, P354, DOI 10.1038/ng.306; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; WU FCW, 1991, J CLIN ENDOCR METAB, V72, P1229, DOI 10.1210/jcem-72-6-1229; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Wu JW, 2014, P NATL ACAD SCI USA, V111, pE2851, DOI 10.1073/pnas.1407777111; Yingling VR, 2006, BONE, V38, P67, DOI 10.1016/j.bone.2005.07.001; Zhou W, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-141; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	61	13	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129738	10.1371/journal.pone.0129738	http://dx.doi.org/10.1371/journal.pone.0129738			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061962	gold, Green Submitted, Green Published			2022-12-26	WOS:000355979500161
J	Szwarc, MM; Kommagani, R; Jacob, AP; Dougall, WC; Ittmann, MM; Lydon, JP				Szwarc, Maria M.; Kommagani, Ramakrishna; Jacob, Allison P.; Dougall, William C.; Ittmann, Michael M.; Lydon, John P.			Aberrant Activation of the RANK Signaling Receptor Induces Murine Salivary Gland Tumors	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; SQUAMOUS-CELL CARCINOMA; BREAST-CANCER CELLS; KAPPA-B LIGAND; MAMMARY-GLAND; BONE DESTRUCTION; STEM-CELLS; IN-VIVO; METASTASIS; EXPRESSION	Unlike cancers of related exocrine tissues such as the mammary and prostate gland, diagnosis and treatment of aggressive salivary gland malignancies have not markedly advanced in decades. Effective clinical management of malignant salivary gland cancers is undercut by our limited knowledge concerning the key molecular signals that underpin the etiopathogenesis of this rare and heterogeneous head and neck cancer. Without knowledge of the critical signals that drive salivary gland tumorigenesis, tumor vulnerabilities cannot be exploited that allow for targeted molecular therapies. This knowledge insufficiency is further exacerbated by a paucity of preclinical mouse models (as compared to other cancer fields) with which to both study salivary gland pathobiology and test novel intervention strategies. Using a mouse transgenic approach, we demonstrate that deregulation of the Receptor Activator of NFkB Ligand (RANKL)/RANK signaling axis results in rapid tumor development in all three major salivary glands. In line with its established role in other exocrine gland cancers (i.e., breast cancer), the RANKL/RANK signaling axis elicits an aggressive salivary gland tumor phenotype both at the histologic and molecular level. Despite the ability of this cytokine signaling axis to drive advanced stage disease within a short latency period, early blockade of RANKL/RANK signaling markedly attenuates the development of malignant salivary gland neoplasms. Together, our findings have uncovered a tumorigenic role for RANKL/RANK in the salivary gland and suggest that targeting this pathway may represent a novel therapeutic intervention approach in the prevention and/or treatment of this understudied head and neck cancer.	[Szwarc, Maria M.; Kommagani, Ramakrishna; Lydon, John P.] Baylor Coll Med, Dept Mol Cellular Biol, Houston, TX 77030 USA; [Jacob, Allison P.; Dougall, William C.] Amgen Inc, TIU, Seattle, WA USA; [Ittmann, Michael M.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Ittmann, Michael M.] Michael E DeBakey VAMC, Houston, TX USA	Baylor College of Medicine; Amgen; Baylor College of Medicine	Lydon, JP (corresponding author), Baylor Coll Med, Dept Mol Cellular Biol, One Baylor Plaza, Houston, TX 77030 USA.	jlydon@bcm.tmc.edu		Dougall, William/0000-0001-9487-251X; Kommagani, Ramakrishna/0000-0003-0403-0971	NIH/NCI [CA-077530, P30 CA-125123]; Amgen Inc.; NATIONAL CANCER INSTITUTE [P30CA125123, R01CA077530, R29CA077530] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Amgen Inc.(Amgen); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded from NIH/NCI grant CA-077530 to JPL and P30 CA-125123 to the Dan L. Duncan Cancer Center supporting Human Tissue Acquisition and Pathology Core. Amgen Inc. provided support in the form of salaries for authors APJ and WCD but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelstein DJ, 2012, SEMIN RADIAT ONCOL, V22, P245, DOI 10.1016/j.semradonc.2012.03.009; Armstrong AP, 2008, PROSTATE, V68, P92, DOI 10.1002/pros.20678; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Beleut M, 2010, P NATL ACAD SCI USA, V107, P2989, DOI 10.1073/pnas.0915148107; Blake ML, 2014, CLIN EXP METASTAS, V31, P233, DOI 10.1007/s10585-013-9624-3; Boukheris H, 2009, CANC EPIDEMIOL BIOMA, V18, P2899, DOI DOI 10.1158/1055-9965.EPI-09-0638; Buduneli N, 2008, J CLIN PERIODONTOL, V35, P846, DOI 10.1111/j.1600-051X.2008.01310.x; Casellas J, 2011, ANIMAL, V5, P1, DOI 10.1017/S1751731110001667; Casimiro S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063153; Eghbali-Fatourechi G, 2003, J CLIN INVEST, V111, P1221, DOI 10.1172/JCI200317215; Eveson J., 2005, PATHOLOGY GENETICS H, P209; Fernandez-Valdivia R, 2012, MOL CELL ENDOCRINOL, V357, P91, DOI 10.1016/j.mce.2011.09.030; Fernandez-Valdivia R, 2009, DEV BIOL, V328, P127, DOI 10.1016/j.ydbio.2009.01.019; Gillespie MB, 2012, CURR TREAT OPTION ON, V13, P58, DOI 10.1007/s11864-011-0174-0; Gonzalez-Suarez E, 2007, MOL CELL BIOL, V27, P1442, DOI 10.1128/MCB.01298-06; Gonzalez-Suarez E, 2011, CLIN TRANSL ONCOL, V13, P222, DOI 10.1007/s12094-011-0646-5; Gonzalez-Suarez E, 2010, NATURE, V468, P103, DOI 10.1038/nature09495; Graziano V, 2011, BBA-REV CANCER, V1816, P57, DOI 10.1016/j.bbcan.2011.04.002; Grimm M, 2015, ODONTOLOGY, V103, P36, DOI 10.1007/s10266-013-0133-2; Gunther EJ, 2002, FASEB J, V16, DOI 10.1096/fj.01-0551com; Holland PM, 2010, CANCER BIOL THER, V9, P539, DOI 10.4161/cbt.9.7.11266; Ismail PM, 2002, MOL ENDOCRINOL, V16, P2475, DOI 10.1210/me.2002-0169; Jimi E, 2011, ORAL DIS, V17, P462, DOI 10.1111/j.1601-0825.2010.01781.x; Jimi E, 2013, INT J ONCOL, V42, P803, DOI 10.3892/ijo.2013.1794; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Kokkinos MI, 2007, CELLS TISSUES ORGANS, V185, P191, DOI 10.1159/000101320; Kupas V, 2011, J INVEST DERMATOL, V131, P944, DOI 10.1038/jid.2010.377; Lacey DL, 2012, NAT REV DRUG DISCOV, V11, P401, DOI 10.1038/nrd3705; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lydon JP, 2010, NATURE, V465, P695, DOI 10.1038/465695a; Lynch CC, 2005, CANCER CELL, V7, P485, DOI 10.1016/j.ccr.2005.04.013; Mikami S, 2009, J PATHOL, V218, P530, DOI 10.1002/path.2567; Miller RE, 2014, J THORAC ONCOL, V9, P345, DOI 10.1097/JTO.0000000000000070; Mukherjee A, 2010, FASEB J, V24, P4408, DOI 10.1096/fj.10-157982; Nakamura ES, 2006, CLIN EXP METASTAS, V23, P9, DOI 10.1007/s10585-006-9006-1; Nekulova M, 2011, CELL MOL BIOL LETT, V16, P296, DOI 10.2478/s11658-011-0009-9; Odero-Marah VA, 2008, CELL RES, V18, P858, DOI 10.1038/cr.2008.84; Palafox M, 2012, CANCER RES, V72, P2879, DOI 10.1158/0008-5472.CAN-12-0044; Pasquale P, 2013, STEM CELLS, V31, P1954, DOI 10.1002/stem.1454; Pearse RN, 2001, P NATL ACAD SCI USA, V98, P11581, DOI 10.1073/pnas.201394498; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Quan JJ, 2012, PATHOLOGY, V44, P221, DOI 10.1097/PAT.0b013e3283513f3b; Romas E, 2002, BONE, V30, P340, DOI 10.1016/S8756-3282(01)00682-2; Sabbota AL, 2010, CANCER RES, V70, P5558, DOI 10.1158/0008-5472.CAN-09-4416; Sato K, 2013, AM J PATHOL, V182, P1890, DOI 10.1016/j.ajpath.2013.01.038; Schramek D, 2010, NATURE, V468, P98, DOI 10.1038/nature09387; Seifert G., 1991, WHO INT HISTOLOGICAL, Vsecond, P27; Shin M, 2011, CARCINOGENESIS, V32, P1634, DOI 10.1093/carcin/bgr198; Sigl V, 2014, CYTOKINE GROWTH F R, V25, P205, DOI 10.1016/j.cytogfr.2014.01.002; Smith A, 2013, ORAL ONCOL, V49, P287, DOI 10.1016/j.oraloncology.2012.10.009; Song FN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108507; Stevens JC, 2007, TRENDS MOL MED, V13, P512, DOI 10.1016/j.molmed.2007.10.001; Tada T, 2009, CANCER LETT, V274, P124, DOI 10.1016/j.canlet.2008.09.015; Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707; Tang ZN, 2011, ONCOL REP, V26, P1243, DOI 10.3892/or.2011.1368; Tobon-Arroyave SI, 2012, J CLIN PERIODONTOL, V39, P1132, DOI 10.1111/jcpe.12012; Tsubaki M, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-62; Walsh MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00511; Yamada T, 2011, AM J PATHOL, V178, P2845, DOI 10.1016/j.ajpath.2011.02.003; Zhang XY, 2013, ORAL ONCOL, V49, P119, DOI 10.1016/j.oraloncology.2012.08.004	62	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0128467	10.1371/journal.pone.0128467	http://dx.doi.org/10.1371/journal.pone.0128467			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061636	gold, Green Submitted, Green Published			2022-12-26	WOS:000355979500084
J	Wiel, C; Gras, B; Vindrieux, D; Warnier, M; Gitenay, D; Le Calve, B; Ferrand, M; Augert, A; Bernard, D				Wiel, C.; Gras, B.; Vindrieux, D.; Warnier, M.; Gitenay, D.; Le Calve, B.; Ferrand, M.; Augert, A.; Bernard, D.			Multidrug resistance protein 3 loss promotes tumor formation by inducing senescence escape	ONCOGENE			English	Article							ONCOGENE-INDUCED SENESCENCE; TRANSPORT; CANCER; SUPPRESSION; MRP3; MICE	Oncogenic-stress-induced senescence (OIS) is a stress response allowing normal cells, when receiving oncogenic signals, to stably arrest their proliferation. OIS thus acts to prevent aberrant cell proliferation and tumor formation. To identify novel tumor suppressive pathways, we have recently completed a loss-of-function genetic screen to identify novel genes promoting escape from OIS and thus, potentially, tumor formation when their functions are lost. Using this approach, we unexpectedly found that loss of function of the multidrug resistance protein 3 (MRP3 or ABCC3) promotes escape from OIS in human epithelial cells. Importantly, ABCC3 expression is reduced in human skin tumors, and ABCC3-knockout mice display increased sensitivity to RAS-induced skin carcinogenesis, concomitantly with decreased OIS. ABCC3 participates in resistance to chemotherapy via its transporter activity. Our data show that this transporter activity is involved in ABCC3-induced senescence, demonstrating that this protein has a complex role in cancer, since its loss of function may promote escape from OIS and tumor formation whereas its gain of function promotes resistance to chemotherapy.	[Wiel, C.; Gras, B.; Vindrieux, D.; Warnier, M.; Gitenay, D.; Le Calve, B.; Ferrand, M.; Augert, A.; Bernard, D.] Ctr Rech Cancerol Lyon, INSERM, U1052, Senescence Escape Mech Lab Tumoral Escape Dept, Lyon, France; [Wiel, C.; Gras, B.; Vindrieux, D.; Warnier, M.; Gitenay, D.; Le Calve, B.; Ferrand, M.; Augert, A.; Bernard, D.] CNRS, UMR5286, Lyon, France; [Wiel, C.; Gras, B.; Vindrieux, D.; Warnier, M.; Gitenay, D.; Le Calve, B.; Ferrand, M.; Augert, A.; Bernard, D.] Ctr Leon Berard, F-69373 Lyon, France; [Wiel, C.; Gras, B.; Vindrieux, D.; Warnier, M.; Gitenay, D.; Le Calve, B.; Ferrand, M.; Augert, A.; Bernard, D.] Univ Lyon, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UNICANCER; Centre Leon Berard	Bernard, D (corresponding author), Ctr Leon Berard, INSERM, CRCL, U1052,CNRS,UMR 5286, 28 Rue Laennec, F-69373 Lyon 08, France.	david.bernard@lyon.unicancer.fr	; Bernard, David/D-6265-2018	Gitenay, Delphine/0000-0002-6043-4519; Vindrieux, David/0000-0002-4713-5768; Bernard, David/0000-0002-1557-2074	French National Cancer Institute [plbio 2010-181]; Ligue contre le Cancer, comite de la Savoie; Fondation ARC; RTRS Fondation Synergie Lyon Cancer; Ligue Nationale contre le Cancer; Fondation pour la Recherche Medicale	French National Cancer Institute(Institut National du Cancer (INCA) France); Ligue contre le Cancer, comite de la Savoie; Fondation ARC; RTRS Fondation Synergie Lyon Cancer; Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	We thank Lea Payen for advice and Sarah Kabani for critical reading of the manuscript. This work was carried out with the support of the French National Cancer Institute (grants plbio 2010-181), the 'Ligue contre le Cancer, comite de la Savoie', the 'Fondation ARC', and the 'RTRS Fondation Synergie Lyon Cancer'. CW is supported by the 'Ligue Nationale contre le Cancer' and the 'Fondation pour la Recherche Medicale'.	Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120; Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Ben-Porath I, 2004, J CLIN INVEST, V113, P8, DOI 10.1172/JCI200420663; Bianchi-Smiraglia A, 2012, CELL CYCLE, V11, P4147, DOI 10.4161/cc.22589; BIZUB D, 1986, P NATL ACAD SCI USA, V83, P6048, DOI 10.1073/pnas.83.16.6048; Chen ZS, 2011, FEBS J, V278, P3226, DOI 10.1111/j.1742-4658.2011.08235.x; Christoffersen NR, 2010, CELL DEATH DIFFER, V17, P236, DOI 10.1038/cdd.2009.109; Cipriano R, 2011, P NATL ACAD SCI USA, V108, P8668, DOI 10.1073/pnas.1015022108; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; Ewald JA, 2010, JNCI-J NATL CANCER I, V102, P1536, DOI 10.1093/jnci/djq364; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; Gitenay D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.63; Gitenay D, 2014, ONCOTARGET, V5, P5845, DOI 10.18632/oncotarget.2286; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Henderson MJ, 2011, J NATL CANCER I, V103, P1236, DOI 10.1093/jnci/djr256; Humbert N, 2010, EMBO J, V29, P376, DOI 10.1038/emboj.2009.342; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Kool M, 1999, P NATL ACAD SCI USA, V96, P6914, DOI 10.1073/pnas.96.12.6914; Kruh GD, 2003, ONCOGENE, V22, P7537, DOI 10.1038/sj.onc.1206953; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Lallet-Daher H, 2013, CANCER RES, V73, P5253, DOI 10.1158/0008-5472.CAN-12-3690; Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815; Nelson DM, 2014, AGE, V36, P1049, DOI 10.1007/s11357-014-9637-0; Scurr LL, 2010, CELL, V141, P717, DOI 10.1016/j.cell.2010.04.021; Van De Wetering K, 2009, GASTROENTEROLOGY, V137, P1725, DOI 10.1053/j.gastro.2009.06.052; Vindrieux D, 2013, CANCER RES, V73, P6334, DOI 10.1158/0008-5472.CAN-13-0318; Wiel C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.382; Wiel C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4792; Zelcer N, 2006, J HEPATOL, V44, P768, DOI 10.1016/j.jhep.2005.07.022; Zhang H, 2003, P NATL ACAD SCI USA, V100, P3251, DOI 10.1073/pnas.2627983100	34	3	3	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 24	2016	35	12					1596	1601		10.1038/onc.2015.218	http://dx.doi.org/10.1038/onc.2015.218			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DH8RJ	26073088				2022-12-26	WOS:000373063600012
J	Chandrahas, V; Glinton, K; Liang, Z; Donahue, DL; Ploplis, VA; Castellino, FJ				Chandrahas, Vishwanatha; Glinton, Kristofor; Liang, Zhong; Donahue, Deborah L.; Ploplis, Victoria A.; Castellino, Francis J.			Direct Host Plasminogen Binding to Bacterial Surface M-protein in Pattern D Strains of Streptococcus pyogenes Is Required for Activation by Its Natural Coinherited SK2b Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCI; CLUSTER 2B STREPTOKINASE; FUNCTIONAL DIFFERENCES; INTERNAL SEQUENCE; VIRULENCE FACTOR; TISSUE TROPISM; PATHOGENESIS; FIBRINOGEN; DOMAIN; PAM	Streptokinase (SK), secreted by Group A Streptococcus (GAS), is a single-chain similar to 47-kDa protein containing three consecutive primary sequence regions that comprise its alpha, beta, and gamma modules. Phylogenetic analyses of the variable beta-domain sequences from different GAS strains suggest that SKs can be arranged into two clusters, SK1 and SK2, with a subdivision of SK2 into SK2a and SK2b. SK2b is secreted by skin-tropic Pattern D M-protein strains that also express plasminogen (human Pg (hPg)) binding Group A streptococcal M-protein (PAM) as its major cell surface M-protein. SK2a-expressing strains are associated with nasopharynx tropicity, and many of these strains express human fibrinogen (hFg) binding Pattern A-C M-proteins, e.g. M1. PAM interacts with hPg directly, whereas M1 binds to hPg indirectly via M1-bound hFg. Subsequently, SK is secreted by GAS and activates hPg to plasmin (hPm), thus generating a proteolytic surface on GAS that enhances its dissemination. Due to these different modes of hPg/hPm recognition by GAS, full characterizations of the mechanisms of activation of hPg by SK2a and SK2b and their roles in GAS virulence are important topics. To more fully examine these subjects, isogenic chimeric SK- and M-protein-containing GAS strains were generated, and the virulence of these chimeric strains were analyzed in mice. We show that SK and M-protein alterations influenced the virulence of GAS and were associated with the different natures of hPg activation and hPm binding. These studies demonstrate that GAS virulence can be explained by disparate hPg activation by SK2a and SK2b coupled with the coinherited M-proteins of these strains.	[Castellino, Francis J.] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA; Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame	Castellino, FJ (corresponding author), Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA.	fcastell@nd.edu	Chandrahas, Vishwanatha K./I-8256-2019; Regan, Clinton/E-6250-2012	Chandrahas, Vishwanatha K./0000-0001-8227-5021; Glinton, Kristofor/0000-0001-9301-7132	National Institutes of Health [HL013423]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL013423, R01HL013423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL013423. The authors declare that they have no conflicts of interest with the contents of this article.	AKESSON P, 1994, BIOCHEM J, V300, P877, DOI 10.1042/bj3000877; ANONICK PK, 1991, BIOCHEM J, V275, P53, DOI 10.1042/bj2750053; BESSEN D, 1989, J EXP MED, V169, P269, DOI 10.1084/jem.169.1.269; Bessen DE, 1999, J INFECT DIS, V179, P627, DOI 10.1086/314631; Bessen DE, 1996, J INFECT DIS, V173, P896, DOI 10.1093/infdis/173.4.896; Bessen DE, 2000, J INFECT DIS, V182, P1109, DOI 10.1086/315842; Bessen DE, 2011, J BACTERIOL, V193, P6651, DOI 10.1128/JB.05263-11; Bessen DE, 2009, INFECT GENET EVOL, V9, P581, DOI 10.1016/j.meegid.2009.03.002; Bessen DE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-59; Bhattacharya S, 2014, J BIOL CHEM, V289, P21684, DOI 10.1074/jbc.M114.570218; BROCKWAY WJ, 1972, ARCH BIOCHEM BIOPHYS, V151, P194, DOI 10.1016/0003-9861(72)90488-2; CASTELLINO FJ, 1981, METHOD ENZYMOL, V80, P365; Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; Conejero-Lara F, 1998, PROTEIN SCI, V7, P2190, DOI 10.1002/pro.5560071017; Cook SM, 2012, MOL MICROBIOL, V86, P1052, DOI 10.1111/mmi.12037; Cunningham MW, 2008, ADV EXP MED BIOL, V609, P29, DOI 10.1007/978-0-387-73960-1_3; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; FISCHETTI VA, 1991, SCI AM, V264, P58, DOI 10.1038/scientificamerican0691-58; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Fu QH, 2008, J BIOL CHEM, V283, P1580, DOI 10.1074/jbc.M705063200; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; HOLLINGSHEAD SK, 1994, MOL BIOL EVOL, V11, P208; HOLLINGSHEAD SK, 1993, MOL MICROBIOL, V8, P707, DOI 10.1111/j.1365-2958.1993.tb01614.x; Iwaki T, 2005, CURR DRUG TARGETS, V6, P535, DOI 10.2174/1389450054546006; Kalia A, 2004, J BACTERIOL, V186, P110, DOI 10.1128/JB.186.1.110-121.2004; Liang Z, 2013, J BIOL CHEM, V288, P6561, DOI 10.1074/jbc.M112.442657; Macheboeuf P, 2011, NATURE, V472, P64, DOI 10.1038/nature09967; MALKE H, 1993, ZBL BAKT-INT J MED M, V278, P246; Mayfield JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100698; McArthur JD, 2008, FASEB J, V22, P3146, DOI 10.1096/fj.08-109348; McKay FC, 2004, INFECT IMMUN, V72, P364, DOI 10.1128/IAI.72.1.364-370.2004; McNamara C, 2008, SCIENCE, V319, P1405, DOI 10.1126/science.1154470; MUSSER JM, 1991, P NATL ACAD SCI USA, V88, P2668, DOI 10.1073/pnas.88.7.2668; Nilsen SL, 1999, J BIOL CHEM, V274, P22380, DOI 10.1074/jbc.274.32.22380; NOVOKHATNY VV, 1984, J MOL BIOL, V179, P215, DOI 10.1016/0022-2836(84)90466-2; Ringdahl U, 1998, J BIOL CHEM, V273, P6424, DOI 10.1074/jbc.273.11.6424; Ringdahl U, 2000, METHODS, V21, P143, DOI 10.1006/meth.2000.0985; Ringdahl U, 2000, MOL MICROBIOL, V37, P1318, DOI 10.1046/j.1365-2958.2000.02062.x; SCHICK LA, 1973, BIOCHEMISTRY-US, V12, P4315, DOI 10.1021/bi00746a003; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SHANKAR H, 1987, J BIOMED MATER RES, V21, P897, DOI 10.1002/jbm.820210706; SOTTRUPJENSEN L, 1978, PROGR CHEM FIBRINOLY, V3, P191; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Svensson MD, 2002, MICROBIOL-SGM, V148, P3933, DOI 10.1099/00221287-148-12-3933; Tart AH, 2007, TRENDS MICROBIOL, V15, P318, DOI 10.1016/j.tim.2007.05.001; Walker MJ, 2005, TRENDS MICROBIOL, V13, P308, DOI 10.1016/j.tim.2005.05.006; Wang M, 2010, J STRUCT BIOL, V169, P349, DOI 10.1016/j.jsb.2009.09.011; WHITNACK E, 1985, J BACTERIOL, V164, P350, DOI 10.1128/JB.164.1.350-358.1985; Wistedt AC, 1998, J BIOL CHEM, V273, P24420, DOI 10.1074/jbc.273.38.24420; Zhang Y, 2014, BIOCHEM BIOPH RES CO, V444, P595, DOI 10.1016/j.bbrc.2014.01.109; Zhang YL, 2013, FEBS LETT, V587, P1304, DOI 10.1016/j.febslet.2013.02.033; Zhang YL, 2012, J BIOL CHEM, V287, P42093, DOI 10.1074/jbc.M112.417808	54	17	17	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18833	18842		10.1074/jbc.M115.655365	http://dx.doi.org/10.1074/jbc.M115.655365			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26070561	hybrid, Green Published			2022-12-26	WOS:000358512100049
J	Mercer, JL; Argus, JP; Crabtree, DM; Keenan, MM; Wilks, MQ; Chi, JTA; Bensinger, SJ; Lavau, CP; Wechsler, DS				Mercer, Jacob L.; Argus, Joseph P.; Crabtree, Donna M.; Keenan, Melissa M.; Wilks, Moses Q.; Chi, Jen-Tsan Ashley; Bensinger, Steven J.; Lavau, Catherine P.; Wechsler, Daniel S.			Modulation of PICALM Levels Perturbs Cellular Cholesterol Homeostasis	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; MYELOID-LEUKEMIA CALM; ALZHEIMERS-DISEASE; UBIQUITIN LIGASE; COATED PITS; PROTEIN; RECEPTOR; FUSION; GENE; TRAFFICKING	PICALM (Phosphatidyl Inositol Clathrin Assembly Lymphoid Myeloid protein) is a ubiquitously expressed protein that plays a role in clathrin-mediated endocytosis. PICALM also affects the internalization and trafficking of SNAREs and modulates macroautophagy. Chromosomal translocations that result in the fusion of PICALM to heterologous proteins cause leukemias, and genome-wide association studies have linked PICALM Single Nucleotide Polymorphisms (SNPs) to Alzheimer's disease. To obtain insight into the biological role of PICALM, we performed gene expression studies of PICALM-deficient and PICALM-expressing cells. Pathway analysis demonstrated that PICALM expression influences the expression of genes that encode proteins involved in cholesterol biosynthesis and lipoprotein uptake. Gas Chromatography-Mass Spectrometry (GC-MS) studies indicated that loss of PICALM increases cellular cholesterol pool size. Isotopic labeling studies revealed that loss of PICALM alters increased net scavenging of cholesterol. Flow cytometry analyses confirmed that internalization of the LDL receptor is enhanced in PICALM-deficient cells as a result of higher levels of LDLR expression. These findings suggest that PICALM is required for cellular cholesterol homeostasis and point to a novel mechanism by which PICALM alterations may contribute to disease.	[Mercer, Jacob L.; Wechsler, Daniel S.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27705 USA; [Argus, Joseph P.; Bensinger, Steven J.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Mol & Med Pharmacol, Los Angeles, CA USA; [Crabtree, Donna M.; Lavau, Catherine P.; Wechsler, Daniel S.] Duke Univ, Dept Pediat, Div Pediat Hematol Oncol, Durham, NC 27706 USA; [Keenan, Melissa M.; Chi, Jen-Tsan Ashley] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC USA; [Keenan, Melissa M.; Chi, Jen-Tsan Ashley] Duke Univ, Ctr Genom & Computat Biol, Durham, NC USA; [Wilks, Moses Q.] Massachusetts Gen Hosp, Dept Radiol, Ctr Adv Med Imaging Sci, Boston, MA 02114 USA	Duke University; University of California System; University of California Los Angeles; Duke University; Duke University; Duke University; Harvard University; Massachusetts General Hospital	Wechsler, DS (corresponding author), Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27705 USA.	dan.wechsler@duke.edu	Lavau, Catherine/Q-2928-2019; Chi, Jen-Tsan/AAI-4125-2020	Chi, Jen-Tsan/0000-0003-3433-903X; Lavau, Catherine/0000-0003-4800-1320	National Institutes of Health CBI Grant [T32 GM008469]; University of California Los Angeles Graduate Division (JPA); Sontag Foundation; National Institutes of Health [AI093768]; V Foundation/Applebee's Research Grant; St. Baldrick's Research Grant; Hyundai Hope On Wheels Grant; Schiffman Family Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007754, T32GM007184] Funding Source: NIH RePORTER	National Institutes of Health CBI Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Los Angeles Graduate Division (JPA); Sontag Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V Foundation/Applebee's Research Grant; St. Baldrick's Research Grant; Hyundai Hope On Wheels Grant; Schiffman Family Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health CBI Grant (T32 GM008469) and the University of California Los Angeles Graduate Division (JPA); the Sontag Foundation and the National Institutes of Health (AI093768 - SJB); and a V Foundation/Applebee's Research Grant, a St. Baldrick's Research Grant, a Hyundai Hope On Wheels Grant and a Schiffman Family Award (to DSW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhaleem M, 2007, LEUKEMIA, V21, P352, DOI 10.1038/sj.leu.2404503; Anderson RGW, 2003, TRENDS CELL BIOL, V13, P534, DOI 10.1016/j.tcb.2003.08.007; Ando K, 2013, ACTA NEUROPATHOL, V125, P861, DOI 10.1007/s00401-013-1111-z; Baig S, 2010, J NEUROPATH EXP NEUR, V69, P1071, DOI 10.1097/NEN.0b013e3181f52e01; Bhattacharyya R, 2010, BBA-MOL CELL BIOL L, V1801, P960, DOI 10.1016/j.bbalip.2010.04.003; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; Bohlander SK, 2000, LEUKEMIA, V14, P93, DOI 10.1038/sj.leu.2401614; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Conway AE, 2015, LEUKEMIA, V29, P423, DOI 10.1038/leu.2014.221; Conway AE, 2013, BLOOD, V121, P4758, DOI 10.1182/blood-2012-06-435792; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Corneveaux JJ, 2010, HUM MOL GENET, V19, P3295, DOI 10.1093/hmg/ddq221; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; Du CC, 1999, BLOOD, V94, P793, DOI 10.1182/blood.V94.2.793.414k43_793_802; Eden ER, 2007, HUM MOL GENET, V16, P2751, DOI 10.1093/hmg/ddm232; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Garuti R, 2005, J BIOL CHEM, V280, P40996, DOI 10.1074/jbc.M509394200; Gatza ML, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2899; Girard E, 2014, TRAFFIC, V15, P309, DOI 10.1111/tra.12143; Girard E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029042; Goedeke L, 2012, CELL MOL LIFE SCI, V69, P915, DOI 10.1007/s00018-011-0857-5; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Harel A, 2008, TRAFFIC, V9, P417, DOI 10.1111/j.1600-0854.2007.00694.x; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; HAWLEY RG, 1994, GENE THER, V1, P136; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Ikonen E, 2006, PHYSIOL REV, V86, P1237, DOI 10.1152/physrev.00022.2005; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jun G, 2010, ARCH NEUROL-CHICAGO, V67, P1473, DOI 10.1001/archneurol.2010.201; Kanatsu K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4386; Karasinska JM, 2011, NAT REV NEUROL, V7, P561, DOI 10.1038/nrneurol.2011.132; KELLEHER JK, 1992, AM J PHYSIOL, V262, pE118, DOI 10.1152/ajpendo.1992.262.1.E118; Kingston R E, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1013s31; Klebig ML, 2003, P NATL ACAD SCI USA, V100, P8360, DOI 10.1073/pnas.1432634100; Koo SJ, 2011, P NATL ACAD SCI USA, V108, P13540, DOI 10.1073/pnas.1107067108; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Legendre-Guillemin V, 2004, J CELL SCI, V117, P9, DOI 10.1242/jcs.00928; LISCUM L, 1987, J BIOL CHEM, V262, P17002; Maurer ME, 2006, J CELL SCI, V119, P4235, DOI 10.1242/jcs.03217; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Meyerholz A, 2005, TRAFFIC, V6, P1225, DOI 10.1111/j.1600-0854.2005.00355.x; Miller SE, 2011, CELL, V147, P1118, DOI 10.1016/j.cell.2011.10.038; Moreau K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5998; Moreau K, 2013, TRENDS BIOCHEM SCI, V38, P57, DOI 10.1016/j.tibs.2012.11.004; Morgen K, 2014, ALZHEIMERS DEMENT, V10, pS269, DOI 10.1016/j.jalz.2013.11.001; Mori T, 2001, J NEUROPATH EXP NEUR, V60, P778, DOI 10.1093/jnen/60.8.778; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Peake KB, 2010, FEBS LETT, V584, P2731, DOI 10.1016/j.febslet.2010.04.047; Qi YP, 1997, J NEUROSCI, V17, P1217; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Rai S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109441; Robinet P, 2006, TRAFFIC, V7, P811, DOI 10.1111/j.1600-0854.2006.00435.x; Sahlender DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064514; Sarkar S, 2014, AUTOPHAGY, V10, P1137, DOI 10.4161/auto.28623; Sarkar S, 2013, CELL REP, V5, P1302, DOI 10.1016/j.celrep.2013.10.042; Scotland PB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044252; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000851; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; SURI C, 1993, J NEUROSCI, V13, P1280; Suzuki M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031854; Tang XH, 2012, CANCER RES, V72, P491, DOI 10.1158/0008-5472.CAN-11-2076; Tebar F, 1999, MOL BIOL CELL, V10, P2687, DOI 10.1091/mbc.10.8.2687; Thomas RS, 2011, BIOCHEM BIOPH RES CO, V415, P656, DOI 10.1016/j.bbrc.2011.10.131; Vance JE, 2006, FEBS LETT, V580, P5518, DOI 10.1016/j.febslet.2006.06.008; Vecchi M, 2001, J CELL BIOL, V153, P1511, DOI 10.1083/jcb.153.7.1511; Williams KJ, 2013, CANCER RES, V73, P2850, DOI 10.1158/0008-5472.CAN-13-0382-T; Xiao QL, 2012, J BIOL CHEM, V287, P21279, DOI 10.1074/jbc.M111.338376; Xu W, 2015, MOL NEUROBIOL, V52, P399, DOI 10.1007/s12035-014-8878-3; Yu LQ, 2003, J BIOL CHEM, V278, P15565, DOI 10.1074/jbc.M301311200; Zelcer N, 2014, MOL CELL BIOL, V34, P1262, DOI 10.1128/MCB.01140-13; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9	81	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129776	10.1371/journal.pone.0129776	http://dx.doi.org/10.1371/journal.pone.0129776			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075887	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900102
J	Dellafiore, MA; Montserrat, JM; Iribarren, AM				Dellafiore, Maria A.; Montserrat, Javier M.; Iribarren, Adolfo M.			Exploring the Use of a Guanine-Rich Catalytic DNA for Sulfoxide Preparation	PLOS ONE			English	Article							PEROXIDASE-ACTIVITY; DNAZYME; APTAMERS; SULFIDES	A guanine-rich DNA oligonucleotide complexed with hemin was used to catalyze controlled oxygen transfer reactions to different sulfides for sulfoxide preparation in the presence of H2O2. Comparable activities were obtained when using fully modified L-DNA. In addition, oligonucleotide immobilization led to an active catalyst which could be successfully recovered and reused without loss of activity.	[Dellafiore, Maria A.; Montserrat, Javier M.; Iribarren, Adolfo M.] Consejo Nacl Invest Cient & Tecn, INGEBI, Lab Quim Acidos Nucle, RA-1033 Buenos Aires, DF, Argentina; [Montserrat, Javier M.] Univ Nacl Gral Sarmiento, Inst Ciencias, Los Polvorines, Provincia De Bu, Argentina; [Iribarren, Adolfo M.] Univ Nacl Quilmes, Lab Biotransformac, Bernal, Provincia De Bu, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Montserrat, JM (corresponding author), Consejo Nacl Invest Cient & Tecn, INGEBI, Lab Quim Acidos Nucle, RA-1033 Buenos Aires, DF, Argentina.	jmontser@ungs.edu.ar		MONTSERRAT, Josep Maria/0000-0003-3098-4605	Agencia Nacional de Promocion de la Ciencia y la Tecnologia (ANPCyT), Argentina [PICT2011-0367]	Agencia Nacional de Promocion de la Ciencia y la Tecnologia (ANPCyT), Argentina	This work was supported by the Agencia Nacional de Promocion de la Ciencia y la Tecnologia (ANPCyT), Argentina, Grant Number: PICT2011-0367. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetumjbi MA, 1983, MED HYPOTHESES, V12, P222; CARRENO MC, 1995, CHEM REV, V95, P1717, DOI 10.1021/cr00038a002; Garnock-Jones KP, 2009, CNS DRUGS, V23, P793, DOI 10.2165/1120329-000000000-00000; Kosman J, 2011, ANAL CHIM ACTA, V707, P7, DOI 10.1016/j.aca.2011.08.050; KOTELANSKI B, 1973, CLIN PHARMACOL THER, V14, P427; Kowalski P, 2005, TETRAHEDRON, V61, P1933, DOI 10.1016/j.tet.2004.11.041; Kumar ABVK, 2009, J KOREAN SOC APPL BI, V52, P34, DOI 10.3839/jksabc.2009.006; Li BL, 2009, ANAL CHIM ACTA, V651, P234, DOI 10.1016/j.aca.2009.09.009; Li C, 2012, CHEM COMMUN, V48, P8347, DOI 10.1039/c2cc32919k; Li YF, 1997, BIOCHEMISTRY-US, V36, P5589, DOI 10.1021/bi962694n; Li YF, 1996, BIOCHEMISTRY-US, V35, P6911, DOI 10.1021/bi960038h; MARINO JP, 1991, J ORG CHEM, V56, P1349, DOI 10.1021/jo00004a002; Padmanabhan S, 2001, BIOORG MED CHEM LETT, V11, P501, DOI 10.1016/S0960-894X(00)00695-8; Poon LCH, 2011, J AM CHEM SOC, V133, P1877, DOI 10.1021/ja108571a; Riddell D, 1996, BIOCHEM PHARMACOL, V52, P1177, DOI 10.1016/0006-2952(96)00455-8; Rojas AM, 2007, BIOTECHNOL LETT, V29, P227, DOI 10.1007/s10529-006-9228-y; Schwartz IF, 2002, CLIN SCI, V102, P487, DOI 10.1042/CS20010221; Sen D, 2011, CRIT REV BIOCHEM MOL, V46, P478, DOI 10.3109/10409238.2011.618220; Spencer CM, 2000, DRUGS, V60, P321, DOI 10.2165/00003495-200060020-00006; Taylor D, 2014, CHEMOSPHERE, V115, P95, DOI 10.1016/j.chemosphere.2014.01.011; Travascio P, 1998, CHEM BIOL, V5, P505, DOI 10.1016/S1074-5521(98)90006-0; Zhang M, 2012, CHEM BIODIVERS, V9, P170, DOI 10.1002/cbdv.201100040	22	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129695	10.1371/journal.pone.0129695	http://dx.doi.org/10.1371/journal.pone.0129695			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066510	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000099
J	Dumoulin, PC; Trop, SA; Ma, JX; Zhang, H; Sherman, MA; Levitskaya, J				Dumoulin, Peter C.; Trop, Stefanie A.; Ma, Jinxia; Zhang, Hao; Sherman, Matthew A.; Levitskaya, Jelena			Flow Cytometry Based Detection and Isolation of Plasmodium falciparum Liver Stages In Vitro	PLOS ONE			English	Article							MALARIA CIRCUMSPOROZOITE PROTEIN; HEPARAN-SULFATE PROTEOGLYCANS; BERGHEI SPOROZOITE INVASION; HEPATIC STAGES; PARASITE; ANTIBODIES; INFECTION; VACCINE; CELLS; AUTOFLUORESCENCE	Malaria, the disease caused by Plasmodium parasites, remains a major global health burden. The liver stage of Plasmodium falciparum infection is a leading target for immunological and pharmacological interventions. Therefore, novel approaches providing specific detection and isolation of live P. falciparum exoerythrocytic forms (EEFs) are warranted. Utilizing a recently generated parasite strain expressing green fluorescent protein (GFP) we established a method which, allows for detection and isolation of developing live P. falciparum liver stages by flow cytometry. Using this technique we compared the susceptibility of five immortalized human hepatocyte cell lines and primary hepatocyte cultures from three donors to infection by P. falciparum sporozoites. Here, we show that EEFs can be detected and isolated from in vitro infected cultures of the HC-04 cell line and primary human hepatocytes. We confirmed the presence of developing parasites in sorted live human hepatocytes and characterized their morphology by fluorescence microscopy. Finally, we validated the practical applications of our approach by re-examining the importance of host ligand CD81 for hepatocyte infection by P. falciparum sporozoites in vitro and assessment of the inhibitory activity of anti-sporozoite antibodies. This methodology provides us with the tools to study both, the basic biology of the P. falciparum liver stage and the effects of host-derived factors on the development of P. falciparum EEFs.	[Dumoulin, Peter C.; Trop, Stefanie A.; Ma, Jinxia; Zhang, Hao; Levitskaya, Jelena] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Sherman, Matthew A.] Triangle Res Labs, Durham, NC 27709 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Levitskaya, J (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.	lelena1@jhu.edu		Trop, Stefanie/0000-0003-0094-248X	JHMRI; Bloomberg Philanthropies; National Institutes of Health [RR00052]	JHMRI; Bloomberg Philanthropies; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Triangle Research Labs provided support in the form of salaries for authors [MS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by a pilot grant from the JHMRI and the Bloomberg Philanthropies. The supply of human blood was supported by the National Institutes of Health, Grant RR00052. Funders did not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amino R, 2008, CELL HOST MICROBE, V3, P88, DOI 10.1016/j.chom.2007.12.007; ANKER R, 1990, EUR J IMMUNOL, V20, P2757, DOI 10.1002/eji.1830201233; Baum J, 2013, PATHOG GLOB HEALTH, V107, P107, DOI 10.1179/2047772413Z.000000000121; Behet MC, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-136; Bei AK, 2012, INT J PARASITOL, V42, P575, DOI 10.1016/j.ijpara.2012.03.006; Butler NS, 2012, TRENDS IMMUNOL, V33, P247, DOI 10.1016/j.it.2012.02.001; Costa FTM, 2006, BRAZ J MED BIOL RES, V39, P1525, DOI 10.1590/S0100-879X2006001200003; Croce AC, 2010, LASER SURG MED, V42, P371, DOI 10.1002/lsm.20923; Croce AC, 2004, PHOTOCH PHOTOBIO SCI, V3, P920, DOI 10.1039/b407358d; Deal C, 2014, P NATL ACAD SCI USA, V111, P12528, DOI 10.1073/pnas.1407362111; Duffy PE, 2012, EXPERT REV VACCINES, V11, P1261, DOI [10.1586/ERV.12.92, 10.1586/erv.12.92]; Foquet L, 2014, J CLIN INVEST, V124, P140, DOI 10.1172/JCI70349; Frevert U, 2005, PLOS BIOL, V3, P1034, DOI 10.1371/journal.pbio.0030192; Frevert U, 1996, MOL BIOCHEM PARASIT, V76, P257, DOI 10.1016/0166-6851(95)02563-4; FREVERT U, 1993, J EXP MED, V177, P1287, DOI 10.1084/jem.177.5.1287; Hafalla JC, 2011, IMMUNOL REV, V240, P297, DOI 10.1111/j.1600-065X.2010.00988.x; HOLLINGDALE MR, 1983, AM J TROP MED HYG, V32, P682, DOI 10.4269/ajtmh.1983.32.682; Hugel FU, 1996, MOL BIOCHEM PARASIT, V81, P151, DOI 10.1016/0166-6851(96)02701-6; Ishino T, 2005, CELL MICROBIOL, V7, P199, DOI 10.1111/j.1462-5822.2004.00447.x; Li FQ, 2012, J IMMUNOL METHODS, V386, P101, DOI 10.1016/j.jim.2012.08.014; Ma JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075321; Macete EV, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-11; March S, 2013, CELL HOST MICROBE, V14, P104, DOI 10.1016/j.chom.2013.06.005; MAZIER D, 1985, SCIENCE, V227, P440, DOI 10.1126/science.3880923; Mota MM, 2000, EXP PARASITOL, V96, P257, DOI 10.1006/expr.2000.4570; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; NARDIN EH, 1982, J EXP MED, V156, P20, DOI 10.1084/jem.156.1.20; PFEIFER AMA, 1993, P NATL ACAD SCI USA, V90, P5123, DOI 10.1073/pnas.90.11.5123; Pinzon-Ortiz C, 2001, J BIOL CHEM, V276, P26784, DOI 10.1074/jbc.M104038200; Pradel G, 2002, MOL MICROBIOL, V45, P637, DOI 10.1046/j.1365-2958.2002.03057.x; Prudencio M, 2008, CELL MICROBIOL, V10, P218, DOI 10.1111/j.1462-5822.2007.01032.x; Prudencio M, 2011, TRENDS PARASITOL, V27, P565, DOI 10.1016/j.pt.2011.09.004; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Sacci JB, 2006, INT J PARASITOL, V36, P353, DOI 10.1016/j.ijpara.2005.10.014; SACCI JB, 1992, P NATL ACAD SCI USA, V89, P3701, DOI 10.1073/pnas.89.9.3701; Sattabongkot J, 2006, AM J TROP MED HYG, V74, P708, DOI 10.4269/ajtmh.2006.74.708; Schoone GJ, 2000, J CLIN MICROBIOL, V38, P4072, DOI 10.1128/JCM.38.11.4072-4075.2000; Schwenk RJ, 2011, TRENDS PARASITOL, V27, P306, DOI 10.1016/j.pt.2011.02.002; Sidjanski S, 1997, AM J TROP MED HYG, V57, P426, DOI 10.4269/ajtmh.1997.57.426; Silvie O, 2003, NAT MED, V9, P93, DOI 10.1038/nm808; Silvie O, 2006, CELL MICROBIOL, V8, P1134, DOI 10.1111/j.1462-5822.2006.00697.x; Spence PJ, 2012, CURR OPIN IMMUNOL, V24, P444, DOI 10.1016/j.coi.2012.05.003; STEWART MJ, 1986, INFECT IMMUN, V51, P859, DOI 10.1128/IAI.51.3.859-864.1986; Talman AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009156; Tarun AS, 2006, INT J PARASITOL, V36, P1283, DOI 10.1016/j.ijpara.2006.06.009; Tavares Joana, 2013, Methods Mol Biol, V923, P401; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tran TM, 2013, CLIN INFECT DIS, V57, P40, DOI 10.1093/cid/cit174; Tse SW, 2011, MEM I OSWALDO CRUZ, V106, P172, DOI 10.1590/S0074-02762011000900022; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; Vanderberg JP, 2004, INT J PARASITOL, V34, P991, DOI 10.1016/j.ijpara.2004.05.005; VANDERBERG JP, 1974, J PROTOZOOL, V21, P527, DOI 10.1111/j.1550-7408.1974.tb03693.x; Vaughan AM, 2008, CELL HOST MICROBE, V4, P209, DOI 10.1016/j.chom.2008.08.010; Vaughan AM, 2012, J CLIN INVEST, V122, P3618, DOI 10.1172/JCI62684; World Health Organization, 2013, WORLD MAL REP 2013 G; Young L, 2010, NAT PROTOC, V5, P929, DOI 10.1038/nprot.2010.43; ZAVALA F, 1985, SCIENCE, V228, P1436, DOI 10.1126/science.2409595	57	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129623	10.1371/journal.pone.0129623	http://dx.doi.org/10.1371/journal.pone.0129623			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070149	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000097
J	Ioerger, M; Henry, KL; Chen, PY; Cigularov, KP; Tomazic, RG				Ioerger, Michael; Henry, Kimberly L.; Chen, Peter Y.; Cigularov, Konstantin P.; Tomazic, Rocco G.			Beyond Same-Sex Attraction: Gender-Variant-Based Victimization Is Associated with Suicidal Behavior and Substance Use for Other-Sex Attracted Adolescents	PLOS ONE			English	Article							TRANSGENDER YOUTH; SCHOOL VICTIMIZATION; GAY; ORIENTATION; STUDENTS; OUTCOMES; HEALTH; RISK; HETERONORMATIVITY; ATYPICALITY	Gender-variant-based victimization is victimization based on the way others perceive an individual to convey masculine, feminine, and androgynous characteristics through their appearance, mannerisms, and behaviors. Previous work identifies gender-variant-based victimization as a risk factor for health-risking outcomes among same-sex attracted youths. The current study seeks to examine this relationship among other-sex attracted youths and same-sex attracted youth, and determine if gender-variant-based victimization is similarly or differentially associated with poor outcomes between these two groups. Anonymous data from a school-based survey of 2,438 racially diverse middle and high school students in the Eastern U.S. was examined. For other-sex attracted adolescents, gender-variantbased victimization was associated with a higher odds of suicidal thoughts and behaviors, regular use of cigarettes, and drug use. When compared to same-sex attracted adolescents, the harmful relationship between gender-variant-based victimization and each of these outcomes was similar in nature. These findings suggest that gender-variant-based victimization has potentially serious implications for the psychological wellbeing and substance use of other-sex attracted adolescents, not just same-sex attracted adolescents, supporting the need to address gender expression as a basis for victimization separate from sexuality- or gender-minority status. The impact that gender-variant-based victimization has on all adolescents should not be overlooked in research and interventions aimed at addressing sexual orientation-based and gender-variant-based victimization, substance use, and suicide prevention.	[Ioerger, Michael] Syracuse Univ, Dept Psychol, Syracuse, NY 13244 USA; [Henry, Kimberly L.] Colorado State Univ, Dept Psychol, Ft Collins, CO 80523 USA; [Chen, Peter Y.] Auburn Univ, Dept Psychol, Auburn, AL 36849 USA; [Cigularov, Konstantin P.] Old Dominion Univ, Dept Psychol, Norfolk, VA USA; [Tomazic, Rocco G.] Borough Freehold Publ Sch, Freehold, NJ USA	Syracuse University; Colorado State University; Auburn University System; Auburn University; Old Dominion University	Ioerger, M (corresponding author), Syracuse Univ, Dept Psychol, Syracuse, NY 13244 USA.	mkioerge@syr.edu	Ioerger, Michael/G-5074-2017	Ioerger, Michael/0000-0002-2282-4022; Henry, Kimberly/0000-0002-2303-3759	Colorado State University Libraries Open Access Research and Scholarship Fund	Colorado State University Libraries Open Access Research and Scholarship Fund	Colorado State University Libraries Open Access Research and Scholarship Fund.	Berlan ED, 2010, J ADOLESCENT HEALTH, V46, P366, DOI 10.1016/j.jadohealth.2009.10.015; Birkett M, 2009, J YOUTH ADOLESCENCE, V38, P989, DOI 10.1007/s10964-008-9389-1; Collier KL, 2013, J SEX RES, V50, P299, DOI 10.1080/00224499.2012.750639; D'Augelli AR, 2006, J INTERPERS VIOLENCE, V21, P1462, DOI 10.1177/0886260506293482; Greytak EA, 2009, HARSH REALITIES THE; Grossman AH, 2006, J HOMOSEXUAL, V51, P111, DOI 10.1300/J082v51n01_06; Hendricks ML, 2012, PROF PSYCHOL-RES PR, V43, P460, DOI 10.1037/a0029597; Joiner T.E, 2010, MYTHS ABOUT SUICIDE; Kitzinger C, 2005, SOC PROBL, V52, P477, DOI 10.1525/sp.2005.52.4.477; Knol MJ, 2007, INT J EPIDEMIOL, V36, P1111, DOI 10.1093/ije/dym157; Knol MJ, 2012, INT J EPIDEMIOL, V41, P514, DOI 10.1093/ije/dyr218; Lee EAE, 2011, SEX ROLES, V64, P90, DOI 10.1007/s11199-010-9883-2; Lewinsohn PM, 1996, CLIN PSYCHOL-SCI PR, V3, P25, DOI 10.1111/j.1468-2850.1996.tb00056.x; McCann PD, 2010, HEALTH SOCIOL REV, V19, P505; McGuire JK, 2010, J YOUTH ADOLESCENCE, V39, P1175, DOI 10.1007/s10964-010-9540-7; MEYER IH, 1995, J HEALTH SOC BEHAV, V36, P38, DOI 10.2307/2137286; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Nayak A, 1996, J GENDER STUD, V5, P211, DOI 10.1080/09589236.1996.9960644; Pascoe C. J., 2005, SEXUALITIES, V8, P329, DOI [DOI 10.1177/1363460705053337, 10.1177/1363460705053337]; Phoenix A, 2003, J SOC ISSUES, V59, P179, DOI 10.1111/1540-4560.t01-1-00011; Ploderl M, 2010, J HOMOSEXUAL, V57, P819, DOI 10.1080/00918369.2010.493401; Poteat VP, 2007, J EARLY ADOLESCENCE, V27, P175, DOI 10.1177/0272431606294839; Rieger G, 2012, ARCH SEX BEHAV, V41, P611, DOI 10.1007/s10508-011-9738-0; Robinson JP, 2011, EDUC RESEARCHER, V40, P315, DOI 10.3102/0013189X11422112; Russell ST, 2001, AM J PUBLIC HEALTH, V91, P1276, DOI 10.2105/AJPH.91.8.1276; Russell ST, 2011, J SCHOOL HEALTH, V81, P223, DOI 10.1111/j.1746-1561.2011.00583.x; Stoudt BG, 2006, MEN MASC, V8, P273, DOI 10.1177/1097184X05282070; Swearer SM, 2008, SCHOOL PSYCHOL REV, V37, P160; Toomey RB, 2012, J ADOLESCENCE, V35, P187, DOI 10.1016/j.adolescence.2011.03.001; Toomey RB, 2010, DEV PSYCHOL, V46, P1580, DOI 10.1037/a0020705; Carrera MV, 2011, EDUC PSYCHOL REV, V23, P479, DOI 10.1007/s10648-011-9171-x; Wilkinson L, 2009, GENDER SOC, V23, P542, DOI 10.1177/0891243209339913; Young R, 2004, SEX ROLES, V50, P525, DOI 10.1023/B:SERS.0000023072.53886.86; Yu L, 2010, SEX ROLES, V62, P100, DOI 10.1007/s11199-009-9709-2	34	10	10	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129976	10.1371/journal.pone.0129976	http://dx.doi.org/10.1371/journal.pone.0129976			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6GR	26068796	Green Submitted, Green Published, gold			2022-12-26	WOS:000356327000130
J	Tobo, A; Tobo, M; Nakakura, T; Ebara, M; Tomura, H; Mogi, C; Im, DS; Murata, N; Kuwabara, A; Ito, S; Fukuda, H; Arisawa, M; Shuto, S; Nakaya, M; Kurose, H; Sato, K; Okajima, F				Tobo, Ayaka; Tobo, Masayuki; Nakakura, Takashi; Ebara, Masashi; Tomura, Hideaki; Mogi, Chihiro; Im, Dong-Soon; Murata, Naoya; Kuwabara, Atsushi; Ito, Saki; Fukuda, Hayato; Arisawa, Mitsuhiro; Shuto, Satoshi; Nakaya, Michio; Kurose, Hitoshi; Sato, Koichi; Okajima, Fumikazu			Characterization of Imidazopyridine Compounds as Negative Allosteric Modulators of Proton-Sensing GPR4 in Extracellular Acidification-Induced Responses	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; ACIDIC PH; MEDIATED INTERNALIZATION; OGR1; G2A; PSYCHOSINE; AGONIST; SPHINGOSYLPHOSPHORYLCHOLINE; ACCUMULATION; INHIBITION	G protein-coupled receptor 4 (GPR4), previously proposed as the receptor for sphingosylphosphorylcholine, has recently been identified as the proton-sensing G protein-coupled receptor (GPCR) coupling to multiple intracellular signaling pathways, including the G(s) protein/cAMP and G(13) protein/Rho. In the present study, we characterized some imidazopyridine compounds as GPR4 modulators that modify GPR4 receptor function. In the cells that express proton-sensing GPCRs, including GPR4, OGR1, TDAG8, and G2A, extracellular acidification stimulates serum responsive element (SRE)-driven transcriptional activity, which has been shown to reflect Rho activity, with different proton sensitivities. Imidazopyridine compounds inhibited the moderately acidic pH-induced SRE activity only in GPR4-expressing cells. Acidic pH-stimulated cAMP accumulation, mRNA expression of inflammatory genes, and GPR4 internalization within GPR4-expressing cells were all inhibited by the GPR4 modulator. We further compared the inhibition property of the imidazopyridine compound with psychosine, which has been shown to selectively inhibit actions induced by proton-sensing GPCRs, including GPR4. In the GPR4 mutant, in which certain histidine residues were mutated to phenylalanine, proton sensitivity was significantly shifted to the right, and psychosine failed to further inhibit acidic pH-induced SRE activation. On the other hand, the imidazopyridine compound almost completely inhibited acidic pH-induced action in mutant GPR4. We conclude that some imidazopyridine compounds show specificity to GPR4 as negative allosteric modulators with a different action mode from psychosine, an antagonist susceptible to histidine residues, and are useful for characterizing GPR4-mediated acidic pH-induced biological actions.	[Tobo, Ayaka; Tobo, Masayuki; Nakakura, Takashi; Ebara, Masashi; Tomura, Hideaki; Mogi, Chihiro; Murata, Naoya; Kuwabara, Atsushi; Sato, Koichi; Okajima, Fumikazu] Gunma Univ, Inst Mol & Cellular Regulat, Lab Signal Transduct, Maebashi, Gunma 371, Japan; [Im, Dong-Soon] Pusan Natl Univ, Coll Pharm, Pharmacol Lab, Busan, South Korea; [Ito, Saki; Fukuda, Hayato; Arisawa, Mitsuhiro; Shuto, Satoshi] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido 060, Japan; [Shuto, Satoshi] Hokkaido Univ, Ctr Res & Educ Drug Discovery, Sapporo, Hokkaido, Japan; [Nakaya, Michio; Kurose, Hitoshi] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Fukuoka 812, Japan	Gunma University; Pusan National University; Hokkaido University; Hokkaido University; Kyushu University	Sato, K (corresponding author), Gunma Univ, Inst Mol & Cellular Regulat, Lab Signal Transduct, Maebashi, Gunma 371, Japan.	kosato@gunma-u.ac.jp; okajima@gunma-u.ac.jp	Shuto, Satoshi/AAH-4998-2020; Im, Dong-Soon/AAH-9104-2020; Arisawa, Mitsuhiro/D-9098-2012	Shuto, Satoshi/0000-0001-7850-8064; Sato, Koichi/0000-0001-7694-4014; Nakakura, Takashi/0000-0003-1898-563X; IM, DONG-SOON/0000-0001-8054-8946; ARISAWA, Mitsuhiro/0000-0002-7937-670X	Japan Society for the Promotion of Science (JSPS) [23659029, 25670617]; National Research Foundation of Korea (NRF) [NRF-2011-0021158]; Joint research program of Institute for Molecular and Cellular Regulation, Gunma University [11025, 14017]; Ministry of Education, Science and Technology; ministry of Education, Culture, Sports, Science and Technology (MEXT)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Joint research program of Institute for Molecular and Cellular Regulation, Gunma University; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The work was supported by the following: Grant-in-Aid for Challenging Exploratory Research (23659029 and 25670617), Japan Society for the Promotion of Science (JSPS), http://www.jsps.go.jp/jgrantsinaid/03_keikaku/download.html, FO; Basic Science Research Program through the National Research Foundation of Korea (NRF) (NRF-2011-0021158), Ministry of Education, Science and Technology, http://www.nrf.re.kr/nrf_eng_cms/, DI; Joint research program of the Institute for Molecular and Cellular Regulation, Gunma University (11025), The ministry of Education, Culture, Sports, Science and Technology (MEXT), http://www.imcr.gunma-u.ac.jp/activity/activity3, HK; and Joint research program of the Institute for Molecular and Cellular Regulation, Gunma University (14017), The ministry of Education, Culture, Sports, Science and Technology (MEXT), http://www.imcr.gunma-u.ac.jp/activity/activity3, MN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki H, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/712962; Aoki H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079985; Bernat V, 2014, ACS CHEM BIOL, V9, P2664, DOI 10.1021/cb500678c; Bhowmick N, 1998, ENDOCRINOLOGY, V139, P3185, DOI 10.1210/en.139.7.3185; Chen AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027586; Dong LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061991; Engers DW, 2014, DRUG DISCOV TODAY TE, V10, pe269; Fukunaga S, 2006, LIFE SCI, V80, P17, DOI 10.1016/j.lfs.2006.08.022; Ichimonji I, 2010, AM J PHYSIOL-LUNG C, V299, pL567, DOI 10.1152/ajplung.00415.2009; Im DS, 2001, J CELL BIOL, V153, P429, DOI 10.1083/jcb.153.2.429; Jin Y, 2014, J NEUROCHEM, V129, P683, DOI 10.1111/jnc.12661; Justus CR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00354; Kabarowski JH, 2009, PROSTAG OTH LIPID M, V89, P73, DOI 10.1016/j.prostaglandins.2009.04.007; Kanazawa T, 2000, J CELL BIOL, V149, P943, DOI 10.1083/jcb.149.4.943; Kimura T, 2001, J BIOL CHEM, V276, P31780, DOI 10.1074/jbc.M104353200; Kimura T, 2010, J BIOL CHEM, V285, P4387, DOI 10.1074/jbc.M109.043869; Kotake M, 2014, CELL SIGNAL, V26, P2326, DOI 10.1016/j.cellsig.2014.07.010; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; Li YD, 2014, PEDIATR NEUROL, V51, P600, DOI 10.1016/j.pediatrneurol.2014.08.003; Liu JP, 2010, AM J PHYSIOL-HEART C, V299, pH731, DOI 10.1152/ajpheart.00977.2009; Liu JP, 2010, PHARMACOL RES, V61, P499, DOI 10.1016/j.phrs.2010.02.013; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Matsuzaki S, 2011, BIOCHEM BIOPH RES CO, V413, P499, DOI 10.1016/j.bbrc.2011.08.087; Mogi C, 2005, J PHARMACOL SCI, V99, P160, DOI 10.1254/jphs.FP0050599; Murakami N, 2004, J BIOL CHEM, V279, P42484, DOI 10.1074/jbc.M406561200; Navarro A, 1999, BRAIN RES, V816, P47, DOI 10.1016/S0006-8993(98)01062-2; Obinata H, 2009, PROSTAG OTH LIPID M, V89, P66, DOI 10.1016/j.prostaglandins.2008.11.002; Okajima F, 2013, CELL SIGNAL, V25, P2263, DOI 10.1016/j.cellsig.2013.07.022; Pfeiffer R, 1998, EXP CELL RES, V244, P327, DOI 10.1006/excr.1998.4159; Radu CG, 2005, P NATL ACAD SCI USA, V102, P1632, DOI 10.1073/pnas.0409415102; Roettger BF, 1997, MOL PHARMACOL, V51, P357; Saki M, 2004, International patent application, Patent No. [WO 2004/093912 A1, 2004093912, PCT/JP2004/005930, WO2004/093912 A1]; Seuwen K, 2006, J RECEPT SIG TRANSD, V26, P599, DOI 10.1080/10799890600932220; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Suzuki K, 1998, NEUROCHEM RES, V23, P251, DOI 10.1023/A:1022436928925; Taracido IC, 2009, United States patent application, Patent No. [12/468,706, 12468706]; Tobo M, 2007, CELL SIGNAL, V19, P1745, DOI 10.1016/j.cellsig.2007.03.009; Tomura H, 2005, J BIOL CHEM, V280, P34458, DOI 10.1074/jbc.M505287200; Tomura H, 2005, CELL SIGNAL, V17, P1466, DOI 10.1016/j.cellsig.2005.06.002; Tomura H, 2008, J BONE MINER RES, V23, P1129, DOI 10.1359/JBMR.080236; Voccoli V, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.483; Wang JQ, 2004, J BIOL CHEM, V279, P45626, DOI 10.1074/jbc.M406966200; Willins DL, 1998, ANN NY ACAD SCI, V861, P121, DOI 10.1111/j.1749-6632.1998.tb10182.x; Xu Y, 2002, BBA-MOL CELL BIOL L, V1582, P81, DOI 10.1016/S1388-1981(02)00140-3	44	23	23	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129334	10.1371/journal.pone.0129334	http://dx.doi.org/10.1371/journal.pone.0129334			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070068	Green Submitted, Green Published, gold			2022-12-26	WOS:000356327000066
J	Burdine, LJ; Burdine, MS; Moreland, L; Fogel, B; Orr, LM; James, J; Turnage, RH; Tackett, AJ				Burdine, Lyle J.; Burdine, Marie Schluterman; Moreland, Linley; Fogel, Brad; Orr, Lisa M.; James, Jennifer; Turnage, Richard H.; Tackett, Alan J.			Proteomic Identification of DNA-PK Involvement within the RET Signaling Pathway	PLOS ONE			English	Article							MEDULLARY-THYROID CARCINOMA; TYROSINE KINASE ACTIVATION; N-MC CELLS; CANCER-CELLS; GENOMIC LOCUS; INHIBITION; PHOSPHORYLATION; PROTOONCOGENE; PROGRESSION; APOPTOSIS	Constitutive activation of the Rearranged during Transfection (RET) proto-oncogene leads to the development of MEN2A medullary thyroid cancer (MTC). The relatively clear genotype/phenotype relationship seen with RET mutations and the development of MEN2A is unusual in the fact that a single gene activity can drive the progression towards metastatic disease. Despite knowing the oncogene responsible for MEN2A, MTC, like most tumors of neural crest origin, remains largely resistant to chemotherapy. Constitutive activation of RET in a SK-N-MC cell line model reduces cell sensitivity to chemotherapy. In an attempt to identify components of the machinery responsible for the observed RET induced chemoresistance, we performed a proteomic screen of histones and associated proteins in cells with a constitutively active RET signaling pathway. The proteomic approach identified DNA-PKcs, a DNA damage response protein, as a target of the RET signaling pathway. Active DNA-PKcs, which is phosphorylated at site serine 2056 and localized to chromatin, was elevated within our model. Treatment with the RET inhibitor RPI-1 significantly reduced s2056 phosphorylation in RET cells as well as in a human medullary thyroid cancer cell line. Additionally, inhibition of DNA-PKcs activity diminished the chemoresistance observed in both cell lines. Importantly, we show that activated DNA-PKcs is elevated in medullary thyroid tumor samples and that expression correlates with expression of RET in thyroid tumors. These results highlight one mechanism by which RET signaling likely primes cells for rapid response to DNA damage and suggests DNA-PKcs as an additional target in MTC.	[Burdine, Lyle J.; Turnage, Richard H.] Univ Arkansas Med Sci, Dept Surg, Little Rock, AR 72205 USA; [Burdine, Marie Schluterman; Moreland, Linley; Orr, Lisa M.; Tackett, Alan J.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Fogel, Brad; James, Jennifer] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Burdine, LJ (corresponding author), Univ Arkansas Med Sci, Dept Surg, Little Rock, AR 72205 USA.	LJBurdine@UAMS.edu	Burdine, Lyle/GLR-7495-2022; Burdine, Marie Schluterman/GLU-1812-2022	Burdine, Marie Schluterman/0000-0002-3940-5748	UAMS Department of Surgery	UAMS Department of Surgery	This work was funded by the UAMS Department of Surgery.	An J, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-18; Byrum S, 2011, J CUTAN PATHOL, V38, P933, DOI 10.1111/j.1600-0560.2011.01761.x; Byrum SD, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt822; Byrum SD, 2012, CELL REP, V2, P198, DOI 10.1016/j.celrep.2012.06.019; CARLOMAGNO F, 1995, BIOCHEM BIOPH RES CO, V207, P1022, DOI 10.1006/bbrc.1995.1287; Carter MT, 2001, CYTOGENET CELL GENET, V95, P169, DOI 10.1159/000059341; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; Cuccuru G, 2004, JNCI-J NATL CANCER I, V96, P1006, DOI 10.1093/jnci/djh184; Davis AJ, 2013, TRANSL CANCER RES, V2, P130, DOI 10.3978/j.issn.2218-676X.2013.04.02; Dittmann K, 2005, RADIOTHER ONCOL, V76, P157, DOI 10.1016/j.radonc.2005.06.022; Du L, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-70; Hansford JR, 2000, J MED GENET, V37, P817, DOI 10.1136/jmg.37.11.817; Jufvas A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015960; Minjgee M, 2011, INT J RADIAT ONCOL, V81, P1506, DOI 10.1016/j.ijrobp.2011.05.057; Mologni L, 2011, CURR MED CHEM, V18, P162, DOI 10.2174/092986711794088308; Munck JM, 2012, MOL CANCER THER, V11, P1789, DOI 10.1158/1535-7163.MCT-11-0535; Narita N, 2009, ONCOGENE, V28, P3058, DOI 10.1038/onc.2009.164; Pacini F, 2010, CLIN ONCOL-UK, V22, P475, DOI 10.1016/j.clon.2010.05.002; Pandit SD, 1997, J BIOL CHEM, V272, P2199; Phay JE, 2010, CLIN CANCER RES, V16, P5936, DOI 10.1158/1078-0432.CCR-09-0786; Plaza-Menacho I, 2006, TRENDS GENET, V22, P627, DOI 10.1016/j.tig.2006.09.005; Skinner MA, 2008, ANTICANCER RES, V28, P2019; Stronach EA, 2011, NEOPLASIA, V13, P1069, DOI 10.1593/neo.111032; Toulany M, 2012, MOL CANCER RES, V10, P945, DOI 10.1158/1541-7786.MCR-11-0592; vanPuijenbroek AAFL, 1997, ONCOGENE, V14, P1147, DOI 10.1038/sj.onc.1200911; vanWeering DHJ, 1995, ONCOGENE, V11, P2207; vanWeering DHJ, 1997, J BIOL CHEM, V272, P249; Verbeek HHG, 2011, J CLIN ENDOCR METAB, V96, pE991, DOI 10.1210/jc.2010-2381; Yamada Y, 2010, ADV GENET, V70, P177, DOI [10.1016/B978-0-12-380866-0.60007-1, 10.1016/S0065-2660(10)70007-9]; Zhao Y, 2006, CANCER RES, V66, P5354, DOI 10.1158/0008-5472.CAN-05-4275	30	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0127943	10.1371/journal.pone.0127943	http://dx.doi.org/10.1371/journal.pone.0127943			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26065416	Green Published, gold, Green Submitted			2022-12-26	WOS:000356100900015
J	Albeke, SE; Nibbelink, NP; Ben-David, M				Albeke, Shannon E.; Nibbelink, Nathan P.; Ben-David, Merav			Modeling Behavior by Coastal River Otter (Lontra Canadensis) in Response to Prey Availability in Prince William Sound, Alaska: A Spatially-Explicit Individual-Based Approach	PLOS ONE			English	Article							VALDEZ OIL-SPILL; RANDOM-WALK MODELS; CLIMATE-CHANGE; NORTHERN GULF; LIFE-HISTORY; HOME RANGES; NITROGEN DEPOSITION; MIGRATION PHENOLOGY; LUTRA-CANADENSIS; ANIMAL MOVEMENT	Effects of climate change on animal behavior and cascading ecosystem responses are rarely evaluated. In coastal Alaska, social river otters (Lontra Canadensis), largely males, cooperatively forage on schooling fish and use latrine sites to communicate group associations and dominance. Conversely, solitary otters, mainly females, feed on intertidal-demersal fish and display mutual avoidance via scent marking. This behavioral variability creates "hotspots" of nutrient deposition and affects plant productivity and diversity on the terrestrial landscape. Because the abundance of schooling pelagic fish is predicted to decline with climate change, we developed a spatially-explicit individual-based model (IBM) of otter behavior and tested six scenarios based on potential shifts to distribution patterns of schooling fish. Emergent patterns from the IBM closely mimicked observed otter behavior and landscape use in the absence of explicit rules of intraspecific attraction or repulsion. Model results were most sensitive to rules regarding spatial memory and activity state following an encounter with a fish school. With declining availability of schooling fish, the number of social groups and the time simulated otters spent in the company of conspecifics declined. Concurrently, model results suggested an elevation of defecation rate, a 25% increase in nitrogen transport to the terrestrial landscape, and significant changes to the spatial distribution of "hotspots" with declines in schooling fish availability. However, reductions in availability of schooling fish could lead to declines in otter density over time.	[Albeke, Shannon E.] Univ Wyoming, Wyoming Geog Informat Sci Ctr, Laramie, WY 82071 USA; [Nibbelink, Nathan P.] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Ben-David, Merav] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA	University of Wyoming; University System of Georgia; University of Georgia; University of Wyoming	Albeke, SE (corresponding author), Univ Wyoming, Wyoming Geog Informat Sci Ctr, Laramie, WY 82071 USA.	salbeke@uwyo.edu	Kang, Sonia/L-4802-2016; Albeke, Shannon/J-1668-2012	Kang, Sonia/0000-0002-0293-5323; Albeke, Shannon/0000-0001-7297-8049	National Science Foundation [0454474]; University of Georgia; Warnell School of Forestry and Natural Resources; University of Wyoming	National Science Foundation(National Science Foundation (NSF)); University of Georgia; Warnell School of Forestry and Natural Resources; University of Wyoming	Funding for this project was provided by the National Science Foundation (http://www.nsf.gov/) DEB #0454474, the University of Georgia (http://uga.edu) Warnell School of Forestry and Natural Resources (http://www.warnell.uga.edu/), and the University of Wyoming (http://uwyo.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeke SE, 2010, INFLUENCE INDIVIDUAL; ALT W, 1980, J MATH BIOL, V9, P147, DOI 10.1007/BF00275919; Amstrup SC, 2005, HDB CAPTURE RECAPTUR; Anderson PJ, 1997, 9701 U AL, P531; Anderson WB, 1998, OIKOS, V81, P75, DOI 10.2307/3546469; Anthony JA, 2000, J EXP MAR BIOL ECOL, V248, P53, DOI 10.1016/S0022-0981(00)00159-3; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Avgar T, 2013, ECOL MODEL, V251, P158, DOI 10.1016/j.ecolmodel.2012.12.002; Bargmann G, 1998, FORAGE FISH MANAGEME, P77; Barocas A, 2012, MEASURING ASS RIVER; Ben-David M, 1998, ECOLOGY, V79, P2567, DOI 10.2307/176846; Ben-David M, 2005, ECOLOGY, V86, P1331, DOI 10.1890/04-0783; Blackwell PG, 1997, ECOL MODEL, V100, P87, DOI 10.1016/S0304-3800(97)00153-1; Blundell Gail M., 2000, P325; Blundell GM, 2004, BEHAV ECOL, V15, P705, DOI 10.1093/beheco/arh110; Blundell GM, 2002, BEHAV ECOL, V13, P134, DOI 10.1093/beheco/13.1.134; Blundell GM, 2002, MOL ECOL, V11, P289, DOI 10.1046/j.0962-1083.2001.01440.x; Blundell GM, 2001, ECOL MONOGR, V71, P469, DOI 10.1890/0012-9615(2001)071[0469:LHREOS]2.0.CO;2; BOWYER RT, 1995, J MAMMAL, V76, P1, DOI 10.2307/1382309; Bowyer RT, 2003, WILDLIFE MONOGR, P1; Brown ED, 2002, ICES J MAR SCI, V59, P983, DOI 10.1006/jmsc.2002.1281; Brown ED, 1999, LOW WAKE FI, V16, P499; CARR GM, 1986, ANIM BEHAV, V34, P1540, DOI 10.1016/S0003-3472(86)80223-8; Chapman J. A., 1982, WILD MAMMALS N AM BI; Cherry SG, 2013, J ANIM ECOL, V82, P912, DOI 10.1111/1365-2656.12050; CLAYTON NS, 1995, J NEUROSCI, V15, P2796; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; Colchero F, 2009, J ANIM ECOL, V78, P666, DOI 10.1111/j.1365-2656.2009.01528.x; Cooney RT, 2001, FISH OCEANOGR, V10, P1, DOI 10.1046/j.1054-6006.2001.00039.x; Crait JR, 2006, AM MIDL NAT, V156, P189, DOI 10.1674/0003-0031(2006)156[189:LSBORO]2.0.CO;2; Croll DA, 2005, SCIENCE, V307, P1959, DOI 10.1126/science.1108485; Czembor CA, 2011, J APPL ECOL, V48, P736, DOI 10.1111/j.1365-2664.2011.01971.x; Dean TA, 1998, MAR POLLUT BULL, V36, P201, DOI 10.1016/S0025-326X(97)00184-7; Dean TA, 1996, AM FISH S S, V18, P412; Dean TA, 2000, ENVIRON BIOL FISH, V57, P271, DOI 10.1023/A:1007652730085; DUNNING JB, 1995, ECOL APPL, V5, P3, DOI 10.2307/1942045; Durner GM, 2009, ECOL MONOGR, V79, P25, DOI 10.1890/07-2089.1; Gibeault S, 2000, PRIMATES, V41, P147, DOI 10.1007/BF02557796; GIBLIN AE, 1991, ECOL MONOGR, V61, P415, DOI 10.2307/2937049; Gilfillan ES, 1995, AM SOC TEST MATER, V1219, P444, DOI 10.1520/STP19872S; Gorman TA, 2006, J MAMMAL, V87, P740, DOI 10.1644/05-MAMM-A-337R1.1; Graham CH, 2010, ECOGRAPHY, V33, P1062, DOI 10.1111/j.1600-0587.2010.06430.x; Grimm V, 1999, ECOL MODEL, V115, P129, DOI 10.1016/S0304-3800(98)00188-4; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Guertin DA, 2012, J WILDLIFE MANAGE, V76, P1540, DOI 10.1002/jwmg.439; HAEGELE CW, 1985, CAN J FISH AQUAT SCI, V42, P39, DOI 10.1139/f85-261; Hansen H, 2009, ETHOLOGY, V115, P384, DOI 10.1111/j.1439-0310.2009.01624.x; HILL MO, 1980, VEGETATIO, V42, P47, DOI 10.1007/BF00048870; Hobson KA, 1999, J WILDLIFE MANAGE, V63, P14, DOI 10.2307/3802483; Holding ML, 2012, BRAIN BEHAV EVOLUT, V79, P144, DOI 10.1159/000335034; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; Hunter CM, 2010, ECOLOGY, V91, P2883, DOI 10.1890/09-1641.1; Hyvonen R, 2007, NEW PHYTOL, V173, P463, DOI 10.1111/j.1469-8137.2007.01967.x; Jenni L, 2003, P ROY SOC B-BIOL SCI, V270, P1467, DOI 10.1098/rspb.2003.2394; Jewett SC, 2008, 605 N PAC RES BOARD; Jiguet F, 2007, GLOBAL CHANGE BIOL, V13, P1672, DOI 10.1111/j.1365-2486.2007.01386.x; Kean EF, 2011, CHEM SENSES, V36, P555, DOI 10.1093/chemse/bjr025; KRUUK H, 1991, J APPL ECOL, V28, P95, DOI 10.2307/2404116; Lariviere Serge, 1998, Mammalian Species, V587, P1; LARSEN DN, 1984, J WILDLIFE MANAGE, V48, P1446, DOI 10.2307/3801818; Larsen DN, 1983, HABITATS MOVEMENTS F; Lavenex P, 2000, J COMP NEUROL, V425, P152; Lenth R., 2019, Journal of Statistical Software, V60, P1; Lilleskov EA, 2001, ECOL APPL, V11, P397, DOI 10.1890/1051-0761(2001)011[0397:EFACCO]2.0.CO;2; Lopez U., 2012, INTERFACE FOCUS; Lukeman R, 2010, P NATL ACAD SCI USA, V107, P12576, DOI 10.1073/pnas.1001763107; MANGEL M, 1990, ANIM BEHAV, V39, P1163, DOI 10.1016/S0003-3472(05)80788-2; Marra PP, 2005, OECOLOGIA, V142, P307, DOI 10.1007/s00442-004-1725-x; MCROY CP, 1970, J FISH RES BOARD CAN, V27, P1811, DOI 10.1139/f70-199; MCROY CP, 1968, PAC SCI, V22, P507; Melquist W.E., 1983, WILDLIFE MONOGR, V83, P3; Mowry RA, 2011, J WILDLIFE MANAGE, V75, P1625, DOI 10.1002/jwmg.193; Mulder CPH, 2001, OECOLOGIA, V127, P350, DOI 10.1007/s004420000600; NGDC, 2007, BATH TOP REL; NOAA, 2007, TID STAT LOC RANG; Norcross BL, 2001, FISH OCEANOGR, V10, P42, DOI 10.1046/j.1054-6006.2001.00040.x; Oksanen J, 1997, J VEG SCI, V8, P447, DOI 10.2307/3237336; Ormseth OA, 2000, J COMP PHYSIOL B, V170, P419, DOI 10.1007/s003600000119; OTHMER HG, 1988, J MATH BIOL, V26, P263, DOI 10.1007/BF00277392; Ott KE, 2009, RECOLONIZATION LOCAL; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Pascual M, 1999, ECOLOGY, V80, P2225, DOI 10.1890/0012-9658(1999)080[2225:FITPDS]2.0.CO;2; PATLAK CLIFFORD S., 1953, BULL MATH BIOPHYS, V15, P311, DOI 10.1007/BF02476407; Pearson WH, 2012, REV FISH BIOL FISHER, V22, P95, DOI 10.1007/s11160-011-9225-7; Penttila D., 2007, MARINE FORAGE FISHES; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Post E, 1999, NATURE, V401, P905, DOI 10.1038/44814; R Core Team, 2012, R LANG ENV STAT COMP; Railsback SF, 2001, ECOL MODEL, V139, P47, DOI 10.1016/S0304-3800(01)00228-9; Regehr EV, 2010, J ANIM ECOL, V79, P117, DOI 10.1111/j.1365-2656.2009.01603.x; Robards MD, 1999, J FISH BIOL, V54, P1050, DOI 10.1006/jfbi.1999.0941; ROCK KR, 1994, CAN FIELD NAT, V108, P367; Roe AM, 2010, ECOLOGY, V91, P3177, DOI 10.1890/09-1216.1; Roe AM, 2008, EFFECTS COASTAL RIVE; Rostain RR, 2004, ANIM BEHAV, V68, P703, DOI 10.1016/j.anbehav.2003.10.027; Saino N, 2009, BIOL LETTERS, V5, P539, DOI 10.1098/rsbl.2009.0312; Schluessel V, 2012, ZOOLOGY, V115, P346, DOI 10.1016/j.zool.2012.05.001; Serfass TL, 1995, CAN FIELD NAT, V109, P458; Shumway CA, 2008, BRAIN BEHAV EVOLUT, V72, P123, DOI 10.1159/000151472; Spencer WD, 2012, J MAMMAL, V93, P929, DOI 10.1644/12-MAMM-S-061.1; Stekoll MS, 1996, AM FISH S S, V18, P177; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; TESTA JW, 1994, J MAMMAL, V75, P1021, DOI 10.2307/1382485; Thomas CD, 2011, METHODS ECOL EVOL, V2, P125, DOI 10.1111/j.2041-210X.2010.00065.x; Thorsteinson LK, 2002, FISHES ALASKA; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001; Uchmanski J, 1996, TRENDS ECOL EVOL, V11, P437, DOI 10.1016/0169-5347(96)20091-6; Vincenot CE, 2011, ECOL MODEL, V222, P210, DOI 10.1016/j.ecolmodel.2010.09.029; Vuilleumier S, 2006, ECOL MODEL, V190, P159, DOI 10.1016/j.ecolmodel.2005.04.017; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wiederholt R, 2010, BIOL LETTERS, V6, P257, DOI 10.1098/rsbl.2009.0710; Wilmers CC, 2012, FRONT ECOL ENVIRON, V10, P409, DOI 10.1890/110176	114	6	6	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0126208	10.1371/journal.pone.0126208	http://dx.doi.org/10.1371/journal.pone.0126208			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061497	Green Published, gold, Green Submitted			2022-12-26	WOS:000355979500012
J	Nogueira, SSD; Fernandes, IK; Costa, TSO; Nogueira, SLG; Mendl, M				da Cunha Nogueira, Selene Siqueira; Fernandes, Iurianny Karla; Oliveira Costa, Thaise Silva; Gama Nogueira-Filho, Sergio Luiz; Mendl, Michael			Does Trapping Influence Decision-Making under Ambiguity in White-Lipped Peccary (Tayassu pecari)?	PLOS ONE			English	Article							STARLINGS STURNUS-VULGARIS; COGNITIVE BIAS; HOME-RANGE; ENVIRONMENTAL ENRICHMENT; COLLARED PECCARIES; ANIMAL EMOTION; MEXICO; TASK; PATTERNS; CALAKMUL	The white-lipped peccary (Tayassu pecari) is an endangered species whose bold antipredator behaviour in comparison to related species may increase its vulnerability to hunting and predation. We used a judgement bias test to investigate whether captive peccaries that had recently experienced a trapping event made more 'pessimistic' decisions under ambiguity. If so, this would indicate (i) that the procedure may induce a negative affective state and hence have welfare implications, and (ii) that the species is able to adopt a cautious response style despite its bold phenotype. Eight individuals were trained to 'go' to a baited food bowl when a positive auditory cue (whistle; CS+) was given and to 'no-go' when a negative cue (horn A; CS-) was sounded to avoid a loud sound and empty food bowl. An 'ambiguous' auditory cue (bell; CSA) was presented to probe decision-making under ambiguity. Individuals were subjected to three tests in the order: T1 (control-no trap), T2 (24h after-trap procedure), and T3 (control-no trap). In each test, each animal was exposed to 10 judgement bias trials of each of the three cue types: CS+, CS-, CSA. We recorded whether animals reached the food bowl within 60s ('go' response) and their response speed (m/s). The animals varied in their responses to the CSA cue depending on test type. In all tests, animals made more 'go' responses to CS+ than CSA. During control tests (T1 and T3), the peccaries showed higher proportions of 'go' responses to CSA than to CS-. In T2, however, the animals showed similar proportions of 'go' responses to CSA and CS-, treating the ambiguous cue similarly to the negative cue. There were differences in their response speed according to cue type: peccaries were faster to respond to CS+ than to CS- and CSA. Trapping thus appeared to cause a 'pessimistic' judgement bias in peccaries, which may reflect a negative affective state with implications for the welfare and management of captive individuals, and also function to increase caution and survival chances following such an event in the wild environment.	[da Cunha Nogueira, Selene Siqueira; Fernandes, Iurianny Karla; Oliveira Costa, Thaise Silva; Gama Nogueira-Filho, Sergio Luiz] Univ Estadual Santa Cruz, Ilheus, BA, Brazil; [Mendl, Michael] Univ Bristol, Bristol, Avon, England	Universidade Estadual de Santa Cruz; University of Bristol	Nogueira, SSD (corresponding author), Univ Estadual Santa Cruz, Ilheus, BA, Brazil.	selene.nogueira@pq.cnpq.br	Nogueira, Selene/I-1843-2013; Mendl, Michael T/D-7220-2016; Nogueira-Filho, Sérgio L.G./F-6264-2014; Nogueira, Selene/W-5237-2019	Nogueira, Selene/0000-0001-8078-4172; Mendl, Michael T/0000-0002-5302-1871; Nogueira, Selene/0000-0001-8078-4172; Nogueira-Filho, Sergio/0000-0001-5392-0773	National Counsel of Technological and Scientific Development (CNPq) [476741/2010-6]; CAPES (PROCAD-NF); CNPq [306154/2010-2, 305428/2012-8]; CAPES (PNPD)	National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (PROCAD-NF)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (PNPD)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was under the auspices of the National Counsel of Technological and Scientific Development (CNPq Process # 476741/2010-6) and CAPES (PROCAD-NF and PNPD-2010). SSCN and SLGNF were supported by the CNPq (Process # 306154/2010-2 and 305428/2012-8, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altrichter M, 2012, ORYX, V46, P87, DOI 10.1017/S0030605311000421; [Anonymous], 2007, LEARNING BEHAV CONT; Bateson M, 2007, ANIM WELFARE, V16, P33; Bateson M, 2011, CURR BIOL, V21, P1070, DOI 10.1016/j.cub.2011.05.017; Bethell EJ, 2012, ANIM WELFARE, V21, P185, DOI 10.7120/09627286.21.2.185; Brilot BO, 2010, ANIM COGN, V13, P721, DOI 10.1007/s10071-010-0323-z; Burman OHP, 2008, ANIM BEHAV, V76, P801, DOI 10.1016/j.anbehav.2008.02.014; Cullen L, 2001, ORYX, V35, P137, DOI 10.1017/S0030605300031690; Jacomo ATD, 2013, J MAMMAL, V94, P137, DOI 10.1644/11-MAMM-A-411.1; Desire L, 2002, BEHAV PROCESS, V60, P165, DOI 10.1016/S0376-6357(02)00081-5; Destrez A, 2013, APPL ANIM BEHAV SCI, V148, P28, DOI 10.1016/j.applanim.2013.07.016; Douglas C, 2012, APPL ANIM BEHAV SCI, V139, P65, DOI 10.1016/j.applanim.2012.02.018; Doyle RE, 2010, BEHAV PROCESS, V83, P349, DOI 10.1016/j.beproc.2010.01.019; Fragoso JMV, 1998, BIOTROPICA, V30, P458, DOI 10.1111/j.1744-7429.1998.tb00080.x; Fragoso JMV, 1999, J MAMMAL, V80, P993, DOI 10.2307/1383270; GALLAGHER JF, 1984, J WILDLIFE MANAGE, V48, P749, DOI 10.2307/3801422; Harding EJ, 2004, NATURE, V427, P312, DOI 10.1038/427312a; Iwamura T, 2014, ENVIRON MODELL SOFTW, V58, P109, DOI 10.1016/j.envsoft.2014.03.008; Keen HA, 2014, ANIM COGN, V17, P529, DOI 10.1007/s10071-013-0684-1; Keuroghlian A., 2013, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2013-1.RLTS.T41778A44051115.EN; KILTIE RA, 1980, THESIS PRINCETON U P; Matheson SM, 2008, APPL ANIM BEHAV SCI, V109, P374, DOI 10.1016/j.applanim.2007.03.007; Mendl M, 2010, P ROY SOC B-BIOL SCI, V277, P2895, DOI 10.1098/rspb.2010.0303; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; Morellet N, 2009, WILDLIFE BIOL, V15, P278, DOI 10.2981/08-084; Murphy E, 2013, APPL ANIM BEHAV SCI, V148, P64, DOI 10.1016/j.applanim.2013.07.011; Nogueira SSC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086080; Nogueira-Filho Sergio L.G., 2012, Suiform Soundings, V11, P21; Paul ES, 2005, NEUROSCI BIOBEHAV R, V29, P469, DOI 10.1016/j.neubiorev.2005.01.002; Peres CA, 1996, BIOL CONSERV, V77, P115, DOI 10.1016/0006-3207(96)00010-9; Peres CA, 2001, CONSERV BIOL, V15, P1490, DOI 10.1046/j.1523-1739.2001.01089.x; Reyna-Hurtado R, 2012, J MAMMAL, V93, P124, DOI 10.1644/10-MAMM-A-384.1; Reyna-Hurtado R, 2010, ORYX, V44, P89, DOI 10.1017/S0030605309990664; Reyna-Hurtado R, 2009, J MAMMAL, V90, P1199, DOI 10.1644/08-MAMM-A-246.1; Rygula R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051959; Shepard GH, 2012, AM ANTHROPOL, V114, P652, DOI 10.1111/j.1548-1433.2012.01514.x; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sowls LK., 1997, JAVELINAS OTHER PECC; Teixeira CP, 2007, ANIM BEHAV, V73, P1, DOI 10.1016/j.anbehav.2006.06.002; Ticktin T, 2003, BIOTROPICA, V35, P189, DOI 10.1111/j.1744-7429.2003.tb00278.x; Weber M, 2006, WILDLIFE SOC B, V34, P1480, DOI 10.2193/0091-7648(2006)34[1480:TTOTCW]2.0.CO;2	41	12	13	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0127868	10.1371/journal.pone.0127868	http://dx.doi.org/10.1371/journal.pone.0127868			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK1PO	26061658	Green Published, Green Submitted, gold			2022-12-26	WOS:000355979500062
J	Kim, K; Lee, SC; Lee, J; Lee, HO; Joh, HJ; Kim, NH; Park, HS; Yang, TJ				Kim, Kyunghee; Lee, Sang-Choon; Lee, Junki; Lee, Hyun Oh; Joh, Ho Jun; Kim, Nam-Hoon; Park, Hyun-Seung; Yang, Tae-Jin			Comprehensive Survey of Genetic Diversity in Chloroplast Genomes and 45S nrDNAs within Panax ginseng Species	PLOS ONE			English	Article							NUCLEAR RIBOSOMAL DNA; PHYLOGENETIC ANALYSIS; KOREAN GINSENG; LAND PLANTS; SEQUENCES; EVOLUTION; AUTHENTICATION; MITOCHONDRIAL; ANNOTATION; GENERATION	We report complete sequences of chloroplast (cp) genome and 45S nuclear ribosomal DNA (45S nrDNA) for 11 Panax ginseng cultivars. We have obtained complete sequences of cp and 45S nrDNA, the representative barcoding target sequences for cytoplasm and nuclear genome, respectively, based on low coverage NGS sequence of each cultivar. The cp genomes sizes ranged from 156,241 to 156,425 bp and the major size variation was derived from differences in copy number of tandem repeats in the ycf1 gene and in the intergenic regions of rps16-trnUUG and rpl32-trnUAG. The complete 45S nrDNA unit sequences were 11,091 bp, representing a consensus single transcriptional unit with an intergenic spacer region. Comparative analysis of these sequences as well as those previously reported for three Chinese accessions identified very rare but unique polymorphism in the cp genome within P. ginseng cultivars. There were 12 intra-species polymorphisms (six SNPs and six InDels) among 14 cultivars. We also identified five SNPs from 45S nrDNA of 11 Korean ginseng cultivars. From the 17 unique informative polymorphic sites, we developed six reliable markers for analysis of ginseng diversity and cultivar authentication.	[Kim, Kyunghee; Lee, Sang-Choon; Lee, Junki; Lee, Hyun Oh; Joh, Ho Jun; Kim, Nam-Hoon; Park, Hyun-Seung; Yang, Tae-Jin] Seoul Natl Univ, Coll Agr & Life Sci, Plant Genom & Breeding Inst, Dept Plant Sci, Seoul 151921, South Korea; [Kim, Kyunghee; Lee, Sang-Choon; Lee, Junki; Lee, Hyun Oh; Joh, Ho Jun; Kim, Nam-Hoon; Park, Hyun-Seung; Yang, Tae-Jin] Seoul Natl Univ, Coll Agr & Life Sci, Res Inst Agr & Life Sci, Seoul 151921, South Korea; [Kim, Kyunghee] Phyzen Genom Inst, Seoul 151836, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Yang, TJ (corresponding author), Seoul Natl Univ, Coll Agr & Life Sci, Plant Genom & Breeding Inst, Dept Plant Sci, Seoul 151921, South Korea.	tjyang@snu.ac.kr	Yang, Tae-Jin/AAT-5274-2020		Technology Development Program for Agriculture and Forestry, Ministry for Food, Agriculture, Forestry and Fisheries [609001]; National Institute of Biological Resources under the Ministry of Environment, Republic of Korea; "Next-Generation BioGreen21 Program for Agriculture & Technology Development)" Rural Development Administration [PJ01100801]	Technology Development Program for Agriculture and Forestry, Ministry for Food, Agriculture, Forestry and Fisheries; National Institute of Biological Resources under the Ministry of Environment, Republic of Korea; "Next-Generation BioGreen21 Program for Agriculture & Technology Development)" Rural Development Administration	This research was carried out with the supports by Technology Development Program for Agriculture and Forestry, Ministry for Food, Agriculture, Forestry and Fisheries (Grant no. 609001), "Next-Generation BioGreen21 Program for Agriculture & Technology Development (Project No. PJ01100801)" Rural Development Administration, and " The Genetic Evaluation of Important Biological Resources 2012, 2013" from the National Institute of Biological Resources under the Ministry of Environment, Republic of Korea.	Ahn INok, 2008, Journal of Ginseng Research, V32, P15; Allen GC, 2006, NAT PROTOC, V1, P2320, DOI 10.1038/nprot.2006.384; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Cho KS, 2006, MOL CELLS, V21, P411; Choi HI, 2014, PLANT J, V77, P906, DOI 10.1111/tpj.12441; Choi KT, 1992, J GINSENG RES, V16, P164; Dickison WC, 1996, AM J BOT, V83, P405, DOI 10.2307/2446210; Downie SR, 1996, MOL PHYLOGENET EVOL, V6, P1, DOI 10.1006/mpev.1996.0053; Drescher A, 2000, PLANT J, V22, P97, DOI 10.1046/j.1365-313x.2000.00722.x; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Jung J, 2014, J GINSENG RES, V38, P123, DOI 10.1016/j.jgr.2013.11.017; Kim JH, 2013, GENET RESOUR CROP EV, V60, P413, DOI 10.1007/s10722-012-9844-4; Kim KJ, 2004, DNA RES, V11, P247, DOI 10.1093/dnares/11.4.247; Kim NH, 2014, J GINSENG RES, V38, P130, DOI 10.1016/j.jgr.2013.12.005; Kim NH, 2012, J GINSENG RES, V36, P298, DOI 10.5142/jgr.2012.36.3.298; Kim OT, 2007, PLANT BIOTECHNOL REP, V1, P163, DOI 10.1007/s11816-007-0019-2; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Kwon WS, 2001, J GINSENG RES, V25, P41; Lee J.S., 2008, J GINSENG RES, V32, P257, DOI DOI 10.5142/JGR.2008.32.3.257; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Nikiforova SV, 2013, MOL BIOL EVOL, V30, P1751, DOI 10.1093/molbev/mst092; Park MJ, 2006, FOOD RES INT, V39, P568, DOI 10.1016/j.foodres.2005.11.004; Wen J, 2001, SYST BOT, V26, P144; Wicke S, 2011, MOL PHYLOGENET EVOL, V61, P321, DOI 10.1016/j.ympev.2011.06.023; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; YOKOTA Y, 1989, J BIOL CHEM, V264, P17649; You FM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-59	30	116	123	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0117159	10.1371/journal.pone.0117159	http://dx.doi.org/10.1371/journal.pone.0117159			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061692	Green Submitted, Green Published, gold			2022-12-26	WOS:000355979500001
J	Zhang, TT; Coates, BS; Ge, X; Bai, SX; He, KL; Wang, ZY				Zhang, Tiantao; Coates, Brad S.; Ge, Xing; Bai, Shuxiong; He, Kanglai; Wang, Zhenying			Male- and Female-Biased Gene Expression of Olfactory-Related Genes in the Antennae of Asian Corn Borer, Ostrinia furnacalis (Guenee) (Lepidoptera: Crambidae)	PLOS ONE			English	Article							PHEROMONE-BINDING-PROTEINS; HOST-PLANT EXPERIENCE; SEX-PHEROMONE; NATURAL VARIATION; INSECT OLFACTION; ODORANT RECEPTOR; LIGAND-BINDING; MOTH; SILKWORM; CLONING	The Asian corn borer (ACB), Ostrinia furnacalis (Guenee), is a destructive pest insect of cultivated corn crops, for which antennal-expressed receptors are important to detect olfactory cues for mate attraction and oviposition. Few olfactory related genes were reported in ACB, so we sequenced and characterized the transcriptome of male and female O. furnacalis antennae. Non-normalized male and female O. furnacalis antennal cDNA libraries were sequenced on the Illumina HiSeq 2000 and assembled into a reference transcriptome. Functional gene annotations identified putative olfactory-related genes; 56 odorant receptors (ORs), 23 odorant binding proteins (OBPs), and 10 CSPs. RNA-seq estimates of gene expression respectively showed up-and down-regulation of 79 and 30 genes in female compared to male antennae, which included up-regulation of 8 ORs and 1 PBP gene in male antennae as well as 3 ORs in female antennae. Quantitative real-time RT-PCR analyses validated strong male antennal-biased expression of OfurOR3, 4, 6, 7, 8, 11, 12, 13 and 14 transcripts, whereas OfurOR17 and 18 were specially expressed in female antennae. Sex-biases gene expression described here provides important insight in gene functionalization, and provides candidate genes putatively involved in environmental perception, host plant attraction, and mate recognition.	[Zhang, Tiantao; Ge, Xing; Bai, Shuxiong; He, Kanglai; Wang, Zhenying] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Coates, Brad S.] Iowa State Univ, USDA, ARS, Corn Insects & Crop Genet Res Unit, Ames, IA 50011 USA	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Iowa State University; United States Department of Agriculture (USDA)	Wang, ZY (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	zywang@ippcaas.cn		Coates, Brad/0000-0001-8908-1529; Zhang, Tiantao/0000-0002-7746-7931	National Natural Science Foundation of China [31201753]; Special Fund for Agro-scientific Research in the Public Interest [201303026]; United States Department of Agriculture; 565 Agricultural 566 Research Service (USDA-ARS; CRIS Project) [3625-22000-017-00]; Iowa Agriculture 567 and Home Economics Experiment Station, Ames, IA [3543]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; United States Department of Agriculture(United States Department of Agriculture (USDA)); 565 Agricultural 566 Research Service (USDA-ARS; CRIS Project); Iowa Agriculture 567 and Home Economics Experiment Station, Ames, IA	This work was supported by the National Natural Science Foundation of China (31201753) and Special Fund for Agro-scientific Research in the Public Interest (201303026). A portion of research data analyses and interpretation was supported by the United States Department of Agriculture, 565 Agricultural 566 Research Service (USDA-ARS; CRIS Project 3625-22000-017-00) and the Iowa Agriculture 567 and Home Economics Experiment Station, Ames, IA (Project 3543).	Allen JE, 2011, INSECT BIOCHEM MOLEC, V41, P141, DOI 10.1016/j.ibmb.2010.10.005; Anderson AR, 2009, INSECT BIOCHEM MOLEC, V39, P189, DOI 10.1016/j.ibmb.2008.11.002; Anderson P, 2013, ANIM BEHAV, V85, P1169, DOI 10.1016/j.anbehav.2013.03.002; Angeli S, 1999, EUR J BIOCHEM, V262, P745, DOI 10.1046/j.1432-1327.1999.00438.x; Arya GH, 2010, GENETICS, V186, P1475, DOI 10.1534/genetics.110.123166; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Biessmann H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009471; Campanacci V, 2003, P NATL ACAD SCI USA, V100, P5069, DOI 10.1073/pnas.0836654100; Carey AF, 2011, P NATL ACAD SCI USA, V108, P12987, DOI 10.1073/pnas.1103472108; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Damberger FF, 2007, J MOL BIOL, V373, P811, DOI 10.1016/j.jmb.2007.07.078; Development Core Team, 2014, R LANG ENV STAT COMP; Force A, 1999, GENETICS, V151, P1531; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gong DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-332; Grosse-Wilde E, 2006, CHEM SENSES, V31, P547, DOI 10.1093/chemse/bjj059; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Grosse-Wilde E, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00022; Gu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042871; Guo W, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001291; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Knolhoff LM, 2014, ANNU REV ENTOMOL, V59, P263, DOI 10.1146/annurev-ento-011613-161945; KRIEGER J, 1991, BIOCHIM BIOPHYS ACTA, V1088, P277, DOI 10.1016/0167-4781(91)90064-S; Lartigue A, 2002, J BIOL CHEM, V277, P32094, DOI 10.1074/jbc.M204371200; Lassance JM, 2010, J CHEM ECOL, V36, P1155, DOI 10.1007/s10886-010-9856-5; Lassance JM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-10; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Leal WS, 1999, FEBS LETT, V464, P85, DOI 10.1016/S0014-5793(99)01683-X; Leary GP, 2012, P NATL ACAD SCI USA, V109, P14081, DOI 10.1073/pnas.1204661109; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048260; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maleszka R, 1997, GENE, V202, P39, DOI 10.1016/S0378-1119(97)00448-4; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; Megido RC, 2014, ARTHROPOD-PLANT INTE, V8, P293, DOI 10.1007/s11829-014-9315-2; Miura N, 2009, INT J BIOL SCI, V5, P319; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NAFUS DM, 1991, TROP PEST MANAGE, V37, P41, DOI 10.1080/09670879109371535; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Nakano R, 2008, P NATL ACAD SCI USA, V105, P11812, DOI 10.1073/pnas.0804056105; Ohno S., 1970, P1; Ozaki M, 2003, CHEM SENSES, V28, P349, DOI 10.1093/chemse/28.4.349; Pabinger Stephan, 2014, Biomol Detect Quantif, V1, P23; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pelosi P, 2005, CHEM SENSES, V30, pI291, DOI 10.1093/chemse/bjh229; Plettner E, 2000, BIOCHEMISTRY-US, V39, P8953, DOI 10.1021/bi000461x; Poivet E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060263; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; ROYER L, 1992, CAN ENTOMOL, V124, P113, DOI 10.4039/Ent124113-1; Sakurai T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002115; Sato K, 2009, RESULTS PROBL CELL D, V47, P121, DOI 10.1007/400_2008_10; Schlaepfer MA, 2000, CAN J ZOOL, V78, P2045, DOI 10.1139/cjz-78-11-2045; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Syed Z, 2006, P NATL ACAD SCI USA, V103, P16538, DOI 10.1073/pnas.0607874103; Takanashi T, 2006, J EXP BIOL, V209, P4946, DOI 10.1242/jeb.02587; Takanashi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013144; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka K, 2009, CURR BIOL, V19, P881, DOI 10.1016/j.cub.2009.04.035; Vieira FG, 2011, GENOME BIOL EVOLUTIO; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Vogt RG, 2002, J EXP BIOL, V205, P719; Vogt Richard G., 2003, P391, DOI 10.1016/B978-012107151-6/50016-5; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang P, 2010, GENETICS, V184, P759, DOI 10.1534/genetics.109.113340; Wanner KW, 2007, INSECT MOL BIOL, V16, P107, DOI 10.1111/j.1365-2583.2007.00708.x; Wanner KW, 2007, P NATL ACAD SCI USA, V104, P14383, DOI 10.1073/pnas.0705459104; Wanner KW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008685; Win AT, 2013, ETHOLOGY, V119, P325, DOI 10.1111/eth.12069; Xia QY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r162; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Xu W, 2011, BIOCHEM BIOPH RES CO, V404, P335, DOI 10.1016/j.bbrc.2010.11.119; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yin XW, 2013, CELLULAR MOL LIFE SC, P1; Zhang YD, 2013, SCI WORLD J, DOI 10.1155/2013/130134; Zhao WM, 2011, BIOINFORMATICS, V27, P3076, DOI 10.1093/bioinformatics/btr504; Zhou JJ, 2010, VITAM HORM, V83, P241, DOI 10.1016/S0083-6729(10)83010-9	81	33	41	6	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0128550	10.1371/journal.pone.0128550	http://dx.doi.org/10.1371/journal.pone.0128550			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26062030	Green Submitted, Green Published, gold			2022-12-26	WOS:000355979500088
J	Lei, LL; West, J; Yan, ZJ; Gao, XL; Fang, P; Dennis, JH; Gnatovskiy, L; Wang, WD; Kingston, RE; Wang, Z				Lei, Lenglam; West, Jason; Yan, Zhijiang; Gao, Xiaolin; Fang, Peng; Dennis, Jonathan H.; Gnatovskiy, Leonid; Wang, Weidong; Kingston, Robert E.; Wang, Zhong			BAF250a Protein Regulates Nucleosome Occupancy and Histone Modifications in Priming Embryonic Stem Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-REMODELING COMPLEX; TRANSCRIPTIONAL NETWORK; SELF-RENEWAL; PLURIPOTENCY; GENOME; ESBAF; PROMOTERS; COMPONENT; CLUSTERS; REGIONS	The unique chromatin signature of ES cells is fundamental to the pluripotency and differentiation of ES cells. One key feature is the poised chromatin state of master developmental genes that are transcriptionally repressed in ES cells but ready to be activated in response to differentiation signals. Poised chromatin in ES cells contains both H3 Lys-4 trimethylation (H3K4me3) and H3 Lys-27 trimethylation (H3K27me3) methylation, indicating activating and repressing potential. However, the contribution of non-covalent chromatin structure to the poised state is not well understood. To address whether remodeling of nucleosomes is important to the poised state, we characterized the function of BAF250a, a key regulatory subunit of the ES cell ATP-dependent Brahma-associated factor (BAF) chromatin remodeling complex (esBAF). Acute deletion of BAF250a disrupted the differentiation potential of ES cells by altering the expression timing of key developmental genes and pluripotent genes. Our genome-wide nucleosome and histone modification analyses indicated that the disruption of gene expression timing was largely due to changes of chromatin structures at poised genes, particularly those key developmental genes mediated by BAF250a. Specifically, BAF250a deletion caused a nucleosome occupancy increase at H3K4me3- and/or H3K27me3-associated promoters. Moreover, H3K27me3 levels and the number of bivalent promoter genes were reduced in BAF250aKOES cells. We revealed that BAF250a ablation led to elevated Brg1 but reduced Suz12 recruitment at nucleosome occupancy-increased regions, indicating an unexpected and complicated role of BAF250a in regulating esBAF and Polycomb repressive complex (PRC) activities. Together, our studies identified that BAF250a mediates esBAF and PRC functions to establish the poised chromatin configuration in ES cells, which is essential for the proper differentiation of ES cells.	[Lei, Lenglam; Gnatovskiy, Leonid; Wang, Zhong] Univ Michigan, Dept Cardiac Surg, Cardiovasc Res Ctr, Ann Arbor, MI 48109 USA; [West, Jason; Kingston, Robert E.] Harvard Univ, Sch Med, Dept Mol Biol, Boston, MA 02114 USA; [Gao, Xiaolin; Fang, Peng] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Yan, Zhijiang; Wang, Weidong] NIA, Genome Instabil & Chromatin Remodeling Sect, NIH, Baltimore, MD 21224 USA; Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	University of Michigan System; University of Michigan; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); State University System of Florida; Florida State University	Wang, Z (corresponding author), Univ Michigan, Dept Cardiac Surg, Cardiovasc Res Ctr, 2800 Plymouth Rd, Ann Arbor, MI 48109 USA.	zhongw@med.umich.edu	Regan, Clinton/E-6250-2012; Wang, Weidong/AAV-2446-2021; Lei, IENG LAM/AAT-8216-2020; West, Jason/I-4445-2014	Lei, IENG LAM/0000-0002-0248-6871; Wang, Weidong/0000-0002-0658-7928; West, Jason/0000-0002-7252-8651	National Institutes of Health [HL109054]; Intramural Research Program of the NIA/National Institutes of Health [AG000650-10]; Samuel and Jean Frankel Cardiovascular Center, University of Michigan (Inaugural Fund); NATIONAL INSTITUTE ON AGING [ZIAAG000661] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NIA/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Samuel and Jean Frankel Cardiovascular Center, University of Michigan (Inaugural Fund); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant HL109054 (to W. Z.) and Intramural Research Program of the NIA/National Institutes of Health Grant AG000650-10 (to W. W.). This work was also supported by the Samuel and Jean Frankel Cardiovascular Center, University of Michigan (Inaugural Fund) (to W. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bowman SK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-466; Chen KF, 2013, GENOME RES, V23, P341, DOI 10.1101/gr.142067.112; Chen KF, 2013, GENOME RES, V23, P312, DOI 10.1101/gr.141952.112; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Deng T, 2013, MOL CELL BIOL, V33, P3377, DOI 10.1128/MCB.00435-13; Dennis JH, 2007, GENOME RES, V17, P928, DOI 10.1101/gr.5636607; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Ho L, 2011, NAT CELL BIOL, V13, P903, DOI 10.1038/ncb2285; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Hu GQ, 2013, CELL STEM CELL, V12, P180, DOI 10.1016/j.stem.2012.11.003; Hu GQ, 2011, GENOME RES, V21, P1650, DOI 10.1101/gr.121145.111; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kharchenko PV, 2008, GENOME RES, V18, P1554, DOI 10.1101/gr.075952.107; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lorch Y, 2010, P NATL ACAD SCI USA, V107, P3458, DOI 10.1073/pnas.1000398107; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mattout A, 2010, CURR OPIN CELL BIOL, V22, P334, DOI 10.1016/j.ceb.2010.02.001; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nagy A., 2003, MANIPULATING MOUSE E; Narlikar GJ, 2013, CELL, V154, P490, DOI 10.1016/j.cell.2013.07.011; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Takahashi T, 2003, CIRCULATION, V107, P1912, DOI 10.1161/01.CIR.0000064899.53876.A3; Tolstorukov MY, 2013, P NATL ACAD SCI USA, V110, P10165, DOI 10.1073/pnas.1302209110; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; Whitehouse I, 1999, NATURE, V400, P784, DOI 10.1038/23506; Woo CJ, 2013, MOL CELL BIOL, V33, P3274, DOI 10.1128/MCB.00275-13; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Yan Z, 2008, STEM CELLS, V26, P1155, DOI 10.1634/stemcells.2007-0846; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340	35	31	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19343	19352		10.1074/jbc.M115.637389	http://dx.doi.org/10.1074/jbc.M115.637389			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26070559	Green Published, hybrid			2022-12-26	WOS:000358781100045
J	Raum, P; Lamparter, J; Ponto, KA; Peto, T; Hoehn, R; Schulz, A; Schneider, A; Wild, PS; Pfeiffer, N; Mirshahi, A				Raum, Philipp; Lamparter, Julia; Ponto, Katharina A.; Peto, Tunde; Hoehn, Rene; Schulz, Andreas; Schneider, Astrid; Wild, Philipp S.; Pfeiffer, Norbert; Mirshahi, Alireza			Prevalence and Cardiovascular Associations of Diabetic Retinopathy and Maculopathy: Results from the Gutenberg Health Study	PLOS ONE			English	Article							RISK-FACTORS; TYPE-2; EYE; RANIBIZUMAB; POPULATION; GLUCOSE; DISEASE; EDEMA	Objective Diabetic retinopathy (DR) is the leading cause of blindness in people of working age. The purpose of this paper is to report the prevalence and cardiovascular associations of diabetic retinopathy and maculopathy (DMac) in Germany. Research Design and Methods The Gutenberg Health Study (GHS) is a population-based study with 15,010 participants aged between 35 at 74 years from the city of Mainz and the district of Mainz-Bingen. We determined the weighted prevalence of DR and DMac by assessing fundus photographs of persons with diabetes from the GHS data base. Diabetes was defined as HbA1c >= 6.5%, known diagnosis diabetes mellitus or known diabetes medication. Furthermore, we analysed the association between DR and cardiovascular risk factors and diseases. Results Overall, 7.5% (1,124/15,010) of the GHS cohort had diabetes. Of these, 27.7% were unaware of their disease and thus were newly diagnosed by their participation in the GHS. The prevalence of DR and DMac was 21.7% and 2.3%, respectively among patients with diabetes. Vision-threatening disease was present in 5% of the diabetic cohort. In the multivariable analysis DR (all types) was associated with age (Odds Ratio [95% confidence interval]: 0.97 [0.955-0.992]; p = 0.006) arterial hypertension (1.90 [1.190-3.044]; p = 0.0072) and vision-threatening DR with obesity (3.29 [1.504-7.206]; p = 0.0029). DR (all stages) and vision-threatening DR were associated with duration of diabetes (1.09 [1.068-1.114]; p < 0.0001 and 1.18 [1.137-1.222]; p < 0.0001, respectively). Conclusions Our calculations suggest that more than a quarter-million persons have vision-threatening diabetic retinal disease in Germany. Prevalence of DR was lower in the GHS compared to East-Asian studies. Associations were found with age, arterial hypertension, obesity, and duration of diabetes mellitus.	[Raum, Philipp; Lamparter, Julia; Ponto, Katharina A.; Hoehn, Rene; Pfeiffer, Norbert; Mirshahi, Alireza] Univ Med Ctr, Dept Ophthalmol, Mainz, Germany; [Peto, Tunde] Moorfields Eye Hosp, NIHR Biomed Res Ctr, London, England; [Peto, Tunde] UCL Inst Ophthalmol, London, England; [Schulz, Andreas; Schneider, Astrid] Univ Med Ctr, Biomed Stat, Mainz, Germany; [Ponto, Katharina A.; Wild, Philipp S.] Univ Med Ctr, CTH, Mainz, Germany; [Wild, Philipp S.] Univ Med Ctr, Dept Med 2, Mainz, Germany; [Wild, Philipp S.] Univ Med Ctr, German Ctr Heart & Circulat Syst Res DZHK, Mainz, Germany; [Mirshahi, Alireza] Dardenne Eye Hosp, Bonn, Germany	Johannes Gutenberg University of Mainz; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Mirshahi, A (corresponding author), Univ Med Ctr, Dept Ophthalmol, Mainz, Germany.	dr.mirshahi@gmail.com	Peto, Tunde/G-8812-2018; Ponto, Katharina/AAF-3890-2020; Pfeiffer, Norbert/AAO-7586-2020; Wild, Philipp S./M-2106-2019	Peto, Tunde/0000-0001-6265-0381; Hohn, Rene/0000-0003-2870-1469; Wild, Philipp/0000-0003-4413-9752	government of Rhineland-Palatinate ("Stiftung Rheinland-Pfalz fur Innovation") [AZ 961-386261/733]; research program "Wissen schafft Zukunft"; research program "Center for Translational Vascular Biology (CTVB)"; Center for Thrombosis and Haemostasis (CTH) of the Johannes Gutenberg-University of Mainz; Boehringer Ingelheim; PHILIPS Medical Systems; Novartis; Federal Ministry of Education and Research (BMBF) [01EO1003]	government of Rhineland-Palatinate ("Stiftung Rheinland-Pfalz fur Innovation"); research program "Wissen schafft Zukunft"; research program "Center for Translational Vascular Biology (CTVB)"; Center for Thrombosis and Haemostasis (CTH) of the Johannes Gutenberg-University of Mainz; Boehringer Ingelheim(Boehringer Ingelheim); PHILIPS Medical Systems; Novartis(Novartis); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The Gutenberg Health Study is funded through the government of Rhineland-Palatinate ("Stiftung Rheinland-Pfalz fur Innovation", contract AZ 961-386261/733), the research programs "Wissen schafft Zukunft" and "Center for Translational Vascular Biology (CTVB)" as well as the Center for Thrombosis and Haemostasis (CTH) of the Johannes Gutenberg-University of Mainz, and its contract with Boehringer Ingelheim, PHILIPS Medical Systems and Novartis including an unrestricted grant for the Gutenberg Health Study. Philipp Wild and Katharina Ponto are funded by the Federal Ministry of Education and Research (BMBF 01EO1003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Maskari Fatma, 2007, BMC Ophthalmol, V7, P11; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; [Anonymous], 1991, Ophthalmology, V98, P786; Bandello F, 2003, Semin Ophthalmol, V18, P251; Bertelsen G, 2013, ACTA OPHTHALMOL, V91, P716, DOI [10.1111/j.1755-3768.2012.2542.x, 10.1111/j.1755-3768.2012.02542.x]; Cheng YZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101289; Cheung N, 2007, DIABETES CARE, V30, P1742, DOI 10.2337/dc07-0264; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Do DV, 2013, JAMA OPHTHALMOL, V131, P139, DOI 10.1001/2013.jamaophthalmol.91; Fletcher EL, 2007, CURR PHARM DESIGN, V13, P2699, DOI 10.2174/138161207781662920; Fletcher Erica L, 2005, Clin Exp Optom, V88, P132; Furthauer J, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-47; Gardner T W, 2000, Diabetes Technol Ther, V2, P601; Hoffmann EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066158; Jorgensen ME, 2010, J CLIN ENDOCR METAB, V95, pE333, DOI 10.1210/jc.2010-0710; Lamparter J, 2014, J DIABETES COMPLICAT, V28, P482, DOI 10.1016/j.jdiacomp.2014.02.008; Lieth E, 2000, CLIN EXP OPHTHALMOL, V28, P3, DOI 10.1046/j.1442-9071.2000.00222.x; Lilly M, 2009, CAN FAM PHYSICIAN, V55, P363; Ly A, 2011, INVEST OPHTH VIS SCI, V52, P9316, DOI 10.1167/iovs.11-7879; Malkani S, 2011, AM J MED, V124, P395, DOI 10.1016/j.amjmed.2010.11.025; Matthaei S, 2009, EXP CLIN ENDOCR DIAB, V117, P522, DOI 10.1055/s-0029-1239559; Mirshahi A, 2013, OPHTHALMOLOGE, V110, P210, DOI 10.1007/s00347-012-2666-0; Mitchell P, 1998, OPHTHALMOLOGY, V105, P406, DOI 10.1016/S0161-6420(98)93019-6; Mitchell P, 2011, OPHTHALMOLOGY, V118, P615, DOI 10.1016/j.ophtha.2011.01.031; Rathmann W, 2012, ANN MED, V44, P170, DOI 10.3109/07853890.2010.531759; Rema M, 2005, INVEST OPHTH VIS SCI, V46, P2328, DOI 10.1167/iovs.05-0019; Sanford M, 2013, DRUGS, V73, P187, DOI 10.1007/s40265-013-0010-x; Sasaki M, 2014, INVEST OPHTH VIS SCI, V55, P1749, DOI 10.1167/iovs.13-13035; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; STOLK RP, 1995, DIABETES, V44, P11, DOI 10.2337/diabetes.44.1.11; Thomas BJ, 2013, CAN J OPHTHALMOL, V48, P22, DOI 10.1016/j.jcjo.2012.11.012; Tomic M, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/818671; Vujosevic S, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/905058; Wang FH, 2009, OPHTHALMOLOGY, V116, P461, DOI 10.1016/j.ophtha.2008.10.003; Wild PS, 2012, BUNDESGESUNDHEITSBLA, V55, P824, DOI 10.1007/s00103-012-1502-7; Wong TY, 2008, OPHTHALMOLOGY, V115, P1869, DOI 10.1016/j.ophtha.2008.05.014; Xie XW, 2008, GRAEF ARCH CLIN EXP, V246, P1519, DOI 10.1007/s00417-008-0884-6; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Zhang XZ, 2010, JAMA-J AM MED ASSOC, V304, P649, DOI 10.1001/jama.2010.1111	39	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0127188	10.1371/journal.pone.0127188	http://dx.doi.org/10.1371/journal.pone.0127188			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075604	Green Submitted, Green Published, gold			2022-12-26	WOS:000356329900010
J	Takatsuki, H; Satoh, K; Sano, K; Fuse, T; Nakagaki, T; Mori, T; Ishibashi, D; Mihara, B; Takao, M; Iwasaki, Y; Yoshida, M; Atarashi, R; Nishida, N				Takatsuki, Hanae; Satoh, Katsuya; Sano, Kazunori; Fuse, Takayuki; Nakagaki, Takehiro; Mori, Tsuyoshi; Ishibashi, Daisuke; Mihara, Ban; Takao, Masaki; Iwasaki, Yasushi; Yoshida, Mari; Atarashi, Ryuichiro; Nishida, Noriyuki			Rapid and Quantitative Assay of Amyloid-Seeding Activity in Human Brains Affected with Prion Diseases	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; TO-PERSON TRANSMISSION; MICE EXPRESSING HUMAN; BLOOD-TRANSFUSION; SPONGIFORM ENCEPHALOPATHY; PROTEIN; SUSCEPTIBILITY; CHIMPANZEES; CONVERSION; SCRAPIE	The infectious agents of the transmissible spongiform encephalopathies are composed of amyloidogenic prion protein, PrPSc. Real-time quaking-induced conversion can amplify very small amounts of PrPSc seeds in tissues/body fluids of patients or animals. Using this in vitro PrP-amyloid amplification assay, we quantitated the seeding activity of affected human brains. End-point assay using serially diluted brain homogenates of sporadic Creutzfeldt-Jakob disease patients demonstrated that 50% seeding dose (SD50) is reached approximately 10(10)/g brain (values varies 10(8.79-10.63)/g). A genetic case (GSS-P102L) yielded a similar level of seeding activity in an autopsy brain sample. The range of PrPSc concentrations in the samples, determined by dot-blot assay, was 0.6-5.4 mu g/g brain; therefore, we estimated that 1 SD50 unit was equivalent to 0.06-0.27 fg of PrPSc. The SD50 values of the affected brains dropped more than three orders of magnitude after autoclaving at 121 degrees C. This new method for quantitation of human prion activity provides a new way to reduce the risk of iatrogenic prion transmission.	[Takatsuki, Hanae; Satoh, Katsuya; Fuse, Takayuki; Nakagaki, Takehiro; Mori, Tsuyoshi; Ishibashi, Daisuke; Atarashi, Ryuichiro; Nishida, Noriyuki] Nagasaki Univ, Dept Mol Microbiol & Immunol, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Sano, Kazunori] Fukuoka Univ, Fac Pharmaceut Sci, Dept Physiol & Pharmacol, Fukuoka 81401, Japan; [Mihara, Ban; Takao, Masaki] Mihara Mem Hosp, Inst Brain & Blood Vessels, Dept Neurol, Isesaki, Japan; [Takao, Masaki] Saitama Med Univ, Dept Neurol, Int Med Ctr, Saitama, Japan; [Iwasaki, Yasushi; Yoshida, Mari] Aichi Med Univ, Inst Med Sci Aging, Dept Neuropathol, Nagakute, Aichi, Japan	Nagasaki University; Fukuoka University; Saitama Medical University; Aichi Medical University	Satoh, K (corresponding author), Nagasaki Univ, Dept Mol Microbiol & Immunol, Grad Sch Biomed Sci, Nagasaki 852, Japan.	satoh-prion@nagasaki-u.ac.jp		Nakagaki, Takehiro/0000-0003-1960-8326	Research Committee of Surveillance and Infection Control of Prion Disease; Research Committee of Prion Disease and Slow Virus Infection of the Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [24591268, 14507303, 23300127, 23790998]; Japan Society for the Promotion of Science; Research Committee on Surveillance and Infection Control of Prion Disease of the Ministry of Health, Labour and Welfare of Japan; Ministry of Health, Labour and Welfare of Japan; Takeda Science Foundation; Grants-in-Aid for Scientific Research [25461514] Funding Source: KAKEN	Research Committee of Surveillance and Infection Control of Prion Disease; Research Committee of Prion Disease and Slow Virus Infection of the Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research Committee on Surveillance and Infection Control of Prion Disease of the Ministry of Health, Labour and Welfare of Japan; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid from the Research Committee of Surveillance and Infection Control of Prion Disease and from the Research Committee of Prion Disease and Slow Virus Infection of the Ministry of Health, Labour and Welfare of Japan. Dr. Satoh received research support from a Grant-in Aid for Scientific Research (C) (24591268) and Scientific Research (B) (Overseas Academic Research) (14507303) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and the Japan Society for the Promotion of Science. This work was supported by Grants-in-Aid from the Research Committee on Surveillance and Infection Control of Prion Disease of the Ministry of Health, Labour and Welfare of Japan. Dr. Atarashi received research support from a Grant-in-Aid for Scientific Research (B) (23300127) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a grant from the Ministry of Health, Labour and Welfare of Japan, as well as a grant from the Takeda Science Foundation. Dr. Sano received research support from a Grant-in-Aid for Young Scientific Researchers (B) (23790998) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Atarashi R, 2011, NAT MED, V17, P175, DOI 10.1038/nm.2294; BERNOULLI C, 1977, LANCET, V1, P478; COLLINGE J, 1995, NATURE, V378, P779, DOI 10.1038/378779a0; DUFFY P, 1974, NEW ENGL J MED, V290, P692; GAJDUSEK DC, 1966, NATURE, V209, P794, DOI 10.1038/209794a0; GAJDUSEK DC, 1967, SCIENCE, V155, P212; GIBBS CJ, 1969, SCIENCE, V165, P1023, DOI 10.1126/science.165.3897.1023; GIBBS CJ, 1968, SCIENCE, V161, P388, DOI 10.1126/science.161.3839.388; GIBBS CJ, 1972, NATURE, V236, P73, DOI 10.1038/236073a0; Glatzel M, 2003, NEW ENGL J MED, V349, P1812, DOI 10.1056/NEJMoa030351; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; KOCH TK, 1985, NEW ENGL J MED, V313, P731, DOI 10.1056/NEJM198509193131206; Korth C, 2003, P NATL ACAD SCI USA, V100, P4784, DOI 10.1073/pnas.2627989100; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Rubenstein R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066352; Shi S, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-44; TAGUCHI F, 1991, ARCH VIROL, V119, P297, DOI 10.1007/BF01310679; Taguchi Y, 2003, AM J PATHOL, V163, P2585, DOI 10.1016/S0002-9440(10)63613-9; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; TELLING GC, 1994, P NATL ACAD SCI USA, V91, P9936, DOI 10.1073/pnas.91.21.9936; THADANI V, 1988, J NEUROSURG, V69, P766, DOI 10.3171/jns.1988.69.5.0766; Vascellari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048969; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; WILL RG, 1982, J NEUROL NEUROSUR PS, V45, P235, DOI 10.1136/jnnp.45.3.235; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8	29	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0126930	10.1371/journal.pone.0126930	http://dx.doi.org/10.1371/journal.pone.0126930			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070208	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000004
J	Elkot, AFA; Chhuneja, P; Kaur, S; Saluja, M; Keller, B; Singh, K				Elkot, Ahmed Fawzy Abdelnaby; Chhuneja, Parveen; Kaur, Satinder; Saluja, Manny; Keller, Beat; Singh, Kuldeep			Marker Assisted Transfer of Two Powdery Mildew Resistance Genes PmTb7A.1 and PmTb7A.2 from Triticum boeoticum (Boiss.) to Triticum aestivum (L.)	PLOS ONE			English	Article							ADULT-PLANT RESISTANCE; COMMON WHEAT; STRIPE RUST; CHROMOSOMAL LOCATION; WINTER-WHEAT; T-MONOCOCCUM; GRAIN-YIELD; IDENTIFICATION; LEAF; INHERITANCE	Powdery mildew (PM), caused by Blumeria graminis f. sp. tritici, is one of the important wheat diseases, worldwide. Two PM resistance genes, designated as PmTb7A.1 and PmTb7A.2, were identified in T. boeoticum acc. pau5088 and mapped on chromosome 7AL approximately 48cM apart. Two resistance gene analogue (RGA)-STS markers Ta7AL-4556232 and 7AL-4426363 were identified to be linked to the PmTb7A.1 and PmTb7A.2, at a distance of 0.6cM and 6.0cM, respectively. In the present study, following marker assisted selection (MAS), the two genes were transferred to T. aestivum using T. durum as bridging species. As many as 12,317 florets of F-1 of the cross T. durum /T. boeoticum were pollinated with T. aestivum lines PBW343-IL and PBW621 to produce 61 and 65 seeds, respectively, of three-way F-1. The resulting F(1)s of the cross T. durum/T. boeoticum//T.aestivum were screened with marker flanking both the PM resistance genes PmTb7A.1 and PmTb7A.2 (foreground selection) and the selected plants were backcrossed to generate BC1F1. Marker assisted selection was carried both in BC1F1 and the BC2F1 generations. Introgression of alien chromatin in BC2F1 plants varied from 15.4 -62.9 percent. Out of more than 110 BC2F1 plants showing introgression for markers linked to the two PM resistance genes, 40 agronomically desirable plants were selected for background selection for the carrier chromosome to identify the plants with minimum of the alien introgression. Cytological analysis showed that most plants have chromosome number ranging from 40-42. The BC2F2 plants homozygous for the two genes have been identified. These will be crossed to generate lines combining both the PM resistance genes but with minimal of the alien introgression. The PM resistance gene PmTb7A.1 maps in a region very close to Sr22, a stem rust resistance gene effective against the race Ug99. Analysis of selected plants with markers linked to Sr22 showed introgression of Sr22 from T. boeoticum in several BC(2)F(1)plants. Thus, in addition to PM resistance, these progeny might also carry resistance to stem rust race Ug99.	[Elkot, Ahmed Fawzy Abdelnaby; Chhuneja, Parveen; Kaur, Satinder; Saluja, Manny; Singh, Kuldeep] Punjab Agr Univ, Sch Agr Biotechnol, Ludhiana 141004, Punjab, India; [Keller, Beat] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland	Punjab Agricultural University; University of Zurich	Singh, K (corresponding author), Punjab Agr Univ, Sch Agr Biotechnol, Ludhiana 141004, Punjab, India.	kuldeep35@pau.edu	Elkot, Ahmed Fawzy/AAG-6428-2021; SAB, Parveen Chhuneja -/H-5456-2019; Keller, Beat/K-3093-2019	Elkot, Ahmed Fawzy/0000-0003-2967-2137; Keller, Beat/0000-0003-2379-9225; Singh, Kuldeep/0000-0001-5239-6586	Indian Council of Agricultural Research (ICAR), New Delhi	Indian Council of Agricultural Research (ICAR), New Delhi(Indian Council of Agricultural Research (ICAR))	Ahmed Fawzy Abdelnaby Elkot was supported by Indian Council of Agricultural Research (ICAR), New Delhi under ICAR International Fellowship Programme for pursuing PhD at PAU Ludhiana from Jan 2011 to Dec 2014.	Allen GC, 2006, NAT PROTOC, V1, P2320, DOI 10.1038/nprot.2006.384; Ben-David R, 2010, THEOR APPL GENET, V121, P499, DOI 10.1007/s00122-010-1326-5; BENNETT FGA, 1982, PLANT PATHOL, V31, P261, DOI 10.1111/j.1365-3059.1982.tb01277.x; BENNETT FGA, 1984, PLANT PATHOL, V33, P279, DOI 10.1111/j.1365-3059.1984.tb01324.x; BRIGGLE LW, 1969, CROP SCI, V9, P70, DOI 10.2135/cropsci1969.0011183X000900010023x; Chaudhary H.K., 2014, ALIEN GENE TRANSFER, V2, P1, DOI [10.1007/978-1-4614-9572-7_1, DOI 10.1007/978-1-4614-9572-7_1, DOI 10.1007/978-1-4614-9572-7_]; Chen WQ, 2013, EUPHYTICA, V192, P339, DOI 10.1007/s10681-012-0854-2; Chhuneja P, 2014, THEOR APPL GENET UND; Chhuneja P, 2008, THEOR APPL GENET, V116, P313, DOI 10.1007/s00122-007-0668-0; Chhuneja P, 2012, THEOR APPL GENET, V124, P1051, DOI 10.1007/s00122-011-1768-4; Dhaliwal H. S., 1993, Biodiversity and wheat improvement., P123; EVERTS KL, 1992, PHYTOPATHOLOGY, V82, P1273, DOI 10.1094/Phyto-82-1273; FELDMAN M, 1981, SCI AM, V244, P102, DOI 10.1038/scientificamerican0181-102; GERECHTERAMITAI ZK, 1971, EUPHYTICA, V20, P281, DOI 10.1007/BF00056088; GRIFFEY CA, 1993, PLANT DIS, V77, P618, DOI 10.1094/PD-77-0618; Han Jun, 2009, Acta Agronomica Sinica, V35, P1791, DOI 10.3724/SP.J.1006.2009.01791; Hao YF, 2015, THEOR APPL GENET, V128, P465, DOI 10.1007/s00122-014-2445-1; Hasabnis S. N., 1997, Karnataka Journal of Agricultural Sciences, V10, P1235; He RL, 2009, THEOR APPL GENET, V118, P1173, DOI 10.1007/s00122-009-0971-z; Hsam SLK, 1998, THEOR APPL GENET, V96, P1129, DOI 10.1007/s001220050848; Hua W, 2009, THEOR APPL GENET, V119, P223, DOI 10.1007/s00122-009-1031-4; Hurni S, 2014, PLANT J, V79, P904, DOI 10.1111/tpj.12593; Hussien T, 1997, PLANT DIS, V81, P582, DOI 10.1094/PDIS.1997.81.6.582; Ji XL, 2008, EUPHYTICA, V159, P385, DOI 10.1007/s10681-007-9540-1; Kapoor A. S., 1993, Indian Journal of Mycology and Plant Pathology, V23, P90; KERBER ER, 1973, CAN J GENET CYTOL, V15, P397, DOI 10.1139/g73-050; KERBER ER, 1983, P 6 INT WHEAT GEN S, P813; LEATH S, 1990, PLANT DIS, V74, P747, DOI 10.1094/PD-74-0747; LEATH S, 1989, PHYTOPATHOLOGY, V79, P152, DOI 10.1094/Phyto-79-152; Li GQ, 2009, THEOR APPL GENET, V119, P531, DOI 10.1007/s00122-009-1061-y; Li N, 2012, J INTEGR AGR, V11, P611, DOI 10.1016/S2095-3119(12)60048-3; Liang SS, 2006, PHYTOPATHOLOGY, V96, P784, DOI 10.1094/PHYTO-96-0784; LIPPS PE, 1989, PHYTOPATHOLOGY, V79, P462, DOI 10.1094/Phyto-79-462; Luo PG, 2009, THEOR APPL GENET, V118, P1059, DOI 10.1007/s00122-009-0962-0; Ma H, 1997, EUPHYTICA, V94, P279, DOI 10.1023/A:1002979706378; Ma HQ, 2011, THEOR APPL GENET, V123, P1099, DOI 10.1007/s00122-011-1651-3; Marone D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-562; Maxwell JJ, 2009, THEOR APPL GENET, V119, P1489, DOI 10.1007/s00122-009-1150-y; McIntosh RA, 2013, CATALOGUE OF GENE SY; Miranda LM, 2007, CROP SCI, V47, P2323, DOI 10.2135/cropsci2007.01.0053; Mohler V, 2013, J APPL GENET, V54, P259, DOI 10.1007/s13353-013-0158-9; Olson EL, 2010, CROP SCI, V50, P1823, DOI 10.2135/cropsci2009.11.0652; Ouyang SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100160; Periyannan SK, 2011, THEOR APPL GENET, V122, P1, DOI 10.1007/s00122-010-1417-3; Perugini LD, 2008, THEOR APPL GENET, V116, P417, DOI 10.1007/s00122-007-0679-x; Petersen S, 2015, THEOR APPL GENET, V128, P303, DOI 10.1007/s00122-014-2430-8; PETERSON RF, 1948, CAN J RES C, V26, P496, DOI 10.1139/cjr48c-033; Qiu YC, 2005, THEOR APPL GENET, V111, P1524, DOI 10.1007/s00122-005-0081-5; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Shi AN, 1998, PHYTOPATHOLOGY, V88, P144, DOI 10.1094/PHYTO.1998.88.2.144; Singh DP, 2009, PI DIS RES, V24, P942; Singh K, 2007, DEV PLANT BREED, V12, P779; Singh K, 2007, THEOR APPL GENET, V115, P301, DOI 10.1007/s00122-007-0543-z; Singrun C, 2003, THEOR APPL GENET, V106, P1420, DOI 10.1007/s00122-002-1187-7; Singrun C, 2004, THEOR APPL GENET, V109, P210, DOI 10.1007/s00122-004-1619-7; Van Berloo R, 2007, GGT VERSION 2 0; Xiao MG, 2013, THEOR APPL GENET, V126, P1397, DOI 10.1007/s00122-013-2060-6; Yao G, 2007, THEOR APPL GENET, V114, P351, DOI 10.1007/s00122-006-0438-4; YOUNG ND, 1989, THEOR APPL GENET, V77, P353, DOI 10.1007/BF00305828	59	19	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128297	10.1371/journal.pone.0128297	http://dx.doi.org/10.1371/journal.pone.0128297			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26066332	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000356100900017
J	Hsu, BY; Bae, YH; Mui, KL; Liu, SL; Assoian, RK				Hsu, Bernadette Y.; Bae, Yong Ho; Mui, Keeley L.; Liu, Shu-Lin; Assoian, Richard K.			Apolipoprotein E3 Inhibits Rho to Regulate the Mechanosensitive Expression of Cox2	PLOS ONE			English	Article							CELL-ADHESION; MECHANICAL-PROPERTIES; STIFFNESS; APOE; HDL; PROLIFERATION; ACTIVATION; MIGRATION; TISSUE	Apolipoprotein E3 (apoE3) is thought to protect against atherosclerosis by enhancing reverse cholesterol transport. However, apoE3 also has cholesterol-independent effects that contribute to its anti-atherogenic properties. These include altering extracellular matrix protein synthesis and inhibiting vascular smooth muscle cell proliferation. Both of these cholesterol-independent effects result from an apoE3-mediated induction of cyclooxygenase-2 (Cox2). Nevertheless, how apoE3 regulates Cox2 remains unknown. Here, we show that apoE3 inhibits the activation of Rho, which reduces the formation of actin stress fibers and focal adhesions and results in cellular softening. Inhibition of Rho-Rho kinase signaling or direct cellular softening recapitulates the effect of apoE3 on Cox2 expression while a constitutively active Rho mutant overrides the apoE3 effect on both intracellular stiffness and Cox2. Thus, our results describe a previously unidentified mechanism by which an atheroprotective apolipoprotein uses Rho to control cellular mechanics and Cox2.	[Hsu, Bernadette Y.; Bae, Yong Ho; Mui, Keeley L.; Liu, Shu-Lin; Assoian, Richard K.] Univ Penn, Inst Translat Med & Therapeut, Program Translat Biomech, Philadelphia, PA 19104 USA; [Hsu, Bernadette Y.; Bae, Yong Ho; Mui, Keeley L.; Liu, Shu-Lin; Assoian, Richard K.] Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Bae, YH (corresponding author), Univ Penn, Inst Translat Med & Therapeut, Program Translat Biomech, Philadelphia, PA 19104 USA.	yob@mail.med.upenn.edu	Bae, Yong Ho/M-8427-2015	Bae, Yong Ho/0000-0002-1838-1652	NIH [HL062250, HL119346, R25CA101871]; American Heart Association; NATIONAL CANCER INSTITUTE [R25CA101871] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL062250, R01HL119346] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grant HL062250 and HL119346. YHB was supported by a post-doctoral fellowship from the American Heart Association. KLM was supported by NIH training grant R25CA101871.	Ali K, 2008, ATHEROSCLEROSIS, V196, P201, DOI 10.1016/j.atherosclerosis.2007.03.038; Bae YH, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004838; Bhadriraju K, 2007, EXP CELL RES, V313, P3616, DOI 10.1016/j.yexcr.2007.07.002; Cho T, 2008, J BIOL CHEM, V283, P30503, DOI 10.1074/jbc.M802648200; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Ishigami M, 2000, ARTERIOSCL THROM VAS, V20, P1020, DOI 10.1161/01.ATV.20.4.1020; Ishigami M, 1998, J BIOL CHEM, V273, P20156, DOI 10.1074/jbc.273.32.20156; Janmey PA, 2013, DIFFERENTIATION, V86, P112, DOI 10.1016/j.diff.2013.07.004; Klein EA, 2007, METHOD ENZYMOL, V426, P155, DOI 10.1016/S0076-6879(07)26008-2; Klein EA, 2009, CURR BIOL, V19, P1511, DOI 10.1016/j.cub.2009.07.069; Kothapalli D, 2004, J CLIN INVEST, V113, P609, DOI 10.1172/JCI200419097; Kothapalli D, 2013, ATHEROSCLEROSIS, V227, P65, DOI 10.1016/j.atherosclerosis.2012.12.003; Kothapalli D, 2012, CELL REP, V2, P1259, DOI 10.1016/j.celrep.2012.09.018; Lamon-Fava S, 2014, CURR OPIN LIPIDOL, V25, P189, DOI 10.1097/MOL.0000000000000070; LEE RT, 1992, ARTERIOSCLER THROMB, V12, P1, DOI 10.1161/01.ATV.12.1.1; Mahley RW, 1999, CURR OPIN LIPIDOL, V10, P207, DOI 10.1097/00041433-199906000-00003; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Riches K, 2013, INT J BIOCHEM CELL B, V45, P1776, DOI 10.1016/j.biocel.2013.05.021; Rye K, 2006, J LIPID RES, V47, P1025, DOI 10.1194/jlr.M500525-JLR200; Schwartz MP, 2010, INTEGR BIOL-UK, V2, P32, DOI 10.1039/b912438a; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; Thorngate FE, 2003, J LIPID RES, V44, P2331, DOI 10.1194/jlr.M300224-JLR200; Wakatsuki T, 2001, J CELL SCI, V114, P1025; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041	29	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128974	10.1371/journal.pone.0128974	http://dx.doi.org/10.1371/journal.pone.0128974			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068461	gold, Green Submitted, Green Published			2022-12-26	WOS:000356100900037
J	Milani, M; Laranjeira, ABA; de Vasconcellos, JF; Brandalise, SR; Nowill, AE; Yunes, JA				Milani, Mateus; Albertoni Laranjeira, Angelo Brunelli; de Vasconcellos, Jaira Ferreira; Brandalise, Silvia Regina; Nowill, Alexandre Eduardo; Yunes, Jose Andres			Plasma Hsp90 Level as a Marker of Early Acute Lymphoblastic Leukemia Engraftment and Progression in Mice	PLOS ONE			English	Article							REGULATORY MECHANISM; DISEASE PROGRESSION; EXPRESSION; MODEL; HSP90-ALPHA; MALIGNANCY; GROWTH; CELLS	Current monitoring of acute lymphoblastic leukemia (ALL) in living mice is based on FACS analysis of blood hCD45+ cells. In this work, we evaluated the use of human IGFBP2, B2M or Hsp90 as soluble markers of leukemia. ELISA for B2M and IGFBP2 resulted in high background levels in healthy animals, precluding its use. Conversely, plasma levels of Hsp90 showed low background and linear correlation to FACS results. In another experiment, we compared Hsp90 levels with percentage of hCD45+ cells in blood, bone marrow, liver and spleen of animals weekly sacrificed. Hsp90 levels proved to be a superior method for the earlier detection of ALL engraftment and correlated linearly to ALL burden and progression in all compartments, even at minimal residual disease levels. Importantly, the Hsp90/hCD45+ ratio was not altered when animals were treated with dexamethasone or a PI3K inhibitor, indicating that chemotherapy does not directly interfere with leukemia production of Hsp90. In conclusion, plasma Hsp90 was validated as a soluble biomarker of ALL, useful for earlier detection of leukemia engraftment, monitoring leukemia kinetics at residual disease levels, and pre-clinical or mouse avatar evaluations of anti-leukemic drugs.	[Milani, Mateus; Albertoni Laranjeira, Angelo Brunelli; de Vasconcellos, Jaira Ferreira; Brandalise, Silvia Regina; Yunes, Jose Andres] Ctr Infantil Boldrini, Mol Biol Lab, Campinas, SP, Brazil; [Nowill, Alexandre Eduardo] Univ Estadual Campinas, FCM, CIPOI, Campinas, SP, Brazil; [Yunes, Jose Andres] Univ Estadual Campinas, FCM, Dept Med Genet, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas	Yunes, JA (corresponding author), Ctr Infantil Boldrini, Mol Biol Lab, Campinas, SP, Brazil.	andres@boldrini.org.br	Nowill, Alexandre Eduardo/I-9038-2012; Brunelli Albertoni Laranjeira, Angelo/H-3601-2016; Brandalise, Silvia Regina/ABG-9609-2021	Nowill, Alexandre Eduardo/0000-0003-0648-6913; Brunelli Albertoni Laranjeira, Angelo/0000-0002-6772-0956; Milani, Mateus/0000-0001-5004-3250; Yunes, Jose Andres/0000-0002-1316-3525; Ferreira de Vasconcellos, Jaira/0000-0001-5011-4493	Sao Paulo Research Foundation (FAPESP) [08/10034-1, 12/12802-1]; FAPESP; National Counsel of Technological and Scientific Development (CNPq)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Sao Paulo Research Foundation (FAPESP) (08/10034-1 and 12/12802-1) to JAY. MM, ABAL and JFV received FAPESP fellowships. JAY received a fellowship from the National Counsel of Technological and Scientific Development (CNPq Productivity fellowship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arguello F, 1996, BLOOD, V87, P4325, DOI 10.1182/blood.V87.10.4325.bloodjournal87104325; Barrott JJ, 2013, FEBS J, V280, P1381, DOI 10.1111/febs.12147; Bien Ewa, 2004, Wiad Lek, V57, P8; Campana D, 2012, CURR HEMATOL MALIG R, V7, P170, DOI 10.1007/s11899-012-0115-4; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Cheng C. Yan, 2008, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V8, P1, DOI 10.2174/187152208783790778; Christoph S, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-10; Dickson PV, 2007, J PEDIATR SURG, V42, P1172, DOI 10.1016/j.jpedsurg.2007.02.027; GLEAVE ME, 1992, CANCER RES, V52, P1598; Hudson WA, 1998, LEUKEMIA, V12, P2029, DOI 10.1038/sj.leu.2401236; Inoue Y, 2007, EXP HEMATOL, V35, P407, DOI 10.1016/j.exphem.2006.11.006; Jensen Mette Munk, 2008, BMC Med Imaging, V8, P16, DOI 10.1186/1471-2342-8-16; Juarez J, 2007, LEUKEMIA, V21, P1249, DOI 10.1038/sj.leu.2404684; Kato I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027042; Keating A, 2013, HIGH LEVEL ENGRAFTME, P2406; Lauten M, 2003, LEUKEMIA, V17, P1551, DOI 10.1038/sj.leu.2403027; Liem NLM, 2004, BLOOD, V103, P3905, DOI 10.1182/blood-2003-08-2911; Lock RB, 2002, BLOOD, V99, P4100, DOI 10.1182/blood.V99.11.4100; Malaney P, 2014, CANCER LETT, V344, P1, DOI 10.1016/j.canlet.2013.10.010; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Mohnike K., 1998, HAEMATOL BLOOD TRANS, V39, P375, DOI [10.1007/978-3-642-71960-8, DOI 10.1007/978-3-642-71960-8]; Silveira AB, 2015, ONCOTARGET; Song XM, 2010, J BIOL CHEM, V285, P40039, DOI 10.1074/jbc.M110.181941; Szymanska B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033894; Tissing WJE, 2005, LEUKEMIA, V19, P727, DOI 10.1038/sj.leu.2403681; Wang XF, 2009, P NATL ACAD SCI USA, V106, P21288, DOI 10.1073/pnas.0908151106; Xiao K, 1996, J Tongji Med Univ, V16, P212; YUFU Y, 1992, LEUKEMIA RES, V16, P597, DOI 10.1016/0145-2126(92)90008-U	28	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129298	10.1371/journal.pone.0129298	http://dx.doi.org/10.1371/journal.pone.0129298			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068922	Green Published, gold, Green Submitted			2022-12-26	WOS:000356100900048
J	Tebbens, RJD; Pallansch, MA; Wassilak, SGF; Cochi, SL; Thompson, KM				Tebbens, Radboud J. Duintjer; Pallansch, Mark A.; Wassilak, Steven G. F.; Cochi, Stephen L.; Thompson, Kimberly M.			Combinations of Quality and Frequency of Immunization Activities to Stop and Prevent Poliovirus Transmission in the High-Risk Area of Northwest Nigeria	PLOS ONE			English	Article							VACCINE-DERIVED POLIOVIRUS; POPULATION IMMUNITY; WILD POLIOVIRUS; PARALYTIC POLIOMYELITIS; ERADICATION; EPIDEMIOLOGY; CIRCULATION; STRATEGIES; EMERGENCE; OUTBREAK	Background Frequent supplemental immunization activities (SIAs) with the oral poliovirus vaccine (OPV) represent the primary strategy to interrupt poliovirus transmission in the last endemic areas. Materials and Methods Using a differential-equation based poliovirus transmission model tailored to high-risk areas in Nigeria, we perform one-way and multi-way sensitivity analyses to demonstrate the impact of different assumptions about routine immunization (RI) and the frequency and quality of SIAs on population immunity to transmission and persistence or emergence of circulating vaccine-derived polioviruses (cVDPVs) after OPV cessation. Results More trivalent OPV use remains critical to avoid serotype 2 cVDPVs. RI schedules with or without inactivated polio vaccine (IPV) could significantly improve population immunity if coverage increases well above current levels in under-vaccinated subpopulations. Similarly, the impact of SIAs on overall population immunity and cVDPV risks depends on their ability to reach under-vaccinated groups (i.e., SIA quality). Lower SIA coverage in the under-vaccinated subpopulation results in a higher frequency of SIAs needed to maintain high enough population immunity to avoid cVDPVs after OPV cessation. Conclusions National immunization program managers in northwest Nigeria should recognize the benefits of increasing RI and SIA quality. Sufficiently improving RI coverage and improving SIA quality will reduce the frequency of SIAs required to stop and prevent future poliovirus transmission. Better information about the incremental costs to identify and reach under-vaccinated children would help determine the optimal balance between spending to increase SIA and RI quality and spending to increase SIA frequency.	[Tebbens, Radboud J. Duintjer; Thompson, Kimberly M.] Kid Risk Inc, Orlando, FL 32832 USA; [Pallansch, Mark A.] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Wassilak, Steven G. F.; Cochi, Stephen L.] Ctr Dis Control & Prevent, Global Immunizat Div, Ctr Global Hlth, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Tebbens, RJD (corresponding author), Kid Risk Inc, Orlando, FL 32832 USA.	rdt@kidrisk.org		Thompson, Kimberly/0000-0002-0849-9147	US Centers for Disease Control and Prevention [U66IP000519]; National Center for Immunization and Respiratory Diseases (NCIRD) [U66IP000519] Funding Source: NIH RePORTER	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for Immunization and Respiratory Diseases (NCIRD)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	RJDT and KMT acknowledge support for this work from the US Centers for Disease Control and Prevention under Contract U66IP000519. The contents of this article are solely the responsibility of the authors and do not represent the official views of the US Centers for Disease Control and Prevention.	Anis E, 2013, EUROSURVEILLANCE, V18, P2, DOI 10.2807/1560-7917.ES2013.18.38.20586; [Anonymous], 2001, Wkly Epidemiol Rec, V76, P95; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P1393; Bahl S, 2014, MMWR-MORBID MORTAL W, V63, pCOVER1; Barau I, 2014, J INFECT DIS, V210, pS102, DOI 10.1093/infdis/jiu010; Burns CC, 2014, J INFECT DIS, V210, pS283, DOI 10.1093/infdis/jiu295; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P145; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Galindo M, 2007, NEW ENGL J MED, V356, P1536, DOI 10.1056/NEJMoa054960; Hird TR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002599; HULL HF, 1994, LANCET, V343, P1331, DOI 10.1016/S0140-6736(94)92472-4; Jafari H, 2014, SCIENCE, V345, P922, DOI 10.1126/science.1255006; Jenkins HE, 2010, NEW ENGL J MED, V362, P2360, DOI 10.1056/NEJMoa0910074; Kalkowska DA, 2015, J INFECT DIS, V211, P1800, DOI 10.1093/infdis/jiu674; Kalkowska DA, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0791-5; Kalkowska DA, 2014, J INFECT DIS, V210, pS398, DOI 10.1093/infdis/jit844; Kalkowska DA, 2014, J INFECT DIS, V210, pS412, DOI 10.1093/infdis/jit834; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Kew OM, 2014, MMWR-MORBID MORTAL W, V63, P1031; Mach O, 2014, J INFECT DIS, V210, pS275, DOI 10.1093/infdis/jit454; Nathanson N, 2010, AM J EPIDEMIOL, V172, P1213, DOI 10.1093/aje/kwq320; National Population Commission of Nigeria, 2014, NIG DEM HLTH SURV 20; PATRIARCA PA, 1991, REV INFECT DIS, V13, P926; Polio Global Eradication Initiative, 2013, POL ER ENDG STRAT PL; Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat, 2013, WORLD POP PROSP 2012; Sabin AB, 1986, BMJ-BRIT MED J, V292, P513; Tebbens RJD, 2014, J INFECT DIS, V210, pS485, DOI 10.1093/infdis/jit838; Tebbens RJD, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-45; Tebbens RJD, 2013, RISK ANAL, V33, P680, DOI 10.1111/risa.12022; Tebbens RJD, 2013, RISK ANAL, V33, P544, DOI 10.1111/j.1539-6924.2012.01864.x; Tebbens RJD, 2013, RISK ANAL, V33, P703, DOI 10.1111/risa.12044; Tebbens RJD, 2013, RISK ANAL, V33, P606, DOI 10.1111/risa.12031; Thompson KM, 2008, AM J PUBLIC HEALTH, V98, P1322, DOI 10.2105/AJPH.2007.122192; Thompson KM, 2007, LANCET, V369, P1363, DOI 10.1016/S0140-6736(07)60532-7; Thompson KM, 2015, VACCINE, V33, P1568, DOI 10.1016/j.vaccine.2015.02.013; Thompson KM, 2014, LANCET, V384, P1480, DOI 10.1016/S0140-6736(14)60983-1; Thompson KM, 2014, EXPERT REV VACCINES, V13, P221, DOI 10.1586/14760584.2014.864563; Thompson KM, 2014, J INFECT DIS, V210, pS475, DOI 10.1093/infdis/jit845; Thompson KM, 2013, RISK ANAL, V33, P647, DOI 10.1111/j.1539-6924.2012.01891.x; Thompson KM, 2013, RISK ANAL, V33, P516, DOI 10.1111/risa.12019; Thompson KM, UNPUB; Wassilak S, 2011, J INFECT DIS, V203, P898, DOI 10.1093/infdis/jiq140; World Health Organization, 2015, GLOB POL ER IN CIRC; World Health Organization, 2015, GLOB POL ER IN LIST; World Health Organization, 2005, WHOPOL0502	45	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0130123	10.1371/journal.pone.0130123	http://dx.doi.org/10.1371/journal.pone.0130123			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK3FB	26068928	Green Published, gold, Green Submitted			2022-12-26	WOS:000356100900100
J	Han, HH; Li, FQ; Yan, WX; Guo, YC; Li, N; Liu, XM; Zhu, JH; Xu, J; Chen, Y; Li, XG; Lv, H; Zhang, YQ; Cai, T; Chen, YZ				Han, Haihong; Li, Fengqin; Yan, Weixing; Guo, Yunchang; Li, Ning; Liu, Xiumei; Zhu, Jianghui; Xu, Jin; Chen, Yan; Li, Xiugui; Lv, Hong; Zhang, Yiqian; Cai, Te; Chen, Yuzhen			Temporal and Spatial Variation in the Abundance of Total and Pathogenic Vibrio parahaemolyticus in Shellfish in China	PLOS ONE			English	Article							REAL-TIME PCR; GULF-OF-MEXICO; THERMOSTABLE DIRECT HEMOLYSIN; QUANTITATIVE DETECTION; SEASONAL ABUNDANCE; DISEASE OUTBREAKS; AMERICAN OYSTERS; EASTERN CHINA; SEAFOOD; O3-K6	We investigated the abundance of total and pathogenic Vibrio parahaemolyticus in shellfish sampled from four provinces in China during May 2013 and March 2014 using the most probable number-polymerase chain reaction (MPN-PCR) method. Total V. parahaemolyticus was detected in 67.7% of 496 samples. A total of 38.1% and 10.1% of samples exceeded 1,000 MPN g(-1) and 10,000 MPN g(-1), respectively. V. parahaemolyticus densities followed a seasonal and geographical trend, with Guangxi and Sichuan shellfish possessing total V. parahaemolyticus levels that were 100-fold higher than those of the Liaoning and Shandong regions. Moreover, the levels of V. parahaemolyticus were at least 10-fold higher in the summer and autumn than in the cooler seasons. Pathogenic V. parahaemolyticus levels were generally lower than total V. parahaemolyticus levels by several log units and tended to be high in samples contaminated with high total V. parahaemolyticus levels. The aqua farms had a lower prevalence but higher abundance of total V. parahaemolyticus compared to retail markets. The catering markets showed the lowest levels of total V. parahaemolyticus, but 20.0% of samples exceeded 1,000 MPN g(-1). The levels of both total and pathogenic V. parahaemolyticus in oysters were higher than in clams. The log-transformed abundance of V. parahaemolyticus was significantly correlated with both water temperature and air temperature but not water salinity. These results provide baseline contamination data of V. parahaemolyticus in shellfish in China, which can be applied to local risk assessments to prioritize risk control to key sectors and evaluate the effectiveness of future control measures.	[Han, Haihong] Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Hlth, Beijing, Peoples R China; [Han, Haihong; Li, Fengqin; Yan, Weixing; Guo, Yunchang; Li, Ning; Liu, Xiumei; Zhu, Jianghui; Xu, Jin; Chen, Yan] China Natl Ctr Food Safety Risk Assessment, Key Lab Food Safety Risk Assessment, Minist Hlth, Beijing, Peoples R China; [Li, Xiugui] Guangxi Reg Ctr Dis Control & Prevent, Inst Microbiol Examinat, Nanning, Peoples R China; [Lv, Hong] Sichuan Prov Ctr Dis Control & Prevent, Inst Microbiol Examinat, Chengdu, Peoples R China; [Zhang, Yiqian] Univ Waterloo, Fac Sci, Waterloo, ON N2L 3G1, Canada; [Cai, Te] Dalian Xigang Dist Ctr Dis Control & Prevent, Dept Testing, Dalian, Peoples R China; [Chen, Yuzhen] Shandong Prov Ctr Dis Control & Prevent, Inst Bacterial Infect Dis Control, Jinan, Peoples R China	Chinese Center for Disease Control & Prevention; University of Waterloo	Guo, YC (corresponding author), China Natl Ctr Food Safety Risk Assessment, Key Lab Food Safety Risk Assessment, Minist Hlth, Beijing, Peoples R China.	gych@cfsa.net.cn; lining@cfsa.net.cn	Chen, Yan/AGL-5103-2022	Chen, Yan/0000-0001-7120-9571	National Key Technology R&D Program of the People's Republic of China [2012BAK01B02]	National Key Technology R&D Program of the People's Republic of China(National Key Technology R&D Program)	This work was financially supported by the National Key Technology R&D Program of the People's Republic of China (No. 2012BAK01B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bej AK, 1999, J MICROBIOL METH, V36, P215, DOI 10.1016/S0167-7012(99)00037-8; Cai TX, 2006, FEMS IMMUNOL MED MIC, V46, P180, DOI 10.1111/j.1574-695X.2005.00016.x; Chen Y, 2010, BIOMED ENVIRON SCI, V23, P32, DOI 10.1016/S0895-3988(10)60028-1; Chiou CS, 2000, J CLIN MICROBIOL, V38, P4621, DOI 10.1128/JCM.38.12.4621-4625.2000; DePaola A, 2003, APPL ENVIRON MICROB, V69, P1521, DOI 10.1128/AEM.69.3.1521-1526.2003; DePaola A, 2003, APPL ENVIRON MICROB, V69, P3999, DOI 10.1128/AEM.69.7.3999-4005.2003; DePaola A, 2000, APPL ENVIRON MICROB, V66, P4649, DOI 10.1128/AEM.66.11.4649-4654.2000; Flores-Primo A, 2014, J FOOD PROTECT, V77, P1069, DOI 10.4315/0362-028X.JFP-13-482; Food and Drug Administration (FDA), 2005, QUANTITATIVE RISK AS; Gooch JA, 2002, J FOOD PROTECT, V65, P970, DOI 10.4315/0362-028X-65.6.970; Hara-Kudo Y, 2001, APPL ENVIRON MICROB, V67, P5819, DOI 10.1128/AEM.67.12.5819-5823.2001; HHS FDA., 1997, NAT SHELLF SAN PROGR; Jiang XP, 1996, APPL ENVIRON MICROB, V62, P1300, DOI 10.1128/AEM.62.4.1300-1305.1996; JOSEPH SW, 1982, CRC CR REV MICROBIOL, V10, P77, DOI 10.3109/10408418209113506; Lin C, 2004, INT J FOOD MICROBIOL, V92, P207, DOI 10.1016/j.ijfoodmicro.2003.10.004; Lozano-Leon A, 2003, FEMS MICROBIOL LETT, V226, P281, DOI 10.1016/S0378-1097(03)00604-9; Luan XY, 2008, CURR MICROBIOL, V57, P218, DOI 10.1007/s00284-008-9177-x; Matsumoto C, 2000, J CLIN MICROBIOL, V38, P578, DOI 10.1128/JCM.38.2.578-585.2000; Miwai N, 2006, J FOOD HYG SOC JPN, V47, P41, DOI 10.3358/shokueishi.47.41; Myers ML, 2003, APPL ENVIRON MICROB, V69, P2194, DOI 10.1128/AEM.69.4.2194-2200.2003; Nair GB, 2007, CLIN MICROBIOL REV, V20, P39, DOI 10.1128/CMR.00025-06; Nasu H, 2000, J CLIN MICROBIOL, V38, P2156; NHFPC China., 2013, 292212013 NHFPC GB; Nigro OD, 2011, APPL ENVIRON MICROB, V77, P5384, DOI 10.1128/AEM.02509-10; NISHIBUCHI M, 1995, INFECT IMMUN, V63, P2093, DOI 10.1128/IAI.63.6.2093-2099.1995; Nordstrom JL, 2007, APPL ENVIRON MICROB, V73, P5840, DOI 10.1128/AEM.00460-07; Okuda N, 1997, J CLIN MICROBIOL, V35, P3150, DOI 10.1128/JCM.35.12.3150-3155.1997; Parveen S, 2008, INT J FOOD MICROBIOL, V128, P354, DOI 10.1016/j.ijfoodmicro.2008.09.019; Potasman I, 2002, CLIN INFECT DIS, V35, P921, DOI 10.1086/342330; Randa MA, 2004, APPL ENVIRON MICROB, V70, P5469, DOI 10.1128/AEM.70.9.5469-5476.2004; RIPPEY SR, 1994, CLIN MICROBIOL REV, V7, P419, DOI 10.1128/CMR.7.4.419-425.1994; Rizvi AV, 2010, ANTON LEEUW INT J G, V98, P279, DOI 10.1007/s10482-010-9436-2; Rodgers C, 2014, J APPL MICROBIOL, V117, P1198, DOI 10.1111/jam.12608; Serracca L, 2011, LETT APPL MICROBIOL, V53, P403, DOI 10.1111/j.1472-765X.2011.03119.x; Smolikova L.M., 2001, MIKROBIOL EPIDEMIOL, V6, P3; Su YC, 2007, FOOD MICROBIOL, V24, P549, DOI 10.1016/j.fm.2007.01.005; TANIGUCHI H, 1986, MICROB PATHOGENESIS, V1, P425, DOI 10.1016/0882-4010(86)90004-5; Wang SJ, 2007, FEMS IMMUNOL MED MIC, V51, P8, DOI 10.1111/j.1574-695X.2007.00305.x; Ward LN, 2006, APPL ENVIRON MICROB, V72, P2031, DOI 10.1128/AEM.72.3.2031-2042.2006; Yang ZQ, 2008, INT J FOOD MICROBIOL, V125, P279, DOI 10.1016/j.ijfoodmicro.2008.04.007; Zimmerman AM, 2007, APPL ENVIRON MICROB, V73, P7589, DOI 10.1128/AEM.01700-07	41	16	18	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0130302	10.1371/journal.pone.0130302	http://dx.doi.org/10.1371/journal.pone.0130302			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061712	Green Published, gold, Green Submitted			2022-12-26	WOS:000355979500171
J	Humtsoe, JO; Pham, E; Louie, RJ; Chan, DA; Kramer, RH				Humtsoe, J. O.; Pham, E.; Louie, R. J.; Chan, D. A.; Kramer, R. H.			ErbB3 upregulation by the HNSCC 3D microenvironment modulates cell survival and growth	ONCOGENE			English	Article							MULTICELLULAR TUMOR SPHEROIDS; HYPOXIA-INDUCIBLE FACTORS; TYROSINE KINASE; CARCINOMA-CELLS; NECK-CANCER; MESENCHYMAL TRANSITION; BREAST-CANCER; EXPRESSION; RECEPTOR; THERAPY	Head and neck squamous carcinomas (HNSCC) present as dense epithelioid three-dimensional (3D) tumor nests that can mediate signals via the human epidermal growth factor receptor (ErbB) tyrosine kinase family to promote intratumoral survival and growth. We examined the role of the tumor microenvironment on ErbB receptor family expression and found that the status of intercellular organization altered the receptor profile. We showed that HNSCC cells forced into tumor island-like 3D aggregates strongly upregulated ErbB3 at the level of transcription. Not only was the elevated ErbB3 responsive to HRG-beta 1-induced enhanced signaling mechanism, but also analysis by siRNA-knockdown and kinase inhibitor strategies revealed that the ErbB3/AKT signaling pathway was sufficient to enhance tumor cell survival and growth potential. Elevated ErbB3 expression in the high-density 3D culture system was strongly associated with hypoxia-induced HIF-1 alpha. Hypoxia-regulated ErbB3 expression was mediated by the HIF-1 alpha-binding consensus sequence in the ErbB3 proximal promoter. The findings show that the local 3D tumor microenvironment can trigger reprograming and switching of ErbB family members and thereby influence ErbB3-driven tumor growth.	[Humtsoe, J. O.; Pham, E.; Kramer, R. H.] Univ Calif San Francisco, Dept Cell & Tissue Biol, 521 Parnassus Ave, San Francisco, CA 94143 USA; [Louie, R. J.; Chan, D. A.] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kramer, RH (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, 521 Parnassus Ave, San Francisco, CA 94143 USA.	randall.kramer@ucsf.edu			UCSF REAC Award; Cancer Research Coordinating Committee; National Institutes of Health [R01 DE022565]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022565] Funding Source: NIH RePORTER	UCSF REAC Award; Cancer Research Coordinating Committee; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Dr Colleen Sweeney (University of California at Davis) for the kind gift of the ErbB3-promoter constructs and Dr Fan Yang (University of California San Francisco) for providing samples of xenograft specimens. This research was supported by grants from UCSF REAC Award (to RHK), Cancer Research Coordinating Committee (to RHK), and National Institutes of Health, R01 DE022565 (to RHK).	Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a; Abel EV, 2013, J CLIN INVEST, V123, P2155, DOI 10.1172/JCI65780; Agani F, 2013, CURR CANCER DRUG TAR, V13, P245, DOI 10.2174/1568009611313030003; Amin DN, 2012, BIOCHEM J, V447, P417, DOI 10.1042/BJ20120724; Amin DN, 2010, SEMIN CELL DEV BIOL, V21, P944, DOI 10.1016/j.semcdb.2010.08.007; Bates RC, 2000, CRIT REV ONCOL HEMAT, V36, P61, DOI 10.1016/S1040-8428(00)00077-9; Breslin S, 2013, DRUG DISCOV TODAY, V18, P240, DOI 10.1016/j.drudis.2012.10.003; Cavalot A, 2007, HEAD NECK-J SCI SPEC, V29, P655, DOI 10.1002/hed.20574; Chan DA, 2009, CANCER CELL, V15, P527, DOI 10.1016/j.ccr.2009.04.010; Chen QM, 2004, BIOCHEM BIOPH RES CO, V315, P850, DOI 10.1016/j.bbrc.2004.01.143; Ciardiello F, 2003, EUR J CANCER, V39, P1348, DOI 10.1016/S0959-8049(03)00235-1; Cohen RB, 2014, CANCER TREAT REV, V40, P567, DOI 10.1016/j.ctrv.2013.10.002; Del Sordo R, J ORAL PATHOL MED, V39, P79; Dery MAC, 2005, INT J BIOCHEM CELL B, V37, P535, DOI 10.1016/j.biocel.2004.08.012; Dubessy C, 2000, CRIT REV ONCOL HEMAT, V36, P179, DOI 10.1016/S1040-8428(00)00085-8; Friedrich J, 2007, INT J RADIAT BIOL, V83, P849, DOI 10.1080/09553000701727531; Funayama T, 1998, ONCOLOGY-BASEL, V55, P161, DOI 10.1159/000011851; Garrett JT, 2011, P NATL ACAD SCI USA, V108, P5021, DOI 10.1073/pnas.1016140108; He J, 2012, EMBO REP, V13, P1116, DOI 10.1038/embor.2012.162; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Humtsoe JO, 2010, ONCOGENE, V29, P1214, DOI 10.1038/onc.2009.419; Humtsoe JO, 2012, EXP CELL RES, V318, P379, DOI 10.1016/j.yexcr.2011.11.011; Iorio MV, 2009, CANCER RES, V69, P2195, DOI 10.1158/0008-5472.CAN-08-2920; Jain A, 2010, CANCER RES, V70, P1989, DOI 10.1158/0008-5472.CAN-09-3326; Jathal Maitreyee K., 2011, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V11, P131; Krig SR, 2010, ONCOGENE, V29, P5500, DOI 10.1038/onc.2010.289; Krig SR, ONCOGENE, V29, P5500; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Luca AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059689; MATSUMOTO K, 1989, J ORAL PATHOL MED, V18, P498, DOI 10.1111/j.1600-0714.1989.tb01350.x; Narayan M, 2009, CANCER RES, V69, P2191, DOI 10.1158/0008-5472.CAN-08-1056; Paatero I, 2014, J BIOL CHEM, V289, P22459, DOI 10.1074/jbc.M113.533497; Page H, 2013, CELL TISSUE RES, V352, P123, DOI 10.1007/s00441-012-1441-5; Perez-Sayans M, 2011, CANCER LETT, V313, P1, DOI 10.1016/j.canlet.2011.08.017; Pickl M, 2009, ONCOGENE, V28, P461, DOI 10.1038/onc.2008.394; Rabinowits G, 2012, ORAL ONCOL, V48, P1085, DOI 10.1016/j.oraloncology.2012.06.016; Rogers SJ, 2005, CANCER METAST REV, V24, P47, DOI 10.1007/s10555-005-5047-1; Roskoski R, 2014, PHARMACOL RES, V79, P34, DOI 10.1016/j.phrs.2013.11.002; Santini MT, 2000, CRIT REV ONCOL HEMAT, V36, P75, DOI 10.1016/S1040-8428(00)00078-0; Sasabe E, 2010, FREE RADICAL BIO MED, V48, P1321, DOI 10.1016/j.freeradbiomed.2010.02.013; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, ONCOGENE, V29, P625; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Shames DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056765; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; SHINTANI S, 1995, CANCER LETT, V95, P79, DOI 10.1016/0304-3835(95)03866-U; SHWEIKI D, 1995, P NATL ACAD SCI USA, V92, P768, DOI 10.1073/pnas.92.3.768; Sithanandam G, 2008, CANCER GENE THER, V15, P413, DOI 10.1038/cgt.2008.15; Takikita M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-126; Wilson TR, 2011, CANCER CELL, V20, P158, DOI 10.1016/j.ccr.2011.07.011; Xia C, 2007, CANCER RES, V67, P10823, DOI 10.1158/0008-5472.CAN-07-0783; Xia WY, 1997, CLIN CANCER RES, V3, P3; Xia WY, 1999, CLIN CANCER RES, V5, P4164; Zhu CH, 2001, J BIOL CHEM, V276, P14407, DOI 10.1074/jbc.M009708200; Ziober BL, 2001, CRIT REV ORAL BIOL M, V12, P499, DOI 10.1177/10454411010120060401; Zou YF, 2010, J RADIAT RES, V51, P47, DOI 10.1269/jrr.09070; Zuo JH, 2010, MOL CANCER RES, V8, P170, DOI 10.1158/1541-7786.MCR-09-0354	59	10	10	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 24	2016	35	12					1554	1564		10.1038/onc.2015.220	http://dx.doi.org/10.1038/onc.2015.220			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DH8RJ	26073080				2022-12-26	WOS:000373063600008
J	Toda, A; Tsurumura, T; Yoshida, T; Tsumori, Y; Tsuge, H				Toda, Akiyuki; Tsurumura, Toshiharu; Yoshida, Toru; Tsumori, Yayoi; Tsuge, Hideaki			Rho GTPase Recognition by C3 Exoenzyme Based on C3-RhoA Complex Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATING EXOENZYME; ACTIN STRESS FIBERS; CRYSTAL-STRUCTURE; CLOSTRIDIUM-BOTULINUM; STAPHYLOCOCCUS-AUREUS; BACILLUS-CEREUS; PROTEIN; RIBOSYLTRANSFERASE; BINDING; TOXIN	C3 exoenzyme is a mono-ADP-ribosyltransferase (ART) that catalyzes transfer of an ADP-ribose moiety from NAD(+) to Rho GTPases. C3 has long been used to study the diverse regulatory functions of Rho GTPases. How C3 recognizes its substrate and how ADP-ribosylation proceeds are still poorly understood. Crystal structures of C3-RhoA complex reveal that C3 recognizes RhoA via the switch I, switch II, and interswitch regions. In C3-RhoA(GTP) and C3-RhoA(GDP), switch I and II adopt the GDP and GTP conformations, respectively, which explains why C3 can ADP-ribosylate both nucleotide forms. Based on structural information, we successfully changed Cdc42 to an active substrate with combined mutations in the C3-Rho GTPase interface. Moreover, the structure reflects the close relationship among Gln-183 in the QXE motif (C3), a modified Asn-41 residue (RhoA) and NC1 of NAD(H), which suggests that C3 is the prototype ART. These structures show directly for the first time that the ARTT loop is the key to target protein recognition, and they also serve to bridge the gaps among independent studies of Rho GTPases and C3.	[Toda, Akiyuki; Tsurumura, Toshiharu; Yoshida, Toru; Tsumori, Yayoi; Tsuge, Hideaki] Kyoto Sangyo Univ, Fac Life Sci, Dept Bioresource & Environm Sci, Kamigamo Motoyama, Kyoto 6038555, Japan; [Tsurumura, Toshiharu; Yoshida, Toru; Tsuge, Hideaki] Kyoto Sangyo Univ, Struct Biol Res Ctr, Kamigamo Motoyama, Kyoto 6038555, Japan	Kyoto Sangyo University; Kyoto Sangyo University	Tsuge, H (corresponding author), Kyoto Sangyo Univ, Fac Life Sci, Kamigamo Motoyama, Kyoto 6038555, Japan.	tsuge@cc.kyoto-su.ac.jp	Tsuge, Hideaki/ABF-6424-2021	Tsuge, Hideaki/0000-0003-0166-9163	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; MEXT of Japan [15K08289, 25121733]	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work supported in part by a Strategic Research Foundation Grant-aided project for private universities from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan and by Grants-in-aid for Scientific Research 15K08289 and 25121733 from MEXT of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Aktories K, 2005, REV PHYSIOL BIOCH P, V152, P1, DOI 10.1007/s10254-004-0034-4; AKTORIES K, 1989, TRENDS PHARMACOL SCI, V10, P415, DOI 10.1016/0165-6147(89)90191-0; AKTORIES K, 1987, FEBS LETT, V212, P109, DOI 10.1016/0014-5793(87)81566-1; Aktories K, 2011, NAT REV MICROBIOL, V9, P487, DOI 10.1038/nrmicro2592; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Derewenda U, 2004, STRUCTURE, V12, P1955, DOI 10.1016/j.str.2004.09.003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans HR, 2003, J BIOL CHEM, V278, P45924, DOI 10.1074/jbc.M307719200; Genth H, 2003, J BIOL CHEM, V278, P28523, DOI 10.1074/jbc.M301915200; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Han S, 2002, INT J MED MICROBIOL, V291, P523; Han S, 1999, NAT STRUCT BIOL, V6, P932, DOI 10.1038/13300; Han SI, 2001, J MOL BIOL, V305, P95, DOI 10.1006/jmbi.2000.4292; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Holbourn KP, 2005, P NATL ACAD SCI USA, V102, P5357, DOI 10.1073/pnas.0501525102; Ihara K, 1998, J BIOL CHEM, V273, P9656, DOI 10.1074/jbc.273.16.9656; INOUE S, 1991, BIOCHEM BIOPH RES CO, V174, P459, DOI 10.1016/0006-291X(91)91438-I; Joosten RP, 2011, BIOINFORMATICS, V27, P3392, DOI 10.1093/bioinformatics/btr590; JUST I, 1995, BIOCHEMISTRY-US, V34, P334, DOI 10.1021/bi00001a041; JUST I, 1992, J BIOL CHEM, V267, P10274; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Menetrey J, 2002, J BIOL CHEM, V277, P30950, DOI 10.1074/jbc.M201844200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEMOTO Y, 1991, J BIOL CHEM, V266, P19312; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; O'Neal CJ, 2005, SCIENCE, V309, P1093, DOI 10.1126/science.1113398; OHASHI Y, 1987, J BIOL CHEM, V262, P1430; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pautsch A, 2005, EMBO J, V24, P3670, DOI 10.1038/sj.emboj.7600813; POPOFF M, 1990, NUCLEIC ACIDS RES, V18, P1291, DOI 10.1093/nar/18.5.1291; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ridley AJ, 2004, CELL, V116, P357, DOI 10.1016/S0092-8674(04)00123-0; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; RUBIN EJ, 1988, MOL CELL BIOL, V8, P418, DOI 10.1128/MCB.8.1.418; Schleberger C, 2006, J MOL BIOL, V364, P705, DOI 10.1016/j.jmb.2006.09.002; Sehr P, 1998, BIOCHEMISTRY-US, V37, P5296, DOI 10.1021/bi972592c; SEKINE A, 1989, J BIOL CHEM, V264, P8602; Sundriyal A, 2009, J BIOL CHEM, V284, P28713, DOI 10.1074/jbc.M109.043018; Tsuge H, 2003, J MOL BIOL, V325, P471, DOI 10.1016/S0022-2836(02)01247-0; Tsuge H, 2008, P NATL ACAD SCI USA, V105, P7399, DOI 10.1073/pnas.0801215105; Tsuge H, 2015, CURR TOP MICROBIOL, V384, P69, DOI 10.1007/82_2014_415; Tsurumura T, 2013, P NATL ACAD SCI USA, V110, P4267, DOI 10.1073/pnas.1217227110; Vogelsgesang M, 2008, FEBS LETT, V582, P1032, DOI 10.1016/j.febslet.2008.02.051; Wei YY, 1997, NAT STRUCT BIOL, V4, P699, DOI 10.1038/nsb0997-699; Wilde C, 2003, BIOCHEMISTRY-US, V42, P9694, DOI 10.1021/bi034583b; Wilde C, 2002, J BIOL CHEM, V277, P14771, DOI 10.1074/jbc.M201072200; Wilde C, 2002, BIOCHEMISTRY-US, V41, P1539, DOI 10.1021/bi015809i; Wilde C, 2002, TRENDS MICROBIOL, V10, P5, DOI 10.1016/S0966-842X(01)02281-8; Xiao JY, 2010, NAT STRUCT MOL BIOL, V17, P1004, DOI 10.1038/nsmb.1867; Yamaguchi T, 2001, INFECT IMMUN, V69, P7760, DOI 10.1128/IAI.69.12.7760-7771.2001	53	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19423	19432		10.1074/jbc.M115.653220	http://dx.doi.org/10.1074/jbc.M115.653220			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26067270	Green Published, hybrid			2022-12-26	WOS:000359364600003
J	Gebhardt, S; Oberholzer, L				Gebhardt, Stefan; Oberholzer, Leana			Elective Delivery at Term after a Previous Unexplained Intra-Uterine Fetal Death: Audit of Delivery Outcome at Tygerberg Hospital, South Africa	PLOS ONE			English	Article							LATE PRETERM; STILLBIRTH; RISK; POPULATION; SUBSEQUENT; RECURRENCE; PREGNANCY	Objectives To assess the delivery outcome in a pregnancy with a previous unexplained intra-uterine death by elective induction of labour at term. Methods An audit of the pregnancy outcome of all women within the catchment area with a current singleton pregnancy; and a previous unexplained or unexplored singleton fetal demise >= 24 weeks (or 500 grams birth weight if gestation unknown) after planned routine induction of labour at full term (39-40 weeks). Results During the audit period, 306 patients with a previous intra-uterine fetal death were referred for further management. Of these, 161 had a clear indication for earlier intervention and were excluded from the protocol. Of the remaining 145 patients, 9 met further exclusion criteria and there were 2 patients who defaulted. Forty-two of the remaining study patients (with no known previous medical problems) developed complications during their antenatal course that necessitated a change in clinical management and earlier (<39 weeks) delivery. Of the remaining 92 patients in the audit, 47 (51%) went into spontaneous labour before their induction date; all 92 women delivered without major complications. There were no intra-uterine deaths prior to induction. Conclusions Careful follow up at a high risk clinic identifies new or concealed maternal or fetal complications in 29% of patients with a previous intra-uterine death and no obvious maternal or fetal disease in the index pregnancy. When all risks are excluded and the pregnancy allowed to progress to full term (39-40 weeks) before an induction is offered, 50% will go into spontaneous labour.	[Gebhardt, Stefan] Univ Stellenbosch, Dept Obstet & Gynaecol, Cape Town, South Africa; Tygerberg Hosp, Cape Town, South Africa	Stellenbosch University; Tygerberg Hospital	Gebhardt, S (corresponding author), Univ Stellenbosch, Dept Obstet & Gynaecol, Cape Town, South Africa.	gsgeb@sun.ac.za		Gebhardt, Gabriel/0000-0001-8999-8193				Bhattacharya S, 2010, BJOG-INT J OBSTET GY, V117, P1243, DOI 10.1111/j.1471-0528.2010.02641.x; Black M, 2008, BJOG-INT J OBSTET GY, V115, P269, DOI 10.1111/j.1471-0528.2007.01562.x; Fretts RC, 2005, AM J OBSTET GYNECOL, V193, P1923, DOI 10.1016/j.ajog.2005.03.074; Getahun D, 2009, AM J OBSTET GYNECOL, V201, pe1, DOI DOI 10.1016/J.AJ0G.2009.06.071; Kramer MS, 2013, PAEDIATR PERINAT EP, V27, P7, DOI 10.1111/ppe.12031; Leunen K, 2003, J TROP PEDIATRICS, V49, P231, DOI 10.1093/tropej/49.4.231; Odendaal HJ, 2013, SAJOG-S AFR J OBSTET, V19, P67, DOI 10.7196/SAJOG.662; Pattinson RC., 2011, SAVING BABIES 2008 9, P29; Salihu HM, 2011, EARLY HUM DEV, V87, P641, DOI 10.1016/j.earlhumdev.2011.05.001; Sharma PP, 2007, PAEDIATR PERINAT EP, V21, P24, DOI 10.1111/j.1365-3016.2007.00834.x; Silver RM, 2011, SEMIN PERINATOL, V35, P302, DOI 10.1053/j.semperi.2011.05.006; Stock SJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2838	12	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130254	10.1371/journal.pone.0130254	http://dx.doi.org/10.1371/journal.pone.0130254			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076349	gold, Green Published			2022-12-26	WOS:000356329900159
J	Mwalusepo, S; Tonnang, HEZ; Massawe, ES; Okuku, GO; Khadioli, N; Johansson, T; Calatayud, PA; Le Ru, BP				Mwalusepo, Sizah; Tonnang, Henri E. Z.; Massawe, Estomih S.; Okuku, Gerphas O.; Khadioli, Nancy; Johansson, Tino; Calatayud, Paul-Andre; Le Ru, Bruno Pierre			Predicting the Impact of Temperature Change on the Future Distribution of Maize Stem Borers and Their Natural Enemies along East African Mountain Gradients Using Phenology Models	PLOS ONE			English	Article							PARTELLUS SWINHOE LEPIDOPTERA; CLIMATE-CHANGE; BUSSEOLA-FUSCA; RANGE; BIODIVERSITY; IRRIGATION; CRAMBIDAE; EXPANSION; ABUNDANCE; SORGHUM	Lepidopteran stem borers are among the most important pests of maize in East Africa. The objective of the present study was to predict the impact of temperature change on the distribution and abundance of the crambid Chilo partellus, the noctuid Busseola fusca, and their larval parasitoids Cotesia flavipes and Cotesia sesamiae at local scale along Kilimanjaro and Taita Hills gradients in Tanzania and Kenya, respectively. Temperature-dependent phenology models of pests and parasitoids were used in a geographic information system for mapping. The three risk indices namely establishment, generation, and activity indices were computed using current temperature data record from local weather stations and future (i.e., 2055) climatic condition based on downscaled climate change data from the AFRICLIM database. The calculations were carried out using index interpolator, a sub-module of the Insect Life Cycle Modeling (ILCYM) software. Thin plate algorithm was used for interpolation of the indices. Our study confirmed that temperature was a key factor explaining the distribution of stem borers and their natural enemies but other climatic factors and factors related to the top-down regulation of pests by parasitoids (host-parasitoid synchrony) also played a role. Results based on temperature only indicated a worsening of stem borer impact on maize production along the two East African mountain gradients studied. This was attributed to three main changes occurring simultaneously: (1) range expansion of the lowland species C. partellus in areas above 1200 m.a.s.l.; (2) increase of the number of pest generations across all altitudes, thus by 2055 damage by both pests will increase in the most productive maize zones of both transects; (3) disruption of the geographical distribution of pests and their larval parasitoids will cause an improvement of biological control at altitude below 1200 m.a.s.l. and a deterioration above 1200 m.a.s.l. The predicted increase in pest activity will significantly increase maize yield losses in all agro-ecological zones across both transects but to a much greater extent in lower areas.	[Mwalusepo, Sizah; Tonnang, Henri E. Z.; Johansson, Tino; Calatayud, Paul-Andre; Le Ru, Bruno Pierre] Icipe African Insect Sci Food & Hlth, CHIESA Project, Nairobi, Kenya; [Mwalusepo, Sizah; Massawe, Estomih S.] Univ Dar Es Salaam, Dept Math, Dar Es Salaam, Tanzania; [Mwalusepo, Sizah] Dar Es Salaam Inst Technol, Dept Gen studies, Dar Es Salaam, Tanzania; [Okuku, Gerphas O.; Khadioli, Nancy] Icipe African Insect Sci Food & Hlth, NSBB Project, Nairobi, Kenya; [Calatayud, Paul-Andre; Le Ru, Bruno Pierre] CNRS, Lab Evolut Genomes Comportement & Ecol, EGCE, IRD,UMR 247, Gif Sur Yvette, France; [Calatayud, Paul-Andre; Le Ru, Bruno Pierre] Univ Paris 11, Orsay, France	International Centre of Insect Physiology & Ecology (ICIPE); University of Dar es Salaam; International Centre of Insect Physiology & Ecology (ICIPE); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Le Ru, BP (corresponding author), Icipe African Insect Sci Food & Hlth, CHIESA Project, Nairobi, Kenya.	bleru@icipe.org	LE RU, BRUNO/C-5862-2011; TONNANG, Henri/AAQ-2206-2021; Paul-André, Calatayud/K-3282-2019; Calatayud, Paul-andre/AAG-8117-2020; Le Ru, bruno/K-3480-2016	TONNANG, Henri/0000-0002-9424-9186; Calatayud, Paul-andre/0000-0002-9482-4646; Le Ru, bruno/0000-0002-4208-3727; Johansson, Tino Petri/0000-0002-2381-5144	Ministry for Foreign Affairs of Finland	Ministry for Foreign Affairs of Finland	This research was conducted under the Climate Change Impacts on Ecosystem Services and Food Security in Eastern Africa (CHIESA) project. CHIESA is funded by the Ministry for Foreign Affairs of Finland.	AATF (African Agricultural Technology Foundation), 2009, BAS STUD SMALLH FARM; ABRAHAM C C, 1972, Agricultural Research Journal of Kerala, V10, P141; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Banziger M, 2006, AGR WATER MANAGE, V80, P212, DOI 10.1016/j.agwat.2005.07.014; Bassler C, 2014, PLOS ONE, V8; Battisti A, 2006, GLOBAL CHANGE BIOL, V12, P662, DOI 10.1111/j.1365-2486.2006.01124.x; Boko M, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P433; Briere JF, 1999, ENVIRON ENTOMOL, V28, P22, DOI 10.1093/ee/28.1.22; CEPF (CRITICAL ECOSYSTEM PARTNERSHIP FUND), 2012, EC PROF E ARC MOUNT; Chabi-Olaye A, 2005, AGR ECOSYST ENVIRON, V108, P17, DOI 10.1016/j.agee.2004.12.004; Christy JR, 2009, J CLIMATE, V22, P3342, DOI 10.1175/2008JCLI2726.1; Coulson SJ, 2002, DIVERS DISTRIB, V8, P327, DOI 10.1046/j.1472-4642.2002.00157.x; De Groote H, 2004, P 7 E SO AFRICA REGI, P401; De Groote Hugo, 2002, Insect Science and its Application, V22, P89; Edenhofer O., 2014, CONTRIBUTION WORKING; Ellers J, 2002, ECOL ENTOMOL, V27, P279, DOI 10.1046/j.1365-2311.2002.00421.x; Fand BB, 2014, ECOL MODEL, V288, P62, DOI 10.1016/j.ecolmodel.2014.05.018; Farre I, 2006, AGR WATER MANAGE, V83, P135, DOI 10.1016/j.agwat.2005.11.001; Geurts K, 2014, B ENTOMOL RES, V104, P288, DOI 10.1017/S0007485313000722; Hance T, 2007, ANNU REV ENTOMOL, V52, P107, DOI 10.1146/annurev.ento.52.110405.091333; Harris K. M., 1992, ICRISAT Information Bulletin; Hartley Stephen, 2003, New Zealand Entomologist, V26, P91; Hassan RM, 1998, MAIZE TECHNOLOGY DEVELOPMENT AND TRANSFER, P43; HILBERT DW, 1983, ENVIRON ENTOMOL, V12, P1, DOI 10.1093/ee/12.1.1; Hodkinson ID, 1998, ARCTIC ALPINE RES, V30, P78, DOI 10.2307/1551747; Jaramillo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024528; Jarvis A, 2012, TROP PLANT BIOL, V5, P9, DOI 10.1007/s12042-012-9096-7; Jepsen JU, 2008, J ANIM ECOL, V77, P257, DOI 10.1111/j.1365-2656.2007.01339.x; Kfir R, 1997, ANN ENTOMOL SOC AM, V90, P619, DOI 10.1093/aesa/90.5.619; Kfir R, 2002, ANNU REV ENTOMOL, V47, P701, DOI 10.1146/annurev.ento.47.091201.145254; Khadioli N, 2014, ANN APPL BIOL, V165, P373, DOI 10.1111/aab.12157; Khadioli N, 2014, B ENTOMOL RES, V104, P809, DOI 10.1017/S0007485314000601; Khadioli N, 2015, THESIS NAIROBI U NAI, P145; Tran JK, 2007, ECOL APPL, V17, P882, DOI 10.1890/06-0512; Kroschel J, 2013, AGR FOREST METEOROL, V170, P228, DOI 10.1016/j.agrformet.2012.06.017; Ladanyi M, 2010, APPL ECOL ENV RES, V8, P143, DOI 10.15666/aeer/0802_143151; Latimer AM, 2006, ECOL APPL, V16, P33, DOI 10.1890/04-0609; Levine RS, 2004, AM J TROP MED HYG, V70, P105, DOI 10.4269/ajtmh.2004.70.105; LOGAN JA, 1976, ENVIRON ENTOMOL, V5, P1133, DOI 10.1093/ee/5.6.1133; Lyon B, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050337; Maeda EE, 2011, J ENVIRON MANAGE, V92, P982, DOI 10.1016/j.jenvman.2010.11.005; Maeda EE, 2010, AGR SYST, V103, P609, DOI 10.1016/j.agsy.2010.07.004; Mailafiya DM, 2010, BIOL CONTROL, V54, P1, DOI 10.1016/j.biocontrol.2009.11.008; Marts PJ, 2015, AFRICAN J ECOLOGY, V53, P103, DOI DOI 10.1111/AJE.12180; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; Matsuo Y, 2006, FUNCT ECOL, V20, P300, DOI 10.1111/j.1365-2435.2006.01097.x; Menendez Rosa, 2007, Tijdschrift voor Entomologie, V150, P355; Mgoo VH, 2006, ANN SOC ENTOMOL FR, V42, P487, DOI 10.1080/00379271.2006.10697483; Niang I, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1199; Ong'amo GO, 2006, ANN SOC ENTOMOL FR, V42, P171, DOI 10.1080/00379271.2006.10700620; ONYANGO FO, 1994, ENTOMOL EXP APPL, V73, P139, DOI 10.1007/BF02383419; Overholt W.A., 2000, P52; OVERHOLT WA, 1994, B ENTOMOL RES, V84, P367, DOI 10.1017/S0007485300032491; Pachauri R.K, 2007, CONTRIBUTION WORKING, P104, DOI DOI 10.1017/CBO9780511546013; Peterson David L., 2012, U S Forest Service Pacific Northwest Research Station General Technical Report PNW-GTR, P1; Platts PJ, 2008, ECOL MODEL, V218, P121, DOI 10.1016/j.ecolmodel.2008.06.028; Platts PJ, 2010, DIVERS DISTRIB, V16, P628, DOI 10.1111/j.1472-4642.2010.00668.x; Platts PJ, 2012, THESIS U YORK; Rasmann S, 2014, J ECOL, V102, P930, DOI 10.1111/1365-2745.12253; Regniere J, 2012, BIOL INVASIONS, V14, P1571, DOI 10.1007/s10530-010-9918-1; Rosenthal DM, 2012, TROP PLANT BIOL, V5, P30, DOI 10.1007/s12042-011-9086-1; Schellnhuber HJ, 2013, TURN HEAT CLIMATE EX, P1; SHARPE PJH, 1977, J THEOR BIOL, V64, P649, DOI 10.1016/0022-5193(77)90265-X; Sithole SZ, 1989, INT WORKSH SORGH STE; Smale M, 2001, 5659 WORLD BANK, P1; Sporleder M, 2008, ADV CROP RES, V10, P15; Sporleder M., 2013, ILCYM INSECT LIFE CY, P193; STINNER RE, 1974, CAN ENTOMOL, V106, P519, DOI 10.4039/Ent106519-5; Stoeckli S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035723; Tams W.H.T., 1932, ENTOMOLOGIST, V65, P124; Thornton PK, 2011, PHILOS T R SOC A, V369, P117, DOI 10.1098/rsta.2010.0246; Thornton PK, 2010, AGR SYST, V103, P73, DOI 10.1016/j.agsy.2009.09.003; UNEP, 2009, KEN ATL OUR CHANG EV; WAGNER TL, 1984, ANN ENTOMOL SOC AM, V77, P208, DOI 10.1093/aesa/77.2.208; WAGNER TL, 1991, J AGR ENTOMOL, V8, P251; Waithaka M, 2013, E AFRICAN CLIMATE CH; Wale M, 2006, ANN SOC ENTOMOL FR, V42, P389, DOI 10.1080/00379271.2006.10697471; Ward NL, 2007, GLOBAL CHANGE BIOL, V13, P1605, DOI 10.1111/j.1365-2486.2007.01399.x; Williams A., 2011, CLIM DYNAM, P1, DOI [10.1007/s00382-010-0984-y, DOI 10.1007/S00382-010-0984-Y]; Zhou G, 2001, ECOL APPL, V11, P1554, DOI 10.2307/3060939	81	45	47	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130427	10.1371/journal.pone.0130427	http://dx.doi.org/10.1371/journal.pone.0130427			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075605	Green Published, Green Submitted, gold			2022-12-26	WOS:000356329900172
J	Sousa, JB; Vieira-Rocha, MS; Arribas, SM; Gonzalez, MC; Fresco, P; Diniz, C				Sousa, Joana Beatriz; Vieira-Rocha, Maria Sofia; Arribas, Silvia M.; Gonzalez, Maria Carmen; Fresco, Paula; Diniz, Carmen			Endothelial and Neuronal Nitric Oxide Activate Distinct Pathways on Sympathetic Neurotransmission in Rat Tail and Mesenteric Arteries	PLOS ONE			English	Article							EXTRACELLULAR ADENOSINE ACCUMULATION; HIPPOCAMPAL SYNAPTIC-TRANSMISSION; SPONTANEOUSLY HYPERTENSIVE-RATS; RECEPTOR-MEDIATED FACILITATION; H-3 NOREPINEPHRINE RELEASE; PROTEIN-KINASE-C; NORADRENALINE RELEASE; A(1)-ADENOSINE RECEPTORS; NERVE-STIMULATION; FOREBRAIN NEURONS	Nitric oxide (NO) seems to contribute to vascular homeostasis regulating neurotransmission. This work aimed at assessing the influence of NO from different sources and respective intracellular pathways on sympathetic neurotransmission, in two vascular beds. Electrically-evoked [H-3]-noradrenaline release was assessed in rat mesenteric and tail arteries in the presence of NO donors or endothelial/neuronal nitric oxide synthase (NOS) inhibitors. The influence of NO on adenosine-mediated effects was also studied using selective antagonists for adenosine receptors subtypes. Location of neuronal NOS (nNOS) was investigated by immunohistochemistry (with specific antibodies for nNOS and for Schwann cells) and Confocal Microscopy. Results indicated that: 1) in mesenteric arteries, noradrenaline release was reduced by NO donors and it was increased by nNOS inhibitors; the effect of NO donors was only abolished by the adenosine A(1) receptors antagonist; 2) in tail arteries, noradrenaline release was increased by NO donors and it was reduced by eNOS inhibitors; adenosine receptors antagonists were devoid of effect; 3) confocal microscopy showed nNOS staining in adventitial cells, some co-localized with Schwann cells. nNOS staining and its co-localization with Schwann cells were significantly lower in tail compared to mesenteric arteries. In conclusion, in mesenteric arteries, nNOS, mainly located in Schwann cells, seems to be the main source of NO influencing perivascular sympathetic neurotransmission with an inhibitory effect, mediated by adenosine A1 receptors activation. Instead, in tail arteries endothelial NO seems to play a more relevant role and has a facilitatory effect, independent of adenosine receptors activation.	[Sousa, Joana Beatriz; Vieira-Rocha, Maria Sofia; Fresco, Paula; Diniz, Carmen] Univ Porto, Fac Pharm, Dept Drug Sci, Pharmacol Lab, P-4100 Oporto, Portugal; [Sousa, Joana Beatriz; Vieira-Rocha, Maria Sofia; Diniz, Carmen] Univ Porto, LAQV REQUIMTE, Oporto, Portugal; [Arribas, Silvia M.; Gonzalez, Maria Carmen] Univ Autonoma Madrid, Fac Med, Dept Physiol, Madrid, Spain	Universidade do Porto; Universidade do Porto; Autonomous University of Madrid	Sousa, JB (corresponding author), Univ Porto, Fac Pharm, Dept Drug Sci, Pharmacol Lab, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	joanabeatrizsousa@gmail.com	, CDiniz/D-6293-2013; Sousa, Joana/N-4763-2019; Gonzalez-Garcia, M Carmen/AAE-9533-2019; Fresco, Paula/D-4845-2013	, CDiniz/0000-0003-4668-9360; Sousa, Joana/0000-0002-1744-7840; Gonzalez-Garcia, M Carmen/0000-0002-5522-0786; Fresco, Paula/0000-0001-6705-7798; Arribas, Silvia M/0000-0001-7103-6105	FEDER through Program of Operational Competitiveness Factors - COMPETE; National Funds through Foundation for Science and Technology (FCT) [PEst C/EQB/LA0006/2011]; FCT	FEDER through Program of Operational Competitiveness Factors - COMPETE; National Funds through Foundation for Science and Technology (FCT); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by FEDER through Program of Operational Competitiveness Factors - COMPETE and by National Funds through Foundation for Science and Technology (FCT): Grant No. PEst C/EQB/LA0006/2011. JBS was supported by PhD grant (SFRH/BD//2009) - FCT (URL: http://www.fct.pt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDICKS K, 1994, MICROSC RES TECHNIQ, V29, P161, DOI 10.1002/jemt.1070290214; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Andrew PJ, 1999, CARDIOVASC RES, V43, P521, DOI 10.1016/S0008-6363(99)00115-7; Arrigoni E, 2006, EUR J NEUROSCI, V24, P2471, DOI 10.1111/j.1460-9568.2006.05124.x; Blanco-Rivero J, 2013, J HYPERTENS, V31, P916, DOI 10.1097/HJH.0b013e32835f749c; Blanco-Rivero J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053802; Boison D, 2013, PHARMACOL REV, V65, P906, DOI 10.1124/pr.112.006361; Bon CLM, 2001, NEUROPHARMACOLOGY, V40, P501, DOI 10.1016/S0028-3908(00)00193-3; Brassai A, 2002, NEUROCHEM INT, V41, P279, DOI 10.1016/S0197-0186(02)00012-8; Brorson JR, 1999, J NEUROSCI, V19, P147, DOI 10.1523/JNEUROSCI.19-01-00147.1999; Brown GC, 2003, MOL NEUROBIOL, V27, P325, DOI 10.1385/MN:27:3:325; BUTT E, 1993, NEUROCHEM RES, V18, P27, DOI 10.1007/BF00966920; Castro AF, 1998, AM J PHYSIOL-CELL PH, V275, pC113, DOI 10.1152/ajpcell.1998.275.1.C113; CHEN C, 1995, J PHYSIOL-LONDON, V482, P521, DOI 10.1113/jphysiol.1995.sp020537; del Campo L, 2009, J HYPERTENS, V27, P791, DOI 10.1097/HJH.0b013e32832531e6; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; Diniz C, 2004, EUR J PHARMACOL, V504, P17, DOI 10.1016/j.ejphar.2004.09.048; Domek-Lopacinska K, 2005, J Physiol Pharmacol, V56 Suppl 2, P15; Domenico R, 2004, CURR PHARM DESIGN, V10, P1667, DOI 10.2174/1381612043384709; Fragata IR, 2006, EUR J PHARMACOL, V543, P32, DOI 10.1016/j.ejphar.2006.05.043; Fresco P, 2004, CARDIOVASC RES, V63, P739, DOI 10.1016/j.cardiores.2004.05.015; Fresco P, 2002, BRIT J PHARMACOL, V136, P230, DOI 10.1038/sj.bjp.0704686; Fresco P, 2007, NEUROCHEM INT, V51, P47, DOI 10.1016/j.neuint.2007.03.009; Gautier C, 2006, BIOCHEM BIOPH RES CO, V341, P816, DOI 10.1016/j.bbrc.2006.01.031; GONZALEZ C, 1990, CAN J PHYSIOL PHARM, V68, P104, DOI 10.1139/y90-016; Jo YH, 1999, NAT NEUROSCI, V2, P241, DOI 10.1038/6344; Johnson CD, 2010, ADV PHYSIOL EDUC, V34, P217, DOI 10.1152/advan.00070.2010; Kolo LL, 2004, AM J PHYSIOL-HEART C, V287, pH1842, DOI 10.1152/ajpheart.00013.2004; Kolo LL, 2004, AM J PHYSIOL-HEART C, V286, pH296, DOI 10.1152/ajpheart.00668.2003; Koyama T, 2010, HYPERTENS RES, V33, P485, DOI 10.1038/hr.2010.48; Li D, 2007, HYPERTENSION, V50, P69, DOI 10.1161/HYPERTENSIONAHA.107.088591; Lo WC, 1998, HYPERTENSION, V32, P1034, DOI 10.1161/01.HYP.32.6.1034; LONART G, 1995, J PHARMACOL EXP THER, V275, P7; LONART G, 1995, J PHARMACOL EXP THER, V275, P14; Lovatt D, 2012, P NATL ACAD SCI USA, V109, P6265, DOI 10.1073/pnas.1120997109; Lu Y, 2003, EUR J NEUROSCI, V17, P1213, DOI 10.1046/j.1460-9568.2003.02554.x; Macarthur H, 2011, ACTA PHYSIOL, V203, P37, DOI 10.1111/j.1748-1716.2010.02242.x; Martire M, 1998, EUR J PHARMACOL, V350, P345, DOI 10.1016/S0014-2999(98)00269-6; Michel T, 2010, PFLUG ARCH EUR J PHY, V459, P807, DOI 10.1007/s00424-009-0765-9; Mohan RM, 2000, CARDIOVASC RES, V47, P81, DOI 10.1016/S0008-6363(00)00057-2; Pankratov Y, 2007, J GEN PHYSIOL, V129, P257, DOI 10.1085/jgp.200609693; Pilz RB, 2005, FRONT BIOSCI-LANDMRK, V10, P1239, DOI 10.2741/1616; Prast H, 2001, PROG NEUROBIOL, V64, P51, DOI 10.1016/S0301-0082(00)00044-7; Queiroz G, 2004, NEUROPHARMACOLOGY, V47, P216, DOI 10.1016/j.neuropharm.2004.03.015; Rocha-Pereira C, 2013, NEUROCHEM INT, V62, P399, DOI 10.1016/j.neuint.2013.02.010; Rocha-Pereira C, 2013, J PHARMACOL SCI, V122, P59, DOI 10.1254/jphs.12266FP; Rosenberg PA, 2000, J NEUROSCI, V20, P6294, DOI 10.1523/JNEUROSCI.20-16-06294.2000; SCHWARZ P, 1995, CIRC RES, V77, P841, DOI 10.1161/01.RES.77.4.841; Shinozuka K, 2002, JPN J PHARMACOL, V88, P19, DOI 10.1254/jjp.88.19; Sinclair CJD, 2001, BRIT J PHARMACOL, V134, P1037, DOI 10.1038/sj.bjp.0704349; Song MS, 2002, NEUROSCI LETT, V326, P41, DOI 10.1016/S0304-3940(02)00290-2; Sousa JB, 2015, NEUROCHEM INT, V80, P7, DOI 10.1016/j.neuint.2014.11.001; Sousa JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105540; Stegbauer J, 2008, AM J PHYSIOL-REG I, V294, pR421, DOI 10.1152/ajpregu.00481.2007; Talaia C, 2011, EUR J PHARMACOL, V652, P33, DOI 10.1016/j.ejphar.2010.10.075; Tripovic D, 2013, J PHYSIOL-LONDON, V591, P2867, DOI 10.1113/jphysiol.2012.250365; VAZDASILVA MJ, 1995, N-S ARCH PHARMACOL, V352, P640; VONKUGELGEN I, 1995, BRIT J PHARMACOL, V115, P247; Webb AJ, 2008, CIRC RES, V103, P957, DOI 10.1161/CIRCRESAHA.108.175810; WHITE TD, 1990, ANN NY ACAD SCI, V603, P287; Xavier FE, 2011, EUR J PHARMACOL, V654, P280, DOI 10.1016/j.ejphar.2011.01.007; Xu ZL, 2005, CARDIOVASC RES, V65, P803, DOI 10.1016/j.cardiores.2004.12.004; Yoshida M, 1998, EUR J PHARMACOL, V357, P213, DOI 10.1016/S0014-2999(98)00566-4; Yu M, 2002, J APPL PHYSIOL, V93, P1391, DOI 10.1152/japplphysiol.00247.2002	64	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129224	10.1371/journal.pone.0129224	http://dx.doi.org/10.1371/journal.pone.0129224			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075386	gold, Green Published, Green Submitted			2022-12-26	WOS:000356329900054
J	Thurber, KA; Dobbins, T; Kirk, M; Dance, P; Banwell, C				Thurber, Katherine A.; Dobbins, Timothy; Kirk, Martyn; Dance, Phyll; Banwell, Cathy			Early Life Predictors of Increased Body Mass Index among Indigenous Australian Children	PLOS ONE			English	Article							BIRTH-WEIGHT PERCENTILES; RISK; OBESITY; DISEASE; PREGNANCY	Aboriginal and Torres Strait Islander Australians are more likely than non-Indigenous Australians to be obese and experience chronic disease in adulthood-conditions linked to being overweight in childhood. Birthweight and prenatal exposures are associated with increased Body Mass Index (BMI) in other populations, but the relationship is unclear for Indigenous children. The Longitudinal Study of Indigenous Children is an ongoing cohort study of up to 1,759 children across Australia. We used a multilevel model to examine the association between children's birthweight and BMI z-score in 2011, at age 3-9 years, adjusted for sociodemographic and maternal factors. Complete data were available for 682 of the 1,264 children participating in the 2011 survey; we repeated the analyses in the full sample with BMI recorded (n=1,152) after multilevel multiple imputation. One in ten children were born large for gestational age, and 17% were born small for gestational age. Increasing birthweight predicted increasing BMI; a 1-unit increase in birthweight z-score was associated with a 0.22-unit (95% CI: 0.13, 0.31) increase in childhood BMI z-score. Maternal smoking during pregnancy was associated with a significant increase (0.25; 95% CI: 0.05, 0.45) in BMI z-score. The multiple imputation analysis indicated that our findings were not distorted by biases in the missing data. High birthweight may be a risk indicator for overweight and obesity among Indigenous children. National targets to reduce the incidence of low birthweight which measure progress by an increase in the population's average birthweight may be ignoring a significant health risk; both ends of the spectrum must be considered. Interventions to improve maternal health during pregnancy are the first step to decreasing the prevalence of high BMI among the next generation of Indigenous children.	[Thurber, Katherine A.; Dobbins, Timothy; Kirk, Martyn; Banwell, Cathy] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Res Sch Populat Hlth, Canberra, ACT, Australia; [Dance, Phyll] Australian Natl Univ, Sch Med, Canberra, ACT, Australia; [Dance, Phyll] Australian Natl Univ, Natl Ctr Indigenous Studies, Canberra, ACT, Australia	Australian National University; Australian National University; Australian National University	Thurber, KA (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Res Sch Populat Hlth, Canberra, ACT, Australia.	katherine.thurber@anu.edu.au	Dobbins, Timothy A/I-5819-2013; Dobbins, Timothy/AAS-1422-2020	Dobbins, Timothy A/0000-0003-1841-9056; Dobbins, Timothy/0000-0003-1841-9056; Kirk, Martyn/0000-0001-5432-5984; Banwell, Cathy/0000-0001-6808-1052	Australian National University; Fulbright-Anne Wexler Master's Scholarship in Public Policy	Australian National University(Australian National University); Fulbright-Anne Wexler Master's Scholarship in Public Policy	This work was supported by the Australian National University and the Fulbright-Anne Wexler Master's Scholarship in Public Policy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Mamun A, 2006, AM J EPIDEMIOL, V164, P317, DOI 10.1093/aje/kwj209; Australian Bureau of Statistics, 2014, AB TORR STRAIT ISL B, DOI [10.1186/1471-2288-12-90, DOI 10.1186/1471-2288-12-90]; [Australian Bureau of Statistics Statistics ABo], 2013, LIF TABL AB TORR STR; Australian Bureau of Statistics, 2014, WEEKL PAYR JOBS WAG; Australian Institute of Health and Welfare, 2014, BIRTHW BAB BORN IND; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Bell LM, 2007, J CLIN ENDOCR METAB, V92, P517, DOI 10.1210/jc.2006-1714; Biddle N, 2009, RANKING REGIONS REVI; Blossner M, 2009, WHO ANTHROPLUS PERSO; Carpenter JR, 2011, J STAT SOFTW, V45, P1; Chamberlain C, 2014, AUST NZ J OBSTET GYN, V54, P433, DOI 10.1111/ajo.12213; Council of Australian Governments Reform Council, 2014, HEALTHC AUSTR 2012 1; de Onis M, 2010, INT J PEDIATR OBES, V5, P458, DOI 10.3109/17477161003615583; de Onis M, 2012, PUBLIC HEALTH NUTR, V15, P142, DOI 10.1017/S1368980011001315; Dobbins TA, 2012, MED J AUSTRALIA, V197, P291, DOI 10.5694/mja11.11331; Gomez-Ambrosi J, 2012, INT J OBESITY, V36, P286, DOI 10.1038/ijo.2011.100; Han JC, 2010, LANCET, V375, P1737, DOI 10.1016/S0140-6736(10)60171-7; Hardy LL, 2014, MED J AUSTRALIA, V200, P667, DOI 10.5694/mja13.10614; Hewitt B, 2012, LONGITUDINAL STUDY I, P1; Hilder L, 2014, PERINATAL STAT SERIE, V30; Koupil I, 2008, INT J OBESITY, V32, P73, DOI 10.1038/sj.ijo.0803681; Lausten-Thomsen Ulrik, 2013, Eur J Pediatr, V172, P747, DOI 10.1007/s00431-013-1949-z; Ludwig DS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001521; Malcolm J, 2012, DIABETES-METAB RES, V28, P307, DOI 10.1002/dmrr.2275; McNamara BJ, 2012, INT J EPIDEMIOL, V41, P1661, DOI 10.1093/ije/dys190; Moller SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109184; Nohr EA, 2013, INT J EPIDEMIOL, V42, P1016, DOI 10.1093/ije/dyt102; Oldroyd J, 2011, EUR J PEDIATR, V170, P899, DOI 10.1007/s00431-010-1375-4; Passey ME, 2013, MED J AUSTRALIA, V199, P39, DOI 10.5694/mja12.11848; Pink B, 2011, AUSTR STAT GEOGRAPHY; Roberts CL, 1999, MED J AUSTRALIA, V170, P114, DOI 10.5694/j.1326-5377.1999.tb127678.x; Schellong K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047776; Smylie Janet, 2010, Open Womens Health J, P7; Steering Committee for the Review of Government Service Provision, 2014, OV IND DIS KEY IND 2; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Thrift AP, 2014, MED J AUSTRALIA, V201, P592, DOI 10.5694/mja13.11170; Thurber K. A., 2014, Public Health Research & Practice, V25, pe2511407; Thurber KA, 2012, THESIS AUSTR NATL U; Thurber KA, 2014, INT J EPIDEMIOL; Vos T, 2009, INT J EPIDEMIOL, V38, P470, DOI 10.1093/ije/dyn240; Wicklow BA, 2015, BEST PRACT RES CL OB, V29, P43, DOI 10.1016/j.bpobgyn.2014.04.017; World Health Organization, WHO ANTHR VERS 3 2 2	42	11	12	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130039	10.1371/journal.pone.0130039	http://dx.doi.org/10.1371/journal.pone.0130039			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075400	gold, Green Published			2022-12-26	WOS:000356329900126
J	Kishimoto, Y; Yamamoto, S; Suzuki, K; Toyoda, H; Kano, M; Tsukada, H; Kirino, Y				Kishimoto, Yasushi; Yamamoto, Shigeyuki; Suzuki, Kazutaka; Toyoda, Haruyoshi; Kano, Masanobu; Tsukada, Hideo; Kirino, Yutaka			Implicit Memory in Monkeys: Development of a Delay Eyeblink Conditioning System with Parallel Electromyographic and High-Speed Video Measurements	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; EYELID RESPONSES; CEREBELLAR DEGENERATION; CONSCIOUS MONKEYS; BEHAVING RABBITS; MAMMALIAN BRAIN; MOUSE MODEL; TRACE; AWARENESS; RECEPTOR	Delay eyeblink conditioning, a cerebellum-dependent learning paradigm, has been applied to various mammalian species but not yet to monkeys. We therefore developed an accurate measuring system that we believe is the first system suitable for delay eyeblink conditioning in a monkey species (Macaca mulatta). Monkey eyeblinking was simultaneously monitored by orbicularis oculi electromyographic (OO-EMG) measurements and a high-speed camera-based tracking system built around a 1-kHz CMOS image sensor. A 1-kHz tone was the conditioned stimulus (CS), while an air puff (0.02 MPa) was the unconditioned stimulus. EMG analysis showed that the monkeys exhibited a conditioned response (CR) incidence of more than 60% of trials during the 5-day acquisition phase and an extinguished CR during the 2-day extinction phase. The camera system yielded similar results. Hence, we conclude that both methods are effective in evaluating monkey eyeblink conditioning. This system incorporating two different measuring principles enabled us to elucidate the relationship between the actual presence of eyelid closure and OO-EMG activity. An interesting finding permitted by the new system was that the monkeys frequently exhibited obvious CRs even when they produced visible facial signs of drowsiness or microsleep. Indeed, the probability of observing a CR in a given trial was not influenced by whether the monkeys closed their eyelids just before CS onset, suggesting that this memory could be expressed independently of wakefulness. This work presents a novel system for cognitive assessment in monkeys that will be useful for elucidating the neural mechanisms of implicit learning in nonhuman primates.	[Kishimoto, Yasushi; Kirino, Yutaka] Tokushima Bunri Univ, Dept Neurobiophys, Kagawa Sch Pharmaceut Sci, Sanuki, Kagawa, Japan; [Yamamoto, Shigeyuki; Suzuki, Kazutaka; Toyoda, Haruyoshi; Tsukada, Hideo] Hamamatsu Photon KK, Cent Res Lab, Hamakita Ku, Hamamatsu, Shizuoka, Japan; [Kano, Masanobu] Univ Tokyo, Grad Sch Med, Dept Neurophysiol, Bunkyo Ku, Tokyo, Japan	Tokushima Bunri University; Hamamatsu Photonics; University of Tokyo	Kirino, Y (corresponding author), Tokushima Bunri Univ, Dept Neurobiophys, Kagawa Sch Pharmaceut Sci, Sanuki, Kagawa, Japan.	y-kirino@tokushima.bunri-u.ac.jp	Kishimoto, Yasushi/AAH-4923-2021	Kano, Masanobu/0000-0002-0725-3292; Kishimoto, Yasushi/0000-0002-4828-1249	Hamamatsu Photonics K.K.;  [21220006];  [90441592];  [20790084];  [24590068]	Hamamatsu Photonics K.K.; ; ; ; 	This study was supported by Grants-in-Aid for Scientific Research (21220006 and 90441592 to Y. Kishimoto, 20790084 to MK, and 24590068 to Y. Kirino). URL: http://www.jsps.go.jp/english/e-grants/. Hamamatsu Photonics K.K., provided support in the form of salaries for authors SY, KS, H. Toyoda, and H. Tsukada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adachi K, 2004, IEEJ T, V124, P776; AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; ANDREWS SJ, 1995, DEV PSYCHOBIOL, V28, P307, DOI 10.1002/dev.420280602; Attwell PJE, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0003.1999; Attwell PJE, 2002, NEURON, V34, P1011, DOI 10.1016/S0896-6273(02)00719-5; Carretero-Guillen A, 2015, CEREB CORTEX, V25, P1278, DOI 10.1093/cercor/bht321; Clark RE, 1998, SCIENCE, V280, P77, DOI 10.1126/science.280.5360.77; Clark RE, 1998, BEHAV NEUROSCI, V112, P1062, DOI 10.1037/0735-7044.112.5.1062; DAUM I, 1989, J NEUROL NEUROSUR PS, V52, P47, DOI 10.1136/jnnp.52.1.47; ESLINGER PJ, 1986, J NEUROSCI, V6, P3006; Gerwig M, 2008, EXP BRAIN RES, V187, P85, DOI 10.1007/s00221-008-1283-2; Gerwig M, 2005, J NEUROSCI, V25, P3919, DOI 10.1523/JNEUROSCI.0266-05.2005; Gruart A, 2008, NEUROBIOL DIS, V30, P439, DOI 10.1016/j.nbd.2008.03.001; GRUART A, 1995, J NEUROPHYSIOL, V74, P226, DOI 10.1152/jn.1995.74.1.226; Hesslow G, 1998, SCIENCE, V280, P1817; Hilgard ER, 1936, PSYCHOL MONOGR, V47, P186, DOI 10.1037/h0093413; Inoue K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039149; Ito M, 2002, ANN NY ACAD SCI, V978, P273, DOI 10.1111/j.1749-6632.2002.tb07574.x; KEIFER J, 1995, J NEUROSCI, V15, P5036; Kim JJ, 1997, TRENDS NEUROSCI, V20, P177, DOI 10.1016/S0166-2236(96)10081-3; Kishimoto Y, 2006, J NEUROSCI, V26, P1562, DOI 10.1523/JNEUROSCI.4142-05.2006; Kishimoto Y, 2006, J NEUROSCI, V26, P8829, DOI 10.1523/JNEUROSCI.1236-06.2006; Kishimoto Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060627; Kishimoto Y, 2013, NEUROSCI LETT, V538, P15, DOI 10.1016/j.neulet.2013.01.025; Kishimoto Y, 2012, NEUROSCI LETT, V506, P155, DOI 10.1016/j.neulet.2011.10.071; Koekkoek SKE, 2003, SCIENCE, V301, P1736, DOI 10.1126/science.1088383; Koekkoek SKE, 2002, J NEUROPHYSIOL, V88, P2124, DOI 10.1152/jn.2002.88.4.2124; KRUPA DJ, 1993, SCIENCE, V260, P989, DOI 10.1126/science.8493536; Larner AJ, 1997, DEMENT GERIATR COGN, V8, P203, DOI 10.1159/000106632; Leal-Campanario R, 2013, J NEUROSCI, V33, P4378, DOI 10.1523/JNEUROSCI.5560-12.2013; Lisberger SG, 2009, NEUROSCIENCE, V162, P763, DOI 10.1016/j.neuroscience.2009.03.059; Lovibond PF, 2011, BIOL PSYCHOL, V87, P393, DOI 10.1016/j.biopsycho.2011.05.002; Malla AM, 2010, IEEE ENG MED BIO, P6741, DOI 10.1109/IEMBS.2010.5626013; Manns JR, 2001, COGN AFFECT BEHAV NE, V1, P192, DOI 10.3758/CABN.1.2.192; Marquis DG, 1937, BRAIN, V60, P1, DOI 10.1093/brain/60.1.1; Mauk MD, 1997, NEURON, V18, P343, DOI 10.1016/S0896-6273(00)81235-0; MCCORMICK DA, 1984, SCIENCE, V223, P296, DOI 10.1126/science.6701513; Miyata M, 2011, J NEUROSCI, V31, P6067, DOI 10.1523/JNEUROSCI.5651-10.2011; Nakamura Yoshiko, 2008, Nippon Ganka Gakkai Zasshi, V112, P1059; PENNYPACKER HS, 1966, J EXP ANAL BEHAV, V9, P601, DOI 10.1901/jeab.1966.9-601; Sanchez-Campusano R, 2007, J NEUROSCI, V27, P6620, DOI 10.1523/JNEUROSCI.0488-07.2007; Sanchez-Campusano R, 2009, J NEUROSCI, V29, P10750, DOI 10.1523/JNEUROSCI.2178-09.2009; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Skosnik PD, 2008, NEUROPSYCHOPHARMACOL, V33, P1432, DOI 10.1038/sj.npp.1301506; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; Sugiyama Y, 2005, IEEE J SOLID-ST CIRC, V40, P2816, DOI 10.1109/JSSC.2005.858475; Tachibana M, 2012, CELL, V148, P285, DOI 10.1016/j.cell.2011.12.007; TAKECHI H, 1994, NEUROSCI LETT, V182, P279, DOI 10.1016/0304-3940(94)90816-8; Takumi M, 2002, P IAPR WORK MACH VIS, V8-37, P384; Thompson RF, 1996, P NATL ACAD SCI USA, V93, P13438, DOI 10.1073/pnas.93.24.13438; THOMPSON RF, 1994, ANNU REV NEUROSCI, V17, P519, DOI 10.1146/annurev.neuro.17.1.519; THOMPSON RF, 1997, CEREBELLUM COGNITION, P152; TOPKA H, 1993, BRAIN, V116, P961, DOI 10.1093/brain/116.4.961; Woodruff- Pak DS, 2000, EYEBLINK CLASSICAL C, VII; Woodruff-Pak DS, 2000, EYEBLINK CLASSICAL C, VI; WoodruffPak DS, 1996, NEUROBIOL AGING, V17, P397, DOI 10.1016/0197-4580(96)00022-X; Yamamoto S, 2013, NEUROPSYCHOPHARMACOL, V38, P2666, DOI 10.1038/npp.2013.176; Yamamoto S, 2011, NEUROPSYCHOPHARMACOL, V36, P1455, DOI 10.1038/npp.2011.31; Yeo CH, 1998, TRENDS COGN SCI, V2, P322, DOI 10.1016/S1364-6613(98)01219-4	59	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129828	10.1371/journal.pone.0129828	http://dx.doi.org/10.1371/journal.pone.0129828			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068663	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000112
J	Nowack, N; Wittsiepe, J; Kasper-Sonnenberg, M; Wilhelm, M; Scholmerich, A				Nowack, Nikola; Wittsiepe, Juergen; Kasper-Sonnenberg, Monika; Wilhelm, Michael; Schoelmerich, Axel			Influence of Low-Level Prenatal Exposure to PCDD/Fs and PCBs on Empathizing, Systemizing and Autistic Traits: Results from the Duisburg Birth Cohort Study	PLOS ONE			English	Article							POLYCHLORINATED-BIPHENYLS PCBS; ENDOCRINE-DISRUPTING CHEMICALS; PERSISTENT ORGANIC POLLUTANTS; SOCIAL RESPONSIVENESS SCALE; HAZARDOUS AIR-POLLUTANTS; HIGH-FUNCTIONING AUTISM; 4TH DIGIT RATIO; FETAL TESTOSTERONE; SPECTRUM DISORDERS; GENE-EXPRESSION	Background Polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDD/Fs) and polychlorinated biphenyls (PCBs) are assumed to act as endocrine disruptor chemicals. Prenatal exposure to these pollutants might influence fetal steroid hormone levels, which are thought to be related to sex-typical development and autistic traits. Objectives We examined associations of prenatal levels of PCDD/Fs and PCBs with autism traits and sex-typical behaviour in childhood. Methods We measured levels of PCDD/Fs and PCBs in maternal blood samples during pregnancy using gas chromatography/high-resolution mass spectrometry. Sex-typical behaviour was assessed at 9 years of age (n = 96) and autistic traits at 10 years of age using the Social Responsiveness Scale (SRS; n = 100). Multiple regression analyses were conducted to estimate the associations between prenatal exposure and outcome variables. Results Blood concentrations (WHO2005-TEq) of Sigma PCDD/Fs ranged from 2.93-46.45 pg/g (lipid base) (median = 12.91 pg/g (lipid base)) and concentrations of Sigma PCBs were in the range of 1.24-25.47 pg/g (lipid base) (median = 6.85 pg/g (lipid base)) which is within the range of German background exposure. We found significant negative associations between PCDD/F levels in maternal blood and SRS scores in the whole group (beta = -6.66, p < .05), in girls (beta = -10.98, p < .05) and, in one SRS subscale, in boys (beta = -6.86, p < .05). For PCB levels, associations with one SRS subscale were significant for the whole study group as were associations with two subscales in girls. We did not find significant associations between PCDD/F or PCB levels and sex-typical behaviour for either sex. Conclusions In an earlier part of this study, prenatal exposure to PCDD/Fs and PCBs was found to be associated with lower testosterone levels, therefore, our findings are consistent with the idea that autism spectrum conditions are related to fetal androgen levels. Several possible mechanisms, through which PCDD/Fs and PCBs might influence autistic behaviour, are discussed.	[Nowack, Nikola; Schoelmerich, Axel] Ruhr Univ Bochum, Dept Dev Psychol, D-44801 Bochum, Germany; [Wittsiepe, Juergen; Kasper-Sonnenberg, Monika; Wilhelm, Michael] Ruhr Univ Bochum, Dept Hyg Social & Environm Med, D-44801 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Nowack, N (corresponding author), Ruhr Univ Bochum, Dept Dev Psychol, Univ Str 150, D-44801 Bochum, Germany.	Nikola.Nowack@rub.de	Kasper-Sonnenberg, Monika/AAH-2769-2021; Schoelmerich, Axel/C-9039-2009	Kasper-Sonnenberg, Monika/0000-0002-9435-1391; Schoelmerich, Axel/0000-0002-9844-3920; Schoelmerich, Axel/0000-0002-2597-3365	NorthRhine-Westphalia State Environment Agency; German Federal Environment Agency [3708 61 201 3]	NorthRhine-Westphalia State Environment Agency; German Federal Environment Agency	The study was initiated and financially supported by the NorthRhine-Westphalia State Environment Agency (http://www.lanuv.nrw.de/englisch/home.htm). The follow-up was funded by the German Federal Environment Agency (3708 61 201 3; http://www.umweltbundesamt.de/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Salman F, 2012, TOXICOL APPL PHARM, V263, P7, DOI 10.1016/j.taap.2012.05.016; American Psychiatric Association DSM-IV, 1994, DSM 4 DIAGN STAT MAN; Asperger H, 1944, ARCH PSYCHIAT NERVEN, V117, P76, DOI 10.1007/BF01837709; Auyeung B, 2006, EUR J ENDOCRINOL, V155, pS123, DOI 10.1530/eje.1.02260; Auyeung B, 2012, ARCH SEX BEHAV, V41, P571, DOI 10.1007/s10508-011-9864-8; Auyeung B, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-11; Auyeung B, 2009, J AUTISM DEV DISORD, V39, P1509, DOI 10.1007/s10803-009-0772-x; Auyeung B, 2009, PSYCHOL SCI, V20, P144, DOI 10.1111/j.1467-9280.2009.02279.x; Auyeung B, 2009, BRIT J PSYCHOL, V100, P1, DOI 10.1348/000712608X311731; Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Baron-Cohen S, 2015, MOL PSYCHIATR, V20, P369, DOI 10.1038/mp.2014.48; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; Baron-Cohen S, 2009, BRIT J PSYCHIAT, V194, P500, DOI 10.1192/bjp.bp.108.059345; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Becerra TA, 2013, ENVIRON HEALTH PERSP, V121, P380, DOI 10.1289/ehp.1205827; Berghuis SA, 2013, NEUROTOXICOLOGY, V38, P124, DOI 10.1016/j.neuro.2013.07.003; Bjork C, 2013, REPROD TOXICOL, V35, P144, DOI 10.1016/j.reprotox.2012.10.010; Bjork C, 2011, REPROD TOXICOL, V32, P293, DOI 10.1016/j.reprotox.2011.06.075; Bolte S, 2008, AUTISM RES, V1, P354, DOI 10.1002/aur.49; Bolte S., 2008, SKALA ERFASSUNG SOZI; Bolte S, 2011, J AUTISM DEV DISORD, V41, P66, DOI 10.1007/s10803-010-1024-9; Bonefeld-Jorgensen EC, 2001, TOXICOLOGY, V158, P141, DOI 10.1016/S0300-483X(00)00368-1; Braun JM, 2014, ENVIRON HEALTH PERSP, V122, P513, DOI 10.1289/ehp.1307261; BREEDLOVE SM, 1992, J NEUROSCI, V12, P4133; Brouwer A, 1999, ENVIRON HEALTH PERSP, V107, P639, DOI 10.2307/3434557; Cao YG, 2008, INT J HYG ENVIR HEAL, V211, P30, DOI 10.1016/j.ijheh.2007.04.005; Center for Disease Control and Prevention, 2014, AUT SPECTR DIS ASD D; Chakrabarti B, 2009, AUTISM RES, V2, P157, DOI 10.1002/aur.80; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; Chapman E, 2006, SOC NEUROSCI-UK, V1, P135, DOI 10.1080/17470910600992239; Charman T, 2007, BRIT J PSYCHIAT, V191, P554, DOI 10.1192/bjp.bp.107.040196; Cheslack-Postava K, 2013, NEUROTOXICOL TERATOL, V38, P1, DOI 10.1016/j.ntt.2013.04.001; Chung YW, 2001, PHYSIOL BEHAV, V74, P363, DOI 10.1016/S0031-9384(01)00579-0; Cohen-Bendahan CCC, 2005, NEUROSCI BIOBEHAV R, V29, P353, DOI 10.1016/j.neubiorev.2004.11.004; Colciago A, 2006, REPROD TOXICOL, V22, P738, DOI 10.1016/j.reprotox.2006.07.002; Constantino J. N., 2005, SOCIAL RESPONSIVENES; Constantino JN, 2003, J AUTISM DEV DISORD, V33, P427, DOI 10.1023/A:1025014929212; Constantino JN., 2002, SOCIAL RESPONSIVENES; Constantino JN, 2007, J AM ACAD CHILD PSY, V46, P1668, DOI 10.1097/chi.0b013e318157cb23; Faass O, 2013, GEN COMP ENDOCR, V188, P232, DOI 10.1016/j.ygcen.2013.04.008; Fatemi SH, 2012, CEREBELLUM, V11, P777, DOI 10.1007/s12311-012-0355-9; Goncharov A, 2009, ENVIRON HEALTH PERSP, V117, P1454, DOI 10.1289/ehp.0800134; Gorski R A, 1985, J Anim Sci, V61 Suppl 3, P38; Hagmar L, 2003, THYROID, V13, P1021, DOI 10.1089/105072503770867192; HAMPSON E, 1995, J PSYCHIATR NEUROSCI, V20, P397; Hedges VL, 2012, FRONT NEUROENDOCRIN, V33, P403, DOI 10.1016/j.yfrne.2012.08.005; Henningsson S, 2009, PSYCHONEUROENDOCRINO, V34, P752, DOI 10.1016/j.psyneuen.2008.12.007; Hertz-Picciotto I, 2009, EPIDEMIOLOGY, V20, P84, DOI 10.1097/EDE.0b013e3181902d15; HINES M, 1985, J NEUROSCI, V5, P40; Hu VW, 2012, NEUROTOXICOLOGY, V33, P1434, DOI 10.1016/j.neuro.2012.07.009; Hu VW, 2009, AUTISM RES, V2, P78, DOI 10.1002/aur.73; JACOBSON CD, 1981, J NEUROSCI, V1, P1142; Jolliffe T, 1997, J CHILD PSYCHOL PSYC, V38, P527, DOI 10.1111/j.1469-7610.1997.tb01539.x; Kajta M, 2009, NEUROSCIENCE, V158, P811, DOI 10.1016/j.neuroscience.2008.10.045; Kalkbrenner AE, 2014, CURR PROB PEDIATR AD, V44, P1, DOI [10.1016/j.cppeds.2013.10.008, DOI 10.1016/J.CPPEDS.2013.10.008]; Kalkbrenner AE, 2010, EPIDEMIOLOGY, V21, P631, DOI 10.1097/EDE.0b013e3181e65d76; Kerdivel G, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/501851; Kester MHA, 2000, ENDOCRINOLOGY, V141, P1897, DOI 10.1210/en.141.5.1897; Kester MHA, 2002, J CLIN ENDOCR METAB, V87, P1142, DOI 10.1210/jc.87.3.1142; Kim SM, 2010, PSYCHIAT INVEST, V7, P122, DOI 10.4306/pi.2010.7.2.122; Kimura D, 1996, CURR OPIN NEUROBIOL, V6, P259, DOI 10.1016/S0959-4388(96)80081-X; Kimura-Kuroda J, 2007, CHEMOSPHERE, V67, pS412, DOI 10.1016/j.chemosphere.2006.05.137; Klinge CM, 2000, ARCH BIOCHEM BIOPHYS, V373, P163, DOI 10.1006/abbi.1999.1552; Knickmeyer R, 2006, HORM BEHAV, V49, P282, DOI 10.1016/j.yhbeh.2005.08.010; Knickmeyer R, 2005, J CHILD PSYCHOL PSYC, V46, P198, DOI 10.1111/j.1469-7610.2004.00349.x; Knickmeyer RC, 2006, J CHILD NEUROL, V21, P825, DOI 10.1177/08830738060210101601; Landrigan PJ, 2001, MOL GENET METAB, V73, P11, DOI 10.1006/mgme.2001.3177; Larsson M, 2009, NEUROTOXICOLOGY, V30, P822, DOI 10.1016/j.neuro.2009.01.011; Lenz KM, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00026; Lutchmaya S, 2002, INFANT BEHAV DEV, V25, P327, DOI 10.1016/S0163-6383(02)00094-2; Lutchmaya S, 2002, INFANT BEHAV DEV, V24, P418; Manning JT, 2003, EVOL HUM BEHAV, V24, P399, DOI 10.1016/S1090-5138(03)00052-7; Manning JT, 2001, DEV MED CHILD NEUROL, V43, P160, DOI 10.1017/S0012162201000317; Meeker JD, 2010, SYST BIOL REPROD MED, V56, P122, DOI 10.3109/19396360903443658; Miodovnik A, 2011, NEUROTOXICOLOGY, V32, P261, DOI 10.1016/j.neuro.2010.12.009; Mitchell MM, 2012, ENVIRON MOL MUTAGEN, V53, P589, DOI 10.1002/em.21722; Morris JA, 2005, J COMP NEUROL, V487, P217, DOI 10.1002/cne.20558; Morris JA, 2004, NAT NEUROSCI, V7, P1034, DOI 10.1038/nn1325; Murray MJ, 2011, J AUTISM DEV DISORD, V41, P1586, DOI 10.1007/s10803-011-1178-0; Nakagami A, 2011, DEV PSYCHOBIOL, V53, P79, DOI 10.1002/dev.20493; Negishi T, 2006, TOXICOL LETT, V160, P233, DOI 10.1016/j.toxlet.2005.07.008; Neugebauer J, 2015, INT J HYG ENVIR HEAL, V218, P153, DOI 10.1016/j.ijheh.2014.09.005; Nguyen A, 2010, FASEB J, V24, P3036, DOI 10.1096/fj.10-154484; Nishijo M, 2014, MOL PSYCHIATR, V19, P1220, DOI 10.1038/mp.2014.18; Otake Takamitsu, 2006, Environmental Health and Preventive Medicine, V11, P65, DOI 10.1007/BF02898144; Portigal CL, 2002, TOXICOL APPL PHARM, V179, P185, DOI 10.1006/taap.2002.9371; Rennert A, 2012, J TOXICOL ENV HEAL A, V75, P1232, DOI 10.1080/15287394.2012.709375; Roberts AL, 2013, ENVIRON HEALTH PERSP, V121, P978, DOI 10.1289/ehp.1206187; Roberts EM, 2007, ENVIRON HEALTH PERSP, V115, P1482, DOI 10.1289/ehp.10168; Roze E, 2009, ENVIRON HEALTH PERSP, V117, P1953, DOI 10.1289/ehp.0901015; Sarachana T, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-39; Sarachana T, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-14; Sarachana T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017116; SCHANTZ SL, 1995, FUND APPL TOXICOL, V26, P117, DOI 10.1006/faat.1995.1081; Schantz SL, 1996, NEUROTOXICOL TERATOL, V18, P305; SCHANTZ SL, 1992, NEUROTOXICOL TERATOL, V14, P433, DOI 10.1016/0892-0362(92)90054-E; Scholmerich A., 2011, EMPATHY SYSTEMIZING; STEIN SA, 1991, ADV EXP MED BIOL, V299, P47; Sutcliffe JS, 2008, SCIENCE, V321, P208, DOI 10.1126/science.1160555; Swan SH., 2008, ENCY ECOLOGY, P1265, DOI DOI 10.1016/B978-008045405-4.00245-7; Tewes U., 2006, WECHSLER INTELLIGENZ; Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055; Volk HE, 2013, JAMA PSYCHIAT, V70, P71, DOI 10.1001/jamapsychiatry.2013.266; Volk HE, 2011, ENVIRON HEALTH PERSP, V119, P873, DOI 10.1289/ehp.1002835; Vreugdenhil HJI, 2002, ENVIRON HEALTH PERSP, V110, pA593, DOI 10.1289/ehp.021100593; Wallen K, 1996, HORM BEHAV, V30, P364, DOI 10.1006/hbeh.1996.0042; Wang XQ, 2002, PHYSIOL BEHAV, V75, P689, DOI 10.1016/S0031-9384(02)00673-X; Warner J, 2012, SCI TOTAL ENVIRON, V414, P81, DOI 10.1016/j.scitotenv.2011.10.044; Wilhelm M, 2008, MUTAT RES-REV MUTAT, V659, P83, DOI 10.1016/j.mrrev.2007.11.002; Windham GC, 2006, ENVIRON HEALTH PERSP, V114, P1438, DOI 10.1289/ehp.9120; Winneke G, 2002, TOXICOLOGY, V181, P161, DOI 10.1016/S0300-483X(02)00274-3; Winneke G, 2014, ENVIRON HEALTH PERSP, V122, P292, DOI 10.1289/ehp.1306533; Wittsiepe J, 2000, CHEMOSPHERE, V40, P1103, DOI 10.1016/S0045-6535(99)00359-8; Wittsiepe J, 2007, CHEMOSPHERE, V67, pS286, DOI 10.1016/j.chemosphere.2006.05.118; Wright DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031661; Wu MV, 2011, CURR OPIN NEUROBIOL, V21, P116, DOI 10.1016/j.conb.2010.09.014; Zoeller RT, 2012, ENDOCRINOLOGY, V153, P4097, DOI 10.1210/en.2012-1422	119	43	44	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129906	10.1371/journal.pone.0129906	http://dx.doi.org/10.1371/journal.pone.0129906			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066795	Green Published, Green Submitted, gold			2022-12-26	WOS:000356327000122
J	Butler, MJ; Behringer, DC; Dolan, TW; Moss, J; Shields, JD				Butler, Mark J.; Behringer, Donald C., Jr.; Dolan, Thomas W., III; Moss, Jessica; Shields, Jeffrey D.			Behavioral Immunity Suppresses an Epizootic in Caribbean Spiny Lobsters	PLOS ONE			English	Article							VIRUS 1 PAV1; PANULIRUS-ARGUS; DISEASE AVOIDANCE; PATHOGEN TRANSMISSION; SPATIALLY EXPLICIT; INFECTIOUS-DISEASE; SOCIAL-BEHAVIOR; FLORIDA BAY; GROUP-SIZE; PREDATION	Sociality has evolved in a wide range of animal taxa but infectious diseases spread rapidly in populations of aggregated individuals, potentially negating the advantages of their social interactions. To disengage from the coevolutionary struggle with pathogens, some hosts have evolved various forms of "behavioral immunity"; yet, the effectiveness of such behaviors in controlling epizootics in the wild is untested. Here we show how one form of behavioral immunity (i.e., the aversion of diseased conspecifics) practiced by Caribbean spiny lobsters (Panulirus argus) when subject to the socially transmitted PaV1 virus, appears to have prevented an epizootic over a large seascape. We capitalized on a "natural experiment" in which a die-off of sponges in the Florida Keys (USA) resulted in a loss of shelters for juvenile lobsters over a similar to 2500km(2) region. Lobsters were thus concentrated in the few remaining shelters, presumably increasing their exposure to the contagious virus. Despite this spatial reorganization of the population, viral prevalence in lobsters remained unchanged after the sponge die-off and for years thereafter. A field experiment in which we introduced either a healthy or PaV1-infected lobster into lobster aggregations in natural dens confirmed that spiny lobsters practice behavioral immunity. Healthy lobsters vacated dens occupied by PaV1-infected lobsters despite the scarcity of alternative shelters and the higher risk of predation they faced when searching for a new den. Simulations from a spatially-explicit, individual-based model confirmed our empirical results, demonstrating the efficacy of behavioral immunity in preventing epizootics in this system.	[Butler, Mark J.; Dolan, Thomas W., III] Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA; [Behringer, Donald C., Jr.] Univ Florida, Sch Forest Resources & Conservat, Program Fisheries & Aquat Sci, Gainesville, FL 32653 USA; [Behringer, Donald C., Jr.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32653 USA; [Dolan, Thomas W., III] USVI, Dept Planning & Nat Resources, Bur Fisheries, Frederiksted, VI 00840, Australia; [Moss, Jessica; Shields, Jeffrey D.] Coll William & Mary, Virginia Inst Marine Sci, Gloucester Point, VA 23062 USA	Old Dominion University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; William & Mary; Virginia Institute of Marine Science	Butler, MJ (corresponding author), Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA.	mbutler@odu.edu			National Science Foundation - Biological Oceanography Award [OCE-0928930, OCE-0929086]	National Science Foundation - Biological Oceanography Award	Funding Agendy: National Science Foundation - Biological Oceanography Award Numbers: OCE-0928930 and OCE-0929086.	Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Anderson JR, 2013, MAR ECOL PROG SER, V474, P191, DOI 10.3354/meps10091; Barlow ND, 1996, J APPL ECOL, V33, P303, DOI 10.2307/2404752; Behringer DC, 2008, J EXP MAR BIOL ECOL, V359, P26, DOI 10.1016/j.jembe.2008.02.012; Behringer DC, 2006, NATURE, V441, P421, DOI 10.1038/441421a; Behringer DC, 2011, DIS AQUAT ORGAN, V94, P153, DOI 10.3354/dao02326; Behringer DC, 2010, BEHAV ECOL SOCIOBIOL, V64, P747, DOI 10.1007/s00265-009-0892-5; Berger DK, 2001, MAR FRESHWATER RES, V52, P1049, DOI 10.1071/MF01076; Brooks CP, 2008, AM NAT, V172, P149, DOI 10.1086/589451; Butler MJ, 2008, DIS AQUAT ORGAN, V79, P173, DOI 10.3354/dao01899; Butler MJ, 1995, MAR ECOL PROG SER, V129, P119, DOI 10.3354/meps129119; Butler MJ, 2005, ECOL APPL, V15, P902, DOI 10.1890/04-1081; BUTLER MJ, 1991, J CRUSTACEAN BIOL, V11, P23, DOI 10.2307/1548541; Butler MJ, 1997, CAN J FISH AQUAT SCI, V54, P452; Butler MJ, 1997, B MAR SCI, V61, P3; Childress MJ, 1996, ANIM BEHAV, V51, P675, DOI 10.1006/anbe.1996.0071; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; CRFM, 2013, CRFM ANN REP APRIL 1, P43; Curtis V, 2011, PHILOS T R SOC B, V366, P389, DOI 10.1098/rstb.2010.0117; Daly EW, 2011, OECOLOGIA, V165, P1043, DOI 10.1007/s00442-010-1778-y; Dolan TW, 2006, J CRUSTACEAN BIOL, V26, P565, DOI 10.1651/S-2742.1; Dolan TW, 2014, ECOLOGY, V95, P2346, DOI 10.1890/13-0118.1; Edmunds PJ, 2001, P NATL ACAD SCI USA, V98, P5067, DOI 10.1073/pnas.071524598; Ezenwa VO, 2004, BEHAV ECOL, V15, P446, DOI 10.1093/beheco/arh028; FORCUCCI D, 1994, B MAR SCI, V54, P805; Genovart M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009774; Grenfell B. T., 1995, ECOLOGY INFECT DIS N; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell D, 2004, FRONT ECOL ENVIRON, V2, P375, DOI 10.1890/1540-9295(2004)002[0375:TRTOOD]2.0.CO;2; Heinze J, 2010, CURR BIOL, V20, P249, DOI 10.1016/j.cub.2009.12.031; Herrnkind WF, 1997, MAR FRESHWATER RES, V48, P759, DOI 10.1071/MF97193; HERRNKIND WF, 1986, MAR ECOL PROG SER, V34, P23, DOI 10.3354/meps034023; HUDSON PJ, 1992, J ANIM ECOL, V61, P681, DOI 10.2307/5623; Hughes WOH, 2002, P ROY SOC B-BIOL SCI, V269, P1811, DOI 10.1098/rspb.2002.2113; Krumm CE, 2009, BIOL LET, DOI [10.1098/rsbl, DOI 10.1098/RSBL]; Lafferty KD, 1996, ECOLOGY, V77, P1390, DOI 10.2307/2265536; LOEHLE C, 1995, ECOLOGY, V76, P326, DOI 10.2307/1941192; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; McCallum H, 2003, ECOL LETT, V6, P1062, DOI 10.1046/j.1461-0248.2003.00545.x; Montgomery-Fullerton MM, 2007, DIS AQUAT ORGAN, V76, P1, DOI 10.3354/dao076001; Moss J, 2013, DIS AQUAT ORGAN, V104, P129, DOI 10.3354/dao02589; Moss J, 2012, AQUAT BIOL, V14, P223, DOI 10.3354/ab00395; Mydlarz LD, 2006, ANNU REV ECOL EVOL S, V37, P251, DOI 10.1146/annurev.ecolsys.37.091305.110103; Navarrete CD, 2006, EVOL HUM BEHAV, V27, P270, DOI 10.1016/j.evolhumbehav.2005.12.001; Ostfeld RS, 2005, TRENDS ECOL EVOL, V20, P328, DOI 10.1016/j.tree.2005.03.009; Ostfeld RS, 2004, FRONT ECOL ENVIRON, V2, P13, DOI 10.1890/1540-9295(2004)002[0013:APGFYH]2.0.CO;2; Packer C, 2003, ECOL LETT, V6, P797, DOI 10.1046/j.1461-0248.2003.00500.x; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Rowley JJL, 2007, DIS AQUAT ORGAN, V77, P1, DOI 10.3354/dao01830; Rueppell O, 2010, J EVOLUTION BIOL, V23, P1538, DOI 10.1111/j.1420-9101.2010.02022.x; Schaller M, 2011, ADV CULTURAL PSYCHOL; Schratwieser J., 1999, THESIS OLD DOMINION; Sharp WC, 2000, J CRUSTACEAN BIOL, V20, P510, DOI 10.1651/0278-0372(2000)020[0510:TUOCMT]2.0.CO;2; Shen SF, 2014, AM NAT, V183, P301, DOI 10.1086/674378; Shields JD, 2004, DIS AQUAT ORGAN, V59, P109, DOI 10.3354/dao059109; SMITH KN, 1992, J EXP MAR BIOL ECOL, V157, P3, DOI 10.1016/0022-0981(92)90070-Q; Thrall PH, 2002, PLANT PATHOL, V51, P169, DOI 10.1046/j.1365-3059.2002.00683.x; Tragust S, 2013, CURR BIOL, V23, P76, DOI 10.1016/j.cub.2012.11.034; Wild MA, 2011, J WILDLIFE DIS, V47, P78, DOI 10.7589/0090-3558-47.1.78; Zylberberg M, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0856	61	22	22	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0126374	10.1371/journal.pone.0126374	http://dx.doi.org/10.1371/journal.pone.0126374			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061629	Green Published, Green Submitted, gold			2022-12-26	WOS:000355979500013
J	Fugier, E; Dumont, A; Malleron, A; Poquet, E; Pons, JM; Baron, A; Vauzeilles, B; Dukan, S				Fugier, Emilie; Dumont, Audrey; Malleron, Annie; Poquet, Enora; Pons, Jordi Mas; Baron, Aurelie; Vauzeilles, Boris; Dukan, Sam			Rapid and Specific Enrichment of Culturable Gram Negative Bacteria Using Non-Lethal Copper-Free Click Chemistry Coupled with Magnetic Beads Separation	PLOS ONE			English	Article							ESCHERICHIA-COLI O157; REAL-TIME PCR; IMMUNOMAGNETIC SEPARATION; SALMONELLA-TYPHIMURIUM; LISTERIA-MONOCYTOGENES; QUANTITATIVE DETECTION; TERMINAL ALKYNES; SURFACE WATERS; SOLID-PHASE; LIPOPOLYSACCHARIDE	Currently, identification of pathogenic bacteria present at very low concentration requires a preliminary culture-based enrichment step. Many research efforts focus on the possibility to shorten this pre-enrichment step which is needed to reach the minimal number of cells that allows efficient identification. Rapid microbiological controls are a real public health issue and are required in food processing, water quality assessment or clinical pathology. Thus, the development of new methods for faster detection and isolation of pathogenic culturable bacteria is necessary. Here we describe a specific enrichment technique for culturable Gram negative bacteria, based on non-lethal click chemistry and the use of magnetic beads that allows fast detection and isolation. The assimilation and incorporation of an analog of Kdo, an essential component of lipopolysaccharides, possessing a bio-orthogonal azido function (Kdo-N-3), allow functionalization of almost all Gram negative bacteria at the membrane level. Detection can be realized through strain-promoted azide-cyclooctyne cycloaddition, an example of click chemistry, which interestingly does not affect bacterial growth. Using E. coli as an example of Gram negative bacterium, we demonstrate the excellent specificity of the technique to detect culturable E. coli among bacterial mixtures also containing either dead E. coli, or live B. subtilis (as a model of microorganism not containing Kdo). Finally, in order to specifically isolate and concentrate culturable E. coli cells, we performed separation using magnetic beads in combination with click chemistry. This work highlights the efficiency of our technique to rapidly enrich and concentrate culturable Gram negative bacteria among other microorganisms that do not possess Kdo within their cell envelope.	[Fugier, Emilie; Dumont, Audrey; Dukan, Sam] Aix Marseille Univ, CNRS, IMM, Lab Chim Bacterienne,UMR 7283, F-13402 Marseille, France; [Malleron, Annie; Vauzeilles, Boris] CNRS, F-91405 Orsay, France; [Malleron, Annie; Vauzeilles, Boris] Univ Paris 11, Inst Chim Mol & Mat Orsay, Lab Synth Biomol, UMR 8182, F-91405 Orsay, France; [Poquet, Enora; Pons, Jordi Mas; Baron, Aurelie; Vauzeilles, Boris] Ctr Rech Gif, CNRS, Inst Chim Subst Nat, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Vauzeilles, B (corresponding author), CNRS, F-91405 Orsay, France.	boris.vauzeilles@cnrs.fr; sam.dukan@click4tag.com	Vauzeilles, Boris/G-2225-2017	BARON, Aurelie/0000-0002-1843-9017	Centre National de la Recherche Scientifique (CNRS); Societe d'Acceleration du Transfert de Technologies SATT Sud Est; Fondation pour la Recherche Medicale (FRM) [DCM20121225768]	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Societe d'Acceleration du Transfert de Technologies SATT Sud Est; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This work was supported by the Centre National de la Recherche Scientifique (CNRS), The Societe d'Acceleration du Transfert de Technologies SATT Sud Est, and the Fondation pour la Recherche Medicale (FRM - convention DCM20121225768).	Baskin JM, 2007, P NATL ACAD SCI USA, V104, P16793, DOI 10.1073/pnas.0707090104; Cipolla L, 2010, NAT PROD REP, V27, P1618, DOI 10.1039/c004750n; CUDJOE KS, 1995, INT J FOOD MICROBIOL, V27, P11, DOI 10.1016/0168-1605(94)00134-R; Debets MF, 2010, CHEM COMMUN, V46, P97, DOI 10.1039/b917797c; Ducret A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007282; Dumont A, 2012, ANGEW CHEM INT EDIT, V51, P3143, DOI 10.1002/anie.201108127; Fu Z, 2005, INT J FOOD MICROBIOL, V99, P47, DOI 10.1016/j.ijfoodmicro.2004.07.013; Jenikova Gabriela, 2000, International Microbiology, V3, P225; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; Kuzmin A, 2010, BIOCONJUGATE CHEM, V21, P2076, DOI 10.1021/bc100306u; Lee HJ, 2009, BIOSENS BIOELECTRON, V24, P3550, DOI 10.1016/j.bios.2009.05.010; Leone S, 2007, J NAT PROD, V70, P1624, DOI 10.1021/np0702988; LUND A, 1988, J CLIN MICROBIOL, V26, P2572, DOI 10.1128/JCM.26.12.2572-2575.1988; Meredith TC, 2006, ACS CHEM BIOL, V1, P33, DOI 10.1021/cb0500015; Romieu A, 2011, ORG BIOMOL CHEM, V9, P5337, DOI 10.1039/c1ob05730h; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Shelton DR, 2004, J MICROBIOL METH, V58, P223, DOI 10.1016/j.mimet.2004.03.017; Shelton DR, 2003, J MICROBIOL METH, V55, P717, DOI 10.1016/j.mimet.2003.07.004; Shelton DR, 2001, APPL ENVIRON MICROB, V67, P2908, DOI 10.1128/AEM.67.7.2908-2915.2001; Tang YJ, 2013, THERANOSTICS, V3, P85, DOI 10.7150/thno.5588; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; Tu SI, 2009, SENSORS-BASEL, V9, P717, DOI 10.3390/s90200717; Vinogradov E, 2003, CARBOHYD RES, V338, P1991, DOI 10.1016/S0008-6215(03)00325-2; Wang LX, 2007, J FOOD PROTECT, V70, P1366, DOI 10.4315/0362-028X-70.6.1366; Watarai M, 2005, J VET MED SCI, V67, P449, DOI 10.1292/jvms.67.449; WRIGHT DJ, 1994, EPIDEMIOL INFECT, V113, P31, DOI 10.1017/S0950268800051438; Yang H, 2007, INT J FOOD MICROBIOL, V118, P132, DOI 10.1016/j.ijfoodmicro.2007.06.019; Yang YJ, 2013, FOOD MICROBIOL, V34, P418, DOI 10.1016/j.fm.2013.01.004; Yazdankhah SP, 1999, VET MICROBIOL, V67, P113, DOI 10.1016/S0378-1135(99)00035-8; Yazdankhah SP, 2001, J MICROBIOL METH, V47, P369, DOI 10.1016/S0167-7012(01)00350-5; Yu H, 1996, APPL ENVIRON MICROB, V62, P587, DOI 10.1128/AEM.62.2.587-592.1996	31	23	23	1	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0127700	10.1371/journal.pone.0127700	http://dx.doi.org/10.1371/journal.pone.0127700			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061695	Green Published, Green Submitted, gold			2022-12-26	WOS:000355979500051
J	Al-Safadi, S; Branchaud, M; Rutherford, S; Amir, S				Al-Safadi, Sherin; Branchaud, Marie; Rutherford, Spencer; Amir, Shimon			Glucocorticoids and Stress-Induced Changes in the Expression of PERIOD1 in the Rat Forebrain	PLOS ONE			English	Article							DORSOMEDIAL HYPOTHALAMIC NUCLEUS; PERIPHERAL CIRCADIAN CLOCKS; CENTRAL EXTENDED AMYGDALA; STRIA TERMINALIS; BED NUCLEUS; GENE-EXPRESSION; OVAL NUCLEUS; PARAVENTRICULAR NUCLEUS; DIURNAL RHYTHMS; PROTEIN	The secretion of glucocorticoids in mammals is under circadian control, but glucocorticoids themselves are also implicated in modulating circadian clock gene expression. We have shown that the expression of the circadian clock protein PER1 in the forebrain is modulated by stress, and that this effect is associated with changes in plasma corticosterone levels, suggesting a possible role for glucocorticoids in the mediation of stress-induced changes in the expression of PER1 in the brain. To study this, we assessed the effects of adrenalectomy and of pretreatment with the glucocorticoid receptor antagonist, mifepristone, on the expression of PER1 in select limbic and hypothalamic regions following acute exposure to a neurogenic stressor, restraint, or a systemic stressor, 2-Deoxy-D-glucose (2DG) in rats. Acute restraint suppressed PER1 expression in the oval nucleus of the bed nucleus of the stria terminalis (BNSTov) and the central nucleus of the amygdala (CEAl), whereas 2DG increased PER1 in both regions. Both stressors increased PER1 expression in the paraventricular (PVN) and dorsomedial (DMH) nuclei of the hypothalamus, and the piriform cortex (Pi). Adrenalectomy and pretreatment with mifepristone reversed the effects of both stressors on PER1 expression in the BNSTov and CEAl, and blocked their effects in the DMH. In contrast, both treatments enhanced the effects of restraint and 2DG on PER1 levels in the PVN. Stress-induced PER1 expression in the Pi was unaffected by either treatment. PER1 expression in the suprachiasmatic nucleus, the master circadian clock, was not altered by either exposure to stress or by the glucocorticoid manipulations. Together, the results demonstrate a key role for glucocorticoid signaling in stress-induced changes in PER1 expression in the brain.	[Al-Safadi, Sherin; Amir, Shimon] Concordia Univ, Dept Biol, Montreal, PQ H4B 1R6, Canada; [Al-Safadi, Sherin; Branchaud, Marie; Rutherford, Spencer; Amir, Shimon] Concordia Univ, Ctr Studies Behav Neurobiol, Dept Psychol, Montreal, PQ H4B 1R6, Canada	Concordia University - Canada; Concordia University - Canada	Amir, S (corresponding author), Concordia Univ, Dept Biol, SP-375-07,7141 Sherbrooke St West, Montreal, PQ H4B 1R6, Canada.	shimon.amir@concordia.ca	Rutherford, Spencer/GPS-9422-2022; Amir, Shimon/AAE-4635-2022		Natural Sciences and Engineering Research Council of Canada (NSERC); les Fonds de la recherche en sante Quebec (FRSQ); Concordia University Research Chair Program	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); les Fonds de la recherche en sante Quebec (FRSQ); Concordia University Research Chair Program	This study was supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC), les Fonds de la recherche en sante Quebec (FRSQ) and the Concordia University Research Chair Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi M, 2000, GENE DEV, V14, P645; Akhisaroglu M, 2004, PHARMACOL BIOCHEM BE, V79, P37, DOI 10.1016/j.pbb.2004.06.014; Al-Safadi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111166; Albrecht U, 2012, NEURON, V74, P246, DOI 10.1016/j.neuron.2012.04.006; Amir S, 2004, J NEUROSCI, V24, P781, DOI 10.1523/JNEUROSCI.4488-03.2004; Amir S, 2006, NEUROSCI LETT, V407, P254, DOI 10.1016/j.neulet.2006.08.057; Anisman H, 2001, BEHAV NEUROSCI, V115, P443, DOI 10.1037/0735-7044.115.2.443; Bailey TW, 2001, AM J PHYSIOL-REG I, V280, pR8, DOI 10.1152/ajpregu.2001.280.1.R8; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Chen YZ, 2001, NEWS PHYSIOL SCI, V16, P292; Davis M, 1999, ANN NY ACAD SCI, V877, P281, DOI 10.1111/j.1749-6632.1999.tb09273.x; Day HEW, 2005, EUR J NEUROSCI, V21, P441, DOI 10.1111/j.1460-9568.2005.03865.x; Di S, 2003, J NEUROSCI, V23, P4850; Dickmeis T, 2013, MOL CELL ENDOCRINOL, V380, P2, DOI 10.1016/j.mce.2013.05.012; Dickmeis T, 2009, J ENDOCRINOL, V200, P3, DOI 10.1677/JOE-08-0415; Dong L, 2011, AM J PSYCHIAT, V168, P1090, DOI 10.1176/appi.ajp.2011.10111579; Fuchs E, 2003, PHYSIOL BEHAV, V79, P417, DOI 10.1016/S0031-9384(03)00161-6; Gery S, 2007, CLIN CANCER RES, V13, P1399, DOI 10.1158/1078-0432.CCR-06-1730; HONKANIEMI J, 1992, NEUROENDOCRINOLOGY, V55, P451, DOI 10.1159/000126156; Kalsbeek A, 2012, MOL CELL ENDOCRINOL, V349, P20, DOI 10.1016/j.mce.2011.06.042; Keim SR, 1996, BRAIN RES, V739, P46, DOI 10.1016/S0006-8993(96)00810-4; Koresh O, 2012, EUR NEUROPSYCHOPHARM, V22, P205, DOI 10.1016/j.euroneuro.2011.07.012; Kozicz T, 2002, EUR J NEUROSCI, V16, P823, DOI 10.1046/j.1460-9568.2002.02129.x; Lamont EW, 2005, P NATL ACAD SCI USA, V102, P4180, DOI 10.1073/pnas.0500901102; Li HY, 1998, J COMP NEUROL, V393, P244; Meerlo P, 2002, STRESS, V5, P15, DOI 10.1080/102538902900012323; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Nader N, 2010, TRENDS ENDOCRIN MET, V21, P277, DOI 10.1016/j.tem.2009.12.011; O'Callaghan EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047087; Paladino N, 2010, J NEUROIMMUNOL, V225, P62, DOI 10.1016/j.jneuroim.2010.04.015; Pantazopoulos H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020658; POMPEI P, 1995, MOL BRAIN RES, V33, P209, DOI 10.1016/0169-328X(95)00115-9; Segall LA, 2006, NEUROSCIENCE, V140, P753, DOI 10.1016/j.neuroscience.2006.03.037; Segall LA, 2009, NEUROSCI LETT, V457, P58, DOI 10.1016/j.neulet.2009.03.083; Segall LA, 2010, J MOL NEUROSCI, V42, P168, DOI 10.1007/s12031-010-9341-1; Segall LA, 2010, J MOL NEUROSCI, V42, P176, DOI 10.1007/s12031-010-9375-4; Spencer S, 2013, EUR J NEUROSCI, V37, P242, DOI 10.1111/ejn.12010; Strehl C, 2011, ARTHRITIS RHEUM-US, V63, P3779, DOI 10.1002/art.30637; Takahashi S, 2001, ENDOCRINOLOGY, V142, P4910, DOI 10.1210/en.142.11.4910; Tasker JG, 2006, ENDOCRINOLOGY, V147, P5549, DOI 10.1210/en.2006-0981; Tasker JG, 2005, INTEGR COMP BIOL, V45, P665, DOI 10.1093/icb/45.4.665; Vernocchi S, 2013, MOL CELL PROTEOMICS, V12, P1764, DOI 10.1074/mcp.M112.022947; Verwey M, 2009, EUR J NEUROSCI, V29, P2217, DOI 10.1111/j.1460-9568.2009.06766.x; Weibel L, 2002, J BIOL RHYTHM, V17, P438, DOI 10.1177/074873002237138; Weiser MJ, 2011, J NEUROENDOCRINOL, V23, P1231, DOI 10.1111/j.1365-2826.2011.02217.x; Wong CCP, 2012, J NEURAL TRANSM, V119, P1111, DOI 10.1007/s00702-012-0829-4; Yamamoto T, 2005, J BIOL CHEM, V280, P42036, DOI 10.1074/jbc.M509600200; Yang XM, 2009, CHRONOBIOL INT, V26, P1323, DOI 10.3109/07420520903431301; Zalachoras I, 2013, P NATL ACAD SCI USA, V110, P7910, DOI 10.1073/pnas.1219411110; Zhang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016212	51	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130085	10.1371/journal.pone.0130085	http://dx.doi.org/10.1371/journal.pone.0130085			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075608	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000356329900136
J	Calderon, MJ; Ploegman, AG; Bailey, B; Jung, DO; Navratil, AM; Ellsworth, BS				Calderon, Michael J.; Ploegman, Adam G.; Bailey, Brock; Jung, Deborah O.; Navratil, Amy M.; Ellsworth, Buffy S.			Loss of Foxm1 Results in Reduced Somatotrope Cell Number during Mouse Embryogenesis	PLOS ONE			English	Article							FORKHEAD TRANSCRIPTION FACTORS; GENE-EXPRESSION; PITUITARY ORGANOGENESIS; GLUCOSE-HOMEOSTASIS; BETA-CATENIN; CYCLE EXIT; MICE; FOXL2; PROLIFERATION; PROTEIN	FOXM1, a member of the forkhead box transcription factor family, plays a key role in cell cycling progression by regulating the expression of critical G1/S and G2/M phase transition genes. In vivo studies reveal that Foxm1 null mice have a 91% lethality rate at e18.5 due to significant cardiovascular and hepatic hypoplasia. Thus, FOXM1 has emerged as a key protein regulating mitotic division and cell proliferation necessary for embryogenesis. In the current study, we assess the requirement for Foxm1 in the developing pituitary gland. We find that Foxm1 is expressed in the pituitary at embryonic days 10.5-e18.5 and localizes with markers for active cell proliferation (BrdU). Interestingly, direct analysis of Foxm1 null mice at various embryonic ages, reveals no difference in gross pituitary morphology or cell proliferation. We do observe a downward trend in overall pituitary cell number and a small reduction in pituitary size in e18.5 embryos suggesting there may be subtle changes in pituitary proliferation not detected with our proliferation makers. Consistent with this, Foxm1 null mice have reductions in both the somatotrope and gonadotrope cell populations.	[Calderon, Michael J.; Ploegman, Adam G.; Bailey, Brock; Jung, Deborah O.; Ellsworth, Buffy S.] So Illinois Univ, Dept Physiol, Carbondale, IL 62901 USA; [Navratil, Amy M.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA	Southern Illinois University System; Southern Illinois University; University of Wyoming	Ellsworth, BS (corresponding author), So Illinois Univ, Dept Physiol, Carbondale, IL 62901 USA.	bellsworth@siumed.edu		Jung, Deborah/0000-0002-8307-8772	Southern Illinois School of Medicine Central Research Committee; Eunice Kennedy Shriver National Institute of Child Health and Human Development [R15HD063469-01]; National Center for Research Resources [P20RR016474]; National Institute of General Medical Sciences from the National Institutes of Health [P20GM103432]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R15HD063469] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103432] Funding Source: NIH RePORTER	Southern Illinois School of Medicine Central Research Committee; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from Southern Illinois School of Medicine Central Research Committee (B. S. E) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R15HD063469-01, B. S. E.), the National Center for Research Resources (P20RR016474, A. M. N.) and the National Institute of General Medical Sciences (P20GM103432, A. M. N.) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arriola DJ, 2012, J BIOL CHEM, V287, P33424, DOI 10.1074/jbc.M112.362103; Bilodeau S, 2009, MOL CELL BIOL, V29, P1895, DOI 10.1128/MCB.01885-08; Brannick KE, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100636; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Calvisi DF, 2009, GUT, V58, P679, DOI 10.1136/gut.2008.152652; Carninci P, 2003, GENOME RES, V13, P1273, DOI 10.1101/gr.1119703; Cheung CC, 2007, PITUITARY, V10, P335, DOI 10.1007/s11102-007-0051-9; Coss D, 2010, TRENDS ENDOCRIN MET, V21, P562, DOI 10.1016/j.tem.2010.05.006; Costa RH, 2005, NAT CELL BIOL, V7, P108, DOI 10.1038/ncb0205-108; Davis SW, 2010, MOL CELL ENDOCRINOL, V323, P4, DOI 10.1016/j.mce.2009.12.012; Ellsworth BS, 2003, MOL CELL ENDOCRINOL, V206, P93, DOI 10.1016/S0303-7207(03)00235-1; Ellsworth BS, 2006, MOL ENDOCRINOL, V20, P2796, DOI 10.1210/me.2005-0303; GODFREY VL, 1991, P NATL ACAD SCI USA, V88, P5528, DOI 10.1073/pnas.88.13.5528; Gumbel JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052156; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; JAPON MA, 1994, J HISTOCHEM CYTOCHEM, V42, P1117, DOI 10.1177/42.8.8027530; Jung DO, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094904; Justice NJ, 2011, MOL ENDOCRINOL, V25, P1404, DOI 10.1210/me.2011-0093; Kim IM, 2005, J BIOL CHEM, V280, P22278, DOI 10.1074/jbc.M500936200; Koo CY, 2012, BBA-GENE REGUL MECH, V1819, P28, DOI 10.1016/j.bbagrm.2011.09.004; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Krupczak-Hollis K, 2004, DEV BIOL, V276, P74, DOI 10.1016/j.ydbio.2004.08.022; Lamba P, 2009, MOL ENDOCRINOL, V23, P1001, DOI 10.1210/me.2008-0324; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyon MF, 1986, MOUSE NEWS LETT, V74, P93; Martinez-Gac L, 2004, MOL CELL BIOL, V24, P2181, DOI 10.1128/MCB.24.5.2181-2189.2004; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Mirzayans F, 2000, EUR J HUM GENET, V8, P71, DOI 10.1038/sj.ejhg.5200354; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Nishimura DY, 2001, AM J HUM GENET, V68, P364, DOI 10.1086/318183; Norquay LD, 2006, MOL ENDOCRINOL, V20, P598, DOI 10.1210/me.2005-0221; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Ramakrishna S, 2007, DEV DYNAM, V236, P1000, DOI 10.1002/dvdy.21113; Salisbury TB, 2008, MOL ENDOCRINOL, V22, P1295, DOI 10.1210/me.2007-0515; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen W, 2001, J BIOL CHEM, V276, P42812, DOI 10.1074/jbc.M106344200; Shih DQ, 1999, P NATL ACAD SCI USA, V96, P10152, DOI 10.1073/pnas.96.18.10152; Tran S, 2013, MOL ENDOCRINOL, V27, P407, DOI 10.1210/me.2012-1286; Treier M, 1998, GENE DEV, V12, P1691, DOI 10.1101/gad.12.11.1691; Waite E, 2010, ENDOCRINOLOGY, V151, P234, DOI 10.1210/en.2009-0539; Wierstra I, 2013, ADV CANCER RES, V118, P97, DOI 10.1016/B978-0-12-407173-5.00004-2; Wijchers PJEC, 2006, BIOCHEM J, V397, P233, DOI 10.1042/BJ20060387; Zhang N, 2011, CANCER CELL, V20, P427, DOI 10.1016/j.ccr.2011.08.016; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhu XY, 2007, PHYSIOL REV, V87, P933, DOI 10.1152/physrev.00006.2006	47	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128942	10.1371/journal.pone.0128942	http://dx.doi.org/10.1371/journal.pone.0128942			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075743	Green Published, Green Submitted, gold			2022-12-26	WOS:000356329900038
J	Li, LT; Dong, JB; Wang, XH; Guo, HM; Wang, HJ; Zhao, J; Qiu, YL; Abuduxikuer, K; Wang, JS				Li, Liting; Dong, Jibin; Wang, Xiaohong; Guo, Hongmei; Wang, Huijun; Zhao, Jing; Qiu, Yiling; Abuduxikuer, Kuerbanjiang; Wang, Jianshe			JAG1 Mutation Spectrum and Origin in Chinese Children with Clinical Features of Alagille Syndrome	PLOS ONE			English	Article							GENE; FAMILIES	Alagille syndrome is an autosomal dominant disorder that results from defects in the Notch signaling pathway, which is most frequently due to JAG1 mutations. This study investigated the rate, spectrum, and origin of JAG1 mutations in 91 Chinese children presenting with at least two clinical features of Alagille syndrome (cholestasis, heart murmur, skeletal abnormalities, ocular abnormalities, characteristic facial features, and renal abnormalities). Direct sequencing and/or multiplex-ligation-dependent probe amplification were performed in these patients, and segregation analysis was performed using samples available from the parents. JAG1 disease-causing mutations were detected in 70/91 (76.9%) patients, including 29/70 (41.4%) small deletions, 6/70 (8.6%) small insertions, 16/70 (22.9%) nonsense mutations, 8/70 (11.4%) splice-site mutations, 6/70 (9.4%) missense mutations, and 5/70 (7.1%) gross deletions. Of the mutations detected, 45/62 (72.6%) were novel, and almost all were unique, with the exception of c.439C>T, c.439+1G>A, c.703C>T, c.1382_1383delAC, c.2698C>T, and c.2990C>A, which were detected in two cases each; three cases exhibited entire gene deletions. A majority (69.2%) of the point and frameshift mutations could be detected by the sequencing of eleven exons (exons 3, 5, 6, 11, 14, 16, 18, 21, and 23-25). The mutation detection rate was 50.0% (10/20) in atypical cases that only presented with two or three clinical features of Alagille syndrome. Segregation analysis revealed that 81.1% (30/37) of these mutations were de novo. In conclusion, JAG1 mutations are present in the majority of Chinese pediatric patients with clinical features of Alagille syndrome, and the mutations concentrate on different exons from other reports. Genetic study is important for the diagnosis of atypical Alagille syndrome in Chinese patients.	[Li, Liting; Wang, Xiaohong; Zhao, Jing; Qiu, Yiling; Abuduxikuer, Kuerbanjiang; Wang, Jianshe] Fudan Univ, Childrens Hosp, Ctr Pediat Liver Dis, Shanghai 200433, Peoples R China; [Dong, Jibin] Fudan Univ, Sch Pharm, Shanghai 200433, Peoples R China; [Guo, Hongmei] Nanjing Med Univ, Nanjing Childrens Hosp, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China; [Wang, Huijun] Fudan Univ, Translat Med Res Ctr Children Dev & Dis, Shanghai Key Lab Birth Defect, Mol Genet Diag Ctr,Pediat Res Inst,Childrens Hosp, Shanghai 200433, Peoples R China; [Wang, Jianshe] Fudan Univ, Jinshan Hosp, Dept Pediat, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Nanjing Medical University; Fudan University; Fudan University	Wang, JS (corresponding author), Fudan Univ, Childrens Hosp, Ctr Pediat Liver Dis, Shanghai 200433, Peoples R China.	jshwang@shmu.edu.cn	wang, xiao/HGB-7081-2022; Abuduxikuer, Kuerbanjiang/T-6521-2019; wang, huimin/HDM-8421-2022; wang, hui/GRS-4730-2022; wang, Jian-She/F-1154-2011	wang, xiao/0000-0002-4088-3341; Abuduxikuer, Kuerbanjiang/0000-0003-0298-3269; wang, jianshe/0000-0003-0823-586X	National Natural Science Foundation of China [81070281, 81361128006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research work was supported by the National Natural Science Foundation of China (No. 81070281 and No. 81361128006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAGILLE D, 1987, J PEDIATR-US, V110, P195, DOI 10.1016/S0022-3476(87)80153-1; Crosnier C, 1999, GASTROENTEROLOGY, V116, P1141, DOI 10.1016/S0016-5085(99)70017-X; Crosnier C, 2001, HUM MUTAT, V17, DOI 10.1002/1098-1004(2001)17:1<72::AID-HUMU11>3.0.CO;2-U; DANKS DM, 1977, ARCH DIS CHILD, V52, P360, DOI 10.1136/adc.52.5.360; Giannakudis J, 2001, EUR J HUM GENET, V9, P209, DOI 10.1038/sj.ejhg.5200613; Guegan K, 2012, CLIN GENET, V82, P33, DOI 10.1111/j.1399-0004.2011.01749.x; Heritage ML, 2000, HUM MUTAT, V16, P408, DOI 10.1002/1098-1004(200011)16:5<408::AID-HUMU5>3.0.CO;2-9; Jurkiewicz D, 2005, HUM MUTAT, V25, DOI 10.1002/humu.9313; Kamath BM, 2007, LIVER DISEASE IN CHILDREN, 3RD EDITION, P326, DOI 10.1017/CBO9780511547409.017; Krantz ID, 1998, AM J HUM GENET, V62, P1361, DOI 10.1086/301875; Onouchi Y, 1999, J HUM GENET, V44, P235, DOI 10.1007/s100380050150; Pilia G, 1999, HUM MUTAT, V14, P394, DOI 10.1002/(SICI)1098-1004(199911)14:5<394::AID-HUMU5>3.0.CO;2-1; Ropke Albrecht, 2003, Hum Mutat, V21, P100, DOI 10.1002/humu.9102; Spinner NB, 2001, HUM MUTAT, V17, P18, DOI 10.1002/1098-1004(2001)17:1<18::AID-HUMU3>3.0.CO;2-T; Turnpenny PD, 2012, EUR J HUM GENET, V20, P251, DOI 10.1038/ejhg.2011.181; Wang HL, 2012, GENE, V499, P191, DOI 10.1016/j.gene.2012.02.038; Warthen DM, 2006, HUM MUTAT, V27, P436, DOI 10.1002/humu.20310	17	19	32	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130355	10.1371/journal.pone.0130355	http://dx.doi.org/10.1371/journal.pone.0130355			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076142	gold, Green Published, Green Submitted			2022-12-26	WOS:000356329900167
J	Vannini, C; Volpi, M; Lardicci, C				Vannini, Claudia; Volpi, Marta; Lardicci, Claudio			A Multi Size-Level Assessment of Benthic Marine Communities in a Coastal Environment: Are They Different Sides of the Same Coin?	PLOS ONE			English	Article							SUBUNIT RIBOSOMAL-RNA; BODY-SIZE; ECOLOGICAL HEALTH; ORGANISM SIZE; BACTERIA; INDICATORS; MACROFAUNA; DIVERSITY; MEIOFAUNA	Organism body size has been demonstrated to be a discriminating element in shaping the response of living beings to environmental factors, thus playing a fundamental role in community structuring. Despite the importance of studies elucidating relations among communities of different size levels in ecosystems, the attempts that have been made in this sense are still very scarce and a reliable approach for these research still has to be defined. We characterized the benthic communities of bacteria, microbial eukaryotes, meiofauna and macrofauna in a coastal environment, encompassing a 10000-fold gradient in body size, testing and discussing a mixed approach of molecular fingerprinting for microbes and morphological observations for meio-and macrofauna. We found no correlation among structures of the different size-level communities: this suggests that community composition at one size-level could have no (or very low) influence on the community composition at other size-levels. Moreover, each community responds in a different way to the environmental parameters and with a degree of sensitivity which seems to increase with organism size. Therefore, our data indicate that the characterization of all the different size levels is clearly a necessity in order to study the dynamics really acting in a system.	[Vannini, Claudia; Volpi, Marta; Lardicci, Claudio] Univ Pisa, Dept Biol, Pisa, Italy; [Volpi, Marta] Univ Aarhus, Ctr Geomicrobiol, Inst Bioscience, Aarhus, Denmark	University of Pisa; Aarhus University	Vannini, C (corresponding author), Univ Pisa, Dept Biol, Pisa, Italy.	claudia.vannini@unipi.it	lardicci, claudio/K-8698-2018	LARDICCI, CLAUDIO/0000-0001-5356-7914	University of Pisa	University of Pisa	This work was funded by University of Pisa, Lardicci 308-60% 2012 and Vannini 565-60% 2012. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anfuso G, 2011, GEOMORPHOLOGY, V129, P204, DOI 10.1016/j.geomorph.2011.01.023; Beisner BE, 2006, ECOLOGY, V87, P2985, DOI 10.1890/0012-9658(2006)87[2985:TROEAS]2.0.CO;2; Bernhard AE, 2000, APPL ENVIRON MICROB, V66, P1587, DOI 10.1128/AEM.66.4.1587-1594.2000; BROWN JH, 1993, AM NAT, V142, P573, DOI 10.1086/285558; Case T., 1986, COMMUNITY ECOL, P98; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Danovaro R, 1996, MAR BIOL, V127, P1, DOI 10.1007/BF00993638; Doi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069594; Farjalla VF, 2012, ECOLOGY, V93, P1752, DOI 10.1890/11-1144.1; Fierer N, 2011, ECOLOGY, V92, P797, DOI 10.1890/10-1170.1; Gorley C.K., 2006, GETTING STARTED PRIM; Heino J, 2011, FRESHWATER BIOL, V56, P1703, DOI 10.1111/j.1365-2427.2011.02610.x; Hyland J, 2005, MAR ECOL PROG SER, V295, P91, DOI 10.3354/meps295091; Lear G, 2009, FRESHWATER BIOL, V54, P1532, DOI 10.1111/j.1365-2427.2009.02190.x; Lear G, 2011, AQUAT ECOL, V45, P517, DOI 10.1007/s10452-011-9372-x; Longmuir A, 2007, ECOLOGY, V88, P1663, DOI 10.1890/06-1448.1; Mellin C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020141; Meng XF, 2012, RES MICROBIOL, V163, P349, DOI 10.1016/j.resmic.2012.03.005; Papageorgiou N, 2007, HELGOLAND MAR RES, V61, P31, DOI 10.1007/s10152-006-0051-6; Pusceddu A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091056; Shurin JB, 2009, OECOLOGIA, V159, P151, DOI 10.1007/s00442-008-1174-z; Soininen J, 2013, ECOLOGY, V94, P660, DOI 10.1890/12-0777.1; Somboonna N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S29; Suzuki M, 1998, APPL ENVIRON MICROB, V64, P4522; Tataranni M, 2010, ENVIRON POLLUT, V158, P26, DOI 10.1016/j.envpol.2009.08.020; Van de Peer Y, 1998, NUCLEIC ACIDS RES, V26, P179, DOI 10.1093/nar/26.1.179; Velghe K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057019; Warwick RM, 2001, OCEANOGR MAR BIOL, V39, P207; White EP, 2007, TRENDS ECOL EVOL, V22, P323, DOI 10.1016/j.tree.2007.03.007; Wieltschnig C, 2008, MICROB ECOL, V56, P1, DOI 10.1007/s00248-007-9318-y; Wish M., 1978, MULTIDIMENSIONAL SCA; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; Woodward G, 2002, J ANIM ECOL, V71, P1063, DOI 10.1046/j.1365-2656.2002.00669.x; Wuyts J, 2000, NUCLEIC ACIDS RES, V28, P4698, DOI 10.1093/nar/28.23.4698; [No title captured]	36	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129942	10.1371/journal.pone.0129942	http://dx.doi.org/10.1371/journal.pone.0129942			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075405	Green Published, Green Submitted, gold			2022-12-26	WOS:000356329900117
J	Yang, J; Liu, XX; Ai, DN; Fan, JF; Zheng, YJ; Li, F; Huo, L; Wang, YT				Yang, Jian; Liu, Xinxin; Ai, Danni; Fan, Jingfan; Zheng, Youjing; Li, Fang; Huo, Li; Wang, Yongtian			PET Index of Bone Glucose Metabolism (PIBGM) Classification of PET/CT Data for Fever of Unknown Origin Diagnosis	PLOS ONE			English	Article							STANDARDIZED UPTAKE VALUES; PROSTATE-CANCER; ACTIVE CONTOURS; NORMAL-TISSUES; SCAN INDEX; FDG-PET; F-18-FDG; CT; SEGMENTATION; SPECIFICITY	Objectives Fever of unknown origin (FUO) remains a challenge in clinical practice. Fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) is helpful in diagnosing the etiology of FUO. This paper aims to develop a completely automatic classification method based on PET/CT data for the computer-assisted diagnosis of FUO. Methods We retrospectively analyzed the FDG PET/CT scan of 175 FUO patients, 79 males and 96 females. The final diagnosis of all FUO patients was achieved through pathology or clinical evaluation, including 108 normal patients and 67 FUO patients. CT anatomic information was used to acquire bone functional information from PET images. The skeletal system of FUO patients was classified by analyzing the standardized uptake value (SUV) and the PET index of bone glucose metabolism (PIBGM). The SUV distributions in the bone marrow and the bone cortex were also studied in detail. Results The SUV and PIBGM of the bone marrow only slightly differed between the FUO patients and normal people, whereas the SUV of whole bone structures and the PIBGM of the bone cortex significantly differed between the normal people and FUO patients. The method detected 43 patients from 67 FUO patients, with sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of 64.18%, 95%, 93.48%, 72.73%, and 83.33%, respectively. Conclusion The experimental results demonstrate that the study can achieve automatic classification of FUO patients by the proposed novel biomarker of PIBGM, which has the potential to be utilized in clinical practice.	[Yang, Jian; Liu, Xinxin; Ai, Danni; Fan, Jingfan; Wang, Yongtian] Beijing Inst Technol, Sch Opt & Elect, Beijing Engn Res Ctr Mixed Real & Adv Display, Beijing 100081, Peoples R China; [Zheng, Youjing; Li, Fang; Huo, Li] Beijing Union Med Coll Hosp, PET Ctr, Dept Nucl Med, Beijing 100032, Peoples R China	Beijing Institute of Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Huo, L (corresponding author), Beijing Union Med Coll Hosp, PET Ctr, Dept Nucl Med, Beijing 100032, Peoples R China.	huoli@pumch.cn	Fan, Jingfan/AAT-3761-2020	Fan, Jingfan/0000-0003-4857-6490	National Basic Research Program of China [2013CB328806]; Key Projects in the National Science and Technology Pillar Program [2013BAI01B01]; National Hi-Tech Research and Development Program [2013AA013703]; National Natural Science Foundation of China [81071188]	National Basic Research Program of China(National Basic Research Program of China); Key Projects in the National Science and Technology Pillar Program; National Hi-Tech Research and Development Program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2013CB328806), the Key Projects in the National Science and Technology Pillar Program (2013BAI01B01), the National Hi-Tech Research and Development Program (2013AA013703) and the National Natural Science Foundation of China (81071188).	Arnow PM, 1997, LANCET, V350, P575, DOI 10.1016/S0140-6736(97)07061-X; Nakayo EMB, 2012, REV ESP MED NUCL IMA, V31, P178, DOI 10.1016/j.remn.2011.08.007; Bleeker-Rovers CP, 2007, MEDICINE, V86, P26, DOI 10.1097/md.0b013e31802fe858; Blokhuis GJ, 2014, EUR J NUCL MED MOL I, V41, P1916, DOI 10.1007/s00259-014-2801-z; Brenner H, 1997, STAT MED, V16, P981, DOI 10.1002/(SICI)1097-0258(19970515)16:9<981::AID-SIM510>3.0.CO;2-N; Buysschaert Ian, 2004, Eur J Intern Med, V15, P151, DOI 10.1016/j.ejim.2004.01.018; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Crouzet J, 2012, EUR J CLIN MICROBIOL, V31, P1727, DOI 10.1007/s10096-011-1440-6; Dennis ER, 2012, J CLIN ONCOL, V30, P519, DOI 10.1200/JCO.2011.36.5791; Dong MJ, 2011, EUR J RADIOL, V80, P834, DOI 10.1016/j.ejrad.2010.11.018; Durack D T, 1991, Curr Clin Top Infect Dis, V11, P35; Ferda J, 2010, EUR J RADIOL, V73, P518, DOI 10.1016/j.ejrad.2008.12.014; Imbriaco M, 1998, CLIN CANCER RES, V4, P1765; Kaboteh R, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-9; Kaim AH, 2002, RADIOLOGY, V223, P446, DOI 10.1148/radiol.2232010914; Kang Y, 2003, IEEE T MED IMAGING, V22, P586, DOI 10.1109/TMI.2003.812265; Keidar Z, 2008, J NUCL MED, V49, P1980, DOI 10.2967/jnumed.108.054692; Kim YJ, 2012, INTERN MED J, V42, P834, DOI 10.1111/j.1445-5994.2012.02828.x; Kouijzer IJE, 2013, SEMIN NUCL MED, V43, P333, DOI 10.1053/j.semnuclmed.2013.04.005; Kubota K, 2011, ANN NUCL MED, V25, P355, DOI 10.1007/s12149-011-0470-6; Kucukardali Y, 2008, INT J INFECT DIS, V12, P71, DOI 10.1016/j.ijid.2007.04.013; Meller J, 2000, EUR J NUCL MED, V27, P1617, DOI 10.1007/s002590000341; Paquet N, 2004, J NUCL MED, V45, P784; Pedersen TI, 2012, SCAND J INFECT DIS, V44, P18, DOI 10.3109/00365548.2011.603741; PETERSDORF R, 1961, MEDICINE, V40, P1, DOI 10.1097/00005792-196102000-00001; Seshadri N, 2012, J INFECTION, V65, P71, DOI 10.1016/j.jinf.2012.02.008; Sheng JF, 2011, EUR J INTERN MED, V22, P112, DOI 10.1016/j.ejim.2010.09.015; Truc PTH, 2010, J DIGIT IMAGING, V23, P793, DOI 10.1007/s10278-009-9210-z; van Stralen KJ, 2009, KIDNEY INT, V75, P1257, DOI 10.1038/ki.2009.92; YAMADA S, 1995, J NUCL MED, V36, P1301; ZASADNY K, 1992, RADIOLOGY, V185, P186	31	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130173	10.1371/journal.pone.030173	http://dx.doi.org/10.1371/journal.pone.030173			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076139				2022-12-26	WOS:000356329900149
J	Jamal, S; Goyal, S; Shanker, A; Grover, A				Jamal, Salma; Goyal, Sukriti; Shanker, Asheesh; Grover, Abhinav			Checking the STEP-Associated Trafficking and Internalization of Glutamate Receptors for Reduced Cognitive Deficits: A Machine Learning Approach-Based Cheminformatics Study and Its Application for Drug Repurposing	PLOS ONE			English	Article							ACCURATE DOCKING; FORCE-FIELD; CLASSIFICATION; PROTEIN; PREDICTION; MODELS; LIGAND; GLIDE	Background Alzheimer's disease, a lethal neurodegenerative disorder that leads to progressive memory loss, is the most common form of dementia. Owing to the complexity of the disease, its root cause still remains unclear. The existing anti-Alzheimer's drugs are unable to cure the disease while the current therapeutic options have provided only limited help in restoring moderate memory and remain ineffective at restricting the disease's progression. The striatal-enriched protein tyrosine phosphatase (STEP) has been shown to be involved in the internalization of the receptor, N-methyl D-aspartate (NMDR) and thus is associated with the disease. The present study was performed using machine learning algorithms, docking protocol and molecular dynamics (MD) simulations to develop STEP inhibitors, which could be novel anti-Alzheimer's molecules. Methods The present study deals with the generation of computational predictive models based on chemical descriptors of compounds using machine learning approaches followed by substructure fragment analysis. To perform this analysis, the 2D molecular descriptors were generated and machine learning algorithms (Naive Bayes, Random Forest and Sequential Minimization Optimization) were utilized. The binding mechanisms and the molecular interactions between the predicted active compounds and the target protein were modelled using docking methods. Further, the stability of the protein-ligand complex was evaluated using MD simulation studies. The substructure fragment analysis was performed using Substructure fingerprint (SubFp), which was further explored using a predefined dictionary. Results The present study demonstrates that the computational methodology used can be employed to examine the biological activities of small molecules and prioritize them for experimental screening. Large unscreened chemical libraries can be screened to identify potential novel hits and accelerate the drug discovery process. Additionally, the chemical libraries can be searched for significant substructure patterns as reported in the present study, thus possibly contributing to the activity of these molecules.	[Jamal, Salma; Goyal, Sukriti; Shanker, Asheesh] Banasthali Univ, Dept Biosci & Biotechnol, Tonk, Rajasthan, India; [Grover, Abhinav] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India	Banasthali Vidyapith; Jawaharlal Nehru University, New Delhi	Grover, A (corresponding author), Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India.	abhinavgr@gmail.com			Department of Science and Technology, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India))	AG is thankful to Department of Science and Technology, Government of India for the financial support.	Alzheimer's Association, 2013, ALZH DIS FACTS FIG S; Ambure P, 2014, EXPERT OPIN DRUG DIS, V9, P697, DOI 10.1517/17460441.2014.909404; Anderson C, 2011, LANCET NEUROL, V10, P43, DOI 10.1016/S1474-4422(10)70250-7; [Anonymous], LIGPREP V 2 3; Appleby BS, 2013, DEMENT GERIATR COGN, V35, P1, DOI 10.1159/000345791; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernardi A, 2012, INT J NANOMED, V7, P4927, DOI 10.2147/IJN.S35333; Bouckaert RR, 2010, J MACH LEARN RES, V11, P2533; Breiman L., 2001, MACH LEARN, V45, P5; Cheng FX, 2011, J CHEM INF MODEL, V51, P996, DOI 10.1021/ci200028n; Corbett A, 2013, PHARMACEUTICALS, V6, P1304, DOI 10.3390/ph6101304; Corbett A, 2012, NAT REV DRUG DISCOV, V11, P833, DOI 10.1038/nrd3869; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Coskuner O, 2014, J ALZHEIMERS DIS, V41, P561, DOI 10.3233/JAD-132300; Das UN, 2008, PROSTAGLANDINS LEUKO, P78111; Desmond, 2013, SCHRODINGER DESMOND; Dong N, 2005, ACTA PHARMACOL SIN, V26, P107, DOI 10.1111/j.1745-7254.2005.00014.x; Fiandaca MS, 2014, ALZHEIMERS DEMENT, V10, pS196, DOI 10.1016/j.jalz.2014.04.015; Ford AH, 2010, NEUROLOGY, V75, P1540, DOI 10.1212/WNL.0b013e3181f962c4; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hann M, 1999, J CHEM INF COMP SCI, V39, P897, DOI 10.1021/ci990423o; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hubsher G, 2012, NEUROLOGY, V78, P1096, DOI 10.1212/WNL.0b013e31824e8f0d; Huth JR, 2005, J AM CHEM SOC, V127, P217, DOI 10.1021/ja0455547; Jaturapatporn D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006378.pub2; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Klepsch F, 2014, J CHEM INF MODEL, V54, P218, DOI 10.1021/ci400289j; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Koutsoukas A, 2013, J CHEM INF MODEL, V53, P1957, DOI 10.1021/ci300435j; Li H, 2006, J MOL GRAPH MODEL, V25, P313, DOI 10.1016/j.jmgm.2006.01.007; Li QY, 2008, MOL PHARMACEUT, V5, P117, DOI 10.1021/mp700124e; Lithell H, 2003, J HYPERTENS, V21, P875, DOI 10.1097/00004872-200305000-00011; Liu KJ, 2005, J CHEM INF MODEL, V45, P515, DOI 10.1021/ci049847v; Lv W, 2010, EUR J MED CHEM, V45, P1167, DOI 10.1016/j.ejmech.2009.12.038; McCarren P, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-51; Meng XB, 2014, TOXICOL APPL PHARM, V279, P63, DOI 10.1016/j.taap.2014.03.026; Mogi M, 2008, BIOCHEM BIOPH RES CO, V375, P446, DOI 10.1016/j.bbrc.2008.08.032; Periwal Vinita, 2012, BMC Pharmacology, V12, P1, DOI 10.1186/1471-2210-12-1; Periwal Vinita, 2011, BMC Res Notes, V4, P504, DOI 10.1186/1756-0500-4-504; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Schierz AC, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-21; Schrodinger L., 2011, SCHRODINGER SOFTWARE; Singla D, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-49; Sun HM, 2012, J CHEM INF MODEL, V52, P1798, DOI 10.1021/ci3001875; Svetnik V, 2003, J CHEM INF COMP SCI, V43, P1947, DOI 10.1021/ci034160g; Thatcher GRJ, 2004, J ALZHEIMERS DIS, V6, pS75; Venkitaramani DV, 2009, SYNAPSE, V63, P69, DOI 10.1002/syn.20608; Wang J, 2007, J CLIN INVEST, V117, P3393, DOI 10.1172/JCI31547; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Wimo A, 2013, WORLD ALZHEIMER REPO; Xu J, 2009, J NEUROSCI, V29, P9330, DOI 10.1523/JNEUROSCI.2212-09.2009; Yap CW, 2011, J COMPUT CHEM, V32, P1466, DOI 10.1002/jcc.21707; Yiannopoulou KG, 2013, THER ADV NEUROL DISO, V6, P19, DOI 10.1177/1756285612461679; Yongfang Z, 2010, P NATL ACAD SCI USA, V10744; Yutaka F, 2013, BIOINFORMATION, V92; Zhang Y, 2008, J NEUROSCI, V28, P10561, DOI 10.1523/JNEUROSCI.2666-08.2008	61	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129370	10.1371/journal.pone.0129370	http://dx.doi.org/10.1371/journal.pone.0129370			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066505	Green Published, Green Submitted, gold			2022-12-26	WOS:000356327000068
J	Miyamoto, Y; Baba, Y; Sakamoto, Y; Ohuchi, M; Tokunaga, R; Kurashige, J; Hiyoshi, Y; Iwagami, S; Yoshida, N; Watanabe, M; Baba, H				Miyamoto, Yuji; Baba, Yoshifumi; Sakamoto, Yasuo; Ohuchi, Mayuko; Tokunaga, Ryuma; Kurashige, Junji; Hiyoshi, Yukiharu; Iwagami, Shiro; Yoshida, Naoya; Watanabe, Masayuki; Baba, Hideo			Negative Impact of Skeletal Muscle Loss after Systemic Chemotherapy in Patients with Unresectable Colorectal Cancer	PLOS ONE			English	Article							BODY-COMPOSITION; CLINICAL-IMPLICATIONS; HEPATIC RESECTION; SARCOPENIA; DETERMINANT; MORTALITY; SURVIVAL; TOXICITY; OUTCOMES	Background Skeletal muscle depletion (sarcopenia) is closely associated with limited physical ability and high mortality. This study evaluated the prognostic significance of skeletal muscle status before and after chemotherapy in patients with unresectable colorectal cancer (CRC). Methods We conducted a retrospective analysis of 215 consecutive patients with unresectable CRC who underwent systemic chemotherapy. Skeletal muscle cross-sectional area was measured by computed tomography. We evaluated the prognostic value of skeletal muscle mass before chemotherapy and the rate of skeletal muscle change in cross-sectional area after chemotherapy. Results One-hundred-eighty-two patients met our inclusion criteria. There were no significant differences in progression-free survival (PFS) or overall survival (OS) associated with skeletal muscle mass before chemotherapy. However, 22 patients with skeletal muscle loss (>5%) after chemotherapy showed significantly shorter PFS and OS compared with those without skeletal muscle loss (PFS, log-rank p = 0.029; OS, log-rank p = 0.009). Multivariate Cox regression analysis revealed that skeletal muscle loss after chemotherapy (hazard ratio, 2.079; 95% confidence interval, 1.194-3.619; p = 0.010) was independently associated with OS. Conclusions Skeletal muscle loss after chemotherapy was an independent, negative prognostic factor in unresectable CRC.	[Miyamoto, Yuji; Baba, Yoshifumi; Sakamoto, Yasuo; Ohuchi, Mayuko; Tokunaga, Ryuma; Kurashige, Junji; Hiyoshi, Yukiharu; Iwagami, Shiro; Yoshida, Naoya; Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto, Japan; [Watanabe, Masayuki] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Tokyo, Japan	Kumamoto University; Japanese Foundation for Cancer Research	Baba, H (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto, Japan.	hdobaba@kumamoto-u.ac.jp		Miyamoto, Yuji/0000-0003-3948-5044	Japan Society for the Promotion of Science (JSPS) [26462020]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (C), grant number 26462020.	Antoun S, 2013, CURR OPIN SUPPORT PA, V7, P383, DOI 10.1097/SPC.0000000000000011; Barret M, 2014, NUTR CANCER, V66, P583, DOI 10.1080/01635581.2014.894103; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Collins J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003697; Dodson S, 2011, ANNU REV MED, V62, P265, DOI 10.1146/annurev-med-061509-131248; Hasselager R, 2014, LANGENBECK ARCH SURG, V399, P287, DOI 10.1007/s00423-014-1174-x; Iritani S, J GASTROENTEROL, DOI [10.1007/s00535-014-0964-92014, DOI 10.1007/S00535-014-0964-92014]; Kopetz S, 2009, J CLIN ONCOL, V27, P3677, DOI 10.1200/JCO.2008.20.5278; Kovarik M, 2014, LUNG CANCER, V84, P1, DOI 10.1016/j.lungcan.2014.01.020; Lieffers JR, 2012, BRIT J CANCER, V107, P931, DOI 10.1038/bjc.2012.350; Matsuda A, 2014, JPN J CLIN ONCOL, V44, P388, DOI 10.1093/jjco/hyu003; Meulenbeld HJ, 2008, ANN ONCOL, V19, P1600, DOI 10.1093/annonc/mdn176; Peng PD, 2011, HPB, V13, P439, DOI 10.1111/j.1477-2574.2011.00301.x; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Prado CMM, 2007, CLIN CANCER RES, V13, P3264, DOI 10.1158/1078-0432.CCR-06-3067; Prado CMM, 2009, CLIN CANCER RES, V15, P2920, DOI 10.1158/1078-0432.CCR-08-2242; Sabel MS, 2011, ANN SURG ONCOL, V18, P3579, DOI 10.1245/s10434-011-1976-9; SEGAL MR, 1988, BIOMETRICS, V44, P35, DOI 10.2307/2531894; Stene GB, 2014, ACTA ONCOL, P1; Tan BHL, 2009, CLIN CANCER RES, V15, P6973, DOI 10.1158/1078-0432.CCR-09-1525; van Vledder MG, 2012, BRIT J SURG, V99, P550, DOI 10.1002/bjs.7823; Voron T, 2015, ANN SURG, V261, P1173, DOI 10.1097/SLA.0000000000000743; Yip C, 2014, EUR RADIOL, V24, P998, DOI 10.1007/s00330-014-3110-4	23	97	97	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129742	10.1371/journal.pone.0129742	http://dx.doi.org/10.1371/journal.pone.0129742			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26069972	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000103
J	Sato, T; Katagiri, K; Kojima, K; Komeya, M; Yao, M; Ogawa, T				Sato, Takuya; Katagiri, Kumiko; Kojima, Kazuaki; Komeya, Mitsuru; Yao, Masahiro; Ogawa, Takehiko			In Vitro Spermatogenesis in Explanted Adult Mouse Testis Tissues	PLOS ONE			English	Article							ORGAN-CULTURE; SEMINIFEROUS EPITHELIUM; SERTOLI-CELLS; SPERM; MICE; PROTEIN; SYNCHRONIZATION; METABOLISM; MARKER; RAT	Research on in vitro spermatogenesis is important for elucidating the spermatogenic mechanism. We previously developed an organ culture method which can support spermatogenesis from spermatogonial stem cells up to sperm formation using immature mouse testis tissues. In this study, we examined whether it is also applicable to mature testis tissues of adult mice. We used two lines of transgenic mice, Acrosin-GFP and Gsg2-GFP, which carry the marker GFP gene specific for meiotic and haploid cells, respectively. Testis tissue fragments of adult GFP mice, aged from 4 to 29 weeks old, which express GFP at full extension, were cultured in medium supplemented with 10% KSR or AlbuMAX. GFP expression decreased rapidly and became the lowest at 7 to 14 days of culture, but then slightly increased during the following culture period. This increase reflected de novo spermatogenesis, confirmed by BrdU labeling in spermatocytes and spermatids. We also used vitamin A-deficient mice, whose testes contain only spermatogonia. The testes of those mice at 13-21 weeks old, showing no GFP expression at explantation, gained GFP expression during culturing, and spermatogenesis was confirmed histologically. In addition, the adult testis tissues of Sl/Sl(d) mutant mice, which lack spermatogenesis due to Kit ligand mutation, were cultured with recombinant Kit ligand to induce spermatogenesis up to haploid formation. Although the efficiency of spermatogenesis was lower than that of pup, present results showed that the organ culture method is effective for the culturing of mature adult mouse testis tissue, demonstrated by the induction of spermatogenesis from spermatogonia to haploid cells.	[Sato, Takuya; Katagiri, Kumiko; Kojima, Kazuaki; Ogawa, Takehiko] Yokohama City Univ, Assoc Med Sci, Lab Prote, Inst Mol Med & Life Sci, Yokohama, Kanagawa 232, Japan; [Komeya, Mitsuru; Yao, Masahiro; Ogawa, Takehiko] Yokohama City Univ, Grad Sch Med, Dept Urol, Yokohama, Kanagawa 232, Japan	Yokohama City University; Yokohama City University	Ogawa, T (corresponding author), Yokohama City Univ, Assoc Med Sci, Lab Prote, Inst Mol Med & Life Sci, Yokohama, Kanagawa 232, Japan.	ogawa@med.yokohama-cu.ac.jp	Sato, Takuya/F-8251-2017; Sato, Takuya/X-9143-2019	Sato, Takuya/0000-0002-6198-2234; Sato, Takuya/0000-0002-6198-2234	grant for Establishment of Research Center for Clinical Proteomics of Posttranslational Modifications;  [25114007];  [24390371];  [26713012]; Grants-in-Aid for Scientific Research [25114007] Funding Source: KAKEN	grant for Establishment of Research Center for Clinical Proteomics of Posttranslational Modifications; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Supported by a Grant-in-Aid for Scientific Research on Innovative Areas, 'Mechanisms regulating gamete formation in animals' 25114007 (to T.O.); Grant-in-Aid for Scientific Research (B) 24390371 (to T.O.); grant for Establishment of Research Center for Clinical Proteomics of Posttranslational Modifications (to T.O.); and Grant-in-Aid for Young Scientists (A) 26713012 (to T.S.).	Arregui L, 2008, ANIM REPROD SCI, V106, P65, DOI 10.1016/j.anireprosci.2007.03.026; BARRETT LA, 1976, CANCER RES, V36, P1003; Bergh A, 2001, BIOL REPROD, V64, P13, DOI 10.1095/biolreprod64.1.13; DAVIS JMG, 1967, BRIT J EXP PATHOL, V48, P371; Farias JG, 2005, ANDROLOGIA, V37, P47, DOI 10.1111/j.1439-0272.2004.00651.x; Freshney RI, 2000, ORGANOTYPIC CULTURE; Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203; HILLMAN EA, 1983, CANCER RES, V43, P245; Hinton BT, 1993, FLUID SECRETION AND; Honaramooz A, 2002, NATURE, V418, P778, DOI 10.1038/nature00918; MORALES C, 1987, ENDOCRINOLOGY, V121, P432, DOI 10.1210/endo-121-1-432; Nakanishi T, 1999, FEBS LETT, V449, P277, DOI 10.1016/S0014-5793(99)00433-0; PLACKE ME, 1987, TOXICOL APPL PHARM, V90, P284, DOI 10.1016/0041-008X(87)90336-X; Rodriguez-Sosa JR, 2009, REPRODUCTION, V138, P187, DOI 10.1530/REP-09-0012; Russell LD, 1990, HISTOLOGICAL HISTOLO; Sato T, 2012, P NATL ACAD SCI USA, V109, P16934, DOI 10.1073/pnas.1211845109; Sato T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1478; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; Schlatt S, 2002, REPRODUCTION, V124, P339, DOI 10.1530/rep.0.1240339; Sugimoto R, 2012, MECH DEVELOP, V128, P610, DOI 10.1016/j.mod.2011.12.003; SUMMERLIN WT, 1970, J INVEST DERMATOL, V55, P310, DOI 10.1111/1523-1747.ep12260178; Tanaka H, 1999, J BIOL CHEM, V274, P17049, DOI 10.1074/jbc.274.24.17049; Tripiciano A, 1999, J CELL BIOL, V145, P1027, DOI 10.1083/jcb.145.5.1027; TROWELL OA, 1959, EXP CELL RES, V16, P118, DOI 10.1016/0014-4827(59)90201-0; VANPELT AMM, 1990, BIOL REPROD, V43, P363, DOI 10.1095/biolreprod43.3.363; Ventela S, 2000, TISSUE CELL, V32, P501, DOI [10.1016/S0040-8166(00)80006-3, 10.1054/tice.2000.0140]; Yokonishi Tetsuhiro, 2013, Methods Mol Biol, V927, P479	27	38	40	5	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130171	10.1371/journal.pone.0130171	http://dx.doi.org/10.1371/journal.pone.0130171			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26065832	Green Submitted, Green Published, gold			2022-12-26	WOS:000356327000145
J	Zhang, HJ; Wang, RQ; Wang, X; Du, N; Ge, XL; Du, YD; Liu, J				Zhang, Haijie; Wang, Renqing; Wang, Xiao; Du, Ning; Ge, Xiuli; Du, Yuanda; Liu, Jian			Recurrent Water Level Fluctuation Alleviates the Effects of Submergence Stress on the Invasive Riparian Plant Alternanthera philoxeroides	PLOS ONE			English	Article							2 WETLAND PLANTS; PHENOTYPIC PLASTICITY; DE-SUBMERGENCE; QUIESCENCE STRATEGIES; BIOMASS ALLOCATION; RESOURCE PULSES; ALLIGATOR WEED; RESPONSES; GROWTH; SURVIVAL	Recurrent water level fluctuation and submergence of plants are common in riparian zones. Our study objectives were to test the independent and interactive effects of submergence level and fluctuation frequency on a globally important riparian invasive plant, Alternanthera philoxeroides. To this end, we conducted a greenhouse experiment, in which ramets of the plants, obtained from a wetland in China, were treated with four fluctuation frequencies (0, 3, 6, and 12 cycles over a 96-day experimental period) under three water levels (0, 10, and 30 cm). We found that effects of fluctuation frequency were non-significant, negative, and positive under water levels of 0, 10 and 30 cm, respectively. As fluctuation frequency increased, the effects of increasing water level decreased significantly. When water levels were high, A. philoxeroides allocated greater biomass to shoot production probably in order to elongate and escape from submergence. However, as fluctuation frequency increased, biomass investment in roots and leaves also increased, probably in order to maximize nutrient absorption and photosynthesis, respectively. These results suggest that water level fluctuation may alleviate the effects of submergence on A. philoxeroides. In addition, A. philoxeroides showed significant phenotypic plasticity, adjusting its functional traits, such as number of nodes and leaves per stem, as well as stem diameter and pith cavity diameter, according to recurrent water level fluctuation. We conclude that A. philoxeroides may perform better in shallow water zones under conditions of disturbance that include recurrent water level fluctuation. This ability to adapt to disturbance likely promotes its growth and invasion in disturbed habitats.	[Zhang, Haijie; Wang, Renqing; Du, Yuanda; Liu, Jian] Shandong Univ, Inst Environm Res, Jinan 250100, Peoples R China; [Wang, Renqing; Wang, Xiao; Du, Ning] Shandong Univ, Sch Life Sci, Jinan 250100, Peoples R China; [Wang, Renqing; Wang, Xiao; Du, Ning] Shandong Univ, Shandong Prov Engn & Technol Res Ctr Vegetat Ecol, Jinan 250100, Peoples R China; [Ge, Xiuli] Qilu Univ Technol, Sch Environm Sci & Engn, Jinan, Peoples R China	Shandong University; Shandong University; Shandong University; Qilu University of Technology	Liu, J (corresponding author), Shandong Univ, Inst Environm Res, Jinan 250100, Peoples R China.	ecology@sdu.edu.cn	Liu, Jian/AAG-9184-2019; Liu, Jian/T-1760-2017	Liu, Jian/0000-0003-1920-2641; Liu, Jian/0000-0003-1920-2641	National Natural Science Foundation of China [31200426, 31400356]; National Water Special Project [2012ZX07203-004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Water Special Project	This study was financially supported by "National Natural Science Foundation of China" (No. 31200426, 31400356) and "National Water Special Project" (No. 2012ZX07203-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumberger T, 2012, AQUAT BOT, V102, P65, DOI 10.1016/j.aquabot.2012.05.003; Benschop JJ, 2005, PLANT J, V44, P756, DOI 10.1111/j.1365-313X.2005.02563.x; Callieri C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109526; Castillo JM, 2005, ESTUARIES, V28, P761, DOI 10.1007/BF02732913; Chen Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081456; Colmer TD, 2009, FUNCT PLANT BIOL, V36, P665, DOI 10.1071/FP09144; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Deegan BM, 2007, AQUAT BOT, V86, P309, DOI 10.1016/j.aquabot.2006.11.006; Drenovsky RE, 2012, ANN BOT-LONDON, V110, P141, DOI 10.1093/aob/mcs100; Evtimova VV, 2014, J APPL ECOL, V51, P1282, DOI 10.1111/1365-2664.12297; Gao J, 2012, AQUAT BIOL, V17, P295, DOI [10.3354/ab00484, DOI 10.3354/AB00484]; Geng YP, 2007, BIOL INVASIONS, V9, P245, DOI 10.1007/s10530-006-9029-1; Geng YP, 2006, ACTA OECOL, V30, P380, DOI 10.1016/j.actao.2006.07.002; Holt RD, 2008, ECOLOGY, V89, P671, DOI 10.1890/07-0348.1; JULIEN MH, 1995, J AQUAT PLANT MANAGE, V33, P55; Kawano N, 2009, ANN BOT-LONDON, V103, P161, DOI 10.1093/aob/mcn171; Licausi F, 2011, NATURE, V479, P419, DOI 10.1038/nature10536; Lin JinCheng, 2004, Acta Agriculturae Shanghai, V20, P96; Lorbiecke R, 1999, PLANT PHYSIOL, V119, P21, DOI 10.1104/pp.119.1.21; Luo FL, 2014, ANN BOT-LONDON, V113, P1265, DOI 10.1093/aob/mcu057; Luo FL, 2012, J PLANT PHYSIOL, V169, P1680, DOI 10.1016/j.jplph.2012.06.015; Luo FL, 2011, ANN BOT-LONDON, V107, P49, DOI 10.1093/aob/mcq212; Luo FL, 2009, ANN BOT-LONDON, V104, P1435, DOI 10.1093/aob/mcp257; Miao SL, 2009, AM NAT, V173, P113, DOI 10.1086/593307; MIAO SL, 1990, ECOLOGY, V71, P2166, DOI 10.2307/1938630; Paillisson JM, 2011, ECOL ENG, V37, P241, DOI 10.1016/j.ecoleng.2010.11.017; Parolin P, 2001, OECOLOGIA, V128, P326, DOI 10.1007/s004420100660; Polacik KA, 2013, ENVIRON EXP BOT, V89, P19, DOI 10.1016/j.envexpbot.2012.12.005; Rich SM, 2012, ANN BOT-LONDON, V110, P405, DOI 10.1093/aob/mcs051; Sauter M, 2013, CURR OPIN PLANT BIOL, V16, P282, DOI 10.1016/j.pbi.2013.03.013; SCHAT H, 1984, OECOLOGIA, V62, P279, DOI 10.1007/BF00379027; Smith RGB, 2007, PLANT ECOL, V188, P103, DOI 10.1007/s11258-006-9151-2; Tao Y, 2009, J PLANT BIOL, V52, P403, DOI 10.1007/s12374-009-9051-9; Voesenek LACJ, 2013, CURR OPIN PLANT BIOL, V16, P647, DOI 10.1016/j.pbi.2013.06.008; Voesenek LACJ, 2006, NEW PHYTOL, V170, P213, DOI 10.1111/j.1469-8137.2006.01692.x; Voesenek LACJ, 2003, ANN BOT-LONDON, V91, P205, DOI 10.1093/aob/mcf116; Vretare V, 2001, AQUAT BOT, V69, P127, DOI 10.1016/S0304-3770(01)00134-6; Wang Hai-Feng, 2008, Wuhan Zhiwuxue Yanjiu, V26, P147; Wei H, 2014, J FRESHWATER ECOL, V29, P101, DOI 10.1080/02705060.2013.833142; Yang LH, 2008, ECOLOGY, V89, P621, DOI 10.1890/07-0175.1; You WH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097246; Yu LF, 2009, FUND APPL LIMNOL, V174, P295, DOI 10.1127/1863-9135/2009/0174-0295; Zhang XK, 2013, J PLANT ECOL, V6, P64, DOI 10.1093/jpe/rts009; Zhu GR, 2012, HYDROBIOLOGIA, V696, P77, DOI 10.1007/s10750-012-1185-y	44	5	5	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129549	10.1371/journal.pone.0129549	http://dx.doi.org/10.1371/journal.pone.0129549			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066509	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000088
J	Dhiman, H; Kapoor, S; Sivadas, A; Sivasubbu, S; Scaria, V				Dhiman, Heena; Kapoor, Shruti; Sivadas, Ambily; Sivasubbu, Sridhar; Scaria, Vinod			zflncRNApedia: A Comprehensive Online Resource for Zebrafish Long Non-Coding RNAs	PLOS ONE			English	Article							GENOME BROWSER; GENE; SEQ; TRANSITION; STRATEGIES; EVOLUTION; FEATURES	Recent transcriptome annotation using deep sequencing approaches have annotated a large number of long non-coding RNAs in zebrafish, a popular model organism for human diseases. These studies characterized lncRNAs in critical developmental stages as well as adult tissues. Each of the studies has uncovered a distinct set of lncRNAs, with minor overlaps. The availability of the raw RNA-Seq datasets in public domain encompassing critical developmental time-points and adult tissues provides us with a unique opportunity to understand the spatiotemporal expression patterns of lncRNAs. In the present report, we created a catalog of lncRNAs in zebrafish, derived largely from the three annotation sets, as well as manual curation of literature to compile a total of 2,267 lncRNA transcripts in zebrafish. The lncRNAs were further classified based on the genomic context and relationship with protein coding gene neighbors into 4 categories. Analysis revealed a total of 86 intronic, 309 promoter associated, 485 overlapping and 1,386 lincRNAs. We created a comprehensive resource which houses the annotation of lncRNAs as well as associated information including expression levels, promoter epigenetic marks, genomic variants and retroviral insertion mutants. The resource also hosts a genome browser where the datasets could be browsed in the genome context. To the best of our knowledge, this is the first comprehensive resource providing a unified catalog of lncRNAs in zebrafish.	[Dhiman, Heena; Kapoor, Shruti; Sivadas, Ambily; Scaria, Vinod] CSIR Inst Genom & Integrat Biol, GN Ramachandran Knowledge Ctr Genome Informat, Delhi 110020, India; [Kapoor, Shruti; Scaria, Vinod] Acad Sci & Innovat Res AcSIR, Anusandhan Bhawan, Delhi 110001, India; [Sivasubbu, Sridhar] CSIR Inst Genom & Integrat Biol, Genom & Mol Med, Delhi 110025, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Sivasubbu, S (corresponding author), CSIR Inst Genom & Integrat Biol, Genom & Mol Med, Mathura Rd, Delhi 110025, India.	s.sivasubbu@igib.res.in; vinods@igib.res.in	Scaria, Vinod/AAS-3151-2021; KAPOOR, SHRUTI/GLS-3871-2022	Sivadas, Ambily/0000-0001-5694-3866; Scaria, Vinod/0000-0001-7644-7181; KAPOOR, SHRUTI/0000-0003-4216-8488	Council of Scientific and Industrial Research (CSIR) India [BSC0123]; CSIR, India	Council of Scientific and Industrial Research (CSIR) India(Council of Scientific & Industrial Research (CSIR) - India); CSIR, India(Council of Scientific & Industrial Research (CSIR) - India)	Authors acknowledge funding from the Council of Scientific and Industrial Research (CSIR) India through grant BSC0123 (GENCODE-C). SK also acknowledges a senior research fellowship from CSIR, India.	Aday AW, 2011, DEV BIOL, V357, P450, DOI 10.1016/j.ydbio.2011.03.007; Bhartiya D, 2012, EXPERT OPIN DRUG DIS, V7, P503, DOI 10.1517/17460441.2012.682055; Bogdanovic O, 2012, GENOME RES, V22, P2043, DOI 10.1101/gr.134833.111; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chew GL, 2013, DEVELOPMENT, V140, P2828, DOI 10.1242/dev.098343; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Ganis JJ, 2012, DEV BIOL, V366, P185, DOI 10.1016/j.ydbio.2012.03.021; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Haque S, 2014, ZEBRAFISH, V11, P499, DOI 10.1089/zeb.2014.0994; Irimia M, 2012, GENOME RES, V22, P2356, DOI 10.1101/gr.139725.112; Kapranov P, 2005, GENOME RES, V15, P987, DOI 10.1101/gr.3455305; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Kaushik K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083616; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kondrychyn I, 2011, ZEBRAFISH, V8, P181, DOI 10.1089/zeb.2011.0718; Kurokawa R, 2009, RNA BIOL, V6, P233, DOI 10.4161/rna.6.3.8329; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Neguembor MV, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-8; Paik EJ, 2013, STEM CELL REP, V1, P425, DOI 10.1016/j.stemcr.2013.10.001; Park C, 2014, BIOINFORMATICS, V30, P2480, DOI 10.1093/bioinformatics/btu325; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Qi P, 2013, MODERN PATHOL, V26, P155, DOI 10.1038/modpathol.2012.160; Quek XC, 2015, NUCLEIC ACIDS RES, V43, pD168, DOI 10.1093/nar/gku988; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sati S, 2012, NUCLEIC ACIDS RES, V40, P10018, DOI 10.1093/nar/gks776; Skinner ME, 2009, GENOME RES, V19, P1630, DOI 10.1101/gr.094607.109; Soshnev AA, 2011, GENETICS, V189, P455, DOI 10.1534/genetics.111.131706; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Varshney GK, 2013, NUCLEIC ACIDS RES, V41, pD861, DOI 10.1093/nar/gks946; Xu C, 2012, DEV CELL, V22, P625, DOI 10.1016/j.devcel.2012.01.003; Yan B, 2012, GENOMICS, V99, P76, DOI 10.1016/j.ygeno.2011.12.002; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	38	20	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129997	10.1371/journal.pone.0129997	http://dx.doi.org/10.1371/journal.pone.0129997			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26065909	Green Submitted, Green Published, gold			2022-12-26	WOS:000356100900091
J	DuVall, JA; Borba, JC; Shafagati, N; Luzader, D; Shukla, N; Li, JY; Kehn-Hall, K; Kendall, MM; Feldman, SH; Landers, JP				DuVall, Jacquelyn A.; Borba, Juliane C.; Shafagati, Nazly; Luzader, Deborah; Shukla, Nishant; Li, Jingyi; Kehn-Hall, Kylene; Kendall, Melissa M.; Feldman, Sanford H.; Landers, James P.			Optical Imaging of Paramagnetic Bead-DNA Aggregation Inhibition Allows for Low Copy Number Detection of Infectious Pathogens	PLOS ONE			English	Article							RAPID DETECTION; BIOLOGICAL SAMPLES; PURIFICATION; VIRUS; EXTRACTION; EXPRESSION; ADHERENCE; PROTEIN; CELLS	DNA-paramagnetic silica bead aggregation in a rotating magnetic field facilitates the quantification of DNA with femtogram sensitivity, but yields no sequence-specific information. Here we provide an original description of aggregation inhibition for the detection of DNA and RNA in a sequence-specific manner following loop-mediated isothermal amplification (LAMP). The fragments generated via LAMP fail to induce chaotrope-mediated bead aggregation; however, due to their ability to passivate the bead surface, they effectively inhibit bead aggregation by longer 'trigger' DNA. We demonstrate the utility of aggregation inhibition as a method for the detection of bacterial and viral pathogens with sensitivity that approaches single copies of the target. We successfully use this methodology for the detection of notable food-borne pathogens Escherichia coli O157:H7 and Salmonella enterica, as well as Rift Valley fever virus, a weaponizable virus of national security concern. We also show the concentration dependence of aggregation inhibition, suggesting the potential for quantification of target nucleic acid in clinical and environmental samples. Lastly, we demonstrate the ability to rapidly detect infectious pathogens by utilizing a cell phone and custom-written application (App), making this novel detection modality fully portable for point-of-care use.	[DuVall, Jacquelyn A.; Borba, Juliane C.; Li, Jingyi; Landers, James P.] Univ Virginia, Dept Chem, Charlottesville, VA 22903 USA; [Shafagati, Nazly; Kehn-Hall, Kylene] George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA USA; [Luzader, Deborah; Kendall, Melissa M.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA USA; [Shukla, Nishant] Univ Virginia, Dept Comp Sci, Charlottesville, VA 22903 USA; [Feldman, Sanford H.] Univ Virginia, Ctr Comparat Med, Charlottesville, VA USA; [Landers, James P.] Univ Virginia, Dept Mech Engn, Charlottesville, VA USA; [Landers, James P.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA	University of Virginia; George Mason University; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia	Landers, JP (corresponding author), Univ Virginia, Dept Chem, Charlottesville, VA 22903 USA.	jpl5e@virginia.edu	Kehn-Hall, Kylene/I-5752-2013; Feldman, Sanford/AAH-7070-2021	Luzader, Deborah/0000-0002-7453-406X; Kehn-Hall, Kylene/0000-0001-8036-7213				Bienvenue JM, 2006, J FORENSIC SCI, V51, P266, DOI 10.1111/j.1556-4029.2006.00054.x; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Breadmore MC, 2003, ANAL CHEM, V75, P1880, DOI 10.1021/ac0204855; California Food Emergency Response Team, 2007, INVESTIGATION OF AN; Chaudhuri RR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008801; Chen SY, 2011, APPL ENVIRON MICROB, V77, P4008, DOI 10.1128/AEM.00354-11; GRIFFIN PM, 1988, ANN INTERN MED, V109, P705, DOI 10.7326/0003-4819-109-9-705; Hagan KA, 2008, ANAL CHEM, V80, P8453, DOI 10.1021/ac8011945; Ikegami T, 2009, VACCINE, V27, pD69, DOI 10.1016/j.vaccine.2009.07.046; Kiilerich-Pedersen K, 2013, BIOSENS BIOELECTRON, V49, P374, DOI 10.1016/j.bios.2013.05.046; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lazcka O, 2007, BIOSENS BIOELECTRON, V22, P1205, DOI 10.1016/j.bios.2006.06.036; Le Roux CA, 2009, J CLIN MICROBIOL, V47, P645, DOI 10.1128/JCM.01412-08; Leland DS, 2007, CLIN MICROBIOL REV, V20, P49, DOI 10.1128/CMR.00002-06; Leslie DC, 2012, J AM CHEM SOC, V134, P5689, DOI 10.1021/ja300839n; Li JY, 2013, ANAL CHEM, V85, P11233, DOI 10.1021/ac401402h; Luisi PL, 2010, MINIMAL CELL BIOPHYS, P65; Lundberg L, 2013, ANTIVIR RES, V100, P662, DOI 10.1016/j.antiviral.2013.10.004; Mohawk KL, 2010, MICROB PATHOGENESIS, V48, P131, DOI 10.1016/j.micpath.2010.01.003; Narayanan A, 2011, EXPERT OPIN INV DRUG, V20, P239, DOI 10.1517/13543784.2011.547852; NATARO JP, 1994, J BACTERIOL, V176, P4691, DOI 10.1128/JB.176.15.4691-4699.1994; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450, DOI 10.1128/CMR.11.3.450; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Schena M, 1996, P NATL ACAD SCI USA, V93, P10614, DOI 10.1073/pnas.93.20.10614; Shafagati N, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002296; Szretter K, 2005, CURR PROTOC MICROBIO; Tian HJ, 2000, ANAL BIOCHEM, V283, P175, DOI 10.1006/abio.2000.4577; VOGELSTEIN B, 1979, P NATL ACAD SCI USA, V76, P615, DOI 10.1073/pnas.76.2.615; Wang F, 2012, J CLIN MICROBIOL, V50, P91, DOI 10.1128/JCM.05612-11; WELLS JG, 1983, J CLIN MICROBIOL, V18, P512, DOI 10.1128/JCM.18.3.512-520.1983; WU SX, 1991, ACTA PAEDIATR SCAND, V80, P1019; Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064; Yao ZY, 2013, APPL ENVIRON MICROB, V79, P1755, DOI 10.1128/AEM.03605-12; Zhao XH, 2010, MOL BIOL REP, V37, P2183, DOI 10.1007/s11033-009-9700-6	35	18	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129830	10.1371/journal.pone.0129830	http://dx.doi.org/10.1371/journal.pone.0129830			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068926	Green Submitted, gold, Green Published			2022-12-26	WOS:000356100900082
J	Huan, YJ; Wu, ZF; Zhang, JG; Zhu, J; Liu, ZH; Song, XX				Huan, Yanjun; Wu, Zhanfeng; Zhang, Jiguang; Zhu, Jiang; Liu, Zhonghua; Song, Xuexiong			Epigenetic Modification Agents Improve Gene-Specific Methylation Reprogramming in Porcine Cloned Embryos	PLOS ONE			English	Article							CELL NUCLEAR TRANSFER; DNA METHYLATION; BOVINE EMBRYOS; SOMATIC-CELLS; MOUSE EMBRYOS; EXPRESSION; CLONING; 5-HYDROXYMETHYLCYTOSINE; 5-AZA-2'-DEOXYCYTIDINE; EMBRYOGENESIS	Incomplete DNA methylation reprogramming in cloned embryos leads to poor cloning efficiency. Epigenetic modification agents can improve genomic methylation reprogramming and the development of cloned embryos, however, the effect of epigenetic modification agents on gene-specific methylation reprogramming remains poorly studied. Here, we investigated DNA methylation reprogramming of pluripotency (Oct4) and tissue specific (Thy1) genes during early embryo development in pigs. In this study, we found that compared with in vitro fertilized counterparts, cloned embryos displayed the disrupted patterns of Oct4 demethylation and Thy1 remethylation. When 5-aza-2'-deoxycytidine (5-aza-dC) or trichostatin A (TSA) enhanced the development of cloned embryos, the transcripts of DNA methyltransferases (Dnmt1 and Dnmt3a), histone acetyltransferase 1 (Hat1) and histone deacetylase 1 (Hdac1) and the methylation and expression patterns of Oct4 and Thy1 became similar to those detected in in vitro fertilized counterparts. Further studies showed that Dnmt1 knockdown in cloned embryos enhanced the methylation reprogramming of Oct4 and Thy1 and promoted the activation of Oct4 and the silence of Thy1. In conclusion, our results demonstrated that cloned embryos displayed incomplete gene-specific methylation reprogramming and disrupted expression patterns of pluripotency and tissue specific genes, and epigenetic modification agents improved gene-specific methylation reprogramming and expression pattern by regulating epigenetic modification related genes. This work would have important implications in improving cloning efficiency.	[Huan, Yanjun; Song, Xuexiong] Qingdao Agr Univ, Coll Anim Sci & Technol, Qingdao, Shandong, Peoples R China; [Wu, Zhanfeng; Zhang, Jiguang] Shouguang City Hosp Chinese Med, Weifang, Shandong, Peoples R China; [Zhu, Jiang; Liu, Zhonghua] Northeast Agr Univ, Coll Life Sci, Harbin, Heilongjiang Pr, Peoples R China	Qingdao Agricultural University; Northeast Agricultural University - China	Liu, ZH (corresponding author), Northeast Agr Univ, Coll Life Sci, Harbin, Heilongjiang Pr, Peoples R China.	liu086@126.com; sxx1959@163.com	Liu, Zhonghua/AAO-3590-2021; Liu, Zhunghua/F-2485-2010	Liu, Zhonghua/0000-0002-9199-6493; Liu, Zhunghua/0000-0002-9199-6493; , Yanjun/0000-0001-7334-4582	Genetically Modified Organisms Breeding Major Projects [2009ZX08006-007B]; China Postdoctoral Science Foundation [2014M551943]; special foundation of Postdoctoral Innovation Project in Shandong Province of China [201402044]	Genetically Modified Organisms Breeding Major Projects; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); special foundation of Postdoctoral Innovation Project in Shandong Province of China	Genetically Modified Organisms Breeding Major Projects (2009ZX08006-007B) to XXS, http://www.moa.gov.cn/; China Postdoctoral Science Foundation (2014M551943) to YJH, http://bg.chinapostdoctor.org.cn/; the special foundation of Postdoctoral Innovation Project in Shandong Province of China (201402044) to YJH, http://www.sdhrss.gov.cn/cm/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Cantone I, 2013, NAT STRUCT MOL BIOL, V20, P282, DOI 10.1038/nsmb.2489; Chen Hong Ping, 2015, Critical Reviews in Oncogenesis, V20, P35; Chen ZX, 2011, J BIOL CHEM, V286, P18347, DOI 10.1074/jbc.R110.205286; Deng Dajun, 2014, Yichuan, V36, P403, DOI 10.3724/SP.J.1005.2014.0403; Ding X, 2008, THERIOGENOLOGY, V70, P622, DOI 10.1016/j.theriogenology.2008.04.042; Esch D, 2013, NAT CELL BIOL ADV ON; Huan YJ, 2014, J REPROD DEVELOP, V60, P377, DOI 10.1262/jrd.2014-062; Huan YJ, 2013, J REPROD DEVELOP, V59, P442, DOI 10.1262/jrd.2013-026; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Ji Huili, 2014, Yichuan, V36, P1211, DOI 10.3724/SP.J.1005.2014.1211; Kong Qing-Ran, 2011, Yichuan, V33, P749, DOI 10.3724/SP.J.1005.2011.00749; Lee KiHo, 2013, Animal Frontiers, V3, P56, DOI 10.2527/af.2013-0034; Li E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019133; Long CR, 2014, MOL REPROD DEV, V81, P183, DOI 10.1002/mrd.22271; Ma PP, 2008, DEV BIOL, V319, P110, DOI 10.1016/j.ydbio.2008.04.011; Messerschmidt DM, 2014, GENE DEV, V28, P812, DOI 10.1101/gad.234294.113; Miyamoto K, 2009, BIOL REPROD, V80, P935, DOI 10.1095/biolreprod.108.073676; Mizutani E, 2015, METHODS MOL BIOL, V1222, P101, DOI 10.1007/978-1-4939-1594-1_8; Niemann H, 2008, REPRODUCTION, V135, P151, DOI 10.1530/REP-07-0397; Niemann H, 2010, CELL REPROGRAM, V12, P33, DOI 10.1089/cell.2009.0063; Peat JR, 2012, NAT GENET, V44, P965, DOI 10.1038/ng.2393; Rodriguez-Osorio N, 2012, THERIOGENOLOGY, V78, P1869, DOI 10.1016/j.theriogenology.2012.05.030; Tamada H, 2004, CYTOGENET GENOME RES, V105, P285, DOI 10.1159/000078200; Wang YS, 2011, CELL REPROGRAM, V13, P297, DOI 10.1089/cell.2010.0098; Wei YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020154; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Xu WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064705; Yamanaka K, 2011, J REPROD DEVELOP, V57, P393, DOI 10.1262/jrd.10-181A; Yin LJ, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-26; Zhao JG, 2010, CELL TISSUE RES, V341, P13, DOI 10.1007/s00441-010-1000-x; Zhao MT, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.104471	33	24	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129803	10.1371/journal.pone.0129803	http://dx.doi.org/10.1371/journal.pone.0129803			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068219	gold, Green Published, Green Submitted			2022-12-26	WOS:000356100900079
J	Stein, C; Makarewicz, O; Bohnert, JA; Pfeifer, Y; Kesselmeier, M; Hagel, S; Pletz, MW				Stein, Claudia; Makarewicz, Oliwia; Bohnert, Juergen A.; Pfeifer, Yvonne; Kesselmeier, Miriam; Hagel, Stefan; Pletz, Mathias W.			Three Dimensional Checkerboard Synergy Analysis of Colistin, Meropenem, Tigecycline against Multidrug-Resistant Clinical Klebsiella pneumonia Isolates	PLOS ONE			English	Article							BETA-LACTAMASE PRODUCTION; COMBINATION THERAPY; ERTAPENEM-RESISTANT; PORIN; DERIVATIVES; MORTALITY; IMPACT; SPREAD	The spread of carbapenem-non-susceptible Klebsiella pneumoniae strains bearing different resistance determinants is a rising problem worldwide. Especially infections with KPC (Klebsiella pneumoniae carbapenemase) - producers are associated with high mortality rates due to limited treatment options. Recent clinical studies of KPC-blood stream infections revealed that colistin-based combination therapy with a carbapenem and/or tigecycline was associated with significantly decreased mortality rates when compared to colistin monotherapy. However, it remains unclear if these observations can be transferred to K. pneumoniae harboring other mechanisms of carbapenem resistance. A three-dimensional synergy analysis was performed to evaluate the benefits of a triple combination with meropenem, tigecycline and colistin against 20 K. pneumoniae isolates harboring different beta-lactamases. To examine the mechanism behind the clinically observed synergistic effect, efflux properties and outer membrane porin (Omp) genes (ompK35 and ompK36) were also analyzed. Synergism was found for colistin-based double combinations for strains exhibiting high minimal inhibition concentrations against all of the three antibiotics. Adding a third antibiotic did not result in further increased synergistic effect in these strains. Antagonism did not occur. These results support the idea that colistin-based double combinations might be sufficient and the most effective combination partner for colistin should be chosen according to its MIC.	[Stein, Claudia; Makarewicz, Oliwia; Hagel, Stefan; Pletz, Mathias W.] Jena Univ Hosp, Ctr Infect Dis & Infect Control, D-07747 Jena, Germany; [Bohnert, Juergen A.] Jena Univ Hosp, Inst Med Microbiol, D-07747 Jena, Germany; [Pfeifer, Yvonne] Robert Koch Inst, Nosocomial Pathogens & Antibiot Resistance, D-8855 Wernigerode, Germany; [Kesselmeier, Miriam] Jena Univ Hosp, Ctr Sepsis Control & Care, Clin Epidemiol Integrated Res & Treatment Ctr, D-07747 Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Robert Koch Institute; Friedrich Schiller University of Jena	Stein, C (corresponding author), Jena Univ Hosp, Ctr Infect Dis & Infect Control, D-07747 Jena, Germany.	Claudia.Stein@med.uni-jena.de	Kesselmeier, Miriam/G-5546-2016; Pletz, Mathias Wilhelm/H-9782-2019; Hagel, Stefan/AAE-1174-2022	Kesselmeier, Miriam/0000-0001-6462-2579; Pletz, Mathias Wilhelm/0000-0001-8157-2753; Hagel, Stefan/0000-0003-2999-6131; Makarewicz, Oliwia/0000-0002-4404-1862	German Ministry of Education and Research [01KI1204, 01EO1002]; ARGUS-Stiftung	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); ARGUS-Stiftung	This work was supported by grants from the German Ministry of Education and Research (grant numbers 01KI1204 and 01EO1002) and from ARGUS-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTI S, 1995, INFECT IMMUN, V63, P903; Bauer G, 2004, J ANTIMICROB CHEMOTH, V53, P592, DOI 10.1093/jac/dkh125; Betts JW, 2014, ANTIMICROB AGENTS CH, V58, P3541, DOI 10.1128/AAC.02449-14; Bohnert JA, 2010, ANTIMICROB AGENTS CH, V54, P3770, DOI 10.1128/AAC.00620-10; Borer A, 2009, INFECT CONT HOSP EP, V30, P972, DOI 10.1086/605922; CHEN CCH, 1972, ANTIMICROB AGENTS CH, V22, P331, DOI 10.1128/AAC.2.5.331; Clancy CJ, 2013, ANTIMICROB AGENTS CH, V57, P5258, DOI 10.1128/AAC.01069-13; Daikos GL, 2014, ANTIMICROB AGENTS CH, V58, P2322, DOI 10.1128/AAC.02166-13; den Hollander JG, 1998, ANTIMICROB AGENTS CH, V42, P744, DOI 10.1128/AAC.42.4.744; Doern GV, 2011, J CLIN MICROBIOL, V49, P3109, DOI 10.1128/JCM.00580-11; Domenech-Sanchez A, 2003, ANTIMICROB AGENTS CH, V47, P3332, DOI 10.1128/AAC.47.10.3332-3335.2003; European Centre for Disease Prevention and Control (ECDC), 2013, ANNUAL EPIDEMIOLOGIC; Garcia-Fernandez A, 2010, ANTIMICROB AGENTS CH, V54, P4178, DOI 10.1128/AAC.01301-09; Garcia-Sureda L, 2011, ANTIMICROB AGENTS CH, V55, P1803, DOI 10.1128/AAC.01441-10; Gerasimenko D. V., 2004, Prikladnaya Biokhimiya i Mikrobiologiya, V40, P301; Grill MF, 2011, BRIT J CLIN PHARMACO, V72, P381, DOI 10.1111/j.1365-2125.2011.03991.x; Handzlik J, 2013, BIOORGAN MED CHEM, V21, P135, DOI 10.1016/j.bmc.2012.10.053; Handzlik J, 2012, BIOORGAN MED CHEM, V20, P4245, DOI 10.1016/j.bmc.2012.05.064; Hong JH, 2013, ANTIMICROB AGENTS CH, V57, P2147, DOI 10.1128/AAC.02411-12; Kaczmarek FM, 2006, ANTIMICROB AGENTS CH, V50, P3396, DOI 10.1128/AAC.00285-06; Lee CH, 2007, J ANTIMICROB CHEMOTH, V60, P410, DOI 10.1093/jac/dkm215; Martinez-Martinez L, 2008, CLIN MICROBIOL INFEC, V14, P82, DOI 10.1111/j.1469-0691.2007.01860.x; NIKAIDO H, 1994, J BIOL CHEM, V269, P3905; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Novais A, 2012, EUR J CLIN MICROBIOL, V31, P3057, DOI 10.1007/s10096-012-1665-z; Patel G, 2008, INFECT CONT HOSP EP, V29, P1099, DOI 10.1086/592412; Paul M, 2014, J ANTIMICROB CHEMOTH, V69, P2305, DOI 10.1093/jac/dku168; Plachouras D, 2009, ANTIMICROB AGENTS CH, V53, P3430, DOI 10.1128/AAC.01361-08; Poulou A, 2013, J CLIN MICROBIOL, V51, P3176, DOI 10.1128/JCM.01244-13; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Qureshi ZA, 2012, ANTIMICROB AGENTS CH, V56, P2108, DOI 10.1128/AAC.06268-11; Tsai YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079640; Tumbarello M, 2012, CLIN INFECT DIS, V55, P943, DOI 10.1093/cid/cis588; Wang XD, 2009, J MED MICROBIOL, V58, P1196, DOI 10.1099/jmm.0.008094-0; Watkins RR, 2015, EXPERT REV ANTI-INFE, V13, P405, DOI 10.1586/14787210.2015.1018825; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001	36	53	56	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0126479	10.1371/journal.pone.0126479	http://dx.doi.org/10.1371/journal.pone.0126479			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067824	gold, Green Published			2022-12-26	WOS:000356100900009
J	Villarreal, FD; Kultz, D				Villarreal, Fernando D.; Kueltz, Dietmar			Direct Ionic Regulation of the Activity of Myo-Inositol Biosynthesis Enzymes in Mozambique Tilapia	PLOS ONE			English	Article							INOSITOL MONOPHOSPHATASE; OREOCHROMIS-MOSSAMBICUS; 1-PHOSPHATE SYNTHASE; ORGANIC OSMOLYTES; CRYSTAL-STRUCTURE; EPITHELIAL-CELLS; NA+/H+ EXCHANGE; EXPRESSION; MECHANISM; LITHIUM	Myo-inositol (Ins) is a major compatible osmolyte in many cells, including those of Mozambique tilapia (Oreochromis mossambicus). Ins biosynthesis is highly up-regulated in tilapia and other euryhaline fish exposed to hyperosmotic stress. In this study, enzymatic regulation of two enzymes of Ins biosynthesis, Ins phosphate synthase (MIPS) and inositol monophosphatase (IMPase), by direct ionic effects is analyzed. Specific MIPS and IMPase isoforms from Mozambique tilapia (MIPS-160 and IMPase 1) were selected based on experimental, phylogenetic, and structural evidence supporting their role for Ins biosynthesis during hyperosmotic stress. Recombinant tilapia IMPase 1 and MIPS-160 activity was assayed in vitro at ionic conditions that mimic changes in the intracellular milieu during hyperosmotic stress. The in vitro activities of MIPS-160 and IMPase 1 are highest at alkaline pH of 8.8. IMPase 1 catalytic efficiency is strongly increased during hyperosmolality (particularly for the substrate D-Ins-3-phosphate, Ins-3P), mainly as a result of [Na+] elevation. Furthermore, the substrate-specificity of IMPase 1 towards D-Ins-1-phosphate (Ins-1P) is lower than towards Ins-3P. Because MIPS catalysis results in Ins-3P this results represents additional evidence for IMPase 1 being the isoform that mediates Ins biosynthesis in tilapia. Our data collectively demonstrate that the Ins biosynthesis enzymes are activated under ionic conditions that cells are exposed to during hypertonicity, resulting in Ins accumulation, which, in turn, results in restoration of intracellular ion homeostasis. We propose that the unique and direct ionic regulation of the activities of Ins biosynthesis enzymes represents an efficient biochemical feedback loop for regulation of intracellular physiological ion homeostasis during hyperosmotic stress.	[Villarreal, Fernando D.; Kueltz, Dietmar] Univ Calif Davis, Dept Anim Sci, EcoPhysiol Prote Lab, Davis, CA 95616 USA	University of California System; University of California Davis	Villarreal, FD (corresponding author), Univ Calif Davis, Dept Anim Sci, EcoPhysiol Prote Lab, One Shields Ave, Davis, CA 95616 USA.	fvillarreal@ucdavis.edu	, DK/AAU-3163-2021	Villarreal, Fernando/0000-0002-4034-1243	NIEHS [P42ES004699]; NSF [IOB-13355098]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004699] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [1355098] Funding Source: National Science Foundation	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was funded by NIEHS grant P42ES004699 and NSF grant IOB-13355098 to DK.	ACKERMANN KE, 1987, BIOCHEM J, V242, P517, DOI 10.1042/bj2420517; Alcazar-Roman AR, 2008, CHROMOSOMA, V117, P1, DOI 10.1007/s00412-007-0126-4; Alfieri RR, 2007, PFLUG ARCH EUR J PHY, V454, P173, DOI 10.1007/s00424-006-0195-x; Atack JR, 1997, MED RES REV, V17, P215, DOI 10.1002/(SICI)1098-1128(199703)17:2<215::AID-MED3>3.0.CO;2-2; BARNETT JEG, 1970, BIOCHEM J, V119, P183, DOI 10.1042/bj1190183; Bhattacharyya S, 2012, BIOCHIMIE, V94, P879, DOI 10.1016/j.biochi.2011.12.007; BONE R, 1994, BIOCHEMISTRY-US, V33, P9468, DOI 10.1021/bi00198a012; Burg MB, 2008, J BIOL CHEM, V283, P7309, DOI 10.1074/jbc.R700042200; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Burg MB, 1997, ANNU REV PHYSIOL, V59, P437, DOI 10.1146/annurev.physiol.59.1.437; Burg MB, 1996, FASEB J, V10, P1598, DOI 10.1096/fasebj.10.14.9002551; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Chang JCH, 2007, J EXP BIOL, V210, P3494, DOI 10.1242/jeb.007146; Chu SL, 2006, AQUACULTURE, V251, P537, DOI 10.1016/j.aquaculture.2005.05.040; Deranieh RM, 2013, J BIOL CHEM, V288, P26822, DOI 10.1074/jbc.M113.479121; Eddy F, 1993, THE VERTEBRATE GAS T, P35; EISENBERG F, 1987, METHOD ENZYMOL, V141, P127; Fiess JC, 2007, COMP BIOCHEM PHYS A, V146, P252, DOI 10.1016/j.cbpa.2006.10.027; Fiol DF, 2006, COMP BIOCHEM PHYS D, V1, P344, DOI 10.1016/j.cbd.2006.08.002; Fossat B, 1997, J EXP BIOL, V200, P2369; Gardell AM, 2013, J EXP BIOL, V216, P4615, DOI 10.1242/jeb.088906; GARNER MM, 1994, AM J PHYSIOL, V266, pC877, DOI 10.1152/ajpcell.1994.266.4.C877; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GEE NS, 1988, BIOCHEM J, V249, P883, DOI 10.1042/bj2490883; Geiger James H., 2006, V39, P157; Gill R, 2005, ACTA CRYSTALLOGR D, V61, P545, DOI 10.1107/S0907444905004038; GREASLEY PJ, 1994, EUR J BIOCHEM, V222, P453, DOI 10.1111/j.1432-1033.1994.tb18885.x; GRINSTEIN S, 1985, J GEN PHYSIOL, V85, P765, DOI 10.1085/jgp.85.5.765; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Jin XS, 2003, ACTA CRYSTALLOGR D, V59, P1154, DOI 10.1107/S0907444903008205; Johnson KA, 2001, BIOCHEMISTRY-US, V40, P618, DOI 10.1021/bi0016422; Ju SL, 2004, J BIOL CHEM, V279, P21759, DOI 10.1074/jbc.M312078200; Kalujnaia S, 2013, AM J PHYSIOL-REG I, V305, pR369, DOI 10.1152/ajpregu.00044.2013; Kalujnaia S, 2010, FASEB J, V24, P3981, DOI 10.1096/fj.10-161000; Kristensen DM, 2011, BRIEF BIOINFORM, V12, P379, DOI 10.1093/bib/bbr030; Kultz D, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P1373; Kultz D, 2013, FISH PHYSIOL, V32, P45, DOI 10.1016/B978-0-12-396951-4.00002-5; Kultz D, 2012, PHYSIOLOGY, V27, P259, DOI 10.1152/physiol.00014.2012; Kultz D, 1998, CONTRIB NEPHROL, V123, P94, DOI 10.1159/000059923; KWON HM, 1992, J BIOL CHEM, V267, P6297; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee J, 2006, COMP BIOCHEM PHYS D, V1, P328, DOI 10.1016/j.cbd.2006.07.001; Lin CY, 2005, NUCLEIC ACIDS RES, V33, pW553, DOI 10.1093/nar/gki494; LOEWUS MW, 1984, J BIOL CHEM, V259, P7644; MAJERUS PW, 1992, ANNU REV BIOCHEM, V61, P225, DOI 10.1146/annurev.bi.61.070192.001301; Majumder AL, 1997, BBA-LIPID LIPID MET, V1348, P245, DOI 10.1016/S0005-2760(97)00122-7; MAUCK LA, 1980, BIOCHEMISTRY-US, V19, P3623, DOI 10.1021/bi00556a031; Mevarech M, 2000, BIOPHYS CHEM, V86, P155, DOI 10.1016/S0301-4622(00)00126-5; Michell RH, 2008, NAT REV MOL CELL BIO, V9, P151, DOI 10.1038/nrm2334; MORGAN IJ, 1994, J EXP BIOL, V194, P139; Neuhofer W, 2005, CONTRIB NEPHROL, V148, P21, DOI 10.1159/000086041; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Parks SK, 2010, COMP BIOCHEM PHYS A, V155, P139, DOI 10.1016/j.cbpa.2009.10.025; Part P, 1996, J COMP PHYSIOL B, V166, P37; PARTHASARATHY L, 1994, LIFE SCI, V54, P1127, DOI 10.1016/0024-3205(94)00835-3; Paul S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r70; RayChaudhuri A, 1997, PLANT PHYSIOL, V115, P727, DOI 10.1104/pp.115.2.727; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sacchi R, 2013, J EXP BIOL, V216, P4626, DOI 10.1242/jeb.093823; Sandbichler AM, 2004, J COMP PHYSIOL B, V174, P601, DOI 10.1007/s00360-004-0449-x; Schomburg I, 2013, NUCLEIC ACIDS RES, V41, pD764, DOI 10.1093/nar/gks1049; Seelan RS, 2009, J BIOL CHEM, V284, P9443, DOI 10.1074/jbc.M900206200; Shaltiel G, 2004, BIOL PSYCHIAT, V56, P868, DOI 10.1016/j.biopsych.2004.08.027; Shamir A, 2007, BIPOLAR DISORD, V9, P766, DOI 10.1111/j.1399-5618.2007.00440.x; Singh LR, 2011, LIFE SCI, V88, P117, DOI 10.1016/j.lfs.2010.10.020; Singh N, 2012, ACTA CRYSTALLOGR F, V68, P1149, DOI 10.1107/S1744309112035191; SOMERO GN, 1986, AM J PHYSIOL, V251, pR197, DOI 10.1152/ajpregu.1986.251.2.R197; Somero GN, 2010, COMPREHENSIVE PHYSL, P441; Stein AJ, 2002, J BIOL CHEM, V277, P9484, DOI 10.1074/jbc.M109371200; Tadeo X, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000257; Tian F, 1999, J AM CHEM SOC, V121, P5795, DOI 10.1021/ja9900196; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Uldry M, 2001, EMBO J, V20, P4467, DOI 10.1093/emboj/20.16.4467; Vaden DL, 2001, J BIOL CHEM, V276, P15466, DOI 10.1074/jbc.M004179200; Wehner F, 2004, REV PHYSIOL BIOCH P, V148, P1, DOI 10.1007/s10254-003-0009-x; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730	76	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0123212	10.1371/journal.pone.0123212	http://dx.doi.org/10.1371/journal.pone.0123212			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26066044	Green Published, Green Submitted, gold			2022-12-26	WOS:000356100900002
J	Tian, HP; Lun, SM; Huang, HJ; He, R; Kong, PZ; Wang, QS; Li, XQ; Feng, YM				Tian, Hong-Pan; Lun, Shu-Min; Huang, Huan-Jing; He, Rui; Kong, Peng-Zhou; Wang, Qing-Shan; Li, Xiao-Qing; Feng, Yu-Mei			DNA Methylation Affects the SP1-regulated Transcription of FOXF2 in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GENE-EXPRESSION; HUMAN PROSTATE; FACTOR SP1; TGF-BETA; METASTASIS; METHYLTRANSFERASES; PROLIFERATION; PROGRESSION; MECHANISMS	FOXF2 (forkhead box F2) is a mesenchyme-specific transcription factor that plays a critical role in tissue homeostasis through the maintenance of epithelial polarity. In a previous study, we demonstrated that FOXF2 is specifically expressed in basal-like breast cancer (BLBC) cells and functions as an epithelial-mesenchymal transition suppressor. FOXF2 deficiency enhances the metastatic ability of BLBC cells through activation of the epithelial-mesenchymal transition program, but reduces cell proliferation. In this study, we demonstrate that CpG island methylation of the FOXF2 proximal promoter region is involved in the regulatory mechanism of the subtype-specific expression of FOXF2 in breast cancer cells. DNMT1, DNMT3A, and DNMT3B commonly or individually contributed to this DNA methylation in different breast cancer cells. SP1 regulated the transcriptional activity of FOXF2 through direct binding to the proximal promoter region, whereas this binding was abrogated through DNA methylation. FOXF2 mediated the SP1-regulated suppression of progression and promotion of proliferation of non-methylated BLBC cells. Thus, we conclude that the subtype-specific expression and function of FOXF2 in breast cancer cells are regulated through the combined effects of DNA methylation and SP1 transcriptional regulation.	[Tian, Hong-Pan; Lun, Shu-Min; Huang, Huan-Jing; He, Rui; Kong, Peng-Zhou; Wang, Qing-Shan; Li, Xiao-Qing; Feng, Yu-Mei] Tianjin Med Univ Canc Inst & Hosp, Dept Biochem & Mol Biol, Natl Clin Res Ctr Canc, Tianjin 300060, Peoples R China; [Wang, Qing-Shan; Li, Xiao-Qing; Feng, Yu-Mei] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Minist Educ, Key Lab Breast Canc Prevent & Treatment, Tianjin 300060, Peoples R China	Tianjin Medical University; Tianjin Medical University	Feng, YM (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Dept Biochem & Mol Biol, Huan Hu Xi Rd, Tianjin 300060, Peoples R China.	ymfeng@tijmu.edu.cn			National Natural Science Foundation of China [81272357, 81472680]; Major Program of Applied Basic Research Projects of Tianjin Grant [13JCZDJC30100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Program of Applied Basic Research Projects of Tianjin Grant	This work was supported by National Natural Science Foundation of China Grants 81272357 and 81472680 and Major Program of Applied Basic Research Projects of Tianjin Grant 13JCZDJC30100. The authors declare that they have no conflicts of interest with the contents of this article.	Aitola M, 2000, DEV DYNAM, V218, P136, DOI 10.1002/(SICI)1097-0177(200005)218:1<136::AID-DVDY12>3.0.CO;2-U; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Chang HC, 2006, CANCER RES, V66, P8413, DOI 10.1158/0008-5472.CAN-06-0685; Denis H, 2011, EMBO REP, V12, P647, DOI 10.1038/embor.2011.110; Dunwell T, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-44; Guo D, 2012, BIOCHEM BIOPH RES CO, V428, P80, DOI 10.1016/j.bbrc.2012.10.010; Hatzis C, 2011, JAMA-J AM MED ASSOC, V305, P1873, DOI 10.1001/jama.2011.593; Hirata H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055502; Hsu TI, 2012, ONCOGENE, V31, P3973, DOI 10.1038/onc.2011.568; Huang Y, 2014, TRENDS GENET, V30, P464, DOI 10.1016/j.tig.2014.07.005; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Jungert K, 2007, CANCER RES, V67, P1563, DOI 10.1158/0008-5472.CAN-06-1670; Kolesnikoff N, 2014, J BIOL CHEM, V289, P11194, DOI 10.1074/jbc.M113.529172; Kong PZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061591; Liu YN, 2005, ONCOGENE, V24, P8277, DOI 10.1038/sj.onc.1208991; Lu SY, 2010, INT J CANCER, V126, P416, DOI 10.1002/ijc.24761; Medvedeva YA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-119; Narayan VA, 1997, J BIOL CHEM, V272, P7801, DOI 10.1074/jbc.272.12.7801; Ormestad M, 2006, DEVELOPMENT, V133, P833, DOI 10.1242/dev.02252; Reamon-Buettner SM, 2008, CANCER RES, V68, P7587, DOI 10.1158/0008-5472.CAN-08-0967; Shen L, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2013.48; Shi W, 2011, CANCER RES, V71, P2926, DOI 10.1158/0008-5472.CAN-10-3369; Sun LN, 2013, JNCI-J NATL CANCER I, V105, P887, DOI 10.1093/jnci/djt118; Turek-Plewa J, 2005, CELL MOL BIOL LETT, V10, P631; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; van der Heul-Nieuwenhuijsen L, 2006, BJU INT, V98, P886, DOI 10.1111/j.1464-410X.2006.06427.x; van der Heul-Nieuwenhuijsen L, 2009, BJU INT, V103, P1574, DOI 10.1111/j.1464-410X.2009.08351.x; Verras M, 2007, CANCER RES, V67, P967, DOI 10.1158/0008-5472.CAN-06-3552; Wang QS, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0531-1; Wang T, 2003, DEV BIOL, V259, P83, DOI 10.1016/S0012-1606(03)00176-3; Wu CY, 2012, TRENDS GENET, V28, P454, DOI 10.1016/j.tig.2012.05.005; Yu Y, 2014, BRIT J CANCER, V110, P724, DOI 10.1038/bjc.2013.768; Yue L, 2013, CARCINOGENESIS, V34, P927, DOI 10.1093/carcin/bgs399	33	38	41	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19173	19183		10.1074/jbc.M114.636126	http://dx.doi.org/10.1074/jbc.M114.636126			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26070560	Green Published, hybrid			2022-12-26	WOS:000358781100032
J	Borek, WE; Zou, J; Rappsilber, J; Sawin, KE				Borek, Weronika E.; Zou, Juan; Rappsilber, Juri; Sawin, Kenneth E.			Deletion of Genes Encoding Arginase Improves Use of "Heavy" Isotope-Labeled Arginine for Mass Spectrometry in Fission Yeast	PLOS ONE			English	Article							CELL-CULTURE SILAC; AMINO-ACIDS; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; QUANTITATIVE PROTEOMICS; AMMONIA ASSIMILATION; METABOLISM; MECHANISMS; CONVERSION; COMPLEXES	The use of "heavy" isotope-labeled arginine for stable isotope labeling by amino acids in cell culture (SILAC) mass spectrometry in the fission yeast Schizosaccharomyces pombe is hindered by the fact that under normal conditions, arginine is extensively catabolized in vivo, resulting in the appearance of "heavy"-isotope label in several other amino acids, most notably proline, but also glutamate, glutamine and lysine. This "arginine conversion problem" significantly impairs quantification of mass spectra. Previously, we developed a method to prevent arginine conversion in fission yeast SILAC, based on deletion of genes involved in arginine catabolism. Here we show that although this method is indeed successful when C-13(6)-arginine (Arg-6) is used for labeling, it is less successful when C-13(6) N-15(4)-arginine (Arg-10), a theoretically preferable label, is used. In particular, we find that with this method, "heavy"-isotope label derived from Arg-10 is observed in amino acids other than arginine, indicating metabolic conversion of Arg-10. Arg-10 conversion, which severely complicates both MS and MS/MS analysis, is further confirmed by the presence of C-13(5) N-15(2)-arginine (Arg-7) in arginine-containing peptides from Arg-10-labeled cells. We describe how all of the problems associated with the use of Arg-10 can be overcome by a simple modification of our original method. We show that simultaneous deletion of the fission yeast arginase genes car1+ and aru1+ prevents virtually all of the arginine conversion that would otherwise result from the use of Arg-10. This solution should enable a wider use of heavy isotopelabeled amino acids in fission yeast SILAC.	[Borek, Weronika E.; Zou, Juan; Rappsilber, Juri; Sawin, Kenneth E.] Univ Edinburgh, Sch Biol Sci, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland; [Rappsilber, Juri] Tech Univ Berlin, Dept Bioanalyt, Inst Biotechnol, Berlin, Germany	University of Edinburgh; Technical University of Berlin	Rappsilber, J (corresponding author), Univ Edinburgh, Sch Biol Sci, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland.	juri.rappsilber@ed.ac.uk; ken.sawin@ed.ac.uk	Rappsilber, Juri/ABF-3328-2020; Rappsilber, Juri/B-7265-2015	Rappsilber, Juri/0000-0001-5999-1310; Sawin, Kenneth/0000-0002-2607-2219; Zou, Juan/0000-0003-2594-6217	Wellcome Trust [094517, 092076]; Wellcome Trust Senior Research Fellowship [103139, 091020]; Cancer Research UK [C20060/A10789]	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Senior Research Fellowship(Wellcome Trust); Cancer Research UK(Cancer Research UK)	This work was supported by a Wellcome Trust grant [094517] to KES and Wellcome Trust Senior Research Fellowship [103139] and instrument grant [091020] to JR (www.wellcome.ac.uk). WEB was supported by a PhD Studentship [C20060/A10789] from Cancer Research UK (http://www.cancerresearchuk.org). The Wellcome Trust Centre for Cell Biology is supported by core funding from the Wellcome Trust [092076]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendall SC, 2008, MOL CELL PROTEOMICS, V7, P1587, DOI 10.1074/mcp.M800113-MCP200; Bicho CC, 2010, MOL CELL PROTEOMICS, V9, P1567, DOI 10.1074/mcp.M110.000208; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Blagoev B, 2006, METHODS, V40, P243, DOI 10.1016/j.ymeth.2006.08.001; Carpy A, 2015, MOL CELL PROTEOMICS, V14, P243, DOI 10.1074/mcp.O114.045302; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; DAVIS RH, 1986, MICROBIOL REV, V50, P280, DOI 10.1128/MMBR.50.3.280-313.1986; Eitinger T, 2000, J BIOL CHEM, V275, P18029, DOI 10.1074/jbc.M001978200; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Gopinath RK, 2014, GENOME BIOL EVOL, V6, P2851, DOI 10.1093/gbe/evu226; Gunaratne J, 2013, MOL CELL PROTEOMICS, V12, P1741, DOI 10.1074/mcp.M112.023754; Harigaya Y, 2007, CHROMOSOME RES, V15, P523, DOI 10.1007/s10577-007-1151-0; Hauf S, 2013, BIOCHEM SOC T, V41, P1755, DOI 10.1042/BST20130240; Hilger M, 2012, J PROTEOME RES, V11, P982, DOI 10.1021/pr200740a; Janson ME, 2005, J CELL BIOL, V169, P297, DOI 10.1083/jcb.200410119; JOHNSON B, 1974, J GEN MICROBIOL, V85, P169, DOI 10.1099/00221287-85-1-169; Koch A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001588; Larance M, 2011, NAT METHODS, V8, P849, DOI [10.1038/NMETH.1679, 10.1038/nmeth.1679]; Maaheimo H, 2001, EUR J BIOCHEM, V268, P2464, DOI 10.1046/j.1432-1327.2001.02126.x; Maiolica A, 2007, MOL CELL PROTEOMICS, V6, P2200, DOI 10.1074/mcp.M700274-MCP200; Marguerat S, 2012, CELL, V151, P671, DOI 10.1016/j.cell.2012.09.019; Olsson I, 2011, CURR GENET, V57, P1, DOI 10.1007/s00294-010-0327-x; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2003, J PROTEOME RES, V2, P173, DOI 10.1021/pr0255708; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Otsubo Y, 2008, CRIT REV BIOCHEM MOL, V43, P277, DOI [10.1080/10409230802254911, 10.1080/10409230802254911 ]; PERYSINAKIS A, 1995, CURR MICROBIOL, V30, P367, DOI 10.1007/BF00369864; Piel M, 2009, CURR BIOL, V19, pR823, DOI 10.1016/j.cub.2009.08.012; Pronk JT, 1996, YEAST, V12, P1607, DOI 10.1002/(SICI)1097-0061(199612)12:16<1607::AID-YEA70>3.0.CO;2-4; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Samejima I, 2005, MOL BIOL CELL, V16, P3040, DOI 10.1091/mbc.e04-11-1003; Sanso M, 2013, BIOCHEM SOC T, V41, P1660, DOI 10.1042/BST20130238; VANANDEL JG, 1977, ARCH MICROBIOL, V111, P265, DOI 10.1007/BF00549365; Venkatram S, 2005, MOL BIOL CELL, V16, P3052, DOI 10.1091/mbc.E04-12-1043	35	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129548	10.1371/journal.pone.0129548	http://dx.doi.org/10.1371/journal.pone.0129548			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075619	gold, Green Published, Green Submitted			2022-12-26	WOS:000356329900082
J	Faddeeva, A; Studer, RA; Kraaijeveld, K; Sie, D; Ylstra, B; Marien, J; op den Camp, HJM; Datema, E; den Dunnen, JT; van Straalen, NM; Roelofs, D				Faddeeva, A.; Studer, R. A.; Kraaijeveld, K.; Sie, D.; Ylstra, B.; Marien, J.; op den Camp, H. J. M.; Datema, E.; den Dunnen, J. T.; van Straalen, N. M.; Roelofs, D.			Collembolan Transcriptomes Highlight Molecular Evolution of Hexapods and Provide Clues on the Adaptation to Terrestrial Life	PLOS ONE			English	Article							DETECTING POSITIVE SELECTION; HEAVY-METAL TOLERANCE; ORCHESELLA-CINCTA; PANCRUSTACEAN PHYLOGENY; SEQUENCE ALIGNMENT; GENOME SEQUENCE; SODIUM-CHANNEL; SOIL ARTHROPOD; INSECT GENOMES; GENES	Background Collembola (springtails) represent a soil-living lineage of hexapods in between insects and crustaceans. Consequently, their genomes may hold key information on the early processes leading to evolution of Hexapoda from a crustacean ancestor. Method We assembled and annotated transcriptomes of the Collembola Folsomia candida and Orchesella cincta, and performed comparative analysis with protein-coding gene sequences of three crustaceans and three insects to identify adaptive signatures associated with the evolution of hexapods within the pancrustacean clade. Results Assembly of the springtail transcriptomes resulted in 37,730 transcripts with predicted open reading frames for Folsomia candida and 32,154 for Orchesella cincta, of which 34.2% were functionally annotated for Folsomia candida and 38.4% for Orchesella cincta. Subsequently, we predicted orthologous clusters among eight species and applied the branch-site test to detect episodic positive selection in the Hexapoda and Collembola lineages. A subset of 250 genes showed significant positive selection along the Hexapoda branch and 57 in the Collembola lineage. Gene Ontology categories enriched in these genes include metabolism, stress response (i.e. DNA repair, immune response), ion transport, ATP metabolism, regulation and development- related processes (i.e. eye development, neurological development). Conclusions We suggest that the identified gene families represent processes that have played a key role in the divergence of hexapods within the pancrustacean clade that eventually evolved into the most species-rich group of all animals, the hexapods. Furthermore, some adaptive signatures in collembolans may provide valuable clues to understand evolution of hexapods on land.	[Faddeeva, A.; Kraaijeveld, K.; Marien, J.; van Straalen, N. M.; Roelofs, D.] Vrije Univ Amsterdam, Dept Ecol Sci, Amsterdam, Netherlands; [Studer, R. A.] EMBL European Bioinformat Inst, Cambridge, England; [Sie, D.; Ylstra, B.] Vrije Univ Amsterdam Med Ctr, Microarray Facil, Amsterdam, Netherlands; [op den Camp, H. J. M.] Radboud Univ Nijmegen, Dept Microbiol, NL-6525 ED Nijmegen, Netherlands; [Datema, E.] Keygene NV, Wageningen, Netherlands; [den Dunnen, J. T.] Leiden Univ, Med Ctr, Leiden Genome Technol Ctr, Human & Clin Genet, Leiden, Netherlands	Vrije Universiteit Amsterdam; European Molecular Biology Laboratory (EMBL); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Radboud University Nijmegen; Keygene N.V.; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Faddeeva, A (corresponding author), Vrije Univ Amsterdam, Dept Ecol Sci, Amsterdam, Netherlands.	ann.faddeeva@gmail.com	dunnen, johan den/ABH-4228-2020; Camp, Huub J.M. Op den/F-5114-2011; Ylstra, Bauke/D-2906-2012	dunnen, johan den/0000-0002-6304-1710; Camp, Huub J.M. Op den/0000-0003-1990-9030; Ylstra, Bauke/0000-0001-9479-3010; Marien, Janine/0000-0001-7600-5594; Roelofs, Dick/0000-0003-3954-3590; Studer, Romain A/0000-0003-0687-9848; Sie, Daoud/0000-0001-6762-2582	Dutch Biotechnology based Ecologically Balanced Sustainable Industrial Consortium (BE-BASIC) [F08.001.03]; European Union FP7 large scale intergration Project 'Sustainable Nanotechnologies (SUN)' [604305]; Keygene NV	Dutch Biotechnology based Ecologically Balanced Sustainable Industrial Consortium (BE-BASIC); European Union FP7 large scale intergration Project 'Sustainable Nanotechnologies (SUN)'; Keygene NV(Keygene N.V.)	This research was supported by a grant from the Dutch Biotechnology based Ecologically Balanced Sustainable Industrial Consortium (BE-BASIC), grant number F08.001.03, http://www.bebasic.org. In addition, D. Roelofs is supported by the European Union FP7 large scale intergration Project 'Sustainable Nanotechnologies (SUN)', Grant number 604305. Keygene NV provided support in the form of salaries for E. Datema, but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	1KITE Consortium, 1KITE 1K INS TRANSCR; Alexa A, 2006, TOPGO ENV ANAL GENE; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews S, FASTQC QUALITY CONTR; [Anonymous], 2012, UNIVEC UNIVEC CORE D; [Anonymous], 2013, UPDATED GENE OMES MR; Areal H, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-368; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Cook CE, 2005, P ROY SOC B-BIOL SCI, V272, P1295, DOI 10.1098/rspb.2004.3042; D'Haese CA, 2002, P ROY SOC B-BIOL SCI, V269, P1143, DOI 10.1098/rspb.2002.1981; Dabney A., QVALUE Q VALUE ESTIM; Dell'Ampio E, 2014, MOL BIOL EVOL, V31, P239, DOI 10.1093/molbev/mst196; EISENBEIS G, 1982, J INSECT PHYSIOL, V28, P11, DOI 10.1016/0022-1910(82)90017-8; Engel MS, 2004, NATURE, V427, P627, DOI 10.1038/nature02291; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Forster F, 2012, BIOINFORM BIOL INSIG, V6, P69, DOI 10.4137/BBI.S9150; Fountain MT, 2005, ANNU REV ENTOMOL, V50, P201, DOI 10.1146/annurev.ento.50.071803.130331; Franc NC, 1996, IMMUNITY, V4, P431, DOI 10.1016/S1074-7613(00)80410-0; Ge RL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2860; Gharib WH, 2013, MOL BIOL EVOL, V30, P1675, DOI 10.1093/molbev/mst062; Gibson AK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-135; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Holloway AK, 2007, PLOS GENET, V3, P2007, DOI 10.1371/journal.pgen.0030187; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Konopova B, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-2; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Marquis O, 2009, AQUAT TOXICOL, V95, P152, DOI 10.1016/j.aquatox.2009.09.001; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW677, DOI 10.1093/nar/gki394; Misof B, 2014, SCIENCE, V346, P763, DOI 10.1126/science.1257570; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Montoya-Burgos JI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024800; Nickerl J, 2013, ZOOMORPHOLOGY, V132, P183, DOI 10.1007/s00435-012-0181-0; Nota B, 2008, ENVIRON SCI TECHNOL, V42, P8152, DOI 10.1021/es801472r; Nota B, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-236; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oakley TH, 2013, MOL BIOL EVOL, V30, P215, DOI 10.1093/molbev/mss216; Oliver TA, 2010, GENOME BIOL EVOL, V2, P800, DOI 10.1093/gbe/evq063; Ometto L, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-7; Organisation for Economic Co-operation and Development OECD, 2009, TEST 232 COLL REPR T; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; PONGE JF, 1991, GEODERMA, V49, P33, DOI 10.1016/0016-7061(91)90090-G; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Pruitt K, 2013, NCBI HDB; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Rands CM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-95; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Rehm P, 2011, MOL PHYLOGENET EVOL, V61, P880, DOI 10.1016/j.ympev.2011.09.003; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Roelofs D, 2007, INSECT BIOCHEM MOLEC, V37, P287, DOI 10.1016/j.ibmb.2006.11.013; Roelofs D, 2013, MOL BIOL EVOL, V30, P541, DOI 10.1093/molbev/mss269; Roelofs D, 2009, MOL ECOL, V18, P3227, DOI 10.1111/j.1365-294X.2009.04261.x; Rota-Stabelli O, 2013, CURR BIOL, V23, P392, DOI 10.1016/j.cub.2013.01.026; Sanchez-Gracia A, 2009, HEREDITY, V103, P208, DOI 10.1038/hdy.2009.55; Savard J, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-7; Schauvliege R, 2007, J CELL MOL MED, V11, P453, DOI 10.1111/j.1582-4934.2007.00040.x; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Simola DF, 2013, GENOME RES, V23, P1235, DOI 10.1101/gr.155408.113; Studer RA, 2008, GENOME RES, V18, P1393, DOI 10.1101/gr.076992.108; Studer RA, 2011, PHYSIOL GENOMICS, V43, P844, DOI 10.1152/physiolgenomics.00002.2011; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Sweder K., 2002, Journal of Biomedicine & Biotechnology, V2, P94, DOI 10.1155/S1110724302205033; Tautz D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/nrg3053; The International Organization for Standardization (ISO), 1999, GUID 11267 SOIL QUAL; Timmermans MJTN, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-83; Timmermans MJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-341; Van Straalen N.M., 2011, INTRO ECOLOGICAL GEN; VERHOEF HA, 1983, PEDOBIOLOGIA, V25, P3; von Reumont BM, 2012, MOL BIOL EVOL, V29, P1031, DOI 10.1093/molbev/msr270; Wissler L, 2013, GENOME BIOL EVOL, V5, P439, DOI 10.1093/gbe/evt009; Wissler L, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-8; Yamada T, 2011, NUCLEIC ACIDS RES, V39, pW412, DOI 10.1093/nar/gkr313; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yang ZH, 2011, MOL BIOL EVOL, V28, P1217, DOI 10.1093/molbev/msq303; Yang ZH, 2009, P NATL ACAD SCI USA, V106, pE95, DOI 10.1073/pnas.0904550106; Yim HS, 2014, NAT GENET, V46, P88, DOI 10.1038/ng.2835; Zakon HH, 2006, P NATL ACAD SCI USA, V103, P3675, DOI 10.1073/pnas.0600160103; Zhang JZ, 2006, NAT GENET, V38, P819, DOI 10.1038/ng1812; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhou Q, 2008, GENOME RES, V18, P1446, DOI 10.1101/gr.076588.108; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031; Zhulidov PA, 2005, RUSS J BIOORG CHEM+, V31, P170, DOI 10.1007/s11171-005-0023-7	96	19	19	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130600	10.1371/journal.pone.0130600	http://dx.doi.org/10.1371/journal.pone.0130600			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075903	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900183
J	Qu, JL; Qu, XJ; Li, Z; Zhang, JD; Liu, J; Teng, YE; Jin, B; Zhao, MF; Yu, P; Shi, J; Fu, LY; Wang, ZN; Liu, YP				Qu, Jing-lei; Qu, Xiu-juan; Li, Zhi; Zhang, Jing-dong; Liu, Jing; Teng, Yue-e; Jin, Bo; Zhao, Ming-fang; Yu, Ping; Shi, Jing; Fu, Ling-yu; Wang, Zhen-ning; Liu, Yun-peng			Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric Cancer	PLOS ONE			English	Article							PREOPERATIVE NEUTROPHIL-LYMPHOCYTE; LONG-TERM OUTCOMES; STAGE; CHEMOTHERAPY; RESECTION; RATIO; RECURRENCE; SURGERY; TRIAL; INDEX	Prognostic models are generally used to predict gastric cancer outcomes. However, no model combining patient-, tumor- and host-related factors has been established to predict outcomes after radical gastrectomy, especially outcomes of patients without nodal involvement. The aim of this study was to develop a prognostic model based on the systemic inflammatory response and clinicopathological factors of resectable gastric cancer and determine whether the model can improve prognostic accuracy in node-negative patients. We reviewed the clinical, laboratory, histopathological and survival data of 1397 patients who underwent radical gastrectomy between 2007 and 2013. Patients were split into development and validation sets of 1123 and 274 patients, respectively. Among all 1397 patients, 545 had node-negative gastric cancer; 440 were included in the development set, 105 were included in the validation set. A prognostic model was constructed from the development set. The scoring system was based on hazard ratios in a Cox proportional hazard model. In the multivariate analysis, age, tumor size, Lauren type, depth of invasion, lymph node metastasis, and the neutrophil-lymphocyte ratio were independent prognostic indicators of overall survival. A prognostic model was then established based on the significant factors. Patients were categorized into five groups according to their scores. The 3-year survival rates for the low-to high-risk groups were 98.9%, 92.8%, 82.4%, 58.4%, and 36.9%, respectively (P < 0.001). The prognostic model clearly discriminated patients with stage pT1-4N0M0 tumor into four risk groups with significant differences in the 3-year survival rates (P < 0.001). Compared with the pathological T stage, the model improved the predictive accuracy of the 3-year survival rate by 5% for node-negative patients. The prognostic scores also stratified the patients with stage pT4aN0M0 tumor into significantly different risk groups (P = 0.004). Furthermore, the predictive value of this model was validated in an independent set of 274 patients. This model, which included the systemic inflammatory markers and clinicopathological factors, is more effective in predicting the prognosis of node-negative gastric cancer than traditional staging systems. Patients in the high-risk group might be good candidates for adjuvant chemotherapy.	[Qu, Jing-lei; Qu, Xiu-juan; Li, Zhi; Zhang, Jing-dong; Liu, Jing; Teng, Yue-e; Jin, Bo; Zhao, Ming-fang; Yu, Ping; Shi, Jing; Liu, Yun-peng] China Med Univ, Hosp 1, Dept Med Oncol, Shenyang 110001, Liaoning, Peoples R China; [Fu, Ling-yu] China Med Univ, Hosp 1, Dept Clin Epidemiol & Evidence Based Med, Shenyang 110001, Liaoning, Peoples R China; [Wang, Zhen-ning] China Med Univ, Hosp 1, Dept Surg Oncol, Shenyang 110001, Liaoning, Peoples R China	China Medical University; China Medical University; China Medical University	Qu, JL (corresponding author), China Med Univ, Hosp 1, Dept Med Oncol, Shenyang 110001, Liaoning, Peoples R China.	qujinglei@hotmail.com; qu_xiujuan@hotmail.com; cmuliuyunpeng@hotmail.com	Gao, Peng/B-8031-2013; wang, zhen ning/E-1878-2011; Zhang, Jing/GWZ-7332-2022; Li, Zhi/ABE-5902-2022	wang, zhen ning/0000-0003-0557-3097; Li, Zhi/0000-0002-6437-0348	National Natural Science Foundation of China [81372547, 81372485, 81172369]; National Science and Technology Major Project of the Ministry of Science and Technology of China [2013ZX09303002]; Science and Technology Plan Project of Liaoning Province [2014225013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of the Ministry of Science and Technology of China; Science and Technology Plan Project of Liaoning Province	This study was supported by the National Natural Science Foundation of China (No. 81372547, No. 81372485, No. 81172369), National Science and Technology Major Project of the Ministry of Science and Technology of China (No. 2013ZX09303002), and Science and Technology Plan Project of Liaoning Province (No. 2014225013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Bentrem D, 2007, ANN SURG ONCOL, V14, P1853, DOI 10.1245/s10434-006-9037-5; Chou HH, 2013, AM J SURG, V205, P623, DOI 10.1016/j.amjsurg.2012.04.014; Costa MLV, 2006, ANN SURG ONCOL, V13, P843, DOI 10.1245/ASO.2006.05.040; Di Maio M, 2010, EUR J CANCER, V46, P735, DOI 10.1016/j.ejca.2009.12.013; Diaz-Nieto R, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008415.pub2; Du CY, 2011, J GASTROINTEST SURG, V15, P2153, DOI 10.1007/s11605-011-1684-6; Edge SB, 2009, AM JOINT COMMITTEE C, DOI [10.1245/s10434-009-0530-5, DOI 10.1245/S10434-009-0530-5]; Jeong JY, 2012, J GASTRIC CANCER, V12, P210, DOI 10.5230/jgc.2012.12.4.210; Jiang N, 2014, BIOMARKERS, V19, P444, DOI 10.3109/1354750X.2014.926567; Jiang X, 2012, BRIT J CANCER, V107, P275, DOI 10.1038/bjc.2012.262; Kanagavel D, 2010, ANN ONCOL, V21, P1779, DOI 10.1093/annonc/mdq032; Koo DH, 2011, CANCER CHEMOTH PHARM, V68, P913, DOI 10.1007/s00280-011-1561-8; Lee JH, 2015, WORLD J SURG, V39, P732, DOI 10.1007/s00268-014-2846-y; Li XB, 2014, HEPATO-GASTROENTEROL, V61, P535, DOI 10.5754/hge13684; Marrelli D, 2005, ANN SURG, V241, P247, DOI 10.1097/01.sla.0000152019.14741.97; Migita K, 2013, ANN SURG ONCOL, V20, P2647, DOI 10.1245/s10434-013-2926-5; Mohri Y, 2010, WORLD J SURG, V34, P285, DOI 10.1007/s00268-009-0302-1; Paramanathan A, 2014, SURG ONCOL, V23, P31, DOI 10.1016/j.suronc.2013.12.001; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Shimada H, 2010, GASTRIC CANCER, V13, P170, DOI 10.1007/s10120-010-0554-3; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Solal-Celigny P, 2004, BLOOD, V104, P1258, DOI 10.1182/blood-2003-12-4434; Wang DS, 2012, TUMOR BIOL, V33, P749, DOI 10.1007/s13277-011-0285-z; Xu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101061; Yamashita H, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-147	26	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128540	10.1371/journal.pone.0128540	http://dx.doi.org/10.1371/journal.pone.0128540			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075713	Green Published, Green Submitted, gold			2022-12-26	WOS:000356329900020
J	Zhang, B; Liang, L; Chen, WB; Liang, CH; Zhang, SX				Zhang, Bin; Liang, Long; Chen, Wenbo; Liang, Changhong; Zhang, Shuixing			An Updated Study to Determine Association between Gadolinium-Based Contrast Agents and Nephrogenic Systemic Fibrosis	PLOS ONE			English	Article							RESONANCE-IMAGING CONTRAST; RENAL-FAILURE; CASE SERIES; DISEASE; RISK; GADODIAMIDE; MRI; PREVALENCE; EXPOSURE; DIALYSIS	Background Nephrogenic systemic fibrosis (NSF) is a rare but serious disorder disease affecting patients with advanced renal disease. Although multiple studies have indicated an association between gadolinium-based contrast agents (GBCAs) and NSF, some studies published after 2007 found no association. We therefore performed a meta-analysis to evaluate the association and analyze related (co) factors. Methods Studies for analysis were identified by searching PubMed, Embase, and the Cochrane Central Register of Controlled Trials through December 2014. Pooled odds ratios (OR) with 95% confidence intervals (CI) were calculated using the fixed-effects model. Statistical heterogeneity was assessed by Q statistics and the I-2 test. Publication bias was evaluated using Begg's test, Egger's test, funnel plot, and classic fail-safe N. Study quality was assessed using the Newcastle-Ottawa Scale. We also conducted sensitivity analyses, subgroup analyses and a cumulative meta-analysis. All statistical analyses were performed using Comprehensive Meta-Analysis 2.0. Results A total of 14 studies (6,398 patients) met the inclusion criteria, but 3 were excluded since they reported no NSF events. Meta-analysis of controlled trials indicated a significant association between GBCAs and NSF development (OR = 16.504; 95% CI: 7.455-36.533; P < 0.001) and between gadodiamide and NSF (OR = 20.037; 95% CI: 3.725-107.784; P < 0.001). No statistical heterogeneity was observed across studies (P = 0.819, I-2 = 0%; P = 0.874, I-2 = 0%, respectively). Cumulative analysis demonstrated that the pooled ORs for association between GBCAs and NSF decreased post-2007 compared to pre-2007 (OR = 26.708; 95% CI: 10.273-69.436; P<0.001). Conclusions Although this updated meta-analysis found a significant association between GBCAs and the incidence of NSF in patients with advanced renal disease, the association decreased after 2007. More studies, especially randomized controlled trials, are warranted to examine the potential association between GBCAs other than gadodiamide and NSF.	[Zhang, Bin; Liang, Long; Chen, Wenbo; Liang, Changhong; Zhang, Shuixing] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Radiol, Guangzhou, Guangdong, Peoples R China; [Zhang, Bin; Liang, Long] Southern Med Univ, Grad Coll, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Southern Medical University - China	Zhang, SX (corresponding author), Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Radiol, Guangzhou, Guangdong, Peoples R China.	shui7515@hotmail.com	Zhang, Bin/AAH-4560-2019; Zhang, Bin/M-3689-2014; Liang, Chang Hong/L-1885-2016	Zhang, Bin/0000-0002-6286-6227; Zhang, Bin/0000-0001-7313-9300; 	National Scientific Foundation of China [81171329]; Guangdong Science Foundation [S2011010000790]	National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Science Foundation	This study was supported by grants from National Scientific Foundation of China (No: 81171329) and Guangdong Science Foundation (No: S2011010000790). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abujudeh HH, 2009, RADIOLOGY, V253, P81, DOI 10.1148/radiol.2531082160; Agarwal R, 2009, NEPHROL DIAL TRANSPL, V24, P856, DOI 10.1093/ndt/gfn593; Altman DG, 2001, SYSTEMATIC REV HLTH; Amet S, 2014, INVEST RADIOL, V49, P109, DOI 10.1097/RLI.0000000000000000; Becker S, 2012, NEPHRON CLIN PRACT, V121, pC91, DOI 10.1159/000345150; Besheli LD, 2014, CLIN RADIOL, V69, P661, DOI 10.1016/j.crad.2014.01.003; Bhave G, 2008, J UROLOGY, V180, P830, DOI 10.1016/j.juro.2008.05.005; Broome DR, 2008, EUR J RADIOL, V66, P230, DOI 10.1016/j.ejrad.2008.02.011; Broome DR, 2007, AM J ROENTGENOL, V188, P586, DOI 10.2214/AJR.06.1094; Caccetta T, 2008, AUSTRALAS J DERMATOL, V49, P48, DOI 10.1111/j.1440-0960.2007.00426.x; Chao CC, 2008, J FORMOS MED ASSOC, V107, P270, DOI 10.1016/S0929-6646(08)60147-3; Cheng S., 2007, Morbidity and Mortality Weekly Report, V56, P137; Collidge TA, 2007, RADIOLOGY, V245, P168, DOI 10.1148/radiol.2451070353; de Campos ROP, 2011, AM J ROENTGENOL, V196, P545, DOI 10.2214/AJR.10.4500; Deo A, 2007, CLIN J AM SOC NEPHRO, V2, P264, DOI 10.2215/CJN.03921106; Deray G, 2013, EUR RADIOL, V23, P1250, DOI 10.1007/s00330-012-2705-x; Edward M, 2010, RADIOLOGY, V256, P735, DOI 10.1148/radiol.10091131; Elmholdt TR, 2011, BRIT J DERMATOL, V165, P828, DOI 10.1111/j.1365-2133.2011.10465.x; Grebe SO, 2008, CLIN EXP NEPHROL, V12, P403, DOI 10.1007/s10157-008-0063-4; Grobner T, 2008, SEMIN DIALYSIS, V21, P135, DOI 10.1111/j.1525-139X.2007.00406.x; Heinz-Peer G, 2010, EUR J RADIOL, V76, P129, DOI 10.1016/j.ejrad.2009.06.028; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; High WA, 2007, J AM ACAD DERMATOL, V56, P21, DOI 10.1016/j.jaad.2006.10.047; Hoppe H, 2010, EUR RADIOL, V20, P595, DOI 10.1007/s00330-009-1586-0; Introcaso CE, 2007, INT J DERMATOL, V46, P447, DOI 10.1111/j.1365-4632.2007.03301.x; Ishiguchi Tsuneo, 2010, Drugs R D, V10, P133, DOI 10.2165/11539140-000000000-00000; Janus N, 2010, EUR J RADIOL, V73, P357, DOI 10.1016/j.ejrad.2008.11.021; Kallen A, 2008, AM J KIDNEY DIS, V51, P966, DOI 10.1053/j.ajkd.2007.12.036; Kielstein JT, 2010, INTERNIST, V51, P39, DOI 10.1007/s00108-009-2408-9; Kim KH, 2010, AM J KIDNEY DIS, V56, P458, DOI 10.1053/j.ajkd.2010.03.027; Kitajima K, 2012, INT J UROL, V19, P806, DOI 10.1111/j.1442-2042.2012.03042.x; Marckmann P, 2006, J AM SOC NEPHROL, V17, P2359, DOI 10.1681/ASN.2006060601; Martin DR, 2010, J MAGN RESON IMAGING, V31, P440, DOI 10.1002/jmri.22024; Moher David, 2009, Open Med, V3, pe123; Moreno-Romero JA, 2007, BRIT J DERMATOL, V157, P783, DOI 10.1111/j.1365-2133.2007.08067.x; Nacif MS, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-18; Ng YY, 2007, AM J ROENTGENOL, V188, pW582, DOI 10.2214/AJR.07.0047; OConnell D, 2019, NEWCASTLE OTTAWA SCA; Othersen JB, 2007, NEPHROL DIAL TRANSPL, V22, P3179, DOI 10.1093/ndt/gfm584; Penfield JG, 2008, SEMIN DIALYSIS, V21, P129, DOI 10.1111/j.1525-139X.2007.00408.x; Reiter T, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-31; Rydahl C, 2008, INVEST RADIOL, V43, P141, DOI 10.1097/RLI.0b013e31815a3407; Todd DJ, 2007, ARTHRITIS RHEUM, V56, P3433, DOI 10.1002/art.22925; Wang YB, 2011, RADIOLOGY, V260, P105, DOI 10.1148/radiol.11102340; Wiginton CD, 2008, AM J ROENTGENOL, V190, P1060, DOI 10.2214/AJR.07.2822; Yang L, 2012, RADIOLOGY, V265, P248, DOI 10.1148/radiol.12112783; Zou ZT, 2011, JACC-CARDIOVASC IMAG, V4, P1206, DOI 10.1016/j.jcmg.2011.08.013; Zou ZT, 2009, J MAGN RESON IMAGING, V30, P1309, DOI 10.1002/jmri.21769	48	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129720	10.1371/journal.pone.0129720	http://dx.doi.org/10.1371/journal.pone.0129720			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076348	Green Published, Green Submitted, gold			2022-12-26	WOS:000356329900096
J	Endo, T; Hayasaka, M; Ogasawra, H; Kimura, O; Kotaki, Y; Haraguchi, K				Endo, Tetsuya; Hayasaka, Moriaki; Ogasawra, Hideki; Kimura, Osamu; Kotaki, Yuichi; Haraguchi, Koichi			Relationships among Mercury Concentration, and Stable Isotope Ratios of Carbon and Nitrogen in the Scalp Hair of Residents from Seven Countries: Effects of Marine Fish and C4 Plants Consumption	PLOS ONE			English	Article							FOOD-WEB; TROPHIC RELATIONSHIPS; DIET; DELTA-N-15; JAPANESE; BIOMAGNIFICATION; POPULATIONS; COMMUNITY; WHALES; N-15	We analyzed the Hg concentration, and delta C-13 and delta N-15 values in the scalp hair of residents from seven countries; Vietnam, New Zealand, Spain, the USA, South Korea, Brazil and Japan. Relationships among the data in each country and among the seven countries were then examined. The highest Hg concentration as well as the highest or higher delta N-15 value in each country was found in the hair of a heavy marine fish-eater, whereas the lowest Hg concentration and delta N-15 value were found in the hair of a vegetarian or non (marginal)-fish eater. Hg concentrations were positively correlated with the delta N-15 values in each country, and increased markedly in samples with delta N-15 values exceeding 9.0%, probably due to fish consumption. The highest Hg concentration could be found in sample, with a delta C-13 value between -19 and -18%, probably reflecting the delta C-13 value of the marine food web.	[Endo, Tetsuya; Kimura, Osamu] Hlth Sci Univ Hokkaido, Sch Pharmaceut Sci, Ishikari, Hokkaido 0610293, Japan; [Hayasaka, Moriaki] Sapporo Higashi Tokusyukai Hosp, Higashi Ku, Sapporo, Hokkaido 0650033, Japan; [Kotaki, Yuichi] Kitasato Univ, Sch Marine Biosci, Sagamihara, Kanagawa 2520373, Japan; [Haraguchi, Koichi] Daiichi Coll Pharmaceut Sci, Minami Ku, Fukuoka 8158511, Japan	Health Sciences University of Hokkaido; Kitasato University	Endo, T (corresponding author), Hlth Sci Univ Hokkaido, Sch Pharmaceut Sci, 1757 Kanazawa, Ishikari, Hokkaido 0610293, Japan.	endotty@hoku-iryo-u.ac.jp		Endo, Tetsuya/0000-0003-4278-5689	Japan Society for the Promotion of Science [24614012, 24310049]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partially supported by a Grant-in-Aid for Scientific Research (C) (No. 24614012 O. K.) and a Grant-in-Aid for Scientific Research (B) (No. 24310049 K. H.) from Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Majed NB, 2000, ENVIRON POLLUT, V109, P239, DOI 10.1016/S0269-7491(99)00261-4; Barbosa AC, 2001, ARCH ENVIRON CON TOX, V40, P439, DOI 10.1007/s002440010195; Bisi TL, 2012, ECOL INDIC, V18, P291, DOI 10.1016/j.ecolind.2011.11.015; Bol R, 2002, RAPID COMMUN MASS SP, V16, P2195, DOI 10.1002/rcm.706; Buchardt B, 2007, CHEM GEOL, V244, P316, DOI 10.1016/j.chemgeo.2007.06.022; Campbell LM, 2005, SCI TOTAL ENVIRON, V351, P247, DOI 10.1016/j.scitotenv.2005.02.043; Chen CY, 2009, ENVIRON SCI TECHNOL, V43, P1804, DOI 10.1021/es8017122; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Diez S, 2008, ENVIRON INT, V34, P162, DOI 10.1016/j.envint.2007.07.015; Elhamri H, 2007, FOOD ADDIT CONTAM A, V24, P1236, DOI 10.1080/02652030701329611; Endo T, 2002, SCI TOTAL ENVIRON, V300, P15, DOI 10.1016/S0048-9697(02)00137-7; Endo T, 2013, MAR POLLUT BULL, V69, P116, DOI 10.1016/j.marpolbul.2013.01.018; Endo T, 2012, ECOTOX ENVIRON SAFE, V79, P35, DOI 10.1016/j.ecoenv.2012.01.020; Endo T, 2010, MAR POLLUT BULL, V60, P743, DOI 10.1016/j.marpolbul.2009.11.020; Endo T, 2010, ENVIRON SCI TECHNOL, V44, P2675, DOI 10.1021/es903534r; Freire C, 2010, ENVIRON RES, V110, P96, DOI 10.1016/j.envres.2009.10.005; Harmelin-Vivien M, 2012, MAR POLLUT BULL, V64, P974, DOI 10.1016/j.marpolbul.2012.02.014; Hisamichi Y, 2010, ENVIRON SCI TECHNOL, V44, P5971, DOI 10.1021/es1008856; HOBSON KA, 1992, MAR ECOL PROG SER, V84, P9, DOI 10.3354/meps084009; Hong SR, 2009, NUTR RES PRACT, V3, P212, DOI 10.4162/nrp.2009.3.3.212; Huelsemann F, 2009, RAPID COMMUN MASS SP, V23, P2448, DOI 10.1002/rcm.4039; JECFA, 2003, 61 M JOINT FAO WHO E; Karimi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074695; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Kim SA, 2008, SCI TOTAL ENVIRON, V402, P36, DOI 10.1016/j.scitotenv.2008.04.010; Lee WC, 2000, ENVIRON TOXICOL PHAR, V8, P275, DOI 10.1016/S1382-6689(00)00044-2; Macko SA, 1999, PHILOS T ROY SOC B, V354, P65, DOI 10.1098/rstb.1999.0360; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Mutzel E, 2009, INT J LEGAL MED, V123, P35, DOI 10.1007/s00414-008-0286-7; Nardoto GB, 2006, AM J PHYS ANTHROPOL, V131, P137, DOI 10.1002/ajpa.20409; O'Connell TC, 2001, J ARCHAEOL SCI, V28, P1247, DOI 10.1006/jasc.2001.0698; O'Connell TC, 1999, AM J PHYS ANTHROPOL, V108, P409, DOI 10.1002/(SICI)1096-8644(199904)108:4&lt;409::AID-AJPA3&gt;3.0.CO;2-E; Park S, 2006, NUTR REV, V64, P250, DOI 10.1301/nr.2006.may.250-256; Petzke KJ, 2010, CURR OPIN CLIN NUTR, V13, P532, DOI 10.1097/MCO.0b013e32833c3c84; Tayasu I, 2011, LIMNOLOGY, V12, P261, DOI 10.1007/s10201-011-0345-5; Thompson AH, 2010, AM J PHYS ANTHROPOL, V141, P440, DOI 10.1002/ajpa.21162; Tokui Noritaka, 2000, Journal of UOEH, V22, P219; Valenzuela LO, 2011, RAPID COMMUN MASS SP, V25, P861, DOI 10.1002/rcm.4934; Walker JL, 1999, MAR MAMMAL SCI, V15, P335, DOI 10.1111/j.1748-7692.1999.tb00805.x; Weihe Pal, 2002, Int J Circumpolar Health, V61, P41; WHO, 1990, INT PROGR CHEM SAF E; Xiao HY, 2010, ENVIRON POLLUT, V158, P1726, DOI 10.1016/j.envpol.2009.11.016; YAMAGUCHI S, 1975, AM J PUBLIC HEALTH, V65, P484, DOI 10.2105/AJPH.65.5.484; Yasutake A, 2004, J HEALTH SCI, V50, P120; Yasutake A, 2003, TOHOKU J EXP MED, V199, P161, DOI 10.1620/tjem.199.161; Yoshinaga J, 1996, AM J PHYS ANTHROPOL, V100, P23	47	10	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128149	10.1371/journal.pone.0128149	http://dx.doi.org/10.1371/journal.pone.0128149			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26065892	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000015
J	Huh, Y; Cho, J				Huh, Yeowool; Cho, Jeiwon			Changes in Activity of the Same Thalamic Neurons to Repeated Nociception in Behaving Mice	PLOS ONE			English	Article							SPINAL-CORD-INJURY; ECCENTRIC EXERCISE; THALAMOCORTICAL DYSRHYTHMIA; REPEATED BOUTS; MUSCLE DAMAGE; FORMALIN TEST; CENTRAL PAIN; STIMULATION; RAT; INHIBITION	The sensory thalamus has been reported to play a key role in central pain sensory modulation and processing, but its response to repeated nociception at thalamic level is not well known. Current study investigated thalamic response to repeated nociception by recording and comparing the activity of the same thalamic neuron during the 1st and 2nd formalin injection induced nociception, with a week interval between injections, in awake and behaving mice. Behaviorally, the 2nd injection induced greater nociceptive responses than the 1st. Thalamic activity mirrored these behavioral changes with greater firing rate during the 2nd injection. Analysis of tonic and burst firing, characteristic firing pattern of thalamic neurons, revealed that tonic firing activity was potentiated while burst firing activity was not significantly changed by the 2nd injection relative to the 1st. Likewise, burst firing property changes, which has been consistently associated with different phases of nociception, were not induced by the 2nd injection. Overall, data suggest that repeated nociception potentiated responsiveness of thalamic neurons and confirmed that tonic firing transmits nociceptive signals.	[Huh, Yeowool; Cho, Jeiwon] Korea Inst Sci & Technol, Ctr Neural Sci, Seoul, South Korea; [Cho, Jeiwon] Univ Sci & Technol, Neurosci, Taejon, South Korea	Korea Institute of Science & Technology (KIST)	Cho, J (corresponding author), Korea Inst Sci & Technol, Ctr Neural Sci, L7313 Hawolgok Dong, Seoul, South Korea.	jeiwon@kist.re.kr			National Research Foundation of Korea (NRF) - Korean government (MSIP) [2012R1A2A2A02011838]; Korea Institute of Science and Technology Intramural Fund [2E25210]	National Research Foundation of Korea (NRF) - Korean government (MSIP); Korea Institute of Science and Technology Intramural Fund	This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (No. 2012R1A2A2A02011838) and Korea Institute of Science and Technology Intramural Fund (2E25210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Burstein R, 2010, ANN NEUROL, V68, P81, DOI 10.1002/ana.21994; Dessem D, 2011, PAIN RES TREAT, V2011, DOI 10.1155/2011/647967; Dostrovsky J O, 2000, Prog Brain Res, V129, P245; DOSTROVSKY JO, 1990, PAIN, V40, P93, DOI 10.1016/0304-3959(90)91056-O; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; Fuggetta G, 2013, EXP NEUROL, V245, P87, DOI 10.1016/j.expneurol.2012.10.010; Gerke MB, 2003, NEUROSCIENCE, V117, P715, DOI 10.1016/S0306-4522(02)00961-2; GUILBAUD G, 1980, PAIN, V8, P303, DOI 10.1016/0304-3959(80)90076-7; Hains BC, 2006, J NEUROPHYSIOL, V95, P3343, DOI 10.1152/jn.01009.2005; Henry JL, 1999, PAIN, V82, P57, DOI 10.1016/S0304-3959(99)00033-0; HIRAYAMA T, 1989, STEREOT FUNCT NEUROS, V52, P120, DOI 10.1159/000099492; Huh Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067655; Huh Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030699; Jones E.G., 2007, THALAMUS, VVolume 1, P575; Jones EG, 2010, PAIN, V150, P4, DOI 10.1016/j.pain.2010.03.022; Kolhekar R, 1997, PAIN, V71, P31, DOI 10.1016/S0304-3959(97)03334-4; Le Bars D, 2001, PHARMACOL REV, V53, P597; Lee JI, 2005, J NEUROPHYSIOL, V94, P1676, DOI 10.1152/jn.00343.2005; LENZ FA, 1995, NAT MED, V1, P910, DOI 10.1038/nm0995-910; LENZ FA, 1991, ADV PAIN RES THER, V19, P141; LENZ FA, 1989, BRAIN RES, V496, P357, DOI 10.1016/0006-8993(89)91088-3; Li K, 2010, J PAIN, V11, P1056, DOI 10.1016/j.jpain.2010.01.268; Light, 2010, TRANSLATIONAL PAIN R; LIVINGSTONE MS, 1981, NATURE, V291, P554, DOI 10.1038/291554a0; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; LU SM, 1992, J NEUROPHYSIOL, V68, P2185, DOI 10.1152/jn.1992.68.6.2185; MAFFEI L, 1965, SCIENCE, V149, P563, DOI 10.1126/science.149.3683.563; MCCORMICK DA, 1990, NEUROSCIENCE, V39, P103, DOI 10.1016/0306-4522(90)90225-S; McHugh MP, 2003, SCAND J MED SCI SPOR, V13, P88, DOI 10.1034/j.1600-0838.2003.02477.x; NOSAKA K, 1995, MED SCI SPORT EXER, V27, P1263; PESCHANSKI M, 1980, BRAIN RES, V197, P401, DOI 10.1016/0006-8993(80)91125-7; Pizza FX, 1996, J APPL PHYSIOL, V80, P47, DOI 10.1152/jappl.1996.80.1.47; Radhakrishnan V, 1999, PAIN, V80, P567, DOI 10.1016/S0304-3959(98)00248-6; Rengachary J, 2011, FRONT HUM NEUROSCI, V5, DOI [10.3389/fnhum.2011.00029, 10.3389/fnhum.2011.00069]; SACCO P, 1992, EXP PHYSIOL, V77, P757, DOI 10.1113/expphysiol.1992.sp003642; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588	38	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129395	10.1371/journal.pone.0129395	http://dx.doi.org/10.1371/journal.pone.0129395			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070157	Green Submitted, gold, Green Published			2022-12-26	WOS:000356327000072
J	Nussbaumer-Ochsner, Y; Stolk, J; da Silva, LFF; van Schadewijk, A; de Jeu, RC; Prins, FA; Mauad, T; Rabe, KF; Hiemstra, PS				Nussbaumer-Ochsner, Yvonne; Stolk, Jan; Ferraz da Silva, Luiz F.; van Schadewijk, Annemarie; de Jeu, Ronald C.; Prins, Frans A.; Mauad, Thais; Rabe, Klaus F.; Hiemstra, Pieter S.			Association of Lung Inflammatory Cells with Small Airways Function and Exhaled Breath Markers in Smokers - Is There a Specific Role for Mast Cells?	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; COPD; EXPRESSION; ASTHMA; IL-17A; AIR; STANDARDIZATION; VOLUMES; TISSUE; TRIAL	Background Smoking is associated with a mixed inflammatory infiltrate in the airways. We evaluated whether airway inflammation in smokers is related to lung function parameters and inflammatory markers in exhaled breath. Methods Thirty-seven smokers undergoing lung resection for primary lung cancer were assessed pre-operatively by lung function testing including single-breath-nitrogen washout test (sb-N2- test), measurement of fractional exhaled nitric oxide (FeNO) and pH/8-isoprostane in exhaled breath condensate (EBC). Lung tissue sections containing cancer-free large (LA) and small airways (SA) were stained for inflammatory cells. Mucosal (MCT) respectively connective tissue mast cells (MCTC) and interleukin-17A (IL-17A) expression by mast cells was analysed using a double-staining protocol. Results The median number of neutrophils, macrophages and mast cells infiltrating the lamina propria and adventitia of SA was higher than in LA. Both MCTC and MCT were higher in the lamina propria of SA compared to LA (MCTC: 49 vs. 27.4 cells/mm(2); MCT: 162.5 vs. 35.4 cells/mm(2); P<0.005 for both instances). IL-17A expression was predominantly detected in MCTC of LA. Significant correlations were found for the slope of phase III % pred. of the sb-N2-test (r(s)=-0.39), for the FEV1% pred. (r(s)=0.37) and for FEV1/FVC ratio (r(s)=0.38) with MCT in SA (P<0.05 for all instances). 8-isoprostane concentration correlated with the mast cells in the SA (r(s)=0.44), there was no correlation for pH or FeNO with cellular distribution in SA. Conclusions Neutrophils, macrophages and mast cells are more prominent in the SA indicating that these cells are involved in the development of small airway dysfunction in smokers. Among these cell types, the best correlation was found for mast cells with lung function parameters and inflammatory markers in exhaled breath. Furthermore, the observed predominant expression of IL-17A in mast cells warrants further investigation to elucidate their role in smoking-induced lung injury, despite the lack of correlation with lung function and exhaled breath parameters.	[Nussbaumer-Ochsner, Yvonne; Stolk, Jan; van Schadewijk, Annemarie; de Jeu, Ronald C.; Rabe, Klaus F.; Hiemstra, Pieter S.] Leiden Univ, Med Ctr LUMC, Dept Pulmonol, Leiden, Netherlands; [Ferraz da Silva, Luiz F.; Mauad, Thais] Univ Sao Paulo, Sch Med, Dept Pathol, Sao Paulo, Brazil; [Prins, Frans A.] Leiden Univ, Dept Pathol, Med Ctr LUMC, Leiden, Netherlands; [Rabe, Klaus F.] Grosshansdorf Hosp, Ctr Pneumol & Thorac Surg, Grosshansdorf, Germany	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Universidade de Sao Paulo; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Grosshansdorf Hospital	Nussbaumer-Ochsner, Y (corresponding author), Leiden Univ, Med Ctr LUMC, Dept Pulmonol, Leiden, Netherlands.	yvonne.nussbaumer@hispeed.ch	/V-8478-2019; Hiemstra, Pieter S/K-8587-2018; Silva, Luiz/D-2760-2012; Rabe, Klaus F./AAW-6296-2021	Hiemstra, Pieter S/0000-0002-0238-5982; Silva, Luiz/0000-0002-0181-6357; Rabe, Klaus F./0000-0002-7020-1401	Swiss National Science Foundation [PBZHP3-131017]; CNP (Brazilian National Research Council)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); CNP (Brazilian National Research Council)	Yvonne Nussbaumer-Ochsner was funded by a grant from the Swiss National Science Foundation (PBZHP3-131017). Thais Mauad is funded by CNP (Brazilian National Research Council). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson CK, 2010, AM J RESP CRIT CARE, V181, P206, DOI 10.1164/rccm.200906-0932OC; Battaglia S, 2005, THORAX, V60, P639, DOI 10.1136/thx.2004.035279; Battaglia S, 2007, J CLIN PATHOL, V60, P907, DOI 10.1136/jcp.2006.037002; Borrill Zoe L, 2008, Int J Chron Obstruct Pulmon Dis, V3, P171; BUIST AS, 1973, AM REV RESPIR DIS, V107, P744; Chang Y, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0145-7; Chen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020333; COSIO M, 1978, NEW ENGL J MED, V298, P1277, DOI 10.1056/NEJM197806082982303; Doe C, 2010, CHEST, V138, P1140, DOI 10.1378/chest.09-3058; Ekberg-Jansson A, 2005, RESP MED, V99, P75, DOI 10.1016/j.rmed.2004.05.013; Eustace A, 2010, CHEST; Eustace A, 2011, CHEST, V139, P1089, DOI 10.1378/chest.10-0779; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2015, GLOB STRAT DIAGN MAN; Gosman MM, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-64; Grashoff WFH, 1997, AM J PATHOL, V151, P1785; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Inonu H, 2012, RESP CARE, V57, P413, DOI 10.4187/respcare.01302; IRANI AA, 1986, P NATL ACAD SCI USA, V83, P4464, DOI 10.1073/pnas.83.12.4464; Koczulla R, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-78; Lapperre TS, 2007, CHEST, V131, P53, DOI 10.1378/chest.06-0796; Lapperre TS, 2009, ANN INTERN MED, V151, P517, DOI 10.7326/0003-4819-151-8-200910200-00004; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Noordenbos T, 2012, ARTHRITIS RHEUM-US, V64, P99, DOI 10.1002/art.33396; Rahman Irfan, 2005, Treat Respir Med, V4, P175, DOI 10.2165/00151829-200504030-00003; Saetta M, 1999, AM J RESP CRIT CARE, V160, pS17, DOI 10.1164/ajrccm.160.supplement_1.6; Shaw DE, 2007, AM J RESP CRIT CARE, V176, P231, DOI 10.1164/rccm.200610-1427OC; Shen N, 2011, INHAL TOXICOL, V23, P212, DOI 10.3109/08958378.2011.559603; Suurmond J, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3466; van der Loos CM, 2008, J HISTOCHEM CYTOCHEM, V56, P313, DOI 10.1369/jhc.2007.950170; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Xiong WN, 2007, J HUAZHONG U SCI-MED, V27, P498, DOI 10.1007/s11596-007-0505-3; Zhang JQ, 2013, INT IMMUNOPHARMACOL, V15, P58, DOI 10.1016/j.intimp.2012.10.018; Zhang L, 2013, COPD, V10, P459, DOI 10.3109/15412555.2013.770456	34	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129426	10.1371/journal.pone.0129426	http://dx.doi.org/10.1371/journal.pone.0129426			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26069967	gold, Green Submitted, Green Published			2022-12-26	WOS:000356327000074
J	Scolforo, HF; Scolforo, JRS; Mello, CR; Mello, JM; Ferraz, AC				Scolforo, Henrique Ferraco; Soares Scolforo, Jose Roberto; Mello, Carlos Rogerio; Mello, Jose Marcio; Ferraz Filho, Antonio Carlos			Spatial Distribution of Aboveground Carbon Stock of the Arboreal Vegetation in Brazilian Biomes of Savanna, Atlantic Forest and Semi-Arid Woodland	PLOS ONE			English	Article							RAINFALL EROSIVITY; VARIABILITY; EQUATIONS; BIOMASS	The objective of this study was to map the spatial distribution of aboveground carbon stock (using Regression-kriging) of arboreal plants in the Atlantic Forest, Semi-arid woodland, and Savanna Biomes in Minas Gerais State, southeastern Brazil. The database used in this study was obtained from 163 forest fragments, totaling 4,146 plots of 1,000 m(2) distributed in these Biomes. A geographical model for carbon stock estimation was parameterized as a function of Biome, latitude and altitude. This model was applied over the samples and the residuals generated were mapped based on geostatistical procedures, selecting the exponential semivariogram theoretical model for conducting ordinary Kriging. The aboveground carbon stock was found to have a greater concentration in the north of the State, where the largest contingent of native vegetation is located, mainly the Savanna Biome, with Wooded Savanna and Shrub Savanna phytophysiognomes. The largest weighted averages of carbon stock per hectare were found in the south-center region (48.6 Mg/ha) and in the southern part of the eastern region (48.4 Mg/ha) of Minas Gerais State, due to the greatest predominance of Atlantic Forest Biome forest fragments. The smallest weighted averages per hectare were found in the central (21.2 Mg/ha), northern (20.4 Mg/ha), and northwestern (20.7 Mg/ha) regions of Minas Gerais State, where Savanna Biome fragments are predominant, in the phytophysiognomes Wooded Savanna and Shrub Savanna.	[Scolforo, Henrique Ferraco] N Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA; [Soares Scolforo, Jose Roberto; Mello, Jose Marcio; Ferraz Filho, Antonio Carlos] Univ Fed Lavras, Dept Forest Sci, Lavras, MG, Brazil; [Mello, Carlos Rogerio] Univ Fed Lavras, Dept Engn, Lavras, MG, Brazil	University of North Carolina; North Carolina State University; Universidade Federal de Lavras; Universidade Federal de Lavras	Scolforo, JRS (corresponding author), Univ Fed Lavras, Dept Forest Sci, Lavras, MG, Brazil.	jscolforo@dcf.ufla.br	SCOLFORO, JOSE/GLV-1991-2022; DE MELLO, JOSÉ MARCIO/S-9935-2019; Mello, Carlos/G-5821-2012; Filho, Antonio Ferraz/D-7283-2016	SCOLFORO, JOSE/0000-0002-5888-6751; Mello, Carlos/0000-0002-6033-5342; Filho, Antonio Ferraz/0000-0001-9178-918X; Mello, Jose Marcio de/0000-0002-0522-5060	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Instituto Estadual de Florestas (IEF)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Instituto Estadual de Florestas (IEF)	The authors are grateful to the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), and the Instituto Estadual de Florestas (IEF) for supporting this work. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105519; Black J.T, 1992, MULTIVARIATE DATA AN; CAMBARDELLA CA, 1994, SOIL SCI SOC AM J, V58, P1501, DOI 10.2136/sssaj1994.03615995005800050033x; Carvalho L.D., 2008, ZONEAMENTO ECOLOGICO, P89; Curi N., 1992, Informe Agropecuario (Belo Horizonte), V16, P5; de Mello CR, 2012, CIENC AGROTEC, V36, P53, DOI 10.1590/S1413-70542012000100007; de Rezende MG, 2013, BIOTA NEOTROP, V13, P201, DOI 10.1590/S1676-06032013000400019; Environmental systems research institute, 2010, GEOST AN; FERREIRA DF, 2008, ESTATISTICA MULTIVAR; Gomes Ana Paula de Souza, 2006, Acta Bot. Bras., V20, P37; Gomide L. R., 2005, Cerne, V11, P376; Hengl T, 2007, COMPUT GEOSCI-UK, V33, P1301, DOI 10.1016/j.cageo.2007.05.001; HERSHEY RR, 1996, SPATIAL ACCURACY ASS, P73; Instituto Brasileiro de Geografia e Estatistica, 2010, BRAS PROD INT BRUT P; Journel A. G., 1978, MINING GEOSTATISTICS; KAUFFMAN JB, 1994, J ECOL, V82, P519, DOI 10.2307/2261261; LEITAO-FILHO H.F., 1994, AN ACAD BRAS CIENC, V66, P91; Galeana-Pizana JM, 2014, INT J APPL EARTH OBS, V30, P179, DOI 10.1016/j.jag.2014.02.005; Mello CR, 2013, GEODERMA, V202, P88, DOI 10.1016/j.geoderma.2013.03.009; Mello Carlos R. de, 2009, Rev. bras. eng. agríc. ambient., V13, P68, DOI 10.1590/S1415-43662009000100010; Menezes MD, 2011, THESIS FEDERAL U LAV; Meusburger K, 2012, HYDROL EARTH SYST SC, V16, P167, DOI 10.5194/hess-16-167-2012; Miller J, 2007, ECOL MODEL, V202, P225, DOI 10.1016/j.ecolmodel.2006.12.012; Morais VA, 2013, CERNE, V19, P237, DOI 10.1590/S0104-77602013000200007; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; Oliveira MBL., 2006, REV BRAS METEOROL, V21, P378; OLIVEIRA-FILHO A. T, 2008, INVENTARIO FLORESTAL; Previtali FS, 2013, REDD REV ESPACO DIAL, V7, P1; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reboita Michelle Simões, 2010, Rev. bras. meteorol., V25, P185, DOI 10.1590/S0102-77862010000200004; Rezende A. V., 2006, Scientia Forestalis, P65; Ribeiro P.J, 2001, R NEWS, V1, P14, DOI DOI 10.1159/000323281; Rodrigues GSSC, 2011, REV GEOGRAFICA AM CE, V2, P1; Rufini AL, 2010, CERNE, V16, P1, DOI 10.1590/S0104-77602010000100001; Yamamoto JK, 2013, GEOESTATISTICA CONCE	35	37	38	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128781	10.1371/journal.pone.0128781	http://dx.doi.org/10.1371/journal.pone.0128781			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066508	Green Published, Green Submitted, gold			2022-12-26	WOS:000356327000029
J	Soons, J; Genbrugge, A; Podos, J; Adriaens, D; Aerts, P; Dirckx, J; Herrel, A				Soons, Joris; Genbrugge, Annelies; Podos, Jeffrey; Adriaens, Dominique; Aerts, Peter; Dirckx, Joris; Herrel, Anthony			Is Beak Morphology in Darwin's Finches Tuned to Loading Demands?	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; BITE FORCE; MECHANICAL FUNCTION; APPARENT DENSITY; CANCELLOUS BONE; GEOSPIZA-FORTIS; BIRD BEAKS; EVOLUTION; SHAPE; PERFORMANCE	One of nature's premier illustrations of adaptive evolution concerns the tight correspondence in birds between beak morphology and feeding behavior. In seed-crushing birds, beaks have been suggested to evolve at least in part to avoid fracture. Yet, we know little about mechanical relationships between beak shape, stress dissipation, and fracture avoidance. This study tests these relationships for Darwin's finches, a clade of birds renowned for their diversity in beak form and function. We obtained anatomical data from micro-CT scans and dissections, which in turn informed the construction of finite element models of the bony beak and rhamphotheca. Our models offer two new insights. First, engineering safety factors are found to range between 1 and 2.5 under natural loading conditions, with the lowest safety factors being observed in species with the highest bite forces. Second, size-scaled finite element (FE) models reveal a correspondence between inferred beak loading profiles and observed feeding strategies (e.g. edge-crushing versus tip-biting), with safety factors decreasing for base-crushers biting at the beak tip. Additionally, we identify significant correlations between safety factors, keratin thickness at bite locations, and beak aspect ratio (depth versus length). These lines of evidence together suggest that beak shape indeed evolves to resist feeding forces.	[Soons, Joris; Genbrugge, Annelies; Dirckx, Joris] Univ Antwerp, Lab Biomed Phys, B-2020 Antwerp, Belgium; [Genbrugge, Annelies; Adriaens, Dominique] Univ Ghent, Evolutionary Morphol Vertebrates, B-9000 Ghent, Belgium; [Podos, Jeffrey] Univ Massachusetts, Dept Biol, Morrill Sci Ctr 221, Amherst, MA 01003 USA; [Aerts, Peter; Herrel, Anthony] Univ Antwerp, Dept Biol, B-2610 Antwerp, Belgium; [Aerts, Peter] Univ Ghent, Dept Movement & Sports Sci, B-9000 Ghent, Belgium; [Herrel, Anthony] Museum Natl Hist Nat, Dept Ecol & Gest Biodiversite, F-75231 Paris 5, France	University of Antwerp; Ghent University; University of Massachusetts System; University of Massachusetts Amherst; University of Antwerp; Ghent University; Museum National d'Histoire Naturelle (MNHN)	Soons, J (corresponding author), Univ Antwerp, Lab Biomed Phys, Groenenborgerlaan 171, B-2020 Antwerp, Belgium.	joris.soons@ua.ac.be	Adriaens, Dominique/G-1587-2010; Podos, Jeff/I-3843-2019; Herrel, Anthony/C-3712-2013	Adriaens, Dominique/0000-0003-3610-2773; Herrel, Anthony/0000-0003-0991-4434; Podos, Jeffrey/0000-0002-2546-7999; Aerts, Peter/0000-0002-6867-5421	National Science Foundation under NSF [ECS-0335765]; Research Foundation - Flanders (FWO); University of Antwerp; NSF [IBN-0347291]	National Science Foundation under NSF(National Science Foundation (NSF)); Research Foundation - Flanders (FWO)(FWO); University of Antwerp; NSF(National Science Foundation (NSF))	This work was performed in part at the Center for Nanoscale Systems (CNS), a member of the National Nanotechnology Infrastructure Network (NNIN), which is supported by the National Science Foundation under NSF award no. ECS-0335765. CNS is part of the Faculty of Arts and Sciences at Harvard University. Financial support to this project was provided by the Research Foundation - Flanders (FWO) to JS, an interdisciplinary research grant of the special research fund of the University of Antwerp to PA, JD, AH, a PHC Tournesol project to AH, AG and DA, and JP was supported by NSF grant IBN-0347291. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthaume MA, 2012, J THEOR BIOL, V300, P242, DOI 10.1016/j.jtbi.2012.01.031; BOAG PT, 1981, SCIENCE, V214, P82, DOI 10.1126/science.214.4516.82; BOCK WJ, 1964, J MORPHOL, V114, P1, DOI 10.1002/jmor.1051140102; Bout RG, 2002, VERTEBRATE BIOMECHAN, VII, P49; Bowman R.I., 1961, MORPHOLOGICAL DIFFER; Campas O, 2010, P NATL ACAD SCI USA, V107, P3356, DOI 10.1073/pnas.0911575107; CARTER DR, 1976, SCIENCE, V194, P1174, DOI 10.1126/science.996549; Chou SF, 2012, MAT SCI ENG A-STRUCT, V557, P36, DOI 10.1016/j.msea.2012.05.111; Currey JD., 2006, BONES STRUCTURE MECH; Dumont ER, 2009, J THEOR BIOL, V256, P96, DOI 10.1016/j.jtbi.2008.08.017; Farren L, 2004, J EXP BIOL, V207, P735, DOI 10.1242/jeb.00814; Fitton LC, 2015, ANAT REC, V298, P107, DOI 10.1002/ar.23075; Ford CM, 1996, J BIOMECH, V29, P1309, DOI 10.1016/0021-9290(96)00062-0; Foster DJ, 2008, J EVOLUTION BIOL, V21, P263, DOI 10.1111/j.1420-9101.2007.01449.x; Fyhrie DP, 2000, BONE, V26, P169, DOI 10.1016/S8756-3282(99)00246-X; Genbrugge A, 2012, J ANAT, V221, P383, DOI 10.1111/j.1469-7580.2012.01561.x; Genbrugge A, 2011, J ANAT, V219, P676, DOI 10.1111/j.1469-7580.2011.01437.x; Genbrugge A, 2011, J ANAT, V219, P115, DOI 10.1111/j.1469-7580.2011.01388.x; Grant P.R., 1999, RECOGNITION STATES L, V2; Grant P. R., 2008, WHY SPECIES MULTIPLY; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; GRANT PR, 1981, PROC R SOC SER B-BIO, V212, P403, DOI 10.1098/rspb.1981.0046; Herrel A, 2005, FUNCT ECOL, V19, P43, DOI 10.1111/j.0269-8463.2005.00923.x; Herrel A, 2005, J EVOLUTION BIOL, V18, P669, DOI 10.1111/j.1420-9101.2004.00857.x; Herrel A, 2010, EMU, V110, P39, DOI 10.1071/MU09034; Herrel A, 2009, FUNCT ECOL, V23, P119, DOI 10.1111/j.1365-2435.2008.01494.x; Kupczik K, 2007, J ANAT, V210, P41, DOI 10.1111/j.1469-7580.2006.00662.x; Lack D., 1947, DARWINS FINCHES; Li BW, 2010, J EXP BIOL, V213, P479, DOI 10.1242/jeb.035428; Loeb G. E., 1986, ELECTROMYOGRAPHY EXP; MAAS S, 2008, FEBIO FINITE ELEMENT; MENDEZ J, 1960, METABOLISM, V9, P184; Nigg B., 2007, BIOMECHANICS MUSCULO; Nuijens FW, 1997, J MORPHOL, V232, P1, DOI 10.1002/(SICI)1097-4687(199704)232:1<1::AID-JMOR1>3.0.CO;2-G; Panagiotopoulou O, 2011, J ANAT, V218, P75, DOI 10.1111/j.1469-7580.2010.01257.x; Rayfield EJ, 2007, ANNU REV EARTH PL SC, V35, P541, DOI 10.1146/annurev.earth.35.031306.140104; RICE JC, 1988, J BIOMECH, V21, P155, DOI 10.1016/0021-9290(88)90008-5; Richmond BG, 2005, ANAT REC PART A, V283A, P259, DOI 10.1002/ar.a.20169; Ross CF, 2005, ANAT REC PART A, V283A, P253, DOI 10.1002/ar.a.20177; Si H, 2006, TETGEN QUALITY TETRA; Soons J, 2012, J R SOC INTERFACE, V9, P1787, DOI 10.1098/rsif.2011.0910; Soons J, 2012, J R SOC INTERFACE, V9, P1381, DOI 10.1098/rsif.2011.0667; Soons J, 2010, PHILOS T R SOC B, V365, P1093, DOI 10.1098/rstb.2009.0280; Temeles EJ, 2003, SCIENCE, V300, P630, DOI 10.1126/science.1080003; Temeles EJ, 2009, ECOLOGY, V90, P1147, DOI 10.1890/08-0695.1; van der Meij MAA, 2004, J EXP BIOL, V207, P2745, DOI 10.1242/jeb.01091; van der Meij MAA, 2008, J EXP BIOL, V211, P1668, DOI 10.1242/jeb.015289; Vogel S., 2003, COMP BIOMECHANICS LI; Yamada H., 1970, STRENGTH BIOL MAT	49	36	36	3	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129479	10.1371/journal.pone.0129479	http://dx.doi.org/10.1371/journal.pone.0129479			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068929	Green Published, Green Submitted, gold			2022-12-26	WOS:000356327000082
J	Deng, WW; Clausen, J; Boden, S; Oliver, SN; Casao, MC; Ford, B; Anderssen, RS; Trevaskis, B				Deng, Weiwei; Clausen, Jenni; Boden, Scott; Oliver, Sandra N.; Casao, M. Cristina; Ford, Brett; Anderssen, Robert S.; Trevaskis, Ben			Dawn and Dusk Set States of the Circadian Oscillator in Sprouting Barley (Hordeum vulgare) Seedlings	PLOS ONE			English	Article							FLOWERING-TIME GENES; ARABIDOPSIS-THALIANA; CLOCK; PROTEIN; EXPRESSION; RHYTHMS; LIGHT; GIGANTEA; VERNALIZATION; ADAPTATION	The plant circadian clock is an internal timekeeper that coordinates biological processes with daily changes in the external environment. The transcript levels of clock genes, which oscillate to control circadian outputs, were examined during early seedling development in barley (Hordeum vulgare), a model for temperate cereal crops. Oscillations of clock gene transcript levels do not occur in barley seedlings grown in darkness or constant light but were observed with day-night cycles. A dark-to-light transition influenced transcript levels of some clock genes but triggered only weak oscillations of gene expression, whereas a light-to-dark transition triggered robust oscillations. Single light pulses of 6, 12 or 18 hours induced robust oscillations. The light-to-dark transition was the primary determinant of the timing of subsequent peaks of clock gene expression. After the light-to-dark transition the timing of peak transcript levels of clock gene also varied depending on the length of the preceding light pulse. Thus, a single photoperiod can trigger initiation of photoperiod-dependent circadian rhythms in barley seedlings. Photoperiod-specific rhythms of clock gene expression were observed in two week old barley plants. Changing the timing of dusk altered clock gene expression patterns within a single day, showing that alteration of circadian oscillator behaviour is amongst the most rapid molecular responses to changing photoperiod in barley. A barley EARLY FLOWERING3 mutant, which exhibits rapid photoperiod-insensitive flowering behaviour, does not establish clock rhythms in response to a single photoperiod. The data presented show that dawn and dusk cues are important signals for setting the state of the circadian oscillator during early development of barley and that the circadian oscillator of barley exhibits photoperiod-dependent oscillation states.	[Deng, Weiwei; Clausen, Jenni; Boden, Scott; Oliver, Sandra N.; Ford, Brett; Trevaskis, Ben] CSIRO, Agr, Canberra, ACT 2601, Australia; [Casao, M. Cristina] Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany; [Anderssen, Robert S.] CSIRO, Digital Prod, Canberra, ACT 2601, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Max Planck Society; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Trevaskis, B (corresponding author), CSIRO, Agr, GPO Box 1600, Canberra, ACT 2601, Australia.	Ben.Trevaskis@csiro.au	Boden, Scott/ABC-6639-2020; Boden, Scott/H-8857-2015; Trevaskis, Ben/B-5350-2011; Ford, Brett/C-3285-2014	Boden, Scott/0000-0001-5297-4067; Trevaskis, Ben/0000-0001-7277-4994; Ford, Brett/0000-0002-7467-0950	vacation scholarship from the Commonwealth Scientific and Industrial Organisation	vacation scholarship from the Commonwealth Scientific and Industrial Organisation	JC was supported by a vacation scholarship from the Commonwealth Scientific and Industrial Organisation http://www.csiro.au/Portals/Careers/Work-experience-and-scholarships/Vacationscholarships/About-vacation-scholarship-scheme.aspx.	Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Barak S, 2000, TRENDS PLANT SCI, V5, P517, DOI 10.1016/S1360-1385(00)01785-4; Barrero JM, 2009, PLANT PHYSIOL, V150, P1006, DOI 10.1104/pp.109.137901; Campoli C, 2013, NEW PHYTOL, V199, P1045, DOI 10.1111/nph.12346; Campoli C, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-97; Campoli C, 2012, PLANT J, V69, P868, DOI 10.1111/j.1365-313X.2011.04839.x; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Corbesier L, 2005, PLANT CELL ENVIRON, V28, P54, DOI 10.1111/j.1365-3040.2005.01283.x; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Dalchau N, 2011, P NATL ACAD SCI USA, V108, P5104, DOI 10.1073/pnas.1015452108; Dixon LE, 2014, NEW PHYTOL, V203, P568, DOI 10.1111/nph.12853; Doyle MR, 2002, NATURE, V58, P386; Dunford RP, 2005, THEOR APPL GENET, V110, P925, DOI 10.1007/s00122-004-1912-5; Edwards KD, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.81; Faure S, 2012, P NATL ACAD SCI USA, V109, P8328, DOI 10.1073/pnas.1120496109; Fowler S, 1999, EMBO J, V18, P4679, DOI 10.1093/emboj/18.17.4679; Gendron JM, 2012, P NATL ACAD SCI USA, V109, P3167, DOI 10.1073/pnas.1200355109; Haydon MJ, 2013, NATURE, V502, P689, DOI 10.1038/nature12603; Hazen SP, 2005, P NATL ACAD SCI USA, V102, P10387, DOI 10.1073/pnas.0503029102; Herrero E, 2012, PLANT CELL, V24, P428, DOI 10.1105/tpc.111.093807; Huang W, 2012, SCIENCE, V336, P75, DOI 10.1126/science.1219075; Kaczorowski KA, 2003, PLANT CELL, V15, P2654, DOI 10.1105/tpc.015065; Karayekov E, 2013, PLANT CELL, V25, P2892, DOI 10.1105/tpc.113.114306; Kikis EA, 2005, PLANT J, V44, P300, DOI 10.1111/j.1365-313X.2005.02531.x; Makino S, 2001, PLANT CELL PHYSIOL, V42, P334, DOI 10.1093/pcp/pce036; Matsushika A, 2000, PLANT CELL PHYSIOL, V41, P1002, DOI 10.1093/pcp/pcd043; McClung CR, 2001, ANNU REV PLANT PHYS, V52, P139, DOI 10.1146/annurev.arplant.52.1.139; McWatters HG, 2000, NATURE, V408, P716, DOI 10.1038/35047079; Millar AJ, 2003, J EXP BIOL, V55, P227; Murakami M, 2007, PLANT CELL PHYSIOL, V48, P110, DOI 10.1093/pcp/pcl043; Nagel DH, 2012, CURR BIOL, V22, pR648, DOI 10.1016/j.cub.2012.07.025; Nusinow DA, 2011, NATURE, V475, P398, DOI 10.1038/nature10182; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; Pokhilko A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.6; Salome PA, 2008, PLANT PHYSIOL, V147, P1110, DOI 10.1104/pp.108.117622; Sasani S, 2009, J EXP BOT, V60, P2169, DOI 10.1093/jxb/erp098; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Somers DE, 1998, DEVELOPMENT, V125, P485; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Thomashow MF, 2010, PLANT PHYSIOL, V154, P571, DOI 10.1104/pp.110.161794; Trevaskis B, 2006, PLANT PHYSIOL, V140, P1397, DOI 10.1104/pp.105.073486; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Yakir E, 2011, PLANT J, V68, P520, DOI 10.1111/j.1365-313X.2011.04707.x; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996; Zakhrabekova S, 2012, P NATL ACAD SCI USA, V109, P4326, DOI 10.1073/pnas.1113009109; Zhong HH, 1998, PLANT CELL, V10, P2005, DOI 10.1105/tpc.10.12.2005	49	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129781	10.1371/journal.pone.0129781	http://dx.doi.org/10.1371/journal.pone.0129781			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068005	gold, Green Published			2022-12-26	WOS:000356100900078
J	Ou, Q; Chen, YC; Zhuo, SQ; Tian, XT; He, CH; Lu, XL; Gao, XL				Ou, Qiong; Chen, Yong-Chi; Zhuo, Sheng-Qing; Tian, Xiang-Ting; He, Chun-Huan; Lu, Xi-Lin; Gao, Xing-Lin			Continuous Positive Airway Pressure Treatment Reduces Mortality in Elderly Patients with Moderate to Severe Obstructive Severe Sleep Apnea: A Cohort Study	PLOS ONE			English	Article							RISK-FACTOR; ASSOCIATION; HYPERTENSION; STROKE	Obstructive sleep apnea (OSA) is much more prevalent in older people than in middle-aged or young populations, and has been associated with cardiovascular disease. Continuous positive airway pressure (CPAP) is the first-line therapy for OSA, but its long-term clinical benefit in the elderly is unclear. Here, we carried out a prospective cohort study to explore the survival rate and incidence of cardiovascular events in elderly patients with moderate to severe OSA who did or did not receive CPAP treatment. The study included 130 patients (104 male, 26 female; mean age: 77.8 +/- 6.2 years) who were followed up for a mean of 5 +/- 2.54 years (range, 1-8 years). Thirty-six patients received CPAP and 88 had no CPAP. The results showed that mortality in the untreated group (21.6%) was significantly higher than in the CPAP group (5.6%). Kaplan-Meier survival analysis showed that the survival rate in the CPAP group was 94.4%, which was markedly higher than the rate of 78.4% in the untreated group. The incidence of cardiovascular events was 13.9% in the CPAP group and 55.7% in the untreated group. The present study provides evidence that CPAP can reduce mortality in older patients with moderate to severe OSA, and lead to a good long-term prognosis. The study also indicates that death in older OSA patients is associated with cardiovascular disease and diabetes.	[Ou, Qiong; Gao, Xing-Lin] Guangdong Acad Med Sci, Guangdong Prov Inst Geriatr, Guangdong Gen Hosp, Sleep Ctr,Dept Resp Med, Guangzhou, Guangdong, Peoples R China; [Chen, Yong-Chi; Zhuo, Sheng-Qing; Tian, Xiang-Ting; He, Chun-Huan] Guangdong Acad Med Sci, Guangdong Prov Inst Geriatr, Dept Cardiol, Guangdong Gen Hosp, Guangzhou, Guangdong, Peoples R China; [Lu, Xi-Lin] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Sun Yat Sen University	Gao, XL (corresponding author), Guangdong Acad Med Sci, Guangdong Prov Inst Geriatr, Guangdong Gen Hosp, Sleep Ctr,Dept Resp Med, Guangzhou, Guangdong, Peoples R China.	xinglingao@hotmail.com			National Key Clinical Department, National Key Discipline [Y3016]; Guangdong Key Laboratory For Diagnosis and Treatment of Major Neurological Diseases [2010A060801005]; Guangdong Technological grant [2008B030301188, 2012B031800107]; Guangdong Department of Science & Technology Translational Medicine Center [2011A080300002]	National Key Clinical Department, National Key Discipline; Guangdong Key Laboratory For Diagnosis and Treatment of Major Neurological Diseases; Guangdong Technological grant; Guangdong Department of Science & Technology Translational Medicine Center	This study was supported by grants from the National Key Clinical Department, National Key Discipline (No. Y3016), Guangdong Key Laboratory For Diagnosis and Treatment of Major Neurological Diseases(No. 2010A060801005), Guangdong Technological grant (No. 2008B030301188, 2012B031800107), and Guangdong Department of Science & Technology Translational Medicine Center grant (No. 2011A080300002).	AncoliIsrael S, 1996, SLEEP, V19, P277, DOI 10.1093/sleep/19.4.277; Arzt M, 2005, AM J RESP CRIT CARE, V172, P1447, DOI 10.1164/rccm.200505-702OC; BLIWISE DL, 1988, AM J PUBLIC HEALTH, V78, P544, DOI 10.2105/AJPH.78.5.544; Campos-Rodriguez F, 2005, CHEST, V128, P624, DOI 10.1378/chest.128.2.624; Caples SM, 2005, ANN INTERN MED, V142, P187, DOI 10.7326/0003-4819-142-3-200502010-00010; Doherty LS, 2005, CHEST, V127, P2076, DOI 10.1378/chest.127.6.2076; Endeshaw Y, 2006, J AM GERIATR SOC, V54, P1740, DOI 10.1111/j.1532-5415.2006.00924.x; Groth M, 2005, CLIN GERIATR MED, V21, P701, DOI 10.1016/j.cger.2005.06.009; Lavie P, 2009, J SLEEP RES, V18, P397, DOI 10.1111/j.1365-2869.2009.00754.x; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; Lopez-Jimenez F, 2008, CHEST, V133, P793, DOI 10.1378/chest.07-0800; Maekawa M, 2000, Nihon Rinsho, V58, P1702; Martinez-Garcia AA, 2005, CHEST, V128, P2123, DOI 10.1378/chest.128.4.2123; McMahon Joseph P, 2003, WMJ, V102, P36; Mehra R, 2006, AM J RESP CRIT CARE, V173, P910, DOI 10.1164/rccm.200509-1442OC; Munoz R, 2006, STROKE, V37, P2317, DOI 10.1161/01.STR.0000236560.15735.0f; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Norman D, 2008, CLIN GERIATR MED, V24, P151, DOI 10.1016/j.cger.2007.08.006; Ohayon MM, 2000, J PSYCHOSOM RES, V48, P593, DOI 10.1016/S0022-3999(00)00142-2; Parish JM, 2004, MAYO CLIN PROC, V79, P1036, DOI 10.4065/79.8.1036; Robinson GV, 2004, THORAX, V59, P777, DOI 10.1136/thx.2003.018739; Sforza E, 2004, EUR RESPIR J, V24, P279, DOI 10.1183/09031936.04.00091903; Silverberg D S, 2001, Curr Hypertens Rep, V3, P209, DOI 10.1007/s11906-001-0040-8; Skinner MA, 2005, CHEST, V127, P66, DOI 10.1378/chest.127.1.66; Thurnheer R, 2007, SWISS MED WKLY, V137, P217; Weaver TE, 2007, SLEEP MED REV, V11, P99, DOI 10.1016/j.smrv.2006.08.001; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Young T, 2000, SLEEP, V23, pS122	29	32	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0127775	10.1371/journal.pone.0127775	http://dx.doi.org/10.1371/journal.pone.0127775			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK3FB	26068440	gold, Green Submitted, Green Published			2022-12-26	WOS:000356100900012
J	Park, J; Lai, LX; Samuel, MS; Wax, D; Prather, RS; Tian, XC				Park, Joonghoon; Lai, Liangxue; Samuel, Melissa S.; Wax, David; Prather, Randall S.; Tian, Xiuchun			Disruption of Mitochondrion-To-Nucleus Interaction in Deceased Cloned Piglets	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; DNA; HETEROPLASMY; CELLS; FETAL; OOCYTES; FETUSES; GENOME; KIDNEY; BRAIN	Most animals produced by somatic cell nuclear transfer (SCNT) are heteroplasmic for mitochondrial DNA (mtDNA). Oxidative phosphorylation (OXPHOS) in clones therefore requires the coordinated expression of genes encoded by the nuclear DNA and the two sources of mitochondria. Such interaction is rarely studied because most clones are generated using slaughterhouse oocytes of unrecorded origin. Here we traced the maternal lineages of seven diseased and five one-month-old live cloned piglets by sequencing their mtDNA. Additionally by using a 13K oligonucleotide microarray, we compared the expression profiles of nuclear and mtDNA-encoded genes that are involved in mitochondrial functions and regulation between the cloned groups and their age-matched controls (n=5 per group). We found that the oocytes used to generate the cloned piglets were of either the Large White or Duroc background, and oocyte genetic background was not related to the clones' survival. Expression profiles of mtDNA-encoded genes in clones and controls showed intermixed clustering patterns without treatment or maternal lineage-dependency. In contrast, clones and controls clustered separately for their global and nuclear DNA-encoded mitochondrial genes in the lungs for both the deceased and live groups. Functional annotation of differentially expressed genes encoded by both nuclear and mtDNA revealed abnormal gene expression in the mitochondrial OXPHOS pathway in deceased clones. Among the nine differentially expressed genes of the OXPHOS pathway, seven were down-regulated in deceased clones compared to controls, suggesting deficiencies in mitochondrial functions. Together, these data demonstrate that the coordination of expression of mitochondrial genes encoded by nuclear and mtDNA is disrupted in the lung of diseased clones.	[Park, Joonghoon; Tian, Xiuchun] Univ Connecticut, Dept Anim Sci, Storrs, CT 06269 USA; [Park, Joonghoon; Tian, Xiuchun] Univ Connecticut, Ctr Regenerat Biol, Storrs, CT 06269 USA; [Lai, Liangxue; Samuel, Melissa S.; Wax, David; Prather, Randall S.] Univ Missouri, Dept Anim Sci, Columbia, MO 65211 USA	University of Connecticut; University of Connecticut; University of Missouri System; University of Missouri Columbia	Tian, XC (corresponding author), Univ Connecticut, Dept Anim Sci, Storrs, CT 06269 USA.	xiuchun.tian@uconn.edu		Prather, Randall/0000-0002-6012-4035	USDA Regional Research Project [W2171]; USDA-ARS [58-1265-0-040]	USDA Regional Research Project; USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The work received the following grant support: USDA Regional Research Project W2171 and USDA-ARS contract 58-1265-0-040.	Acton BM, 2007, BIOL REPROD, V77, P569, DOI 10.1095/biolreprod.107.060806; Bruggerhoff K, 2002, BIOL REPROD, V66, P367, DOI 10.1095/biolreprod66.2.367; Burgstaller JP, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-141; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Carroll JA, 2005, DOMEST ANIM ENDOCRIN, V29, P564, DOI 10.1016/j.domaniend.2005.03.009; Chen JQ, 2007, MOL REPROD DEV, V74, P568, DOI 10.1002/mrd.20647; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Cotter D, 2004, NUCLEIC ACIDS RES, V32, pD463, DOI 10.1093/nar/gkh048; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dietrich JB, 2004, ANN NY ACAD SCI, V1025, P345, DOI 10.1196/annals.1316.042; Dmitrenka V, 2005, CANCER LETT, V218, P99, DOI 10.1016/j.canlet.2004.07.001; Haut S, 2003, HUM GENET, V113, P118, DOI 10.1007/s00439-003-0946-0; Hiendleder S, 1999, MOL REPROD DEV, V54, P24, DOI 10.1002/(SICI)1098-2795(199909)54:1&lt;24::AID-MRD4&gt;3.0.CO;2-S; Hiendleder S, 2004, BIOL REPROD, V70, P1196, DOI 10.1095/biolreprod.103.023028; Hiendleder S, 2003, BIOL REPROD, V68, P159, DOI 10.1095/biolreprod.102.008201; Hsieh SY, 2006, PROTEOMICS, V6, P5322, DOI 10.1002/pmic.200500541; Jensen KB, 2006, P NATL ACAD SCI USA, V103, P11958, DOI 10.1073/pnas.0601886103; Jiao F, 2007, MOL REPROD DEV, V74, P1278, DOI 10.1002/mrd.20698; Kim KI, 2002, ANIM GENET, V33, P19, DOI 10.1046/j.1365-2052.2002.00784.x; Kishigami S, 2008, EXP CELL RES, V314, P1945, DOI 10.1016/j.yexcr.2008.01.027; Kulawiec M, 2006, CANCER BIOL THER, V5, P967, DOI 10.4161/cbt.5.8.2880; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Lan GC, 2006, MOL REPROD DEV, V73, P834, DOI 10.1002/mrd.20443; LATHAM KE, 1994, DEVELOPMENT, V120, P3419; Lee JH, 2010, CELL REPROGRAM, V12, P347, DOI 10.1089/cell.2009.0096; Li HS, 2001, PHYSIOL GENOMICS, V6, P91, DOI 10.1152/physiolgenomics.2001.6.2.91; Li Y, 2007, J BIOL CHEM; McKenzie M, 2000, J BIOL CHEM, V275, P31514, DOI 10.1074/jbc.M004070200; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Ogonuki N, 2002, NAT GENET, V30, P253, DOI 10.1038/ng841; OHTA S, 1988, J BIOL CHEM, V263, P11257; Park J, 2010, ALTERED GENE E UNPUB, DOI [10.1089/cell.2010.0004, DOI 10.1089/CELL.2010.0004]; Park J, 2011, CELL REPROGRAM, V13, P215, DOI 10.1089/cell.2010.0088; Park J, 2010, CELL REPROGRAM, V12, P589, DOI 10.1089/cell.2010.0004; Piruat JI, 2005, J BIOL CHEM, V280, P42676, DOI 10.1074/jbc.M507044200; Powell AM, 2004, BIOL REPROD, V71, P210, DOI 10.1095/biolreprod.104.027193; Tagliaro C. H., 1999, Ciencia Rural, V29, P319, DOI 10.1590/S0103-84781999000200022; Traven A, 2001, J BIOL CHEM, V276, P4020, DOI 10.1074/jbc.M006807200; Urakawa M, 2004, THERIOGENOLOGY, V62, P714, DOI 10.1016/j.theriogenology.2003.11.024; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wong LJC, 2005, CLIN CHIM ACTA, V354, P1, DOI 10.1016/j.cccn.2004.11.003; YAN WL, 1994, GENOMICS, V24, P375, DOI 10.1006/geno.1994.1631; Yan ZH, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-31; Zhao SH, 2005, GENOMICS, V86, P618, DOI 10.1016/j.ygeno.2005.08.001	45	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129378	10.1371/journal.pone.0129378	http://dx.doi.org/10.1371/journal.pone.0129378			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067091	Green Published, Green Submitted, gold			2022-12-26	WOS:000356100900053
J	Rodriguez, C; Soulie, C; Marcelin, AG; Calvez, V; Descamps, D; Charpentier, C; Flandre, P; Recordon-Pinson, P; Bellecave, P; Pawlotsky, JM; Masquelier, B				Rodriguez, Christophe; Soulie, Cathia; Marcelin, Anne-Genevieve; Calvez, Vincent; Descamps, Diane; Charpentier, Charlotte; Flandre, Philippe; Recordon-Pinson, Patricia; Bellecave, Pantxika; Pawlotsky, Jean-Michel; Masquelier, Bernard		ANRS AC11 Study Grp	HIV-1 Coreceptor Usage Assessment by Ultra-Deep Pyrosequencing and Response to Maraviroc	PLOS ONE			English	Article							ROC CURVES; TROPISM; ASSAY; CCR5; PREDICTION	Background Maraviroc is an HIV entry inhibitor that alters the conformation of CCR5 and is poorly efficient in patients infected by viruses that use CXCR4 as an entry coreceptor. The goal of this study was to assess the capacity of ultra-deep pyrosequencing (UDPS) and different data analysis approaches to characterize HIV tropism at baseline and predict the therapeutic outcome on maraviroc treatment. Methods 113 patients with detectable HIV-1 RNA on HAART were treated with maraviroc. The virological response was assessed at months 1, 3 and 6. The sequence of the HIV V3 loop was determined at baseline and prediction of maraviroc response by different software and interpretation algorithms was analyzed. Results UDPS followed by analysis with the Pyrotrop software or geno2pheno algorithm provided better prediction of the response to maraviroc than Sanger sequencing. We also found that the H34Y/S substitution in the V3 loop was the strongest individual predictor of maraviroc response, stronger than substitutions at positions 11 or 25 classically used in interpretation algorithms. Conclusions UDPS is a powerful tool that can be used with confidence to predict maraviroc response in HIV-1-infected patients. Improvement of the predictive value of interpretation algorithms is possible and our results suggest that adding the H34S/Y substitution would substantially improve the performance of the 11/25/charge rule.	[Rodriguez, Christophe; Pawlotsky, Jean-Michel] Univ Paris Est, Henri Mondor Hosp, Natl Reference Ctr Viral Hepatitis B C & Delta, Dept Virol, Creteil, France; [Rodriguez, Christophe; Pawlotsky, Jean-Michel] INSERM U955, Creteil, France; [Soulie, Cathia; Marcelin, Anne-Genevieve; Calvez, Vincent] Hop La Pitie Salpetriere, Dept Virol, Paris, France; [Descamps, Diane; Charpentier, Charlotte] HUPNVS, Bichat Claude Bernard Hosp, Dept Virol, Paris, France; [Flandre, Philippe] INSERM U943 UPMC, UMR S 943, Paris, France; [Recordon-Pinson, Patricia; Bellecave, Pantxika; Masquelier, Bernard] Univ Bordeaux, Univ Hosp Bordeaux, Dept Virol, Bordeaux, France; [Recordon-Pinson, Patricia; Bellecave, Pantxika; Masquelier, Bernard] Univ Bordeaux, UMR5234, Bordeaux, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Pawlotsky, JM (corresponding author), Univ Paris Est, Henri Mondor Hosp, Natl Reference Ctr Viral Hepatitis B C & Delta, Dept Virol, Creteil, France.	jean.michel.pawlotsky@hmn.aphp.fr	André, Patrice/M-8139-2014; rodriguez, christophe/B-8024-2012; SOULIE, CATHIA/AIF-3965-2022; Pawlotsky, Jean-Michel/R-8159-2018; Flandre, Philippe/N-6314-2017; de ROUGEMONT, Alexis/M-1090-2016; Rogez, Sylvie/O-8891-2016; Charpentier, Charlotte/C-3579-2019; chaillon, antoine/GNH-1623-2022; Recordon-Pinson, Patricia/AAV-1295-2021; Chaillon, Antoine/GNH-6121-2022; Marcelin, Anne-Genevieve/D-8272-2014	André, Patrice/0000-0002-5834-7395; rodriguez, christophe/0000-0001-8128-4030; Flandre, Philippe/0000-0002-2612-3522; de ROUGEMONT, Alexis/0000-0002-3084-9414; Rogez, Sylvie/0000-0002-4092-7164; Recordon-Pinson, Patricia/0000-0001-6002-0941; Marcelin, Anne-Genevieve/0000-0003-4808-8999; Fafi-Kremer, Samira/0000-0003-3886-7833; VABRET, Astrid/0000-0002-8940-7645; Pawlotsky, Jean-Michel/0000-0003-0745-7559; Trabaud, Mary-Anne/0000-0001-8614-1071; PLANTIER, Jean-Christophe/0000-0001-6417-4083; Raymond, Stephanie/0000-0002-3780-5844; BOURLET, Thomas/0000-0002-9226-1149	project "Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)" within the 7th Framework Program of the European Community (FP7); National Agency for Research on AIDS and Viral Hepatitis (ANRS); ANRS	project "Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)" within the 7th Framework Program of the European Community (FP7); National Agency for Research on AIDS and Viral Hepatitis (ANRS)(French National Research Agency (ANR)); ANRS(ANRSFrench National Research Agency (ANR))	This research has been funded as part of the project "Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)" within the 7th Framework Program of the European Community (FP7) and by the National Agency for Research on AIDS and Viral Hepatitis (ANRS). C.R. is the recipient of a pre-doctoral fellowship from ANRS.	Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Bandos AI, 2005, STAT MED, V24, P2873, DOI 10.1002/sim.2149; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Chen MJ, 2013, BIOINFORMATICS, V29, P451, DOI 10.1093/bioinformatics/btt002; Daumer M, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-30; DEJONG JJ, 1992, J VIROL, V66, P6777, DOI 10.1128/JVI.66.11.6777-6780.1992; Delobel P, 2007, J CLIN MICROBIOL, V45, P1572, DOI 10.1128/JCM.02090-06; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Gibson RM, 2014, ANTIMICROB AGENTS CH, V58, P2167, DOI 10.1128/AAC.02710-13; Kagan RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046334; Lengauer T, 2007, NAT BIOTECHNOL, V25, P1407, DOI 10.1038/nbt1371; Poveda E, 2012, AIDS REV, V14, P208; R Core Team, 2018, R LANG ENV STAT COMP; Raymond S, 2008, AIDS, V22, pF11, DOI 10.1097/QAD.0b013e32830ebcd4; Recordon-Pinson P, 2010, ANTIMICROB AGENTS CH, V54, P3335, DOI 10.1128/AAC.00148-10; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rodriguez C, 2013, HEPATOLOGY, V58, P890, DOI 10.1002/hep.26383; Rose JD, 2009, CURR OPIN HIV AIDS, V4, P136, DOI 10.1097/COH.0b013e328322f973; Saliou A, 2011, ANTIMICROB AGENTS CH, V55, P2831, DOI 10.1128/AAC.00091-11; Swenson LC, 2011, CLIN INFECT DIS, V53, P732, DOI 10.1093/cid/cir493; Swenson LC, 2011, J INFECT DIS, V203, P237, DOI 10.1093/infdis/jiq030; Vandekerckhove L, 2011, J ANTIMICROB CHEMOTH, V66, P265, DOI 10.1093/jac/dkq458; Westby M, 2006, J VIROL, V80, P4909, DOI 10.1128/JVI.80.10.4909-4920.2006; Whitcomb JM, 2007, ANTIMICROB AGENTS CH, V51, P566, DOI 10.1128/AAC.00853-06	24	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0127816	10.1371/journal.pone.0127816	http://dx.doi.org/10.1371/journal.pone.0127816			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068869	Green Submitted, Green Published, gold			2022-12-26	WOS:000356100900013
J	Shen, TC; Lin, CL; Wei, CC; Chen, CH; Tu, CY; Hsia, TC; Shih, CM; Hsu, WH; Sung, FC; Kao, CH				Shen, Te-Chun; Lin, Cheng-Li; Wei, Chang-Ching; Chen, Chia-Hung; Tu, Chih-Yen; Hsia, Te-Chun; Shih, Chuen-Ming; Hsu, Wu-Huei; Sung, Fung-Chang; Kao, Chia-Hung			Risk of Obstructive Sleep Apnea in Adult Patients with Asthma: A Population-Based Cohort Study in Taiwan	PLOS ONE			English	Article							UPPER AIRWAY; ASSOCIATION; SYMPTOMS; RHINITIS; COMMON; AWAKE	Background There are several publications reported that obstructive sleep apnea (OSA) was associated with asthma. However, large-scaled, population-based cohort study has been limited. We aimed to examine the risk of OSA among adult patients with asthma in an Asian population. Methods We conducted a retrospective cohort study using data from the National Health Insurance (NHI) of Taiwan. The asthma cohort included 38,840 newly diagnosed patients between 2000 and 2010. The date of diagnosis was defined as the index date. Each patient was randomly matched with four people without asthma according to gender, age, and the index year as the comparison cohort. The occurrence of OSA was followed up until the end of 2011. The risk of OSA was estimated using the Cox proportional hazard model after adjusting for gender, age, and comorbidities. Results The overall incidence of OSA was 2.51-fold greater in the asthma cohort than in the comparison cohort (12.1 versus 4.84 per 1000 person-years). Compared to non-asthma subjects, the adjusted hazard ratio (aHR) of OSA increased to 1.78 for asthma patients with one or less annual emergency room (ER) visit, and 23.8 for those who visited ER more than once per year. In addition, aHR in patients with inhaled steroid treatment compared to those without steroid treatment was 1.33 (95% CI = 1.01-1.76). Conclusion Patients with asthma have a significantly higher risk of developing OSA than the general population. The results suggest that the risk of OSA is proportional to asthma control and patients with inhaled steroid treatment have a higher risk for OSA than those without steroid treatment.	[Shen, Te-Chun; Wei, Chang-Ching; Sung, Fung-Chang; Kao, Chia-Hung] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Shen, Te-Chun; Chen, Chia-Hung; Tu, Chih-Yen; Hsia, Te-Chun; Shih, Chuen-Ming; Hsu, Wu-Huei] China Med Univ Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Taichung, Taiwan; [Lin, Cheng-Li; Sung, Fung-Chang] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Wei, Chang-Ching] China Med Univ Hosp, Div Nephrol, Dept Pediat, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Kao, CH (corresponding author), China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan.	d10040@mail.cmuh.org.tw		Shen, Te-Chun/0000-0002-9427-1068	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW103-TDU-B-212-113002]	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence	This work was supported by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW103-TDU-B-212-113002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	[Anonymous], 2014, GLOB STRAT ASTHM MAN; Boulet LP, 2009, EUR RESPIR J, V33, P897, DOI 10.1183/09031936.00121308; Braido F, 2014, RESP CARE, V59, P1851, DOI 10.4187/respcare.03084; Byun MK, 2013, YONSEI MED J, V54, P942, DOI 10.3349/ymj.2013.54.4.942; Chen YL, 2014, J CLIN ENDOCR METAB, V99, P2441, DOI 10.1210/jc.2014-1718; Chung WS, 2014, EUR J INTERN MED, V25, P941, DOI 10.1016/j.ejim.2014.10.023; Chung WS, 2014, EUR J CLIN INVEST, V44, P1025, DOI 10.1111/eci.12336; Ciftci TU, 2005, RESP MED, V99, P529, DOI 10.1016/j.rmed.2004.10.011; Cruz AA, 2007, ALLERGY, V62, P1, DOI 10.1111/j.1398-9995.2007.01551.x; Ekici A, 2005, CHEST, V128, P3358, DOI 10.1378/chest.128.5.3358; FITZPATRICK MF, 1993, EUR RESPIR J, V6, P531; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Goodwin RD, 2003, ARCH GEN PSYCHIAT, V60, P1125, DOI 10.1001/archpsyc.60.11.1125; GUILLEMINAULT C, 1988, EUR RESPIR J, V1, P902; Janson C, 1996, EUR RESPIR J, V9, P2132, DOI 10.1183/09031936.96.09102132; Kang JH, 2012, UROLOGY, V79, P340, DOI 10.1016/j.urology.2011.08.040; Larsson LG, 2001, RESP MED, V95, P423, DOI 10.1053/rmed.2001.1054; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Prasad B, 2014, SLEEP MED REV, V18, P165, DOI 10.1016/j.smrv.2013.04.004; Puthalapattu S, 2014, J INVEST MED, V62, P665, DOI 10.2310/JIM.0000000000000065; Reid MB, 2002, AM J RESP CRIT CARE, V166, P479, DOI 10.1164/rccm.2202005; Salles C, 2013, J BRAS PNEUMOL, V39, P604, DOI 10.1590/S1806-37132013000500011; SCHWAB RJ, 1993, AM REV RESPIR DIS, V148, P1385, DOI 10.1164/ajrccm/148.5.1385; SHIPLEY JE, 1992, SLEEP, V15, P514, DOI 10.1093/sleep/15.6.514; Teodorescu M, 2015, JAMA-J AM MED ASSOC, V313, P156, DOI 10.1001/jama.2014.17822; Teodorescu M, 2014, J CLIN SLEEP MED, V10, P183, DOI 10.5664/jcsm.3450; Teodorescu Mihaela, 2013, Sleep Disord, V2013, P251567, DOI 10.1155/2013/251567; Tishler PV, 2003, JAMA-J AM MED ASSOC, V289, P2230, DOI 10.1001/jama.289.17.2230; Weiss JW, 1999, PROG CARDIOVASC DIS, V41, P367, DOI 10.1053/pcad.1999.0410367; Rabelo FAW, 2013, BRAZ J OTORHINOLAR, V79, P100, DOI 10.5935/1808-8694.20130017; Yamasaki A, 2014, INT J GEN MED, V7, P505, DOI 10.2147/IJGM.S72713; Yigla M, 2003, J ASTHMA, V40, P865, DOI 10.1081/JAS-120023577; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080	33	33	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128461	10.1371/journal.pone.0128461	http://dx.doi.org/10.1371/journal.pone.0128461			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067280	gold, Green Published, Green Submitted			2022-12-26	WOS:000356100900022
J	Garcia-Betancourt, T; Higuera-Mendieta, DR; Gonzalez-Uribe, C; Cortes, S; Quintero, J				Garcia-Betancourt, Tatiana; Rocio Higuera-Mendieta, Diana; Gonzalez-Uribe, Catalina; Cortes, Sebastian; Quintero, Juliana			Understanding Water Storage Practices of Urban Residents of an Endemic Dengue Area in Colombia: Perceptions, Rationale and Socio-Demographic Characteristics	PLOS ONE			English	Article							AEDES-AEGYPTI; KNOWLEDGE; CONTAINERS; COUNTRIES; AMERICA; ADULTS; CITY	Introduction The main preventive measure against dengue virus transmission is often based on actions to control Ae. Aegypti reproduction by targeting water containers of clean and stagnant water. Household water storage has received special attention in prevention strategies but the evidence about the rationale of this human practice is limited. The objective was to identify and describe water storage practices among residents of an urban area in Colombia (Girardot) and its association with reported perceptions, rationales and socio-demographic characteristics with a mixed methods approach. Methods Knowledge, attitudes and practices and entomological surveys from 1,721 households and 26 semi-structured interviews were conducted among residents of Girardot and technicians of the local vector borne disease program. A multivariate analysis was performed to identify associations between a water storage practice and socio-demographic characteristics, and knowledge, attitudes and practices about dengue and immature forms of the vector, which were then triangulated with qualitative information. Results Water storage is a cultural practice in Girardot. There are two main reasons for storage: The scarcity concern based on a long history of shortages of water in the region and the perception of high prices in water rates, contrary to what was reported by the local water company. The practice of water storage was associated with being a housewife (Inverse OR: 2.6, 95% CI 1.5-4.3). The use of stored water depends on the type of container used, while water stored in alberca (Intra household cement basins) is mainly used for domestic cleaning chores, water in plastic containers is used for cooking. Conclusions It is essential to understand social practices that can increase or reduce the number of breeding sites of Ae. Aegypti. Identification of individuals who store water and the rationale of such storage allow a better understanding of the social dynamics that lead to water accumulation.	[Garcia-Betancourt, Tatiana; Rocio Higuera-Mendieta, Diana; Gonzalez-Uribe, Catalina; Cortes, Sebastian; Quintero, Juliana] Fdn Santa Fe Bogot, CEIS, Bogota, Colombia		Garcia-Betancourt, T (corresponding author), Fdn Santa Fe Bogot, CEIS, Bogota, Colombia.	tatiana.garcia@ecosaludetvcolombia.org		Gonzalez-Uribe, Catalina/0000-0002-3322-5017; Quintero Espinosa, Juliana/0000-0003-3005-4184	Special Programme for Research and Training in Tropical Diseases (TDR) at the World Health Organization; Regional Office for the Americas (PAHO); Ecosystem and Human Health Program of the International Development Research Centre (IDRC) of Canada [104951-001]	Special Programme for Research and Training in Tropical Diseases (TDR) at the World Health Organization; Regional Office for the Americas (PAHO); Ecosystem and Human Health Program of the International Development Research Centre (IDRC) of Canada	The Special Programme for Research and Training in Tropical Diseases (TDR) at the World Health Organization, in collaboration with its Regional Office for the Americas (PAHO) formed a partnership with the Ecosystem and Human Health Program of the International Development Research Centre (IDRC) of Canada to develop the research program under the title "Towards Improved Dengue and Chagas Disease Control through Innovative Ecosystem Management and Community-Directed Interventions: An Eco-Bio-Social Research Programme on Dengue and Chagas Disease in Latin America and the Caribbean" (IDRC grant Project Number 104951-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuagyr, 2014, TAR SERV AC ALC JUN; BARRERA R, 1993, J AM MOSQUITO CONTR, V9, P189; Camacho L, 2006, 17 SEM NAC HIDR HIDR; Camara de Comercio de Bogota Facultad de Ciencias Universidad Nacional, 2007, PLAN COMP VID GIR 20; Caprara A, 2009, CAD SAUDE PUBLICA, V25, pS125, DOI 10.1590/S0102-311X2009001300012; DANE, 2013, PROYECC POBL 2005 20, DOI [10.1016/j.recot.2013.05.002, DOI 10.1016/J.RECOT.2013.05.002]; Erlanger TE, 2008, MED VET ENTOMOL, V22, P203, DOI 10.1111/j.1365-2915.2008.00740.x; Hairi Farizah, 2003, Asia Pac J Public Health, V15, P37, DOI 10.1177/101053950301500107; Hemme RR, 2009, ACTA TROP, V112, P59, DOI 10.1016/j.actatropica.2009.06.008; JICK TD, 1979, ADMIN SCI QUART, V24, P602, DOI 10.2307/2392366; Kalof L., 2008, ESSENTIAL SOCIAL RES; Kroeger A, 2006, BMJ-BRIT MED J, V332, P1247, DOI 10.1136/bmj.332.7552.1247; Kumar VA, 2010, TROP BIOMED, V27, P330; San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346; Maciel-de-Freitas R, 2011, TROP MED INT HEALTH, V16, P965, DOI 10.1111/j.1365-3156.2011.02797.x; Ministerio de Salud y Proteccion Social Organizacion Panamericana de la Salud, 2006, ESTR GEST INT NAC CO; MPS INS OPS, 2011, GEST VIG ENT CONTR T; Naing C, 2011, J COMMUN HEALTH, V36, P1044, DOI 10.1007/s10900-011-9407-1; Nalongsack S, 2009, NAGOYA J MED SCI, V71, P29; Pacheco-Coral Adriana del Pilar, 2010, Rev Salud Publica (Bogota), V12, P380; Padilla J, 2012, DENGUE COLOMBIA EPID, DOI [10.4269/ajtmh.14-0145, DOI 10.4269/AJTMH.14-0145]; Padmanabha H, 2010, ECOHEALTH, V7, P78, DOI 10.1007/s10393-010-0301-6; Pan American Health Organization (PAHO), 2014, NUMB REP CAS DENG SE; Panagos A, 2005, REV PANAM SALUD PUBL, V17, P225; Pasin L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082775; Patton M, 2015, UTILIZATION FOCUSED, VFourth; Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395; Pylypa Jen, 2009, Anthropol Med, V16, P73, DOI 10.1080/13648470802426292; Quintero J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-38; Quintero J, 2009, CAD SAUDE PUBLICA, V25, pS93, DOI 10.1590/S0102-311X2009001300009; Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503; Sivigila, 2013, NUM CAS DENG GIR CUN; Suarez R, 2009, CAD SAUDE PUBLICA, V25, pS104, DOI 10.1590/S0102-311X2009001300010; Suaya JA, 2009, AM J TROP MED HYG, V80, P846, DOI 10.4269/ajtmh.2009.80.846; Subbaraman R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-173; Superintendencia de Servicios Publicos Domiciliariosias, 2014, SIST UN INF SERV PUB; Sutherst RW, 2004, CLIN MICROBIOL REV, V17, P136, DOI 10.1128/CMR.17.1.136-173.2004; Syed M, 2010, J PAK MED ASSOC, V60, P243; Tiempo El, 1994, EL TIEMPO, V1; Tran HP, 2010, INT HEALTH, V2, P136, DOI 10.1016/j.inhe.2009.12.007; Tsuzuki A, 2009, AM J TROP MED HYG, V80, P752, DOI 10.4269/ajtmh.2009.80.752; Whiteford LM, 1997, MED ANTHROPOL Q, V11, P202, DOI 10.1525/maq.1997.11.2.202; WHO, 2012, GLOB STRAT DENG PREV, DOI [10.1371/journal.pntd.0003396, DOI 10.1371/JOURNAL.PNTD.0003396]; WHO, 2012, COMPR GUID PREV CONT; World Health Organization, 2012, WHO HDB INT VECT MAN	45	31	32	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129054	10.1371/journal.pone.0129054	http://dx.doi.org/10.1371/journal.pone.0129054			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK1PO	26061628	Green Published, gold, Green Submitted			2022-12-26	WOS:000355979500121
J	Itaguchi, Y; Yamada, C; Fukuzawa, K				Itaguchi, Yoshihiro; Yamada, Chiharu; Fukuzawa, Kazuyoshi			Writing in the Air: Contributions of Finger Movement to Cognitive Processing	PLOS ONE			English	Article							CIRCUITS; DISCONNECTION; RECOGNITION; IMITATION; LANGUAGE; ALEXIA	The present study investigated the interactions between motor action and cognitive processing with particular reference to kanji-culture individuals. Kanji-culture individuals often move their finger as if they are writing when they are solving cognitive tasks, for example, when they try to recall the spelling of English words. This behavior is called kusho, meaning air-writing in Japanese. However, its functional role is still unknown. To reveal the role of kusho behavior in cognitive processing, we conducted a series of experiments, employing two different cognitive tasks, a construction task and a stroke count task. To distinguish the effects of the kinetic aspects of kusho behavior, we set three hand conditions in the tasks; participants were instructed to use either kusho, unrelated finger movements or do nothing during the response time. To isolate possible visual effects, two visual conditions in which participants saw their hand and the other in which they did not, were introduced. We used the number of correct responses and response time as measures of the task performance. The results showed that kusho behavior has different functional roles in the two types of cognitive tasks. In the construction task, the visual feedback from finger movement facilitated identifying a character, whereas the kinetic feedback or motor commands for the behavior did not help to solve the task. In the stroke count task, by contrast, the kinetic aspects of the finger movements influenced counting performance depending on the type of the finger movement. Regardless of the visual condition, kusho behavior improved task performance and unrelated finger movements degraded it. These results indicated that motor behavior contributes to cognitive processes. We discussed possible mechanisms of the modality dependent contribution. These findings might lead to better understanding of the complex interaction between action and cognition in daily life.	[Itaguchi, Yoshihiro; Yamada, Chiharu; Fukuzawa, Kazuyoshi] Waseda Univ, Fac Letters Arts & Sci, Psychol Sect, Tokyo, Japan	Waseda University	Itaguchi, Y (corresponding author), Sapporo Med Univ, Sch Hlth Sci, Dept Phys Therapy, Sapporo, Hokkaido, Japan.	itaguchi@ruri.waseda.jp	Itaguchi, Yoshihiro/AAK-7239-2020; Yamada, Chiharu/ABA-5897-2020	Itaguchi, Yoshihiro/0000-0002-2033-2171; Yamada, Chiharu/0000-0003-1018-095X	Japan Society for the Promotion of Science KAKENHI Grant [25876089]	Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 25876089. http://www.jsps.go.jp/english/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano S., 1999, NIHONGO NO GOI TOKUS; Andres M, 2008, CURR DIR PSYCHOL SCI, V17, P313, DOI 10.1111/j.1467-8721.2008.00597.x; Andres M, 2007, J COGNITIVE NEUROSCI, V19, P563, DOI 10.1162/jocn.2007.19.4.563; Badets A, 2011, EXP PSYCHOL, V58, P287, DOI 10.1027/1618-3169/a000095; Badets A, 2010, COGNITION, V115, P46, DOI 10.1016/j.cognition.2009.11.007; Bender A, 2012, COGNITION, V124, P156, DOI 10.1016/j.cognition.2012.05.005; BENDER MB, 1982, J NEUROL SCI, V53, P531, DOI 10.1016/0022-510X(82)90249-0; Brass M, 2000, BRAIN COGNITION, V44, P124, DOI 10.1006/brcg.2000.1225; Buccino G, 2004, NEURON, V42, P323, DOI 10.1016/S0896-6273(04)00181-3; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; Dehaene S, 1996, NEUROPSYCHOLOGIA, V34, P1097, DOI 10.1016/0028-3932(96)00027-9; DEJERINE J., 1892, MEMOIRES SOC BIOL, V4, P61; Dejerine J., 1891, M M SOC BIOL, V3, P197; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Fischer M. H., 2011, FRONT PSYCHOL, V17, P2; Foglia L, 2013, WIRES COGN SCI, V4, P319, DOI 10.1002/wcs.1226; Fukatsu R, 1998, BRAIN, V121, P843, DOI 10.1093/brain/121.5.843; Fukuzawa K, 1986, CLIN APHASIOL, V16, P197; Goldin-Meadow S, 2001, PSYCHOL SCI, V12, P516, DOI 10.1111/1467-9280.00395; Goldin-Meadow S, 2009, PSYCHOL SCI, V20, P267, DOI 10.1111/j.1467-9280.2009.02297.x; Goldstein Kurt, 1948, LANGUAGE LANGUAGE DI; Haslinger B, 2002, COGNITIVE BRAIN RES, V13, P159, DOI 10.1016/S0926-6410(01)00104-5; Hoosain R, 1991, PSYCHOLINGUISTIC IMP; Ihori N, 2000, EUR NEUROL, V44, P65, DOI 10.1159/000008199; Inui, 2002, JPN J NEUROPSYCHOL, V18, P68; Jonas M, 2007, NEUROIMAGE, V36, pT44, DOI 10.1016/j.neuroimage.2007.03.028; KASHIWAGI T, 1989, APHASIOLOGY, V3, P75, DOI 10.1080/02687038908248977; Kashu K, 1979, JINBUN KENKYU, V29, P103; Kess JF, 2001, JAPAN GLOBAL AGE, P175; LANDIS T, 1982, PSYCHOL MED, V12, P515, DOI 10.1017/S0033291700055616; LEVINE DN, 1988, BRAIN LANG, V35, P172, DOI 10.1016/0093-934X(88)90107-1; Maher LM, 1998, J INT NEUROPSYCH SOC, V4, P636, DOI 10.1017/S1355617798466128; Matsuo K, 2003, COGNITIVE BRAIN RES, V17, P263, DOI 10.1016/S0926-6410(03)00114-9; Matsuo K, 2001, BRAIN RES BULL, V55, P549, DOI 10.1016/S0361-9230(01)00564-0; Mayer E, 1999, BRAIN, V122, P1107, DOI 10.1093/brain/122.6.1107; Michaux N, 2013, EXP PSYCHOL, V60, P197, DOI 10.1027/1618-3169/a000188; Miyamoto, 1994, JAPANESE PSYCHOLINGU, V24; Pesenti M, 2000, J COGNITIVE NEUROSCI, V12, P461, DOI 10.1162/089892900562273; SASAKI M, 1987, INT J BEHAV DEV, V10, P135, DOI 10.1177/016502548701000201; Siok WT, 2004, NATURE, V431, P71, DOI 10.1038/nature02865; Yim-Ng YY, 2000, INT J LANG COMM DIS, V35, P567	42	7	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0128419	10.1371/journal.pone.0128419	http://dx.doi.org/10.1371/journal.pone.0128419			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK1PO	26061273	Green Published, Green Submitted, gold			2022-12-26	WOS:000355979500081
J	Liu, YH; Lu, GM; Zhang, D				Liu, Yahui; Lu, Guangming; Zhang, David			An Effective 3D Ear Acquisition System	PLOS ONE			English	Article							RECOGNITION; RECONSTRUCTION; EXTRACTION; FIELD	The human ear is a new feature in biometrics that has several merits over the more common face, fingerprint and iris biometrics. It can be easily captured from a distance without a fully cooperative subject. Also, the ear has a relatively stable structure that does not change much with the age and facial expressions. In this paper, we present a novel method of 3D ear acquisition system by using triangulation imaging principle, and the experiment results show that this design is efficient and can be used for ear recognition.	[Liu, Yahui; Lu, Guangming] Harbin Inst Technol, Shenzhen Grad Sch, Dept Comp Sci & Technol, Shenzhen, Peoples R China; [Zhang, David] Hong Kong Polytech Univ, Biometr Res Ctr, Dept Comp, Kowloon, Hong Kong, Peoples R China	Harbin Institute of Technology; University Town of Shenzhen; Hong Kong Polytechnic University	Zhang, D (corresponding author), Harbin Inst Technol, Shenzhen Grad Sch, Dept Comp Sci & Technol, Shenzhen, Peoples R China.	cvpro1024@gmail.com	Zhang, David D/O-9396-2016; Zhang, Hao/HHM-1940-2022	Zhang, David D/0000-0002-5027-5286; LIU, Yahui/0000-0002-4632-2369; liu, yahui/0000-0002-8764-0769	GRF fund from the HKSAR Government; central fund from Hong Kong Polytechnic University; NSFC fund [61332011, 61020106004, 61272292, 61271344]; Shenzhen Fundamental Research fund [JCYJ20130401152508661]; Key Laboratory of Network Oriented Intelligent Computation, Shenzhen, China	GRF fund from the HKSAR Government; central fund from Hong Kong Polytechnic University; NSFC fund(National Natural Science Foundation of China (NSFC)); Shenzhen Fundamental Research fund; Key Laboratory of Network Oriented Intelligent Computation, Shenzhen, China	The work is supported by the GRF fund from the HKSAR Government, the central fund from Hong Kong Polytechnic University, the NSFC fund (61332011, 61020106004, 61272292, 61271344), Shenzhen Fundamental Research fund (JCYJ20130401152508661), and Key Laboratory of Network Oriented Intelligent Computation, Shenzhen, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaza A, 2010, BIOM THEOR APPL SYST; Abaza A, 2013, ACM COMPUT SURV, V45, DOI 10.1145/2431211.2431221; Azevedo TCS, 2010, COMPUT METHOD BIOMEC, V13, P359, DOI 10.1080/10255840903251288; Azevedo TCS, 2009, COMPUT METH APPL SCI, V13, P117; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Burge M, 2000, PATT REC 15 INT C IE; Chen H, 2009, IEEE T PATTERN ANAL, V31, P172, DOI 10.1109/TPAMI.2008.176; Chen H, 2007, IEEE T PATTERN ANAL, V29, P718, DOI 10.1109/TPAMI.2007.1005; Chora M, 2005, EAR BIOMETRICS BASED; Hurley DJ, 2005, COMPUT VIS IMAGE UND, V98, P491, DOI 10.1016/j.cviu.2004.11.001; Iannarelli A., 1989, FORENSIC IDENTIFICAT; Islam SMS, 2012, ACM COMPUT SURV, V44, DOI 10.1145/2187671.2187676; Islam SMS, 2011, INT J COMPUT VISION, V95, P52, DOI 10.1007/s11263-011-0436-0; JAIN AK, 1999, BIOMETRICS PERSONAL; Kakadiaris IA, 2007, IEEE T PATTERN ANAL, V29, P640, DOI 10.1109/TPAMI.2007.1017; Li W, 2012, IEEE T SYST MAN CY A, V42, P443, DOI 10.1109/TSMCA.2011.2164066; Liu F, 2013, TOUCHLESS MULTIVIEW; Liu F, 2014, PATTERN RECOGN, V47, P178, DOI 10.1016/j.patcog.2013.06.009; Oliveira FPM, 2014, COMPUT METHOD BIOMEC, V17, P73, DOI 10.1080/10255842.2012.670855; Pang YW, 2011, SIGNAL PROCESS, V91, P773, DOI 10.1016/j.sigpro.2010.08.010; Purkait R, 2008, FORENSIC SCI INT, V178, P112, DOI 10.1016/j.forsciint.2008.02.009; Turk Greg, 1994, P 21 ANN C COMP GRAP; Yan P, 2007, IEEE T PATTERN ANAL, V29, P1297, DOI 10.1109/TPAMI.2007.1067; Zhang D, 2003, IEEE T PATTERN ANAL, V25, P1041, DOI 10.1109/TPAMI.2003.1227981; Zhang D., 2013, AUTOMATED BIOMETRICS, V7; Zhang D, 2010, PATTERN RECOGN, V43, P358, DOI 10.1016/j.patcog.2009.04.026; Zhang D, 2009, TEXT RES J, V79, P3, DOI 10.1177/0040517507101401; Zhang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095506; Zhang YB, 2007, LECT NOTES COMPUT SC, V4781, P154; Zhou JD, 2012, IEEE T INF FOREN SEC, V7, P978, DOI 10.1109/TIFS.2012.2189005	31	3	3	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129439	10.1371/journal.pone.0129439	http://dx.doi.org/10.1371/journal.pone.0129439			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061553	Green Submitted, Green Published, gold			2022-12-26	WOS:000355979500144
J	Restrepo, NA; Farber-Eger, E; Goodloe, R; Haines, JL; Crawford, DC				Restrepo, Nicole A.; Farber-Eger, Eric; Goodloe, Robert; Haines, Jonathan L.; Crawford, Dana C.			Extracting Primary Open-Angle Glaucoma from Electronic Medical Records for Genetic Association Studies	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; AFRICAN-AMERICANS; SUSCEPTIBILITY LOCI; PREVALENCE; VARIANTS; IDENTIFY; RISK; IDENTIFICATION; PREDICTORS; TRAITS	Electronic medical records (EMRs) are being widely implemented for use in genetic and genomic studies. As a phenotypic rich resource, EMRs provide researchers with the opportunity to identify disease cohorts and perform genotype-phenotype association studies. The Epidemiologic Architecture for Genes Linked to Environment (EAGLE) study, as part of the Population Architecture using Genomics and Epidemiology (PAGE) I study, has genotyped more than 15,000 individuals of diverse genetic ancestry in BioVU, the Vanderbilt University Medical Center's biorepository linked to a de-identified version of the EMR (EAGLE BioVU). Here we develop and deploy an algorithm utilizing data mining techniques to identify primary open-angle glaucoma (POAG) in African Americans from EAGLE BioVU for genetic association studies. The algorithm described here was designed using a combination of diagnostic codes, current procedural terminology billing codes, and free text searches to identify POAG status in situations where gold-standard digital photography cannot be accessed. The case algorithm identified 267 potential POAG subjects but underperformed after manual review with a positive predictive value of 51.6% and an accuracy of 76.3%. The control algorithm identified controls with a negative predictive value of 98.3%. Although the case algorithm requires more downstream manual review for use in large-scale studies, it provides a basis by which to extract a specific clinical subtype of glaucoma from EMRs in the absence of digital photographs.	[Restrepo, Nicole A.; Farber-Eger, Eric; Goodloe, Robert] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37235 USA; [Haines, Jonathan L.; Crawford, Dana C.] Case Western Reserve Univ, Inst Computat Biol, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA	Vanderbilt University; Case Western Reserve University	Crawford, DC (corresponding author), Case Western Reserve Univ, Inst Computat Biol, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA.	dana.crawford@case.edu	Crawford, Dana/O-5578-2019; Haines, Jonathan/C-3374-2012	Crawford, Dana/0000-0002-6437-6248; Haines, Jonathan/0000-0002-4351-4728	National Institutes of Health [U01 HG004798]; Vanderbilt University Medical Center's BioVU; National Center for Advancing Translational Sciences [2 UL1 TR000445-06]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University Medical Center's BioVU; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by National Institutes of Health U01 HG004798 and its ARRA supplements. The dataset(s) used for the analyses described were obtained from Vanderbilt University Medical Center's BioVU which is supported by institutional funding and the National Center for Research Resources, Grant UL1 RR024975-01 (now at the National Center for Advancing Translational Sciences, Grant 2 UL1 TR000445-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burdon KP, 2011, NAT GENET, V43, P574, DOI 10.1038/ng.824; Cheng I, 2013, PLEIOTROPIC EFFECTS; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Crawford DC, HUMAN HERED IN PRESS; Crimmins E. M., 2004, CRITICAL PERSPECTIVE; Crosslin DR, 2013, HUM MOL GENET, V22, P2119, DOI 10.1093/hmg/ddt010; Crosslin DR, 2012, HUM GENET, V131, P639, DOI 10.1007/s00439-011-1103-9; Delaney JT, 2012, CLIN PHARMACOL THER, V91, P257, DOI 10.1038/clpt.2011.221; Denny JC, 2011, AM J HUM GENET, V89, P529, DOI 10.1016/j.ajhg.2011.09.008; Denny JC, 2010, CIRCULATION, V122, P2016, DOI 10.1161/CIRCULATIONAHA.110.948828; Ding KY, 2013, G3-GENES GENOM GENET, V3, P1061, DOI 10.1534/g3.113.006452; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Friedman DS, 1999, OPHTHALMOLOGY, V106, P1049, DOI 10.1016/S0161-6420(99)90267-1; Gong J, 2013, AM J HUM GENET, V93, P661, DOI 10.1016/j.ajhg.2013.08.012; Jeff JM, 2013, ANN HUM GENET, V77, P321, DOI 10.1111/ahg.12023; Kho AN, 2012, J AM MED INFORM ASSN, V19, P212, DOI 10.1136/amiajnl-2011-000439; Kho AN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001807; Kocarnik JM, 2014, J INVEST DERMATOL, V134, P2049, DOI 10.1038/jid.2014.53; Kohane IS, 2011, NAT REV GENET, V12, P417, DOI 10.1038/nrg2999; Ladapo JA, 2012, ARCH OPHTHALMOL-CHIC, V130, P365, DOI 10.1001/archopthalmol.2011.1224; Liu YT, 2013, INVEST OPHTH VIS SCI, V54, P6248, DOI 10.1167/iovs.13-12779; Malinowski JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111301; Matise TC, 2011, AM J EPIDEMIOL, V174, P849, DOI 10.1093/aje/kwr160; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; Nakano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033389; Newton KM, 2013, J AM MED INFORM ASSN, V20, pE147, DOI 10.1136/amiajnl-2012-000896; Ng MCY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004517; Oetjens M, 2014, BIOCOMPUT-PAC SYM, P253; Osman W, 2012, HUM MOL GENET, V21, P2836, DOI 10.1093/hmg/dds103; Peissig PL, 2012, J AM MED INFORM ASSN, V19, P225, DOI 10.1136/amiajnl-2011-000456; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramirez AH, 2012, PHARMACOGENOMICS, V13, P407, DOI [10.2217/PGS.11.164, 10.2217/pgs.11.164]; Rasmussen-Torvik LJ, 2012, CTS-CLIN TRANSL SCI, V5, P394, DOI 10.1111/j.1752-8062.2012.00446.x; Resnikoff S, 2002, B WORLD HEALTH ORGAN, V82, P844; Ritchie MD, 2013, CIRCULATION, V127, P1377, DOI 10.1161/CIRCULATIONAHA.112.000604; Ritchie MD, 2010, AM J HUM GENET, V86, P560, DOI 10.1016/j.ajhg.2010.03.003; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Stein JD, 2011, OPHTHALMOLOGY, V118, P1031, DOI 10.1016/j.ophtha.2010.10.024; Vajaranant TS, 2012, AM J OPHTHALMOL, V154, P303, DOI 10.1016/j.ajo.2012.02.024; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Wiggs JL, 2012, PLOS GENET, V8, P413, DOI 10.1371/journal.pgen.1002654	41	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0127817	10.1371/journal.pone.0127817	http://dx.doi.org/10.1371/journal.pone.0127817			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK1PO	26061293	Green Published, Green Submitted, gold			2022-12-26	WOS:000355979500059
J	Shao, BY; Liao, L; Yu, Y; Shuai, Y; Su, XX; Jing, H; Yang, DQ; Jin, Y				Shao, Bingyi; Liao, Li; Yu, Yang; Shuai, Yi; Su, Xiaoxia; Jing, Huan; Yang, Deqin; Jin, Yan			Estrogen preserves Fas ligand levels by inhibiting microRNA-181a in bone marrow-derived mesenchymal stem cells to maintain bone remodeling balance	FASEB JOURNAL			English	Article						apoptosis; osteoclast; osteoporosis; gene regulation; cell transplantation	RECEPTOR-ALPHA; OSTEOBLAST PROGENITORS; APOPTOSIS; TRANSPLANTATION; EXPRESSION; RESORPTION; GROWTH; CXCR4; RANK; MASS	Estrogen protects bone loss by promoting Fas ligand (FasL) transcription in osteoclasts and osteoblasts to induce apoptosis of osteoclasts. Bone marrow-derived mesenchymal stem cells (BMMSCs) express FasL protein, which is necessary for BMMSCs to induce T-cell apoptosis in cell therapy. However, the physiologic function of FasL in BMMSCs is unknown. In this study, using an in vitro coculture system and an in vivo BMMSC transplantation assay, we found that BMMSCs potently induced apoptosis of osteoclasts through the FasL/Fas pathway. Estrogen was necessary for this process as a promoter of FasL protein accumulation in BMMSCs. Furthermore, estrogen elevated FasL protein accumulation, not by increasing FasL gene transcription, but through microRNA-mediated posttranscriptional regulation. In brief, estrogen down-regulated expression of miR-181a, a negative modulator of FasL targeting the 3'-UTR of FasL mRNA. Estrogen deficiency resulted in excessive miR-181a, which decreased FasL protein levels to suppress BMMSC-induced osteoclast apoptosis. Furthermore, knockdown of miR-181a recovered the BMMSC defect to induce osteoclast apoptosis during estrogen deficiency. Taken together, our results showed that estrogen preserves FasL protein accumulation by inhibiting miR-181a expression in BMMSCs to maintain bone remodeling balance, suggesting a novel mechanism by which estrogen preserves bone mass.	[Shao, Bingyi; Liao, Li; Yu, Yang; Shuai, Yi; Jing, Huan; Jin, Yan] Fourth Mil Med Univ, Sch Stomatol, State Key Lab Mil Stomatol, Ctr Tissue Engn, Xian 710032, Shaanxi, Peoples R China; [Liao, Li; Shuai, Yi; Jing, Huan] Fourth Mil Med Univ, Sch Stomatol, Dept Oral Histol & Pathol, State Key Lab Mil Stomatol, Xian 710032, Shaanxi, Peoples R China; [Liao, Li; Shuai, Yi; Jing, Huan; Jin, Yan] Fourth Mil Med Univ, Res & Dev Ctr Tissue Engn, Xian 710032, Shaanxi, Peoples R China; [Shao, Bingyi; Yu, Yang; Yang, Deqin] Chongqing Med Univ, Affiliated Hosp Stomatol, Chongqing, Peoples R China; [Shao, Bingyi; Yu, Yang; Yang, Deqin] Chongqing Res Ctr Oral Dis & Biomed Sci, Chongqing, Peoples R China; [Su, Xiaoxia] Xi An Jiao Tong Univ, Coll Med, Inst Neurobiol Environm & Genes Related Dis, Key Lab,Educ Minist, Xian 710049, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Chongqing Medical University; Xi'an Jiaotong University	Jin, Y (corresponding author), Fourth Mil Med Univ, Sch Stomatol, State Key Lab Mil Stomatol, Ctr Tissue Engn, 145 West Changle Rd, Xian 710032, Shaanxi, Peoples R China.	yangdeqin@gmail.com; yanjin@fmmu.edu.cn	Jin, Yan/I-4204-2013; Liao, Li/U-6866-2017	Liao, Li/0000-0003-0030-1009; Yang, Deqin/0000-0002-2579-8384	National Major Scientific Research Program of China [2011CB964700]; Nature Science Foundation of China [31030033, 81470710]	National Major Scientific Research Program of China; Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grant 2011CB964700 from the National Major Scientific Research Program of China, and Grants 31030033 and 81470710 from the Nature Science Foundation of China. The authors declare no conflicts of interest.	Akiyama K, 2012, CELL STEM CELL, V10, P544, DOI 10.1016/j.stem.2012.03.007; Almeida M, 2013, J CLIN INVEST, V123, P394, DOI 10.1172/JCI65910; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Boyce BF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2165; Cho SW, 2009, MOL THER, V17, P1979, DOI 10.1038/mt.2009.153; Di Gregorio GB, 2001, J CLIN INVEST, V107, P803, DOI 10.1172/JCI11653; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; HUGHES DE, 1995, J BONE MINER RES, V10, P1478; Hughes DE, 1996, NAT MED, V2, P1132, DOI 10.1038/nm1096-1132; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Kameda T, 1997, J EXP MED, V186, P489, DOI 10.1084/jem.186.4.489; Khosla S, 2012, TRENDS ENDOCRIN MET, V23, P576, DOI 10.1016/j.tem.2012.03.008; Klinge CM, 2012, TRENDS ENDOCRIN MET, V23, P223, DOI 10.1016/j.tem.2012.03.002; Kobayashi Y, 2000, J BONE MINER RES, V15, P1924, DOI 10.1359/jbmr.2000.15.10.1924; Krum SA, 2008, EMBO J, V27, P535, DOI 10.1038/sj.emboj.7601984; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; Liao L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.130; Lien CY, 2009, J BONE MINER RES, V24, P837, DOI [10.1359/jbmr.081257, 10.1359/JBMR.081257]; Liu YL, 2011, STEM CELLS, V29, P1804, DOI 10.1002/stem.728; Maatta JA, 2013, FASEB J, V27, P478, DOI 10.1096/fj.12-213587; Maillot G, 2009, CANCER RES, V69, P8332, DOI 10.1158/0008-5472.CAN-09-2206; Manavalan TT, 2011, CANCER LETT, V313, P26, DOI 10.1016/j.canlet.2011.08.018; Modder UI, 2011, BONE, V49, P202, DOI 10.1016/j.bone.2011.04.015; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Novack DV, 2007, CELL METAB, V6, P254, DOI 10.1016/j.cmet.2007.09.007; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Qian PX, 2011, CANCER RES, V71, P6463, DOI 10.1158/0008-5472.CAN-11-1322; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Tome M, 2011, CELL DEATH DIFFER, V18, P985, DOI 10.1038/cdd.2010.167; van Rooij E, 2012, NAT REV DRUG DISCOV, V11, P860, DOI 10.1038/nrd3864; Xian LL, 2012, NAT MED, V18, P1095, DOI 10.1038/nm.2793; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yang N, 2013, J BONE MINER RES, V28, P559, DOI 10.1002/jbmr.1798	37	31	38	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3935	3944		10.1096/fj.15-272823	http://dx.doi.org/10.1096/fj.15-272823			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26062603				2022-12-26	WOS:000359915600028
J	Fu, YH; Xu, ZZ; Lu, ZJ; Zhao, S; Mathews, DH				Fu, Yinghan; Xu, Zhenjiang Zech; Lu, Zhi J.; Zhao, Shan; Mathews, David H.			Discovery of Novel ncRNA Sequences in Multiple Genome Alignments on the Basis of Conserved and Stable Secondary Structures	PLOS ONE			English	Article							NONCODING RNA GENES; STRUCTURE PREDICTION; ALGORITHM; MODEL; CONSTRAINTS; PARAMETERS; STABILITY; THOUSANDS; DATABASE; BROWSER	Recently, non-coding RNAs (ncRNAs) have been discovered with novel functions, and it has been appreciated that there is pervasive transcription of genomes. Moreover, many novel ncRNAs are not conserved on the primary sequence level. Therefore, de novo computational ncRNA detection that is accurate and efficient is desirable. The purpose of this study is to develop a ncRNA detection method based on conservation of structure in more than two genomes. A new method called Multifind, using Multilign, was developed. Multilign predicts the common secondary structure for multiple input sequences. Multifind then uses measures of structure conservation to estimate the probability that the input sequences are a conserved ncRNA using a classification support vector machine. Multilign is based on Dynalign, which folds and aligns two sequences simultaneously using a scoring scheme that does not include sequence identity; its structure prediction quality is therefore not affected by input sequence diversity. Additionally, ensemble defect was introduced to Multifind as an additional discriminating feature that quantifies the compactness of the folding space for a sequence. Benchmarks showed Multifind performs better than RNAz and LocARNATE+RNAz, a method that uses RNAz on structure alignments generated by LocARNATE, on testing sequences extracted from the Rfam database. For de novo ncRNA discovery in three genomes, Multifind and LocARNATE+RNAz had an advantage over RNAz in low similarity regions of genome alignments. Additionally, Multifind and LocARNATE+RNAz found different subsets of known ncRNA sequences, suggesting the two approaches are complementary.	[Fu, Yinghan; Xu, Zhenjiang Zech; Zhao, Shan; Mathews, David H.] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Fu, Yinghan; Xu, Zhenjiang Zech; Zhao, Shan; Mathews, David H.] Univ Rochester, Med Ctr, Ctr RNA Biol, Rochester, NY 14642 USA; [Lu, Zhi J.] Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China; [Mathews, David H.] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA	University of Rochester; University of Rochester; Tsinghua University; University of Rochester	Mathews, DH (corresponding author), Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA.	David_Mathews@urmc.rochester.edu	Xu, Zhenjiang Zech/F-6493-2012	Xu, Zhenjiang Zech/0000-0003-1080-024X	United States National Institutes of Health [R01GM076485]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076485] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Grant funding was provided by the United States National Institutes of Health, R01GM076485 to DHM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Chan CY, 2008, J MATH BIOL, V56, P93, DOI 10.1007/s00285-007-0129-z; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chodroff RA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r72; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Deng W, 2003, J BACTERIOL, V185, P2330, DOI 10.1128/JB.185.7.2330-2337.2003; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Fouts DE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000141; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gardner Paul P, 2011, Nucleic Acids Res, V39, pD141, DOI 10.1093/nar/gkq1129; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Gruber AR, 2010, BIOCOMPUT-PAC SYM, P69; Gruber AR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-122; Harmanci AO, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-130; Holt KE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-36; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lu ZJ, 2009, RNA, V15, P1805, DOI 10.1261/rna.1643609; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mathews DH, 2002, J MOL BIOL, V317, P191, DOI 10.1006/jmbi.2001.5351; Mathews DH, 2002, BIOCHEMISTRY-US, V41, P869, DOI 10.1021/bi011441d; Ohnishi Y, 2008, J BACTERIOL, V190, P4050, DOI 10.1128/JB.00204-08; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Rivas E, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-8; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Torarinsson E, 2008, GENOME RES, V18, P242, DOI 10.1101/gr.6887408; Torarinsson E, 2006, GENOME RES, V16, P885, DOI 10.1101/gr.5226606; Turner DH, 2010, NUCLEIC ACIDS RES, V38, pD280, DOI 10.1093/nar/gkp892; Vockenhuber MP, 2011, RNA BIOL, V8, P468, DOI 10.4161/rna.8.3.14421; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Washietl S, 2007, GENOME RES, V17, P852, DOI 10.1101/gr.5650707; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Xu ZJ, 2011, BIOINFORMATICS, V27, P626, DOI 10.1093/bioinformatics/btq726; Yao ZZ, 2006, BIOINFORMATICS, V22, P445, DOI 10.1093/bioinformatics/btk008; Zadeh JN, 2011, J COMPUT CHEM, V32, P439, DOI 10.1002/jcc.21633	45	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130200	10.1371/journal.pone.0130200	http://dx.doi.org/10.1371/journal.pone.0130200			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075601	Green Published, Green Submitted, gold			2022-12-26	WOS:000356329900154
J	Kano, F; Hirata, S; Call, J				Kano, Fumihiro; Hirata, Satoshi; Call, Josep			Social Attention in the Two Species of Pan: Bonobos Make More Eye Contact than Chimpanzees	PLOS ONE			English	Article							TOOL USE; GAZE; HUMANS; FACE; TROGLODYTES; FIXATION; PATTERNS; CONSPECIFICS; PRIMATES; INFANTS	Humans' two closest primate living relatives, bonobos and chimpanzees, differ behaviorally, cognitively, and emotionally in several ways despite their general similarities. While bonobos show more affiliative behaviors towards conspecifics, chimpanzees display more overt and severe aggression against conspecifics. From a cognitive standpoint, bonobos perform better in social coordination, gaze-following and food-related cooperation, while chimpanzees excel in tasks requiring extractive foraging skills. We hypothesized that attention and motivation play an important role in shaping the species differences in behavior, cognition, and emotion. Thus, we predicted that bonobos would pay more attention to the other individuals' face and eyes, as those are related to social affiliation and social coordination, while chimpanzees would pay more attention to the action target objects, as they are related to foraging. Using eye-tracking we examined the bonobos' and chimpanzees' spontaneous scanning of pictures that included eyes, mouth, face, genitals, and action target objects of conspecifics. Although bonobos and chimpanzees viewed those elements overall similarly, bonobos viewed the face and eyes longer than chimpanzees, whereas chimpanzees viewed the other elements, the mouth, action target objects and genitals, longer than bonobos. In a discriminant analysis, the individual variation in viewing patterns robustly predicted the species of individuals, thus clearly demonstrating species-specific viewing patterns. We suggest that such attentional and motivational differences between bonobos and chimpanzees could have partly contributed to shaping the species-specific behaviors, cognition, and emotion of these species, even in a relatively short period of evolutionary time.	[Hirata, Satoshi] Kyoto Univ, Wildlife Res Ctr, Kumamoto Sanctuary, Kumamoto 990, Japan; [Kano, Fumihiro] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan; [Kano, Fumihiro; Call, Josep] Max Planck Inst Evolutionare Anthropol, Dept Dev & Comparat Psychol, D-04103 Leipzig, Germany; [Kano, Fumihiro] Japan Soc Promot Sci, Tokyo, Japan; [Call, Josep] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland	Kyoto University; Kyoto University; Max Planck Society; Japan Society for the Promotion of Science; University of St Andrews	Kano, F (corresponding author), Kyoto Univ, Wildlife Res Ctr, Kumamoto Sanctuary, Kumamoto 990, Japan.	fkanou@gmail.com		Call Balaguer, Josep/0000-0002-8597-8336; Kano, Fumihiro/0000-0003-4534-6630	JSPS [26885040, 26245069]; MEXT [24000001]; MEXT-PRI-Human Evolution;  [JSPS-LGP-U04]; Grants-in-Aid for Scientific Research [26245069] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT-PRI-Human Evolution; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was conducted in part under FK's post-doc program; the Japan Society for Promotion of Science (JSPS) for study abroad. FK and SH respectively received JSPS KAKENHI Grant Number 26885040 and 26245069 URL: http://www.jsps.go.jp/english/. This study was in part funded by JSPS KAKENHI Grant Number 26885040 and 26245069, MEXT KAKENHI Grant Number 24000001, JSPS-LGP-U04, JSPS core-to-core type A CCSN, and MEXT-PRI-Human Evolution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	ARGYLE M, 1965, SOCIOMETRY, V28, P289, DOI 10.2307/2786027; Bard KA, 2005, DEV PSYCHOL, V41, P616, DOI 10.1037/0012-1649.41.4.616; Baron-Cohen S, 2009, ANN NY ACAD SCI, V1156, P68, DOI 10.1111/j.1749-6632.2009.04467.x; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; Conty L, 2006, SPATIAL VISION, V19, P529, DOI 10.1163/156856806779194026; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; de Waal F.B.M., 1990, PEACEMAKING PRIMATES; de Waal FB., 1990, SOCIOSEXUAL BEHAV US, P378; Deaner RO, 2005, CURR BIOL, V15, P543, DOI 10.1016/j.cub.2005.01.044; Ebitz RB, 2013, P NATL ACAD SCI USA, V110, P11630, DOI 10.1073/pnas.1305230110; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; Ferrari PF, 2009, CURR BIOL, V19, P1768, DOI 10.1016/j.cub.2009.08.055; Fletcher-Watson S, 2008, PERCEPTION, V37, P571, DOI 10.1068/p5705; Furuichi T, 2011, EVOL ANTHROPOL, V20, P131, DOI 10.1002/evan.20308; Gomez Juan Carlos, 1996, P131; Gothard KM, 2004, ANIM COGN, V7, P25, DOI 10.1007/s10071-003-0179-6; Gruber T, 2010, ANIM BEHAV, V80, P1023, DOI 10.1016/j.anbehav.2010.09.005; Guastella AJ, 2008, BIOL PSYCHIAT, V63, P3, DOI 10.1016/j.biopsych.2007.06.026; Guo K, 2003, EXP BRAIN RES, V150, P363, DOI 10.1007/s00221-003-1429-1; Guo K, 2007, EXP BRAIN RES, V181, P673, DOI 10.1007/s00221-007-1038-5; Happe F, 1999, TRENDS COGN SCI, V3, P216, DOI 10.1016/S1364-6613(99)01318-2; Hare B, 2000, ANIM BEHAV, V59, P771, DOI 10.1006/anbe.1999.1377; Hare B, 2007, CURR BIOL, V17, P619, DOI 10.1016/j.cub.2007.02.040; Hare B, 2012, ANIM BEHAV, V83, P573, DOI 10.1016/j.anbehav.2011.12.007; Herrmann E, 2011, DEVELOPMENTAL SCI, V14, P1393, DOI 10.1111/j.1467-7687.2011.01082.x; Herrmann E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012438; Hershler O, 2005, VISION RES, V45, P1707, DOI 10.1016/j.visres.2004.12.021; Hirata S, 2010, ANIM COGN, V13, P679, DOI 10.1007/s10071-010-0316-y; Hohmann G, 2003, CURR ANTHROPOL, V44, P563, DOI 10.1086/377649; Jones W, 2013, NATURE, V504, P427, DOI 10.1038/nature12715; JORDAN C, 1982, J HUM EVOL, V11, P36; Kano F, 2014, ANIM BEHAV, V91, P137, DOI 10.1016/j.anbehav.2014.03.011; Kano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059785; Kano F, 2012, J COMP PSYCHOL, V126, P388, DOI 10.1037/a0029615; Kano F, 2011, VISION RES, V51, P2348, DOI 10.1016/j.visres.2011.09.006; Kano F, 2010, ANIM BEHAV, V79, P227, DOI 10.1016/j.anbehav.2009.11.003; Kano T., 1982, Primates, V23, P453, DOI 10.1007/BF02381327; Kawashima R, 1999, BRAIN, V122, P779, DOI 10.1093/brain/122.4.779; KEATING CF, 1982, PERCEPTION, V11, P211, DOI 10.1068/p110211; KLEINKE CL, 1986, PSYCHOL BULL, V100, P78, DOI 10.1037/0033-2909.100.1.78; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Koops K, CHIMPANZEES IN PRESS; Lutchmaya S, 2002, INFANT BEHAV DEV, V25, P327, DOI 10.1016/S0163-6383(02)00094-2; MacLean EL, 2014, BEHAVIOUR IN PRESS; Matsuzawa T., 2006, COGNITIVE DEV CHIMPA; McIntyre MH, 2009, J HUM EVOL, V56, P361, DOI 10.1016/j.jhevol.2008.12.004; Mosher CP, 2014, CURR BIOL, V24, P2459, DOI 10.1016/j.cub.2014.08.063; Myowa-Yamakoshi M, 2003, COGNITION, V89, pB53, DOI 10.1016/S0010-0277(03)00071-4; Myowa-Yamakoshi M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1695; Nagasawa M, 2015, SCIENCE, V348, P333, DOI 10.1126/science.1261022; Oliva JL, 2015, ANIM COGN, V18, P767, DOI 10.1007/s10071-015-0843-7; Palagi E, 2006, AM J PHYS ANTHROPOL, V129, P418, DOI 10.1002/ajpa.20289; Rilling JK, 2012, SOC COGN AFFECT NEUR, V7, P369, DOI 10.1093/scan/nsr017; Rosati AG, 2007, CURR BIOL, V17, P1663, DOI 10.1016/j.cub.2007.08.033; Rosati AG, 2012, DEVELOPMENTAL SCI, V15, P840, DOI 10.1111/j.1467-7687.2012.01182.x; Ruiz A, 2009, ANIM COGN, V12, P427, DOI 10.1007/s10071-008-0202-z; Schick KD, 1999, J ARCHAEOL SCI, V26, P821, DOI 10.1006/jasc.1998.0350; Senju A, 2009, TRENDS COGN SCI, V13, P127, DOI 10.1016/j.tics.2008.11.009; Staes N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113364; Takeshita H, 1996, PRIMATES, V37, P423, DOI 10.1007/BF02381377; Tan JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051922; THOMSEN CE, 1974, ANIM BEHAV, V22, P144, DOI 10.1016/S0003-3472(74)80063-1; Tomonaga M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009131; van de Waal E, 2010, P ROY SOC B-BIOL SCI, V277, P2105, DOI 10.1098/rspb.2009.2260; van Schaik CP, 1999, J HUM EVOL, V36, P719, DOI 10.1006/jhev.1999.0304; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Wilson ML, 2014, NATURE, V513, P414, DOI 10.1038/nature13727; YAMAGIWA J, 1992, PRIMATES, V33, P523, DOI 10.1007/BF02381153	68	55	56	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129684	10.1371/journal.pone.0129684	http://dx.doi.org/10.1371/journal.pone.0129684			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26075710	gold, Green Published			2022-12-26	WOS:000356329900092
J	Khandaker, MU; Asaduzzaman, K; Nawi, SM; Usman, AR; Amin, YM; Daar, E; Bradley, DA; Ahmed, H; Okhunov, AA				Khandaker, M. U.; Asaduzzaman, Kh; Nawi, S. M.; Usman, A. R.; Amin, Y. M.; Daar, E.; Bradley, D. A.; Ahmed, H.; Okhunov, A. A.			Assessment of Radiation and Heavy Metals Risk due to the Dietary Intake of Marine Fishes (Rastrelliger kanagurta) from the Straits of Malacca	PLOS ONE			English	Article							NATURAL RADIOACTIVITY; BLACK-SEA; RADIONUCLIDE; ORGANISMS; AREA; BAY; CARCINOGENICITY; EXPOSURE; RA-226; PO-210	The environment of the Straits of Malacca receives pollution as a result of various industrial and anthropogenic sources, making systematic studies crucial in determining the prevailing water quality. Present study concerns concentrations of natural radionuclides and heavy metals in marine fish (Rastrelliger kanagurta) collected from the Straits of Malacca, since aquatic stock form an important source of the daily diet of the surrouding populace. Assessment was made of the concentrations of key indicator radionuclides (Ra-226, Th-232, K-40) and heavy metals (As, Mn, Fe, Cr, Ni, Zn, Cu, Co, Sr, Al, Hg and Pb) together with various radiation indices linked to the consumption of seafish. The annual effective dose for all detected radionuclides for all study locations has been found to be within UNSCEAR acceptable limits as has the associated life-time cancer risk. The overall contamination of the sampled fish from heavy metals was also found to be within limits of tolerance.	[Khandaker, M. U.; Asaduzzaman, Kh; Nawi, S. M.; Usman, A. R.; Amin, Y. M.; Bradley, D. A.] Univ Malaya, Dept Phys, Fac Sci, Kuala Lumpur 50603, Malaysia; [Daar, E.; Bradley, D. A.] Univ Surrey, Dept Phys, Guildford GU2 7XH, Surrey, England; [Daar, E.] Univ Jordan, Dept Phys, Fac Sci, Amman 11942, Jordan; [Ahmed, H.] Jazan Univ, Dept Phys, Fac Sci, Gizan 22822, Saudi Arabia; [Okhunov, A. A.] Int Islamic Univ Malaya, Dept Engn Sci, Kuala Lumpur 50728, Malaysia	Universiti Malaya; University of Surrey; University of Jordan; Jazan University	Khandaker, MU (corresponding author), Univ Malaya, Dept Phys, Fac Sci, Kuala Lumpur 50603, Malaysia.	mu_khandaker@um.edu.my	MOHD AMIN, YUSOFF/B-5339-2010; Khandaker, Mayeen Uddin/F-5376-2011; Khandoker, Asaduzzaman/J-9209-2013; Okhunov, Abdurahim/AAZ-5609-2020	Khandaker, Mayeen Uddin/0000-0003-3772-294X; Khandoker, Asaduzzaman/0000-0003-2420-6743; Usman, Ahmed Rufai/0000-0002-4469-7335	University of Malaya [RP006D-13AFR, UM.C/HIR/MOHE/SC/33]	University of Malaya(Universiti Malaya)	This work was supported by University of Malaya Research Grant: RP006D-13AFR and UM.C/HIR/MOHE/SC/33; fund receiver: MUK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasisiar F., 2004, J RADIAT RES, V2, P35; Alam L, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-43; ALAM MN, 1995, APPL RADIAT ISOTOPES, V46, P363, DOI 10.1016/0969-8043(95)00013-4; Alina M., 2012, International Food Research Journal, V19, P135; Amin YM, 2013, RADIAT PROT DOSIM, V156, P475, DOI 10.1093/rpd/nct097; Amin YM, 2013, APPL RADIAT ISOTOPES, V80, P109, DOI 10.1016/j.apradiso.2013.06.014; [Anonymous], 1996, SAF SER INT AT EN AG, V115; Antoine JMR, 2012, J FOOD COMPOS ANAL, V26, P111, DOI 10.1016/j.jfca.2012.01.003; Ariffin NAN, 2011, J ANAL SCI METH INST, V1, P1; Arogunjo AM, 2009, J ENVIRON RADIOACTIV, V100, P232, DOI 10.1016/j.jenvrad.2008.12.004; Asaduzzaman K, 2015, ANN NUCL ENERGY, V76, P85, DOI 10.1016/j.anucene.2014.09.036; Asaduzzaman K, 2014, J ENVIRON RADIOACTIV, V135, P120, DOI 10.1016/j.jenvrad.2014.04.009; Awudu AR, 2012, J RADIOANAL NUCL CH, V291, P635, DOI 10.1007/s10967-011-1444-9; Aydin D, 2015, FOOD ADDIT CONTAM B, V8, P25, DOI 10.1080/19393210.2014.949873; BLAYLOCK BG, 1982, NUCL SAFETY, V23, P427; Bogatov S., 2009, RADIOPROTECTION, V44, P159; Bose-O'Reilly S, 2010, CURR PROB PEDIATR AD, V40, P186, DOI 10.1016/j.cppeds.2010.07.002; Carvalho FP, 2011, ICES J MAR SCI, V68, P333, DOI 10.1093/icesjms/fsq088; Choi MS, 2008, J ENVIRON RADIOACTIV, V99, P1319, DOI 10.1016/j.jenvrad.2008.04.003; Connan O, 2007, J ENVIRON RADIOACTIV, V97, P168, DOI 10.1016/j.jenvrad.2007.04.004; De Boeck M, 2003, MUTAT RES-FUND MOL M, V533, P135, DOI 10.1016/j.mrfmmm.2003.07.012; FAO, 2001, JOINT FAO WHO EXP CO; Fishbein L, 1987, GENOTOXIC CARCINOGEN, P339; Fraizier A, 1976, IAEASM19918, P679; Freeman DB, 2004, STRAITS MALACCA GATE, P528; Gerber GB, 2002, CRIT REV ONCOL HEMAT, V42, P25, DOI 10.1016/S1040-8428(01)00178-0; Ghose S, 2000, RADIAT PROT DOSIM, V87, P287, DOI 10.1093/oxfordjournals.rpd.a033010; Gorur FK, 2012, CHEMOSPHERE, V87, P356, DOI 10.1016/j.chemosphere.2011.12.022; GUARY JC, 1977, HEALTH PHYS, V32, P21, DOI 10.1097/00004032-197701000-00003; Health Canada, 2007, HUM HLTH RISK ASS ME; Hvistendahl M., 2007, COAL ASH IS MORE RAD; Hyde, 1960, RADIOCHEMISTRY THORI; IAEA (International Atomic Energy Agency), 1995, IAEATECDOC838; ICRP, 1994, ICRP PUBL, V67; Kalay Mustafa, 2000, Turkish Journal of Zoology, V24, P429; Khan MF, 2011, MAR POLLUT BULL, V62, P399, DOI 10.1016/j.marpolbul.2010.12.016; Khan MF, 2011, TOXICOL ENVIRON CHEM, V93, P549, DOI 10.1080/02772248.2010.548118; Khandaker MU, 2015, RADIAT PROT DOSIM, V167, P196, DOI 10.1093/rpd/ncv243; Khandaker MU, 2012, RADIAT PROT DOSIM, V152, P33, DOI 10.1093/rpd/ncs145; Khandaker MU, 2013, RADIAT PHYS CHEM, V88, P1, DOI 10.1016/j.radphyschem.2013.02.034; Makon T.B., 2011, WORLD J NUCL SCI TEC, V1, P37, DOI [DOI 10.4236/WJNST.2011.12007, 10.4236/wjnst.2011.12007]; Mir-Marques A, 2012, J FOOD COMPOS ANAL, V27, P160, DOI 10.1016/j.jfca.2012.06.006; Patra A.C., 2013, RADIAT PROT DOSIM, P1; Pentreath RJ, 1980, P INT S IMP RAD REL, P241; Real A, 2004, J RADIOL PROT, V24, pA123, DOI 10.1088/0952-4746/24/4A/008; Rojas E, 1999, MUTAT RES-GEN TOX EN, V443, P157, DOI 10.1016/S1383-5742(99)00018-6; Roychowdhury T, 2003, SCI TOTAL ENVIRON, V308, P15, DOI 10.1016/S0048-9697(02)00612-5; Stern AH, 2010, ENVIRON RES, V110, P798, DOI 10.1016/j.envres.2010.08.002; Topcuoglu S, 2002, ENVIRON INT, V27, P521, DOI 10.1016/S0160-4120(01)00099-X; Turkmen A, 2005, FOOD CHEM, V91, P167, DOI 10.1016/j.foodchem.2004.08.008; Tuzen M, 2009, FOOD CHEM TOXICOL, V47, P1785, DOI 10.1016/j.fct.2009.04.029; UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Radiation), 1982, ION RAD SOURC BIOL E; UNSCEAR (United Nations Scientific Committee on the effects of Atomic Radiation), 2000, EXP NAT RAD SOURC, P140; UNSCEAR (United Nations Scientific Committee on the effects of Atomic Radiation) Sources and effects of Ionizing radiation, 2008, SOURC EFF LON RAD EX; USEPA, 1999, 13 USEPA; Usero J, 2004, ENVIRON INT, V29, P949, DOI 10.1016/S0160-4120(03)00061-8; VOLESKY B, 1995, BIOTECHNOL PROGR, V11, P235, DOI 10.1021/bp00033a001; WHO, 1996, CHEM ASP; Zhuang P, 2009, SCI TOTAL ENVIRON, V407, P1551, DOI 10.1016/j.scitotenv.2008.10.061	59	28	29	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128790	10.1371/journal.pone.0128790	http://dx.doi.org/10.1371/journal.pone.0128790			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075909	Green Submitted, Green Published, gold			2022-12-26	WOS:000356329900030
J	Lokody, IB; Francis, JC; Gardiner, JR; Erler, JT; Swain, A				Lokody, Isabel B.; Francis, Jeffrey C.; Gardiner, Jennifer R.; Erler, Janine T.; Swain, Amanda			Pten Regulates Epithelial Cytodifferentiation during Prostate Development	PLOS ONE			English	Article							STEM-CELL; MURINE; LEADS; MORPHOGENESIS; NKX3.1; BASAL; SUBPOPULATION; INACTIVATION; HYPERPLASIA; ACTIVATION	Gene expression and functional studies have indicated that the molecular programmes involved in prostate development are also active in prostate cancer. PTEN has been implicated in human prostate cancer and is frequently mutated in this disease. Here, using the Nkx3.1: Cre mouse strain and a genetic deletion approach, we investigate the role of Pten specifically in the developing mouse prostate epithelia. In contrast to its role in other developing organs, this gene is dispensable for the initial developmental processes such as budding and branching. However, as cytodifferentiation progresses, abnormal luminal cells fill the ductal lumens together with augmented epithelial proliferation. This phenotype resembles the hyperplasia seen in postnatal Pten deletion models that develop neoplasia at later stages. Consistent with this, gene expression analysis showed a number of genes affected that are shared with Pten mutant prostate cancer models, including a decrease in androgen receptor regulated genes. In depth analysis of the phenotype of these mice during development revealed that loss of Pten leads to the precocious differentiation of epithelial cells towards a luminal cell fate. This study provides novel insight into the role of Pten in prostate development as part of the process of coordinating the differentiation and proliferation of cell types in time and space to form a functional organ.	[Lokody, Isabel B.; Francis, Jeffrey C.; Gardiner, Jennifer R.; Erler, Janine T.; Swain, Amanda] Inst Canc Res, Div Canc Biol, London SW3 6JB, England; [Erler, Janine T.] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Copenhagen	Swain, A (corresponding author), Inst Canc Res, Div Canc Biol, 237 Fulham Rd, London SW3 6JB, England.	amanda.swain@icr.ac.uk		Francis, Jeff/0000-0001-6646-5749; Swain, Amanda/0000-0001-8666-1608; Erler, Janine/0000-0001-8675-6527	Institute of Cancer Research; Novo Nordisk Fonden [NNF12OC1015992] Funding Source: researchfish	Institute of Cancer Research; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Institute of Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Choi N, 2012, CANCER CELL, V21, P253, DOI 10.1016/j.ccr.2012.01.005; CUNHA GR, 1987, ENDOCR REV, V8, P338, DOI 10.1210/edrv-8-3-338; Dahia PLM, 2000, ENDOCR-RELAT CANCER, V7, P115, DOI 10.1677/erc.0.0070115; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; DONJACOUR AA, 1993, ENDOCRINOLOGY, V132, P2342, DOI 10.1210/en.132.6.2342; Francis JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003180; Gardiner JR, 2012, DEVELOPMENT, V139, P3456, DOI 10.1242/dev.079400; Ghosh S, 2011, DEV BIOL, V360, P329, DOI 10.1016/j.ydbio.2011.09.027; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; Higano CS, 2013, ONCOTARGETS THER, V6, P785, DOI 10.2147/OTT.S33077; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P2884, DOI 10.1073/pnas.042688999; Koltai T, 2014, ONCOTARGETS THER, V7, P447, DOI 10.2147/OTT.S58622; Korsten H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005662; Lei QY, 2006, CANCER CELL, V9, P367, DOI 10.1016/j.ccr.2006.03.031; LEONG KG, 2008, NATURE; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Li G, 2002, DEVELOPMENT, V129, P4159; Ma XQ, 2005, CANCER RES, V65, P5730, DOI 10.1158/0008-5472.CAN-04-4519; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Pritchard C, 2009, CANCER RES, V69, P1739, DOI 10.1158/0008-5472.CAN-07-6817; Schaeffer EM, 2008, ONCOGENE, V27, P7180, DOI 10.1038/onc.2008.327; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stoyanova T, 2012, GENE DEV, V26, P2271, DOI 10.1101/gad.196451.112; SUGIMURA Y, 1986, BIOL REPROD, V34, P985, DOI 10.1095/biolreprod34.5.985; Suzuki A, 2003, CANCER RES, V63, P674; Suzuki H, 1998, CANCER RES, V58, P204; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thomsen MK, 2008, DEV BIOL, V316, P302, DOI 10.1016/j.ydbio.2008.01.030; Thomson AA, 2006, DIFFERENTIATION, V74, P382, DOI 10.1111/j.1432-0436.2006.00101.x; Trerotola M, 2013, ONCOGENE, V32, P222, DOI 10.1038/onc.2012.36; Van de Sande T, 2005, J PATHOL, V206, P214, DOI 10.1002/path.1760; Wang SY, 2006, P NATL ACAD SCI USA, V103, P1480, DOI 10.1073/pnas.0510652103; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang YZ, 2001, DIFFERENTIATION, V68, P270, DOI 10.1046/j.1432-0436.2001.680414.x; Wang ZA, 2013, NAT CELL BIOL, V15, P274, DOI 10.1038/ncb2697; Yanagi S, 2007, J CLIN INVEST, V117, P2929, DOI 10.1172/JCI31854; Yue SH, 2014, CELL METAB, V19, P393, DOI 10.1016/j.cmet.2014.01.019	42	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129470	10.1371/journal.pone.0129470	http://dx.doi.org/10.1371/journal.pone.0129470			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076167	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900077
J	Romkema, S; Bongers, RM; van der Sluis, CK				Romkema, Sietske; Bongers, Raoul M.; van der Sluis, Corry K.			Influence of Inter-Training Intervals on Intermanual Transfer Effects in Upper-Limb Prosthesis Training: A Randomized Pre-Posttest Study	PLOS ONE			English	Article							DISTRIBUTED PRACTICE; BILATERAL TRANSFER; SKILL; PERFORMANCE; ACQUISITION; HANDS; TASK; COMPONENTS; SIMULATOR; RECALL	Improvement in prosthetic training using intermanual transfer (the transfer of motor skills from the trained, "unaffected" hand to the untrained, "affected" hand) has been shown in previous studies. The aim of this study is to determine the influence of the inter-training interval on the magnitude of the intermanual transfer effects. This was done using a mechanistic, randomized, single-blinded pretest-posttest design. Sixty-four able-bodied, righthanded participants were randomly assigned to the Short and Long Interval Training Groups and the Short and Long Interval Control Groups. The Short and Long Interval Training Groups used a prosthesis simulator in their training program. The Short and Long Interval Control Groups executed a sham training program, that is, a dummy training program in which the same muscles were trained as with the prosthesis simulator. The Short Interval Training Group and the Short Interval Control Groups trained on consecutive days, while the Long Interval Training Group and Long Interval Control Group trained twice a week. To determine the improvement in skills, a test was administered before, immediately after, and at two points in time after the training. Training was performed with the "unaffected" arm; tests were performed with the "affected" arm. The outcome measurements were: the movement time (the time from the beginning of the movement until completion of the task); the duration of maximum hand opening, (the opening of the prosthetic hand while grasping an object); and the grip-force control (the error from the required grip-force during a tracking task). Intermanual transfer was found in movement times, but not in hand opening or gripforce control. The length of the inter-training interval did not affect the magnitude of intermanual transfer effects. No difference in the intermanual transfer effect in upper-limb prosthesis training was found for training on a daily basis as compared to training twice a week.	[Romkema, Sietske; van der Sluis, Corry K.] Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Groningen, Netherlands; [Bongers, Raoul M.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands	University of Groningen; University of Groningen	Romkema, S (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Groningen, Netherlands.	s.romkema@umcg.nl	Bongers, Raoul/C-1094-2012	Bongers, Raoul/0000-0002-3518-7464	Fonds NutsOhra [1103-029]; Revalidatiefonds [R2011147]; Stichting Beatrixoord [210.130]; OIM Stichting [1103]	Fonds NutsOhra; Revalidatiefonds; Stichting Beatrixoord; OIM Stichting	This study was supported by Fonds NutsOhra [grant number 1103-029]; http://www.revalidatiefonds.nl/ Revalidatiefonds [grant number R2011147]; Stichting Beatrixoord [grant number 210.130]; and OIM Stichting [grant number 1103]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins D, 1992, ATLAS OF LIMB PROSTH; Bongers RM, 2012, HUM MOVEMENT SCI, V31, P487, DOI 10.1016/j.humov.2011.07.014; Bonzano L, 2011, HUM BRAIN MAPP, V32, P218, DOI 10.1002/hbm.21011; Bouwsema H, 2008, ARCH PHYS MED REHAB, V89, P1759, DOI 10.1016/j.apmr.2007.12.046; Bouwsema H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098301; Bouwsema H, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-16; Bouwsema H, 2012, J REHABIL RES DEV, V49, P1331, DOI 10.1682/JRRD.2011.09.0179; Bouwsema H, 2010, ARCH PHYS MED REHAB, V91, P1442, DOI 10.1016/j.apmr.2010.06.025; CARRON AV, 1969, RES QUART, V40, P481, DOI 10.1080/10671188.1969.10614866; Cepeda NJ, 2006, PSYCHOL BULL, V132, P354, DOI 10.1037/0033-2909.132.3.354; Cepeda NJ, 2009, EXP PSYCHOL, V56, P236, DOI 10.1027/1618-3169.56.4.236; Di Pino G, 2009, PROG NEUROBIOL, V88, P114, DOI 10.1016/j.pneurobio.2009.03.001; Donovan JJ, 1999, J APPL PSYCHOL, V84, P795, DOI 10.1037/0021-9010.84.5.795; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gaine WJ, 1997, J HAND SURG-BRIT EUR, V22B, P73, DOI 10.1016/S0266-7681(97)80023-X; HALSBAND U, 1992, NEUROREPORT, V3, P397, DOI 10.1097/00001756-199205000-00005; HICKS RE, 1983, AM J PSYCHOL, V96, P223, DOI 10.2307/1422813; IMAMIZU H, 1995, J EXP PSYCHOL HUMAN, V21, P719, DOI 10.1037/0096-1523.21.4.719; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Kornmeier J, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00203; Kumar S, 2005, LATERALITY, V10, P337, DOI 10.1080/13576500442000120; LASZLO JI, 1970, J MOTOR BEHAV, V2, P261, DOI 10.1080/00222895.1970.10734884; Lee M, 2010, J PHYSIOL-LONDON, V588, P201, DOI 10.1113/jphysiol.2009.183855; LEE TD, 1988, RES Q EXERCISE SPORT, V59, P277, DOI 10.1080/02701367.1988.10609373; Light CM, 2002, ARCH PHYS MED REHAB, V83, P776, DOI 10.1053/apmr.2002.32737; Malone J M, 1984, J Rehabil Res Dev, V21, P33; Mitchell EL, 2011, AM J SURG, V201, P31, DOI 10.1016/j.amjsurg.2010.07.040; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Panzer S, 2014, EXP AGING RES, V40, P107, DOI 10.1080/0361073X.2014.857566; Park JH, 2002, J MOTOR BEHAV, V34, P253, DOI 10.1080/00222890209601944; PARLOW SE, 1989, BRAIN COGNITION, V11, P98, DOI 10.1016/0278-2626(89)90008-0; PARLOW SE, 1991, BEHAV BRAIN RES, V46, P1, DOI 10.1016/S0166-4328(05)80091-9; Romkema S, 2015, PHYS THER; Romkema S, 2013, PHYS THER, V93, P22, DOI 10.2522/ptj.20120058; Savion-Lemieux T, 2005, EXP BRAIN RES, V161, P423, DOI 10.1007/s00221-004-2085-9; Schulze K, 2002, CORTEX, V38, P805, DOI 10.1016/S0010-9452(08)70047-9; Senff O, 2011, LATERALITY, V16, P227, DOI 10.1080/13576500903549414; Siengsukon CF, 2009, PHYS THER, V89, P370, DOI 10.2522/ptj.20080310; Smurr LM, 2008, J HAND THER, V21, P160, DOI 10.1197/j.jht.2007.09.006; Takeuchi N, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/823285; Teixeira LA, 2000, BRAIN COGNITION, V44, P455, DOI 10.1006/brcg.1999.1205; Thakur RC, 1977, J PSYCHOL RES, V21, P135; Toppino TC, 2002, J EXP PSYCHOL LEARN, V28, P437, DOI 10.1037//0278-7393.28.3.437; Uehara I, 1998, PERCEPT MOTOR SKILL, V87, P1427, DOI 10.2466/pms.1998.87.3f.1427; van Mier HI, 2006, NEUROPSYCHOLOGIA, V44, P939, DOI 10.1016/j.neuropsychologia.2005.08.010; VANLUNTEREN A, 1983, PROSTHET ORTHOT INT, V7, P141; Weeks DL, 2003, ARCH PHYS MED REHAB, V84, P437, DOI 10.1053/apmr.2003.50014	48	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128747	10.1371/journal.pone.0128747	http://dx.doi.org/10.1371/journal.pone.0128747			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26075396	gold, Green Published, Green Submitted			2022-12-26	WOS:000356329900027
J	Schou, MF; Loeschcke, V; Kristensen, TN				Schou, Mads Fristrup; Loeschcke, Volker; Kristensen, Torsten Nygaard			Strong Costs and Benefits of Winter Acclimatization in Drosophila melanogaster	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; DEVELOPMENTAL TEMPERATURE; COLD-ACCLIMATION; THERMAL LIMITS; CLIMATE-CHANGE; EVOLUTIONARY; TOLERANCE; RESISTANCE; FIELD; EXTREMES	Studies on thermal acclimation in insects are often performed on animals acclimated in the laboratory under conditions that are not ecologically relevant. Costs and benefits of acclimation responses under such conditions may not reflect costs and benefits in natural populations subjected to daily and seasonal temperature fluctuations. Here we estimated costs and benefits in thermal tolerance limits in relation to winter acclimatization of Drosophila melanogaster. We sampled flies from a natural habitat during winter in Denmark (field flies) and compared heat and cold tolerance of these to that of flies collected from the same natural population, but acclimated to 25 degrees C or 13 degrees C in the laboratory (laboratory flies). We further obtained thermal performance curves for egg-to-adult viability of field and laboratory (25 degrees C) flies, to estimate possible cross-generational effects of acclimation. We found much higher cold tolerance and a lowered heat tolerance in field flies compared to laboratory flies reared at 25 degrees C. Flies reared in the laboratory at 13 degrees C exhibited the same thermal cost-benefit relations as the winter acclimatized flies. We also found a cost of winter acclimatization in terms of decreased egg-to-adult viability at high temperatures of eggs laid by winter acclimatized flies. Based on our findings we suggest that winter acclimatization in nature can induce strong benefits in terms of increased cold tolerance. These benefits can be reproduced in the laboratory under ecologically relevant rearing and testing conditions, and should be incorporated in species distribution modelling. Winter acclimatization also leads to decreased heat tolerance. This may create a mismatch between acclimation responses and the thermal environment, e.g. if temperatures suddenly increase during spring, under current and expected more variable future climatic conditions.	[Schou, Mads Fristrup; Loeschcke, Volker] Aarhus Univ, Dept Biosci, Aarhus C, Denmark; [Kristensen, Torsten Nygaard] Aalborg Univ, Dept Chem & Biosci, Aalborg, Denmark	Aarhus University; Aalborg University	Schou, MF (corresponding author), Aarhus Univ, Dept Biosci, Aarhus C, Denmark.	mads.schou@biology.au.dk	Schou, Mads Fristrup/J-2148-2014; Loeschcke, Volker/J-2527-2013; Kristensen, Torsten N/C-5031-2015	Schou, Mads Fristrup/0000-0001-5521-5269; Loeschcke, Volker/0000-0003-1450-0754; Kristensen, Torsten N/0000-0001-6204-8753				Andersen JL, 2015, FUNCT ECOL, V29, P55, DOI 10.1111/1365-2435.12310; Angilletta MJ, 2002, J THERM BIOL, V27, P199, DOI 10.1016/S0306-4565(01)00084-5; Bale JS, 2010, J EXP BIOL, V213, P980, DOI 10.1242/jeb.037911; Bergland AO, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004775; Bouletreau-Merle J, 2002, EVOL ECOL, V16, P309, DOI 10.1023/A:1020216230976; Chidawanyika F, 2011, EVOL APPL, V4, P534, DOI 10.1111/j.1752-4571.2010.00168.x; Chown S.L., 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1002/joc.5086; Chown SL, 2007, ADV INSECT PHYSIOL, V33, P50; Chown SL, 2010, CLIM RES, V43, P3, DOI 10.3354/cr00879; Chown SL, 2009, FUNCT ECOL, V23, P133, DOI 10.1111/j.1365-2435.2008.01481.x; Clusella-Trullas S, 2011, AM NAT, V177, P738, DOI 10.1086/660021; David J. R., 1983, GENET BIOL DROSOPHIL, P107; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Diamond SE, 2012, GLOBAL CHANGE BIOL, V18, P448, DOI 10.1111/j.1365-2486.2011.02542.x; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Ferrer A, 2013, J EVOLUTION BIOL, V26, P2321, DOI 10.1111/jeb.12218; Fuller A, 2010, PHYSIOL BIOCHEM ZOOL, V83, P713, DOI 10.1086/652242; Gibert P, 2001, PHYSIOL BIOCHEM ZOOL, V74, P429, DOI 10.1086/320429; Gilchrist GW, 2001, EVOLUTION, V55, P209, DOI 10.1111/j.0014-3820.2001.tb01287.x; Goto SG, 1998, J INSECT PHYSIOL, V44, P1009, DOI 10.1016/S0022-1910(97)00143-1; Harshman LG, 2000, TRENDS ECOL EVOL, V15, P32, DOI 10.1016/S0169-5347(99)01756-5; Hijmans R.J., 2014, RASTER GEOGRAPHIC DA, V2, P15; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoffmann AA, 2010, J EXP BIOL, V213, P870, DOI 10.1242/jeb.037630; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Hoffmann AA, 2002, ECOL LETT, V5, P614, DOI 10.1046/j.1461-0248.2002.00367.x; Hofmann GE, 2010, ANNU REV PHYSIOL, V72, P127, DOI 10.1146/annurev-physiol-021909-135900; Huey RB, 1999, AM ZOOL, V39, P323; IZQUIERDO JI, 1991, ENTOMOL EXP APPL, V59, P51, DOI 10.1007/BF00187965; Jeffs CT, 2014, ENTOMOL EXP APPL, V150, P240, DOI 10.1111/eea.12160; Kellermann V, 2012, EVOLUTION, V66, P3377, DOI 10.1111/j.1558-5646.2012.01685.x; Kellermann V, 2009, SCIENCE, V325, P1244, DOI 10.1126/science.1175443; Kelly VE, 2012, PARKINSONS DIS-US, V2012, DOI [10.1155/2012/918719, 10.1073/pnas.1207553109]; Kelty JD, 2001, J EXP BIOL, V204, P1659; Kelty J, 2007, PHYSIOL ENTOMOL, V32, P343, DOI 10.1111/j.1365-3032.2007.00584.x; Kristensen TN, 2008, P NATL ACAD SCI USA, V105, P216, DOI 10.1073/pnas.0708074105; LEE RE, 1987, SCIENCE, V238, P1415, DOI 10.1126/science.238.4832.1415; LEVINS R, 1969, AM NAT, V103, P483, DOI 10.1086/282616; Loeschcke V, 2007, AM NAT, V169, P175, DOI 10.1086/510632; MacMillan HA, 2012, P NATL ACAD SCI USA, V109, P20750, DOI 10.1073/pnas.1212788109; MacMillan HA, 2011, J INSECT PHYSIOL, V57, P12, DOI 10.1016/j.jinsphys.2010.10.004; Mitchell KA, 2010, FUNCT ECOL, V24, P694, DOI 10.1111/j.1365-2435.2009.01666.x; Overgaard J, 2007, J INSECT PHYSIOL, V53, P1218, DOI 10.1016/j.jinsphys.2007.06.012; Overgaard J, 2014, GLOBAL CHANGE BIOL, V20, P1738, DOI 10.1111/gcb.12521; Overgaard J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032758; Overgaard J, 2011, J THERM BIOL, V36, P409, DOI 10.1016/j.jtherbio.2011.07.005; R Core Team, 2021, R LANGUAGE ENV STAT; Rako L, 2006, J INSECT PHYSIOL, V52, P94, DOI 10.1016/j.jinsphys.2005.09.007; SAUNDERS DS, 1989, P NATL ACAD SCI USA, V86, P3748, DOI 10.1073/pnas.86.10.3748; Schiffer M, 2013, J EXP BIOL, V216, P3790, DOI 10.1242/jeb.085126; Schou MF, 2013, FLY, V7, DOI 10.4161/fly.22758; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sorensen JG, 2015, J INSECT PHYSIOL, V77, P9, DOI 10.1016/j.jinsphys.2015.03.014; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Tatar M, 2001, AM NAT, V158, P248, DOI 10.1086/321320; Terblanche JS, 2011, J EXP BIOL, V214, P3713, DOI 10.1242/jeb.061283; Tobler R, 2014, MOL BIOL EVOL, V31, P364, DOI 10.1093/molbev/mst205; Vesala L, 2011, J INSECT PHYSIOL, V57, P46, DOI 10.1016/j.jinsphys.2010.09.007; ZACHARIASSEN KE, 1985, PHYSIOL REV, V65, P799, DOI 10.1152/physrev.1985.65.4.799; Zuur Alain F., 2009, P1	60	37	38	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130307	10.1371/journal.pone.0130307	http://dx.doi.org/10.1371/journal.pone.0130307			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075607	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900163
J	Fei, DL; Zhang, HC; Diao, QY; Jiang, LL; Wang, Q; Zhong, Y; Fan, ZB; Ma, MX				Fei, Dongliang; Zhang, Haochun; Diao, Qingyun; Jiang, Lili; Wang, Qiang; Zhong, Yi; Fan, Zhaobin; Ma, Mingxiao			Codon Optimization, Expression in Escherichia coli, and Immunogenicity of Recombinant Chinese Sacbrood Virus (CSBV) Structural Proteins VP1, VP2, and VP3	PLOS ONE			English	Article							HONEY-BEE; TOXOPLASMA-GONDII; GENE-EXPRESSION; MECHANISMS; PROTEOMICS; SEQUENCE; IMMUNITY	Chinese sacbrood virus (CSBV) is a small RNA virus family belonging to the genus Iflavirus that causes larval death, and even the collapse of entire bee colonies. The virus particle is spherical, non-enveloped, and its viral capsid is composed of four proteins, although the functions of the structural proteins are unclear. In this study, we used codon recoding to express the recombinant proteins VP1, VP2, and VP3 in Escherichia coli. SDS-PAGE analysis and Western blotting revealed that the target genes were expressed at high levels. Mice were then immunized with the purified, recombinant proteins, and antibody levels and lymphocyte proliferation were analyzed by ELISA and the MTT assay, respectively. The results show that the recombinant proteins induced high antibody levels and promoted lymphocyte proliferation. Polyclonal antibodies directed against these proteins will aid future studies of the molecular pathogenesis of CSBV.	[Fei, Dongliang; Zhang, Haochun; Jiang, Lili; Zhong, Yi; Fan, Zhaobin; Ma, Mingxiao] Liaoning Med Univ, Anim Husb & Vet Inst, Jinzhou, Peoples R China; [Diao, Qingyun] Chinese Acad Agr Sci, Honeybee Res Inst, Beijing 100193, Peoples R China; [Wang, Qiang] Liaoning Water Conservancy Vocat Coll, Shenyang, Peoples R China	Jinzhou Medical University; Chinese Academy of Agricultural Sciences	Ma, MX (corresponding author), Liaoning Med Univ, Anim Husb & Vet Inst, Jinzhou, Peoples R China.	371751697@qq.com	?, ?/AAU-8474-2021		National Natural Science Foundation of China [31372435]; Science and Technology Department of Liaoning Province [2014022047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Liaoning Province	This work was supported by grants from the National Natural Science Foundation of China (No. 31372435) and the Science and Technology Department of Liaoning Province (No. 2014022047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HX, 2012, J INVERTEBR PATHOL, V109, P160, DOI 10.1016/j.jip.2011.10.006; Bailey L, 1976, Adv Virus Res, V20, P271, DOI 10.1016/S0065-3527(08)60507-2; BAILEY L, 1964, VIROLOGY, V23, P425, DOI 10.1016/0042-6822(64)90266-1; Bhakta Gajadhar, 2014, Results Immunol, V4, P46, DOI 10.1016/j.rinim.2014.04.001; Bull JC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003083; Choe SE, 2012, VIROLOGY, V432, P155, DOI 10.1016/j.virol.2012.06.008; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Feng JX, 1998, J ELECT MICROS, V17, P387; Feng M, 2013, J PROTEOMICS, V87, P1, DOI 10.1016/j.jprot.2013.05.021; Fernandez-Sainz IJ, 2014, VIROLOGY, V456, P121, DOI 10.1016/j.virol.2014.03.005; Freiberg M, 2012, GENET MOL RES, V11, P3310, DOI 10.4238/2012.September.12.14; Gao JP, 2013, J VET SCI, V14, P441, DOI 10.4142/jvs.2013.14.4.441; Ghosh RC, 1999, J GEN VIROL, V80, P1541, DOI 10.1099/0022-1317-80-6-1541; Han B, 2013, J PROTEOME RES, V12, P1881, DOI 10.1021/pr301226d; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Hussmann KL, 2014, J GEN VIROL, V95, P1991, DOI 10.1099/vir.0.065474-0; Laguia-Becher M, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-52; Liu XJ, 2010, CURR MICROBIOL, V61, P422, DOI 10.1007/s00284-010-9633-2; Liu YS, 2013, APPL MICROBIOL BIOT, V97, P10349, DOI 10.1007/s00253-013-5264-4; Ma Ming-xiao, 2010, Chinese Journal of Biologicals, V23, P425; Ma MX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052670; Ma MX, 2011, COMP FUNCT GENOM, DOI 10.1155/2011/409386; Menzella HG, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-15; Nguyen NTB, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00076-12; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Sun XJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-429; Wang Q, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/732017; Welch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007002; Xia XC, 2014, ARCH VIROL, V159, P3435, DOI 10.1007/s00705-014-2183-3; Xie ZH, 2011, J APIC SCI, V55, P77; Xu ShuFa, 2011, Journal of Shanghai Jiaotong University - Agricultural Science, V29, P44; Yan Xun, 2008, Chinese Bulletin of Entomology, V45, P483; Zorina V. N., 2013, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P111; Zylicz-Stachula A, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-7	35	13	14	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128486	10.1371/journal.pone.0128486	http://dx.doi.org/10.1371/journal.pone.0128486			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26067659	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000018
J	Gotze, S; Schumacher, EC; Kordes, C; Haussinger, D				Goetze, Silke; Schumacher, Eva C.; Kordes, Claus; Haeussinger, Dieter			Epigenetic Changes during Hepatic Stellate Cell Activation	PLOS ONE			English	Article							FAT-STORING CELLS; DNA METHYLATION; LIVER FIBROSIS; SITES; PROLIFERATION; CONTRACTION; EXPRESSION; CONTRIBUTE; PHENOTYPE; LIPOCYTES	Background and Aims Hepatic stellate cells (HSC), which can participate in liver regeneration and fibrogenesis, have recently been identified as liver-resident mesenchymal stem cells. During their activation HSC adopt a myofibroblast-like phenotype accompanied by profound changes in the gene expression profile. DNA methylation changes at single genes have been reported during HSC activation and may participate in the regulation of this process, but comprehensive DNA methylation analyses are still missing. The aim of the present study was to elucidate the role of DNA methylation during in vitro activation of HSC. Methods and Results The analysis of DNA methylation changes by antibody-based assays revealed a strong decrease in the global DNA methylation level during culture-induced activation of HSC. To identify genes which may be regulated by DNA methylation, we performed a genome-wide Methyl-MiniSeq EpiQuest sequencing comparing quiescent and early culture-activated HSC. Approximately 400 differentially methylated regions with a methylation change of at least 20% were identified, showing either hypo-or hypermethylation during activation. Further analysis of selected genes for DNA methylation and expression were performed revealing a good correlation between DNA methylation changes and gene expression. Furthermore, global DNA demethylation during HSC activation was investigated by 5-bromo-2-deoxyuridine assay and L-mimosine treatment showing that demethylation was independent of DNA synthesis and thereby excluding a passive DNA demethylation mechanism. Conclusions In summary, in vitro activation of HSC initiated strong DNA methylation changes, which were associated with gene regulation. These results indicate that epigenetic mechanisms are important for the control of early HSC activation. Furthermore, the data show that global DNA demethylation during activation is based on an active DNA demethylation mechanism.	[Goetze, Silke; Schumacher, Eva C.; Kordes, Claus; Haeussinger, Dieter] Univ Dusseldorf, Clin Gastroenterol Hepatol & Infect Dis, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Haussinger, D (corresponding author), Univ Dusseldorf, Clin Gastroenterol Hepatol & Infect Dis, Dusseldorf, Germany.	haeussin@uni-duesseldorf.de	Kordes, Claus/AFM-1775-2022	Kordes, Claus/0000-0003-0782-1998	German Research Foundation (DFG) through the Collaborative Research Center [SFB 974]; Research Commission of the Medical Faculty of the Heinrich Heine University Dusseldorf [58/2012]	German Research Foundation (DFG) through the Collaborative Research Center(German Research Foundation (DFG)); Research Commission of the Medical Faculty of the Heinrich Heine University Dusseldorf	This work was supported by the German Research Foundation (DFG) through the Collaborative Research Center SFB 974 "Communication and Systems Relevance during Liver Injury and Regeneration" (http://gepris.dfg.de/gepris/projekt/190586431) and the Research Commission of the Medical Faculty of the Heinrich Heine University Dusseldorf (58/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barchitta M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109478; Berdasco M, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt83; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Bian EB, 2014, TOXICOL LETT, V224, P175, DOI 10.1016/j.toxlet.2013.10.038; Bian EB, 2013, CELL SIGNAL, V25, P355, DOI 10.1016/j.cellsig.2012.10.007; Bian EB, 2012, TOXICOL APPL PHARM, V264, P13, DOI 10.1016/j.taap.2012.06.022; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Broske AM, 2009, NAT GENET, V41, P1207, DOI 10.1038/ng.463; Castilho-Fernandes A, 2011, EXP MOL PATHOL, V91, P664, DOI 10.1016/j.yexmp.2011.09.002; Chuang JC, 2007, PEDIATR RES, V61, p24R, DOI 10.1203/pdr.0b013e3180457684; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; FRIEDMAN SL, 1989, J BIOL CHEM, V264, P10756; FRIEDMAN SL, 1985, P NATL ACAD SCI USA, V82, P8681, DOI 10.1073/pnas.82.24.8681; Gao XD, 2014, LIVER INT, V34, P136, DOI 10.1111/liv.12264; GARD AL, 1985, J NEUROIMMUNOL, V8, P359, DOI 10.1016/S0165-5728(85)80073-4; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Guo CJ, 2013, FEBS LETT, V587, P3792, DOI 10.1016/j.febslet.2013.09.047; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; HENDRIKS HFJ, 1985, EXP CELL RES, V160, P138, DOI 10.1016/0014-4827(85)90243-5; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ishikawa T, 2012, HEPATOLOGY, V55, P1215, DOI 10.1002/hep.24796; Jiang F, 2006, J HEPATOL, V45, P401, DOI 10.1016/j.jhep.2006.03.016; Jones PA, 1999, TRENDS GENET, V15, P34, DOI 10.1016/S0168-9525(98)01636-9; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kordes C, 2008, BIOCHEM BIOPH RES CO, V367, P116, DOI 10.1016/j.bbrc.2007.12.085; Kordes C, 2014, J CLIN INVEST, V124, P5503, DOI 10.1172/JCI74119; Kordes C, 2013, J CLIN INVEST, V123, P1874, DOI 10.1172/JCI66027; Kordes C, 2013, CELL PHYSIOL BIOCHEM, V31, P290, DOI 10.1159/000343368; Lakner AM, 2010, WORLD J GASTROENTERO, V16, P5047, DOI 10.3748/wjg.v16.i40.5047; Leakey TI, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn210; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Mann DA, 2008, J GASTROEN HEPATOL, V23, pS108, DOI 10.1111/j.1440-1746.2007.05295.x; Mann J, 2007, CELL DEATH DIFFER, V14, P275, DOI 10.1038/sj.cdd.4401979; Matsui H, 2005, EUR J PHARMACOL, V509, P31, DOI 10.1016/j.ejphar.2004.12.041; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Nagae G, 2011, HUM MOL GENET, V20, P2710, DOI 10.1093/hmg/ddr170; Oakes CC, 2006, EPIGENETICS-US, V1, P146, DOI 10.4161/epi.1.3.3392; Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623; Rashid ST, 2012, J PROTEOME RES, V11, P4052, DOI 10.1021/pr3000927; Reister S, 2011, STEM CELLS DEV, V20, P1687, DOI 10.1089/scd.2010.0418; Richards KL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004941; Sawitza I, 2009, HEPATOLOGY, V50, P1617, DOI 10.1002/hep.23184; Seisenberger S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0330; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; Tsukamoto H, 2011, HEPATOL RES, V41, P675, DOI 10.1111/j.1872-034X.2011.00804.x; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; YOKOI Y, 1984, HEPATOLOGY, V4, P709, DOI 10.1002/hep.1840040425; Zeybel M, 2013, J HEPATOL, V59, P1349, DOI 10.1016/j.jhep.2013.05.039; Zhang F, 2014, INT IMMUNOPHARMACOL, V19, P193, DOI 10.1016/j.intimp.2014.01.021; Zhao Q, 2013, TOHOKU J EXP MED, V229, P35, DOI 10.1620/tjem.229.35; Zheng JJ, 2014, FEBS J, V281, P88, DOI 10.1111/febs.12574	51	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128745	10.1371/journal.pone.0128745	http://dx.doi.org/10.1371/journal.pone.0128745			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26065684	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000026
J	Yousaf, M; Ghaffar, T; Qamar, S				Yousaf, Muhammad; Ghaffar, Tayabia; Qamar, Shamsul			Application of Central Upwind Scheme for Solving Special Relativistic Hydrodynamic Equations	PLOS ONE			English	Article							KINETIC SCHEMES; DISSIPATION; FLOWS	The accurate modeling of various features in high energy astrophysical scenarios requires the solution of the Einstein equations together with those of special relativistic hydrodynamics (SRHD). Such models are more complicated than the non-relativistic ones due to the nonlinear relations between the conserved and state variables. A high-resolution shock-capturing central upwind scheme is implemented to solve the given set of equations. The proposed technique uses the precise information of local propagation speeds to avoid the excessive numerical diffusion. The second order accuracy of the scheme is obtained with the use of MUSCL-type initial reconstruction and Runge-Kutta time stepping method. After a discussion of the equations solved and of the techniques employed, a series of one and two-dimensional test problems are carried out. To validate the method and assess its accuracy, the staggered central and the kinetic flux-vector splitting schemes are also applied to the same model. The scheme is robust and efficient. Its results are comparable to those obtained from the sophisticated algorithms, even in the case of highly relativistic two-dimensional test problems.	[Yousaf, Muhammad; Qamar, Shamsul] COMSATS Inst Informat Technol, Dept Math, Islamabad, Pakistan; [Ghaffar, Tayabia] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan	COMSATS University Islamabad (CUI); Quaid I Azam University	Yousaf, M (corresponding author), COMSATS Inst Informat Technol, Dept Math, Pk Rd, Islamabad, Pakistan.	myousaf@comsats.edu.pk						Aloy MA, 1999, ASTROPHYS J SUPPL S, V122, P151, DOI 10.1086/313214; Balbas J, 2009, ESAIM-MATH MODEL NUM, V43, P333, DOI 10.1051/m2an:2008050; Bryson S, 2005, IMA J NUMER ANAL, V25, P113, DOI 10.1093/imanum/drh015; Csernai L. P., 1994, INTRO RELATIVISTIC H; Donat R, 1996, J COMPUT PHYS, V125, P42, DOI 10.1006/jcph.1996.0078; Kunik M, 2004, SIAM J SCI COMPUT, V26, P196, DOI 10.1137/S1064827503422208; Kunik M, 2004, NUMER MATH, V97, P159, DOI 10.1007/s00211-003-0510-9; Kunik M, 2003, J COMPUT PHYS, V187, P572, DOI 10.1016/S0021-9991(03)00125-6; Kurganov A, 2000, J COMPUT PHYS, V160, P241, DOI 10.1006/jcph.2000.6459; Kurganov A, 2007, COMMUN COMPUT PHYS, V2, P141; Kurganov A, 2009, SIAM J SCI COMPUT, V31, P1742, DOI 10.1137/080719091; Marti J.M, 1999, LIVING REV RELATIV, V2, P1; Marti JM, 1996, J COMPUT PHYS, V123, P1, DOI 10.1006/jcph.1996.0001; MARTI JM, 1995, ASTROPHYS J, V448, pL105, DOI 10.1086/309606; NESSYAHU H, 1990, J COMPUT PHYS, V87, P408, DOI 10.1016/0021-9991(90)90260-8; PIRAN T, 1993, MON NOT R ASTRON SOC, V263, P861, DOI 10.1093/mnras/263.4.861; Qamar S, 2013, COMPUT MATH APPL, V65, P1220, DOI 10.1016/j.camwa.2013.02.021; Qamar S, 2012, J COMPUT PHYS, V231, P3928, DOI 10.1016/j.jcp.2012.01.039; Qamar S, 2011, COMPUT PHYS COMMUN, V182, P994, DOI 10.1016/j.cpc.2010.12.044; Qamar S, 2005, INT J COMP METH-SING, V2, P49, DOI 10.1142/S0219876205000338; SCHNEIDER V, 1993, J COMPUT PHYS, V105, P92, DOI 10.1006/jcph.1993.1056; Tang HZ, 2000, COMPUT FLUIDS, V29, P917, DOI 10.1016/S0045-7930(99)00042-0; Van Dyke, 1982, ALBUM FLUID MOTION; Yang JY, 1997, J COMPUT PHYS, V136, P19, DOI 10.1006/jcph.1997.5767	27	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128698	10.1371/journal.pone.0128698	http://dx.doi.org/10.1371/journal.pone.0128698			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070067	Green Published, Green Submitted, gold			2022-12-26	WOS:000356327000024
J	Eriani, G; Karam, J; Jacinto, J; Richard, EM; Geslain, R				Eriani, Gilbert; Karam, Joseph; Jacinto, Jomel; Richard, Erin Morris; Geslain, Renaud			MIST, a Novel Approach to Reveal Hidden Substrate Specificity in Aminoacyl-tRNA Synthetases	PLOS ONE			English	Article							GENETIC-CODE; RECOGNITION SETS; YEAST; IDENTITY; ENZYME; ACTIVATION; EXPRESSION; SEQUENCE; ACCEPTOR; KINASE	Aminoacyl-tRNA synthetases (AARSs) constitute a family of RNA-binding proteins, that participate in the translation of the genetic code, by covalently linking amino acids to appropriate tRNAs. Due to their fundamental importance for cell life, AARSs are likely to be one of the most ancient families of enzymes and have therefore been characterized extensively. Paradoxically, little is known about their capacity to discriminate tRNAs mainly because of the practical challenges that represent precise and systematic tRNA identification. This work describes a new technical and conceptual approach named MIST (Microarray Identification of Shifted tRNAs) designed to study the formation of tRNA/AARS complexes independently from the aminoacylation reaction. MIST combines electrophoretic mobility shift assays with microarray analyses. Although MIST is a non-cellular assay, it fully integrates the notion of tRNA competition. In this study we focus on yeast cytoplasmic Arginyl-tRNA synthetase (yArgRS) and investigate in depth its ability to discriminate cellular tRNAs. We report that yArgRS in submicromolar concentrations binds cognate and non-cognate tRNAs with a wide range of apparent affinities. In particular, we demonstrate that yArgRS binds preferentially to type II tRNAs but does not support their misaminoacylation. Our results reveal important new trends in tRNA/AARS complex formation and potential deep physiological implications.	[Eriani, Gilbert] Univ Strasbourg, Architecture & React ARN, CNRS, Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France; [Karam, Joseph; Jacinto, Jomel; Richard, Erin Morris; Geslain, Renaud] Coll Charleston, Dept Biol, Lab tRNA Biol, Charleston, SC 29424 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; College of Charleston	Geslain, R (corresponding author), Coll Charleston, Dept Biol, Lab tRNA Biol, Charleston, SC 29424 USA.	geslainr@cofc.edu		Karam, Joseph/0000-0002-4536-7362; Eriani, Gilbert/0000-0002-8518-4675	Research and Development, College of Charleston; Centre National de la Recherche Scientifique [ANR11SVSE8-025-01]	Research and Development, College of Charleston; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This study was supported in party by Research and Development, College of Charleston (to RG) and by ANR11SVSE8-025-01, Centre National de la Recherche Scientifique (to GE).	Bezerra AR, 2013, P NATL ACAD SCI USA, V110, P11079, DOI 10.1073/pnas.1302094110; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Copela LA, 2006, RNA, V12, P644, DOI 10.1261/rna.2307206; Curnow AW, 1997, P NATL ACAD SCI USA, V94, P11819, DOI 10.1073/pnas.94.22.11819; Cusack S., 1990, NATURE, V347, P347; de Pouplana LR, 2001, CELL, V104, P191, DOI 10.1016/S0092-8674(01)00204-5; Delagoutte B, 2000, EMBO J, V19, P5599, DOI 10.1093/emboj/19.21.5599; Dittmar KA, 2004, J MOL BIOL, V337, P31, DOI 10.1016/j.jmb.2004.01.024; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; EBEL JP, 1973, BIOCHIMIE, V55, P547, DOI 10.1016/S0300-9084(73)80415-8; El Yacoubi B, 2012, ANNU REV GENET, V46, P69, DOI 10.1146/annurev-genet-110711-155641; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Fender A, 2004, NUCLEIC ACIDS RES, V32, P5076, DOI 10.1093/nar/gkh843; Frugier M, 2005, EMBO REP, V6, P860, DOI 10.1038/sj.embor.7400481; Fukunaga R, 2005, NAT STRUCT MOL BIOL, V12, P915, DOI 10.1038/nsmb985; Galburt EA, 2002, STRUCTURE, V10, P1249, DOI 10.1016/S0969-2126(02)00835-3; GANGLOFF J, 1976, EUR J BIOCHEM, V65, P177, DOI 10.1111/j.1432-1033.1976.tb10403.x; Geslain R, 2003, NUCLEIC ACIDS RES, V31, P4729, DOI 10.1093/nar/gkg685; Geslain R, 2006, J BIOL CHEM, V281, P38217, DOI 10.1074/jbc.M607862200; Geslain R, 2010, J MOL BIOL, V396, P821, DOI 10.1016/j.jmb.2009.12.018; Godinic-Mikulcic V, 2014, NUCLEIC ACIDS RES, V42, P5191, DOI 10.1093/nar/gku164; Godinic-Mikulcic V, 2011, J BIOL CHEM, V286, P3396, DOI 10.1074/jbc.M110.168526; Goodenbour JM, 2006, NUCLEIC ACIDS RES, V34, P6137, DOI 10.1093/nar/gkl725; Hopper AK, 2013, GENETICS, V194, P43, DOI 10.1534/genetics.112.147470; Ibba M, 2004, GENE DEV, V18, P731, DOI 10.1101/gad.1187404; Kim S, 2011, NAT REV CANCER, V11, P708, DOI 10.1038/nrc3124; Krishnakumar R, 2013, CHEMBIOCHEM, V14, P1967, DOI 10.1002/cbic.201300444; Li L, 2011, P NATL ACAD SCI USA, V108, P9378, DOI 10.1073/pnas.1016460108; MCCLAIN WH, 1993, J MOL BIOL, V234, P257, DOI 10.1006/jmbi.1993.1582; MEHLER AH, 1967, J BIOL CHEM, V242, P5495; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; Pavon-Eternod M, 2010, RNA, V16, P267, DOI 10.1261/rna.1928110; Pavon-Eternod M, 2009, NUCLEIC ACIDS RES, V37, P7268, DOI 10.1093/nar/gkp787; Roy H, 2003, P NATL ACAD SCI USA, V100, P9837, DOI 10.1073/pnas.1632156100; SCHIMMEL P, 1993, P NATL ACAD SCI USA, V90, P8763, DOI 10.1073/pnas.90.19.8763; Sissler M, 1996, EMBO J, V15, P5069, DOI 10.1002/j.1460-2075.1996.tb00887.x; Sissler M, 1997, NUCLEIC ACIDS RES, V25, P4899, DOI 10.1093/nar/25.24.4899; Tocchini-Valentini G, 2000, J MOL BIOL, V298, P779, DOI 10.1006/jmbi.2000.3694; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; Zaborske JM, 2009, J BIOL CHEM, V284, P25254, DOI 10.1074/jbc.M109.000877	40	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0130042	10.1371/journal.pone.0130042	http://dx.doi.org/10.1371/journal.pone.0130042			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067673	Green Published, gold, Green Submitted			2022-12-26	WOS:000356100900096
J	Johnson, JL; Wittgenstein, H; Mitchell, SE; Hyma, KE; Temnykh, SV; Kharlamova, AV; Gulevich, RG; Vladimirova, AV; Fong, HWF; Acland, GM; Trut, LN; Kukekova, AV				Johnson, Jennifer L.; Wittgenstein, Helena; Mitchell, Sharon E.; Hyma, Katie E.; Temnykh, Svetlana V.; Kharlamova, Anastasiya V.; Gulevich, Rimma G.; Vladimirova, Anastasiya V.; Fong, Hiu Wa Flora; Acland, Gregory M.; Trut, Lyudmila N.; Kukekova, Anna V.			Genotyping-By-Sequencing (GBS) Detects Genetic Structure and Confirms Behavioral QTL in Tame and Aggressive Foxes (Vulpes vulpes)	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; LINKAGE DISEQUILIBRIUM; SILVER FOX; COUP-TFII; RED FOX; GENOME; DOMESTICATION; DOG; SELECTION; MAP	The silver fox (Vulpes vulpes) offers a novel model for studying the genetics of social behavior and animal domestication. Selection of foxes, separately, for tame and for aggressive behavior has yielded two strains with markedly different, genetically determined, behavioral phenotypes. Tame strain foxes are eager to establish human contact while foxes from the aggressive strain are aggressive and difficult to handle. These strains have been maintained as separate outbred lines for over 40 generations but their genetic structure has not been previously investigated. We applied a genotyping-by-sequencing (GBS) approach to provide insights into the genetic composition of these fox populations. Sequence analysis of EcoT22I genomic libraries of tame and aggressive foxes identified 48,294 high quality SNPs. Population structure analysis revealed genetic divergence between the two strains and more diversity in the aggressive strain than in the tame one. Significant differences in allele frequency between the strains were identified for 68 SNPs. Three of these SNPs were located on fox chromosome 14 within an interval of a previously identified behavioral QTL, further supporting the importance of this region for behavior. The GBS SNP data confirmed that significant genetic diversity has been preserved in both fox populations despite many years of selective breeding. Analysis of SNP allele frequencies in the two populations identified several regions of genetic divergence between the tame and aggressive foxes, some of which may represent targets of selection for behavior. The GBS protocol used in this study significantly expanded genomic resources for the fox, and can be adapted for SNP discovery and genotyping in other canid species.	[Johnson, Jennifer L.; Fong, Hiu Wa Flora; Kukekova, Anna V.] Univ Illinois, Dept Anim Sci, Coll ACES, Urbana, IL 61801 USA; [Wittgenstein, Helena; Temnykh, Svetlana V.; Acland, Gregory M.] Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA; [Mitchell, Sharon E.; Hyma, Katie E.] Cornell Univ, Genom Div Facil, Inst Biotechnol, Ithaca, NY 14853 USA; [Kharlamova, Anastasiya V.; Gulevich, Rimma G.; Vladimirova, Anastasiya V.; Trut, Lyudmila N.] Russian Acad Sci, Inst Cytol & Genet, Novosibirsk 630090, Russia	University of Illinois System; University of Illinois Urbana-Champaign; Cornell University; Cornell University; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS	Kukekova, AV (corresponding author), Univ Illinois, Dept Anim Sci, Coll ACES, Urbana, IL 61801 USA.	avk@illinois.edu		Johnson, Jennifer/0000-0002-3339-4419	National Institutes of Health grant [MH077811]; NIH FIRCA grant [TW008098]; Russian Fund for Basic Research [05-04-4837]; FCP grant [84-74]; USDA Federal Hatch Project [538922]; University of Illinois at Urbana-Champaign Campus Research Board grant [RB14039]; FOGARTY INTERNATIONAL CENTER [R03TW008098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077811] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH FIRCA grant; Russian Fund for Basic Research(Russian Foundation for Basic Research (RFBR)); FCP grant; USDA Federal Hatch Project; University of Illinois at Urbana-Champaign Campus Research Board grant; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by National Institutes of Health grant MH077811 (A. V. Kukekova), NIH FIRCA grant TW008098 (LNT), grant # 05-04-4837 (LNT) from the Russian Fund for Basic Research, FCP grant # 84-74 (A. V. Kukekova), USDA Federal Hatch Project # 538922 (A. V. Kukekova), and University of Illinois at Urbana-Champaign Campus Research Board grant #RB14039 (A. V. Kukekova). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert FW, 2011, HEREDITY, V107, P205, DOI 10.1038/hdy.2011.4; Alfano C, 2014, CELL MOL LIFE SCI, V71, P43, DOI 10.1007/s00018-013-1320-6; Badke YM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-24; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Becker SED, 2011, CHROMOSOME RES, V19, P685, DOI 10.1007/s10577-011-9233-4; BELYAEV DK, 1979, J HERED, V70, P301, DOI 10.1093/oxfordjournals.jhered.a109263; BELYAEV DK, 1969, SCI J, V5, P47; Bohmanova J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-421; Chen CG, 2006, J BIOL CHEM, V281, P7983, DOI 10.1074/jbc.M509805200; Chu K, 1997, J MOL ENDOCRINOL, V19, P163, DOI 10.1677/jme.0.0190163; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; De Donato M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062137; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Etter PD, 2011, METHODS MOL BIOL, V772, P157, DOI 10.1007/978-1-61779-228-1_9; Falush D, 2003, GENETICS, V164, P1567; Freedman AH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004016; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Green P., 1990, DOCUMENTATION CRIMAP; Hedrick P.W., 2011, GENETICS POPULATIONS, V4th ed.; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Johansson AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001188; Kukekova AV, 2007, GENOME RES, V17, P387, DOI 10.1101/gr.5893307; Kukekova AV, 2014, GENETICS AND THE BEHAVIOR OF DOMESTIC ANIMALS, 2ND EDITION, P361, DOI 10.1016/B978-0-12-394586-0.00010-X; Kukekova AV, 2012, MAMM GENOME, V23, P164, DOI 10.1007/s00335-011-9373-z; Kukekova AV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-482; Kukekova AV, 2011, BEHAV GENET, V41, P593, DOI 10.1007/s10519-010-9418-1; Kukekova AV, 2004, J HERED, V95, P185, DOI 10.1093/jhered/esh033; Kukekova AV, 2013, GENETICS COMPLEX INT; Lamichhaney S, 2015, NATURE, V518, P371, DOI 10.1038/nature14181; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Liu SP, 2014, CELL, V157, P785, DOI 10.1016/j.cell.2014.03.054; Lu F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003215; Moon S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1330-x; Poh YP, 2014, PLOS ONE, V9, DOI [DOI 10.1371/journal.pone.0110579, 10.1371/journal.pone.0110579]; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qanbari S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004148; Reinchisi G, 2012, CEREB CORTEX, V22, P2820, DOI 10.1093/cercor/bhr359; Rozen S, 2000, Methods Mol Biol, V132, P365; Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sargolzaei M, 2008, J DAIRY SCI, V91, P2106, DOI 10.3168/jds.2007-0553; Seaton G, 2006, P 8 WORLD C GEN APPL; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Tang K, 2012, DEVELOPMENT, V139, P1630, DOI 10.1242/dev.075564; Trut LN, 1999, AM SCI, V87, P160, DOI 10.1511/1999.20.813; Trut LN, 2004, RUSS J GENET+, V40, P644, DOI 10.1023/B:RUGE.0000033312.92773.c1; TRUT LN, 1980, P 14 INT C GEN, V2, P123; Trut L, 2009, BIOESSAYS, V31, P349, DOI 10.1002/bies.200800070; Trut LN, 2012, GENETICS OF THE DOG, 2ND EDITION, P12, DOI 10.1079/9781845939403.0012; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Wayne RK, 1997, SYST BIOL, V46, P622, DOI 10.2307/2413498; Weber JN, 2013, NATURE, V493, P402, DOI 10.1038/nature11816; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wong AK, 2010, GENETICS, V184, P595, DOI 10.1534/genetics.109.106831; Yang F, 2000, CHROMOSOME RES, V8, P93, DOI 10.1023/A:1009251917072; Yang F, 1999, GENOMICS, V62, P189, DOI 10.1006/geno.1999.5989; Young AC, 2008, CHROMOSOME RES, V16, P1193, DOI 10.1007/s10577-008-1268-9	61	28	28	0	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0127013	10.1371/journal.pone.0127013	http://dx.doi.org/10.1371/journal.pone.0127013			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061395	Green Submitted, Green Published, gold			2022-12-26	WOS:000355979500023
J	Tamiya, H; Yasunaga, H; Matusi, H; Fushimi, K; Ogawa, S; Akishita, M				Tamiya, Hiroyuki; Yasunaga, Hideo; Matusi, Hiroki; Fushimi, Kiyohide; Ogawa, Sumito; Akishita, Masahiro			Hypnotics and the Occurrence of Bone Fractures in Hospitalized Dementia Patients: A Matched Case-Control Study Using a National Inpatient Database	PLOS ONE			English	Article							NURSING-HOME RESIDENTS; PSYCHOLOGICAL SYMPTOMS; ALZHEIMERS-DISEASE; ELDERLY PERSONS; HIP-FRACTURES; RISK-FACTORS; FALLS; INJURIES; PEOPLE; PREDICTORS	Background Preventing falls and bone fractures in hospital care is an important issue in geriatric medicine. Use of hypnotics is a potential risk factor for falls and bone fractures in older patients. However, data are lacking on the association between use of hypnotics and the occurrence of bone fracture. Methods We used a national inpatient database including 1,057 hospitals in Japan and included dementia patients aged 50 years or older who were hospitalized during a period of 12 months between April 2012 and March 2013. The primary outcome was the occurrence of bone fracture during hospitalization. Use of hypnotics was compared between patients with and without bone fracture in this matched case-control study. Results Of 140,494 patients, 830 patients suffered from in-hospital fracture. A 1:4 matching with age, sex and hospital created 817 cases with fracture and 3,158 matched patients without fracture. With adjustment for the Charlson comorbidity index, emergent admission, activities of daily living, and scores for level walking, a higher occurrence of fractures were seen with short-acting benzodiazepine hypnotics (odds ratio, 1.43; 95% confidence interval, 1.19-1.73; P<0.001), ultrashort-acting non-benzodiazepine hypnotics (1.66; 1.37-2.01; P<0.001), hydroxyzine (1.45; 1.15-1.82, P=0.001), risperidone and perospirone (1.37; 1.08-1.73; P=0.010). Other drug groups were not significantly associated with the occurrence of in-hospital fracture. Conclusions Short-acting benzodiazepine hypnotics and ultrashort-acting non-benzodiazepine hypnotics may increase risk of bone fracture in hospitalized dementia patients.	[Tamiya, Hiroyuki; Ogawa, Sumito; Akishita, Masahiro] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Tokyo, Japan; [Yasunaga, Hideo; Matusi, Hiroki] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hlth Policy & Informat, Tokyo, Japan	University of Tokyo; University of Tokyo; Tokyo Medical & Dental University (TMDU)	Ogawa, S (corresponding author), Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Tokyo, Japan.	suogawa-tky@umin.ac.jp	van Griensven, Martijn/F-5808-2012	van Griensven, Martijn/0000-0001-5104-9881; Tamiya, Hiroyuki/0000-0001-8283-070X; Yasunaga, Hideo/0000-0002-6017-469X	Daiichi-Sankyo; Takeda	Daiichi-Sankyo(Daiichi Sankyo Company Limited); Takeda(Takeda Pharmaceutical Company Ltd)	The authors have read the journal's policy and have the following competing interests: MA received research grant support by Daiichi-Sankyo and Takeda, and honoraria for educational lectures by Daiichi-Sankyo Takeda, Eisai, Novartis and Mochida. SO received honoraria for educational lectures by Abbott and Daiichi-Sankyo. Other authors declare no conflict of interest. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Asada T, 1996, AGE AGEING, V25, P22, DOI 10.1093/ageing/25.1.22; Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Berry SD, 2013, JAMA INTERN MED, V173, P754, DOI 10.1001/jamainternmed.2013.3795; BUCHNER DM, 1987, JAMA-J AM MED ASSOC, V257, P1492, DOI 10.1001/jama.257.11.1492; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Dehejia RH, 1999, J AM STAT ASSOC, V94, P1053, DOI 10.2307/2669919; Halfon P, 2001, J CLIN EPIDEMIOL, V54, P1258, DOI 10.1016/S0895-4356(01)00406-1; Hamada T, 2013, CRIT CARE, V17, DOI 10.1186/cc13029; Iwagami M, 2014, CRIT CARE MED, V42, P1187, DOI 10.1097/CCM.0000000000000150; Iwasaki K, 2005, J CLIN PSYCHIAT, V66, P248, DOI 10.4088/JCP.v66n0214; Kolla BP, 2013, J HOSP MED, V8, P1, DOI 10.1002/jhm.1985; Lin IF, 2007, EPIDEMIOLOGY, V18, P446, DOI 10.1097/EDE.0b013e318064630a; Llorca PM, 2002, J CLIN PSYCHIAT, V63, P1020, DOI 10.4088/JCP.v63n1112; MAGAZINER J, 1990, J GERONTOL, V45, pM101, DOI 10.1093/geronj/45.3.M101; Mizukami K, 2009, INT J NEUROPSYCHOPH, V12, P191, DOI 10.1017/S146114570800970X; MORGAN VR, 1985, AM J PUBLIC HEALTH, V75, P775, DOI 10.2105/AJPH.75.7.775; Obayashi K, 2013, DRUGS R&D, V13, P159, DOI 10.1007/s40268-013-0019-3; Okahara K, 2010, PROG NEURO-PSYCHOPH, V34, P532, DOI 10.1016/j.pnpbp.2010.02.013; OLESKE DM, 1995, J AM GERIATR SOC, V43, P741, DOI 10.1111/j.1532-5415.1995.tb07042.x; Oliver D, 2008, QUAL SAF HEALTH CARE, V17, P431, DOI 10.1136/qshc.2007.024703; RUBENSTEIN LZ, 1994, ANN INTERN MED, V121, P442, DOI 10.7326/0003-4819-121-6-199409150-00009; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Sumitani M, 2011, ANESTHESIOLOGY, V114, P84, DOI 10.1097/ALN.0b013e318200197d; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Tutuarima JA, 1997, STROKE, V28, P297, DOI 10.1161/01.STR.28.2.297; van Doorn C, 2003, J AM GERIATR SOC, V51, P1213, DOI 10.1046/j.1532-5415.2003.51404.x; VANDIJK PTM, 1993, GERONTOLOGIST, V33, P200, DOI 10.1093/geront/33.2.200; Wang PS, 2001, J AM GERIATR SOC, V49, P1685, DOI 10.1111/j.1532-5415.2001.49280.x; Woolcott JC, 2009, ARCH INTERN MED, V169, P1952, DOI 10.1001/archinternmed.2009.357; Zhao Z, 2004, REV ECON STAT, V86, P91, DOI 10.1162/003465304323023705	30	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129366	10.1371/journal.pone.0129366	http://dx.doi.org/10.1371/journal.pone.0129366			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061231	gold, Green Published			2022-12-26	WOS:000355979500141
J	Park, HG; Park, WJ; Kothapalli, KSD; Brenna, JT				Park, Hui Gyu; Park, Woo Jung; Kothapalli, Kumar S. D.; Brenna, J. Thomas			The fatty acid desaturase 2 (FADS2) gene product catalyzes Delta 4 desaturation to yield n-3 docosahexaenoic acid and n-6 docosapentaenoic acid in human cells	FASEB JOURNAL			English	Article						metabolism; nutrition; polyunsaturated fatty acids; Delta 6 desaturation	TANDEM MASS-SPECTROMETRY; DOUBLE-BOND LOCALIZATION; ALPHA-LINOLENIC ACID; ACYL-COA OXIDASE; METHYL-ESTERS; FUNCTIONAL-CHARACTERIZATION; NUTRITIONAL REGULATION; PEROXISOMAL DISORDERS; ARACHIDONIC-ACID; RAT-LIVER	Docosahexaenoic acid (DHA) is a Delta 4-desaturated C22 fatty acid and the limiting highly unsaturated fatty acid (HUFA) in neural tissue. The biosynthesis of Delta 4-desaturated docosanoid fatty acids 22:6n-3 and 22:5n-6 are believed to proceed via a circuitous biochemical pathway requiring repeated use of a fatty acid desaturase 2 (FADS2) protein to perform Delta 6 desaturation on C24 fatty acids in the endoplasmic reticulum followed by 1 round of beta-oxidation in the peroxisomes. We demonstrate here that the FADS2 gene product can directly Delta 4-desaturate 22:5n-3-->22:6n-3 (DHA) and 22:4n-6-->22:5n-6. Human MCF-7 cells lacking functional FADS2-mediated Delta 6-desaturase were stably transformed with FADS2, FADS1, or empty vector. When incubated with 22:5n-3 or 22:4n-6, FADS2 stable cells produce 22:6n-3 or 22:5n-6, respectively. Similarly, FADS2 stable cells when incubated with d5-18:3n-3 show synthesis of d5-22:6n-3 with no labeling of 24:5n-3 or 24:6n-3 at 24 h. Further, both C24 fatty acids are shown to be products of the respective C22 fatty acids via elongation. Our results demonstrate that the FADS2 classical transcript mediates direct Delta 4 desaturation to yield 22:6n-3 and 22:5n-6 in human cells, as has been widely shown previously for desaturation by fish and many other organisms.	[Park, Hui Gyu; Park, Woo Jung; Kothapalli, Kumar S. D.; Brenna, J. Thomas] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Brenna, J. Thomas] Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA; [Park, Woo Jung] Gangneung Wonju Natl Univ, Dept Marine Food Sci & Technol, Kangwon, South Korea	Cornell University; Cornell University; Kangnung Wonju National University	Brenna, JT (corresponding author), Cornell Univ, Div Nutr Sci, 244 Garden Ave, Ithaca, NY 14853 USA.	ksk25@cornell.edu; jtb4@cornell.edu		Brenna, James Thomas/0000-0001-9494-4245	U.S. National Institutes of Health (NIH) from National Center for Complementary and Integrative Health [R01 AT007003]; Office of Dietary Supplements; National Center for Complementary & Integrative Health [R01AT007003] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) from National Center for Complementary and Integrative Health; Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by U.S. National Institutes of Health (NIH) Grant R01 AT007003 from the National Center for Complementary and Integrative Health (formerly the National Center for Complementary and Alternative Medicine) and the Office of Dietary Supplements. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	[Anonymous], 2014, PROTEIN MOL WEIGHT C; BRECKENR.WC, 1971, BRAIN RES, V33, P581, DOI 10.1016/0006-8993(71)90143-0; Brenna JT, 2013, CURR OPIN CLIN NUTR, V16, P548, DOI 10.1097/MCO.0b013e328363bc0a; Brenna JT, 2009, PROSTAG LEUKOTR ESS, V80, P85, DOI 10.1016/j.plefa.2009.01.004; Brenna JT, 2002, CURR OPIN CLIN NUTR, V5, P127, DOI 10.1097/00075197-200203000-00002; Brenner RR, 2003, PROSTAG LEUKOTR ESS, V68, P151, DOI 10.1016/S0952-3278(02)00265-X; Diau GY, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-11; Ferdinandusse S, 2001, J LIPID RES, V42, P1987; Fonseca-Madrigal J, 2014, J LIPID RES, V55, P1408, DOI 10.1194/jlr.M049791; GARCES R, 1993, ANAL BIOCHEM, V211, P139, DOI 10.1006/abio.1993.1244; Gibson RA, 2013, PROSTAG LEUKOTR ESS, V88, P139, DOI 10.1016/j.plefa.2012.04.003; GRAMMATIKOS SI, 1994, BRIT J CANCER, V70, P219, DOI 10.1038/bjc.1994.283; HUGHES S, 1985, BIOCHEM J, V225, P307, DOI 10.1042/bj2250307; Infante JP, 1997, MOL CELL BIOCHEM, V168, P101, DOI 10.1023/A:1006895209833; Infante JP, 2002, MOL GENET METAB, V75, P108, DOI 10.1006/mgme.2001.3279; Infante JP, 1998, FEBS LETT, V431, P1, DOI 10.1016/S0014-5793(98)00720-0; INNIS SM, 1991, PROG LIPID RES, V30, P39, DOI 10.1016/0163-7827(91)90006-Q; JAKOBSSON A, 1990, BIOCHIM BIOPHYS ACTA, V1046, P277, DOI 10.1016/0005-2760(90)90242-P; Kaduce TL, 2008, J NEUROCHEM, V105, P1525, DOI 10.1111/j.1471-4159.2008.05274.x; Kuah MK, 2015, BBA-MOL CELL BIOL L, V1851, P248, DOI 10.1016/j.bbalip.2014.12.012; Lapillonne A, 2013, J PEDIATR-US, V162, pS37, DOI 10.1016/j.jpeds.2012.11.052; Lawrence P, 2006, ANAL CHEM, V78, P1312, DOI 10.1021/ac0516584; Leonard AE, 2002, LIPIDS, V37, P733, DOI 10.1007/s11745-002-0955-6; Li YY, 2010, P NATL ACAD SCI USA, V107, P16840, DOI 10.1073/pnas.1008429107; Lin YH, 2005, J LIPID RES, V46, P1962, DOI 10.1194/jlr.M500127-JLR200; MARTINEZ M, 1992, BRAIN RES, V583, P171, DOI 10.1016/S0006-8993(10)80021-6; Meyer A, 2003, BIOCHEMISTRY-US, V42, P9779, DOI 10.1021/bi034731y; Michaud AL, 2005, RAPID COMMUN MASS SP, V19, P363, DOI 10.1002/rcm.1797; Michaud AL, 2003, ANAL CHEM, V75, P4925, DOI 10.1021/ac034221+; Michaud AL, 2002, ANAL BIOCHEM, V307, P348, DOI 10.1016/S0003-2697(02)00037-4; Mohammed BS, 1997, BIOCHEM J, V326, P425, DOI 10.1042/bj3260425; Moon YA, 2009, J LIPID RES, V50, P412, DOI 10.1194/jlr.M800383-JLR200; MOORE SA, 1995, J LIPID RES, V36, P2433; Morais S, 2012, BBA-MOL CELL BIOL L, V1821, P660, DOI 10.1016/j.bbalip.2011.12.011; Morale SE, 2005, EARLY HUM DEV, V81, P197, DOI 10.1016/j.earlhumdev.2004.09.008; Oosterveer MH, 2009, J BIOL CHEM, V284, P34036, DOI 10.1074/jbc.M109.051052; Park WJ, 2012, J LIPID RES, V53, P1502, DOI 10.1194/jlr.M025312; Park WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028186; Park WJ, 2010, MOL BIOL REP, V37, P2403, DOI 10.1007/s11033-009-9750-9; Park WJ, 2009, GENE, V446, P28, DOI 10.1016/j.gene.2009.06.016; Park WJ, 2009, J LIPID RES, V50, P1195, DOI 10.1194/jlr.M800630-JLR200; Pauter AM, 2014, J LIPID RES, V55, P718, DOI 10.1194/jlr.M046151; Pedrono F, 2010, J LIPID RES, V51, P472, DOI 10.1194/jlr.M000588; Qiu X, 2001, J BIOL CHEM, V276, P31561, DOI 10.1074/jbc.M102971200; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; STOFFEL W, 1970, H-S Z PHYSIOL CHEM, V351, P1545, DOI 10.1515/bchm2.1970.351.2.1545; STOFFEL W, 1966, NATURWISSENSCHAFTEN, V53, P621, DOI 10.1007/BF00602718; Stroud CK, 2009, J LIPID RES, V50, P1870, DOI 10.1194/jlr.M900039-JLR200; Su HM, 1998, ANAL BIOCHEM, V261, P43, DOI 10.1006/abio.1998.2706; Su HM, 2001, J BIOL CHEM, V276, P38115; Tonon T, 2003, FEBS LETT, V553, P440, DOI 10.1016/S0014-5793(03)01078-0; Trevizan L, 2012, LIPIDS, V47, P413, DOI 10.1007/s11745-011-3651-0; Tripodi KEJ, 2006, FEBS J, V273, P271, DOI 10.1111/j.1742-4658.2005.05049.x; Van Pelt CK, 1999, ANAL CHEM, V71, P1981, DOI 10.1021/ac981387f; Van Pelt CK, 1999, J AM SOC MASS SPECTR, V10, P1253; VESLOSADA A, 1995, MOL CELL BIOCHEM, V142, P163, DOI 10.1007/BF00928937; VOSS A, 1991, J BIOL CHEM, V266, P19995; WANG N, 1993, BIOCHEMISTRY-US, V32, P13703, DOI 10.1021/bi00212a040; Zadravec D, 2011, J LIPID RES, V52, P245, DOI 10.1194/jlr.M011346; Zhou YH, 2008, LIPIDS, V43, P525, DOI 10.1007/s11745-008-3186-1	60	94	95	0	32	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3911	3919		10.1096/fj.15-271783	http://dx.doi.org/10.1096/fj.15-271783			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26065859	Green Published			2022-12-26	WOS:000359915600026
J	Agarwal, V; Talens, S; Grandits, AM; Blom, AM				Agarwal, Vaibhav; Talens, Simone; Grandits, Alexander M.; Blom, Anna M.			A Novel Interaction between Complement Inhibitor C4b-binding Protein and Plasminogen That Enhances Plasminogen Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPEPTIDASE O PEPO; STREPTOCOCCUS-PNEUMONIAE; INNATE IMMUNITY; BINDING-PROTEIN; THROMBIN GENERATION; C4-BINDING PROTEIN; SYSTEM; COAGULATION; EVASION; FIBRIN	The complement, coagulation, and fibrinolytic systems are crucial for the maintenance of tissue homeostasis. To date numerous interactions and cross-talks have been identified between these cascades. In line with this, here we propose a novel, hitherto unknown interaction between the complement inhibitor C4b-binding protein (C4BP) and plasminogen of the fibrinolytic pathway. Binding of C4BP to Streptococcus pneumoniae is a known virulence mechanism of this pathogen and it was increased in the presence of plasminogen. Interestingly, the acute phase variant of C4BP lacking the beta-chain and protein S binds plasminogen much stronger than the main isoform containing the beta-chain and protein S. Indeed, the complement control protein (CCP) 8 domain of C4BP, which would otherwise be sterically hindered by the beta-chain, primarily mediates this interaction. Moreover, the lysine-binding sites in plasminogen kringle domains facilitate the C4BP-plasminogen interaction. Furthermore, C4BP readily forms complexes with plasminogen in fluid phase and such complexes are present in human serum and plasma. Importantly, whereas the presence of plasminogen did not affect the factor I cofactor activity of C4BP, the activation of plasminogen by urokinase-type plasminogen activator to active plasmin was significantly augmented in the presence of C4BP. Taken together, our data demonstrate a novel interaction between two proteins of the complement and fibrinolytic system. Most complexes might be formed during the acute phase of inflammation and have an effect on the homeostasis at the site of injury or acute inflammation.	[Agarwal, Vaibhav; Talens, Simone; Grandits, Alexander M.; Blom, Anna M.] Lund Univ, Med Prot Chem, Translat Med, S-20502 Malmo, Sweden	Lund University	Blom, AM (corresponding author), Wallenberg Inst & Labs, Floor 4,Inga Marie Nilssons St 53, S-20502 Malmo, Sweden.	anna.blom@med.lu.se	Blom, Anna/B-9607-2009; Blom, Anna/AFS-7369-2022	Blom, Anna/0000-0002-1348-1734; Grandits, Alexander Michael/0000-0001-9929-1861	Swedish Research Council [K2012-66X-14928-09-5]; Foundation of Torsten Soderberg; Foundation of Osterlund; Foundation of Greta and Johan Kock; Foundation of King Gustav V's 80th Anniversary; Foundation of Knut and Alice Wallenberg; Foundation of Inga-Britt and Arne Lundberg; Foundation of Ake Wiberg; Royal Physiographic Society in Lund; Skane University Hospital; Swedish Society for Medical Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Foundation of Torsten Soderberg; Foundation of Osterlund; Foundation of Greta and Johan Kock; Foundation of King Gustav V's 80th Anniversary; Foundation of Knut and Alice Wallenberg(Knut & Alice Wallenberg Foundation); Foundation of Inga-Britt and Arne Lundberg; Foundation of Ake Wiberg; Royal Physiographic Society in Lund; Skane University Hospital; Swedish Society for Medical Research	This work was supported in part by Swedish Research Council Grant K2012-66X-14928-09-5, Foundations of Torsten Soderberg, Osterlund, Greta and Johan Kock, King Gustav V's 80th Anniversary, Knut and Alice Wallenberg, Inga-Britt and Arne Lundberg, Ake Wiberg, Royal Physiographic Society in Lund, and the Skane University Hospital. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a postdoctoral stipend from Swedish Society for Medical Research.	Agarwal V, 2014, J BIOL CHEM, V289, P15833, DOI 10.1074/jbc.M113.530212; Agarwal V, 2013, J BIOL CHEM, V288, P6849, DOI 10.1074/jbc.M112.405530; Agarwal V, 2012, J IMMUNOL, V189, P3575, DOI 10.4049/jimmunol.1102934; Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678; Amara U, 2008, ADV EXP MED BIOL, V632, P71, DOI 10.1007/978-0-387-78952-1_6; ANGLESCANO E, 1994, CHEM PHYS LIPIDS, V67-8, P353, DOI 10.1016/0009-3084(94)90157-0; Avirutnan P, 2011, J IMMUNOL, V187, P424, DOI 10.4049/jimmunol.1100750; Barthel D, 2012, J BIOL CHEM, V287, P18831, DOI 10.1074/jbc.M111.323287; Barthel D, 2012, J IMMUNOL, V188, P379, DOI 10.4049/jimmunol.1101927; Bergmann S, 2013, INT J MED MICROBIOL, V303, P452, DOI 10.1016/j.ijmm.2013.06.002; Blom AM, 2001, J BIOL CHEM, V276, P27136, DOI 10.1074/jbc.M102445200; Blom AM, 2009, MOL IMMUNOL, V46, P2808, DOI 10.1016/j.molimm.2009.04.025; CASTELLINO FJ, 1981, METHOD ENZYMOL, V80, P365; Castellino FJ, 1997, CIBA F SYMP, V212, P46; Cesarman-Maus G, 2005, BRIT J HAEMATOL, V129, P307, DOI 10.1111/j.1365-2141.2005.05444.x; Chavakis T, 2005, BLOOD, V105, P1036, DOI 10.1182/blood-2004-01-0166; DAHLBACK B, 1991, THROMB HAEMOSTASIS, V66, P49; DAHLBACK B, 1983, BIOCHEM J, V209, P847, DOI 10.1042/bj2090847; DAHLBACK B, 1981, P NATL ACAD SCI-BIOL, V78, P2512, DOI 10.1073/pnas.78.4.2512; Duboscq C, 1997, THROMB RES, V86, P505, DOI 10.1016/S0049-3848(97)00099-6; Frick IM, 2006, EMBO J, V25, P5569, DOI 10.1038/sj.emboj.7601422; FUJITA T, 1979, J EXP MED, V150, P267, DOI 10.1084/jem.150.2.267; FUJITA T, 1978, J EXP MED, V148, P1044, DOI 10.1084/jem.148.4.1044; GIGLI I, 1979, P NATL ACAD SCI USA, V76, P6596, DOI 10.1073/pnas.76.12.6596; HILLARP A, 1989, FEBS LETT, V259, P53, DOI 10.1016/0014-5793(89)81492-9; Holers VM, 2014, ANNU REV IMMUNOL, V32, P433, DOI 10.1146/annurev-immunol-032713-120154; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Koch TK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047638; Koenigs A, 2013, J BIOL CHEM, V288, P25229, DOI 10.1074/jbc.M112.413872; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006; MIYASHITA C, 1988, Haemostasis, V18, P7; Nilsson SC, 2009, EUR J IMMUNOL, V39, P310, DOI 10.1002/eji.200838702; NORMAN DG, 1991, J MOL BIOL, V219, P717, DOI 10.1016/0022-2836(91)90666-T; PLOW EF, 1995, FASEB J, V9, P939, DOI 10.1096/fasebj.9.10.7615163; PONTING CP, 1992, BLOOD COAGUL FIBRIN, V3, P605, DOI 10.1097/00001721-199210000-00012; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Ritis K, 2006, J IMMUNOL, V177, P4794, DOI 10.4049/jimmunol.177.7.4794; ROSENBERG RD, 1984, J CLIN INVEST, V74, P1, DOI 10.1172/JCI111389; Sjoberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003; Smeesters PR, 2010, TRENDS MICROBIOL, V18, P275, DOI 10.1016/j.tim.2010.02.007; Souza NM, 2012, MICROB PATHOGENESIS, V53, P125, DOI 10.1016/j.micpath.2012.06.001; WIMAN B, 1979, BIOCHIM BIOPHYS ACTA, V579, P142, DOI 10.1016/0005-2795(79)90094-1; Wolberg AS, 2008, TRANSFUS APHER SCI, V38, P15, DOI 10.1016/j.transci.2007.12.005; Wolberg AS, 2007, BLOOD REV, V21, P131, DOI 10.1016/j.blre.2006.11.001; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	46	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18333	18342		10.1074/jbc.M114.619494	http://dx.doi.org/10.1074/jbc.M114.619494			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26067271	Green Published, hybrid			2022-12-26	WOS:000358512100007
J	Huang, Y; Sun, LP; Liu, NN; Wei, Q; Jiang, LZ; Tong, XM; Ye, X				Huang, Yan; Sun, Liping; Liu, Ningning; Wei, Qian; Jiang, Liangzhen; Tong, Xiaomei; Ye, Xin			Polo-like Kinase 1 (Plk1) Up-regulates Telomerase Activity by Affecting Human Telomerase Reverse Transcriptase (hTERT) Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC SUBUNIT; E3 LIGASE; PHOSPHORYLATION; PROTEIN; MITOSIS; TRF1; CYTOKINESIS; DEGRADATION; PHOSPHATASE; PROTEOLYSIS	Maintenance of telomere is regulated by active telomerase complex, including telomerase holoenzyme and its associated proteins. The activity of telomerase is precisely controlled in cells, and its dysregulation is one of the hallmarks of cancer. The telomerase catalytic subunit human telomerase reverse transcriptase (hTERT) plays a central role for telomerase activity. In this study, we indentified that Polo-like kinase 1 (Plk1) is a novel telomerase-associated protein. Plk1 can interact with hTERT independently of its kinase activity. More importantly, we found that Plk1 is associated with active telomerase complex. In addition, we demonstrated that knockdown of Plk1 caused the reduction of telomerase activity, whereas overexpression of Plk1 increased telomerase activity. Further analysis showed that overexpression of Plk1 led to a significant increase of hTERT protein by prolonging its half-life but did not affect the level of hTERT mRNA. Furthermore, we found that Plk1 enhanced the chromatin loading of hTERT and inhibited its ubiquitination. This implied that Plk1 affected hTERT stability by inhibiting its ubiquitin-mediated degradation. Collectively, these observations suggested that Plk1 is a positive modulator of telomerase by enhancing the stability of hTERT.	[Huang, Yan; Sun, Liping; Liu, Ningning; Wei, Qian; Jiang, Liangzhen; Tong, Xiaomei; Ye, Xin] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Huang, Yan; Sun, Liping; Liu, Ningning; Wei, Qian; Jiang, Liangzhen] Univ Chinese Acad Sci, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ye, X (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, 1 Beichen West Rd, Beijing 100101, Peoples R China.	yex@im.ac.cn		Liu, Ningning/0000-0002-3868-8395	National Natural Science Foundation of China [81272272, 31471278]; Ministry of Science and Technology of China [2013ZX10004611, 2012CB519003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported in part by National Natural Science Foundation of China Grants 81272272 and 31471278 and Ministry of Science and Technology of China Grants 2013ZX10004611 and 2012CB519003. The authors declare that they have no conflicts of interest with the contents of this article.	Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Chai WH, 2002, J BIOL CHEM, V277, P47242, DOI 10.1074/jbc.M208542200; Chang JT, 2006, BRIT J CANCER, V94, P870, DOI 10.1038/sj.bjc.6603008; de Lange T, 1998, NATURE, V392, P753, DOI 10.1038/33790; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Forsythe HL, 2001, J BIOL CHEM, V276, P15571, DOI 10.1074/jbc.C100055200; Fraile JM, 2012, ONCOGENE, V31, P2373, DOI 10.1038/onc.2011.443; Greenberg RA, 1999, ONCOGENE, V18, P1219, DOI 10.1038/sj.onc.1202669; Ha GH, 2012, CELL DEATH DIFFER, V19, P321, DOI 10.1038/cdd.2011.101; Harrington L, 1997, GENE DEV, V11, P3109, DOI 10.1101/gad.11.23.3109; Holt SE, 1999, GENE DEV, V13, P817, DOI 10.1101/gad.13.7.817; Jung HY, 2013, J BIOL CHEM, V288, P7252, DOI 10.1074/jbc.M112.416792; Kang SS, 1999, J BIOL CHEM, V274, P13085, DOI 10.1074/jbc.274.19.13085; Kharbanda S, 2000, CURR BIOL, V10, P568, DOI 10.1016/S0960-9822(00)00483-8; Kim J, 2014, BIOCHEM BIOPH RES CO, V443, P1124, DOI 10.1016/j.bbrc.2013.12.118; Kim JH, 2005, GENE DEV, V19, P776, DOI 10.1101/gad.1289405; Kishi K, 2009, MOL CELL BIOL, V29, P3134, DOI 10.1128/MCB.01663-08; Lee GE, 2004, J BIOL CHEM, V279, P34750, DOI 10.1074/jbc.M401843200; Lee JH, 2010, J BIOL CHEM, V285, P42033, DOI 10.1074/jbc.M110.149831; Liao ZL, 2013, INT IMMUNOPHARMACOL, V16, P444, DOI 10.1016/j.intimp.2013.05.006; Lobjois V, 2011, BIOCHEM BIOPH RES CO, V410, P87, DOI 10.1016/j.bbrc.2011.05.110; Marcand S, 2000, CURR BIOL, V10, P487, DOI 10.1016/S0960-9822(00)00450-4; Munoz P, 2009, MOL CELL BIOL, V29, P1608, DOI 10.1128/MCB.01339-08; Neef R, 2007, NAT CELL BIOL, V9, P436, DOI 10.1038/ncb1557; O'Donovan DS, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.208; Oh W, 2010, ONCOGENE, V29, P4101, DOI 10.1038/onc.2010.160; Okamoto K, 2008, J BIOL CHEM, V283, P23981, DOI 10.1074/jbc.M802395200; Park JE, 2010, CELL MOL LIFE SCI, V67, P1957, DOI 10.1007/s00018-010-0279-9; Seimiya H, 2000, EMBO J, V19, P2652, DOI 10.1093/emboj/19.11.2652; Soohoo CY, 2011, J BIOL CHEM, V286, P3894, DOI 10.1074/jbc.M110.180174; Takaki T, 2008, CURR OPIN CELL BIOL, V20, P650, DOI 10.1016/j.ceb.2008.10.005; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; Wang C, 2010, EUR J CELL BIOL, V89, P748, DOI 10.1016/j.ejcb.2010.05.005; Wang J, 1998, GENE DEV, V12, P1769, DOI 10.1101/gad.12.12.1769; Weinrich SL, 1997, NAT GENET, V17, P498, DOI 10.1038/ng1297-498; Wu ZQ, 2008, P NATL ACAD SCI USA, V105, P1919, DOI 10.1073/pnas.0712063105; Ye JZS, 2004, NAT GENET, V36, P618, DOI 10.1038/ng1360; Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4	41	9	9	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18865	18873		10.1074/jbc.M114.635375	http://dx.doi.org/10.1074/jbc.M114.635375			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26070557	Green Published, hybrid			2022-12-26	WOS:000358512100052
J	Suarez, MH; Dopazo, GA; Lopez, DL; Espinosa, F				Hernandez Suarez, Marcos; Astray Dopazo, Gonzalo; Larios Lopez, Dina; Espinosa, Francisco			Identification of Relevant Phytochemical Constituents for Characterization and Authentication of Tomatoes by General Linear Model Linked to Automatic Interaction Detection (GLM-AID) and Artificial Neural Network Models (ANNs)	PLOS ONE			English	Article							ANTIOXIDANT CONTENT; SEASONAL-VARIATIONS; QUALITY; PREDICTION; CLASSIFICATION; TEMPERATURE; SYSTEMS; ACID	There are a large number of tomato cultivars with a wide range of morphological, chemical, nutritional and sensorial characteristics. Many factors are known to affect the nutrient content of tomato cultivars. A complete understanding of the effect of these factors would require an exhaustive experimental design, multidisciplinary scientific approach and a suitable statistical method. Some multivariate analytical techniques such as Principal Component Analysis (PCA) or Factor Analysis (FA) have been widely applied in order to search for patterns in the behaviour and reduce the dimensionality of a data set by a new set of uncorrelated latent variables. However, in some cases it is not useful to replace the original variables with these latent variables. In this study, Automatic Interaction Detection (AID) algorithm and Artificial Neural Network (ANN) models were applied as alternative to the PCA, AF and other multivariate analytical techniques in order to identify the relevant phytochemical constituents for characterization and authentication of tomatoes. To prove the feasibility of AID algorithm and ANN models to achieve the purpose of this study, both methods were applied on a data set with twenty five chemical parameters analysed on 167 tomato samples from Tenerife (Spain). Each tomato sample was defined by three factors: cultivar, agricultural practice and harvest date. General Linear Model linked to AID (GLM-AID) tree-structured was organized into 3 levels according to the number of factors. p-Coumaric acid was the compound the allowed to distinguish the tomato samples according to the day of harvest. More than one chemical parameter was necessary to distinguish among different agricultural practices and among the tomato cultivars. Several ANN models, with 25 and 10 input variables, for the prediction of cultivar, agricultural practice and harvest date, were developed. Finally, the models with 10 input variables were chosen with fit's goodness between 44 and 100%. The lowest fits were for the cultivar classification, this low percentage suggests that other kind of chemical parameter should be used to identify tomato cultivars.	[Hernandez Suarez, Marcos] Aula Dei Sci Technol Pk Fdn, Zaragoza, Spain; [Astray Dopazo, Gonzalo; Larios Lopez, Dina] Ohio Univ, Coll Arts & Sci, Dept Geol Sci, Athens, OH 45701 USA; [Astray Dopazo, Gonzalo] Univ Vigo, Fac Sci, Dept Phys Chem, Orense, Spain; [Espinosa, Francisco] Univ Extremadura, Fac Sci, Dept Plant Physiol Ecol & Earth Sci, Badajoz, Spain	University System of Ohio; Ohio University; Universidade de Vigo; Universidad de Extremadura	Espinosa, F (corresponding author), Univ Extremadura, Fac Sci, Dept Plant Physiol Ecol & Earth Sci, Badajoz, Spain.	espinosa@unex.es	Espinosa, Francisco/I-8205-2018	Espinosa, Francisco/0000-0002-6467-0359; Lopez, Dina/0000-0003-2680-5862; Astray, Gonzalo/0000-0002-0890-1191	Xunta de Galicia, Conselleria de Cultura, Educacion e Ordenacion Universitaria [P.P.0000 421S 140.08]; regional Government of Extremadura [GR10084]	Xunta de Galicia, Conselleria de Cultura, Educacion e Ordenacion Universitaria(Xunta de Galicia); regional Government of Extremadura	GAD thanks Xunta de Galicia, Conselleria de Cultura, Educacion e Ordenacion Universitaria, for the Postdoctoral grant (Plan I2C), P.P.0000 421S 140.08, and FE thanks the regional Government of Extremadura by the support to the research Group FBCMP (GR10084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2007, ENCY MEASUREMENT STA, V3, P103; AOAC, 1990, OFFICIAL METHODS ANA; Araujo P, 2011, J ENVIRON MONITOR, V13, P35, DOI 10.1039/c0em00478b; Arvanitoyannis IS, 2007, CRIT REV FOOD SCI, V47, P675, DOI 10.1080/10408390600948568; Bilgili M, 2007, RENEW ENERG, V32, P2350, DOI 10.1016/j.renene.2006.12.001; Biswas MK, 2011, SCI HORTIC-AMSTERDAM, V129, P798, DOI 10.1016/j.scienta.2011.06.015; Canene-Adams K, 2005, J NUTR, V135, P1226, DOI 10.1093/jn/135.5.1226; Cebolla-Cornejo J, 2011, J AGR FOOD CHEM, V59, P2440, DOI 10.1021/jf1045427; Chuang Y H, 1967, Comput Biomed Res, V1, P173; Claye SS, 1996, FOOD CHEM, V57, P305, DOI 10.1016/0308-8146(95)00250-2; Fanasca S, 2006, J AGR FOOD CHEM, V54, P4319, DOI 10.1021/jf0602572; GABRIEL KR, 1971, BIOMETRIKA, V58, P453, DOI 10.1093/biomet/58.3.453; Galindo Villardon M.P., 1986, QUESTIIO, V10, P13; Gautier H, 2008, J AGR FOOD CHEM, V56, P1241, DOI 10.1021/jf072196t; Grattan SR, 1999, SCI HORTIC-AMSTERDAM, V78, P127, DOI 10.1016/S0304-4238(98)00192-7; Gundersen V, 2001, J AGR FOOD CHEM, V49, P3808, DOI 10.1021/jf0103774; Hernandez M, 2014, J PLANT NUTR SOIL SC, V177, P443, DOI 10.1002/jpln.201200642; Hernandez Suarez M, 2013, TOMATOES CULTIVATION, P191; HUNT KJ, 1992, AUTOMATICA, V28, P1083, DOI 10.1016/0005-1098(92)90053-I; KLEINFELD D, 1986, P NATL ACAD SCI USA, V83, P9469, DOI 10.1073/pnas.83.24.9469; Lamia K, 2010, SCI HORTIC-AMSTERDAM, V127, P54, DOI 10.1016/j.scienta.2010.09.012; Larcher W, 2003, PHYSL PLANT ECOLOGY, pChapter 6; Leonardi C, 2000, J AGR FOOD CHEM, V48, P4723, DOI 10.1021/jf000225t; Loh WY, 1997, STAT SINICA, V7, P815; Lutsenko EA, 2004, MOL CELL BIOL, V24, P3150, DOI 10.1128/MCB.24.8.3150-3156.2004; Max JFJ, 2009, SCI HORTIC-AMSTERDAM, V122, P179, DOI 10.1016/j.scienta.2009.05.007; Moldes OA, 2013, TENSIDE SURFACT DET, V50, P360, DOI 10.3139/113.110268; MORGAN JN, 1963, J AM STAT ASSOC, V58, P415, DOI 10.2307/2283276; Raffo A, 2006, J FOOD COMPOS ANAL, V19, P11, DOI 10.1016/j.jfca.2005.02.003; Galdon BR, 2010, J AGR FOOD CHEM, V58, P11435, DOI 10.1021/jf102014j; Rosales MA, 2006, J SCI FOOD AGR, V86, P1545, DOI 10.1002/jsfa.2546; Santesmases Mestre M, 2009, DYANE VERSION 4 DISE; Slimestad R, 2005, J AGR FOOD CHEM, V53, P3114, DOI 10.1021/jf047864e; Sutariya V., 2013, OPEN BIOINFORM J, V7, P49, DOI [DOI 10.2174/1875036201307010049, 10.2174/1875036201307010049]; Tedeschi P, 2011, J FOOD COMPOS ANAL, V24, P131, DOI 10.1016/j.jfca.2010.06.008; Thybo AK, 2006, LWT-FOOD SCI TECHNOL, V39, P835, DOI 10.1016/j.lwt.2005.09.010; Yin HB, 2002, TRANSPORT RES C-EMER, V10, P85, DOI 10.1016/S0968-090X(01)00004-3; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P225, DOI 10.1016/B978-0-12-386903-6.00009-5; Zhang GQ, 1998, INT J FORECASTING, V14, P35, DOI 10.1016/S0169-2070(97)00044-7; Zhang YD, 2009, EXPERT SYST APPL, V36, P8849, DOI 10.1016/j.eswa.2008.11.028	40	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128566	10.1371/journal.pone.0128566	http://dx.doi.org/10.1371/journal.pone.0128566			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075889	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900021
J	Jia, FJ; Wan, XM; Zhu, W; Sun, D; Zheng, CC; Liu, P; Huang, JG				Jia, Fengjuan; Wan, Xiaomin; Zhu, Wei; Sun, Dan; Zheng, Chengchao; Liu, Pei; Huang, Jinguang			Overexpression of Mitochondrial Phosphate Transporter 3 Severely Hampers Plant Development through Regulating Mitochondrial Function in Arabidopsis	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; OXIDATIVE STRESS; TRANSPORTER; EXPRESSION; POLLEN; PROTEIN; GROWTH; IDENTIFICATION; ACCUMULATION; RESPIRATION	Mitochondria are abundant and important organelles present in nearly all eukaryotic cells, which maintain metabolic communication with the cytosol through mitochondrial carriers. The mitochondrial membrane localized phosphate transporter (MPT) plays vital roles in diverse development and signaling processes, especially the ATP biosynthesis. Among the three MPT genes in Arabidopsis genome, AtMPT3 was proven to be a major member, and its overexpression gave rise to multiple developmental defects including curly leaves with deep color, dwarfed stature, and reduced fertility. Transcript profiles revealed that genes involved in plant metabolism, cellular redox homeostasis, alternative respiration pathway, and leaf and flower development were obviously altered in AtMPT3 overexpression (OEMPT3) plants. Moreover, OEMPT3 plants also accumulated higher ATP content, faster respiration rate and more reactive oxygen species (ROS) than wild type plants. Overall, our studies showed that AtMPT3 was indispensable for Arabidopsis normal growth and development, and provided new sights to investigate its possible regulation mechanisms.	[Jia, Fengjuan; Wan, Xiaomin; Zhu, Wei; Sun, Dan; Zheng, Chengchao; Huang, Jinguang] Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Liu, Pei] Shandong Agr Univ, Coll Food Sci & Engn, Tai An, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University	Liu, P (corresponding author), Shandong Agr Univ, Coll Food Sci & Engn, Tai An, Shandong, Peoples R China.	liupei83224@sdau.edu.cn; jghuang@sdau.edu.cn			National Natural Science Foundation in China [31370305, 31000121]	National Natural Science Foundation in China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation (Grant No. 31370305, 31000121) in China.	ALEXANDER MP, 1969, STAIN TECHNOL, V44, P117, DOI 10.3109/10520296909063335; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bartoli CG, 2006, J EXP BOT, V57, P1621, DOI 10.1093/jxb/erl005; Busi MV, 2006, PLANT J, V48, P873, DOI 10.1111/j.1365-313X.2006.02923.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DEIKMAN J, 1995, PLANT PHYSIOL, V108, P47, DOI 10.1104/pp.108.1.47; Gomez-Casati DF, 2002, FEBS LETT, V532, P70, DOI 10.1016/S0014-5793(02)03631-1; Gray MW, 2001, GENOME BIOL, V2; Hamel P, 2004, MOL MICROBIOL, V51, P307, DOI 10.1046/j.1365-2958.2003.03810.x; Huang X, 2008, PLANTA, V228, P545, DOI 10.1007/s00425-008-0757-6; Juszczuk IM, 2003, ACTA BIOCHIM POL, V50, P1257; Kawai-Yamada M, 2004, PLANT CELL, V16, P21, DOI 10.1105/tpc.014613; Kaya H, 2014, PLANT CELL, V26, P1069, DOI 10.1105/tpc.113.120642; Kiiskinen M, 1997, PLANT MOL BIOL, V35, P271, DOI 10.1023/A:1005868715571; Li LG, 2008, MOL PLANT, V1, P675, DOI 10.1093/mp/ssn031; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Lohse M, 2010, PLANT PHYSIOL, V153, P642, DOI 10.1104/pp.109.152553; Marechal A, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-42; Mayr JA, 2007, AM J HUM GENET, V80, P478, DOI 10.1086/511788; McInnis SM, 2006, NEW PHYTOL, V172, P221, DOI 10.1111/j.1469-8137.2006.01875.x; Meyer EH, 2009, PLANT PHYSIOL, V151, P603, DOI 10.1104/pp.109.141770; Millar AH, 2003, PLANT PHYSIOL, V131, P443, DOI 10.1104/pp.009985; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakamori K, 2002, PLANT CELL PHYSIOL, V43, P1250, DOI 10.1093/pcp/pcf141; Orozco-Cardenas M, 1999, P NATL ACAD SCI USA, V96, P6553, DOI 10.1073/pnas.96.11.6553; Ozgur R, 2014, J EXP BOT, V65, P1377, DOI 10.1093/jxb/eru034; Palmieri F, 1996, BBA-BIOENERGETICS, V1275, P127, DOI 10.1016/0005-2728(96)00062-X; Palmieri F, 2009, J BIOL CHEM, V284, P31249, DOI 10.1074/jbc.M109.041830; Palmieri L, 2008, PLANT PHYSIOL, V148, P1797, DOI 10.1104/pp.108.130310; Peterhansel C, 1997, PLANT CELL, V9, P1397, DOI 10.1105/tpc.9.8.1397; Picault N, 2004, TRENDS PLANT SCI, V9, P138, DOI 10.1016/j.tplants.2004.01.007; Picault N, 2002, J BIOL CHEM, V277, P24204, DOI 10.1074/jbc.M202702200; Potocky M, 2007, NEW PHYTOL, V174, P742, DOI 10.1111/j.1469-8137.2007.02042.x; SARASTE M, 1982, FEBS LETT, V144, P250, DOI 10.1016/0014-5793(82)80648-0; Smith AMO, 2004, J BIOL CHEM, V279, P51944, DOI 10.1074/jbc.M408920200; Takabatake R, 1999, PLANT MOL BIOL, V40, P479, DOI 10.1023/A:1006285009435; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tomaz T, 2010, PLANT PHYSIOL, V154, P1143, DOI 10.1104/pp.110.161612; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1211, DOI 10.1111/j.1365-3040.2009.01978.x; WALKER JE, 1993, J BIOENERG BIOMEMBR, V25, P435, DOI 10.1007/BF01108401; Yaeno T, 2004, PLANT J, V40, P931, DOI 10.1111/j.1365-313X.2004.02260.x; Yuan H, 2012, PLANT J, V70, P432, DOI 10.1111/j.1365-313X.2011.04883.x; Zhou HP, 2012, PLANT CELL, V24, P5106, DOI 10.1105/tpc.112.106393; Zhu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043530	45	28	29	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129717	10.1371/journal.pone.0129717	http://dx.doi.org/10.1371/journal.pone.0129717			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076137	gold, Green Published, Green Submitted			2022-12-26	WOS:000356329900095
J	Lin, CP; Ko, CY; Kuo, CI; Liu, MS; Schafleitner, R; Chen, LFO				Lin, Ching-Ping; Ko, Chia-Yun; Kuo, Ching-I; Liu, Mao-Sen; Schafleitner, Roland; Chen, Long-Fang Oliver			Transcriptional Slippage and RNA Editing Increase the Diversity of Transcripts in Chloroplasts: Insight from Deep Sequencing of Vigna radiata Genome and Transcriptome	PLOS ONE			English	Article							GENE-EXPRESSION; ORGANELLAR GENOMES; PLASTID ANCESTOR; EVOLUTION; ORGANIZATION; PROTEIN; MAIZE; DNA; DIVERSIFICATION; CONSERVATION	We performed deep sequencing of the nuclear and organellar genomes of three mungbean genotypes: Vigna radiata ssp. sublobata TC1966, V. radiata var. radiata NM92 and the recombinant inbred line RIL59 derived from a cross between TC1966 and NM92. Moreover, we performed deep sequencing of the RIL59 transcriptome to investigate transcript variability. The mungbean chloroplast genome has a quadripartite structure including a pair of inverted repeats separated by two single copy regions. A total of 213 simple sequence repeats were identified in the chloroplast genomes of NM92 and RIL59; 78 single nucleotide variants and nine indels were discovered in comparing the chloroplast genomes of TC1966 and NM92. Analysis of the mungbean chloroplast transcriptome revealed mRNAs that were affected by transcriptional slippage and RNA editing. Transcriptional slippage frequency was positively correlated with the length of simple sequence repeats of the mungbean chloroplast genome (R-2=0.9911). In total, 41 C-to-U editing sites were found in 23 chloroplast genes and in one intergenic spacer. No editing site that swapped U to C was found. A combination of bioinformatics and experimental methods revealed that the plastid-encoded RNA polymerase-transcribed genes psbF and ndhA are affected by transcriptional slippage in mungbean and in main lineages of land plants, including three dicots (Glycine max, Brassica rapa, and Nicotiana tabacum), two monocots (Oryza sativa and Zea mays), two gymnosperms (Pinus taeda and Ginkgo biloba) and one moss (Physcomitrella patens). Transcript analysis of the rps2 gene showed that transcriptional slippage could affect transcripts at single sequence repeat regions with poly-A runs. It showed that transcriptional slippage together with incomplete RNA editing may cause sequence diversity of transcripts in chloroplasts of land plants.	[Lin, Ching-Ping; Ko, Chia-Yun; Kuo, Ching-I; Liu, Mao-Sen; Chen, Long-Fang Oliver] Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan; [Lin, Ching-Ping] Univ Taipei, Dept Earth & Life Sci, Taipei 10048, Taiwan; [Schafleitner, Roland] AVRDC World Vegetable Ctr, Tainan 74199, Taiwan	Academia Sinica - Taiwan; University of Taipei	Chen, LFO (corresponding author), Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan.	ochenlf@gate.sinica.edu.tw		Schafleitner, Roland/0000-0003-3637-7603	Innovative Translational Agricultural Research Program Academia Sinica Taiwan [2014CP04]	Innovative Translational Agricultural Research Program Academia Sinica Taiwan	This work was supported by the Innovative Translational Agricultural Research Program (Project #2014CP04) Academia Sinica Taiwan (http://itar.programs.sinica.edu.tw/index.php) to LFOC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alverson AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016404; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Baranov PV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r25; Barkan A, 2011, PLANT PHYSIOL, V155, P1520, DOI 10.1104/pp.110.171231; Bentolila S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003584; BOCK R, 1993, MOL GEN GENET, V240, P238, DOI 10.1007/BF00277062; Borner T, 2014, ADVAN PL BIO, V5, P3, DOI 10.1007/978-1-4939-1136-3_1; Chang S, 1999, PLANT MOL BIOL REP, V11, P113; Chevreux B., 1999, GERMAN C BIOINFORMAT, V99, P45; Clarke LA, 2001, J CLIN PATHOL-MOL PA, V54, P351, DOI 10.1136/mp.54.5.351; Corneille S, 2000, MOL GEN GENET, V264, P419, DOI 10.1007/s004380000295; Deusch O, 2008, MOL BIOL EVOL, V25, P748, DOI 10.1093/molbev/msn022; FALVEY AK, 1976, NUCLEIC ACIDS RES, V3, P79, DOI 10.1093/nar/3.1.79; Freyer R, 1997, P NATL ACAD SCI USA, V94, P6285, DOI 10.1073/pnas.94.12.6285; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Gray MW, 1999, CURR OPIN GENET DEV, V9, P678, DOI 10.1016/S0959-437X(99)00030-1; Green BR, 2011, PLANT J, V66, P34, DOI 10.1111/j.1365-313X.2011.04541.x; Guo WH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117075; Hahn C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt371; HOCH B, 1991, NATURE, V353, P178, DOI 10.1038/353178a0; Inada M, 2004, PLANT CELL PHYSIOL, V45, P1615, DOI 10.1093/pcp/pch191; Jiang Y, 2012, GENET MOL RES, V11, P987, DOI 10.4238/2012.April.19.4; Kahlau S, 2006, J MOL EVOL, V63, P194, DOI 10.1007/s00239-005-0254-5; Kang YJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6443; Keeling PJ, 2010, PHILOS T R SOC B, V365, P729, DOI 10.1098/rstb.2009.0103; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kleine T, 2009, ANNU REV PLANT BIOL, V60, P115, DOI 10.1146/annurev.arplant.043008.092119; Knoop V, 2011, CELL MOL LIFE SCI, V68, P567, DOI 10.1007/s00018-010-0538-9; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin CP, 2010, GENOME BIOL EVOL, V2, P504, DOI 10.1093/gbe/evq036; Maier RM, 1996, PLANT MOL BIOL, V32, P343, DOI 10.1007/BF00039390; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Martin W, 1998, NATURE, V393, P162, DOI 10.1038/30234; MOR TS, 1995, MOL GEN GENET, V246, P600, DOI 10.1007/BF00298966; NECKERMANN K, 1994, GENE, V146, P177, DOI 10.1016/0378-1119(94)90290-9; de Alda JAGO, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5937; PALMER JD, 1985, ANNU REV GENET, V19, P325, DOI 10.1146/annurev.ge.19.120185.001545; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ruwe H, 2013, FEBS LETT, V587, P1429, DOI 10.1016/j.febslet.2013.03.022; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Smith DR, 2011, GENOME BIOL EVOL, V3, P743, DOI [10.1093/gbe/evr001, 10.1093/gbe/evr068]; Stern DB, 2010, ANNU REV PLANT BIOL, V61, P125, DOI 10.1146/annurev-arplant-042809-112242; Sun T, 2013, P NATL ACAD SCI USA, V110, pE1169, DOI 10.1073/pnas.1220162110; Tamas I, 2008, P NATL ACAD SCI USA, V105, P14934, DOI 10.1073/pnas.0806554105; Tangphatsornruang S, 2010, DNA RES, V17, P11, DOI 10.1093/dnares/dsp025; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; WAGNER LA, 1990, NUCLEIC ACIDS RES, V18, P3529, DOI 10.1093/nar/18.12.3529; Wakasugi T, 1996, P NATL ACAD SCI USA, V93, P8766, DOI 10.1073/pnas.93.16.8766; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yagi Y, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00061; Zhang Q, 2003, PLANT CELL PHYSIOL, V44, P941, DOI 10.1093/pcp/pcg121	54	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129396	10.1371/journal.pone.0129396	http://dx.doi.org/10.1371/journal.pone.0129396			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076132	Green Submitted, Green Published, gold			2022-12-26	WOS:000356329900068
J	Nichols, BS; Schindler, CE; Brown, JQ; Wilke, LG; Mulvey, CS; Krieger, MS; Gallagher, J; Geradts, J; Greenup, RA; Von Windheim, JA; Ramanujam, N				Nichols, Brandon S.; Schindler, Christine E.; Brown, Jonathon Q.; Wilke, Lee G.; Mulvey, Christine S.; Krieger, Marlee S.; Gallagher, Jennifer; Geradts, Joseph; Greenup, Rachel A.; Von Windheim, Jesko A.; Ramanujam, Nirmala			A Quantitative Diffuse Reflectance Imaging (QDRI) System for Comprehensive Surveillance of the Morphological Landscape in Breast Tumor Margins	PLOS ONE			English	Article							TISSUE OPTICAL-PROPERTIES; IN-VIVO; MONTE-CARLO; CONSERVING SURGERY; RADIATION-THERAPY; POSITIVE MARGINS; SURGICAL MARGINS; LOCAL RECURRENCE; INVERSE MODEL; STAGE-I	In an ongoing effort to address the clear clinical unmet needs surrounding breast conserving surgery (BCS), our group has developed a next-generation multiplexed optical-fiber-based tool to assess breast tumor margin status during initial surgeries. Specifically detailed in this work is the performance and clinical validation of a research-grade intra-operative tool for margin assessment based on diffuse optical spectroscopy. Previous work published by our group has illustrated the proof-of-concept generations of this device; here we incorporate a highly optimized quantitative diffuse reflectance imaging (QDRI) system utilizing a widefield (imaging area = 17cm(2)) 49-channel multiplexed fiber optic probe, a custom raster-scanning imaging platform, a custom dual-channel white LED source, and an astronomy grade imaging CCD and spectrograph. The system signal to noise ratio (SNR) was found to be greater than 40dB for all channels. Optical property estimation error was found to be less than 10%, on average, over a wide range of absorption (mu(a) = 0-8.9cm(-1)) and scattering (mu(s)' = 7.0-9.7cm(-1)) coefficients. Very low inter-channel and CCD crosstalk was observed (2% max) when used on turbid media (including breast tissue). A raster-scanning mechanism was developed to achieve sub-pixel resolution and was found to be optimally performed at an upsample factor of 8, affording 0.75mm spatially resolved diffuse reflectance images (lambda = 450-600nm) of an entire margin (area = 17cm(2)) in 13.8 minutes (1.23cm(2)/min). Moreover, controlled pressure application at the probe-tissue interface afforded by the imaging platform reduces repeated scan variability, providing <1% variation across repeated scans of clinical specimens. We demonstrate the clinical utility of this device through a pilot 20-patient study of high-resolution optical parameter maps of the ratio of the beta-carotene concentration to the reduced scattering coefficient. An empirical cumulative distribution function (eCDF) analysis is used to reduce optical property maps to quantitative distributions representing the morphological landscape of breast tumor margins. The optimizations presented in this work provide an avenue to rapidly survey large tissue areas on intra-operative time scales with improved sensitivity to regions of focal disease that may otherwise be overlooked.	[Nichols, Brandon S.; Schindler, Christine E.; Mulvey, Christine S.; Krieger, Marlee S.; Ramanujam, Nirmala] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Geradts, Joseph] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Gallagher, Jennifer; Greenup, Rachel A.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Wilke, Lee G.] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Madison, WI USA; [Brown, Jonathon Q.; Krieger, Marlee S.; Von Windheim, Jesko A.; Ramanujam, Nirmala] Zenalux Biomed, Res Triangle Pk, NC USA; [Brown, Jonathon Q.] Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA; [Von Windheim, Jesko A.] Duke Univ, Div Environm Sci & Policy, Durham, NC USA	Duke University; Duke University; Duke University; University of Wisconsin System; University of Wisconsin Madison; Tulane University; Duke University	Nichols, BS (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	brandon.nichols@duke.edu	Ramanujam, Nimmi/AAA-7575-2021	Ramanujam, Nimmi/0000-0001-7319-8415; Nichols, Brandon/0000-0002-9561-1802	Department of Defense (DOD) [W81XWH-09-1-0410]; Small Business Technology Transfer (STTR) phase II [2R42CA128160-02]; Zenalux, Inc.; NATIONAL CANCER INSTITUTE [R42CA128160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011574] Funding Source: NIH RePORTER	Department of Defense (DOD)(United States Department of Defense); Small Business Technology Transfer (STTR) phase II; Zenalux, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This project was supported by the Department of Defense (DOD) (http://www.defense.gov/) Grant Number W81XWH-09-1-0410 and by the Small Business Technology Transfer (STTR) (http://www.sbir.gov) phase II Grant Number 2R42CA128160-02 "Fast Spectral Imaging Device For Tumor Margin Mapping" awarded to Zenalux, Inc. and Duke University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Zenalux, Inc. provided support in the form of salaries for authors JQB, MSK, JAvW, and NR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amelink A, 2008, ORAL ONCOL, V44, P65, DOI 10.1016/j.oraloncology.2006.12.011; Amelink A, 2005, J PHOTOCH PHOTOBIO B, V79, P243, DOI 10.1016/j.jphotobiol.2005.01.006; Arifler D, 2005, APPL OPTICS, V44, P4291, DOI 10.1364/AO.44.004291; Badizadegan K, 2004, FARADAY DISCUSS, V126, P265, DOI 10.1039/b305410a; Bender JE, 2009, OPT EXPRESS, V17, P23396, DOI 10.1364/OE.17.023396; Bender JE, 2009, IEEE T BIO-MED ENG, V56, P960, DOI 10.1109/TBME.2008.2005994; Bigio IJ, 2004, CANCER BIOL THER, V3, P259, DOI 10.4161/cbt.3.3.694; Brown JQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069906; Brown JQ, 2010, IEEE J SEL TOP QUANT, V16, P530, DOI 10.1109/JSTQE.2009.2033257; Brown JQ, 2009, CURR OPIN BIOTECH, V20, P119, DOI 10.1016/j.copbio.2009.02.004; Brown JQ, 2009, CANCER RES, V69, P2919, DOI 10.1158/0008-5472.CAN-08-3370; Bydlon TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051418; Bydlon TM, 2010, OPT EXPRESS, V18, P8058, DOI 10.1364/OE.18.008058; Chang VTC, 2009, NEOPLASIA, V11, P325, DOI 10.1593/neo.81386; Elkhuizen PHM, 1998, INT J RADIAT ONCOL, V40, P859, DOI 10.1016/S0360-3016(97)00917-6; Graham RA, 2002, AM J SURG, V184, P89, DOI 10.1016/S0002-9610(02)00902-9; Houssami N, 2014, ANN SURG ONCOL, V21, P717, DOI 10.1245/s10434-014-3480-5; Huston TL, 2006, AM J SURG, V192, P509, DOI 10.1016/j.amjsurg.2006.06.021; Jacobs L, 2008, ANN SURG ONCOL, V15, P1271, DOI 10.1245/s10434-007-9766-0; Kanick SC, 2014, BIOMED OPT EXPRESS, V5, P3376, DOI 10.1364/BOE.5.003376; Keller MD, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3600708; Kennedy S, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2770; Kunos C, 2006, BREAST J, V12, P28, DOI 10.1111/j.1075-122X.2006.00181.x; Laughney AM, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3455; Laughney AM, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.3.036012; LAZOVICH D, 1991, JAMA-J AM MED ASSOC, V266, P3433, DOI 10.1001/jama.266.24.3433; Lim L, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.11.117003; Lin WC, 2000, J BIOMED OPT, V5, P214, DOI 10.1117/1.429989; Liu Q, 2011, WORLD J CLIN ONCOL, V2, P50, DOI 10.5306/wjco.v2.i1.50; Lue N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030887; Marin NM, 2005, GYNECOL ONCOL, V99, pS116, DOI 10.1016/j.ygyno.2005.07.054; Maxim PG, 2005, TECHNOL CANCER RES T, V4, P227, DOI 10.1177/153303460500400301; Mendez JE, 2006, AM J SURG, V192, P538, DOI 10.1016/j.amjsurg.2006.06.009; Mirabal YN, 2002, J BIOMED OPT, V7, P587, DOI 10.1117/1.1502675; Morrow M, 2001, J CLIN ONCOL, V19, P2254, DOI 10.1200/JCO.2001.19.8.2254; Muller MG, 2003, CANCER-AM CANCER SOC, V97, P1681, DOI 10.1002/cncr.11255; Nguyen FT, 2009, CANCER RES, V69, P8790, DOI 10.1158/0008-5472.CAN-08-4340; Nichols BS, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.5.057001; Nieman LT, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2907450; Nold RJ, 2000, AM J SURG, V180, P413, DOI 10.1016/S0002-9610(00)00501-8; Palmer GM, 2006, APPL OPTICS, V45, P1072, DOI 10.1364/AO.45.001072; Palmer GM, 2006, APPL OPTICS, V45, P1062, DOI 10.1364/AO.45.001062; Palmer GM, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2907161; Park CC, 2000, J CLIN ONCOL, V18, P1668, DOI 10.1200/JCO.2000.18.8.1668; Sanchez C, 2010, AM SURGEON, V76, P331; Schwarz RA, 2008, APPL OPTICS, V47, P825, DOI 10.1364/AO.47.000825; Sharwani A, 2006, ORAL ONCOL, V42, P343, DOI 10.1016/j.oraloncology.2005.08.008; Skala MC, 2007, OPT EXPRESS, V15, P7863, DOI 10.1364/OE.15.007863; Sunar U, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2397548; Utzinger U, 2001, LASER SURG MED, V28, P56, DOI 10.1002/1096-9101(2001)28:1<56::AID-LSM1017>3.0.CO;2-L; Wang HW, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1854679; WANG LH, 1995, COMPUT METH PROG BIO, V47, P131, DOI 10.1016/0169-2607(95)01640-F; Wilke LG, 2014, JAMA SURG, V149, P1296, DOI 10.1001/jamasurg.2014.926; Wilke LG, 2009, AM J SURG, V198, P566, DOI 10.1016/j.amjsurg.2009.06.018; Zhu CF, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1897398; Zhu CF, 2006, LASER SURG MED, V38, P714, DOI 10.1002/lsm.20356; Zonios G, 1999, APPL OPTICS, V38, P6628, DOI 10.1364/AO.38.006628	57	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0127525	10.1371/journal.pone.0127525	http://dx.doi.org/10.1371/journal.pone.0127525			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076123	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900014
J	da Luz, JMR; Paes, SA; Ribeiro, KVG; Mendes, IR; Kasuya, MCM				Rodrigues da Luz, Jose Maria; Paes, Sirlaine Albino; Goncalves Ribeiro, Karla Veloso; Mendes, Igor Rodrigues; Megumi Kasuya, Maria Catarina			Degradation of Green Polyethylene by Pleurotus ostreatus	PLOS ONE			English	Article							BIODEGRADATION; LACCASE; ENZYME; POLYMERS; LDPE	We studied the biodegradation of green polyethylene (GP) by Pleurotus ostreatus. The GP was developed from renewable raw materials to help to reduce the emissions of greenhouse gases. However, little information regarding the biodegradation of GP discarded in the environment is available. P. ostreatus is a lignocellulolytic fungus that has been used in bioremediation processes for agroindustrial residues, pollutants, and recalcitrant compounds. Recently, we showed the potential of this fungus to degrade oxo-biodegradable polyethylene. GP plastic bags were exposed to sunlight for up to 120 days to induce the initial photodegradation of the polymers. After this period, no cracks, pits, or new functional groups in the structure of GP were observed. Fragments of these bags were used as the substrate for the growth of P. ostreatus. After 30 d of incubation, physical and chemical alterations in the structure of GP were observed. We conclude that the exposure of GP to sunlight and its subsequent incubation in the presence of P. ostreatus can decrease the half-life of GP and facilitate the mineralization of these polymers.	[Rodrigues da Luz, Jose Maria; Paes, Sirlaine Albino; Goncalves Ribeiro, Karla Veloso; Mendes, Igor Rodrigues; Megumi Kasuya, Maria Catarina] Univ Fed Vicosa, Dept Microbiol, Vicosa, MG, Brazil	Universidade Federal de Vicosa	Kasuya, MCM (corresponding author), Univ Fed Vicosa, Dept Microbiol, Vicosa, MG, Brazil.	mkasuya@ufv.br	Kasuya, Maria Catarina Megumi/E-1123-2013; da Luz, José Maria/B-2276-2018	Kasuya, Maria Catarina Megumi/0000-0002-9539-9370; da Luz, José Maria/0000-0001-9826-7982	Brazilian Financial Agency: CAPES; Brazilian Financial Agency: CNPq; Brazilian Financial Agency: FAPEMIG	Brazilian Financial Agency: CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Financial Agency: CNPq; Brazilian Financial Agency: FAPEMIG	This research was supported by the Brazilian Financial Agencies: CAPES, CNPq, and FAPEMIG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts JF, 2009, INT J FOOD MICROBIOL, V135, P47, DOI 10.1016/j.ijfoodmicro.2009.07.022; Arutchelvi J, 2008, INDIAN J BIOTECHNOL, V7, P9; Bonhomme S, 2003, POLYM DEGRAD STABIL, V81, P441, DOI 10.1016/S0141-3910(03)00129-0; Braskem, 2013, GREEN POL BIOP INN T; Cavallazzi JRP, 2004, J FOOD AGRIC ENVIRON, V2, P291; Chiellini E, 2007, POLYM DEGRAD STABIL, V92, P1378, DOI 10.1016/j.polymdegradstab.2007.03.007; Cohen R, 2002, APPL MICROBIOL BIOT, V58, P582, DOI 10.1007/s00253-002-0930-y; Contat-Rodrigo L, 2002, J APPL POLYM SCI, V83, P1683, DOI 10.1002/app.10087; El-Sharkawi H., 2012, ISRN SOIL SCI, V7, DOI [10.5402/2012/310727, DOI 10.5402/2012/310727]; Gross RA, 2002, SCIENCE, V297, P803, DOI 10.1126/science.297.5582.803; Grube Martin, 2009, Fungal Biology Reviews, V23, P72, DOI 10.1016/j.fbr.2009.10.001; HEINEMEYER O, 1989, PLANT SOIL, V116, P191, DOI 10.1007/BF02214547; KASUYA MCM, 2012, FEEDSTOCKS PRODUCTIO, V1, P487; Koutny M, 2006, POLYM DEGRAD STABIL, V91, P1495, DOI 10.1016/j.polymdegradstab.2005.10.007; Li KT, 2012, J APPL POLYM SCI, V123, P1169, DOI 10.1002/app.34579; Luz JMR, 2013, PLOS ONE, V8, P8, DOI DOI 10.1371/J0URNAL.P0NE.0069386.G003; Majcherczyk A, 1998, ENZYME MICROB TECH, V22, P335, DOI 10.1016/S0141-0229(97)00199-3; Nunes M. D., 2012, Journal of Food Research, V1, P113; Nyanhongo GS, 2006, ENZYME MICROB TECH, V39, P1197, DOI 10.1016/j.enzmictec.2006.03.004; Ohtake Y, 1998, POLYM DEGRAD STABIL, V60, P79, DOI 10.1016/S0141-3910(97)00032-3; Ojeda TFM, 2009, POLYM DEGRAD STABIL, V94, P965, DOI 10.1016/j.polymdegradstab.2009.03.011; da Luz JMR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107438; da Luz JMR, 2012, BRAZ J MICROBIOL, V43, P1508, DOI [10.1590/S1517-83822012000400035, 10.1590/S1517-838220120004000035]; da Luz JMR, 2013, LWT-FOOD SCI TECHNOL, V50, P575, DOI 10.1016/j.lwt.2012.08.006; Perez SR, 2008, BIODEGRADATION, V19, P519, DOI 10.1007/s10532-007-9157-z; Roldan-Carrillo T, 2003, BIORESOURCE TECHNOL, V86, P1, DOI 10.1016/S0960-8524(02)00142-6; Sanchez C, 2009, BIOTECHNOL ADV, V27, P185, DOI 10.1016/j.biotechadv.2008.11.001; Santo M, 2013, INT BIODETER BIODEGR, V84, P204, DOI 10.1016/j.ibiod.2012.03.001; Shah AA, 2008, BIOTECHNOL ADV, V26, P246, DOI 10.1016/j.biotechadv.2007.12.005; Shimao M, 2001, CURR OPIN BIOTECH, V12, P242, DOI 10.1016/S0958-1669(00)00206-8; Sivan A, 2011, CURR OPIN BIOTECH, V22, P422, DOI 10.1016/j.copbio.2011.01.013; Sudhakar M, 2008, INT BIODETER BIODEGR, V61, P203, DOI 10.1016/j.ibiod.2007.07.011; Yara R, 2006, J MICROBIOL, V44, P263	33	17	17	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0126047	10.1371/journal.pone.0126047	http://dx.doi.org/10.1371/journal.pone.0126047			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076188	Green Published, Green Submitted, gold			2022-12-26	WOS:000356329900005
J	Walaza, S; Cohen, C; Nanoo, A; Cohen, AL; McAnerney, J; von Mollendorf, C; Moyes, J; Tempia, S				Walaza, Sibongile; Cohen, Cheryl; Nanoo, Ananta; Cohen, Adam L.; McAnerney, Johanna; von Mollendorf, Claire; Moyes, Jocelyn; Tempia, Stefano			Excess Mortality Associated with Influenza among Tuberculosis Deaths in South Africa, 1999-2009	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; UNITED-STATES; HIV; INFECTION; AGE; COHORT	Background Published data on the interaction between influenza and pulmonary tuberculosis (PTB) are limited. We aimed to estimate the influenza-associated mortality among individuals with PTB in South Africa from 1999-2009. Methods We modelled the excess influenza-associated mortality by applying Poisson regression models to monthly PTB and non-tuberculosis respiratory deaths, using laboratory-confirmed influenza as a covariate. Results PTB deaths increased each winter, coinciding with influenza virus circulation. Among individuals of any age, mean annual influenza-associated PTB mortality rate was 164/100,000 person-years (n = 439). The rate of non-tuberculosis respiratory deaths was 27/100,000 (n = 1125) for HIV-infected and 5/100,000 (n = 2367) for HIV-uninfected individuals of all ages. Among individuals aged <65 years, influenza-associated PTB mortality risk was elevated compared to influenza-associated non-tuberculosis respiratory deaths in HIV-infected (relative risk (RR): 5.2; 95% CI: 4.6-5.9) and HIV-uninfected individuals (RR: 61.0; CI: 41.4-91.0). Among individuals aged >= 65 years, influenza-associated PTB mortality risk was elevated compared to influenza-associated non-tuberculosis respiratory deaths in HIV-uninfected individuals (RR: 13.0; 95% CI: 12.0-14.0). Conclusion We observed an increased risk of influenza-associated mortality in persons with PTB compared to non-tuberculosis respiratory deaths. If confirmed in other settings, our findings may support recommendations for active inclusion of patients with TB for influenza vaccination and empiric influenza anti-viral treatment of patients with TB during influenza epidemics.	[Walaza, Sibongile; Cohen, Cheryl; Nanoo, Ananta; McAnerney, Johanna; von Mollendorf, Claire; Moyes, Jocelyn; Tempia, Stefano] Natl Inst Communicable Dis, Natl Hlth Lab Serv, Johannesburg, South Africa; [Cohen, Adam L.; Tempia, Stefano] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Cohen, Adam L.; Tempia, Stefano] Ctr Dis Control & Prevent, Influenza Div, Pretoria, South Africa; [Walaza, Sibongile; Cohen, Cheryl; von Mollendorf, Claire; Moyes, Jocelyn] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); Centers for Disease Control & Prevention - USA; University of Witwatersrand	Walaza, S (corresponding author), Natl Inst Communicable Dis, Natl Hlth Lab Serv, Johannesburg, South Africa.	sibongilew@nicd.ac.za; stefanot@nicd.ac.za	Moyes, Jocelyn/AAF-7882-2019	Cohen, Cheryl/0000-0003-0376-2302				Actuarial Society of South Africa A, 2013, AIDS DEM MOD; Archer B, 2009, EURO SURVEILL, V14; Brundage JF, 2006, LANCET INFECT DIS, V6, P303, DOI 10.1016/S1473-3099(06)70466-2; Chow A, 2006, EMERG INFECT DIS, V12, P114, DOI 10.3201/eid1201.050826; Cohen C, 2013, EMERG INFECT DIS, V19, P1766, DOI 10.3201/eid1911.130546; Cohen C, 2010, CLIN INFECT DIS, V51, P1362, DOI 10.1086/657314; Darikwa TB, 2011, LEVEL TRENDS CHILD M, P159; Florido M, 2013, J IMMUNOL, V191, P302, DOI 10.4049/jimmunol.1202824; Glezen WP, 2003, JAMA-J AM MED ASSOC, V289, P2500, DOI 10.1001/jama.289.19.2500-a; Goldstein E, 2012, EPIDEMIOLOGY, V23, P829, DOI 10.1097/EDE.0b013e31826c2dda; Groenewald P, 2005, AIDS, V19, P744, DOI 10.1097/01.aids.0000166105.74756.62; *HLTH NDO, 2011, NAT STRAT PLAN HIV S; Johnson LF, 2012, S AFR J HIV MED, P22; McAnerney JM, 2012, J INFECT DIS, V206, pS153, DOI 10.1093/infdis/jis575; Nannan N, 2012, UNDER 5 MORTALITY ST; Nanoo A, 2013, 44 WORLD C LUNG HLTH, pS369; Noymer A, 2000, POPUL DEV REV, V26, P565, DOI 10.1111/j.1728-4457.2000.00565.x; Noymer A, 2011, VACCINE, V29, pB38, DOI 10.1016/j.vaccine.2011.02.053; Noymer A, 2009, SOC SCI MED, V68, P1599, DOI 10.1016/j.socscimed.2009.02.021; Nunes B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020661; Oei W, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/124861; Roth S, 2012, OTHER RESP VIRUSES; Simonsen L, 2003, JAMA-J AM MED ASSOC, V289, P2499, DOI 10.1001/jama.289.19.2499-b; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; Sonnenberg P, 2005, J INFECT DIS, V191, P150, DOI 10.1086/426827; Statistics South Africa, 2013, MORT CAUS DEATH S AF; Statistics South Africa, 2012, LEVELS AND TRENDS OF; Tempia S, 2015, EMERG INFECT DIS, V21, P600, DOI 10.3201/eid2104.141033; Tempia S, 2014, CLIN INFECT DIS, V58, P1241, DOI 10.1093/cid/ciu095; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Walaza S, 2015, INFLUENZA; Walaza S, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0746-x; WHO, 2014, SEAS INFL; WHO, 2011, WHO GLOBAL TUBERCULO; Wong CM, 2004, CLIN INFECT DIS, V39, P1611, DOI 10.1086/425315; Word Health Organization, GLOB TUB REP 2012; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211	37	23	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129173	10.1371/journal.pone.0129173	http://dx.doi.org/10.1371/journal.pone.0129173			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076197	gold, Green Published, Green Submitted			2022-12-26	WOS:000356329900050
J	Aminoff, EM; Tarr, MJ				Aminoff, Elissa M.; Tarr, Michael J.			Associative Processing Is Inherent in Scene Perception	PLOS ONE			English	Article							PARAHIPPOCAMPAL PLACE AREA; VISUAL SCENES; CORTEX; REPRESENTATION; OBJECT; BRAIN; ROLES	How are complex visual entities such as scenes represented in the human brain? More concretely, along what visual and semantic dimensions are scenes encoded in memory? One hypothesis is that global spatial properties provide a basis for categorizing the neural response patterns arising from scenes. In contrast, non-spatial properties, such as single objects, also account for variance in neural responses. The list of critical scene dimensions has continued to grow-sometimes in a contradictory manner-coming to encompass properties such as geometric layout, big/small, crowded/sparse, and three-dimensionality. We demonstrate that these dimensions may be better understood within the more general framework of associative properties. That is, across both the perceptual and semantic domains, features of scene representations are related to one another through learned associations. Critically, the components of such associations are consistent with the dimensions that are typically invoked to account for scene understanding and its neural bases. Using fMRI, we show that non-scene stimuli displaying novel associations across identities or locations recruit putatively scene-selective regions of the human brain (the parahippocampal/lingual region, the retrosplenial complex, and the transverse occipital sulcus/occipital place area). Moreover, we find that the voxel-wise neural patterns arising from these associations are significantly correlated with the neural patterns arising from everyday scenes providing critical evidence whether the same encoding principals underlie both types of processing. These neuroimaging results provide evidence for the hypothesis that the neural representation of scenes is better understood within the broader theoretical framework of associative processing. In addition, the results demonstrate a division of labor that arises across scene-selective regions when processing associations and scenes providing better understanding of the functional roles of each region within the cortical network that mediates scene processing.	[Aminoff, Elissa M.; Tarr, Michael J.] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Aminoff, Elissa M.; Tarr, Michael J.] Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Aminoff, EM (corresponding author), Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA.	eaminoff@cmu.edu	Aminoff, Elissa/AAF-7718-2019	Aminoff, Elissa/0000-0002-6455-8930	Office of Naval Research MURI [N000141010934]; National Science Foundation [1439237]	Office of Naval Research MURI(MURIOffice of Naval Research); National Science Foundation(National Science Foundation (NSF))	This research was supported by the Office of Naval Research MURI contract N000141010934 (to E.A. & M.T.) and by the National Science Foundation 1439237 (to E.A. & M.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 1996, CEREB CORTEX, V6, P823, DOI 10.1093/cercor/6.6.823; Aminoff E, 2007, CEREB CORTEX, V17, P1493, DOI 10.1093/cercor/bhl078; Aminoff E, 2008, J COGNITIVE NEUROSCI, V20, P2226, DOI 10.1162/jocn.2008.20156; Aminoff EM, 2013, TRENDS COGN SCI, V17, P379, DOI 10.1016/j.tics.2013.06.009; Baldassano C, 2013, NEUROIMAGE, V75, P228, DOI 10.1016/j.neuroimage.2013.02.073; Bar M, 2003, NEURON, V38, P347, DOI 10.1016/S0896-6273(03)00167-3; Bar M, 2008, J NEUROSCI, V28, P8539, DOI 10.1523/JNEUROSCI.0987-08.2008; Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; Bettencourt KC, 2013, J COGNITIVE NEUROSCI, V16, P1, DOI [10.1016/j.neuron.2012.04.036, DOI 10.1016/J.NEURON.2012.04.036]; BIEDERMAN I, 1982, COGNITIVE PSYCHOL, V14, P143, DOI 10.1016/0010-0285(82)90007-X; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Diedrichsen J, 2005, NEUROIMAGE, V27, P624, DOI 10.1016/j.neuroimage.2005.04.039; Dilks DD, 2013, J NEUROSCI, V33, P1331, DOI 10.1523/JNEUROSCI.4081-12.2013; Eichenbaum HE, 2001, CONDITIONING CONSCIO; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; Epstein RA, 2007, CEREB CORTEX, V17, P1680, DOI 10.1093/cercor/bhl079; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Greene MR, 2009, COGNITIVE PSYCHOL, V58, P137, DOI 10.1016/j.cogpsych.2008.06.001; Harel A, 2013, CEREB CORTEX, V23, P947, DOI 10.1093/cercor/bhs091; Hasson U, 2003, NEURON, V37, P1027, DOI 10.1016/S0896-6273(03)00144-2; Henderson JM, 1999, ANNU REV PSYCHOL, V50, P243, DOI 10.1146/annurev.psych.50.1.243; Insausti R, 1998, AM J NEURORADIOL, V19, P659; Janzen G, 2004, NAT NEUROSCI, V7, P673, DOI 10.1038/nn1257; Kravitz DJ, 2011, J NEUROSCI, V31, P7322, DOI 10.1523/JNEUROSCI.4588-10.2011; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; Linsley D, 2015, CEREB CORTEX, V25, P2267, DOI 10.1093/cercor/bhu034; Litman L, 2009, HIPPOCAMPUS, V19, P308, DOI 10.1002/hipo.20515; MacEvoy SP, 2007, J NEUROPHYSIOL, V98, P2089, DOI 10.1152/jn.00438.2007; Maguire EA, 2001, SCAND J PSYCHOL, V42, P225, DOI 10.1111/1467-9450.00233; Megevand P, 2014, J NEUROSCI, V34, P5399, DOI 10.1523/JNEUROSCI.5202-13.2014; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; Mullally SL, 2011, J NEUROSCI, V31, P7441, DOI 10.1523/JNEUROSCI.0267-11.2011; Nasr S, 2011, J NEUROSCI, V31, P13771, DOI 10.1523/JNEUROSCI.2792-11.2011; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; PALMER SE, 1975, MEM COGNITION, V3, P519, DOI 10.3758/BF03197524; Park S, 2015, CEREB CORTEX, V25, P1792, DOI 10.1093/cercor/bht418; Park S, 2011, J NEUROSCI, V31, P1333, DOI 10.1523/JNEUROSCI.3885-10.2011; Park S, 2009, NEUROIMAGE, V47, P1747, DOI 10.1016/j.neuroimage.2009.04.058; Reber PJ, 2002, HIPPOCAMPUS, V12, P363, DOI 10.1002/hipo.10018; Remy F, 2014, BRAIN COGNITION, V84, P34, DOI 10.1016/j.bandc.2013.10.008; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; Stansbury DE, 2013, NEURON, V79, P1025, DOI 10.1016/j.neuron.2013.06.034; Staresina BP, 2010, J NEUROSCI, V30, P9890, DOI 10.1523/JNEUROSCI.0826-10.2010; Stevens WD, 2012, CEREB CORTEX, V22, P1935, DOI 10.1093/cercor/bhr273; Torralba A, 2003, NETWORK-COMP NEURAL, V14, P391, DOI 10.1088/0954-898X/14/3/302; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Walther DB, 2011, P NATL ACAD SCI USA, V108, P9661, DOI 10.1073/pnas.1015666108; Watson DM, 2014, NEUROIMAGE, V99, P402, DOI 10.1016/j.neuroimage.2014.05.045	50	22	23	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128840	10.1371/journal.pone.0128840	http://dx.doi.org/10.1371/journal.pone.0128840			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6GR	26070142	Green Published, Green Submitted, gold			2022-12-26	WOS:000356327000031
J	Andersen, MN; Olsen, AMS; Madsen, JC; Faber, J; Torp-Pedersen, C; Gislason, GH; Selmer, C				Andersen, Mette Nygaard; Olsen, Anne-Marie Schjerning; Madsen, Jesper Clausager; Faber, Jens; Torp-Pedersen, Christian; Gislason, Gunnar Hilmar; Selmer, Christian			Levothyroxine Substitution in Patients with Subclinical Hypothyroidism and the Risk of Myocardial Infarction and Mortality	PLOS ONE			English	Article							AMERICAN THYROID ASSOCIATION; ISCHEMIC-HEART-DISEASE; ALL-CAUSE MORTALITY; L-THYROXINE; SUBDINICAL HYPOTHYROIDISM; CARDIOVASCULAR RISK; DOUBLE-BLIND; GUIDELINES; THERAPY; HYPERTHYROIDISM	Background Subclinical hypothyroidism is associated with a number of cardiovascular risk factors, yet only limited data exist on long-term outcome of levothyroxine treatment of this condition with respect to hard end-points. The aim of this retrospective cohort study was to determine effects of levothyroxine treatment on myocardial infarction (MI), cardiovascular death and all-cause mortality, in patients with subclinical hypothyroidism. Methods and Results Primary care patients aged 18 years and older that underwent thyroid function tests between 2000 and 2009 were enrolled. Participants were identified by individual-level linkage of nationwide registers. Patients with subclinical hypothyroidism at baseline were included in the study. Exclusion criteria included a history of thyroid disease, related medication or medication affecting thyroid function. The total cohort comprised 628,953 patients of which 12,212 (1.9%) had subclinical hypothyroidism (mean age 55.2 [SD +/- 18.8] years; 79.8% female). Within the first six months 2,483 (20.3%) patients claimed a prescription for levothyroxine. During a median follow-up of 5.0 (IQR: 5.2) years, 358 MI's and 1,566 (12.8%) deaths were observed. Out of these, 766 of the deaths were cardiovascular related. No beneficial effects were found in levothyroxine treated patients on MI (IRR 1.08 [95% CI: 0.81 to 1.44]), cardiovascular death (IRR 1.02 [95% CI: 0.83 to 1.25]) or all-cause mortality (IRR 1.03 [95% CI: 0.90 to 1.19]), except in patients under the age of 65 years (IRR 0.63 [95% CI: 0.40 to 0.99]). Conclusion Levothyroxine substitution in subclinical hypothyroid patients does not indicate an association with lower mortality or decreased risk of MI.	[Andersen, Mette Nygaard; Olsen, Anne-Marie Schjerning; Gislason, Gunnar Hilmar] Gentofte Univ Hosp, Dept Cardiol, Hellerup, Denmark; [Madsen, Jesper Clausager] Elect Lab Capital Reg, Copenhagen, Denmark; [Faber, Jens] Herlev Univ Hosp, Dept Endocrinol, DK-2730 Herlev, Denmark; [Faber, Jens; Gislason, Gunnar Hilmar] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Torp-Pedersen, Christian] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark; [Gislason, Gunnar Hilmar] Danish Heart Fdn, Copenhagen, Denmark; [Gislason, Gunnar Hilmar] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Selmer, Christian] Amager Univ Hosp, Dept Internal Med, Amager, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Aalborg University; University of Southern Denmark	Andersen, MN (corresponding author), Gentofte Univ Hosp, Dept Cardiol, Hellerup, Denmark.	mette.nygaard.andersen@gmail.com	Selmer, Christian/H-3314-2019; Gislason, Gunnar/B-7561-2009	Selmer, Christian/0000-0002-0534-3163; Gislason, Gunnar/0000-0002-0548-402X	Lundbeck Foundation; Agnes and Knut Morks Foundation; Novo Nordisk Fonden [NNF12OC1015957] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Agnes and Knut Morks Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	The study was funded with a 1-year scholarship for MNA by The Lundbeck Foundation. The Lundbeck Foundation had no influence in the study design or manuscript writing process nor have they seen the results or final manuscript. The Music publishers Agnes and Knut Morks Foundation funded the work with a travel grant for MNA with the aim to participate in the conference of Endocrine Society in Chicago, Illinois, June 2014.	Appelhof BC, 2005, J CLIN ENDOCR METAB, V90, P2666, DOI 10.1210/jc.2004-2111; Baadsgaard M, 2011, SCAND J PUBLIC HEALT, V39, P103, DOI 10.1177/1403494811405098; BIONDI B, 1993, J CLIN ENDOCR METAB, V77, P334, DOI 10.1210/jc.77.2.334; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; Cappola AR, 2006, JAMA-J AM MED ASSOC, V295, P1033, DOI 10.1001/jama.295.9.1033; Cohen-Lehman J, 2010, NAT REV ENDOCRINOL, V6, P34, DOI 10.1038/nrendo.2009.225; Cooper DS, 2012, LANCET, V379, P1142, DOI 10.1016/S0140-6736(11)60276-6; COOPER DS, 1984, ANN INTERN MED, V101, P18, DOI 10.7326/0003-4819-101-1-18; Danese Mark D., 2000, Journal of Clinical Endocrinology and Metabolism, V85, P2993, DOI 10.1210/jc.85.9.2993; Duntas LH, 2001, THYROID, V11, P361, DOI 10.1089/10507250152039091; EVERED DC, 1973, BRIT MED J, V1, P657, DOI 10.1136/bmj.1.5854.657; FABER J, 1994, EUR J ENDOCRINOL, V130, P350, DOI 10.1530/eje.0.1300350; Fosbol EL, 2008, PHARMACOEPIDEM DR S, V17, P822, DOI 10.1002/pds.1592; Fox CS, 2008, ARCH INTERN MED, V168, P587, DOI 10.1001/archinte.168.6.587; Garber JR, 2012, ENDOCR PRACT, V18, P989, DOI 10.4158/EP12280.GL; Gharib H, 2005, J CLIN ENDOCR METAB, V90, P581, DOI 10.1210/jc.2004-1231; Gislason GH, 2006, CIRCULATION, V113, P2906, DOI 10.1161/CIRCULATIONAHA.106.616219; Gussekloo J, 2004, JAMA-J AM MED ASSOC, V292, P2591, DOI 10.1001/jama.292.21.2591; Hak AE, 2000, ANN INTERN MED, V132, P270, DOI 10.7326/0003-4819-132-4-200002150-00004; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Huber G, 2002, J CLIN ENDOCR METAB, V87, P3221, DOI 10.1210/jc.87.7.3221; Imaizumi M, 2004, J CLIN ENDOCR METAB, V89, P3365, DOI 10.1210/jc.2003-031089; Jonklaas J, 2014, THYROID, V24, P1670, DOI 10.1089/thy.2014.0028; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Knudsen N, 2005, J CLIN ENDOCR METAB, V90, P4019, DOI 10.1210/jc.2004-2225; KUNG AWC, 1995, CLIN ENDOCRINOL, V43, P445, DOI 10.1111/j.1365-2265.1995.tb02616.x; Lazarus JH, 2009, BEST PRACT RES CL EN, V23, P723, DOI 10.1016/j.beem.2009.06.002; Liu D, 2010, J HUM HYPERTENS, V24, P134, DOI 10.1038/jhh.2009.44; Luboshitzky R, 2002, THYROID, V12, P421, DOI 10.1089/105072502760043512; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Maratou E, 2009, EUR J ENDOCRINOL, V160, P785, DOI 10.1530/EJE-08-0797; Nuttall M, 2006, J CLIN EPIDEMIOL, V59, P265, DOI 10.1016/j.jclinepi.2005.07.015; Nyrnes A, 2006, INT J OBESITY, V30, P100, DOI 10.1038/sj.ijo.0803112; Owen PJD, 2003, TRENDS ENDOCRIN MET, V14, P257, DOI 10.1016/S1043-2760(03)00108-5; PARLE JV, 1993, BRIT J GEN PRACT, V43, P107; Pearce SHS, 2013, EUR THYROID J, V2, P215, DOI 10.1159/000356507; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Razvi S, 2007, J CLIN ENDOCR METAB, V92, P1715, DOI 10.1210/jc.2006-1869; Razvi S, 2012, ARCH INTERN MED, V172, P811, DOI 10.1001/archinternmed.2012.1159; Razvi S, 2010, J CLIN ENDOCR METAB, V95, P1734, DOI 10.1210/jc.2009-1749; Rodondi N, 2005, ARCH INTERN MED, V165, P2460, DOI 10.1001/archinte.165.21.2460; Rodondi N, 2010, JAMA-J AM MED ASSOC, V304, P1365, DOI 10.1001/jama.2010.1361; Ross DS, 2001, ENDOCRIN METAB CLIN, V30, P245, DOI 10.1016/S0889-8529(05)70186-9; ROSS DS, 1987, AM J MED, V82, P1167, DOI 10.1016/0002-9343(87)90219-1; Selmer C, 2014, J CLIN ENDOCR METAB, V99, P2372, DOI 10.1210/jc.2013-4184; Singh S, 2008, INT J CARDIOL, V125, P41, DOI 10.1016/j.ijcard.2007.02.027; Somwaru LL, 2012, J CLIN ENDOCR METAB, V97, P1962, DOI 10.1210/jc.2011-3047; Stott DJ, 2014, EUR THYROID J, V3, P137, DOI 10.1159/000360621; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; Tanis BC, 1996, CLIN ENDOCRINOL, V44, P643, DOI 10.1046/j.1365-2265.1996.739560.x; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; Vanderpump M, 2003, TRENDS ENDOCRIN MET, V14, P262, DOI 10.1016/S1043-2760(03)00103-6; Villar HCCE, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003419.pub2; Walsh JP, 2005, ARCH INTERN MED, V165, P2467, DOI 10.1001/archinte.165.21.2467	56	36	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129793	10.1371/journal.pone.0129793	http://dx.doi.org/10.1371/journal.pone.0129793			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26069971	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000107
J	Fukushima, A; Nakamura, M; Suzuki, H; Saito, K; Yamazaki, M				Fukushima, Atsushi; Nakamura, Michimi; Suzuki, Hideyuki; Saito, Kazuki; Yamazaki, Mami			High-Throughput Sequencing and De Novo Assembly of Red and Green Forms of the Perilla frutescens var. crispa Transcriptome	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; FLAVONOID BIOSYNTHETIC-PATHWAY; CHEMO-VARIETAL FORMS; RNA-SEQ DATA; ANTHOCYANIN BIOSYNTHESIS; GENE-EXPRESSION; FUNCTIONAL EXPRESSION; ARABIDOPSIS-THALIANA; REFERENCE GENOME; BIOCONDUCTOR PACKAGE	Perilla frutescens var. crispa (Labiatae) has two chemo-varietal forms, i.e. red and green forms of perilla, that differ in the production of anthocyanins. To facilitate molecular biological and biochemical studies in perilla-specialized metabolism we used Illumina RNA-sequencing technology in our comprehensive comparison of the transcriptome map of the leaves of red and green forms of perilla. Sequencing generated over 1.2 billion short reads with an average length of 101 nt. De novo transcriptome assembly yielded 47,788 and 47,840 unigenes in the red and green forms of perilla plants, respectively. Comparison of the assembled unigenes and existing perilla cDNA sequences showed highly reliable alignment. All unigenes were annotated with gene ontology (GO) and Enzyme Commission numbers and entered into the Kyoto Encyclopedia of Genes and Genomes. We identified 68 differentially expressed genes (DEGs) in red and green forms of perilla. GO enrichment analysis of the DEGs showed that genes involved in the anthocyanin metabolic process were enriched. Differential expression analysis revealed that the transcript level of anthocyanin biosynthetic unigenes encoding flavonoid 3'-hydroxylase, dihydroflavonol 4-reductase, and anthocyanidin synthase was significantly higher in red perilla, while the transcript level of unigenes encoding limonene synthase was significantly higher in green perilla. Our data serve as a basis for future research on perilla bio-engineering and provide a shortcut for the characterization of new functional genes in P. frutescens.	[Fukushima, Atsushi; Saito, Kazuki] RIKEN, Ctr Sustainable Resource Sci, Yokohama, Kanagawa 2300045, Japan; [Nakamura, Michimi; Saito, Kazuki; Yamazaki, Mami] Chiba Univ, Grad Sch Pharmaceut Sci, Chiba, Chiba 2638522, Japan; [Suzuki, Hideyuki] Kazusa DNA Res Inst, Kisarazu, Chiba 2920818, Japan	RIKEN; Chiba University; Kazusa DNA Research Institute	Fukushima, A (corresponding author), RIKEN, Ctr Sustainable Resource Sci, Yokohama, Kanagawa 2300045, Japan.	atsushi.fukushima@riken.jp; mamiy@faculty.chiba-u.jp	Saito, Kazuki/D-2670-2009; Yamazaki, Mami/A-9050-2010; Suzuki, Hideyuki/J-7571-2016; Fukushima, Atsushi/C-9279-2017	Saito, Kazuki/0000-0001-6310-5342; Yamazaki, Mami/0000-0001-6157-5287; Fukushima, Atsushi/0000-0001-9015-1694	Health Labour Sciences Research Grant from The Ministry of Health Labour and Welfare; JSPS [24390030]	Health Labour Sciences Research Grant from The Ministry of Health Labour and Welfare; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported, in part, by Health Labour Sciences Research Grant from The Ministry of Health Labour and Welfare, and JSPS KAKENHI Grant Number 24390030. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Benson DA, 2015, NUCLEIC ACIDS RES, V43, pD30, DOI 10.1093/nar/gku1216; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Carey CC, 2004, PLANT CELL, V16, P450, DOI 10.1105/tpc.018796; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Degenhardt J, 2009, PHYTOCHEMISTRY, V70, P1621, DOI 10.1016/j.phytochem.2009.07.030; Devic M, 1999, PLANT J, V19, P387, DOI 10.1046/j.1365-313X.1999.00529.x; Feller A, 2011, PLANT J, V66, P94, DOI 10.1111/j.1365-313X.2010.04459.x; Fukushima A, 2014, J EXP BOT, V65, P5619, DOI 10.1093/jxb/eru322; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Gong L, 2013, P NATL ACAD SCI USA, V110, P20320, DOI 10.1073/pnas.1319681110; Gong ZZ, 1999, MOL GEN GENET, V262, P65, DOI 10.1007/PL00008639; Gong ZZ, 1999, PLANT MOL BIOL, V41, P33, DOI 10.1023/A:1006237529040; Gong ZZ, 1997, PLANT MOL BIOL, V35, P915, DOI 10.1023/A:1005959203396; Gongora-Castillo E, 2013, NAT PROD REP, V30, P490, DOI 10.1039/c3np20099j; Gongora-Castillo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052506; Goto N, 2010, BIOINFORMATICS, V26, P2617, DOI 10.1093/bioinformatics/btq475; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GROTEWOLD E, 1994, CELL, V76, P543, DOI 10.1016/0092-8674(94)90117-1; Hancock JM, 1996, NAT GENET, V14, P14, DOI 10.1038/ng0996-14; Hichri I, 2011, J EXP BOT, V62, P2465, DOI 10.1093/jxb/erq442; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kitada C, 2001, PLANT CELL PHYSIOL, V42, P1338, DOI 10.1093/pcp/pce169; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; KONDO T, 1989, AGR BIOL CHEM TOKYO, V53, P797; Kosuge T, 2014, NUCLEIC ACIDS RES, V42, pD44, DOI 10.1093/nar/gkt1066; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee SC, 2014, J PLANT BIOL, V57, P312, DOI 10.1007/s12374-014-0263-2; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Loza-Tavera H, 1999, ADV EXP MED BIOL, V464, P49; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Moura JCMS, 2010, J INTEGR PLANT BIOL, V52, P360, DOI 10.1111/j.1744-7909.2010.00892.x; Matsuda F, 2012, PLANT J, V70, P624, DOI 10.1111/j.1365-313X.2012.04903.x; Mau CJD, 2010, PHYTOCHEMISTRY, V71, P373, DOI 10.1016/j.phytochem.2009.12.002; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Pages H, 2009, BIOSTRINGS STRING OB; Procissi A, 1997, PLANT CELL, V9, P1547, DOI 10.1105/tpc.9.9.1547; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saito K, 1999, PLANT J, V17, P181, DOI 10.1046/j.1365-313X.1999.00365.x; Saito K, 2002, NEW PHYTOL, V155, P9, DOI 10.1046/j.1469-8137.2002.00440.x; Saito K, 2013, PLANT PHYSIOL BIOCH, V72, P21, DOI 10.1016/j.plaphy.2013.02.001; Schoenbohm C, 2000, BIOL CHEM, V381, P749, DOI 10.1515/BC.2000.095; Shin J, 2007, PLANT J, V49, P981, DOI 10.1111/j.1365-313X.2006.03021.x; SHIRLEY BW, 1992, PLANT CELL, V4, P333, DOI 10.1105/tpc.4.3.333; Sompornpailin K, 2002, PLANT MOL BIOL, V50, P485, DOI 10.1023/A:1019850921627; Sun JQ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-219; Suzuki H, 2003, BIOCHEMISTRY-US, V42, P1764, DOI 10.1021/bi020618g; Tabanca N, 2015, IND CROP PROD, V65, P36, DOI 10.1016/j.indcrop.2014.11.043; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tohge T, 2005, PLANT J, V42, P218, DOI 10.1111/j.1365-313X.2005.02371.x; Tong W, 2015, GENE, V559, P155, DOI 10.1016/j.gene.2015.01.028; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Winkel-Shirley B, 2002, CURR OPIN PLANT BIOL, V5, P218, DOI 10.1016/S1369-5266(02)00256-X; Yamazaki M, 1999, J BIOL CHEM, V274, P7405, DOI 10.1074/jbc.274.11.7405; Yamazaki M, 2003, PHYTOCHEMISTRY, V62, P987, DOI 10.1016/S0031-9422(02)00721-5; Yamazaki M, 2002, CELL MOL LIFE SCI, V59, P1246, DOI 10.1007/s00018-002-8503-x; Yamazaki M, 2008, FEBS J, V275, P3494, DOI 10.1111/j.1742-4658.2008.06496.x; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yonekura-Sakakibara K, 2008, PLANT CELL, V20, P2160, DOI 10.1105/tpc.108.058040; Yonekura-Sakakibara K, 2014, PLANT J, V79, P769, DOI 10.1111/tpj.12580; Yonekura-Sakakibara K, 2012, PLANT J, V69, P154, DOI 10.1111/j.1365-313X.2011.04779.x; Yuba A, 1996, ARCH BIOCHEM BIOPHYS, V332, P280, DOI 10.1006/abbi.1996.0343	65	32	36	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129154	10.1371/journal.pone.0129154	http://dx.doi.org/10.1371/journal.pone.0129154			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070213	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000053
J	Lee, CY; Thompson, GR; Hastey, CJ; Hodge, GC; Lunetta, JM; Pappagianis, D; Heinrich, V				Lee, Cheng-Yuk; Thompson, George R., III; Hastey, Christine J.; Hodge, Gregory C.; Lunetta, Jennine M.; Pappagianis, Demosthenes; Heinrich, Volkmar			Coccidioides Endospores and Spherules Draw Strong Chemotactic, Adhesive, and Phagocytic Responses by Individual Human Neutrophils	PLOS ONE			English	Article							ASPERGILLUS-FUMIGATUS; DENDRITIC CELLS; IN-VITRO; IMMITIS; MORPHOGENESIS; MACROPHAGES; MECHANICS; VIRULENCE; CAPSULE; ANTIGEN	Coccidioides spp. are dimorphic pathogenic fungi whose parasitic forms cause coccidioidomycosis (Valley fever) in mammalian hosts. We use an innovative interdisciplinary approach to analyze one-on-one encounters between human neutrophils and two forms of Coccidioides posadasii. To examine the mechanisms by which the innate immune system coordinates different stages of the host response to fungal pathogens, we dissect the immune-cell response into chemotaxis, adhesion, and phagocytosis. Our single-cell technique reveals a surprisingly strong response by initially quiescent neutrophils to close encounters with C. posadasii, both from a distance (by complement-mediated chemotaxis) as well as upon contact (by serum-dependent adhesion and phagocytosis). This response closely resembles neutrophil interactions with Candida albicans and zymosan particles, and is significantly stronger than the neutrophil responses to Cryptococcus neoformans, Aspergillus fumigatus, and Rhizopus oryzae under identical conditions. The vigorous in vitro neutrophil response suggests that C. posadasii evades in vivo recognition by neutrophils through suppression of long-range mobilization and recruitment of the immune cells. This observation elucidates an important paradigm of the recognition of microbes, i.e., that intact immunotaxis comprises an intricate spatiotemporal hierarchy of distinct chemotactic processes. Moreover, in contrast to earlier reports, human neutrophils exhibit vigorous chemotaxis toward, and frustrated phagocytosis of, the large spherules of C. posadasii under physiological-like conditions. Finally, neutrophils from healthy donors and patients with chronic coccidioidomycosis display subtle differences in their responses to antibodycoated beads, even though the patient cells appear to interact normally with C. posadasii endospores.	[Lee, Cheng-Yuk; Hastey, Christine J.; Heinrich, Volkmar] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Thompson, George R., III; Hodge, Gregory C.; Lunetta, Jennine M.; Pappagianis, Demosthenes] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Thompson, George R., III] Univ Calif Davis, Med Ctr, Dept Internal Med, Div Infect Dis, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Heinrich, V (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	vheinrich@ucdavis.edu	Heinrich, Volkmar/D-1169-2009	Heinrich, Volkmar/0000-0002-4932-5012; Lunetta, Jennine/0000-0002-7821-0257	National Institutes of Health, USA [R01 AI072391]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072391, R43AI051202] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health, USA, grant R01 AI072391 (VH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P105; BEAMAN L, 1981, INFECT IMMUN, V34, P347, DOI 10.1128/IAI.34.2.347-353.1981; BEAMAN L, 1980, INFECT IMMUN, V29, P1200; BEAMAN L, 1980, INFECT IMMUN, V28, P594; Behnsen J, 2007, PLOS PATHOG, V3, P138, DOI 10.1371/journal.ppat.0030013; Bonnett CR, 2006, INFECT IMMUN, V74, P6528, DOI 10.1128/IAI.00909-06; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Brown GD, 2012, SCIENCE, V336, P647, DOI 10.1126/science.1222236; Brown Jennifer, 2013, Clin Epidemiol, V5, P185, DOI 10.2147/CLEP.S34434; Chosewood LC, 2009, BIOSAFETY MICROBIOLO; CONVERSE JL, 1959, J BACTERIOL, V78, P231, DOI 10.1128/JB.78.2.231-239.1959; Cox RA, 2004, CLIN MICROBIOL REV, V17, P804, DOI 10.1128/CMR.17.4.804-839.2004; Del Poeta M, 2004, EUKARYOT CELL, V3, P1067, DOI 10.1128/EC.3.5.1067-1075.2004; DICARLO FJ, 1958, SCIENCE, V127, P756, DOI 10.1126/science.127.3301.756-a; Drummond RA, 2011, CURR OPIN MICROBIOL, V14, P392, DOI 10.1016/j.mib.2011.07.001; DRUTZ DJ, 1983, J INFECT DIS, V147, P372, DOI 10.1093/infdis/147.3.372; Ecker EE, 1943, J IMMUNOL, V47, P181; EINSTEIN HE, 1993, CLIN INFECT DIS, V16, P349, DOI 10.1093/clind/16.3.349; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; FREY CL, 1986, J INFECT DIS, V153, P933, DOI 10.1093/infdis/153.5.933; Galgiani JN, 2005, CLIN INFECT DIS, V41, P1217, DOI 10.1086/496991; GALGIANI JN, 1986, J INFECT DIS, V153, P217, DOI 10.1093/infdis/153.2.217; GALGIANI JN, 1982, J INFECT DIS, V146, P56, DOI 10.1093/infdis/146.1.56; GALGIANI JN, 1978, INFECT IMMUN, V21, P862, DOI 10.1128/IAI.21.3.862-865.1978; Graupmann-Kuzma A, 2008, J AM ANIM HOSP ASSOC, V44, P226, DOI 10.5326/0440226; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; HED J, 1982, IMMUNOLOGY, V45, P727; Heinrich V, 2005, LANGMUIR, V21, P1962, DOI 10.1021/la047801q; Heinrich V, 2011, J CELL SCI, V124, P3041, DOI 10.1242/jcs.086413; Herant M, 2005, J CELL SCI, V118, P1789, DOI 10.1242/jcs.02275; Herant M, 2006, J CELL SCI, V119, P1903, DOI 10.1242/jcs.02876; Herant M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001068; Hung CY, 2001, INFECT IMMUN, V69, P2211, DOI 10.1128/IAI.69.4.2211-2222.2001; HUPPERT M, 1982, MYCOPATHOLOGIA, V78, P107, DOI 10.1007/BF00442634; Jimenez-A MD, 2008, GENES IMMUN, V9, P338, DOI 10.1038/gene.2008.23; Kirkland TN, 1996, EMERG INFECT DIS, V2, P192, DOI 10.3201/eid0203.960305; Kolivras KN, 2003, INT J BIOMETEOROL, V47, P87, DOI 10.1007/s00484-002-0155-x; KOZEL TR, 1988, REV INFECT DIS, V10, pS436; KOZEL TR, 1987, CLIN EXP IMMUNOL, V70, P238; Kupferschmidt K, 2012, SCIENCE, V337, P636, DOI 10.1126/science.337.6095.636; Lam J, 2009, BIOPHYS J, V96, P248, DOI 10.1529/biophysj.108.139154; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lee CY, 2011, J CELL SCI, V124, P1106, DOI 10.1242/jcs.078592; Mankovich AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054735; Marsden-Haug N, 2013, CLIN INFECT DIS, V56, P847, DOI 10.1093/cid/cis1028; McDonald JU, 2011, FASEB J, V25, P1972, DOI 10.1096/fj.10-178517; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miller MB, 2004, J CLIN MICROBIOL, V42, P2347, DOI 10.1128/JCM.42.5.2347-2349.2004; Mirbod-Donovan F, 2006, INFECT IMMUN, V74, P504, DOI 10.1128/IAI.74.1.504-515.2006; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; NATHAN CF, 1987, J CLIN INVEST, V80, P1550, DOI 10.1172/JCI113241; O'Meara TR, 2012, CLIN MICROBIOL REV, V25, P387, DOI 10.1128/CMR.00001-12; Pillemer L, 1941, J BIOL CHEM, V137, P139; PONTOW SE, 1992, INT REV CYTOL, V137B, P221; RAAB SS, 1993, AM J CLIN PATHOL, V99, P582, DOI 10.1093/ajcp/99.5.582; Richards JO, 2002, J IMMUNOL, V169, P2020, DOI 10.4049/jimmunol.169.4.2020; Richards JO, 2001, J INFECT DIS, V184, P1220, DOI 10.1086/323664; SEGAL GP, 1985, J INFECT DIS, V151, P890, DOI 10.1093/infdis/151.5.890; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shevchenko MA, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-78; Shubitz LE, 2007, ANN NY ACAD SCI, V1111, P395, DOI 10.1196/annals.1406.007; SUN SH, 1976, SABOURAUDIA, V14, P185; Sunenshine RH, 2007, ANN NY ACAD SCI, V1111, P96, DOI 10.1196/annals.1406.045; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Thompson GR, 2011, SEMIN RESP CRIT CARE, V32, P754, DOI 10.1055/s-0031-1295723; Thompson GR, 2011, CLIN INFECT DIS, V53, pE20, DOI 10.1093/cid/cir466; Tsang CA, 2013, MMWR-MORBID MORTAL W, V62, P217; van Bruggen R, 2009, MOL IMMUNOL, V47, P575, DOI 10.1016/j.molimm.2009.09.018; Viriyakosol S, 2005, INFECT IMMUN, V73, P1553, DOI 10.1128/IAI.73.3.1553-1560.2005; Voelz K, 2010, EUKARYOT CELL, V9, P835, DOI 10.1128/EC.00039-10; Wangdi T, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004306	71	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129522	10.1371/journal.pone.0129522	http://dx.doi.org/10.1371/journal.pone.0129522			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070210	Green Published, Green Submitted, gold			2022-12-26	WOS:000356327000085
J	Van Lancker, V; Baeye, M				Van Lancker, Vera; Baeye, Matthias			Wave Glider Monitoring of Sediment Transport and Dredge Plumes in a Shallow Marine Sandbank Environment	PLOS ONE			English	Article							SUSPENDED PARTICULATE MATTER; SOUTHERN NORTH-SEA; ZOOPLANKTON; VARIABILITY; EVOLUTION; INTEGRITY; VELOCITY; FLOOR; BAY	As human pressure on the marine environment increases, safeguarding healthy and productive seas increasingly necessitates integrated, time-and cost-effective environmental monitoring. Employment of a Wave Glider proved very useful for the study of sediment transport in a shallow sandbank area in the Belgian part of the North Sea. During 22 days, data on surface and water-column currents and turbidity were recorded along 39 loops around an aggregate-extraction site. Correlation with wave and tidal-amplitude data allowed the quantification of current-and wave-induced advection and resuspension, important background information to assess dredging impacts. Important anomalies in suspended particulate matter concentrations in the water column suggested dredging-induced overflow of sediments in the near field (i.e., dynamic plume), and settling of finer-grained material in the far field (i.e., passive plume). Capturing the latter is a successful outcome to this experiment, since the location of dispersion and settling of a passive plume is highly dependent on the ruling hydro-meteorological conditions and thus difficult to predict. Deposition of the observed sediment plumes may cause habitat changes in the long-term.	[Van Lancker, Vera; Baeye, Matthias] Royal Belgian Inst Nat Sci, Operat Directorate Nat Environm, Brussels, Belgium	Royal Belgian Institute of Natural Sciences	Van Lancker, V (corresponding author), Royal Belgian Inst Nat Sci, Operat Directorate Nat Environm, Brussels, Belgium.	vera.vanlancker@naturalsciences.be	Van Lancker, Vera/AAY-2555-2020; Van Lancker, Vera/ABA-8526-2020	Van Lancker, Vera/0000-0002-8088-9713	project MOZ4 (Flemish Authorities, Agency Maritime Services and Coast, Coast) [211.177]; Belgian Science Policy [BR/121/A2/TILES]; ZAGRI	project MOZ4 (Flemish Authorities, Agency Maritime Services and Coast, Coast); Belgian Science Policy(Belgian Federal Science Policy Office); ZAGRI	Liquid Robotics (www.liquidr.com) provided the platform and sensors to conduct the experiment. This involvement does not alter our adherence to PLOS ONE policies on sharing data and materials. The study design relates to the project MOZ4 (Flemish Authorities, Agency Maritime Services and Coast, Coast, contract 211.177). Data collection and analysis were supported by the ZAGRI contract, a continuous monitoring programme, paid from the revenues of marine aggregate extraction activities. The paper contributes also to the Brain-be project TILES (Transnational and Integrated Long-term marine Exploitation Strategies), subsidised by Belgian Science Policy under contract BR/121/A2/TILES (grant VVL).	Binot J, 2007, EUROPEAN OCEAN RES F, P62; Black KS, 2001, CONT SHELF RES, V21, P859, DOI 10.1016/S0278-4343(00)00116-3; Borja A, 2008, MAR POLLUT BULL, V56, P1519, DOI 10.1016/j.marpolbul.2008.07.005; Borja A, 2010, MAR POLLUT BULL, V60, P2175, DOI 10.1016/j.marpolbul.2010.09.026; Brown CJ, 2009, APPL ACOUST, V70, P1242, DOI 10.1016/j.apacoust.2008.08.004; Cacchione DA, 2006, CONT SHELF RES, V26, P2319, DOI 10.1016/j.csr.2006.07.027; Chen ZQ, 2007, REMOTE SENS ENVIRON, V109, P207, DOI 10.1016/j.rse.2006.12.019; Daniel T, 2011, OCEAN DYNAM, V61, P1509, DOI 10.1007/s10236-011-0408-5; de Jonge VN, 2006, MAR POLLUT BULL, V53, P5, DOI 10.1016/j.marpolbul.2005.11.026; Degrendele K, 2010, J COASTAL RES, P77, DOI 10.2112/SI51-007.1; Deines K. L., 1999, 6 WORK C CURR MEAS, VI, P249, DOI DOI 10.1109/CCM.1999.755249; Duclos PA, 2013, J COASTAL RES, V29, P25, DOI 10.2112/JCOASTRES-D-12-00148.1; Favali P, 2006, ANN GEOPHYS-ITALY, V49, P515; Ferri G, 2015, IEEE J OCEANIC ENG, V40, P710, DOI 10.1109/JOE.2014.2359361; Fettweis M, 2008, ESTUAR COAST SHELF S, V78, P426, DOI 10.1016/j.ecss.2008.01.007; Fettweis M, 2007, CONT SHELF RES, V27, P1568, DOI 10.1016/j.csr.2007.01.017; Fettweis MP, 2011, OCEAN DYNAM, V61, P157, DOI 10.1007/s10236-010-0310-6; Fong DA, 2006, LIMNOL OCEANOGR-METH, V4, P58, DOI 10.4319/lom.2006.4.58; Foster SD, 2014, METHODS ECOL EVOL, V5, P287, DOI 10.1111/2041-210X.12156; Gartner JW, 2004, MAR GEOL, V211, P169, DOI 10.1016/j.margeo.2004.07.001; Giardino A, 2010, J COASTAL RES, P127, DOI 10.2112/SI51-012.1; Goff JA, 2005, CONT SHELF RES, V25, P461, DOI 10.1016/j.csr.2004.09.019; Guerrero M, 2012, FLOW MEAS INSTRUM, V23, P40, DOI 10.1016/j.flowmeasinst.2011.10.003; Haelters J, 2007, DESIGNATION MARINE P, P46; Harris PT, 2012, GEOHAB ATLAS SEAFLOO; Hitchcock DR, 2004, J COASTAL RES, V20, P101, DOI 10.2112/1551-5036(2004)20[101:PIOMAD]2.0.CO;2; Hull T., 2013, WAVE GLIDER TRIAL, P18; Jiang SN, 2007, DEEP-SEA RES PT I, V54, P608, DOI 10.1016/j.dsr.2006.12.011; Liquid Robotics Inc, 2010, WAV GLID MOD 08 US M, P190; Lorke A, 2004, FRESHWATER BIOL, V49, P1280, DOI 10.1111/j.1365-2427.2004.01267.x; Luyten PJ, 2011, MUMM COUPLED HYDRODY, P1177; Manley J.E., 2008, OCEANS 2008, P1, DOI DOI 10.1109/OCEANS.2008.5152052; Miles T, 2013, CONT SHELF RES, V63, pS36, DOI 10.1016/j.csr.2012.08.006; Monna S, 2014, J MARINE SYST, V130, P12, DOI 10.1016/j.jmarsys.2013.09.010; Munday E, 2014, 144 ANN M AM FISH SO; Newell RC, 1999, MAR POLLUT BULL, V38, P809, DOI 10.1016/S0025-326X(99)00045-4; Palinkas CM, 2010, MAR GEOL, V274, P151, DOI 10.1016/j.margeo.2010.03.012; Petersen W, 2014, J MARINE SYST, V140, P4, DOI 10.1016/j.jmarsys.2014.07.003; Piterbarg L, 2014, J MARINE SYST, V129, P381, DOI 10.1016/j.jmarsys.2013.08.003; Rice J, 2012, ECOL INDIC, V12, P174, DOI 10.1016/j.ecolind.2011.03.021; Rochelle-Newall E, 2014, ENVIRON MONIT ASSESS, V186, P589, DOI 10.1007/s10661-013-3401-2; Smith SJ, 2011, CONT SHELF RES, V31, pS50, DOI 10.1016/j.csr.2010.04.002; Spearman J, 2011, TERRA AQUA, V125, P14; Sternberg RW, 1999, J SEA RES, V41, P55, DOI 10.1016/S1385-1101(98)00037-9; Sternberg RW, 2001, CONT SHELF RES, V21, P509, DOI 10.1016/S0278-4343(00)00103-5; Tallis H, 2010, MAR POLICY, V34, P340, DOI 10.1016/j.marpol.2009.08.003; Thorne PD, 2002, CONT SHELF RES, V22, P603, DOI 10.1016/S0278-4343(01)00101-7; Van den Branden R, 2013, AUTOMATISCHE REGISTR; van Haren H, 2009, CONT SHELF RES, V29, P1809, DOI 10.1016/j.csr.2009.06.002; Van Lancker V, 2014, MONITORING IMPACT EX; Van Lancker V, 2015, MONITORING IMPACT EX, P74; Van Lancker V, 2012, ELSEV INSIGHT, P251, DOI 10.1016/B978-0-12-385140-6.00014-1; Vanhellemont Q., 2011, P COASTGIS 2011 C HE, P5; Vera RMV, 2010, J COASTAL RES, P151, DOI 10.2112/SI51-014.1; Villareal TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092280; Vincent CE, 1998, MAR GEOL, V150, P113, DOI 10.1016/S0025-3227(98)00048-6; Williams JJ, 1998, CONT SHELF RES, V18, P1215, DOI 10.1016/S0278-4343(98)00041-7; Wood J.D., 2007, OCEANS, P1, DOI DOI 10.1109/OCEANS.2007.4449165; Wynn RB, 2014, MAR GEOL, V352, P451, DOI 10.1016/j.margeo.2014.03.012	59	17	17	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128948	10.1371/journal.pone.0128948	http://dx.doi.org/10.1371/journal.pone.0128948			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070156	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000035
J	Xiao, M; Wang, J; Lin, ZT; Lu, Y; Li, ZM; White, SW; Miller, DD; Li, W				Xiao, Min; Wang, Jin; Lin, Zongtao; Lu, Yan; Li, Zhenmei; White, Stephen W.; Miller, Duane D.; Li, Wei			Design, Synthesis and Structure-Activity Relationship Studies of Novel Survivin Inhibitors with Potent Anti-Proliferative Properties	PLOS ONE			English	Article							TARGET STABILITY DARTS; P-GLYCOPROTEIN; TUBULIN POLYMERIZATION; MULTIDRUG-RESISTANCE; CANCER CELLS; EXPRESSION; APOPTOSIS; ANGIOGENESIS; DISCOVERY; IDENTIFICATION	The anti-apoptotic protein survivin is highly expressed in most human cancer cells, but has very low expression in normal differentiated cells. Thus survivin is considered as an attractive cancer drug target. Herein we report the design and synthesis of a series of novel survivin inhibitors based on the oxyquinoline scaffold from our recently identified hit compound UC-112. These new analogs were tested against a panel of cancer cell lines including one with multidrug-resistant phenotype. Eight of these new UC-112 analogs showed IC50 values in the nanomole range in anti-proliferative assays. The best three compounds among them along with UC-112 were submitted for NCI-60 cancer cell line screening. The results indicated that structural modification from UC-112 to our best compound 4g has improved activity by four folds (2.2 mu M for UC-112 vs. 0.5 mu M for 4g, average GI(50) values over all cancer cell lines in the NCI-60 panel). Western blot analyses demonstrated the new compounds maintained high selectivity for survivin inhibition over other members in the inhibition of apoptosis protein family. When tested in an A375 human melanoma xenograft model, the most active compound 4g effectively suppressed tumor growth and strongly induced cancer cell apoptosis in tumor tissues. This novel scaffold is promising for the development of selective survivin inhibitors as potential anticancer agents.	[Xiao, Min; Wang, Jin; Lin, Zongtao; Lu, Yan; Miller, Duane D.; Li, Wei] Univ Tennessee, Hlth Sci Ctr, Dept Pharmaceut Sci, Memphis, TN 38163 USA; [Li, Zhenmei; White, Stephen W.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA	University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital	Li, W (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Pharmaceut Sci, Memphis, TN 38163 USA.	wli@uthsc.edu	Lin, Zongtao/GYU-9038-2022; Lin, Zongtao/J-3854-2019; White, Stephen W/N-8164-2018	Lin, Zongtao/0000-0002-6017-338X; Wang, Jin/0000-0001-5420-5704; Li, Wei/0000-0002-9522-4474	NIH [R01CA148706, 1S10OD010678-01, 1S10RR026377-01]; Center for Integrative and Translational Genomics; Molecular Resource Center at the University of Tennessee; University of Tennessee Research Foundation; University of Tennessee Health Science Center; NATIONAL CANCER INSTITUTE [R01CA148706] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026377] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010678] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Integrative and Translational Genomics; Molecular Resource Center at the University of Tennessee; University of Tennessee Research Foundation; University of Tennessee Health Science Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is partially supported by NIH grants R01CA148706, 1S10OD010678-01, 1S10RR026377-01, and a pilot grant from the Center for Integrative and Translational Genomics and the Molecular Resource Center at the University of Tennessee. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors thank the University of Tennessee Research Foundation for providing funds to send compound 4g to Eurofins Panlabs for profiling its drug-like properties. Jin Wang acknowledges the support of the Alma and Hal Reagan Fellowship from University of Tennessee Health Science Center. The authors thank Mr. Zongtao Lin for performing the HRMS characterization for all final compounds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Chen JJ, 2012, J MED CHEM, V55, P7285, DOI 10.1021/jm300564b; Conway EM, 2003, AM J PATHOL, V163, P935, DOI 10.1016/S0002-9440(10)63453-0; Derry MM, 2014, CURR CANCER DRUG TAR, V14, P323, DOI 10.2174/1568009614666140411101942; Dong XW, 2009, CANCER RES, V69, P3918, DOI 10.1158/0008-5472.CAN-08-2747; Farruggia G, 2010, J ORG CHEM, V75, P6275, DOI 10.1021/jo101173t; Giodini A, 2002, CANCER RES, V62, P2462; Grossman D, 2001, J CLIN INVEST, V108, P991, DOI 10.1172/JCI200113345; Himmi B, 2008, J HETEROCYCLIC CHEM, V45, P1023, DOI 10.1002/jhet.5570450411; Iwai M, 2011, DRUG METAB DISPOS, V39, P2314, DOI 10.1124/dmd.111.040733; Kawasaki H, 2001, CANCER, V91, P2026, DOI 10.1002/1097-0142(20010601)91:11<2026::AID-CNCR1228>3.0.CO;2-E; Leonessa F, 1996, BRIT J CANCER, V73, P154, DOI 10.1038/bjc.1996.29; Lomenick Brett, 2011, Curr Protoc Chem Biol, V3, P163; Lomenick B, 2009, P NATL ACAD SCI USA, V106, P21984, DOI 10.1073/pnas.0910040106; Lu Y, 2014, J MED CHEM, V57, P7355, DOI 10.1021/jm500764v; Nomura T, 2005, ONCOL REP, V14, P993; O'Connor DS, 2000, AM J PATHOL, V156, P393, DOI 10.1016/S0002-9440(10)64742-6; Pai MY, 2015, METHODS MOL BIOL, V1263, P287, DOI 10.1007/978-1-4939-2269-7_22; Pennati M, 2007, CARCINOGENESIS, V28, P1133, DOI 10.1093/carcin/bgm047; Ryan BM, 2009, CANCER TREAT REV, V35, P553, DOI 10.1016/j.ctrv.2009.05.003; Sangthong S, 2013, BIOORG MED CHEM LETT, V23, P6156, DOI 10.1016/j.bmcl.2013.09.004; Satoh K, 2001, CANCER, V92, P271, DOI 10.1002/1097-0142(20010715)92:2<271::AID-CNCR1319>3.0.CO;2-0; Shin S, 2001, BIOCHEMISTRY-US, V40, P1117, DOI 10.1021/bi001603q; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Tamm I, 1998, CANCER RES, V58, P5315; Tirro E, 2006, CANCER RES, V66, P4263, DOI 10.1158/0008-5472.CAN-05-3248; Tsutsui S, 2006, BREAST CANCER RES TR, V98, P261, DOI 10.1007/s10549-005-9157-9; Tu SP, 2003, CANCER RES, V63, P7724; Uchiyama-Kokubu N, 2001, ANTI-CANCER DRUG, V12, P769, DOI 10.1097/00001813-200110000-00009; Vader G, 2006, EMBO REP, V7, P85, DOI 10.1038/sj.embor.7400562; Wang J, 2014, J PHARMACOL EXP THER, V349, P319, DOI 10.1124/jpet.113.212019; Wang Z, 2012, PHARM RES-DORDR, V29, P3040, DOI 10.1007/s11095-012-0726-4; Xiao M, 2013, J MED CHEM, V56, P3318, DOI 10.1021/jm4001117; Yang Y, 2011, J COLLOID INTERF SCI, V362, P157, DOI 10.1016/j.jcis.2011.06.008; Zhang SH, 2003, J PHARMACOL EXP THER, V304, P1258, DOI 10.1124/jpet.102.044412	36	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129807	10.1371/journal.pone.0129807	http://dx.doi.org/10.1371/journal.pone.0129807			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070194	Green Published, Green Submitted, gold			2022-12-26	WOS:000356327000110
J	Zou, H; Liu, XZ; Han, T; Hu, D; Wang, Y; Yuan, Y; Gu, JH; Bian, JC; Zhu, JQ; Liu, ZP				Zou, Hui; Liu, Xuezhong; Han, Tao; Hu, Di; Wang, Yi; Yuan, Yan; Gu, Jianhong; Bian, Jianchun; Zhu, Jiaqiao; Liu, Zong-ping			Salidroside Protects against Cadmium-Induced Hepatotoxicity in Rats via GJIC and MAPK Pathways	PLOS ONE			English	Article							JUNCTIONAL INTERCELLULAR COMMUNICATION; H2O2-INDUCED INHIBITION; GAP-JUNCTION; CELL-DEATH; APOPTOSIS; LIVER; CONNEXINS; CHANNELS; KINASE; DAMAGE	It is known that cadmium (Cd) induces cytotoxicity in hepatocytes; however, the underlying mechanism is unclear. Here, we studied the molecular mechanisms of Cd-induced hepatotoxicity in rat liver cells (BRL 3A) and in vivo. We observed that Cd treatment was associated with a time-and concentration-dependent decrease in the cell index (CI) of BRL 3A cells and cellular organelle ultrastructure injury in the rat liver. Meanwhile, Cd treatment resulted in the inhibition of gap junction intercellular communication (GJIC) and activation of mitogen-activated protein kinase (MAPK) pathways. Gap junction blocker 18-beta-glycyrrhetinic acid (GA), administered in combination with Cd, exacerbated cytotoxic injury in BRL 3A cells; however, GA had a protective effect on healthy cells co-cultured with Cd-exposed cells in a co-culture system. Cd-induced cytotoxic injury could be attenuated by co-treatment with an extracellular signal-regulated kinase (ERK) inhibitor (U0126) and a p38 inhibitor (SB202190) but was not affected by co-treatment with a c-Jun N-terminal kinase (JNK) inhibitor (SP600125). These results indicate that ERK and p38 play critical roles in Cd-induced hepatotoxicity and mediate the function of gap junctions. Moreover, MAPKs induce changes in GJIC by controlling connexin gene expression, while GJIC has little effect on the Cd-induced activation of MAPK pathways. Collectively, our study has identified a possible mechanistic pathway of Cd-induced hepatotoxicity in vitro and in vivo, and identified the participation of GJIC and MAPK-mediated pathways in Cd-induced hepatotoxicity. Furthermore, we have shown that salidroside may be a functional chemopreventative agent that ameliorates the negative effects of Cd via GJIC and MAPK pathways.	[Zhu, Jiaqiao] Yangzhou Univ, Coll Vet Med, Yangzhou 225009, Jiangsu, Peoples R China; Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China	Yangzhou University	Zhu, JQ (corresponding author), Yangzhou Univ, Coll Vet Med, Yangzhou 225009, Jiangsu, Peoples R China.	jqzhu1998@163.com; liuzongping@yzu.edu.cn		YUAN, YAN/0000-0002-1658-5328	National Natural Science Foundation of China [31101866, 31172373, 31302058]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (No. 31101866 to Yan Yuan; No. 31172373 to Zong-ping Liu; No. 31302058 to Yi Wang) (http://www.nsfc.gov.cn/Portal0/default152.htm) and a project Funded by Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) (http://jsycw.ec.js.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boucherie S, 2013, BIOL CELL, V105, P561, DOI 10.1111/boc.201200092; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen L, 2008, J NEUROCHEM, V105, P251, DOI 10.1111/j.1471-4159.2007.05133.x; Chen SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045763; Decrock E, 2009, CELL DEATH DIFFER, V16, P151, DOI 10.1038/cdd.2008.138; DUDLEY RE, 1984, TOXICOL APPL PHARM, V76, P150, DOI 10.1016/0041-008X(84)90038-3; ELFOULY MH, 1987, EXP CELL RES, V168, P422, DOI 10.1016/0014-4827(87)90014-0; Gong G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105944; Guo S, 2014, TOXICOL LETT, V229, P150, DOI 10.1016/j.toxlet.2014.05.026; Hu WY, 2002, TOXICOL SCI, V68, P429, DOI 10.1093/toxsci/68.2.429; Hu XL, 2010, CELL BIOL TOXICOL, V26, P499, DOI 10.1007/s10565-010-9159-1; Hwang JW, 2005, J AGR FOOD CHEM, V53, P8205, DOI 10.1021/jf051747h; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Jeong SH, 2000, TOXICOL SCI, V57, P156, DOI 10.1093/toxsci/57.1.156; Jiang CY, 2014, BIOL TRACE ELEM RES, V158, P249, DOI 10.1007/s12011-014-9918-6; Kameritsch P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.105; Keogh RJ, 2010, PLACENTA, V31, P347, DOI 10.1016/j.placenta.2010.02.008; Kim JS, 2009, FOOD CHEM TOXICOL, V47, P404, DOI 10.1016/j.fct.2008.11.038; Klaassen CD, 2009, TOXICOL APPL PHARM, V238, P215, DOI 10.1016/j.taap.2009.03.026; Levin M, 2007, PROG BIOPHYS MOL BIO, V94, P186, DOI 10.1016/j.pbiomolbio.2007.03.005; Li XF, 2011, BRAIN RES, V1382, P9, DOI 10.1016/j.brainres.2011.01.015; Mao GX, 2010, BIOMED ENVIRON SCI, V23, P161, DOI 10.1016/S0895-3988(10)60047-5; MATESIC DF, 1994, MOL CARCINOGEN, V10, P226, DOI 10.1002/mc.2940100407; Rockwell P, 2004, CELL SIGNAL, V16, P343, DOI 10.1016/j.cellsig.2003.08.006; Ruch RJ, 2001, J CELL BIOCHEM, V83, P163, DOI 10.1002/jcb.1227; Rummel AM, 1999, TOXICOL SCI, V49, P232, DOI 10.1093/toxsci/49.2.232; Spray D, 1993, PROG LIVER DIS, V12, P1; Tan CB, 2009, BIOL PHARM BULL, V32, P1359, DOI 10.1248/bpb.32.1359; Tang YB, 2014, BRIT J PHARMACOL, V171, P2440, DOI 10.1111/bph.12611; Thevenod F, 2009, TOXICOL APPL PHARM, V238, P221, DOI 10.1016/j.taap.2009.01.013; Trosko J, 1990, IN VITRO TOXICOL, V3, P9; Trosko JE, 2011, J CELL COMMUN SIGNAL, V5, P53, DOI 10.1007/s12079-010-0108-9; Trosko James E., 1998, Frontiers in Bioscience, V3, pD208; TROSKO JE, 1993, LIFE SCI, V53, P1, DOI 10.1016/0024-3205(93)90606-4; Trosko JE, 1989, CELL CELL COMMUNICAT, P111; Upham BL, 1997, CARCINOGENESIS, V18, P37, DOI 10.1093/carcin/18.1.37; Upham BL, 2009, ANTIOXID REDOX SIGN, V11, P297, DOI 10.1089/ars.2008.2146; Vinken M, 2006, CELL SIGNAL, V18, P592, DOI 10.1016/j.cellsig.2005.08.012; Vinken M, 2008, HEPATOLOGY, V47, P1077, DOI 10.1002/hep.22049; Vinken M, 2011, BBA-REV CANCER, V1815, P13, DOI 10.1016/j.bbcan.2010.08.004; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wang JC, 2014, BIOL TRACE ELEM RES, V161, P180, DOI 10.1007/s12011-014-0105-6; Wang J, 2014, ONCOL LETT, V7, P1159, DOI 10.3892/ol.2014.1863; Wilson MR, 2000, EXP CELL RES, V254, P257, DOI 10.1006/excr.1999.4771; Wu YL, 2008, BIOL PHARM BULL, V31, P1523, DOI 10.1248/bpb.31.1523; Xing JZ, 2005, CHEM RES TOXICOL, V18, P154, DOI 10.1021/tx049721s; Xu BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019052; Xu J, 2003, J BIOCHEM MOL TOXIC, V17, P67, DOI 10.1002/jbt.10062; Zhang YR, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/516051; Zheng KL, 2014, BIOCHEM BIOPH RES CO, V451, P79, DOI 10.1016/j.bbrc.2014.07.072; Zhong XY, 2014, BIOL PHARM BULL, V37, P1199, DOI 10.1248/bpb.b14-00100; Zhou JZ, 2014, FEBS LETT, V588, P1186, DOI 10.1016/j.febslet.2014.01.001; Zhu Y, 2011, DNA CELL BIOL, V30, P809, DOI 10.1089/dna.2010.1183	53	27	30	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129788	10.1371/journal.pone.0129788	http://dx.doi.org/10.1371/journal.pone.0129788			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070151	gold, Green Published, Green Submitted			2022-12-26	WOS:000356327000105
J	Camerino, GM; Desaphy, JF; De Bellis, M; Capogrosso, RF; Cozzoli, A; Dinardo, MM; Caloiero, R; Musaraj, K; Fonzino, A; Conte, E; Jagerschmidt, C; Namour, F; Liantonio, A; De Luca, A; Camerino, DC; Pierno, S				Camerino, Giulia Maria; Desaphy, Jean-Francois; De Bellis, Michela; Capogrosso, Roberta Francesca; Cozzoli, Anna; Dinardo, Maria Maddalena; Caloiero, Roberta; Musaraj, Kejla; Fonzino, Adriano; Conte, Elena; Jagerschmidt, Catherine; Namour, Florence; Liantonio, Antonella; De Luca, Annamaria; Camerino, Diana Conte; Pierno, Sabata			Effects of Nandrolone in the Counteraction of Skeletal Muscle Atrophy in a Mouse Model of Muscle Disuse: Molecular Biology and Functional Evaluation	PLOS ONE			English	Article							HINDLIMB-UNLOADED MICE; RAT SOLEUS MUSCLE; GENE-EXPRESSION; ANABOLIC-STEROIDS; TESTOSTERONE SUPPLEMENTATION; CONTRACTILE PROPERTIES; DENERVATION ATROPHY; MUSCULAR-DYSTROPHY; OXIDATIVE STRESS; MYOSIN ISOFORMS	Muscle disuse produces severe atrophy and a slow-to-fast phenotype transition in the postural Soleus (Sol) muscle of rodents. Antioxidants, amino-acids and growth factors were ineffective to ameliorate muscle atrophy. Here we evaluate the effects of nandrolone (ND), an anabolic steroid, on mouse skeletal muscle atrophy induced by hindlimb unloading (HU). Mice were pre-treated for 2-weeks before HU and during the 2-weeks of HU. Muscle weight and total protein content were reduced in HU mice and a restoration of these parameters was found in ND-treated HU mice. The analysis of gene expression by real-time PCR demonstrates an increase of MuRF-1 during HU but minor involvement of other catabolic pathways. However, ND did not affect MuRF-1 expression. The evaluation of anabolic pathways showed no change in mTOR and eIF2-kinase mRNA expression, but the protein expression of the eukaryotic initiation factor eIF2 was reduced during HU and restored by ND. Moreover we found an involvement of regenerative pathways, since the increase of MyoD observed after HU suggests the promotion of myogenic stem cell differentiation in response to atrophy. At the same time, Notch-1 expression was down-regulated. Interestingly, the ND treatment prevented changes in MyoD and Notch-1 expression. On the contrary, there was no evidence for an effect of ND on the change of muscle phenotype induced by HU, since no effect of treatment was observed on the resting gCl, restCa and contractile properties in Sol muscle. Accordingly, PGC1 alpha and myosin heavy chain expression, indexes of the phenotype transition, were not restored in ND-treated HU mice. We hypothesize that ND is unable to directly affect the phenotype transition when the specialized motor unit firing pattern of stimulation is lacking. Nevertheless, through stimulation of protein synthesis, ND preserves protein content and muscle weight, which may result advantageous to the affected skeletal muscle for functional recovery.	[Camerino, Giulia Maria; Desaphy, Jean-Francois; De Bellis, Michela; Capogrosso, Roberta Francesca; Cozzoli, Anna; Dinardo, Maria Maddalena; Caloiero, Roberta; Musaraj, Kejla; Fonzino, Adriano; Conte, Elena; Liantonio, Antonella; De Luca, Annamaria; Camerino, Diana Conte; Pierno, Sabata] Univ Bari Aldo Moro, Dept Pharm & Drug Sci, Pharmacol Sect, Bari, Italy; [Jagerschmidt, Catherine; Namour, Florence] Galapagos SASU, Romainville, France	Universita degli Studi di Bari Aldo Moro; Galapagos NV	Pierno, S (corresponding author), Univ Bari Aldo Moro, Dept Pharm & Drug Sci, Pharmacol Sect, Bari, Italy.	sabata.pierno@uniba.it	De Bellis, Michela/ABE-2595-2020; Conte, Elena/AAF-4055-2019; Desaphy, Jean-Francois/T-6191-2019; Conte, Elena/AAV-3153-2020	Conte, Elena/0000-0001-8571-5125; Desaphy, Jean-Francois/0000-0001-8816-9369; De Luca, Annamaria/0000-0002-5652-7341; Camerino, Giulia Maria/0000-0003-1410-6327; Pierno, Sabata/0000-0003-3121-2666; Liantonio, Antonella/0000-0002-4103-7577	Italian Space Agency (project OSMA "Osteoporosis and Muscle Atrophy); Galapagos-SASU, Romainville, France	Italian Space Agency (project OSMA "Osteoporosis and Muscle Atrophy); Galapagos-SASU, Romainville, France	The Italian Space Agency (project OSMA "Osteoporosis and Muscle Atrophy) to DCC and Galapagos-SASU, Romainville, France to DCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors [CJ, FN] and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andrianjafiniony T, 2010, AM J PHYSIOL-CELL PH, V299, pC307, DOI 10.1152/ajpcell.00069.2010; Attaix Didier, 2005, J Support Oncol, V3, P221; Bajotto G, 2006, J NUTR SCI VITAMINOL, V52, P233, DOI 10.3177/jnsv.52.233; Baldwin KM, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00284; Bartoli M, 2005, INT J BIOCHEM CELL B, V37, P2115, DOI 10.1016/j.biocel.2004.12.012; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bodine SC, 2013, INT J BIOCHEM CELL B, V45, P2200, DOI 10.1016/j.biocel.2013.06.011; Bouhlel A, 2003, JPN J PHYSIOL, V53, P77, DOI 10.2170/jjphysiol.53.77; Brocca L, 2010, EXP PHYSIOL, V95, P331, DOI 10.1113/expphysiol.2009.050245; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Burdi R, 2009, J APPL PHYSIOL, V106, P1311, DOI 10.1152/japplphysiol.90985.2008; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caiozzo VJ, 1996, J APPL PHYSIOL, V81, P123, DOI 10.1152/jappl.1996.81.1.123; Camerino GM, 2014, PFLUG ARCH EUR J PHY, V466, P2215, DOI 10.1007/s00424-014-1495-1; Camerino GM, 2014, HUM MOL GENET, V23, P5720, DOI 10.1093/hmg/ddu287; Camerino GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072028; Camerino GM, 2011, BIOCHEM PHARMACOL, V81, P1054, DOI 10.1016/j.bcp.2011.01.022; Cannavino J, 2014, J PHYSIOL-LONDON, V592, P4575, DOI 10.1113/jphysiol.2014.275545; Cea LA, 2013, P NATL ACAD SCI USA, V110, P16229, DOI 10.1073/pnas.1312331110; Chen CT, 2013, SCI WORLD J, DOI 10.1155/2013/643954; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Costelli P, 2005, INT J BIOCHEM CELL B, V37, P2134, DOI 10.1016/j.biocel.2005.03.010; Cozzoli A, 2013, PHARMACOL RES, V72, P9, DOI 10.1016/j.phrs.2013.03.003; De Luca A, 1998, BRIT J PHARMACOL, V125, P477, DOI 10.1038/sj.bjp.0702107; de Paoli FV, 2013, J PHYSIOL-LONDON, V591, P531, DOI 10.1113/jphysiol.2012.243246; De-Doncker L, 2005, J EXP BIOL, V208, P4585, DOI 10.1242/jeb.01931; Desaphy JF, 2010, PHARMACOL RES, V61, P553, DOI 10.1016/j.phrs.2010.01.012; Desaphy JF, 2005, NEUROBIOL DIS, V18, P356, DOI 10.1016/j.nbd.2004.09.016; Desaphy JF, 2001, BRAIN, V124, P1100, DOI 10.1093/brain/124.6.1100; Dudgeon WD, 2006, HIV MED, V7, P299, DOI 10.1111/j.1468-1293.2006.00380.x; Fitts RH, 2001, J EXP BIOL, V204, P3201; Fraysse B, 2006, NEUROBIOL DIS, V21, P372, DOI 10.1016/j.nbd.2005.07.012; Fraysse B, 2003, FASEB J, V17, P1916, DOI 10.1096/fj.02-1012fje; Glass DJ, 2010, CURR TOP MICROBIOL, V346, P267, DOI 10.1007/82_2010_78; Gold J, 1996, AIDS, V10, P745, DOI 10.1097/00002030-199606001-00008; Gregory CM, 2003, SPINAL CORD, V41, P23, DOI 10.1038/sj.sc.3101370; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guarnieri S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107753; Guasconi V, 2008, CURR OPIN CLIN NUTR, V11, P233, DOI 10.1097/MCO.0b013e3282fa1810; Guo BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030348; Holterhus PM, 2002, J STEROID BIOCHEM, V82, P269, DOI 10.1016/S0960-0760(02)00220-0; Johansen KL, 2006, J AM SOC NEPHROL, V17, P2307, DOI 10.1681/ASN.2006010034; Kicman AT, 2008, BRIT J PHARMACOL, V154, P502, DOI 10.1038/bjp.2008.165; Kovacheva EL, 2010, ENDOCRINOLOGY, V151, P628, DOI 10.1210/en.2009-1177; McMahon CD, 2003, AM J PHYSIOL-ENDOC M, V285, pE82, DOI 10.1152/ajpendo.00275.2002; Miyazaki M, 2008, MED SCI SPORT EXER, V40, P848, DOI 10.1249/MSS.0b013e318163275f; Motohashi N, 2014, JOVE-J VIS EXP, DOI 10.3791/50846; Mourikis P, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-2; NICKS DK, 1989, J ANAT, V163, P1; Pellegrino MA, 2003, J PHYSIOL-LONDON, V546, P677, DOI 10.1113/jphysiol.2002.027375; Pierno S, 2002, BRAIN, V125, P1510, DOI 10.1093/brain/awf162; Pierno S, 2007, J PHYSIOL-LONDON, V584, P983, DOI 10.1113/jphysiol.2007.141358; Pierno S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065167; Pierno S, 2012, AMINO ACIDS, V43, P431, DOI 10.1007/s00726-011-1099-4; Qin WP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-596; REEL JR, 1979, FERTIL STERIL, V31, P552; Reid MB, 2005, AM J PHYSIOL-REG I, V288, pR1423, DOI 10.1152/ajpregu.00545.2004; Sabourin LA, 1999, J CELL BIOL, V144, P631, DOI 10.1083/jcb.144.4.631; Sandona D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033232; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Sinha-Hikim I, 2006, J CLIN ENDOCR METAB, V91, P3024, DOI 10.1210/jc.2006-0357; Skipworth RJE, 2006, SURG-J R COLL SURG E, V4, P273, DOI 10.1016/S1479-666X(06)80004-1; Stevenson EJ, 2003, J PHYSIOL-LONDON, V551, P33, DOI 10.1113/jphysiol.2003.044701; Sugiura T, 2005, AM J PHYSIOL-REG I, V288, pR1273, DOI 10.1152/ajpregu.00688.2004; Taillandier D, 1996, BIOCHEM J, V316, P65, DOI 10.1042/bj3160065; Talmadge RJ, 2000, MUSCLE NERVE, V23, P661, DOI 10.1002/(SICI)1097-4598(200005)23:5<661::AID-MUS3>3.0.CO;2-J; Taylor DC, 1999, AM J SPORT MED, V27, P718, DOI 10.1177/03635465990270060601; Velema MS, 2012, CURR OPIN PULM MED, V18, P118, DOI 10.1097/MCP.0b013e32834e9001; Wimalawansa SM, 1999, J APPL PHYSIOL, V86, P1841, DOI 10.1152/jappl.1999.86.6.1841; Zhao JB, 2008, MUSCLE NERVE, V37, P42, DOI 10.1002/mus.20888	70	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129686	10.1371/journal.pone.0129686	http://dx.doi.org/10.1371/journal.pone.0129686			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26066046	Green Submitted, Green Published, gold			2022-12-26	WOS:000356100900070
J	Kim, J; Chung, YG; Park, JY; Chung, SC; Wallraven, C; Bulthoff, HH; Kim, SP				Kim, Junsuk; Chung, Yoon Gi; Park, Jang-Yeon; Chung, Soon-Cheol; Wallraven, Christian; Buelthoff, Heinrich H.; Kim, Sung-Phil			Decoding Accuracy in Supplementary Motor Cortex Correlates with Perceptual Sensitivity to Tactile Roughness	PLOS ONE			English	Article							NEURAL CODES; TEXTURE-DISCRIMINATION; NEURONAL-ACTIVITY; DECISION-MAKING; PREMOTOR CORTEX; BRAIN; AREA; PATTERNS; PARIETAL; FMRI	Perceptual sensitivity to tactile roughness varies across individuals for the same degree of roughness. A number of neurophysiological studies have investigated the neural substrates of tactile roughness perception, but the neural processing underlying the strong individual differences in perceptual roughness sensitivity remains unknown. In this study, we explored the human brain activation patterns associated with the behavioral discriminability of surface texture roughness using functional magnetic resonance imaging (fMRI). First, a whole-brain searchlight multi-voxel pattern analysis (MVPA) was used to find brain regions from which we could decode roughness information. The searchlight MVPA revealed four brain regions showing significant decoding results: the supplementary motor area (SMA), contralateral postcentral gyrus (S1), and superior portion of the bilateral temporal pole (STP). Next, we evaluated the behavioral roughness discrimination sensitivity of each individual using the just-noticeable difference (JND) and correlated this with the decoding accuracy in each of the four regions. We found that only the SMA showed a significant correlation between neuronal decoding accuracy and JND across individuals; Participants with a smaller JND (i.e., better discrimination ability) exhibited higher decoding accuracy from their voxel response patterns in the SMA. Our findings suggest that multivariate voxel response patterns presented in the SMA represent individual perceptual sensitivity to tactile roughness and people with greater perceptual sensitivity to tactile roughness are likely to have more distinct neural representations of different roughness levels in their SMA.	[Kim, Junsuk; Wallraven, Christian; Buelthoff, Heinrich H.] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Chung, Yoon Gi; Park, Jang-Yeon] Sungkyunkwan Univ, IBS Ctr Neurosci Imaging Res, Suwon, South Korea; [Park, Jang-Yeon] Sungkyunkwan Univ, Dept Global Biomed Engn, Suwon, South Korea; [Chung, Soon-Cheol] Konkuk Univ, Sch Biomed Engn, Chungju, South Korea; [Buelthoff, Heinrich H.] Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, D-72076 Tubingen, Germany; [Kim, Sung-Phil] Ulsan Natl Inst Sci & Technol, Dept Human & Syst Engn, Ulsan, South Korea	Korea University; Institute for Basic Science - Korea (IBS); Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Konkuk University; Max Planck Society; Ulsan National Institute of Science & Technology (UNIST)	Kim, SP (corresponding author), Ulsan Natl Inst Sci & Technol, Dept Human & Syst Engn, Ulsan, South Korea.	heinrich.buelthoff@tuebingen.mpg.de; spkim@unist.ac.kr	Kim, Junsuk/L-1495-2017; Bülthoff, Heinrich/AAC-8818-2019; Bülthoff, Heinrich H/J-6579-2012	Kim, Junsuk/0000-0002-7252-3420; Bülthoff, Heinrich H/0000-0003-2568-0607; Wallraven, Christian/0000-0002-2604-9115	Pioneer Research Center Program through the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning [NRF-2011-0027921]; Brain Korea 21 Plus Program through the National Research Foundation of Korea - Ministry of Education	Pioneer Research Center Program through the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning; Brain Korea 21 Plus Program through the National Research Foundation of Korea - Ministry of Education	This research was supported by the Pioneer Research Center Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning (NRF-2011-0027921) and by the Brain Korea 21 Plus Program through the National Research Foundation of Korea funded by the Ministry of Education.	Arabzadeh E, 2006, J NEUROSCI, V26, P9216, DOI 10.1523/JNEUROSCI.1491-06.2006; Boecker H, 1995, HUM BRAIN MAPP, V3, P236, DOI 10.1002/hbm.460030307; BURTON H, 1994, CAN J PHYSIOL PHARM, V72, P546, DOI 10.1139/y94-079; Burton H, 1997, CEREB CORTEX, V7, P3, DOI 10.1093/cercor/7.1.3; Carey LM, 2008, NEUROIMAGE, V39, P40, DOI 10.1016/j.neuroimage.2007.08.026; Chen XM, 2010, J NEUROSCI, V30, P14657, DOI 10.1523/JNEUROSCI.2669-10.2010; CONNOR CE, 1990, J NEUROSCI, V10, P3823, DOI 10.1523/JNEUROSCI.10-12-03823.1990; Fruend I, 2011, J VISION, V11, DOI 10.1167/11.6.16; GESCHEIDER GA, 1990, J ACOUST SOC AM, V87, P330, DOI 10.1121/1.399300; Gescheider GA, 1997, PSYCHOPHYSICS FUNDAM; Grant AC, 2005, EPILEPSIA, V46, P534, DOI 10.1111/j.0013-9580.2005.54604.x; HALSBAND U, 1994, NEUROSCI RES, V20, P149, DOI 10.1016/0168-0102(94)90032-9; HALSBAND U, 1993, BRAIN, V116, P243, DOI 10.1093/brain/116.1.243; Harada T, 2004, J NEUROSCI, V24, P7524, DOI 10.1523/JNEUROSCI.1395-04.2004; Hartmann S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003831; Haxby JV, 2012, NEUROIMAGE, V62, P852, DOI 10.1016/j.neuroimage.2012.03.016; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Hebart MN, 2012, NEUROIMAGE, V63, P1393, DOI 10.1016/j.neuroimage.2012.08.027; Hernandez A, 2002, NEURON, V33, P959, DOI 10.1016/S0896-6273(02)00613-X; Hollins M, 2000, PERCEPT PSYCHOPHYS, V62, P1534, DOI 10.3758/BF03212154; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; JOHNSON KO, 1992, ANNU REV NEUROSCI, V15, P227, DOI 10.1146/annurev.ne.15.030192.001303; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kitada R, 2005, NEUROIMAGE, V25, P90, DOI 10.1016/j.neuroimage.2004.11.026; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; LEDERMAN SJ, 1982, PERCEPT PSYCHOPHYS, V32, P109, DOI 10.3758/BF03204270; Liang M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2979; Libouton X, 2010, BEHAV BRAIN RES, V208, P473, DOI 10.1016/j.bbr.2009.12.017; Luna R, 2005, NAT NEUROSCI, V8, P1210, DOI 10.1038/nn1513; Macar F, 1999, EXP BRAIN RES, V125, P271, DOI 10.1007/s002210050683; Macar Francoise, 2006, Cogn Process, V7, P89, DOI 10.1007/s10339-005-0025-7; Meftah E, 2000, EXP BRAIN RES, V132, P351, DOI 10.1007/s002210000348; Mita A, 2009, NAT NEUROSCI, V12, P502, DOI 10.1038/nn.2272; Miyaoka T, 1999, J ACOUST SOC AM, V105, P2485, DOI 10.1121/1.426852; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Oosterhof NN, 2010, J NEUROPHYSIOL, V104, P1077, DOI 10.1152/jn.00326.2010; OSULLIVAN BT, 1994, EUR J NEUROSCI, V6, P137, DOI 10.1111/j.1460-9568.1994.tb00255.x; Peelen MV, 2010, J NEUROSCI, V30, P10127, DOI 10.1523/JNEUROSCI.2161-10.2010; Pleger B, 2006, J NEUROSCI, V26, P12596, DOI 10.1523/JNEUROSCI.4275-06.2006; Ro T, 2013, CEREB CORTEX, V23, P1724, DOI 10.1093/cercor/bhs166; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Romo R, 2002, NAT NEUROSCI, V5, P1217, DOI 10.1038/nn950; Ross HE, 1996, EH WEBER TACTILE SEN, DOI [10.1016/j.neulet.2007.12.054, DOI 10.1016/J.NEULET.2007.12.054]; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; Schurmann M, 2006, NEUROIMAGE, V30, P1325, DOI 10.1016/j.neuroimage.2005.11.020; Servos P, 2001, COGNITIVE BRAIN RES, V12, P307, DOI 10.1016/S0926-6410(01)00041-6; Shima K, 2000, J NEUROPHYSIOL, V84, P2148, DOI 10.1152/jn.2000.84.4.2148; Simoes-Franklin C, 2011, HUM BRAIN MAPP, V32, P1067, DOI 10.1002/hbm.21091; STEVENS SS, 1962, J EXP PSYCHOL, V64, P489, DOI 10.1037/h0042621; TANJI J, 1994, NEUROSCI RES, V19, P251, DOI 10.1016/0168-0102(94)90038-8; TAYLOR MM, 1975, PERCEPT PSYCHOPHYS, V17, P23, DOI 10.3758/BF03203993; Verrillo RT, 1999, SOMATOSENS MOT RES, V16, P352; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; WOODWARD KL, 1993, SOMATOSENS MOT RES, V10, P63, DOI 10.3109/08990229309028824	54	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129777	10.1371/journal.pone.0129777	http://dx.doi.org/10.1371/journal.pone.0129777			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067832	Green Published, Green Submitted, gold			2022-12-26	WOS:000356100900077
J	Lang, FF; Qin, ZY; Li, F; Zhang, HL; Fang, ZH; Hao, EK				Lang, Fangfang; Qin, Zhaoyang; Li, Fang; Zhang, Huilin; Fang, Zhenghui; Hao, Enkui			Apoptotic Cell Death Induced by Resveratrol Is Partially Mediated by the Autophagy Pathway in Human Ovarian Cancer Cells	PLOS ONE			English	Article							DOUBLE-EDGED-SWORD; OXIDATIVE STRESS; ERK; CARCINOMA; INDUCTION; MECHANISM; DISEASE; ACID	Resveratrol (trans-3,4,5'-trihydroxystilbene) is an active compound in food, such as red grapes, peanuts, and berries. Resveratrol exhibits an anticancer effect on various human cancer cells. However, the mechanism of resveratrol-induced anti-cancer effect at the molecular level remains to be elucidated. In this study, the mechanism underlying the anti-cancer effect of resveratrol in human ovarian cancer cells (OVCAR-3 and Caov-3) was investigated using various molecular biology techniques, such as flow cytometry, western blotting, and RNA interference, with a major focus on the potential role of autophagy in resveratrol-induced apoptotic cell death. We demonstrated that resveratrol induced reactive oxygen species (ROS) generation, which triggers autophagy and subsequent apoptotic cell death. Resveratrol induced ATG5 expression and promoted LC3 cleavage. The apoptotic cell death induced by resveratrol was attenuated by both pharmacological and genetic inhibition of autophagy. The autophagy inhibitor chloroquine, which functions at the late stage of autophagy, significantly reduced resveratrol-induced cell death and caspase 3 activity in human ovarian cancer cells. We also demonstrated that targeting ATG5 by siRNA also suppressed resveratrol-induced apoptotic cell death. Thus, we concluded that a common pathway between autophagy and apoptosis exists in resveratrol-induced cell death in OVCAR-3 human ovarian cancer cells.	[Hao, Enkui] Shandong Univ, Qianfoshan Hosp, Dept Cardiol, Jinan 250100, Peoples R China; [Lang, Fangfang; Fang, Zhenghui] Shandong Univ, Jinan Cent Hosp, Dept Obstet & Gynecol, Jinan 250100, Peoples R China; [Qin, Zhaoyang] Rizhao Peoples Hosp, Dept Gen Surg, Rizhao, Peoples R China; [Li, Fang] Shandong Univ, Jinan Cent Hosp, Dept Hlth, Jinan 250100, Peoples R China; [Zhang, Huilin] Shandong Univ, Jinan Cent Hosp, Cent Lab, Jinan 250100, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Hao, EK (corresponding author), Shandong Univ, Qianfoshan Hosp, Dept Cardiol, Jinan 250100, Peoples R China.	haoenkui@sdu.edu.cn			promotive research fund for young and middle-aged scientists of Shandong Province [07-21]	promotive research fund for young and middle-aged scientists of Shandong Province	This study was supported by the promotive research fund for young and middle-aged scientists of Shandong Province (Grant No. 07-21). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu-Fernandez V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056881; Cheong H, 2012, NAT BIOTECHNOL, V30, P671, DOI 10.1038/nbt.2285; Davis M, 2014, GYNECOL ONCOL, V132, P760, DOI 10.1016/j.ygyno.2014.01.012; Delmas D, 2006, CURR DRUG TARGETS, V7, P423, DOI 10.2174/138945006776359331; Delmas D, 2011, CURR MED CHEM, V18, P1100, DOI 10.2174/092986711795029708; Duan WJ, 2013, MOL NUTR FOOD RES, V57, P1145, DOI 10.1002/mnfr.201200662; Juan ME, 2008, J AGR FOOD CHEM, V56, P4813, DOI 10.1021/jf800175a; Gupta SC, 2013, J BIOL CHEM, V288, P32343, DOI 10.1074/jbc.M113.455188; Hao EK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069452; Jayson GC, 2014, LANCET, V384, P1376, DOI 10.1016/S0140-6736(13)62146-7; Kimura T, 2013, CANCER RES, V73, P3, DOI 10.1158/0008-5472.CAN-12-2464; Kubisch J, 2013, SEMIN CANCER BIOL, V23, P252, DOI 10.1016/j.semcancer.2013.06.009; Lamy L, 2013, CANCER CELL, V23, P435, DOI 10.1016/j.ccr.2013.02.017; Le Corre L, 2005, MOL NUTR FOOD RES, V49, P462, DOI 10.1002/mnfr.200400094; Li L, 2012, FREE RADICAL BIO MED, V53, P1399, DOI 10.1016/j.freeradbiomed.2012.07.011; Lin HY, 2013, J CELL BIOCHEM, V114, P1940, DOI 10.1002/jcb.24539; Malik SA, 2011, ONCOGENE, V30, P3918, DOI 10.1038/onc.2011.104; Malik SA, 2011, AUTOPHAGY, V7, P914, DOI 10.4161/auto.7.8.15785; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Martinet W, 2009, CLIN SCI, V116, P697, DOI 10.1042/CS20080508; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Mukhopadhyay P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015705; Puissant A, 2008, FASEB J, V22, P1894, DOI 10.1096/fj.07-101394; Puissant A, 2010, AUTOPHAGY, V6, P655, DOI 10.4161/auto.6.5.12126; Puissant A, 2010, CANCER RES, V70, P1042, DOI 10.1158/0008-5472.CAN-09-3537; Santos Juliana A, 2013, Recent Pat Food Nutr Agric, V5, P144, DOI 10.2174/18761429113059990001; Scarlatti F, 2008, CELL DEATH DIFFER, V15, P1318, DOI 10.1038/cdd.2008.51; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Tan BJ, 2013, INT J ONCOL, V42, P1605, DOI 10.3892/ijo.2013.1843; Tang QS, 2013, CANCER LETT, V336, P325, DOI 10.1016/j.canlet.2013.03.023; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Tyagi A, 2005, CARCINOGENESIS, V26, P1978, DOI 10.1093/carcin/bgi165; Vang O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019881; Vergara D, 2012, MOL BIOSYST, V8, P1078, DOI 10.1039/c2mb05486h; Wenzel U, 2005, APOPTOSIS, V10, P359, DOI 10.1007/s10495-005-0810-x; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Wong CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009996; Wu Zhaoju, 2010, Genes Cancer, V1, P40, DOI 10.1177/1947601909358324; Zhang YB, 2014, MOL PHARMACEUT, V11, P1282, DOI 10.1021/mp400749f	39	77	80	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129196	10.1371/journal.pone.0129196	http://dx.doi.org/10.1371/journal.pone.0129196			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067645	Green Published, Green Submitted, gold			2022-12-26	WOS:000356100900045
J	Leonards, U; Fennell, JG; Oliva, G; Drake, A; Redmill, DW				Leonards, Ute; Fennell, John G.; Oliva, Gaby; Drake, Alex; Redmill, David W.			Treacherous Pavements: Paving Slab Patterns Modify Intended Walking Directions	PLOS ONE			English	Article							OPTIC FLOW; MOTION; STATISTICS; PERCEPTION; TASK	Current understanding in locomotion research is that, for humans, navigating natural environments relies heavily on visual input; in contrast, walking on even ground in man-made obstacle and hazard-free environments is so highly automated that visual information derived from floor patterns should not affect locomotion and in particular have no impact on the direction of travel. The vision literature on motion perception would suggest otherwise; specifically that oblique floor patterns may induce substantial veering away from the intended direction of travel due to the so-called aperture problem. Here, we tested these contrasting predictions by letting participants walk over commonly encountered floor patterns (paving slabs) and investigating participants' ability to walk "straight ahead" for different pattern orientations. We show that, depending on pattern orientation, participants veered considerably over the measured travel distance (up to 8% across trials), in line with predictions derived from the literature on motion perception. We argue that these findings are important to the study of locomotion, and, if also observed in real world environments, might have implications for architectural design.	[Leonards, Ute; Fennell, John G.; Oliva, Gaby; Drake, Alex; Redmill, David W.] Univ Bristol, Sch Expt Psychol, Bristol, Avon, England	University of Bristol	Leonards, U (corresponding author), Univ Bristol, Sch Expt Psychol, Bristol, Avon, England.	ute.leonards@bristol.ac.uk	Fennell, John G/V-5947-2018	Fennell, John G/0000-0003-2991-3391; Leonards, Ute/0000-0001-6143-7466; Drake, Alexander/0000-0002-9462-6287	Wellcome Trust [WT089367AIA]; BRACE Charity (Bristol Research into Alzheimer's and Care of the Elderly)	Wellcome Trust(Wellcome TrustEuropean Commission); BRACE Charity (Bristol Research into Alzheimer's and Care of the Elderly)	This work was supported by an equipment grant from the Wellcome Trust (WT089367AIA) to set up the laboratory, and a grant awarded to UL from the BRACE Charity (Bristol Research into Alzheimer's and Care of the Elderly; http://www.alzheimers-brace.org), as a basis for further work examining the impact of the visual environment on falls risk in older people. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; Alais D, 1997, VISION RES, V37, P143, DOI 10.1016/0042-6989(95)00320-7; BRESSAN P, 1995, PERCEPTION, V24, P1165, DOI 10.1068/p241165; Calow D, 2007, NETWORK-COMP NEURAL, V18, P343, DOI 10.1080/09548980701642277; GIBSON EJ, 1979, PERCEPTION, V8, P609, DOI 10.1068/p080609; GIBSON JJ, 1958, BRIT J PSYCHOL, V49, P182, DOI 10.1111/j.2044-8295.1958.tb00656.x; Guertin PA, 2009, BRAIN RES REV, V62, P45, DOI 10.1016/j.brainresrev.2009.08.002; Kim B, 2010, J NEUROSCI, V30, P2340, DOI 10.1523/JNEUROSCI.1730-09.2010; Logan D, 2010, EXP BRAIN RES, V206, P337, DOI 10.1007/s00221-010-2414-0; Roth S, 2007, INT J COMPUT VISION, V74, P33, DOI 10.1007/s11263-006-0016-x; Salinas E, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00085; Shankar S, 2011, J NEUROSCI, V31, P8406, DOI 10.1523/JNEUROSCI.1419-11.2011; Wann JP, 2000, VISION RES, V40, P2533, DOI 10.1016/S0042-6989(00)00115-2; Warren PA, 2009, CURR BIOL, V19, P1555, DOI 10.1016/j.cub.2009.07.057; Warren WH, 2001, NAT NEUROSCI, V4, P213, DOI 10.1038/84054; WHO global report on falls prevention in older age, 2007, 2007 WHO TECHN M FAL; Wuerger S, 1996, PERCEPTION, V25, P1317, DOI 10.1068/p251317	17	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0130034	10.1371/journal.pone.0130034	http://dx.doi.org/10.1371/journal.pone.0130034			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067491	Green Published, gold, Green Submitted			2022-12-26	WOS:000356100900095
J	Li, R; Zhou, H; Wei, W; Wang, C; Sun, YC; Gao, P				Li, Rui; Zhou, Hui; Wei, Wei; Wang, Chen; Sun, Ying Chun; Gao, Ping			Effects of Mechanical and Chemical Pretreatments of Zirconia or Fiber Posts on Resin Cement Bonding	PLOS ONE			English	Article							SURFACE TREATMENTS; SILANE SYSTEM; STRENGTH; COMPOSITE; ADHESION; MICROTENSILE; TITANIUM	The bonding strength between resin cement and posts is important for post and core restorations. An important method of improving the bonding strength is the use of various surface pretreatments of the post. In this study, the surfaces of zirconia (fiber) posts were treated by mechanical and/or chemical methods such as sandblasting and silanization. The bonding strength between the zirconia (fiber) post and the resin cement was measured by a push-out method after thermocycling based on the adhesion to Panavia F 2.0 resin cement. The zirconia and fiber posts exhibited different bonding strengths after sandblasting and/or silanization because of the different strengths and chemical structures. The zirconia post showed a high bonding strength of up to 17.1 MPa after a combined treatment of sandblasting and silanization because of the rough surface and covalent bonds at the interface. This effect was also enhanced by using 1,2-bis(trimethoxysilyl)ethane for the formation of a flexible layer at the interface. In contrast, a high bonding strength of 13.9 MPa was obtained for the fiber post treated by silane agents because the sandblasting treatment resulted in damage to the fiber post, as observed by scanning electron microscopy. The results indicated that the improvement in the bonding strength between the post and the resin cement could be controlled by different chemical and/or mechanical treatments. Enhanced bonding strength depended on covalent bonding and the surface roughness. A zirconia post with high bonding strength could potentially be used for the restoration of teeth in the future.	[Li, Rui; Zhou, Hui; Wei, Wei; Wang, Chen; Sun, Ying Chun; Gao, Ping] Tianjin Med Univ, Stomatol Hosp, Dept Prosthodont, Tianjin, Peoples R China	Tianjin Medical University	Gao, P (corresponding author), Tianjin Med Univ, Stomatol Hosp, Dept Prosthodont, Tianjin, Peoples R China.	kqxiufulirui@tijmu.edu.cn			Natural Science Foundation of Tianjin, China [12JCYBJC31300]	Natural Science Foundation of Tianjin, China(Natural Science Foundation of Tianjin)	This study is financially supported by Natural Science Foundation of Tianjin, China (12JCYBJC31300).	Aboushelib MN, 2013, J PROSTHODONT, V22, P190, DOI 10.1111/j.1532-849X.2012.00920.x; Almufleh BS, 2014, J PROSTHET DENT, V112, P957, DOI 10.1016/j.prosdent.2014.04.022; [Anonymous], 2015, TECHN BROCH; Bitter K, 2007, AM J DENT, V20, P353; Blatz MB, 2003, J PROSTHET DENT, V89, P268, DOI 10.1067/mpr.2003.50; Borges GA, 2003, J PROSTHET DENT, V89, P479, DOI 10.1016/S0022-3913(02)52704-9; Bottino MA, 2005, INT J PROSTHODONT, V18, P60; Chen D, 2014, J PROSTHET DENT, V112, P1406, DOI 10.1016/j.prosdent.2014.05.017; Chevalier J, 2004, BIOMATERIALS, V25, P5539, DOI 10.1016/j.biomaterials.2004.01.002; D'Arcangelo C, 2007, J ENDODONT, V33, P264, DOI 10.1016/j.joen.2006.10.015; Edwin P., 1991, SILANE COUPLING AGEN, V2nd ed., P31, DOI [10.1007/978-1-4899-2070-6_2, DOI 10.1007/978-1-4899-2070-6_2]; Elsaka SE, 2013, DENT MATER, V27, P165; Fazi G, 2012, AM J DENT, V25, P73; Ferrari M, 2007, AM J DENT, V20, P287; Goracci C, 2004, EUR J ORAL SCI, V112, P353, DOI 10.1111/j.1600-0722.2004.00146.x; Goracci C, 2005, DENT MATER, V21, P437, DOI 10.1016/j.dental.2004.07.012; Inokoshi M, 2013, J DENT, V41, P170, DOI 10.1016/j.jdent.2012.10.017; Kilicarslan MA, 2004, J PROSTHET DENT, V92, P365, DOI 10.1016/j.prosdent.2004.07.001; Li R, 2010, J ORAL REHABIL, V37, P560, DOI 10.1111/j.1365-2842.2010.02060.x; Li R, 2014, BIO-MED MATER ENG, V24, P2117, DOI 10.3233/BME-141022; Liu D, 2015, J MECH BEHAV BIOMED, V46, P23, DOI 10.1016/j.jmbbm.2015.02.015; Malferrari S, 2003, INT J PROSTHODONT, V16, P39; Manicardi CA, 2011, J ENDODONT, V37, P531, DOI 10.1016/j.joen.2010.12.009; Matinlinna JP, 2006, J DENT, V34, P740, DOI 10.1016/j.jdent.2006.01.008; Matinlinna JP, 2004, INT J PROSTHODONT, V17, P155; Matinlinna J, 2008, ACTA ODONTOL SCAND, V66, P250, DOI 10.1080/00016350802247131; Matinlinna JP, 2006, DENT MATER, V22, P824, DOI 10.1016/j.dental.2005.11.035; Matinlinna JP, 2010, SILICON-NETH, V2, P79, DOI 10.1007/s12633-010-9039-6; Matinlinna JP, 2011, J ADHES SCI TECHNOL, V25, P179, DOI 10.1163/016942410X503302; Mazzitelli C, 2008, J DENT RES, V87, P186, DOI 10.1177/154405910808700204; Patierno JM, 1996, ENDOD DENT TRAUMATOL, V12, P227; ROYDHOUSE RH, 1970, J DENT RES, V49, P131, DOI 10.1177/00220345700490010501; Sahafi A, 2003, J ADHES DENT, V5, P153; Samimi P, 2014, OPER DENT, V39, pE217, DOI 10.2341/11-486-L; Soejima H, 2013, DENT MATER J, V32, P659, DOI 10.4012/dmj.2013-078; Yun JY, 2010, DENT MATER, V26, P650, DOI 10.1016/j.dental.2010.03.008; Zicari F, 2012, DENT MATER, V28, P287, DOI 10.1016/j.dental.2011.11.003	37	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129690	10.1371/journal.pone.0129690	http://dx.doi.org/10.1371/journal.pone.0129690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26066349	Green Published, gold, Green Submitted			2022-12-26	WOS:000356100900071
J	Raja, MAG; Katas, H; Wen, TJ				Raja, Maria Abdul Ghafoor; Katas, Haliza; Wen, Thum Jing			Stability, Intracellular Delivery, and Release of siRNA from Chitosan Nanoparticles Using Different Cross-Linkers	PLOS ONE			English	Article							GENE DELIVERY; MECHANISM; VECTORS	Chitosan (CS) nanoparticles have been extensively studied for siRNA delivery; however, their stability and efficacy are highly dependent on the types of cross-linker used. To address this issue, three common cross-linkers; tripolyphosphate (TPP), dextran sulphate (DS) and poly-D-glutamic acid (PGA) were used to prepare siRNA loaded CS-TPP/DS/PGA nanoparticles by ionic gelation method. The resulting nanoparticles were compared with regard to their physicochemical properties including particle size, zeta potential, morphology, binding and encapsulation efficiencies. Among all the formulations prepared with different cross linkers, CS-TPP-siRNA had the smallest particle size (ranged from 127 +/- 9.7 to 455 +/- 12.9 nm) with zeta potential ranged from +25.1 +/- 1.5 to +39.4 +/- 0.5 mV, and high entrapment (>95%) and binding efficiencies. Similarly, CS-TPP nanoparticles showed better siRNA protection during storage at 4 degrees C and as determined by serum protection assay. TEM micrographs revealed the assorted morphology of CS-TPP-siRNA nanoparticles in contrast to irregular morphology displayed by CS-DS-siRNA and CS-PGA-siRNA nanoparticles. All siRNA loaded CS-TPP/DS/PGA nanoparticles showed initial burst release followed by sustained release of siRNA. Moreover, all the formulations showed low and concentration-dependent cytotoxicity with human colorectal cancer cells (DLD-1), in vitro. The cellular uptake studies with CS-TPP-siRNA nanoparticles showed successful delivery of siRNA within cytoplasm of DLD-1 cells. The results demonstrate that ionically cross-linked CS-TPP nanoparticles are biocompatible non-viral gene delivery system and generate a solid ground for further optimization studies, for example with regard to steric stabilization and targeting.	[Raja, Maria Abdul Ghafoor; Katas, Haliza; Wen, Thum Jing] Univ Kebangsaan Malaysia, Ctr Drug Delivery Res, Fac Pharm, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia	Katas, H (corresponding author), Univ Kebangsaan Malaysia, Ctr Drug Delivery Res, Fac Pharm, Kuala Lumpur, Malaysia.	haliz12@hotmail.com	KATAS, HALIZA/I-6417-2016	KATAS, HALIZA/0000-0001-7249-1628	Ministry of Higher Education Exploratory Research Grant [ERGS/1/2011/SKK/UKM/02/11]	Ministry of Higher Education Exploratory Research Grant	This work was supported by the Ministry of Higher Education Exploratory Research Grant Scheme ERGS/1/2011/SKK/UKM/02/11 to HK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2007, J CLIN INVEST, V117, P3623, DOI 10.1172/JCI33494; Al-Qadi S, 2011, CARBOHYD POLYM, V86, P25, DOI 10.1016/j.carbpol.2011.03.022; Anitha A, 2011, CARBOHYD POLYM, V84, P1158, DOI 10.1016/j.carbpol.2011.01.005; Avadi MR, 2010, NANOMED-NANOTECHNOL, V6, P58, DOI 10.1016/j.nano.2009.04.007; Baldrick P, 2010, REGUL TOXICOL PHARM, V56, P290, DOI 10.1016/j.yrtph.2009.09.015; Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4; Csaba N, 2009, INT J PHARMACEUT, V382, P205, DOI 10.1016/j.ijpharm.2009.07.028; Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; Dudhani AR, 2010, CARBOHYD POLYM, V81, P243, DOI 10.1016/j.carbpol.2010.02.026; Fan W, 2012, COLLOID SURFACE B, V90, P21, DOI 10.1016/j.colsurfb.2011.09.042; FELGNER JH, 1994, J BIOL CHEM, V269, P2550; Ge CC, 2011, P NATL ACAD SCI USA, V108, P16968, DOI 10.1073/pnas.1105270108; Germershaus O, 2008, J CONTROL RELEASE, V125, P145, DOI 10.1016/j.jconrel.2007.10.013; Hamidi M, 2008, ADV DRUG DELIVER REV, V60, P1638, DOI 10.1016/j.addr.2008.08.002; Hickerson RP, 2008, OLIGONUCLEOTIDES, V18, P345, DOI 10.1089/oli.2008.0149; Hu WB, 2011, ACS NANO, V5, P3693, DOI 10.1021/nn200021j; Illum L, 1998, PHARM RES-DORDR, V15, P1326; Katas H, 2006, J CONTROL RELEASE, V115, P216, DOI 10.1016/j.jconrel.2006.07.021; Kim SH, 2006, BIOCONJUGATE CHEM, V17, P241, DOI 10.1021/bc050289f; Kirchhoff F, 2008, CELL, V134, P566, DOI 10.1016/j.cell.2008.08.004; Kleemann E, 2005, J CONTROL RELEASE, V109, P299, DOI 10.1016/j.jconrel.2005.09.036; Ko JA, 2002, INT J PHARMACEUT, V249, P165, DOI 10.1016/S0378-5173(02)00487-8; Li SD, 2007, J CONTROL RELEASE, V123, P181, DOI 10.1016/j.jconrel.2007.09.004; Lin YH, 2005, BIOMACROMOLECULES, V6, P1104, DOI 10.1021/bm049312a; Liu F, 2002, J CONTROL RELEASE, V78, P259, DOI 10.1016/S0168-3659(01)00494-1; Liu ZH, 2008, ADV DRUG DELIVER REV, V60, P1650, DOI 10.1016/j.addr.2008.09.001; Lundstrom K, 2003, TRENDS BIOTECHNOL, V21, P117, DOI 10.1016/S0167-7799(02)00042-2; Malmo J, 2011, BIOMACROMOLECULES, V12, P721, DOI 10.1021/bm1013525; Papadimitriou SA, 2012, INT J PHARMACEUT, V430, P318, DOI 10.1016/j.ijpharm.2012.04.004; Piao LZ, 2013, NANOMED-NANOTECHNOL, V9, P122, DOI 10.1016/j.nano.2012.03.008; Raja MAG, 2013, J NANOMATER, V2013, DOI 10.1155/2013/653892; Rampino A, 2013, INT J PHARMACEUT, V455, P219, DOI 10.1016/j.ijpharm.2013.07.034; Rodrigues S, 2012, CARBOHYD POLYM, V89, P282, DOI 10.1016/j.carbpol.2012.03.010; Savic R, 2003, SCIENCE, V300, P615, DOI 10.1126/science.1078192; Shim MS, 2010, FEBS J, V277, P4814, DOI 10.1111/j.1742-4658.2010.07904.x; Strand SP, 2008, BIOMACROMOLECULES, V9, P3268, DOI 10.1021/bm800832u; Tsai ML, 2011, CARBOHYD POLYM, V84, P756, DOI 10.1016/j.carbpol.2010.04.040; Tsao CT, 2011, CARBOHYD POLYM, V84, P812, DOI 10.1016/j.carbpol.2010.04.034; Vandenberg GW, 2001, J CONTROL RELEASE, V77, P297, DOI 10.1016/S0168-3659(01)00517-X	40	64	66	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128963	10.1371/journal.pone.0128963	http://dx.doi.org/10.1371/journal.pone.0128963			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068222	Green Published, gold, Green Submitted			2022-12-26	WOS:000356100900036
J	Wandu, WS; Tan, CY; Ogbeifun, O; Vistica, BP; Shi, GP; Hinshaw, SJH; Xie, C; Chen, X; Klinman, DM; Cai, HB; Gery, I				Wandu, Wambui S.; Tan, Cuiyan; Ogbeifun, Osato; Vistica, Barbara P.; Shi, Guangpu; Hinshaw, Samuel J. H.; Xie, Chengsong; Chen, Xi; Klinman, Dennis M.; Cai, Huaibin; Gery, Igal			Leucine-Rich Repeat Kinase 2 (Lrrk2) Deficiency Diminishes the Development of Experimental Autoimmune Uveitis (EAU) and the Adaptive Immune Response	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; SUSCEPTIBILITY LOCI; CROHNS-DISEASE; T-CELLS; TH17; INNATE	Background Mutations in LRRK2 are related to certain forms of Parkinson's disease and, possibly, to the pathogenesis of Crohn's disease. In both these diseases inflammatory processes participate in the pathogenic process. LRRK2 is expressed in lymphoid cells and, interestingly, Lrrk2 (-/-) mice were reported to develop more severe experimental colitis than their wild type (WT) controls. Here, we examined the possible involvement of LRRK2 in the pathogenesis of experimental autoimmune uveitis (EAU), an animal model for human uveitis, by testing Lrrk2 (-/-) mice for their capacity to develop this experimental eye disease and related immune responses. Methods Lrrk2 (-/-) mice and their WT controls (C57Bl/6) were immunized with interphotoreceptor retinoid-binding protein (IRBP) and compared for their development of EAU, delayed type hypersensitivity (DTH) by skin tests, production of cytokines in culture, and expression of interferon (IFN)-gamma, interleukin (IL)-17 and FoxP3 by spleen cells, using flow cytometry. Peritoneal macrophages were examined for their production of cytokines/chemokines in culture following stimulation with LPS or the oligodeoxynucleotide CpG. The Lrrk2 (-/-) and WT mice were also compared for their response to bovine serum albumin (BSA). Results The Lrrk2 (-/-) mice developed lower levels of EAU, DTH responses and cytokine production by lymphocytes than did their WT controls. Intracellular expression of IFN-gamma and IL-17, by spleen cells, and secretion of cytokines/chemokines by activated peritoneal macrophages of Lrrk2 (-/-) mice trended toward diminished levels, although variabilities were noted. The expression levels of FoxP3 by Lrrk2 (-/-) spleen cells, however, were similar to those seen in WT controls. Consistent with their low response to IRBP, Lrrk2 (-/-) mice responded to BSA less vigorously than their WT controls. Conclusions Lrrk2 deficiency in mice diminished the development of EAU and the related adaptive immune responses to IRBP as compared to the WT controls.	[Wandu, Wambui S.; Tan, Cuiyan; Ogbeifun, Osato; Vistica, Barbara P.; Shi, Guangpu; Hinshaw, Samuel J. H.; Gery, Igal] NEI, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Xie, Chengsong; Chen, Xi; Cai, Huaibin] NIA, Neurogenet Lab, NIH, Transgen Sect, Bethesda, MD 20892 USA; [Klinman, Dennis M.] NCI, NIH, Canc & Inflammat Program, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gery, I (corresponding author), NEI, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	geryi@nei.nih.gov	Cai, Huaibin/H-3359-2013	Cai, Huaibin/0000-0002-8596-6108	National Eye Institute; National Institute on Aging, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010853] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [ZIAEY000069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000945, ZIAAG000944, ZIAAG000943] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by intramural funding by National Eye Institute (IG) and National Institute on Aging (HC), National Institutes of Health. The National Eye Institute and National Institute on Aging had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Caspi RR, 2010, J CLIN INVEST, V120, P3073, DOI 10.1172/JCI42440; Cox CA, 2008, J IMMUNOL, V180, P7414, DOI 10.4049/jimmunol.180.11.7414; Dachsel JC, 2010, ARCH NEUROL-CHICAGO, V67, P542, DOI 10.1001/archneurol.2010.79; Dzamko N, 2012, BIOCHEM SOC T, V40, P1134, DOI 10.1042/BST20120119; Dzamko N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039132; Forrester JV, 2013, INT REV IMMUNOL, V32, P76, DOI 10.3109/08830185.2012.747524; Gardet A, 2010, J IMMUNOL, V185, P5577, DOI 10.4049/jimmunol.1000548; Geremia A, 2014, AUTOIMMUN REV, V13, P3, DOI 10.1016/j.autrev.2013.06.004; Hakimi M, 2011, J NEURAL TRANSM, V118, P795, DOI 10.1007/s00702-011-0653-2; Hold GL, 2014, WORLD J GASTROENTERO, V20, P1192, DOI 10.3748/wjg.v20.i5.1192; Kaser A, 2009, SEMIN IMMUNOL, V21, P156, DOI 10.1016/j.smim.2009.01.001; Kim B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034693; Liu ZH, 2011, NAT IMMUNOL, V12, P1063, DOI 10.1038/ni.2113; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Moehle MS, 2012, J NEUROSCI, V32, P1602, DOI 10.1523/JNEUROSCI.5601-11.2012; Ness D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066164; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Nussenblatt RB, 1996, J AUTOIMMUN, V9, P575, DOI 10.1006/jaut.1996.0077; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Russo I, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-52; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schapansky J, 2014, NEUROSCIENCE, DOI [10.1016/j.neuroscience.2014.09.049, DOI 10.1016/J.NEUR0SCIENCE.2014.09.049]; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Shi GP, 2013, J IMMUNOL, V191, P415, DOI 10.4049/jimmunol.1201732; Siegmund B, 2010, IMMUNITY, V32, P300, DOI 10.1016/j.immuni.2010.03.010; Sutton CE, 2012, EUR J IMMUNOL, V42, P2221, DOI 10.1002/eji.201242569; Thevenet J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021519; Umeno J, 2011, INFLAMM BOWEL DIS, V17, P2407, DOI 10.1002/ibd.21651; Vistica BP, 2012, MOL VIS, V18, P1858	30	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128906	10.1371/journal.pone.0128906	http://dx.doi.org/10.1371/journal.pone.0128906			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067490	Green Published, gold, Green Submitted			2022-12-26	WOS:000356100900033
J	Lipkie, TE; Morrow, AL; Jouni, ZE; McMahon, RJ; Ferruzzi, MG				Lipkie, Tristan E.; Morrow, Ardythe L.; Jouni, Zeina E.; McMahon, Robert J.; Ferruzzi, Mario G.			Longitudinal Survey of Carotenoids in Human Milk from Urban Cohorts in China, Mexico, and the USA	PLOS ONE			English	Article							MAJOR CAROTENOIDS; LUTEIN; ZEAXANTHIN; ISOMERS; PLASMA; IDENTIFICATION; SECRETION; TRANSPORT; VITAMIN; INFANTS	Emerging evidence indicates that carotenoids may have particular roles in infant nutrition and development, yet data on the profile and bioavailability of carotenoids from human milk remain sparse. Milk was longitudinally collected at 2, 4, 13, and 26 weeks postpartum from twenty mothers each in China, Mexico, and the USA in the Global Exploration of Human Milk Study (n = 60 donors, n = 240 samples). Maternal and neonatal plasma was analyzed for carotenoids from the USA cohort at 4 weeks postpartum. Carotenoids were analyzed by HPLC and total lipids by Creamatocrit. Across all countries and lactation stages, the top four carotenoids were lutein (median 114.4 nmol/L), beta-carotene (49.4 nmol/L), beta-cryptoxanthin (33.8 nmol/L), and lycopene (33.7 nmol/L). Non-provitamin A carotenoids (nmol/L) and total lipids (g/L) decreased (p<0.05) with increasing lactation stage, except the provitamin A carotenoids alpha-and beta-cryptoxanthin and beta-carotene did not significantly change (p>0.05) with lactation stage. Total carotenoid content and lutein content were greatest from China, yet lycopene was lowest from China (p<0.0001). Lutein, beta-cryptoxanthin, and beta-carotene, and lycopene concentrations in milk were significantly correlated to maternal plasma and neonatal plasma concentrations (p<0.05), with the exception that lycopene was not significantly associated between human milk and neonatal plasma (p>0.3). This enhanced understanding of neonatal exposure to carotenoids during development may help guide dietary recommendations and design of human milk mimetics.	[Lipkie, Tristan E.; Ferruzzi, Mario G.] Purdue Univ, Dept Food Sci, W Lafayette, IN 47907 USA; [Morrow, Ardythe L.] Cincinnati Childrens Hosp, Dept Pediat, Cincinnati, OH USA; [Jouni, Zeina E.; McMahon, Robert J.] Mead Johnson Nutr Inst, Global Discovery & Analyt Sci, Evansville, IN USA; [Ferruzzi, Mario G.] Purdue Univ, Dept Nutr Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Cincinnati Children's Hospital Medical Center; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Ferruzzi, MG (corresponding author), Purdue Univ, Dept Food Sci, Smith Hall, W Lafayette, IN 47907 USA.	mferruzz@purdue.edu	Morrow, Ardythe/GQO-8482-2022	Ferruzzi, Mario/0000-0003-1384-2672	Mead Johnson Pediatric Institute; United States Department of Agriculture Foods for Health [2008-38420-18741]; Mead Johnson Nutrition Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	Mead Johnson Pediatric Institute; United States Department of Agriculture Foods for Health; Mead Johnson Nutrition Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by the Mead Johnson Pediatric Institute and the United States Department of Agriculture Foods for Health Grant No. 2008-38420-18741. Mead Johnson Nutrition Institute provided support in the form of salaries for authors ZJ & RM but did not have any additional role in data collection and analysis, or decision to publish.	Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002; Barker FM, 2011, INVEST OPHTH VIS SCI, V52, P3934, DOI 10.1167/iovs.10-5898; BATES CJ, 1995, LANCET, V345, P31, DOI 10.1016/S0140-6736(95)91157-X; Bernstein PS, 2013, INVEST OPHTH VIS SCI, V54, P4034, DOI 10.1167/iovs.13-11891; BITMAN J, 1986, J PEDIATR GASTR NUTR, V5, P608, DOI 10.1097/00005176-198607000-00018; Canfield LM, 2003, EUR J NUTR, V42, P133, DOI 10.1007/s00394-003-0403-9; Chauveau-Duriot B, 2010, ANAL BIOANAL CHEM, V397, P777, DOI 10.1007/s00216-010-3594-y; de Azeredo VB, 2008, NUTRITION, V24, P133, DOI 10.1016/j.nut.2007.10.011; During A, 2004, ARCH BIOCHEM BIOPHYS, V430, P77, DOI 10.1016/j.abb.2004.03.024; EMENHISER C, 1995, J CHROMATOGR A, V707, P205, DOI 10.1016/0021-9673(95)00336-L; Erdman JW, 2009, ARCH BIOCHEM BIOPHYS, V483, P229, DOI 10.1016/j.abb.2008.10.022; Ferruzzi MG, 2001, J CHROMATOGR B, V760, P289, DOI 10.1016/S0378-4347(01)00288-2; GIULIANO AR, 1994, J NUTR BIOCHEM, V5, P551, DOI 10.1016/0955-2863(94)90054-X; Jackson JG, 1998, J NUTR BIOCHEM, V9, P2, DOI 10.1016/S0955-2863(97)00132-0; Jensen RG, 1999, LIPIDS, V34, P1243, DOI 10.1007/s11745-999-0477-2; Jewell VC, 2004, EUR J CLIN NUTR, V58, P90, DOI 10.1038/sj.ejcn.1601753; Johnson EJ, 2005, INVEST OPHTH VIS SCI, V46, P692, DOI 10.1167/iovs.02-1192; Kean EG, 2008, J AGR FOOD CHEM, V56, P9918, DOI 10.1021/jf8018613; Kent JC, 2007, J MIDWIFERY WOM HEAL, V52, P564, DOI 10.1016/j.jmwh.2007.04.007; Khachik F, 1997, ANAL CHEM, V69, P1873, DOI 10.1021/ac961085i; Khachik F, 1997, INVEST OPHTH VIS SCI, V38, P1802; Kim YK, 2011, FASEB J, V25, P1641, DOI 10.1096/fj.10-175448; Lipkie TE, 2014, MOL NUTR FOOD RES, V58, P2014, DOI 10.1002/mnfr.201400126; LUCAS A, 1978, BRIT MED J, V1, P1018, DOI 10.1136/bmj.1.6119.1018; McManaman JL, 2006, J MAMMARY GLAND BIOL, V11, P249, DOI 10.1007/s10911-006-9031-3; Meneses F, 2005, NUTR RES, V25, P443, DOI 10.1016/j.nutres.2005.03.003; ROMANCHIK JE, 1995, J NUTR, V125, P2610; Rubin LP, 2012, J PERINATOL, V32, P418, DOI 10.1038/jp.2011.87; Ruhl R, 2013, INT ARCH ALLERGY IMM, V161, P99, DOI 10.1159/000345958; Schweigert FJ, 2004, EUR J NUTR, V43, P39, DOI 10.1007/s00394-004-0439-5; Section on Breastfeeding, 2012, Pediatrics, V129, pe827, DOI 10.1542/peds.2011-3552; Shennan DB, 2000, PHYSIOL REV, V80, P925, DOI 10.1152/physrev.2000.80.3.925; Song BJ, 2013, NUTRITION, V29, P195, DOI 10.1016/j.nut.2012.07.015; Stam J, 2013, AM J CLIN NUTR, V98, p521S, DOI 10.3945/ajcn.112.044370; Updike AA, 2003, J AGR FOOD CHEM, V51, P6184, DOI 10.1021/jf030350f; Woo JG, 2013, J NUTR, V143, P166, DOI 10.3945/jn.112.163857	36	43	45	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0127729	10.1371/journal.pone.0127729	http://dx.doi.org/10.1371/journal.pone.0127729			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061885	Green Published, Green Submitted, gold			2022-12-26	WOS:000355979500053
J	Yap, JYS; Rohner, T; Greenfield, A; Van der Merwe, M; McPherson, H; Glenn, W; Kornfeld, G; Marendy, E; Pan, AYH; Wilton, A; Wilkins, MR; Rossetto, M; Delaney, SK				Yap, Jia-Yee S.; Rohner, Thore; Greenfield, Abigail; Van der Merwe, Marlien; McPherson, Hannah; Glenn, Wendy; Kornfeld, Geoff; Marendy, Elessa; Pan, Annie Y. H.; Wilton, Alan; Wilkins, Marc R.; Rossetto, Maurizio; Delaney, Sven K.			Complete Chloroplast Genome of the Wollemi Pine (Wollemia nobilis): Structure and Evolution	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; INVERTED REPEAT COPIES; NEW-ZEALAND; DETECTING MICROSATELLITES; AGATHIS ARAUCARIACEAE; PHYLOGENETIC ANALYSIS; TANDEM REPEATS; DNA-SEQUENCES; CODON USAGE; SEED PLANTS	The Wollemi pine (Wollemia nobilis) is a rare Southern conifer with striking morphological similarity to fossil pines. A small population of W. nobilis was discovered in 1994 in a remote canyon system in the Wollemi National Park (near Sydney, Australia). This population contains fewer than 100 individuals and is critically endangered. Previous genetic studies of the Wollemi pine have investigated its evolutionary relationship with other pines in the family Araucariaceae, and have suggested that the Wollemi pine genome contains little or no variation. However, these studies were performed prior to the widespread use of genome sequencing, and their conclusions were based on a limited fraction of the Wollemi pine genome. In this study, we address this problem by determining the entire sequence of the W. nobilis chloroplast genome. A detailed analysis of the structure of the genome is presented, and the evolution of the genome is inferred by comparison with the chloroplast sequences of other members of the Araucariaceae and the related family Podocarpaceae. Pairwise alignments of whole genome sequences, and the presence of unique pseudogenes, gene duplications and insertions in W. nobilis and Araucariaceae, indicate that the W. nobilis chloroplast genome is most similar to that of its sister taxon Agathis. However, the W. nobilis genome contains an unusually high number of repetitive sequences, and these could be used in future studies to investigate and conserve any remnant genetic diversity in the Wollemi pine.	[Yap, Jia-Yee S.; Greenfield, Abigail; Van der Merwe, Marlien; McPherson, Hannah; Rossetto, Maurizio] Natl Herbarium New South Wales, Sydney, NSW, Australia; [Yap, Jia-Yee S.; Greenfield, Abigail; Glenn, Wendy; Kornfeld, Geoff; Marendy, Elessa; Pan, Annie Y. H.; Wilton, Alan; Wilkins, Marc R.; Delaney, Sven K.] Univ New S Wales, Sch Biotechnol & Biomol Biosci, Kensington, NSW 2033, Australia; [Rohner, Thore] Hanze Univ Appl Sci, NL-9747 AS Groningen, Netherlands	University of New South Wales Sydney	Delaney, SK (corresponding author), Flinders Univ S Australia, Sch Med, Bedford Pk, SA 5042, Australia.	dela0118@flinders.edu.au		Delaney, Sven/0000-0003-1416-3014	Bioplatforms Australia; Ramaciotti Centre for Genomics (University of New South Wales); Royal Botanic Gardens and Domain Trust (Sydney); Faculty of Science, University of New South Wales	Bioplatforms Australia; Ramaciotti Centre for Genomics (University of New South Wales); Royal Botanic Gardens and Domain Trust (Sydney); Faculty of Science, University of New South Wales	Funding for this work was provided by a grant from Bioplatforms Australia (www.bioplatforms.com.au) to AW and SKD, the Ramaciotti Centre for Genomics (University of New South Wales) (www.ramaciotti.unsw.edu.au), the Royal Botanic Gardens and Domain Trust (Sydney) (www.rbgsyd.nsw.gov.au) and an Early Career Research Grant from the Faculty of Science, University of New South Wales to SKD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Biffin E, 2010, SYST BIOL, V59, P594, DOI 10.1093/sysbio/syq030; Blanca JM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-285; Burrows GE, 2007, ANN BOT-LONDON, V99, P609, DOI 10.1093/aob/mcm003; Burrows GE, 2003, ANN BOT-LONDON, V92, P835, DOI 10.1093/aob/mcg207; Chambers TC, 1998, INT J PLANT SCI, V159, P160, DOI 10.1086/297534; Chaw SM, 2005, MOL PHYLOGENET EVOL, V37, P214, DOI 10.1016/j.ympev.2005.01.006; Chevreux B, 2005, THESIS RUPRECHT KARL; Conran JG, 2000, AUST J BOT, V48, P715, DOI 10.1071/BT99062; Cosner ME, 1997, CURR GENET, V31, P419, DOI 10.1007/s002940050225; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; DOYLE JJ, 1995, SYST BOT, V20, P272, DOI 10.2307/2419496; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Echt CS, 1998, MOL ECOL, V7, P307, DOI 10.1046/j.1365-294X.1998.00350.x; Escapa IH, 2013, INT J PLANT SCI, V174, P1153, DOI 10.1086/672369; Fleischmann TT, 2011, PLANT CELL, V23, P3137, DOI 10.1105/tpc.111.088906; Gilmore S., 1997, Telopea, V7, P275; Hausner G, 2006, MOL BIOL EVOL, V23, P380, DOI 10.1093/molbev/msj047; Hill R.S., 1995, ECOLOGY SO CONIFERS; Hill RS, 2008, AUST SYST BOT, V21, P162, DOI 10.1071/SB08006; Hirao T, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-70; Do HDK, 2014, GENOME BIOL EVOL, V6, P1699, DOI 10.1093/gbe/evu138; Jansen RK, 2012, ADV PHOTOSYNTHESIS R, P103, DOI DOI 10.1007/978-94-007-2920-9_5; Jones W. G., 1995, Telopea, V6, P173; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kershaw P, 2001, ANNU REV ECOL SYST, V32, P397, DOI 10.1146/annurev.ecolsys.32.081501.114059; Kikuchi S, 2013, SCIENCE, V339, P571, DOI 10.1126/science.1229262; Knapp M, 2007, SYST BIOL, V56, P862, DOI 10.1080/10635150701636412; Kranitz ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110308; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Leclercq S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-125; Lee DE, 2007, NEW ZEAL J BOT, V45, P565, DOI 10.1080/00288250709509739; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li XW, 2015, BIOL REV, V90, P157, DOI 10.1111/brv.12104; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Macphail MK, 1995, GEOL TODAY, V11, P48; Mayer C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-277; McPherson H, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-8; Merkel A, 2008, EVOL BIOINFORM, V4, P1; Mogensen HL, 1996, AM J BOT, V83, P383, DOI 10.2307/2446172; Morton BR, 2003, J MOL EVOL, V56, P616, DOI 10.1007/s00239-002-2430-1; Peakall R, 2003, MOL ECOL, V12, P2331, DOI 10.1046/j.1365-294X.2003.01926.x; Pyke KA, 1999, PLANT CELL, V11, P549, DOI 10.1105/tpc.11.4.549; Quinn C. J., 2002, Kew Bulletin, V57, P513, DOI 10.2307/4110984; REBOUD X, 1994, HEREDITY, V72, P132, DOI 10.1038/hdy.1994.19; Rouwendal GJA, 1997, PLANT MOL BIOL, V33, P989, DOI 10.1023/A:1005740823703; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Steane DA, 2005, DNA RES, V12, P215, DOI 10.1093/dnares/dsi006; Stefanovic S, 1998, AM J BOT, V85, P688, DOI 10.2307/2446539; Stockler K, 2002, SYST BIOL, V51, P827, DOI 10.1080/10635150290102474; Sugiura C, 2004, PLANT J, V40, P314, DOI 10.1111/j.1365-313X.2004.02202.x; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Vieira LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090618; WAKASUGI T, 1994, P NATL ACAD SCI USA, V91, P9794, DOI 10.1073/pnas.91.21.9794; Wu CS, 2007, MOL BIOL EVOL, V24, P1366, DOI 10.1093/molbev/msm059; Wu CS, 2014, PLANT BIOTECHNOL J, V12, P344, DOI 10.1111/pbi.12141; Wu CS, 2011, GENOME BIOL EVOL, V3, P1284, DOI 10.1093/gbe/evr095; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yi X, 2013, GENOME BIOL EVOL, V5, P688, DOI 10.1093/gbe/evt042; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zonneveld BJM, 2012, PLANT SYST EVOL, V298, P1249, DOI 10.1007/s00606-012-0631-7	65	22	23	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0128126	10.1371/journal.pone.0128126	http://dx.doi.org/10.1371/journal.pone.0128126			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061691	Green Published, Green Submitted, gold			2022-12-26	WOS:000355979500075
J	Fedorenko, IV; Abel, EV; Koomen, JM; Fang, B; Wood, ER; Chen, YA; Fisher, KJ; Iyengar, S; Dahlman, KB; Wargo, JA; Flaherty, KT; Sosman, JA; Sondak, VK; Messina, JL; Gibney, GT; Smalley, KSM				Fedorenko, I. V.; Abel, E. V.; Koomen, J. M.; Fang, B.; Wood, E. R.; Chen, Y. A.; Fisher, K. J.; Iyengar, S.; Dahlman, K. B.; Wargo, J. A.; Flaherty, K. T.; Sosman, J. A.; Sondak, V. K.; Messina, J. L.; Gibney, G. T.; Smalley, K. S. M.			Fibronectin induction abrogates the BRAF inhibitor response of BRAF V600E/PTEN-null melanoma cells	ONCOGENE			English	Article							E-CADHERIN; EXTRACELLULAR-MATRIX; ADAPTIVE RESISTANCE; DRUG-RESISTANCE; RAF INHIBITORS; B-RAF; BRAF(V600E); ACTIVATION; GROWTH; PHOSPHORYLATION	The mechanisms by which some melanoma cells adapt to Serine/threonine-protein kinase B-Raf (BRAF) inhibitor therapy are incompletely understood. In the present study, we used mass spectrometry-based phosphoproteomics to determine how BRAF inhibition remodeled the signaling network of melanoma cell lines that were BRAF mutant and PTEN null. Short-term BRAF inhibition was associated with marked changes in fibronectin-based adhesion signaling that were PTEN dependent. These effects were recapitulated through BRAF siRNA knockdown and following treatment with chemotherapeutic drugs. Increased fibronectin expression was also observed in mouse xenograft models as well as specimens from melanoma patients undergoing BRAF inhibitor treatment. Analysis of a melanoma tissue microarray showed loss of PTEN expression to predict for a lower overall survival, with a trend for even lower survival being seen when loss of fibronectin was included in the analysis. Mechanistically, the induction of fibronectin limited the responses of these PTEN-null melanoma cell lines to vemurafenib, with enhanced cytotoxicity observed following the knockdown of either fibronectin or its receptor alpha(5)beta(1) integrin. This in turn abrogated the cytotoxic response to BRAF inhibition via increased AKT signaling, which prevented the induction of cell death by maintaining the expression of the pro-survival protein Mcl-1. The protection conveyed by the induction of FN expression could be overcome through combined treatment with a BRAF and PI3K inhibitor.	[Fedorenko, I. V.; Koomen, J. M.; Wood, E. R.; Smalley, K. S. M.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, 12902 Magnolia Dr, Tampa, FL 33612 USA; [Abel, E. V.] Thomas Jefferson Univ, Dept Canc Biol, Philadelphia, PA 19107 USA; [Fang, B.; Wood, E. R.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Prote, Tampa, FL 33612 USA; [Chen, Y. A.; Fisher, K. J.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat & Bioinformat, Tampa, FL 33612 USA; [Iyengar, S.; Sondak, V. K.; Messina, J. L.; Gibney, G. T.; Smalley, K. S. M.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Cutaneous Oncol, Tampa, FL 33612 USA; [Dahlman, K. B.; Sosman, J. A.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Wargo, J. A.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Flaherty, K. T.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Jefferson University; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Vanderbilt University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Smalley, KSM (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, 12902 Magnolia Dr, Tampa, FL 33612 USA.	keiran.smalley@moffitt.org	Smalley, Inna/AAR-8638-2021; Smalley, Inna/G-9016-2015	Smalley, Inna/0000-0002-6796-9145; Smalley, Inna/0000-0002-6796-9145; Smalley, Keiran/0000-0003-1089-9307; Chen, yian/0000-0003-1468-3490	National Institutes of Health [R01 CA161107]; NATIONAL CANCER INSTITUTE [P30CA076292, R01CA161107, P50CA168536] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Gideon Bollag (Plexxikon) for providing vemurafenib and the PLX4720 chow; Noel Clark, Ashley Troutman, Kelli Noyd, Jayme O'Neal and Holly Crandell for assistance with IHC staining; Marta Perez and Monica Torres for assistance with xenograft studies; Agnieszka Kasprazak and Joseph Johnson for assistance with microscopy; and Laura Hall for assistance with qRT-PCR. The work in the Smalley laboratory is supported by R01 CA161107 from the National Institutes of Health.	Abel EV, 2013, J CLIN INVEST, V123, P2155, DOI 10.1172/JCI65780; Boisvert-Adamo K, 2006, ONCOGENE, V25, P4848, DOI 10.1038/sj.onc.1209493; Boyd SC, 2013, J INVEST DERMATOL, V133, P1269, DOI 10.1038/jid.2012.421; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Domina AM, 2004, ONCOGENE, V23, P5301, DOI 10.1038/sj.onc.1207692; Fedorenko IV, 2011, BIOCHEM PHARMACOL, V82, P201, DOI 10.1016/j.bcp.2011.05.015; Girotti MR, 2013, CANCER DISCOV, V3, P158, DOI 10.1158/2159-8290.CD-12-0386; Gopal YNV, 2010, CANCER RES, V70, P8736, DOI 10.1158/0008-5472.CAN-10-0902; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Hsu MY, 2000, AM J PATHOL, V156, P1515, DOI 10.1016/S0002-9440(10)65023-7; Huang Q, 2011, NAT MED, V17, P860, DOI 10.1038/nm.2385; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; Li G, 2001, ONCOGENE, V20, P8125, DOI 10.1038/sj.onc.1205034; Li JN, 2010, NAT CHEM BIOL, V6, P291, DOI [10.1038/NCHEMBIO.332, 10.1038/nchembio.332]; Lito P, 2012, CANCER CELL, V22, P668, DOI 10.1016/j.ccr.2012.10.009; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; McArthur GA, 2014, LANCET ONCOL, V15, P323, DOI 10.1016/S1470-2045(14)70012-9; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Mulholland DJ, 2012, CANCER RES, V72, P1878, DOI 10.1158/0008-5472.CAN-11-3132; Muranen T, 2012, CANCER CELL, V21, P227, DOI 10.1016/j.ccr.2011.12.024; Muro AF, 2008, AM J RESP CRIT CARE, V177, P638, DOI 10.1164/rccm.200708-1291OC; Nathanson KL, 2013, CLIN CANCER RES, V19, P4868, DOI 10.1158/1078-0432.CCR-13-0827; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Old WM, 2009, MOL CELL, V34, P115, DOI 10.1016/j.molcel.2009.03.007; Paraiso KHT, 2011, CANCER RES, V71, P2750, DOI 10.1158/0008-5472.CAN-10-2954; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Remily-Wood ER, 2011, PROTEOM CLIN APPL, V5, P383, DOI 10.1002/prca.201000115; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sethi T, 1999, NAT MED, V5, P662, DOI 10.1038/9511; Sherman-Baust CA, 2003, CANCER CELL, V3, P377, DOI 10.1016/S1535-6108(03)00058-8; Solit DB, 2011, NEW ENGL J MED, V364, P772, DOI 10.1056/NEJMcibr1013704; Sondergaard JN, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-39; Song LB, 2009, J CLIN INVEST, V119, P3626, DOI 10.1172/JCI39374; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Sun C, 2014, NATURE, V508, P118, DOI 10.1038/nature13121; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Wang JM, 1999, MOL CELL BIOL, V19, P6195; White ES, 2006, AM J RESP CRIT CARE, V173, P112, DOI 10.1164/rccm.200507-1058OC; Xiang Y, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005520; Xing F, 2012, ONCOGENE, V31, P446, DOI 10.1038/onc.2011.250; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522	50	49	53	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 10	2016	35	10					1225	1235		10.1038/onc.2015.188	http://dx.doi.org/10.1038/onc.2015.188			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DG0NY	26073081	Green Accepted			2022-12-26	WOS:000371763100003
J	Benesch, MGK; Tang, XY; Dewald, J; Dong, WF; Mackey, JR; Hemmings, DG; McMullen, TPW; Brindley, DN				Benesch, Matthew G. K.; Tang, Xiaoyun; Dewald, Jay; Dong, Wei-Feng; Mackey, John R.; Hemmings, Denise G.; McMullen, Todd P. W.; Brindley, David N.			Tumor-induced inflammation in mammary adipose tissue stimulates a vicious cycle of autotaxin expression and breast cancer progression	FASEB JOURNAL			English	Article						chemokines; cytokines; lysophosphatidate; syngeneic mouse model; tumor stroma	LPA AXIS; IN-VIVO; RESISTANCE; LYSOPHOSPHATIDATE; DIFFERENTIATION; PROMOTES; INHIBITION; RECEPTOR; BINDING; OBESITY	Compared to normal tissues, many cancer cells overexpress autotaxin (ATX). This secreted enzyme produces extracellular lysophosphatidate, which signals through 6 GPCRs to drive cancer progression. Our previous work showed that ATX inhibition decreases 4T1 breast tumor growth in BALB/c mice by 60% for about 11 d. However, 4T1 cells do not produce significant ATX. Instead, the ATX is produced by adjacent mammary adipose tissue. We investigated the molecular basis of this interaction in human and mouse breast tumors. Inflammatory mediators secreted by breast cancer cells increased ATX production in adipose tissue. The increased lysophosphatidate signaling further increased inflammatory mediator production in adipose tissue and tumors. Blocking ATX activity in mice bearing 4T1 tumors with 10 mg/kg/d ONO-8430506 (a competitive ATX inhibitor, IC90 = 100 nM; Ono Pharma Co., Ltd., Osaka, Japan) broke this vicious inflammatory cycle by decreasing 20 inflammatory mediators by 1.5-8-fold in cancer-inflamed adipose tissue. There was no significant decrease in inflammatory mediator levels in fat pads that did not bear tumors. ONO-8430506 also decreased plasma TNF-alpha and G-CSF cytokine levels by >70% and leukocyte infiltration in breast tumors and adjacent adipose tissue by >50%. Hence, blocking tumor-driven inflammation by ATX inhibition is effective in decreasing tumor growth in breast cancers where the cancer cells express negligible ATX.	[Benesch, Matthew G. K.; Tang, Xiaoyun; Dewald, Jay; Brindley, David N.] Univ Alberta, Dept Biochem, Signal Transduct Res Grp, Edmonton, AB T6G 2S2, Canada; [Dong, Wei-Feng] Univ Alberta, Dept Lab Med, Edmonton, AB T6G 2S2, Canada; [Mackey, John R.] Univ Alberta, Dept Oncol, Edmonton, AB T6G 2S2, Canada; [Hemmings, Denise G.] Univ Alberta, Dept Obstet & Gynecol, Edmonton, AB T6G 2S2, Canada; [Hemmings, Denise G.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2S2, Canada; [McMullen, Todd P. W.] Univ Alberta, Dept Surg, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta	Brindley, DN (corresponding author), Univ Alberta, Dept Biochem, 357 Heritage Med Res Ctr, Edmonton, AB T6G 2S2, Canada.	david.brindley@ualberta.ca	Benesch, Matthew/GRF-0677-2022	Benesch, Matthew/0000-0002-1326-684X	Vanier Canada Graduate Scholarship (Government of Canada); Canadian Institutes of Health Research (CIHR); Alberta Innovates-Health Solutions; Killam Trust Award; Canadian Breast Cancer Foundation (CBCF); CBCF; Women and Children's Health Research Institute of the University of Alberta; Ono Pharma, Ltd.	Vanier Canada Graduate Scholarship (Government of Canada); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions; Killam Trust Award; Canadian Breast Cancer Foundation (CBCF); CBCF; Women and Children's Health Research Institute of the University of Alberta(University of Alberta); Ono Pharma, Ltd.	The authors thank the University of Alberta Department of Oncology Cell Imaging Facility and Alberta Diabetes Institute HistoCore for assistance. M.G.K.B. received a Vanier Canada Graduate Scholarship (Government of Canada), a Canadian Institutes of Health Research (CIHR) M.D./Ph.D. Studentship, an M.D./Ph.D. Studentship from Alberta Innovates-Health Solutions, and a Killam Trust Award. X.T. held a research fellowship from the Canadian Breast Cancer Foundation (CBCF). The work was supported by grants from CBCF and the Women and Children's Health Research Institute of the University of Alberta and by Ono Pharma, Ltd. D.N.B. and T.P.W.M. have received consulting fees from Ono Pharma, Ltd. The other authors declare no conflicts of interest.	Barber MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041456; Bekele RT, 2012, CLIN LIPIDOL, V7, P313, DOI 10.2217/CLP.12.30; Benesch MGK, 2015, ENDOCR-RELAT CANCER, V22, P593, DOI 10.1530/ERC-15-0045; Benesch MGK, 2015, J LIPID RES, V56, P1134, DOI 10.1194/jlr.M057661; Benesch MGK, 2014, FEBS LETT, V588, P2712, DOI 10.1016/j.febslet.2014.02.009; Benesch MGK, 2014, FASEB J, V28, P2655, DOI 10.1096/fj.13-248641; Bernardi M, 2014, J CLIN EXP HEPATOL, V4, P302, DOI 10.1016/j.jceh.2014.08.007; Boucher J, 2005, DIABETOLOGIA, V48, P569, DOI 10.1007/s00125-004-1660-8; Bourgoin SG, 2010, CURR OPIN INVEST DR, V11, P515; Brindley D. N., 2015, MELANOMA CURRENT CLI, P297, DOI [10.5772/59013, DOI 10.5772/59013]; Brindley DN, 2013, BBA-MOL CELL BIOL L, V1831, P74, DOI 10.1016/j.bbalip.2012.08.015; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; Britschgi A, 2012, CANCER CELL, V22, P796, DOI 10.1016/j.ccr.2012.10.023; Brown KA, 2014, J MAMMARY GLAND BIOL, V19, P183, DOI 10.1007/s10911-014-9321-0; Carswell KA, 2012, METHODS MOL BIOL, V806, P203, DOI 10.1007/978-1-61779-367-7_14; Chung AS, 2013, NAT MED, V19, P1114, DOI 10.1038/nm.3291; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; De Pergola G, 2013, J OBES, V2013, DOI 10.1155/2013/291546; Deng W, 2007, GASTROENTEROLOGY, V132, P1834, DOI 10.1053/j.gastro.2007.03.038; Dusaulcy R, 2011, J LIPID RES, V52, P1247, DOI 10.1194/jlr.M014985; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Euer N, 2002, ANTICANCER RES, V22, P733; Federico L, 2012, MOL ENDOCRINOL, V26, P786, DOI 10.1210/me.2011-1229; Ferry G, 2003, J BIOL CHEM, V278, P18162, DOI 10.1074/jbc.M301158200; Fulkerson Z, 2011, J BIOL CHEM, V286, P34654, DOI 10.1074/jbc.M111.276725; Gaetano CG, 2009, MOL CARCINOGEN, V48, P801, DOI 10.1002/mc.20524; Germain DR, 2011, BREAST CANCER RES TR, V127, P53, DOI 10.1007/s10549-010-0943-7; Gutschalk CM, 2006, CANCER RES, V66, P8026, DOI 10.1158/0008-5472.CAN-06-0158; HACKETT AJ, 1977, J NATL CANCER I, V58, P1795, DOI 10.1093/jnci/58.6.1795; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hausmann J, 2011, NAT STRUCT MOL BIOL, V18, P198, DOI 10.1038/nsmb.1980; Houben AJS, 2013, J BIOL CHEM, V288, P510, DOI 10.1074/jbc.M112.358416; Hozumi H, 2013, LAB INVEST, V93, P508, DOI 10.1038/labinvest.2013.45; Ikeda H, 2012, CLIN CHIM ACTA, V413, P1817, DOI 10.1016/j.cca.2012.07.014; Jankowski Maciej, 2011, Enzyme Res, V2011, P194857, DOI 10.4061/2011/194857; Kawalec P, 2015, CLIN BREAST CANCER, V15, P90, DOI 10.1016/j.clbc.2014.10.006; Kehlen A, 2004, INT J CANCER, V109, P833, DOI 10.1002/ijc.20022; Kishi Y, 2006, J BIOL CHEM, V281, P17492, DOI 10.1074/jbc.M601803200; Knowlden S, 2014, J IMMUNOL, V192, P851, DOI 10.4049/jimmunol.1302831; Lai SL, 2012, DEVELOPMENT, V139, P4439, DOI 10.1242/dev.081745; Lawlor KE, 2004, P NATL ACAD SCI USA, V101, P11398, DOI 10.1073/pnas.0404328101; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; MURATA J, 1994, J BIOL CHEM, V269, P30479; Nakanaga K, 2010, J BIOCHEM, V148, P13, DOI 10.1093/jb/mvq052; Nikitopoulou I, 2012, J EXP MED, V209, P923, DOI 10.1084/jem.20112012; Okudaira S, 2010, BIOCHIMIE, V92, P698, DOI 10.1016/j.biochi.2010.04.015; Popnikolov NK, 2012, TUMOR BIOL, V33, P2237, DOI 10.1007/s13277-012-0485-1; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Samadi N, 2009, ONCOGENE, V28, P1028, DOI 10.1038/onc.2008.442; Samadi N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020608; Samadi N, 2011, BIOCHIMIE, V93, P61, DOI 10.1016/j.biochi.2010.08.002; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sundaram Sneha, 2013, J Carcinog, V12, P19, DOI 10.4103/1477-3163.119606; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Tang N, 2014, J CELL MOL MED, V18, P156, DOI 10.1111/jcmm.12178; Teo K, 2014, BIOCHEM J, V463, P157, DOI 10.1042/BJ20140680; Turner MD, 2014, BBA-MOL CELL RES, V1843, P2563, DOI 10.1016/j.bbamcr.2014.05.014; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Venkatraman G, 2015, FASEB J, V29, P772, DOI 10.1096/fj.14-262659; Vidot S, 2010, CELL SIGNAL, V22, P926, DOI 10.1016/j.cellsig.2010.01.017; Yuelling LW, 2012, GLIA, V60, P1605, DOI 10.1002/glia.22381; Yung YC, 2014, J LIPID RES, V55, P1192, DOI 10.1194/jlr.R046458; Zhang JD, 2012, J PATHOL, V228, P241, DOI 10.1002/path.4069; Zhang RH, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-11; Zhao CQ, 2011, J LIPID RES, V52, P1307, DOI 10.1194/jlr.M008045	66	71	72	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3990	4000		10.1096/fj.15-274480	http://dx.doi.org/10.1096/fj.15-274480			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26071407				2022-12-26	WOS:000359915600033
J	Kuznetsova, E; Nocek, B; Brown, G; Makarova, KS; Flick, R; Wolf, YI; Khusnutdinova, A; Evdokimova, E; Jin, K; Tan, K; Hanson, AD; Hasnain, G; Zallot, R; de Crecy-Lagard, V; Babu, M; Savchenko, A; Joachimiak, A; Edwards, AM; Koonin, EV; Yakunin, AF				Kuznetsova, Ekaterina; Nocek, Boguslaw; Brown, Greg; Makarova, Kira S.; Flick, Robert; Wolf, Yuri I.; Khusnutdinova, Anna; Evdokimova, Elena; Jin, Ke; Tan, Kemin; Hanson, Andrew D.; Hasnain, Ghulam; Zallot, Remi; de Crecy-Lagard, Valerie; Babu, Mohan; Savchenko, Alexei; Joachimiak, Andrzej; Edwards, Aled M.; Koonin, Eugene V.; Yakunin, Alexander F.			Functional Diversity of Haloacid Dehalogenase Superfamily Phosphatases from Saccharomyces cerevisiae BIOCHEMICAL, STRUCTURAL, AND EVOLUTIONARY INSIGHTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE; ESCHERICHIA-COLI; GENE ENCODES; MITOCHONDRIAL PHOSPHATASE; ENZYME PROMISCUITY; ETHANOL-PRODUCTION; PROVIDE INSIGHT; BUDDING YEAST; ABASIC SITES; EYES ABSENT	The haloacid dehalogenase (HAD)-like enzymes comprise a large superfamily of phosphohydrolases present in all organisms. The Saccharomyces cerevisiae genome encodes at least 19 soluble HADs, including 10 uncharacterized proteins. Here, we biochemically characterized 13 yeast phosphatases from the HAD superfamily, which includes both specific and promiscuous enzymes active against various phosphorylated metabolites and peptides with several HADs implicated in detoxification of phosphorylated compounds and pseudouridine. The crystal structures of four yeast HADs provided insight into their active sites, whereas the structure of the YKR070W dimer in complex with substrate revealed a composite substrate-binding site. Although the S. cerevisiae and Escherichia coli HADs share low sequence similarities, the comparison of their substrate profiles revealed seven phosphatases with common preferred substrates. The cluster of secondary substrates supporting significant activity of both S. cerevisiae and E. coli HADs includes 28 common metabolites that appear to represent the pool of potential activities for the evolution of novel HAD phosphatases. Evolution of novel substrate specificities of HAD phosphatases shows no strict correlation with sequence divergence. Thus, evolution of the HAD superfamily combines the conservation of the overall substrate pool and the substrate profiles of some enzymes with remarkable biochemical and structural flexibility of other superfamily members.	[Edwards, Aled M.] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Nocek, Boguslaw; Tan, Kemin; Joachimiak, Andrzej; Edwards, Aled M.] Argonne Natl Lab, Midwest Ctr Struct Genom & Struct Biol Ctr, Biosci Div, Argonne, IL 60439 USA; [Brown, Greg; Flick, Robert; Khusnutdinova, Anna; Evdokimova, Elena; Savchenko, Alexei; Yakunin, Alexander F.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada; [Makarova, Kira S.; Wolf, Yuri I.; Koonin, Eugene V.] Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA; [Jin, Ke; Babu, Mohan] Univ Regina, Dept Biochem, Res & Innovat Ctr, Regina, SK S4S 0A2, Canada; [Hanson, Andrew D.; Hasnain, Ghulam; Zallot, Remi; de Crecy-Lagard, Valerie; Babu, Mohan] Univ Florida, Dept Hort Sci, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA	University of Toronto; Structural Genomics Consortium; United States Department of Energy (DOE); Argonne National Laboratory; University of Toronto; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University of Regina; State University System of Florida; University of Florida	Yakunin, AF (corresponding author), Univ Toronto, Dept Chem Engn & Appl Chem, 200 Coll St, Toronto, ON M5S 3E5, Canada.	a.iakounine@utoronto.ca	Khusnutdinova, Anna/AAU-8164-2020; Mohan, Babu P./I-7362-2019; Regan, Clinton/E-6250-2012; Zallot, Rémi/J-9645-2019; de Crecy-Lagard, Valerie/AAN-8995-2020; ZALLOT, Rémi/D-3933-2014	Zallot, Rémi/0000-0002-7317-1578; ZALLOT, Rémi/0000-0002-7317-1578; Joachimiak, Andrzej/0000-0003-2535-6209; Yakunin, Alexander/0000-0003-0813-6490; Edwards, Aled/0000-0002-4782-6016; Wolf, Yuri/0000-0002-0247-8708	National Institutes of Health [GM094585]; Government of Canada through Genome Canada; Ontario Genomics Institute; Ontario Research Fund [2009-OGI-ABC-1405, ORF-GL2-01-004]; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; U. S. National Science Foundation [IOS-1025398]; Direct For Biological Sciences [1025398, 1153413] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094585] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM000061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute; Ontario Research Fund; United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); U. S. National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported, in whole or in part, by National Institutes of Health Grant GM094585 (to A. J.). This work was also supported by the Government of Canada through Genome Canada, the Ontario Genomics Institute, and the Ontario Research Fund (Grants 2009-OGI-ABC-1405 and ORF-GL2-01-004 to A. F. Y.), by the United States Department of Energy, Office of Biological and Environmental Research, under Contract DE-AC02-06CH11357 (to A. J.), and by U. S. National Science Foundation Grant IOS-1025398 (to A. D. H.). The authors declare that they have no conflict of interest with the content of this article.	Allen KN, 2009, CURR OPIN STRUC BIOL, V19, P658, DOI 10.1016/j.sbi.2009.09.008; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Anton BP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001638; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P127, DOI 10.1016/S0968-0004(98)01189-X; Archambault J, 1998, J BIOL CHEM, V273, P27593, DOI 10.1074/jbc.273.42.27593; Binkowski TA, 2003, NUCLEIC ACIDS RES, V31, P3352, DOI 10.1093/nar/gkg512; Blaby-Haas CE, 2011, TRENDS BIOTECHNOL, V29, P174, DOI 10.1016/j.tibtech.2011.01.001; Bogan KL, 2009, J BIOL CHEM, V284, P34861, DOI 10.1074/jbc.M109.056689; Boiteux S, 2004, DNA REPAIR, V3, P1, DOI 10.1016/j.dnarep.2003.10.002; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Brenner SE, 1999, TRENDS GENET, V15, P132, DOI 10.1016/S0168-9525(99)01706-0; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; BUCALA R, 1985, P NATL ACAD SCI USA, V82, P8439, DOI 10.1073/pnas.82.24.8439; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; Carlile TM, 2014, NATURE, V515, P143, DOI 10.1038/nature13802; Charette M, 2000, IUBMB LIFE, V49, P341; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; Christendat D, 2000, NAT STRUCT BIOL, V7, P903; Costanzo MC, 2014, NUCLEIC ACIDS RES, V42, pD717, DOI 10.1093/nar/gkt1158; COWTAN KD, 1993, ACTA CRYSTALLOGR D, V49, P148, DOI 10.1107/S0907444992007698; Daiyasu H, 2002, PROTEIN ENG, V15, P987, DOI 10.1093/protein/15.12.987; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; FONDA ML, 1992, J BIOL CHEM, V267, P15978; Fortpied J, 2006, J BIOL CHEM, V281, P18378, DOI 10.1074/jbc.M513208200; Frishman D, 2007, CHEM REV, V107, P3448, DOI 10.1021/cr068303k; Fujitomi K, 2012, BIORESOURCE TECHNOL, V111, P161, DOI 10.1016/j.biortech.2012.01.161; Galperin MY, 2010, TRENDS BIOTECHNOL, V28, P398, DOI 10.1016/j.tibtech.2010.05.006; Galperin MY, 2000, NAT BIOTECHNOL, V18, P609, DOI 10.1038/76443; Galperin MY, 2004, NUCLEIC ACIDS RES, V32, P5452, DOI 10.1093/nar/gkh885; Gerlt JA, 2011, BIOCHEMISTRY-US, V50, P9950, DOI 10.1021/bi201312u; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; GOLDBERG IH, 1963, J BIOL CHEM, V238, P1793; Goyer A, 2013, BIOCHEM J, V454, P533, DOI 10.1042/BJ20130516; Graef M, 2013, MOL BIOL CELL, V24, P2918, DOI 10.1091/mbc.E13-07-0381; Green ML, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-76; Guldan H, 2008, BIOCHEMISTRY-US, V47, P7376, DOI 10.1021/bi8005779; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Hanson AD, 2010, BIOCHEM J, V425, P1, DOI 10.1042/BJ20091328; Heering HA, 1997, J AM CHEM SOC, V119, P11628, DOI 10.1021/ja9723242; Huang H, 2011, BIOCHEMISTRY-US, V50, P8937, DOI 10.1021/bi201181q; IRANI MH, 1977, J BACTERIOL, V132, P398, DOI 10.1128/JB.132.2.398-410.1977; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Itoh Roichi, 2003, BMC Biochem, V4, P4, DOI 10.1186/1471-2091-4-4; Jang YM, 2003, J BIOL CHEM, V278, P50040, DOI 10.1074/jbc.M309619200; Jiang LH, 2002, FEBS LETT, V527, P323, DOI 10.1016/S0014-5793(02)03247-7; Jurgenson CT, 2009, ANNU REV BIOCHEM, V78, P569, DOI 10.1146/annurev.biochem.78.072407.102340; KADNER RJ, 1992, J GEN MICROBIOL, V138, P2007, DOI 10.1099/00221287-138-10-2007; KAHAN FM, 1962, J BIOL CHEM, V237, P3778; KANEKO Y, 1989, MOL GEN GENET, V220, P133, DOI 10.1007/BF00260867; Karp PD, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-401; KEPES F, 1988, J BIOL CHEM, V263, P9155; Kestler C, 2014, J BIOL CHEM, V289, P3094, DOI 10.1074/jbc.M113.536482; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kim SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057048; Kim YC, 2004, J BIOL CHEM, V279, P517, DOI 10.1074/jbc.M306054200; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; Kneidinger B, 2002, J BACTERIOL, V184, P363, DOI 10.1128/JB.184.2.363-369.2002; Kobor MS, 1999, MOL CELL, V4, P55, DOI 10.1016/S1097-2765(00)80187-2; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; Kuznetsova E, 2005, FEMS MICROBIOL REV, V29, P263, DOI 10.1016/j.femsre.2004.12.006; Kuznetsova E, 2006, J BIOL CHEM, V281, P36149, DOI 10.1074/jbc.M605449200; Kuznetsova E, 2010, J BIOL CHEM, V285, P21049, DOI 10.1074/jbc.M110.118315; Lappalainen P, 1997, EMBO J, V16, P5520, DOI 10.1093/emboj/16.18.5520; Lebedev AA, 2008, ACTA CRYSTALLOGR D, V64, P33, DOI 10.1107/S0907444907049839; LEE AT, 1987, P NATL ACAD SCI USA, V84, P8311, DOI 10.1073/pnas.84.23.8311; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Lifshitz Z, 2014, INFECT IMMUN, V82, P3740, DOI 10.1128/IAI.01729-14; Lu G, 2007, GENE DEV, V21, P784, DOI 10.1101/gad.1499107; LUMENG L, 1975, J BIOL CHEM, V250, P8126; Lynch M, 2000, GENETICS, V154, P459; MELCHER K, 1992, CURR GENET, V21, P295, DOI 10.1007/BF00351686; Moffatt CE, 2012, CELL MICROBIOL, V14, P577, DOI 10.1111/j.1462-5822.2011.01743.x; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; Mukherjee T, 2011, BBA-PROTEINS PROTEOM, V1814, P1585, DOI 10.1016/j.bbapap.2011.06.018; Nakanishi T, 2002, J BIOL CHEM, V277, P22103, DOI 10.1074/jbc.M200573200; Nevoigt E, 1997, FEMS MICROBIOL REV, V21, P231, DOI 10.1111/j.1574-6976.1997.tb00352.x; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Nobeli I, 2003, J MOL BIOL, V334, P697, DOI 10.1016/j.jmb.2003.10.008; Norbeck J, 1996, J BIOL CHEM, V271, P13875, DOI 10.1074/jbc.271.23.13875; Norin M, 2002, TRENDS BIOTECHNOL, V20, P79, DOI 10.1016/S0167-7799(01)01884-4; Nosaka K, 2006, APPL MICROBIOL BIOT, V72, P30, DOI 10.1007/s00253-006-0464-9; Osman C, 2010, EMBO J, V29, P1976, DOI 10.1038/emboj.2010.98; Osterman A, 2003, CURR OPIN CHEM BIOL, V7, P238, DOI 10.1016/S1367-5931(03)00027-9; Otterlei M, 2000, EMBO J, V19, P5542, DOI 10.1093/emboj/19.20.5542; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pagliarini DJ, 2005, MOL CELL, V19, P197, DOI 10.1016/j.molcel.2005.06.008; Pahlman AK, 2001, J BIOL CHEM, V276, P3555, DOI 10.1074/jbc.M007164200; Pandya C, 2014, J BIOL CHEM, V289, P30229, DOI 10.1074/jbc.R114.572990; Papenfort K, 2013, CELL, V153, P426, DOI 10.1016/j.cell.2013.03.003; Pellicer MT, 2003, J BACTERIOL, V185, P5815, DOI 10.1128/JB.185.19.5815-5821.2003; Percudani R, 2003, EMBO REP, V4, P850, DOI 10.1038/sj.embor.embor914; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Preumont A, 2008, J BIOL CHEM, V283, P25238, DOI 10.1074/jbc.M804122200; Preumont A, 2010, BIOCHEM J, V431, P237, DOI 10.1042/BJ20100174; Rachel WA, 2004, THEOR POPUL BIOL, V66, P93, DOI 10.1016/j.tpb.2004.03.004; RANDEZGIL F, 1995, YEAST, V11, P1233, DOI 10.1002/yea.320111303; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; Reddy VS, 2008, J BIOL CHEM, V283, P8846, DOI 10.1074/jbc.M706752200; Rosenbaum G, 2006, J SYNCHROTRON RADIAT, V13, P30, DOI 10.1107/S0909049505036721; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; SCHRYVERS A, 1978, J BIOL CHEM, V253, P783; Seifried A, 2014, J BIOL CHEM, V289, P3416, DOI 10.1074/jbc.M113.503359; Selengut JD, 2001, BIOCHEMISTRY-US, V40, P12704, DOI 10.1021/bi011405e; Shi N, 2011, PROTEINS, V79, P1358, DOI 10.1002/prot.22969; Sorokina M, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-10; Su WM, 2014, J BIOL CHEM, V289, P34699, DOI 10.1074/jbc.M114.614883; Takeda K, 2009, P NATL ACAD SCI USA, V106, P12301, DOI 10.1073/pnas.0901823106; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tchigvintsev A, 2013, CHEM BIOL, V20, P1386, DOI 10.1016/j.chembiol.2013.09.011; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Theriot JA, 1997, J CELL BIOL, V136, P1165, DOI 10.1083/jcb.136.6.1165; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; Tremblay LW, 2006, BIOCHEMISTRY-US, V45, P1183, DOI 10.1021/bi051842j; Tuleva B, 1998, FEMS MICROBIOL LETT, V161, P139; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Van Vleet JH, 2008, METAB ENG, V10, P360, DOI 10.1016/j.ymben.2007.12.002; Vance JR, 2001, J BIOL CHEM, V276, P15073, DOI 10.1074/jbc.M011075200; VANDERCAMMEN A, 1989, EUR J BIOCHEM, V182, P613, DOI 10.1111/j.1432-1033.1989.tb14870.x; Wang WR, 2001, STRUCTURE, V9, P65, DOI 10.1016/S0969-2126(00)00558-X; Wilson WA, 2002, MOL CELL PROTEOMICS, V1, P232, DOI 10.1074/mcp.M100024-MCP200; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wu J, 2003, J BIOL CHEM, V278, P18117, DOI 10.1074/jbc.M301983200; Xu YF, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.21; Zhang RG, 2001, STRUCTURE, V9, P1095, DOI 10.1016/S0969-2126(01)00675-X	133	53	57	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18678	18698		10.1074/jbc.M115.657916	http://dx.doi.org/10.1074/jbc.M115.657916			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26071590	Green Published, hybrid			2022-12-26	WOS:000358512100037
J	Jaiswal, V; Gahlaut, V; Mathur, S; Agarwal, P; Khandelwal, MK; Khurana, JP; Tyagi, AK; Balyan, HS; Gupta, PK				Jaiswal, Vandana; Gahlaut, Vijay; Mathur, Saloni; Agarwal, Priyanka; Khandelwal, Manoj Kumar; Khurana, Jitendra Paul; Tyagi, Akhilesh Kumar; Balyan, Harindra Singh; Gupta, Pushpendra Kumar			Identification of Novel SNP in Promoter Sequence of TaGW2-6A Associated with Grain Weight and Other Agronomic Traits in Wheat (Triticum aestivum L.)	PLOS ONE			English	Article							QTL ANALYSIS; BREAD WHEAT; NATURAL VARIATION; PROTEIN-KINASE; GENETIC-MAP; KERNEL SIZE; MAJOR QTL; RICE; YIELD; WIDTH	TaGW2 is an orthologue of rice gene OsGW2, which encodes E3 RING ubiquitin ligase and controls the grain size in rice. In wheat, three copies of TaGW2 have been identified and mapped on wheat homoeologous group 6 viz. TaGW2-6A, TaGW2-6B and TaGW2-6D. In the present study, using as many as 207 Indian wheat genotypes, we identified four SNPs including two novel SNPs (SNP-988 and SNP-494) in the promoter sequence of TaGW2-6A. All the four SNPs were G/A or A/G substitutions (transitions). Out of the four SNPs, SNP-494 was causal, since it was found associated with grain weight. The mean TGW (41.1 g) of genotypes with the allele SNP-494_A was significantly higher than mean TGW (38.6 g) of genotypes with the allele SNP-494_G. SNP-494 also regulates the expression of TaGW2-6Aso that the wheat genotypes with SNP-494_G have higher expression and lower TGW and the genotypes with SNP-494_A have lower expression but higher TGW. Besides, SNP-494 was also found associated with grain length-width ratio, awn length, spike length, grain protein content, peduncle length and plant height. This suggested that gene TaGW2-6A not only controls grain size, but also controls other agronomic traits. In the promoter region, SNP-494 was present in 'CGCG' motif that plays an important role in Ca2+/calmodulin mediated regulation of genes. A user-friendly CAPS marker was also developed to identify the desirable allele of causal SNP (SNP-494) for use in marker-assisted selection for improvement of grain weight in wheat. Using four SNPs, five haplotypes were identified; of these, Hap_5 (G_A_G_A) was found to be a desirable haplotype having significantly higher grain weight (41.13g) relative to other four haplotypes (36.33-39.16 g).	[Jaiswal, Vandana; Gahlaut, Vijay; Agarwal, Priyanka; Balyan, Harindra Singh; Gupta, Pushpendra Kumar] Ch Charan Singh Univ, Dept Genet & Plant Breeding, Meerut, Uttar Pradesh, India; [Mathur, Saloni; Khurana, Jitendra Paul] Univ Delhi, Interdisciplinary Ctr Plant Genom, New Delhi, India; [Khandelwal, Manoj Kumar] Indian Agr Res Inst, New Delhi, India; [Khurana, Jitendra Paul] Univ Delhi, Dept Plant Mol Biol, New Delhi, India; [Tyagi, Akhilesh Kumar] Natl Inst Plant Genome Res, New Delhi, India	Chaudhary Charan Singh University; University of Delhi; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; University of Delhi; Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Gupta, PK (corresponding author), Ch Charan Singh Univ, Dept Genet & Plant Breeding, Meerut, Uttar Pradesh, India.	pkgupta36@gmail.com	Balyan, H./AAI-9077-2020; Gahlaut, Vijay/K-4904-2012	Gahlaut, Vijay/0000-0003-4381-3573; Jaiswal, Vandana/0000-0001-8620-7595	Department of Biotechnology, New Delhi; Department of Science Technology (Funds for Improvement of Science and Technology infrastructure program), New Delhi; University Grants Commission (Special Assistance Program-Departmental Research Support Program), New Delhi; NASI-Senior Scientist; SRF; CSIR	Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India); Department of Science Technology (Funds for Improvement of Science and Technology infrastructure program), New Delhi; University Grants Commission (Special Assistance Program-Departmental Research Support Program), New Delhi(University Grants Commission, India); NASI-Senior Scientist; SRF; CSIR(Council of Scientific & Industrial Research (CSIR) - India)	Thanks are due to the Department of Biotechnology, New Delhi, Department of Science Technology (Funds for Improvement of Science and Technology infrastructure program), New Delhi and University Grants Commission (Special Assistance Program-Departmental Research Support Program), New Delhi for support which facilitated this study. PKG was awarded the position of NASI-Senior Scientist, VG was awarded SRF under the same program. CSIR awarded SRF to VJ.	[Anonymous], 2014, OPEN J GENET, DOI DOI 10.4236/OJGEN.2014.43024; [Anonymous], RES B; Asano T, 2002, PLANT CELL, V14, P619, DOI 10.1105/tpc.010454; Bednarek J, 2012, J EXP BOT, V63, P5945, DOI 10.1093/jxb/ers249; Botwright TL, 2002, AUST J AGR RES, V53, P1137, DOI 10.1071/AR02007; Campos-Soriano L, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-90; Dholakia BB, 2003, PLANT BREEDING, V122, P392, DOI 10.1046/j.1439-0523.2003.00896.x; Dong LL, 2014, MOL BREEDING, V34, P937, DOI 10.1007/s11032-014-0087-2; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Gao ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042637; Groos C, 2003, THEOR APPL GENET, V106, P1032, DOI 10.1007/s00122-002-1111-1; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hong YT, 2014, FUNCT INTEGR GENOMIC, V14, P341, DOI 10.1007/s10142-014-0380-5; Huang XQ, 2006, THEOR APPL GENET, V113, P753, DOI 10.1007/s00122-006-0346-7; Ishimaru K, 2013, NAT GENET, V45, P707, DOI 10.1038/ng.2612; Kato K, 2000, THEOR APPL GENET, V101, P1114, DOI 10.1007/s001220051587; Kumar N, 2006, EUPHYTICA, V151, P135, DOI 10.1007/s10681-006-9133-4; Kunert A, 2007, THEOR APPL GENET, V115, P683, DOI 10.1007/s00122-007-0600-7; Li Q, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-143; Li SS, 2007, MOL BREEDING, V20, P167, DOI 10.1007/s11032-007-9080-3; Liu SK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-53; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maphosa L, 2014, THEOR APPL GENET, V127, P1607, DOI 10.1007/s00122-014-2322-y; MARSHALL DR, 1986, AUST J AGR RES, V37, P331, DOI 10.1071/AR9860331; Marza F, 2005, THEOR APPL GENET, V21, P1, DOI DOI 10.1007/S00122-005-0172-3; McCartney CA, 2005, GENOME, V48, P870, DOI 10.1139/g05-055; Mir RR, 2012, MOL BREEDING, V29, P963, DOI 10.1007/s11032-011-9693-4; Nie HZ, 2012, PLANT PHYSIOL, V158, P1847, DOI 10.1104/pp.111.192310; Peng JH, 2003, P NATL ACAD SCI USA, V100, P2489, DOI 10.1073/pnas.252763199; Quarrie SA, 2005, THEOR APPL GENET, V110, P865, DOI 10.1007/s00122-004-1902-7; Ramya P, 2010, J APPL GENET, V51, P421, DOI 10.1007/BF03208872; Roeder MIS, 2008, FUNCT INTEGR GENOMIC, V8, P79, DOI 10.1007/s10142-007-0053-8; Saghai-Maroof MA, 1984, P NATL ACAD SCI USA, V91, P5466, DOI DOI 10.1073/PNAS.91.12.5466; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Su ZQ, 2011, THEOR APPL GENET, V122, P211, DOI 10.1007/s00122-010-1437-z; Sun XY, 2009, EUPHYTICA, V165, P615, DOI 10.1007/s10681-008-9794-2; Teixeira LK, 2013, ANNU REV BIOCHEM, V82, P387, DOI 10.1146/annurev-biochem-060410-105307; Varshney RK, 2000, THEOR APPL GENET, V100, P1290, DOI 10.1007/s001220051437; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Weng JF, 2008, CELL RES, V18, P1199, DOI 10.1038/cr.2008.307; Wu QH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118144; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yang TB, 2002, J BIOL CHEM, V277, P45049, DOI 10.1074/jbc.M207941200; Yang ZB, 2012, THEOR APPL GENET, V125, P1057, DOI 10.1007/s00122-012-1895-6; Yue AQ, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0266-9; Zhang YJ, 2014, MOL BREEDING, V34, P1097, DOI 10.1007/s11032-014-0102-7	48	43	48	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129400	10.1371/journal.pone.0129400	http://dx.doi.org/10.1371/journal.pone.0129400			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076351	gold, Green Published, Green Submitted			2022-12-26	WOS:000356329900069
J	Cramer, RD				Cramer, Richard D.			Template CoMFA Generates Single 3D-QSAR Models that, for Twelve of Twelve Biological Targets, Predict All ChEMBL-Tabulated Affinities	PLOS ONE			English	Article							MOLECULAR SIMILARITY; DESIGN	The possible applicability of the new template CoMFA methodology to the prediction of unknown biological affinities was explored. For twelve selected targets, all ChEMBL binding affinities were used as training and/or prediction sets, making these 3D-QSAR models the most structurally diverse and among the largest ever. For six of the targets, X-ray crystallographic structures provided the aligned templates required as input (BACE, cdk1, chk2, carbonic anhydrase-II, factor Xa, PTP1B). For all targets including the other six (hERG, cyp3A4 binding, endocrine receptor, COX2, D2, and GABAa), six modeling protocols applied to only three familiar ligands provided six alternate sets of aligned templates. The statistical qualities of the six or seven models thus resulting for each individual target were remarkably similar. Also, perhaps unexpectedly, the standard deviations of the errors of cross-validation predictions accompanying model derivations were indistinguishable from the standard deviations of the errors of truly prospective predictions. These standard deviations of prediction ranged from 0.70 to 1.14 log units and averaged 0.89 (8x in concentration units) over the twelve targets, representing an average reduction of almost 50% in uncertainty, compared to the null hypothesis of "predicting" an unknown affinity to be the average of known affinities. These errors of prediction are similar to those from Tanimoto coefficients of fragment occurrence frequencies, the predominant approach to side effect prediction, which template CoMFA can augment by identifying additional active structural classes, by improving Tanimoto-only predictions, by yielding quantitative predictions of potency, and by providing interpretable guidance for avoiding or enhancing any specific target response.	Certara Corp, Discovery Div, Santa Fe, NM 87505 USA		Cramer, RD (corresponding author), Certara Corp, Discovery Div, Santa Fe, NM 87505 USA.	rdcramer3@gmail.com			Certara Corporation	Certara Corporation	This study was funded by Certara Corporation. Author Richard D. Cramer was employed by Certara Corporation during the course of the study. Certara owns the key technology "template CoMFA" and the following patents/patent applications: Method for Aligning Molecules in Three Dimensions Based upon Their Correspondence to an Exemplary Template Molecule for Use in Performing 3D QSAR Analyses" (Provisional patent US20150025871 A1). This does not alter the author's adherence to PLOS ONE policies on sharing data and materials.	[Anonymous], 1993, 3D QSAR DRUG DESIGN; Bender A, 2004, ORG BIOMOL CHEM, V2, P3204, DOI 10.1039/b409813g; Bender A, 2005, J CHEM INF MODEL, V45, P1369, DOI 10.1021/ci0500177; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; Boulesteix AL, 2007, BRIEF BIOINFORM, V8, P32, DOI 10.1093/bib/bb1016; Cherkasov A, 2014, J MED CHEM, V57, P4977, DOI 10.1021/jm4004285; Clark M, 1993, QUANT STRUCT-ACT REL, V1, P269; Clark RD, 2004, J COMPUT AID MOL DES, V18, P563, DOI 10.1007/s10822-004-4077-z; Cramer RD, 1996, J MED CHEM, V39, P3060, DOI 10.1021/jm960291f; Cramer RD, 2003, J MED CHEM, V46, P374, DOI 10.1021/jm020194o; CRAMER RD, 1988, J AM CHEM SOC, V110, P5959, DOI 10.1021/ja00226a005; Cramer RD, 2014, J CHEM INF MODEL, V54, P2147, DOI 10.1021/ci500230a; Cramer RD, 2014, J CHEM INF MODEL, V54, P660, DOI 10.1021/ci400696v; Cramer RD, 2011, J COMPUT AID MOL DES, V25, P197, DOI 10.1007/s10822-010-9403-z; Golbraikh A, 2002, J MOL GRAPH MODEL, V20, P269, DOI 10.1016/S1093-3263(01)00123-1; Hopkins AL, 2014, NAT REV DRUG DISCOV, V13, P105, DOI 10.1038/nrd4163; Jain AN, 2004, J MED CHEM, V47, P947, DOI 10.1021/jm030520f; Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h; Jilek RJ, 2004, J CHEM INF COMP SCI, V44, P1221, DOI 10.1021/ci049961d; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Lounkine E, 2012, NATURE, V486, P361, DOI 10.1038/nature11159; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Oprea TI, 2007, REV COMPUTATIONAL CH, V11; Rusinko A, 1988, CONCORD PROGRAM RAPI; Stouch TR, 2012, J COMPUT AID MOL DES, V26, P125, DOI 10.1007/s10822-012-9541-6; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n; Wendt B, 2014, J COMPUT AID MOL DES, V28, P803, DOI 10.1007/s10822-014-9761-z; Willett P, 2006, DRUG DISCOV TODAY, V11, P1046, DOI 10.1016/j.drudis.2006.10.005	29	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129307	10.1371/journal.pone.0129307	http://dx.doi.org/10.1371/journal.pone.0129307			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26065424	Green Submitted, Green Published, gold			2022-12-26	WOS:000356327000062
J	Khan, K; Agarwal, P; Shanware, A; Sane, VA				Khan, Kasim; Agarwal, Pallavi; Shanware, Arti; Sane, Vidhu Aniruddha			Heterologous Expression of Two Jatropha Aquaporins Imparts Drought and Salt Tolerance and Improves Seed Viability in Transgenic Arabidopsis thaliana	PLOS ONE			English	Article							WATER CHANNEL PROTEINS; MULTIFUNCTIONAL WATER; PLANT AQUAPORINS; OVER-EXPRESSION; MIP GENES; STRESS; MEMBRANE; RICE; PLASMA; PHOTOSYNTHESIS	Drought and high salinity are environmental conditions that cause adverse effects on the growth and productivity of crops. Aquaporins are small integral membrane proteins that belong to the family of the major intrinsic proteins (MIPs), with members in animals, plants and microbes, where they facilitate the transport of water and/or small neutral solutes thereby affecting water balance. In this study we characterized two aquaporin genes namely, plasma membrane intrinsic protein (PIP2; 7) and tonoplast intrinsic protein TIP1; 3 from Jatropha curcas that are localised to the plasma membrane and vacuole respectively. Transgenic Arabidopsis thaliana lines over-expressing JcPIP2; 7 and JcTIP1; 3 under a constitutive promoter show improved germination under high salt and mannitol compared to control seeds. These transgenic plants also show increased root length under abiotic stress conditions compared to wild type Col-0 plants. Transgenic lines exposed to drought conditions by withholding water for 20 days, were able to withstand water stress and attained normal growth after re-watering unlike control plants which could not survive. Transgenic lines also had better seed yield than control under salt stress. Importantly, seed viability of transgenic plants grown under high salt concentration was 35%-45% compared to less than 5% for control seeds obtained from plants growing under salt stress. The effect of JcPIP2; 7 and JcTIP1; 3 on improving germination and seed viability in drought and salinity make these important candidates for genetic manipulation of plants for growth in saline soils.	[Khan, Kasim; Agarwal, Pallavi; Sane, Vidhu Aniruddha] CSIR, Natl Bot Res Inst, Plant Gene Express Lab, Lucknow 226001, Uttar Pradesh, India; [Shanware, Arti] RTMNU, Rajiv Gandhi Biotechnol Ctr, Nagpur, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); Rashtrasant Tukadoji Maharaj Nagpur University	Sane, VA (corresponding author), CSIR, Natl Bot Res Inst, Plant Gene Express Lab, Lucknow 226001, Uttar Pradesh, India.	sanevidhu@rediffmail.com	Khan, Kasim/GXV-3268-2022; Sane, Vidhu/AAN-2524-2020; Khan, Kasim/ABA-1117-2021	Khan, Kasim/0000-0001-7336-2764; 	Department of Biotechnology, India	Department of Biotechnology, India(Department of Biotechnology (DBT) India)	Department of Biotechnology, India funded project.	AGRE P, 1992, CLIN RES, V40, P176; Alexandersson E, 2005, PLANT MOL BIOL, V59, P469, DOI 10.1007/s11103-005-0352-1; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AZAIZEH H, 1992, PLANT PHYSIOL, V99, P886, DOI 10.1104/pp.99.3.886; Boursiac Y, 2005, PLANT PHYSIOL, V139, P790, DOI 10.1104/pp.105.065029; Carvajal M, 1999, PHYSIOL PLANTARUM, V105, P95, DOI 10.1034/j.1399-3054.1999.105115.x; Chaves MM, 2002, ANN BOT-LONDON, V89, P907, DOI 10.1093/aob/mcf105; CHRISPEELS MJ, 1994, PLANT PHYSIOL, V105, P9, DOI 10.1104/pp.105.1.9; CHRISPEELS MJ, 1994, TRENDS BIOCHEM SCI, V19, P421, DOI 10.1016/0968-0004(94)90091-4; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cornic G, 2000, TRENDS PLANT SCI, V5, P187, DOI 10.1016/S1360-1385(00)01625-3; di Pietro M, 2013, MOL CELL PROTEOMICS, V12, P3886, DOI 10.1074/mcp.M113.028241; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; Fouquet R, 2008, PLANT CELL REP, V27, P1541, DOI 10.1007/s00299-008-0566-1; Gao YP, 1999, PLANT MOL BIOL, V40, P635, DOI 10.1023/A:1006212216876; Gao ZX, 2010, PLANT CELL PHYSIOL, V51, P767, DOI 10.1093/pcp/pcq036; Gomes D, 2009, BBA-BIOMEMBRANES, V1788, P1213, DOI 10.1016/j.bbamem.2009.03.009; Guo L, 2006, CELL RES, V16, P277, DOI 10.1038/sj.cr.7310035; Hachez C, 2006, BBA-BIOMEMBRANES, V1758, P1142, DOI 10.1016/j.bbamem.2006.02.017; Han GL, 2014, PLANT MOL BIOL, V86, P237, DOI 10.1007/s11103-014-0226-5; Ishikawa F, 2005, FEBS LETT, V579, P5814, DOI 10.1016/j.febslet.2005.09.076; Jang HY, 2013, J PLANT PHYSIOL, V170, P1028, DOI 10.1016/j.jplph.2013.03.001; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; Kaldenhoff R, 2008, PLANT CELL ENVIRON, V31, P658, DOI 10.1111/j.1365-3040.2008.01792.x; Katsuhara M, 2003, PLANT CELL PHYSIOL, V44, P1378, DOI 10.1093/pcp/pcg167; Krich HH, 2000, PLANT PHYSIOL, V123, P111; Laur J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111751; Lian HL, 2006, CELL RES, V16, P651, DOI 10.1038/sj.cr.7310068; Liu HY, 2007, CELL RES, V17, P638, DOI 10.1038/cr.2007.34; MAGGIO A, 1995, PLANT PHYSIOL, V109, P331, DOI 10.1104/pp.109.1.331; Maurel C, 1997, P NATL ACAD SCI USA, V94, P7103, DOI 10.1073/pnas.94.13.7103; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; Misra A, 2013, PHYTOCHEMISTRY, V96, P37, DOI 10.1016/j.phytochem.2013.09.020; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Park W, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-142; Peng YH, 2007, PLANTA, V226, P729, DOI 10.1007/s00425-007-0520-4; Qadir M, 2014, NAT RESOUR FORUM, V38, P282, DOI 10.1111/1477-8947.12054; Quigley F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2001-3-1-research0001; Sade N, 2009, NEW PHYTOL, V181, P651, DOI 10.1111/j.1469-8137.2008.02689.x; Sakurai J, 2005, PLANT CELL PHYSIOL, V46, P1568, DOI 10.1093/pcp/pci172; Sato S, 2011, DNA RES, V18, P65, DOI 10.1093/dnares/dsq030; Schaffner AR, 1998, PLANTA, V204, P131, DOI 10.1007/s004250050239; Singh RK, 2009, J PLANT BIOCHEM BIOT, V18, P77, DOI 10.1007/BF03263299; Smart LB, 2001, PLANT CELL PHYSIOL, V42, P686, DOI 10.1093/pcp/pce085; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tyerman SD, 2002, PLANT CELL ENVIRON, V25, P173, DOI 10.1046/j.0016-8025.2001.00791.x; Wang LL, 2014, PLANT CELL PHYSIOL, V55, P148, DOI 10.1093/pcp/pct166; Weigel D., 2002, ARABIDOPSIS LAB MANU; Zhou Y, 2007, PLANT CELL ENVIRON, V30, P1566, DOI 10.1111/j.1365-3040.2007.01732.x; Zhu CF, 2005, J EXP BOT, V56, P2971, DOI 10.1093/jxb/eri294	51	45	49	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128866	10.1371/journal.pone.0128866	http://dx.doi.org/10.1371/journal.pone.0128866			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26067295	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000032
J	Magalhaes, MF; Dibai, AV; Guirro, ECD; Girasol, CE; de Oliveira, AK; Dias, FRC; Guirro, RRDJ				Magalhaes, Marina Figueiredo; Dibai-Filho, Almir Vieira; de Oliveira Guirro, Elaine Caldeira; Girasol, Carlos Eduardo; de Oliveira, Alessandra Kelly; Cancio Dias, Fabiana Rodrigues; de Jesus Guirro, Rinaldo Roberto			Evolution of Skin Temperature after the Application of Compressive Forces on Tendon, Muscle and Myofascial Trigger Point	PLOS ONE			English	Article							UPPER TRAPEZIUS MUSCLE; INFRARED IMAGE-ANALYSIS; LOW-BACK-PAIN; TEMPOROMANDIBULAR DISORDER; INTERRATER RELIABILITY; CUTANEOUS TEMPERATURE; MASTICATORY MUSCLES; THERMOGRAPHY; DIAGNOSIS; MASSAGE	Some assessment and diagnosis methods require palpation or the application of certain forces on the skin, which affects the structures beneath, we highlight the importance of defining possible influences on skin temperature as a result of this physical contact. Thus, the aim of the present study is to determine the ideal time for performing thermographic examination after palpation based on the assessment of skin temperature evolution. Randomized and crossover study carried out with 15 computer-user volunteers of both genders, between 18 and 45 years of age, who were submitted to compressive forces of 0, 1, 2 and 3 kg/cm(2) for 30 seconds with a washout period of 48 hours using a portable digital dynamometer. Compressive forces were applied on the following spots on the dominant upper limb: myofascial trigger point in the levator scapulae, biceps brachii muscle and palmaris longus tendon. Volunteers were examined by means of infrared thermography before and after the application of compressive forces (15, 30, 45 and 60 minutes). In most comparisons made over time, a significant decrease was observed 30, 45 and 60 minutes after the application of compressive forces (p < 0.05) on the palmaris longus tendon and biceps brachii muscle. However, no difference was observed when comparing the different compressive forces (p > 0.05). In conclusion, infrared thermography can be used after assessment or diagnosis methods focused on the application of forces on tendons and muscles, provided the procedure is performed 15 minutes after contact with the skin. Regarding to the myofascial trigger point, the thermographic examination can be performed within 60 minutes after the contact with the skin.	[Magalhaes, Marina Figueiredo; Dibai-Filho, Almir Vieira; de Oliveira Guirro, Elaine Caldeira; Girasol, Carlos Eduardo; de Oliveira, Alessandra Kelly; Cancio Dias, Fabiana Rodrigues; de Jesus Guirro, Rinaldo Roberto] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Biomech Med & Rehabil Locomotor Apparatus, Postgrad Program Rehabil & Funct Performance, BR-14049 Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo	Guirro, RRDJ (corresponding author), Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Biomech Med & Rehabil Locomotor Apparatus, Postgrad Program Rehabil & Funct Performance, BR-14049 Ribeirao Preto, SP, Brazil.	rguirro@fmrp.usp.br	Guirro, Elaine CO/C-3107-2015; Girasol, Carlos Eduardo/L-6628-2018; Dibai Filho, Almir Vieira/B-3871-2013; Guirro, Rinaldo R J/B-5134-2013	Girasol, Carlos Eduardo/0000-0002-3901-582X; Dibai Filho, Almir Vieira/0000-0001-5403-8248; Guirro, Rinaldo R J/0000-0001-7491-3388	Sao Paulo Research Foundation (FAPESP) [2013/07732-7, 2013/19368-8, 2013/09753-1]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Sao Paulo Research Foundation (FAPESP, grants 2013/07732-7, 2013/19368-8 and 2013/09753-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balbinot LF, 2012, CLINICS, V67, P1419, DOI 10.6061/clinics/2012(12)12; Marins JCB, 2014, INFRARED PHYS TECHN, V65, P30, DOI 10.1016/j.infrared.2014.02.008; Marins JCB, 2014, J THERM BIOL, V42, P1, DOI 10.1016/j.jtherbio.2014.02.020; Bron C, 2012, CURR PAIN HEADACHE R, V16, P439, DOI 10.1007/s11916-012-0289-4; Costa ACS, 2013, REV BRAS FISIOTER, V17, P24, DOI 10.1590/S1413-35552012005000058; Dibai AV, 2013, J MANIP PHYSIOL THER, V36, P245, DOI 10.1016/j.jmpt.2013.04.007; Dibai AV, 2012, J MANIP PHYSIOL THER, V35, P413, DOI 10.1016/j.jmpt.2012.04.006; Dibai AV, 2015, BRAZ J PHYS THER, V19, P122, DOI 10.1590/bjpt-rbf.2014.0076; Dibai AV, 2015, J MANIP PHYSIOL THER, V38, P86, DOI 10.1016/j.jmpt.2014.10.010; Fernandez-de-las-Penas C, 2012, CLIN J PAIN, V28, P511, DOI 10.1097/AJP.0b013e31823984e2; Gerwin RD, 1997, PAIN, V69, P65, DOI 10.1016/S0304-3959(96)03248-4; Haddad DS, 2012, DENTOMAXILLOFAC RAD, V41, P621, DOI 10.1259/dmfr/98504520; Holey LA, 2011, J MANIP PHYSIOL THER, V34, P457, DOI 10.1016/j.jmpt.2011.05.012; Lahiri BB, 2012, INFRARED PHYS TECHN, V55, P221, DOI 10.1016/j.infrared.2012.03.007; Miller JM, 2012, INT J SPORTS PHYS TH, V7, P167; Oliveira-Campelo NM, 2013, J MANIP PHYSIOL THER, V36, P300, DOI 10.1016/j.jmpt.2013.04.008; Park JW, 2012, INT J ORAL MAX SURG, V41, P103, DOI 10.1016/j.ijom.2011.09.010; Reiman MP, 2013, J ORTHOP SPORT PHYS, V43, P222, DOI 10.2519/jospt.2013.4343; Ring EFJ, 2012, PHYSIOL MEAS, V33, pR33, DOI 10.1088/0967-3334/33/3/R33; Rodrigues-Bigaton D, 2013, J MANIP PHYSIOL THER, V36, P253, DOI 10.1016/j.jmpt.2013.04.006; Roy A, 2006, J MANIP PHYSIOL THER, V29; Roy RA, 2008, J MANIP PHYSIOL THER, V31, P230, DOI 10.1016/j.jmpt.2008.02.006; Roy RA, 2013, J MANIP PHYSIOL THER, V36, P44, DOI 10.1016/j.jmpt.2012.12.002; Roy RA, 2010, J MANIP PHYSIOL THER, V33, P238, DOI 10.1016/j.jmpt.2010.01.008; Sefton JM, 2010, J ALTERN COMPLEM MED, V16, P723, DOI 10.1089/acm.2009.0441; Shah JP, 2008, ARCH PHYS MED REHAB, V89, P16, DOI 10.1016/j.apmr.2007.10.018; Simons DG, 1999, MYOFASCIAL PAIN DYSF, V1, P2, DOI DOI 10.1097/00008506-200101000-00026; Szentkuti A, 2011, PERIOD BIOL, V113, P385; Wishart GC, 2010, EJSO-EUR J SURG ONC, V36, P535, DOI 10.1016/j.ejso.2010.04.003; Zaproudina N, 2006, J MANIP PHYSIOL THER, V29, P219, DOI 10.1016/j.jmpt.2006.01.003	30	21	21	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129034	10.1371/journal.pone.0129034	http://dx.doi.org/10.1371/journal.pone.0129034			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070073	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000038
J	Punt, S; Thijssen, VL; Vrolijk, J; de Kroon, CD; Gorter, A; Jordanova, ES				Punt, Simone; Thijssen, Victor L.; Vrolijk, Johannes; de Kroon, Cornelis D.; Gorter, Arko; Jordanova, Ekaterina S.			Galectin-1,-3 and-9 Expression and Clinical Significance in Squamous Cervical Cancer	PLOS ONE			English	Article							TUMOR PROGRESSION; PROGNOSTIC-FACTOR; BIOLOGY; ANGIOGENESIS; CARCINOMA; TARGET	Galectins are proteins that bind beta-galactoside sugars and provide a new type of potential biomarkers and therapeutic targets in cancer. Galectin-1, -3 and -9 have become the focus of different research groups, but their expression and function in cervical cancer is still unclear. The aim of this study was to determine the phenotype of galectin-1, -3 and -9 expressing cells and the association with clinico-pathological parameters in cervical cancer. Galectin expression was scored in tumor cells, tumor epithelium infiltrating immune cells and stromal cells in squamous cervical cancer (n = 160). Correlations with clinico-pathological parameters and survival were studied according to the REMARK recommendations. We additionally investigated whether the galectins were expressed by tumor cells, fibroblasts, macrophages and T cells. Galectin-1 and -9 were both expressed by tumor cells in 11% of samples, while 84% expressed galectin-3. Strong galectin-1 expression by tumor cells was an independent predictor for poor survival (hazard ratio: 8.02, p = 0.001) and correlated with increased tumor invasion (p = 0.032) and receiving post-operative radiotherapy (p = 0.020). Weak and positive tumor cell galectin-3 expression were correlated with increased and decreased tumor invasion, respectively (p = 0.012). Tumor cell expression of galectin-9 showed a trend toward improved survival (p = 0.087). The predominant immune cell type expressing galectin-1, -3 and -9 were CD163(+) macrophages. Galectin-1 and -3 were expressed by a minor population of T cells. Galectin-1 was mainly expressed by fibroblasts in the tumor stroma. To conclude, while tumor cell expression of galectin-9 seemed to represent a beneficial response, galectin-1 expression might be used as a marker for a more aggressive anti-cancer treatment.	[Punt, Simone; Gorter, Arko; Jordanova, Ekaterina S.] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; [Thijssen, Victor L.] Vrije Univ Amsterdam, Med Ctr, Dept Med Oncol, Angiogenesis Lab, Amsterdam, Netherlands; [Vrolijk, Johannes] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands; [de Kroon, Cornelis D.] Leiden Univ, Med Ctr, Dept Gynecol, Leiden, Netherlands; [Jordanova, Ekaterina S.] Vrije Univ Amsterdam, Med Ctr, Ctr Gynecol Oncol Amsterdam, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam	Jordanova, ES (corresponding author), Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands.	E.S.Jordanova@lumc.nl	Thijssen, Victor LJL/B-2792-2009	Thijssen, Victor LJL/0000-0002-6146-1842; Jordanova, Ekaterina S./0000-0002-8121-1322; Punt, Simone/0000-0002-6675-728X	Dutch Cancer Society [UL2010-4801, VU2009-4358]	Dutch Cancer Society(KWF Kankerbestrijding)	The Dutch Cancer Society (http://www.kwf.nl) financially supported SP (grant UL2010-4801) and VLT (grant VU2009-4358). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001216; Balan Vitaly, 2010, Cancers (Basel), V2, P592, DOI 10.3390/cancers2020592; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Compagno D, 2014, GLYCOBIOLOGY, V24, P899, DOI 10.1093/glycob/cwu055; Dalotto-Moreno T, 2013, CANCER RES, V73, P1107, DOI 10.1158/0008-5472.CAN-12-2418; Fortuna-Costa A, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00138; Fu H, 2015, TUMOUR BIOL; Heusschen R, 2014, BBA-MOL BASIS DIS, V1842, P284, DOI 10.1016/j.bbadis.2013.12.003; Heusschen R, 2013, BBA-REV CANCER, V1836, P177, DOI 10.1016/j.bbcan.2013.04.006; Hirashima M, 2002, GLYCOCONJUGATE J, V19, P593, DOI 10.1023/B:GLYC.0000014090.63206.2f; Huang EY, 2013, INT J RADIAT ONCOL, V87, P975, DOI 10.1016/j.ijrobp.2013.08.037; Irie A, 2005, CLIN CANCER RES, V11, P2962, DOI 10.1158/1078-0432.CCR-04-0861; Jung EJ, 2007, INT J CANCER, V120, P2331, DOI 10.1002/ijc.22434; Kageshita T, 2002, INT J CANCER, V99, P809, DOI 10.1002/ijc.10436; Katoh S, 2014, TOHOKU J EXP MED, V232, P263, DOI 10.1620/tjem.232.263; Kim HJ, 2013, HUM PATHOL, V44, P62, DOI 10.1016/j.humpath.2012.04.010; Kim HJ, 2012, EUR J CANCER, V48, P1914, DOI 10.1016/j.ejca.2012.02.005; Kohrenhagen N, 2006, INT J GYNECOL CANCER, V16, P2018, DOI 10.1111/j.1525-1438.2006.00741.x; Laderach DJ, 2013, CANCER RES, V73, P86, DOI 10.1158/0008-5472.CAN-12-1260; Le QT, 2005, J CLIN ONCOL, V23, P8932, DOI 10.1200/JCO.2005.02.0206; Lee JW, 2006, J CANCER RES CLIN, V132, P241, DOI 10.1007/s00432-005-0069-1; Liang M, 2008, J CANCER RES CLIN, V134, P899, DOI 10.1007/s00432-008-0352-z; Markowska AI, 2010, J EXP MED, V207, P1981, DOI 10.1084/jem.20090121; McSharry BP, 2014, J VIROL, V88, P10990, DOI 10.1128/JVI.01259-14; Miranda FA, 2009, J HISTOCHEM CYTOCHEM, V57, P665, DOI 10.1369/jhc.2009.952960; Novak R, 2012, BBA-GEN SUBJECTS, V1820, P1383, DOI 10.1016/j.bbagen.2011.11.014; Ochieng J, 2002, GLYCOCONJUGATE J, V19, P527, DOI 10.1023/B:GLYC.0000014082.99675.2f; Punt S, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.984539; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; Righi A, 2013, HUM PATHOL, V44, P2400, DOI 10.1016/j.humpath.2013.05.020; Rubinstein N, 2004, CANCER CELL, V5, P241, DOI 10.1016/S1535-6108(04)00024-8; Ruiter DJ, 1998, EUR J CANCER, V34, P1334, DOI 10.1016/S0959-8049(98)00151-8; Schulkens IA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107988; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Tandon R, 2014, AIDS RES HUM RETROV, V30, P654, DOI [10.1089/aid.2014.0004, 10.1089/AID.2014.0004]; Thijssen VL, 2015, BBA-REV CANCER, V1855, P235, DOI 10.1016/j.bbcan.2015.03.003; Thijssen VL, 2013, CYTOKINE GROWTH F R, V24, P547, DOI 10.1016/j.cytogfr.2013.07.003; Thijssen VLJL, 2006, P NATL ACAD SCI USA, V103, P15975, DOI 10.1073/pnas.0603883103; Van Vlierberghe RLP, 2005, MICROSC RES TECHNIQ, V67, P15, DOI 10.1002/jemt.20181; Veschi V, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.68; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Zhang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103482; Zhou X, 2014, ONCOTARGET; Zhou XS, 2014, GENE, V546, P403, DOI 10.1016/j.gene.2014.04.066	46	42	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129119	10.1371/journal.pone.0129119	http://dx.doi.org/10.1371/journal.pone.0129119			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066796	gold, Green Published, Green Submitted			2022-12-26	WOS:000356327000048
J	Stoy, PC; Quaife, T				Stoy, Paul C.; Quaife, Tristan			Probabilistic Downscaling of Remote Sensing Data with Applications for Multi-Scale Biogeochemical Flux Modeling	PLOS ONE			English	Article							LEAF-AREA INDEX; MAXIMUM-ENTROPY PRODUCTION; OPTIMUM PIXEL SIZE; ECOSYSTEM FUNCTION; ARCTIC LANDSCAPE; CO2 FLUX; VEGETATION; INFORMATION; MICROTOPOGRAPHY; PHOTOSYNTHESIS	Upscaling ecological information to larger scales in space and downscaling remote sensing observations or model simulations to finer scales remain grand challenges in Earth system science. Downscaling often involves inferring subgrid information from coarse-scale data, and such ill-posed problems are classically addressed using regularization. Here, we apply two-dimensional Tikhonov Regularization (2DTR) to simulate subgrid surface patterns for ecological applications. Specifically, we test the ability of 2DTR to simulate the spatial statistics of high-resolution (4 m) remote sensing observations of the normalized difference vegetation index (NDVI) in a tundra landscape. We find that the 2DTR approach as applied here can capture the major mode of spatial variability of the high-resolution information, but not multiple modes of spatial variability, and that the Lagrange multiplier (.) used to impose the condition of smoothness across space is related to the range of the experimental semivariogram. We used observed and 2DTR-simulated maps of NDVI to estimate landscape-level leaf area index (LAI) and gross primary productivity (GPP). NDVI maps simulated using a. value that approximates the range of observed NDVI result in a landscape-level GPP estimate that differs by ca 2% from those created using observed NDVI. Following findings that GPP per unit LAI is lower near vegetation patch edges, we simulated vegetation patch edges using multiple approaches and found that simulated GPP declined by up to 12% as a result. 2DTR can generate random landscapes rapidly and can be applied to disaggregate ecological information and compare of spatial observations against simulated landscapes.	[Stoy, Paul C.] Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA; [Quaife, Tristan] Univ Reading, Dept Meteorol, Reading, Berks, England	Montana State University System; Montana State University Bozeman; University of Reading	Stoy, PC (corresponding author), Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA.	paul.stoy@montana.edu	Stoy, Paul/D-3709-2011; Quaife, Tristan L/C-1355-2008	Stoy, Paul/0000-0002-6053-6232; Quaife, Tristan L/0000-0001-6896-4613	National Science Foundation [1021095, 1241881]; Marie Curie Incoming International Fellowship programme; Montana State University; Natural Environment Research Council [ARSF 03/17]; Brian Huntley; USDA National Institute of Food and Agriculture, Hatch project [228396]; UK National Centre for Earth Observation; NERC [nceo020004] Funding Source: UKRI; Direct For Biological Sciences [1241881] Funding Source: National Science Foundation; Emerging Frontiers [1241810, 1241860] Funding Source: National Science Foundation; Natural Environment Research Council [nceo020004] Funding Source: researchfish	National Science Foundation(National Science Foundation (NSF)); Marie Curie Incoming International Fellowship programme; Montana State University; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Brian Huntley; USDA National Institute of Food and Agriculture, Hatch project; UK National Centre for Earth Observation; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors acknowledge funding from the National Science Foundation (Scaling ecosystem function: Novel Approaches from MaxEnt and Multiresolution', DBI #1021095 and Collaborative Research: Building Forest Management into Earth System Modeling: Scaling from Stand to Continent, EF #1241881), the Marie Curie Incoming International Fellowship programme, Montana State University, and the Natural Environment Research Council, grant number ARSF 03/17 for the ASRF flight that carried the ATM sensor, as well as Brian Huntley for financial support of this mission. This work was supported by the USDA National Institute of Food and Agriculture, Hatch project 228396. Quaife is supported by the UK National Centre for Earth Observation.	Aleina FC, 2013, EARTH SYST DYNAM, V4, P187, DOI 10.5194/esd-4-187-2013; Anderson MC, 2003, AGRON J, V95, P1408, DOI 10.2134/agronj2003.1408; Asner GP, 2003, GLOBAL ECOL BIOGEOGR, V12, P191, DOI 10.1046/j.1466-822X.2003.00026.x; BUBIER J, 1993, CAN J BOT, V71, P1056, DOI 10.1139/b93-122; Chapin FS, 2005, SCIENCE, V310, P657, DOI 10.1126/science.1117368; CHEN JQ, 1992, ECOL APPL, V2, P387, DOI 10.2307/1941873; Datcu M, 1998, IEEE T GEOSCI REMOTE, V36, P1431, DOI 10.1109/36.718847; Dewar RC, 2005, UND COM SYS, P41; Dewar RC, 2008, J THEOR BIOL, V251, P389, DOI 10.1016/j.jtbi.2007.12.007; Dudik M, 2007, J MACH LEARN RES, V8, P1217; Fletcher BJ, 2012, J ECOL, V100, P441, DOI 10.1111/j.1365-2745.2011.01913.x; Fletcher BJ, 2010, OECOLOGIA, V163, P47, DOI 10.1007/s00442-009-1532-5; Fox AM, 2008, J GEOPHYS RES, V22; Gallagher M, 2006, IEEE T EVOLUT COMPUT, V10, P590, DOI 10.1109/TEVC.2005.863628; Gardner RH, 1987, LANDSCAPE ECOL, V1, P19, DOI 10.1007/BF02275262; GULL SF, 1984, IEE PROC-F, V131, P646, DOI 10.1049/ip-f-1.1984.0099; Hargitai H, 2014, ICE WEDGE POLYGON EN, P1, DOI [10.1007/978-1-4614-9213-9_193-1, DOI 10.1007/978-1-4614-9213-9_193-1]; Hargrove WW, 2002, CONSERV ECOL, V6; Harte J, 2008, ECOLOGY, V89, P2700, DOI 10.1890/07-1369.1; Harte J, 2009, ECOL LETT, V12, P789, DOI 10.1111/j.1461-0248.2009.01328.x; Hiebeler D, 2000, ECOLOGY, V81, P1629, DOI 10.1890/0012-9658(2000)081[1629:POFLWS]2.0.CO;2; JARVIS PG, 1995, PLANT CELL ENVIRON, V18, P1079, DOI 10.1111/j.1365-3040.1995.tb00620.x; Johnston CE, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/8/085004; Jupp TE, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007343; Kleidon A, 2009, NATURWISSENSCHAFTEN, V96, P653, DOI 10.1007/s00114-009-0509-x; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Kullback S., 1997, INFORM THEORY STAT; Kumar S, 2009, FRONT ECOL ENVIRON, V7, P415, DOI 10.1890/080054; Kustas WP, 2000, REMOTE SENS ENVIRON, V74, P327, DOI 10.1016/S0034-4257(99)00081-4; Lipson DA, 2012, BIOGEOSCIENCES, V9, P577, DOI 10.5194/bg-9-577-2012; MALCOLM JR, 1994, ECOLOGY, V75, P2438, DOI 10.2307/1940897; McGuire AD, 2009, ECOL MONOGR, V79, P523, DOI 10.1890/08-2025.1; MEJIA JM, 1974, WATER RESOUR RES, V10, P705, DOI 10.1029/WR010i004p00705; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Muster S, 2012, TELLUS B, V64, DOI 10.3402/tellusb.v64i0.17301; ONEILL RV, 1992, LANDSCAPE ECOL, V7, P55, DOI 10.1007/BF02573957; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Quaife T, 2010, IEEE T GEOSCI REMOTE, V48, P2445, DOI 10.1109/TGRS.2009.2038901; Rahman AF, 2003, REMOTE SENS ENVIRON, V84, P192, DOI 10.1016/S0034-4257(02)00107-4; RASTETTER EB, 1992, ECOL APPL, V2, P55, DOI 10.2307/1941889; Raynolds MK, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000512; Reza F. M., 1994, INTRO INFORM THEORY; Ruel JJ, 1999, TRENDS ECOL EVOL, V14, P361, DOI 10.1016/S0169-5347(99)01664-X; Saatchi S, 2008, REMOTE SENS ENVIRON, V112, P2000, DOI 10.1016/j.rse.2008.01.008; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Shaver GR, 2007, J ECOL, V95, P802, DOI 10.1111/j.1365-2745.2007.01259.x; Shaver GR, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0485; SKILLING J, 1984, MON NOT R ASTRON SOC, V211, P111, DOI 10.1093/mnras/211.1.111; Skurikhin AN, 2013, REMOTE SENS LETT, V4, P1077, DOI 10.1080/2150704X.2013.840404; Spadavecchia L, 2008, J ECOL, V96, P1238, DOI 10.1111/j.1365-2745.2008.01424.x; Stoy PC, 2009, ECOSYSTEMS, V12, P574, DOI 10.1007/s10021-009-9243-7; Stoy PC, 2013, ARCT ANTARCT ALP RES, V45, P275, DOI 10.1657/1938-4246-45.2.275; Stoy PC, 2009, LANDSCAPE ECOL, V24, P971, DOI 10.1007/s10980-009-9367-3; Street LE, 2007, J ECOL, V95, P139, DOI 10.1111/j.1365-2745.2006.01187.x; Street LE, 2012, FUNCT ECOL, V26, P365, DOI 10.1111/j.1365-2435.2011.01954.x; Tikhonov A., 1977, SOLUTION ILL POSED P; van Wijk MT, 2005, ECOL APPL, V15, P1462, DOI 10.1890/03-5354; Venema V, 2006, NONLINEAR PROC GEOPH, V13, P321, DOI 10.5194/npg-13-321-2006; Venema V, 2006, TELLUS A, V58, P104, DOI 10.1111/j.1600-0870.2006.00160.x; Walker DA, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000504; Walker DA, 2004, PERMAFROST PERIGLAC, V15, P171, DOI 10.1002/ppp.487; Williams M, 2008, GLOBAL CHANGE BIOL, V14, P1517, DOI 10.1111/j.1365-2486.2008.01590.x	62	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128935	10.1371/journal.pone.0128935	http://dx.doi.org/10.1371/journal.pone.0128935			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26067835	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000356327000034
J	Guo, J; Hao, CY; Zhang, Y; Zhang, BQ; Cheng, XM; Qin, L; Li, T; Shi, WP; Chang, XP; Jing, RL; Yang, WY; Hu, WJ; Zhang, XY; Cheng, SH				Guo, Jie; Hao, Chenyang; Zhang, Yong; Zhang, Boqiao; Cheng, Xiaoming; Qin, Lin; Li, Tian; Shi, Weiping; Chang, Xiaoping; Jing, Ruilian; Yang, Wuyun; Hu, Wenjing; Zhang, Xueyong; Cheng, Shunhe			Association and Validation of Yield-Favored Alleles in Chinese Cultivars of Common Wheat (Triticumaestivum L.)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; LINEAR UNBIASED PREDICTION; SPATIAL GENETIC-STRUCTURE; LINKAGE DISEQUILIBRIUM; JOINT LINKAGE; AGRONOMIC TRAITS; CHROMOSOME 3A; MAPPING QTLS; GRAIN-YIELD; WEIGHT	Common wheat is one of the most important crops in China, which is the largest producer in the world. A set of 230 cultivars was used to identify yield-related loci by association mapping. This set was tested for seven yield-related traits, viz. plant height (PH), spike length (SL), spikelet number per spike (SNPS), kernel number per spike (KNPS), thousand-kernel weight (TKW), kernel weight per spike (KWPS), and sterile spikelet number (SSN) per plant in four environments. A total of 106 simple sequence repeat (SSR) markers distributed on all 21 chromosomes were used to screen the set. Twenty-one and 19 of them were associated with KNPS and TKW, respectively. Association mapping detected 73 significant associations across 50 SSRs, and the phenotypic variation explained (R-2) by the associations ranged from 1.54 to 23.93%. The associated loci were distributed on all chromosomes except 4A, 7A, and 7D. Significant and potentially new alleles were present on 8 chromosomes, namely1A, 1D, 2A, 2D, 3D, 4B, 5B, and 6B. Further analysis showed that genetic effects of associated loci were greatly influenced by association panels, and the R2 of crucial loci were lower in modern cultivars than in the mini core collection, probably caused by strong selection in wheat breeding. In order to confirm the results of association analysis, yield-related favorable alleles Xgwm135-1A(138), Xgwm337-1D(186), Xgwm102-2D(144), and Xgwm132-6B(128) were evaluated in a double haploid (DH) population derived from Hanxuan10 xLumai14. These favorable alleles that were validated in various populations might be valuable in breeding for high-yield.	[Guo, Jie; Qin, Lin; Cheng, Shunhe] Nanjing Agr Univ, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Zhang, Yong; Zhang, Boqiao; Cheng, Xiaoming; Shi, Weiping; Hu, Wenjing; Cheng, Shunhe] Lixiahe Agr Inst Jiangsu Prov, Minist Agr, Key Lab Wheat Biol & Genet Improvement Low & Midd, Yangzhou, Jiangsu, Peoples R China; [Hao, Chenyang; Li, Tian; Chang, Xiaoping; Jing, Ruilian; Zhang, Xueyong] Chinese Acad Agr Sci, Key Lab Crop Gene Resources & Germplasm Enhanceme, Minist Agr, Inst Crop Sci, Beijing 100193, Peoples R China; [Yang, Wuyun] Sichuan Acad Agr Sci, Crop Res Inst, Chengdu, Sichuan, Peoples R China	Nanjing Agricultural University; Jiangsu Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs; Sichuan Academy of Agricultural Sciences (SAAS)	Zhang, XY (corresponding author), Chinese Acad Agr Sci, Key Lab Crop Gene Resources & Germplasm Enhanceme, Minist Agr, Inst Crop Sci, Beijing 100193, Peoples R China.	zhangxueyong@caas.cn; yzcsh1939@126.com			Chinese Ministry of Science and Technology [2011CB100100]; China Agricultural Research System [CARS-3-1-1]; National High-Tech R&D Program of China [2012AA101105]; National Science and Technology Infrastructure Program [2011BAD35B03]; National Natural Science Foundation of China [31301320]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); China Agricultural Research System; National High-Tech R&D Program of China(National High Technology Research and Development Program of China); National Science and Technology Infrastructure Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Chinese Ministry of Science and Technology (2011CB100100; http://www.973.gov.cn/AreaAppl.aspx), the China Agricultural Research System (CARS-3-1-1; http://www.caaswheat.cn/), the National High-Tech R&D Program of China (2012AA101105; http://www.863.gov.cn/), the National Science and Technology Infrastructure Program (2011BAD35B03; http://www.nsfc.gov.cn/), and the National Natural Science Foundation of China (31301320; http://www.nsfc.gov.cn/).	Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bernardo R, 1996, CROP SCI, V36, P50, DOI [10.2135/cropsci1996.0011183X003600040009x, 10.2135/cropsci1996.0011183X003600040007x]; Bernardo R, 1996, THEOR APPL GENET, V93, P262, DOI 10.1007/BF00225755; Bernardo R, 1996, THEOR APPL GENET, V93, P1098, DOI 10.1007/BF00230131; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Campbell BT, 2003, CROP SCI, V43, P1493, DOI 10.2135/cropsci2003.1493; Cui F, 2011, THEOR APPL GENET, V122, P1517, DOI 10.1007/s00122-011-1551-6; Cuthbert JL, 2008, THEOR APPL GENET, V117, P595, DOI 10.1007/s00122-008-0804-5; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FAO (Food and Agricultural Organization of the United Nations), 2014, FAOSTAT DAT; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Ge HM, 2012, CROP SCI, V52, P1218, DOI 10.2135/cropsci2010.12.0680; Groos C, 2003, THEOR APPL GENET, V106, P1032, DOI 10.1007/s00122-002-1111-1; Gupta PK, 2006, GENOME, V49, P565, DOI 10.1139/G06-063; Hai L, 2008, PLANT SCI, V175, P226, DOI 10.1016/j.plantsci.2008.03.006; Hao CY, 2008, CHINESE SCI BULL, V53, P1518, DOI 10.1007/s11434-008-0212-x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hung HY, 2012, P NATL ACAD SCI USA, V109, pE1913, DOI 10.1073/pnas.1203189109; Jing RL, 1999, BIOTECHNOLOGY, V9, P4; Kato K, 2000, THEOR APPL GENET, V101, P1114, DOI 10.1007/s001220051587; Kato K, 1999, THEOR APPL GENET, V98, P472, DOI 10.1007/s001220051094; Korir PC, 2013, THEOR APPL GENET, V126, P1659, DOI 10.1007/s00122-013-2082-0; Korzun V, 1998, THEOR APPL GENET, V96, P1104, DOI 10.1007/s001220050845; Kumar N, 2007, MOL BREEDING, V19, P163, DOI 10.1007/s11032-006-9056-8; Laperche A, 2007, THEOR APPL GENET, V115, P399, DOI 10.1007/s00122-007-0575-4; Li N, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-114; Li SS, 2007, MOL BREEDING, V20, P167, DOI 10.1007/s11032-007-9080-3; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Lu YL, 2010, P NATL ACAD SCI USA, V107, P19585, DOI 10.1073/pnas.1006105107; Ma ZQ, 2007, MOL GENET GENOMICS, V277, P31, DOI 10.1007/s00438-006-0166-0; Marza F, 2006, THEOR APPL GENET, V112, P688, DOI 10.1007/s00122-005-0172-3; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Qin L, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-107; Quarrie SA, 2006, J EXP BOT, V57, P2627, DOI 10.1093/jxb/erl026; Ramya P, 2010, J APPL GENET, V51, P421, DOI 10.1007/BF03208872; Sajjad M, 2014, CEREAL RES COMMUN, V42, P177, DOI 10.1556/CRC.2013.0061; Schnurbusch T, 2003, THEOR APPL GENET, V107, P1226, DOI 10.1007/s00122-003-1372-3; Shah MM, 1999, CROP SCI, V39, P1728, DOI 10.2135/cropsci1999.3961728x; SHARP PJ, 1989, THEOR APPL GENET, V78, P342, DOI 10.1007/BF00265294; Shi JQ, 2009, GENETICS, V182, P851, DOI 10.1534/genetics.109.101642; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Su ZQ, 2011, THEOR APPL GENET, V122, P211, DOI 10.1007/s00122-010-1437-z; Sun XC, 2010, THEOR APPL GENET, V120, P1041, DOI 10.1007/s00122-009-1232-x; Tyagi S, 2014, MOL BREEDING, V34, P167, DOI 10.1007/s11032-014-0027-1; Wang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047917; Wang RX, 2009, THEOR APPL GENET, V118, P313, DOI 10.1007/s00122-008-0901-5; Worland AJ, 1998, THEOR APPL GENET, V96, P1110, DOI 10.1007/s001220050846; Wu RL, 2002, GENETICS, V160, P779; Wu RL, 2001, GENETICS, V157, P899; Wu XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031249; Wu XY, 2014, MOL BREEDING, V33, P129, DOI 10.1007/s11032-013-9939-4; Xu YF, 2014, THEOR APPL GENET, V127, P59, DOI 10.1007/s00122-013-2201-y; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang DL, 2012, PLANTA, V236, P1507, DOI 10.1007/s00425-012-1708-9; Zhang LY, 2010, J INTEGR PLANT BIOL, V52, P996, DOI 10.1111/j.1744-7909.2010.00967.x; Zhang XY, 2002, THEOR APPL GENET, V106, P112, DOI 10.1007/s00122-002-1016-z; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhou Yang, 2003, Acta Agronomica Sinica, V29, P810; Zhuang QS., 2003, CHINESE WHEAT IMPROV	61	10	11	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0130029	10.1371/journal.pone.0130029	http://dx.doi.org/10.1371/journal.pone.0130029			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067129	Green Published, gold, Green Submitted			2022-12-26	WOS:000356100900093
J	Huh, WB; Kim, JE; Kang, YG; Park, G; Lim, TG; Kwon, JY; Song, DS; Jeong, EH; Lee, CC; Son, JE; Seo, SG; Lee, E; Kim, JR; Lee, CY; Park, JS; Lee, KW				Huh, Won Bum; Kim, Jong-Eun; Kang, Young-Gyu; Park, Gaeun; Lim, Tae-gyu; Kwon, Jung Yeon; Song, Da Som; Jeong, Eun Hee; Lee, Charles C.; Son, Joe Eun; Seo, Sang Gwon; Lee, Eunjung; Kim, Jong Rhan; Lee, Chang Yong; Park, Jun Seong; Lee, Ki Won			Brown Pine Leaf Extract and Its Active Component Trans-Communic Acid Inhibit UVB-Induced MMP-1 Expression by Targeting PI3K	PLOS ONE			English	Article							ULTRAVIOLET-B IRRADIATION; MATRIX METALLOPROTEINASES; MECHANISMS; ACTIVATION; MODEL; GENE; CONSTITUENTS; DITERPENES; DENSIFLORA; THICKNESS	Japanese red pine (Pinus densiflora) is widely present in China, Japan, and Korea. Its green pine leaves have traditionally been used as a food as well as a coloring agent. After being shed, pine leaves change their color from green to brown within two years, and although the brown pine leaves are abundantly available, their value has not been closely assessed. In this study, we investigated the potential anti-photoaging properties of brown pine leaves for skin. Brown pine leaf extract (BPLE) inhibited UVB-induced matrix metalloproteinase-1 (MMP-1) expression to a greater extent than pine leaf extract (PLE) in human keratinocytes and a human skin equivalent model. HPLC analysis revealed that the quantity of trans-communic acid (TCA) and dehydroabietic acid (DAA) significantly increases when the pine leaf color changes from green to brown. BPLE and TCA elicited reductions in UVB-induced MMP-1 mRNA expression and activator protein-1 (AP-1) transactivation by reducing DNA binding activity of phospho-c-Jun, c-fos and Fra-1. BPLE and TCA also inhibited UVB-induced Akt phosphorylation, but not mitogen activated protein kinase (MAPK), known regulators of AP-1 transactivation. We additionally found that BPLE and TCA inhibited phosphoinositide 3-kinase (PI3K), the upstream kinase of Akt, in vitro. In summary, both BPLE and its active component TCA exhibit protective effects against UVB-induced skin aging. Taken together, these findings underline the potential for BPLE and TCA to be utilized as anti-wrinkling agents and cosmetic ingredients, as they suppress UVB-induced MMP-1 expression.	[Huh, Won Bum; Kim, Jong-Eun; Park, Gaeun; Lim, Tae-gyu; Kwon, Jung Yeon; Song, Da Som; Jeong, Eun Hee; Son, Joe Eun; Seo, Sang Gwon; Lee, Eunjung; Kim, Jong Rhan; Lee, Ki Won] Seoul Natl Univ, Dept Agr Biotechnol, Ctr Food & Bioconvergence, WCU Biomodulat Major, Seoul, South Korea; [Huh, Won Bum; Kim, Jong-Eun; Park, Gaeun; Lim, Tae-gyu; Kwon, Jung Yeon; Song, Da Som; Jeong, Eun Hee; Son, Joe Eun; Seo, Sang Gwon; Lee, Eunjung; Kim, Jong Rhan; Lee, Ki Won] Seoul Natl Univ, Adv Inst Convergence Technol, Suwon, South Korea; [Kang, Young-Gyu; Park, Jun Seong] Amorepacif Corp R&D Ctr, Skin Res Inst, Yongin, South Korea; [Lee, Charles C.; Lee, Chang Yong] Cornell Univ, Dept Food Sci & Technol, Ithaca, NY 14456 USA; [Lee, Eunjung] Korea Food Res Inst, Tradit Alcohol Beverage Res Team, Songnam, South Korea; [Lee, Chang Yong] King Abdulaziz Univ, Dept Biochem, Jeddah 21413, Saudi Arabia	Seoul National University (SNU); Seoul National University (SNU); Cornell University; Korea Food Research Institute (KFRI); King Abdulaziz University	Park, JS (corresponding author), Amorepacif Corp R&D Ctr, Skin Res Inst, Yongin, South Korea.	superbody@amorepacific.com; kiwon@snu.ac.kr	kim, jong-eun/B-3550-2017; Lee, Ki Won/M-4114-2018; Lim, Tae-Gyu/AAO-8475-2020; Son, Joe/AAB-7384-2020	kim, jong-eun/0000-0002-5030-6126; Lim, Tae-Gyu/0000-0001-6930-9565; Son, Joe/0000-0003-3066-2796	R & D program of MOTIE/KIAT (Establishment of Infra Structure for Anti-aging Industry Support) [N0000697]; Leap Research Program Grant through the National Research Foundation - Ministry of Science, ICT and Future Planning of Republic of Korea [2010-0029233]	R & D program of MOTIE/KIAT (Establishment of Infra Structure for Anti-aging Industry Support); Leap Research Program Grant through the National Research Foundation - Ministry of Science, ICT and Future Planning of Republic of Korea	This work was supported by the R & D program (N0000697) of MOTIE/KIAT (Establishment of Infra Structure for Anti-aging Industry Support) and the Leap Research Program Grant (2010-0029233) through the National Research Foundation funded by the Ministry of Science, ICT and Future Planning of Republic of Korea.	ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Aragane Y, 1997, P NATL ACAD SCI USA, V94, P11490, DOI 10.1073/pnas.94.21.11490; Barrero AF, 2012, MOLECULES, V17, P1448, DOI 10.3390/molecules17021448; Beissert S, 1999, J INVEST DERM SYMP P, V4, P61, DOI 10.1038/sj.jidsp.5640183; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Bode A M, 2000, Lancet Oncol, V1, P181, DOI 10.1016/S1470-2045(00)00029-2; Bode Ann M, 2003, Sci STKE, V2003, pRE2, DOI 10.1126/stke.2003.167.re2; Brenneisen P, 2002, ANN NY ACAD SCI, V973, P31, DOI 10.1111/j.1749-6632.2002.tb04602.x; BRULS WAG, 1984, PHOTOCHEM PHOTOBIOL, V40, P485, DOI 10.1111/j.1751-1097.1984.tb04622.x; Chen WX, 1999, ONCOGENE, V18, P7469, DOI 10.1038/sj.onc.1203210; CHEUNG HTA, 1993, TETRAHEDRON, V49, P7903, DOI 10.1016/S0040-4020(01)88015-7; Chiang HM, 2011, FOOD CHEM TOXICOL, V49, P309, DOI 10.1016/j.fct.2010.10.034; Chung JH, 2003, PHOTODERMATOL PHOTO, V19, P109, DOI 10.1034/j.1600-0781.2003.00027.x; Dickinson SE, 2011, MOL CARCINOGEN, V50, P469, DOI 10.1002/mc.20734; Eckl KM, 2011, J INVEST DERMATOL, V131, P1938, DOI 10.1038/jid.2011.126; Evans-Johnson JA, 2013, J PHOTOCH PHOTOBIO B, V126, P17, DOI 10.1016/j.jphotobiol.2013.07.006; Fisher G J, 1998, J Investig Dermatol Symp Proc, V3, P61; Fisher GJ, 2002, ARCH DERMATOL, V138, P1462, DOI 10.1001/archderm.138.11.1462; Fisher GJ, 1996, NATURE, V379, P335, DOI 10.1038/379335a0; Fisher GJ, 1997, NEW ENGL J MED, V337, P1419, DOI 10.1056/NEJM199711133372003; Fisher GJ, 1997, NEW ENGL J MED, V1997, P20; Fumarola C, 2014, BIOCHEM PHARMACOL, V90, P197, DOI 10.1016/j.bcp.2014.05.011; Gilchrest BA, 1996, PHOTOCHEM PHOTOBIOL, V63, P1, DOI 10.1111/j.1751-1097.1996.tb02988.x; Gordien AY, 2009, J ETHNOPHARMACOL, V126, P500, DOI 10.1016/j.jep.2009.09.007; Huang CS, 2000, MOL CARCINOGEN, V27, P65, DOI 10.1002/(SICI)1098-2744(200002)27:2<65::AID-MC2>3.0.CO;2-E; Hwang YP, 2011, J DERMATOL SCI, V61, P23, DOI 10.1016/j.jdermsci.2010.10.016; Jiang Yunyao, 2012, Prev Nutr Food Sci, V17, P116, DOI 10.3746/pnf.2012.17.2.116; Kahari VM, 1997, EXP DERMATOL, V6, P199, DOI 10.1111/j.1600-0625.1997.tb00164.x; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kim JE, 2010, BIOCHEM PHARMACOL, V79, P1473, DOI 10.1016/j.bcp.2010.01.008; Klotz LO, 1997, FEBS LETT, V408, P289, DOI 10.1016/S0014-5793(97)00440-7; Kwon JH, 2010, ARCH PHARM RES, V33, P2011, DOI 10.1007/s12272-010-1217-y; Li Y, 2010, J DERMATOL SCI, V60, P105, DOI 10.1016/j.jdermsci.2010.08.003; Lim JH, 2008, CHEMOSPHERE, V73, P470, DOI 10.1016/j.chemosphere.2008.06.048; Liu YB, 2011, FOOD CHEM, V124, P527, DOI 10.1016/j.foodchem.2010.06.064; Matsumura Yasuhiro, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S146239940200532X; MAUVIEL A, 1993, J CELL BIOCHEM, V53, P288, DOI 10.1002/jcb.240530404; Muhammad I, 1995, PHYTOTHER RES, V9, P584, DOI 10.1002/ptr.2650090810; Oh JH, 2006, J CELL PHYSIOL, V209, P775, DOI 10.1002/jcp.20754; Perez-Sanchez A, 2014, J PHOTOCH PHOTOBIO B, V136, P12, DOI 10.1016/j.jphotobiol.2014.04.007; Pinus desiflora, PIN DES; Rittie L, 2002, AGEING RES REV, V1, P705, DOI 10.1016/S1568-1637(02)00024-7; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; SHIMIZU M, 1994, BIOL PHARM BULL, V17, P665; Tanaka R, 2000, CANCER LETT, V161, P165, DOI 10.1016/S0304-3835(00)00584-X; van Beek TA, 2007, J NAT PROD, V70, P154, DOI 10.1021/np060325e; van den Bogaard EH, 2014, J INVEST DERMATOL, V134, P719, DOI 10.1038/jid.2013.417; Vincenti MP, 1996, CRIT REV EUKAR GENE, V6, P391, DOI 10.1615/CritRevEukarGeneExpr.v6.i4.40; Vogt P K, 1990, Adv Cancer Res, V55, P1, DOI 10.1016/S0065-230X(08)60466-2; Walker SL., 2003, FITZPATRICKS DERMATO, P1275; Wang S, 2014, EXP DERMATOL, V23, P524, DOI 10.1111/exd.12451; Xu YR, 2006, AM J PATHOL, V169, P823, DOI 10.2353/ajpath.2006.050449; Zhao Y, 1996, J BIOL CHEM, V271, P29773, DOI 10.1074/jbc.271.47.29773	53	18	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128365	10.1371/journal.pone.0128365	http://dx.doi.org/10.1371/journal.pone.0128365			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26066652	gold, Green Published, Green Submitted			2022-12-26	WOS:000356100900019
J	Perez-Rios, M; Fernandez, E; Schiaffino, A; Nebot, M; Lopez, MJ				Perez-Rios, Monica; Fernandez, Esteve; Schiaffino, Anna; Nebot, Manel; Jose Lopez, Maria			Changes in the Prevalence of Tobacco Consumption and the Profile of Spanish Smokers after a Comprehensive Smoke-Free Policy	PLOS ONE			English	Article							SELF-REPORTED SMOKING; NICOTINE DEPENDENCE; FAGERSTROM TEST; GENERAL-POPULATION; ACCURACY; VALIDITY; EXPOSURE; COTININE; HEALTH; SPAIN	Background A partial smoke-free regulation in Spain was introduced on January 1, 2006, which was subsequently amended to introduce a comprehensive smoke-free policy from 2 January 2011 onward. The objective of this study was to compare the prevalence of tobacco consumption in Spain and the profile of smokers before (2006) and after (2011) the comprehensive smoking ban passed in 2010. Methods Two independent, cross-sectional, population-based surveys were carried out among the adult (>= 18 years old) Spanish population in 2006 and 2011 through telephone interviews. Both surveys used the same methods and questionnaire. Nicotine dependence was assessed with the Fagerstrom Test for nicotine dependence and readiness to quit according to the stages of change. Results The prevalence of tobacco consumption showed a nonsignificant decrease from 23.4% in 2006 to 20.7% in 2011. No changes were observed in nicotine dependence or readiness to quit. In 2011, most smokers (76%) showed low nicotine dependence and were mainly in the precontemplation stage (72%). Conclusions The prevalence of smokers has slightly decreased since the introduction of the total smoking ban in Spain. No differences were found in nicotine dependence or readiness to quit.	[Perez-Rios, Monica] Galician Hlth Author, Galician Directorate Publ Hlth, Epidemiol Unit, Santiago De Compostela, Spain; [Perez-Rios, Monica; Nebot, Manel; Jose Lopez, Maria] Biomed Res Ctr Network Epidemiol & Publ Hlth CIBE, Granada, Spain; [Perez-Rios, Monica] Univ Santiago de Compostela, Sch Med, Dept Prevent Med & Publ Hlth, Santiago De Compostela, Spain; [Fernandez, Esteve; Schiaffino, Anna] Inst Invest Biomed Bellvitge IDIBELL, ICO, Canc Control & Prevent Programme, Tobacco Control Unit, Barcelona, Spain; [Fernandez, Esteve] Univ Barcelona, Sch Med, Dept Clin Sci, Barcelona, Spain; [Nebot, Manel; Jose Lopez, Maria] Agencia Salut Publ Barcelona, Barcelona, Spain; [Jose Lopez, Maria] Inst Biomed Res IIB St Pau, Barcelona, Spain	Universidade de Santiago de Compostela; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Public Health Agency of Barcelona	Perez-Rios, M (corresponding author), Galician Hlth Author, Galician Directorate Publ Hlth, Epidemiol Unit, Santiago De Compostela, Spain.	monica.perez.rios@usc.es	Lopez, Maria/HHC-3659-2022; Pérez-Ríos, Mónica/AAA-5941-2019; Fernandez, Esteve/A-9750-2008	Fernandez, Esteve/0000-0003-4239-723X; Lopez Medina, Maria Jose/0000-0003-4402-2239; Perez-Rios, Monica/0000-0003-4456-6631	Instituto de Salud Carlos III, Ministry of Health, Government of Spain [FIS PI10/00400]; Ministry of Universities and Research of Catalonia [2009SGR192, 2009SGR1345]; Instituto de Salud Carlos III of Spain [RD12/0036/0053]	Instituto de Salud Carlos III, Ministry of Health, Government of Spain(Instituto de Salud Carlos III); Ministry of Universities and Research of Catalonia; Instituto de Salud Carlos III of Spain(Instituto de Salud Carlos III)	This work was supported by the Instituto de Salud Carlos III, Ministry of Health, Government of Spain (FIS PI10/00400). The Ministry of Universities and Research of Catalonia (grants 2009SGR192 and 2009SGR1345) partially supported the work of Perez-Rios, Schiaffino, Lopez and Fernandez, and the Instituto de Salud Carlos III of Spain (grant RD12/0036/0053) partially supported the work of Fernandez.	[Anonymous], 2009, EV IMP LEY MED SAN F; Callinan JE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005992.pub2; Casado JB, 2001, ARCH BRONCONEUMOL, V37, P75, DOI 10.1016/S0300-2896(01)75018-1; Romero CC, 2012, REV ESP SALUD PUBLIC, V86, P177; Chaiton MO, 2008, J PUBLIC HEALTH POL, V29, P307, DOI 10.1057/jphp.2008.14; Etter JF, 2008, ADDICTION, V103, P1576, DOI 10.1111/j.1360-0443.2008.02300.x; Fagerstrom K, 2008, ADDICTION, V103, P841, DOI 10.1111/j.1360-0443.2008.02190.x; FAGERSTROM KO, 1989, J BEHAV MED, V12, P159, DOI 10.1007/BF00846549; Fernandez E, 2003, MED CLIN-BARCELONA, V120, P14, DOI 10.1157/13042014; Fernandez E, 2011, TOB CONTROL, V20, P325; Fu M, 2011, ADICCIONES, V23, P103, DOI 10.20882/adicciones.153; Fu M, 2009, ADDICTION, V104, P326, DOI 10.1111/j.1360-0443.2008.02485.x; Gallus S, 2007, PREV MED, V45, P198, DOI 10.1016/j.ypmed.2007.03.009; Gorber SC, 2009, NICOTINE TOB RES, V11, P12, DOI 10.1093/ntr/ntn010; HALEY NJ, 1985, CLIN CHEM, V31, P1598; Heloma A, 2003, ADDICTION, V98, P1111, DOI 10.1046/j.1360-0443.2003.00429.x; Jimenez Ruiz C A, 2000, Arch Bronconeumol, V36, P241; Ruiz CAJ, 2014, RESPIRATION, V87, P190, DOI 10.1159/000355083; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Lopez-Nicolas A, 2013, TOB CONTROL, V22, DOI 10.1136/tobaccocontrol-2011-050344; LUEPKER RV, 1989, AM J PUBLIC HEALTH, V79, P202, DOI 10.2105/AJPH.79.2.202; Lund M, 2011, NICOTINE TOB RES, V13, P1132, DOI 10.1093/ntr/ntr166; Lushchenkova O, 2008, REV ESP CARDIOL, V61, P687, DOI 10.1016/S1885-5857(08)60205-4; Marcus S, 2004, SMOKING TOBACCO CONT, V15; Martinez-Sanchez JM, 2013, GAC SANIT, V27, P61, DOI 10.1016/j.gaceta.2012.05.003; PATRICK DL, 1994, AM J PUBLIC HEALTH, V84, P1086, DOI 10.2105/AJPH.84.7.1086; Perez-Rios M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-493; PETITTI DB, 1981, AM J PUBLIC HEALTH, V71, P308, DOI 10.2105/AJPH.71.3.308; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; Thyrian JR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-2; Wilson LM, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/961724	31	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128305	10.1371/journal.pone.0128305	http://dx.doi.org/10.1371/journal.pone.0128305			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK3FB	26066497	Green Published, gold, Green Submitted			2022-12-26	WOS:000356100900018
J	McAlinden, C; Wang, QM; Pesudovs, K; Yang, X; Bao, FJ; Yu, A; Lin, SS; Feng, YF; Huang, JH				McAlinden, Colm; Wang, Qinmei; Pesudovs, Konrad; Yang, Xin; Bao, Fangjun; Yu, Ayong; Lin, Shishi; Feng, Yifan; Huang, Jinhai			Axial Length Measurement Failure Rates with the IOLMaster and Lenstar LS 900 in Eyes with Cataract	PLOS ONE			English	Article							PARTIAL COHERENCE INTERFEROMETRY; INTRAOCULAR-LENS; POWER CALCULATION; OPTICAL BIOMETRY; APPLANATION ULTRASOUND; OCULAR BIOMETRY; REFLECTOMETRY; REPEATABILITY; AGREEMENT; SURGERY	Purpose To evaluate axial length (AL) measurement failure rate with the IOLMaster (Carl Zeiss AG, Germany) and Lenstar LS 900 (Haag-Streit AG, Switzerland) in eyes with cataract. Methods Two hundred and ninety-six eyes of 170 patients with cataract were enrolled. Cataract type and severity were graded using the Lens Opacities Classification System III (LOCS III) and AL measurements were attempted with IOLMaster (version 5.4) and Lenstar LS 900 (version 1.1). Chi-squared analysis was used to assess if the difference in AL measurement acquisition rate was statistically significant between the two devices. The association of the different cataract types and severity with the AL measurement acquisition rate was evaluated with logistic regression analysis. Results AL measurements were obtained in 184 eyes (62.16%) using the IOLMaster and 191 eyes (64.53%) using the Lenstar, which corresponds to a failure rate of 37.84% and 35.47% respectively. Chi-square analysis indicated no significant difference between the Lenstar and IOLMaster for AL measurement failure rate (x(2) = 0.356, P = 0.550). Logistic regression analysis indicated no association between acquisition rates and cortical or nuclear cataracts with either device. There was a statistically significant association between acquisition rates and increasing severity of posterior subcapsular cataracts with the IOLMaster (beta = -1.491, P<0.001) and Lenstar LS 900 (beta= -1.507, P<0.001). Conclusion The IOLMaster and Lenstar LS 900 have similar AL measurement failure rates (35-38%) for Chinese public hospital cataract patients. Increasing severity of posterior subcapsular cataracts was problematic for both devices.	[McAlinden, Colm; Wang, Qinmei; Yang, Xin; Bao, Fangjun; Yu, Ayong; Lin, Shishi; Feng, Yifan; Huang, Jinhai] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Wang, Qinmei; Bao, Fangjun; Yu, Ayong; Huang, Jinhai] Minist Hlth PR China, Key Lab Vis Sci, Wenzhou, Zhejiang, Peoples R China; [McAlinden, Colm; Pesudovs, Konrad] Flinders Univ S Australia, Adelaide, SA 5001, Australia	Wenzhou Medical University; Flinders University South Australia	Huang, JH (corresponding author), Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China.	vip999vip@163.com	Pesudovs, Konrad/T-9403-2019; Huang, Jinhai/ABH-4519-2020	Pesudovs, Konrad/0000-0002-6322-9369; 	Natural Science Foundation of China [81300807]; Foundation of Wenzhou City Science & Technology Bureau [J20140014, Y20140705, Y20140159]; National Science and Technology Ministry [2012BAI08B04]; health Bureau of Zhejiang Province [2012KYB135]; Scientific Research Fund of Zhejiang Provincial Education Department [Y201223147]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Wenzhou City Science & Technology Bureau; National Science and Technology Ministry; health Bureau of Zhejiang Province; Scientific Research Fund of Zhejiang Provincial Education Department	Supported in part by the Natural Science Foundation of China (81300807); Foundation of Wenzhou City Science & Technology Bureau (J20140014, Y20140705, Y20140159; www.wzkj.gov.cn); the National Science and Technology Ministry (2012BAI08B04); the health Bureau of Zhejiang Province (2012KYB135; www.zjmed.org.cn); and the Scientific Research Fund of Zhejiang Provincial Education Department (Y201223147; www.zjedu.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckhurst PJ, 2009, BRIT J OPHTHALMOL, V93, P949, DOI 10.1136/bjo.2008.156554; Chen WH, 2012, J CATARACT REFR SURG, V38, P1626, DOI 10.1016/j.jcrs.2012.04.031; Chen YA, 2011, J CATARACT REFR SURG, V37, P513, DOI 10.1016/j.jcrs.2010.10.041; Cruysberg LPJ, 2010, BRIT J OPHTHALMOL, V94, P106, DOI 10.1136/bjo.2009.161729; Epitropoulos A, 2014, CLIN OPHTHALMOL, V8, P1369, DOI 10.2147/OPTH.S62653; Freeman G, 2005, ACTA OPHTHALMOL SCAN, V83, P439, DOI 10.1111/j.1600-0420.2005.00473.x; Hill W, 2008, J CATARACT REFR SURG, V34, P920, DOI 10.1016/j.jcrs.2008.02.021; Hodge W, 2007, CAN MED ASSOC J, V176, P1285, DOI 10.1503/cmaj.060962; Hoffer KJ, 2010, J CATARACT REFR SURG, V36, P644, DOI 10.1016/j.jcrs.2009.11.007; Holzer MP, 2009, BRIT J OPHTHALMOL, V93, P807, DOI 10.1136/bjo.2008.152736; Huang JH, 2012, OPTOMETRY VISION SCI, V89, P1691, DOI 10.1097/OPX.0b013e3182772f4f; Hui S, 2014, INDIAN J OPHTHALMOL, V62, P931, DOI 10.4103/0301-4738.143930; Jasvinder S, 2011, EYE, V25, P717, DOI 10.1038/eye.2011.28; Liampa Z, 2010, KLIN MONATSBL AUGENH, V227, P285, DOI 10.1055/s-0029-1245182; McAlinden C, 2011, OPHTHAL PHYSL OPT, V31, P330, DOI 10.1111/j.1475-1313.2011.00851.x; McAlinden C, 2011, J CATARACT REFR SURG, V37, P441, DOI 10.1016/j.jcrs.2010.08.055; Micieli JA, 2011, CAN MED ASSOC J, V183, P1621, DOI 10.1503/cmaj.110549; Nemeth J, 2003, J CATARACT REFR SURG, V29, P85, DOI 10.1016/S0886-3350(02)01500-6; O'Donnell C, 2011, CONTACT LENS ANTERIO, V34, P26, DOI 10.1016/j.clae.2010.10.006; Rabsilber TM, 2010, J CATARACT REFR SURG, V36, P230, DOI 10.1016/j.jcrs.2009.09.016; Rajan MS, 2002, EYE, V16, P552, DOI 10.1038/sj.eye.6700157; Read SA, 2010, OPTOMETRY VISION SCI, V87, P656, DOI 10.1097/OPX.0b013e3181e87dd3; Rohrer K, 2009, OPHTHALMOLOGY, V116, P2087, DOI 10.1016/j.ophtha.2009.04.019; Roncevic MB, 2011, GRAEF ARCH CLIN EXP, V249, P83, DOI 10.1007/s00417-010-1546-z; Roncevic MB, 2011, GRAEF ARCH CLIN EXP, V249, P69, DOI 10.1007/s00417-010-1509-4; Salouti R, 2011, OPTOMETRY, V82, P140, DOI 10.1016/j.optm.2010.07.025; Siahmed K, 2001, J FR OPHTALMOL, V24, P922; Skiadaresi E, 2012, ARCH OPHTHALMOL-CHIC, V130, P1377, DOI 10.1001/archophthalmol.2012.1603; Suto C, 2007, J CATARACT REFR SURG, V33, P2062, DOI 10.1016/j.jcrs.2007.07.031; Tappeiner C, 2010, BRIT J OPHTHALMOL, V94, P666, DOI 10.1136/bjo.2009.167700; Tehrani M, 2003, J CATARACT REFR SURG, V29, P741, DOI 10.1016/S0886-3350(02)01740-6; Vogel A, 2001, J CATARACT REFR SURG, V27, P1961, DOI 10.1016/S0886-3350(01)01214-7	32	36	40	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0128929	10.1371/journal.pone.0128929	http://dx.doi.org/10.1371/journal.pone.0128929			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061554	Green Submitted, Green Published, gold			2022-12-26	WOS:000355979500109
J	Geng, SH; White, SN; Paine, ML; Snead, ML				Geng, Shuhui; White, Shane N.; Paine, Michael L.; Snead, Malcolm L.			Protein Interaction between Ameloblastin and Proteasome Subunit alpha Type 3 Can Facilitate Redistribution of Ameloblastin Domains within Forming Enamel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; AMELOGENIN NANOSPHERES; MATRIX; STAGE; BINDING; BIOMINERALIZATION; IDENTIFICATION; 20S; LOCALIZATION; DEGRADATION	Enamel is a bioceramic tissue composed of thousands of hydroxyapatite crystallites aligned in parallel within boundaries fabricated by a single ameloblast cell. Enamel is the hardest tissue in the vertebrate body; however, it starts development as a self-organizing assembly of matrix proteins that control crystallite habit. Here, we examine ameloblastin, a protein that is initially distributed uniformly across the cell boundary but redistributes to the lateral margins of the extracellular matrix following secretion thus producing cell-defined boundaries within the matrix and the mineral phase. The yeast two-hybrid assay identified that proteasome subunit alpha type 3 (Psma3) interacts with ameloblastin. Confocal microscopy confirmed Psma3 co-distribution with ameloblastin at the ameloblast secretory end piece. Co-immunoprecipitation assay of mouse ameloblast cell lysates with either ameloblastin or Psma3 antibody identified each reciprocal protein partner. Protein engineering demonstrated that only the ameloblastin C terminus interacts with Psma3. We show that 20S proteasome digestion of ameloblastin in vitro generates an N-terminal cleavage fragment consistent with the in vivo pattern of ameloblastin distribution. These findings suggest a novel pathway participating in control of protein distribution within the extracellular space that serves to regulate the protein-mineral interactions essential to biomineralization.	[Geng, Shuhui; Paine, Michael L.; Snead, Malcolm L.] Univ So Calif, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA; [White, Shane N.] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90095 USA	University of Southern California; University of California System; University of California Los Angeles	Snead, ML (corresponding author), Univ So Calif, Ctr Craniofacial Mol Biol, 2250 Alcazar St,CSA 142, Los Angeles, CA 90033 USA.	mlsnead@usc.edu	Snead, Malcolm L/A-1372-2015	Snead, Malcolm L/0000-0002-4496-6478; Geng, Shuhui/0000-0003-4787-2458	National Institutes of Health from USPHS [DE13045, DE06988]; NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013045, R01DE006988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE013045] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE13045 (to M. L. S.) and DE06988 (to M. L. S.) from USPHS and NIDCR. The authors declare that they have no conflicts of interest with the contents of this article.	Ausubel F. M., 2008, CURRENT PROTOCOLS MO; Bae MH, 2002, BBA-MOL CELL RES, V1592, P163, DOI 10.1016/S0167-4889(02)00310-5; Baldassarri M, 2008, J DENT RES, V87, P645, DOI 10.1177/154405910808700711; Bartlett JD, 2004, J DENT RES, V83, P909, DOI 10.1177/154405910408301204; Bess KL, 2003, BIOCHEM J, V374, P667, DOI 10.1042/BJ20030769; Beyeler M, 2010, EXP CELL RES, V316, P1202, DOI 10.1016/j.yexcr.2009.12.019; Boelens WC, 2001, BBA-PROTEIN STRUCT M, V1544, P311, DOI 10.1016/S0167-4838(00)00243-0; BOYDE A, 1979, J DENT RES, V58, P981, DOI 10.1177/00220345790580025101; Boyde A, 1987, Adv Dent Res, V1, P135; Boyde A, 1997, CIBA F SYMP, V205, P18; Chun YHP, 2010, J DENT RES, V89, P1414, DOI 10.1177/0022034510379223; Chun YHP, 2010, J DENT RES, V89, P785, DOI 10.1177/0022034510366903; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Du C, 2005, SCIENCE, V307, P1450, DOI 10.1126/science.1105675; EASTOE JE, 1979, J DENT RES, V58, P753, DOI 10.1177/00220345790580022701; Elenich LA, 1999, IMMUNOGENETICS, V49, P835, DOI 10.1007/s002510050562; Fang PA, 2011, P NATL ACAD SCI USA, V108, P14097, DOI 10.1073/pnas.1106228108; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FINCHAM AG, 1995, J STRUCT BIOL, V115, P50, DOI 10.1006/jsbi.1995.1029; Fincham AG, 1999, J STRUCT BIOL, V126, P270, DOI 10.1006/jsbi.1999.4130; Fong CD, 1996, J BONE MINER RES, V11, P892; Fong H, 2003, J BONE MINER RES, V18, P2052, DOI 10.1359/jbmr.2003.18.11.2052; Fukumoto S, 2005, CONNECT TISSUE RES, V46, P220, DOI 10.1080/03008200500344017; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; Hu CC, 1997, J DENT RES, V76, P648, DOI 10.1177/00220345970760020501; Hu JCC, 2003, CRIT REV ORAL BIOL M, V14, P387, DOI 10.1177/154411130301400602; Imbeni V, 2005, NAT MATER, V4, P229, DOI 10.1038/nmat1323; Iwasaki K, 2005, J DENT RES, V84, P1127, DOI 10.1177/154405910508401207; Iwata T, 2007, J DENT RES, V86, P153, DOI 10.1177/154405910708600209; Krebsbach PH, 1996, J BIOL CHEM, V271, P4431; Lacruz RS, 2013, J DENT RES, V92, P122, DOI 10.1177/0022034512470954; Lacruz RS, 2012, J BIOL RHYTHM, V27, P237, DOI 10.1177/0748730412442830; Lacruz RS, 2011, EUR J ORAL SCI, V119, P149, DOI 10.1111/j.1600-0722.2011.00881.x; LANDY A, 1989, ANNU REV BIOCHEM, V58, P913, DOI 10.1146/annurev.biochem.58.1.913; LI B, 1993, FASEB J, V7, P957, DOI 10.1096/fasebj.7.10.8344494; Moffatt P, 2006, BIOCHEM J, V399, P37, DOI 10.1042/BJ20060662; Moradian-Oldak J, 2000, J STRUCT BIOL, V131, P27, DOI 10.1006/jsbi.2000.4237; Mueller O, 2012, J MOL NEUROSCI, V46, P509, DOI 10.1007/s12031-011-9631-2; Murakami C, 1997, HISTOCHEM CELL BIOL, V107, P485, DOI 10.1007/s004180050136; Nanci A, 1998, J HISTOCHEM CYTOCHEM, V46, P911, DOI 10.1177/002215549804600806; Paine CT, 1998, CONNECT TISSUE RES, V38, P257, DOI 10.3109/03008209809017046; Paine ML, 2008, J DENT RES, V87, P391, DOI 10.1177/154405910808700415; Paine ML, 2003, J BIOL CHEM, V278, P19447, DOI 10.1074/jbc.M300445200; Paine ML, 2001, MATRIX BIOL, V20, P273, DOI 10.1016/S0945-053X(01)00153-6; Paine ML, 1997, J BONE MINER RES, V12, P221, DOI 10.1359/jbmr.1997.12.2.221; Paine ML, 2000, J STRUCT BIOL, V132, P191, DOI 10.1006/jsbi.2000.4324; PETERS JM, 1994, J BIOL CHEM, V269, P7709; ROBINSON C, 1981, CALCIFIED TISSUE INT, V33, P513, DOI 10.1007/BF02409483; Shi Z, 2015, ONCOGENE, V34, P2538, DOI 10.1038/onc.2014.171; Shu FJ, 2003, MOL CELL BIOCHEM, V254, P157, DOI 10.1023/A:1027317014159; Simmer JP, 2010, J DENT RES, V89, P1024, DOI 10.1177/0022034510375829; SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701; Sixt SU, 2008, BBA-MOL BASIS DIS, V1782, P817, DOI 10.1016/j.bbadis.2008.06.005; Sixt SU, 2007, AM J PHYSIOL-LUNG C, V292, pL1280, DOI 10.1152/ajplung.00140.2006; Sixt Stephan Urs, 2010, Proc Am Thorac Soc, V7, P91, DOI 10.1513/pats.200906-035JS; Smith CE, 2005, J BONE MINER RES, V20, P240, DOI 10.1359/JBMR.041002; SMITH CE, 1995, INT J DEV BIOL, V39, P153; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; SMITH CE, 1995, CALCIFIED TISSUE INT, V57, P133, DOI 10.1007/BF00298434; Smith CE, 2009, EUR J ORAL SCI, V117, P485, DOI 10.1111/j.1600-0722.2009.00666.x; Snead ML, 1996, J BONE MINER RES, V11, P899; TERMINE JD, 1979, J DENT RES, V58, P773, DOI 10.1177/00220345790580022901; Tomes J., 1849, PHIL T, V140, P529; UCHIDA T, 1991, HISTOCHEMISTRY, V96, P129, DOI 10.1007/BF00315983; Uchida T, 1997, J HISTOCHEM CYTOCHEM, V45, P1329, DOI 10.1177/002215549704501002; Vymetal J, 2008, EUR J ORAL SCI, V116, P124, DOI 10.1111/j.1600-0722.2008.00526.x; Wald T, 2013, J BIOL CHEM, V288, P22333, DOI 10.1074/jbc.M113.456012; Wald T, 2011, EUR J ORAL SCI, V119, P261, DOI 10.1111/j.1600-0722.2011.00913.x; Wang HJ, 2005, J BONE MINER RES, V20, P1032, DOI 10.1359/JBMR.050111; WARSHAWSKY H, 1971, ANAT RECORD, V169, P585, DOI 10.1002/ar.1091690308; Wazen RM, 2009, MATRIX BIOL, V28, P292, DOI 10.1016/j.matbio.2009.04.004; White SN, 2005, J PROSTHET DENT, V94, P330, DOI 10.1016/j.prosdent.2005.08.013; White SN, 2001, J DENT RES, V80, P321, DOI 10.1177/00220345010800010501; Zhou YL, 2000, J BIOL CHEM, V275, P29066, DOI 10.1074/jbc.M002031200; Zhou YL, 2000, J BIOL CHEM, V275, P12273, DOI 10.1074/jbc.275.16.12273; Zhu DH, 2006, J BIOL CHEM, V281, P21173, DOI 10.1074/jbc.M510757200	77	5	5	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20661	20673		10.1074/jbc.M115.640185	http://dx.doi.org/10.1074/jbc.M115.640185			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26070558	hybrid, Green Published			2022-12-26	WOS:000360011800003
J	Zhou, XX; Cooper, KL; Sun, X; Liu, KJ; Hudson, LG				Zhou, Xixi; Cooper, Karen L.; Sun, Xi; Liu, Ke J.; Hudson, Laurie G.			Selective Sensitization of Zinc Finger Protein Oxidation by Reactive Oxygen Species through Arsenic Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARP-1 ACTIVITY; ULTRAVIOLET-RADIATION; REDOX REGULATION; STRAND BREAKS; DNA-REPAIR; STRESS; POLY(ADP-RIBOSYL)ATION; INHIBITION; CHEMISTRY; INTERACTS	Cysteine oxidation induced by reactive oxygen species (ROS) on redox-sensitive targets such as zinc finger proteins plays a critical role in redox signaling and subsequent biological outcomes. We found that arsenic exposure led to oxidation of certain zinc finger proteins based on arsenic interaction with zinc finger motifs. Analysis of zinc finger proteins isolated from arsenic-exposed cells and zinc finger peptides by mass spectrometry demonstrated preferential oxidation of C3H1 and C4 zinc finger configurations. C2H2 zinc finger proteins that do not bind arsenic were not oxidized by arsenic-generated ROS in the cellular environment. The findings suggest that selectivity in arsenic binding to zinc fingers with three or more cysteines defines the target proteins for oxidation by ROS. This represents a novel mechanism of selective protein oxidation and demonstrates how an environmental factor may sensitize certain target proteins for oxidation, thus altering the oxidation profile and redox regulation.	[Zhou, Xixi; Cooper, Karen L.; Sun, Xi; Liu, Ke J.; Hudson, Laurie G.] Univ New Mexico, Coll Pharm, Dept Pharmaceut Sci, Hlth Sci Ctr, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center	Liu, KJ (corresponding author), Univ New Mexico, Coll Pharm, Dept Pharmaceut Sci, Hlth Sci Ctr, Albuquerque, NM 87131 USA.	kliu@salud.unm.edu; lhudson@salud.unm.edu	Zhou, Xixi/F-1760-2011; Regan, Clinton/E-6250-2012	Zhou, Xixi/0000-0003-4202-8821; 	National Institutes of Health [R01ES15826, R01ES021100, R01CA182969, P30CA118100]; University of New Mexico Environmental Health Signature Program; NATIONAL CANCER INSTITUTE [P30CA118100, R01CA182969] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021100, R01ES015826] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of New Mexico Environmental Health Signature Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01ES15826, R01ES021100, and R01CA182969. This work was also supported by National Institutes of Health Grant P30CA118100 (to the University of New Mexico Cancer Center) through a postdoctoral matching grant and a pilot award and by a pilot project from the University of New Mexico Environmental Health Signature Program. The authors declare that they have no conflicts of interest with the contents of this article.	Bossak K, 2015, CHEM RES TOXICOL, V28, P191, DOI 10.1021/tx500320f; Chen K, 2012, CURR ATHEROSCLER REP, V14, P476, DOI 10.1007/s11883-012-0266-8; Cooper KL, 2014, TOXICOL LETT, V224, P407, DOI 10.1016/j.toxlet.2013.11.010; Cooper KL, 2007, TOXICOL APPL PHARM, V218, P119, DOI 10.1016/j.taap.2006.09.020; Cooper KL, 2013, TOXICOL APPL PHARM, V269, P81, DOI 10.1016/j.taap.2013.03.008; Cooper KL, 2009, FREE RADICAL BIO MED, V47, P381, DOI 10.1016/j.freeradbiomed.2009.04.034; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/NCHEMBIO.607, 10.1038/nchembio.607]; Ding W, 2009, J BIOL CHEM, V284, P6809, DOI 10.1074/jbc.M805566200; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Eustermann S, 2011, J MOL BIOL, V407, P149, DOI 10.1016/j.jmb.2011.01.034; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Go YM, 2013, J BIOL CHEM, V288, P26512, DOI 10.1074/jbc.R113.464131; Hartwig A, 2003, INT J CANCER, V104, P1, DOI 10.1002/ijc.10911; Hartwig A, 2013, FREE RADICAL BIO MED, V55, P63, DOI 10.1016/j.freeradbiomed.2012.11.009; Huang B, 2010, FREE RADICAL BIO MED, V49, P447, DOI 10.1016/j.freeradbiomed.2010.05.001; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Klomsiri C, 2011, ANTIOXID REDOX SIGN, V14, P1065, DOI 10.1089/ars.2010.3376; Kopera E, 2004, CHEM RES TOXICOL, V17, P1452, DOI 10.1021/tx049842s; Kroncke KD, 2009, ANTIOXID REDOX SIGN, V11, P1015, DOI [10.1089/ars.2008.2269, 10.1089/ARS.2008.2269]; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Maret W, 2013, METAL IONS LIFE SCI, V12, P479, DOI 10.1007/978-94-007-5561-1_14; Miki H, 2012, J BIOCHEM, V151, P255, DOI 10.1093/jb/mvs006; Murphy MP, 2011, CELL METAB, V13, P361, DOI 10.1016/j.cmet.2011.03.010; Niedermeyer THJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044913; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Oteiza PI, 2012, FREE RADICAL BIO MED, V53, P1748, DOI 10.1016/j.freeradbiomed.2012.08.568; Paulsen CE, 2013, CHEM REV, V113, P4633, DOI 10.1021/cr300163e; Payne JC, 2003, BIOCHEMISTRY-US, V42, P14214, DOI 10.1021/bi035002l; Qin XJ, 2008, TOXICOL APPL PHARM, V232, P41, DOI 10.1016/j.taap.2008.05.019; RAGO R, 1990, ANAL BIOCHEM, V191, P31; Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006; Sabharwal SS, 2014, NAT REV CANCER, V14, P709, DOI 10.1038/nrc3803; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Sosa V, 2013, AGEING RES REV, V12, P376, DOI 10.1016/j.arr.2012.10.004; Sun X, 2014, TOXICOL APPL PHARM, V274, P313, DOI 10.1016/j.taap.2013.11.010; Walter I, 2007, DNA REPAIR, V6, P61, DOI 10.1016/j.dnarep.2006.08.008; Wang F, 2013, FREE RADICAL BIO MED, V61, P249, DOI 10.1016/j.freeradbiomed.2013.04.019; Wang Y, 2012, ANTIOXID REDOX SIGN, V16, P649, DOI 10.1089/ars.2011.4313; Yager JW, 1997, MUTAT RES-REV MUTAT, V386, P345, DOI 10.1016/S1383-5742(97)00011-2; You JS, 2000, BIOCHEMISTRY-US, V39, P12953, DOI 10.1021/bi001206f; Zhou XX, 2014, CHEM RES TOXICOL, V27, P690, DOI 10.1021/tx500022j; Zhou XX, 2011, J BIOL CHEM, V286, P22855, DOI 10.1074/jbc.M111.232926	43	38	38	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18361	18369		10.1074/jbc.M115.663906	http://dx.doi.org/10.1074/jbc.M115.663906			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26063799	Green Published, hybrid			2022-12-26	WOS:000358512100009
J	Duarte-Guterman, P; Lieblich, SE; Chow, C; Galea, LAM				Duarte-Guterman, Paula; Lieblich, Stephanie E.; Chow, Carmen; Galea, Liisa A. M.			Estradiol and GPER Activation Differentially Affect Cell Proliferation but Not GPER Expression in the Hippocampus of Adult Female Rats	PLOS ONE			English	Article							COUPLED ESTROGEN-RECEPTOR; SPATIAL-LEARNING TASK; DENTATE GYRUS; NEUROGENESIS; PROTEIN; GPR30; MEMORY; BRAIN; NEURONS; HORMONES	Estradiol increases cell proliferation in the dentate gyrus of the female rodent but it is not known whether the G protein-coupled estrogen receptor (GPER), a membrane receptor, is involved in this process, nor whether there are regional differences in estradiol's effects on cell proliferation. Thus, we investigated whether estradiol exerts its effects on cell proliferation in the dorsal and ventral dentate gyrus through GPER, using the GPER agonist, G1, and antagonist, G15. Ovariectomized adult female rats received a single injection of either: 17 beta-estradiol (10 mu g), G1 (0.1, 5, 10 mu g), G15 (40 mu g), G15 and estradiol, or vehicle (oil, DMSO, or oil+DMSO). After 30 min, animals received an injection of bromodeoxyuridine (BrdU) and were perfused 24 h later. Acute treatment with estradiol increased, while the GPER agonist G1 (5 mu g) decreased, the number of BrdU+ cells in the dentate gyrus relative to controls. The GPER antagonist, G15 increased the number of BrdU+ cells relative to control in the dorsal region and decreased the number of BrdU+ cells in the ventral region. However, G15 treatment in conjunction with estradiol partially eliminated the estradiol-induced increase in cell proliferation in the dorsal dentate gyrus. Furthermore, G1 decreased the expression of GPER in the dentate gyrus but not the CA1 and CA3 regions of the hippocampus. In summary, we found that activation of GPER decreased cell proliferation and GPER expression in the dentate gyrus of young female rats, presenting a potential and novel estrogen- independent role for this receptor in the adult hippocampus.	[Duarte-Guterman, Paula; Lieblich, Stephanie E.; Chow, Carmen; Galea, Liisa A. M.] Univ British Columbia, Dept Psychol, Program Neurosci, Ctr Brain Hlth, Vancouver, BC, Canada	University of British Columbia	Galea, LAM (corresponding author), Univ British Columbia, Dept Psychol, Program Neurosci, Ctr Brain Hlth, Vancouver, BC, Canada.	lgalea@psych.ubc.ca	; Duarte-Guterman, Paula/C-9676-2013	Galea, Liisa/0000-0003-2874-9972; Duarte-Guterman, Paula/0000-0002-1695-8147	Canadian Institutes of Health Research (LAMG) [MOP102568]; Natural Sciences and Engineering Research Council of Canada (NSERC); Alzheimer Society of Canada; NSERC	Canadian Institutes of Health Research (LAMG)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alzheimer Society of Canada; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this research was provided by the Canadian Institutes of Health Research (LAMG; MOP102568). LAMG also has funding from the Natural Sciences and Engineering Research Council of Canada (NSERC) and Alzheimer Society of Canada. PDG was funded by a postdoctoral fellowship from NSERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Amrein I, 2009, BIOL LETTERS, V5, P141, DOI 10.1098/rsbl.2008.0511; Baker LD, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.07.002; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Barha CK, 2009, J NEUROENDOCRINOL, V21, P155, DOI 10.1111/j.1365-2826.2008.01809.x; Barha CK, 2011, EXP NEUROL, V231, P72, DOI 10.1016/j.expneurol.2011.05.016; Batenburg WW, 2012, CARDIOVASC RES, V94, P136, DOI 10.1093/cvr/cvs016; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Brailoiu E, 2007, J ENDOCRINOL, V193, P311, DOI 10.1677/JOE-07-0017; Broughton BRS, 2013, NEUROSIGNALS, V21, P229, DOI 10.1159/000338019; Brummelte S, 2010, NEUROSCIENCE, V168, P680, DOI 10.1016/j.neuroscience.2010.04.023; Butz M, 2006, NEURAL NETWORKS, V19, P1490, DOI 10.1016/j.neunet.2006.07.007; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Cheng SB, 2014, MOL CELL ENDOCRINOL, V382, P950, DOI 10.1016/j.mce.2013.11.005; Chow C, 2013, PSYCHONEUROENDOCRINO, V38, P1236, DOI 10.1016/j.psyneuen.2012.11.007; Dennis MK, 2011, J STEROID BIOCHEM, V127, P358, DOI 10.1016/j.jsbmb.2011.07.002; Dennis MK, 2009, NAT CHEM BIOL, V5, P421, DOI 10.1038/nchembio.168; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Fowler CD, 2005, J COMP NEUROL, V489, P166, DOI 10.1002/cne.20638; Fuchs E, 2000, EUR J NEUROSCI, V12, P2211, DOI 10.1046/j.1460-9568.2000.00130.x; Galea LAM, 2013, J NEUROENDOCRINOL, V25, P1039, DOI 10.1111/jne.12070; Galea LAM, 2001, BEHAV BRAIN RES, V126, P115, DOI 10.1016/S0166-4328(01)00255-8; Galea LAM, 2008, CAN J EXP PSYCHOL, V62, P247, DOI 10.1037/a0014501; Gros R, 2013, AM J PHYSIOL-CELL PH, V304, pC532, DOI 10.1152/ajpcell.00203.2012; Gros R, 2011, HYPERTENSION, V57, P442, DOI 10.1161/HYPERTENSIONAHA.110.161653; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Hammond R, 2012, HORM BEHAV, V62, P367, DOI 10.1016/j.yhbeh.2012.07.004; Hammond R, 2009, HORM BEHAV, V56, P309, DOI 10.1016/j.yhbeh.2009.06.008; Hamson DK, 2013, ENDOCRINOLOGY, V154, P3294, DOI 10.1210/en.2013-1129; Hawley WR, 2014, BEHAV BRAIN RES, V262, P68, DOI 10.1016/j.bbr.2014.01.006; Hazell GGJ, 2009, J ENDOCRINOL, V202, P223, DOI 10.1677/JOE-09-0066; Holmes MM, 2002, BEHAV NEUROSCI, V116, P928, DOI 10.1037//0735-7044.116.5.928; Isgor C, 2005, NEUROSCIENCE, V134, P847, DOI 10.1016/j.neuroscience.2005.05.008; Kastenberger I, 2012, PSYCHOPHARMACOLOGY, V221, P527, DOI 10.1007/s00213-011-2599-3; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kim DS, 2008, J COMP NEUROL, V511, P581, DOI 10.1002/cne.21851; Langer G, 2010, STEROIDS, V75, P603, DOI 10.1016/j.steroids.2009.12.006; Liu NJ, 2011, J NEUROSCI, V31, P11836, DOI 10.1523/JNEUROSCI.1901-11.2011; Matsuda KI, 2008, NEUROSCI LETT, V441, P94, DOI 10.1016/j.neulet.2008.05.108; Mazzucco CA, 2006, NEUROSCIENCE, V141, P1793, DOI 10.1016/j.neuroscience.2006.05.032; Mazzucco CA, 2008, BEHAV BRAIN RES, V191, P111, DOI 10.1016/j.bbr.2008.03.016; McClure RES, 2013, HORM BEHAV, V63, P144, DOI 10.1016/j.yhbeh.2012.09.011; Micevych P, 2009, FRONT NEUROENDOCRIN, V30, P315, DOI 10.1016/j.yfrne.2009.04.011; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Nagy AI, 2005, DRUG DEVELOP RES, V66, P142, DOI 10.1002/ddr.20053; Ormerod BK, 2003, J NEUROBIOL, V55, P247, DOI 10.1002/neu.10181; Ormerod BK, 2001, NEUROSCIENCE, V102, P369, DOI 10.1016/S0306-4522(00)00474-7; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Petrie WK, 2013, OBSTET GYNECOL INT, V2013, DOI 10.1155/2013/472720; Prossnitz ER, 2008, J STEROID BIOCHEM, V109, P350, DOI 10.1016/j.jsbmb.2008.03.006; Qiu J, 2003, J NEUROSCI, V23, P9529; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shors TJ, 1998, NEUROREPORT, V9, P419, DOI 10.1097/00001756-199802160-00012; Snyder JS, 2009, HIPPOCAMPUS, V19, P360, DOI 10.1002/hipo.20525; Spary EJ, 2013, NEUROSIGNALS, V21, P14, DOI 10.1159/000333296; Srivastava DP, 2013, J NEUROENDOCRINOL, V25, P1219, DOI 10.1111/jne.12071; Tanapat P, 1999, J NEUROSCI, V19, P5792, DOI 10.1523/JNEUROSCI.19-14-05792.1999; Tanapat P, 2005, J COMP NEUROL, V481, P252, DOI 10.1002/cne.20385; ter Horst J, 2012, CELL MOL NEUROBIOL, V32, P725, DOI 10.1007/s10571-011-9774-2; Tian Z, 2013, PSYCHONEUROENDOCRINO, V38, P2218, DOI 10.1016/j.psyneuen.2013.04.011; Toran-Allerand CD, 2002, J NEUROSCI, V22, P8391; Vasudevan N, 2008, FRONT NEUROENDOCRIN, V29, P238, DOI 10.1016/j.yfrne.2007.08.003; VIAU V, 1991, ENDOCRINOLOGY, V129, P2503, DOI 10.1210/endo-129-5-2503; Wong EYH, 2005, EUR J NEUROSCI, V22, P785, DOI 10.1111/j.1460-9568.2005.04277.x; Wood GE, 2001, BEHAV NEUROSCI, V115, P175, DOI 10.1037//0735-7044.115.1.175; WOOLLEY CS, 1992, J NEUROSCI, V12, P2549; Xu H, 2009, NEUROSCIENCE, V158, P1599, DOI 10.1016/j.neuroscience.2008.11.028	69	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129880	10.1371/journal.pone.0129880	http://dx.doi.org/10.1371/journal.pone.0129880			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075609	Green Submitted, Green Published, gold			2022-12-26	WOS:000356329900109
J	Chiappini, N; Cantisani, R; Pancotto, L; Ruggiero, P; Rosa, D; Manetti, A; Romano, A; Montagnani, F; Bertholet, S; Castellino, F; Del Giudice, G				Chiappini, Nico; Cantisani, Rocco; Pancotto, Laura; Ruggiero, Paolo; Rosa, Domenico; Manetti, Andrea; Romano, Antonio; Montagnani, Francesca; Bertholet, Sylvie; Castellino, Flora; Del Giudice, Giuseppe			Innate Response Activator (IRA) B Cells Reside in Human Tonsils and Internalize Bacteria In Vitro	PLOS ONE			English	Article							MOUSE B-1 CELLS; MARGINAL ZONE; HUMAN EQUIVALENT; LYMPHOCYTES; ANTIBODY; CD43; PROTEINS; SEPSIS; SUBSET; CD5	Innate response activator (IRA) B cells have been described in mice as a subset of B-1a B cells that produce granulocyte/macrophage colony-stimulating factor (GM-CSF) and have been found in the spleen upon activation. In humans, identification, tissue localization and functionality of these lymphocytes are poorly understood. We hypothesized that IRA B cells could reside in human palatine tonsils, which are a first line of defense from infection of the upper respiratory tract. In the present work, we used flow cytometry and confocal microscopy to identify and characterize human IRA (hIRA) B cells in tonsils. We show that CD19(+)CD20(+)GM-CSF+ B cells are present in the tonsils of all the subjects studied at a frequency ranging between similar to 0.2% and similar to 0.4% of the conventional CD19(+)CD20(+)GM-CSF- B cells. These cells reside within the B cell follicles, are mostly IgM(+)IgD(+), express CD5 and show phagocytic activity. Our results support a role for hIRA B cells in the effector immune response to infections in tonsils.	[Chiappini, Nico; Cantisani, Rocco; Pancotto, Laura; Ruggiero, Paolo; Rosa, Domenico; Manetti, Andrea; Bertholet, Sylvie; Castellino, Flora; Del Giudice, Giuseppe] Novartis Vaccines & Diagnost, Res Ctr, Siena, Italy; [Romano, Antonio] Univ Hosp Le Scotte, Dept Otorhinolaryngol, Siena, Italy; [Montagnani, Francesca] Univ Hosp Le Scotte, Dept Med Biotechnol, Infect Unit, Siena, Italy	Novartis; University of Siena; University Hospital of Siena; University of Siena; University Hospital of Siena	Chiappini, N (corresponding author), Novartis Vaccines & Diagnost, Res Ctr, Via Fiorentina 1, Siena, Italy.	nico.x.chiappini@gsk.com; rocco.x.cantisani@gsk.com	Montagnani, Francesca/R-3334-2016; Cantisani, Rocco/K-2224-2018	Montagnani, Francesca/0000-0002-2267-1337; Cantisani, Rocco/0000-0002-6836-3399	Novartis Vaccines (GSK company)	Novartis Vaccines (GSK company)	Novartis Vaccines (a GSK company) provided support in the form of salaries for authors (NC, RC, LP, PR, DR, AGOM, SB, GDG), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; BURASTERO SE, 1988, J EXP MED, V168, P1979, DOI 10.1084/jem.168.6.1979; CASALI P, 1987, SCIENCE, V236, P77, DOI 10.1126/science.3105056; Cerutti A, 2013, NAT REV IMMUNOL, V13, P118, DOI 10.1038/nri3383; de Araujo TH, 2013, CELL IMMUNOL, V281, P27, DOI 10.1016/j.cellimm.2013.01.002; Descatoire M, 2011, J EXP MED, V208, P2563, DOI 10.1084/jem.20112232; Djoumerska-Alexieva I, 2013, AUTOIMMUN REV, V12, P653, DOI 10.1016/j.autrev.2012.10.010; Garcia-Perez BE, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-246; Fuda FS, 2009, AM J CLIN PATHOL, V132, P733, DOI 10.1309/AJCPU5E3NXEKLFIY; Gao JX, 2012, EUR J IMMUNOL, V42, P982, DOI 10.1002/eji.201141519; Griffin DO, 2011, J EXP MED, V208, P2566, DOI 10.1084/jem.20111761; Griffin DO, 2011, J EXP MED, V208, P67, DOI 10.1084/jem.20101499; Hilgendorf I, 2014, CIRCULATION, V129, P1677, DOI 10.1161/CIRCULATIONAHA.113.006381; Horikawa M, 2013, J IMMUNOL, V190, P1158, DOI 10.4049/jimmunol.1201427; Jackson SM, 2008, ADV IMMUNOL, V98, P151, DOI 10.1016/S0065-2776(08)00405-7; Magri G, 2014, NAT IMMUNOL, V15, P354, DOI 10.1038/ni.2830; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Perez-Andres M, 2011, J EXP MED, V208, P2565, DOI 10.1084/jem.20112203; Rauch PJ, 2012, SCIENCE, V335, P597, DOI 10.1126/science.1215173; Rothstein TL, 2013, ANN NY ACAD SCI, V1285, P97, DOI 10.1111/nyas.12137; Seveau S, 2000, BLOOD, V95, P2462; SHELLEY CS, 1990, BIOCHEM J, V270, P569, DOI 10.1042/bj2700569; Tedder TF, 2015, J IMMUNOL, V194, P1395, DOI 10.4049/jimmunol.1401329; Warren TL, 2000, CURR OPIN HEMATOL, V7, P168, DOI 10.1097/00062752-200005000-00007; Weber GF, 2014, J EXP MED, V211, P1243, DOI 10.1084/jem.20131471; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885	27	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129879	10.1371/journal.pone.0129879	http://dx.doi.org/10.1371/journal.pone.0129879			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066485	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000118
J	Poncet, A; Gencer, B; Blondon, M; Gex-Fabry, M; Combescure, C; Shah, D; Schwartz, PJ; Besson, M; Girardin, FR				Poncet, Antoine; Gencer, Baris; Blondon, Marc; Gex-Fabry, Marianne; Combescure, Christophe; Shah, Dipen; Schwartz, Peter J.; Besson, Marie; Girardin, Francois R.			Electrocardiographic Screening for Prolonged QT Interval to Reduce Sudden Cardiac Death in Psychiatric Patients: A Cost-Effectiveness Analysis	PLOS ONE			English	Article							INDUCED LONG QT; DRUG-THERAPY; DE-POINTES; RISK; HEALTH; ANTIPSYCHOTICS; ABNORMALITIES; TORSADE	Importance Sudden cardiac death is a leading cause of mortality in psychiatric patients. Long QT (LQT) is common in this population and predisposes to Torsades-de-Pointes (TdP) and subsequent mortality. Objective To estimate the cost-effectiveness of electrocardiographic screening to detect LQT in psychiatric inpatients. Design, Setting, and Participants We built a decision analytic model based on a decision tree to evaluate the cost-effectiveness and utility of LQT screening from a health care perspective. LQT proportion parameters were derived from an in-hospital cross-sectional study. We performed experts' elicitation to estimate the risk of TdP, given extent of QT prolongation. A TdP reduction of 65% after LQT detection was based on positive drug dechallenge rate and through adequate treatment and electrolyte adjustments. The base-case model uncertainty was assessed with one-way and probabilistic sensitivity analyses. Finally, the TdP related mortality and TdP avoidance parameters were varied in a two-way sensitivity analysis to assess their effect on the Incremental Cost-Effectiveness Ratio (ICER). Main Outcomes and Measures Costs, Quality Ajusted Life Year (QALY), ICER, and probability of cost effectiveness thresholds ($10 000, $25 000, and $50 000 per QALY). Results In the base-case scenario, the numbers of patients needed to screen were 1128 and 2817 to avoid one TdP and one death, respectively. The ICER of systematic ECG screening was $8644 (95%CI, 3144-82 498) per QALY. The probability of cost-effectiveness was 96% at a willingness-to-pay of $ 50 000 for one QALY. In sensitivity analyses, results were sensitive to the case-fatality of TdP episodes and to the TdP reduction following the diagnosis of LQT. Conclusion and Relevance In psychiatric hospitals, performing systematic ECG screening at admission help reduce the number of sudden cardiac deaths in a cost-effective fashion.	[Poncet, Antoine; Combescure, Christophe] Univ Hosp Geneva, Dept Hlth & Community Med, CH-1205 Geneva, Switzerland; [Gencer, Baris; Blondon, Marc; Gex-Fabry, Marianne; Combescure, Christophe; Shah, Dipen; Besson, Marie; Girardin, Francois R.] Univ Geneva, CH-1205 Geneva, Switzerland; [Gencer, Baris; Shah, Dipen] Univ Hosp Geneva, Div Cardiol, CH-1205 Geneva, Switzerland; [Blondon, Marc] Univ Hosp Geneva, Dept Internal Med, CH-1205 Geneva, Switzerland; [Gex-Fabry, Marianne] Univ Hosp Geneva, Dept Psychiat, CH-1205 Geneva, Switzerland; [Schwartz, Peter J.] IRCCS Ist Auxol Italiano, Ctr Cardiac Arrhythmias Genet Origin, Milan, Italy; [Besson, Marie; Girardin, Francois R.] Univ Hosp Geneva, Dept Anesthesiol Intens Care & Clin Pharmacol, CH-1205 Geneva, Switzerland; [Girardin, Francois R.] Univ Hosp Geneva, Med Directorate, CH-1205 Geneva, Switzerland; [Girardin, Francois R.] Univ York, Ctr Hlth Econ, York, N Yorkshire, England	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva; IRCCS Istituto Auxologico Italiano; University of Geneva; University of Geneva; University of York - UK	Girardin, FR (corresponding author), Univ Hosp Geneva, Dept Anesthesiol Intens Care & Clin Pharmacol, Rue Gabrielle Perret Gentil 4, CH-1205 Geneva, Switzerland.	francois.girardin@hcuge.ch	poncet, antoine/AAB-9984-2019; Besson, Marie/AAG-3253-2019; Gencer, Baris/AAO-2305-2020; Schwartz, Peter J/J-4267-2016; Girardin, Francois/F-5443-2017; Blondon, Marc/AAE-5464-2019	Schwartz, Peter J/0000-0003-0367-1048; Girardin, Francois/0000-0002-0842-927X; Gencer, Baris/0000-0002-8954-9694	Department of Anesthesiology, Intensive Care, Clinical Pharmacology and Toxicology (University Hospitals of Geneva); Medical Directorate of the University Hospitals of Geneva; Swiss National Science Foundation (SNSF, Inflammation and acute coronary syndromes (ACS) - Novel strategies for prevention and clinical management) [SPUM33C30-140336]; Geneva University Hospital (CRG) [71-225]	Department of Anesthesiology, Intensive Care, Clinical Pharmacology and Toxicology (University Hospitals of Geneva); Medical Directorate of the University Hospitals of Geneva; Swiss National Science Foundation (SNSF, Inflammation and acute coronary syndromes (ACS) - Novel strategies for prevention and clinical management)(Swiss National Science Foundation (SNSF)); Geneva University Hospital (CRG)	The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The Department of Anesthesiology, Intensive Care, Clinical Pharmacology and Toxicology (University Hospitals of Geneva), and the Medical Directorate of the University Hospitals of Geneva supported the economic assessment for safety guidance in psychiatry. BG's research on cardiovascular prevention is supported by a grant from the Swiss National Science Foundation (SNSF SPUM33C30-140336, Inflammation and acute coronary syndromes (ACS) - Novel strategies for prevention and clinical management) and by a grant from the Geneva University Hospital (CRG 71-225) for the development of research projects.	Auer R, 2012, JAMA-J AM MED ASSOC, V307, P1497, DOI 10.1001/jama.2012.434; Behr ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078511; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Chan A, 2007, QJM-INT J MED, V100, P609, DOI 10.1093/qjmed/hcm072; Claxton K, 2011, HEALTH ECON, V20, P2, DOI 10.1002/hec.1612; De Ponti F, 2000, LANCET, V356, P75, DOI 10.1016/S0140-6736(05)73412-7; Girardin FR, 2013, AM J PSYCHIAT, V170, P1468, DOI 10.1176/appi.ajp.2013.12060860; Grigore B, 2013, PHARMACOECONOMICS, V31, P991, DOI 10.1007/s40273-013-0092-z; Hannerz H, 2001, PUBLIC HEALTH, V115, P328; McCabe C, 2008, PHARMACOECONOMICS, V26, P733, DOI 10.2165/00019053-200826090-00004; Moran PS, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009586.pub2; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Quaglini S, 2006, EUR HEART J, V27, P1824, DOI 10.1093/eurheartj/ehl115; Ray WA, 2009, NEW ENGL J MED, V360, P225, DOI 10.1056/NEJMoa0806994; Reilly JG, 2000, LANCET, V355, P1048, DOI 10.1016/S0140-6736(00)02035-3; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; SALLE P, 1985, ANN CARDIOL ANGEIOL, V34, P381; Sarganas G, 2014, EUROPACE, V16, P101, DOI 10.1093/europace/eut214; Saul JP, 2014, HEART RYTHM; Schwartz PJ, 2009, CIRCULATION, V120, P1761, DOI 10.1161/CIRCULATIONAHA.109.863209; Straus SMJM, 2004, ARCH INTERN MED, V164, P1293, DOI 10.1001/archinte.164.12.1293; Straus SMJM, 2005, EUR HEART J, V26, P2007, DOI 10.1093/eurheartj/ehi312; Sullivan PW, 2006, MED DECIS MAKING, V26, P401, DOI 10.1177/0272989X06290496; TARMED, TARIFF BROWSER VERSI; Watanabe E, 2014, HEART RHYTHM, V11, P1418, DOI 10.1016/j.hrthm.2014.04.036; Weeke P, 2014, CLIN PHARMACOL THER, V96, P490, DOI 10.1038/clpt.2014.139; Weeke P, 2014, J AM COLL CARDIOL, V63, P1430, DOI 10.1016/j.jacc.2014.01.031; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253	28	18	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0127213	10.1371/journal.pone.0127213	http://dx.doi.org/10.1371/journal.pone.0127213			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6GR	26070071	Green Submitted, gold, Green Published			2022-12-26	WOS:000356327000006
J	Saumell, S; Sole, F; Arenillas, L; Montoro, J; Valcarcel, D; Pedro, C; Sanzo, C; Luno, E; Gimenez, T; Arnan, M; Pomares, H; De Paz, R; Arrizabalaga, B; Jerez, A; Martinez, AB; Sanchez-Castro, J; Rodriguez-Gambarte, JD; Raya, JM; Rios, E; Rodriguez-Rivera, M; Espinet, B; Florensa, L				Saumell, Silvia; Sole, Francesc; Arenillas, Leonor; Montoro, Julia; Valcarcel, David; Pedro, Carme; Sanzo, Carmen; Luno, Elisa; Gimenez, Teresa; Arnan, Montserrat; Pomares, Helena; De Paz, Raquel; Arrizabalaga, Beatriz; Jerez, Andres; Martinez, Ana B.; Sanchez-Castro, Judith; Rodriguez-Gambarte, Juan D.; Raya, Jose M.; Rios, Eduardo; Rodriguez-Rivera, Maria; Espinet, Blanca; Florensa, Lourdes			Trisomy 8, a Cytogenetic Abnormality in Myelodysplastic Syndromes, Is Constitutional or Not?	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; CELL LINEAGE INVOLVEMENT; ACUTE-LEUKEMIA; MOSAICISM; GROWTH	Isolated trisomy 8 is not considered presumptive evidence of myelodysplastic syndrome (MDS) in cases without minimal morphological criteria. One reason given is that trisomy 8 (+8) can be found as a constitutional mosaicism (cT8M). We tried to clarify the incidence of cT8M in myeloid neoplasms, specifically in MDS, and the diagnostic value of isolated +8 in MDS. Twenty-two MDS and 10 other myeloid neoplasms carrying +8 were studied. Trisomy 8 was determined in peripheral blood by conventional cytogenetics (CC) and on granulocytes, CD3+ lymphocytes and oral mucosa cells by fluorescence in situ hybridization (FISH). In peripheral blood CC, +8 was seen in 4/32 patients. By FISH, only one patient with chronic myelomonocytic leukemia showed +8 in all cell samples and was interpreted as a cT8M. In our series +8 was acquired in all MDS. Probably, once discarded cT8M by FISH from CD3+ lymphocytes and non-hematological cells, +8 should be considered with enough evidence to MDS.	[Saumell, Silvia; Arenillas, Leonor; Rodriguez-Rivera, Maria; Espinet, Blanca; Florensa, Lourdes] Hosp del Mar, Serv Patol, Lab Citol Hematol & Citogenet Mol, Barcelona, Spain; [Saumell, Silvia; Arenillas, Leonor; Pedro, Carme; Rodriguez-Rivera, Maria; Espinet, Blanca; Florensa, Lourdes] Hosp del Mar Med Res Inst IMIM, Canc Res Program, GRETNHE, Barcelona, Spain; [Saumell, Silvia] Univ Autonoma Barcelona, Fac Med, Dept Med, Bellaterra, Spain; [Sole, Francesc] Inst Recerca Leucemia Josep Carreras, Cytogenet Platform, Badalona, Spain; [Montoro, Julia; Valcarcel, David] Hosp Valle De Hebron, Serv Hematol, Barcelona, Spain; [Pedro, Carme] Hosp del Mar, Serv Hematol Clin, Barcelona, Spain; [Sanzo, Carmen; Luno, Elisa] Univ Oviedo, Hosp Cent Asturias, Serv Hematol, E-33080 Oviedo, Spain; [Gimenez, Teresa] Hosp Univ Joan XXIII, Serv Hematol, Tarragona, Spain; [Arnan, Montserrat; Pomares, Helena] Hosp Duran & Reynals, Inst Catala Oncol, Serv Hematol, Lhospitalet Llobregat, Spain; [De Paz, Raquel] Hosp Univ La Paz, Serv Hematol, Madrid, Spain; [Arrizabalaga, Beatriz] Hosp Univ Cruces, Serv Hematol, Baracaldo, Spain; [Jerez, Andres; Martinez, Ana B.] Hosp Morales Meseguer, Serv Hematol, Murcia, Spain; [Sanchez-Castro, Judith] Hosp Arnau Vilanova, Serv Hematol, Lleida, Spain; [Rodriguez-Gambarte, Juan D.] Hosp Univ Ramon & Cajal, Serv Hematol, Madrid, Spain; [Raya, Jose M.] Hosp Univ Canarias, Serv Hematol, San Cristobal la Laguna, Tenerife, Spain; [Rios, Eduardo] Hosp Univ Valme, Sevicio Hematol, Seville, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona; Institut de Recerca Contra la Leucemia Josep Carreras (IJC); Hospital Universitari Vall d'Hebron; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Central University Hospital Asturias; University of Oviedo; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; Hospital Universitario La Paz; Hospital Universitario Cruces; University Hospital Arnau de Vilanova; Hospital Universitario Ramon y Cajal; Universidad de la Laguna; Hospital Valme	Florensa, L (corresponding author), Hosp del Mar, Serv Patol, Lab Citol Hematol & Citogenet Mol, Barcelona, Spain.	lflorensa@parcdesalutmar.cat	valcarcel, david/T-8770-2019; Valcárcel, David/AAE-6584-2019; Jerez, Andrés/AAF-1699-2019; Arenillas, Leonor/ABG-1057-2020; Solé, Francesc/K-8373-2012; Saumell, Silvia/H-6175-2017; MONTORO, JULIA/H-6174-2017	Valcárcel, David/0000-0002-8747-078X; Solé, Francesc/0000-0002-3251-2161; Arenillas, Leonor/0000-0002-8176-7179; Florensa, Lourdes/0000-0001-5906-3311; Espinet, Blanca/0000-0002-4294-8145; Rios Herranz, Eduardo/0000-0002-4072-3911; Saumell, Silvia/0000-0001-8635-4376; MONTORO, JULIA/0000-0001-9532-7417	Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Spain [FI07/00107, CA08/00141, PI07/1009, PI 11/02010]; Red Tematica de InvestigacionCooperativa en Cancer (RTICC, FEDER) [RD06/0020/0031, RD07/0020/2004, RD12/0036/0044]; Agencia de Gestio d'Ajuts Universitaris i de Recerca", Departament d'Innovacio, Universitats i Empresa [SGR 541/2009]; Accion COST: European Genetic and Epigentic Study on AML and MDS [BM0801]; Sociedad Espanola de Hematologia y Hemoterapia (SEHH)	Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Spain(Instituto de Salud Carlos III); Red Tematica de InvestigacionCooperativa en Cancer (RTICC, FEDER); Agencia de Gestio d'Ajuts Universitaris i de Recerca", Departament d'Innovacio, Universitats i Empresa; Accion COST: European Genetic and Epigentic Study on AML and MDS; Sociedad Espanola de Hematologia y Hemoterapia (SEHH)	This work was supported by Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Spain (FI07/00107, CA08/00141; PI07/1009 and PI 11/02010); Red Tematica de InvestigacionCooperativa en Cancer (RTICC, FEDER) (RD06/0020/0031 and RD07/0020/2004; RD12/0036/0044); SGR 541/2009 ("Agencia de Gestio d'Ajuts Universitaris i de Recerca", Departament d'Innovacio, Universitats i Empresa); Accion COST BM0801: European Genetic and Epigentic Study on AML and MDS; Sociedad Espanola de Hematologia y Hemoterapia (SEHH) 2011 and 2012 fellowships.	ANASTASI J, 1993, BLOOD, V81, P1580; Barrett J, 2000, SEMIN HEMATOL, V37, P15; Becker K, 2009, AM J MED GENET A, V149A, P982, DOI 10.1002/ajmg.a.32756; Bernell P, 1996, LEUKEMIA, V10, P662; Brunning RD, 2008, WHO CLASSIFICATION T; Danesino C, 1998, AM J MED GENET, V80, P540, DOI 10.1002/(SICI)1096-8628(19981228)80:5<540::AID-AJMG25>3.0.CO;2-8; FAGIOLI F, 1995, CANCER GENET CYTOGEN, V82, P116, DOI 10.1016/0165-4608(94)00228-4; Ganmore I, 2009, HUM MOL GENET, V18, pR84, DOI 10.1093/hmg/ddp084; Greenberg PL, 2012, BLOOD, V120, P2454, DOI 10.1182/blood-2012-03-420489; HASLE H, 1995, CANCER GENET CYTOGEN, V79, P79, DOI 10.1016/0165-4608(94)00099-W; Hastings R, 2012, ECA NEWSLETTER, V30, P11; KIBBELAAR RE, 1992, BLOOD, V79, P1823; Maciejewski JP, 2002, BLOOD, V99, P3129, DOI 10.1182/blood.V99.9.3129; Mallo M, 2013, BRIT J HAEMATOL, V162, P74, DOI 10.1111/bjh.12354; Maserati E, 2002, GENE CHROMOSOME CANC, V33, P93, DOI 10.1002/gcc.1214; NIELSEN J, 1991, HUM GENET, V87, P81, DOI 10.1007/BF01213097; Ripperger T, 2011, BRIT J HAEMATOL, V155, P209, DOI 10.1111/j.1365-2141.2011.08817.x; Saitoh K, 1998, BLOOD, V92, P2886, DOI 10.1182/blood.V92.8.2886.420k11_2886_2892; Saumell S, 2012, BRIT J HAEMATOL, V159, P311, DOI 10.1111/bjh.12035; Seghezzi L, 1996, GENE CHROMOSOME CANC, V17, P94, DOI 10.1002/(SICI)1098-2264(199610)17:2<94::AID-GCC4>3.0.CO;2-W; Shaffer L.G., 2013, INT SYSTEM HUMAN CYT; Sloand EM, 2005, BLOOD, V106, P841, DOI 10.1182/blood-2004-05-2017; SOENEN V, 1995, BRIT J HAEMATOL, V90, P701, DOI 10.1111/j.1365-2141.1995.tb05604.x; Tefferi A, 2009, NEW ENGL J MED, V361, P1872, DOI 10.1056/NEJMra0902908; Tiu RV, 2011, BLOOD, V117, P4552, DOI 10.1182/blood-2010-07-295857; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496	27	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129375	10.1371/journal.pone.0129375	http://dx.doi.org/10.1371/journal.pone.0129375			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066831	Green Published, Green Submitted, gold			2022-12-26	WOS:000356327000069
J	Zhang, Q; Zhang, Y; Li, K; Wang, HY; Li, HZ; Zheng, JN				Zhang, Qing; Zhang, Yang; Li, Ke; Wang, Haiyu; Li, Huizhong; Zheng, Junnian			A Novel Strategy to Improve the Therapeutic Efficacy of Gemcitabine for Non-Small Cell Lung Cancer by the Tumor-Penetrating Peptide iRGD	PLOS ONE			English	Article							ELDERLY-PATIENTS; SINGLE-AGENT; MODIFIED LIPOSOMES; GROWTH-FACTOR; CHEMOTHERAPY; COMBINATION; PACLITAXEL; NANOPARTICLES; GLYCOPROTEIN; DOXORUBICIN	Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, comprising approximately 75-80% of all lung cancers. Gemcitabine is an approved chemotherapy drug for NSCLC. The objective of this study was to develop a novel strategy to improve the therapeutic efficacy of Gemcitabine for NSCLC by the co-administered iRGD peptide. We showed that the rates of positive expression of alpha v beta 3, alpha v beta 5 and NRP-1 in the A549 cell line were 68.5%, 35.3% and 94.5%, respectively. The amount of Evans Blue accumulated in the tumor of Evans Blue+iRGD group was 2.5 times that of Evans Blue group. The rates of growth inhibition of the tumors of the iRGD group, the Gemcitabine group and the Gemcitabine+iRGD group were 8%, 59.8% and 86.9%, respectively. The results of mechanism studies showed that PCNA expression in the Gemcitabine+iRGD group decreased 71.5% compared with that in Gemcitabine group. The rate of apoptosis in the Gemcitabine+iRGD group was 2.2 time that of the Gemcitabine group. Therefore, the tumor-penetrating Peptide iRGD can enhance the tumor-penetrating ability and therapeutic efficacy of Gemcitabine in the A549 xenograft. The combined application of Gemcitabine with iRGD may be a novel strategy to enhance the clinical therapeutic efficacy of Gemcitabine in patients with NSCLC.	[Zhang, Qing; Zhang, Yang; Li, Ke; Wang, Haiyu; Li, Huizhong; Zheng, Junnian] Xuzhou Med Coll, Inst Canc, Xuzhou 221002, Jiangsu, Peoples R China; [Zheng, Junnian] Xuzhou Med Coll, Inst Canc, Jiangsu Ctr Collaborat & Innovat Canc Biotherapy, Xuzhou 221002, Jiangsu, Peoples R China; [Zhang, Yang] Southeast Univ, Affiliated Hosp, Xuzhou Med Coll, Dept Oncol,Xuzhou Cent Hosp,Xuzhou Clin Sch, Xuzhou 221009, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University; Southeast University - China; Xuzhou Medical University	Zheng, JN (corresponding author), Xuzhou Med Coll, Inst Canc, Xuzhou 221002, Jiangsu, Peoples R China.	jnzheng@xzmc.edu.cn			Natural Science Foundation of Jiangsu Province [BK2012146]; National Natural Science Foundation of China [81301946]; Jiangsu Provincial Office of Education Foundation [JHB2012-34]; China Postdoctoral Science Foundation funded project [2013M540467]; Xuzhou Medical College Foundation [2012KJZ23]	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Office of Education Foundation; China Postdoctoral Science Foundation funded project(China Postdoctoral Science Foundation); Xuzhou Medical College Foundation	This work was supported by Natural Science Foundation of Jiangsu Province (BK2012146, http://www.jstd.gov.cn/), National Natural Science Foundation of China (81301946, http://www.nsfc.gov.cn/), Jiangsu Provincial Office of Education Foundation (JHB2012-34, http://www.ec.js.edu.cn/), China Postdoctoral Science Foundation funded project (2013M540467, http://res.chinapostdoctor.org.cn/BshWeb/index.shtml), and Xuzhou Medical College Foundation (2012KJZ23, http://www.xzmc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa K, 2013, LUNG CANCER, V82, P390, DOI 10.1016/j.lungcan.2013.09.012; Akashi Y, 2014, BRIT J CANCER, V110, P1481, DOI 10.1038/bjc.2014.49; Altavilla G, 2000, ANTICANCER RES, V20, P3675; Baker JHE, 2008, CLIN CANCER RES, V14, P2171, DOI 10.1158/1078-0432.CCR-07-4465; Bianco V, 2002, ANTICANCER RES, V22, P3053; Cao K, 2012, CANCER BIOTHER RADIO, V27, P259, DOI 10.1089/cbr.2011.1126; Cerqueira NMFSA, 2007, CHEM-EUR J, V13, P8507, DOI 10.1002/chem.200700260; Cortes-Funes H, 2002, SEMIN ONCOL, V29, P26, DOI 10.1053/sonc.2002.33530; Dai WB, 2015, DRUG DELIV, V22, P10, DOI 10.3109/10717544.2014.903580; Dancey J, 1997, EUR J CANCER, V33, pS2, DOI 10.1016/S0959-8049(96)00325-5; Du R, 2014, INT J NANOMED, V9, P3091, DOI 10.2147/IJN.S65664; Ferrigno D, 2000, LUNG CANCER-J IASLC, V29, P91, DOI 10.1016/S0169-5002(00)00112-4; Gridelli C, 2003, JNCI-J NATL CANCER I, V95, P362, DOI 10.1093/jnci/95.5.362; Gridelli C, 2008, LUNG CANCER, V61, P67, DOI 10.1016/j.lungcan.2007.12.002; Gu GZ, 2013, BIOMATERIALS, V34, P5138, DOI 10.1016/j.biomaterials.2013.03.036; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Higgins B, 2004, ANTI-CANCER DRUG, V15, P503, DOI 10.1097/01.cad.0000127664.66472.60; Kim IY, 2009, J CONTROL RELEASE, V140, P55, DOI 10.1016/j.jconrel.2009.07.005; Kim MK, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-98; Kraus-Berthier L, 2000, CLIN CANCER RES, V6, P297; Marx G, 2002, LUNG CANCER-J IASLC, V38, pS51; Mortenson MM, 2004, CANCER CHEMOTH PHARM, V54, P343, DOI 10.1007/s00280-004-0811-4; Pauwels B, 2005, ONCOLOGIST, V10, P34, DOI 10.1634/theoncologist.10-1-34; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; Primeau AJ, 2005, CLIN CANCER RES, V11, P8782, DOI 10.1158/1078-0432.CCR-05-1664; Quoix E, 2005, LUNG CANCER-J IASLC, V47, P405, DOI 10.1016/j.lungcan.2004.08.012; Ren HN, 2009, MOL CANCER THER, V8, P1106, DOI 10.1158/1535-7163.MCT-08-0779; Ricci S, 2000, LUNG CANCER, V27, P75, DOI 10.1016/S0169-5002(99)00098-7; Roth L, 2012, ONCOGENE, V31, P3754, DOI 10.1038/onc.2011.537; Sanchez AJ, 2006, J VIROL, V80, P514, DOI 10.1128/JVI.80.1.514-525.2006; Shelley MD, 2011, BJU INT, V108, P168, DOI 10.1111/j.1464-410X.2011.10341.x; Shen JN, 2014, MOL PHARMACEUT, V11, P2579, DOI 10.1021/mp400576f; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Song WT, 2012, MACROMOL BIOSCI, V12, P1514, DOI 10.1002/mabi.201200145; Spiro SG, 2002, AM J RESP CRIT CARE, V166, P1166, DOI 10.1164/rccm.200202-070SO; Su SS, 2013, BIOMATERIALS, V34, P3523, DOI 10.1016/j.biomaterials.2013.01.083; Sugahara KN, 2010, SCIENCE, V328, P1031, DOI 10.1126/science.1183057; Sugahara KN, 2009, CANCER CELL, V16, P510, DOI 10.1016/j.ccr.2009.10.013; Takebayashi R, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-34; Teesalu T, 2009, P NATL ACAD SCI USA, V106, P16157, DOI 10.1073/pnas.0908201106; Wang H, 2006, MOL CANCER THER, V5, P1585, DOI 10.1158/1535-7163.MCT-06-0094; Wang K, 2014, BIOMATERIALS, V35, P8735, DOI 10.1016/j.biomaterials.2014.06.042; Wang Lin-Run, 2005, J Zhejiang Univ Sci B, V6, P446, DOI 10.1631/jzus.2005.B0446; Wool-Lewis RJ, 1999, J VIROL, V73, P1419, DOI 10.1128/JVI.73.2.1419-1426.1999; Yang P, 2005, CHEST, V128, P452, DOI 10.1378/chest.128.1.452; Yu KF, 2013, INT J NANOMED, V8, P2473, DOI 10.2147/IJN.S46962; Zhang HT, 2011, ANTI-CANCER DRUG, V22, P409, DOI 10.1097/CAD.0b013e328342050d; Zhang Q, 2012, CANCER BIOTHER RADIO, V27, P384, DOI 10.1089/cbr.2012.1209; Zhang Y, 2013, MOL THER, V21, P1559, DOI 10.1038/mt.2013.120	49	24	25	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129865	10.1371/journal.pone.0129865	http://dx.doi.org/10.1371/journal.pone.0129865			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066322	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000117
J	Oguz, T; Macias, D; Tintore, J				Oguz, Temel; Macias, Diego; Tintore, Joaquin			Ageostrophic Frontal Processes Controlling Phytoplankton Production in the Catalano-Balearic Sea (Western Mediterranean)	PLOS ONE			English	Article							MESOSCALE VARIABILITY; ENGRAULIS-ENCRASICOLUS; SURFACE CIRCULATION; FRONTOGENESIS; SUBDUCTION; LARVAE; MODEL; COORDINATE; DYNAMICS; EDDIES	Buoyancy-induced unstable boundary currents and the accompanying retrograde density fronts are often the sites of pronounced mesoscale activity, ageostrophic frontal processes, and associated high biological production in marginal seas. Biophysical model simulations of the Catalano-Balearic Sea (Western Mediterranean) illustrated that the unstable and non-linear southward frontal boundary current along the Spanish coast resulted in a strain-driven frontogenesis mechanism. High upwelling velocities of up to 80 m d(-1) injected nutrients into the photic layer and promoted enhanced production on the less dense, onshore side of the front characterized by negative relative vorticity. Additional down-front wind stress and heat flux ( cooling) intensified boundary current instabilities and thus ageostrophic cross-frontal circulation and augmented production. Specifically, entrainment of nutrients by relatively strong buoyancy-induced vertical mixing gave rise to a more widespread phytoplankton biomass distribution within the onshore side of the front. Mesoscale cyclonic eddies contributed to production through an eddy pumping mechanism, but it was less effective and more limited regionally than the frontal processes. The model was configured for the Catalano-Balearic Sea, but the mechanisms and model findings apply to other marginal seas with similar unstable frontal boundary current systems.	[Oguz, Temel; Tintore, Joaquin] SOCIB, Balear Islands Coastal Ocean Observing & Forecast, Palma de Mallorca, Spain; [Oguz, Temel] Middle E Tech Univ, Inst Marine Sci, TR-33731 Erdemli, Mersin, Turkey; [Macias, Diego] European Commiss, Joint Res Ctr, Inst Environm & Sustainabil, Water Resources Unit, I-2749 Ispra, Italy; [Tintore, Joaquin] IMEDEA CSIC UIB, Esporles 07190, Spain	Middle East Technical University; European Commission Joint Research Centre; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears	Macias, D (corresponding author), European Commiss, Joint Res Ctr, Inst Environm & Sustainabil, Water Resources Unit, Via E Fermi, I-2749 Ispra, Italy.	diego.macias-moy@jrc.ec.europa.eu	oguz, temel/J-4252-2017; Macías, Diego/G-1972-2010	Macías, Diego/0000-0002-7772-255X; Tintore, Joaquin/0000-0002-6311-0093	EU funded PERSEUS project (Policy-oriented marine Environmental Research in the Southern European Seas, FP7) [287600]; Grantholder 30 position - European Commission	EU funded PERSEUS project (Policy-oriented marine Environmental Research in the Southern European Seas, FP7); Grantholder 30 position - European Commission	Support from the EU funded PERSEUS project (Policy-oriented marine Environmental Research in the Southern European Seas, FP7/No. 287600) is gratefully acknowledged. DM was supported by a Grantholder 30 position funded by the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz M, 2007, PROG OCEANOGR, V74, P294, DOI 10.1016/j.pocean.2007.04.003; Balbin R, 2012, CONT SHELF RES, V47, P28, DOI 10.1016/j.csr.2012.06.008; Bouffard J, 2012, PROG OCEANOGR, V106, P62, DOI 10.1016/j.pocean.2012.06.007; Bouffard J, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC006087; Capet X, 2008, J PHYS OCEANOGR, V38, P44, DOI 10.1175/2007JPO3672.1; Casella E, 2011, J MARINE SYST, V88, P12, DOI 10.1016/j.jmarsys.2011.02.019; CASTELLON A, 1990, Scientia Marina, V54, P269; de Puelles MLF, 2004, ICES J MAR SCI, V61, P654, DOI 10.1016/j.icesjms.2004.03.031; Estrada M, 1999, J PLANKTON RES, V21, P1, DOI 10.1093/plankt/21.1.1; Font J., 1988, OCEANOGRAPHIE PELAGI, VSP, P51; Fuentes VL, 2010, HYDROBIOLOGIA, V645, P23, DOI 10.1007/s10750-010-0205-z; HOSKINS BJ, 1982, ANNU REV FLUID MECH, V14, P131, DOI 10.1146/annurev.fl.14.010182.001023; Jordi A, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2009JC005301; Klein P, 2009, ANNU REV MAR SCI, V1, P351, DOI 10.1146/annurev.marine.010908.163704; Lapeyre G, 2006, J PHYS OCEANOGR, V36, P1577, DOI 10.1175/JPO2923.1; LAVIOLETTE PE, 1990, J GEOPHYS RES-OCEANS, V95, P1559, DOI 10.1029/JC095iC02p01559; Levy M, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001577; Levy M, 2001, J MAR RES, V59, P535, DOI 10.1357/002224001762842181; Lopez-Jurado JL, 2008, J MARINE SYST, V71, P303, DOI 10.1016/j.jmarsys.2007.03.007; Mahadevan A, 2006, OCEAN MODEL, V14, P241, DOI 10.1016/j.ocemod.2006.05.006; Mason E, 2013, J GEOPHYS RES-OCEANS, V118, P3007, DOI 10.1002/jgrc.20234; MCCALPIN JD, 1994, INT J NUMER METH FL, V18, P361, DOI 10.1002/fld.1650180404; Mellor G. L., 2004, PROGRAM ATMOSPHERIC; MELLOR GL, 1982, REV GEOPHYS, V20, P851, DOI 10.1029/RG020i004p00851; Mellor GL, 1998, J ATMOS OCEAN TECH, V15, P1122, DOI 10.1175/1520-0426(1998)015<1122:SCPGEA>2.0.CO;2; Monserrat S, 2008, J MARINE SYST, V71, P413, DOI 10.1016/j.jmarsys.2006.11.012; Morote E, 2010, ICES J MAR SCI, V67, P897, DOI 10.1093/icesjms/fsp302; Nagai T, 2008, DYNAM ATMOS OCEANS, V45, P229, DOI 10.1016/j.dynatmoce.2007.12.001; Oguz T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111482; Oguz T, 2013, PROG OCEANOGR, V112, P1, DOI 10.1016/j.pocean.2013.03.001; Pascual A, 2004, J PHYS OCEANOGR, V34, P2274, DOI 10.1175/1520-0485(2004)034<2274:AQAOAM>2.0.CO;2; Pascual A, 2010, SEA TECHNOL, V51, P32; Pinot JM, 1995, PROG OCEANOGR, V36, P343, DOI 10.1016/0079-6611(96)00003-1; Pinot JM, 2002, PROG OCEANOGR, V55, P335, DOI 10.1016/S0079-6611(02)00139-8; PINOT JM, 1994, DEEP-SEA RES PT I, V41, P897, DOI 10.1016/0967-0637(94)90082-5; Sabates A, 2004, DEEP-SEA RES PT I, V51, P545, DOI 10.1016/j.dsr.2003.11.003; Sabates A, 2013, J MARINE SYST, V111, P108, DOI 10.1016/j.jmarsys.2012.10.002; Salat J, 2002, CONT SHELF RES, V22, P327, DOI 10.1016/S0278-4343(01)00031-0; Shchepetkin AF, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001047; SPALL MA, 1995, J GEOPHYS RES-OCEANS, V100, P2543, DOI 10.1029/94JC02860; Thomas LN, 2005, J PHYS OCEANOGR, V35, P1086, DOI 10.1175/JPO2737.1; TINTORE J, 1991, J PHYS OCEANOGR, V21, P811, DOI 10.1175/1520-0485(1991)021<0811:MDAVMI>2.0.CO;2; Tintore J., 2013, MARINE TECHNOLOGY SO, V47, P1; TINTORE JQ, 1990, J GEOPHYS RES-OCEANS, V95, P1627, DOI 10.1029/JC095iC02p01627; Villate F, 2014, J MARINE SYST, V139, P9, DOI 10.1016/j.jmarsys.2014.05.004; Wang DP, 2011, OCEAN MODEL, V38, P161, DOI 10.1016/j.ocemod.2011.02.012; WANG DP, 1993, J MAR RES, V51, P497, DOI 10.1357/0022240933224034; WANG DP, 1988, J MAR RES, V46, P321, DOI 10.1357/002224088785113586; Yoshikawa Y, 2012, J PHYS OCEANOGR, V42, P991, DOI 10.1175/JPO-D-11-0154.1	49	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129045	10.1371/journal.pone.0129045	http://dx.doi.org/10.1371/journal.pone.0129045			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26065688	Green Published, gold, Green Submitted			2022-12-26	WOS:000356100900041
J	Hichijo, N; Tanaka, E; Kawai, N; van Ruijven, LJ; Langenbach, GEJ				Hichijo, Natsuko; Tanaka, Eiji; Kawai, Nobuhiko; van Ruijven, Leo J.; Langenbach, Geerling E. J.			Effects of Decreased Occlusal Loading during Growth on the Mandibular Bone Characteristics	PLOS ONE			English	Article							MASTICATORY FUNCTION; ALVEOLAR BONE; MYOTONIC-DYSTROPHY; FOOD CONSISTENCY; MINERAL DENSITY; MUSCLE; ADAPTATION; STRENGTH; SIZE; MASS	Background Bone mass and mineralization are largely influenced by loading. The purpose of this study was to evaluate the reaction of the entire mandibular bone in response to decreased load during growth. It is hypothesized that decreased muscular loading will lead to bone changes as seen during disuse, i.e. loss of bone mass. Methods and Findings Ten 21-day-old Wistar strain male rats were divided into two groups (each n=5) and fed on either a hard-or soft-diet for 11 weeks. Micro-computed tomography was used for the investigation of bone mineralization, bone volume, bone volume fraction (BV/TV) and morphological analysis. Mandibular mineralization patterns were very consistent, showing a lower degree of mineralization in the ramus than in the corpus. In the soft-diet group, mineralization below the molars was significantly increased (p<0.05) compared to the hard diet group. Also, bone volume and BV/TV of the condyle and the masseter attachment were decreased in the soft-diet group (p<0.05). Morphological analysis showed inhibited growth of the ramus in the soft-diet group (p<0.05). Conclusion Decreased loading by a soft diet causes significant changes in the mandible. However, these changes are very region-specific, probably depending on the alterations in the local loading regime. The results suggest that muscle activity during growth is very important for bone quality and morphology.	[Hichijo, Natsuko] Univ Tokushima, Grad Sch Oral Sci, Dept Orthodont & Dentofacial Orthoped, Tokushima 770, Japan; [Tanaka, Eiji; Kawai, Nobuhiko] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Orthodont & Dentofacial Orthoped, Tokushima 770, Japan; [Tanaka, Eiji] King Abdulaziz Univ, Fac Dent, Dept Orthodont, Jeddah 21413, Saudi Arabia; [van Ruijven, Leo J.; Langenbach, Geerling E. J.] Univ Amsterdam, ACTA, Res Inst MOVE, Dept Oral Cell Biol & Funct Anat, Amsterdam, Netherlands; [van Ruijven, Leo J.; Langenbach, Geerling E. J.] Vrije Univ Amsterdam, Amsterdam, Netherlands	Tokushima University; Tokushima University; King Abdulaziz University; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Tanaka, E (corresponding author), Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Orthodont & Dentofacial Orthoped, Tokushima 770, Japan.	etanaka@tokushima-u.ac.jp	Tanaka, Eiji/E-7105-2015	Tanaka, Eiji/0000-0002-2707-1613	Ministry of Education, Culture, Sports, Science and Technology, Japan [26463095, 26293436]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by Grants-in-Aid 26293436 (E.T.) and 26463095 (N.K.) for Science Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bresin A, 1999, EUR J ORAL SCI, V107, P35, DOI 10.1046/j.0909-8836.1999.eos107107.x; Burr DB, 1997, J BONE MINER RES, V12, P1547, DOI 10.1359/jbmr.1997.12.10.1547; Cullen DM, 2001, J APPL PHYSIOL, V91, P1971, DOI 10.1152/jappl.2001.91.5.1971; Daly RM, 2006, OSTEOPOROSIS INT, V17, P1258, DOI 10.1007/s00198-006-0114-1; Daly RM, 2004, BONE, V34, P281, DOI 10.1016/j.bone.2003.11.009; de Jong WC, 2013, BONE, V55, P391, DOI 10.1016/j.bone.2013.04.026; Denes BJ, 2013, EUR J ORAL SCI, V121, P532, DOI 10.1111/eos.12092; Enlow DH, 1990, FACIAL GROWTH, P130; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Frost HM, 2001, ANAT RECORD, V262, P398, DOI 10.1002/ar.1049; Hichijo N, 2014, J ORAL REHABIL, V41, P581, DOI 10.1111/joor.12171; KANNUS P, 1994, BONE, V15, P279, DOI 10.1016/8756-3282(94)90289-5; Kawai N, 2010, J ANAT, V216, P717, DOI 10.1111/j.1469-7580.2010.01235.x; KILIARIDIS S, 1989, EUR J ORTHODONT, V11, P131, DOI 10.1093/oxfordjournals.ejo.a035975; KUSTERS ST, 1991, J DENT RES, V70, P192, DOI 10.1177/00220345910700030701; Lang T, 2004, J BONE MINER RES, V19, P1006, DOI 10.1359/JBMR.040307; Mavropoulos A, 2004, BONE, V35, P191, DOI 10.1016/j.bone.2004.03.020; Mavropoulos A, 2010, BONE, V47, P687, DOI 10.1016/j.bone.2010.06.025; Mulder L, 2004, ACTA RADIOL, V45, P769, DOI 10.1080/02841850410008171; Nurmi-Lawton JA, 2004, J BONE MINER RES, V19, P314, DOI 10.1359/JBMR.0301222; Odman C, 1996, J ORAL REHABIL, V23, P5, DOI 10.1111/j.1365-2842.1996.tb00804.x; Poliachik SL, 2010, BONE, V46, P18, DOI 10.1016/j.bone.2009.10.025; Qin YX, 2010, J MUSCULOSKEL NEURON, V10, P12; RUBIN CT, 1985, CALCIFIED TISSUE INT, V37, P411, DOI 10.1007/BF02553711; Sato H, 2005, AM J ORTHOD DENTOFAC, V128, P766, DOI 10.1016/j.ajodo.2005.05.046; SHUTTLEWORTH CA, 1983, INT REV CONNECT TISS, V10, P211; Tanaka E, 2007, ANN BIOMED ENG, V35, P1617, DOI 10.1007/s10439-007-9330-x; Tuner CH, 2000, BONE, V27, P339; Warner SE, 2006, BONE, V38, P257, DOI 10.1016/j.bone.2005.08.009; Watanabe Y, 2004, J BONE MINER RES, V19, P1771, DOI 10.1359/JBMR.040811; Yonemitsu K, 2007, ARCH ORAL BIOL, V52, P487, DOI 10.1016/j.archoralbio.2006.10.019; Zanoteli E, 2002, ORAL SURG ORAL MED O, V94, P262, DOI 10.1067/moe.2002.124580	32	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129290	10.1371/journal.pone.0129290	http://dx.doi.org/10.1371/journal.pone.0129290			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26062027	Green Published, gold			2022-12-26	WOS:000355979500137
J	Kato, Y; Nagao, Y				Kato, Yoku; Nagao, Yoshikazu			Changes in Sperm Motility and Capacitation Induce Chromosomal Aberration of the Bovine Embryo following Intracytoplasmic Sperm Injection	PLOS ONE			English	Article							HYPERACTIVATED MOTILITY; ACROSOME REACTION; OXIDATIVE STRESS; BULL SPERM; OOCYTES; SPERMATOZOA; FERTILIZATION; MITOCHONDRIA; PHOSPHORYLATION; ACTIVATION	Intracytoplasmic sperm injection (ICSI) has become the method of choice to treat human male infertility. One of the outstanding problems associated with this technique is our current lack of knowledge concerning the effect of sperm capacitation and motility upon the subsequent development of oocytes following ICSI. In the present study, we first examined the capacitation state of sperm exhibiting normal motility, along with sperm that had been activated, and examined the effect of reactive oxygen species (ROS) produced by these sperm types upon embryogenesis following bovine in vitro fertilization (IVF) and ICSI. Data showed that activated sperm reduced the chromosomal integrity of IVF/ICSI embryos at the blastocyst stage, while capacitated sperm produced ROS in capacitation media. Secondly, we treated sperm with carbonyl cyanide m-chlorophenyl hydrazine (CCCP), a chemical known to uncouple cell respiration within the mitochondria, and investigated the effect of this treatment upon blastocyst formation and chromosomal integrity at the blastocyst stage. Activated sperm in which the mitochondria had been treated with CCCP reduced levels of chromosomal aberration at the blastocyst stage following ICSI, by reducing mitochondrial activity in activated sperm. In conclusion, these findings suggest that capacitated sperm exhibiting activated motility induced chromosomal aberration during development to the blastocyst stage following ICSI. The injection of sperm exhibiting normal motility, or activated sperm in which mitochondrial activity had been reduced, improved the quality of ICSIderived embryos. Therefore, the selection of sperm exhibiting progressive motility may not always be better for early embryo development and fetal growth following human ICSI, and that the use of a bovine model may contribute to a deeper understanding of sperm selection for human ICSI embryo development.	[Kato, Yoku; Nagao, Yoshikazu] Tokyo Univ Agr & Technol, United Grad Sch Agr Sci, Dept Anim Prod Sci, Fuchu, Tokyo 1838509, Japan; [Kato, Yoku; Nagao, Yoshikazu] Utsunomiya Univ, Fac Agr, Univ Farm, Mohka, Tochigi 3214415, Japan	Tokyo University of Agriculture & Technology; Utsunomiya University	Nagao, Y (corresponding author), Tokyo Univ Agr & Technol, United Grad Sch Agr Sci, Dept Anim Prod Sci, Fuchu, Tokyo 1838509, Japan.	ynagao@cc.utsunomiya-u.ac.jp						Aitken RJ, 2011, ASIAN J ANDROL, V13, P36, DOI 10.1038/aja.2010.68; Ajduk A, 2006, BIOL REPROD, V75, P442, DOI 10.1095/biolreprod.106.053223; Andersen AN, 2006, INT J ANDROL, V29, P12, DOI 10.1111/j.1365-2605.2005.00577.x; Bailey JL, 2010, SYST BIOL REPROD MED, V56, P334, DOI 10.3109/19396368.2010.512377; Betts DH, 2008, MOL HUM REPROD, V14, P445, DOI 10.1093/molehr/gan035; Betts DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086978; Burruel V, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110981; Caglar GS, 2005, IN VIVO, V19, P623; Chen SJ, 2013, ARCH GYNECOL OBSTET, V288, P191, DOI 10.1007/s00404-013-2801-4; de Lamirande E, 2008, BBA-PROTEINS PROTEOM, V1784, P106, DOI 10.1016/j.bbapap.2007.08.024; Devine PJ, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095224; DOZORTSEV D, 1994, HUM REPROD, V9, P2139, DOI 10.1093/oxfordjournals.humrep.a138406; Emuta Chie, 2001, Journal of Reproduction and Development, V47, P399, DOI 10.1262/jrd.47.399; Fatehi AN, 2005, ZYGOTE, V13, P177, DOI 10.1017/S0967199405003126; Ferramosca A, 2008, INT J ANDROL, V31, P337, DOI 10.1111/j.1365-2605.2007.00775.x; FRASER LR, 1995, MOL REPROD DEV, V40, P233, DOI 10.1002/mrd.1080400213; Gianaroli L, 2010, FERTIL STERIL, V93, P807, DOI 10.1016/j.fertnstert.2008.10.024; Ho HC, 2002, DEV BIOL, V250, P208, DOI 10.1006/dbio.2002.0797; Ho HC, 2001, REPRODUCTION, V122, P519, DOI 10.1530/rep.0.1220519; Hung PH, 2008, BIOL REPROD, V79, P367, DOI 10.1095/biolreprod.107.066357; Kato Y, 2011, ZYGOTE, V19, P21, DOI 10.1017/S0967199410000304; KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709; Koppers AJ, 2008, J CLIN ENDOCR METAB, V93, P3199, DOI 10.1210/jc.2007-2616; Kothari S, 2010, INDIAN J EXP BIOL, V48, P425; Kumar V, 2006, BIOL REPROD, V75, P767, DOI 10.1095/biolreprod.106.053587; Mariappa D, 2010, MOL REPROD DEV, V77, P182, DOI 10.1002/mrd.21131; Martin MJ, 2000, BIOL REPROD, V63, P109, DOI 10.1095/biolreprod63.1.109; Morozumi K, 2005, P NATL ACAD SCI USA, V102, P14209, DOI 10.1073/pnas.0507005102; Morozumi K, 2006, P NATL ACAD SCI USA, V103, P17661, DOI 10.1073/pnas.0608183103; NAGAO Y, 1994, THERIOGENOLOGY, V41, P681, DOI 10.1016/0093-691X(94)90177-K; NAGAO Y, 2010, ZYGOTE, V24, P1; Nagao Y, 2008, ZYGOTE, V16, P127, DOI 10.1017/S0967199408004644; Nagy ZP, 1995, HUM REPROD, V10, P3171, DOI 10.1093/oxfordjournals.humrep.a135881; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; O'Flaherty C, 2006, FREE RADICAL BIO MED, V40, P1045, DOI 10.1016/j.freeradbiomed.2005.10.055; O'Flaherty C, 2003, INT J ANDROL, V26, P109, DOI 10.1046/j.1365-2605.2003.00404.x; Oikawa T, 2005, ANIM REPROD SCI, V86, P187, DOI 10.1016/j.anireprosci.2004.07.003; PALERMO G, 1992, LANCET, V340, P17, DOI 10.1016/0140-6736(92)92425-F; Palermo GD, 2012, FERTIL STERIL, V97, P248, DOI 10.1016/j.fertnstert.2011.12.037; Piomboni P, 2012, INT J ANDROL, V35, P109, DOI 10.1111/j.1365-2605.2011.01218.x; Sagirkaya H, 2007, ANIM REPROD SCI, V101, P225, DOI 10.1016/j.anireprosci.2006.09.016; Sarentonglaga B, 2013, J REPROD DEVELOP, V59, P168, DOI 10.1262/jrd.2012-163; Song BS, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.097949; Suarez SS, 2008, HUM REPROD UPDATE, V14, P647, DOI 10.1093/humupd/dmn029; Sutovsky P, 2004, REPROD BIOMED ONLINE, V8, P24, DOI 10.1016/S1472-6483(10)60495-6; Tantibhedhyangkul J, 2014, ANDROLOGY-US, V2, P875, DOI 10.1111/j.2047-2927.2014.00263.x; Tateno H, 2007, BIOL REPROD, V77, P336, DOI 10.1095/biolreprod.106.057778; Van Steirteghem A, 2012, HUM REPROD, V27, P3363, DOI 10.1093/humrep/des414; Yoshizawa M, 1999, THERIOGENOLOGY, V51, P1239, DOI 10.1016/S0093-691X(99)00068-0	49	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129285	10.1371/journal.pone.0129285	http://dx.doi.org/10.1371/journal.pone.0129285			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061876	Green Submitted, Green Published, gold			2022-12-26	WOS:000355979500136
J	Marx, FM; Fiebig, L; Hauer, B; Brodhun, B; Glaser-Paschke, G; Magdorf, K; Haas, W				Marx, Florian M.; Fiebig, Lena; Hauer, Barbara; Brodhun, Bonita; Glaser-Paschke, Gisela; Magdorf, Klaus; Haas, Walter			Higher Rate of Tuberculosis in Second Generation Migrants Compared to Native Residents in a Metropolitan Setting in Western Europe	PLOS ONE			English	Article							LOW-INCIDENCE COUNTRY; PULMONARY TUBERCULOSIS; IMMIGRATION; TRANSMISSION; NETHERLANDS; CESSATION; REFUGEES; NEWBORN; CITIES; NORWAY	Background In Western Europe, migrants constitute an important risk group for tuberculosis, but little is known about successive generations of migrants. We aimed to characterize migration among tuberculosis cases in Berlin and to estimate annual rates of tuberculosis in two subsequent migrant generations. We hypothesized that second generation migrants born in Germany are at higher risk of tuberculosis compared to native (non-migrant) residents. Methods A prospective cross-sectional study was conducted. All tuberculosis cases reported to health authorities in Berlin between 11/2010 and 10/2011 were eligible. Interviews were conducted using a structured questionnaire including demographic data, migration history of patients and their parents, and language use. Tuberculosis rates were estimated using 2011 census data. Results Of 314 tuberculosis cases reported, 154 (49.0%) participated. Of these, 81 (52.6%) were first-, 14 (9.1%) were second generation migrants, and 59 (38.3%) were native residents. The tuberculosis rate per 100,000 individuals was 28.3 (95CI: 24.0-32.6) in first-, 10.2 (95% CI: 6.1-16.6) in second generation migrants, and 4.6 (95% CI: 3.7-5.6) in native residents. When combining information from the standard notification variables country of birth and citizenship, the sensitivity to detect second generation migration was 28.6%. Conclusions There is a higher rate of tuberculosis among second generation migrants compared to native residents in Berlin. This may be explained by presumably frequent contact and transmission within migrant populations. Second generation migration is insufficiently captured by the surveillance variables country of birth and citizenship. Surveillance systems in Western Europe should allow for quantifying the tuberculosis burden in this important risk group.	[Marx, Florian M.; Magdorf, Klaus] Charite, Dept Pediat Pneumol & Immunol, D-13353 Berlin, Germany; [Marx, Florian M.; Magdorf, Klaus] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA; [Fiebig, Lena; Hauer, Barbara; Brodhun, Bonita; Haas, Walter] Robert Koch Inst, Dept Infect Dis Epidemiol, Resp Infect Unit, Berlin, Germany; [Glaser-Paschke, Gisela] Publ Hlth Off Berlin Lichtenberg, Ctr TB, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Brigham & Women's Hospital; Robert Koch Institute	Marx, FM (corresponding author), Charite, Dept Pediat Pneumol & Immunol, D-13353 Berlin, Germany.	florian.marx@charite.de	Marx, Florian/AAD-7148-2019	Marx, Florian/0000-0003-4630-4598; Fiebig, Lena/0000-0002-5977-0507	Oskar Helene Heim Foundation, Berlin	Oskar Helene Heim Foundation, Berlin	This study was conducted thanks to a study grant provided by the Oskar Helene Heim Foundation, Berlin (URL:http://www.stiftung-ohh.de) to KM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barniol J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-197; Blumberg HM, LANCET, V375, P2127; Borgdorff MW, 2010, EUR RESPIR J, V36, P339, DOI 10.1183/09031936.00155409; Bothamley GH, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-896; Bundesamt Statistisches, 2011, BEV ERW BEV MIGR ERG; Cayla JA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-127; Dahle UR, 2007, AM J RESP CRIT CARE, V176, P930, DOI 10.1164/rccm.200702-187OC; European Centre for Disease Prevention and Control/WHO Regional Office for Europe, 2013, TUB SURV MON EUR; Farah MG, 2005, INT J EPIDEMIOL, V34, P1005, DOI 10.1093/ije/dyi058; Fiebig L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049111; Gilbert RL, 2009, INT J TUBERC LUNG D, V13, P645; Marques TVGA, 2012, CAN MED ASSOC J, V184, pE531, DOI 10.1503/cmaj.109-4214; Heldal E, 2008, INT J TUBERC LUNG D, V12, P878; Hofler M, 2005, SOC PSYCH PSYCH EPID, V40, P291, DOI 10.1007/s00127-005-0882-5; Johnsen NL, 2005, INT J TUBERC LUNG D, V9, P37; Kamper-Jorgensen Z, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-60; Lillebaek T, 2002, EMERG INFECT DIS, V8, P679, DOI 10.3201/eid0807.010482; MCCARTHY OR, 1984, BRIT J DIS CHEST, V78, P248, DOI 10.1016/S0007-0971(84)80118-7; Nejat S, 2012, PEDIATR INFECT DIS J, V31, P224, DOI 10.1097/INF.0b013e31823d923c; Ormerod LP, 2001, J INFECTION, V43, P132, DOI 10.1053/jinf.2001.0872; RIEDER HL, 1994, EUR RESPIR J, V7, P1545, DOI 10.1183/09031936.94.07081545; Robert Koch-Institut, 2013, BERICHT EPIDEMIOLOGI; ROMANUS V, 1987, PEDIATR INFECT DIS J, V6, P272, DOI 10.1097/00006454-198703000-00014; ROMANUS V, 1983, TUBERCLE, V64, P101, DOI 10.1016/0041-3879(83)90034-X; Tafuri S, 2011, AM J INFECT CONTROL, V39, P495, DOI 10.1016/j.ajic.2010.10.013; Valin N, 2005, INT J TUBERC LUNG D, V9, P528; Van Hest NA, 2014, EUROSURVEILLANCE, V19, P20728; van Leth F, 2009, EUR J PUBLIC HEALTH, V19, P424, DOI 10.1093/eurpub/ckp042; Vos AM, 2004, EMERG INFECT DIS, V10, P736, DOI 10.3201/eid1004.030530; Vries G. de, 2014, Eurosurveillance, V19, P20726; Wilcke JTR, 1998, INT J TUBERC LUNG D, V2, P219; World Health Organization European Ministerial Forum, 2007, BERL DECL TUB; World Health Organization Regional Office for Europe, 2007, TUB LARG CIT; Zenner D, 2013, LANCET, V382, P1311, DOI 10.1016/S0140-6736(13)62113-3	34	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							10	10.1371/journal.pone.0119693	http://dx.doi.org/10.1371/journal.pone.0119693			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061733	Green Published, gold, Green Submitted			2022-12-26	WOS:000355979500002
J	Silva-Rocha, R; Pontelli, MC; Furtado, GP; Zaramela, LS; Koide, T				Silva-Rocha, Rafael; Pontelli, Marjorie Cornejo; Furtado, Gilvan Pessoa; Zaramela, Livia Soares; Koide, Tie			Development of New Modular Genetic Tools for Engineering the Halophilic Archaeon Halobacterium salinarum	PLOS ONE			English	Article							SYNTHETIC BIOLOGY; MODEL; ORGANISMS; STANDARD; BACTERIA; PLATFORM; VECTORS; DOMAINS; SYSTEM; NRC-1	Our ability to genetically manipulate living organisms is usually constrained by the efficiency of the genetic tools available for the system of interest. In this report, we present the design, construction and characterization of a set of four new modular vectors, the pHsal series, for engineering Halobacterium salinarum, a model halophilic archaeon widely used in systems biology studies. The pHsal shuttle vectors are organized in four modules: (i) the E. coli's specific part, containing a ColE1 origin of replication and an ampicillin resistance marker, (ii) the resistance marker and (iii) the replication origin, which are specific to H. salinarum and (iv) the cargo, which will carry a sequence of interest cloned in a multiple cloning site, flanked by universal M13 primers. Each module was constructed using only minimal functional elements that were sequence edited to eliminate redundant restriction sites useful for cloning. This optimization process allowed the construction of vectors with reduced sizes compared to currently available platforms and expanded multiple cloning sites. Additionally, the strong constitutive promoter of the fer2 gene was sequence optimized and incorporated into the platform to allow high-level expression of heterologous genes in H. salinarum. The system also includes a new minimal suicide vector for the generation of knockouts and/or the incorporation of chromosomal tags, as well as a vector for promoter probing using a GFP gene as reporter. This new set of optimized vectors should strongly facilitate the engineering of H. salinarum and similar strategies could be implemented for other archaea.	[Silva-Rocha, Rafael; Pontelli, Marjorie Cornejo; Furtado, Gilvan Pessoa; Zaramela, Livia Soares; Koide, Tie] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Biochem & Immunol, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo	Koide, T (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Biochem & Immunol, Ribeirao Preto, SP, Brazil.	tkoide@fmrp.usp.br	Silva-Rocha, Rafael/H-4929-2012; Zaramela, Lívia Soares/AAD-2687-2022; Pontelli, Marjorie/T-7833-2019; Koide, Tie/D-4406-2014	Silva-Rocha, Rafael/0000-0001-6319-631X; Zaramela, Lívia Soares/0000-0002-1065-3799; Koide, Tie/0000-0003-4760-2423; Pessoa Furtado, Gilvan/0000-0002-8797-7783; Pontelli, Marjorie/0000-0003-3173-5977	Young Researcher Program of Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [09/09532-0]; Edital Universal do Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [473660/2013-0, 470120/2009-6]; Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA); Nucleo de Apoio a Pesquisa em Biologia Computacional e Genomica (NAP-NUBIC) from Universidade de Sao Paulo; FAPESP [13/04125-2, 11/07487-7, 13/23712-6]; CAPES	Young Researcher Program of Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Edital Universal do Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA); Nucleo de Apoio a Pesquisa em Biologia Computacional e Genomica (NAP-NUBIC) from Universidade de Sao Paulo; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Young Researcher Program of Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - http://fapesp.br/en/) [09/09532-0 to TK], Edital Universal do Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - http://www.cnpq.br/) [473660/2013-0 to TK, 470120/2009-6 to TK], Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA); Nucleo de Apoio a Pesquisa em Biologia Computacional e Genomica (NAP-NUBIC) from Universidade de Sao Paulo; fellowships from FAPESP [13/04125-2 to RSR, 11/07487-7 to LSZ, 13/23712-6 to GPF] and CAPES [to MCP].	Allers T, 2005, NAT REV GENET, V6, P58, DOI 10.1038/nrg1504; Arkin A, 2008, NAT BIOTECHNOL, V26, P771, DOI 10.1038/nbt0708-771; Bell SD, 1998, TRENDS MICROBIOL, V6, P222, DOI 10.1016/S0966-842X(98)01281-5; Bonneau R, 2007, CELL, V131, P1354, DOI 10.1016/j.cell.2007.10.053; Brooks AN, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145160; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Danner S, 1996, MOL MICROBIOL, V19, P1265, DOI 10.1111/j.1365-2958.1996.tb02471.x; EBERT K, 1984, MOL GEN GENET, V194, P91, DOI 10.1007/BF00383502; Farkas JA, 2013, ANNU REV GENET, V47, P539, DOI 10.1146/annurev-genet-111212-133225; Gonzalez O, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000332; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Huang HH, 2010, NUCLEIC ACIDS RES, V38, P2577, DOI 10.1093/nar/gkq164; Hundt S, 2007, J BACTERIOL, V189, P6936, DOI 10.1128/JB.00559-07; Koide T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.42; Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668; Lee TS, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-12; Leigh JA, 2011, FEMS MICROBIOL REV, V35, P577, DOI 10.1111/j.1574-6976.2011.00265.x; Leuko S, 2009, J PROTEOME RES, V8, P2218, DOI 10.1021/pr800663c; Lienert F, 2014, NAT REV MOL CELL BIO, V15, P95, DOI 10.1038/nrm3738; Liu WS, 2013, NAT REV GENET, V14, P781, DOI 10.1038/nrg3583; MUNRO S, 1984, EMBO J, V3, P3087, DOI 10.1002/j.1460-2075.1984.tb02263.x; Peck RF, 2000, MOL MICROBIOL, V35, P667, DOI 10.1046/j.1365-2958.2000.01739.x; Robb F.T., 1995, ARCHAEA LAB MANUAL; Sarrion-Perdigones A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021622; Seitzer P, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-317; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; Silva-Rocha R, 2013, NUCLEIC ACIDS RES, V41, pD666, DOI 10.1093/nar/gks1119; van den Burg B, 2003, CURR OPIN MICROBIOL, V6, P213, DOI 10.1016/S1369-5274(03)00060-2; Van PT, 2008, J PROTEOME RES, V7, P3755, DOI 10.1021/pr800031f; Wilbanks EG, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks063; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	32	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129215	10.1371/journal.pone.0129215	http://dx.doi.org/10.1371/journal.pone.0129215			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061363	Green Submitted, Green Published, gold			2022-12-26	WOS:000355979500131
J	Wilson, DA; Derraik, JGB; Rowe, DL; Hofman, PL; Cutfield, WS				Wilson, Dyanne A.; Derraik, Jose G. B.; Rowe, Deborah L.; Hofman, Paul L.; Cutfield, Wayne S.			Earlier Menarche Is Associated with Lower Insulin Sensitivity and Increased Adiposity in Young Adult Women	PLOS ONE			English	Article							BODY-COMPOSITION; RISK-FACTORS; AGE; PUBERTY; RESISTANCE; GROWTH; WEIGHT; GIRLS; SECRETION; OBESITY	Objective We aimed to assess whether age at menarche was associated with insulin sensitivity in young adult women. Methods We studied 54 healthy young women aged 20-30 years. Participants were grouped according to age at menarche: Early (<= 11.0 years; n=13), Average (>12.0 and <= 13.0 years; n=28), and Late (>= 14.0 years, n=13). Primary outcome was insulin sensitivity measured using intravenous glucose tolerance tests and Bergman's minimal model. Body composition was assessed using whole-body dual-energy X-ray absorptiometry. Results Earlier menarche was associated with lower insulin sensitivity (p=0.015). There was also a continuous increase in adiposity with younger age at menarche, which was associated with increased weight (p=0.001), BMI (p=0.002), total body fat (p=0.049), and truncal fat (p=0.020). Stratified analyses showed that insulin sensitivity in Early women (5.5x10(-4).min(-1)(mU/l)) was lower than in Average (8.0x10(-4).min(-1)(mU/l), p=0.021) and Late (8.6x10(-4).min(-1)(mU/l), p=0.033) groups. Early women (weight=66.1 kg; BMI=24.1 kg/m(2)) were considerably heavier and fatter than Average (59.0 kg, p=0.004; 21.4 kg/m(2), p=0.002) and Late (57.0 kg, p=0.001; 20.8 kg/m(2), p=0.0009) women. Conclusions Early menarche is associated with lower insulin sensitivity and increased adiposity in young adulthood, potentially increasing the risk of type 2 diabetes and the metabolic syndrome later in life.	[Wilson, Dyanne A.; Derraik, Jose G. B.; Hofman, Paul L.; Cutfield, Wayne S.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Rowe, Deborah L.] Univ Auckland, Fac Med & Hlth Sci, Sch Nursing, Auckland 1, New Zealand	University of Auckland; University of Auckland	Cutfield, WS (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	w.cutfield@auckland.ac.nz	Derraik, José Guilherme Behrensdorf/A-1925-2008	Derraik, José Guilherme Behrensdorf/0000-0003-1226-1956	Southern Trust Grant	Southern Trust Grant	This work was funded by a Southern Trust Grant (DAW WSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Akter S, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-99; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Burcelin R, 2003, ENDOCRINOLOGY, V144, P4484, DOI 10.1210/en.2003-0457; Buyken AE, 2009, AM J CLIN NUTR, V89, P221, DOI 10.3945/ajcn.2008.26733; Chen LW, 2011, J CLIN ENDOCR METAB, V96, pE1007, DOI 10.1210/jc.2010-2526; Chiarelli F, 2008, EUR J ENDOCRINOL, V159, pS67, DOI 10.1530/EJE-08-0245; Chumlea WC, 2003, PEDIATRICS, V111, P110, DOI 10.1542/peds.111.1.110; Cunningham MJ, 1999, BIOL REPROD, V60, P216, DOI 10.1095/biolreprod60.2.216; CUTFIELD WS, 1990, J CLIN ENDOCR METAB, V70, P1644, DOI 10.1210/jcem-70-6-1644; DAMON A, 1974, HUM BIOL, V46, P381; Dostalova I, 2007, PHYSIOL RES, V56, P587, DOI 10.33549/physiolres.931089; Douglas NM, 2007, J PAEDIATR CHILD H, V43, P173, DOI 10.1111/j.1440-1754.2007.01038.x; Facchini FS, 2001, J CLIN ENDOCR METAB, V86, P3574, DOI 10.1210/jc.86.8.3574; Feng Y, 2008, ATHEROSCLEROSIS, V196, P590, DOI 10.1016/j.atherosclerosis.2007.06.016; Freedman David S, 2003, BMC Pediatr, V3, P3, DOI 10.1186/1471-2431-3-3; Gamba M, 2006, MOL CELL ENDOCRINOL, V254, P133, DOI 10.1016/j.mce.2006.04.023; GARN SM, 1986, AM J CLIN NUTR, V43, P879, DOI 10.1093/ajcn/43.6.879; GODSLAND IF, 1992, J CLIN ENDOCR METAB, V74, P64, DOI 10.1210/jc.74.1.64; Hannon TS, 2007, J CLIN ENDOCR METAB, V92, P3033, DOI 10.1210/jc.2007-0308; He CY, 2010, AM J EPIDEMIOL, V171, P334, DOI 10.1093/aje/kwp372; Herman-Giddens ME, 2007, J ADOLESCENT HEALTH, V40, P201, DOI 10.1016/j.jadohealth.2006.12.019; Ibanez L, 2006, J CLIN ENDOCR METAB, V91, P2068, DOI 10.1210/jc.2005-2329; Ibanez L, 2011, FERTIL STERIL, V95, P727, DOI 10.1016/j.fertnstert.2010.08.052; Keizer-Schrama SMPFD, 2001, HUM REPROD UPDATE, V7, P287; Kivimaki M, 2008, AM J CLIN NUTR, V87, P1876, DOI 10.1093/ajcn/87.6.1876; KOJIMA T, 1993, AM J OBSTET GYNECOL, V169, P1540, DOI 10.1016/0002-9378(93)90432-I; Lee JM, 2007, PEDIATRICS, V119, pE624, DOI 10.1542/peds.2006-2188; Martos-Moreno GA, 2010, MOL CELL ENDOCRINOL, V324, P70, DOI 10.1016/j.mce.2009.12.017; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Moran A, 2002, J CLIN ENDOCR METAB, V87, P4817, DOI 10.1210/jc.2002-020517; Moran A, 1999, DIABETES, V48, P2039, DOI 10.2337/diabetes.48.10.2039; Must A, 2002, AM J EPIDEMIOL, V155, P672, DOI 10.1093/aje/155.7.672; Must A, 2005, PEDIATRICS, V116, P620, DOI 10.1542/peds.2004-1604; Neville KA, 2005, ARCH DIS CHILD, V90, P258, DOI 10.1136/adc.2004.053959; Ong KK, 2007, PLOS MED, V4, P737, DOI 10.1371/journal.pmed.0040132; Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019; Pozo J, 2002, BEST PRACT RES CL EN, V16, P73, DOI 10.1053/beem.2002.0182; Pralong FP, 2010, MOL CELL ENDOCRINOL, V324, P82, DOI 10.1016/j.mce.2010.01.037; Pulido JME, 1999, ARCH MED RES, V30, P19, DOI 10.1016/S0188-0128(98)00008-6; Sanchez-Garrido MA, 2013, HORM BEHAV, V64, P187, DOI 10.1016/j.yhbeh.2013.01.014; Stockl D, 2012, DIABETOLOGIA, V55, P681, DOI 10.1007/s00125-011-2410-3; Stockl D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026076; Trikudanathan S, 2013, J CLIN ENDOCR METAB, V98, P236, DOI 10.1210/jc.2012-1785; vanLenthe FJ, 1996, AM J CLIN NUTR, V64, P18, DOI 10.1093/ajcn/64.1.18; Wilson DA, 2010, J PEDIATR-US, V156, P308, DOI 10.1016/j.jpeds.2009.08.038; Yeung EH, 2010, J CLIN ENDOCR METAB, V95, P5435, DOI 10.1210/jc.2010-0702	46	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0128427	10.1371/journal.pone.0128427	http://dx.doi.org/10.1371/journal.pone.0128427			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061526	Green Submitted, Green Published, gold			2022-12-26	WOS:000355979500083
J	Bonci, D; Coppola, V; Patrizii, M; Addario, A; Cannistraci, A; Francescangeli, F; Pecci, R; Muto, G; Collura, D; Bedini, R; Zeuner, A; Valtieri, M; Sentinelli, S; Benassi, MS; Gallucci, M; Carlini, P; Piccolo, S; De Maria, R				Bonci, D.; Coppola, V.; Patrizii, M.; Addario, A.; Cannistraci, A.; Francescangeli, F.; Pecci, R.; Muto, G.; Collura, D.; Bedini, R.; Zeuner, A.; Valtieri, M.; Sentinelli, S.; Benassi, M. S.; Gallucci, M.; Carlini, P.; Piccolo, S.; De Maria, R.			A microRNA code for prostate cancer metastasis	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR-BETA; TGF-BETA; BREAST-CANCER; STEM-CELLS; BONE-METASTASIS; SELF-RENEWAL; TUMOR; RAS; PROGRESSION	Although the development of bone metastasis is a major detrimental event in prostate cancer, the molecular mechanisms responsible for bone homing and destruction remain largely unknown. Here we show that loss of miR-15 and miR-16 in cooperation with increased miR-21 expression promote prostate cancer spreading and bone lesions. This combination of microRNA endows bone-metastatic potential to prostate cancer cells. Concomitant loss of miR-15/miR-16 and gain of miR-21 aberrantly activate TGF-beta and Hedgehog signaling, that mediate local invasion, distant bone marrow colonization and osteolysis by prostate cancer cells. These findings establish a new molecular circuitry for prostate cancer metastasis that was validated in patients' cohorts. Our data indicate a network of biomarkers and druggable pathways to improve patient treatment.	[Bonci, D.; Coppola, V.; Patrizii, M.; Addario, A.; Cannistraci, A.; Francescangeli, F.; Zeuner, A.; Valtieri, M.] Ist Super Sanita, Dept Hematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy; [Bonci, D.; Sentinelli, S.; Gallucci, M.; Carlini, P.; De Maria, R.] Regina Elena Inst Canc Res, Sci Directorate, Rome, Italy; [Pecci, R.; Bedini, R.] Ist Super Sanita, Dept Technol & Hlth, Viale Regina Elena 299, I-00161 Rome, Italy; [Muto, G.; Collura, D.] S Giovanni Bosco Hosp, Dept Urol, Turin, Italy; [Muto, G.] Campus Biomed Univ, Dept Urol, Rome, Italy; [Benassi, M. S.] Ist Ortoped Rizzoli, Lab Expt Oncol, Bologna, Italy; [Piccolo, S.] Univ Padua, Sch Med, Dept Mol Med, Padua, Italy	Istituto Superiore di Sanita (ISS); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Istituto Superiore di Sanita (ISS); University Campus Bio-Medico - Rome Italy; IRCCS Istituto Ortopedico Rizzoli; University of Padua	Bonci, D; De Maria, R (corresponding author), IRE, Regina Elena Canc Inst, Italian Natl Canc Inst Regina Elena, Viale Elio Chianesi 53, I-00144 Rome, Italy.	desiree.bonci@iss.it; demaria@ifo.it	Francescangeli, Federica/K-6500-2016; Bedini, Rossella/B-2465-2013; De Maria, Ruggero/S-6385-2019; Zeuner, Ann/K-8607-2016; Bonci, Desiree/K-6488-2016; Addario, Antonio/AAC-4707-2022; valtieri, mauro/H-1044-2016; Coppola, Valeria/K-5120-2016; Zeuner, Ann/A-8529-2010; Gallucci, Michele/K-9600-2016	Francescangeli, Federica/0000-0002-1086-5265; De Maria, Ruggero/0000-0003-2255-0583; Bonci, Desiree/0000-0002-2472-5140; Addario, Antonio/0000-0001-8527-8738; valtieri, mauro/0000-0002-9139-6754; Coppola, Valeria/0000-0002-5745-2572; collura, devis/0000-0002-8964-5248; Bedini, Rossella/0000-0002-0830-6632; Zeuner, Ann/0000-0002-8295-3715; PICCOLO, STEFANO/0000-0002-2037-0004; Gallucci, Michele/0000-0002-3637-6531; Muto, Giovanni/0000-0003-3593-6450; Pecci, Raffaella/0000-0002-6500-9124	National Ministry of Health; Italy-USA microRNA program; Italian Association for Cancer Research (AIRC); Fondazione Roma	National Ministry of Health; Italy-USA microRNA program; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Roma(Fondazione RomaEuropean Commission)	We thank Giuseppe Loreto, Tania Merlino, Laura De Salvo and Roberto Giaconella for their technical support. We thank Michelangelo Cordenonsi, Maria Musumeci and Marcello Maugeri-Sacca for manuscript discussion. This manuscript has been supported by National Ministry of Health, Under-forty researcher and Italy-USA microRNA program to DB and the Italian Association for Cancer Research (AIRC) and Fondazione Roma funding to RDM.	Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhattacharya R, 2009, CANCER RES, V69, P9090, DOI 10.1158/0008-5472.CAN-09-2552; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chan E, 2011, TRENDS MOL MED, V17, P235, DOI 10.1016/j.molmed.2011.01.008; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Coppola V, 2013, ONCOGENE, V32, P1843, DOI 10.1038/onc.2012.194; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Das S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034374; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Frezzetti D, 2011, ONCOGENE, V30, P275, DOI 10.1038/onc.2010.416; Grusch M, 2010, CURR CANCER DRUG TAR, V10, P849, DOI 10.2174/156800910793357943; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Javelaud D, 2012, FEBS LETT, V586, P2016, DOI 10.1016/j.febslet.2012.05.011; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Karaa ZS, 2009, RNA, V15, P249, DOI 10.1261/rna.1301109; Kim C, 2010, NAT REV CLIN ONCOL, V7, P340, DOI 10.1038/nrclinonc.2010.61; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Lawrence MG, 2011, PROSTATE, V71, P1198, DOI 10.1002/pros.21335; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528; Lukacs RU, 2010, CELL STEM CELL, V7, P682, DOI 10.1016/j.stem.2010.11.013; Luo J, 2002, CANCER RES, V62, P2220; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martello G, 2007, NATURE, V449, P183, DOI 10.1038/nature06100; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mishra S, 2011, PROSTATE, V71, P1441, DOI 10.1002/pros.21361; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Musumeci M, 2011, ONCOGENE, V30, P4231, DOI 10.1038/onc.2011.140; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Perrot CY, 2013, PHARMACOL THERAPEUT, V137, P183, DOI 10.1016/j.pharmthera.2012.10.002; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Pratap J, 2006, CANCER METAST REV, V25, P589, DOI 10.1007/s10555-006-9032-0; Ribas J, 2009, CANCER RES, V69, P7165, DOI 10.1158/0008-5472.CAN-09-1448; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Sanchez P, 2005, CANCER RES, V65, P2990, DOI 10.1158/0008-5472.CAN-05-0439; Shariat SF, 2004, CLIN CANCER RES, V10, P1992, DOI 10.1158/1078-0432.CCR-0768-03; Shi L, 2014, CANCER RES, V74, P532, DOI 10.1158/0008-5472.CAN-13-2203; Shirakihara T, 2011, EMBO J, V30, P783, DOI 10.1038/emboj.2010.351; Smith MR, 2012, LANCET, V379, P39, DOI 10.1016/S0140-6736(11)61226-9; Sorrentino A, 2008, EXP HEMATOL, V36, P1035, DOI 10.1016/j.exphem.2008.03.004; Stinchfield MJ, 2012, DEVELOPMENT, V139, P2721, DOI 10.1242/dev.077206; Sturge J, 2011, NAT REV CLIN ONCOL, V8, P357, DOI 10.1038/nrclinonc.2011.67; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Talotta F, 2009, ONCOGENE, V28, P73, DOI 10.1038/onc.2008.370; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Teicher BA, 2001, CANCER METAST REV, V20, P133, DOI 10.1023/A:1013177011767; Valtieri M, 2008, J CELL PHYSIOL, V217, P296, DOI 10.1002/jcp.21521; Vo BT, 2011, PROSTATE, V71, P1084, DOI 10.1002/pros.21326; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Zhang HL, 2011, PROSTATE, V71, P326, DOI 10.1002/pros.21246	66	94	100	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 3	2016	35	9					1180	1192		10.1038/onc.2015.176	http://dx.doi.org/10.1038/onc.2015.176			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DF4WH	26073083	hybrid, Green Published			2022-12-26	WOS:000371351700012
J	Guo, A; Hall, D; Zhang, CM; Peng, TQ; Miller, JD; Kutschke, W; Grueter, CE; Johnson, FL; Lin, RZ; Song, LS				Guo, Ang; Hall, Duane; Zhang, Caimei; Peng, Tianqing; Miller, Jordan D.; Kutschke, William; Grueter, Chad E.; Johnson, Frances L.; Lin, Richard Z.; Song, Long-Sheng			Molecular Determinants of Calpain-dependent Cleavage of Junctophilin-2 Protein in Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-TUBULE; RYANODINE RECEPTORS; HEART-FAILURE; CONTRACTILE DYSFUNCTION; SARCOPLASMIC-RETICULUM; MYOCARDIAL-INFARCTION; CA2+ CHANNEL; RAT-HEART; HYPERTROPHY; CALPASTATIN	Junctophilin-2 (JP2), a membrane-binding protein that provides a structural bridge between the plasmalemma and sarcoplasmic reticulum, is essential for precise Ca2+-induced Ca2+ release during excitation-contraction coupling in cardiomyocytes. In animal and human failing hearts, expression of JP2 is decreased markedly, but the molecular mechanisms underlying JP2 down-regulation remain incompletely defined. In mouse hearts, ischemia/reperfusion injury resulted in acute JP2 down-regulation, which was attenuated by pretreatment with the calpain inhibitor MDL-28170 or by transgenic overexpression of calpastatin, an endogenous calpain inhibitor. Using a combination of computational analysis to predict calpain cleavage sites and in vitro calpain proteolysis reactions, we identified four putative calpain cleavage sites within JP2 with three N-terminal and one C-terminal cleavage sites. Mutagenesis defined the C-terminal region of JP2 as the predominant calpain cleavage site. Exogenous expression of putative JP2 cleavage fragments was not sufficient to rescue Ca2+ handling in JP2-deficient cardiomyocytes, indicating that cleaved JP2 is non-functional for normal Ca2+-induced Ca2+ release. These data provide new molecular insights into the posttranslational regulatory mechanisms of JP2 in cardiac diseases.	[Guo, Ang; Hall, Duane; Zhang, Caimei; Kutschke, William; Grueter, Chad E.; Johnson, Frances L.; Song, Long-Sheng] Univ Iowa, Carver Coll Med, Dept Internal Med, Div Cardiovasc Med, Iowa City, IA 52242 USA; [Guo, Ang; Hall, Duane; Zhang, Caimei; Kutschke, William; Grueter, Chad E.; Johnson, Frances L.; Song, Long-Sheng] Univ Iowa, Carver Coll Med, Francois M Abboud Cardiovasc Res Ctr, Iowa City, IA 52242 USA; [Peng, Tianqing] Univ Western Ontario, Dept Med, London, ON N6A 4G5, Canada; [Peng, Tianqing] Univ Western Ontario, Dept Pathol, London, ON N6A 4G5, Canada; [Miller, Jordan D.] Mayo Clin, Div Cardiovasc Surg, Rochester, MN 55905 USA; [Lin, Richard Z.] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	University of Iowa; University of Iowa; Western University (University of Western Ontario); Western University (University of Western Ontario); Mayo Clinic; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Song, LS (corresponding author), Univ Iowa, Carver Coll Med, Dept Internal Med, Div Cardiovasc Med, Iowa City, IA 52242 USA.	long-sheng-song@uiowa.edu	Hall, Duane/ACD-6815-2022; Regan, Clinton/E-6250-2012; Peng, Tianqing/G-3340-2011; Guo, Ang/M-3549-2013	Hall, Duane/0000-0003-2228-0966; Miller, Jordan/0000-0002-9868-4097; Guo, Ang/0000-0002-5551-2279; Song, Long-Sheng/0000-0002-6035-8106; Grueter, Chad/0000-0001-8950-742X; Lin, Richard/0000-0002-3967-0859	National Institutes of Health [R01 HL090905]; American Heart Association [13POST14630077]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090905, R01HL111121] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002263] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL090905 (to L. S. S.). This work was also supported by American Heart Association Postdoctoral Fellowship 13POST14630077 (to A. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Arthur GD, 1997, MOL CELL BIOCHEM, V176, P241, DOI 10.1023/A:1006857213829; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Chen BY, 2013, CARDIOVASC RES, V100, P54, DOI 10.1093/cvr/cvt180; Chen BY, 2012, FASEB J, V26, P2531, DOI 10.1096/fj.11-199505; Chen M, 2001, J BIOL CHEM, V276, P30724, DOI 10.1074/jbc.M103701200; Chen M, 2002, J BIOL CHEM, V277, P29181, DOI 10.1074/jbc.M204951200; duVerle DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019035; Franzini-Armstrong C, 1999, BIOPHYS J, V77, P1528, DOI 10.1016/S0006-3495(99)77000-1; French JP, 2006, AM J PHYSIOL-HEART C, V290, pH128, DOI 10.1152/ajpheart.00739.2005; Golini L, 2011, J BIOL CHEM, V286, P43717, DOI 10.1074/jbc.M111.292755; Gomez AM, 2001, CIRCULATION, V104, P688, DOI 10.1161/hc3201.092285; Greyson CR, 2008, J MOL CELL CARDIOL, V44, P59, DOI 10.1016/j.yjmcc.2007.10.010; Guo A, 2014, P NATL ACAD SCI USA, V111, P12240, DOI 10.1073/pnas.1412729111; Guo A, 2013, CARDIOVASC RES, V98, P204, DOI 10.1093/cvr/cvt020; Guo A, 2012, J BIOL CHEM, V287, P16670, DOI 10.1074/jbc.M112.340927; Hall SRR, 2005, J HEART LUNG TRANSPL, V24, P1639, DOI 10.1016/j.healun.2004.11.004; Heidrich FM, 2009, CIRC RES, V104, pE19, DOI 10.1161/CIRCRESAHA.108.191072; Inserte J, 2012, CARDIOVASC RES, V96, P23, DOI 10.1093/cvr/cvs232; Jayasinghe ID, 2012, BIOPHYS J, V102, pL9, DOI 10.1016/j.bpj.2012.01.034; Kashef F, 2012, J BIOL CHEM, V287, P30268, DOI 10.1074/jbc.M112.368415; Landstrom AP, 2007, J MOL CELL CARDIOL, V42, P1026, DOI 10.1016/j.yjmcc.2007.04.006; Landstrom AP, 2011, CIRC-HEART FAIL, V4, P214, DOI 10.1161/CIRCHEARTFAILURE.110.958694; Letavernier E, 2008, CIRC RES, V102, P720, DOI 10.1161/CIRCRESAHA.107.160077; Li RC, 2013, CIRC RES, V112, P601, DOI 10.1161/CIRCRESAHA.112.300806; Li XP, 2009, CARDIOVASC RES, V83, P72, DOI 10.1093/cvr/cvp100; Li Y, 2011, DIABETES, V60, P2985, DOI 10.2337/db10-1333; Litwin SE, 2000, CIRC RES, V87, P1040, DOI 10.1161/01.RES.87.11.1040; Liu Z, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0027887, 10.1371/journal.pone.0019001]; Maekawa A, 2003, J MOL CELL CARDIOL, V35, P1277, DOI 10.1016/S0022-2828(03)00238-4; Minamisawa S, 2004, BIOCHEM BIOPH RES CO, V325, P852, DOI 10.1016/j.bbrc.2004.10.107; Murphy RM, 2013, J PHYSIOL-LONDON, V591, P719, DOI 10.1113/jphysiol.2012.243279; Patterson C, 2011, CIRC RES, V109, P453, DOI 10.1161/CIRCRESAHA.110.239749; Peltier J, 2006, J AM SOC NEPHROL, V17, P3415, DOI 10.1681/ASN.2006050542; Sandmann S, 2001, BRIT J PHARMACOL, V132, P767, DOI 10.1038/sj.bjp.0703860; Singh RB, 2004, J MOL CELL CARDIOL, V37, P101, DOI 10.1016/j.yjmcc.2004.04.009; Song LS, 2012, CIRC RES, V111, P816, DOI 10.1161/CIRCRESAHA.112.278390; Song LS, 2006, P NATL ACAD SCI USA, V103, P4305, DOI 10.1073/pnas.0509324103; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Takeshima H., 2015, CELL CALCIUM, DOI 10.1016/j.ceca.2015.01.007; van Oort RJ, 2011, CIRCULATION, V123, P979, DOI 10.1161/CIRCULATIONAHA.110.006437; Wang SQ, 2001, NATURE, V410, P592, DOI 10.1038/35069083; Wei S, 2010, CIRC RES, V107, P520, DOI 10.1161/CIRCRESAHA.109.212324; Wu CYC, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000527; Xu M, 2007, PLOS BIOL, V5, P203, DOI 10.1371/journal.pbio.0050021; Xu M, 2012, CIRC RES, V111, P837, DOI 10.1161/CIRCRESAHA.112.277418; YOSHIDA K, 1995, CIRC RES, V77, P603, DOI 10.1161/01.RES.77.3.603; Zhang HB, 2013, CARDIOVASC RES, V98, P269, DOI 10.1093/cvr/cvt030	47	48	51	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17946	17955		10.1074/jbc.M115.652396	http://dx.doi.org/10.1074/jbc.M115.652396			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26063807	Green Published, hybrid			2022-12-26	WOS:000358511700028
J	Robertson, CL; Srivastava, J; Siddiq, A; Gredler, R; Emdad, L; Rajasekaran, D; Akiel, M; Shen, XN; Corwin, F; Sundaresan, G; Zweit, J; Croniger, C; Gao, XL; Ghosh, S; Hylemon, PB; Subler, MA; Windle, JJ; Fisher, PB; Sarkar, D				Robertson, Chadia L.; Srivastava, Jyoti; Siddiq, Ayesha; Gredler, Rachel; Emdad, Luni; Rajasekaran, Devaraja; Akiel, Maaged; Shen, Xue-Ning; Corwin, Frank; Sundaresan, Gobalakrishnan; Zweit, Jamal; Croniger, Colleen; Gao, Xiaoli; Ghosh, Shobha; Hylemon, Philip B.; Subler, Mark A.; Windle, Jolene J.; Fisher, Paul B.; Sarkar, Devanand			Astrocyte Elevated Gene-1 (AEG-1) Regulates Lipid Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; RECEPTOR LXR-ALPHA; NUCLEAR RECEPTOR; PEROXISOME PROLIFERATOR; PPAR-ALPHA; X-RECEPTOR; CHOLESTEROL; EXPRESSION; IDENTIFICATION; ABSORPTION	Astrocyte elevated gene-1 (AEG-1), also known as MTDH (metadherin) or LYRIC, is an established oncogene. However, the physiological function of AEG-1 is not known. To address this question, we generated an AEG-1 knock-out mouse (AEG-1KO) and characterized it. Although AEG-1KO mice were viable and fertile, they were significantly leaner with prominently less body fat and lived significantly longer compared with wild type (WT). When fed a high fat and cholesterol diet (HFD), WT mice rapidly gained weight, whereas AEG-1KO mice did not gain weight at all. This phenotype of AEG-1KO mice is due to decreased fat absorption from the intestines, not because of decreased fat synthesis or increased fat consumption. AEG-1 interacts with retinoid X receptor (RXR) and inhibits RXR function. In enterocytes of AEG-1KO mice, we observed increased activity of RXR heterodimer partners, liver X receptor and peroxisome proliferator-activated receptor-alpha, key inhibitors of intestinal fat absorption. Inhibition of fat absorption in AEG-1KO mice was further augmented when fed an HFD providing ligands to liver X receptor and peroxisome proliferator-activated receptor-alpha. Our studies reveal a novel role of AEG-1 in regulating nuclear receptors controlling lipid metabolism. AEG-1 may significantly modulate the effects of HFD and thereby function as a unique determinant of obesity.	[Robertson, Chadia L.; Srivastava, Jyoti; Siddiq, Ayesha; Gredler, Rachel; Emdad, Luni; Rajasekaran, Devaraja; Akiel, Maaged; Shen, Xue-Ning; Subler, Mark A.; Windle, Jolene J.; Fisher, Paul B.; Sarkar, Devanand] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23298 USA; [Robertson, Chadia L.] Virginia Commonwealth Univ, Dept Biochem, Richmond, VA 23298 USA; [Corwin, Frank; Sundaresan, Gobalakrishnan; Zweit, Jamal] Virginia Commonwealth Univ, Dept Radiol, Richmond, VA 23298 USA; [Ghosh, Shobha] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23298 USA; [Hylemon, Philip B.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Windle, Jolene J.; Fisher, Paul B.; Sarkar, Devanand] Virginia Commonwealth Univ, VCU Massey Canc Ctr, Richmond, VA 23298 USA; [Fisher, Paul B.; Sarkar, Devanand] Virginia Commonwealth Univ, VCU Inst Mol Med, Richmond, VA 23298 USA; [Croniger, Colleen] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; [Gao, Xiaoli] Univ Texas Hlth Sci Ctr San Antonio, Inst Mass Spectrometry Lab, San Antonio, TX 78229 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Case Western Reserve University; University of Texas System; University of Texas Health San Antonio	Sarkar, D (corresponding author), Virginia Commonwealth Univ, Dept Human & Mol Genet, 1220 East Broad St,POB 980035, Richmond, VA 23298 USA.	dsarkar@vcu.edu	Srivastava, Jyoti/AAD-7610-2022; Regan, Clinton/E-6250-2012; Akiel, Maaged/B-5109-2014	Akiel, Maaged/0000-0002-0211-2837; Windle, Jolene/0000-0001-6690-385X; Gobalakrishnan, Sundaresan/0000-0002-9620-5611	National Institutes of Health, NCI [R01 CA138540, R21 CA183954]; National Institutes of Health [R01 CA134721]; James S. McDonnell Foundation; National Institutes of Health, NIDDK [T32DK007150]; NATIONAL CANCER INSTITUTE [R21CA183954, R01CA138540, R01CA134721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007150] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grants R01 CA138540 and R21 CA183954 (to D. S.) and National Institutes of Health Grant R01 CA134721 (to P. B. F.). This work was also supported in part by grants from The James S. McDonnell Foundation. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by National Institutes of Health, NIDDK, Grant T32DK007150.	Bederman IR, 2009, J BIOL CHEM, V284, P6101, DOI 10.1074/jbc.M808668200; Bonamassa B, 2013, TRENDS ENDOCRIN MET, V24, P120, DOI 10.1016/j.tem.2012.10.004; Britt DE, 2004, EXP CELL RES, V300, P134, DOI 10.1016/j.yexcr.2004.06.026; Brown DM, 2004, CANCER CELL, V5, P365, DOI 10.1016/S1535-6108(04)00079-0; Chinetti G, 2001, NAT MED, V7, P53, DOI 10.1038/83348; CLARK SB, 1973, J LIPID RES, V14, P581; Diraison F, 1997, J MASS SPECTROM, V32, P81, DOI 10.1002/(SICI)1096-9888(199701)32:1<81::AID-JMS454>3.0.CO;2-2; Emdad L, 2009, P NATL ACAD SCI USA, V106, P21300, DOI 10.1073/pnas.0910936106; Ferre P, 2004, DIABETES, V53, pS43, DOI 10.2337/diabetes.53.2007.S43; Glatz JFC, 1996, PROG LIPID RES, V35, P243, DOI 10.1016/S0163-7827(96)00006-9; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Houten SM, 2010, J INHERIT METAB DIS, V33, P469, DOI 10.1007/s10545-010-9061-2; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Huynh FK, 2014, METHOD ENZYMOL, V542, P391, DOI 10.1016/B978-0-12-416618-9.00020-0; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Jeon HY, 2010, GENE EXPR PATTERNS, V10, P361, DOI 10.1016/j.gep.2010.08.004; Kang DC, 2005, GENE, V353, P8, DOI [10.1016/j.gene.2005.04.006, 10.1016/j.gene.2005.04.005]; Kimura R, 2013, OBES RES CLIN PRACT, V7, pE353, DOI 10.1016/j.orcp.2013.05.005; Kimura R, 2011, BIOCHEM BIOPH RES CO, V410, P1, DOI 10.1016/j.bbrc.2011.05.057; Lee SG, 2008, ONCOGENE, V27, P1114, DOI 10.1038/sj.onc.1210713; Lee SG, 2013, ADV CANCER RES, V120, P1, DOI 10.1016/B978-0-12-401676-7.00001-2; LEE WNP, 1994, AM J PHYSIOL, V266, pE372, DOI 10.1152/ajpendo.1994.266.3.E372; Lefebvre P, 2010, TRENDS ENDOCRIN MET, V21, P676, DOI 10.1016/j.tem.2010.06.009; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; Masson CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010380; Meng XB, 2015, J BIOL CHEM, V290, P11853, DOI 10.1074/jbc.M114.627653; Repa JJ, 2002, J BIOL CHEM, V277, P18793, DOI 10.1074/jbc.M109927200; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Robertson CL, 2014, CANCER RES, V74, P6184, DOI 10.1158/0008-5472.CAN-14-1357; Sarkar D, 2013, ADV CANCER RES, V120, P39, DOI 10.1016/B978-0-12-401676-7.00002-4; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Srivastava J, 2014, CANCER RES, V74, P4364, DOI 10.1158/0008-5472.CAN-14-0421; Srivastava J, 2012, HEPATOLOGY, V56, P1782, DOI 10.1002/hep.25868; Su ZZ, 2002, ONCOGENE, V21, P3592, DOI 10.1038/sj.onc.1205445; TURLEY SD, 1994, J LIPID RES, V35, P328; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Wahli W, 2012, TRENDS ENDOCRIN MET, V23, P351, DOI 10.1016/j.tem.2012.05.001; Yoo BK, 2010, CANCER RES, V70, P3249, DOI 10.1158/0008-5472.CAN-09-4009; Yoo BK, 2009, P NATL ACAD SCI USA, V106, P12938, DOI 10.1073/pnas.0901451106; Yoo BK, 2009, J CLIN INVEST, V119, P465, DOI 10.1172/JCI36460	40	17	17	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					18227	18236		10.1074/jbc.M115.661801	http://dx.doi.org/10.1074/jbc.M115.661801			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26070567	Green Published, hybrid			2022-12-26	WOS:000358511700051
J	Andrianavalona, TH; Ramihangihajason, TN; Rasoamiaramanana, A; Ward, DJ; Ali, JR; Samonds, KE				Andrianavalona, Tsiory H.; Ramihangihajason, Tolotra N.; Rasoamiaramanana, Armand; Ward, David J.; Ali, Jason R.; Samonds, Karen E.			Miocene Shark and Batoid Fauna from Nosy Makamby (Mahajanga Basin, Northwestern Madagascar)	PLOS ONE			English	Article							VERTEBRATE FAUNA; MAHAKAMBY; ISLAND; FISH	Madagascar is well known for producing exceptional fossils. However, the record for selachians remains relatively poorly known. Paleontological reconnaissance on the island of Nosy Makamby, off northwest Madagascar, has produced a previously undescribed assemblage of Miocene fossils. Based on isolated teeth, ten taxonomic groups are identified: Otodus, Carcharhinus, Galeocerdo, Rhizoprionodon, Sphyrna, Hemipristis, Squatina, Rostroraja, Himantura and Myliobatidae. Six are newly described from Madagascar for the Cenozoic (Galeocerdo, Rhizoprionodon, Sphyrna, Squatina, Rostroraja and Himantura). In association with these specimens, remains of both invertebrates (e.g., corals, gastropods, bivalves) and vertebrates (e.g., bony fish, turtles, crocodylians, and sirenianmammals) were also recovered. The sedimentary facies are highly suggestive of a near-shore/coastal plain depositional environment. This faunal association shares similarities to contemporaneous sites reported from North America and Europe and gives a glimpse into the paleoenvironment of Madagascar's Miocene, suggesting that this region was warm, tropical shallow-water marine.	[Andrianavalona, Tsiory H.; Ramihangihajason, Tolotra N.; Rasoamiaramanana, Armand] Fac Sci, Dept Paleontol & Anthropol Biol, Antananarivo, Madagascar; [Ward, David J.] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England; [Ali, Jason R.] Univ Hong Kong, Dept Earth Sci, Hong Kong, Hong Kong, Peoples R China; [Samonds, Karen E.] No Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA	Natural History Museum London; University of Hong Kong; Northern Illinois University	Andrianavalona, TH (corresponding author), Fac Sci, Dept Paleontol & Anthropol Biol, Univ Antananarivo 101, Antananarivo, Madagascar.	tsioryandrianavalona@gmail.com	Samonds, Karen/AAL-1766-2021	Ali, Jason Richard/0000-0002-5214-620X; Samonds, Karen/0000-0003-3597-9215	University of Queensland; Northern Illinois University	University of Queensland(University of Queensland); Northern Illinois University	National Geographic supported fieldwork in 2010 and 2013; in 2011 it was funded by the University of Queensland, and in 2014 by Northern Illinois University.	Adnet S, 2010, GEOL MAG, V147, P860, DOI 10.1017/S0016756810000348; Ali JR, 2010, NATURE, V463, P653, DOI 10.1038/nature08706; Ameghino F., 1901, ANALES SOC CIENTIFIC, V51, P65; Ameghino F., 1901, ANALES SOC CIENTIFIC, V51, P65; Argyriou T, 2015, J AFR EARTH SCI, V102, P86, DOI 10.1016/j.jafrearsci.2014.11.008; Besairie H., 1972, GEOLOGIE MADAGASCAR, VI; Bor Taco, 2012, Palaeontos, V21, P1; Cappetta H., 2012, HDB PALAEOICHTHYOLOG; Cappetta Henri, 2006, Rivista Piemontese di Storia Naturale, V27, P33; Charbonnier S, 2012, GEODIVERSITAS, V34, P873, DOI 10.5252/g2012n4a9; COLLIGNON M., 1927, ANN PALEONTOL, V16, P135; Cooke A., 2003, P179; Dartevelle E., 1943, ANN MUSEE CONGO BE A, V2, P1; Dartevelle E., 1959, ANN MUSEE CONGO BELG, V2, P257; Goodman SM, 2003, NATURAL HIST MADAGAS; Gottfried MD, 2001, CRETACEOUS RES, V22, P491, DOI 10.1006/cres.2001.0269; JONET S, 1968, Revista da Faculdade de Ciencias Universidade de Lisboa Serie C Ciencias Naturais, V15, P233; Kent B. W., 1994, FOSSIL SHARKS CHESAP; Melluso L, 2009, J GEOL SOC LONDON, V166, P283, DOI 10.1144/0016-76492007-147; Mualler A., 1999, LEIPZEGER GEOWISSENS, V9-10, P1; Pickford M, 2008, S AFR J SCI, V104, P231; Priem F, 1914, B SOC GEOLOGIQUE FRA, V14, P118; Priem F, 1907, COM SERV GEOL PORTUG, V7, P74; Priem MF, 1907, B SOC GEOL FR, V4, P462; Purdy RW, 2001, SM C PALEOB, V90, P71; Rabarison JA, 1996, CONTRIBUTION ETUDE D; Ramihangihajason TN, 2014, J AFR EARTH SCI, V100, P409, DOI 10.1016/j.jafrearsci.2014.07.013; Rathbone J, 2011, CREATE SPACE INDEPEN, V236, P26; Reinecke Thomas, 2011, Palaeontos, V20, P1; Sahni A., 1981, BIOL MEMOIRS, V5, P83; Samonds K, 2007, J VERTEBR PALEONTOL, V27, p139A; Samonds Karen, 2002, Journal of Vertebrate Paleontology, V22, p102A; Samonds KE, 2012, P NATL ACAD SCI USA, V109, P5352, DOI 10.1073/pnas.1113993109; Samonds KE, MIDDLE EOCENE NEOSEL; Sharma KM, 2010, CURR SCI INDIA, V99, P804; THOMSON K S, 1982, Postilla, P1; Underwood CJ, 2011, P GEOLOGIST ASSOC, V122, P47, DOI 10.1016/j.pgeola.2010.09.004; Ward David J., 2001, Central Mediterranean Naturalist, V3, P131; Ward DJ, 1983, ZOOLOGICAL J LINNEAN, V82, P245	39	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129444	10.1371/journal.pone.0129444	http://dx.doi.org/10.1371/journal.pone.0129444			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075723	Green Submitted, Green Published, gold			2022-12-26	WOS:000356329900074
J	Cheng, XJ; Gao, Y; Zhao, YW; Cheng, XD				Cheng, Xiao-Juan; Gao, Yuan; Zhao, Yu-Wu; Cheng, Xiao-Dong			Sodium Chloride Increases A beta Levels by Suppressing A beta Clearance in Cultured Cells	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; BLOOD-PRESSURE; INDUCTION; STRESS; BRAIN	Recent studies suggest that high-salt diet is associated with cognitive decline in human and mouse. The fact that genetic factors account for less than 50% cases of sporadic Alzheimer's disease (AD) highlights the important contribution of environmental factors, such as high-salt diet, in AD pathogenesis. However, whether and how high-salt diet fits the "amyloid cascade" hypothesis remains unexplored. Here, we show sodium chloride (NaCl) could increase A beta levels in the medium of HEK293 cells overexpressing amyloid precursor protein (APP) or C99 fragment. NaCl treatment dose not affect APP level, gamma secretase level or activity. Instead, NaCl treatment suppresses the capacity of cells to clear A beta and reduces Apolipoprotein E (ApoE) level. Finally, NaCl treated THP-1 or BV2 cells are inefficient in clearing A beta when co-cultured with rat primary neurons. Our study suggests that high-salt diet may increase AD risk by directly modulating A beta levels.	[Cheng, Xiao-Juan; Zhao, Yu-Wu] Shanghai Jiao Tong Univ, Dept Neurol, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China; [Gao, Yuan] Shanghai Jiao Tong Univ, Sch Med, Dept Neurol, Shanghai 200030, Peoples R China; [Gao, Yuan] Shanghai Jiao Tong Univ, Sch Med, Inst Neurol, Rui Jin Hosp, Shanghai 200030, Peoples R China; [Gao, Yuan] Kunming Univ Sci & Technol, Dept Neurol, Peoples Hosp Yunnan Prov 1, Kunming, Peoples R China; [Cheng, Xiao-Dong] Tongji Univ, Sch Life Sci & Technol, East Hosp, Shanghai 200092, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Kunming University of Science & Technology; Tongji University	Zhao, YW (corresponding author), Shanghai Jiao Tong Univ, Dept Neurol, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China.	zhaoyuwu2005@126.com; xctj92@163.com						Afsar B, 2013, HIGH BLOOD PRESS CAR, V20, P19, DOI 10.1007/s40292-013-0002-7; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Fiocco AJ, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.07.004; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Jellinger KA, 2007, J NEUROL SCI, V257, P80, DOI 10.1016/j.jns.2007.01.045; Kilander L, 1998, HYPERTENSION, V31, P780, DOI 10.1161/01.HYP.31.3.780; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Liu YZ, 2014, NEUROBIOL LEARN MEM, V114, P10, DOI 10.1016/j.nlm.2014.04.010; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; Neher JJ, 2011, J IMMUNOL, V186, P4973, DOI 10.4049/jimmunol.1003600; Raber J, 2004, NEUROBIOL AGING, V25, P641, DOI 10.1016/j.neurobiolaging.2003.12.023; Rondanelli M, 1998, PANMINERVA MED, V40, P191; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Skoog I, 1996, LANCET, V347, P1141, DOI 10.1016/S0140-6736(96)90608-X; Stalder AK, 2005, J NEUROSCI, V25, P11125, DOI 10.1523/JNEUROSCI.2545-05.2005; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Zhao LZ, 2009, J NEUROSCI, V29, P3603, DOI 10.1523/JNEUROSCI.5302-08.2009	21	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130432	10.1371/journal.pone.0130432	http://dx.doi.org/10.1371/journal.pone.0130432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075716	Green Published, Green Submitted, gold			2022-12-26	WOS:000356329900173
J	Kean, TJ; Dennis, JE				Kean, Thomas J.; Dennis, James E.			Synoviocyte Derived-Extracellular Matrix Enhances Human Articular Chondrocyte Proliferation and Maintains Re-Differentiation Capacity at Both Low and Atmospheric Oxygen Tensions	PLOS ONE			English	Article							TERM-FOLLOW-UP; IN-VITRO; GENE-EXPRESSION; CULTURE-SYSTEM; II COLLAGEN; STEM-CELLS; OSTEOARTHRITIC CHONDROCYTES; HYALINE CARTILAGE; HYPOXIA PROMOTES; PROGENITOR CELLS	Background Current tissue engineering methods are insufficient for total joint resurfacing, and chondrocytes undergo de-differentiation when expanded on tissue culture plastic. De-differentiated chondrocytes show poor re-differentiation in culture, giving reduced glycosaminoglycan (GAG) and collagen matrix accumulation. To address this, porcine synoviocyte-derived extracellular matrix and low (5%) oxygen tension were assessed for their ability to enhance human articular chondrocyte expansion and maintain re-differentiation potential. Methods Porcine synoviocyte matrices were devitalized using 3 non-detergent methods. These devitalized synoviocyte matrices were compared against tissue culture plastic for their ability to support human chondrocyte expansion. Expansion was further compared at both low (5%), and atmospheric (20%) oxygen tension on all surfaces. Expanded cells then underwent chondrogenic re-differentiation in aggregate culture at both low and atmospheric oxygen tension. Aggregates were assessed for their GAG and collagen content both biochemically and histologically. Results Human chondrocytes expanded twice as fast on devitalized synoviocyte matrix vs. tissue culture plastic, and cells retained their re-differentiation capacity for twice the number of population doublings. There was no significant difference in growth rate between low and atmospheric oxygen tension. There was significantly less collagen type I, collagen type II, aggrecan and more MMP13 expression in cells expanded on synoviocyte matrix vs. tissue culture plastic. There were also significant effects due to oxygen tension on gene expression, wherein there was greater collagen type I, collagen type II, SOX9 and less MMP13 expression on tissue culture plastic compared to synoviocyte matrix. There was a significant increase in GAG, but not collagen, accumulation in chondrocyte aggregates re-differentiated at low oxygen tension over that achieved in atmospheric oxygen conditions. Conclusions Synoviocyte-derived matrix supports enhanced expansion of human chondrocytes such that the chondrocytes are maintained in a state from which they can re-differentiate into a cartilage phenotype after significantly more population doublings. Also, low oxygen tension supports GAG, but not collagen, accumulation. These findings are a step towards the production of a more functional, tissue engineered cartilage.	[Kean, Thomas J.; Dennis, James E.] Case Western Reserve Univ, Dept Orthopaed, Cleveland, OH 44106 USA; [Kean, Thomas J.; Dennis, James E.] Benaroya Res Inst Virginia Mason, Matrix Biol Program, Seattle, WA USA; [Kean, Thomas J.; Dennis, James E.] Baylor Coll Med, Orthoped Surg, Houston, TX 77030 USA	Case Western Reserve University; Benaroya Research Institute; Virginia Mason Medical Center; Baylor College of Medicine	Kean, TJ (corresponding author), Baylor Coll Med, Orthoped Surg, Houston, TX 77030 USA.	thomas.kean@bcm.edu	Kean, Thomas/AAI-8010-2021	Kean, Thomas/0000-0001-6844-3404	National Institutes of Health [AR053622, DE015322]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR053622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding was provided through National Institutes of Health (www.nih.gov) grants AR053622 (National Institute of Arthritis and Musculoskeletal and Skin Diseases) and DE015322 (National Institute of Dental & Craniofacial Research) to JED. The funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner T, 2003, MATRIX BIOL, V22, P363, DOI 10.1016/S0945-053X(03)00049-0; Albrecht C, 2011, OSTEOARTHR CARTILAGE, V19, P1219, DOI 10.1016/j.joca.2011.07.004; Androjna C, 2008, TISSUE ENG PT A, V14, P559, DOI 10.1089/tea.2006.0361; Babur BK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058865; BASSETT CA, 1961, NATURE, V190, P460, DOI 10.1038/190460a0; Beekhuizen M, 2011, ARTHRITIS RHEUM-US, V63, P1918, DOI 10.1002/art.30364; Beris AE, 2012, AM J SPORT MED, V40, P562, DOI 10.1177/0363546511428778; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; CARRINO DA, 1991, BIOCHEM INT, V24, P485; Cebotari S, 2010, ARTIF ORGANS, V34, P206, DOI 10.1111/j.1525-1594.2009.00796.x; Collins JA, 2013, OSTEOARTHR CARTILAGE, V21, P1790, DOI 10.1016/j.joca.2013.06.028; Coyle CH, 2009, J ORTHOP RES, V27, P793, DOI 10.1002/jor.20816; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Dare EV, 2009, TISSUE ENG PT A, V15, P2285, DOI 10.1089/ten.tea.2008.0228; Das RHJ, 2010, J ORTHOP RES, V28, P537, DOI 10.1002/jor.20994; Dell'Accio F, 2001, ARTHRITIS RHEUM-US, V44, P1608, DOI 10.1002/1529-0131(200107)44:7<1608::AID-ART284>3.0.CO;2-T; Duval E, 2012, BIOMATERIALS, V33, P6042, DOI 10.1016/j.biomaterials.2012.04.061; Duval E, 2009, ARTHRITIS RHEUM-US, V60, P3038, DOI 10.1002/art.24851; Egli RJ, 2008, J ORTHOP RES, V26, P977, DOI 10.1002/jor.20603; Foldager CB, 2011, ACTA ORTHOP, V82, P234, DOI 10.3109/17453674.2011.566135; Gawlitta D, 2012, TISSUE ENG PT A, V18, P1957, DOI [10.1089/ten.tea.2011.0657, 10.1089/ten.TEA.2011.0657]; Gikas PD, 2009, J BONE JOINT SURG BR, V91B, P997, DOI 10.1302/0301-620X.91B8.21824; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Giovannini S, 2010, J CELL PHYSIOL, V222, P411, DOI 10.1002/jcp.21965; Grunder T, 2004, OSTEOARTHR CARTILAGE, V12, P559, DOI 10.1016/j.joca.2004.04.001; Gudas R, 2005, ARTHROSCOPY, V21, P1066, DOI 10.1016/j.arthro.2005.06.018; Ham KD, 2004, OSTEOARTHR CARTILAGE, V12, P160, DOI 10.1016/j.joca.2003.08.002; Hayes AJ, 2008, J HISTOCHEM CYTOCHEM, V56, P125, DOI 10.1369/jhc.7A7320.2007; He F, 2009, TISSUE ENG PT A, V15, P3809, DOI [10.1089/ten.tea.2009.0188, 10.1089/ten.TEA.2009.0188]; Hellingman CA, 2012, J TISSUE ENG REGEN M, V6, pe1, DOI 10.1002/term.502; Henderson JH, 2010, TISSUE ENG PT A, V16, P1585, DOI [10.1089/ten.tea.2009.0411, 10.1089/ten.TEA.2009.0411]; Hunter WVI, 1743, PHILOS T R SOC LOND, V42, P514, DOI [10.1098/rstl.1742.0079, DOI 10.1098/RSTL.1742.0079)]; Ignat'eva NY, 2007, J ANAL CHEM+, V62, P51, DOI 10.1134/S106193480701011X; Jakob M, 2001, J CELL BIOCHEM, V81, P368, DOI 10.1002/1097-4644(20010501)81:2<368::AID-JCB1051>3.0.CO;2-J; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Kim TK, 2003, OSTEOARTHR CARTILAGE, V11, P653, DOI 10.1016/S1063-4584(03)00120-1; Kon E, 2013, BONE JOINT RES, V2, P18, DOI 10.1302/2046-3758.22.2000092; Legendre F, 2013, TISSUE ENG PART C-ME, V19, P550, DOI [10.1089/ten.tec.2012.0508, 10.1089/ten.TEC.2012.0508]; Lennon Donald P., 1996, In Vitro Cellular and Developmental Biology Animal, V32, P602, DOI 10.1007/BF02724045; Lin Z, 2008, J ORTHOP RES, V26, P1230, DOI 10.1002/jor.20523; Ma B, 2013, OSTEOARTHR CARTILAGE, V21, P599, DOI 10.1016/j.joca.2013.01.014; Malda J, 2004, OSTEOARTHR CARTILAGE, V12, P306, DOI 10.1016/j.joca.2003.12.001; Malda J, 2003, CRIT REV BIOTECHNOL, V23, P175, DOI 10.1080/714037688; Markway BD, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4272; Murphy CL, 2004, J CELL PHYSIOL, V199, P451, DOI 10.1002/jcp.10481; Pei M, 2012, J CELL PHYSIOL, V227, P2163, DOI 10.1002/jcp.22950; Pei M, 2011, TISSUE ENG PT A, V17, P3067, DOI [10.1089/ten.TEA.2011.0158, 10.1089/ten.tea.2011.0158]; Peterson L, 2010, AM J SPORT MED, V38, P1117, DOI 10.1177/0363546509357915; Qu CJ, 2012, CELL TISSUE RES, V348, P109, DOI 10.1007/s00441-012-1366-z; Schnabel M, 2002, OSTEOARTHR CARTILAGE, V10, P62, DOI 10.1053/joca.2001.0482; Schrobback K, 2012, CELL TISSUE RES, V347, P649, DOI 10.1007/s00441-011-1193-7; Shahdadfar A, 2008, TISSUE ENG PT A, V14, P1999, DOI 10.1089/ten.tea.2007.0344; Shekkeris A, 2012, J BONE JOINT SUR S36, V94-B, P12; Steinhagen J, 2010, TISSUE CELL, V42, P151, DOI 10.1016/j.tice.2010.03.003; Strobel S, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2942; Thoms BL, 2013, ARTHRITIS RHEUM-US, V65, P1302, DOI 10.1002/art.37867; Thoms BL, 2010, J BIOL CHEM, V285, P20472, DOI 10.1074/jbc.M110.115238; van Osch GJVM, 2002, BIORHEOLOGY, V39, P215; Whitney GA, 2012, BIORESEARCH OPEN ACC, V1, P157, DOI 10.1089/biores.2012.0231; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Yang KGA, 2006, TISSUE ENG, V12, P2435, DOI 10.1089/ten.2006.12.2435	62	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129961	10.1371/journal.pone.0129961	http://dx.doi.org/10.1371/journal.pone.0129961			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075742	Green Submitted, gold, Green Published			2022-12-26	WOS:000356329900119
J	Li, YD; Wang, YD; Zhai, ZG; Guo, XJ; Yang, YH; Lu, XZ				Li, Yidan; Wang, Yidan; Zhai, Zhenguo; Guo, Xiaojuan; Yang, Yuanhua; Lu, Xiuzhang			Real-Time Three-Dimensional Echocardiography to Assess Right Ventricle Function in Patients with Pulmonary Hypertension	PLOS ONE			English	Article							HEART; VALIDATION; VOLUMES; ADULTS; MRI	Background The convenience and availability of real-time three-dimensional echocardiography (RT3DE) makes it an attractive candidate for assessing right ventricle function. However, the viability of RT3DE is not conclusive. Aim of Study This study aims to evaluate RT3DE relative to cardiac magnetic resonance and 2-dimensional echocardiography (2DE) for measuring right ventricular systolic function in patients with pulmonary hypertension. Methods Patients with pulmonary hypertension (n = 23) underwent cardiac magnetic resonance, 2DE, and RT3DE. Specifically, 2DE was used to measure the right ventricular index of myocardial performance (RIMP), fractional area change, tricuspid annular plane systolic excursion (TAPSE), and tissue Doppler-derived tricuspid annular systolic velocity (S'). Cardiac magnetic resonance and RT3DE were used to measure right ventricular end-diastolic volume (RVEDV) and end-systolic volume (RVESV). The right ventricular ejection fraction (RVEF) was calculated. Results Regarding the measurements taken by 2DE, RVEF positively correlated with fractional area change (r = 0.595, P = 0.003) and S'(r = 0.489, P = 0.018), and negatively correlated with RIMP (r = -0.745, P = 0.000). There was no association between RVEF and TAPSE (r = -0.029, P = 0.896). There existed a close correlation between the values of RVEDV, RVESV, and RVEF as measured by RT3DE and CMR respectively (P<0.001); Bland-Altmanan analyses showed good agreement between them. Conclusion RT3DE was a viable method for noninvasive, accurate assessment of right ventricular systolic function in patients with pulmonary hypertension.	[Li, Yidan; Wang, Yidan; Lu, Xiuzhang] Capital Med Univ, Beijing Chao Yang Hosp, Dept Echocardiog, Ctr Heart, Beijing 100020, Peoples R China; [Zhai, Zhenguo; Yang, Yuanhua] Capital Med Univ, Beijing Chao Yang Hosp, Dept Resp Med, Beijing 100020, Peoples R China; [Zhai, Zhenguo; Yang, Yuanhua] Capital Med Univ, Beijing Key Lab Resp & Pulm Circulat, Beijing Inst Resp Med, Beijing 100020, Peoples R China; [Guo, Xiaojuan] Capital Med Univ, Beijing Chao Yang Hosp, Dept Radiol, Beijing 100020, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University; Capital Medical University	Li, YD (corresponding author), Capital Med Univ, Beijing Chao Yang Hosp, Dept Echocardiog, Ctr Heart, Beijing 100020, Peoples R China.	chaoyanglxz@163.com	Zhai, Zhen/GYA-1598-2022		National Natural Science Foundation of China [81401420]; Fund of Beijing excellent talent training Plan [2013D003034000012]; Fund of clinical application of capital project [Z141107002514074]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund of Beijing excellent talent training Plan; Fund of clinical application of capital project	This study was supported by the National Natural Science Foundation of China (Grant No. 81401420); the Fund of Beijing excellent talent training Plan (Grant No. 2013D003034000012), and Fund of clinical application of capital project (Grant No. Z141107002514074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell A, 2014, EUR HEART J-CARD IMG, V15, P257, DOI 10.1093/ehjci/jet145; Bradlow WM, 2010, J MAGN RESON IMAGING, V31, P117, DOI 10.1002/jmri.22011; Di Bello V, 2013, ECHOCARDIOGR-J CARD, V30, P820, DOI 10.1111/echo.12137; Hsiao SH, 2006, J AM SOC ECHOCARDIOG, V19, P902, DOI 10.1016/j.echo.2006.01.014; Inami T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094587; Kind T, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-35; Krishnamurthy R, 2010, J MAGN RESON IMAGING, V31, P872, DOI 10.1002/jmri.22123; Lang RM, 2012, J AM SOC ECHOCARDIOG, V25, P3, DOI 10.1016/j.echo.2011.11.010; Malenfant S, 2013, PULM CIRC, V3, P278, DOI 10.4103/2045-8932.114752; Morcos P, 2009, INT J CARDIOVAS IMAG, V25, P263, DOI 10.1007/s10554-008-9387-0; Ostenfeld E, 2012, CARDIOVASC ULTRASOUN, V10, DOI 10.1186/1476-7120-10-1; Pulver AF, 2009, PACE, V32, P450, DOI 10.1111/j.1540-8159.2009.02304.x; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Sasaki T, 2011, CIRC-CARDIOVASC IMAG, V4, P662, DOI 10.1161/CIRCIMAGING.111.965764; Smith JL, 2003, INT J CARDIOVAS IMAG, V19, P189, DOI 10.1023/A:1023655705807; Sugeng L, 2010, JACC-CARDIOVASC IMAG, V3, P10, DOI 10.1016/j.jcmg.2009.09.017; van der Zwaan HB, 2010, J AM SOC ECHOCARDIOG, V23, P134, DOI 10.1016/j.echo.2009.12.001; Zheng MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058494	18	17	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129557	10.1371/journal.pone.0129557	http://dx.doi.org/10.1371/journal.pone.0129557			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075788	Green Published, Green Submitted, gold			2022-12-26	WOS:000356329900083
J	Wang, YN; Yang, CH; Gu, QQ; Sims, M; Gu, WW; Pfeffer, LM; Yue, JM				Wang, Yinan; Yang, Chuanhe; Gu, Qingqing; Sims, Michelle; Gu, Weiwang; Pfeffer, Lawrence M.; Yue, Junming			KLF4 Promotes Angiogenesis by Activating VEGF Signaling in Human Retinal Microvascular Endothelial Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; KRUPPEL-LIKE FACTOR-2; GROWTH-FACTOR; DIABETIC-RETINOPATHY; MEDIATED ANGIOGENESIS; CANCER; NEOVASCULARIZATION; PATHWAY; PROLIFERATION; METASTASIS	The transcription factor Kruppel-like factor 4 (KLF4) has been implicated in regulating cell proliferation, migration and differentiation in a variety of human cells and is one of four factors required for the induction of pluripotent stem cell reprogramming. However, its role has not been addressed in ocular neovascular diseases. This study investigated the role of KLF4 in angiogenesis and underlying molecular mechanisms in human retinal microvascular endothelial cells (HRMECs). The functional role of KLF4 in HRMECs was determined following lentiviral vector mediated inducible expression and shRNA knockdown of KLF4. Inducible expression of KLF4 promotes cell proliferation, migration and tube formation. In contrast, silencing KLF4 inhibits cell proliferation, migration, tube formation and induces apoptosis in HRMECs. KLF4 promotes angiogenesis by transcriptionally activating VEGF expression, thus activating the VEGF signaling pathway in HRMECs.	[Wang, Yinan; Yang, Chuanhe; Gu, Qingqing; Sims, Michelle; Pfeffer, Lawrence M.; Yue, Junming] Univ Tennessee, Dept Pathol & Lab Med, Hlth Sci Ctr, Memphis, TN USA; [Wang, Yinan; Yang, Chuanhe; Gu, Qingqing; Sims, Michelle; Pfeffer, Lawrence M.; Yue, Junming] Univ Tennessee, Ctr Canc Res, Hlth Sci Ctr, Memphis, TN USA; [Wang, Yinan; Gu, Weiwang] Southern Med Univ, Dept Lab Anim Ctr, Guangzhou, Guangdong, Peoples R China	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Southern Medical University - China	Gu, WW (corresponding author), Southern Med Univ, Dept Lab Anim Ctr, Guangzhou, Guangdong, Peoples R China.	guww100@163.com; jyue@uthsc.eduf		Pfeffer, Lawrence/0000-0003-2809-1234	NIH [HL095957]; UTHSC startup and West Cancer Center; Chinese Government [2011DFA33290]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL095957] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UTHSC startup and West Cancer Center; Chinese Government; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grants from NIH (HL095957), UTHSC startup and West Cancer Center to JY and Chinese Government (2011DFA33290) to WG.	[Anonymous], 2007, DRUG THER B, V45, P49; Barot M, 2013, FUTURE MED CHEM, V5, P301, DOI [10.4155/fmc.12.206, 10.4155/FMC.12.206]; Bertolino P, 2005, CHEST, V128, p585S, DOI 10.1378/chest.128.6_suppl.585S; Bhattacharya R, 2005, J BIOL CHEM, V280, P28848, DOI 10.1074/jbc.C500200200; Boon RA, 2011, EUR HEART J, V32, P371, DOI 10.1093/eurheartj/ehq137; Browning AC, 2012, BRIT J OPHTHALMOL, V96, P128, DOI 10.1136/bjophthalmol-2011-300572; Chen ZX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105331; Chiplunkar AR, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-40; Cleaver N, 2013, J DRUGS DERMATOL, V12, P1052; Das A, 2006, J BIOL CHEM, V281, P39105, DOI 10.1074/jbc.M607720200; Fantozzi A, 2014, CANCER RES, V74, P1566, DOI 10.1158/0008-5472.CAN-13-1641; Gambrelle J, 2013, J FR OPHTALMOL, V36, P431, DOI 10.1016/j.jfo.2012.11.005; Hale AT, 2014, J BIOL CHEM, V289, P12016, DOI 10.1074/jbc.M113.530956; Helbing T, 2010, CARDIOVASC RES, V85, P551, DOI 10.1093/cvr/cvp314; Huang TS, 2014, J CELL MOL MED, V18, P1358, DOI 10.1111/jcmm.12300; Jang Jung Hyun, 2012, Korean J Ophthalmol, V26, P478, DOI 10.3341/kjo.2012.26.6.478; Lin ZS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043593; List AF, 2001, ONCOLOGIST, V6, P24, DOI 10.1634/theoncologist.6-suppl_5-24; Liu YN, 2012, MOL CELL BIOL, V32, P941, DOI 10.1128/MCB.06306-11; Maeshima Y, 2001, J BIOL CHEM, V276, P15240, DOI 10.1074/jbc.M007764200; Mukhopadhyay D, 1997, MOL CELL BIOL, V17, P5629, DOI 10.1128/MCB.17.9.5629; Nagai R, 2005, J THROMB HAEMOST, V3, P1569, DOI 10.1111/j.1538-7836.2005.01366.x; Pei JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081109; Ptaszynska MM, 2010, MOL CANCER RES, V8, P309, DOI 10.1158/1541-7786.MCR-09-0288; Shibuya M, 2006, J BIOCHEM MOL BIOL, V39, P469; Shibuya M, 2006, ENDOTHELIUM-J ENDOTH, V13, P63, DOI 10.1080/10623320600697955; Shibuya M, 2014, BIOMOL THER, V22, P1, DOI 10.4062/biomolther.2013.113; Shiozaki A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038049; Spilsbury K, 2000, AM J PATHOL, V157, P135, DOI 10.1016/S0002-9440(10)64525-7; Villarreal G, 2010, BIOCHEM BIOPH RES CO, V391, P984, DOI 10.1016/j.bbrc.2009.12.002; Wara AK, 2011, BLOOD, V118, P6450, DOI 10.1182/blood-2011-06-363713; Yagi H, 2008, MOL CANCER THER, V7, P3441, DOI 10.1158/1535-7163.MCT-08-0417; Yang DHA, 2013, INT J BIOCHEM CELL B, V45, P419, DOI 10.1016/j.biocel.2012.11.007; Yang WZ, 2013, EXP EYE RES, V115, P96, DOI 10.1016/j.exer.2013.06.011; Yang Y, 2013, MOL CELL ENDOCRINOL, V378, P46, DOI 10.1016/j.mce.2013.04.021; Yang ZH, 2014, AM J PATHOL, V184, P1230, DOI 10.1016/j.ajpath.2013.12.023; Yori JL, 2011, NEOPLASIA, V13, P601, DOI 10.1593/neo.11260; Yue JM, 2010, BIOCHEM BIOPH RES CO, V394, P667, DOI 10.1016/j.bbrc.2010.03.047; Zheng XM, 2013, BIOCHEM BIOPH RES CO, V437, P625, DOI 10.1016/j.bbrc.2013.07.017	39	34	34	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130341	10.1371/journal.pone.0130341	http://dx.doi.org/10.1371/journal.pone.0130341			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075898	gold, Green Submitted, Green Published			2022-12-26	WOS:000356329900165
J	Chan, KF; Alter, L; Barthold, SW; Parveen, N				Chan, Kamfai; Alter, Laura; Barthold, Stephen W.; Parveen, Nikhat			Disruption of bbe02 by Insertion of a Luciferase Gene Increases Transformation Efficiency of Borrelia burgdorferi and Allows Live Imaging in Lyme Disease Susceptible C3H Mice	PLOS ONE			English	Article							BINDING PROTEIN; PLASMID CONTENT; LIGHT-EMISSION; INFECTIVITY; SPIROCHETE; MICROBIOTA; EXPRESSION; KINETICS; IMPACT; BIOLUMINESCENCE	Lyme disease is the most prevalent tick-borne disease in North America and Europe. The causative agent, Borrelia burgdorferi persists in the white-footed mouse. Infection with B. burgdorferi can cause acute to persistent multisystemic Lyme disease in humans. Some disease manifestations are also exhibited in the mouse model of Lyme disease. Genetic manipulation of B. burgdorferi remains difficult. First, B. burgdorferi contains a large number of endogenous plasmids with unique sequences encoding unknown functions. The presence of these plasmids needs to be confirmed after each genetic manipulation. Second, the restriction modification defense systems, including that encoded by bbe02 gene lead to low transformation efficiency in B. burgdorferi. Therefore, studying the molecular basis of Lyme pathogenesis is a challenge. Furthermore, investigation of the role of a specific B. burgdorferi protein throughout infection requires a large number of mice, making it labor intensive and expensive. To overcome the problems associated with low transformation efficiency and to reduce the number of mice needed for experiments, we disrupted the bbe02 gene of a highly infectious and pathogenic B. burgdorferi strain, N40 D10/E9 through insertion of a firefly luciferase gene. The bbe02 mutant shows higher transformation efficiency and maintains luciferase activity throughout infection as detected by live imaging of mice. Infectivity and pathogenesis of this mutant were comparable to the wild-type N40 strain. This mutant will serve as an ideal parental strain to examine the roles of various B. burgdorferi proteins in Lyme pathogenesis in the mouse model in the future.	[Chan, Kamfai; Alter, Laura; Parveen, Nikhat] Rutgers State Univ, New Jersey Med Sch, Dept Mol Genet Biochem & Microbiol, Newark, NJ 07103 USA; [Barthold, Stephen W.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of California System; University of California Davis	Parveen, N (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Mol Genet Biochem & Microbiol, Newark, NJ 07103 USA.	Parveeni@njms.rutgers.edu		Parveen, Nikhat/0000-0003-0592-0693	National Institutes of Health [AI089921]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089921] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by AI089921 grant to NP from National Institutes of Health.	BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; BARTHOLD SW, 1992, AM J TROP MED HYG, V47, P605, DOI 10.4269/ajtmh.1992.47.605; BARTHOLD SW, 1990, J INFECT DIS, V162, P133, DOI 10.1093/infdis/162.1.133; BARTHOLD SW, 1991, AM J PATHOL, V139, P263; Blevins JS, 2007, APPL ENVIRON MICROB, V73, P1501, DOI 10.1128/AEM.02454-06; Blumenthal RM, 2002, MODERN MICROBIAL GEN, P177, DOI [10.1002/047122197X.ch7, DOI 10.1002/047122197X.CH7]; Brisson D, 2012, ANNU REV GENET, V46, P515, DOI 10.1146/annurev-genet-011112-112140; Bunikis I, 2011, J MICROBIOL METH, V86, P243, DOI 10.1016/j.mimet.2011.05.004; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Casjens SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033280; Casjens SR, 2010, BORRELIA MOLECULAR B, P550; Chan KF, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-157; Chan KF, 2012, INFECT IMMUN, V80, P1519, DOI 10.1128/IAI.06326-11; Chen Q, 2008, J BACTERIOL, V190, P7885, DOI 10.1128/JB.00324-08; Chow J, 2011, CURR OPIN IMMUNOL, V23, P473, DOI 10.1016/j.coi.2011.07.010; Contag CH, 1995, MOL MICROBIOL, V18, P593, DOI 10.1111/j.1365-2958.1995.mmi_18040593.x; Foucault ML, 2010, APPL ENVIRON MICROB, V76, P264, DOI 10.1128/AEM.01686-09; Frank KL, 2003, J BACTERIOL, V185, P6723, DOI 10.1128/JB.185.22.6723-6727.2003; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gilbert MA, 2007, MOL MICROBIOL, V63, P1259, DOI 10.1111/j.1365-2958.2007.05593.x; Graham J, 2011, PEDIATR EMERG CARE, V27, P141, DOI [10.1097/PEC.0b013e318209f0b3, 10.1097/01.PEC.0000394507.43840.f1]; Greer LF, 2002, LUMINESCENCE, V17, P43, DOI 10.1002/bio.676; Hakkila K, 2002, ANAL BIOCHEM, V301, P235, DOI 10.1006/abio.2001.5517; Hutchens M, 2007, CELL MICROBIOL, V9, P2315, DOI 10.1111/j.1462-5822.2007.00995.x; Hyde JA, 2011, MOL MICROBIOL, V82, P99, DOI 10.1111/j.1365-2958.2011.07801.x; Iyer R, 2001, J CLIN MICROBIOL, V39, P2954, DOI 10.1128/JCM.39.8.2954-2957.2001; Jacobs MB, 2006, INFECT IMMUN, V74, P3678, DOI 10.1128/IAI.00043-06; Kaiser P, 2012, IMMUNOL REV, V245, P56, DOI 10.1111/j.1600-065X.2011.01070.x; Karp M, 1999, BIOMOL ENG, V16, P101, DOI 10.1016/S1050-3862(99)00039-X; Kawabata H, 2004, INFECT IMMUN, V72, P7147, DOI 10.1128/IAI.72.12.7147-7154.2004; Kobayashi I, 2001, NUCLEIC ACIDS RES, V29, P3742, DOI 10.1093/nar/29.18.3742; Kurittu J, 2000, J FOOD PROTECT, V63, P953, DOI 10.4315/0362-028X-63.7.953; Labandeira-Rey M, 2003, INFECT IMMUN, V71, P4608, DOI 10.1128/IAI.71.8.4608-4613.2003; Lawrenz MB, 2002, INFECT IMMUN, V70, P4798, DOI 10.1128/IAI.70.9.4798-4804.2002; Lin T, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00063; Lin T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047532; Makarova KS, 2013, NUCLEIC ACIDS RES, V41, P4360, DOI 10.1093/nar/gkt157; MEIGHEN EA, 1993, FASEB J, V7, P1016, DOI 10.1096/fasebj.7.11.8370470; MEIGHEN EA, 1993, ADV MICROB PHYSIOL, V34, P1, DOI 10.1016/S0065-2911(08)60027-2; Moriarty TJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000090; Norman MU, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000169; Noverr MC, 2005, CLIN EXP ALLERGY, V35, P1511, DOI 10.1111/j.1365-2222.2005.02379.x; Ogden NH, 2011, APPL ENVIRON MICROB, V77, P3244, DOI 10.1128/AEM.02636-10; Parveen N, 2006, INFECT IMMUN, V74, P3016, DOI 10.1128/IAI.74.5.3016-3020.2006; Parveen N, 2000, MOL MICROBIOL, V35, P1220, DOI 10.1046/j.1365-2958.2000.01792.x; Purser JE, 2003, MOL MICROBIOL, V48, P753, DOI 10.1046/j.1365-2958.2003.03452.x; Purser JE, 2000, P NATL ACAD SCI USA, V97, P13865, DOI 10.1073/pnas.97.25.13865; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Rego ROM, 2011, J BACTERIOL, V193, P1161, DOI 10.1128/JB.01176-10; Rizzoli A., 2011, EUROSURVEILLANCE, V16; Rosa PA, 2010, BORRELIA MOL BIOL HO, P550; Russell SL, 2013, GUT MICROBES, V4, P158, DOI 10.4161/gmic.23567; Saidac DS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-43; Samuels D S, 1995, Methods Mol Biol, V47, P253; SAMUELS DS, 1994, J BACTERIOL, V176, P6045, DOI 10.1128/jb.176.19.6045-6049.1994; Seshu J, 2006, MOL MICROBIOL, V59, P1591, DOI 10.1111/j.1365-2958.2005.05042.x; Shaw DK, 2012, MOL MICROBIOL, V83, P319, DOI 10.1111/j.1365-2958.2011.07932.x; STEERE AC, 1983, ANN INTERN MED, V99, P76, DOI 10.7326/0003-4819-99-1-76; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; Thompson JF, 1997, J BIOL CHEM, V272, P18766, DOI 10.1074/jbc.272.30.18766; Tilly K, 2006, INFECT IMMUN, V74, P3554, DOI 10.1128/IAI.01950-05; Wang DC, 2003, MOL MICROBIOL, V47, P1407, DOI 10.1046/j.1365-2958.2003.03386.x; Wang G, 2001, INFECT IMMUN, V69, P4303, DOI 10.1128/IAI.69.7.4303-4312.2001; Wiles S, 2009, METHODS MOL BIOL, V574, P137, DOI 10.1007/978-1-60327-321-3_12	64	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129532	10.1371/journal.pone.0129532	http://dx.doi.org/10.1371/journal.pone.0129532			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26069970	Green Submitted, Green Published, gold			2022-12-26	WOS:000356327000086
J	Cioffi, MD; Bertollo, LAC; Villa, MA; de Oliveira, EA; Tanomtong, A; Yano, CF; Supiwong, W; Chaveerach, A				Cioffi, Marcelo de Bello; Carlos Bertollo, Luiz Antonio; Villa, Mateo Andres; de Oliveira, Ezequiel Aguiar; Tanomtong, Alongklod; Yano, Cassia Fernanda; Supiwong, Weerayuth; Chaveerach, Arunrat			Genomic Organization of Repetitive DNA Elements and Its Implications for the Chromosomal Evolution of Channid Fishes (Actinopterygii, Perciformes)	PLOS ONE			English	Article							HOPLIAS-MALABARICUS; ERYTHRINIDAE FISH; SNAKEHEAD FISH; SPECIATION; DIFFERENTIATION; REARRANGEMENTS; CHARACIFORMES; EVENTS; PISCES	Channid fishes, commonly referred to as "snakeheads", are currently very important in Asian fishery and aquaculture due to the substantial decline in natural populations because of overexploitation. A large degree of chromosomal variation has been found in this family, mainly through the use of conventional cytogenetic investigations. In this study, we analyzed the karyotype structure and the distribution of 7 repetitive DNA sequences in several Channa species from different Thailand river basins. The aim of this study was to investigate the chromosomal differentiation among species and populations to improve upon the knowledge of its biodiversity and evolutionary history. Rearrangements, such as pericentric inversions, fusions and polyploidization, appear to be important events during the karyotypic evolution of this genus, resulting in the chromosomal diversity observed among the distinct species and even among populations of the same species. In addition, such variability is also increased by the genomic dynamism of repetitive elements, particularly by the differential distribution and accumulation of rDNA sequences on chromosomes. This marked diversity is likely linked to the lifestyle of the snakehead fishes and their population fragmentation, as already identified for other fish species. The karyotypic features highlight the biodiversity of the channid fishes and justify a taxonomic revision of the genus Channa, as well as of the Channidae family as a whole, as some nominal species may actually constitute species complexes.	[Cioffi, Marcelo de Bello; Carlos Bertollo, Luiz Antonio; de Oliveira, Ezequiel Aguiar; Yano, Cassia Fernanda] Univ Fed Sao Carlos, Dept Genet & Evolucao, Sao Paulo, Brazil; [Villa, Mateo Andres] Univ Georgia, Franklin Coll Arts & Sci, Athens, GA 30602 USA; [Tanomtong, Alongklod; Chaveerach, Arunrat] Khon Kaen Univ, Dept Biol, Fac Sci, Khon Kaen, Thailand; [Supiwong, Weerayuth] Khon Kaen Univ, Fac Engn & Appl Sci, Muang 43000, Nong Kai, Thailand; [Chaveerach, Arunrat] Khon Kaen Univ, Genet & Environm Toxicol Res Grp, Khon Kaen, Thailand	Universidade Federal de Sao Carlos; University System of Georgia; University of Georgia; Khon Kaen University; Khon Kaen University; Khon Kaen University	Chaveerach, A (corresponding author), Khon Kaen Univ, Dept Biol, Fac Sci, Khon Kaen, Thailand.	raccha@kku.ac.th	Supiwong, Weerayuth/ABA-4309-2020; Cioffi, Marcelo/AFK-6402-2022; de Oliveira, Ezequiel Aguiar/D-4925-2018; Cioffi, Marcelo/AAG-4675-2022; Tanomtong, Alongklod/ABA-4321-2020; Chaveerach, Arunrat/C-1364-2009	Cioffi, Marcelo/0000-0003-4340-1464; de Oliveira, Ezequiel Aguiar/0000-0002-8264-8884; Cioffi, Marcelo/0000-0003-4340-1464; Tanomtong, Alongklod/0000-0002-8466-3594; Yano, Cassia Fernanda/0000-0002-8118-2867; Chaveerach, Arunrat/0000-0002-7466-4243	Genetics and Environmental Toxicology Research Group (Khon Kaen University); Brazilian agency CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)	Genetics and Environmental Toxicology Research Group (Khon Kaen University); Brazilian agency CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was financially supported by the Genetics and Environmental Toxicology Research Group (Khon Kaen University) and by the Brazilian agency CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson EAS, 2010, MOL PHYLOGENET EVOL, V56, P707, DOI 10.1016/j.ympev.2010.03.027; [Anonymous], 2007, FRESHWATER FISH DIST; [Anonymous], 1990, GUIDE FRESHWATER FIS; BERTOLLO L A C, 1978, Revista Brasileira de Genetica, V1, P103; Bertollo LAC, 2000, CHROMOSOME RES, V8, P603, DOI 10.1023/A:1009233907558; Bertollo Luiz Antonio Carlos, 2007, P195; Brum M.J.I., 1997, J COMP BIOL, V2, P91; Butlin RK, 2005, MOL ECOL, V14, P2621, DOI 10.1111/j.1365-294X.2005.02617.x; Cioffi MB, 2012, GENOME DYNAM, V7, P197, DOI 10.1159/000337950; Cioffi MB, 2011, CYTOGENET GENOME RES, V132, P188, DOI 10.1159/000321571; Cioffi MB, 2009, CYTOGENET GENOME RES, V125, P132, DOI 10.1159/000227838; Cioffi MB, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-271; David P, 2009, PLANT PHYSIOL, V151, P1048, DOI 10.1104/pp.109.142109; Dimitri P, 1997, P NATL ACAD SCI USA, V94, P8052, DOI 10.1073/pnas.94.15.8052; Donsakul T, 1991, FS DEP BIOL WICH MAG; Faria R, 2010, TRENDS ECOL EVOL, V25, P660, DOI 10.1016/j.tree.2010.07.008; Feldman M, 2005, CYTOGENET GENOME RES, V109, P250, DOI 10.1159/000082407; Karr J.R., 1975, P258; Kejnovsky E, 2009, HEREDITY, V102, P533, DOI 10.1038/hdy.2009.17; Kubat Z, 2008, GENOME, V51, P350, DOI 10.1139/G08-024; Kumar R, 2013, CARYOLOGIA, V66, P109, DOI 10.1080/00087114.2013.821829; Leggatt RA, 2003, REV FISH BIOL FISHER, V13, P237, DOI 10.1023/B:RFBF.0000033049.00668.fe; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; LIM JK, 1994, BIOESSAYS, V16, P269, DOI 10.1002/bies.950160410; Lima PA, 2014, CYTOGENET GENOME RES, V142, P197, DOI 10.1159/000360492; Ma XF, 2005, CYTOGENET GENOME RES, V109, P236, DOI 10.1159/000082406; Martins C, 2006, GENETICA, V127, P133, DOI 10.1007/s10709-005-2674-y; Martins NF, 2013, REV FISH BIOL FISHER, V23, P261, DOI 10.1007/s11160-012-9292-4; Matsunaga S, 2009, HEREDITY, V102, P525, DOI 10.1038/hdy.2009.36; Molina Wagner Franco, 2007, P69; Molina WF, 2002, CARYOLOGIA, V55, P299, DOI 10.1080/00087114.2002.10797880; Musikasinthorn P, 2001, ICHTHYOL RES, V48, P319, DOI 10.1007/s10228-001-8153-2; Naorem S, 2006, CARYOLOGIA, V59, P235, DOI 10.1080/00087114.2006.10797920; Near TJ, 2004, EVOLUTION, V58, P2798; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; Poltronieri J, 2014, CYTOGENET GENOME RES, V142, P40, DOI 10.1159/000355908; Rahman AKA, 1989, FRESHWATERFISHES BAN; Rainboth WJ, 1996, TAXONOMY SYSTEMATICS; Raskina O, 2008, CYTOGENET GENOME RES, V120, P351, DOI 10.1159/000121084; RISHI KK, 1990, CARYOLOGIA, V43, P163, DOI 10.1080/00087114.1990.10796995; Sayer MDJ, 2005, FISH FISH, V6, P186, DOI 10.1111/j.1467-2979.2005.00193.x; SCHWARZACHER T, 1989, ANN BOT-LONDON, V64, P315, DOI 10.1093/oxfordjournals.aob.a087847; Singh M, 2013, MOL BIOL REP, V40, P723, DOI 10.1007/s11033-012-2112-z; Supiwong W, 2009, CYTOLOGIA, V74, P317, DOI 10.1508/cytologia.74.317; Symonova R, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-42; Tanomtong A, 2014, CYTOLOGIA, V79, P15, DOI 10.1508/cytologia.79.15; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; Wainwright P.C., 1994, ECOLOGICAL MORPHOLOG; Xu DD, 2013, MOL CYTOGENET, V6, DOI 10.1186/1755-8166-6-12; Yano CF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090946	51	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130199	10.1371/journal.pone.0130199	http://dx.doi.org/10.1371/journal.pone.0130199			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26067030	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000148
J	Kerubo, G; Khamadi, S; Okoth, V; Madise, N; Ezeh, A; Abdalla, Z; Mwau, M				Kerubo, Glennah; Khamadi, Samoel; Okoth, Vincent; Madise, Nyovani; Ezeh, Alex; Abdalla, Ziraba; Mwau, Matilu			Hepatitis B, Hepatitis C and HIV-1 Coinfection in Two Informal Urban Settlements in Nairobi, Kenya	PLOS ONE			English	Article							INFECTED PATIENTS; VIRUS-INFECTIONS; PREVALENCE; RISK; METAANALYSIS; AFRICA; COHORT	Background HIV-1 and Hepatitis B and C viruses coinfection is common in Sub-Saharan Africa due to similar routes of transmission and high levels of poverty. Most studies on HIV-1 and Hepatitis B and C viruses have occurred in hospital settings and blood transfusion units. Data on Hepatitis B and C viruses and HIV-1 coinfection in informal urban settlements in Kenya are scanty, yet they could partly explain the disproportionately high morbidity and mortality associated with HIV-1 infections in these slums. Objectives The objective of this study was to determine the prevalence of HIV and Hepatitis B and C dual infection in urban slums in Nairobi. Methods Blood samples were collected from residents of Viwandani and Korogocho between 2006 and 2007. A structured questionnaire was used to obtain socio-demographic data from participants. Samples were screened for Hepatitis B surface antigen (HBsAg), anti-HCV and anti-HIV-1. Statistical analysis was done using STATA. Results Samples were successfully collected from 418 (32%) men and 890 (68%) females. The HIV-1, HBV and HCV prevalence was 20.4%, 13.3% and 0.76% respectively at the time of the study. Of the 268 (20.4%) HIV-1 positive participants, 56 (4.26%) had HBV while 6 (0.46%) had HCV. Of the 1041 HIV-1 negative participants, 117 (8.9%) had HBV while 4 (0.31%) had HCV. Only two people (0.15%) were co-infected with all the three viruses together. Discussion The odds of getting hepatitis infection were higher in HIV-1 participants (for HBV OR 2.08, p<0.005 and for HCV OR 5.93, p<0.005). HIV prevalence rates were similar in both informal settlements. HIV infection was highest in age group 35-39 years and among the divorced/separated or widowed. Prevalence of all viruses was highest in those who did not have any formal education. Conclusion The HIV prevalence in these informal settlements suggests a higher rate than what is observed nationally. The prevalence rates of HBV are significantly higher in the HIV-1 positive and negative populations. HCV as well as triple HIV-1, HBV and HCV coinfection are uncommon in Korogocho and Viwandani. This clearly indicates the need for HIV-1 control programmes and hepatitis B virus vaccination to be promoted through public awareness as preventive strategy.	[Kerubo, Glennah] Jomo Kenyatta Univ Agr & Technol, Inst Trop Med & Infect Dis, Nairobi, Kenya; [Khamadi, Samoel; Okoth, Vincent] Kenya Govt Med Res Ctr, Ctr Virus Res, Nairobi, Kenya; [Mwau, Matilu] Kenya Govt Med Res Ctr, Ctr Infect & Parasit Dis Control Res, Busia, Kenya; [Madise, Nyovani; Ezeh, Alex; Abdalla, Ziraba] African Populat Hlth Res Ctr, Nairobi, Kenya	Jomo Kenyatta University of Agriculture & Technology; Kenya Medical Research Institute; Kenya Medical Research Institute; African Population & Health Research Centre	Kerubo, G (corresponding author), Jomo Kenyatta Univ Agr & Technol, Inst Trop Med & Infect Dis, Nairobi, Kenya.	glenakerubo@gmail.com	Khamadi, Samoel Ashimosi/GXZ-6071-2022; Ezeh, Alex/AAN-8646-2020	Ezeh, Alex/0000-0002-1309-4697; Ziraba, Abdhalah/0000-0002-3417-6536; Madise, Nyovani/0000-0002-2813-5295	African Population Health Research Centre	African Population Health Research Centre	This work was supported by the African Population Health Research Centre, www.aphrc.org, in the design purchase of the laboratory requirements (to MM). The funders played a role in data collection and analysis, decision to publish and preparation of the manuscript.	Apurva A., 2007, AIDS REV, V9, P25; Ashraf H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-208; Barth RE, 2010, INT J INFECT DIS, V14, pE1024, DOI 10.1016/j.ijid.2010.06.013; Bigogo G, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-376; Chen JJ, 2011, HEPATOB PANCREAT DIS, V10, P122, DOI 10.1016/S1499-3872(11)60020-9; Daw MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098793; Ezegbudo C., 2004, SHIRAZ E MED J, V5, P122; Goni BW, 2013, NIGER J CLIN PRACT, V16, P530, DOI 10.4103/1119-3077.116908; Harania R., 2008, 4 INT WORKSH HIV 1 H; Hoffmann CJ, 2007, LANCET INFECT DIS, V7, P402, DOI 10.1016/S1473-3099(07)70135-4; Hyams C., J MED VIROLOGY, V28; Jobarteh M, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-230; Kabiru CW, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-685; Kapembwa KC, 2011, J GLOB INFECT DIS, V3, P269, DOI 10.4103/0974-777X.83534; Karoney MJ, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.44.2199; Lodenyo H, 2000, E AFR MED J, V77, P13; Madise NJ, 2012, HEALTH PLACE, V18, P1144, DOI 10.1016/j.healthplace.2012.04.003; Mboto CI, 2010, BRIT J BIOMED SCI, V67, P140, DOI 10.1080/09674845.2010.11730311; McKinnon LR, 2014, SEX TRANSM INFECT, V90, P237, DOI 10.1136/sextrans-2013-051310; Moore E, 2010, J INFECTION, V61, P155, DOI 10.1016/j.jinf.2010.04.009; Muasya T, 2008, East Afr Med J, V85, P318; Mwangi J., 1999, E AFR MED J, V76, P135; Otedo A E O, 2004, East Afr Med J, V81, P626; Otegbayo JA, 2008, ANN HEPATOL, V7, P152, DOI 10.1016/S1665-2681(19)31872-1; Rouet F, 2004, J MED VIROL, V74, P34, DOI 10.1002/jmv.20143; Rusine J, 2013, PLOS ONE, V8; Shimelis T, 2007, SEX TRANSM INFECT, V84, P37, DOI 10.1136/sti.2007.027326; Sims OT, 2015, SOCIAL WORK PUBLIC H, P1, DOI [10.1080/19371918.2014.938388, DOI 10.1080/19371918.2014.938388]; Singal AK, 2009, WORLD J GASTROENTERO, V15, P3713, DOI 10.3748/wjg.15.3713; Sy Theodore, 2006, Int J Med Sci, V3, P41; Taiwo Modupe B, 2012, PAN AFRICAN MED J; Thio CL, 2009, HEPATOLOGY, V49, pS138, DOI 10.1002/hep.22883; Zoufaly A, 2012, INT J STD AIDS, V23, P435, DOI 10.1258/ijsa.2011.011279	33	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129247	10.1371/journal.pone.0129247	http://dx.doi.org/10.1371/journal.pone.0129247			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068212	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000058
J	Ma, XW; Fu, YN; Xiao, H; Song, Y; Chen, RF; Shen, J; An, XB; Shen, Q; Li, ZJ; Zhang, YY				Ma, Xiaowei; Fu, Yongnan; Xiao, Han; Song, Yao; Chen, Ruifei; Shen, Jing; An, Xiangbo; Shen, Qiang; Li, Zijian; Zhang, Youyi			Cardiac Fibrosis Alleviated by Exercise Training Is AMPK-Dependent	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; LEFT-VENTRICULAR HYPERTROPHY; VEIN ENDOTHELIAL-CELLS; KAPPA-B ACTIVATION; OXIDATIVE STRESS; HEART-FAILURE; NAD(P)H OXIDASE; SKELETAL-MUSCLE; UP-REGULATION; EXPRESSION	Regular exercise can protect the heart against external stimuli, but the mechanism is not well understood. We determined the role of adenosine monophosphate-activated protein kinase (AMPK) in regulating swimming exercise-mediated cardiac protection against beta-adrenergic receptor overstimulation with isoproterenol (ISO) in mice. Ten-week-old AMPK alpha 2(+/+) and AMPK alpha 2-knockout (AMPK alpha 2(-/-)) littermates were subjected to 4 weeks of swimming training (50 min daily, 6 days a week) or housed under sedentary conditions. The mice received daily subcutaneous injection of ISO (5 mg/kg/d), a nonselective beta-adrenergic receptor agonist, during the last 2 weeks of swimming training. Swimming training alleviated ISO-induced cardiac fibrosis in AMPK alpha 2(+/+) mice but not AMPK alpha 2(-/-) mice. Swimming training activated cardiac AMPK in AMPK alpha 2(+/+) mice. Furthermore, swimming training attenuated ISO-induced production of reactive oxygen species (ROS) and expression of NADPH oxidase and promoted the expression of antioxidant enzymes in AMPK alpha 2(+/+) mice but not AMPK alpha 2(-/-) mice. In conclusion, swimming training attenuates ISO-induced cardiac fibrosis by inhibiting the NADPH oxidase-ROS pathway mediated by AMPK activation. Our findings provide a new mechanism for the cardioprotective effects of exercise.	[Ma, Xiaowei; Fu, Yongnan; Xiao, Han; Song, Yao; Chen, Ruifei; Shen, Jing; An, Xiangbo; Shen, Qiang; Li, Zijian; Zhang, Youyi] Peking Univ, Hosp 3, Inst Vasc Med,Minist Hlth,Minist Educ, Key Lab Mol Cardiovasc Sci,Key Lab Cardiovasc Mol, Beijing 100871, Peoples R China; [Ma, Xiaowei; Fu, Yongnan; Xiao, Han; Song, Yao; Chen, Ruifei; Shen, Jing; An, Xiangbo; Shen, Qiang; Li, Zijian; Zhang, Youyi] Beijing Key Lab Cardiovasc Receptors Res, Beijing, Peoples R China; [Fu, Yongnan] Nanchang Univ, Affiliated Hosp 1, Nanchang, Peoples R China	Peking University; Nanchang University	Zhang, YY (corresponding author), Peking Univ, Hosp 3, Inst Vasc Med,Minist Hlth,Minist Educ, Key Lab Mol Cardiovasc Sci,Key Lab Cardiovasc Mol, Beijing 100871, Peoples R China.	zhangyy@bjmu.edu.cn	Xiao, Han/T-5032-2019	Song, Yao/0000-0003-1699-759X	Natural Science Foundation of China (NSFC) [81030001]; National Key Basic Research Program of the People's Republic of China [2012CB51800]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of the People's Republic of China	This work was supported by the Natural Science Foundation of China (NSFC, 81030001); the National Key Basic Research Program of the People's Republic of China (2012CB51800). YYZ received the fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams V, 2005, CIRCULATION, V111, P555, DOI 10.1161/01.CIR.0000154560.88933.7E; Ago T, 2010, CIRC RES, V106, P1253, DOI 10.1161/CIRCRESAHA.109.213116; Brooks SV, 2008, J PHYSIOL-LONDON, V586, P3979, DOI 10.1113/jphysiol.2008.155382; Coven DL, 2003, AM J PHYSIOL-ENDOC M, V285, pE629, DOI 10.1152/ajpendo.00171.2003; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; Dean RG, 2005, J HISTOCHEM CYTOCHEM, V53, P1245, DOI 10.1369/jhc.4A6560.2005; Devaraj S, 2008, ARTERIOSCL THROM VAS, V28, P1368, DOI 10.1161/ATVBAHA.108.163303; Dobrzyn P, 2013, AM J PHYSIOL-ENDOC M, V304, pE1348, DOI 10.1152/ajpendo.00603.2012; Fukuyama Y, 2007, J DENT RES, V86, P903, DOI 10.1177/154405910708600919; Gomez-Cabrera MC, 2008, FREE RADICAL BIO MED, V44, P126, DOI 10.1016/j.freeradbiomed.2007.02.001; Gundewar S, 2009, CIRC RES, V104, P403, DOI 10.1161/CIRCRESAHA.108.190918; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; Ido Y, 2002, DIABETES, V51, P159, DOI 10.2337/diabetes.51.1.159; Kim HG, 2011, BRIT J PHARMACOL, V162, P1096, DOI 10.1111/j.1476-5381.2010.01101.x; Kirchhof P, 2006, CIRCULATION, V114, P1799, DOI 10.1161/CIRCULATIONAHA.106.624502; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Kuroda J, 2010, P NATL ACAD SCI USA, V107, P15565, DOI 10.1073/pnas.1002178107; Kwak HB, 2011, FASEB J, V25, P1106, DOI 10.1096/fj.10-172924; Leask A, 2007, CARDIOVASC RES, V74, P207, DOI 10.1016/j.cardiores.2006.07.012; Leosco D, 2008, CARDIOVASC RES, V78, P385, DOI 10.1093/cvr/cvm109; Li HL, 2007, J CELL BIOCHEM, V100, P1086, DOI 10.1002/jcb.21197; Li L, 2011, BASIC RES CARDIOL, V106, P1221, DOI 10.1007/s00395-011-0213-9; Li XN, 2009, DIABETES, V58, P2246, DOI 10.2337/db08-1512; Mou YA, 2009, CARDIOVASC RES, V81, P555, DOI 10.1093/cvr/cvn229; Musi N, 2005, FEBS LETT, V579, P2045, DOI 10.1016/j.febslet.2005.02.052; Peter PS, 2007, J CLIN INVEST, V117, P1335, DOI 10.1172/JCI29576; Purnomo Yudi, 2013, Cardiovascular & Hematological Disorders - Drug Targets, V13, P165; Radak Z, 2008, FREE RADICAL BIO MED, V44, P153, DOI 10.1016/j.freeradbiomed.2007.01.029; Sanderson JE, 2001, HEART, V86, P701, DOI 10.1136/heart.86.6.701; Sasaki H, 2009, CIRCULATION, V119, P2568, DOI 10.1161/CIRCULATIONAHA.108.798561; Seeland U, 2002, EUR J CLIN INVEST, V32, P295, DOI 10.1046/j.1365-2362.2002.00985.x; Srivastava S, 2007, CARDIOVASC RES, V74, P445, DOI 10.1016/j.cardiores.2007.02.016; Wang J, 2005, CIRC RES, V97, P821, DOI 10.1161/01.RES.0000185833.42544.06; Wang SX, 2010, CIRC RES, V106, P1117, DOI 10.1161/CIRCRESAHA.109.212530; Xiao H, 2010, CARDIOVASC RES, V87, P504, DOI 10.1093/cvr/cvq066; Xiao XY, 2010, J NUTR BIOCHEM, V21, P621, DOI 10.1016/j.jnutbio.2009.03.011; Xu Q, 2011, BRIT J PHARMACOL, V162, P1012, DOI 10.1111/j.1476-5381.2010.01043.x; Xu XH, 2008, CARDIOVASC RES, V78, P523, DOI 10.1093/cvr/cvn028; Zhang GX, 2005, CARDIOVASC RES, V65, P230, DOI 10.1016/j.cardiores.2004.08.013; Zhang P, 2008, HYPERTENSION, V52, P918, DOI 10.1161/HYPERTENSIONAHA.108.114702; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	43	43	47	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129971	10.1371/journal.pone.0129971	http://dx.doi.org/10.1371/journal.pone.0129971			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068068	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000127
J	Seiler, SMF; Baumgartner, C; Hirschberger, J; Beer, AJ; Bruhschwein, A; Kreutzmann, N; Laberke, S; Wergin, MC; Meyer-Lindenberg, A; Brandl, J; von Thaden, AK; Farrell, E; Schwaiger, M				Seiler, Stefanie M. F.; Baumgartner, Christine; Hirschberger, Johannes; Beer, Ambros J.; Bruhschwein, Andreas; Kreutzmann, Nina; Laberke, Silja; Wergin, Melanie C.; Meyer-Lindenberg, Andrea; Brandl, Johanna; von Thaden, Anne-Kathrin; Farrell, Eliane; Schwaiger, Markus			Comparative Oncology: Evaluation of 2-Deoxy-2-[18F]fluoro-D-glucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) for the Staging of Dogs with Malignant Tumors	PLOS ONE			English	Article							PRIMARY LUNG-TUMORS; HISTIOCYTIC SARCOMA; F-18-FDG UPTAKE; LYMPH-NODES; CANCER; THERAPY; CT; PROGNOSIS; DIAGNOSIS; (18)FDG	Introduction 2-Deoxy-2-[18F]fluoro-D-glucose PET/CT is a well-established imaging method for staging, restaging and therapy-control in human medicine. In veterinary medicine, this imaging method could prove to be an attractive and innovative alternative to conventional imaging in order to improve staging and restaging. The aim of this study was both to evaluate the effectiveness of this image-guided method in canine patients with spontaneously occurring cancer as well as to illustrate the dog as a well-suited animal model for comparative oncology. Methods Ten dogs with various malignant tumors were included in the study and underwent a whole body FDG PET/CT. One patient has a second PET-CT 5 months after the first study. Patients were diagnosed with histiocytic sarcoma (n = 1), malignant lymphoma (n = 2), mammary carcinoma (n = 4), sertoli cell tumor (n = 1), gastrointestinal stromal tumor (GIST) (n = 1) and lung tumor (n = 1). PET/CT data were analyzed with the help of a 5-point scale in consideration of the patients' medical histories. Results In seven of the ten dogs, the treatment protocol and prognosis were significantly changed due to the results of FDG PET/CT. In the patients with lymphoma (n = 2) tumor extent could be defined on PET/CT because of increased FDG uptake in multiple lymph nodes. This led to the recommendation for a therapeutic polychemotherapy as a treatment. In one of the dogs with mammary carcinoma (n = 4) and in the patient with the lung tumor (n = 1), surgery was cancelled due to the discovery of multiple metastasis. Consequently no treatment was recommended. Conclusion FDG PET/CT offers additional information in canine patients with malignant disease with a potential improvement of staging and restaging. The encouraging data of this clinical study highlights the possibility to further improve innovative diagnostic and staging methods with regard to comparative oncology. In the future, performing PET/CT not only for staging but also in therapy control could offer a significant improvement in the management of dogs with malignant tumors.	[Seiler, Stefanie M. F.; Hirschberger, Johannes; Kreutzmann, Nina; Laberke, Silja; Wergin, Melanie C.] Univ Munich, Clin Small Anim Med, Ctr Clin Vet Med, D-80539 Munich, Germany; [Seiler, Stefanie M. F.; Baumgartner, Christine; Brandl, Johanna; von Thaden, Anne-Kathrin] Tech Univ Munich, Ctr Preclin Res, D-81675 Munich, Germany; [Bruhschwein, Andreas; Meyer-Lindenberg, Andrea] Univ Munich, Clin Small Anim Surg & Reprod, Fac Vet, D-80539 Munich, Germany; [Beer, Ambros J.; Farrell, Eliane; Schwaiger, Markus] Univ Munich, Dept Nucl Med, D-81675 Munich, Germany	University of Munich; Technical University of Munich; University of Munich; University of Munich	Hirschberger, J (corresponding author), Univ Munich, Clin Small Anim Med, Ctr Clin Vet Med, D-80539 Munich, Germany.	hirschberger@lmu.de	Beer, Ambros J./AAA-5539-2022	Beer, Ambros J./0000-0001-9042-7806; schwaiger, markus/0000-0002-2305-7144; Wergin, Melanie/0000-0003-3224-3210; Hirschberger, Johannes/0000-0002-1382-6114; Meyer-Lindenberg, Andrea/0000-0001-6137-3773				Adams VJ, 2010, J SMALL ANIM PRACT, V51, P512, DOI 10.1111/j.1748-5827.2010.00974.x; Akgul AG, 2014, J BUON, V19, P836; Ballegeer EA, 2006, VET RADIOL ULTRASOUN, V47, P228, DOI 10.1111/j.1740-8261.2006.00132.x; Bangerter M, 1998, ANN ONCOL, V9, P1117, DOI 10.1023/A:1008486928190; Bednaruk-Mlynski E, 2015, LEUKEMIA LYMPHOMA, V56, P377, DOI 10.3109/10428194.2014.919635; Blodgett TM, 2007, RADIOLOGY, V242, P360, DOI 10.1148/radiol.2422051113; Bomanji JB, 2001, LANCET ONCOL, V2, P157, DOI 10.1016/S1470-2045(00)00257-6; Bombardieri E, 2001, Q J NUCL MED, V45, P245; Craig LE, 2002, VET PATHOL, V39, P66, DOI 10.1354/vp.39-1-66; De Leyn P, 2007, EUR J CARDIO-THORAC, V32, P1, DOI 10.1016/j.ejcts.2007.01.075; Eubank WB, 1998, AM J ROENTGENOL, V171, P1103, DOI 10.2214/ajr.171.4.9763005; Gayed I, 2004, J NUCL MED, V45, P17; Hansen AE, 2012, RADIOTHER ONCOL, V102, P424, DOI 10.1016/j.radonc.2011.10.021; Hansen AE, 2011, VET RADIOL ULTRASOUN, V52, P201, DOI 10.1111/j.1740-8261.2010.01757.x; Hansen K, 2004, EUR J CANCER, V40, P858, DOI 10.1016/j.ejca.2003.11.031; Herrmann K, 2007, CLIN CANCER RES, V13, P3552, DOI 10.1158/1078-0432.CCR-06-3025; Hutchings M, 2006, HAEMATOLOGICA, V91, P482; Ionut V, 2004, AM J VET RES, V65, P1124, DOI 10.2460/ajvr.2004.65.1124; Kamiyama Y, 2005, WORLD J SURG, V29, P1429, DOI 10.1007/s00268-005-0045-6; Kang BT, 2009, J VET MED SCI, V71, P1397, DOI 10.1292/jvms.001397; Khanna C, 2006, NAT BIOTECHNOL, V24, P1065, DOI 10.1038/nbt0906-1065b; LARSON SM, 1981, J NUCL MED, V22, P875; Lawrence J, 2009, VET RADIOL ULTRASOUN, V50, P660, DOI 10.1111/j.1740-8261.2009.01612.x; LeBlanc AK, 2008, VET RADIOL ULTRASOUN, V49, P182, DOI 10.1111/j.1740-8261.2008.00348.x; LeBlanc AK, 2012, VET RADIOL ULTRASOUN, V53, P348, DOI 10.1111/j.1740-8261.2012.01925.x; LeBlanc AK, 2009, VET RADIOL ULTRASOUN, V50, P436, DOI 10.1111/j.1740-8261.2009.01562.x; Leblanc AK, 2009, VET RADIOL ULTRASOUN, V50, P215, DOI 10.1111/j.1740-8261.2009.01520.x; Lee MS, 2010, VET RADIOL ULTRASOUN, V51, P670, DOI 10.1111/j.1740-8261.2010.01727.x; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Makis W, 2011, CLIN NUCL MED, V36, pE37, DOI 10.1097/RLU.0b013e3182173979; McNiel EA, 1997, J AM VET MED ASSOC, V211, P1422; Munker R, 2004, ANN ONCOL, V15, P1699, DOI 10.1093/annonc/mdh426; OGILVIE GK, 1989, J AM VET MED ASSOC, V195, P106; Ozulker T, 2010, ANN NUCL MED, V24, P35, DOI 10.1007/s12149-009-0321-x; PAGE RL, 1994, J NUCL MED, V35, P1506; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; Park JW, 2011, J GASTRIC CANCER, V11, P173, DOI 10.5230/jgc.2011.11.3.173; PIEPSZ A, 1990, EUR J NUCL MED, V17, P127; Raj P, 2013, UPDATES SURG-ITALY, V65, P103, DOI 10.1007/s13304-013-0205-4; Rashid RM, 2013, CUTIS, V91, P141; Rauscher I, 2014, J NUCL MED, V55, P724, DOI 10.2967/jnumed.113.129247; Roberts PF, 2000, ANN THORAC SURG, V70, P1154, DOI 10.1016/S0003-4975(00)01769-0; Song BI, 2012, J NUCL MED, V53, P1337, DOI 10.2967/jnumed.111.098640; Stroup SP, 2012, CLIN EXP METASTAS, V29, P673, DOI 10.1007/s10585-012-9498-9; Toloza EM, 2003, CHEST, V123, p137S, DOI 10.1378/chest.123.1_suppl.137S; Toriihara A, 2013, AM J ROENTGENOL, V201, P639, DOI 10.2214/AJR.12.10395; TRIM CM, 1983, AM J VET RES, V44, P329; Vail DM, 2000, CANCER INVEST, V18, P781, DOI 10.3109/07357900009012210; Ferrusola EV, 2012, REV ESP ENFERM DIG, V104, P360, DOI 10.4321/s1130-01082012000700005; Wagner M, 2003, CANCER RES, V63, P2681; Weber WA, 1999, STRAHLENTHER ONKOL, V175, P356, DOI 10.1007/s000660050022; Weber WA, 2000, NUCL MED BIOL, V27, P683, DOI 10.1016/S0969-8051(00)00141-4	52	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0127800	10.1371/journal.pone.0127800	http://dx.doi.org/10.1371/journal.pone.0127800			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068641	gold, Green Published, Green Submitted			2022-12-26	WOS:000356327000011
J	Tsetsos, K; Pfeffer, T; Jentgens, P; Donner, TH				Tsetsos, Konstantinos; Pfeffer, Thomas; Jentgens, Pia; Donner, Tobias H.			Action Planning and the Timescale of Evidence Accumulation	PLOS ONE			English	Article							PERCEPTUAL DECISION-MAKING; LATERAL INTRAPARIETAL AREA; HUMAN BRAIN; OSCILLATORY ACTIVITY; SUPERIOR COLLICULUS; GENERAL MECHANISM; VISUAL-MOTION; EYE-MOVEMENTS; CORTEX; INTEGRATION	Perceptual decisions are based on the temporal integration of sensory evidence for different states of the outside world. The timescale of this integration process varies widely across behavioral contexts and individuals, and it is diagnostic for the underlying neural mechanisms. In many situations, the decision-maker knows the required mapping between perceptual evidence and motor response (henceforth termed "sensory-motor contingency") before decision formation. Here, the integrated evidence can be directly translated into a motor plan and, indeed, neural signatures of the integration process are evident as build-up activity in premotor brain regions. In other situations, however, the sensory-motor contingencies are unknown at the time of decision formation. We used behavioral psychophysics and computational modeling to test if knowledge about sensory-motor contingencies affects the timescale of perceptual evidence integration. We asked human observers to perform the same motion discrimination task, with or without trial-to-trial variations of the mapping between perceptual choice and motor response. When the mapping varied, it was either instructed before or after the stimulus presentation. We quantified the timescale of evidence integration under these different sensory-motor mapping conditions by means of two approaches. First, we analyzed subjects' discrimination threshold as a function of stimulus duration. Second, we fitted a dynamical decision-making model to subjects' choice behavior. The results from both approaches indicated that observers (i) integrated motion information for several hundred ms, (ii) used a shorter than optimal integration timescale, and (iii) used the same integration timescale under all sensory-motor mappings. We conclude that the mechanisms limiting the timescale of perceptual decisions are largely independent from long-term learning (under fixed mapping) or rapid acquisition (under variable mapping) of sensory-motor contingencies. This conclusion has implications for neurophysiological and neuroimaging studies of perceptual decision-making.	[Tsetsos, Konstantinos] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Pfeffer, Thomas; Jentgens, Pia; Donner, Tobias H.] Univ Amsterdam, Dept Psychol, NL-1018 XA Amsterdam, Netherlands; [Pfeffer, Thomas; Donner, Tobias H.] Univ Amsterdam, Amsterdam Brain & Cognit, NL-1018 WS Amsterdam, Netherlands; [Pfeffer, Thomas] Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, D-20246 Hamburg, Germany; [Jentgens, Pia] Netherlands Inst Neurosci, NL-1105 BA Amsterdam, Netherlands; [Donner, Tobias H.] Charitein Ctr Comput, Bernstein Ctr Computat Neurosci, D-10115 Berlin, Germany	University of Oxford; University of Amsterdam; University of Amsterdam; University of Hamburg; University Medical Center Hamburg-Eppendorf; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Donner, TH (corresponding author), Univ Amsterdam, Dept Psychol, Weesperpl 4, NL-1018 XA Amsterdam, Netherlands.	T.H.Donner@uva.nl	Tsetsos, Konstantinos/G-8302-2015	Tsetsos, Konstantinos/0000-0003-2709-7634; Pfeffer, Thomas/0000-0001-9561-3085; Donner, Tobias H./0000-0002-7559-6019	Amsterdam Brain and Cognition Priority Program [ABC2014-01]; European Union [604102(v1), Call-ID FP7-ICT-2013-FET-F]	Amsterdam Brain and Cognition Priority Program; European Union(European Commission)	This work was funded by the Amsterdam Brain and Cognition Priority Program (Grant number: ABC2014-01, http://abc.uva.nl/research/nav) and the European Union FP7, Human Brain Project (Grant number: Call-ID FP7-ICT-2013-FET-F, Project ID: 604102(v1), http://www.humanbrainproject.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bair W, 1996, NEURAL COMPUT, V8, P1185, DOI 10.1162/neco.1996.8.6.1185; Bennur S, 2011, J NEUROSCI, V31, P913, DOI 10.1523/JNEUROSCI.4417-10.2011; Bogacz R, 2004, BEHAV RES METH INS C, V36, P732, DOI 10.3758/BF03206554; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Bogacz R, 2010, TRENDS NEUROSCI, V33, P10, DOI 10.1016/j.tins.2009.09.002; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Brody CD, 2003, CURR OPIN NEUROBIOL, V13, P204, DOI 10.1016/S0959-4388(03)00050-3; Brunton BW, 2013, SCIENCE, V340, P95, DOI 10.1126/science.1233912; Burr DC, 2001, VISION RES, V41, P1891, DOI 10.1016/S0042-6989(01)00072-4; Carrasco M, 2001, P NATL ACAD SCI USA, V98, P5363, DOI 10.1073/pnas.081074098; Connolly PM, 2009, J NEUROSCI, V29, P2136, DOI 10.1523/JNEUROSCI.3962-08.2009; de Lange FP, 2013, J NEUROSCI, V33, P1400, DOI 10.1523/JNEUROSCI.1094-12.2013; Donner TH, 2007, J NEUROPHYSIOL, V98, P345, DOI 10.1152/jn.01141.2006; Donner TH, 2009, CURR BIOL, V19, P1581, DOI 10.1016/j.cub.2009.07.066; Efron B., 1993, INTRO BOOTSTRAP; Filimon F, 2013, J NEUROSCI, V33, P2121, DOI 10.1523/JNEUROSCI.2334-12.2013; Freedman DJ, 2011, NAT NEUROSCI, V14, P143, DOI 10.1038/nn.2740; Gao JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016749; Gold JI, 2003, J NEUROSCI, V23, P632, DOI 10.1523/JNEUROSCI.23-02-00632.2003; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Gould IC, 2012, J NEUROSCI, V32, P13805, DOI 10.1523/JNEUROSCI.2200-12.2012; Hanks TD, 2015, NATURE, V520, P220, DOI 10.1038/nature14066; Hebart M.N., 2014, CEREB CORTEX; Hebart MN, 2012, NEUROIMAGE, V63, P1393, DOI 10.1016/j.neuroimage.2012.08.027; Heekeren HR, 2004, NATURE, V431, P859, DOI 10.1038/nature02966; Honey CJ, 2012, NEURON, V76, P423, DOI 10.1016/j.neuron.2012.08.011; Horwitz GD, 2004, J NEUROPHYSIOL, V91, P2281, DOI 10.1152/jn.00872.2003; Horwitz GD, 2001, J NEUROPHYSIOL, V86, P2543, DOI 10.1152/jn.2001.86.5.2543; Kiani R, 2008, J NEUROSCI, V28, P3017, DOI 10.1523/JNEUROSCI.4761-07.2008; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; Liu TS, 2011, J NEUROPHYSIOL, V106, P2383, DOI 10.1152/jn.00413.2011; Luce RD, 1986, RESPONSE TIMES THEIR; Marshall JAR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043443; Merten K, 2012, P NATL ACAD SCI USA, V109, P6289, DOI 10.1073/pnas.1121084109; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; NICKERSON DM, 1989, PHYSIOL ZOOL, V62, P866, DOI 10.1086/physzool.62.4.30157934; O'Connell RG, 2012, NAT NEUROSCI, V15, P1729, DOI 10.1038/nn.3248; Ossmy O, 2013, CURR BIOL, V23, P981, DOI 10.1016/j.cub.2013.04.039; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; QUICK RF, 1974, KYBERNETIK, V16, P65, DOI 10.1007/BF00271628; Rahnev D, 2011, J NEUROSCI, V31, P10741, DOI 10.1523/JNEUROSCI.1478-11.2011; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Roitman JD, 2002, J NEUROSCI, V22, P9475; Rorie AE, 2005, TRENDS COGN SCI, V9, P41, DOI 10.1016/j.tics.2004.12.007; Schall JD, 1999, ANNU REV NEUROSCI, V22, P241, DOI 10.1146/annurev.neuro.22.1.241; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Siegel M, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00021; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Tsetsos K, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00079; Tsetsos K, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00063; Uchida N, 2006, NAT REV NEUROSCI, V7, P485, DOI 10.1038/nrn1933; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; WATAMANIUK SNJ, 1992, VISION RES, V32, P2341, DOI 10.1016/0042-6989(92)90097-3; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wyart V, 2012, NEURON, V76, P847, DOI 10.1016/j.neuron.2012.09.015; Zariwala HA, 2013, NEURON, V78, P339, DOI 10.1016/j.neuron.2013.02.010	58	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129473	10.1371/journal.pone.0129473	http://dx.doi.org/10.1371/journal.pone.0129473			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068458	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000356327000079
J	Singh, K; Kochar, E; Prasad, NG				Singh, Karan; Kochar, Ekta; Prasad, N. G.			Egg Viability, Mating Frequency and Male Mating Ability Evolve in Populations of Drosophila melanogaster Selected for Resistance to Cold Shock	PLOS ONE			English	Article							MALE-STERILITY; STRESS RESISTANCE; LOW-TEMPERATURES; PHENOTYPIC PLASTICITY; EXTREME TEMPERATURES; NATURAL-SELECTION; HEAT-STRESS; TRADE-OFFS; EVOLUTION; TOLERANCE	Background Ability to resist temperature shock is an important component of fitness of insects and other ectotherms. Increased resistance to temperature shock is known to affect life-history traits. Temperature shock is also known to affect reproductive traits such as mating ability and viability of gametes. Therefore selection for increased temperature shock resistance can affect the evolution of reproductive traits. Methods We selected replicate populations of Drosophila melanogaster for resistance to cold shock. We then investigated the evolution of reproductive behavior along with other components of fitness-larval survivorship, adult mortality, fecundity, egg viability in these populations. Results We found that larval survivorship, adult mortality and fecundity post cold shock were not significantly different between selected and control populations. However, compared to the control populations, the selected populations laid significantly higher percentage of fertile eggs (egg viability) 24 hours post cold shock. The selected populations had higher mating frequency both with and without cold shock. After being subjected to cold shock, males from the selected populations successfully mated with significantly more non-virgin females and sired significantly more progeny compared to control males. Conclusions A number of studies have reported the evolution of survivorship in response to selection for temperature shock resistance. Our results clearly indicate that adaptation to cold shock can involve changes in components of reproductive fitness. Our results have important implications for our understanding of how reproductive behavior can evolve in response to thermal stress.	[Singh, Karan; Kochar, Ekta; Prasad, N. G.] Indian Inst Sci Educ & Res Mohali, Knowledge City 140306, Punjab, India	Indian Institute of Science Education & Research (IISER) - Mohali	Prasad, NG (corresponding author), Indian Inst Sci Educ & Res Mohali, Sector 81,PO Manauli, Knowledge City 140306, Punjab, India.	prasad@iisermohali.ac.in	Singh, Karan/AAH-3752-2022	Singh, Karan/0000-0002-2496-028X; Prasad, N G/0000-0002-0410-5518	Indian Institute of Science Education and Research Mohali	Indian Institute of Science Education and Research Mohali	This work supported by Indian Institute of Science Education and Research Mohali. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AR, 2005, GENET RES, V85, P15, DOI 10.1017/S0016672304007281; [Anonymous], 2010, LOW TEMPERATURE BIOL; Ayrinhac A, 2004, FUNCT ECOL, V18, P700, DOI 10.1111/j.0269-8463.2004.00904.x; Borash DJ, 2000, J INSECT PHYSIOL, V46, P763, DOI 10.1016/S0022-1910(99)00165-1; Bubliy OA, 2005, J EVOLUTION BIOL, V18, P789, DOI 10.1111/j.1420-9101.2005.00928.x; Chakir M, 2002, GENETICA, V114, P195, DOI 10.1023/A:1015154329762; CHEN CP, 1993, ECOL ENTOMOL, V18, P184, DOI 10.1111/j.1365-2311.1993.tb01088.x; Chippindale AK, 1998, EVOLUTION, V52, P1342, DOI 10.2307/2411304; Chippindale AK, 1996, EVOLUTION, V50, P753, DOI [10.2307/2410848, 10.1111/j.1558-5646.1996.tb03885.x]; Chown S.L., 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1002/joc.5086; Collett JI, 2001, EVOLUTION, V55, P840, DOI 10.1554/0014-3820(2001)055[0840:AFDPSA]2.0.CO;2; CZAJKA MC, 1990, J EXP BIOL, V148, P245; David Jean R., 2008, Journal de la Societe de Biologie, V202, P113, DOI 10.1051/jbio:2008014; David JR, 2005, J EVOLUTION BIOL, V18, P838, DOI 10.1111/j.1420-9101.2005.00914.x; DENLINGER DL, 1998, TEMPERATURE SENSITIV; Dillon ME, 2007, J EXP BIOL, V210, P2897, DOI 10.1242/jeb.007591; Dolgin ES, 2006, J EVOLUTION BIOL, V19, P1894, DOI 10.1111/j.1420-9101.2006.01168.x; Gerken AR, 2015, P NATL ACAD SCI USA, V112, P4399, DOI 10.1073/pnas.1503456112; Gilchrist GW, 1997, PHYSIOL ZOOL, V70, P403, DOI 10.1086/515853; Hance T, 2007, ANNU REV ENTOMOL, V52, P107, DOI 10.1146/annurev.ento.52.110405.091333; Hoffmann AA, 2005, FUNCT ECOL, V19, P222, DOI 10.1111/j.1365-2435.2005.00959.x; Hoffmann AA, 2002, ECOL LETT, V5, P614, DOI 10.1046/j.1461-0248.2002.00367.x; Hoffmann AA, 2007, GENETICA, V129, P133, DOI 10.1007/s10709-006-9010-z; Joshi A, 1996, EVOL ECOL, V10, P463, DOI 10.1007/BF01237879; Kellermann V, 2012, EVOLUTION, V66, P3377, DOI 10.1111/j.1558-5646.2012.01685.x; Kingsolver JG, 2009, AM NAT, V174, P755, DOI 10.1086/648310; Lacoume S, 2007, J INSECT PHYSIOL, V53, P1008, DOI 10.1016/j.jinsphys.2007.05.006; Lefevre GJ., 1962, DROS INFORM SERV, V1962, P86; MacMillan HA, 2015, J EXP BIOL, V218, P423, DOI 10.1242/jeb.115790; MacMillan HA, 2009, INSECT SCI, V16, P263, DOI 10.1111/j.1744-7917.2009.01251.x; Malmendal A, 2006, AM J PHYSIOL-REG I, V291, pR205, DOI 10.1152/ajpregu.00867.2005; Manier MK, 2010, SCIENCE, V328, P354, DOI 10.1126/science.1187096; Marshall KE, 2010, P ROY SOC B-BIOL SCI, V277, P963, DOI 10.1098/rspb.2009.1807; Mockett RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092228; Nandy B, 2013, EVOLUTION, V67, P2133, DOI 10.1111/evo.12076; NOVITSKI E, 1949, BIOL BULL, V97, P150, DOI 10.2307/1538294; Overgaard J, 2007, J INSECT PHYSIOL, V53, P1218, DOI 10.1016/j.jinsphys.2007.06.012; Overgaard Johannes, 2010, P276, DOI 10.1017/CBO9780511675997.012; Prasad NG, 2007, AM NAT, V169, P29, DOI 10.1086/509941; Prasad NG, 2003, EVOL ECOL RES, V5, P903; Rinehart JP, 2000, PHYSIOL ENTOMOL, V25, P330, DOI 10.1046/j.1365-3032.2000.00201.x; Rohmer C, 2004, J EXP BIOL, V207, P2735, DOI 10.1242/jeb.01087; ROSE MR, 1984, EVOLUTION, V38, P1004, DOI 10.1111/j.1558-5646.1984.tb00370.x; Schmidt PS, 2008, EVOLUTION, V62, P1204, DOI 10.1111/j.1558-5646.2008.00351.x; SCHNEBEL EM, 1984, EVOLUTION, V38, P1296, DOI 10.1111/j.1558-5646.1984.tb05651.x; Scott M, 1997, ENTOMOL EXP APPL, V85, P211, DOI 10.1023/A:1003173612155; Sinclair BJ, 2003, TRENDS ECOL EVOL, V18, P257, DOI 10.1016/S0169-5347(03)00014-4; Strachan LA, 2011, PHYSIOL BIOCHEM ZOOL, V84, P43, DOI 10.1086/657147; Svetec N, 2011, MOL ECOL, V20, P530, DOI 10.1111/j.1365-294X.2010.04951.x; Nguyen TM, 2013, J INSECT PHYSIOL, V59, P248, DOI 10.1016/j.jinsphys.2012.12.001; TUCIC N, 1979, EVOLUTION, V33, P350, DOI 10.1111/j.1558-5646.1979.tb04688.x; van Lieshout E, 2013, ECOL EVOL, V3, P2859, DOI 10.1002/ece3.667; Watson MJO, 1996, EVOLUTION, V50, P1182, DOI 10.1111/j.1558-5646.1996.tb02359.x; Zhang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075923; Zizzari ZV, 2011, J INSECT PHYSIOL, V57, P421, DOI 10.1016/j.jinsphys.2011.01.002	55	16	16	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129992	10.1371/journal.pone.0129992	http://dx.doi.org/10.1371/journal.pone.0129992			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26065704	Green Published, gold, Green Submitted			2022-12-26	WOS:000356100900090
J	Gianella, S; Smith, DM; Daar, ES; Dube, MP; Lisco, A; Vanpouille, C; Margolis, L; Haubrich, RH; Morris, SR				Gianella, Sara; Smith, Davey M.; Daar, Eric S.; Dube, Michael P.; Lisco, Andrea; Vanpouille, Christophe; Margolis, Leonid; Haubrich, Richard H.; Morris, Sheldon R.			Genital Cytomegalovirus Replication Predicts Syphilis Acquisition among HIV-1 Infected Men Who Have Sex with Men	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; HIV-INFECTION; TRANSMISSION; HERPESVIRUSES; ASSOCIATION; ACTIVATION; BLOOD; WOMEN; MCP-1; SEMEN	Objective Sexually transmitted infections (STI) are common among HIV-infected men who have sex with men (MSM). While behavioral factors are important in STI acquisition, other biological factors such as immune modulation due to chronic viral infection may further predispose to STI acquisition. Design Post Hoc analysis including data collected over 12 months of follow-up from 131 HIV-infected MSM receiving antiretroviral therapy and screened for incident bacterial STI every 3 months. Methods Genital secretions collected at baseline were used to measure herpesvirus replication and inflammatory cytokines. Baseline predictors of STI were determined using survival analysis of time to incident STI. Results All participants were seropositive for cytomegalovirus (CMV), and 52% had detectable genital CMV at baseline. Thirty-five individuals acquired STI during follow-up, sometimes with multiple pathogen (17 syphilis, 21 gonorrhea, 14 chlamydia). Syphilis acquisition was associated with genital CMV replication at baseline (19.1% CMV-shedders versus 4.8% nonshedders, p=0.03) and younger age (p=0.02). Lower seminal MCP-1 was associated with higher seminal CMV levels and with syphilis acquisition (p<0.01). For syphilis acquisition, in multivariable Cox-Proportional Hazard model adjusted hazard rates were 3.56 (95% CI: 1.00-12.73) for baseline CMV replication and 2.50 (0.92-6.77) for younger age. Conclusions This post hoc analysis suggest that CMV-associated decrease in seminal MCP-1 levels might predispose HIV-infected MSM to syphilis acquisition, but not other STI. Future studies should determine underlying mechanisms and if a causal association exists.	[Gianella, Sara; Smith, Davey M.; Haubrich, Richard H.; Morris, Sheldon R.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Smith, Davey M.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Daar, Eric S.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [Dube, Michael P.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Lisco, Andrea] NIAID, NIH, Bethesda, MD 20892 USA; [Vanpouille, Christophe; Margolis, Leonid] NICHHD, NIH, Bethesda, MD 20892 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Gianella, S (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.	gianella@ucsd.edu	Lisco, Andrea/L-2105-2019	Lisco, Andrea/0000-0002-1475-356X; Gianella, Sara/0000-0002-9927-0849; Smith, Davey/0000-0003-3603-1733	Department of Veterans Affairs; James Pendleton Charitable Trust; amfAR grant [108537]; FAIR; U.S. National Institutes of Health (NIH) [P30-AI027763, R24AI106039, AI69432, AI043638, MH62512, MH083552, MH101012, AI100665, AI077304, AI36214, AI047745, AI74621, GM093939, AI080353, AI306214, AI27670, AI064086, AI43638, 7-UM1 AI068636-07]; CTRI grant [UL1TR000100]; California HIV/AIDS Research Program [RN07-SD-702, MC08-SD-700, EI-11-SD-005]; National Center for Advancing Translational Sciences through UCLA CTSI Grant [UL1TR000124]; National Institute of General Medical Sciences grant [GM093939]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001416] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000100, UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI080353, UM1AI069432, K24AI064086, U01AI027670, U01AI069432, R21AI047745, P30AI036214, U01AI043638, K24AI100665, R56AI047745, P30AI027763, R01AI047745, P01AI074621, R24AI106039, UM1AI068636, R21AI077304] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100974, P30MH062512, R01MH083552, R01MH101012] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); James Pendleton Charitable Trust; amfAR grant; FAIR; U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTRI grant; California HIV/AIDS Research Program; National Center for Advancing Translational Sciences through UCLA CTSI Grant; National Institute of General Medical Sciences grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Department of Veterans Affairs; by the James Pendleton Charitable Trust; by amfAR grant 108537 with support from FAIR; by U.S. National Institutes of Health (NIH) awards P30-AI027763 (CNIHR), R24AI106039, AI69432, AI043638, MH62512, MH083552, MH101012, AI100665, AI077304, AI36214, AI047745, AI74621, GM093939, AI080353, AI306214 (CFAR), AI27670 (ACTU), AI064086 (K24 to RHH), AI43638, and 7-UM1 AI068636-07; by CTRI grant: UL1TR000100; by California HIV/AIDS Research Program RN07-SD-702, MC08-SD-700 and EI-11-SD-005; by the National Center for Advancing Translational Sciences through UCLA CTSI Grant UL1TR000124; and by National Institute of General Medical Sciences grant GM093939. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyrer C, 2008, SEX TRANSM INFECT, V84, P410, DOI 10.1136/sti.2008.033290; Bongers G, 2010, J CLIN INVEST, V120, P3969, DOI 10.1172/JCI42563; Butler DM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000447; Celum C, 2014, ANN INTERN MED, V161, P11, DOI 10.7326/M13-2471; Centers for Disease Control and Prevention, 2014, MORB MORT WEEKL REP; Chaillon A, 2014, AIDS RES HUM RETROV, V30, P165, DOI [10.1089/aid.2013.0202, 10.1089/AID.2013.0202]; Cohen MS, 1998, LANCET, V351, P5, DOI 10.1016/S0140-6736(98)90002-2; Cruz AR, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001717; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Gianella S, 2013, CLIN INFECT DIS, V57, P441, DOI 10.1093/cid/cit252; Gianella S, 2013, J INFECT DIS, V207, P898, DOI 10.1093/infdis/jis777; Gianella S, 2013, J INFECT DIS, V207, P257, DOI 10.1093/infdis/jis683; Gianella S, 2013, AIDS, V27, P39, DOI 10.1097/QAD.0b013e3283573305; Gianella S, 2012, J VIROL, V86, P1307, DOI 10.1128/JVI.06077-11; Hales DB, 1999, ENDOCRINE, V10, P201, DOI 10.1007/BF02738619; Hamilton ST, 2013, J GEN VIROL, V94, P2495, DOI 10.1099/vir.0.052878-0; Hirsch AJ, 1999, J VIROL, V73, P404, DOI 10.1128/JVI.73.1.404-410.1999; Jankovic S, 2011, INT J ORAL MAX SURG, V40, P271, DOI 10.1016/j.ijom.2010.11.004; Lajoie J, 2014, J INFECT DIS, V210, P319, DOI 10.1093/infdis/jiu023; Lisco Andrea, 2009, Curr HIV/AIDS Rep, V6, P5, DOI 10.1007/s11904-009-0002-3; Lisco A, 2012, J INFECT DIS, V205, P97, DOI 10.1093/infdis/jir700; Lisco A, 2009, CELL HOST MICROBE, V6, P403, DOI 10.1016/j.chom.2009.10.010; Maartens G, 2014, LANCET, V384, P258, DOI 10.1016/S0140-6736(14)60164-1; MACKOWIAK PA, 1991, EPIDEMIOL INFECT, V107, P411, DOI 10.1017/S0950268800049050; Marcus JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091513; Mayer KH, 2012, SEX TRANSM DIS, V39, P1, DOI 10.1097/OLQ.0b013e31823b1922; Mayer KH, 2011, CLIN INFECT DIS, V53, pS79, DOI 10.1093/cid/cir696; Nagot N, 2007, SEX TRANSM INFECT, V83, P365, DOI 10.1136/sti.2007.024794; Nelson DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036298; Petrara MR, 2012, J CLIN VIROL, V53, P195, DOI 10.1016/j.jcv.2011.12.013; Rottingen JA, 2001, SEX TRANSM DIS, V28, P579; Sexton J, 2005, SEX TRANSM DIS, V32, P351, DOI 10.1097/01.olq.0000154504.54686.d1; Solomon MM, 2014, CLIN INFECT DIS, V59, P1020, DOI 10.1093/cid/ciu450; Taylor MM, 2008, SEX TRANSM DIS, V35, P430, DOI 10.1097/OLQ.0b013e3181644b5e; Verdugo F, 2015, CLIN ORAL INVEST, V19, P535, DOI 10.1007/s00784-014-1250-1; Ward H, 2010, CURR OPIN HIV AIDS, V5, P305, DOI 10.1097/COH.0b013e32833a8844; Wertheim JO, 2014, J INFECT DIS, V209, P304, DOI 10.1093/infdis/jit524; Zetola NM, 2007, CLIN INFECT DIS, V44, P1222, DOI 10.1086/513427; Zhang RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115134	39	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0130410	10.1371/journal.pone.0130410	http://dx.doi.org/10.1371/journal.pone.0130410			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061824	Green Published, Green Submitted, gold			2022-12-26	WOS:000355979500172
J	Gingnell, M; Bannbers, E; Moes, H; Engman, J; Sylven, S; Skalkidou, A; Kask, K; Wikstrom, J; Sundstrom-Poromaa, I				Gingnell, Malin; Bannbers, Elin; Moes, Harmen; Engman, Jonas; Sylven, Sara; Skalkidou, Alkistis; Kask, Kristiina; Wikstrom, Johan; Sundstrom-Poromaa, Inger			Emotion Reactivity Is Increased 4-6 Weeks Postpartum in Healthy Women: A Longitudinal fMRI Study	PLOS ONE			English	Article							PARENTAL PREOCCUPATION; AMYGDALA REACTIVITY; INSULA ACTIVATION; BRAIN RESPONSE; DSM-IV; DEPRESSION; MOTHERS; ANTICIPATION; SEROTONIN; PITUITARY	Marked endocrine alterations occur after delivery. Most women cope well with these changes, but the postpartum period is associated with an increased risk of depressive episodes. Previous studies of emotion processing have focused on maternal-infant bonding or postpartum depression (PPD), and longitudinal studies of the neural correlates of emotion processing throughout the postpartum period in healthy women are lacking. In this study, 13 women, without signs of post partum depression, underwent fMRI with an emotional face matching task and completed the MADRS-S, STAI-S, and EPDS within 48 h (early postpartum) and 4-6 weeks after delivery (late postpartum). Also, data from a previous study including 15 naturally cycling controls assessed in the luteal and follicular phase of the menstrual cycle was used. Women had lower reactivity in insula, middle frontal gyrus (MFG), and inferior frontal gyrus (IFG) in the early as compared to the late postpartum assessment. Insular reactivity was positively correlated with anxiety in the early postpartum period and with depressive symptoms late postpartum. Reactivity in insula and IFG were greater in postpartum women than in non-pregnant control subjects. Brain reactivity was not correlated with serum estradiol or progesterone levels. Increased reactivity in the insula, IFG, and MFG may reflect normal postpartum adaptation, but correlation with self-rated symptoms of depression and anxiety in these otherwise healthy postpartum women, may also suggest that these changes place susceptible women at increased risk of PPD. These findings contribute to our understanding of the neurobiological aspects of the postpartum period, which might shed light on the mechanisms underlying affective puerperal disorders, such as PPD.	[Gingnell, Malin; Bannbers, Elin; Moes, Harmen; Sylven, Sara; Skalkidou, Alkistis; Kask, Kristiina; Sundstrom-Poromaa, Inger] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Gingnell, Malin; Engman, Jonas] Uppsala Univ, Dept Psychol, Uppsala, Sweden; [Wikstrom, Johan] Uppsala Univ, Dept Radiol Oncol & Radiat Sci, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University	Gingnell, M (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.	malin.gingnell@psyk.uu.se	/AGX-8250-2022; /ABC-6294-2021; Skalkidou, Alkistis/C-1521-2015	Skalkidou, Alkistis/0000-0002-4935-7532; Gingnell, Malin/0000-0001-5310-6843; Sundstrom Poromaa, Inger/0000-0002-2491-2042; Sylven, Sara M/0000-0002-3142-5111; Wikstrom, Johan/0000-0002-9481-6857	Swedish Research Council [K2008-54X-200642-01-3]; Swedish Council for Working Life and Social Research projects [2007-1955]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research projects	The major funding for the study comes from the Swedish Research Council project K2008-54X-200642-01-3 (Sundstrom Poromaa) and the Swedish Council for Working Life and Social Research projects 2007-1955 (Sundstrom Poromaa).	Altemus M, 2004, BIOL PSYCHIAT, V56, P386, DOI 10.1016/j.biopsych.2004.06.002; ALTEMUS M, 1995, J CLIN ENDOCR METAB, V80, P2954, DOI 10.1210/jc.80.10.2954; Andreano JM, 2010, NEUROIMAGE, V53, P1286, DOI 10.1016/j.neuroimage.2010.07.011; Bannbers E, 2013, BEHAV BRAIN RES, V241, P132, DOI 10.1016/j.bbr.2012.12.003; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; Bayer J, 2014, NEUROBIOL LEARN MEM, V110, P55, DOI 10.1016/j.nlm.2014.01.017; Bloch M, 2000, AM J PSYCHIAT, V157, P924, DOI 10.1176/appi.ajp.157.6.924; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; DAWOOD MY, 1981, J CLIN ENDOCR METAB, V52, P678, DOI 10.1210/jcem-52-4-678; Doornbos B, 2008, PROG NEURO-PSYCHOPH, V32, P1320, DOI 10.1016/j.pnpbp.2008.04.010; Dreher JC, 2007, P NATL ACAD SCI USA, V104, P2465, DOI 10.1073/pnas.0605569104; Epperson CN, 2006, PSYCHOPHARMACOLOGY, V186, P425, DOI 10.1007/s00213-006-0313-7; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Gingnell M, 2013, PSYCHONEUROENDOCRINO, V38, P1133, DOI 10.1016/j.psyneuen.2012.11.006; Gingnell M, 2012, HORM BEHAV, V62, P400, DOI 10.1016/j.yhbeh.2012.07.005; Grattan D, 2011, J NEUROENDOCRINOL, V23, P1188, DOI 10.1111/j.1365-2826.2011.02175.x; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hellgren C, 2012, ARCH WOMEN MENT HLTH, V15, P87, DOI 10.1007/s00737-012-0261-7; Kendall-Tackett K, 2007, INT BREASTFEED J, V2, DOI 10.1186/1746-4358-2-6; Kim P, 2014, SOC NEUROSCI-UK, V9, P522, DOI 10.1080/17470919.2014.933713; Kim P, 2013, INFANT MENT HEALTH J, V34, P104, DOI 10.1002/imhj.21359; Kim P, 2011, J CHILD PSYCHOL PSYC, V52, P907, DOI 10.1111/j.1469-7610.2011.02406.x; Kim P, 2010, BEHAV NEUROSCI, V124, P695, DOI 10.1037/a0020884; Leckman JF, 2004, J NEURAL TRANSM, V111, P753, DOI 10.1007/s00702-003-0067-x; Leibenluft E, 2004, BIOL PSYCHIAT, V56, P225, DOI 10.1016/j.biopsych.2004.05.017; Lenzi D, 2009, CEREB CORTEX, V19, P1124, DOI 10.1093/cercor/bhn153; Love T, 2010, FERTIL STERIL, V93, P1929, DOI 10.1016/j.fertnstert.2008.12.056; M' Bailara K, 2006, PSYCHONEUROENDOCRINO, V31, P407, DOI 10.1016/j.psyneuen.2005.10.001; MAES M, 1992, J PSYCHOSOM RES, V36, P191, DOI 10.1016/0022-3999(92)90028-Z; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Meinlschmidt G, 2010, STRESS, V13, P163, DOI 10.3109/10253890903128632; Mitterschiffthaler MT, 2003, NEUROREPORT, V14, P177, DOI 10.1097/00001756-200302100-00003; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Moses-Kolko EL, 2008, FERTIL STERIL, V89, P685, DOI 10.1016/j.fertnstert.2007.03.059; Moses-Kolko EL, 2011, BIOL PSYCHIAT, V70, P395, DOI 10.1016/j.biopsych.2011.02.021; Moses-Kolko EL, 2010, AM J PSYCHIAT, V167, P1373, DOI 10.1176/appi.ajp.2010.09081235; Newman LK, 2011, AUST NZ J PSYCHIAT, V45, P109, DOI 10.3109/00048674.2010.527821; NISSEN E, 1995, ACTA OBSTET GYN SCAN, V74, P530, DOI 10.3109/00016349509024384; Noriuchi M, 2008, BIOL PSYCHIAT, V63, P415, DOI 10.1016/j.biopsych.2007.05.018; O'Hara MW, 2013, ANNU REV CLIN PSYCHO, V9, P379, DOI 10.1146/annurev-clinpsy-050212-185612; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Poromaa IS, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00380; Protopopescu X, 2005, P NATL ACAD SCI USA, V102, P16060, DOI 10.1073/pnas.0502818102; Reck C, 2009, J AFFECT DISORDERS, V113, P77, DOI 10.1016/j.jad.2008.05.003; Rupp HA, 2014, SOC COGN AFFECT NEUR, V9, P48, DOI 10.1093/scan/nss100; Sacher J, 2010, ARCH GEN PSYCHIAT, V67, P468, DOI 10.1001/archgenpsychiatry.2010.32; Seifritz E, 2003, BIOL PSYCHIAT, V54, P1367, DOI 10.1016/S0006-3223(03)00697-8; Shafir T, 2012, BEHAV BRAIN RES, V226, P147, DOI 10.1016/j.bbr.2011.09.012; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Silverman ME, 2007, CNS SPECTRUMS, V12, P853, DOI 10.1017/S1092852900015595; Silverman ME, 2011, ARCH WOMEN MENT HLTH, V14, P355, DOI 10.1007/s00737-011-0226-2; Simmons A, 2006, BIOL PSYCHIAT, V60, P402, DOI 10.1016/j.biopsych.2006.04.038; Smith R, 1997, HORM METAB RES, V19, P41; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Stein MB, 2007, AM J PSYCHIAT, V164, P318, DOI 10.1176/appi.ajp.164.2.318; Strigo IA, 2008, ARCH GEN PSYCHIAT, V65, P1275, DOI 10.1001/archpsyc.65.11.1275; Summerlin JL., 1997, NEUROIMAGE, V5, pS633, DOI DOI 10.1002/(SICI)1097-0193(1997)5:4<238:AID-HBM6>3.0.C0;2-4; Swain JE, 2014, BRAIN RES, V1580, P78, DOI 10.1016/j.brainres.2014.03.007; Swain JE, 2008, J CHILD PSYCHOL PSYC, V49, P1042, DOI 10.1111/j.1469-7610.2008.01963.x; van Wingen GA, 2011, NEUROSCIENCE, V191, P38, DOI 10.1016/j.neuroscience.2011.04.042	64	36	37	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0128964	10.1371/journal.pone.0128964	http://dx.doi.org/10.1371/journal.pone.0128964			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061879	Green Published, gold, Green Submitted			2022-12-26	WOS:000355979500112
J	Gormezano, LJ; Rockwell, RF				Gormezano, Linda J.; Rockwell, Robert F.			The Energetic Value of Land-Based Foods in Western Hudson Bay and Their Potential to Alleviate Energy Deficits of Starving Adult Male Polar Bears	PLOS ONE			English	Article							LESSER-SNOW-GEESE; ICE-FREE SEASON; URSUS-MARITIMUS; CLIMATE-CHANGE; BODY-COMPOSITION; REPRODUCTIVE SUCCESS; PHOCA-HISPIDA; CANADA-GEESE; RINGED SEALS; FREE PERIOD	Climate change is predicted to expand the ice-free season in western Hudson Bay and when it grows to 180 days, 28-48% of adult male polar bears are projected to starve unless nutritional deficits can be offset by foods consumed on land. We updated a dynamic energy budget model developed by Molnar et al. to allow influx of additional energy from novel terrestrial foods (lesser snow geese, eggs, caribou) that polar bears currently consume as part of a mixed diet while on land. We calculated the units of each prey, alone and in combination, needed to alleviate these lethal energy deficits under conditions of resting or limited movement (2 km d(-1)) prior to starvation. We further considered the total energy available from each sex and age class of each animal prey over the period they would overlap land-bound polar bears and calculated the maximum number of starving adult males that could be sustained on each food during the ice-free season. Our results suggest that the net energy from land-based food, after subtracting costs of limited movement to obtain it, could eliminate all projected nutritional deficits of starving adult male polar bears and likely other demographic groups as well. The hunting tactics employed, success rates as well as behavior and abundance of each prey will determine the realized energetic values for individual polar bears. Although climate change may cause a phenological mismatch between polar bears and their historical ice-based prey, it may simultaneously yield a new match with certain land-based foods. If polar bears can transition their foraging behavior to effectively exploit these resources, predictions for starvation-related mortality may be overestimated for western Hudson Bay. We also discuss potential complications with stable-carbon isotope studies to evaluate utilization of land-based foods by polar bears including metabolic effects of capture-related stress and consuming a mixed diet.	[Gormezano, Linda J.; Rockwell, Robert F.] Amer Museum Nat Hist, Div Vertebrate Zool, New York, NY 10024 USA	American Museum of Natural History (AMNH)	Gormezano, LJ (corresponding author), Idaho Dept Fish & Game, Headquarters Off, Boise, ID 83707 USA.	gormezano@gmail.com						Abraham Kenneth F., 2012, Rangifer, V32, P269; Abraham KF, 1998, RANGIFER, V10, P221; Alisauskas RT, 2011, WILDLIFE MONOGR, P1, DOI 10.1002/wmon.5; ANKNEY CD, 1978, AUK, V95, P459; ANKNEY CD, 1979, AUK, V96, P68; ANKNEY CD, 1980, J WILDLIFE MANAGE, V44, P174, DOI 10.2307/3808363; Atkinson SN, 1996, PHYSIOL ZOOL, V69, P304, DOI 10.1086/physzool.69.2.30164186; ATKINSON SN, 1995, FUNCT ECOL, V9, P559, DOI 10.2307/2390145; AUBIN AE, 1986, CONDOR, V88, P365, DOI 10.2307/1368884; Aubry LM, 2013, GLOBAL CHANGE BIOL, V19, P149, DOI 10.1111/gcb.12013; Badzinski SS, 2002, AUK, V119, P221, DOI 10.1642/0004-8038(2002)119[0221:GADOPC]2.0.CO;2; Badzinski SS, 2001, AUK, V118, P687, DOI 10.1642/0004-8038(2001)118[0687:COEANO]2.0.CO;2; Balme G, 2007, ANIM BEHAV, V74, P589, DOI 10.1016/j.anbehav.2006.12.014; BERGERUD AT, 1996, RANGIFER, V9, P95, DOI DOI 10.7557/2.16.4.1225; BEST RC, 1985, CAN J ZOOL, V63, P1033, DOI 10.1139/z85-155; Brook RK, 2002, ARCTIC, V55, P193; Cattet MRL, 2000, THESIS U SASKATCHEWA; CHASSIN PS, 1976, PHYSIOL ZOOL, V49, P1; Chow BA, 2011, COMP BIOCHEM PHYS A, V158, P111, DOI 10.1016/j.cbpa.2010.09.017; Cooch F.G., 1956, WILDFOWL TRUST ANN R, V8, P58; COOKE F, 1995, SNOW GEESE PEROUSE B; Cresswell W, 2010, ANIM BEHAV, V80, P643, DOI 10.1016/j.anbehav.2010.06.024; DEROCHER AE, 1993, ARCTIC, V46, P251; Derocher AE, 2000, POLAR BIOL, V23, P675, DOI 10.1007/s003000000138; Derocher AE, 2004, INTEGR COMP BIOL, V44, P163, DOI 10.1093/icb/44.2.163; DEROCHER AE, 1990, CAN J ZOOL, V68, P1395, DOI 10.1139/z90-208; DONALDSON GM, 1995, CAN FIELD NAT, V109, P112; Drent R., 2008, CIRCUMPOLAR STUDIES, V4, P59; Estes JA, 2003, J ANIM ECOL, V72, P144, DOI 10.1046/j.1365-2656.2003.00690.x; Feinman RD, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-27; Gagnon AS, 2005, ARCTIC, V58, P370, DOI 10.14430/arctic451; Gerhart KL, 1996, J WILDLIFE MANAGE, V60, P713, DOI 10.2307/3802369; Gilbert Barrie K., 1999, Symposia of the Zoological Society of London, V72, P225; Gormezano LJ, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-51; Gormezano LJ, 2013, ECOL EVOL, V3, P3509, DOI 10.1002/ece3.740; Gormezano LJ, 2014, THESIS CITY U NEW YO; GRIFFITH B, 2002, ARCTIC REFUGE COASTA, P8; Gunn A, 2011, 10 CAN COUNC RES MIN; Hobson KA, 2009, CAN J ZOOL, V87, P50, DOI 10.1139/Z08-137; Hobson KA, 1997, MAR MAMMAL SCI, V13, P359, DOI 10.1111/j.1748-7692.1997.tb00645.x; Hobson KA, 2002, DEEP-SEA RES PT II, V49, P5131, DOI 10.1016/S0967-0645(02)00182-0; Hobson KA, 2011, AUK, V128, P156, DOI 10.1525/auk.2010.10086; Hochheim K, 2010, LITTLE LESS ARCTIC: TOP PREDATORS IN THE WORLDS LARGEST NORTHERN INLAND SEA, HUDSON BAY, P39, DOI 10.1007/978-90-481-9121-5_2; Hohman William L., 1992, P128; HURST RJ, 1982, CAN J ZOOL, V60, P40, DOI 10.1139/z82-005; Iles DT, 2013, POLAR BIOL, V36, P1373, DOI 10.1007/s00300-013-1341-5; Joly K, 2011, ECOGRAPHY, V34, P345, DOI 10.1111/j.1600-0587.2010.06377.x; Koch T.J., 1975, YEAR POLAR BEAR; Koettlitz R, 1898, P R PHYS SOC, V14, P78; Kooijman S. A. L. M., 2010, DYNAMIC ENERGY BUDGE; Koons DN, 2014, J ANIM ECOL, V83, P365, DOI 10.1111/1365-2656.12133; LATOUR PB, 1981, CAN J ZOOL, V59, P1763, DOI 10.1139/z81-242; Madsen J, 1998, NORSK POLARINST SKRI, P221; MCEWAN EH, 1966, CAN J ZOOLOG, V44, P401, DOI 10.1139/z66-043; MCMILLAN C, 1980, AQUAT BOT, V9, P237, DOI 10.1016/0304-3770(80)90025-X; Molnar PK, 2010, BIOL CONSERV, V143, P1612, DOI 10.1016/j.biocon.2010.04.004; Molnar PK, 2009, J EXP BIOL, V212, P2313, DOI 10.1242/jeb.026146; MOLNAR PK, 2009, THESIS U ALBERTA; O'Connor R.J., 1984, GROWTH DEV BIRDS; Ovsyanikov Nikita G., 1996, Journal of Wildlife Research, V1, P254; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Pedersen A., 1966, POLAR ANIMALS; Post E, 2008, PHILOS T R SOC B, V363, P2369, DOI 10.1098/rstb.2007.2207; R Development Core Team, R LANG ENV STAT COMP; RAMSAY MA, 1991, OECOLOGIA, V86, P598, DOI 10.1007/BF00318328; Regehr EV, 2007, J WILDLIFE MANAGE, V71, P2673, DOI 10.2193/2006-180; Reimers E., 1983, Acta Zoologica Fennica, P69; Robbins C. T., 1993, WILDLIFE FEEDING NUT; Rockwell RF, 2009, POLAR BIOL, V32, P539, DOI 10.1007/s00300-008-0548-3; ROCKWELL RF, 2012, EVALUATION SPECIAL M, P178; Rockwell RF, 2011, OIKOS, V120, P696, DOI 10.1111/j.1600-0706.2010.18837.x; Romanoff AL., 1967, BIOCH AVIAN EMBRYO; Roth JD, 2002, OECOLOGIA, V133, P70, DOI 10.1007/s00442-002-1004-7; Russell DE, 1993, RANGIFER, V8, P1, DOI DOI 10.7557/2.13.5.1057; Russell DE, 2002, TECHNICAL REPORT SER, V390; RUSSELL RH, 1975, ARCTIC, V28, P117; Schmidt-Nielsen K, 1997, ANIMAL PHYSL ADAPTAT; SCHMIDTNIELSEN K, 1972, SCIENCE, V177, P222, DOI 10.1126/science.177.4045.222; Sharma S, 2009, GLOBAL CHANGE BIOL, V15, P2549, DOI 10.1111/j.1365-2486.2009.01945.x; SLATTERY SM, 1995, CONDOR, V97, P970, DOI 10.2307/1369536; Smith AE, 1996, CAN FIELD NAT, V110, P339; Smith PA, 2010, POLAR BIOL, V33, P1149, DOI 10.1007/s00300-010-0791-2; SMITH TG, 1980, CAN J ZOOL, V58, P2201, DOI 10.1139/z80-302; Stempniewicz L, 2014, POLAR REC, V50, P216, DOI 10.1017/S0032247413000053; STEPHENSON RL, 1984, MAR BIOL, V81, P223, DOI 10.1007/BF00393216; Stirling I, 1995, CAN J FISH AQUAT SCI, V52, P2594, DOI 10.1139/f95-849; STIRLING I, 1975, CAN J ZOOL, V53, P1021, DOI 10.1139/z75-117; STIRLING I, 1974, CAN J ZOOL, V52, P1191, DOI 10.1139/z74-157; Stirling I., 1977, 33 CAN WILDL SERV; Stirling I, 2006, ARCTIC, V59, P261; StuartSmith AK, 1997, J WILDLIFE MANAGE, V61, P622, DOI 10.2307/3802170; TAYLOR CR, 1982, ANNU REV PHYSIOL, V44, P97, DOI 10.1146/annurev.ph.44.030182.000525; Thiemann GW, 2008, ECOL MONOGR, V78, P591, DOI 10.1890/07-1050.1; WALSH NE, 1992, J WILDLIFE MANAGE, V56, P465, DOI 10.2307/3808860; WEISSMAN C, 1990, ANESTHESIOLOGY, V73, P308, DOI 10.1097/00000542-199008000-00020; WHITTEN KR, 1992, J WILDLIFE MANAGE, V56, P201, DOI 10.2307/3808814; Williams TM, 2004, INT CONGR SER, V1275, P351, DOI 10.1016/j.ics.2004.08.069; Winiarski KJ, 2012, J ANIM ECOL, V81, P1132, DOI 10.1111/j.1365-2656.2012.01981.x	99	20	20	1	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0128520	10.1371/journal.pone.0128520	http://dx.doi.org/10.1371/journal.pone.0128520			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061693	Green Published, gold			2022-12-26	WOS:000355979500085
J	Meyer, ML; Williams, KD; Eisenberger, NI				Meyer, Meghan L.; Williams, Kipling D.; Eisenberger, Naomi I.			Why Social Pain Can Live on: Different Neural Mechanisms Are Associated with Reliving Social and Physical Pain	PLOS ONE			English	Article							PARIETAL OPERCULUM; BRAIN MECHANISMS; MEMORY; CORTEX; SELF; REJECTION; COGNITION; SYSTEMS; FMRI; REPRESENTATIONS	Although social and physical pain recruit overlapping neural activity in regions associated with the affective component of pain, the two pains can diverge in their phenomenology. Most notably, feelings of social pain can be re-experienced or "relived," even when the painful episode has long passed, whereas feelings of physical pain cannot be easily relived once the painful episode subsides. Here, we observed that reliving social (vs. physical) pain led to greater self-reported re-experienced pain and greater activity in affective pain regions (dorsal anterior cingulate cortex and anterior insula). Moreover, the degree of relived pain correlated positively with affective pain system activity. In contrast, reliving physical (vs. social) pain led to greater activity in the sensory-discriminative pain system (primary and secondary somatosensory cortex and posterior insula), which did not correlate with relived pain. Preferential engagement of these different pain mechanisms may reflect the use of different top-down neurocognitive pathways to elicit the pain. Social pain reliving recruited dorsomedial prefrontal cortex, often associated with mental state processing, which functionally correlated with affective pain system responses. In contrast, physical pain reliving recruited inferior frontal gyrus, known to be involved in body state processing, which functionally correlated with activation in the sensory pain system. These results update the physical-social pain overlap hypothesis: while overlapping mechanisms support live social and physical pain, distinct mechanisms guide internally-generated pain.	[Meyer, Meghan L.; Eisenberger, Naomi I.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; [Williams, Kipling D.] Purdue Univ, Dept Psychol, W Lafayette, IN 47907 USA	University of California System; University of California Los Angeles; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Meyer, ML (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA.	mlmeyer@ucla.edu			UCLA funding	UCLA funding	This research was supported by UCLA funding.	Albanese MC, 2007, J NEUROSCI, V27, P4612, DOI 10.1523/JNEUROSCI.0695-07.2007; Ames DL, 2013, PSYCHOL SCI, V24, P1755, DOI 10.1177/0956797613480507; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; BERTHIER M, 1988, ANN NEUROL, V24, P41, DOI 10.1002/ana.410240109; Berthier M, ANN NEUROLOGY, V24, P41; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Burgos-Robles A, 2009, J NEUROSCI, V29, P8474, DOI 10.1523/JNEUROSCI.0378-09.2009; Caspers S, 2008, BRAIN STRUCT FUNCT, V212, P481, DOI 10.1007/s00429-008-0195-z; Chen ZS, 2008, PSYCHOL SCI, V19, P789, DOI 10.1111/j.1467-9280.2008.02158.x; Chen ZS, 2012, EUR J SOC PSYCHOL, V42, P314, DOI 10.1002/ejsp.1861; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; DeWall CN, 2010, PSYCHOL SCI, V21, P931, DOI 10.1177/0956797610374741; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; Eickhoff SB, 2006, CEREB CORTEX, V16, P254, DOI 10.1093/cercor/bhi105; Eisenberger NI, 2011, J COGNITIVE NEUROSCI, V23, P3448, DOI 10.1162/jocn_a_00027; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; ERSKINE A, 1990, PAIN, V41, P255, DOI 10.1016/0304-3959(90)90002-U; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Fairhurst M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048711; Foltz EL, 1962, J NEUROSURGERY, V19; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Gray K, 2008, PSYCHOL SCI, V19, P1260, DOI 10.1111/j.1467-9280.2008.02208.x; GREENSPAN JD, 1992, PAIN, V50, P29, DOI 10.1016/0304-3959(92)90109-O; HANSSON RO, 1990, J SOC PERS RELAT, V7, P451, DOI 10.1177/0265407590074003; Kaplan JT, 2008, SOC COGN AFFECT NEUR, V3, P218, DOI 10.1093/scan/nsn014; Kelly S, 2007, J PAIN, V8, P307, DOI 10.1016/j.jpain.2006.08.010; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Kross E, 2011, P NATL ACAD SCI USA, V108, P6270, DOI 10.1073/pnas.1102693108; Leary MR, 2001, BEHAV BADLY AVERSIVE; Lieberman M.D., 2010, HDB SOCIAL PSYCHOL, V5th edition, P143, DOI DOI 10.1002/9780470561119.SOCPSY001005; Lieberman MD, 2004, NEUROIMAGE, V22, P447, DOI 10.1016/j.neuroimage.2004.01.037; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Meyer ML, 2012, P NATL ACAD SCI USA, V109, P1883, DOI 10.1073/pnas.1121077109; Mitchell JP, 2004, J NEUROSCI, V24, P4912, DOI 10.1523/JNEUROSCI.0481-04.2004; MORLEY S, 1993, PAIN, V55, P55, DOI 10.1016/0304-3959(93)90184-Q; Moro V, 2008, NEURON, V60, P235, DOI 10.1016/j.neuron.2008.09.022; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Ploner M, 1999, PAIN, V81, P211, DOI 10.1016/S0304-3959(99)00012-3; Rosen LH, 2012, J APPL DEV PSYCHOL, V33, P273, DOI 10.1016/j.appdev.2012.07.006; Satpute AB, 2014, CEREB CORTEX, V24, P1269, DOI 10.1093/cercor/bhs408; Schacter DL, 2012, NEURON, V76, P677, DOI 10.1016/j.neuron.2012.11.001; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seidel S, 2011, MIRROR THERAPY IN LO, DOI [10.1002/acn3.89, DOI 10.1002/ACN3.89]; Spitzer B, 2014, HUM BRAIN MAPP, V35, P2412, DOI 10.1002/hbm.22337; Spunt RP, 2012, J NEUROSCI, V32, P3575, DOI 10.1523/JNEUROSCI.5715-11.2012; Treede RD, 1999, PAIN, V79, P105, DOI 10.1016/S0304-3959(98)00184-5; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uddin LQ, 2007, TRENDS COGN SCI, V11, P153, DOI 10.1016/j.tics.2007.01.001; Urgesi C, 2007, J NEUROSCI, V27, P8023, DOI 10.1523/JNEUROSCI.0789-07.2007; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Vogt BA, 2003, EUR J NEUROSCI, V18, P3134, DOI 10.1111/j.1460-9568.2003.03034.x; Woo CW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6380; Zaki J, 2007, SOC NEUROSCI-UK, V2, P276, DOI 10.1080/17470910701401973	55	28	29	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0128294	10.1371/journal.pone.0128294	http://dx.doi.org/10.1371/journal.pone.0128294			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK1PO	26061877	gold, Green Submitted, Green Published			2022-12-26	WOS:000355979500077
J	Peng, MZ; Peng, F; Zhang, CZ; Wang, QG; Li, Z; Hu, HY; Liu, SD; Xu, BB; Zhu, WZ; Han, YD; Lin, Q				Peng, Mingzheng; Peng, Fei; Zhang, Chengzhong; Wang, Qingguo; Li, Zhao; Hu, Haiyang; Liu, Sida; Xu, Binbin; Zhu, Wenzhuo; Han, Yudong; Lin, Qiang			Preoperative Prediction of Ki-67 Labeling Index By Three-dimensional CT Image Parameters for Differential Diagnosis Of Ground-Glass Opacity (GGO)	PLOS ONE			English	Article							ATYPICAL ADENOMATOUS HYPERPLASIA; LIMITED-RESECTION TRIAL; SMALL PULMONARY NODULES; IA LUNG ADENOCARCINOMA; THIN-SECTION CT; PROGNOSTIC-SIGNIFICANCE; PROLIFERATION INDEX; CANCER; KI67; HISTOPATHOLOGY	The aim of this study was to predict Ki-67 labeling index (LI) preoperatively by three-dimensional (3D) CT image parameters for pathologic assessment of GGO nodules. Diameter, total volume (TV), the maximum CT number (MAX), average CT number (AVG) and standard deviation of CT number within the whole GGO nodule (STD) were measured by 3D CT workstation. By detection of immunohistochemistry and Image Software Pro Plus 6.0, different Ki-67 LI were measured and statistically analyzed among preinvasive adenocarcinoma (PIA), minimally invasive adenocarcinoma (MIA) and invasive adenocarcinoma (IAC). Receiver operating characteristic (ROC) curve, Spearman correlation analysis and multiple linear regression analysis with cross-validation were performed to further research a quantitative correlation between Ki-67 labeling index and radiological parameters. Diameter, TV, MAX, AVG and STD increased along with PIA, MIA and IAC significantly and consecutively. In the multiple linear regression model by a stepwise way, we obtained an equation: prediction of Ki-67 LI=0.022*STD+0.001*TV+2.137 (R=0.595, R's square=0.354, p<0.001), which can predict Ki-67 LI as a proliferative marker preoperatively. Diameter, TV, MAX, AVG and STD could discriminate pathologic categories of GGO nodules significantly. Ki-67 LI of early lung adenocarcinoma presenting GGO can be predicted by radiologic parameters based on 3D CT for differential diagnosis.	[Peng, Mingzheng; Li, Zhao; Hu, Haiyang; Liu, Sida; Xu, Binbin; Zhu, Wenzhuo; Han, Yudong; Lin, Qiang] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Sch Med, Dept Thorac Surg, Shanghai 200030, Peoples R China; [Peng, Fei] Hunan Normal Univ, Peoples Hosp Hunan Prov, Sch Med, Dept Nephrol, Changsha, Hunan, Peoples R China; [Zhang, Chengzhong; Wang, Qingguo] Hunan Normal Univ, Shanghai Peoples Hosp 1, Sch Med, Dept Radiol, Changsha, Hunan, Peoples R China	Shanghai Jiao Tong University; Hunan Normal University; Hunan Normal University	Lin, Q (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Sch Med, Dept Thorac Surg, Shanghai 200030, Peoples R China.	peng.mz@foxmail.com						Absmanner B, 2010, BIOCHEM J, V426, P205, DOI 10.1042/BJ20091121; Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Alexandrakis MG, 2004, AM J CLIN ONCOL-CANC, V27, P8, DOI 10.1097/01.coc.0000045810.91816.41; Aoki T, 2000, AM J ROENTGENOL, V174, P763, DOI 10.2214/ajr.174.3.1740763; Austin JHM, 1996, RADIOLOGY, V200, P327, DOI 10.1148/radiology.200.2.8685321; Awai K, 2006, RADIOLOGY, V239, P276, DOI 10.1148/radiol.2383050167; Berghoff AS, 2014, STRAHLENTHER ONKOL, V190, P676, DOI 10.1007/s00066-014-0639-8; Blatt RJ, 2004, COMPUT METH PROG BIO, V75, P75, DOI 10.1016/j.cmpb.2003.11.001; Borezuk AC, 2009, AM J SURG PATHOL, V33, P462, DOI 10.1097/PAS.0b013e318190157c; Chen BY, 2013, MED PHYS, V40, DOI 10.1118/1.4823463; Ciancio N, 2012, MULTIDISCIP RESP MED, V7, DOI 10.1186/2049-6958-7-29; Collins J, 1997, AM J ROENTGENOL, V169, P355, DOI 10.2214/ajr.169.2.9242736; Francisco Jairo Silva, 2004, Braz. oral res., V18, P100, DOI 10.1590/S1806-83242004000200002; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Henschke CI, 2002, AM J ROENTGENOL, V178, P1053, DOI 10.2214/ajr.178.5.1781053; Ikeda K, 2007, CHEST, V132, P984, DOI 10.1378/chest.07-0793; Jang HJ, 1996, RADIOLOGY, V199, P485, DOI 10.1148/radiology.199.2.8668800; Jennings SG, 2004, RADIOLOGY, V231, P866, DOI 10.1148/radiol.2313030715; Ji Yong, 2014, J Biomed Res, V28, P462, DOI 10.7555/JBR.27.20130084; Kakinuma R, 2004, J COMPUT ASSIST TOMO, V28, P17, DOI 10.1097/00004728-200401000-00003; Kausch I, 2005, BJU INT, V95, P415, DOI 10.1111/j.1464-410X.2005.05312.x; Kodama K, 2008, EUR J CARDIO-THORAC, V34, P1068, DOI 10.1016/j.ejcts.2008.07.044; Kostis WJ, 2004, RADIOLOGY, V231, P446, DOI 10.1148/radiol.2312030553; Lee HY, 2014, AM J ROENTGENOL, V202, pW224, DOI 10.2214/AJR.13.11819; Lee HY, 2011, J THORAC IMAG, V26, P106, DOI 10.1097/RTI.0b013e3181fbaa64; Lei B, 2013, HISTOPATHOLOGY, V63, P696, DOI 10.1111/his.12215; Li F, 2004, RADIOLOGY, V233, P793, DOI 10.1148/radiol.2333031018; Li RL, 2004, CLIN CANCER RES, V10, P4118, DOI 10.1158/1078-0432.CCR-1052-03; Linning E, 2009, ACAD RADIOL, V16, P934, DOI 10.1016/j.acra.2009.02.020; Maksimovic R, 2000, INT J MED INFORM, V58, P29, DOI 10.1016/S1386-5056(00)00073-3; Marten K, 2004, J THORAC IMAG, V19, P156, DOI 10.1097/01.rti.0000131591.12777.a8; Matsumoto T, 2012, EUR J CARDIO-THORAC, V41, P1098, DOI 10.1093/ejcts/ezr152; Nakajima R, 2002, J COMPUT ASSIST TOMO, V26, P323, DOI 10.1097/00004728-200205000-00001; Nakao M, 2012, J THORAC ONCOL, V7, P1563, DOI 10.1097/JTO.0b013e3182641b5c; Nakata M, 2003, ANN THORAC SURG, V75, P1601, DOI 10.1016/S0003-4975(02)04815-4; Nakata M, 2002, CHEST, V121, P1464, DOI 10.1378/chest.121.5.1464; Neubauer AS, 2008, ACTA OPHTHALMOL, V86, P177, DOI 10.1111/j.1600-0420.2007.01029.x; Nomori H, 2003, J THORAC CARDIOV SUR, V126, P1584, DOI 10.1016/S0022-5223(03)00885-7; Nomori H, 2003, ANN THORAC SURG, V76, P867, DOI 10.1016/S0003-4975(03)00729-X; Oda S, 2010, AM J ROENTGENOL, V194, P398, DOI 10.2214/AJR.09.2583; Park CM, 2006, KOREAN J RADIOL, V7, P80, DOI 10.3348/kjr.2006.7.2.80; Rawlinson A, 2005, J DENT, V33, P781, DOI 10.1016/j.jdent.2005.01.013; Revel MP, 2004, RADIOLOGY, V231, P459, DOI 10.1148/radiol.2312030241; Sakurai H, 2004, AM J SURG PATHOL, V28, P198, DOI 10.1097/00000478-200402000-00007; SCAGLIOTTI GV, 1993, EUR J CANCER, V29A, P363, DOI 10.1016/0959-8049(93)90387-U; SCHLUTER C, 1993, J CELL BIOL, V123, P513, DOI 10.1083/jcb.123.3.513; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Son JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104066; Stuart-Harris R, 2008, BREAST, V17, P323, DOI 10.1016/j.breast.2008.02.002; Suzuki K, 2002, ANN THORAC SURG, V74, P1635, DOI 10.1016/S0003-4975(02)03895-X; Takahashi M, 2014, J THORAC CARDIOV SUR, V147, P54, DOI 10.1016/j.jtcvs.2013.08.058; Tian H, 2011, TUMOR BIOL, V32, P273, DOI 10.1007/s13277-010-0119-4; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Tsutani Y, 2014, CHEST, V145, P66, DOI 10.1378/chest.13-1094; Urruticoechea A, 2005, J CLIN ONCOL, V23, P7212, DOI 10.1200/JCO.2005.07.501; Wang CJ, 2009, APPL IMMUNOHISTO M M, V17, P530, DOI 10.1097/PAI.0b013e3181a13bf2; Yankelevitz DF, 2000, RADIOLOGY, V217, P251, DOI 10.1148/radiology.217.1.r00oc33251; Yoshida J, 2005, J THORAC CARDIOV SUR, V129, P991, DOI 10.1016/j.jtcvs.2004.07.038	60	7	9	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129206	10.1371/journal.pone.0129206	http://dx.doi.org/10.1371/journal.pone.0129206			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061252	Green Published, gold, Green Submitted			2022-12-26	WOS:000355979500130
J	Taylor, P; Asner, G; Dahlin, K; Anderson, C; Knapp, D; Martin, R; Mascaro, J; Chazdon, R; Cole, R; Wanek, W; Hofhansl, F; Malavassi, E; Vilchez-Alvarado, B; Townsend, A				Taylor, Philip; Asner, Gregory; Dahlin, Kyla; Anderson, Christopher; Knapp, David; Martin, Roberta; Mascaro, Joseph; Chazdon, Robin; Cole, Rebecca; Wanek, Wolfgang; Hofhansl, Florian; Malavassi, Edgar; Vilchez-Alvarado, Braulio; Townsend, Alan			Landscape-Scale Controls on Aboveground Forest Carbon Stocks on the Osa Peninsula, Costa Rica	PLOS ONE			English	Article							TROPICAL FOREST; BIOLOGICAL CORRIDOR; SPATIAL-PATTERNS; BIOMASS; PRODUCTIVITY; DENSITY; GROWTH; CLIMATE; SOIL; DECOMPOSITION	Tropical forests store large amounts of carbon in tree biomass, although the environmental controls on forest carbon stocks remain poorly resolved. Emerging airborne remote sensing techniques offer a powerful approach to understand how aboveground carbon density (ACD) varies across tropical landscapes. In this study, we evaluate the accuracy of the Carnegie Airborne Observatory (CAO) Light Detection and Ranging (LiDAR) system to detect top-of-canopy tree height (TCH) and ACD across the Osa Peninsula, Costa Rica. LiDAR and field-estimated TCH and ACD were highly correlated across a wide range of forest ages and types. Top-of-canopy height (TCH) reached 67 m, and ACD surpassed 225 Mg C ha(-1), indicating both that airborne CAO LiDAR-based estimates of ACD are accurate in tall, high-biomass forests and that the Osa Peninsula harbors some of the most carbon-rich forests in the Neotropics. We also examined the relative influence of lithologic, topoedaphic and climatic factors on regional patterns in ACD, which are known to influence ACD by regulating forest productivity and turnover. Analyses revealed a spatially nested set of factors controlling ACD patterns, with geologic variation explaining up to 16% of the mapped ACD variation at the regional scale, while local variation in topographic slope explained an additional 18%. Lithologic and topoedaphic factors also explained more ACD variation at 30-m than at 100-m spatial resolution, suggesting that environmental filtering depends on the spatial scale of terrain variation. Our result indicate that patterns in ACD are partially controlled by spatial variation in geologic history and geomorphic processes underpinning topographic diversity across landscapes. ACD also exhibited spatial autocorrelation, which may reflect biological processes that influence ACD, such as the assembly of species or phenotypes across the landscape, but additional research is needed to resolve how abiotic and biotic factors contribute to ACD variation across high biomass, high diversity tropical landscapes.	[Taylor, Philip; Cole, Rebecca; Townsend, Alan] Univ Colorado, Inst Art & Alpine Res, Boulder, CO 80303 USA; [Asner, Gregory; Anderson, Christopher; Knapp, David; Martin, Roberta; Mascaro, Joseph] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA; [Dahlin, Kyla] Natl Ctr Atmospher Res, Adv Study Program, Boulder, CO 80307 USA; [Chazdon, Robin] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA; [Wanek, Wolfgang; Hofhansl, Florian] Univ Vienna, Dept Microbiol & Ecosyst Sci, A-1010 Vienna, Austria; [Malavassi, Edgar; Vilchez-Alvarado, Braulio] Escuela Ingn Forestal, Inst Tecnol Costa Rica, Cartago, Costa Rica	University of Colorado System; University of Colorado Boulder; Carnegie Institution for Science; National Center Atmospheric Research (NCAR) - USA; University of Connecticut; University of Vienna; Instituto Tecnologico de Costa Rica	Taylor, P (corresponding author), Univ Colorado, Inst Art & Alpine Res, Boulder, CO 80303 USA.	philipgrahamtaylor@gmail.com	Townsend, Alan/AAE-9602-2019; Hofhansl, Florian/E-6656-2012; Asner, Gregory/G-9268-2013; Wanek, Wolfgang/E-7001-2012; Chazdon, Robin/O-9766-2018; Martin, Roberta/A-5073-2015	Hofhansl, Florian/0000-0003-0073-0946; Asner, Gregory/0000-0001-7893-6421; Wanek, Wolfgang/0000-0003-2178-8258; Chazdon, Robin/0000-0002-7349-5687; Anderson, Christopher/0000-0001-7392-4368; Dahlin, Kyla/0000-0002-6016-2605; Martin, Roberta/0000-0003-3509-8530	Blue Moon Foundation; National Science Foundation [0918835]; John D. and Catherine T. MacArthur Foundation; Carnegie Institution for Science; Austrian Ministry of Sciences and Research (BM.W_F) [BMWF-4.409/30-1114/2009]	Blue Moon Foundation; National Science Foundation(National Science Foundation (NSF)); John D. and Catherine T. MacArthur Foundation; Carnegie Institution for Science; Austrian Ministry of Sciences and Research (BM.W_F)	This research was funded by the Blue Moon Foundation, National Science Foundation (Award Number 0918835), the John D. and Catherine T. MacArthur Foundation and the endowment of the Carnegie Institution for Science. The authors also acknowledge funding from the Austrian Ministry of Sciences and Research (BM.W_F) for project BMWF-4.409/30-1114/2009. The Carnegie Airborne Observatory is made possible by the Avatar Alliance Foundation, Grantham Foundation for the Protection of the Environment, John D. and Catherine T. MacArthur Foundation, Gordon and Betty Moore Foundation, W. M. Keck Foundation, Margaret A. Cargill Foundation, Mary Anne Nyburg Baker and G. Leonard Baker Jr., and William R. Hearst III.	Asner GP, 2005, SCIENCE, V310, P480, DOI 10.1126/science.1118051; Asner GP, 2014, P NATL ACAD SCI USA, V111, P5604, DOI 10.1073/pnas.1401181111; Asner GP, 2014, REMOTE SENS ENVIRON, V140, P614, DOI 10.1016/j.rse.2013.09.023; Asner GP, 2012, OECOLOGIA, V168, P1147, DOI 10.1007/s00442-011-2165-z; Asner GP, 2011, NEW PHYTOL, V189, P999, DOI 10.1111/j.1469-8137.2010.03549.x; Asner GP, 2010, P NATL ACAD SCI USA, V107, P16738, DOI 10.1073/pnas.1004875107; Bern CR, 2005, ECOLOGY, V86, P626, DOI 10.1890/03-0766; Buchs DM, 2009, GEOL SOC SPEC PUBL, V328, P411, DOI 10.1144/SP328.17; Chadwick OA, 2013, GEOLOGY, V41, P1171, DOI 10.1130/G34721.1; Chao KJ, 2008, J ECOL, V96, P281, DOI 10.1111/j.1365-2745.2007.01343.x; Chave J, 2010, BIOGEOSCIENCES, V7, P43, DOI 10.5194/bg-7-43-2010; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Cleveland CC, 2011, ECOL LETT, V14, P939, DOI 10.1111/j.1461-0248.2011.01658.x; Colgan MS, 2012, BIOGEOSCIENCES, V9, P1809, DOI 10.5194/bg-9-1809-2012; Dahlin KM, 2013, P NATL ACAD SCI USA, V110, P6895, DOI 10.1073/pnas.1215513110; Dahlin KM, 2012, ECOL APPL, V22, P104, DOI 10.1890/11-1401.1; del Aguila-Pasquel J, 2014, PLANT ECOL DIVERS, V7, P71, DOI 10.1080/17550874.2013.798365; Detto M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076296; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Feldpausch T., 2012, BIOGEOSCIENCES, V9, P1, DOI DOI 10.5194/bg-9-3381-2012; Fortunel C, 2014, J ECOL, V102, P145, DOI 10.1111/1365-2745.12160; Gardner T, 2001, GEOLOGY, V29, P151, DOI 10.1130/0091-7613(2001)029<0151:HFBRIR>2.0.CO;2; Gibbs H.K., 2007, GEOGRAPHICAL DISTRIB; Girardin CAJ, 2014, PLANT ECOL DIVERS, V7, P161, DOI 10.1080/17550874.2013.820806; Gobakken T, 2012, REMOTE SENS ENVIRON, V123, P443, DOI 10.1016/j.rse.2012.01.025; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Holyoak M, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P1; Houghton RA, 2005, GLOBAL CHANGE BIOL, V11, P945, DOI 10.1111/j.1365-2486.2005.00955.x; Kaspari M, 2008, ECOL LETT, V11, P35, DOI 10.1111/j.1461-0248.2007.01124.x; Kearsley E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3269; Komiyama A, 2008, AQUAT BOT, V89, P128, DOI 10.1016/j.aquabot.2007.12.006; Lebrija-Trejos E, 2010, ECOLOGY, V91, P386, DOI 10.1890/08-1449.1; Lichstein JW, 2002, ECOL MONOGR, V72, P445, DOI 10.1890/0012-9615(2002)072[0445:SAAAMI]2.0.CO;2; Logue JB, 2011, TRENDS ECOL EVOL, V26, P482, DOI 10.1016/j.tree.2011.04.009; Malhi Y, 2004, GLOBAL CHANGE BIOL, V10, P563, DOI 10.1111/j.1529-8817.2003.00778.x; Malhi Y, 2006, GLOBAL CHANGE BIOL, V12, P1107, DOI 10.1111/j.1365-2486.2006.01120.x; Malhi Y, 2012, J ECOL, V100, P65, DOI 10.1111/j.1365-2745.2011.01916.x; Malhi Y, 2009, GLOBAL CHANGE BIOL, V15, P1255, DOI 10.1111/j.1365-2486.2008.01780.x; Marmion M, 2009, ECOL MODEL, V220, P3512, DOI 10.1016/j.ecolmodel.2008.10.019; Martinelli LA, 1999, BIOGEOCHEMISTRY, V46, P45, DOI 10.1023/A:1006100128782; Mascaro J, 2011, BIOGEOSCIENCES, V8, P1615, DOI 10.5194/bg-8-1615-2011; Mascaro J, 2011, REMOTE SENS ENVIRON, V115, P3770, DOI 10.1016/j.rse.2011.07.019; Meynard CN, 2013, J BIOGEOGR, V40, P1560, DOI 10.1111/jbi.12116; Mitchard ETA, 2014, GLOBAL ECOL BIOGEOGR, V23, P935, DOI 10.1111/geb.12168; Morales-Salazar M, 2012, REV FOR MESOAM KURU-, V9, P19, DOI 10.18845/rfmk.v9i23.487; Morales-Salazar MS, 2013, REV FOR MESOAM KURU-, V10, P1; Moritz C, 2013, OIKOS, V122, P1401, DOI 10.1111/j.1600-0706.2013.00377.x; Nardoto GB, 2008, ECOSYSTEMS, V11, P1234, DOI 10.1007/s10021-008-9189-1; Omasa K, 2003, ENVIRON SCI TECHNOL, V37, P1198, DOI 10.1021/es0259887; Phillips OL, 2004, PHILOS T R SOC B, V359, P381, DOI 10.1098/rstb.2003.1438; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Porder S, 2007, ECOSYSTEMS, V10, P158, DOI 10.1007/s10021-006-9011-x; Porder S, 2009, ECOLOGY, V90, P623, DOI 10.1890/07-1739.1; Quesada CA, 2012, BIOGEOSCIENCES, V9, P2203, DOI 10.5194/bg-9-2203-2012; Quesada CA, 2010, BIOGEOSCIENCES, V7, P1515, DOI 10.5194/bg-7-1515-2010; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Scatena FN, GEOMORPHOLOGY DISTUR; Slik JWF, 2010, GLOBAL ECOL BIOGEOGR, V19, P50, DOI 10.1111/j.1466-8238.2009.00489.x; Takyu M, 2003, OECOLOGIA, V134, P397, DOI 10.1007/s00442-002-1115-1; Taylor PG, 2015, ECOLOGY, V96, P1229, DOI 10.1890/13-1418.1; Townsend AR, 2008, TRENDS ECOL EVOL, V23, P424, DOI 10.1016/j.tree.2008.04.009; Townsend AR, 2007, ECOLOGY, V88, P107, DOI 10.1890/0012-9658(2007)88[107:COFNRI]2.0.CO;2; Trenkamp R, 2002, J S AM EARTH SCI, V15, P157, DOI 10.1016/S0895-9811(02)00018-4; Vanwalleghem T, 2013, J GEOPHYS RES-EARTH, V118, P331, DOI 10.1029/2011JF002296; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; Walker LR, 2013, SHIFTING INFLUENCE A; Wanek W., 2008, NATURAL CULTURAL HIS, P155; Weissenhofer A., 2005, STRUCTURE VEGETATION; Wieder WR, 2013, BIOGEOCHEMISTRY, V113, P629, DOI 10.1007/s10533-012-9793-1; Wright SJ, 2011, ECOLOGY, V92, P1616, DOI 10.1890/10-1558.1; Zanne AE, 2009, GLOBAL WOOD DENSITY; Zolkos SG, 2013, REMOTE SENS ENVIRON, V128, P289, DOI 10.1016/j.rse.2012.10.017	72	39	42	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0126748	10.1371/journal.pone.0126748	http://dx.doi.org/10.1371/journal.pone.0126748			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061884	Green Published, Green Submitted, gold			2022-12-26	WOS:000355979500016
J	Yun, HJ; Kwak, K; Lee, JM				Yun, Hyuk Jin; Kwak, Kichang; Lee, Jong-Min		Alzheimer's Dis Neuroimaging Initi	Multimodal Discrimination of Alzheimer's Disease Based on Regional Cortical Atrophy and Hypometabolism	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; POSITRON-EMISSION-TOMOGRAPHY; MONKEY RETROSPLENIAL CORTEX; PARTIAL VOLUME CORRECTION; AUTOMATED 3-D EXTRACTION; VOXEL-BASED MORPHOMETRY; SURFACE-BASED ANALYSIS; FDG-PET; FEATURE-SELECTION; NEUROFIBRILLARY TANGLES	Structural MR image (MRI) and F-18-Fluorodeoxyglucose-positron emission tomography (FDG-PET) have been widely employed in diagnosis of both Alzheimer's disease (AD) and mild cognitive impairment (MCI) pathology, which has led to the development of methods to distinguish AD and MCI from normal controls (NC). Synaptic dysfunction leads to a reduction in the rate of metabolism of glucose in the brain and is thought to represent AD progression. FDG-PET has the unique ability to estimate glucose metabolism, providing information on the distribution of hypometabolism. In addition, patients with AD exhibit significant neuronal loss in cerebral regions, and previous AD research has shown that structural MRI can be used to sensitively measure cortical atrophy. In this paper, we introduced a new method to discriminate AD from NC based on complementary information obtained by FDG and MRI. For accurate classification, surface-based features were employed and 12 predefined regions were selected from previous studies based on both MRI and FDG-PET. Partial least square linear discriminant analysis was employed for making diagnoses. We obtained 93.6% classification accuracy, 90.1% sensitivity, and 96.5% specificity in discriminating AD from NC. The classification scheme had an accuracy of 76.5% and sensitivity and specificity of 46.5% and 89.6%, respectively, for discriminating MCI from AD. Our method exhibited a superior classification performance compared with single modal approaches and yielded parallel accuracy to previous multimodal classification studies using MRI and FDG-PET.	[Yun, Hyuk Jin; Kwak, Kichang; Lee, Jong-Min; Alzheimer's Dis Neuroimaging Initi] Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea	Hanyang University	Lee, JM (corresponding author), Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea.	ljm@hanyang.ac.kr		Yun, Hyuk Jin/0000-0002-9876-314X	National Research Foundation of Korea (NRF) grant - Korea government (MEST) [2011-0028333]; NATIONAL INSTITUTE ON AGING [U01AG024904] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF) grant - Korea government (MEST); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Research Foundation of Korea (NRF) grant, funded by the Korea government (MEST) (2011-0028333). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Aston JAD, 2002, J CEREBR BLOOD F MET, V22, P1019, DOI 10.1097/00004647-200208000-00014; Bishop C. M, 2006, PATTERN RECOGNITION; Boulesteix A.-L., 2004, STAT APPL GENET MOL, V3, P1075, DOI DOI 10.2202/1544-6115.1075; Boykov Y, 2001, IEEE T PATTERN ANAL, V23, P1222, DOI 10.1109/34.969114; Braak H, 1996, ACTA NEUROL SCAND, V93, P3; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Chaves R, 2009, NEUROSCI LETT, V461, P293, DOI 10.1016/j.neulet.2009.06.052; Chen Y, 2011, NEUROLOGY, V77, P1977, DOI 10.1212/WNL.0b013e31823a0ef7; Chetelat G, 2008, NEUROPSYCHOLOGIA, V46, P1721, DOI 10.1016/j.neuropsychologia.2007.11.037; Chetelat G, 2008, BRAIN, V131, P60, DOI 10.1093/brain/awm288; Chetelat G, 2005, NEUROIMAGE, V27, P934, DOI 10.1016/j.neuroimage.2005.05.015; Chetelat G, 2005, NEUROCASE, V11, P14, DOI 10.1080/13554790490896938; Chetelat G, 2003, NEUROIMAGE, V18, P525, DOI 10.1016/S1053-8119(02)00026-5; Chetelat G, 2003, NEUROLOGY, V60, P1374, DOI 10.1212/01.WNL.0000055847.17752.E6; Cho Y, 2012, NEUROIMAGE, V59, P2217, DOI 10.1016/j.neuroimage.2011.09.085; Chu C, 2012, NEUROIMAGE, V60, P59, DOI 10.1016/j.neuroimage.2011.11.066; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Convit A, 1997, NEUROBIOL AGING, V18, P131, DOI 10.1016/S0197-4580(97)00001-8; Cuingnet R, 2011, NEUROIMAGE, V56, P766, DOI 10.1016/j.neuroimage.2010.06.013; Dai ZJ, 2012, NEUROIMAGE, V59, P2187, DOI 10.1016/j.neuroimage.2011.10.003; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DAVATZIKOS C, 2011, NEUROBIOL AGING, V32, P2322, DOI [DOI 10.1016/J.NEUR0BI0LAGING.2010.05.023, DOI 10.1016/J.NEUROBIOLAGING.2010.05.023]; Davatzikos C, 2008, NEUROBIOL AGING, V29, P514, DOI 10.1016/j.neurobiolaging.2006.11.010; Oliveira PPD, 2010, J ALZHEIMERS DIS, V19, P1263, DOI 10.3233/JAD-2010-1322; Desikan RS, 2009, BRAIN, V132, P2048, DOI 10.1093/brain/awp123; Devanand DP, 2006, NEUROPSYCHOPHARMACOL, V31, P1327, DOI 10.1038/sj.npp.1300942; Ewers M, 2013, NEUROLOGY, V80, P1194, DOI 10.1212/WNL.0b013e31828970c2; Fan Y, 2008, NEUROIMAGE, V39, P1731, DOI 10.1016/j.neuroimage.2007.10.031; Fennema-Notestine C, 2009, BEHAV NEUROL, V21, P3, DOI [10.3233/BEN-2009-0230, 10.1155/2009/698156]; Foster NL, 2007, BRAIN, V130, P2616, DOI 10.1093/brain/awm177; Fukutani Y, 2000, PSYCHIAT CLIN NEUROS, V54, P523, DOI 10.1046/j.1440-1819.2000.00747.x; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Gray KR, 2013, NEUROIMAGE, V65, P167, DOI 10.1016/j.neuroimage.2012.09.065; Gray KR, 2012, NEUROIMAGE, V60, P221, DOI 10.1016/j.neuroimage.2011.12.071; Guyon I, 2003, J MACH LEARN RES, V3, P26; Haroutunian V, 1999, ARCH NEUROL-CHICAGO, V56, P713, DOI 10.1001/archneur.56.6.713; Herholz K, 2003, ANN NUCL MED, V17, P79, DOI 10.1007/BF02988444; Hinrichs C, 2011, NEUROIMAGE, V55, P574, DOI 10.1016/j.neuroimage.2010.10.081; Im K, 2006, NEUROIMAGE, V31, P31, DOI 10.1016/j.neuroimage.2005.11.042; Ishii K, 1997, J NUCL MED, V38, P925; JACK CR, 1992, NEUROLOGY, V42, P183, DOI 10.1212/WNL.42.1.183; Kanda T, 2008, EUR J NUCL MED MOL I, V35, P2227, DOI 10.1007/s00259-008-0871-5; Karow DS, 2010, RADIOLOGY, V256, P932, DOI 10.1148/radiol.10091402; KENNEDY C, 1978, ANN NEUROL, V4, P293, DOI 10.1002/ana.410040402; KILLIANY RJ, 1993, ARCH NEUROL-CHICAGO, V50, P949, DOI 10.1001/archneur.1993.00540090052010; Kim JS, 2005, NEUROIMAGE, V27, P210, DOI 10.1016/j.neuroimage.2005.03.036; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Kobayashi Y, 2003, J COMP NEUROL, V466, P48, DOI 10.1002/cne.10883; Kobayashi Y, 2007, J COMP NEUROL, V502, P810, DOI 10.1002/cne.21346; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Kwak K, 2013, MAGN RESON IMAGING, V31, P1190, DOI 10.1016/j.mri.2013.04.008; Landau SM, 2011, NEUROBIOL AGING, V32, P1207, DOI 10.1016/j.neurobiolaging.2009.07.002; Langbaum JBS, 2009, NEUROIMAGE, V45, P1107, DOI 10.1016/j.neuroimage.2008.12.072; Lerch JP, 2008, NEUROBIOL AGING, V29, P23, DOI 10.1016/j.neurobiolaging.2006.09.013; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; Liu F, 2014, NEUROIMAGE, V84, P466, DOI 10.1016/j.neuroimage.2013.09.015; Liu X, 2013, NEUROIMAGE, V83, P148, DOI 10.1016/j.neuroimage.2013.06.033; Lyttelton O, 2007, NEUROIMAGE, V34, P1535, DOI 10.1016/j.neuroimage.2006.10.041; MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534; Magnin B, 2009, NEURORADIOLOGY, V51, P73, DOI 10.1007/s00234-008-0463-x; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; MELTZER CC, 1990, J COMPUT ASSIST TOMO, V14, P561, DOI 10.1097/00004728-199007000-00011; Mielke R, 1998, J NEURAL TRANSM, V105, P821, DOI 10.1007/s007020050097; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; Misra C, 2009, NEUROIMAGE, V44, P1415, DOI 10.1016/j.neuroimage.2008.10.031; Mosconi L, 2005, NEUROLOGY, V64, P1860, DOI 10.1212/01.WNL.0000163856.13524.08; Mosconi L, 2004, NEUROLOGY, V63, P2332, DOI 10.1212/01.WNL.0000147469.18313.3B; Mosconi L, 2008, J NUCL MED, V49, P390, DOI 10.2967/jnumed.107.045385; MUFSON EJ, 1984, J COMP NEUROL, V225, P31, DOI 10.1002/cne.902250105; Nestor PJ, 2003, ANN NEUROL, V54, P343, DOI 10.1002/ana.10669; Nestor PJ, 2004, NAT MED, V10, pS34, DOI 10.1038/nrn1433; Nordlund A, 2005, J NEUROL NEUROSUR PS, V76, P1485, DOI 10.1136/jnnp.2004.050385; Park HJ, 2006, NEUROIMAGE, V31, P1434, DOI 10.1016/j.neuroimage.2006.02.001; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Querbes O, 2009, BRAIN, V132, P2036, DOI 10.1093/brain/awp105; Rabinovici GD, 2008, ANN NEUROL, V64, P388, DOI 10.1002/ana.21451; Robbins S, 2004, MED IMAGE ANAL, V8, P311, DOI 10.1016/j.media.2004.06.009; Salas-Gonzalez D, 2010, MED PHYS, V37, P6084, DOI 10.1118/1.3488894; Scheff SW, 2003, NEUROBIOL AGING, V24, P1029, DOI 10.1016/j.neurobiolaging.2003.08.002; Schroeter ML, 2009, NEUROIMAGE, V47, P1196, DOI 10.1016/j.neuroimage.2009.05.037; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Suykens JAK, 1999, NEURAL PROCESS LETT, V9, P293, DOI 10.1023/A:1018628609742; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Thomas BA, 2011, EUR J NUCL MED MOL I, V38, P1104, DOI 10.1007/s00259-011-1745-9; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Hoesen GW, 2000, ANN NY ACAD SCI, V911, P254; Van Hoesen GW, 2000, CEREB CORTEX, V10, P243, DOI 10.1093/cercor/10.3.243; Vemuri P, 2009, NEUROLOGY, V73, P294, DOI 10.1212/WNL.0b013e3181af79fb; VERWEIJ PJM, 1993, STAT MED, V12, P2305, DOI 10.1002/sim.4780122407; Walhovd KB, 2010, AM J NEURORADIOL, V31, P347, DOI 10.3174/ajnr.A1809; Walhovd KB, 2009, NEUROIMAGE, V45, P215, DOI 10.1016/j.neuroimage.2008.10.053; Wee CY, 2013, HUM BRAIN MAPP, V34, P3411, DOI 10.1002/hbm.22156; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Yoon CW, 2013, CEREBELLUM, V12, P35, DOI 10.1007/s12311-012-0388-0; Zaidi H, 2006, NEUROIMAGE, V32, P1591, DOI 10.1016/j.neuroimage.2006.05.031; Zhang DQ, 2011, NEUROIMAGE, V55, P856, DOI 10.1016/j.neuroimage.2011.01.008	98	17	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129250	10.1371/journal.pone.0129250	http://dx.doi.org/10.1371/journal.pone.0129250			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061669	Green Published, gold, Green Submitted			2022-12-26	WOS:000355979500134
J	Kim, J; Liu, Y; Qiu, M; Xu, Y				Kim, J.; Liu, Y.; Qiu, M.; Xu, Y.			Pluripotency factor Nanog is tumorigenic by deregulating DNA damage response in somatic cells	ONCOGENE			English	Article							CYCLE ARREST; P53; ACTIVATION; EXPRESSION; INVASION; ATM	The pluripotency gene Nanog is not expressed in normal adult tissues but is overexpressed in some human cancers. However, the tumorigenic roles of Nanog remain unclear. The ectopic expression of Nanog is not sufficient to induce spontaneous tumors in mice but can promote metastasis of established tumors by activating the expression of metastatic genes. The expression of Nanog in mouse skin activates tumor suppressor p53, leading to the differentiation of epidermal stem cells. In the absence of p53, Nanog induces spontaneous squamous cell carcinoma, identifying a novel role of Nanog in tumorigenesis. Therefore, the induction of p53 and differentiation in Nanog-expressing skin suppresses the tumorigenic activities of Nanog, which include the induction of DNA double-stranded break damage. Notably, Nanog interacts with the KRAB-associated protein 1 (KAP1) and inhibits its sumoylation activity, impairing KAP1-mediated chromatin remodeling, which is important for efficiently activating DNA damage response. In summary, Nanog is an oncogene with multiple roles in promoting tumorigenesis and metastasis.	[Kim, J.; Liu, Y.; Xu, Y.] Southern Med Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China; [Kim, J.; Qiu, M.; Xu, Y.] Univ Calif San Diego, Div Biol Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA	Southern Medical University - China; University of California System; University of California San Diego	Xu, Y (corresponding author), Univ Calif San Diego, Div Biol Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	yangxu@ucsd.edu		Xu, Yang/0000-0001-5574-921X	Chinese Ministry of Science and Technology [2012CB966900, 2013ZX10002008002]; CIRM [RC1-00148]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); CIRM(California Institute for Regenerative Medicine)	We thank Dr Manando Nakasaki for help with skin analysis, Dr Colin Jamora for providing K14-cre transgenic mice, and the UCSD Cancer Center Histology Core for help with the histological analysis. This work was supported by grants from Chinese Ministry of Science and Technology (2012CB966900 and 2013ZX10002008002) and CIRM (RC1-00148).	Badeaux MA, 2013, CELL CYCLE, V12, P2395, DOI 10.4161/cc.25402; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chiu SJ, 2009, CHEM-BIOL INTERACT, V182, P173, DOI 10.1016/j.cbi.2009.08.019; Costa Y, 2013, NATURE, V495, P370, DOI 10.1038/nature11925; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; Falk M, 2008, BBA-MOL CELL RES, V1783, P2398, DOI 10.1016/j.bbamcr.2008.07.010; Fischedick G, 2014, STEM CELL RES, V13, P300, DOI 10.1016/j.scr.2014.08.001; Gandarillas A, 2012, CELL CYCLE, V11, P4507, DOI 10.4161/cc.22529; Goodarzi AA, 2011, NAT STRUCT MOL BIOL, V18, P831, DOI 10.1038/nsmb.2077; Han JH, 2012, CANCER LETT, V321, P80, DOI 10.1016/j.canlet.2012.02.021; Ho BT, 2012, J BIOL CHEM, V287, P18656, DOI 10.1074/jbc.M111.322883; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kim J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.87; Kim YC, 2009, NAT CELL BIOL, V11, P92, DOI 10.1038/ncb1817; Kuramoto N, 2002, J CLIN INVEST, V109, P243, DOI 10.1172/JCI200213563; Lin YL, 2011, MOL CELL BIOCHEM, V351, P109, DOI 10.1007/s11010-011-0717-5; Liu DP, 2010, NAT CELL BIOL, V12, P993, DOI 10.1038/ncb2100; Lu X, 2014, ONCOGENE, V33, P2655, DOI 10.1038/onc.2013.209; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Moretto-Zita M, 2010, P NATL ACAD SCI USA, V107, P13312, DOI 10.1073/pnas.1005847107; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Noh KH, 2012, J CLIN INVEST, V122, P4077, DOI 10.1172/JCI64057; Piazzolla D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5226; Piestun D, 2006, BIOCHEM BIOPH RES CO, V343, P279, DOI 10.1016/j.bbrc.2006.02.152; Santaliz-Ruiz LEIV, 2014, INT J CANCER, V135, P2741, DOI 10.1002/ijc.28690; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Siu MKY, 2013, ONCOGENE, V32, P3500, DOI 10.1038/onc.2012.363; Sun C, 2013, INT J BIOCHEM CELL B, V45, P1099, DOI 10.1016/j.biocel.2013.02.017; Takata H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075622; Theunissen TW, 2011, PHILOS T R SOC B, V366, P2222, DOI 10.1098/rstb.2011.0003; Thomson JA, 1998, CURR TOP DEV BIOL, V38, P133; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135	36	13	13	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 10	2016	35	10					1334	1340		10.1038/onc.2015.205	http://dx.doi.org/10.1038/onc.2015.205			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DG0NY	26073077				2022-12-26	WOS:000371763100014
J	Schneider, D; Kaiser, W; Stutz, C; Holinski, A; Mayans, O; Babinger, P				Schneider, Daniel; Kaiser, Wolfgang; Stutz, Cian; Holinski, Alexandra; Mayans, Olga; Babinger, Patrick			YbiB from Escherichia coli, the Defining Member of the Novel TrpD2 Family of Prokaryotic DNA-binding Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE; ANTHRANILATE PHOSPHORIBOSYLTRANSFERASE; CRYSTAL-STRUCTURE; MYCOBACTERIUM-TUBERCULOSIS; SULFOLOBUS-SOLFATARICUS; METABOLIC ENZYME; HELICASE; GLYCOSYLASE; DENSITY; SYSTEM	We present the crystal structure and biochemical characterization of Escherichia coli YbiB, a member of the hitherto uncharacterized TrpD2 protein family. Our results demonstrate that the functional diversity of proteins with a common fold can be far greater than predictable by computational annotation. The TrpD2 proteins show high structural homology to anthranilate phosphoribosyltransferase (TrpD) and nucleoside phosphorylase class II enzymes but bind with high affinity (K-D = 10-100 nM) to nucleic acids without detectable sequence specificity. The difference in affinity between single-and double-stranded DNA is minor. Results suggest that multiple YbiB molecules bind to one longer DNA molecule in a cooperative manner. The YbiB protein is a homodimer that, therefore, has two electropositive DNA binding grooves. But due to negative cooperativity within the dimer, only one groove binds DNA in in vitro experiments. A monomerized variant remains able to bind DNA with similar affinity, but the negative cooperative effect is eliminated. The ybiB gene forms an operon with the DNA helicase gene dinG and is under LexA control, being induced by DNA-damaging agents. Thus, speculatively, the TrpD2 proteins may be part of the LexA-controlled SOS response in bacteria.	[Schneider, Daniel; Kaiser, Wolfgang; Holinski, Alexandra; Babinger, Patrick] Univ Regensburg, Inst Biophys & Phys Biochem, D-93040 Regensburg, Germany; [Stutz, Cian; Mayans, Olga] Univ Basel, Div Struct Biol, Biozentrum, CH-4056 Basel, Switzerland; [Mayans, Olga] Univ Liverpool, Inst Integrat Biol, Liverpool L69 7ZB, Merseyside, England	University of Regensburg; University of Basel; University of Liverpool	Babinger, P (corresponding author), Univ Regensburg, Inst Biophys & Phys Biochem, D-93040 Regensburg, Germany.	patrick.babinger@ur.de		Mayans, Olga/0000-0001-6876-8532; Holinski, Alexandra/0000-0003-2321-5568; Babinger, Patrick/0000-0002-7490-6732				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Boubakri H, 2010, EMBO J, V29, P145, DOI 10.1038/emboj.2009.308; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Castell A, 2013, BIOCHEMISTRY-US, V52, P1776, DOI 10.1021/bi301387m; Cheng ZS, 2012, FEBS LETT, V586, P3825, DOI 10.1016/j.febslet.2012.09.032; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gao XF, 2006, J STRUCT BIOL, V154, P20, DOI 10.1016/j.jsb.2005.11.014; Grippon S, 2011, NUCLEIC ACIDS RES, V39, P2593, DOI 10.1093/nar/gkq913; Hwang J, 2012, J MOL MICROB BIOTECH, V22, P135, DOI 10.1159/000339832; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kim C, 2002, FEBS LETT, V523, P239, DOI 10.1016/S0014-5793(02)02905-8; Koroleva O, 2007, EMBO J, V26, P867, DOI 10.1038/sj.emboj.7601537; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lee CE, 2006, J MOL BIOL, V355, P784, DOI 10.1016/j.jmb.2005.11.016; Marino M, 2006, J BIOL CHEM, V281, P21410, DOI 10.1074/jbc.M601403200; Mayans O, 2002, EMBO J, V21, P3245, DOI 10.1093/emboj/cdf298; McRobbie AM, 2012, BIOCHEM J, V442, P77, DOI 10.1042/BJ20111903; Morgan MT, 2011, NUCLEIC ACIDS RES, V39, P2319, DOI 10.1093/nar/gkq1164; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; POMERANTZ SC, 1990, METHOD ENZYMOL, V193, P796, DOI 10.1016/0076-6879(90)93452-Q; Pugmire MJ, 2002, BIOCHEM J, V361, P1, DOI 10.1042/0264-6021:3610001; Pugmire MJ, 1998, STRUCTURE, V6, P1467, DOI 10.1016/S0969-2126(98)00145-2; Pugmire WJ, 1998, J MOL BIOL, V281, P285, DOI 10.1006/jmbi.1998.1941; REINSTEIN J, 1990, BIOCHEMISTRY-US, V29, P7440, DOI 10.1021/bi00484a013; Rogozin IB, 2002, NUCLEIC ACIDS RES, V30, P2212, DOI 10.1093/nar/30.10.2212; Schlee S, 2009, BIOCHEMISTRY-US, V48, P5199, DOI 10.1021/bi802335s; Schwab T, 2008, J MOL BIOL, V376, P506, DOI 10.1016/j.jmb.2007.11.078; Schwab T, 2011, CHEMBIOCHEM, V12, P1581, DOI 10.1002/cbic.201000770; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Thomason Lynn, 2007, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0117s79; Van Dyk TK, 2001, J BACTERIOL, V183, P5496, DOI 10.1128/JB.183.19.5496-5505.2001; Voloshin ON, 2007, J BIOL CHEM, V282, P18437, DOI 10.1074/jbc.M700376200; Voloshin ON, 2003, J BIOL CHEM, V278, P28284, DOI 10.1074/jbc.M301188200; Wang Wenyan, 2002, Methods Mol Biol, V182, P37; Wu YH, 2012, ANAL BIOCHEM, V423, P15, DOI 10.1016/j.ab.2012.01.012; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597	42	3	3	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19527	19539		10.1074/jbc.M114.620575	http://dx.doi.org/10.1074/jbc.M114.620575			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26063803	hybrid, Green Published			2022-12-26	WOS:000359364600013
J	Mooren, OL; Kim, J; Li, JM; Cooper, JA				Mooren, Olivia L.; Kim, Joanna; Li, Jinmei; Cooper, John A.			Role of N-WASP in Endothelial Monolayer Formation and Integrity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VE-CADHERIN; VASCULAR-PERMEABILITY; FOCAL ADHESION; ACTIN; JUNCTIONS; MAINTAIN; COMPLEX; GTPASES	Endothelial cells (ECs) form a monolayer that serves as a barrier between the blood and the underlying tissue. ECs tightly regulate their cell-cell junctions, controlling the passage of soluble materials and immune cells across the monolayer barrier. Westudied the role of N-WASP, a key regulator of Arp2/3 complex and actin assembly, in EC monolayers. We report that N-WASP regulates endothelial monolayer integrity by affecting the organization of cell junctions. Depletion of N-WASP resulted in an increase in transendothelial electrical resistance, a measure of monolayer integrity. N-WASP depletion increased the width of cell-cell junctions and altered the organization of F-actin and VE-cadherin at junctions. N-WASP was not present at cell-cell junctions in monolayers under resting conditions, but it was recruited following treatment with sphingosine-1-phosphate. Taken together, our results reveal a novel role for N-WASP in remodeling EC junctions, which is critical for monolayer integrity and function.	[Mooren, Olivia L.; Kim, Joanna; Li, Jinmei; Cooper, John A.] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Cooper, JA (corresponding author), Campus Box 8228,660 S Euclid Ave, St Louis, MO 63110 USA.	jacooper@wustl.edu	Regan, Clinton/E-6250-2012; Kim, Joanna/U-5556-2018; Cooper, John/D-4448-2014	Kim, Joanna/0000-0001-7877-9446; Cooper, John/0000-0002-0933-4571	National Institutes of Health [R01 GM 38542]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM 38542. The authors declare that they have no conflicts of interest with the contents of this article.	Abu Taha A, 2014, MOL BIOL CELL, V25, P245, DOI 10.1091/mbc.E13-07-0404; Aghajanian A, 2008, J THROMB HAEMOST, V6, P1453, DOI 10.1111/j.1538-7836.2008.03087.x; Alcaide P, 2008, BLOOD, V112, P2770, DOI 10.1182/blood-2008-03-147181; Bakker W, 2009, CELL TISSUE RES, V335, P165, DOI 10.1007/s00441-008-0685-6; Belvitch P, 2012, MICROVASC RES, V83, P22, DOI 10.1016/j.mvr.2011.08.012; Blum MS, 1997, AM J PHYSIOL-HEART C, V273, pH286, DOI 10.1152/ajpheart.1997.273.1.H286; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Clark PR, 2007, J INVEST DERMATOL, V127, P762, DOI 10.1038/sj.jid.5700670; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Derivery E, 2010, BIOESSAYS, V32, P119, DOI 10.1002/bies.200900123; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Citalan-Madrid AF, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.26938; Helgeson LA, 2013, ELIFE, V2, DOI 10.7554/eLife.00884; Kovacs EM, 2011, NAT CELL BIOL, V13, P934, DOI 10.1038/ncb2290; Kumar P, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001112; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Mooren OL, 2014, MOL BIOL CELL, V25, P4115, DOI 10.1091/mbc.E14-05-0976; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; Padrick SB, 2011, P NATL ACAD SCI USA, V108, pE472, DOI 10.1073/pnas.1100236108; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rajput C, 2013, J BIOL CHEM, V288, P4241, DOI 10.1074/jbc.M112.440396; Rigor RR, 2013, MED RES REV, V33, P911, DOI 10.1002/med.21270; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schnoor M, 2011, J EXP MED, V208, P1721, DOI 10.1084/jem.20101920; Sima AV, 2009, CELL TISSUE RES, V335, P191, DOI 10.1007/s00441-008-0678-5; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; STOLPEN AH, 1986, AM J PATHOL, V123, P16; Sun XG, 2009, MICROVASC RES, V77, P304, DOI 10.1016/j.mvr.2008.12.004; Ti SC, 2011, P NATL ACAD SCI USA, V108, pE463, DOI 10.1073/pnas.1100125108; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; Wojciak-Stothard B, 2002, VASC PHARMACOL, V39, P187, DOI 10.1016/S1537-1891(03)00008-9; Wu XY, 2004, J BIOL CHEM, V279, P43392, DOI 10.1074/jbc.M408959200; Xiao KY, 2005, MOL BIOL CELL, V16, P5141, DOI 10.1091/mbc.E05-05-0440; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001	36	6	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18796	18805		10.1074/jbc.M115.668285	http://dx.doi.org/10.1074/jbc.M115.668285			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26070569	Green Published, hybrid			2022-12-26	WOS:000358512100046
J	Abd El Wahed, A; Patel, P; Faye, O; Thaloengsok, S; Heidenreich, D; Matangkasombut, P; Manopwisedjaroen, K; Sakuntabhai, A; Sall, AA; Hufert, FT; Weidmann, M				Abd El Wahed, Ahmed; Patel, Pranav; Faye, Oumar; Thaloengsok, Sasikanya; Heidenreich, Doris; Matangkasombut, Ponpan; Manopwisedjaroen, Khajohnpong; Sakuntabhai, Anavaj; Sall, Amadou A.; Hufert, Frank T.; Weidmann, Manfred			Recombinase Polymerase Amplification Assay for Rapid Diagnostics of Dengue Infection	PLOS ONE			English	Article							MEDIATED ISOTHERMAL AMPLIFICATION; TIME RT-PCR; VIRUS SEROTYPES; FEVER; DIFFERENTIATION; SENSITIVITY; PERFORMANCE; ANTIGEN; FROZEN	Background Over 2.5 billion people are exposed to the risk of contracting dengue fever (DF). Early diagnosis of DF helps to diminish its burden on public health. Real-time reverse transcription polymerase amplification assays (RT-PCR) are the standard method for molecular detection of the dengue virus (DENV). Real-time RT-PCR analysis is not suitable for on-site screening since mobile devices are large, expensive, and complex. In this study, two RT-recombinase polymerase amplification (RT-RPA) assays were developed to detect DENV1-4. Methodology/Principal Findings Using two quantitative RNA molecular standards, the analytical sensitivity of a RT-RPA targeting the 3'non-translated region of DENV1-4 was found to range from 14 (DENV4) to 241 (DENV1-3) RNA molecules detected. The assay was specific and did not cross detect other Flaviviruses. The RT-RPA assay was tested in a mobile laboratory combining magneticbead based total nucleic acid extraction and a portable detection device in Kedougou (Senegal) and in Bangkok (Thailand). In Kedougou, the RT-RPA was operated at an ambient temperature of 38 degrees C with auxiliary electricity tapped from a motor vehicle and yielded a clinical sensitivity and specificity of 98% (n=31) and 100% (n=23), respectively. While in the field trial in Bangkok, the clinical sensitivity and specificity were 72% (n=90) and 100% (n=41), respectively. Conclusions/Significance During the first 5 days of infection, the developed DENV1-4 RT-RPA assays constitute a suitable accurate and rapid assay for DENV diagnosis. Moreover, the use of a portable fluorescence-reading device broadens its application potential to the point-of-care for outbreak investigations.	[Abd El Wahed, Ahmed] German Primate Ctr, Unit Infect Models, Gottingen, Germany; [Abd El Wahed, Ahmed] Mansoura Univ, Dept Virol, Dakahlia, Egypt; [Patel, Pranav] Robert Koch Inst, Ctr Biol Threats & Special Pathogens, CBS1 Highly Pathogen Viruses, Berlin, Germany; [Faye, Oumar; Sall, Amadou A.] Inst Pasteur, Arbovirus Unit, Dakar, Senegal; [Thaloengsok, Sasikanya; Matangkasombut, Ponpan; Manopwisedjaroen, Khajohnpong] Mahidol Univ, Fac Sci, Dept Microbiol, Bangkok 10700, Thailand; [Heidenreich, Doris] Univ Med Ctr, Dept Virol, Gottingen, Germany; [Matangkasombut, Ponpan] Mahidol Univ, Fac Sci, Syst Biol Dis Res Unit, Bangkok 10700, Thailand; [Matangkasombut, Ponpan] Mahidol Univ, Ctr Emerging & Neglected Infect Dis, Bangkok 10700, Thailand; [Sakuntabhai, Anavaj] Inst Pasteur, Funct Genet Infect Dis Unit, Paris, France; [Hufert, Frank T.] Brandenburg Med Sch Theodor Fontane Senftenberg, Inst Microbiol & Virol, Brandenburg, Germany; [Weidmann, Manfred] Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland	Deutsches Primatenzentrum (DPZ); Egyptian Knowledge Bank (EKB); Mansoura University; Robert Koch Institute; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Mahidol University; University of Gottingen; Mahidol University; Mahidol University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Stirling	Weidmann, M (corresponding author), Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland.	m.w.weidmann@stir.ac.uk	Weidmann, Manfred/G-1817-2015; Faye, Oumar/T-7168-2019	Weidmann, Manfred/0000-0002-7063-7491; Faye, Oumar/0000-0002-3478-1322; Abd El Wahed, Ahmed/0000-0003-3347-6075; Heidenreich, Doris/0000-0002-2010-9017	Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ) [VN 811-40270]; Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative; European Commission [282 378]	Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ); Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative; European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was funded by a grant from the Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ) contract no: VN 811-40270. http://www.giz.de. The Bangkok cohort study was funded by the Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative, and European Commission Seventh Framework Programme [FP7/2007-2013] for the DENFREE project under Grant Agreement number 282 378.	Abd El Wahed A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071642, 10.1371/currents.outbreaks.62df1c7c75ffc96cd59034531e2e8364]; Amer HM, 2013, J VIROL METHODS, V193, P337, DOI 10.1016/j.jviromet.2013.06.027; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Blacksell SD, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/151967; Blacksell SD, 2012, CLIN VACCINE IMMUNOL, V19, P804, DOI 10.1128/CVI.05717-11; Botling J, 2009, DIAGN MOL PATHOL, V18, P44, DOI 10.1097/PDM.0b013e3181857e92; Boyle DS, 2013, MBIO, V4, DOI 10.1128/mBio.00135-13; Carneiro AR, 2012, MEM I OSWALDO CRUZ, V107, P805, DOI 10.1590/S0074-02762012000600016; COMPTON J, 1991, NATURE, V350, P91, DOI 10.1038/350091a0; Daep CA, 2014, J NEUROVIROL, V20, P539, DOI 10.1007/s13365-014-0285-z; Daher RK, 2015, MOL CELL PROBE, V29, P116, DOI 10.1016/j.mcp.2014.11.005; Escadafal C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002730; Euler M, 2013, J CLIN MICROBIOL, V51, P1110, DOI 10.1128/JCM.02704-12; Euler M, 2012, J CLIN VIROL, V54, P308, DOI 10.1016/j.jcv.2012.05.006; Euler M, 2012, J CLIN MICROBIOL, V50, P2234, DOI 10.1128/JCM.06504-11; Felix AC, 2012, CLIN VACCINE IMMUNOL, V19, P1972, DOI 10.1128/CVI.00535-12; Gan VC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060946; Gusev Y, 2001, AM J PATHOL, V159, P63, DOI 10.1016/S0002-9440(10)61674-4; Holmes EC, 1998, BRIT MED BULL, V54, P533; Holmes KC, 1998, ACTA CRYSTALLOGR A, V54, P789, DOI 10.1107/S0108767398010307; Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005; Kien DTH, 2011, J VIROL METHODS, V177, P168, DOI 10.1016/j.jviromet.2011.08.002; Lai YL, 2007, J CLIN MICROBIOL, V45, P935, DOI 10.1128/JCM.01258-06; Li SH, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-360; Medina Freddy, 2012, Curr Protoc Microbiol, VChapter 15, DOI 10.1002/9780471729259.mc15d02s27; Messer WB, 2003, EMERG INFECT DIS, V9, P800; Mutter GL, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-88; Najioullah F, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-164; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Paranavitane SA, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0570-8; Parida M, 2005, J CLIN MICROBIOL, V43, P2895, DOI 10.1128/JCM.43.6.2895-2903.2005; Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459; Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204; Pongsiri P, 2012, ASIAN PAC J TROP MED, V5, P342, DOI 10.1016/S1995-7645(12)60055-8; Sahni Ajay Kumar, 2013, Med J Armed Forces India, V69, P246, DOI 10.1016/j.mjafi.2012.07.017; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311; Ibarra AMS, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1135; Teoh BT, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-387; Thisyakorn Usa, 2014, Ther Adv Vaccines, V2, P3, DOI 10.1177/2051013613507862; Torres C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-240; Van Ness J, 2003, P NATL ACAD SCI USA, V100, P4504, DOI 10.1073/pnas.0730811100; Vincent M, 2004, EMBO REP, V5, P795, DOI 10.1038/sj.embor.7400200; Wagner D, 2004, EMERG INFECT DIS, V10, P1872, DOI 10.3201/eid1010.031037; Weidmann M, 2003, J CLIN MICROBIOL, V41, P1565, DOI 10.1128/JCM.41.4.1565-1568.2003; Whiley DM, 2006, J CLIN VIROL, V35, P81, DOI 10.1016/j.jcv.2005.05.002; WHO, 2014, DENG FACT SHEETS; Wu SJL, 2001, J CLIN MICROBIOL, V39, P2794, DOI 10.1128/JCM.39.8.2794-2798.2001; Yamada KI, 2002, J CLIN VIROL, V24, P203, DOI 10.1016/S1386-6532(01)00250-5	49	92	95	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129682	10.1371/journal.pone.0129682	http://dx.doi.org/10.1371/journal.pone.0129682			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075598	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900091
J	Barbadoro, P; Di Tondo, E; Menditto, VG; Pennacchietti, L; Regnicoli, F; Di Stanislao, F; D'Errico, MM; Prospero, E				Barbadoro, Pamela; Di Tondo, Elena; Menditto, Vincenzo Giannicola; Pennacchietti, Lucia; Regnicoli, Februa; Di Stanislao, Francesco; D'Errico, Marcello Mario; Prospero, Emilia			Emergency Department Non-Urgent Visits and Hospital Readmissions Are Associated with Different Socio-Economic Variables in Italy	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; PRIMARY-CARE; 30-DAY READMISSIONS; HEART-FAILURE; HEALTH; NEEDS	Objective The aim of this paper was to evaluate socio-economic factors associated to poor primary care utilization by studying two specific subjects: the hospital readmission rate, and the use of the Emergency Department (ED) for non-urgent visits. Methods The study was carried out by the analysis of administrative database for hospital readmission and with a specific survey for non-urgent ED use. Results Among the 416,698 sampled admissions, 6.39% (95% CI, 6.32-6.47) of re-admissions have been registered; the distribution shows a high frequency of events in the age 65-84 years group, and in the intermediate care hospitals (51.97%; 95% CI 51.37-52.57). The regression model has shown the significant role played by age, type of structure (geriatric acute care), and deprivation index of the area of residence on the readmission, however, after adjusting for the intensity of primary care, the role of deprivation was no more significant. Non-urgent ED visits accounted for the 12.10%, (95% CI 9.38-15.27) of the total number of respondents to the questionnaire (N = 504). The likelihood of performing a non-urgent ED visit was higher among patients aged <65 years (OR 3.2, 95% CI 1.3-7.8 p = 0.008), while it was lower among those perceiving as urgent their health problem (OR 0.50, 95% CI 0.30-0.90). Conclusions In the Italian context repeated readmissions and ED utilization are linked to different trajectories, besides the increasing age and comorbidity of patients are the factors that are related to repeated admissions, the self-perceived trust in diagnostic technologies is an important risk factor in determining ED visits. Better use of public national health care service is mandatory, since its correct utilization is associated to increasing equity and better health care utilization.	[Barbadoro, Pamela; Di Tondo, Elena; Pennacchietti, Lucia; Di Stanislao, Francesco; D'Errico, Marcello Mario; Prospero, Emilia] Univ Politecn Marche, Dept Biomed Sci & Publ Hlth, Ancona, Italy; [Barbadoro, Pamela; D'Errico, Marcello Mario; Prospero, Emilia] AOU Osped Riuniti, Hosp Hyg Serv, Ancona, Italy; [Menditto, Vincenzo Giannicola; Regnicoli, Februa] AOU Osped Riuniti, Dept Emergency Care, Ancona, Italy	Marche Polytechnic University	Barbadoro, P (corresponding author), Univ Politecn Marche, Dept Biomed Sci & Publ Hlth, Ancona, Italy.	p.barbadoro@univpm.it	barbadoro, pamela/AAC-5041-2022; Menditto, Vincenzo G/CAE-9845-2022; menditto, vincenzo g/ABF-1651-2020	Menditto, Vincenzo G/0000-0001-6231-2251; menditto, vincenzo g/0000-0001-6231-2251; Prospero, Emilia/0000-0002-2387-8639	ministry of health	ministry of health	The study was funded by the ministry of health.	Agency for Healthcare Research and Quality (AHRQ), AG HEALTHC RES QUAL; [Anonymous], 2014, INT J HLTH POLICY MA; Ansari Z, 2006, MED CARE RES REV, V63, P719, DOI 10.1177/1077558706293637; Bianco A, 2003, PUBLIC HEALTH, V117, P250, DOI 10.1016/S0033-3506(03)00069-6; Billings J, 2000, Issue Brief (Commonw Fund), P1; Billings J, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001667; Cadum E, 1999, Epidemiol Prev, V23, P175; Chetty VK, 2011, AM FAM PHYSICIAN, V83, P1054; David G, 2015, HEALTH SERV RES, V50, P418, DOI 10.1111/1475-6773.12218; Devaux M., 2013, EUR J HLTH EC; Dharmarajan K, 2013, JAMA-J AM MED ASSOC, V309, P355, DOI 10.1001/jama.2012.216476; Fischer C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112282; Friedman B, 2004, MED CARE RES REV, V61, P225, DOI 10.1177/1077558704263799; Gerhardt Geoffrey, 2014, Medicare Medicaid Res Rev, V4, DOI 10.5600/mmrr2014-004-01-b03; Grol R, 2006, HEALTH AFFAIR, V25, P1733, DOI 10.1377/hlthaff.25.6.1733; GRUMBACH K, 1993, AM J PUBLIC HEALTH, V83, P372, DOI 10.2105/AJPH.83.3.372; Halfon P, 2002, J CLIN EPIDEMIOL, V55, P573, DOI 10.1016/S0895-4356(01)00521-2; Hasan O, 2010, J GEN INTERN MED, V25, P211, DOI 10.1007/s11606-009-1196-1; Hebert C, 2014, BMC MED INFORM DECIS, V14, DOI 10.1186/1472-6947-14-65; Hoeck S, 2014, INT J ENV RES PUB HE, V11, P355, DOI 10.3390/ijerph110100355; Horwitz LI, 2014, ANN INTERN MED, V161, pS66, DOI 10.7326/M13-3000; Huibers L, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-105; Hurst J, 2001, OECD LABOUR MARKET S, V47; Italian National Institute of Health, NAT OUTC IND SYST; Kelley E., 2006, OECD HLTH WORKING PA, V23; Lang T, 1996, J EPIDEMIOL COMMUN H, V50, P456, DOI 10.1136/jech.50.4.456; Lee Eun Whan, 2012, J Prev Med Public Health, V45, P259, DOI 10.3961/jpmph.2012.45.4.259; Lindenauer PK, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f521; Lowe RA, 2005, MED CARE, V43, P792, DOI 10.1097/01.mlr.0000170413.60054.54; Majeed A, 2012, ANN INTERN MED, V156, P67, DOI 10.7326/0003-4819-156-1-201201030-00019; Mckee M, 2009, LANCET, V373, P349, DOI 10.1016/S0140-6736(09)60098-2; Ministry of Health, 2011, REL SULL STAT SAN PA; Roberts L, 2014, EMERG MED J, V31, P786; Shadmi E, 2015, MED CARE, V53, P283, DOI 10.1097/MLR.0000000000000315; Shaw EK, 2013, J HEALTH CARE POOR U, V24, P1288, DOI 10.1353/hpu.2013.0140; Sibbritt D W, 1995, J Qual Clin Pract, V15, P211; van der Linden MC, 2014, INT J EMERG MED, V7, DOI 10.1186/s12245-014-0028-1; van Walraven C, 2011, CAN MED ASSOC J, V183, pE391, DOI 10.1503/cmaj.101860; Vedovetto A, 2014, HEALTH SERV RES, V49, P1290, DOI 10.1111/1475-6773.12161; Wang M, 2014, J EVAL CLIN PRACT, V20, P20, DOI 10.1111/jep.12074; Zapatero A, 2012, EUR J INTERN MED, V23, P451, DOI 10.1016/j.ejim.2012.01.005	41	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0127823	10.1371/journal.pone.0127823	http://dx.doi.org/10.1371/journal.pone.0127823			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26076346	Green Submitted, Green Published, gold			2022-12-26	WOS:000356329900015
J	Lin, YS; Chen, TH; Hung, SP; Chen, DY; Mao, CT; Tsai, ML; Chang, ST; Wang, CC; Wen, MS; Chen, MC				Lin, Yu-Sheng; Chen, Tien-Hsing; Hung, Sheng-Ping; Chen, Dong Yi; Mao, Chun-Tai; Tsai, Ming-Lung; Chang, Shih-Tai; Wang, Chun-Chieh; Wen, Ming-Shien; Chen, Mien-Cheng			Impact of Pacemaker Lead Characteristics on Pacemaker Related Infection and Heart Perforation: A Nationwide Population-Based Cohort Study	PLOS ONE			English	Article							ELECTRONIC DEVICE INFECTIONS; RISK-FACTORS; CARDIOVERTER-DEFIBRILLATORS; CONSECUTIVE PATIENTS; ESC GUIDELINES; RATES; MANAGEMENT; IMPLANTATION; COMPLICATION; PREDICTORS	Background Several risk factors for pacemaker (PM) related complications have been reported. However, no study has investigated the impact of lead characteristics on pacemaker-related complications. Methods and Results Patients who received a new pacemaker implant from January 1997 to December 2011 were selected from the Taiwan National Health Insurance Database. This population was grouped according to the pacemaker lead characteristics in terms of fixation and insulation. The impact of the characteristics of leads on early heart perforation was analyzed by multivariable logistic regression analysis, while the impact of the lead characteristics on early and late infection and late heart perforation over a three-year period were analyzed using Cox regression. This study included 36,104 patients with a mean age of 73.4 +/- 12.5 years. In terms of both early and late heart perforations, there were no significant differences between groups across the different types of fixation and insulations. In the multivariable Cox regression analysis, the pacemaker-related infection rate was significantly lower in the active fixation only group compared to either the both fixation (OR, 0.23; 95% CI, 0.07-0.80; P = 0.020) or the passive fixation group (OR, 0.26; 95% CI, 0.08-0.83; P = 0.023). Conclusions There was no difference in heart perforation between active and passive fixation leads. Active fixation leads were associated with reduced risk of pacemaker-related infection.	[Lin, Yu-Sheng; Chang, Shih-Tai] Chang Gung Mem Hosp, Div Cardiol, Dept Internal Med, Chiayi, Taiwan; [Lin, Yu-Sheng] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Kaohsiung, Taiwan; [Chen, Tien-Hsing; Chen, Dong Yi; Tsai, Ming-Lung; Wang, Chun-Chieh; Wen, Ming-Shien] Chang Gung Mem Hosp, Div Cardiol, Linkou, Taiwan; [Hung, Sheng-Ping] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Mao, Chun-Tai] Chang Gung Mem Hosp, Dept Med, Cardiol Sect, Keelung, Taiwan; [Chen, Mien-Cheng] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Div Cardiol, Kaohsiung, Taiwan; [Chen, Mien-Cheng] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Chen, MC (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Div Cardiol, Kaohsiung, Taiwan.	chenmien@ms76.hinet.net						Brignole M, 2013, EUR HEART J, V34, P2281, DOI 10.1093/eurheartj/eht150; Cabell CH, 2004, AM HEART J, V147, P582, DOI 10.1016/j.ahj.2003.06.005; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Danik SB, 2007, HEART RHYTHM, V4, P439, DOI 10.1016/j.hrthm.2006.12.044; Dasgupta A, 2007, AM J KIDNEY DIS, V49, P656, DOI 10.1053/j.ajkd.2007.02.272; Dickstein K, 2010, EUR HEART J, V31, P2677, DOI 10.1093/eurheartj/ehq337; Geyfman V, 2007, PACE, V30, P498, DOI 10.1111/j.1540-8159.2007.00699.x; Johansen JB, 2011, EUR HEART J, V32, P991, DOI 10.1093/eurheartj/ehq497; Klug D, 2007, CIRCULATION, V116, P1349, DOI 10.1161/CIRCULATIONAHA.106.678664; Lekkerkerker JC, 2009, HEART, V95, P715, DOI 10.1136/hrt.2008.151985; Mahapatra S, 2005, HEART RHYTHM, V2, P907, DOI 10.1016/j.hrthm.2005.06.011; Mond HG, 2011, PACE, V34, P1013, DOI 10.1111/j.1540-8159.2011.03150.x; National Health Insurance Administration Ministry of Health and Welfare Taiwan ROC, 2014, NATL HLTH INSURANCE; Nery PB, 2010, J CARDIOVASC ELECTR, V21, P786, DOI 10.1111/j.1540-8167.2009.01690.x; Ohlow MA, 2013, CIRC J, V77, P975, DOI 10.1253/circj.CJ-12-0707; Piekarz J, 2012, ARCH MED SCI, V8, P70, DOI 10.5114/aoms.2012.27284; Refaat MM, 2010, CLIN CARDIOL, V33, P466, DOI 10.1002/clc.20803; Selcuk H, 2006, PACE, V29, P429, DOI 10.1111/j.1540-8159.2006.00366.x; Sohail MR, 2007, CLIN INFECT DIS, V45, P166, DOI 10.1086/518889; Sohail MR, 2011, ARCH INTERN MED, V171, P1821, DOI 10.1001/archinternmed.2011.441; Sohail MR, 2011, J INTERV CARD ELECTR, V31, P171, DOI 10.1007/s10840-010-9537-x; Sterlinski M, 2009, EUROPACE, V11, P206, DOI 10.1093/europace/eun363; Tompkins C, 2011, J CARDIOVASC ELECTR, V22, P1099, DOI 10.1111/j.1540-8167.2011.02066.x; Voigt A, 2010, PACE, V33, P414, DOI 10.1111/j.1540-8159.2009.02569.x	24	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128320	10.1371/journal.pone.0128320	http://dx.doi.org/10.1371/journal.pone.0128320			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075602	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900019
J	Sonnaert, M; Kerckhofs, G; Papantoniou, I; Van Vlierberghe, S; Boterberg, V; Dubruel, P; Luyten, FP; Schrooten, J; Geris, L				Sonnaert, Maarten; Kerckhofs, Greet; Papantoniou, Ioannis; Van Vlierberghe, Sandra; Boterberg, Veerle; Dubruel, Peter; Luyten, Frank P.; Schrooten, Jan; Geris, Liesbet			Multifactorial Optimization of Contrast-Enhanced Nanofocus Computed Tomography for Quantitative Analysis of Neo-Tissue Formation in Tissue Engineering Constructs	PLOS ONE			English	Article							VERSATILE TOOL; MICRO-CT; SCAFFOLDS; BIOLOGY; 2D	To progress the fields of tissue engineering (TE) and regenerative medicine, development of quantitative methods for non-invasive three dimensional characterization of engineered constructs (i.e. cells/tissue combined with scaffolds) becomes essential. In this study, we have defined the most optimal staining conditions for contrast-enhanced nanofocus computed tomography for three dimensional visualization and quantitative analysis of in vitro engineered neo-tissue (i.e. extracellular matrix containing cells) in perfusion bioreactor-developed Ti6Al4V constructs. A fractional factorial 'design of experiments' approach was used to elucidate the influence of the staining time and concentration of two contrast agents (Hexabrix and phosphotungstic acid) and the neo-tissue volume on the image contrast and dataset quality. Additionally, the neo-tissue shrinkage that was induced by phosphotungstic acid staining was quantified to determine the operating window within which this contrast agent can be accurately applied. For Hexabrix the staining concentration was the main parameter influencing image contrast and dataset quality. Using phosphotungstic acid the staining concentration had a significant influence on the image contrast while both staining concentration and neo-tissue volume had an influence on the dataset quality. The use of high concentrations of phosphotungstic acid did however introduce significant shrinkage of the neo-tissue indicating that, despite sub-optimal image contrast, low concentrations of this staining agent should be used to enable quantitative analysis. To conclude, design of experiments allowed us to define the most optimal staining conditions for contrast-enhanced nanofocus computed tomography to be used as a routine screening tool of neo-tissue formation in Ti6Al4V constructs, transforming it into a robust three dimensional quality control methodology.	[Sonnaert, Maarten; Kerckhofs, Greet; Papantoniou, Ioannis; Luyten, Frank P.; Schrooten, Jan; Geris, Liesbet] Katholieke Univ Leuven, Div Skeletal Tissue Engn, Prometheus, Leuven, Belgium; [Sonnaert, Maarten; Schrooten, Jan] Katholieke Univ Leuven, Dept Mat Engn, Heverlee, Belgium; [Kerckhofs, Greet; Papantoniou, Ioannis; Luyten, Frank P.] Katholieke Univ Leuven, Dept Dev & Regenerat, Skeletal Biol & Engn Res Ctr, Leuven, Belgium; [Kerckhofs, Greet; Geris, Liesbet] Univ Liege, Biomech Res Unit, Liege, Belgium; [Van Vlierberghe, Sandra; Boterberg, Veerle; Dubruel, Peter] Univ Ghent, Polymer Chem & Biomat Grp, B-9000 Ghent, Belgium; [Geris, Liesbet] Katholieke Univ Leuven, Dept Mech Engn, Biomech Sect, Heverlee, Belgium	KU Leuven; KU Leuven; KU Leuven; University of Liege; Ghent University; KU Leuven	Kerckhofs, G (corresponding author), Katholieke Univ Leuven, Div Skeletal Tissue Engn, Prometheus, Leuven, Belgium.	greet.kerckhofs@med.kuleuven.be	Kerckhofs, Greet/J-5006-2016; Van Vlierberghe, Sandra./AAN-7863-2021; Papantoniou, Ioannis/ABF-1528-2021; Luyten, Frank/GPS-7793-2022; geris, liesbet/D-2343-2016	Kerckhofs, Greet/0000-0002-1750-8324; geris, liesbet/0000-0002-8180-1445; Dubruel, Peter/0000-0002-5928-7726; Van Vlierberghe, Sandra/0000-0001-7688-1682; Papantoniou, Ioannis/0000-0002-4754-5492	Ph.D. grant of the Agency for Innovation by Science and Technology [IWT/111457]; Research Foundation - Flanders [FWO/12R4315N]; European Research Council under the European Union's Seventh Framework Program (FP7)/ERC grant [279100, 294191]; Research Foundation Flanders (FWO, Belgium)	Ph.D. grant of the Agency for Innovation by Science and Technology; Research Foundation - Flanders(FWO); European Research Council under the European Union's Seventh Framework Program (FP7)/ERC grant(European Research Council (ERC)); Research Foundation Flanders (FWO, Belgium)(FWO)	MS is supported by a Ph.D. grant of the Agency for Innovation by Science and Technology (IWT/ 111457 - http://www.iwt.be/english/welcome). GK is currently financed by a postdoctoral grant of the Research Foundation - Flanders (FWO/12R4315N - http://www.fwo.be/en/). GK and LG acknowledge support by the European Research Council under the European Union's Seventh Framework Program (FP7/2007-2013)/ERC grant agreement no 279100 (http://erc.europa.eu/funding-and-grants). IP was supported by the European Research Council under the European Union's Seventh Framework Program (FP7/2007-2013)/ERC grant agreement REJOIND no 294191. SVV would like to acknowledge the Research Foundation Flanders (FWO, Belgium) for financial support under the form of a post-doctoral fellowship and a Research Grant ('Development of the ideal tissue engineering scaffold by merging state-of-the-art processing techniques', FWO Krediet aan Navorsers). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel A, 2011, TISSUE ENG PART B-RE, V17, P321, DOI [10.1089/ten.teb.2011.0230, 10.1089/ten.TEB.2011.0230]; Berneel E, 2012, J BIOMED MATER RES A, V100A, P1783, DOI 10.1002/jbm.a.34125; Berneel EM, 2012, J TISSUE ENG REGEN M, V6, P372; Buytaert JAN, 2013, J HISTOCHEM CYTOCHEM, V61, P382, DOI 10.1369/0022155413478613; DAVIS TJ, 1995, NATURE, V373, P595, DOI 10.1038/373595a0; De Bari C, 2006, ARTHRITIS RHEUM, V54, P1209, DOI 10.1002/art.21753; Desmet T, 2010, MACROMOL BIOSCI, V10, P1484, DOI 10.1002/mabi.201000147; Eniwumide JO, 2007, EUR CELLS MATER, V14, P30, DOI 10.22203/eCM.v014a03; Fei J, 2010, ANAT REC, V293, P1984, DOI 10.1002/ar.21270; Granton PV, 2008, MED PHYS, V35, P5030, DOI 10.1118/1.2987668; Hedberg EL, 2005, TISSUE ENG, V11, P1356, DOI 10.1089/ten.2005.11.1356; Jeffery NS, 2011, J BIOMECH, V44, P189, DOI 10.1016/j.jbiomech.2010.08.027; Jones AC, 2007, BIOMATERIALS, V28, P2491, DOI 10.1016/j.biomaterials.2007.01.046; Kerckhofs G, 2014, CARTILAGE, V5, P55, DOI 10.1177/1947603513501175; Kerckhofs G, 2013, EUR CELLS MATER, V25, P179, DOI 10.22203/eCM.v025a13; Kreutz C, 2009, FEBS J, V276, P923, DOI 10.1111/j.1742-4658.2008.06843.x; Lakin BA, 2013, OSTEOARTHR CARTILAGE, V21, P60, DOI 10.1016/j.joca.2012.09.007; Langer M, 2010, J MICROSC-OXFORD, V238, P230, DOI [10.1111/j.1365-2818.2009.03345.x, 10.1111/j.1365-2818.2009.03545.x]; Lusic H, 2013, CHEM REV, V113, P1641, DOI 10.1021/cr200358s; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; Nam SY, 2015, TISSUE ENG PART B-RE, V21, P88, DOI [10.1089/ten.teb.2014.0180, 10.1089/ten.TEB.2014.0180]; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Papantoniou I, 2014, TISSUE ENG PART C-ME, V20, P177, DOI [10.1089/ten.tec.2013.0041, 10.1089/ten.TEC.2013.0041]; Papantoniou I, 2013, TISSUE ENG PART C-ME, V19, P596, DOI [10.1089/ten.tec.2012.0526, 10.1089/ten.TEC.2012.0526]; Pauwels E, 2013, J MICROSC-OXFORD, V250, P21, DOI 10.1111/jmi.12013; Schulz-Mirbach T, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-63; Smith LE, 2010, MICROSC RES TECHNIQ, V73, P1123, DOI 10.1002/jemt.20859; Sonnaert M, 2017, J TISSUE ENG REGEN M, V11, P519, DOI 10.1002/term.1951; Sonnaert M, 2015, TISSUE ENG PART C-ME, V21, P519, DOI [10.1089/ten.tec.2014.0255, 10.1089/ten.TEC.2014.0255]; Van Bael S, 2011, MAT SCI ENG A-STRUCT, V528, P7423, DOI 10.1016/j.msea.2011.06.045; van Lenthe GH, 2007, BIOMATERIALS, V28, P2479, DOI 10.1016/j.biomaterials.2007.01.017; Vickerton P, 2013, J ANAT, V223, P185, DOI 10.1111/joa.12068; Voronov RS, 2013, TISSUE ENG PART C-ME, V19, P327, DOI [10.1089/ten.tec.2011.0612, 10.1089/ten.TEC.2011.0612]; Wilkins SW, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0021; Wong MD, 2012, DEVELOPMENT, V139, P3248, DOI 10.1242/dev.082016; Xie L, 2010, OSTEOARTHR CARTILAGE, V18, P65, DOI 10.1016/j.joca.2009.07.014	37	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130227	10.1371/journal.pone.0130227	http://dx.doi.org/10.1371/journal.pone.0130227			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076131	Green Submitted, Green Published, gold			2022-12-26	WOS:000356329900158
J	Tookes, H; Chanelle, D; Li, H; Khalid, R; Doblecki-Lewis, S				Tookes, Hansel; Diaz, Chanelle; Li, Hua; Khalid, Rafi; Doblecki-Lewis, Susanne			A Cost Analysis of Hospitalizations for Infections Related to Injection Drug Use at a County Safety-Net Hospital in Miami, Florida	PLOS ONE			English	Article							SOFT-TISSUE INFECTIONS; NECROTIZING FASCIITIS; NEEDLE EXCHANGE; RISK-FACTORS; BACTERIAL-INFECTIONS; SYRINGE PROGRAMS; SAN-FRANCISCO; ENDOCARDITIS; ABSCESSES; CARE	Background Infections related to injection drug use are common. Harm reduction strategies such as syringe exchange programs and skin care clinics aim to prevent these infections in injection drug users (IDUs). Syringe exchange programs are currently prohibited by law in Florida. The goal of this study was to estimate the mortality and cost of injection drug use-related bacterial infections over a 12-month period to the county safety-net hospital in Miami, Florida. Additionally, the prevalence of HIV and hepatitis C virus among this cohort of hospitalized IDUs was estimated. Methods and Findings IDUs discharged from Jackson Memorial Hospital were identified using the International Classification of Diseases, Ninth Revision, codes for illicit drug abuse and endocarditis, bacteremia or sepsis, osteomyelitis and skin and soft tissue infections (SSTIs). 349 IDUs were identified for chart abstraction and 92% were either uninsured or had publicly funded insurance. SSTIs, the most common infection, were reported in 64% of IDUs. HIV seroprevalence was 17%. Seventeen patients (4.9%) died during their hospitalization. The total cost for treatment for injection drug use-related infections to Jackson Memorial Hospital over the 12-month period was $11.4 million. Conclusions Injection drug use-related bacterial infections represent a significant morbidity for IDUs in Miami-Dade County and a substantial financial cost to the county hospital. Strategies aimed at reducing risk of infections associated with injection drug use could decrease morbidity and the cost associated with these common, yet preventable infections.	[Tookes, Hansel] Jackson Mem Hosp, Dept Internal Med, Miami, FL 33136 USA; [Diaz, Chanelle] Univ Miami, Miller Sch Med, Dept Med Educ, Miami, FL 33136 USA; [Li, Hua] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA; [Khalid, Rafi] Jackson Mem Hosp, Dept Jackson Hlth Syst Res, Miami, FL 33136 USA; [Doblecki-Lewis, Susanne] Univ Miami, Miller Sch Med, Div Infect Dis, Dept Internal Med, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami	Tookes, H (corresponding author), Jackson Mem Hosp, Dept Internal Med, Miami, FL 33136 USA.	hetookes@med.miami.edu			Infectious Diseases Society of America Medical Scholars Program; Jackson Memorial Hospital Department of Internal Medicine Resident Scholarly Activity Program	Infectious Diseases Society of America Medical Scholars Program; Jackson Memorial Hospital Department of Internal Medicine Resident Scholarly Activity Program	This work was supported by the Infectious Diseases Society of America Medical Scholars Program to HT SD, (http://www.idsociety.org/Medical_Scholars_Program/) and the Jackson Memorial Hospital Department of Internal Medicine Resident Scholarly Activity Program to HT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Hospital Directory, 2015, JACKS MEM HOSP FAC P; Belani HK, 2008, J HIV-AIDS SOC SERV, V7, P229, DOI 10.1080/15381500802307492; Binswanger IA, 2000, CLIN INFECT DIS, V30, P579, DOI 10.1086/313703; Binswanger IA, 2008, J STUD ALCOHOL DRUGS, V69, P924, DOI 10.15288/jsad.2008.69.924; Broz D, 2014, MMWR SURVEILL SUMM, V63, P1; Centers for Disease Control and Prevention, 2012, HIV SURV REP DIAGN H, V24; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P381; Chen JL, 2001, CLIN INFECT DIS, V33, P6, DOI 10.1086/320874; Cooper HLF, 2007, CLIN INFECT DIS, V45, P1200, DOI 10.1086/522176; del Giudice P, 2004, BRIT J DERMATOL, V150, P1, DOI 10.1111/j.1365-2133.2004.05607.x; Department of Health, 2013, AG LEG BILL AN HB 73; Ebright JR, 2002, INFECT DIS CLIN N AM, V16, P697, DOI 10.1016/S0891-5520(02)00017-X; Frontera JA, 2000, CLIN INFECT DIS, V30, P374, DOI 10.1086/313664; Gebo KA, 2005, JAIDS-J ACQ IMM DEF, V40, P609, DOI 10.1097/01.qai.0000171727.55553.78; Gold M, 1997, CAN MED ASSOC J, V157, P255; Gordon RJ, 2005, NEW ENGL J MED, V353, P1945, DOI 10.1056/NEJMra042823; Hall JN, 2014, DRUG ABUSE TRENDS MI, P6; Harris HW, 2002, ARCH SURG-CHICAGO, V137, P1217, DOI 10.1001/archsurg.137.11.1217; Heinzerling KG, 2006, J URBAN HEALTH, V83, P176, DOI 10.1007/s11524-005-9021-6; Holtgrave DR, 1998, J ACQ IMMUN DEF SYND, V18, pS133, DOI 10.1097/00042560-199802001-00022; Hyshka E, 2012, INT J DRUG POLICY, V23, P261, DOI 10.1016/j.drugpo.2012.03.006; Jain V, 2008, J INFECTION, V57, P132, DOI 10.1016/j.jinf.2008.05.008; Kak V, 2002, INFECT DIS CLIN N AM, V16, P681, DOI 10.1016/S0891-5520(02)00016-8; Kimura AC, 2004, CLIN INFECT DIS, V38, pE87, DOI 10.1086/383471; Kwon JA, 2012, AIDS, V26, P2201, DOI 10.1097/QAD.0b013e3283578b5d; Lloyd-Smith Elisa, 2005, Harm Reduct J, V2, P24, DOI 10.1186/1477-7517-2-24; Lloyd-Smith E, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-405; Lonergan S, 2004, J EMERG MED, V26, P47, DOI 10.1016/j.jemermed.2003.06.003; Lurie P, 1998, J ACQ IMMUN DEF SYND, V18, pS126, DOI 10.1097/00042560-199802001-00021; Marks M, 2013, J INFECTION, V66, P95, DOI 10.1016/j.jinf.2012.10.004; Micallef L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101717; Murphy EL, 2001, CLIN INFECT DIS, V33, P35, DOI 10.1086/320879; Palepu A, 2001, CAN MED ASSOC J, V165, P415; Phillips KT, 2010, AM J DRUG ALCOHOL AB, V36, P92, DOI 10.3109/00952991003592311; Saydain G, 2010, J CRIT CARE, V25, P248, DOI 10.1016/j.jcrc.2009.09.007; Simmen HP, 1995, J HAND SURG-BRIT EUR, V20B, P797, DOI 10.1016/S0266-7681(95)80050-6; Spijkerman IJB, 1996, J CLIN EPIDEMIOL, V49, P1149, DOI 10.1016/0895-4356(96)00180-1; Stein MD, 2001, DRUG ALCOHOL DEPEN, V64, P117, DOI 10.1016/S0376-8716(00)00235-0; Sweeney R, 2009, AUST NZ J PUBL HEAL, V33, P352, DOI 10.1111/j.1753-6405.2009.00407.x; Takahashi TA, 2007, J GEN INTERN MED, V22, P382, DOI 10.1007/s11606-006-0079-y; Takahashi TA, 2010, J BEHAV HEALTH SER R, V37, P508, DOI 10.1007/s11414-009-9177-z; Tempalski B, 2009, J URBAN HEALTH, V86, P132, DOI 10.1007/s11524-008-9328-1; Tookes HE, 2012, DRUG ALCOHOL DEPEN, V123, P255, DOI 10.1016/j.drugalcdep.2011.12.001; Tunkel AR, 2002, INFECT DIS CLIN N AM, V16, P589, DOI 10.1016/S0891-5520(02)00015-6; U.S. Census Bureau, 2013, MIAM DAD COUNT QUICK	45	85	86	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129360	10.1371/journal.pone.0129360	http://dx.doi.org/10.1371/journal.pone.0129360			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075888	Green Submitted, Green Published, gold			2022-12-26	WOS:000356329900066
J	Smorodinova, N; Lantova, L; Blaha, M; Melenovsky, V; Hanzelka, J; Pirk, J; Kautzner, J; Kucera, T				Smorodinova, Natalia; Lantova, Lucie; Blaha, Martin; Melenovsky, Vojtech; Hanzelka, Jan; Pirk, Jan; Kautzner, Josef; Kucera, Tomas			Bioptic Study of Left and Right Atrial Interstitium in Cardiac Patients with and without Atrial Fibrillation: Interatrial but Not Rhythm-Based Differences	PLOS ONE			English	Article							MITRAL-VALVE DISEASE; EXTRACELLULAR-MATRIX; HEART; FIBROSIS; TISSUE	One of the generally recognized factors contributing to the initiation and maintenance of atrial fibrillation (AF) is structural remodeling of the myocardium that affects both atrial cardiomyocytes as well as interstitium. The goal of this study was to characterize morphologically and functionally interstitium of atria in patients with AF or in sinus rhythm (SR) who were indicated to heart surgery. Patient population consisted of 46 subjects (19 with long-term persistent AF, and 27 in SR) undergoing coronary bypass or valve surgery. Peroperative bioptic samples of the left and the right atria were examined using immunohistochemistry to visualize and quantify collagen I, collagen III, elastin, desmin, smooth muscle actin, endothelium and Vascular Endothelial Growth Factor (VEGF). The content of interstitial elastin, collagen I, and collagen III in atrial tissue was similar in AF and SR groups. However, the right atrium was more than twofold more abundant in elastin as compared with the left atrium and similar difference was found for collagen I and III. The right atrium showed also higher VEGF expression and lower microvascular density as compared to the left atrium. No significant changes in atrial extracellular matrix fiber content, microvascular density and angiogenic signaling, attributable to AF, were found in this cohort of patients with structural heart disease. This finding suggests that interstitial fibrosis and other morphological changes in atrial tissue are rather linked to structural heart disease than to AF per se. Significant regional differences in interstitial structure between right and left atrium is a novel observation that deserves further investigation.	[Smorodinova, Natalia; Lantova, Lucie; Hanzelka, Jan; Kucera, Tomas] Charles Univ Prague, Fac Med 1, Inst Histol & Embryol, Prague, Czech Republic; [Blaha, Martin; Melenovsky, Vojtech; Kautzner, Josef] Inst Clin & Expt Med IKEM, Dept Cardiol, Prague, Czech Republic; [Pirk, Jan] Inst Clin & Expt Med IKEM, Dept Cardiovasc Surg, Prague, Czech Republic	Charles University Prague; Institute for Clinical & Experimental Medicine (IKEM); Institute for Clinical & Experimental Medicine (IKEM)	Kucera, T (corresponding author), Charles Univ Prague, Fac Med 1, Inst Histol & Embryol, Prague, Czech Republic.	tkucer@lf1.cuni.cz	Kučera, Tomáš/C-7532-2017; Smorodinova, Natalia/Q-6111-2017; Melenovsky, Vojtech/T-9422-2019; Blaha, Martin/G-5015-2015; lantova, Lucie/Q-9412-2017; Smorodinova, Natalia/AAK-6820-2020	Kučera, Tomáš/0000-0003-2134-4657; Smorodinova, Natalia/0000-0003-1211-8703; Melenovsky, Vojtech/0000-0001-8921-7078; Blaha, Martin/0000-0003-3597-6604; lantova, Lucie/0000-0002-4619-6059; Smorodinova, Natalia/0000-0003-1211-8703; Blaha, Martin/0000-0003-4626-3757	Research Program of Charles University [PRVOUK P25/LF1/2, P27/LF1/1]; Ministry of Health for Development of Research Organization [00023001]; EU Operational Program Prague -Competitiveness: project CEVKOON [CZ.2.16/3.1.00/22126]; UNCE (University research centre) [204013]; Charles University in Prague	Research Program of Charles University; Ministry of Health for Development of Research Organization; EU Operational Program Prague -Competitiveness: project CEVKOON; UNCE (University research centre); Charles University in Prague	This work was supported by the Research Program of Charles University - PRVOUK P25/LF1/2 and P27/LF1/1, Ministry of Health for Development of Research Organization 00023001 (IKEM, institutional support) and by the EU Operational Program Prague-Competitiveness: project CEVKOON (CZ.2.16/3.1.00/22126). Lucie Lantova was partially supported by UNCE (University research centre) 204013, a funding program of the Charles University in Prague. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; Anne W, 2005, CARDIOVASC RES, V67, P655, DOI 10.1016/j.cardiores.2005.04.016; Boldt A, 2004, HEART, V90, P400, DOI 10.1136/hrt.2003.015347; Darby AE, 2012, CIRCULATION, V125, P945, DOI 10.1161/CIRCULATIONAHA.111.019935; De Jong AM, 2011, CARDIOVASC RES, V89, P754, DOI 10.1093/cvr/cvq357; de Oliveira IM, 2013, CARDIOVASC PATHOL, V22, P65, DOI 10.1016/j.carpath.2012.06.001; Ferreira JP, 2015, INT J MOL SCI, V16, P3133, DOI 10.3390/ijms16023133; Fomovsky GM, 2010, J MOL CELL CARDIOL, V48, P490, DOI 10.1016/j.yjmcc.2009.08.003; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Gramley F, 2010, CARDIOVASC PATHOL, V19, P102, DOI 10.1016/j.carpath.2008.11.001; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Kostin S, 2002, CARDIOVASC RES, V54, P361, DOI 10.1016/S0008-6363(02)00273-0; Ogi H, 2010, CIRC J, V74, P1815, DOI 10.1253/circj.CJ-09-0969; Platonov PG, 2011, J AM COLL CARDIOL, V58, P2225, DOI 10.1016/j.jacc.2011.05.061; Polyakova V, 2008, J CELL MOL MED, V12, P189, DOI 10.1111/j.1582-4934.2008.00219.x; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; TILTON RG, 1979, MICROVASC RES, V18, P325, DOI 10.1016/0026-2862(79)90041-4; Wakili R, 2011, J CLIN INVEST, V121, P2955, DOI 10.1172/JCI46315; Wyse DG, 2014, J AM COLL CARDIOL, V63, P1715, DOI 10.1016/j.jacc.2014.01.023; Zhao JC, 2012, CIRC-ARRHYTHMIA ELEC, V5, P361, DOI 10.1161/CIRCEP.111.967950	20	18	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129124	10.1371/journal.pone.0129124	http://dx.doi.org/10.1371/journal.pone.0129124			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26067062	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000050
J	Pacheco-Colon, I; Washington, SD; Sprouse, C; Helman, G; Gropman, AL; VanMeter, JW				Pacheco-Colon, Ileana; Washington, Stuart D.; Sprouse, Courtney; Helman, Guy; Gropman, Andrea L.; VanMeter, John W.			Reduced Functional Connectivity of Default Mode and Set-Maintenance Networks in Ornithine Transcarbamylase Deficiency	PLOS ONE			English	Article							SUPERIOR FRONTAL GYRUS; WORKING-MEMORY; CINGULATE CORTEX; BRAIN NETWORKS; INBORN-ERRORS; ACTIVATION; COGNITION; CARRIERS; DISEASE; COMMON	Background and Purpose Ornithine transcarbamylase deficiency (OTCD) is an X-chromosome linked urea cycle disorder (UCD) that causes hyperammonemic episodes leading to white matter injury and impairments in executive functioning, working memory, and motor planning. This study aims to investigate differences in functional connectivity of two resting-state networks-default mode and set-maintenance-between OTCD patients and healthy controls. Methods Sixteen patients with partial OTCD and twenty-two control participants underwent a resting-state scan using 3T fMRI. Combining independent component analysis (ICA) and region-of-interest (ROI) analyses, we identified the nodes that comprised each network in each group, and assessed internodal connectivity. Results Group comparisons revealed reduced functional connectivity in the default mode network (DMN) of OTCD patients, particularly between the anterior cingulate cortex/medial prefrontal cortex (ACC/mPFC) node and bilateral inferior parietal lobule (IPL), as well as between the ACC/mPFC node and the posterior cingulate cortex (PCC) node. Patients also showed reduced connectivity in the set-maintenance network, especially between right anterior insula/frontal operculum (aI/fO) node and bilateral superior frontal gyrus (SFG), as well as between the right aI/fO and ACC and between the ACC and right SFG. Conclusion Internodal functional connectivity in the DMN and set-maintenance network is reduced in patients with partial OTCD compared to controls, most likely due to hyperammonemia-related white matter damage. Because several of the affected areas are involved in executive functioning, it is postulated that this reduced connectivity is an underlying cause of the deficits OTCD patients display in this cognitive domain.	[Pacheco-Colon, Ileana; Washington, Stuart D.; Gropman, Andrea L.; VanMeter, John W.] Georgetown Univ, Ctr Funct & Mol Imaging, Washington, DC 20057 USA; [Pacheco-Colon, Ileana; Washington, Stuart D.; VanMeter, John W.] Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC USA; [Sprouse, Courtney; Helman, Guy; Gropman, Andrea L.] Childrens Natl Hlth Syst, Dept Neurogenet, Washington, DC USA; [Sprouse, Courtney; Gropman, Andrea L.] George Washington Univ Hlth Sci, Washington, DC USA; [Gropman, Andrea L.] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA	Georgetown University; Georgetown University; Children's National Health System; George Washington University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Pacheco-Colon, I (corresponding author), Georgetown Univ, Ctr Funct & Mol Imaging, Washington, DC 20057 USA.	pachecoileana@gmail.com	VanMeter, John W/D-2589-2018; Helman, Guy T/C-7935-2017; Lang, Steven/AAE-8102-2021	VanMeter, John W/0000-0002-7012-5197; Helman, Guy T/0000-0002-4784-7423; Lang, Steven/0000-0003-1669-9146; Pacheco-Colon, Ileana/0000-0001-7908-8428	NIH-National Institute of Child Health and Human Development [5U54HD061221, 1KL2RR031974-01, 2P30HD040677-11]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD040677, U54HD061221] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR031974] Funding Source: NIH RePORTER	NIH-National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was completed as part of NIH-funded grants National Institute of Child Health and Human Development 5U54HD061221, 1KL2RR031974-01, and 2P30HD040677-11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Applegarth DA, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.1.e10; BATSHAW ML, 1986, J PEDIATR-US, V108, P236, DOI 10.1016/S0022-3476(86)80989-1; BATSHAW ML, 1980, NEW ENGL J MED, V302, P482, DOI 10.1056/NEJM198002283020902; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Brusilow S W, 1996, Adv Pediatr, V43, P127; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Caldovic L, 2003, HUM GENET, V112, P364, DOI 10.1007/s00439-003-0909-5; Caldovic L, 2002, BIOCHEM BIOPH RES CO, V299, P581, DOI 10.1016/S0006-291X(02)02696-7; Callicott JH, 1999, CEREB CORTEX, V9, P20, DOI 10.1093/cercor/9.1.20; Carter CS, 1995, NEUROIMAGE, V2, P264, DOI 10.1006/nimg.1995.1034; Cutini S, 2008, NEUROIMAGE, V42, P945, DOI 10.1016/j.neuroimage.2008.05.013; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Dionisi-Vici C, 2002, J PEDIATR-US, V140, P321, DOI 10.1067/mpd.2002.122394; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; du Boisgueheneuc F, 2006, BRAIN, V129, P3315, DOI 10.1093/brain/awl244; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Ford JH, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00307; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gropman AL, 2008, MOL GENET METAB, V95, P21, DOI 10.1016/j.ymgme.2008.06.003; Gropman AL, 2010, AM J NEURORADIOL, V31, P1719, DOI 10.3174/ajnr.A2122; Gropman AL, 2004, MOL GENET METAB, V81, pS58, DOI 10.1016/j.ymgme.2003.11.016; Gropman AL, 2013, HUM BRAIN MAPP, V34, P753, DOI 10.1002/hbm.21470; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Gyato K, 2004, ANN NEUROL, V55, P80, DOI 10.1002/ana.10794; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; KANG ES, 1973, J PEDIATR-US, V82, P642, DOI 10.1016/S0022-3476(73)80590-6; Kim H, 2010, NEUROIMAGE, V50, P1648, DOI 10.1016/j.neuroimage.2010.01.051; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; McCullough BA, 2000, AM J MED GENET, V93, P313, DOI 10.1002/1096-8628(20000814)93:4<313::AID-AJMG11>3.0.CO;2-M; MSALL M, 1984, NEW ENGL J MED, V310, P1500, DOI 10.1056/NEJM198406073102304; Msall M, 1988, Acta Paediatr Jpn, V30, P435; NAGATA N, 1991, AM J MED GENET, V39, P228, DOI 10.1002/ajmg.1320390226; Nelson SM, 2010, BRAIN STRUCT FUNCT, V214, P669, DOI 10.1007/s00429-010-0260-2; Nicolaides P, 2002, ARCH DIS CHILD, V86, P54, DOI 10.1136/adc.86.1.54; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Qi RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041376; Rama P, 2001, NEUROIMAGE, V13, P1090, DOI 10.1006/nimg.2001.0777; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Spreng RN, 2010, J COGNITIVE NEUROSCI, V22, P1112, DOI 10.1162/jocn.2009.21282; Sprouse C, 2014, MOL GENET METAB, V113, P136, DOI 10.1016/j.ymgme.2014.05.007; Uddin LQ, 2008, J NEUROSCI METH, V169, P249, DOI 10.1016/j.jneumeth.2007.11.031; Uddin LQ, 2013, TRENDS COGN SCI, V17, P600, DOI 10.1016/j.tics.2013.09.011; Uddin LQ, 2011, J NEUROSCI, V31, P18578, DOI 10.1523/JNEUROSCI.4465-11.2011; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Washington SD, 2014, HUM BRAIN MAPP, V35, P1284, DOI 10.1002/hbm.22252; Zhang LJ, 2012, HUM BRAIN MAPP, V33, P1384, DOI 10.1002/hbm.21295	55	1	1	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129595	10.1371/journal.pone.0129595	http://dx.doi.org/10.1371/journal.pone.0129595			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067829	Green Published, Green Submitted, gold			2022-12-26	WOS:000356100900061
J	Varela, S; Lima-Ribeiro, MS; Terribile, LC				Varela, Sara; Lima-Ribeiro, Matheus S.; Terribile, Levi Carina			A Short Guide to the Climatic Variables of the Last Glacial Maximum for Biogeographers	PLOS ONE			English	Article							MODELS	Ecological niche models are widely used for mapping the distribution of species during the last glacial maximum (LGM). Although the selection of the variables and General Circulation Models (GCMs) used for constructing those maps determine the model predictions, we still lack a discussion about which variables and which GCM should be included in the analysis and why. Here, we analyzed the climatic predictions for the LGM of 9 different GCMs in order to help biogeographers to select their GCMs and climatic layers for mapping the species ranges in the LGM. We 1) map the discrepancies between the climatic predictions of the nine GCMs available for the LGM, 2) analyze the similarities and differences between the GCMs and group them to help researchers choose the appropriate GCMs for calibrating and projecting their ecological niche models (ENM) during the LGM, and 3) quantify the agreement of the predictions for each bioclimatic variable to help researchers avoid the environmental variables with a poor consensus between models. Our results indicate that, in absolute values, GCMs have a strong disagreement in their temperature predictions for temperate areas, while the uncertainties for the precipitation variables are in the tropics. In spite of the discrepancies between model predictions, temperature variables (BIO1-BIO11) are highly correlated between models. Precipitation variables (BIO12-BIO19) show no correlation between models, and specifically, BIO14 (precipitation of the driest month) and BIO15 (Precipitation Seasonality (Coefficient of Variation)) show the highest level of discrepancy between GCMs. Following our results, we strongly recommend the use of different GCMs for constructing or projecting ENMs, particularly when predicting the distribution of species that inhabit the tropics and the temperate areas of the Northern and Southern Hemispheres, because climatic predictions for those areas vary greatly among GCMs. We also recommend the exclusion of BIO14 and BIO15 from ENMs because those variables show a high level of discrepancy between GCMs. Thus, by excluding them, we decrease the level of uncertainty of our predictions.	[Varela, Sara] Charles Univ Prague, Fac Sci, Dept Ecol, Prague, Czech Republic; [Varela, Sara] Leibniz Inst Evolut & Biodivers Sci, Museum Naturkunde, Berlin, Germany; [Lima-Ribeiro, Matheus S.; Terribile, Levi Carina] UFG, Dept Ciencias Biol, Jatai, Go, Brazil	Charles University Prague; Leibniz Institut fur Evolutions und Biodiversitatsforschung; Universidade Federal de Goias	Varela, S (corresponding author), Charles Univ Prague, Fac Sci, Dept Ecol, Prague, Czech Republic.	svarela@paleobiogeography.org	Terribile, Levi Carina/AAW-1102-2021; LIMA-RIBEIRO, MATHEUS S./H-9503-2014; Varela, Sara/J-7725-2016	Terribile, Levi Carina/0000-0001-8420-9300; LIMA-RIBEIRO, MATHEUS S./0000-0002-3322-1702; Varela, Sara/0000-0002-5756-5737	Education for Competitiveness Operational Programme (ECOP) project 'Support of establishment, development and mobility of quality research teams at the Charles University' [CZ.1.07/2.3.00/30.0022]; European Science Foundation; Czech Republic; CNPq [563727/2010-1, 473811/2013-8]; FAPEG [2012/1026.700.1086, 2012-1026.700.1086]; CNPq researcher fellowship	Education for Competitiveness Operational Programme (ECOP) project 'Support of establishment, development and mobility of quality research teams at the Charles University'; European Science Foundation(European Science Foundation (ESF)European Commission); Czech Republic(Czech Republic Government); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEG(Fundacao de Amparo a Pesquisa do Estado do Goias (FAPEG)); CNPq researcher fellowship	This paper was made possible by funding from the Education for Competitiveness Operational Programme (ECOP) project 'Support of establishment, development and mobility of quality research teams at the Charles University' (CZ.1.07/2.3.00/30.0022). SV is funded by the European Science Foundation and Czech Republic. Research projects of LCT and MSLR are supported by CNPq (processes 563727/2010-1 and 473811/2013-8) and FAPEG (2012/1026.700.1086). LCT is supported by a CNPq researcher fellowship. MSLR thanks FAPEG for financial support to his research in paleobiology (process number 2012-1026.700.1086).	Abellan P, 2011, GLOBAL ECOL BIOGEOGR, V20, P87, DOI 10.1111/j.1466-8238.2010.00572.x; [Anonymous], 2013, MAPTOOLS TOOLS READI; Barrientos R, 2014, MOL ECOL, V23, P390, DOI 10.1111/mec.12588; Collevatti RG, 2013, J BIOGEOGR, V40, P345, DOI 10.1111/jbi.12005; Daly C, 2002, CLIM RES, V22, P99, DOI 10.3354/cr022099; de Lima NE, 2014, J BIOGEOGR, V41, P673, DOI 10.1111/jbi.12269; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hartkamp A.D., 1999, NGG GIS SERIES, V99-01; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2013, RASTER GEOGRAPHIC DA; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Kohler P, 2010, QUATERNARY SCI REV, V29, P129, DOI 10.1016/j.quascirev.2009.09.026; Lima-Ribeiro MS, 2012, NAT CONSERVACAO, V10, P145, DOI 10.4322/natcon.2012.022; Lucas A., 2014, ANOTHER MULTIDIMENSI; McGuffie K., 2014, CLIMATE MODELLING PR; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Peltier WR, 2007, GEOL SOC AM SPEC PAP, V426, P5, DOI 10.1130/2007.2426(02); Pierce D, 2014, INTERFACE UNIDATA NE; Plate T., 2011, ABIND COMBINE MULTID; R Core Team, 2021, R LANGUAGE ENV STAT; Roberts DR, 2012, GLOBAL ECOL BIOGEOGR, V21, P121, DOI 10.1111/j.1466-8238.2011.00657.x; Shin SI, 2003, CLIM DYNAM, V20, P127, DOI 10.1007/s00382-002-0260-x; Svenning JC, 2011, QUATERNARY SCI REV, V30, P2930, DOI 10.1016/j.quascirev.2011.06.012; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Varela S, 2010, ZONA ARQUEOLOGICA, V13, P68; Varela S, 2011, APPL MODELOS DISTRIB; Varela S, 2014, ECOGRAPHY, V37, P1084, DOI 10.1111/j.1600-0587.2013.00441.x; Varela S, 2011, PALAEOGEOGR PALAEOCL, V310, P451, DOI 10.1016/j.palaeo.2011.07.021; Varela S, 2010, QUATERNARY SCI REV, V29, P2027, DOI 10.1016/j.quascirev.2010.04.017; Wilby RL, 2004, INTERGOVERNMENTAL PA	34	78	81	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129037	10.1371/journal.pone.0129037	http://dx.doi.org/10.1371/journal.pone.0129037			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068930	Green Published, gold, Green Submitted			2022-12-26	WOS:000356100900039
J	Xiong, HH; Huang, XQ; Li, Y; Li, JH; Xian, JF; Huang, YQ				Xiong, Huahui; Huang, Xiaoqing; Li, Yong; Li, Jianhong; Xian, Junfang; Huang, Yaqi			A Method for Accurate Reconstructions of the Upper Airway Using Magnetic Resonance Images	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; NASAL CAVITY; 3-DIMENSIONAL ANALYSIS; PHARYNGEAL COLLAPSE; ACOUSTIC RHINOMETRY; DRUG-DELIVERY; MODEL; FLOW; SURGERY; SEGMENTATION	Objective The purpose of this study is to provide an optimized method to reconstruct the structure of the upper airway (UA) based on magnetic resonance imaging (MRI) that can faithfully show the anatomical structure with a smooth surface without artificial modifications. Methods MRI was performed on the head and neck of a healthy young male participant in the axial, coronal and sagittal planes to acquire images of the UA. The level set method was used to segment the boundary of the UA. The boundaries in the three scanning planes were registered according to the positions of crossing points and anatomical characteristics using a Matlab program. Finally, the three-dimensional (3D) NURBS (Non-Uniform Rational B-Splines) surface of the UA was constructed using the registered boundaries in all three different planes. Results A smooth 3D structure of the UA was constructed, which captured the anatomical features from the three anatomical planes, particularly the location of the anterior wall of the nasopharynx. The volume and area of every cross section of the UA can be calculated from the constructed 3D model of UA. Conclusions A complete scheme of reconstruction of the UA was proposed, which can be used to measure and evaluate the 3D upper airway accurately.	[Xiong, Huahui; Huang, Xiaoqing; Li, Yong; Huang, Yaqi] Capital Med Univ, Sch Biomed Engn, Beijing, Peoples R China; [Xiong, Huahui; Huang, Xiaoqing; Li, Yong; Huang, Yaqi] Capital Med Univ, Beijing Key Lab Fundamental Res Biomech Clin Appl, Beijing, Peoples R China; [Li, Jianhong; Xian, Junfang] Capital Med Univ, Beijing Tongren Hosp, Dept Radiol, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Xian, JF (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Radiol, Beijing, Peoples R China.	cjr.xianjunfang@vip.163.com; yqhuang@ccmu.edu.cn			National Science and Technology Pillar Program of China [2012BAI05B03]; National Natural Science Foundation of China [81171422]; Key Projects in Science and Technology Program of Beijing Municipal Education Commission, China [KZ201210025022]; Beijing outstanding talent training program, China [2011D005018000009]; China postdoctoral science foundation [2011M500026]	National Science and Technology Pillar Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in Science and Technology Program of Beijing Municipal Education Commission, China; Beijing outstanding talent training program, China; China postdoctoral science foundation(China Postdoctoral Science Foundation)	YH is supported by grants from the National Science and Technology Pillar Program of China (2012BAI05B03), the National Natural Science Foundation of China (81171422), and the Key Projects in Science and Technology Program of Beijing Municipal Education Commission, China (KZ201210025022). HX is supported by a grant from the Beijing outstanding talent training program, China (2011D005018000009). JX is supported by a grant from the China postdoctoral science foundation (2011M500026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GM, 2004, J BIOMECH ENG-T ASME, V126, P604, DOI 10.1115/1.1800554; Alsufyani NA, 2012, DENTOMAXILLOFAC RAD, V41, P276, DOI 10.1259/dmfr/79433138; Chen XB, 2010, J AEROSOL MED PULM D, V23, P329, DOI 10.1089/jamp.2009.0776; Cisonni J, 2013, J BIOMECH, V46, P2504, DOI 10.1016/j.jbiomech.2013.07.007; El AS, 2011, J ORAL MAXIL SURG, V69, P2424, DOI 10.1016/j.joms.2010.11.046; Elad D, 2008, RESP PHYSIOL NEUROBI, V163, P121, DOI 10.1016/j.resp.2008.05.002; Furuhashi A, 2013, J ORAL REHABIL, V40, P582, DOI 10.1111/joor.12059; GRYMER LF, 1989, LARYNGOSCOPE, V99, P1180; Haralambidis A, 2009, AM J ORTHOD DENTOFAC, V136, P815, DOI 10.1016/j.ajodo.2008.03.020; Huang YQ, 2007, LARYNGOSCOPE, V117, P648, DOI 10.1097/MLG.0b013e318030ca55; Huang YQ, 2005, CHEST, V128, P1324, DOI 10.1378/chest.128.3.1324; Huang YQ, 2005, J APPL PHYSIOL, V99, P1138, DOI 10.1152/japplphysiol.00668.2004; Inthavong K, 2011, COMPUT METHOD BIOMEC, V14, P633, DOI 10.1080/10255842.2010.493510; Kim SK, 2013, J BIOMECH, V46, P299, DOI 10.1016/j.jbiomech.2012.11.022; Kleven M, 2005, FOOD BIOPROD PROCESS, V83, P107, DOI 10.1205/fbp.04403; Li CM, 2011, IEEE T IMAGE PROCESS, V20, P2007, DOI 10.1109/TIP.2011.2146190; Li CM, 2010, IEEE T IMAGE PROCESS, V19, P3243, DOI 10.1109/TIP.2010.2069690; Liu Y, 2009, J APPL PHYSIOL, V106, P784, DOI 10.1152/japplphysiol.90376.2008; Ma W, 1998, INT J ADV MANUF TECH, V14, P918, DOI 10.1007/BF01179082; Malhotra A, 2002, LANCET, V360, P237, DOI 10.1016/S0140-6736(02)09464-3; Malhotra A, 2002, AM J RESP CRIT CARE, V166, P1388, DOI 10.1164/rccm.2112072; Mihaescu M, 2008, ANN OTO RHINOL LARYN, V117, P303, DOI 10.1177/000348940811700411; Mitiche A, 2010, SPRINGER TOP SIGN PR, V5, P1; Mylavarapu G, 2013, J BIOMECH, V46, P1979, DOI 10.1016/j.jbiomech.2013.06.016; Mylavarapu G, 2009, J BIOMECH, V42, P1553, DOI 10.1016/j.jbiomech.2009.03.035; Schendel SA, 2014, AM J ORTHOD DENTOFAC, V146, P385, DOI 10.1016/j.ajodo.2014.01.026; Schwab RJ, 2003, AM J RESP CRIT CARE, V168, P522, DOI 10.1164/rccm.200208-866OC; Shome B, 1998, J BIOMECH ENG-T ASME, V120, P416, DOI 10.1115/1.2798009; Sievers KW, 2000, EUR J RADIOL, V33, P185, DOI 10.1016/S0720-048X(99)00142-4; Stratemann S, 2011, AM J ORTHOD DENTOFAC, V140, P607, DOI 10.1016/j.ajodo.2010.12.019; Stuck BA, 2008, SLEEP MED REV, V12, P411, DOI 10.1016/j.smrv.2007.08.009; Terheyden H, 2000, J APPL PHYSIOL, V89, P1013, DOI 10.1152/jappl.2000.89.3.1013; Tu JY, 2013, COMPUTATIONAL FLUID, P45; Wang TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095544; Wang Y, 2012, INT J NUMER METH BIO, V28, P528, DOI 10.1002/cnm.1486; Weissheimer A, 2012, AM J ORTHOD DENTOFAC, V142, P801, DOI 10.1016/j.ajodo.2012.07.015; Xu C, 2009, MED ENG PHYS, V31, P1343, DOI 10.1016/j.medengphy.2009.08.006; Zhao MY, 2013, J BIOMECH, V46, P42; Zhu JH, 2012, J BIOMECH, V45, P1992, DOI 10.1016/j.jbiomech.2012.04.027; ZINREICH SJ, 1988, J COMPUT ASSIST TOMO, V12, P1014, DOI 10.1097/00004728-198811000-00019	41	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0130186	10.1371/journal.pone.0130186	http://dx.doi.org/10.1371/journal.pone.0130186			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26066461	Green Submitted, gold, Green Published			2022-12-26	WOS:000356100900102
J	Zhao, HP; Steiger, A; Nohner, M; Ye, H				Zhao, Huiping; Steiger, Amanda; Nohner, Mitch; Ye, Hui			Specific Intensity Direct Current (DC) Electric Field Improves Neural Stem Cell Migration and Enhances Differentiation towards beta-III-Tubulin plus Neurons	PLOS ONE			English	Article							FREQUENCY ELECTROMAGNETIC-FIELDS; SPINAL-CORD-INJURY; PROGENITOR CELLS; OSTEOGENIC DIFFERENTIATION; SUBVENTRICULAR ZONE; NEUROLOGICAL RECOVERY; CALCIUM; STROKE; RAT; NEUROGENESIS	Control of stem cell migration and differentiation is vital for efficient stem cell therapy. Literature reporting electric field-guided migration and differentiation is emerging. However, it is unknown if a field that causes cell migration is also capable of guiding cell differentiation- and the mechanisms for these processes remain unclear. Here, we report that a 115 V/m direct current (DC) electric field can induce directional migration of neural precursor cells (NPCs). Whole cell patching revealed that the cell membrane depolarized in the electric field, and buffering of extracellular calcium via EGTA prevented cell migration under these conditions. Immunocytochemical staining indicated that the same electric intensity could also be used to enhance differentiation and increase the percentage of cell differentiation into neurons, but not astrocytes and oligodendrocytes. The results indicate that DC electric field of this specific intensity is capable of promoting cell directional migration and orchestrating functional differentiation, suggestively mediated by calcium influx during DC field exposure.	[Zhao, Huiping; Steiger, Amanda; Nohner, Mitch; Ye, Hui] Loyola Univ, Dept Biol, Chicago, IL 60626 USA	Loyola University Chicago	Ye, H (corresponding author), Loyola Univ, Dept Biol, Chicago, IL 60626 USA.	hye1@luc.edu			Loyola University Chicago	Loyola University Chicago	Amanda Steiger is supported by the MS program from Loyola University Chicago. Mitch Nohner is supported by the Mulcahy Scholars Program from Loyola University Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariza CA, 2010, STEM CELL REV REP, V6, P585, DOI 10.1007/s12015-010-9171-0; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Ayoob JC, 2004, J NEUROSCI, V24, P6639, DOI 10.1523/JNEUROSCI.1104-04.2004; Babona-Pilipos R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023808; Bikson M, 2001, J PHYSIOL-LONDON, V531, P181, DOI 10.1111/j.1469-7793.2001.0181j.x; Bosgraaf L, 2002, EMBO J, V21, P4560, DOI 10.1093/emboj/cdf438; Cao L, 2015, STEM CELL REV REP, V11, P75, DOI 10.1007/s12015-014-9524-1; Cao L, 2013, EMBO REP, V14, P184, DOI 10.1038/embor.2012.215; Chan AY, 1998, J CELL SCI, V111, P199; COOPER MS, 1984, P NATL ACAD SCI-BIOL, V81, P160, DOI 10.1073/pnas.81.1.160; Coulter CB, 1921, J GEN PHYSIOL, V3, P309, DOI 10.1085/jgp.3.3.309; D'Ascenzo M, 2006, EUR J NEUROSCI, V23, P935, DOI 10.1111/j.1460-9568.2006.04628.x; Erlandsson A, 2011, EXP NEUROL, V230, P48, DOI 10.1016/j.expneurol.2010.05.018; Feng JF, 2012, STEM CELLS, V30, P349, DOI 10.1002/stem.779; Gaetani R, 2009, CARDIOVASC RES, V82, P411, DOI 10.1093/cvr/cvp067; Gao RC, 2011, EUKARYOT CELL, V10, P1251, DOI 10.1128/EC.05066-11; Hess R, 2012, BIOMATERIALS, V33, P8975, DOI 10.1016/j.biomaterials.2012.08.056; Hronik-Tupaj M, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-9; Jouni FJ, 2014, DIFFERENTIATION, V87, P230, DOI 10.1016/j.diff.2014.06.001; Kang KS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.11; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Kobelt LJ, 2014, ANN BIOMED ENG, V42, P2164, DOI 10.1007/s10439-014-1058-9; Kolb B, 2007, J CEREBR BLOOD F MET, V27, P983, DOI 10.1038/sj.jcbfm.9600402; Komitova M, 2005, STROKE, V36, P1278, DOI 10.1161/01.STR.0000166197.94147.59; Kotnik T, 2006, BIOPHYS J, V90, P480, DOI 10.1529/biophysj.105.070771; Lee J, 1999, NATURE, V400, P382, DOI 10.1038/22578; Li L, 2008, STEM CELLS, V26, P2193, DOI 10.1634/stemcells.2007-1022; Li YC, 2014, STEM CELL REV REP, V10, P653, DOI 10.1007/s12015-014-9518-z; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Liu J, 2015, EXP NEUROL, V263, P113, DOI 10.1016/j.expneurol.2014.09.014; Liu Y, 2013, ACTA BIOMATER, V9, P8075, DOI 10.1016/j.actbio.2013.06.001; Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004; Matos MA, 2010, BIOTECHNOL PROGR, V26, P664, DOI 10.1002/btpr.389; McCullen SD, 2010, TISSUE ENG PART C-ME, V16, P1377, DOI [10.1089/ten.tec.2009.0751, 10.1089/ten.TEC.2009.0751]; Meng XT, 2011, EXP NEUROL, V227, P210, DOI 10.1016/j.expneurol.2010.11.002; Mycielska ME, 2004, J CELL SCI, V117, P1631, DOI 10.1242/jcs.01125; ONUMA EK, 1988, J CELL BIOL, V106, P2067, DOI 10.1083/jcb.106.6.2067; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Pavesi A, 2014, BIOTECHNOL BIOENG, V111, P1452, DOI 10.1002/bit.25201; Piacentini R, 2008, J CELL PHYSIOL, V215, P129, DOI 10.1002/jcp.21293; Postma M, 2004, EMBO REP, V5, P35, DOI 10.1038/sj.embor.7400051; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Ruff CA, 2013, J NEUROSCI, V33, P11899, DOI 10.1523/JNEUROSCI.1131-13.2013; Scarlett SS, 2009, BBA-BIOMEMBRANES, V1788, P1168, DOI 10.1016/j.bbamem.2009.02.006; SCHWAN H P, 1957, Adv Biol Med Phys, V5, P147; Small JV, 1998, BBA-MOL CELL RES, V1404, P271, DOI 10.1016/S0167-4889(98)00080-9; Spedden E, 2012, BIOPHYS J, V103, P868, DOI 10.1016/j.bpj.2012.08.005; Stroh A, 2011, STEM CELLS, V29, P78, DOI 10.1002/stem.558; Tekle E, 2005, BIOPHYS J, V89, P274, DOI 10.1529/biophysj.104.054494; Teramoto T, 2003, J CLIN INVEST, V111, P1125, DOI 10.1172/JCI200317170; Thrivikraman G, 2014, BIOMATERIALS, V35, P6219, DOI 10.1016/j.biomaterials.2014.04.018; Wehrle-Haller B, 2003, INT J BIOCHEM CELL B, V35, P39, DOI 10.1016/S1357-2725(02)00071-7; WERTH JL, 1994, J NEUROSCI, V14, P348; White JA, 2004, J BIOL CHEM, V279, P22964, DOI 10.1074/jbc.M311135200; Zhang RL, 2001, NEUROSCIENCE, V105, P33, DOI 10.1016/S0306-4522(01)00117-8	55	41	42	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129625	10.1371/journal.pone.0129625	http://dx.doi.org/10.1371/journal.pone.0129625			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068466	Green Submitted, Green Published, gold			2022-12-26	WOS:000356100900063
J	Blasi, B; Tafer, H; Tesei, D; Sterflinger, K				Blasi, Barbara; Tafer, Hakim; Tesei, Donatella; Sterflinger, Katja			From Glacier to Sauna: RNA-Seq of the Human Pathogen Black Fungus Exophiala dermatitidis under Varying Temperature Conditions Exhibits Common and Novel Fungal Response	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CIRCULAR RNA; COLD SHOCK; YEAST; DIVERSITY; ANNOTATION; ADAPTATION; PROTEIN; GENES; PHEOHYPHOMYCOSIS	Exophiala dermatitidis (Wangiella dermatitidis) belongs to the group of the so-called black yeasts. Thanks in part to its thick and strongly melanized cell walls, E. dermatitidis is extremely tolerant to various kinds of stress, including extreme pH, temperature and desiccation. E. dermatitidis is also the agent responsible for various severe illnesses in humans, such as pneumonia and keratitis, and might lead to fatal brain infections. Due to its association with the human environment, its poly-extremophilic lifestyle and its pathogenicity in humans, E. dermatitidis has become an important model organism. In this study we present the functional analysis of the transcriptional response of the fungus at 1 degrees C and 45 degrees C, in comparison with that at 37 degrees C, for two different exposition times, i.e. 1 hour and 1 week. At 1 degrees C, E. dermatitidis uses a large repertoire of tools to acclimatize, such as lipid membrane fluidization, trehalose production or cytoskeleton rearrangement, which allows the fungus to remain metabolically active. At 45 degrees C, the fungus drifts into a replicative state and increases the activity of the Golgi apparatus. As a novel finding, our study provides evidence that, apart from the protein coding genes, non-coding RNAs, circular RNAs as well as fusion-transcripts are differentially regulated and that the function of the fusion-transcripts can be related to the corresponding temperature condition. This work establishes that E. dermatitidis adapts to its environment by modulating coding and non-coding gene transcription levels and through the regulation of chimeric and circular RNAs.	[Blasi, Barbara; Tafer, Hakim; Tesei, Donatella; Sterflinger, Katja] Univ Nat Resources & Life Sci, Dept Biotechnol, VIBT Extremophile Ctr, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna	Blasi, B (corresponding author), Univ Nat Resources & Life Sci, Dept Biotechnol, VIBT Extremophile Ctr, Vienna, Austria.	barbara.blasi@boku.ac.at	TESEI, Donatella/AAQ-3690-2021	Tesei, Donatella/0000-0002-3247-066X; Blasi, Barbara/0000-0002-3776-6363; Sterflinger, Katja/0000-0002-0296-6728; Tafer, Hakim/0000-0002-6252-9802	FWF (Fonds zur Forderung der wissenschaftlichen Forschung) [FWF P 24206-B16]; Austrian Science Fund (FWF) [P 24206] Funding Source: researchfish	FWF (Fonds zur Forderung der wissenschaftlichen Forschung)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by FWF (Fonds zur Forderung der wissenschaftlichen Forschung) Grant number FWF P 24206-B16. http://www.fwf.ac.at/	Aguilera J, 2007, FEMS MICROBIOL REV, V31, P327, DOI 10.1111/j.1574-6976.2007.00066.x; Al-Fageeh MB, 2006, BIOCHEM J, V397, P247, DOI 10.1042/BJ20060166; Awan AR, 2013, P NATL ACAD SCI USA, V110, P12762, DOI 10.1073/pnas.1218353110; Barria C, 2013, MICROBIOL-SGM, V159, P2437, DOI 10.1099/mic.0.052209-0; Bartschat S, 2014, BIOINFORMATICS, V30, P115, DOI 10.1093/bioinformatics/btt604; Branda E, 2010, FEMS MICROBIOL ECOL, V72, P354, DOI 10.1111/j.1574-6941.2010.00864.x; Carlson M, 2014, USE GOSTATS CATEGORY, P1; Cerqueira GC, 2014, NUCL ACIDS RES, V42; Chen ZH, 2014, G3-GENES GENOM GENET, V4, P561, DOI 10.1534/g3.113.009241; Choudhury RR, 2005, BIOCHEM SOC SYMP, V72, P31, DOI 10.1042/bss0720031; D'Arcangelo JG, 2013, BBA-MOL CELL RES, V1833, P2464, DOI 10.1016/j.bbamcr.2013.02.003; Dadachova E, 2008, CURR OPIN MICROBIOL, V11, P525, DOI 10.1016/j.mib.2008.09.013; Dahlsten E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089958; Danan M, 2012, NUCLEIC ACIDS RES, V40, P3131, DOI 10.1093/nar/gkr1009; De Hoog G. S., 2000, ATLAS CLIN FUNGI; Dieci G, 2009, GENOMICS, V94, P83, DOI 10.1016/j.ygeno.2009.05.002; Dogen A, 2013, MED MYCOL, V51, P493, DOI 10.3109/13693786.2012.738313; Farrell AD, 2008, ANN BOT-LONDON, V102, P287, DOI 10.1093/aob/mcn091; Feofilova EP, 2000, MICROBIOLOGY+, V69, P509, DOI 10.1007/BF02756800; Goff L, 2012, CUMMERBUND ANAL EXPL; Gostincar C, 2011, FUNGAL BIOL-UK, V115, P1008, DOI 10.1016/j.funbio.2011.03.004; GRABOWSKI PJ, 1981, CELL, V23, P467, DOI 10.1016/0092-8674(81)90142-2; Hageskal G, 2006, APPL ENVIRON MICROB, V72, P7586, DOI 10.1128/AEM.01628-06; Hamada N, 2010, BIOCONTROL SCI, V15, P51, DOI 10.4265/bio.15.51; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; Heinrichs G, 2013, MYCOPATHOLOGIA, V175, P399, DOI 10.1007/s11046-013-9619-2; Heinrichs G, 2013, MYCOPATHOLOGIA, V175, P387, DOI 10.1007/s11046-013-9618-3; Hoffmann S, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r34; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Hurry V, 2000, PLANT J, V24, P383, DOI 10.1046/j.1365-313x.2000.00888.x; Iyer S, 1998, PLANT PHYSIOL, V116, P203, DOI 10.1104/pp.116.1.203; Jara P, 2010, J NEUROENDOCRINOL, V22, P979, DOI 10.1111/j.1365-2826.2010.02040.x; Jawdekar GW, 2008, BBA-GENE REGUL MECH, V1779, P295, DOI 10.1016/j.bbagrm.2008.04.001; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kondori N, 2014, J CYST FIBROS, V13, P391, DOI 10.1016/j.jcf.2013.12.007; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lin JQ, 2013, FUNGAL GENET BIOL, V56, P78, DOI 10.1016/j.fgb.2013.04.007; Lopez-Malo M, 2014, BIOTECHNOL PROGR, V30, P776, DOI 10.1002/btpr.1915; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luo YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058547; Matos T, 2002, MYCOSES, V45, P373, DOI 10.1046/j.1439-0507.2002.00779.x; Matos T, 2003, ANTON LEEUW INT J G, V83, P293, DOI 10.1023/A:1023373329502; Moore A, 1997, CYTOTECHNOLOGY, V23, P47, DOI 10.1023/A:1007919921991; Morgan M, 2007, INTRO GSEABASE, P1; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; NISHIMURA K, 1987, MYCOPATHOLOGIA, V97, P17, DOI 10.1007/BF00437326; Nishimura K, 1998, IFM LIST PATHOG FUNG; Nitsche A, 2014, J EXP ZOOL PART B, V322, P342, DOI 10.1002/jez.b.22542; Novodvorska M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-246; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Core Team, 2014, R LANG ENV STAT COMP, DOI [10.1016/j.jneumeth.2014.06.019, DOI 10.1016/J.JNEUMETH.2014.06.019]; Randau L, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r63; Reinisch KM, 2007, CURR OPIN STRUC BIOL, V17, P209, DOI 10.1016/j.sbi.2007.03.012; Robertson KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048674; Roth Z, 2005, REPRODUCTION, V129, P235, DOI 10.1530/rep.1.00394; Ruibal Constantino, 2005, Mycological Progress, V4, P23, DOI 10.1007/s11557-006-0107-7; Salgia SR, 2003, RNA, V9, P319, DOI 10.1261/rna.2118203; Seim I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3212; Selbmann L, 2005, STUD MYCOL, P1; Selbmann L, 2008, STUD MYCOL, P1, DOI 10.3114/sim.2008.61.01; Sert HB, 2007, ANTON LEEUW INT J G, V91, P217, DOI 10.1007/s10482-006-9111-9; Somer L, 2002, CELL STRESS CHAPERON, V7, P47, DOI 10.1379/1466-1268(2002)007<0047:TECCIA>2.0.CO;2; Sood S, 2014, INDIAN J MED MICROBI, V32, P188, DOI 10.4103/0255-0857.129830; Sterflinger K, 2006, BIODIVERSITY AND ECOPHYSIOLOGY OF YEASTS, P501, DOI 10.1007/3-540-30985-3_20; Sterflinger K, 2000, GEOMICROBIOL J, V17, P97, DOI 10.1080/01490450050023791; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Takagi H, 1997, APPL MICROBIOL BIOT, V47, P405, DOI 10.1007/s002530050948; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell Cole, 2012, NAT PROTOC, V7, P562, DOI [10.1038/nprot.2012.016, DOI 10.1038/NPROT.2012.016]; Vaz ABM, 2011, BRAZ J MICROBIOL, V42, P937, DOI [10.1590/S1517-83822011000300012, 10.1590/S1517-838220110003000012]; Vicente VA, 2014, FUNGAL DIVERS, V65, P47, DOI 10.1007/s13225-013-0246-5; Wang PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090859; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Zakharova K, 2013, MYCOPATHOLOGIA, V175, P537, DOI 10.1007/s11046-012-9592-1; Zalar P, 2011, FUNGAL BIOL-UK, V115, P997, DOI 10.1016/j.funbio.2011.04.007	77	22	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0127103	10.1371/journal.pone.0127103	http://dx.doi.org/10.1371/journal.pone.0127103			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061625	gold, Green Submitted, Green Published			2022-12-26	WOS:000355979500025
J	Bransburg-Zabary, S; Virozub, A; Mimouni, FB				Bransburg-Zabary, Sharron; Virozub, Alexander; Mimouni, Francis B.			Human Milk Warming Temperatures Using a Simulation of Currently Available Storage and Warming Methods	PLOS ONE			English	Article							BREAST-MILK; INFANTS; STABILITY; FORTIFIER; BANKING; PROTEIN; GROWTH	Human milk handling guidelines are very demanding, based upon solid scientific evidence that handling methods can make a real difference in infant health and nutrition. Indeed, properly stored milk maintains many of its unique qualities and continues to be the second and third best infant feeding alternatives, much superior to artificial feeding. Container type and shape, mode of steering, amount of air exposure and storage temperature may adversely affect milk stability and composition. Heating above physiological temperatures significantly impacts nutritional and immunological properties of milk. In spite of this knowledge, there are no strict guidelines regarding milk warming. Human milk is often heated in electrical-based bottle warmers that can exceed 80 degrees C, a temperature at which many beneficial human milk properties disappear. High temperatures can also induce fat profile variations as compared with fresh human milk. In this manuscript we estimate the amount of damage due to overheating during warming using a heat flow simulation of a regular water based bottle warmer. To do so, we carried out a series of warming simulations which provided us with dynamic temperature fields within bottled milk. We simulated the use of a hot water-bath at 80 degrees C to heat bottled refrigerated milk (60ml and 178 ml) to demonstrate that large milk portions are overheated (above 40 degrees C). It seems that the contemporary storage method (upright feeding tool, i.e. bottle) and bottle warming device, are not optimize to preserve the unique properties of human milk. Health workers and parents should be aware of this problem especially when it relates to sick neonates and preemies that cannot be directly fed at the breast.	[Bransburg-Zabary, Sharron] Nanobebe LTD, IL-7239 Tel Aviv, Israel; [Virozub, Alexander] Technion Israel Inst Technol, Dept Chem Engn, IL-32000 Haifa, Israel; [Mimouni, Francis B.] Shaare Tzedek Med Ctr, Jerusalem, Israel	Technion Israel Institute of Technology; Hebrew University of Jerusalem; Shaare Zedek Medical Center	Bransburg-Zabary, S (corresponding author), Nanobebe LTD, IL-7239 Tel Aviv, Israel.	S.Zabary@nanobebe.com			nanobebe LTD.	nanobebe LTD.	nanobebe LTD., provided support in the form of a salary for author SBZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams SA, 2014, BREASTFEED MED, V9, P281, DOI 10.1089/bfm.2014.0024; Ahrabi AF, 2013, EARLY HUM DEV, V89, pS51, DOI 10.1016/j.earlhumdev.2013.08.006; Ankrah NA, 2000, J TROP PEDIATRICS, V46, P111, DOI 10.1093/tropej/46.2.111; [Anonymous], 2002, FIFTY FIFTY WORLD HE; ATKINSON SA, 1981, J PEDIATR-US, V99, P617, DOI 10.1016/S0022-3476(81)80275-2; Baby Bottle Museum, 2011, THE HISTORY OF BOTTL; Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002; Bartick M, 2010, PEDIATRICS, V125, pE1048, DOI 10.1542/peds.2009-1616; BJORKSTEN B, 1980, BMJ-BRIT MED J, V281, P765, DOI 10.1136/bmj.281.6243.765; Brown F, 2008, BURNS, V34, P648, DOI 10.1016/j.burns.2007.09.012; Cacho N, 2014, ADV NUTR, V5, P114, DOI 10.3945/an.113.004820; Chan Gary M, 2003, J Perinatol, V23, P620, DOI 10.1038/sj.jp.7211003; Chan GM, 2007, BREASTFEED MED, V2, P205, DOI 10.1089/bfm.2007.0015; Czank C, 2009, PEDIATR RES, V66, P374, DOI 10.1203/PDR.0b013e3181b4554a; Donovan S. M., 2008, Nutrition in pediatrics: basic science and clinical applications, P341; Douglas-Escobar M, 2013, JAMA PEDIATR, V167, P374, DOI 10.1001/jamapediatrics.2013.497; Dumm M, 2013, ADV NEONAT CARE, V13, P279, DOI 10.1097/ANC.0b013e31829d8c3a; Eidelman AI, 2012, PEDIATRICS, V129, pE827, DOI 10.1542/peds.2011-3552; Fox PF, 1998, DAIRY CHEMISTRY AND; Glenn E, 2002, THE PHYSICS FACTBOOK; Gonzales I, 1995, Neonatal Netw, V14, P39; Hamosh M, 1997, J PEDIATR GASTR NUTR, V24, P38, DOI 10.1097/00005176-199701000-00010; HAMOSH M, 1987, BIOL NEONATE, V52, P50; Hamosh M, 1996, PEDIATRICS, V97, P492; Handa D, 2014, J PERINATOL, V34, P863, DOI 10.1038/jp.2014.113; Handa D, 2013, PEDIATR CLIN N AM, V60, P1, DOI 10.1016/j.pcl.2012.10.004; Igumbor E. O., 2000, Central African Journal of Medicine, V46, P247; Jelen P, 1997, TRENDS FOOD SCI TECH, V3, P428; Jones F, 2011, BEST PRACTICE FOR EX; Jones F, 2006, BEST PRACTICE FOR EX; LAVINE M, 1987, J PEDIATR GASTR NUTR, V6, P769, DOI 10.1097/00005176-198709000-00019; Lawrence R, 2011, BREASTFEEDING FOR TH; Lawrence RA, 2001, ADV NUTR RES, V10, P389; Lessaris KJ, 2000, BIOL NEONATE, V77, P156, DOI 10.1159/000014210; Meinzen-Derr J, 2009, J PERINATOL, V29, P57, DOI 10.1038/jp.2008.117; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Penn AH, 2012, PEDIATR RES, V72, P560, DOI 10.1038/pr.2012.125; QUAN R, 1994, CLIN PEDIATR, V33, P325, DOI 10.1177/000992289403300602; Riordan J, 2010, BREASTFEEDING AND TH; Silvestre D, 2006, BRIT J BIOMED SCI, V63, P59, DOI 10.1080/09674845.2006.11732721; Stevens EE, 2009, J PERINAT EDUC, V18, P32, DOI 10.1624/105812409X426314; The Academy of Breastfeeding Medicine Protocol Committee, 2010, ABM CLINICAL PROTOCO; WARDELL JM, 1984, PEDIATR RES, V18, P382, DOI 10.1203/00006450-198404000-00017; Welty J, 2009, FUNDAMENTALS OF MOME; WILLIAMSON S, 1978, ARCH DIS CHILD, V53, P555, DOI 10.1136/adc.53.7.555	45	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0128806	10.1371/journal.pone.0128806	http://dx.doi.org/10.1371/journal.pone.0128806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061694	gold, Green Published, Green Submitted			2022-12-26	WOS:000355979500098
J	Zhang, YT; Liu, J; Zhang, JZ; Liu, HB; Liu, S; Zhai, LM; Wang, HY; Lei, QL; Ren, TZ; Yin, CB				Zhang, Yitao; Liu, Jian; Zhang, Jizong; Liu, Hongbin; Liu, Shen; Zhai, Limei; Wang, Hongyuan; Lei, Qiuliang; Ren, Tianzhi; Yin, Changbin			Row Ratios of Intercropping Maize and Soybean Can Affect Agronomic Efficiency of the System and Subsequent Wheat	PLOS ONE			English	Article							CROPPING SYSTEMS; INTERSPECIFIC INTERACTIONS; NITROGEN-FIXATION; YIELD; GROWTH; SOLE; PRODUCTIVITY; AGRICULTURE; WHEAT/MAIZE; COMPETITION	Intercropping is regarded as an important agricultural practice to improve crop production and environmental quality in the regions with intensive agricultural production, e.g., northern China. To optimize agronomic advantage of maize (Zea mays L.) and soybean (Glycine max L.) intercropping system compared to monoculture of maize, two sequential experiments were conducted. Experiment 1 was to screening the optimal cropping system in summer that had the highest yields and economic benefits, and Experiment 2 was to identify the optimum row ratio of the intercrops selected from Experiment 1. Results of Experiment 1 showed that maize intercropping with soybean (maize parallel to soybean) was the optimal cropping system in summer. Compared to conventional monoculture of maize, maize parallel to soybean had significant advantage in yield, economy, land utilization ratio and reducing soil nitrate nitrogen (N) accumulation, as well as better residual effect on the subsequent wheat (Triticum aestivum L.) crop. Experiment 2 showed that intercropping systems reduced use of N fertilizer per unit land area and increased relative biomass of intercropped maize, due to promoted photosynthetic efficiency of border rows and N utilization during symbiotic period. Intercropping advantage began to emerge at tasseling stage after N topdressing for maize. Among all treatments with different row ratios, alternating four maize rows with six soybean rows (4M:6S) had the largest land equivalent ratio (1.30), total N accumulation in crops (258 kg ha(-1)), and economic benefit (3,408 USD ha(-1)). Compared to maize monoculture, 4M:6S had significantly lower nitrate-N accumulation in soil both after harvest of maize and after harvest of the subsequent wheat, but it did not decrease yield of wheat. The most important advantage of 4M:6S was to increase biomass of intercropped maize and soybean, which further led to the increase of total N accumulation by crops as well as economic benefit. In conclusion, alternating four maize rows with six soybean rows was the optimum row ratio in maize parallel to soybean system, though this needs to be further confirmed by pluri-annual trials.	[Zhang, Yitao; Zhang, Jizong; Liu, Hongbin; Liu, Shen; Zhai, Limei; Wang, Hongyuan; Lei, Qiuliang; Yin, Changbin] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Key Lab Nonpoint Source Pollut Control, Minist Agr, Beijing 100081, Peoples R China; [Liu, Jian] USDA ARS, Pasture Syst & Watershed Management Res Unit, University Pk, PA 16802 USA; [Ren, Tianzhi] Agroenvironm Protect Inst, Minist Agr, Tianjin 300191, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs; United States Department of Agriculture (USDA); Chinese Academy of Agricultural Sciences; Agro-Environmental Protection Institute, CAAS; Ministry of Agriculture & Rural Affairs	Zhang, JZ (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Key Lab Nonpoint Source Pollut Control, Minist Agr, Beijing 100081, Peoples R China.	zhangjizong@caas.cn; rentianzhi@caas.cn	Liu, Jian/P-4050-2014	Liu, Jian/0000-0003-4199-1296	Special Fund for Agro-scientific Research in the Public Interest from the Ministry of Agriculture, China [201003014, 200903011]	Special Fund for Agro-scientific Research in the Public Interest from the Ministry of Agriculture, China	This study was funded by the Special Fund for Agro-scientific Research in the Public Interest from the Ministry of Agriculture, China (201003014, 200903011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergkvist G, 2011, FIELD CROP RES, V120, P292, DOI 10.1016/j.fcr.2010.11.001; Betencourt E, 2012, SOIL BIOL BIOCHEM, V46, P181, DOI 10.1016/j.soilbio.2011.11.015; Blumenberg M, 2013, BIOGEOSCIENCES, V10, P2725, DOI 10.5194/bg-10-2725-2013; Caviglia OP, 2011, AGRON J, V103, P1081, DOI 10.2134/agronj2011.0019; Chen W, 2012, CHINA AGR ECON REV, V4, P499, DOI 10.1108/17561371211284849; Corre-Hellou G, 2006, PLANT SOIL, V282, P195, DOI 10.1007/s11104-005-5777-4; Fan FL, 2006, PLANT SOIL, V283, P275, DOI 10.1007/s11104-006-0019-y; Fan YZ, 2011, PHOTOSYNTHETICA, V49, P112, DOI 10.1007/s11099-011-0016-0; Jannoura R, 2014, EUR J AGRON, V52, P259, DOI 10.1016/j.eja.2013.09.001; Ju XT, 2006, ENVIRON POLLUT, V143, P117, DOI 10.1016/j.envpol.2005.11.005; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Lesoing GW, 1999, AGRON J, V91, P807, DOI 10.2134/agronj1999.915807x; Li CJ, 2011, PLANT SOIL, V342, P221, DOI 10.1007/s11104-010-0686-6; Li L, 2001, FIELD CROP RES, V71, P173, DOI 10.1016/S0378-4290(01)00157-5; Li L, 2001, FIELD CROP RES, V71, P123, DOI 10.1016/S0378-4290(01)00156-3; Li QZ, 2011, PLANT SOIL, V339, P147, DOI 10.1007/s11104-010-0561-5; Li YH, 2008, THEOR APPL GENET, V117, P857, DOI 10.1007/s00122-008-0825-0; Li YY, 2009, PLANT SOIL, V323, P295, DOI 10.1007/s11104-009-9938-8; Lithourgidis AS, 2011, EUR J AGRON, V34, P287, DOI 10.1016/j.eja.2011.02.007; Liu TD, 2012, PHOTOSYNTHETICA, V50, P215, DOI 10.1007/s11099-012-0011-0; Lv Y, 2014, CROP SCI, V54, P914, DOI 10.2135/cropsci2013.06.0403; Ma KF, 2012, TREE GENET GENOMES, V8, P1407, DOI 10.1007/s11295-012-0527-2; Mao LL, 2014, FIELD CROP RES, V155, P67, DOI 10.1016/j.fcr.2013.09.021; Midega CAO, 2014, FIELD CROP RES, V155, P144, DOI 10.1016/j.fcr.2013.09.012; Neugschwandtner RW, 2014, FIELD CROP RES, V155, P159, DOI 10.1016/j.fcr.2013.09.010; Olasantan FO, 1998, J AGR SCI-CAMBRIDGE, V131, P293, DOI 10.1017/S0021859698005711; Paltridge NG, 2014, AGRON J, V106, P337, DOI 10.2134/agronj2013.0411; Perez DV, 2001, COMMUN SOIL SCI PLAN, V32, P295, DOI 10.1081/CSS-100103008; Pietsch D, 2012, GEODERMA, V185, P48, DOI 10.1016/j.geoderma.2012.03.027; Prasad RB, 2005, EXP AGR, V41, P365, DOI 10.1017/S0014479705002693; Qin AZ, 2013, FIELD CROP RES, V144, P1, DOI 10.1016/j.fcr.2012.12.005; Ramesh P, 2002, J AGRON CROP SCI, V188, P81, DOI 10.1046/j.1439-037X.2002.00538.x; TARIAH NM, 1985, FIELD CROP RES, V12, P81, DOI 10.1016/0378-4290(85)90055-3; Thierfelder C, 2012, FIELD CROP RES, V137, P237, DOI 10.1016/j.fcr.2012.08.017; Wu KX, 2014, AGR ECOSYST ENVIRON, V188, P147, DOI 10.1016/j.agee.2014.02.026; Wu KX, 2012, FIELD CROP RES, V139, P63, DOI 10.1016/j.fcr.2012.10.002; Xia HY, 2013, FIELD CROP RES, V154, P53, DOI 10.1016/j.fcr.2013.07.011; Zhang F, 2004, PLANT SOIL, V260, P89, DOI 10.1023/B:PLSO.0000030192.15621.20; Zhang FS, 2003, PLANT SOIL, V248, P305, DOI 10.1023/A:1022352229863; Zhang GG, 2011, FIELD CROP RES, V124, P66, DOI 10.1016/j.fcr.2011.06.006; Zhang L, 2008, PLANT SOIL, V303, P55, DOI 10.1007/s11104-007-9442-y; Zhang YY, 2012, J ENVIRON SCI, V24, P160, DOI 10.1016/S1001-0742(10)60594-3; Zuo YM, 2008, PLANT SOIL, V306, P23, DOI 10.1007/s11104-007-9484-1	43	44	53	5	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129245	10.1371/journal.pone.0129245	http://dx.doi.org/10.1371/journal.pone.0129245			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061566	Green Published, gold, Green Submitted			2022-12-26	WOS:000355979500133
J	Gwiazda, K; Bonifacio, G; Vullo, S; Kellenberger, S				Gwiazda, Karolina; Bonifacio, Gaetano; Vullo, Sabrina; Kellenberger, Stephan			Extracellular Subunit Interactions Control Transitions between Functional States of Acid-sensing Ion Channel 1a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODULATION; MEMBRANE; NEURONS; COMPLEX; PROTONS; SITES; BRAIN	Acid-sensingion channels(ASICs) are neuronal, voltage-independent Na+ channels that are transiently activated by extracellular acidification. They are involved in pain sensation, the expression of fear, and in neurodegeneration after ischemic stroke. Our study investigates the role of extracellular subunit interactions in ASIC1a function. We identified two regions involved in critical intersubunit interactions. First, formation of an engineered disulfide bond between the palm and thumb domains leads to partial channel closure. Second, linking Glu-235 of a finger loop to either one of two different residues of the knuckle of a neighboring subunit opens the channel at physiological pH or disrupts its activity. This suggests that one finger-knuckle disulfide bond (E235C/K393C) sets the channel in an open state, whereas the other (E235C/Y389C) switches the channel to a non-conducting state. Voltage-clamp fluorometry experiments indicate that both the finger loop and the knuckle move away from the beta-ball residue Trp-233 during acidification and subsequent desensitization. Together, these observations reveal that ASIC1a opening is accompanied by a distance increase between adjacent thumb and palm domains as well as a movement of Glu-235 relative to the knuckle helix. Our study identifies subunit interactions in the extracellular loop and shows that dynamic changes of these interactions are critical for normal ASIC function.	[Gwiazda, Karolina; Bonifacio, Gaetano; Vullo, Sabrina; Kellenberger, Stephan] Univ Lausanne, Dept Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland	University of Lausanne	Kellenberger, S (corresponding author), Univ Lausanne, Dept Pharmacol & Toxicol, Rue Bugnon 27, CH-1005 Lausanne, Switzerland.	Stephan.Kellenberger@unil.ch		Kellenberger, Stephan/0000-0003-1755-6198	Swiss National Science Foundation [13003A_153419]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grant 13003A_153419 (to S. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams CM, 1999, J BIOL CHEM, V274, P15500, DOI 10.1074/jbc.274.22.15500; Alijevic O, 2012, J BIOL CHEM, V287, P36059, DOI 10.1074/jbc.M112.360487; Baconguis I, 2014, CELL, V156, P717, DOI 10.1016/j.cell.2014.01.011; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Bartoi T, 2014, P NATL ACAD SCI USA, V111, P8281, DOI 10.1073/pnas.1324060111; Bonifacio G, 2014, J GEN PHYSIOL, V143, P105, DOI 10.1085/jgp.201311053; Chen XM, 2007, J PHYSIOL-LONDON, V579, P657, DOI 10.1113/jphysiol.2006.120733; Cho JH, 2007, AM J PHYSIOL-CELL PH, V292, pC2161, DOI 10.1152/ajpcell.00598.2006; Chu XP, 2006, J NEUROSCI, V26, P5329, DOI 10.1523/JNEUROSCI.0938-06.2006; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Hill, 2001, ION CHANNELS EXCITAB, P441; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kellenberger S, 2015, PHARMACOL REV, V67, P1, DOI 10.1124/pr.114.009225; KLEYMAN TR, 1988, J MEMBRANE BIOL, V105, P1, DOI 10.1007/BF01871102; Krauson AJ, 2013, J BIOL CHEM, V288, P34375, DOI 10.1074/jbc.M113.504324; KRISHTAL OA, 1981, NEUROSCIENCE, V6, P2599, DOI 10.1016/0306-4522(81)90105-6; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Liechti LA, 2010, J BIOL CHEM, V285, P16315, DOI 10.1074/jbc.M109.092015; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Pantazis A, 2012, J GEN PHYSIOL, V140, P207, DOI 10.1085/jgp.201210807; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Roy S, 2013, FASEB J, V27, P5034, DOI 10.1096/fj.13-230680; Vukicevic M, 2006, J BIOL CHEM, V281, P714, DOI 10.1074/jbc.M510472200; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Wemmie JA, 2013, NAT REV NEUROSCI, V14, P461, DOI 10.1038/nrn3529; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zha XM, 2009, P NATL ACAD SCI USA, V106, P3573, DOI 10.1073/pnas.0813402106	32	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17956	17966		10.1074/jbc.M115.641688	http://dx.doi.org/10.1074/jbc.M115.641688			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26070563	Green Published, hybrid			2022-12-26	WOS:000358511700029
J	Jinadasa, T; Josephson, CB; Boucher, A; Orlowski, J				Jinadasa, Tushare; Josephson, Colin B.; Boucher, Annie; Orlowski, John			Determinants of Cation Permeation and Drug Sensitivity in Predicted Transmembrane Helix 9 and Adjoining Exofacial Re-entrant Loop 5 of Na+/H+ Exchanger NHE1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-HYDROGEN EXCHANGE; CELL-VOLUME REGULATION; NA-H EXCHANGE; FUNCTIONAL-CHARACTERIZATION; TARGETED DISRUPTION; PH REGULATION; STEADY-STATE; PDGFR-ALPHA; SEGMENT-IV; INHIBITION	Mammalian Na+/H+ exchangers (NHEs) regulate numerous physiological processes and are involved in the pathogenesis of several diseases, including tissue ischemia and reperfusion injuries, cardiac hypertrophy and failure, and cancer progression. Hence, NHEs are being targeted for pharmaceutical-based clinical therapies, but pertinent information regarding the structural elements involved in cation translocation and drug binding remains incomplete. Molecular manipulations of the prototypical NHE1 isoform have implicated several predicted membrane-spanning (M) helices, most notably M4, M9, and M11, as important determinants of cation permeation and drug sensitivity. Here, we have used substituted-cysteine accessibility mutagenesis and thiol-modifying methanethiosulfonate (MTS) reagents to further probe the involvement of evolutionarily conserved sites withinM9(residues 342-363) and the adjacent exofacial re-entrant loop 5 between M9 and M10 (EL5; residues 364-415) of a cysteine-less variant of rat NHE1 on its kinetic and pharmacological properties. MTS treatment significantly reduced the activity of mutants containing substitutions within M9 (H353C, S355C, and G356C) and EL5 (G403C and S405C). In the absence of MTS, mutants S355C, G403C, and S405C showed modest to significant decreases in their apparent affinities for Na-o(+) and/or H-i(+). In addition, mutations Y370C and E395C within EL5, whereas failing to confer sensitivity to MTS, nevertheless, reduced the affinity for Na-o(+), but not for H-i(+). The Y370C mutant also exhibited higher affinity for ethylisopropylamiloride, a competitive antagonist of Na-o(+) transport. Collectively, these results further implicate helix M9 and EL5 of NHE1 as important elements involved in cation transport and inhibitor sensitivity, which may inform rational drug design.	[Jinadasa, Tushare; Josephson, Colin B.; Boucher, Annie; Orlowski, John] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Josephson, Colin B.] Univ Calgary, Foothills Med Ctr, Div Clin Neurosci, Calgary, AB T2N 2T9, Canada	McGill University; University of Calgary	Orlowski, J (corresponding author), Bellini Life Sci Bldg,Rm 166,3649 Promenade Sir W, Montreal, PQ H3G 0B1, Canada.	john.orlowski@mcgill.ca		Orlowski, John/0000-0001-7371-175X	Canadian Institutes for Health Research [MOP-11221, MOP-111191]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes for Health Research Grants MOP-11221 and MOP-111191 (to J. O.). The authors declare that they have no conflicts of interest with the contents of this article.	Aharonovitz O, 2000, J CELL BIOL, V150, P213, DOI 10.1083/jcb.150.1.213; Amith SR, 2013, CANCER RES, V73, P1259, DOI 10.1158/0008-5472.CAN-12-4031; Ayoub IM, 2003, CIRCULATION, V107, P1804, DOI 10.1161/01.CIR.0000058704.45646.0D; BELIVEAU R, 1988, BIOCHEM BIOPH RES CO, V152, P484, DOI 10.1016/S0006-291X(88)80739-3; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Cengiz P, 2011, ANTIOXID REDOX SIGN, V14, P1803, DOI 10.1089/ars.2010.3468; Chahine M, 2005, J MOL CELL CARDIOL, V38, P571, DOI 10.1016/j.yjmcc.2005.01.003; Chaitman BR, 2003, J CARDIAC SURG, V18, P13, DOI 10.1046/j.1540-8191.18.s1.3.x; Chiamvimonvat N, 1996, NEURON, V16, P1037, DOI 10.1016/S0896-6273(00)80127-0; Clement DL, 2013, J CELL SCI, V126, P953, DOI 10.1242/jcs.116426; Counillon L, 1997, BIOCHEMISTRY-US, V36, P2951, DOI 10.1021/bi9615405; COUNILLON L, 1994, BIOCHEMISTRY-US, V33, P10463, DOI 10.1021/bi00200a030; COUNILLON L, 1993, P NATL ACAD SCI USA, V90, P4508, DOI 10.1073/pnas.90.10.4508; Deisl C, 2013, P NATL ACAD SCI USA, V110, P10004, DOI 10.1073/pnas.1220009110; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Ding J, 2006, J BIOL CHEM, V281, P29817, DOI 10.1074/jbc.M606152200; DOKTOR HS, 1991, J HUM HYPERTENS, V5, P161; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FAFOURNOUX P, 1994, J BIOL CHEM, V269, P2589; FRANCHI A, 1986, P NATL ACAD SCI USA, V83, P9388, DOI 10.1073/pnas.83.24.9388; Fuster D, 2008, J GEN PHYSIOL, V132, P465, DOI 10.1085/jgp.200810016; Gawenis LR, 2005, J BIOL CHEM, V280, P12781, DOI 10.1074/jbc.M414118200; Gekle M, 2001, J PHYSIOL-LONDON, V531, P619, DOI 10.1111/j.1469-7793.2001.0619h.x; Hayashi H, 2008, AM J PHYSIOL-CELL PH, V294, pC526, DOI 10.1152/ajpcell.00219.2007; Hisamitsu T, 2004, BIOCHEMISTRY-US, V43, P11135, DOI 10.1021/bi049367x; Hisamitsu T, 2006, BIOCHEMISTRY-US, V45, P13346, DOI 10.1021/bi0608616; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Horikawa N, 2001, PHARMACOLOGY, V63, P76, DOI 10.1159/000056116; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; IVES HE, 1983, J BIOL CHEM, V258, P9710; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Karmazyn M, 2001, BASIC RES CARDIOL, V96, P325, DOI 10.1007/s003950170040; Karmazyn M, 1996, CAN J CARDIOL, V12, P1074; Karmazyn M, 2008, J MOL CELL CARDIOL, V44, P647, DOI 10.1016/j.yjmcc.2008.01.005; Karmazyn M, 2013, J MOL CELL CARDIOL, V61, P77, DOI 10.1016/j.yjmcc.2013.02.006; Kevelaitis E, 2005, EUR J CARDIO-THORAC, V27, P111, DOI 10.1016/j.ejcts.2004.08.032; Khadilkar A, 2001, J BIOL CHEM, V276, P43792, DOI 10.1074/jbc.M106659200; KINSELLA JL, 1981, AM J PHYSIOL, V241, pF374, DOI 10.1152/ajprenal.1981.241.4.F374; Lacroix J, 2004, EMBO REP, V5, P91, DOI 10.1038/sj.embor.7400035; Landau M, 2007, J BIOL CHEM, V282, P37854, DOI 10.1074/jbc.M705460200; Lee BL, 2009, J BIOL CHEM, V284, P11546, DOI 10.1074/jbc.M809201200; Loo SY, 2012, CURR PHARM DESIGN, V18, P1372; Lou XH, 2011, AM J PHYSIOL-CELL PH, V301, pC1431, DOI 10.1152/ajpcell.00154.2011; Masereel B, 2003, EUR J MED CHEM, V38, P547, DOI 10.1016/S0223-5234(03)00100-4; Mentzer RM, 2008, ANN THORAC SURG, V85, P1261, DOI 10.1016/j.athoracsur.2007.10.054; Moncoq K, 2008, J BIOL CHEM, V283, P4145, DOI 10.1074/jbc.M704844200; Nygaard EB, 2011, J BIOL CHEM, V286, P634, DOI 10.1074/jbc.M110.159202; Orlowski J, 1996, J BIOL CHEM, V271, P19922, DOI 10.1074/jbc.271.33.19922; Orlowski J, 2011, COMPR PHYSIOL, V1, P2083, DOI 10.1002/cphy.c110020; OTSU K, 1992, J BIOL CHEM, V267, P8089; OTSU K, 1993, J BIOL CHEM, V268, P3184; OTSU K, 1989, P NATL ACAD SCI USA, V86, P4818, DOI 10.1073/pnas.86.13.4818; Park JW, 2005, J PHARMACOL SCI, V98, P439, DOI 10.1254/jphs.FP0050078; Park K, 2001, J BIOL CHEM, V276, P27042, DOI 10.1074/jbc.M102901200; Putney LK, 2003, J BIOL CHEM, V278, P44645, DOI 10.1074/jbc.M308099200; Reddy T, 2008, J BIOL CHEM, V283, P22018, DOI 10.1074/jbc.M803447200; Reshkin SJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0100; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; ROTIN D, 1989, AM J PHYSIOL, V257, pC1158, DOI 10.1152/ajpcell.1989.257.6.C1158; Schneider H, 1997, J BIOL CHEM, V272, P16158, DOI 10.1074/jbc.272.26.16158; Schneider L, 2009, J CELL BIOL, V185, P163, DOI 10.1083/jcb.200806019; Schultheis PJ, 1998, J CLIN INVEST, V101, P1243, DOI 10.1172/JCI1249; Schushan M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.L110.159202; SEMPLICINI A, 1989, J MEMBRANE BIOL, V107, P219, DOI 10.1007/BF01871937; Shrode LD, 1998, AM J PHYSIOL-CELL PH, V275, pC431, DOI 10.1152/ajpcell.1998.275.2.C431; Slepkov ER, 2007, BIOCHEM J, V401, P623, DOI 10.1042/BJ20061062; Slepkov ER, 2005, J BIOL CHEM, V280, P17863, DOI 10.1074/jbc.M409608200; Slepkov ER, 2004, BIOCHEM J, V379, P31, DOI 10.1042/BJ20030884; Stock C, 2009, PFLUG ARCH EUR J PHY, V458, P981, DOI 10.1007/s00424-009-0677-8; Tang XB, 1998, J BIOL CHEM, V273, P22545, DOI 10.1074/jbc.273.35.22545; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Tikhonov DB, 2005, BIOPHYS J, V88, P184, DOI 10.1529/biophysj.104.048173; Touret N, 2001, BIOCHEMISTRY-US, V40, P5095, DOI 10.1021/bi0025464; Tsushima RG, 1997, J GEN PHYSIOL, V110, P59, DOI 10.1085/jgp.110.1.59; Tzeng J, 2010, J BIOL CHEM, V285, P36656, DOI 10.1074/jbc.M110.161471; Wakabayashi S, 2000, J BIOL CHEM, V275, P7942, DOI 10.1074/jbc.275.11.7942; Wakabayashi S, 2003, J BIOL CHEM, V278, P43580, DOI 10.1074/jbc.M306690200; Wakabayashi S, 2003, J BIOL CHEM, V278, P11828, DOI 10.1074/jbc.M213243200; WANG DH, 1995, AM J PHYSIOL-CELL PH, V269, pC392, DOI 10.1152/ajpcell.1995.269.2.C392; Williams KA, 2000, NATURE, V403, P112, DOI 10.1038/47534; Wu D, 2013, J SURG RES, V181, pE75, DOI 10.1016/j.jss.2012.07.026; Wu ML, 1997, J MOL CELL CARDIOL, V29, P1131, DOI 10.1006/jmcc.1996.0338; XU M, 1993, J BIOL CHEM, V268, P21505; Zeymer U, 2001, J AM COLL CARDIOL, V38, P1644	86	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					18173	18186		10.1074/jbc.M115.642199	http://dx.doi.org/10.1074/jbc.M115.642199			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26063808	Green Published, hybrid			2022-12-26	WOS:000358511700047
J	Galloway, AWE; Winder, M				Galloway, Aaron W. E.; Winder, Monika			Partitioning the Relative Importance of Phylogeny and Environmental Conditions on Phytoplankton Fatty Acids	PLOS ONE			English	Article							CLIMATE-CHANGE IMPACTS; PLANKTONIC FOOD-WEB; MARINE ECOSYSTEMS; LIPID-COMPOSITION; ANTHROPOGENIC NITROGEN; DOCOSAHEXAENOIC ACID; AQUATIC ECOSYSTEMS; NANNOCHLOROPSIS SP; LIGHT-INTENSITY; LAKE WASHINGTON	Essential fatty acids (EFA), which are primarily generated by phytoplankton, limit growth and reproduction in diverse heterotrophs. The biochemical composition of phytoplankton is well-known to be governed both by phylogeny and environmental conditions. Nutrients, light, salinity, and temperature all affect both phytoplankton growth and fatty acid composition. However, the relative importance of taxonomy and environment on algal fatty acid content has yet to be comparatively quantified, thus inhibiting predictions of changes to phytoplankton food quality in response to global environmental change. We compiled 1145 published marine and freshwater phytoplankton fatty acid profiles, consisting of 208 species from six major taxonomic groups, cultured in a wide range of environmental conditions, and used a multivariate distance-based linear model to quantify the total variation explained by each variable. Our results show that taxonomic group accounts for 3-4 times more variation in phytoplankton fatty acids than the most important growth condition variables. The results underscore that environmental conditions clearly affect phytoplankton fatty acid profiles, but also show that conditions account for relatively low variation compared to phylogeny. This suggests that the underlying mechanism determining basal food quality in aquatic habitats is primarily phytoplankton community composition, and allows for prediction of environmental- scale EFA dynamics based on phytoplankton community data. We used the compiled dataset to calculate seasonal dynamics of long-chain EFA (LCEFA; >= C-20-omega 3 and omega-6 polyunsaturated fatty acid) concentrations and omega-3 omega-6 EFA ratios in Lake Washington using a multi-decadal phytoplankton community time series. These analyses quantify temporal dynamics of algal-derived LCEFA and food quality in a freshwater ecosystem that has undergone large community changes as a result of shifting resource management practices, highlighting diatoms, cryptophytes and dinoflagellates as key sources of LCEFA. Moreover, the analyses indicate that future shifts towards cyanobacteria-dominated communities will result in lower LCEFA content in aquatic ecosystems.	[Galloway, Aaron W. E.; Winder, Monika] Univ Calif Davis, Watershed Sci Ctr, John Muir Inst Environm, Davis, CA USA; [Winder, Monika] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden	University of California System; University of California Davis; Stockholm University	Galloway, AWE (corresponding author), Univ Oregon, Oregon Inst Marine Biol, Charleston, OR 97420 USA.	aaron.galloway@gmail.com			Interagency Ecological Program under California Department of Water Resources [4600008137T5]	Interagency Ecological Program under California Department of Water Resources	Financial support to MW and AWEG by the Interagency Ecological Program under California Department of Water Resources agreement number 4600008137T5 is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKMAN RG, 1968, J FISH RES BOARD CAN, V25, P1603, DOI 10.1139/f68-145; AHLGREN G, 1990, J PLANKTON RES, V12, P809, DOI 10.1093/plankt/12.4.809; Ahlgren G, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P147, DOI 10.1007/978-0-387-89366-2_7; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arts MT, 2001, CAN J FISH AQUAT SCI, V58, P122, DOI 10.1139/cjfas-58-1-122; Bec A, 2010, FRESHWATER BIOL, V55, P1958, DOI 10.1111/j.1365-2427.2010.02429.x; BELL MV, 1995, LIPIDS, V30, P443, DOI 10.1007/BF02536303; Bi R, 2014, J PHYCOL, V50, P117, DOI 10.1111/jpy.12140; Breteler WCMK, 1999, MAR BIOL, V135, P191, DOI 10.1007/s002270050616; Brett MT, 2006, LIMNOL OCEANOGR, V51, P2428, DOI 10.4319/lo.2006.51.5.2428; Brett MT, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P115, DOI 10.1007/978-0-387-89366-2_6; Brett MT, 1997, FRESHWATER BIOL, V38, P483, DOI 10.1046/j.1365-2427.1997.00220.x; Broglio E, 2003, AQUAT MICROB ECOL, V31, P267, DOI 10.3354/ame031267; Budge SM, 2014, ICES J MAR SCI, V71, P1885, DOI 10.1093/icesjms/fsu003; Cashman MJ, 2013, FRESHWATER BIOL, V58, P1447, DOI 10.1111/fwb.12142; Castell JD, 2004, AQUACULTURE, V242, P417, DOI 10.1016/j.aquaculture.2003.11.003; Cloern JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024465; Cloern JE, 1996, REV GEOPHYS, V34, P127, DOI 10.1029/96RG00986; Copeman LA, 2002, AQUACULTURE, V210, P285, DOI 10.1016/S0044-8486(01)00849-3; Dalsgaard J, 2003, ADV MAR BIOL, V46, P225, DOI 10.1016/S0065-2881(03)46005-7; Danielsdottir MG, 2007, HYDROBIOLOGIA, V589, P29, DOI 10.1007/s10750-007-0714-6; Desvilettes C, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P25, DOI 10.1007/978-0-387-89366-2_2; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Downing J., 2014, GLOBAL ENVIRON CHANG, P221; Edmondson W. T., 1994, Lake and Reservoir Management, V10, P75; Fabregas J, 2004, WORLD J MICROB BIOT, V20, P31, DOI 10.1023/B:WIBI.0000013288.67536.ed; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Francis TB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110363; Fuiman LA, 2015, ECOLOGY, V96, P362, DOI 10.1890/14-0571.1; Galloway AWE, 2012, J PHYCOL, V48, P956, DOI 10.1111/j.1529-8817.2012.01173.x; Gladyshev MI, 2013, PROSTAG OTH LIPID M, V107, P117, DOI 10.1016/j.prostaglandins.2013.03.002; Guschina IA, 2006, PROG LIPID RES, V45, P160, DOI 10.1016/j.plipres.2006.01.001; Guschina IA, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P1, DOI 10.1007/978-0-387-89366-2_1; Hampton SE, 2006, LIMNOL OCEANOGR, V51, P2042, DOI 10.4319/lo.2006.51.5.2042; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hartwich M, 2012, FRESHWATER BIOL, V57, P1385, DOI 10.1111/j.1365-2427.2012.02799.x; Holtgrieve GW, 2011, SCIENCE, V334, P1545, DOI 10.1126/science.1212267; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Hughes AD, 2011, J EXP MAR BIOL ECOL, V409, P229, DOI 10.1016/j.jembe.2011.08.027; JONASDOTTIR SH, 1994, MAR BIOL, V121, P67, DOI 10.1007/BF00349475; Kahru M, 2014, BIOGEOSCIENCES, V11, P3619, DOI 10.5194/bg-11-3619-2014; Kaushal SS, 2010, FRONT ECOL ENVIRON, V8, P461, DOI 10.1890/090037; Kelly JR, 2012, MAR ECOL PROG SER, V446, P1, DOI 10.3354/meps09559; Lang I, 2011, BMC PLANT BIOL, V11, P124, DOI DOI 10.1186/1471-2229-11-124; Lau DCP, 2013, LIMNOL OCEANOGR, V58, P1149, DOI 10.4319/lo.2013.58.4.1149; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Leu E, 2006, CAN J FISH AQUAT SCI, V63, P2760, DOI 10.1139/F06-159; Lewis WM, 2011, ENVIRON SCI TECHNOL, V45, P10300, DOI 10.1021/es202401p; Litzow MA, 2006, MAR ECOL PROG SER, V315, P1, DOI 10.3354/meps315001; Lowe AT, 2014, OIKOS, V123, P1341, DOI 10.1111/oik.01392; Markensten H, 2010, ECOL APPL, V20, P752, DOI 10.1890/08-2109.1; Marshall CT, 1999, NATURE, V402, P288, DOI 10.1038/46272; Martin-Creuzburg D, 2005, AQUAT MICROB ECOL, V41, P271, DOI 10.3354/ame041271; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; Milke LM, 2006, AQUACULTURE, V260, P272, DOI 10.1016/j.aquaculture.2006.06.004; Muller-Navarra DC, 2008, INT REV HYDROBIOL, V93, P489, DOI 10.1002/iroh.200711046; Muller-Navarra DC, 2004, NATURE, V427, P69, DOI 10.1038/nature02210; Muller-Navarra DC, 2000, NATURE, V403, P74, DOI 10.1038/47469; Naylor RL, 2009, P NATL ACAD SCI USA, V106, P15103, DOI 10.1073/pnas.0905235106; NIXON SW, 1988, LIMNOL OCEANOGR, V33, P1005, DOI 10.4319/lo.1988.33.4_part_2.1005; Paerl HW, 2012, WATER RES, V46, P1349, DOI 10.1016/j.watres.2011.08.002; Park S, 2003, AQUAT ECOL, V37, P123, DOI 10.1023/A:1023972425915; Parrish CC, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P309, DOI 10.1007/978-0-387-89366-2_13; Paulsen M, 2014, MAR BIOL, V161, P239, DOI 10.1007/s00227-013-2313-6; Pernet F, 2007, J EXP BIOL, V210, P2999, DOI 10.1242/jeb.006007; Piepho M, 2012, J PHYCOL, V48, P64, DOI 10.1111/j.1529-8817.2011.01103.x; Pond D, 1996, MAR ECOL PROG SER, V143, P45, DOI 10.3354/meps143045; R Development Core Team, 2014, R LANG ENV STAT COMP; Rabalais NN, 2009, ICES J MAR SCI, V66, P1528, DOI 10.1093/icesjms/fsp047; Ravet JL, 2010, ECOLOGY, V91, P180, DOI 10.1890/08-2037.1; Raymond WW, 2014, MAR ECOL PROG SER, V509, P213, DOI 10.3354/meps10888; REITAN KI, 1994, J PHYCOL, V30, P972, DOI 10.1111/j.0022-3646.1994.00972.x; RENAUD SM, 1991, J APPL PHYCOL, V3, P43, DOI 10.1007/BF00003918; Renaud SM, 2002, AQUACULTURE, V211, P195, DOI 10.1016/S0044-8486(01)00875-4; Reuss N, 2002, MAR BIOL, V141, P423, DOI 10.1007/s00227-002-0841-6; Rojbek MC, 2012, MAR ECOL PROG SER, V471, P215, DOI 10.3354/meps10012; Rossoll D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034737; Sargent J, 1999, AQUACULTURE, V177, P191, DOI 10.1016/S0044-8486(99)00083-6; Scavia D, 2002, ESTUARIES, V25, P149, DOI 10.1007/BF02691304; Schneider P, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045059; Schwenk D, 2013, AQUAT ECOL, V47, P415, DOI 10.1007/s10452-013-9454-z; SHERR E, 1988, LIMNOL OCEANOGR, V33, P1225, DOI 10.4319/lo.1988.33.5.1225; Sperfeld E, 2012, FRESHWATER BIOL, V57, P497, DOI 10.1111/j.1365-2427.2011.02719.x; Strandberg U, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00382.1; SUKENIK A, 1989, J PHYCOL, V25, P686, DOI 10.1111/j.0022-3646.1989.00686.x; Sushchik NN, 2004, FRESHWATER BIOL, V49, P1206, DOI 10.1111/j.1365-2427.2004.01263.x; Taipale S, 2013, AQUAT MICROB ECOL, V71, P165, DOI 10.3354/ame01671; THOMPSON PA, 1992, J PHYCOL, V28, P488, DOI 10.1111/j.0022-3646.1992.00488.x; Underwood GJC, 1999, ADV ECOL RES, V29, P93; Wacker A, 2012, FUNCT ECOL, V26, P1135, DOI 10.1111/j.1365-2435.2012.02047.x; Wagner ND, 2013, ECOL LETT, V16, P535, DOI 10.1111/ele.12067; WATANABE T, 1983, AQUACULTURE, V34, P115, DOI 10.1016/0044-8486(83)90296-X; Winder M, 2004, GLOBAL CHANGE BIOL, V10, P1844, DOI 10.1111/j.1365-2486.2004.00849.x; Winder M, 2012, HYDROBIOLOGIA, V698, P5, DOI 10.1007/s10750-012-1149-2; Winder M, 2011, ECOL LETT, V14, P749, DOI 10.1111/j.1461-0248.2011.01635.x; Winder M, 2011, ESTUAR COAST, V34, P675, DOI 10.1007/s12237-010-9342-x; Zhukova NV, 1999, AQUAT MICROB ECOL, V17, P153, DOI 10.3354/ame017153	99	114	114	5	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130053	10.1371/journal.pone.0130053	http://dx.doi.org/10.1371/journal.pone.0130053			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076015	Green Submitted, Green Published, gold			2022-12-26	WOS:000356329900130
J	Lee, SM; Park, JS; Norwitz, ER; Kim, SM; Lee, J; Park, CW; Kim, BJ; Jun, JK				Lee, Seung Mi; Park, Joong Shin; Norwitz, Errol R.; Kim, Sun Min; Lee, JoonHo; Park, Chan-Wook; Kim, Byoung Jae; Jun, Jong Kwan			Presenting Twins Are Exposed to Higher Levels of Inflammatory Mediators than Nonpresenting Twins as Early as the Midtrimester of Pregnancy	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; BIRTH-ORDER; NEONATAL MORBIDITY; GESTATIONAL-AGE; AMNIOTIC-FLUID; PRETERM LABOR; UREAPLASMA-UREALYTICUM; LUNG; DELIVERY; MODE	Objective Presenting twins are less likely to develop respiratory complications than non-presenting twins. The precise reason for this difference is not well understood, although it is known that the presence of inflammation reduces the risk of respiratory morbidity at birth. To further investigate this association, we compared the concentrations of inflammatory biomarkers in mid-trimester amniotic fluid (AF) of asymptomatic twin pairs. Study Design The study population consisted of women with twin pregnancies who underwent mid-trimester amniocentesis (15-20 weeks) for routine clinical indications and delivered at term. AF was analyzed for pro-inflammatory cytokines (IL-1 beta, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12, IL-13, IL-15, IFN-gamma, TNF-alpha), matrix metalloproteinases (MMP-1, MMP-2, MMP-3, MMP-8, MMP-9, MMP-12), and chemokines (Complement Factor D/Adipsin, Serpin E1/PAI-1, Adiponectin/ Acrp30, CRP, CCL2/MCP-1, Leptin, Resistin) using Luminex Performance Assay multiplex kits. Data were analyzed using Wilcoxon signed rank test. Results A total of 82 twin pairs were enrolled. Mid-trimester AF concentrations of IL-8, MMP-8, CRP, MCP-1, leptin, and resistin were significantly higher in the presenting twin compared with the non-presenting twin (p<0.05 for each). Differences in AF concentrations of IL-8, MMP-8, and CRP persisted after adjustment for the fetal growth restriction at the time of birth and chorionicity. Conclusion These data suggest that, as early as the mid-trimester, the presenting fetus in an otherwise uncomplicated twin pregnancy is exposed to higher levels of pro-inflammatory mediators (especially IL-8, MMP-8, and CRP) than its non-presenting co-twin. Whether this pro-inflammatory milieu reduces the risk of neonatal respiratory morbidity at birth or has other functional implications needs to be further evaluated.	[Lee, Seung Mi; Park, Joong Shin; Kim, Sun Min; Lee, JoonHo; Park, Chan-Wook; Kim, Byoung Jae; Jun, Jong Kwan] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Lee, Seung Mi; Kim, Byoung Jae] Seoul Natl Univ, Seoul Metropolitan Govt, Boramae Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea; [Norwitz, Errol R.] Tufts Univ, Sch Med, Dept Obstet & Gynecol, Boston, MA 02111 USA	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Tufts University	Park, JS (corresponding author), Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.	jsparkmd@snu.ac.kr	Park, Joong Shin/D-5741-2012; PARK, Chan-Wook/G-3663-2013	Park, Joong Shin/0000-0002-5246-0477; PARK, Chan-Wook/0000-0002-1290-6438	Korea Health R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI12C00240300]	Korea Health R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant from the Korea Health R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI12C00240300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews WW, 2006, AM J OBSTET GYNECOL, V195, P803, DOI 10.1016/j.ajog.2006.06.083; Armson BA, 2006, OBSTET GYNECOL, V108, P556, DOI 10.1097/01.AOG.0000227747.37184.0a; ARNOLD C, 1987, NEW ENGL J MED, V317, P1121, DOI 10.1056/NEJM198710293171805; Been JV, 2009, ARCH DIS CHILD-FETAL, V94, pF218, DOI 10.1136/adc.2008.150458; Bry K, 1997, J CLIN INVEST, V99, P2992, DOI 10.1172/JCI119494; Bry K, 2001, ACTA PAEDIATR, V90, P74; CASSELL GH, 1983, SEX TRANSM DIS, V10, P294; Collins JJP, 2012, AM J PHYSIOL-LUNG C, V303, pL778, DOI 10.1152/ajplung.00280.2011; D'Antonio F, 2013, ULTRASOUND OBST GYN, V41, P274, DOI 10.1002/uog.12310; Dempsey E, 2005, AM J PERINAT, V22, P155, DOI 10.1055/s-2005-865020; Gerber S, 2003, J INFECT DIS, V187, P518, DOI 10.1086/368205; GRAY DJ, 1992, PRENATAL DIAG, V12, P111, DOI 10.1002/pd.1970120206; Hacking D, 2001, ARCH DIS CHILD-FETAL, V84, pF117, DOI 10.1136/fn.84.2.F117; Hartley RS, 2005, J MATERN-FETAL NEO M, V17, P375, DOI 10.1080/147670505000132484; Herbst A, 2008, BJOG-INT J OBSTET GY, V115, P1512, DOI 10.1111/j.1471-0528.2008.01899.x; HOROWITZ S, 1995, J REPROD MED, V40, P375; Jobe Alan H, 2005, J Perinatol, V25 Suppl 2, pS31, DOI 10.1038/sj.jp.7211317; Kaukola T, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.07.070; Khairy P, 2006, CIRCULATION, V113, P517, DOI 10.1161/CIRCULATIONAHA.105.589655; Kramer BW, 2008, J PERINATOL, V28, pS21, DOI 10.1038/jp.2008.46; Kuypers E, 2012, AM J PHYSIOL-LUNG C, V302, pL380, DOI 10.1152/ajplung.00338.2011; Lahra MM, 2009, ARCH DIS CHILD-FETAL, V94, pF13, DOI 10.1136/adc.2007.135889; Lambermont VA, 2014, PEDIATR RES, V75, P500, DOI 10.1038/pr.2014.3; Lee J, 2009, J PERINAT MED, V37, P53, DOI 10.1515/JPM.2009.036; Martin Joyce A, 2010, Natl Vital Stat Rep, V59, P3; PRINS RP, 1994, AM J OBSTET GYNECOL, V170, P1649; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; SHINWELL ES, 2004, ARCH DIS CHILD, V89, P145, DOI [DOI 10.1136/adc.2002.021584, DOI 10.1136/ADC.2002.021584]; Sibony O, 2003, EUR J OBSTET GYN R B, V108, P157; Smith GCS, 2002, BRIT MED J, V325, P1004, DOI 10.1136/bmj.325.7371.1004; Smith GCS, 2007, BMJ-BRIT MED J, V334, P576, DOI 10.1136/bmj.39118.483819.55; van Nimwegen FA, 2011, J ALLERGY CLIN IMMUN, V128, P948, DOI 10.1016/j.jaci.2011.07.027; Watterberg KL, 1996, PEDIATRICS, V97, P210; Wen SW, 2004, AM J OBSTET GYNECOL, V191, P773, DOI 10.1016/j.ajog.2004.04.009; Wen SW, 2004, AM J OBSTET GYNECOL, V191, P778, DOI 10.1016/j.ajog.2004.05.013; WYSHAK G, 1963, JAMA-J AM MED ASSOC, V186, P869; Xu WL, 2011, NEUROLOGY, V76, P1568, DOI 10.1212/WNL.0b013e3182190d09; Yoon BH, 2001, AM J OBSTET GYNECOL, V185, P1130, DOI 10.1067/mob.2001.117680; Yoon BH, 2001, AM J OBSTET GYNECOL, V185, P1162, DOI 10.1067/mob.2001.117678	39	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0125346	10.1371/journal.pone.0125346	http://dx.doi.org/10.1371/journal.pone.0125346			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076029	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900004
J	Sacco, ICN; Suda, EY; Vigneron, V; Sartor, CD				Sacco, Isabel C. N.; Suda, Eneida Yuri; Vigneron, Vincent; Sartor, Cristina Dallemole			An 'Importance' Map of Signs and Symptoms to Classify Diabetic Polyneuropathy: An Exploratory Data Analysis	PLOS ONE			English	Article							FOOT ULCER RISK; SCREENING-TESTS; NEUROPATHY; ASSOCIATION; DIAGNOSIS	Aims/Hypothesis Early diagnosis of diabetic polyneuropathy (DPN) is critical for a good prognosis. We aimed to identify different groups of patients, based on the various common clinical signs and symptoms of DPN, that represent a progressive worsening of the disease before the onset of plantar ulceration or amputation. We also sought to identify the most important DPN-related variables that can discriminate between groups, thus representing the most informative variables for early detection. Methods In 193 diabetic patients, we assessed 16 DPN-related signs, symptoms, and foot characteristics, based on the literature and the International Consensus on the Diabetic Foot. We used multiple correspondence analysis and the Kohonen algorithm to group the variables into micro and macro-classes and to identify clusters of patients that represent different DPN conditions. Results Four distinct groups were observed. One group showed no indication of DPN. The remaining groups were characterized by a progressive loss of the vibration perception, without a worsening of symptoms or tactile perception. The 2 intermediate groups presented different aspects of DPN: one showed mostly DPN symptoms and the other showed the incipient vibration impairment, callus and crack formation, and foot arch alteration. The fourth group showed more severe foot and DPN conditions, including ulceration and amputation, absence of vibration and tactile perception (irrespective of how many compromised foot areas), and worse foot deformities and callus and crack formation. Conclusion Vibration perception was more informative than tactile sensitivity in discriminating early DPN onset because its impairment was evident in more groups. Symptoms and callus and cracks did not discriminate the severity status and should be interpreted in association with other clinical variables. Reconsideration of the current screening techniques is needed to clinically determine the early onset of neuropathy using tactile perception.	[Sacco, Isabel C. N.; Suda, Eneida Yuri; Sartor, Cristina Dallemole] Univ Sao Paulo, Sch Med, Dept Phys Therapy & Speech & Occupat Therapy, Sao Paulo, Brazil; [Vigneron, Vincent] Univ Evry, Informat Biol Integrat & Syst Complexes, Evry, France	Universidade de Sao Paulo; UDICE-French Research Universities; Universite Paris Saclay	Sacco, ICN (corresponding author), Univ Sao Paulo, Sch Med, Dept Phys Therapy & Speech & Occupat Therapy, Sao Paulo, Brazil.	icnsacco@usp.br	Suda, Eneida Yuri/H-8534-2019; Suda, Eneida Yuri/C-7231-2013; Sacco, Isabel/T-2630-2019; Sacco, Isabel/D-7172-2011; Sartor, Cristina D/C-6806-2013	Suda, Eneida Yuri/0000-0002-6346-0317; Suda, Eneida Yuri/0000-0002-6346-0317; Sacco, Isabel/0000-0003-1254-0007; Sacco, Isabel/0000-0003-1254-0007; Sartor, Cristina D/0000-0002-8461-8048	Sao Paulo Research Foundation [2011/19304-4, 2013/06123-7]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [151531/2013-7]; Catedras Francesas no Estado Sao Paulo	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Catedras Francesas no Estado Sao Paulo	This study was funded by Sao Paulo Research Foundation (scholarship CDS process number 2011/19304-4, scholarship to EYS 2013/06123-7), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, grant for finantial support process number 151531/2013-7), and Catedras Francesas no Estado Sao Paulo 2013 (scholarship to VV).	Andersen EB, 1989, INTRO ANAL CATEGORIC; Asad A, 2010, J PAK MED ASSOC, V60, P166; Bakker K, 2012, DIABETES-METAB RES, V28, P225, DOI 10.1002/dmrr.2253; Boulton AJM, 2004, DIABETES CARE, V27, P1458, DOI 10.2337/diacare.27.6.1458; Boulton AJM, 2004, DIABETOLOGIA, V47, P1343, DOI 10.1007/s00125-004-1463-y; Cowley MS, 2008, DIABETES RES CLIN PR, V82, P226, DOI 10.1016/j.diabres.2008.07.025; Dyck PJ, 2011, DIABETES METAB RES R; England JD, 2005, NEUROLOGY, V64, P199, DOI 10.1212/01.WNL.0000149522.32823.EA; FELDMAN EL, 1994, DIABETES CARE, V17, P1281, DOI 10.2337/diacare.17.11.1281; Forouzandeh F, 2005, ACTA NEUROL SCAND, V112, P409, DOI 10.1111/j.1600-0404.2005.00494.x; Gin H, 2006, DIABETES METAB, V32, P367, DOI 10.1016/S1262-3636(07)70293-8; Kohonen T., 1995, SELF ORG MAPS, DOI [10.1007/978-3-642-97610-0, DOI 10.1007/978-3-642-97610-0]; KUMAR S, 1991, DIABETES RES CLIN PR, V13, P63, DOI 10.1016/0168-8227(91)90034-B; Lebart L, 1995, STAT EXPLORATOIRE DO; Ledoux WR, 2005, J REHABIL RES DEV, V42, P665, DOI 10.1682/JRRD.2004.11.0144; Leese GP, 2006, INT J CLIN PRACT, V60, P541, DOI 10.1111/j.1368-5031.2006.00899.x; Lunetta M, 1998, DIABETES RES CLIN PR, V39, P165, DOI 10.1016/S0168-8227(98)00005-9; Meijer JWG, 2002, DIABETIC MED, V19, P962, DOI 10.1046/j.1464-5491.2002.00819.x; Moghtaderi A, 2006, CLIN NEUROL NEUROSUR, V108, P477, DOI 10.1016/j.clineuro.2005.08.003; Perkins BA, 2003, CLIN NEUROPHYSIOL, V114, P1167, DOI 10.1016/S1388-2457(03)00025-7; Perkins BA, 2001, DIABETES CARE, V24, P250, DOI 10.2337/diacare.24.2.250; Ritter H., 1992, NEURAL COMPUTATION S; SAPORTA G, 1990, PROBABILITES ANAL DO; SOSENKO JM, 1990, DIABETES CARE, V13, P1057, DOI 10.2337/diacare.13.10.1057; VEVES A, 1992, DIABETOLOGIA, V35, P660, DOI 10.1007/BF00400259; Vigneron V., 2008, FUZZY EC REV, V13; Vigneron V, 1999, ACSEG 99 REUS SPAIN	27	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129763	10.1371/journal.pone.0129763	http://dx.doi.org/10.1371/journal.pone.0129763			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075711	gold, Green Published, Green Submitted			2022-12-26	WOS:000356329900101
J	Santio, NM; Eerola, SK; Paatero, I; Yli-Kauhaluoma, J; Anizon, F; Moreau, P; Tuomela, J; Harkonen, P; Koskinen, PJ				Santio, Niina M.; Eerola, Sini K.; Paatero, Ilkka; Yli-Kauhaluoma, Jari; Anizon, Fabrice; Moreau, Pascale; Tuomela, Johanna; Harkonen, Pirkko; Koskinen, Paivi J.			Pim Kinases Promote Migration and Metastatic Growth of Prostate Cancer Xenografts	PLOS ONE			English	Article							SERINE/THREONINE KINASES; CELL-MIGRATION; TUMOR-GROWTH; NUDE-MICE; EXPRESSION; INHIBITORS; CARCINOMA; CXCR4; OVEREXPRESSION; ACTIVATION	Background and methods Pim family proteins are oncogenic kinases implicated in several types of cancer and involved in regulation of cell proliferation, survival as well as motility. Here we have investigated the ability of Pim kinases to promote metastatic growth of prostate cancer cells in two xenograft models for human prostate cancer. We have also evaluated the efficacy of Pim-selective inhibitors to antagonize these effects. Results We show here that tumorigenic growth of both subcutaneously and orthotopically inoculated prostate cancer xenografts is enhanced by stable overexpression of either Pim-1 or Pim-3. Moreover, Pim-overexpressing orthotopic prostate tumors are highly invasive and able to migrate not only to the nearby prostate-draining lymph nodes, but also into the lungs to form metastases. When the xenografted mice are daily treated with the Pim-selective inhibitor DHPCC-9, both the volumes as well as the metastatic capacity of the tumors are drastically decreased. Interestingly, the Pim-promoted metastatic growth of the orthotopic xenografts is associated with enhanced angiogenesis and lymphangiogenesis. Furthermore, forced Pim expression also increases phosphorylation of the CXCR4 chemokine receptor, which may enable the tumor cells to migrate towards tissues such as the lungs that express the CXCL12 chemokine ligand. Conclusions Our results indicate that Pim overexpression enhances the invasive properties of prostate cancer cells in vivo. These effects can be reduced by the Pim-selective inhibitor DHPCC-9, which can reach tumor tissues without serious side effects. Thus, Pim-targeting therapies with DHPCC-9-like compounds may help to prevent progression of local prostate carcinomas to fatally metastatic malignancies.	[Santio, Niina M.; Eerola, Sini K.; Koskinen, Paivi J.] Univ Turku, Dept Biol, Sect Genet & Physiol, SF-20500 Turku, Finland; [Santio, Niina M.] Univ Turku, Drug Res Doctoral Programme, FIN-20520 Turku, Finland; [Paatero, Ilkka] Univ Turku, Dept Med Biochem & Genet, Inst Biomed, FIN-20520 Turku, Finland; [Yli-Kauhaluoma, Jari] Univ Helsinki, Fac Pharm, Div Pharmaceut Chem & Technol, FIN-00014 Helsinki, Finland; [Anizon, Fabrice; Moreau, Pascale] Univ Clermont Ferrand, Univ Clermont Auvergne, Inst Chim Clermont Ferrand, F-63000 Clermont Ferrand, France; [Anizon, Fabrice; Moreau, Pascale] CNRS, F-63178 Aubiere, France; [Tuomela, Johanna; Harkonen, Pirkko] Univ Turku, Dept Cell Biol & Anat, Inst Biomed, FIN-20520 Turku, Finland; [Tuomela, Johanna] Pharmatest Serv Ltd, Turku 20520, Finland	University of Turku; University of Turku; University of Turku; University of Helsinki; Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); University of Turku; Pharmatest Services	Koskinen, PJ (corresponding author), Univ Turku, Dept Biol, Sect Genet & Physiol, SF-20500 Turku, Finland.	paivi.koskinen@utu.fi	ANIZON, Fabrice/M-7940-2016; Koskinen, Päivi J/G-8939-2014; Paatero, Ilkka/AAE-7542-2019; Moreau, Pascale/M-9020-2016	ANIZON, Fabrice/0000-0001-7869-9622; Paatero, Ilkka/0000-0001-5926-2396; Moreau, Pascale/0000-0001-6527-7586; Yli-Kauhaluoma, Jari/0000-0003-0370-7653; Tuomela, Johanna/0000-0003-4390-4563; Koskinen, Paivi/0000-0002-6864-4457	Academy of Finland [121533, 269541]; TULI Program of the University of Turku; Sigrid Juselius Foundation; FinPharma Doctoral Program; Emil Aaltonen Foundation; Cancer Organizations for the Western Finland; Orion-Farmos Research Foundation; Finnish Cultural Foundation; Turku University Foundation; Walter och Lisi Wahls Stiftelse fur Naturvetenskaplig Forskning	Academy of Finland(Academy of Finland); TULI Program of the University of Turku; Sigrid Juselius Foundation(Sigrid Juselius Foundation); FinPharma Doctoral Program; Emil Aaltonen Foundation; Cancer Organizations for the Western Finland; Orion-Farmos Research Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Turku University Foundation; Walter och Lisi Wahls Stiftelse fur Naturvetenskaplig Forskning	This work was supported by the Academy of Finland (grant 121533 to PJK, grant 269541 to PH), TULI Program of the University of Turku (PJK), Sigrid Juselius Foundation (PH), FinPharma Doctoral Program (NMS), Emil Aaltonen Foundation (NMS), Cancer Organizations for the Western Finland (NMS), Orion-Farmos Research Foundation (NMS), Finnish Cultural Foundation (NMS), Turku University Foundation (SKE), and Walter och Lisi Wahls Stiftelse fur Naturvetenskaplig Forskning (JYK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Johanna Tuomela was employed by Pharmatest Services Ltd for a period during the study. Pharmatest did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of JT is articulated in the 'author contributions' section.	Akue-Gedu R, 2009, J MED CHEM, V52, P6369, DOI 10.1021/jm901018f; Anizon F, 2010, CURR MED CHEM, V17, P4114, DOI 10.2174/092986710793348554; Arunesh GM, 2014, EXPERT OPIN THER PAT, V24, P5, DOI 10.1517/13543776.2014.848196; Aumuller IB, 2009, ORG LETT, V11, P5363, DOI 10.1021/ol902283q; Bachmann M, 2005, INT J BIOCHEM CELL B, V37, P726, DOI 10.1016/j.biocel.2004.11.005; Brault L, 2012, BRIT J CANCER, V107, P491, DOI 10.1038/bjc.2012.272; Brault L, 2010, HAEMATOL-HEMATOL J, V95, P1004, DOI 10.3324/haematol.2009.017079; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; Chen WW, 2005, MOL CANCER RES, V3, P443, DOI 10.1158/1541-7786.MCR-05-0007; Chinni SR, 2006, PROSTATE, V66, P32, DOI 10.1002/pros.20318; CUYPERS HT, 1984, CELL, V37, P141; Decker S, 2014, MOL CANCER THER, V13, P1231, DOI 10.1158/1535-7163.MCT-13-0575-T; Evans JD., 1996, STRAIGHTFORWARD STAT; Foulks JM, 2014, NEOPLASIA, V16, P403, DOI 10.1016/j.neo.2014.05.004; Furusato B, 2010, PATHOL INT, V60, P497, DOI 10.1111/j.1440-1827.2010.02548.x; Grundler R, 2009, J EXP MED, V206, P1957, DOI 10.1084/jem.20082074; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kiriazis A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055409; Kukreja P, 2005, CANCER RES, V65, P9891, DOI 10.1158/0008-5472.CAN-05-1293; Liu HT, 2010, J SURG ONCOL, V102, P683, DOI 10.1002/jso.21627; Mikkers H, 2004, MOL CELL BIOL, V24, P6104, DOI 10.1128/MCB.24.13.6104-6115.2004; Morwick T, 2010, EXPERT OPIN THER PAT, V20, P193, DOI 10.1517/13543770903496442; Nuusslein-Volhard C, 2002, ZEBRAFISH PRACTICAL; Peltola K, 2009, NEOPLASIA, V11, P629, DOI 10.1593/neo.81038; Qian KC, 2005, J BIOL CHEM, V280, P6130, DOI 10.1074/jbc.M409123200; Ruohola JK, 1999, MOL CELL ENDOCRINOL, V149, P29, DOI 10.1016/S0303-7207(99)00003-9; Santio NM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-279; Singh S, 2004, LAB INVEST, V84, P1666, DOI 10.1038/labinvest.3700181; STEPHENSON RA, 1992, J NATL CANCER I, V84, P951, DOI 10.1093/jnci/84.12.951; Sussman Mark A, 2009, Expert Rev Cardiovasc Ther, V7, P929, DOI 10.1586/erc.09.48; Taichman RS, 2002, CANCER RES, V62, P1832; Tanaka S, 2009, MOL MED REP, V2, P313, DOI 10.3892/mmr_00000102; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Tuomela J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-362; Tuomela JM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-81; Zhang P, 2009, J CELL PHYSIOL, V220, P82, DOI 10.1002/jcp.21733	36	48	52	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130340	10.1371/journal.pone.0130340	http://dx.doi.org/10.1371/journal.pone.0130340			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075720	Green Submitted, Green Published, gold			2022-12-26	WOS:000356329900164
J	Girling, SJ; Campbell-Palmer, R; Pizzi, R; Fraser, MA; Cracknell, J; Arnemo, J; Rosell, F				Girling, Simon J.; Campbell-Palmer, Roisin; Pizzi, Romain; Fraser, Mary A.; Cracknell, Jonathan; Arnemo, Jon; Rosell, Frank			Haematology and Serum Biochemistry Parameters and Variations in the Eurasian Beaver (Castor fiber)	PLOS ONE			English	Article							WESTERN-EUROPE; GREAT-BRITAIN; REINTRODUCTIONS; POPULATION; CANADENSIS; ANESTHESIA; CHEMISTRY; CAPTURE; STOCK	Haematology parameters (N = 24) and serum biochemistry parameters (N = 35) were determined for wild Eurasian beavers (Castor fiber), between 6 months -12 years old. Of the population tested in this study, N = 18 Eurasian beavers were from Norway and N = 17 originating from Bavaria but now living extensively in a reserve in England. All blood samples were collected from beavers via the ventral tail vein. All beavers were chemically restrained using inhalant isoflurane in 100% oxygen prior to blood sampling. Results were determined for haematological and serum biochemical parameters for the species and were compared between the two different populations with differences in means estimated and significant differences being noted. Standard blood parameters for the Eurasian beaver were determined and their ranges characterised using percentiles. Whilst the majority of blood parameters between the two populations showed no significant variation, haemoglobin, packed cell volume, mean cell haemoglobin and white blood cell counts showed significantly greater values (p<0.01) in the Bavarian origin population than the Norwegian; neutrophil counts, alpha 2 globulins, cholesterol, sodium: potassium ratios and phosphorus levels showed significantly (p<0.05) greater values in Bavarian versus Norwegian; and potassium, bile acids, gamma globulins, urea, creatinine and total calcium values levels showed significantly (p<0.05) greater values in Norwegian versus Bavarian relict populations. No significant differences were noted between male and female beavers or between sexually immature (<3 years old) and sexually mature (>= 3 years old) beavers in the animals sampled. With Eurasian beaver reintroduction encouraged by legislation throughout Europe, knowledge of baseline blood values for the species and any variations therein is essential when assessing their health and welfare and the success or failure of any reintroduction program. This is the first study to produce base-line blood values and their variations for the Eurasian beaver.	[Girling, Simon J.; Pizzi, Romain] Royal Zool Soc Scotland, Living Collect, Vet Dept, Edinburgh, Midlothian, Scotland; [Campbell-Palmer, Roisin] Telemark Univ Coll, Dept Environm & Hlth Studies, Fac Arts & Sci, Bo I Telemark, Norway; [Campbell-Palmer, Roisin; Rosell, Frank] Royal Zool Soc Scotland, Conservat Programmes, Edinburgh, Midlothian, Scotland; [Fraser, Mary A.] Edinburgh Napier Univ, Sch Life Sport & Social Sci, Edinburgh, Midlothian, Scotland; [Cracknell, Jonathan] Longleat Safari & Adventure Pk, Warminster, Wilts, England; [Arnemo, Jon] Hedmark Univ Coll, Fac Appl Ecol & Agr Sci, Dept Forestry & Wildlife Management, Koppang, Norway; [Arnemo, Jon] Swedish Univ Agr Sci, Fac Forest Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden	University College of Southeast Norway; Edinburgh Napier University; Inland Norway University of Applied Sciences; Swedish University of Agricultural Sciences	Girling, SJ (corresponding author), Royal Zool Soc Scotland, Living Collect, Vet Dept, Edinburgh, Midlothian, Scotland.	sgirling@rzss.org.uk	Pizzi, Romain/AAW-6360-2020; Fraser, Mary/AAU-9232-2021	Pizzi, Romain/0000-0002-9030-9559; Fraser, Mary/0000-0002-2588-7520; Girling, Simon/0000-0001-9927-9491	Longleat Safari; Adventure Park	Longleat Safari; Adventure Park	The authors received no specific funding for this work. Longleat Safari and Adventure Park provided support in the form of salaries for authors [JC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions' section.	[Anonymous], 2004, SMALL ANIMAL CLIN DI; Barlow AM, 2011, VET REC, V169, DOI 10.1136/vr.d4673; BENNETT PM, 1991, VET REC, V128, P496, DOI 10.1136/vr.128.21.496; CLARK JD, 1986, ZOO WILD ANIMAL MED, P727; DiBartola S.P., 2004, SMALL ANIMAL CLIN DI, P117; Durka W, 2005, MOL ECOL, V14, P3843, DOI 10.1111/j.1365-294X.2005.02704.x; Eisele PH, 1997, CONTEMP TOP LAB ANIM, V36, P97; Goodman G, 2012, J WILDLIFE DIS, V48, P971, DOI 10.7589/2011-06-153; GREENE SA, 1991, AM J VET RES, V52, P665; Halley DJ, 2002, MAMMAL REV, V32, P153, DOI 10.1046/j.1365-2907.2002.00106.x; Halley D, 2012, BALT FOR, V18, P168; Halley Duncan J., 2003, Lutra, V46, P91; Halley DJ, 2011, MAMMAL REV, V41, P40, DOI 10.1111/j.1365-2907.2010.00167.x; ISIS, 2002, REF VAL CAPT N AM BE; Jenkins JR, 2008, J EXOT PET MED, V17, P16, DOI 10.1053/j.jepm.2007.12.004; Kaneko J., 2008, CLIN BIOCH DOMESTIC, V6th, P889; KITTS W. D., 1958, CANADIAN JOUR ZOOL, V36, P279, DOI 10.1139/z58-026; Marco I, 1999, RES VET SCI, V66, P81, DOI 10.1053/rvsc.1998.0248; Martino PE, 2012, J ZOO WILDLIFE MED, V43, P240, DOI 10.1638/2010-0154.1; Masek T, 2009, EUR J WILDLIFE RES, V55, P561, DOI 10.1007/s10344-009-0276-1; Mayer J., 2013, EXOTIC ANIMAL FORMUL, P476; Milner JM, 2003, CAN J ZOOL, V81, P1566, DOI [10.1139/z03-152, 10.1139/Z03-152]; Ness R. D., 2005, EXOTIC ANIMAL FORMUL, P375; Nolet BA, 1998, BIOL CONSERV, V83, P165, DOI 10.1016/S0006-3207(97)00066-9; Novak M., 1987, WILD FURBEARER MANAG, P283; Pilny Anthony A., 2008, Veterinary Clinics of North America Exotic Animal Practice, V11, P523, DOI 10.1016/j.cvex.2008.04.001; Rosef Oav, 2004, Rangifer, V24, P79; Rosell F, 1999, WILDLIFE BIOL, V5, P119, DOI 10.2981/wlb.1999.015; Rosell F, 2001, WILDLIFE SOC B, V29, P269; Rosell F, 2012, MAMMAL REV, V42, P319, DOI 10.1111/j.1365-2907.2011.00197.x; Senn H, 2014, EVOL APPL, V7, P645, DOI 10.1111/eva.12162; STEVENSON A. B., 1959, CANADIAN JOUR ZOOL, V37, P9, DOI 10.1139/z59-002; Swenson M. J, 1984, DUKES PHYSL DOMESTIC, P15; Thoresen SI, 2009, VET CLIN PATH, V38, P224, DOI 10.1111/j.1939-165X.2008.00105.x; Wesche P., 2009, BSAVA manual of rodents and ferrets, P42; Willard MD, 2004, SMALL ANIMAL CLIN DI, P208; Zharkov I. V., 1967, ACTA THERIOL, V12, P27, DOI 10.4098/AT.arch.67-3	37	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128775	10.1371/journal.pone.0128775	http://dx.doi.org/10.1371/journal.pone.0128775			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066344	Green Published, Green Submitted, gold			2022-12-26	WOS:000356327000028
J	Novkovic, B; Kimura, MT				Novkovic, Biljana; Kimura, Masahito T.			Phylogeography, Interaction Patterns and the Evolution of Host Choice in Drosophila-Parasitoid Systems in Ryukyu Archipelago and Taiwan	PLOS ONE			English	Article							FRUGIVOROUS DROSOPHILIDS; SUBTROPICAL ISLAND; POPULATION-GROWTH; COEVOLUTION; SPECIATION; JAPAN; PARAMETERS; DISPERSAL; DIVERSITY; ABUNDANCE	Island biotas provide a great opportunity to study not only the phylogeographic patterns of a group of species, but also to explore the differentiation in their coevolutionary interactions. Drosophila and their parasitoids are exemplary systems for studying complex interaction patterns. However, there is a lack of studies combining interaction-based and molecular marker-based methods. We applied an integrated approach combining phylogeography, interaction, and host-choice behavior studies, with the aim to understand how coevolutionary interactions evolve in Drosophila-parasitoid island populations. The study focused on the three most abundant Drosophila species in Ryukyu archipelago and Taiwan: D. albomicans, D. bipectinata, and D. takahashii, and the Drosophila-parasitoid Leptopilina ryukyuensis. We determined mitochondrial COI haplotypes for samples representing five island populations of Drosophila and four island populations of L. ryukyuensis. We additionally sequenced parts of the autosomal Gpdh for Drosophila samples, and the ITS2 for parasitoid samples. Phylogenetic and coalescent analyses were used to test for demographic events and to place them in a temporal framework. Geographical differences in Drosophilaparasitoid interactions were studied in host-acceptance, host-suitability, and host-choice experiments. All four species showed species-specific phylogeographic patterns. A general trend of the haplotype diversity increasing towards the south was observed. D. albomicans showed very high COI haplotype diversity, and had the most phylogeographically structured populations, with differentiation into the northern and the southern population-group, divided by the Kerama gap. Differentiation in host suitability was observed only between highly structured populations of D. albomicans, possibly facilitated by restricted gene flow. Differentiation in host-acceptance in D. takahashii, and host-acceptance and host-choice in L. ryukyuensis was found, despite there being no differentiation in these two species according to molecular markers. Host choice assays show that L. ryukyuensis populations that have had more time to coevolve adapt their behavior to exploit the most suitable host - D. albomicans. L. ryukyuensis parasitoids on border ranges may, on the other hand, benefit from broader host-acceptance, that may facilitate adaptation to uncertain and variable environments. All results indicate that Drosophila-parasitoid populations in the Ryukyu archipelago and Taiwan have different evolutionary trajectories, and coevolve in a dynamic, complex, and local-specific way.	[Novkovic, Biljana; Kimura, Masahito T.] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan	Hokkaido University	Novkovic, B (corresponding author), Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan.	biljanan@ees.hokudai.ac.jp		Novkovic, Biljana/0000-0002-7854-5006				Althoff DM, 2008, MOL ECOL, V17, P3917, DOI 10.1111/j.1365-294X.2008.03874.x; Althoff DM, 1999, EVOLUTION, V53, P818, DOI 10.1111/j.1558-5646.1999.tb05375.x; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Benkman CW, 2001, EVOLUTION, V55, P282, DOI 10.1111/j.0014-3820.2001.tb01293.x; Brodie ED, 2002, EVOLUTION, V56, P2067; Carroll SP, 1997, EVOLUTION, V51, P1182, DOI [10.1111/j.1558-5646.1997.tb03966.x, 10.2307/2411048]; CHANG HY, 1989, J MOL EVOL, V28, P337, DOI 10.1007/BF02103430; Chen Weijing, 1994, Acta Genetica Sinica, V21, P179; Chesser RK, 1996, GENETICS, V144, P1225; Chiang TY, 2006, TAXON, V55, P31, DOI 10.2307/25065526; Dubuffet A, 2006, PHYSIOL ENTOMOL, V31, P170, DOI 10.1111/j.1365-3032.2006.00505.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Filatov DA, 2009, BIOINFORMATICS, V25, P3189, DOI 10.1093/bioinformatics/btp572; Fitzpatrick BM, 2009, MOL ECOL, V18, P3961, DOI 10.1111/j.1365-294X.2009.04314.x; Fu YX, 1997, GENETICS, V147, P915; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hawkins BA, 1994, PATTERN PROCESS HOST; Hayward A, 2006, MOL ECOL, V15, P479, DOI 10.1111/j.1365-294X.2005.02811.x; Hirai Yoshiyuki, 2000, Entomological Science, V3, P273; Hurtado LA, 2004, MOL ECOL, V13, P1365, DOI 10.1111/j.1365-294X.2004.02169.x; Kimura M., 2000, TROPICS, V10, P5, DOI [10.3759/tropics.10.5, DOI 10.3759/TROPICS.10.5]; Kimura MT, 2012, J NAT HIST, V46, P1947, DOI 10.1080/00222933.2012.707239; Kohnen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047156; Kondo M, 2008, ENTOMOL SCI, V11, P7, DOI 10.1111/j.1479-8298.2007.00250.x; Kopp A, 2005, GENET RES, V85, P23, DOI 10.1017/S0016672305007317; KRAAIJEVELD AR, 1994, PHYSIOL ENTOMOL, V19, P9, DOI 10.1111/j.1365-3032.1994.tb01068.x; Lapchin L, 2002, AM NAT, V160, P245, DOI 10.1086/341020; MANTEL N, 1967, CANCER RES, V27, P209; Markow TA, 2000, OIKOS, V89, P378, DOI 10.1034/j.1600-0706.2000.890219.x; Moraes EM, 2009, J BIOGEOGR, V36, P2136, DOI 10.1111/j.1365-2699.2009.02145.x; Motokawa M., 2000, TROPICS, V10, P63, DOI [10.3759/tropics.10.63, DOI 10.3759/TR0PICS.10.63]; Nicholls JA, 2010, MOL ECOL, V19, P592, DOI 10.1111/j.1365-294X.2009.04499.x; Novkovic B, 2012, EUR J ENTOMOL, V109, P517, DOI 10.14411/eje.2012.065; Novkovic B, 2011, ENTOMOL SCI, V14, P333, DOI 10.1111/j.1479-8298.2011.00459.x; OHSAKO T, 1994, JPN J GENET, V69, P183, DOI 10.1266/jjg.69.183; Osozawa S, 2012, INT GEOL REV, V54, P1369, DOI 10.1080/00206814.2011.639954; Ota H, 1998, RES POPUL ECOL, V40, P189, DOI 10.1007/BF02763404; Otsuka H., 2000, TROPICS, V10, P25, DOI [10.3759/tropics.10.25, DOI 10.3759/TROPICS.10.25]; Pannebakker BA, 2008, ENTOMOL EXP APPL, V127, P48, DOI 10.1111/j.1570-7458.2008.00666.x; Prugnolle F, 2002, HEREDITY, V88, P161, DOI 10.1038/sj.hdy.6800060; R Core Team, 2021, R LANGUAGE ENV STAT; Ravikumar H, 2011, J GENET, V90, P507; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schneider S, 1999, GENETICS, V152, P1079; SLATKIN M, 1991, GENETICS, V129, P555; Su XZ, 1999, SCIENCE, V286, P1351, DOI 10.1126/science.286.5443.1351; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson J. N., 2005, INTERSPEC INTERACT; WANG W, 1994, SCI CHINA SER B, V37, P1329; WATANABE TK, 1983, JPN J GENET, V58, P269, DOI 10.1266/jjg.58.269; Watase S, 1912, ANNOT ZOOL JAPON, V8, P108; Withers T., 2005, Second International Symposium on Biological Control of Arthropods, Davos, Switzerland, 12-16 September, 2005, P620; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064	56	3	3	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129132	10.1371/journal.pone.0129132	http://dx.doi.org/10.1371/journal.pone.0129132			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070158	Green Submitted, Green Published, gold			2022-12-26	WOS:000356327000052
J	Yan, R; Zhang, YM; Cai, DW; Liu, YJ; Cuconati, A; Guo, HT				Yan, Ran; Zhang, Yongmei; Cai, Dawei; Liu, Yuanjie; Cuconati, Andrea; Guo, Haitao			Spinoculation Enhances HBV Infection in NTCP-Reconstituted Hepatocytes	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; CLOSED CIRCULAR DNA; TAUROCHOLATE COTRANSPORTING POLYPEPTIDE; MEDIATED GENE-TRANSFER; CENTRIFUGAL ENHANCEMENT; MEMBRANE TRANSPORTER; CYCLOSPORINE-A; ENTRY; CELLS; IDENTIFICATION	Hepatitis B virus (HBV) infection and its sequelae remain a major public health burden, but both HBV basic research and the development of antiviral therapeutics have been hindered by the lack of an efficient in vitro infection system. Recently, sodium taurocholate cotransporting polypeptide (NTCP) has been identified as the HBV receptor. We herein report that we established a NTCP-complemented HepG2 cell line (HepG2-NTCP12) that supports HBV infection, albeit at a low infectivity level following the reported infection procedures. In our attempts to optimize the infection conditions, we found that the centrifugation of HepG2-NTCP12 cells during HBV inoculation (termed "spinoculation") significantly enhanced the virus infectivity. Moreover, the infection level gradually increased with accelerated speed of spinoculation up to 1,000g tested. However, the enhancement of HBV infection was not significantly dependent upon the duration of centrifugation. Furthermore, covalently closed circular (ccc) DNA was detected in infected cells under optimized infection condition by conventional Southern blot, suggesting a successful establishment of HBV infection after spinoculation. Finally, the parental HepG2 cells remained uninfected under HBV spinoculation, and HBV entry inhibitors targeting NTCP blocked HBV infection when cells were spinoculated, suggesting the authentic virus entry mechanism is unaltered under centrifugal inoculation. Our data suggest that spinoculation could serve as a standard protocol for enhancing the efficiency of HBV infection in vitro.	[Yan, Ran; Cai, Dawei; Liu, Yuanjie; Guo, Haitao] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Zhang, Yongmei] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200040, Peoples R China; [Cuconati, Andrea] Hepatitis B Fdn, Baruch S Blumberg Inst, Doylestown, PA 18902 USA	Indiana University System; Indiana University Bloomington; Fudan University	Guo, HT (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	haitguo@iupui.edu	Cuconati, Andrea/GWV-4662-2022; Cuconati, Andrea/AAI-7533-2020	Cuconati, Andrea/0000-0001-5123-0381	National Institutes of Health [R01AI094474, R21AI103838]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094474, R21AI103838] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health (grant numbers R01AI094474 and R21AI103838, http://nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asabe S, 2009, J VIROL, V83, P9652, DOI 10.1128/JVI.00867-09; BAHNSON AB, 1995, J VIROL METHODS, V54, P131, DOI 10.1016/0166-0934(95)00035-S; Bardens A, 2011, CELL MICROBIOL, V13, P602, DOI 10.1111/j.1462-5822.2010.01557.x; Block Timothy M, 2007, Clin Liver Dis, V11, P685, DOI 10.1016/j.cld.2007.08.002; BUNNELL BA, 1995, P NATL ACAD SCI USA, V92, P7739, DOI 10.1073/pnas.92.17.7739; Cai Dawei, 2013, Methods Mol Biol, V1030, P151, DOI 10.1007/978-1-62703-484-5_13; Cai DW, 2012, ANTIMICROB AGENTS CH, V56, P4277, DOI 10.1128/AAC.00473-12; Chai N, 2008, J VIROL, V82, P7812, DOI 10.1128/JVI.00561-08; Gao WF, 2007, J VIROL, V81, P6164, DOI 10.1128/JVI.02721-06; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Guo H, 2007, J VIROL, V81, P12472, DOI 10.1128/JVI.01123-07; Guo HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043270; Guo HT, 2011, ANTIMICROB AGENTS CH, V55, P478, DOI 10.1128/AAC.00989-10; Guo HT, 2010, J VIROL, V84, P387, DOI 10.1128/JVI.01921-09; Guo J, 2011, J VIROL, V85, P9824, DOI 10.1128/JVI.05170-11; HAGENBUCH B, 1994, J CLIN INVEST, V93, P1326, DOI 10.1172/JCI117091; HO WZ, 1993, J LEUKOCYTE BIOL, V53, P208, DOI 10.1002/jlb.53.2.208; Huang HC, 2012, J VIROL, V86, P9443, DOI 10.1128/JVI.00873-12; HUDSON JB, 1976, VIROLOGY, V72, P235, DOI 10.1016/0042-6822(76)90326-3; Iwamoto M, 2014, BIOCHEM BIOPH RES CO, V443, P808, DOI 10.1016/j.bbrc.2013.12.052; Kotani N, 2012, MOL PHARMACEUT, V9, P3434, DOI 10.1021/mp300171p; Lindenbach BD, 2013, NAT REV MICROBIOL, V11, P688, DOI 10.1038/nrmicro3098; Mao RC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003494; Ni Y, 2014, GASTROENTEROLOGY, V146, P1070, DOI 10.1053/j.gastro.2013.12.024; Ning XJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002255; Nkongolo S, 2014, J HEPATOL, V60, P723, DOI 10.1016/j.jhep.2013.11.022; NybergHoffman C, 1997, NAT MED, V3, P808, DOI 10.1038/nm0797-808; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; OSBORN JE, 1968, J VIROL, V2, P853, DOI 10.1128/JVI.2.9.853-858.1968; PADGETT BL, 1962, P SOC EXP BIOL MED, V111, P364; Park IH, 2014, ANTIVIR RES, V104, P118, DOI 10.1016/j.antiviral.2014.01.021; Reading SA, 2001, J VIROL METHODS, V98, P167, DOI 10.1016/S0166-0934(01)00368-8; Scanlan PM, 2005, J VIROL METHODS, V128, P104, DOI 10.1016/j.jviromet.2005.04.008; Schulze A, 2007, HEPATOLOGY, V46, P1759, DOI 10.1002/hep.21896; Schulze-Bergkamen H, 2003, J HEPATOL, V38, P736, DOI 10.1016/S0168-8278(03)00120-X; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Seeger C, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.68; Seeger C, 2013, GUT, V62, P1093, DOI 10.1136/gutjnl-2013-304594; SUNDIN DR, 1989, J CLIN MICROBIOL, V27, P1659, DOI 10.1128/JCM.27.7.1659-1660.1989; TENSER RB, 1978, INFECT IMMUN, V21, P281, DOI 10.1128/IAI.21.1.281-285.1978; Tong SP, 2014, GASTROENTEROLOGY, V146, P902, DOI 10.1053/j.gastro.2014.02.024; Trepo C, 2014, LANCET, V384, P2053, DOI 10.1016/S0140-6736(14)60220-8; Watashi K, 2014, HEPATOLOGY, V59, P1726, DOI 10.1002/hep.26982; Yan H, 2014, J VIROL, V88, P3273, DOI 10.1128/JVI.03478-13; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; Ye L, 2008, J VIROL METHODS, V148, P161, DOI 10.1016/j.jviromet.2007.11.002; Zhang YM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110442	47	48	50	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129889	10.1371/journal.pone.0129889	http://dx.doi.org/10.1371/journal.pone.0129889			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070202	gold, Green Submitted, Green Published			2022-12-26	WOS:000356327000119
J	Zhang, K; Wang, LN; Lin, GG; Sun, Y; Zhang, R; Xie, JH; Li, JM				Zhang, Kuo; Wang, Lunan; Lin, Guigao; Sun, Yu; Zhang, Rui; Xie, Jiehong; Li, Jinming			Results of the National External Quality Assessment for Toxoplasmosis Serological Testing in China	PLOS ONE			English	Article							IMMUNOGLOBULIN-G IGG; GONDII INFECTION; ANTIBODIES; CYTOMEGALOVIRUS; SERODIAGNOSIS; IMMUNOASSAY; STRATEGIES; VIRUS	Background Toxoplasmosis is typically diagnosed by serologic testing. External quality assessment (EQA) of clinical laboratories could ensure the accuracy and reliability of serological tests. We assessed the quality of toxoplasma serological assays in Chinese clinical laboratories by an EQA performed between 2004 and 2013 by the National Center for Clinical Laboratories. Methodology and Findings EQA panels were prepared and shipped at room temperature to participating laboratories that employed toxoplasma IgG and IgM serological detection. By 2013, 5,384 EQA test reports for toxoplasma-specific IgM and 2,666 reports for toxoplasma-specific IgG were collected. Enzyme-linked immunosorbent (ELISA) and chemical immunofluorescent assays were the most commonly used detection methods. The overall coincidence rates of negative samples were better than those of positive samples. The overall EQA score for toxoplasma-specific IgM detection ranged between 84.3% and 99.6%. The ratio of laboratories that achieved correct IgG detection ranged from 61.1% to 99.3%. However, the inter-and intra-assay variabilities were found to be considerable. The most common problem was failure to detect low titers of antibody. Conclusion The EQA scheme showed an improvement in toxoplasma serological testing in China. However, further optimization of assay sensitivity to detect challenging samples remains a future challenge.	[Zhang, Kuo; Wang, Lunan; Lin, Guigao; Sun, Yu; Zhang, Rui; Xie, Jiehong; Li, Jinming] Beijing Hosp, Natl Ctr Clin Labs, Beijing, Peoples R China; [Zhang, Kuo; Li, Jinming] Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch, Beijing 100730, Peoples R China	Beijing Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Li, JM (corresponding author), Beijing Hosp, Natl Ctr Clin Labs, Beijing, Peoples R China.	jmli@nccl.org.cn	Wang, Lunan/AAS-9785-2021	Wang, Lunan/0000-0003-3163-7891	National Natural Science Foundation of China [81201347]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (81201347). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binnicker MJ, 2010, CLIN VACCINE IMMUNOL, V17, P1734, DOI 10.1128/CVI.00332-10; Curdt I, 2009, J CLIN MICROBIOL, V47, P603, DOI 10.1128/JCM.01076-08; Gilligan PH, 2004, J CLIN MICROBIOL, V42, P1391, DOI 10.1128/JCM.42.4.1391-1395.2004; Guzel O, 2009, CLIN BIOCHEM, V42, P274, DOI 10.1016/j.clinbiochem.2008.09.011; Hofgartner WT, 1997, J CLIN MICROBIOL, V35, P3313; Holec-Gasior L, 2013, CLIN VACCINE IMMUNOL, V20, P1343, DOI 10.1128/CVI.00117-13; Jenum PA, 1998, J CLIN MICROBIOL, V36, P2907, DOI 10.1128/JCM.36.10.2907-2913.1998; Joynson DHM, 2001, TOXOPLASMOSIS COMPRE; Manser MM, 2010, J CLIN PATHOL, V63, P1112, DOI 10.1136/jcp.2010.077214; Remington JS, 2004, J CLIN MICROBIOL, V42, P941, DOI 10.1128/JCM.42.3.941-945.2004; Robert-Gangneux F, 2012, CLIN MICROBIOL REV, V25, P264, DOI 10.1128/CMR.05013-11; Roberts A, 2001, EUR J CLIN MICROBIOL, V20, P467; Saadatnia G, 2012, SCAND J INFECT DIS, V44, P805, DOI 10.3109/00365548.2012.693197; TSUDA F, 1984, GASTROENTEROLOGY, V87, P159; Wilson M, 1997, J CLIN MICROBIOL, V35, P3112, DOI 10.1128/JCM.35.12.3112-3115.1997; Xiao Y, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-4	16	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130003	10.1371/journal.pone.0130003	http://dx.doi.org/10.1371/journal.pone.0130003			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066047	Green Submitted, Green Published, gold			2022-12-26	WOS:000356327000132
J	Cadario, F; Savastio, S; Magnani, C; Cena, T; Pagliardini, V; Bellomo, G; Bagnati, M; Vidali, M; Pozzi, E; Pamparana, S; Zaffaroni, M; Genoni, G; Bona, G				Cadario, Francesco; Savastio, Silvia; Magnani, Corrado; Cena, Tiziana; Pagliardini, Veronica; Bellomo, Giorgio; Bagnati, Marco; Vidali, Matteo; Pozzi, Erica; Pamparana, Stella; Zaffaroni, Mauro; Genoni, Giulia; Bona, Gianni			High Prevalence of Vitamin D Deficiency in Native versus Migrant Mothers and Newborns in the North of Italy: A Call to Act with a Stronger Prevention Program	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; D SUPPLEMENTATION; D INSUFFICIENCY; CORD-BLOOD; PREGNANCY; RISK; IMMUNOASSAYS; VALIDITY; HEALTH	Background Vitamin D status during pregnancy is related to neonatal vitamin D status. Vitamin D deficiency has been associated with an increased risk of rickets in children and osteomalacia in adults. Aim of this study was to investigate 25OHD levels in maternal serum and in neonatal blood spots in native and migrant populations living in Novara (North Italy, 45 degrees N latitude). Methods and Findings We carried out a cross sectional study from April 1st 2012 to March 30th 2013, in a tertiary Care Center. Maternal blood samples after delivery and newborns' blood spots were analyzed for 25OHD levels in 533 pairs. Maternal country of origin, skin phototype, vitamin D dietary intake and supplementation during pregnancy were recorded. Multivariate regression analysis, showed a link between neonatal and maternal 25OHD levels (R-square: 0.664). Severely deficient 25OHD values (<25 nmol/L) were found in 38% of Italian and in 76.2% of migrant's newborns (p < 0.0001), and in 18% of Italian and 48,4% of migrant mothers (p < 0.0001) while 25OHD deficiency (>= 25 and <50 nmol/L) was shown in 40.1% of Italian and 21.7% of migrant's newborns (p < 0.0001), and in 43.6% of Italian and 41.3% of migrant mothers (p < 0.0001). Italian newborns and mothers had higher 25OHD levels (34.4 +/- 19.2 and 44.9 +/- 21.2nmol/L) than migrants (17.7 +/- 13.7 and 29.7 +/- 16.5nmol/L; p < 0.0001). A linear decrease of 25OHD levels was found with increasing skin pigmentation (phototype I 42.1 +/- 18.2 vs phototype VI 17.9 +/- 10.1 nmol/l; p < 0.0001). Vitamin D supplementation resulted in higher 25OHD values both in mothers and in their newborns (p < 0.0001). Conclusions Vitamin D insufficiency in pregnancy and in newborns is frequent especially among migrants. A prevention program in Piedmont should urgently be considered and people identified as being at risk should be closely monitored. Vitamin D supplementation should be taken into account when considering a preventative health care policy.	[Cadario, Francesco; Savastio, Silvia; Pozzi, Erica; Pamparana, Stella; Zaffaroni, Mauro; Genoni, Giulia; Bona, Gianni] Univ Piemonte Orientale Amedeo Avogadro, Dept Hlth Sci, Div Pediat, Novara, Italy; [Cadario, Francesco; Bona, Gianni] IRCAD Interdisciplinary Res Ctr Autoimmune Dis, Novara, Italy; [Magnani, Corrado; Cena, Tiziana] Univ Piemonte Orientale Amedeo Avogadro, Dept Translat Med, Unit Med Stat & Canc Epidemiol, Novara, Italy; [Magnani, Corrado; Cena, Tiziana] CPO Piemonte, Novara, Italy; [Pagliardini, Veronica] Univ Turin, Turin, Italy; [Bellomo, Giorgio; Bagnati, Marco; Vidali, Matteo] Univ Piemonte Orientale Amedeo Avogadro, Cent Lab, Maggiore Carita Hosp, Novara, Italy	University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; Centro di Riferimento per Epidemiologia e la Prevenzione Oncologica in Piemonte; University of Turin; University of Eastern Piedmont Amedeo Avogadro	Cadario, F (corresponding author), Univ Piemonte Orientale Amedeo Avogadro, Dept Hlth Sci, Div Pediat, Novara, Italy.	francesco.cadario@maggioreosp.novara.it	Pozzi, Erica/AAC-2570-2022; Vidali, Matteo/T-2621-2019; Cadario, Francesco/AAA-1240-2019; Savastio, Silvia/AAC-6475-2022	Pozzi, Erica/0000-0003-0937-8010; Vidali, Matteo/0000-0001-9991-7502; Savastio, Silvia/0000-0002-5867-3246; Cadario, Francesco/0000-0001-8808-834X	De Agostini Foundation of Novara	De Agostini Foundation of Novara	This work was supported by De Agostini Foundation of Novara.	Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7; Baiz N, 2014, J ALLERGY CLIN IMMUN, V133, P147, DOI 10.1016/j.jaci.2013.05.017; Basile LA, 2007, J PERINATOL, V27, P568, DOI 10.1038/sj.jp.7211796; Bertino E, 2010, J PEDIATR GASTR NUTR, V51, P353, DOI 10.1097/MPG.0b013e3181da213e; Bodnar LM, 2010, J NUTR, V140, P999, DOI 10.3945/jn.109.119636; Bollati V, 2010, HEREDITY, V105, P105, DOI 10.1038/hdy.2010.2; Cadario F, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-35; Camargo CA, 2011, PEDIATRICS, V127, pE180, DOI 10.1542/peds.2010-0442; Cheung CL, 2013, J HUM GENET, V58, P749, DOI 10.1038/jhg.2013.84; Cooper JD, 2011, DIABETES, V60, P1624, DOI 10.2337/db10-1656; De-Regil LM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008873.pub2; Elkum N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113102; Eyles D, 2009, CLIN CHIM ACTA, V403, P145, DOI 10.1016/j.cca.2009.02.005; Eyles DW, 2010, PAEDIATR PERINAT EP, V24, P303, DOI 10.1111/j.1365-3016.2010.01105.x; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Gaggero M, 2010, Minerva Ginecol, V62, P91; Gallo S, 2013, J NUTR, V143, P148, DOI 10.3945/jn.112.167858; Grant C.C., 2014, PEDIATRICS, V133, P143, DOI [DOI 10.1002/YD.20107, 10.1542/peds.2013-2602]; Heaney RP, 2008, AM J CLIN NUTR, V88, p541S, DOI 10.1093/ajcn/88.2.541S; Hewison M, 2012, CLIN ENDOCRINOL, V76, P315, DOI 10.1111/j.1365-2265.2011.04261.x; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hollis BW, 2006, AM J CLIN NUTR, V84, P273; Hollis BW, 2013, CALCIFIED TISSUE INT, V92, P128, DOI 10.1007/s00223-012-9607-4; Hollis BW, 2011, J BONE MINER RES, V26, P2341, DOI 10.1002/jbmr.463; Hsu SA, 2013, J STEROID BIOCHEM, V136, P139, DOI 10.1016/j.jsbmb.2012.11.005; Kinder BW, 2011, EXPERT REV CLIN IMMU, V7, P255, DOI [10.1586/eci.11.12, 10.1586/ECI.11.12]; Koivula MK, 2013, CLIN LAB, V59, P397, DOI 10.7754/Clin.Lab.2012.120527; Lai JKC, 2010, MOL NUTR FOOD RES, V54, P1062, DOI 10.1002/mnfr.200900468; Mutlu GY, 2014, HORM RES PAEDIAT, V81, P402, DOI 10.1159/000358833; Pisani P, 1997, INT J EPIDEMIOL, V26, pS152, DOI 10.1093/ije/26.suppl_1.S152; Raab J, 2014, DIABETOLOGIA, V57, P902, DOI 10.1007/s00125-014-3181-4; Ross AC, 2011, Dietary Reference Intakes for Calcium and Vitamin D, P1; Thandrayen K, 2012, RHEUM DIS CLIN N AM, V38, P61, DOI 10.1016/j.rdc.2012.03.007; Thorne-Lyman A, 2012, PAEDIATR PERINAT EP, V26, P75, DOI 10.1111/j.1365-3016.2012.01283.x; Trump DL, 2010, CANCER J, V16, P1, DOI 10.1097/PPO.0b013e3181c51ee6; Wacker M, 2013, NUTRIENTS, V5, P111, DOI 10.3390/nu5010111; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Weinert LS, 2014, MATERN CHILD HLTH J, P19; Yap C, 2014, DIABETES CARE, V37, P1837, DOI 10.2337/dc14-0155	39	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129586	10.1371/journal.pone.0129586	http://dx.doi.org/10.1371/journal.pone.0129586			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067469	gold, Green Published, Green Submitted			2022-12-26	WOS:000356100900059
J	Dozolme, D; Brunet-Gouet, E; Passerieux, C; Amorim, MA				Dozolme, Dorian; Brunet-Gouet, Eric; Passerieux, Christine; Amorim, Michel-Ange			Neuroelectric Correlates of Pragmatic Emotional Incongruence Processing: Empathy Matters	PLOS ONE			English	Article							EXPRESSION; N400; VALIDATION; POTENTIALS; QUOTIENT; N170	The emotions people feel can be simulated internally based on emotional situational contexts. In the present study, we assessed the behavioral and neuroelectric effects of seeing an unexpected emotional facial expression. We investigated the correct answer rate, response times and Event-Related Potential (ERP) effects during an incongruence paradigm between emotional faces and sentential contexts allowing emotional inferences. Most of the 36 healthy participants were recruited from a larger population (1 463 subjects), based on their scores on the Empathy Questionnaire (EQ). Regression analyses were conducted on these ratings using EQ factors as predictors (cognitive empathy, emotional reactivity and social skills). Recognition of pragmatic emotional incongruence was less accurate (P < .05) and slower (P < .05) than recognition of congruence. The incongruence effect on response times was inversely predicted by social skills. A significant N400 incongruence effect was found at the centro-parietal (P < .001) and centro-posterior midline (P < .01) electrodes. Cognitive empathy predicted the incongruence effect in the left occipital region, in the N400 time window. Finally, incongruence effects were also found on the LPP wave, in frontal midline and dorso-frontal regions, (P < .05), with no modulation by empathy. Processing pragmatic emotional incongruence is more cognitively demanding than congruence (as reflected by both behavioral and ERP data). This processing shows modulation by personality factors at the behavioral (through self-reported social skills) and neuroelectric levels (through self-reported cognitive empathy).	[Dozolme, Dorian; Amorim, Michel-Ange] Univ Paris 11, Lab CIAMS Complexite Innovat Act Motrices & Sport, Orsay, France; [Brunet-Gouet, Eric; Passerieux, Christine] Univ Versailles St Quentin, Ctr Hosp Versailles, HandiResp Rech Clin & Sante Publ Handicaps Psych, EA4047, Le Chesnay, France	UDICE-French Research Universities; Universite Paris Saclay; Centre Hospitalier de Versailles; UDICE-French Research Universities; Universite Paris Saclay	Dozolme, D (corresponding author), Univ Paris 11, Lab CIAMS Complexite Innovat Act Motrices & Sport, Orsay, France.	dorian.dozolme@u-psud.fr	Amorim, Michel-Ange/E-7209-2017; brunet-gouet, eric/AAR-5741-2020	Amorim, Michel-Ange/0000-0002-8455-1437; brunet-gouet, eric/0000-0002-3784-7817; Dozolme, Dorian/0000-0001-9843-4277	Agence Nationale de la Recherche, EMCO (COMPARSE project)	Agence Nationale de la Recherche, EMCO (COMPARSE project)(French National Research Agency (ANR))	The reported research was funded by a grant from Agence Nationale de la Recherche, EMCO 2011 (COMPARSE project), received by MAA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado L, 2013, COGN AFFECT BEHAV NE, V13, P284, DOI 10.3758/s13415-012-0137-3; Baetens K, 2011, BRAIN RES, V1418, P83, DOI 10.1016/j.brainres.2011.08.067; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Berthoz S, 2008, CAN J PSYCHIAT, V53, P469, DOI 10.1177/070674370805300712; Chakrabarti B, 2006, SOC NEUROSCI-UK, V1, P364, DOI 10.1080/17470910601041317; Chung G, 1996, PSYCHOPHYSIOLOGY, V33, P218, DOI 10.1111/j.1469-8986.1996.tb00419.x; Courgeon M, 2008, PROCEEDINGS OF THE A; Delaney-Busch N, 2013, COGN AFFECT BEHAV NE, V13, P473, DOI 10.3758/s13415-013-0159-5; deVega M, 1996, COGNITION EMOTION, V10, P303; Dieguez-Risco T, 2013, SOC NEUROSCI-UK, V8, P601, DOI 10.1080/17470919.2013.834842; Ekman P, 2003, UNMASKING THE FACE A; Farina E., 2007, PSYCHOL LANGUAGE COM, V11, P3; Ferstl EC, 2005, J COGNITIVE NEUROSCI, V17, P724, DOI 10.1162/0898929053747658; Forabosco Giovannantonio, 2008, LODZ PAPERS PRAGMATI, V4, P45, DOI DOI 10.2478/V10016-008-0003-5; GERNSBACHER MA, 1992, COGNITION EMOTION, V6, P89, DOI 10.1080/02699939208411061; Hietanen JK, 2013, BIOL PSYCHOL, V92, P114, DOI 10.1016/j.biopsycho.2012.10.005; Ibanez A, 2012, SOC NEUROSCI-UK, V7, P632, DOI 10.1080/17470919.2012.691078; Krombholz A, 2007, BIOL PSYCHOL, V76, P156, DOI 10.1016/j.biopsycho.2007.07.004; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lawrence EJ, 2004, PSYCHOL MED, V34, P911, DOI 10.1017/S0033291703001624; Leon I, 2010, EMOTION, V10, P863, DOI 10.1037/a0019983; Leuthold H, 2012, SOC COGN AFFECT NEUR, V7, P457, DOI 10.1093/scan/nsr029; Moreno EM, 2011, BIOL PSYCHOL, V88, P131, DOI 10.1016/j.biopsycho.2011.07.003; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Rak N, 2009, DOES THE SEMANTIC IN; Russ JB, 2008, BEHAV RES METHODS, V40, P935, DOI 10.3758/BRM.40.4.935; Schendan HE, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00329; Siemer M, 2007, EMOTION, V7, P1, DOI 10.1037/1528-3542.7.1.1; Van Berkum JJA, 2009, PSYCHOL SCI, V20, P1092, DOI 10.1111/j.1467-9280.2009.02411.x; van den Brink D, 2012, SOC COGN AFFECT NEUR, V7, P173, DOI 10.1093/scan/nsq094; Zwaan RA, 2004, PSYCHOL LEARN MOTIV, V44, P35; Zwaan RolfA., 2005, GROUNDING COGNITION, P224, DOI DOI 10.1017/CBO9780511499968.010	32	8	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129770	10.1371/journal.pone.0129770	http://dx.doi.org/10.1371/journal.pone.0129770			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK3FB	26067672	Green Submitted, gold, Green Published			2022-12-26	WOS:000356100900076
J	Chen, Y; Wang, YY; Zhao, T; Yang, JW; Feng, SL; Nazeer, W; Zhang, TZ; Zhou, BL				Chen, Yu; Wang, Yingying; Zhao, Ting; Yang, Jianwei; Feng, Shouli; Nazeer, Wajad; Zhang, Tianzhen; Zhou, Baoliang			A New Synthetic Amphiploid (AADDAA) between Gossypium hirsutum and G-arboreum Lays the Foundation for Transferring Resistances to Verticillium and Drought	PLOS ONE			English	Article							GENETIC DIVERSITY; INTERSPECIFIC HYBRIDIZATION; LINKAGE MAP; COTTON; L.; EVOLUTION; GROWTH	Gossypium arboreum, a cultivated cotton species (2n = 26, AA) native to Asia, possesses invaluable characteristics unavailable in the tetraploid cultivated cotton gene pool, such as resistance to pests and diseases and tolerance to abiotic stresses. However, it is quite difficult to transfer favorable traits into Upland cotton through conventional methods due to the cross-incompatibility of G. hirsutum (2n = 52, AADD) and G. arboreum. Here, we improved an embryo rescue technique to overcome the cross-incompatibility between these two parents for transferring favorable genes from G. arboreum into G. hirsutum. Our results indicate that MSB2K supplemented with 0.5 mgl(-1) kinetin and 250 mg(-1) casein hydrolysate is an efficient initial medium for rescuing early (3 d after pollination) hybrid embryos. Eight putative hybrids were successfully obtained, which were further verified and characterized by cytology, molecular markers and morphological analysis. The putative hybrids were subsequently treated with different concentrations of colchicine solution to double their chromosomes. The results demonstrate that four putative hybrid plants were successfully chromosome-doubled by treatment with 0.1% colchicine for 24 h and become amphiploid, which were confirmed by cytological observation, self-fertilization and backcrossing. Preliminary assessments of resistance at seedling stage indicate that the synthetic amphiploid showed highly resistant to Verticillium and drought. The synthetic amphiploid between G. hirsutum x G. arboreum would lay the foundation for developing G. arboreum-introgressed lines with the uniform genetic background of G. hirsutum acc TM-1, which would greatly enhance and simplify the mining, isolation, characterization, cloning and use of G. arboreum-specific desirable genes in future cotton breeding programs.	[Chen, Yu; Wang, Yingying; Zhao, Ting; Yang, Jianwei; Feng, Shouli; Nazeer, Wajad; Zhang, Tianzhen; Zhou, Baoliang] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, MOE Hybrid Cotton R&D Engn Res Ctr, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Zhou, BL (corresponding author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, MOE Hybrid Cotton R&D Engn Res Ctr, Nanjing, Jiangsu, Peoples R China.	baoliangzhou@njau.edu.cn	Nazeer, Wajad/P-7943-2014	Nazeer, Wajad/0000-0001-7479-6409	National Key Technology Support Program of China [2013BAD01B03-04]; Independent Innovation Funds for Agricultural Technology of Jiangsu Province, China [CX (14) 2065]; Jiangsu Collaborative Innovation Center for Modern Crop Production; National Natural Science Foundation of China [30571184, 31271771]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Key Technology Support Program of China(National Key Technology R&D Program); Independent Innovation Funds for Agricultural Technology of Jiangsu Province, China; Jiangsu Collaborative Innovation Center for Modern Crop Production; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was financially supported in part by the National Key Technology Support Program of China during the Twelfth Five-year Plan Period [grant number 2013BAD01B03-04], the Independent Innovation Funds for Agricultural Technology of Jiangsu Province, China [grant number CX (14) 2065], Jiangsu Collaborative Innovation Center for Modern Crop Production, the National Natural Science Foundation of China [grant numbers 30571184, 31271771], and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar KP, 2010, ANN APPL BIOL, V157, P135, DOI 10.1111/j.1744-7348.2010.00416.x; BEASLEY CA, 1973, AM J BOT, V60, P130, DOI 10.2307/2441099; Campbell BT, 2010, CROP SCI, V50, P1161, DOI 10.2135/cropsci2009.09.0551; Chen Y, 2014, THEOR APPL GENET, V127, P1105, DOI 10.1007/s00122-014-2283-1; Eid AAH, 1973, CELLULE, V69, P361; Fang DD, 2013, EUPHYTICA, V191, P391, DOI 10.1007/s10681-013-0886-2; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; GERSTEL DU, 1956, EVOLUTION, V10, P408, DOI 10.2307/2407000; GILL MS, 1984, EUPHYTICA, V33, P305, DOI 10.1007/BF00021126; GILL MS, 1987, EUPHYTICA, V36, P625, DOI 10.1007/BF00041512; Gu B, 1993, ACTA GOSSYPII SINICA, V5, P79; Guo WZ, 2007, GENETICS, V176, P527, DOI 10.1534/genetics.107.070375; Gutierrez OA, 2002, CROP SCI, V42, P1841, DOI 10.2135/cropsci2002.1841; Iqbal MJ, 2001, THEOR APPL GENET, V103, P547, DOI 10.1007/PL00002908; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Liang ZL, 2002, SCI CHINA SER C, V45, P331, DOI 10.1360/02yc9036; Luo J, 2011, CHINA COTTON, V38, P25; Luo JunYu, 2012, Journal of Northwest A & F University - Natural Science Edition, V40, P81; Ma Z. Y., 1997, COTTON SCI, V9, P15; Ma ZhiYing, 1998, Journal of Hebei Agricultural University, V21, P1; Mehetre S. S., 2004, Indian Journal of Biotechnology, V3, P29; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Qian SY, 1992, SCI AGR SINICA, V25, P44, DOI [DOI 10.1093/GENETICS/51.5.689, 10.1093/genetics/51.5.689]; Sacks EJ, 2008, PLANT CELL TISS ORG, V93, P15, DOI 10.1007/s11240-007-9316-2; SCHONFELD MA, 1988, CROP SCI, V28, P526, DOI 10.2135/cropsci1988.0011183X002800030021x; Shi L. Y., 1997, COTTON SCI, V9, P273; STEWART JM, 1978, J HERED, V69, P404, DOI 10.1093/oxfordjournals.jhered.a108982; STEWART JMD, 1977, PLANTA, V137, P113, DOI 10.1007/BF00387547; Tahir MS, 2011, CYTOLOGIA, V76, P193, DOI 10.1508/cytologia.76.193; THENGANE S, 1986, PLANT CELL TISS ORG, V6, P209, DOI 10.1007/BF00040006; Tyagi P, 2014, THEOR APPL GENET, V127, P283, DOI 10.1007/s00122-013-2217-3; Van Becelaere G, 2005, CROP SCI, V45, P2281, DOI 10.2135/cropsci2004.0715; Wang K, 2006, THEOR APPL GENET, V113, P73, DOI 10.1007/s00122-006-0273-7; WENDEL JF, 1992, AM J BOT, V79, P1291, DOI 10.2307/2445058; Wu ZB, 1999, HUBEI AGR SCI, V5, P16; XIANG XL, 1989, CHINESE ASIAN COTTON; Yang C, 2008, PLANT SCI, V174, P290, DOI 10.1016/j.plantsci.2007.11.016; Zhang J, 2002, THEOR APPL GENET, V105, P1166, DOI 10.1007/s00122-002-1100-4; Zhang JinFa, 2000, Journal of Cotton Science, V4, P193; Zhang Ling, 2010, Cotton Science, V22, P110	41	13	14	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0128981	10.1371/journal.pone.0128981	http://dx.doi.org/10.1371/journal.pone.0128981			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061996	gold, Green Published, Green Submitted			2022-12-26	WOS:000355979500113
J	Hsing, CH; Chen, CL; Lin, WC; Lin, CF				Hsing, Chung-Hsi; Chen, Chia-Ling; Lin, Wei-Chieh; Lin, Chiou-Feng			Propofol Treatment Inhibits Constitutive Apoptosis in Human Primary Neutrophils and Granulocyte-Differentiated Human HL60 Cells	PLOS ONE			English	Article							SYNTHASE; ACTIVATION; PROTECTS; INJURY	Apoptosis regulation is essential for neutrophil homeostasis. We previously demonstrated that a process involving glycogen synthase kinase (GSK)-3 beta determines neutrophil apoptosis. As for this apoptotic process, an overdose of propofol (2,6-Diisopropylphenol; 25 mu g/ml or 140 mu M) also causes GSK-3 beta-mediated macrophage apoptosis; however, the early deactivation of GSK-3 beta with low-dose propofol has been shown. Therefore, we hypothesize that low-dose propofol may induce neutrophil survival via GSK-3 beta inactivation. Following in vitro culture, the therapeutic concentration of propofol (10 mu g/ml or 56 mu M) treatment decreased constitutive apoptosis in isolated human primary neutrophils and in granulocyte-differentiated HL60 cells after all-trans retinoic acid (1 mu M) treatment. The inactivation of phosphatidylinositol 3-kinase (PI3-kinase)/AKT and the activation of GSK-3 beta results in myeloid cell leukemia 1 (Mcl-1) down-regulation, the loss of the mitochondrial transmembrane potential, and caspase-3 activation in these cells, which is accompanied by apoptosis. Notably, propofol treatment attenuates these effects in a PI3-kinase-regulated manner. We found that propofol initiates PI3-kinase/AKT-mediated GSK-3 beta inactivation and Mcl-1 stabilization, rescuing the constitutive apoptosis in primary neutrophils and granulocyte-differentiated acute promyelocytic leukemia HL60 cells.	[Hsing, Chung-Hsi] Chi Mei Med Ctr, Dept Anesthesiol, Tainan, Taiwan; [Hsing, Chung-Hsi] Taipei Med Univ, Coll Med, Dept Anesthesiol, Taipei, Taiwan; [Chen, Chia-Ling] Taipei Med Univ, Translat Res Ctr, Taipei, Taiwan; [Lin, Wei-Chieh] Natl Cheng Kung Univ, Coll Med, Dept Internal Med, Tainan 70101, Taiwan; [Lin, Chiou-Feng] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Lin, Chiou-Feng] Taipei Med Univ, Coll Med, Dept Microbiol & Immunol, Taipei, Taiwan	Chi Mei Hospital; Taipei Medical University; Taipei Medical University; National Cheng Kung University; Taipei Medical University; Taipei Medical University	Lin, CF (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan.	cflin2014@tmu.edu.tw			Ministry of Science and Technology, Taiwan [MOST100-2320-B-006-009-MY3]; Chi Mei Medical Center [104CM-TMU-03]; Taipei Medical University, Taiwan	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Chi Mei Medical Center; Taipei Medical University, Taiwan	This work was supported by grants MOST100-2320-B-006-009-MY3 from Ministry of Science and Technology, Taiwan and 104CM-TMU-03 from Chi Mei Medical Center and Taipei Medical University, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown KA, 2006, LANCET, V368, P157, DOI 10.1016/S0140-6736(06)69005-3; Chang H, 2002, CAN J ANAESTH, V49, P477, DOI 10.1007/BF03017924; DAVIDSON JAH, 1995, BRIT J ANAESTH, V74, P315, DOI 10.1093/bja/74.3.315; Erol A, 2009, EUR J ANAESTH, V26, P150, DOI 10.1097/EJA.0b013e328319bfeb; Fox S, 2010, J INNATE IMMUN, V2, P216, DOI 10.1159/000284367; GEPTS E, 1987, ANESTH ANALG, V66, P1256; Hoesel LM, 2005, SHOCK, V24, P40, DOI 10.1097/01.shk.0000170353.80318.d5; Hofman Paul, 2004, Current Drug Targets - Inflammation and Allergy, V3, P1, DOI 10.2174/1568010043483935; Hsing CH, 2012, ANESTHESIOLOGY, V116, P868, DOI 10.1097/ALN.0b013e31824af68a; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kim Won Ho, 2011, Acta Anaesthesiol Taiwan, V49, P83, DOI 10.1016/j.aat.2011.08.004; Klein JB, 2000, J IMMUNOL, V164, P4286, DOI 10.4049/jimmunol.164.8.4286; Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004; Luo HBR, 2008, AM J HEMATOL, V83, P288, DOI 10.1002/ajh.21078; MACKENZIE N, 1987, ANAESTHESIA, V42, P3, DOI 10.1111/j.1365-2044.1987.tb02936.x; Marik PE, 2005, PHARMACOTHERAPY, V25, p28S, DOI 10.1592/phco.2005.25.5_Part_2.28S; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Murphy PG, 1996, EUR J ANAESTH, V13, P471, DOI 10.1046/j.1365-2346.1996.00003.x; Takahashi-Yanaga F, 2013, BIOCHEM PHARMACOL, V86, P191, DOI 10.1016/j.bcp.2013.04.022; Trapani G, 2000, CURR MED CHEM, V7, P249, DOI 10.2174/0929867003375335; Vasile B, 2003, INTENS CARE MED, V29, P1417, DOI 10.1007/s00134-003-1905-x; Wang BH, 2009, BIOCHEM BIOPH RES CO, V389, P105, DOI 10.1016/j.bbrc.2009.08.097; Wang CY, 2014, BIOCHEM PHARMACOL, V88, P86, DOI 10.1016/j.bcp.2013.12.021; Wang HY, 2009, BRAIN RES, V1297, P177, DOI 10.1016/j.brainres.2009.08.054; Witko-Sarsat V, 2011, TRENDS IMMUNOL, V32, P117, DOI 10.1016/j.it.2011.01.001; Wu KC, 2013, ONCOL REP, V30, P2304, DOI 10.3892/or.2013.2722; Xu J, 2008, NEUROPHARMACOLOGY, V54, P1029, DOI 10.1016/j.neuropharm.2008.01.014; Yang SC, 2013, J IMMUNOL, V190, P6511, DOI 10.4049/jimmunol.1202215; Yang TT, 2013, J MOL MED, V91, P207, DOI 10.1007/s00109-012-0944-6	29	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129693	10.1371/journal.pone.0129693	http://dx.doi.org/10.1371/journal.pone.0129693			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061531	Green Published, gold, Green Submitted			2022-12-26	WOS:000355979500157
J	Huang, FZ; Long, Z; Chen, Z; Li, JD; Hu, ZM; Qiu, R; Zhuang, W; Tang, BS; Xia, K; Jiang, H				Huang, Fengzhen; Long, Zhe; Chen, Zhao; Li, Jiada; Hu, Zhengmao; Qiu, Rong; Zhuang, Wei; Tang, Beisha; Xia, Kun; Jiang, Hong			Investigation of Gene Regulatory Networks Associated with Autism Spectrum Disorder Based on MiRNA Expression in China	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; MICRORNAS; CHILDREN; BRAIN; ABNORMALITIES; UBIQUITIN; RISK; DYSREGULATION; POPULATION; BIOMARKERS	Autism spectrum disorder (ASD) comprise a group of neurodevelopmental disorders characterized by deficits in social and communication capacities and repetitive behaviors. Increasing neuroscientific evidence indicates that the neuropathology of ASD is widespread and involves epigenetic regulation in the brain. Differentially expressed miRNAs in the peripheral blood from autism patients were identified by high-throughput miRNA microarray analyses. Five of these miRNAs were confirmed through quantitative reverse transcription-polymerase chain reaction (qRT-PCR) analysis. A search for candidate target genes of the five confirmed miRNAs was performed through a Kyoto encyclopedia of genes and genomes (KEGG) biological pathways and Gene Ontology enrichment analysis of gene function to identify gene regulatory networks. To the best of our knowledge, this study provides the first global miRNA expression profile of ASD in China. The differentially expressed miR-34b may potentially explain the higher percentage of male ASD patients, and the aberrantly expressed miR-103a-3p may contribute to the abnormal ubiquitin-mediated proteolysis observed in ASD.	[Huang, Fengzhen; Long, Zhe; Chen, Zhao; Tang, Beisha; Jiang, Hong] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha 410008, Hunan, Peoples R China; [Li, Jiada; Hu, Zhengmao; Tang, Beisha; Xia, Kun; Jiang, Hong] Cent S Univ, State Key Lab Med Genet China, Changsha 410078, Hunan, Peoples R China; [Tang, Beisha; Jiang, Hong] Cent S Univ, Key Lab Hunan Prov Neurodegenerat Disorders, Changsha 410008, Hunan, Peoples R China; [Qiu, Rong] Cent S Univ, Sch Informat Sci & Engn, Changsha 410083, Hunan, Peoples R China; [Qiu, Rong] Hunan Engn Lab Adv Control & Intelligent Automat, Changsha 410083, Hunan, Peoples R China; [Zhuang, Wei] Cent S Univ, Xiangya Hosp, Dept Thorac Surg, Changsha 410008, Hunan, Peoples R China; [Huang, Fengzhen] Univ South China, Peoples Hosp Chenzhou 1, Dept Neurol, Chenzhou 423000, Hunan, Peoples R China; [Huang, Fengzhen] Univ South China, Peoples Hosp Chenzhou 1, Inst Translat Med, Chenzhou 423000, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University; Central South University; University of South China; University of South China	Jiang, H (corresponding author), Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha 410008, Hunan, Peoples R China.	jianghong73868@126.com	XIA, KUN/AAO-3525-2020		National Basic Research Program (973 Program) [2012CB944601, 2012CB517902, 2011CB510002]; National Natural Science Foundation of China [81410308019, 81471156, 81271260, 30971585, 31401135]; Hunan Funds for Distinguished Young Scientists [14JJ1008]; Xinjiang Natural Science Foundation [201318101-4]; Natural Science Foundation of Hunan Province [2012SK3194]; Undergraduate Innovation Project of Central South University [YB13028, 201410533324]; Graduate Innovation Project of Central South University [2014zzts078]; Research projects of the First People's Hospital of Chenzhou [N2014-017]; High-level medical personnel of Hunan province "225" Project	National Basic Research Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Funds for Distinguished Young Scientists; Xinjiang Natural Science Foundation; Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); Undergraduate Innovation Project of Central South University; Graduate Innovation Project of Central South University; Research projects of the First People's Hospital of Chenzhou; High-level medical personnel of Hunan province "225" Project	This study was supported by the National Basic Research Program (973 Program) (Nos. 2012CB944601, 2012CB517902 and 2011CB510002 to Hong Jiang), the National Natural Science Foundation of China (Nos. 81410308019, 81471156, 81271260, 30971585 to Hong Jiang; No 31401135 to Rong Qiu), Hunan Funds for Distinguished Young Scientists (No. 14JJ1008 to Hong Jiang), Xinjiang Natural Science Foundation (No. 201318101-4 to Hong Jiang), Natural Science Foundation of Hunan Province (No 2012SK3194 to Wei Zhuang), the Undergraduate Innovation Project of Central South University (No. YB13028, 201410533324 to Hong Jiang), Graduate Innovation Project of Central South University (No. 2014zzts078 to Zhao Chen), Research projects of the First People's Hospital of Chenzhou (No. N2014-017, to Fengzhen Huang) and High-level medical personnel of Hunan province "225" Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elneel K, 2008, NEUROGENETICS, V9, P153, DOI 10.1007/s10048-008-0133-5; Arvey A, 2012, GENOME RES, V22, P1723, DOI 10.1101/gr.127712.111; Aw S, 2012, CELL RES, V22, P1218, DOI 10.1038/cr.2012.59; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cheever A, 2010, RNA, V16, P1530, DOI 10.1261/rna.2022210; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; Connolly AM, 2006, BIOL PSYCHIAT, V59, P354, DOI 10.1016/j.biopsych.2005.07.004; Corbett BA, 2006, PSYCHONEUROENDOCRINO, V31, P59, DOI 10.1016/j.psyneuen.2005.05.011; Dawson S, 2009, AM J EPIDEMIOL, V169, P1296, DOI 10.1093/aje/kwp059; DeJong H, 2014, J AUTISM DEV DISORD, V44, P2127, DOI 10.1007/s10803-014-2085-y; Dincel N, 2013, INDIAN J MED RES, V138, P900; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Gkogkas CG, 2013, NATURE, V493, P371, DOI 10.1038/nature11628; Goyal DK, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00029; Halepoto DM, 2014, JCPSP-J COLL PHYSICI, V24, P274, DOI 04.2014/JCPSP.274278; Holt R, 2011, EMBO MOL MED, V3, P438, DOI 10.1002/emmm.201100157; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karayannis T, 2014, NATURE, V511, P236, DOI 10.1038/nature13248; Koh JY, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0064-z; Kolevzon A, 2007, ARCH PEDIAT ADOL MED, V161, P326, DOI 10.1001/archpedi.161.4.326; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kuhn DE, 2008, BIOCHEM BIOPH RES CO, V370, P473, DOI 10.1016/j.bbrc.2008.03.120; Lehman NL, 2009, ACTA NEUROPATHOL, V118, P329, DOI 10.1007/s00401-009-0560-x; Li YQ, 2013, CLINICS, V68, P75, DOI 10.6061/clinics/2013(01)OA12; Liu N, 2012, NATURE, V482, P519, DOI 10.1038/nature10810; Liu Z, 2005, ACTA PAEDIATR, V94, P386, DOI 10.1080/08035250410023304; Lozoya T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087698; Lu ATH, 2013, MOL PSYCHIATR, V18, P226, DOI 10.1038/mp.2011.155; Martin PM, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.75; Mukaetova-Ladinska EB, 2004, NEUROPATH APPL NEURO, V30, P615, DOI 10.1111/j.1365-2990.2004.00574.x; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Neves-Pereira M, 2009, J MED GENET, V46, P759, DOI 10.1136/jmg.2009.066852; Penzes P, 2013, J NEUROCHEM, V126, P165, DOI 10.1111/jnc.12261; Pescucci C, 2003, CLIN GENET, V64, P497, DOI 10.1046/j.1399-0004.2003.00176.x; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Rossignol DA, 2012, MOL PSYCHIATR, V17, P389, DOI 10.1038/mp.2011.165; Russo AJ, 2009, BIOMARK INSIGHTS, V4, P181; Sarachana T, 2010, GENOME MED, V2, DOI 10.1186/gm144; Scholer N, 2010, EXP HEMATOL, V38, P1126, DOI 10.1016/j.exphem.2010.10.004; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Seno MMG, 2011, BRAIN RES, V1380, P85, DOI 10.1016/j.brainres.2010.09.046; Sevcikova S, 2013, LEUKEMIA LYMPHOMA, V54, P189, DOI 10.3109/10428194.2012.704030; Shi YT, 2014, INT J NEUROSCI, V124, P97, DOI 10.3109/00207454.2013.827679; Singh AS, 2013, PROG NEURO-PSYCHOPH, V45, P131, DOI 10.1016/j.pnpbp.2013.04.015; Siniscalco D, 2012, J AUTISM DEV DISORD, V42, P1403, DOI 10.1007/s10803-011-1373-z; Stern Michael, 2011, Front Endocrinol (Lausanne), V2, P54, DOI 10.3389/fendo.2011.00054; Talebizadeh Z, 2008, AUTISM RES, V1, P240, DOI 10.1002/aur.33; Vasu MM, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-40; Waltes R, 2014, J NEURAL TRANSM, V121, P1107, DOI 10.1007/s00702-014-1230-2; Wilfred BR, 2007, MOL GENET METAB, V91, P209, DOI 10.1016/j.ymgme.2007.03.011; Wingate M, 2014, MMWR SURVEILL SUMM, V63; Wu H, 2010, P NATL ACAD SCI USA, V107, P18161, DOI 10.1073/pnas.1005595107; Xia K, 2014, MOL PSYCHIATR, V19, P1212, DOI 10.1038/mp.2013.146; Xu XL, 2011, J NEUROSCI, V31, P13705, DOI 10.1523/JNEUROSCI.2827-11.2011; Yi JJ, 2005, NEURON, V47, P629, DOI 10.1016/j.neuron.2005.07.008; Zhao CN, 2013, SCI REP-UK, V3, DOI 10.1038/srep01329	60	34	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129052	10.1371/journal.pone.0129052	http://dx.doi.org/10.1371/journal.pone.0129052			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061495	Green Published, Green Submitted, gold			2022-12-26	WOS:000355979500120
J	Stockenhuber, R; Zoller, S; Shimizu-Inatsugi, R; Gugerli, F; Shimizu, KK; Widmer, A; Fischer, MC				Stockenhuber, Reinhold; Zoller, Stefan; Shimizu-Inatsugi, Rie; Gugerli, Felix; Shimizu, Kentaro K.; Widmer, Alex; Fischer, Martin C.			Efficient Detection of Novel Nuclear Markers for Brassicaceae by Transcriptome Sequencing	PLOS ONE			English	Article							DNA-SEQUENCES; PHYLOGENETIC MARKERS; MAXIMUM-LIKELIHOOD; EVOLUTION; ARABIDOPSIS; UTILITY; GENES; RECONSTRUCTION; IDENTIFICATION; PHYLOGENOMICS	The lack of DNA sequence information for most non-model organisms impairs the design of primers that are universally applicable for the study of molecular polymorphisms in nuclear markers. Next-generation sequencing (NGS) techniques nowadays provide a powerful approach to overcome this limitation. We present a flexible and inexpensive method to identify large numbers of nuclear primer pairs that amplify in most Brassicaceae species. We first obtained and mapped NGS transcriptome sequencing reads from two of the distantly related Brassicaceae species, Cardamine hirsuta and Arabis alpina, onto the Arabidopsis thaliana reference genome, and then identified short conserved sequence motifs among the three species bioinformatically. From these, primer pairs to amplify coding regions (nuclear protein coding loci, NPCL) and exon-primed intron-crossing sequences (EPIC) were developed. We identified 2,334 universally applicable primer pairs, targeting 1,164 genes, which provide a large pool of markers as readily usable genomic resource that will help addressing novel questions in the Brassicaceae family. Testing a subset of the newly designed nuclear primer pairs revealed that a great majority yielded a single amplicon in all of the 30 investigated Brassicaceae taxa. Sequence analysis and phylogenetic reconstruction with a subset of these markers on different levels of phylogenetic divergence in the mustard family were compared with previous studies. The results corroborate the usefulness of the newly developed primer pairs, e.g., for phylogenetic analyses or population genetic studies. Thus, our method provides a cost-effective approach for designing nuclear loci across a broad range of taxa and is compatible with current NGS technologies.	[Stockenhuber, Reinhold; Shimizu-Inatsugi, Rie; Shimizu, Kentaro K.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Zoller, Stefan] ETH, Genet Div Ctr, Zurich, Switzerland; [Gugerli, Felix] WSL Swiss Fed Res Inst, Birmensdorf, Switzerland; [Stockenhuber, Reinhold; Widmer, Alex; Fischer, Martin C.] ETH, Inst Integrat Biol, Zurich, Switzerland	University of Zurich; ETH Zurich; Swiss Federal Institute for Forest, Snow & Landscape Research; ETH Zurich	Fischer, MC (corresponding author), ETH, Inst Integrat Biol, Zurich, Switzerland.	martin.fischer@env.ethz.ch	Gugerli, Felix/U-7195-2019; Gugerli, Felix/C-9369-2009; Fischer, Martin C./AAE-7287-2019; Fischer, Martin C/D-4326-2012; Widmer, Alex/B-6841-2009	Gugerli, Felix/0000-0003-3878-1845; Gugerli, Felix/0000-0003-3878-1845; Fischer, Martin C./0000-0002-1888-1809; Fischer, Martin C/0000-0002-1888-1809; Widmer, Alex/0000-0001-8253-5137; Shimizu Inatsugi, Rie/0000-0002-9899-591X; Shimizu, Kentaro K./0000-0002-6483-1781	Swiss National Science Foundation (Sinergia project) [CRSI33_127155]; University Research Priority Program in Systems Biology/Functional Genomics;  [ProDoc PDFMP3_137084]	Swiss National Science Foundation (Sinergia project)(Swiss National Science Foundation (SNSF)); University Research Priority Program in Systems Biology/Functional Genomics; 	The study was funded by the Swiss National Science Foundation (Sinergia project CRSI33_127155), ProDoc PDFMP3_137084 and University Research Priority Program in Systems Biology/Functional Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shehbaz IA, 2011, BRASSICACEAE MUSTARD; Al-Shehbaz IA, 2012, TAXON, V61, P931, DOI 10.1002/tax.615002; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Beilstein MA, 2008, AM J BOT, V95, P1307, DOI 10.3732/ajb.0800065; Beilstein MA, 2010, P NATL ACAD SCI USA, V107, P18724, DOI 10.1073/pnas.0909766107; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Bybee SM, 2011, GENOME BIOL EVOL, V3, P1312, DOI 10.1093/gbe/evr106; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; CHASE MW, 1993, ANN MO BOT GARD, V80, P528, DOI 10.2307/2399846; Chenuil A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-276; CORNISHBOWDEN A, 1985, NUCLEIC ACIDS RES, V13, P3021, DOI 10.1093/nar/13.9.3021; Couvreur TLP, 2010, MOL BIOL EVOL, V27, P55, DOI 10.1093/molbev/msp202; Cronn RC, 2002, AM J BOT, V89, P707, DOI 10.3732/ajb.89.4.707; Curto MA, 2012, MOL PHYLOGENET EVOL, V63, P758, DOI 10.1016/j.ympev.2012.02.010; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Duarte JM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-61; Fink S, 2010, SYST BIOL, V59, P548, DOI 10.1093/sysbio/syq042; Franzke A, 1999, THEOR APPL GENET, V98, P831, DOI 10.1007/s001220051140; Franzke A, 2011, TRENDS PLANT SCI, V16, P108, DOI 10.1016/j.tplants.2010.11.005; Funari VA, 2010, GENE EXPRESSION, V14, P321, DOI 10.3727/105221610X12717040569820; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harpke D, 2006, MOL PHYLOGENET EVOL, V41, P579, DOI 10.1016/j.ympev.2006.05.036; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; HILLIS DM, 1992, J HERED, V83, P189, DOI 10.1093/oxfordjournals.jhered.a111190; Huang CC, 2012, GENE, V499, P194, DOI 10.1016/j.gene.2012.02.037; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, CURRENT PROTOCOLS BI, V13; Huang S, 2001, MOL ECOL, V10, P2669, DOI 10.1046/j.0962-1083.2001.01395.x; JOHNSON LA, 1994, SYST BOT, V19, P143, DOI 10.2307/2419718; Kagale S, 2014, PLANT CELL, V26, P2777, DOI 10.1105/tpc.114.126391; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Koch MA, 2007, MOL BIOL EVOL, V24, P63, DOI 10.1093/molbev/msl130; Koch MA, 2012, TAXON, V61, P1001, DOI 10.1002/tax.615007; Lemmon AR, 2012, SYST BIOL, V61, P745, DOI 10.1093/sysbio/sys051; Li CH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-44; Li CH, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-90; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lihova J, 2006, MOL PHYLOGENET EVOL, V39, P759, DOI 10.1016/j.ympev.2006.01.027; Lysak MA, 2006, PLANT SYST EVOL, V259, P175, DOI 10.1007/s00606-006-0418-9; Lysak MA, 2011, PLANT GENET GENOMICS, V9, P1, DOI 10.1007/978-1-4419-7118-0_1; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Marshall HD, 2001, MOL BIOL EVOL, V18, P2136, DOI 10.1093/oxfordjournals.molbev.a003757; Mayol M, 2001, MOL PHYLOGENET EVOL, V19, P167, DOI 10.1006/mpev.2001.0934; McCormack JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054848; Meudt HM, 2007, TRENDS PLANT SCI, V12, P106, DOI 10.1016/j.tplants.2007.02.001; O'Neill EM, 2013, MOL ECOL, V22, P111, DOI 10.1111/mec.12049; Poczai P, 2010, MOL BIOL REP, V37, P1897, DOI 10.1007/s11033-009-9630-3; Rozen S, 2000, Methods Mol Biol, V132, P365; Russell A, 2010, ANN BOT-LONDON, V106, P37, DOI 10.1093/aob/mcq092; Salas-Leiva DE, 2014, MOL ECOLOGY RESOURCE; Sang T, 2002, CRIT REV BIOCHEM MOL, V37, P121, DOI 10.1080/10409230290771474; Shen XX, 2013, MOL BIOL EVOL, V30, P2235, DOI 10.1093/molbev/mst122; Shimizu-Inatsugi R, 2009, MOL ECOL, V18, P4024, DOI 10.1111/j.1365-294X.2009.04329.x; Small RL, 2004, AUST SYST BOT, V17, P145, DOI 10.1071/SB03015; Soltis DE, 2009, CRIT REV PLANT SCI, V28, P1, DOI 10.1080/07352680802665297; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomson RC, 2010, MOL ECOL, V19, P2184, DOI 10.1111/j.1365-294X.2010.04650.x; Tonnabel J, 2014, MOL PHYLOGENET EVOL, V70, P37, DOI 10.1016/j.ympev.2013.07.027; Treangen Todd J, 2011, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1108s33; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315	68	4	4	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0128181	10.1371/journal.pone.0128181	http://dx.doi.org/10.1371/journal.pone.0128181			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061739	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000355979500076
J	Tang, K; Knipp, M; Liu, BB; Cox, N; Stabel, R; He, Q; Zhou, M; Scheer, H; Zhao, KH; Gartner, W				Tang, Kun; Knipp, Markus; Liu, Bing-Bing; Cox, Nicholas; Stabel, Robert; He, Qi; Zhou, Ming; Scheer, Hugo; Zhao, Kai-Hong; Gaertner, Wolfgang			Redox-dependent Ligand Switching in a Sensory Heme-binding GAF Domain of the Cyanobacterium Nostoc sp PCC7120	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNETIC CIRCULAR-DICHROISM; MYCOBACTERIUM-TUBERCULOSIS DOSS; RESONANCE RAMAN-SPECTRA; SWISS-MODEL; PROTEIN INTERACTIONS; AXIAL LIGAND; FE(III) HEME; DNA-BINDING; CO; COMPLEXES	The genome of the cyanobacterium Nostoc sp. PCC7120 carries three genes (all4978, all7016, and alr7522) encoding putative heme/binding GAF (cGMP-specific phosphodiesterases, adenylyl cyclases, and FhlA) proteins that were annotated as transcriptional regulators. They are composed of an N-terminal cofactor domain and a C-terminal helix-turn-helix motif. All4978 showed the highest affinity for protoheme binding. The heme binding capability of All7016 was moderate, and Alr7522 did not bind heme at all. The "as isolated" form of All4978, identified by Soret band (lambda(max) = 427 nm), was assigned by electronic absorption, EPR, and resonance Raman spectroscopy as a hexa-coordinated low spin Fe-III heme with a distal cysteine ligand (absorption of delta-band around 360 nm). The protoheme cofactor is noncovalently incorporated. Reduction of the heme could be accomplished by chemically using sodium dithionite and electrospectrochemically; this latter method yielded remarkably low midpoint potentials of -445 and -453 mV(following Soret and alpha-band absorption changes, respectively). The reduced form of the heme (FeII state) binds both NO and CO. Cysteine coordination of the as isolated FeIII protein is unambiguous, but interestingly, the reduced heme instead displays spectral features indicative of histidine coordination. Cys-His ligand switches have been reported as putative signaling mechanisms in other heme-binding proteins; however, these novel cyanobacterial proteins are the first where such a ligand-switch mechanism has been observed in a GAF domain. DNA binding of the helix-turn-helix domain was investigated using a DNA sequence motif from its own promoter region. Formation of a protein-DNA complex preferentially formed in ferric state of the protein.	[Tang, Kun; Liu, Bing-Bing; He, Qi; Zhou, Ming; Zhao, Kai-Hong] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China; [Tang, Kun; Knipp, Markus; Cox, Nicholas; Stabel, Robert; Gaertner, Wolfgang] Max Planck Inst Chem Energy Convers, D-45470 Mulheim, Germany; [Knipp, Markus] Ruhr Univ Bochum, Fac Chem & Biochem, Resolv, D-44780 Bochum, Germany; [Scheer, Hugo] Univ Munich, Dept Biol 1, D-80638 Munich, Germany	Huazhong Agricultural University; Max Planck Society; Ruhr University Bochum; University of Munich	Zhao, KH (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China.	khzhao@163.com; wolfgang.gaertner@cec.mpg.de	liu, bb/GXA-2527-2022; Cox, Nicholas/J-8047-2014; Tang, Kun/GSD-3218-2022	Cox, Nicholas/0000-0002-7815-6115; 	Max-Planck-Society; Cluster of Excellence RESOLV - Deutsche Forschungsgemeinschaft [EXC 1069]; China Scholar Council; National Natural Science Foundation of China [31370777, 31110103912, 31270893, 21472055]	Max-Planck-Society(Max Planck SocietyFoundation CELLEX); Cluster of Excellence RESOLV - Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); China Scholar Council; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the Max-Planck-Society and the Cluster of Excellence RESOLV (EXC 1069) funded by the Deutsche Forschungsgemeinschaft. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a grant from the China Scholar Council.; Recipient of Grant 31370777 from the National Natural Science Foundation of China.; Recipient of National Natural Science Foundation of China Grant 31110103912.; Recipient of National Natural Science Foundation of China Grants 31270893 and 21472055.	Andersen JF, 2000, BIOCHEMISTRY-US, V39, P10118, DOI 10.1021/bi000766b; ANDERSSON LA, 1989, J BIOL CHEM, V264, P19099; Aono S, 1998, J BIOL CHEM, V273, P25757, DOI 10.1074/jbc.273.40.25757; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; CHEEK J, 2000, PORPHYRIN HDB, V7, P339; CHEESMAN MR, 1991, ADV INORG CHEM, V36, P201, DOI 10.1016/S0898-8838(08)60040-9; Chim N, 2014, J INORG BIOCHEM, V133, P118, DOI 10.1016/j.jinorgbio.2013.11.003; Cho HY, 2009, J BIOL CHEM, V284, P13057, DOI 10.1074/jbc.M808905200; CHOI S, 1982, J AM CHEM SOC, V104, P4345, DOI 10.1021/ja00380a006; Dawson J. H., 1989, IRON PORPHYRINS 3, P1; DAWSON JH, 1978, BIOCHEMISTRY-US, V17, P33, DOI 10.1021/bi00594a006; DAWSON JH, 1987, CHEM REV, V87, P1255, DOI 10.1021/cr00081a015; Ding XD, 1999, J AM CHEM SOC, V121, P128, DOI 10.1021/ja982979i; DOLINGER PM, 1974, P NATL ACAD SCI USA, V71, P399, DOI 10.1073/pnas.71.2.399; EATON WA, 1967, J CHEM PHYS, V46, P2533, DOI 10.1063/1.1841081; Fan BC, 1997, BIOCHEMISTRY-US, V36, P12660, DOI 10.1021/bi9715369; FEIS A, 1994, BIOCHEMISTRY-US, V33, P4577, DOI 10.1021/bi00181a019; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; Girvan HM, 2013, J BIOL CHEM, V288, P13194, DOI 10.1074/jbc.R112.422642; Green J, 2009, CURR OPIN MICROBIOL, V12, P145, DOI 10.1016/j.mib.2009.01.008; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; He CM, 2013, J INORG BIOCHEM, V122, P38, DOI 10.1016/j.jinorgbio.2013.01.012; Ho YSJ, 2000, EMBO J, V19, P5288, DOI 10.1093/emboj/19.20.5288; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Ibrahim M, 2006, J AM CHEM SOC, V128, P16834, DOI 10.1021/ja064859d; Igarashi J, 2008, J BIOL CHEM, V283, P18782, DOI 10.1074/jbc.M801400200; Ioanoviciu A, 2007, BIOCHEMISTRY-US, V46, P4250, DOI 10.1021/bi602422p; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kincaid J. R., 2000, PORPHYRIN HDB, P225; KITAGAWA T, 1976, J AM CHEM SOC, V98, P5169, DOI 10.1021/ja00433a019; Knipp M, 2011, IUBMB LIFE, V63, P304, DOI 10.1002/iub.451; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Lanzilotta WN, 2000, NAT STRUCT BIOL, V7, P876; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li D, 2004, J BIOL CHEM, V279, P26489, DOI 10.1074/jbc.M400968200; Maes EM, 2001, J AM CHEM SOC, V123, P11664, DOI 10.1021/ja0031927; Maris AE, 2002, NAT STRUCT BIOL, V9, P771, DOI 10.1038/nsb845; Marvin KA, 2009, BIOCHEMISTRY-US, V48, P7056, DOI 10.1021/bi900697c; MAYHEW SG, 1978, EUR J BIOCHEM, V85, P535, DOI 10.1111/j.1432-1033.1978.tb12269.x; Molitor B, 2013, J BIOL CHEM, V288, P18458, DOI 10.1074/jbc.M113.476267; Moran L. A., 1994, BIOCHEMISTRY-US, P1427; Nash AI, 2011, P NATL ACAD SCI USA, V108, P9449, DOI 10.1073/pnas.1100262108; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ohmori M, 2001, DNA RES, V8, P271, DOI 10.1093/dnares/8.6.271; Pardee KI, 2009, PLOS BIOL, V7, P384, DOI 10.1371/journal.pbio.1000043; Podust LM, 2008, BIOCHEMISTRY-US, V47, P12523, DOI 10.1021/bi8012356; Reinking J, 2005, CELL, V122, P195, DOI 10.1016/j.cell.2005.07.005; Rockwell NC, 2010, CHEMPHYSCHEM, V11, P1172, DOI 10.1002/cphc.200900894; Sardiwal S, 2005, J MOL BIOL, V353, P929, DOI 10.1016/j.jmb.2005.09.011; SHIMIZU T, 1981, BIOCHIM BIOPHYS ACTA, V669, P46, DOI 10.1016/0005-2795(81)90222-1; Shimizu T, 2012, J INORG BIOCHEM, V108, P171, DOI 10.1016/j.jinorgbio.2011.08.018; Smith AT, 2012, J BIOL INORG CHEM, V17, P1071, DOI 10.1007/s00775-012-0920-1; SONO M, 1982, J BIOL CHEM, V257, P8308; Sousa EHS, 2007, PROTEIN SCI, V16, P1708, DOI 10.1110/ps.072897707; SPIRO TG, 1979, J AM CHEM SOC, V101, P2648, DOI 10.1021/ja00504a027; Spiro TG, 1988, BIOL APPL RAMAN SPEC, V3, P1; Spiro TG, 2013, COORDIN CHEM REV, V257, P511, DOI 10.1016/j.ccr.2012.05.008; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Sun YH, 2013, BIOCHEMISTRY-US, V52, P5941, DOI 10.1021/bi400541v; SUTHERLAND JC, 1980, ANNU REV BIOPHYS BIO, V9, P293, DOI 10.1146/annurev.bb.09.060180.001453; Tang K, 2012, BBA-BIOENERGETICS, V1817, P1030, DOI 10.1016/j.bbabio.2012.03.018; TAYLOR CPS, 1977, BIOCHIM BIOPHYS ACTA, V491, P137, DOI 10.1016/0005-2795(77)90049-6; TEALE FWJ, 1959, BIOCHIM BIOPHYS ACTA, V35, P543, DOI 10.1016/0006-3002(59)90407-X; Tomita T, 2002, BIOCHEMISTRY-US, V41, P4819, DOI 10.1021/bi0158831; Uchida T, 1998, J BIOL CHEM, V273, P19988, DOI 10.1074/jbc.273.32.19988; Uchida T, 2005, J BIOL CHEM, V280, P21358, DOI 10.1074/jbc.M412350200; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Vogel KM, 1999, BIOCHEMISTRY-US, V38, P2679, DOI 10.1021/bi982375r; Vogel KM, 2000, INORG CHIM ACTA, V297, P11, DOI 10.1016/S0020-1693(99)00253-4; Walker FA, 1999, COORDIN CHEM REV, V185-6, P471, DOI 10.1016/S0010-8545(99)00029-6; Yin L, 2012, J BIOL CHEM, V287, P13850, DOI 10.1074/jbc.M112.346494; Yukl ET, 2008, BIOCHEMISTRY-US, V47, P12532, DOI 10.1021/bi801234w; Zheng Z, 2009, PROTEINS, V75, P719, DOI 10.1002/prot.22282	76	10	10	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19067	19080		10.1074/jbc.M115.654087	http://dx.doi.org/10.1074/jbc.M115.654087			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26063806	Green Published, hybrid			2022-12-26	WOS:000358781100024
J	Gupta, S; Smith, C; Auclair, S; Delgadillo, AD; Garg, NJ				Gupta, Shivali; Smith, Charity; Auclair, Sarah; Delgadillo, Anahi De Jesus; Garg, Nisha Jain			Therapeutic Efficacy of a Subunit Vaccine in Controlling Chronic Trypanosoma cruzi Infection and Chagas Disease Is Enhanced by Glutathione Peroxidase Over-Expression	PLOS ONE			English	Article							TERT-BUTYL-NITRONE; OXIDATIVE STRESS; DNA VACCINES; BENZNIDAZOLE; PROTEIN; MICE; CARDIOMYOPATHY; MECHANISMS; CANDIDATES	Trypanosoma cruzi-induced oxidative and inflammatory responses are implicated in chagasic cardiomyopathy. In this study, we examined the therapeutic utility of a subunit vaccine against T. cruzi and determined if glutathione peroxidase (GPx1, antioxidant) protects the heart from chagasic pathogenesis. C57BL/6 mice (wild-type (WT) and GPx1 transgenic (GPx(tg)) were infected with T. cruzi and at 45 days post-infection (dpi), immunized with TcG2/TcG4 vaccine delivered by a DNA-prime/Protein-boost (D/P) approach. The plasma and tissue-sections were analyzed on 150 dpi for parasite burden, inflammatory and oxidative stress markers, inflammatory infiltrate and fibrosis. WT mice infected with T. cruzi had significantly more blood and tissue parasite burden compared with infected/GPx(tg) mice (n = 5-8, p<0.01). Therapeutic vaccination provided > 15-fold reduction in blood and tissue parasites in both WT and GPx(tg) mice. The increase in plasma levels of myeloperoxidase (MPO, 24.7%) and nitrite (iNOS activity, 45%) was associated with myocardial increase in oxidant levels (3-4-fold) and non-responsive antioxidant status in chagasic/WT mice; and these responses were not controlled after vaccination (n = 5-7). The GPx(tg) mice were better equipped than the WT mice in controlling T. cruzi-induced inflammatory and oxidative stress markers. Extensive myocardial and skeletal tissue inflammation noted in chagasic/ WT mice, was significantly more compared with chagasic/GPx(tg) mice (n = 4-6, p<0.05). Vaccination was equally effective in reducing the chronic inflammatory infiltrate in the heart and skeletal tissue of infected WT and GPx(tg) mice (n = 6, p<0.05). Hypertrophy (increased BNP and ANP mRNA) and fibrosis (increased collagen) of the heart were extensively present in chronically-infected WT and GPx(tg) mice and notably decreased after therapeutic vaccination. We conclude the therapeutic delivery of D/P vaccine was effective in arresting the chronic parasite persistence and chagasic pathology; and GPx1 over-expression provided additive benefits in reducing the parasite burden, inflammatory/oxidative stress and cardiac remodeling in Chagas disease.	[Gupta, Shivali; Smith, Charity; Auclair, Sarah; Delgadillo, Anahi De Jesus; Garg, Nisha Jain] Univ Texas Med Branch, Sch Med, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Garg, Nisha Jain] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Garg, Nisha Jain] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA; [Garg, Nisha Jain] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Gupta, S (corresponding author), Univ Texas Med Branch, Sch Med, Dept Microbiol & Immunol, Galveston, TX 77555 USA.	shivali.04@gmail.com; nigarg@utmb.edu		Auclair, Sarah/0000-0002-4701-1087	National Institutes of Health/National Institute of Allergy and Infectious Diseases [2RO1AI05478-07]; Sealy Center for Vaccine Development (SCVD); National Institute of General Medicine Sciences [R25 GM069285]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM069285] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Sealy Center for Vaccine Development (SCVD); National Institute of General Medicine Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a grant from the National Institutes of Health/National Institute of Allergy and Infectious Diseases (2RO1AI05478-07) to NJG. SG is a recipient of a Sealy Center for Vaccine Development (SCVD) postdoctoral fellowship. CS was a recipient of training fellowship on a grant from the National Institute of General Medicine Sciences (R25 GM069285) to Dr. David W Niesel.	Aparicio-Burgos JE, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001050; Barbosa JL, 2014, AM J THER; Beck MA, 1998, FASEB J, V12, P1143, DOI 10.1096/fasebj.12.12.1143; Bern C, 2011, NEW ENGL J MED, V364, P2527, DOI 10.1056/NEJMct1014204; Bhatia V, 2004, INFECT IMMUN, V72, P6245, DOI 10.1128/IAI.72.11.6245-6254.2004; Bhatia V, 2008, CLIN VACCINE IMMUNOL, V15, P1158, DOI 10.1128/CVI.00144-08; Bhatia V, 2005, EXPERT REV VACCINES, V4, P867, DOI 10.1586/14760584.4.6.867; Bhatia V, 2009, VACCINES FOR BIODEFENSE AND EMERGING AND NEGLECTED DISEASES, P1423, DOI 10.1016/B978-0-12-369408-9.00069-X; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Caldas IS, 2008, PARASITOL RES, V103, P413, DOI 10.1007/s00436-008-0992-6; Castillo-Riquelme M, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000336; Cunha-Neto E, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/683230; de Gusmao AS, 2012, REV SOC BRAS MED TRO, V45, P51, DOI 10.1590/S0037-86822012000100010; Dhiman M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000302; Dhiman M, 2011, J PATHOL, V225, P583, DOI 10.1002/path.2975; Donnelly JJ, 2005, J IMMUNOL, V175, P633, DOI 10.4049/jimmunol.175.2.633; Dreesen L, 2014, INFECT IMMUN, V82, P3333, DOI 10.1128/IAI.01536-14; Dumonteil E, 2004, INFECT IMMUN, V72, P46, DOI 10.1128/IAI.72.1.46-53.2004; Garg N, 2004, BIOCHEM J, V381, P743, DOI 10.1042/BJ20040356; Gupta S., 2009, INTERDISCIP PERSPECT, V2009, P1, DOI [DOI 10.1155/2009/190354, 10.1155/2009/190354]; Gupta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059434; Gupta S, 2012, VACCINE, V30, P7179, DOI 10.1016/j.vaccine.2012.10.018; Gupta S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000797; Halliwell B, 1999, FREE RADICAL RES, V31, P261, DOI 10.1080/10715769900300841; Huygen K, 2005, MICROBES INFECT, V7, P932, DOI 10.1016/j.micinf.2005.03.010; Kleinbongard P, 2002, METHOD ENZYMOL, V359, P158; Lee BY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000916; Lescure FX, 2010, LANCET INFECT DIS, V10, P556, DOI 10.1016/S1473-3099(10)70098-0; Macao LB, 2007, INT J CARDIOL, V123, P43, DOI 10.1016/j.ijcard.2006.11.118; Machado FS, 2012, SEMIN IMMUNOPATHOL, V34, P753, DOI 10.1007/s00281-012-0351-7; Miller Nicholas J., 1993, Biochemical Society Transactions, V21, p95S; Nagajyothi F, 2012, CELL MICROBIOL, V14, P634, DOI 10.1111/j.1462-5822.2012.01764.x; Pinazo MJ, 2013, ANTIMICROB AGENTS CH, V57, P390, DOI 10.1128/AAC.01401-12; Pinazo MJ, 2010, ANTIMICROB AGENTS CH, V54, P4896, DOI 10.1128/AAC.00537-10; Quijano-Hernandez I, 2011, HUM VACCINES, V7, P1184, DOI 10.4161/hv.7.11.17016; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Scharpe J, 2009, AM J KIDNEY DIS, V54, P77, DOI 10.1053/j.ajkd.2008.11.032; Sheldon RA, 2008, INT J DEV NEUROSCI, V26, P87, DOI 10.1016/j.ijdevneu.2007.08.010; Sheldon RA, 2007, PEDIATR RES, V61, P666, DOI 10.1203/pdr.0b013e318053664c; Carvalho MDT, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/230129; Vazquez-Chagoyan JC, 2011, ADV PARASIT, V75, P121, DOI 10.1016/B978-0-12-385863-4.00006-X; Wen JJ, 2008, MICROBES INFECT, V10, P1201, DOI 10.1016/j.micinf.2008.06.013; Wen JJ, 2006, AM J PATHOL, V169, P1953, DOI 10.2353/ajpath.2006.060475; Wen JJ, 2010, J AM COLL CARDIOL, V55, P2499, DOI 10.1016/j.jacc.2010.02.030; Wen JJ, 2004, FREE RADICAL BIO MED, V37, P1821, DOI 10.1016/j.freeradbiomed.2004.08.018; WitkoSarsat V, 1996, KIDNEY INT, V49, P1304, DOI 10.1038/ki.1996.186; World Health Organization, 2010, CHAGAS DISEASE CONTR; Yatmaz S, 2013, AM J RESP CELL MOL, V48, P17, DOI 10.1165/rcmb.2011-0345OC; Zapata-Estrella H, 2006, IMMUNOL LETT, V103, P186, DOI 10.1016/j.imlet.2005.11.015; Zeng RH, 2008, BIOCHEM BIOPH RES CO, V377, P495, DOI 10.1016/j.bbrc.2008.10.002	50	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130562	10.1371/journal.pone.0130562	http://dx.doi.org/10.1371/journal.pone.0130562			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075398	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900180
J	Konoike, N; Kotozaki, Y; Jeong, HJ; Miyazaki, A; Sakaki, K; Shinada, T; Sugiura, M; Kawashima, R; Nakamura, K				Konoike, Naho; Kotozaki, Yuka; Jeong, Hyeonjeong; Miyazaki, Atsuko; Sakaki, Kohei; Shinada, Takamitsu; Sugiura, Motoaki; Kawashima, Ryuta; Nakamura, Katsuki			Temporal and Motor Representation of Rhythm in Fronto-Parietal Cortical Areas: An fMRI Study	PLOS ONE			English	Article							DORSAL PREMOTOR CORTEX; FUNCTIONAL-ANATOMY; BRAIN ACTIVATION; NEURAL BASIS; SEQUENCE; SUPPLEMENTARY; MOVEMENT; SYNCHRONIZATION; PERFORMANCE; MECHANISMS	When sounds occur with temporally structured patterns, we can feel a rhythm. To memorize a rhythm, perception of its temporal patterns and organization of them into a hierarchically structured sequence are necessary. On the other hand, rhythm perception can often cause unintentional body movements. Thus, we hypothesized that rhythm information can be manifested in two different ways; temporal and motor representations. The motor representation depends on effectors, such as the finger or foot, whereas the temporal representation is effector-independent. We tested our hypothesis with a working memory paradigm to elucidate neuronal correlates of temporal or motor representation of rhythm and to reveal the neural networks associated with these representations. We measured brain activity by fMRI while participants memorized rhythms and reproduced them by tapping with the right finger, left finger, or foot, or by articulation. The right inferior frontal gyrus and the inferior parietal lobule exhibited significant effector-independent activations during encoding and retrieval of rhythm information, whereas the left inferior parietal lobule and supplementary motor area (SMA) showed effector-dependent activations during retrieval. These results suggest that temporal sequences of rhythm are probably represented in the right fronto-parietal network, whereas motor sequences of rhythm can be represented in the SMA-parietal network.	[Konoike, Naho; Nakamura, Katsuki] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 4848506, Japan; [Kotozaki, Yuka; Jeong, Hyeonjeong; Miyazaki, Atsuko; Sakaki, Kohei; Shinada, Takamitsu; Sugiura, Motoaki; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Aoba Ku, Sendai, Miyagi 9808575, Japan	Kyoto University; Tohoku University	Nakamura, K (corresponding author), Kyoto Univ, Primate Res Inst, Kanrin 41-2, Inuyama, Aichi 4848506, Japan.	nakamura.katsuki.4z@kyoto-u.ac.jp	Kotozaki, Yuka/ABA-2267-2020; Kotozaki, Yuka/ABA-2922-2020; Jeong, Hyeonjeong/T-1958-2019	Kotozaki, Yuka/0000-0002-4659-1200; Konoike, Naho/0000-0003-2563-7537; Jeong, Hyeonjeong/0000-0002-5094-5390	Cooperative Research Project Program of the Institute of Development, Aging and Cancer, Tohoku University [25.39]; Ministry of Education, Culture, Sports, Science and Technology, Japan [4103, 21120009];  [26.40083]; Grants-in-Aid for Scientific Research [14J40083] Funding Source: KAKEN	Cooperative Research Project Program of the Institute of Development, Aging and Cancer, Tohoku University; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Cooperative Research Project Program of the Institute of Development, Aging and Cancer, Tohoku University (No. 25.39), http://www.idac.tohoku.ac.jp/ja/joint/; a Grant-in-Aid for Scientific Research on Innovative Areas "Neural creativity for communication (No. 4103)" of Ministry of Education, Culture, Sports, Science and Technology, Japan to KN (No. 21120009), http://dynamic-brain.jp/; and a Grant-in-Aid for Japan Society for the Promotion of Science Fellows to NK (No. 26.40083), http://www.jsps.go.jp/jpd/.	Battelli L, 2003, BRAIN, V126, P2164, DOI 10.1093/brain/awg221; Battellil L, 2008, CURR OPIN NEUROBIOL, V18, P120, DOI 10.1016/j.conb.2008.08.004; Bengtsson SL, 2009, CORTEX, V45, P62, DOI 10.1016/j.cortex.2008.07.002; Bengtsson SL, 2006, NEUROIMAGE, V30, P272, DOI 10.1016/j.neuroimage.2005.09.019; Bengtsson SL, 2005, EUR J NEUROSCI, V22, P3255, DOI 10.1111/j.1460-9568.2005.04517.x; Bengtsson SL, 2004, EUR J NEUROSCI, V19, P2591, DOI 10.1111/j.0953-816X.2004.03269.x; Chen JL, 2008, CEREB CORTEX, V18, P2844, DOI 10.1093/cercor/bhn042; Chen JL, 2006, NEUROIMAGE, V32, P1771, DOI 10.1016/j.neuroimage.2006.04.207; Chen SHA, 2005, NEUROIMAGE, V24, P332, DOI 10.1016/j.neuroimage.2004.08.032; Coull JT, 2013, NEUROPSYCHOLOGIA, V51, P309, DOI 10.1016/j.neuropsychologia.2012.08.017; Coull JT, 2004, SCIENCE, V303, P1506, DOI 10.1126/science.1091573; Doyon J, 2002, P NATL ACAD SCI USA, V99, P1017, DOI 10.1073/pnas.022615199; Ehrsson HH, 2003, J NEUROPHYSIOL, V90, P3304, DOI 10.1152/jn.01113.2002; Frey S, 2008, J NEUROSCI, V28, P11435, DOI 10.1523/JNEUROSCI.2388-08.2008; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Grahn JA, 2007, J COGNITIVE NEUROSCI, V19, P893, DOI 10.1162/jocn.2007.19.5.893; Grahn JA, 2013, CEREB CORTEX, V23, P913, DOI 10.1093/cercor/bhs083; HALSBAND U, 1993, BRAIN, V116, P243, DOI 10.1093/brain/116.1.243; Harrington DL, 2010, CEREB CORTEX, V20, P1274, DOI 10.1093/cercor/bhp194; Harrington DL, 1998, J NEUROSCI, V18, P1085; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; HINKE RM, 1993, NEUROREPORT, V4, P675, DOI 10.1097/00001756-199306000-00018; Karabanov A, 2009, NEUROIMAGE, V44, P480, DOI 10.1016/j.neuroimage.2008.08.047; Koelsch S, 2005, TRENDS COGN SCI, V9, P578, DOI 10.1016/j.tics.2005.10.001; Konoike N, 2012, NEUROIMAGE, V63, P328, DOI 10.1016/j.neuroimage.2012.07.002; Lacourse MG, 2005, NEUROIMAGE, V27, P505, DOI 10.1016/j.neuroimage.2005.04.025; Lewis PA, 2004, NEUROPSYCHOLOGIA, V42, P1301, DOI 10.1016/j.neuropsychologia.2004.03.001; Ligeois-Chauvel C, 1998, BRAIN, V121, P1853, DOI 10.1093/brain/121.10.1853; Lim CJ, 2006, ANAT REC PART A, V288A, P435, DOI 10.1002/ar.a.20316; Maess B, 2001, NAT NEUROSCI, V4, P540, DOI 10.1038/87502; Meister IG, 2009, EUR J NEUROSCI, V29, P2074, DOI 10.1111/j.1460-9568.2009.06729.x; Midorikawa A, 2003, NEUROCASE, V9, P232, DOI 10.1076/neur.9.3.232.15558; MUSHIAKE H, 1990, EXP BRAIN RES, V82, P208; Oliveri M, 2009, NEUROIMAGE, V46, P1173, DOI 10.1016/j.neuroimage.2009.03.042; Patel AD, 2003, NAT NEUROSCI, V6, P674, DOI 10.1038/nn1082; PETRIDES M, 1988, J COMP NEUROL, V273, P52, DOI 10.1002/cne.902730106; Ramnani N, 2001, J COGNITIVE NEUROSCI, V13, P952, DOI 10.1162/089892901753165863; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Sakai K, 1998, J NEUROSCI, V18, P1827; Sakai K, 1999, J NEUROSCI, V19, P10074; Schubotz RI, 2001, CEREB CORTEX, V11, P210, DOI 10.1093/cercor/11.3.210; Shima K, 1998, J NEUROPHYSIOL, V80, P3247, DOI 10.1152/jn.1998.80.6.3247; Stenneken P, 2006, BRAIN RES, V1084, P123, DOI 10.1016/j.brainres.2006.02.057; Thiebaut de Schotten M, 2012, CORTEX, V48, P82, DOI 10.1016/j.cortex.2011.10.001; Udden J, 2012, PHILOS T R SOC B, V367, P2023, DOI 10.1098/rstb.2012.0009; Ullen F, 2007, PHYSIOL BEHAV, V92, P193, DOI 10.1016/j.physbeh.2007.05.036	47	19	20	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130120	10.1371/journal.pone.0130120	http://dx.doi.org/10.1371/journal.pone.0130120			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076024	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900139
J	Liu, S; Niger, C; Koh, EY; Stains, JP				Liu, Shuo; Niger, Corinne; Koh, Eugene Y.; Stains, Joseph P.			Connexin43 Mediated Delivery of ADAMTS5 Targeting siRNAs from Mesenchymal Stem Cells to Synovial Fibroblasts	PLOS ONE			English	Article							ARTICULAR CHONDROCYTES; GAP-JUNCTIONS; FUNCTIONAL EXPRESSION; OSTEOARTHRITIS; INTERLEUKIN-1-BETA	Osteoarthritis is a joint-destructive disease that has no effective cure. Human mesenchymal stem cells (hMSCs) could offer therapeutic benefit in the treatment of arthritic diseases by suppressing inflammation and permitting tissue regeneration, but first these cells must overcome the catabolic environment of the diseased joint. Likewise, gene therapy also offers therapeutic promise given its ability to directly modulate key catabolic factors that mediate joint deterioration, although it too has limitations. In the current study, we explore an approach that combines hMSCs and gene therapy. Specifically, we test the use of hMSC as a vehicle to deliver ADAMTS5 (an aggrecanase with a key role in osteoarthritis)-targeting siRNAs to SW982 synovial fibroblast-like cells via connexin43 containing gap junctions. Accordingly, we transduced hMSCs with ADAMTS5-targeting shRNA or non-targeted shRNA, and co-cultured them with synovial fibroblasts to allow delivery of siRNAs from hMSC to synovial fibroblasts. We found that co-culture of hMSCs-shRNA-ADAMTS5 and synovial fibroblasts reduced ADAMTS5 expression relative to co-culture of hMSCs-shRNA-control and synovial fibroblasts. Furthermore, ADAMTS5 was specifically reduced in the synovial fibroblasts populations as determined by fluorescence-activated cell sorting, suggesting transfer of the siRNA between cells. To test if Cx43-containing gap junctions are involved in the transfer of siRNA, we co-cultured hMSCs-shRNA-ADAMTS5 cells with synovial fibroblasts in which connexin43 was knocked down. Under these conditions, ADAMTS5 levels were not inhibited by co-culture, indicating that connexin43 mediates the delivery of siRNA from hMSCs to synovial fibroblasts. In total, our findings demonstrate that hMSCs can function as donor cells to host and deliver siRNAs to synovial fibroblasts via connexin43 gap junction in vitro. These data may have implications in the combination of hMSCs and gene therapy to treat diseases like osteoarthritis, in vivo.	[Liu, Shuo; Niger, Corinne; Koh, Eugene Y.; Stains, Joseph P.] Univ Maryland, Sch Med, Dept Orthopaed, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Stains, JP (corresponding author), Univ Maryland, Sch Med, Dept Orthopaed, Baltimore, MD 21201 USA.	jstai002@umaryland.edu			National Institutes of Health/National Institute of Arthritis, Musculoskeletal and Skin Diseases [R01 AR063631, R01 AR052719]; Maryland Stem Cell Research Fund [2012-MSCRFE-0154]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052719, R01AR063631] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Arthritis, Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Maryland Stem Cell Research Fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health/National Institute of Arthritis, Musculoskeletal and Skin Diseases, grants R01 AR063631 and R01 AR052719 (no role), and the Maryland Stem Cell Research Fund, grant 2012-MSCRFE-0154 (no role).	Aucher A, 2013, J IMMUNOL, V191, P6250, DOI 10.4049/jimmunol.1301728; Bondeson J, 2008, CLIN EXP RHEUMATOL, V26, P139; Brink PR, 2012, BBA-BIOMEMBRANES, V1818, P2076, DOI 10.1016/j.bbamem.2011.09.025; Buo AM, 2014, FEBS LETT, V588, P1315, DOI 10.1016/j.febslet.2014.01.025; Casagrande D, 2015, J SHOULDER ELB SURG, V24, P382, DOI 10.1016/j.jse.2014.11.039; Dazzi F, 2012, IMMUNOLOGY, V137, P206, DOI 10.1111/j.1365-2567.2012.03621.x; De Miguel MP, 2012, CURR MOL MED, V12, P574; Diao HJ, 2013, REGEN MED, V8, P257, DOI [10.2217/RME.13.22, 10.2217/rme.13.22]; Farini A, 2014, STEM CELLS INT, V2014, DOI 10.1155/2014/306573; Fosang AJ, 2008, EUR CELLS MATER, V15, P11, DOI 10.22203/eCM.v015a02; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Grigolo B, 2009, TISSUE ENG PART C-ME, V15, P647, DOI [10.1089/ten.tec.2008.0569, 10.1089/ten.TEC.2008.0569]; Gupta A, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-425; Herve JC, 2013, CELL TISSUE RES, V352, P21, DOI 10.1007/s00441-012-1485-6; Hou ML, 2013, J NEUROSCI METH, V220, P18, DOI 10.1016/j.jneumeth.2013.08.007; Katakowski M, 2010, CANCER RES, V70, P8259, DOI 10.1158/0008-5472.CAN-10-0604; Kizana E, 2009, GENE THER, V16, P1163, DOI 10.1038/gt.2009.64; Kolomytkin OV, 1997, AM J PHYSIOL-REG I, V273, pR1822; Kolomytkin OV, 2002, AM J PHYSIOL-CELL PH, V282, pC1254, DOI 10.1152/ajpcell.01166.2000; Lee AS, 2013, GENE, V527, P440, DOI 10.1016/j.gene.2013.05.069; Lee CH, 2009, TISSUE ENG PT A, V15, P3923, DOI 10.1089/ten.TEA.2008.0653; Lim PK, 2011, CANCER RES, V71, P1550, DOI 10.1158/0008-5472.CAN-10-2372; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Marino AA, 2004, CLIN ORTHOP RELAT R, P224, DOI 10.1097/01.blo.0000129346.29945.3b; Mayan MD, 2015, ANN RHEUM DIS, V74, P275, DOI 10.1136/annrheumdis-2013-204244; Mayan MD, 2013, AM J PATHOL, V182, P1337, DOI 10.1016/j.ajpath.2012.12.018; Murphy MB, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.94; Nanjundaiah SM, 2012, J BIOL CHEM, V287, P22216, DOI 10.1074/jbc.M112.356816; Niger C, 2013, J BONE MINER RES, V28, P1468, DOI 10.1002/jbmr.1867; Niger C, 2010, BIOL CELL, V102, P37, DOI 10.1042/BC20090056; Re'em T, 2012, BIOMATERIALS, V33, P751, DOI 10.1016/j.biomaterials.2011.10.007; Scanzello CR, 2012, BONE, V51, P249, DOI 10.1016/j.bone.2012.02.012; Sohni A, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/130763; Tonon R, 2002, BIORHEOLOGY, V39, P153; Tonon R, 2000, J BONE MINER RES, V15, P1669, DOI 10.1359/jbmr.2000.15.9.1669; Valiunas V, 2005, J PHYSIOL-LONDON, V568, P459, DOI 10.1113/jphysiol.2005.090985; Valiunas V, 2004, J PHYSIOL-LONDON, V555, P617, DOI 10.1113/jphysiol.2003.058719; Vankemmelbeke MN, 2001, EUR J BIOCHEM, V268, P1259, DOI 10.1046/j.1432-1327.2001.01990.x; Wolvetang EJ, 2007, BIOCHEM BIOPH RES CO, V363, P610, DOI 10.1016/j.bbrc.2007.09.035; Wylie JD, 2012, J ORTHOP RES, V30, P226, DOI 10.1002/jor.21508	40	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129999	10.1371/journal.pone.0129999	http://dx.doi.org/10.1371/journal.pone.0129999			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076025	Green Published, Green Submitted, gold			2022-12-26	WOS:000356329900121
J	Tong, X; Zhang, DQ; Arthurs, B; Li, P; Durudogan, L; Gupta, N; Yin, L				Tong, Xin; Zhang, Deqiang; Arthurs, Blake; Li, Pei; Durudogan, Leigh; Gupta, Neil; Yin, Lei			Palmitate Inhibits SIRT1-Dependent BMAL1/CLOCK Interaction and Disrupts Circadian Gene Oscillations in Hepatocytes	PLOS ONE			English	Article							HIGH-FAT-DIET; CONTROLS LIPID-METABOLISM; PANCREATIC BETA-CELLS; INSULIN-RESISTANCE; DEACETYLASE SIRT1; ENERGY-METABOLISM; CLOCK GENES; RHYTHMS; EXPRESSION; OBESITY	Elevated levels of serum saturated fatty acid palmitate have been shown to promote insulin resistance, increase cellular ROS production, and trigger cell apoptosis in hepatocytes during the development of obesity. However, it remains unclear whether palmitate directly impacts the circadian clock in hepatocytes, which coordinates nutritional inputs and hormonal signaling with downstream metabolic outputs. Here we presented evidence that the molecular clock is a novel target of palmitate in hepatocytes. Palmitate exposure at low dose inhibits the molecular clock activity and suppresses the cyclic expression of circadian targets including Dbp, Nr1d1 and Per2 in hepatocytes. Palmitate treatment does not seem to alter localization or reduce protein expression of BMAL1 and CLOCK, the two core components of the molecular clock in hepatocytes. Instead, palmitate destabilizes the protein-protein interaction between BMAL1-CLOCK in a dose and time-dependent manner. Furthermore, we showed that SIRT1 activators could reverse the inhibitory action of palmitate on BMAL1-CLOCK interaction and the clock gene expression, whereas inhibitors of NAD synthesis mimic the palmitate effects on the clock function. In summary, our findings demonstrated that palmitate inhibits the clock function by suppressing SIRT1 function in hepatocytes.	[Tong, Xin; Zhang, Deqiang; Arthurs, Blake; Li, Pei; Durudogan, Leigh; Gupta, Neil; Yin, Lei] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Yin, L (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	leiyin@umich.edu	Zhang, Deqiang/J-9199-2016	TONG, XIN/0000-0002-4832-8940; Li, Pei/0000-0003-1837-2753	NIH [DK077449, AA022720, P30 DK089503]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH funding (DK077449 and AA022720 to LY) and a pilot grant from NIH P30 DK089503. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Bellet MM, 2013, P NATL ACAD SCI USA, V110, P3333, DOI 10.1073/pnas.1214266110; Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Caruso R, 2014, MUCOSAL IMMUNOL, V7, P1467, DOI 10.1038/mi.2014.35; Cazanave SC, 2011, J BIOL CHEM, V286, P39336, DOI 10.1074/jbc.M111.280420; Challet E, 2013, PROG MOL BIOL TRANSL, V119, P105, DOI 10.1016/B978-0-12-396971-2.00005-1; Challet E, 2010, J COMP PHYSIOL B, V180, P631, DOI 10.1007/s00360-010-0451-4; Chang HC, 2013, CELL, V153, P1448, DOI 10.1016/j.cell.2013.05.027; Chavda B, 2014, EXPERT OPIN DRUG DIS, V9, P1005, DOI 10.1517/17460441.2014.933802; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Dardente H, 2007, BIOCHEM J, V402, P525, DOI 10.1042/BJ20060827; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Dibner C, 2009, EMBO J, V28, P123, DOI 10.1038/emboj.2008.262; Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Fick LJ, 2011, BIOCHEM BIOPH RES CO, V413, P414, DOI 10.1016/j.bbrc.2011.08.103; Froy O, 2007, FRONT NEUROENDOCRIN, V28, P61, DOI 10.1016/j.yfrne.2007.03.001; Gao D, 2010, J BIOL CHEM, V285, P29965, DOI 10.1074/jbc.M110.128694; Gao ZG, 2011, J BIOL CHEM, V286, P22227, DOI 10.1074/jbc.M111.228874; Greco JA, 2014, AM J PHYSIOL-REG I, V307, pR1049, DOI 10.1152/ajpregu.00100.2014; Grimaldi B, 2010, CELL METAB, V12, P509, DOI 10.1016/j.cmet.2010.10.005; Hasmann M, 2003, CANCER RES, V63, P7436; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hsieh MC, 2010, INT J OBESITY, V34, P227, DOI 10.1038/ijo.2009.228; Huang NA, 2012, SCIENCE, V337, P189, DOI 10.1126/science.1222804; Huang WY, 2011, J CLIN INVEST, V121, P2133, DOI 10.1172/JCI46043; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Kim EJ, 2012, HEPATOLOGY, V55, P1379, DOI 10.1002/hep.25529; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kraegen EW, 2001, EXP CLIN ENDOCR DIAB, V109, pS516; Kraegen EW, 2001, EXP CLIN ENDOCR DIAB, V109, pS189, DOI 10.1055/s-2001-18581; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lau P, 2008, J BIOL CHEM, V283, P18411, DOI 10.1074/jbc.M710526200; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Li SM, 2009, J APPL PHYSIOL, V107, P1959, DOI 10.1152/japplphysiol.00467.2009; Li XL, 2013, ACTA BIOCH BIOPH SIN, V45, P51, DOI 10.1093/abbs/gms108; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; Mendoza J, 2007, J NEUROENDOCRINOL, V19, P127, DOI 10.1111/j.1365-2826.2006.01510.x; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; Nie YZ, 2009, NAT CELL BIOL, V11, P492, DOI 10.1038/ncb1857; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Sahar S, 2009, NAT REV CANCER, V9, P886, DOI 10.1038/nrc2747; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Shao D, 2014, J BIOL CHEM, V289, P7293, DOI 10.1074/jbc.M113.520403; Shimba S, PLOS ONE, V6, DOI [10.1371/journal.pone.0025231PONE-D-11-09950, DOI 10.1371/JOURNAL.PONE.0025231PONE-D-11-09950]; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Thompson KJ, 2015, ADV EXP MED BIOL, V815, P361, DOI 10.1007/978-3-319-09614-8_21; Tong X, 2010, J BIOL CHEM, V285, P36401, DOI 10.1074/jbc.M110.172866; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; TURINSKY J, 1990, J BIOL CHEM, V265, P7933; Vetterli L, 2011, AGING-US, V3, P444, DOI 10.18632/aging.100304; Wu L, 2012, BBA-MOL BASIS DIS, V1822, P1815, DOI 10.1016/j.bbadis.2012.08.009; Yanagihara H, 2006, CHRONOBIOL INT, V23, P905, DOI 10.1080/07420520600827103; Yin L, 2010, P NATL ACAD SCI USA, V107, P11614, DOI 10.1073/pnas.1000438107; Yuan HP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015726; Zhang DQ, 2014, J BIOL CHEM, V289, P25925, DOI 10.1074/jbc.M114.567628; Zhou B, 2014, HEPATOLOGY, V59, P2196, DOI 10.1002/hep.26992	72	24	24	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130047	10.1371/journal.pone.0130047	http://dx.doi.org/10.1371/journal.pone.0130047			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075729	gold, Green Published, Green Submitted			2022-12-26	WOS:000356329900128
J	Toyoshima, A; Yasuhara, T; Kameda, M; Morimoto, J; Takeuchi, H; Wang, FF; Sasaki, T; Sasada, S; Shinko, A; Wakamori, T; Okazaki, M; Kondo, A; Agari, T; Borlongan, CV; Date, I				Toyoshima, Atsuhiko; Yasuhara, Takao; Kameda, Masahiro; Morimoto, Jun; Takeuchi, Hayato; Wang, Feifei; Sasaki, Tatsuya; Sasada, Susumu; Shinko, Aiko; Wakamori, Takaaki; Okazaki, Mihoko; Kondo, Akihiko; Agari, Takashi; Borlongan, Cesario V.; Date, Isao			Intra-Arterial Transplantation of Allogeneic Mesenchymal Stem Cells Mounts Neuroprotective Effects in a Transient Ischemic Stroke Model in Rats: Analyses of Therapeutic Time Window and Its Mechanisms	PLOS ONE			English	Article							MARROW MONONUCLEAR-CELLS; BLOOD-BRAIN-BARRIER; EXPERIMENTAL INTRACEREBRAL HEMORRHAGE; CEREBRAL-ARTERY OCCLUSION; FACTOR-SECRETING CELLS; BONE-MARROW; FUNCTIONAL RECOVERY; STROMAL CELLS; REPERFUSION INJURY; NEURAL STEM	Objective Intra-arterial stem cell transplantation exerts neuroprotective effects for ischemic stroke. However, the optimal therapeutic time window and mechanisms have not been completely understood. In this study, we investigated the relationship between the timing of intra-arterial transplantation of allogeneic mesenchymal stem cells (MSCs) in ischemic stroke model in rats and its efficacy in acute phase. Methods Adult male Wistar rats weighing 200 to 250g received right middle cerebral artery occlusion (MCAO) for 90 minutes. MSCs (1x10(6)cells/ 1ml PBS) were intra-arterially injected at either 1, 6, 24, or 48 hours (1, 6, 24, 48h group) after MCAO. PBS (1ml) was intra-arterially injected to control rats at 1 hour after MCAO. Behavioral test was performed immediately after reperfusion, and at 3, 7 days after MCAO using the Modified Neurological Severity Score (mNSS). Rats were euthanized at 7 days after MCAO for evaluation of infarct volumes and the migration of MSCs. In order to explore potential mechanisms of action, the upregulation of neurotrophic factor and chemotactic cytokine (bFGF, SDF-1 alpha) induced by cell transplantation was examined in another cohort of rats that received intra-arterial transplantation at 24 hours after recanalization then euthanized at 7 days after MCAO for protein assays. Results Behavioral test at 3 and 7 days after transplantation revealed that stroke rats in 24h group displayed the most robust significant improvements in mNSS compared to stroke rats in all other groups (p's<0.05). Similarly, the infarct volumes of stroke rats in 24h group were much significantly decreased compared to those in all other groups (p's<0.05). These observed behavioral and histological effects were accompanied by MSC survival and migration, with the highest number of integrated MSCs detected in the 24h group. Moreover, bFGF and SDF-1 alpha levels of the infarcted cortex were highly elevated in the 24h group compared to control group (p's<0.05). Conclusions These results suggest that intra-arterial allogeneic transplantation of MSCs provides post-stroke functional recovery and reduction of infarct volumes in ischemic stroke model of rats. The upregulation of bFGF and SDF-1 alpha likely played a key mechanistic role in enabling MSC to afford functional effects in stroke. MSC transplantation at 24 hours after recanalization appears to be the optimal timing for ischemic stroke model, which should guide the design of clinical trials of cell transplantation for stroke patients.	[Toyoshima, Atsuhiko; Yasuhara, Takao; Kameda, Masahiro; Morimoto, Jun; Takeuchi, Hayato; Sasaki, Tatsuya; Sasada, Susumu; Shinko, Aiko; Wakamori, Takaaki; Okazaki, Mihoko; Kondo, Akihiko; Agari, Takashi; Date, Isao] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol Surg, Kita Ku, Okayama 7008558, Japan; [Wang, Feifei] Kochi Univ, Sch Med, Ctr Innovat & Translat Med, Nankoku, Kochi 7838505, Japan; [Borlongan, Cesario V.] Univ S Florida, Coll Med, Dept Neurosurg, Tampa, FL 33612 USA	Okayama University; Kochi University; State University System of Florida; University of South Florida	Yasuhara, T (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol Surg, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	tyasu37@cc.okayama-u.ac.jp	Yasuhara, Takao/AEU-1075-2022; Kondo, Akihiko/A-2130-2015		Kaken [26293323]; Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science (JSPS)	Kaken(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by all coauthors and by Kaken Grants-in-Aid for Scientific Research to Dr. Date (Grant Number #26293323). Kaken is a database provided by the National Institute of Informatics with support of the Ministry of Education, Culture, Sports, Science and Technology and the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2009, STROKE, V40, pE598, DOI 10.1161/STROKEAHA.109.563627; Bao XJ, 2011, BRAIN RES, V1367, P103, DOI 10.1016/j.brainres.2010.10.063; Battistella V, 2011, REGEN MED, V6, P45, DOI 10.2217/RME.10.97; Borlongan CV, 2012, CURR PHARM DESIGN, V18, P3670; Borlongan CV, 2004, STROKE, V35, P2385, DOI 10.1161/01.STR.0000141680.49960.d7; Brenneman M, 2010, J CEREBR BLOOD F MET, V30, P140, DOI 10.1038/jcbfm.2009.198; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chua JY, 2011, J CEREBR BLOOD F MET, V31, P1263, DOI 10.1038/jcbfm.2010.213; Friedrich MAG, 2012, CELL TRANSPLANT, V21, pS13, DOI 10.3727/096368912X612512; Fujiwara K, 2003, J NEUROSURG, V99, P1053, DOI 10.3171/jns.2003.99.6.1053; Guzman R, 2008, STROKE, V39, P1300, DOI 10.1161/STROKEAHA.107.500470; Guzman R, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E14; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; Horie N, 2011, STEM CELLS, V29, P274, DOI 10.1002/stem.584; Ishizaka S, 2013, STROKE, V44, P720, DOI 10.1161/STROKEAHA.112.677328; Jin KL, 2005, NEUROBIOL DIS, V18, P366, DOI 10.1016/j.nbd.2004.10.010; Kameda M, 2007, EUR J NEUROSCI, V26, P1462, DOI 10.1111/j.1460-9568.2007.05776.x; Kamiya N, 2008, LIFE SCI, V83, P433, DOI 10.1016/j.lfs.2008.07.018; Keimpema E, 2009, NEUROPATH APPL NEURO, V35, P89, DOI 10.1111/j.1365-2990.2008.00961.x; Khatri R, 2012, NEUROLOGY, V79, pS52, DOI 10.1212/WNL.0b013e3182697e70; Komatsu K, 2010, BRAIN RES, V1334, P84, DOI 10.1016/j.brainres.2010.04.006; Kurozumi K, 2004, MOL THER, V9, P189, DOI 10.1016/j.ymthe.2003.10.012; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Mitkari B, 2013, EXP NEUROL, V239, P158, DOI 10.1016/j.expneurol.2012.09.018; Moisan A, 2012, NMR BIOMED, V25, P1340, DOI 10.1002/nbm.2806; Moniche F, 2012, STROKE, V43, P2242, DOI 10.1161/STROKEAHA.112.659409; Okuma Y, 2013, NEUROSCI LETT, V554, P156, DOI 10.1016/j.neulet.2013.08.058; Rosenblum S, 2012, STROKE, V43, P1624, DOI 10.1161/STROKEAHA.111.637884; Sato K, 2013, INT J MOL SCI, V14, P21513, DOI 10.3390/ijms141121513; Savitz SI, 2011, ANN NEUROL, V70, P59, DOI 10.1002/ana.22458; Seyfried D, 2004, J NEUROSURG, V101, P104, DOI 10.3171/jns.2004.101.1.0104; Seyfried DM, 2008, BRAIN RES, V1224, P12, DOI 10.1016/j.brainres.2008.05.080; Shen LH, 2006, NEUROSCIENCE, V137, P393, DOI 10.1016/j.neuroscience.2005.08.092; Shen LH, 2007, STROKE, V38, P2150, DOI 10.1161/STROKEAHA.106.481218; Shinozuka K, 2013, BRAIN SCI, V3, P239, DOI 10.3390/brainsci3010239; Shyu WC, 2008, J PHARMACOL EXP THER, V324, P834, DOI 10.1124/jpet.107.127746; Wakabayashi K, 2010, J NEUROSCI RES, V88, P1017, DOI 10.1002/jnr.22279; Walczak P, 2008, STROKE, V39, P1569, DOI 10.1161/STROKEAHA.107.502047; Wang FF, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-52; Wang LQ, 2014, CNS NEUROSCI THER, V20, P317, DOI 10.1111/cns.12216; Wang Y, 2008, BRAIN RES, V1195, P104, DOI 10.1016/j.brainres.2007.11.068; Warach S, 2004, STROKE, V35, P2659, DOI 10.1161/01.STR.0000144051.32131.09; Yasuhara T, 2006, FRONT BIOSCI-LANDMRK, V11, P760, DOI 10.2741/1834	44	62	68	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0127302	10.1371/journal.pone.0127302	http://dx.doi.org/10.1371/journal.pone.0127302			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075717	Green Submitted, gold, Green Published			2022-12-26	WOS:000356329900011
J	Tse, A; Verkhivker, GM				Tse, Amanda; Verkhivker, Gennady M.			Molecular Determinants Underlying Binding Specificities of the ABL Kinase Inhibitors: Combining Alanine Scanning of Binding Hot Spots with Network Analysis of Residue Interactions and Coevolution	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; GENERAL FORCE-FIELD; FUNCTIONALLY IMPORTANT RESIDUES; PROTEIN CONFORMATIONAL-CHANGES; BCR-ABL; TYROSINE KINASE; C-SRC; DYNAMICS SIMULATIONS; DOMAIN MUTATIONS; IN-VITRO	Quantifying binding specificity and drug resistance of protein kinase inhibitors is of fundamental importance and remains highly challenging due to complex interplay of structural and thermodynamic factors. In this work, molecular simulations and computational alanine scanning are combined with the network-based approaches to characterize molecular determinants underlying binding specificities of the ABL kinase inhibitors. The proposed theoretical framework unveiled a relationship between ligand binding and inhibitor-mediated changes in the residue interaction networks. By using topological parameters, we have described the organization of the residue interaction networks and networks of coevolving residues in the ABL kinase structures. This analysis has shown that functionally critical regulatory residues can simultaneously embody strong coevolutionary signal and high network centrality with a propensity to be energetic hot spots for drug binding. We have found that selective (Nilotinib) and promiscuous (Bosutinib, Dasatinib) kinase inhibitors can use their energetic hot spots to differentially modulate stability of the residue interaction networks, thus inhibiting or promoting conformational equilibrium between inactive and active states. According to our results, Nilotinib binding may induce a significant network-bridging effect and enhance centrality of the hot spot residues that stabilize structural environment favored by the specific kinase form. In contrast, Bosutinib and Dasatinib can incur modest changes in the residue interaction network in which ligand binding is primarily coupled only with the identity of the gate-keeper residue. These factors may promote structural adaptability of the active kinase states in binding with these promiscuous inhibitors. Our results have related ligand-induced changes in the residue interaction networks with drug resistance effects, showing that network robustness may be compromised by targeted mutations of key mediating residues. This study has outlined mechanisms by which inhibitor binding could	[Tse, Amanda; Verkhivker, Gennady M.] Chapman Univ, Grad Program Computat & Data Sci, Schmid Coll Sci & Technol, Orange, CA 92866 USA; [Verkhivker, Gennady M.] Chapman Univ, Sch Pharm, Irvine, CA USA	Chapman University System; Chapman University; Chapman University System; Chapman University	Verkhivker, GM (corresponding author), Chapman Univ, Grad Program Computat & Data Sci, Schmid Coll Sci & Technol, Orange, CA 92866 USA.	verkhivk@chapman.edu	Verkhivker, Gennady/V-9404-2018	Verkhivker, Gennady/0000-0002-4507-4471	Chapman University	Chapman University	This work is supported by funding from Chapman University. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041430; Aleksandrov A, 2010, J BIOL CHEM, V285, P13807, DOI 10.1074/jbc.M110.109660; Aleksandrov A, 2010, J COMPUT CHEM, V31, P1550, DOI 10.1002/jcc.21442; Allen M., 2017, COMPUTER SIMULATIONS, V2nd; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; ANDERSEN HC, 1980, J CHEM PHYS, V72, P2384, DOI 10.1063/1.439486; Artim SC, 2012, BIOCHEM J, V448, P213, DOI 10.1042/BJ20121365; Atilgan AR, 2004, BIOPHYS J, V86, P85, DOI 10.1016/S0006-3495(04)74086-2; Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Beygelzimer A, 2005, PHYSICA A, V357, P593, DOI 10.1016/j.physa.2005.03.040; Boran ADW, 2010, CURR OPIN DRUG DISC, V13, P297; Branford S, 2009, BLOOD, V114, P5426, DOI 10.1182/blood-2009-08-215939; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; Buffa P, 2014, FASEB J, V28, P1221, DOI 10.1096/fj.13-236992; Carter TA, 2005, P NATL ACAD SCI USA, V102, P11011, DOI 10.1073/pnas.0504952102; Cassuto O, 2012, ONCOTARGET, V3, P1557; Chakrabarti S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008591; Chakrabarti S, 2009, PROTEINS, V75, P231, DOI 10.1002/prot.22239; Cortes J, 2007, BLOOD, V110, P4005, DOI 10.1182/blood-2007-03-080838; Cowan-Jacob SW, 2014, FUTURE MED CHEM, V6, P541, DOI 10.4155/fmc.13.216; Csermely P, 2013, J COMPLEX NETW, V1, P93, DOI 10.1093/comnet/cnt016; Csermely P, 2013, PHARMACOL THERAPEUT, V138, P333, DOI 10.1016/j.pharmthera.2013.01.016; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Dar AC, 2011, ANNU REV BIOCHEM, V80, P769, DOI 10.1146/annurev-biochem-090308-173656; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; de Juan D, 2013, NAT REV GENET, V14, P249, DOI 10.1038/nrg3414; del Sol A, 2005, BIOINFORMATICS, V21, P1311, DOI 10.1093/bioinformatics/bti167; del Sol A, 2005, PROTEINS, V58, P672, DOI 10.1002/prot.20348; del Sol A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100063; del Sol A, 2006, PROTEIN SCI, V15, P2120, DOI 10.1110/ps.062249106; del Sol A, 2010, CURR OPIN BIOTECH, V21, P566, DOI 10.1016/j.copbio.2010.07.010; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; Dixit A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002179; Dixit A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000487; Dokholyan NV, 2002, P NATL ACAD SCI USA, V99, P8637, DOI 10.1073/pnas.122076099; Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Eyal E, 2006, BIOINFORMATICS, V22, P2619, DOI 10.1093/bioinformatics/btl448; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Farenc C, 2011, FEBS LETT, V585, P3593, DOI 10.1016/j.febslet.2011.10.028; Fernandez-Fuentes N, 2006, NUCLEIC ACIDS RES, V34, pW173, DOI 10.1093/nar/gkl113; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD364, DOI 10.1093/nar/gkt1210; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; FLOYD RW, 1962, COMMUN ACM, V5, P345, DOI 10.1145/367766.368168; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Frisch M.J., 2009, GAUSSIAN 09 LINUX VE; Getlik M, 2009, J MED CHEM, V52, P3915, DOI 10.1021/jm9002928; Giansanti P, 2014, ACS CHEM BIOL, V9, P1490, DOI 10.1021/cb500116c; Gibbons DL, 2014, P NATL ACAD SCI USA, V111, P3550, DOI 10.1073/pnas.1321173111; Greene LH, 2003, J MOL BIOL, V334, P781, DOI 10.1016/j.jmb.2003.08.061; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Hantschel O, 2007, P NATL ACAD SCI USA, V104, P13283, DOI 10.1073/pnas.0702654104; Hantschel Oliver, 2012, Genes Cancer, V3, P436, DOI 10.1177/1947601912458584; Hantschel O, 2012, CANCER RES, V72, P4890, DOI 10.1158/0008-5472.CAN-12-1276; Hari SB, 2013, ACS CHEM BIOL, V8, P2734, DOI 10.1021/cb400663k; Hoffman NG, 2003, VIROLOGY, V314, P536, DOI 10.1016/S0042-6822(03)00484-7; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hsu YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009455; Hu ZJ, 2007, PLOS COMPUT BIOL, V3, P1097, DOI 10.1371/journal.pcbi.0030117; Hughes T, 2009, J CLIN ONCOL, V27, P4204, DOI 10.1200/JCO.2009.21.8230; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huo S, 2002, J COMPUT CHEM, V23, P15, DOI 10.1002/jcc.1153; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Iacob RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015929; Jabbour E, 2009, BLOOD, V114, P2037, DOI 10.1182/blood-2009-01-197715; James KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113488; Jeon J, 2011, MOL BIOL EVOL, V28, P2675, DOI 10.1093/molbev/msr094; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kanna N, 1999, J MOL BIOL, V292, P441, DOI 10.1006/jmbi.1999.3058; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kitano H, 2007, NAT REV DRUG DISCOV, V6, P202, DOI 10.1038/nrd2195; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; KORBER BTM, 1993, P NATL ACAD SCI USA, V90, P7176, DOI 10.1073/pnas.90.15.7176; Kornev AP, 2008, P NATL ACAD SCI USA, V105, P14377, DOI 10.1073/pnas.0807988105; Koukos PI, 2013, J COMPUT CHEM, V34, P2310, DOI 10.1002/jcc.23381; Kowarsch A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000923; Lamontanara AJ, 2013, BBA-PROTEINS PROTEOM, V1834, P1449, DOI 10.1016/j.bbapap.2012.12.009; Laurini E, 2013, MOL ONCOL, V7, P968, DOI 10.1016/j.molonc.2013.06.001; Lee BC, 2008, PROTEINS, V72, P863, DOI 10.1002/prot.21972; Lee TS, 2008, CANCER-AM CANCER SOC, V112, P1744, DOI 10.1002/cncr.23355; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Levinson NM, 2014, NAT CHEM BIOL, V10, P127, DOI [10.1038/NCHEMBIO.1404, 10.1038/nchembio.1404]; Levinson NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029828; Lin YL, 2014, J AM CHEM SOC, V136, P14753, DOI 10.1021/ja504146x; Lin YL, 2013, J AM CHEM SOC, V135, P14741, DOI 10.1021/ja405939x; Lin YL, 2013, P NATL ACAD SCI USA, V110, P1664, DOI 10.1073/pnas.1214330110; Liu Y, 2012, MOL BIOL EVOL, V29, P2253, DOI 10.1093/molbev/mss097; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Louzada VHP, 2013, J COMPLEX NETW, V1, P150, DOI 10.1093/comnet/cnt010; Lovera S, 2012, J AM CHEM SOC, V134, P2496, DOI 10.1021/ja210751t; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MacKerell Alexander D. Jr., 2000, Biopolymers, V56, P257, DOI 10.1002/1097-0282(2000)56:4<257::AID-BIP10029>3.0.CO;2-W; Marcotte DJ, 2010, PROTEIN SCI, V19, P429, DOI 10.1002/pro.321; Buslje CM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000978; Buslje CM, 2009, BIOINFORMATICS, V25, P1125, DOI 10.1093/bioinformatics/btp135; Marsh JA, 2013, J MOL BIOL, V425, P3250, DOI 10.1016/j.jmb.2013.06.019; Marsh JA, 2011, STRUCTURE, V19, P859, DOI 10.1016/j.str.2011.03.010; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; Mayne CG, 2013, J COMPUT CHEM, V34, P2757, DOI 10.1002/jcc.23422; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; McMurrough TA, 2014, P NATL ACAD SCI USA, V111, pE2376, DOI 10.1073/pnas.1322352111; Meharena HS, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001680; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Moreira IS, 2007, J COMPUT CHEM, V28, P644, DOI 10.1002/jcc.20566; Muckelbauer J, 2011, CHEM BIOL DRUG DES, V78, P739, DOI 10.1111/j.1747-0285.2011.01230.x; Muller MC, 2009, BLOOD, V114, P4944, DOI 10.1182/blood-2009-04-214221; Muratore KE, 2009, BIOCHEMISTRY-US, V48, P3378, DOI 10.1021/bi900057g; Nagar B, 2002, CANCER RES, V62, P4236; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; O'Hare T, 2005, CANCER RES, V65, P4500, DOI 10.1158/0008-5472.CAN-05-0259; O'Hare T, 2004, BLOOD, V104, P2532, DOI 10.1182/blood-2004-05-1851; O'Hare T, 2009, CANCER CELL, V16, P401, DOI 10.1016/j.ccr.2009.09.028; Oruganty K, 2012, PHILOS T R SOC B, V367, P2529, DOI 10.1098/rstb.2012.0015; Panjarian S, 2013, J BIOL CHEM, V288, P5443, DOI 10.1074/jbc.R112.438382; Pei JF, 2014, J AM CHEM SOC, V136, P11556, DOI 10.1021/ja504810z; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pricl S, 2005, MOL CANCER THER, V4, P1167, DOI 10.1158/1535-7163.MCT-05-0101; Puttini M, 2006, CANCER RES, V66, P11314, DOI 10.1158/0008-5472.CAN-06-1199; Redaelli S, 2012, AM J HEMATOL, V87, pE125, DOI 10.1002/ajh.23338; Redaelli S, 2009, J CLIN ONCOL, V27, P469, DOI 10.1200/JCO.2008.19.8853; Reddy E Premkumar, 2012, Genes Cancer, V3, P447, DOI 10.1177/1947601912462126; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Roskoski R, 2014, PHARMACOL RES, V79, P34, DOI 10.1016/j.phrs.2013.11.002; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schneider CM, 2011, P NATL ACAD SCI USA, V108, P3838, DOI 10.1073/pnas.1009440108; Seeliger MA, 2007, STRUCTURE, V15, P299, DOI 10.1016/j.str.2007.01.015; Seeliger MA, 2009, CANCER RES, V69, P2384, DOI 10.1158/0008-5472.CAN-08-3953; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Shan YB, 2009, P NATL ACAD SCI USA, V106, P139, DOI 10.1073/pnas.0811223106; Simonetti FL, 2013, NUCLEIC ACIDS RES, V41, pW8, DOI 10.1093/nar/gkt427; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; Soverini S, 2014, CANCER-AM CANCER SOC, V120, P1002, DOI 10.1002/cncr.28522; Soverini S, 2011, BLOOD, V118, P1208, DOI 10.1182/blood-2010-12-326405; Soverini S, 2011, ONCOLOGIST, V16, P868, DOI 10.1634/theoncologist.2010-0388; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Szilagyi A, 2013, CURR TOP MED CHEM, V13, P64, DOI 10.2174/1568026611313010007; Tanneeru K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078556; Taylor SS, 2013, BBA-PROTEINS PROTEOM, V1834, P1271, DOI 10.1016/j.bbapap.2013.03.007; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; Taylor SS, 2012, PHILOS T R SOC B, V367, P2517, DOI 10.1098/rstb.2012.0054; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Ten Eyck LF, 2008, BBA-PROTEINS PROTEOM, V1784, P238, DOI 10.1016/j.bbapap.2007.11.002; Teppa E, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-235; Tokarski JS, 2006, CANCER RES, V66, P5790, DOI 10.1158/0008-5472.CAN-05-4187; Tsai CJ, 2009, MOL BIOSYST, V5, P207, DOI 10.1039/b819720b; Vajpai N, 2008, J BIOL CHEM, V283, P18292, DOI 10.1074/jbc.M801337200; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3155, DOI 10.1021/ci3003649; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3144, DOI 10.1021/ci300363c; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Vendruscolo M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061910; Verkhivker GA, 2007, BIOPOLYMERS, V85, P333, DOI 10.1002/bip.20656; Wang JW, 2013, FEBS LETT, V587, P136, DOI 10.1016/j.febslet.2012.11.001; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Williams NK, 2009, J BIOL CHEM, V284, P284, DOI 10.1074/jbc.M807850200; Wodicka LM, 2010, CHEM BIOL, V17, P1241, DOI 10.1016/j.chembiol.2010.09.010; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Xie L, 2012, ANNU REV PHARMACOL, V52, P361, DOI 10.1146/annurev-pharmtox-010611-134630; Xu F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005913; Yang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116551; Yeang CH, 2007, PLOS COMPUT BIOL, V3, P2122, DOI 10.1371/journal.pcbi.0030211; Yesselman JD, 2012, J COMPUT CHEM, V33, P189, DOI 10.1002/jcc.21963; Zabriskie MS, 2014, CANCER CELL, V26, P428, DOI 10.1016/j.ccr.2014.07.006; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhao YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117506; Zhao Z, 2014, ACS CHEM BIOL, V9, P1230, DOI 10.1021/cb500129t; Zhou TJ, 2011, CHEM BIOL DRUG DES, V77, P1, DOI 10.1111/j.1747-0285.2010.01054.x	183	28	28	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130203	10.1371/journal.pone.0130203	http://dx.doi.org/10.1371/journal.pone.0130203			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075886	Green Submitted, Green Published, gold			2022-12-26	WOS:000356329900156
J	Vitiazeva, V; Kattla, JJ; Flowers, SA; Linden, SK; Premaratne, P; Weijdegard, B; Sundfeldt, K; Karlsson, NG				Vitiazeva, Varvara; Kattla, Jayesh J.; Flowers, Sarah A.; Linden, Sara K.; Premaratne, Pushpa; Weijdegard, Birgitta; Sundfeldt, Karin; Karlsson, Niclas G.			The O-Linked Glycome and Blood Group Antigens ABO on Mucin-Type Glycoproteins in Mucinous and Serous Epithelial Ovarian Tumors	PLOS ONE			English	Article							CARBOHYDRATE ANTIGENS; BIOMARKERS HE-4; EXPRESSION; CANCER; PROTEINS; GLYCOSYLATION; IDENTIFICATION; DIAGNOSIS; GLYCANS; CA-125	Background Mucins are heavily O-glycosylated proteins where the glycosylation has been shown to play an important role in cancer. Normal epithelial ovarian cells do not express secreted mucins, but their abnormal expression has previously been described in epithelial ovarian cancer and may relate to tumor formation and progression. The cyst fluids were shown to be a rich source for acidic glycoproteins. The study of these proteins can potentially lead to the identification of more effective biomarkers for ovarian cancer. Methods In this study, we analyzed the expression of the MUC5AC and the O-glycosylation of acidic glycoproteins secreted into ovarian cyst fluids. The samples were obtained from patients with serous and mucinous ovarian tumors of different stages (benign, borderline, malignant) and grades. The O-linked oligosaccharides were released and analyzed by negative-ion graphitized carbon Liquid Chromatography (LC) coupled to Electrospray Ionization tandem Mass Spectrometry (ESI-MSn). The LC-ESI-MSn of the oligosaccharides from ovarian cyst fluids displayed differences in expression of fucose containing structures such as blood group ABO antigens and Lewis-type epitopes. Results The obtained data showed that serous and mucinous benign adenomas, mucinous low malignant potential carcinomas (LMPs, borderline) and mucinous low-grade carcinomas have a high level of blood groups and Lewis type epitopes. In contrast, this type of fucosylated structures were low abundant in the high-grade mucinous carcinomas or in serous carcinomas. In addition, the ovarian tumors that showed a high level of expression of blood group antigens also revealed a strong reactivity towards the MUC5AC antibody. To visualize the differences between serous and mucinous ovarian tumors based on the O-glycosylation, a hierarchical cluster analysis was performed using mass spectrometry average compositions (MSAC). Conclusion Mucinous benign and LMPs along with mucinous low-grade carcinomas appear to be different from serous and high-grade mucinous carcinomas based on their O-glycan profiles.	[Vitiazeva, Varvara; Kattla, Jayesh J.; Flowers, Sarah A.; Linden, Sara K.; Premaratne, Pushpa; Karlsson, Niclas G.] Univ Gothenburg, Dept Med Biochem, Gothenburg, Sweden; [Weijdegard, Birgitta; Sundfeldt, Karin] Univ Gothenburg, Inst Clin Sci, Sahlgrenska Canc Ctr, Dept Obstet & Gynecol, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Vitiazeva, V (corresponding author), Univ Gothenburg, Dept Med Biochem, Gothenburg, Sweden.	varvara.vitiazeva@gu.se	Karlsson, Niclas/G-5235-2013; Lindén, Sara K/A-3271-2011	Karlsson, Niclas/0000-0002-3045-2628; Lindén, Sara K/0000-0002-7751-9586; Flowers, Sarah/0000-0002-3513-2260	Swedish Research Council [2013-5895, 2010-5322, 342-2004-4434]; County Council of Vastra Gotaland [ALFGBG-290371, 437281]; Swedish Foundation for International Cooperation in Research and Higher Education (STINT); Knut and Alice Wallenberg foundation [KAW2007.0118]	Swedish Research Council(Swedish Research CouncilEuropean Commission); County Council of Vastra Gotaland; Swedish Foundation for International Cooperation in Research and Higher Education (STINT); Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation)	This work was supported by the Swedish Research Council (http://www.vr.se/) (2013-5895 and 2010-5322) the County Council of Vastra Gotaland (http://www.fou.nu/is/alfgbg/) (ALFGBG-290371 and 437281) and by The Swedish Foundation for International Cooperation in Research and Higher Education (STINT) (http://www.stint.se/en/). The LTQ mass spectrometer was obtained by a grant from the Swedish Research Council (342-2004-4434) and the LTQ Orbitrap was obtained from a grant from Knut and Alice Wallenberg foundation (https://www.wallenberg.com/kaw/en) (KAW2007.0118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTARAS MM, 1988, GYNECOL ONCOL, V30, P26, DOI 10.1016/0090-8258(88)90042-X; Andersch-Bjorkman Y, 2007, MOL CELL PROTEOMICS, V6, P708, DOI 10.1074/mcp.M600439-MCP200; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Boman F, 2001, J PATHOL, V193, P339, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH798>3.0.CO;2-9; Byrd JC, 2004, CANCER METAST REV, V23, P77, DOI 10.1023/A:1025815113599; Chauhan SC, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-21; CORDONCARDO C, 1986, INT J CANCER, V37, P667, DOI 10.1002/ijc.2910370505; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; DALLENBACHHELLWEG G, 1984, J CANCER RES CLIN, V107, P71, DOI 10.1007/BF00399375; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Eriksson J, 2004, J PROTEOME RES, V3, P32, DOI 10.1021/pr034048y; Federici MF, 1999, INT J CANCER, V81, P193, DOI 10.1002/(SICI)1097-0215(19990412)81:2<193::AID-IJC5>3.0.CO;2-S; Feng H, 2002, JPN J CLIN ONCOL, V32, P525, DOI 10.1093/jjco/hyf111; Giuntoli RL, 1998, CANCER RES, V58, P5546; Gustafsson JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084430; Hayes CA, 2012, BIOINFORMATICS, V28, P1669, DOI 10.1093/bioinformatics/bts242; Hayes CA, 2011, BIOINFORMATICS, V27, P1343, DOI 10.1093/bioinformatics/btr137; Hess V, 2004, J CLIN ONCOL, V22, P1040, DOI 10.1200/JCO.2004.08.078; Holschneider CH, 2000, SEMIN SURG ONCOL, V19, P3, DOI 10.1002/1098-2388(200007/08)19:1<3::AID-SSU2>3.0.CO;2-S; JACOBS I, 1989, HUM REPROD, V4, P1; Jin CS, 2012, J BIOL CHEM, V287, P35922, DOI 10.1074/jbc.M112.363119; Karlsson NG, 2004, J AM SOC MASS SPECTR, V15, P659, DOI 10.1016/j.jasms.2004.01.002; Karlsson NG, 2012, GLYCOBIOLOGY, V22, P918, DOI 10.1093/glycob/cws060; Kelemen LE, 2011, LANCET ONCOL, V12, P1071, DOI 10.1016/S1470-2045(11)70058-4; Kim YS, 1996, GLYCOCONJUGATE J, V13, P693, DOI 10.1007/BF00702333; Koda Y, 2001, Leg Med (Tokyo), V3, P2, DOI 10.1016/S1344-6223(01)00005-0; Kristjansdottir B, 2013, GYNECOL ONCOL, V131, P52, DOI 10.1016/j.ygyno.2013.07.094; Kristjansdottir Bjorg, 2012, Clin Proteomics, V9, P14, DOI 10.1186/1559-0275-9-14; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Lau SK, 2004, AM J CLIN PATHOL, V122, P61, DOI 10.1309/9R6673QEC06D86Y4; Le Pendu J, 2001, APMIS, V109, P9; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Linden S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040002; MATSUMOTO H, 1993, CANCER-AM CANCER SOC, V72, P75, DOI 10.1002/1097-0142(19930701)72:1<75::AID-CNCR2820720116>3.0.CO;2-Z; Medeiros LR, 2009, EUR J OBSTET GYN R B, V142, P99, DOI 10.1016/j.ejogrb.2008.08.011; Meyer T, 2000, BRIT J CANCER, V82, P1535; Moore RG, 2008, GYNECOL ONCOL, V108, P402, DOI 10.1016/j.ygyno.2007.10.017; Nolen B, 2009, GYNECOL ONCOL, V112, P47, DOI 10.1016/j.ygyno.2008.09.043; Partheen K, 2011, J GYNECOL ONCOL, V22, P244, DOI 10.3802/jgo.2011.22.4.244; Remmers N, 2013, CLIN CANCER RES, V19, P1981, DOI 10.1158/1078-0432.CCR-12-2662; Rosen DG, 2005, GYNECOL ONCOL, V99, P267, DOI 10.1016/j.ygyno.2005.06.040; Rossez Y, 2012, GLYCOBIOLOGY, V22, P1193, DOI 10.1093/glycob/cws072; SCHOENTAG R, 1987, CANCER RES, V47, P1695; Schulz BL, 2002, ANAL CHEM, V74, P6088, DOI 10.1021/ac025890a; Singh AP, 2008, LANCET ONCOL, V9, P1076, DOI 10.1016/S1470-2045(08)70277-8; Sugai M, 2008, PATHOL INT, V58, P681, DOI 10.1111/j.1440-1827.2008.02293.x; Tarp MA, 2008, BBA-GEN SUBJECTS, V1780, P546, DOI 10.1016/j.bbagen.2007.09.010; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; VOWDEN P, 1986, BRIT J CANCER, V53, P313, DOI 10.1038/bjc.1986.54; Wamunyokoli FW, 2006, CLIN CANCER RES, V12, P690, DOI 10.1158/1078-0432.CCR-05-1110; Welshinger M, 1996, GYNECOL ONCOL, V62, P106, DOI 10.1006/gyno.1996.0198; Wilson NL, 2002, J PROTEOME RES, V1, P521, DOI 10.1021/pr025538d; Wongkham S, 2003, CANCER LETT, V195, P93, DOI 10.1016/S0304-3835(02)00691-2; Yin BWT, 1996, INT J CANCER, V65, P406, DOI 10.1002/(SICI)1097-0215(19960208)65:4<406::AID-IJC2>3.3.CO;2-5; Zhuang HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068994	56	19	19	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130197	10.1371/journal.pone.0130197	http://dx.doi.org/10.1371/journal.pone.0130197			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075384	Green Published, Green Submitted, gold			2022-12-26	WOS:000356329900153
J	Wylam, ME; Sathish, V; VanOosten, SK; Freeman, M; Burkholder, D; Thompson, MA; Pabelick, CM; Prakash, YS				Wylam, Mark E.; Sathish, Venkatachalem; VanOosten, Sarah Kay; Freeman, Michelle; Burkholder, David; Thompson, Michael A.; Pabelick, Christina M.; Prakash, Y. S.			Mechanisms of Cigarette Smoke Effects on Human Airway Smooth Muscle	PLOS ONE			English	Article							OPERATED CA2+ ENTRY; ION CHANNELS; ADP-RIBOSE; IN-VITRO; PROLIFERATION; RELEASE; INFLUX; RESPONSIVENESS; OSCILLATIONS; ASSOCIATION	Cigarette smoke contributes to or exacerbates airway diseases such as asthma and COPD, where airway hyperresponsiveness and airway smooth muscle (ASM) proliferation are key features. While factors such as inflammation contribute to asthma in part by enhancing agonist-induced intracellular Ca2+ ([Ca2+]i) responses of ASM, the mechanisms by which cigarette smoke affect ASM are still under investigation. In the present study, we tested the hypothesis that cigarette smoke enhances the expression and function of Ca2+ regulatory proteins leading to increased store operated Ca2+ entry (SOCE) and cell proliferation. Using isolated human ASM (hASM) cells, incubated in the presence and absence cigarette smoke extract (CSE) we determined ([Ca2+]i) responses and expression of relevant proteins as well as ASM proliferation, reactive oxidant species (ROS) and cytokine generation. CSE enhanced [Ca2+]i responses to agonist and SOCE: effects mediated by increased expression of TRPC3, CD38, STIM1, and/or Orai1, evident by attenuation of CSE effects when siRNAs against these proteins were used, particularly Orai1. CSE also increased hASM ROS generation and cytokine secretion. In addition, we found in the airways of patients with long-term smoking history, TRPC3 and CD38 expression were significantly increased compared to life-long never-smokers, supporting the role of these proteins in smoking effects. Finally, CSE enhanced hASM proliferation, an effect confirmed by upregulation of PCNA and Cyclin E. These results support a critical role for Ca2+ regulatory proteins and enhanced SOCE to alter airway structure and function in smoking-related airway disease.	[Wylam, Mark E.] Mayo Clin, Coll Med, Dept Internal Med, Rochester, MN 55905 USA; [Wylam, Mark E.] Mayo Clin, Coll Med, Dept Pediat, Rochester, MN USA; [Sathish, Venkatachalem; VanOosten, Sarah Kay; Freeman, Michelle; Burkholder, David; Thompson, Michael A.; Pabelick, Christina M.; Prakash, Y. S.] Mayo Clin, Coll Med, Dept Anesthesiol, Rochester, MN USA; [Sathish, Venkatachalem; Pabelick, Christina M.; Prakash, Y. S.] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Wylam, ME (corresponding author), Mayo Clin, Coll Med, Dept Internal Med, Rochester, MN 55905 USA.	wylam.mark@mayo.edu		Prakash, Y S/0000-0002-2968-224X; venkatachalem, sathish/0000-0001-9770-8299	NIH [HL090595, HL088029, HL056470]; Career Development Award from the Annenberg Foundation Award; Flight Attendants Medical Research Institute (FAMRI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056470, R01HL088029] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Career Development Award from the Annenberg Foundation Award; Flight Attendants Medical Research Institute (FAMRI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by a Career Development Award from the Annenberg Foundation Award (Wylam), the Flight Attendants Medical Research Institute (FAMRI; Sathish, Pabelick), and NIH R01 grants HL090595 (Pabelick), HL088029, and HL056470 (Prakash). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SS, 2007, EUR RESPIR J, V29, P834, DOI 10.1183/09031936.00112606; Aravamudan B, 2012, J CELL MOL MED, V16, P812, DOI 10.1111/j.1582-4934.2011.01356.x; Ay B, 2006, AM J PHYSIOL-LUNG C, V290, pL278, DOI 10.1152/ajplung.00188.2005; Ay B, 2004, AM J PHYSIOL-LUNG C, V286, pL909, DOI 10.1152/ajplung.00317.2003; Billington CK, 2003, RESP RES, V4; BLUE ML, 1978, AM REV RESPIR DIS, V117, P317; Bogeski I, 2012, J PHYSIOL-LONDON, V590, P4193, DOI 10.1113/jphysiol.2012.230565; Chiba Y, 2005, AM J RESP CELL MOL, V33, P574, DOI 10.1165/rcmb.2005-0177OC; CHILMONCZYK BA, 1993, NEW ENGL J MED, V328, P1665, DOI 10.1056/NEJM199306103282303; DeHaven WI, 2009, J PHYSIOL-LONDON, V587, P2275, DOI 10.1113/jphysiol.2009.170431; Deshpande DA, 2005, AM J RESP CELL MOL, V32, P149, DOI 10.1165/rcmb.2004-0243OC; Deshpande DA, 2003, FASEB J, V17, P452, DOI 10.1096/fj.02-0450fje; Fantozzi I, 2003, AM J PHYSIOL-LUNG C, V285, pL1233, DOI 10.1152/ajplung.00445.2002; Flouris AD, 2009, AM J RESP CRIT CARE, V179, P1029, DOI 10.1164/rccm.200812-1920OC; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; Hall IP, 2000, EUR RESPIR J, V15, P1120, DOI 10.1034/j.1399-3003.2000.01523.x; Jude JA, 2012, AM J RESP CELL MOL, V47, P427, DOI 10.1165/rcmb.2012-0025OC; Kannan MS, 1997, AM J PHYSIOL-LUNG C, V272, pL659, DOI 10.1152/ajplung.1997.272.4.L659; Mahn K, 2009, P NATL ACAD SCI USA, V106, P10775, DOI 10.1073/pnas.0902295106; MURRAY AB, 1986, J ALLERGY CLIN IMMUN, V77, P575, DOI 10.1016/0091-6749(86)90348-9; Ohga K, 2008, PULM PHARMACOL THER, V21, P360, DOI 10.1016/j.pupt.2007.09.003; PANETTIERI RA, 1990, AM J PHYSIOL, V259, pL365, DOI 10.1152/ajplung.1990.259.6.L365; Pera T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-48; Prakash YS, 1998, AM J PHYSIOL-CELL PH, V274, pC1653, DOI 10.1152/ajpcell.1998.274.6.C1653; Prakash YS, 1997, AM J PHYSIOL-CELL PH, V272, pC966, DOI 10.1152/ajpcell.1997.272.3.C966; ROCHE E, 1994, CELL CALCIUM, V16, P331, DOI 10.1016/0143-4160(94)90097-3; Salido GM, 2011, ADV EXP MED BIOL, V704, P413, DOI 10.1007/978-94-007-0265-3_23; Sathish V, 2012, EUR RESPIR J, V40, P470, DOI 10.1183/09031936.00090511; Sieck GC, 2008, AM J PHYSIOL-LUNG C, V294, pL378, DOI 10.1152/ajplung.00394.2007; Smelter DF, 2010, J IMMUNOL, V185, P3035, DOI 10.4049/jimmunol.1000252; Smyth JT, 2010, J CELL MOL MED, V14, P2337, DOI 10.1111/j.1582-4934.2010.01168.x; Stephens NL, 2001, LUNG, V179, P333, DOI 10.1007/s004080000073; Sweeney M, 2002, J APPL PHYSIOL, V92, P1594, DOI 10.1152/japplphysiol.00722.2001; Trian T, 2007, J EXP MED, V204, P3173, DOI 10.1084/jem.20070956; Vassallo R, 2005, J IMMUNOL, V175, P2684, DOI 10.4049/jimmunol.175.4.2684; White RA, 2003, FASEB J, V17, P482, DOI 10.1096/fj.02-0622fje; White TA, 2006, AM J RESP CELL MOL B; White TA, 2006, AM J RESP CELL MOL, V35, P243, DOI 10.1165/rcmb.2006-0003OC; Wylam ME, 2012, RESP PHYSIOL NEUROBI, V181, P99, DOI 10.1016/j.resp.2012.01.011; Xing A-p, 2012, J BIOMED BIOTECHNOL, V2012, P7; Yu Y, 2003, AM J PHYSIOL-CELL PH, V284, pC316, DOI 10.1152/ajpcell.00125.2002; Zou JJ, 2011, J APPL PHYSIOL, V110, P1256, DOI 10.1152/japplphysiol.01124.2010	42	35	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128778	10.1371/journal.pone.0128778	http://dx.doi.org/10.1371/journal.pone.0128778			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075746	Green Submitted, gold, Green Published			2022-12-26	WOS:000356329900029
J	Yin, W; Song, YL; Du, YG; Bian, Z				Yin, Wei; Song, Yaling; Du, Yangge; Bian, Zhuan			Differentially Expressed Genes in EEC and LMS Syndromes	PLOS ONE			English	Article							CLEFT LIP/PALATE SYNDROME; RAPP-HODGKIN-SYNDROME; ECTODERMAL DYSPLASIA; HAY-WELLS; AEC SYNDROME; TP63 GENE; P63 GENE; SPECTRUM; MUTATION; CANCER	Objectives Ectrodactyly ectodermal dysplasia cleft lip/palate (EEC) syndrome and limb-mammary syndrome (LMS) share a similar phenotype and the same pathogenic gene, which complicates the ability to distinguish between these diagnoses. The current study aims to identify a potential and practical clinical biomarker to distinguish EEC from LMS. Methods Two EEC pedigrees and one LMS pedigree that have been previously reported were reanalyzed. After confirmation of the causative mutations for these new patients, whole-genome expression microarray analysis was performed to assess the molecular genetic changes in these families. Results Five new patients with classic symptoms were reported, and these individuals exhibited the same mutation as their relatives (c.812G>C; c.611G>A; and c.680G>A). According to the whole genome expression results, the EEC patients exhibited different gene expression characteristics compared with the LMS patients. More than 5,000 genes were differentially expressed (changes >2 or <0.5-fold) among the EEC patients, LMS patients and healthy individuals. The top three altered pathways have been implicated in apoptosis, the hematopoietic cell lineage and the Toll-like receptor signaling pathway. Conclusion Our results provide additional clinical and molecular information regarding EEC and LMS and suggest that peripheral blood cytokines may represent a promising clinical biomarker for the diagnosis of these syndromes.	[Yin, Wei; Song, Yaling; Bian, Zhuan] Wuhan Univ, Minist Educ, Key Lab Oral Biomed Engn, Hosp & Sch Stomatol, Wuhan 430072, Hubei, Peoples R China; [Yin, Wei] Dalian Med Univ, Coll Stomatol, Dept Endodont & Periodont, Dalian, Liaoning, Peoples R China; [Du, Yangge] Wuhan Univ, Sch Stomatol, Wuhan 430072, Hubei, Peoples R China	Wuhan University; Dalian Medical University; Wuhan University	Bian, Z (corresponding author), Wuhan Univ, Minist Educ, Key Lab Oral Biomed Engn, Hosp & Sch Stomatol, Wuhan 430072, Hubei, Peoples R China.	bianzhuan@whu.edu.cn		Song, Yaling/0000-0003-0747-7381	National Natural Scientific Foundation of China [81120108010]; Hubei-MOST KLOS KLOBME [201402]; China postdoctoral science foundation; Education Department of Liaoning Province [L2013347]; Natural Scientific Foundation of Liaoning [2014023037]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei-MOST KLOS KLOBME; China postdoctoral science foundation(China Postdoctoral Science Foundation); Education Department of Liaoning Province; Natural Scientific Foundation of Liaoning	This work was supported by grants from the National Natural Scientific Foundation of China (81120108010), the open research fund program of Hubei-MOST KLOS & KLOBME (201402), the China postdoctoral science foundation (2014), the general scientific research project of Education Department of Liaoning Province (L2013347) and the Natural Scientific Foundation of Liaoning (2014023037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avitan-Hersh E, 2010, PEDIATR DERMATOL, V27, P643, DOI 10.1111/j.1525-1470.2010.01131.x; Bertola DR, 2004, CLIN GENET, V66, P79, DOI 10.1111/j.0009-9163.2004.00278.x; Brunner HG, 2002, J MED GENET, V39, P377, DOI 10.1136/jmg.39.6.377; CAMBIAGHI S, 1994, BRIT J DERMATOL, V130, P97, DOI 10.1111/j.1365-2133.1994.tb06891.x; Chiu YE, 2011, PEDIATR DERMATOL, V28, P15, DOI 10.1111/j.1525-1470.2009.00976.x; Clements SE, 2010, BRIT J DERMATOL, V163, P624, DOI 10.1111/j.1365-2133.2010.09859.x; Dianzani I, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.12.e133; Feng YM, 2007, BREAST CANCER RES TR, V103, P319, DOI 10.1007/s10549-006-9385-7; Graziano V, 2011, BBA-REV CANCER, V1816, P57, DOI 10.1016/j.bbcan.2011.04.002; Kannu P, 2006, AM J MED GENET A, V140A, P887, DOI 10.1002/ajmg.a.31187; Prontera P, 2008, GENET COUNSEL, V19, P397; Rinne T, 2009, AM J MED GENET A, V149A, P1948, DOI 10.1002/ajmg.a.32793; Steele JA, 2005, PEDIATR DERMATOL, V22, P415, DOI 10.1111/j.1525-1470.2005.00105.x; The National Center for Biotechnology Information, 2015, TP63 TUMOR PROT; Vakonaki E, 2012, J CANCER RES CLIN, V138, P1271, DOI 10.1007/s00432-012-1200-8; Wei JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035337; Wu GJ, 2003, CANCER RES, V63, P2351; Yin W, 2010, J DENT RES, V89, P813, DOI 10.1177/0022034510366804	18	3	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129432	10.1371/journal.pone.0129432	http://dx.doi.org/10.1371/journal.pone.0129432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075610	Green Submitted, Green Published, gold			2022-12-26	WOS:000356329900073
J	Zhuang, XJ; Tang, WH; Liu, CY; Zhu, JL; Feng, X; Yan, J; Lian, Y; Liu, P; Qiao, J				Zhuang, Xin-Jie; Tang, Wen-hao; Liu, Chang-yu; Zhu, Jin-liang; Feng, Xue; Yan, Jie; Lian, Ying; Liu, Ping; Qiao, Jie			Identification and Characterization of Xlr5c as a Novel Nuclear Localization Protein in Mouse Germ Cells	PLOS ONE			English	Article							GENE FAMILY XLR; HISTONE ACETYLTRANSFERASE; COGNITIVE FUNCTION; EXPRESSION; INTERACTS; SYNAPSIS; SEQUENCE; ENCODES; ELEMENT; MICE	Background Spermatogenesis is the complex process by which diploid stem cells generate haploid germ cells in gamete production. Members of the Xlr (X-chromosome linked, lymphocyte regulated) superfamily play essential roles in spermatogenesis. The expression, localization and role in spermatogenesis of one such member, Xlr5c, has not been reported previously. Methodology/Principal Findings Xlr5c mRNA and protein levels in murine testes and other tissues were investigated using RT-PCR and Western blotting. Xlr5c was abundantly transcribed in mouse testes, particularly during the early stages of spermatogenesis and throughout prophase I in the nuclei of spermatocytes. Xlr5c was specifically localized at synaptonemal complexes(SCs) region in preleptotene and pachytene spermatocytes, as was the homologous Xlr protein Sycp3. Conclusions/Significance These results suggest that Xlr5c was abundantly transcribed in germ cells, localized at SCs region, where it may play a potential role during the early stages of spermatogenesis. Identification and characterization of this novel testis protein may offer a new perspective for understanding of the molecular mechanisms involved in germ cell differentiation.	[Zhuang, Xin-Jie; Liu, Chang-yu; Zhu, Jin-liang; Feng, Xue; Yan, Jie; Lian, Ying; Liu, Ping; Qiao, Jie] Peking Univ, Hosp 3, Ctr Reprod Med,Dept Obstet & Gynecol, Key Lab Assisted Reprod,Minist Educ, Beijing 100191, Peoples R China; [Tang, Wen-hao] Peking Univ, Hosp 3, Dept Urol, Beijing 100191, Peoples R China	Peking University; Peking University	Zhuang, XJ (corresponding author), Peking Univ, Hosp 3, Ctr Reprod Med,Dept Obstet & Gynecol, Key Lab Assisted Reprod,Minist Educ, Beijing 100191, Peoples R China.	Zhuangxinjie902@163.com; Bysylp@sina.com; Jie.qiao@263.net		Qiao, Jie/0000-0003-2126-1376	National Natural Science Foundation of China for Young Scholars [81200466, 81300483, 31401256, 81200470]; National Natural Science Foundation of China [81070534]	National Natural Science Foundation of China for Young Scholars(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China for Young Scholars (NO. 81200466, 81300483, 31401256 and 81200470) and National Natural Science Foundation of China (NO. 81070534).	BERGSAGEL PL, 1994, GENE, V150, P345, DOI 10.1016/0378-1119(94)90450-2; CALENDA A, 1994, EMBO J, V13, P100, DOI 10.1002/j.1460-2075.1994.tb06239.x; Cocquet J, 2010, MOL BIOL CELL, V21, P3497, DOI 10.1091/mbc.E10-07-0601; Cocquet J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000244; COHEN DI, 1985, NATURE, V314, P369, DOI 10.1038/314369a0; Davies W, 2005, NAT GENET, V37, P625, DOI 10.1038/ng1577; Escalier D, 1999, J IMMUNOL, V162, P292; Kesler SR, 2003, BIOL PSYCHIAT, V54, P636, DOI 10.1016/S0006-3223(03)00289-0; Pelttari J, 2001, MOL CELL BIOL, V21, P5667, DOI 10.1128/MCB.21.16.5667-5677.2001; Raefski AS, 2005, NAT GENET, V37, P620, DOI 10.1038/ng1567; Reynard LN, 2007, BIOL REPROD, V77, P329, DOI 10.1095/biolreprod.107.061101; Reynard LN, 2009, BIOL REPROD, V81, P250, DOI 10.1095/biolreprod.108.075382; Shi YQ, 2013, GENE, V527, P352, DOI 10.1016/j.gene.2013.06.033; Shi YQ, 2011, GENE, V485, P153, DOI 10.1016/j.gene.2011.06.025; SIEGEL JN, 1987, J EXP MED, V166, P1702, DOI 10.1084/jem.166.6.1702; Skuse DH, 1997, NATURE, V387, P705, DOI 10.1038/42706; THORNHILL AR, 1993, DEVELOPMENT, V118, P171; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; Zhuang XJ, 2014, CELL CYCLE, V13, P2230, DOI 10.4161/cc.29265; Zhuang XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020866	20	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130087	10.1371/journal.pone.0130087	http://dx.doi.org/10.1371/journal.pone.0130087			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075718	Green Submitted, Green Published, gold			2022-12-26	WOS:000356329900137
J	Bernhardt, A; Wehrl, M; Paul, B; Hochmuth, T; Schumacher, M; Schutz, K; Gelinsky, M				Bernhardt, Anne; Wehrl, Markus; Paul, Birgit; Hochmuth, Thomas; Schumacher, Matthias; Schuetz, Kathleen; Gelinsky, Michael			Improved Sterilization of Sensitive Biomaterials with Supercritical Carbon Dioxide at Low Temperature	PLOS ONE			English	Article							GAMMA-IRRADIATION; TERMINAL STERILIZATION; BACTERIAL-SPORES; ALGINATE HYDROGELS; INACTIVATION; DEGRADATION; COLLAGEN; MODEL; WATER	The development of bio-resorbable implant materials is rapidly going on. Sterilization of those materials is inevitable to assure the hygienic requirements for critical medical devices according to the medical device directive (MDD, 93/42/EG). Biopolymer-containing biomaterials are often highly sensitive towards classical sterilization procedures like steam, ethylene oxide treatment or gamma irradiation. Supercritical CO2 (scCO(2)) treatment is a promising strategy for the terminal sterilization of sensitive biomaterials at low temperature. In combination with low amounts of additives scCO(2) treatment effectively inactivates microorganisms including bacterial spores. We established a scCO(2) sterilization procedure under addition of 0.25% water, 0.15% hydrogen peroxide and 0.5% acetic anhydride. The procedure was successfully tested for the inactivation of a wide panel of microorganisms including endospores of different bacterial species, vegetative cells of gram positive and negative bacteria including mycobacteria, fungi including yeast, and bacteriophages. For robust testing of the sterilization effect with regard to later application of implant materials sterilization all microorganisms were embedded in alginate/agarose cylinders that were used as Process Challenge Devices (PCD). These PCD served as surrogate models for bioresorbable 3D scaffolds. Furthermore, the impact of scCO(2) sterilization on mechanical properties of polysaccharide-based hydrogels and collagen-based scaffolds was analyzed. The procedure was shown to be less compromising on mechanical and rheological properties compared to established low-temperature sterilization methods like gamma irradiation and ethylene oxide exposure as well as conventional steam sterilization. Cytocompatibility of alginate gels and scaffolds from mineralized collagen was compared after sterilization with ethylene oxide, gamma irradiation, steam sterilization and scCO(2) treatment. Human mesenchymal stem cell viability and proliferation were not compromised by scCO(2) treatment of these materials and scaffolds. We conclude that scCO(2) sterilization under addition of water, hydrogen peroxide and acetic anhydride is a very effective, gentle, non-cytotoxic and thus a promising alternative sterilization method especially for biomaterials.	[Bernhardt, Anne; Paul, Birgit; Schumacher, Matthias; Schuetz, Kathleen; Gelinsky, Michael] Tech Univ Dresden, Ctr Translat Bone Joint & Soft Tissue Res, Med Fak, D-01062 Dresden, Germany; [Wehrl, Markus; Hochmuth, Thomas] Wfk Cleaning Technol Inst eV, Krefeld, Germany	Technische Universitat Dresden	Bernhardt, A (corresponding author), Tech Univ Dresden, Ctr Translat Bone Joint & Soft Tissue Res, Med Fak, D-01062 Dresden, Germany.	anne.bernhardt@tu-dresden.de	Gelinsky, Michael/A-9680-2012; Bernhardt, Anne/O-1242-2015; Schumacher, Matthias/I-1530-2013	Gelinsky, Michael/0000-0001-9075-5121; Bernhardt, Anne/0000-0002-1903-1929; Schumacher, Matthias/0000-0001-7207-7355; Paul, Birgit/0000-0001-7963-1048	program Industrielle Gemeinschaftsforschung und - entwicklung (IGF) by the Federal Ministry of Economic Affairs and Energy (BMWi) [IGF 17455 BG]; German Research Foundation; Open Access Publication Funds of the TU Dresden	program Industrielle Gemeinschaftsforschung und - entwicklung (IGF) by the Federal Ministry of Economic Affairs and Energy (BMWi); German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of the TU Dresden	This project was supported within the funding program Industrielle Gemeinschaftsforschung und - entwicklung (IGF) by the Federal Ministry of Economic Affairs and Energy (BMWi) due to a decision of the German Parliament (Grant number IGF 17455 BG). Support was also received from the German Research Foundation and the Open Access Publication Funds of the TU Dresden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2013, J BIOMED MATER RES B, V101, P1182, DOI 10.1002/jbm.b.32928; [Anonymous], 5561 EN; Baldini T, 2016, KNEE SURG SPORT TR A, V24, P3971, DOI 10.1007/s00167-014-3221-0; Bernhardt A, 2009, J BIOMED MATER RES A, V90A, P852, DOI 10.1002/jbm.a.32144; Cardoso DA, 2014, MACROMOL BIOSCI, V14, P872, DOI 10.1002/mabi.201300415; Chang L., 2011, FORMOSAN J MUSCULOSK, V2, P55; Checinska A, 2011, J MICROBIOL METH, V87, P70, DOI 10.1016/j.mimet.2011.07.008; DAMINK LHHO, 1995, J BIOMED MATER RES, V29, P149, DOI 10.1002/jbm.820290203; Delgado LM, 2014, EXPERT REV MED DEVIC, V11, P305, DOI 10.1586/17434440.2014.900436; Dillow A, 1999, Supercritical fluid sterilization method, Patent No. [WO 1999066960 A3, 1999066960]; Dillow AK, 1999, P NATL ACAD SCI USA, V96, P10344, DOI 10.1073/pnas.96.18.10344; Donati I, 2012, BIOMACROMOLECULES, V13, P1152, DOI 10.1021/bm300053d; Fatimi A, 2010, J MATER SCI-MATER M, V21, P1799, DOI 10.1007/s10856-010-4047-z; FRANCIS AW, 1954, J PHYS CHEM-US, V58, P1099, DOI 10.1021/j150522a014; Gelinsky M, 2008, CHEM ENG J, V137, P84, DOI 10.1016/j.cej.2007.09.029; Hemmer JD, 2007, J BIOMED MATER RES B, V80B, P511, DOI 10.1002/jbm.b.30625; Herdegen V, 2014, CHEM ENG TECHNOL, V37, P1891, DOI 10.1002/ceat.201300679; Hu TZ, 2014, BIO-MED MATER ENG, V24, P1837, DOI 10.3233/BME-140994; Jimenez A, 2008, BIOTECHNOL BIOENG, V101, P1344, DOI 10.1002/bit.21983; Karajanagi SS, 2011, BIOTECHNOL BIOENG, V108, P1716, DOI 10.1002/bit.23105; Kong HJ, 2003, BIOMATERIALS, V24, P4023, DOI 10.1016/S0142-9612(03)00295-3; KUME T, 1983, AGR BIOL CHEM TOKYO, V47, P889, DOI 10.1080/00021369.1983.10865740; Lee DW, 2003, J AGR FOOD CHEM, V51, P4819, DOI 10.1021/jf021053y; Matthews KH, 2006, INT J PHARMACEUT, V313, P78, DOI 10.1016/j.ijpharm.2006.01.023; Matuska AM, 2015, J BIOMED MATER RES B, V103, P397, DOI 10.1002/jbm.b.33213; Murray KA, 2013, J MECH BEHAV BIOMED, V17, P252, DOI 10.1016/j.jmbbm.2012.09.011; Nichols A., 2009, J ORTHOP, V6; Ofori-Kwakye K, 2005, J SCI TECHNOL, V25, P46; Oyane A, 2003, J BIOMED MATER RES A, V65A, P188, DOI 10.1002/jbm.a.10482; Park HS, 2013, INT J FOOD MICROBIOL, V166, P207, DOI 10.1016/j.ijfoodmicro.2013.07.015; Phillip E, 2013, J BIOMED MATER RES B, V101B, P532, DOI 10.1002/jbm.b.32853; Qiu QQ, 2009, J BIOMED MATER RES B, V91B, P572, DOI 10.1002/jbm.b.31431; Reverchon Ernesto, 2010, Recent Patents on Chemical Engineering, V3, P142, DOI 10.2174/1874478811003020142; Russell N, 2013, BIOMATERIALS, V34, P8185, DOI 10.1016/j.biomaterials.2013.07.022; Russell N, 2013, J BIOMECH, V46, P1670, DOI 10.1016/j.jbiomech.2013.04.006; Sabirzyanov AN, 2002, HIGH TEMP+, V40, P203, DOI 10.1023/A:1015294905132; Shieh E, 2009, J MICROBIOL METH, V76, P247, DOI 10.1016/j.mimet.2008.11.005; Spilimbergo S, 2003, BIOTECHNOL BIOENG, V84, P627, DOI 10.1002/bit.10783; Stoppel WL, 2014, J BIOMED MATER RES B, V102, P877, DOI 10.1002/jbm.b.33070; Watanabe T, 2003, APPL ENVIRON MICROB, V69, P7124, DOI 10.1128/AEM.69.12.7124-7129.2003; Wehmeyer JL, 2015, TISSUE ENG PART C-ME, V21, P649, DOI [10.1089/ten.tec.2014.0304, 10.1089/ten.TEC.2014.0304]; White A, 2006, J BIOTECHNOL, V123, P504, DOI 10.1016/j.jbiotec.2005.12.033; Zhang J, 2006, J SUPERCRIT FLUID, V38, P354, DOI 10.1016/j.supflu.2005.05.005; Zhang J, 2006, J MICROBIOL METH, V66, P479, DOI 10.1016/j.mimet.2006.01.012	44	69	71	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129205	10.1371/journal.pone.0129205	http://dx.doi.org/10.1371/journal.pone.0129205			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26067982	gold, Green Published, Green Submitted			2022-12-26	WOS:000356327000055
J	Zhang, T; Yao, YF				Zhang, Tao; Yao, Yi-Feng			Endophytic Fungal Communities Associated with Vascular Plants in the High Arctic Zone Are Highly Diverse and Host-Plant Specific	PLOS ONE			English	Article							ROOT-ASSOCIATED FUNGI; ARBUSCULAR MYCORRHIZAL; GEOGRAPHIC STRUCTURE; DRYAS-OCTOPETALA; SYMBIOTIC FUNGI; BIODIVERSITY; TUNDRA; DISTANCE; SVALBARD; HABITAT	This study assessed the diversity and distribution of endophytic fungal communities associated with the leaves and stems of four vascular plant species in the High Arctic using 454 pyrosequencing with fungal-specific primers targeting the ITS region. Endophytic fungal communities showed high diversity. The 76,691 sequences obtained belonged to 250 operational taxonomic units (OTUs). Of these OTUs, 190 belonged to Ascomycota, 50 to Basidiomycota, 1 to Chytridiomycota, and 9 to unknown fungi. The dominant orders were Helotiales, Pleosporales, Capnodiales, and Tremellales, whereas the common known fungal genera were Cryptococcus, Rhizosphaera, Mycopappus, Melampsora, Tetracladium, Phaeosphaeria, Mrakia, Venturia, and Leptosphaeria. Both the climate and host-related factors might shape the fungal communities associated with the four Arctic plant species in this region. These results suggested the presence of an interesting endophytic fungal community and could improve our understanding of fungal evolution and ecology in the Arctic terrestrial ecosystems.	[Zhang, Tao] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China; [Zhang, Tao] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China; [Zhang, Tao] Peking Union Med Coll, Beijing 100021, Peoples R China; [Yao, Yi-Feng] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Institute of Botany, CAS	Zhang, T (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China.	zhangtaoim@126.com			National Natural Science Foundation of China (NSFC) [31300115, 41271222]; Polar Strategic Research Foundation of China [20120302]; Chinese Arctic and Antarctic Administration, State Oceanic Administration [2013YR06006, 2013YR05005]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Polar Strategic Research Foundation of China; Chinese Arctic and Antarctic Administration, State Oceanic Administration	Funding has been provided by the National Natural Science Foundation of China (NSFC) (Nos. 31300115 and 41271222), Polar Strategic Research Foundation of China (No. 20120302), and Projects of the Chinese Arctic and Antarctic Administration, State Oceanic Administration (Nos. 2013YR06006 and 2013YR05005). The funders had role in data collection.	Arnold AE, 2007, ECOLOGY, V88, P541, DOI 10.1890/05-1459; Arnold AE, 2001, MYCOL RES, V105, P1502, DOI 10.1017/S0953756201004956; Arnold AE, 2008, TROPICAL FOREST COMM, P254; Bastian M., 2009, ICWSM, DOI DOI 10.1136/QSHC.2004.010033; Bergero R, 1999, POLAR BIOL, V21, P361, DOI 10.1007/s003000050374; Bjorbaekmo MFM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-244; Blaalid R, 2014, MOL ECOL, V23, P649, DOI 10.1111/mec.12622; Botnen S, 2014, MOL ECOL, V23, P975, DOI 10.1111/mec.12646; Butinar L, 2007, ANTON LEEUW INT J G, V91, P277, DOI 10.1007/s10482-006-9117-3; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cordier T, 2012, FUNGAL ECOL, V5, P509, DOI 10.1016/j.funeco.2011.12.004; Costa I. P. M.W., 2012, MYCOTAXON, V119, P494, DOI DOI 10.5248/119.493; Dalpe Y, 1998, CAN J BOT, V76, P1930, DOI 10.1139/cjb-76-11-1930; Day MJ, 2006, MYCOTAXON, V98, P261; Elvebakk A., 1996, CATALOGUE SVALBARD P; FISHER PJ, 1995, MYCOLOGIA, V87, P319, DOI 10.2307/3760828; Ganley RJ, 2004, P NATL ACAD SCI USA, V101, P10107, DOI 10.1073/pnas.0401513101; Gardes M, 1996, NEW PHYTOL, V133, P147, DOI 10.1111/j.1469-8137.1996.tb04350.x; Gawas-Sakhalkar P, 2011, CURR SCI INDIA, V100, P1701; Geml J, 2012, J BIOGEOGR, V39, P74, DOI 10.1111/j.1365-2699.2011.02588.x; Gjoerevoll O, 1999, FLOWERS OF SVALBARD; Gunde-Cimerman N, 2003, PHYS CHEM EARTH, V28, P1273, DOI 10.1016/j.pce.2003.08.056; HELANDER ML, 1993, MICROBIAL ECOL, V26, P227, DOI 10.1007/BF00176955; Higgins KL, 2007, MOL PHYLOGENET EVOL, V42, P543, DOI 10.1016/j.ympev.2006.07.012; Hobbie JE, 2006, ECOLOGY, V87, P816, DOI 10.1890/0012-9658(2006)87[816:NISFAP]2.0.CO;2; Jumpponen A, 2009, NEW PHYTOL, V184, P438, DOI 10.1111/j.1469-8137.2009.02990.x; Kembel SW, 2014, BOTANY, V92, DOI 10.1139/cjb-2013-0194; Kurek Ewa, 2007, Polish Polar Research, V28, P57; Li HY, 2012, FUNGAL DIVERS, V54, P79, DOI 10.1007/s13225-012-0153-1; Mucciarelli M, 2003, NEW PHYTOL, V158, P579, DOI 10.1046/j.1469-8137.2003.00762.x; Nissinen RM, 2012, FEMS MICROBIOL ECOL, V82, P510, DOI 10.1111/j.1574-6941.2012.01464.x; Olsson PA, 2004, CAN J BOT, V82, P1547, DOI [10.1139/b04-111, 10.1139/B04-111]; Pang K., 2011, POLAR RES, V30, P1, DOI [10.3402/polar.v30i0.5859, DOI 10.3402/POLAR.V30I0.5859]; Paul Narayan Chandra, 2006, Mycobiology, V34, P185, DOI 10.4489/MYCO.2006.34.4.185; PETRINI O, 1988, T BRIT MYCOL SOC, V91, P233, DOI 10.1016/S0007-1536(88)80210-9; Petrini O, 1991, MICROBIAL ECOLOGY LE, P179, DOI DOI 10.1007/978-1-4612-3168-4_9; Robinson CH, 1998, MYCOL RES, V102, P573, DOI 10.1017/S0953756297005492; Rodriguez RJ, 2008, ISME J, V2, P404, DOI 10.1038/ismej.2007.106; Rosa LH, 2009, POLAR BIOL, V32, P161, DOI 10.1007/s00300-008-0515-z; Rosa LH, 2010, FEMS MICROBIOL ECOL, V73, P178, DOI 10.1111/j.1574-6941.2010.00872.x; Singh P, 2012, POLAR BIOL, V35, P575, DOI 10.1007/s00300-011-1103-1; Sun X, 2012, FUNGAL ECOL, V5, P624, DOI 10.1016/j.funeco.2012.04.001; Sun X, 2011, FUNGAL DIVERS, V47, P85, DOI 10.1007/s13225-010-0086-5; Timling I, 2014, MOL ECOL, V23, P3258, DOI 10.1111/mec.12743; U'Ren JM, 2012, AM J BOT, V99, P898, DOI 10.3732/ajb.1100459; Vare H., 1992, Mycorrhiza, V1, P93, DOI 10.1007/BF00203256; Vega FE, 2010, FUNGAL ECOL, V3, P122, DOI [10.1016/j.funeco.2009.05.001, 10.1016/j.funeco.2009.07.002]; Vincent WF, 2010, ISME J, V4, P1089, DOI 10.1038/ismej.2010.108; Vishniac HS, 1996, BIODIVERS CONSERV, V5, P1365, DOI 10.1007/BF00051983; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; WOOKEY PA, 1994, OIKOS, V70, P131, DOI 10.2307/3545708; Zalar P, 2014, COLD ADAPTED YEASTS, P49, DOI DOI 10.1007/978-3-642-39681-6_3	52	44	49	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130051	10.1371/journal.pone.0130051	http://dx.doi.org/10.1371/journal.pone.0130051			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26067836	Green Submitted, Green Published, gold			2022-12-26	WOS:000356327000138
J	Leszczyszyn-Pynka, M; Aksak-Was, B; Urbanska, A; Parczewski, M				Leszczyszyn-Pynka, Magdalena; Aksak-Was, Bogusz; Urbanska, Anna; Parczewski, Milosz			Protective Effect of HLA-B*5701 and HLA-C-35 Genetic Variants in HIV-Positive Caucasians from Northern Poland	PLOS ONE			English	Article							HLA-C EXPRESSION; NATURAL-KILLER; SINGLE NUCLEOTIDE; ASSOCIATION; DETERMINANTS; PRESSURE; ALLELES; LIGAND	Aim of the Study Association of two HLA class I variants with HIV-1 pretreatment viremia, CD4+ T cell count at the care-entry and CD4+ T cell nadir. Methods 414 HIV-positive Caucasians (30% women) aged 19-73 years were genotyped for HLA-C -35 (rs9264942) and HLA-B*5701 variants. HIV-1 viral load, as well as CD4+ T cell count at care-entry and nadir, were compared across alleles, genotypes and haplotypes. Results HLA-C -35 C/C genotype was found in 17.6% patients, C/T genotype in 48.1%, and T/T genotype in 34.3% patients. HLA-B*5701 variant was present in 5.8% of studied population. HIV plasma viremia in the group with C allele was significantly lower (p=0.0002) compared to T/T group [mean:4.66 log (SD:1.03) vs. 5.07 (SD:0.85) log HIV-RNA copies/ml, respectively], while CD4+ T cell count at baseline was notably higher among C allele carriers compared to T/T homozygotes [median: 318 (IQR:127-537) cells/mu l vs. median: 203 (IQR:55-410) cells/mu l, respectively] (p=0.0007). Moreover, CD4+ T cell nadir among patients with C allele [median: 205 (IQR:83.5-390) cells/mu l] was significantly higher compared to T/T group [median: 133 (IQR:46-328) cells/mu l] (p=0.006). Among cases with HLA-B*5701 allele, significantly lower pretreatment viremia and higher baseline CD4+ T cell count were found (mean: 4.08 [SD:1.2] vs. mean: 4.84 [SD:0.97] log HIV-RNA copies/ml, p=0.003 and 431 vs. 270 cells/mu l, p=0.04, respectively) compared to HLA-B*5701 negative individuals. The lowest viremia (mean: 3.85 log [SD:1.3]) HIV-RNA copies/ml and the highest baseline and nadir CD4+ T cell [median: 476 (IQR:304-682) vs. median: 361 (IQR:205-574) cells/mu l, respectively) were found in individuals with HLA-B*5701(+)/HLA-C -35 C/C haplotype. Conclusions HLA-C -35 C and HLA-B*5701 allele exert a favorable effect on the immunological (higher baseline and nadir CD4+ T cell count) and virologic (lower pretreatment HIV viral load) variables. This protective effect is additive for the compound HLA-B*5701(+)/HLA-C -35 C/C haplotype.	[Leszczyszyn-Pynka, Magdalena; Aksak-Was, Bogusz; Urbanska, Anna; Parczewski, Milosz] Pomeranian Med Univ, Dept Infect Trop Dis & Acquired Immunodeficiency, Szczecin, Poland	Pomeranian Medical University	Leszczyszyn-Pynka, M (corresponding author), Pomeranian Med Univ, Dept Infect Trop Dis & Acquired Immunodeficiency, Szczecin, Poland.	mlpynka@interia.pl	Parczewski, Milosz/I-1869-2014; Aksak-Wąs, Bogusz/ABF-7068-2021; Aksak-Wąs, Bogusz/AFK-2240-2022	Parczewski, Milosz/0000-0003-1869-1084; Aksak-Wąs, Bogusz/0000-0003-2092-3737; Aksak-Wąs, Bogusz/0000-0003-2092-3737	Polish Ministry of Science and Higher Education [NCN NN 402613840]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This study was financially supported by the Polish Ministry of Science and Higher Education grant number NCN NN 402613840. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2009, J INTERN MED, V265, P29, DOI 10.1111/j.1365-2796.2008.02045.x; Apps R, 2013, SCIENCE, V340, P87, DOI 10.1126/science.1232685; Ballana E, 2012, IMMUNOBIOLOGY, V217, P889, DOI 10.1016/j.imbio.2011.12.012; Blais ME, 2012, J IMMUNOL, V188, P4663, DOI 10.4049/jimmunol.1103472; Blais ME, 2011, IMMUNOLOGY, V133, P1, DOI 10.1111/j.1365-2567.2011.03422.x; Carrington M, 2012, ANNU REV MED, V63, P131, DOI 10.1146/annurev-med-062909-130018; Casado C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011079; Catano G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003636; COLONNA M, 1993, P NATL ACAD SCI USA, V90, P12000, DOI 10.1073/pnas.90.24.12000; Corrah TW, 2011, J VIROL, V85, P3367, DOI 10.1128/JVI.02276-10; Elahi S, 2012, INT J BIOCHEM CELL B, V44, P1361, DOI 10.1016/j.biocel.2012.05.003; Falk CS, 1997, IMMUNOL RES, V16, P203, DOI 10.1007/BF02786363; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Honda K, 2011, EUR J IMMUNOL, V41, P97, DOI 10.1002/eji.201040841; Jose MS, 2013, AIDS, V27, P2587, DOI 10.1097/01.aids.0000432613.95455.71; Kamya P, 2011, J VIROL, V85, P5949, DOI 10.1128/JVI.02652-10; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kloverpris HN, 2012, J VIROL, V86, P11493, DOI 10.1128/JVI.01020-12; Kloverpris HN, 2012, J VIROL, V86, P919, DOI 10.1128/JVI.06150-11; Kulkarni S, 2011, NATURE, V472, P495, DOI 10.1038/nature09914; Kulpa DA, 2011, IMMUNOLOGY, V134, P116, DOI 10.1111/j.1365-2567.2011.03474.x; Majorczyk E, 2014, HUM IMMUNOL, V75, P504, DOI 10.1016/j.humimm.2014.04.003; Matthews PC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047799; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Shrestha S, 2009, AIDS, V23, P673, DOI 10.1097/QAD.0b013e328325d414; Suppiah V, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001092; Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486; Tiemessen CT, 2011, JAIDS-J ACQ IMM DEF, V57, P181, DOI 10.1097/QAI.0b013e3182174a76; Vaidya SA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-139; van Manen D, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-70	31	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0127867	10.1371/journal.pone.0127867	http://dx.doi.org/10.1371/journal.pone.0127867			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068923	Green Published, Green Submitted, gold			2022-12-26	WOS:000356100900014
J	Selamat, W; Tay, PLF; Baskaran, Y; Manser, E				Selamat, Widyawilis; Tay, Pei-Ling Felicia; Baskaran, Yohendran; Manser, Ed			The Cdc42 Effector Kinase PAK4 Localizes to Cell-Cell Junctions and Contributes to Establishing Cell Polarity	PLOS ONE			English	Article							ADENOMATOUS POLYPOSIS-COLI; BETA-CATENIN; MEDIATED PHOSPHORYLATION; P21-ACTIVATED KINASES; BINDING PARTNER; TIGHT JUNCTIONS; PROTEIN; ACTIN; MIGRATION; COMPLEX	The serine/threonine kinase PAK4 is a Cdc42 effector whose role is not well understood; overexpression of PAK4 has been associated with some cancers, and there are reports that correlate kinase level with increased cell migration in vitro. Here we report that PAK4 is primarily associated with cell-cell junctions in all the cell lines we tested, and fails to accumulate at focal adhesions or at the leading edge of migrating cells. In U2OS osteosarcoma and MCF-7 breast cancer cell lines, PAK4 depletion did not affect collective cell migration, but affected cell polarization. By contrast, Cdc42 depletion (as reported by many studies) caused a strong defect in junctional assembly in multiple cells lines. We also report that the depletion of PAK4 protein or treatment of cells with the PAK4 inhibitor PF-3758309 can lead to defects in centrosome reorientation (polarization) after cell monolayer wounding. These experiments are consistent with PAK4 forming part of a conserved cell-cell junctional polarity Cdc42 complex. We also confirm beta-catenin as a target for PAK4 in these cells. Treatment of cells with PF-3758309 caused inhibition of beta-catenin Ser-675 phosphorylation, which is located predominantly at cell-cell junctions.	[Selamat, Widyawilis; Tay, Pei-Ling Felicia; Baskaran, Yohendran; Manser, Ed] ASTAR, Inst Mol & Cell Biol, Small G Prot Signaling & Kinases sGSK Grp, Inst Mol & Cell Biol, Singapore, Singapore; [Manser, Ed] ASTAR, Inst Med Biol, Singapore, Singapore; [Manser, Ed] Natl Univ Singapore, Dept Pharmacol, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); National University of Singapore	Manser, E (corresponding author), ASTAR, Inst Mol & Cell Biol, Small G Prot Signaling & Kinases sGSK Grp, Inst Mol & Cell Biol, Singapore, Singapore.	ed.manser@imb.a-star.edu.sg	Manser, Edward/ABD-2301-2020	Baskaran, Yohendran/0000-0001-7021-3042	GSK-IMCB Research fund	GSK-IMCB Research fund	This work was supported by the GSK-IMCB Research fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; ADAMS AEM, 1990, J CELL BIOL, V111, P131, DOI 10.1083/jcb.111.1.131; Ahmed T, 2008, CELL SIGNAL, V20, P1320, DOI 10.1016/j.cellsig.2008.02.021; Ang SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013064; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Arias-Romero LE, 2013, CANCER RES, V73, P3671, DOI 10.1158/0008-5472.CAN-12-4453; Barth AIM, 2008, SEMIN CELL DEV BIOL, V19, P245, DOI 10.1016/j.semcdb.2008.02.003; Baskaran Y, 2012, EMBO REP, V13, P653, DOI 10.1038/embor.2012.75; Bastea LI, 2013, BIOCHEM J, V455, P251, DOI 10.1042/BJ20130281; Bidlingmaier S, 2004, J CELL BIOL, V164, P207, DOI 10.1083/jcb.200307065; Bompard G, 2010, J CELL BIOL, V190, P807, DOI 10.1083/jcb.200912056; Callow MG, 2005, J CELL SCI, V118, P1861, DOI 10.1242/jcs.02313; Callow MG, 2002, J BIOL CHEM, V277, P550, DOI 10.1074/jbc.M105732200; Cau JL, 2005, J CELL SCI, V118, P2579, DOI 10.1242/jcs.02385; Chatterjee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034343; Chen SL, 2008, CANCER BIOL THER, V7, P1793, DOI 10.4161/cbt.7.11.6840; Chilov D, 2011, DEV BIOL, V357, P259, DOI 10.1016/j.ydbio.2011.06.029; Czuchra A, 2005, MOL BIOL CELL, V16, P4473, DOI 10.1091/mbc.E05-01-0061; Dart AE, 2013, EUR J CELL BIOL, V92, P129, DOI 10.1016/j.ejcb.2013.03.002; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; DRUBIN DG, 1991, CELL, V65, P1093, DOI 10.1016/0092-8674(91)90001-F; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Erasmus J, 2010, BIOL CELL, V102, P13, DOI 10.1042/BC20090048; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Faure S, 2005, DEV BIOL, V277, P472, DOI 10.1016/j.ydbio.2004.10.005; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Fukuhara A, 2003, J BIOL CHEM, V278, P51885, DOI 10.1074/jbc.M308015200; Gao L, 2002, CURR BIOL, V12, P221, DOI 10.1016/S0960-9822(01)00663-7; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Ha BH, 2012, P NATL ACAD SCI USA, V109, P16107, DOI 10.1073/pnas.1214447109; Haddad E, 2001, BLOOD, V97, P33, DOI 10.1182/blood.V97.1.33; Haq S, 2003, P NATL ACAD SCI USA, V100, P4610, DOI 10.1073/pnas.0835895100; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Huo L, 2011, EMBO J, V30, P665, DOI 10.1038/emboj.2010.353; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Ivanov AI, 2005, BIOESSAYS, V27, P356, DOI 10.1002/bies.20203; Jaffer ZM, 2002, INT J BIOCHEM CELL B, V34, P713, DOI 10.1016/S1357-2725(01)00158-3; Jin D, 2015, BIOCH J; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Johansson AS, 2000, J CELL SCI, V113, P3267; Kim SE, 2013, SCIENCE, V340, P867, DOI 10.1126/science.1232389; Koh W, 2008, J CELL SCI, V121, P989, DOI 10.1242/jcs.020693; Koh W, 2009, J CELL SCI, V122, P1812, DOI 10.1242/jcs.045799; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; Law SHW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100268; Li XD, 2010, INT J BIOCHEM CELL B, V42, P70, DOI 10.1016/j.biocel.2009.09.008; Li Y, 2012, BBA-MOL CELL RES, V1823, P465, DOI 10.1016/j.bbamcr.2011.11.013; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Liu YY, 2008, MOL CANCER RES, V6, P1215, DOI 10.1158/1541-7786.MCR-08-0087; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Melzig J, 1998, CURR BIOL, V8, P1223, DOI 10.1016/S0960-9822(07)00514-3; Menzel N, 2008, BIOCHEM J, V416, P231, DOI 10.1042/BJ20080465; Mitsushima M, 2009, MOL CELL BIOL, V29, P2816, DOI 10.1128/MCB.01713-08; Murray PJ, 2010, BIOPHYS J, V99, P716, DOI 10.1016/j.bpj.2010.05.016; Muthuswamy SK, 2012, ANNU REV CELL DEV BI, V28, P599, DOI 10.1146/annurev-cellbio-092910-154244; Nekrasova T, 2008, DEV BIOL, V322, P95, DOI 10.1016/j.ydbio.2008.07.006; Nekrasova T, 2012, TRANSGENIC RES, V21, P797, DOI 10.1007/s11248-011-9578-7; Ng YW, 2010, STRUCTURE, V18, P879, DOI 10.1016/j.str.2010.04.011; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Noritake J, 2004, MOL BIOL CELL, V15, P1065, DOI 10.1091/mbc.E03-08-0582; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; Ozaki C, 2010, CELL STRUCT FUNCT, V35, P81, DOI 10.1247/csf.10009; Paliouras GN, 2009, MOL CELL BIOL, V29, P3018, DOI 10.1128/MCB.01286-08; Pandey A, 2002, ONCOGENE, V21, P3939, DOI 10.1038/sj.onc.1205478; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Qu J, 2003, MOL CELL BIOL, V23, P7122, DOI 10.1128/MCB.23.20.7122-7133.2003; Rennefahrt UEE, 2007, J BIOL CHEM, V282, P15667, DOI 10.1074/jbc.M700253200; Rojas R, 2001, MOL BIOL CELL, V12, P2257, DOI 10.1091/mbc.12.8.2257; Ryu BJ, 2014, MOL CELL BIOCHEM, V389, P69, DOI 10.1007/s11010-013-1928-8; Schneeberger D, 2003, DEVELOPMENT, V130, P427, DOI 10.1242/dev.00248; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Siu MKY, 2010, P NATL ACAD SCI USA, V107, P18622, DOI 10.1073/pnas.0907481107; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; Tan I, 2008, CELL, V135, P123, DOI 10.1016/j.cell.2008.09.018; Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Tzima E, 2003, J BIOL CHEM, V278, P31020, DOI 10.1074/jbc.M301179200; Wakefield JG, 2003, J CELL SCI, V116, P637, DOI 10.1242/jcs.00273; Wallace SW, 2010, MOL BIOL CELL, V21, P2996, DOI 10.1091/mbc.E10-05-0429; Welchman DP, 2007, DEV BIOL, V305, P347, DOI 10.1016/j.ydbio.2007.02.022; Wells CM, 2010, J CELL SCI, V123, P1663, DOI 10.1242/jcs.055707; Wells CM, 2010, BIOCHEM J, V425, P465, DOI 10.1042/BJ20091173; Wells CM, 2002, J CELL SCI, V115, P3947, DOI 10.1242/jcs.00080; Wittmann T, 2003, J CELL BIOL, V161, P845, DOI 10.1083/jcb.200303082; Wu SK, 2014, NAT CELL BIOL, V16, P167, DOI 10.1038/ncb2900; Yamanaka T, 2001, GENES CELLS, V6, P721, DOI 10.1046/j.1365-2443.2001.00453.x; Zhang HQ, 2002, J CELL BIOL, V158, P1287, DOI 10.1083/jcb.200207008; Zhang HJ, 2011, CARCINOGENESIS, V32, P765, DOI 10.1093/carcin/bgr033; ZHANG SM, 1995, SEPAR SCI TECHNOL, V30, P1, DOI 10.1080/01496399508012211; Zhao Zhuo-Shen, 2012, Cell Logist, V2, P59; Zhu G, 2012, ONCOGENE, V31, P1001, DOI 10.1038/onc.2011.294	99	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129634	10.1371/journal.pone.0129634	http://dx.doi.org/10.1371/journal.pone.0129634			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068882	gold, Green Published, Green Submitted			2022-12-26	WOS:000356100900065
J	Maebe, K; Meeus, I; Ganne, M; De Meulemeester, T; Biesmeijer, K; Smagghe, G				Maebe, Kevin; Meeus, Ivan; Ganne, Maarten; De Meulemeester, Thibaut; Biesmeijer, Koos; Smagghe, Guy			Microsatellite Analysis of Museum Specimens Reveals Historical Differences in Genetic Diversity between Declining and More Stable Bombus Species	PLOS ONE			English	Article							EFFECTIVE POPULATION SIZES; TEMPORAL STABILITY; COMPUTER-PROGRAM; BUMBLEBEE; CONSERVATION; HYMENOPTERA; DISTANCE; CONSEQUENCES; POLLINATORS; BOTTLENECK	Worldwide most pollinators, e.g. bumblebees, are undergoing global declines. Loss of genetic diversity can play an essential role in these observed declines. In this paper, we investigated the level of genetic diversity of seven declining Bombus species and four more stable species with the use of microsatellite loci. Hereto we genotyped a unique collection of museum specimens. Specimens were collected between 1918 and 1926, in 6 provinces of the Netherlands which allowed us to make interspecific comparisons of genetic diversity. For the stable species B. pascuorum, we also selected populations from two additional time periods: 1949-1955 and 1975-1990. The genetic diversity and population structure in B. pascuorum remained constant over the three time periods. However, populations of declining bumblebee species showed a significantly lower genetic diversity than co-occurring stable species before their major declines. This historical difference indicates that the repeatedly observed reduced genetic diversity in recent populations of declining bumblebee species is not caused solely by the decline itself. The historically low genetic diversity in the declined species may be due to the fact that these species were already rare, making them more vulnerable to the major drivers of bumblebee decline.	[Maebe, Kevin; Meeus, Ivan; Ganne, Maarten; Smagghe, Guy] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, B-9000 Ghent, Belgium; [De Meulemeester, Thibaut; Biesmeijer, Koos] Naturalis Biodivers Ctr, Leiden, Netherlands	Ghent University; Naturalis Biodiversity Center	Maebe, K (corresponding author), Univ Ghent, Fac Biosci Engn, Dept Crop Protect, Coupure Links 653, B-9000 Ghent, Belgium.	kevin.maebe@ugent.be; guy.smagghe@ugent.be	Smagghe, Guy/AAE-8914-2019	Smagghe, Guy/0000-0001-8334-3313; Biesmeijer, Koos/0000-0003-0328-0573; Maebe, Kevin/0000-0002-3741-2143	Research Foundation of Flanders (FWO-Vlaanderen) [G.0558.12N]; Special Research Fund of Ghent University (BOF-UGent); Belgian Research Policy, Research Programme Science For A Sustainable Development (Belspo)	Research Foundation of Flanders (FWO-Vlaanderen)(FWO); Special Research Fund of Ghent University (BOF-UGent); Belgian Research Policy, Research Programme Science For A Sustainable Development (Belspo)	This work was supported by the Research Foundation of Flanders (FWO-Vlaanderen, G.0558.12N; www.fwo.be); the Special Research Fund of Ghent University (BOF-UGent; www.ugent.be); and the Belgian Research Policy, Research Programme Science For A Sustainable Development (Belspo; www.belspo.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley MV, 2009, MOL ECOL RESOUR, V9, P1127, DOI 10.1111/j.1755-0998.2009.02562.x; Ashley M.V., 2008, COMPUTATIONAL BIOL N; Ball F. J., 1914, Annales de la Societe Entomologique de Belgique, V58; Ball JF, 1920, ANN SOC ENTOMOLOGIUE, V60, P31; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bouzat JL, 1998, AM NAT, V152, P1, DOI 10.1086/286145; Brown JW, 2007, MOL ECOL, V16, P327, DOI 10.1111/j.1365-294X.2007.03151.x; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Carvalheiro LG, 2013, ECOL LETT, V16, P870, DOI 10.1111/ele.12121; Chapuis MP, 2008, MOL ECOL, V17, P3640, DOI 10.1111/j.1365-294X.2008.03869.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Charman TG, 2010, MOL ECOL, V19, P2661, DOI 10.1111/j.1365-294X.2010.04697.x; Connop S, 2010, INSECT CONSERV DIVER, V143, P2739, DOI [10.1111/j.1752-4598.2010.00116, DOI 10.1111/J.1752-4598.2010.00116]; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Darvill B, 2006, MOL ECOL, V15, P601, DOI 10.1111/j.1365-294X.2006.02797.x; Darvill B, 2010, MOL ECOL, V19, P53, DOI 10.1111/j.1365-294X.2009.04423.x; Ellis JS, 2006, MOL ECOL, V15, P4375, DOI 10.1111/j.1365-294X.2006.03121.x; ESTOUP A, 1993, NUCLEIC ACIDS RES, V21, P1427, DOI 10.1093/nar/21.6.1427; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Funk CR, 2006, MOL ECOL NOTES, V6, P83, DOI 10.1111/j.1471-8286.2005.01147.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Goulson D, 2011, CONSERV GENET, V12, P867, DOI 10.1007/s10592-011-0190-4; Goulson D, 2010, BUMBLEBEES BEHAV ECO, P96; Hansen MM, 2002, MOL ECOL, V11, P2523, DOI 10.1046/j.1365-294X.2002.01634.x; Heath DD, 2002, MOL ECOL, V11, P197, DOI 10.1046/j.1365-294X.2002.01434.x; Hoffman EA, 2004, EVOLUTION, V58, P2536; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kraus FB, 2009, J ANIM ECOL, V78, P247, DOI 10.1111/j.1365-2656.2008.01479.x; Kraus FB, 2011, CONSERV GENET, V12, P187, DOI 10.1007/s10592-010-0131-7; Leonard JA, 2008, MOL ECOL, V17, P4186, DOI 10.1111/j.1365-294X.2008.03891.x; Lozier JD, 2011, MOL ECOL, V20, P4870, DOI 10.1111/j.1365-294X.2011.05314.x; Maebe K, 2013, APIDOLOGIE, V44, P188, DOI 10.1007/s13592-012-0170-9; Miller CR, 2003, P NATL ACAD SCI USA, V100, P4334, DOI 10.1073/pnas.0735531100; NEI M, 1978, GENETICS, V89, P583; Peakall R., 2006, GENALEX 6 GENETIC AN; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; Peeters T. M. J., 2003, BEDREIGDE VERDWENEN; Pertoldi C, 2001, P ROY SOC B-BIOL SCI, V268, P1775, DOI 10.1098/rspb.2001.1762; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; RASMONT P, 1988, ANN SOC ROY ZOOL BEL, V118, P141; Rasmont P, 2010, ATLAS EUROPEAN BEES; Rasmont P, FAUNISTIC DRIFT APOI; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Ruzzante DE, 2001, CONSERV GENET, V2, P257, DOI 10.1023/A:1012247213644; Schmid-Hempel P, 2007, HEREDITY, V99, P414, DOI 10.1038/sj.hdy.6801017; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Whitehorn PR, 2011, P ROY SOC B-BIOL SCI, V278, P1195, DOI 10.1098/rspb.2010.1550; Williams PH, 2009, APIDOLOGIE, V40, P367, DOI 10.1051/apido/2009025; Zayed A, 2009, APIDOLOGIE, V40, P237, DOI 10.1051/apido/2009026	56	16	16	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0127870	10.1371/journal.pone.0127870	http://dx.doi.org/10.1371/journal.pone.0127870			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061732	Green Submitted, Green Published, gold			2022-12-26	WOS:000355979500063
J	Marques, E; Englund, JI; Tervonen, TA; Virkunen, E; Laakso, M; Myllynen, M; Makela, A; Ahvenainen, M; Lepikhova, T; Monni, O; Hautaniemi, S; Klefstrom, J				Marques, E.; Englund, J. I.; Tervonen, T. A.; Virkunen, E.; Laakso, M.; Myllynen, M.; Makela, A.; Ahvenainen, M.; Lepikhova, T.; Monni, O.; Hautaniemi, S.; Klefstrom, J.			Par6G suppresses cell proliferation and is targeted by loss-of-function mutations in multiple cancers	ONCOGENE			English	Article							TIGHT JUNCTION FORMATION; MYC-INDUCED APOPTOSIS; C-MYC; POLARITY; LOCALIZATION; DROSOPHILA; GENES; AKT; TUMORIGENESIS; MORPHOGENESIS	Differentiated epithelial structure communicates with individual constituent epithelial cells to suppress their proliferation activity. However, the pathways linking epithelial structure to cessation of the cell proliferation machinery or to unscheduled proliferation in the context of tumorigenesis are not well defined. Here we demonstrate the strong impact of compromised epithelial integrity on normal and oncogenic Myc-driven proliferation in three-dimensional mammary epithelial organoid culture. Systematic silencing of 34 human homologs of Drosophila genes, with previously established functions in control of epithelial integrity, demonstrates a role for human genes of apico-basal polarity, Wnt and Hippo pathways and actin dynamics in regulation of the size, integrity and cell proliferation in organoids. Perturbation of these pathways leads to diverse functional interactions with Myc: manifested as a RhoA-dependent synthetic lethality and Par6-dependent effects on the cell cycle. Furthermore, we show a role for Par6G as a negative regulator of the phosphatidylinositol 3'-kinase/phosphoinositide-dependent protein kinase 1/Akt pathway and epithelial cell proliferation and evidence for frequent inactivation of Par6G gene in epithelial cancers. The findings demonstrate that determinants of epithelial structure regulate the cell proliferation activity via conserved and cancer-relevant regulatory circuitries, which are important for epithelial cell cycle restriction and may provide new targets for therapeutic intervention.	[Marques, E.; Englund, J. I.; Tervonen, T. A.; Virkunen, E.; Myllynen, M.; Makela, A.; Ahvenainen, M.; Klefstrom, J.] Univ Helsinki, Translat Canc Biol, Res Programs Unit, Canc Cell Circuitry Lab, FIN-00014 Helsinki, Finland; [Marques, E.; Englund, J. I.; Tervonen, T. A.; Virkunen, E.; Myllynen, M.; Makela, A.; Ahvenainen, M.; Klefstrom, J.] Univ Helsinki, Inst Biomed, FIN-00014 Helsinki, Finland; [Laakso, M.; Hautaniemi, S.] Univ Helsinki, Genome Scale Biol Program, Syst Biol Lab, FIN-00014 Helsinki, Finland; [Laakso, M.; Lepikhova, T.; Monni, O.; Hautaniemi, S.] Univ Helsinki, Inst Biomed, Biomedicum Helsinki, FIN-00014 Helsinki, Finland; [Lepikhova, T.; Monni, O.] Univ Helsinki, Genome Scale Biol Program, FIN-00014 Helsinki, Finland; [Lepikhova, T.] Univ Helsinki, Mol Oncol Lab, FIN-00014 Helsinki, Finland; [Lepikhova, T.] Univ Helsinki, Mol Canc Biol Program, Inst Clin Med, Biomedicum Helsinki, FIN-00014 Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki	Klefstrom, J (corresponding author), Univ Helsinki, Translat Canc Biol Res Program, Canc Cell Circuitry Lab, Haartmaninkatu 8,Room B507,POB 63, FIN-00014 Helsinki, Finland.	Juha.Klefstrom@helsinki.fi	Englund, Johanna/GYJ-7086-2022; Englund, Johanna/ABG-6420-2021; Hautaniemi, Sampsa/A-3122-2009; Hautaniemi, Sampsa/CAG-0362-2022	Englund, Johanna/0000-0001-9637-6843; Hautaniemi, Sampsa/0000-0002-7749-2694; Hautaniemi, Sampsa/0000-0002-7749-2694	Academy of Finland; Center of Excellence in Cancer Genetics Research; TEKES; Sigrid Juselius Foundation; Finnish Cancer Organizations; Helsinki Graduate Program in Biotechnology and Molecular Biology; Innovative Medicines Initiative Joint Undertaking [115188]	Academy of Finland(Academy of Finland); Center of Excellence in Cancer Genetics Research; TEKES(Finnish Funding Agency for Technology & Innovation (TEKES)); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Organizations; Helsinki Graduate Program in Biotechnology and Molecular Biology; Innovative Medicines Initiative Joint Undertaking	We thank all the members of Klefstrom laboratory for discussions and critical comments. We thank Tiina Raatikainen and Tarja Valimaki for technical assistance and Biomedicum Imaging Unit and Biomedicum Functional Genomics Unit for core services and technical support. This study was funded by the Academy of Finland (to JK and SH), Center of Excellence in Cancer Genetics Research (to SH and ML), TEKES, Sigrid Juselius Foundation, Finnish Cancer Organizations (to JK), Helsinki Graduate Program in Biotechnology and Molecular Biology (to EM) and Innovative Medicines Initiative Joint Undertaking under grant agreement no. 115188 (to JK).	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Assemat E, 2008, BBA-BIOMEMBRANES, V1778, P614, DOI 10.1016/j.bbamem.2007.08.029; Avruch J, 2012, SEMIN CELL DEV BIOL, V23, P770, DOI 10.1016/j.semcdb.2012.07.002; Banks L, 2012, NAT REV CANCER, V12, P876, DOI 10.1038/nrc3400; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Bouchard C, 2004, EMBO J, V23, P2830, DOI 10.1038/sj.emboj.7600279; Brody T, 1999, TRENDS GENET, V15, P333, DOI 10.1016/S0168-9525(99)01775-8; Brumby AM, 2005, NAT REV CANCER, V5, P626, DOI 10.1038/nrc1671; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Cameron ER, 2004, ONCOGENE, V23, P4308, DOI 10.1038/sj.onc.1207130; Chan JC, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001754; Chatterjee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034343; Chen A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-552; Cheng TL, 2004, EXP CELL RES, V295, P497, DOI 10.1016/j.yexcr.2004.02.002; Clegg NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017449; Cunliffe HE, 2012, AM J CANCER RES, V2, P478; Curto M, 2008, BRIT J CANCER, V98, P256, DOI 10.1038/sj.bjc.6604002; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Fogg VC, 2005, J CELL SCI, V118, P2859, DOI 10.1242/jcs.02412; Gonzalez-Mariscal L, 2012, ANN NY ACAD SCI, V1257, P133, DOI 10.1111/j.1749-6632.2012.06537.x; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hariharan IK, 2006, ANNU REV GENET, V40, P335, DOI 10.1146/annurev.genet.39.073003.100738; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189; Huang L, 2010, CURR OPIN GENET DEV, V20, P41, DOI 10.1016/j.gde.2009.12.001; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Lee MH, 2008, J CELL SCI, V121, P1141, DOI 10.1242/jcs.016634; Leung CT, 2012, NATURE, V482, P410, DOI 10.1038/nature10826; Link W, 2005, J CELL BIOCHEM, V95, P979, DOI 10.1002/jcb.20479; Ma Z, 2007, J CELL BIOL, V179, P23, DOI 10.1083/jcb.200706097; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; McCaffrey LM, 2012, CANCER CELL, V22, P601, DOI 10.1016/j.ccr.2012.10.003; McCrea PD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002923; Niggli V, 2008, INT J BIOCHEM CELL B, V40, P344, DOI 10.1016/j.biocel.2007.02.012; Nolan ME, 2008, CANCER RES, V68, P8201, DOI 10.1158/0008-5472.CAN-07-6567; Oka T, 2010, BIOCHEM J, V432, P461, DOI 10.1042/BJ20100870; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Partanen JI, 2007, P NATL ACAD SCI USA, V104, P14694, DOI 10.1073/pnas.0704677104; Partanen JI, 2012, P NATL ACAD SCI USA, V109, pE388, DOI 10.1073/pnas.1120421109; Partanen JI, 2009, CELL CYCLE, V8, P716, DOI 10.4161/cc.8.5.7786; Royer C, 2011, CELL DEATH DIFFER, V18, P1470, DOI 10.1038/cdd.2011.60; Sourisseau T, 2006, MOL CELL BIOL, V26, P2387, DOI 10.1128/MCB.26.6.2387-2398.2006; Tervonen TA, 2011, ADV CANCER RES, V111, P97, DOI 10.1016/B978-0-12-385524-4.00003-9; Vleugel M, 2012, DEV CELL, V23, P239, DOI 10.1016/j.devcel.2012.06.013; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Weber KL, 2007, J CELL SCI, V120, P3625, DOI 10.1242/jcs.011445; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Weyrich P, 2007, MOL CELL ENDOCRINOL, V268, P30, DOI 10.1016/j.mce.2007.01.011; Whyte J, 2010, J CELL SCI, V123, P3316, DOI 10.1242/jcs.065243; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045	54	14	14	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 17	2016	35	11					1386	1398		10.1038/onc.2015.196	http://dx.doi.org/10.1038/onc.2015.196			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DG6LQ	26073086	Green Published, hybrid			2022-12-26	WOS:000372196400005
J	Ekelund, F; Harder, CB; Knudsen, BE; Aamand, J				Ekelund, Flemming; Harder, Christoffer Bugge; Knudsen, Berith Elkaer; Aamand, Jens			Aminobacter MSH1-Mineralisation of BAM in Sand-Filters Depends on Biological Diversity	PLOS ONE			English	Article							2,6-DICHLOROBENZAMIDE BAM; HERBICIDE DICHLOBENIL; MICROBIAL DIVERSITY; COMMUNITY STRUCTURE; AGRICULTURAL SOIL; BATCH CULTURE; STERILE SOIL; DEGRADATION; MINERALIZATION; PROTOZOA	BAM (2,6-dichlorobenzamide) is a metabolite of the pesticide dichlobenil. Naturally occurring bacteria that can utilize BAM are rare. Often the compound cannot be degraded before it reaches the groundwater and therefore it poses a serious threat to drinking water supplies. The bacterial strain Aminobacter MSH1 is a BAM degrader and therefore a potential candidate to be amended to sand filters in waterworks to remediate BAM polluted drinking water. A common problem in bioremediation is that bacteria artificially introduced into new diverse environments often thrive poorly, which is even more unfortunate because biologically diverse environments may ensure a more complete decomposition. To test the bioaugmentative potential of MSH1, we used a serial dilution approach to construct microcosms with different biological diversity. Subsequently, we amended Aminobacter MSH1 to the microcosms in two final concentrations; i.e. 10(5) cells mL(-1) and 10(7) cells mL(-1). We anticipated that BAM degradation would be most efficient at " intermediate diversities" as low diversity would counteract decomposition because of incomplete decomposition of metabolites and high diversity would be detrimental because of eradication of Aminobacter MSH1. This hypothesis was only confirmed when Aminobacter MSH1 was amended in concentrations of 10(5) cells mL(-1). Our findings suggest that Aminobacter MSH1 is a very promising bioremediator at several diversity levels.	[Ekelund, Flemming; Harder, Christoffer Bugge] Univ Copenhagen, Dept Biol, DK-2100 Copenhagen O, Denmark; [Knudsen, Berith Elkaer; Aamand, Jens] Geol Survey Denmark & Greenland, Dept Geochem, DK-1350 Copenhagen, Denmark	University of Copenhagen; Geological Survey Of Denmark & Greenland	Ekelund, F (corresponding author), Univ Copenhagen, Dept Biol, Univ Pk 15, DK-2100 Copenhagen O, Denmark.	fekelund@bio.ku.dk		Aamand, Jens/0000-0002-4641-639X	Danish Council for Strategic Research [DSF-2104- 08-0012]; Danish Council for Independent Research [DFF-4002-00274]	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	All authors received funding from The Danish Council for Strategic Research (ufm.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-strategic-research) (DSF-2104- 08-0012; MIRESOWA).FE received funding from the Danish Council for Independent Research (DFF-4002-00274, ufm.dk/en/research-and-innovation/councils-and-commissions/the-danish-council- for-independent-research; OP-RICE-ING). No individuals employed or contracted by the funders (other than the named authors) played any role in: study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers CN, 2015, ENVIRON SCI TECHNOL, V49, P839, DOI 10.1021/es5046452; Albers CN, 2014, APPL MICROBIOL BIOT, V98, P957, DOI 10.1007/s00253-013-4942-6; Altenburger A, 2010, SOIL BIOL BIOCHEM, V42, P1636, DOI 10.1016/j.soilbio.2010.05.011; Benner J, 2013, WATER RES, V47, P5955, DOI 10.1016/j.watres.2013.07.015; Clausen L, 2007, J CONTAM HYDROL, V89, P157, DOI 10.1016/j.jconhyd.2006.04.004; Cutler DW, 1923, ANN APPL BIOL, V10, P137, DOI 10.1111/j.1744-7348.1923.tb05660.x; Darby BJ, 2014, OECOLOGIA, V175, P243, DOI 10.1007/s00442-014-2883-0; EKELUND F, 1994, FEMS MICROBIOL REV, V15, P321, DOI 10.1111/j.1574-6976.1994.tb00144.x; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Franklin RB, 2001, APPL ENVIRON MICROB, V67, P702, DOI 10.1128/AEM.67.2.702-712.2001; Fuentes MS, 2014, INT J ENVIRON SCI TE, V11, P1147, DOI 10.1007/s13762-013-0314-0; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Holtze MS, 2008, ENVIRON POLLUT, V154, P155, DOI 10.1016/j.envpol.2007.09.020; Johnke J, 2014, CURR OPIN BIOTECH, V27, P185, DOI 10.1016/j.copbio.2014.02.003; Liu MQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045306; Mattison RG, 2005, MICROBIAL ECOL, V49, P142, DOI 10.1007/s00248-003-0226-5; Pedersen AL, 2011, FEMS MICROBIOL LETT, V316, P16, DOI 10.1111/j.1574-6968.2010.02182.x; Ronn R, 2001, BIOL FERT SOILS, V33, P126, DOI 10.1007/s003740000299; Simonsen A, 2006, ENVIRON POLLUT, V144, P289, DOI 10.1016/j.envpol.2005.11.047; Siripattanakul S, 2009, J APPL MICROBIOL, V106, P986, DOI 10.1111/j.1365-2672.2008.04075.x; Sorensen SR, 2007, APPL ENVIRON MICROB, V73, P399, DOI 10.1128/AEM.01498-06; Sorensen SR, 2003, PEST MANAG SCI, V59, P1118, DOI [10.1002/ps.739, 10.1002/PS.739]; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; Tso SF, 2006, MICROB ECOL, V51, P460, DOI 10.1007/s00248-006-9058-4; vanVeen JA, 1997, MICROBIOL MOL BIOL R, V61, P121, DOI 10.1128/.61.2.121-135.1997; Vestergard M, 2011, SOIL BIOL BIOCHEM, V43, P1379, DOI 10.1016/j.soilbio.2011.02.008; Wertz S, 2006, ENVIRON MICROBIOL, V8, P2162, DOI 10.1111/j.1462-2920.2006.01098.x; Yang CY, 2010, BIODEGRADATION, V21, P97, DOI 10.1007/s10532-009-9284-9; Yang WJ, 2014, SOIL BIOL BIOCHEM, V69, P197, DOI 10.1016/j.soilbio.2013.10.030	30	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128838	10.1371/journal.pone.0128838	http://dx.doi.org/10.1371/journal.pone.0128838			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076202	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900032
J	Macfarlane, MD; Jakabek, D; Walterfang, M; Vestberg, S; Velakoulis, D; Wilkes, FA; Nilsson, C; van Westen, D; Looi, JCL; Santillo, AF				Macfarlane, Matthew D.; Jakabek, David; Walterfang, Mark; Vestberg, Susanna; Velakoulis, Dennis; Wilkes, Fiona A.; Nilsson, Christer; van Westen, Danielle; Looi, Jeffrey C. L.; Santillo, Alexander Frizell			Striatal Atrophy in the Behavioural Variant of Frontotemporal Dementia: Correlation with Diagnosis, Negative Symptoms and Disease Severity	PLOS ONE			English	Article							CAUDATE-NUCLEUS; BASAL GANGLIA; LOBAR DEGENERATION; RELIABILITY; CIRCUITS; PATTERNS; MRI; CONNECTIVITY; MORPHOLOGY; NETWORKS	Introduction Behavioural variant frontotemporal dementia (bvFTD) is associated with changes in dorsal striatal parts of the basal ganglia (caudate nucleus and putamen), related to dysfunction in the cortico-striato-thalamic circuits which help mediate executive and motor functions. We aimed to determine whether the size and shape of striatal structures correlated with diagnosis of bvFTD, and measures of clinical severity, behaviour and cognition. Materials and Methods Magnetic resonance imaging scans from 28 patients with bvFTD and 26 healthy controls were manually traced using image analysis software (ITK-SNAP). The resulting 3-D objects underwent volumetric analysis and shape analysis, through spherical harmonic description with point distribution models (SPHARM-PDM). Correlations with size and shape were sought with clinical measures in the bvTFD group, including Frontal Behavioural Inventory, Clinical Dementia Rating for bvFTD, Color Word Interference, Hayling part B and Brixton tests, and Trail-Making Test. Results Caudate nuclei and putamina were significantly smaller in the bvFTD group compared to controls (left caudate 16% smaller, partial eta squared 0.173, p=0.003; right caudate 11% smaller, partial eta squared 0.103, p=0.023; left putamen 18% smaller, partial eta squared 0.179, p=0.002; right putamen 12% smaller, partial eta squared 0.081, p=0.045), with global shape deflation in the caudate bilaterally but no localised shape change in putamen. In the bvFTD group, shape deflations on the left, corresponding to afferent connections from dorsolateral prefrontal mediofrontal/anterior cingulate and orbitofrontal cortex, correlated with worsening disease severity. Global shape deflation in the putamen correlated with Frontal Behavioural Inventory scores-higher scoring on negative symptoms was associated with the left putamen, while positive symptoms were associated with the right. Other cognitive tests had poor completion rates. Conclusion Behavioural symptoms and severity of bvFTD are correlated with abnormalities in striatal size and shape. This adds to the promise of imaging the striatum as a biomarker in this disease.	[Macfarlane, Matthew D.] Illawarra Shoalhaven Local Hlth Dist, Wollongong, NSW, Australia; [Macfarlane, Matthew D.; Jakabek, David] Univ Wollongong, Grad Sch Med, Wollongong, NSW, Australia; [Walterfang, Mark; Velakoulis, Dennis] Royal Melbourne Hosp, Melbourne Neuropsychiat Ctr, Melbourne, Vic, Australia; [Walterfang, Mark; Velakoulis, Dennis] Univ Melbourne, Melbourne, Vic, Australia; [Vestberg, Susanna] Lund Univ, Dept Psychol, Lund, Sweden; [Wilkes, Fiona A.] Australian Natl Univ, Sch Med4, Sch Clin Med, Res Ctr Neurosci Ageing,Acad Unit Psychiat & Addi, Canberra, ACT, Australia; [Nilsson, Christer; Santillo, Alexander Frizell] Lund Univ, Dept Clin Sci, Clin Memory Res Unit, Lund, Sweden; [van Westen, Danielle] Skane Univ Hosp, Ctr Med Imaging & Physiol, Lund, Sweden; [van Westen, Danielle] Lund Univ, Dept Clin Sci, Diagnost Radiol, Lund, Sweden; [Santillo, Alexander Frizell] Lund Univ, Dept Clin Sci, Geriatr Psychiat Unit, Lund, Sweden	University of Wollongong; Royal Melbourne Hospital; University of Melbourne; Lund University; Australian National University; Lund University; Lund University; Skane University Hospital; Lund University; Lund University	Santillo, AF (corresponding author), Lund Univ, Dept Clin Sci, Clin Memory Res Unit, Lund, Sweden.	alexander.santillo@med.lu.se	Walterfang, Mark/H-4930-2011	Walterfang, Mark/0000-0002-1389-3691; Looi, Jeffrey/0000-0003-3351-6911; van Westen, Danielle/0000-0001-8649-9874; Santillo, Alexander/0000-0001-9717-0820	Swedish Alzheimer foundation; Thureus foundation	Swedish Alzheimer foundation; Thureus foundation	JCLL self-funded travel costs and computer infrastructure to coordinate research in Australia and Sweden. The LUPROFS study received funding from The Swedish Alzheimer foundation, Thureus foundation, and benefited from the regional agreement on medical training and clinical research (ALF) between the Skane Regional Council and Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Burgess P.W., 1997, HAYLING BRIXTON TEST; Delis DC, 2001, DELIS KAPLAN EXECUTI; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; ENIGMA-Consortium, ORG HUM BRAIN MAPP 2; Eslinger PJ, 2012, BEHAV NEUROL, V25, P127, DOI [10.3233/BEN-2011-0351, 10.1155/2012/286427]; Farb NAS, 2013, CORTEX, V49, P1856, DOI 10.1016/j.cortex.2012.09.008; Franceschi M, 2005, ANN NEUROL, V57, P216, DOI 10.1002/ana.20365; Garibotto V, 2011, NEUROBIOL AGING, V32, P875, DOI 10.1016/j.neurobiolaging.2009.05.004; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Grahn JA, 2009, BEHAV BRAIN RES, V199, P53, DOI 10.1016/j.bbr.2008.11.020; Grahn JA, 2008, PROG NEUROBIOL, V86, P141, DOI 10.1016/j.pneurobio.2008.09.004; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Halabi C, 2013, ALZ DIS ASSOC DIS, V27, P74, DOI 10.1097/WAD.0b013e31824a7df4; Josephs KA, 2010, EUR J NEUROL, V17, P969, DOI 10.1111/j.1468-1331.2010.02975.x; Kertesz A, 1997, CAN J NEUROL SCI, V24, P29, DOI 10.1017/S0317167100021053; Kim EJ, 2007, J NEUROL NEUROSUR PS, V78, P1375, DOI 10.1136/jnnp.2006.114231; Looi JCL, 2008, AM J NEURORADIOL, V29, P1537, DOI 10.3174/ajnr.A1168; Looi JCL, 2013, MOL PSYCHIATR, V18, P417, DOI 10.1038/mp.2012.54; Looi JCL, 2009, AM J NEURORADIOL, V30, P1552, DOI 10.3174/ajnr.A1640; Looi JCL, 2012, AUST NZ J PSYCHIAT, V46, P1145, DOI 10.1177/0004867412457224; Looi JCL, 2012, AUST NZ J PSYCHIAT, V46, P422, DOI 10.1177/0004867411432076; Looi JCL, 2008, PSYCHIAT RES-NEUROIM, V163, P279, DOI 10.1016/j.pscychresns.2007.07.005; Looi JCL, 2011, PSYCHIAT RES-NEUROIM, V191, P98, DOI 10.1016/j.pscychresns.2010.09.014; Macfarlane MD, 2013, PSYCHIAT RES-NEUROIM, V214, P16, DOI 10.1016/j.pscychresns.2013.05.010; MEGA MS, 1994, J NEUROPSYCH CLIN N, V6, P358; Perry DC, 2014, BRAIN, V137, P1621, DOI 10.1093/brain/awu075; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Reitan R.M, 1958, TRAIL MAKING TEST MA; Santillo AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066932; Schroeter ML, 2014, CORTEX, V57, P22, DOI 10.1016/j.cortex.2014.02.022; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Styner M, 2006, INSIGHT J, P1; Styner M., 2007, P SOC PHOTO-OPT INS, p[65123, z1], DOI DOI 10.1117/12.708467; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Wittenberg D, 2008, NEUROPSYCHOL REV, V18, P91, DOI 10.1007/s11065-008-9056-z; Woolley JD, 2007, NEUROLOGY, V69, P1424, DOI 10.1212/01.wnl.0000277461.06713.23; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zamboni G, 2008, NEUROLOGY, V71, P736, DOI 10.1212/01.wnl.0000324920.96835.95	42	17	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129692	10.1371/journal.pone.0129692	http://dx.doi.org/10.1371/journal.pone.0129692			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26075893	gold, Green Published			2022-12-26	WOS:000356329900093
J	Norman, BC; Xenopoulos, MA; Braun, D; Frost, PC				Norman, Beth C.; Xenopoulos, Marguerite A.; Braun, Daniel; Frost, Paul C.			Phosphorus Availability Alters the Effects of Silver Nanoparticles on Periphyton Growth and Stoichiometry	PLOS ONE			English	Article							CHLAMYDOMONAS-REINHARDTII; NATURAL-WATERS; PSEUDOKIRCHNERIELLA-SUBCAPITATA; DAPHNIA-MAGNA; GREEN-ALGA; TOXICITY; FRESH; IMPACT; NANOSILVER; SOILS	Exposure to silver nanoparticles (AgNPs) may alter the structure and function of freshwater ecosystems. However, there remains a paucity of studies investigating the effects of AgNP exposure on freshwater communities in the natural environment where interactions with the ambient environment may modify AgNP toxicity. We used nutrient diffusing substrates to determine the interactive effects of AgNP exposure and phosphorus (P) enrichment on natural assemblages of periphyton in three Canadian Shield lakes. The lakes were all phosphorus poor and spanned a gradient of dissolved organic carbon availability. Ag slowly accumulated in the exposed periphyton, which decreased periphyton carbon and chlorophyll a content and increased periphyton C:P and N:P in the carbon rich lakes. We found significant interactions between AgNP and P treatments on periphyton carbon, autotroph standing crop and periphyton stoichiometry in the carbon poor lake such that P enhanced the negative effects of AgNPs on chlorophyll a and lessened the impact of AgNP exposure on periphyton stoichiometry. Our results contrast with those of other studies demonstrating that P addition decreases metal toxicity for phytoplankton, suggesting that benthic and pelagic primary producers may react differently to AgNP exposure and highlighting the importance of in situ assays when assessing potential effects of AgNPs in fresh waters.	[Norman, Beth C.; Xenopoulos, Marguerite A.; Braun, Daniel; Frost, Paul C.] Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada	Trent University	Norman, BC (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	bcheever@msu.edu	Frost, Paul/AAT-6633-2021		Natural Sciences and Engineering Research Council of Canada; Environment Canada Youth Internship Science Horizon Program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Environment Canada Youth Internship Science Horizon Program	This work was funded by the Natural Sciences and Engineering Research Council of Canada via a Strategic Grant as well as the Environment Canada Youth Internship Science Horizon Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaout CL, 2012, ENVIRON SCI TECHNOL, V46, P5387, DOI 10.1021/es204540z; Barranguet C, 2002, ENVIRON TOXICOL CHEM, V21, P1955, DOI 10.1002/etc.5620210925; Benn T, 2010, J ENVIRON QUAL, V39, P1875, DOI 10.2134/jeq2009.0363; Bernhardt ES, 2010, J ENVIRON QUAL, V39, P1954, DOI 10.2134/jeq2009.0479; CARRICK HJ, 1988, CAN J FISH AQUAT SCI, V45, P271, DOI 10.1139/f88-032; Choi OK, 2009, WATER SCI TECHNOL, V59, P1699, DOI 10.2166/wst.2009.205; Choi O, 2009, WATER RES, V43, P1879, DOI 10.1016/j.watres.2009.01.029; Colman BP, 2014, ENVIRON SCI TECHNOL, V48, P5229, DOI 10.1021/es405454v; Colman BP, 2012, ECOTOXICOLOGY, V21, P1867, DOI 10.1007/s10646-012-0920-5; Colman BP, 2013, PLOS ONE, P8; Cross WF, 2005, FRESHWATER BIOL, V50, P1895, DOI 10.1111/j.1365-2427.2005.01458.x; Das P, 2014, ENVIRON SCI TECHNOL, V48, P4573, DOI 10.1021/es405039w; Das P, 2012, ENVIRON SCI TECHNOL, V46, P9120, DOI 10.1021/es3019918; Das P, 2012, ENVIRON TOXICOL CHEM, V31, P122, DOI 10.1002/etc.716; Elias D, 2014, PLOS ONE, P9; Fabrega J, 2011, CHEMOSPHERE, V85, P961, DOI 10.1016/j.chemosphere.2011.06.066; Fabrega J, 2009, ENVIRON SCI TECHNOL, V43, P7285, DOI 10.1021/es803259g; FAIRCHILD GW, 1985, ECOLOGY, V66, P465, DOI 10.2307/1940395; Fortin C, 2001, ENVIRON SCI TECHNOL, V35, P2214, DOI 10.1021/es0017965; Frost PC, 2002, FRESHWATER BIOL, V47, P173, DOI 10.1046/j.1365-2427.2002.00796.x; Funck JA, 2013, AQUAT TOXICOL, V144, P199, DOI 10.1016/j.aquatox.2013.10.001; Furtado LM, 2014, ENVIRON CHEM, V11, P419, DOI 10.1071/EN14064; Gao J, 2009, ENVIRON SCI TECHNOL, V43, P3322, DOI 10.1021/es803315v; Griffitt RJ, 2008, ENVIRON TOXICOL CHEM, V27, P1972, DOI 10.1897/08-002.1; Hiriart-Baer VP, 2006, AQUAT TOXICOL, V78, P136, DOI 10.1016/j.aquatox.2006.02.027; Hoppe M, 2014, ENVIRON SCI TECHNOL, V48, P12628, DOI 10.1021/es5026189; Jacobson AR, 2005, WATER AIR SOIL POLL, V160, P41, DOI 10.1007/s11270-005-3860-3; Jepersen A, 1987, ARCH HYDROBIOL, V109, P445; Jeppesen E, 2003, ECOSYSTEMS, V6, P313, DOI 10.1007/PL00021503; Kennedy AJ, 2012, ENVIRON SCI TECHNOL, V46, P10772, DOI 10.1021/es302322y; Kennedy AJ, 2010, ENVIRON SCI TECHNOL, V44, P9571, DOI 10.1021/es1025382; Leclerc S, 2014, ENVIRON SCI TECHNOL, V48, P358, DOI 10.1021/es404037z; Li WR, 2010, APPL MICROBIOL BIOT, V85, P1115, DOI 10.1007/s00253-009-2159-5; Lowry GV, 2012, ENVIRON SCI TECHNOL, V46, P7027, DOI 10.1021/es204608d; Maurer-Jones MA, 2013, ANAL CHEM, V85, P3036, DOI 10.1021/ac303636s; McTeer J, 2014, NANOTOXICOLOGY, V8, P305, DOI 10.3109/17435390.2013.778346; Miao AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015196; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Mulholland PJ, 2008, NATURE, V452, P202, DOI 10.1038/nature06686; Navarro E, 2008, ENVIRON SCI TECHNOL, V42, P8959, DOI 10.1021/es801785m; Oukarroum A, 2012, ECOTOX ENVIRON SAFE, V78, P80, DOI 10.1016/j.ecoenv.2011.11.012; Pan B, 2012, EUR J SOIL SCI, V63, P437, DOI 10.1111/j.1365-2389.2012.01475.x; Peyrot C, 2014, ENVIRON TOXICOL CHEM, V33, P115, DOI 10.1002/etc.2398; Pillai S, 2014, P NATL ACAD SCI USA, V111, P3490, DOI 10.1073/pnas.1319388111; Pradhan A, 2011, MICROB ECOL, V62, P58, DOI 10.1007/s00248-011-9861-4; Ribeiro F, 2014, SCI TOTAL ENVIRON, V466, P232, DOI 10.1016/j.scitotenv.2013.06.101; RIBER HH, 1987, LIMNOL OCEANOGR, V32, P1181, DOI 10.4319/lo.1987.32.6.1181; Riedel GF, 2003, ESTUARIES, V26, P339, DOI 10.1007/BF02695972; Rosi-Marshall EJ, 2012, ECOSYSTEMS, V15, P867, DOI 10.1007/s10021-012-9553-z; Serra A, 2010, ECOTOXICOLOGY, V19, P770, DOI 10.1007/s10646-009-0454-7; STEINMAN AD, 1995, J N AM BENTHOL SOC, V14, P371, DOI 10.2307/1467203; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Stevenson LM, 2013, PLOS ONE, P8; Turner A, 2012, ECOTOXICOLOGY, V21, P148, DOI 10.1007/s10646-011-0774-2; TURNER MA, 1994, CAN J FISH AQUAT SCI, V51, P2784, DOI 10.1139/f94-278; TWISS MR, 1992, J PHYCOL, V28, P291, DOI 10.1111/j.0022-3646.1992.00291.x; VALDERRAMA JC, 1981, MAR CHEM, V10, P109, DOI 10.1016/0304-4203(81)90027-X; Wang WX, 2006, ENVIRON POLLUT, V142, P303, DOI 10.1016/j.envpol.2005.10.005; Xiu ZM, 2011, ENVIRON SCI TECHNOL, V45, P9003, DOI 10.1021/es201918f; Yuan ZH, 2013, CHEMOSPHERE, V90, P1404, DOI 10.1016/j.chemosphere.2012.08.032	60	12	12	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129328	10.1371/journal.pone.0129328	http://dx.doi.org/10.1371/journal.pone.0129328			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075715	gold, Green Published, Green Submitted			2022-12-26	WOS:000356329900065
J	Vicario, R; Peg, V; Morancho, B; Zacarias-Fluck, M; Zhang, JJ; Martinez-Barriocanal, A; Jimenez, AN; Aura, C; Burgues, O; Lluch, A; Cortes, J; Nuciforo, P; Rubio, IT; Marangoni, E; Deeds, J; Boehm, M; Schlegel, R; Tabernero, J; Mosher, R; Arribas, J				Vicario, Rocio; Peg, Vicente; Morancho, Beatriz; Zacarias-Fluck, Mariano; Zhang, Junjie; Martinez-Barriocanal, Agueda; Navarro Jimenez, Alexandra; Aura, Claudia; Burgues, Octavio; Lluch, Ana; Cortes, Javier; Nuciforo, Paolo; Rubio, Isabel T.; Marangoni, Elisabetta; Deeds, James; Boehm, Markus; Schlegel, Robert; Tabernero, Josep; Mosher, Rebecca; Arribas, Joaquin			Patterns of HER2 Gene Amplification and Response to Anti-HER2 Therapies	PLOS ONE			English	Article							BREAST-CANCER; GROWTH; NETWORK	A chromosomal region that includes the gene encoding HER2, a receptor tyrosine kinase (RTK), is amplified in 20% of breast cancers. Although these tumors tend to respond to drugs directed against HER2, they frequently become resistant and resume their malignant progression. Gene amplification in double minutes (DMs), which are extrachromosomal entities whose number can be dynamically regulated, has been suggested to facilitate the acquisition of resistance to therapies targeting RTKs. Here we show that similar to 30% of HER2-positive tumors show amplification in DMs. However, these tumors respond to trastuzumab in a similar fashion than those with amplification of the HER2 gene within chromosomes. Furthermore, in different models of resistance to anti-HER2 therapies, the number of DMs containing HER2 is maintained, even when the acquisition of resistance is concomitant with loss of HER2 protein expression. Thus, both clinical and preclinical data show that, despite expectations, loss of HER2 protein expression due to loss of DMs containing HER2 is not a likely mechanism of resistance to anti-HER2 therapies.	[Vicario, Rocio; Morancho, Beatriz; Zacarias-Fluck, Mariano; Zhang, Junjie; Martinez-Barriocanal, Agueda; Arribas, Joaquin] Univ Autonoma Barcelona, Vall dHebron Inst Oncol VHIO, Preclin Oncol Program, Barcelona 08035, Spain; [Cortes, Javier; Rubio, Isabel T.; Tabernero, Josep] Univ Autonoma Barcelona, Vall dHebron Inst Oncol VHIO, Clin Oncol Program, Barcelona 08035, Spain; [Aura, Claudia; Nuciforo, Paolo] Univ Autonoma Barcelona, Vall dHebron Inst Oncol VHIO, Mol Oncol Program, Barcelona 08035, Spain; [Peg, Vicente; Navarro Jimenez, Alexandra] Vall dHebron Univ Hosp, Dept Pathol, Barcelona 08035, Spain; [Burgues, Octavio] INCLIVA Biomed Res Inst, Hosp Clin Univ, Dept Pathol, Valencia 46010, Spain; [Lluch, Ana] INCLIVA Biomed Res Inst, Hosp Clin Univ, Dept Oncol, Valencia 46010, Spain; [Marangoni, Elisabetta] Inst Curie, Translat Res Dept, F-75005 Paris, France; [Deeds, James; Schlegel, Robert; Mosher, Rebecca] Novartis Oncol Translat Res, Cambridge, MA 02139 USA; [Boehm, Markus] Novartis Pharma AG, CH-4002 Basel, Switzerland; [Vicario, Rocio; Arribas, Joaquin] Univ Autonoma Barcelona, Dept Biochem & Mol Biol, Bellaterra 08193, Spain; [Arribas, Joaquin] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain	Autonomous University of Barcelona; Vall d'Hebron Institut d'Oncologia (VHIO); Autonomous University of Barcelona; Vall d'Hebron Institut d'Oncologia (VHIO); Autonomous University of Barcelona; Vall d'Hebron Institut d'Oncologia (VHIO); Hospital Universitari Vall d'Hebron; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Novartis; Autonomous University of Barcelona; ICREA	Mosher, R (corresponding author), Novartis Oncol Translat Res, Cambridge, MA 02139 USA.	rebecca.mosher@novartis.com; jarribas@vhio.net	Peg., Vicente/AAC-9447-2020; Nuciforo, Paolo/Q-2885-2019; rubio, isabel/U-4259-2018; Burgues, Octavio/ABH-9634-2020; Burgues, Octavio/ABC-8699-2021; Peg, Vicente/E-9160-2018; Marangoni, Elisabetta/GSO-3945-2022; Zacarias-Fluck, Mariano F./D-9406-2019; Martinez, Agueda/AAB-7186-2019; Morancho, Beatriz/AAD-3540-2021; Lluch, Ana/R-5493-2019; Tabernero, Josep/AAG-5026-2019; Arribas, Joaquin/M-4482-2014; Miquel, Josep Maria/AAG-3508-2019	Peg., Vicente/0000-0002-5203-6166; rubio, isabel/0000-0003-0035-0679; Peg, Vicente/0000-0002-5203-6166; Marangoni, Elisabetta/0000-0002-3337-6448; Zacarias-Fluck, Mariano F./0000-0002-7171-4268; Martinez, Agueda/0000-0002-8809-160X; Morancho, Beatriz/0000-0003-3369-8647; Lluch, Ana/0000-0003-2766-407X; Tabernero, Josep/0000-0002-2495-8139; Arribas, Joaquin/0000-0002-0504-0664; Nuciforo, Paolo/0000-0003-1380-0990; Cortes, Javier/0000-0001-7623-1583	Novartis Pharma within the Consorcio de Investigacion Biomedica y Oncologica Translacional Framework Programme; Breast Cancer Research Foundation (BCRF); Spanish Association Against Cancer (Asociacion Espanola Contra el Cancer, AECC); Instituto de Salud Carlos III (Intrasalud) [PI12/02536]; Network of Cooperative Cancer Research [RTICC-RD12/0036/0057/0070/0012]; Ministerio de Economia y Competitividad [JCI-2011-10960]; Novartis; ICREA Funding Source: Custom	Novartis Pharma within the Consorcio de Investigacion Biomedica y Oncologica Translacional Framework Programme; Breast Cancer Research Foundation (BCRF); Spanish Association Against Cancer (Asociacion Espanola Contra el Cancer, AECC); Instituto de Salud Carlos III (Intrasalud); Network of Cooperative Cancer Research; Ministerio de Economia y Competitividad(Spanish Government); Novartis(Novartis); ICREA(ICREA)	This work has been supported by Novartis Pharma within the Consorcio de Investigacion Biomedica y Oncologica Translacional Framework Programme, the Breast Cancer Research Foundation (BCRF), Spanish Association Against Cancer (Asociacion Espanola Contra el Cancer, AECC) and Instituto de Salud Carlos III (Intrasalud PI12/02536) to JA and the Network of Cooperative Cancer Research (RTICC-RD12/0036/0057/0070/0012) to JA, JT, JC and AL. AM-B is supported by a Juan de la Cierva postdoctoral fellow from Ministerio de Economia y Competitividad (JCI-2011-10960). JD, MB, RS, and RM are employed by Novartis and received funding in the form of salaries. The funders participated in study design, decision to publish, and preparation of the manuscript.	Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Bonavia R, 2011, CANCER RES, V71, P4055, DOI 10.1158/0008-5472.CAN-11-0153; Gianni L, 2010, LANCET, V375, P377, DOI 10.1016/S0140-6736(09)61964-4; Gradishar WJ, 2012, NEW ENGL J MED, V366, P176, DOI 10.1056/NEJMe1113641; Hoff Von DD, 1992, P NATL ACAD SCI USA, V89, P8165; KAUFMAN RJ, 1981, MOL CELL BIOL, V1, P1084, DOI 10.1128/MCB.1.12.1084; Parra-Palau JL, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju291; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; Mittendorf EA, 2009, CLIN CANCER RES, V15, P7381, DOI 10.1158/1078-0432.CCR-09-1735; Nathanson DA, 2014, SCIENCE, V343, P72, DOI 10.1126/science.1241328; Niikura N, 2012, J CLIN ONCOL, V30, P593, DOI 10.1200/JCO.2010.33.8889; Pedersen K, 2009, MOL CELL BIOL, V29, P3319, DOI 10.1128/MCB.01803-08; Sahlberg KK, 2013, MOL ONCOL, V7, P392, DOI 10.1016/j.molonc.2012.10.012; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Xuan QJ, 2015, BREAST CANCER RES TR, V150, P581, DOI 10.1007/s10549-015-3334-2; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Yu LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071988	18	35	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129876	10.1371/journal.pone.0129876	http://dx.doi.org/10.1371/journal.pone.0129876			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075403	Green Published, Green Submitted, gold			2022-12-26	WOS:000356329900108
J	Cobaugh, KL; Schaeffer, SM; DeBruyn, JM				Cobaugh, Kelly L.; Schaeffer, Sean M.; DeBruyn, Jennifer M.			Functional and Structural Succession of Soil Microbial Communities below Decomposing Human Cadavers	PLOS ONE			English	Article							HERMETIA-ILLUCENS DIPTERA; NITROGEN-FERTILIZATION; CARRION DECOMPOSITION; LEUCINE INCORPORATION; OVIS-ARIES; TIME; STRATIOMYIDAE; TERRESTRIAL; INTERFACE; THYMIDINE	The ecological succession of microbes during cadaver decomposition has garnered interest in both basic and applied research contexts (e.g. community assembly and dynamics; forensic indicator of time since death). Yet current understanding of microbial ecology during decomposition is almost entirely based on plant litter. We know very little about microbes recycling carcass-derived organic matter despite the unique decomposition processes. Our objective was to quantify the taxonomic and functional succession of microbial populations in soils below decomposing cadavers, testing the hypotheses that a) periods of increased activity during decomposition are associated with particular taxa; and b) human-associated taxa are introduced to soils, but do not persist outside their host. We collected soils from beneath four cadavers throughout decomposition, and analyzed soil chemistry, microbial activity and bacterial community structure. As expected, decomposition resulted in pulses of soil C and nutrients (particularly ammonia) and stimulated microbial activity. There was no change in total bacterial abundances, however we observed distinct changes in both function and community composition. During active decay (7 - 12 days postmortem), respiration and biomass production rates were high: the community was dominated by Proteobacteria (increased from 15.0 to 26.1% relative abundance) and Firmicutes (increased from 1.0 to 29.0%), with reduced Acidobacteria abundances (decreased from 30.4 to 9.8%). Once decay rates slowed (10 - 23 d postmortem), respiration was elevated, but biomass production rates dropped dramatically; this community with low growth efficiency was dominated by Firmicutes (increased to 50.9%) and other anaerobic taxa. Human-associated bacteria, including the obligately anaerobic Bacteroides, were detected at high concentrations in soil throughout decomposition, up to 198 d postmortem. Our results revealed the pattern of functional and compositional succession in soil microbial communities during decomposition of human-derived organic matter, provided insight into decomposition processes, and identified putative predictor populations for time since death estimation.	[Cobaugh, Kelly L.; Schaeffer, Sean M.; DeBruyn, Jennifer M.] Univ Tennessee, Dept Biosyst Engn & Soil Sci, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	DeBruyn, JM (corresponding author), Univ Tennessee, Dept Biosyst Engn & Soil Sci, Knoxville, TN 37996 USA.	jdebruyn@utk.edu	Schaeffer, Sean M/G-5071-2012; DeBruyn, Jennifer M./A-8813-2010	DeBruyn, Jennifer M./0000-0002-2993-4144; Schaeffer, Sean/0000-0002-9684-2952	University of Tennessee AgResearch; Microbiology Across Campuses Educational and Research Venture	University of Tennessee AgResearch; Microbiology Across Campuses Educational and Research Venture	Funding for this study was provided by University of Tennessee AgResearch and Microbiology Across Campuses Educational and Research Venture to JMD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUASHOUR J, 1994, WATER AIR SOIL POLL, V75, P141, DOI 10.1007/BF01100406; Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Amin MGM, 2013, APPL ENVIRON MICROB, V79, P535, DOI 10.1128/AEM.02506-12; Anderson J. P. E., 1982, METHODS SOIL ANAL 2; Baath E, 2001, SOIL BIOL BIOCHEM, V33, P1571, DOI 10.1016/S0038-0717(01)00073-6; Baldrian P, 2012, ISME J, V6, P248, DOI 10.1038/ismej.2011.95; Bastviken D, 2001, APPL ENVIRON MICROB, V67, P2916, DOI 10.1128/AEM.67.7.2916-2921.2001; Benninger LA, 2008, FORENSIC SCI INT, V180, P70, DOI 10.1016/j.forsciint.2008.07.001; Berry D F, 1991, Biotechnology, V15, P57; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Carter DO, 2008, APPL SOIL ECOL, V40, P129, DOI 10.1016/j.apsoil.2008.03.010; Carter DO, 2007, NATURWISSENSCHAFTEN, V94, P12, DOI 10.1007/s00114-006-0159-1; Carter DO, 2006, SOIL BIOL BIOCHEM, V38, P1139, DOI 10.1016/j.soilbio.2005.09.014; Carter DO, 2010, FORENSIC SCI INT, V200, P60, DOI 10.1016/j.forsciint.2010.03.031; Creamer CA, 2015, SOIL BIOL BIOCHEM, V80, P175, DOI 10.1016/j.soilbio.2014.10.008; Damann FE, 2012, FORENSIC SCI INT, V222, P4, DOI 10.1016/j.forsciint.2012.04.028; Danell K, 2002, ARCTIC, V55, P389; DeBruyn JM, 2011, APPL ENVIRON MICROB, V77, P6295, DOI 10.1128/AEM.05005-11; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Finley S. J., 2014, INT J LEGAL MED, P1, DOI DOI 10.1007/S00414-014-0996-Y; Fonseca G, 2011, AQUAT BIOL, V13, P27, DOI 10.3354/ab00347; Gorley C.K., 2006, GETTING STARTED PRIM; Haskell Neal H., 1997, P415; Haslam TCF, 2009, J FORENSIC SCI, V54, P900, DOI 10.1111/j.1556-4029.2009.01070.x; Hauther KA, J FORENSIC IN PRESS; Heimesaat MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040758; Heinemeyer A, 2009, SOIL CARBON DYNAMICS, P76, DOI DOI 10.1017/CB09780511711794.006; Holley RA, 2006, J ENVIRON QUAL, V35, P1170, DOI 10.2134/jeq2005.0449; Hopkins DW, 2000, APPL SOIL ECOL, V14, P283, DOI 10.1016/S0929-1393(00)00063-9; Howard GT, 2010, INT BIODETER BIODEGR, V64, P300, DOI 10.1016/j.ibiod.2010.02.006; Hutchison ML, 2004, APPL ENVIRON MICROB, V70, P5111, DOI 10.1128/AEM.70.9.5111-5118.2004; Hyde ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077733; Jaenicke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014519; Jiang XP, 2002, APPL ENVIRON MICROB, V68, P2605, DOI 10.1128/AEM.68.5.2605-2609.2002; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Layton A, 2006, APPL ENVIRON MICROB, V72, P4214, DOI 10.1128/AEM.01036-05; Lee YY, 2013, INT J SYST EVOL MICR, V63, P4224, DOI 10.1099/ijs.0.049098-0; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Macdonald BCT, 2014, SOIL BIOL BIOCHEM, V69, P132, DOI 10.1016/j.soilbio.2013.10.042; McClain ME, 2003, ECOSYSTEMS, V6, P301, DOI 10.1007/s10021-003-0161-9; McGuire KL, 2010, SOIL BIOL BIOCHEM, V42, P529, DOI 10.1016/j.soilbio.2009.11.016; Metcalf JL, 2013, ELIFE, V2, DOI 10.7554/eLife.01104; MICHEL PH, 1993, SOIL BIOL BIOCHEM, V25, P943, DOI 10.1016/0038-0717(93)90097-U; Moorhead DL, 2006, ECOL MONOGR, V76, P151, DOI 10.1890/0012-9615(2006)076[0151:ATMOLD]2.0.CO;2; Moreno LI, 2011, J MICROBIOL METH, V84, P388, DOI 10.1016/j.mimet.2010.11.023; Nemergut DR, 2008, ENVIRON MICROBIOL, V10, P3093, DOI 10.1111/j.1462-2920.2008.01735.x; OSTROLENK M, 1947, J BACTERIOL, V53, P197, DOI 10.1128/JB.53.2.197-203.1947; Parkinson RA, 2009, CRIMINAL AND ENVIRONMENTAL SOIL FORENSICS, P379, DOI 10.1007/978-1-4020-9204-6_24; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Parmenter RR, 2009, ECOL MONOGR, V79, P637, DOI 10.1890/08-0972.1; PAYNE JA, 1965, ECOLOGY, V46, P592, DOI 10.2307/1934999; Pechal JL, 2014, INT J LEGAL MED, V128, P193, DOI 10.1007/s00414-013-0872-1; Pujol-Luz JR, 2008, J FORENSIC SCI, V53, P476, DOI 10.1111/j.1556-4029.2008.00659.x; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ramirez KS, 2010, ECOLOGY, V91, P3463, DOI 10.1890/10-0426.1; Santarella-Mellwig R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000281; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Swann LM, 2010, ANAL CHIM ACTA, V682, P9, DOI 10.1016/j.aca.2010.09.052; Towne EG, 2000, OECOLOGIA, V122, P232, DOI 10.1007/PL00008851; Ueki A, 2009, INT J SYST EVOL MICR, V59, P3161, DOI 10.1099/ijs.0.011858-0; VASS AA, 1992, J FORENSIC SCI, V37, P1236; Voriskova J, 2013, ISME J, V7, P477, DOI 10.1038/ismej.2012.116; Wilson AS, 2007, FORENSIC SCI INT, V169, P6, DOI 10.1016/j.forsciint.2006.07.023; ZAK DR, 1990, ECOLOGY, V71, P651, DOI 10.2307/1940319	66	90	91	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130201	10.1371/journal.pone.0130201	http://dx.doi.org/10.1371/journal.pone.0130201			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26067226	Green Submitted, gold, Green Published			2022-12-26	WOS:000356327000149
J	Ioannou, CI; Pereda, E; Lindsen, JP; Bhattacharya, J				Ioannou, Christos I.; Pereda, Ernesto; Lindsen, Job P.; Bhattacharya, Joydeep			Electrical Brain Responses to an Auditory Illusion and the Impact of Musical Expertise	PLOS ONE			English	Article							STEADY-STATE RESPONSES; GAMMA-BAND; PHASE-SYNCHRONIZATION; BINAURAL-BEAT; FUNCTIONAL CONNECTIVITY; HZ FLICKER; ALPHA-BAND; HUMAN EEG; NETWORKS; RHYTHMS	The presentation of two sinusoidal tones, one to each ear, with a slight frequency mismatch yields an auditory illusion of a beating frequency equal to the frequency difference between the two tones; this is known as binaural beat (BB). The effect of brief BB stimulation on scalp EEG is not conclusively demonstrated. Further, no studies have examined the impact of musical training associated with BB stimulation, yet musicians' brains are often associated with enhanced auditory processing. In this study, we analysed EEG brain responses from two groups, musicians and non-musicians, when stimulated by short presentation (1 min) of binaural beats with beat frequency varying from 1 Hz to 48 Hz. We focused our analysis on alpha and gamma band EEG signals, and they were analysed in terms of spectral power, and functional connectivity as measured by two phase synchrony based measures, phase locking value and phase lag index. Finally, these measures were used to characterize the degree of centrality, segregation and integration of the functional brain network. We found that beat frequencies belonging to alpha band produced the most significant steady-state responses across groups. Further, processing of low frequency (delta, theta, alpha) binaural beats had significant impact on cortical network patterns in the alpha band oscillations. Altogether these results provide a neurophysiological account of cortical responses to BB stimulation at varying frequencies, and demonstrate a modulation of cortico-cortical connectivity in musicians' brains, and further suggest a kind of neuronal entrainment of a linear and nonlinear relationship to the beating frequencies.	[Ioannou, Christos I.; Lindsen, Job P.; Bhattacharya, Joydeep] Univ London, Dept Psychol, London, England; [Ioannou, Christos I.] Hannover Univ Mus Drama & Media, Inst Mus Physiol & Musicians Med, Hannover, Germany; [Pereda, Ernesto] Univ La Laguna, Dept Ind Engn, Elect Engn & Bioengn Grp, Tenerife, Spain; [Pereda, Ernesto] Univ La Laguna, Inst Biomed Technol CIBICAN, Tenerife, Spain	University of London; Universidad de la Laguna; Universidad de la Laguna	Bhattacharya, J (corresponding author), Univ London, Dept Psychol, London, England.	j.bhattacharya@gold.ac.uk	Pereda, Ernesto/K-5185-2014; De Pablo, Ernesto Pereda/AAB-7440-2021	Pereda, Ernesto/0000-0001-5965-164X; De Pablo, Ernesto Pereda/0000-0001-5965-164X	Spanish MINECO (Ministerio de Economia y Competitividad); MEC (Ministry of Science and Technology) [TEC2012-38453-C04-03, PRX12/00564]	Spanish MINECO (Ministerio de Economia y Competitividad)(Spanish Government); MEC (Ministry of Science and Technology)	E. Pereda acknowledges the financial support of the Spanish MINECO (Ministerio de Economia y Competitividad) and MEC (Ministry of Science and Technology) under grants TEC2012-38453-C04-03 and PRX12/00564, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Adrian ED, 1934, BRAIN, V57, P355, DOI 10.1093/brain/57.4.355; Atwater F. H., 2001, P TANS, P1; Bangert M, 2006, NEUROIMAGE, V30, P917, DOI 10.1016/j.neuroimage.2005.10.044; Bengtsson SL, 2009, CORTEX, V45, P62, DOI 10.1016/j.cortex.2008.07.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattacharya J, 2001, J NEUROSCI, V21, P6329, DOI 10.1523/JNEUROSCI.21-16-06329.2001; Bhattacharya J, 2002, COGNITIVE BRAIN RES, V13, P179, DOI 10.1016/S0926-6410(01)00110-0; Bhattacharya J, 2001, NEUROREPORT, V12, P371, DOI 10.1097/00001756-200102120-00037; Bialonski S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022826; Brady B, 2000, AM J CLIN HYPN, V43, P53, DOI 10.1080/00029157.2000.10404255; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Buzsaki G, 2013, NEURON, V80, P751, DOI 10.1016/j.neuron.2013.10.002; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Christodoulakis M, 2015, MODERN ELECTROENCEPH, P103, DOI DOI 10.1007/7657_2013_65; Cohen MX, 2015, J NEUROSCI METH, V250, P137, DOI 10.1016/j.jneumeth.2014.09.005; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DON M, 1993, J ACOUST SOC AM, V94, P2135, DOI 10.1121/1.407485; Donner TH, 2011, TRENDS COGN SCI, V15, P191, DOI 10.1016/j.tics.2011.03.007; Draganova R, 2008, CEREB CORTEX, V18, P1193, DOI 10.1093/cercor/bhm153; Ducommun CY, 2002, NEUROIMAGE, V16, P76, DOI 10.1006/nimg.2002.1062; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Fischer I, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.123902; Fornito A, 2013, NEUROIMAGE, V80, P426, DOI 10.1016/j.neuroimage.2013.04.087; Foxe JJ, 1998, NEUROREPORT, V9, P3929, DOI 10.1097/00001756-199812010-00030; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; GOLDBERG JM, 1969, J NEUROPHYSIOL, V32, P613, DOI 10.1152/jn.1969.32.4.613; Goldstein JM, 2005, NEUROPSYCHOLOGY, V19, P509, DOI 10.1037/0894-4105.19.4.509; Gollo LL, 2010, NEUROIMAGE, V52, P947, DOI 10.1016/j.neuroimage.2009.11.058; Gollo LL, 2010, BMC NEUROSCIENCE S1, V11, pP17; Goodin P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034789; Haig AR, 2000, NEUROREPORT, V11, P669, DOI 10.1097/00001756-200003200-00004; Herholz SC, 2012, NEURON, V76, P486, DOI 10.1016/j.neuron.2012.10.011; Herrmann CS, 2001, EXP BRAIN RES, V137, P346, DOI 10.1007/s002210100682; Hillebrand A, 2012, NEUROIMAGE, V59, P3909, DOI 10.1016/j.neuroimage.2011.11.005; Hyde KL, 2009, J NEUROSCI, V29, P3019, DOI 10.1523/JNEUROSCI.5118-08.2009; Joudaki Amir, 2012, PLoS One, V7, pe35673, DOI 10.1371/journal.pone.0035673; Joyce M., 2000, J NEUROTHER, V4, P9, DOI [10.1300/J184v04n02_04, DOI 10.1300/J184V04N02_04]; Kaneko K, 2003, HEARING RES, V183, P1, DOI 10.1016/S0378-5955(03)00186-2; Karino S, 2006, J NEUROPHYSIOL, V96, P1927, DOI 10.1152/jn.00859.2005; Kasprzak C, 2011, ACTA PHYS POL A, V119, P986, DOI 10.12693/APhysPolA.119.986; Keenan JP, 2001, NEUROIMAGE, V14, P1402, DOI 10.1006/nimg.2001.0925; Kelly SP, 2006, J NEUROPHYSIOL, V95, P3844, DOI 10.1152/jn.01234.2005; Kim DJ, 2013, NEUROIMAGE-CLIN, V2, P414, DOI 10.1016/j.nicl.2013.03.007; Kishon-Rabin Liat, 2001, Journal of Basic and Clinical Physiology and Pharmacology, V12, P125; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Kramer MA, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.061916; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; KUWADA S, 1979, SCIENCE, V206, P586, DOI 10.1126/science.493964; Lange J, 2013, J NEUROSCI, V33, P3212, DOI 10.1523/JNEUROSCI.3755-12.2013; Langer N, 2012, HUM BRAIN MAPP, V33, P1393, DOI 10.1002/hbm.21297; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; LICKLIDER JCR, 1950, J ACOUST SOC AM, V22, P468, DOI 10.1121/1.1906629; LOPESDAS.FH, 1974, KYBERNETIK, V15, P27, DOI 10.1007/BF00270757; Lutz A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001897; Meister IG, 2004, COGNITIVE BRAIN RES, V19, P219, DOI 10.1016/j.cogbrainres.2003.12.005; Meskaldji DE, 2013, NEUROIMAGE, V80, P416, DOI 10.1016/j.neuroimage.2013.04.084; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; Munte TF, 2002, NAT REV NEUROSCI, V3, P473, DOI 10.1038/nrn843; NEHER A, 1961, ELECTROEN CLIN NEURO, V13, P449, DOI 10.1016/0013-4694(61)90014-1; Niso G, 2013, NEUROINFORMATICS, V11, P405, DOI 10.1007/s12021-013-9186-1; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Nomura T, 2006, J GASTROEN HEPATOL, V21, P54, DOI 10.1111/j.1440-1746.2005.04204.x; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; OSTER G, 1973, SCI AM, V229, P94, DOI 10.1038/scientificamerican1073-94; PALMER AR, 1986, HEARING RES, V24, P1, DOI 10.1016/0378-5955(86)90002-X; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; Pearce MT, 2010, NEUROIMAGE, V50, P302, DOI 10.1016/j.neuroimage.2009.12.019; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; PERROTT DR, 1977, J ACOUST SOC AM, V61, P1288, DOI 10.1121/1.381430; Pfurtscheller G, 1996, INT J PSYCHOPHYSIOL, V24, P39, DOI 10.1016/S0167-8760(96)00066-9; Picton TW, 2003, INT J AUDIOL, V42, P177, DOI 10.3109/14992020309101316; PLUTCHIK R, 1966, PERCEPT MOTOR SKILL, V23, P955, DOI 10.2466/pms.1966.23.3.955; Porz S, 2014, CHAOS, V24, DOI 10.1063/1.4890568; Pratt H, 2009, CLIN NEUROPHYSIOL, V120, P1514, DOI 10.1016/j.clinph.2009.06.014; Quraan MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068609; Regan D., 1989, HUMAN BRAIN ELECTROP; Reiterer S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00334; ROGERS LJ, 1981, J NEUROSCI METH, V4, P257, DOI 10.1016/0165-0270(81)90037-6; ROSE JE, 1967, J NEUROPHYSIOL, V30, P769, DOI 10.1152/jn.1967.30.4.769; Rosenfeld JP, 1997, APPL PSYCHOPHYS BIOF, V22, P3, DOI 10.1023/A:1026233624772; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; Schwarz DWF, 2005, CLIN NEUROPHYSIOL, V116, P658, DOI 10.1016/j.clinph.2004.09.014; Shahin AJ, 2008, NEUROIMAGE, V41, P113, DOI 10.1016/j.neuroimage.2008.01.067; Stam CJ, 2012, CLIN NEUROPHYSIOL, V123, P1067, DOI 10.1016/j.clinph.2012.01.011; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Tewarie P, 2014, NEUROIMAGE, V88, P308, DOI 10.1016/j.neuroimage.2013.10.022; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Tobias JV, 1963, REP CIV AEROMED RES, P1; Toman J, 1941, J NEUROPHYSIOL, V4, P51, DOI 10.1152/jn.1941.4.1.51; van Straaten ECW, 2013, EUR NEUROPSYCHOPHARM, V23, P7, DOI 10.1016/j.euroneuro.2012.10.010; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; VanRullen R, 2006, J NEUROSCI, V26, P502, DOI 10.1523/JNEUROSCI.4654-05.2006; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vernon D, 2012, INT J PSYCHOPHYSIOLO; Vicente R, 2008, P NATL ACAD SCI USA, V105, P17157, DOI 10.1073/pnas.0809353105; Vinck M, 2011, NEUROIMAGE, V55, P1548, DOI 10.1016/j.neuroimage.2011.01.055; WALTER WG, 1946, NATURE, V158, P540, DOI 10.1038/158540a0; Weisz N, 2005, PLOS MED, V2, P546, DOI 10.1371/journal.pmed.0020153; Weisz N, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00073; Williams J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-21; Williams JH, 2001, NEUROSCIENCE, V104, P283, DOI 10.1016/S0306-4522(00)00579-0; ZWISLOCKI J, 1953, J ACOUST SOC AM, V25, P752, DOI 10.1121/1.1907171	106	18	18	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129486	10.1371/journal.pone.0129486	http://dx.doi.org/10.1371/journal.pone.0129486			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26065708	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000356327000083
J	Perez-Roca, F; Rodrigo-Morales, E; Garzon, I; Oliveira, AC; Martin-Piedra, MA; Carriel, V; Ortiz-Perez, AI; Sanchez-Montesinos, I; Campos, A; Alaminos, M				Perez-Roca, Fernando; Rodrigo-Morales, Esther; Garzon, Ingrid; Oliveira, Ana-Celeste; Martin-Piedra, Miguel-Angel; Carriel, Victor; Ortiz-Perez, Ana-Isabel; Sanchez-Montesinos, Indalecio; Campos, Antonio; Alaminos, Miguel			Effects of Four Formulations of Prostaglandin Analogs on Eye Surface Cells. A Comparative Study	PLOS ONE			English	Article							PRESERVATIVE-FREE TAFLUPROST; OPEN-ANGLE GLAUCOMA; BENZALKONIUM CHLORIDE; IN-VITRO; OCULAR HYPERTENSION; TOPICAL PROSTAGLANDINS; CONJUNCTIVAL HYPEREMIA; CHANG CONJUNCTIVAL; EPITHELIAL-CELLS; LATANOPROST	We evaluated the cytotoxic effects of four prostaglandin analogs (PGAs) used to treat glaucoma. First we established primary cultures of conjunctival stromal cells from healthy donors. Then cell cultures were incubated with different concentrations (0, 0.1, 1, 5, 25, 50 and 100%) of commercial formulations of bimatoprost, tafluprost, travoprost and latanoprost for increasing periods (5 and 30 min, 1 h, 6 h and 24 h) and cell survival was assessed with three different methods: WST-1, MTT and calcein/AM-ethidium homodimer-1 assays. Our results showed that all PGAs were associated with a certain level of cell damage, which correlated significantly with the concentration of PGA used, and to a lesser extent with culture time. Tafluprost tended to be less toxic than bimatoprost, travoprost and latanoprost after all culture periods. The results for WST-1, MTT and calcein/AM-ethidium homodimer-1 correlated closely. When the average lethal dose 50 was calculated, we found that the most cytotoxic drug was latanoprost, whereas tafluprost was the most sparing of the ocular surface in vitro. These results indicate the need to design novel PGAs with high effectiveness but free from the cytotoxic effects that we found, or at least to obtain drugs that are functional at low dosages. The fact that the commercial formulation of tafluprost used in this work was preservative-free may support the current tendency to eliminate preservatives from eye drops for clinical use.	[Perez-Roca, Fernando; Ortiz-Perez, Ana-Isabel] Hosp Gen Basico Baza, E-18800 Granada, Spain; [Perez-Roca, Fernando] Univ Granada, PhD Program Biomed, Granada 18012, Spain; [Rodrigo-Morales, Esther] Hosp La Inmaculada, Huercal Overa 04600, Almeria, Spain; [Garzon, Ingrid; Oliveira, Ana-Celeste; Martin-Piedra, Miguel-Angel; Carriel, Victor; Campos, Antonio; Alaminos, Miguel] Univ Granada, Dept Histol, Tissue Engn Grp, Granada 18012, Spain; [Garzon, Ingrid; Martin-Piedra, Miguel-Angel; Carriel, Victor; Campos, Antonio; Alaminos, Miguel] Inst Invest Biosanitaria Ibs GRANADA, Granada 18012, Spain; [Sanchez-Montesinos, Indalecio] Univ Granada, Dept Human Anat & Embryol, Granada 18012, Spain	University of Granada; University of Granada; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada	Alaminos, M (corresponding author), Univ Granada, Dept Histol, Tissue Engn Grp, Granada 18012, Spain.	malaminos@ugr.es	Martin-Piedra, Miguel Angel/F-3664-2019; Oliveira, Ana Carolina/GRF-1435-2022; ALAMINOS, MIGUEL/N-9960-2016; ARAYA, VICTOR CARRIEL/H-9425-2018	Martin-Piedra, Miguel Angel/0000-0002-4639-3175; ALAMINOS, MIGUEL/0000-0003-4876-2672; ARAYA, VICTOR CARRIEL/0000-0002-8114-5644; Campos, A/0000-0003-4061-8182	Spanish Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I+D+I) from the Spanish Ministry of Economy and Competitiveness (Instituto de Salud Carlos III) [FIS PI11/1582, FIS PI14/0955]; FEDER; European Union; Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia, Spain (Proyectos de Excelencia) [P10-CTS-6060]	Spanish Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I+D+I) from the Spanish Ministry of Economy and Competitiveness (Instituto de Salud Carlos III); FEDER(European Commission); European Union(European Commission); Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia, Spain (Proyectos de Excelencia)(Junta de Andalucia)	This study was supported by the Spanish Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I+D+I) from the Spanish Ministry of Economy and Competitiveness (Instituto de Salud Carlos III), grants FIS PI11/1582 and FIS PI14/0955 (co-financed by FEDER funds, European Union) and by Grant P10-CTS-6060 from the Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia, Spain (Proyectos de Excelencia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson MB, 2003, ADV THER, V20, P1, DOI 10.1007/BF02850114; Alm A, 2014, CLIN OPHTHALMOL, V8, P1967, DOI 10.2147/OPTH.S59162; Baudouin C, 2004, OPHTHALMOLOGY, V111, P2186, DOI 10.1016/j.ophtha.2004.06.023; Baudouin C, 2010, PROG RETIN EYE RES, V29, P312, DOI 10.1016/j.preteyeres.2010.03.001; Bean GW, 2008, SURV OPHTHALMOL, V53, pS69, DOI 10.1016/j.survophthal.2008.08.012; Bolivar G, 2015, ACTA OPHTHALMOL, V93, pE495, DOI 10.1111/aos.12689; Brasnu E, 2008, MOL VIS, V14, P394; Brasnu E, 2008, CURR EYE RES, V33, P303, DOI 10.1080/02713680801971857; Brignole-Baudouin F, 2011, CURR EYE RES, V36, P979, DOI 10.3109/02713683.2011.578781; BROADWAY DC, 1994, ARCH OPHTHALMOL-CHIC, V112, P1446, DOI 10.1001/archopht.1994.01090230060021; Oliveira AC, 2014, EXP BIOL MED, V239, P71, DOI 10.1177/1535370213503274; CRAWFORD K, 1987, ARCH OPHTHALMOL-CHIC, V105, P1112, DOI 10.1001/archopht.1987.01060080114039; Dutkiewicz R, 2000, EXP EYE RES, V70, P563, DOI 10.1006/exer.1999.0819; Feldman RM, 2003, J OCUL PHARMACOL TH, V19, P23, DOI 10.1089/108076803762718088; Guenoun JM, 2005, INVEST OPHTH VIS SCI, V46, P4594, DOI 10.1167/iovs.05-0776; Hu DN, 2000, EXP EYE RES, V70, P113, DOI 10.1006/exer.1999.0760; Jaenen N, 2007, EUR J OPHTHALMOL, V17, P341, DOI 10.1177/112067210701700311; Jean MD, 1999, INVEST OPHTH VIS SCI, V40, P619; Kim Eun Joo, 2013, Korean J Ophthalmol, V27, P446, DOI 10.3341/kjo.2013.27.6.446; Le Bourlais C, 1998, PROG RETIN EYE RES, V17, P33, DOI 10.1016/S1350-9462(97)00002-5; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Liang H, 2008, BRIT J OPHTHALMOL, V92, P1275, DOI 10.1136/bjo.2008.138768; Lindquist NG, 1999, EXP EYE RES, V69, P431, DOI 10.1006/exer.1999.0718; Michee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072459; Netland PA, 2001, AM J OPHTHALMOL, V132, P472, DOI 10.1016/S0002-9394(01)01177-1; Noecker RJ, 2004, CORNEA, V23, P490, DOI 10.1097/01.ico.0000116526.57227.82; Pellinen P, 2012, CURR EYE RES, V37, P145, DOI 10.3109/02713683.2011.626909; Pisella PJ, 2002, BRIT J OPHTHALMOL, V86, P418, DOI 10.1136/bjo.86.4.418; Pisella PJ, 2000, OPHTHALMIC RES, V32, P3, DOI 10.1159/000055579; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Radcliffe NM, 2014, CLIN OPHTHALMOL, V8, P2541, DOI 10.2147/OPTH.S76053; Schachtschabel U, 2000, Curr Opin Ophthalmol, V11, P112; Schmidl D, 2015, J OCUL PHARMACOL TH, V31, P63, DOI 10.1089/jop.2014.0067; Sjoquist B, 1998, DRUG METAB DISPOS, V26, P745; Spittel H, 2014, CYTOGENET GENOME RES, V142, P151, DOI 10.1159/000360776; Stalmans I, 2013, EUR J OPHTHALMOL, V23, P518, DOI 10.5301/ejo.5000270; Stewart WC, 2003, AM J OPHTHALMOL, V135, P314, DOI 10.1016/S0002-9394(02)01980-3; Toris CB, 2008, SURV OPHTHALMOL, V53, pS107, DOI 10.1016/j.survophthal.2008.08.010; Yamazaki S, 2010, JPN J OPHTHALMOL, V54, P7, DOI 10.1007/s10384-009-0754-8	39	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129419	10.1371/journal.pone.0129419	http://dx.doi.org/10.1371/journal.pone.0129419			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26067827	Green Published, Green Submitted, gold			2022-12-26	WOS:000356327000073
J	Phannasil, P; Thuwajit, C; Warnnissorn, M; Wallace, JC; MacDonald, MJ; Jitrapakdee, S				Phannasil, Phatchariya; Thuwajit, Chanitra; Warnnissorn, Malee; Wallace, John C.; MacDonald, Michael J.; Jitrapakdee, Sarawut			Pyruvate Carboxylase Is Up-Regulated in Breast Cancer and Essential to Support Growth and Invasion of MDA-MB-231 Cells	PLOS ONE			English	Article							INSULIN-SECRETION; FUNCTIONAL EXPRESSION; GLUTAMINE-METABOLISM; METASTASIS; MYC; HYPOXIA; TRANSFORMATION; CATAPLEROSIS; ANAPLEROSIS; OXIDATION	Pyruvate carboxylase (PC) is an anaplerotic enzyme that catalyzes the carboxylation of pyruvate to oxaloacetate, which is crucial for replenishing tricarboxylic acid cycle intermediates when they are used for biosynthetic purposes. We examined the expression of PC by immunohistochemistry of paraffin-embedded breast tissue sections of 57 breast cancer patients with different stages of cancer progression. PC was expressed in the cancerous areas of breast tissue at higher levels than in the non-cancerous areas. We also found statistical association between the levels of PC expression and tumor size and tumor stage (P < 0.05). The involvement of PC with these two parameters was further studied in four breast cancer cell lines with different metastatic potentials; i.e., MCF-7, SKBR3 (low metastasis), MDA-MB-435 (moderate metastasis) and MDA-MB-231 (high metastasis). The abundance of both PC mRNA and protein in MDA-MB-231 and MDA-MB-435 cells was 2-3-fold higher than that in MCF-7 and SKBR3 cells. siRNA-mediated knockdown of PC expression in MDA-MB-231 and MDA-MB-435 cells resulted in a 50% reduction of cell proliferation, migration and in vitro invasion ability, under both glutamine-dependent and glutamine-depleted conditions. Overexpression of PC in MCF-7 cells resulted in a 2-fold increase in their proliferation rate, migration and invasion abilities. Taken together the above results suggest that anaplerosis via PC is important for breast cancer cells to support their growth and motility.	[Phannasil, Phatchariya; Jitrapakdee, Sarawut] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand; [Thuwajit, Chanitra] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Immunol, Bangkok 10700, Thailand; [Warnnissorn, Malee] Mahidol Univ, Fac Med, Dept Pathol, Bangkok 10700, Thailand; [Wallace, John C.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [MacDonald, Michael J.] Univ Wisconsin, Sch Med & Publ Hlth, Childrens Diabet Ctr, Madison, WI USA	Mahidol University; Mahidol University; Mahidol University; University of Adelaide; University of Wisconsin System; University of Wisconsin Madison	Jitrapakdee, S (corresponding author), Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand.	sarawut.jit@mahidol.ac.th	Thuwajit, Chanitra/AAT-7933-2021; , John/AAP-5150-2020	MacDonald, Michael/0000-0002-0201-9245; Thuwajit, Chanitra/0000-0001-9506-6405	Thailand Research Fund [BRG5780007]; RGJ-PhD scholarship from Thailand Research Fund [PHD/0142/2552]; Mahidol University	Thailand Research Fund(Thailand Research Fund (TRF)); RGJ-PhD scholarship from Thailand Research Fund; Mahidol University	This work was supported by grant BRG5780007 from the Thailand Research Fund and Mahidol University to SJ. PP was supported by the RGJ-PhD scholarship (PHD/0142/2552) from the Thailand Research Fund. The funders had no role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; EAGLE H, 1955, SCIENCE, V122, P501, DOI 10.1126/science.122.3168.501; Fan TWM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-41; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Graham KA, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.3.12207; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Henry O, 2011, METAB ENG, V13, P499, DOI 10.1016/j.ymben.2011.05.004; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Hua YQ, 2011, J PROTEOME RES, V10, P3513, DOI 10.1021/pr200147g; Izquierdo-Garcia JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108289; Jitrapakdee S, 1999, BIOCHEM BIOPH RES CO, V266, P512, DOI 10.1006/bbrc.1999.1846; Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709; Kim JW, 2007, MOL CELL BIOL, V27, P7381, DOI 10.1128/MCB.00440-07; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kim SH, 2007, APPL MICROBIOL BIOT, V76, P659, DOI 10.1007/s00253-007-1041-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee SY, 2012, CANCER RES, V72, P3607, DOI 10.1158/0008-5472.CAN-12-0006; Leithner K, 2015, ONCOGENE, V34, P1044, DOI 10.1038/onc.2014.47; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu X, 2010, J BIOL CHEM, V285, P9317, DOI 10.1074/jbc.C110.104448; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; Mego M, 2010, NAT REV CLIN ONCOL, V7, P693, DOI 10.1038/nrclinonc.2010.171; Mullen AR, 2014, CELL REP, V7, P1679, DOI 10.1016/j.celrep.2014.04.037; Nieman KM, 2013, BBA-MOL CELL BIOL L, V1831, P1533, DOI 10.1016/j.bbalip.2013.02.010; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; ROHDE M, 1991, ARCH BIOCHEM BIOPHYS, V290, P197, DOI 10.1016/0003-9861(91)90608-L; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; Scott DA, 2011, J BIOL CHEM, V286, P42626, DOI 10.1074/jbc.M111.282046; Sellers K, 2015, J CLIN INVEST, V125, P687, DOI 10.1172/JCI72873; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thonpho A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055139; Thonpho A, 2010, BIOCHEM BIOPH RES CO, V393, P714, DOI 10.1016/j.bbrc.2010.02.067; Ushio-Fukai M, 2008, CANCER LETT, V266, P37, DOI 10.1016/j.canlet.2008.02.044; Vallee C, 2014, J BIOTECHNOL, V169, P63, DOI 10.1016/j.jbiotec.2013.11.002; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8; Yang M, 2011, J CLIN INVEST, V12, P3652; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508	53	64	66	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129848	10.1371/journal.pone.0129848	http://dx.doi.org/10.1371/journal.pone.0129848			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070193	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000114
J	Birko, S; Dove, ES; Ozdemir, V				Birko, Stanislav; Dove, Edward S.; Oezdemir, Vural			A Delphi Technology Foresight Study: Mapping Social Construction of Scientific Evidence on Metagenomics Tests for Water Safety	PLOS ONE			English	Article							PERSONALIZED MEDICINE; PATHOGENIC BACTERIA; SCIENCE; GOVERNANCE; PHARMACOGENOMICS; ASSOCIATION; FRAMEWORKS; INNOVATION; DIVERSITY; SOCIOLOGY	Access to clean water is a grand challenge in the 21st century. Water safety testing for pathogens currently depends on surrogate measures such as fecal indicator bacteria (e.g., E. coli). Metagenomics concerns high-throughput, culture-independent, unbiased shotgun sequencing of DNA from environmental samples that might transform water safety by detecting waterborne pathogens directly instead of their surrogates. Yet emerging innovations such as metagenomics are often fiercely contested. Innovations are subject to shaping/construction not only by technology but also social systems/values in which they are embedded, such as experts' attitudes towards new scientific evidence. We conducted a classic three-round Delphi survey, comprised of 107 questions. A multidisciplinary expert panel (n = 24) representing the continuum of discovery scientists and policymakers evaluated the emergence of metagenomics tests. To the best of our knowledge, we report here the first Delphi foresight study of experts' attitudes on (1) the top 10 priority evidentiary criteria for adoption of metagenomics tests for water safety, (2) the specific issues critical to governance of metagenomics innovation trajectory where there is consensus or dissensus among experts, (3) the anticipated time lapse from discovery to practice of metagenomics tests, and (4) the role and timing of public engagement in development of metagenomics tests. The ability of a test to distinguish between harmful and benign waterborne organisms, analytical/clinical sensitivity, and reproducibility were the top three evidentiary criteria for adoption of metagenomics. Experts agree that metagenomic testing will provide novel information but there is dissensus on whether metagenomics will replace the current water safety testing methods or impact the public health end points (e.g., reduction in boil water advisories). Interestingly, experts view the publics relevant in a "downstream capacity" for adoption of metagenomics rather than a co-productionist role at the "upstream" scientific design stage of metagenomics tests. In summary, these findings offer strategic foresight to govern metagenomics innovations symmetrically: by identifying areas where acceleration (e.g., consensus areas) and deceleration/reconsideration (e.g., dissensus areas) of the innovation trajectory might be warranted. Additionally, we show how scientific evidence is subject to potential social construction by experts' value systems and the need for greater upstream public engagement on metagenomics innovations.	[Oezdemir, Vural] Gaziantep Univ, Fac Commun, TR-27310 Sehitkamil, Gaziantep, Turkey; [Oezdemir, Vural] Gaziantep Univ, Dept Ind Engn, Off President Int Technol & Innovat Policy, TR-27310 Sehitkamil, Gaziantep, Turkey; [Oezdemir, Vural] Amrita Univ, Amrita Vishwa Vidyapeetham, Sch Biotechnol, Vallikavu, Kerala, India; [Birko, Stanislav] McGill Univ, Fac Med, Dept Human Genet, Ctr Genom & Policy, Montreal, PQ, Canada; [Dove, Edward S.] Univ Edinburgh, J Kenyon Mason Inst Med Life Sci & Law, Sch Law, Edinburgh, Midlothian, Scotland	Gaziantep University; Gaziantep University; Amrita Vishwa Vidyapeetham; McGill University; University of Edinburgh	Ozdemir, V (corresponding author), Gaziantep Univ, Fac Commun, Univ Bulvari, TR-27310 Sehitkamil, Gaziantep, Turkey.	vural.ozdemir@alumni.utoronto.ca			Genome Canada	Genome Canada(Genome Canada)	This work was supported by a research grant on technology governance to Dr. Vural Ozdemir from Genome Canada. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akondi KB, 2013, OMICS, V17, P61, DOI 10.1089/omi.2012.0082; Beech B, 1997, J ADV NURS, V25, P331, DOI 10.1046/j.1365-2648.1997.1997025331.x; Birch K, 2013, SCI TECHNOL HUM VAL, V38, P299, DOI 10.1177/0162243912442398; Bonneuil C, 2014, SOC STUD SCI, V44, P901, DOI 10.1177/0306312714548258; Calvert J, 2013, BIOSOCIETIES, V8, P466, DOI 10.1057/biosoc.2013.27; Chow CET, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00265; Collingridge D, 1980, SOCIAL CONTROL TECHN; Cook C, 2013, CAN WATER RESOUR J, V38, P185, DOI 10.1080/07011784.2013.822186; Dandara C, 2014, OMICS, V18, P733, DOI 10.1089/omi.2014.0145; De Vries R, 2004, J LAW MED ETHICS, V32, P279, DOI 10.1111/j.1748-720X.2004.tb00475.x; Delbecq AL, 1975, J HUMAN SCI; Dove ES, 2014, EMBO REP, V15, P462, DOI 10.1002/embr.201438683; Dove Edward S., 2013, Current Pharmacogenomics & Personalized Medicine, V11, P253; Dove ES, 2013, PERS MED, V10, P213, DOI 10.2217/PME.13.10; Fancello L, 2013, ISME J, V7, P359, DOI 10.1038/ismej.2012.101; Ferguson AS, 2012, SCI TOTAL ENVIRON, V431, P314, DOI 10.1016/j.scitotenv.2012.05.060; Fisher E, 2011, SCI ENG ETHICS, V17, P607, DOI 10.1007/s11948-011-9331-x; Goldstein ST, 1996, ANN INTERN MED, V124, P459, DOI 10.7326/0003-4819-124-5-199603010-00001; Grantham TE, 2010, FRESHWATER BIOL, V55, P188, DOI 10.1111/j.1365-2427.2009.02379.x; Green B, 1999, HEALTH SOC CARE COMM, V7, P198, DOI 10.1046/j.1365-2524.1999.00176.x; GRIMES DJ, 1986, MICROBIOL SCI, V3, P324; Guston D.H., 2002, TECHNOL SOC, V24, P93, DOI [DOI 10.1016/S0160-791X(01)00047-1, https://doi.org/10.1016/S0160-791X(01)00047-1]; Guston DH, 2012, MINERVA, V50, P363, DOI 10.1007/s11024-012-9204-8; Haffeld Just, 2013, Current Pharmacogenomics & Personalized Medicine, V11, P309; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Harwood VJ, 2005, APPL ENVIRON MICROB, V71, P3163, DOI 10.1128/AEM.71.6.3163-3170.2005; Hekim N, 2014, OMICS, V18, P415, DOI 10.1089/omi.2014.0079; Hoover RS, 2011, IEEE T PROF COMMUN, V54, P68, DOI 10.1109/TPC.2009.2036896; Jasanoff S, 2013, GUARDIAN; Jin H, 2014, ANN MICROBIOL, V64, P689, DOI 10.1007/s13213-013-0704-z; McQuaig S, 2012, APPL ENVIRON MICROB, V78, P6423, DOI 10.1128/AEM.00024-12; Mead D., 2001, NURSE RES, V8, P4, DOI DOI 10.7748/nr2001.07.8.4.4.c6162; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING GE; Miller RR, 2013, GENOME MED, V5, DOI 10.1186/gm485; Neelakanta Girish, 2013, Microbiol Insights, V6, P37, DOI 10.4137/MBI.S10819; Ngueng Feze I, 2014, J ENV LAW PRACTICE, V26, P201; Ozdemir V, 2013, OMICS, V17, P1, DOI 10.1089/omi.2012.0111; Ostrom, 2015, GOVERNING COMMONS EV, DOI DOI 10.1017/CBO9780511807763; Ostrom E, 1999, ANNU REV POLIT SCI, V2, P493, DOI 10.1146/annurev.polisci.2.1.493; Ozdemir V, 2015, OXFORD TXB GLOBAL PU; Ozdemir V, 2014, ROUTLEDGE HDB GLOBAL, DOI [10.4324/9781315818719.ch6, DOI 10.4324/9781315818719.CH6]; Ozdemir V, 2015, NATURE INDI IN PRESS; Ozdemir V, 2015, AM J BIOETHICS, V15, P64, DOI 10.1080/15265161.2015.1021976; Ozdemir V, 2015, EMBO REP, V16, P267, DOI 10.15252/embr.201439548; Ozdemir V, 2014, PERS MED, V11, P687, DOI 10.2217/pme.14.70; Ozdemir V, 2014, OMICS, V18, P211, DOI 10.1089/omi.2014.0029; Ozdemir V, 2014, OMICS, V18, P1, DOI 10.1089/omi.2013.0170; Ozdemir V, 2011, OMICS, V15, P637, DOI 10.1089/omi.2011.0087; PACE NR, 1985, ASM NEWS, V51, P4; Petersen A, 2013, SOC SCI MED, V98, P264, DOI 10.1016/j.socscimed.2012.12.030; Port JA, 2014, ENVIRON HEALTH PERSP, V122, P222, DOI 10.1289/ehp.1307009; Qu XL, 2013, ACCOUNTS CHEM RES, V46, P834, DOI 10.1021/ar300029v; Rajan K.S., 2006, BIOCAPITAL CONSTITUT; Rose N, 2013, THEOR CULT SOC, V30, P3, DOI 10.1177/0263276412456569; Rowe G, 1999, INT J FORECASTING, V15, P353, DOI 10.1016/S0169-2070(99)00018-7; Staley C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00524; STALEY JT, 1985, ANNU REV MICROBIOL, V39, P321, DOI 10.1146/annurev.mi.39.100185.001541; Taylor-Alexander S, 2013, NEW GENET SOC, V32, P333, DOI 10.1080/14636778.2013.845076; Thoreau F, 2012, POLITICA SOC, V11, P205, DOI DOI 10.5007/2175-7984.2012v11n20p205; Tomaru A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096274; Tutton R, 2011, SOCIOL HEALTH ILL, V33, P1081, DOI 10.1111/j.1467-9566.2011.01348.x; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wicks P, 2011, NAT BIOTECHNOL, V29, P411, DOI 10.1038/nbt.1837; Yearley S, 2004, MAKING SENSE SCI UND; Zhao FF, 2014, OMICS, V18, P222, DOI 10.1089/omi.2013.0108; Zizek S, 2011, COMMUNICATION	67	14	15	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129706	10.1371/journal.pone.0129706	http://dx.doi.org/10.1371/journal.pone.0129706			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK3FB	26066837	Green Published, gold, Green Submitted			2022-12-26	WOS:000356100900073
J	Cao, MC; Xu, HG; Le, ZF; Zhu, MC; Cao, Y				Cao, Mingchang; Xu, Haigen; Le, Zhifang; Zhu, Mingchang; Cao, Yun			A Multi-Scale Approach to Investigating the Red-Crowned Crane-Habitat Relationship in the Yellow River Delta Nature Reserve, China: Implications for Conservation	PLOS ONE			English	Article							SPECIES-ENVIRONMENT RELATIONSHIPS; BIOSPHERE RESERVE; GRUS-JAPONENSIS; ECOLOGY; SELECTION; SCALE; MODELS; BIRDS; DECOMPOSITION; REGRESSION	The red-crowned crane (Grus japonensis (Statius Muller, 1776)) is a rare and endangered species that lives in wetlands. In this study, we used variance partitioning and hierarchical partitioning methods to explore the red-crowned crane-habitat relationship at multiple scales in the Yellow River Delta Nature Reserve (YRDNR). In addition, we used habitat modeling to identify the cranes' habitat distribution pattern and protection gaps in the YRDNR. The variance partitioning results showed that habitat variables accounted for a substantially larger total and pure variation in crane occupancy than the variation accounted for by spatial variables at the first level. Landscape factors had the largest total (45.13%) and independent effects (17.42%) at the second level. The hierarchical partitioning results showed that the percentage of seepweed tidal flats were the main limiting factor at the landscape scale. Vegetation coverage contributed the greatest independent explanatory power at the plot scale, and patch area was the predominant factor at the patch scale. Our habitat modeling results showed that crane suitable habitat covered more than 26% of the reserve area and that there remained a large protection gap with an area of 20,455 ha, which accounted for 69.51% of the total suitable habitat of cranes. Our study indicates that landscape and plot factors make a relatively large contribution to crane occupancy and that the focus of conservation effects should be directed toward landscape-and plot-level factors by enhancing the protection of seepweed tidal flats, tamarisk-seepweed tidal flats, reed marshes and other natural wetlands. We propose that efforts should be made to strengthen wetland restoration, adjust functional zoning maps, and improve the management of human disturbance in the YRDNR.	[Cao, Mingchang; Xu, Haigen; Le, Zhifang; Cao, Yun] Minist Environm Protect, Nanjing Inst Environm Sci, Nanjing, Jiangsu, Peoples R China; [Zhu, Mingchang] Hubei Univ, Wuhan, Hubei Province, Peoples R China	Hubei University	Cao, MC (corresponding author), Minist Environm Protect, Nanjing Inst Environm Sci, Nanjing, Jiangsu, Peoples R China.	caomingc@163.com			National Natural Science Foundation of China [41101424, 31461143033]; Jiangsu Province Natural Science Foundation [BK2011083]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Natural Science Foundation(Natural Science Foundation of Jiangsu Province)	This study was funded by the National Natural Science Foundation of China (No. 41101424 and 31461143033) and the Jiangsu Province Natural Science Foundation (No. BK2011083).	Anderson MJ, 1998, AUST J ECOL, V23, P158, DOI 10.1111/j.1442-9993.1998.tb00713.x; Augustin NH, 1996, J APPL ECOL, V33, P339, DOI 10.2307/2404755; Bamford M., 2008, MIGRATORY SHOREBIRDS; Battin J, 2006, CONDOR, V108, P59, DOI 10.1650/0010-5422(2006)108[0059:CCATDA]2.0.CO;2; Benitez-Lopez A, 2014, ENVIRON CONSERV, V41, P132, DOI 10.1017/S0376892913000192; Best LB, 1986, WILDLIFE 2000 MODELI, P209; Bi XL, 2011, OCEAN COAST MANAGE, V54, P256, DOI 10.1016/j.ocecoaman.2010.12.005; Bivand R, 2012, SPDEP SPATIAL DEPEND; Cao Ming-chang, 2008, Journal of Forestry Research (Harbin), V19, P141, DOI 10.1007/s11676-008-0024-5; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cui BS, 2009, ECOL ENG, V35, P1090, DOI 10.1016/j.ecoleng.2009.03.022; Cushman SA, 2004, ECOL APPL, V14, P1090, DOI 10.1890/03-5131; Cushman SA, 2002, LANDSCAPE ECOL, V17, P637, DOI 10.1023/A:1021571603605; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fletcher RJ, 2008, LANDSCAPE ECOL, V23, P727, DOI 10.1007/s10980-008-9233-8; Freeman E, 2012, PRESECNEABSENCE PRES; Graf RF, 2005, LANDSCAPE ECOL, V20, P703, DOI 10.1007/s10980-005-0063-7; Grand J, 2003, BIOL CONSERV, V112, P307, DOI 10.1016/S0006-3207(02)00323-3; Heikkinen RK, 2005, P ROY SOC B-BIOL SCI, V272, P2203, DOI 10.1098/rspb.2005.3212; Heikkinen RK, 2004, J APPL ECOL, V41, P824, DOI 10.1111/j.0021-8901.2004.00938.x; IUCN, IUCN RED LIST THREAT; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Jones J, 2001, AUK, V118, P557, DOI 10.1642/0004-8038(2001)118[0557:HSSIAE]2.0.CO;2; Lawler JJ, 2006, CONDOR, V108, P47, DOI 10.1650/0010-5422(2006)108[0047:AVATIM]2.0.CO;2; Lee SD, 2007, BIOL CONSERV, V138, P286, DOI 10.1016/j.biocon.2007.04.007; Lemaitre J, 2012, BIODIVERS CONSERV, V21, P3355, DOI 10.1007/s10531-012-0366-3; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Li DL, 2014, BIRD CONSERV INT, V24, P416, DOI 10.1017/S0959270913000555; Li DL, 2013, BIRD CONSERV INT, V23, P184, DOI 10.1017/S0959270913000099; Li DL, 2011, ESTUAR COAST SHELF S, V91, P325, DOI 10.1016/j.ecss.2010.10.028; Li Zhongqiu, 2011, Chinese Birds, V2, P147; Liu CY, 2013, CURR ZOOL, V59, P604, DOI 10.1093/czoolo/59.5.604; Ma ZJ, 2009, J APPL ECOL, V46, P527, DOI 10.1111/j.1365-2664.2008.01528.x; Ma ZJ, 1999, IBIS, V141, P135, DOI 10.1111/j.1474-919X.1999.tb04272.x; Mac Nally R, 2000, BIODIVERS CONSERV, V9, P655, DOI 10.1023/A:1008985925162; Mac Nally R, 2002, BIODIVERS CONSERV, V11, P1397, DOI 10.1023/A:1016250716679; MaGarigal K, 2012, FRAGSTATS SPATIAL PA; R Development Core Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Shu Ying, 2006, Shengtaixue Zazhi, V25, P954; Su Liying, 2012, Chinese Birds, V3, P147; Sun Xian-bin, 2011, Shengtaixue Zazhi, V30, P694; Walsh C, 2008, PART HIERARCHICAL PA; Wang H, 2013, REG ENVIRON CHANGE, V13, P115, DOI 10.1007/s10113-012-0325-2; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Xiao D.N., 2001, LANDSCAPE ECOLOGY RE; ZHAO YM, 1995, SCI SURVEY YELLOW RI; Zou Hongfei, 2007, Journal of Northeast Forestry University, V35, P56	47	13	14	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129833	10.1371/journal.pone.0129833	http://dx.doi.org/10.1371/journal.pone.0129833			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26065417	Green Published, gold, Green Submitted			2022-12-26	WOS:000356100900083
J	Kumbhare, SV; Dhotre, DP; Dhar, SK; Jani, K; Apte, DA; Shouche, YS; Sharma, A				Kumbhare, Shreyas V.; Dhotre, Dhiraj P.; Dhar, Sunil Kumar; Jani, Kunal; Apte, Deepak A.; Shouche, Yogesh S.; Sharma, Avinash			Insights into Diversity and Imputed Metabolic Potential of Bacterial Communities in the Continental Shelf of Agatti Island	PLOS ONE			English	Article							SP-NOV.; GEN.-NOV.; LAKSHADWEEP ARCHIPELAGO; ALTEROMONAS-MACLEODII; MICROBIAL COMMUNITIES; EMENDED DESCRIPTION; MARINE-SEDIMENTS; KAVARATTI ISLAND; GENOME SEQUENCE; ORGANIC-MATTER	Marine microbes play a key role and contribute largely to the global biogeochemical cycles. This study aims to explore microbial diversity from one such ecological hotspot, the continental shelf of Agatti Island. Sediment samples from various depths of the continental shelf were analyzed for bacterial diversity using deep sequencing technology along with the culturable approach. Additionally, imputed metagenomic approach was carried out to understand the functional aspects of microbial community especially for microbial genes important in nutrient uptake, survival and biogeochemical cycling in the marine environment. Using culturable approach, 28 bacterial strains representing 9 genera were isolated from various depths of continental shelf. The microbial community structure throughout the samples was dominated by phylum Proteobacteria and harbored various bacterioplanktons as well. Significant differences were observed in bacterial diversity within a short region of the continental shelf (1-40 meters) i.e. between upper continental shelf samples (UCS) with lesser depths (i.e. 1-20 meters) and lower continental shelf samples (LCS) with greater depths (i.e. 25-40 meters). By using imputed metagenomic approach, this study also discusses several adaptive mechanisms which enable microbes to survive in nutritionally deprived conditions, and also help to understand the influence of nutrition availability on bacterial diversity.	[Kumbhare, Shreyas V.; Dhotre, Dhiraj P.; Dhar, Sunil Kumar; Jani, Kunal; Shouche, Yogesh S.; Sharma, Avinash] Natl Ctr Cell Sci, Microbial Culture Collect, Pune 411007, Maharashtra, India; [Apte, Deepak A.] Bombay Nat Hist Soc, Conservat Dept, Bombay 400001, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Sharma, A (corresponding author), Natl Ctr Cell Sci, Microbial Culture Collect, Pune 411007, Maharashtra, India.	avinash@nccs.res.in	Sharma, Avinash/AAD-9549-2020; Dhar, Sunil/GQH-3927-2022	Sharma, Avinash/0000-0001-9372-0178; Jani, Kunal/0000-0001-7971-4337; Apte, Deepak/0000-0001-5565-4659; Dhotre, Dhiraj/0000-0002-5000-7396	Department of Biotechnology (DBT), Government of India; Microbial Culture Collection Project [BT/PR10054/NDB/52/94/2007]	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Microbial Culture Collection Project	The work was funded by the Department of Biotechnology (DBT), Government of India; Microbial Culture Collection Project Grant No. BT/PR10054/NDB/52/94/2007 URL:http://dbtindia.nic.in/index.asp. Author who received the funding: YSS.	Acha EM, 2004, J MARINE SYST, V44, P83, DOI 10.1016/j.jmarsys.2003.09.005; Allers E, 2007, ENVIRON MICROBIOL, V9, P2417, DOI 10.1111/j.1462-2920.2007.01360.x; Aravindraja C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076724; Asker D, 2007, SYST APPL MICROBIOL, V30, P291, DOI 10.1016/j.syapm.2006.12.003; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Bridoux MC, 2010, GEOCHIM COSMOCHIM AC, V74, P4044, DOI 10.1016/j.gca.2010.04.010; Buchan A, 2005, APPL ENVIRON MICROB, V71, P5665, DOI 10.1128/AEM.71.10.5665-5677.2005; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHEN CM, 1990, J BIOL CHEM, V265, P4461; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fennel K, 2010, OCEAN SCI, V6, P539, DOI 10.5194/os-6-539-2010; Gonzaga A, 2012, J BACTERIOL, V194, P6998, DOI 10.1128/JB.01565-12; Gopi M, 2012, ASIAN PAC J TROP MED, V5, P142, DOI 10.1016/S1995-7645(12)60013-3; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hamdan LJ, 2013, ISME J, V7, P685, DOI 10.1038/ismej.2012.143; Hameed A, 2014, INT J SYST EVOL MICR, V64, P2729, DOI 10.1099/ijs.0.060962-0; Ivanova EP, 2004, INT J SYST EVOL MICR, V54, P475, DOI 10.1099/ijs.0.02654-0; JAMES SR, 1990, SYST APPL MICROBIOL, V13, P270, DOI 10.1016/S0723-2020(11)80198-0; Jiao NZ, 2011, APPL ENVIRON MICROB, V77, P7439, DOI 10.1128/AEM.05640-11; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Karl DM, 2008, NAT GEOSCI, V1, P473, DOI 10.1038/ngeo234; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lecroq B, 2011, P NATL ACAD SCI USA, V108, P13177, DOI 10.1073/pnas.1018426108; Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003; Lopez-Perez M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00696; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Oh C, 2011, J BACTERIOL, V193, P5557, DOI 10.1128/JB.05793-11; Prakash O, 2014, INT J SYST EVOL MICR, V64, P1389, DOI 10.1099/ijs.0.059782-0; Prakash O, 2012, INT J SYST EVOL MICR, V62, P2457, DOI 10.1099/ijs.0.035840-0; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shah P, 2008, MOL MICROBIOL, V68, P4, DOI 10.1111/j.1365-2958.2008.06126.x; Sharma A, 2014, INT J SYST EVOL MICR, V64, P3010, DOI 10.1099/ijs.0.064295-0; Sudhanandh VS, 2013, INDIAN J GEO-MAR SCI, V42, P177; Vorholt JA, 1998, J BACTERIOL, V180, P5351, DOI 10.1128/JB.180.20.5351-5356.1998; Wang DZ, 2014, J PROTEOMICS, V97, P27, DOI 10.1016/j.jprot.2013.08.024; Wang H, 2012, INT J SYST EVOL MICR, V62, P223, DOI 10.1099/ijs.0.025536-0; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Y, 2012, APPL ENVIRON MICROB, V78, P8264, DOI 10.1128/AEM.01821-12; Williams TJ, 2014, TRENDS MICROBIOL, V22, P248, DOI 10.1016/j.tim.2014.03.004; Williams TJ, 2013, ENVIRON MICROBIOL, V15, P1302, DOI 10.1111/1462-2920.12017; Wyrtiki K, 1971, OCEANOGRAPHIC ATLAS; Wyrtki K., 1973, BIOL INDIAN OCEAN, P19; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570	45	20	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129864	10.1371/journal.pone.0129864	http://dx.doi.org/10.1371/journal.pone.0129864			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26066038	gold, Green Published, Green Submitted			2022-12-26	WOS:000356100900084
J	Mancini, M; Greco, A; Tedeschi, E; Palma, G; Ragucci, M; Bruzzone, MG; Coda, ARD; Torino, E; Scotti, A; Zucca, I; Salvatore, M				Mancini, Marcello; Greco, Adelaide; Tedeschi, Enrico; Palma, Giuseppe; Ragucci, Monica; Bruzzone, Maria Grazia; Coda, Anna Rita Daniela; Torino, Enza; Scotti, Alessandro; Zucca, Ileana; Salvatore, Marco			Head and Neck Veins of the Mouse. A Magnetic Resonance, Micro Computed Tomography and High Frequency Color Doppler Ultrasound Study	PLOS ONE			English	Article							TRANSIENT GLOBAL AMNESIA; JUGULAR VENOUS REFLUX; CEREBRAL VASCULATURE; BRAIN; ANATOMY; SYSTEM	To characterize the anatomy of the venous outflow of the mouse brain using different imaging techniques. Ten C57/black male mice (age range: 7-8 weeks) were imaged with high-frequency Ultrasound, Magnetic Resonance Angiography and ex-vivo Microcomputed tomography of the head and neck. Under general anesthesia, Ultrasound of neck veins was performed with a 20MHz transducer; head and neck Magnetic Resonance Angiography data were collected on 9.4T or 7T scanners, and ex-vivo Microcomputed tomography angiography was obtained by filling the vessels with a radiopaque inert silicone rubber compound. All procedures were approved by the local ethical committee. The dorsal intracranial venous system is quite similar in mice and humans. Instead, the mouse Internal Jugular Veins are tiny vessels receiving the sigmoid sinuses and tributaries from cerebellum, occipital lobe and midbrain, while the majority of the cerebral blood, i.e. from the olfactory bulbs and fronto-parietal lobes, is apparently drained through skull base connections into the External Jugular Vein. Three main intra-extracranial anastomoses, absent in humans, are: 1) the petrosquamous sinus, draining into the posterior facial vein, 2) the veins of the olfactory bulb, draining into the superficial temporal vein through a foramen of the frontal bone 3) the cavernous sinus, draining in the External Jugular Vein through a foramen of the sphenoid bone. The anatomical structure of the mouse cranial venous outflow as depicted by Ultrasound, Microcomputed tomography and Magnetic Resonance Angiography is different from humans, with multiple connections between intra-and extra-cranial veins.	[Mancini, Marcello; Palma, Giuseppe; Coda, Anna Rita Daniela] CNR, Inst Biostruct & Bioimaging, Naples, Italy; [Greco, Adelaide; Tedeschi, Enrico; Ragucci, Monica] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy; [Greco, Adelaide] CEINGE Biotecnol Avanzate, Naples, Italy; [Bruzzone, Maria Grazia] IRCCS Fdn Carlo Besta Neurol Inst, Unit Neuroradiol, Milan, Italy; [Torino, Enza] Ist Italiano Tecnol, Ctr Adv Biomat Hlth Care CRIB, Naples, Italy; [Scotti, Alessandro; Zucca, Ileana] IRCCS Fdn Carlo Besta Neurol Inst, Sci Direct, Milan, Italy; [Salvatore, Marco] IRCCS SDN, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Naples Federico II; CEINGE Biotecnologie Avanzate; IRCCS Istituto Neurologico Besta; Istituto Italiano di Tecnologia - IIT; IRCCS Istituto Neurologico Besta; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN)	Mancini, M (corresponding author), CNR, Inst Biostruct & Bioimaging, Naples, Italy.	direttore@ibb.cnr.it	Palma, Giuseppe/GXV-0228-2022; Palma, Giuseppe/AAX-1413-2020; Greco, Adelaide/C-7679-2018; Bruzzone, Maria/AAM-4478-2021; Tedeschi, Enrico/AAN-7112-2020; Salvatore, Marco/K-8083-2016; Torino, Enza/E-9803-2011	Palma, Giuseppe/0000-0002-0210-268X; Greco, Adelaide/0000-0001-6841-1963; Bruzzone, Maria/0000-0002-2786-1471; Tedeschi, Enrico/0000-0002-0511-0132; Salvatore, Marco/0000-0001-9734-7702; Torino, Enza/0000-0002-8905-1925	Italian Ministry for Education University and Research [2010XE5L2R_004]	Italian Ministry for Education University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by a research grant from the Italian Ministry for Education University and Research in the framework of PRIN (2010XE5L2R_004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkawi NM, 2001, LANCET, V357, P639, DOI 10.1016/S0140-6736(05)71434-3; Atkinson W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033671; Beggs C, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-157; Beggs CB, 2014, J MAGN RESON IMAGING, V40, P1215, DOI 10.1002/jmri.24468; Chuang YM, 2005, EUR NEUROL, V53, P78, DOI 10.1159/000084651; Chung CP, 2007, ULTRASOUND MED BIOL, V33, P1727, DOI 10.1016/j.ultrasmedbio.2007.05.018; Chung CP, 2014, J ALZHEIMERS DIS, V39, P601, DOI 10.3233/JAD-131112; Chung CP, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-9; Chung CP, 2011, ANN NEUROL, V69, P553, DOI 10.1002/ana.22276; Chung CP, 2010, CEREBROVASC DIS, V29, P122, DOI 10.1159/000262307; Doepp F, 2008, CEPHALALGIA, V28, P182, DOI 10.1111/j.1468-2982.2007.01484.x; Dorr A, 2007, NEUROIMAGE, V35, P1409, DOI 10.1016/j.neuroimage.2006.12.040; Dorr AE, 2008, NEUROIMAGE, V42, P60, DOI 10.1016/j.neuroimage.2008.03.037; Ghanavati S, 2014, J NEUROSCI METH, V221, P70, DOI 10.1016/j.jneumeth.2013.09.002; Gisolf J, 2004, J PHYSIOL-LONDON, V560, P317, DOI 10.1113/jphysiol.2004.070409; Hofmann M, 1900, Z MORPHOL ANTHROPOL, V2, P247; Jeppsson PG, 1960, LUND U ARSSKR NF AVD, V256, P1; Krause W, 1884, ANATOMIE KANINCHENS; Lewis SL, 1998, LANCET, V352, P397, DOI 10.1016/S0140-6736(98)01442-1; Pathak AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022643; SCREMIN OU, 1982, J CEREBR BLOOD F MET, V2, P55, DOI 10.1038/jcbfm.1982.6; SZABO K, 1990, ANAT EMBRYOL, V182, P225; Valdueza JM, 2000, LANCET, V355, P200; Weyers JJ, 2012, JOVE-J VIS EXP, DOI 10.3791/3740; Zamboni P, 2009, J NEUROL NEUROSUR PS, V80, P392, DOI 10.1136/jnnp.2008.157164; Zivadinov R, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-260	26	15	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129912	10.1371/journal.pone.0129912	http://dx.doi.org/10.1371/journal.pone.0129912			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067061	Green Published, gold, Green Submitted			2022-12-26	WOS:000356100900085
J	Ikeda, J; Ichiki, T; Takahara, Y; Kojima, H; Sankoda, C; Kitamoto, S; Tokunou, T; Sunagawa, K				Ikeda, Jiro; Ichiki, Toshihiro; Takahara, Yusuke; Kojima, Hiroshi; Sankoda, Chikahiro; Kitamoto, Shiro; Tokunou, Tomotake; Sunagawa, Kenji			PPAR gamma Agonists Attenuate Palmitate-Induced ER Stress through Up-Regulation of SCD-1 in Macrophages	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; STEAROYL-COA DESATURASE; UNFOLDED PROTEIN RESPONSE; ACTIVATED RECEPTOR-GAMMA; BETA-CELLS; ATHEROSCLEROSIS; MICE; APOPTOSIS; EXPRESSION; PIOGLITAZONE	Background Clinical trials have shown that treatment of patients with type 2 diabetes with pioglitazone, a peroxisome proliferator-activated receptor (PPAR). agonist, reduces cardiovascular events. However, the effect of PPAR. agonists on endoplasmic reticulum (ER) stress that plays an important role in the progression of atherosclerosis has not been determined. We sought to determine the effect of PPAR. agonists on ER stress induced by palmitate, the most abundant saturated fatty acid in the serum. Methods and Results Protein expression of ER stress marker was evaluated by Western blot analysis and stearoyl- CoA desaturase1 (SCD-1) mRNA expression was evaluated by qRT-PCR. Macrophage apoptosis was detected by flowcytometry. Pioglitazone and rosiglitazone reduced palmitate- induced phosphorylation of PERK, a marker of ER stress, in RAW264.7, a murine macrophage cell line. Pioglitazone also suppressed palmitate-induced apoptosis in association with inhibition of CHOP expression, JNK phosphorylation and cleavage of caspase-3. These effects of pioglitazone were reversed by GW9662, a PPAR. antagonist, indicating that PPAR. is involved in this process. PPAR. agonists increased expression of SCD-1 that introduces a double bond on the acyl chain of long-chain fatty acid. 4-(2-Chlorophenoxy)- N-(3-(3-methylcarbamoyl)phenyl)piperidine-1-carboxamide, an inhibitor of SCD-1, abolished the anti-ER stress and anti-apoptotic effects of pioglitazone. These results suggest that PPAR. agonists attenuate palmitate-induced ER stress and apoptosis through SCD-1 induction. Up-regulation of SCD-1 may contribute to the reduction of cardiovascular events by treatment with PPAR gamma agonists.	[Ikeda, Jiro; Ichiki, Toshihiro; Takahara, Yusuke; Kojima, Hiroshi; Sankoda, Chikahiro; Kitamoto, Shiro; Tokunou, Tomotake; Sunagawa, Kenji] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka 812, Japan; [Ichiki, Toshihiro; Kitamoto, Shiro] Kyushu Univ, Grad Sch Med Sci, Dept Adv Therapeut Cardiovasc Dis, Fukuoka 812, Japan	Kyushu University; Kyushu University	Ichiki, T (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka 812, Japan.	ichiki@cardiol.med.kyushu-u.ac.jp	Tokunou, Tomotake/AAG-3403-2019		Scientific Research for Ministry of Education, Culture, Sports and Technology of Japan [23659421]	Scientific Research for Ministry of Education, Culture, Sports and Technology of Japan	This study is supported by a grant-in-aid for Scientific Research for Ministry of Education, Culture, Sports and Technology of Japan (23659421 to T.I.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranova I, 2002, INFECT IMMUN, V70, P2995, DOI 10.1128/IAI.70.6.2995-3003.2002; Brown JM, 2008, CIRCULATION, V118, P1467, DOI 10.1161/CIRCULATIONAHA.108.793182; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Evans-Molina C, 2009, MOL CELL BIOL, V29, P2053, DOI 10.1128/MCB.01179-08; Guo W, 2007, AM J PHYSIOL-ENDOC M, V293, pE576, DOI 10.1152/ajpendo.00523.2006; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Koeberle A, 2012, J BIOL CHEM, V287, P27244, DOI 10.1074/jbc.M111.274829; Kurebayashi S, 1997, DIABETES, V46, P2115, DOI 10.2337/diabetes.46.12.2115; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Liu J, 2005, ARTERIOSCL THROM VAS, V25, P174, DOI 10.1161/01.ATV.0000148548.47755.22; MacDonald MLE, 2009, ARTERIOSCL THROM VAS, V29, P341, DOI 10.1161/ATVBAHA.108.181099; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; Myoishi M, 2007, CIRCULATION, V116, P1226, DOI 10.1161/CIRCULATIONAHA.106.682054; Nakayama T, 2010, INT J CARDIOL, V138, P157, DOI 10.1016/j.ijcard.2008.08.031; Park Y, 2012, INFLAMM RES, V61, P465, DOI 10.1007/s00011-011-0433-3; Peter A, 2008, AM J PHYSIOL-ENDOC M, V295, pE339, DOI 10.1152/ajpendo.00022.2008; Quan JX, 2014, J DIABETES, V6, P33, DOI 10.1111/1753-0407.12073; RALPH P, 1977, J IMMUNOL, V119, P950; Riserus U, 2005, DIABETES, V54, P1379, DOI 10.2337/diabetes.54.5.1379; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Tabas I, 2005, ARTERIOSCL THROM VAS, V25, P2255, DOI 10.1161/01.ATV.0000184783.04864.9f; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Thorn K, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-108; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Toyama T, 2007, J PHARMACOL SCI, V104, P137, DOI 10.1254/jphs.FP0060997; Weber SM, 2004, AM J PHYSIOL-ENDOC M, V287, pE1171, DOI 10.1152/ajpendo.00331.2004; Yoshiuchi K, 2009, ENDOCR J, V56, P1103, DOI 10.1507/endocrj.K09E-140; Zang CB, 2009, MOL CANCER THER, V8, P2296, DOI 10.1158/1535-7163.MCT-09-0347; Zhang L, 2001, BIOCHEM J, V357, P183, DOI 10.1042/0264-6021:3570183; Zhang YH, 2006, AM J PHYSIOL-RENAL, V290, pF1065, DOI 10.1152/ajprenal.00131.2005; Zhou J, 2005, CIRCULATION, V111, P1814, DOI 10.1161/01.CIR.0000160864.31351.C1	33	29	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0128546	10.1371/journal.pone.0128546	http://dx.doi.org/10.1371/journal.pone.0128546			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061913	gold, Green Published, Green Submitted			2022-12-26	WOS:000355979500087
J	Saraiva, FO; Minamisava, R; Vieira, MAD; Bierrenbach, AL; Andrade, AL				Saraiva, Fabricia Oliveira; Minamisava, Ruth; da Silva Vieira, Maria Aparecida; Bierrenbach, Ana Luiza; Andrade, Ana Lucia			Vaccination Coverage and Compliance with Three Recommended Schedules of 10-Valent Pneumococcal Conjugate Vaccine during the First Year of Its Introduction in Brazil: A Cross-Sectional Study	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CHILDHOOD IMMUNIZATION; CHILDREN; DISEASE; TIMELINESS; INFECTIONS; PARENTS	Pneumococcal 10-valent conjugate vaccine (PCV10) was introduced to Brazil's National Immunization Program (NIP) in 2010. During the first year of vaccine introduction three schedules were used to deal with age at initiation of PCV for catch-up purposes: 3 primary doses + 1 booster (for children aged <= 6 months), a catch-up schedule of 2 doses + 1 booster (7-11 months), and a catch-up schedule of a single dose (12-15 months). The purpose of this study was to assess the magnitude and associated risk factors for under-vaccination or lack of on time vaccination six to eight months after PCV10 introduction. A household survey was conducted in the municipality of Goiania with 1,237 children, who were retroactively classified into one of three age groups, as a factor of the child's age relatively to 30 days after PCV10 introduction. Socioeconomic characteristics and vaccination dates were obtained during home interviews. Vaccination coverage was defined as the percentage of children who completed the recommended number of doses. Compliance with recommended schedules was defined as the percentage of children who received all valid doses at the NIP recommended time interval. Adjusted prevalence ratios (PR) of variables independently associated with coverage and compliance were estimated by log binomial regression. Coverage of DTP-Hib was used for comparison purposes. Overall, vaccination coverage was 54.6% (95% CI 52.1-57.7%), lower than DTP-Hib coverage (93.0%; 95% CI 91.5-94.3%). Compliance with recommended schedules was 16.8%(95% CI: 14.7-18.6%). Children 7-11 months old had lower coverage (40.7%) and compliance (6.3%) compared to children aged 12-15 months (coverage: 88.8%; compliance: 35.6%) and <= 6 months old (coverage: 54%; compliance: 18.8%). Having private health insurance was associated with higher PCV10 coverage (PR= 1.25; 95% CI: 1.06-1.47, p=0.007), and compliance PR=1.09; 95% CI: 1.02-1.16, p=0.015). Although PCV10 coverage rapidly increased shortly after vaccination introduction, it was not matched by compliance with recommended schedules. Public initiatives should target compliance of PCV10 because of the burden of pneumococcal diseases on childhood morbidity and mortality.	[Saraiva, Fabricia Oliveira; Bierrenbach, Ana Luiza; Andrade, Ana Lucia] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Dept Community Hlth, Goiania, Go, Brazil; [Minamisava, Ruth] Univ Fed Goias, Sch Nursing, Dept Pediat, Goiania, Go, Brazil; [da Silva Vieira, Maria Aparecida] Pontifical Catholic Univ, Nursing Phys Therapy & Nutr Dept, Goiania, Go, Brazil; [Bierrenbach, Ana Luiza] Hosp Sirio Libanes, Res & Educ Inst IEP, Sao Paulo, Brazil	Universidade Federal de Goias; Universidade Federal de Goias; Hospital Sirio Libanes	Saraiva, FO (corresponding author), Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Dept Community Hlth, Goiania, Go, Brazil.	fah79o@hotmail.com	Bierrenbach, Ana L/F-3185-2014	Bierrenbach, Ana L/0000-0002-6837-0636; Oliveira, Fabricia da Silva/0000-0001-9419-5280; Minamisava, Ruth/0000-0001-9352-5567	National Council for Scientific and Technological Development (CNPq); National Institute of Science and Technology for Health (IATS) [573826/2008-0, 306096/2010-2]; Research Foundation of the Goias State/FAPEG-GO, Brazil [PRONEX/07-2009]; Foundation for Research Support/FUNAPE-GO, Federal University of Goias [34131]; National Council for Scientific and Technological Development [133581/2013-6]	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institute of Science and Technology for Health (IATS); Research Foundation of the Goias State/FAPEG-GO, Brazil; Foundation for Research Support/FUNAPE-GO, Federal University of Goias; National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding provided by the National Council for Scientific and Technological Development (CNPq) and the National Institute of Science and Technology for Health (IATS) (#573826/2008-0; 306096/2010-2; http://www.cnpq.br/; http://www.iats.com.br/); the Research Foundation of the Goias State/FAPEG-GO, Brazil (Grant: PRONEX/07-2009; http://www.fapeg.go.gov.br/sitefapeg/); the Foundation for Research Support/FUNAPE-GO, Federal University of Goias (#34131; http://www.funape.org.br/site/). FOS was granted a Master Scholarship by the National Council for Scientific and Technological Development (#133581/2013-6; http://www.cnpq.br/).	Andrade AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098128; Andrade AL, 2012, VACCINE, V30, P1901, DOI 10.1016/j.vaccine.2011.12.012; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P129; [Anonymous], 2011, MMWR; Atkinson W, 2011, EPIDEMIOLOGY PREVENT, P9; Atkinson W, 2011, EPIDEMIOLOGY PREVENT, P233; Barata RB, 2012, J EPIDEMIOL COMMUN H, V66, P934, DOI 10.1136/jech-2011-200341; Bhat RY, 2013, INT J TUBERC LUNG D, V17, P418, DOI 10.5588/ijtld.12.0117; Black CL, 2012, MMWR-MORBID MORTAL W, V61, P689; Braeckman T, 2014, EURO SURVEILL, V19; Centers for Disease Control and Prevention. (CDC), 2005, MMWR-MORBID MORTAL W, V55, P988; Chan Y. H., 2004, SMJ Singapore Medical Journal, V45, P55; Teixeira AMD, 2010, EPIDEMIOL SERV SAUDE, V19, P217; Diekema DS, 2012, NEW ENGL J MED, V366, P391, DOI 10.1056/NEJMp1113008; Domingues CMAS, 2013, EPIDEMIOL SERV SAUDE, V22, P9, DOI 10.5123/S1679-49742013000100002; Domingues CMAS, 2014, LANCET RESP MED, V2, P464, DOI 10.1016/S2213-2600(14)70060-8; Durando P, 2009, VACCINE, V27, P3459, DOI 10.1016/j.vaccine.2009.01.052; Ferreira-Guerrero E, 2013, SALUD PUBLICA MEXICO, V55, pS307; Fiocruz, BRAZ VACC SCHED CHIL; Gierisch JM, 2010, AM J HEALTH BEHAV, V34, P669; Gram L, 2014, TROP MED INT HEALTH, V19, P802, DOI 10.1111/tmi.12324; Hamid A, 2010, CAN J PUBLIC HEALTH, V101, P20, DOI 10.1007/BF03405555; Hammer LD, 2010, PEDIATRICS, V125, P1295, DOI 10.1542/peds.2010-0743; Harboe ZB, 2014, EPI NEWS DIS VACCINE, DOI [10.1016/j.sste.2011.07.005, DOI 10.1016/J.SSTE.2011.07.005]; Harrington PM, 1999, BRIT J GEN PRACT, V49, P901; Kleinbaum DG, 2012, STAT BIOL HEALTH, P55, DOI 10.1007/978-1-4419-6646-9_2; Leask J, 2011, NATURE, V473, P443, DOI 10.1038/473443a; Luman ET, 2008, AM J PREV MED, V34, P463, DOI 10.1016/j.amepre.2008.01.033; Miranda VMM, 2007, AM J INFECT CONTROL, V35, P286, DOI 10.1016/j.ajic.2006.10.008; Moraes JC, 2007, INQUERITO COBERTURA; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Parve Julie, 2004, Nurse Pract, V29, P35, DOI 10.1097/00006205-200404000-00006; Porto Silvia Marta, 2006, Ciênc. saúde coletiva, V11, P895; Programa das Nacoes Unidas para o Desenvolvimento, 2013, IND DES HUM GOIAN GO; Rainey JJ, 2011, VACCINE, V29, P8215, DOI 10.1016/j.vaccine.2011.08.096; Ritvo P, 2005, NAT MED, V11, pS20, DOI 10.1038/nm1220; Scheurer DB, 2006, AM J MED QUAL, V21, P18, DOI 10.1177/1062860605280314; Sharts-Hopko NC, 2009, MCN-AM J MATERN-CHIL, V34, P80, DOI 10.1097/01.NMC.0000347300.39714.19; Smith PJ, 2007, PEDIATRICS, V120, pE1165, DOI 10.1542/peds.2007-0037; Thorn LKAM, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-180; Valentiner-Branth P, 2010, EPI NEWS DIS VACCINE, DOI [10.1016/j.sste.2011.07.005, DOI 10.1016/J.SSTE.2011.07.005]; Womack Jamie Michelle, 2010, JAAPA, V23, P42; Zhu VJ, 2012, ARTIF INTELL MED, V56, P51, DOI 10.1016/j.artmed.2012.04.004	43	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0128656	10.1371/journal.pone.0128656	http://dx.doi.org/10.1371/journal.pone.0128656			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061276	gold, Green Published, Green Submitted			2022-12-26	WOS:000355979500094
J	Dickreuter, E; Eke, I; Krause, M; Borgmann, K; van Vugt, MA; Cordes, N				Dickreuter, E.; Eke, I.; Krause, M.; Borgmann, K.; van Vugt, M. A.; Cordes, N.			Targeting of beta 1 integrins impairs DNA repair for radiosensitization of head and neck cancer cells	ONCOGENE			English	Article							DOUBLE-STRAND BREAKS; CONTEXTUAL SYNTHETIC LETHALITY; FOCAL ADHESION KINASE; EXTRACELLULAR-MATRIX; INHIBITION; INTEGRINS; PATHWAY; KU; PROLIFERATION; FIBRONECTIN	beta 1 Integrin-mediated cell-extracellular matrix interactions allow cancer cell survival and confer therapy resistance. It was shown that inhibition of beta 1 integrins sensitizes cells to radiotherapy. Here, we examined the impact of beta 1 integrin targeting on the repair of radiation-induced DNA double-strand breaks (DSBs). beta 1 Integrin inhibition was accomplished using the monoclonal antibody AIIB2 and experiments were performed in three-dimensional cell cultures and tumor xenografts of human head and neck squamous cell carcinoma (HNSCC) cell lines. AIIB2, X-ray irradiation, small interfering RNA-mediated knockdown and Olaparib treatment were performed and residual DSB number, protein and gene expression, non-homologous end joining (NHEJ) activity as well as clonogenic survival were determined. beta 1 Integrin targeting impaired repair of radiogenic DSB (gamma H2AX/53BP1, pDNA-PKcs T2609 foci) in vitro and in vivo and reduced the protein expression of Ku70, Rad50 and Nbs1. Further, we identified Ku70, Ku80 and DNA-PKcs but not poly(ADP-ribose) polymerase (PARP)-1 to reside in the beta 1 integrin pathway. Intriguingly, combined inhibition of beta 1 integrin and PARP using Olaparib was significantly more effective than either treatment alone in non-irradiated and irradiated HNSCC cells. Here, we support beta 1 integrins as potential cancer targets and highlight a regulatory role for beta 1 integrins in the repair of radiogenic DNA damage via classical NHEJ. Further, the data suggest combined targeting of beta 1 integrin and PARP as promising approach for radiosensitization of HNSCC.	[Dickreuter, E.; Eke, I.; Krause, M.; Cordes, N.] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Fac Med, OncoRay Natl Ctr Radiat Res Oncol, D-01062 Dresden, Germany; [Dickreuter, E.; Eke, I.; Krause, M.; Cordes, N.] Helmholtz Zentrum Dresden Rossendorf, D-01314 Dresden, Germany; [Eke, I.; Krause, M.; Cordes, N.] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Radiat Oncol, D-01062 Dresden, Germany; [Krause, M.; Cordes, N.] Helmholtz Zentrum Dresden Rossendorf, Inst Radiooncol, D-01314 Dresden, Germany; [Krause, M.; Cordes, N.] German Canc Consortium DKTK, D-01307 Dresden, Germany; [Krause, M.; Cordes, N.] German Canc Res Ctr, Heidelberg, Germany; [Borgmann, K.] Univ Med Ctr Hamburg Eppendorf, Clin Radiotherapy & Radiooncol, Lab Radiobiol & Expt Radiooncol, Hamburg, Germany; [van Vugt, M. A.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Groningen	Cordes, N (corresponding author), Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Fac Med, OncoRay Natl Ctr Radiat Res Oncol, Fetscherstr 74-PF 41, D-01307 Dresden, Germany.	Nils.Cordes@OncoRay.de	; Eke, Iris/B-9251-2016	Krause, Mechthild/0000-0003-1776-9556; Eke, Iris/0000-0002-3591-019X; Cordes, Nils/0000-0001-5684-629X	Deutsche Krebshilfe e.V. [108976]; EFRE Europaische Fonds fur regionale Entwicklung, Europa fordert Sachsen [100066308]	Deutsche Krebshilfe e.V.(Deutsche Krebshilfe); EFRE Europaische Fonds fur regionale Entwicklung, Europa fordert Sachsen	The research and authors were funded in part by the Deutsche Krebshilfe e.V. (108976 to N.C.) and the EFRE Europaische Fonds fur regionale Entwicklung, Europa fordert Sachsen (100066308). We are grateful to R Grenman for providing HNSCC cell lines, DD Schlaepfer for providing mouse FAK cDNA and J Stark for providing NHEJ reporter plasmids. We further thank I Lange for performing real-time PCR experiments, L Stolz-Kieslich and A Zielinski for technical assistance and I Kurth for help with FACS analysis. We appreciate critical reading of the manuscript by E Hammond and A Vehlow.	Albert M, 2012, RADIOTHER ONCOL, V104, P230, DOI 10.1016/j.radonc.2012.06.010; Almeida EAC, 2000, J CELL BIOL, V149, P741, DOI 10.1083/jcb.149.3.741; Barkan D, 2010, EUR J CANCER, V46, P1181, DOI 10.1016/j.ejca.2010.02.027; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Borgmann K, 2004, INT J RADIAT ONCOL, V58, P445, DOI 10.1016/j.ijrobp.2003.09.036; Chan N, 2010, CANCER RES, V70, P8045, DOI 10.1158/0008-5472.CAN-10-2352; Chan N, 2010, CLIN CANCER RES, V16, P4553, DOI 10.1158/1078-0432.CCR-10-0527; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Cheng Q, 2011, NUCLEIC ACIDS RES, V39, P9605, DOI 10.1093/nar/gkr656; Couto CAM, 2011, J CELL BIOL, V194, P367, DOI 10.1083/jcb.201012132; Eke I, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju419; Eke I, 2015, SEMIN CANCER BIOL, V31, P65, DOI 10.1016/j.semcancer.2014.07.009; Eke I, 2013, CANCER RES, V73, P5869, DOI 10.1158/0008-5472.CAN-13-0344; Eke I, 2013, CANCER RES, V73, P297, DOI 10.1158/0008-5472.CAN-12-2021; Eke I, 2012, INT J RADIAT ONCOL, V84, pE515, DOI 10.1016/j.ijrobp.2012.06.012; Eke I, 2012, J CLIN INVEST, V122, P1529, DOI 10.1172/JCI61350; Estrugo D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000269; Hammel M, 2010, J BIOL CHEM, V285, P1414, DOI 10.1074/jbc.M109.065615; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; Hehlgans S, 2012, INT J RADIAT ONCOL, V83, pE669, DOI 10.1016/j.ijrobp.2012.01.065; Hehlgans S, 2009, RADIOTHER ONCOL, V92, P371, DOI 10.1016/j.radonc.2009.08.001; Helleday T, 2005, CELL CYCLE, V4, P1176, DOI 10.4161/cc.4.9.2031; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jean C, 2011, ONCOGENE, V30, P2697, DOI 10.1038/onc.2011.27; Jean C, 2014, J CELL BIOL, V204, P247, DOI 10.1083/jcb.201307067; Jones CB, 2001, MOL PHARMACOL, V59, P69, DOI 10.1124/mol.59.1.69; Klein TJ, 2010, SEMIN RADIAT ONCOL, V20, P282, DOI 10.1016/j.semradonc.2010.05.006; Kotter A, 2014, MOL ONCOL, V8, P1616, DOI 10.1016/j.molonc.2014.06.008; Krajewska M, 2013, ONCOGENE, V32, P3001, DOI 10.1038/onc.2012.296; Krause M, 2007, RADIOTHER ONCOL, V83, P316, DOI 10.1016/j.radonc.2007.04.014; Kumareswaran R, 2012, J CELL SCI, V125, P189, DOI 10.1242/jcs.092262; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Mansour WY, 2013, DNA REPAIR, V12, P1134, DOI 10.1016/j.dnarep.2013.10.005; Mansour WY, 2010, NUCLEIC ACIDS RES, V38, P6065, DOI 10.1093/nar/gkq387; Mladenov E, 2011, MUTAT RES-FUND MOL M, V711, P61, DOI 10.1016/j.mrfmmm.2011.02.005; Park CC, 2008, CANCER RES, V68, P4398, DOI 10.1158/0008-5472.CAN-07-6390; Peng YL, 2002, CANCER RES, V62, P6400; Rose JL, 2007, J PHARMACOL EXP THER, V321, P318, DOI 10.1124/jpet.106.113498; Serrels A, 2012, INT J CANCER, V131, P287, DOI 10.1002/ijc.26351; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Spagnolo L, 2006, MOL CELL, V22, P511, DOI 10.1016/j.molcel.2006.04.013; Storch K, 2010, CANCER RES, V70, P3925, DOI 10.1158/0008-5472.CAN-09-3848; Tomar A, 2009, CURR OPIN CELL BIOL, V21, P676, DOI 10.1016/j.ceb.2009.05.006; Tutt ANJ, 2005, COLD SH Q B, V70, P139, DOI 10.1101/sqb.2005.70.012; Vandersickel V, 2010, J RADIAT RES, V51, P633, DOI 10.1269/jrr.10033; Williams GJ, 2010, DNA REPAIR, V9, P1299, DOI 10.1016/j.dnarep.2010.10.001; Yan H, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-50	50	48	48	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 17	2016	35	11					1353	1362		10.1038/onc.2015.212	http://dx.doi.org/10.1038/onc.2015.212			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DG6LQ	26073085				2022-12-26	WOS:000372196400002
J	Dal Bosco, L; Weber, GE; Parfitt, GM; Cordeiro, AP; Sahoo, SK; Fantini, C; Klosterhoff, MC; Romano, LA; Furtado, CA; Santos, AP; Monserrat, JM; Barros, DM				Dal Bosco, Lidiane; Weber, Gisele E.; Parfitt, Gustavo M.; Cordeiro, Arthur P.; Sahoo, Sangram K.; Fantini, Cristiano; Klosterhoff, Marta C.; Romano, Luis Alberto; Furtado, Clascidia A.; Santos, Adelina P.; Monserrat, Jose M.; Barros, Daniela M.			Biopersistence of PEGylated Carbon Nanotubes Promotes a Delayed Antioxidant Response after Infusion into the Rat Hippocampus	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; OXIDATIVE STRESS; BRAIN; DYSFUNCTION; EVALUATE; NEURONS; DAMAGE; SWCNT; FEAR	Carbon nanotubes are promising nanomaterials for the diagnosis and treatment of brain disorders. However, the ability of these nanomaterials to cross cell membranes and interact with neural cells brings the need for the assessment of their potential adverse effects on the nervous system. This study aimed to investigate the biopersistence of single-walled carbon nanotubes functionalized with polyethylene glycol (SWCNT-PEG) directly infused into the rat hippocampus. Contextual fear conditioning, Y-maze and open field tasks were performed to evaluate the effects of SWCNT-PEG on memory and locomotor activity. The effects of SWCNT-PEG on oxidative stress and morphology of the hippocampus were assessed 1 and 7 days after infusion of the dispersions at 0.5, 1.0 and 2.1 mg/mL. Raman analysis of the hippocampal homogenates indicates the biopersistence of SWCNT-PEG in the hippocampus 7 days post-injection. The infusion of the dispersions had no effect on the acquisition or persistence of the contextual fear memory; likewise, the spatial recognition memory and locomotor activity were not affected by SWCNT-PEG. Histological examination revealed no remarkable morphological alterations after nanomaterial exposure. One day after the infusion, SWCNT-PEG dispersions at 0.5 and 1.0 mg/mL were able to decrease total antioxidant capacity without modifying the levels of reactive oxygen species or lipid hydroperoxides in the hippocampus. Moreover, SWCNT-PEG dispersions at all concentrations induced antioxidant defenses and reduced reactive oxygen species production in the hippocampus at 7 days post-injection. In this work, we found a time-dependent change in antioxidant defenses after the exposure to SWCNT-PEG. We hypothesized that the persistence of the nanomaterial in the tissue can induce an antioxidant response that might have provided resistance to an initial insult. Such antioxidant delayed response may constitute an adaptive response to the biopersistence of SWCNT-PEG in the hippocampus.	[Dal Bosco, Lidiane; Weber, Gisele E.; Parfitt, Gustavo M.; Monserrat, Jose M.; Barros, Daniela M.] Univ Fed Rio Grande, Inst Ciencias Biol, Programa Posgrad Ciencias Fisiol Fisiol Anim Comp, Rio Grande, RS, Brazil; [Cordeiro, Arthur P.] Univ Fed Rio Grande, Escola Quim & Alimentos, Rio Grande, RS, Brazil; [Sahoo, Sangram K.; Fantini, Cristiano] Univ Fed Minas Gerais, Dept Fis, Inst Ciencias Exatas, BR-30161 Belo Horizonte, MG, Brazil; [Klosterhoff, Marta C.; Romano, Luis Alberto] Univ Fed Rio Grande, Inst Oceanog, Programa Posgrad Aquicultura, Rio Grande, RS, Brazil; [Furtado, Clascidia A.; Santos, Adelina P.] Ctr Desenvolvimento Tecnol Nucl, Lab Quim Nanoestruturas, Belo Horizonte, MG, Brazil	Universidade Federal do Rio Grande; Universidade Federal do Rio Grande; Universidade Federal de Minas Gerais; Universidade Federal do Rio Grande; Centro de Desenvolvimento da Tecnologia Nuclear (CDTN)	Barros, DM (corresponding author), Univ Fed Rio Grande, Inst Ciencias Biol, Programa Posgrad Ciencias Fisiol Fisiol Anim Comp, Rio Grande, RS, Brazil.	barrosdm@yahoo.com.br	Leite, Cristiano Fantini/N-3946-2017; Santos, Adelina/V-3087-2019; Monserrat, Jose Maria/L-1154-2014; Furtado, Clascidia/AAE-2801-2020	Monserrat, Jose Maria/0000-0002-9463-3049; Romano, Luis/0000-0003-3144-3579; Poester Cordeiro, Arthur/0000-0001-6660-004X; Parfitt, Gustavo/0000-0003-0168-4099	Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul [11/2037-9]; Nanotoxicology Network - National Council for Scientific and Technological Development - CNPq [552131/2011-3]; Instituto Nacional de Ciencia e Tecnologia de Nanomateriais de Carbono - CNPq [574020/2008-0]; CNPq	Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Nanotoxicology Network - National Council for Scientific and Technological Development - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia de Nanomateriais de Carbono - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	DB was supported by Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul, process number 11/2037-9. www.fapergs.rs.gov.br. DB and JM were supported by Nanotoxicology Network - National Council for Scientific and Technological Development - CNPq, process number 552131/2011-3. www.cnpq.br. DB, JM, CF, CAF, AS were supported by Instituto Nacional de Ciencia e Tecnologia de Nanomateriais de Carbono - CNPq process number 574020/2008-0). www.cnpq.br. DB, JM, CF, CAF, AS were also supported by productivity research fellowships from CNPq. www.cnpq.br.	Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; Acheson DT, 2012, NEUROPHARMACOLOGY, V62, P674, DOI 10.1016/j.neuropharm.2011.04.029; Al Faraj A, 2011, INT J NANOMED, V6, P351, DOI 10.2147/IJN.S16653; Al-Jamal KT, 2011, P NATL ACAD SCI USA, V108, P10952, DOI 10.1073/pnas.1100930108; Allen BL, 2009, J AM CHEM SOC, V131, P17194, DOI 10.1021/ja9083623; Amado LL, 2009, SCI TOTAL ENVIRON, V407, P2115, DOI 10.1016/j.scitotenv.2008.11.038; Bagheri M, 2011, NEUROBIOL LEARN MEM, V95, P270, DOI 10.1016/j.nlm.2010.12.001; Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025; Cai XQ, 2008, J NEUROSCI RES, V86, P3622, DOI 10.1002/jnr.21805; Cellot G, 2010, SMALL, V6, P2630, DOI 10.1002/smll.201000906; Crouzier D, 2010, TOXICOLOGY, V272, P39, DOI 10.1016/j.tox.2010.04.001; da Rocha AM, 2013, COMP BIOCHEM PHYS A, V165, P460, DOI 10.1016/j.cbpa.2013.03.025; Dal Bosco L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/104135; de Aguiar RB, 2008, BIOGERONTOLOGY, V9, P285, DOI 10.1007/s10522-008-9137-7; Dillon AC, 2004, J NANOSCI NANOTECHNO, V4, P691, DOI 10.1166/jnn.2004.116; Dresselhaus MS, 2003, J NANOSCI NANOTECHNO, V3, P19, DOI 10.1166/jnn.2003.189; Fabbro A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073621; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; Fenoglio I, 2006, FREE RADICAL BIO MED, V40, P1227, DOI 10.1016/j.freeradbiomed.2005.11.010; Galhardi F, 2009, FOOD CHEM TOXICOL, V47, P2655, DOI 10.1016/j.fct.2009.07.030; Jones DP, 2006, ANTIOXID REDOX SIGN, V8, P1865, DOI 10.1089/ars.2006.8.1865; Kagan VE, 2010, NAT NANOTECHNOL, V5, P354, DOI [10.1038/NNANO.2010.44, 10.1038/nnano.2010.44]; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Kotchey GP, 2013, J MATER CHEM B, V1, P302, DOI 10.1039/c2tb00047d; Kuzmany H, 2001, EUR PHYS J B, V22, P307, DOI 10.1007/s100510170108; Lee HJ, 2011, NAT NANOTECHNOL, V6, P120, DOI 10.1038/nnano.2010.281; Liu XY, 2010, CARBON, V48, P1961, DOI 10.1016/j.carbon.2010.02.002; Liu XD, 2014, INT J NANOMED, V9, P823, DOI 10.2147/IJN.S56339; Liu Z, 2008, P NATL ACAD SCI USA, V105, P1410, DOI 10.1073/pnas.0707654105; Maher P, 2006, ANTIOXID REDOX SIGN, V8, P1941, DOI 10.1089/ars.2006.8.1941; Maren S, 2013, NAT REV NEUROSCI, V14, P417, DOI 10.1038/nrn3492; Meng L, 2013, TOXICOLOGY, V313, P49, DOI 10.1016/j.tox.2012.11.011; Monserrat JM, 2003, ARCH ENVIRON CON TOX, V45, P177, DOI 10.1007/s00244-003-0073-x; Nunes A, 2012, NANOMEDICINE-UK, V7, P1485, DOI [10.2217/NNM.12.33, 10.2217/nnm.12.33]; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pickering C, 2015, PHARMACOL BIOCHEM BE, V132, P63, DOI 10.1016/j.pbb.2015.02.021; Pioli EY, 2008, NEUROSCIENCE, V153, P1213, DOI 10.1016/j.neuroscience.2008.01.084; Ren JF, 2012, BIOMATERIALS, V33, P3324, DOI 10.1016/j.biomaterials.2012.01.025; Ren L, 2010, ENVIRON SCI TECHNOL, V44, P6954, DOI 10.1021/es101821m; Shvedova AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030923; Vlasova II, 2012, TOXICOL APPL PHARM, V264, P131, DOI 10.1016/j.taap.2012.07.027; Wang JY, 2012, TOXICOL IN VITRO, V26, P32, DOI 10.1016/j.tiv.2011.10.004; Weber GEB, 2014, TOXICOL APPL PHARM, V280, P484, DOI 10.1016/j.taap.2014.08.018; White CC, 2003, ANAL BIOCHEM, V318, P175, DOI 10.1016/S0003-2697(03)00143-X; Zhang YB, 2011, ACS NANO, V5, P7020, DOI 10.1021/nn2016259	45	15	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129156	10.1371/journal.pone.0129156	http://dx.doi.org/10.1371/journal.pone.0129156			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075787	gold, Green Published, Green Submitted			2022-12-26	WOS:000356329900047
J	Merlin, A; Bonis, A; Damgaard, CF; Mesleard, F				Merlin, Amandine; Bonis, Anne; Damgaard, Christian F.; Mesleard, Francois			Competition Is a Strong Driving Factor in Wetlands, Peaking during Drying Out Periods	PLOS ONE			English	Article							SPATIAL-PATTERNS; POSITIVE INTERACTIONS; PLANT INTERACTIONS; FLOODING GRADIENT; GROWTH; VEGETATION; DEPTH; MARSH; DISTURBANCE; MECHANISMS	The aim of the study is to investigate the relative importance of plant-plant interactions with regard to flooding and drought effect on perennial plant performances in wetlands. Flooding is expected to be the major driver and, accordingly, the importance of drought is hardly if ever taken into account. Focusing on five widespread species, the growth, the survival and the competitive ability of plants were monitored on permanent plots spread along two elevation gradients. Flooding duration and drought intensity were found to vary substantially along the similar to 0.5 meter range elevation gradient. Flooding and drought alternate over the hydrological year and the pin-point surveys were thus conducted over the course of one year. The data were modeled taking into account survival, recruitment and competitive growth throughout flooding and drying out periods. Flooding and drought both directly impacted the plant performances and their competitive effect, with the effect of drought being much more general among species and of higher magnitude than flooding. The importance of competition was found to be high for all species, particularly during the drying out period. It varied more along the flooding gradient than along the drought gradient. The higher flooding tolerance shown by the studied species compared to drought may be related to species specific growth timing together with efficient response traits. These results offer new insights into the filters operating over the species pools. This suggests that the drying out period and drought conditions may be even more important for species' relative success and the importance of competition than the flooding pattern. The general applicability of this result, obtained in mild Atlantic climate and fertile wetlands, remains to be studied.	[Merlin, Amandine; Bonis, Anne] Univ Rennes 1, CNRS, OSUR, UMR ECOBIO Ecosyst 6553,Biodivers,Evolut, Rennes, France; [Merlin, Amandine; Mesleard, Francois] Ctr Rech Tour du Valat, Arles, France; [Damgaard, Christian F.] Aarhus Univ, Dept Biosci Plant & Insect Ecol, Silkeborg, Denmark; [Mesleard, Francois] UMR CNRS 7263 IRD 237 Aix Marseille Univ, IUT Univ Avignon & Pays Vaucluse, Inst Mediterraneen Biodivers & Ecol, Marseille, France	Centre National de la Recherche Scientifique (CNRS); Universite Rennes 2; Universite de Rennes; Aarhus University; UDICE-French Research Universities; Aix-Marseille Universite	Bonis, A (corresponding author), Univ Rennes 1, CNRS, OSUR, UMR ECOBIO Ecosyst 6553,Biodivers,Evolut, Rennes, France.	anne.bonis@univ-rennes1.fr	Bonis, Anne/AAJ-1009-2021; Damgaard, Christian/G-2441-2010	Damgaard, Christian/0000-0003-3932-4312; Bonis, Anne/0000-0001-5034-9575	Ministere de l'Enseignement Superieur et de la Recherche Francais; Parc Naturel Regional du Marais poitevin	Ministere de l'Enseignement Superieur et de la Recherche Francais; Parc Naturel Regional du Marais poitevin	AM received a PhD grant from the Ministere de l'Enseignement Superieur et de la Recherche Francais. The Parc Naturel Regional du Marais poitevin provided the funding for maintaining the in situ grazing experimental setting. The authors thank the mairie des Magnils-Reigniers for granting permission to work in the common.	Aarssen LW, 2002, OIKOS, V96, P531, DOI 10.1034/j.1600-0706.2002.960314.x; Amiaud B, 1998, WETLANDS, V18, P482, DOI 10.1007/BF03161540; [Anonymous], 2001, PLANT STRATEGIES VEG; Baldwin AH, 2001, WETLANDS, V21, P519, DOI 10.1672/0277-5212(2001)021[0519:HCAVOT]2.0.CO;2; BARBOUR MG, 1978, OECOLOGIA, V37, P93, DOI 10.1007/BF00349995; Bartelheimer M, 2010, J ECOL, V98, P126, DOI 10.1111/j.1365-2745.2009.01598.x; Benot ML, 2011, BOTANY, V89, P43, DOI 10.1139/B10-082; Benot ML, 2010, EVOL ECOL, V24, P1475, DOI 10.1007/s10682-010-9415-0; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; BERTNESS MD, 1987, ECOL MONOGR, V57, P129, DOI 10.2307/1942621; Bouzille JB, 1997, PLANT ECOL, V132, P39, DOI 10.1023/A:1009743018006; Brooker RW, 2008, J ECOL, V96, P703, DOI 10.1111/j.1365-2745.2008.01373.x; Brooker RW, 1998, OIKOS, V81, P196, DOI 10.2307/3546481; Brose U, 2005, PLANT ECOL, V178, P51, DOI 10.1007/s11258-004-2487-6; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; Casanova MT, 2000, PLANT ECOL, V147, P237, DOI 10.1023/A:1009875226637; CLEVERING OA, 1995, NEW PHYTOL, V130, P105, DOI 10.1111/j.1469-8137.1995.tb01820.x; COOPER A, 1982, NEW PHYTOL, V90, P263, DOI 10.1111/j.1469-8137.1982.tb03258.x; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Damgaard C, 2014, J ENVIRON SCI HEAL B, V49, P897, DOI 10.1080/03601234.2014.951571; Damgaard C, 2011, AGR ECOSYST ENVIRON, V142, P374, DOI 10.1016/j.agee.2011.06.008; Damgaard C, 2010, J ECOL, V98, P1, DOI 10.1111/j.1365-2745.2009.01587.x; Damgaard C, 2009, PLANT ECOL, V201, P687, DOI 10.1007/s11258-008-9521-z; De Wilde M, 2014, EVOL ECOL, V28, P1155, DOI 10.1007/s10682-014-9725-8; DONG M, 1994, OIKOS, V70, P99, DOI 10.2307/3545704; Dumont B, 2012, AGR ECOSYST ENVIRON, V153, P50, DOI 10.1016/j.agee.2012.03.003; Erler DV, 2010, LIMNOL OCEANOGR, V55, P1172, DOI 10.4319/lo.2010.55.3.1172; Fayolle A, 2009, OECOLOGIA, V159, P817, DOI 10.1007/s00442-008-1254-0; Feng S, 2014, WATER AIR SOIL POLL, V225, P1; Fraser LH, 2008, PLANT ECOL, V195, P33, DOI 10.1007/s11258-007-9296-7; Freckleton RP, 2009, J ECOL, V97, P379, DOI 10.1111/j.1365-2745.2009.01497.x; Gardarin A, 2014, J APPL ECOL, V51, P1207, DOI 10.1111/1365-2664.12293; Gaucherand S, 2006, J VEG SCI, V17, P455, DOI 10.1111/j.1654-1103.2006.tb02466.x; Goldberg D. E., 1990, Perspectives on plant competition., P27; Gowing D. J. G., 1998, HYDROLOGY CHANGING E, VI, P473; Guo HY, 2012, ECOLOGY, V93, P90, DOI 10.1890/11-0487.1; He Q, 2013, ECOL LETT, V16, P695, DOI 10.1111/ele.12080; Howard TG, 2001, ECOLOGY, V82, P979, DOI 10.1890/0012-9658(2001)082[0979:CRHFGG]2.0.CO;2; Jung V, 2009, J VEG SCI, V20, P433, DOI 10.1111/j.1654-1103.2009.05786.x; La Peyre MKG, 2001, ECOLOGY, V82, P62, DOI 10.2307/2680086; Lenssen JPM, 2004, J ECOL, V92, P696, DOI 10.1111/j.0022-0477.2004.00895.x; Lenssen JPM, 2004, J VEG SCI, V15, P305, DOI 10.1658/1100-9233(2004)015[0305:DDFWCM]2.0.CO;2; Lenssen JPM, 1998, PLANT ECOL, V139, P13, DOI 10.1023/A:1009754505028; Lucassen ECHET, 2005, PLANT SOIL, V269, P109, DOI 10.1007/s11104-004-0554-3; Maalouf JP, 2012, ANN BOT-LONDON, V110, P821, DOI 10.1093/aob/mcs152; MESLEARD F, 1995, J VEG SCI, V6, P683, DOI 10.2307/3236438; Mony C, 2010, AQUAT BOT, V92, P99, DOI 10.1016/j.aquabot.2009.10.011; Mueller-Dombois D, 1996, ECOLOGY, V47, P644; Peltzer DA, 2001, J ECOL, V89, P519, DOI 10.1046/j.1365-2745.2001.00570.x; Rascio N, 2002, CRIT REV PLANT SCI, V21, P401, DOI 10.1080/0735-260291044296; Rossignol N, 2006, APPL SOIL ECOL, V31, P62, DOI 10.1016/j.apsoil.2005.04.004; SHIPLEY B, 1991, CAN J BOT, V69, P1420, DOI 10.1139/b91-184; Silvertown J, 2004, TRENDS ECOL EVOL, V19, P605, DOI 10.1016/j.tree.2004.09.003; Silvertown J, 1999, NATURE, V400, P61, DOI 10.1038/21877; SOUKUPOVA L, 1994, FOLIA GEOBOT PHYTOTX, V29, P227, DOI 10.1007/BF02803797; van Eck WHJM, 2004, OIKOS, V107, P393, DOI 10.1111/j.0030-1299.2004.13083.x; Violle C, 2006, IAHS-AISH P, V303, P334; Violle C, 2011, OIKOS, V120, P389, DOI 10.1111/j.1600-0706.2010.18525.x; Volder A, 1997, AQUAT BOT, V58, P113, DOI 10.1016/S0304-3770(97)00018-1; Warwick NWM, 2003, AQUAT BOT, V77, P153, DOI 10.1016/S0304-3770(03)00102-5; WELDEN CW, 1986, Q REV BIOL, V61, P23, DOI 10.1086/414724; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; WILSON SD, 1986, ECOLOGY, V67, P1236, DOI 10.2307/1938679	63	12	12	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130152	10.1371/journal.pone.0130152	http://dx.doi.org/10.1371/journal.pone.0130152			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075597	Green Published, Green Submitted, gold			2022-12-26	WOS:000356329900145
J	Yuri, S; Nishikawa, M; Yanagawa, N; Jo, OD; Yanagawa, N				Yuri, Shunsuke; Nishikawa, Masaki; Yanagawa, Naomi; Jo, Oak D.; Yanagawa, Norimoto			Maintenance of Mouse Nephron Progenitor Cells in Aggregates with Gamma-Secretase Inhibitor	PLOS ONE			English	Article							KIDNEY DEVELOPMENT; IN-VIVO; DIFFERENTIATION; REAGGREGATION; DISSOCIATION; MESENCHYME; RENEWAL; IDENTIFICATION; ORGANOGENESIS; MORPHOGENESIS	Knowledge on how to maintain and expand nephron progenitor cells (NPC) in vitro is important to provide a potentially valuable source for kidney replacement therapies. In our present study, we examined the possibility of optimizing NPC maintenance in the "re-aggregate" system. We found that Six2-expressing (Six2(+))-NPC could be maintained in aggregates reconstituted with dispersed cells from E12.5 mouse embryonic kidneys for at least up to 21 days in culture. The maintenance of Six2(+)-NPC required the presence of ureteric bud cells. The number of Six2(+)-NPC increased by more than 20-fold at day 21, but plateaued after day 14. In an attempt to further sustain NPC proliferation by passage subculture, we found that the new (P1) aggregates reconstituted from the original (P0) aggregates failed to maintain NPC. However, based on the similarity between P1 aggregates and aggregates derived from E15.5 embryonic kidneys, we suspected that the differentiated NPC in P1 aggregates may interfere with NPC maintenance. In support of this notion, we found that preventing NPC differentiation by DAPT, a gamma-secretase inhibitor that inhibits Notch signaling pathway, was effective to maintain and expand Six2(+)-NPC in P1 aggregates by up to 65-fold. The Six2(+)-NPC in P1 aggregates retained their potential to epithelialize upon exposure to Wnt signal. In conclusion, we demonstrated in our present study that the "re-aggregation" system can be useful for in vitro maintenance of NPC when combined with gamma-secretase inhibitor.	[Yuri, Shunsuke; Nishikawa, Masaki; Yanagawa, Naomi; Jo, Oak D.; Yanagawa, Norimoto] Greater Los Angeles Vet Affairs Healthcare Syst S, Med & Res Serv, Sepulveda, CA 91343 USA; [Yuri, Shunsuke; Nishikawa, Masaki; Yanagawa, Naomi; Jo, Oak D.; Yanagawa, Norimoto] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Yuri, S (corresponding author), Greater Los Angeles Vet Affairs Healthcare Syst S, Med & Res Serv, Sepulveda, CA 91343 USA.	shunsukeyuri@ucla.edu; nori@ucla.edu			Chau-Li Foundation	Chau-Li Foundation	This study was supported by generous funds provided by the Chau-Li Foundation (to NY).	Barak H, 2012, DEV CELL, V22, P1191, DOI 10.1016/j.devcel.2012.04.018; Blank U, 2009, DEVELOPMENT, V136, P3557, DOI 10.1242/dev.036335; Boyle S, 2008, DEV BIOL, V313, P234, DOI 10.1016/j.ydbio.2007.10.014; Brown AC, 2013, P NATL ACAD SCI USA, V110, P4640, DOI 10.1073/pnas.1213971110; Brown AC, 2011, DEVELOPMENT, V138, P5099, DOI 10.1242/dev.065995; Buck SB, 2008, BIOTECHNIQUES, V44, P927, DOI 10.2144/000112812; Carroll TJ, 2013, J AM SOC NEPHROL, V24, P873, DOI 10.1681/ASN.2012090931; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Chang CH, 2012, NEPHRON EXP NEPHROL, V121, pE79, DOI 10.1159/000345514; Cheng HT, 2003, DEVELOPMENT, V130, P5031, DOI 10.1242/dev.00697; Cheng HT, 2007, DEVELOPMENT, V134, P801, DOI 10.1242/dev.02773; Chi X, 2009, GENESIS, V47, P61, DOI 10.1002/dvg.20452; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; Das A, 2013, NAT CELL BIOL, V15, P1035, DOI 10.1038/ncb2828; Davies JA, 2014, PEDIATR NEPHROL, V29, P519, DOI 10.1007/s00467-013-2579-4; Dressler GR, 2009, DEVELOPMENT, V136, P3863, DOI 10.1242/dev.034876; Fetting JL, 2014, DEVELOPMENT, V141, P17, DOI 10.1242/dev.089078; Fujimura S, 2010, J AM SOC NEPHROL, V21, P803, DOI 10.1681/ASN.2009040353; Ganeva V, 2011, ORGANOGENESIS, V7, P83, DOI 10.4161/org.7.2.14881; Hatini V, 1996, GENE DEV, V10, P1467, DOI 10.1101/gad.10.12.1467; Hendry C, 2011, PEDIATR NEPHROL, V26, P1395, DOI 10.1007/s00467-010-1750-4; Herzlinger D, 2014, SEMIN CELL DEV BIOL, V36, P50, DOI 10.1016/j.semcdb.2014.08.002; Hum S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088400; Kanda S, 2014, J AM SOC NEPHROL, V25, P2584, DOI 10.1681/ASN.2013080896; Karner CM, 2011, DEVELOPMENT, V138, P1247, DOI 10.1242/dev.057646; Karner CM, 2010, DEV DYNAM, V239, P2014, DOI 10.1002/dvdy.22340; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Kobayashi A, 2014, STEM CELL REP, V3, P650, DOI 10.1016/j.stemcr.2014.08.008; Kopan R, 2014, CURR TOP DEV BIOL, V107, P293, DOI 10.1016/B978-0-12-416022-4.00011-1; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kuure S, 2007, J AM SOC NEPHROL, V18, P1130, DOI 10.1681/ASN.2006111206; Liu ZY, 2013, DEV CELL, V25, P585, DOI 10.1016/j.devcel.2013.05.022; Mendelsohn C, 1999, DEVELOPMENT, V126, P1139; Nishinakamura R, 2011, PEDIATR NEPHROL, V26, P1463, DOI 10.1007/s00467-011-1806-0; Osafune K, 2006, DEVELOPMENT, V133, P151, DOI 10.1242/dev.02174; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; Short KM, 2014, DEV CELL, V29, P188, DOI 10.1016/j.devcel.2014.02.017; Unbekandt M, 2010, KIDNEY INT, V77, P407, DOI 10.1038/ki.2009.482; Xinaris C, 2012, J AM SOC NEPHROL, V23, P1857, DOI 10.1681/ASN.2012050505	40	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129242	10.1371/journal.pone.0129242	http://dx.doi.org/10.1371/journal.pone.0129242			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075891	Green Published, gold			2022-12-26	WOS:000356329900057
J	Freitas, J; Teixeira, A; Silva, S; Oliveira, C; Dias, MS				Freitas, Joao; Teixeira, Antonio; Silva, Samuel; Oliveira, Catarina; Dias, Miguel Sales			Detecting Nasal Vowels in Speech Interfaces Based on Surface Electromyography	PLOS ONE			English	Article							MUSCLE-ACTIVITY; UPRIGHT	Nasality is a very important characteristic of several languages, European Portuguese being one of them. This paper addresses the challenge of nasality detection in surface electromyography (EMG) based speech interfaces. We explore the existence of useful information about the velum movement and also assess if muscles deeper down in the face and neck region can be measured using surface electrodes, and the best electrode location to do so. The procedure we adopted uses Real-Time Magnetic Resonance Imaging (RT-MRI), collected from a set of speakers, providing a method to interpret EMG data. By ensuring compatible data recording conditions, and proper time alignment between the EMG and the RT-MRI data, we are able to accurately estimate the time when the velum moves and the type of movement when a nasal vowel occurs. The combination of these two sources revealed interesting and distinct characteristics in the EMG signal when a nasal vowel is uttered, which motivated a classification experiment. Overall results of this experiment provide evidence that it is possible to detect velum movement using sensors positioned below the ear, between mastoid process and the mandible, in the upper neck region. In a frame-based classification scenario, error rates as low as 32.5% for all speakers and 23.4% for the best speaker have been achieved, for nasal vowel detection. This outcome stands as an encouraging result, fostering the grounds for deeper exploration of the proposed approach as a promising route to the development of an EMG-based speech interface for languages with strong nasal characteristics.	[Freitas, Joao; Dias, Miguel Sales] Microsoft Portugal, Microsoft Language Dev Ctr, Lisbon, Portugal; [Freitas, Joao; Teixeira, Antonio; Silva, Samuel] Univ Aveiro, Dept Elect Telecommun & Informat, P-3800 Aveiro, Portugal; [Freitas, Joao; Teixeira, Antonio; Silva, Samuel; Oliveira, Catarina] Univ Aveiro, Inst Elect & Telemat Engn IEETA, P-3800 Aveiro, Portugal; [Oliveira, Catarina] Univ Aveiro, Hlth Sch, P-3800 Aveiro, Portugal; [Dias, Miguel Sales] Inst Univ Lisboa ISCTE IUL, ISTAR IUL, Lisbon, Portugal	Microsoft; Universidade de Aveiro; Universidade de Aveiro; Universidade de Aveiro; Instituto Universitario de Lisboa	Freitas, J (corresponding author), Microsoft Portugal, Microsoft Language Dev Ctr, Lisbon, Portugal.	t-joaof@microsoft.com; ajst@ua.pt	Tsoy, Tatiana/N-7096-2019; Darrigran, Gustavo/L-6191-2019; Gonzalez-Cabrera, Joel/B-2279-2013; Teixeira, António J. S./A-4958-2012; Dumas, Guillaume/E-3756-2012; 中谷, 壽男/C-3220-2015; Tomas, Acacio RG/K-1118-2012; Vitullo, Alfredo/F-9744-2015; Zandonai, Thomas/V-2946-2019; Su, Chien-Wei/C-1521-2012; Jaffé, Rodolfo/K-3230-2013; Mazzucchelli, Trevor G/B-6659-2013; Gahlaut, Vijay/K-4904-2012; Sim, Edmund Ui-Hang/J-2863-2019; Sandström, Ulf/G-2833-2011; Gul, Taza/R-7774-2019; Sales Dias, Jose/M-5392-2013	Gonzalez-Cabrera, Joel/0000-0002-8338-370X; Teixeira, António J. S./0000-0002-7675-1236; Dumas, Guillaume/0000-0002-2253-1844; 中谷, 壽男/0000-0003-4949-5123; Tomas, Acacio RG/0000-0002-5794-1819; Vitullo, Alfredo/0000-0002-4833-5147; Zandonai, Thomas/0000-0002-7606-9675; Su, Chien-Wei/0000-0003-3889-7004; Jaffé, Rodolfo/0000-0002-2101-5282; Mazzucchelli, Trevor G/0000-0002-8306-3917; Gahlaut, Vijay/0000-0003-4381-3573; Sim, Edmund Ui-Hang/0000-0001-8652-8495; Sandström, Ulf/0000-0003-1292-8239; Gul, Taza/0000-0003-1376-8345; Sales Dias, Jose/0000-0002-1445-2695; Silva, Samuel/0000-0002-9858-8249; Oliveira, Catarina/0000-0002-3389-3082	Marie Curie Actions, Project IRIS (FP7-PEOPLE-IAPP) [610986]; Marie Curie Golem (FP7-PEOPLE-IAPP) [251415]; National Funds through the Foundation for Science and Technology (FST); Institute for Electronics and Telematics Engineering (IEETA) Research Unit [UID/CEC/00127/2013, Incentivo/EEI/UI0127/2014]; Project HERON II [PTDC/EEA-PLP/098298/2008]; Quadro de Referencia Estrategico Nacional (QREN); Mais Centro Program, Project Cloud Thinking [CENTRO-07-ST24-FEDER-002031]; Fundação para a Ciência e a Tecnologia [Incentivo/EEI/UI0127/2014, PTDC/EEA-PLP/098298/2008, UID/CEC/00127/2013] Funding Source: FCT	Marie Curie Actions, Project IRIS (FP7-PEOPLE-IAPP); Marie Curie Golem (FP7-PEOPLE-IAPP); National Funds through the Foundation for Science and Technology (FST); Institute for Electronics and Telematics Engineering (IEETA) Research Unit; Project HERON II; Quadro de Referencia Estrategico Nacional (QREN); Mais Centro Program, Project Cloud Thinking; Fundação para a Ciência e a Tecnologia	JF, SS, AT, MSD: Marie Curie Actions, Project IRIS (ref. 610986, FP7-PEOPLE-2013-IAPP) JF, MSD: Marie Curie Golem (ref. 251415, FP7-PEOPLE-2009-IAPP). AT, SS, CO: National Funds through the Foundation for Science and Technology (FST), Institute for Electronics and Telematics Engineering (IEETA) Research Unit (ref. UID/CEC/00127/2013 and Incentivo/EEI/UI0127/2014) and Project HERON II (PTDC/EEA-PLP/098298/2008). SS: Quadro de Referencia Estrategico Nacional (QREN), Mais Centro Program, Project Cloud Thinking (ref. CENTRO-07-ST24-FEDER-002031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida A, 1976, READINGS PORTUGUESE, P348; Beddor Patrice S., 1993, NASALS NASALIZATION, P171; BELLBERTI F, 1976, J SPEECH HEAR RES, V19, P225, DOI 10.1044/jshr.1902.225; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Cover T.M., 2006, FDN CYBERNATICS, P748, DOI DOI 10.1002/047174882X; Denby B, 2010, SPEECH COMMUN, V52, P270, DOI 10.1016/j.specom.2009.08.002; Ellis D., 2003, DYNAMIC TIME WARP DT; Engwall O., 2006, SPEECH PRODUCTION MO, P301; Everitt B. H. T., 2009, HDB STAT ANAL USING; Feng JL, 2012, IEEE SIGNAL PROC MAG, V29, P177, DOI 10.1109/MSP.2011.943131; Flynn R, 2008, SPEECH COMMUN, V50, P797, DOI 10.1016/j.specom.2008.05.004; Freitas Joao, 2012, Proceedings of the International Conference on Bio-inspired Systems and Signal Processing (BIOSIGNALS 2012), P91; Freitas J, 2012, COMM COM INF SC, V328, P227; Fritzell B, 1969, ACTA OTOLARYNGOLICA, V50; Hardcastle W.J., 1976, PHYSL SPEECH PRODUCT; Heistermann T., 2014, P BIOS, P189; HUDGINS B, 1993, IEEE T BIO-MED ENG, V40, P82, DOI 10.1109/10.204774; Kitamura T, 2005, ACOUST SCI TECHNOL, V26, P465, DOI 10.1250/ast.26.465; KUEHN DP, 1982, CLEFT PALATE J, V19, P25; KUEHN DP, 1988, CLEFT PALATE J, V25, P348; Lacerda A, 1966, REV LAB FONETICA EXP, V6, P5; Lubker J F, 1968, Cleft Palate J, V5, P1; Maier-Hein L, 2005, 2005 IEEE Workshop on Automatic Speech Recognition and Understanding (ASRU), P331; McGill S, 1996, J BIOMECH, V29, P1503, DOI 10.1016/0021-9290(96)84547-7; MOON JB, 1995, CLEFT PALATE-CRAN J, V32, P371, DOI 10.1597/1545-1569(1995)032<0371:EOGOVM>2.3.CO;2; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Perry JL, 2011, CLEFT PALATE-CRAN J, V48, P123, DOI 10.1597/09-256; R Core Team, 2016, R FDN STAT COMP; Sampson R., 1999, NASAL VOWEL EVOLUTIO; Seikel J.A., 2009, ANATOMY PHYSL SPEECH, V4th; Silva S, 2012, LNCS; Stone M, 2007, J ACOUST SOC AM, V122, P532, DOI 10.1121/1.2715659; Teixeira A., 2012, LNCS, V7243, P306, DOI DOI 10.1007/978-3-642-28885-2_; Teixeira A, 2000, THESIS U AVEIRO; Tiede M.K., 2000, P 5 SEMINAR SPEECH P, P25; Wand M, 2011, BIOSIGNALS 2011, P295; WINTER DA, 1987, ELECTROEN CLIN NEURO, V67, P402, DOI 10.1016/0013-4694(87)90003-4; Wrench A., 2011, P INT C PHON SCI 17, P2161; Xuan Huang, 2021, 2021 IEEE Intl Conf on Dependable, Autonomic and Secure Computing, Intl Conf on Pervasive Intelligence and Computing, Intl Conf on Cloud and Big Data Computing, Intl Conf on Cyber Science and Technology Congress (DASC/PiCom/CBDCom/CyberSciTech), P867, DOI 10.1109/DASC-PICom-CBDCom-CyberSciTech52372.2021.00144; Yao YY, 2003, STUD FUZZ SOFT COMP, V119, P115	40	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0127040	10.1371/journal.pone.0127040	http://dx.doi.org/10.1371/journal.pone.0127040			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26069968	gold, Green Published, Green Submitted			2022-12-26	WOS:000356327000005
J	Lin, IF; Yamada, T; Komine, Y; Kato, N; Kato, M; Kashino, M				Lin, I-Fan; Yamada, Takashi; Komine, Yoko; Kato, Nobumasa; Kato, Masaharu; Kashino, Makio			Vocal Identity Recognition in Autism Spectrum Disorder	PLOS ONE			English	Article							EMOTION RECOGNITION; VOICE PERCEPTION; COMPLEX SOUNDS; CHILDREN; SPEECH; GENDER; FACE	Voices can convey information about a speaker. When forming an abstract representation of a speaker, it is important to extract relevant features from acoustic signals that are invariant to the modulation of these signals. This study investigated the way in which individuals with autism spectrum disorder (ASD) recognize and memorize vocal identity. The ASD group and control group performed similarly in a task when asked to choose the name of the newly-learned speaker based on his or her voice, and the ASD group outperformed the control group in a subsequent familiarity test when asked to discriminate the previously trained voices and untrained voices. These findings suggest that individuals with ASD recognized and memorized voices as well as the neurotypical individuals did, but they categorized voices in a different way: individuals with ASD categorized voices quantitatively based on the exact acoustic features, while neurotypical individuals categorized voices qualitatively based on the acoustic patterns correlated to the speakers' physical and mental properties.	[Lin, I-Fan; Kato, Masaharu; Kashino, Makio] NTT Corp, NTT Commun Sci Labs, Atsugi, Kanagawa, Japan; [Yamada, Takashi; Komine, Yoko; Kato, Nobumasa] Showa Univ, Med Inst Dev Disabil Res, Tokyo, Japan; [Yamada, Takashi] ATR Brain Informat Commun Res Lab Grp, Kyoto, Japan; [Kato, Masaharu] Doshisha Univ, Ctr Baby Sci, Kyoto 602, Japan; [Kashino, Makio] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Informat Proc, Yokohama, Kanagawa 227, Japan; [Kashino, Makio] JST, CREST, Atsugi, Kanagawa, Japan	Nippon Telegraph & Telephone Corporation; Showa University; Doshisha University; Tokyo Institute of Technology; Japan Science & Technology Agency (JST)	Lin, IF (corresponding author), NTT Corp, NTT Commun Sci Labs, Atsugi, Kanagawa, Japan.	lin.ifan@lab.ntt.co.jp; kashino.makio@lab.ntt.co.jp	Lin, Ifan/HHM-7112-2022		Ministry of Education, Culture, Sports, Science and Technology [24119006]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The work reported in this paper has been supported by Grant-in-Aid for Scientific Research on Innovative Areas "Constructive Developmental Science" (No. 24119006) from The Ministry of Education, Culture, Sports, Science and Technology (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NTT Corporation provided support in the form of salaries for authors [full: Makio Kashino; partial: I-Fan Lin and Masaharu Kato], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abrams DA, 2013, P NATL ACAD SCI USA, V110, P12060, DOI 10.1073/pnas.1302982110; American Psychatric Association, 2000, DIAGN STAT MAN MENT; Belin P, 2011, BRIT J PSYCHOL, V102, P711, DOI 10.1111/j.2044-8295.2011.02041.x; Boddaert N, 2004, AM J PSYCHIAT, V161, P2117, DOI 10.1176/appi.ajp.161.11.2117; Boddaert N, 2003, AM J PSYCHIAT, V160, P2057, DOI 10.1176/appi.ajp.160.11.2057; Boucher J, 1998, J CHILD PSYCHOL PSYC, V39, P171, DOI 10.1111/1469-7610.00311; Boucher J, 2000, J CHILD PSYCHOL PSYC, V41, P847, DOI 10.1017/S0021963099006149; CHILDERS DG, 1991, J ACOUST SOC AM, V90, P1841, DOI 10.1121/1.401664; Dawson G, 1998, J AUTISM DEV DISORD, V28, P479, DOI 10.1023/A:1026043926488; Garrido L, 2009, NEUROPSYCHOLOGIA, V47, P123, DOI 10.1016/j.neuropsychologia.2008.08.003; Gervais H, 2004, NAT NEUROSCI, V7, P801, DOI 10.1038/nn1291; Golan O, 2007, J AUTISM DEV DISORD, V37, P1096, DOI 10.1007/s10803-006-0252-5; Groen W, 2008, J AUTISM DEV DISORD, V38, P1819, DOI 10.1007/s10803-008-0572-8; Heaton P, 2009, PHILOS T R SOC B, V364, P1443, DOI 10.1098/rstb.2008.0327; KASUYA H, 1986, SPEECH COMMUN, V5, P171, DOI 10.1016/0167-6393(86)90006-3; KLIN A, 1991, J AUTISM DEV DISORD, V21, P29, DOI 10.1007/BF02206995; KUWABARA H, 1995, SPEECH COMMUN, V16, P165, DOI 10.1016/0167-6393(94)00053-D; LANCKER DV, 1985, J PHON, V13, P19; Lancker DV, 1985, J PHONETICS, V13, P39; Loveland KA, 1997, DEV PSYCHOPATHOL, V9, P579, DOI 10.1017/S0954579497001351; MURRAY IR, 1993, J ACOUST SOC AM, V93, P1097, DOI 10.1121/1.405558; Peppe S, 2007, J SPEECH LANG HEAR R, V50, P1015, DOI 10.1044/1092-4388(2007/071); Simmons DR, 2009, VISION RES, V49, P2705, DOI 10.1016/j.visres.2009.08.005; Soulieres I, 2007, J AUTISM DEV DISORD, V37, P481, DOI 10.1007/s10803-006-0172-4; Weigelt S, 2012, NEUROSCI BIOBEHAV R, V36, P1060, DOI 10.1016/j.neubiorev.2011.12.008; Yovel G, 2013, TRENDS COGN SCI, V17, P263, DOI 10.1016/j.tics.2013.04.004; Zaske R, 2014, J NEUROSCI, V34, P10821, DOI 10.1523/JNEUROSCI.0581-14.2014; Zaske R, 2010, HEARING RES, V268, P38, DOI 10.1016/j.heares.2010.04.011	28	12	12	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129451	10.1371/journal.pone.0129451	http://dx.doi.org/10.1371/journal.pone.0129451			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6GR	26070199	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000077
J	Mamonova, T; Zhang, QM; Khajeh, JA; Bu, ZM; Bisello, A; Friedman, PA				Mamonova, Tatyana; Zhang, Qiangmin; Khajeh, Jahan Ali; Bu, Zimei; Bisello, Alessandro; Friedman, Peter A.			Canonical and Noncanonical Sites Determine NPT2A Binding Selectivity to NHERF1 PDZ1	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; PROTEIN INTERACTIONS; STRUCTURAL BASIS; DOMAIN; RECEPTOR; SEQUENCE; PARTNERS; CFTR; PH; RECOGNITION	Na+/H+ Exchanger Regulatory Factor-1 (NHERF1) is a scaffolding protein containing 2 PDZ domains that coordinates the assembly and trafficking of transmembrane receptors and ion channels. Most target proteins harboring a C-terminus recognition motif bind more-or-less equivalently to the either PDZ domain, which contain identical core-binding motifs. However some substrates such as the type II sodium-dependent phosphate co-transporter (NPT2A), uniquely bind only one PDZ domain. We sought to define the structural determinants responsible for the specificity of interaction between NHERF1 PDZ domains and NPT2A. By performing all-atom/explicit-solvent molecular dynamics (MD) simulations in combination with biological mutagenesis, fluorescent polarization (FP) binding assays, and isothermal titration calorimetry (ITC), we found that in addition to canonical interactions of residues at 0 and -2 positions, Arg at the -1 position of NPT2A plays a critical role in association with Glu43 and His27 of PDZ1 that are absent in PDZ2. Experimentally introduced mutation in PDZ1 (Glu43Asp and His27Asn) decreased binding to NPT2A. Conversely, introduction of Asp183Glu and Asn167His mutations in PDZ2 promoted the formation of favorable interactions yielding micromolar KDs. The results describe novel determinants within both the PDZ domain and outside the canonical PDZ-recognition motif that are responsible for discrimination of NPT2A between two PDZ domains. The results challenge general paradigms for PDZ recognition and suggest new targets for drug development.	[Mamonova, Tatyana; Zhang, Qiangmin; Bisello, Alessandro; Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Khajeh, Jahan Ali] CUNY City Coll, Dept Chem & Biochem, Chem & Biochem PhD program, New York, NY 10031 USA; [Bu, Zimei] CUNY City Coll, Dept Chem, New York, NY 10031 USA; [Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City College of New York (CUNY); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mamonova, T (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA.	tbm7@pitt.edu			National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [DK069998]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069998] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Support was provided by National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases grant DK069998.	Amacher JF, 2014, STRUCTURE, V22, P82, DOI 10.1016/j.str.2013.09.019; Amacher JF, 2013, J BIOL CHEM, V288, P5114, DOI 10.1074/jbc.M112.401588; Ardura JA, 2011, PHARMACOL REV, V63, P882, DOI 10.1124/pr.110.004176; Bhattacharya S, 2013, J MOL BIOL, V425, P2509, DOI 10.1016/j.jmb.2013.04.001; Bhattacharyya R, 2003, J PROTEOME RES, V2, P255, DOI 10.1021/pr025584d; Case D, 2006, AMBER 9; Chen JR, 2008, NAT BIOTECHNOL, V26, P1041, DOI 10.1038/nbt.1489; Cushing PR, 2008, BIOCHEMISTRY-US, V47, P10084, DOI 10.1021/bi8003928; Ernst A, 2014, J MOL BIOL, V426, P3509, DOI 10.1016/j.jmb.2014.08.012; Gisler SM, 2008, MOL CELL PROTEOMICS, V7, P1362, DOI 10.1074/mcp.M800079-MCP200; Gisler SM, 2001, J BIOL CHEM, V276, P9206, DOI 10.1074/jbc.M008745200; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Hawkins JC, 2012, IEEE ACM T COMPUT BI, V9, P1492, DOI 10.1109/TCBB.2012.54; Heyda J, 2010, J PHYS CHEM B, V114, P8744, DOI 10.1021/jp101031v; Hui S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-27; Jacobs DJ, 2001, PROTEINS, V44, P150, DOI 10.1002/prot.1081; Karthikeyan S, 2002, J BIOL CHEM, V277, P18973, DOI 10.1074/jbc.M201507200; Karthikeyan S, 2001, J BIOL CHEM, V276, P19683, DOI 10.1074/jbc.C100154200; Karthikeyan S, 2001, J MOL BIOL, V308, P963, DOI 10.1006/jmbi.2001.4634; Khundmiri SJ, 2008, AM J PHYSIOL-RENAL, V294, pF840, DOI 10.1152/ajprenal.00180.2007; Kurnikov IV, HAMILTONIAN RES LARG; Lee RJ, 1996, BBA-MOL CELL RES, V1312, P237, DOI 10.1016/0167-4889(96)00041-9; Lu GR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076219; Mahon MJ, 2004, J BIOL CHEM, V279, P23550, DOI 10.1074/jbc.M313229200; Mamonova T, 2012, BIOCHEMISTRY-US, V51, P3110, DOI 10.1021/bi201213w; Maouyo D, 2000, AM J PHYSIOL-CELL PH, V278, pC973, DOI 10.1152/ajpcell.2000.278.5.C973; Prasad H, 2015, J BIOL CHEM, V290, P5311, DOI 10.1074/jbc.M114.602219; Roehrl MHA, 2004, BIOCHEMISTRY-US, V43, P16056, DOI 10.1021/bi048233g; Shenolikar S, 2001, AM J PHYSIOL-RENAL, V280, pF389, DOI 10.1152/ajprenal.2001.280.3.F389; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; STICKLE DF, 1992, J MOL BIOL, V226, P1143, DOI 10.1016/0022-2836(92)91058-W; Tiwari G, 2014, J CHEM INF MODEL, V54, P1143, DOI 10.1021/ci400627y; Voltz JW, 2001, ONCOGENE, V20, P6309, DOI 10.1038/sj.onc.1204774; Wang B, 2008, MOL BIOL CELL, V19, P1637, DOI 10.1091/mbc.E07-11-1114; Wang B, 2012, J BIOL CHEM, V287, P24148, DOI 10.1074/jbc.M112.369405; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; Xu D, 1997, PROTEIN ENG, V10, P999, DOI 10.1093/protein/10.9.999; Ye F, 2013, BIOCHEM J, V455, P1, DOI 10.1042/BJ20130783	38	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129554	10.1371/journal.pone.0129554	http://dx.doi.org/10.1371/journal.pone.0129554			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070212	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000356327000089
J	Mann, BF; Chen, HM; Herndon, EM; Chu, RK; Tolic, N; Portier, EF; Chowdhury, TR; Robinson, EW; Callister, SJ; Wullschleger, SD; Graham, DE; Liang, LY; Gu, BH				Mann, Benjamin F.; Chen, Hongmei; Herndon, Elizabeth M.; Chu, Rosalie K.; Tolic, Nikola; Portier, Evan F.; Chowdhury, Taniya Roy; Robinson, Errol W.; Callister, Stephen J.; Wullschleger, Stan D.; Graham, David E.; Liang, Liyuan; Gu, Baohua			Indexing Permafrost Soil Organic Matter Degradation Using High-Resolution Mass Spectrometry	PLOS ONE			English	Article							NITROGEN MINERALIZATION; TEMPERATURE SENSITIVITY; ALPINE TUNDRA; CARBON; SYSTEM; ECOSYSTEMS; PROTEOMICS; CHEMISTRY; TRANSECT; TURNOVER	Microbial degradation of soil organic matter (SOM) is a key process for terrestrial carbon cycling, although the molecular details of these transformations remain unclear. This study reports the application of ultrahigh resolution mass spectrometry to profile the molecular composition of SOM and its degradation during a simulated warming experiment. A soil sample, collected near Barrow, Alaska, USA, was subjected to a 40-day incubation under anoxic conditions and analyzed before and after the incubation to determine changes of SOM composition. A CHO index based on molecular C, H, and O data was utilized to codify SOM components according to their observed degradation potentials. Compounds with a CHO index score between -1 and 0 in a water-soluble fraction (WSF) demonstrated high degradation potential, with a highest shift of CHO index occurred in the N-containing group of compounds, while similar stoichiometries in a base-soluble fraction (BSF) did not. Additionally, compared with the classical H:C vs O:C van Krevelen diagram, CHO index allowed for direct visualization of the distribution of heteroatoms such as N in the identified SOM compounds. We demonstrate that CHO index is useful not only in characterizing arctic SOM at the molecular level but also enabling quantitative description of SOM degradation, thereby facilitating incorporation of the high resolution MS datasets to future mechanistic models of SOM degradation and prediction of greenhouse gas emissions.	[Mann, Benjamin F.; Chen, Hongmei; Herndon, Elizabeth M.; Portier, Evan F.; Wullschleger, Stan D.; Liang, Liyuan; Gu, Baohua] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; [Herndon, Elizabeth M.] Kent State Univ, Dept Geol, Kent, OH 44242 USA; [Chu, Rosalie K.; Tolic, Nikola; Robinson, Errol W.; Callister, Stephen J.] Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA 99352 USA; [Chowdhury, Taniya Roy; Graham, David E.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory	Gu, BH (corresponding author), Oak Ridge Natl Lab, Div Environm Sci, POB 2008, Oak Ridge, TN 37831 USA.	gub1@ornl.gov	Wullschleger, Stan D/B-8297-2012; Gu, Baohua/B-9511-2012; Graham, David E/F-8578-2010; Chen, Hongmei/S-3911-2019; Liang, Liyuan/O-7213-2014; Chen, Hongmei/T-9222-2017	Wullschleger, Stan D/0000-0002-9869-0446; Gu, Baohua/0000-0002-7299-2956; Graham, David E/0000-0001-8968-7344; Chen, Hongmei/0000-0003-2460-838X; Liang, Liyuan/0000-0003-1338-0324; Chen, Hongmei/0000-0003-2460-838X; Herndon, Elizabeth/0000-0002-9194-5493	U.S. Department of Energy (DOE), Office of Science, Biological and Environmental Research (BER) at Oak Ridge National Laboratory; BER Genome Sciences Program Pan-omics project	U.S. Department of Energy (DOE), Office of Science, Biological and Environmental Research (BER) at Oak Ridge National Laboratory(United States Department of Energy (DOE)); BER Genome Sciences Program Pan-omics project	This research was supported in part by the U.S. Department of Energy (DOE), Office of Science, Biological and Environmental Research (BER) at Oak Ridge National Laboratory. A portion of this research was funded by BER Genome Sciences Program Pan-omics project and performed in the Environmental Molecular Sciences Laboratory at Pacific Northwest National Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2014, FRONT MICROBIOL, V5; Anderson NL, 1998, ELECTROPHORESIS, V19, P1853, DOI 10.1002/elps.1150191103; Bae E, 2011, ANAL CHEM, V83, P4193, DOI 10.1021/ac200464q; Bhatia MP, 2010, GEOCHIM COSMOCHIM AC, V74, P3768, DOI 10.1016/j.gca.2010.03.035; Biasi C, 2005, RAPID COMMUN MASS SP, V19, P1401, DOI 10.1002/rcm.1911; Brown TL, 2000, ANAL CHEM, V72, P384, DOI 10.1021/ac9902087; Chen HM, 2011, LIMNOL OCEANOGR-METH, V9, P582, DOI 10.4319/lom.2011.9.582; Chen J, 2003, CHEMOSPHERE, V50, P639, DOI 10.1016/S0045-6535(02)00616-1; Chen J, 2002, CHEMOSPHERE, V48, P59, DOI 10.1016/S0045-6535(02)00041-3; Chowdhury TR, 2015, GLOBAL CHANGE BIOL, V21, P722, DOI 10.1111/gcb.12762; Coolen MJL, 2011, ENVIRON MICROBIOL, V13, P2299, DOI 10.1111/j.1462-2920.2011.02489.x; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; Dai XY, 2002, J ANAL APPL PYROL, V62, P249, DOI 10.1016/S0165-2370(01)00123-1; FISK MC, 1995, SOIL SCI SOC AM J, V59, P1036, DOI 10.2136/sssaj1995.03615995005900040012x; Haddix ML, 2011, SOIL SCI SOC AM J, V75, P56, DOI 10.2136/sssaj2010.0118; Jaffe R, 2012, GEOCHIM COSMOCHIM AC, V94, P95, DOI 10.1016/j.gca.2012.06.031; Jenkinson DS, 2008, EUR J SOIL SCI, V59, P400, DOI 10.1111/j.1365-2389.2008.01026.x; Kim S, 2003, ANAL CHEM, V75, P5336, DOI 10.1021/ac034415p; Kleber M, 2011, GLOBAL CHANGE BIOL, V17, P1097, DOI 10.1111/j.1365-2486.2010.02278.x; Koch BP, 2007, ANAL CHEM, V79, P1758, DOI 10.1021/ac061949s; Koch BP, 2006, RAPID COMMUN MASS SP, V20, P926, DOI 10.1002/rcm.2386; Kujawinski EB, 2006, ANAL CHEM, V78, P4363, DOI 10.1021/ac0600306; Kujawinski EB, 2009, GEOCHIM COSMOCHIM AC, V73, P4384, DOI 10.1016/j.gca.2009.04.033; Lipson DA, 2012, BIOGEOSCIENCES, V9, P577, DOI 10.5194/bg-9-577-2012; Lipson DA, 1998, OECOLOGIA, V113, P406, DOI 10.1007/s004420050393; Malik A, 2013, SOIL BIOL BIOCHEM, V62, P115, DOI 10.1016/j.soilbio.2013.02.022; Masiello CA, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000534; Monga O, 2014, BIOGEOSCIENCES, V11, P2201, DOI 10.5194/bg-11-2201-2014; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; OECHEL WC, 1993, NATURE, V361, P520, DOI 10.1038/361520a0; Pare MC, 2013, ARCT ANTARCT ALP RES, V45, P88, DOI 10.1657/1938-4246-45.1.88; Parton WJ, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001193; Perminova IV, 2014, ENVIRON SCI TECHNOL, V48, P7461, DOI 10.1021/es5015423; Riley WJ, 2014, GEOSCI MODEL DEV, V7, P1335, DOI 10.5194/gmd-7-1335-2014; Rostad CE, 2004, ANAL CHIM ACTA, V523, P269, DOI 10.1016/j.aca.2004.06.065; Roth VN, 2013, GEOCHIM COSMOCHIM AC, V123, P93, DOI 10.1016/j.gca.2013.09.002; RYAN MG, 1990, CAN J FOREST RES, V20, P166, DOI 10.1139/x90-023; Said-Pullicino D, 2007, CHEMOSPHERE, V66, P2166, DOI 10.1016/j.chemosphere.2006.09.010; Schulten HR, 1997, BIOL FERT SOILS, V26, P1, DOI 10.1007/s003740050335; Sistla SA, 2012, NEW PHYTOL, V196, P68, DOI 10.1111/j.1469-8137.2012.04234.x; Sleighter RL, 2008, MAR CHEM, V110, P140, DOI 10.1016/j.marchem.2008.04.008; Stevenson FJ, 1982, HUMUS CHEM; Tang JY, 2015, NAT CLIM CHANGE, V5, P56, DOI [10.1038/NCLIMATE2438, 10.1038/nclimate2438]; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Tfaily MM, 2015, ANAL CHEM, DOI [10.1021/acs.analchem.1025b00116, DOI 10.1021/ACS.ANALCHEM.1025B00116]; Trumbore S, 2009, ANNU REV EARTH PL SC, V37, P47, DOI 10.1146/annurev.earth.36.031207.124300; Van Krevelen D., 1950, GRAPHICAL STAT METHO, V29, P269, DOI DOI 10.1520/D0850-11.1; Weintraub MN, 2003, ECOSYSTEMS, V6, P129, DOI 10.1007/s10021-002-0124-6; White D, 1999, J ANAL APPL PYROL, V50, P63, DOI 10.1016/S0165-2370(99)00003-0; Xu XF, 2014, ECOL LETT, V17, P547, DOI 10.1111/ele.12254	50	59	61	11	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130557	10.1371/journal.pone.0130557	http://dx.doi.org/10.1371/journal.pone.0130557			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068586	Green Submitted, Green Published, gold			2022-12-26	WOS:000356327000158
J	Mugnai, R; Sattamini, A; dos Santos, JAA; Regua-Mangia, AH				Mugnai, Riccardo; Sattamini, Ana; Albuquerque dos Santos, Jose Augusto; Regua-Mangia, Adriana Hamond			A Survey of Escherichia coli and Salmonella in the Hyporheic Zone of a Subtropical Stream: Their Bacteriological, Physicochemical and Environmental Relationships	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; FECAL CONTAMINATION; INDICATOR BACTERIA; SURVIVAL; WATER; SEDIMENTS; FOREST; PATTERNS; SURFACE; GROWTH	The Hyporheic Zone is among the most important interstitial freshwater habitats, but the relationship between biotic and abiotic factors in this zone remains under-explored. Enterobacteria were expected to be present, but no specific studies had ever confirmed this prediction. The aim of this study was, therefore, to evaluate the total coliforms, Escherichia coli and Salmonella spp. in hyporheic water and to determine the relationship of the physical, chemical and environmental factors at different depths in a rainforest stream. To this end, thirty-six water samples were collected at three depths in sites located in the first, second and third orders in diverse substrates. The total coliforms, Escherichia coli and Salmonella sp. were evaluated in terms of their CFU/ml. In the interstitial samples, coliforms were detected in 100% of the samples. The total coliform counts had higher values at intermediate depths, while Escherichia coli and Salmonella spp. instead had higher values at intermediate and large depths, often reaching or exceeding the values of the surface samples. Our results revealed that Salmonella spp. and the coliforms have different microhabitat preferences. Salmonella spp. and coliform species prefer deposition areas, such as lateral sides of pools, curves and bars, but they have a tendency to distribute into different depths, likely due to temperature differences. Salmonella spp. prefer compact substrata, with fewer fluids passing through and with upwelling areas with lower oxygen inflow. The coliform species showed the opposite preference. Our results suggest that bacterial variation is related to environmental factors and physical-chemical parameters within the HZ and may play a key role in the microbial diversity and distribution in these ecosystems.	[Mugnai, Riccardo] Univ Fed Rio de Janeiro, Dept Invertebrados Museu Nacl, Lab Aracnol, Rio De Janeiro, Brazil; [Sattamini, Ana; Albuquerque dos Santos, Jose Augusto] Fundacao Oswaldo Cruz, Lab Avaliacao & Promocao Saude Ambiental, Rio De Janeiro, Brazil; [Regua-Mangia, Adriana Hamond] Fundacao Oswaldo Cruz, Dept Ciencias Biol, Lab Epidemiol Mol Doencas Infecciosas, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Mugnai, R (corresponding author), Univ Fed Rio de Janeiro, Dept Invertebrados Museu Nacl, Lab Aracnol, Rio De Janeiro, Brazil.	mugnai.riccardo@gmail.com	MUGNAI, RICCARDO/ABE-1180-2021	MUGNAI, RICCARDO/0000-0002-4476-3099				Akter S, 2013, EPIDEMIOL INFECT, V141, P2516, DOI 10.1017/S0950268813000320; Anderson JK, 2005, HYDROL PROCESS, V19, P2931, DOI 10.1002/hyp.5791; Anderson ML, 2005, APPL ENVIRON MICROB, V71, P3041, DOI 10.1128/AEM.71.6.3041-3048.2005; APHA, 2005, STAND METH EX WAT WA, V20th; Ateba BH, 2012, J ENV SCI WAT RES, V1, P243; Barbour M.T., 1999, EPA841B99002, P197; Barlocher F, 2006, MICROB ECOL, V52, P708, DOI 10.1007/s00248-006-9102-4; Bencala KE, 2000, HYDROL PROCESS, V14, P2797, DOI 10.1002/1099-1085(20001030)14:15<2797::AID-HYP402>3.0.CO;2-6; Berman GC, 2000, ENVIRON MANAGE, V1, P1; BERMUDEZ M, 1988, APPL ENVIRON MICROB, V54, P979; Braioni MG, 2002, FRESHWAT SCI, V2; Brasil. Ministerio da Saude Fundacao Nacional de Saude, 1999, MAN TECN AN AG CONS, P211; Brasil. Ministerio das Minas e Energia, 1987, IBGE BRASILIA, V32, P775; BRETSCHKO G, 1988, PROC INT ASSOC THE 3, V23, P1333; Brunke M, 1997, FRESHWATER BIOL, V37, P1, DOI 10.1046/j.1365-2427.1997.00143.x; BURTON GA, 1987, APPL ENVIRON MICROB, V53, P633, DOI 10.1128/AEM.53.4.633-638.1987; Byamukama D, 2000, APPL ENVIRON MICROB, V66, P864, DOI 10.1128/AEM.66.2.864-868.2000; Byappanahalli MN, 1998, WATER SCI TECHNOL, V38, P171, DOI 10.1016/S0273-1223(98)00820-8; CARRILLO M, 1985, APPL ENVIRON MICROB, V50, P468, DOI 10.1128/AEM.50.2.468-476.1985; Committee on Indicators for Waterborne Pathogens-National Research Council, 2004, IND WAT PATH; Danielpol DL, 2008, GROUNDWATER SCI POLI; Danyluk MD, 2008, J APPL MICROBIOL, V104, P1391, DOI 10.1111/j.1365-2672.2007.03662.x; Rebello RCD, 2014, SCI TOTAL ENVIRON, V490, P19, DOI 10.1016/j.scitotenv.2014.04.040; Desmarais TR, 2002, APPL ENVIRON MICROB, V68, P1165, DOI 10.1128/AEM.68.3.1165-1172.2002; Dole-Olivier MJ, 1998, FRESHWATER BIOL, V40, P93, DOI 10.1046/j.1365-2427.1998.00335.x; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Duke JR, 2007, HYDROL PROCESS, V21, P141, DOI 10.1002/hyp.6228; Eaton A.D., 2005, STANDARD METHODS EXA, P1368; FEEMA. Fundacao Estadual de Engenharia do Meio Ambiente (Rio de Janeiro), 1982, SUMULA, V3, P86; FISH JT, 1995, LETT APPL MICROBIOL, V20, P277, DOI 10.1111/j.1472-765X.1995.tb00445.x; Franken RJM, 2001, HYDROBIOLOGIA, V444, P183, DOI 10.1023/A:1017598005228; FUNASA. Ministerio da Saude (BR), 2006, MAN PRAT AN AG; Gibbons SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097435; Gilbride K., 2014, WATERBORNE PATHOGENS; Halda-Alija L, 2001, MICROBIAL ECOL, V42, P286, DOI 10.1007/s00248-001-0021-0; Harwood VJ, 2014, FEMS MICROBIOL REV, V38, P1, DOI 10.1111/1574-6976.12031; Harwood VJ, 2000, APPL ENVIRON MICROB, V66, P3698, DOI 10.1128/AEM.66.9.3698-3704.2000; HENDRICKS CW, 1967, WATER RES, V1, P567, DOI 10.1016/0043-1354(67)90039-5; HENDRICKS CW, 1971, APPL MICROBIOL, V21, P379, DOI 10.1128/AEM.21.2.379-380.1971; HOFF GL, 1977, J HERPETOL, V11, P123, DOI 10.2307/1563132; JIMENEZ L, 1989, J APPL BACTERIOL, V67, P61, DOI 10.1111/j.1365-2672.1989.tb04955.x; KAWAKAMI M, 1984, J IMMUNOL, V132, P2578; Khebiza MY, 2006, ITAL J ZOOL, V73, P153, DOI 10.1080/11250000600679462; Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788; LEICHTFRIED M, 1991, INT VER THEOR ANGEW, V24, P1921; Leichtfried M, 1988, VERH INT VEREIN LIMN, V23, P1325, DOI DOI 10.1080/03680770.1987.11898016-; Levantesi C, 2012, FOOD RES INT, V45, P587, DOI 10.1016/j.foodres.2011.06.037; LINS ZEA C., 1964, AN MICROBIOL, V12, P19; Maal-Bared R, 2013, SCI TOTAL ENVIRON, V443, P315, DOI 10.1016/j.scitotenv.2012.10.106; Malard F, 2002, EVKCT200100121 PASCA; Martins FD, 2011, BIOL J LINN SOC, V104, P499, DOI 10.1111/j.1095-8312.2011.01745.x; MCFETERS GA, 1974, APPL MICROBIOL, V27, P823, DOI 10.1128/AEM.27.5.823-829.1974; Orghidan T., 1959, ARCH HYDROBIOL, V55, P392; PEREZROSAS N, 1989, APPL ENVIRON MICROB, V55, P495; PUSCH M, 1994, ARCH HYDROBIOL, V130, P35; RICHARDS C, 1994, GREAT BASIN NAT, V54, P106; RIVERA SC, 1988, APPL ENVIRON MICROB, V54, P513, DOI 10.1128/AEM.54.2.513-517.1988; SAVAGEAU MA, 1983, AM NAT, V122, P732, DOI 10.1086/284168; Savichtcheva O, 2006, WATER RES, V40, P2463, DOI 10.1016/j.watres.2006.04.040; SHERER BM, 1992, J ENVIRON QUAL, V21, P591, DOI 10.2134/jeq1992.00472425002100040011x; Simpson VR, 2002, VET J, V163, P128, DOI 10.1053/tvjl.2001.0662; Solo-Gabriele HM, 2000, APPL ENVIRON MICROB, V66, P230, DOI 10.1128/AEM.66.1.230-237.2000; STENSTROM TA, 1989, APPL ENVIRON MICROB, V55, P142; Storey RG, 1999, FRESHWATER BIOL, V41, P119, DOI 10.1046/j.1365-2427.1999.00377.x; Strahler A.N., 1957, EOS T AM GEOPHYS UNI, V38, P912, DOI [10.1029/TR038i006p00913, DOI 10.1029/TR038I006P00913]; Tallon P, 2005, WATER AIR SOIL POLL, V166, P139, DOI 10.1007/s11270-005-7905-4; TERBRAAK CJF, 1995, AQUAT SCI, V57, P255, DOI 10.1007/BF00877430; Toranzos G. A., 1997, Manual of environmental microbiology., P184; Torres AG, 2010, PATHOGENIC ESCHERICH, P1; Wang ZY, 2012, WORLD J MICROB BIOT, V28, P2741, DOI 10.1007/s11274-012-1085-3; WHITE D S, 1987, Journal of the North American Benthological Society, V6, P85, DOI 10.2307/1467218; WHITE DS, 1990, HYDROBIOLOGIA, V196, P149, DOI 10.1007/BF00006106; Williams N.D., 2010, PATHOGENIC ESCHERICH, V1st ed., P8; Winfield MD, 2003, APPL ENVIRON MICROB, V69, P3687, DOI 10.1128/AEM.69.7.3687-3694.2003	74	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129382	10.1371/journal.pone.0129382	http://dx.doi.org/10.1371/journal.pone.0129382			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26067288	Green Published, Green Submitted, gold			2022-12-26	WOS:000356327000070
J	Raboanatahiry, NH; Lu, GY; Li, MT				Raboanatahiry, Nadia Haingotiana; Lu, Guangyuan; Li, Maoteng			Computational Prediction of acyl-coA Binding Proteins Structure in Brassica napus	PLOS ONE			English	Article							ANKYRIN-REPEAT; ACBP2 INTERACTS; LIGAND-BINDING; COENZYME; OVEREXPRESSION; EXPRESSION; LOCALIZATION; EVOLUTION; ALTERS; ATEBP	Acyl-coA binding proteins could transport acyl-coA esters from plastid to endoplasmic reticulum, prior to fatty acid biosynthesis, leading to the formation of triacylglycerol. The structure and the subcellular localization of acyl-coA binding proteins (ACBP) in Brassica napus were computationally predicted in this study. Earlier, the structure analysis of ACBPs was limited to the small ACBPs, the current study focused on all four classes of ACBPs. Physicochemical parameters including the size and the length, the intron-exon structure, the isoelectric point, the hydrophobicity, and the amino acid composition were studied. Furthermore, identification of conserved residues and conserved domains were carried out. Secondary structure and tertiary structure of ACBPs were also studied. Finally, subcellular localization of ACBPs was predicted. The findings indicated that the physicochemical parameters and subcellular localizations of ACBPs in Brassica napus were identical to Arabidopsis thaliana. Conserved domain analysis indicated that ACBPs contain two or three kelch domains that belong to different families. Identical residues in acyl-coA binding domains corresponded to eight amino acid residues in all ACBPs of B. napus. However, conserved residues of common ACBPs in all species of animal, plant, bacteria and fungi were only inclusive in small ACBPs. Alpha-helixes were displayed and conserved in all the acyl-coA binding domains, representing almost the half of the protein structure. The findings confirm high similarities in ACBPs between A. thaliana and B. napus, they might share the same functions but loss or gain might be possible.	[Raboanatahiry, Nadia Haingotiana; Li, Maoteng] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Peoples R China; [Lu, Guangyuan] Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan 430062, Hubei, Peoples R China; [Raboanatahiry, Nadia Haingotiana; Li, Maoteng] Hubei Collaborat Innovat Ctr Characterist Resourc, Huanggang 435599, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS	Lu, GY (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan 430062, Hubei, Peoples R China.	luwiz@oilcrops.cn; limaoteng426@mail.hust.edu.cn			International Cooperation in Science and Technology Projects [2014DFA32210]; National Natural Science Foundation of China [31171582]; National Basic Research Program of China [2015CB150205]; New Century Talents Support Program of the Ministry of Education of China [NCET110172]	International Cooperation in Science and Technology Projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); New Century Talents Support Program of the Ministry of Education of China	The International Cooperation in Science and Technology Projects (2014DFA32210), the National Natural Science Foundation of China (31171582), the National Basic Research Program of China (2015CB150205) and New Century Talents Support Program of the Ministry of Education of China (NCET110172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bennett V, 2001, CURR OPIN CELL BIOL, V13, P61, DOI 10.1016/S0955-0674(00)00175-7; Blum T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-274; BORK P, 1994, J MOL BIOL, V236, P1277, DOI 10.1016/0022-2836(94)90056-6; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; Brown AP, 1998, PLANT PHYSIOL BIOCH, V36, P629, DOI 10.1016/S0981-9428(98)80011-9; Bryant SH, 1996, IUCR MACR CRYST COMP; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Burton M, 2005, BIOCHEM J, V392, P299, DOI 10.1042/BJ20050664; Buttner M, 1997, P NATL ACAD SCI USA, V94, P5961, DOI 10.1073/pnas.94.11.5961; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Chen QF, 2008, PLANT PHYSIOL, V148, P304, DOI 10.1104/pp.108.123331; CHOI D, 1994, P NATL ACAD SCI USA, V91, P2329, DOI 10.1073/pnas.91.6.2329; Chye ML, 1999, PLANT J, V18, P205, DOI 10.1046/j.1365-313X.1999.00443.x; Chye ML, 1998, PLANT MOL BIOL, V38, P827, DOI 10.1023/A:1006052108468; Chye ML, 2000, PLANT MOL BIOL, V44, P711, DOI 10.1023/A:1026524108095; Chye ML, 2010, BIOCATALYSIS MOL ENG, P83; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; DAVIS LH, 1990, J BIOL CHEM, V265, P10589; Du ZY, 2015, PLANT CELL ENVIRON, V38, P101, DOI 10.1111/pce.12382; Du ZY, 2013, PLANTA, V238, P239, DOI 10.1007/s00425-013-1904-2; Du ZY, 2013, PLANT J, V74, P294, DOI 10.1111/tpj.12121; Du ZY, 2013, PLANT CELL ENVIRON, V36, P300, DOI 10.1111/j.1365-3040.2012.02574.x; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Engeseth NJ, 1996, ARCH BIOCHEM BIOPHYS, V331, P55, DOI 10.1006/abbi.1996.0282; Faergeman NJ, 2007, MOL CELL BIOCHEM, V299, P55, DOI 10.1007/s11010-005-9040-3; Faergeman NJ, 1996, BIOCHEMISTRY-US, V35, P14118, DOI 10.1021/bi960545z; Fox SR, 2000, BIOCHEM J, V352, P525, DOI 10.1042/0264-6021:3520525; Gao W, 2009, NEW PHYTOL, V181, P89, DOI 10.1111/j.1469-8137.2008.02631.x; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Gorina S, 1996, SCIENCE, V274, P1001, DOI 10.1126/science.274.5289.1001; Gossett RE, 1996, LIPIDS, V31, P895, DOI 10.1007/BF02522684; Huang H, 2005, BIOCHEMISTRY-US, V44, P10282, DOI 10.1021/bi0477891; ITO N, 1991, NATURE, V350, P87, DOI 10.1038/350087a0; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KNUDSEN J, 1994, BIOCHEM J, V302, P479, DOI 10.1042/bj3020479; Kragelund BB, 1999, BIOCHEMISTRY-US, V38, P2386, DOI 10.1021/bi982427c; KRAGELUND BB, 1993, J MOL BIOL, V230, P1260, DOI 10.1006/jmbi.1993.1240; Letunic I, 2014, NUCL ACIDS RES; Leung KC, 2006, PLANTA, V223, P871, DOI 10.1007/s00425-005-0139-2; Leung KC, 2004, PLANT MOL BIOL, V55, P297, DOI 10.1007/s11103-004-0642-z; Li HY, 2008, J EXP BOT, V59, P3997, DOI 10.1093/jxb/ern241; Li HY, 2004, PLANT MOL BIOL, V54, P233, DOI 10.1023/B:PLAN.0000028790.75090.ab; Li HY, 2003, PLANT MOL BIOL, V51, P483, DOI 10.1023/A:1022330304402; Liao P, 2014, PLANT CELL PHYSIOL, V55, P1055, DOI 10.1093/pcp/pcu037; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MADEJ T, 1995, PROTEINS, V23, P356, DOI 10.1002/prot.340230309; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Mosavi LK, 2002, P NATL ACAD SCI USA, V99, P16029, DOI 10.1073/pnas.252537899; Pacovsky RS, 1996, THESIS MICHIGAN STAT; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; ROSENDAL J, 1993, BIOCHEM J, V290, P321, DOI 10.1042/bj2900321; Rubtsov AM, 2000, FEBS LETT, V482, P1, DOI 10.1016/S0014-5793(00)01924-4; Schjerling CK, 1996, J BIOL CHEM, V271, P22514, DOI 10.1074/jbc.271.37.22514; Tse MH, 2005, THESIS U HONG KONG; Wei LQ, 2009, J INTEGR PLANT BIOL, V51, P140, DOI 10.1111/j.1744-7909.2008.00791.x; Xiao S, 2008, PLANT MOL BIOL, V68, P571, DOI 10.1007/s11103-008-9392-7; Xiao S, 2011, PROG LIPID RES, V50, P141, DOI 10.1016/j.plipres.2010.11.002; Xiao S, 2010, PLANT CELL, V22, P1463, DOI 10.1105/tpc.110.075333; Xiao S, 2009, PLANT PHYSIOL BIOCH, V47, P479, DOI 10.1016/j.plaphy.2008.12.002; Xie LJ, 2015, PLANT J, V81, P53, DOI 10.1111/tpj.12692; XUE FY, 1993, CELL, V72, P681, DOI 10.1016/0092-8674(93)90397-9; Xue Y, 2014, J EXP BOT, V65, P5473, DOI 10.1093/jxb/eru304; Yurchenko O, 2014, PLANT PHYSIOL, V165, P550, DOI 10.1104/pp.114.238071; Zheng SX, 2012, J EXPT BOT, P1, DOI [10.1093/jxb/err241, DOI 10.1093/JXB/ERR241]	70	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129650	10.1371/journal.pone.0129650	http://dx.doi.org/10.1371/journal.pone.0129650			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26065422	Green Submitted, Green Published, gold			2022-12-26	WOS:000356100900067
J	De-Simone, FI; Sariyer, R; Otalora, YL; Yarandi, S; Craigie, M; Gordon, J; Sariyer, IK				De-Simone, Francesca Isabella; Sariyer, Rahsan; Otalora, Yolanda-Lopez; Yarandi, Shadan; Craigie, Michael; Gordon, Jennifer; Sariyer, Ilker Kudret			IFN-Gamma Inhibits JC Virus Replication in Glial Cells by Suppressing T-Antigen Expression	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; HUMAN POLYOMAVIRUS JC; INTERFERON-GAMMA; BETA-CATENIN; TYROSINE PHOSPHORYLATION; GENE-EXPRESSION; ANTIVIRAL STATE; NATALIZUMAB; INFECTION; PROTEINS	Objective Patients undergoing immune modulatory therapies for the treatment of autoimmune diseases such as multiple sclerosis, and individuals with an impaired-immune system, most notably AIDS patients, are in the high risk group of developing progressive multifocal leukoencephalopathy (PML), an often lethal disease of the brain characterized by lytic infection of oligodendrocytes in the central nervous system (CNS) with JC virus (JCV). The immune system plays an important regulatory role in controlling JCV reactivation from latent sites by limiting viral gene expression and replication. However, little is known regarding the molecular mechanisms responsible for this regulation. Methods and Results Here, we investigated the impact of soluble immune mediators secreted by activated PBMCs on viral replication and gene expression by cell culture models and molecular virology techniques. Our data revealed that viral gene expression and viral replication were suppressed by soluble immune mediators. Further studies demonstrated that soluble immune mediators secreted by activated PBMCs inhibit viral replication induced by T-antigen, the major viral regulatory protein, by suppressing its expression in glial cells. This unexpected suppression of T-antigen was mainly associated with the suppression of translational initiation. Cytokine/chemokine array studies using conditioned media from activated PBMCs revealed several candidate cytokines with possible roles in this regulation. Among them, only IFN-gamma showed a robust inhibition of T-antigen expression. While potential roles for IFN-beta, and to a lesser extent IFN-alpha have been described for JCV, IFN-gamma has not been previously implicated. Further analysis of IFN-gamma signaling pathway revealed a novel role of Jak1 signaling in control of viral T-antigen expression. Furthermore, IFN-gamma suppressed JCV replication and viral propagation in primary human fetal glial cells, and showed a strong anti-JCV activity. Conclusions Our results suggest a novel role for IFN-gamma in the regulation of JCV gene expression via downregulation of the major viral regulatory protein, T-antigen, and provide a new avenue of research to understand molecular mechanisms for downregulation of viral reactivation that may lead to development of novel strategies for the treatment of PML.	[De-Simone, Francesca Isabella; Sariyer, Rahsan; Otalora, Yolanda-Lopez; Yarandi, Shadan; Craigie, Michael; Gordon, Jennifer; Sariyer, Ilker Kudret] Temple Univ, Ctr Neurovirol, Sch Med, Dept Neurosci, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Sariyer, IK (corresponding author), Temple Univ, Ctr Neurovirol, Sch Med, Dept Neurosci, 3500 North Broad St,7th Floor, Philadelphia, PA 19140 USA.	isariyer@temple.edu	Sariyer, Ilker/AAE-7677-2020	Craigie, Michael/0000-0001-5990-9110	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI101192, R21NS081447]; Comprehensive NeuroAIDS Center (CNAC NIMH grant) at Temple University School of Medicine [P30MH092177]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH092177, T32MH079785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS081447] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Comprehensive NeuroAIDS Center (CNAC NIMH grant) at Temple University School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award numbers R01AI101192 and R21NS081447. This study utilized services offered by core facilities of the Comprehensive NeuroAIDS Center (CNAC NIMH grant number P30MH092177) at Temple University School of Medicine. The funding organizations played no role in the design of the study, in the collection, analysis, and interpretation of the data and in the decision to submit the manuscript for publication.	Abend JR, 2007, J VIROL, V81, P272, DOI 10.1128/JVI.01571-06; Atzeni F, 2013, AUTOIMMUN REV, V12, P575, DOI 10.1016/j.autrev.2012.10.020; Bayliss J, 2013, J INFECT DIS, V207, P133, DOI 10.1093/infdis/jis668; Bayliss J, 2011, PATHOLOGY, V43, P362, DOI 10.1097/PAT.0b013e3283463558; Beltrami S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053447; Berger JR, 2011, DISCOV MED, V12, P495; Bhattacharyya R, 2007, ONCOGENE, V26, P7628, DOI 10.1038/sj.onc.1210576; Brew BJ, 2010, NAT REV NEUROL, V6, P667, DOI 10.1038/nrneurol.2010.164; Briscoe J, 1996, EMBO J, V15, P799, DOI 10.1002/j.1460-2075.1996.tb00415.x; Carson KR, 2009, LANCET ONCOL, V10, P816, DOI 10.1016/S1470-2045(09)70161-5; Chahin S, 2014, J NEUROVIROL; Del Valle L, 2008, J NEUROPATH EXP NEUR, V67, P729, DOI 10.1097/NEN.0b013e318180e631; Delbue S, 2008, J MED VIROL, V80, P2147, DOI 10.1002/jmv.21313; Egli A, 2009, J INFECT DIS, V199, P837, DOI 10.1086/597126; Enam S, 2002, CANCER RES, V62, P7093; Frisque RJ, 2001, J NEUROVIROL, V7, P293, DOI 10.1080/13550280152537120; Gan DD, 2004, ONCOGENE, V23, P483, DOI 10.1038/sj.onc.1207018; Giacobbi NS, 2015, VIROLOGY, V476, P377, DOI 10.1016/j.virol.2014.12.032; GREENLUND AC, 1994, EMBO J, V13, P1591, DOI 10.1002/j.1460-2075.1994.tb06422.x; GREENLUND AC, 1995, IMMUNITY, V2, P677, DOI 10.1016/1074-7613(95)90012-8; Gualco E, 2010, CELL DEATH DIFFER, V17, P439, DOI 10.1038/cdd.2009.146; HEIM MH, 1995, SCIENCE, V267, P1347, DOI 10.1126/science.7871432; HOLMAN RC, 1991, NEUROLOGY, V41, P1733, DOI 10.1212/WNL.41.11.1733; IGARASHI K, 1994, J BIOL CHEM, V269, P14333; Khalili K, 2008, J CELL PHYSIOL, V215, P309, DOI 10.1002/jcp.21326; Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P369, DOI 10.1056/NEJMoa051782; Koralnik IJ, 2002, J NEUROVIROL, V8, P59, DOI 10.1080/13550280290167894; Langer-Gould A, 2005, NEW ENGL J MED, V353, P375, DOI 10.1056/NEJMoa051847; LASHGARI MS, 1989, VIROLOGY, V170, P292, DOI 10.1016/0042-6822(89)90381-4; Ousman SS, 2012, NAT NEUROSCI, V15, P1096, DOI 10.1038/nn.3161; Safak M, 1999, J VIROL, V73, P10146, DOI 10.1128/JVI.73.12.10146-10157.1999; San-Andres FJ, 2003, CLIN INFECT DIS, V36, P1177, DOI 10.1086/374358; Saribas AS, 2010, FUTURE VIROL, V5, P313, DOI 10.2217/FVL.10.12; Sariyer IK, 2008, VIROLOGY, V375, P464, DOI 10.1016/j.virol.2008.02.020; Sariyer IK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045000; Sariyer IK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014630; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Tan CS, 2010, J VIROL, V84, P9200, DOI 10.1128/JVI.00609-10; Tan CS, 2009, J INFECT DIS, V199, P881, DOI 10.1086/597117; Uleri E, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-147; Vugmeyster Y, 2004, CLIN IMMUNOL, V113, P38, DOI 10.1016/j.clim.2004.06.001; Wilson JJ, 2011, J VIROL, V85, P10126, DOI 10.1128/JVI.00761-11; Wollebo HS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-264; Zhang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083766	44	32	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129694	10.1371/journal.pone.0129694	http://dx.doi.org/10.1371/journal.pone.0129694			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061652	Green Submitted, Green Published, gold			2022-12-26	WOS:000355979500158
J	Ma, LN; Li, Y; Wang, JY; Zhu, H; Yang, W; Cao, RJ; Qian, YY; Feng, M				Ma, Lina; Li, Yun; Wang, Jieyu; Zhu, Hong; Yang, Wei; Cao, Ruojin; Qian, Yuying; Feng, Ming			Quality of Life Is Related to Social Support in Elderly Osteoporosis Patients in a Chinese Population	PLOS ONE			English	Article							BONE-MINERAL DENSITY; POSTMENOPAUSAL OSTEOPOROSIS; SOCIOECONOMIC-STATUS; DEPRESSIVE SYMPTOMS; ASSOCIATION; FRACTURE; FAMILY; WOMEN; BEHAVIORS; STRESS	Objective To explore the association between quality of life and social support in elderly osteoporosis patients in a Chinese population. Methods A total of 214 elderly patients who underwent bone mineral density screening were divided into two groups: elderly patients with primary osteoporosis (case group, n = 112) and normal elderly patients (control group, n = 102). Quality of life and social support were compared between the two groups. Results Quality of life and social support were significantly different between the case and control groups. The physical function, role-physical, bodily pain, general health, vitality, social-functioning, role-emotional and mental health scores in case group were significantly lower than those in the control group (P < 0.01). The objective support, subjective support, utilization of support, and total scores in case group were significantly lower than those in the control group (P < 0.01). Quality of life and social support were positively correlated in the case group (r = 0.672, P < 0.01). Conclusion Quality of life and social support in elderly patients with osteoporosis in China were poorer than in elderly patients without osteoporosis and were positively correlated. Our findings indicate that increased efforts to improve the social support and quality of life in elderly osteoporosis patients are urgently needed in China. Further longitudinal studies should be conducted to provide more clinical evidence to determine causative factors for the observed association between risk factors and outcomes.	[Ma, Lina; Li, Yun; Wang, Jieyu; Zhu, Hong; Yang, Wei; Cao, Ruojin; Qian, Yuying; Feng, Ming] Capital Med Univ, Xuan Wu Hosp, Dept Geriatr, Beijing 100053, Peoples R China	Capital Medical University	Li, Y (corresponding author), Capital Med Univ, Xuan Wu Hosp, Dept Geriatr, Beijing 100053, Peoples R China.	liy_xw@sina.com	Ma, Lina/R-6802-2016; wang, jie/GRS-0942-2022	Ma, Lina/0000-0001-7630-6960; 	MOE (Ministry of Education in China) Project of Humanities and Social Sciences [12YJCZH146]; Beijing Municipal Health Bureau Research Fund [Jing 13-02]; Beijing Excellent Talent Fund [20140000204400001]	MOE (Ministry of Education in China) Project of Humanities and Social Sciences; Beijing Municipal Health Bureau Research Fund; Beijing Excellent Talent Fund	MOE (Ministry of Education in China) Project of Humanities and Social Sciences (12YJCZH146), Beijing Municipal Health Bureau Research Fund (Jing 13-02) and Beijing Excellent Talent Fund (20140000204400001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen B, 2015, J BONE MINER RES, V30, P1553, DOI 10.1002/jbmr.2478; Adachi JD, 2003, OSTEOPOROSIS INT, V14, P895, DOI 10.1007/s00198-003-1483-3; ALEXEEVA L, 1994, WHO TECH REP SER, V843, P1; Besser Sarah Jane, 2012, Arch Osteoporos, V7, P115, DOI 10.1007/s11657-012-0089-9; Brennan SL, 2013, AUST NZ J PUBL HEAL, V37, P226, DOI 10.1111/1753-6405.12063; Bucholz EM, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001252; CAMERONJR, 1963, SCIENCE, V142, P230, DOI 10.1126/science.142.3589.230; Cesarec Gordana, 2014, Coll Antropol, V38, P247; Cong Z, 2011, INT J SOC WELF, V20, pS4, DOI 10.1111/j.1468-2397.2011.00823.x; DuPertuis LL, 2001, J AGING HEALTH, V13, P494, DOI 10.1177/089826430101300403; Ebesunun M O, 2014, Afr J Med Med Sci, V43, P41; Ford MA, 2011, J OSTEOPOROS, V2011, DOI 10.4061/2011/729219; GREENDALE GA, 1995, J AM GERIATR SOC, V43, P955, DOI 10.1111/j.1532-5415.1995.tb05557.x; [郭文斌 Guo Wenbin], 2003, [中国心理卫生杂志, Chinese Mental Health Journal], V17, P693; Hodge AM, 2013, MATURITAS, V75, P361, DOI 10.1016/j.maturitas.2013.05.002; Hongo M, 2012, OSTEOPOROSIS INT, V23, P1029, DOI 10.1007/s00198-011-1624-z; Huang CY, 2015, OSTEOPOROSIS INT, V26, P875, DOI 10.1007/s00198-014-2963-3; Huang SS, 2014, ENDOKRYNOL POL, V65, P96, DOI 10.5603/EP.2014.0014; Ievers-Landis CE, 2003, J PEDIATR PSYCHOL, V28, P335, DOI 10.1093/jpepsy/jsg023; Santini ZI, 2015, J AFFECT DISORDERS, V175, P53, DOI 10.1016/j.jad.2014.12.049; Kessenich CR, 2012, REHABIL NURS, V25, P88; Lau EMC, 2015, J CLIN DENSITOM, V18, P519, DOI 10.1016/j.jocd.2014.11.001; Lau Y, 2014, ARCH PSYCHIAT NURS, V28, P305, DOI 10.1016/j.apnu.2014.05.009; Lee CNY, 2015, JPN J NURS SCI, V12, P232, DOI 10.1111/jjns.12063; Li HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090051; Liu L, 2014, J HLTH PSYCHOL; Ma YH, 2007, J INTERVENT RADIOL, V16, P497; Mookadam F, 2004, ARCH INTERN MED, V164, P1514, DOI 10.1001/archinte.164.14.1514; Ng CWL, 2014, ANN ACAD MED SINGAP, V43, P576; Organization W.H., 1998, GUID PRECL EV CLIN T; Pitsilka DA, 2015, CLIN EXP RHEUMATOL, V33, P27; Schroder G, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-101; Snellman G, 2014, J CLIN ENDOCR METAB, V99, P781, DOI 10.1210/jc.2013-1738; Sok SR, 2011, J CLIN NURS, V20, P1606, DOI 10.1111/j.1365-2702.2010.03551.x; Sun W, 2015, ARCH GERONTOL GERIAT, V60, P311, DOI 10.1016/j.archger.2014.12.002; Sutton BS, 2015, QUAL LIFE RES; Tadic I, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-74; Tian Q, 2014, J HLTH PSYCHOL; Tremollieres F, 2010, MATURITAS, V65, P348, DOI 10.1016/j.maturitas.2009.12.023; Vujasinovic-Stupar Nada, 2005, Med Pregl, V58, P453, DOI 10.2298/MPNS0510453V; Wang CX, 2008, CHINESE J REHAB, V23, P250; [汪关宝 WANG Guanbao], 2008, [中国全科医学, Chinese General Practice], V11, P1229; Wang XM, 2014, INT J MENT HEALTH SY, V8, DOI 10.1186/1752-4458-8-41; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wilson S, 2012, OSTEOPOROSIS INT, V23, P2749, DOI 10.1007/s00198-012-2050-6; Wu Q., 1995, CHIN J OSTEOPOROSIS, V1, P76; Wu Z, 2015, J GERONTOL B; Xu JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079045; Yamashita CH, 2013, REV ESC ENFERM USP, V47, P1359, DOI 10.1590/S0080-623420130000600016; Yeung GTY, 2007, EUR J AGEING, V4, P219, DOI 10.1007/s10433-007-0065-1; Zhang J, 2014, COMMUNITY MENT HLTH; Zhou YC, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0136-4; Zhou ZH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/192376	53	18	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0127849	10.1371/journal.pone.0127849	http://dx.doi.org/10.1371/journal.pone.0127849			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK1PO	26061550	Green Submitted, gold, Green Published			2022-12-26	WOS:000355979500061
J	Sistiaga, A; Wrangham, R; Rothman, JM; Summons, RE				Sistiaga, Ainara; Wrangham, Richard; Rothman, Jessica M.; Summons, Roger E.			New Insights into the Evolution of the Human Diet from Faecal Biomarker Analysis in Wild Chimpanzee and Gorilla Faeces	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; EARLY HOMINID; DOCOSAHEXAENOIC ACID; ISOTOPIC EVIDENCE; KIBALE FOREST; BILE-ACIDS; CHOLESTEROL; STEROLS; MEAT; COPROSTANOL	Our understanding of early human diets is based on reconstructed biomechanics of hominin jaws, bone and teeth isotopic data, tooth wear patterns, lithic, taphonomic and zooarchaeological data, which do not provide information about the relative amounts of different types of foods that contributed most to early human diets. Faecal biomarkers are proving to be a valuable tool in identifying relative proportions of plant and animal tissues in Palaeolithic diets. A limiting factor in the application of the faecal biomarker approach is the striking absence of data related to the occurrence of faecal biomarkers in non-human primate faeces. In this study we explored the nature and proportions of sterols and stanols excreted by our closest living relatives. This investigation reports the first faecal biomarker data for wild chimpanzee (Pan troglodytes) and mountain gorilla (Gorilla beringei). Our results suggest that the chemometric analysis of faecal biomarkers is a useful tool for distinguishing between NHP and human faecal matter, and hence, it could provide information for palaeodietary research and early human diets.	[Sistiaga, Ainara; Summons, Roger E.] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Sistiaga, Ainara] Univ La Laguna, E-38207 San Cristobal la Laguna, Spain; [Wrangham, Richard] Harvard Univ, Cambridge, MA 02138 USA; [Rothman, Jessica M.] CUNY, Hunter Coll, New York, NY 10021 USA	Massachusetts Institute of Technology (MIT); Universidad de la Laguna; Harvard University; City University of New York (CUNY) System; Hunter College (CUNY)	Sistiaga, A (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	msistiag@ull.es	Sistiaga, Ainara/AAB-7769-2021; Summons, Roger Everett/AAL-3789-2020	Sistiaga, Ainara/0000-0003-1732-7010; 	Canarian Government; European Asociation of Organic Geochemistry; National Science Foundation [BCS-0849380, BCS-0648481, IOS-0416125]; Cornell University; NASA Astrobiology Institute [NNA13AA90A]; Agencia Canaria de Investigacion, Innovacion and Sociedad de la Informacion; European Social Funds	Canarian Government; European Asociation of Organic Geochemistry; National Science Foundation(National Science Foundation (NSF)); Cornell University; NASA Astrobiology Institute; Agencia Canaria de Investigacion, Innovacion and Sociedad de la Informacion; European Social Funds(European Social Fund (ESF))	This research was funded by a Canarian Government predoctoral grant and a European Asociation of Organic Geochemistry travel award to AS. Long-term data-collection by KCP was supported by grants from the National Science Foundation (BCS-0849380, BCS-0648481 and IOS-0416125) to RW and M. Muller, and funds for faecal collection by JMR was supported by Cornell University. Research at Massachusetts Institute of Technology was supported by a grant (NNA13AA90A) from NASA Astrobiology Institute to RES. yawara for research permission and field support. The authors' acknowledge the funds awarded to University of La Laguna by the Agencia Canaria de Investigacion, Innovacion and Sociedad de la Informacion, cofunded by 85% with European Social Funds.	AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Aiello LC, 2012, CURR ANTHROPOL, V53, pS267, DOI 10.1086/667709; Anderson GJ, 2005, PEDIATR RES, V58, P865, DOI 10.1203/01.pdr.0000182188.31596.5a; [Anonymous], 1990, FOOD INSECTS NEWSL; Archer W, 2014, J HUM EVOL, V77, P74, DOI 10.1016/j.jhevol.2014.02.012; Arnason U, 1998, J MOL EVOL, V47, P718, DOI 10.1007/PL00006431; AUSMAN LM, 1993, COMP BIOCHEM PHYS B, V105, P655, DOI 10.1016/0305-0491(93)90102-B; BARTLETT PD, 1987, MAR POLLUT BULL, V18, P27, DOI 10.1016/0025-326X(87)90653-9; Berzenay Y, 1959, B SOC ROYAL ZOO DANV, V10, P1; BETHELL PH, 1994, J ARCHAEOL SCI, V21, P619, DOI 10.1006/jasc.1994.1061; BHATTACHARYYA AK, 1984, ATHEROSCLEROSIS, V53, P225, DOI 10.1016/0021-9150(84)90123-0; BHATTACHARYYA AK, 1989, NUTR CANCER, V12, P69, DOI 10.1080/01635588909514003; Birk JJ, 2011, J ARCHAEOL SCI, V38, P1209, DOI 10.1016/j.jas.2010.12.015; Blumenschine RJ, 2006, EARLY HOMININ DIETS, P167; Boesch C, 2001, MG BEH ECOL, P453; Braun DR, 2010, P NATL ACAD SCI USA, V107, P10002, DOI 10.1073/pnas.1002181107; Brenna JT, 2014, J HUM EVOL, V77, P99, DOI 10.1016/j.jhevol.2014.02.017; Bull ID, 2002, ENVIRON INT, V27, P647, DOI 10.1016/S0160-4120(01)00124-6; Bull ID, 1999, ANTIQUITY, V73, P86, DOI 10.1017/S0003598X0008786X; Bunn H. T., 2001, MEAT EATING HUMAN EV, P199; BUNN HT, 1986, CURR ANTHROPOL, V27, P431, DOI 10.1086/203467; BUNN HT, 1981, NATURE, V291, P574, DOI 10.1038/291574a0; Carlson BA, 2007, AM J HUM BIOL, V19, P585, DOI 10.1002/ajhb.20683; Carlson BA, 2013, AM J PRIMATOL, V75, P342, DOI 10.1002/ajp.22112; Cerling TE, 2013, P NATL ACAD SCI USA, V110, P10501, DOI 10.1073/pnas.1222568110; CHAPMAN CA, 1993, AM J PRIMATOL, V31, P263, DOI 10.1002/ajp.1350310403; Chivers D.J., 1984, P213; Cohen B., 1993, COTTON TOP TAMARIN P, P241; Conklin-Brittain NL, 1998, INT J PRIMATOL, V19, P971, DOI 10.1023/A:1020370119096; Conklin-Brittain NL, 1997, P NUTR SOC, V56, p322A; Cordain L, 2002, EUR J CLIN NUTR, V56, pS42, DOI 10.1038/sj.ejcn.1601353; Cordain L, 2002, EUR J CLIN NUTR, V56, P181, DOI 10.1038/sj.ejcn.1601307; Cordain L, 2001, WORLD REV NUTR DIET, V90, P144; Cordain L, 2000, AM J CLIN NUTR, V71, P682, DOI 10.1093/ajcn/71.3.682; CRAWFORD MA, 1992, NUTR REV, V50, P3; Cunnane SC, 2014, J HUM EVOL, V77, P88, DOI 10.1016/j.jhevol.2014.05.001; DELEON MP, 1987, CANCER RES, V47, P305; Dominguez-Rodrigo M, 2005, J HUM EVOL, V48, P109, DOI 10.1016/j.jhevol.2004.09.004; Dominguez-Rodrigo M, 2014, QUATERN INT, V322, P129, DOI 10.1016/j.quaint.2013.08.015; Dominguez-Rodrigo M, 2009, J HUM EVOL, V57, P260, DOI 10.1016/j.jhevol.2009.04.006; Dominguez-Rodrigo M, 2002, J WORLD PREHIST, V16, P1, DOI 10.1023/A:1014507129795; Dominguez-Rodrigo M, 2015, REV EARLY H IN PRESS; Dominguez-Rodrigo M, 2011, P NATL ACAD SCI USA, V108, pE117, DOI 10.1073/pnas.1104647108; Dominguez-Rodrigo M, 2010, P NATL ACAD SCI USA, V107, P20929, DOI 10.1073/pnas.1013711107; DominguezRodrigo M, 2007, VERTEBR PALEOBIOL PA, P1; Eaton S. Boyd, 2002, P7; EATON SB, 1992, LIPIDS, V27, P814, DOI 10.1007/BF02535856; EGLINTON G, 1991, PHILOS T ROY SOC B, V333, P315, DOI 10.1098/rstb.1991.0081; Evershed RP, 1996, ACS SYM SER, V625, P157, DOI 10.1021/bk-1996-0625.ch013; Ferraro JV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062174; Finch CE, 2004, Q REV BIOL, V79, P3, DOI 10.1086/381662; Finch CE, 1999, NEUROBIOL AGING, V20, P407, DOI 10.1016/S0197-4580(99)00053-6; Foley RA, 2009, PRINCIPLES HUMAN EVO; Foley Robert, 2001, P305; Gerard Philippe, 2013, Pathogens, V3, P14, DOI 10.3390/pathogens3010014; Gomez Zapata A, 2014, THESIS; GOULD RG, 1969, METABOLIS, V18, P652, DOI 10.1016/0026-0495(69)90078-X; GRIMALT JO, 1990, ENVIRON SCI TECHNOL, V24, P357, DOI 10.1021/es00073a011; Hazard SE, 2007, PFLUG ARCH EUR J PHY, V453, P745, DOI 10.1007/s00424-005-0040-7; Holliday TW, 2012, CURR ANTHROPOL, V53, pS330, DOI 10.1086/667360; ILLMAN RJ, 1993, J NUTR, V123, P1094; Janssen MA, 2005, P ANN C N AM ASS COM; Kappelman J, 2014, J HUM EVOL, V77, P117, DOI 10.1016/j.jhevol.2014.03.008; Kidambi S, 2006, FUTURE LIPIDOL, V1, P357, DOI 10.2217/17460875.1.3.357; Kuipers RS, 2010, BRIT J NUTR, V104, P1666, DOI 10.1017/S0007114510002679; KUNSMAN JE, 1981, J FOOD SCI, V46, P1785, DOI 10.1111/j.1365-2621.1981.tb04485.x; Laden G, 2005, J HUM EVOL, V49, P482, DOI 10.1016/j.jhevol.2005.05.007; LEAF AA, 1992, EARLY HUM DEV, V30, P183, DOI 10.1016/0378-3782(92)90068-R; Leeming R, 1996, WATER RES, V30, P2893, DOI 10.1016/S0043-1354(96)00011-5; Leeming R, 1998, WATER SCI TECHNOL, V38, P15, DOI 10.2166/wst.1998.0369; Lin DS, 2001, AM J CLIN NUTR, V74, P44; MALENKY RK, 1994, AM J PRIMATOL, V32, P1, DOI 10.1002/ajp.1350320102; Mann GV, 1972, MED PRIMATOLOGY 3; MCMURRY MP, 1985, AM J CLIN NUTR, V41, P1289, DOI 10.1093/ajcn/41.6.1289; McPherron SP, 2010, NATURE, V466, P857, DOI 10.1038/nature09248; Melendez I, 2013, SCI REP-UK, V3, DOI 10.1038/srep02768; MIDTVEDT AC, 1993, J PEDIATR GASTR NUTR, V17, P161, DOI 10.1097/00005176-199308000-00006; MIDTVEDT T, 1990, APMIS, V98, P839, DOI 10.1111/j.1699-0463.1990.tb05004.x; Milton K, 1999, EVOL ANTHROPOL, V8, P11, DOI 10.1002/(SICI)1520-6505(1999)8:1<11::AID-EVAN6>3.3.CO;2-D; Milton K., 1987, FOOD EVOLUTION THEOR, P93; MURTAUGH JJ, 1967, J WATER POLLUT CON F, V39, P404; Navder K P, 1992, Indian J Med Sci, V46, P275; NELSON CA, 1984, LIPIDS, V19, P656, DOI 10.1007/BF02534525; Pante MC, 2015, QUATERN INT, V355, P164, DOI 10.1016/j.quaint.2014.09.007; Peters KE, 2004, BIOMARKER GUIDE, V1; Reiner WB, 2014, AM J PRIMATOL, V76, P281, DOI 10.1002/ajp.22232; Roche H, 1999, NATURE, V399, P57, DOI 10.1038/19959; Rothman JM, 2008, OECOLOGIA, V155, P111, DOI 10.1007/s00442-007-0901-1; Rothman JM, 2006, AM J PRIMATOL, V68, P675, DOI 10.1002/ajp.20243; Rothman JM, 2011, BIOL LETTERS, V7, P847, DOI 10.1098/rsbl.2011.0321; Saim N, 2009, WATER RES, V43, P5023, DOI 10.1016/j.watres.2009.08.052; Schoeninger Margaret J., 2001, P179; Shah VG, 2007, WATER RES, V41, P3691, DOI 10.1016/j.watres.2007.04.006; Simpson IA, 1998, J ARCHAEOL SCI, V25, P729, DOI 10.1006/jasc.1997.0216; SINCLAIR AJ, 1975, P NUTR SOC, V34, P287, DOI 10.1079/PNS19750051; Sistiaga A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101045; SPETH JD, 1989, J HUM EVOL, V18, P329, DOI 10.1016/0047-2484(89)90035-3; SPETH JD, 1983, J ANTHROPOL ARCHAEOL, V2, P1, DOI 10.1016/0278-4165(83)90006-5; Speth JohnD., 2010, INTERD CONTRIB ARCH; Sponheimer M, 1999, SCIENCE, V283, P368, DOI 10.1126/science.283.5400.368; Sponheimer M, 2013, P NATL ACAD SCI USA, V110, P10513, DOI 10.1073/pnas.1222579110; Srinivasan S R, 1976, Adv Exp Med Biol, V67, P65; SRINIVASAN SR, 1974, COMP BIOCHEM PHYSIOL, V47, P711, DOI 10.1016/0305-0491(74)90016-9; Stanford Craig B., 2001, P122; Stanford Craig B., 1999, HUNTING APES MEAT EA; Steinetz BG, 1996, J MED PRIMATOL, V25, P17, DOI 10.1111/j.1600-0684.1996.tb00188.x; Stewart KM, 2014, J HUM EVOL, V77, P1, DOI 10.1016/j.jhevol.2014.10.003; STEWART KM, 1994, J HUM EVOL, V27, P229, DOI 10.1006/jhev.1994.1044; Stiner MC, 2002, J ARCHAEOL RES, V10, P1, DOI 10.1023/A:1014588307174; STRUHSAKER T. T., 1997, ECOLOGY AFRICAN RAIN; SUBBIAH M T R, 1972, International Journal of Biochemistry, V3, P430, DOI 10.1016/0020-711X(72)90094-8; SVOBODA JA, 1991, LIPIDS, V26, P614, DOI 10.1007/BF02536425; Tattersall I, 2014, J HUM EVOL, V77, P141, DOI 10.1016/j.jhevol.2014.10.004; Teaford Mark F., 2002, P143; Teaford MF, 2000, P NATL ACAD SCI USA, V97, P13506, DOI 10.1073/pnas.260368897; Toth N., 2006, OLDOWAN CASE STUDIES; Tyagi P, 2007, CHEMOSPHERE, V69, P1617, DOI 10.1016/j.chemosphere.2007.05.039; Uehara S, 1997, PRIMATES, V38, P193, DOI 10.1007/BF02382009; Ungar PS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002044; Ungar PS, 2012, J HUM EVOL, V63, P429, DOI 10.1016/j.jhevol.2011.04.006; US Department of Agriculture, NAT NUTR DAT STAND R; Vane CH, 2010, SCI TOTAL ENVIRON, V409, P345, DOI 10.1016/j.scitotenv.2010.09.033; VENKATESAN MI, 1990, ENVIRON SCI TECHNOL, V24, P208, DOI 10.1021/es00072a009; WILKINS TD, 1974, CANCER RES, V34, P2250; Wilson ML, 2012, ANIM BEHAV, V83, P277, DOI 10.1016/j.anbehav.2011.11.004; Wrangham R. W., 1975, THESIS; Wrangham RW, 1998, INT J PRIMATOL, V19, P949, DOI 10.1023/A:1020318102257; Wrangham RW, 1999, CURR ANTHROPOL, V40, P567, DOI 10.1086/300083; WRANGHAM RW, 1991, PHILOS T ROY SOC B, V334, P171, DOI 10.1098/rstb.1991.0106; Wrangham RW, 2009, CATCHING FIRE COOKIN	130	13	14	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0128931	10.1371/journal.pone.0128931	http://dx.doi.org/10.1371/journal.pone.0128931			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061730	Green Published, gold			2022-12-26	WOS:000355979500111
J	Kaneko, I; Sabir, MS; Dussik, CM; Whitfield, GK; Karrys, A; Hsieh, JC; Haussler, MR; Meyer, MB; Pike, JW; Jurutka, PW				Kaneko, Ichiro; Sabir, Marya S.; Dussik, Christopher M.; Whitfield, G. Kerr; Karrys, Amitis; Hsieh, Jui-Cheng; Haussler, Mark R.; Meyer, Mark B.; Pike, J. Wesley; Jurutka, Peter W.			1,25-Dihydroxyvitamin D regulates expression of the tryptophan hydroxylase 2 and leptin genes: implication for behavioral influences of vitamin D	FASEB JOURNAL			English	Article						CNS; chromatin immunoprecipitation; neuropsychiatric disorders; cis-regulatory module; serotonin	D-RECEPTOR; HIPPOCAMPAL-NEURONS; RESPONSIVE ELEMENT; DOWN-REGULATION; ADIPOSE-TISSUE; 3T3-L1 CELLS; BRAIN; D-3; MICE; DIFFERENTIATION	To investigate vitamin D-related control of brain-expressed genes, candidate vitamin D responsive elements (VDREs) at -7/-10 kb in human tryptophan hydroxylase (TPH) 2 were probed. Both VDREs bound the vitamin D receptor (VDR)-retinoid X receptor (RXR) complex and drove reporter gene transcription in response to 1,25-dihydroxyvitamin D-3 (1,25D). Brain TPH2 mRNA, encoding the rate-limiting enzyme in serotonin synthesis, was induced 2.2-fold by 10 nM 1,25D in human U87 glioblastoma cells and 47.8-fold in rat serotonergic RN46A-B14 cells. 1,25D regulation of leptin (Lep), encoding a serotoninlike satiety factor, was also examined. In mouse adipocytes, 1,25D repressed leptin mRNA levels by at least 84%, whereas 1,25D induced leptin mRNA 15.1-fold in human glioblastoma cells. Chromatin immunoprecipitation sequencing analysis of the mouse Lep gene in response to 1,25D revealed a cluster of regulatory sites (cis-regulatory module; CRM) at -28 kb that 1,25D-dependently docked VDR, RXR, C/EBP beta, and RUNX2. This CRM harbored 3 VDREs and single C/EBP beta and RUNX2 sites. Therefore, the expression of human TPH2 and mouse Lep are governed by 1,25D, potentially via respective VDREs located at -7/-10 kb and -28 kb. These results imply that vitamin D affects brain serotonin concentrations, which may be relevant to psychiatric disorders, such as autism, and may control leptin levels and affect eating behavior.	[Kaneko, Ichiro; Whitfield, G. Kerr; Karrys, Amitis; Hsieh, Jui-Cheng; Haussler, Mark R.; Jurutka, Peter W.] Univ Arizona, Coll Med, Dept Basic Med Sci, Phoenix, AZ USA; [Kaneko, Ichiro; Sabir, Marya S.; Dussik, Christopher M.; Karrys, Amitis; Jurutka, Peter W.] Univ Arizona, Sch Math & Nat Sci, Phoenix, AZ USA; [Meyer, Mark B.; Pike, J. Wesley] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA	University of Arizona; University of Arizona; University of Wisconsin System; University of Wisconsin Madison	Jurutka, PW (corresponding author), Sch Math & Nat Sci, 4701 W Thunderbird Rd, Phoenix, AZ 85306 USA.	pjurutka@asu.edu		Haussler, Mark/0000-0002-7097-1801				Blumberg JM, 2006, J BIOL CHEM, V281, P11205, DOI 10.1074/jbc.M510343200; Brewer LD, 2001, J NEUROSCI, V21, P98, DOI 10.1523/JNEUROSCI.21-01-00098.2001; Brown J, 2003, NEUROSCI LETT, V343, P139, DOI 10.1016/S0304-3940(03)00303-3; Cieslak K, 2014, SCHIZOPHR RES, V159, P543, DOI 10.1016/j.schres.2014.08.031; Confavreux CB, 2011, KIDNEY INT, V79, pS14, DOI 10.1038/ki.2011.25; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Groves NJ, 2013, BEHAV BRAIN RES, V241, P120, DOI 10.1016/j.bbr.2012.12.001; Gutknecht L, 2009, EUR NEUROPSYCHOPHARM, V19, P266, DOI 10.1016/j.euroneuro.2008.12.005; Harms LR, 2011, BEST PRACT RES CL EN, V25, P657, DOI 10.1016/j.beem.2011.05.009; Haussler MR, 2013, CALCIFIED TISSUE INT, V92, P77, DOI 10.1007/s00223-012-9619-0; Haussler MR, 2011, BEST PRACT RES CL EN, V25, P543, DOI 10.1016/j.beem.2011.05.010; Hiroi R, 2013, J NEUROCHEM, V127, P487, DOI 10.1111/jnc.12401; Hsieh JC, 2003, ENDOCRINOLOGY, V144, P5065, DOI 10.1210/en.2003-0635; Jiang P, 2014, NUTRIENTS, V6, P6048, DOI 10.3390/nu6126048; Keisala T, 2009, J STEROID BIOCHEM, V115, P91, DOI 10.1016/j.jsbmb.2009.03.007; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kong J, 2006, AM J PHYSIOL-ENDOC M, V290, pE916, DOI 10.1152/ajpendo.00410.2005; Kong J, 2013, J ENDOCRINOL, V216, P265, DOI 10.1530/JOE-12-0344; Lenicov FR, 2007, J NEUROCHEM, V103, P2047, DOI 10.1111/j.1471-4159.2007.04903.x; Lesch K.P., 2005, NOVART FDN SYMP, V268, P167; Lesch K. P., 2005, NOVART FDN SYMP, V268, P140; Lesch Klaus-Peter, 2005, Novartis Found Symp, V268, P111; LOVENBERG W, 1967, SCIENCE, V155, P217, DOI 10.1126/science.155.3759.217; Malloy PJ, 2013, MOL ENDOCRINOL, V27, P1632, DOI 10.1210/me.2013-1037; Menendez C, 2001, J ENDOCRINOL, V170, P425, DOI 10.1677/joe.0.1700425; Meyer MB, 2014, J BIOL CHEM, V289, P19539, DOI 10.1074/jbc.M114.578104; Meyer MB, 2014, J BIOL CHEM, V289, P16016, DOI 10.1074/jbc.M114.552216; Meyer MB, 2010, J STEROID BIOCHEM, V121, P136, DOI 10.1016/j.jsbmb.2010.02.011; Mix H, 2000, GUT, V47, P481, DOI 10.1136/gut.47.4.481; Morash B, 1999, ENDOCRINOLOGY, V140, P5995, DOI 10.1210/en.140.12.5995; Narvaez CJ, 2009, ENDOCRINOLOGY, V150, P651, DOI 10.1210/en.2008-1118; Patrick RP, 2015, FASEB J, V29, P2207, DOI 10.1096/fj.14-268342; Patrick RP, 2014, FASEB J, V28, P2398, DOI 10.1096/fj.13-246546; Pike JW, 2014, J STEROID BIOCHEM, V144, P5, DOI 10.1016/j.jsbmb.2013.11.004; Pike J Wesley, 2014, Bonekey Rep, V3, P482, DOI 10.1038/bonekey.2013.216; Pike JW, 2010, J STEROID BIOCHEM, V121, P130, DOI 10.1016/j.jsbmb.2010.02.036; Shen WW, 2014, SCI REP-UK, V4, DOI 10.1038/srep05282; Taniura H, 2006, J NEUROSCI RES, V83, P1179, DOI 10.1002/jnr.20824; TERPENING CM, 1991, MOL ENDOCRINOL, V5, P373, DOI 10.1210/mend-5-3-373; Thompson PD, 2002, BIOCHEM BIOPH RES CO, V299, P730, DOI 10.1016/S0006-291X(02)02742-0; Wang Y, 2000, NEUROPHARMACOLOGY, V39, P873, DOI 10.1016/S0028-3908(99)00255-5; Wrann CD, 2012, ADIPOCYTE, V1, P168, DOI 10.4161/adip.20574; Wrase J, 2006, COGN AFFECT BEHAV NE, V6, P53, DOI 10.3758/CABN.6.1.53; Yuksel RN, 2014, THER ADV PSYCHOPHARM, V4, P268, DOI 10.1177/2045125314553612; Zhang XD, 2004, SCIENCE, V305, P217, DOI 10.1126/science.1097540	45	97	101	0	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					4023	4035		10.1096/fj.14-269811	http://dx.doi.org/10.1096/fj.14-269811			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26071405				2022-12-26	WOS:000359915600036
J	Mattar, CN; Wong, AMS; Hoefer, K; Alonso-Ferrero, ME; Buckley, SMK; Howe, SJ; Cooper, JD; Waddington, SN; Chan, JKY; Rahim, AA				Mattar, Citra N.; Wong, Andrew M. S.; Hoefer, Klemens; Alonso-Ferrero, Maria E.; Buckley, Suzanne M. K.; Howe, Steven J.; Cooper, Jonathan D.; Waddington, Simon N.; Chan, Jerry K. Y.; Rahim, Ahad A.			Systemic gene delivery following intravenous administration of AAV9 to fetal and neonatal mice and late-gestation nonhuman primates	FASEB JOURNAL			English	Article						perinatal; viral vectors; murine; macaques; metabolic diseases	IN-VIVO; THERAPY; VECTOR; TRANSDUCTION; BRAIN; EXPRESSION; EPITHELIA; FUTURE	Several acute monogenic diseases affect multiple body systems, causing death in childhood. The development of novel therapies for such conditions is challenging. However, improvements in gene delivery technology mean that gene therapy has the potential to treat such disorders. We evaluated the ability of the AAV9 vector to mediate systemic gene delivery after intravenous administration to perinatal mice and late-gestation nonhuman primates (NHPs). Titer-matched single-stranded (ss) and self-complementary (sc) AAV9 carrying the green fluorescent protein (GFP) reporter gene were intravenously administered to fetal and neonatal mice, with noninjected age-matched mice used as the control. Extensive GFP expression was observed in organs throughout the body, with the epithelial and muscle cells being particularly well transduced. ssAAV9 carrying the WPRE sequence mediated significantly more gene expression than its sc counterpart, which lacked the woodchuck hepatitis virus posttranscriptional regulatory element (WPRE) sequence. To examine a realistic scale-up to larger models or potentially patients for such an approach, AAV9 was intravenously administered to late-gestation NHPs by using a clinically relevant protocol. Widespread systemic gene expression was measured throughout the body, with cellular tropisms similar to those observed in the mouse studies and no observable adverse events. This study confirms that AAV9 can safely mediate systemic gene delivery in small and large animal models and supports its potential use in clinical systemic gene therapy protocols.	[Mattar, Citra N.; Chan, Jerry K. Y.] Natl Univ Singapore, Dept Obstet & Gynaecol, Expt Fetal Med Grp, Singapore 117548, Singapore; [Wong, Andrew M. S.; Hoefer, Klemens; Cooper, Jonathan D.] Kings Coll London, Inst Psychiat, Pediat Storage Disorders Lab, London WC2R 2LS, England; [Alonso-Ferrero, Maria E.; Howe, Steven J.] UCL, Inst Child Hlth, London WC1E 6HX, England; [Buckley, Suzanne M. K.; Waddington, Simon N.] UCL, Inst Womens Hlth, Gene Transfer Technol Grp, London WC1E 6HX, England; [Rahim, Ahad A.] UCL, UCL Sch Pharm, Dept Pharmacol, London WC1E 6HX, England; [Waddington, Simon N.] Univ Witwatersrand, Fac Hlth Sci, Antiviral Gene Therapy Res Unit, Johannesburg, South Africa; [Chan, Jerry K. Y.] KK Womens & Childrens Tower, Dept Reprod Med, Singapore, Singapore; [Chan, Jerry K. Y.] Duke NUS Grad Med Sch, Canc & Stem Cell Biol, Singapore, Singapore	National University of Singapore; University of London; King's College London; University of London; University College London; University of London; University College London; University of London; University College London; University of Witwatersrand; KK Women's & Children's Hospital; National University of Singapore	Waddington, SN (corresponding author), UCL, Inst Womens Hlth, Gene Transfer Technol Grp, 86-96 Chenies Mews, London WC1E 6HX, England.	s.waddington@ucl.ac.uk	Cooper, Jonathan/V-9962-2019; rahim, abdul/AAC-6745-2021; Waddington, Simon/G-3778-2011	Cooper, Jonathan/0000-0003-1339-4750; rahim, abdul/0000-0002-0269-9156; Waddington, Simon/0000-0003-4970-4730; Mattar, Citra Nurfarah/0000-0003-0068-6957; Buckley, Suzanne/0000-0003-1286-1003	UK Medical Research Council Grant [G1000709]; UK Gauchers Association; Niemann-Pick Disease Group; National Brain Iron Accumulation Disorders Association; Medical Research Council [G1000709] Funding Source: researchfish; MRC [G1000709] Funding Source: UKRI	UK Medical Research Council Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Gauchers Association; Niemann-Pick Disease Group; National Brain Iron Accumulation Disorders Association; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Medical Research Council Grant G1000709. A.A.R. and S.N.W. have also received support from the UK Gauchers Association. A.A.R. received support from the Niemann-Pick Disease Group and National Brain Iron Accumulation Disorders Association.	Bell CL, 2011, J CLIN INVEST, V121, P2427, DOI 10.1172/JCI57367; Berry SM, 2013, AM J OBSTET GYNECOL, V209, P170, DOI 10.1016/j.ajog.2013.07.014; Bevan AK, 2011, MOL THER, V19, P1971, DOI 10.1038/mt.2011.157; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Boutin S, 2010, HUM GENE THER, V21, P704, DOI 10.1089/hum.2009.182; Buckley SMK, 2011, THER DELIV, V2, P461, DOI 10.4155/TDE.11.17; Calcedo R, 2011, CLIN VACCINE IMMUNOL, V18, P1586, DOI 10.1128/CVI.05107-11; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Chandler RJ, 2015, J CLIN INVEST, V125, P870, DOI 10.1172/JCI79213; Coutelle Charles, 2012, Methods Mol Biol, V891, P1, DOI 10.1007/978-1-61779-873-3_1; David AL, 2008, BEST PRACT RES CL OB, V22, P203, DOI 10.1016/j.bpobgyn.2007.08.008; Di Pasquale G, 2006, MOL THER, V13, P506, DOI 10.1016/j.ymthe.2005.11.007; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Gaspar HB, 2004, LANCET, V364, P2181, DOI 10.1016/S0140-6736(04)17590-9; Goker-Alpan O, 2011, MOL GENET METAB, V104, P438, DOI 10.1016/j.ymgme.2011.08.004; Haddad MR, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.27; Katwal AB, 2013, GENE THER, V20, P930, DOI 10.1038/gt.2013.16; Limberis MP, 2009, MOL THER, V17, P294, DOI 10.1038/mt.2008.261; Mattar CN, 2013, GENE THER, V20, P69, DOI 10.1038/gt.2011.216; Mattar CN, 2012, BEST PRACT RES CL OB, V26, P697, DOI 10.1016/j.bpobgyn.2012.06.006; Mattar CN, 2011, EXPERT OPIN BIOL TH, V11, P1257, DOI 10.1517/14712598.2011.585153; Mattar CNZ, 2011, MOL THER, V19, P1950, DOI 10.1038/mt.2011.107; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Orvisky E, 2000, PEDIATR RES, V48, P233, DOI 10.1203/00006450-200008000-00018; Paterna JC, 2000, GENE THER, V7, P1304, DOI 10.1038/sj.gt.3301221; Rahim AA, 2011, FASEB J, V25, P3505, DOI 10.1096/fj.11-182311; Shen S, 2011, J BIOL CHEM, V286, P13532, DOI 10.1074/jbc.M110.210922; Waddington SN, 2003, BLOOD, V101, P1359, DOI 10.1182/blood-2002-03-0779; Weatherall D., 2006, USE NONHUMAN PRIMATE	30	19	22	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3876	3888		10.1096/fj.14-269092	http://dx.doi.org/10.1096/fj.14-269092			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26062602	Green Published			2022-12-26	WOS:000359915600023
J	Patel, C; Douard, V; Yu, SY; Gao, N; Ferraris, RP				Patel, Chirag; Douard, Veronique; Yu, Shiyan; Gao, Nan; Ferraris, Ronaldo P.			Transport, metabolism, and endosomal trafficking-dependent regulation of intestinal fructose absorption	FASEB JOURNAL			English	Article						GLUT5; ketohexokinase; Rab11a; sugar	GLUCOSE-ABSORPTION; UNITED-STATES; CELLS; EXPRESSION; INDUCTION; GENE; MICE; ACTIVATION; PATHWAY; SUGAR	Dietary fructose that is linked to metabolic abnormalities can up-regulate its own absorption, but the underlying regulatory mechanisms are not known. We hypothesized that glucose transporter (GLUT) protein, member 5 (GLUT5) is the primary fructose transporter and that fructose absorption via GLUT5, metabolism via ketohexokinase (KHK), as well as GLUT5 trafficking to the apical membrane via the Ras-related protein-in-brain 11 (Rab11)a-dependent endosomes are each required for regulation. Introducing fructose but not lysine and glucose solutions into the lumen increased by 2- to 10-fold the heterogeneous nuclear RNA, mRNA, protein, and activity levels of GLUT5 in adult wild-type mice consuming chow. Levels of GLUT5 were > 100-fold that of candidate apical fructose transporters GLUTs 7, 8, and 12 whose expression, and that of GLUT 2 and the sodium-dependent glucose transporter protein 1 (SGLT1), was not regulated by luminal fructose. GLUT5-knockout (KO) mice exhibited no facilitative fructose transport and no compensatory increases in activity and expression of SGLT1 and other GLUTs. Fructose could not up-regulate GLUT5 in GLUT5-KO, KHK-KO, and intestinal epithelial cell-specific Rab11a-KO mice. The fructose-specific metabolite glyceraldehyde did not increase GLUT5 expression. GLUT5 is the primary transporter responsible for facilitative absorption of fructose, and its regulation specifically requires fructose uptake and metabolism and normal GLUT5 trafficking to the apical membrane.	[Patel, Chirag; Douard, Veronique; Ferraris, Ronaldo P.] Rutgers State Univ, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA; [Yu, Shiyan; Gao, Nan] Rutgers State Univ, Sch Arts & Sci, Dept Biol Sci, Newark, NJ 07103 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick	Ferraris, RP (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Physiol & Pharmacol, 185 South Orange Ave,MSB H-621, Newark, NJ 07103 USA.	ferraris@njms.rutgers.edu	douard, veronique/U-2364-2018; Douard, veronique/AAU-6271-2020		U.S. National Science Foundation [IOS-1121049, 1456673]; U.S. National Institutes of Health Grant from the National Institute of Diabetes and Digestive and Kidney Diseases [DK085194, DK093809, DK102934]; National Cancer Institute [CA178599]; NATIONAL CANCER INSTITUTE [R21CA178599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK085194, R01DK102934, R03DK093809] Funding Source: NIH RePORTER	U.S. National Science Foundation(National Science Foundation (NSF)); U.S. National Institutes of Health Grant from the National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors are grateful to Drs. E. David, I. Monteiro, P. Tharabenjasin, and E. Topaktas [New Jersey Medical School (NJMS)] as well as to Ms. J. Lee (NJMS), C. Monteiro (NJMS), D. O'Neill (University of Alberta), and Mr. D. Simon (NJMS) for help with experiments and/or for valuable discussion. The authors are especially grateful to Profs. C. Cheeseman (University of Alberta), R. Johnson (University of Colorado), and J. Zuo (St. Jude's Children's Hospital) for the gifts of GLUT5 antibody, the KHK-KO, and the GLUT5-KO mice, respectively. C. P. maintained animal models, conducted all experiments, analyzed the data, and helped in experimental design and manuscript preparation. V.D. helped design the studies, perform experiments, analyze data, and finalize the manuscript. S.Y. helped maintain animals, perform experiments, and analyze data. N.G. analyzed data as well as revised and finalized the manuscript. R.P.F. helped design the experiment, coordinated activities of coauthors and collaborators, helped analyze all data, then revised as well as finalized the manuscript. This work was supported by U.S. National Science Foundation Grants IOS-1121049 and 1456673 (to R.P.F.). The study also received support with U.S. National Institutes of Health Grants DK085194, DK093809, DK102934 from the National Institute of Diabetes and Digestive and Kidney Diseases, and CA178599 from the National Cancer Institute (to N.G.). This work was performed in partial fulfillment of the Ph.D. degree in biomedical sciences at the Graduate School of Biomedical Sciences, Rutgers University for C.P. The authors declare no conflicts of interest.	Asipu A, 2003, DIABETES, V52, P2426, DOI 10.2337/diabetes.52.9.2426; Barone S, 2009, J BIOL CHEM, V284, P5056, DOI 10.1074/jbc.M808128200; BURANT CF, 1992, J BIOL CHEM, V267, P14523; Cheeseman C, 2008, AM J PHYSIOL-ENDOC M, V295, pE238, DOI 10.1152/ajpendo.90394.2008; Corpe CP, 1998, BBA-MOL CELL RES, V1402, P229, DOI 10.1016/S0167-4889(97)00155-9; Cramm-Behrens CI, 2008, TRAFFIC, V9, P2206, DOI 10.1111/j.1600-0854.2008.00829.x; Cui XL, 2005, AM J PHYSIOL-GASTR L, V288, pG1310, DOI 10.1152/ajpgi.00550.2004; DAVIES J, 1994, BIOCHEM J, V304, P295, DOI 10.1042/bj3040295; DeBosch BJ, 2013, MOL ENDOCRINOL, V27, P1887, DOI 10.1210/me.2013-1137; DeBosch BJ, 2012, ENDOCRINOLOGY, V153, P4181, DOI 10.1210/en.2012-1541; Diggle CP, 2010, RHEUMATOLOGY, V49, P1056, DOI 10.1093/rheumatology/keq048; Douard V, 2008, ENDOCRINOLOGY, V149, P409, DOI 10.1210/en.2007-0906; Douard V, 2013, J PHYSIOL-LONDON, V591, P401, DOI 10.1113/jphysiol.2011.215731; Gjymishka A, 2009, BIOCHEM J, V417, P695, DOI 10.1042/BJ20081706; Gorboulev V, 2012, DIABETES, V61, P187, DOI 10.2337/db11-1029; Honma K, 2013, BIOSCI BIOTECH BIOCH, V77, P2188, DOI 10.1271/bbb.130300; Ishimoto T, 2012, P NATL ACAD SCI USA, V109, P4320, DOI 10.1073/pnas.1119908109; Jiang L, 2001, AM J PHYSIOL-GASTR L, V280, pG113, DOI 10.1152/ajpgi.2001.280.1.G113; Jiang L, 2001, AM J PHYSIOL-REG I, V281, pR1274, DOI 10.1152/ajpregu.2001.281.4.R1274; Kellett GL, 2008, ANNU REV NUTR, V28, P35, DOI 10.1146/annurev.nutr.28.061807.155518; MacDonald CJ, 2009, J BIOL CHEM, V284, P22099, DOI 10.1074/jbc.M109.021063; Manolescu AR, 2007, PHYSIOLOGY, V22, P234, DOI 10.1152/physiol.00011.2007; Marriott BP, 2009, J NUTR, V139, pS1228, DOI 10.3945/jn.108.098277; MAYES PA, 1993, AM J CLIN NUTR, V58, P754; Moran AW, 2014, J DAIRY SCI, V97, P4955, DOI 10.3168/jds.2014-8004; Pujol-Gimenez J, 2013, J PHYSIOL BIOCHEM, V69, P325, DOI 10.1007/s13105-012-0213-8; Rencurel F, 1996, BIOCHEM J, V314, P903, DOI 10.1042/bj3140903; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; Scotto KW, 2003, ONCOGENE, V22, P7496, DOI 10.1038/sj.onc.1206950; Sobajima T, 2015, BIOL OPEN, V4, P86, DOI 10.1242/bio.20148532; Sun Y, 2014, MOL BIOL CELL, V25, P1159, DOI 10.1091/mbc.E13-08-0493; Suzuki T, 2011, BIOCHEM J, V435, P43, DOI 10.1042/BJ20101987; Tharabenjasin P, 2014, AM J PHYSIOL-GASTR L, V306, pG1, DOI 10.1152/ajpgi.00263.2013; Welsh JA, 2011, AM J CLIN NUTR, V94, P726, DOI 10.3945/ajcn.111.018366; Welz T, 2014, TRENDS CELL BIOL, V24, P407, DOI 10.1016/j.tcb.2014.02.004; Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009; Wu XD, 2008, BRAIN RES, V1210, P20, DOI 10.1016/j.brainres.2008.02.094; Yu SY, 2014, EMBO J, V33, P1882, DOI 10.15252/embj.201487888	38	54	58	8	36	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					4046	4058		10.1096/fj.15-272195	http://dx.doi.org/10.1096/fj.15-272195			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26071406	Green Published			2022-12-26	WOS:000359915600038
J	Chen, JQ; Mori, H; Cardiff, RD; Trott, JF; Hovey, RC; Hubbard, NE; Engelberg, JA; Tepper, CG; Willis, BJ; Khan, IH; Ravindran, RK; Chan, SR; Schreiber, RD; Borowsky, AD				Chen, Jane Q.; Mori, Hidetoshi; Cardiff, Robert D.; Trott, Josephine F.; Hovey, Russell C.; Hubbard, Neil E.; Engelberg, Jesse A.; Tepper, Clifford G.; Willis, Brandon J.; Khan, Imran H.; Ravindran, Resmi K.; Chan, Szeman R.; Schreiber, Robert D.; Borowsky, Alexander D.			Abnormal Mammary Development in 129: STAT1-Null Mice is Stroma-Dependent	PLOS ONE			English	Article							MOUSE MAMMARY; TARGETED DISRUPTION; GROWTH-FACTOR; TUMOR VIRUS; PROLACTIN; PROGESTERONE; CANCER; DIFFERENTIATION; CLASSIFICATION; MORPHOGENESIS	Female 129:Stat1-null mice (129S6/SvEvTac-Stat1(tm1Rds) homozygous) uniquely develop estrogen-receptor (ER)-positive mammary tumors. Herein we report that the mammary glands (MG) of these mice have altered growth and development with abnormal terminal end buds alongside defective branching morphogenesis and ductal elongation. We also find that the 129:Stat1-null mammary fat pad (MFP) fails to sustain the growth of 129S6/SvEv wild-type and Stat1-null epithelium. These abnormalities are partially reversed by elevated serum progesterone and prolactin whereas transplantation of wild-type bone marrow into 129:Stat1-null mice does not reverse the MG developmental defects. Medium conditioned by 129:Stat1-null epithelium-cleared MFP does not stimulate epithelial proliferation, whereas it is stimulated by medium conditioned by epithelium-cleared MFP from either wildtype or 129:Stat1-null females having elevated progesterone and prolactin. Microarrays and multiplexed cytokine assays reveal that the MG of 129:Stat1-null mice has lower levels of growth factors that have been implicated in normal MG growth and development. Transplanted 129:Stat1-null tumors and their isolated cells also grow slower in 129:Stat1-null MG compared to wild-type recipient MG. These studies demonstrate that growth of normal and neoplastic 129:Stat1-null epithelium is dependent on the hormonal milieu and on factors from the mammary stroma such as cytokines. While the individual or combined effects of these factors remains to be resolved, our data supports the role of STAT1 in maintaining a tumor-suppressive MG microenvironment.	[Chen, Jane Q.; Mori, Hidetoshi; Cardiff, Robert D.; Hubbard, Neil E.; Engelberg, Jesse A.; Khan, Imran H.; Ravindran, Resmi K.; Borowsky, Alexander D.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Trott, Josephine F.; Hovey, Russell C.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Tepper, Clifford G.] Univ Calif Davis, Sch Med, Ctr Canc, Div Basic Sci, Sacramento, CA 95817 USA; [Tepper, Clifford G.] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Willis, Brandon J.] Univ Calif Davis, Mouse Biol Program, Davis, CA 95616 USA; [Chan, Szeman R.; Schreiber, Robert D.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Borowsky, Alexander D.] Univ Calif Davis, Dept Pathol & Lab Med, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Washington University (WUSTL); University of California System; University of California Davis	Borowsky, AD (corresponding author), Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA.	adborowsky@ucdavis.edu	Borowsky, Alexander D/S-5404-2017; Schreiber, Robert/Q-7550-2019; Khan, imran/GQQ-2176-2022; Khan, Imran Ali/GVT-0232-2022	Khan, Imran Ali/0000-0002-8774-2896; Schreiber, Robert/0000-0003-1590-2341	National Cancer Institute's Mouse Models of Human Cancers Consortium [U01 CA141541, U01 CA141582]; Congressionally Directed Medical Research Program [W81XWH-10-1-0855]; NATIONAL CANCER INSTITUTE [U01CA141582, U01CA141541, P30CA093373] Funding Source: NIH RePORTER	National Cancer Institute's Mouse Models of Human Cancers Consortium; Congressionally Directed Medical Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by grants U01 CA141541 and U01 CA141582 (RC, AB, RS) from the National Cancer Institute's Mouse Models of Human Cancers Consortium and from the Congressionally Directed Medical Research Program grant W81XWH-10-1-0855 (RH and RC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annamalai D, 2014, J CELL BIOCHEM, V115, P1308, DOI 10.1002/jcb.24785; Aupperlee MD, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3431; Bailey Sarah G, 2012, JAKSTAT, V1, P197, DOI 10.4161/jkst.20967; BECK JC, 1989, IN VITRO CELL DEV B, V25, P409, DOI 10.1007/BF02624625; Borowsky AD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a009670; Brandebourg T, 2007, DIABETES OBES METAB, V9, P464, DOI 10.1111/j.1463-1326.2006.00671.x; Brooks CL, 2012, ENDOCR REV, V33, P504, DOI 10.1210/er.2011-1040; BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V; Cardiff RD, 2000, J MAMMARY GLAND BIOL, V5, P421, DOI 10.1023/A:1009534129331; Cardiff RD, 2006, TOXICOL PATHOL, V34, P699, DOI 10.1080/01926230600930129; Cardiff RD, 2013, LAB INVEST, V93, P480, DOI 10.1038/labinvest.2013.10; Carre N, 2014, BIOCHIMIE, V97, P16, DOI 10.1016/j.biochi.2013.09.023; Chan SR, 2014, CELL DEATH DIFFER, V21, P234, DOI 10.1038/cdd.2013.116; Chan SR, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3100; Chapman RS, 1999, BRIT J CANCER, V80, P10; Coussens LM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003285; DANIELSON KG, 1984, P NATL ACAD SCI-BIOL, V81, P3756, DOI 10.1073/pnas.81.12.3756; DaSilva L, 1996, MOL CELL ENDOCRINOL, V117, P131, DOI 10.1016/0303-7207(95)03738-1; DAVID M, 1994, P NATL ACAD SCI USA, V91, P7174, DOI 10.1073/pnas.91.15.7174; DEOME KB, 1959, CANCER RES, V19, P515; Dunn T.B., 1958, PHYSIOPATHOLOGY CANC, P38; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Fortin A, 2007, ANNU REV GENOM HUM G, V8, P163, DOI 10.1146/annurev.genom.8.080706.092315; Haricharan S, 2014, MOL CELL ENDOCRINOL, V382, P560, DOI 10.1016/j.mce.2013.03.014; Hovey RC, 1998, IN VITRO CELL DEV-AN, V34, P385; Hovey RC, 2001, DEV DYNAM, V222, P192, DOI 10.1002/dvdy.1179; Hovey RC, 2010, J MAMMARY GLAND BIOL, V15, P279, DOI 10.1007/s10911-010-9187-8; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Hughes Katherine, 2012, JAKSTAT, V1, P151, DOI 10.4161/jkst.19691; Ignacak A, 2012, J PHYSIOL PHARMACOL, V63, P435; Ingman WV, 2006, DEV DYNAM, V235, P3222, DOI 10.1002/dvdy.20972; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Khaled WT, 2007, DEVELOPMENT, V134, P2739, DOI 10.1242/dev.003194; King JY, 2005, PHYSIOL GENOMICS, V23, P103, DOI 10.1152/physiolgenomics.00101.2005; Klover PJ, 2010, NEOPLASIA, V12, P899, DOI 10.1593/neo.10716; Koromilas Antonis E, 2013, JAKSTAT, V2, pe23353, DOI 10.4161/jkst.23353; Krishhan VV, 2009, CRIT REV BIOTECHNOL, V29, P29, DOI 10.1080/07388550802688847; Lee HJ, 2012, MOL CELL ENDOCRINOL, V357, P101, DOI 10.1016/j.mce.2011.09.020; Lee SH, 2013, J IMMUNOL, V191, P4223, DOI 10.4049/jimmunol.1300910; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; Mantovani G, 1998, CRIT REV ONCOGENESIS, V9, P99, DOI 10.1615/CritRevOncog.v9.i2.10; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Morabito JE, 2008, J MOL ENDOCRINOL, V41, P75, DOI 10.1677/JME-08-0027; Mori H, 2012, AM J PATHOL, V180, P2249, DOI 10.1016/j.ajpath.2012.02.032; Neville MC, 1998, J MAMMARY GLAND BIOL, V3, P109, DOI 10.1023/A:1018786604818; O'Sullivan T, 2012, J EXP MED, V209, P1869, DOI 10.1084/jem.20112738; OLIVER MH, 1989, J CELL SCI, V92, P513; Philp JAC, 1996, FEBS LETT, V396, P77, DOI 10.1016/0014-5793(96)01069-1; PUMA JP, 1982, J VIROL, V43, P158, DOI 10.1128/JVI.43.1.158-165.1982; Raven JF, 2011, CELL CYCLE, V10, P794, DOI 10.4161/cc.10.5.14956; Ravindran R, 2013, CLIN VACCINE IMMUNOL, V20, P1283, DOI 10.1128/CVI.00213-13; Richer JK, 1998, J BIOL CHEM, V273, P31317, DOI 10.1074/jbc.273.47.31317; Rosner A, 2002, AM J PATHOL, V161, P1087, DOI 10.1016/S0002-9440(10)64269-1; Ruan WF, 2005, ENDOCRINOLOGY, V146, P1170, DOI 10.1210/en.2004-1360; Rudmann D, 2012, TOXICOL PATHOL, V40, p7S, DOI 10.1177/0192623312454242; SASS B, 1979, J NATL CANCER I, V62, P1287; Satoh J-i, 2013, CLIN EXP NEUROIMMUNO, V5, P1, DOI DOI 10.4137/GRSB.S11433GRSB-7-2013-041; Schedin P, 2010, J MAMMARY GLAND BIOL, V15, P275, DOI 10.1007/s10911-010-9191-z; Schneckenleithner C, 2011, ONCOTARGET, V2, P1043; SKARDA J, 1989, ENDOCRINOL EXP, V23, P17; Spath GF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000381; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Vesely MD, 2013, ANN NY ACAD SCI, V1284, P1, DOI 10.1111/nyas.12105; Wang YF, 1997, MOL ENDOCRINOL, V11, P1353, DOI 10.1210/me.11.9.1353; Xu Dong, 2013, JAKSTAT, V2, pe27203, DOI 10.4161/jkst.27203; YOUNG LJT, 1984, CANCER RES, V44, P4333	66	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129895	10.1371/journal.pone.0129895	http://dx.doi.org/10.1371/journal.pone.0129895			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075897	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900111
J	Soto-Mendez, MJ; Romero-Abal, ME; Aguilera, CM; Rico, MC; Solomons, NW; Schumann, K; Gil, A				Jose Soto-Mendez, Mara; Eugenia Romero-Abal, Maria; Maria Aguilera, Concepcion; Cruz Rico, Maria; Solomons, Noel W.; Schuemann, Klaus; Gil, Angel			Associations among Inflammatory Biomarkers in the Circulating, Plasmatic, Salivary and Intraluminal Anatomical Compartments in Apparently Healthy Preschool Children from the Western Highlands of Guatemala	PLOS ONE			English	Article							FECAL CALPROTECTIN; BOWEL-DISEASE; LINEAR GROWTH; YOUNG-ADULTS; SERUM; INTERLEUKIN-6; CYTOKINES; STRESS; INFECTION; RESPONSES	Background Undernutrition and inflammation are related in many ways; for instance, non-hygienic environments are associated with both poor growth and immunostimulation in children. Objective To describe any existing interaction among different inflammation biomarkers measured in the distinct anatomical compartments of whole blood, feces, plasma and saliva. Methods In this descriptive, cross-sectional study, samples of whole blood, feces, plasma and saliva were collected on the 8th and last week of observation among 87 attendees (42 girls and 45 boys) of 3 daycare centers offering a common 40-day rotating menu in Guatemala's Western Highlands. Analyses included white blood cell count (WBC), fecal calprotectin, and plasmatic and salivary cytokines including IL-1B, IL-6, IL-8, IL-10 and TNF-alpha. Associations were assessed using Spearman rank-order and goodness-of-fit correlations, as indicated, followed by backwards-elimination multiple regression analyses to determine predictor variables for IL-10 in both anatomical compartments. Results Of a total of 66 cross-tabulations in the Spearman hemi-matrix, 22 (33%) were significantly associated. All 10 paired associations among the salivary cytokines had a significant r value, whereas 7 of 10 possible associations among plasma cytokines were significant. Associations across anatomical compartments, however, were rarely significant. IL-10 in both biological fluids were higher than corresponding reference values. When a multiple regression model was run in order to determine independent predictors for IL-10 in each anatomical compartment separately, IL-6, IL-8 and TNF-alpha emerged as predictors in plasma (r(2) = 0.514) and IL-1B, IL-8 and TNF-alpha remained as independent predictors in saliva (r(2) = 0.762). Significant cross-interactions were seen with WBC, but not with fecal calprotectin. Conclusion Interactions ranged from robust within the same anatomical compartment to limited to nil across distinct anatomical compartments. The prominence of the anti-inflammatory cytokine, IL-10, in both plasma and saliva is consistent with its counter-regulatory role facing a broad front of elevated pro-inflammatory cytokines in the same compartment.	[Jose Soto-Mendez, Mara; Eugenia Romero-Abal, Maria; Solomons, Noel W.] Ctr Studies Sensory Impairment Aging & Metab CeSS, Guatemala City, Guatemala; [Maria Aguilera, Concepcion; Cruz Rico, Maria; Gil, Angel] Univ Granada, Ctr Biomed Res, Inst Nutr & Food Technol, Dept Biochem & Mol Biol 2, Granada, Spain; [Schuemann, Klaus] Tech Univ Munich, Res Ctr Nutr & Food Sci, ZIEL, Mol Nutr Unit, Freising Weihenstephan, Germany	University of Granada; Technical University of Munich	Soto-Mendez, MJ (corresponding author), Ctr Studies Sensory Impairment Aging & Metab CeSS, Guatemala City, Guatemala.	clinicanutricion@gmail.com	Gil, Angel/L-2275-2014; Gil, Angel/ABA-7621-2020; Aguilera, Concepcion M/M-1663-2014; Rico, Maria/G-4601-2016; Méndez, María José Soto/X-6982-2019	Gil, Angel/0000-0001-7663-0939; Gil, Angel/0000-0001-7663-0939; Aguilera, Concepcion M/0000-0002-1451-4788; Rico, Maria/0000-0001-7742-5742; Méndez, María José Soto/0000-0002-1012-4715	Hildegard Grunow Foundation, Munich, Germany; Department of Biochemistry and Molecular Biology II from Granada University, Granada, Spain	Hildegard Grunow Foundation, Munich, Germany; Department of Biochemistry and Molecular Biology II from Granada University, Granada, Spain	Studies were funded by the Hildegard Grunow Foundation, Munich, Germany and the Department of Biochemistry and Molecular Biology II from Granada University, Granada, Spain.	Abdel-Haq A, 2014, J ORAL PATHOL MED, V43, P734, DOI 10.1111/jop.12199; Assareh A, 2013, KOREAN CIRC J, V43, P246, DOI 10.4070/kcj.2013.43.4.246; Beard JL, 2006, AM J CLIN NUTR, V84, P1498, DOI 10.1093/ajcn/84.6.1498; BEISEL WR, 1995, AM J CLIN NUTR, V62, P813, DOI 10.1093/ajcn/62.4.813; Berngard SC, 2013, EARLY HUM DEV, V89, P967, DOI 10.1016/j.earlhumdev.2013.09.008; Boy E, 2002, ENVIRON HEALTH PERSP, V110, P109, DOI 10.1289/ehp.02110109; Brogden KA, 2013, EXPERT REV ANTI-INFE, V11, P1097, DOI 10.1586/14787210.2013.836059; Browne RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059498; Burri E, 2014, EXPERT REV GASTROENT, V8, P197, DOI 10.1586/17474124.2014.869476; Byrne ML, 2013, BRAIN BEHAV IMMUN, V34, P164, DOI 10.1016/j.bbi.2013.08.010; Chen W, 2010, DIABETES CARE, V33, P2474, DOI 10.2337/dc10-0619; COATES ME, 1963, BRIT J NUTR, V17, P141, DOI 10.1079/BJN19630015; Cvikl B, 2015, CLIN ORAL INVEST, V19, P385, DOI 10.1007/s00784-014-1232-3; Dafar A, 2014, J IMMUNOL METHODS, V408, P46, DOI 10.1016/j.jim.2014.04.013; Dakovic D, 2013, J CLIN PEDIATR DENT, V37, P377, DOI 10.17796/jcpd.37.4.l135531h4542gj66; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; Duffy T, 2011, THESIS U ALBERTA EDM; Ersche KD, 2014, BIOL PSYCHIAT, V75, P140, DOI 10.1016/j.biopsych.2013.08.004; FAO, 2013, PAN SEG AL NUTR AM L; Fernandez-Botran R, 2011, BRAIN BEHAV IMMUN, V25, P314, DOI 10.1016/j.bbi.2010.09.023; Grisius MM, 1997, J RHEUMATOL, V24, P1089; Hamzavi M, 2013, ASIAN PAC J CANCER P, V14, P1681, DOI 10.7314/APJCP.2013.14.3.1681; HILL DC, 1953, POULTRY SCI, V32, P462, DOI 10.3382/ps.0320462; Izawa S, 2013, BIOL PSYCHOL, V94, P249, DOI 10.1016/j.biopsycho.2013.06.006; KEUSCH GT, 1986, ANNU REV NUTR, V6, P131, DOI 10.1146/annurev.nu.06.070186.001023; Minetto MA, 2007, EUR J APPL PHYSIOL, V101, P249, DOI 10.1007/s00421-007-0484-x; Moore HD, 2014, RADIAT RES, V181, P521, DOI 10.1667/RR13586.1; Newton TL, 2014, BIOL PSYCHOL, V99, P150, DOI 10.1016/j.biopsycho.2014.03.009; Ngure FM, 2014, ANN NY ACAD SCI, V1308, P118, DOI 10.1111/nyas.12330; Nizam N, 2014, J PERIODONTOL, V85, pE251, DOI 10.1902/jop.2014.130579; NOAKES PS, 2013, WOODHEAD PUBL FOOD S, P3, DOI DOI 10.1007/978-0-387-39241-7_2; Odiere MR, 2013, J NUTR, V143, P100, DOI 10.3945/jn.112.160457; Olza J, 2014, PUBLIC HEALTH NUTR, V2, P11; Olza J, 2012, DIABETES CARE, V35, P2373, DOI 10.2337/dc12-0614; Pfister KM, 2014, CLIN PERINATOL, V41, P309, DOI 10.1016/j.clp.2014.02.004; Prandelli C, 2013, INT J IMMUNOPATH PH, V26, P633, DOI 10.1177/039463201302600307; Prasad G, 2013, INT J DENT, V2013, DOI 10.1155/2013/813756; Prendergast AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086928; Rathnayake N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061356; Riis JL, 2014, DEV PSYCHOBIOL, V56, P797, DOI 10.1002/dev.21149; ROURA E, 1992, J NUTR, V122, P2383, DOI 10.1093/jn/122.12.2383; Rytter MJH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105017; Said HS, 2014, DNA RES, V21, P15, DOI 10.1093/dnares/dst037; Slavish DC, 2015, BRAIN BEHAV IMMUN, V44, P253, DOI 10.1016/j.bbi.2014.08.008; Smith DL, 2012, PREHOSP EMERG CARE, V16, P128, DOI 10.3109/10903127.2011.614044; Sobel J, 1998, AM J TROP MED HYG, V59, P380, DOI 10.4269/ajtmh.1998.59.380; Solomons NW, 2015, PUBLIC HEALTH NUTR, V18, P1737, DOI 10.1017/S136898001400264X; SOLOMONS NW, 1993, NUTR REV, V51, P327, DOI 10.1111/j.1753-4887.1993.tb03758.x; Thomas MV, 2009, J PERIODONTOL, V80, P1146, DOI 10.1902/jop.2009.080654; van Rheenen PF, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3369; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; Yi B, 2014, BRAIN BEHAV IMMUN, V40, P203, DOI 10.1016/j.bbi.2014.03.018	52	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129158	10.1371/journal.pone.0129158	http://dx.doi.org/10.1371/journal.pone.0129158			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075910	Green Published, Green Submitted, gold			2022-12-26	WOS:000356329900048
J	Wannier, TM; Moore, MM; Mou, Y; Mayo, SL				Wannier, Timothy M.; Moore, Matthew M.; Mou, Yun; Mayo, Stephen L.			Computational Design of the beta-Sheet Surface of a Red Fluorescent Protein Allows Control of Protein Oligomerization	PLOS ONE			English	Article							DIRECTED EVOLUTION; MONOMERIC RED; CHROMOPHORE; ISOMERIZATION; OPTIMIZATION; MATURATION; LIBRARY; VERSION; BRIGHT; ORANGE	Computational design has been used with mixed success for the design of protein surfaces, with directed evolution heretofore providing better practical solutions than explicit design. Directed evolution, however, requires a tractable high-throughput screen because the random nature of mutation does not enrich for desired traits. Here we demonstrate the successful design of the beta-sheet surface of a red fluorescent protein (RFP), enabling control over its oligomerization. To isolate the problem of surface design, we created a hybrid RFP from DsRed and mCherry with a stabilized protein core that allows for monomerization without loss of fluorescence. We designed an explicit library for which 93 of 96 (97%) of the protein variants are soluble, stably fluorescent, and monomeric. RFPs are heavily used in biology, but are natively tetrameric, and creating RFP monomers has proven extremely difficult. We show that surface design and core engineering are separate problems in RFP development and that the next generation of RFP markers will depend on improved methods for core design.	[Wannier, Timothy M.; Mayo, Stephen L.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Moore, Matthew M.; Mou, Yun; Mayo, Stephen L.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Mayo, SL (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	steve@mayo.caltech.edu	Mou, Yun/O-1080-2018; Wannier, Timothy/ABD-5479-2020	Mou, Yun/0000-0001-5423-9031; Wannier, Timothy/0000-0002-4165-4751	National Security Science and Engineering Faculty Fellowship (NSSEFF) [N00244-09-1-0011, N00244-09-1-0082]; Gordon and Betty Moore Foundation [GBMF2809]; National Institute of Health grant [1R21EB018579-01]; Defense Advanced Research Projects Agency Protein Design Processes Program; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB018579] Funding Source: NIH RePORTER	National Security Science and Engineering Faculty Fellowship (NSSEFF); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Institute of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency Protein Design Processes Program; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the Defense Advanced Research Projects Agency Protein Design Processes Program, a National Security Science and Engineering Faculty Fellowship (NSSEFF N00244-09-1-0011, N00244-09-1-0082), the Gordon and Betty Moore Foundation through Grant GBMF2809 to the Caltech Programmable Molecular Technology Initiative and a National Institute of Health grant (1R21EB018579-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti JJ, 2010, P NATL ACAD SCI USA, V107, P4004, DOI 10.1073/pnas.0910781107; Ai HW, 2006, BIOCHEM J, V400, P531, DOI 10.1042/BJ20060874; Ai HW, 2014, NAT PROTOC, V9, P910, DOI 10.1038/nprot.2014.054; Akerboom J, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00002; Alieva NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002680; Allen BD, 2006, J COMPUT CHEM, V27, P1071, DOI 10.1002/jcc.20420; Allen BD, 2010, P NATL ACAD SCI USA, V107, P19838, DOI 10.1073/pnas.1012985107; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; DUNBRACK RL, 1993, J MOL BIOL, V230, P543, DOI 10.1006/jmbi.1993.1170; Esvelt KM, 2011, NATURE, V472, P499, DOI 10.1038/nature09929; Famm K, 2008, J MOL BIOL, V376, P926, DOI 10.1016/j.jmb.2007.10.075; Fukuchi S, 2001, J MOL BIOL, V309, P835, DOI 10.1006/jmbi.2001.4718; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Henderson JN, 2009, J AM CHEM SOC, V131, P13212, DOI 10.1021/ja904665x; Hu XZ, 2008, STRUCTURE, V16, P1799, DOI 10.1016/j.str.2008.09.013; Karasawa S, 2003, J BIOL CHEM, V278, P34167, DOI 10.1074/jbc.M304063200; Karasawa S, 2004, BIOCHEM J, V381, P307, DOI 10.1042/BJ20040321; Kredel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004391; Nanda V, 2005, J AM CHEM SOC, V127, P5804, DOI 10.1021/ja050553f; Pletnev S, 2008, J BIOL CHEM, V283, P28980, DOI 10.1074/jbc.M800599200; Privett HK, 2012, P NATL ACAD SCI USA, V109, P3790, DOI 10.1073/pnas.1118082108; Samish I, 2011, ANNU REV PHYS CHEM, V62, P129, DOI 10.1146/annurev-physchem-032210-103509; Shagin DA, 2004, MOL BIOL EVOL, V21, P841, DOI 10.1093/molbev/msh079; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shemiakina II, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2208; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Strack RL, 2008, NAT METHODS, V5, P955, DOI 10.1038/nmeth.1264; Street AG, 2000, PHYS REV LETT, V84, P5010, DOI 10.1103/PhysRevLett.84.5010; Strongin DE, 2007, PROTEIN ENG DES SEL, V20, P525, DOI 10.1093/protein/gzm046; Takako K, 2006, NAT BIOTECHNOL, V24, P577, DOI [10.1038/nbt1207, DOI 10.1038/NBT1207]; Tubbs JL, 2005, BIOCHEMISTRY-US, V44, P9833, DOI 10.1021/bi0472907; Wall MA, 2000, NAT STRUCT BIOL, V7, P1133; Wang SY, 2014, P NATL ACAD SCI USA, V111, P8452, DOI 10.1073/pnas.1406593111; Wannier TM, 2014, PROTEIN SCI, V23, P1148, DOI 10.1002/pro.2498; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101	36	8	10	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130582	10.1371/journal.pone.0130582	http://dx.doi.org/10.1371/journal.pone.0130582			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075618	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000356329900181
J	Heo, SK; Noh, EK; Yoon, DJ; Jo, JC; Choi, Y; Koh, S; Baek, JH; Park, JH; Min, YJ; Kim, H				Heo, Sook-Kyoung; Noh, Eui-Kyu; Yoon, Dong-Joon; Jo, Jae-Cheol; Choi, Yunsuk; Koh, SuJin; Baek, Jin Ho; Park, Jae-Hoo; Min, Young Joo; Kim, Hawk			Radotinib Induces Apoptosis of CD11b(+) Cells Differentiated from Acute Myeloid Leukemia Cells	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; SRC FAMILY KINASES; RETINOIC ACID; DASATINIB; LYN; EXPRESSION; GROWTH; CANCER; GENE; LINE	Radotinib, developed as a BCR/ABL tyrosine kinase inhibitor (TKI), is approved for the second-line treatment of chronic myeloid leukemia (CML) in South Korea. However, therapeutic effects of radotinib in acute myeloid leukemia (AML) are unknown. In the present study, we demonstrate that radotinib significantly decreases the viability of AML cells in a dose-dependent manner. Kasumi-1 cells were more sensitive to radotinib than NB4, HL60, or THP-1 cell lines. Furthermore, radotinib induced CD11b expression in NB4, THP-1, and Kasumi-1 cells either in presence or absence of all trans-retinoic acid (ATRA). We found that radotinib promoted differentiation and induced CD11b expression in AML cells by downregulating LYN. However, CD11b expression induced by ATRA in HL60 cells was decreased by radotinib through upregulation of LYN. Furthermore, radotinib mainly induced apoptosis of CD11b(+) cells in the total population of AML cells. Radotinib also increased apoptosis of CD11b(+) HL60 cells when they were differentiated by ATRA/dasatinib treatment. We show that radotinib induced apoptosis via caspase-3 activation and the loss of mitochondrial membrane potential (Delta psi(m)) in CD11b(+) cells differentiated from AML cells. Our results suggest that radotinib may be used as a candidate drug in AML or a chemosensitizer for treatment of AML by other therapeutics.	[Heo, Sook-Kyoung; Yoon, Dong-Joon; Kim, Hawk] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Biomed Res Ctr, Ulsan 682060, South Korea; [Noh, Eui-Kyu; Jo, Jae-Cheol; Choi, Yunsuk; Koh, SuJin; Baek, Jin Ho; Min, Young Joo; Kim, Hawk] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Hematol & Oncol, Ulsan 682714, South Korea; [Park, Jae-Hoo] Myongji Hosp, Dept Hematol & Oncol, Gyeonggi Do 412270, South Korea	University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital; Myongji Hospital	Kim, H (corresponding author), Univ Ulsan, Coll Med, Ulsan Univ Hosp, Biomed Res Ctr, Ulsan 682060, South Korea.	kimhawkmd@gmail.com	Jo, Jae-Cheol/CAE-9453-2022	Jo, Jae-Cheol/0000-0001-6014-7977; Choi, Yunsuk/0000-0002-7983-8089	Priority Research Center Program through National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2009-0094050]; Basic Science Research Program through NRF - Ministry of Education [NRF-2014R1A1A3051393]	Priority Research Center Program through National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Basic Science Research Program through NRF - Ministry of Education	This work was supported by the Priority Research Center Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2009-0094050). This research was also supported by the Basic Science Research Program through the NRF funded by the Ministry of Education (NRF-2014R1A1A3051393). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates RC, 2001, CANCER RES, V61, P5275; Boehrer S, 2008, BLOOD, V111, P2170, DOI 10.1182/blood-2007-07-100362; Montero JC, 2011, CLIN CANCER RES, V17, P5546, DOI 10.1158/1078-0432.CCR-10-2616; Chernoivanenko IS, 2014, FASEB J; Congleton J, 2012, LEUKEMIA, V26, P1180, DOI 10.1038/leu.2011.390; DeRemer DL, 2008, CLIN THER, V30, P1956, DOI 10.1016/j.clinthera.2008.11.014; Dos Santos C, 2013, BLOOD, V122, P1900, DOI 10.1182/blood-2012-11-466425; Fang YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066915; Gianni' M, 2001, BLOOD, V97, P3234, DOI 10.1182/blood.V97.10.3234; Goldenberg-Furmanov M, 2004, CANCER RES, V64, P1058, DOI 10.1158/0008-5472.CAN-03-2420; Guerrouahen BS, 2010, CLIN CANCER RES, V16, P1149, DOI 10.1158/1078-0432.CCR-09-2416; Heo SK, 2015, EUR J PHARMACOL, V747, P36, DOI 10.1016/j.ejphar.2014.10.064; Heo SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098859; Hochgrafe F, 2010, CANCER RES, V70, P9391, DOI 10.1158/0008-5472.CAN-10-0911; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Hussein K, 2009, ANN HEMATOL, V88, P1059, DOI 10.1007/s00277-009-0727-5; Ingley E, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-21; Kim SH, 2014, HAEMATOLOGICA, V99, P1191, DOI 10.3324/haematol.2013.096776; Kropf PL, 2010, LEUKEMIA, V24, P663, DOI 10.1038/leu.2009.267; Lainey Elodie, 2013, Cell Cycle, V12, P2978, DOI 10.4161/cc.26016; Larizza L, 2005, LEUKEMIA LYMPHOMA, V46, P247, DOI 10.1080/10428190400007565; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Mauro MJ, 2001, ONCOLOGIST, V6, P233, DOI 10.1634/theoncologist.6-3-233; McCormack PL, 2011, DRUGS, V71, P1771, DOI 10.2165/11207580-000000000-00000; Miranda MB, 2007, MOL CANCER THER, V6, P3081, DOI 10.1158/1535-7163.MCT-07-0514; Noh EK, 2010, LEUKEMIA RES, V34, P1501, DOI 10.1016/j.leukres.2010.02.016; Pession A, 2003, ONCOGENE, V22, P8671, DOI 10.1038/sj.onc.1207125; Stegmaier K, 2005, BLOOD, V106, P2841, DOI 10.1182/blood-2005-02-0488; Stettner AR, 2005, CANCER RES, V65, P5535, DOI 10.1158/0008-5472.CAN-04-3688; Xu YK, 2005, IMMUNITY, V22, P9, DOI 10.1016/j.immuni.2004.12.004; Zhang HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100960	31	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129853	10.1371/journal.pone.0129853	http://dx.doi.org/10.1371/journal.pone.0129853			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26065685	Green Published, Green Submitted, gold			2022-12-26	WOS:000356327000115
J	Milewska, M; Romano, D; Herrero, A; Guerriero, ML; Birtwistle, M; Quehenberger, F; Hatzl, S; Kholodenko, BN; Segatto, O; Kolch, W; Zebisch, A				Milewska, Malgorzata; Romano, David; Herrero, Ana; Guerriero, Maria Luisa; Birtwistle, Marc; Quehenberger, Franz; Hatzl, Stefan; Kholodenko, Boris N.; Segatto, Oreste; Kolch, Walter; Zebisch, Armin			Mitogen-Inducible Gene-6 Mediates Feedback Inhibition from Mutated BRAF towards the Epidermal Growth Factor Receptor and Thereby Limits Malignant Transformation	PLOS ONE			English	Article							PAPILLARY THYROID-CANCER; FACIO-CUTANEOUS SYNDROME; EGF RECEPTOR; B-RAF; BRAF(V600E) INHIBITION; GERMLINE MUTATIONS; NEGATIVE REGULATOR; ERK ACTIVATION; K-RAS; MIG-6	BRAF functions in the RAS-extracellular signal-regulated kinase (ERK) signaling cascade. Activation of this pathway is necessary to mediate the transforming potential of oncogenic BRAF, however, it may also cause a negative feedback that inhibits the epidermal growth factor receptor (EGFR). Mitogen-inducible gene-6 (MIG-6) is a potent inhibitor of the EGFR and has been demonstrated to function as a tumor suppressor. As MIG-6 can be induced via RAS-ERK signaling, we investigated its potential involvement in this negative regulatory loop. Focus formation assays were performed and demonstrated that MIG-6 significantly reduces malignant transformation induced by oncogenic BRAF. Although this genetic interaction was mirrored by a physical interaction between MIG-6 and BRAF, we did not observe a direct regulation of BRAF kinase activity by MIG-6. Interestingly, a selective chemical EGFR inhibitor suppressed transformation to a similar degree as MIG-6, whereas combining these approaches had no synergistic effect. By analyzing a range of BRAF mutated and wildtype cell line models, we could show that BRAF V600E causes a strong upregulation of MIG-6, which was mediated at the transcriptional level via the RAS-ERK pathway and resulted in downregulation of EGFR activation. This feedback loop is operational in tumors, as shown by the analysis of almost 400 patients with papillary thyroid cancer (PTC). Presence of BRAF V600E correlated with increased MIG-6 expression on the one hand, and with inactivation of the EGFR and of PI3K/AKT signaling on the other hand. Importantly, we also observed a more aggressive disease phenotype when BRAF V600E coexisted with low MIG-6 expression. Finally, analysis of methylation data was performed and revealed that higher methylation of MIG-6 correlated to its decreased expression. Taken together, we demonstrate that MIG-6 efficiently reduces cellular transformation driven by oncogenic BRAF by orchestrating a negative feedback circuit directed towards the EGFR.	[Milewska, Malgorzata; Romano, David; Herrero, Ana; Guerriero, Maria Luisa; Kholodenko, Boris N.; Kolch, Walter] Univ Coll Dublin, Syst Biol Ireland, Dublin 2, Ireland; [Birtwistle, Marc] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Quehenberger, Franz] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria; [Hatzl, Stefan; Zebisch, Armin] Med Univ Graz, Div Hematol, Graz, Austria; [Kholodenko, Boris N.; Kolch, Walter] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland; [Kholodenko, Boris N.; Kolch, Walter] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland; [Segatto, Oreste] Regina Elena Inst Canc Res, Immunol Lab, Rome, Italy	University College Dublin; Icahn School of Medicine at Mount Sinai; Medical University of Graz; Medical University of Graz; University College Dublin; University College Dublin; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Zebisch, A (corresponding author), Med Univ Graz, Div Hematol, Graz, Austria.	armin.zebisch@medunigraz.at	Kolch, Walter/ABF-2102-2021; Admin, SBI/HGB-2738-2022; HERRERO, ANA/GOV-3351-2022; Quehenberger, Franz/AAV-1446-2020; Zebisch, Armin/AGS-9409-2022; Quehenberger, Franz/N-8825-2019	HERRERO, ANA/0000-0001-8065-2225; Quehenberger, Franz/0000-0003-0764-9497; Zebisch, Armin/0000-0002-4861-7021; Kholodenko, Boris/0000-0002-9483-4975; Kolch, Walter/0000-0001-5777-5016; Segatto, Oreste/0000-0003-2561-1142; Birtwistle, Marc/0000-0002-0341-0705	Science Foundation Ireland [06/CE/B1129]; European Union FP7 "PRIMES" [278568]; Austrian Science Fund [P 26619-B19]; EMBO long term fellowship [ALTF 454-2007]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104184] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Union FP7 "PRIMES"; Austrian Science Fund(Austrian Science Fund (FWF)); EMBO long term fellowship(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	WK was supported by the Science Foundation Ireland (http://www.sfi.ie/) under Grant No. 06/CE/B1129 and the European Union FP7 Grant No. 278568 "PRIMES" (http://www.primes-fp7.eu/). Work in the laboratory of AZ was supported by the Austrian Science Fund under Grant No. P 26619-B19. AZ was further supported by an EMBO long term fellowship (http://www.embo.org/; ALTF 454-2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Anastasi S, 2007, ONCOGENE, V26, P7833, DOI 10.1038/sj.onc.1210590; Anastasi S, 2005, ONCOGENE, V24, P4540, DOI 10.1038/sj.onc.1208658; Anastasi S, 2003, ONCOGENE, V22, P4221, DOI 10.1038/sj.onc.1206516; Bollag G, 2012, NAT REV DRUG DISCOV, V11, P873, DOI 10.1038/nrd3847; Caronia LM, 2011, CLIN CANCER RES, V17, P7511, DOI 10.1158/1078-0432.CCR-11-1155; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dultz LA, 2013, SURGERY, V154, P1239, DOI 10.1016/j.surg.2013.06.024; Ferby I, 2006, NAT MED, V12, P568, DOI 10.1038/nm1401; Fiorini M, 2002, ONCOGENE, V21, P6530, DOI 10.1038/sj.onc.1205823; Freeman AK, 2013, MOL CELL, V49, P751, DOI 10.1016/j.molcel.2012.12.018; Frosi Y, 2010, J CELL BIOL, V189, P557, DOI 10.1083/jcb.201002032; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Girotti MR, 2013, CANCER DISCOV, V3, P158, DOI 10.1158/2159-8290.CD-12-0386; Huang TG, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-30; Jin N, 2009, DEVELOPMENT, V136, P3347, DOI 10.1242/dev.032979; Jin N, 2011, CLIN CANCER RES, V17, P6482, DOI 10.1158/1078-0432.CCR-11-0933; Keeton AB, 2004, BBA-GENE STRUCT EXPR, V1679, P248, DOI 10.1016/j.bbaexp.2004.07.002; Kim TH, 2010, ONCOGENE, V29, P3770, DOI 10.1038/onc.2010.126; Kim TH, 2014, CANCER RES, V74, P7371, DOI 10.1158/0008-5472.CAN-14-0794; KIM TH, 2012, CANCER-AM CANCER SOC, V118, P1764, DOI DOI 10.1002/cncr.26500; Li C, 2012, J CLIN ENDOCR METAB, V97, P4559, DOI 10.1210/jc.2012-2104; Li ZX, 2012, MOL CARCINOGEN, V51, P522, DOI 10.1002/mc.20815; Liebmann C, 2011, MOL CELL ENDOCRINOL, V331, P222, DOI 10.1016/j.mce.2010.04.008; Lin CI, 2011, SURGERY, V150, P1295, DOI 10.1016/j.surg.2011.09.014; Lin CI, 2011, J CLIN ENDOCR METAB, V96, pE554, DOI 10.1210/jc.2010-1800; Liu J, 2015, CELL REP, V10, P1599, DOI 10.1016/j.celrep.2015.02.014; Liu N, 2012, EMBO J, V31, P2365, DOI 10.1038/emboj.2012.88; Maity TK, 2015, CANCER DISCOV, V5, P534, DOI 10.1158/2159-8290.CD-14-0750; MASUI H, 1993, J CELL BIOL, V120, P85, DOI 10.1083/jcb.120.1.85; Matallanas D, 2011, MOL CELL, V44, P893, DOI 10.1016/j.molcel.2011.10.016; Montero-Conde C, 2013, CANCER DISCOV, V3, P520, DOI 10.1158/2159-8290.CD-12-0531; Navas C, 2012, CANCER CELL, V22, P318, DOI 10.1016/j.ccr.2012.08.001; Niihori T, 2006, NAT GENET, V38, P294, DOI 10.1038/ng1749; Pacini F, 2010, ANN ONCOL, V21, pv214, DOI 10.1093/annonc/mdq190; Parmenter TJ, 2014, CANCER DISCOV, V4, P423, DOI 10.1158/2159-8290.CD-13-0440; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Reschke M, 2010, HEPATOLOGY, V51, P1383, DOI 10.1002/hep.23428; Ritt DA, 2010, MOL CELL BIOL, V30, P806, DOI 10.1128/MCB.00569-09; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Ruan DT, 2008, SURGERY, V144, P908, DOI 10.1016/j.surg.2008.07.028; Sharungbam GD, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-70; Sibilia M, 2000, CELL, V102, P211, DOI 10.1016/S0092-8674(00)00026-X; Solca FF, 2004, J PHARMACOL EXP THER, V311, P502, DOI 10.1124/jpet.104.069138; Sun C, 2014, NATURE, V508, P118, DOI 10.1038/nature13121; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Ying HQ, 2010, P NATL ACAD SCI USA, V107, P6912, DOI 10.1073/pnas.0914930107; Zandi R, 2007, CELL SIGNAL, V19, P2013, DOI 10.1016/j.cellsig.2007.06.023; Zebisch A, 2006, CELL MOL LIFE SCI, V63, P1314, DOI 10.1007/s00018-006-6005-y; Zebisch A, 2005, LEUKEMIA, V19, P685, DOI 10.1038/sj.leu.2403713; Zebisch A, 2012, LEUKEMIA, V26, P1842, DOI 10.1038/leu.2012.61; Zebisch A, 2009, LEUKEMIA, V23, P1049, DOI 10.1038/leu.2009.68; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998; Zhang YW, 2007, ONCOGENE, V26, P269, DOI 10.1038/sj.onc.1209790; Zhang YW, 2013, FUTURE ASPECTS TUMOR	59	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129859	10.1371/journal.pone.0129859	http://dx.doi.org/10.1371/journal.pone.0129859			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26065894	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000116
J	Putcha, BDK; Jia, X; Katkoori, VR; Salih, C; Shanmugam, C; Jadhav, T; Bovell, LC; Behring, MP; Callens, T; Messiaen, L; Bae, S; Grizzle, WE; Singh, KP; Manne, U				Putcha, Balananda-Dhurjati Kumar; Jia, Xu; Katkoori, Venkat Rao; Salih, Chura; Shanmugam, Chandrakumar; Jadhav, Trafina; Bovell, Liselle C.; Behring, Michael P.; Callens, Tom; Messiaen, Ludwine; Bae, Sejong; Grizzle, William E.; Singh, Karan P.; Manne, Upender			Clinical Implications of Rabphillin-3A-Like Gene Alterations in Breast Cancer	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; COLORECTAL ADENOCARCINOMA; ALLELIC LOSS; PROGNOSTIC-SIGNIFICANCE; P53; HETEROZYGOSITY; CARCINOMAS; 17P13.3; TUMORS; CHROMOSOME-17P	For the rabphillin-3A-like (RPH3AL) gene, a putative tumor suppressor, the clinical significance of genetic alterations in breast cancers was evaluated. DNA and RNA were extracted from formalin-fixed, paraffin-embedded (FFPE) cancers and matching normal tissues. DNA samples were assessed for loss of heterozygosity (LOH) at the 17p13.3 locus of RPH3AL and the 17p13.1 locus of the tumor suppressor, TP53. RPH3AL was sequenced, and single nucleotide polymorphisms (SNPs) were genotyped. RNA samples were evaluated for expression of RPH3AL, and FFPE tissues were profiled for its phenotypic expression. Alterations in RPH3AL were correlated with clinicopathological features, LOH of TP53, and patient survival. Of 121 cancers, 80 had LOH at one of the RPH3AL locus. LOH of RHP3AL was associated with nodal metastasis, advanced stage, large tumor size, and poor survival. Although similar to 50% were positive for LOH at the RPH3AL and TP53 loci, 19 of 105 exhibited LOH only at the RPH3AL locus. Of these, 12 were non-Hispanic Caucasians (Whites), 15 had large tumors, and 12 were older (>50 years). Patients exhibiting LOH at both loci had shorter survival than those without LOH at these loci (log-rank, P = 0.014). LOH at the TP53 locus alone was not associated with survival. Analyses of RPH3AL identified missense point mutations in 19 of 125 cases, a SNP (C>A) in the 5' untranslated region at -25 (5'UTR-25) in 26 of 104, and a SNP (G>T) in the intronic region at 43 bp downstream to exon-6 (intron-6-43) in 79 of 118. Genotype C/A or A/A of the SNP at 5'UTR-25 and genotype T/T of a SNP at intron-6-43 were predominantly in Whites. Low levels of RNA and protein expression of RPH3AL were present in cancers relative to normal tissues. Thus, genetic alterations in RPH3AL are associated with aggressive behavior of breast cancers and with short survival of patients.	[Putcha, Balananda-Dhurjati Kumar; Jia, Xu; Katkoori, Venkat Rao; Salih, Chura; Shanmugam, Chandrakumar; Jadhav, Trafina; Bovell, Liselle C.; Grizzle, William E.; Manne, Upender] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Behring, Michael P.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA; [Callens, Tom; Messiaen, Ludwine] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Bae, Sejong; Singh, Karan P.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Bae, Sejong; Grizzle, William E.; Singh, Karan P.; Manne, Upender] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Manne, U (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	manne@uab.edu	B., Liselle/AAN-9721-2020	bae, sejong/0000-0001-9982-3223	UAB Breast SPORE grant of the National Institutes of Health/National Cancer Institute [3P50CA089019-08S1]; Susan G. Komen Grant [POP138306]; UAB SPORE; NATIONAL CANCER INSTITUTE [P30CA013148, P50CA089019] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R24HL123767] Funding Source: NIH RePORTER	UAB Breast SPORE grant of the National Institutes of Health/National Cancer Institute; Susan G. Komen Grant(Susan G. Komen Breast Cancer Foundation); UAB SPORE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a pilot grant from UAB Breast SPORE grant of the National Institutes of Health/National Cancer Institute (3P50CA089019-08S1) and Susan G. Komen Grant POP138306 to Dr. U. Manne. Supplemental funds of the UAB SPORE were used to train Dr. Liselle Bovell, a minority graduate student at UAB.	Allison P. D., 1995, SURVIVAL ANAL USING; BATRA SK, 1995, J NEURO-ONCOL, V24, P39, DOI 10.1007/BF01052657; BIEGEL JA, 1992, CANCER RES, V52, P3391; Chen JS, 2011, CLIN CHIM ACTA, V412, P1417, DOI 10.1016/j.cca.2011.04.020; Chopin V, 2006, M S-MED SCI, V22, P54, DOI 10.1051/medsci/200622154; COLES C, 1990, LANCET, V336, P761, DOI 10.1016/0140-6736(90)93236-I; CORNELIS RS, 1994, CANCER RES, V54, P4200; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Fredricks DN, 1999, BIOTECHNIQUES, V26, P198, DOI 10.2144/99262bm04; Goi T, 2002, ONCOL REP, V9, P1189; Ho JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039469; JIN XM, 1995, CARCINOGENESIS, V16, P2205, DOI 10.1093/carcin/16.9.2205; Johnson SM, 2002, INT J CANCER, V98, P205, DOI 10.1002/ijc.10197; Kamat N, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-373; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Katkoori VR, 2008, FRONT BIOSCI-LANDMRK, V13, P1050, DOI 10.2741/2742; Katkoori VR, 2009, CLIN CANCER RES, V15, P2406, DOI 10.1158/1078-0432.CCR-08-1719; Kato M, 1996, J BIOL CHEM, V271, P31775, DOI 10.1074/jbc.271.50.31775; Kawakami K, 2002, JPN J CANCER RES, V93, P1221, DOI 10.1111/j.1349-7006.2002.tb01227.x; Kleinbaum DG, 1996, SURVIVAL ANAL SELF L; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Kotake K, 1997, J BIOL CHEM, V272, P29407, DOI 10.1074/jbc.272.47.29407; Kristensen VN, 1999, CANCER RES, V59, P2825; Letouze E, 2012, J CLIN ENDOCR METAB, V97, pE1284, DOI 10.1210/jc.2012-1184; Manne U, 1997, INT J CANCER, V74, P346, DOI 10.1002/(SICI)1097-0215(19970620)74:3<346::AID-IJC19>3.0.CO;2-9; Matsumoto M, 2004, P NATL ACAD SCI USA, V101, P8313, DOI 10.1073/pnas.0306709101; MATSUMURA K, 1992, CANCER RES, V52, P3474; MCDONALD JD, 1994, GENOMICS, V23, P229, DOI 10.1006/geno.1994.1481; MERLO GR, 1992, AM J PATHOL, V140, P215; Myers RB, 1994, J NATL CANC I, V86; NAGAI MA, 1994, BRIT J CANCER, V69, P754, DOI 10.1038/bjc.1994.142; Niederacher D, 1997, GENE CHROMOSOME CANC, V18, P181, DOI 10.1002/(SICI)1098-2264(199703)18:3<181::AID-GCC5>3.0.CO;2-Y; Ogata S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037048; Park WS, 2003, J KOREAN MED SCI, V18, P501, DOI 10.3346/jkms.2003.18.4.501; Phelan CM, 1998, CANCER RES, V58, P1004; Randerson-Moor JA, 2004, J INVEST DERMATOL, V123, P755, DOI 10.1111/j.0022-202X.2004.23304.x; Roncuzzi L, 2005, ONCOL REP, V14, P471; Sakano S, 2003, INT J CANCER, V104, P98, DOI 10.1002/ijc.10919; Shanmugam C, 2009, BIOTECH HISTOCHEM, V84, P39, DOI 10.1080/10520290902738878; Shirasaki F, 2001, CANCER RES, V61, P7422; Signori E, 2001, ONCOGENE, V20, P4596, DOI 10.1038/sj.onc.1204620; Smith JS, 1999, GENOMICS, V59, P97, DOI 10.1006/geno.1999.5864; Thiagalingam S, 2001, P NATL ACAD SCI USA, V98, P2698, DOI 10.1073/pnas.051625398; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wieland I, 1999, ONCOGENE, V18, P4530, DOI 10.1038/sj.onc.1202806; Wu XF, 2002, JNCI-J NATL CANCER I, V94, P681; Zhang JH, 2004, CARCINOGENESIS, V25, P2479, DOI 10.1093/carcin/bgh247	50	33	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129216	10.1371/journal.pone.0129216	http://dx.doi.org/10.1371/journal.pone.0129216			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070152	Green Submitted, Green Published, gold			2022-12-26	WOS:000356327000056
J	Rocco-Machado, N; Cosentino-Gomes, D; Meyer-Fernandes, JR				Rocco-Machado, Nathalia; Cosentino-Gomes, Daniela; Meyer-Fernandes, Jose Roberto			Modulation of Na+/K+ ATPase Activity by Hydrogen Peroxide Generated through Heme in L-amazonensis	PLOS ONE			English	Article							PROTEIN-KINASE-C; LEISHMANIA-AMAZONENSIS; CUTANEOUS LEISHMANIASIS; RHODNIUS-PROLIXUS; ACTIVATION; IRON; BIOSYNTHESIS; MITOCHONDRIA; PHOSPHATASE; INHIBITION	Leishmania amazonensisis a protozoan parasite that occurs in many areas of Brazil and causes skin lesions. Using this parasite, our group showed the activation of Na+/K+ ATPase through a signaling cascade that involves the presence of heme and protein kinase C (PKC) activity. Heme is an important biomolecule that has pro-oxidant activity and signaling capacity. Reactive oxygen species (ROS) can act as second messengers, which are required in various signaling cascades. Our goal in this work is to investigate the role of hydrogen peroxide (H2O2) generated in the presence of heme in the Na+/K+ ATPase activity of L. amazonensis. Our results show that increasing concentrations of heme stimulates the production of H2O2 in a dose-dependent manner until a concentration of 2.5 mu M heme. To confirm that the effect of heme on the Na+/K+ ATPase is through the generation of H2O2, we measured enzyme activity using increasing concentrations of H2O2 and, as expected, the activity increased in a dose-dependent manner until a concentration of 0.1 mu M H2O2. To investigate the role of PKC in this signaling pathway, we observed the production of H2O2 in the presence of its activator phorbol 12-myristate 13-acetate (PMA) and its inhibitor calphostin C. Both showed no effect on the generation of H2O2. Furthermore, we found that PKC activity is increased in the presence of H2O2, and that in the presence of calphostin C, H2O2 is unable to activate the Na+/K+ ATPase. 100 mu M of Mito-TEMPO was capable of abolishing the stimulatory effect of heme on Na+/K+ ATPase activity, indicating that mitochondria might be the source of the hydrogen peroxide production induced by heme. The modulation of L. amazonensis Na+/K+ ATPase by H2O2 opens new possibilities for understanding the signaling pathways of this parasite.	[Rocco-Machado, Nathalia; Cosentino-Gomes, Daniela; Meyer-Fernandes, Jose Roberto] Univ Fed Rio de Janeiro, CCS, Inst Med Biochem Leopoldo Meis, Ilha Fundao, BR-21941590 Rio De Janeiro, RJ, Brazil; [Rocco-Machado, Nathalia; Cosentino-Gomes, Daniela; Meyer-Fernandes, Jose Roberto] CCS, Inst Natl Sci & Technol Struct Biol & Bioimage IN, Ilha Fundao, BR-21941590 Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro	Rocco-Machado, N (corresponding author), Univ Fed Rio de Janeiro, CCS, Inst Med Biochem Leopoldo Meis, Ilha Fundao, Cidade Univ, BR-21941590 Rio De Janeiro, RJ, Brazil.	rocco@bioqmed.ufrj.br; meyer@bioqmed.ufrj.br	Cosentino-Gomes, Daniela/F-9374-2013; Machado, Nathalia Rocco/X-9731-2018	Cosentino-Gomes, Daniela/0000-0001-5690-5413; Rocco Machado, Nathalia/0000-0002-0127-3540	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPQ2014]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [CAPES2013]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro [FAPERJ2014]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants from the following Brazilian Agencies: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (grant: CNPQ2014, http://cnpq.br), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (grant: CAPES2013, http://www.capes.gov.br) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (grant: FAPERJ2014, www.faperj.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-Amaral EE, 2010, EXP PARASITOL, V124, P436, DOI 10.1016/j.exppara.2009.12.012; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Alvarez N, 2002, J ENZYM INHIB MED CH, V17, P443, DOI 10.1080/1475636021000005749; Alvarez-Rueda N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007581; Antinori S, 2012, EUR J CLIN MICROBIOL, V31, P109, DOI 10.1007/s10096-011-1276-0; BALLA G, 1991, LAB INVEST, V64, P648; Barcellos-de-Souza P, 2013, AM J PHYSIOL-CELL PH, V304, pC170, DOI 10.1152/ajpcell.00078.2012; Campos-Salinas J, 2011, MOL MICROBIOL, V79, P1430, DOI 10.1111/j.1365-2958.2010.07531.x; Caruso-Neves C, 1988, COMP BIOCH PHYSL B, V119, P807; Carvalho S, 2009, ACTA TROP, V109, P131, DOI 10.1016/j.actatropica.2008.10.007; CHANG KP, 1975, P NATL ACAD SCI USA, V72, P2979, DOI 10.1073/pnas.72.8.2979; Huynh C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002795; Cosentino-Gomes D, 2012, INT J MOL SCI, V13, P10697, DOI 10.3390/ijms130910697; Cosentino-Gomes D, 2009, FREE RADICAL BIO MED, V47, P152, DOI 10.1016/j.freeradbiomed.2009.04.020; Cross JV, 2006, ANTIOXID REDOX SIGN, V8, P1819, DOI 10.1089/ars.2006.8.1819; Das J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012602; Nogueira NPD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025935; de Almeida-Amaral EE, 2008, EXP PARASITOL, V118, P165, DOI 10.1016/j.exppara.2007.07.001; de Almeida-Amaral EE, 2007, EXP PARASITOL, V116, P419, DOI 10.1016/j.exppara.2007.02.010; Dikalov S, 2011, FREE RADICAL BIO MED, V51, P1289, DOI 10.1016/j.freeradbiomed.2011.06.033; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Dutta S, 2008, EXP PARASITOL, V118, P629, DOI 10.1016/j.exppara.2007.11.013; Felibertt P, 1995, MOL BIOCHEM PARASIT, V74, P179, DOI 10.1016/0166-6851(95)02497-2; Fernandez PL, 2010, J BIOL CHEM, V285, P32844, DOI 10.1074/jbc.M110.146076; Flannery AR, 2011, J BIOL CHEM, V286, P23266, DOI 10.1074/jbc.M111.229674; GALBRAITH RA, 1988, MOL BIOCHEM PARASIT, V29, P47, DOI 10.1016/0166-6851(88)90118-1; Graca-Souza AV, 2002, BLOOD, V99, P4160, DOI 10.1182/blood.V99.11.4160; Graca-Souza AV, 1999, J BIOL CHEM, V274, P9673, DOI 10.1074/jbc.274.14.9673; Groeger G, 2009, J NEUROCHEM, V109, P1544, DOI 10.1111/j.1471-4159.2009.06081.x; Ijssennagger N, 2013, CARCINOGENESIS, V34, P1628, DOI 10.1093/carcin/bgt084; Kaur H, 2003, FEBS LETT, V543, P113, DOI 10.1016/S0014-5793(03)00420-4; KOBAYASHI E, 1989, BIOCHEM BIOPH RES CO, V159, P548, DOI 10.1016/0006-291X(89)90028-4; Kunwar A, 2007, J CELL BIOCHEM, V102, P1214, DOI 10.1002/jcb.21348; Kupcho K, 2003, ANAL BIOCHEM, V317, P210, DOI 10.1016/S0003-2697(03)00094-0; Leite MS, 2009, EXP PARASITOL, V121, P137, DOI 10.1016/j.exppara.2008.10.018; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martiny A, 1999, MOL BIOCHEM PARASIT, V102, P1, DOI 10.1016/S0166-6851(99)00067-5; Miguel DC, 2013, INFECT IMMUN, V81, P3620, DOI 10.1128/IAI.00687-13; Mittra B, 2013, J EXP MED, V210, P401, DOI 10.1084/jem.20121368; Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110; Otterbein LE, 2000, AM J PHYSIOL-LUNG C, V279, pL1029, DOI 10.1152/ajplung.2000.279.6.L1029; Paes Marcia Cristina, 2011, Journal of Parasitology Research, V2011, DOI 10.1155/2011/174614; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Reithinger R, 2007, LANCET INFECT DIS, V7, P581, DOI 10.1016/S1473-3099(07)70209-8; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; SAITOH T, 1986, BRAIN RES, V379, P196, DOI 10.1016/0006-8993(86)90277-5; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; Silveira FT, 2009, PARASITE IMMUNOL, V31, P423, DOI 10.1111/j.1365-3024.2009.01116.x; TAMAOKI T, 1990, ADV SEC MESS PHOSPH, V24, P497; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Vannier-Santos MA, 2002, CURR PHARM DESIGN, V8, P297, DOI 10.2174/1381612023396230; VANNIERSANTOS MA, 1995, EUR J CELL BIOL, V67, P112; Votyakova TV, 2004, ARCH BIOCHEM BIOPHYS, V431, P138, DOI 10.1016/j.abb.2004.07.025; Wagener FADTG, 2003, PHARMACOL REV, V55, P551, DOI 10.1124/pr.55.3.5; WARREN LG, 1960, J PARASITOL, V46, P529, DOI 10.2307/3274932; Wilson R, 1987, Dev Biol Stand, V66, P161	56	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129604	10.1371/journal.pone.0129604	http://dx.doi.org/10.1371/journal.pone.0129604			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070143	gold, Green Submitted, Green Published			2022-12-26	WOS:000356327000093
J	Willemen, L; Cottam, AJ; Drakou, EG; Burgess, ND				Willemen, Louise; Cottam, Andrew J.; Drakou, Evangelia G.; Burgess, Neil D.			Using Social Media to Measure the Contribution of Red List Species to the Nature-Based Tourism Potential of African Protected Areas	PLOS ONE			English	Article							ECOSYSTEM SERVICES; PREFERENCES; SUPPORT; SCIENCE	Cultural ecosystem services are defined by people's perception of the environment, which make them hard to quantify systematically. Methods to describe cultural benefits from ecosystems typically include resource-demanding survey techniques, which are not suitable to assess cultural ecosystem services for large areas. In this paper we explore a method to quantify cultural benefits through the enjoyment of natured-based tourism, by assessing the potential tourism attractiveness of species for each protected area in Africa using the IUCN's Red List of Threatened Species. We use the number of pictures of wildlife posted on a photo sharing website as a proxy for charisma, popularity, and ease of observation, as these factors combined are assumed to determine how attractive species are for the global wildlife tourist. Based on photo counts of 2473 African animals and plants, species that seem most attractive to nature-based tourism are the Lion, African Elephant and Leopard. Combining the photo counts with species range data, African protected areas with the highest potential to attract wildlife tourists based on attractive species occurrence were Samburu National Reserve in Kenya, Mukogodo Forest Reserve located just north of Mount Kenya, and Addo Elephant National Park in South-Africa. The proposed method requires only three data sources which are freely accessible and available online, which could make the proposed index tractable for large scale quantitative ecosystem service assessments. The index directly links species presence to the tourism potential of protected areas, making the connection between nature and human benefits explicit, but excludes other important contributing factors for tourism, such as accessibility and safety. This social media based index provides a broad understanding of those species that are popular globally; in many cases these are not the species of highest conservation concern.	[Willemen, Louise] Univ Twente, Dept Nat Resources, Fac Geoinformat Sci & Earth Observat ITC, NL-7500 AE Enschede, Netherlands; [Cottam, Andrew J.; Drakou, Evangelia G.] European Commiss Joint Res Ctr, Inst Environm & Sustainabil, Ispra, Italy; [Burgess, Neil D.] UNEP World Conservat Monitoring Ctr, Cambridge, England; [Burgess, Neil D.] Nat Hist Museum Denmark, Ctr Marcoecol Evolut & Climate, Copenhagen, Denmark	University of Twente; European Commission Joint Research Centre; EC JRC ISPRA Site	Willemen, L (corresponding author), Univ Twente, Dept Nat Resources, Fac Geoinformat Sci & Earth Observat ITC, POB 217, NL-7500 AE Enschede, Netherlands.	l.l.Willemen@utwente.nl	Willemen, Louise/O-2306-2015; Drakou, Evangelia/S-9511-2019; Willemen, Louise/AAC-7935-2019	Willemen, Louise/0000-0003-1026-5865; Drakou, Evangelia/0000-0003-4404-629X; Willemen, Louise/0000-0003-1026-5865	European Union [CRIS DEC 2010/ 022-121]	European Union(European Commission)	Andrew Cottom and Evangelia Drakou were funded by the European Union under the 10th EDF for the BIOPAMA (Biodiversity and Protected Areas Management) project (Intra-ACP envelope: CRIS DEC 2010/ 022-121).	Balmford A, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002074; Bayliss J, 2014, ECOSYST SERV, V8, P75, DOI 10.1016/j.ecoser.2014.02.006; CASALEGNO S, 2013, PLOS ONE, V8; Catlin J, 2013, BIOL CONSERV, V157, P93, DOI 10.1016/j.biocon.2012.07.022; Chan KMA, 2012, ECOL ECON, V74, P8, DOI 10.1016/j.ecolecon.2011.11.011; Crossman ND, 2013, ECOSYST SERV, V4, P4, DOI 10.1016/j.ecoser.2013.02.001; Daniel TC, 2012, P NATL ACAD SCI USA, V109, P8812, DOI 10.1073/pnas.1114773109; de Groot RS, 2010, ECOL COMPLEX, V7, P260, DOI 10.1016/j.ecocom.2009.10.006; de Pinho JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088842; Di Minin E, 2013, ANIM CONSERV, V16, P249, DOI 10.1111/j.1469-1795.2012.00595.x; Dudley N., 2011, SOLUTIONS, V2, P87; Dudley N, 2008, GUIDELINES APPL PROT, DOI DOI 10.2305/IUCN.CH.2008.PAPS.2.EN; Egoh B, 2012, INDICATORS MAPPING E; Ghermandi A, 2013, ECOL ECON, V86, P1, DOI 10.1016/j.ecolecon.2012.11.006; Goldman RL, 2008, P NATL ACAD SCI USA, V105, P9445, DOI 10.1073/pnas.0800208105; Gomez-Baggethun E, 2011, PROG PHYS GEOG, V35, P613, DOI 10.1177/0309133311421708; Guimaraes MH, 2015, TOURISM MANAGE, V46, P102, DOI 10.1016/j.tourman.2014.06.016; Haines-Young R., 2010, ECOSYSTEM ECOLOGY NE, DOI DOI 10.1017/CBO9780511750458.007; Hernandez-Morcillo M, 2013, ECOL INDIC, V29, P434, DOI 10.1016/j.ecolind.2013.01.013; Juffe-Bignoli D, 2014, PROTECTED PLANET REP; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lindsey Peter A., 2007, Journal of Ecotourism, V6, P19, DOI 10.2167/joe133.0; Liu W., 2012, PLOS ONE, V7; Maciejewski K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088192; Maes J, 2012, ECOSYST SERV, V1, P31, DOI 10.1016/j.ecoser.2012.06.004; Mansfeld Y., 2006, TOURISM SECURITY SAF, P29; Milcu AI, 2013, ECOL SOC, V18, DOI 10.5751/ES-05790-180344; Novelli M, 2012, ANN TOURISM RES, V39, P1446, DOI 10.1016/j.annals.2012.03.003; Osipova E., 2014, BENEFITS NATURAL WOR; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Seppelt R, 2011, J APPL ECOL; Stokes DL, 2007, HUM ECOL, V35, P361, DOI 10.1007/s10745-006-9056-7; Verissimo D, 2014, CONSERV BIOL, V28, P269, DOI 10.1111/cobi.12142; Ward PI, 1998, CONSERV BIOL, V12, P1408, DOI 10.1046/j.1523-1739.1998.97402.x; WBCSD - World Business Council for Sustainable Development, 2011, GUID CORP EC VAL FRA; Weyland F, 2014, ECOL INDIC, V39, P34, DOI 10.1016/j.ecolind.2013.11.023; Wood SA, 2013, SCI REP-UK, V3, DOI 10.1038/srep02976	37	72	74	3	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129785	10.1371/journal.pone.0129785	http://dx.doi.org/10.1371/journal.pone.0129785			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6GR	26068111	Green Published, Green Submitted, gold			2022-12-26	WOS:000356327000104
J	Costela, FM; Otero-Millan, J; McCamy, MB; Macknik, SL; Di Stasi, LL; Rieiro, H; Leigh, JR; Troncoso, XG; Jazi, AN; Martinez-Conde, S				Costela, Francisco M.; Otero-Millan, Jorge; McCamy, Michael B.; Macknik, Stephen L.; Di Stasi, Leandro L.; Rieiro, Hector; Leigh, John R.; Troncoso, Xoana G.; Jazi, Ali Najafian; Martinez-Conde, Susana			Characteristics of Spontaneous Square-Wave Jerks in the Healthy Macaque Monkey during Visual Fixation	PLOS ONE			English	Article							SACCADIC INTRUSIONS; EYE-MOVEMENTS; SUPERIOR COLLICULUS; COVERT ATTENTION; RHESUS-MONKEY; MICROSACCADES; PERCEPTION; MECHANISMS; GENERATION; VISION	Saccadic intrusions (SIs), predominantly horizontal saccades that interrupt accurate fixation, include square-wave jerks (SWJs; the most common type of SI), which consist of an initial saccade away from the fixation target followed, after a short delay, by a return saccade that brings the eye back onto target. SWJs are present in most human subjects, but are prominent by their increased frequency and size in certain parkinsonian disorders and in recessive, hereditary spinocerebellar ataxias. SWJs have been also documented in monkeys with tectal and cerebellar etiologies, but no studies to date have investigated the occurrence of SWJs in healthy nonhuman primates. Here we set out to determine the characteristics of SWJs in healthy rhesus macaques (Macaca mulatta) during attempted fixation of a small visual target. Our results indicate that SWJs are common in healthy nonhuman primates. We moreover found primate SWJs to share many characteristics with human SWJs, including the relationship between the size of a saccade and its likelihood to be part of a SWJ. One main discrepancy between monkey and human SWJs was that monkey SWJs tended to be more vertical than horizontal, whereas human SWJs have a strong horizontal preference. Yet, our combined data indicate that primate and human SWJs play a similar role in fixation correction, suggesting that they share a comparable coupling mechanism at the oculomotor generation level. These findings constrain the potential brain areas and mechanisms underlying the generation of fixational saccades in human and nonhuman primates.	[Costela, Francisco M.; Otero-Millan, Jorge; McCamy, Michael B.; Macknik, Stephen L.; Di Stasi, Leandro L.; Rieiro, Hector; Troncoso, Xoana G.; Jazi, Ali Najafian; Martinez-Conde, Susana] Barrow Neurol Inst, Dept Neurobiol, Phoenix, AZ 85013 USA; [Costela, Francisco M.] Arizona State Univ, Interdisciplinary Grad program Neurosci, Tempe, AZ USA; [Otero-Millan, Jorge] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Macknik, Stephen L.; Martinez-Conde, Susana] Suny Downstate Med Ctr, Dept Ophthalmol, Brooklyn, NY 11203 USA; [Di Stasi, Leandro L.] Univ Granada, Mind Brain & Behav Res Ctr, Granada, Spain; [Rieiro, Hector] Univ Vigo, Dept Signal Theory & Commun, Vigo 36310, Spain; [Leigh, John R.] Case Western Reserve Univ, Vet Affairs Med Ctr, Cleveland, OH 44106 USA; [Troncoso, Xoana G.] UPR CNRS 3293, Unite Neurosci Informat & Complexite, Gif Sur Yvette, France	Barrow Neurological Institute; Arizona State University; Arizona State University-Tempe; Johns Hopkins University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of Granada; Universidade de Vigo; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Martinez-Conde, S (corresponding author), Barrow Neurol Inst, Dept Neurobiol, Phoenix, AZ 85013 USA.	smart@neuralcorrelate.com	Di Stasi, Leandro Luigi/V-7551-2017; Costela, Francisco M/ABG-7910-2020; Otero-Millan, Jorge/A-4193-2014; Macknik, Stephen L./H-7704-2019	Di Stasi, Leandro Luigi/0000-0001-6763-6546; Costela, Francisco M/0000-0002-3530-6224; Otero-Millan, Jorge/0000-0002-9789-8392; Macknik, Stephen L./0000-0002-3143-9230; Troncoso, Xoana/0000-0001-7343-1272; Rieiro, Hector/0000-0002-4312-9432	Barrow Neurological Foundation; National Science Foundations [0852636, 1153786, 0726113]	Barrow Neurological Foundation; National Science Foundations(National Science Foundation (NSF))	This study was supported by Barrow Neurological Foundation (http://www.thebarrow.org/) to SLM and SMC. National Science Foundations (Awards 0852636 and 1153786 to SMC and Award 0726113 to SLM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi R, 2004, VISION RES, V44, P2675, DOI 10.1016/j.visres.2004.05.009; Betta E, 2006, NEUROREPORT, V17, P1001, DOI 10.1097/01.wnr.0000223392.82198.6d; Carasig D, 2006, VISION RES, V46, P1161, DOI 10.1016/j.visres.2005.05.024; Costela FM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110889; Cui J, 2009, VISION RES, V49, P228, DOI 10.1016/j.visres.2008.10.015; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Engbert R, 2006, P NATL ACAD SCI USA, V103, P7192, DOI 10.1073/pnas.0509557103; Engbert R, 2006, PROG BRAIN RES, V154, P177, DOI 10.1016/S0079-6123(06)54009-9; Fahey MC, 2008, BRAIN, V131, P1035, DOI 10.1093/brain/awm323; Gnadt JW, 2013, F1000RESEARCH, DOI 10.12688/f1000research.2-85.v1; Goffart L, 2012, J NEUROSCI, V32, P10627, DOI 10.1523/JNEUROSCI.0696-12.2012; Gowen E, 2007, BRAIN RES, V1141, P154, DOI 10.1016/j.brainres.2007.01.047; Hafed ZM, 2011, EUR J NEUROSCI, V33, P2101, DOI 10.1111/j.1460-9568.2011.07694.x; Hafed ZM, 2009, SCIENCE, V323, P940, DOI 10.1126/science.1166112; Izawa Y, 2009, J NEUROPHYSIOL, V102, P2410, DOI 10.1152/jn.00234.2009; KAPOULA ZA, 1986, EXP BRAIN RES, V61, P386; Laubrock J, 2005, VISION RES, V45, P721, DOI 10.1016/j.visres.2004.09.029; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Martinez-Conde S, 2006, NEURON, V49, P297, DOI 10.1016/j.neuron.2005.11.033; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; Martinez-Conde S, 2002, P NATL ACAD SCI USA, V99, P13920, DOI 10.1073/pnas.212500599; Martinez-Conde S, 2000, NAT NEUROSCI, V3, P251, DOI 10.1038/72961; Martinez-Conde S, 2006, PROG BRAIN RES, V154, P151; Martinez-Conde S, 2013, NAT REV NEUROSCI, V14, P83, DOI 10.1038/nrn3405; Martinez-Conde S, 2009, TRENDS NEUROSCI, V32, P463, DOI 10.1016/j.tins.2009.05.006; Martinez-Conde S, 2008, J VISION, V8, DOI [10.1167/8.14.28, 10.1167/8.14.i]; McCamy MB, 2013, PEERJ, V1, DOI 10.7717/peerj.9; McCamy MB, 2013, PEERJ, V1, DOI 10.7717/peerj.14; Moller F, 2002, GRAEF ARCH CLIN EXP, V240, P765, DOI 10.1007/s00417-002-0519-2; Otero-Millan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058535; Otero-Millan J, 2011, ANN NY ACAD SCI, V1233, P107, DOI 10.1111/j.1749-6632.2011.06177.x; Otero-Millan J, 2011, J NEUROSCI, V31, P4379, DOI 10.1523/JNEUROSCI.2600-10.2011; RASCOL O, 1991, J NEUROL NEUROSUR PS, V54, P599, DOI 10.1136/jnnp.54.7.599; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Rolfs M, 2006, EXP BRAIN RES, V169, P369, DOI 10.1007/s00221-005-0148-1; Rolfs M, 2009, VISION RES, V49, P2415, DOI 10.1016/j.visres.2009.08.010; Rolfs M, 2008, J VISION, V8, DOI 10.1167/8.11.5; Siegenthaler E, 2014, EUR J NEUROSCI, V39, P287, DOI 10.1111/ejn.12395; Troncoso XG, 2005, PERCEPTION, V34, P409, DOI 10.1068/p5383; Troncoso XG, 2008, P NATL ACAD SCI USA, V105, P16033, DOI 10.1073/pnas.0709389105; Troncoso XG, 2008, J VISION, V8, DOI 10.1167/8.14.15; WEBER H, 1989, J HIRNFORSCH, V30, P603	42	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0126485	10.1371/journal.pone.0126485	http://dx.doi.org/10.1371/journal.pone.0126485			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067994	Green Published, Green Submitted, gold			2022-12-26	WOS:000356100900010
J	Schrandt, MN; Powers, SP				Schrandt, Meagan N.; Powers, Sean P.			Facilitation and Dominance in a Schooling Predator: Foraging Behavior of Florida Pompano, Trachinotus carolinus	PLOS ONE			English	Article							SHOAL SIZE; FISH; PROFITABILITY	Presumably an individual's risk of predation is reduced by group membership and this 'safety in numbers' concept has been readily applied to investigations of schooling prey; however, foraging in groups may also be beneficial. We tested the hypothesis that, when feeding in groups, foraging of a coastal fish (Florida Pompano, Trachinotus carolinus) on a benthic prey source would be facilitated (i.e. fish feeding in groups will consume more prey items). Although this question has been addressed for other fish species, it has not been previously addressed for Florida Pompano, a fish known to exhibit schooling behavior and that is used for aquaculture, where understanding the feeding ecology is important for healthy and efficient grow-out. In this experiment, juvenile Florida Pompano were offered a fixed number of coquina clams (Donax spp.) for one hour either in a group or as individuals. The following day they were tested in the opposite configuration. Fish in groups achieved greater consumption (average of 26 clams consumed by the entire group) than the individuals comprising the group (average of 14 clams consumed [sum of clams consumed by all individuals of the group]). Fish in groups also had fewer unsuccessful foraging attempts (2.75 compared to 4.75 hr(-1)) and tended to have a shorter latency until the first feeding activity. Our results suggest fish in groups were more comfortable feeding and more successful in their feeding attempts. Interestingly, the consumption benefit of group foraging was not shared by all not all fish within a group consumed equal numbers of clams. Taken together, the results support our hypothesis that foraging in a group provides facilitation, but the short-term benefits are not equally shared by all individuals.	[Schrandt, Meagan N.; Powers, Sean P.] Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA; [Schrandt, Meagan N.; Powers, Sean P.] Dauphin Isl Sea Lab, Dauphin Isl, AL USA	University of South Alabama; Dauphin Island Sea Lab	Schrandt, MN (corresponding author), Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA.	mschrandt@disl.org		Powers, Sean/0000-0002-4770-9944	University of South Alabama	University of South Alabama	Support for this project was provided by the University of South Alabama. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAIRD TA, 1991, ENVIRON BIOL FISH, V31, P307, DOI 10.1007/BF00000697; CLARK CW, 1986, THEOR POPUL BIOL, V30, P45, DOI 10.1016/0040-5809(86)90024-9; Conrad JL, 2011, J FISH BIOL, V78, P395, DOI 10.1111/j.1095-8649.2010.02874.x; Ellers O, 1988, THESIS DUKE U DURHAM; Foster EG, 2001, J EXP MAR BIOL ECOL, V261, P93, DOI 10.1016/S0022-0981(01)00265-9; FOSTER WA, 1981, NATURE, V293, P466, DOI 10.1038/293466a0; GIBSON RN, 1992, J FISH BIOL, V40, P577, DOI 10.1111/j.1095-8649.1992.tb02607.x; Grand TC, 1999, ANIM BEHAV, V58, P443, DOI 10.1006/anbe.1999.1174; KNOTT DM, 1983, ESTUAR COAST SHELF S, V16, P573, DOI 10.1016/0272-7714(83)90087-2; Krause J, 2000, BIOL REV, V75, P477; Lindquist N, 2001, IMPACTS BEACH NOURIS; MAGURRAN AE, 1983, BEHAV ECOL SOCIOBIOL, V12, P147, DOI 10.1007/BF00343206; MAGURRAN AE, 1990, ANN ZOOL FENN, V27, P51; Manning LM, 2003, OECOLOGIA, V134, P415, DOI 10.1007/s00442-002-1134-y; McLachlan A., 1988, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, P449; MILINSKI M, 1984, ANIM BEHAV, V32, P233, DOI 10.1016/S0003-3472(84)80342-5; MODDE T, 1983, Northeast Gulf Science, V6, P109; Pavlov D.S., 2000, J ICHTHYOL+, V40, pS163; Pereira PHC, 2013, J FISH BIOL, V82, P1226, DOI 10.1111/jfb.12054; Pereira PHC, 2013, ACTA ETHOL, V16, P53, DOI 10.1007/s10211-012-0130-4; Pitcher T.J., 1986, P294; Pitcher T. J., 1993, BEHAV TELEOST FISHES, DOI [10.1007/978-94-011-1578-0_12, DOI 10.1007/978-94-011-1578-0_12, DOI 10.1007/978-94-011-1578-0_]; PITCHER TJ, 1983, ANIM BEHAV, V31, P546, DOI 10.1016/S0003-3472(83)80078-5; PITCHER TJ, 1982, BEHAV ECOL SOCIOBIOL, V10, P149, DOI 10.1007/BF00300175; Pitcher TJ., 2001, ENCY OCEAN SCI, P975, DOI DOI 10.1006/RWOS.2001.0022; RANTA E, 1991, J FISH BIOL, V39, P733, DOI 10.1111/j.1095-8649.1991.tb04402.x; Ross SW, 1996, REV SYNTHESIS DATA S; RYER CH, 1991, ENVIRON BIOL FISH, V30, P317, DOI 10.1007/BF02028847; Ryer CH, 1998, ENVIRON BIOL FISH, V52, P467, DOI 10.1023/A:1007433014921; Strubin C, 2011, ETHOLOGY, V117, P961, DOI 10.1111/j.1439-0310.2011.01966.x; Verweij MC, 2006, MAR BIOL, V149, P1291, DOI 10.1007/s00227-006-0305-5; Wheeler KN, 2002, PROCEEDINGS OF THE FIFTY-THIRD ANNUAL GULF AND CARIBBEAN FISHERIES INSTITUTE, P659	32	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0130095	10.1371/journal.pone.0130095	http://dx.doi.org/10.1371/journal.pone.0130095			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068114	Green Submitted, Green Published, gold			2022-12-26	WOS:000356100900097
J	Gosain, A; Barlow-Anacker, AJ; Erickson, CS; Pierre, JF; Heneghan, AF; Epstein, ML; Kudsk, KA				Gosain, Ankush; Barlow-Anacker, Amanda J.; Erickson, Chris S.; Pierre, Joseph F.; Heneghan, Aaron F.; Epstein, Miles L.; Kudsk, Kenneth A.			Impaired Cellular Immunity in the Murine Neural Crest Conditional Deletion of Endothelin Receptor-B Model of Hirschsprung's Disease	PLOS ONE			English	Article							ENTERIC NERVOUS-SYSTEM; PEYERS-PATCHES; INTESTINAL AGANGLIONOSIS; ANATOMICAL EVIDENCE; SURGICAL-CORRECTION; ULCERATIVE-COLITIS; CROHNS-DISEASE; L-SELECTIN; RAT MODEL; ENTEROCOLITIS	Hirschsprung's disease (HSCR) is characterized by aganglionosis from failure of neural crest cell (NCC) migration to the distal hindgut. Up to 40% of HSCR patients suffer Hirschsprung's-associated enterocolitis (HAEC), with an incidence that is unchanged from the pre-operative to the post-operative state. Recent reports indicate that signaling pathways involved in NCC migration may also be involved in the development of secondary lymphoid organs. We hypothesize that gastrointestinal (GI) mucosal immune defects occur in HSCR that may contribute to enterocolitis. EdnrB was deleted from the neural crest (EdnrB(NCC-/-)) resulting in mutants with defective NCC migration, distal colonic aganglionosis and the development of enterocolitis. The mucosal immune apparatus of these mice was interrogated at post-natal day (P) 2124, prior to histological signs of enterocolitis. We found that EdnrB(NCC-/-) display lymphopenia of their Peyer's Patches, the major inductive site of GI mucosal immunity. EdnrB(NCC-/-) Peyer's Patches demonstrate decreased B-lymphocytes, specifically IgM(+)IgD(hi) (Mature) B-lymphocytes, which are normally activated and produce IgA following antigen presentation. EdnrB(NCC-/-) animals demonstrate decreased small intestinal secretory IgA, but unchanged nasal and bronchial airway secretory IgA, indicating a gut-specific defect in IgA production or secretion. In the spleen, which is the primary source of IgA-producing Mature B-lymphocytes, EdnrB(NCC-/-) animals display decreased B-lymphocytes, but an increase in Mature B-lymphocytes. EdnrB(NCC-/-) spleens are also small and show altered architecture, with decreased red pulp and a paucity of B-lymphocytes in the germinal centers and marginal zone. Taken together, these findings suggest impaired GI mucosal immunity in EdnrB(NCC-/-) animals, with the spleen as a potential site of the defect. These findings build upon the growing body of literature that suggests that intestinal defects in HSCR are not restricted to the aganglionic colon but extend proximally, even into the ganglionated small intestine and immune cells.	[Gosain, Ankush; Barlow-Anacker, Amanda J.; Erickson, Chris S.; Pierre, Joseph F.; Heneghan, Aaron F.; Kudsk, Kenneth A.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Surg, Madison, WI 53706 USA; [Gosain, Ankush; Epstein, Miles L.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurosci, Madison, WI USA; [Kudsk, Kenneth A.] William S Middleton Mem Vet Adm Med Ctr, Vet Adm Surg Serv, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital	Gosain, A (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Surg, Madison, WI 53706 USA.	gosain@surgery.wisc.edu	Pierre, Joseph/HCH-3993-2022; Pierre, Joseph F./AAA-2469-2020	Pierre, Joseph/0000-0003-0070-0106; Gosain, Ankush/0000-0002-0428-1503; Pierre, Joseph/0000-0002-4248-1290	National Institutes of Health [NIDDK RO1DK081634, NIDDK K08DK098271]; Veteran's Affairs Office of Research and Development (Biomedical Laboratory Research & Development Award) [I01BX001672]; Central Surgical Association Foundation (Turcotte Award); American Pediatric Surgical Association Foundation Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081634, K08DK098271] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran's Affairs Office of Research and Development (Biomedical Laboratory Research & Development Award); Central Surgical Association Foundation (Turcotte Award); American Pediatric Surgical Association Foundation Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (NIDDK RO1DK081634) to MLE, the Veteran's Affairs Office of Research and Development (Biomedical Laboratory Research & Development Award I01BX001672) to KAK, the Central Surgical Association Foundation (2012 Turcotte Award) to AG, the American Pediatric Surgical Association Foundation Award to AG, and the National Institutes of Health (NIDDK K08DK098271) to AG. The contents of this article do not represent the views of the Veterans Affairs or the United States Government (KAK).	Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Ano Y, 2009, PROTEIN PEPTIDE LETT, V16, P247, DOI 10.2174/092986609787601642; Anthoni C, 2006, INT J COLORECTAL DIS, V21, P409, DOI 10.1007/s00384-005-0015-3; Aslam A, 1997, J PEDIATR SURG, V32, P1206, DOI 10.1016/S0022-3468(97)90683-7; Auricchio A, 1996, HUM MOL GENET, V5, P351, DOI 10.1093/hmg/5.3.351; Austin KM, 2012, SEMIN PEDIATR SURG, V21, P319, DOI 10.1053/j.sempedsurg.2012.07.006; Balemba OB, 1999, J ANAT, V195, P1, DOI 10.1046/j.1469-7580.1999.19510001.x; Balemba OB, 1998, J ANAT, V192, P257, DOI 10.1046/j.1469-7580.1998.19220257.x; BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; BERG EL, 1993, NATURE, V366, P695, DOI 10.1038/366695a0; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; Best KE, 2012, BIRTH DEFECTS RES A, V94, P477, DOI 10.1002/bdra.23016; BILL AH, 1962, AM J SURG, V103, P70, DOI 10.1016/0002-9610(62)90016-8; Bondurand N, 2006, DEVELOPMENT, V133, P2075, DOI 10.1242/dev.02375; Brandtzaeg P, 2009, SCAND J IMMUNOL, V70, P505, DOI 10.1111/j.1365-3083.2009.02319.x; Buckanovich RJ, 2008, NAT MED, V14, P28, DOI 10.1038/nm1699; Cheng Z, 2011, PEDIATR SURG INT, V27, P145, DOI 10.1007/s00383-010-2787-y; Cheng Z, 2010, J PEDIATR SURG, V45, P475, DOI 10.1016/j.jpedsurg.2009.06.009; Chiocchetti R, 2008, CELL TISSUE RES, V332, P185, DOI 10.1007/s00441-008-0583-y; Coles M, 2010, PROG MOL BIOL TRANSL, V92, P177, DOI 10.1016/S1877-1173(10)92008-5; De Filippo C, 2010, PEDIATR SURG INT, V26, P465, DOI 10.1007/s00383-010-2586-5; Druckenbrod NR, 2008, GENESIS, V46, P396, DOI 10.1002/dvg.20415; Erickson CS, 2012, J COMP NEUROL, V520, P620, DOI 10.1002/cne.22755; Fagarasan S, 2004, CURR OPIN IMMUNOL, V16, P277, DOI 10.1016/j.coi.2004.03.005; Frykman PK, 2015, EUR J IMMUNOL, V45, P807, DOI 10.1002/eji.201444737; Frykman PK, 2012, SEMIN PEDIATR SURG, V21, P328, DOI 10.1053/j.sempedsurg.2012.07.007; FUJIMOTO T, 1988, PEDIATR RES, V24, P152, DOI 10.1203/00006450-198808000-00002; Gabriel SB, 2002, NAT GENET, V31, P89, DOI 10.1038/ng868; Gariepy CE, 1998, J CLIN INVEST, V102, P1092, DOI 10.1172/JCI3702; Gershon MD, 2010, TRENDS NEUROSCI, V33, P446, DOI 10.1016/j.tins.2010.06.002; GLOTZER DJ, 1966, ARCH SURG-CHICAGO, V92, P1; Green BT, 2003, J NEUROIMMUNOL, V141, P74, DOI 10.1016/S0165-5728(03)00225-X; Guruli G, 2004, BLOOD, V104, P2107, DOI 10.1182/blood-2003-10-3559; Harris NL, 2006, J IMMUNOL, V177, P6256, DOI 10.4049/jimmunol.177.9.6256; Hogaboam CM, 1996, EUR J PHARMACOL, V309, P261, DOI 10.1016/0014-2999(96)00276-2; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; IMAMURA A, 1992, GUT, V33, P801, DOI 10.1136/gut.33.6.801; Kaleczyc J, 2010, J COMP PATHOL, V143, P248, DOI 10.1016/j.jcpa.2010.04.003; Kandalaft LE, 2009, CLIN CANCER RES, V15, P4521, DOI 10.1158/1078-0432.CCR-08-0543; Khimji AK, 2010, CELL SIGNAL, V22, P1615, DOI 10.1016/j.cellsig.2010.05.002; KRAMMER HJ, 1993, CELL TISSUE RES, V272, P267, DOI 10.1007/BF00302732; Kusafuka T, 1997, J PEDIATR SURG, V32, P501, DOI 10.1016/S0022-3468(97)90616-3; Kusafuka T, 1996, HUM MOL GENET, V5, P347, DOI 10.1093/hmg/5.3.347; Lee CC, 2012, PEDIATR NEONATOL, V53, P133, DOI 10.1016/j.pedneo.2012.01.011; Letizia C, 1998, ITAL J GASTROENTEROL, V30, P266; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; Malendowicz LK, 1998, LIFE SCI, V62, P1959, DOI 10.1016/S0024-3205(98)00165-9; MARTY TL, 1995, J PEDIATR SURG, V30, P655, DOI 10.1016/0022-3468(95)90682-7; Mundt E, 2010, SEMIN PEDIATR SURG, V19, P107, DOI 10.1053/j.sempedsurg.2009.11.015; MURCH SH, 1992, LANCET, V339, P381, DOI 10.1016/0140-6736(92)90077-G; Murphy F, 2005, PEDIATR SURG INT, V21, P773, DOI 10.1007/s00383-005-1551-1; Nagy N, 2006, DEV BIOL, V293, P203, DOI 10.1016/j.ydbio.2006.01.032; Pascual D W, 1994, Immunomethods, V5, P56, DOI 10.1006/immu.1994.1038; Patel A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002734; Pierre JF, 2014, J PEDIATR SURG, V49, P1242, DOI 10.1016/j.jpedsurg.2014.01.060; POLLEY TZ, 1985, ANN SURG, V202, P349, DOI 10.1097/00000658-198509000-00012; Prato AP, 2011, PEDIATR SURG INT, V27, P473, DOI 10.1007/s00383-010-2848-2; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; Reese SR, 2005, SURGERY, V137, P209, DOI 10.1016/j.surg.2004.08.003; Rosado MM, 2009, MUCOSAL IMMUNOL, V2, P351, DOI 10.1038/mi.2009.15; Sampaio ALF, 2000, INFLAMM RES, V49, P170, DOI 10.1007/s000110050577; Sanchez-Mejias A, 2010, GENET MED, V12, P39, DOI 10.1097/GIM.0b013e3181c371b0; Sasselli V, 2012, DEV BIOL, V366, P64, DOI 10.1016/j.ydbio.2012.01.012; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Shen DH, 2009, WORLD J PEDIATR, V5, P201, DOI 10.1007/s12519-009-0038-x; TEITELBAUM DH, 1989, J PEDIATR SURG, V24, P1271, DOI 10.1016/S0022-3468(89)80566-4; Thiagarajah JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099944; Toti P, 2004, AM J CLIN PATHOL, V122, P765, DOI 10.1309/RV6E9BMC9954A2WU; Veiga-Fernandes H, 2007, NATURE, V446, P547, DOI 10.1038/nature05597; Vilagos B, 2012, J EXP MED, V209, P775, DOI 10.1084/jem.20112422; Vulchanova L, 2007, J NEUROIMMUNOL, V185, P64, DOI 10.1016/j.jneuroim.2007.01.014; Ward NL, 2012, NEUROGASTROENT MOTIL, V24, P874, DOI 10.1111/j.1365-2982.2012.01937.x; Yamaguchi E, 2007, J GASTROEN HEPATOL, V22, P1134, DOI 10.1111/j.1440-1746.2006.04822.x; Zaitoun I, 2013, NEUROGASTROENT MOTIL, V25, pE233, DOI 10.1111/nmo.12083; Zhao LF, 2010, J PEDIATR SURG, V45, P206, DOI 10.1016/j.jpedsurg.2009.10.035	76	25	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0128822	10.1371/journal.pone.0128822	http://dx.doi.org/10.1371/journal.pone.0128822			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061883	Green Submitted, gold, Green Published			2022-12-26	WOS:000355979500100
J	Isono, T; Yamashita, K; Momose, D; Kobayashi, H; Kitamura, M; Nishiyama, Y; Hosoya, T; Kanda, H; Kudo, A; Okada, N; Yagi, T; Nakata, K; Mineki, S; Tokunaga, E				Isono, Takumi; Yamashita, Kyohei; Momose, Daisuke; Kobayashi, Hiroki; Kitamura, Masashi; Nishiyama, Yusuke; Hosoya, Takahiro; Kanda, Hiroaki; Kudo, Ayane; Okada, Norihide; Yagi, Takafumi; Nakata, Kazuaki; Mineki, Shigeru; Tokunaga, Eiji			Scan-Free Absorbance Spectral Imaging A(x, y, lambda) of Single Live Algal Cells for Quantifying Absorbance of Cell Suspensions	PLOS ONE			English	Article							CHLAMYDOMONAS-REINHARDTII; CHLOROPHYLL-A; ABSORPTION; EYESPOT; SYSTEM; MICROALGAE; EUGLENA	Label-free, non-invasive, rapid absorbance spectral imaging A(x, y, lambda) microscopy of single live cells at 1.2 mu m x 1.2 mu m resolution with an NA = 0.85 objective was developed and applied to unicellular green algae Chlamydomonas reinhardtii. By introducing the fiber assembly to rearrange a two-dimensional image to the one-dimensional array to fit the slit of an imaging spectrograph equipped with a CCD detector, scan-free acquisition of three-dimensional information of A(x, y, lambda was realized. The space-resolved absorbance spectra of the eyespot, an orange organelle about 1 mu m, were extracted from the green-color background in a chlorophyll-rich single live cell absorbance image. Characteristic absorbance change in the cell suspension after hydrogen photoproduction in C. reinhardtii was investigated to find a single 715-nm absorption peak was locally distributed within single cells. The formula to calculate the absorbance of cell suspensions from that of single cells was presented to obtain a quantitative, parameter-free agreement with the experiment. It is quantitatively shown that the average number of chlorophylls per cell is significantly underestimated when it is evaluated from the absorbance of the cell suspensions due to the package effect.	[Isono, Takumi; Yamashita, Kyohei; Momose, Daisuke; Kobayashi, Hiroki; Kitamura, Masashi; Nishiyama, Yusuke; Hosoya, Takahiro; Kanda, Hiroaki; Kudo, Ayane; Okada, Norihide; Yagi, Takafumi; Nakata, Kazuaki; Tokunaga, Eiji] Tokyo Univ Sci, Fac Sci, Dept Phys, Shinjuku Ku, Tokyo 1628601, Japan; [Mineki, Shigeru] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Noda, Chiba 2788510, Japan; [Tokunaga, Eiji] Tokyo Univ Sci, Res Ctr Green & Safety Sci, Shinjuku Ku, Tokyo 1628601, Japan	Tokyo University of Science; Tokyo University of Science; Tokyo University of Science	Tokunaga, E (corresponding author), Tokyo Univ Sci, Fac Sci, Dept Phys, Shinjuku Ku, 1-3 Kagurazaka, Tokyo 1628601, Japan.	eiji@rs.kagu.tus.ac.jp	Tokunaga, Eiji/AAQ-3910-2021	Nakata, Kazuaki/0000-0001-7076-9956	Tokyo University of Science; Research Center for Green and Safety Sciences, Tokyo University of Science	Tokyo University of Science; Research Center for Green and Safety Sciences, Tokyo University of Science	This work was funded by Tokyo University of Science and Research Center for Green and Safety Sciences, Tokyo University of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; BRICAUD A, 1986, APPL OPTICS, V25, P571, DOI 10.1364/AO.25.000571; BROWN JS, 1963, BIOCHIM BIOPHYS ACTA, V75, P299, DOI 10.1016/0006-3002(63)90616-4; Chen M, 2010, SCIENCE, V329, P1318, DOI 10.1126/science.1191127; CRESCITELLI F, 1992, VISION RES, V32, P1593, DOI 10.1016/0042-6989(92)90152-9; Harris E.H, 2009, INTRO CHLAMYDOMONAS; Kirk J. T. O., 1983, LIGHT PHOTOSYNTHESIS; Kreimer G, 2009, CURR GENET, V55, P19, DOI 10.1007/s00294-008-0224-8; KUNIEDA R, 1965, PLANT CELL PHYSIOL, V6, P431; Lee JY, 2012, IEEE J SEL TOP QUANT, V18, P1130, DOI 10.1109/JSTQE.2011.2164239; Matsuoka H, 2002, J BIOTECHNOL, V94, P299, DOI 10.1016/S0168-1656(01)00431-X; Melis A, 2001, PLANT PHYSIOL, V127, P740, DOI 10.1104/pp.127.3.740; Mimuro M., 2011, CHLOROPHYLLS STRUCTU; MOREL A, 1981, DEEP-SEA RES, V28, P1375, DOI 10.1016/0198-0149(81)90039-X; Ort DR, 2011, PLANT PHYSIOL, V155, P79, DOI 10.1104/pp.110.165886; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Riano-Pachon DM, 2008, GENETICS, V179, P31, DOI 10.1534/genetics.107.086090; Sakurai H, 2013, J PHOTOCH PHOTOBIO C, V17, P1, DOI 10.1016/j.jphotochemrev.2013.05.001; Schmidt M, 2006, PLANT CELL, V18, P1908, DOI 10.1105/tpc.106.041749; Service RF, 2011, SCIENCE, V333, P1238, DOI 10.1126/science.333.6047.1238; Shiho M, 2012, PROCEDIA ENVIRON SCI, V15, P90, DOI 10.1016/j.proenv.2012.05.014; STROTHER GK, 1961, J PROTOZOOL, V8, P261, DOI 10.1111/j.1550-7408.1961.tb01213.x; Tamiaki H, 2013, J PHOTOCH PHOTOBIO A, V252, P60, DOI 10.1016/j.jphotochem.2012.10.022; van de Hulst H.C., 1981, LIGHT SCATTERING SMA; Varfolomeev SD, 2011, APPL BIOCHEM MICRO+, V47, P789, DOI 10.1134/S0003683811090079; Wondraczek L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3047; Yang J., 2013, WALL STREET J	27	8	8	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0128002	10.1371/journal.pone.0128002	http://dx.doi.org/10.1371/journal.pone.0128002			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061268	Green Published, Green Submitted, gold			2022-12-26	WOS:000355979500071
J	Lonnqvist, S; Rakar, J; Briheim, K; Kratz, G				Lonnqvist, Susanna; Rakar, Jonathan; Briheim, Kristina; Kratz, Gunnar			Biodegradable Gelatin Microcarriers Facilitate Re-Epithelialization of Human Cutaneous Wounds - An In Vitro Study in Human Skin	PLOS ONE			English	Article							EPIDERMAL-KERATINOCYTES; ACTIVATION; MECHANISMS; EXPRESSION	The possibility to use a suspended tridimensional matrix as scaffolding for re-epithelialization of in vitro cutaneous wounds was investigated with the aid of a human in vitro wound healing model based on viable full thickness skin. Macroporous gelatin microcarriers, CultiSpher-S, were applied to in vitro wounds and cultured for 21 days. Tissue sections showed incorporation of wound edge keratinocytes into the microcarriers and thicker neoepidermis in wounds treated with microcarriers. Thickness of the neoepidermis was measured digitally, using immunohistochemical staining of keratins as epithelial demarcation. Air-lifting of wounds enhanced stratification in control wounds as well as wounds with CultiSpher-S. Immunohistochemical staining revealed expression of keratin 5, keratin 10, and laminin 5 in the neoepidermal component. We conclude that the CultiSpher-S microcarriers can function as tissue guiding scaffold for re-epithelialization of cutaneous wounds.	[Lonnqvist, Susanna; Rakar, Jonathan; Briheim, Kristina; Kratz, Gunnar] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Expt Plast Surg, Linkoping, Sweden; [Rakar, Jonathan] Linkoping Univ, Dept Clin & Expt Med, Ctr Integrat Regenerat Med IGEN, Linkoping, Sweden; [Kratz, Gunnar] Dept Hand & Plast Surg, Linkoping, Region Ostergot, Sweden	Linkoping University; Linkoping University	Lonnqvist, S (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Expt Plast Surg, Linkoping, Sweden.	susanna.lonnqvist@liu.se	Rakar, Jonathan/N-1061-2019	Rakar, Jonathan/0000-0003-0992-2549; Kratz, Gunnar/0000-0002-0476-2155				BOYCE ST, 1995, ANN SURG, V222, P743, DOI 10.1097/00000658-199512000-00008; Brown BN, 2013, TRANSL RES; Burgeson RE, 1997, CURR OPIN CELL BIOL, V9, P651, DOI 10.1016/S0955-0674(97)80118-4; Freedberg IM, 2001, J INVEST DERMATOL, V116, P633, DOI 10.1046/j.1523-1747.2001.01327.x; GREEN H, 1977, CELL, V11, P405, DOI 10.1016/0092-8674(77)90058-7; Huss FRM, 2010, J PLAST RECONSTR AES, V63, P848, DOI 10.1016/j.bjps.2009.01.068; Janes SM, 2009, CELL RES, V19, P328, DOI 10.1038/cr.2008.281; Kirsner R. S., 2013, INT WOUND J; Kratz G, 1998, MICROSC RES TECHNIQ, V42, P345, DOI 10.1002/(SICI)1097-0029(19980901)42:5<345::AID-JEMT5>3.0.CO;2-O; Laplante AF, 2001, FASEB J, V15, P2377, DOI 10.1096/fj.01-0250com; LERSCH R, 1989, MOL CELL BIOL, V9, P3685, DOI 10.1128/MCB.9.9.3685; Martin Y, 2011, TISSUE ENG PART B-RE, V17, P71, DOI [10.1089/ten.teb.2010.0559, 10.1089/ten.TEB.2010.0559]; NEUMANN PM, 1981, J BIOMED MATER RES, V15, P9, DOI 10.1002/jbm.820150105; Nilsson K, 1988, Biotechnol Genet Eng Rev, V6, P403; Nishiyama T, 2000, J DERMATOL SCI, V24, pS51, DOI 10.1016/S0923-1811(00)00142-0; QUINLAN RA, 1985, ANN NY ACAD SCI, V455, P282, DOI 10.1111/j.1749-6632.1985.tb50418.x; RIGAL C, 1991, J INVEST DERMATOL, V96, P777, DOI 10.1111/1523-1747.ep12471745; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schultz GS, 2011, WOUND REPAIR REGEN, V19, P134, DOI 10.1111/j.1524-475X.2011.00673.x; SELA M, 1960, BIOCHEM J, V75, P91, DOI 10.1042/bj0750091; Seland H, 2010, BURNS, V37, P99, DOI [10.3233/WOR-2010-1061, DOI 10.3233/WOR-2010-1061]; Silva MMCG, 2006, BIOMATERIALS, V27, P5909, DOI 10.1016/j.biomaterials.2006.08.010; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Voigt M, 1999, TISSUE ENG, V5, P563, DOI 10.1089/ten.1999.5.563; WILKINS LM, 1994, BIOTECHNOL BIOENG, V43, P747, DOI 10.1002/bit.260430809	25	9	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0128093	10.1371/journal.pone.0128093	http://dx.doi.org/10.1371/journal.pone.0128093			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061630	Green Submitted, Green Published, gold			2022-12-26	WOS:000355979500074
J	Morgan, RF				Morgan, Ryan FitzGerald			Three New Species of Deltoblastus Fay from the Permian of Timor	PLOS ONE			English	Article								Deltoblastus is a genus of Permian blastoid comprised of 15 species, each differing based on subtle thecal morphology differences. Three new species are introduced here, based on characteristics present which distinguish individuals from established morphotypes. In order to guarantee a more complete understanding of the genus, a complex character matrix containing all 15 named and three new species was created, defining all species based on the presence or absence of 30 unique traits. Differences in character compositions give evidence for unique thecal morphologies, supporting the three new species which are proposed.	[Morgan, Ryan FitzGerald] Tarleton State Univ, Dept Chem Geosci & Phys, Stephenville, TX 76401 USA; [Morgan, Ryan FitzGerald] Baylor Univ, Dept Geol, Waco, TX 76798 USA	Texas A&M University System; Tarleton State University; Baylor University	Morgan, RF (corresponding author), Tarleton State Univ, Dept Chem Geosci & Phys, Stephenville, TX 76401 USA.	rmorgan@tarleton.edu						Bather FA, 1908, GEOLOGISCHE MITTLEIL, V25, P303; Charlton TR, 2002, J ASIAN EARTH SCI, V20, P719, DOI 10.1016/S1367-9120(02)00018-4; ETHERIDGE R., 1886, CATALOGUE BLASTOIDEA; Fay R. O., 1961, Oklahoma Geology Notes, V21, P36; JANSEN H., 1934, K AKAD WETENSCH AMSTERDAM PROC SECT SCI, V37, P819; SAY T, 1825, J ACAD NATURAL SCI P, V4, P289; TEICHERT CURT, 1951, PALAONT ZEITSCHR [STUTTGART], V24, P76; Wanner J., 1922, JAARBOOK MIJNWEZEN N, V51, P163; Wanner J., 1924, PALAONTOLOGIE TUM 14, P1; Waters J.A., 1990, PALAEOZOIC PALAEOBIO, V12, P339; Webster GD, 2007, PALAEONTOL Z, V81, P399, DOI 10.1007/BF02990251	11	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0127727	10.1371/journal.pone.0127727	http://dx.doi.org/10.1371/journal.pone.0127727			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061737	Green Published, gold, Green Submitted			2022-12-26	WOS:000355979500052
J	Vaman, VSA; Poppe, H; Houben, R; Grunewald, TGP; Goebeler, M; Butt, E				Vaman, Anjana V. S.; Poppe, Heiko; Houben, Roland; Grunewald, Thomas G. P.; Goebeler, Matthias; Butt, Elke			LASP1, a Newly Identified Melanocytic Protein with a Possible Role in Melanin Release, but Not in Melanoma Progression	PLOS ONE			English	Article							MEDIATED MEMBRANE FISSION; SH3 DOMAIN PROTEIN-1; NUCLEAR-LOCALIZATION; CELL-PROLIFERATION; GENE-EXPRESSION; ACTIN-BINDING; BREAST-CANCER; IN-VITRO; LIM; MIGRATION	The LIM and SH3 protein 1 (LASP1) is a focal adhesion protein. Its expression is increased in many malignant tumors. However, little is known about the physiological role of the protein. In the present study, we investigated the expression and function of LASP1 in normal skin, melanocytic nevi and malignant melanoma. In normal skin, a distinct LASP1 expression is visible only in the basal epidermal layer while in nevi LASP1 protein is detected in all melanocytes. Melanoma exhibit no increase in LASP1 mRNA compared to normal skin. In melanocytes, the protein is bound to dynamin and mainly localized at late melanosomes along the edges and at the tips of the cell. Knockdown of LASP1 results in increased melanin concentration in the cells. Collectively, we identified LASP1 as a hitherto unknown protein in melanocytes and as novel partner of dynamin in the physiological process of membrane constriction and melanosome vesicle release.	[Vaman, Anjana V. S.; Poppe, Heiko; Butt, Elke] Univ Hosp Wurzburg, Inst Clin Biochem & Pathobiochem, D-97070 Wurzburg, Germany; [Poppe, Heiko; Houben, Roland; Goebeler, Matthias] Univ Hosp Wurzburg, Dept Dermatol, D-97070 Wurzburg, Germany; [Grunewald, Thomas G. P.] Univ Munich, Inst Pathol, Lab Pediat Sarcoma Biol, D-80539 Munich, Germany	University of Wurzburg; University of Wurzburg; University of Munich	Butt, E (corresponding author), Univ Hosp Wurzburg, Inst Clin Biochem & Pathobiochem, D-97070 Wurzburg, Germany.	butt@klin-biochem.uni-wuerzburg.de	Goebeler, Matthias/P-3612-2019; Grünewald, Thomas G. P./O-2317-2013	Grünewald, Thomas G. P./0000-0003-0920-7377; Houben, Roland/0000-0003-4538-2324				Akhmanova A, 2010, CURR OPIN CELL BIOL, V22, P479, DOI 10.1016/j.ceb.2010.04.008; Ando H, 2012, J INVEST DERMATOL, V132, P1222, DOI 10.1038/jid.2011.413; Ando Hideya, 2011, Cell Logist, V1, P12, DOI 10.4161/cl.1.1.13638; Anitei M, 2012, NAT CELL BIOL, V14, P11, DOI 10.1038/ncb2409; Ardelt P, 2013, UROL ONCOL-SEMIN ORI, V31, P1591, DOI 10.1016/j.urolonc.2012.02.002; Butt E, 2003, J BIOL CHEM, V278, P15601, DOI 10.1074/jbc.M209009200; Chew CS, 2008, AM J PHYSIOL-GASTR L, V295, pG37, DOI 10.1152/ajpgi.90247.2008; Chew CS, 2000, J CELL SCI, V113, P2035; Chew CS, 2002, J CELL SCI, V115, P4787, DOI 10.1242/jcs.00174; Chi A, 2006, J PROTEOME RES, V5, P3135, DOI 10.1021/pr060363j; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Faelber K, 2012, STRUCTURE, V20, P1621, DOI 10.1016/j.str.2012.08.028; Frietsch JJ, 2010, BRIT J CANCER, V102, P1645, DOI 10.1038/sj.bjc.6605685; Frietsch JJ, 2014, ONCOTARGET, V5, P5257, DOI 10.18632/oncotarget.2072; Gobeil S, 2008, GENE DEV, V22, P2932, DOI 10.1101/gad.1714608; Gray CH, 2009, J BIOL CHEM, V284, P30498, DOI 10.1074/jbc.M109.023259; Grunewald TGP, 2007, BRIT J CANCER, V96, P296, DOI 10.1038/sj.bjc.6603545; Grunewald TGP, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-31; Grunewald TGP, 2007, BMC CANCER, V7, P1, DOI 10.1186/1471-2407-7-198; Grunewald TGP, 2013, BIOL CELL, V105, P535, DOI 10.1111/boc.201300041; Hailer A, 2014, ONCOTARGET, V5, P4144, DOI 10.18632/oncotarget.1928; Houben R, 2012, INT J CANCER, V130, P847, DOI 10.1002/ijc.26076; Houben R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022096; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Keicher C, 2004, BIOCHEM BIOPH RES CO, V324, P308, DOI 10.1016/j.bbrc.2004.08.235; Kushimoto T, 2001, P NATL ACAD SCI USA, V98, P10698, DOI 10.1073/pnas.191184798; Li B, 2004, J BIOL CHEM, V279, P20401, DOI 10.1074/jbc.M310304200; Lin YH, 2004, J CELL BIOL, V165, P421, DOI 10.1083/jcb.200311045; MARSHALL ES, 1994, EUR J CANCER, V30A, P1370, DOI 10.1016/0959-8049(94)90188-0; Mihlan S, 2013, ONCOGENE, V32, P2107, DOI 10.1038/onc.2012.216; Morlot S, 2013, ANNU REV BIOPHYS, V42, P629, DOI 10.1146/annurev-biophys-050511-102247; Okamoto CT, 2002, J CONTROL RELEASE, V78, P35, DOI 10.1016/S0168-3659(01)00479-5; Orth MF, 2015, ONCOTARGET, V6, P26, DOI 10.18632/oncotarget.3083; Panaviene Z, 2007, CELL TISSUE RES, V327, P353, DOI 10.1007/s00441-006-0305-2; Raman D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010050; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; REMMELE W, 1987, PATHOLOGE, V8, P138; Roth RB, 2006, NEUROGENETICS, V7, P67, DOI 10.1007/s10048-006-0032-6; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Schreiber V, 1998, GENE, V207, P171, DOI 10.1016/S0378-1119(97)00622-7; Schreiber VR, 1998, MOL MED, V4, P675, DOI 10.1007/BF03401929; Shimizu F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083187; Stolting M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035340; Tang RX, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-163; Traenka C, 2010, CANCER RES, V70, P8003, DOI 10.1158/0008-5472.CAN-10-0592; Ugurel S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000236; Wang B, 2009, J HEPATOL, V50, P528, DOI 10.1016/j.jhep.2008.10.025; Wang H, 2013, EUR J CANCER, V49, P974, DOI 10.1016/j.ejca.2012.09.032; Wasmeier C, 2008, J CELL SCI, V121, P3995, DOI 10.1242/jcs.040667; Watabe H, 2008, J INVEST DERMATOL, V128, P162, DOI 10.1038/sj.jid.5701019; Watabe Hidenori, 2005, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0314s26; Willier S, 2013, BIOL CELL, V105, P317, DOI 10.1111/boc.201300011; Wu XF, 2014, CURR OPIN CELL BIOL, V29, P1, DOI 10.1016/j.ceb.2014.02.003; Yang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100557; Zhao LA, 2010, GUT, V59, P1226, DOI 10.1136/gut.2009.202739; Zhao TS, 2015, CANCER RES, V75, P111, DOI 10.1158/0008-5472.CAN-14-2040; Zheng J, 2014, J CANCER RES CLIN, V140, P1891, DOI 10.1007/s00432-014-1759-3	57	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129219	10.1371/journal.pone.0129219	http://dx.doi.org/10.1371/journal.pone.0129219			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061439	Green Published, gold, Green Submitted			2022-12-26	WOS:000355979500132
J	Elguindy, MM; Nakamaru-Ogiso, E				Elguindy, Mahmoud M.; Nakamaru-Ogiso, Eiko			Apoptosis-inducing Factor (AIF) and Its Family Member Protein, AMID, Are Rotenone-sensitive NADH: Ubiquinone Oxidoreductases (NDH-2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERNAL ALTERNATIVE NADH; AEROBIC RESPIRATORY-CHAIN; ESCHERICHIA-COLI; QUINONE OXIDOREDUCTASE; MITOCHONDRIAL NADH; COMPLEX-I; REGULATES APOPTOSIS; INTERMEMBRANE-SPACE; MEMBRANE DOMAIN; FACTOR LEADS	Apoptosis-inducing factor (AIF) and AMID (AIF-homologous mitochondrion-associated inducer of death) are flavoproteins. Although AIF was originally discovered as a caspase-independent cell death effector, bioenergetic roles of AIF, particularly relating to complex I functions, have since emerged. However, the role of AIF in mitochondrial respiration and redox metabolism has remained unknown. Here, we investigated the redox properties of human AIF and AMID by comparing them with yeast Ndi1, a type 2 NADH: ubiquinone oxidoreductase (NDH-2) regarded as alternative complex I. Isolated AIF and AMID containing naturally incorporated FAD displayed no NADH oxidase activities. However, after reconstituting isolated AIF or AMID into bacterial or mitochondrial membranes, N-terminally tagged AIF and AMID displayed substantial NADH:O-2 activities and supported NADH-linked proton pumping activities in the host membranes almost as efficiently as Ndi1. NADH: ubiquinone-1 activities in the reconstituted membranes were highly sensitive to 2-n-heptyl-4-hydroxyquinoline-N-oxide (IC50 = similar to 1 mu M), a quinone-binding inhibitor. Overexpressing N-terminally tagged AIF and AMID enhanced the growth of a double knock-out Escherichia coli strain lacking complex I and NDH-2. In contrast, C-terminally tagged AIF and NADH-binding site mutants of N-terminally tagged AIF and AMID failed to show both NADH:O-2 activity and the growth-enhancing effect. The disease mutant AIF Delta R201 showed decreased NADH:O-2 activity and growth-enhancing effect. Furthermore, we surprisingly found that the redox activities of N-terminally tagged AIF and AMID were sensitive to rotenone, a well known complex I inhibitor. We propose that AIF and AMID are previously unidentified mammalian NDH-2 enzymes, whose bioenergetic function could be supplemental NADH oxidation in cells.	[Elguindy, Mahmoud M.; Nakamaru-Ogiso, Eiko] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Johnson Res Fdn, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Nakamaru-Ogiso, E (corresponding author), Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, 422 Curie Blvd, Philadelphia, PA 19104 USA.	eikoo@mail.med.upenn.edu	Regan, Clinton/E-6250-2012	Elguindy, Mahmoud/0000-0001-9151-1751	National Institutes of Health [RO1GM097409]; American Heart Association [11SDG5560001]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097409] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1GM097409 (to E. N.-O.). This work was also supported by American Heart Association Grant 11SDG5560001 (to E. N.-O.). The authors declare that they have no conflicts of interest with the contents of this article.	Apostolova N, 2006, CELL DEATH DIFFER, V13, P354, DOI 10.1038/sj.cdd.4401776; Bilyy R, 2008, APOPTOSIS, V13, P729, DOI 10.1007/s10495-008-0198-5; Brown D, 2006, P NATL ACAD SCI USA, V103, P9918, DOI 10.1073/pnas.0603950103; Churbanova IY, 2008, J BIOL CHEM, V283, P5622, DOI 10.1074/jbc.M709147200; Duarte M, 2003, BIOCHEM J, V371, P1005, DOI 10.1042/BJ20021374; Feng Y, 2012, NATURE, V491, P478, DOI 10.1038/nature11541; Garofano A, 2006, YEAST, V23, P1129, DOI 10.1002/yea.1426; Ghelli A, 1997, J BIOCHEM, V121, P746; Ghezzi D, 2010, AM J HUM GENET, V86, P639, DOI 10.1016/j.ajhg.2010.03.002; Hangen E, 2010, TRENDS BIOCHEM SCI, V35, P278, DOI 10.1016/j.tibs.2009.12.008; Heikal A, 2014, MOL MICROBIOL, V91, P950, DOI 10.1111/mmi.12507; HOPPEL C, 1979, J BIOL CHEM, V254, P4164; Iwata M, 2012, P NATL ACAD SCI USA, V109, P15247, DOI 10.1073/pnas.1210059109; Jeuken LJC, 2006, J AM CHEM SOC, V128, P1711, DOI 10.1021/ja056972u; Joza N, 2008, CELL DEATH DIFFER, V15, P1009, DOI 10.1038/cdd.2008.24; Joza N, 2005, MOL CELL BIOL, V25, P10261, DOI 10.1128/MCB.25.23.10261-10272.2005; Joza N, 2009, ANN NY ACAD SCI, V1171, P2, DOI 10.1111/j.1749-6632.2009.04681.x; Kao MC, 2005, BIOCHEMISTRY-US, V44, P3562, DOI 10.1021/bi0476477; Kim MS, 2004, J BIOCHEM MOL BIOL, V37, P753; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li W, 2006, MOL BIOL CELL, V17, P1802, DOI 10.1091/mbc.E05-04-0333; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Luttik MAH, 1998, J BIOL CHEM, V273, P24529, DOI 10.1074/jbc.273.38.24529; Marshall KR, 2005, J BIOL CHEM, V280, P30735, DOI 10.1074/jbc.M414018200; MARSHALL LE, 1978, BIOCHIM BIOPHYS ACTA, V543, P590, DOI 10.1016/0304-4165(78)90315-X; Mate MJ, 2002, NAT STRUCT BIOL, V9, P442, DOI 10.1038/nsb793; Matsuno-Yagi A., 1985, BIOL CHEM, V260, P11424; MATSUSHITA K, 1987, BIOCHEMISTRY-US, V26, P7732, DOI 10.1021/bi00398a029; MAYHEW SG, 1974, EUR J BIOCHEM, V44, P579, DOI 10.1111/j.1432-1033.1974.tb03515.x; Miramar MD, 2001, J BIOL CHEM, V276, P16391, DOI 10.1074/jbc.M010498200; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Mogi T, 2009, FEMS MICROBIOL LETT, V291, P157, DOI 10.1111/j.1574-6968.2008.01451.x; Nadanaciva S, 2007, TOXICOL IN VITRO, V21, P902, DOI 10.1016/j.tiv.2007.01.011; Nakamaru-Ogiso E, 2005, J BIOL CHEM, V280, P301, DOI 10.1074/jbc.M410377200; NEGRI A, 1987, J BIOL CHEM, V262, P10026; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Peng M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000061; Polster BM, 2013, NEUROCHEM INT, V62, P695, DOI 10.1016/j.neuint.2012.12.002; Sevrioukova IF, 2011, ANTIOXID REDOX SIGN, V14, P2545, DOI 10.1089/ars.2010.3445; Sinha PK, 2009, J BIOL CHEM, V284, P9814, DOI 10.1074/jbc.M809468200; SLED VD, 1994, BIOCHEMISTRY-US, V33, P10069, DOI 10.1021/bi00199a034; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; TOKUDA H, 1984, J BIOL CHEM, V259, P7785; Urbano A, 2005, EMBO J, V24, P2815, DOI 10.1038/sj.emboj.7600746; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; Varecha M, 2007, APOPTOSIS, V12, P1155, DOI 10.1007/s10495-007-0061-0; Varecha M, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-59; Verner Z, 2013, PARASITOLOGY, V140, P328, DOI 10.1017/S003118201200162X; Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194; Wilkinson JC, 2008, MOL CELL BIOL, V28, P237, DOI 10.1128/MCB.01065-07; Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138; Yamashita T, 2007, J BIOL CHEM, V282, P6012, DOI 10.1074/jbc.M610646200; Ye H, 2002, NAT STRUCT BIOL, V9, P680, DOI 10.1038/nsb836	54	64	67	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20815	20826		10.1074/jbc.M115.641498	http://dx.doi.org/10.1074/jbc.M115.641498			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26063804	hybrid, Green Published			2022-12-26	WOS:000360011800019
J	Allan, ERO; Yates, RM				Allan, Euan Ramsay Orr; Yates, Robin Michael			Redundancy between Cysteine Cathepsins in Murine Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; LYSOSOMAL THIOL REDUCTASE; MYELIN BASIC-PROTEIN; T-CELL SELECTION; INVARIANT CHAIN; NADPH OXIDASE; PHAGOSOMAL PROTEOLYSIS; ANTIGEN PRESENTATION; MULTIPLE-SCLEROSIS; S INHIBITORS	The cysteine cathepsins B, S, and L are functionally linked to antigen processing, and hence to autoimmune disorders such as multiple sclerosis. Stemming from several studies that demonstrate that mice can be protected from experimental autoimmune encephalomyelitis (EAE) through the pharmacologic inhibition of cysteine cathepsins, it has been suggested that targeting these enzymes in multiple sclerosis may be of therapeutic benefit. Utilizing mice deficient in cysteine cathepsins both individually and in combination, we found that the myelin-associated antigen myelin oligodendrocyte glycoprotein (MOG) was efficiently processed and presented by macrophages to CD4+ T cells in the individual absence of cathepsin B, S or L. Similarly, mice deficient in cathepsin B or S were susceptible to MOG-induced EAE and displayed clinical progression and immune infiltration into the CNS, similar to their wild-type counterparts. Owing to a previously described CD4+ T cell deficiency in mice deficient in cathepsin L, such mice were protected from EAE. When multiple cysteine cathepsins were simultaneously inhibited via genetic deletion of both cathepsins B and S, or by a cathepsin inhibitor (LHVS), MHC-II surface expression, MOG antigen presentation and EAE were attenuated or prevented. This study demonstrates the functional redundancy between cathepsin B, S and L in EAE, and suggests that the inhibition of multiple cysteine cathepsins may be needed to modulate autoimmune disorders such as multiple sclerosis.	[Allan, Euan Ramsay Orr; Yates, Robin Michael] Univ Calgary, Fac Vet Med, Dept Comparat Biol & Expt Med, Calgary, AB T2N 1N4, Canada; [Yates, Robin Michael] Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Calgary	Yates, RM (corresponding author), Univ Calgary, Fac Vet Med, Dept Comparat Biol & Expt Med, Calgary, AB T2N 1N4, Canada.	rmyates@ucalgary.ca	Yates, Robin/K-5032-2015	Yates, Robin/0000-0003-3122-1845	Canadian Institutes of Health Research [MOP-111256]; Multiple Sclerosis Society of Canada; EndMS training network and Alberta Innovates - Health Solutions	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Multiple Sclerosis Society of Canada; EndMS training network and Alberta Innovates - Health Solutions	This work was supported by the Canadian Institutes of Health Research (MOP-111256) and the Multiple Sclerosis Society of Canada. Graduate student support was provided by the EndMS training network and Alberta Innovates - Health Solutions.	Agrawal SM, 2011, J NEUROSCI, V31, P669, DOI 10.1523/JNEUROSCI.3659-10.2011; Allan ERO, 2014, J IMMUNOL, V192, P4989, DOI 10.4049/jimmunol.1302896; Balce DR, 2014, J BIOL CHEM, V289, P31891, DOI 10.1074/jbc.M114.584391; Balce DR, 2011, BLOOD, V118, P4199, DOI 10.1182/blood-2011-01-328906; Baugh M, 2011, J AUTOIMMUN, V36, P201, DOI 10.1016/j.jaut.2011.01.003; Beck H, 2001, EUR J IMMUNOL, V31, P3726, DOI 10.1002/1521-4141(200112)31:12<3726::AID-IMMU3726>3.0.CO;2-O; Beers C, 2003, J EXP MED, V197, P169, DOI 10.1084/jem.20020978; Belizaire R, 2009, P NATL ACAD SCI USA, V106, P17463, DOI 10.1073/pnas.0908583106; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; BEVER CT, 1994, NEUROLOGY, V44, P745, DOI 10.1212/WNL.44.4.745; BOEHME DH, 1978, NEUROCHEM RES, V3, P185, DOI 10.1007/BF00964059; Brand DD, 2003, SPRINGER SEMIN IMMUN, V25, P3, DOI 10.1007/s00281-003-0127-1; Choi SH, 2005, J NEUROCHEM, V95, P1755, DOI 10.1111/j.1471-4159.2005.03503.x; Desai SN, 2006, EUR J PHARMACOL, V538, P168, DOI 10.1016/j.ejphar.2006.03.051; Deussing J, 1998, P NATL ACAD SCI USA, V95, P4516, DOI 10.1073/pnas.95.8.4516; Fissolo N, 2008, EUR J IMMUNOL, V38, P2401, DOI 10.1002/eji.200838413; Fujii H, 2012, BIOL BLOOD MARROW TR, V18, P546, DOI 10.1016/j.bbmt.2011.11.027; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; GOVINDARAJAN KR, 1974, BRAIN RES, V67, P141, DOI 10.1016/0006-8993(74)90304-7; GOVINDARAJAN KR, 1974, J NEUROL SCI, V23, P81, DOI 10.1016/0022-510X(74)90144-0; Gresser O, 2001, EUR J IMMUNOL, V31, P1813, DOI 10.1002/1521-4141(200106)31:6<1813::AID-IMMU1813>3.0.CO;2-8; Haves-Zburof D, 2011, J CELL MOL MED, V15, P2421, DOI 10.1111/j.1582-4934.2010.01229.x; Honey K, 2002, J EXP MED, V195, P1349, DOI 10.1084/jem.20011904; Honey K, 2001, J BIOL CHEM, V276, P22573, DOI 10.1074/jbc.M101851200; Hori S, 2003, ADV IMMUNOL, V81, P331, DOI 10.1016/S0065-2776(03)81008-8; Hsieh CS, 2002, J IMMUNOL, V168, P2618, DOI 10.4049/jimmunol.168.6.2618; Hsing LC, 2005, IMMUNOL REV, V207, P229, DOI 10.1111/j.0105-2896.2005.00310.x; Irie O, 2008, BIOORG MED CHEM LETT, V18, P5280, DOI 10.1016/j.bmcl.2008.08.067; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; Kikuchi H, 2003, ACTA NEUROPATHOL, V105, P462, DOI 10.1007/s00401-002-0667-9; Lee-Dutra A, 2011, EXPERT OPIN THER PAT, V21, P311, DOI 10.1517/13543776.2011.553800; Liuzzo JP, 1999, MOL MED, V5, P334, DOI 10.1007/BF03402069; Lockwood TD, 2002, ANTIOXID REDOX SIGN, V4, P681, DOI 10.1089/15230860260220193; Manoury B, 2002, NAT IMMUNOL, V3, P169, DOI 10.1038/ni754; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Nakagawa TY, 1999, IMMUNITY, V10, P207, DOI 10.1016/S1074-7613(00)80021-7; Nakahara J, 2010, ARCH IMMUNOL THER EX, V58, P325, DOI 10.1007/s00005-010-0094-x; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Podolin PL, 2008, J IMMUNOL, V180, P7989, DOI 10.4049/jimmunol.180.12.7989; Riese RJ, 1998, J CLIN INVEST, V101, P2351, DOI 10.1172/JCI1158; Rybicka JM, 2012, EMBO J, V31, P932, DOI 10.1038/emboj.2011.440; Rybicka JM, 2010, P NATL ACAD SCI USA, V107, P10496, DOI 10.1073/pnas.0914867107; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; Stoeckle C, 2012, J AUTOIMMUN, V38, P332, DOI 10.1016/j.jaut.2012.02.003; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Underhill DM, 1999, J EXP MED, V190, P1909, DOI 10.1084/jem.190.12.1909; van der Veen RC, 2000, J IMMUNOL, V164, P5177, DOI 10.4049/jimmunol.164.10.5177; Vasiljeva O, 2007, CURR PHARM DESIGN, V13, P387, DOI 10.2174/138161207780162962; Villadangos JA, 1997, J EXP MED, V186, P549, DOI 10.1084/jem.186.4.549; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477	51	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128945	10.1371/journal.pone.0128945	http://dx.doi.org/10.1371/journal.pone.0128945			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075905	gold, Green Published, Green Submitted			2022-12-26	WOS:000356329900039
J	Wang, QX; Yan, DD; Liu, PF; Mao, LG; Wang, D; Fang, WS; Li, Y; Ouyang, CB; Guo, MX; Cao, AC				Wang, Qiuxia; Yan, Dongdong; Liu, Pengfei; Mao, Liangang; Wang, Dong; Fang, Wensheng; Li, Yuan; Ouyang, Canbin; Guo, Meixia; Cao, Aocheng			Chloropicrin Emission Reduction by Soil Amendment with Biochar	PLOS ONE			English	Article							ROOT-KNOT NEMATODES; AGRICULTURAL FUMIGANTS; 1,3-DICHLOROPROPENE; EFFICACY; FUMIGATION; STRAWBERRY; TOMATOES; SORPTION; MANURE; FILMS	Biochar has sorption capacity, and can be used to enhance the sequestration of volatile organic contaminants such as pesticides in soil. Chloropicrin (CP) is an important soil fumigant for the production of many fruit and vegetable crops, but its emissions must be minimized to reduce exposure risks and air pollution. The objective of this study was to determine the capacity of biochar to adsorb CP and the effect of biochar amendments to soil on CP emission, concentration in the soil gas phase, degradation in soil and CP bioactivity for controlling soil borne pests. CP emission and concentration in the soil air phase were measured from packed soil columns after fumigant injection at 20-cm depth and application of selected doses of biocharto the surface 5 cm soil. Laboratory incubation and fumigation experiments were conducted to determine the capacity of biochar to adsorb CP, the effects on CP degradation and, separately, CP's bioactivity on soil borne pests in soil amended with biochar. Biochar amendment at 2% to 5% (w/w) greatly reduced total CP emission losses by 85.7% - 97.7% compared to fumigation without biochar. CP concentrations in the soil gas-phase, especially in the top 5 cm of soil, were reduced within 48 h following application. The half-life of CP decreased from 13.6 h to 6.4 h as the biochar rate increased from 0% to 5%. CP and its metabolite (dichloronitromethane) both degraded more rapidly in pure biochar than in soil. The biochar used in the present study had a maximum adsorption capacity for CP of less than 5 mg g(-1). There were no negative effects on pathogen and nematode control when the biochar used in this study was less than 1% (on a weight basis) in soil. Biochar amendment to soil reduced the emissions of CP. CP concentrations in the top 5 cm of soil gas-phase were reduced. CP degradation was accelerated with the addition of biochar. The biochar used in the present study had a low adsorption capacity for CP. There were no negative effects on pathogen and nematode control when the biochar amendment rate was less than 1% (by weight). The findings would be useful for establishing guidelines for biochar use in soil fumigation.	[Wang, Qiuxia; Yan, Dongdong; Liu, Pengfei; Mao, Liangang; Fang, Wensheng; Li, Yuan; Ouyang, Canbin; Guo, Meixia; Cao, Aocheng] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Wang, Dong] USDA ARS, San Joaquin Valley Agr Sci Ctr, Water Management Res Unit, Parlier, DC USA	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; United States Department of Agriculture (USDA)	Cao, AC (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	caoac@vip.sina.com	yan, dongdong/M-4629-2017	Yan, Dongdong/0000-0002-8196-4615	National Natural Science Foundation project of China [30900958]; Beijing Nova program [2010B064]	National Natural Science Foundation project of China(National Natural Science Foundation of China (NSFC)); Beijing Nova program(Beijing Municipal Science & Technology Commission)	This research was financially supported by the National Natural Science Foundation project of China (30900958) and Beijing Nova program (No. 2010B064).	Amonette J. E., 2009, CHARACTERISTICS BIOC; Ashworth DJ, 2009, ENVIRON SCI TECHNOL, V43, P5073, DOI 10.1021/es900049g; Cao XD, 2011, ENVIRON SCI TECHNOL, V45, P4884, DOI 10.1021/es103752u; Chellemi DO, 2011, J ENVIRON QUAL, V40, P1204, DOI 10.2134/jeq2010.0494; Cole SK, 2007, ENVIRON SCI TECHNOL, V41, P863, DOI 10.1021/es061410b; De Cal A, 2005, APPL SOIL ECOL, V28, P47, DOI 10.1016/j.apsoil.2004.06.005; Desaeger JA, 2008, PEST MANAG SCI, V64, P230, DOI 10.1002/ps.1503; Gan J, 1997, J ENVIRON QUAL, V26, P310, DOI 10.2134/jeq1997.00472425002600010043x; Gao SD, 2013, ENVIRON SCI TECHNOL, V47, P405, DOI 10.1021/es303557y; Gao SD, 2009, J AGR FOOD CHEM, V57, P5428, DOI 10.1021/jf900245f; Gilreath JP, 2005, CROP PROT, V24, P285, DOI 10.1016/j.cropro.2004.08.008; Graber ER, 2011, SOIL SCI SOC AM J, V75, P1365, DOI 10.2136/sssaj2010.0435; Hagner M, 2013, EUR J SOIL BIOL, V58, P1, DOI 10.1016/j.ejsobi.2013.05.002; Ji XX, 2013, CROP PROT, V45, P1, DOI 10.1016/j.cropro.2012.11.018; Jones DL, 2011, SOIL BIOL BIOCHEM, V43, P804, DOI 10.1016/j.soilbio.2010.12.015; KOMADA H, 1975, Review of Plant Protection Research, V8, P114; Lehmann J, 2007, FRONT ECOL ENVIRON, V5, P381, DOI 10.1890/1540-9295(2007)5[381:BITB]2.0.CO;2; Li JF, 2013, PLANT SOIL, V370, P333, DOI 10.1007/s11104-013-1639-7; Liang B, 2006, SOIL SCI SOC AM J, V70, P1719, DOI 10.2136/sssaj2005.0383; Lombardo S, 2012, CROP PROT, V37, P59, DOI 10.1016/j.cropro.2012.02.010; MASAGO H, 1977, PHYTOPATHOLOGY, V67, P425, DOI 10.1094/Phyto-67-425; Meszaros E, 2007, IND ENG CHEM RES, V46, P5943, DOI 10.1021/ie0615842; Minuto A, 2006, CROP PROT, V25, P1244, DOI 10.1016/j.cropro.2006.03.017; Oriel M, 2009, REV ENVIRON CONTAM T, V200, P1, DOI 10.1007/978-1-4419-0028-9_1; Pesonen M, 2012, TOXICOL LETT, V211, P239, DOI 10.1016/j.toxlet.2012.04.002; Qian YR, 2011, ENVIRON SCI TECHNOL, V45, P9711, DOI 10.1021/es201278p; Qin RJ, 2009, J AGR FOOD CHEM, V57, P9063, DOI 10.1021/jf901737a; Spotti C, 2011, ACTA HORTIC, V914, P267, DOI 10.17660/ActaHortic.2011.914.48; Tatarkova V, 2013, ECOTOX ENVIRON SAFE, V92, P215, DOI 10.1016/j.ecoenv.2013.02.005; United States Environmental Protection Agency, 2009, AM RER EL DEC RED CH; Wang QX, 2014, J ENVIRON QUAL, V43, P1656, DOI 10.2134/jeq2014.02.0075; Yan DD, 2012, J AGR FOOD CHEM, V60, P5023, DOI 10.1021/jf300532x; Yates SR, 2011, J ENVIRON QUAL, V40, P1347, DOI 10.2134/jeq2011.0142; Zhang Y, 2007, CHEMOSPHERE, V68, P445, DOI 10.1016/j.chemosphere.2006.12.083	34	8	10	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129448	10.1371/journal.pone.0129448	http://dx.doi.org/10.1371/journal.pone.0129448			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075904	gold, Green Submitted, Green Published			2022-12-26	WOS:000356329900075
J	Kodama, K; Furuyama, N; Inamura, T				Kodama, Kentaro; Furuyama, Nobuhiro; Inamura, Tetsunari			Differing Dynamics of Intrapersonal and Interpersonal Coordination: Two-finger and Four-Finger Tapping Experiments	PLOS ONE			English	Article							SENSORIMOTOR SYNCHRONIZATION; INTERLIMB COORDINATION; PHASE-TRANSITIONS; ENTRAINMENT; INFORMATION; ATTRACTORS; MOVEMENTS; MODEL; SPEED	Finger-tapping experiments were conducted to examine whether the dynamics of intrapersonal and interpersonal coordination systems can be described equally by the Haken-Kelso-Bunz model, which describes inter-limb coordination dynamics. This article reports the results of finger-tapping experiments conducted in both systems. Two within-subject factors were investigated: the phase mode and the number of fingers. In the intrapersonal experiment (Experiment 1), the participants were asked to tap, paced by a gradually hastening auditory metronome, looking at their fingers moving, using the index finger in the two finger condition, or the index and middle finger in the four-finger condition. In the interpersonal experiment (Experiment 2), pairs of participants performed the task while each participant used the outside hand, tapping with the index finger in the two finger condition, or the index and middle finger in the four-finger condition. Some results did not agree with the HKB model predictions. First, from Experiment 1, no significant difference was observed in the movement stability between the in-phase and anti-phase modes in the two finger condition. Second, from Experiment 2, no significant difference was found in the movement stability between the in-phase and anti-phase mode in the four-finger condition. From these findings, different coordination dynamics were inferred between intrapersonal and interpersonal coordination systems against prediction from the previous studies. Results were discussed according to differences between intrapersonal and interpersonal coordination systems in the availability of perceptual information and the complexity in the interaction between limbs derived from a nested structure.	[Kodama, Kentaro] Kanagawa Univ, Kanagawa Ku, Yokohama, Kanagawa, Japan; [Furuyama, Nobuhiro] Waseda Univ, Tokorozawa, Saitama, Japan; [Inamura, Tetsunari] Res Org Informat & Syst, Natl Inst Informat, Chiyoda Ku, Tokyo 1018430, Japan; [Inamura, Tetsunari] Grad Univ Adv Studies, Chiyoda Ku, Tokyo, Japan	Kanagawa University; Waseda University; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan; Graduate University for Advanced Studies - Japan	Kodama, K (corresponding author), Kanagawa Univ, Kanagawa Ku, 3-27-1 Rokkakubashi, Yokohama, Kanagawa, Japan.	kkodama@kanagawa-u.ac.jp	Inamura, Tetsunari/ADW-8458-2022		 [12J02928]		This work was supported by a Grant-in-Aid for JSPS(The Japan Society for the Promotion of Science) Fellows Number 12J02928 to KK (http://www.jsps.go.jp/). The funder had roles in data analysis and preparation of the manuscript.	Beek PJ, 1996, J EXP PSYCHOL HUMAN, V22, P1077; Bernstein N.A., 1996, RES ECOL PS; Black DR, 2007, MOTOR CONTROL, V11, P348, DOI 10.1123/mcj.11.4.348; BUCHANAN JJ, 1993, EXP BRAIN RES, V94, P131; BYBLOW WD, 1994, HUM MOVEMENT SCI, V13, P3, DOI 10.1016/0167-9457(94)90027-2; CARSON RG, 1995, EXP BRAIN RES, V105, P465; Coco MI, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00510; Coey C, 2011, EXP BRAIN RES, V211, P483, DOI 10.1007/s00221-011-2689-9; Fink PW, 2000, EXP BRAIN RES, V134, P9, DOI 10.1007/s002210000439; Forrester L, 2000, J MOTOR BEHAV, V32, P176, DOI 10.1080/00222890009601369; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Haken H., 1977, SPRINGER SERIES SYNE; Hove MJ, 2009, SOC COGNITION, V27, P949, DOI 10.1521/soco.2009.27.6.949; KAY BA, 1987, J EXP PSYCHOL HUMAN, V13, P178, DOI 10.1037/0096-1523.13.2.178; Kelso J, 1984, AM J PHYSIOL-REG I, V15, pR1000, DOI DOI 10.1152/ajpregu.1984.246.6.R1000; KELSO JAS, 1990, ATTENTION PERFORM, V8, P139; Kelso JAS, 2001, P ROY SOC B-BIOL SCI, V268, P1207; Kelso S., 1995, DYNAMIC PATTERNS SEL; Kelty-Stephen DG, 2013, ECOL PSYCHOL, V25, P1, DOI 10.1080/10407413.2013.753804; Kodama K, 2012, 12 EUR WORKSH EC PSY, V32; Kudo K, 2006, J EXP PSYCHOL HUMAN, V32, P599, DOI 10.1037/0096-1523.32.3.599; Latash ML, 2008, SYNERGY; Lopresti-Goodman SM, 2008, J MOTOR BEHAV, V40, P3, DOI 10.3200/JMBR.40.1.3-10; Loseby PN, 2001, HUM MOVEMENT SCI, V20, P531, DOI 10.1016/S0167-9457(01)00066-5; MacKenzie CL, 1983, SOC NEUR ABSTR, V9, P1033; Marwan N, 2013, CROSSRECURRENCEPLOTT; Mechsner F, 2004, J EXP PSYCHOL HUMAN, V30, P490, DOI 10.1037/0096-1523.30.3.490; Mechsner F, 2001, NATURE, V414, P69, DOI 10.1038/35102060; Miles LK, 2010, EUR J SOC PSYCHOL, V40, P52, DOI 10.1002/ejsp.721; Miles LK, 2009, J EXP SOC PSYCHOL, V45, P585, DOI 10.1016/j.jesp.2009.02.002; Pellecchia GL, 2005, COGNITIVE SCI, V29, P531, DOI 10.1207/s15516709cog0000_12; PEPER CE, 1991, NATO ADV SCI I D-BEH, V62, P413; Ramenzoni VC, 2012, HUM MOVEMENT SCI, V31, P1253, DOI 10.1016/j.humov.2011.12.004; Ramenzoni VC, 2011, EXP BRAIN RES, V211, P447, DOI 10.1007/s00221-011-2653-8; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; Richardson MJ, 2008, NEUROSCI LETT, V438, P340, DOI 10.1016/j.neulet.2008.04.083; Richardson MJ, 2007, HUM MOVEMENT SCI, V26, P867, DOI 10.1016/j.humov.2007.07.002; Riek S, 2005, HUM MOVEMENT SCI, V24, P798, DOI 10.1016/j.humov.2005.10.002; RYAN TA, 1960, PSYCHOL BULL, V57, P318, DOI 10.1037/h0044320; Schmidt RC, 2007, J EXP PSYCHOL HUMAN, V33, P860, DOI 10.1037/0096-1523.33.4.860; Schmidt RC, 1998, J EXP PSYCHOL HUMAN, V24, P884, DOI 10.1037/0096-1523.24.3.884; SCHMIDT RC, 1994, BIOL CYBERN, V70, P369, DOI 10.1007/BF00200334; SCHMIDT RC, 1990, J EXP PSYCHOL HUMAN, V16, P227, DOI 10.1037/0096-1523.16.2.227; Shockley K, 2005, TUTORIALS CONT NONLI; SWINNEN SP, 1992, HUM MOVEMENT SCI, V11, P615, DOI 10.1016/0167-9457(92)90018-7; van Ulzen NR, 2008, NEUROSCI LETT, V432, P88, DOI 10.1016/j.neulet.2007.11.070; van Ulzen NR, 2010, NEUROSCI LETT, V474, P79, DOI 10.1016/j.neulet.2010.03.008; Varlet M, 2011, J EXP PSYCHOL HUMAN, V37, P473, DOI 10.1037/a0020552; Webber Jr C.L., 2005, TUTORIALS CONT NONLI, V94, P26; WING AM, 1989, PSYCHOL RES-PSYCH FO, V51, P28, DOI 10.1007/BF00309273; YAMANISHI J, 1980, BIOL CYBERN, V37, P219, DOI 10.1007/BF00337040; ZANONE PG, 1992, J EXP PSYCHOL HUMAN, V18, P403, DOI 10.1037/0096-1523.18.2.403; ZBILUT JP, 1992, PHYS LETT A, V171, P199, DOI 10.1016/0375-9601(92)90426-M; Zbilut JP, 1998, PHYS LETT A, V246, P122, DOI 10.1016/S0375-9601(98)00457-5	55	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129358	10.1371/journal.pone.0129358	http://dx.doi.org/10.1371/journal.pone.0129358			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6GR	26070119	Green Submitted, gold, Green Published			2022-12-26	WOS:000356327000067
J	Tseng, CN; Huang, GS; Yu, PJ; Lou, MF				Tseng, Chien-Ning; Huang, Guey-Shiun; Yu, Po-Jui; Lou, Meei-Fang			A Qualitative Study of Family Caregiver Experiences of Managing Incontinence in Stroke Survivors	PLOS ONE			English	Article							URINARY-INCONTINENCE; OF-LIFE; IMPACT; PREVALENCE; BURDEN; HEALTH	Background Incontinence is a common problem faced by family caregivers that is recognized as a major burden and predictor of institutionalization. However, few studies have evaluated the experiences of family caregivers caring for stroke survivors with incontinence. Purpose To describe experiences of caregivers managing incontinence in stroke survivors. Design This qualitative descriptive study employed a grounded-theory approach. Methods Semi-structured in-depth interviews with ten family caregivers of stroke survivors with incontinence were conducted during 2011. Audiotaped interviews were transcribed and analyzed using content analysis. Findings Data analysis identified four themes: chaos, hypervigilance, exhaustion, and creating a new life. There were nine related subcategories: fluster, dirtiness, urgency, fear of potential health-hazard, physically demanding and time-consuming, mentally draining, financial burden, learning by doing, and attitude adjustment. Together, these described a process of struggling to cope with the care of stroke survivors with urinary/fecal incontinence. Of the four categories, "creating a new life" developed gradually over time to orient caregivers to their new life, while the other three categories occurred in a chronological order. Conclusion The research highlighted unique caring experiences of family caregivers of stroke patients, which focused solely on the 'incontinence issue'. Understanding these experiences may help nurses provide better support and resources for family caregivers when caring for stroke survivors with incontinence.	[Tseng, Chien-Ning] Cardinal Tien Coll Healthcare & Management, Dept Nursing, New Taipei City, Taiwan; [Huang, Guey-Shiun; Yu, Po-Jui; Lou, Meei-Fang] Natl Taiwan Univ, Coll Med, Sch Nursing, Taipei, Taiwan	National Taiwan University	Lou, MF (corresponding author), Natl Taiwan Univ, Coll Med, Sch Nursing, Taipei, Taiwan.	mfalou@ntu.edu.tw		LOU, MEEI-FANG/0000-0001-6574-8050; HUANG, GUEY-SHIUN/0000-0003-2170-0084	Ministry of Science and Technology of the Republic of China [NSC97-2314-B-002-159-MY3]	Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan)	This study was supported by the Ministry of Science and Technology of the Republic of China (NSC97-2314-B-002-159-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaweel W, 2012, NEUROUROL URODYNAM, V31, P642, DOI 10.1002/nau.22201; Armstrong M, 2000, Nurs Stand, V14, P33; Backstrom B, 2010, SCAND J CARING SCI, V24, P116, DOI 10.1111/j.1471-6712.2009.00694.x; Bharucha AE, 2005, GASTROENTEROLOGY, V129, P42, DOI 10.1053/j.gastro.2005.04.006; Cassells C, 2003, J ADV NURS, V42, P607, DOI 10.1046/j.1365-2648.2003.02664.x; Chou KR, 1998, NURS RES, V6, P358; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Dalvandi A, 2010, INT NURS REV, V57, P247, DOI 10.1111/j.1466-7657.2009.00786.x; Franzen-Dahlin A, 2007, J CLIN NURS, V16, P885, DOI 10.1111/j.1365-2702.2006.01744.x; Gosman-Hedstrom G, 2012, SCAND J CARING SCI, V26, P587, DOI 10.1111/j.1471-6712.2012.00975.x; Green TL, 2010, J STROKE CEREBROVASC, V19, P10, DOI 10.1016/j.jstrokecerebrovasdis.2009.02.005; Green TL, 2009, INT J NURS STUD, V46, P1194, DOI 10.1016/j.ijnurstu.2009.02.008; Haley WE, 2009, STROKE, V40, P2129, DOI 10.1161/STROKEAHA.108.545269; Hayder D, 2008, Z GERONTOL GERIATR, V41, P261, DOI 10.1007/s00391-008-0560-9; Horrocks S, 2004, FAM PRACT, V21, P689, DOI 10.1093/fampra/cmh622; King BD, 1994, COPING BOWEL BLADDER; King RB, 2010, J NEUROSCI NURS, V42, P302, DOI 10.1097/JNN.0b013e3181f8a575; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; McCullagh E, 2005, STROKE, V36, P2181, DOI 10.1161/01.STR.0000181755.23914.53; Ministry of Health and Welfare, 2014, MOST STAT B 2013 STA; Olsson F, 2015, J CLIN NURS, V24, P141, DOI 10.1111/jocn.12617; OUSLANDER JG, 1990, J AM GERIATR SOC, V38, P440, DOI 10.1111/j.1532-5415.1990.tb03543.x; Peden-McAlpine C, 2008, WESTERN J NURS RES, V30, P817, DOI 10.1177/0193945907312974; Pierce LL, 2012, REHABIL NURS, V37, P258, DOI 10.1002/rnj.35; Rasmussen JL, 2010, SCAND J CARING SCI, V24, P108, DOI 10.1111/j.1471-6712.2009.00693.x; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Saban KL, 2012, J NEUROSCI NURS, V44, P2, DOI 10.1097/JNN.0b013e31823ae4f9; White Carole L, 2006, J Neurosci Nurs, V38, P354	28	14	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129540	10.1371/journal.pone.0129540	http://dx.doi.org/10.1371/journal.pone.0129540			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6GR	26066345	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000087
J	Yeo, SH; Wolpert, DM; Franklin, DW				Yeo, Sang-Hoon; Wolpert, Daniel M.; Franklin, David W.			Coordinate Representations for Interference Reduction in Motor Learning	PLOS ONE			English	Article							SIMILAR HAND PATHS; ARM MOVEMENTS; REACHING MOVEMENTS; IMPEDANCE CONTROL; INTERNAL-MODELS; FORCE-FIELDS; BODY SCHEMA; VISUAL CUES; SHORT-TERM; ADAPTATION	When opposing force fields are presented alternately or randomly across trials for identical reaching movements, subjects learn neither force field, a behavior termed 'interference'. Studies have shown that a small difference in the endpoint posture of the limb reduces this interference. However, any difference in the limb's endpoint location typically changes the hand position, joint angles and the hand orientation making it ambiguous as to which of these changes underlies the ability to learn dynamics that normally interfere. Here we examine the extent to which each of these three possible coordinate systems-Cartesian hand position, shoulder and elbow joint angles, or hand orientation-underlies the reduction in interference. Subjects performed goal-directed reaching movements in five different limb configurations designed so that different pairs of these configurations involved a change in only one coordinate system. By specifically assigning clockwise and counter-clockwise force fields to the configurations we could create three different conditions in which the direction of the force field could only be uniquely distinguished in one of the three coordinate systems. We examined the ability to learn the two fields based on each of the coordinate systems. The largest reduction of interference was observed when the field direction was linked to the hand orientation with smaller reductions in the other two conditions. This result demonstrates that the strongest reduction in interference occurred with changes in the hand orientation, suggesting that hand orientation may have a privileged role in reducing motor interference for changes in the endpoint posture of the limb.	[Yeo, Sang-Hoon; Wolpert, Daniel M.; Franklin, David W.] Univ Cambridge, Dept Engn, Computat & Biol Learning Lab, Cambridge CB2 1PZ, England; [Yeo, Sang-Hoon] Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham, W Midlands, England	University of Cambridge; University of Birmingham	Yeo, SH (corresponding author), Univ Cambridge, Dept Engn, Computat & Biol Learning Lab, Cambridge CB2 1PZ, England.	s.yeo@bham.ac.uk	Franklin, David/A-2371-2009	Franklin, David/0000-0001-9530-0820; Wolpert, Daniel/0000-0003-2011-2790	Wellcome Trust [WT091547MA, WT097803MA]; Human Frontier Science Program; Royal Society Noreen Murray Professorship in Neurobiology	Wellcome Trust(Wellcome TrustEuropean Commission); Human Frontier Science Program(Human Frontier Science Program); Royal Society Noreen Murray Professorship in Neurobiology	This work was financially supported by the Wellcome Trust (WT091547MA to DF, and WT097803MA, http://www.wellcome.ac.uk/, to DW), Human Frontier Science Program (http://www.hfsp.org/, to DW) and the Royal Society Noreen Murray Professorship in Neurobiology (https://royalsociety.org/, to DW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addou T, 2011, J NEUROPHYSIOL, V106, P163, DOI 10.1152/jn.00869.2010; Berniker M, 2014, J NEUROPHYSIOL, V111, P1165, DOI 10.1152/jn.00493.2013; Berniker M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002210; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Brayanov JB, 2012, J NEUROSCI, V32, P14951, DOI 10.1523/JNEUROSCI.1928-12.2012; Caithness G, 2004, J NEUROSCI, V24, P8662, DOI 10.1523/JNEUROSCI.2214-04.2004; Cothros N, 2009, J NEUROPHYSIOL, V102, P2112, DOI 10.1152/jn.00493.2009; Crevecoeur F, 2013, J NEUROPHYSIOL, V110, P1323, DOI 10.1152/jn.00216.2013; Eberman B., 1994, P ASME DYN SYS CONT, V55-1, P353; Franklin DW, 2003, J NEUROPHYSIOL, V90, P3270, DOI 10.1152/jn.01112.2002; Franklin S, 2012, J NEUROPHYSIOL, V108, P467, DOI 10.1152/jn.01123.2011; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Hirashima M, 2012, CURR BIOL, V22, P432, DOI 10.1016/j.cub.2012.01.042; Howard IS, 2013, J NEUROPHYSIOL, V109, P2632, DOI 10.1152/jn.00773.2012; Howard IS, 2012, J NEUROSCI, V32, P12756, DOI 10.1523/JNEUROSCI.5909-11.2012; Howard IS, 2009, J NEUROSCI METH, V181, P199, DOI 10.1016/j.jneumeth.2009.05.005; Hwang EJ, 2003, PLOS BIOL, V1, P209, DOI 10.1371/journal.pbio.0000025; Hwang EJ, 2006, EXP BRAIN RES, V173, P425, DOI 10.1007/s00221-006-0391-0; Ingram JN, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002196; Ingram JN, 2010, CURR BIOL, V20, P618, DOI 10.1016/j.cub.2010.01.054; Iriki A, 1996, NEUROREPORT, V7, P2325; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; Karniel A, 2002, EXP BRAIN RES, V143, P520, DOI 10.1007/s00221-002-1054-4; KETTNER RE, 1988, J NEUROSCI, V8, P2938; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; Krouchev NI, 2003, J NEUROPHYSIOL, V89, P1165, DOI 10.1152/jn.00779.2002; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; Li CSR, 2001, NEURON, V30, P593, DOI 10.1016/S0896-6273(01)00301-4; Malfait N, 2002, J NEUROSCI, V22, P9656; Malfait N, 2005, J NEUROPHYSIOL, V93, P3327, DOI 10.1152/jn.00883.2004; Maravita A, 2004, TRENDS COGN SCI, V8, P79, DOI 10.1016/j.tics.2003.12.008; Milner TE, 2005, J PHYSIOL-LONDON, V567, P651, DOI 10.1113/jphysiol.2005.090449; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Osu R, 2004, NAT NEUROSCI, V7, P111, DOI 10.1038/nn1184; Osu R, 2002, J NEUROPHYSIOL, V88, P991, DOI 10.1152/jn.2002.88.2.991; Richter S, 2004, PSYCHOL RES-PSYCH FO, V68, P245, DOI 10.1007/s00426-003-0140-y; RUBY LK, 1988, J HAND SURG-AM, V13A, P1, DOI 10.1016/0363-5023(88)90189-X; Scheidt RA, 2000, J NEUROPHYSIOL, V84, P853, DOI 10.1152/jn.2000.84.2.853; Scott SH, 1997, J NEUROPHYSIOL, V77, P826, DOI 10.1152/jn.1997.77.2.826; SCOTT SH, 1995, J NEUROPHYSIOL, V73, P2563, DOI 10.1152/jn.1995.73.6.2563; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 1997, J NEUROSCI, V17, P409, DOI 10.1523/JNEUROSCI.17-01-00409.1997; Shadmehr R, 2000, J NEUROSCI, V20, P7807; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Takahashi CD, 2001, J NEUROPHYSIOL, V86, P1047, DOI 10.1152/jn.2001.86.2.1047; Todorov E, 2000, NAT NEUROSCI, V3, P391, DOI 10.1038/73964; Wada Y, 2003, NEUROSCI RES, V46, P319, DOI 10.1016/S0168-0102(03)00094-4	49	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129388	10.1371/journal.pone.0129388	http://dx.doi.org/10.1371/journal.pone.0129388			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6GR	26067480	gold, Green Published, Green Submitted			2022-12-26	WOS:000356327000071
J	Banni, M; Sforzini, S; Franzellitti, S; Oliveri, C; Viarengo, A; Fabbri, E				Banni, Mohamed; Sforzini, Susanna; Franzellitti, Silvia; Oliveri, Caterina; Viarengo, Aldo; Fabbri, Elena			Molecular and Cellular Effects Induced in Mytilus galloprovincialis Treated with Oxytetracycline at Different Temperatures	PLOS ONE			English	Article							SOLID-PHASE EXTRACTION; PERSONAL-CARE PRODUCTS; OXIDATIVE STRESS; CLIMATE-CHANGE; BIOCHEMICAL MARKERS; MESSENGER-RNA; EXPRESSION; PHYSIOLOGY; BIOMARKERS; EXPOSURE	The present study evaluatedthe interactive effects of temperature (16 degrees C and 24 degrees C) and a 4-day treatment with the antibiotic oxytetracycline (OTC) at 1 and 100 mu g/L on cellular and molecular parameters in the mussel Mytilus galloprovincialis. Lysosomal membrane stability (LMS), a sensitive biomarker of impaired health status in this organism, was assessed in the digestive glands. In addition, oxidative stress markers and the expression of mRNAs encoding proteins involved in antioxidant defense (catalase (cat) and glutathione-S-transferase (gst)) and the heat shock response (hsp90, hsp70, and hsp27) were evaluated in the gills, the target tissue of soluble chemicals. Finally, cAMP levels, which represent an important cell signaling pathway related to oxidative stress and the response to temperature challenges, were also determined in the gills. Exposure to heat stress as well as to OTC rendered a decrease in LMS and an increase in malonedialdehyde accumulation (MDA). CAT activity was not significantly modified, whereas GST activity decreased at 24 degrees C. Cat and gst expression levels were reduced in animals kept at 24 degrees C compared to 16 degrees C in the presence or absence of OTC. At 16 degrees C, treatment with OTC caused a significant increase in cat and gst transcript levels. Hsp27 mRNA was significantly up-regulated at all conditions compared to controls at 16 degrees C. cAMP levels were increased at 24 degrees C independent of the presence of OTC. PCA analysis showed that 37.21% and 25.89% of the total variance was explained by temperature and OTC treatment, respectively. Interestingly, a clear interaction was observed in animals exposed to both stressors increasing LMS and MDA accumulation and reducing hsp27 gene expression regulation. These interactions may suggest a risk for the organisms due to temperature increases in contaminated seawaters.	[Banni, Mohamed; Sforzini, Susanna; Oliveri, Caterina; Viarengo, Aldo] Univ Piemonte Orientale, Dept Sci & Technol Innovat DiSIT, I-15121 Alessandria, Italy; [Banni, Mohamed] ISA, Lab Biochem & Environm Toxicol, Sousse, Tunisia; [Franzellitti, Silvia; Fabbri, Elena] Univ Bologna, Dept Biol Geol & Environm Sci, I-40100 Bologna, Italy; [Franzellitti, Silvia; Fabbri, Elena] Univ Bologna, Interdept Ctr Environm Sci Res, I-48123 Ravenna, Italy	University of Eastern Piedmont Amedeo Avogadro; Universite de Tunis-El-Manar; Institut Salah Azaiez; University of Bologna; University of Bologna	Banni, M (corresponding author), Univ Piemonte Orientale, Dept Sci & Technol Innovat DiSIT, Vle T Michel 11, I-15121 Alessandria, Italy.	m_banni@yahoo.fr	; Banni, Mohamed/M-2144-2014	Viarengo, Aldo/0000-0002-1557-6526; Sforzini, Susanna/0000-0002-7310-7605; FABBRI, Elena/0000-0002-9957-8202; Banni, Mohamed/0000-0001-9764-0343; Franzellitti, Silvia/0000-0001-6104-7812	FP7 EU Project MEECE (Marine Ecosystem Evolution in a Changing Environment) [212085]	FP7 EU Project MEECE (Marine Ecosystem Evolution in a Changing Environment)	This work was funded by FP7 EU Project MEECE (Marine Ecosystem Evolution in a Changing Environment, Contract Number 212085) 2008-2013.	Allen JI, 2004, MAR ENVIRON RES, V58, P227, DOI 10.1016/j.marenvres.2004.03.119; Angilletta MJ, 2009, ECOLOGY, V90, P2933, DOI 10.1890/08-2224.1; Atli G, 2006, COMP BIOCHEM PHYS C, V143, P218, DOI 10.1016/j.cbpc.2006.02.003; Banni M, 2014, COMP BIOCHEM PHYS C, V160, P23, DOI 10.1016/j.cbpc.2013.11.005; Banni M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018904; Banni M, 2009, COMP BIOCHEM PHYS C, V149, P414, DOI 10.1016/j.cbpc.2008.09.017; Bu Q, 2014, J HAZARD MATER, P189; Calamari D, 2003, ENVIRON SCI TECHNOL, V37, P1241, DOI 10.1021/es020158e; Canesi L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019803; Carere M, 2012, TRAC-TREND ANAL CHEM, V36, P15, DOI 10.1016/j.trac.2012.03.005; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Crane M, 2006, SCI TOTAL ENVIRON, V367, P23, DOI 10.1016/j.scitotenv.2006.04.010; Dondero F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-195; Elia AC, 2014, FISH PHYSIOL BIOCHEM, V40, P1055, DOI 10.1007/s10695-013-9905-4; Fabbri E, 2008, J EXP ZOOL PART A, V309A, P157, DOI 10.1002/jez.441; Fabbri E, 2010, J EXP ZOOL PART A, V313A, P179, DOI 10.1002/jez.592; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Fent K, 2006, AQUAT TOXICOL, V76, P122, DOI 10.1016/j.aquatox.2005.09.009; Franzellitti S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061634; Franzellitti S, 2012, AQUAT TOXICOL, V124, P125, DOI 10.1016/j.aquatox.2012.07.011; Franzellitti S, 2011, AQUAT TOXICOL, V101, P299, DOI 10.1016/j.aquatox.2010.11.001; Gagne F, 2006, COMP BIOCHEM PHYS C, V143, P179, DOI 10.1016/j.cbpc.2006.01.008; Gao ML, 2014, ENVIRON TOXICOL PHAR, V37, P689, DOI 10.1016/j.etap.2014.02.004; Ruas CBG, 2008, ECOTOX ENVIRON SAFE, V71, P86, DOI 10.1016/j.ecoenv.2007.08.018; Gerard-Monnier D, 1998, CHEM RES TOXICOL, V11, P1176, DOI 10.1021/tx9701790; Gomiero A, 2014, ENVIRON POLLUT, V194, P262, DOI 10.1016/j.envpol.2014.07.035; Gust M, 2012, ENVIRON POLLUT, V169, P50, DOI 10.1016/j.envpol.2012.05.020; Helmuth B, 2002, SCIENCE, V298, P1015, DOI 10.1126/science.1076814; Helmuth B, 2009, J EXP BIOL, V212, P753, DOI 10.1242/jeb.023861; Kamel N, 2012, ARCH ENVIRON CON TOX, V63, P534, DOI 10.1007/s00244-012-9790-3; Kolar B, 2014, CHEMOSPHERE, V115, P75, DOI 10.1016/j.chemosphere.2014.02.049; Kolodziejska M, 2013, CHEMOSPHERE, V92, P1253, DOI 10.1016/j.chemosphere.2013.04.057; Koutsogiannaki S, 2014, AQUAT TOXICOL, V146, P186, DOI 10.1016/j.aquatox.2013.11.005; Lee HB, 2005, J CHROMATOGR A, V1094, P122, DOI 10.1016/j.chroma.2005.07.070; Liu FJ, 2014, AQUAT TOXICOL, V146, P76, DOI 10.1016/j.aquatox.2013.10.028; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McVeigh A, 2004, MAR ENVIRON RES, V58, P821, DOI 10.1016/j.marenvres.2004.03.099; Mimeault C, 2006, TOXICOLOGY, V228, P140, DOI 10.1016/j.tox.2006.08.025; Monaco CJ, 2011, ADV MAR BIOL, V60, P123, DOI 10.1016/B978-0-12-385529-9.00003-2; Moore MN, 2008, METHOD ENZYMOL, V451, P581, DOI 10.1016/S0076-6879(08)03233-3; MOORE MN, 1987, EXPERIENTIA, V43, P320, DOI 10.1007/BF01945568; Na GS, 2013, MAR POLLUT BULL, V69, P233, DOI 10.1016/j.marpolbul.2012.12.028; Negri A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066802; Petrenko I U, 1995, Antibiot Khimioter, V40, P3; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Piano A, 2002, CELL STRESS CHAPERON, V7, P250, DOI 10.1379/1466-1268(2002)007<0250:HEITSO>2.0.CO;2; Pickens LB, 2010, J BIOL CHEM, V285, P27509, DOI 10.1074/jbc.R110.130419; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; QUINLAN GJ, 1988, FREE RADICAL BIO MED, V5, P341, DOI 10.1016/0891-5849(88)90106-2; Raftopoulou M, 2006, NAT CELL BIOL, V8, P429, DOI 10.1038/ncb0506-429; Rajagopal S, 2005, BIOFOULING, V21, P87, DOI 10.1080/08927010500133584; Ratasuk N, 2012, J ENVIRON SCI HEAL A, V47, P1687, DOI 10.1080/10934529.2012.687274; Reemtsma T., 2006, ORGANIC POLLUTANTS W; Santos LHMLM, 2010, J HAZARD MATER, V175, P45, DOI 10.1016/j.jhazmat.2009.10.100; Smit CE, 1997, ECOTOX ENVIRON SAFE, V37, P213, DOI 10.1006/eesa.1997.1558; Somero GN, 2012, ANNU REV MAR SCI, V4, P39, DOI 10.1146/annurev-marine-120710-100935; Tomanek L, 2010, J EXP BIOL, V213, P3559, DOI 10.1242/jeb.041228; Vergani L, 2005, FEBS J, V272, P6014, DOI 10.1111/j.1742-4658.2005.04993.x; Verlecar XN, 2007, CHEM-BIOL INTERACT, V167, P219, DOI 10.1016/j.cbi.2007.01.018; Viarengo A, 2007, COMP BIOCHEM PHYS C, V146, P281, DOI 10.1016/j.cbpc.2007.04.011; Vidal-Linan L, 2013, SCI TOTAL ENVIRON, V461, P56, DOI 10.1016/j.scitotenv.2013.04.079; Vieno NM, 2006, J CHROMATOGR A, V1134, P101, DOI 10.1016/j.chroma.2006.08.077; Weigel S, 2002, SCI TOTAL ENVIRON, V295, P131, DOI 10.1016/S0048-9697(02)00064-5	63	19	19	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128468	10.1371/journal.pone.0128468	http://dx.doi.org/10.1371/journal.pone.0128468			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067465	Green Published, Green Submitted, gold			2022-12-26	WOS:000356100900023
J	de Paula, FJA; de Araujo, IM; Carvalho, AL; Elias, J; Salmon, CEG; Nogueira-Barbosa, MH				de Paula, Francisco J. A.; de Araujo, Iana M.; Carvalho, Adriana L.; Elias, Jorge, Jr.; Salmon, Carlos E. G.; Nogueira-Barbosa, Marcello H.			The Relationship of Fat Distribution and Insulin Resistance with Lumbar Spine Bone Mass in Women	PLOS ONE			English	Article							ADIPOSE-TISSUE; MARROW FAT; DENSITY; OBESITY; OSTEOBLASTS; STRENGTH; DISEASE	Bone marrow harbors a significant amount of body adipose tissue (BMAT). While BMAT might be a source of energy for bone modeling and remodeling, its increment can also represent impairment of osteoblast differentiation. The relationship between BMAT, bone mass and insulin sensitivity is only partially understood and seems to depend on the circumstances. The present study was designed to assess the association of BMAT with bone mineral density in the lumbar spine as well as with visceral adipose tissue, intrahepatic lipids, HOMA-IR, and serum levels of insulin and glucose. This cross-sectional clinical investigation included 31 non-diabetic women, but 11 had a pre-diabetes status. Dual X-ray energy absorptiometry was used to measure bone mineral density and magnetic resonance imaging was used to assess fat deposition in BMAT, visceral adipose tissue and liver. Our results suggest that in non-diabetic, there is an inverse relationship between bone mineral density in lumbar spine and BMAT and a trend persists after adjustment for weight, age, BMI and height. While there is a positive association between visceral adipose tissue and intrahepatic lipids with serum insulin levels, there is no association between BMAT and serum levels of insulin. Conversely, a positive relationship was observed between BMAT and serum glucose levels, whereas this association was not observed with other fat deposits. These relationships did not apply after adjustment for body weight, BMI, height and age. The present study shows that in a group of predominantly non-obese women the association between insulin resistance and BMAT is not an early event, as occurs with visceral adipose tissue and intrahepatic lipids. On the other hand, BMAT has a negative relationship with bone mineral density. Taken together, the results support the view that bone has a complex and non-linear relationship with energy metabolism.	[de Paula, Francisco J. A.; de Araujo, Iana M.; Carvalho, Adriana L.; Elias, Jorge, Jr.; Nogueira-Barbosa, Marcello H.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Internal Med, Ribeirao Preto, Brazil; [Salmon, Carlos E. G.] Univ Sao Paulo, Fac Philosophy Sci & Arts Ribeirao Preto, Dept Phys, Ribeirao Preto, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	de Paula, FJA (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Internal Med, Ribeirao Preto, Brazil.	fjpaula@fmrp.usp.br	Salmon, Carlos Ernesto Garrido/C-6326-2012; Elias Junior, Jorge/A-6683-2008; Nogueira-Barbosa, Marcello H/D-7681-2012; de Paula, Francisco/D-5026-2012; de Araújo, Iana/S-3504-2017	Salmon, Carlos Ernesto Garrido/0000-0003-1441-1524; Elias Junior, Jorge/0000-0002-1158-1045; Nogueira-Barbosa, Marcello H/0000-0002-7436-5315; de Paula, Francisco/0000-0003-1262-3486; de Araújo, Iana/0000-0003-0903-4787	FAPESP [2012/14603-6, 2012/09527-9, 2013/09853-6]; NAP-DIN; FAEPA; National Council for Scientific and Technological Development (CNPq) [306027/2011-9]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NAP-DIN; FAEPA; National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by FAPESP 2012/14603-6, NAP-DIN and FAEPA. FJAP received financial support from the National Council for Scientific and Technological Development (CNPq) 306027/2011-9, IMA from FAPESP (2012/09527-9) and ALC from FAPESP (2013/09853-6).	Bredella MA, 2013, RADIOLOGY, V269, P533, DOI 10.1148/radiol.13130375; Bredella MA, 2011, BONE, V48, P748, DOI 10.1016/j.bone.2010.12.011; Bredella MA, 2009, J CLIN ENDOCR METAB, V94, P2129, DOI 10.1210/jc.2008-2532; Cawthorn WP, 2014, CELL METAB, V20, P368, DOI 10.1016/j.cmet.2014.06.003; Clark EM, 2006, J CLIN ENDOCR METAB, V91, P2534, DOI 10.1210/jc.2006-0332; de Paula FJA, 2010, DIABETES-METAB RES, V26, P622, DOI 10.1002/dmrr.1135; Dimitri P, 2015, J CLIN ENDOCR METAB, V100, P594, DOI 10.1210/jc.2014-3199; Fishbein M, 2005, J CLIN GASTROENTEROL, V39, P619, DOI 10.1097/00004836-200508000-00012; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; Hanley DA, 2003, J BONE MINER RES, V18, P784, DOI 10.1359/jbmr.2003.18.4.784; Hatipoglu HG, 2007, AM J NEURORADIOL, V28, P1934, DOI 10.3174/ajnr.A0704; Kitajima M, 2007, MED MOL MORPHOL, V40, P150, DOI 10.1007/s00795-007-0367-6; Lazarenko OP, 2007, ENDOCRINOLOGY, V148, P2669, DOI 10.1210/en.2006-1587; Malkov S, 2015, J BONE MINER RES; Misra Madhusmita, 2013, Pediatr Endocrinol Rev, V11, P21; Moyer-Mileur LJ, 2008, J BONE MINER RES, V23, P1884, DOI 10.1359/JBMR.080713; Pasarin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032785; Premaor MO, 2014, ARQ BRAS ENDOCRINOL, V58, P470, DOI 10.1590/0004-2730000003274; Premaor MO, 2010, J BONE MINER RES, V25, P292, DOI 10.1359/jbmr.091004; Reid IR, 2008, OSTEOPOROSIS INT, V19, P595, DOI 10.1007/s00198-007-0492-z; REID IR, 1994, OSTEOPOROSIS INT, V4, P362, DOI 10.1007/BF01622199; Riddle RC, 2014, J CLIN INVEST, V124, P1465, DOI 10.1172/JCI75554; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Russell M, 2010, J CLIN ENDOCR METAB, V95, P1247, DOI 10.1210/jc.2009-1475; Saito M, 2006, OSTEOPOROSIS INT, V17, P1514, DOI 10.1007/s00198-006-0155-5; Sroga GE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117046; Tsatsoulis A, 2013, METABOLISM, V62, P622, DOI 10.1016/j.metabol.2012.11.004	27	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129764	10.1371/journal.pone.0129764	http://dx.doi.org/10.1371/journal.pone.0129764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067489	Green Published, Green Submitted, gold			2022-12-26	WOS:000356100900075
J	Moreira, PFD; Gangl, K; Vieira, FDM; Ynoue, LH; Linhart, B; Flicker, S; Fiebig, H; Swoboda, I; Focke-Tejkl, M; Taketomi, EA; Valenta, R; Niederberger, V				de Sousa Moreira, Priscila Ferreira; Gangl, Katharina; Machado Vieira, Francisco de Assis; Ynoue, Leandro Hideki; Linhart, Birgit; Flicker, Sabine; Fiebig, Helmut; Swoboda, Ines; Focke-Tejkl, Margarete; Taketomi, Ernesto Akio; Valenta, Rudolf; Niederberger, Verena			Allergen Microarray Indicates Pooideae Sensitization in Brazilian Grass Pollen Allergic Patients	PLOS ONE			English	Article							PHLEUM-PRATENSE POLLEN; DIAGNOSTIC GATEKEEPERS; LOLIUM-MULTIFLORUM; RECOMBINANT; IGE; IMMUNOTHERAPY; POLLINOSIS; PREVALENCE; ANTIBODIES; PROTEIN	Background Grass pollen, in particular from Lolium multiflorum is a major allergen source in temperate climate zones of Southern Brazil. The IgE sensitization profile of Brazilian grass pollen allergic patients to individual allergen molecules has not been analyzed yet. Objective To analyze the IgE sensitization profile of a Brazilian grass pollen allergic population using individual allergen molecules. Methods We analyzed sera from 78 grass pollen allergic patients for the presence of IgE antibodies specific for 103 purified micro-arrayed natural and recombinant allergens by chip technology. IgE-ELISA inhibition experiments with Lolium multiflorum, Phleum pratense extracts and a recombinant fusion protein consisting of Phl p 1, Phl p 2, Phl p 5 and Phl p 6 were performed to investigate cross-reactivities. Results Within the Brazilian grass pollen allergic patients, the most frequently recognized allergens were Phl p 1 (95%), Phl p 5 (82%), Phl p 2 (76%) followed by Phl p 4 (64%), Phl p 6 (45%), Phl p 11 (18%) and Phl p 12 (18%). Most patients were sensitized only to grass pollen allergens but not to allergens from other sources. A high degree of IgE cross-reactivity between Phleum pratense, Lolium multiflorum and the recombinant timothy grass fusion protein was found. Conclusions Component-resolved analysis of sera from Brazilian grass pollen allergic patients reveals an IgE recognition profile compatible with a typical Pooideae sensitization. The high degree of cross-reactivity between Phleum pratense and Lolium multiflorum allergens suggests that diagnosis and immunotherapy can be achieved with timothy grass pollen allergens in the studied population.	[de Sousa Moreira, Priscila Ferreira; Ynoue, Leandro Hideki; Taketomi, Ernesto Akio] Univ Fed Uberlandia, Inst Biomed Sci, Lab Allergy & Clin Immunol, BR-38400 Uberlandia, MG, Brazil; [de Sousa Moreira, Priscila Ferreira; Gangl, Katharina; Niederberger, Verena] Med Univ Vienna, Dept Otorhinolaryngol, Vienna, Austria; [de Sousa Moreira, Priscila Ferreira; Gangl, Katharina; Swoboda, Ines; Focke-Tejkl, Margarete; Valenta, Rudolf] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, Div Immunopathol,Christian Doppler Lab Allergy Re, Vienna, Austria; [Machado Vieira, Francisco de Assis] Univ Caxias, Dept Med, Caxias, RS, Brazil; [Linhart, Birgit; Flicker, Sabine] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, Div Immunopathol, Vienna, Austria; [Fiebig, Helmut] Allergopharma J Ganzer KG, Reinbek, Germany	Universidade Federal de Uberlandia; Medical University of Vienna; Medical University of Vienna; Universidade de Caxias do Sul; Medical University of Vienna; Allergopharma	Valenta, R (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, Div Immunopathol,Christian Doppler Lab Allergy Re, Vienna, Austria.	rudolf.valenta@meduniwien.ac.at		Flicker, Sabine/0000-0003-4768-8693; Linhart, Birgit/0000-0001-6857-3049; Valenta, Rudolf/0000-0001-5944-3365; Swoboda, Ines/0000-0002-9164-1721	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior = Coordination for the Improvement of Higher Education Personnel) [BEX 3442/08-0]; FWF (Fonds zur Forderung der wissenschaftlichen Forschung = Austrian Science Fund) [SFB 4613, SFB4605, P23350-B11, F4607]; Biomay AG Research Grant; Christian Doppler Laboratory for Allergy Research	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior = Coordination for the Improvement of Higher Education Personnel); FWF (Fonds zur Forderung der wissenschaftlichen Forschung = Austrian Science Fund); Biomay AG Research Grant; Christian Doppler Laboratory for Allergy Research	Funding for this study was received from CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior = Coordination for the Improvement of Higher Education Personnel) Grant Number: BEX 3442/08-0; to EAT. URL: http://www.capes.gov.br/; FWF (Fonds zur Forderung der wissenschaftlichen Forschung = Austrian Science Fund) Grant Number: SFB 4613 to VN; Grant Number SFB4605 to RV; Grant Number P23350-B11 to BL; Grant Number F4607 to SF. URL: http://www.fwf.ac.at/de/projects/sfb.html; Biomay AG Research Grant to RV. URL: http://www.biomay.com/; Christian Doppler Laboratory for Allergy Research to RV. URL: https://www.cdg.ac.at/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson K, 2003, INT ARCH ALLERGY IMM, V130, P87, DOI 10.1159/000069013; ARRUDA LK, 1991, CLIN EXP ALLERGY, V21, P433, DOI 10.1111/j.1365-2222.1991.tb01683.x; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Bernardes CT, 2010, BRAZ J MED BIOL RES, V43, P166, DOI 10.1590/S0100-879X2010005000004; Bousquet PJ, 2010, ANN EPIDEMIOL, V20, P797, DOI 10.1016/j.annepidem.2010.05.012; Eckl-Dorna J, 2010, J ALLERGY CLIN IMMUN, V126, P1315, DOI 10.1016/j.jaci.2010.06.012; Hiller R, 2002, FASEB J, V16, P414, DOI 10.1096/fj.01-0711fje; Jutel M, 2005, J ALLERGY CLIN IMMUN, V116, P608, DOI 10.1016/j.jaci.2005.06.004; Kazemi-Shirazi L, 2002, INT ARCH ALLERGY IMM, V127, P259, DOI 10.1159/000057742; KNOX RB, 1993, MOLECULAR BIOLOGY AND IMMUNOLOGY OF ALLERGENS, P31; Linhart B, 2005, J ALLERGY CLIN IMMUN, V115, P1010, DOI 10.1016/j.jaci.2004.12.1142; Marth K, 2004, J ALLERGY CLIN IMMUN, V113, P470, DOI 10.1016/j.jaci.2003.11.042; Niederberger V, 1998, J ALLERGY CLIN IMMUN, V101, P258, DOI 10.1016/S0091-6749(98)70391-4; Pastorino AC, 2008, ALLERGOL IMMUNOPATH, V36, P9, DOI 10.1157/13115665; PETERSEN A, 1995, INT ARCH ALLERGY IMM, V108, P49, DOI 10.1159/000237117; Sopelete MC, 2006, INT ARCH ALLERGY IMM, V140, P121, DOI 10.1159/000092531; Suck R, 2000, CLIN EXP ALLERGY, V30, P1395, DOI 10.1046/j.1365-2222.2000.00886.x; Suphioglu C, 2000, CLIN EXP ALLERGY, V30, P1335, DOI 10.1046/j.1365-2222.2000.00955.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VALENTA R, 1992, INT ARCH ALLERGY IMM, V97, P287, DOI 10.1159/000236135; Valenta R, 1999, CLIN EXP ALLERGY, V29, P896; Vergamini SMN, 2006, RS REV BRAS ALEG IMU, V29, P14; Vieira FAM, 2003, REV BRAS ALERGIA IMU, V26, P37; VIEIRA FAM, 1989, REV BRAS ALERGIA IMU, V12, P73; Vrtala S, 1999, J IMMUNOL, V163, P5489; Weber RW, 2003, J ALLERGY CLIN IMMUN, V112, P229, DOI 10.1067/mai.2003.1683; Weghofer M, 2008, ALLERGY, V63, P758, DOI 10.1111/j.1398-9995.2008.01647.x; Weghofer M, 2008, INT ARCH ALLERGY IMM, V147, P101, DOI 10.1159/000135696; Weghofer M, 2013, J IMMUNOL, V190, P3059, DOI 10.4049/jimmunol.1202288; Weinmayr G, 2008, EUR RESPIR J, V32, P1250, DOI 10.1183/09031936.00157807	30	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128402	10.1371/journal.pone.0128402	http://dx.doi.org/10.1371/journal.pone.0128402			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067084	Green Published, Green Submitted, gold			2022-12-26	WOS:000356100900021
J	Hobson, KA; Kardynal, KJ; Van Wilgenburg, SL; Albrecht, G; Salvadori, A; Cadman, MD; Liechti, F; Fox, JW				Hobson, Keith A.; Kardynal, Kevin J.; Van Wilgenburg, Steven L.; Albrecht, Gretchen; Salvadori, Antonio; Cadman, Michael D.; Liechti, Felix; Fox, James W.			A Continent-Wide Migratory Divide in North American Breeding Barn Swallows (Hirundo rustica)	PLOS ONE			English	Article							TRACKING; SURVIVAL	Populations of most North American aerial insectivores have undergone steep population declines over the past 40 years but the relative importance of factors operating on breeding, wintering, or stopover sites remains unknown. We used archival light-level geolocators to track the phenology, movements and winter locations of barn swallows (Hirdundo rustica; n = 27) from populations across North America to determine their migratory connectivity. We identified an east-west continental migratory divide for barn swallows with birds from western regions (Washington State, USA (n = 8) and Saskatchewan, Canada (n = 5)) traveling shorter distances to wintering areas ranging from Oregon to northern Colombia than eastern populations (Ontario (n = 3) and New Brunswick (n = 10), Canada) which wintered in South America south of the Amazon basin. A single swallow from a stable population in Alabama shared a similar migration route to eastern barn swallows but wintered farther north in northeast Brazil indicating a potential leap frog pattern migratory among eastern birds. Six of 9 (67%) birds from the two eastern populations and Alabama underwent a loop migration west of fall migration routes including around the Gulf of Mexico travelling a mean of 2,224 km and 722 km longer on spring migration, respectively. Longer migration distances, including the requirement to cross the Caribbean Sea and Gulf of Mexico and subsequent shorter sedentary wintering periods, may exacerbate declines for populations breeding in northeastern North America.	[Hobson, Keith A.; Kardynal, Kevin J.; Van Wilgenburg, Steven L.] Environm Canada, Sci & Technol Branch, Saskatoon, SK, Canada; [Albrecht, Gretchen] Woodland Pk Zoo, Seattle, WA USA; [Cadman, Michael D.] Environm Canada, Canadian Wildlife Serv, Burlington, ON L7R 4A6, Canada; [Liechti, Felix] Swiss Ornithol Inst, Sempach, Switzerland; [Fox, James W.] Migrate Technol, Cambridge, England	Environment & Climate Change Canada; Environment & Climate Change Canada; Canadian Wildlife Service; Swiss Ornithological Institute	Hobson, KA (corresponding author), Environm Canada, Sci & Technol Branch, Saskatoon, SK, Canada.	Keith.Hobson@ec.gc.ca	Hobson, Keith/Q-9306-2019	Van Wilgenburg, Steven/0000-0002-6742-4567	Migrate Technology	Migrate Technology	Migrate Technology provided support in the form of salaries for author JWF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Ambrosini R, 2009, J THEOR BIOL, V257, P203, DOI 10.1016/j.jtbi.2008.11.019; Bowlin MS, 2010, METHODS ECOL EVOL, V1, P398, DOI 10.1111/j.2041-210X.2010.00043.x; Brown CR, 1999, BIRDS N AM ONLINE; Cao MK, 2004, ECOSYSTEMS, V7, P233, DOI 10.1007/s10021-003-0189-x; Costantini D, 2013, CURR ZOOL, V59, P697, DOI 10.1093/czoolo/59.6.697; Drake A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097152; Faaborg J, 2010, ECOL MONOGR, V80, P3, DOI 10.1890/09-0395.1; Fudickar AM, 2012, METHODS ECOL EVOL, V3, P47, DOI 10.1111/j.2041-210X.2011.00136.x; Garcia-Perez B, 2014, AUK, V131, P351, DOI 10.1642/AUK-13-145.1; Garcia-Perez B, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00116.1; Gruebler MU, 2014, ECOL EVOL, V4, P756, DOI 10.1002/ece3.984; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hill Roger D., 1994, P227; Hobson Keith A., 2013, Animal Migration, V1, P8, DOI 10.2478/ami-2012-0002; Hobson KA, 2015, AUK, V132, P540, DOI 10.1642/AUK-14-260.1; Holmgren M, 2001, TRENDS ECOL EVOL, V16, P89, DOI 10.1016/S0169-5347(00)02052-8; Jonsen ID, 2013, DEEP-SEA RES PT II, V88-89, P34, DOI 10.1016/j.dsr2.2012.07.008; Kalman RE., 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Liechti F, 2015, J AVIAN BIOL, V46, P254, DOI 10.1111/jav.00485; Lisovski S, 2012, METHODS ECOL EVOL, V3, P1055, DOI 10.1111/j.2041-210X.2012.00248.x; Lisovski S, 2012, METHODS ECOL EVOL, V3, P603, DOI 10.1111/j.2041-210X.2012.00185.x; McKinnon Emily A., 2013, Animal Migration, V1, P31, DOI 10.2478/ami-2013-0001; Michel NL, CONTINENTAL SC UNPUB; Naef-Daenzer B, 2007, J AVIAN BIOL, V38, P404, DOI 10.1111/j.2007.0908-8857.03863.x; Nebel S, 2010, AVIAN CONSERV ECOL, V5; Newton I, 2006, J ORNITHOL, V147, P146, DOI 10.1007/s10336-006-0058-4; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Nielsen A, 2007, CAN J FISH AQUAT SCI, V64, P1055, DOI 10.1139/F07-064; Norris DR, 2004, P ROY SOC B-BIOL SCI, V271, P59, DOI 10.1098/rspb.2003.2569; Paquette SR, 2013, ECOL APPL, V23, P122, DOI 10.1890/12-0068.1; Paxton KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095383; R Core Team, 2014, R LANG ENV STAT COMP, DOI [10.1016/j.jneumeth.2014.06.019, DOI 10.1016/J.JNEUMETH.2014.06.019]; RAPPOLE JH, 1991, J FIELD ORNITHOL, V62, P335; Saino N, 2004, P ROY SOC B-BIOL SCI, V271, P681, DOI 10.1098/rspb.2003.2656; Scandolara C, 2014, J AVIAN BIOL, V45, P417, DOI 10.1111/jav.00412; Schreinemachers P, 2012, FOOD POLICY, V37, P616, DOI 10.1016/j.foodpol.2012.06.003; Sherry Thomas W., 1995, P85; Sibert J, 2002, ADD ON PACKAGE STAT; Sibert JR, 2003, FISH OCEANOGR, V12, P141, DOI 10.1046/j.1365-2419.2003.00228.x; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Trenberth KE, 2000, J CLIMATE, V13, P4358, DOI 10.1175/1520-0442(2000)013<4358:TSORSL>2.0.CO;2; Vincenty T., 1975, SURVEY REV, V23, P88, DOI [10.1179/sre.1975.23.176.88, DOI 10.1179/SRE.1975.23.176.88]; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1	44	53	54	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129340	10.1371/journal.pone.0129340	http://dx.doi.org/10.1371/journal.pone.0129340			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26065914	gold, Green Submitted, Green Published			2022-12-26	WOS:000356100900049
J	Kourtidis, A; Yanagisawa, M; Huveldt, D; Copland, JA; Anastasiadis, PZ				Kourtidis, Antonis; Yanagisawa, Masahiro; Huveldt, Deborah; Copland, John A.; Anastasiadis, Panos Z.			Pro-Tumorigenic Phosphorylation of p120 Catenin in Renal and Breast Cancer	PLOS ONE			English	Article							HUMAN P120(CTN) CATENIN; E-CADHERIN; BETA-CATENIN; TYROSINE PHOSPHORYLATION; MESENCHYMAL TRANSITION; ALPHA-CATENIN; CELL-ADHESION; EXPRESSION; P120-CATENIN; PROTEIN	Altered protein expression and phosphorylation are common events during malignant transformation. These perturbations have been widely explored in the context of E-cadherin cell-cell adhesion complexes, which are central in the maintenance of the normal epithelial phenotype. A major component of these complexes is p120 catenin (p120), which binds and stabilizes E-cadherin to promote its adhesive and tumor suppressing function. However, p120 is also an essential mediator of pro-tumorigenic signals driven by oncogenes, such as Src, and can be phosphorylated at multiple sites. Although alterations in p120 expression have been extensively studied by immunohistochemistry (IHC) in the context of tumor progression, little is known about the status and role of p120 phosphorylation in cancer. Here we show that tyrosine and threonine phosphorylation of p120 in two sites, Y228 and T916, is elevated in renal and breast tumor tissue samples. We also show that tyrosine phosphorylation of p120 at its N-terminus, including at the Y228 site is required for its pro-tumorigenic potential. In contrast, phosphorylation of p120 at T916 does not affect this p120 function. However, phosphorylation of p120 at T916 interferes with epitope recognition of the most commonly used p120 antibody, namely pp120. As a result, this antibody selectively under-represents p120 levels in tumor tissues, where p120 is phosphorylated. Overall, our data support a role of p120 phosphorylation as a marker and mediator of tumor transformation. Importantly, they also argue that the level and localization of p120 in human cancer tissues immunostained with pp120 needs to be re-evaluated.	[Kourtidis, Antonis; Yanagisawa, Masahiro; Huveldt, Deborah; Copland, John A.; Anastasiadis, Panos Z.] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA	Mayo Clinic	Anastasiadis, PZ (corresponding author), Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA.	panos@mayo.edu		Kourtidis, Antonis/0000-0002-8128-6391	National Institute of Neurological Disorders and Stroke R01 grant [NS069753]; Jay and Deanie Stein Career Development Award for Cancer Research at Mayo Clinic; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069753] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke R01 grant; Jay and Deanie Stein Career Development Award for Cancer Research at Mayo Clinic; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by a National Institute of Neurological Disorders and Stroke R01 grant to P.Z.A. (NS069753). http://www.ninds.nih.gov. AK is supported by the Jay and Deanie Stein Career Development Award for Cancer Research at Mayo Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho S, 1999, J CELL BIOCHEM, V73, P390, DOI 10.1002/(SICI)1097-4644(19990601)73:3<390::AID-JCB10>3.3.CO;2-T; Anastasiadis PZ, 2000, J CELL SCI, V113, P1319; Bellovin DI, 2005, CANCER RES, V65, P10938, DOI 10.1158/0008-5472.CAN-05-1947; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Campbell M, 2006, EXP EYE RES, V83, P484, DOI 10.1016/j.exer.2006.01.032; Castano J, 2007, MOL CELL BIOL, V27, P1745, DOI 10.1128/MCB.01974-06; Chauvet N, 2004, J COMP NEUROL, V479, P15, DOI 10.1002/cne.20301; Chetty R, 2008, AM J CLIN PATHOL, V130, P71, DOI 10.1309/FEYD99TXC4LMYVA5; Corsino PE, 2008, NEOPLASIA, V10, P1240, DOI 10.1593/neo.08710; Dabbs DJ, 2007, AM J SURG PATHOL, V31, P427, DOI 10.1097/01.pas.0000213386.63160.3f; Dai SD, 2007, LUNG CANCER, V57, P54, DOI 10.1016/j.lungcan.2007.02.008; Dann SG, 2014, ONCOGENE, V33, P1385, DOI 10.1038/onc.2013.91; Davis MA, 2006, DEV CELL, V10, P21, DOI 10.1016/j.devcel.2005.12.004; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; del Valle-Perez B, 2011, J CELL SCI, V124, P2298, DOI 10.1242/jcs.082693; Dohn MR, 2009, J CELL BIOL, V184, P437, DOI 10.1083/jcb.200807096; Esposito NN, 2007, MODERN PATHOL, V20, P130, DOI 10.1038/modpathol.3800721; Fukumoto Y, 2008, EXP CELL RES, V314, P52, DOI 10.1016/j.yexcr.2007.07.024; Greco C, 2010, CANCER RES, V70, P7674, DOI 10.1158/0008-5472.CAN-09-4482; Hamada S, 2013, J CELL PHYSIOL, V228, P1255, DOI 10.1002/jcp.24280; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoshino T, 2005, J BIOL CHEM, V280, P24095, DOI 10.1074/jbc.M414447200; Humar B, 2007, CANCER RES, V67, P2480, DOI 10.1158/0008-5472.CAN-06-3021; Huveldt D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056505; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Ishiyama N, 2010, CELL, V141, P117, DOI 10.1016/j.cell.2010.01.017; Johnson E, 2010, J BIOL CHEM, V285, P29491, DOI 10.1074/jbc.M110.136770; Keirsebilck A, 1998, GENOMICS, V50, P129, DOI 10.1006/geno.1998.5325; Kourtidis A, 2013, PROG MOL BIOL TRANSL, V116, P409, DOI 10.1016/B978-0-12-394311-8.00018-2; Liapis G, 2007, APMIS, V115, P104, DOI 10.1111/j.1600-0463.2007.apm_517.x; Liu Y, 2009, LUNG CANCER, V63, P375, DOI 10.1016/j.lungcan.2008.12.012; Ma LW, 2012, J CLIN PATHOL, V65, P315, DOI 10.1136/jclinpath-2011-200516; Mariner DJ, 2004, J CELL SCI, V117, P1339, DOI 10.1242/jcs.01001; Mariner DJ, 2001, J BIOL CHEM, V276, P28006, DOI 10.1074/jbc.M102443200; Mayerle J, 2003, GASTROENTEROLOGY, V124, P949, DOI 10.1053/gast.2003.50142; Miao YA, 2010, MED ONCOL, V27, P880, DOI 10.1007/s12032-009-9300-2; Mo YY, 1996, CANCER RES, V56, P2633; Nakopoulou L, 2002, HISTOPATHOLOGY, V40, P536, DOI 10.1046/j.1365-2559.2002.01392.x; Neto BS, 2008, BJU INT, V101, P746, DOI 10.1111/j.1464-410X.2007.07264.x; Ozawa M, 2001, J CELL SCI, V114, P503; Peglion F, 2014, NAT CELL BIOL, V16, P639, DOI 10.1038/ncb2985; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Petrova YI, 2012, MOL BIOL CELL, V23, P2092, DOI 10.1091/mbc.E11-12-1060; Pieters T, 2012, FRONT BIOSCI-LANDMRK, V17, P1669, DOI 10.2741/4012; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P629, DOI 10.1128/MCB.9.2.629; REYNOLDS AB, 1994, MOL CELL BIOL, V14, P8333, DOI 10.1128/MCB.14.12.8333; REYNOLDS AB, 1992, ONCOGENE, V7, P2439; Sarrio D, 2004, ONCOGENE, V23, P3272, DOI 10.1038/sj.onc.1207439; Sarrio D, 2006, HUM PATHOL, V37, P1042, DOI 10.1016/j.humpath.2006.03.003; Schackmann RCJ, 2013, CANCER RES, V73, P4937, DOI 10.1158/0008-5472.CAN-13-0180; Smalley-Freed WG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019880; Smalley-Freed WG, 2010, J CLIN INVEST, V120, P1824, DOI 10.1172/JCI41414; Soto E, 2008, J CELL BIOL, V183, P737, DOI 10.1083/jcb.200805113; STADDON JM, 1995, J CELL BIOL, V130, P369, DOI 10.1083/jcb.130.2.369; Stefansson IM, 2004, J CLIN ONCOL, V22, P1242, DOI 10.1200/JCO.2004.09.034; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; van Oort IM, 2007, PROSTATE, V67, P1432, DOI 10.1002/pros.20626; Wang EH, 2006, HISTOL HISTOPATHOL, V21, P841, DOI 10.14670/HH-21.841; Wu J, 1998, HYBRIDOMA, V17, P175, DOI 10.1089/hyb.1998.17.175; Xia XB, 2004, HYBRIDOMA HYBRIDOM, V23, P343, DOI 10.1089/hyb.2004.23.343; Xia XB, 2003, BIOCHEMISTRY-US, V42, P9195, DOI 10.1021/bi034597h; Yanagisawa M, 2008, J BIOL CHEM, V283, P18344, DOI 10.1074/jbc.M801192200; Yanagisawa M, 2006, J CELL BIOL, V174, P1087, DOI 10.1083/jcb.200605022; Yang ZQ, 2010, MOL CARCINOGEN, V49, P508, DOI 10.1002/mc.20622; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779; Yu J, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-36; Zhang PX, 2011, INT J ONCOL, V38, P1625, DOI 10.3892/ijo.2011.995; Zhu JXX, 2013, SCI CHINA CHEM, V56, P1, DOI 10.1007/s11426-012-4811-7	68	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129964	10.1371/journal.pone.0129964	http://dx.doi.org/10.1371/journal.pone.0129964			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067913	Green Published, gold, Green Submitted			2022-12-26	WOS:000356100900087
J	Liang, YX; Yang, J; Yuan, TF; So, KF				Liang, Yu-Xiang; Yang, Jian; Yuan, Ti-Fei; So, Kwok-Fai			Uptake of Retrograde Tracers by Intact Optic Nerve Axons: A New Way to Label Retinal Ganglion Cells	PLOS ONE			English	Article							QUANTITATIVE IN-VIVO; ADULT-RAT; COMPUTERIZED ANALYSIS; SPATIAL-DISTRIBUTION; SURVIVAL; OPHTHALMOLOGY; TRANSECTION; FLUOROGOLD; EYES; MICE	Retrograde labelling of retinal ganglion cells with optic nerve transection often leads to degeneration of ganglion cells in prolonged experiments. Here we report that an intact optic nerve could uptake retrograde tracers applied onto the surface of the nerve, leading to high efficiency labelling of ganglion cells in the retina with long-term survival of cells. This method labelled a similar number of ganglion cells (2289 +/- 174 at 2 days) as the retrograde labeling technique from the superior colliculus (2250 +/- 94) or optic nerve stump (2279 +/- 114) after transection. This finding provides an alternative way to label retinal ganglion cells without damaging the optic tract. This will facilitate anatomical studies in identifying the morphology and connectivity of retinal ganglion cells, allowing secondary or triple labelling manipulations for long-term investigations.	[Liang, Yu-Xiang; So, Kwok-Fai] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China; [Liang, Yu-Xiang; Yang, Jian; So, Kwok-Fai] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Yuan, Ti-Fei; So, Kwok-Fai] Univ Hong Kong, Dept Ophthalmol, Hong Kong, Hong Kong, Peoples R China; [Yuan, Ti-Fei] Nanjing Normal Univ, Sch Psychol, Nanjing, Jiangsu, Peoples R China; [So, Kwok-Fai] Jinan Univ, GHM Inst CNS Regenerat, Guangzhou, Guangdong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; Nanjing Normal University; Jinan University	Liang, YX (corresponding author), Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China.	yxliang@hku.hk; ytf0707@126.com; hrmaskf@hku.hk		So, Kwok-Fai/0000-0003-4039-4246	Funds of Leading Talents of Guangdong; Programme of Introducing Talents of Discipline to Universities [B14036]; Project of International; Taiwan Science and Technology Cooperation Innovation Platform in Universities in Guangdong Province [2013gjhz0002]; National Program on Key Basic Research Project of China (973 Program) [2011CB707501]; "Hundred Talents program"; "Qing Lan Project" of Nanjing Normal University; Jiangsu Provincial Natural Science Foundation [BK20140917]; Hong Kong, Macao	Funds of Leading Talents of Guangdong; Programme of Introducing Talents of Discipline to Universities; Project of International; Taiwan Science and Technology Cooperation Innovation Platform in Universities in Guangdong Province; National Program on Key Basic Research Project of China (973 Program)(National Basic Research Program of China); "Hundred Talents program"(Chinese Academy of Sciences); "Qing Lan Project" of Nanjing Normal University; Jiangsu Provincial Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Hong Kong, Macao	The work is supported by Funds of Leading Talents of Guangdong (2013), Programme of Introducing Talents of Discipline to Universities (B14036), and Project of International, as well as Hong Kong, Macao & Taiwan Science and Technology Cooperation Innovation Platform in Universities in Guangdong Province (2013gjhz0002), National Program on Key Basic Research Project of China (973 Program, 2011CB707501) (KS). The work is also supported by "Hundred Talents program", "Qing Lan Project" of Nanjing Normal University and Jiangsu Provincial Natural Science Foundation (No. BK20140917) (TY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong RA, 2013, OPHTHAL PHYSL OPT, V33, P7, DOI 10.1111/opo.12009; BENTIVOGLIO M, 1980, NEUROSCI LETT, V18, P19, DOI 10.1016/0304-3940(80)90207-4; BENTIVOGLIO M, 1980, NEUROSCI LETT, V18, P25, DOI 10.1016/0304-3940(80)90208-6; Chiu K., 2008, J VIS EXP, V17, P16, DOI DOI 10.3791/819; Danias J, 2006, EXP EYE RES, V82, P219, DOI 10.1016/j.exer.2005.06.013; Danias J, 2003, INVEST OPHTH VIS SCI, V44, P5151, DOI 10.1167/iovs.02-1101; Danias J, 2002, INVEST OPHTH VIS SCI, V43, P587; Fan Q, 2011, INVEST OPHTH VIS SCI, V52, P6059, DOI 10.1167/iovs.10-7108; Fu QL, 2009, NEUROSCIENCE, V162, P375, DOI 10.1016/j.neuroscience.2009.04.075; Fu QL, 2008, INVEST OPHTH VIS SCI, V49, P975, DOI 10.1167/iovs.07-1199; Galindo-Romero C, 2011, EXP EYE RES, V92, P377, DOI 10.1016/j.exer.2011.02.008; Gomez-Ramirez AM, 1999, INVEST OPHTH VIS SCI, V40, P414; GRAFSTEIN B, 1982, EXP NEUROL, V76, P318, DOI 10.1016/0014-4886(82)90212-6; KELLY JP, 1975, J COMP NEUROL, V163, P65, DOI 10.1002/cne.901630105; Kobbert C, 2000, PROG NEUROBIOL, V62, P327, DOI 10.1016/S0301-0082(00)00019-8; Li HY, 2015, CELL TRANSPLANT, V24, P403, DOI 10.3727/096368915X686896; Li HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068881; LINDEN R, 1983, BRAIN RES, V272, P145, DOI 10.1016/0006-8993(83)90371-2; Lopez-Herrera MPL, 2002, EXP NEUROL, V178, P243, DOI 10.1006/exnr.2002.8043; LUND RD, 1965, SCIENCE, V149, P1506, DOI 10.1126/science.149.3691.1506; MISANTONE LJ, 1984, J NEUROCYTOL, V13, P449, DOI 10.1007/BF01148334; Murdoch IE, 1998, BRIT J OPHTHALMOL, V82, P971, DOI 10.1136/bjo.82.8.971; PeinadoRamon P, 1996, INVEST OPHTH VIS SCI, V37, P489; PERRY VH, 1981, NEUROSCIENCE, V6, P931, DOI 10.1016/0306-4522(81)90174-3; RAY WA, 1985, INVEST OPHTH VIS SCI, V26, P1186; Reichstein D, 2007, EXP EYE RES, V84, P13, DOI 10.1016/j.exer.2006.08.009; RICHARDSON PM, 1982, J NEUROCYTOL, V11, P949, DOI 10.1007/BF01148310; ROSNER B, 1982, BIOMETRICS, V38, P105, DOI 10.2307/2530293; Salinas-Navarro M, 2009, VISION RES, V49, P637, DOI 10.1016/j.visres.2009.01.010; Salinas-Navarro M, 2009, VISION RES, V49, P115, DOI 10.1016/j.visres.2008.09.029; SCHMUED L, 1990, BRAIN RES, V526, P127, DOI 10.1016/0006-8993(90)90258-D; SCHMUED LC, 1986, BRAIN RES, V377, P147, DOI 10.1016/0006-8993(86)91199-6; SellesNavarro I, 1996, INVEST OPHTH VIS SCI, V37, P2002; SILVERMAN AJ, 1990, SYNAPSE, V6, P154, DOI 10.1002/syn.890060206; THANOS S, 1987, BRAIN RES, V406, P317, DOI 10.1016/0006-8993(87)90799-2; VIDALSANZ M, 1987, J NEUROSCI, V7, P2894; VIDALSANZ M, 1988, EXP NEUROL, V102, P92, DOI 10.1016/0014-4886(88)90081-7; VILLEGASPEREZ MP, 1993, J NEUROBIOL, V24, P23, DOI 10.1002/neu.480240103; WESSENDORF MW, 1991, BRAIN RES, V553, P135, DOI 10.1016/0006-8993(91)90241-M; Yuan TF, 2015, SCI REPORTS IN PRESS	40	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128718	10.1371/journal.pone.0128718	http://dx.doi.org/10.1371/journal.pone.0128718			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26065419	Green Published, Green Submitted, gold			2022-12-26	WOS:000356100900028
J	Mangino, G; Famiglietti, M; Capone, C; Veroni, C; Percario, ZA; Leone, S; Fiorucci, G; Lulf, S; Romeo, G; Agresti, C; Persichini, T; Geyer, M; Affabris, E				Mangino, Giorgio; Famiglietti, Marylinda; Capone, Caterina; Veroni, Caterina; Percario, Zulema Antonia; Leone, Stefano; Fiorucci, Gianna; Luelf, Sebastian; Romeo, Giovanna; Agresti, Cristina; Persichini, Tiziana; Geyer, Matthias; Affabris, Elisabetta			HIV-1 Myristoylated Nef Treatment of Murine Microglial Cells Activates Inducible Nitric Oxide Synthase, NO2 Production and Neurotoxic Activity	PLOS ONE			English	Article							NF-KAPPA-B; VIRUS TYPE-1 NEF; HIGHLY SELECTIVE INHIBITOR; IMMUNODEFICIENCY-VIRUS; HUMAN MONOCYTES/MACROPHAGES; HUMAN MONOCYTE/MACROPHAGES; SIGNALING PATHWAY; TRANSGENIC MICE; SOLUBLE FACTORS; NERVOUS-SYSTEM	Background The potential role of the human immunodeficiency virus-1 (HIV-1) accessory protein Nef in the pathogenesis of neuroAIDS is still poorly understood. Nef is a molecular adapter that influences several cellular signal transduction events and membrane trafficking. In human macrophages, Nef expression induces the production of extracellular factors (e.g. pro-inflammatory chemokines and cytokines) and the recruitment of T cells, thus favoring their infection and its own transfer to uninfected cells via exosomes, cellular protrusions or cell-to-cell contacts. Murine cells are normally not permissive for HIV-1 but, in transgenic mice, Nef is a major disease determinant. Both in human and murine macrophages, myristoylated Nef (myr(+)Nef) treatment has been shown to activate NF-kappa B, MAP kinases and interferon responsive factor 3 (IRF-3), thereby inducing tyrosine phosphorylation of signal transducers and activator of transcription (STAT)-1, STAT-2 and STAT-3 through the production of proinflammatory factors. Methodology/Principal Findings We report that treatment of BV-2 murine microglial cells with myr(+)Nef leads to STAT-1, -2 and -3 tyrosine phosphorylation and upregulates the expression of inducible nitric oxide synthase (iNOS) with production of nitric oxide. We provide evidence that extracellular Nef regulates iNOS expression through NF-kappa B activation and, at least in part, interferon-beta (IFN beta) release that acts in concert with Nef. All of these effects require both myristoylation and a highly conserved acidic cluster in the viral protein. Finally, we report that Nef induces the release of neurotoxic factors in the supernatants of microglial cells. Conclusions These results suggest a potential role of extracellular Nef in promoting neuronal injury in the murine model. They also indicate a possible interplay between Nef and host factors in the pathogenesis of neuroAIDS through the production of reactive nitrogen species in microglial cells.	[Mangino, Giorgio; Famiglietti, Marylinda; Capone, Caterina; Percario, Zulema Antonia; Leone, Stefano; Persichini, Tiziana; Affabris, Elisabetta] Univ Rome Tre, Dept Sci, I-00146 Rome, Italy; [Mangino, Giorgio; Romeo, Giovanna] Sapienza Univ Rome, Dept Medicosurg Sci & Biotechnol, Latina, Italy; [Veroni, Caterina; Agresti, Cristina] Ist Super Sanita, Dept Cell Biol & Neurosci, Rome, Italy; [Fiorucci, Gianna; Romeo, Giovanna] CNR, Inst Mol Biol & Pathol, Rome, Italy; [Geyer, Matthias] Ctr Adv European Studies & Res, Grp Phys Biochem, Bonn, Germany	Italfarmaco; Roma Tre University; Sapienza University Rome; Istituto Superiore di Sanita (ISS); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Center of Advanced European Studies & Research (CAESAR)	Affabris, E (corresponding author), Univ Rome Tre, Dept Sci, I-00146 Rome, Italy.	elisabetta.affabris@uniroma3.it	Veroni, Caterina/AAA-5454-2021; Fiorucci, Gianna/B-3064-2013; Mangino, Giorgio/C-7310-2009; Veroni, Caterina/J-5795-2016; Romeo, Giovanna/AAB-2613-2019; romeo, giovanna/P-8348-2015	Veroni, Caterina/0000-0002-6043-1051; Mangino, Giorgio/0000-0002-8950-9780; Veroni, Caterina/0000-0002-6043-1051; Geyer, Matthias/0000-0002-7718-5002; AFFABRIS, Elisabetta/0000-0001-5142-8144; Agresti, Cristina/0000-0002-9225-7190; Leone, Stefano/0000-0001-6339-6397; romeo, giovanna/0000-0002-7638-1001; PERSICHINI, TIZIANA/0000-0001-8291-6706	Italian National Research Program on AIDS of the Istituto Superiore di Sanita, Rome, Italy [N.40.G1]; PRIN-MIUR (Progetti Rilevante Interesse Nazionale-Ministero dell'Universita e della Ricerca Scientifica), Italy [20072J9RWM_002]	Italian National Research Program on AIDS of the Istituto Superiore di Sanita, Rome, Italy; PRIN-MIUR (Progetti Rilevante Interesse Nazionale-Ministero dell'Universita e della Ricerca Scientifica), Italy(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by grants from the Italian National Research Program on AIDS of the Istituto Superiore di Sanita (Affabris N.40.G1), Rome, Italy, and from PRIN-MIUR (Progetti Rilevante Interesse Nazionale-Ministero dell'Universita e della Ricerca Scientifica) 2007 (Affabris prot. 20072J9RWM_002), Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharjee S, 2014, BRAIN BEHAV IMMUN, V40, P74, DOI 10.1016/j.bbi.2014.02.016; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Baur AS, 2011, TRENDS MICROBIOL, V19, P435, DOI 10.1016/j.tim.2011.06.002; Beyer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045466; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Breuer S, 2006, BIOCHEMISTRY-US, V45, P2339, DOI 10.1021/bi052052c; Brigino E, 1997, P NATL ACAD SCI USA, V94, P3178, DOI 10.1073/pnas.94.7.3178; BROWN K, 1993, P NATL ACAD SCI USA, V90, P2532, DOI 10.1073/pnas.90.6.2532; BUONASSISI V, 1962, P NATL ACAD SCI USA, V48, P1184, DOI 10.1073/pnas.48.7.1184; Burdo TH, 2013, IMMUNOL REV, V254, P102, DOI 10.1111/imr.12068; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; BURN JH, 1965, ANNU REV PHARMACOLOG, V5, P163, DOI 10.1146/annurev.pa.05.040165.001115; Colasanti M, 1997, J BIOL CHEM, V272, P7582, DOI 10.1074/jbc.272.12.7582; Colasanti M, 2000, BRAIN RES BULL, V52, P155, DOI 10.1016/S0361-9230(00)00262-8; COLASANTI M, 1995, NEUROSCI LETT, V200, P144, DOI 10.1016/0304-3940(95)12101-9; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Dube B, 2005, J PSYCHIATR NEUROSCI, V30, P237; Federico M, 2001, BLOOD, V98, P2752, DOI 10.1182/blood.V98.9.2752; Fujii Y, 1996, FEBS LETT, V393, P93, DOI 10.1016/0014-5793(96)00859-9; Gartner S, 2000, SCIENCE, V287, P602, DOI 10.1126/science.287.5453.602; GELBARD HA, 1994, J VIROL, V68, P4628, DOI 10.1128/JVI.68.7.4628-4635.1994; GENIS P, 1992, J EXP MED, V176, P1703, DOI 10.1084/jem.176.6.1703; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Griffin DE, 1997, J CLIN INVEST, V100, P2948, DOI 10.1172/JCI119847; Gulizia RJ, 1997, J VIROL, V71, P4161, DOI 10.1128/JVI.71.5.4161-4164.1997; Hanna Z, 1998, J VIROL, V72, P121, DOI 10.1128/JVI.72.1.121-132.1998; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Joska JA, 2011, AFR J PSYCHIATRY, V14, P17; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kirchhoff F, 2008, CELL MOL LIFE SCI, V65, P2621, DOI 10.1007/s00018-008-8094-2; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; KORBER BTM, 1994, J VIROL, V68, P7467, DOI 10.1128/JVI.68.11.7467-7481.1994; Lamers SL, 2012, INT REV IMMUNOL, V31, P432, DOI 10.3109/08830185.2012.737073; Lamers SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016659; LASSMANN H, 1991, REV NEUROL-FRANCE, V147, P763; LEONARD JM, 1988, SCIENCE, V242, P1665, DOI 10.1126/science.3201255; Mangino G, 2007, J VIROL, V81, P2777, DOI 10.1128/JVI.01640-06; Mangino G, 2012, VIRAL IMMUNOL, V25, P117, DOI 10.1089/vim.2011.0082; Mangino G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022982; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mayer B, 1997, TRENDS BIOCHEM SCI, V22, P477, DOI 10.1016/S0968-0004(97)01147-X; McIntyre KW, 2003, ARTHRITIS RHEUM-US, V48, P2652, DOI 10.1002/art.11131; Messmer D, 2002, AIDS RES HUM RETROV, V18, P1043, DOI 10.1089/08892220260235407; Olivetta E, 2003, J IMMUNOL, V170, P1716, DOI 10.4049/jimmunol.170.4.1716; PELUSO R, 1985, VIROLOGY, V147, P231, DOI 10.1016/0042-6822(85)90246-6; Percario Z, 2003, J LEUKOCYTE BIOL, V74, P821, DOI 10.1189/jlb.0403161; Percario Z, 2011, HIV HOST INTERACTION, P61; Percario ZA, 2015, CYTOKINE GROWTH F R, V26, P159, DOI 10.1016/j.cytogfr.2014.11.010; POWER C, 1994, J VIROL, V68, P4643, DOI 10.1128/JVI.68.7.4643-4649.1994; PRICE RW, 1988, SCIENCE, V239, P586, DOI 10.1126/science.3277272; PULLIAM L, 1991, J CLIN INVEST, V87, P503, DOI 10.1172/JCI115024; Qiao XG, 2006, NAT IMMUNOL, V7, P302, DOI 10.1038/ni1302; Quaranta MG, 2003, FASEB J, V17, P2025, DOI 10.1096/fj.03-0272com; Quaranta MG, 2002, EXP CELL RES, V275, P243, DOI 10.1006/excr.2002.5497; RACOOSIN EL, 1989, J EXP MED, V170, P1635, DOI 10.1084/jem.170.5.1635; Radja F, 2003, J VIROL, V77, P11745, DOI 10.1128/JVI.77.21.11745-11753.2003; RESNICK L, 1988, NEUROLOGY, V38, P9, DOI 10.1212/WNL.38.1.9; Rodriguez-Pascual F, 2000, J BIOL CHEM, V275, P26040, DOI 10.1074/jbc.M910460199; Rubartelli A, 2007, TRENDS IMMUNOL, V28, P429, DOI 10.1016/j.it.2007.08.004; Saha RN, 2006, ANTIOXID REDOX SIGN, V8, P929, DOI 10.1089/ars.2006.8.929; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Shi B, 1996, J CLIN INVEST, V98, P1979, DOI 10.1172/JCI119002; Stansley B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-115; STUEHR DJ, 1987, J IMMUNOL, V139, P518; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Swingler S, 1999, NAT MED, V5, P997, DOI 10.1038/12433; Swingler S, 2003, NATURE, V424, P213, DOI 10.1038/nature01749; Tsikas D, 2005, FREE RADICAL RES, V39, P797, DOI 10.1080/10715760500053651; van Marle G, 2004, VIROLOGY, V329, P302, DOI 10.1016/j.virol.2004.08.024; Veroni C, 2010, MOL CELL NEUROSCI, V45, P234, DOI 10.1016/j.mcn.2010.06.014; WERNER T, 1991, AIDS, V5, P1301, DOI 10.1097/00002030-199111000-00003; WESSELINGH SL, 1993, ANN NEUROL, V33, P576, DOI 10.1002/ana.410330604; Williams KC, 2001, J EXP MED, V193, P905, DOI 10.1084/jem.193.8.905; Woods SP, 2009, NEUROPSYCHOL REV, V19, P152, DOI 10.1007/s11065-009-9102-5; XIE QW, 1994, J BIOL CHEM, V269, P4705; Yoshioka M, 1995, ADV NEUROIMMUNOL, V5, P335, DOI 10.1016/0960-5428(95)00012-Q; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com	80	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0130189	10.1371/journal.pone.0130189	http://dx.doi.org/10.1371/journal.pone.0130189			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26066624	Green Published, Green Submitted, gold			2022-12-26	WOS:000356100900103
J	Ssemakalu, CC; Ubomba-Jaswa, E; Motaung, KS; Pillay, M				Ssemakalu, Cornelius Cano; Ubomba-Jaswa, Eunice; Motaung, Keolebogile Shirley; Pillay, Michael			The Effect of Solar Irradiated Vibrio cholerae on the Secretion of Pro-Inflammatory Cytokines and Chemokines by the JAWS II Dendritic Cell Line In Vitro	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; DISINFECTION SODIS; DRINKING-WATER; ESCHERICHIA-COLI; MACROPHAGES; INACTIVATION; ALPHA; MIP-1-ALPHA; NEUTROPHIL; POLIOVIRUS	The use of solar irradiation to sterilize water prior to its consumption has resulted in the reduction of water related illnesses in waterborne disease endemic communities worldwide. Currently, research on solar water disinfection (SODIS) has been directed towards understanding the underlying mechanisms through which solar irradiation inactivates the culturability of microorganisms in water, enhancement of the disinfection process, and the health impact of SODIS water consumption. However, the immunological consequences of SODIS water consumption have not been explored. In this study, we investigated the effect that solar irradiated V. cholerae may have had on the secretion of cytokines and chemokines by the JAWS II dendritic cell line in vitro. The JAWS II dendritic cell line was stimulated with the different strains of V. cholerae that had been: (i) prepared in PBS, (ii) inactivated through a combination of heat and chemical, (iii) solar irradiated, and (iv) non-solar irradiated, in bottled water. As controls, LPS (1 mu g/ml) and CTB (1 mu g/ml) were used as stimulants. After 48 hours of stimulation the tissue culture media from each treatment was qualitatively and quantitatively analysed for the presence of IL-1 alpha, IL-1 beta, IL-6, IL-7, IL-10, IL-12p40, IL-12p70, IL-15, MIP-1 alpha, MIP-1 beta, MIP-2, RANTES, TNF-alpha, IL-23 and IL-27. Results showed that solar irradiated cultures of V. cholerae induced dendritic cells to secrete significant (p<0.05) levels of pro-inflammatory cytokines in comparison to the unstimulated dendritic cells. Furthermore, the amount of pro-inflammatory cytokines secreted by the dendritic cells in response to solar irradiated cultures of V. cholerae was not as high as observed in treatments involving non-solar irradiated cultures of V. cholerae or LPS. Our results suggest that solar irradiated microorganisms are capable of inducing the secretion of pro-inflammatory cytokines and chemokines. This novel finding is key towards understanding the possible immunological consequences of consuming SODIS treated water.	[Ssemakalu, Cornelius Cano; Pillay, Michael] Vaal Univ Technol, Fac Appl & Comp Sci, Dept Biotechnol, ZA-1900 Gauteng, South Africa; [Ubomba-Jaswa, Eunice] CSIR, Nat Resources & Environm, ZA-0001 Pretoria, Gauteng, South Africa; [Motaung, Keolebogile Shirley] Tshwane Univ Technol, Dept Biomed Sci, ZA-0001 Pretoria, Gauteng, South Africa	Vaal University of Technology (VUT); Council for Scientific & Industrial Research (CSIR) - South Africa; Tshwane University of Technology	Pillay, M (corresponding author), Vaal Univ Technol, Fac Appl & Comp Sci, Dept Biotechnol, Vanderbijlpk, ZA-1900 Gauteng, South Africa.	mpillay@vut.ac.za	Motaung, Shirley/AAD-1428-2019	Motaung, Keolebogile Shirley Caroline Mamotswere/0000-0001-8503-9868; Ssemakalu, Cornelius/0000-0003-3895-2018	Vaal University of Technology	Vaal University of Technology	The Vaal University of Technology provided the funds to carry out this work through the Hubs and Spoke Scholarship programme. Other than that, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Saez L, 2006, APPL ENVIRON MICROB, V72, P5806, DOI 10.1128/AEM.00597-06; BAILEY CA, 1983, APPL ENVIRON MICROB, V46, P44, DOI 10.1128/AEM.46.1.44-49.1983; Bandyopadhaya A, 2007, FEBS J, V274, P4631, DOI 10.1111/j.1742-4658.2007.05991.x; Berney M, 2006, MICROBIOL-SGM, V152, P1719, DOI 10.1099/mic.0.28617-0; Bolger CE, 2005, J LEUKOCYTE BIOL, V77, P893, DOI 10.1189/jlb.1104637; Bondeson J, 1997, GEN PHARMACOL-VASC S, V29, P127, DOI 10.1016/S0306-3623(96)00419-3; Bosshard F, 2010, ENVIRON MICROBIOL, V12, P2931, DOI 10.1111/j.1462-2920.2010.02268.x; Bosshard F, 2010, MICROBIOL-SGM, V156, P2006, DOI 10.1099/mic.0.038471-0; Burkart V, 2002, J IMMUNOL, V168, P1730, DOI 10.4049/jimmunol.168.4.1730; Chatterjee D, 2013, J BIOL CHEM, V288, P4299, DOI 10.1074/jbc.M112.408302; Connolly NC, 2005, AIDS REV, V7, P168; Conroy RM, 2001, ARCH DIS CHILD, V85, P293, DOI 10.1136/adc.85.4.293; CRYZ SJ, 1982, INFECT IMMUN, V38, P21, DOI 10.1128/IAI.38.1.21-26.1982; CRYZ SJ, 1982, DEV BIOLOGICALS, V53, P67; Daudelin JF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/126189; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Dixon GLJ, 2001, INFECT IMMUN, V69, P4351, DOI 10.1128/IAI.69.7.4351-4357.2001; du Preez M, 2010, ENVIRON SCI TECHNOL, V44, P8744, DOI 10.1021/es103328j; Egger M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017278; Elasri MO, 1999, APPL ENVIRON MICROB, V65, P2025; Ertl H, 2003, DNA VACCINES; Heaselgrave W, 2006, LETT APPL MICROBIOL, V43, P125, DOI 10.1111/j.1472-765X.2006.01940.x; Heaselgrave W, 2012, J WATER HEALTH, V10, P531, DOI 10.2166/wh.2012.128; Hsieh CH, 2008, J IMMUNOL, V181, P2806, DOI 10.4049/jimmunol.181.4.2806; Jiang XZ, 2008, INFECT IMMUN, V76, P2392, DOI 10.1128/IAI.01584-07; Kernacki KA, 2000, J IMMUNOL, V164, P1037, DOI 10.4049/jimmunol.164.2.1037; Lavelle EC, 2003, J IMMUNOL, V171, P2384, DOI 10.4049/jimmunol.171.5.2384; Lore K, 1998, J IMMUNOL METHODS, V214, P97, DOI 10.1016/S0022-1759(98)00040-4; Mackay V. L., 1997, IMMORTALIZED DENDRIT; McGuigan KG, 2012, J HAZARD MATER, V235, P29, DOI 10.1016/j.jhazmat.2012.07.053; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Merrell DS, 2000, INFECT IMMUN, V68, P6691, DOI 10.1128/IAI.68.12.6691-6696.2000; Muriel M., 2003, FUNDAMENTAL IMMUNOLO, P840; Nath A, 1999, J BIOL CHEM, V274, P17098, DOI 10.1074/jbc.274.24.17098; Navntoft C, 2008, J PHOTOCH PHOTOBIO B, V93, P155, DOI 10.1016/j.jphotobiol.2008.08.002; Ohtsuka Y, 2001, GUT, V49, P526, DOI 10.1136/gut.49.4.526; Pastor CM, 2003, LAB INVEST, V83, P471, DOI 10.1097/01.LAB.0000063928.91314.9F; POLI G, 1992, PATHOBIOLOGY, V60, P246, DOI 10.1159/000163729; Qiu XY, 2004, APPL ENVIRON MICROB, V70, P6435, DOI 10.1128/AEM.70.11.6435-6443.2004; Queen J, 2012, INFECT IMMUN, V80, P2905, DOI 10.1128/IAI.00356-12; Rosellini N., 2010, MILLENNIUM DEV GOALS, P63; Rowan NJ, 2004, TRENDS FOOD SCI TECH, V15, P462, DOI 10.1016/j.tifs.2004.02.009; Rufener S, 2010, J HEALTH POPUL NUTR, V28, P34, DOI 10.3329/jhpn.v28i1.4521; Rui HP, 2010, P NATL ACAD SCI USA, V107, P4359, DOI 10.1073/pnas.0915164107; Satchell KJF, 2003, MICROBES INFECT, V5, P1241, DOI 10.1016/j.micinf.2003.08.007; Schytte Blix IJ, 1999, J PERIODONTAL RES, V34, P30; Sieve AN, 2010, EUR J IMMUNOL, V40, P2236, DOI 10.1002/eji.200939759; Ssemakalu CC, 2011, EVALUATION EFFECTS S; Ssemakalu CC, 2013, S AFR J SCI, V109, DOI 10.1590/sajs.2013/20130061; Ssemakalu CC, 2014, J WATER HEALTH, V12, P393, DOI 10.2166/wh.2014.158; Tanabe SI, 2008, J PERIODONTAL RES, V43, P372, DOI 10.1111/j.1600-0765.2007.01049.x; Terpos E, 2003, BRIT J HAEMATOL, V123, P106, DOI 10.1046/j.1365-2141.2003.04561.x; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Turner DA, 2010, J CELL SCI, V123, P2834, DOI 10.1242/jcs.069641; Ubomba-Jaswa E, 2010, J CHEM TECHNOL BIOT, V85, P1028, DOI 10.1002/jctb.2398; WHO, 1996, GUID DRINK WAT QUAL; WHO, 2014, WEEKLY EPIDEMIOLOGIC; WHO/UNICEF(WHO/UnitedNationsInternationalChildren's Fund), 2014, PROGR DRINK WAT SAN; Zychlinsky A, 1997, TRENDS MICROBIOL, V5, P201, DOI 10.1016/S0966-842X(97)01044-5	59	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0130190	10.1371/journal.pone.0130190	http://dx.doi.org/10.1371/journal.pone.0130190			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26066787	gold, Green Published			2022-12-26	WOS:000356100900104
J	Sun, JY; Li, LT; Yuan, S; Zhou, YQ				Sun, Jiuyi; Li, Lintao; Yuan, Shuai; Zhou, Yiqin			Analysis of Early Postoperative Pain in the First and Second Knee in Staged Bilateral Total Knee Arthroplasty: A Retrospective Controlled Study	PLOS ONE			English	Article							CENTRAL SENSITIZATION; REPLACEMENT; SAFETY; METAANALYSIS; TOLERANCE; MORTALITY; EFFICACY; EMBOLISM; SURGERY	Objective A retrospective analysis of early postoperative pain in the first and second knee in staged bilateral total knee arthroplasty (TKA) to provide a clinical evidence for the change of analgesic strategy. Methods From January 2009 to January 2013, 87 cases which meet the inclusion criterion were retrospectively reviewed. In stage TKA, the postoperative pain in the first and second knee at 24h, 48h, 72h after operation were compared using the visual analogue scale (VAS) score in the rest and maximum knee flexion position. The difference in pain scores (Delta VAS) was also compared between the second and first knee at different time intervals (less than 6 months, 6-12 months, more than 12 months). Results The VAS scores in the second knee were significantly higher than those in the first knee at 24h, 48h after surgery, but with no difference at 72h. The Delta VAS in the group of less than 6 months was significantly higher than of those more than 6 months, and there was no difference in Delta VAS between group of 6-12 months and group of more than 12 months. Conclusions Patient receiving staged bilateral TKA experiences greater postoperative pain within 48h after operation in the second knee than in the first knee, which can provide a clinical evidence to enhance the analgesic strategy in the second operation of the staged bilateral TKA. And for the management of postoperative pain in staged bilateral TKA, it's better to recommend that the interval between two operations should be more than 6 months, which may reduce the postoperative pain in the second knee, improve patient satisfaction, and speed up patient's rehabilitation process.	[Sun, Jiuyi] PLA 455 Hosp, Dept Orthoped, Shanghai, Peoples R China; [Li, Lintao; Yuan, Shuai; Zhou, Yiqin] Second Mil Med Univ, Dept Orthoped, Affiliated Hosp 2, Shanghai, Peoples R China	Naval Medical University	Zhou, YQ (corresponding author), Second Mil Med Univ, Dept Orthoped, Affiliated Hosp 2, Shanghai, Peoples R China.	drzhouyq@gmail.com						Arendt-Nielsen L, 2010, PAIN, V149, P573, DOI 10.1016/j.pain.2010.04.003; Barrett J, 2006, J BONE JOINT SURG AM, V88A, P2146, DOI 10.2106/JBJS.E.01323; Carli F, 2010, BRIT J SURG, V97, P1187, DOI 10.1002/bjs.7102; Cheng Long, 2009, CHIN J JOINT SURG, V3, P30; Cohen RG, 1997, J ARTHROPLASTY, V12, P497, DOI 10.1016/S0883-5403(97)90171-6; Collett BJ, 1998, BRIT J ANAESTH, V81, P58, DOI 10.1093/bja/81.1.58; Cross 3rd WW, 2006, CLIN ORTHOP RELAT R, V446, P34, DOI [10.1097/01.blo.0000214436.49527.5e, DOI 10.1097/01.BLO.0000214436.49527.5E]; Dalury DF, 2009, J BONE JOINT SURG BR, V91B, P357, DOI 10.1302/0301-620X.91B3.21771; Fei Zhang, 2013, CHIN J JOINT SURG, V7, P33; Fu PeiLiang, 2008, Chinese Journal of Orthopaedics, V28, P541; GOLDSTEIN A, 1969, J PHARMACOL EXP THER, V169, P175; Hu J, 2011, ARCH ORTHOP TRAUM SU, V131, P1291, DOI 10.1007/s00402-011-1287-4; Husted H, 2011, J BONE JOINT SURG BR, V93B, P351, DOI 10.1302/0301-620X.93B3.25296; JANKIEWICZ JJ, 1994, CLIN ORTHOP RELAT R, P94; Jenny JY, 2013, ORTHOP TRAUMATOL-SUR, V99, P191, DOI 10.1016/j.otsr.2012.12.015; Kim MH, 2014, PAIN, V155, P22, DOI 10.1016/j.pain.2013.08.027; Kim S, 2011, J ARTHROPLASTY, V26, P1198, DOI 10.1016/j.arth.2011.01.004; Kim YH, 2001, J ARTHROPLASTY, V16, P730, DOI 10.1054/arth.2001.23723; Leitch KK, 2005, CAN J SURG, V48, P273; Leonard L, 2003, J ARTHROPLASTY, V18, P972, DOI 10.1016/S0883-5403(03)00282-1; Mangaleshkar SR, 2001, KNEE, V8, P207, DOI 10.1016/S0968-0160(01)00085-0; Memtsoudis SG, 2013, CLIN ORTHOP RELAT R, V471, P17, DOI [10.1007/s11999-012-2608-9, 10.1007/s11999-012-2682-z]; MORREY BF, 1987, J BONE JOINT SURG AM, V69A, P484, DOI 10.2106/00004623-198769040-00002; Oakes DA, 2004, CLIN ORTHOP RELAT R, P87, DOI 10.1097/01.blo.0000147133.75432.86; Odum SM, 2013, J BONE JOINT SURG AM, V95A, P1441, DOI 10.2106/JBJS.L.00373; Patil N, 2008, ORTHOPEDICS, V31, P780, DOI 10.3928/01477447-20080801-23; Qutob M, 2013, J ARTHROPLASTY, V28, P1148, DOI 10.1016/j.arth.2013.01.022; Restrepo C, 2007, J BONE JOINT SURG AM, V89A, P1220, DOI 10.2106/JBJS.F.01353; Ritter M, 1997, CLIN ORTHOP RELAT R, P99; SOUDRY M, 1985, J BONE JOINT SURG AM, V67A, P573, DOI 10.2106/00004623-198567040-00011; Suokas AK, 2012, OSTEOARTHR CARTILAGE, V20, P1075, DOI 10.1016/j.joca.2012.06.009; Suzuki R, 2005, NEUROSIGNALS, V14, P175, DOI 10.1159/000087656; Vulcano E, 2013, J KNEE SURG, V26, P273, DOI 10.1055/s-0032-1329721; Wieseler-Frank J, 2004, NEUROCHEM INT, V45, P389, DOI 10.1016/j.neuint.2003.09.009; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Wortzel HS, 2009, J NEUROPSYCH CLIN N, V21, P463, DOI 10.1176/appi.neuropsych.21.4.463; YAKSH TL, 1983, J PHARMACOL EXP THER, V226, P303	38	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129973	10.1371/journal.pone.0129973	http://dx.doi.org/10.1371/journal.pone.0129973			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068371	Green Published, gold, Green Submitted			2022-12-26	WOS:000356100900088
J	Ben Sadok, I; Martinez, S; Moutier, N; Garcia, G; Leon, L; Belaj, A; De La Rosa, R; Khadari, B; Costes, E				Ben Sadok, Ines; Martinez, Sebastien; Moutier, Nathalie; Garcia, Gilbert; Leon, Lorenzo; Belaj, Angelina; De La Rosa, Raul; Khadari, Bouchaib; Costes, Evelyne			Plasticity in Vegetative Growth over Contrasted Growing Sites of an F1 Olive Tree Progeny during Its Juvenile Phase	PLOS ONE			English	Article							COMPLEX ARCHITECTURAL TRAITS; X ENVIRONMENT INTERACTIONS; HYDRAULIC ARCHITECTURE; GENETIC ARCHITECTURE; RECURRENT SELECTION; PLANT ARCHITECTURE; GENOTYPE; DENSITY; STABILITY; L.	Climatic changes impact fruit tree growth and severely limit their production. Investigating the tree ability to cope with environmental variations is thus necessary to adapt breeding and management strategies in order to ensure sustainable production. In this study, we assessed the genetic parameters and genotype by environment interaction (GxE) during the early tree growth. One hundred and twenty olive seedlings derived from the cross 'Oliviere' x 'Arbequina' were examined across two sites with contrasted environments, accounting for ontogenetic trends over three years. Models including the year of growth, branching order, environment, genotype effects, and their interactions were built with variance function and covariance structure of residuals when necessary. After selection of a model, broad sense heritabilities were estimated. Despite strong environmental effect on most traits, no GxE was found. Moreover, the internal structure of traits co-variation was similar in both sites. Ontogenetic growth variation, related to (i) the overall tree form and (ii) the growth and branching habit at growth unit scale, was not altered by the environment. Finally, a moderate to strong genetic control was identified for traits at the whole tree scale and at internode scale. Among all studied traits, the maximal internode length exhibited the highest heritability (H-2 = 0.74). Considering the determinant role of this trait in tree architecture and its stability across environments, this study consolidates its relevance for breeding.	[Ben Sadok, Ines; Martinez, Sebastien; Moutier, Nathalie; Garcia, Gilbert; Khadari, Bouchaib; Costes, Evelyne] INRA, UMR Ameliorat Genet & Adaptat Plantes Mediterrane, F-34060 Montpellier, France; [Ben Sadok, Ines] Montpellier SupAgro, UMR Ameliorat Genet & Adaptat Plantes Mediterrane, Montpellier, France; [Ben Sadok, Ines] Inst Olivier Sfax, Sfax, Tunisia; [Ben Sadok, Ines] Univ Sci Sfax, Sfax, Tunisia; [Leon, Lorenzo; Belaj, Angelina; De La Rosa, Raul] Ctr Alameda Obispo, Inst Invest & Formac Agr & Pesquera, Cordoba, Spain	INRAE; Institut Agro; Montpellier SupAgro; Institut de l'Olivier; Universite de Sfax; Universite de Sfax	Costes, E (corresponding author), INRA, UMR Ameliorat Genet & Adaptat Plantes Mediterrane, Campus Cirad, F-34060 Montpellier, France.	costes@supagro.inra.fr	Belaj, Angjelina/A-8476-2016; De la Rosa, Raul/B-5755-2008; Khadari, Bouchaib/K-7965-2015; Ben sadok, Inès/M-4647-2015; De la Rosa, Raul/AIB-1463-2022; Angjelina, Belaj/AAN-7305-2021; Leon, Lorenzo/N-7355-2013	De la Rosa, Raul/0000-0002-0752-9607; De la Rosa, Raul/0000-0002-0752-9607; Angjelina, Belaj/0000-0002-4526-0979; Leon, Lorenzo/0000-0002-5664-3393	Department of Genetics and Plant Breeding of INRA Montpellier and FranceAgriMer SIVAL [2010-1919]; Erasmus-Averroes; French University Agency	Department of Genetics and Plant Breeding of INRA Montpellier and FranceAgriMer SIVAL; Erasmus-Averroes; French University Agency	This work was partly supported by the Department of Genetics and Plant Breeding of INRA Montpellier and FranceAgriMer SIVAL no 2010-1919 project 'RegulOlive'. The work was carried out in the frame of a Collaboration Agreement between IFAPA (Spain) and INRA (France) for cooperation on olive breeding research. Ines Ben Sadok, PhD, was supported by fellowships from Erasmus-Averroes and French University Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arslanoglu F, 2010, BULG J AGRIC SCI, V16, P181; Atkinson D, 1996, TRENDS PLANT SCI, V1, P119, DOI 10.1016/S1360-1385(96)90006-0; Baltunis BS, 2010, SILVAE GENET, V59, P113, DOI 10.1515/sg-2010-0014; Barthelemy D., 1997, Modelisation et simulation de l'architecture des vegetaux., P89; Barthelemy D, 2007, ANN BOT-LONDON, V99, P375, DOI 10.1093/aob/mcl260; Bellini E., 2008, Advances in Horticultural Science, V22, P73; Ben Sadok I, 2013, TREE GENET GENOMES, V9, P205, DOI 10.1007/s11295-012-0548-x; Besnard G, 1998, ORIGINS AGR CROP DOM, P224; Bidel LPR, 2000, J EXP BOT, V51, P755, DOI 10.1093/jexbot/51.345.755; Bjorkman O., 1979, PLANTS THEIR ATMOSPH; Bond BJ, 2000, TRENDS PLANT SCI, V5, P349, DOI 10.1016/S1360-1385(00)01691-5; Bouvet JM, 2005, ANN BOT-LONDON, V96, P811, DOI 10.1093/aob/mci231; BRETHARTE MS, 1991, PLANTA, V185, P462, DOI 10.1007/BF00202954; Chloupek O, 2005, THEOR APPL GENET, V111, P1316, DOI 10.1007/s00122-005-0060-x; Cochard H, 2000, J EXP BOT, V51, P1255, DOI 10.1093/jexbot/51.348.1255; Cochard H, 2005, TREE PHYSIOL, V25, P1545, DOI 10.1093/treephys/25.12.1545; Costes E., 2006, Horticultural Reviews, V32, P1; Costes E, 2003, ANN BOT-LONDON, V91, P91, DOI 10.1093/aob/mcg010; Curnel Y, 2003, SILVAE GENET, V52, P45; Da Silva D, 2014, ANN BOT-LONDON, V114, P739, DOI 10.1093/aob/mcu034; Demir I, 1991, J EGE U AGR FACULTY, V28, P7; El Bakkali A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061265; Escofier B., 2008, ANAL FACTORIELLES SI; Ferguson L., 2010, Advances in Horticultural Science, V24, P53; Finn CE, 2003, J AM SOC HORTIC SCI, V128, P196, DOI 10.21273/JASHS.128.2.0196; Fournier D, 1998, ACTA HORTIC, P557, DOI 10.17660/ActaHortic.1998.465.69; Gallais A., 1989, THEORIE SELECTION AM; Godin C, 1999, ANN BOT-LONDON, V84, P343, DOI 10.1006/anbo.1999.0923; Guitton B, 2012, J EXP BOT, V63, P131, DOI 10.1093/jxb/err261; Hackett W. P., 1985, Horticultural Reviews, V7, P109, DOI 10.1002/9781118060735.ch3; Halle F., 1978, TROPICAL TREES FORES, Vfirst; Hammami SBM, 2011, SCI HORTIC-AMSTERDAM, V129, P761, DOI 10.1016/j.scienta.2011.05.038; Holland JB, 2002, EUPHYTICA, V126, P265, DOI 10.1023/A:1016394208780; ISIK K, 1995, SILVAE GENET, V44, P116; Khush GS, 2001, NAT REV GENET, V2, P815, DOI 10.1038/35093585; King GJ, 2000, THEOR APPL GENET, V100, P1074, DOI 10.1007/s001220051389; KNAPP SJ, 1985, CROP SCI, V25, P192, DOI 10.2135/cropsci1985.0011183X002500010046x; Koo YB, 2007, SILVAE GENET, V56, P93, DOI 10.1515/sg-2007-0015; Laghari S., 2003, ASIAN J PLANT SCI, V2, P480, DOI [10.3923/ajps.2003.480.482, DOI 10.3923/AJPS.2003.480.482]; Laurens F., 2000, Fruits (Paris), V55, P141; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; LEROY T, 1993, EUPHYTICA, V67, P113, DOI 10.1007/BF00022734; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; Maguylo K, 2004, ACTA HORTIC, V732, P93; McCulloh KA, 2005, TREE PHYSIOL, V25, P257, DOI 10.1093/treephys/25.3.257; McKeand SE, 1997, THEOR APPL GENET, V94, P1015, DOI 10.1007/s001220050509; Moutier N, 2004, ACTA HORTIC, P689, DOI 10.17660/ActaHortic.2004.636.86; Muller B, 2011, J EXP BOT, V62, P1715, DOI 10.1093/jxb/erq438; Nassir AL, 2011, NOT BOT HORTI AGROBO, V39, P220; Niklas KJ, 1998, ANN BOT-LONDON, V81, P11, DOI 10.1006/anbo.1997.0505; Osorio LF, 2003, THEOR APPL GENET, V106, P735, DOI 10.1007/s00122-002-1124-9; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pigliucci M., 2004, PHENOTYPIC INTEGRATI; Pinheiro JC, 2000, MIXED EFFECTS MODELS, P206; R Core Team, 2020, R LANG ENV STAT COMP; Rallo P, 2008, AUST J AGR RES, V59, P933, DOI 10.1071/AR08013; Rebetzke GJ, 2012, FIELD CROP RES, V126, P87, DOI 10.1016/j.fcr.2011.09.022; Rennenberg H, 2006, PLANT BIOLOGY, V8, P556, DOI 10.1055/s-2006-924084; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Rosati A, 2013, SCI HORTIC-AMSTERDAM, V161, P24, DOI 10.1016/j.scienta.2013.06.044; Santalla M, 2001, CAN J PLANT SCI, V81, P601, DOI 10.4141/P00-114; Saporta G., 1990, PROBABILITE ANAL DON; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Segura V, 2007, GENOME, V50, P159, DOI 10.1139/G07-002; Segura V, 2006, TREE GENET GENOMES, V2, P140, DOI 10.1007/s11295-006-0037-1; SHARP RE, 1990, PLANT PHYSIOL, V93, P1337, DOI 10.1104/pp.93.4.1337; Shelbourne CJA, 1997, FRI B, P129; Spatz H.-C., 1995, Biomimetics, V3, P141; Thompson R, 2008, P R SOC B, V275, P679, DOI 10.1098/rspb.2007.1417; Tombesi A, 2002, ACTA HORTIC, P291, DOI 10.17660/ActaHortic.2002.586.56; Vasseur F, 2011, PLANT CELL ENVIRON, V34, P1563, DOI 10.1111/j.1365-3040.2011.02353.x; Wagner GP, 2011, NAT REV GENET, V12, P204, DOI 10.1038/nrg2949; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; WU HX, 2005, FOREST SCI, V5, P1; Wu RL, 2006, NAT REV GENET, V7, P229, DOI 10.1038/nrg1804; Wu RL, 2004, GENETICS, V166, P1541, DOI 10.1534/genetics.166.3.1541; Xu LK, 2003, TREE PHYSIOL, V23, P865, DOI 10.1093/treephys/23.13.865	77	5	5	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0127539	10.1371/journal.pone.0127539	http://dx.doi.org/10.1371/journal.pone.0127539			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26062090	gold, Green Published, Green Submitted			2022-12-26	WOS:000355979500041
J	Daryanto, S; Wang, LX; Jacinthe, PA				Daryanto, Stefani; Wang, Lixin; Jacinthe, Pierre-Andre			Global Synthesis of Drought Effects on Food Legume Production	PLOS ONE			English	Article							WATER RELATIONS; PHYSIOLOGICAL-RESPONSES; SOYBEAN CULTIVARS; NITROGEN-FIXATION; GRAIN LEGUMES; SEED YIELD; TOLERANCE; DEFICIT; STRESS; GROWTH	Food legume crops play important roles in conservation farming systems and contribute to food security in the developing world. However, in many regions of the world, their production has been adversely affected by drought. Although water scarcity is a severe abiotic constraint of legume crops productivity, it remains unclear how the effects of drought covary with legume species, soil texture, agroclimatic region, and drought timing. To address these uncertainties, we collected literature data between 1980 and 2014 that reported monoculture legume yield responses to drought under field conditions, and analyzed this data set using meta-analysis techniques. Our results showed that the amount of water reduction was positively related with yield reduction, but the extent of the impact varied with legume species and the phenological state during which drought occurred. Overall, lentil (Lens culinaris), groundnut (Arachis hypogaea), and pigeon pea (Cajanus cajan) were found to experience lower drought-induced yield reduction compared to legumes such as cowpea (Vigna unguiculata) and green gram (Vigna radiate). Yield reduction was generally greater when legumes experienced drought during their reproductive stage compared to during their vegetative stage. Legumes grown in soil with medium texture also exhibited greater yield reduction compared to those planted on soil of either coarse or fine texture. In contrast, regions and their associated climatic factors did not significantly affect legume yield reduction. In the face of changing climate, our study provides useful information for agricultural planning and research directions for development of drought-resistant legume species to improve adaptation and resilience of agricultural systems in the drought-prone regions of the world.	[Daryanto, Stefani; Wang, Lixin; Jacinthe, Pierre-Andre] IUPUI, Dept Earth Sci, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Wang, LX (corresponding author), IUPUI, Dept Earth Sci, Indianapolis, IN 46202 USA.	lxwang@iupui.edu	Wang, Lixin/A-2572-2008	Wang, Lixin/0000-0003-0968-1247; Daryanto, Stefani/0000-0001-6264-9401	Schlumberger Foundation Faculty for the Future fellowship; U.S. Department of Agriculture [2014-51130-22492]; Indiana University Purdue University Indianapolis (IUPUI) Open Access Publishing Fund	Schlumberger Foundation Faculty for the Future fellowship(Schlumberger); U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Indiana University Purdue University Indianapolis (IUPUI) Open Access Publishing Fund	This research is supported through Schlumberger Foundation Faculty for the Future fellowship to SD (http://www.facultyforthefuture.net), a U.S. Department of Agriculture grant (2014-51130-22492) to LW and PAJ (http://www.usda.gov), and Indiana University Purdue University Indianapolis (IUPUI) Open Access Publishing Fund (https://www.ulib.iupui.edu/digitalscholarship/oafund) to LW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate T., 2012, TROPICAL GRAIN LEGUM; Akibode S, 2011, GLOBAL REGIONAL TREN; ANTOLIN MC, 1995, PLANT SCI, V107, P159, DOI 10.1016/0168-9452(95)04108-7; Bagayoko M, 2000, PLANT SOIL, V218, P103, DOI 10.1023/A:1014957605852; BECK DP, 1991, AGRON J, V83, P334, DOI 10.2134/agronj1991.00021962008300020015x; Bruinsma J., 2009, RESOURCE OUTLOOK 205; Campos PS, 1999, PHOTOSYNTHETICA, V36, P79, DOI 10.1023/A:1007018804086; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Chaves MM, 2002, ANN BOT-LONDON, V89, P907, DOI 10.1093/aob/mcf105; DAVIES WJ, 1991, ANNU REV PLANT PHYS, V42, P55, DOI 10.1146/annurev.pp.42.060191.000415; de Carvalho MHC, 1998, ENVIRON EXP BOT, V40, P197, DOI 10.1016/S0098-8472(98)00037-9; DEVRIES JD, 1989, FIELD CROP RES, V21, P215, DOI 10.1016/0378-4290(89)90004-X; Dogan E, 2007, FIELD CROP RES, V103, P154, DOI 10.1016/j.fcr.2007.05.009; Duranti M, 2006, FITOTERAPIA, V77, P67, DOI 10.1016/j.fitote.2005.11.008; FAO, DEF CLASS COMM 4 PUL; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; Frechilla S, 2000, J PLANT PHYSIOL, V157, P609, DOI 10.1016/S0176-1617(00)80003-6; Frederick JR, 2001, CROP SCI, V41, P759, DOI 10.2135/cropsci2001.413759x; FREDERICK JR, 1991, FIELD CROP RES, V27, P71, DOI 10.1016/0378-4290(91)90023-O; Gowda C. L. L., 2009, INT C GRAIN LEG QUAL, P282; Karrou M, 2012, AGR WATER MANAGE, V107, P94, DOI 10.1016/j.agwat.2012.01.014; Li FR, 2000, AMBIO, V29, P477, DOI 10.1639/0044-7447(2000)029[0477:RHAAIS]2.0.CO;2; Lodeiro AR, 2000, PLANT SCI, V154, P31, DOI 10.1016/S0168-9452(99)00246-0; Mafakheri A, 2010, AUST J CROP SCI, V4, P580; Manavalan LP, 2009, PLANT CELL PHYSIOL, V50, P1260, DOI 10.1093/pcp/pcp082; Novak V, 2006, BIOLOGIA, V61, pS289, DOI 10.2478/s11756-006-0175-9; Nunes C, 2008, ENVIRON EXP BOT, V63, P289, DOI 10.1016/j.envexpbot.2007.11.004; Olesen JE, 2011, EUR J AGRON, V34, P96, DOI 10.1016/j.eja.2010.11.003; Oya T, 2004, PLANT PROD SCI, V7, P129, DOI 10.1626/pps.7.129; PANDEY RK, 1984, AGRON J, V76, P549, DOI 10.2134/agronj1984.00021962007600040009x; PETERSON PR, 1992, AGRON J, V84, P774, DOI 10.2134/agronj1992.00021962008400050003x; Pinheiro C, 2001, J EXP BOT, V52, P1063, DOI 10.1093/jexbot/52.358.1063; Postel SL, 2000, ECOL APPL, V10, P941, DOI 10.1890/1051-0761(2000)010[0941:EAEOWS]2.0.CO;2; Price GD, 2014, NATURE, V513, P497, DOI 10.1038/nature13749; REDDY CR, 1993, AGR WATER MANAGE, V23, P1, DOI 10.1016/0378-3774(93)90016-4; Rockstrom J, 2009, WATER RESOUR RES, V45, DOI 10.1029/2007WR006767; Rosenberg MS, 2000, METAWIN STAT SOFTWAR; Sainju UM, 2005, AGRON J, V97, P1279, DOI 10.2134/agronj2004.0213; Scoones I., 1996, HAZARDS OPPORTUNITIE; Serraj R, 1999, J EXP BOT, V50, P143, DOI 10.1093/jexbot/50.331.143; SHEIN EV, 1995, PLANT SOIL, V171, P351, DOI 10.1007/BF00010291; Sinclair TR, 2004, TRENDS PLANT SCI, V9, P70, DOI 10.1016/j.tplants.2003.12.008; SINCLAIR TR, 1986, AUST J PLANT PHYSIOL, V13, P329, DOI 10.1071/PP9860329; Sinha S. K., 1977, FOOD LEGUMES DISTRIB; Smil V, 1999, GLOBAL BIOGEOCHEM CY, V13, P647, DOI 10.1029/1999GB900015; SMITH DL, 1988, CAN J PLANT SCI, V68, P957, DOI 10.4141/cjps88-116; SPONCHIADO BN, 1989, EXP AGR, V25, P249, DOI 10.1017/S0014479700016756; Sprent J. I., 2008, V7, P1; Streeter JG, 2003, PLANT CELL ENVIRON, V26, P1199, DOI 10.1046/j.1365-3040.2003.01041.x; SUBBARAO GV, 1995, CRIT REV PLANT SCI, V14, P469, DOI 10.1080/713608125; Subbarao GV, 2000, J PLANT PHYSIOL, V157, P651, DOI 10.1016/S0176-1617(00)80008-5; Sultani MI, 2007, INT J ENVIRON SCI TE, V4, P109, DOI 10.1007/BF03325968; Tilahun Amede, 2003, Sinet, Ethiopian Journal of Science, V26, P37; Travlos I. S., 2006, Journal of Agronomy, V5, P609; Tuner NC, 1986, ADV AGRON, V39, P1; Vadez V., 2008, Journal of Food Legumes, V21, P77; Wang L, 2012, HYDROL EARTH SYST SC, V16, P2585, DOI 10.5194/hess-16-2585-2012	57	109	114	4	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0127401	10.1371/journal.pone.0127401	http://dx.doi.org/10.1371/journal.pone.0127401			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061704	Green Submitted, Green Published, gold			2022-12-26	WOS:000355979500038
J	van Leeuwen, J; Berg, DK; Pfeffer, PL				van Leeuwen, Jessica; Berg, Debra K.; Pfeffer, Peter L.			Morphological and Gene Expression Changes in Cattle Embryos from Hatched Blastocyst to Early Gastrulation Stages after Transfer of In Vitro Produced Embryos	PLOS ONE			English	Article							ANTERIOR VISCERAL ENDODERM; POSTHATCHING DEVELOPMENT; TROPHOBLAST DEVELOPMENT; PRIMITIVE STREAK; BEEF HEIFERS; MOUSE; EOMESODERMIN; CELLS; BRACHYURY; PATTERN	A detailed morphological staging system for cattle embryos at stages following blastocyst hatching and preceding gastrulation is presented here together with spatiotemporal mapping of gene expression for BMP4, BRACHYURY, CERBERUS1 (CER1), CRIPTO, EOMESODERMIN, FURIN and NODAL. Five stages are defined based on distinct developmental events. The first of these is the differentiation of the visceral hypoblast underlying the epiblast, from the parietal hypoblast underlying the mural trophoblast. The second concerns the formation of an asymmetrically positioned, morphologically recognisable region within the visceral hypoblast that is marked by the presence of CER1 and absence of BMP4 expression. We have termed this the anterior visceral hypoblast or AVH. Intra-epiblast cavity formation and the disappearance of the polar trophoblast overlying the epiblast (Rauber's layer) have been mapped in relation to AVH formation. The third chronological event involves the transition of the epiblast into the embryonic ectoderm with concomitant onset of posterior NODAL, EOMES and BRACHYURY expression. Lastly, gastrulation commences as the posterior medial embryonic ectoderm layer thickens to form the primitive streak and cells ingress between the embryonic ectoderm and hypoblast. At this stage a novel domain of CER1 expression is seen whereas the AVH disappears. Comparison with the mouse reveals that while gene expression patterns at the onset of gastrulation are well conserved, asymmetry establishment, which relies on extraembryonic tissues such as the hypoblast and trophoblast, has diverged in terms of both gene expression and morphology.	[van Leeuwen, Jessica; Berg, Debra K.] AgRes Ruakura, Anim Prod Sect, Hamilton, New Zealand; [van Leeuwen, Jessica] Univ Waikato, Dept Biol Sci, Hamilton, New Zealand; [Pfeffer, Peter L.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand	AgResearch - New Zealand; University of Waikato; Victoria University Wellington	Pfeffer, PL (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.	peter.pfeffer@vuw.ac.nz	Pfeffer, Peter/J-7675-2017; Berg, Debbie/GYJ-3287-2022	Pfeffer, Peter/0000-0001-5933-9728; Berg, Debbie/0000-0002-3287-0356	AgResearch Ruakura	AgResearch Ruakura	AgResearch Ruakura provided support in the form of salaries for authors JvL, DKB and PLP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; AYALON N, 1978, J REPROD FERTIL, V54, P483, DOI 10.1530/jrf.0.0540483; Beck S, 2002, NAT CELL BIOL, V4, P981, DOI 10.1038/ncb890; Belo JA, 1997, MECH DEVELOP, V68, P45, DOI 10.1016/S0925-4773(97)00125-1; Berg DK, 2010, THERIOGENOLOGY, V73, P250, DOI 10.1016/j.theriogenology.2009.09.005; Blomberg L, 2008, REPRODUCTION, V135, P181, DOI 10.1530/REP-07-0355; BOYD H, 1969, BRIT VET J, V125, P87, DOI 10.1016/S0007-1935(17)49112-3; Brennan J, 2001, NATURE, V411, P965, DOI 10.1038/35082103; Chu JH, 2010, DEV BIOL, V342, P63, DOI 10.1016/j.ydbio.2010.03.009; COPP AJ, 1988, PLACENTA, V9, P643, DOI 10.1016/0143-4004(88)90008-2; Degrelle SA, 2005, DEV BIOL, V288, P448, DOI 10.1016/j.ydbio.2005.09.043; Ding JX, 1998, NATURE, V395, P702, DOI 10.1038/27215; Diskin MG, 2008, REPROD DOMEST ANIM, V43, P260, DOI 10.1111/j.1439-0531.2008.01171.x; Diskin MG, 2012, REPROD FERT DEVELOP, V24, P244, DOI 10.1071/RD11914; DISKIN MG, 1980, J REPROD FERTIL, V59, P463, DOI 10.1530/jrf.0.0590463; Donnison M, 2015, DEV BIOL, V397, P77, DOI 10.1016/j.ydbio.2014.10.011; Dunne LD, 2000, ANIM REPROD SCI, V58, P39, DOI 10.1016/S0378-4320(99)00088-3; Guillomot M, 2004, REPRODUCTION, V127, P491, DOI 10.1530/rep.1.00057; Hassoun R, 2009, DIFFERENTIATION, V78, P301, DOI 10.1016/j.diff.2009.07.006; Hopf C, 2011, DEV GENES EVOL, V221, P209, DOI 10.1007/s00427-011-0373-5; Hue I, 2001, DEV GENES EVOL, V211, P157, DOI 10.1007/s004270100138; Idkowiak J, 2004, DEV GENES EVOL, V214, P591, DOI 10.1007/s00427-004-0436-y; Idkowiak J, 2004, SEMIN CELL DEV BIOL, V15, P607, DOI 10.1016/j.semcdb.2004.04.007; Kaufman MH, 1995, ATLAS MOUSE DEV; Kinder SJ, 2001, DEVELOPMENT, V128, P3623; Kumar A, 2015, DEV BIOL, V400, P1, DOI 10.1016/j.ydbio.2014.12.016; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maddox-Hyttel P, 2003, REPRODUCTION, V125, P607, DOI 10.1530/rep.0.1250607; Mesnard D, 2006, DEVELOPMENT, V133, P2497, DOI 10.1242/dev.02413; Nagy A., 2003, MANIPULATING MOUSE E; Nowotschin S, 2013, GENE DEV, V27, P997, DOI 10.1101/gad.215152.113; Oestrup O, 2009, REPROD DOMEST ANIM, V44, P39, DOI 10.1111/j.1439-0531.2009.01482.x; Pearton DJ, 2011, DEV BIOL, V360, P343, DOI 10.1016/j.ydbio.2011.10.007; Perea-Gomez A, 2002, DEV CELL, V3, P745, DOI 10.1016/S1534-5807(02)00321-0; Pfeffer PL, 2014, REPROD DOMESTIC RUMI, VVIII, P89; Pfister S, 2007, GENE EXPR PATTERNS, V7, P558, DOI 10.1016/j.modgep.2007.01.005; Rivera-Perez JA, 2005, DEV BIOL, V288, P363, DOI 10.1016/j.ydbio.2005.09.012; ROCHE JF, 1981, VET REC, V109, P401, DOI 10.1136/vr.109.18.401; Rodriguez TA, 2005, DEVELOPMENT, V132, P2513, DOI 10.1242/dev.01847; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Sheng G, 2014, DEV BIOL; Simmons DG, 2005, DEV BIOL, V284, P12, DOI 10.1016/j.ydbio.2005.05.010; Smith C, 2007, REPRODUCTION, V133, P231, DOI 10.1530/rep.1.0966; Smith CS, 2010, CELL REPROGRAM, V12, P699, DOI 10.1089/cell.2010.0040; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Stern CD, 2012, DEVELOPMENT, V139, P1059, DOI 10.1242/dev.070730; Sun RZ, 2015, ZYGOTE, V23, P266, DOI 10.1017/S0967199413000531; Takaoka K, 2011, NAT CELL BIOL, V13, P743, DOI 10.1038/ncb2251; Magana GV, 2014, DEV BIOL, V387, P15, DOI 10.1016/j.ydbio.2014.01.008; van Leeuwen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096843; Vejlsted M, 2006, THERIOGENOLOGY, V65, P153, DOI 10.1016/j.theriogenology.2005.09.021; Wolf XA, 2012, GENE EXPR PATTERNS, V12, P85, DOI 10.1016/j.gep.2011.06.003; Yamamoto M, 2009, J CELL BIOL, V184, P323, DOI 10.1083/jcb.200808044	54	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129787	10.1371/journal.pone.0129787	http://dx.doi.org/10.1371/journal.pone.0129787			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076128	Green Published, Green Submitted, gold			2022-12-26	WOS:000356329900104
J	Worby, CJ; Read, TD				Worby, Colin J.; Read, Timothy D.			'SEEDY' (Simulation of Evolutionary and Epidemiological Dynamics): An R Package to Follow Accumulation of Within-Host Mutation in Pathogens	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; TRANSMISSION TREES; MODELS	Genome sequencing is an increasingly common component of infectious disease outbreak investigations. However, the relationship between pathogen transmission and observed genetic data is complex, and dependent on several uncertain factors. As such, simulation of pathogen dynamics is an important tool for interpreting observed genomic data in an infectious disease outbreak setting, in order to test hypotheses and to explore the range of outcomes consistent with a given set of parameters. We introduce 'seedy', an R package for the simulation of evolutionary and epidemiological dynamics (http://cran.r-project.org/web/packages/seedy/). Our software implements stochastic models for the accumulation of mutations within hosts, as well as individual-level disease transmission. By allowing variables such as the transmission bottleneck size, within-host effective population size and population mixing rates to be specified by the user, our package offers a flexible framework to investigate evolutionary dynamics during disease outbreaks. Furthermore, our software provides theoretical pairwise genetic distance distributions to provide a likelihood of person-to-person transmission based on genomic observations, and using this framework, implements transmission route assessment for genomic data collected during an outbreak. Our open source software provides an accessible platform for users to explore pathogen evolution and outbreak dynamics via simulation, and offers tools to assess observed genomic data in this context.	[Worby, Colin J.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Ctr Communicable Dis Dynam, Boston, MA 02115 USA; [Read, Timothy D.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA; [Read, Timothy D.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA	Harvard University; Harvard T.H. Chan School of Public Health; Emory University; Emory University	Worby, CJ (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Ctr Communicable Dis Dynam, Boston, MA 02115 USA.	cworby@hsph.harvard.edu		Read, Timothy/0000-0001-8966-9680; Worby, Colin/0000-0002-9132-7249	National Institute of General Medical Sciences of the National Institutes of Health [U54GM088558]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences of the National Institutes of Health under award number U54GM088558. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aring;ogren J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089112; Bansal S, 2007, J R SOC INTERFACE, V4, P879, DOI 10.1098/rsif.2007.1100; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Cottam EM, 2008, P ROY SOC B-BIOL SCI, V275, P887, DOI 10.1098/rspb.2007.1442; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Didelot X, 2014, MOL BIOL EVOL, V31, P1869, DOI 10.1093/molbev/msu121; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Golubchik T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061319; Jenness SM, 2014, EPIMODEL MATH MODELI; Jombart T, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003457; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Koelle K, 2012, J R SOC INTERFACE, V9, P997, DOI 10.1098/rsif.2011.0495; Koelle K, 2010, J R SOC INTERFACE, V7, P1257, DOI 10.1098/rsif.2010.0007; Leventhal GE, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002413; Long SW, 2014, MBIO, V5, DOI 10.1128/mBio.01692-14; Maddison DR, 1997, SYST BIOL, V46, P590, DOI 10.2307/2413497; Morelli MJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002768; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Price JR, 2014, CLIN INFECT DIS, V58, P609, DOI 10.1093/cid/cit807; R Core Team, 2021, R LANGUAGE ENV STAT; Reuter S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002175; Robinson K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003105; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Somboonna N, 2011, MBIO, V2, DOI 10.1128/mBio.00045-11; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Torok ME, 2013, J CLIN MICROBIOL, V51, P611, DOI 10.1128/JCM.02279-12; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Worby CJ, 2014, GENETICS, V198, P1395, DOI 10.1534/genetics.114.171538; Ypma RJF, 2012, P ROY SOC B-BIOL SCI, V279, P444, DOI 10.1098/rspb.2011.0913; Ypma RJF, 2013, GENETICS, V195, P1055, DOI 10.1534/genetics.113.154856	31	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129745	10.1371/journal.pone.0129745	http://dx.doi.org/10.1371/journal.pone.0129745			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075402	gold, Green Published, Green Submitted			2022-12-26	WOS:000356329900099
J	Zheng, YX; Wu, JM; Feng, XS; Jia, Y; Huang, J; Hao, ZH; Zhao, SY; Wang, JH				Zheng, Yaxin; Wu, Jiming; Feng, Xuesong; Jia, Ying; Huang, Jian; Hao, Zhihui; Zhao, Songyan; Wang, Jinhui			In silico Analysis and Experimental Validation of Lignan Extracts from Kadsura longipedunculata for Potential 5-HT1AR Agonists	PLOS ONE			English	Article							C-18 DIBENZOCYCLOOCTADIENE LIGNANS; MODULATE MEMORY CONSOLIDATION; ANTIDEPRESSANT-LIKE ACTIVITY; CHINENSIS TURCZ. BAILL.; NITRIC-OXIDE SYNTHASE; BLOOD-BRAIN-BARRIER; MASS-SPECTROMETRY; MAJOR DEPRESSION; RAT HIPPOCAMPUS; STRESSED MICE	Objectives Kadsura longipedunculata (KL) has been widely used for the treatment of insomnia in traditional Chinese medicine. The aim of this study was to explore the mechanism of the sedative and hypnotic effects of KL. Materials and Methods The content of KL was evaluated by HPLC-TOF-MS, and a potential target was found and used to construct its 3D structure to screen for potential ligands among the compounds in KL by using bioinformatics analysis, including similarity ensemble approach (SEA) docking, homology modeling, molecular docking and ligand-based pharmacophore. The PCPA-induced insomnia rat model was then applied to confirm the potential targets related to the sedative effects of KL by performing the forced swimming test (FST), the tail suspension test (TST) and the measurement of target-related proteins using western blotting and immunofluorescence. Results Bioinformatics analysis showed that most of lignan compounds in KL were optimal ligands for the 5-HT1A receptor (5-HT1AR), and they were found to be potential targets related to sedative effects; the main lignan content of KL extracts was characterized by HPLC-TOFMS, with 7 proposed lignans detected. Administration of KL could significantly reduce FST and TST immobility time in the PCPA-induced 5HT-depleted insomnia rat model. The expressions of proteins related to the 5-HT1AR pathway were regulated by extracts of KL in a concentration-dependent manner, indicating that extracts of KL had 5-HT1AR agonist-like effects. Conclusion In silico analysis and experimental validation together demonstrated that lignan extracts from KL can target 5-HT1AR in insomniac rats, which could shed light on its use as a potential 5-HT1AR agonist drug.	[Zheng, Yaxin; Wu, Jiming; Huang, Jian; Wang, Jinhui] Shenyang Pharmaceut Univ, Minist Educ, Key Lab Struct Based Drug Design & Discovery, Shenyang 110016, Peoples R China; [Feng, Xuesong] China Med Univ, Sch Pharm, Shenyang 110122, Peoples R China; [Jia, Ying] Shenyang Pharmaceut Univ, Sch Tradit Chinese Mat Med, Shenyang 110016, Peoples R China; [Hao, Zhihui] Shenyang Pharmaceut Univ, Anim Ctr, Shenyang 110016, Peoples R China; [Zhao, Songyan] Shenyang Pharmaceut Univ, Sch Life Sci, Shenyang 110016, Peoples R China	Shenyang Pharmaceutical University; China Medical University; Shenyang Pharmaceutical University; Shenyang Pharmaceutical University; Shenyang Pharmaceutical University	Huang, J (corresponding author), Shenyang Pharmaceut Univ, Minist Educ, Key Lab Struct Based Drug Design & Discovery, Shenyang 110016, Peoples R China.	13504051049@163.com; 15999290001@163.com			Key Projects of the National Science and Technology Pillar Program [2012BAI30B02]; National Natural Science Foundation of China [U1303124, 81260628]; Shengyang Science and Technology Project [F12-157-9-00]; Liaoning Science and Technology Project [2013226027-4]; Natural Science Foundation of Liaoning Province, China [201202252]	Key Projects of the National Science and Technology Pillar Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shengyang Science and Technology Project; Liaoning Science and Technology Project; Natural Science Foundation of Liaoning Province, China(Natural Science Foundation of Liaoning Province)	The authors gratefully acknowledge the financial support of the Key Projects of the National Science and Technology Pillar Program (No. 2012BAI30B02), the National Natural Science Foundation of China (U1303124, 81260628), the Shengyang Science and Technology Project (F12-157-9-00), the Liaoning Science and Technology Project (2013226027-4), and the Natural Science Foundation of Liaoning Province, China (No. 201202252). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert PR, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00035; Alfajaro MM, 2014, RES VET SCI, V96, P567, DOI 10.1016/j.rvsc.2014.03.011; Bevilaqua L, 1997, BEHAV PHARMACOL, V8, P331, DOI 10.1097/00008877-199708000-00006; Bevilaqua L, 1997, BRAZ J MED BIOL RES, V30, P967, DOI 10.1590/S0100-879X1997000800009; Chen WW, 2011, PHYTOMEDICINE, V18, P1144, DOI 10.1016/j.phymed.2011.06.004; Chiavegatto S, 2001, P NATL ACAD SCI USA, V98, P1277, DOI 10.1073/pnas.031487198; Chun JN, 2014, FITOTERAPIA, V97, P224, DOI 10.1016/j.fitote.2014.06.014; Clark DE, 1999, J PHARM SCI, V88, P815, DOI 10.1021/js980402t; Cortes-Canteli M, 2008, J CELL SCI, V121, P1224, DOI 10.1242/jcs.025031; Datla KP, 1996, NEUROPHARMACOLOGY, V35, P315, DOI 10.1016/0028-3908(96)00175-X; Deacon RMJ, 2002, BEHAV NEUROSCI, V116, P494, DOI 10.1037//0735-7044.116.3.494; Dhingra D, 2012, PHARMACOL REP, V64, P796, DOI 10.1016/S1734-1140(12)70875-7; Dong K, 2012, J NAT PROD, V75, P249, DOI 10.1021/np200937h; Einat H, 2001, BEHAV BRAIN RES, V118, P77, DOI 10.1016/S0166-4328(00)00314-4; Gautam BK, 2013, PHARMACOL BIOCHEM BE, V109, P91, DOI 10.1016/j.pbb.2013.05.006; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Han Y, 2015, ANAL METHODS-UK, V7, P830, DOI 10.1039/c4ay02340d; Heusler P, 2010, N-S ARCH PHARMACOL, V382, P321, DOI 10.1007/s00210-010-0551-4; Hou CW, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-15; Huang X, 2007, J MASS SPECTROM, V42, P1148, DOI 10.1002/jms.1246; Jeong JJ, 2012, INT J ONCOL, V41, P1358, DOI 10.3892/ijo.2012.1582; Jin Z, 2013, PLANTA MED, V79, P1408, DOI 10.1055/s-0033-1350698; Kempermann G, 2002, BIPOLAR DISORD, V4, P17, DOI 10.1034/j.1399-5618.2002.40101.x; Kim Mun Hee, 2014, J Exerc Nutrition Biochem, V18, P97, DOI 10.5717/jenb.2014.18.1.97; Kuo YH, 2005, PLANTA MED, V71, P646, DOI 10.1055/s-2005-871271; Lauder JM, 2000, INT J DEV NEUROSCI, V18, P171, DOI 10.1016/S0736-5748(99)00085-4; Lin JW, 2012, NEURO-ONCOLOGY, V14, P302, DOI 10.1093/neuonc/nor217; Liu HT, 2009, MAGN RESON CHEM, V47, P609, DOI 10.1002/mrc.2430; Liu MM, 2012, EUR J MED CHEM, V52, P33, DOI 10.1016/j.ejmech.2012.03.002; Lu XY, 2008, NEUROPEPTIDES, V42, P387, DOI 10.1016/j.npep.2008.04.009; Ma WH, 2007, CHEM BIODIVERS, V4, P966, DOI 10.1002/cbdv.200790087; Mizrahi C, 2004, INT IMMUNOPHARMACOL, V4, P1125, DOI 10.1016/j.intimp.2004.05.001; Mulyaningsih S, 2010, J PHARM PHARMACOL, V62, P1037, DOI 10.1111/j.2042-7158.2010.01119.x; Pu JX, 2008, CHEM PHARM BULL, V56, P1143, DOI 10.1248/cpb.56.1143; Pu JX, 2008, PHYTOCHEMISTRY, V69, P1266, DOI 10.1016/j.phytochem.2007.11.019; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shen YC, 2007, CHEM PHARM BULL, V55, P280, DOI 10.1248/cpb.55.280; Sullivan SS, 2009, EXPERT OPIN EMERG DR, V14, P411, DOI 10.1517/14728210903171948; Wang HJ, 2013, CARBOHYD POLYM, V97, P710, DOI 10.1016/j.carbpol.2013.05.042; Wang SY, 2015, CELL PROLIFERAT, V48, P86, DOI 10.1111/cpr.12157; Wang W, 2006, PLANTA MED, V72, P450, DOI 10.1055/s-2005-916263; Wei BB, 2013, J MASS SPECTROM, V48, P448, DOI 10.1002/jms.3176; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Xu LL, 2013, J CHEM INF MODEL, V53, P3202, DOI 10.1021/ci400481p; Yang CP, 2013, TOXICOL APPL PHARM, V273, P561, DOI 10.1016/j.taap.2013.09.030; Zaugg J, 2011, PHYTOCHEMISTRY, V72, P2385, DOI 10.1016/j.phytochem.2011.08.014; Zhang J, 2010, J NEUROSCI, V30, P2433, DOI 10.1523/JNEUROSCI.5880-09.2010; Zhou Y, 2011, J PHARMACEUT BIOMED, V56, P916, DOI 10.1016/j.jpba.2011.07.045; Zisapel N, 2012, EXPERT OPIN EMERG DR, V17, P299, DOI 10.1517/14728214.2012.690735	49	5	6	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130055	10.1371/journal.pone.0130055	http://dx.doi.org/10.1371/journal.pone.0130055			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076134	gold, Green Submitted, Green Published			2022-12-26	WOS:000356329900131
J	Contini, E; Paganini, I; Sestini, R; Candita, L; Capone, GL; Barbetti, L; Falconi, S; Frusconi, S; Giotti, I; Giuliani, C; Torricelli, F; Benelli, M; Papi, L				Contini, Elisa; Paganini, Irene; Sestini, Roberta; Candita, Luisa; Capone, Gabriele Lorenzo; Barbetti, Lorenzo; Falconi, Serena; Frusconi, Sabrina; Giotti, Irene; Giuliani, Costanza; Torricelli, Francesca; Benelli, Matteo; Papi, Laura			A Systematic Assessment of Accuracy in Detecting Somatic Mosaic Variants by Deep Amplicon Sequencing: Application to NF2 Gene	PLOS ONE			English	Article							RESOLUTION MELTING ANALYSIS; NEUROFIBROMATOSIS 2; COLD-PCR; TYPE-2 NEUROFIBROMATOSIS; UNITED-KINGDOM; DIGITAL PCR; MUTATIONS; TRANSMISSION; SENSITIVITY; PREVALENCE	The accurate detection of low-allelic variants is still challenging, particularly for the identification of somatic mosaicism, where matched control sample is not available. High throughput sequencing, by the simultaneous and independent analysis of thousands of different DNA fragments, might overcome many of the limits of traditional methods, greatly increasing the sensitivity. However, it is necessary to take into account the high number of false positives that may arise due to the lack of matched control samples. Here, we applied deep amplicon sequencing to the analysis of samples with known genotype and variant allele fraction (VAF) followed by a tailored statistical analysis. This method allowed to define a minimum value of VAF for detecting mosaic variants with high accuracy. Then, we exploited the estimated VAF to select candidate alterations in NF2 gene in 34 samples with unknown genotype (30 blood and 4 tumor DNAs), demonstrating the suitability of our method. The strategy we propose optimizes the use of deep amplicon sequencing for the identification of low abundance variants. Moreover, our method can be applied to different high throughput sequencing approaches to estimate the background noise and define the accuracy of the experimental design.	[Contini, Elisa; Falconi, Serena; Frusconi, Sabrina; Giotti, Irene; Giuliani, Costanza; Torricelli, Francesca; Benelli, Matteo] Careggi Univ Hosp, Diagnost Genet Unit, Florence, Italy; [Paganini, Irene; Sestini, Roberta; Candita, Luisa; Capone, Gabriele Lorenzo; Barbetti, Lorenzo; Papi, Laura] Univ Florence, Dept Biomed Expt & Clin Sci, Med Genet, Florence, Italy	University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence	Benelli, M (corresponding author), Careggi Univ Hosp, Diagnost Genet Unit, Florence, Italy.	ire.paganini@gmail.com; ire.paganini@gmail.com	Paganini, Irene/AHH-4604-2022; Benelli, Matteo/I-2497-2018; Candita, Luisa/AAC-1562-2019	Benelli, Matteo/0000-0003-1227-356X; Papi, Laura/0000-0003-4552-9517; SESTINI, ROBERTA/0000-0002-7500-9988; Contini, Elisa/0000-0003-2111-6435; Paganini, Irene/0000-0001-6867-0244	Istituto Toscano Tumori	Istituto Toscano Tumori	This project is funded by Istituto Toscano Tumori (www.ittumori.it) LP received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Z, 2014, HUM MUTAT, V35, P384, DOI 10.1002/humu.22488; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; EVANS DGR, 1992, J MED GENET, V29, P847, DOI 10.1136/jmg.29.12.847; EVANS DGR, 1992, J MED GENET, V29, P841, DOI 10.1136/jmg.29.12.841; Evans GR, 2007, J MED GENET, V44, P424, DOI 10.1136/jmg.2006.047753; Flaherty P, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr861; Gutmann DH, 1997, JAMA-J AM MED ASSOC, V278, P51, DOI 10.1001/jama.278.1.51; Harismendy O, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3584; Kluwe L, 2003, J MED GENET, V40, P109, DOI 10.1136/jmg.40.2.109; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Milbury CA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq899; Milbury CA, 2009, CLIN CHEM, V55, P2130, DOI 10.1373/clinchem.2009.131029; Miotke L, 2014, ANAL CHEM, V86, P2618, DOI 10.1021/ac403843j; Moyhuddin A, 2003, J MED GENET, V40, P459, DOI 10.1136/jmg.40.6.459; MULVIHILL JJ, 1990, ANN INTERN MED, V113, P39, DOI 10.7326/0003-4819-113-1-39; Paganini I, 2014, J MOL DIAGN, V16, P393, DOI 10.1016/j.jmoldx.2014.02.007; PARRY DM, 1994, AM J MED GENET, V52, P450, DOI 10.1002/ajmg.1320520411; Reed GH, 2004, CLIN CHEM, V50, P1748, DOI 10.1373/clinchem.2003.029751; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Sestini R, 2008, GENET TEST, V12, P311, DOI 10.1089/gte.2007.0096; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Xu HL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-244; Youssoufian H, 2002, NAT REV GENET, V3, P748, DOI 10.1038/nrg906	26	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129099	10.1371/journal.pone.0129099	http://dx.doi.org/10.1371/journal.pone.0129099			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066488	gold, Green Published, Green Submitted			2022-12-26	WOS:000356327000045
J	Niedringhaus, M; Chen, X; Dzakpasu, R				Niedringhaus, Mark; Chen, Xin; Dzakpasu, Rhonda			Long-Term Dynamical Constraints on Pharmacologically Evoked Potentiation Imply Activity Conservation within In Vitro Hippocampal Networks	PLOS ONE			English	Article							SYNAPTIC-TRANSMISSION; DENTATE AREA; MEMORY; PLASTICITY; PHASE; LTP	This paper describes a long-term study of network dynamics from in vitro, cultured hippocampal neurons after a pharmacological induction of synaptic potentiation. We plate a suspension of hippocampal neurons on an array of extracellular electrodes and record electrical activity in the absence of the drugs several days after treatment. While previous studies have reported on potentiation lasting up to a few hours after treatment, to the best of our knowledge, this is the first report to characterize the network effects of a potentiating mechanism several days after treatment. Using this reduced, two-dimensional in vitro network of hippocampal neurons, we show that the effects of potentiation are persistent over time but are modulated under a conservation of spike principle. We suggest that this conservation principle might be mediated by the appearance of a resonant inter-spike interval that prevents the network from advancing towards a state of hyperexcitability.	[Niedringhaus, Mark; Dzakpasu, Rhonda] Georgetown Univ, Med Ctr, Interdisciplinary Program Neurosci, Washington, DC 20007 USA; [Chen, Xin; Dzakpasu, Rhonda] Georgetown Univ, Dept Phys, Washington, DC 20057 USA; [Chen, Xin; Dzakpasu, Rhonda] Georgetown Univ, Med Ctr, Dept Physiol & Pharmacol, Washington, DC 20007 USA	Georgetown University; Georgetown University; Georgetown University	Dzakpasu, R (corresponding author), Georgetown Univ, Med Ctr, Interdisciplinary Program Neurosci, Washington, DC 20007 USA.	rd259@georgetown.edu	Dzakpasu, Rhonda/F-8060-2019	Dzakpasu, Rhonda/0000-0002-7223-4602	National Science Foundation [1205919]; Luce Foundation	National Science Foundation(National Science Foundation (NSF)); Luce Foundation	Dr. Niedringhaus, Dr. Chen, and Dr. Dzakpasu were supported by the National Science Foundation (grant no. 1205919) and the Luce Foundation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bakkum DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002088; Barad M, 1998, P NATL ACAD SCI USA, V95, P15020, DOI 10.1073/pnas.95.25.15020; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1970, J PHYSIOL-LONDON, V207, pP61; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bologna LL, 2010, NEUROSCIENCE, V165, P692, DOI 10.1016/j.neuroscience.2009.11.018; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Esposti F, 2009, IEEE T NEUR SYS REH, V17, P364, DOI 10.1109/TNSRE.2009.2022832; FANO U, 1947, PHYS REV, V72, P26, DOI 10.1103/PhysRev.72.26; Feller MB, 1999, NEURON, V22, P653, DOI 10.1016/S0896-6273(00)80724-2; Gandolfo M, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056001; Grabrucker A, 2009, CELL TISSUE RES, V338, P333, DOI 10.1007/s00441-009-0881-z; Granger AJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0136; Guitart-Masip M, 2013, J NEUROSCI, V33, P442, DOI 10.1523/JNEUROSCI.2573-12.2013; Izhikevich EM, 2003, TRENDS NEUROSCI, V26, P161, DOI 10.1016/S0166-2236(03)00034-1; Jacobs J, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0304; Jezek K, 2011, NATURE, V478, P246, DOI 10.1038/nature10439; Kaplan R, 2014, HIPPOCAMPUS, V24, P656, DOI 10.1002/hipo.22255; Leondopulos SS, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026015; Lisman J, 2003, PHILOS T ROY SOC B, V358, P829, DOI 10.1098/rstb.2002.1242; Lisman JE, 2013, NEURON, V77, P1002, DOI 10.1016/j.neuron.2013.03.007; LOMO T, 1966, ACTA PHYSIOL SCAND, VS 68, P128; MADISON DV, 1991, ANNU REV NEUROSCI, V14, P379, DOI 10.1146/annurev.ne.14.030191.002115; Malenka RC, 2003, NAT REV NEUROSCI, V4, P923, DOI 10.1038/nrn1258; Meyer D, 2014, NEURON, V82, P430, DOI 10.1016/j.neuron.2014.02.031; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Nicoll RA, 2003, PHILOS T R SOC B, V358, P721, DOI 10.1098/rstb.2002.1228; Niedringhaus M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057144; Niedringhaus M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042631; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Otmakhov N, 2004, J NEUROPHYSIOL, V91, P1955, DOI 10.1152/jn.00941.2003; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Payne HL, 2008, MOL MEMBR BIOL, V25, P353, DOI 10.1080/09687680801986480; Potter SM, 2001, J NEUROSCI METH, V110, P17, DOI 10.1016/S0165-0270(01)00412-5; Segev R, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011920; Tabak J, 2010, J NEUROPHYSIOL, V103, P2208, DOI 10.1152/jn.00857.2009; Takesian AE, 2013, PROG BRAIN RES, V207, P3, DOI 10.1016/B978-0-444-63327-9.00001-1; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11	43	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129324	10.1371/journal.pone.0129324	http://dx.doi.org/10.1371/journal.pone.0129324			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070215	gold, Green Published, Green Submitted			2022-12-26	WOS:000356327000064
J	Litzlbauer, J; Schifferer, M; Ng, D; Fabritius, A; Thestrup, T; Griesbeck, O				Litzlbauer, Julia; Schifferer, Martina; Ng, David; Fabritius, Arne; Thestrup, Thomas; Griesbeck, Oliver			Large Scale Bacterial Colony Screening of Diversified FRET Biosensors	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; FLUORESCENT INDICATORS; CALCIUM; CA2+; DYNAMICS; SENSORS; PROTEIN	Biosensors based on Forster Resonance Energy Transfer (FRET) between fluorescent protein mutants have started to revolutionize physiology and biochemistry. However, many types of FRET biosensors show relatively small FRET changes, making measurements with these probes challenging when used under sub-optimal experimental conditions. Thus, a major effort in the field currently lies in designing new optimization strategies for these types of sensors. Here we describe procedures for optimizing FRET changes by large scale screening of mutant biosensor libraries in bacterial colonies. We describe optimization of biosensor expression, permeabilization of bacteria, software tools for analysis, and screening conditions. The procedures reported here may help in improving FRET changes in multiple suitable classes of biosensors.	[Litzlbauer, Julia; Schifferer, Martina; Ng, David; Fabritius, Arne; Thestrup, Thomas; Griesbeck, Oliver] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany	Max Planck Society	Griesbeck, O (corresponding author), Max Planck Inst Neurobiol, Klopferspitz 18, D-82152 Martinsried, Germany.	griesbeck@neuro.mpg.de		Griesbeck, Oliver/0000-0001-5883-5594	Max-Planck Society; Deutsche Forschungsgemeinschaft [SFB 870]	Max-Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Max-Planck Society and the Deutsche Forschungsgemeinschaft (SFB 870). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belal ASF, 2014, MOL BIOSYST, V10, P191, DOI 10.1039/c3mb70402e; Campbell AK, 2007, ARCH BIOCHEM BIOPHYS, V468, P107, DOI 10.1016/j.abb.2007.09.006; Carlotti B, 2010, PHYS CHEM CHEM PHYS, V12, P15580, DOI 10.1039/c0cp00044b; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Fehr M, 2005, BIOCHEM SOC T, V33, P287, DOI 10.1042/BST0330287; Fritz RD, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004135; GANGOLA P, 1987, J BIOL CHEM, V262, P12570; Gao YQ, 2013, APPL MICROBIOL BIOT, V97, P7121, DOI 10.1007/s00253-013-5100-x; Geiger A, 2012, BIOPHYS J, V102, P2401, DOI 10.1016/j.bpj.2012.03.065; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Hires SA, 2008, P NATL ACAD SCI USA, V105, P4411, DOI 10.1073/pnas.0712008105; Ibraheem A, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-105; Jones HE, 1999, CELL CALCIUM, V25, P265, DOI 10.1054/ceca.1999.0028; KATSU T, 1984, FEBS LETT, V166, P175, DOI 10.1016/0014-5793(84)80067-8; Klarenbeek JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019170; Komatsu N, 2011, MOL BIOL CELL, V22, P4647, DOI 10.1091/mbc.E11-01-0072; Mank M, 2006, BIOPHYS J, V90, P1790, DOI 10.1529/biophysj.105.073536; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Mank M, 2008, CHEM REV, V108, P1550, DOI 10.1021/cr078213v; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Newman RH, 2011, CHEM REV, V111, P3614, DOI 10.1021/cr100002u; Piljic A, 2011, ACS CHEM BIOL, V6, P685, DOI 10.1021/cb100402n; Russwurm M, 2007, BIOCHEM J, V407, P69, DOI 10.1042/BJ20070348; Schifferer M, 2012, J AM CHEM SOC, V134, P15185, DOI 10.1021/ja3055673; Schleifenbaum A, 2004, J AM CHEM SOC, V126, P11786, DOI 10.1021/ja0460155; Thestrup T, 2014, NAT METHODS, V11, P175, DOI [10.1038/NMETH.2773, 10.1038/nmeth.2773]; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; van der Krogt GNM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001916; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Wardill TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077728; Yasuda R, 2006, CURR OPIN NEUROBIOL, V16, P551, DOI 10.1016/j.conb.2006.08.012; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798; Zhang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1288; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	36	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0119860	10.1371/journal.pone.0119860	http://dx.doi.org/10.1371/journal.pone.0119860			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061878	gold, Green Published, Green Submitted			2022-12-26	WOS:000355979500003
J	Waheed, S; Sakr, A; Chheda, ND; Lucas, GM; Estrella, M; Fine, DM; Atta, MG				Waheed, Sana; Sakr, Ahmad; Chheda, Neha D.; Lucas, Gregory M.; Estrella, Michelle; Fine, Derek M.; Atta, Mohamed G.			Outcomes of Renal Transplantation in HIV-1 Associated Nephropathy	PLOS ONE			English	Article							KIDNEY-TRANSPLANTATION; INFECTED PATIENTS; NEGATIVE PATIENTS; RECIPIENTS; SURVIVAL; DISEASE; IMMUNOSUPPRESSION; SAFETY; LIVER; RISK	Introduction Several studies have demonstrated that renal transplantation in HIV positive patients is both safe and effective. However, none of these studies have specifically examined outcomes in patients with HIV-associated nephropathy (HIVAN). Methods Medical records of all HIV-infected patients who underwent kidney transplantation at Johns Hopkins Hospital between September 2006 and January 2014 were reviewed. Data was collected to examine baseline characteristics and outcomes of transplant recipients with HIVAN defined pathologically as collapsing focal segmental glomerulosclerosis (FSGS) with tubulo-interstitial disease. Results and Discussion During the study period, a total of 16 patients with HIV infection underwent renal transplantation. Of those, 11 patients were identified to have biopsy-proven HIVAN as the primary cause of their end stage renal disease (ESRD) and were included in this study. They were predominantly African American males with a mean age of 47.6 years. Seven (64%) patients developed delayed graft function (DGF), and 6 (54%) patients required post-operative dialysis within one week of transplant. Graft survival rates at 1 and 3 years were 100% and 81%, respectively. Acute rejection rates at 1 and 3 years were 18% and 27%, respectively. During a mean follow up of 3.4 years, one patient died. Conclusions Acute rejection rates in HIVAN patients in this study are higher than reported in the general ESRD population, which is similar to findings from prior studies of patients with HIV infection and ESRD of various causes. The high rejection rates appear to have no impact on short or intermediate term graft survival.	[Waheed, Sana] Univ Wisconsin, Sch Med, Med, Madison, WI USA; [Sakr, Ahmad] Ain Shams Fac Med, Cairo, Egypt; [Chheda, Neha D.; Lucas, Gregory M.; Estrella, Michelle; Fine, Derek M.; Atta, Mohamed G.] Johns Hopkins Sch Med, Med, Baltimore, MD 21205 USA	University of Wisconsin System; University of Wisconsin Madison; Egyptian Knowledge Bank (EKB); Ain Shams University; Johns Hopkins University; Johns Hopkins Medicine	Atta, MG (corresponding author), Johns Hopkins Sch Med, Med, Baltimore, MD 21205 USA.	matta1@jhmi.edu			National Institute of Diabetes and Digestive and Kidney Diseases [P01DK056492]; National Institute on Drug Abuse [K24 DA035684, R01 DA026770]; Johns Hopkins University Center for AIDS Research [P30 AI094189]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK056492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA035684, R01DA026770] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Johns Hopkins University Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Dr. Atta is supported by the National Institute of Diabetes and Digestive and Kidney Diseases grant P01DK056492. Dr. Lucas was supported by the National Institute on Drug Abuse (K24 DA035684 and R01 DA026770) and by the Johns Hopkins University Center for AIDS Research (P30 AI094189).	Agarwal D K, 2012, Indian J Nephrol, V22, P139, DOI 10.4103/0971-4065.97139; Atta MG, 2007, CLIN INFECT DIS, V45, P1625, DOI 10.1086/523728; Bhagani S, 2006, HIV MED, V7, P133, DOI 10.1111/j.1468-1293.2006.00367.x; Campara M, 2008, TRANSPLANTATION, V86, P176, DOI 10.1097/TP.0b013e31817cf403; Canaud G, 2014, J AM SOC NEPHROL, V25, P407, DOI 10.1681/ASN.2013050564; Dave MB, 1998, CLIN NEPHROL, V50, P367; Duan KI, 2010, AM J TRANSPLANT, V10, P416, DOI 10.1111/j.1600-6143.2009.02931.x; Gomez V, 2013, TRANSPL P, V45, P1255, DOI 10.1016/j.transproceed.2013.02.032; Kumar MSA, 2005, KIDNEY INT, V67, P1622, DOI 10.1111/j.1523-1755.2005.00245.x; Lee BT, 2012, AM J TRANSPLANT, V12, P1924, DOI 10.1111/j.1600-6143.2012.04033.x; Locke JE, 2014, TRANSPLANTATION, V97, P446, DOI 10.1097/01.TP.0000436905.54640.8c; Lucas GM, 2014, CLIN INFECT DIS, V59, pE96, DOI 10.1093/cid/ciu617; Matas AJ, 2014, AM J TRANSPLANT, V14, P11, DOI 10.1111/ajt.12579; Mocroft A, 2010, JAIDS-J ACQ IMM DEF, V55, P262, DOI 10.1097/QAI.0b013e3181e9be6b; Moore J, 2010, TRANSPLANTATION, V90, P1113, DOI 10.1097/TP.0b013e3181f86966; Nicoletto BB, 2014, TRANSPLANTATION, V98, P167, DOI 10.1097/TP.0000000000000028; Qiu JX, 2006, TRANSPLANTATION, V81, P1658, DOI 10.1097/01.tp.0000226074.97314.e0; Roland ME, 2008, AM J TRANSPLANT, V8, P355, DOI 10.1111/j.1600-6143.2007.02061.x; Smith KY, 2009, AIDS, V23, P1547, DOI 10.1097/QAD.0b013e32832cbcc2; Stock PG, 2014, AM J TRANSPLANT, V14, P1136, DOI 10.1111/ajt.12699; Stock PG, 2010, NEW ENGL J MED, V363, P2004, DOI 10.1056/NEJMoa1001197; Stock PG, 2003, TRANSPLANTATION, V76, P370, DOI 10.1097/01.TP.0000075973.73064.A6; Trullas JC, 2007, AIDS RES HUM RETROV, V23, P1161, DOI 10.1089/aid.2007.0015; van Maarseveen EM, 2012, AIDS PATIENT CARE ST, V26, P568, DOI 10.1089/apc.2012.0169	24	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129702	10.1371/journal.pone.0129702	http://dx.doi.org/10.1371/journal.pone.0129702			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061701	gold, Green Submitted, Green Published			2022-12-26	WOS:000355979500159
J	Yasuda, T; Oda, S; Hibi, Y; Satoh, S; Nagata, K; Hirakawa, K; Kutsuna, N; Sagara, H; Mitani, H				Yasuda, Takako; Oda, Shoji; Hibi, Yusuke; Satoh, Satomi; Nagata, Kento; Hirakawa, Kei; Kutsuna, Natsumaro; Sagara, Hiroshi; Mitani, Hiroshi			Embryonic Medaka Model of Microglia in the Developing CNS Allowing In Vivo Analysis of Their Spatiotemporal Recruitment in Response to Irradiation	PLOS ONE			English	Article							ORYZIAS-LATIPES; APOLIPOPROTEIN-E; DEVELOPING BRAIN; CELL-DEATH; ALZHEIMERS-DISEASE; NEURAL DEVELOPMENT; EARLY MACROPHAGES; APOPTOTIC CELLS; ZEBRAFISH; RADIATION	Radiation therapy (RT) is pivotal in the treatment of many central nervous system (CNS) pathologies; however, exposure to RT in children is associated with a higher risk of secondary CNS tumors. Although recent research interest has focused on the reparative and therapeutic role of microglia, their recruitment following RT has not been elucidated, especially in the developing CNS. Here, we investigated the spatiotemporal dynamics of microglia during tissue repair in the irradiated embryonic medaka brain by whole-mount in situ hybridization using a probe for Apolipoprotein E (ApoE), a marker for activated microglia in teleosts. Three-dimensional imaging of the distribution of ApoE-expressing microglia in the irradiated embryonic brain clearly showed that ApoE-expressing microglia were abundant only in the late phase of phagocytosis during tissue repair induced by irradiation, while few microglia expressed ApoE in the initial phase of phagocytosis. This strongly suggests that ApoE has a significant function in the late phase of phagocytosis by microglia in the medaka brain. In addition, the distribution of microglia in p53-deficient embryos at the late phase of phagocytosis was almost the same as in wild-type embryos, despite the low numbers of irradiation-induced apoptotic neurons, suggesting that constant numbers of activated microglia were recruited at the late phase of phagocytosis irrespective of the extent of neuronal injury. This medaka model of microglia demonstrated specific recruitment after irradiation in the developing CNS and could provide a useful potential therapeutic strategy to counteract the detrimental effects of RT.	[Yasuda, Takako; Oda, Shoji; Hibi, Yusuke; Satoh, Satomi; Nagata, Kento; Hirakawa, Kei; Kutsuna, Natsumaro; Mitani, Hiroshi] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan; [Sagara, Hiroshi] Univ Tokyo, Inst Med Sci, Med Prote Lab, Fine Morphol Anal Grp,Minato Ku, Tokyo, Japan	University of Tokyo; University of Tokyo	Yasuda, T (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Biosci Bldg, Kashiwa, Chiba, Japan.	t_yasuda@ib.k.u-tokyo.ac.jp	Sagara, Hiroshi/GRX-7740-2022	Sagara, Hiroshi/0000-0001-8456-8362	Ministry of Education, Culture, Sports, Science and Technology of Japan [22510056, 25514002, 21221003]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was partly supported by a Grant-in-Aid for Scientific Research (C) Number 22510056 and 25514002 to TY and Scientific Research (S) Number 21221003 to HM from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Babin PJ, 1997, P NATL ACAD SCI USA, V94, P8622, DOI 10.1073/pnas.94.16.8622; Burrell K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038366; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Furutani-Seiki M, 2004, MECH DEVELOP, V121, P629, DOI 10.1016/j.mod.2004.05.010; FurutaniSeiki M, 1996, DEVELOPMENT, V123, P229; Hauser PS, 2011, PROG LIPID RES, V50, P62, DOI 10.1016/j.plipres.2010.09.001; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; HYODOTAGUCHI Y, 1985, ZOOL SCI, V2, P305; Ishikawa Y, 2000, BIOESSAYS, V22, P487, DOI 10.1002/(SICI)1521-1878(200005)22:5&lt;487::AID-BIES11&gt;3.0.CO;2-8; Ishikawa Y, 2007, BRAIN BEHAV EVOLUT, V69, P87, DOI 10.1159/000095197; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; Kettenmann H, 2007, NATURE, V446, P987, DOI 10.1038/nature05713; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; LEBLANC AC, 1990, J NEUROSCI RES, V25, P162, DOI 10.1002/jnr.490250203; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Miyamoto A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00070; Neglia JP, 2006, J NATL CANCER I, V98, P1528, DOI 10.1093/jnci/djj411; Nijhawan D, 2000, ANNU REV NEUROSCI, V23, P73, DOI 10.1146/annurev.neuro.23.1.73; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; OPPENHEIM RW, 1985, TRENDS NEUROSCI, V8, P487, DOI 10.1016/0166-2236(85)90175-4; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Platt N, 1998, TRENDS CELL BIOL, V8, P365, DOI 10.1016/S0962-8924(98)01329-4; Ransohoff RM, 2011, SCIENCE, V333, P1391, DOI 10.1126/science.1212112; Schlegelmilch T, 2011, CURR OPIN NEUROBIOL, V21, P5, DOI 10.1016/j.conb.2010.08.004; Shima A, 2004, MECH DEVELOP, V121, P599, DOI 10.1016/j.mod.2004.03.011; Streit WJ, 2004, J NEUROSCI RES, V77, P1, DOI 10.1002/jnr.20093; Taniguchi Y, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r116; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006; Yasuda T, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.133; Yasuda T, 2008, J RADIAT RES, V49, P533, DOI 10.1269/jrr.08030; Yasuda T, 2006, J RADIAT RES, V47, P295, DOI 10.1269/jrr.0617; Yasuda T, 2011, INT J RADIAT BIOL, V87, P915, DOI 10.3109/09553002.2011.584944; Yasuda T, 2009, J RADIAT RES, V50, P487, DOI 10.1269/jrr.09043; Zhang XM, 2012, EXP NEUROL, V233, P323, DOI 10.1016/j.expneurol.2011.10.024	40	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0127325	10.1371/journal.pone.0127325	http://dx.doi.org/10.1371/journal.pone.0127325			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061282	gold, Green Published, Green Submitted			2022-12-26	WOS:000355979500034
J	Huang, W; Dong, Z; Chen, Y; Wang, F; Wang, CJ; Peng, H; He, Y; Hangoc, G; Pollok, K; Sandusky, G; Fu, XY; Broxmeyer, HE; Zhang, ZY; Liu, JY; Zhang, JT				Huang, W.; Dong, Z.; Chen, Y.; Wang, F.; Wang, C. J.; Peng, H.; He, Y.; Hangoc, G.; Pollok, K.; Sandusky, G.; Fu, X-Y; Broxmeyer, H. E.; Zhang, Z-Y; Liu, J-Y; Zhang, J-T			Small-molecule inhibitors targeting the DNA-binding domain of STAT3 suppress tumor growth, metastasis and STAT3 target gene expression in vivo	ONCOGENE			English	Article							SIGNAL TRANSDUCER; CANCER; TRANSCRIPTION; ACTIVATOR; PHOSPHORYLATION; IL-6	Signal transducer and activator of transcription 3 (STAT3) is constitutively activated in malignant tumors and has important roles in multiple aspects of cancer aggressiveness. Thus targeting STAT3 promises to be an attractive strategy for treatment of advanced metastatic tumors. Although many STAT3 inhibitors targeting the SH2 domain have been reported, few have moved into clinical trials. Targeting the DNA-binding domain (DBD) of STAT3, however, has been avoided due to its 'undruggable' nature and potentially limited selectivity. In a previous study, we reported an improved in silico approach targeting the DBD of STAT3 that resulted in a small-molecule STAT3 inhibitor (inS3-54). Further studies, however, showed that inS3-54 has off-target effect although it is selective to STAT3 over STAT1. In this study, we describe an extensive structure and activity-guided hit optimization and mechanistic characterization effort, which led to identification of an improved lead compound (inS3-54A18) with increased specificity and pharmacological properties. InS3-54A18 not only binds directly to the DBD and inhibits the DNA-binding activity of STAT3 both in vitro and in situ but also effectively inhibits the constitutive and interleukin-6-stimulated expression of STAT3 downstream target genes. InS3-54A18 is completely soluble in an oral formulation and effectively inhibits lung xenograft tumor growth and metastasis with little adverse effect on animals. Thus inS3-54A18 may serve as a potential candidate for further development as anticancer therapeutics targeting the DBD of human STAT3 and DBD of transcription factors may not be 'undruggable' as previously thought.	[Huang, W.; Dong, Z.; Chen, Y.; Wang, F.; Wang, C. J.; Peng, H.; Pollok, K.; Liu, J-Y; Zhang, J-T] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [He, Y.; Zhang, Z-Y] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Hangoc, G.; Fu, X-Y; Broxmeyer, H. E.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Pollok, K.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Pollok, K.; Sandusky, G.; Fu, X-Y; Broxmeyer, H. E.; Zhang, Z-Y; Zhang, J-T] Indiana Univ Sch Med, IU Simon Canc Ctr, 980W Walnut St, Indianapolis, IN 46202 USA; [Sandusky, G.] Indiana Univ Sch Med, Dept Pathol & Mol Med, Indianapolis, IN 46202 USA; [Liu, J-Y] Indiana Univ Purdue Univ, Dept Comp & Informat Sci, Indianapolis, IN 46202 USA; [Huang, W.] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; Peking University	Zhang, JT (corresponding author), Indiana Univ Sch Med, IU Simon Canc Ctr, 980W Walnut St, Indianapolis, IN 46202 USA.; Liu, JY (corresponding author), IUPUI, Dept Comp & Informat Sci, 635 Barnhill Dr,MS550, Indianapolis, IN 46202 USA.	jliu2@iu.edu; jianzhan@iu.edu	Zhang, Jian-Ting/L-8334-2015	Wang, Chao/0000-0001-8951-5657; Zhang, Jian-Ting/0000-0002-2803-9914	Lung Cancer Working Group at IUSCC	Lung Cancer Working Group at IUSCC	We thank Anthony Sinn in the In Vivo Therapeutics Core and Sheng Zhang in the Chemical Genomics Core for their technical assistance for in vivo studies and chemical synthesis, respectively. Jiayuh Lin at Ohio State University provided MDA-MB-231-STAT3 cells with the STAT3-dependent luciferase reporter while George R Stark at Cleveland Clinic provided STAT1 cDNA. This work was supported in part by the Lung Cancer Working Group at IUSCC.	Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Caboni L, 2013, MED RES REV, V33, P1081, DOI 10.1002/med.21275; Chen Z, 2008, MED RES REV, V28, P185, DOI 10.1002/med.20101; Cheng L, 2004, CLIN CANCER RES, V10, P3064, DOI 10.1158/1078-0432.CCR-03-0652; Chiarle R, 2005, NAT MED, V11, P623, DOI 10.1038/nm1249; Choi CH, 2010, J OBSTET GYNAECOL RE, V36, P304, DOI 10.1111/j.1447-0756.2009.01131.x; Debnath B, 2012, J MED CHEM, V55, P6645, DOI 10.1021/jm300207s; Deng JX, 2007, CURR CANCER DRUG TAR, V7, P91, DOI 10.2174/156800907780006922; Devarajan E, 2009, CURR MOL MED, V9, P626, DOI 10.2174/156652409788488720; Diaz N, 2006, CLIN CANCER RES, V12, P20, DOI 10.1158/1078-0432.CCR-04-1749; Dolled-Filhart M, 2003, CLIN CANCER RES, V9, P594; Fletcher S, 2009, CHEMBIOCHEM, V10, P1959, DOI 10.1002/cbic.200900172; Hao WS, 2008, BIOORG MED CHEM LETT, V18, P4988, DOI 10.1016/j.bmcl.2008.08.032; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Huang W, 2014, ACS CHEM BIOL, V9, P1188, DOI 10.1021/cb500071v; Lee H, 2011, CURR TOP MICROBIOL, V344, P41, DOI 10.1007/82_2010_51; Leung CH, 2013, MED RES REV, V33, P823, DOI 10.1002/med.21266; Lin L, 2010, CANCER RES, V70, P2445, DOI 10.1158/0008-5472.CAN-09-2468; Lin L, 2010, NEOPLASIA, V12, P39, DOI 10.1593/neo.91196; Mantel C, 2012, BLOOD, V120, P2589, DOI 10.1182/blood-2012-01-404004; Nkansah E, 2013, FEBS LETT, V587, P833, DOI 10.1016/j.febslet.2013.01.065; Ren ZY, 2003, BIOORG MED CHEM LETT, V13, P633, DOI 10.1016/S0960-894X(02)01050-8; Schust J, 2004, ANAL BIOCHEM, V330, P114, DOI 10.1016/j.ab.2004.03.024; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Siddiquee KAZ, 2007, ACS CHEM BIOL, V2, P787, DOI 10.1021/cb7001973; Song H, 2005, P NATL ACAD SCI USA, V102, P4700, DOI 10.1073/pnas.0409894102; Timofeeva OA, 2012, J BIOL CHEM, V287, P14192, DOI 10.1074/jbc.M111.323899; Turkson J, 2004, MOL CANCER THER, V3, P261; Turkson J, 2001, J BIOL CHEM, V276, P45443, DOI 10.1074/jbc.M107527200; Welte T, 2003, P NATL ACAD SCI USA, V100, P1879, DOI 10.1073/PNAS.0237137100; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yang Youyun, 2011, Int J Biochem Mol Biol, V2, P89; Yue P, 2009, EXPERT OPIN INV DRUG, V18, P45, DOI 10.1517/13543780802565791 	35	62	67	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 11	2016	35	6					783	792		10.1038/onc.2015.215	http://dx.doi.org/10.1038/onc.2015.215			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DE0RF	26073084				2022-12-26	WOS:000370331300011
J	Ganss, C; Lussi, A; Peutzfeldt, A; Attia, NN; Schlueter, N				Ganss, Carolina; Lussi, Adrian; Peutzfeldt, Anne; Attia, Nader Naguib; Schlueter, Nadine			Impact of Sn/F Pre-Treatments on the Durability of Protective Coatings against Dentine Erosion/Abrasion	PLOS ONE			English	Article							BOND STRENGTH; ADHESIVE SYSTEMS; EROSION; TOOTHPASTES; ABRASION; EFFICACY; SURFACES; RINSE	For preventing erosive wear in dentine, coating with adhesives has been suggested as an alternative to fluoridation. However, clinical studies have revealed limited efficacy. As there is first evidence that Sn2+ increases bond strength of the adhesive Clearfil SE (Kuraray), the aim of the present study was to investigate whether pre-treatment with different Sn2+/F- solutions improves the durability of Clearfil SE coatings. Dentine samples (eight groups, n=16/group) were freed of smear layer (0.5% citric acid, 10 s), treated (15 s) either with no solution (control), aminefluoride (AmF, 500 ppm F-, pH 4.5), SnCl2 (800/1600 ppm Sn2+; pH 1.5), SnCl2/AmF (500 ppm F-, 800 ppm Sn2+, pH 1.5/3.0/4.5), or Elmex Erosion Protection Rinse (EP, 500 ppm F-, 800 ppm Sn2+, pH 4.5; GABA International), then rinsed with water (15 s) and individually covered with Clearfil SE. Subsequently the specimens were subjected to an erosion/abrasion protocol consisting of 1320 cycles of immersion in 0.5% citric acid (5 degrees C/55 degrees C; 2 min) and automated brushing (15 s, 200 g, NaF-toothpaste, RDA 80). As the coatings proved stable up to 1320 cycles, 60 modified cycles (brushing time 30 min/cycle) were added. Wear was measured profilometrically. After SnCl2/AmF, pH 4.5 or EP pretreatment all except one coating survived. In the other groups, almost all coatings were lost and there was no significant difference to the control group. Pre-treatment with a Sn2+/F- solution at pH 4.5 seems able to improve the durability of adhesive coatings, rendering these an attractive option in preventing erosive wear in dentine.	[Ganss, Carolina; Attia, Nader Naguib; Schlueter, Nadine] Univ Giessen, Dept Conservat & Prevent Dent, Dent Clin, D-35390 Giessen, Germany; [Lussi, Adrian; Peutzfeldt, Anne] Univ Bern, Sch Dent Med, Dept Prevent Restorat & Pediat Dent, Bern, Switzerland	Justus Liebig University Giessen; University of Bern	Ganss, C (corresponding author), Univ Giessen, Dept Conservat & Prevent Dent, Dent Clin, D-35390 Giessen, Germany.	carolina.ganss@dentist.med.uni-giessen.de	Schlueter, Nadine/AAV-3591-2021					Azzopardi A, 2004, BRIT DENT J, V196, P351, DOI 10.1038/sj.bdj.4811083; Flury S, 2013, CLIN ORAL INVEST, V17, P217, DOI 10.1007/s00784-012-0697-1; Fukegawa D, 2006, J DENT RES, V85, P941, DOI 10.1177/154405910608501014; Ganss C, 2014, CARIES RES, V48, P163, DOI 10.1159/000354679; Ganss C, 2012, J DENT, V40, P1036, DOI 10.1016/j.jdent.2012.08.005; Ganss C, 2010, J DENT RES, V89, P1214, DOI 10.1177/0022034510375291; Ganss C, 2013, MONOGR ORAL SCI, V23, P88, DOI 10.1159/000350475; Ganss C, 2012, AM J DENT, V25, P351; Ghahremani D, 2017, ARAB J CHEM, V10, pS461, DOI 10.1016/j.arabjc.2012.10.006; Hiraishi N, 2014, J DENT, V42, P484, DOI 10.1016/j.jdent.2013.12.016; Lussi A, 2011, CARIES RES, V45, P2, DOI 10.1159/000325915; Peumans M, 2005, DENT MATER, V21, P864, DOI 10.1016/j.dental.2005.02.003; Peutzfeldt A, 2014, CLIN ORAL INVEST, V18, P535, DOI 10.1007/s00784-013-0975-6; Scherrer SS, 2010, DENT MATER, V26, pE78, DOI 10.1016/j.dental.2009.12.002; Schlueter N, 2013, J DENT, V41, P642, DOI 10.1016/j.jdent.2013.03.009; Sundaram G, 2007, OPER DENT, V32, P539, DOI 10.2341/06-177; Sundaram G, 2007, J DENT, V35, P814, DOI 10.1016/j.jdent.2007.07.015; Sundaram G, 2004, J ORAL REHABIL, V31, P505, DOI 10.1111/j.1365-2842.2004.01243.x; Van Landuyt KL, 2007, BIOMATERIALS, V28, P3757, DOI 10.1016/j.biomaterials.2007.04.044; Van Landuyt KL, 2006, J DENT, V34, P77, DOI 10.1016/j.jdent.2005.04.001; Wegehaupt FJ, 2012, INT J DENT, V2012, DOI 10.1155/2012/874359; Wegehaupt FJ, 2013, ACTA ODONTOL SCAND, V71, P1188, DOI 10.3109/00016357.2012.757361; Yoshida Y, 2012, J DENT RES, V91, P1060, DOI 10.1177/0022034512460396; Yoshida Y, 2012, J DENT RES, V91, P376, DOI 10.1177/0022034512437375; Zimmerli B, 2012, CLIN ORAL INVEST, V16, P1451, DOI 10.1007/s00784-011-0650-8	25	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0123889	10.1371/journal.pone.0123889	http://dx.doi.org/10.1371/journal.pone.0123889			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075906	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900003
J	Priori, D; Colombo, M; Clavenzani, P; Jansman, AJM; Lalles, JP; Trevisi, P; Bosi, P				Priori, Davide; Colombo, Michela; Clavenzani, Paolo; Jansman, Alfons J. M.; Lalles, Jean-Paul; Trevisi, Paolo; Bosi, Paolo			The Olfactory Receptor OR51E1 Is Present along the Gastrointestinal Tract of Pigs, Co-Localizes with Enteroendocrine Cells and Is Modulated by Intestinal Microbiota	PLOS ONE			English	Article							ENTEROTOXIGENIC ESCHERICHIA-COLI; BUTYRATE-PRODUCING BACTERIA; FATTY-ACID RECEPTOR; NET ABSORPTION; GENE-EXPRESSION; TASTE RECEPTORS; GUT MICROBIOTA; ODORANT; SEROTONIN; COLOSTRUM	The relevance of the butyrate-sensing olfactory receptor OR51E1 for gastrointestinal (GIT) functioning has not been considered so far. We investigated in young pigs the distribution of OR51E1 along the GIT, its relation with some endocrine markers, its variation with age and after interventions affecting the gut environment and intestinal microbiota. Immuno-reactive cells for OR51E1 and chromogranin A (CgA) were counted in cardial (CA), fundic (FU), pyloric (PL) duodenal (DU), jejunal (JE), ileal (IL), cecal (CE), colonic (CO) and rectal (RE) mucosae. OR51E1 co-localization with serotonin (5HT) and peptide YY (PYY) were evaluated in PL and CO respectively. FU and PL tissues were also sampled from 84 piglets reared from sows receiving either or not oral antibiotics (amoxicillin) around parturition, and sacrificed at days 14, 21, 28 (weaning) and 42 of age. JE samples were also obtained from 12 caesarean-derived piglets that were orally associated with simple (SA) or complex (CA) microbiota in the postnatal phase, and of which on days 26-37 of age jejunal loops were perfused for 8 h with enterotoxigenic Escherichia coli F4 (ETEC), Lactobacillus amylovorus or saline (CTRL). Tissue densities of OR51E1+ cells were in decreasing order: PL=DU>FU=CA>JE=IL=CE=CO=RE. OR51E1+ cells showed an enteroendocrine nature containing gastrointestinal hormones such as PYY or 5HT. OR51E1 gene expression in PL and FU increased during and after the suckling period (p<0.05). It was marginally reduced in offspring from antibiotic-treated sows (tendency, p=0.073), vs. control. Jejunal OR51E1 gene expression was reduced in piglets early associated with SA, compared with CA, and in ETEC-perfused loops vs. CTRL (p<0.01). Our results indicate that OR51E1 is related to GIT enteroendocrine activity. Moreover age, pathogen challenge and dietary manipulations influencing the gastrointestinal luminal microenvironment significantly affect the OR51E1 gene expression in GIT tissues presumably in association with the release of microbial metabolites.	[Priori, Davide; Colombo, Michela; Trevisi, Paolo; Bosi, Paolo] Univ Bologna, DISTAL, Bologna, Italy; [Clavenzani, Paolo] Univ Bologna, Dept Vet Sci, Ozzano Nellemilia, BO, Italy; [Jansman, Alfons J. M.] Wageningen UR Livestock Res, Wageningen, Netherlands; [Lalles, Jean-Paul] INRA, ADNC UR1341, St Gilles, France	University of Bologna; University of Bologna; Wageningen University & Research; INRAE	Bosi, P (corresponding author), Univ Bologna, DISTAL, Bologna, Italy.	paolo.bosi@unibo.it		TREVISI, PAOLO/0000-0001-7019-6828; Lalles, Jean-Paul/0000-0003-2732-5350	European Union [227549]	European Union(European Commission)	This work was financially supported by the European Union (contract No. 227549) through the Interplay project. The authors are solely responsible for the work described in this paper, and their opinions are not necessarily those of the European Union.	Adipietro KA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002821; Arnal ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118092; Arnal ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087967; Belenguer A, 2006, APPL ENVIRON MICROB, V72, P3593, DOI 10.1128/AEM.72.5.3593-3599.2006; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; BERG RD, 1975, INFECT IMMUN, V11, P320, DOI 10.1128/IAI.11.2.320-329.1975; Bosi P, 2004, J ANIM SCI, V82, P1764; Braun T, 2007, GASTROENTEROLOGY, V132, P1890, DOI 10.1053/j.gastro.2007.02.036; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]; Cherbut C, 1988, AM J PHYSIOL-GASTR L, V275, pG1415; Colombo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111447; Depoortere I, 2014, GUT, V63, P179, DOI 10.1136/gutjnl-2013-305112; Dibner JJ, 2008, J APPL POULTRY RES, V17, P174, DOI 10.3382/japr.2007-00100; Nguyen DT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-584; Elizondo-Salazar JA, 2009, J DAIRY SCI, V92, P4565, DOI 10.3168/jds.2009-2188; Feldmesser E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-121; Flegel C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055368; Foster SR, 2014, PHARMACOL THERAPEUT, V142, P41, DOI 10.1016/j.pharmthera.2013.11.004; Fujita Y, 2007, J RECEPT SIG TRANSD, V27, P323, DOI 10.1080/10799890701534180; Gershon MD, 2013, CURR OPIN ENDOCRINOL, V20, P14, DOI 10.1097/MED.0b013e32835bc703; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Godden S, 2006, J DAIRY SCI, V89, P3476, DOI 10.3168/jds.S0022-0302(06)72386-4; Gu XL, 2014, AM J RESP CELL MOL, V50, P637, DOI 10.1165/rcmb.2013-0199OC; Jansman AJM, 2012, J ANIM SCI, V90, P433, DOI 10.2527/jas.53850; Kang N, 2012, BMB REP, V45, P612, DOI 10.5483/BMBRep.2012.45.11.232; Karaki SI, 2008, J MOL HISTOL, V39, P135, DOI 10.1007/s10735-007-9145-y; Kiers JL, 2006, BRIT J NUTR, V95, P1193, DOI 10.1079/BJN20061772; Laycock G, 2012, VET IMMUNOL IMMUNOP, V149, P216, DOI 10.1016/j.vetimm.2012.07.004; Lee K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-596; Leja J, 2009, MODERN PATHOL, V22, P261, DOI 10.1038/modpathol.2008.174; Levine UY, 2013, APPL ENVIRON MICROB, V79, P3879, DOI 10.1128/AEM.00589-13; Li N, 2011, AM J PATHOL, V178, P662, DOI 10.1016/j.ajpath.2010.10.028; Li YR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001230; LONGO WE, 1991, SCAND J GASTROENTERO, V26, P442, DOI 10.3109/00365529108996507; Mazzoni M, 2013, J CELL MOL MED, V17, P466, DOI 10.1111/jcmm.12026; Metzler-Zebeli BU, 2011, FEMS MICROBIOL ECOL, V75, P402, DOI 10.1111/j.1574-6941.2010.01017.x; NABUURS MJA, 1993, RES VET SCI, V55, P108, DOI 10.1016/0034-5288(93)90043-F; NABUURS MJA, 1994, RES VET SCI, V56, P379, DOI 10.1016/0034-5288(94)90156-2; Nutten S, 2007, CLIN VACCINE IMMUNOL, V14, P190, DOI 10.1128/CVI.00055-06; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Priori D, 2013, ENERGY PROTEIN METAB, P295; Schumann A, 2005, PHYSIOL GENOMICS, V23, P235, DOI 10.1152/physiolgenomics.00057.2005; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Tajima K, 2010, ANAEROBE, V16, P6, DOI 10.1016/j.anaerobe.2009.04.002; Tazoe H, 2009, BIOMED RES-TOKYO, V30, P149, DOI 10.2220/biomedres.30.149; Theodorakis MJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE550, DOI 10.1152/ajpendo.00326.2004; Thompson CL, 2008, ISME J, V2, P739, DOI 10.1038/ismej.2008.29; Trevisi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081473; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Warner MJ, 2010, BIOCHEM J, V427, P333, DOI 10.1042/BJ20091861; Zentek J, 2012, ARCH ANIM NUTR, V66, P14, DOI 10.1080/1745039X.2011.644916; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800	52	38	39	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129501	10.1371/journal.pone.0129501	http://dx.doi.org/10.1371/journal.pone.0129501			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076344	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900078
J	Tan, K; An, L; Wang, SM; Wang, XD; Zhang, ZN; Miao, K; Sui, LL; He, SZ; Nie, JZ; Wu, ZH; Tian, JH				Tan, Kun; An, Lei; Wang, Shu-Min; Wang, Xiao-Dong; Zhang, Zhen-Ni; Miao, Kai; Sui, Lin-Lin; He, Shu-Zhi; Nie, Jing-Zhou; Wu, Zhong-Hong; Tian, Jian-Hui			Actin Disorganization Plays a Vital Role in Impaired Embryonic Development of In Vitro-Produced Mouse Preimplantation Embryos	PLOS ONE			English	Article							MELATONIN PROMOTES; CELLULAR CONTROL; GENE-EXPRESSION; 2-CELL EMBRYOS; BOVINE OOCYTES; FERTILIZATION; MICE; VIVO; MICROFILAMENTS; IMPLANTATION	Assisted reproductive technology (ART) is being increasingly applied to overcome infertility. However, the in vitro production process, the main procedure of ART, can lead to aberrant embryonic development and health-related problems in offspring. Understanding the mechanisms underlying the ART-induced side effects is important to improve the ART process. In this study, we carried out comparative transcriptome profiling between in vivo-(IVO) and in vitro-produced (IVP) mouse blastocysts. Our results suggested that aberrant actin organization might be a major factor contributing to the impaired development of IVP embryos. To test this, we examined the effect of actin disorganization on the development of IVP preimplantation embryos. Specific disruption of actin organization by cytochalasin B (CB) indicated that well-organized actin is essential for in vitro embryonic development. Supplementing the culture medium with 10(-9) M melatonin, a cytoskeletal modulator in adult somatic cells, significantly reversed the disrupted expression patterns of genes related to actin organization, including Arhgef2, Bcl2, Coro2b, Flnc, and Palld. Immunofluorescence analysis showed that melatonin treatment of IVP embryos significantly improved the distribution and organization of actin filaments (F-actin) from the 8-cell stage onwards. More importantly, we found that melatonin alleviated the CB-mediated aberrant F-actin distribution and organization and rescued CB-induced impaired embryonic development. This is the first study to indicate that actin disorganization is implicated in impaired development of IVP embryos during the preimplantation stage. We also demonstrated that improving actin organization is a promising strategy to optimize existing IVP systems.	[Tan, Kun; An, Lei; Wang, Shu-Min; Wang, Xiao-Dong; Zhang, Zhen-Ni; Miao, Kai; Sui, Lin-Lin; He, Shu-Zhi; Nie, Jing-Zhou; Wu, Zhong-Hong; Tian, Jian-Hui] China Agr Univ, Natl Engn Lab Anim Breeding, Key Lab Anim Genet Breeding & Reprod, Minist Agr,Coll Anim Sci & Technol, Beijing 100094, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Tian, JH (corresponding author), China Agr Univ, Natl Engn Lab Anim Breeding, Key Lab Anim Genet Breeding & Reprod, Minist Agr,Coll Anim Sci & Technol, Beijing 100094, Peoples R China.	tianjh@cau.edu.cn	Tan, Kun/Z-1045-2019; An, Lei/GQB-0039-2022	Tan, Kun/0000-0002-8567-7795; 	National Natural Science Foundation of China [31472092]; Earmarked Fund for the Innovative Teams of Beijing Swine Industrialization Research Program; National High-Tech RD Program [2011AA100303, 2013AA102506]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Earmarked Fund for the Innovative Teams of Beijing Swine Industrialization Research Program; National High-Tech RD Program(National High Technology Research and Development Program of China)	This work was supported by grants from the National Natural Science Foundation of China (No. 31472092), the Earmarked Fund for the Innovative Teams of Beijing Swine Industrialization Research Program, and the National High-Tech R&D Program (Nos. 2011AA100303, 2013AA102506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecia JA, 2002, VET RES COMMUN, V26, P151, DOI 10.1023/A:1014099719034; Abeydeera LR, 2002, THERIOGENOLOGY, V57, P257, DOI 10.1016/S0093-691X(01)00670-7; Ali AA, 2003, THERIOGENOLOGY, V59, P939, DOI 10.1016/S0093-691X(02)01125-1; Benitez-King G, 2009, HISTOL HISTOPATHOL, V24, P789, DOI 10.14670/HH-24.789; Biggers JD, 2005, HUM REPROD, V20, P3376, DOI 10.1093/humrep/dei228; Boumela I, 2011, REPRODUCTION, V141, P549, DOI 10.1530/REP-10-0504; Bovellan M, 2014, CURR BIOL, V24, P1628, DOI 10.1016/j.cub.2014.05.069; Delle Piane L, 2010, HUM REPROD, V25, P2039, DOI 10.1093/humrep/deq165; Doherty GJ, 2008, ANNU REV BIOPHYS, V37, P65, DOI 10.1146/annurev.biophys.37.032807.125912; Driver AM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-118; Duan X, 2015, HUM REPROD, V30, P1643, DOI 10.1093/humrep/dev091; Galano A, 2013, J PINEAL RES, V54, P245, DOI 10.1111/jpi.12010; Gao C, 2012, J PINEAL RES, V52, P305, DOI 10.1111/j.1600-079X.2011.00944.x; Giritharan G, 2007, REPRODUCTION, V134, P63, DOI 10.1530/REP-06-0247; Ishizuka B, 2000, J PINEAL RES, V28, P48, DOI 10.1034/j.1600-079x.2000.280107.x; Ke HN, 2010, CELL RES, V20, P458, DOI 10.1038/cr.2010.21; Kuijk EW, 2012, DEVELOPMENT, V139, P871, DOI 10.1242/dev.071688; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; Long CR, 1998, MOL REPROD DEV, V51, P59, DOI 10.1002/(SICI)1098-2795(199809)51:1&lt;59::AID-MRD7&gt;3.0.CO;2-V; Luo HJ, 2005, MOL CELL NEUROSCI, V29, P507, DOI 10.1016/j.mcn.2004.12.002; MACLEANFLETCHER S, 1980, CELL, V20, P329, DOI 10.1016/0092-8674(80)90619-4; Mathes AM, 2008, J PINEAL RES, V45, P337, DOI 10.1111/j.1600-079X.2008.00583.x; Nagy A., 2003, MANIPULATING MOUSE E; Natarajan M, 2001, J PINEAL RES, V31, P228, DOI 10.1034/j.1600-079X.2001.310306.x; Nie JZ, 2013, J PROTEOME RES, V12, P3843, DOI 10.1021/pr301044b; Niedenberger BA, 2014, REPRODUCTION; Okamoto H, 2004, J CLIN INVEST, V114, P214, DOI 10.1172/JCI200421645; Oliver VF, 2012, FERTIL STERIL, V97, P147, DOI 10.1016/j.fertnstert.2011.10.027; Pang YW, 2013, J PINEAL RES, V54, P389, DOI 10.1111/jpi.12024; PINYOPUMMINTR T, 1991, BIOL REPROD, V45, P736, DOI 10.1095/biolreprod45.5.736; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rivera RM, 2008, HUM MOL GENET, V17, P1, DOI 10.1093/hmg/ddm280; Rosenwaks Z, 2007, P NATL ACAD SCI USA, V104, P5709, DOI 10.1073/pnas.0701316104; Schieve LA, 2002, NEW ENGL J MED, V346, P731, DOI 10.1056/NEJMoa010806; Sekaran S, 2003, CURR BIOL, V13, P1290, DOI 10.1016/S0960-9822(03)00510-4; Shawlot W, 1998, TRANSGENIC RES, V7, P95, DOI 10.1023/A:1008816308171; Sun QY, 2006, REPRODUCTION, V131, P193, DOI 10.1530/rep.1.00847; Tamura H, 2008, J PINEAL RES, V44, P280, DOI 10.1111/j.1600-079X.2007.00524.X; Teodoro BG, 2014, J PINEAL RES; Tian XZ, 2010, ENDOCR RES, V35, P17, DOI 10.3109/07435800903539607; Tremoleda JL, 2003, BIOL REPROD, V69, P1895, DOI 10.1095/biolreprod.103.018515; Wang F, 2014, J PINEAL RES, V56, P333, DOI 10.1111/jpi.12126; Wang F, 2013, J PINEAL RES, V55, P267, DOI 10.1111/jpi.12069; Wang P, 2013, ZYGOTE, V26, P1; Wang WH, 1999, BIOL REPROD, V60, P1020, DOI 10.1095/biolreprod60.4.1020; Welch MD, 2002, ANNU REV CELL DEV BI, V18, P247, DOI 10.1146/annurev.cellbio.18.040202.112133; Zhu ZY, 2003, BIOL REPROD, V68, P943, DOI 10.1095/biolreprod.102.009910	48	20	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130382	10.1371/journal.pone.0130382	http://dx.doi.org/10.1371/journal.pone.0130382			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076347	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900168
J	Wang, K; Wang, DM; Pan, L; Yu, YW; Dong, F; Li, L; Wang, L; Liu, T; Zeng, XJ; Sun, LX; Zhu, GJ; Feng, K; Jonasson, JM; Wu, ZL; Xu, K; Pang, XL; Chen, T; Pan, H; Ma, J; Zhong, Y; Ping, B; Shan, GL				Wang, Ke; Wang, Dingming; Pan, Li; Yu, Yangwen; Dong, Fen; Li, Ling; Wang, Li; Liu, Tao; Zeng, Xianjia; Sun, Liangxian; Zhu, Guangjin; Feng, Kui; Jonasson, Junmei Miao; Wu, Zhenglai; Xu, Ke; Pang, Xinglong; Chen, Ting; Pan, Hui; Ma, Jin; Zhong, Yong; Ping, Bo; Shan, Guangliang			Prevalence of Obesity and Related Factors among Bouyei and Han Peoples in Guizhou Province, Southwest China	PLOS ONE			English	Article							BODY-MASS INDEX; WAIST CIRCUMFERENCE; RISK-FACTORS; SOCIOECONOMIC-STATUS; ABDOMINAL OBESITY; BLOOD-PRESSURE; OVERWEIGHT; HYPERTENSION; ASSOCIATION; COUNTRIES	Objective To investigate the prevalence of general and abdominal obesity and associated factors in Bouyei and Han peoples. Design A cross-sectional study was carried out in Guizhou province, southwest China in 2012, with multi-stage sampling to enroll 4551 participants aged 20 to 80 years. General and abdominal obesity were defined by World Health Organization (WHO) for Chinese. A design-based analysis was performed to evaluate prevalence of obesity and its related factors. Results Bouyei people had a significantly lower prevalence of general obesity (4.8% vs. 10.9%, p < 0.05) and abdominal obesity (13.6% vs. 26.8%, p < 0.05) than that in Han people. Prevalence of obesity increased with age until middle-age period and declined thereafter. Men aged 40-49 years group and women aged 50-59 years group have the highest prevalence of general obesity. Prevalence of abdominal obesity was higher than that of general obesity. Middle-age, Higher income, Han people were significantly associated with an increased risk of General/abdominal obesity. Conclusions Bouyei people had a lower prevalence of general and abdominal obesity than the Han people. Etiological studies should be conducted to determine underlying genetic factors and dietary factors.	[Wang, Ke; Pan, Li; Dong, Fen; Wang, Li; Zeng, Xianjia; Zhu, Guangjin; Feng, Kui; Wu, Zhenglai; Shan, Guangliang] Chinese Acad Med Sci, Sch Basic Med, Peking Union Med Coll, Inst Basic Med Sci, Beijing 100005, Peoples R China; [Wang, Dingming; Yu, Yangwen; Li, Ling; Liu, Tao; Sun, Liangxian] Guizhou Ctr Dis Control & Prevent, Guiyang 550004, Guizhou, Peoples R China; [Jonasson, Junmei Miao] Univ Gothenburg, Sahlgrenska Acad, Dept Publ Hlth & Community Med, Sect Social Med,Inst Med, Gothenburg, Sweden; [Xu, Ke; Pang, Xinglong; Chen, Ting; Pan, Hui; Ma, Jin; Zhong, Yong] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China; [Xu, Ke; Pang, Xinglong; Chen, Ting; Pan, Hui; Ma, Jin; Zhong, Yong] Peking Union Med Coll, Beijing 100730, Peoples R China; [Ping, Bo] Longli Ctr Dis Control & Prevent, Longli 551200, Guizhou, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; University of Gothenburg; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Ping, B (corresponding author), Longli Ctr Dis Control & Prevent, Longli 551200, Guizhou, Peoples R China.	gzlljkpb@126.com; guangliang_shan@hotmail.com	Jonasson, Junmei Miao/AAB-8053-2019	Jonasson, Junmei Miao/0000-0003-0206-8538	National Science and Technology Pillar Program during the Twelfth Five-Year Plan Period; Ministry of Science and Technology of China [2012BAI37B02]	National Science and Technology Pillar Program during the Twelfth Five-Year Plan Period; Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This study was supported by the National Science and Technology Pillar Program during the Twelfth Five-Year Plan Period sponsored by the Ministry of Science and Technology of China (Grant No. 2012BAI37B02). GS received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi Kiyoshi, 2006, Journal of Physiological Anthropology, V25, P371, DOI 10.2114/jpa2.25.371; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bei-Fan Z, 2002, ASIA PAC J CLIN NUTR, V11, pS685, DOI 10.1046/j.1440-6047.11.s8.9.x; Berg AO, 2004, ANN INTERN MED, V140, P554, DOI 10.7326/0003-4819-140-7-200404060-00016; Bigaard J, 2005, INT J OBESITY, V29, P778, DOI 10.1038/sj.ijo.0802976; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Chen CM, 2008, OBES REV, V9, P14, DOI 10.1111/j.1467-789X.2007.00433.x; Deitel M, 2003, OBES SURG, V13, P329, DOI 10.1381/096089203765887598; Doll S, 2002, INT J OBESITY, V26, P48, DOI 10.1038/sj.ijo.0801854; Erem C, 2004, OBES RES, V12, P1117, DOI 10.1038/oby.2004.140; FLEGAL KM, 1995, NEW ENGL J MED, V333, P1165, DOI 10.1056/NEJM199511023331801; Gao Y, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-919; HALL JE, 1993, HYPERTENSION, V22, P292, DOI 10.1161/01.HYP.22.3.292; HE J, 1991, AM J EPIDEMIOL, V134, P1085, DOI 10.1093/oxfordjournals.aje.a116012; Hong SY, 2012, EUR J CANCER PREV, V21, P523, DOI 10.1097/CEJ.0b013e328351c775; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Katulanda P, 2010, OBES REV, V11, P751, DOI 10.1111/j.1467-789X.2010.00746.x; Kim JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045815; Lee CMY, 2007, OBES REV, V8, P191, DOI 10.1111/j.1467-789X.2006.00292.x; Lemeshow S, 1998, AM J EPIDEMIOL, V148, P298; Li Bai-hui, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P915; Li Shengmei ZY, 2014, CHINA FOREIGN MED TR, V33; Li Xiao-yan, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P683; Liu Cheng, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P1139; Liu L, 2004, INT C SER, V262, P168; Lumley T., 2004, J STAT SOFTWARE, V9, P1; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Otgontuya D Jr, 2009, Malays J Nutr, V15, P185; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; POPKIN BM, 1994, NUTR REV, V52, P285, DOI 10.1111/j.1753-4887.1994.tb01460.x; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Wang W, 2001, Zhonghua Liu Xing Bing Xue Za Zhi, V22, P129; Wu YF, 2006, BMJ-BRIT MED J, V333, P362, DOI 10.1136/bmj.333.7564.362; Xi B, 2012, OBES REV, V13, P287, DOI 10.1111/j.1467-789X.2011.00944.x; Xu Y, 2003, CHINESE J DIS CONTRO, V7	35	9	11	5	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129230	10.1371/journal.pone.0129230	http://dx.doi.org/10.1371/journal.pone.0129230			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075708	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900056
J	Zhang, W; Kong, X; Wang, ZJ; Luo, S; Huang, W; Zhang, LJ				Zhang, Wei; Kong, Xiang; Wang, Zhen J.; Luo, Song; Huang, Wei; Zhang, Long Jiang			Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Gd-EOB-DTPA for the Evaluation of Liver Fibrosis Induced by Carbon Tetrachloride in Rats	PLOS ONE			English	Article							HEPATIC-FIBROSIS; NONINVASIVE ASSESSMENT; DCE-MRI; CIRRHOSIS; PARAMETERS; QUANTIFICATION; ELASTOGRAPHY; EXPERIENCE; CARCINOMA; CANCER	Purpose To investigate the utility of dynamic contrast-enhanced MRI (DCE-MRI) with Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) for detecting liver fibrosis induced by carbon tetrachloride (CCl4) in rats. Methods This study was approved by the institutional animal care and use committee. Liver fibrosis in rats was induced by intraperitoneal injection of 1 mL/kg 50% CCl4 twice a week for 4-13 weeks. Control rats were injected with saline. Liver fibrosis was graded using the Metaviar score: no fibrosis (F0), mild fibrosis (F1-F2) and advanced fibrosis (F3-F4). DCE-MRI with Gd-EOB-DTPA was performed for all rats. K-trans, K-ep, V-e and iAUC of the liver parenchyma were measured. Relative enhancement (RE) value of the liver was calculated on T-1-weighted images at 15, 20 and 25 min after Gd-EOB-DTPA administration. Results Thirty-five rats were included: no fibrosis (n=13), mild fibrosis (n=11) and advanced fibrosis (n=11). K-trans and iAUC values were highest in advanced fibrosis group and lowest in no fibrosis group (P<0.05). The area under the receiver operating characteristic curve (AUROC) for fibrosis (stages F1 and greater) were 0.773 and 0.882 for K-trans and iAUC, respectively. AUROC for advanced fibrosis were 0.835 and 0.867 for K-trans and iAUC, respectively. K-ep and RE values were not able to differentiate fibrosis stages (all P>0.05). Conclusion K-trans and iAUC obtained from DCE-MRI with Gd-EOB-DTPA are useful for the detection and staging of rat liver fibrosis induced by CCl4.	[Zhang, Wei; Kong, Xiang; Luo, Song; Huang, Wei; Zhang, Long Jiang] Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Imaging, Nanjing 210002, Jiangsu, Peoples R China; [Wang, Zhen J.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA	Nanjing University; University of California System; University of California San Francisco	Huang, W (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Imaging, Nanjing 210002, Jiangsu, Peoples R China.	radiology@126.com; kevinzhlj@163.com			National Natural Science Foundation of China [81171313]; Program for New Century Excellent Talents in the University [NCET-12-0260]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in the University(Program for New Century Excellent Talents in University (NCET))	This work was supported by grants from National Natural Science Foundation of China (grant No. 81171313 to L.J.Z.), and the Program for New Century Excellent Talents in the University (NCET-12-0260 to L.J.Z.).	Alonzi R, 2007, EUR J RADIOL, V63, P335, DOI 10.1016/j.ejrad.2007.06.028; Aryal MP, 2014, MAGN RESON MED, V71, P2206, DOI 10.1002/mrm.24873; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Boss MK, 2013, VET COMP ONCOL, V11, P87, DOI 10.1111/j.1476-5829.2011.00305.x; Chen BB, 2012, EUR RADIOL, V22, P171, DOI 10.1007/s00330-011-2249-5; Dyvorne HA, 2013, RADIOLOGY, V266, P920, DOI 10.1148/radiol.12120686; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Faria SC, 2009, RADIOGRAPHICS, V29, P1615, DOI 10.1148/rg.296095512; Feier D, 2013, RADIOLOGY, V269, P459, DOI 10.1148/radiol.13122482; Gulberg V, 2002, HEPATOLOGY, V35, P630, DOI 10.1053/jhep.2002.31722; Hahn OM, 2008, J CLIN ONCOL, V26, P4572, DOI 10.1200/JCO.2007.15.5655; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Jaw TS, 2012, KAOHSIUNG J MED SCI, V28, P130, DOI 10.1016/j.kjms.2011.10.017; Kim D, 2013, RADIOLOGY, V268, P411, DOI 10.1148/radiol.13121193; Leach MO, 2012, EUR RADIOL, V22, P1451, DOI 10.1007/s00330-012-2446-x; Leung VYF, 2013, RADIOLOGY, V269, P910, DOI 10.1148/radiol.13130128; Ma CM, 2014, LIFE SCI, V108, P104, DOI 10.1016/j.lfs.2014.05.016; Mross K, 2009, VASC CELL, V1, DOI 10.1186/2040-2384-1-5; Noren B, 2013, EUR RADIOL, V23, P174, DOI 10.1007/s00330-012-2583-2; Patel J, 2010, J MAGN RESON IMAGING, V31, P589, DOI 10.1002/jmri.22081; Sahin S, 2000, J PHYSIOL-LONDON, V528, P199, DOI 10.1111/j.1469-7793.2000.00199.x; Saito S, 2013, INVEST RADIOL, V48, P548, DOI 10.1097/RLI.0b013e3182856a06; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Seale MK, 2009, RADIOGRAPHICS, V29, P1725, DOI 10.1148/rg.296095515; Thukral A, 2007, RADIOLOGY, V244, P727, DOI 10.1148/radiol.2443060926; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Tsai JH, 2008, J VIRAL HEPATITIS, V15, P508, DOI 10.1111/j.1365-2893.2008.00971.x; Tsuda N, 2010, RADIOLOGY, V256, P767, DOI 10.1148/radiol.10092065; Van Beers BE, 2003, MAGN RESON MED, V49, P692, DOI 10.1002/mrm.10420; Varenika V, 2013, RADIOLOGY, V266, P151, DOI 10.1148/radiol.12112452; Verloh N, 2013, EUR J RADIOL, V82, P1710, DOI 10.1016/j.ejrad.2013.05.033; Walker-Samuel S, 2006, PHYS MED BIOL, V51, P3593, DOI 10.1088/0031-9155/51/14/021; Zissen MH, 2013, AM J ROENTGENOL, V201, P1204, DOI 10.2214/AJR.12.10039	34	22	34	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129621	10.1371/journal.pone.0129621	http://dx.doi.org/10.1371/journal.pone.0129621			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076199	Green Published, Green Submitted, gold			2022-12-26	WOS:000356329900086
J	Hue, I; Evain-Brion, D; Fournier, T; Degrelle, SA				Hue, Isabelle; Evain-Brion, Daniele; Fournier, Thierry; Degrelle, Severine A.			Primary Bovine Extra-Embryonic Cultured Cells: A New Resource for the Study of In Vivo Peri-Implanting Phenotypes and Mesoderm Formation	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; EPITHELIAL-MESENCHYMAL TRANSITIONS; MOUSE EMBRYO; TROPHOBLAST DEVELOPMENT; FETAL MEMBRANES; INTERFERON TAU; CT-1 CELLS; EXPRESSION; GENES; DIFFERENTIATION	In addition to nourishing the embryo, extra-embryonic tissues (EETs) contribute to early embryonic patterning, primitive hematopoiesis, and fetal health. These tissues are of major importance for human medicine, as well as for efforts to improve livestock efficiency, but they remain incompletely understood. In bovines, EETs are accessible easily, in large amounts, and prior to implantation. We took advantage of this system to describe, in vitro and in vivo, the cell types present in bovine EETs at Day 18 of development. Specifically, we characterized the gene expression patterns and phenotypes of bovine extra-embryonic ectoderm (or trophoblast; bTC), endoderm (bXEC), and mesoderm (bXMC) cells in culture and compared them to their respective in vivo micro-dissected cells. After a week of culture, certain characteristics (e.g., gene expression) of the in vitro cells were altered with respect to the in vivo cells, but we were able to identify "cores" of cell-type-specific (and substrate-independent) genes that were shared between in vitro and in vivo samples. In addition, many cellular phenotypes were cell-type-specific with regard to extracellular adhesion. We evaluated the ability of individual bXMCs to migrate and spread on micro-patterns, and observed that they easily adapted to diverse environments, similar to in vivo EE mesoderm cells, which encounter different EE epithelia to form chorion, yolk sac, and allantois. With these tissue interactions, different functions arose that were detected in silico and corroborated in vivo at D21-D25. Moreover, analysis of bXMCs allowed us to identify the EE cell ring surrounding the embryonic disc (ED) at D14-15 as mesoderm cells, which had been hypothesized but not shown prior to this study. We envision these data will serve as a major resource for the future in the analysis of peri-implanting phenotypes in response to the maternal metabolism and contribute to subsequent studies of placental/fetal development in eutherians.	[Hue, Isabelle; Degrelle, Severine A.] INRA, Biol Dev & Reprod UMR1198, Jouy En Josas, France; [Evain-Brion, Daniele; Fournier, Thierry; Degrelle, Severine A.] INSERM, Fac Sci Pharmaceut & Biol, UMR S1139, U767, Paris, France; [Evain-Brion, Daniele; Fournier, Thierry; Degrelle, Severine A.] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Evain-Brion, Daniele; Degrelle, Severine A.] PremUp Fdn, Paris, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Degrelle, SA (corresponding author), INRA, Biol Dev & Reprod UMR1198, Jouy En Josas, France.	severine.degrelle@inserm.fr	Hue, Isabelle/AAD-2341-2020; Degrelle, Severine/AAC-1726-2020; Fournier, Thierry C/E-5836-2016	Hue, Isabelle/0000-0002-3873-9738; Degrelle, Severine/0000-0001-6263-4875; Fournier, Thierry/0000-0002-7515-339X	PremUp foundation; INRA Department program ACI PHASE; INRA Department program AIP AGROBI; INRA Department program EMBIC European network of excellence headed at INRA	PremUp foundation; INRA Department program ACI PHASE; INRA Department program AIP AGROBI; INRA Department program EMBIC European network of excellence headed at INRA	This work was supported by PremUp foundation (S.A.D. post-doctoral fellowship), INRA Department programs ACI PHASE 2008, 2009, AIP AGROBI and EMBIC European network of excellence headed at INRA by O. Sandra.	Alev C, 2013, DEVELOPMENT, V140, P2691, DOI 10.1242/dev.094318; Arora R, 2012, BLOOD, V120, P2562, DOI 10.1182/blood-2012-03-390070; Bai H, 2011, J REPROD DEVELOP, V57, P518, DOI 10.1262/jrd.10-186K; Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Blomberg LA, 2006, MOL REPROD DEV, V73, P1491, DOI 10.1002/mrd.20503; Brown K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012016; Bruderer M, 2013, J VASC RES, V50, P265, DOI 10.1159/000353287; Bruhl T, 2004, CIRC RES, V94, P743, DOI 10.1161/01.RES.0000120861.27064.09; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; Costello I, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-54; Degrelle SA, 2011, PLACENTA, V32, P917, DOI 10.1016/j.placenta.2011.08.014; Degrelle SA, 2005, DEV BIOL, V288, P448, DOI 10.1016/j.ydbio.2005.09.043; Degrelle SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038309; Degrelle SA, 2011, REPRODUCTION, V141, P79, DOI 10.1530/REP-10-0174; Degrelle SA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-46; Evseenko D, 2010, P NATL ACAD SCI USA, V107, P13742, DOI 10.1073/pnas.1002077107; Ferner K, 2011, RESP PHYSIOL NEUROBI, V178, P39, DOI 10.1016/j.resp.2011.03.029; Ferrer-Vaquer A, 2010, CELL ADHES MIGR, V4, P447, DOI 10.4161/cam.4.3.10771; Flechon JE, 2004, GENESIS, V38, P13, DOI 10.1002/gene.10244; Fraser ST, 2009, J CELL BIOCHEM, V107, P586, DOI 10.1002/jcb.22165; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Gaivao MMF, 2014, THERIOGENOLOGY, V82, P354, DOI 10.1016/j.theriogenology.2014.04.018; Galat V, 2012, STEM CELLS DEV, V21, P1250, DOI 10.1089/scd.2010.0578; Genbacev O, 2011, STEM CELLS, V29, P1427, DOI 10.1002/stem.686; Gerbaud P, 2011, ENDOCRINOLOGY, V152, P5017, DOI 10.1210/en.2011-1193; Guillomot M, 2004, REPRODUCTION, V127, P491, DOI 10.1530/rep.1.00057; Guo W, 2014, ONCOGENE, V33, P537, DOI 10.1038/onc.2013.260; Hassoun R, 2009, DIFFERENTIATION, V78, P301, DOI 10.1016/j.diff.2009.07.006; Horejs CM, 2014, P NATL ACAD SCI USA, V111, P5908, DOI 10.1073/pnas.1403139111; Hue I, 2001, DEV GENES EVOL, V211, P157, DOI 10.1007/s004270100138; Hue I, 2013, METHODS MOL BIOL, V1074, P125, DOI 10.1007/978-1-62703-628-3_10; Hue I, 2012, ANIM REPROD SCI, V134, P19, DOI 10.1016/j.anireprosci.2012.08.007; Katsumoto K, 2011, DEVELOPMENT, V138, P1947, DOI 10.1242/dev.058719; Kinder SJ, 1999, DEVELOPMENT, V126, P4691; Koh S, 2014, THERIOGENOLOGY, V81, P103, DOI 10.1016/j.theriogenology.2013.09.009; Li HS, 2014, EMBO J, V33, P1383, DOI 10.15252/embj.201387594; Lim J, 2012, DEVELOPMENT, V139, P3471, DOI 10.1242/dev.071209; Maddox-Hyttel P, 2003, REPRODUCTION, V125, P607, DOI 10.1530/rep.0.1250607; Mammoto A, 2012, J CELL SCI, V125, P3061, DOI 10.1242/jcs.093005; Mancanares CAF, 2013, MICROSC RES TECHNIQ, V76, P756, DOI 10.1002/jemt.22227; Martal JL, 1998, BIOCHIMIE, V80, P755, DOI 10.1016/S0300-9084(99)80029-7; Maruotti J, 2012, MOL REPROD DEV, V79, P461, DOI 10.1002/mrd.22051; Mendjan S., 2014, CELL STEM CELL; Miyazaki H, 2002, PLACENTA, V23, P613, DOI 10.1053/plac.2002.0846; Moerkamp AT, 2013, DEV GROWTH DIFFER, V55, P301, DOI 10.1111/dgd.12036; Moissoglu K, 2014, CURR BIOL, V24, pR23, DOI 10.1016/j.cub.2013.10.075; Nagatomo H, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.108993; Oliveira VC, 2015, J TISSUE ENG REGENER; Palis J, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00003; Pennington KA, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-12; PERRY JS, 1981, J REPROD FERTIL, V62, P321; Pfeffer PL, 2012, REPRODUCTION, V143, P231, DOI 10.1530/REP-11-0374; Rakic JM, 2003, INVEST OPHTH VIS SCI, V44, P3186, DOI 10.1167/iovs.02-1092; Ramos-Ibeas P, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.118430; Richard C, 2014, THERIOGENOLOGY; Roberts RM, 2014, REPRODUCTION, V147, pD1, DOI 10.1530/REP-14-0080; Rugg-Gunn PJ, 2012, DEV CELL, V22, P887, DOI 10.1016/j.devcel.2012.01.005; Sakurai T, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100180; Schiffmacher AT, 2013, MOL REPROD DEV, V80, P826, DOI 10.1002/mrd.22212; Schiller HB, 2013, NAT CELL BIOL, V15, P625, DOI 10.1038/ncb2747; Schwartz B, 2014, MECH DEV; Scotti M, 2012, DEVELOPMENT, V139, P731, DOI 10.1242/dev.075408; Shimada A, 2001, PLACENTA, V22, P652, DOI 10.1053/plac.2001.0702; Smith M.A., 2014, TRENDS CELL BIOL; Swiers G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3924; Talbot NC, 2000, BIOL REPROD, V62, P235, DOI 10.1095/biolreprod62.2.235; Talbot NC, 2014, CYTOTECHNOLOGY; Talbot NC, 2007, IN VITRO CELL DEV-AN, V43, P72, DOI 10.1007/s11626-007-9014-8; TAM PPL, 1987, DEVELOPMENT, V99, P109; Tarrade A, 2001, LAB INVEST, V81, P1199, DOI 10.1038/labinvest.3780334; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Touzard E, 2013, REPRODUCTION, V146, P347, DOI 10.1530/REP-13-0143; Valour D, 2014, PHYSIOL GENOMICS, V46, P39, DOI 10.1152/physiolgenomics.00091.2013; Wang JH, 2009, CR BIOL, V332, P986, DOI 10.1016/j.crvi.2009.09.004; Warmflash A, 2014, NAT METHODS, V11, P847, DOI [10.1038/nmeth.3016, 10.1038/NMETH.3016]; WHEATLEY SC, 1993, DEVELOPMENT, V119, P295; Winograd-Katz SE, 2014, NAT REV MOL CELL BIO, V15, P273, DOI 10.1038/nrm3769; WOODING FBP, 1992, PLACENTA, V13, P101, DOI 10.1016/0143-4004(92)90025-O; Yamakoshi S, 2012, REPRODUCTION, V143, P377, DOI 10.1530/REP-11-0364; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001	80	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0127330	10.1371/journal.pone.0127330	http://dx.doi.org/10.1371/journal.pone.0127330			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070137	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000007
J	Martin-Moreno, AM; Roncador, G; Maestre, L; Mata, E; Jimenez, S; Martinez-Torrecuadrada, JL; Reyes-Garcia, AI; Rubio, C; Tomas, JF; Estevez, M; Pulford, K; Piris, MA; Garcia, JF				Martin-Moreno, Ana M.; Roncador, Giovanna; Maestre, Lorena; Mata, Elena; Jimenez, Scherezade; Martinez-Torrecuadrada, Jorge L.; Reyes-Garcia, Ana I.; Rubio, Carmen; Tomas, Jose F.; Estevez, Monica; Pulford, Karen; Piris, Miguel A.; Garcia, Juan F.			CSF1R Protein Expression in Reactive Lymphoid Tissues and Lymphoma: Its Relevance in Classical Hodgkin Lymphoma	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; COLONY-STIMULATING FACTOR; REED-STERNBERG CELLS; FOLLICULAR LYMPHOMA; FACTOR-I; SURVIVAL; PROGRESSION; PROGNOSIS; MICROENVIRONMENT; INHIBITOR	Tumour-associated macrophages (TAMs) have been associated with survival in classic Hodgkin lymphoma (cHL) and other lymphoma types. The maturation and differentiation of tissue macrophages depends upon interactions between colony-stimulating factor 1 receptor (CSF1R) and its ligands. There remains, however, a lack of consistent information on CSF1R expression in TAMs. A new monoclonal antibody, FER216, was generated to investigate CSF1R protein distribution in formalin fixed tissue samples from 24 reactive lymphoid tissues and 187 different lymphoma types. We also analysed the distribution of CSF1R+, CD68+ and CD163+ macrophages by double immunostaining, and studied the relationship between CSF1R expression and survival in an independent series of 249 cHL patients. CSF1R+ TAMs were less frequent in B-cell lymphocytic leukaemia and lymphoblastic B-cell lymphoma than in diffuse large B-cell lymphoma, peripheral T-cell lymphoma, angioimmunoblastic T-cell lymphoma and cHL. HRS cells in cHL and, with the exception of three cases of anaplastic large cell lymphoma, the neoplastic cells in NHLs, lacked detectable CSF1R protein. A CSF1R+ enriched microenvironment in cHL was associated with shorter survival in an independent series of 249 cHL patients. CSF1R pathway activation was evident in the cHL and inactivation of this pathway could be a potential therapeutic target in cHL cases.	[Martin-Moreno, Ana M.; Mata, Elena; Rubio, Carmen; Garcia, Juan F.] MD Anderson Canc Ctr, Dept Pathol, Madrid, Spain; [Roncador, Giovanna; Maestre, Lorena; Jimenez, Scherezade; Reyes-Garcia, Ana I.] Spanish Natl Canc Ctr CNIO, Monoclonal Antibodies Unit, Madrid, Spain; [Martinez-Torrecuadrada, Jorge L.] Spanish Natl Canc Ctr CNIO, Prote Unit, Madrid, Spain; [Tomas, Jose F.; Estevez, Monica] MD Anderson Canc Ctr, Dept Haematol, Madrid, Spain; [Pulford, Karen] Univ Oxford, John Radcliffe Hosp, Nuffield Div Clin Lab Sci, Radcliffe Dept Med, Oxford OX3 9DU, England; [Piris, Miguel A.] Hosp Univ Marques de Valdecilla, Dept Pathol, Santander, Spain	University of Texas System; UTMD Anderson Cancer Center; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); University of Texas System; UTMD Anderson Cancer Center; University of Oxford; Hospital Universitario Marques de Valdecilla (HUMV)	Garcia, JF (corresponding author), MD Anderson Canc Ctr, Dept Pathol, Madrid, Spain.	jfgarcia@mdanderson.es	GARCIA, JUAN/L-2118-2016; Martinez-Torrecuadrada, Jorge L./AAG-1090-2019; Piris, Miguel A/AAP-1445-2020; Piris, Miguel A/B-7067-2008; Maestre, Lorena/L-1352-2014; Roncador, Giovanna/L-1764-2014	Piris, Miguel A/0000-0001-5839-3634; Piris, Miguel A/0000-0001-5839-3634; Maestre, Lorena/0000-0001-8743-0422; Roncador, Giovanna/0000-0002-9807-2875; Martinez-Torrecuadrada, Jorge Luis/0000-0002-8240-6623; Rubio, Carmen/0000-0002-8275-5866	Fondo de Investigaciones Sanitarias - Ministerio de Ciencia e Innovacion [PI12/1832]; Spanish Cancer Research Networks-RTICC [RD12/0036/0060]; Fondo Europeo de Desarrollo Regional (FEDER); Asociacion Espanola Contra el Cancer (AECC Scientific Foundation)	Fondo de Investigaciones Sanitarias - Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentInstituto de Salud Carlos III); Spanish Cancer Research Networks-RTICC; Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Asociacion Espanola Contra el Cancer (AECC Scientific Foundation)	This work was supported by grants from the Fondo de Investigaciones Sanitarias - Ministerio de Ciencia e Innovacion (PI12/1832), and Spanish Cancer Research Networks-RTICC (RD12/0036/0060), cofunded by the Fondo Europeo de Desarrollo Regional (FEDER), and the Asociacion Espanola Contra el Cancer (AECC Scientific Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinelli C, 2011, ANN ONCOL, V22, P153; Alvaro T, 2005, CLIN CANCER RES, V11, P1467, DOI 10.1158/1078-0432.CCR-04-1869; Alvaro T, 2006, HAEMATOLOGICA, V91, P1605; Azambuja D, 2012, ANN ONCOL, V23, P736, DOI 10.1093/annonc/mdr157; Canioni D, 2008, J CLIN ONCOL, V26, P440, DOI 10.1200/JCO.2007.12.8298; Chetaille B, 2009, BLOOD, V113, P2765, DOI 10.1182/blood-2008-07-168096; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Devilard E, 2002, ONCOGENE, V21, P3095, DOI 10.1038/sj.onc.1205418; Dominguez-Soto A, 2011, J IMMUNOL, V186, P2192, DOI 10.4049/jimmunol.1000475; Espinosa I, 2011, AM J PATHOL, V179, P2100, DOI 10.1016/j.ajpath.2011.06.021; Espinosa I, 2009, AM J PATHOL, V174, P2347, DOI 10.2353/ajpath.2009.081037; Farinha P, 2005, BLOOD, V106, P2169, DOI 10.1182/blood-2005-04-1565; He HH, 2012, BLOOD, V120, P3152, DOI 10.1182/blood-2012-04-422758; HSU PL, 1991, INT J HEMATOL, V54, P315; Jakovic LR, 2011, LEUKEMIA LYMPHOMA, V52, P1913, DOI 10.3109/10428194.2011.580026; Kamper P, 2011, HAEMATOL-HEMATOL J, V96, P269, DOI 10.3324/haematol.2010.031542; Kanzler H, 1996, J EXP MED, V184, P1495, DOI 10.1084/jem.184.4.1495; Koh YW, 2014, AM J CLIN PATHOL, V141, P573, DOI 10.1309/AJCPR92TDDFARISU; Lamagna C, 2006, J LEUKOCYTE BIOL, V80, P705, DOI 10.1189/jlb.1105656; Lamprecht B, 2010, NAT MED, V16, P571, DOI 10.1038/nm.2129; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; MacDonald KPA, 2010, BLOOD, V116, P3955, DOI 10.1182/blood-2010-02-266296; Madan B, 2012, J IMMUNOL, V189, P4123, DOI 10.4049/jimmunol.1200675; Manthey CL, 2009, MOL CANCER THER, V8, P3151, DOI 10.1158/1535-7163.MCT-09-0255; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; Mitchem JB, 2013, CANCER RES, V73, P1128, DOI 10.1158/0008-5472.CAN-12-2731; Muenst S, 2009, HUM PATHOL, V40, P1715, DOI 10.1016/j.humpath.2009.03.025; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Ries CH, 2014, CANCER CELL, V25, P846, DOI 10.1016/j.ccr.2014.05.016; Sanchez-Aguilera A, 2006, BLOOD, V108, P662, DOI 10.1182/blood-2005-12-5125; Sanchez-Espiridion B, 2012, HAEMATOL-HEMATOL J, V97, P1080, DOI 10.3324/haematol.2011.055459; Sielska M, 2013, J PATHOL, V230, P310, DOI 10.1002/path.4192; Skinnider BF, 2002, BLOOD, V99, P4283, DOI 10.1182/blood-2002-01-0099; Steidl C, 2012, BLOOD, V120, P3530, DOI 10.1182/blood-2012-06-439570; Steidl C, 2011, J CLIN ONCOL, V29, P1812, DOI 10.1200/JCO.2010.32.8401; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Tan KL, 2012, BLOOD, V120, P3280, DOI 10.1182/blood-2012-04-421057; TANG RP, 1992, J CELL BIOCHEM, V50, P350, DOI 10.1002/jcb.240500403; Tzankov A, 2008, HAEMATOLOGICA, V93, P193, DOI 10.3324/haematol.11702; Ullrich K, 2011, BRIT J HAEMATOL, V155, P398, DOI 10.1111/j.1365-2141.2011.08685.x; Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Xu JY, 2013, CANCER RES, V73, P2782, DOI 10.1158/0008-5472.CAN-12-3981	46	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0125203	10.1371/journal.pone.0125203	http://dx.doi.org/10.1371/journal.pone.0125203			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066800	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000002
J	Park, KA; Lyu, I; Yoon, J; Jeong, U; Oh, JE; Lim, HW; Oh, SY				Park, Kyung-Ah; Lyu, Injeong; Yoon, Jungmin; Jeong, Unchang; Oh, Jae-Eung; Lim, Han Woong; Oh, Sei Yeul			Muscle Union Procedure in Patients with Paralytic Strabismus	PLOS ONE			English	Article							TRANSPOSITION; RECTUS	To present the surgical outcomes of a muscle union procedure in patients with paralytic strabismus, this retrospective study included 27 patients with paralytic strabismus who underwent a muscle union procedure. In this procedure, the two vertical rectus muscles are united with the paralytic horizontal muscle without splitting the muscles. Postoperative ocular deviations, complications, surgical success rates, and reoperation rates were obtained by examining the medical records of the patients. Seventeen patients had a sixth cranial nerve palsy, seven patients had a third cranial nerve palsy, and three patients had a medial rectus muscle palsy after endoscopic sinus surgery. The mean preoperative angle of horizontal deviation in the primary position was 56 +/- 21 prism diopters. The mean follow-up period was 12 +/-+/- 9 months. The mean final postoperative ocular deviation was 8 +/- 13 prism diopters. The success rate was 74%, and the reoperation rate was 0%. No significant complications, including anterior ischemia, occurred in any of the patients. One patient exhibited an increase in intraocular pressure in the immediate postoperative period, but this resolved spontaneously within 1 week. Our muscle union procedure was effective in patients with paralytic strabismus, especially in patients with a large angle of deviation. This muscle union procedure is potentially a suitable option for muscle transposition in patients with paralytic strabismus who have large-angle deviation or a significant residual angle after conventional surgery.	[Park, Kyung-Ah; Lyu, Injeong; Oh, Sei Yeul] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea; [Yoon, Jungmin; Jeong, Unchang; Oh, Jae-Eung] Hanyang Univ, Sch Mech Engn, Seoul 133791, South Korea; [Lim, Han Woong] Hanyang Univ, Coll Med, Dept Ophthalmol, Seoul 133791, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Hanyang University; Hanyang University	Oh, SY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea.	syoh@skku.edu	Lim, HW/GRY-3517-2022		Korea Healthcare Technology RD Project; Ministry of Health and Welfare, Republic of Korea [HI10C2020]	Korea Healthcare Technology RD Project; Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI10C2020).	Buckley EG, 1995, ATLAS OPHTHALMIC SUR, P140; Clark RA, 2002, AM J OPHTHALMOL, V133, P119, DOI 10.1016/S0002-9394(01)01264-8; Foster R S, 1997, J AAPOS, V1, P20, DOI 10.1016/S1091-8531(97)90019-7; Hussein MAW, 2003, AM J OPHTHALMOL, V136, P947, DOI 10.1016/S0002-9394(03)00486-0; Iizuka M, 2008, J AAPOS, V12, P27, DOI 10.1016/j.jaapos.2007.06.017; JENSEN C D, 1964, Trans Pac Coast Otoophthalmol Soc Annu Meet, V45, P359; KEECH RV, 1990, ARCH OPHTHALMOL-CHIC, V108, P176, DOI 10.1001/archopht.1990.01070040028016; Park Kyung-Ah, 2013, J Pediatr Ophthalmol Strabismus, V50 Online, pe11, DOI 10.3928/01913913-20130306-01; ROSENBAUM AL, 1989, ARCH OPHTHALMOL-CHIC, V107, P820, DOI 10.1001/archopht.1989.01070010842025	9	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129035	10.1371/journal.pone.0129035	http://dx.doi.org/10.1371/journal.pone.0129035			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070148	gold, Green Submitted, Green Published			2022-12-26	WOS:000356327000039
J	Mizugaki, S; Maehara, Y; Okanoya, K; Myowa-Yamakoshi, M				Mizugaki, Sanae; Maehara, Yukio; Okanoya, Kazuo; Myowa-Yamakoshi, Masako			The Power of an Infant's Smile: Maternal Physiological Responses to Infant Emotional Expressions	PLOS ONE			English	Article							BRAIN; ATTACHMENT; DEPRESSION; LAUGHTER; RECOVERY; MOTHERS; ADULTS; CRIES	Infant emotional expressions, such as distress cries, evoke maternal physiological reactions. Most of which involve accelerated sympathetic nervous activity. Comparatively little is known about effects of positive infant expressions, such as happy smiles, on maternal physiological responses. This study investigated how physiological and psychological maternal states change in response to infants' emotional expressions. Thirty first-time mothers viewed films of their own 6-to 7-month-old infants' affective behavior. Each observed a video of a distress cry followed by a video showing one of two expressions (randomly assigned): a happy smiling face (smile condition) or a calm neutral face (neutral condition). Both before and after the session, participants completed a self-report inventory assessing their emotional states. The results of the self-report inventory revealed no effects of exposure to the infant videos. However, the mothers in the smile condition, but not in the neutral condition, showed deceleration of skin conductance. These findings demonstrate that the mothers who observed their infants smiling showed decreased sympathetic activity. We propose that an infant's positive emotional expression may affect the branch of the maternal stress-response system that modulates the homeostatic balance of the sympathetic and parasympathetic nervous systems.	[Mizugaki, Sanae; Myowa-Yamakoshi, Masako] Kyoto Univ, Grad Sch Educ, Kyoto, Japan; [Maehara, Yukio] Nagasaki Univ, Fac Educ, Nagasaki 852, Japan; [Okanoya, Kazuo] Univ Tokyo, Dept Cognit & Behav Sci, Tokyo 1538902, Japan	Kyoto University; Nagasaki University; University of Tokyo	Myowa-Yamakoshi, M (corresponding author), Kyoto Univ, Grad Sch Educ, Kyoto, Japan.	myowa.masako.4x@kyoto-u.ac.jp	Myowa, Masako/E-8965-2010		Japan Society for the Promotion of Science; Ministry of Education Culture, Sports, Science and Technology [24119005, 24300103]; ERATO Okanoya Emotional Information Project, Japan Science and Technology Agency	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ERATO Okanoya Emotional Information Project, Japan Science and Technology Agency	This study was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science and the Ministry of Education Culture, Sports, Science and Technology (24119005, 24300103) to M. Myowa-Yamakoshi, and ERATO Okanoya Emotional Information Project, Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOWLBY J, 1982, AM J ORTHOPSYCHIAT, V52, P664, DOI 10.1111/j.1939-0025.1982.tb01456.x; Bowlby J, 1969, ATTACHMENT LOSS SEPA; Codispoti M, 2001, PSYCHOPHYSIOLOGY, V38, P474, DOI 10.1111/1469-8986.3830474; COLE PM, 1992, CHILD DEV, V63, P314, DOI 10.1111/j.1467-8624.1992.tb01629.x; Critchley HD, 2000, J NEUROSCI, V20, P3033; CROWE HP, 1992, CHILD ABUSE NEGLECT, V16, P19, DOI 10.1016/0145-2134(92)90005-C; Del Vecchio T, 2009, INFANT BEHAV DEV, V32, P117, DOI 10.1016/j.infbeh.2008.10.005; DONOVAN WL, 1978, PSYCHOPHYSIOLOGY, V15, P68, DOI 10.1111/j.1469-8986.1978.tb01337.x; ERBER R, 1992, J EXP SOC PSYCHOL, V28, P339, DOI 10.1016/0022-1031(92)90050-T; Fredrickson BL, 1998, COGNITION EMOTION, V12, P191; Fredrickson BL, 2000, MOTIV EMOTION, V24, P237, DOI 10.1023/A:1010796329158; FRODI AM, 1980, CHILD DEV, V51, P238, DOI 10.2307/1129612; Fujimura T, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00212; FUREDY JJ, 1989, PHYSIOL BEHAV, V46, P903, DOI 10.1016/0031-9384(89)90056-5; Giardino J, 2008, HORM BEHAV, V53, P149, DOI 10.1016/j.yhbeh.2007.09.010; Groh AM, 2009, DEV PSYCHOL, V45, P889, DOI 10.1037/a0014943; Hsu HC, 2001, INFANT BEHAV DEV, V24, P107, DOI 10.1016/S0163-6383(01)00061-3; Iida S, 2012, COGN AFFECT BEHAV NE, V12, P337, DOI 10.3758/s13415-012-0084-z; Iida S, 2011, COGN AFFECT BEHAV NE, V11, P476, DOI 10.3758/s13415-011-0045-y; Joosen KJ, 2013, INFANCY, V18, P414, DOI 10.1111/j.1532-7078.2012.00122.x; KOESTER LS, 1989, INT J BEHAV DEV, V12, P143, DOI 10.1177/016502548901200201; Levenson R. W., 1988, SOCIAL PSYCHOPHYSIOL, P17; Murray L, 2003, Arch Womens Ment Health, V6 Suppl 2, pS71, DOI 10.1007/s00737-003-0007-7; MURRAY L, 1992, J CHILD PSYCHOL PSYC, V33, P543, DOI 10.1111/j.1469-7610.1992.tb00890.x; Murray L, 1997, PSYCHOL MED, V27, P253, DOI 10.1017/S0033291796004564; Myowa-Yamakoshi Masako, 2010, P23; NWOKAH E, 1993, HUMOR, V6, P137, DOI 10.1515/humr.1993.6.2.137; NWOKAH EE, 1994, INFANT BEHAV DEV, V17, P23, DOI 10.1016/0163-6383(94)90019-1; Out D, 2010, GENES BRAIN BEHAV, V9, P868, DOI 10.1111/j.1601-183X.2010.00624.x; Riem MME, 2012, NEUROPSYCHOPHARMACOL, V37, P1257, DOI 10.1038/npp.2011.313; Sato A., 2001, JAPANESE J PERSONALI, V19, P138, DOI [DOI 10.2132/jjpjspp.9.2_138, DOI 10.2132/JJPJSPP.9.2_138]; Sokhadze EM, 2007, APPL PSYCHOPHYS BIOF, V32, P31, DOI 10.1007/s10484-007-9033-y; Strathearn L, 2008, PEDIATRICS, V122, P40, DOI 10.1542/peds.2007-1566; Strathearn L, 2009, NEUROPSYCHOPHARMACOL, V34, P2655, DOI 10.1038/npp.2009.103; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WOLFE DA, 1983, BEHAV ASSESS, V5, P363; Yuan JW, 2010, EMOTION, V10, P467, DOI 10.1037/a0018699	37	5	6	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129672	10.1371/journal.pone.0129672	http://dx.doi.org/10.1371/journal.pone.0129672			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK3FB	26065903	Green Published, gold, Green Submitted			2022-12-26	WOS:000356100900069
J	Saia, S; Ruisi, P; Fileccia, V; Di Miceli, G; Amato, G; Martinelli, F				Saia, Sergio; Ruisi, Paolo; Fileccia, Veronica; Di Miceli, Giuseppe; Amato, Gaetano; Martinelli, Federico			Metabolomics Suggests That Soil Inoculation with Arbuscular Mycorrhizal Fungi Decreased Free Amino Acid Content in Roots of Durum Wheat Grown under N-Limited, P-Rich Field Conditions	PLOS ONE			English	Article							REGULATORY NETWORKS; NITROGEN UPTAKE; PIPECOLIC ACID; METABOLISM; TRANSPORT; COLONIZATION; ARABIDOPSIS; RHIZOBACTERIA; TRANSLOCATION; CARBOHYDRATE	Arbuscular mycorrhizal fungi (AMF) have a major impact on plant nutrition, defence against pathogens, a plant's reaction to stressful environments, soil fertility, and a plant's relationship with other microorganisms. Such effects imply a broad reprogramming of the plant's metabolic activity. However, little information is available regarding the role of AMF and their relation to other soil plant growth-promoting microorganisms in the plant metabolome, especially under realistic field conditions. In the present experiment, we evaluated the effects of inoculation with AMF, either alone or in combination with plant growth-promoting rhizobacteria (PGPR), on the metabolome and changes in metabolic pathways in the roots of durum wheat (Triticum durum Desf.) grown under N-limited agronomic conditions in a P-rich environment. These two treatments were compared to infection by the natural AMF population (NAT). Soil inoculation with AMF almost doubled wheat root colonization by AMF and decreased the root concentrations of most compounds in all metabolic pathways, especially amino acids (AA) and saturated fatty acids, whereas inoculation with AMF+ PGPR increased the concentrations of such compounds compared to inoculation with AMF alone. Enrichment metabolomics analyses showed that AA metabolic pathways were mostly changed by the treatments, with reduced amination activity in roots most likely due to a shift from the biosynthesis of common AA to Y-amino butyric acid. The root metabolome differed between AMF and NAT but not AMF+ PGPR and AMF or NAT. Because the PGPR used were potent mineralisers, and AMF can retain most nitrogen (N) taken as organic compounds for their own growth, it is likely that this result was due to an increased concentration of mineral N in soil inoculated with AMF+ PGPR compared to AMF alone.	[Saia, Sergio; Ruisi, Paolo; Fileccia, Veronica; Di Miceli, Giuseppe; Amato, Gaetano; Martinelli, Federico] Univ Palermo, Dipartimento Sci Agr & Forestali, Palermo, Italy; [Saia, Sergio; Di Miceli, Giuseppe] Univ Palermo, Fdn A&S Lima Mancuso, Palermo, Italy	University of Palermo; University of Palermo	Martinelli, F (corresponding author), Univ Palermo, Dipartimento Sci Agr & Forestali, Palermo, Italy.	federico.martinelli@unipa.it	Amato, Gaetano/E-1105-2011; Saia, Sergio/K-7535-2012; Martinelli, Federico/F-7697-2013; Amato, Gaetano/AAT-2213-2020; Ruisi, Paolo/L-9337-2015	Amato, Gaetano/0000-0003-0660-7594; Saia, Sergio/0000-0001-5465-8500; Amato, Gaetano/0000-0003-0660-7594; DI MICELI, Giuseppe/0000-0002-8076-5972; Ruisi, Paolo/0000-0002-5807-6986	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Italy [PON01 01145-ISCOCEM]	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Italy(Ministry of Education, Universities and Research (MIUR))	The present research was funded by the project "Sviluppo tecnologico e innovazione per la sostenibilita e competitivita della cerealicoltura meridionale (PON01 01145-ISCOCEM)" (person in charge: Dr. Giuseppe Di Miceli - Fondazione A. e S. Lima Mancuso) of the Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Karaki G, 2004, MYCORRHIZA, V14, P263, DOI 10.1007/s00572-003-0265-2; Artursson V, 2006, ENVIRON MICROBIOL, V8, P1, DOI 10.1111/j.1462-2920.2005.00942.x; Bago B, 2003, PLANT PHYSIOL, V131, P1496, DOI 10.1104/pp.102.007765; Bago B, 2002, PLANT PHYSIOL, V128, P108, DOI 10.1104/pp.010466; Barea JM, 2002, NUTR CYCL AGROECOSYS, V63, P35, DOI 10.1023/A:1020589732436; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bouche N, 2004, TRENDS PLANT SCI, V9, P110, DOI 10.1016/j.tplants.2004.01.006; Carvalhais LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068555; Carvalhais LC, 2011, J PLANT NUTR SOIL SC, V174, P3, DOI 10.1002/jpln.201000085; Ceccarelli N, 2010, PLANT SOIL, V335, P311, DOI 10.1007/s11104-010-0417-z; Chagoyen M, 2011, BIOINFORMATICS, V27, P730, DOI 10.1093/bioinformatics/btr001; Fellbaum CR, 2012, P NATL ACAD SCI USA, V109, P2666, DOI 10.1073/pnas.1118650109; Fester T, 2011, OECOLOGIA, V167, P913, DOI 10.1007/s00442-011-2037-6; Gao XP, 2010, J SCI FOOD AGR, V90, P750, DOI 10.1002/jsfa.3878; Germida JJ, 1996, BIOL FERT SOILS, V23, P113, DOI 10.1007/s003740050147; Gika HG, 2014, J CHROMATOGR B, V966, P1, DOI 10.1016/j.jchromb.2014.01.054; Giovannetti M., 1980, New Phytologist, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Glick BR, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/963401; Govindarajulu M, 2005, NATURE, V435, P819, DOI 10.1038/nature03610; Guether M, 2009, PLANT PHYSIOL, V150, P73, DOI 10.1104/pp.109.136390; Guether M, 2009, NEW PHYTOL, V182, P200, DOI 10.1111/j.1469-8137.2008.02725.x; Gullberg J, 2004, ANAL BIOCHEM, V331, P283, DOI 10.1016/j.ab.2004.04.037; Helber N, 2011, PLANT CELL, V23, P3812, DOI 10.1105/tpc.111.089813; Hodge A, 2015, PLANT SOIL, V386, P1, DOI 10.1007/s11104-014-2162-1; Hodge A, 2010, P NATL ACAD SCI USA, V107, P13754, DOI 10.1073/pnas.1005874107; Jin H, 2005, NEW PHYTOL, V168, P687, DOI 10.1111/j.1469-8137.2005.01536.x; Johnson NC, 2015, NEW PHYTOL, V205, P1473, DOI 10.1111/nph.13172; Justes E, 1997, DIAGNOSTIC PROCED CR; Kind T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-234; Kobae Y, 2014, PLANT CELL PHYSIOL, V55, P1945, DOI 10.1093/pcp/pcu123; Laparre J, 2014, MOL PLANT, V7, P554, DOI 10.1093/mp/sst136; Larimer AL, 2010, SYMBIOSIS, V51, P139, DOI 10.1007/s13199-010-0083-1; Leader DP, 2011, RAPID COMMUN MASS SP, V25, P3422, DOI 10.1002/rcm.5245; Lee DY, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-7; Leigh J, 2011, FEMS MICROBIOL ECOL, V76, P428, DOI 10.1111/j.1574-6941.2011.01066.x; Lekberg Y, 2014, BOTANY, V92, DOI 10.1139/cjb-2013-0182; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; LONGNECKER N, 1993, CROP SCI, V33, P154, DOI 10.2135/cropsci1993.0011183X003300010028x; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Martinelli F, 2013, SCI HORTIC-AMSTERDAM, V159, P52, DOI 10.1016/j.scienta.2013.04.039; Martinelli F, 2012, SCI HORTIC-AMSTERDAM, V144, P201, DOI 10.1016/j.scienta.2012.07.012; Moche M, 2010, PLANTA, V231, P425, DOI 10.1007/s00425-009-1057-5; Mohammad A, 2004, AGR ECOSYST ENVIRON, V103, P245, DOI 10.1016/j.agee.2003.09.017; Morcuende R, 2007, PLANT CELL ENVIRON, V30, P85, DOI 10.1111/j.1365-3040.2006.01608.x; Navarova H, 2012, PLANT CELL, V24, P5123, DOI 10.1105/tpc.112.103564; PALFI G, 1968, PLANT SOIL, V29, P285, DOI 10.1007/BF01348946; Pfeffer PE, 1999, PLANT PHYSIOL, V120, P587, DOI 10.1104/pp.120.2.587; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; Pii Y, 2015, BIOL FERT SOILS, V51, P403, DOI 10.1007/s00374-015-0996-1; Ramos-Gonzalez MI, 2005, J BACTERIOL, V187, P4033, DOI 10.1128/JB.187.12.4033-4041.2005; Rasmussen S, 2008, PLANT PHYSIOL, V146, P1440, DOI 10.1104/pp.107.111898; Ryu CM, 2003, P NATL ACAD SCI USA, V100, P4927, DOI 10.1073/pnas.0730845100; Saia S, 2014, J AGR SCI-CAMBRIDGE, V152, P370, DOI 10.1017/S002185961300004X; Saia S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090738; SAS, 2008, SAS STAT 9 2 USER S; Scheible WR, 2004, PLANT PHYSIOL, V136, P2483, DOI 10.1104/pp.104.047019; Schliemann W, 2008, PHYTOCHEMISTRY, V69, P112, DOI 10.1016/j.phytochem.2007.06.032; Smith SE, 2011, ANNU REV PLANT BIOL, V62, P227, DOI 10.1146/annurev-arplant-042110-103846; Smith SE, 2008, MYCORRHIZAL SYMBIOSI, DOI [10.1126/science.1208473, DOI 10.1126/SCIENCE.1208473]; Somers E, 2004, CRIT REV MICROBIOL, V30, P205, DOI 10.1080/10408410490468786; Strehmel N, 2014, METABOLOMICS, V10, P324, DOI 10.1007/s11306-013-0569-y; Tanaka Y, 2005, PLANT CELL ENVIRON, V28, P1247, DOI 10.1111/j.1365-3040.2005.01360.x; Teng W, 2013, J EXP BOT, V64, P1403, DOI 10.1093/jxb/ert023; Vogel-Adghough D, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.26366; Vranova V, 2011, PLANT SOIL, V342, P31, DOI 10.1007/s11104-010-0673-y; Walker V, 2012, PLANT SOIL, V356, P151, DOI 10.1007/s11104-011-0960-2; Weckwerth W, 2004, PROTEOMICS, V4, P78, DOI 10.1002/pmic.200200500	68	39	44	3	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129591	10.1371/journal.pone.0129591	http://dx.doi.org/10.1371/journal.pone.0129591			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067663	Green Published, gold, Green Submitted			2022-12-26	WOS:000356100900060
J	Mhadhbi, M; Chaouch, M; Ajroud, K; Darghouth, MA; BenAbderrazak, S				Mhadhbi, Moez; Chaouch, Melek; Ajroud, Kaouthar; Darghouth, Mohamed Aziz; BenAbderrazak, Souha			Sequence Polymorphism of Cytochrome b Gene in Theileria annulata Tunisian Isolates and Its Association with Buparvaquone Treatment Failure	PLOS ONE			English	Article							ATOVAQUONE RESISTANCE; MOLECULAR-BASIS; TOXOPLASMA-GONDII; DRUG-RESISTANCE; MUTATIONS; HYDROXYNAPHTHOQUINONE; DIVERSITY; CARINII; MALARIA; COMPLEX	Background Buparvaquone (BW 720C) is the major hydroxynaphtoquinone active against tropical theileriosis (Theileria annulata infection). Previous studies showed that buparvaquone, similarly to others hydroxynaphtoquinone, probably acts by binding to cytochrome b (cyt b) inhibiting the electron transport chain in the parasite. Several observations suggested that T. annulatais becoming resistant to buparvaquone in many endemic regions (Tunisia, Turkey and Iran), which may hinder the development of bovine livestock in these areas. Methodology/Principal Findings In the present study we sought to determine whether point mutations in T. annulata cytochrome b gene could be associated to buparvaquone resistance. A total of 28 clones were studied in this work, 19 of which were obtained from 3 resistant isolates (ST2/12, ST2/13 and ST2/19) collected at different time after treatment, from a field treatment failure and nine clones isolated from 4 sensitive stocks of T. annulata(Beja, Battan, Jed4 and Sousse). The cytochrome b gene was amplified and sequenced. We identified five point mutations at the protein sequences (114, 129, 253, 262 and 347) specific for the clones isolated from resistant stocks. Two of them affecting 68% (13/19) of resistant clones, are present in the drug-binding site Q(02) region at the position 253 in three resistant clones and at the position 262 in 11 out of 19 resistant clones. These two mutations substitute a neutral and hydrophobic amino acids by polar and hydrophilic ones which could interfere with the drug binding capabilities. When we compared our sequences to the Iranian ones, the phylogenetic tree analyses show the presence of a geographical sub-structuring in the population of T. annulata. Conclusions/Significance Taken together, our results suggest that the cytochrome b gene may be used as a tool to discriminate between different T. annulata genotypes and also as a genetic marker to characterize resistant isolates of T. annulata.	[Mhadhbi, Moez; Darghouth, Mohamed Aziz] Univ Manouba, Ecole Natl Med Vet, Parasitol Lab, Sidi Thabet 2020, Tunisia; [Chaouch, Melek; Ajroud, Kaouthar; BenAbderrazak, Souha] Inst Pasteur Tunis, Lab Parasitol Med Biotechnol & Biomol, Tunis, Tunisia; [Mhadhbi, Moez] Univ Carthage, Fac Sci Bizerte, Tunis, Tunisia	Universite de la Manouba; Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Carthage	BenAbderrazak, S (corresponding author), Inst Pasteur Tunis, Lab Parasitol Med Biotechnol & Biomol, Tunis, Tunisia.	souha.benabderrazak@pasteur.rns.tn	Chaouch, Melek/AAF-8954-2019; Mhadhbi, Moez/S-3742-2018; Chaouch, Melek/AAL-8888-2021	Mhadhbi, Moez/0000-0002-4857-1780; Chaouch, Melek/0000-0001-5868-4204; Darghouth, Mohamed Aziz/0000-0003-1730-7431	Wellcome Trust Foundation [075820/A/04/]	Wellcome Trust Foundation(Wellcome Trust)	Wellcome Trust Foundation Ref: 075820/A/04/, MAD SB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENMILED L, 1994, PARASITOLOGY, V108, P51, DOI 10.1017/S0031182000078513; Bilgic HB, 2010, VET PARASITOL, V174, P341, DOI 10.1016/j.vetpar.2010.08.025; BOEHM P, 1981, J MED CHEM, V24, P295, DOI 10.1021/jm00135a011; Brown C G, 1990, Parassitologia, V32, P23; CROFT SL, 1992, J ANTIMICROB CHEMOTH, V30, P827, DOI 10.1093/jac/30.6.827; Darghouth MA, 1996, PARASITOL RES, V82, P647, DOI 10.1007/s004360050179; Darghouth MA, 1994, FINAL REPORT PROJECT; FEAGIN JE, 1992, MOL BIOCHEM PARASIT, V52, P145, DOI 10.1016/0166-6851(92)90046-M; Fivelman Quinton L, 2002, Malar J, V1, P1; FRY M, 1984, BIOCHEM PHARMACOL, V33, P2115, DOI 10.1016/0006-2952(84)90581-1; FRY M, 1992, BIOCHEM PHARMACOL, V43, P1545, DOI 10.1016/0006-2952(92)90213-3; Gharbi M, 2011, REV SCI TECH OIE, V30, P763; Hacilarlioglu S, 2012, JOINT C EM RE EM EP; HUDSON AT, 1991, DRUG EXP CLIN RES, V17, P427; Kaneshiro ES, 2001, J EUKARYOT MICROBIOL, p172S; Kessl JJ, 2007, TRENDS PARASITOL, V23, P494, DOI 10.1016/j.pt.2007.08.004; Kessl JJ, 2006, MOL BIOCHEM PARASIT, V146, P255, DOI 10.1016/j.molbiopara.2005.12.002; Kessl JJ, 2005, J BIOL CHEM, V280, P17142, DOI 10.1074/jbc.M500388200; Kessl JJ, 2004, J BIOL CHEM, V279, P2817, DOI 10.1074/jbc.M309984200; Korsinczky M, 2000, ANTIMICROB AGENTS CH, V44, P2100, DOI 10.1128/AAC.44.8.2100-2108.2000; MARTIN YC, 1973, J MED CHEM, V16, P1089, DOI 10.1021/jm00268a005; McFadden DC, 2000, MOL BIOCHEM PARASIT, V108, P1, DOI 10.1016/S0166-6851(00)00184-5; McHardy N., 1985, Immunization against theileriosis in Africa. Proceedings of a Joint Workshop, 1-5 October 1984, Nairobi, Kenya, ILRAD & FAO., P88; MCHARDY N, 1985, RES VET SCI, V39, P29, DOI 10.1016/S0034-5288(18)31765-X; MCHARDY N, 1985, RES VET SCI, V39, P1; Mhadhbi M, 2010, VET PARASITOL, V169, P241, DOI 10.1016/j.vetpar.2010.01.013; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; Sharifiyazdi H, 2012, VET PARASITOL, V187, P431, DOI 10.1016/j.vetpar.2012.01.016; SHIELS B, 1986, VET PARASITOL, V21, P1, DOI 10.1016/0304-4017(86)90137-8; Srivastava IK, 1999, MOL MICROBIOL, V33, P704, DOI 10.1046/j.1365-2958.1999.01515.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor LH, 2003, PARASITOLOGY, V126, P241, DOI 10.1017/S0031182002002810; Walker DJ, 1998, J INFECT DIS, V178, P1767, DOI 10.1086/314509; Walker DJ, 1998, DRUG RESIST UPDATE, V1, P201, DOI 10.1016/S1368-7646(98)80040-X; Weir W, 2011, INT J PARASITOL, V41, P193, DOI 10.1016/j.ijpara.2010.08.004	35	33	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129678	10.1371/journal.pone.0129678	http://dx.doi.org/10.1371/journal.pone.0129678			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061414	Green Published, gold, Green Submitted			2022-12-26	WOS:000355979500156
J	van Hinsbergen, DJJ; de Groot, LV; van Schaik, SJ; Spakman, W; Bijl, PK; Sluijs, A; Langereis, CG; Brinkhuis, H				van Hinsbergen, Douwe J. J.; de Groot, Lennart V.; van Schaik, Sebastiaan J.; Spakman, Wim; Bijl, Peter K.; Sluijs, Appy; Langereis, Cor G.; Brinkhuis, Henk			A Paleolatitude Calculator for Paleoclimate Studies	PLOS ONE			English	Article							TRUE POLAR WANDER; LARGE IGNEOUS PROVINCES; OCEAN TEMPERATURES; TECTONIC EVOLUTION; PACIFIC; CLIMATE; SUBDUCTION; RECONSTRUCTIONS; SURFACE; HOTSPOT	Realistic appraisal of paleoclimatic information obtained from a particular location requires accurate knowledge of its paleolatitude defined relative to the Earth's spin-axis. This is crucial to, among others, correctly assess the amount of solar energy received at a location at the moment of sediment deposition. The paleolatitude of an arbitrary location can in principle be reconstructed from tectonic plate reconstructions that (1) restore the relative motions between plates based on (marine) magnetic anomalies, and (2) reconstruct all plates relative to the spin axis using a paleomagnetic reference frame based on a global apparent polar wander path. Whereas many studies do employ high-quality relative plate reconstructions, the necessity of using a paleomagnetic reference frame for climate studies rather than a mantle reference frame appears under-appreciated. In this paper, we briefly summarize the theory of plate tectonic reconstructions and their reference frames tailored towards applications of paleoclimate reconstruction, and show that using a mantle reference frame, which defines plate positions relative to the mantle, instead of a paleomagnetic reference frame may introduce errors in paleolatitude of more than 15 degrees (>1500 km). This is because mantle reference frames cannot constrain, or are specifically corrected for the effects of true polar wander. We used the latest, state-of-the-art plate reconstructions to build a global plate circuit, and developed an online, user-friendly paleolatitude calculator for the last 200 million years by placing this plate circuit in three widely used global apparent polar wander paths. As a novelty, this calculator adds error bars to paleolatitude estimates that can be incorporated in climate modeling. The calculator is available at www.paleolatitude.org. We illustrate the use of the paleolatitude calculator by showing how an apparent wide spread in Eocene sea surface temperatures of southern high latitudes may be in part explained by a much wider paleolatitudinal distribution of sites than previously assumed.	[van Hinsbergen, Douwe J. J.; de Groot, Lennart V.; Spakman, Wim; Bijl, Peter K.; Sluijs, Appy; Langereis, Cor G.; Brinkhuis, Henk] Univ Utrecht, Dept Earth Sci, Utrecht, Netherlands; [van Schaik, Sebastiaan J.] Univ Oxford, E Res Ctr, Oxford, England; [Spakman, Wim] Univ Oslo, CEED, Oslo, Norway; [Brinkhuis, Henk] Royal Netherlands Inst Sea Res NIOZ, Den Burg, Netherlands	Utrecht University; University of Oxford; University of Oslo; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	van Hinsbergen, DJJ (corresponding author), Univ Utrecht, Dept Earth Sci, Utrecht, Netherlands.	D.J.J.vanHinsbergen@uu.nl	van Hinsbergen, Douwe J.J./X-1239-2019; Sluijs, Appy/B-3726-2009	Sluijs, Appy/0000-0003-2382-0215; Brinkhuis, Henk/0000-0003-0253-6610; van Hinsbergen, Douwe/0000-0003-3410-0344; Spakman, Wim/0000-0002-9557-778X; Langereis, Cor/0000-0001-9232-2178; de Groot, Lennart/0000-0002-1151-5662; Bijl, Peter/0000-0002-1710-4012	ERC [306810, 259627]; NWO Vidi grant [864.11.004, 863.13.002]; Research Council of Norway through its Centres of Excellence [223272]; Netherlands Earth System Science Centre (NESSC)	ERC(European Research Council (ERC)European Commission); NWO Vidi grant(Netherlands Organization for Scientific Research (NWO)); Research Council of Norway through its Centres of Excellence(Research Council of Norway); Netherlands Earth System Science Centre (NESSC)	DJJvH and AS acknowledge the ERC for Starting Grants, numbers 306810 (SINK) and 259627 (DINOPRO), respectively. DJJvH is supported through NWO Vidi grant no 864.11.004. PKB acknowledges NWO Veni grant no 863.13.002. WS acknowledges support of the Research Council of Norway through its Centres of Excellence funding scheme, project number 223272. This paper contributes to the ESF EUROCORES program TOPO-EUROPE. AS thanks the Netherlands Earth System Science Centre (NESSC) for funding paleoclimate sensitivity science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barron EJ, 1987, PALEOCEANOGRAPHY, V2, P729, DOI 10.1029/PA002i006p00729; BESSE J, 1991, J GEOPHYS RES-SOLID, V96, P4029, DOI 10.1029/90JB01916; Besse J, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2000JB000050; Bijl PK, 2013, P NATL ACAD SCI USA, V110, P9645, DOI 10.1073/pnas.1220872110; Bijl PK, 2009, NATURE, V461, P776, DOI 10.1038/nature08399; Boschman LM, 2014, EARTH-SCI REV, V138, P102, DOI 10.1016/j.earscirev.2014.08.007; Boyden J. A, 2011, GEOINFORMATICS CYBER, P95, DOI DOI 10.1017/CBO9780511976308.008; Burgess CE, 2008, GEOLOGY, V36, P651, DOI 10.1130/G24762A.1; Burke K, 2004, EARTH PLANET SC LETT, V227, P531, DOI 10.1016/j.epsl.2004.09.015; Butler RF, 1992, PALEOMAGNETISM; CANDE SC, 1995, J GEOPHYS RES-SOL EA, V100, P6093, DOI 10.1029/94JB03098; Collier JS, 2008, EARTH PLANET SC LETT, V272, P264, DOI 10.1016/j.epsl.2008.04.045; Cox A., 2009, PLATE TECTONICS IT W; Deenen MHL, 2011, GEOPHYS J INT, V186, P509, DOI 10.1111/j.1365-246X.2011.05050.x; Domeier M, 2014, GEOSCI FRONT, V5, P303, DOI 10.1016/j.gsf.2014.01.002; Doubrovine PV, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB009072; Doubrovine PV, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2008JB005584; Douglas PMJ, 2014, P NATL ACAD SCI USA, V111, P6582, DOI 10.1073/pnas.1321441111; Edenhofer O., 2014, CONTRIBUTION WORKING; FISHER R, 1953, PROC R SOC LON SER-A, V217, P295, DOI 10.1098/rspa.1953.0064; Frieling J, 2014, GEOLOGY, V42, P767, DOI 10.1130/G35724.1; Ganerod M, 2011, GEOL SOC SPEC PUBL, V357, P229, DOI 10.1144/SP357.12; GOLD T, 1955, NATURE, V175, P526, DOI 10.1038/175526a0; GOLDREICH P, 1969, J GEOPHYS RES, V74, P2555, DOI 10.1029/JB074i010p02555; Golonka J, 2003, MAR PETROL GEOL, V20, P211, DOI 10.1016/S0264-8172(03)00043-6; GREENWOOD DR, 1995, GEOLOGY, V23, P1044, DOI 10.1130/0091-7613(1995)023<1044:ECCALT>2.3.CO;2; Hall R, 2002, J ASIAN EARTH SCI, V20, P353, DOI 10.1016/S1367-9120(01)00069-4; Hall RL, 2012, INT J PHILOS RELIG, V71, P1, DOI 10.1007/s11153-012-9334-9; Hay WW, 1999, GEOL S AM S, P1; Hollis CJ, 2012, EARTH PLANET SC LETT, V349, P53, DOI 10.1016/j.epsl.2012.06.024; Hollis CJ, 2009, GEOLOGY, V37; HOSPERS J, 1954, NATURE, V173, P1183, DOI 10.1038/1731183a0; Houben A, 2012, UTRECHT STUDIES EART, V28; Huber M, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001014; Huber M, 2011, CLIM PAST, V7, P603, DOI 10.5194/cp-7-603-2011; Johnson CL, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001696; Kent DV, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB007205; Kim JH, 2010, GEOCHIM COSMOCHIM AC, V74, P4639, DOI 10.1016/j.gca.2010.05.027; LEPICHON X, 1968, J GEOPHYS RES, V73, P3661, DOI 10.1029/JB073i012p03661; Liu ZH, 2009, SCIENCE, V323, P1187, DOI 10.1126/science.1166368; Mattei M, 2014, GEOLOGY, V42, P555, DOI 10.1130/G35467.1; McQuarrie N, 2013, GEOLOGY, V41, P315, DOI 10.1130/G33591.1; Meijers MJM, 2010, EARTH PLANET SC LETT, V296, P210, DOI 10.1016/j.epsl.2010.04.052; MORGAN WJ, 1971, NATURE, V230, P42, DOI 10.1038/230042a0; Muller RD, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001743; MULLER RD, 1993, GEOLOGY, V21, P275, DOI 10.1130/0091-7613(1993)021<0275:RPMRTT>2.3.CO;2; Muttoni G, 2005, NATURE, V434, P59, DOI 10.1038/nature03378; Muttoni G, 2013, PALAEOGEOGR PALAEOCL, V386, P415, DOI 10.1016/j.palaeo.2013.06.011; Nokleberg WJ, 2000, 1626 US GEOL SURV; O'Neill C, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000784; Pearson PN, 2007, GEOLOGY, V35, P211, DOI 10.1130/G23175A.1; Pearson PN, 2009, NATURE, V461, P1110, DOI 10.1038/nature08447; Sangiorgi F, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001487; Schellart WP, 2006, EARTH-SCI REV, V76, P191, DOI 10.1016/j.earscirev.2006.01.002; Scotese C.R, 2001, ATLAS EARTH HIST; Seton M, 2012, EARTH-SCI REV, V113, P212, DOI 10.1016/j.earscirev.2012.03.002; Sigloch K, 2013, NATURE, V496, P50, DOI 10.1038/nature12019; Sluijs A, 2006, NATURE, V441, P610, DOI 10.1038/nature04668; Sluijs A, 2009, NAT GEOSCI, V2, P777, DOI 10.1038/NGEO668; Sluijs A, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2008PA001615; Stampfli GM, 2002, EARTH PLANET SC LETT, V196, P17, DOI 10.1016/S0012-821X(01)00588-X; Steinberger B, 2004, NATURE, V430, P167, DOI 10.1038/nature02660; Steinberger B, 2008, NATURE, V452, P620, DOI 10.1038/nature06824; Steinberger B, 2015, TERRA NOVA, V27, P1, DOI 10.1111/ter.12133; Steinberger B, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003808; Tarduno JA, 1997, EARTH PLANET SC LETT, V153, P171, DOI 10.1016/S0012-821X(97)00169-6; Tarduno J, 2009, SCIENCE, V324, P50, DOI 10.1126/science.1161256; Torsvik TH, 2008, REV GEOPHYS, V46, DOI 10.1029/2007RG000227; Torsvik TH, 2014, P NATL ACAD SCI USA, V111, P8735, DOI 10.1073/pnas.1318135111; Torsvik TH, 2012, EARTH-SCI REV, V114, P325, DOI 10.1016/j.earscirev.2012.06.007; Torsvik TH, 2010, NATURE, V466, P352, DOI 10.1038/nature09216; Torsvik TH, 2008, EARTH PLANET SC LETT, V276, P273, DOI 10.1016/j.epsl.2008.09.026; Torsvik TH, 2006, GEOPHYS J INT, V167, P1447, DOI 10.1111/j.1365-246X.2006.03158.x; van der Meer DG, 2012, NAT GEOSCI, V5, P215, DOI [10.1038/NGEO1401, 10.1038/ngeo1401]; van der Meer DG, 2010, NAT GEOSCI, V3, P36, DOI 10.1038/NGEO708; van Hinsbergen DJJ, 2014, SOLID EARTH, V5, P611, DOI 10.5194/se-5-611-2014; van Hinsbergen DJJ, 2014, TECTONICS, V33, P393, DOI 10.1002/2013TC003349; van Hinsbergen DJJ, 2012, TECTONICS, V31, DOI 10.1029/2012TC003132; van Hinsbergen DJJ, 2012, P NATL ACAD SCI USA, V109, P7659, DOI 10.1073/pnas.1117262109; van Hinsbergen DJJ, 2011, TECTONICS, V30, DOI 10.1029/2011TC002908; VINE FJ, 1963, NATURE, V199, P947, DOI 10.1038/199947a0; Vissers RLM, 2012, EARTH-SCI REV, V114, P61, DOI 10.1016/j.earscirev.2012.05.001; Vissers RLM, 2012, EARTH-SCI REV, V110, P93, DOI 10.1016/j.earscirev.2011.11.001; Vissers RLM, 2013, EARTH PLANET SC LETT, V380, P138, DOI 10.1016/j.epsl.2013.08.033; WILSON JT, 1963, CAN J PHYS, V41, P863, DOI 10.1139/p63-094; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zahirovic S, 2014, SOLID EARTH, V5, P227, DOI 10.5194/se-5-227-2014; Zhang YG, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2013.0096	89	298	302	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0126946	10.1371/journal.pone.0126946	http://dx.doi.org/10.1371/journal.pone.0126946			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061262	gold, Green Published			2022-12-26	WOS:000355979500022
J	Chan, WK; Howe, K; Clegg, JM; Guimond, SE; Price, DJ; Turnbull, JE; Pratt, T				Chan, Wai Kit; Howe, Katherine; Clegg, James M.; Guimond, Scott E.; Price, David J.; Turnbull, Jeremy E.; Pratt, Thomas			2-O Heparan Sulfate Sulfation by Hs2st Is Required for Erk/Mapk Signalling Activation at the Mid-Gestational Mouse Telencephalic Midline	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; FACTOR RECEPTOR; CRYSTAL-STRUCTURE; FGF; SPECIFICITY; EXPRESSION; PROLIFERATION; NEUROGENESIS; NEURONS; BINDING	Heparan sulfate (HS) is a linear carbohydrate composed of polymerized uronateglucosamine disaccharide units that decorates cell surface and secreted glycoproteins in the extracellular matrix. In mammals HS is subjected to differential sulfation by fifteen different heparan sulfotransferase (HST) enzymes of which Hs2st uniquely catalyzes the sulfation of the 2-O position of the uronate in HS. HS sulfation is postulated to be important for regulation of signaling pathways by facilitating the interaction of HS with signaling proteins including those of the Fibroblast Growth Factor (Fgf) family which signal through phosphorylation of extracellular signal-regulated kinases Erk1/2. In the developing mouse telencephalon Fgf2 signaling regulates proliferation and neurogenesis. Loss of Hs2st function phenocopies the thinned cerebral cortex of mutant mice in which Fgf2 or Erk1/2 function are abrogated, suggesting the hypothesis that 2-O-sulfated HS structures play a specific role in Fgf2/Erk signaling pathway in this context in vivo. This study investigated the molecular role of 2-O sulfation in Fgf2/Erk signaling in the developing telencephalic midline midway through mouse embryogenesis at E12.5. We examined the expression of Hs2st, Fgf2, and Erk1/2 activity in wild-type and Hs2st(-/-) mice. We found that Hs2st is expressed at high levels at the midline correlating with high levels of Erk1/2 activation and Erk1/2 activation was drastically reduced in the Hs2st(-/-) mutant at the rostral telencephalic midline. We also found that 2-O sulfation is specifically required for the binding of Fgf2 protein to Fgfr1, its major cell-surface receptor at the rostral telencephalic midline. We conclude that 2-O sulfated HS structures generated by Hs2st are needed to form productive signaling complexes between HS, Fgf2 and Fgfr1 that activate Erk1/2 at the midline. Overall, our data suggest the interesting possibility that differential expression of Hs2st targets the rostral telencephalic midline for high levels of Erk signaling by increasing the sensitivity of cells to an Fgf2 signal that is rather more widespread.	[Chan, Wai Kit; Howe, Katherine; Clegg, James M.; Price, David J.; Pratt, Thomas] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland; [Guimond, Scott E.; Turnbull, Jeremy E.] Univ Liverpool, Inst Integrat Biol, Dept Biochem, Ctr Glycobiol, Liverpool L69 7ZB, Merseyside, England	University of Edinburgh; University of Liverpool	Pratt, T (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland.	t.pratt@ed.ac.uk		Price, David/0000-0002-5318-307X; Chan, Kit Yee/0000-0002-3465-8383; Chan, Wai Kit/0000-0002-8097-0802; Pratt, Thomas/0000-0002-7105-3527; Guimond, Scott/0000-0002-5903-418X	MRC [G0701460]; Darwin International Scholarship; University of Edinburgh Global Research Scholarship; Medical Research Council [G0701460]; Wellcome Trust [094832/Z/10/Z]; Biotechnology and Biological Sciences Research Council [BB/M00693X/1] Funding Source: researchfish; BBSRC [BB/M00693X/1] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Darwin International Scholarship; University of Edinburgh Global Research Scholarship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by grants to TP from the MRC (G0701460). WKC is supported by a studentship from the Darwin International Scholarship and University of Edinburgh Global Research Scholarship. This work was also supported by the Medical Research Council (Grant G0701460), http://www.mrc.ac.uk/, and The Wellcome Trust (Grants 094832/Z/10/Z), http://www.wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen BL, 2003, J CELL BIOL, V163, P637, DOI 10.1083/jcb.200307053; Bai XM, 1996, J BIOL CHEM, V271, P17711, DOI 10.1074/jbc.271.30.17711; Bansal R, 2003, DEV NEUROSCI-BASEL, V25, P83, DOI 10.1159/000072258; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Bulow HE, 2004, NEURON, V41, P723, DOI 10.1016/S0896-6273(04)00084-4; Carlsson Pernilla, 2012, Handb Exp Pharmacol, P23, DOI 10.1007/978-3-642-23056-1_2; Clegg JM, 2014, J NEUROSCI, V34, P2389, DOI 10.1523/JNEUROSCI.3157-13.2014; Conway CD, 2011, J NEUROSCI, V31, P1955, DOI 10.1523/JNEUROSCI.2579-10.2011; Guimond SE, 2009, J BIOL CHEM, V284, P25714, DOI 10.1074/jbc.M109.032755; HABUCHI H, 1992, BIOCHEM J, V285, P805, DOI 10.1042/bj2850805; Holt CE, 2005, NEURON, V46, P169, DOI 10.1016/j.neuron.2005.03.021; Iwata T, 2009, DEV GROWTH DIFFER, V51, P299, DOI 10.1111/j.1440-169X.2009.01104.x; Kinnunen T, 2005, P NATL ACAD SCI USA, V102, P1507, DOI 10.1073/pnas.0401591102; Kobayashi M, 1997, J BIOL CHEM, V272, P13980, DOI 10.1074/jbc.272.21.13980; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Lee JS, 2004, NAT REV GENET, V5, P923, DOI 10.1038/nrg1490; Liu X, 2014, CELL SIGNAL; Loo BM, 2000, INT J BIOCHEM CELL B, V32, P489, DOI 10.1016/S1357-2725(99)00145-4; MACCARANA M, 1994, J BIOL CHEM, V269, P3903; McLaughlin D, 2003, MECH DEVELOP, V120, P1481, DOI 10.1016/j.mod.2003.08.008; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; Nakato H, 2002, BBA-GEN SUBJECTS, V1573, P312, DOI 10.1016/S0304-4165(02)00398-7; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; Pan Y, 2006, DEVELOPMENT, V133, P4933, DOI 10.1242/dev.02679; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Pucilowska J, 2012, J NEUROSCI, V32, P8663, DOI 10.1523/JNEUROSCI.1107-12.2012; Qu XX, 2011, J BIOL CHEM, V286, P14435, DOI 10.1074/jbc.M111.225003; Raballo R, 2000, J NEUROSCI, V20, P5012; Sahara S, 2009, NEURON, V63, P48, DOI 10.1016/j.neuron.2009.06.006; Samuels IS, 2008, J NEUROSCI, V28, P6983, DOI 10.1523/JNEUROSCI.0679-08.2008; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Shin DM, 2004, J NEUROSCI, V24, P2247, DOI 10.1523/JNEUROSCI.5285-03.2004; Skidmore MA, 2006, J CHROMATOGR A, V1135, P52, DOI 10.1016/j.chroma.2006.09.064; Skidmore MA, 2010, NAT PROTOC, V5, P1983, DOI 10.1038/nprot.2010.145; Stauber DJ, 2000, P NATL ACAD SCI USA, V97, P49, DOI 10.1073/pnas.97.1.49; Toyoda R, 2010, DEVELOPMENT, V137, P3439, DOI 10.1242/dev.055392; Vaccarino FM, 2009, J AUTISM DEV DISORD, V39, P511, DOI 10.1007/s10803-008-0653-8; Vaccarino FM, 1999, NAT NEUROSCI, V2, P485, DOI 10.1038/8163; Yoon KJ, 2004, J NEUROSCI, V24, P9497, DOI 10.1523/JNEUROSCI.0993-04.2004	40	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130147	10.1371/journal.pone.0130147	http://dx.doi.org/10.1371/journal.pone.0130147			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075383	Green Published, gold			2022-12-26	WOS:000356329900144
J	Espinosa-Carrasco, G; Villard, M; Le Saout, C; Louis-Plence, P; Vicente, R; Hernandez, J				Espinosa-Carrasco, Gabriel; Villard, Marine; Le Saout, Cecile; Louis-Plence, Pascale; Vicente, Rita; Hernandez, Javier			Systemic LPS Translocation Activates Cross-Presenting Dendritic Cells but Is Dispensable for the Breakdown of CD8(+) T Cell Peripheral Tolerance in Irradiated Mice	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; TOTAL-BODY IRRADIATION; MEMORY-LIKE CD8(+); HOMEOSTATIC PROLIFERATION; CUTTING EDGE; MICROBIAL TRANSLOCATION; IMMUNE-SYSTEM; IN-VIVO; SELF-ANTIGENS; HELPER-CELLS	Lymphodepletion is currently used to enhance the efficacy of cytotoxic T lymphocyte adoptive transfer immunotherapy against cancer. This beneficial effect of conditioning regimens is due, at least in part, to promoting the breakdown of peripheral CD8(+) T cell tolerance. Lymphodepletion by total body irradiation induces systemic translocation of commensal bacteria LPS from the gastrointestinal tract. Since LPS is a potent activator of the innate immune system, including antigen presenting dendritic cells, we hypothesized that LPS translocation could be required for the breakdown of peripheral tolerance observed in irradiated mice. To address this issue, we have treated irradiated mice with antibiotics in order to prevent LPS translocation and utilized them in T cell adoptive transfer experiments. Surprisingly, we found that despite of completely blocking LPS translocation into the bloodstream, antibiotic treatment did not prevent the breakdown of peripheral tolerance. Although irradiation induced the activation of cross-presenting CD8(+) dendritic cells in the lymphoid tissue, LPS could not solely account for this effect. Activation of dendritic cells by mechanisms other than LPS translocation is sufficient to promote the differentiation of potentially autoreactive CD8(+) T cells into effectors in irradiated mice. Our data indicate that LPS translocation is dispensable for the breakdown of CD8(+) T cell tolerance in irradiated mice.	[Espinosa-Carrasco, Gabriel; Villard, Marine; Louis-Plence, Pascale; Vicente, Rita; Hernandez, Javier] INSERM, Inst Regenerat Med & Biotherapy, U1183, F-34295 Montpellier, France; [Espinosa-Carrasco, Gabriel; Villard, Marine; Louis-Plence, Pascale; Vicente, Rita; Hernandez, Javier] Univ Montpellier, UFR Med, F-34000 Montpellier, France; [Le Saout, Cecile] NIAID, CMRS, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Hernandez, J (corresponding author), INSERM, Inst Regenerat Med & Biotherapy, U1183, F-34295 Montpellier, France.	francisco-javier.hernandez@inserm.fr	Espinosa Carrasco, Gabriel/AFR-8047-2022; Louis-Plence, Pascale/H-1553-2015	Louis-Plence, Pascale/0000-0001-7701-5241; VILLARD, Marine/0000-0002-3905-8993; Hernandez, Javier/0000-0002-7218-7519	European Community SUDOE-FEDER [IMMUNONET SOE1/P1/E014]; La Ligue Contre le Cancer Herault	European Community SUDOE-FEDER; La Ligue Contre le Cancer Herault	This work was supported by grants from the European Community SUDOE-FEDER (Contract # IMMUNONET SOE1/P1/E014) and La Ligue Contre le Cancer Herault to JH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony PA, 2005, J IMMUNOL, V174, P2591, DOI 10.4049/jimmunol.174.5.2591; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; Bogdandi EN, 2010, RADIAT RES, V174, P480, DOI 10.1667/RR2160.1; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2012, ANNU REV IMMUNOL, V30, P149, DOI 10.1146/annurev-immunol-020711-075001; Brown IE, 2006, J IMMUNOL, V177, P4521, DOI 10.4049/jimmunol.177.7.4521; Caradonna L, 2000, J ENDOTOXIN RES, V6, P205, DOI 10.1177/09680519000060030101; Cho BK, 2000, J EXP MED, V192, P549, DOI 10.1084/jem.192.4.549; Cooke KR, 1998, J CLIN INVEST, V102, P1882, DOI 10.1172/JCI4285; Cooke KR, 2002, J ENDOTOXIN RES, V8, P441, DOI 10.1179/096805102125001046; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Dummer W, 2002, J CLIN INVEST, V110, P185, DOI 10.1172/JCI200215175; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Gallo PM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00138; Gattinoni L, 2005, J EXP MED, V202, P907, DOI 10.1084/jem.20050732; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Goldrath AW, 2000, J EXP MED, V192, P557, DOI 10.1084/jem.192.4.557; Hamilton SE, 2006, NAT IMMUNOL, V7, P475, DOI 10.1038/ni1326; Hamilton-Williams EE, 2005, J IMMUNOL, V174, P1159, DOI 10.4049/jimmunol.174.3.1159; Hernandez J, 2002, J EXP MED, V196, P323, DOI 10.1084/jem.20011612; Hernandez J, 2001, J EXP MED, V194, P707, DOI 10.1084/jem.194.6.707; Hill GR, 1997, BLOOD, V90, P3204, DOI 10.1182/blood.V90.8.3204; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Jankovic D, 2013, J EXP MED, V210, P1899, DOI 10.1084/jem.20130084; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Khoruts A, 2005, IMMUNOL LETT, V98, P23, DOI 10.1016/j.imlet.2004.10.022; Kieper WC, 2005, J IMMUNOL, V174, P3158, DOI 10.4049/jimmunol.174.6.3158; Kieper WC, 1999, P NATL ACAD SCI USA, V96, P13306, DOI 10.1073/pnas.96.23.13306; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Langrehr JM, 2000, TRANSPLANTATION, V69, P2415, DOI 10.1097/00007890-200006150-00035; Le Saout C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012659; Le Saout C, 2008, P NATL ACAD SCI USA, V105, P19414, DOI 10.1073/pnas.0807743105; LO D, 1992, EUR J IMMUNOL, V22, P1013, DOI 10.1002/eji.1830220421; LUMSDEN AB, 1988, HEPATOLOGY, V8, P232, DOI 10.1002/hep.1840080207; Mildner A, 2014, IMMUNITY, V40, P642, DOI 10.1016/j.immuni.2014.04.016; Morgan DJ, 1996, J IMMUNOL, V157, P978; Murali-Krishna K, 2000, J IMMUNOL, V165, P1733, DOI 10.4049/jimmunol.165.4.1733; NANDA NK, 1995, CELL, V82, P13, DOI 10.1016/0092-8674(95)90047-0; Oelert T, 2010, BLOOD, V115, P2196, DOI 10.1182/blood-2009-06-227298; Opal SM, 1999, J INFECT DIS, V180, P1584, DOI 10.1086/315093; Paulos CM, 2007, J CLIN INVEST, V117, P2197, DOI 10.1172/JCI32205; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Sandler NG, 2011, GASTROENTEROLOGY, V141, P1220, DOI 10.1053/j.gastro.2011.06.063; Scheinecker C, 2002, J EXP MED, V196, P1079, DOI 10.1084/jem.20020991; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; SCOTT B, 1994, IMMUNITY, V1, P73, DOI 10.1016/1074-7613(94)90011-6; Scott MJ, 2009, HEPATOLOGY, V49, P1695, DOI 10.1002/hep.22839; Shalapour S, 2010, EUR J IMMUNOL, V40, P2391, DOI 10.1002/eji.201040441; Sirinivasan M, 2009, CYTOKINE, V46, P147, DOI 10.1016/j.cyto.2009.01.010; Surana NK, 2014, J CLIN INVEST, V124, P4197, DOI 10.1172/JCI72332; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Viret C, 1999, IMMUNITY, V10, P559, DOI 10.1016/S1074-7613(00)80055-2; Xing Y, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006957	59	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130041	10.1371/journal.pone.0130041	http://dx.doi.org/10.1371/journal.pone.0130041			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075613	Green Published, Green Submitted, gold			2022-12-26	WOS:000356329900127
J	Inoue, S; Kobayashi, F; Nishihara, M; Arai, YCP; Ikemoto, T; Kawai, T; Inoue, M; Hasegawa, T; Ushida, T				Inoue, Shinsuke; Kobayashi, Fumio; Nishihara, Makoto; Arai, Young-Chang P.; Ikemoto, Tatsunori; Kawai, Takashi; Inoue, Masayuki; Hasegawa, Tomomi; Ushida, Takahiro			Chronic Pain in the Japanese Community-Prevalence, Characteristics and Impact on Quality of Life	PLOS ONE			English	Article							PRIMARY-CARE PATIENTS; GENERAL-POPULATION; MUSCULOSKELETAL PAIN; RHEUMATOID-ARTHRITIS; WEATHER SENSITIVITY; EPIDEMIOLOGY; DEPRESSION; ASSOCIATION; DISABILITY; COMPLAINTS	Background Chronic pain is recognized as a public health problem that affects the general population physically, psychologically, and socially. However, there is little knowledge about the associated factors of chronic pain, such as the influence of weather, family structure, daily exercise, and work status. Objectives This survey had three aims: 1) to estimate the prevalence of chronic pain in Japan, 2) to analyze these associated factors, and 3) to evaluate the social burden due to chronic pain. Methods We conducted a cross-sectional postal survey in a sample of 6000 adults aged >= 20 years. The response rate was 43.8%. Results The mean age of the respondents was 57.7 years (range 20-99 years); 39.3% met the criteria for chronic pain (lasting >= 3 months). Approximately a quarter of the respondents reported that their chronic pain was adversely influenced by bad weather and also oncoming bad weather. Risk factors for chronic pain, as determined by a logistic regression model, included being an older female, being unemployed, living alone, and no daily exercise. Individuals with chronic pain showed significantly lower quality of life and significantly higher psychological distress scores than those without chronic pain. The mean annual duration of absence from work of working-age respondents was 9.6 days (range 1-365 days). Conclusions Our findings revealed that high prevalence and severity of chronic pain, associated factors, and significant impact on quality of life in the adult Japanese population. A detailed understanding of factors associated with chronic pain is essential for establishing a management strategy for primary care.	[Inoue, Shinsuke; Nishihara, Makoto; Arai, Young-Chang P.; Kawai, Takashi; Ushida, Takahiro] Aichi Med Univ, Ctr Multidisciplinary Pain, Nagakuteshi, Aichi 4801195, Japan; [Kobayashi, Fumio; Hasegawa, Tomomi] Aichi Med Univ, Dept Hlth & Psychosocial Med, Nagakuteshi, Aichi 4801195, Japan; [Ikemoto, Tatsunori; Inoue, Masayuki] Aichi Med Univ, Sch Med, Inst Phys Fitness Sports Med & Rehabil, Nagakuteshi, Aichi 4801195, Japan	Aichi Medical University; Aichi Medical University; Aichi Medical University	Inoue, S (corresponding author), Aichi Med Univ, Ctr Multidisciplinary Pain, Nagakuteshi, Aichi 4801195, Japan.	misty-ssk@umin.net	Ikemoto, Tatsunori/E-3839-2018	Ikemoto, Tatsunori/0000-0002-4521-7639	Ministry of Health, Labour and Welfare of Japan	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was a multidisciplinary research project supported by a Grant-in-Aid (2010-2013) for Scientific Research from the Ministry of Health, Labour and Welfare of Japan. http://www.mhlw.go.jp/english/.	ANDERSSON HI, 1993, CLIN J PAIN, V9, P174, DOI 10.1097/00002508-199309000-00004; [Anonymous], 2012, JAP STAT YB; ARAMOTO H, 2003, J JPN COLL ANGIOL, V43, P9; Azevedo LF, 2012, J PAIN, V13, P773, DOI 10.1016/j.jpain.2012.05.012; Bair MJ, 2008, PSYCHOSOM MED, V70, P890, DOI 10.1097/PSY.0b013e318185c510; Becker N, 2000, PAIN, V84, P203, DOI 10.1016/S0304-3959(99)00209-2; Blyth FM, 2001, PAIN, V89, P127, DOI 10.1016/S0304-3959(00)00355-9; BOWSHER D, 1991, Pain Clinic, V4, P223; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Catala E, 2002, EUR J PAIN-LONDON, V6, P133, DOI 10.1053/eujp.2001.0310; CROFT P, 1993, J RHEUMATOL, V20, P710; CROOK J, 1984, PAIN, V18, P299, DOI 10.1016/0304-3959(84)90824-8; Elliott AM, 1999, LANCET, V354, P1248, DOI 10.1016/S0140-6736(99)03057-3; Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257; Gorin AA, 1999, PAIN, V81, P173, DOI 10.1016/S0304-3959(99)00010-X; Guo HR, 1999, AM J PUBLIC HEALTH, V89, P1029, DOI 10.2105/AJPH.89.7.1029; Hachimori A, 2009, JPN J GERIATRIC PSYC, V20, P1009; Hattori S, 2004, PAIN CLINIC, V25, P1541; Hildebrandt VH, 2002, ERGONOMICS, V45, P32, DOI 10.1080/00140130110110629; Ikeda S, 2001, QOL MEASUREMENT HDB; Johannes CB, 2010, J PAIN, V11, P1230, DOI 10.1016/j.jpain.2010.07.002; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kurita GP, 2012, PAIN, V153, P2332, DOI 10.1016/j.pain.2012.07.023; Ministry of Health Labour and Welfare Japan, FIN REP MONTHL LAB S; Mitchell SW, 1877, AM J MED SCI, V73, P305; Moulin Dwight E, 2002, Pain Res Manag, V7, P179; Nakamae T, 2010, PSYCHIAT CLIN NEUROS, V64, P372, DOI 10.1111/j.1440-1819.2010.02100.x; Nakamura M, 2011, J ORTHOP SCI, V16, P424, DOI 10.1007/s00776-011-0102-y; National Tax Agency Japan, NAT TAX AG REP 2012; Neville A, 2008, ISR MED ASSOC J, V10, P676; Ng KFJ, 2002, CLIN J PAIN, V18, P275, DOI 10.1097/00002508-200209000-00001; Oga T, 2003, QUAL LIFE RES, V12, P555, DOI 10.1023/A:1025051829223; Ohayon MM, 2004, J CLIN PSYCHIAT, V65, P5; PATBERG WR, 1985, J RHEUMATOL, V12, P711; Pizzi LT, 2005, DIS MANAG HEALTH OUT, V13, P201, DOI 10.2165/00115677-200513030-00005; Raftery MN, 2011, PAIN, V152, P1096, DOI 10.1016/j.pain.2011.01.019; Redelmeier DA, 1996, P NATL ACAD SCI USA, V93, P2895, DOI 10.1073/pnas.93.7.2895; Rustoen T, 2004, EUR J PAIN, V8, P555, DOI 10.1016/j.ejpain.2004.02.002; Sa KN, 2008, PAIN, V139, P498, DOI 10.1016/j.pain.2008.06.008; Sakamaki H, 2006, VALUE HEALTH, V9, P47, DOI 10.1111/j.1524-4733.2006.00080.x; Sato J, 2011, NEUROSCI LETT, V503, P152, DOI 10.1016/j.neulet.2011.08.030; Shibata M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090984; SHUTTY MS, 1992, PAIN, V49, P199, DOI 10.1016/0304-3959(92)90143-Y; SMITH GR, 1992, GEN HOSP PSYCHIAT, V14, P265, DOI 10.1016/0163-8343(92)90097-T; Soares JJF, 2004, EUR J PAIN, V8, P79, DOI 10.1016/S1090-3801(03)00083-1; Soares JJF, 2003, INT J BEHAV MED, V10, P181, DOI 10.1207/S15327558IJBM1002_07; Stewart WF, 2003, JAMA-J AM MED ASSOC, V290, P2443, DOI 10.1001/jama.290.18.2443; Strusberg I, 2002, J RHEUMATOL, V29, P335; Tajima R, 2010, CLIN EXP NEPHROL, V14, P340, DOI 10.1007/s10157-010-0304-1; Toblin RL, 2011, PAIN, V152, P1249, DOI 10.1016/j.pain.2010.12.036; Uehara M, 2013, SPINE J, V13, P391, DOI 10.1016/j.spinee.2012.11.012; VonKorff M, 1996, BRIT J PSYCHIAT, V168, P101, DOI 10.1192/S0007125000298474; Wilder FV, 2003, RHEUMATOLOGY, V42, P955, DOI 10.1093/rheumatology/keg264; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Yeo SN, 2009, ANN ACAD MED SINGAP, V38, P937	55	77	80	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129262	10.1371/journal.pone.0129262	http://dx.doi.org/10.1371/journal.pone.0129262			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26076135	Green Published, Green Submitted, gold			2022-12-26	WOS:000356329900059
J	Ye, L; Yu, HS; Li, CW; Hirsch, ML; Zhang, LG; Samulski, RJ; Li, WP; Liu, Z				Ye, Lei; Yu, Haisheng; Li, Chengwen; Hirsch, Matthew L.; Zhang, Liguo; Samulski, R. Jude; Li, Wuping; Liu, Zhong			Adeno-Associated Virus Vector Mediated Delivery of the HBV Genome Induces Chronic Hepatitis B Virus Infection and Liver Fibrosis in Mice	PLOS ONE			English	Article							TAUROCHOLATE COTRANSPORTING POLYPEPTIDE; CHRONIC VIRAL-HEPATITIS; TRANSGENIC MICE; SURFACE-ANTIGEN; MOUSE MODEL; TUPAIA HEPATOCYTES; CARRIER STATE; T-LYMPHOCYTE; IN-VITRO; EXPRESSION	Liver cirrhosis and hepatocellular carcinomas are major health problems of chronic hepatitis B virus (HBV) infection. To date, rare model has reproduced liver fibrosis associated with long-term HBV infection which in turn has hindered both the understanding of HBV biology and the development of new treatment options. Here, using adeno-associated virus serotype 8 (AAV8) mediated delivery of a 1.2-kb HBV genome, we successfully generated a chronic HBV infectious mouse model that presents the associated liver fibrosis observed following human infection. After AAV8/HBV1.2 vector administration, mice demonstrated effective HBV replication and transcription which resulted in HBV antigen expression and viremia over 6 months. Although no obvious acute inflammatory response was noted, these mice still developed chronic liver disease and hepatic fibrogenesis as demonstrated by increased ground glass-like hepatocytes, an increasing trend of collagen deposition and upregulated fibrosis markers, including type I collagen, type III collagen, tissue inhibitor of metalloproteinase (TIMP), and transforming growth factor-beta 1(TGF-beta 1). Taken together, AAV-mediated HBV gene delivery to the mouse liver, induced HBV persistent infection accompanied by liver fibrosis which can serve as a model for investigating the precise mechanisms underlying liver fibrosis following chronic HBV infection as well as for the potential development of novel therapeutics.	[Ye, Lei; Li, Wuping; Liu, Zhong] Chinese Acad Med Sci, Inst Blood Transfus, Chengdu, Peoples R China; [Ye, Lei; Li, Wuping; Liu, Zhong] Peking Union Med Coll, Chengdu, Peoples R China; [Yu, Haisheng; Zhang, Liguo] Chinese Acad Sci, Inst Biophys, Key Lab Immun & Infect, Beijing 100080, Peoples R China; [Li, Chengwen; Hirsch, Matthew L.; Samulski, R. Jude] Univ N Carolina, Dept Pharmacol, Gene Therapy Ctr, Chapel Hill, NC USA; [Li, Wuping] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Chengdu, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Blood Transfusion - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of North Carolina; University of North Carolina Chapel Hill; Chinese Academy of Medical Sciences - Peking Union Medical College	Li, WP (corresponding author), Chinese Acad Med Sci, Inst Blood Transfus, Chengdu, Peoples R China.	lwpzhr@sina.com	Liu, Zhong/ABH-8584-2020	liu, zhong/0000-0001-8173-9656; zhang, li guo/0000-0002-9795-0314	Peking Union Medical College graduated student innovation fund [2011-1001-033]; Institute of Pathogen Biology, Chinese Academy of Medical Sciences [2011IPB106]	Peking Union Medical College graduated student innovation fund; Institute of Pathogen Biology, Chinese Academy of Medical Sciences	Peking Union Medical College graduated student innovation fund, 2011-1001-033, LY. The basic grant of Institute of Pathogen Biology, Chinese Academy of Medical Sciences, 2011IPB106, WPL.	ARAKI K, 1989, P NATL ACAD SCI USA, V86, P207, DOI 10.1073/pnas.86.1.207; ARTHUR MJP, 1995, J HEPATOL, V22, P43; BARKER LF, 1973, J INFECT DIS, V127, P648, DOI 10.1093/infdis/127.6.648; Barrera A, 2005, J VIROL, V79, P9786, DOI 10.1128/JVI.79.15.9786-9798.2005; Baumert TF, 2005, HEPATOLOGY, V41, P247, DOI 10.1002/hep.20553; Bedossa P, 2003, J PATHOL, V200, P504, DOI 10.1002/path.1397; Bertoni R, 1998, J IMMUNOL, V161, P4447; Bility MT, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004032; BRATTIG NW, 1983, HEPATOLOGY, V3, P638; Brunetto MR, 2013, J HEPATOL, V59, P1153, DOI 10.1016/j.jhep.2013.07.017; CHISARI FV, 1985, SCIENCE, V230, P1157, DOI 10.1126/science.3865369; CHISARI FV, 1995, HEPATOLOGY, V22, P1316, DOI 10.1016/0270-9139(95)90645-2; CHISARI FV, 1987, P NATL ACAD SCI USA, V84, P6909, DOI 10.1073/pnas.84.19.6909; Constandinou C, 2005, METH MOLEC MED, V117, P237; Dion S, 2013, J VIROL, V87, P5554, DOI 10.1128/JVI.03134-12; Dong QM, 2009, J VIROL METHODS, V159, P135, DOI 10.1016/j.jviromet.2009.03.012; DUSHEIKO GM, 1983, J CLIN INVEST, V71, P1104, DOI 10.1172/JCI110860; Eng FJ, 2000, AM J PHYSIOL-GASTR L, V279, pG7, DOI 10.1152/ajpgi.2000.279.1.G7; FERNAN A, 1989, CLIN EXP IMMUNOL, V76, P222; GERBER MA, 1974, AM J PATHOL, V75, P489; GERBER MA, 1974, P SOC EXP BIOL MED, V145, P863, DOI 10.3181/00379727-145-37912; GUIDOTTI LG, 1995, J VIROL, V69, P6158, DOI 10.1128/JVI.69.10.6158-6169.1995; Gutierrez-Reyes G, 2007, ARCH MED RES, V38, P644, DOI 10.1016/j.arcmed.2006.10.001; HOOFNAGLE JH, 1987, HEPATOLOGY, V7, P758, DOI 10.1002/hep.1840070424; Hoofnagle JH, 1997, NEW ENGL J MED, V336, P347, DOI 10.1056/NEJM199701303360507; Huang LR, 2006, P NATL ACAD SCI USA, V103, P17862, DOI 10.1073/pnas.0608578103; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Iredale JP, 1996, HEPATOLOGY, V24, P176, DOI 10.1002/hep.510240129; Isogawa M, 2005, VIROLOGY, V333, P293, DOI 10.1016/j.virol.2005.01.004; Ke L, 2011, TRANSFUSION, V51, P1909, DOI 10.1111/j.1537-2995.2011.03067.x; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Kim H, 2008, RADIOLOGY, V247, P696, DOI 10.1148/radiol.2473070605; KNITTEL T, 1992, GASTROENTEROLOGY, V102, P1724, DOI 10.1016/0016-5085(92)91736-N; Lai CL, 1998, NEW ENGL J MED, V339, P61, DOI 10.1056/NEJM199807093390201; Lalazar A, 1997, GENE, V195, P235, DOI 10.1016/S0378-1119(97)00159-5; Lau DTY, 1997, GASTROENTEROLOGY, V113, P1660, DOI 10.1053/gast.1997.v113.pm9352870; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; MABIT H, 1994, J GEN VIROL, V75, P2681, DOI 10.1099/0022-1317-75-10-2681; McMahon BJ, 2001, ANN INTERN MED, V135, P759, DOI 10.7326/0003-4819-135-9-200111060-00006; Nebbia G, 2012, QJM-INT J MED, V105, P109, DOI 10.1093/qjmed/hcr270; NOWICKI MJ, 1986, HEPATOLOGY, V6, P180, DOI 10.1002/hep.1840060205; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; PETERS M, 1991, HEPATOLOGY, V13, P977, DOI 10.1016/0270-9139(91)90273-X; Sprinzl MF, 2001, J VIROL, V75, P5108, DOI 10.1128/JVI.75.11.5108-5118.2001; TSUKAMOTO H, 1990, SEMIN LIVER DIS, V10, P56, DOI 10.1055/s-2008-1040457; World health organisation (WHO), 2015, GLOB ACT PLAN ANT RE, V19; Wu EX, 2007, MAGN RESON MED, V58, P687, DOI 10.1002/mrm.21350; Xiao X, 1998, J VIROL, V72, P2224, DOI 10.1128/JVI.72.3.2224-2232.1998; YAMADA G, 1993, INTERNAL MED, V32, P911, DOI 10.2169/internalmedicine.32.911; Yan H, 2013, J VIROL, V87, P7977, DOI 10.1128/JVI.03540-12; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; Yang D, 2014, CELL MOL IMMUNOL, V11, P71, DOI 10.1038/cmi.2013.43; Yang PL, 2002, P NATL ACAD SCI USA, V99, P13825, DOI 10.1073/pnas.202398599; Zhang Q, 2014, J VIRAL HEPATITIS, V21, P525, DOI 10.1111/jvh.12177; Zhong GC, 2013, J VIROL, V87, P7176, DOI 10.1128/JVI.03533-12	55	28	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130052	10.1371/journal.pone.0130052	http://dx.doi.org/10.1371/journal.pone.0130052			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075890	Green Submitted, gold, Green Published			2022-12-26	WOS:000356329900129
J	Hu, HT; Rashotte, AM; Singh, NK; Weaver, DB; Goertzen, LR; Singh, SR; Locy, RD				Hu, Hongtao; Rashotte, Aaron M.; Singh, Narendra K.; Weaver, David B.; Goertzen, Leslie R.; Singh, Shree R.; Locy, Robert D.			The Complexity of Posttranscriptional Small RNA Regulatory Networks Revealed by In Silico Analysis of Gossypium arboreum L. Leaf, Flower and Boll Small Regulatory RNAs	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; TRANS-ACTING SIRNAS; ANTISENSE TRANSCRIPTS; NAT-SIRNAS; ARABIDOPSIS; MICRORNAS; BIOGENESIS; EXPRESSION; SEQUENCE; GENES	MicroRNAs (miRNAs) and secondary small interfering RNAs (principally phased siRNAs or trans-acting siRNAs) are two distinct subfamilies of small RNAs (sRNAs) that are emerging as key regulators of posttranscriptional gene expression in plants. Both miRNAs and secondary-siRNAs (sec-siRNAs) are processed from longer RNA precursors by DICER-LIKE proteins (DCLs). Gossypium arboreum L., also known as tree cotton or Asian cotton, is a diploid, possibly ancestral relative of tetraploid Gossypium hirsutum L., the predominant type of commercially grown cotton worldwide known as upland cotton. To understand the biological significance of these gene regulators in G. arboreum, a bioinformatics analysis was performed on G. arboreum small RNAs produced from G. arboreum leaf, flower, and boll tissues. Consequently, 263 miRNAs derived from 353 precursors, including 155 conserved miRNAs (cs-miRNAs) and 108 novel lineage-specific miRNAs (ls-miRNAs). Along with miRNAs, 2,033 miRNA variants (isomiRNAs) were identified as well. Those isomiRNAs with variation at the 3'-miRNA end were expressed at the highest levels, compared to other types of variants. In addition, 755 pha-siRNAs derived 319 pha-siRNA gene transcripts (PGTs) were identified, and the potential pha-siRNA initiators were predicted. Also, 2,251 non-phased siRNAs were found as well, of which 1,088 appeared to be produced by socalled cis-or trans-cleavage of the PGTs observed at positions differing from pha-siRNAs. Of those sRNAs, 148 miRNAs/isomiRNAs and 274 phased/non-phased siRNAs were differentially expressed in one or more pairs of tissues examined. Target analysis revealed that target genes for both miRNAs and pha-siRNAs are involved a broad range of metabolic and enzymatic activities. We demonstrate that secondary siRNA production could result from initial cleavage of precursors by both miRNAs or isomiRNAs, and that subsequently produced phased and unphased siRNAs could result that also serve as triggers of a second round of both cis- and trans-cleavage of additional siRNAs, leading to the formation of complex sRNA regulatory networks mediating posttranscriptional gene silencing. Results from this study extended our knowledge on G. arboreum sRNAs and their biological importance, which would facilitate future studies on regulatory mechanism of tissue development in cotton and other plant species.	[Hu, Hongtao; Rashotte, Aaron M.; Singh, Narendra K.; Goertzen, Leslie R.; Locy, Robert D.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Weaver, David B.] Auburn Univ, Dept Crop Soil & Environm Sci, Auburn, AL 36849 USA; [Hu, Hongtao; Singh, Shree R.] Alabama State Univ, Ctr Nano Biotechnol Res, Montgomery, AL 36104 USA	Auburn University System; Auburn University; Auburn University System; Auburn University	Locy, RD (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.	hzh0005@tigermail.auburn.edu; locyrob@auburn.edu		Rashotte, Aaron/0000-0001-5034-4395; Singh, Shree R./0000-0002-3571-2222	Cotton, Inc.; Alabama Cotton Commission [07-936AL, 10-675AL]; Hatch Multistate [ALA021-1-10008]; National Institute of Food and Agriculture, USDA; NIFA-USDA Grant; Department of Biological Sciences, Auburn University	Cotton, Inc.; Alabama Cotton Commission; Hatch Multistate; National Institute of Food and Agriculture, USDA(United States Department of Agriculture (USDA)); NIFA-USDA Grant; Department of Biological Sciences, Auburn University	This work was funded in part with funding from Cotton, Inc.; Cary, NC. This funding was obtained in conjunction with the Alabama Cotton Commission - the grant numbers that funded these efforts were: 07-936AL; 10-675AL. This funding was awarded to RDL, NKS, & DBW. Further, the authors declare that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The primary research funding for this work was derived from a Hatch Multistate Grant No. ALA021-1-10008 Awarded by the National Institute of Food and Agriculture, USDA. The award was made through the Alabama Agricultural Experiment Station to RDL, DBW, & NKS. Funding during the course of his PhD program to HH was obtained as a Teaching Assistantship from the Department of Biological Sciences, Auburn University, and Research Assistantship funding was obtained from the above mentioned NIFA-USDA Grant.	Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Axtell MJ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-221; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Cho SH, 2012, PLANT CELL, V24, P4837, DOI 10.1105/tpc.112.103176; Cloonan N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r126; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; Dai XB, 2008, NUCLEIC ACIDS RES, V36, pW114, DOI 10.1093/nar/gkn297; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Eamens AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035933; Eamens AL, 2009, RNA, V15, P2219, DOI 10.1261/rna.1646909; Fei Q, 2013, PLANT CELL; Fei QL, 2013, PLANT CELL, V25, P2400, DOI 10.1105/tpc.113.114652; Gotz S, 2011, BIOINFORMATICS, V27, P919, DOI 10.1093/bioinformatics/btr059; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Gong L, 2013, GENOME BIOL EVOL, V5, P2449, DOI 10.1093/gbe/evt196; Gou JY, 2011, PLANT CELL, V23, P1512, DOI 10.1105/tpc.111.084525; Groszmann M, 2011, P NATL ACAD SCI USA, V108, P2617, DOI 10.1073/pnas.1019217108; Hackenberg M, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-214; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Jeong DH, 2013, PLANT PHYSIOL, V162, P1225, DOI 10.1104/pp.113.219873; Jeong DH, 2011, PLANT CELL, V23, P4185, DOI 10.1105/tpc.111.089045; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Liu DQ, 2006, GENET RESOUR CROP EV, V53, P1145, DOI 10.1007/s10722-005-1304-y; Llorens F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-104; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Marin E, 2010, PLANT CELL, V22, P1104, DOI 10.1105/tpc.109.072553; Marker S, 2010, NUCLEIC ACIDS RES, V38, P4092, DOI 10.1093/nar/gkq131; McGahon MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065809; Mehetre SS, 2003, CURR SCI INDIA, V84, P1510; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Nag A, 2009, P NATL ACAD SCI USA, V106, P22534, DOI 10.1073/pnas.0908718106; Pang MX, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r122; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Qi XP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004971; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Romanel E, 2012, PLANT MOL BIOL; Sato K, 2009, NUCLEIC ACIDS RES, V37, pW277, DOI 10.1093/nar/gkp367; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shin JH, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003411; Si-Ammour A, 2011, PLANT PHYSIOL, V157, P683, DOI 10.1104/pp.111.180083; Song XW, 2012, PLANT J, V69, P462, DOI 10.1111/j.1365-313X.2011.04805.x; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Thieme CJ, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00272; Vazquez F, 2008, NUCLEIC ACIDS RES, V36, P6429, DOI 10.1093/nar/gkn670; Visser M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095782; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Xia R, 2013, PLANT CELL; Xia R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r47; Xie KB, 2012, PLANT PHYSIOL, V158, P1382, DOI 10.1104/pp.111.190488; Xu Q, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-246; Xue W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-629; Yan Z, 2013, MOL PLANT MICROBE IN, V26, P1371, DOI 10.1094/MPMI-04-13-0111-R; Yang XY, 2013, J EXP BOT, V64, P1521, DOI 10.1093/jxb/ert013; Yoon EK, 2010, NUCLEIC ACIDS RES, V38, P1382, DOI 10.1093/nar/gkp1128; Yoshikawa M, 2013, P NATL ACAD SCI USA, V110, P4117, DOI 10.1073/pnas.1217050110; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Yu X, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-208; Zhai JX, 2011, GENE DEV, V25, P2540, DOI 10.1101/gad.177527.111; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang CQ, 2013, INT J MOL SCI, V14, P14689, DOI 10.3390/ijms140714689; Zhang CQ, 2012, BIOINFORMATICS, V28, P2561, DOI 10.1093/bioinformatics/bts500; Zhang XM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r20; Zhao HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078755; Zhao XP, 1998, GENOME RES, V8, P479, DOI 10.1101/gr.8.5.479; Zhou HJ, 2012, NUCLEIC ACIDS RES, V40, P5864, DOI 10.1093/nar/gks247; Zhu QH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084390; Zhu QH, 2011, J EXP BOT, V62, P487, DOI 10.1093/jxb/erq295	79	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0127468	10.1371/journal.pone.0127468	http://dx.doi.org/10.1371/journal.pone.0127468			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070200	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000008
J	Larson, FV; Lai, MC; Wagner, AP; Baron-Cohen, S; Holland, AJ				Larson, Felicity V.; Lai, Meng-Chuan; Wagner, Adam P.; Baron-Cohen, Simon; Holland, Anthony J.		MRC AIMS Consortium	Testing the 'Extreme Female Brain' Theory of Psychosis in Adults with Autism Spectrum Disorder with or without Co-Morbid Psychosis	PLOS ONE			English	Article							HIGH-FUNCTIONING AUTISM; SYSTEMATIZING QUOTIENT; EMPATHY QUOTIENT; DIAGNOSTIC INTERVIEW; ASPERGER-SYNDROME; SCHIZOPHRENIA; RELIABILITY; SCHIZOTYPY; MALES; AQ	Introduction Males and females in the general population differ, on average, in their drive for empathizing (higher in females) and systemizing (higher in males). People with autism spectrum disorder (ASD) show a drive for systemizing over empathizing, irrespective of sex, which led to the conceptualisation of ASD as an 'extreme of the typical male brain'. The opposite cognitive profile, an 'extreme of the typical female brain', has been proposed to be linked to conditions such as psychosis and mania/hypomania. Methods We compared an empathizing-over-systemizing bias (for short 'empathizing bias') in individuals with ASD, who had experienced psychotic illness (N = 64) and who had not (N = 71). Results There were overall differences in the distribution of cognitive style. Adults with ASD who had experienced psychosis were more likely to show an empathizing bias than adults with ASD who had no history of psychosis. This was modulated by IQ, and the group-difference was driven mainly by individuals with above-average IQ. In women with ASD and psychosis, the link between mania/ hypomania and an empathizing bias was greater than in men with ASD. Conclusions The bias for empathizing over systemizing may be linked to the presence of psychosis in people with ASD. Further research is needed in a variety of clinical populations, to understand the role an empathizing bias may play in the development and manifestation of mental illness.	[Larson, Felicity V.; Wagner, Adam P.; Holland, Anthony J.] Univ Cambridge, Dept Psychiat, Cambridge Intellectual & Dev Disabil Res Grp, Cambridge, England; [Lai, Meng-Chuan; Baron-Cohen, Simon] Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England; [Lai, Meng-Chuan] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Lai, Meng-Chuan] Coll Med, Taipei, Taiwan; [Wagner, Adam P.; Baron-Cohen, Simon; Holland, Anthony J.] NIHR CLAHRC East England, Cambridge, England; [Baron-Cohen, Simon; Holland, Anthony J.] Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge, England	University of Cambridge; University of Cambridge; National Taiwan University; National Taiwan University Hospital	Holland, AJ (corresponding author), Univ Cambridge, Dept Psychiat, Cambridge Intellectual & Dev Disabil Res Grp, Cambridge, England.	ajh1008@cam.ac.uk	Murphy, Clodagh M/F-1464-2010; Wagner, Adam P/AAA-4346-2019; Williams, Steve C/D-6979-2011; Lai, Meng-Chuan/K-7407-2016; Ecker, Christine/E-5194-2010; Catani, Marco/H-7801-2012	Murphy, Clodagh M/0000-0002-6350-0155; Wagner, Adam P/0000-0002-9101-3477; Williams, Steve C/0000-0003-4299-1941; Lai, Meng-Chuan/0000-0002-9593-5508; Ecker, Christine/0000-0002-1003-5931; Chakrabarti, Bhismadev/0000-0002-6649-7895; Wheelwright, Sally/0000-0003-0657-2483; Happe, Francesca/0000-0001-9226-4000; Catani, Marco/0000-0002-5488-6463; Henty, Julian/0000-0001-8694-451X; Baron-Cohen, Simon/0000-0001-9217-2544	Medical Research Council (United Kingdom) [G0400061]; Baily Thomas Charitable Trust; Medical Research Council (MRC) United Kingdom; William Binks Autism Neuroscience Fellowship; European Autism Interventions-A Multicentre Study for Developing New Medications (EU-AIMS); Wolfson College, Cambridge; NIHR Collaboration for Leadership in Applied Health Research and Care East of England at the Cambridgeshire; Peterborough NHS Foundation Trust; MRC; Autism Research Trust; EU-AIMS; MRC [G0400061, G0600977] Funding Source: UKRI; Medical Research Council [G0400061, 1127912, G0600977] Funding Source: researchfish; National Institute for Health Research [RP-PG-0606-1045, NF-SI-0510-10268, NF-SI-0509-10211] Funding Source: researchfish	Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Baily Thomas Charitable Trust; Medical Research Council (MRC) United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); William Binks Autism Neuroscience Fellowship; European Autism Interventions-A Multicentre Study for Developing New Medications (EU-AIMS); Wolfson College, Cambridge; NIHR Collaboration for Leadership in Applied Health Research and Care East of England at the Cambridgeshire; Peterborough NHS Foundation Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Autism Research Trust; EU-AIMS; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Medical Research Council (United Kingdom); http://www.mrc.ac.uk/; Grant number G0400061; funding received by MCL and SBC. FVL was supported by the Medical Research Council (MRC) United Kingdom and the Baily Thomas Charitable Trust. M-CL was supported by the William Binks Autism Neuroscience Fellowship, the European Autism Interventions-A Multicentre Study for Developing New Medications (EU-AIMS), and Wolfson College, Cambridge. APW and AJH received support from the NIHR Collaboration for Leadership in Applied Health Research and Care East of England at the Cambridgeshire and Peterborough NHS Foundation Trust during the preparation of this manuscript. SB-C was supported by the MRC, EU-AIMS, and the Autism Research Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L. S., 1991, MULTIPLE REGRESSION; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Asperger H, 1944, ARCH PSYCHIAT NERVEN, V117, P76, DOI 10.1007/BF01837709; Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2015, MOL PSYCHIATR, V20, P369, DOI 10.1038/mp.2014.48; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; Baron-Cohen S, 2005, J AUTISM DEV DISORD, V35, P807, DOI 10.1007/s10803-005-0026-5; Baron-Cohen S., 1997, MINDBLINDNESS ESSAY; Baron-Cohen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102251; Baron-Cohen S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001081; Bejerot S, 2012, BRIT J PSYCHIAT, V201, P116, DOI 10.1192/bjp.bp.111.097899; Brosnan M, 2014, J AUTISM DEV DISORD, V44, P513, DOI 10.1007/s10803-013-1897-5; Brosnan M, 2013, PSYCHOSIS, V5, P71, DOI 10.1080/17522439.2011.626526; Brosnan M, 2010, PERS INDIV DIFFER, V49, P738, DOI 10.1016/j.paid.2010.06.018; Castle DJ, 2006, PSYCHOL MED, V36, P69, DOI 10.1017/S0033291705005969; Cohen J., 1983, APPL MULTIPLE REGRES; Crespi B, 2008, BEHAV BRAIN SCI, V31, P241, DOI 10.1017/S0140525X08004214; Crespi B, 2010, P NATL ACAD SCI USA, V107, P1736, DOI 10.1073/pnas.0906080106; Dammann G., 2003, SOCIAL BRAIN EVOLUTI, P373; Davies W, 2008, BEHAV BRAIN SCI, V31, P265, DOI 10.1017/S0140525X08004263; Dinsdale NL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063316; Fanous A, 2001, ARCH GEN PSYCHIAT, V58, P669, DOI 10.1001/archpsyc.58.7.669; GAZZANIGA M. S., 1985, SOCIAL BRAIN DISCOVE; Goldenfeld N, 2005, CLIN NEUROPSYCHIATR, V2, P338; Hallerback MU, 2012, PSYCHIAT RES, V198, P12, DOI 10.1016/j.psychres.2012.01.016; Konstantareas MM, 2006, J AUTISM DEV DISORD, V36, P143, DOI 10.1007/s10803-005-0051-4; Lai MC, 2013, BRAIN, V136, P2799, DOI 10.1093/brain/awt216; Lai MC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001544; Lai MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047198; Lai MC, 2012, NEUROIMAGE, V61, P1347, DOI 10.1016/j.neuroimage.2012.03.018; Lai MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020835; Langdon R, 1999, COGNITION, V71, P43, DOI 10.1016/S0010-0277(99)00018-9; Larson FV, 2015, PSYCHOSIS AUTI UNPUB; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; MCGUFFIN P, 1991, ARCH GEN PSYCHIAT, V48, P764; Montag C, 2011, PSYCHIAT RES, V186, P203, DOI 10.1016/j.psychres.2010.09.006; O'Connor BP, 1998, EDUC PSYCHOL MEAS, V58, P836, DOI 10.1177/0013164498058005009; Ousley Opal, 2014, Curr Dev Disord Rep, V1, P20; Prosser H, 1998, J INTELL DISABIL RES, V42, P264, DOI 10.1046/j.1365-2788.1998.00146.x; Russell-Smith SN, 2013, J AUTISM DEV DISORD, V43, P695, DOI 10.1007/s10803-012-1614-9; Samson AC, 2012, EMOTION, V12, P659, DOI 10.1037/a0027975; Schurhoff F, 2005, SCHIZOPHR RES, V80, P235, DOI 10.1016/j.schres.2005.07.009; Skokauskas N, 2010, PSYCHOPATHOLOGY, V43, P8, DOI 10.1159/000255958; SPITZER RL, 1979, ARCH GEN PSYCHIAT, V36, P1381; Starling J, 2009, CURR PSYCHIAT REP, V11, P190, DOI 10.1007/s11920-009-0030-0; Tantam D., 1991, AUTISM ASPERGER SYND, P147, DOI DOI 10.1017/CBO9780511526770.005; Wakabayashi A, 2006, PERS INDIV DIFFER, V41, P929, DOI 10.1016/j.paid.2006.03.017; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wheelwright S, 2006, BRAIN RES, V1079, P47, DOI 10.1016/j.brainres.2006.01.012; World Health Organization, 2019, INT STAT CLASS DIS R, V11th Edn; Zahn-Waxler C, 2008, ANNU REV CLIN PSYCHO, V4, P275, DOI 10.1146/annurev.clinpsy.3.022806.091358	54	12	12	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128102	10.1371/journal.pone.0128102	http://dx.doi.org/10.1371/journal.pone.0128102			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6GR	26069955	Green Accepted, gold, Green Published			2022-12-26	WOS:000356327000014
J	Liu, X; Wang, BJ; Xu, L				Liu, Xiao; Wang, Baojin; Xu, Luo			Statistical Analysis of Hurst Exponents of Essential/Nonessential Genes in 33 Bacterial Genomes	PLOS ONE			English	Article							CONDITIONALLY ESSENTIAL GENES; LONG-RANGE CORRELATIONS; DNA-SEQUENCES; VIBRIO-CHOLERAE; IDENTIFICATION	Methods for identifying essential genes currently depend predominantly on biochemical experiments. However, there is demand for improved computational methods for determining gene essentiality. In this study, we used the Hurst exponent, a characteristic parameter to describe long-range correlation in DNA, and analyzed its distribution in 33 bacterial genomes. In most genomes (31 out of 33) the significance levels of the Hurst exponents of the essential genes were significantly higher than for the corresponding full-gene-set, whereas the significance levels of the Hurst exponents of the nonessential genes remained unchanged or increased only slightly. All of the Hurst exponents of essential genes followed a normal distribution, with one exception. We therefore propose that the distribution feature of Hurst exponents of essential genes can be used as a classification index for essential gene prediction in bacteria. For computer-aided design in the field of synthetic biology, this feature can build a restraint for pre- or post-design checking of bacterial essential genes. Moreover, considering the relationship between gene essentiality and evolution, the Hurst exponents could be used as a descriptive parameter related to evolutionary level, or be added to the annotation of each gene.	[Liu, Xiao; Wang, Baojin; Xu, Luo] Chongqing Univ, Coll Commun Engn, Chongqing 400044, Peoples R China	Chongqing University	Liu, X (corresponding author), Chongqing Univ, Coll Commun Engn, 174 ShaPingBa Dist, Chongqing 400044, Peoples R China.	liuxiao@cqu.edu.cn			National Natural Science Foundation of China [61001157]; China Postdoctoral Science Foundation [2012M521673]; Fundamental Research Funds for the Central Universities [106112014CDJZR165503, CDJRC10160011, CDJZR12160007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (Grant No. 61001157), China Postdoctoral Science Foundation funded project (Grant No. 2012M521673) and the Fundamental Research Funds for the Central Universities (Project No. 106112014CDJZR165503, CDJRC10160011, CDJZR12160007).	Bergmiller T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002803; Bijlsma JJE, 2007, APPL ENVIRON MICROB, V73, P1514, DOI 10.1128/AEM.01900-06; Cameron DE, 2008, P NATL ACAD SCI USA, V105, P8736, DOI 10.1073/pnas.0803281105; Chao MC, 2013, NUCLEIC ACIDS RES, V41, P9033, DOI 10.1093/nar/gkt654; CHATZIDIMITRIOUDREISMANN CA, 1993, NATURE, V361, P212, DOI 10.1038/361212b0; Clay O, 2001, GENE, V276, P33, DOI 10.1016/S0378-1119(01)00666-7; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Commichau FM, 2013, MOL BIOSYST, V9, P1068, DOI 10.1039/c3mb25595f; CONSTANTINE W, 2014, FRACTAL TIME SERIES; Joyce AR, 2006, J BACTERIOL, V188, P8259, DOI 10.1128/JB.00740-06; Juhas M, 2011, TRENDS CELL BIOL, V21, P562, DOI 10.1016/j.tcb.2011.07.005; Liu X, 2012, INTEGR BIOL-UK, V4, P93, DOI 10.1039/c1ib00030f; Liu XL, 2010, PHYS LETT A, V374, P2163, DOI 10.1016/j.physleta.2010.03.024; Lu X, 1998, PHYS REV E, V58, P3578, DOI 10.1103/PhysRevE.58.3578; Lu Y, 2014, CURR BIOINFORM, V9, P89, DOI 10.2174/1574893608999140109113434; Luo H, 2014, NUCLEIC ACIDS RES, V42, pD574, DOI 10.1093/nar/gkt1131; R Core Team, 2014, R FDN STAT COMP R LA; Stan C, 2013, J THEOR BIOL, V321, P54, DOI 10.1016/j.jtbi.2012.12.027; STANLEY HE, 1994, PHYSICA A, V205, P214, DOI 10.1016/0378-4371(94)90502-9; Yamada M, 2014, NEURAL COMPUT, V26, P185, DOI 10.1162/NECO_a_00537; Yang L, 2014, GENE, V551, P138, DOI 10.1016/j.gene.2014.08.046; Yu ZG, 2002, CHINESE PHYS, V11, P1313, DOI 10.1088/1009-1963/11/12/318	22	26	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129716	10.1371/journal.pone.0129716	http://dx.doi.org/10.1371/journal.pone.0129716			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26067107	Green Submitted, Green Published, gold			2022-12-26	WOS:000356327000100
J	Luo, HY; Wang, XJ; Zhan, GM; Wei, GR; Zhou, XL; Zhao, J; Huang, LL; Kang, ZS				Luo, Huaiyong; Wang, Xiaojie; Zhan, Gangming; Wei, Guorong; Zhou, Xinli; Zhao, Jing; Huang, Lili; Kang, Zhensheng			Genome-Wide Analysis of Simple Sequence Repeats and Efficient Development of Polymorphic SSR Markers Based on Whole Genome Re-Sequencing of Multiple Isolates of the Wheat Stripe Rust Fungus	PLOS ONE			English	Article							F-SP TRITICI; PUCCINIA-STRIIFORMIS; MICROSATELLITE MARKERS; PHI-BASE; YELLOW RUST; PATHOGEN; RECOMBINATION; ASSOCIATION; DIVERSITY; LOCI	The biotrophic parasitic fungus Puccinia striiformis f. sp. tritici (Pst) causes stripe rust, a devastating disease of wheat, endangering global food security. Because the Pst population is highly dynamic, it is difficult to develop wheat cultivars with durable and highly effective resistance. Simple sequence repeats (SSRs) are widely used as molecular markers in genetic studies to determine population structure in many organisms. However, only a small number of SSR markers have been developed for Pst. In this study, a total of 4,792 SSR loci were identified using the whole genome sequences of six isolates from different regions of the world, with a marker density of one SSR per 22.95 kb. The majority of the SSRs were di- and tri-nucleotide repeats. A database containing 1,113 SSR markers were established. Through in silico comparison, the previously reported SSR markers were found mainly in exons, whereas the SSR markers in the database were mostly in intergenic regions. Furthermore, 105 polymorphic SSR markers were confirmed in silico by their identical positions and nucleotide variations with INDELs identified among the six isolates. When 104 in silico polymorphic SSR markers were used to genotype 21 Pst isolates, 84 produced the target bands, and 82 of them were polymorphic and revealed the genetic relationships among the isolates. The results show that whole genome re-sequencing of multiple isolates provides an ideal resource for developing SSR markers, and the newly developed SSR markers are useful for genetic and population studies of the wheat stripe rust fungus.	[Luo, Huaiyong; Wang, Xiaojie; Zhan, Gangming; Wei, Guorong; Zhou, Xinli; Zhao, Jing; Huang, Lili; Kang, Zhensheng] Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China; [Luo, Huaiyong; Wang, Xiaojie; Zhan, Gangming; Wei, Guorong; Zhou, Xinli; Zhao, Jing; Huang, Lili; Kang, Zhensheng] State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Kang, ZS (corresponding author), Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China.	wangxiaojie@nwsuaf.edu.cn; kangzs@nwsuaf.edu.cn		Kang, Zhensheng/0000-0001-5575-0122; Huang, Lan/0000-0001-9594-4722	National High Technology Research and Development Program of China [2012AA101503]; National Basic Research Program [2013CB127700]; Chinese Ministry of Education [313048]; young star of science and technology, Shaanxi [2012KJXX-15]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program(National Basic Research Program of China); Chinese Ministry of Education(Ministry of Education, China); young star of science and technology, Shaanxi	This research was supported by the grant No.2012AA101503 from the National High Technology Research and Development Program of China (www.863.gov.cn) to XW, the grant No.2013CB127700 from National Basic Research Program (www.973.gov.cn) to KZ, the Key Grant Project No.313048 from the Chinese Ministry of Education (http://www.moe.gov.cn/) to XW, and the grant NO.2012KJXX-15 from the young star of science and technology, Shaanxi to XW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003903; Ali Sajid, 2011, BMC Res Notes, V4, P240, DOI 10.1186/1756-0500-4-240; Andris M, 2012, MOL ECOL RESOUR, V12, P779, DOI 10.1111/j.1755-0998.2012.03155.x; Arias MC, 2013, MOL ECOL RESOUR, V13, P760, DOI 10.1111/1755-0998.12121; Bahri B, 2009, CONSERV GENET, V10, P1425, DOI 10.1007/s10592-008-9752-5; Bayles RA, 2000, AGRONOMIE, V20, P805, DOI 10.1051/agro:2000176; Brown JKM, 2002, SCIENCE, V297, P537, DOI 10.1126/science.1072678; Cai GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082408; Cantu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024230; Chen CQ, 2009, MOL ECOL RESOUR, V9, P236, DOI 10.1111/j.1755-0998.2008.02423.x; Chen WQ, 2014, MOL PLANT PATHOL, V15, P433, DOI 10.1111/mpp.12116; Cheng P, 2014, PHYTOPATHOLOGY, V104, P1208, DOI 10.1094/PHYTO-11-13-0314-R; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Dai M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S7; Dempewolf H, 2010, MOL ECOL RESOUR, V10, P1048, DOI 10.1111/j.1755-0998.2010.02859.x; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Duan X, 2010, MYCOLOGIA, V102, P44, DOI 10.3852/08-098; Dutech C, 2007, FUNGAL GENET BIOL, V44, P933, DOI 10.1016/j.fgb.2007.05.003; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Enjalbert J, 2002, MOL ECOL NOTES, V2, P563, DOI 10.1046/j.1471-8286.2002.00322.x; Feng L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110896; Gow JL, 2006, MOL ECOL NOTES, V6, P873, DOI 10.1111/j.1471-8286.2006.01382.x; Gow JL, 2011, EVOL APPL, V4, P763, DOI 10.1111/j.1752-4571.2011.00198.x; Gow JL, 2005, GENETICA, V124, P77, DOI 10.1007/s10709-005-0204-6; Hasan M, 2008, THEOR APPL GENET, V116, P1035, DOI 10.1007/s00122-008-0733-3; Hovmoller MS, 2008, MOL ECOL, V17, P3818, DOI 10.1111/j.1365-294X.2008.03886.x; Hovmoller MS, 2011, ANNU REV PHYTOPATHOL, V49, P197, DOI 10.1146/annurev-phyto-072910-095230; Huang J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1268-z; Johansson H, 2008, MOL ECOL RESOUR, V8, P1408, DOI 10.1111/j.1755-0998.2008.02206.x; Karaoglu H, 2005, MOL BIOL EVOL, V22, P639, DOI [10.1093/molbev/mis057, 10.1093/molbev/msi057]; Kolmer JA, 2005, CURR OPIN PLANT BIOL, V8, P441, DOI 10.1016/j.pbi.2005.05.001; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075149; Mboup M, 2009, FUNGAL GENET BIOL, V46, P299, DOI 10.1016/j.fgb.2008.12.007; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Metzgar D, 2000, GENOME RES, V10, P72; NELSON RJ, 1994, APPL ENVIRON MICROB, V60, P3275, DOI 10.1128/AEM.60.9.3275-3283.1994; Park R, 2011, EUPHYTICA, V179, P109, DOI 10.1007/s10681-011-0375-4; Pembleton LW, 2013, CROP PASTURE SCI, V64, P244, DOI 10.1071/CP12392; Rodriguez-Algaba J, 2014, FUNGAL GENET BIOL, V70, P77, DOI 10.1016/j.fgb.2014.07.005; Rohlf F, 2008, NTSYSPC NUMERICAL TA, DOI [10.1080/10934529.2012.645784, DOI 10.1080/10934529.2012.645784]; Rotmistrovsky K, 2004, NUCLEIC ACIDS RES, V32, pW108, DOI 10.1093/nar/gkh450; Schlotterer C, 1998, CURR BIOL, V8, pR132, DOI 10.1016/S0960-9822(98)70989-3; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; Shewry PR, 2009, J EXP BOT, V60, P1537, DOI 10.1093/jxb/erp058; Shigemizu D, 2013, SCI REP-UK, V3, DOI 10.1038/srep02161; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Sweet MJ, 2012, ADV APPL MICROBIOL, V81, P169, DOI 10.1016/B978-0-12-394382-8.00005-8; Urban M, 2015, NUCLEIC ACIDS RES, V43, pD645, DOI 10.1093/nar/gku1165; Vik U, 2012, AM J BOT, V99, pE344, DOI 10.3732/ajb.1200028; WELLINGS CR, 1990, PLANT PATHOL, V39, P316, DOI 10.1111/j.1365-3059.1990.tb02509.x; Winnenburg R, 2008, NUCLEIC ACIDS RES, V36, pD572, DOI 10.1093/nar/gkm858; Winnenburg R, 2006, NUCLEIC ACIDS RES, V34, pD459, DOI 10.1093/nar/gkj047; Xia W, 2014, MOL BREEDING, V34, P525, DOI 10.1007/s11032-014-0055-x; Xu J, 2013, DNA RES, V20, P497, DOI 10.1093/dnares/dst026; Zhan GM, 2013, WORLD J MICROB BIOT, V29, P173, DOI 10.1007/s11274-012-1170-7; Zhan GM, 2012, FUNGAL BIOL-UK, V116, P643, DOI 10.1016/j.funbio.2012.03.004; Zheng WM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3673	58	24	30	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130362	10.1371/journal.pone.0130362	http://dx.doi.org/10.1371/journal.pone.0130362			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068192	Green Published, Green Submitted, gold			2022-12-26	WOS:000356327000156
J	Marciente, R; Bobrowiec, PED; Magnusson, WE				Marciente, Rodrigo; Bobrowiec, Paulo Estefano D.; Magnusson, William E.			Ground-Vegetation Clutter Affects Phyllostomid Bat Assemblage Structure in Lowland Amazonian Forest	PLOS ONE			English	Article							CAROLLIA-PERSPICILLATA; INSECTIVOROUS BATS; SPECIES-DIVERSITY; FORAGING BEHAVIOR; FRUGIVOROUS BATS; NESTED SUBSETS; FRUIT BATS; HABITAT; ABUNDANCE; PREY	Vegetation clutter is a limiting factor for bats that forage near ground level, and may determine the distribution of species and guilds. However, many studies that evaluated the effects of vegetation clutter on bats have used qualitative descriptions rather than direct measurements of vegetation density. Moreover, few studies have evaluated the effect of vegetation clutter on a regional scale. Here, we evaluate the influence of the physical obstruction of vegetation on phyllostomid-bat assemblages along a 520 km transect in continuous Amazonian forest. We sampled bats using mist nets in eight localities during 80 nights (3840 net-hours) and estimated the ground-vegetation density with digital photographs. The total number of species, number of animalivorous species, total number of frugivorous species, number of understory frugivorous species, and abundance of canopy frugivorous bats were negatively associated with vegetation clutter. The bat assemblages showed a nested structure in relation to degree of clutter, with animalivorous and understory frugivorous bats distributed throughout the vegetation-clutter gradient, while canopy frugivores were restricted to sites with more open vegetation. The species distribution along the gradient of vegetation clutter was not closely associated with wing morphology, but aspect ratio and wing load differed between frugivores and animalivores. Vegetation structure plays an important role in structuring assemblages of the bats at the regional scale by increasing beta diversity between sites. Differences in foraging strategy and diet of the guilds seem to have contributed more to the spatial distribution of bats than the wing characteristics of the species alone.	[Marciente, Rodrigo; Bobrowiec, Paulo Estefano D.; Magnusson, William E.] Inst Nacl Pesquisas Amazozia, Coordenacao Biodiversidade, Manaus, Amazonas, Brazil		Bobrowiec, PED (corresponding author), Inst Nacl Pesquisas Amazozia, Coordenacao Biodiversidade, Manaus, Amazonas, Brazil.	paulobobro@gmail.com	Bobrowiec, Paulo Estefano D./A-2630-2013; Marciente, Rodrigo/AAP-1710-2021	Dineli Bobrowiec, Paulo Estefano/0000-0002-8945-6105	Programa de Pesquisa em Biodiversidade (PPBio); National Institute for Science, Technology and Innovation for Amazonian Biodiversity (INCT-CENBAM); Instituto Nacional de Pesquisas da Amazonia (INPA); Bat Conservation International; Fundacao de Amparo a Pesquisa do Amazonas (FAPEAM); Instituto Chico Mendes de Conservacao da Biodiversidade (ICMBio) of Humaita; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [132573/2010-5]; Fundacao Amazonica de Defesa da Biosfera (FDB); PEDB by a Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [02499/09-6]	Programa de Pesquisa em Biodiversidade (PPBio); National Institute for Science, Technology and Innovation for Amazonian Biodiversity (INCT-CENBAM); Instituto Nacional de Pesquisas da Amazonia (INPA); Bat Conservation International; Fundacao de Amparo a Pesquisa do Amazonas (FAPEAM); Instituto Chico Mendes de Conservacao da Biodiversidade (ICMBio) of Humaita; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Amazonica de Defesa da Biosfera (FDB); PEDB by a Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Programa de Pesquisa em Biodiversidade (PPBio), National Institute for Science, Technology and Innovation for Amazonian Biodiversity (INCT-CENBAM), Instituto Nacional de Pesquisas da Amazonia (INPA), Bat Conservation International, Fundacao de Amparo a Pesquisa do Amazonas (FAPEAM), and Instituto Chico Mendes de Conservacao da Biodiversidade (ICMBio) of Humaita have funded field work. RM was supported by a fellowship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq 132573/2010-5) and Fundacao Amazonica de Defesa da Biosfera (FDB) and PEDB by a Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) post-doctoral scholarship (02499/09-6).	Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Andrade TY, 2013, J MAMMAL, V94, P1094, DOI 10.1644/12-MAMM-A-244.1; [Anonymous], 2014, R LANG ENV STAT COMP; Arlettaz R, 2001, NATURE, V414, P742, DOI 10.1038/414742a; BARCLAY RMR, 1994, ANIM BEHAV, V48, P1013, DOI 10.1006/anbe.1994.1334; Bernard E, 2003, BIOTROPICA, V35, P262, DOI 10.1111/j.1744-7429.2003.tb00285.x; Bernardes C, 2011, BIOTA NEOTROP, V11, P83, DOI 10.1590/S1676-06032011000300006; Bobrowiec PED, 2010, ANIM CONSERV, V13, P204, DOI 10.1111/j.1469-1795.2009.00322.x; Bobrowiec PED, 2014, BIOTROPICA, V46, P312, DOI 10.1111/btp.12102; BONACCORSO FJ, 1987, J ANIM ECOL, V56, P907, DOI 10.2307/4956; Costa FRC, 2010, NAT CONSERVACAO, V8, P3, DOI 10.4322/natcon.00801001; Caras T, 2009, J TROP ECOL, V25, P97, DOI 10.1017/S0266467408005671; Charles-Dominique P., 2001, PATRIMOINES NATURELS, V49, P1; Colwell RK, 2013, ESTIMATES STAT ESTIM; Cosson JF, 1999, J TROP ECOL, V15, P515, DOI 10.1017/S026646749900098X; Denzinger A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00164; Dinnage R, 2012, ECOL LETT, V15, P1308, DOI 10.1111/j.1461-0248.2012.01854.x; Estrada A., 2004, Animal Biodiversity and Conservation, V27, P5; Estrada-Villegas S, 2012, ECOLOGY, V93, P1183, DOI 10.1890/11-0275.1; Fahr J, 2011, ECOGRAPHY, V34, P177, DOI 10.1111/j.1600-0587.2010.05510.x; FENTON MB, 1990, CAN J ZOOL, V68, P411, DOI 10.1139/z90-061; Fleming, 1986, FRUGIVORES SEED DISP, P105, DOI DOI 10.1007/978-94-009-4812-9_11; FLEMING TH, 1977, ECOLOGY, V58, P619, DOI 10.2307/1939011; FLEMING TH, 1991, J MAMMAL, V72, P493, DOI 10.2307/1382132; Ford WM, 2005, BIOL CONSERV, V126, P528, DOI 10.1016/j.biocon.2005.07.003; Galindo-Gonzalez J, 2000, CONSERV BIOL, V14, P1693, DOI [10.1046/j.1523-1739.2000.99072.x, 10.1111/j.1523-1739.2000.99072.x]; Gardner A.L., 2008, MAMMALS S AM MARSUPI; Giannini NP, 2004, OIKOS, V105, P209, DOI 10.1111/j.0030-1299.2004.12690.x; Gotelli N.J., 1996, NULL MODELS ECOLOGY; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hagen EM, 2011, OECOLOGIA, V166, P751, DOI 10.1007/s00442-011-1913-4; HEITHAUS ER, 1978, ECOL MONOGR, V48, P127, DOI 10.2307/2937296; Henry M, 2007, J ANIM ECOL, V76, P801, DOI 10.1111/j.1365-2656.2007.01258.x; IBGE-Instituto Brasileiro de Geografia e Estatistica, 2004, EST AM VEG; Jensen ME, 2001, J EXP BIOL, V204, P199; Jung K, 2012, J APPL ECOL, V49, P523, DOI 10.1111/j.1365-2664.2012.02116.x; Jung K, 2011, DIVERS DISTRIB, V17, P262, DOI 10.1111/j.1472-4642.2010.00738.x; Kalko EKV, 1998, ZOOL-ANAL COMPLEX SY, V101, P281; Kalko Elisabeth K.V., 1996, P503, DOI 10.1016/B978-012178075-3/50017-9; Kalko Elisabeth K.V., 1998, P197; Kusch J, 2004, FOLIA ZOOL, V53, P113; Law B, 2002, J APPL ECOL, V39, P605, DOI 10.1046/j.1365-2664.2002.00739.x; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Legendre P., 2012, NUMERICAL ECOLOGY, V3rd ed.; Lim BK, 2001, BIODIVERS CONSERV, V10, P613, DOI 10.1023/A:1016660123189; Lobova TA, 2009, SEED DISPERSAL BATS; Lopez-Gonzalez C, 2004, J BIOGEOGR, V31, P33, DOI 10.1111/j.1365-2699.2004.00940.x; Magnusson William E., 2005, Biota Neotrop., V5, P19, DOI 10.1590/S1676-06032005000300002; Marinello MM, 2014, CAN J ZOOL, V92, P141, DOI 10.1139/cjz-2013-0127; Marques JT, 2012, ACTA CHIROPTEROL, V14, P183, DOI 10.3161/150811012X654862; Marsden SJ, 2002, FOREST ECOL MANAG, V165, P117, DOI 10.1016/S0378-1127(01)00653-3; McGill BJ, 2010, SCIENCE, V328, P575, DOI 10.1126/science.1188528; Medellin RA, 2000, CONSERV BIOL, V14, P1666, DOI [10.1046/j.1523-1739.2000.99068.x, 10.1111/j.1523-1739.2000.99068.x]; Meyer CFJ, 2008, DIVERS DISTRIB, V14, P644, DOI 10.1111/j.1472-4642.2007.00462.x; MORRISON DW, 1980, J MAMMAL, V61, P20, DOI 10.2307/1379953; Moulatlet GM, 2014, BIOTROPICA, V46, P395, DOI 10.1111/btp.12117; Muller J, 2012, OECOLOGIA, V169, P673, DOI 10.1007/s00442-011-2247-y; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Oksanen J., 2016, R PACKAG; PATTERSON BD, 1986, BIOL J LINN SOC, V28, P65, DOI 10.1111/j.1095-8312.1986.tb01749.x; Patterson BD, 2003, BAT ECOLOGY, P536; Pellissier L, 2013, ECOL LETT, V16, P600, DOI 10.1111/ele.12083; Peters SL, 2006, CONSERV BIOL, V20, P1410, DOI 10.1111/j.1523-1739.2006.00526.x; Rainho A, 2010, J APPL ECOL, V47, P850, DOI 10.1111/j.1365-2664.2010.01820.x; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Rex K, 2011, J TROP ECOL, V27, P211, DOI 10.1017/S0266467411000022; Rodriguez-San Pedro A, 2015, EUR J WILDLIFE RES, V61, P177, DOI 10.1007/s10344-014-0871-7; Schietti J, 2014, PLANT ECOL DIVERS, V7, P241, DOI 10.1080/17550874.2013.783642; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Simmons JB, 2002, AM MUS NOVIT, P1; Sombroek W, 2001, AMBIO, V30, P388, DOI 10.1639/0044-7447(2001)030[0388:SATPOA]2.0.CO;2; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Thies W, 1998, BEHAV ECOL SOCIOBIOL, V42, P397, DOI 10.1007/s002650050454; Walsh AL, 1996, J APPL ECOL, V33, P519, DOI 10.2307/2404981; Whitfeld TJS, 2012, ECOLOGY, V93, pS211, DOI 10.1890/11-0503.1; Willig MR, 2007, BIOTROPICA, V39, P737, DOI 10.1111/j.1744-7429.2007.00322.x; Zehm A, 2003, FLORA, V198, P142, DOI 10.1078/0367-2530-00086; Zuur Alain F., 2009, P1	80	22	23	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129560	10.1371/journal.pone.0129560	http://dx.doi.org/10.1371/journal.pone.0129560			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066654	Green Submitted, gold, Green Published			2022-12-26	WOS:000356327000090
J	McCabe, RM; Grutsch, JF; Braun, DP; Nutakki, SB				McCabe, Ryan M.; Grutsch, James F.; Braun, Donald P.; Nutakki, Swetha B.			Fatigue as a Driver of Overall Quality of Life in Cancer Patients	PLOS ONE			English	Article							LUNG; ONCOLOGY; DETERMINANTS; VARIABLES; SURVIVAL	Background This manuscript describes an approach for analyzing large amounts of disparate clinical data to elucidate the most impactful factor(s) that relate to a meaningful clinical outcome, in this case, the quality of life of cancer patients. The relationships between clinical and quality of life variables were evaluated using the EORTC QLQ-C30 global health domain-a validated surrogate variable for overall cancer patient well-being. Methods A cross-sectional study design was used to evaluate the determinants of global health in cancer patients who initiated treatment at two regional medical centers between January 2001 and December 2009. Variables analyzed included 15 EORTC QLQ-C30 scales, age at diagnosis, gender, newly diagnosed/recurrent disease status, and stage. The decision tree algorithm, perhaps unfamiliar to practicing clinicians, evaluates the relative contribution of individual parameters in classifying a clinically meaningful functional endpoint, such as the global health of a patient. Findings Multiple patient characteristics were identified as important contributors. Fatigue, in particular, emerged as the most prevalent indicator of cancer patients' quality of life in 16/23 clinically relevant subsets. This analysis allowed results to be stated in a clinically-intuitive, rule set format using the language and quantities of the Quality of Life (QoL) tool itself. Interpretation By applying the classification algorithms to a large data set, identification of fatigue as a root factor in driving global health and overall QoL was revealed. The ability to practice mining of clinical data sets to uncover critical clinical insights that are immediately applicable to patient care practices is illustrated.	[McCabe, Ryan M.; Grutsch, James F.; Braun, Donald P.; Nutakki, Swetha B.] Canc Treatment Ctr Amer, Med & Sci, Zion, IL 60099 USA; [Grutsch, James F.] Univ Illinois, Sch Publ Hlth, Dept Epidemiol, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Nutakki, SB (corresponding author), Canc Treatment Ctr Amer, Med & Sci, Zion, IL 60099 USA.	swetha.bose@gmail.com			Cancer Treatment Centers of America	Cancer Treatment Centers of America	The research program is funded by Cancer Treatment Centers of America. Cancer Treatment Centers of America provided support in the form of salaries for authors Ryan M McCabe, James F Grutsch, Donald P Braun and Swetha B Nutakki but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Altman D, 2000, 6 INT C PHOT CORR OT, P175; Bakas T, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-134; Beijer S, 2008, INT J CANCER, V123, P232, DOI 10.1002/ijc.23497; Bingener J, 2014, J GASTROINTESTINAL S; Bowling A, 2001, MEASURING DIS REV DI, V18; Breiman L., 1984, WADSWORTH STAT PROBA, V19, P368, DOI DOI 10.1111/gcb.12809; Cleeland CS, 2013, CANCER-AM CANCER SOC, V119, P4333, DOI 10.1002/cncr.28376; Cocks K, 2011, J CLIN ONCOL, V29, P89, DOI 10.1200/JCO.2010.28.0107; Dagnelie PC, 2007, ANN ONCOL, V18, P940, DOI 10.1093/annonc/mdm057; Ferrans Carol Estwing, 2007, J Natl Cancer Inst Monogr, P22, DOI 10.1093/jncimonographs/lgm008; Grutsch JF, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-193; Gundy CM, 2012, QUAL LIFE RES, V21, P1607, DOI 10.1007/s11136-011-0082-6; Hubbard JM, 2014, J ONCOL PRACT, V10, P248, DOI 10.1200/JOP.2013.001276; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Levin RD, 2005, BRIT J CANCER, V93, P1202, DOI 10.1038/sj.bjc.6602859; Lior R., 2007, DATA MINING DECISION; Lis CG, 2009, PATIENT PREFER ADHER, V3, P287; McCabe RM, 2008, USING DATA MINING PR, V3; McCabe RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099445; Osoba D, 1998, J CLIN ONCOL, V16, P139, DOI 10.1200/JCO.1998.16.1.139; Podgorelec Vili, 2002, J Med Syst, V26, P445, DOI 10.1023/A:1016409317640; Qi YW, 2009, J THORAC ONCOL, V4, P1075, DOI 10.1097/JTO.0b013e3181ae27f5; Quinten C, 2009, LANCET ONCOL, V10, P865, DOI 10.1016/S1470-2045(09)70200-1; Scott N., 2008, EORTC QLQ C30 REFERE; Sloan JA, 2012, J CLIN ONCOL, V30, P1699, DOI 10.1200/JCO.2010.34.5629; Sprangers MAG, 2010, QUAL LIFE RES, V19, P1395, DOI 10.1007/s11136-010-9759-5; Steptoe A, 2005, P NATL ACAD SCI USA, V102, P6508, DOI 10.1073/pnas.0409174102; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; Witten I.H., 2005, MOR KAUF D, P560	30	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130023	10.1371/journal.pone.0130023	http://dx.doi.org/10.1371/journal.pone.0130023			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070133	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000136
J	Salat, D; Winkler, A; Urlaub, H; Gessler, M				Salat, Daniela; Winkler, Anja; Urlaub, Henning; Gessler, Manfred			Hey bHLH Proteins Interact with a FBXO45 Containing SCF Ubiquitin Ligase Complex and Induce Its Translocation into the Nucleus	PLOS ONE			English	Article							F-BOX PROTEIN; SYNAPSE FORMATION; BINDING-PROTEIN; IDENTIFICATION; PROMOTES; GENE; PROTEOLYSIS; DEGRADATION; REPRESSION; EXPRESSION	The Hey protein family, comprising Hey1, Hey2 and HeyL in mammals, conveys Notch signals in many cell types. The helix-loop-helix (HLH) domain as well as the Orange domain, mediate homo- and heterodimerization of these transcription factors. Although distinct interaction partners have been identified so far, their physiological relevance for Hey functions is still largely unclear. Using a tandem affinity purification approach and mass spectrometry analysis we identified members of an ubiquitin E3-ligase complex consisting of FBXO45, PAM and SKP1 as novel Hey1 associated proteins. There is a direct interaction between Hey1 and FBXO45, whereas FBXO45 is needed to mediate indirect Hey1 binding to SKP1. Expression of Hey1 induces translocation of FBXO45 and PAM into the nucleus. Hey1 is a short-lived protein that is degraded by the proteasome, but there is no evidence for FBXO45-dependent ubiquitination of Hey1. On the contrary, Hey1 mediated nuclear translocation of FBXO45 and its associated ubiquitin ligase complex may extend its spectrum to additional nuclear targets triggering their ubiquitination. This suggests a novel mechanism of action for Hey bHLH factors.	[Salat, Daniela; Winkler, Anja; Gessler, Manfred] Univ Wurzburg, Bioctr, Theodor Boveri Inst, Dev Biochem, D-97070 Wurzburg, Germany; [Urlaub, Henning] Max Planck Inst Biophys Chem, Univ Med Ctr, Inst Clin Chem, Bioanalyt Mass Spectrometry, D-37077 Gottingen, Germany; [Gessler, Manfred] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, D-97070 Wurzburg, Germany	University of Wurzburg; Max Planck Society; University of Gottingen; University of Wurzburg	Gessler, M (corresponding author), Univ Wurzburg, Bioctr, Theodor Boveri Inst, Dev Biochem, D-97070 Wurzburg, Germany.	gessler@biozentrum.uni-wuerzburg.de		Gessler, Manfred/0000-0002-7915-6045	German Research Foundation (DFG); University of Wuerzburg; Deutsche Forschungsgemeinschaft [SFB 688 (TP A16)]	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. This work was supported by the Deutsche Forschungsgemeinschaft through SFB 688 (TP A16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Belandia B, 2005, MOL CELL BIOL, V25, P1425, DOI 10.1128/MCB.25.4.1425-1436.2005; Burgess RW, 2004, MOL CELL BIOL, V24, P1096, DOI 10.1128/MCB.24.3.1096-1105.2004; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Chen XR, 2014, IEEE T DIELECT EL IN, V21, P45, DOI [10.1109/TDEI.2013.004108, 10.1109/TDEI.2014.6740724]; Chin MT, 2000, J BIOL CHEM, V275, P6381, DOI 10.1074/jbc.275.9.6381; Chung FZ, 2014, J BIOL CHEM, V289, P28448, DOI 10.1074/jbc.M114.561241; Craig KL, 1999, PROG BIOPHYS MOL BIO, V72, P299, DOI 10.1016/S0079-6107(99)00010-3; D'Souza J, 2005, DEVELOPMENT, V132, P247, DOI 10.1242/dev.01578; Doetzlhofer A, 2009, DEV CELL, V16, P58, DOI 10.1016/j.devcel.2008.11.008; Fischer A, 2005, MOL CELL BIOL, V25, P8960, DOI 10.1128/MCB.25.20.8960-8970.2005; Fischer A, 2002, COLD SPRING HARB SYM, V67, P63, DOI 10.1101/sqb.2002.67.63; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Fischer A, 2007, CIRC RES, V100, P856, DOI 10.1161/01.RES.0000260913.95642.3b; Fukada S, 2011, DEVELOPMENT, V138, P4609, DOI 10.1242/dev.067165; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; Gould F, 2009, J VIROL, V83, P6727, DOI 10.1128/JVI.00351-09; Grill B, 2012, J NEUROSCI, V32, P2628, DOI 10.1523/JNEUROSCI.2901-11.2012; Guo QB, 1998, P NATL ACAD SCI USA, V95, P9172, DOI 10.1073/pnas.95.16.9172; Han LF, 2014, CANCER RES, V74, P6509, DOI 10.1158/0008-5472.CAN-14-0816; Heisig J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002728; Holland S, 2011, J BIOL CHEM, V286, P3671, DOI 10.1074/jbc.M110.154765; Iso T, 2001, MOL CELL BIOL, V21, P6080, DOI 10.1128/MCB.21.17.6080-6089.2001; Jalali A, 2011, J NEUROSCI RES, V89, P299, DOI 10.1002/jnr.22562; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Lavery DN, 2011, J BIOL CHEM, V286, P17796, DOI 10.1074/jbc.M110.198655; Leimeister C, 2000, DEV BIOL, V227, P91, DOI 10.1006/dbio.2000.9884; Nelson DE, 2011, J BIOL CHEM, V286, P19804, DOI 10.1074/jbc.M111.220079; Nguyen BA, 2009, BMC BIOINFORMATICS, V10, P202, DOI [10.1186/1471-2105-10-202, DOI 10.1186/1471-2105-10-202]; Peschiaroli A, 2009, ONCOGENE, V28, P3157, DOI 10.1038/onc.2009.177; Po MD, 2010, CURR OPIN NEUROBIOL, V20, P100, DOI 10.1016/j.conb.2009.12.007; Saiga T, 2009, MOL CELL BIOL, V29, P3529, DOI 10.1128/MCB.00364-09; Satow T, 2001, J NEUROSCI, V21, P1265; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Scholich K, 2001, J BIOL CHEM, V276, P47583, DOI 10.1074/jbc.M107816200; Sharma J, 2014, J BIOL CHEM, V289, P34654, DOI 10.1074/jbc.M114.614065; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Smaldone S, 2004, MOL CELL BIOL, V24, P1058, DOI 10.1128/MCB.24.3.1058-1069.2004; Tada H, 2010, J BIOL CHEM, V285, P3840, DOI 10.1074/jbc.M109.046284; Tu XL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002577; Van Wayenbergh R, 2003, DEV DYNAM, V228, P716, DOI 10.1002/dvdy.10406; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wiese C, 2010, PEDIATR CARDIOL, V31, P363, DOI 10.1007/s00246-009-9609-9; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Xu M, 2015, ONCOTARGET, V6, P979, DOI 10.18632/oncotarget.2825; Yoshida K, 2005, ONCOL REP, V14, P531; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069	49	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130288	10.1371/journal.pone.0130288	http://dx.doi.org/10.1371/journal.pone.0130288			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068074	Green Published, Green Submitted, gold			2022-12-26	WOS:000356327000153
J	Wu, ZZ; Zhang, H; Wang, ZB; Bin, SY; He, HL; Lin, JT				Wu, Zhongzhen; Zhang, He; Wang, Zhengbing; Bin, Shuying; He, Hualiang; Lin, Jintian			Discovery of Chemosensory Genes in the Oriental Fruit Fly, Bactrocera dorsalis	PLOS ONE			English	Article							ODORANT-BINDING-PROTEINS; COMPARATIVE GENOMIC ANALYSIS; EXPRESSED SEQUENCE TAGS; PHEROMONE-BINDING; METHYL EUGENOL; OLFACTORY RECEPTORS; SOLUBLE-PROTEINS; IDENTIFICATION; DIPTERA; FAMILY	The oriental fruit fly, Bactrocera dorsalis, is a devastating fruit fly pest in tropical and subtropical countries. Like other insects, this fly uses its chemosensory system to efficiently interact with its environment. However, our understanding of the molecular components comprising B. dorsalis chemosensory system is limited. Using next generation sequencing technologies, we sequenced the transcriptome of four B. dorsalis developmental stages: egg, larva, pupa and adult chemosensory tissues. A total of 31 candidate odorant binding proteins (OBPs), 4 candidate chemosensory proteins (CSPs), 23 candidate odorant receptors (ORs), 11 candidate ionotropic receptors (IRs), 6 candidate gustatory receptors (GRs) and 3 candidate sensory neuron membrane proteins (SNMPs) were identified. The tissue distributions of the OBP and CSP transcripts were determined by RT-PCR and a subset of nine genes were further characterized. The predicted proteins from these genes shared high sequence similarity to Drosophila melanogaster pheromone binding protein related proteins (PBPRPs). Interestingly, one OBP (BdorOBP19c) was exclusively expressed in the sex pheromone glands of mature females. RT-PCR was also used to compare the expression of the candidate genes in the antennae of male and female B. dorsalis adults. These antennae-enriched OBPs, CSPs, ORs, IRs and SNMPs could play a role in the detection of pheromones and general odorants and thus could be useful target genes for the integrated pest management of B. dorsalis and other agricultural pests.	[Wu, Zhongzhen; Zhang, He; Wang, Zhengbing; Bin, Shuying; He, Hualiang; Lin, Jintian] Zhongkai Univ Agr & Engn, Inst Management Invas Alien Species, Guangzhou, Guangdong, Peoples R China	Zhongkai University of Agriculture & Engineering	Lin, JT (corresponding author), Zhongkai Univ Agr & Engn, Inst Management Invas Alien Species, Guangzhou, Guangdong, Peoples R China.	linjtian@163.com		Wang, Zhengbing/0000-0003-4460-0369	National Natural Science Foundation of China [31171852]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31171852).	Allwood AJ, 1999, RAFFLES B ZOOL, P1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Asahina K, 2008, CURR BIOL, V18, P1153, DOI 10.1016/j.cub.2008.06.075; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Chen YA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-416; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Croset V, 2010, J NEUROGENET, V24, P30; Damodaram KJP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085764; Dani FR, 2011, CHEM SENSES, V36, P335, DOI 10.1093/chemse/bjq137; Findlay GD, 2008, PLOS BIOL, V6, P1417, DOI 10.1371/journal.pbio.0060178; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Geib SM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-942; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Graham LA, 2003, MOL CELL PROTEOMICS, V2, P541, DOI 10.1074/mcp.M300018-MCP200; Grosse-Wilde E, 2006, CHEM SENSES, V31, P547, DOI 10.1093/chemse/bjj059; Gu SH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-636; Gu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042871; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Hsu JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040950; Iovinella I, 2011, J PROTEOME RES, V10, P3439, DOI 10.1021/pr2000754; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; Jayanthi PDK, 2014, J CHEM ECOL, V40, P259, DOI 10.1007/s10886-014-0403-7; Jayanthi PDK, 2002, CURR SCI INDIA, V82, P266; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Kain P, 2013, NATURE, V502, P507, DOI 10.1038/nature12594; Kaissling KE, 2001, CHEM SENSES, V26, P125, DOI 10.1093/chemse/26.2.125; Katoh Kazutaka, 2010, Bioinformatics, V26, P1899, DOI 10.1093/bioinformatics/btq224; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumaran N, 2013, ANIM BEHAV, V85, P781, DOI 10.1016/j.anbehav.2013.01.024; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Li S, 2008, BIOCHEM BIOPH RES CO, V372, P464, DOI 10.1016/j.bbrc.2008.05.064; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017788; Liu R, 2012, INSECT MOL BIOL, V21, P41, DOI 10.1111/j.1365-2583.2011.01114.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maleszka J, 2007, DEV GENES EVOL, V217, P189, DOI 10.1007/s00427-006-0127-y; Marinotti O, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-15; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Montell C, 2009, CURR OPIN NEUROBIOL, V19, P345, DOI 10.1016/j.conb.2009.07.001; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; PELOSI P, 1995, COMP BIOCHEM PHYS B, V111, P503, DOI 10.1016/0305-0491(95)00019-5; Pelosi P, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00320; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PIKIELNY CW, 1994, NEURON, V12, P35, DOI 10.1016/0896-6273(94)90150-3; Pophof B, 2004, CHEM SENSES, V29, P117, DOI 10.1093/chemse/bjh012; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Schumacher MC, 2015, SCAND J UROL, V49, P35, DOI 10.3109/21681805.2014.932840; Schwarz D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-633; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Shen GM, 2013, INSECT MOL BIOL, V22, P354, DOI 10.1111/imb.12026; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; Shen GM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-76; Siciliano P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085523; Sun YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030040; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan KH, 2012, J INSECT SCI, V12, P1, DOI 10.1673/031.012.5601; Tauxe GM, 2013, CELL, V155, P1365, DOI 10.1016/j.cell.2013.11.013; Turner SL, 2009, NATURE, V461, P277, DOI 10.1038/nature08295; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vargas RI, 2010, VITAM HORM, V83, P575, DOI 10.1016/S0083-6729(10)83023-7; Vieira FG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r235; Vieira FG, 2011, GENOME BIOL EVOL, V3, P476, DOI 10.1093/gbe/evr033; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Vogt RG, 2009, INSECT BIOCHEM MOLEC, V39, P448, DOI 10.1016/j.ibmb.2009.03.007; Wan XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036176; Whiteman NK, 2008, TRENDS ECOL EVOL, V23, P473, DOI 10.1016/j.tree.2008.05.010; Wu ZZ, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-55; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Xu YL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-632; Yang WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094470; Yi X, 2014, J CHEM ECOL, V40, P267, DOI 10.1007/s10886-014-0406-4; Yi X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077295; Zhang TT, 2013, J INTEGR AGR, V12, P853, DOI 10.1016/S2095-3119(13)60304-4; Zhang YN, 2014, GENE, V536, P279, DOI 10.1016/j.gene.2013.12.011; Zheng WW, 2013, INT J MOL SCI, V14, P14936, DOI 10.3390/ijms140714936; Zheng WW, 2012, J INSECT PHYSIOL, V58, P1122, DOI 10.1016/j.jinsphys.2012.05.011; Zhou JJ, 2010, VITAM HORM, V83, P241, DOI 10.1016/S0083-6729(10)83010-9; Zhou XH, 2013, BIOL CHEM, V394, P43, DOI 10.1515/hsz-2012-0114	88	34	38	6	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129794	10.1371/journal.pone.0129794	http://dx.doi.org/10.1371/journal.pone.0129794			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070069	Green Submitted, Green Published, gold			2022-12-26	WOS:000356327000108
J	Pereira, MG; Visbal, G; Salgado, LT; Vidal, JC; Godinho, JLP; De Cicco, NNT; Atella, GC; de Souza, W; Cunha-e-Silva, N				Pereira, Miria Gomes; Visbal, Gonzalo; Salgado, Leonardo T.; Vidal, Juliana Cunha; Godinho, Joseane L. P.; De Cicco, Nuccia N. T.; Atella, Georgia C.; de Souza, Wanderley; Cunha-e-Silva, Narcisa			Trypanosoma cruzi Epimastigotes Are Able to Manage Internal Cholesterol Levels under Nutritional Lipid Stress Conditions	PLOS ONE			English	Article							ACYL-COENZYME-A; ACYLTRANSFERASE INHIBITOR; PLASMA-MEMBRANE; CYTO-TOXICITY; PROLIFERATION; STORAGE; METHYLTRANSFERASE; COMPLEXES; CYTOSTOME; SURVIVAL	Trypanosoma cruzi epimastigotes store high amounts of cholesterol and cholesteryl esters in reservosomes. These unique organelles are responsible for cellular digestion by providing substrates for homeostasis and parasite differentiation. Here we demonstrate that under nutritional lipid stress, epimastigotes preferentially mobilized reservosome lipid stocks, instead of lipid bodies, leading to the consumption of parasite cholesterol reservoirs and production of ergosterol. Starved epimastigotes acquired more LDL-NBD-cholesterol by endocytosis and distributed the exogenous cholesterol to their membranes faster than control parasites. Moreover, the parasites were able to manage internal cholesterol levels, alternating between consumption and accumulation. With normal lipid availability, parasites esterified cholesterol exhibiting an ACAT-like activity that was sensitive to Avasimibe in a dose-dependent manner. This result also implies that exogenous cholesterol has a role in lipid reservoirs in epimastigotes.	[Pereira, Miria Gomes; Vidal, Juliana Cunha; Godinho, Joseane L. P.; de Souza, Wanderley; Cunha-e-Silva, Narcisa] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Ultraestrutura Celular Hertha Meyer, BR-21941 Rio De Janeiro, Brazil; [Visbal, Gonzalo; de Souza, Wanderley] Qualidade & Tecnol INMETRO, Inst Nacl Metrol, Rio De Janeiro, Brazil; [Salgado, Leonardo T.] Inst Pesquisas Jardim Bot Rio de Janerio, Rio De Janeiro, Brazil; [Pereira, Miria Gomes; De Cicco, Nuccia N. T.; Atella, Georgia C.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Lab Bioquim Lipidios & Lipoprot, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); Universidade Federal do Rio de Janeiro	Cunha-e-Silva, N (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Ultraestrutura Celular Hertha Meyer, BR-21941 Rio De Janeiro, Brazil.	narcisa@biof.ufrj.br	Atella, Georgia/AAK-7897-2020; Pereira, Miria G/AAJ-9998-2021; Cunha-e-Silva, Narcisa L/Q-2902-2018; Visbal, Gonzalo/AAT-2766-2020; Salgado, Leonardo T/F-1123-2013	Cunha-e-Silva, Narcisa L/0000-0003-4863-4945; Pereira, Miria G/0000-0001-9103-0448	Fundacao Carlos Chagas Filho de Amparo a Pesquisa no Estado do Rio de Janeiro (FAPERJ) [E-26/102.850/2012, E26/110.576/2010, E-26/101.023/2011]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [305599/2010-0]	Fundacao Carlos Chagas Filho de Amparo a Pesquisa no Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the following sources of funding: grants E-26/102.850/2012 from Fundacao Carlos Chagas Filho de Amparo a Pesquisa no Estado do Rio de Janeiro (FAPERJ) e 305599/2010-0 from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) to NCS, Grants E26/110.576/2010 from Fundacao Carlos Chagas Filho de Amparo a Pesquisa no Estado do Rio de Janeiro (FAPERJ) to WDS and NCS, Fellowship E-26/101.023/2011 from Fundacao Carlos Chagas Filho de Amparo a Pesquisa no Estado do Rio de Janeiro (FAPERJ) to MGP.	Batetta B, 2003, FASEB J, V17, P746, DOI 10.1096/fj.02-0396fje; BELLINI F, 1984, BIOCHIM BIOPHYS ACTA, V777, P209, DOI 10.1016/0005-2736(84)90422-X; Bemlih S, 2010, CANCER BIOL THER, V9, P1025, DOI 10.4161/cbt.9.12.11875; CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93; CASSEL DL, 1984, ATHEROSCLEROSIS, V52, P203, DOI 10.1016/0021-9150(84)90119-9; CHAM BE, 1976, J LIPID RES, V17, P176; Chang TY, 2009, AM J PHYSIOL-ENDOC M, V297, pE1, DOI 10.1152/ajpendo.90926.2008; CHAPMAN MJ, 1981, J LIPID RES, V22, P339; COPPENS I, 1995, J BIOL CHEM, V270, P5736, DOI 10.1074/jbc.270.11.5736; COPPENS I, 1995, MOL BIOCHEM PARASIT, V73, P179, DOI 10.1016/0166-6851(95)00114-G; Correa JR, 2008, EXP PARASITOL, V119, P58, DOI 10.1016/j.exppara.2007.12.010; Cosentino RO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096762; De Cicco NNT, 2012, EXP PARASITOL, V130, P330, DOI 10.1016/j.exppara.2012.02.014; GROSSMANN A, 1976, MILCHWISSENSCHAFT, V31, P721; JACOBS DB, 1983, J IMMUNOL METHODS, V62, P101, DOI 10.1016/0022-1759(83)90115-1; LAZARDI K, 1990, ANTIMICROB AGENTS CH, V34, P2097, DOI 10.1128/AAC.34.11.2097; Lige B, 2013, MOL MICROBIOL, V87, P951, DOI 10.1111/mmi.12142; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nishikawa Y, 2005, CELL MICROBIOL, V7, P849, DOI 10.1111/j.1462-5822.2005.00518.x; Pereira MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022359; Porto-Carreiro I, 2000, EUR J CELL BIOL, V79, P858, DOI 10.1078/0171-9335-00112; Rassi A, 2012, INFECT DIS CLIN N AM, V26, P275, DOI 10.1016/j.idc.2012.03.002; Rodriguez A, 2002, ATHEROSCLEROSIS, V161, P45, DOI 10.1016/S0021-9150(01)00620-7; Rodriguez A, 1999, ARTERIOSCL THROM VAS, V19, P2199, DOI 10.1161/01.ATV.19.9.2199; ROSS AC, 1984, J BIOL CHEM, V259, P815; Sant'Anna C, 2009, PROTEOMICS, V9, P1782, DOI 10.1002/pmic.200800730; SILVA NLD, 1989, MOL BIOCHEM PARASIT, V37, P129, DOI 10.1016/0166-6851(89)90109-6; SOARES MJ, 1991, PARASITOL RES, V77, P461, DOI 10.1007/BF00928410; SOARES MJ, 1989, PARASITOL RES, V75, P522, DOI 10.1007/BF00931160; SOUTOPADRON T, 1983, J PARASITOL, V69, P129, DOI 10.2307/3281287; Torres C, 2004, MOL MICROBIOL, V54, P632, DOI 10.1111/j.1365-2958.2004.04304.x; URBINA JA, 1995, MOL BIOCHEM PARASIT, V73, P199, DOI 10.1016/0166-6851(95)00117-J; Urbina JA, 1997, ANTIMICROB AGENTS CH, V41, P1428, DOI 10.1128/AAC.41.7.1428; Urbina JA, 2009, MEM I OSWALDO CRUZ, V104, P311, DOI 10.1590/S0074-02762009000900041; Visbal G, 2003, ANTIMICROB AGENTS CH, V47, P2966, DOI 10.1128/AAC.47.9.2966-2970.2003; VOGEL WC, 1962, J LAB CLIN MED, V59, P335	36	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128949	10.1371/journal.pone.0128949	http://dx.doi.org/10.1371/journal.pone.0128949			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068009	Green Submitted, Green Published, gold			2022-12-26	WOS:000356100900034
J	Segev, O; Polevikove, A; Blank, L; Goedbloed, D; Kupfer, E; Gershberg, A; Koplovich, A; Blaustein, L				Segev, Ori; Polevikove, Antonina; Blank, Lior; Goedbloed, Daniel; Kuepfer, Eliane; Gershberg, Anna; Koplovich, Avi; Blaustein, Leon			Effects of Tail Clipping on Larval Performance and Tail Regeneration Rates in the Near Eastern Fire Salamander, Salamandra infraimmaculata	PLOS ONE			English	Article							MOSQUITOFISH GAMBUSIA-AFFINIS; SWIMMING PERFORMANCE; APPENDAGE REGENERATION; TEMPORARY POOLS; BODY-SIZE; INJURY; TADPOLES; SURVIVAL; METAMORPHOSIS; PREDATOR	Tail-tip clipping is a common technique for collecting tissue samples from amphibian larvae and adults. Surprisingly, studies of this invasive sampling procedure or of natural tail clipping - i.e., bites inflicted by predators including conspecifics - on the performance and fitness of aquatic larval stages of urodeles are scarce. We conducted two studies in which we assessed the effects of posterior tail clipping (similar to 30 percent of tail) on Near Eastern fire salamander (Salamandra infraimmaculata) larvae. In a laboratory study, we checked regeneration rates of posterior tail-tip clipping at different ages. Regeneration rates were hump-shaped, peaking at the age of similar to 30 days and then decreasing. This variation in tail regeneration rates suggests tradeoffs in resource allocation between regeneration and somatic growth during early and advanced development. In an outdoor artificial pond experiment, under constant larval densities, we assessed how tail clipping of newborn larvae affects survival to, time to, and size at metamorphosis. Repeated measures ANOVA on mean larval survival per pond revealed no effect of tail clipping. Tail clipping had correspondingly no effect on larval growth and development expressed in size (mass and snout-vent length) at, and time to, metamorphosis. We conclude that despite the given variation in tail regeneration rates throughout larval ontogeny, clipping of 30% percent of the posterior tail area seems to have no adverse effects on larval fitness and survival. We suggest that future use of this imperative tool for the study of amphibian should take into account larval developmental stage during the time of application and not just the relative size of the clipped tail sample.	[Segev, Ori; Polevikove, Antonina; Blank, Lior; Gershberg, Anna; Koplovich, Avi; Blaustein, Leon] Univ Haifa, Fac Nat Sci, Inst Evolut, IL-3498838 Haifa, Israel; [Segev, Ori; Polevikove, Antonina; Blank, Lior; Gershberg, Anna; Koplovich, Avi; Blaustein, Leon] Univ Haifa, Fac Nat Sci, Dept Evolutionary & Environm Biol, IL-3498838 Haifa, Israel; [Blank, Lior] ARO, Dept Plant Pathol & Weed Res, IL-50250 Bet Dagan, Israel; [Goedbloed, Daniel; Kuepfer, Eliane] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, D-38106 Braunschweig, Germany	University of Haifa; University of Haifa; Braunschweig University of Technology	Segev, O (corresponding author), Univ Haifa, Fac Nat Sci, Inst Evolut, IL-3498838 Haifa, Israel.	orisgv@gmail.com	Blank, Lior/E-5945-2013; Koplovich, Avi/M-4387-2015; Blank, Lior/M-3885-2017	Blank, Lior/0000-0002-8753-0113; Koplovich, Avi/0000-0002-0232-8734; Blank, Lior/0000-0002-8753-0113; Goedbloed, Daniel/0000-0003-2899-4185	German-Israel Project-cooperation (DIP) (DFG) [BL 1271/1-1]; Alan Templeton; Sebastian Steinfartz [SRE 1130/8-1]; Arne Nolte	German-Israel Project-cooperation (DIP) (DFG); Alan Templeton; Sebastian Steinfartz; Arne Nolte	This project was funded by the German-Israel Project-cooperation (DIP) awarded to Leon Blaustein (DFG reference number BL 1271/1-1), Alan Templeton, Sebastian Steinfartz (SRE 1130/8-1), and Arne Nolte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcobendas M, 2004, HERPETOLOGICA, V60, P232, DOI 10.1655/03-55; Anchelin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016955; Anderson TL, 2014, OECOLOGIA, P1, DOI [10.1007/s00442-014-3116-2PMID:25407615, DOI 10.1007/S00442-014-3116-2]; Arendt J, 2010, J MORPHOL, V271, P1044, DOI 10.1002/jmor.10851; Azizi E, 2002, J EXP BIOL, V205, P841; Blair J, 2000, COPEIA, P390, DOI 10.1643/0045-8511(2000)000[0390:VITPOP]2.0.CO;2; Blank L, 2013, ANIM CONSERV, V16, P412, DOI 10.1111/acv.12009; Bouzaffour M, 2010, GEN COMP ENDOCR, V168, P88, DOI 10.1016/j.ygcen.2010.04.006; Broquet T, 2007, CONSERV GENET, V8, P509, DOI 10.1007/s10592-006-9180-3; Cabrera-Guzman E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070121; Cohen Miriam, 2005, Current Herpetology, V24, P55, DOI 10.3105/1345-5834(2005)24[55:TESOIC]2.0.CO;2; Eitam A, 2005, OECOLOGIA, V146, P36, DOI 10.1007/s00442-005-0185-2; Figiel J. C. R., 1991, CAN J ZOOL, V69, P830, DOI [10.1139/z91-125, DOI 10.1139/Z91-125]; Fitzpatrick BM, 2003, J EXP ZOOL PART A, V297A, P147, DOI 10.1002/jez.a.10254; Gillespie JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053041; Grafe TU, 2011, J HERPETOL, V45, P28, DOI 10.1670/10-016.1; Hoff KV, 2000, AM ZOOL, V40, P62, DOI 10.1668/0003-1569(2000)040[0062:TLAMAT]2.0.CO;2; ITEN LE, 1976, J EXP ZOOL, V196, P283, DOI 10.1002/jez.1401960303; Johnson JB, 2008, EVOLUTION, V62, P1243, DOI 10.1111/j.1558-5646.2008.00343.x; Lynn SE, 2013, PHYSIOL BIOCHEM ZOOL, V86, P659, DOI 10.1086/673312; Maginnis TL, 2006, BEHAV ECOL, V17, P857, DOI 10.1093/beheco/arl010; Marvin GA, 2013, J HERPETOL, V47, P174, DOI 10.1670/12-011R; McCarthy MA, 2009, J HERPETOL, V43, P394, DOI 10.1670/08-096R2.1; Mendoza AM, 2012, MOL ECOL RESOUR, V12, P470, DOI 10.1111/j.1755-0998.2011.03107.x; Milanovich JR, 2012, HERPETOL CONSERV BIO, V7, P67; Monaghan JR, 2013, CURR TOP MICROBIOL, V367, P53, DOI 10.1007/82_2012_288; Mott CL, 2014, ETHOLOGY, V120, P42, DOI 10.1111/eth.12178; PARICHY DM, 1992, COPEIA, P129; Phillott Andrea D., 2007, Herpetological Review, V38, P305; Polich RL, 2013, J WILDLIFE MANAGE, V77, P1420, DOI 10.1002/jwmg.596; Prunier J, 2012, MOL ECOL RESOUR, V12, P524, DOI 10.1111/j.1755-0998.2012.03116.x; Sadeh A, 2012, EVOL ECOL RES, V14, P113; Sadeh A, 2009, ECOL LETT, V12, P1158, DOI 10.1111/j.1461-0248.2009.01371.x; Sandoval-Guzman T, 2014, CELL STEM CELL, V14, P174, DOI 10.1016/j.stem.2013.11.007; Segev O, 2009, ANIM CONSERV, V12, P29, DOI 10.1111/j.1469-1795.2008.00217.x; Segev O, 2014, FRESHW SCI, V33, P950, DOI 10.1086/676634; Seifert AW, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-2; Seifert AW, 2012, BIOL REV, V87, P330, DOI 10.1111/j.1469-185X.2011.00199.x; SEMLITSCH RD, 1990, CAN J ZOOL, V68, P1027, DOI 10.1139/z90-149; SEMLITSCH RD, 1988, ECOLOGY, V69, P184, DOI 10.2307/1943173; SEMLITSCH RD, 1989, OECOLOGIA, V81, P100, DOI 10.1007/BF00377017; Shulse CD, 2014, HYDROBIOLOGIA, V723, P131, DOI 10.1007/s10750-013-1502-0; Slack JMW, 2004, PHILOS T R SOC B, V359, P745, DOI 10.1098/rstb.2004.1463; Taniguchi Y, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-27; Vaglia JL, 1997, J MORPHOL, V233, P15, DOI 10.1002/(SICI)1097-4687(199707)233:1<15::AID-JMOR2>3.0.CO;2-N; Van Buskirk J, 2000, J EXP BIOL, V203, P2149; Van Buskirk J, 2003, J HERPETOL, V37, P420, DOI 10.1670/0022-1511(2003)037[0420:TLETTS]2.0.CO;2; VITT LJ, 1986, CAN J ZOOL, V64, P583, DOI 10.1139/z86-086; Voss GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067274; Wells KD., 2010, ECOLOGY BEHAV AMPHIB; WILBUR HM, 1990, COPEIA, P18, DOI 10.2307/1445817; Wilcox SC, 2013, J EXP ZOOL PART A, V319, P495, DOI 10.1002/jez.1813	53	10	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128077	10.1371/journal.pone.0128077	http://dx.doi.org/10.1371/journal.pone.0128077			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26065683	Green Submitted, Green Published, gold			2022-12-26	WOS:000356100900016
J	Inoue, K; Okamoto, M; Shibato, J; Lee, MC; Matsui, T; Rakwal, R; Soya, H				Inoue, Koshiro; Okamoto, Masahiro; Shibato, Junko; Lee, Min Chul; Matsui, Takashi; Rakwal, Randeep; Soya, Hideaki			Long-Term Mild, rather than Intense, Exercise Enhances Adult Hippocampal Neurogenesis and Greatly Changes the Transcriptomic Profile of the Hippocampus	PLOS ONE			English	Article							GROWTH-FACTOR-I; PLASMA CORTICOSTERONE RESPONSE; METHYL-D-ASPARTATE; NEURAL STEM-CELL; DENTATE GYRUS; GENE-EXPRESSION; SYNAPTIC PLASTICITY; NEUROTROPHIC FACTOR; VOLUNTARY EXERCISE; SPATIAL MEMORY	Our six-week treadmill running training (forced exercise) model has revealed that mild exercise (ME) with an intensity below the lactate threshold (LT) is sufficient to enhance spatial memory, while intense exercise (IE) above the LT negates such benefits. To help understand the unrevealed neuronal and signaling/molecular mechanisms of the intensity-dependent cognitive change, in this rat model, we here investigated plasma corticosterone concentration as a marker of stress, adult hippocampal neurogenesis (AHN) as a potential contributor to this ME-induced spatial memory, and comprehensively delineated the hippocampal transcriptomic profile using a whole-genome DNA microarray analysis approach through comparison with IE. Results showed that only IE had the higher corticosterone concentration than control, and that the less intense exercise (ME) is better suited to improve AHN, especially in regards to the survival and maturation of newborn neurons. DNA microarray analysis using a 4 x 44 K Agilent chip revealed that ME regulated more genes than did IE (ME: 604 genes, IE: 415 genes), and only 41 genes were modified with both exercise intensities. The identified molecular components did not comprise well-known factors related to exercise-induced AHN, such as brain-derived neurotrophic factor. Rather, network analysis of the data using Ingenuity Pathway Analysis algorithms revealed that the ME-influenced genes were principally related to lipid metabolism, protein synthesis and inflammatory response, which are recognized as associated with AHN. In contrast, IE-influenced genes linked to excessive inflammatory immune response, which is a negative regulator of hippocampal neuroadaptation, were identified. Collectively, these results in a treadmill running model demonstrate that long-term ME, but not of IE, with minimizing running stress, has beneficial effects on increasing AHN, and provides an ME-specific gene inventory	[Inoue, Koshiro; Okamoto, Masahiro; Shibato, Junko; Lee, Min Chul; Matsui, Takashi; Soya, Hideaki] Univ Tsukuba, Fac Hlth & Sport Sci, Lab Exercise Biochem & Neuroendocrinol, Tsukuba, Ibaraki 3058574, Japan; [Inoue, Koshiro] Hlth Sci Univ Hokkaido, Sch Rehabil Sci, Kanazawa Ku, Ishikari, Hokkaido 0610293, Japan; [Shibato, Junko; Rakwal, Randeep] Showa Univ, Sch Med, Dept Anat, Shinagawa Ku, Tokyo 1428555, Japan; [Lee, Min Chul; Matsui, Takashi] Japan Soc Promot Sci, Tokyo, Japan; [Rakwal, Randeep] Univ Tsukuba, Org Educ Initiat, Tsukuba, Ibaraki 3058577, Japan	University of Tsukuba; Health Sciences University of Hokkaido; Showa University; Japan Society for the Promotion of Science; University of Tsukuba	Soya, H (corresponding author), Univ Tsukuba, Fac Hlth & Sport Sci, Lab Exercise Biochem & Neuroendocrinol, Tsukuba, Ibaraki 3058574, Japan.	hsoya@taiiku.tsukuba.ac.jp	Matsui, Takashi/F-6962-2018; huang, dezhi/ABC-6566-2021	Matsui, Takashi/0000-0002-9990-010X; 	Japan Society for the Promotion of Science [20300214, 23240091]; Ministry of Education, Culture, Sports, Science and Technology, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Japan Society for the Promotion of Science (Grants-in-aid for Scientific Research B 20300214 and A 23240091) and for the Body and Mind Integrated Sports Sciences Project (2010-2013) of the Ministry of Education, Culture, Sports, Science and Technology, Japan.	ADER R, 1970, PHYSIOL BEHAV, V5, P837, DOI 10.1016/0031-9384(70)90168-X; Agis-Balboa RC, 2011, EMBO J, V30, P4071, DOI 10.1038/emboj.2011.293; Ang ET, 2006, BRAIN RES, V1113, P186, DOI 10.1016/j.brainres.2006.07.023; Asakura R, 2011, NEUROREPORT, V22, P881, DOI 10.1097/WNR.0b013e32834bf4ca; Barha CK, 2011, HIPPOCAMPUS, V21, P1216, DOI 10.1002/hipo.20829; Barres BA, 2001, SCIENCE, V294, P1296, DOI 10.1126/science.1066724; BASKIN DG, 1994, ENDOCRINOLOGY, V134, P1952, DOI 10.1210/en.134.4.1952; Binder DK, 2007, PROG BRAIN RES, V163, P371, DOI 10.1016/S0079-6123(07)63022-2; Bjornebekk A, 2006, NEUROPSYCHOPHARMACOL, V31, P256, DOI 10.1038/sj.npp.1300820; Bracko O, 2012, J NEUROSCI, V32, P3376, DOI 10.1523/JNEUROSCI.4248-11.2012; Brown DA, 2007, J APPL PHYSIOL, V103, P1979, DOI 10.1152/japplphysiol.00706.2007; Burger C, 2008, NEUROBIOL LEARN MEM, V89, P379, DOI 10.1016/j.nlm.2007.11.006; BUUCK RJ, 1971, J APPL PHYSIOL, V31, P880, DOI 10.1152/jappl.1971.31.6.880; Chang YT, 2008, PSYCHONEUROENDOCRINO, V33, P1173, DOI 10.1016/j.psyneuen.2008.05.014; Choi JH, 2011, CELL MOL NEUROBIOL, V31, P285, DOI 10.1007/s10571-010-9619-4; Chorna NE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077845; Clark PJ, 2008, NEUROSCIENCE, V155, P1048, DOI 10.1016/j.neuroscience.2008.06.051; Clark PJ, 2012, HIPPOCAMPUS, V22, P1860, DOI 10.1002/hipo.22020; Clark PJ, 2009, HIPPOCAMPUS, V19, P937, DOI 10.1002/hipo.20543; Conrad CD, 2010, PROG NEURO-PSYCHOPH, V34, P742, DOI 10.1016/j.pnpbp.2009.11.003; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Droste SK, 2003, ENDOCRINOLOGY, V144, P3012, DOI 10.1210/en.2003-0097; Duan X, 2008, CURR OPIN NEUROBIOL, V18, P108, DOI 10.1016/j.conb.2008.04.001; Fabel K, 2003, EUR J NEUROSCI, V18, P2803, DOI 10.1111/j.1460-9568.2003.03041.x; FOLLI F, 1994, J NEUROSCI, V14, P6412; FRIEDMAN SB, 1967, PSYCHOSOM MED, V29, P323, DOI 10.1097/00006842-196707000-00003; Ge SY, 2008, J PHYSIOL-LONDON, V586, P3759, DOI 10.1113/jphysiol.2008.155655; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Golan H, 2004, CEREB CORTEX, V14, P97, DOI 10.1093/cercor/bhg108; Goshen I, 2007, PSYCHONEUROENDOCRINO, V32, P1106, DOI 10.1016/j.psyneuen.2007.09.004; Gregoire CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086237; HALTMEYE.GC, 1967, PHYSIOL BEHAV, V2, P61, DOI 10.1016/0031-9384(67)90012-1; Head BP, 2008, FASEB J, V22, P828, DOI 10.1096/fj.07-9299com; Hori M, 2012, DIS MODEL MECH, V5, P270, DOI 10.1242/dmm.008276; Hsieh MT, 2003, LIFE SCI, V73, P1007, DOI 10.1016/S0024-3205(03)00372-2; Huang AM, 2006, J NEURAL TRANSM, V113, P803, DOI 10.1007/s00702-005-0359-4; Hunsberger JG, 2007, NAT MED, V13, P1476, DOI 10.1038/nm1669; Iacono G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068078; Inoue K, 2015, INT J SPORTS MED, V36, P280, DOI 10.1055/s-0034-1390465; KANT GJ, 1987, PHYSIOL BEHAV, V40, P775, DOI 10.1016/0031-9384(87)90282-4; Kawashima H, 2004, LIFE SCI, V76, P763, DOI 10.1016/j.lfs.2004.09.014; Ke Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016643; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Keohane A, 2010, MOL CELL NEUROSCI, V43, P127, DOI 10.1016/j.mcn.2009.10.003; Kimoto T, 2001, ENDOCRINOLOGY, V142, P3578, DOI 10.1210/en.142.8.3578; Kiuchi T, 2012, NEUROSCIENCE, V207, P208, DOI 10.1016/j.neuroscience.2012.01.023; Knobloch M, 2013, NATURE, V493, P226, DOI 10.1038/nature11689; Koehl M, 2008, FASEB J, V22, P2253, DOI 10.1096/fj.07-099101; Lezi E, 2014, NEUROBIOL AGING, V35, P2574, DOI 10.1016/j.neurobiolaging.2014.05.033; Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023; Llorens-Martin M, 2006, HIPPOCAMPUS, V16, P480, DOI 10.1002/hipo.20175; Manadas B, 2009, J PROTEOME RES, V8, P4536, DOI 10.1021/pr900366x; Marlatt MW, 2012, DEV NEUROBIOL, V72, P943, DOI 10.1002/dneu.22009; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Mirescu C, 2006, HIPPOCAMPUS, V16, P233, DOI 10.1002/hipo.20155; Molteni R, 2002, EUR J NEUROSCI, V16, P1107, DOI 10.1046/j.1460-9568.2002.02158.x; Murray Patrick S, 2011, Int J Pept, V2011, P654085, DOI 10.1155/2011/654085; MYERS MG, 1993, ENDOCRINOLOGY, V132, P1421, DOI 10.1210/en.132.4.1421; Nadel J, 2013, BRAIN RES, V1537, P125, DOI 10.1016/j.brainres.2013.09.001; Nishijima T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081245; Oh JY, 2010, J NEUROCHEM, V114, P685, DOI 10.1111/j.1471-4159.2010.06773.x; Ohiwa N, 2006, NEUROSCI RES, V54, P124, DOI 10.1016/j.neures.2005.10.014; Okamoto M, 2012, P NATL ACAD SCI USA, V109, P13100, DOI 10.1073/pnas.1210023109; Okamoto M, 2011, FASEB J, V25, P3570, DOI 10.1096/fj.11-184697; Oomen CA, 2007, EUR J NEUROSCI, V26, P3395, DOI 10.1111/j.1460-9568.2007.05972.x; PAKKENBERG B, 1988, J MICROSC-OXFORD, V150, P1, DOI 10.1111/j.1365-2818.1988.tb04582.x; Patten AR, 2013, LEARN MEMORY, V20, P642, DOI 10.1101/lm.030635.113; Pfrieger FW, 2003, BIOESSAYS, V25, P72, DOI 10.1002/bies.10195; Saito T, 2004, AM J PHYSIOL-REG I, V286, pR484, DOI 10.1152/ajpregu.00453.2003; Selye H, 1936, NATURE, V138, P32, DOI 10.1038/138032a0; Sequeira A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006585; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Snyder JS, 2009, J NEUROSCI, V29, P14484, DOI 10.1523/JNEUROSCI.1768-09.2009; Soya H., 2011, J EXERC NUTR BIOCH, V15, P1, DOI DOI 10.5717/JENB.2011.15.1.1; Soya H., 2001, EXERCISE NUTR ENV ST, P21; Soya H, 2007, NEUROSCI RES, V58, P341, DOI 10.1016/j.neures.2007.04.004; Soya H, 2007, BIOCHEM BIOPH RES CO, V358, P961, DOI 10.1016/j.bbrc.2007.04.173; Stranahan AM, 2010, NEUROBIOL AGING, V31, P1937, DOI 10.1016/j.neurobiolaging.2008.10.016; SWENSON RM, 1983, PHARMACOL BIOCHEM BE, V18, P689, DOI 10.1016/0091-3057(83)90007-2; Tong LQ, 2001, NEUROBIOL DIS, V8, P1046, DOI 10.1006/nbdi.2001.0427; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Trejo JL, 2008, MOL CELL NEUROSCI, V37, P402, DOI 10.1016/j.mcn.2007.10.016; Trejo JL, 2001, J NEUROSCI, V21, P1628, DOI 10.1523/JNEUROSCI.21-05-01628.2001; Uda M, 2006, BRAIN RES, V1104, P64, DOI 10.1016/j.brainres.2006.05.066; Ulrich-Merzenich G, 2012, PHYTOMEDICINE, V19, P930, DOI 10.1016/j.phymed.2012.05.004; Uysal N, 2005, NEUROSCI LETT, V383, P241, DOI 10.1016/j.neulet.2005.04.054; Valor LM, 2012, HIPPOCAMPUS, V22, P929, DOI 10.1002/hipo.20888; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2008, NEUROMOL MED, V10, P128, DOI 10.1007/s12017-008-8028-z; Vance JE, 2005, SEMIN CELL DEV BIOL, V16, P193, DOI 10.1016/j.semcdb.2005.01.005; WEST MJ, 1980, BRAIN RES REV, V2, P317, DOI 10.1016/0165-0173(80)90012-0; Yamamoto M, 1998, J BIOL CHEM, V273, P26962, DOI 10.1074/jbc.273.41.26962; Yang CP, 2011, DEVELOPMENT, V138, P4351, DOI 10.1242/dev.065540; Yau SY, 2014, CELL TRANSPLANT, V23, P481, DOI 10.3727/096368914X678490; Yau SY, 2014, CELL TRANSPLANT, V23, P471, DOI 10.3727/096368914X678283; Yau SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024263; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zheng WH, 2004, J NEUROCHEM, V89, P844, DOI 10.1111/j.1471-4159.2004.02350.x	100	77	82	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0128720	10.1371/journal.pone.0128720	http://dx.doi.org/10.1371/journal.pone.0128720			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061528	Green Published, Green Submitted, gold			2022-12-26	WOS:000355979500096
J	Nakamura, I; Meyer, CG; Sato, K				Nakamura, Itsumi; Meyer, Carl G.; Sato, Katsufumi			Unexpected Positive Buoyancy in Deep Sea Sharks, Hexanchus griseus, and a Echinorhinus cookei	PLOS ONE			English	Article							COST; STRATEGIES; TRANSPORT; SWIM; SINK	We do not expect non air-breathing aquatic animals to exhibit positive buoyancy. Sharks, for example, rely on oil-filled livers instead of gas-filled swim bladders to increase their buoyancy, but are nonetheless ubiquitously regarded as either negatively or neutrally buoyant. Deep-sea sharks have particularly large, oil-filled livers, and are believed to be neutrally buoyant in their natural habitat, but this has never been confirmed. To empirically determine the buoyancy status of two species of deep-sea sharks (bluntnose sixgill sharks, Hexanchus griseus, and a prickly shark, Echinorhinus cookei) in their natural habitat, we used accelerometer-magnetometer data loggers to measure their swimming performance. Both species of deep-sea sharks showed similar diel vertical migrations: they swam at depths of 200-300 m at night and deeper than 500 m during the day. Ambient water temperature was around 15 degrees C at 200-300 m but below 7 degrees C at depths greater than 500 m. During vertical movements, all deep-sea sharks showed higher swimming efforts during descent than ascent to maintain a given swimming speed, and were able to glide uphill for extended periods (several minutes), indicating that these deep-sea sharks are in fact positively buoyant in their natural habitats. This positive buoyancy may adaptive for stealthy hunting (i.e. upward gliding to surprise prey from underneath) or may facilitate evening upward migrations when muscle temperatures are coolest, and swimming most sluggish, after spending the day in deep, cold water. Positive buoyancy could potentially be widespread in fish conducting daily vertical migration in deep-sea habitats.	[Nakamura, Itsumi; Sato, Katsufumi] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan; [Meyer, Carl G.] Univ Hawaii Manoa, Hawaii Inst Marine Biol, Kaneohe, HI USA	University of Tokyo; University of Hawaii System; University of Hawaii Manoa	Nakamura, I (corresponding author), Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan.	itsumi@aori.u-tokyo.ac.jp		Nakamura, Itsumi/0000-0002-1386-7266	Bio-Logging Science, the University of Tokyo (UTBLS); Japan Society for the Promotion of Science [12J07184, 25660152]; National Oceanic and Atmospheric Administration [41.R/FM-28PD]; University of Hawaii Sea Grant College Program, SOEST, under Institutional Grant from NOAA Office of Sea Grant, Department of Commerce [NA05OAR4171048]	Bio-Logging Science, the University of Tokyo (UTBLS); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); University of Hawaii Sea Grant College Program, SOEST, under Institutional Grant from NOAA Office of Sea Grant, Department of Commerce	This study is supported by the "Bio-Logging Science, the University of Tokyo (UTBLS)", Grant-in-Aids for Scientific Research from the Japan Society for the Promotion of Science (12J07184, 25660152), and a grant/cooperative agreement from the National Oceanic and Atmospheric Administration, Project 41.R/FM-28PD, which is sponsored by the University of Hawaii Sea Grant College Program, SOEST, under Institutional Grant No. NA05OAR4171048 from NOAA Office of Sea Grant, Department of Commerce. The views expressed herein are those of the authors and do not necessarily reflect the views of NOAA or any of its subagencies UNIHI-SEAGRANT-JC-08-21. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1965, J EXP BIOL, V43, P131; Andrews KS, 2009, ANIM BEHAV, V78, P525, DOI 10.1016/j.anbehav.2009.05.027; Bailey DM, 2007, DEEP-SEA RES PT I, V54, P99, DOI 10.1016/j.dsr.2006.10.005; BALDRIDGE HD, 1970, COPEIA, P744; BELMAN BW, 1979, MAR BIOL, V50, P275, DOI 10.1007/BF00394209; BONE Q, 1969, J MAR BIOL ASSOC UK, V49, P913, DOI 10.1017/S0025315400038017; CORNER EDS, 1969, PROC R SOC SER B-BIO, V171, P415, DOI 10.1098/rspb.1969.0003; Dawson CL, 2009, MAR ECOL PROG SER, V386, P253, DOI 10.3354/meps08067; DENTON EJ, 1969, PROC R SOC SER B-BIO, V174, P271, DOI 10.1098/rspb.1969.0093; Gleiss AC, 2011, FUNCT ECOL, V25, P595, DOI 10.1111/j.1365-2435.2010.01801.x; Haedrich RL, 1996, J FISH BIOL, V49, P40, DOI 10.1111/j.1095-8649.1996.tb06066.x; Hall FG, 1924, BIOL BULL-US, V47, P79, DOI 10.2307/1536532; Harden-Jones FR, 1951, J EXP BIOL, V28, P553; LEDWELL JR, 1993, NATURE, V364, P701, DOI 10.1038/364701a0; MAGNUSON JJ, 1973, FISH B-NOAA, V71, P337; Miller PJO, 2012, J EXP BIOL, V215, P3622, DOI 10.1242/jeb.070128; Minamikawa S, 2000, J EXP BIOL, V203, P2967; Nakamura I, 2011, MAR ECOL PROG SER, V424, P237, DOI 10.3354/meps08980; Phleger CF, 1998, AM ZOOL, V38, P321; R Core Team, 2021, R LANGUAGE ENV STAT; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005379; Sato K, 2002, J EXP BIOL, V205, P1189; Sato K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02205; Taylor H.F., 1922, B US BUR FISH, V38, P121; Watanabe Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003446; Wetherbee BM, 2000, COMP BIOCHEM PHYS B, V125, P511, DOI 10.1016/S0305-0491(00)00154-1; Williams TM, 2000, SCIENCE, V288, P133, DOI 10.1126/science.288.5463.133	27	19	19	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0127667	10.1371/journal.pone.0127667	http://dx.doi.org/10.1371/journal.pone.0127667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061525	Green Submitted, gold, Green Published			2022-12-26	WOS:000355979500049
J	Rajamuthiah, R; Jayamani, E; Conery, AL; Fuchs, BB; Kim, W; Johnston, T; Vilcinskas, A; Ausubel, FM; Mylonakis, E				Rajamuthiah, Rajmohan; Jayamani, Elamparithi; Conery, Annie L.; Fuchs, Beth Burgwyn; Kim, Wooseong; Johnston, Tatiana; Vilcinskas, Andreas; Ausubel, Frederick M.; Mylonakis, Eleftherios			A Defensin from the Model Beetle Tribolium castaneum Acts Synergistically with Telavancin and Daptomycin against Multidrug Resistant Staphylococcus aureus	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; HOST; IDENTIFICATION; MEMBRANE	The red flour beetle Tribolium castaneum is a common insect pest and has been established as a model beetle to study insect development and immunity. This study demonstrates that defensin 1 from T. castaneum displays in vitro and in vivo antimicrobial activity against drug resistant Staphylococcus aureus strains. The minimum inhibitory concentration (MIC) of defensin 1 against 11 reference and clinical staphylococcal isolates was between 16-64 mu g/ml. The putative mode of action of the defensin peptide is disruption of the bacterial cell membrane. The antibacterial activity of defensin 1 was attenuated by salt concentrations of 1.56 mM and 25 mM for NaCl and CaCl2 respectively. Treatment of defensin 1 with the reducing agent dithiothreitol (DTT) at concentrations 1.56 to 3.13 mM abolished the antimicrobial activity of the peptide. In the presence of subinhibitory concentrations of antibiotics that also target the bacterial cell envelope such as telavancin and daptomycin, the MIC of the peptide was as low as 1 mu g/ml. Moreover, when tested against an S. aureus strain that was defective in D-alanylation of the cell wall, the MIC of the peptide was 0.5 mu g/ml. Defensin 1 exhibited no toxicity against human erythrocytes even at 400 mu g/ml. The in vivo activity of the peptide was validated in a Caenorhabditis elegans-MRSA liquid infection assay. These results suggest that defensin 1 behaves similarly to other cationic AMPs in its mode of action against S. aureus and that the activity of the peptide can be enhanced in combination with other antibiotics with similar modes of action or with compounds that have the ability to decrease D-alanylation of the bacterial cell wall.	[Rajamuthiah, Rajmohan; Jayamani, Elamparithi; Fuchs, Beth Burgwyn; Kim, Wooseong; Johnston, Tatiana; Mylonakis, Eleftherios] Brown Univ, Alpert Med Sch, Rhode Isl Hosp, Div Infect Dis, Providence, RI 02903 USA; [Rajamuthiah, Rajmohan; Jayamani, Elamparithi; Conery, Annie L.; Ausubel, Frederick M.; Mylonakis, Eleftherios] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Boston, MA 02114 USA; [Vilcinskas, Andreas] Univ Giessen, Inst Phytopathol & Appl Zool, D-35392 Giessen, Germany	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Justus Liebig University Giessen	Mylonakis, E (corresponding author), Brown Univ, Alpert Med Sch, Rhode Isl Hosp, Div Infect Dis, Providence, RI 02903 USA.	emylonakis@lifespan.org	Kim, Wooseong/AAQ-3221-2020; Kim, Wooseong/A-9256-2017	Kim, Wooseong/0000-0002-4597-8374; Kim, Wooseong/0000-0002-4597-8374	National Institutes of Health [P01 AI083214, R01 AI085581]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085581, P01AI083214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Health grant P01 AI083214 to EM and FMA and National Institutes of Health grant R01 AI085581 to FMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altincicek B, 2008, DEV COMP IMMUNOL, V32, P585, DOI 10.1016/j.dci.2007.09.005; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; Brown S, 2013, ANNU REV MICROBIOL, V67, P313, DOI 10.1146/annurev-micro-092412-155620; Chu HL, 2013, ANTIMICROB AGENTS CH, V57, P4050, DOI 10.1128/AAC.00252-13; Draper LA, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-212; Eckert R, 2006, ANTIMICROB AGENTS CH, V50, P1480, DOI 10.1128/AAC.50.4.1480-1488.2006; Friedrich CL, 2000, ANTIMICROB AGENTS CH, V44, P2086, DOI 10.1128/AAC.44.8.2086-2092.2000; Hilchie AL, 2013, NAT CHEM BIOL, V9, P761, DOI [10.1038/NCHEMBIO.1393, 10.1038/nchembio.1393]; Lowenberger C, 2001, INSECT BIOCHEM MOLEC, V31, P219, DOI 10.1016/S0965-1748(00)00141-7; Lunde CS, 2009, ANTIMICROB AGENTS CH, V53, P3375, DOI 10.1128/AAC.01710-08; MACK D, 1994, INFECT IMMUN, V62, P3244, DOI 10.1128/IAI.62.8.3244-3253.1994; Maria JPS, 2014, P NATL ACAD SCI USA, V111, P12510, DOI 10.1073/pnas.1404099111; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Mizukawa N, 1999, ORAL DIS, V5, P139; Mondhe M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089082; Nair D, 2011, J BACTERIOL, V193, P2332, DOI 10.1128/JB.00027-11; Ntwasa Monde, 2012, Int J Microbiol, V2012, P101989, DOI 10.1155/2012/101989; Nuding S, 2014, ANTIMICROB AGENTS CH, V58, P5719, DOI 10.1128/AAC.02542-14; Pogliano J, 2012, J BACTERIOL, V194, P4494, DOI 10.1128/JB.00011-12; Poppel AK, 2015, ANTIMICROBIAL AGENTS; Rahnamaeian M, 2015, P ROYAL SOC B; Rajamuthiah R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089189; Rosch JW, 2010, J CLIN INVEST, V120, P627, DOI 10.1172/JCI39843; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Singh PK, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0226-2; Tanaka-Hino M, 2002, EMBO REP, V3, P56, DOI 10.1093/embo-reports/kvf001; Vilcinskas A, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2113; Vilcinskas A, 2011, CURR PHARM DESIGN, V17, P1240, DOI 10.2174/138161211795703799; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x	31	26	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0128576	10.1371/journal.pone.0128576	http://dx.doi.org/10.1371/journal.pone.0128576			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26062137	Green Published, gold, Green Submitted			2022-12-26	WOS:000355979500089
J	Saare, M; Lulla, S; Tonissoo, T; Meier, R; Kask, K; Ruisu, K; Karis, A; Salumets, A; Pooga, M				Saare, Merly; Lulla, Sirje; Tonissoo, Tambet; Meier, Riho; Kask, Keiu; Ruisu, Katrin; Karis, Alar; Salumets, Andres; Pooga, Margus			Expression Pattern and Localization Dynamics of Guanine Nucleotide Exchange Factor RIC8 during Mouse Oogenesis	PLOS ONE			English	Article							CORTICAL LOCALIZATION; ASYMMETRIC DIVISION; SIGNAL-TRANSDUCTION; DROSOPHILA RIC-8; MITOTIC SPINDLE; GENE-EXPRESSION; PROTEIN; ALPHA; RECEPTOR; PROGESTERONE	Targeting of G proteins to the cell cortex and their activation is one of the triggers of both asymmetric and symmetric cell division. Resistance to inhibitors of cholinesterase 8 (RIC8), a guanine nucleotide exchange factor, activates a certain subgroup of G protein alpha-subunits in a receptor independent manner. RIC8 controls the asymmetric cell division in Caenorhabditis elegans and Drosophila melanogaster, and symmetric cell division in cultured mammalian cells, where it regulates the mitotic spindle orientation. Although intensely studied in mitosis, the function of RIC8 in mammalian meiosis has remained unknown. Here we demonstrate that the expression and subcellular localization of RIC8 changes profoundly during mouse oogenesis. Immunofluorescence studies revealed that RIC8 expression is dependent on oocyte growth and cell cycle phase. During oocyte growth, RIC8 is abundantly present in cytoplasm of oocytes at primordial, primary and secondary preantral follicle stages. Later, upon oocyte maturation RIC8 also populates the germinal vesicle, its localization becomes cell cycle dependent, and it associates with chromatin and the meiotic spindle. After fertilization, RIC8 protein converges to the pronuclei and is also detectable at high levels in the nucleolus precursor bodies of both maternal and paternal pronucleus. During first cleavage of zygote RIC8 localizes in the mitotic spindle and cell cortex of forming blastomeres. In addition, we demonstrate that RIC8 co-localizes with its interaction partners G alpha(i1/2): GDP and LGN in meiotic/mitotic spindle, cell cortex and polar bodies of maturing oocytes and zygotes. Downregulation of Ric8 by siRNA leads to interferred translocation of G alpha(i1/2) to cortical region of maturing oocytes and reduction of its levels. RIC8 is also expressed at high level in female reproductive organs e.g. oviduct. Therefore we suggest a regulatory function for RIC8 in mammalian gametogenesis and fertility.	[Saare, Merly; Lulla, Sirje; Tonissoo, Tambet; Meier, Riho; Kask, Keiu; Ruisu, Katrin; Karis, Alar; Pooga, Margus] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Saare, Merly; Lulla, Sirje; Tonissoo, Tambet; Meier, Riho; Salumets, Andres; Pooga, Margus] Competence Ctr Hlth Technol, EE-50410 Tartu, Estonia	University of Tartu	Pooga, M (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Riia 23, EE-51010 Tartu, Estonia.	mpooga@ut.ee	Tõnissoo, Tambet/G-2323-2017; Kask, Keiu/G-6330-2016; Pooga, Margus/A-8575-2011; Salumets, Andres/J-2278-2015; Tõnissoo, Tambet/G-6064-2016	Kask, Keiu/0000-0002-0629-2601; Pooga, Margus/0000-0003-4532-4087; Salumets, Andres/0000-0002-1251-8160; 	Estonian Science Foundation [ETF 8427]; Estonian Ministry of Education and Research [0180019s11]; European Union Regional Development Fund through the Competence Centre on Reproductive Medicine and Biology [EU30020]	Estonian Science Foundation; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); European Union Regional Development Fund through the Competence Centre on Reproductive Medicine and Biology	The current study was supported by grants from the Estonian Science Foundation (ETF 8427), the Estonian Ministry of Education and Research (0180019s11) and European Union Regional Development Fund (grant EU30020) through the Competence Centre on Reproductive Medicine and Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar K, 2005, DEVELOPMENT, V132, P4449, DOI 10.1242/dev.02039; Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; Bjerregaard B, 2004, BIOL REPROD, V70, P925, DOI 10.1095/biolreprod.103.020941; Bylander A, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-48; Chan P, 2013, P NATL ACAD SCI USA, V110, P3794, DOI 10.1073/pnas.1220943110; Couwenbergs C, 2004, CURR BIOL, V14, P1871, DOI 10.1016/j.cub.2004.09.059; David NB, 2005, NAT CELL BIOL, V7, P1083, DOI 10.1038/ncb1319; de Vries WN, 2004, DEVELOPMENT, V131, P4435, DOI 10.1242/dev.01316; Figueroa M, 2009, PROTEIN SCI, V18, P1139, DOI 10.1002/pro.124; Gabay M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002223; Guo XZ, 2009, CELL RES, V19, P838, DOI 10.1038/cr.2009.54; Hampoelz B, 2005, NAT CELL BIOL, V7, P1099, DOI 10.1038/ncb1318; Hess HA, 2004, CELL, V119, P209, DOI 10.1016/j.cell.2004.09.025; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Karteris E, 2006, MOL ENDOCRINOL, V20, P1519, DOI 10.1210/me.2005-0243; Lee J, 2000, BIOL REPROD, V62, P1184, DOI 10.1095/biolreprod62.5.1184; Longo F, 2003, MOL REPROD DEV, V66, P279, DOI 10.1002/mrd.10354; Maldonado-Agurto R, 2011, GENE EXPR PATTERNS, V11, P401, DOI 10.1016/j.gep.2011.06.001; Martin-McCaffrey L, 2004, DEV CELL, V7, P763, DOI 10.1016/j.devcel.2004.10.004; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; Miller KG, 2000, NEURON, V27, P289, DOI 10.1016/S0896-6273(00)00037-4; Miller KG, 2000, GENETICS, V156, P1649; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Monkkonen KS, 2007, HUM REPROD, V22, P1224, DOI 10.1093/humrep/dem022; Nishimura A, 2006, GENES CELLS, V11, P487, DOI 10.1111/j.1365-2443.2006.00959.x; Ogushi S, 2008, SCIENCE, V319, P613, DOI 10.1126/science.1151276; Ogushi S, 2010, J REPROD DEVELOP, V56, P495, DOI 10.1262/jrd.09-184H; Olesen C, 2007, CELL TISSUE RES, V328, P207, DOI 10.1007/s00441-006-0205-5; Probst AV, 2007, CHROMOSOMA, V116, P403, DOI 10.1007/s00412-007-0106-8; Reynolds NK, 2005, GENETICS, V169, P651, DOI 10.1534/genetics.104.031286; Romo X, 2008, J CELL PHYSIOL, V214, P673, DOI 10.1002/jcp.21257; Schade MA, 2005, GENETICS, V169, P631, DOI 10.1534/genetics.104.032334; Sharif B, 2010, J CELL SCI, V123, P4292, DOI 10.1242/jcs.067447; Shinohara H, 1998, EUR J NEUROSCI, V10, P699, DOI 10.1046/j.1460-9568.1998.00088.x; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tall GG, 2005, P NATL ACAD SCI USA, V102, P16584, DOI 10.1073/pnas.0508306102; Tang CJC, 2004, J BIOMED SCI, V11, P370, DOI 10.1159/000077106; Teilmann SC, 2006, J ENDOCRINOL, V191, P525, DOI 10.1677/joe.1.06565; Thomas CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023197; Tonissoo T, 2006, BEHAV BRAIN RES, V167, P42, DOI 10.1016/j.bbr.2005.08.025; Tonissoo T, 2010, DEV DYNAM, V239, P3404, DOI 10.1002/dvdy.22480; Vellano CP, 2011, BIOCHEMISTRY-US, V50, P752, DOI 10.1021/bi101910n; Von Dannecker LEC, 2005, J NEUROSCI, V25, P3793, DOI 10.1523/JNEUROSCI.4595-04.2005; Wang HY, 2005, NAT CELL BIOL, V7, P1091, DOI 10.1038/ncb1317; Wang LM, 2011, J BIOL CHEM, V286, P31055, DOI 10.1074/jbc.M111.253427; Williams CJ, 1996, MOL REPROD DEV, V44, P315, DOI 10.1002/(SICI)1098-2795(199607)44:3&lt;315::AID-MRD5&gt;3.0.CO;2-P; Woodard GE, 2010, MOL CELL BIOL, V30, P3519, DOI 10.1128/MCB.00394-10; Xing BW, 2013, J BIOL CHEM, V288, P32827, DOI 10.1074/jbc.M113.489427; Yang F, 2007, J CELL SCI, V120, P4060, DOI 10.1242/jcs.014795	49	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129131	10.1371/journal.pone.0129131	http://dx.doi.org/10.1371/journal.pone.0129131			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26062014	Green Published, Green Submitted, gold			2022-12-26	WOS:000355979500125
J	Liu, ZY; Dai, XY; Zhu, HP; Zhang, M; Zou, MH				Liu, Zhaoyu; Dai, Xiaoyan; Zhu, Huaiping; Zhang, Miao; Zou, Ming-Hui			Lipopolysaccharides Promote S-Nitrosylation and Proteasomal Degradation of Liver Kinase B1 (LKB1) in Macrophages in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; ACTIVATED PROTEIN-KINASE; PEUTZ-JEGHERS-SYNDROME; EXPRESSION; PHOSPHORYLATION; INDUCTION; STABILITY	LKB1 (liver kinase B1) plays important roles in tumor suppression, energy metabolism, and, recently, in innate immune responses. However, how LKB1 is regulated under physiological or pathological conditions is still unclear. Here, we report that LKB1 protein (but not mRNA) was decreased in both LPS-treated RAW 264.7 cells and peritoneal macrophages isolated from LPS/challenged mice. Additional LPS treatment promoted protein ubiquitination and degradation of LKB1. Pharmacological inhibition or gene silencing of inducible NOS abrogated LPS-induced LKB1 degradation, whereas exposure of RAW 264.7 cells to S-nitroso-L-glutathione, a NO donor, triggered LKB1 S-nitrosylation. Consistently, mutation of one cysteine (C430S) in LKB1 prevented LPS-induced S-nitrosylation, ubiquitination, and degradation. Moreover, S-nitrosylation and ubiquitination of LKB1 were confirmed in macrophages from LPS-challenged mice in vivo. Co-administration of the inducible NOS inhibitor S-methylisothiourea or the proteasome inhibitor MG132 prevented LPS-induced LKB1 degradation and improved the survival rate. Finally, mice lacking LKB1 in macrophages had significantly lower survival rates in response to LPS challenge compared with wild-type mice. Thus, we concluded that LKB1 is degraded by LPS treatment via S-nitrosylation- dependent proteasome pathways, and this had a protective role in LPS-induced septic shock.	[Liu, Zhaoyu; Dai, Xiaoyan; Zhu, Huaiping; Zhang, Miao; Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Sect Mol Med, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Zou, MH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, BSEB 306A,941 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	ming-hui-zou@ouhsc.edu	liu, zhao/GXV-6141-2022; Regan, Clinton/E-6250-2012		National Institutes of Health [HL079584, HL080499, HL074399, HL089920, HL096032, HL105157, HL110488, AG047776, HL128014]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096032, R01HL110488, R01HL079584, R01HL105157, R01HL128014, R01HL074399, R01HL080499, R01HL089920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL079584, HL080499, HL074399, HL089920, HL096032, HL105157, HL110488, and AG047776 (to M.-H. Z.) and HL128014 (to Z. Xie). The authors declare that they have no conflicts of interest with the contents of this article.	Adamson DC, 1996, SCIENCE, V274, P1917, DOI 10.1126/science.274.5294.1917; Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Azad N, 2006, J BIOL CHEM, V281, P34124, DOI 10.1074/jbc.M602551200; Banan A, 2001, AM J PHYSIOL-GASTR L, V280, pG1234, DOI 10.1152/ajpgi.2001.280.6.G1234; Brown KA, 2011, J STEROID BIOCHEM, V127, P439, DOI 10.1016/j.jsbmb.2011.06.005; Calamaras TD, 2012, J BIOL CHEM, V287, P42400, DOI 10.1074/jbc.M112.385831; Guix FX, 2005, PROG NEUROBIOL, V76, P126, DOI 10.1016/j.pneurobio.2005.06.001; Haywood GA, 1996, CIRCULATION, V93, P1087, DOI 10.1161/01.CIR.93.6.1087; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Huang H, 2014, ATHEROSCLEROSIS, V235, P213, DOI 10.1016/j.atherosclerosis.2014.04.020; Ikeda Y, 2009, J BIOL CHEM, V284, P35839, DOI 10.1074/jbc.M109.057273; JENKINS DC, 1995, P NATL ACAD SCI USA, V92, P4392, DOI 10.1073/pnas.92.10.4392; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Kim S, 2004, MOL CELL BIOL, V24, P330, DOI 10.1128/MCB.24.1.330-337.2004; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; LASKIN DL, 1995, ANNU REV PHARMACOL, V35, P655, DOI 10.1146/annurev.pharmtox.35.1.655; Liu ZY, 2015, J BIOL CHEM, V290, P2312, DOI 10.1074/jbc.M114.616441; McInnes KJ, 2012, INT J OBESITY, V36, P982, DOI 10.1038/ijo.2011.172; Nicholson S, 1996, J EXP MED, V183, P2293, DOI 10.1084/jem.183.5.2293; Nony P, 2003, ONCOGENE, V22, P9165, DOI 10.1038/sj.onc.1207179; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; Numajiri N, 2011, P NATL ACAD SCI USA, V108, P10349, DOI 10.1073/pnas.1103503108; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; Qu J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001085; Romeo GR, 2007, CIRC RES, V101, P357, DOI 10.1161/CIRCRESAHA.107.151399; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shi ZQ, 2013, P NATL ACAD SCI USA, V110, P3137, DOI 10.1073/pnas.1215501110; Stachura J, 1996, J PHYSIOL PHARMACOL, V47, P131; Tousoulis D, 2012, CURR VASC PHARMACOL, V10, P4, DOI 10.2174/157016112798829760; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Xie ZL, 2009, MOL CELL BIOL, V29, P3582, DOI 10.1128/MCB.01417-08; Xue Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011290; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zu Y, 2010, CIRC RES, V106, P1384, DOI 10.1161/CIRCRESAHA.109.215483	34	18	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19011	19017		10.1074/jbc.M115.649210	http://dx.doi.org/10.1074/jbc.M115.649210			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26070564	Green Published, hybrid			2022-12-26	WOS:000358781100019
J	Jin, ZC; Bian, F; Tomcik, K; Kelleher, JK; Zhang, GF; Brunengraber, H				Jin, Zhicheng; Bian, Fang; Tomcik, Kristyen; Kelleher, Joanne K.; Zhang, Guo-Fang; Brunengraber, Henri			Compartmentation of Metabolism of the C-12-, C-9-, and C-5-n-dicarboxylates in Rat Liver, Investigated by Mass Isotopomer Analysis ANAPLEROSIS FROM DODECANEDIOATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL ACETYL-COA; DICARBOXYLIC-ACIDS; BETA-OXIDATION; FATTY-ACIDS; MALONYL-COA; ACETATE; HEPATOCYTES; CHAIN; PATHWAY; HEART	We investigated the compartmentation of the catabolism of dodecanedioate (DODA), azelate, and glutarate in perfused rat livers, using a combination of metabolomics and mass isotopomer analyses. Livers were perfused with recirculating or nonrecirculating buffer containing one fully C-13-labeled dicarboxylate. Information on the peroxisomal versus mitochondrial catabolism was gathered from the labeling patterns of acetyl-CoA proxies, i.e. total acetyl-CoA, the acetyl moiety of citrate, C-1+2 of beta-hydroxybutyrate, malonyl-CoA, and acetylcarnitine. Additional information was obtained from the labeling patterns of citric acid cycle intermediates and related compounds. Thedata characterize the partial oxidation of DODA and azelate in peroxisomes, with terminal oxidation in mitochondria. We did not find evidence of peroxisomal oxidation of glutarate. Unexpectedly, DODA contributes a substantial fraction to anaplerosis of the citric acid cycle. This opens the possibility to use water-soluble DODA in nutritional or pharmacological anaplerotic therapy whenother anaplerotic substrates are impractical or contraindicated, e.g. in propionic acidemia and methylmalonic acidemia.	[Jin, Zhicheng; Bian, Fang; Tomcik, Kristyen; Zhang, Guo-Fang; Brunengraber, Henri] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; [Kelleher, Joanne K.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Case Western Reserve University; Massachusetts Institute of Technology (MIT)	Brunengraber, H (corresponding author), Case Western Reserve Univ, Sch Med, 10900 Euclid Ave WG 48, Cleveland, OH 44106 USA.	hxb8@case.edu	Regan, Clinton/E-6250-2012	Jin, Zhicheng/0000-0003-2770-9549	National Institutes of Health [R33DK070291, 5T32DK0077319]; American Heart Association [12GRNT12050453]; Cleveland Mt. Sinai Health Care Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R33DK070291] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Cleveland Mt. Sinai Health Care Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Roadmap Grant R33DK070291 (to H. B.) and Fellowship Training Grant 5T32DK0077319 (to Z. J.), American Heart Association Grant 12GRNT12050453 (to G. F. Z.), and the Cleveland Mt. Sinai Health Care Foundation. The authors declare that they have no conflicts of interests of this article.	BERGSETH S, 1990, BIOCHIM BIOPHYS ACTA, V1042, P182, DOI 10.1016/0005-2760(90)90005-I; Bian F, 2005, J BIOL CHEM, V280, P9265, DOI 10.1074/jbc.M412850200; Bian F, 2006, J MOL CELL CARDIOL, V41, P868, DOI 10.1016/j.yjmcc.2006.08.011; BIEBER LL, 1988, ANNU REV BIOCHEM, V57, P261, DOI 10.1146/annurev.bi.57.070188.001401; BRUNENGRABER H, 1973, J BIOL CHEM, V248, P2656; Brunengraber H, 2006, J INHERIT METAB DIS, V29, P327, DOI 10.1007/s10545-006-0320-1; CHANG HC, 1966, J BIOL CHEM, V241, P2421; CRABTREE B, 1989, BIOCHEM J, V257, P673, DOI 10.1042/bj2570673; CRABTREE B, 1990, BIOCHEM J, V270, P219, DOI 10.1042/bj2700219; Dils R, 1975, Methods Enzymol, V35, P74, DOI 10.1016/0076-6879(75)35140-9; Harris SR, 2011, J BIOL CHEM, V286, P5895, DOI 10.1074/jbc.M110.196808; Hunt MC, 2014, BIOCHIMIE, V98, P45, DOI 10.1016/j.biochi.2013.12.018; Kasumov T, 2005, BIOCHEM J, V389, P397, DOI 10.1042/BJ20050144; Kolker S, 2007, J INHERIT METAB DIS, V30, P5, DOI 10.1007/s10545-006-0451-4; Korman SH, 2000, J INHERIT METAB DIS, V23, P425, DOI 10.1023/A:1005624523611; Korman SH, 2005, MOL GENET METAB, V86, P337, DOI 10.1016/j.ymgme.2005.07.022; LEIGHTON F, 1989, J BIOL CHEM, V264, P10347; Matsubara T, 2012, CELL METAB, V16, P634, DOI 10.1016/j.cmet.2012.10.006; Mingrone G, 1999, JPEN-PARENTER ENTER, V23, P80, DOI 10.1177/014860719902300280; Mingrone G, 2013, BRIT J CLIN PHARMACO, V75, P671, DOI 10.1111/j.1365-2125.2012.04177.x; OSMUNDSEN H, 1991, BIOCHIM BIOPHYS ACTA, V1085, P141, DOI 10.1016/0005-2760(91)90089-Z; Reszko AE, 2003, J BIOL CHEM, V278, P34959, DOI 10.1074/jbc.M302013200; ROCCHICCIOLI F, 1986, PEDIATR RES, V20, P62, DOI 10.1203/00006450-198601000-00018; Roe CR, 2002, J CLIN INVEST, V110, P259, DOI [10.1172/JCI200215311, 10.1172/JCI0215311]; ROTHSTEIN M, 1952, J BIOL CHEM, V199, P199; Shah SH, 2012, AM HEART J, V163, P844, DOI 10.1016/j.ahj.2012.02.005; Thielitz A, 2015, J EUR ACAD DERMATOL, V29, P789, DOI 10.1111/jdv.12823; Tomcik K, 2011, ANAL BIOCHEM, V410, P110, DOI 10.1016/j.ab.2010.11.030; TSERNG KY, 1991, J BIOL CHEM, V266, P2924; VAMECQ J, 1985, BIOCHEM J, V230, P683, DOI 10.1042/bj2300683; VAMECQ J, 1989, AM J PHYSIOL, V256, pG680, DOI 10.1152/ajpgi.1989.256.4.G680; Westin MAK, 2005, J BIOL CHEM, V280, P38125, DOI 10.1074/jbc.M508479200; Zhang GF, 2011, J BIOL CHEM, V286, P23631, DOI 10.1074/jbc.R110.171405; Zhang GF, 2009, J BIOL CHEM, V284, P33521, DOI 10.1074/jbc.M109.055665; ZHANG Y, 1994, J BIOL CHEM, V269, P11025	35	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18671	18677		10.1074/jbc.M115.651737	http://dx.doi.org/10.1074/jbc.M115.651737			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26070565	hybrid, Green Published			2022-12-26	WOS:000358512100036
J	Thapa, N; Choi, SY; Tan, XJ; Wise, T; Anderson, RA				Thapa, Narendra; Choi, Suyong; Tan, Xiaojun; Wise, Thomas; Anderson, Richard A.			Phosphatidylinositol Phosphate 5-Kinase I gamma and Phosphoinositide 3-Kinase/Akt Signaling Couple to Promote Oncogenic Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; TYROSINE PHOSPHORYLATION; PTDINS(4,5)P-2 SYNTHESIS; FOCAL ADHESIONS; CELL REGULATION; TUMOR-CELLS; C-SRC; KINASE; ACTIVATION; BINDING	The assembly of signaling complexes at the plasma membrane is required for the initiation and propagation of cellular signaling upon cell activation. The class I PI3K and the serine/threonine-specific protein kinase Akt signaling pathways (PI3K/Akt) are often activated in tumors. These pathways are initiated by the generation of phosphatidylinositol 3,4,5-triphosphate (PIP3) by PI3K-mediated phosphorylation of phosphatidylinositol 4,5-biphosphate (PIP2), synthesized by phosphatidylinositol 4-phosphate 5-kinase (PIPKI) enzymes. The mechanism of how tumor cells recruit and organize the PIP2-synthesizing enzymes with PI3K in the plasma membrane for activation of PI3K/Akt signaling is not defined. Here, we demonstrated a role for the phosphatidylinositol 4-phosphate5-kinase I gamma (PIPKI gamma) inPI3K/Aktsignaling. PIPKI gamma is overexpressed in triple-negative breast cancers. Loss of PIPKI gamma or its focal adhesion-targeting variant, PIPKI gamma i2, impaired PI3K/Akt activation upon stimulation with growth factors or extracellular matrix proteins in different tumor cells. PIPKI gamma i2 assembles into a complex containing Src and PI3K; Src was required for the recruitment of PI3K enzyme into the complex. PIPKI gamma i2 interaction with Src and its lipid kinase activity were required for promoting PI3K/Akt signaling. These results define a mechanism by which PIPKI gamma i2 and PI3K are integrated into a complex regulated by Src, resulting in the spatial generation of PIP2, which is the substrate PI3K required for PIP3 generation and subsequent Akt activation. This study elucidates the mechanism by which PIP2-generating enzyme controls Akt activation upstream of a PI3K enzyme. This pathway may represent a signaling nexus required for the survival and growth of metastasizing and circulating tumor cells in vivo.	[Thapa, Narendra; Choi, Suyong; Tan, Xiaojun; Wise, Thomas; Anderson, Richard A.] Univ Wisconsin, Sch Med & Publ Hlth, Mol & Cellular Pharmacol Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Anderson, RA (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, 3750 Med Sci Ctr,1300 Univ Ave, Madison, WI 53706 USA.	raanders@wisc.edu	Regan, Clinton/E-6250-2012; Tan, Xiaojun/N-2142-2017	Tan, Xiaojun/0000-0003-3300-2240; Anderson, Richard/0000-0001-6265-8359; Wise, Thomas/0000-0001-7007-6279	National Institutes of Health [CA104708, GM057549]; American Heart Association [10POST4290052, 13PRE14690057]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA104708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA104708 and GM057549 (to R. A. A). This work was also supported by American Heart Association Grants 10POST4290052 (to N. T.) and 13PRE14690057 (to S. C.) and a Howard Hughes Medical Institute International Student Research Fellowship (to X. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Aksamitiene E, 2010, CELL SIGNAL, V22, P1369, DOI 10.1016/j.cellsig.2010.05.006; Aleshin A, 2010, NEOPLASIA, V12, P599, DOI 10.1593/neo.10328; Arcaro A, 2007, CELL SIGNAL, V19, P1081, DOI 10.1016/j.cellsig.2006.12.003; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Barlow CA, 2010, TRENDS CELL BIOL, V20, P25, DOI 10.1016/j.tcb.2009.09.009; Bunney TD, 2010, NAT REV CANCER, V10, P342, DOI 10.1038/nrc2842; Chen C, 2015, ONCOGENE, V34, P4635, DOI 10.1038/onc.2014.393; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; Choi SY, 2015, BBA-MOL CELL BIOL L, V1851, P711, DOI 10.1016/j.bbalip.2015.01.009; Coll MAL, 2005, ONCOGENE, V24, P1727, DOI 10.1038/sj.onc.1208379; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Cuevas BD, 2001, J BIOL CHEM, V276, P27455, DOI 10.1074/jbc.M100556200; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Divecha N, 2010, CURR BIOL, V20, pR154, DOI 10.1016/j.cub.2010.01.016; Fayngerts SA, 2014, CANCER CELL, V26, P465, DOI 10.1016/j.ccr.2014.07.025; Fincham VJ, 2000, MOL CELL BIOL, V20, P6518, DOI 10.1128/MCB.20.17.6518-6536.2000; Gao XX, 2011, P NATL ACAD SCI USA, V108, P14509, DOI 10.1073/pnas.1019386108; Heck JN, 2007, CRIT REV BIOCHEM MOL, V42, P15, DOI 10.1080/10409230601162752; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Jin W, 2007, CANCER RES, V67, P3192, DOI 10.1158/0008-5472.CAN-06-3526; Kang YB, 2013, CANCER CELL, V23, P573, DOI 10.1016/j.ccr.2013.04.017; Legate KR, 2011, EMBO J, V30, P4539, DOI 10.1038/emboj.2011.332; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Li X, 2013, J CELL SCI, V126, P2617, DOI 10.1242/jcs.117044; Ling K, 2003, J CELL BIOL, V163, P1339, DOI 10.1083/jcb.200310067; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Ling K, 2007, J CELL BIOL, V176, P343, DOI 10.1083/jcb.200606023; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Lu YL, 2003, J BIOL CHEM, V278, P40057, DOI 10.1074/jbc.M303621200; Mori S, 2009, ONCOGENE, V28, P2796, DOI 10.1038/onc.2009.139; Nozu F, 2000, EUR J CELL BIOL, V79, P803, DOI 10.1078/0171-9335-00108; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Plaks V, 2013, SCIENCE, V341, P1186, DOI 10.1126/science.1235226; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Schill NJ, 2009, BIOCHEM J, V422, P473, DOI 10.1042/BJ20090638; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; SIGAL CT, 1994, P NATL ACAD SCI USA, V91, P12253, DOI 10.1073/pnas.91.25.12253; SILVERMAN L, 1992, J CELL BIOL, V119, P415, DOI 10.1083/jcb.119.2.415; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Sun Y, 2013, BIOESSAYS, V35, P513, DOI 10.1002/bies.201200171; Sun Y, 2013, DEV CELL, V25, P144, DOI 10.1016/j.devcel.2013.03.010; Sun Y, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2471; Thapa N, 2013, J BIOL CHEM, V288, P34707, DOI 10.1074/jbc.M113.512848; Thapa N, 2012, DEV CELL, V22, P116, DOI 10.1016/j.devcel.2011.10.030; Toker A, 1998, CURR OPIN CELL BIOL, V10, P254, DOI 10.1016/S0955-0674(98)80148-8; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; Wu ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024775; Xia Y, 2011, BIOCHEM BIOPH RES CO, V411, P416, DOI 10.1016/j.bbrc.2011.06.168; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017	51	27	29	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18843	18854		10.1074/jbc.M114.596742	http://dx.doi.org/10.1074/jbc.M114.596742			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26070568	Green Published, hybrid			2022-12-26	WOS:000358512100050
J	Wojciechowski, D; Fischer, M; Fahlke, C				Wojciechowski, Daniel; Fischer, Martin; Fahlke, Christoph			Tryptophan Scanning Mutagenesis Identifies the Molecular Determinants of Distinct Barttin Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLC-K CHANNELS; CHLORIDE CHANNEL; SENSORINEURAL DEAFNESS; SURFACE EXPRESSION; POTASSIUM CHANNEL; RAT-KIDNEY; DISEASE; DOMAIN; LOCALIZATION; PERTURBATION	CLC-K chloride channels are expressed in the kidney and in the inner ear and require the accessory subunit barttin for proper function and membrane insertion. Barttin exerts multiple functions on CLC-proteins: it modifies protein stability and intracellular trafficking as well as channel activity, ion conduction, and gating. So far, the molecular determinants of these distinct barttin functions have remained elusive. Here we performed serial perturbation mutagenesis to identify the sequence determinants of barttin function. Barttin consists of two transmembrane helices followed by a long intracellular carboxyl terminus, and earlier work demonstrated that the transmembrane core of barttin suffices for most effects on the alpha-subunit. We individually substituted every amino acid of the predicted transmembrane core (amino acids 9-26 and 35-55) with tryptophan, co-expressed mutant barttin with hClC-Ka or V166E rClC-K1, and characterized CLC-K/barttin channels by patch clamp techniques, biochemistry, and confocal microscopy. The majority of mutations left the chaperone function of barttin, i.e. the effects on endoplasmic reticulum exit and surface membrane insertion, unaffected. In contrast, tryptophan insertion at multiple positions resulted in impaired activity of hClC-Ka/barttin and changes in gating of V166E rClC-K1/barttin. These results demonstrate that mutations in a cluster of hydrophobic residues within transmembrane domain 1 affect barttin-CLC-K interaction and impair gating modification by the accessory subunit. Whereas tight interaction is necessary for functional modification, even impaired association of barttin and CLC-K suffices for normal intracellular trafficking. Our findings allow definition of a likely interaction surface and clarify the mechanisms underlying CLC-K channel modification by barttin.	[Wojciechowski, Daniel; Fischer, Martin] Hannover Med Sch, Inst Neurophysiol, D-30625 Hannover, Germany; [Fahlke, Christoph] Forschungszentrum Julich, Inst Complex Syst Zellulare Biophys ICS 4, D-52428 Julich, Germany	Hannover Medical School; Helmholtz Association; Research Center Julich	Fahlke, C (corresponding author), Forschungszentrum Julich, Inst Complex Syst Zellulare Biophys ICS 4, D-52428 Julich, Germany.	c.fahlke@fzjuelich.de	Fahlke, Christoph/G-3635-2013	Fahlke, Christoph/0000-0001-8602-9952	Deutsche Forschungsgemeinschaft [FA301/10]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (FA301/10; to Ch. F). The authors declare that they have no conflicts of interest with the contents of this article.	Accardi A, 2000, J GEN PHYSIOL, V116, P433, DOI 10.1085/jgp.116.3.433; ADACHI S, 1994, J BIOL CHEM, V269, P17677; Birkenhager R, 2001, NAT GENET, V29, P310, DOI 10.1038/ng752; Chen H, 2007, BIOPHYS J, V93, P2332, DOI 10.1529/biophysj.107.109702; Choe S, 1995, P NATL ACAD SCI USA, V92, P12046, DOI 10.1073/pnas.92.26.12046; Collins A, 1997, P NATL ACAD SCI USA, V94, P5456, DOI 10.1073/pnas.94.10.5456; De Feo CJ, 2010, J MEMBRANE BIOL, V234, P113, DOI 10.1007/s00232-010-9239-4; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Fahlke C, 1997, NATURE, V390, P529, DOI 10.1038/37391; Fahlke C, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00155; Fischer M, 2010, J AM SOC NEPHROL, V21, P1281, DOI 10.1681/ASN.2009121274; Gradogna A, 2010, J GEN PHYSIOL, V136, P311, DOI 10.1085/jgp.201010455; Grieve AG, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005298; Hanwell D, 2002, J BIOL CHEM, V277, P9772, DOI 10.1074/jbc.M110904200; Hayama A, 2003, HISTOCHEM CELL BIOL, V119, P485, DOI 10.1007/s00418-003-0535-2; Imbrici P, 2014, BBA-BIOMEMBRANES, V1838, P2484, DOI 10.1016/j.bbamem.2014.05.017; Janssen AGH, 2009, J AM SOC NEPHROL, V20, P145, DOI 10.1681/ASN.2008010102; KIEFERLE S, 1994, P NATL ACAD SCI USA, V91, P6943, DOI 10.1073/pnas.91.15.6943; Kobayashi K, 2001, J AM SOC NEPHROL, V12, P1327, DOI 10.1681/ASN.V1271327; L'Hoste S, 2013, BBA-BIOMEMBRANES, V1828, P2399, DOI 10.1016/j.bbamem.2013.06.012; LANDAU D, 1995, AM J MED GENET, V59, P454, DOI 10.1002/ajmg.1320590411; Li-Smerin YY, 2000, NEURON, V25, P411, DOI 10.1016/S0896-6273(00)80904-6; Matsumura Y, 1999, NAT GENET, V21, P95, DOI 10.1038/5036; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; Nothmann D, 2011, J BIOL CHEM, V286, P3935, DOI 10.1074/jbc.M110.187492; Ozlu F, 2006, PEDIATR NEPHROL, V21, P1056, DOI 10.1007/s00467-006-0108-4; Riazuddin S, 2009, AM J HUM GENET, V85, P273, DOI 10.1016/j.ajhg.2009.07.003; Rickheit G, 2008, EMBO J, V27, P2907, DOI 10.1038/emboj.2008.203; Saviane C, 1999, J GEN PHYSIOL, V113, P457, DOI 10.1085/jgp.113.3.457; Scholl U, 2006, P NATL ACAD SCI USA, V103, P11411, DOI 10.1073/pnas.0601631103; Sesti F, 1998, J GEN PHYSIOL, V112, P651, DOI 10.1085/jgp.112.6.651; Shalev H, 2003, PEDIATRICS, V112, P628, DOI 10.1542/peds.112.3.628; Somasekharan S, 2012, J BIOL CHEM, V287, P17308, DOI 10.1074/jbc.M112.356014; Stolting G, 2014, PFLUG ARCH EUR J PHY, V466, P2191, DOI 10.1007/s00424-014-1490-6; Stolting G, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00378; Stolting G, 2013, PFLUG ARCH EUR J PHY, V465, P1423, DOI 10.1007/s00424-013-1286-0; Tajima M, 2007, BIOCHEM BIOPH RES CO, V362, P858, DOI 10.1016/j.bbrc.2007.08.097; TAUBER R, 1986, EMBO J, V5, P2109, DOI 10.1002/j.1460-2075.1986.tb04473.x; Torres-Salazar D, 2007, J BIOL CHEM, V282, P34719, DOI 10.1074/jbc.M704118200; UCHIDA S, 1995, J CLIN INVEST, V95, P104, DOI 10.1172/JCI117626; UCHIDA S, 1993, J BIOL CHEM, V268, P3821; Waldegger S, 2000, J BIOL CHEM, V275, P24527, DOI 10.1074/jbc.M001987200; Waldegger S, 2002, PFLUG ARCH EUR J PHY, V444, P411, DOI 10.1007/s00424-002-0819-8; Woo SK, 2013, J BIOL CHEM, V288, P36409, DOI 10.1074/jbc.M113.530584; Zuniga L, 2004, J PHYSIOL-LONDON, V555, P671, DOI 10.1113/jphysiol.2003.060046	45	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18732	18743		10.1074/jbc.M114.625376	http://dx.doi.org/10.1074/jbc.M114.625376			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26063802	Green Published, hybrid			2022-12-26	WOS:000358512100041
J	Alqarni, AS; Rushdi, AI; Owayss, AA; Raweh, HS; El-Mubarak, AH; Simoneit, BRT				Alqarni, Abdulaziz S.; Rushdi, Ahmed I.; Owayss, Ayman A.; Raweh, Hael S.; El-Mubarak, Aarif H.; Simoneit, Bernd R. T.			Organic Tracers from Asphalt in Propolis Produced by Urban Honey Bees, Apis mellifera Linn.	PLOS ONE			English	Article							NORTHEASTERN PACIFIC-OCEAN; CHEMICAL-COMPOSITION; HYDROTHERMAL ALTERATION; EGYPTIAN PROPOLIS; CUTICULAR LIPIDS; MOLECULAR MARKER; ESCANABA TROUGH; FUGITIVE DUST; SAO-PAULO; MATTER	Propolis is a gummy material produced by honey bees to protect their hives and currently has drawn the attention of researchers due to its broad clinical use. It has been reported, based only on observations, that honey bees also collect other non-vegetation substances such as paint or asphalt/tar to make propolis. Therefore, propolis samples were collected from bee hives in Riyadh and Al-Bahah, a natural area, Saudi Arabia to determine their compositional characteristics and possible sources of the neutral organic compounds. The samples were extracted with hexane and analyzed by gas chromatography-mass spectrometry. The results showed that the major compounds were (n) under bar -alkanes, (n) under bar -alkenes, methyl (n) under bar -alkanoates, long chain wax esters, triterpenoids and hopanes. The (n) under bar -alkanes (ranging from C-17 to C-40) were significant with relative concentrations varying from 23.8 to 56.8% (mean = 44.9 +/- 9.4%) of the total extracts. Their odd carbon preference index (CPI) ranged from 3.6 to 7.7, with a maximum concentration at heptacosane indicating inputs from higher plant vegetation wax. The relative concentrations of the (n) under bar -alkenes varied from 23.8 to 41.19% (mean = 35.6 +/- 5.1%), with CPI = 12.4-31.4, range from C-25 to C-35 and maximum at tritriacontane. Methyl (n) under bar -alkanoates, ranged from C-12 to C-26 as acids, with concentrations from 3.11 to 33.2%(mean = 9.6 +/- 9.5%). Long chain wax esters and triterpenoids were minor. The main triterpenoids were alpha- and beta-amyrins, amyrones and amyryl acetates. The presence of hopanes in some total extracts (up to 12.5%) indicated that the bees also collected petroleum derivatives from vicinal asphalt and used that as an additional ingredient to make propolis. Therefore, caution should be taken when considering the chemical compositions of propolis as potential sources of natural products for biological and pharmacological applications. Moreover, beekeepers should be aware of the proper source of propolis in the flight range of their bee colonies.	[Alqarni, Abdulaziz S.; Owayss, Ayman A.; Raweh, Hael S.] King Saud Univ, Dept Plant Protect, Coll Food & Agr Sci, Riyadh 11451, Saudi Arabia; [Rushdi, Ahmed I.; El-Mubarak, Aarif H.; Simoneit, Bernd R. T.] King Saud Univ, Coll Food & Agr Sci, Chair Green Energy Res, Riyadh 11451, Saudi Arabia; [Rushdi, Ahmed I.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97333 USA; [Rushdi, Ahmed I.] Sanaa Univ, Dept Earth & Environm Sci, Sanaa, Yemen; [Simoneit, Bernd R. T.] Oregon State Univ, Dept Chem, Corvallis, OR 97331 USA	King Saud University; King Saud University; Oregon State University; Oregon State University	Rushdi, AI (corresponding author), King Saud Univ, Coll Food & Agr Sci, Chair Green Energy Res, Riyadh 11451, Saudi Arabia.	arushdi@ksu.edu.sa	Rushdi, Ahmed/AAF-1679-2019; Alqarni, Abdulaziz S./D-5246-2015	Alqarni, Abdulaziz S./0000-0003-1324-332X	National Plan for Scientific Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia [12-AGR2510.02, 09-ENV842-02]; Distinguished Scientist Program of King Saud University	National Plan for Scientific Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia; Distinguished Scientist Program of King Saud University	This project was funded by the National Plan for Scientific Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia, Awards Numbers (12-AGR2510.02 and 09-ENV842-02). BRTS thanks the Distinguished Scientist Program of King Saud University for partial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Mawla A.M.A., 2011, SPATULA DD, V1, P119; AVATO P, 1990, PHYTOCHEMISTRY, V29, P1571, DOI 10.1016/0031-9422(90)80124-Y; Baker E.A., 1982, PLANT CUTICLE; BANKOVA V, 1992, APIDOLOGIE, V23, P79, DOI 10.1051/apido:19920109; Banskota AH, 2001, PHYTOTHER RES, V15, P561, DOI 10.1002/ptr.1029; BIANCHI G, 1989, PHYTOCHEMISTRY, V28, P165, DOI 10.1016/0031-9422(89)85031-9; Christov R, 1998, Z NATURFORSCH C, V53, P197; CIRASINO L, 1987, CONTACT DERMATITIS, V16, P110, DOI 10.1111/j.1600-0536.1987.tb01394.x; Custodio AR, 2003, J BRAZIL CHEM SOC, V14, P354, DOI 10.1590/S0103-50532003000300003; De Castro S. L., 2001, ARBS Annual Review of Biomedical Sciences, V3, P49; EGLINTON G, 1967, SCIENCE, V156, P1322, DOI 10.1126/science.156.3780.1322; El Hady FKA, 2002, Z NATURFORSCH C, V57, P386; Faure P, 2000, ENVIRON SCI TECHNOL, V34, P1174, DOI 10.1021/es9909733; Ficken KJ, 2000, ORG GEOCHEM, V31, P745, DOI 10.1016/S0146-6380(00)00081-4; Fokt H., 2010, CURR RES TECHNOL ED, P481; HAMILTON RJ, 1995, WAXES CHEM MOL BIOL; Harwood J.L., 1984, LIPIDS PLANTS MICROB; Hegazi AG, 2002, Z NATURFORSCH C, V57, P395; JACKSON LL, 1970, LIPIDS, V5, P239, DOI 10.1007/BF02532475; JACKSON LL, 1972, COMP BIOCHEM PHYSIOL, V41, P331, DOI 10.1016/0305-0491(72)90035-1; KatzavGozansky T, 1997, NATURWISSENSCHAFTEN, V84, P238, DOI 10.1007/s001140050386; Kolattukudy P.E., 1976, CHEM BIOCH NATURAL W, P289; Kolattukudy P.E., 1976, CHEM BIOCH NATURAL W; Kujumgiev A, 1999, J ETHNOPHARMACOL, V64, P235, DOI 10.1016/S0378-8741(98)00131-7; KVENVOLDEN KA, 1990, APPL GEOCHEM, V5, P83, DOI 10.1016/0883-2927(90)90039-8; Marcucci MC, 1998, Z NATURFORSCH C, V53, P117; MARCUCCI MC, 1995, APIDOLOGIE, V26, P83, DOI 10.1051/apido:19950202; Hernandez IM, 2010, J AGR FOOD CHEM, V58, P4725, DOI 10.1021/jf904527n; Mazurek M.A., 1984, IDENTIF ANAL ORGANIC, V22, P353; MONTI M, 1983, CONTACT DERMATITIS, V9, P163, DOI 10.1111/j.1600-0536.1983.tb04341.x; Negri G, 2000, J BRAZIL CHEM SOC, V11, P453; Negri G, 1998, APIDOLOGIE, V29, P305, DOI 10.1051/apido:19980401; Nelson D.R., 1995, WAXES CHEM MOL BIOL, P1; NYEIN MM, 1983, AM BEE J, V123, P732; Peters K. E., 1993, BIOMARKER GUIDE INTE; Popova M, 2011, FOOD CHEM, V126, P1431, DOI 10.1016/j.foodchem.2010.11.130; Rogge WF, 2006, ATMOS ENVIRON, V40, P27, DOI 10.1016/j.atmosenv.2005.07.076; Rogge WF, 2007, ATMOS ENVIRON, V41, P8183, DOI 10.1016/j.atmosenv.2007.06.030; Rushdi AI, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-253; Rushdi AI, 2005, ARCH ENVIRON CON TOX, V49, P457, DOI 10.1007/s00244-004-0002-7; Rushdi AI, 2002, APPL GEOCHEM, V17, P1467, DOI 10.1016/S0883-2927(02)00113-0; Rushdi AI, 2002, APPL GEOCHEM, V17, P1401, DOI 10.1016/S0883-2927(02)00109-9; Sforcin JM, 2011, J ETHNOPHARMACOL, V133, P253, DOI 10.1016/j.jep.2010.10.032; Simone M, 2009, EVOLUTION, V63, P3016, DOI 10.1111/j.1558-5646.2009.00772.x; Simone-Finstrom M, 2010, APIDOLOGIE, V41, P295, DOI 10.1051/apido/2010016; Simoneit B.R.T., 1978, CHEM OCEANOGR, V7, P233; SIMONEIT BRT, 1990, CHEMOSPHERE, V21, P1285, DOI 10.1016/0045-6535(90)90145-J; SIMONEIT BRT, 1991, ENVIRON INT, V17, P405, DOI 10.1016/0160-4120(91)90274-T; SIMONEIT BRT, 1984, ATMOS ENVIRON, V18, P51, DOI 10.1016/0004-6981(84)90228-2; SIMONEIT BRT, 1989, J ATMOS CHEM, V8, P251, DOI 10.1007/BF00051497; SIMONEIT BRT, 1991, ATMOS ENVIRON A-GEN, V25, P2111, DOI 10.1016/0960-1686(91)90088-O; TULLOCH AP, 1971, CHEM PHYS LIPIDS, V6, P235, DOI 10.1016/0009-3084(71)90063-6	52	12	12	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128311	10.1371/journal.pone.0128311	http://dx.doi.org/10.1371/journal.pone.0128311			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075382	gold, Green Published, Green Submitted			2022-12-26	WOS:000356329900018
J	Bannantine, JP; Stabel, JR; Laws, E; Cardieri, MCD; Souza, CD				Bannantine, John P.; Stabel, Judith R.; Laws, Elizabeth; Cardieri, Maria Clara D.; Souza, Cleverson D.			Mycobacterium avium Subspecies paratuberculosis Recombinant Proteins Modulate Antimycobacterial Functions of Bovine Macrophages	PLOS ONE			English	Article							GAMMA-INTERFERON; NITRIC-OXIDE; DAIRY-COWS; TUBERCULOSIS; INTERLEUKIN-10; EXPRESSION; MATURATION; INFECTION; CATTLE; LIPOPROTEINS	It has been shown that Mycobacterium avium subspecies paratuberculosis (M. paratuberculosis) activates the Mitogen Activated Protein Kinase (MAPK) p38 pathway, yet it is unclear which components of M. paratuberculosis are involved in the process. Therefore, a set of 42 M. paratuberculosis recombinant proteins expressed from coding sequences annotated as lipoproteins were screened for their ability to induce IL-10 expression, an indicator of MAPKp38 activation, in bovine monocyte-derived macrophages. A recombinant lipoprotein, designated as MAP3837c, was among a group of 6 proteins that strongly induced IL-10 gene transcription in bovine macrophages, averaging a 3.1-fold increase compared to non-stimulated macrophages. However, a parallel increase in expression of IL-12 and TNF-alpha was only observed in macrophages exposed to a subset of these 6 proteins. Selected recombinant proteins were further analyzed for their ability to enhance survival of M. avium within bovine macrophages as measured by recovered viable bacteria and nitrite production. All 6 IL-10 inducing MAP recombinant proteins along with M. paratuberculosis cells significantly enhanced phosphorylation of MAPK-p38 in bovine macrophages. Although these proteins are likely not post translationally lipidated in E. coli and thus is a limitation in this study, these results form the foundation of how the protein component of the lipoprotein interacts with the immune system. Collectively, these data reveal M. paratuberculosis proteins that might play a role in MAPK-p38 pathway activation and hence in survival of this organism within bovine macrophages.	[Bannantine, John P.; Stabel, Judith R.] USDA ARS, Natl Anim Dis Ctr, Ames, IA 50010 USA; [Laws, Elizabeth; Cardieri, Maria Clara D.; Souza, Cleverson D.] Washington State Univ, Dept Vet Clin Sci, Pullman, WA 99164 USA	United States Department of Agriculture (USDA); Washington State University	Souza, CD (corresponding author), Washington State Univ, Dept Vet Clin Sci, Pullman, WA 99164 USA.	souza@vetmed.wsu.edu		Bannantine, John/0000-0002-5692-7898				Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Bannantine JP, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-2; Bannantine JP, 2010, PROTEIN EXPRES PURIF, V72, P223, DOI 10.1016/j.pep.2010.03.019; Bowdish DME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000474; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Brulle JK, 2010, BIOCHEM BIOPH RES CO, V391, P679, DOI 10.1016/j.bbrc.2009.11.120; Clark IA, 2007, CYTOKINE GROWTH F R, V18, P335, DOI 10.1016/j.cytogfr.2007.04.002; CLEMENS DL, 1995, J EXP MED, V181, P257, DOI 10.1084/jem.181.1.257; Dennis MM, 2008, VET MICROBIOL, V131, P154, DOI 10.1016/j.vetmic.2008.02.017; Early J, 2011, MICROB PATHOGENESIS, V50, P132, DOI 10.1016/j.micpath.2010.12.004; Harris NB, 2001, CLIN MICROBIOL REV, V14, P489, DOI 10.1128/CMR.14.3.489-512.2001; Hostetter JM, 2002, FEMS IMMUNOL MED MIC, V34, P127, DOI 10.1111/j.1574-695X.2002.tb00613.x; JACOBSEN CN, 1993, VET IMMUNOL IMMUNOP, V39, P461, DOI 10.1016/0165-2427(93)90075-F; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Khalifeh MS, 2004, INFECT IMMUN, V72, P1974, DOI 10.1128/IAI.72.4.1974-1982.2004; Kuehnel MP, 2001, CELL MICROBIOL, V3, P551, DOI 10.1046/j.1462-5822.2001.00139.x; Leopold I, 1997, ANAL BIOCHEM, V252, P277, DOI 10.1006/abio.1997.2329; Li LL, 2005, P NATL ACAD SCI USA, V102, P12344, DOI 10.1073/pnas.0505662102; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Noss EH, 2001, J IMMUNOL, V167, P910, DOI 10.4049/jimmunol.167.2.910; Raizman EA, 2009, J DAIRY SCI, V92, P4929, DOI 10.3168/jds.2009-2133; Rampini SK, 2008, MICROBIOL-SGM, V154, P2991, DOI 10.1099/mic.0.2008/018895-0; Sakthi S, 2013, MICROBIOL RES, V168, P407, DOI 10.1016/j.micres.2013.02.007; Simutis FJ, 2007, VET IMMUNOL IMMUNOP, V116, P1, DOI 10.1016/j.vetimm.2006.12.005; Souza C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075924; Souza CD, 2006, MICROB PATHOGENESIS, V41, P59, DOI 10.1016/j.micpath.2006.04.002; Stabel JR, 2008, J DAIRY SCI, V91, P3600, DOI 10.3168/jds.2008-1107; Stabel JR, 2014, J DAIRY SCI, V97, P6296, DOI 10.3168/jds.2014-8204; SUTCLIFFE IC, 1995, J BACTERIOL, V177, P1123, DOI 10.1128/jb.177.5.1123-1128.1995; Tschumi A, 2009, J BIOL CHEM, V284, P27146, DOI 10.1074/jbc.M109.022715; Weiss DJ, 2005, AM J VET RES, V66, P1114, DOI 10.2460/ajvr.2005.66.1114; Weiss DJ, 2005, AM J VET RES, V66, P721, DOI 10.2460/ajvr.2005.66.721; Weiss DJ, 2002, INFECT IMMUN, V70, P5556, DOI 10.1128/IAI.70.10.5556-5561.2002; Weiss DJ, 2008, J LEUKOCYTE BIOL, V83, P48, DOI 10.1189/jlb.0707490; Zhao BY, 1997, INFECT IMMUN, V65, P1761, DOI 10.1128/IAI.65.5.1761-1766.1997	35	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128966	10.1371/journal.pone.0128966	http://dx.doi.org/10.1371/journal.pone.0128966			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076028	Green Submitted, Green Published, gold			2022-12-26	WOS:000356329900040
J	Lai, HM; Li, XM; Yang, YN; Ma, YT; Xu, R; Pan, S; Zhai, H; Liu, F; Chen, BD; Zhao, Q				Lai, Hong-Mei; Li, Xiao-Mei; Yang, Yi-Ning; Ma, Yi-Tong; Xu, Rui; Pan, Shuo; Zhai, Hui; Liu, Fen; Chen, Bang-Dang; Zhao, Qian			Genetic Variation in NFKB1 and NFKBIA and Susceptibility to Coronary Artery Disease in a Chinese Uygur Population	PLOS ONE			English	Article							C-REACTIVE PROTEIN; HEART-DISEASE; PROMOTER POLYMORPHISM; MYOCARDIAL-INFARCTION; UIGHUR POPULATION; KAPPA-B; ASSOCIATION; INTERLEUKIN-6; RISK; ATHEROSCLEROSIS	Objectives Coronary artery disease (CAD) is the most common chronic inflammatory disease worldwide. NF-kappa B, a central regulator of inflammation, is involved in various inflammatory diseases. The aim of this study was to investigate the association between NFKB1 and NFKBIA polymorphisms and the susceptibility to CAD and their impact on plasma levels of IL-6 in a Chinese Uygur population. Methods We genotyped NFKB1-94ins/del ATTG (rs28362491) and NFKBIA3' UTR A/G (rs696) using TaqMan SNP genotyping assays in 960 Uygur CAD cases and Uygur 1060 CAD-negtive controls. IL-6 plasma levels were measured in 360 stable angina pectoris (SAP) cases and 360 controls using ELISA method. Results There was no significant difference in the distribution of the genotypes and alleles of rs696 polymorphism in CAD cases and controls. Significant difference in the frequency of genotypes (P = 0.001) and alleles (P = 0.001) of rs28362491 polymorphism was observed in CAD cases compared to controls. In multivariate logistic regression analysis, SNP rs28362491 was consistently associated with CAD risk in a recessive model after adjustment for cardiovascular risk factors (OR = 1.581, 95% CI 1.222 to 2.046, P<0.001). SAP cases had significantly higher plasma levels of IL-6 compared to controls (P<0.001). General linear model analysis showed rs28362491 was independently associated with increased IL-6 levels by analyses of a recessive model (P<0.001) after adjustment for covariates. Conclusions Our study indicates that NFKB1-94 ins/del ATTG polymorphism may play a role in CAD susceptibility in Chinese Uygur population and is functionally associated with IL-6 expression, suggesting a mechanistic link between NFKB1-94 ins/del ATTG polymorphism and CAD susceptibility.	[Lai, Hong-Mei; Li, Xiao-Mei; Yang, Yi-Ning; Ma, Yi-Tong; Xu, Rui; Zhai, Hui; Zhao, Qian] Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Peoples R China; [Lai, Hong-Mei] Peoples Hosp Xinjiang Uygur Autonomous Reg, Dept Cardiol, Urumqi, Peoples R China; [Lai, Hong-Mei; Li, Xiao-Mei; Yang, Yi-Ning; Ma, Yi-Tong; Xu, Rui; Zhai, Hui; Liu, Fen; Chen, Bang-Dang] Xinjiang Key Lab Cardiovasc Dis Res, Urumqi, Peoples R China; [Liu, Fen; Chen, Bang-Dang] Xinjiang Med Univ, Clin Res Inst, Urumqi, Peoples R China; [Pan, Shuo] Peoples Hosp Shaanxi Prov, Dept Cardiol 1, Xian, Peoples R China	Xinjiang Medical University; Xinjiang Medical University; Xi'an Medical University	Yang, YN (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Peoples R China.	yangyn5126@163.com; myt-xj@163.com			High-technology research and development planning of Xinjiang Uygur Autonomous Region [201417102]	High-technology research and development planning of Xinjiang Uygur Autonomous Region	This work was supported by High-technology research and development planning of Xinjiang Uygur Autonomous Region (201417102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biasillo G, 2010, INTERN EMERG MED, V5, P225, DOI 10.1007/s11739-010-0361-1; Boccardi V, 2011, NUTR METAB CARDIOVAS, V21, P679, DOI 10.1016/j.numecd.2009.12.012; Borm MEA, 2005, INT J IMMUNOGENET, V32, P401, DOI 10.1111/j.1744-313X.2005.00546.x; Cao SJ, 2006, J BIOL CHEM, V281, P26041, DOI 10.1074/jbc.M602222200; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; de Winther MPJ, 2005, ARTERIOSCL THROM VAS, V25, P904, DOI 10.1161/01.ATV.0000160340.72641.87; Fontaine-Bisson B, 2009, ATHEROSCLEROSIS, V204, P465, DOI 10.1016/j.atherosclerosis.2008.10.037; Gao M, 2012, DNA CELL BIOL, V31, P611, DOI 10.1089/dna.2011.1389; Goto Y, 2001, CLIN CANCER RES, V7, P1952; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Koc A, 2014, IMMUNOBIOLOGY, V219, P531, DOI 10.1016/j.imbio.2014.03.009; Koenig W, 2006, ARTERIOSCL THROM VAS, V26, P2745, DOI 10.1161/01.ATV.0000248096.62495.73; Kume K, 2011, J RHEUMATOL, V38, P2169, DOI 10.3899/jrheum.110340; Kuo LT, 2008, INT HEART J, V49, P391, DOI 10.1536/ihj.49.391; Kurylowicz A, 2007, GENES IMMUN, V8, P532, DOI 10.1038/sj.gene.6364418; Li X, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-84; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Luc G, 2003, ARTERIOSCL THROM VAS, V23, P1255, DOI 10.1161/01.ATV.0000079512.66448.1D; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Lusis MJ, 2004, ANNU REV GENOM HUM G, V5, P189, DOI [10.1146/annurev.genom.5.061903.175930, 10.1016/j.tig.2012.03.001]; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Mishra A, 2013, CYTOKINE, V61, P856, DOI 10.1016/j.cyto.2012.12.020; Pereira SG, 2008, INT J BIOCHEM CELL B, V40, P1425, DOI 10.1016/j.biocel.2007.05.004; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Romzova M, 2006, HUM IMMUNOL, V67, P706, DOI 10.1016/j.humimm.2006.05.006; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; SEINO Y, 1994, CYTOKINE, V6, P87, DOI 10.1016/1043-4666(94)90013-2; Vogel U, 2011, ATHEROSCLEROSIS, V219, P200, DOI 10.1016/j.atherosclerosis.2011.06.018; Xie XA, 2011, CLIN CHEM LAB MED, V49, P55, DOI 10.1515/CCLM.2011.024; Xie X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015181; Xie X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013997; Yang YN, 2010, CLIN APPL THROMB-HEM, V16, P579, DOI 10.1177/1076029610364522; Zou JG, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-145; Zuccala A, 2009, G Ital Nefrol, V26, P226	34	22	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129144	10.1371/journal.pone.0129144	http://dx.doi.org/10.1371/journal.pone.0129144			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075620	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900046
J	Ha, BG; Park, JE; Cho, HJ; Shon, YH				Ha, Byung Geun; Park, Jung-Eun; Cho, Hyun-Jung; Shon, Yun Hee			Stimulatory Effects of Balanced Deep Sea Water on Mitochondrial Biogenesis and Function	PLOS ONE			English	Article							MAGNESIUM-DEFICIENCY; ADIPOSE-TISSUE; HIGH-FAT; CALCIUM; PATHWAY; AMPK; APOPTOSIS; PROTEIN; OBESITY; CELLS	The worldwide prevalence of metabolic diseases, including obesity and diabetes, is increasing. Mitochondrial dysfunction is recognized as a core feature of these diseases. Emerging evidence also suggests that defects in mitochondrial biogenesis, number, morphology, fusion, and fission, contribute to the development and progression of metabolic diseases. Our previous studies revealed that balanced deep-sea water (BDSW) has potential as a treatment for diabetes and obesity. In this study, we aimed to investigate the mechanism by which BDSWregulates diabetes and obesity by studying its effects on mitochondrial metabolism. To determine whether BDSWregulates mitochondrial biogenesis and function, we investigated its effects on mitochondrial DNA (mtDNA) content, mitochondrial enzyme activity, and the expression of transcription factors and mitochondria specific genes, as well as on the phosphorylation of signaling molecules associated with mitochondria biogenesis and its function in C2C12 myotubes. BDSWincreased mitochondrial biogenesis in a time and dose-dependent manner. Quantitative real-time PCR revealed that BDSW enhances gene expression of PGC-1 alpha, NRF1, and TFAM for mitochondrial transcription; MFN1/2 and DRP1 for mitochondrial fusion; OPA1 for mitochondrial fission; TOMM40 and TIMM44 for mitochondrial protein import; CPT-1 alpha and MCAD for fatty acid oxidation; CYTC for oxidative phosphorylation. Upregulation of these genes was validated by increased mitochondria staining, CS activity, CytC oxidase activity, NAD(+) to NADH ratio, and the phosphorylation of signaling molecules such as AMPK and SIRT1. Moreover, drinking BDSWremarkably improved mtDNA content in the muscles of HFD-induced obese mice. Taken together, these results suggest that the stimulatory effect of BDSWon mitochondrial biogenesis and function may provide further insights into the regulatory mechanism of BDSW-induced anti-diabetic and anti-obesity action.	[Ha, Byung Geun; Park, Jung-Eun; Cho, Hyun-Jung; Shon, Yun Hee] Kyungpook Natl Univ Hosp, Biomed Res Inst, Taegu, South Korea	Kyungpook National University; Kyungpook National University Hospital	Shon, YH (corresponding author), Kyungpook Natl Univ Hosp, Biomed Res Inst, Taegu, South Korea.	yhshon@hmail.knu.ac.kr			Ministry of Oceans and Fisheries of the Republic of Korea	Ministry of Oceans and Fisheries of the Republic of Korea	This research was supported by a grant (technical development for supporting the DSW industry) from the Ministry of Oceans and Fisheries of the Republic of Korea.	Aguer C, 2012, BEST PRACT RES CL EN, V26, P805, DOI 10.1016/j.beem.2012.06.001; Ames Bruce N., 2005, Molecular Aspects of Medicine, V26, P363, DOI 10.1016/j.mam.2005.07.007; Andreux PA, 2013, NAT REV DRUG DISCOV, V12, P465, DOI 10.1038/nrd4023; [Anonymous], STANDARD METHODS FOR; Bak JP, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-108; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Bussiere FI, 2002, BRIT J NUTR, V87, P107, DOI 10.1079/BJN2001498; Cheng ZY, 2014, CELL CYCLE, V13, P890, DOI 10.4161/cc.28189; Chomentowski P, 2011, J CLIN ENDOCR METAB, V96, P494, DOI 10.1210/jc.2010-0822; Clark TA, 2014, HEART FAIL REV, V19, P123, DOI 10.1007/s10741-013-9380-0; Fujisawa K, 2009, BIOCHEM BIOPH RES CO, V379, P43, DOI 10.1016/j.bbrc.2008.11.141; Galgani JE, 2008, AM J PHYSIOL-ENDOC M, V295, pE1009, DOI 10.1152/ajpendo.90558.2008; Gao AW, 2014, EMBO MOL MED, V6, P580, DOI 10.1002/emmm.201303782; Ha BG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102095; Ha BG, 2014, OBESITY, V22, P1669, DOI 10.1002/oby.20740; Ha BG, 2013, MAR DRUGS, V11, P4193, DOI 10.3390/md11114193; Higashida K, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001603; Hiraoka Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4224; Hsieh CJ, 2011, DIABETES RES CLIN PR, V92, P106, DOI 10.1016/j.diabres.2011.01.010; Huang Han-Yo, 2006, Evid Rep Technol Assess (Full Rep), P1; Hui KY, 2014, CANCER LETT, V354, P189, DOI 10.1016/j.canlet.2014.08.009; Huskisson E, 2007, J INT MED RES, V35, P277, DOI 10.1177/147323000703500301; Katsuda S, 2008, BIOL PHARM BULL, V31, P38, DOI 10.1248/bpb.31.38; Killilea DW, 2008, P NATL ACAD SCI USA, V105, P5768, DOI 10.1073/pnas.0712401105; Kumar SD, 2012, FREE RADICAL BIO MED, V53, P1595, DOI 10.1016/j.freeradbiomed.2012.07.008; Lee H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055106; Lee S, 2015, PEDIATR DIABETES, V16, P211, DOI 10.1111/pedi.12141; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Martin SD, 2014, BBA-GEN SUBJECTS, V1840, P1303, DOI 10.1016/j.bbagen.2013.09.019; Mendelev N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047910; Mostafavi E, 2013, CLIN HEMORHEOL MICRO, V53, P239, DOI 10.3233/CH-2012-1546; Panee J, 2007, J BIOL CHEM, V282, P23759, DOI 10.1074/jbc.M702267200; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Prior SJ, 2014, OBESITY, V22, P451, DOI 10.1002/oby.20609; Rees K, 2013, COCHRANE DB SYST REV, V1; Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Sheu MJ, 2013, MAR DRUGS, V11, P2183, DOI 10.3390/md11062183; Sparks LM, 2009, DIABETES RES CLIN PR, V83, P32, DOI 10.1016/j.diabres.2008.09.052; van de Weijer T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051648; Vijgen GHEJ, 2013, SURG OBES RELAT DIS, V9, P936, DOI 10.1016/j.soard.2013.03.009; Volpe SL, 2013, ADV NUTR, V4, p378S, DOI 10.3945/an.112.003483; Wenz T, 2013, MITOCHONDRION, V13, P134, DOI 10.1016/j.mito.2013.01.006; Wolf Federica I., 2003, Molecular Aspects of Medicine, V24, P11, DOI 10.1016/S0098-2997(02)00088-2; Wright DC, 2007, J BIOL CHEM, V282, P18793, DOI 10.1074/jbc.M611252200; Yeh TS, 2005, ANN NY ACAD SCI, V1042, P157, DOI 10.1196/annals.1338.017; Yoon SO, 2001, FASEB J, V15, P111, DOI 10.1096/fj.01-0398fje; Yuzefovych LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054059; Zhang W, 2014, INFLAMMATION, V37, P478, DOI 10.1007/s10753-013-9761-5	50	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129972	10.1371/journal.pone.0129972	http://dx.doi.org/10.1371/journal.pone.0129972			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068191	Green Submitted, gold, Green Published			2022-12-26	WOS:000356327000128
J	Hoffman-Luca, CG; Yang, CY; Lu, JF; Ziazadeh, D; McEachern, D; Debussche, L; Wang, SM				Hoffman-Luca, C. Gianna; Yang, Chao-Yie; Lu, Jianfeng; Ziazadeh, Daniel; McEachern, Donna; Debussche, Laurent; Wang, Shaomeng			Significant Differences in the Development of Acquired Resistance to the MDM2 Inhibitor SAR405838 between In Vitro and In Vivo Drug Treatment	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; P53 MUTATIONS; CANCER; DNA; ACTIVATION; SENSITIVITY; MECHANISMS; APOPTOSIS; NUTLIN-3; PATHWAY	SAR405838 is a potent and specific MDM2 inhibitor currently being evaluated in Phase I clinical trials for the treatment of human cancer. Using the SJSA-1 osteosarcoma cell line which harbors an amplified MDM2 gene and wild-type p53, we have investigated the acquired resistance mechanisms both in vitro and in vivo to SAR405838. Treatment of SJSA-1 cells with SAR405838 in vitro leads to dose-dependent cell growth inhibition, cell cycle arrest and robust apoptosis. However, prolonged treatment of SJSA-1 cells in vitro with SAR405838 results in profound acquired resistance to the drug. Analysis of in vitro-derived resistant cell lines showed that p53 is mutated in the DNA binding domain and can no longer be activated by SAR405838. Treatment of the parental SJSA-1 xenograft tumors with SAR405838 in mice yields rapid tumor regression but the tumors eventually regrow. Culturing the regrown tumors established a number of sublines, which showed only modest (3-5 times) loss of sensitivity to SAR405838 in vitro. Sequencing of the p53 showed that it retains its wild-type status in these in vivo sublines, with the exception of one subline, which harbors a single heterozygous C176F p53 mutation. Using xenograft models of two in vivo derived sublines, which has either wild-type p53 or p53 containing a single heterozygous C176F mutation, we showed that while SAR405838 effectively achieves partial tumor regression in these models, it no longer induces complete tumor regression and tumors resume growth once the treatment is stopped. Harvesting and culturing tumors obtained from a prolonged treatment with SAR405838 in mice established additional in vivo sublines, which all contain a single heterozygous C176F mutation with no additional p53 mutation detected. Interestingly, SAR405838 can still effectively activate p53 in all sublines containing a single heterozygous C176F mutation, with a moderately reduced potency as compared to that in the parental cell line. Consistently, SAR405838 is 3-5 times less effective in all the in vivo derived sublines containing a single heterozygous C176F p53 mutation than in the SJSA-1 parental cell line in assays of cell growth and apoptosis. Computational modeling suggested that a p53 tetramer containing two wild-type p53 molecules and two C176F mutated molecules can maintain the structural stability and interactions with DNA by formation of additional hydrophobic and cation-p interactions which compensate for the loss of sulphur-zinc coordination. Our data thus show that SJSA-1 tumor cells acquire very different levels of resistance in vitro and in vivo to the MDM2 inhibitor SAR405838. Our present study may have a significant implication for the investigation of resistant mechanisms for other classes of anticancer drugs.	[Hoffman-Luca, C. Gianna; Yang, Chao-Yie; Lu, Jianfeng; Ziazadeh, Daniel; McEachern, Donna; Wang, Shaomeng] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Hoffman-Luca, C. Gianna; Ziazadeh, Daniel; Wang, Shaomeng] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Yang, Chao-Yie; Lu, Jianfeng; McEachern, Donna; Wang, Shaomeng] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Wang, Shaomeng] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Debussche, Laurent] Sanofi Oncol, Vitry Sur Seine, France	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Wang, SM (corresponding author), Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA.	shaomeng@umich.edu	Yang, Chao-Yie/A-3930-2015	Yang, Chao-Yie/0000-0002-5445-0109; Wang, Shaomeng/0000-0002-8782-6950	National Institutes of Health, US [R01CA121279, P30CA046592]; University of Michigan; Sanofi Oncology; NATIONAL CANCER INSTITUTE [R01CA121279, P30CA046592] Funding Source: NIH RePORTER	National Institutes of Health, US(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan(University of Michigan System); Sanofi Oncology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported with funding from the National Institutes of Health, US (R01CA121279 and P30CA046592) and internal funding from the University of Michigan. Sanofi Oncology provided support in the form of salaries for author(s) LD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz MH, 2011, ONCOGENE, V30, P4678, DOI 10.1038/onc.2011.185; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; Case DA, 2012, AMBER 12; Chen YH, 2013, NUCLEIC ACIDS RES, V41, P8368, DOI 10.1093/nar/gkt584; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; FAKHARZADEH SS, 1993, GENOMICS, V15, P283, DOI 10.1006/geno.1993.1058; Freedman DA, 1999, CELL MOL LIFE SCI, V55, P96, DOI 10.1007/s000180050273; Hainaut P, 2000, ADV CANCER RES, V77, P81; Hoffman-Luca CG, 2015, CLIN CANC R IN PRESS; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Long JT, 2010, BLOOD, V116, P71, DOI 10.1182/blood-2010-01-261628; Lu JF, 2008, CANCER RES, V68, P9384, DOI 10.1158/0008-5472.CAN-08-2655; Lu Q, 2007, J PHYS CHEM B, V111, P11538, DOI 10.1021/jp0742261; Michaelis M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.129; Momand J, 2000, GENE, V242, P15, DOI 10.1016/S0378-1119(99)00487-4; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Olivier M, 2005, 25 YEARS OF P53 RESEARCH, P321, DOI 10.1007/1-4020-2922-5_14; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saha MN, 2010, J CLIN PATHOL, V63, P204, DOI 10.1136/jcp.2009.070961; Shangary S, 2008, CLIN CANCER RES, V14, P5318, DOI 10.1158/1078-0432.CCR-07-5136; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; Teodoro JG, 2007, J MOL MED-JMM, V85, P1175, DOI 10.1007/s00109-007-0221-2; Tovar C, 2013, CANCER RES, V73, P2587, DOI 10.1158/0008-5472.CAN-12-2807; Valentine JM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-79; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Verma R, 2010, BIOCHEM PHARMACOL, V79, P565, DOI 10.1016/j.bcp.2009.09.020; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Vu B, 2013, ACS MED CHEM LETT, V4, P466, DOI 10.1021/ml4000657; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang S., 2014, CANC RES; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; YANG LY, 1990, CANCER RES, V50, P3218; Zhao YJ, 2015, J MED CHEM, V58, P1038, DOI 10.1021/jm501092z; Zhao YJ, 2013, J MED CHEM, V56, P5553, DOI 10.1021/jm4005708	44	21	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128807	10.1371/journal.pone.0128807	http://dx.doi.org/10.1371/journal.pone.0128807			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070072	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000030
J	Weiss, RF; Smith, MR; Miller, MG; Cronin, JF				Weiss, Robert F.; Smith, Mitchell R.; Miller, Merlin G.; Cronin, John F.			Progression and Transformation of Clonally Heterogeneous B-cell Lymphoma	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; FOLLICULAR LYMPHOMA; EVOLUTION; IMPACT	Indolent B- cell non-Hodgkin lymphoma can transform into aggressive lymphoma. We extend our prior mathematical model to analyze and predict transformation. To provide additional confidence in our model, we compare it with SCID mouse data for combination therapy of Diffuse Large B-cell Lymphoma, an aggressive form of the disease. We develop a two cell model that includes indolent and aggressive clones but no immune response and use it to predict transformation. An approximate model for the time to transformation is derived that provides insight regarding scaling effects. We then add an immune response and therapeutic measures, and illustrate the complex interactions among the various processes, with a focus on transformation. The implications for initial diagnosis and treatment of non-Hodgkin lymphoma are discussed.	[Weiss, Robert F.; Miller, Merlin G.] Back Bay Biosci LLC, Computat Biol, Boston, MA 02115 USA; [Smith, Mitchell R.] Cleveland Clin, Hematol & Oncol, Cleveland, OH 44106 USA; [Cronin, John F.] Phys Sci Inc, Comp Serv, Andover, MA USA	Cleveland Clinic Foundation; Physical Sciences Inc.	Weiss, RF (corresponding author), Back Bay Biosci LLC, Computat Biol, Boston, MA 02115 USA.	rfdweiss@outlook.com						Carlotti E, 2009, BLOOD, V113, P3553, DOI 10.1182/blood-2008-08-174839; Goldsby RA, 2000, KUBY IMMUNOLOGY; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Link BK, 2013, J CLIN ONCOL, V31, P3272, DOI 10.1200/JCO.2012.48.3990; NORTON L, 1986, CANCER TREAT REP, V70, P163; Rossi D, 2014, BLOOD, V123, P2139, DOI 10.1182/blood-2013-11-539726; Tse Shoemaker AR, 2008, CANCER RES, V68, P3421, DOI [10.1158/0008-5472.CAN-07-5836, DOI 10.1158/0008-5472.CAN-07-5836]; Vandenberg CJ, 2013, BLOOD, V121, P2285, DOI 10.1182/blood-2013-01-475855; Weiss RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081672; Weiss RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051736	11	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130590	10.1371/journal.pone.0130590	http://dx.doi.org/10.1371/journal.pone.0130590			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068800	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000159
J	Zhang, CY; Zhu, SS; Wei, L; Yan, X; Wang, J; Quan, R; She, RP; Hu, FJ; Liu, J				Zhang, Chunyan; Zhu, Shanshan; Wei, Li; Yan, Xu; Wang, Jing; Quan, Rong; She, Ruiping; Hu, Fengjiao; Liu, Jue			Recombinant Flagellin-Porcine Circovirus Type 2 Cap Fusion Protein Promotes Protective Immune Responses in Mice	PLOS ONE			English	Article							MULTISYSTEMIC WASTING SYNDROME; MUCOSAL ADJUVANT ACTIVITY; BACTERIAL FLAGELLIN; RESPIRATORY CHALLENGE; CELLULAR MECHANISMS; PCV2; VACCINES; VIRUS; IMMUNOGENICITY; PIGS	The Cap protein of porcine circovirus type 2 (PCV2) that serves as a major host-protective immunogen was used to develop recombinant vaccines for control of PCV2-associated diseases. Growing research data have demonstrated the high effectiveness of flagellin as an adjuvant for humoral and cellular immune responses. Here, a recombinant protein was designed by fusing a modified version of bacterial flagellin to PCV2 Cap protein and expressed in a baculovirus system. When administered without adjuvant to BALB/c mice, the flagellin-Cap fusion protein elicited stronger PCV2-specific IgG antibody response, higher neutralizing antibody levels, milder histopathological changes and lower viremia, as well as higher secretion of cytokines such as TNF-alpha and IFN-gamma that conferred better protection against virus challenge than those in the recombinant Cap alone-inoculated mice. These results suggest that the recombinant Cap protein when fused to flagellin could elicit better humoral and cellular immune responses against PCV2 infection in a mouse model, thereby acting as an attractive candidate vaccine for control of the PCV2-associated diseases.	[Zhang, Chunyan; Zhu, Shanshan; Wei, Li; Yan, Xu; Wang, Jing; Liu, Jue] Beijing Acad Agr & Forestry Sci, Inst Anim Husb & Vet Med, Beijing Key Lab Prevent & Control Infect Dis Live, Beijing 100097, Peoples R China; [Quan, Rong; She, Ruiping; Hu, Fengjiao] China Agr Univ, Coll Vet Med, Beijing 100197, Peoples R China	Beijing Academy of Agriculture & Forestry; China Agricultural University	Liu, J (corresponding author), Beijing Acad Agr & Forestry Sci, Inst Anim Husb & Vet Med, Beijing Key Lab Prevent & Control Infect Dis Live, 9 Shuguang Garden Middle Rd, Beijing 100097, Peoples R China.	liujue@263.net			National Science Fund for Distinguished Young Scholars [31025028]; Beijing Municipal Science and Technology; People's Republic of China	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Beijing Municipal Science and Technology; People's Republic of China	This work was supported by grants from the National Science Fund for Distinguished Young Scholars (31025028) and the Beijing Municipal Science and Technology Contract Project (Z07010501780701), People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan G, 1998, VET REC, V142, P467; ALLAN GM, 1995, VET MICROBIOL, V44, P49, DOI 10.1016/0378-1135(94)00136-K; Bates JT, 2008, MECH AGEING DEV, V129, P271, DOI 10.1016/j.mad.2008.01.009; Bates JT, 2011, J IMMUNOL, V186, P6255, DOI 10.4049/jimmunol.1001855; Ben-Yedidia T, 1998, IMMUNOL LETT, V64, P9, DOI 10.1016/S0165-2478(98)00073-X; Blanchard P, 2003, VACCINE, V21, P4565, DOI 10.1016/S0264-410X(03)00503-6; Bucarey SA, 2009, VACCINE, V27, P5781, DOI 10.1016/j.vaccine.2009.07.061; Carasova P, 2007, RES VET SCI, V83, P274, DOI 10.1016/j.rvsc.2006.11.013; Cheung AK, 2003, VIROLOGY, V305, P168, DOI 10.1006/viro.2002.1733; Cuadros C, 2004, INFECT IMMUN, V72, P2810, DOI 10.1128/IAI.72.5.2810-2816.2004; Del Prete G, 1998, Int Rev Immunol, V16, P427, DOI 10.3109/08830189809043004; Delaney KN, 2010, VIRAL IMMUNOL, V23, P201, DOI 10.1089/vim.2009.0107; Fan HY, 2008, J VIROL METHODS, V150, P21, DOI 10.1016/j.jviromet.2008.02.011; Fort M, 2008, VACCINE, V26, P1063, DOI 10.1016/j.vaccine.2007.12.019; Fort M, 2009, VACCINE, V27, P4031, DOI 10.1016/j.vaccine.2009.04.028; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Honko AN, 2006, INFECT IMMUN, V74, P1113, DOI 10.1128/IAI.74.2.1113-1120.2006; Honko AN, 2005, IMMUNOL RES, V33, P83, DOI 10.1385/IR:33:1:083; Ju CM, 2005, VET MICROBIOL, V109, P179, DOI 10.1016/j.vetmic.2005.06.001; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim T, 2009, VET MICROBIOL, V138, P318, DOI 10.1016/j.vetmic.2009.04.014; Kiupel M, 2001, VET PATHOL, V38, P74, DOI 10.1354/vp.38-1-74; Kixmoller M, 2008, VACCINE, V26, P3443, DOI 10.1016/j.vaccine.2008.04.032; Lee SE, 2006, INFECT IMMUN, V74, P694, DOI 10.1128/IAI.74.1.694-702.2006; Letran SE, 2011, EUR J IMMUNOL, V41, P29, DOI 10.1002/eji.201040717; Liu G, 2012, VACCINE, V30, P6833, DOI 10.1016/j.vaccine.2012.09.013; Liu GM, 2011, VACCINE, V29, P8677, DOI 10.1016/j.vaccine.2011.08.118; Liu J, 2005, J VIROL, V79, P8262, DOI 10.1128/JVI.79.13.8262-8274.2005; Liu J, 2006, J VIROL, V80, P5065, DOI 10.1128/JVI.80.10.5065-5073.2006; Liu Q, 2001, PROTEIN EXPRES PURIF, V21, P115, DOI 10.1006/prep.2000.1356; Mankertz A, 1998, J GEN VIROL, V79, P381, DOI 10.1099/0022-1317-79-2-381; Martelli P, 2011, VET MICROBIOL, V149, P339, DOI 10.1016/j.vetmic.2010.12.008; McDermott PF, 2000, INFECT IMMUN, V68, P5525, DOI 10.1128/IAI.68.10.5525-5529.2000; McDonald WF, 2007, J INFECT DIS, V195, P1607, DOI 10.1086/517613; McIntosh KA, 2006, CAN J VET RES, V70, P58; McSorley SJ, 2002, J IMMUNOL, V169, P3914, DOI 10.4049/jimmunol.169.7.3914; Means TK, 2003, J IMMUNOL, V170, P5165, DOI 10.4049/jimmunol.170.10.5165; Mizel SB, 2010, J IMMUNOL, V185, P5677, DOI 10.4049/jimmunol.1002156; Mizel SB, 2009, CLIN VACCINE IMMUNOL, V16, P21, DOI 10.1128/CVI.00333-08; Nawagitgul P, 2000, J GEN VIROL, V81, P2281, DOI 10.1099/0022-1317-81-9-2281; Opriessnig T, 2009, VACCINE, V27, P1002, DOI 10.1016/j.vaccine.2008.11.105; Opriessnig T, 2007, J VET DIAGN INVEST, V19, P591, DOI 10.1177/104063870701900601; Perez-Martin E, 2010, VACCINE, V28, P2340, DOI 10.1016/j.vaccine.2009.12.061; Pino O, 2005, INFECT IMMUN, V73, P6763, DOI 10.1128/IAI.73.10.6763-6770.2005; Quintana J, 2002, VET RES, V33, P229, DOI 10.1051/vetres:2002011; Seder RA, 2000, NATURE, V406, P793, DOI 10.1038/35021239; Segales J, 2004, VET MICROBIOL, V98, P151, DOI 10.1016/j.vetmic.2003.10.007; Segales Joaquim, 2005, Animal Health Research Reviews, V6, P119, DOI 10.1079/AHR2005106; Shen HG, 2008, J GEN VIROL, V89, P1857, DOI 10.1099/vir.0.2008/000125-0; TISCHER I, 1987, ARCH VIROL, V96, P39, DOI 10.1007/BF01310989; Wang K, 2008, J VIROL METHODS, V150, P1, DOI 10.1016/j.jviromet.2008.02.014; Wang XW, 2007, VET MICROBIOL, V121, P215, DOI 10.1016/j.vetmic.2006.11.027; Wang XW, 2006, VACCINE, V24, P3374, DOI 10.1016/j.vaccine.2005.12.068; Wang YP, 2013, VACCINE, V31, P833, DOI 10.1016/j.vaccine.2012.11.062	55	9	10	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129617	10.1371/journal.pone.0129617	http://dx.doi.org/10.1371/journal.pone.0129617			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070075	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000096
J	Zhang, D; Zhao, H; Fan, ZJ; Li, MJ; Du, PH; Liu, CM; Li, YP; Li, HT; Cao, HB				Zhang, Di; Zhao, He; Fan, Zhuangjun; Li, Mingjie; Du, Penghui; Liu, Chenming; Li, Yuping; Li, Haitao; Cao, Hongbin			A Highly Sensitive and Selective Hydrogen Peroxide Biosensor Based on Gold Nanoparticles and Three-Dimensional Porous Carbonized Chicken Eggshell Membrane	PLOS ONE			English	Article							DIRECT ELECTRON-TRANSFER; HORSERADISH-PEROXIDASE; ELECTROCHEMICAL BIOSENSOR; FUNCTIONALIZED-GRAPHENE; BIOMASS CARBON; NANOTUBE; IMMOBILIZATION; THIONINE; MEDIATOR; HRP	A sensitive and noble amperometric horseradish peroxidase (HRP) biosensor is fabricated via the deposition of gold nanoparticles (AuNPs) onto a three-dimensional (3D) porous carbonized chicken eggshell membrane (CESM). Due to the synergistic effects of the unique porous carbon architecture and well-distributed AuNPs, the enzyme-modified electrode shows an excellent electrochemical redox behavior. Compared with bare glass carbon electrode (GCE), the cathodic peak current of the enzymatic electrode increases 12.6 times at a formal potential of -100mV (vs. SCE) and charge-transfer resistance decreases 62.8%. Additionally, the AuNPs-CESM electrode exhibits a good biocompatibility, which effectively retains its bioactivity with a surface coverage of HRP 6.39x10(-9)mol cm(-2) (752 times higher than the theoretical monolayer coverage of HRP). Furthermore, the HRP-AuNPs-CESM-GCE electrode, as a biosensor for H2O2 detection, has a good accuracy and high sensitivity with the linear range of 0.01-2.7 mM H2O2 and the detection limit of 3 mu M H2O2(S/N = 3).	[Zhang, Di; Zhao, He; Li, Mingjie; Du, Penghui; Liu, Chenming; Li, Yuping; Cao, Hongbin] Chinese Acad Sci, Beijing Engn Res Ctr Proc Pollut Control, Key Lab Green Proc & Engn, Inst Proc Engn, Beijing 100190, Peoples R China; [Fan, Zhuangjun] Harbin Engn Univ, Key Lab Superlight Mat & Surface Technol, Minist Educ, Coll Mat Sci & Chem Engn, Harbin, Peoples R China; [Li, Haitao] Beijing Acad Sci & Technol, Environm Protect Res Inst Light Ind, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Process Engineering, CAS; Harbin Engineering University; Beijing Academy of Science & Technology	Zhao, H (corresponding author), Chinese Acad Sci, Beijing Engn Res Ctr Proc Pollut Control, Key Lab Green Proc & Engn, Inst Proc Engn, Beijing 100190, Peoples R China.	hzhao@ipe.ac.cn	Zhao, He/D-6011-2014; Fan, Zhuangjun/B-3878-2011	Zhao, He/0000-0002-0162-7388; Du, Penghui/0000-0001-7409-0983; Fan, Zhuangjun/0000-0001-5639-0675	National Natural Science Foundation of China [51108441, 51102238, 21177130, 51209191]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China, grant numbers 51108441 (HZ), 51102238 (CML), 21177130 (YPL), and 51209191 (HTL). HZ participated in the study design, data analysis, decision to publish and preparation of the manuscript. CML, YPL and HTL participated in the data analysis.	Arami M, 2006, CHEMOSPHERE, V65, P1999, DOI 10.1016/j.chemosphere.2006.06.074; Chai HM, 2012, ELECTROANAL, V24, P1129, DOI 10.1002/elan.201200079; Cho SH, 2009, J HAZARD MATER, V162, P1014, DOI 10.1016/j.jhazmat.2008.05.133; Choi MMF, 2004, ENZYME MICROB TECH, V34, P41, DOI 10.1016/j.enzmictec.2003.08.005; Farma R, 2013, INT J ELECTROCHEM SC, V8, P257; Freire RS, 2003, J BRAZIL CHEM SOC, V14, P230, DOI 10.1590/S0103-50532003000200008; Gao FX, 2007, J BIOCHEM BIOPH METH, V70, P407, DOI 10.1016/j.jbbm.2006.09.007; Jeykumari DRS, 2007, CARBON, V45, P1340, DOI 10.1016/j.carbon.2007.01.006; Jeykumari DRS, 2009, CARBON, V47, P957, DOI 10.1016/j.carbon.2008.11.050; Jose MV, 2012, CARBON, V50, P4010, DOI 10.1016/j.carbon.2012.04.044; Kalyani P, 2013, INT J HYDROGEN ENERG, V38, P4034, DOI 10.1016/j.ijhydene.2013.01.048; Koumanova B, 2002, J CHEM TECHNOL BIOT, V77, P539, DOI 10.1002/jctb.601; Li MJ, 2015, CARBON, V86, P197, DOI 10.1016/j.carbon.2015.01.029; Li Z, 2012, ADV ENERGY MATER, V2, P431, DOI 10.1002/aenm.201100548; Liu RJ, 2012, SMALL, V8, P1398, DOI 10.1002/smll.201102298; Liu XQ, 2012, BIOSENS BIOELECTRON, V32, P188, DOI 10.1016/j.bios.2011.12.002; Ma LP, 2009, BIOPROC BIOSYST ENG, V32, P537, DOI 10.1007/s00449-008-0275-8; Nandini S, 2013, J ELECTROANAL CHEM, V689, P233, DOI 10.1016/j.jelechem.2012.11.004; Ruzgas T, 1996, ANAL CHIM ACTA, V330, P123, DOI 10.1016/0003-2670(96)00169-9; Shleev S, 2005, BIOSENS BIOELECTRON, V20, P2517, DOI 10.1016/j.bios.2004.10.003; Su HL, 2008, SMART MATER STRUCT, V17, DOI 10.1088/0964-1726/17/1/015045; Tsai WT, 2006, BIORESOURCE TECHNOL, V97, P488, DOI 10.1016/j.biortech.2005.02.050; Ueda A, 2011, J AM CHEM SOC, V133, P4840, DOI 10.1021/ja108614d; Wang L, 2014, ANAL CHEM, V86, P1414, DOI 10.1021/ac401563m; Wang QX, 2012, MICROCHIM ACTA, V176, P279, DOI 10.1007/s00604-011-0716-y; Yang GH, 2013, CARBON, V61, P357, DOI 10.1016/j.carbon.2013.05.016; Yang GH, 2013, CARBON, V51, P124, DOI 10.1016/j.carbon.2012.08.020; Yin HS, 2009, SENSOR ACTUAT B-CHEM, V137, P747, DOI 10.1016/j.snb.2008.12.046; Zebda A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1365; Zhang KY, 2011, MICROCHIM ACTA, V173, P135, DOI 10.1007/s00604-010-0534-7; Zhao J, 2011, BIOSENS BIOELECTRON, V26, P2297, DOI 10.1016/j.bios.2010.09.056; Zheng Y, 2008, CHINESE J ANAL CHEM, V36, P604, DOI 10.1016/S1872-2040(08)60034-1	32	23	24	0	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130156	10.1371/journal.pone.0130156	http://dx.doi.org/10.1371/journal.pone.0130156			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26069960	Green Submitted, Green Published, gold			2022-12-26	WOS:000356327000144
J	Chao, A; Jost, L; Hsieh, TC; Ma, KH; Sherwin, WB; Rollins, LA				Chao, Anne; Jost, Lou; Hsieh, T. C.; Ma, K. H.; Sherwin, William B.; Rollins, Lee Ann			Expected Shannon Entropy and Shannon Differentiation between Subpopulations for Neutral Genes under the Finite Island Model	PLOS ONE			English	Article							MUTUAL INFORMATION; PHYLOGENETIC DIVERSITY; PARTITIONING DIVERSITY; FUNCTIONAL DIVERSITY; ALLELIC FREQUENCIES; SPECIES-DIVERSITY; POPULATION; NUMBER; INDEX; POLYMORPHISMS	Shannon entropy H and related measures are increasingly used in molecular ecology and population genetics because (1) unlike measures based on heterozygosity or allele number, these measures weigh alleles in proportion to their population fraction, thus capturing a previously-ignored aspect of allele frequency distributions that may be important in many applications; (2) these measures connect directly to the rich predictive mathematics of information theory; (3) Shannon entropy is completely additive and has an explicitly hierarchical nature; and (4) Shannon entropy-based differentiation measures obey strong monotonicity properties that heterozygosity-based measures lack. We derive simple new expressions for the expected values of the Shannon entropy of the equilibrium allele distribution at a neutral locus in a single isolated population under two models of mutation: the infinite allele model and the stepwise mutation model. Surprisingly, this complex stochastic system for each model has an entropy expressable as a simple combination of well-known mathematical functions. Moreover, entropy- and heterozygosity-based measures for each model are linked by simple relationships that are shown by simulations to be approximately valid even far from equilibrium. We also identify a bridge between the two models of mutation. We apply our approach to subdivided populations which follow the finite island model, obtaining the Shannon entropy of the equilibrium allele distributions of the subpopulations and of the total population. We also derive the expected mutual information and normalized mutual information ("Shannon differentiation") between subpopulations at equilibrium, and identify the model parameters that determine them. We apply our measures to data from the common starling (Sturnus vulgaris) in Australia. Our measures provide a test for neutrality that is robust to violations of equilibrium assumptions, as verified on real world data from starlings.	[Chao, Anne; Hsieh, T. C.; Ma, K. H.] Natl Tsing Hua Univ, Inst Stat, Hsinchu, Taiwan; [Jost, Lou] EcoMinga Fdn, Banos, Tungurahua, Ecuador; [Sherwin, William B.] Univ New S Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia; [Sherwin, William B.] Murdoch Univ, Cetacean Res Unit, Murdoch, WA 6150, Australia; [Rollins, Lee Ann] Deakin Univ, Ctr Integrat Ecol, Sch Life & Environm Sci, Geelong, Vic 3217, Australia	National Tsing Hua University; University of New South Wales Sydney; Murdoch University; Deakin University	Chao, A (corresponding author), Natl Tsing Hua Univ, Inst Stat, Hsinchu, Taiwan.	chao@stat.nthu.edu.tw	Rollins, Lee/G-3688-2011; Sherwin, William B B/C-3432-2008	Rollins, Lee/0000-0002-3279-7005; Sherwin, William B B/0000-0002-1578-8473	Mathematics Research Center (of Taiwan Ministry of Science and Technology); Population Biology Foundation; Ministry of Science and Technology, Taiwan [100-2118-M007-006-MY3]	Mathematics Research Center (of Taiwan Ministry of Science and Technology); Population Biology Foundation; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	The Mathematics Research Center (of Taiwan Ministry of Science and Technology), The Population Biology Foundation, and the Ministry of Science and Technology, Taiwan, Contract 100-2118-M007-006-MY3 (http://www.most.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aczel J, 1975, MEASURES INFORM THEI; Allen B, 2009, AM NAT, V174, P236, DOI 10.1086/600101; Andrew RL, 2012, MOL ECOL, V21, P2078, DOI 10.1111/j.1365-294X.2012.05454.x; BARTON NH, 1986, HEREDITY, V56, P409, DOI 10.1038/hdy.1986.63; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Blum MJ, 2012, OECOLOGIA, V168, P83, DOI 10.1007/s00442-011-2078-x; BLYTH CR, 1959, ANN MATH STAT, V30, P71, DOI 10.1214/aoms/1177706360; Brunel H, 2010, BIOINFORMATICS, V26, P1811, DOI 10.1093/bioinformatics/btq273; Buddle CM, 2005, CAN ENTOMOL, V137, P120; Bulit C, 2009, HYDROBIOLOGIA, V624, P29, DOI 10.1007/s10750-008-9664-x; Cadotte MW, 2010, ECOL LETT, V13, P96, DOI 10.1111/j.1461-0248.2009.01405.x; Chanda P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-509; Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727; Chao A, 2008, BIOMETRICS, V64, P1178, DOI 10.1111/j.1541-0420.2008.01010.x; Chao AN, 2014, ANNU REV ECOL EVOL S, V45, P297, DOI 10.1146/annurev-ecolsys-120213-091540; Chao AN, 2013, METHODS ECOL EVOL, V4, P1091, DOI 10.1111/2041-210X.12108; Chao A, 2012, ECOLOGY, V93, P2037, DOI 10.1890/11-1817.1; Chen S, 2013, J HERED, V104, P416, DOI 10.1093/jhered/est015; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Dewar RC, 2011, MOL ECOL, V20, P3156, DOI 10.1111/j.1365-294X.2011.05171.x; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Ellison AM, 2010, ECOLOGY, V91, P1962, DOI 10.1890/09-1692.1; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Fidler AE, 2007, P ROY SOC B-BIOL SCI, V274, P1685, DOI 10.1098/rspb.2007.0337; Gailing O, 2012, BIOCHEM SYST ECOL, V45, P23, DOI 10.1016/j.bse.2012.07.018; Hedrick P.W., 2011, GENETICS POPULATIONS; Higgins SJ, 2006, HDB AUSTR NZ ANTARCT, V7; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; HORN HS, 1966, AM NAT, V100, P419, DOI 10.1086/282436; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Jost Lou, 2011, P66; Jost L, 2010, DIVERS DISTRIB, V16, P65, DOI 10.1111/j.1472-4642.2009.00626.x; Karlin EF, 2011, MOL ECOL, V20, P753, DOI 10.1111/j.1365-294X.2010.04982.x; Keylock CJ, 2005, OIKOS, V109, P203, DOI 10.1111/j.0030-1299.2005.13735.x; KIMURA M, 1964, GENETICS, V49, P725; KIMURA M, 1978, P NATL ACAD SCI USA, V75, P2868, DOI 10.1073/pnas.75.6.2868; KIMURA M, 1975, P NATL ACAD SCI USA, V72, P2761, DOI 10.1073/pnas.72.7.2761; Kitchovitch S, 2009, LECT NOTES COMPUT SC, V5851, P259, DOI 10.1007/978-3-642-11169-3_19; LATTER BDH, 1973, GENETICS, V73, P147; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; MACARTHUR RH, 1965, BIOL REV, V40, P510, DOI 10.1111/j.1469-185X.1965.tb00815.x; MARUYAMA T, 1970, Theoretical Population Biology, V1, P273, DOI 10.1016/0040-5809(70)90047-X; Mellick R, 2011, AUST J BOT, V59, P351, DOI 10.1071/BT10291; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Mueller JC, 2014, MOL ECOL, V23, P2876, DOI 10.1111/mec.12763; Niederstatter H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041885; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; Penner O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014373; Priness I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-111; Renyi A, 1961, ON MEASURES OF ENTRO, V1, P547; Ribeiro AS, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011901; Ricotta C, 2008, COMMUNITY ECOL, V9, P11, DOI 10.1556/ComEc.9.2008.1.2; Rivers MC, 2011, CONSERV GENET, V12, P1333, DOI 10.1007/s10592-011-0234-9; Rollins LA, 2009, THESIS; Rollins LA, 2011, MOL ECOL, V20, P2307, DOI 10.1111/j.1365-294X.2011.05101.x; Rollins LA, 2009, MOL ECOL, V18, P1560, DOI 10.1111/j.1365-294X.2009.04132.x; Rossetto M, 2008, AM J BOT, V95, P321, DOI 10.3732/ajb.95.3.321; Rossetto M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-126; Rousset F, 1996, GENETICS, V142, P1357; Roussett F, 2004, GENETIC STRUCTURE SE; Schall JJ, 2013, PARASITOLOGY, V140, P21, DOI 10.1017/S0031182012001217; Schwanz LE, 2008, P ROY SOC B-BIOL SCI, V275, P2441, DOI 10.1098/rspb.2008.0427; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shapcott A, 2011, AUST J BOT, V59, P215, DOI 10.1071/BT10132; Sherwin WB, 2006, MOL ECOL, V15, P2857, DOI 10.1111/j.1365-294X.2006.02992.x; Sherwin WB, 2010, ENTROPY-SWITZ, V12, P1765, DOI 10.3390/e12071765; Shlush LI, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-47; Smith RD, 2011, ARXIV PREPRINT ARXIV; Swati D, 2007, J BIOSCIENCES, V32, P1169, DOI 10.1007/s12038-007-0119-8; Tsallis C, 2004, CONTINUUM MECH THERM, V16, P223, DOI 10.1007/s00161-004-0174-4; Wagner A, 2008, NAT REV GENET, V9, P965, DOI 10.1038/nrg2473; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Whitlock MC, 1997, GENETICS, V146, P427; Woolnough AP, 2005, OUT BORDER KEEPING S, P183; Wright S, 1931, GENETICS, V16, P0097; Wright S, 1938, P NATL ACAD SCI USA, V24, P253, DOI 10.1073/pnas.24.7.253; Wright S, 1969, EVOLUTION AND THE GE, V2; Wu XS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004578; Xia Z, 2009, BIOINFORMATICS, V25, P2309, DOI 10.1093/bioinformatics/btp423; Yuan XG, 2011, GENES GENOM, V33, P65, DOI 10.1007/s13258-010-0094-6; Zhang J, 2009, INTERNATIONAL JOINT CONFERENCE ON COMPUTATIONAL SCIENCES AND OPTIMIZATION, VOL 1, PROCEEDINGS, P1003, DOI 10.1109/CSO.2009.469; Zhang L, 2009, GENETICA, V137, P355, DOI 10.1007/s10709-009-9399-2	84	31	32	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0125471	10.1371/journal.pone.0125471	http://dx.doi.org/10.1371/journal.pone.0125471			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067448	Green Published, Green Submitted, gold			2022-12-26	WOS:000356100900007
J	Fujisawa, TX; Yatsuga, C; Mabe, H; Yamada, E; Masuda, M; Tomoda, A				Fujisawa, Takashi X.; Yatsuga, Chiho; Mabe, Hiroyo; Yamada, Eiji; Masuda, Masato; Tomoda, Akemi			Anorexia Nervosa during Adolescence Is Associated with Decreased Gray Matter Volume in the Inferior Frontal Gyrus	PLOS ONE			English	Article							INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; STRUCTURAL BRAIN CHANGES; VOXEL-BASED MORPHOMETRY; COGNITIVE CONTROL; CORTEX; INHIBITION; CHILDREN; NEUROBIOLOGY; INFERENCE; RECOVERY	Anorexia nervosa (AN) is an eating disorder characterized by the relentless pursuit to lose weight, mostly through self-starvation, and a distorted body image. AN tends to begin during adolescence among women. However, the underlying neural mechanisms related to AN remain unclear. Using voxel-based morphometry based on magnetic resonance imaging scans, we investigated whether the presence of AN was associated with discernible changes in brain morphology. Participants were 20 un-medicated, right-handed patients with early-onset AN and 14 healthy control subjects. Group differences in gray matter volume (GMV) were assessed using high-resolution, T1-weighted, volumetric magnetic resonance imaging datasets (3T Trio scanner; Siemens AG) and analyzed after controlling for age and total GMV, which was decreased in the bilateral inferior frontal gyrus (IFG) ( left IFG: FWE corrected, p < 0.05; right IFG: uncorrected, p < 0.05) of patients with AN. The GMV in the bilateral IFG correlated significantly with current age (left IFG: r = -.481, p < .05; right IFG: r = -.601, p < .01) and was limited to the AN group. We speculate that decreased IFG volume might lead to deficits in executive functioning or inhibitory control within neural reward systems. Precocious or unbalanced neurological trimming within this particular region might be an important factor for the pathogenesis of AN onset.	[Fujisawa, Takashi X.; Yatsuga, Chiho; Tomoda, Akemi] Univ Fukui, Res Ctr Child Mental Dev, Fukui 910, Japan; [Fujisawa, Takashi X.; Yatsuga, Chiho; Tomoda, Akemi] Chiba Univ, Hamamatsu Univ Sch Med, Kanazawa Univ, Osaka Univ,United Grad Sch Child Dev,Dept Child D, Fukui, Japan; [Mabe, Hiroyo; Yamada, Eiji; Masuda, Masato] Kumamoto Univ, Fac Life Sci, Dept Child Dev, Kumamoto, Japan	University of Fukui; Kanazawa University; Osaka University; Kumamoto University	Tomoda, A (corresponding author), Univ Fukui, Res Ctr Child Mental Dev, Fukui 910, Japan.	atomoda@u-fukui.ac.jp	Fujisawa, Takashi/Z-4461-2019		Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (KAKENHI) [24300149, 25560386, 25750405]; Grants-in-Aid for Scientific Research [25560386] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (B), Young Scientists (B) and Challenging Exploratory Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (KAKENHI: grant numbers 24300149 and 25560386 to Akemi Tomoda, grant number 25750405 to Takashi X, Fujisawa; http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Aron AR, 2014, TRENDS COGN SCI, V18, P177, DOI 10.1016/j.tics.2013.12.003; Asahi S, 2004, EUR ARCH PSY CLIN N, V254, P245, DOI 10.1007/s00406-004-0488-z; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Askenazy F, 1998, BIOL PSYCHIAT, V43, P188, DOI 10.1016/S0006-3223(97)00299-0; Brooks SJ, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-179; Campbell K, 2014, PEDIATRICS, V134, P582, DOI 10.1542/peds.2014-0194; Castro-Fornieles J, 2008, J PSYCHIATR RES, V43, P331, DOI 10.1016/j.jpsychires.2008.03.013; Chowdhury U, 2003, INT J EAT DISORDER, V33, P388, DOI 10.1002/eat.10155; Chui HT, 2008, PEDIATRICS, V122, pE426, DOI 10.1542/peds.2008-0170; DOLAN RJ, 1988, PSYCHOL MED, V18, P349, DOI 10.1017/S0033291700007893; Duann JR, 2009, J NEUROSCI, V29, P10171, DOI 10.1523/JNEUROSCI.1300-09.2009; Fladung AK, 2010, AM J PSYCHIAT, V167, P206, DOI 10.1176/appi.ajp.2009.09010071; Frank GK, 2005, BIOL PSYCHIAT, V58, P908, DOI 10.1016/j.biopsych.2005.05.003; Frank GK, 2004, CNS SPECTRUMS, V9, P539, DOI 10.1017/S1092852900009639; Frank GKW, 2012, NEUROPSYCHOPHARMACOL, V37, P2031, DOI 10.1038/npp.2012.51; Friederich HC, 2012, NEUROIMAGE, V59, P1106, DOI 10.1016/j.neuroimage.2011.09.042; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Galimberti E, 2012, PROG NEURO-PSYCHOPH, V36, P307, DOI 10.1016/j.pnpbp.2011.10.017; Gaudio S, 2011, PSYCHIAT RES-NEUROIM, V191, P24, DOI 10.1016/j.pscychresns.2010.06.007; Golden NH, 1996, J PEDIATR-US, V128, P296, DOI 10.1016/S0022-3476(96)70414-6; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Joos A, 2010, PSYCHIAT RES-NEUROIM, V182, P146, DOI 10.1016/j.pscychresns.2010.02.004; Katzman DK, 1997, ARCH PEDIAT ADOL MED, V151, P793, DOI 10.1001/archpedi.1997.02170450043006; Katzman DK, 1996, J PEDIATR-US, V129, P794, DOI 10.1016/S0022-3476(96)70021-5; Kaye WH, 2013, TRENDS NEUROSCI, V36, P110, DOI 10.1016/j.tins.2013.01.003; Kaye WH, 2009, NAT REV NEUROSCI, V10, P573, DOI 10.1038/nrn2682; King JA, 2015, BIOL PSYCHIAT, V77, P624, DOI 10.1016/j.biopsych.2014.09.005; KOHLMEYER K, 1983, AM J NEURORADIOL, V4, P437; Kohn MR, 1997, ANN NY ACAD SCI, V817, P398, DOI 10.1111/j.1749-6632.1997.tb48238.x; KRIEG JC, 1988, BIOL PSYCHIAT, V23, P377, DOI 10.1016/0006-3223(88)90288-0; Kullmann S, 2014, NEUROIMAGE-CLIN, V4, P615, DOI 10.1016/j.nicl.2014.04.002; Lambe EK, 1997, ARCH GEN PSYCHIAT, V54, P537; Lock J, 2011, AM J PSYCHIAT, V168, P55, DOI 10.1176/appi.ajp.2010.10010056; Luijten M, 2015, PSYCHIAT RES-NEUROIM, V231, P262, DOI 10.1016/j.pscychresns.2015.01.004; Moorhead TWJ, 2005, NEUROIMAGE, V28, P544, DOI 10.1016/j.neuroimage.2005.04.045; Nagamitsu S, 2011, BRAIN DEV-JPN, V33, P35, DOI 10.1016/j.braindev.2009.12.010; Nagamitsu S, 2010, BRAIN DEV-JPN, V32, P162, DOI 10.1016/j.braindev.2009.01.002; Oberndorfer TA, 2011, INT J EAT DISORDER, V44, P1, DOI 10.1002/eat.20750; Schilling C, 2012, NEUROIMAGE, V59, P824, DOI 10.1016/j.neuroimage.2011.07.058; Sheehan DV, 2010, J CLIN PSYCHIAT, V71, P313, DOI 10.4088/JCP.09m05305whi; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sigel Eric, 2008, Adolesc Med State Art Rev, V19, P547; Somerville LH, 2010, CURR OPIN NEUROBIOL, V20, P236, DOI 10.1016/j.conb.2010.01.006; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Talairach J., 1988, COPLANAR STEREOTAXIC; Titova OE, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-110; Tomoda A, 2009, BIOL PSYCHIAT, V66, P642, DOI 10.1016/j.biopsych.2009.04.021; Treasure J, 2010, LANCET, V375, P583, DOI 10.1016/S0140-6736(09)61748-7; Uher R, 2004, AM J PSYCHIAT, V161, P1238, DOI 10.1176/appi.ajp.161.7.1238; Vara AS, 2014, DEV COGN NEUROS-NETH, V10, P129, DOI 10.1016/j.dcn.2014.08.009; Weaver L, 2011, CURR PSYCHIAT REP, V13, P93, DOI 10.1007/s11920-010-0174-y; Wechsler D, 1974, WECHSLER INTELLIGENC; Worsley KJ, 1999, HUM BRAIN MAPP, V8, P98, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<98::AID-HBM5>3.3.CO;2-6	57	25	25	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128548	10.1371/journal.pone.0128548	http://dx.doi.org/10.1371/journal.pone.0128548			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067825	gold, Green Published, Green Submitted			2022-12-26	WOS:000356100900024
J	Johnson, A; Chen, LM; Winne, E; Santana, W; Metcalfe, MG; Mateu-Petit, G; Ridenour, C; Hossain, MJ; Villanueva, J; Zaki, SR; Williams, TL; Cox, NJ; Barr, JR; Donis, RO				Johnson, Adam; Chen, Li-Mei; Winne, Emily; Santana, Wanda; Metcalfe, Maureen G.; Mateu-Petit, Guaniri; Ridenour, Callie; Hossain, M. Jaber; Villanueva, Julie; Zaki, Sherif R.; Williams, Tracie L.; Cox, Nancy J.; Barr, John R.; Donis, Ruben O.			Identification of Influenza A/PR/8/34 Donor Viruses Imparting High Hemagglutinin Yields to Candidate Vaccine Viruses in Eggs	PLOS ONE			English	Article							A VIRUS; PANDEMIC INFLUENZA; MASS-SPECTROMETRY; REVERSE GENETICS; ANTIGEN YIELD; SEED VIRUSES; M2 PROTEIN; PB1 GENE; NEURAMINIDASE; STRAINS	One of the important lessons learned from the 2009 H1N1 pandemic is that a high yield influenza vaccine virus is essential for efficient and timely production of pandemic vaccines in eggs. The current seasonal and pre-pandemic vaccine viruses are generated either by classical reassortment or reverse genetics. Both approaches utilize a high growth virus, generally A/Puerto Rico/8/1934 (PR8), as the donor of all or most of the internal genes, and the wild type virus recommended for inclusion in the vaccine to contribute the hemagglutinin (HA) and neuraminidase (NA) genes encoding the surface glycoproteins. As a result of extensive adaptation through sequential egg passaging, PR8 viruses with different gene sequences and high growth properties have been selected at different laboratories in past decades. The effect of these related but distinct internal PR8 genes on the growth of vaccine viruses in eggs has not been examined previously. Here, we use reverse genetics to analyze systematically the growth and HA antigen yield of reassortant viruses with 3 different PR8 backbones. A panel of 9 different HA/NA gene pairs in combination with each of the 3 different lineages of PR8 internal genes (27 reassortant viruses) was generated to evaluate their performance. Virus and HA yield assays showed that the PR8 internal genes influence HA yields in most subtypes. Although no single PR8 internal gene set outperformed the others in all candidate vaccine viruses, a combination of specific PR8 backbone with individual HA/NA pairs demonstrated improved HA yield and consequently the speed of vaccine production. These findings may be important both for production of seasonal vaccines and for a rapid global vaccine response during a pandemic.	[Johnson, Adam; Chen, Li-Mei; Mateu-Petit, Guaniri; Ridenour, Callie; Hossain, M. Jaber; Villanueva, Julie; Cox, Nancy J.; Donis, Ruben O.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA 30329 USA; [Winne, Emily; Santana, Wanda; Williams, Tracie L.; Barr, John R.] Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Div Sci Lab, Atlanta, GA USA; [Metcalfe, Maureen G.; Zaki, Sherif R.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Chen, LM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA 30329 USA.	bpr5@cdc.gov; rvd6@cdc.gov		Johnson, Adam/0000-0002-3364-1184	US Department of Health and Human Services	US Department of Health and Human Services	The study was funded by the US Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelin A, 2011, VACCINE, V29, P1135, DOI 10.1016/j.vaccine.2010.11.042; Abt M, 2011, VACCINE, V29, P5153, DOI 10.1016/j.vaccine.2011.05.036; Adamo JE, 2009, J VIROL, V83, P4023, DOI 10.1128/JVI.02391-08; [Anonymous], 2003, Wkly Epidemiol Rec, V78, P405; Aubin JT, 2005, EMERG INFECT DIS, V11, P1515; BAEZ M, 1980, J INFECT DIS, V141, P362, DOI 10.1093/infdis/141.3.362; Beale R, 2014, CELL HOST MICROBE, V15, P239, DOI 10.1016/j.chom.2014.01.006; Bialas KM, 2014, J VIROL, V88, P2227, DOI 10.1128/JVI.03354-13; Bin L, 2005, J VIROL, V79, P6763, DOI 10.1128/JVI.79.11.6763-6771.2005; Broadbent AJ, 2011, CURR OPIN VIROL, V1, P254, DOI 10.1016/j.coviro.2011.08.002; Bush RM, 1999, MOL BIOL EVOL, V16, P1457, DOI 10.1093/oxfordjournals.molbev.a026057; Chen HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046378; Cobbin JCA, 2013, J VIROL, V87, P5577, DOI 10.1128/JVI.02856-12; Danieli T, 1996, J CELL BIOL, V133, P559, DOI 10.1083/jcb.133.3.559; de Blasio BF, 2012, PLOS ONE, V7, P327, DOI 10.1371/journal.pone.0030018; de Vries E, 2012, P NATL ACAD SCI USA, V109, P7457, DOI 10.1073/pnas.1200987109; FDA, 2012, SUMM BAS REG ACT FLU; FLUSECURE, 2005, 2 FLUSECURE; Gambaryan AS, 1999, VIROLOGY, V258, P232, DOI 10.1006/viro.1999.9732; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; GREGORY D W, 1973, Journal of Microscopy (Oxford), V99, P251, DOI 10.1111/j.1365-2818.1973.tb04625.x; Harris JR, 2006, MICROSC ANAL, V44, P17; Harvey R, 2008, VACCINE; Harvey R, 2011, J VIROL, V85, P6086, DOI 10.1128/JVI.00096-11; Harvey R, 2010, VACCINE, V28, P8008, DOI 10.1016/j.vaccine.2010.09.006; Hollingsworth TD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001076; Horimoto T, 2006, VACCINE, V24, P3669, DOI 10.1016/j.vaccine.2005.07.005; Horimoto T, 2007, VIROLOGY, V366, P23, DOI 10.1016/j.virol.2007.07.002; Horimoto T, 2006, TRENDS MOL MED, V12, P506, DOI 10.1016/j.molmed.2006.09.003; Jing XH, 2012, VACCINE, V30, P4144, DOI 10.1016/j.vaccine.2012.04.073; Katz G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088288; KILBOURN.ED, 1971, J INFECT DIS, V124, P449, DOI 10.1093/infdis/124.5.449; KILBOURN.ED, 1969, B WORLD HEALTH ORGAN, V41, P643; Lakdawala SS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002443; Matthews J.T., 2006, BRIDGE, DOI DOI 10.1002/jmv.26320; Moules V, 2011, VIROLOGY, V414, P51, DOI 10.1016/j.virol.2011.03.011; Murakami S, 2008, J VIROL, V82, P10502, DOI 10.1128/JVI.00970-08; Naffakh N, 2000, J GEN VIROL, V81, P1283, DOI 10.1099/0022-1317-81-5-1283; Nicolson C, 2012, VACCINE, V30, P745, DOI 10.1016/j.vaccine.2011.11.081; Noda T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2011.00269; PHEMCE, 2012, 2012 PUBL HLTH EM ME; Plant EP, 2012, VACCINE, V31, P207, DOI 10.1016/j.vaccine.2012.10.060; Ramanunninair M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065955; Roberts KL, 2013, J VIROL, V87, P9973, DOI 10.1128/JVI.01363-13; Roberts PC, 1998, VIROLOGY, V240, P127, DOI 10.1006/viro.1997.8916; Robertson JS, 2011, VACCINE, V29, P1836, DOI 10.1016/j.vaccine.2010.12.044; Rossman JS, 2010, J VIROL, V84, P5078, DOI 10.1128/JVI.00119-10; Rudneva IA, 2007, ARCH VIROL, V152, P1139, DOI 10.1007/s00705-006-0931-8; Santana WI, 2014, ANAL CHEM; Seladi-Schulman J, 2013, J VIROL, V87, P13343, DOI 10.1128/JVI.02004-13; Stevens J, 2010, J VIROL, V84, P8287, DOI 10.1128/JVI.00058-10; Subbarao K, 2003, VIROLOGY, V305, P192, DOI 10.1006/viro.2002.1742; Sugita Y, 2011, J GEN VIROL; (U.S.) PsCoAoSaT, 2010, REP PRES REENG INFL; Webby RJ, 2004, LANCET, V363, P1099, DOI 10.1016/S0140-6736(04)15892-3; WHO, 2013, UPD WHO BIOS RISK AS; *WHO, 2006, REV PROD TECHN INFL; WHO-GISRS, 2015, INFL VACC VIR REAG; Widjaja L, 2006, VIROLOGY; Williams TL, 2008, VACCINE, V26, P2510, DOI 10.1016/j.vaccine.2008.03.014; Williams TL, 2012, VACCINE, V30, P2475, DOI 10.1016/j.vaccine.2011.12.056	61	9	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128982	10.1371/journal.pone.0128982	http://dx.doi.org/10.1371/journal.pone.0128982			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068666	Green Submitted, Green Published, gold			2022-12-26	WOS:000356100900038
J	Luo, LQ; Zhu, GF; Xu, HY; Yao, S; Zhou, G; Zhu, YW; Tamada, K; Huang, LQ; Flies, AD; Broadwater, M; Ruff, W; van Deursen, JMA; Melero, I; Zhu, Z; Chen, LP				Luo, Liqun; Zhu, Gefeng; Xu, Haiying; Yao, Sheng; Zhou, Gang; Zhu, Yuwen; Tamada, Koji; Huang, Lanqing; Flies, Andrew D.; Broadwater, Megan; Ruff, William; van Deursen, Jan M. A.; Melero, Ignacio; Zhu, Zhou; Chen, Lieping			B7-H3 Promotes Pathogenesis of Autoimmune Disease and Inflammation by Regulating the Activity of Different T Cell Subsets	PLOS ONE			English	Article							IMMUNE-RESPONSES; MURINE MODEL; COLON-CANCER; B7 FAMILY; IN-VIVO; STIMULATION; ACTIVATION; MEMBER; MOUSE	B7-H3 is a cell surface molecule in the immunoglobulin superfamily that is frequently upregulated in response to autoantigens and pathogens during host T cell immune responses. However, B7-H3's role in the differential regulation of T cell subsets remains largely unknown. Therefore, we constructed a new B7-H3 deficient mouse strain (B7-H3 KO) and evaluated the functions of B7-H3 in the regulation of Th1, Th2, and Th17 subsets in experimental autoimmune encephalomyelitis (EAE), experimental asthma, and collagen-induced arthritis (CIA); these mouse models were used to predict human immune responses in multiple sclerosis, asthma, and rheumatoid arthritis, respectively. Here, we demonstrate that B7-H3 KO mice have significantly less inflammation, decreased pathogenesis, and limited disease progression in both EAE and CIA mouse models when compared with littermates; these results were accompanied by a decrease in IFN-gamma and IL-17 production. In sharp contrast, B7-H3 KO mice developed severe ovalbumin (OVA)-induced asthma with characteristic infiltrations of eosinophils in the lung, increased IL-5 and IL-13 in lavage fluid, and elevated IgE anti-OVA antibodies in the blood. Our results suggest B7-H3 has a costimulatory function on Th1/Th17 but a coinhibitory function on Th2 responses. Our studies reveal that B7-H3 could affect different T cell subsets which have important implications for regulating pathogenesis and disease progression in human autoimmune disease.	[Luo, Liqun] Sun Yat Sen Univ, Inst Immunotherapy, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Gefeng; Zhu, Yuwen; Chen, Lieping] Yale Univ, Sch Med, Dept Immunobiol & Med, New Haven, CT USA; [Xu, Haiying; Zhou, Gang; Tamada, Koji; Huang, Lanqing; Flies, Andrew D.; Broadwater, Megan; Ruff, William] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [van Deursen, Jan M. A.] Mayo Clin, Dept Pediat, Rochester, MN USA; [Melero, Ignacio] Univ Navarra, Dept Med, E-31080 Pamplona, Spain; [Zhu, Zhou] Yale Univ, Sch Med, Dept Med, New Haven, CT USA	Sun Yat Sen University; Yale University; Johns Hopkins University; Mayo Clinic; University of Navarra; Yale University	Luo, LQ (corresponding author), Sun Yat Sen Univ, Inst Immunotherapy, Guangzhou 510275, Guangdong, Peoples R China.	luolq3@mail.sysu.edu.cn; chen.lieping@yale.edu	Flies, Andrew S/Q-7535-2018; Flies, Andrew S/L-3482-2019; Flies, Andrew/B-3122-2008; Melero, Ignacio/T-7600-2019	Flies, Andrew S/0000-0002-4550-1859; Flies, Andrew S/0000-0002-4550-1859; Flies, Andrew/0000-0002-4550-1859; Melero, Ignacio/0000-0002-1360-348X; Ruff, william/0000-0001-5828-6425	985 Project Fund from Sun Yat-Sen University; Guangdong Province Innovative Research Team Program from China [2011Y035]; National Institutes of Health [CA98731, HL107151]; United Technologies Corporation endowed chair from Yale University, USA; NATIONAL CANCER INSTITUTE [R01CA098731, R01CA158202] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107151] Funding Source: NIH RePORTER	985 Project Fund from Sun Yat-Sen University; Guangdong Province Innovative Research Team Program from China; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United Technologies Corporation endowed chair from Yale University, USA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the 985 Project Fund from Sun Yat-Sen University and the Guangdong Province Innovative Research Team Program 2011Y035 from China (LC); National Institutes of Health grant CA98731 (LC) and HL107151 (ZZ), and the United Technologies Corporation endowed chair from Yale University, USA. L. Chen is a member of scientific advisory boards of Pfizer and MedImmune Co. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu R, 2013, IMMUNOL REV, V252, P89, DOI 10.1111/imr.12035; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Chapoval AI, 2001, NAT IMMUNOL, V2, P269, DOI 10.1038/85339; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Fukushima A, 2007, IMMUNOL LETT, V113, P52, DOI 10.1016/j.imlet.2007.07.011; Hashiguchi M, 2008, P NATL ACAD SCI USA, V105, P10495, DOI 10.1073/pnas.0802423105; Hofmeyer KA, 2008, P NATL ACAD SCI USA, V105, P10277, DOI 10.1073/pnas.0805458105; Leitner J, 2009, EUR J IMMUNOL, V39, P1754, DOI 10.1002/eji.200839028; Luo LQ, 2004, J IMMUNOL, V173, P5445, DOI 10.4049/jimmunol.173.9.5445; Lupu CM, 2007, ONCOL REP, V18, P745; Lupu CM, 2006, J GASTROINTEST SURG, V10, P635, DOI 10.1016/j.gassur.2006.02.001; Nagashima O, 2008, J IMMUNOL, V181, P4062, DOI 10.4049/jimmunol.181.6.4062; Prasad DVR, 2004, J IMMUNOL, V173, P2500, DOI 10.4049/jimmunol.173.4.2500; Sevin CM, 2013, AM J RESP CELL MOL, V49, P396, DOI 10.1165/rcmb.2012-0442OC; Steinberger P, 2004, J IMMUNOL, V172, P2352, DOI 10.4049/jimmunol.172.4.2352; Suh WK, 2004, P NATL ACAD SCI USA, V101, P12969, DOI 10.1073/pnas.0405259101; Suh WK, 2003, NAT IMMUNOL, V4, P899, DOI 10.1038/ni967; Sun MY, 2002, J IMMUNOL, V168, P6294, DOI 10.4049/jimmunol.168.12.6294; Sun X, 2003, GENE THER, V10, P1728, DOI 10.1038/sj.gt.3302070; Wang LQ, 2005, EUR J IMMUNOL, V35, P428, DOI 10.1002/eji.200425518; Xu L, 2011, IMMUNOBIOLOGY, V216, P1311, DOI 10.1016/j.imbio.2011.05.013; Yamane H, 2013, IMMUNOL REV, V252, P12, DOI 10.1111/imr.12032; Yamane H, 2012, NAT IMMUNOL, V13, P1037, DOI 10.1038/ni.2431; Yi KH, 2009, IMMUNOL REV, V229, P145, DOI 10.1111/j.1600-065X.2009.00768.x; Zhu YW, 2011, IMMUNITY, V34, P466, DOI 10.1016/j.immuni.2011.04.008	25	30	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0130126	10.1371/journal.pone.0130126	http://dx.doi.org/10.1371/journal.pone.0130126			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26065426	Green Published, gold, Green Submitted			2022-12-26	WOS:000356100900101
J	Repetto-Llamazares, AHV; Larsen, RH; Patzke, S; Fleten, KG; Didierlaurent, D; Pichard, A; Pouget, JP; Dahle, J				Repetto-Llamazares, Ada H. V.; Larsen, Roy H.; Patzke, Sebastian; Fleten, Karianne G.; Didierlaurent, David; Pichard, Alexandre; Pouget, Jean Pierre; Dahle, Jostein			Targeted Cancer Therapy with a Novel Anti-CD37 Beta-Particle Emitting Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma	PLOS ONE			English	Article							B-CELL LYMPHOMA; IBRITUMOMAB TIUXETAN RADIOIMMUNOTHERAPY; ANTIBODY-DRUG CONJUGATE; MONOCLONAL-ANTIBODIES; NUDE-MICE; ANTITUMOR-ACTIVITY; PRETARGETED RADIOIMMUNOTHERAPY; INTERNALIZATION; XENOGRAFTS; RITUXIMAB	Lu-177-DOTA-HH1 (Lu-177-HH1) is a novel anti-CD37 radioimmunoconjugate developed to treat non-Hodgkin lymphoma. Mice with subcutaneous Ramos xenografts were treated with different activities of Lu-177-HH1, Lu-177-DOTA-rituximab (Lu-177-rituximab) and non-specific Lu-177-DOTA-IgG(1) (Lu-177-IgG(1)) and therapeutic effect and toxicity of the treatment were monitored. Significant tumor growth delay and increased survival of mice were observed in mice treated with 530 MBq/kg Lu-177-HH1 as compared with mice treated with similar activities of Lu-177-rituximab or non-specific Lu-177-IgG1, 0.9% NaCl or unlabeled HH1. All mice injected with 530 MBq/kg of Lu-177-HH1 tolerated the treatment well. In contrast, 6 out of 10 mice treated with 530 MBq/kg Lu-177-rituximab experienced severe radiation toxicity. The retention of Lu-177-rituximab in organs of the mononuclear phagocyte system was longer than for Lu-177-HH1, which explains the higher toxicity observed in mice treated with Lu-177-rituximab. In vitro internalization studies showed that Lu-177-HH1 internalizes faster and to a higher extent than Lu-177-rituximab which might be the reason for the better therapeutic effect of Lu-177-HH1.	[Repetto-Llamazares, Ada H. V.; Dahle, Jostein] Nord Nanovector ASA, N-0884 Oslo, Norway; [Repetto-Llamazares, Ada H. V.; Patzke, Sebastian] Oslo Univ Hosp, Inst Canc Res, Dept Radiat Biol, N-0310 Oslo, Norway; [Larsen, Roy H.] Sciencons AS, N-0884 Oslo, Norway; [Fleten, Karianne G.] Oslo Univ Hosp, Inst Canc Res, Dept Tumor Biol, Montebello, N-0310 Oslo, Norway; [Didierlaurent, David] Ctr Rech Canc Toulouse, INSERM, UMR 1037, UPS, F-31062 Toulouse, France; [Pichard, Alexandre; Pouget, Jean Pierre] Univ Montpellier, Inst Natl Sante & Rech Med, Inst Rech Cancerol Montpellier, U896, F-34059 Montpellier, France	University of Oslo; University of Oslo; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Repetto-Llamazares, AHV (corresponding author), Nord Nanovector ASA, Kjelsasveien 168, N-0884 Oslo, Norway.	arepetto@nordicnanovector.com	POUGET, Jean-Pierre/R-6697-2019; Patzke, Sebastian/G-9909-2019; Dahle, Jostein/AAE-7776-2020	POUGET, Jean-Pierre/0000-0001-8551-2029; Patzke, Sebastian/0000-0001-6821-197X; Dahle, Jostein/0000-0002-1447-6005; Pichard, Alexandre/0000-0001-6564-0998	Norwegian Research Council [213633, 219454]; Nordic Nanovector ASA	Norwegian Research Council(Research Council of NorwayEuropean Commission); Nordic Nanovector ASA	This study was partially funded by the Norwegian Research Council (http://www.forskningsradet.no) grant numbers 213633 and 219454 and by Nordic Nanovector ASA (http://www.nordicnanovector.com). Co-authors Ada H. V. Repetto-Llamazares and Jostein Dahle are employed by Nordic Nanovector ASA. Nordic Nanovector ASA provided support in the form of salaries for authors AHVR-L and JD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Roy H. Larsen is affiliated to Sciencons AS. Sciencons AS is a shareholder of Nordic Nanovector ASA. Sciencons AS did not provide support in the form of salary for author RHL, and did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ansell SM, 2014, BLOOD; Beckwith KA, 2014, LEUKEMIA, V28, P1501, DOI 10.1038/leu.2014.32; Beers SA, 2010, BLOOD, V115, P5191, DOI 10.1182/blood-2010-01-263533; Beers SA, 2010, SEMIN HEMATOL, V47, P107, DOI 10.1053/j.seminhematol.2010.01.001; Beum PV, 2011, J IMMUNOL, V187, P3438, DOI 10.4049/jimmunol.1101189; Boross P, 2012, AM J CANCER RES, V2, P676; BRASLAWSKY GR, 1991, CANCER IMMUNOL IMMUN, V33, P367, DOI 10.1007/BF01741596; Brown RS, 1997, NUCL MED BIOL, V24, P657, DOI 10.1016/S0969-8051(97)00099-1; BUCHSBAUM DJ, 1992, CANCER RES, V52, P6476; CAVACINI LA, 1992, CELL IMMUNOL, V144, P296, DOI 10.1016/0008-8749(92)90246-L; Dahle J, 2013, ANTICANCER RES, V33, P85; Davis TA, 2000, J CLIN ONCOL, V18, P3135, DOI 10.1200/JCO.2000.18.17.3135; Deckert J, 2013, BLOOD, V122, P3500, DOI 10.1182/blood-2013-05-505685; EARY JF, 1990, J NUCL MED, V31, P1257; Flinn IW, 2014, BLOOD, V123, P2944, DOI 10.1182/blood-2013-11-531327; Forrer F, 2013, J NUCL MED, V54, P1045, DOI 10.2967/jnumed.112.115170; FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219; FULOP GM, 1990, NATURE, V347, P479, DOI 10.1038/347479a0; GOLDSMITH MA, 1975, CANCER RES, V35, P1354; Gopal AK, 2014, INVEST NEW DRUGS; Graff BA, 2003, BRIT J CANCER, V88, P291, DOI 10.1038/sj.bjc.6600680; Greaves P, 2004, NAT REV DRUG DISCOV, V3, P226, DOI 10.1038/nrd1329; Heider KH, 2011, BLOOD, V118, P4159, DOI 10.1182/blood-2011-04-351932; Kaminski MS, 2005, NEW ENGL J MED, V352, P441, DOI 10.1056/NEJMoa041511; Kaminski MS, 2000, BLOOD, V96, P1259, DOI 10.1182/blood.V96.4.1259.h8001259_1259_1266; KAMINSKI MS, 1992, J CLIN ONCOL, V10, P1696, DOI 10.1200/JCO.1992.10.11.1696; Kvinnsland Y, 2001, RADIAT RES, V155, P288, DOI 10.1667/0033-7587(2001)155[0288:RWAPEM]2.0.CO;2; LINDMO T, 1984, J IMMUNOL METHODS, V72, P77, DOI 10.1016/0022-1759(84)90435-6; Manders JMB, 2002, COMPARATIVE MED, V52, P36; Martin SM, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-49; Mattes MJ, 2008, CLIN CANCER RES, V14, P6154, DOI 10.1158/1078-0432.CCR-08-0404; Michel RB, 2002, CLIN CANCER RES, V8, P2701; Miller WH, 2005, CANCER BIOTHER RADIO, V20, P436, DOI 10.1089/cbr.2005.20.436; Moldenhauer G, 2000, J BIOL REG HOMEOS AG, V14, P281; National Nuclear Data Center, ENSDF DEC DAT MIRD M; Naumovski L, 2005, MOL CANCER THER, V4, P968, DOI 10.1158/1535-7163.MCT-04-0339; NAUTA MM, 1986, BRIT J CANCER, V54, P331, DOI 10.1038/bjc.1986.181; Olson H, 2000, REGUL TOXICOL PHARM, V32, P56, DOI 10.1006/rtph.2000.1399; Oostra DR, 2014, BREAST CANCER-TARGET, V6, P103, DOI 10.2147/BCTT.S67297; Park SI, 2010, BLOOD, V116, P4231, DOI 10.1182/blood-2010-05-282327; Pham T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014498; Postema EJ, 2003, CANCER BIOTHER RADIO, V18, P525, DOI 10.1089/108497803322287592; PRESS OW, 1989, J CLIN ONCOL, V7, P1027, DOI 10.1200/JCO.1989.7.8.1027; PRESS OW, 1993, NEW ENGL J MED, V329, P1219, DOI 10.1056/NEJM199310213291702; PRESS OW, 1989, CANCER RES, V49, P4906; PRESS OW, 1994, BLOOD, V83, P1390; Press OW, 2001, BLOOD, V98, P2535, DOI 10.1182/blood.V98.8.2535; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Repetto-Llamazares A, 2014, ANTICANCER RES, V34, P3263; Repetto-Llamazares AHV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103070; Repetto-Llamazares AHV, 2013, CURR RADIOPHARM, V6, P20, DOI 10.2174/1874471011306010004; Robak T, 2013, 55 AM SOC HEM ANN M; SHARKEY RM, 1990, CANCER RES, V50, pS964; Sieber T, 2003, BRIT J HAEMATOL, V121, P458, DOI 10.1046/j.1365-2141.2003.04305.x; SILOBRCIC V, 1990, INT J CANCER, V45, P325, DOI 10.1002/ijc.2910450220; SMELAND E, 1985, SCAND J IMMUNOL, V21, P205, DOI 10.1111/j.1365-3083.1985.tb01422.x; Vaughan AT, 2014, BLOOD, V123, P669, DOI 10.1182/blood-2013-04-490821; Vervoordeldonk SF, 1996, CANCER IMMUNOL IMMUN, V42, P24, DOI 10.1007/s002620050247; Witzig TE, 2002, J CLIN ONCOL, V20, P3262, DOI 10.1200/JCO.2002.11.017; Witzig TE, 2002, J CLIN ONCOL, V20, P2453, DOI 10.1200/JCO.2002.11.076	60	24	24	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128816	10.1371/journal.pone.0128816	http://dx.doi.org/10.1371/journal.pone.0128816			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26066655	Green Submitted, Green Published, gold			2022-12-26	WOS:000356100900030
J	Tung, YC; Tu, HP; Tsai, WC; Chen, CS; Su, CH; Shi, HY; Lin, CL				Tung, Yi-Ching; Tu, Hung-Pin; Tsai, Wen-Chan; Chen, Cheng-Sheng; Su, Chen-Hsiang; Shi, Hon-Yi; Lin, Chih-Lung			Increased Incidence of Herpes Zoster and Postherpetic Neuralgia in Adult Patients following Traumatic Brain Injury: A Nationwide Population-Based Study in Taiwan	PLOS ONE			English	Article							NUTRITIONAL FACTORS; UNITED-STATES; RISK-FACTORS; EPIDEMIOLOGY; PERSPECTIVE; VACCINATION; DISEASE; IMPACT; COHORT; COSTS	The aims of this study were to estimate the incidences of herpes zoster (HZ) and postherpetic neuralgia (PHN) in patients after traumatic brain injury (TBI). Furthermore, we aimed to explore the risk factors of the development of HZ and PHN in patients after TBI. This population-based, longitudinal analysis was conducted using the Taiwan National Health Insurance Research Database (consisting of 1,000,000 beneficiaries) from 1996 to 2010. Using the longitudinal National Health Insurance Research Database, we conducted a retrospective population-based cohort study to evaluate the incidence of HZ and PHN in adult TBI patients and controls. Kaplan-Meier analysis and Cox regression were used to compare differences in the development of HZ and PHN. The effects of gender, comorbidity and surgery on the risk of HZ and PHN development were assessed by subgroup analyses. Over a 15-year follow-up, the cumulative incidence of HZ in 28,234 TBI patients (604.00/100,000 person-years) was significantly higher than 34,085 controls (322.21/100,000 person-years) (P<0.0001, by log-rank test). Females showed a significantly higher incidence of HZ than males (p for interaction = 0.0010). The time to HZ development in the follow-up period was 5.9 years in TBI patients compared to 9.9 years in the control set (p <0.0001). TBI patients were 2.93 and 2.11 times likely to develop HZ and PHN, respectively, than the general population. The incidences of HZ and PHN in TBI patients were also significantly greater than for controls in the CCI = 0 subgroup. To our knowledge, this is the first population-based cohort study to reveal that TBI is an independent risk factor for HZ and PHN in TBI patients, especially in females. Physician should pay attention to the possibility of HZ and PHN in TBI patients and be aware that HZ vaccination early after brain trauma may lower the incidence of HZ and PHN.	[Tung, Yi-Ching; Tu, Hung-Pin] Kaohsiung Med Univ, Dept Publ Hlth & Environm Med, Coll Med, Kaohsiung, Taiwan; [Tsai, Wen-Chan] Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Cheng-Sheng; Su, Chen-Hsiang] Kaohsiung Med Univ Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Shi, Hon-Yi] Kaohsiung Med Univ Hosp, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan; [Lin, Chih-Lung] Kaohsiung Med Univ Hosp, Dept Neurosurg, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Lin, CL (corresponding author), Kaohsiung Med Univ Hosp, Dept Neurosurg, Kaohsiung, Taiwan.	chihlung1@yahoo.com		Tu, Hung-Pin/0000-0003-1044-2673				Araujo Lara Quirino, 2007, Herpes, V14 Suppl 2, P40; Arvin A, 2005, NEW ENGL J MED, V352, P2266, DOI 10.1056/NEJMp058091; Asadullah K, 1995, Eur J Emerg Med, V2, P184, DOI 10.1097/00063110-199512000-00003; ASADULLAH K, 1995, CRIT CARE MED, V23, P1976, DOI 10.1097/00003246-199512000-00006; Borkar DS, 2013, OPHTHALMOLOGY, V120, P451, DOI 10.1016/j.ophtha.2012.09.007; Chen JY, 2013, INT J EPIDEMIOL, V42, P1873, DOI 10.1093/ije/dyt213; Chen JY, 2012, POPUL HEALTH MANAG, V15, P391, DOI 10.1089/pop.2012.1563; Chen JY, 2009, CLIN J PAIN, V25, P562, DOI 10.1097/AJP.0b013e318193cf32; Chiu HY, 2013, J FORMOS MED ASSOC, V112, P545, DOI 10.1016/j.jfma.2013.06.007; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; DONAHUE JG, 1995, ARCH INTERN MED, V155, P1605, DOI 10.1001/archinte.155.15.1605; Dworkin RH, 2007, CLIN INFECT DIS, V44, pS1, DOI 10.1086/510206; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gnann JW, 2002, NEW ENGL J MED, V347, P340, DOI 10.1056/NEJMcp1302674; Hata A, 2011, INFECTION, V39, P537, DOI 10.1007/s15010-011-0162-0; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jih JS, 2009, ACTA DERM-VENEREOL, V89, P612, DOI 10.2340/00015555-0729; Joesoef RM, 2012, MAYO CLIN PROC, V87, P961, DOI 10.1016/j.mayocp.2012.05.021; Kinchington Paul R, 2012, Herpesviridae, V3, P5, DOI 10.1186/2042-4280-3-5; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; Lesourd B, 2006, P NUTR SOC, V65, P319, DOI 10.1079/PNS2006507; Lin YH, 2010, VACCINE, V28, P1217, DOI 10.1016/j.vaccine.2009.11.029; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Opstelten W, 2009, VACCINE, V27, P192, DOI 10.1016/j.vaccine.2008.10.047; Vila MP, 2014, NUTR HOSP, V29, P3, DOI 10.3305/nh.2014.29.1.6934; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rimland D, 2010, CLIN INFECT DIS, V50, P1000, DOI 10.1086/651078; Ruff RL, 2012, JAMA-J AM MED ASSOC, V308, P2032, DOI 10.1001/jama.2012.14008; SCHMADER K, 1995, J INFECT DIS, V171, P701, DOI 10.1093/infdis/171.3.701; Schmader KE, 2002, CLIN J PAIN, V18, P350, DOI 10.1097/00002508-200211000-00002; Shi HY, 2013, J NEUROSURG, V118, P732, DOI 10.3171/2012.12.JNS12693; Shi HY, 2013, J NEUROSURG, V118, P746, DOI 10.3171/2013.1.JNS121130; Thomas SL, 2004, LANCET INFECT DIS, V4, P26, DOI 10.1016/S1473-3099(03)00857-0; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wung Peter K, 2005, Am J Med, V118, P1416, DOI 10.1016/j.amjmed.2005.06.012; Yang YW, 2011, CAN MED ASSOC J, V183, pE275, DOI 10.1503/cmaj.101137; Yawn BP, 2009, MAYO CLIN PROC, V84, P787, DOI [10.4065/84.9.787, 10.1016/S0025-6196(11)60488-6]	41	10	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129043	10.1371/journal.pone.0129043	http://dx.doi.org/10.1371/journal.pone.0129043			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26065420	Green Published, gold			2022-12-26	WOS:000356100900040
J	Chaubey, G; Kadian, A; Bala, S; Rao, VR				Chaubey, Gyaneshwer; Kadian, Anurag; Bala, Saroj; Rao, Vadlamudi Raghavendra			Genetic Affinity of the Bhil, Kol and Gond Mentioned in Epic Ramayana	PLOS ONE			English	Article							Y-CHROMOSOME; POPULATION; INDIA; SOUTH; DIVERSITY; LANDSCAPE; DIFFUSION; INFERENCE; ASIA	Kol, Bhil and Gond are some of the ancient tribal populations known from the Ramayana, one of the Great epics of India. Though there have been studies about their affinity based on classical and haploid genetic markers, the molecular insights of their relationship with other tribal and caste populations of extant India is expected to give more clarity about the the question of continuity vs. discontinuity. In this study, we scanned >97,000 of single nucleotide polymorphisms among three major ancient tribes mentioned in Ramayana, namely Bhil, Kol and Gond. The results obtained were then compared at inter and intra population levels with neighboring and other world populations. Using various statistical methods, our analysis suggested that the genetic architecture of these tribes (Kol and Gond) was largely similar to their surrounding tribal and caste populations, while Bhil showed closer affinity with Dravidian and Austroasiatic (Munda) speaking tribes. The haplotype based analysis revealed a massive amount of genome sharing among Bhil, Kol, Gond and with other ethnic groups of South Asian descent. On the basis of genetic component sharing among different populations, we anticipate their primary founding over the indigenous Ancestral South Indian (ASI) component has prevailed in the genepool over the last several thousand years.	[Chaubey, Gyaneshwer] Estonian Bioctr, EE-51010 Tartu, Estonia; [Bala, Saroj] I SERVE Delhi Chapter, Inst Sci Res Vedas, Gurgaon 122011, India; [Rao, Vadlamudi Raghavendra] Univ Delhi, Dept Anthropol, Delhi 110007, India	Estonian Biocentre; University of Delhi	Chaubey, G (corresponding author), Estonian Bioctr, Riia23, EE-51010 Tartu, Estonia.	gyanc@ebc.ee	Chaubey, Gyaneshwer/AAC-6409-2019	Chaubey, Gyaneshwer/0000-0003-2899-3852	Center of Excellence of Estonian Biocentre and Institutional Grant [IUT24-1]	Center of Excellence of Estonian Biocentre and Institutional Grant	The authors received no specific funding for this work. GC is supported by Center of Excellence of Estonian Biocentre and Institutional Grant IUT24-1.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Achar BN, 2000, INDIAN J HIST SCI, V35, P73; Agrawal D, 1995, DEMISE ARYAN INVASIO; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; [Anonymous], 2013, ENCY HIND; Behar DM, 2010, NATURE, V466, P238, DOI 10.1038/nature09103; Bhatia H, 1986, GENETIC ALTAS INDIAN, P242; Bhatt G, 1975, CRITICAL EDITION COM; Boivin N, 2007, VERTEBR PALEOBIOL PA, P341, DOI 10.1007/1-4020-5562-5_15; Browning BL, 2009, AM J HUM GENET, V85, P847, DOI 10.1016/j.ajhg.2009.11.004; Bryant Edwin, 2005, INDO ARYAN CONTROVER; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; Chandrasekar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007447; Chattopadhyaya B, 2003, STUDYING EARLY INDIA; Chaubey G., 2010, DEMOGRAPHIC HIST IND; Chaubey G, 2008, INT J HUM GENET, V8, P41, DOI 10.1080/09723757.2008.11886018; Chaubey G, 2007, BIOESSAYS, V29, P91, DOI 10.1002/bies.20525; Chaubey G, 2014, EUR J HUM GENET, V22, P1404, DOI 10.1038/ejhg.2014.36; Chaubey G, 2011, MOL BIOL EVOL, V28, P1013, DOI 10.1093/molbev/msq288; COCKERHAM CC, 1984, BIOMETRICS, V40, P157, DOI 10.2307/2530754; Felsenstein J, 1993, DOCUMENTATION PHYLIP; Frawley D, 2001, RIG VEDA HIST INDIA; Gazi NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075064; Govind H, 1961, INDEX V RAMAYANA 2 V; Guruge Ananda W P, 1991, SOC RAMAYANA; Kazanas N, 1999, RGVEDA INDOEUROPEANS; Kennedy K., 1995, INDO ARYANS ANCIENT, P33; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Krithika S, 2009, AM J PHYS ANTHROPOL, V139, P533, DOI 10.1002/ajpa.21018; Kumar BB., 2005, NAGA IDENTITY; Kumar V, 2008, INT J HUM GENET, V8, P31, DOI 10.1080/09723757.2008.11886017; Lal B., 1997, EARLIEST CIVILIZATIO; Lal B, 2009, DEEP ROOTS INDIAN CI; Lal BB, 2005, HOMELAND ARYANS EVID; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Mastana SS, 2014, ANN HUM BIOL, V41, P287, DOI 10.3109/03014460.2014.922615; MASTANA SS, 1994, ANN HUM BIOL, V21, P241, DOI 10.1080/03014469400003252; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Metspalu M, 2011, AM J HUM GENET, V89, P731, DOI 10.1016/j.ajhg.2011.11.010; Moorjani P, 2013, AM J HUM GENET, V93, P422, DOI 10.1016/j.ajhg.2013.07.006; MOUNTAIN JL, 1995, AM J HUM GENET, V56, P979; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Poddar HP., SRI RAMCHARITMANAS; Poliakov L, 1974, THE ARYAN MYTH; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qamar R, 2002, AM J HUM GENET, V70, P1107, DOI 10.1086/339929; Quintana-Murci L, 2004, AM J HUM GENET, V74, P827, DOI 10.1086/383236; Ramadas G, 1925, MAN INDIA, V5, P1; Raychaudhuri H, 2006, POLITICAL HIST ANCIE; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; RENFREW C, 1991, J ROY ASIATIC SOC, V1, P106, DOI 10.1017/S1356186300000080; Russell, 1916, TRIBES CASTES CENTRA, V4; Sahoo S, 2006, P NATL ACAD SCI USA, V103, P843, DOI 10.1073/pnas.0507714103; Saroj Bala, 2012, HIST VEDIC RAMAYAN E; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; Shaffer J. G., 1984, PEOPLE S ASIA BIOL A, P77; Sharma G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032546; Sharma K, 1967, TULASIDAS RAMAYANA; Singh KS, 1997, PEOPLE OF INDIA; Talageri S, 2000, RIGVEDA HIST ANAL; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thangaraj K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015283; Thanseem I, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-42; Thapar Romila, 1978, ANCIENT INDIAN SOCIA; Tiwari SK, 2002, TRIBAL ROOTS HINDUIS; Trivedi R, 2008, INT J HUM GENET, V8, P97, DOI 10.1080/09723757.2008.11886023; Vidyarthi LP, 1977, TRIBAL CULTURE INDIA; Wheeler M, 1979, ANCIENT CITIES INDUS; Witzel M., 2005, LINGUISTICS ARCHAEOL, P87; Xing JC, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r113; Yunusbayev B, 2012, MOL BIOL EVOL, V29, P359, DOI 10.1093/molbev/msr221	74	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0127655	10.1371/journal.pone.0127655	http://dx.doi.org/10.1371/journal.pone.0127655			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061398	gold, Green Submitted, Green Published			2022-12-26	WOS:000355979500048
J	Doudna, JW; Danielson, BJ				Doudna, John W.; Danielson, Brent J.			Rapid Morphological Change in the Masticatory Structures of an Important Ecosystem Service Provider	PLOS ONE			English	Article							PEROMYSCUS-MANICULATUS; SIZE ALLOMETRY; BITE FORCE; PLASTICITY; EVOLUTION; WILD; FOOD; POPULATION; ADAPTATION; PREDATION	Humans have altered the biotic and abiotic environmental conditions of most organisms. In some cases, such as intensive agriculture, an organism's entire ecosystem is converted to novel conditions. Thus, it is striking that some species continue to thrive under such conditions. The prairie deer mouse (Peromyscus maniculatus bairdii) is an example of such an organism, and so we sought to understand what role evolutionary adaptation played in the success of this species, with particular interest in adaptations to novel foods. In order to understand the evolutionary history of this species' masticatory structures, we examined the maxilla, zygomatic plate, and mandible of historic specimens collected prior to 1910 to specimens collected in 2012 and 2013. We found that mandibles, zygomatic plates, and maxilla have all changed significantly since 1910, and that morphological development has shifted significantly. We present compelling evidence that these differences are due to natural selection as a response to a novel and ubiquitous food source, waste grain (corn, Zea mays and soybean, Glycine max).	[Doudna, John W.; Danielson, Brent J.] Iowa State Univ, Ecol Evolut & Organismal Biol Dept, Ames, IA 50011 USA	Iowa State University	Doudna, JW (corresponding author), Iowa State Univ, Ecol Evolut & Organismal Biol Dept, Ames, IA 50011 USA.	jdoudna@iastate.edu			American Society of Mammalogists	American Society of Mammalogists	JWD received funding from the American Society of Mammalogists Grants-In-Aid (no award number, http://www.mammalsociety.org/committees/grants-aid/#tab6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Alexander HM, 2001, AM J BOT, V88, P623, DOI 10.2307/2657061; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson PSL, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-85; Baverstock H, 2013, J ANAT, V223, P46, DOI 10.1111/joa.12059; BERRY RJ, 1964, EVOLUTION, V18, P468, DOI 10.2307/2406357; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Brown CR, 2013, CURR BIOL, V23, pR233, DOI 10.1016/j.cub.2013.02.023; CLARK WR, 1986, J SOIL WATER CONSERV, V41, P338; Cucchi T, 2014, EVOLUTION, V68, P2804, DOI 10.1111/evo.12476; Davis JL, 2010, J EXP BIOL, V213, P1844, DOI 10.1242/jeb.041129; Desrochers A, 2010, ECOLOGY, V91, P1577, DOI 10.1890/09-2202.1; Doudna J. W., 2014, THESIS IOWA STAT U; Forsman A, 1996, EVOLUTION, V50, P2536, DOI 10.1111/j.1558-5646.1996.tb03642.x; Foster MA, 2010, J WILDLIFE MANAGE, V74, P489, DOI 10.2193/2008-588; GOODALL C, 1991, J ROY STAT SOC B MET, V53, P285, DOI 10.1111/j.2517-6161.1991.tb01825.x; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Jackson D. L., 2002, FARM NATURAL HABITAT, P140; Klingenberg CP, 2013, HYSTRIX, V24, P15, DOI 10.4404/hystrix-24.1-7691; Lopez M. S., 2013, J HERPETOL, V23, P431; Magnhagen C, 2001, FUNCT ECOL, V15, P754, DOI 10.1046/j.0269-8463.2001.00576.x; McPhee ME, 2004, J MAMMAL, V85, P1130, DOI 10.1644/BPR-017.1; Mitteroecker P, 2004, J HUM EVOL, V46, P679, DOI 10.1016/j.jhevol.2004.03.006; Myers P, 1996, J MORPHOL, V229, P229, DOI 10.1002/(SICI)1097-4687(199608)229:2<229::AID-JMOR7>3.0.CO;2-W; Palkovacs EP, 2012, EVOL APPL, V5, P183, DOI 10.1111/j.1752-4571.2011.00212.x; Pergams ORW, 1999, EVOLUTION, V53, P1573, DOI 10.1111/j.1558-5646.1999.tb05420.x; Piras P, 2013, SYST BIOL, V62, P878, DOI 10.1093/sysbio/syt053; R Core Team, 2021, R LANGUAGE ENV STAT; Renaud S, 2010, J ZOOL SYST EVOL RES, V48, P138, DOI 10.1111/j.1439-0469.2009.00527.x; Reznick DN, 2001, GENETICA, V112, P183, DOI 10.1023/A:1013352109042; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rohlf FJ, 2013, TPSDIG2 VERSION 2 17; Samson FB, 2004, WILDLIFE SOC B, V32, P6, DOI 10.2193/0091-7648(2004)32[6:GPEPPA]2.0.CO;2; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; VICKERY WL, 1994, ANIM BEHAV, V47, P55, DOI 10.1006/anbe.1994.1007; Wal EV, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0090; Westerman PR, 2008, J APPL ECOL, V45, P1612, DOI 10.1111/j.1365-2664.2008.01481.x; WHITAKER JO, 1966, J MAMMAL, V47, P473, DOI 10.2307/1377688; Williams CL, 2009, WEED RES, V49, P439, DOI 10.1111/j.1365-3180.2009.00715.x; WILLIAMS CK, 1989, J ANIM ECOL, V58, P495, DOI 10.2307/4844; Williams SH, 2009, J MORPHOL, V270, P1338, DOI 10.1002/jmor.10761; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1	42	7	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0127218	10.1371/journal.pone.0127218	http://dx.doi.org/10.1371/journal.pone.0127218			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061880	Green Published, Green Submitted, gold			2022-12-26	WOS:000355979500028
J	Kim, SY; Kim, AR; Han, KH; Kim, MY; Jeon, EH; Koo, JW; Oh, SH; Choi, BY				Kim, So Young; Kim, Ah Reum; Han, Kyu Hee; Kim, Min Young; Jeon, Eun-Hee; Koo, Ja-Won; Oh, Seung Ha; Choi, Byung Yoon			Residual Hearing in DFNB1 Deafness and Its Clinical Implication in a Korean Population	PLOS ONE			English	Article							GJB2 CONNEXIN-26 DEAFNESS; GENOTYPE-PHENOTYPE CORRELATION; SENSORINEURAL DEAFNESS; MUTATIONS; IMPAIRMENT; CHILDREN; PATHOGENICITY; PENETRANCE; IDENTIFY; SPECTRUM	Introduction The contribution of Gap junction beta-2 protein (GJB2) to the genetic load of deafness and its mutation spectra vary among different ethnic groups. Objective In this study, the mutation spectrum and audiologic features of patients with GJB2 mutations were evaluated with a specific focus on residual hearing. Methods An initial cohort of 588 subjects from 304 families with varying degrees of hearing loss were collected at the otolaryngology clinics of Seoul National University Hospital and Seoul National University Bundang Hospital from September 2010 through January 2014. GJB2 sequencing was carried out for 130 probands with sporadic or autosomal recessive non syndromic hearing loss. The audiograms were evaluated in the GJB2 mutants. Results Of the 130 subjects, 22 (16.9%) were found to carry at least one mutant allele of GJB2. The c.235delC mutation was shown to have the most common allele frequency (39.0%) among GJB2 mutations, followed by p.R143W (26.8%) and p.V37I (9.8%). Among those probands without the p.V37I allele in a trans configuration who showed some degree of residual hearing, the mean air conduction thresholds at 250 and 500 Hz were 57 dB HL and 77.8 dB HL, respectively. The c.235delC mutation showed a particularly wide spectrum of hearing loss, from mild to profound and significantly better hearing thresholds at 250 Hz and 2k Hz than in the non-p.V37I and non-235delC nonsyndromic hearing loss and deafness 1(DFNB1) subjects. Conclusion Despite its reputation as the cause of severe to profound deafness, c.235delC, the most frequent DFNB1 mutation in our cohort, caused a wide range of hearing loss with some residual hearing in low frequencies. This finding can be of paramount help for prediction of low frequency hearing thresholds in very young DFNB1 patients and highlights the importance of soft surgery for cochlear implantation in these patients.	[Kim, So Young; Kim, Ah Reum; Oh, Seung Ha] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Han, Kyu Hee] Natl Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Kim, Min Young; Jeon, Eun-Hee; Koo, Ja-Won; Choi, Byung Yoon] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Songnam, South Korea; [Koo, Ja-Won; Oh, Seung Ha; Choi, Byung Yoon] Seoul Natl Univ, Med Res Ctr, Sensory Organ Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; National Medical Center - Korea; Seoul National University (SNU); Seoul National University (SNU)	Choi, BY (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Songnam, South Korea.	choiby@snubh.org			Korean Healthcare Technology R&D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea [HI14C1867]; Seoul National University Bundang Hospital Research Fund [06-2011-024]	Korean Healthcare Technology R&D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea; Seoul National University Bundang Hospital Research Fund	This study was supported by the Korean Healthcare Technology R&D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea (HI14C1867), and the Seoul National University Bundang Hospital Research Fund (06-2011-024 to B.-Y. Choi). The funding bodies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartsch O, 2010, AUDIOL NEURO-OTOL, V15, P375, DOI 10.1159/000297216; Choi BY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068692; Cohn ES, 1999, PEDIATRICS, V103, P546, DOI 10.1542/peds.103.3.546; Cryns K, 2004, J MED GENET, V41, P147, DOI 10.1136/jmg.2003.013896; Dai P, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-26; Danilenko N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036354; Green GE, 2000, JAMA-J AM MED ASSOC, V284, P1245, DOI 10.1001/jama.284.10.1245; Hayashi C, 2011, INT J PEDIATR OTORHI, V75, P211, DOI 10.1016/j.ijporl.2010.11.001; Houseman MJ, 2001, J MED GENET, V38, P20, DOI 10.1136/jmg.38.1.20; Huculak C, 2006, AM J MED GENET A, V140A, P2394, DOI 10.1002/ajmg.a.31486; Janecke AR, 2002, HUM GENET, V111, P145, DOI 10.1007/s00439-002-0762-y; Karamert R, 2011, INT J PEDIATR OTORHI, V75, P1572, DOI 10.1016/j.ijporl.2011.09.010; Kawasaki A, 2006, INT J PEDIATR OTORHI, V70, P1343, DOI 10.1016/j.ijporl.2006.01.010; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Kenna MA, 2001, ARCH OTOLARYNGOL, V127, P1037, DOI 10.1001/archotol.127.9.1037; Kim SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061592; Liu XZ, 2005, EAR HEARING, V26, P361, DOI 10.1097/00003446-200506000-00011; Liu XZ, 2001, ANN OTO RHINOL LARYN, V110, P356, DOI 10.1177/000348940111000412; Martines F, 2014, EUROPEAN ARCH OTO RH; Mese G, 2004, HUM GENET, V115, P191, DOI 10.1007/s00439-004-1142-6; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Nadeau JH, 2001, NAT REV GENET, V2, P165, DOI 10.1038/35056009; Norris VW, 2006, EAR HEARING, V27, P732, DOI 10.1097/01.aud.0000240492.78561.d3; Oguchi T, 2005, J HUM GENET, V50, P76, DOI 10.1007/s10038-004-0223-7; Pagarkar W, 2006, INT J PEDIATR OTORHI, V70, P1119, DOI 10.1016/j.ijporl.2005.10.026; Park HJ, 2000, LARYNGOSCOPE, V110, P1535, DOI 10.1097/00005537-200009000-00023; Park JH, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0167-8; Petersen MB, 2012, INT J PEDIATR OTORHI, V76, P549, DOI 10.1016/j.ijporl.2012.01.014; Pollak A, 2007, AM J MED GENET A, V143A, P2534, DOI 10.1002/ajmg.a.31982; Popov TM, 2014, AUDITORY OUTCOME COC; Radulescu L, 2012, INT J PEDIATR OTORHI, V76, P90, DOI 10.1016/j.ijporl.2011.10.007; Rebscher SJ, 2008, J REHABIL RES DEV, V45, P731, DOI 10.1682/JRRD.2007.08.0119; Santos RLP, 2005, INT J PEDIATR OTORHI, V69, P165, DOI 10.1016/j.ijporl.2004.08.015; Sinnathuray AR, 2004, OTOL NEUROTOL, V25, P935, DOI 10.1097/00129492-200411000-00013; Snoeckx RL, 2005, AM J HUM GENET, V77, P945, DOI 10.1086/497996; Tsukada K, 2010, CLIN GENET, V78, P464, DOI 10.1111/j.1399-0004.2010.01407.x; Yan D, 2003, HUM GENET, V114, P44, DOI 10.1007/s00439-003-1018-1; Yoshikawa S, 2011, AURIS NASUS LARYNX, V38, P444, DOI 10.1016/j.anl.2010.11.012	38	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0125416	10.1371/journal.pone.0125416	http://dx.doi.org/10.1371/journal.pone.0125416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061264	gold, Green Published, Green Submitted			2022-12-26	WOS:000355979500010
J	Poff, AM; Ward, N; Seyfried, TN; Arnold, P; D'Agostino, DP				Poff, A. M.; Ward, N.; Seyfried, T. N.; Arnold, P.; D'Agostino, D. P.			Non-Toxic Metabolic Management of Metastatic Cancer in VM Mice: Novel Combination of Ketogenic Diet, Ketone Supplementation, and Hyperbaric Oxygen Therapy	PLOS ONE			English	Article							MEDIUM-CHAIN TRIGLYCERIDES; HYPEROXIA RETARDS GROWTH; MALIGNANT BRAIN CANCER; LOW-CARBOHYDRATE DIETS; BLOOD-GLUCOSE LEVELS; RAT MAMMARY-TUMORS; MOUSE MODEL; WEIGHT-LOSS; (R)-3-HYDROXYBUTYL (R)-3-HYDROXYBUTYRATE; GLIOBLASTOMA-MULTIFORME	The Warburg effect and tumor hypoxia underlie a unique cancer metabolic phenotype characterized by glucose dependency and aerobic fermentation. We previously showed that two non-toxic metabolic therapies - the ketogenic diet with concurrent hyperbaric oxygen (KD+ HBOT) and dietary ketone supplementation - could increase survival time in the VM-M3 mouse model of metastatic cancer. We hypothesized that combining these therapies could provide an even greater therapeutic benefit in this model. Mice receiving the combination therapy demonstrated a marked reduction in tumor growth rate and metastatic spread, and lived twice as long as control animals. To further understand the effects of these metabolic therapies, we characterized the effects of high glucose (control), low glucose (LG), ketone supplementation (beta HB), hyperbaric oxygen (HBOT), or combination therapy (LG+beta HB+HBOT) on VM-M3 cells. Individually and combined, these metabolic therapies significantly decreased VM-M3 cell proliferation and viability. HBOT, alone or in combination with LG and beta HB, increased ROS production in VM-M3 cells. This study strongly supports further investigation into this metabolic therapy as a potential non-toxic treatment for late-stage metastatic cancers.	[Poff, A. M.; Ward, N.; D'Agostino, D. P.] Univ S Florida, Dept Mol Pharmacol & Physiol, Morsani Coll Med, Hyperbar Biomed Res Lab, Tampa, FL 33620 USA; [Seyfried, T. N.] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA; [Arnold, P.] Savind Inc, Seymour, IL USA	State University System of Florida; University of South Florida; Boston College	Poff, AM (corresponding author), Univ S Florida, Dept Mol Pharmacol & Physiol, Morsani Coll Med, Hyperbar Biomed Res Lab, Tampa, FL 33620 USA.	abennett@health.usf.edu	D'Agostino, Dominic/GPJ-9744-2022; D'Agostino, Dominic/I-6194-2012	Ward, Nathan/0000-0003-4920-0081; Seyfried, Thomas/0000-0003-1491-3989	University of South Florida; USF [ONR N000140910244]; Scivation, Inc.	University of South Florida; USF; Scivation, Inc.	Patent 12B152PRWO; University of South Florida; D. P. D'Agostino, A. Poff, P. Arnold, "Targeting cancer with metabolic therapy and hyperbaric oxygen." P. Arnold (Savind Inc.) has received financial support (ONR N000140910244) from D. D'Agostino (USF) to synthesize ketone esters. The remaining authors have no conflicts of interest. Funding for this project was supported in part by a charitable contribution from Scivation, Inc.; however, the company did not influence study design, data collection, analysis, or interpretation of results. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahab MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036197; Al-Waili NS, 2006, ARCH MED RES, V37, P991, DOI 10.1016/j.arcmed.2006.05.009; Al-Waili NS, 2005, MED SCI MONITOR, V11, pRA279; Allen BG, 2013, CLIN CANCER RES, V19, P3905, DOI 10.1158/1078-0432.CCR-12-0287; Aykin-Burns N, 2009, BIOCHEM J, V418, P29, DOI 10.1042/BJ20081258; Barbara AM, 1979, AUSTR J EXPT BIOL ME, V57, DOI [10.1038/icb.1979.54, DOI 10.1038/ICB.1979.54]; BASSETT DJP, 1979, J APPL PHYSIOL, V46, P943, DOI 10.1152/jappl.1979.46.5.943; Bayley JP, 2012, CURR OPIN ONCOL, V24, P62, DOI 10.1097/CCO.0b013e32834deb9e; Becker A, 2002, STRAHLENTHER ONKOL, V178, P105, DOI 10.1007/s00066-002-0892-0; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Bennett M, 2008, CANCER TREAT REV, V34, P577, DOI 10.1016/j.ctrv.2008.01.001; Bennewith KL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-504; Beppu T, 2002, J NEURO-ONCOL, V58, P47, DOI 10.1023/A:1015832726054; Bianchini F, 2002, LANCET ONCOL, V3, P565, DOI 10.1016/S1470-2045(02)00849-5; Boveris A, 2000, ANN NY ACAD SCI, V899, P121; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Cahill George F Jr, 2003, Trans Am Clin Climatol Assoc, V114, P149; Champ CE, 2014, J NEURO-ONCOL, V117, P125, DOI 10.1007/s11060-014-1362-0; Chang HT, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-47; Clarke K, 2012, REGUL TOXICOL PHARM, V63, P401, DOI 10.1016/j.yrtph.2012.04.008; Clarke K, 2012, REGUL TOXICOL PHARM, V63, P196, DOI 10.1016/j.yrtph.2012.04.001; CONTRERAS FL, 1988, J NEUROSURG, V68, P137, DOI 10.3171/jns.1988.68.1.0137; D'Agostino D, 2012, 3 INT S DIET THER EP; D'Agostino DP, 2007, J NEUROPHYSIOL, V98, P1030, DOI 10.1152/jn.01003.2006; D'Agostino DP, 2013, AM J PHYSIOL-REG I, V304, pR829, DOI 10.1152/ajpregu.00506.2012; Daruwalla J, 2006, WORLD J SURG, V30, P2112, DOI 10.1007/s00268-006-0190-6; DEDOV I I, 1987, Problemy Endokria, V33, P10; Dhup S, 2012, CURR PHARM DESIGN, V18, P1319, DOI 10.2174/138161212799504902; FEARON KCH, 1988, ANN SURG, V208, P1, DOI 10.1097/00000658-198807000-00001; Feldmeier JJ, 2012, UNDERSEA HYPERBAR M, V39, P1121; Fine EJ, 2012, NUTRITION, V28, P1028, DOI 10.1016/j.nut.2012.05.001; Fine EJ, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-14; Gasior M, 2006, BEHAV PHARMACOL, V17, P431, DOI 10.1097/00008877-200609000-00009; Ghattass K, 2013, CURR CANCER DRUG TAR, V13, P670, DOI 10.2174/15680096113139990004; Gill AL, 2004, QJM-INT J MED, V97, P385, DOI 10.1093/qjmed/hch074; Gillies RJ, 2008, J NUCL MED, V49, p24S, DOI 10.2967/jnumed.107.047258; GRAY LH, 1953, BRIT J RADIOL, V26, P638, DOI 10.1259/0007-1285-26-312-638; Groesbeck DK, 2006, DEV MED CHILD NEUROL, V48, P978, DOI 10.1111/j.1469-8749.2006.tb01269.x; Hoogsteen IJ, 2007, CLIN ONCOL-UK, V19, P385, DOI 10.1016/j.clon.2007.03.001; Hutton JL, 2006, AM J CLIN NUTR, V84, P1163, DOI 10.1093/ajcn/84.5.1163; Huysentruyt LC, 2008, INT J CANCER, V123, P73, DOI 10.1002/ijc.23492; Huysentruyt LC, 2010, INT J CANCER, V126, P65, DOI 10.1002/ijc.24649; Kashiwaya Y, 2013, NEUROBIOL AGING, V34, P1530, DOI 10.1016/j.neurobiolaging.2012.11.023; Kesl S., 2014, METHODS SUSTAINING D; Kohshi K, 1999, BRIT J CANCER, V80, P236, DOI 10.1038/sj.bjc.6690345; Krikorian R, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.10.006; Lim E, 2009, JOVE-J VIS EXP, V1210, DOI [10.3791/1210, DOI 10.3791/1210]; Louie SM, 2013, BBA-MOL CELL BIOL L, V1831, P1499, DOI 10.1016/j.bbalip.2013.02.008; Lum JJ, 2007, GENE DEV, V21, P1037, DOI 10.1101/gad.1529107; Lv MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115147; Lyssiotis CA, 2012, CELL DEATH DIS, V3, DOI [10.1038/cddis.2012.41, 10.1038/cddis.2012.75]; Mabjeesh NJ, 2007, HISTOL HISTOPATHOL, V22, P559, DOI 10.14670/HH-22.559; Manninen AH, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-9; Marin-Hernandez A, 2009, MINI-REV MED CHEM, V9, P1084, DOI 10.2174/138955709788922610; Marsh J, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-33; Masko EM, 2010, CANCER PREV RES, V3, P1124, DOI 10.1158/1940-6207.CAPR-10-0071; Maurer GD, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-315; Meijer TWH, 2012, CLIN CANCER RES, V18, P5585, DOI 10.1158/1078-0432.CCR-12-0858; Moen I, 2012, TARGET ONCOL, V7, P233, DOI 10.1007/s11523-012-0233-x; Moen I, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-446; Moen I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006381; MULLIGAN HD, 1991, BIOCHEM J, V277, P321, DOI 10.1042/bj2770321; NEBELING LC, 1995, J AM DIET ASSOC, V95, P693, DOI 10.1016/S0002-8223(95)00189-1; Otto C, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-122; Paoli A, 2013, EUR J CLIN NUTR, V67, P789, DOI 10.1038/ejcn.2013.116; Paoli A, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-34; PATRONAS NJ, 1985, J NEUROSURG, V62, P816, DOI 10.3171/jns.1985.62.6.0816; Peleg RK, 2013, DIVING HYPERB MED, V43, P218; Poff AM, 2014, INT J CANCER, V135, P1711, DOI 10.1002/ijc.28809; Poff AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065522; Raa A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-23; Rebucci M, 2013, BIOCHEM PHARMACOL, V85, P1219, DOI 10.1016/j.bcp.2013.02.017; Robey IF, 2005, NEOPLASIA, V7, P324, DOI 10.1593/neo.04430; Rohwer N, 2011, DRUG RESIST UPDATE, V14, P191, DOI 10.1016/j.drup.2011.03.001; Schmidt M, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-54; Schoen PJ, 2007, ORAL ONCOL, V43, P379, DOI 10.1016/j.oraloncology.2006.04.009; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Seyfried T.N., 2012, CANC METABOLIC DIS O; Seyfried TN, 2015, CANCER LETT, V356, P289, DOI 10.1016/j.canlet.2014.07.015; Seyfried TN, 2014, CARCINOGENESIS, V35, P515, DOI 10.1093/carcin/bgt480; Seyfried TN, 2011, BBA-BIOENERGETICS, V1807, P577, DOI 10.1016/j.bbabio.2010.08.009; Shelton LM, 2010, INT J CANCER, V127, P2478, DOI 10.1002/ijc.25431; Shelton LM, 2010, J NEURO-ONCOL, V99, P165, DOI 10.1007/s11060-010-0115-y; Shukla SK, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-18; Spitz DR, 2000, ANN NY ACAD SCI, V899, P349, DOI 10.1111/j.1749-6632.2000.tb06199.x; Stafford P, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-74; Stuhr LEB, 2004, CANCER LETT, V210, P35, DOI 10.1016/j.canlet.2004.02.012; Stuhr LEB, 2007, J NEURO-ONCOL, V85, P191, DOI 10.1007/s11060-007-9407-2; Thom SR, 2011, PLAST RECONSTR SURG, V127, p131S, DOI 10.1097/PRS.0b013e3181fbe2bf; TISDALE MJ, 1987, BRIT J CANCER, V56, P39, DOI 10.1038/bjc.1987.149; TISDALE MJ, 1983, BRIT J CANCER, V47, P293, DOI 10.1038/bjc.1983.38; TISDALE MJ, 1988, BRIT J CANCER, V58, P580, DOI 10.1038/bjc.1988.263; Tonorezos ES, 2013, SEMIN ONCOL, V40, P745, DOI 10.1053/j.seminoncol.2013.09.011; TORBATI D, 1986, J NEUROL SCI, V76, P231, DOI 10.1016/0022-510X(86)90171-1; Vaupel P, 2001, MED ONCOL, V18, P243, DOI 10.1385/MO:18:4:243; Vaupel P, 2004, METHOD ENZYMOL, V381, P335; Veech RL, 2004, PROSTAG LEUKOTR ESS, V70, P309, DOI 10.1016/j.plefa.2003.09.007; Veech RL, 2001, IUBMB LIFE, V51, P241; Volek JS, 2002, METABOLISM, V51, P864, DOI 10.1053/meta.2002.32037; Wang J, 2008, CANCER BIOL THER, V7, P1875, DOI 10.4161/cbt.7.12.7067; WU GY, 1988, BIOCHEM J, V255, P139, DOI 10.1042/bj2550139; Zhou WH, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-5; Zuccoli G, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-33	105	48	50	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0127407	10.1371/journal.pone.0127407	http://dx.doi.org/10.1371/journal.pone.0127407			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061868	Green Published, gold			2022-12-26	WOS:000355979500039
J	Queiroz, AM; Sampaio, VS; Mendona, I; Fe, NF; Sachett, J; Ferreira, LCL; Feitosa, E; Wen, FH; Lacerda, M; Monteiro, W				Queiroz, Amanda M.; Sampaio, Vanderson S.; Mendona, Iran; Fe, Nelson F.; Sachett, Jacqueline; Ferreira, Luiz Carlos L.; Feitosa, Esau; Wen, Fan Hui; Lacerda, Marcus; Monteiro, Wuelton			Severity of Scorpion Stings in the Western Brazilian Amazon: A Case-Control Study	PLOS ONE			English	Article							CLINICAL CHARACTERISTICS; ENVENOMATION; CHILDREN; REGION; EPIDEMIOLOGY; SANLIURFA; STATE	Background Scorpion stings are a major public health problem in Brazil, with an increasing number of registered cases every year. Affecting mostly vulnerable populations, the phenomenon is not well described and is considered a neglected disease. In Brazil, the use of anti-venom formulations is provided free of charge. The associate scorpion sting case is subject to compulsory reporting. This paper describes the epidemiology and identifies factors associated with severity of scorpions stings in the state of Amazonas, in the Western Brazilian Amazon. Methodology/Principal Findings This study included all cases of scorpion stings in the state of Amazonas reported to the Brazilian Diseases Surveillance System from January 1, 2007 to December 31, 2014. A case-control study was conducted to identify factors associated with scorpions sting severity. A total of 2,120 cases were reported during this period. The mean incidence rate in the Amazonas was 7.6 per 100,000 inhabitants/year. Scorpion stings showed a large spatial distribution in the state and represent a potential occupational health problem for rural populations. There was a positive correlation between the absolute number of cases and the altimetric river levels in the Central (p<0.001; R-s = 0.479 linear) and Southwest (p = 0.032; linear R-s = 0.261) regions of the state. Cases were mostly classified as mild (68.6%), followed by moderate (26.8%), and severe (4.6%). The overall lethality rate was 0.3%. Lethality rate among children <= 10 years was 1.3%. Age <10 years [OR = 2.58 (95% CI = 1.47-4.55; p = 0.001)], stings occurring in the rural area [OR = 1.97 (95% CI = 1.18-3.29; p = 0.033) and in the South region of the state [OR = 1.85 (95% CI = 1.17-2.93; p = 0.008)] were independently associated with the risk of developing severity. Conclusions/Significance Scorpion stings show an extensive distribution in the Western Brazilian Amazon threatening especially rural populations, children <= 10 in particular. Thus, the mapping of scorpions fauna in different Amazon localities is essential and must be accompanied by the characterization of the main biological activities of the venoms. Urban and farming planning, in parallel with awareness of workers at risk for scorpion stings on the need for personal protective equipment use should be considered as public policies for preventing scorpionism.	[Queiroz, Amanda M.; Sampaio, Vanderson S.; Mendona, Iran; Fe, Nelson F.; Sachett, Jacqueline; Ferreira, Luiz Carlos L.; Feitosa, Esau; Lacerda, Marcus; Monteiro, Wuelton] Fundacao Med Trop Doutor Heitor Vieira Dourado, Dept Ensino & Pesquisa, Manaus, Amazonas, Brazil; [Queiroz, Amanda M.; Sampaio, Vanderson S.; Mendona, Iran; Fe, Nelson F.; Sachett, Jacqueline; Ferreira, Luiz Carlos L.; Feitosa, Esau; Lacerda, Marcus; Monteiro, Wuelton] Univ Estado Amazonas, Escola Super Ciencias Saude, Manaus, Amazonas, Brazil; [Wen, Fan Hui] Inst Butantan, Sao Paulo, Brazil; [Lacerda, Marcus] Fiocruz MS, Inst Pesquisas Leonidas & Maria Deane, Manaus, Amazonas, Brazil	Universidade do Estado do Amazonas; Instituto Butantan; Fundacao Oswaldo Cruz	Monteiro, W (corresponding author), Fundacao Med Trop Doutor Heitor Vieira Dourado, Dept Ensino & Pesquisa, Manaus, Amazonas, Brazil.	wueltonmm@gmail.com	Fan, Hui Wen/C-3750-2019; Sachett, Jacqueline/I-5642-2017; Sampaio, Vanderson/AAQ-1418-2020; Sampaio, Vanderson/M-4337-2015	Sachett, Jacqueline/0000-0001-5723-9977; Sampaio, Vanderson/0000-0001-7307-8851; Sampaio, Vanderson/0000-0001-7307-8851	CAPES (Coordination for the Improvement of Higher Education Personnel/Ministry of Education/Brazil) [88881.068529/2014-01]	CAPES (Coordination for the Improvement of Higher Education Personnel/Ministry of Education/Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the CAPES (Coordination for the Improvement of Higher Education Personnel/Ministry of Education/Brazil; Grant Number 88881.068529/2014-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abourazzak S, 2009, J VENOM ANIM TOXINS, V15, P255, DOI 10.1590/S1678-91992009000200008; Adiguzel S, 2007, TOXICON, V49, P875, DOI 10.1016/j.toxicon.2006.12.012; Almeida RB, 2010, ATLAS SPECIES TITYUS; [Anonymous], CENS DEM 2010; Barros RM, 2014, CIENC SAUDE COLETIVA, V19, P1275, DOI 10.1590/1413-81232014194.01602013; Benmosbah M, 2013, TOXICON, V73, P56, DOI 10.1016/j.toxicon.2013.05.025; Brazil TK, 2010, OS ESCORPIOES; Brazilian Ministry of Health, SIST INF AGR NOT; Brazilian Ministry of Health, 2013, SIST INF AGR NOT SIN; Brazilian Ministry of Health, GUIA VIG SAUD; Brazilian Ministry of Health, 2001, MAN DIAGN TRAT AC AN, P37; Chippaux JP, 2008, ACTA TROP, V107, P71, DOI 10.1016/j.actatropica.2008.05.021; Chowell G, 2006, TOXICON, V47, P753, DOI 10.1016/j.toxicon.2006.02.004; Chowell G, 2005, INT J ENVIRON HEAL R, V15, P425, DOI 10.1080/09603120500392475; Dabo A, 2011, TOXICON, V58, P154, DOI 10.1016/j.toxicon.2011.05.004; de Roodt AR, 2003, TOXICON, V41, P971, DOI 10.1016/S0041-0101(03)00066-7; De Sousa L, 1997, Cad Saude Publica, V13, P45, DOI 10.1590/S0102-311X1997000100013; Ghalim N, 2000, AM J TROP MED HYG, V62, P277, DOI 10.4269/ajtmh.2000.62.277; Gomez JP, 2010, BIOMEDICA, V30, P126, DOI 10.7705/biomedica.v30i1.160; Guerra CMN, 2008, J PEDIAT, V84, P509, DOI [10.2223/JPED.1847, 10.1590/S0021-75572008000700007]; Horta FMB, 2007, REV SOC BRAS MED TRO, V40, P351, DOI 10.1590/S0037-86822007000300022; Instituto Brasileiro de Geografia e Estatistica, REC NAT; Isbister GK, 2014, NEW ENGL J MED, V371, P457, DOI 10.1056/NEJMra1401108; ISMAIL M, 1995, TOXICON, V33, P825, DOI 10.1016/0041-0101(95)00005-7; Khattabi A, 2011, T ROY SOC TROP MED H, V105, P364, DOI 10.1016/j.trstmh.2011.03.007; Lira-da-Silva RM, 2009, GAZ MED BAHIA, V79, P43, DOI [10.5935/abc.2013S009, DOI 10.5935/ABC.2013S009]; Lourenco WR, 2002, SCORPIONS OF BRAZIL; Lourenco WR, 1996, J VENOM ANIM TOXINS, V2, P2; Molaee SM, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu013; Neto HF, 1996, AN ACAD MED, V7, P31; Nunes C S, 2000, Cad Saude Publica, V16, P213, DOI 10.1590/S0102-311X2000000100022; Otero R, 2004, T ROY SOC TROP MED H, V98, P742, DOI 10.1016/j.trstmh.2003.12.018; Ozkan O., 2005, J. Venom. Anim. Toxins incl. Trop. Dis, V11, P479, DOI 10.1590/S1678-91992005000400008; Pardal PPO, 2014, J VENOM ANIM TOXINS, V20, DOI 10.1186/1678-9199-20-3; Pardal Pedro Pereira de Oliveira, 2003, Rev Soc Bras Med Trop, V36, P349; Pardal PPO, 2014, REV PAN-AMAZ SAUDE, V5, P65, DOI DOI 10.5123/S2176-62232014000300008; Pierini SV, 1996, TOXICON, V34, P225, DOI 10.1016/0041-0101(95)00125-5; Rafizadeh S, 2013, J ARTHROPOD-BORNE DI, V7, P66; Reckziegel GC, 2014, J VENOM ANIM TOXINS, V20, DOI 10.1186/1678-9199-20-46; Ribeiro de Albuquerque Cleide Maria, 2013, Revista da Sociedade Brasileira de Medicina Tropical, V46, P484; Souza ARB, 1995, REV SOC BRAS MED TRO, V28, P167; Wen FH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003701; WHO, 2007, RAB ENV NEGL PUBL HL, P32	43	25	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0128819	10.1371/journal.pone.0128819	http://dx.doi.org/10.1371/journal.pone.0128819			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061734	Green Submitted, Green Published, gold			2022-12-26	WOS:000355979500099
J	Rojas-Benitez, D; Thiaville, PC; de Crecy-Lagard, V; Glavic, A				Rojas-Benitez, Diego; Thiaville, Patrick C.; de Crecy-Lagard, Valerie; Glavic, Alvaro			The Levels of a Universally Conserved tRNA Modification Regulate Cell Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P53-RELATED PROTEIN-KINASE; DROSOPHILA-MELANOGASTER; THREONYLCARBAMOYLADENOSINE T(6)A; BIOSYNTHESIS; ACTIVATION; SEQUENCE; TOR; PHOSPHORYLATION; PROLIFERATION; TRANSLATION	N-6-Threonylcarbamoyl-adenosine (t(6)A) is a universal modification occurring at position 37 in nearly all tRNAs that decode A-starting codons, including the eukaryotic initiator tRNA (tRNA(i)(Met)). Yeast lacking central components of the t(6)A synthesis machinery, such as Tcs3p (Kae1p) or Tcs5p (Bud32p), show slow-growth phenotypes. In the present work, we show that loss of the Drosophila tcs3 homolog also leads to a severe reduction in size and demonstrate, for the first time in a non-microbe, that Tcs3 is required for t(6)A synthesis. In Drosophila and in mammals, tRNA(i)(Met) is a limiting factor for cell and animal growth. We report that the t(6)A-modified form of tRNA(i)(Met) is the actual limiting factor. We show that changing the proportion of t(6)A-modified tRNA(i)(Met), by expression of an un-modifiable tRNA(i)(Met) or changing the levels of Tcs3, regulate target of rapamycin (TOR) kinase activity and influences cell and animal growth in vivo. These findings reveal an unprecedented relationship between the translation machinery and TOR, where translation efficiency, limited by the availability of t(6)A-modified tRNA, determines growth potential in eukaryotic cells.	[Rojas-Benitez, Diego; Glavic, Alvaro] Univ Chile, Fac Ciencias, Ctr Regul Genoma, Santiago 7800024, Chile; [Thiaville, Patrick C.; de Crecy-Lagard, Valerie] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA	Universidad de Chile; State University System of Florida; University of Florida	Glavic, A (corresponding author), Univ Chile, Fac Ciencias, Ctr Regul Genoma, Palmeras 3425, Santiago 7800024, Chile.	alglavic@uchile.cl	de Crecy-Lagard, Valerie/AAN-8995-2020; Regan, Clinton/E-6250-2012; Glavic, Alvaro/F-5608-2013	de Crecy-Lagard, Valerie/0000-0002-9955-3785	Company of Biologists; International Union of Biochemistry and Molecular Biology; National Institutes of Health [P40OD018537]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070641] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	Company of Biologists; International Union of Biochemistry and Molecular Biology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank The Company of Biologists and International Union of Biochemistry and Molecular Biology for travel funding (to D. R. B.). Stocks obtained from the Bloomington Drosophila Stock Center (National Institutes of Health Grant P40OD018537) were used in this study.	Abe Y, 2001, J BIOL CHEM, V276, P44003, DOI 10.1074/jbc.M105669200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; COOPER HL, 1980, EXP CELL RES, V127, P351, DOI 10.1016/0014-4827(80)90440-1; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; Cruz C, 2009, GENETICS, V183, P1005, DOI 10.1534/genetics.109.107748; Daugeron MC, 2011, NUCLEIC ACIDS RES, V39, P6148, DOI 10.1093/nar/gkr178; dos Santos G, 2015, NUCLEIC ACIDS RES, V43, pD690, DOI 10.1093/nar/gku1099; El Yacoubi B, 2012, ANNU REV GENET, V46, P69, DOI 10.1146/annurev-genet-110711-155641; El Yacoubi B, 2011, EMBO J, V30, P882, DOI 10.1038/emboj.2010.363; El Yacoubi B, 2009, NUCLEIC ACIDS RES, V37, P2894, DOI 10.1093/nar/gkp152; Torres AG, 2014, TRENDS MOL MED, V20, P306, DOI 10.1016/j.molmed.2014.01.008; Gingold H, 2014, CELL, V158, P1281, DOI 10.1016/j.cell.2014.08.011; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hennig KM, 2006, J CELL BIOL, V173, P963, DOI 10.1083/jcb.200511140; Huynh LN, 2010, CELL CYCLE, V9, P3112, DOI 10.4161/cc.9.15.12525; Ibar C, 2013, DEVELOPMENT, V140, P1282, DOI 10.1242/dev.086918; Kanduc D, 1997, BIOCHEM MOL BIOL INT, V43, P1323; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Lamichhane TN, 2011, RNA, V17, P1846, DOI 10.1261/rna.2628611; Lauhon CT, 2012, BIOCHEMISTRY-US, V51, P8950, DOI 10.1021/bi301233d; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Mei YD, 2010, MOL CELL, V37, P668, DOI 10.1016/j.molcel.2010.01.023; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Morin A, 1998, RNA, V4, P24; Mulder Nicola, 2007, V396, P59; NA JG, 1992, GENETICS, V131, P791; Naor A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043013; Neufeld TP, 2003, CURR TOP MICROBIOL, V279, P139; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Pan T, 2013, ANNU REV GENET, V47, P121, DOI 10.1146/annurev-genet-111212-133522; Pang YLJ, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku945; Pavon-Eternod M, 2013, RNA, V19, P461, DOI 10.1261/rna.037507.112; Perrochia L, 2013, NUCLEIC ACIDS RES, V41, P9484, DOI 10.1093/nar/gkt720; Perrochia L, 2013, NUCLEIC ACIDS RES, V41, P1953, DOI 10.1093/nar/gks1287; Phizicky EM, 2010, FEBS LETT, V584, P265, DOI 10.1016/j.febslet.2009.11.049; POMERANTZ SC, 1990, METHOD ENZYMOL, V193, P796, DOI 10.1016/0076-6879(90)93452-Q; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; Raina M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00171; Rideout EJ, 2012, P NATL ACAD SCI USA, V109, P1139, DOI 10.1073/pnas.1113311109; Rojas-Benitez D, 2013, FLY, V7, P168, DOI 10.4161/fly.25227; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Scheidt V, 2014, MICROB CELL, V1, P416, DOI 10.15698/mic2014.12.179; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHWEIZE.MP, 1969, BIOCHEMISTRY-US, V8, P3283, DOI 10.1021/bi00836a023; SHARP S, 1981, NUCLEIC ACIDS RES, V9, P5867, DOI 10.1093/nar/9.22.5867; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Srinivasan M, 2011, EMBO J, V30, P873, DOI 10.1038/emboj.2010.343; St Pierre SE, 2014, NUCLEIC ACIDS RES, V42, pD780, DOI 10.1093/nar/gkt1092; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Thiaville PC, 2014, RNA BIOL, V11, P1529, DOI 10.4161/15476286.2014.992277; Thiaville PC, 2014, EUKARYOT CELL, V13, P1222, DOI 10.1128/EC.00147-14; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; UNGER MW, 1976, P NATL ACAD SCI USA, V73, P1664, DOI 10.1073/pnas.73.5.1664; van Sluijters DA, 2000, BIOCHEM J, V351, P545, DOI 10.1042/0264-6021:3510545; VOLD BS, 1986, CANCER RES, V46, P3164; WEISSENBACH J, 1981, EUR J BIOCHEM, V116, P207, DOI 10.1111/j.1432-1033.1981.tb05320.x; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Willis IM, 2012, CELL CYCLE, V11, P2769, DOI 10.4161/cc.21257; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014	65	25	26	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18699	18707		10.1074/jbc.M115.665406	http://dx.doi.org/10.1074/jbc.M115.665406			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26063805	Green Published, hybrid			2022-12-26	WOS:000358512100038
J	Han, JF; Zhang, M; Froese, S; Dai, FF; Robitaille, M; Bhattacharjee, A; Huang, XY; Jia, WP; Angers, S; Wheeler, MB; Wei, L				Han, Junfeng; Zhang, Ming; Froese, Sean; Dai, Feihan F.; Robitaille, Melanie; Bhattacharjee, Alpana; Huang, Xinyi; Jia, Weiping; Angers, Stephane; Wheeler, Michael B.; Wei, Li			The Identification of Novel Protein-Protein Interactions in Liver that Affect Glucagon Receptor Activity	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; AFFINITY-PURIFICATION; TAU-PHOSPHORYLATION; COUPLED RECEPTORS; GLP-1 RECEPTOR; INSULIN; FAMILY; HYPERGLYCEMIA; INHIBITION; ANTAGONIST	Glucagon regulates glucose homeostasis by controlling glycogenolysis and gluconeogenesis in the liver. Exaggerated and dysregulated glucagon secretion can exacerbate hyperglycemia contributing to type 2 diabetes (T2D). Thus, it is important to understand how glucagon receptor (GCGR) activity and signaling is controlled in hepatocytes. To better understand this, we sought to identify proteins that interact with the GCGR to affect ligand-dependent receptor activation. A Flag-tagged human GCGR was recombinantly expressed in Chinese hamster ovary (CHO) cells, and GCGR complexes were isolated by affinity purification (AP). Complexes were then analyzed by mass spectrometry (MS), and protein-GCGR interactions were validated by co-immunoprecipitation (Co-IP) and Western blot. This was followed by studies in primary hepatocytes to assess the effects of each interactor on glucagon-dependent glucose production and intracellular cAMP accumulation, and then in immortalized CHO and liver cell lines to further examine cell signaling. Thirty-three unique interactors were identified from the AP-MS screening of GCGR expressing CHO cells in both glucagon liganded and unliganded states. These studies revealed a particularly robust interaction between GCGR and 5 proteins, further validated by Co-IP, Western blot and qPCR. Overexpression of selected interactors in mouse hepatocytes indicated that two interactors, LDLR and TMED2, significantly enhanced glucagon-stimulated glucose production, while YWHAB inhibited glucose production. This was mirrored with glucagon-stimulated cAMP production, with LDLR and TMED2 enhancing and YWHAB inhibiting cAMP accumulation. To further link these interactors to glucose production, key gluconeogenic genes were assessed. Both LDLR and TMED2 stimulated while YWHAB inhibited PEPCK and G6Pase gene expression. In the present study, we have probed the GCGR interactome and found three novel GCGR interactors that control glucagon-stimulated glucose production by modulating cAMP accumulation and genes that control gluconeogenesis. These interactors may be useful targets to control glucose homeostasis in T2D.	[Han, Junfeng; Zhang, Ming; Froese, Sean; Dai, Feihan F.; Bhattacharjee, Alpana; Huang, Xinyi; Wheeler, Michael B.] Univ Toronto, Dept Physiol & Med, Toronto, ON, Canada; [Han, Junfeng; Jia, Weiping; Wei, Li] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Endocrinol & Metab, Shanghai 200030, Peoples R China; [Robitaille, Melanie; Angers, Stephane] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON M5S 1A8, Canada	University of Toronto; Shanghai Jiao Tong University; University of Toronto	Wheeler, MB (corresponding author), Univ Toronto, Dept Physiol & Med, Toronto, ON, Canada.	Michael.Wheeler@utoronto.ca; weili63@hotmail.com	Robitaille, Melanie/ABA-5861-2020; Angers, Stephane/E-1432-2014	Robitaille, Melanie/0000-0001-9354-5162; Angers, Stephane/0000-0001-7241-9044; Wheeler, Michael B./0000-0002-7480-7267	Canadian Institutes of Health Research [MOP-102588, MOP-324754]; Novo Nordisk Diabetes Innovation Award, Natural Science and Engineering Research Council [RGPIN-2015-05286]; Shanghai Jiao Tong University Wuxi Research Institute Operating Grant [2011JDZX021]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Novo Nordisk Diabetes Innovation Award, Natural Science and Engineering Research Council; Shanghai Jiao Tong University Wuxi Research Institute Operating Grant	This work was supported by the Canadian Institutes of Health Research (MOP-102588 and MOP-324754), the Novo Nordisk Diabetes Innovation Award, Natural Science and Engineering Research Council (RGPIN-2015-05286) and the Shanghai Jiao Tong University Wuxi Research Institute Operating Grant (2011JDZX021). The funder had no role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Adiels M, 2005, ARTERIOSCL THROM VAS, V25, P1697, DOI 10.1161/01.ATV.0000172689.53992.25; Agarwal-Mawal A, 2003, J BIOL CHEM, V278, P12722, DOI 10.1074/jbc.M211491200; Ahmed SM, 2011, METHODS MOL BIOL, V756, P357, DOI 10.1007/978-1-61779-160-4_22; Anastas JN, 2012, ONCOGENE, V31, P3696, DOI 10.1038/onc.2011.528; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Brubaker PL, 2002, RECEPTOR CHANNEL, V8, P179, DOI 10.1080/1060682020005155; Chen GI, 2007, METHODS, V42, P298, DOI 10.1016/j.ymeth.2007.02.018; Cho YM, 2012, PHARMACOL THERAPEUT, V135, P247, DOI 10.1016/j.pharmthera.2012.05.009; Contreras I, 2004, PLANT J, V38, P685, DOI 10.1111/j.1365-313X.2004.02075.x; Cryer PE, 2012, ENDOCRINOLOGY, V153, P1039, DOI 10.1210/en.2011-1499; Dai FHF, 2006, J BIOL CHEM, V281, P21942, DOI 10.1074/jbc.M512924200; Daulat AM, 2007, MOL CELL PROTEOMICS, V6, P835, DOI 10.1074/mcp.M600298-MCP200; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gommel DU, 2001, EMBO J, V20, P6751, DOI 10.1093/emboj/20.23.6751; Gu W, 2010, AM J PHYSIOL-ENDOC M, V299, pE624, DOI 10.1152/ajpendo.00102.2010; Hardy AB, 2009, J BIOL CHEM, V284, P30441, DOI 10.1074/jbc.M109.040659; Huang X, 2013, MOL ENDOCRINOL, V27, P1550, DOI 10.1210/me.2013-1047; Kaiser C, 2000, P NATL ACAD SCI USA, V97, P3783, DOI 10.1073/pnas.97.8.3783; Ke JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033676; Kim GH, 2013, PROTEOMICS, V13, P1164, DOI 10.1002/pmic.201200210; KISSEBAH AH, 1983, J CLIN INVEST, V71, P655, DOI 10.1172/JCI110812; Li T, 2007, NEUROSCI LETT, V414, P203, DOI 10.1016/j.neulet.2006.11.073; Li XC, 2006, HYPERTENSION, V47, P580, DOI 10.1161/01.HYP.0000197946.81754.0a; Liu HY, 2012, J PROTEOME RES, V11, P4803, DOI 10.1021/pr2012297; Majoul I, 2001, DEV CELL, V1, P139, DOI 10.1016/S1534-5807(01)00004-1; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Mu J, 2011, DIABETOLOGIA, V54, P2381, DOI 10.1007/s00125-011-2217-2; Mu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049572; Parker JC, 2000, DIABETES, V49, P2079, DOI 10.2337/diabetes.49.12.2079; Sakiyama H, 2008, J BIOL CHEM, V283, P24899, DOI 10.1074/jbc.M804308200; Salehi A, 2006, DIABETES, V55, P2318, DOI 10.2337/db06-0080; Schwenk J, 2010, NATURE, V465, P231, DOI 10.1038/nature08964; Sekar N, 2004, AM J PHYSIOL-ENDOC M, V287, pE128, DOI 10.1152/ajpendo.00400.2003; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Song J, 2012, J PROTEOME RES, V11, P5630, DOI 10.1021/pr300598t; Sonoda N, 2008, P NATL ACAD SCI USA, V105, P6614, DOI 10.1073/pnas.0710402105; Stepanchick A, 2010, BIOCHEM BIOPH RES CO, V395, P136, DOI 10.1016/j.bbrc.2010.03.156; Streicher R, 1996, J BIOL CHEM, V271, P7128, DOI 10.1074/jbc.271.12.7128; Syme CA, 2006, MOL ENDOCRINOL, V20, P3400, DOI 10.1210/me.2006-0178; Tseng CC, 2000, ENDOCRINOLOGY, V141, P947, DOI 10.1210/en.141.3.947; Wu JH, 2003, J BIOL CHEM, V278, P44238, DOI 10.1074/jbc.M309450200; Xiao Q, 2000, J MOL ENDOCRINOL, V25, P321, DOI 10.1677/jme.0.0250321; Xu YZ, 2009, J RECEPT SIG TRANSD, V29, P318, DOI 10.3109/10799890903295150; Yabaluri N, 2010, J BIOSCIENCES, V35, P473, DOI 10.1007/s12038-010-0052-0; Yuan ZF, 2004, J BIOL CHEM, V279, P26105, DOI 10.1074/jbc.M308298200; Zhang M, 2014, MOL CELL PROTEOMICS, V13, P3049, DOI 10.1074/mcp.M114.040196	49	16	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129226	10.1371/journal.pone.0129226	http://dx.doi.org/10.1371/journal.pone.0129226			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075596	Green Submitted, gold, Green Published			2022-12-26	WOS:000356329900055
J	Lee, YR; Na, BK; Moon, EK; Song, SM; Joo, SY; Kong, HH; Goo, YK; Chung, DI; Hong, Y				Lee, Yu-Ran; Na, Byoung-Kuk; Moon, Eun-Kyung; Song, Su-Min; Joo, So-Young; Kong, Hyun-Hee; Goo, Youn-Kyoung; Chung, Dong-Il; Hong, Yeonchul			Essential Role for an M17 Leucine Aminopeptidase in Encystation of Acanthamoeba castellanii	PLOS ONE			English	Article							GIARDIA-LAMBLIA DIFFERENTIATION; LEUCYL AMINOPEPTIDASE; ENTAMOEBA-INVADENS; CYSTEINE PROTEASE; CRYPTOSPORIDIUM-PARVUM; TOXOPLASMA-GONDII; MESSENGER-RNA; SOIL AMOEBA; EXPRESSION; AUTOPHAGY	Encystation of Acanthamoeba leads to the formation of resilient cysts from vegetative trophozoites. This process is essential for parasite survival under unfavorable conditions such as starvation, low temperatures, and exposure to biocides. During encystation, a massive turnover of intracellular components occurs, and a large number of organelles and proteins are degraded by proteases. Previous studies with specific protease inhibitors have shown that cysteine and serine proteases are involved in encystation of Acanthamoeba, but little is known about the role of metalloproteases in this process. Here, we have biochemically characterized an M17 leucine aminopeptidase of Acanthamoeba castellanii (AcLAP) and analyzed its functional involvement in encystation of the parasite. Recombinant AcLAP shared biochemical properties such as optimal pH, requirement of divalent metal ions for activity, substrate specificity for Leu, and inhibition profile by aminopeptidase inhibitors and metal chelators with other characterized M17 family LAPs. AcLAP was highly expressed at a late stage of encystation and mainly localized in the cytoplasm of A. castellanii. Knockdown of AcLAP using small interfering RNA induced a decrease of LAP activity during encystation, a reduction of mature cyst formation, and the formation of abnormal cyst walls. In summary, these results indicate that AcLAP is a typical M17 family enzyme that plays an essential role during encystation of Acanthamoeba.	[Lee, Yu-Ran; Moon, Eun-Kyung; Song, Su-Min; Joo, So-Young; Goo, Youn-Kyoung; Chung, Dong-Il; Hong, Yeonchul] Kyungpook Natl Univ, Sch Med, Dept Parasitol & Trop Med, Daegu 700422, South Korea; [Na, Byoung-Kuk] Gyeongsang Natl Univ, Sch Med, Dept Parasitol & Trop Med, Jinju 660751, South Korea; [Na, Byoung-Kuk] Gyeongsang Natl Univ, Sch Med, Inst Hlth Sci, Jinju 660751, South Korea; [Kong, Hyun-Hee] Dong A Univ, Coll Med, Dept Parasitol, Busan 602714, South Korea	Kyungpook National University; Gyeongsang National University; Gyeongsang National University; Dong A University	Hong, Y (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Parasitol & Trop Med, Daegu 700422, South Korea.	ychong@knu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2009802]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2009802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsam S, 2005, J INFECTION, V51, P150, DOI 10.1016/j.jinf.2004.09.001; BAND RN, 1963, J PROTOZOOL, V10, P101, DOI 10.1111/j.1550-7408.1963.tb01642.x; Bateman E, 2010, PROTEIN EXPRES PURIF, V70, P95, DOI 10.1016/j.pep.2009.10.008; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Beninga J, 1998, J BIOL CHEM, V273, P18734, DOI 10.1074/jbc.273.30.18734; BOWERS B, 1969, J CELL BIOL, V41, P786, DOI 10.1083/jcb.41.3.786; Bruchhaus I, 2003, EUKARYOT CELL, V2, P501, DOI 10.1128/EC.2.3.501-509.2003; Cadavid-Restrepo G, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-46; Cao ZY, 1998, J BIOL CHEM, V273, P15838, DOI 10.1074/jbc.273.25.15838; Davids BJ, 2011, MOL BIOCHEM PARASIT, V175, P169, DOI 10.1016/j.molbiopara.2010.11.008; DuBois KN, 2008, J BIOL CHEM, V283, P18024, DOI 10.1074/jbc.M802133200; Dudley R, 2008, FEMS MICROBIOL LETT, V286, P9, DOI 10.1111/j.1574-6968.2008.01249.x; Ebert F, 2008, PARASITOL INT, V57, P521, DOI 10.1016/j.parint.2008.07.002; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gonzalez J, 1999, EUR J BIOCHEM, V264, P897, DOI 10.1046/j.1432-1327.1999.00682.x; Griffiths A, 1970, ENCYSTMENT AMOEBAE, P105; Hehl AB, 2000, MOL BIOL CELL, V11, P1789, DOI 10.1091/mbc.11.5.1789; Herrera-Camacho I, 2007, FEBS J, V274, P6228, DOI 10.1111/j.1742-4658.2007.06142.x; Jia HL, 2010, MOL BIOCHEM PARASIT, V170, P1, DOI 10.1016/j.molbiopara.2009.11.005; Kang JM, 2011, PARASITOLOGY, V138, P682, DOI 10.1017/S0031182011000199; Khan, 2009, ACANTHAMOEBA BIOL PA; Khunkitti W, 1996, J APPL BACTERIOL, V81, P73, DOI 10.1111/j.1365-2672.1996.tb03284.x; KIM HD, 1993, P NATL ACAD SCI USA, V90, P5006, DOI 10.1073/pnas.90.11.5006; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Lee JY, 2013, EUKARYOT CELL, V12, P567, DOI 10.1128/EC.00308-12; Lee JY, 2010, MOL BIOCHEM PARASIT, V170, P45, DOI 10.1016/j.molbiopara.2009.11.003; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Linder M, 2002, APPL ENVIRON MICROB, V68, P2503, DOI 10.1128/AEM.68.5.2503-2508.2002; Lloyd D, 2001, J EUKARYOT MICROBIOL, V48, P11, DOI 10.1111/j.1550-7408.2001.tb00410.x; Lujan HD, 1997, MICROBIOL MOL BIOL R, V61, P294; Makioka A, 2002, PARASITOL RES, V88, P454, DOI 10.1007/s00436-002-0601-z; Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003; Matsui M, 2006, BIOL CHEM, V387, P1535, DOI 10.1515/BC.2006.191; MATSUSHIMA M, 1991, BIOCHEM BIOPH RES CO, V178, P1459, DOI 10.1016/0006-291X(91)91057-J; Mazur T, 1988, WIAD PARAZYTOL, V35, P11; Moon EK, 2008, EUKARYOT CELL, V7, P1513, DOI 10.1128/EC.00068-08; Moon EK, 2012, MOL BIOCHEM PARASIT, V185, P121, DOI 10.1016/j.molbiopara.2012.07.008; Moon EK, 2011, KOREAN J PARASITOL, V49, P341, DOI 10.3347/kjp.2011.49.4.341; Morty RE, 2002, J BIOL CHEM, V277, P26057, DOI 10.1074/jbc.M202779200; Neff R, ACANTHAMOEBA; NELLEN W, 1982, J MOL BIOL, V159, P1, DOI 10.1016/0022-2836(82)90028-6; Okhuysen PC, 1996, ANTIMICROB AGENTS CH, V40, P2781, DOI 10.1128/AAC.40.12.2781; Picazarri K, 2008, INFECT IMMUN, V76, P278, DOI 10.1128/IAI.00636-07; Poloz Y, 2012, EUKARYOT CELL, V11, P545, DOI 10.1128/EC.05311-11; Rascon AA, 2013, CURR MED CHEM, V20, P3078; RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P183; Schaeffer M, 2006, MOL BIOCHEM PARASIT, V150, P318, DOI 10.1016/j.molbiopara.2006.09.004; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Sharma M, 1996, EXP PARASITOL, V84, P84, DOI 10.1006/expr.1996.0092; Singh U, 2002, MOL MICROBIOL, V44, P721, DOI 10.1046/j.1365-2958.2002.02903.x; Sissons J, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-42; Stack CM, 2007, J BIOL CHEM, V282, P2069, DOI 10.1074/jbc.M609251200; TAYLOR A, 1993, TRENDS BIOCHEM SCI, V18, P167; TAYLOR A, 1993, FASEB J, V7, P290, DOI 10.1096/fasebj.7.2.8440407; Tomkinson B, 1999, TRENDS BIOCHEM SCI, V24, P355, DOI 10.1016/S0968-0004(99)01435-8; TOMLINSON G, 1962, BIOCHIM BIOPHYS ACTA, V63, P194, DOI 10.1016/0006-3002(62)90353-0; Touz Maria C., 2002, Biochemical Journal, V364, P703, DOI 10.1042/BJ20020025; Touz MC, 2002, J BIOL CHEM, V277, P8474, DOI 10.1074/jbc.M110250200; Turner NA, 2000, J ANTIMICROB CHEMOTH, V46, P27, DOI 10.1093/jac/46.1.27; WEISMAN RA, 1976, ANNU REV MICROBIOL, V30, P189, DOI 10.1146/annurev.mi.30.100176.001201; York IA, 2003, IMMUNITY, V18, P429, DOI 10.1016/S1074-7613(03)00058-X	61	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129884	10.1371/journal.pone.0129884	http://dx.doi.org/10.1371/journal.pone.0129884			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075721	gold, Green Submitted, Green Published			2022-12-26	WOS:000356329900110
J	Yue, YJ; Guo, TT; Liu, JB; Guo, J; Yuan, C; Feng, RL; Niu, CN; Sun, XP; Yang, BH				Yue, Yaojing; Guo, Tingting; Liu, Jianbin; Guo, Jian; Yuan, Chao; Feng, Ruilin; Niu, Chune; Sun, Xiaoping; Yang, Bohui			Exploring Differentially Expressed Genes and Natural Antisense Transcripts in Sheep (Ovis aries) Skin with Different Wool Fiber Diameters by Digital Gene Expression Profiling	PLOS ONE			English	Article							HAIR FOLLICLE DEVELOPMENT; PROLINE-RICH PROTEINS; DERMAL PAPILLA VOLUME; REGULATES CELL-CYCLE; RNA-SEQ; NONCODING RNA; INDUCED APOPTOSIS; BOVINE DANDER; STEM-CELLS; BIOLOGY	Wool fiber diameter (WFD) is the most important economic trait of wool. However, the genes specifically controlling WFD remain elusive. In this study, the expression profiles of skin from two groups of Gansu Alpine merino sheep with different WFD (a super-fine wool group [FD = 18.0 +/- 0.5 mu m, n = 3] and a fine wool group [FD= 23.0 +/- 0.5 mu m, n = 3]) were analyzed using next-generation sequencing-based digital gene expression profiling. A total of 40 significant differentially expressed genes (DEGs) were detected, including 9 up-regulated genes and 31 down-regulated genes. Further expression profile analysis of natural antisense transcripts (NATs) showed that more than 30% of the genes presented in sheep skin expression profiles had NATs. A total of 7 NATs with significant differential expression were detected, and all were down-regulated. Among of 40 DEGs, 3 DEGs (AQP8, Bos d2, and SPRR) had significant NATs which were all significantly down-regulated in the super-fine wool group. In total of DEGs and NATs were summarized as 3 main GO categories and 38 subcategories. Among the molecular functions, cellular components and biological processes categories, binding, cell part and metabolic process were the most dominant subcategories, respectively. However, no significant enrichment of GO terms was found (corrected P-value >0.05). The pathways that were significantly enriched with significant DEGs and NATs were mainly the lipoic acid metabolism, bile secretion, salivary secretion and ribosome and phenylalanine metabolism pathways (P < 0.05). The results indicated that expression of NATs and gene transcripts were correlated, suggesting a role in gene regulation. The discovery of these DEGs and NATs could facilitate enhanced selection for super-fine wool sheep through gene-assisted selection or targeted gene manipulation in the future.	[Yue, Yaojing; Guo, Tingting; Liu, Jianbin; Guo, Jian; Yuan, Chao; Feng, Ruilin; Niu, Chune; Sun, Xiaoping; Yang, Bohui] Chinese Acad Agr Sci, Lanzhou Inst Husb & Pharmaceut Sci, Lanzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Institute of Husbandry & Pharmaceutical Sciences, CAAS	Yang, BH (corresponding author), Chinese Acad Agr Sci, Lanzhou Inst Husb & Pharmaceut Sci, Jiangouyan St, Lanzhou, Peoples R China.	lzyangbohui@163.com			Central Level, Scientific Research Institutes for Basic R & D Special Fund Business [1610322015014]; Earmarked Fund for Modern China Wool & Cashmere Technology Research System [nycytx-40-3]; National Natural Science Foundation for Young Scholars of China [31402057]	Central Level, Scientific Research Institutes for Basic R & D Special Fund Business; Earmarked Fund for Modern China Wool & Cashmere Technology Research System; National Natural Science Foundation for Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported by the Central Level, Scientific Research Institutes for Basic R & D Special Fund Business (Grant no. 1610322015014); the Earmarked Fund for Modern China Wool & Cashmere Technology Research System (Grant no. nycytx-40-3); and the National Natural Science Foundation for Young Scholars of China (Grant no. 31402057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson DL, 2004, GENOMICS, V83, P95, DOI 10.1016/S0888-7543(03)00210-6; Adelson DL, 2002, AUST J AGR RES, V53, P1003, DOI 10.1071/AR01200; ALCARAZ MV, 1993, J CUTAN PATHOL, V20, P344, DOI 10.1111/j.1600-0560.1993.tb01273.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; Bostjancic E, 2008, ACTA DERMATOVEN ALP, V17, P95; Botchkarev VA, 2003, J EXP ZOOL PART B, V298B, P164, DOI 10.1002/jez.b.00033; Botchkarev VA, 2006, J INVEST DERMATOL, V126, P1719, DOI 10.1038/sj.jid.5700270; Cadau S, 2013, EUR J DERMATOL, V23, P4, DOI 10.1684/ejd.2013.1972; Calamita G, 2007, J ENDOCRINOL, V192, P111, DOI 10.1677/JOE-06-0058; CANDI E, 1995, J BIOL CHEM, V270, P26382, DOI 10.1074/jbc.270.44.26382; Carmichael GG, 2003, NAT BIOTECHNOL, V21, P371, DOI 10.1038/nbt0403-371; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carregaro F, 2013, ARCH DERMATOL RES, V305, P857, DOI 10.1007/s00403-013-1415-9; Carter HB, 1947, COMMONWEALTH AUSTR C, V215; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; CHASE HB, 1953, ANAT REC, V116, P75, DOI 10.1002/ar.1091160107; Chen HC, 2002, J CLIN INVEST, V109, P175, DOI 10.1172/JCI0213880; Chi W, 2013, DEVELOPMENT, V140, P1676, DOI 10.1242/dev.090662; Clark MB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000625; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Das E, 2013, BIOCHEM BIOPH RES CO, V437, P217, DOI 10.1016/j.bbrc.2013.06.041; De Bessa SA, 2006, INT J MOL MED, V17, P363; Denoeud F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r175; Driskell RR, 2011, J CELL SCI, V124, P1179, DOI 10.1242/jcs.082446; Elliott K, 1999, J INVEST DERMATOL, V113, P873, DOI 10.1046/j.1523-1747.1999.00797.x; Enshell-Seijffers D, 2010, DEV CELL, V18, P633, DOI 10.1016/j.devcel.2010.01.016; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Filipczak PT, 2012, BIOCHEM CELL BIOL, V90, P224, DOI [10.1139/O11-083, 10.1139/o11-083]; Fonseca DJ, 2013, BRIT J DERMATOL, V168, P456, DOI 10.1111/j.1365-2133.2012.11181.x; Galbraith H, 2010, ANIMAL, V4, P1447, DOI 10.1017/S1751731110000741; Galbraith H, 2010, ANIMAL, V4, P1490, DOI 10.1017/S175173111000025X; GIBBS S, 1993, GENOMICS, V16, P630, DOI 10.1006/geno.1993.1240; Glotzer DJ, 2008, DEV BIOL, V315, P459, DOI 10.1016/j.ydbio.2008.01.005; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Haddad F, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-21; Hagedorn C, 2007, EUR HEART J, V28, P249; HARDY MARGARET H., 1956, AUSTRALIAN JOUR BIOL SCI, V9, P423; HAUSMAN GJ, 1982, J ANIM SCI, V54, P1286, DOI 10.2527/jas1982.5461286x; Herrmann T, 2003, J CELL BIOL, V161, P1105, DOI 10.1083/jcb.200207080; Hoen PAC, 2008, NUCL ACIDS RES, V36; Holm LM, 2005, PFLUG ARCH EUR J PHY, V450, P415, DOI 10.1007/s00424-005-1399-1; Holmes RS, 2010, COMP BIOCHEM PHYS D, V5, P217, DOI 10.1016/j.cbd.2010.05.004; IBRAHIM L, 1982, J EMBRYOL EXP MORPH, V72, P209; IMAN NY, 1992, J ANIM SCI, V70, P1110, DOI 10.2527/1992.7041110x; Ishibashi K, 1997, BIOCHEM BIOPH RES CO, V237, P714, DOI 10.1006/bbrc.1997.7219; IshidaYamamoto A, 1997, J INVEST DERMATOL, V108, P12, DOI 10.1111/1523-1747.ep12285611; Jager M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-158; Jiang Y, 2014, SCIENCE, V344, P1168, DOI 10.1126/science.1252806; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Korndorfer IP, 2007, J MOL BIOL, V370, P887, DOI 10.1016/j.jmb.2007.04.065; Lapidot M, 2006, EMBO REP, V7, P1216, DOI 10.1038/sj.embor.7400857; Legue E, 2005, DEVELOPMENT, V132, P4143, DOI 10.1242/dev.01975; Lei MX, 2014, EXP DERMATOL, V23, P407, DOI 10.1111/exd.12416; Lei MX, 2012, HISTOCHEM CELL BIOL, V138, P385, DOI 10.1007/s00418-012-0960-1; Levy-Strumpf N, 1998, ONCOGENE, V17, P3331, DOI 10.1038/sj.onc.1202588; Liu H, 2011, AUSTRALASIAN AGRIBUS, V2011, P19; Ma TH, 1997, BIOCHEM BIOPH RES CO, V240, P324, DOI 10.1006/bbrc.1997.7664; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Mantyjarvi R, 1996, J ALLERGY CLIN IMMUN, V97, P1297, DOI 10.1016/S0091-6749(96)70198-7; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Moore GPM, 1998, J THEOR BIOL, V191, P87, DOI 10.1006/jtbi.1997.0567; MOORE GPM, 1989, GENET RES, V53, P57, DOI 10.1017/S0016672300027865; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Nacken W, 2003, MICROSC RES TECHNIQ, V60, P569, DOI 10.1002/jemt.10299; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Norris BJ, 2005, AUST J EXP AGR, V45, P867, DOI 10.1071/EA05050; Otberg N, 2004, J INVEST DERMATOL, V122, P14, DOI 10.1046/j.0022-202X.2003.22110.x; Pariset L, 2009, NEW BIOTECHNOL, V25, P272, DOI 10.1016/j.nbt.2009.03.013; Plikus MV, 2011, SCIENCE, V332, P586, DOI 10.1126/science.1201647; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Purvis IW, 2007, SMALL RUMINANT RES, V70, P42, DOI 10.1016/j.smallrumres.2007.01.002; Purvis IW, 2005, GENET SEL EVOL, V37, pS97, DOI 10.1051/gse:2004028; Rautiainen J, 1998, J ALLERGY CLIN IMMUN, V101, P349, DOI 10.1016/S0091-6749(98)70247-7; Reiner G, 2000, CYTOGENET CELL GENET, V89, P59, DOI 10.1159/000015565; Rogers GE, 2006, EXP DERMATOL, V15, P931, DOI 10.1111/j.1600-0625.2006.00512.x; Sandilands A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064404; Schmidt-Ullrich R, 2005, BIOESSAYS, V27, P247, DOI 10.1002/bies.20184; Scobie DR, 2000, P NZ SOC ANIMAL PROD; Seiberg M, 2001, EXP DERMATOL, V10, P405, DOI 10.1034/j.1600-0625.2001.100603.x; Sennett R, 2012, SEMIN CELL DEV BIOL, V23, P917, DOI 10.1016/j.semcdb.2012.08.011; Senshu T, 1999, EXP DERMATOL, V8, P392, DOI 10.1111/j.1600-0625.1999.tb00388.x; Shen Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069854; Shendure J, 2008, NAT METHODS, V5, P585, DOI 10.1038/nmeth0708-585; Smith FJD, 2002, BIOCHEM BIOPH RES CO, V297, P818, DOI 10.1016/S0006-291X(02)02288-X; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Strappazzon F, 2010, BIOCHEM BIOPH RES CO, V397, P64, DOI 10.1016/j.bbrc.2010.05.062; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Tiganescu A, 2011, J INVEST DERMATOL, V131, P30, DOI 10.1038/jid.2010.257; Wahlestedt C, 2006, DRUG DISCOV TODAY, V11, P503, DOI 10.1016/j.drudis.2006.04.013; Waluk DP, 2010, FASEB J, V24, P2795, DOI 10.1096/fj.09-148551; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang HC, 2014, BIOCHEM BIOPH RES CO, V446, P1204, DOI 10.1016/j.bbrc.2014.03.086; Wang LQ, 1996, BIOCHEM J, V317, P225, DOI 10.1042/bj3170225; Wang QQ, 2010, GENOMICS, V96, P369, DOI 10.1016/j.ygeno.2010.08.009; Wang XS, 2012, STEM CELLS DEV, V21, P7, DOI 10.1089/scd.2011.0230; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xing K, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-32; YANG K, 1992, ENDOCRINOLOGY, V131, P2120, DOI 10.1210/en.131.5.2120; Yano K, 2001, J CLIN INVEST, V107, P409, DOI 10.1172/JCI11317; Yoshiura K, 2006, NAT GENET, V38, P324, DOI 10.1038/ng1733; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zimmermann N, 2005, AM J RESP CELL MOL, V32, P428, DOI 10.1165/rcmb.2004-0269OC	106	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129249	10.1371/journal.pone.0129249	http://dx.doi.org/10.1371/journal.pone.0129249			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076016	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900058
J	Berents, TL; Carlsen, KCL; Mowinckel, P; Skjerven, HO; Kvenshagen, B; Rolfsjord, LB; Bradley, M; Lieden, A; Carlsen, KH; Gaustad, P; Gjersvik, P				Berents, Teresa Lovold; Carlsen, Karin Cecilie Lodrup; Mowinckel, Petter; Skjerven, Havard Ove; Kvenshagen, Bente; Rolfsjord, Leif Bjarte; Bradley, Maria; Lieden, Agne; Carlsen, Kai-Hakon; Gaustad, Peter; Gjersvik, Petter			Skin Barrier Function and Staphylococcus aureus Colonization in Vestibulum Nasi and Fauces in Healthy Infants and Infants with Eczema: A Population-Based Cohort Study	PLOS ONE			English	Article							TRANSEPIDERMAL WATER-LOSS; ALLERGY CLIN IMMUNOL; ATOPIC-DERMATITIS; LINE VALUES; FILAGGRIN; MUTATIONS; DISEASE; MECHANISMS; GUIDELINES; FEATURES	Atopic eczema (AE) is associated with Staphylococcus aureus (S. aureus) colonization and skin barrier dysfunction, often measured by increased transepidermal water loss (TEWL). In the present study, the primary aim was to see whether Staphylococcus aureus colonization in the vestibulum nasi and/or fauces was associated with increased TEWL in infants with healthy skin and infants with eczema. Secondarily, we aimed to investigate whether TEWL measurements on non-lesional skin on the lateral upper arm is equivalent to volar forearm in infants. In 167 of 240 infants, recruited from the general population, TEWL measurements on the lateral upper arm and volar forearm, using a DermaLab USB, fulfilled our environmental requirements. The mean of three TEWL measurements from each site was used for analysis. The infants were diagnosed with no eczema (n = 110), possible AE (n = 28) or AE (n = 29). DNA samples were analysed for mutations in the filaggrin gene (FLG). Bacterial cultures were reported positive with the identification of at least one culture with Staphylococcus aureus from vestibulum nasi and/or fauces. Staphylococcus aureus colonization, found in 89 infants (53%), was not associated with increased TEWL (i.e. TEWL in the upper quartile), neither on the lateral upper arm or volar forearm (p = 0.08 and p = 0.98, respectively), nor with AE (p = 0.10) or FLG mutation (p = 0.17). TEWL was significantly higher on both measuring sites in infants with AE compared to infants with possible AE and no eczema. FLG mutation was significantly associated with increased TEWL, with a 47% difference in TEWL. We conclude that Staphylococcus aureus in vestibulum nasi and/or fauces was not associated with TEWL, whereas TEWL measurements on the lateral upper arm and volar forearm appear equally appropriate in infants.	[Berents, Teresa Lovold; Carlsen, Karin Cecilie Lodrup; Mowinckel, Petter; Skjerven, Havard Ove; Rolfsjord, Leif Bjarte; Carlsen, Kai-Hakon; Gaustad, Peter; Gjersvik, Petter] Univ Oslo, Inst Clin Med, Oslo, Norway; [Berents, Teresa Lovold; Gjersvik, Petter] Oslo Univ Hosp, Dept Dermatol, N-0450 Oslo, Norway; [Carlsen, Karin Cecilie Lodrup; Mowinckel, Petter; Skjerven, Havard Ove; Carlsen, Kai-Hakon] Oslo Univ Hosp, Dept Pediat, N-0450 Oslo, Norway; [Kvenshagen, Bente] Ostfold Hosp, Dept Pediat, Fredrikstad, Norway; [Rolfsjord, Leif Bjarte] Innlandet Hosp Trust, Dept Pediat, Elverum, Norway; [Bradley, Maria; Lieden, Agne] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med, Stockholm, Sweden; [Bradley, Maria] Karolinska Univ Hosp, Dept Dermatol, Stockholm, Sweden; [Gaustad, Peter] Oslo Univ Hosp, Dept Microbiol, N-0450 Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; Innlandet Hospital Trust; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; University of Oslo	Berents, TL (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.	t.l.berents@medisin.uio.no			Arne Ingels Foundation; Norwegian Asthma and Allergy Association	Arne Ingels Foundation; Norwegian Asthma and Allergy Association	This work was supported by the Arne Ingels Foundation (https://www.unifor.no/Fund.aspx?fund=77) (TLB), and the Norwegian Asthma and Allergy Association (http://www.naaf.no/no/tjenester/Prosjektstotte/Forskningsfondet/) (TLB). The funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.	AOKI T, 1992, ACTA DERM-VENEREOL, P19; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Bath-Hextall FJ, 2010, BRIT J DERMATOL, V163, P12, DOI 10.1111/j.1365-2133.2010.09743.x; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Breuer K, 2002, BRIT J DERMATOL, V147, P55, DOI 10.1046/j.1365-2133.2002.04872.x; Brook I, 1996, INT J DERMATOL, V35, P791, DOI 10.1111/j.1365-4362.1996.tb02975.x; Carson CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048678; Cork MJ, 2009, J INVEST DERMATOL, V129, P1892, DOI 10.1038/jid.2009.133; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cravello B, 2008, SKIN RES TECHNOL, V14, P180, DOI 10.1111/j.1600-0846.2007.00275.x; Elkeeb R, 2010, SKIN RES TECHNOL, V16, P9, DOI 10.1111/j.1600-0846.2009.00406.x; Flohr C, 2010, BRIT J DERMATOL, V163, P1333, DOI 10.1111/j.1365-2133.2010.10068.x; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Gupta J, 2008, J ALLERGY CLIN IMMUN, V121, P725, DOI 10.1016/j.jaci.2007.12.1161; Halkjaer LB, 2006, ARCH DERMATOL, V142, P561, DOI 10.1001/archderm.142.5.561; Hamilton LC, 1991, REGRESSION WITH GRAP; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Howell MD, 2009, J ALLERGY CLIN IMMUN, V124, pR7, DOI 10.1016/j.jaci.2009.07.012; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Jinnestal CL, 2014, INT J DERMATOL, V53, P27, DOI 10.1111/ijd.12198; Kelleher MM, 2013, PEDIATR DERMATOL, V30, P712, DOI 10.1111/pde.12106; Kleesz P, 2012, SKIN PHARMACOL PHYS, V25, P25, DOI 10.1159/000330721; Kottner J, 2013, ARCH DERMATOL RES, V305, P315, DOI 10.1007/s00403-012-1313-6; Kunz B, 1997, DERMATOLOGY, V195, P10, DOI 10.1159/000245677; Lebon A, 2009, ARCH PEDIAT ADOL MED, V163, P745, DOI 10.1001/archpediatrics.2009.117; LEYDEN JJ, 1974, BRIT J DERMATOL, V90, P525, DOI 10.1111/j.1365-2133.1974.tb06447.x; Miajlovic H, 2010, J ALLERGY CLIN IMMUN, V126, P1184, DOI 10.1016/j.jaci.2010.09.015; Na SY, 2012, ANN DERMATOL, V24, P413, DOI 10.5021/ad.2012.24.4.413; Nilsson P, 2006, J CLIN MICROBIOL, V44, P3334, DOI 10.1128/JCM.00880-06; O'Regan GM, 2009, J ALLERGY CLIN IMMUN, V124, pR2, DOI 10.1016/j.jaci.2009.07.013; Ong PY, 2008, PRIMARY CARE, V35, P105, DOI 10.1016/j.pop.2007.09.006; Ong PY, 2014, PEDIATR RES, V75, P171, DOI 10.1038/pr.2013.196; Ong PY, 2010, IMMUNOL ALLERGY CLIN, V30, P309, DOI 10.1016/j.iac.2010.05.001; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; PINNAGODA J, 1990, CONTACT DERMATITIS, V22, P164, DOI 10.1111/j.1600-0536.1990.tb01553.x; Raone B, 2014, PEDIATR DERMATOL, V31, P191, DOI 10.1111/pde.12274; Sandilands A, 2007, NAT GENET, V39, P650, DOI 10.1038/ng2020; Sergeant A, 2009, J INVEST DERMATOL, V129, P1042, DOI 10.1038/jid.2008.324; Shin K, 2011, J DERMATOL SCI, V63, P201, DOI 10.1016/j.jdermsci.2011.05.003; Singh B, 2013, SKIN RES TECHNOL, V19, P207, DOI 10.1111/srt.12043; Skjerven HO, 2013, NEW ENGL J MED, V368, P2286, DOI 10.1056/NEJMoa1301839; Skov L, 2009, BRIT J DERMATOL, V160, P1286, DOI 10.1111/j.1365-2133.2009.09051.x; SOMERVILLE DA, 1969, BRIT J DERMATOL, V81, P248, DOI 10.1111/j.1365-2133.1969.tb13976.x; Steiner M, 2011, SKIN RES TECHNOL, V17, P366, DOI 10.1111/j.1600-0846.2011.00509.x; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P383, DOI 10.1111/j.1365-2133.1994.tb08530.x; Williams JV, 1999, J EMERG MED, V17, P207, DOI 10.1016/S0736-4679(98)00151-6; Yosipovitch G, 2000, PEDIATRICS, V106, P105, DOI 10.1542/peds.106.1.105	48	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130145	10.1371/journal.pone.0130145	http://dx.doi.org/10.1371/journal.pone.0130145			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070153	Green Published, Green Submitted, gold			2022-12-26	WOS:000356327000142
J	Ceglie, FG; Bustamante, MA; Ben Amara, M; Tittarelli, F				Ceglie, Francesco Giovanni; Bustamante, Maria Angeles; Ben Amara, Mouna; Tittarelli, Fabio			The Challenge of Peat Substitution in Organic Seedling Production: Optimization of Growing Media Formulation through Mixture Design and Response Surface Analysis	PLOS ONE			English	Article							SOLID-WASTE COMPOST; SUBSTRATE; ROSEMARY; SPAIN; MELON	Peat replacement is an increasing demand in containerized and transplant production, due to the environmental constraints associated to peat use. However, despite the wide information concerning the use of alternative materials as substrates, it is very complex to establish the best materials and mixtures. This work evaluates the use of mixture design and surface response methodology in a peat substitution experiment using two alternative materials (green compost and palm fibre trunk waste) for transplant production of tomato (Lycopersicon esculentum Mill.); melon, (Cucumis melo L.); and lettuce (Lactuca sativa L.) in organic farming conditions. In general, the substrates showed suitable properties for their use in seedling production, showing the best plant response the mixture of 20% green compost, 39% palm fibre and 31% peat. The mixture design and applied response surface methodology has shown to be an useful approach to optimize substrate formulations in peat substitution experiments to standardize plant responses.	[Ceglie, Francesco Giovanni; Ben Amara, Mouna] Ctr Int Hautes Etud Agronom Mediterraneennes, Mediterranean Agron Inst Bari, Dept Organ Agr, Bari, Italy; [Bustamante, Maria Angeles] Miguel Hernandez Univ, Dept Agrochem & Environm, Alicante, Spain; [Tittarelli, Fabio] Consiglio Ric Sperimentaz Agr, Res Ctr Soil Plant Syst, Rome, Italy	CIHEAM; CIHEAM BARI; Universidad Miguel Hernandez de Elche; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA)	Ceglie, FG (corresponding author), Ctr Int Hautes Etud Agronom Mediterraneennes, Mediterranean Agron Inst Bari, Dept Organ Agr, Bari, Italy.	ceglie@iamb.it	Bustamante, Maria Angeles/ABF-3793-2020; Bustamante, Maria Angeles/H-9171-2013; ceglie, francesco giovanni/E-8323-2015	Bustamante, Maria Angeles/0000-0001-9931-1711; Bustamante, Maria Angeles/0000-0001-9931-1711; ceglie, francesco giovanni/0000-0003-0255-0439; Tittarelli, Fabio/0000-0002-5766-4428	Organic Farming Office of the Italian Ministry of Agriculture	Organic Farming Office of the Italian Ministry of Agriculture	The Organic Farming Office of the Italian Ministry of Agriculture has supported the open access fees of this publication.	Abad M, 2001, BIORESOURCE TECHNOL, V77, P197, DOI 10.1016/S0960-8524(00)00152-8; Altland JE, 2009, HORTSCIENCE, V44, P1861, DOI 10.21273/HORTSCI.44.7.1861; Altmann M., 2008, SOCIOECONOMIC IMPACT; Andreu-Rodriguez J, 2013, COMMUN SOIL SCI PLAN, V44, P598, DOI 10.1080/00103624.2013.745363; Boodt M. de, 1972, Acta Horticulturae, P37; Carmona E, 2012, SCI HORTIC-AMSTERDAM, V137, P69, DOI 10.1016/j.scienta.2012.01.023; Ceglie F, 2014, COMPOSTING SUSTAINAB, P1; Ceglie FG, 2011, COMPOST SCI UTIL, V19, P293; Chong C, 2005, HORTTECHNOLOGY, V15, P739, DOI 10.21273/HORTTECH.15.4.0739; Cocozza C, 2011, BIOMASS BIOENERG, V35, P799, DOI 10.1016/j.biombioe.2010.10.033; De Lucia B, 2013, J PLANT NUTR, V36, P863, DOI 10.1080/01904167.2013.770018; DERRINGER G, 1980, J QUAL TECHNOL, V12, P214, DOI 10.1080/00224065.1980.11980968; Evans MR, 2007, HORTTECHNOLOGY, V17, P312, DOI 10.21273/HORTTECH.17.3.312; Herrera F, 2008, BIORESOURCE TECHNOL, V99, P287, DOI 10.1016/j.biortech.2006.12.042; Holmes S, 2009, ACTA HORTIC, V819, P23; Institute for Environmental Protection and Research (ISPRA), 2001, METH COMP AN ANPA HD, V3; Jayasinghe GY, 2010, J HAZARD MATER, V174, P700, DOI 10.1016/j.jhazmat.2009.09.107; Komilis D, 2011, J ENVIRON MANAGE, V92, P2241, DOI 10.1016/j.jenvman.2011.04.012; Kritsotakis IK, 2011, J CROP IMPROV, V25, P664, DOI 10.1080/15427528.2011.600425; Medina E, 2009, BIORESOURCE TECHNOL, V100, P4227, DOI 10.1016/j.biortech.2009.03.055; Mininni C, 2013, J HORTIC SCI BIOTECH, V88, P345, DOI 10.1080/14620316.2013.11512975; Mininni C, 2012, HORTSCIENCE, V47, P1438, DOI 10.21273/HORTSCI.47.10.1438; Moldes A, 2007, BIORESOURCE TECHNOL, V98, P3069, DOI 10.1016/j.biortech.2006.10.021; Moral R, 2013, ACTA HORTIC, V1013, P25, DOI 10.17660/ActaHortic.2013.1013.1; Nardi JV, 2004, J EUR CERAM SOC, V24, P375, DOI 10.1016/S0955-2219(03)00219-X; Noguera P, 2003, COMMUN SOIL SCI PLAN, V34, P593, DOI 10.1081/CSS-120017842; Raviv M, 2011, ACTA HORTIC, V891, P19; Rea E, 2009, ACTA HORTIC, V807, P541; Rinaldi S, 2014, SCI HORTIC-AMSTERDAM, V176, P218, DOI 10.1016/j.scienta.2014.07.011; SCHEFFE H, 1963, J ROY STAT SOC B, V25, P235; Schmilewski G, 2009, ACTA HORTIC, V819, P33; Tittarelli F, 2009, COMPOST SCI UTIL, V17, P220; Vaughn SF, 2011, IND CROP PROD, V33, P514, DOI 10.1016/j.indcrop.2010.10.034; ZUCCONI F, 1981, BIOCYCLE, V22, P27	34	53	54	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128600	10.1371/journal.pone.0128600	http://dx.doi.org/10.1371/journal.pone.0128600			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070163	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000021
J	Deiana, M; Matczyszyn, K; Massin, J; Olesiak-Banska, J; Andraud, C; Samoc, M				Deiana, Marco; Matczyszyn, Katarzyna; Massin, Julien; Olesiak-Banska, Joanna; Andraud, Chantal; Samoc, Marek			Interactions of Isophorone Derivatives with DNA: Spectroscopic Studies	PLOS ONE			English	Article							HUMAN HOLO-TRANSFERRIN; HUMAN SERUM-ALBUMIN; PROTEIN INTERACTIONS; BINDING MECHANISM; ETHIDIUM-BROMIDE; FLUORESCENCE; ABSORPTION; COMPLEXES; MODE; TAMOXIFEN	Interactions of three new isophorone derivatives, Isoa Isob and Isoc with salmon testes DNA have been investigated using UV-Vis, fluorescence and circular dichroism spectroscopic methods. All the studied compounds interact with DNA through intercalative binding mode. The stoichiometry of the isophorone/DNA adducts was found to be 1:1. The fluorescence quenching data revealed a binding interaction with the base pairs of DNA. The CD data indicate that all the investigated isophorones induce DNA modifications.	[Deiana, Marco; Matczyszyn, Katarzyna; Olesiak-Banska, Joanna; Samoc, Marek] Wroclaw Univ Technol, Fac Chem, Adv Mat Engn & Modelling Grp, PL-50370 Wroclaw, Poland; [Massin, Julien; Andraud, Chantal] Univ Lyon 1, Ecole Normale Super Lyon, CNRS UMR 5182, Lab Chim, F-69365 Lyon, France	Wroclaw University of Science & Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Matczyszyn, K (corresponding author), Wroclaw Univ Technol, Fac Chem, Adv Mat Engn & Modelling Grp, Wyb Wyspianskiego 27, PL-50370 Wroclaw, Poland.	katarzyna.matczyszyn@pwr.edu.pl	Deiana, Marco/AHB-4469-2022; Samoc, Marek/AAK-9439-2020; Olesiak-Banska, Joanna/AAZ-6918-2020; Massin, julien/Q-2724-2017	Samoc, Marek/0000-0002-5404-2455; Massin, julien/0000-0002-9484-1286; Olesiak-Banska, Joanna/0000-0002-7226-0077; Matczyszyn, Katarzyna/0000-0001-8578-8340; Deiana, Marco/0000-0002-7815-4494	NCN Opus grant [DEC-2013/09/B/ST5/03417]; Region Rhone-Alpes (cluster5)	NCN Opus grant; Region Rhone-Alpes (cluster5)(Region Auvergne-Rhone-Alpes)	The financing from NCN Opus grant DEC-2013/09/B/ST5/03417 is highly acknowledged. The authors thank the Region Rhone-Alpes (cluster5) for a grant to J.M. and financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton JK, 2011, COORDIN CHEM REV, V255, P619, DOI 10.1016/j.ccr.2010.09.002; Biver T, 2012, APPL SPECTROSC REV, V47, P272, DOI 10.1080/05704928.2011.641044; Bourassa P, 2014, J PHARMACEUT BIOMED, V95, P193, DOI 10.1016/j.jpba.2014.02.028; Cai X, 2009, CANC TREAT REV, V35, P347; Delplanque A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117277; Dewey T.G., 1991, BIOPHYSICAL BIOCH AS; Dogra S, 2013, J PHOTOCH PHOTOBIO B, V123, P48, DOI 10.1016/j.jphotobiol.2013.03.015; Dorraji PS, 2013, J BRAZIL CHEM SOC, V24, P939, DOI 10.5935/0103-5053.20130123; Grote JG, 2004, J PHYS CHEM B, V108, P8584, DOI 10.1021/jp038056d; Han L, 2014, ACTA A, V123, P487; Han LN, 2014, SPECTROCHIM ACTA A, V123, P497, DOI 10.1016/j.saa.2013.11.088; Kabiri M, 2012, MOLECULES, V17, P3114, DOI 10.3390/molecules17033114; Kashida H, 2006, CHEM-EUR J, V12, P777, DOI 10.1002/chem.200500111; Khalaf AI, 2009, CURR TRENDS MED CHEM, V6, P53; KLOTZ IM, 1971, BIOCHEMISTRY-US, V10, P3065, DOI 10.1021/bi00792a013; LERMAN LS, 1961, J MOL BIOL, V3, P18, DOI 10.1016/S0022-2836(61)80004-1; Lincoln P, 1997, J AM CHEM SOC, V119, P1454, DOI 10.1021/ja9631965; Lorusso D, 2009, EXPERT OPIN INV DRUG, V10, P1703; Mansouri M, 2013, MOLECULES, V18, P789, DOI 10.3390/molecules18010789; Marshall MM, 2015, LANGMUIR, V31, P4582, DOI 10.1021/acs.langmuir.5b00457; Massin J, 2013, OPT MATER, V35, P1810, DOI 10.1016/j.optmat.2013.04.021; Massin J, 2011, CHEM MATER, V23, P862, DOI 10.1021/cm102165r; Matczyszyn K, 2012, J NANOPHOTONICS, V6, DOI 10.1117/1.JNP.6.064505; Nafisi S, 2007, J MOL STRUCT, V827, P35, DOI 10.1016/j.molstruc.2006.05.004; Nakamoto Kazuo, 2008, Methods Biochem Anal, V51, P1; Olesiak-Banska J, 2013, J PHYS CHEM B, V117, P12013, DOI 10.1021/jp407144k; Olesiak-Banska J, 2012, CHEM PHYS, V404, P33, DOI 10.1016/j.chemphys.2012.02.001; Ouameur AA, 2005, BIOPOLYMERS, V77, P129, DOI 10.1002/bip.20173; Purcell M, 1999, J BIOMOL STRUCT DYN, V17, P473, DOI 10.1080/07391102.1999.10508378; Rafique B, 2013, BIOSENS BIOELECTRON, V44, P21, DOI 10.1016/j.bios.2012.12.028; Sahoo BK, 2008, CHEM PHYS, V351, P163, DOI 10.1016/j.chemphys.2008.05.008; Samoc M, 2014, MRS P, P1698; Sarzehi S, 2010, INT J BIOL MACROMOL, V47, P558, DOI 10.1016/j.ijbiomac.2010.08.002; Sattar Z, 2012, SPECTROCHIM ACTA A, V97, P1089, DOI 10.1016/j.saa.2012.07.034; Shakir M, 2009, SPECTROCHIM ACTA A, V71, P1851, DOI 10.1016/j.saa.2008.07.002; Sirajuddin M, 2013, J PHOTOCH PHOTOBIO B, V124, P1, DOI 10.1016/j.jphotobiol.2013.03.013; Steckl AJ, 2007, NAT PHOTONICS, V1, P3, DOI 10.1038/nphoton.2006.56; Stephanos JJ, 1996, J INORG BIOCHEM, V62, P155, DOI 10.1016/0162-0134(95)00144-1; Wang XZ, 2014, SPECTROCHIM ACTA A, V118, P448, DOI 10.1016/j.saa.2013.09.028; WARE WR, 1962, J PHYS CHEM-US, V66, P455, DOI 10.1021/j100809a020; Zhang GW, 2013, SENSOR ACTUAT B-CHEM, V182, P453, DOI 10.1016/j.snb.2013.03.038; Zhong WY, 2004, J PHARM SCI-US, V93, P1039, DOI 10.1002/jps.20005; Zhou XY, 2014, INT J BIOL MACROMOL, V67, P228, DOI 10.1016/j.ijbiomac.2014.03.038	43	28	28	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129817	10.1371/journal.pone.0129817	http://dx.doi.org/10.1371/journal.pone.0129817			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26069963	Green Published, Green Submitted, gold			2022-12-26	WOS:000356327000111
J	Di Grazia, A; Cappiello, F; Imanishi, A; Mastrofrancesco, A; Picardo, M; Paus, R; Mangoni, ML				Di Grazia, Antonio; Cappiello, Floriana; Imanishi, Akiko; Mastrofrancesco, Arianna; Picardo, Mauro; Paus, Ralf; Mangoni, Maria Luisa			The Frog Skin-Derived Antimicrobial Peptide Esculentin-1a(1-21)NH2 Promotes the Migration of Human HaCaT Keratinocytes in an EGF Receptor-Dependent Manner: A Novel Promoter of Human Skin Wound Healing?	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; IN-VITRO ACTIVITY; RANA-ESCULENTA; SIGNAL-TRANSDUCTION; EFFECTOR MOLECULES; EPIDERMAL LAYERS; INNATE IMMUNITY; AMPHIBIAN SKIN; LEOPARD FROGS; LL-37	One of the many functions of skin is to protect the organism against a wide range of pathogens. Antimicrobial peptides (AMPs) produced by the skin epithelium provide an effective chemical shield against microbial pathogens. However, whereas antibacterial/antifungal activities of AMPs have been extensively characterized, much less is known regarding their wound healing-modulatory properties. By using an in vitro re-epithelialisation assay employing special cell-culture inserts, we detected that a derivative of the frog-skin AMP esculentin-1a, named esculentin-1a(1-21)NH2, significantly stimulates migration of immortalized human keratinocytes (HaCaT cells) over a wide range of peptide concentrations (0.025-4 mu M), and this notably more efficiently than human cathelicidin (LL-37). This activity is preserved in primary human epidermal keratinocytes. By using appropriate inhibitors and an enzyme-linked immunosorbent assay we found that the peptide-induced cell migration involves activation of the epidermal growth factor receptor and STAT3 protein. These results suggest that esculentin-1a(1-21)NH2 now deserves to be tested in standard wound healing assays as a novel candidate promoter of skin re-epithelialisation. The established ability of esculentin-1a(1-21)NH2 to kill microbes without harming mammalian cells, namely its high anti-Pseudomonal activity, makes this AMP a particularly attractive candidate wound healing promoter, especially in the management of chronic, often Pseudomonas-infected, skin ulcers.	[Di Grazia, Antonio; Cappiello, Floriana; Mangoni, Maria Luisa] Univ Roma La Sapienza, Fdn Cenci Bolognetti, Ist Pasteur, Dept Biochem Sci, I-00185 Rome, Italy; [Imanishi, Akiko; Paus, Ralf] Univ Manchester, Ctr Dermatol Res, Inst Inflammat & Repair, Manchester, Lancs, England; [Mastrofrancesco, Arianna; Picardo, Mauro] San Gallicano Dermatol Inst, Lab Cutaneous Physiopathol, Rome, Italy; [Mastrofrancesco, Arianna; Picardo, Mauro] San Gallicano Dermatol Inst, Integrated Ctr Metabol Res, Rome, Italy; [Paus, Ralf] Univ Munster, Dept Dermatol, D-48149 Munster, Germany	Fondazione Cenci Bolognetti; Sapienza University Rome; University of Manchester; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); University of Munster	Mangoni, ML (corresponding author), Univ Roma La Sapienza, Fdn Cenci Bolognetti, Ist Pasteur, Dept Biochem Sci, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	marialuisa.mangoni@uniroma1.it	Mastrofrancesco, Arianna/K-2433-2018; Paus, Ralf/B-5279-2015	Mastrofrancesco, Arianna/0000-0003-1231-3832; Paus, Ralf/0000-0002-3492-9358	Sapienza Universita di Roma Project [C26A12NPXZ]	Sapienza Universita di Roma Project	This study was supported by Sapienza Universita di Roma Project C26A12NPXZ (2012) (to M.L.M.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg KM, 2008, J INVEST DERMATOL, V128, P917, DOI 10.1038/sj.jid.5701099; Agerberth B, 2000, BLOOD, V96, P3086, DOI 10.1182/blood.V96.9.3086.h8003086_3086_3093; Andl CD, 2004, AM J PHYSIOL-GASTR L, V287, pG1227, DOI 10.1152/ajpgi.00253.2004; Arnoux V, 2008, MOL BIOL CELL, V19, P4738, DOI 10.1091/mbc.E07-10-1078; Bals R, 1998, INFECT IMMUN, V66, P1225, DOI 10.1128/IAI.66.3.1225-1232.1998; Bals R, 1998, P NATL ACAD SCI USA, V95, P9541, DOI 10.1073/pnas.95.16.9541; Bals R, 1998, J CLIN INVEST, V102, P874, DOI 10.1172/JCI2410; BODEY GP, 1983, REV INFECT DIS, V5, P279; Bowdish DME, 2005, J LEUKOCYTE BIOL, V77, P451, DOI 10.1189/jlb.0704380; Bowers G, 2001, ONCOGENE, V20, P1388, DOI 10.1038/sj.onc.1204255; Braff MH, 2005, J INVEST DERMATOL, V124, P394, DOI 10.1111/j.0022-202X.2004.23443.x; Braff MH, 2005, INFECT IMMUN, V73, P6771, DOI 10.1128/IAI.73.10.6771-6781.2005; Carretero M, 2008, J INVEST DERMATOL, V128, P223, DOI 10.1038/sj.jid.5701043; Conlon JM, 2014, PEPTIDES, V57, P67, DOI 10.1016/j.peptides.2014.04.019; Conlon JM, 2009, BBA-BIOMEMBRANES, V1788, P1556, DOI 10.1016/j.bbamem.2008.09.018; Conlon JM, 2009, ANN NY ACAD SCI, V1163, P75, DOI 10.1111/j.1749-6632.2008.03618.x; De Potter IY, 2001, EXP CELL RES, V271, P315, DOI 10.1006/excr.2001.5390; Demidova-Rice TN, 2012, ADV SKIN WOUND CARE, V25, P304, DOI 10.1097/01.ASW.0000416006.55218.d0; Di Grazia A, 2014, ANTIMICROB AGENTS CH, V58, P2520, DOI 10.1128/AAC.02801-13; Di Nardo A, 2003, J IMMUNOL, V170, P2274, DOI 10.4049/jimmunol.170.5.2274; Do N, 2014, EXP DERMATOL, V23, P326, DOI 10.1111/exd.12384; Islas-Rodriguez AE, 2009, J PEPT SCI, V15, P607, DOI 10.1002/psc.1148; Erspamer V, 1994, AMPHIBIAN BIOL, V1, P395; Feingold KR, 2012, J INVEST DERMATOL, V132, P1951, DOI 10.1038/jid.2012.177; Firat YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093941; Gallo RL, 2013, EXP DERMATOL, V22, P517, DOI 10.1111/exd.12197; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Garcia JRC, 2001, FASEB J, V15, P1819, DOI 10.1096/fj.00-0865fje; Gellatly SL, 2013, PATHOG DIS, V67, P159, DOI 10.1111/2049-632X.12033; Glaser R, 2014, J INVEST DERMATOL, V134, P2347, DOI 10.1038/jid.2014.176; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Grieco P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061614; Groner ML, 2014, J EXP BIOL, V217, P351, DOI 10.1242/jeb.091611; Gudmundsson GH, 1999, J IMMUNOL METHODS, V232, P45, DOI 10.1016/S0022-1759(99)00152-0; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; Haney EF, 2013, BIOPOLYMERS, V100, P572, DOI 10.1002/bip.22250; Harder Juergen, 2005, V86, P22, DOI 10.1159/000086650; Haslam IS, 2014, BIOL REV, V89, P618, DOI 10.1111/brv.12072; He YY, 2008, CANCER RES, V68, P3752, DOI 10.1158/0008-5472.CAN-07-6138; Hoq MI, 2011, J DERMATOL SCI, V64, P108, DOI 10.1016/j.jdermsci.2011.08.001; Huang LC, 2007, CURR EYE RES, V32, P595, DOI 10.1080/02713680701446653; Hulkower Keren I, 2011, Pharmaceutics, V3, P107, DOI 10.3390/pharmaceutics3010107; Ishikawa T, 2009, J DERMATOL SCI, V56, P121, DOI 10.1016/j.jdermsci.2009.07.012; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Kolar SSN, 2015, CELL MOL LIFE SCI, V72, P617, DOI 10.1007/s00018-014-1694-0; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Liu H, 2014, INT J BIOCHEM CELL B, V49, P32, DOI 10.1016/j.biocel.2014.01.010; Luca V, 2013, CELL MOL LIFE SCI, V70, P2773, DOI 10.1007/s00018-013-1291-7; Mangoni ML, 2006, CELL MOL LIFE SCI, V63, P1060, DOI 10.1007/s00018-005-5536-y; Mangoni ML, 2011, CELL MOL LIFE SCI, V68, P2157, DOI 10.1007/s00018-011-0709-3; Mangoni ML, 2009, BBA-BIOMEMBRANES, V1788, P1610, DOI 10.1016/j.bbamem.2009.04.021; Mangoni ML, 2003, PEPTIDES, V24, P1771, DOI 10.1016/j.peptides.2003.07.029; Mangoni ML, 2001, FASEB J, V15, P1431, DOI 10.1096/fj.00-0695fje; Mansour SC, 2014, TRENDS IMMUNOL, V35, P443, DOI 10.1016/j.it.2014.07.004; Marques MM, 1999, EXP CELL RES, V252, P432, DOI 10.1006/excr.1999.4634; Mastrofrancesco A, 2010, EXP DERMATOL, V19, P813, DOI 10.1111/j.1600-0625.2010.01107.x; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; McDermott AM, 2006, BRIT J OPHTHALMOL, V90, P609, DOI 10.1136/bjo.2005.083428; Meier NT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073596; Morizane S, 2012, J DERMATOL, V39, P225, DOI 10.1111/j.1346-8138.2011.01483.x; OSHEROV N, 1994, EUR J BIOCHEM, V225, P1047, DOI 10.1111/j.1432-1033.1994.1047b.x; Oudhoff MJ, 2008, FASEB J, V22, P3805, DOI 10.1096/fj.08-112003; Pask JD, 2013, J EXP BIOL, V216, P2908, DOI 10.1242/jeb.084145; Percival SL, 2012, WOUND REPAIR REGEN, V20, P647, DOI 10.1111/j.1524-475X.2012.00836.x; Percoco G, 2013, EXP DERMATOL, V22, P800, DOI 10.1111/exd.12259; Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023; Ramos R, 2011, PEPTIDES, V32, P1469, DOI 10.1016/j.peptides.2011.06.005; Ramsey JP, 2010, INFECT IMMUN, V78, P3981, DOI 10.1128/IAI.00402-10; Rollins-Smith LA, 2005, INTEGR COMP BIOL, V45, P137, DOI 10.1093/icb/45.1.137; Salzer S, 2014, J DERMATOL SCI, V76, P173, DOI 10.1016/j.jdermsci.2014.09.002; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Schafer C, 2010, CELL ADHES MIGR, V4, P215, DOI 10.4161/cam.4.2.10745; Schroder JM, 2010, CURR OPIN INFECT DIS, V23, P106, DOI 10.1097/QCO.0b013e328335b004; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; Semple F, 2012, J INNATE IMMUN, V4, P337, DOI 10.1159/000336619; Simanski M, 2014, EXP DERMATOL, V23, P230, DOI 10.1111/exd.12365; Simmaco M, 1998, SCAND J IMMUNOL, V48, P357; SIMMACO M, 1994, J BIOL CHEM, V269, P11956; Simmaco M, 1998, BIOPOLYMERS, V47, P435, DOI 10.1002/(SICI)1097-0282(1998)47:6<435::AID-BIP3>3.3.CO;2-#; Spohn D, 2013, MOL PHARMACOL, V78, P865; Steinstraesser L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039373; Steinstraesser L, 2009, INT J MOL SCI, V10, P3951, DOI 10.3390/ijms10093951; Stoll SW, 2012, J INVEST DERMATOL, V132, P2148, DOI 10.1038/jid.2012.78; Taboubi S, 2007, FASEB J, V21, P4047, DOI 10.1096/fj.06-7476com; Tjabringa GS, 2003, J IMMUNOL, V171, P6690, DOI 10.4049/jimmunol.171.12.6690; Tokumaru S, 2005, J IMMUNOL, V175, P4662, DOI 10.4049/jimmunol.175.7.4662; Turner J, 1998, ANTIMICROB AGENTS CH, V42, P2206, DOI 10.1128/AAC.42.9.2206; Uccelletti D, 2010, ANTIMICROB AGENTS CH, V54, P3853, DOI 10.1128/AAC.00154-10; Walter MNM, 2010, EXP CELL RES, V316, P1271, DOI 10.1016/j.yexcr.2010.02.026; Wang G, 2010, ADV M C M, P1, DOI 10.1079/9781845936570.0000; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; WATT FM, 1988, P NATL ACAD SCI USA, V85, P5576, DOI 10.1073/pnas.85.15.5576; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wittersheim M, 2013, EXP DERMATOL, V22, P364, DOI 10.1111/exd.12133; Wolcott R D, 2008, J Wound Care, V17, P513; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x; Yin J, 2010, INVEST OPHTH VIS SCI, V51, P1891, DOI 10.1167/iovs.09-3904; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	100	57	58	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128663	10.1371/journal.pone.0128663	http://dx.doi.org/10.1371/journal.pone.0128663			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068861	Green Submitted, Green Published, gold			2022-12-26	WOS:000356327000022
J	Pereira, AJ; Correa, TD; de Almeida, FP; Deliberato, RO; Lobato, MD; Akamine, N; Silva, E; Cavalcanti, AB				Pereira, Adriano Jose; Correa, Thiago Domingos; de Almeida, Francisca Pereira; Deliberato, Rodrigo Octavio; Lobato, Michelle dos Santos; Akamine, Nelson; Silva, Eliezer; Cavalcanti, Alexandre Biasi			Inaccuracy of Venous Point-of-Care Glucose Measurements in Critically Ill Patients: A Cross-Sectional Study	PLOS ONE			English	Article							BLOOD-GLUCOSE; BEDSIDE GLUCOMETRY; GLYCEMIC CONTROL; ACCURACY; METERS; CAPILLARY; ARTERIAL; RECOMMENDATIONS; HEMATOCRIT; GUIDELINES	Introduction Current guidelines and consensus recommend arterial and venous samples as equally acceptable for blood glucose assessment in point-of-care devices, but there is limited evidence to support this recommendation. We evaluated the accuracy of two devices for bedside point-of-care blood glucose measurements using arterial, fingerstick and catheter venous blood samples in ICU patients, and assessed which factors could impair their accuracy. Methods 145 patients from a 41-bed adult mixed-ICU, in a tertiary care hospital were prospectively enrolled. Fingerstick, central venous (catheter) and arterial blood (indwelling catheter) samples were simultaneously collected, once per patient. Arterial measurements obtained with Precision PCx, and arterial, fingerstick and venous measurements obtained with Accu-chek Advantage II were compared to arterial central lab measurements. Agreement between point-of-care and laboratory measurements were evaluated with Bland-Altman, and multiple linear regression models were used to investigate interference of associated factors. Results Mean difference between Accu-chek arterial samples versus central lab was 10.7 mg/dL (95% LA -21.3 to 42.7 mg/dL), and between Precision PCx versus central lab was 18.6 mg/dL (95% LA -12.6 to 49.5 mg/dL). Accu-chek fingerstick versus central lab arterial samples presented a similar bias (10.0 mg/dL) but a wider 95% LA (-31.8 to 51.8 mg/dL). Agreement between venous samples with arterial central lab was the poorest (mean bias 15.1 mg/dL; 95% LA -51.7 to 81.9). Hyperglycemia, low hematocrit, and acidosis were associated with larger differences between arterial and venous blood measurements with the two glucometers and central lab. Vasopressor administration was associated with increased error for fingerstick measurements. Conclusions Sampling from central venous catheters should not be used for glycemic control in ICU patients. In addition, reliability of the two evaluated glucometers was insufficient. Error with Accu-chek Advantage II increases mostly with central venous samples. Hyperglycemia, lower hematocrit, acidosis, and vasopressor administration increase measurement error.	[Pereira, Adriano Jose; Correa, Thiago Domingos; de Almeida, Francisca Pereira; Deliberato, Rodrigo Octavio; Lobato, Michelle dos Santos; Akamine, Nelson; Silva, Eliezer] Hosp Israelita Albert Einstein, Intens Care Unit, Sao Paulo, SP, Brazil; [Pereira, Adriano Jose] Univ Fed Lavras UFLA, Sch Med, Lavras, MG, Brazil; [Cavalcanti, Alexandre Biasi] Hosp Coracao, Res Inst HCor, Sao Paulo, SP, Brazil	Hospital Israelita Albert Einstein; Universidade Federal de Lavras; Hospital do Coracao - HCor	Pereira, AJ (corresponding author), Hosp Israelita Albert Einstein, Intens Care Unit, Sao Paulo, SP, Brazil.	adrianojop@einstein.br	Pereira, Adriano/F-9342-2014; Cavalcanti, Alexandre/K-5529-2013	Pereira, Adriano/0000-0002-3528-3800; Domingos Correa, Thiago/0000-0001-9546-3910; Cavalcanti, Alexandre/0000-0003-2798-6263	Instituto de Ensino e Pesquisa (IIEP) - Hospital Israelita Albert Einstein [80-05]	Instituto de Ensino e Pesquisa (IIEP) - Hospital Israelita Albert Einstein	This work was funded by "Instituto de Ensino e Pesquisa (IIEP) - Hospital Israelita Albert Einstein" (grant number: 80-05; responsible for the grant: AJP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, ARROW MULTILUMEN CEN; [Anonymous], 1997, TEST METH VITROS CHE; ATKIN SH, 1991, ANN INTERN MED, V114, P1020, DOI 10.7326/0003-4819-114-12-1020; Balion Cynthia, 2006, BMC Pediatr, V6, P28, DOI 10.1186/1471-2431-6-28; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boyd R, 2005, EMERG MED J, V22, P177, DOI 10.1136/emj.2003.011619; BURNETT RW, 1995, EUR J CLIN CHEM CLIN, V33, P247; Critchell CD, 2007, INTENS CARE MED, V33, P2079, DOI 10.1007/s00134-007-0835-4; Desachy A, 2008, MAYO CLIN PROC, V83, P400, DOI 10.4065/83.4.400; Egi M, 2006, ANESTHESIOLOGY, V105, P244, DOI 10.1097/00000542-200608000-00006; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Finfer S, 2013, CRIT CARE, V17, DOI 10.1186/cc12537; Finfer S, 2012, NEW ENGL J MED, V367, P1108, DOI 10.1056/NEJMoa1204942; Finkielman JDW, 2005, CHEST, V127, P1749, DOI 10.1378/chest.127.5.1749; Hoedemaekers CWE, 2008, CRIT CARE MED, V36, P3062, DOI 10.1097/CCM.0b013e318186ffe6; Inoue S, 2013, CRIT CARE, V17, DOI 10.1186/cc12567; Jacobi J, 2012, CRIT CARE MED, V40, P3251, DOI 10.1097/CCM.0b013e3182653269; Kanji S, 2005, CRIT CARE MED, V33, P2778, DOI 10.1097/01.CCM.0000189939.10881.60; Karon BS, 2007, AM J CLIN PATHOL, V127, P919, DOI 10.1309/6RFQCKAAJGKWB8M4; Karon BS, 2009, DIABETES TECHNOL THE, V11, P819, DOI 10.1089/dia.2009.0074; Katz MH, 2003, ANN INTERN MED, V138, P644, DOI 10.7326/0003-4819-138-8-200304150-00012; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Krinsley JS, 2013, CRIT CARE, V17, DOI 10.1186/cc12547; Lacara T, 2007, AM J CRIT CARE, V16, P336; Meex C, 2006, CLIN CHEM LAB MED, V44, P1376, DOI 10.1515/CCLM.2006.249; Meynaar IA, 2009, CRIT CARE MED; Petersen JR, 2008, CLIN CHIM ACTA, V396, P10, DOI 10.1016/j.cca.2008.06.010; Ray JG, 2001, CRIT CARE MED, V29, P2205, DOI 10.1097/00003246-200111000-00025; Rickard CM, 2003, CRIT CARE MED, V31, P1654, DOI 10.1097/01.CCM.0000063448.98777.EF; Sacks DB, 2011, CLIN CHEM, V57, pE1, DOI 10.1373/clinchem.2010.161596; Sacks DB, 2002, CLIN CHEM, V48, P436; Scott MG, 2009, CLIN CHEM, V55, P18, DOI 10.1373/clinchem.2008.117291; STRIJDOM JG, 1993, S AFR MED J, V83, P64; Tang Z, 2000, Diabetes Technol Ther, V2, P349, DOI 10.1089/15209150050194215; Tang ZP, 2000, ARCH PATHOL LAB MED, V124, P1135; Tang ZP, 2000, AM J CLIN PATHOL, V113, P75, DOI 10.1309/QAW1-X5XW-BVRQ-5LKQ; Trajanoski Z, 1996, DIABETES CARE, V19, P1412, DOI 10.2337/diacare.19.12.1412; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Watkinson PJ, 2012, ANN CLIN BIOCHEM, V49, P144, DOI 10.1258/acb.2011.011162	39	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129568	10.1371/journal.pone.0129568	http://dx.doi.org/10.1371/journal.pone.0129568			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26067093	Green Published, Green Submitted, gold			2022-12-26	WOS:000356327000091
J	Roy, S; Banerjee, A; Mawkhlieng, B; Misra, AK; Pattanayak, A; Harish, GD; Singh, SK; Ngachan, SV; Bansal, KC				Roy, Somnath; Banerjee, Amrita; Mawkhlieng, Bandapkuper; Misra, A. K.; Pattanayak, A.; Harish, G. D.; Singh, S. K.; Ngachan, S. V.; Bansal, K. C.			Genetic Diversity and Population Structure in Aromatic and Quality Rice (Oryza sativa L.) Landraces from North-Eastern India	PLOS ONE			English	Article							CONSERVATION; COLLECTION; SOFTWARE; CLASSIFICATION; VARIETIES; INFERENCE; BASMATI; ASSAM; TOOL	The North-eastern (NE) India, comprising of Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Sikkim and Tripura, possess diverse array of locally adapted non-Basmati aromatic germplasm. The germplasm collections from this region could serve as valuable resources in breeding for abiotic stress tolerance, grain yield and cooking/eating quality. To utilize such collections, however, breeders need information about the extent and distribution of genetic diversity present within collections. In this study, we report the result of population genetic analysis of 107 aromatic and quality rice accessions collected from different parts of NE India, as well as classified these accessions in the context of a set of structured global rice cultivars. A total of 322 alleles were amplified by 40 simple sequence repeat (SSR) markers with an average of 8.03 alleles per locus. Average gene diversity was 0.67. Population structure analysis revealed that NE Indian aromatic rice can be subdivided into three genetically distinct population clusters: P1, joha rice accessions from Assam, tai rices from Mizoram and those from Sikkim; P2, chakhao rice germplasm from Manipur; and P3, aromatic rice accessions from Nagaland. Pair-wise F-ST between three groups varied from 0.223 (P1 vs P2) to 0.453 (P2 vs P3). With reference to the global classification of rice cultivars, two major groups (Indica and Japonica) were identified in NE Indian germplasm. The aromatic accessions from Assam, Manipur and Sikkim were assigned to the Indica group, while the accessions from Nagaland exhibited close association with Japonica. The tai accessions of Mizoram along with few chakhao accessions collected from the hill districts of Manipur were identified as admixed. The results highlight the importance of regional genetic studies for understanding diversification of aromatic rice in India. The data also suggest that there is scope for exploiting the genetic diversity of aromatic and quality rice germplasm of NE India for rice improvement.	[Roy, Somnath; Mawkhlieng, Bandapkuper; Misra, A. K.; Harish, G. D.; Singh, S. K.] ICAR Natl Bur Plant Genet Resources, Reg Stn, Umiam, Meghalaya, India; [Banerjee, Amrita; Pattanayak, A.; Ngachan, S. V.] ICAR Res Complex North Eastern Hill Reg, Umiam, Meghalaya, India; [Bansal, K. C.] ICAR Natl Bur Plant Genet Resources, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources; Indian Council of Agricultural Research (ICAR); ICAR - ICAR Research Complex for NEH Region; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources	Roy, S (corresponding author), ICAR Natl Bur Plant Genet Resources, Reg Stn, Umiam, Meghalaya, India.	sroypbr@gmail.com		Roy, Somnath/0000-0001-6590-9758; MAWKHLIENG, BANDAPKUPAR/0000-0003-2999-1584	ICAR-NBPGR	ICAR-NBPGR	This work is carried out under institutional project of ICAR-National Bureau of Plant Genetic Resources (ICAR-NBPGR). The fund utilized from the budget for the North-eastern hill region of ICAR-NBPGR.	Aggarwal RK, 2002, THEOR APPL GENET, V105, P680, DOI 10.1007/s00122-002-0973-6; Bhuyan N, 2007, CURR SCI INDIA, V93, P967; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Choudhury B, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-228; Choudhury DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113094; Das A., 2010, Agricultural Reviews, V31, P1; Das B, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-71; Borba TCD, 2009, GENETICA, V137, P293, DOI 10.1007/s10709-009-9380-0; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; GLASZMANN JC, 1987, THEOR APPL GENET, V74, P21, DOI 10.1007/BF00290078; Hore DK, 2005, GENET RESOUR CROP EV, V52, P1129, DOI 10.1007/s10722-004-6084-2; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Jain S, 2004, THEOR APPL GENET, V109, P965, DOI 10.1007/s00122-004-1700-2; Khush G. S., 2000, P5; Kovach MJ, 2009, P NATL ACAD SCI USA, V106, P14444, DOI 10.1073/pnas.0904077106; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nagaraju J, 2002, P NATL ACAD SCI USA, V99, P5836, DOI 10.1073/pnas.042099099; Ni J, 2002, CROP SCI, V42, P601, DOI 10.2135/cropsci2002.0601; Pavel AB, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-9; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard JK, 2000, GENETICS, V155, P945; Ren XP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088091; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Roy S, 2014, PLANT GENET RESOUR-C, V12, P264, DOI 10.1017/S1479262113000580; Roy S, 2014, PLANT GENET RESOUR-C, V12, P58, DOI 10.1017/S1479262113000282; Sang T, 2007, CURR OPIN GENET DEV, V17, P533, DOI 10.1016/j.gde.2007.09.005; Sarma R. N., 2005, Plant Genetic Resources Newsletter, P34; Singh R. K., 2000, P155; Sweeney M, 2007, ANN BOT-LONDON, V100, P951, DOI 10.1093/aob/mcm128; Thomson MJ, 2007, THEOR APPL GENET, V114, P559, DOI 10.1007/s00122-006-0457-1; VAIRAVAN S, 1973, THEOR APPL GENET, V43, P213, DOI 10.1007/BF00309136; Wang CH, 2014, HEREDITY, V112, P489, DOI 10.1038/hdy.2013.130; Xu YB, 2004, CROP SCI, V44, P1947, DOI 10.2135/cropsci2004.1947; ZHANG QF, 1992, THEOR APPL GENET, V83, P495, DOI 10.1007/BF00226539; Zhao KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010780	41	43	46	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129607	10.1371/journal.pone.0129607	http://dx.doi.org/10.1371/journal.pone.0129607			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26067999	Green Published, Green Submitted, gold			2022-12-26	WOS:000356327000094
J	Sasaki, R; Yamasaki, K; Abiru, S; Komori, A; Nagaoka, S; Saeki, A; Hashimoto, S; Bekki, S; Kugiyama, Y; Kuno, A; Korenaga, M; Togayachi, A; Ocho, M; Mizokami, M; Narimatsu, H; Ichikawa, T; Nakao, K; Yatsuhashi, H				Sasaki, Ryu; Yamasaki, Kazumi; Abiru, Seigo; Komori, Atsumasa; Nagaoka, Shinya; Saeki, Akira; Hashimoto, Satoru; Bekki, Shigemune; Kugiyama, Yuki; Kuno, Atsushi; Korenaga, Masaaki; Togayachi, Akira; Ocho, Makoto; Mizokami, Masashi; Narimatsu, Hisashi; Ichikawa, Tatsuki; Nakao, Kazuhiko; Yatsuhashi, Hiroshi			Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Values Predict the Development of Hepatocellular Carcinoma among Patients with Chronic Hepatitis C after Sustained Virological Response	PLOS ONE			English	Article							TERM-FOLLOW-UP; ALPHA-FETOPROTEIN LEVELS; GENOTYPE 1 INFECTION; INTERFERON THERAPY; VIRUS-INFECTION; RISK-FACTORS; PEGYLATED INTERFERON-ALPHA-2B; LIVER FIBROSIS; STELLATE CELLS; CLASSIFICATION	Measurement of Wisteria floribundaagglutinin-positive human Mac-2 binding protein (WFA(+)-M2BP) in serum was recently shown to be a noninvasive method to assess liver fibrosis. The aim of this study was to evaluate the utility of serum WFA+-M2BP values to predict the development of hepatocellular carcinoma (HCC) in patients who achieved a sustained virological response (SVR) by interferon treatment. For this purpose, we retrospectively analyzed 238 patients with SVR who were treated with interferon in our department. Serum WFA+-M2BP values were measured at pre-treatment (pre-Tx), post-treatment (24 weeks after completion of interferon; post-Tx), the time of HCC diagnosis, and the last clinical visit. Of 238 patients with SVR, HCC developed in 16 (6.8%) patients. The average follow-up period was 9.1 years. The cumulative incidence of HCC was 3.4% at 5 years and 7.5% at 10 years. The median pre-Tx and post-Tx WFA+-M2BP values were 1.69 (range: 0.28 to 12.04 cutoff index (COI)) and 0.80 (range: 0.17 to 5.29 COI), respectively. The WFA+-M2BP values decreased significantly after SVR (P < 0.001). The median post-Tx WFA+-M2BP value in patients who developed HCC was significantly higher than that in patients who did not (P < 0.01). Multivariate analysis disclosed that age (> 60 years), sex (male), pre-Tx platelet count (< 15.0x103/mu L), and post-Tx WFA+-M2BP (> 2.0 COI) were associated with the development of HCC after SVR.	[Sasaki, Ryu; Yamasaki, Kazumi; Abiru, Seigo; Komori, Atsumasa; Nagaoka, Shinya; Saeki, Akira; Hashimoto, Satoru; Bekki, Shigemune; Kugiyama, Yuki; Yatsuhashi, Hiroshi] Natl Hosp Org, Nagasaki Med Ctr, Clin Res Ctr, Omura, Japan; [Kuno, Atsushi; Togayachi, Akira; Ocho, Makoto; Narimatsu, Hisashi] Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Tsukuba, Ibaraki, Japan; [Korenaga, Masaaki; Mizokami, Masashi] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Ichikawa, Japan; [Ichikawa, Tatsuki; Nakao, Kazuhiko] Nagasaki Univ, Grad Sch Biomed Sci, Dept Gastroenterol & Hepatol, Nagasaki 852, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Center for Global Health & Medicine - Japan; Nagasaki University	Yatsuhashi, H (corresponding author), Natl Hosp Org, Nagasaki Med Ctr, Clin Res Ctr, Omura, Japan.	yatsuhashi@nagasaki-mc.com	Togayachi, Akira/M-4144-2018; Kuno, Atsushi/M-2151-2018; Narimatsu, Hisashi/M-4757-2018; Korenaga, Masaaki/AAE-7479-2020	Togayachi, Akira/0000-0003-3600-9149; Kuno, Atsushi/0000-0002-6147-6171; Narimatsu, Hisashi/0000-0002-8402-133X; 	Ministry of Health, Labour and Welfare of Japan	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported in part by Health and Labour Sciences Research Grants for Research on Hepatitis from the Ministry of Health, Labour and Welfare of Japan.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Artini M, 1996, J HEPATOL, V25, P212, DOI 10.1016/S0168-8278(96)80076-6; Asahina Y, 2013, HEPATOLOGY, V58, P1253, DOI 10.1002/hep.26442; Asahina Y, 2010, HEPATOLOGY, V52, P518, DOI 10.1002/hep.23691; Backus LI, 2011, CLIN GASTROENTEROL H, V9, P509, DOI 10.1016/j.cgh.2011.03.004; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bruno S, 2007, HEPATOLOGY, V45, P579, DOI 10.1002/hep.21492; Cheung KJ, 2009, J VIRAL HEPATITIS, V16, P418, DOI 10.1111/j.1365-2893.2009.01083.x; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Di Bisceglie AM, 2005, J HEPATOL, V43, P434, DOI 10.1016/j.jhep.2005.03.019; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hasegawa E, 2007, HEPATOL RES, V37, P793, DOI 10.1111/j.1872-034X.2007.00140.x; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Hu JX, 2013, EXP THER MED, V5, P181, DOI 10.3892/etm.2012.768; Ikeda M, 2005, J GASTROENTEROL, V40, P148, DOI 10.1007/s00535-004-1519-2; Iwasaki Y, 2004, LIVER INT, V24, P603, DOI 10.1111/j.1478-3231.2004.0956.x; Kim KI, 2005, INTERVIROLOGY, V48, P52, DOI 10.1159/000082095; Kiyosawa K, 2004, GASTROENTEROLOGY, V127, pS17, DOI 10.1053/j.gastro.2004.09.012; Kobayashi S, 2007, LIVER INT, V27, P186, DOI 10.1111/j.1478-3231.2006.01406.x; Kuno A, 2013, PROTEOM CLIN APPL, V7, P642, DOI 10.1002/prca.201300010; Kuno A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01065; Lacovazzi PA, 2001, CLIN CHEM LAB MED, V39, P961; Makiyama A, 2004, CANCER-AM CANCER SOC, V101, P1616, DOI 10.1002/cncr.20537; Morgan RL, 2013, ANN INTERN MED, V158, P329, DOI 10.7326/0003-4819-158-5-201303050-00005; Morgan TR, 2010, HEPATOLOGY, V52, P833, DOI 10.1002/hep.23744; Narimatsu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091079; Ogawa E, 2013, J HEPATOL, V58, P495, DOI 10.1016/j.jhep.2012.10.017; Ohno T, 1997, J CLIN MICROBIOL, V35, P201, DOI 10.1128/JCM.35.1.201-207.1997; Pradat P, 2007, J VIRAL HEPATITIS, V14, P556, DOI 10.1111/j.1365-2893.2006.00829.x; Rodriguez-Diaz JL, 2007, CLIN ONCOL-UK, V19, P197, DOI 10.1016/j.clon.2006.12.005; Sasaki T, 1998, EMBO J, V17, P1606, DOI 10.1093/emboj/17.6.1606; Sherman M, 2005, SEMIN LIVER DIS, V25, P143, DOI 10.1055/s-2005-871194; Shindo M, 2001, HEPATOLOGY, V33, P1299, DOI 10.1053/jhep.2001.24100; SIMMONDS P, 1993, J GEN VIROL, V74, P2391, DOI 10.1099/0022-1317-74-11-2391; Singal AG, 2010, CLIN GASTROENTEROL H, V8, P280, DOI 10.1016/j.cgh.2009.11.018; Sun LC, 2013, MOL CELL PROTEOMICS, V12, P395, DOI 10.1074/mcp.M112.020784; Tanaka A, 2007, WORLD J GASTROENTERO, V13, P5180, DOI 10.3748/wjg.v13.i39.5180; Tateyama M, 2011, J GASTROENTEROL, V46, P92, DOI 10.1007/s00535-010-0293-6; Thomas David L, 2005, Clin Liver Dis, V9, P383, DOI 10.1016/j.cld.2005.05.003; Tokita H, 2005, J GASTROEN HEPATOL, V20, P752, DOI 10.1111/j.1440-1746.2005.03800.x; Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036; Watanabe S, 2011, HEPATOL RES, V41, P955, DOI 10.1111/j.1872-034X.2011.00847.x; Yamasaki K, 2014, HEPATOLOGY, V60, P1563, DOI 10.1002/hep.27305; Yoshida H, 1999, ANN INTERN MED, V131, P174, DOI 10.7326/0003-4819-131-3-199908030-00003	49	56	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129053	10.1371/journal.pone.0129053	http://dx.doi.org/10.1371/journal.pone.0129053			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070204	Green Published, Green Submitted, gold			2022-12-26	WOS:000356327000040
J	Vainio, I; Abu Khamidakh, A; Paci, M; Skottman, H; Juuti-Uusitalo, K; Hyttinen, J; Nymark, S				Vainio, Iina; Abu Khamidakh, Amna; Paci, Michelangelo; Skottman, Heli; Juuti-Uusitalo, Kati; Hyttinen, Jari; Nymark, Soile			Computational Model of Ca2+ Wave Propagation in Human Retinal Pigment Epithelial ARPE-19 Cells	PLOS ONE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; KINASE-A INCREASES; PROTEIN-KINASE; CALCIUM OSCILLATIONS; EXTRACELLULAR ATP; FLUID TRANSPORT; TIGHT JUNCTIONS; IN-VITRO; RELEASE; RPE	Objective Computational models of calcium (Ca2+) signaling have been constructed for several cell types. There are, however, no such models for retinal pigment epithelium (RPE). Our aim was to construct a Ca2+ signaling model for RPE based on our experimental data of mechanically induced Ca2+ wave in the in vitro model of RPE, the ARPE-19 monolayer. Methods We combined six essential Ca2+ signaling components into a model: stretch-sensitive Ca2+ channels (SSCCs), P2Y2 receptors, IP3 receptors, ryanodine receptors, Ca2+ pumps, and gap junctions. The cells in our epithelial model are connected to each other to enable transport of signaling molecules. Parameterization was done by tuning the above model components so that the simulated Ca2+ waves reproduced our control experimental data and data where gap junctions were blocked. Results Our model was able to explain Ca2+ signaling in ARPE-19 cells, and the basic mechanism was found to be as follows: 1) Cells near the stimulus site are likely to conduct Ca2+ through plasma membrane SSCCs and gap junctions conduct the Ca2+ and IP3 between cells further away. 2) Most likely the stimulated cell secretes ligand to the extracellular space where the ligand diffusion mediates the Ca2+ signal so that the ligand concentration decreases with distance. 3) The phosphorylation of the IP3 receptor defines the cell's sensitivity to the extracellular ligand attenuating the Ca2+ signal in the distance. Conclusions The developed model was able to simulate an array of experimental data including drug effects. Furthermore, our simulations predict that suramin may interfere ligand binding on P2Y2 receptors or accelerate P2Y2 receptor phosphorylation, which may partially be the reason for Ca2+ wave attenuation by suramin. Being the first RPE Ca2+ signaling model created based on experimental data on ARPE-19 cell line, the model offers a platform for further modeling of native RPE functions.	[Vainio, Iina; Abu Khamidakh, Amna; Paci, Michelangelo; Hyttinen, Jari; Nymark, Soile] Tampere Univ Technol, Dept Elect & Commun Engn, FIN-33101 Tampere, Finland; [Vainio, Iina; Abu Khamidakh, Amna; Paci, Michelangelo; Hyttinen, Jari; Nymark, Soile] Tampere Univ Technol, Inst Biosci & Med Technol, FIN-33101 Tampere, Finland; [Skottman, Heli; Juuti-Uusitalo, Kati] Univ Tampere, Inst Biosci & Med Technol, FIN-33101 Tampere, Finland	Tampere University; Tampere University; Tampere University	Vainio, I (corresponding author), Tampere Univ Technol, Dept Elect & Commun Engn, FIN-33101 Tampere, Finland.	iina.vainio@tut.fi	Hyttinen, Jari A/G-4280-2014; Nymark, Soile/M-9453-2016	Hyttinen, Jari A/0000-0003-1850-3055; Nymark, Soile/0000-0002-9274-0123; Juuti-Uusitalo, Kati/0000-0003-2275-5562; Skottman, Heli/0000-0002-4127-8792	Academy of Finland [252225, 260375, 218050, 137801]; TEKES-the finnish funding agency; Tampere University of Technology	Academy of Finland(Academy of Finland); TEKES-the finnish funding agency; Tampere University of Technology	This study was financially supported by the Academy of Finland (grant numbers 252225, 260375, 218050 and 137801), TEKES-the finnish funding agency for innovation (Human Spare Part Project), and Doctoral Programme of the President of the Tampere University of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablonczy Z, 2011, INVEST OPHTH VIS SCI, V52, P8614, DOI 10.1167/iovs.11-8021; Abu Khamidakh AE, 2013, EXP EYE RES, V108, P129, DOI 10.1016/j.exer.2013.01.009; Ahmado A, 2011, INVEST OPHTH VIS SCI, V52, P7148, DOI 10.1167/iovs.10-6374; Appleby PA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0487; Betzenhauser MJ, 2009, J BIOL CHEM, V284, P25116, DOI 10.1074/jbc.M109.010132; Caron AZ, 2007, CELL CALCIUM, V42, P323, DOI 10.1016/j.ceca.2007.01.002; Chaloux B, 2007, BIOL CELL, V99, P379, DOI 10.1042/BC20060121; Chi KR, 2013, NAT REV DRUG DISCOV, V12, P564, DOI 10.1038/nrd4083; Chung WC, 2005, J PHARMACOL EXP THER, V313, P191, DOI 10.1124/jpet.104.078311; De Pitta M, 2009, J BIOL PHYS, V35, P383, DOI 10.1007/s10867-009-9155-y; Dunn KC, 1998, INVEST OPHTH VIS SCI, V39, P2744; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Fall CP., 2002, COMPUTATIONAL CELL B; FEENEYBURNS L, 1984, INVEST OPHTH VIS SCI, V25, P195; Fink CC, 1999, BIOPHYS J, V77, P617, DOI 10.1016/S0006-3495(99)76918-3; Garg S, 2008, CLIN EXP OPHTHALMOL, V36, P252, DOI 10.1111/j.1442-9071.2008.01710.x; Garrad RC, 1998, J BIOL CHEM, V273, P29437, DOI 10.1074/jbc.273.45.29437; Gelisken F, 2001, AM J OPHTHALMOL, V131, P518, DOI 10.1016/S0002-9394(00)00813-8; Giancoli D. S., 2000, PHYS SCI ENG MODERN; Glotin AL, 2008, FREE RADICAL BIO MED, V44, P1348, DOI 10.1016/j.freeradbiomed.2007.12.023; Guo CM, 2009, CURR EYE RES, V34, P852, DOI 10.3109/02713680903128935; Hamill OP, 2006, PFLUG ARCH EUR J PHY, V453, P333, DOI 10.1007/s00424-006-0131-0; HANSEN M, 1993, J CELL SCI, V106, P995; Himpens B, 1999, FASEB J, V13, pS63; Hofer T, 2002, J NEUROSCI, V22, P4850, DOI 10.1523/JNEUROSCI.22-12-04850.2002; Homolya L, 2000, J CELL BIOL, V150, P1349, DOI 10.1083/jcb.150.6.1349; Huang W, 2004, INVEST OPHTH VIS SCI, V45, P1507, DOI 10.1167/iovs.03-0731; Keizer J, 1996, BIOPHYS J, V71, P3477, DOI 10.1016/S0006-3495(96)79543-7; Kennedy BG, 1996, EXP EYE RES, V63, P547, DOI 10.1006/exer.1996.0145; KONARI K, 1995, EXP EYE RES, V61, P99, DOI 10.1016/S0014-4835(95)80063-8; LeBeau AP, 1999, J GEN PHYSIOL, V113, P851, DOI 10.1085/jgp.113.6.851; Lemon G, 2003, J THEOR BIOL, V223, P93, DOI 10.1016/S0022-5193(03)00079-1; Loeffler KU, 1998, GRAEF ARCH CLIN EXP, V236, P929, DOI 10.1007/s004170050182; Luo Y, 2006, INVEST OPHTH VIS SCI, V47, P3644, DOI 10.1167/iovs.06-0166; MAHAMA PA, 1994, BIOPHYS J, V67, P1345, DOI 10.1016/S0006-3495(94)80606-X; Maminishkis A, 2002, INVEST OPHTH VIS SCI, V43, P3555; MARANTO AR, 1994, J BIOL CHEM, V269, P1222; Mitchell CH, 2001, J PHYSIOL-LONDON, V534, P193, DOI 10.1111/j.1469-7793.2001.00193.x; Nielsen MS, 2012, COMPR PHYSIOL, V2, P1981, DOI 10.1002/cphy.c110051; Peng SM, 2003, INVEST OPHTH VIS SCI, V44, P808, DOI 10.1167/iovs.02-0473; Peterson WM, 1997, J NEUROSCI, V17, P2324; Reigada D, 2005, AM J PHYSIOL-CELL PH, V289, pC617, DOI 10.1152/ajpcell.00542.2004; Reigada D, 2005, AM J PHYSIOL-CELL PH, V288, pC132, DOI 10.1152/ajpcell.00201.2004; Rizzolo LJ, 2007, INT REV CYTOL, V258, P195, DOI 10.1016/S0074-7696(07)58004-6; Ross MH., 1995, HISTOLOGY TEXT ATLAS, V3; SANDERSON MJ, 1994, MOL CELL ENDOCRINOL, V98, P173, DOI 10.1016/0303-7207(94)90136-8; Savolainen V, 2011, ANN BIOMED ENG, V39, P3055, DOI 10.1007/s10439-011-0387-1; SHEN J, 1993, BIOPHYS J, V64, P1323, DOI 10.1016/S0006-3495(93)81498-X; Siefjediers A, 2007, CELL CALCIUM, V41, P303, DOI 10.1016/j.ceca.2006.07.009; Singh RP, 2006, AM J OPHTHALMOL, V142, P160, DOI 10.1016/j.ajo.2006.03.051; Sneyd J, 2003, BIOPHYS J, V85, P1392, DOI 10.1016/S0006-3495(03)74572-X; Stalmans P, 1997, INVEST OPHTH VIS SCI, V38, P176; Stalmans P, 1998, INVEST OPHTH VIS SCI, V39, P1493; Sugiyama T, 1996, J HISTOCHEM CYTOCHEM, V44, P1237, DOI 10.1177/44.11.8918898; Sullivan DM, 1997, J NEUROSCI RES, V49, P43, DOI 10.1002/(SICI)1097-4547(19970701)49:1<43::AID-JNR5>3.0.CO;2-D; Wang JH, 2007, J THEOR BIOL, V245, P510, DOI 10.1016/j.jtbi.2006.11.007; Warren NJ, 2010, EXP PHYSIOL, V95, P232, DOI 10.1113/expphysiol.2009.049585; Wimmers S, 2007, PROG RETIN EYE RES, V26, P263, DOI 10.1016/j.preteyeres.2006.12.002; Wimmers S, 2008, MOL VIS, V14, P2340; Wojcikiewicz RJH, 1998, J BIOL CHEM, V273, P5670, DOI 10.1074/jbc.273.10.5670; Wu D, 2005, BIOPHYS CHEM, V113, P145, DOI 10.1016/j.bpc.2004.09.001; Yamamoto A, 2010, J PHARM SCI-US, V99, P2475, DOI 10.1002/jps.21991; Yang DL, 2011, INVEST OPHTH VIS SCI, V52, P1522, DOI 10.1167/iovs.10-6172; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003	64	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128434	10.1371/journal.pone.0128434	http://dx.doi.org/10.1371/journal.pone.0128434			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070134	gold, Green Published, Green Submitted			2022-12-26	WOS:000356327000017
J	Wei, YJ; Zhou, HK; Zhang, J; Zhang, L; Geng, AL; Liu, FH; Zhao, GP; Wang, SY; Zhou, ZH; Yan, X				Wei, Yongjun; Zhou, Haokui; Zhang, Jun; Zhang, Lei; Geng, Alei; Liu, Fanghua; Zhao, Guoping; Wang, Shengyue; Zhou, Zhihua; Yan, Xing			Insight into Dominant Cellulolytic Bacteria from Two Biogas Digesters and Their Glycoside Hydrolase Genes	PLOS ONE			English	Article							MICROBIAL COMMUNITY; ANAEROBIC-DIGESTION; METAGENOME; DATABASE; REACTOR; DEGRADATION; CELLULASES; GENERATION; CHEMOTAXIS; DISCOVERY	Diverse cellulolytic bacteria are essential for maintaining high lignocellulose degradation ability in biogas digesters. However, little was known about functional genes and gene clusters of dominant cellulolytic bacteria in biogas digesters. This is the foundation to understand lignocellulose degradation mechanisms of biogas digesters and apply these gene resource for optimizing biofuel production. A combination of metagenomic and 16S rRNA gene clone library methods was used to investigate the dominant cellulolytic bacteria and their glycoside hydrolase (GH) genes in two biogas digesters. The 16S rRNA gene analysis revealed that the dominant cellulolytic bacteria were strains closely related to Clostridium straminisolvens and an uncultured cellulolytic bacterium designated BG-1. To recover GH genes from cellulolytic bacteria in general, and BG-1 in particular, a refined assembly approach developed in this study was used to assemble GH genes from metagenomic reads; 163 GH-containing contigs >= 1 kb in length were obtained. Six recovered GH5 genes that were expressed in E. coli demonstrated multiple lignocellulase activities and one had high mannanase activity (1255 U/mg). Eleven fosmid clones harboring the recovered GH-containing contigs were sequenced and assembled into 10 fosmid contigs. The composition of GH genes in the 163 assembled metagenomic contigs and 10 fosmid contigs indicated that diverse GHs and lignocellulose degradation mechanisms were present in the biogas digesters. In particular, a small portion of BG-1 genome information was recovered by PhyloPythiaS analysis. The lignocellulase gene clusters in BG-1 suggested that it might use a possible novel lignocellulose degradation mechanism to efficiently degrade lignocellulose. Dominant cellulolytic bacteria of biogas digester possess diverse GH genes, not only in sequences but also in their functions, which may be applied for production of biofuel in the future.	[Wei, Yongjun; Zhang, Jun; Zhang, Lei; Geng, Alei; Liu, Fanghua; Zhao, Guoping; Zhou, Zhihua; Yan, Xing] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, CAS Key Lab Synthet Biol, Shanghai, Peoples R China; [Zhou, Haokui; Zhao, Guoping] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Zhao, Guoping; Wang, Shengyue] Chinese Natl Human Genome Ctr, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese University of Hong Kong; Prince of Wales Hospital	Zhou, ZH (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, CAS Key Lab Synthet Biol, Shanghai, Peoples R China.	zhouzhihua@sippe.ac.cn; yanxing@sippe.ac.cn	Wei, Yongjun/AAY-5100-2021; 刘, 芳华/H-7907-2014	Wei, Yongjun/0000-0002-1554-1999; 刘, 芳华/0000-0002-1934-3674	National Basic Research Program of China (973 program) [2012CB721103, 2011CB707403]; International Joint Research Program [GJHZ1128]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-J-12]	National Basic Research Program of China (973 program)(National Basic Research Program of China); International Joint Research Program; Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported financially by the National Basic Research Program of China (973 program: 2012CB721103; 2011CB707403), the International Joint Research Program (GJHZ1128), and the Knowledge Innovation Program of the Chinese Academy of Sciences (No. KSCX2-EW-J-12).	Allgaier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008812; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039331; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Burrell PC, 2004, APPL ENVIRON MICROB, V70, P2414, DOI 10.1128/AEM.70.4.2414-2419.2004; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chang A, 2009, NUCLEIC ACIDS RES, V37, pD588, DOI 10.1093/nar/gkn820; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Dai X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040430; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Geng AL, 2012, APPL MICROBIOL BIOT, V96, P951, DOI 10.1007/s00253-012-3873-y; Goberna M, 2009, APPL ENVIRON MICROB, V75, P2566, DOI 10.1128/AEM.02260-08; HEALY FG, 1995, APPL MICROBIOL BIOT, V43, P667, DOI [10.1007/s002530050468, 10.1007/BF00164771]; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jiang XY, 2011, ENERG POLICY, V39, P6073, DOI 10.1016/j.enpol.2011.07.007; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kato S, 2004, INT J SYST EVOL MICR, V54, P2043, DOI 10.1099/ijs.0.63148-0; Kirby JR, 2009, ANNU REV MICROBIOL, V63, P45, DOI 10.1146/annurev.micro.091208.073221; Krause L, 2008, J BIOTECHNOL, V136, P91, DOI 10.1016/j.jbiotec.2008.06.003; Li LL, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-23; Li LL, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-10; Li TL, 2009, ENVIRON MICROBIOL, V11, P889, DOI 10.1111/j.1462-2920.2008.01810.x; Liu FH, 2009, J APPL MICROBIOL, V106, P952, DOI 10.1111/j.1365-2672.2008.04064.x; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Merlino G, 2012, J CHEM TECHNOL BIOT, V87, P1302, DOI 10.1002/jctb.3784; Mou XZ, 2008, NATURE, V451, P708, DOI 10.1038/nature06513; Nelson MC, 2011, BIORESOURCE TECHNOL, V102, P3730, DOI 10.1016/j.biortech.2010.11.119; Newcomb M, 2007, P NATL ACAD SCI USA, V104, P3747, DOI 10.1073/pnas.0700087104; NOIKE T, 1985, BIOTECHNOL BIOENG, V27, P1482, DOI 10.1002/bit.260271013; O'Sullivan C, 2007, J APPL MICROBIOL, V103, P1332, DOI 10.1111/j.1365-2672.2007.03362.x; Patil KR, 2011, NAT METHODS, V8, P191, DOI 10.1038/nmeth0311-191; Patil KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038581; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; Safro M., 2004, HDB MOL MICROBIAL EC, P250, DOI DOI 10.1002/9781118010518.CH46; Schluter A, 2008, J BIOTECHNOL, V136, P77, DOI 10.1016/j.jbiotec.2008.05.008; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Sukharnikov LO, 2011, TRENDS BIOTECHNOL, V29, P473, DOI 10.1016/j.tibtech.2011.04.008; Tang YQ, 2011, APPL MICROBIOL BIOT, V91, P1447, DOI 10.1007/s00253-011-3479-9; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Ueno Y, 2001, APPL MICROBIOL BIOT, V57, P65; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Weiland P, 2010, APPL MICROBIOL BIOT, V85, P849, DOI 10.1007/s00253-009-2246-7; Wirth R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-41; Xia Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053779; Yan X, 2013, APPL MICROBIOL BIOT, V97, P8173, DOI 10.1007/s00253-013-4927-5	47	23	25	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129921	10.1371/journal.pone.0129921	http://dx.doi.org/10.1371/journal.pone.0129921			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070087	gold, Green Published, Green Submitted			2022-12-26	WOS:000356327000125
J	Allen, RB; Forsyth, DM; Allen, RKJ; Affeld, K; MacKenzie, DI				Allen, Robert B.; Forsyth, David M.; Allen, Roy K. J.; Affeld, Kathrin; MacKenzie, Darryl I.			Solar Radiation Determines Site Occupancy of Coexisting Tropical and Temperate Deer Species Introduced to New Zealand Forests	PLOS ONE			English	Article							C-ELAPHUS-SCOTICUS; RED DEER; STAND DEVELOPMENT; CERVUS UNICOLOR; UREWERA FORESTS; NORTH-ISLAND; RESOURCE USE; SIKA-DEER; HABITAT; AVAILABILITY	Assemblages of introduced taxa provide an opportunity to understand how abiotic and biotic factors shape habitat use by coexisting species. We tested hypotheses about habitat selection by two deer species recently introduced to New Zealand's temperate rainforests. We hypothesised that, due to different thermoregulatory abilities, rusa deer (Cervus timorensis; a tropical species) would prefer warmer locations in winter than red deer (Cervus elaphus scoticus; a temperate species). Since adult male rusa deer are aggressive in winter (the rut), we also hypothesised that rusa deer and red deer would not use the same winter locations. Finally, we hypothesised that in summer both species would prefer locations with fertile soils that supported more plant species preferred as food. We used a 250 x 250 m grid of 25 remote cameras to collect images in a 100-ha montane study area over two winters and summers. Plant composition, solar radiation, and soil fertility were also determined for each camera location. Multiseason occupancy models revealed that direct solar radiation was the best predictor of occupancy and detection probabilities for rusa deer in winter. Multistate, multiseason occupancy models provided strong evidence that the detection probability of adult male rusa deer was greater in winter and when other rusa deer were present at a location. Red deer mostly vacated the study area in winter. For the one season that had sufficient camera images of both species (summer 2011) to allow two-species occupancy models to be fitted, the detection probability of rusa deer also increased with solar radiation. Detection probability also varied with plant composition for both deer species. We conclude that habitat use by coexisting tropical and temperate deer species in New Zealand likely depends on the interplay between the thermoregulatory and behavioural traits of the deer and the abiotic and biotic features of the habitat.	[Allen, Robert B.; Affeld, Kathrin] Landcare Res, Lincoln, New Zealand; [Forsyth, David M.] Arthur Rylah Inst Environm Res, Dept Environm Land Water & Planning, Heidelberg, Vic, Australia; [MacKenzie, Darryl I.] Proteus Wildlife Res Consultants, Dunedin, New Zealand	Landcare Research - New Zealand; Arthur Rylah Institute for Environmental Research (ARI)	Allen, RB (corresponding author), Landcare Res, Lincoln, New Zealand.	roballen1706@gmail.com		Forsyth, David/0000-0001-5356-9573	former Foundation for Research, Science and Technology's Ecosystem Resilience Outcome Based Investment grant [C09X0502]; Proteus Wildlife Research Consultants	former Foundation for Research, Science and Technology's Ecosystem Resilience Outcome Based Investment grant; Proteus Wildlife Research Consultants	This work was funded by the authors and the former Foundation for Research, Science and Technology's Ecosystem Resilience Outcome Based Investment grant (contract number C09X0502) to Landcare Research although that funding agency had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Co-author Darryl I. MacKenzie is employed by Proteus Wildlife Research Consultants. Proteus Wildlife Research Consultants provided support in the form of salary for author DIM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	ALBON SD, 1992, OIKOS, V65, P502, DOI 10.2307/3545568; ALLEN RB, 1984, NEW ZEAL J ECOL, V7, P119; Allen RB., 1976, THESIS U CANTERBURY; Anderson D. R., 2008, MODEL BASED INFERENC; Arnold W, 2004, AM J PHYSIOL-REG I, V286, pR174, DOI 10.1152/ajpregu.00593.2002; Asada M, 1996, ECOL RES, V11, P89, DOI 10.1007/BF02347823; Banwell DB, 2006, NZ BIG GAME RECORDS, V4; Barraclough D, 2013, NZ ROD RIFLE, V24, P51; Begon M., 1996, ECOLOGY; Blakemore L.C., 1987, NZ SOIL BUR SCI REP; Buckman H. O., 1971, NATURE PROPERTIES SO; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CANHAM CD, 1988, ECOLOGY, V69, P1634, DOI 10.2307/1941664; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Clinton PW, 2002, CAN J FOREST RES, V32, P344, DOI 10.1139/X01-188; Corbet GB, 1992, MAMMALS INDO MALAYAN; DAVIDSON MM, 1991, NEW ZEAL J ECOL, V15, P31; Dolman PM, 2008, WILDLIFE RES, V35, P202, DOI 10.1071/WR07114; Douglas M.J.W., 1982, Tigerpaper (Bangkok), V9, P1; Dryden ML, 2000, ASIAN AUSTRAL J ANIM, V13, P62; DUNSON WA, 1991, AM NAT, V138, P1067, DOI 10.1086/285270; Dussault C, 2004, ECOSCIENCE, V11, P321, DOI 10.1080/11956860.2004.11682839; ELDER N. L., 1956, NEW ZEALAND JOUR FOREST, V7, P96; Ferretti F, 2012, HYSTRIX, V23, P28, DOI 10.4404/hystrix-23.2-4698; Forsyth DM, 2011, NEW ZEAL J ZOOL, V38, P237, DOI 10.1080/03014223.2011.592200; Forsyth DM, 2010, NEW ZEAL J ECOL, V34, P277; Forsyth DM, 2010, NEW ZEAL J ECOL, V34, P48; Forsyth DM, 1998, OECOLOGIA, V113, P377, DOI 10.1007/s004420050389; Forsyth DM, 2005, FUNCT ECOL, V19, P495, DOI 10.1111/j.1365-2435.2005.00991.x; Forsyth DM, 2002, NEW ZEAL J ZOOL, V29, P323, DOI 10.1080/03014223.2002.9518316; Forsyth DM, 2001, AM NAT, V157, P583, DOI 10.1086/320626; Forsyth DM, ECOL MONOGR IN PRESS; Fraser KW, 1996, OECOLOGIA, V105, P160, DOI 10.1007/BF00328541; Fraser W, 2005, HDB NZ MAMMALS, P442; Frazer GW, 1999, GAP LIGHT ANAL GLA V; Gause G. F., 1934, STRUGGLE EXISTENCE; Gormley AM, 2011, J APPL ECOL, V48, P25, DOI 10.1111/j.1365-2664.2010.01911.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; HAIRSTON NG, 1980, ECOLOGY, V61, P817, DOI 10.2307/1936752; HURST JM, 2007, RECCE METHOD DESCRIB; Husheer SW, 2006, BIOL INVASIONS, V8, P823, DOI 10.1007/s10530-005-4011-x; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kucera TE, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P9, DOI 10.1007/978-4-431-99495-4_2; Latham ADM, 2015, NEW ZEAL J ECOL, V39, P143; Loison A, 1998, OECOLOGIA, V116, P489, DOI 10.1007/s004420050614; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Mackenzie DI, 2009, ECOLOGY, V90, P823, DOI 10.1890/08-0141.1; MacKenzie DI, 2004, J ANIM ECOL, V73, P546, DOI 10.1111/j.0021-8790.2004.00828.x; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; Main MB, 2008, ECOLOGY, V89, P693, DOI 10.1890/07-0645.1; Mason NWH, 2010, J ECOL, V98, P1422, DOI 10.1111/j.1365-2745.2010.01714.x; McKelvey P. J., 1973, 59 NZ FOR SERV; McLaren R.G., 1996, SOIL SCI SUSTAINABLE; Melin M, 2014, GLOBAL CHANGE BIOL, V20, P1115, DOI 10.1111/gcb.12405; Morris DW, 2003, OECOLOGIA, V136, P1, DOI 10.1007/s00442-003-1241-4; NUGENT G, 1993, NZ HUNTING WILDLIFE, V14, P11, DOI DOI 10.1080/00480169; Nugent G, 2005, HDB NZ MAMMALS, V2nd, P401; O'Connell A, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, pV; PAYTON IJ, 1984, NEW ZEAL J BOT, V22, P207, DOI 10.1080/0028825X.1984.10425253; Peltzer DA, 2014, FOREST ECOL MANAG, V331, P165, DOI 10.1016/j.foreco.2014.06.037; R Development Core Team, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Richardson SJ, 2008, FUNCT ECOL, V22, P738, DOI 10.1111/j.1365-2435.2008.01426.x; ROSENZWEIG ML, 1991, AM NAT, V137, pS5, DOI 10.1086/285137; Semiadi G, 1996, J AGR SCI-CAMBRIDGE, V126, P221, DOI 10.1017/S0021859600073172; SEMIADI G, 1995, J AGR SCI, V125, P109, DOI 10.1017/S0021859600074566; STEWART GH, 1987, NEW ZEAL J ECOL, V10, P1; Thomas DL, 2006, J WILDLIFE MANAGE, V70, P324, DOI 10.2193/0022-541X(2006)70[324:SDATFC]2.0.CO;2; van Beest FM, 2012, ANIM BEHAV, V84, P723, DOI 10.1016/j.anbehav.2012.06.032; VANMOURIK S, 1985, APPL ANIM BEHAV SCI, V14, P275, DOI 10.1016/0168-1591(85)90008-5; Wardle J., 1984, NZ BEECHES ECOLOGY U; Wiser SK, 2002, J BIOGEOGR, V29, P767, DOI 10.1046/j.1365-2699.2002.00723.x; Wodzicki K., 1950, INTRO MAMMALS NZ	73	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0128924	10.1371/journal.pone.0128924	http://dx.doi.org/10.1371/journal.pone.0128924			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061426	Green Published, gold			2022-12-26	WOS:000355979500108
J	Archer, SC; Hudson, CD; Green, MJ				Archer, Simon C.; Hudson, Christopher D.; Green, Martin J.			Use of Stochastic Simulation to Evaluate the Reduction in Methane Emissions and Improvement in Reproductive Efficiency from Routine Hormonal Interventions in Dairy Herds	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; ESTRUS SYNCHRONIZATION; COWS; PROGESTERONE; PERFORMANCE; PROGRAMS; IMPACT; FERTILITY; LACTATION; OVULATION	This study predicts the magnitude and between herd variation in changes of methane emissions and production efficiency associated with interventions to improve reproductive efficiency in dairy cows. Data for 10,000 herds of 200 cows were simulated. Probability of conception was predicted daily from the start of the study (parturition) for each cow up to day 300 of lactation. Four scenarios of differing first insemination management were simulated for each herd using the same theoretical cows: A baseline scenario based on breeding from observed oestrus only, synchronisation of oestrus for pre-set first insemination using 2 methods, and a regime using prostaglandin treatments followed by first insemination to observed oestrus. Cows that did not conceive to first insemination were re-inseminated following detection of oestrus. For cows that conceived, gestation length was 280 days with cessation of milking 60 days before calving. Those cows not pregnant after 300 days of lactation were culled and replaced by a heifer. Daily milk yield was calculated for 730 days from the start of the study for each cow. Change in mean reproductive and economic outputs were summarised for each herd following the 3 interventions. For each scenario, methane emissions were determined by daily forage dry matter intake, forage quality, and cow replacement risk. Linear regression was used to summarise relationships. In some circumstances improvement in reproductive efficiency using the programmes investigated was associated with reduced cost and methane emissions compared to reliance on detection of oestrus. Efficiency of oestrus detection and the time to commencement of breeding after calving influenced variability in changes in cost and methane emissions. For an average UK herd this was a saving of at least pound 50 per cow and a 3.6% reduction in methane emissions per L of milk when timing of first insemination was pre-set.	[Archer, Simon C.; Hudson, Christopher D.; Green, Martin J.] Univ Nottingham, Sch Vet Med & Sci, Loughborough, Leics, England	University of Nottingham	Archer, SC (corresponding author), Univ Nottingham, Sch Vet Med & Sci, Loughborough, Leics, England.	simon.archer@nottingham.ac.uk	Archer, S.C./AAD-7010-2020; Green, Martin/F-7066-2011; Hudson, Chris/G-5561-2011	Archer, S.C./0000-0003-4242-5106; Green, Martin/0000-0002-6408-6443; Hudson, Chris/0000-0003-4777-062X	Zoetis [RJ3812]	Zoetis	The study was funded by Zoetis (RJ3812 MJG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderman G., 1993, EN PROT REQ RUM ADV; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2012, WORLD POPULATION PRO; [Anonymous], 2010, MEASURING EFFECTIVEN; [Anonymous], 2013, INVENTORY US GREENHO; Archer SC, 2014, PREV VET MED, V113, P80, DOI 10.1016/j.prevetmed.2013.10.011; Caraviello DZ, 2006, J DAIRY SCI, V89, P4723, DOI 10.3168/jds.S0022-0302(06)72522-X; Chebel RC, 2010, J DAIRY SCI, V93, P922, DOI 10.3168/jds.2009-2301; DairyCo, 2014, DAIR STAT INS GUID; De Vries A, 2006, J DAIRY SCI, V89, P3876, DOI 10.3168/jds.S0022-0302(06)72430-4; Ei-Zarkouny SZ, 2004, J DAIRY SCI, V87, P1024, DOI 10.3168/jds.S0022-0302(04)73248-8; Forde N, 2011, ANIM REPROD SCI, V124, P163, DOI 10.1016/j.anireprosci.2010.08.025; Foresight, 2011, FUT FOOD FARM; FOSTER C, 2006, ENV IMPACTS FOOD PRO; Garnsworthy PC, 2004, ANIM FEED SCI TECH, V112, P211, DOI 10.1016/j.anifeedsci.2003.10.011; Giordano JO, 2012, J DAIRY SCI, V95, P5442, DOI 10.3168/jds.2011-4972; Giordano JO, 2011, J DAIRY SCI, V94, P6216, DOI 10.3168/jds.2011-4376; Herrero M, 2011, ANIM FEED SCI TECH, V166-67, P779, DOI 10.1016/j.anifeedsci.2011.04.083; Higgins HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062993; Hudson CD, 2012, J DAIRY SCI, V95, P3683, DOI 10.3168/jds.2011-4629; Hudson CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103426; Knapp JR, 2014, J DAIRY SCI, V97, P3231, DOI 10.3168/jds.2013-7234; Lips M, 2005, J AGR ECON, V56, P1, DOI 10.1111/j.1477-9552.2005.tb00119.x; MACMILLAN KL, 1982, THERIOGENOLOGY, V18, P245, DOI 10.1016/0093-691X(82)90001-2; Madouasse A, 2012, PREV VET MED, V105, P38, DOI 10.1016/j.prevetmed.2012.02.009; Mawhinney I, 1999, VET REC, V145, P551, DOI 10.1136/vr.145.19.551; McDougall S, 2010, J DAIRY SCI, V93, P1944, DOI 10.3168/jds.2009-2305; Nebel RL, 1998, J DAIRY SCI, V81, P1169, DOI 10.3168/jds.S0022-0302(98)75679-6; PURSLEY JR, 1995, THERIOGENOLOGY, V44, P915, DOI 10.1016/0093-691X(95)00279-H; Rasbash J, 2019, USERS GUIDE MLWIN; Remnant JG, 2015, J DAIRY SCI, V98, P889, DOI 10.3168/jds.2014-8366; Spiegelhalter DJ, 2004, BAYESIAN APPROACHES, DOI DOI 10.1002/0470092602; Steinfeld H., 2006, LIVESTOCKS LONG SHAD, DOI [10.1890/1540-9295(2007)5[4:D]2.0.CO;2, DOI 10.1890/1540-9295(2007)5[4:D]2.0.CO;2]; Stevenson JS, 2006, J DAIRY SCI, V89, P2567, DOI 10.3168/jds.S0022-0302(06)72333-5; Wilkinson JM, 2011, ANIMAL, V5, P1014, DOI 10.1017/S175173111100005X; Xu ZZ, 1997, THERIOGENOLOGY, V47, P687, DOI 10.1016/S0093-691X(97)00027-7; Xu ZZ, 2000, J DAIRY SCI, V83, P471, DOI 10.3168/jds.S0022-0302(00)74905-8	37	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0127846	10.1371/journal.pone.0127846	http://dx.doi.org/10.1371/journal.pone.0127846			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061424	Green Submitted, Green Published, gold			2022-12-26	WOS:000355979500060
J	Lillis, AP; Muratoglu, SC; Au, DT; Migliorini, M; Lee, MJ; Fried, SK; Mikhailenko, I; Strickland, DK				Lillis, Anna P.; Muratoglu, Selen Catania; Au, Dianaly T.; Migliorini, Mary; Lee, Mi-Jeong; Fried, Susan K.; Mikhailenko, Irina; Strickland, Dudley K.			LDL Receptor-Related Protein-1 (LRP1) Regulates Cholesterol Accumulation in Macrophages	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; SMOOTH-MUSCLE-CELLS; ALPHA-2-MACROGLOBULIN RECEPTOR; APOLIPOPROTEIN-E; MEDIATES UPTAKE; AGGREGATED LDL; BONE-MARROW; ATHEROGENIC LIPOPROTEINS; SCAVENGER RECEPTORS; TERMINAL DOMAIN	Within the circulation, cholesterol is transported by lipoprotein particles and is taken up by cells when these particles associate with cellular receptors. In macrophages, excessive lipoprotein particle uptake leads to foam cell formation, which is an early event in the development of atherosclerosis. Currently, mechanisms responsible for foam cell formation are incompletely understood. To date, several macrophage receptors have been identified that contribute to the uptake of modified forms of lipoproteins leading to foam cell formation, but the contribution of the LDL receptor-related protein 1 (LRP1) to this process is not known. To investigate the role of LRP1 in cholesterol accumulation in macrophages, we generated mice with a selective deletion of LRP1 in macrophages on an LDL receptor (LDLR)-deficient background (macLRP1-/-). After feeding mice a high fat diet for 11 weeks, peritoneal macrophages isolated from Lrp(+/+) mice contained significantly higher levels of total cholesterol than those from macLRP1-/- mice. Further analysis revealed that this was due to increased levels of cholesterol esters. Interestingly, macLRP1-/- mice displayed elevated plasma cholesterol and triglyceride levels resulting from accumulation of large, triglyceride-rich lipoprotein particles in the circulation. This increase did not result from an increase in hepatic VLDL biosynthesis, but rather results from a defect in catabolism of triglyceride-rich lipoprotein particles in macLRP1-/- mice. These studies reveal an important in vivo contribution of macrophage LRP1 to cholesterol homeostasis.	[Lillis, Anna P.; Muratoglu, Selen Catania; Au, Dianaly T.; Migliorini, Mary; Mikhailenko, Irina; Strickland, Dudley K.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Muratoglu, Selen Catania; Mikhailenko, Irina; Strickland, Dudley K.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Migliorini, Mary; Strickland, Dudley K.] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA; [Lee, Mi-Jeong; Fried, Susan K.] Boston Univ, Sch Med, Dept Med, Sect Endocrinol Diabet & Nutr, Boston, MA 02118 USA; [Lillis, Anna P.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Boston University; Duke University	Strickland, DK (corresponding author), Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA.	dstrickland@som.umaryland.edu	Lee, Mi-Jeong/ABE-1084-2020; Lee, Mi-Jeong/GXV-9843-2022; Lillis, Anna/AAI-6942-2021	Lee, Mi-Jeong/0000-0002-8171-7913; Lee, Mi-Jeong/0000-0002-8171-7913; Lillis, Anna/0000-0003-4810-9577; Muratoglu Catania, Selen/0000-0002-1804-4875; Au, Dianaly/0000-0002-8797-833X	National Heart, Lung, and Blood Institute, of the National Institutes of Health [R01 HL114379, R01 HL120388, T32 HL007698]; National Institute of Diabetes and Disgestive and Kidney Disease of the National Institutes of Health [P30 DK072488]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120388, T32HL007698, R01HL114379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Disgestive and Kidney Disease of the National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funded by research grants R01 HL114379 (DKS), R01 HL120388 (DKS), T32 HL007698 (DKS), from the National Heart, Lung, and Blood Institute, of the National Institutes of Health, and P30 DK072488 (SKF) from the National Institute of Diabetes and Disgestive and Kidney Disease of the National Institutes of Health.	AaltoSetala K, 1996, J LIPID RES, V37, P1802; AALTOSETALA K, 1992, J CLIN INVEST, V90, P1889, DOI 10.1172/JCI116066; ASHCOM JD, 1990, J CELL BIOL, V110, P1041, DOI 10.1083/jcb.110.4.1041; BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BROWN MS, 1980, J SUPRAMOL STR CELL, V13, P67, DOI 10.1002/jss.400130107; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; Cao CZ, 2006, EMBO J, V25, P1860, DOI 10.1038/sj.emboj.7601082; CHAPPELL DA, 1993, J BIOL CHEM, V268, P14168; CHAPPELL DA, 1994, J BIOL CHEM, V269, P18001; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Devlin CM, 2008, ARTERIOSCL THROM VAS, V28, P1723, DOI 10.1161/ATVBAHA.108.173344; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; FELDMAN SR, 1985, BIOCHEM BIOPH RES CO, V128, P795, DOI 10.1016/0006-291X(85)90117-2; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; Hu L, 2006, ARTERIOSCL THROM VAS, V26, P2710, DOI 10.1161/01.ATV.0000249641.96896.e6; HUSSAIN MM, 1989, J BIOL CHEM, V264, P9571; HUSSAIN MM, 1989, J BIOL CHEM, V264, P17931; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Kanda T, 2009, J CLIN INVEST, V119, P110, DOI 10.1172/JCI36233; Kennedy DW, 1997, BLOOD, V90, P986, DOI 10.1182/blood.V90.3.986.986_986_993; KODAMA T, 1990, NATURE, V343, P531, DOI 10.1038/343531a0; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; KOWAL RC, 1990, J BIOL CHEM, V265, P10771; Kruth HS, 2005, J BIOL CHEM, V280, P2352, DOI 10.1074/jbc.M407167200; Kruth HS, 2002, CURR OPIN LIPIDOL, V13, P483, DOI 10.1097/00041433-200210000-00003; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Leroux A, 2012, J HEPATOL, V57, P141, DOI 10.1016/j.jhep.2012.02.028; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lillis AP, 2008, J IMMUNOL, V181, P364, DOI 10.4049/jimmunol.181.1.364; Linton MF, 1998, J CLIN INVEST, V101, P1726, DOI 10.1172/JCI2181; Llorente-Cortes V, 2007, J LIPID RES, V48, P2133, DOI 10.1194/jlr.M700039-JLR200; Llorente-Cortes V, 2006, ARTERIOSCL THROM VAS, V26, P117, DOI 10.1161/01.ATV.0000193618.32611.8b; Llorente-Cortes V, 2000, ARTERIOSCL THROM VAS, V20, P1572, DOI 10.1161/01.ATV.20.6.1572; Loukinova E, 2002, J BIOL CHEM, V277, P15499, DOI 10.1074/jbc.M200427200; Low H, 2012, JOVE-J VIS EXP, DOI 10.3791/3810; Mahley RW, 2007, J CLIN INVEST, V117, P94, DOI 10.1172/JCI30889; Manning-Tobin JJ, 2009, ARTERIOSCL THROM VAS, V29, P19, DOI 10.1161/ATVBAHA.108.176644; Mehta JL, 2007, CIRC RES, V100, P1634, DOI 10.1161/CIRCRESAHA.107.149724; Migliorini MM, 2003, J BIOL CHEM, V278, P17986, DOI 10.1074/jbc.M212592200; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; MOESTRUP SK, 1989, J BIOL CHEM, V264, P15574; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; Muratoglu SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028846; Muratoglu SC, 2010, J BIOL CHEM, V285, P14308, DOI 10.1074/jbc.M109.046672; Musso G, 2013, PROG LIPID RES, V52, P175, DOI 10.1016/j.plipres.2012.11.002; Newton CS, 2005, J BIOL CHEM, V280, P27872, DOI 10.1074/jbc.M505410200; NILSSONEHLE P, 1976, J LIPID RES, V17, P536; OTTNAD E, 1995, P NATL ACAD SCI USA, V92, P1391, DOI 10.1073/pnas.92.5.1391; Overton CD, 2007, CIRC RES, V100, P670, DOI 10.1161/01.RES.0000260204.40510.aa; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Santamarina-Fojo S, 2001, J LIPID RES, V42, P1339; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; Schissel SL, 1998, J BIOL CHEM, V273, P2738, DOI 10.1074/jbc.273.5.2738; SCHUMAKER VN, 1986, METHOD ENZYMOL, V128, P155; Stanford KI, 2009, J CLIN INVEST, V119, P3236, DOI 10.1172/JCI38251; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; TABAS I, 1993, J BIOL CHEM, V268, P20419; Terrand J, 2009, J BIOL CHEM, V284, P381, DOI 10.1074/jbc.M806538200; TRABER MG, 1980, P NATL ACAD SCI-BIOL, V77, P5466, DOI 10.1073/pnas.77.9.5466; Van Eck M, 2000, ARTERIOSCL THROM VAS, V20, pE53, DOI 10.1161/01.ATV.20.9.e53; Williams KJ, 2008, J CLIN INVEST, V118, P3247, DOI 10.1172/JCI35206; WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551; WILLIAMS SE, 1994, J BIOL CHEM, V269, P8653; Yancey PG, 2011, CIRCULATION, V124, P454, DOI 10.1161/CIRCULATIONAHA.111.032268; Yancey PG, 2010, ARTERIOSCL THROM VAS, V30, P787, DOI 10.1161/ATVBAHA.109.202051; Zhou L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006853; Zurhove K, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164263	72	39	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0128903	10.1371/journal.pone.0128903	http://dx.doi.org/10.1371/journal.pone.0128903			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061292	Green Published, gold, Green Submitted			2022-12-26	WOS:000355979500107
J	Papastamatiou, YP; Watanabe, YY; Bradley, D; Dee, LE; Weng, K; Lowe, CG; Caselle, JE				Papastamatiou, Yannis P.; Watanabe, Yuuki Y.; Bradley, Darcy; Dee, Laura E.; Weng, Kevin; Lowe, Christopher G.; Caselle, Jennifer E.			Drivers of Daily Routines in an Ectothermic Marine Predator: Hunt Warm, Rest Warmer?	PLOS ONE			English	Article							POST-FEEDING THERMOTAXIS; DIEL VERTICAL MIGRATION; TEMPERATURE-DEPENDENCE; REEF SHARKS; BEHAVIOR; PATTERNS; TACTICS	Animal daily routines represent a compromise between maximizing foraging success and optimizing physiological performance, while minimizing the risk of predation. For ectothermic predators, ambient temperature may also influence daily routines through its effects on physiological performance. Temperatures can fluctuate significantly over the diel cycle and ectotherms may synchronize behaviour tomatch thermal regimes in order to optimize fitness. We used bio-logging to quantify activity and body temperature of blacktip reef sharks (Carcharhinus melanopterus) at a tropical atoll. Behavioural observations were used to concurrently measure bite rates in herbivorous reef fishes, as an index of activity for potential diurnal prey. Sharks showed early evening peaks in activity, particularly during ebbing high tides, while body temperatures peaked several hours prior to the period of maximal activity. Herbivores also displayed peaks in activity several hours earlier than the peaks in shark activity. Sharks appeared to be least active while their body temperatures were highest and most active while temperatures were cooling, although we hypothesize that due to thermal inertia they were still warmer than their smaller prey during this period. Sharksmay be most active during early evening periods as they have a sensory advantage under low light conditions and/ or a thermal advantage over cooler prey. Sharks swaminto shallow water during daytime low tide periods potentially to warm up and increase rates of digestion before the nocturnal activity period, which may be a strategy to maximize ingestion rates. "Hunt warm, rest warmer" may help explain the early evening activity seen in other ectothermic predators.	[Papastamatiou, Yannis P.] Univ St Andrews, Sch Biol, Scottish Oceans Inst, St Andrews, Fife, Scotland; [Watanabe, Yuuki Y.] Natl Inst Polar Res, Tachikawa, Tokyo, Japan; [Watanabe, Yuuki Y.] SOKENDAI Grad Univ Adv Studies, Tachikawa, Tokyo, Japan; [Bradley, Darcy; Dee, Laura E.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Weng, Kevin] Virginia Inst Marine Sci, Dept Fisheries Sci, Gloucester Point, VA 23062 USA; [Lowe, Christopher G.] Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA; [Caselle, Jennifer E.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA	University of St Andrews; Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan; Graduate University for Advanced Studies - Japan; University of California System; University of California Santa Barbara; William & Mary; Virginia Institute of Marine Science; California State University System; California State University Long Beach; University of California System; University of California Santa Barbara	Papastamatiou, YP (corresponding author), Univ St Andrews, Sch Biol, Scottish Oceans Inst, St Andrews, Fife, Scotland.	ypapastamatiou@gmail.com	; Weng, Kevin Chi-Ming/C-4709-2013	Watanabe, Yuuki/0000-0001-9731-1769; Bradley, Darcy/0000-0003-2581-8768; Weng, Kevin Chi-Ming/0000-0002-7069-7152; Dee, Laura/0000-0003-0471-1371	MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Funding Council [HR09011]; Japan Society for the Promotion of Science [25850138]; Hawai'i Undersea Research Laboratory/NOAA Coral Reef Conservation Program; U.S. National Science Foundation GRFP; Marisla Foundation	MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Funding Council; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Hawai'i Undersea Research Laboratory/NOAA Coral Reef Conservation Program; U.S. National Science Foundation GRFP(National Science Foundation (NSF)); Marisla Foundation	This work received funding from the MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland), and their support is gratefully acknowledged. MASTS is funded by the Scottish Funding Council (grant reference HR09011) and contributing institutions. Funding was also provided by a Grants-in-Aids for scientific research from the Japan Society for the Promotion of Science (25850138), the Hawai'i Undersea Research Laboratory/NOAA Coral Reef Conservation Program, the U.S. National Science Foundation GRFP, and the Marisla Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernal D, 2012, CRC MAR BIOL SER, P211; Bosiger YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111723; Broekhuis F, 2014, BEHAV ECOL, V25, P1268, DOI 10.1093/beheco/aru122; Brownscombe JW, 2014, MAR ECOL PROG SER, V505, P241, DOI 10.3354/meps10786; Dell AI, 2014, J ANIM ECOL, V83, P70, DOI 10.1111/1365-2656.12081; Dell AI, 2011, P NATL ACAD SCI USA, V108, P10591, DOI 10.1073/pnas.1015178108; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; Di Santo V, 2011, J FISH BIOL, V78, P195, DOI 10.1111/j.1095-8649.2010.02853.x; DiGirolamo AL, 2012, J FISH BIOL, V80, P1436, DOI 10.1111/j.1095-8649.2012.03263.x; Englund G, 2011, ECOL LETT, V14, P914, DOI 10.1111/j.1461-0248.2011.01661.x; Gannon R, 2014, J EXP BIOL, V217, P3033, DOI 10.1242/jeb.104455; Gardiner JM, 2012, CRC MAR BIOL SER, P349; Gleiss AC, 2013, MAR BIOL, V160, P2981, DOI 10.1007/s00227-013-2288-3; Gleiss AC, 2010, J EXP MAR BIOL ECOL, V385, P85, DOI 10.1016/j.jembe.2010.01.012; Halsey LG, 2009, COMP BIOCHEM PHYS A, V152, P197, DOI 10.1016/j.cbpa.2008.09.021; Heurich M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114143; Hight BV, 2007, J EXP MAR BIOL ECOL, V352, P114, DOI 10.1016/j.jembe.2007.07.021; Holbrook SJ, 2002, ECOLOGY, V83, P2855, DOI 10.2307/3072021; Houston AI, 2014, J ANIM ECOL, V83, P30, DOI 10.1111/1365-2656.12096; Hume ID, 2005, PHYSIOLOGICAL ADAPTATIONS TO FEEDING INVERTEBRATES, P43; Jeschke JM, 2007, OECOLOGIA, V152, P357, DOI 10.1007/s00442-006-0654-2; Lowe CG, 2002, J EXP MAR BIOL ECOL, V278, P141, DOI 10.1016/S0022-0981(02)00331-3; McCauley DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038871; Owen SF, 2001, COMP BIOCHEM PHYS A, V128, P631, DOI 10.1016/S1095-6433(00)00340-8; Papastamatiou YP, 2012, J FISH BIOL, V80, P1342, DOI 10.1111/j.1095-8649.2012.03232.x; Papastamatiou YP, 2007, J EXP MAR BIOL ECOL, V345, P129, DOI 10.1016/j.jembe.2007.02.006; Papastamatiou YP, 2009, ECOLOGY, V90, P996, DOI 10.1890/08-0491.1; Pedersen MW, 2013, METHODS ECOL EVOL, V4, P920, DOI 10.1111/2041-210X.12086; Peters Gerrit, 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P203; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Regular PM, 2010, MAR ECOL PROG SER, V415, P295, DOI 10.3354/meps08752; Sims DW, 2006, J ANIM ECOL, V75, P176, DOI 10.1111/j.1365-2656.2005.01033.x; Sims DW, 1996, J MAR BIOL ASSOC UK, V76, P479, DOI 10.1017/S002531540003068X; Smith TB, 2008, CORAL REEFS, V27, P397, DOI 10.1007/s00338-007-0343-6; Speed CW, 2012, MAR ECOL PROG SER, V463, P231, DOI 10.3354/meps09864; STEVENS JD, 1984, PROC R SOC SER B-BIO, V222, P79, DOI 10.1098/rspb.1984.0050; Taylor MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080962; Thorstad EB, 2009, MAR FRESHWATER RES, V60, P183, DOI 10.1071/MF08191; Vaudo JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061907; Watanabe Y, 2004, MAR ECOL PROG SER, V279, P283, DOI 10.3354/meps279283; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; WURTSBAUGH WA, 1988, NATURE, V333, P846, DOI 10.1038/333846a0	43	64	65	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0127807	10.1371/journal.pone.0127807	http://dx.doi.org/10.1371/journal.pone.0127807			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061229	Green Published, gold			2022-12-26	WOS:000355979500058
J	Thomas, A; Ono, K				Thomas, Amber; Ono, Kathryn			Diving Related Changes in the Blood Oxygen Stores of Rehabilitating Harbor Seal Pups (Phoca vitulina)	PLOS ONE			English	Article							IRON-DEFICIENCY ANEMIA; WEDDELL SEALS; HALICHOERUS-GRYPUS; MIROUNGA-LEONINA; BODY-COMPOSITION; MARINE MAMMALS; CAPACITY; ERYTHROPOIETIN; HEMATOLOGY; BEHAVIOR	Harbor seal (Phoca vitulina) pups begin diving within hours of birth, stimulating the development of the blood oxygen (O-2) stores necessary to sustain underwater aerobic metabolism. Since harbor seals experience a brief nursing period, the early-life development of these blood O-2 stores is necessary for successful post-weaning foraging. If mothers and pups become prematurely separated, the pup may be transported to a wildlife rehabilitation center for care. Previous studies suggest that the shallow pools and lack of diving in rehabilitation facilities may lead to under-developed blood O-2 stores, but diving behavior during rehabilitation has not been investigated. This study aimed to simultaneously study the diving behaviors and blood O-2 store development of rehabilitating harbor seal pups. Standard hematology measurements (Hct, Hb, RBC, MCV, MCH, MCHC) were taken to investigate O-2 storage capacity and pups were equipped with time-depth recorders to investigate natural diving behavior while in rehabilitation. Linear mixed models of the data indicate that all measured blood parameters changed with age; however, when compared to literature values for wild harbor seal pups, rehabilitating pups have smaller red blood cells (RBCs) that can store less hemoglobin (Hb) and subsequently, less O-2, potentially limiting their diving capabilities. Wild pups completed longer dives at younger ages (maximum reported <25 days of age: 9 min) in previous studies than the captive pups in this study (maximum <25 days of age: 2.86 min). However, captivity may only affect the rate of development, as long duration dives were observed (maximum during rehabilitation: 13.6 min at 89 days of age). Further, this study suggests that there may be a positive relationship between RBC size and the frequency of long duration dives. Thus, rehabilitating harbor seal pups should be encouraged to make frequent, long duration dives to prepare themselves for post-release foraging.	[Thomas, Amber; Ono, Kathryn] Univ New England, Dept Marine Sci, Biddeford, ME 04005 USA	University of New England - Maine	Thomas, A (corresponding author), Univ New England, Dept Marine Sci, Biddeford, ME 04005 USA.	athomas6@une.edu		Thomas, Amber/0000-0002-9622-5778	University of New England's graduate student fund; National Science Foundation, GK-12 Fellowship [0841361]	University of New England's graduate student fund; National Science Foundation, GK-12 Fellowship	The University of New England's graduate student fund (no grant number available) provided the funds necessary to purchase the equipment utilized in this study. The National Science Foundation, GK-12 Fellowship (grant number: 0841361) provided the tuition support and stipend necessary for AT to complete research. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Baayen RH, 2011, LANGUAGER DATA SETS; Bates D, LME4 LINEAR MIXED EF; Bekkby T, 2000, J SEA RES, V44, P267, DOI 10.1016/S1385-1101(00)00048-4; BONESS DJ, 1992, CAN J ZOOL, V70, P1640, DOI 10.1139/z92-228; Bowen WD, 1999, CAN J ZOOL, V77, P978, DOI 10.1139/cjz-77-6-978; Boyd IL, 1996, CAN J ZOOL, V74, P1696, DOI 10.1139/z96-187; BRYDEN MM, 1969, COMP BIOCHEM PHYSIOL, V28, P139, DOI 10.1016/0010-406X(69)91328-0; Burns JM, 2005, PHYSIOL BIOCHEM ZOOL, V78, P1057, DOI 10.1086/432922; Burns JM, 2004, INT CONGR SER, V1275, P341, DOI 10.1016/j.ics.2004.09.032; Butler PJ, 1997, PHYSIOL REV, V77, P837, DOI 10.1152/physrev.1997.77.3.837; CASTELLINI JM, 1990, J COMP PHYSIOL B, V160, P537, DOI 10.1007/BF00258981; Castellini JM, 1996, MAR MAMMAL SCI, V12, P251, DOI 10.1111/j.1748-7692.1996.tb00574.x; CASTELLINI MA, 1981, J COMP PHYSIOL, V143, P191; Castellini MA, 1991, ADV COMP ENV PHYSL, P105; Cheek D, 1984, EARLY HUM DEV, P75; Clark CA, 2007, J COMP PHYSIOL B, V177, P217, DOI 10.1007/s00360-006-0123-6; Clark CA, 2006, GEN COMP ENDOCR, V147, P262, DOI 10.1016/j.ygcen.2006.01.009; Dan K, 2005, INTERNAL MED, V44, P1025, DOI 10.2169/internalmedicine.44.1025; Fitzmaurice G.M., 2012, APPL LONGITUDINAL AN; Frost KJ, 2006, MAR MAMMAL SCI, V22, P617, DOI 10.1111/j.1748-7692.2006.00056.x; Fry M, 2010, SCHALMS VET HEMATOLO, P246; Gavazza A., 2012, Comparative Clinical Pathology, V21, P545, DOI 10.1007/s00580-010-1127-x; GERACI JR, 1975, J FISH RES BOARD CAN, V32, P2559, DOI 10.1139/f75-302; Hall AJ, 1998, J ZOO WILDLIFE MED, V29, P401; Harrison R. J., 1960, Mammalia Paris, V24, P386; Harvey J, 2001, ATLAS VET HEMATOLOGY, V1st, P87; HARVEY JW, 1982, J AM VET MED ASSOC, V181, P1402; Hindell MA, 2000, PHYSIOL BIOCHEM ZOOL, V73, P790, DOI 10.1086/318104; Horning M, 1997, MAR MAMMAL SCI, V13, P100, DOI 10.1111/j.1748-7692.1997.tb00614.x; Huguenin JE, 2003, AQUACULT ENG, V27, P213, DOI 10.1016/S0144-8609(02)00084-5; JELKMANN W, 1994, CLIN INVESTIGATOR, V72, pS3; JELKMANN W, 1992, PHYSIOL REV, V72, P449, DOI 10.1152/physrev.1992.72.2.449; Jorgensen C, 2001, J EXP BIOL, V204, P3993; Keijer BYE, 1982, J EXP BIOL, V101, P213; KNUDTSON PM, 1977, CALIF FISH GAME, V63, P66; KODAMA AM, 1977, J APPL PHYSIOL, V42, P852, DOI 10.1152/jappl.1977.42.6.852; Kooyman G., 1989, PHYSIOL BEHAV, P23; KOOYMAN GL, 1983, J COMP PHYSIOL, V151, P171, DOI 10.1007/BF00689915; Kooyman GL, 1998, ANNU REV PHYSIOL, V60, P19, DOI 10.1146/annurev.physiol.60.1.19; Lander ME, 2003, J WILDLIFE DIS, V39, P600, DOI 10.7589/0090-3558-39.3.600; Lander ME, 2002, J WILDLIFE MANAGE, V66, P19, DOI 10.2307/3802867; LENFANT C, 1969, AM J PHYSIOL, V216, P1595, DOI 10.1152/ajplegacy.1969.216.6.1595; LENFANT C, 1970, RESP PHYSIOL, V9, P277, DOI 10.1016/0034-5687(70)90076-9; Luque SP., 2007, R NEWS, V7, P8, DOI DOI 10.1155/2007/92385; MATOTH Y, 1971, ACTA PAEDIATR SCAND, V60, P317, DOI 10.1111/j.1651-2227.1971.tb06663.x; Meir JU, 2009, AM J PHYSIOL-REG I, V297, pR927, DOI 10.1152/ajpregu.00247.2009; Moore M, 2007, MAR MAMMAL SCI, V23, P731, DOI 10.1111/j.1748-7692.2007.00146.x; Morrison C, 2012, MAR MAMMAL SCI, V28, pE110, DOI 10.1111/j.1748-7692.2011.00510.x; MUELBERT MMC, 1993, CAN J ZOOL, V71, P1405, DOI 10.1139/z93-194; Noren SR, 2005, PHYSIOL BIOCHEM ZOOL, V78, P482, DOI 10.1086/430228; Palis J, 1998, BLOOD REV, V12, P106, DOI 10.1016/S0268-960X(98)90022-4; Ponganis PJ, 2011, J EXP BIOL, V214, P3325, DOI 10.1242/jeb.031252; Ponganis PJ, 1999, J EXP BIOL, V202, P781; PONGANIS PJ, 1992, AM J PHYSIOL, V262, pR322, DOI 10.1152/ajpregu.1992.262.2.R322; PONGANIS PJ, 1993, PHYSIOL ZOOL, V66, P732, DOI 10.1086/physzool.66.5.30163821; QVIST J, 1981, J APPL PHYSIOL, V50, P999, DOI 10.1152/jappl.1981.50.5.999; Ratcliffe PJ, 1997, KIDNEY INT, V51, P514, DOI 10.1038/ki.1997.72; RIDGWAY SH, 1966, SCIENCE, V151, P456, DOI 10.1126/science.151.3709.456; SIMPSON J, 1993, EARLY HUM DEV, V34, P179, DOI 10.1016/0378-3782(93)90175-T; Skinner JP, 2006, PHYS BEHAV DEV NURSI; Thomas A, 2015, REEFNETDIVEMOVE, DOI [10.5281/zenodo.15416, DOI 10.5281/ZENODO.15416]; Thomas C, 2002, CLIN CHEM, V48, P1066; Thorson Philip H., 1994, P271; Trumble SJ, 2006, MAR MAMMAL SCI, V22, P104, DOI 10.1111/j.1748-7692.2006.00008.x; WILLFORD DC, 1990, RESP PHYSIOL, V79, P137, DOI 10.1016/0034-5687(90)90013-O	65	3	3	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0128930	10.1371/journal.pone.0128930	http://dx.doi.org/10.1371/journal.pone.0128930			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061662	Green Published, Green Submitted, gold			2022-12-26	WOS:000355979500110
J	Choi, MK; Bae, YJ				Choi, Mi-Kyeong; Bae, Yun Jung			Association of Magnesium Intake with High Blood Pressure in Korean Adults: Korea National Health and Nutrition Examination Survey 2007-2009	PLOS ONE			English	Article							DIETARY MAGNESIUM; METABOLIC SYNDROME; ORAL MAGNESIUM; HYPERTENSION; RISK; SUPPLEMENTATION; PREVALENCE; MANAGEMENT; MANGANESE; COPPER	Background Magnesium is known to lower the risk of cardiovascular disease. However, studies on its relationship with hypertension, a single and common cause of various chronic diseases, are limited and their findings are not consistent. The purpose of the present study is to identify the relationship between magnesium intake and high blood pressure (HBP) risk in Koreans. Methods This research is a cross-sectional study based on the 2007 similar to 2009 Korean National Health and Nutritional Examination Survey data. This study investigated 11,685 adults aged over 20 to examine their general characteristics, anthropometry and blood pressure. Daily magnesium intake was analyzed using the 24-hour dietary recall method. To calculate the odds ratio (OR) of HBP risk (130/85 mmHg or over) according to the quartile of magnesium intake (mg/1000kcal) together with its 95% confidence interval (CI), multivariable logistic regression analysis was performed. Results No significant association between dietary magnesium intake and the risk of HBP was found. In obese women, particularly, after adjusting relevant factors, the adjusted odds ratio of HBP prevalence in the highest magnesium intake quartile was 0.40 compared with the lowest magnesium intake quartile (95% CI = 0.25 similar to 0.63, P for trend = 0.0014). Women, especially obese women, were found to have a negative relationship of magnesium intake with HBP. Conclusions The present results indicate that sufficient magnesium intake could be useful in decreasing the high blood pressure risk of obese women.	[Choi, Mi-Kyeong] Kongju Natl Univ, Div Food Sci, Yesan, South Korea; [Bae, Yun Jung] Shinhan Univ, Div Food Sci & Culinary Arts, Uijongbu, South Korea	Kongju National University	Bae, YJ (corresponding author), Shinhan Univ, Div Food Sci & Culinary Arts, Uijongbu, South Korea.	byj@shinhan.ac.kr		Choi, Mi-Kyeong/0000-0002-6227-4053; BAE, YUN JUNG/0000-0003-1185-3095				ALTURA BM, 1994, SCAND J CLIN LAB INV, V54, P5, DOI 10.3109/00365519409095206; Ascherio A, 1996, HYPERTENSION, V27, P1065, DOI 10.1161/01.HYP.27.5.1065; Bae YJ, 2011, BIOL TRACE ELEM RES, V143, P213, DOI 10.1007/s12011-010-8883-y; Bae YJ, 2010, BIOL TRACE ELEM RES, V135, P182, DOI 10.1007/s12011-009-8511-x; Bursztyn M, 2013, J HYPERTENS, V31, P900, DOI 10.1097/HJH.0b013e32835f29f4; CAPPUCCIO FP, 1985, BRIT MED J, V291, P235, DOI 10.1136/bmj.291.6490.235; Choi MK, 2013, BIOL TRACE ELEM RES, V156, P56, DOI 10.1007/s12011-013-9852-z; Damasceno A, 2009, HYPERTENSION, V54, P77, DOI 10.1161/HYPERTENSIONAHA.109.132423; Ford ES, 2007, OBESITY, V15, P1139, DOI 10.1038/oby.2007.628; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; He J, 2009, J HYPERTENS, V27, P48, DOI 10.1097/HJH.0b013e328316bb87; He K, 2006, CIRCULATION, V113, P1675, DOI 10.1161/CIRCULATIONAHA.105.588327; Health Canada, 2010, DIETARY REFERENCE IN; Houston MC, 2008, J CLIN HYPERTENS, V10, P3, DOI 10.1111/j.1751-7176.2008.08575.x; Hruby A, 2014, JACC-CARDIOVASC IMAG, V7, P59, DOI 10.1016/j.jcmg.2013.10.006; *I NAT RUR RES DEV, 2006, FOOD COMP TABL; Itoh K, 1997, BRIT J NUTR, V78, P737, DOI 10.1079/BJN19970191; Jee SH, 2002, AM J HYPERTENS, V15, P691, DOI 10.1016/S0895-7061(02)02964-3; Kang Young Sun, 2013, Electrolyte Blood Press, V11, P46, DOI 10.5049/EBP.2013.11.2.46; Klevay LM, 2002, AM J CLIN NUTR, V75, P550, DOI 10.1093/ajcn/75.3.550; Liu SM, 2006, DIABETES CARE, V29, P1579, DOI 10.2337/dc06-0256; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; MCNEILL DA, 1985, J AM DIET ASSOC, V85, P569; Miura K, 2010, J EPIDEMIOL, V20, pS524, DOI 10.2188/jea.JE20090220; National Statistical Office, 2013, DEATH DEATH RAT CAUS; Resnick LM, 1997, AM J HYPERTENS, V10, P368; Song YQ, 2006, AM J CARDIOL, V98, P1616, DOI 10.1016/j.amjcard.2006.07.040; Sontia Bruno, 2007, Pathophysiology, V14, P205, DOI 10.1016/j.pathophys.2007.09.005; Steffen LM, 2005, AM J CLIN NUTR, V82, P1169, DOI 10.1093/ajcn/82.6.1169; SUNG C-J, 1990, Korean Journal of Nutrition, V23, P25; Sung ChungJa, 2002, Korean Journal of Community Nutrition, V7, P111; The Ministry of Health and Welfare, 2013, NAT HLTH STAT; The Ministry of Health and Welfare Korean Center for Disease Control and Prevention, 2009, NAT HLTH STAT; Touyz R. M., 2003, Molecular Aspects of Medicine, V24, P107, DOI 10.1016/S0098-2997(02)00094-8; Touyz RM, 2006, CURR OPIN NEPHROL HY, V15, P141, DOI 10.1097/01.mnh.0000214773.34480.d4; Yamori Y, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S21; Zhang W, 2012, ATHEROSCLEROSIS, V221, P587, DOI 10.1016/j.atherosclerosis.2012.01.034; Zhao D, 2011, NAT REV CARDIOL, V8, P456, DOI 10.1038/nrcardio.2011.75	38	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130405	10.1371/journal.pone.0130405	http://dx.doi.org/10.1371/journal.pone.0130405			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075385	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900171
J	Naughtin, M; Haftek-Terreau, Z; Xavier, J; Meyer, S; Silvain, M; Jaszczyszyn, Y; Levy, N; Miele, V; Benleulmi, MS; Ruff, M; Parissi, V; Vaillant, C; Lavigne, M				Naughtin, Monica; Haftek-Terreau, Zofia; Xavier, Johan; Meyer, Sam; Silvain, Maud; Jaszczyszyn, Yan; Levy, Nicolas; Miele, Vincent; Benleulmi, Mohamed Salah; Ruff, Marc; Parissi, Vincent; Vaillant, Cedric; Lavigne, Marc			DNA Physical Properties and Nucleosome Positions Are Major Determinants of HIV-1 Integrase Selectivity	PLOS ONE			English	Article							MODULATE RETROVIRAL INTEGRATION; LEUKEMIA-VIRUS INTEGRATION; IN-VITRO; HUMAN GENOME; STRUCTURAL BASIS; SITE SELECTION; PWWP DOMAIN; LEDGF/P75; SEQUENCE; BINDING	Retroviral integrases (INs) catalyse the integration of the reverse transcribed viral DNA into the host cell genome. This process is selective, and chromatin has been proposed to be a major factor regulating this step in the viral life cycle. However, the precise underlying mechanisms are still under investigation. We have developed a new in vitro integration assay using physiologically-relevant, reconstituted genomic acceptor chromatin and high-throughput determination of nucleosome positions and integration sites, in parallel. A quantitative analysis of the resulting data reveals a chromatin-dependent redistribution of the integration sites and establishes a link between integration sites and nucleosome positions. The co-activator LEDGF/p75 enhanced integration but did not modify the integration sites under these conditions. We also conducted an in cellulo genome-wide comparative study of nucleosome positions and human immunodeficiency virus type-1 (HIV-1) integration sites identified experimentally in vivo. These studies confirm a preferential integration in nucleosome-covered regions. Using a DNA mechanical energy model, we show that the physical properties of DNA probed by IN binding are important in determining IN selectivity. These novel in vitro and in vivo approaches confirm that IN has a preference for integration into a nucleosome, and suggest the existence of two levels of IN selectivity. The first depends on the physical properties of the target DNA and notably, the energy required to fit DNA into the IN catalytic pocket. The second depends on the DNA deformation associated with DNA wrapping around a nucleosome. Taken together, these results indicate that HIV-1 IN is a shape-readout DNA binding protein.	[Naughtin, Monica; Haftek-Terreau, Zofia; Xavier, Johan; Lavigne, Marc] Ecole Normale Super Lyon, Lab Joliot Curie, CNRS USR 3010, F-69364 Lyon, France; [Meyer, Sam] Univ Lyon, Microbiol Adaptat & Pathogenie, INSA Lyon, CNRS UMR 5240, Lyon, France; [Silvain, Maud; Jaszczyszyn, Yan] Univ Paris 11, CNRS UMR9198, CEA, Inst Integrat Biol Cell I2BC, F-91198 Gif Sur Yvette, France; [Levy, Nicolas; Ruff, Marc] CNRS, UMR 7104, INSERM U964,UDS, Inst Genet & Biol Mol & Cellulaire,Dept Biol Stru, Illkirch Graffenstaden, France; [Miele, Vincent] Univ Lyon 1, CNRS UMR 5558, Lab Biometrie & Biol Evolut, F-69365 Lyon, France; [Benleulmi, Mohamed Salah; Parissi, Vincent] Univ Bordeaux 2, CNRS, UMR 5234, Lab Microbiol Fondamentale & Pathogenicite, Bordeaux, France; [Vaillant, Cedric] Ecole Normale Super Lyon, Phys Lab, CNRS UMR 5672, F-69364 Lyon, France; [Lavigne, Marc] CNRS, UMR 3569, Dept Virol, Inst Pasteur, Paris, France	Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National des Sciences Appliquees de Lyon - INSA Lyon; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lavigne, M (corresponding author), Ecole Normale Super Lyon, Lab Joliot Curie, CNRS USR 3010, F-69364 Lyon, France.	marc.lavigne@pasteur.fr	HAFTEK-TERREAU, Zofia/F-5127-2018; ruff, marc/J-3011-2013; Meyer, Sam/AAC-8052-2019	HAFTEK-TERREAU, Zofia/0000-0002-4028-3362; ruff, marc/0000-0001-5451-6377; Meyer, Sam/0000-0001-7206-6226; LAVIGNE, Marc/0000-0002-3131-2539; Miele, Vincent/0000-0001-7584-0088	Agence Nationale de recherche sur le VIH et les hepatites; Centre National de la Recherche Scientifique; Agence Nationale de la Recherche; Sidaction; Ecole Normale Superieure de Lyon; Institut Pasteiur de Paris	Agence Nationale de recherche sur le VIH et les hepatites(French National Research Agency (ANR)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Sidaction; Ecole Normale Superieure de Lyon(Grant Agency of the Czech Republic); Institut Pasteiur de Paris	This work was supported by Agence Nationale de recherche sur le VIH et les hepatites: JX VP CV ML; Centre National de la Recherche Scientifique: MN, MR, VP, CV, ML; Agence Nationale de la Recherche: MSB, VP, MR; Sidaction: MR; Ecole Normale Superieure de Lyon: CV, ML; and Institut Pasteiur de Paris: ML.	Allan J, 2012, J MOL BIOL, V417, P152, DOI 10.1016/j.jmb.2012.01.043; Balasubramanian S, 2009, BIOPHYS J, V96, P2245, DOI 10.1016/j.bpj.2008.11.040; Benleulmi MS, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0145-9; Botbol YR, 2008, NUCLEIC ACIDS RES, V36, P1237, DOI 10.1093/nar/gkm1127; Brin E, 2002, J BIOL CHEM, V277, P18357, DOI 10.1074/jbc.M201354200; Brin E, 2002, J BIOL CHEM, V277, P10938, DOI 10.1074/jbc.M108116200; Carteau S, 1999, J VIROL, V73, P6670, DOI 10.1128/JVI.73.8.6670-6679.1999; Carteau S, 1998, J VIROL, V72, P4005, DOI 10.1128/JVI.72.5.4005-4014.1998; Cattoglio C, 2010, BLOOD, V116, P5507, DOI 10.1182/blood-2010-05-283523; Cavazza A, 2013, HUM GENE THER, V24, P119, DOI 10.1089/hum.2012.203; Cherepanov P, 2004, J BIOL CHEM, V279, P48883, DOI 10.1074/jbc.M406307200; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; Chevereau G, 2011, FRONT LIFE SCI, V5, P29, DOI 10.1080/21553769.2012.708882; Chevereau G, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.188103; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Craigie R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006890; De Rijck J, 2013, CELL REP, V5, P886, DOI 10.1016/j.celrep.2013.09.040; Delelis O, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-31; Delelis O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000608; Di Nunzio F, 2013, VIRUS RES, V178, P187, DOI 10.1016/j.virusres.2013.09.003; Eidahl JO, 2013, NUCLEIC ACIDS RES, V41, P3924, DOI 10.1093/nar/gkt074; Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200; Faure A, 2005, NUCLEIC ACIDS RES, V33, P977, DOI 10.1093/nar/gki241; GOODARZI G, 1995, J VIROL, V69, P6090, DOI 10.1128/JVI.69.10.6090-6097.1995; Gupta SS, 2013, J VIROL, V87, P12721, DOI 10.1128/JVI.01942-13; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000259; Henikoff JG, 2011, P NATL ACAD SCI USA, V108, P18318, DOI 10.1073/pnas.1110731108; Hughes AL, 2012, MOL CELL, V48, P5, DOI 10.1016/j.molcel.2012.07.003; Kessl JJ, 2011, NUCLEIC ACIDS RES, V39, P9009, DOI 10.1093/nar/gkr581; Kvaratskhelia M, 2014, NUCLEIC ACIDS RES, V42, P10209, DOI 10.1093/nar/gku769; LaFave MC, 2014, NUCLEIC ACIDS RES, V42, P4257, DOI 10.1093/nar/gkt1399; Leh H, 2000, BIOCHEMISTRY-US, V39, P9285, DOI 10.1021/bi000398b; Lelek M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7483; Lesbats P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001280; Lewinski MK, 2006, PLOS PATHOG, V2, P611, DOI 10.1371/journal.ppat.0020060; Li M, 2009, METHODS, V47, P237, DOI 10.1016/j.ymeth.2009.02.001; Llano M, 2006, J MOL BIOL; Llano M, 2006, SCIENCE; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; Maillot B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060734; Marini B, 2015, NATURE, V521, P227, DOI 10.1038/nature14226; Marshall HM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001340; Michel F, 2009, EMBO J, V28, P980, DOI 10.1038/emboj.2009.41; Miele V, 2008, NUCLEIC ACIDS RES, V36, P3746, DOI 10.1093/nar/gkn262; Milani P, 2009, P NATL ACAD SCI USA, V106, P22257, DOI 10.1073/pnas.0909511106; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Morchikh M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081217; MULLER HP, 1994, EMBO J, V13, P4704, DOI 10.1002/j.1460-2075.1994.tb06794.x; Pandey KK, 2007, J VIROL, V81, P3969, DOI 10.1128/JVI.02322-06; PERCUS JK, 1976, J STAT PHYS, V15, P505, DOI 10.1007/BF01020803; Pradeepa MM, 2014, NUCLEIC ACIDS RES, V42, P9021, DOI 10.1093/nar/gku647; Pradeepa MM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002717; PRUSS D, 1994, J BIOL CHEM, V269, P25031; PRUSS D, 1994, P NATL ACAD SCI USA, V91, P5913, DOI 10.1073/pnas.91.13.5913; PRYCIAK PM, 1992, CELL, V69, P769, DOI 10.1016/0092-8674(92)90289-O; Quashie PK, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-34; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Roth SL, 2011, J VIROL, V85, P7393, DOI 10.1128/JVI.00635-11; Schones DE, 2008, NAT REV GENET, V9, P179, DOI 10.1038/nrg2270; Schrijvers R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002558; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Serrao E, 2014, NUCLEIC ACIDS RES, V42, P5164, DOI 10.1093/nar/gku136; Sexton BS, 2014, GENOME RES, V24, P251, DOI 10.1101/gr.160150.113; Sharma A, 2013, P NATL ACAD SCI USA, V110, P12036, DOI 10.1073/pnas.1307157110; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Shun MC, 2008, J VIROL, V82, P11555, DOI 10.1128/JVI.01561-08; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Taganov KD, 2004, J VIROL, V78, P5848, DOI 10.1128/JVI.78.11.5848-5855.2004; Thastrom A, 1999, J MOL BIOL, V288, P213, DOI 10.1006/jmbi.1999.2686; Thierry S, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0153-9; Turlure F, 2006, NUCLEIC ACIDS RES, V34, P1653, DOI 10.1093/nar/gkl052; Vaillant C, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.218103; Vaillant C, 2010, GENOME RES, V20, P59, DOI 10.1101/gr.096644.109; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; van Nuland R, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-12; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; WORKMAN JL, 1991, METHOD CELL BIOL, V35, P419; Wu XL, 2005, J VIROL, V79, P5211, DOI 10.1128/JVI.79.8.5211-5214.2005; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003; Zhang ZH, 2011, SCIENCE, V332, P977, DOI 10.1126/science.1200508	85	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129427	10.1371/journal.pone.0129427	http://dx.doi.org/10.1371/journal.pone.0129427			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075397	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900072
J	Silva, DP; Varela, S; Nemesio, A; De Marco, P				Silva, Daniel Paiva; Varela, Sara; Nemesio, Andre; De Marco, Paulo, Jr.			Adding Biotic Interactions into Paleodistribution Models: A Host-Cleptoparasite Complex of Neotropical Orchid Bees	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; NICHE MODELS; IMPROVE PREDICTION; CLIMATE STABILITY; EUGLOSSINE BEES; SOUTH-AMERICA; SAMPLING BIAS; GLOBAL CHANGE; APIDAE; EXTINCTION	Orchid bees compose an exclusive Neotropical pollinators group, with bright body coloration. Several of those species build their own nests, while others are reported as nest cleptoparasites. Here, the objective was to evaluate whether the inclusion of a strong biotic interaction, such as the presence of a host species, improved the ability of species distribution models (SDMs) to predict the geographic range of the cleptoparasite species. The target species were Aglae caerulea and its host species Eulaema nigrita. Additionally, since Aglae caerulea is more frequently found in the Amazon rather than the Cerrado areas, a secondary objective was to evaluate whether this species is increasing or decreasing its distribution given South American past and current climatic conditions. SDMs methods (Maxent and Bioclim), in addition with current and past South American climatic conditions, as well as the occurrences for Aglae caerulea and Eulaema nigrita were used to generate the distribution models. The distribution of Aglae caerulea was generated with and without the inclusion of the distribution of Eulaema nigrita as a predictor variable. The results indicate Aglae caerulea was barely affected by past climatic conditions and the populations from the Cerrado savanna could be at least 21,000 years old (the last glacial maximum), as well as the Amazonian ones. On the other hand, in this study, the inclusion of the host-cleptoparasite interaction complex did not statistically improve the quality of the produced models, which means that the geographic range of this cleptoparasite species is mainly constrained by climate and not by the presence of the host species. Nonetheless, this could also be caused by unknown complexes of other Euglossini hosts with Aglae caerulea, which still are still needed to be described by science.	[Silva, Daniel Paiva] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil; [Varela, Sara] Leibniz Inst Evolut & Biodivers Sci, Museum Nat Kunde, Berlin, Germany; [Nemesio, Andre] Univ Fed Uberlandia, Inst Biol, BR-38400 Uberlandia, MG, Brazil; [De Marco, Paulo, Jr.] Univ Fed Goias, Inst Ciencias Biol, Dept Ecol, Theory Metapopulat & Landscape Lab, Goiania, Go, Brazil	Universidade Federal do Para; Leibniz Institut fur Evolutions und Biodiversitatsforschung; Universidade Federal de Uberlandia; Universidade Federal de Goias	Silva, DP (corresponding author), Fed Univ Para, Inst Ciencias Biol, Rua Augusto Correia, BR-66059 Belem, Para, Brazil.	daniel.paivasilva@gmail.com	Nemésio, André/D-1920-2012; Silva, Daniel Paiva/F-8052-2010; De Marco, Paulo/B-2209-2009; Varela, Sara/J-7725-2016	Silva, Daniel Paiva/0000-0002-2457-6245; De Marco, Paulo/0000-0002-3628-6405; Varela, Sara/0000-0002-5756-5737	CNPq grant	CNPq grant(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	PDMJ was continuously supported by several CNPq grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ab'Saber A.N, 1977, GEOMORFOLOGIA, V52, P1, DOI DOI 10.3897/ZOOKEYS.150.2109; Abrahamczyk S, 2011, BIODIVERS CONSERV, V20, P2981, DOI 10.1007/s10531-011-0105-1; Anderson RP, 2011, ECOL MODEL, V222, P2796, DOI 10.1016/j.ecolmodel.2011.04.011; Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; BARRY JP, 1995, SCIENCE, V267, P672, DOI 10.1126/science.267.5198.672; Batalha H, 2013, J ORNITHOL, V154, P41, DOI 10.1007/s10336-012-0866-7; Bigarella JJ, 1975, AN ACAD BRAS CIENC, V47, P411; Burnham K P, 2003, MODEL SELECT MULTIMO; Coimbra-Filho AF, 1996, LIMITES ORIGINAIS BI; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; de Oliveira G, 2014, ECOGRAPHY, V37, P637, DOI 10.1111/j.1600-0587.2013.00564.x; De Oliveira PE, 1999, PALAEOGEOGR PALAEOCL, V152, P319, DOI 10.1016/S0031-0182(99)00061-9; de Vivo M, 2004, J BIOGEOGR, V31, P943, DOI 10.1111/j.1365-2699.2004.01068.x; de Vivo Mario, 1997, Journal of Comparative Biology, V2, P65; dos Anjos-Silva EJ, 2006, NEOTROP ENTOMOL, V35, P868, DOI 10.1590/S1519-566X2006000600024; DRESSLER RL, 1982, ANNU REV ECOL SYST, V13, P373, DOI 10.1146/annurev.es.13.110182.002105; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Ferro VG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107792; Filz KJ, 2015, ORG DIVERS EVOL, V15, P555, DOI 10.1007/s13127-015-0210-1; Freitas F V, 2010, AN 9 ENC AB RIB PRET, P425; Giannini TC, 2013, ECOGRAPHY, V36, P649, DOI 10.1111/j.1600-0587.2012.07191.x; Google Inc, 2015, GOOGL EARTH VERS 7 0; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Gutierrez EE, 2014, ECOGRAPHY, V37, P741, DOI 10.1111/ecog.00620; Hegland SJ, 2009, ECOL LETT, V12, P184, DOI 10.1111/j.1461-0248.2008.01269.x; Heikkinen RK, 2007, GLOBAL ECOL BIOGEOGR, V16, P754, DOI 10.1111/j.1466-8238.2007.00345.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2012, PACKAGE DISMO SPECIE; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Kimsey L.S., 1982, University of California Publications in Entomology, V95, P1; LEDRU MP, 1993, QUATERNARY RES, V39, P90, DOI 10.1006/qres.1993.1011; Lenoir J, 2015, ECOGRAPHY, V38, P15, DOI 10.1111/ecog.00967; Lentz DL, 2008, INT J PLANT SCI, V169, P541, DOI 10.1086/528754; Lima-Ribeiro MD, 2010, QUATERN INT, V222, P230, DOI 10.1016/j.quaint.2009.10.003; Lima-Ribeiro MS, 2012, NAT CONSERVACAO, V10, P145, DOI 10.4322/natcon.2012.022; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Loyola RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046257; Meier ES, 2010, ECOGRAPHY, V33, P1038, DOI 10.1111/j.1600-0587.2010.06229.x; Méio Beatriz B., 2003, Braz. J. Bot., V26, P437, DOI 10.1590/S0100-84042003000400002; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Michener C.D., 2007, BEES WORLD, Vsecond; Morato E.F, 1998, ANAIS ENCONTRO ABELH, P135; Moura DC, 2009, NEOTROP ENTOMOL, V38, P281, DOI 10.1590/S1519-566X2009000200018; Muscarella R, 2014, METHODS ECOL EVOL, V5, P1198, DOI 10.1111/2041-210X.12261; MYERS J. G., 1935, TRANS ROY ENT SOC LONDON, V83, P131; Nemesio A, 2006, J BIOGEOGR, V33, P91, DOI 10.1111/j.1365-2699.2005.01370.x; Nemesio A, 2014, REV BRAS BIOL, V74; Nemesio A, 2006, NEOTROP ENTOMOL, V35, P313, DOI 10.1590/S1519-566X2006000300004; Nemesio A, 2011, ZOOTAXA, P1; Nemesio A, 2013, BIODIVERS CONSERV, V22, P1647, DOI 10.1007/s10531-013-0500-x; Nemesio Andre, 2004, Lundiana, V5, P113; Nix H.A., 1986, ATLAS ELAPID SNAKES, P4; Nogues-Bravo D, 2008, PLOS BIOL, V6, P685, DOI 10.1371/journal.pbio.0060079; Parida M, 2015, J BIOGEOGR, V42, P1210, DOI 10.1111/jbi.12490; Pellissier L, 2010, ECOGRAPHY, V33, P1004, DOI 10.1111/j.1600-0587.2010.06386.x; Peruquetti Rui Carlos, 1999, Revista Brasileira de Zoologia, V16, P101, DOI 10.1590/S0101-81751999000600012; Peterson AT, 2011, MONOGRAPHS POPULATIO, P328, DOI [DOI 10.5860/CHOICE.49-6266, 10.1515/9781400840670, DOI 10.1515/9781400840670]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Rizzini C. T., 1963, REV BRASILEIRA GEOGR, V25, P1; Schweiger O, 2012, GLOBAL ECOL BIOGEOGR, V21, P88, DOI 10.1111/j.1466-8238.2010.00607.x; Silva DP, 2014, NEOTROP ENTOMOL, V43, P509, DOI 10.1007/s13744-014-0244-7; Silva DP, 2014, ECOL MODEL, V273, P200, DOI 10.1016/j.ecolmodel.2013.11.016; Silva DP, 2013, APIDOLOGIE, V44, P673, DOI 10.1007/s13592-013-0216-7; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Svenning J-C, 2014, ECOGRAPHY; Terribile LC, 2012, NAT CONSERVACAO, V10, P152, DOI 10.4322/natcon.2012.025; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tonhasca A, 2002, BIOTROPICA, V34, P416, DOI 10.1111/j.1744-7429.2002.tb00555.x; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Varela S., 2014, Ecosistemas, V23, P46; Varela S, 2014, ECOGRAPHY, V37, P1084, DOI 10.1111/j.1600-0587.2013.00441.x; Varela S, 2010, QUATERNARY SCI REV, V29, P2027, DOI 10.1016/j.quascirev.2010.04.017; Warren RJ, 2014, GLOBAL CHANGE BIOL, V20, P466, DOI 10.1111/gcb.12407; Werneck FP, 2011, QUATERNARY SCI REV, V30, P1630, DOI 10.1016/j.quascirev.2011.03.009; Werneck FP, 2011, GLOBAL ECOL BIOGEOGR, V20, P272, DOI 10.1111/j.1466-8238.2010.00596.x; WILLIAMS NH, 1983, BIOL BULL, V164, P355, DOI 10.2307/1541248; Zucchi R., 1969, Journal of the Faculty of Science Hokkaido University Zoology (6), V17, P271	84	9	10	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129890	10.1371/journal.pone.0129890	http://dx.doi.org/10.1371/journal.pone.0129890			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26069956	Green Published, Green Submitted, gold			2022-12-26	WOS:000356327000120
J	Wang, YL; Zhang, ZC; Wang, HM; Bi, SS				Wang, Yuliang; Zhang, Zaicheng; Wang, Huimin; Bi, Shusheng			Segmentation of the Clustered Cells with Optimized Boundary Detection in Negative Phase Contrast Images	PLOS ONE			English	Article							MICROSCOPY; TRACKING; IDENTIFICATION; ALGORITHM	Cell image segmentation plays a central role in numerous biology studies and clinical applications. As a result, the development of cell image segmentation algorithms with high robustness and accuracy is attracting more and more attention. In this study, an automated cell image segmentation algorithm is developed to get improved cell image segmentation with respect to cell boundary detection and segmentation of the clustered cells for all cells in the field of view in negative phase contrast images. A new method which combines the thresholding method and edge based active contour method was proposed to optimize cell boundary detection. In order to segment clustered cells, the geographic peaks of cell light intensity were utilized to detect numbers and locations of the clustered cells. In this paper, the working principles of the algorithms are described. The influence of parameters in cell boundary detection and the selection of the threshold value on the final segmentation results are investigated. At last, the proposed algorithm is applied to the negative phase contrast images from different experiments. The performance of the proposed method is evaluated. Results show that the proposed method can achieve optimized cell boundary detection and highly accurate segmentation for clustered cells.	[Wang, Yuliang; Zhang, Zaicheng; Bi, Shusheng] Beihang Univ, Sch Mech Engn & Automat, Inst Robot, Beijing 100191, Peoples R China; [Wang, Huimin] Ohio State Univ, Dept Mat Sci & Engn, Columbus, OH 43210 USA	Beihang University; University System of Ohio; Ohio State University	Wang, YL (corresponding author), Beihang Univ, Sch Mech Engn & Automat, Inst Robot, Beijing 100191, Peoples R China.	wangyuliang@buaa.edu.cn	wang, huimin/HDM-8421-2022; zhang, zai cheng/ABB-1226-2020	zhang, zaicheng/0000-0001-7472-1597	National Natural Science Foundation of China [51305019]; Specialized Research Fund for the Doctoral Program of Higher Education [20131102120021]; Beijing Natural Science Foundation [3144030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work is supported by National Natural Science Foundation of China (Grant No. 51305019), Specialized Research Fund for the Doctoral Program of Higher Education (Grant No. 20131102120021) and Beijing Natural Science Foundation (Grant No. 3144030).	Arslan S, 2013, IEEE T MED IMAGING, V32, P1121, DOI 10.1109/TMI.2013.2255309; Baggett D, 2005, CYTOM PART A, V67A, P137, DOI 10.1002/cyto.a.20162; Bhardwaj A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097076; BROWN MJ, 1994, J CELL BIOL, V127, P117, DOI 10.1083/jcb.127.1.117; Bunyak F, 2006, I S BIOMED IMAGING, P1040; Ceelie H, 2007, J CLIN PATHOL, V60, P72, DOI 10.1136/jcp.2005.035402; Chalfoun J, 2013, J MICROSC-OXFORD, V249, P41, DOI 10.1111/j.1365-2818.2012.03678.x; Chalfoun J, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0431-x; Cheng JR, 2009, IEEE T BIO-MED ENG, V56, P741, DOI 10.1109/TBME.2008.2008635; Dzyubachyk O, 2008, I S BIOMED IMAGING, P185, DOI 10.1109/ISBI.2008.4540963; Ersoy I, 2008, IEEE IMAGE PROC, P1804, DOI 10.1109/ICIP.2008.4712127; EVANS E, 1989, BIOPHYS J, V56, P151, DOI 10.1016/S0006-3495(89)82660-8; Farhan M, 2013, BMC BIOINFORMATICS, V14, P1, DOI [10.1186/1471-2105-14-1, DOI 10.1186/1471-2105-14-1]; Farooqui R, 2005, J CELL SCI, V118, P51, DOI 10.1242/jcs.01577; Fenistein D, 2008, CYTOM PART A, V73A, P958, DOI 10.1002/cyto.a.20627; Garcia D, 2010, COMPUT STAT DATA AN, V54, P1167, DOI 10.1016/j.csda.2009.09.020; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Goodman JW, 1995, INTRO FOURIER OPTICS, P220; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kandhavelu M, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-149; Kang SM, 2013, MED IMAGING 2013 IMA; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Kuijper A, 2008, INT C PATT RECOG, P2197; Li K, 2008, MED IMAGE ANAL, V12, P546, DOI 10.1016/j.media.2008.06.001; Li K, 2009, LECT NOTES COMPUT SC, V5636, P362; Lihavainen E, 2012, BIOINFORMATICS, V28, P1050, DOI 10.1093/bioinformatics/bts073; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Malpica N, 1997, CYTOMETRY, V28, P289, DOI 10.1002/(SICI)1097-0320(19970801)28:4<289::AID-CYTO3>3.0.CO;2-7; Mendoz E, 2011, CELL MOL BIOENG, V4, P411, DOI 10.1007/s12195-011-0193-8; Nath SK, 2006, LECT NOTES COMPUT SC, V4190, P101; Parvin B, 2007, IEEE T IMAGE PROCESS, V16, P615, DOI 10.1109/TIP.2007.891154; Rajah TT, 1998, IN VITRO CELL DEV-AN, V34, P626, DOI 10.1007/s11626-996-0009-7; Selinummi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007497; Seroussi I, 2012, J MICROSC-OXFORD, V247, P137, DOI 10.1111/j.1365-2818.2012.03624.x; Silletti S, 1997, Pathol Oncol Res, V3, P230, DOI 10.1007/BF02899927; Soille P., 2004, MORPHOLOGICAL IMAGE, DOI [10.1007/978-3-662-05088-0, DOI 10.1007/978-3-662-05088-0]; Su H, 2013, MED IMAGE ANAL, V17, P746, DOI 10.1016/j.media.2013.04.004; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; VINCENT L, 1991, IEEE T PATTERN ANAL, V13, P583, DOI 10.1109/34.87344; Wang M, 2008, BIOINFORMATICS, V24, P94, DOI 10.1093/bioinformatics/btm530; Wang YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098762; WU KN, 1995, IEEE T BIO-MED ENG, V42, P1, DOI 10.1109/10.362924; Yang L, 2008, LECT NOTES COMPUT SC, V5241, P833, DOI 10.1007/978-3-540-85988-8_99; Yang Z, 2013, MED IMAGING 2013 IMA; Yu X., 2014, Plos One, V9; Zhou XB, 2006, IEEE SIGNAL PROC MAG, V23, P170, DOI 10.1109/MSP.2006.1598095; Zhou XB, 2009, IEEE T INF TECHNOL B, V13, P152, DOI 10.1109/TITB.2008.2007098; Zimmer C, 2002, IEEE T MED IMAGING, V21, P1212, DOI 10.1109/TMI.2002.806292	49	69	71	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130178	10.1371/journal.pone.0130178	http://dx.doi.org/10.1371/journal.pone.0130178			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066315	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000147
J	Bertram, MR; Hamer, GL; Snowden, KF; Hartup, BK; Hamer, SA				Bertram, Miranda R.; Hamer, Gabriel L.; Snowden, Karen F.; Hartup, Barry K.; Hamer, Sarah A.			Coccidian Parasites and Conservation Implications for the Endangered Whooping Crane (Grus americana)	PLOS ONE			English	Article							DISSEMINATED VISCERAL COCCIDIOSIS; SANDHILL CRANES; EIMERIA SPP.; OOCYSTS; DNA; FECES; ASSAY; TIME	While the population of endangered whooping cranes (Grus americana) has grown from 15 individuals in 1941 to an estimated 304 birds today, the population growth is not sufficient to support a down-listing of the species to threatened status. The degree to which disease may be limiting the population growth of whooping cranes is unknown. One disease of potential concern is caused by two crane-associated Eimeria species: Eimeria gruis and E. reichenowi. Unlike most species of Eimeria, which are localized to the intestinal tract, these crane-associated species may multiply systemically and cause a potentially fatal disease. Using a non-invasive sampling approach, we assessed the prevalence and phenology of Eimeria oocysts in whooping crane fecal samples collected across two winter seasons (November 2012-April 2014) at the Aransas National Wildlife Refuge along the Texas Gulf coast. We also compared the ability of microscopy and PCR to detect Eimeria in fecal samples. Across both years, 26.5%(n = 328) of fecal samples were positive for Eimeria based on microscopy. Although the sensitivity of PCR for detecting Eimeria infections seemed to be less than that of microscopy in the first year of the study (8.9% vs. 29.3%, respectively), an improved DNA extraction protocol resulted in increased sensitivity of PCR relative to microscopy in the second year of the study (27.6% and 20.8%, respectively). The proportion of positive samples did not vary significantly between years or among sampling sites. The proportion of Eimeria positive fecal samples varied with date of collection, but there was no consistent pattern of parasite shedding between the two years. We demonstrate that non-invasive fecal collections combined with PCR and DNA sequencing techniques provides a useful tool for monitoring Eimeria infection in cranes. Understanding the epidemiology of coccidiosis is important for management efforts to increase population growth of the endangered whooping crane.	[Bertram, Miranda R.; Hamer, Sarah A.] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; [Hamer, Gabriel L.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Snowden, Karen F.] Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Hartup, Barry K.] Int Crane Fdn, Baraboo, WI USA; [Hartup, Barry K.] Univ Wisconsin, Dept Surg Sci, Madison, WI USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of Wisconsin System; University of Wisconsin Madison	Bertram, MR (corresponding author), Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77843 USA.	mbertram@cvm.tamu.edu; shamer@cvm.tamu.edu	Bertram, Miranda/X-7466-2019	Bertram, Miranda/0000-0003-3321-960X	United States Fish and Wildlife Service, Region 2, Division of Migratory Birds, Avian Health and Disease Program [F12AC00423]; American Association of Zoo and Wildlife Veterinarians, The Wild Animal Health Fund; College of Veterinary Medicine and Biomedical Sciences at Texas AM University; Texas A&M University Online Access to Knowledge (OAK) Fund; University Libraries; Office of the Vice President for Research	United States Fish and Wildlife Service, Region 2, Division of Migratory Birds, Avian Health and Disease Program; American Association of Zoo and Wildlife Veterinarians, The Wild Animal Health Fund; College of Veterinary Medicine and Biomedical Sciences at Texas AM University; Texas A&M University Online Access to Knowledge (OAK) Fund; University Libraries; Office of the Vice President for Research	This work was supported by the United States Fish and Wildlife Service, Region 2, Division of Migratory Birds, Avian Health and Disease Program, Award No. F12AC00423 (SAH, GLH); American Association of Zoo and Wildlife Veterinarians, The Wild Animal Health Fund (MRB, SAH); and the College of Veterinary Medicine and Biomedical Sciences at Texas A&M University (Graduate Merit Fellowship to MRB). The open access publishing fees for this article have been covered by the Texas A&M University Online Access to Knowledge (OAK) Fund, supported by the University Libraries and the Office of the Vice President for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergeson DG, 2001, N AM CRAN WORKSH 200; Berto BP, 2013, PESQUI VET BRASIL, V33, P1441, DOI 10.1590/S0100-736X2013001200008; BOUGHTON DONALD C., 1937, JOUR PARASITOL, V23, P291, DOI 10.2307/3272418; Brawner WR, 1999, CAN J ZOOL, V77, P347, DOI 10.1139/cjz-77-2-347; Butler MJ, 2013, BIOL CONSERV, V162, P89, DOI 10.1016/j.biocon.2013.04.003; CARPENTER JW, 1980, J AM VET MED ASSOC, V177, P845; CARPENTER JW, 1984, J AM VET MED ASSOC, V185, P1342; Carpenter JW., 2003, ZOO WILD ANIMAL MED, V5; Chapman HD, 2013, ADV PARASIT, V83, P93, DOI 10.1016/B978-0-12-407705-8.00002-1; Chavez-Ramirez F, 2012, WETLANDS, V32, P11, DOI 10.1007/s13157-011-0250-z; Cole GA, 2009, J WILDLIFE DIS, V45, P29, DOI 10.7589/0090-3558-45.1.29; COURTNEY CH, 1975, J PARASITOL, V61, P695, DOI 10.2307/3279468; El-Sherry S, 2013, INT J PARASITOL, V43, P679, DOI 10.1016/j.ijpara.2013.03.005; FORRESTER DJ, 1978, J WILDLIFE DIS, V14, P24, DOI 10.7589/0090-3558-14.1.24; Gerhold RW, 2011, J PARASITOL, V97, P892, DOI 10.1645/GE-2816.1; Gil-Weir KC, 2012, J FIELD ORNITHOL, V83, P1, DOI 10.1111/j.1557-9263.2011.00349.x; Greer DM, 2010, BLUE CRAB POPULATION; Harrell W, 2013, REPORT WHOOPING CRAN; Hartman S, 2010, P N AM CRAN WORKSH, V11, P186; Honma H, 2011, MOL ECOL RESOUR, V11, P1033, DOI 10.1111/j.1755-0998.2011.03048.x; Honma H, 2007, PARASITOL RES, V100, P637, DOI 10.1007/s00436-006-0365-y; Honma H, 2011, ENVIRON MICROBIOL, V13, P2876, DOI 10.1111/j.1462-2920.2011.02563.x; Hudson PJ, 1998, SCIENCE, V282, P2256, DOI 10.1126/science.282.5397.2256; HUNT HE, 1989, J WILDLIFE MANAGE, V53, P1150, DOI 10.2307/3809625; Jinneman KC, 1999, J FOOD PROTECT, V62, P682, DOI 10.4315/0362-028X-62.6.682; Kim Y, 2005, J PARASITOL, V91, P199, DOI 10.1645/GE-378R; King RS, 2013, WILDLIFE BIOL, V19, P420, DOI 10.2981/12-133; Kuyt E, 1981, CRANE RES WORLD, P126; Kwon YK, 2006, J WILDLIFE DIS, V42, P712, DOI 10.7589/0090-3558-42.3.712; LANDERS EJ, 1953, J PARASITOL, V39, P547, DOI 10.2307/3273857; Lopez G, 2007, INT J PARASITOL, V37, P559, DOI 10.1016/j.ijpara.2006.12.014; Matsubayashi M, 2005, PARASITOL RES, V97, P80, DOI 10.1007/s00436-005-1404-9; Nelson JT, 1996, WILSON BULL, V108, P728; NOVILLA MN, 1981, J PROTOZOOL, V28, P248, DOI 10.1111/j.1550-7408.1981.tb02844.x; Novilla MN, 2004, AVIAN PATHOL, V33, P275, DOI 10.1080/0307945042000203371; O'Brien MF, 2011, VET REC, V168, P216, DOI 10.1136/vr.c6409; Ogedengbe JD, 2011, INT J PARASITOL, V41, P843, DOI 10.1016/j.ijpara.2011.03.007; PARKER BB, 1986, J WILDLIFE DIS, V22, P25, DOI 10.7589/0090-3558-22.1.25; Pellerdy L. P., 1974, Coccidia and coccidiosis.; Sarashina T, 2006, J VET MED SCI, V68, P873, DOI 10.1292/jvms.68.873; Schnitzler BE, 1998, AVIAN PATHOL, V27, P490, DOI 10.1080/03079459808419373; Snyder SB, 1991, DIS WHOOPING CRANES; Spalding Marilyn G., 2008, P181; Spalding MG, 2003, PARASITES DIS WILD B, P702; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; USFWS, 2014, WINT 2013 2014 WHOOP; USFWS CWS, 2006, INT REC PLAN WHOOP C; Villanua D, 2006, PARASITOLOGY, V133, P251, DOI 10.1017/S003118200600031X; Watson Maggie J., 2013, International Journal for Parasitology Parasites and Wildlife, V2, P190, DOI 10.1016/j.ijppaw.2013.05.001; Woods WG, 2000, INT J PARASITOL, V30, P1019, DOI 10.1016/S0020-7519(00)00084-9; Yabsley Michael J., 2008, P162; Zajac AM, 2012, VET CLIN PARASITOLOG, V8th	52	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0127679	10.1371/journal.pone.0127679	http://dx.doi.org/10.1371/journal.pone.0127679			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061631	Green Published, Green Submitted, gold			2022-12-26	WOS:000355979500050
J	Frenay, ARS; Yazdani, S; Boersema, M; van der Graaf, AM; Waanders, F; van den Born, J; Navis, GJ; van Goor, H				Frenay, Anne-Roos S.; Yazdani, Saleh; Boersema, Miriam; van der Graaf, Anne Marijn; Waanders, Femke; van den Born, Jacob; Navis, Gerjan J.; van Goor, Harry			Incomplete Restoration of Angiotensin II - Induced Renal Extracellular Matrix Deposition and Inflammation Despite Complete Functional Recovery in Rats	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE; OSTEOPONTIN EXPRESSION; INDUCED HYPERTENSION; CONTROLLED TRIAL; NITRIC-OXIDE; AGING KIDNEY; NEPHROPATHY; INJURY; PROTEINURIA	Some diseases associated with a temporary deterioration in kidney function and/or development of proteinuria show an apparently complete functional remission once the initiating trigger is removed. While it was earlier thought that a transient impairment of kidney function is harmless, accumulating evidence now suggests that these patients are more prone to developing renal failure later in life. We therefore sought to investigate to what extent renal functional changes, inflammation and collagen deposition are reversible after cessation of disease induction, potentially explaining residual sensitivity to damage. Using a rat model of Angiotensin II (Ang II)-induced hypertensive renal disease we show the development of severe hypertension (212 +/- 10.43 vs. 146 +/- 1.4 mmHg, p<0.001) and proteinuria (51.4 +/- 6.3 vs. 14.7 +/- 2.0 mg/24h, p<0.01) with declined creatinine clearance (2.0 +/- 0.5 vs. 4.9 +/- 0.6 mL/min, p<0.001) to occur after 3 weeks of Ang II infusion. At the structural level, Ang II infusion resulted in interstitial inflammation (18.8 +/- 4.8 vs. 3.6 +/- 0.5 number of macrophages, p<0.001), renal interstitial collagen deposition and lymphangiogenesis (4.1 +/- 0.4 vs. 2.2 +/- 0.4 number of lymph vessels, p<0.01). Eight weeks after cessation of Ang II, all clinical parameters, pre-fibrotic changes such as myofibroblast transformation and increase in lymph vessel number (lymphangiogenesis) returned to control values. However, glomerular desmin expression, glomerular and periglomerular macrophages and interstitial collagens remained elevated. These dormant abnormalities indicate that after transient renal function decline, inflammation and collagen deposition may persist despite normalization of the initiating pathophysiological stimulus perhaps rendering the kidney more vulnerable to further damage.	[Frenay, Anne-Roos S.; Boersema, Miriam; van der Graaf, Anne Marijn; van Goor, Harry] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-9713 AV Groningen, Netherlands; [Yazdani, Saleh; Waanders, Femke; van den Born, Jacob; Navis, Gerjan J.] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, NL-9713 AV Groningen, Netherlands; [van der Graaf, Anne Marijn] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, NL-9713 AV Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	van Goor, H (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-9713 AV Groningen, Netherlands.	h.van.goor@umcg.nl	van+Goor, Harry/AAS-7712-2020; Yazdani, Saleh/K-9640-2015	Yazdani, Saleh/0000-0002-5162-9904; van Goor, Harry/0000-0002-6670-1577				Agodoa LY, 2001, JAMA-J AM MED ASSOC, V285, P2719, DOI 10.1001/jama.285.21.2719; Anderson S, 2009, J AM SOC NEPHROL, V20, P1199, DOI 10.1681/ASN.2008080860; Attia DM, 2004, J AM SOC NEPHROL, V15, P949, DOI 10.1097/01.ASN.0000118528.00817.8E; Axelsson J, 2013, AM J PHYSIOL-RENAL, V305, pF237, DOI 10.1152/ajprenal.00154.2013; Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; Bohle A, 1979, Contrib Nephrol, V16, P109; BOLTON WK, 1976, AM J PATHOL, V85, P277; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; COUSER WG, 1975, LAB INVEST, V33, P491; Cowley AW, 2013, HYPERTENSION, V62, P85, DOI 10.1161/HYPERTENSIONAHA.113.01194; Dashkevich A, 2010, ANN THORAC SURG, V90, P406, DOI 10.1016/j.athoracsur.2010.03.013; Furber JD, 2006, REJUV RES, V9, P274, DOI 10.1089/rej.2006.9.274; HARVEY ALICE M., 1965, AMER J PHYSIOL, V209, P849; HARVEY AM, 1966, J PHYSIOL-LONDON, V184, P883, DOI 10.1113/jphysiol.1966.sp007954; Heymann F, 2009, J CLIN INVEST, V119, P1286, DOI 10.1172/JCI38399; Hingorani S, 2013, BONE MARROW TRANSPLA; Huggenberger R, 2011, BLOOD, V117, P4667, DOI 10.1182/blood-2010-10-316356; Inserra Felipe, 2009, Ther Adv Cardiovasc Dis, V3, P341, DOI 10.1177/1753944709339195; Jethon A, 2012, PATHOL ONCOL RES, V18, P867, DOI 10.1007/s12253-012-9516-x; JOHNSON RJ, 1992, HYPERTENSION, V19, P464, DOI 10.1161/01.HYP.19.5.464; Jung GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105635; Katta K, 2013, AM J PATHOL, V183, P1571, DOI 10.1016/j.ajpath.2013.07.030; Kerjaschki D, 2006, NAT MED, V12, P230, DOI 10.1038/nm1340; KUNCIO GS, 1991, KIDNEY INT, V39, P550, DOI 10.1038/ki.1991.63; Kwansa AL, 2013, MATRIX BIOL; Lavoz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040490; Li C, 2003, AM J PHYSIOL-RENAL, V284, pF389, DOI 10.1152/ajprenal.00277.2002; Liersch R, 2012, INT J ONCOL, V41, P1455, DOI 10.3892/ijo.2012.1548; Lombardi D, 1999, HYPERTENSION, V33, P1013, DOI 10.1161/01.HYP.33.4.1013; Lu HY, 2013, PHYSIOL RES, V62, P35, DOI 10.33549/physiolres.932380; LUFT FC, 1989, HYPERTENSION, V14, P396, DOI 10.1161/01.HYP.14.4.396; Marshall RP, 2004, AM J PHYSIOL-LUNG C, V286, pL156, DOI 10.1152/ajplung.00313.2002; McDonald SD, 2010, AM J KIDNEY DIS, V55, P1026, DOI 10.1053/j.ajkd.2009.12.036; Nakano T, 2005, HUM PATHOL, V36, P330, DOI 10.1016/j.humpath.2005.01.001; Navar LG, 2000, HYPERTENS RES, V23, P291, DOI 10.1291/hypres.23.291; Nykanen AI, 2010, CIRCULATION, V121, P1413, DOI 10.1161/CIRCULATIONAHA.109.910703; Ortmann J, 2004, HYPERTENSION, V44, P974, DOI 10.1161/01.HYP.0000149249.09147.b4; Parra ER, 2014, CLINICS, V69, P47, DOI 10.6061/clinics/2014(01)07; Qiu ZB, 2012, PHARMAZIE, V67, P553, DOI 10.1691/ph.2012.1123; Razzaque MS, 1998, CELL TISSUE RES, V293, P471, DOI 10.1007/s004410051139; Rees MD, 2008, FREE RADICAL BIO MED, V44, P1973, DOI 10.1016/j.freeradbiomed.2008.03.016; Ruggenenti P, 1997, LANCET, V349, P1857; Ruiz-Torres MP, 2005, J NEPHROL, V18, P334; Satoh M, 2013, LAB INVEST, V93, P334, DOI 10.1038/labinvest.2012.171; Snijder PM, 2014, NITRIC OXIDE-BIOL CH, V42, P87, DOI 10.1016/j.niox.2014.10.002; VANGOOR H, 1992, LAB INVEST, V66, P564; Vikse BE, 2008, NEW ENGL J MED, V359, P800, DOI 10.1056/NEJMoa0706790; Vikse BE, 2012, CLIN J AM SOC NEPHRO, V7, P1819, DOI 10.2215/CJN.01820212; VONTHUN AM, 1994, AM J PHYSIOL, V266, pF120, DOI 10.1152/ajprenal.1994.266.1.F120; Wang IK, 2013, CAN MED ASSOC J, V185, P207, DOI 10.1503/cmaj.120230; WATANABE N, 1986, CLIN CHEM, V32, P1551; Wolak T, 2009, KIDNEY INT, V76, P32, DOI 10.1038/ki.2009.90; Yang HC, 2010, J AM SOC NEPHROL, V21, P1436, DOI 10.1681/ASN.2010020205; Yazdani S, 2014, EXPERT REV MOL MED, V16, DOI 10.1017/erm.2014.18; Yazdani S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050209; Yu XQ, 2000, KIDNEY INT, V58, P1469, DOI 10.1046/j.1523-1755.2000.00309.x; Yu XQ, 1999, AM J PATHOL, V154, P833, DOI 10.1016/S0002-9440(10)65330-8	58	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129732	10.1371/journal.pone.0129732	http://dx.doi.org/10.1371/journal.pone.0129732			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061812	Green Published, gold, Green Submitted			2022-12-26	WOS:000355979500160
J	Kiris, E; Nuss, JE; Stanford, SM; Wanner, LM; Cazares, L; Maestre, MF; Du, HT; Gomba, GY; Burnett, JC; Gussio, R; Bottini, N; Panchal, RG; Kane, CD; Tessarollo, L; Bavari, S				Kiris, Erkan; Nuss, Jonathan E.; Stanford, Stephanie M.; Wanner, Laura M.; Cazares, Lisa; Maestre, Michael F.; Du, Hao T.; Gomba, Glenn Y.; Burnett, James C.; Gussio, Rick; Bottini, Nunzio; Panchal, Rekha G.; Kane, Christopher D.; Tessarollo, Lino; Bavari, Sina			Phosphatase Inhibitors Function as Novel, Broad Spectrum Botulinum Neurotoxin Antagonists in Mouse and Human Embryonic Stem Cell-Derived Motor Neuron-Based Assays	PLOS ONE			English	Article							PROTEIN-KINASE-C; SYNAPTOSOME-ASSOCIATED PROTEIN; DIFFERENTIAL PHOSPHORYLATION; DEPENDENT PHOSPHORYLATION; TYROSINE PHOSPHORYLATION; DIRECTED DIFFERENTIATION; NEUROTRANSMITTER RELEASE; POSSIBLE INVOLVEMENT; CATALYTIC DOMAIN; TERMINAL DOMAIN	There is an urgent need to develop novel treatments to counter Botulinum neurotoxin (BoNT) poisoning. Currently, the majority of BoNT drug development efforts focus on directly inhibiting the proteolytic components of BoNT, i.e. light chains (LC). Although this is a rational approach, previous research has shown that LCs are extremely difficult drug targets and that inhibiting multi-serotype BoNTs with a single LC inhibitor may not be feasible. An alternative approach would target neuronal pathways involved in intoxication/recovery, rather than the LC itself. Phosphorylation-related mechanisms have been implicated in the intoxication pathway( s) of BoNTs. However, the effects of phosphatase inhibitors upon BoNT activity in the physiological target of BoNTs, i.e. motor neurons, have not been investigated. In this study, a small library of phosphatase inhibitors was screened for BoNT antagonismin the context of mouse embryonic stem cell-derived motor neurons (ES-MNs). Four inhibitors were found to function as BoNT/A antagonists. Subsequently, we confirmed that these inhibitors protect against BoNT/A in a dose-dependent manner in human ES-MNs. Additionally, these compounds provide protection when administered in post-intoxication scenario. Importantly, the inhibitors were also effective against BoNT serotypes B and E. To the best of our knowledge, this is the first study showing phosphatase inhibitors as broad-spectrum BoNT antagonists.	[Kiris, Erkan] Geneva Fdn, Tacoma, WA 98402 USA; [Kiris, Erkan; Nuss, Jonathan E.; Wanner, Laura M.; Cazares, Lisa; Du, Hao T.; Gomba, Glenn Y.; Panchal, Rekha G.; Kane, Christopher D.; Bavari, Sina] US Army, Med Res Inst Infect Dis, Dept Mol & Translat Sci, Frederick, MD USA; [Kiris, Erkan; Tessarollo, Lino] NCI, Ctr Canc Res, Mouse Canc Genet Program, Frederick, MD 21701 USA; [Stanford, Stephanie M.; Maestre, Michael F.; Bottini, Nunzio] La Jolla Inst Allergy & Immunol, Div Cellular Biol, La Jolla, CA USA; [Burnett, James C.] NCI, Leidos Biomed Res Inc, CDDG, Frederick, MD 21701 USA; [Burnett, James C.; Gussio, Rick] NCI, CDDG, Dev Therapeut Program, Frederick, MD 21701 USA; [Tessarollo, Lino] Henry M Jackson Fdn, Bethesda, MD USA; [Kane, Christopher D.] US Army, Med Res & Mat Command, TATRC, DoD Biotechnol High Performance Comp Software App, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); La Jolla Institute for Immunology; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	Kiris, E (corresponding author), Geneva Fdn, Tacoma, WA 98402 USA.	erkan.kiris@nih.gov; sina.bavari.civ@mail.mil	Bavari, Sina/L-3642-2019; Cazares, Lisa/M-6356-2019; Cazares, Lisa H/H-1166-2019; Kane, Christopher/C-8256-2019; Kiris, Erkan/AAZ-6719-2020; Ingegnoli, Francesca/B-6226-2017; Panchal, Rekha/None	Bavari, Sina/0000-0001-8424-5635; Cazares, Lisa/0000-0001-5754-6192; Cazares, Lisa H/0000-0001-5754-6192; Kane, Christopher/0000-0002-0469-1668; Kiris, Erkan/0000-0003-2095-0460; Ingegnoli, Francesca/0000-0002-6727-1273; Panchal, Rekha/0000-0001-8621-9078	Defense Threat Reduction Agency; National Institutes of Health [4R33AI101387-03]; National Cancer Institute (NCI), National Institutes of Health (NIH) [HHSN261200800001E]; Intramural Research Program of the NCI, Center for Cancer Research, NIH; Leidos Biomedical Research, Inc.; NATIONAL CANCER INSTITUTE [ZIABC010390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI101387] Funding Source: NIH RePORTER	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NCI, Center for Cancer Research, NIH; Leidos Biomedical Research, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by grants from the Defense Threat Reduction Agency and National Institutes of Health (4R33AI101387-03). For JCB this project has been funded in whole or in part with federal funds from the National Cancer Institute (NCI), National Institutes of Health (NIH), under contract no. HHSN261200800001E. LT has been supported by the Intramural Research Program of the NCI, Center for Cancer Research, NIH. Leidos Biomedical Research, Inc. provided support in the form of salary for author JCB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	American Society of Plastic Surgeons, 2013, PLAST SURG STAT REP; Amoroso MW, 2013, J NEUROSCI, V33, P574, DOI 10.1523/JNEUROSCI.0906-12.2013; Apland JP, 2003, J PROTEIN CHEM, V22, P147, DOI 10.1023/A:1023423013741; Apland JP, 1999, J APPL TOXICOL, V19, pS23, DOI 10.1002/(SICI)1099-1263(199912)19:1+<S23::AID-JAT609>3.0.CO;2-X; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Bajohrs M, 2004, EMBO REP, V5, P1090, DOI 10.1038/sj.embor.7400278; Blanes-Mira C, 2001, BIOCHEMISTRY-US, V40, P2234, DOI 10.1021/bi001919y; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Brunger AT, 2008, CELL MOL LIFE SCI, V65, P2296, DOI 10.1007/s00018-008-8088-0; Chatterjee J, 2013, CURR OPIN CHEM BIOL, V17, P361, DOI 10.1016/j.cbpa.2013.04.008; Chen S, 2012, TOXINS, V4, P913, DOI 10.3390/toxins4100913; Coffield JA, 2009, J PHARMACOL EXP THER, V330, P352, DOI 10.1124/jpet.108.147744; De Munter S, 2013, ACS CHEM BIOL, V8, P36, DOI 10.1021/cb300597g; de Paiva A, 1999, P NATL ACAD SCI USA, V96, P3200, DOI 10.1073/pnas.96.6.3200; Dolly JO, 2009, CURR OPIN PHARMACOL, V9, P326, DOI 10.1016/j.coph.2009.03.004; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dumaual CM, 2006, J HISTOCHEM CYTOCHEM, V54, P1401, DOI 10.1369/jhc.6A7019.2006; Encinar JA, 1998, FEBS LETT, V429, P78, DOI 10.1016/S0014-5793(98)00571-7; FerrerMontiel AV, 1996, J BIOL CHEM, V271, P18322, DOI 10.1074/jbc.271.31.18322; Fischer A, 2013, CURR TOP MICROBIOL, V364, P115, DOI 10.1007/978-3-642-33570-9_6; Fischer A, 2009, P NATL ACAD SCI USA, V106, P1330, DOI 10.1073/pnas.0812839106; Foletti DL, 2000, J NEUROSCI, V20, P4535, DOI 10.1523/JNEUROSCI.20-12-04535.2000; Fuentes F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041536; Gao J, 2012, J BIOL CHEM, V287, P10565, DOI 10.1074/jbc.M111.294645; Hakami RM, 2010, TRENDS MICROBIOL, V18, P164, DOI 10.1016/j.tim.2010.02.001; Hepp R, 2002, FEBS LETT, V532, P52, DOI 10.1016/S0014-5793(02)03629-3; Hu BY, 2010, METHODS MOL BIOL, V636, P123, DOI 10.1007/978-1-60761-691-7_8; Huang PP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019126; Ibanez C, 2004, FEBS LETT, V578, P121, DOI 10.1016/j.febslet.2004.10.084; Iida Y, 2013, NEUROSCI RES, V75, P184, DOI 10.1016/j.neures.2013.01.002; Kalandakanond S, 2001, J PHARMACOL EXP THER, V296, P749; Kataoka M, 2000, J NEUROCHEM, V74, P2058, DOI 10.1046/j.1471-4159.2000.0742058.x; Keller JE, 1999, FEBS LETT, V456, P137, DOI 10.1016/S0014-5793(99)00948-5; Keller JE, 2001, J BIOL CHEM, V276, P13476, DOI 10.1074/jbc.M010992200; Kiris E, 2015, NEUROTOX RES, V27, P384, DOI 10.1007/s12640-015-9526-z; Kiris E, 2014, CURR TOP MED CHEM, V14, P2044, DOI 10.2174/1568026614666141022093350; Kiris E, 2014, EXPERT REV MOL DIAGN, V14, P153, DOI 10.1586/14737159.2014.867808; Kiris E, 2011, STEM CELL RES, V6, P195, DOI 10.1016/j.scr.2011.01.002; Kota KP, 2014, JOVE-J VIS EXP, DOI 10.3791/51915; Larsen JC, 2009, DRUG DEVELOP RES, V70, P266, DOI 10.1002/ddr.20304; Lau CG, 2010, J NEUROSCI, V30, P242, DOI 10.1523/JNEUROSCI.4933-08.2010; Lazo JS, 2001, J MED CHEM, V44, P4042, DOI 10.1021/jm0102046; Lee H, 2007, STEM CELLS, V25, P1931, DOI 10.1634/stemcells.2007-0097; Li B, 2011, BIOORGAN MED CHEM, V19, P7338, DOI 10.1016/j.bmc.2011.10.062; Li B, 2011, MOLECULES, V16, P202, DOI 10.3390/molecules16010202; Li XJ, 2008, STEM CELLS, V26, P886, DOI 10.1634/stemcells.2007-0620; Liljebris C, 2004, J PHARMACOL EXP THER, V309, P711, DOI 10.1124/jpet.103.062745; McConnell JL, 2009, MOL PHARMACOL, V75, P1249, DOI 10.1124/mol.108.053140; McNutt P, 2011, BIOCHEM BIOPH RES CO, V405, P85, DOI 10.1016/j.bbrc.2010.12.132; Montal M, 2010, ANNU REV BIOCHEM, V79, P591, DOI 10.1146/annurev.biochem.051908.125345; Montecucco C, 2005, CURR OPIN PHARMACOL, V5, P274, DOI 10.1016/j.coph.2004.12.006; Nagy G, 2004, NEURON, V41, P417, DOI 10.1016/S0896-6273(04)00038-8; Nagy G, 2002, J NEUROSCI, V22, P9278; Nuss JE, 2010, J BIOMOL SCREEN, V15, P928, DOI 10.1177/1087057110374996; Nuss JE, 2010, J BIOMOL SCREEN, V15, P42, DOI 10.1177/1087057109354779; Opsenica I, 2012, EUR J MED CHEM, V53, P374, DOI 10.1016/j.ejmech.2012.03.043; Opsenica IM, 2013, J MED CHEM, V56, P5860, DOI 10.1021/jm4006077; Ozek C, 2014, J BIOL CHEM, V289, P31682, DOI 10.1074/jbc.M114.603621; Panchal RG, 2009, J BIOL CHEM, V284, P12874, DOI 10.1074/jbc.M809633200; Pathak MK, 2002, MOL CANCER THER, V1, P1255; Pellett S, 2007, FEBS LETT, V581, P4803, DOI 10.1016/j.febslet.2007.08.078; Pellett S, 2011, BIOCHEM BIOPH RES CO, V404, P388, DOI 10.1016/j.bbrc.2010.11.128; REYNOLDS IJ, 1992, J NEUROSCI, V12, P970; Rios P, 2013, FEBS J, V280, P505, DOI 10.1111/j.1742-4658.2012.08565.x; Risinger C, 1999, J NEUROCHEM, V72, P614, DOI 10.1046/j.1471-4159.1999.0720614.x; Rossetto O, 2014, NAT REV MICROBIOL, V12, P535, DOI 10.1038/nrmicro3295; Sheth AN, 2008, CLIN INFECT DIS, V47, P1245, DOI 10.1086/592574; Shimazaki Y, 1996, J BIOL CHEM, V271, P14548, DOI 10.1074/jbc.271.24.14548; Shu YL, 2008, J NEUROSCI, V28, P21, DOI 10.1523/JNEUROSCI.2352-07.2008; Snyder DA, 2006, CELL BIOCHEM BIOPHYS, V45, P111, DOI 10.1385/CBB:45:1:111; Sobel J, 2004, EMERG INFECT DIS, V10, P1606, DOI 10.3201/eid1009.030745; Sun SH, 2012, BIOCHEMISTRY-US, V51, P5655, DOI 10.1021/bi3004928; Takahashi M, 2003, J PHARMACOL SCI, V93, P41, DOI 10.1254/jphs.93.41; Takano S, 1996, MOL BRAIN RES, V40, P105, DOI 10.1016/0169-328X(96)00035-6; Tighe AP, 2013, TOXICON, V67, P87, DOI 10.1016/j.toxicon.2012.11.011; Tighe AP, 2012, TOXICON; Toth S, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00102; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Urbanek RA, 2001, J MED CHEM, V44, P1777, DOI 10.1021/jm000447i; Videnovic M, 2014, J MED CHEM, V57, P4134, DOI 10.1021/jm500033r; Wang QP, 2004, BIOCHEMISTRY-US, V43, P4294, DOI 10.1021/bi035986e; Wein LM, 2005, P NATL ACAD SCI USA, V102, P9984, DOI 10.1073/pnas.0408526102; Wichterle Hynek, 2008, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01h01s5; Yang Y, 2007, J GEN PHYSIOL, V129, P233, DOI 10.1085/jgp.200609685; Zhang Y, 2006, J NEUROSCI, V26, P8819, DOI 10.1523/JNEUROSCI.2593-06.2006	87	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129264	10.1371/journal.pone.0129264	http://dx.doi.org/10.1371/journal.pone.0129264			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061731	Green Submitted, gold, Green Published			2022-12-26	WOS:000355979500135
J	Li, WQ; Koutmou, KS; Leahy, DJ; Li, M				Li, Weiqiang; Koutmou, Kristin S.; Leahy, Daniel J.; Li, Min			Systemic RNA Interference Deficiency-1 (SID-1) Extracellular Domain Selectively Binds Long Double-stranded RNA and Is Required for RNA Transport by SID-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURE PREDICTION; ECTOPIC EXPRESSION; PROTEIN; DSRNA; WEB; FILAMENTS; SEQUENCE; CELLS	During systemic RNA interference (RNAi) in Caenorhabditis elegans, RNA spreads across different cells and tissues in a process that requires the systemic RNA interference deficient-1 (sid-1) gene, which encodes an integral membrane protein. SID-1 acts cell-autonomously and is required for cellular import of interfering RNAs. Heterologous expression of SID-1 in Drosophila Schneider 2 cells enables passive uptake of dsRNA and subsequent soaking RNAi. Previous studies have suggested that SID-1 may serve as an RNA channel, but its precise molecular role remains unclear. To test the hypothesis that SID-1 mediates a direct biochemical recognition of RNA molecule and subsequent permeation, we expressed the extracellular domain (ECD) of SID-1 and purified it to near homogeneity. Recombinant purified SID-1ECD selectively binds dsRNA but not dsDNA in a length-dependent and sequence-independent manner. Genetic missense mutations in SID-1 ECD causal for deficient systemic RNAi resulted in significant reduction in its affinity for dsRNA. Furthermore, full-length proteins with these mutations decrease SID-1-mediated RNA transport efficiency, providing evidence that dsRNA binding to SID-1 ECD is related to RNA transport. To examine the functional similarity of mammalian homologs of SID-1 (SIDT1 and SIDT2), we expressed and purified mouse SIDT1 and SIDT2 ECDs. We show that they bind long dsRNA in vitro, supportive of dsRNA recognition. In summary, our study illustrates the functional importance of SID-1 ECD as a dsRNA binding domain that contributes to RNA transport.	[Li, Weiqiang; Li, Min] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Koutmou, Kristin S.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Li, Weiqiang; Leahy, Daniel J.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Li, Min] GlaxoSmithKline, King Of Prussia, PA 19406 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; GlaxoSmithKline	Li, M (corresponding author), GlaxoSmithKline, 709 Swedeland Rd, King Of Prussia, PA 19406 USA.	min.x.li@gsk.com	Regan, Clinton/E-6250-2012		National Institutes of Health [GM078579, MH084691, R01GM099321, F32 GM100608]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM100608, R01GM099321, R01GM078579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084691] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants GM078579 and MH084691 (to M.L.), R01GM099321 (to D.L.), and F32 GM100608 (to K.S.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Beattie TR, 2012, EMBO J, V31, P1556, DOI 10.1038/emboj.2012.12; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Calixto A, 2010, NAT METHODS, V7, P554, DOI [10.1038/NMETH.1463, 10.1038/nmeth.1463]; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; DRAPER DE, 1978, J MOL BIOL, V122, P339; Elhassan MO, 2012, J BIOL CHEM, V287, P5267, DOI 10.1074/jbc.M111.318865; Feinberg EH, 2003, SCIENCE, V301, P1545, DOI 10.1126/science.1087117; Gao JL, 2010, BIOCHEM BIOPH RES CO, V402, P588, DOI 10.1016/j.bbrc.2010.09.133; Hunter CP, 2006, COLD SPRING HARB SYM, V71, P95, DOI 10.1101/sqb.2006.71.060; Jordan GE, 2008, BIOINFORMATICS, V24, P1641, DOI 10.1093/bioinformatics/btn235; Jose AM, 2009, P NATL ACAD SCI USA, V106, P2283, DOI 10.1073/pnas.0809760106; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kobayashi I, 2012, INSECT BIOCHEM MOLEC, V42, P148, DOI 10.1016/j.ibmb.2011.11.007; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Leahy DJ, 2000, PROTEIN EXPRES PURIF, V20, P500, DOI 10.1006/prep.2000.1331; Li Y, 2013, SCIENCE, V342, P231, DOI 10.1126/science.1241911; Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930; Mon H, 2012, RNA BIOL, V9, P40, DOI 10.4161/rna.9.1.18084; Morrone SR, 2014, P NATL ACAD SCI USA, V111, pE62, DOI 10.1073/pnas.1313577111; Peisley A, 2011, P NATL ACAD SCI USA, V108, P21010, DOI 10.1073/pnas.1113651108; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Pratt AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033607; Ren RW, 2011, DEV COMP IMMUNOL, V35, P692, DOI 10.1016/j.dci.2011.02.003; Sarov-Blat L, 1998, J BIOL CHEM, V273, P5520, DOI 10.1074/jbc.273.10.5520; Schott DH, 2005, P NATL ACAD SCI USA, V102, P18420, DOI 10.1073/pnas.0507123102; Serna-Rico A, 2002, J BIOL CHEM, V277, P6733, DOI 10.1074/jbc.M109312200; Shih JD, 2011, RNA, V17, P1057, DOI 10.1261/rna.2596511; Shih JD, 2009, RNA, V15, P384, DOI 10.1261/rna.1286409; Tsang SY, 2007, BIOCHEM BIOPH RES CO, V357, P480, DOI 10.1016/j.bbrc.2007.03.187; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Xu J, 2013, APPL MICROBIOL BIOT, V97, P5921, DOI 10.1007/s00253-013-4785-1	32	28	30	0	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					18904	18913		10.1074/jbc.M115.658864	http://dx.doi.org/10.1074/jbc.M115.658864			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26067272	Green Published, hybrid			2022-12-26	WOS:000358781100003
J	Huang, J; Frimpong, EA				Huang, Jian; Frimpong, Emmanuel A.			Using Historical Atlas Data to Develop High-Resolution Distribution Models of Freshwater Fishes	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; CLIMATE-CHANGE; SPATIAL AUTOCORRELATION; ECOLOGICAL DATA; HABITAT; COMMUNITY; AREA; TRANSFERABILITY; PREDICTION; NETWORK	Understanding the spatial pattern of species distributions is fundamental in biogeography, and conservation and resource management applications. Most species distribution models (SDMs) require or prefer species presence and absence data for adequate estimation of model parameters. However, observations with unreliable or unreported species absences dominate and limit the implementation of SDMs. Presence-only models generally yield less accurate predictions of species distribution, and make it difficult to incorporate spatial autocorrelation. The availability of large amounts of historical presence records for freshwater fishes of the United States provides an opportunity for deriving reliable absences from data reported as presence-only, when sampling was predominantly community-based. In this study, we used boosted regression trees (BRT), logistic regression, and MaxEnt models to assess the performance of a historical metacommunity database with inferred absences, for modeling fish distributions, investigating the effect of model choice and data properties thereby. With models of the distribution of 76 native, non-game fish species of varied traits and rarity attributes in four river basins across the United States, we show that model accuracy depends on data quality (e.g., sample size, location precision), species' rarity, statistical modeling technique, and consideration of spatial autocorrelation. The cross-validation area under the receiver-operating-characteristic curve (AUC) tended to be high in the spatial presence-absence models at the highest level of resolution for species with large geographic ranges and small local populations. Prevalence affected training but not validation AUC. The key habitat predictors identified and the fish-habitat relationships evaluated through partial dependence plots corroborated most previous studies. The communitybased SDM framework broadens our capability to model species distributions by innovatively removing the constraint of lack of species absence data, thus providing a robust prediction of distribution for stream fishes in other regions where historical data exist, and for other taxa (e.g., benthic macroinvertebrates, birds) usually observed by community-based sampling designs.	[Huang, Jian; Frimpong, Emmanuel A.] Virginia Polytech Inst & State Univ, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Frimpong, EA (corresponding author), Virginia Polytech Inst & State Univ, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA.	frimp@vt.edu			US Geological Survey Aquatic Gap Analysis Program [RWO 156]; Virginia Tech Libraries	US Geological Survey Aquatic Gap Analysis Program; Virginia Tech Libraries	US Geological Survey Aquatic Gap Analysis Program funded this work under fund # RWO 156. Virginia Tech Libraries fully funded the publication of this article through its Open Access Subvention Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Bahn V, 2008, ECOL MODEL, V213, P285, DOI 10.1016/j.ecolmodel.2007.12.005; Bani L, 2002, CONSERV BIOL, V16, P826, DOI 10.1046/j.1523-1739.2002.01082.x; Bond N, 2011, MAR FRESHWATER RES, V62, P1043, DOI 10.1071/MF10286; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brind'Amour A, 2005, LIMNOL OCEANOGR, V50, P465, DOI 10.4319/lo.2005.50.2.0465; Brotons L, 2004, ECOGRAPHY, V27, P437, DOI 10.1111/j.0906-7590.2004.03764.x; Brown Larry R., 2009, Urban Ecosystems, V12, P391, DOI 10.1007/s11252-009-0082-2; Chu C, 2005, DIVERS DISTRIB, V11, P299, DOI 10.1111/j.1366-9516.2005.00153.x; Clark ME, 2001, ECOL APPL, V11, P161, DOI 10.1890/1051-0761(2001)011[0161:PCCEOA]2.0.CO;2; Diez JM, 2007, ECOLOGY, V88, P3144, DOI 10.1890/07-0047.1; Diniz JAF, 1998, EVOLUTION, V52, P1247, DOI 10.1111/j.1558-5646.1998.tb02006.x; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Environmental Protection Agency (EPA) United States Geological Survey (USGS) Horizon Systems Corporations, 2012, DAT NHDPLUSV2 DAT; Environmental Protection Agency (EPA) United States Geological Survey (USGS) Horizon Systems Corporations, 2010, DAT NHDPLUSV1 DAT; Esselman PC, 2011, FRESHWATER BIOL, V56, P71, DOI 10.1111/j.1365-2427.2010.02417.x; Franklin J, 2009, MAPPING SPECIES DIST; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Friedman JH, 2003, STAT MED, V22, P1365, DOI 10.1002/sim.1501; Frimpong EA, 2009, FISHERIES, V34, P487, DOI 10.1577/1548-8446-34.10.487; Gilpin M.E., 1991, METAPOPULATION DYNAM; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Herborg LM, 2007, CAN J FISH AQUAT SCI, V64, P1723, DOI 10.1139/F07-130; Hijmans R.J., 2013, DISMO SPECIES DISTRI, V0, P8; Hirzel AH, 2004, J APPL ECOL, V41, P1103, DOI 10.1111/j.0021-8901.2004.00980.x; Huang J, 2011, J N AM BENTHOL SOC, V30, P923, DOI 10.1899/10-172.1; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Jobson HE, 1996, US GEOLOGICAL SURVEY, V96, P4013; Kearney M, 2006, OIKOS, V115, P186, DOI 10.1111/j.2006.0030-1299.14908.x; Kelly M, 2002, PHOTOGRAMM ENG REM S, V68, P1001; Legendre P. D., 2012, PCNM MEM SPATIAL EIG; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lyons J, 2010, J FISH BIOL, V77, P1867, DOI 10.1111/j.1095-8649.2010.02763.x; MacKenzie DI, 2002, ECOLOGY, V83, P2387, DOI 10.2307/3071800; McKay L, 2012, NHDPLUS VERSION 2 US; Michener W.K., 2000, ECOLOGICAL DATA DESI; Miller J, 2010, HDB APPL SPATIAL ANA, P685; Moisen GG, 2006, ECOL MODEL, V199, P176, DOI 10.1016/j.ecolmodel.2006.05.021; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Mugodo J, 2006, HYDROBIOLOGIA, V572, P59, DOI 10.1007/s10750-006-0252-7; National Fish Habitat Board, 2012, NAT FISH HAB ACT PLA; NatureServe, 2014, IUCN RED LIST THREAT; NELSON J S, 1976, P416; Niu SQ, 2012, FRESHWATER BIOL, V57, P2367, DOI 10.1111/fwb.12016; Pacifici K, 2012, METHODS ECOL EVOL, V3, P721, DOI 10.1111/j.2041-210X.2012.00201.x; Pearce J, 1998, RESTOR ECOL, V6, P238, DOI 10.1046/j.1526-100X.1998.00636.x; Peres-Neto PR, 2010, AM FISHERIES SOC S, P685; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pollock LJ, 2014, METHODS ECOL EVOL, V5, P397, DOI 10.1111/2041-210X.12180; Price CP, 2006, US GEOLOGICAL SURVEY, V240; PRISM Climate Group Oregon State University, 2004, DAT PRISM CLIM DAT; Pritt JJ, 2014, ECOL INDIC, V39, P169, DOI 10.1016/j.ecolind.2013.12.016; Pritt JJ, 2010, CONSERV BIOL, V24, P1249, DOI 10.1111/j.1523-1739.2010.01488.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rabinowitz D., 1981, BIOL ASPECTS RARE PL, P205, DOI DOI 10.1177/004728702237415; Santika T, 2011, GLOBAL ECOL BIOGEOGR, V20, P181, DOI 10.1111/j.1466-8238.2010.00581.x; Schlosser IJ, 1995, AM FISH S S, V17, P392; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; STRAHLER AN, 1952, GEOL SOC AM BULL, V63, P1117, DOI 10.1130/0016-7606(1952)63[1117:HAAOET]2.0.CO;2; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913; Wenger SJ, 2012, METHODS ECOL EVOL, V3, P260, DOI 10.1111/j.2041-210X.2011.00170.x; Wildt A., 1978, ANAL COVARIANCE; WILSON DS, 1992, ECOLOGY, V73, P1984, DOI 10.2307/1941449; Yackulic CB, 2013, METHODS ECOL EVOL, V4, P236, DOI 10.1111/2041-210x.12004; Zarkami R, 2012, ECOL MODEL, V230, P44, DOI 10.1016/j.ecolmodel.2012.01.011; Zimmermann NE, 2010, ECOGRAPHY, V33, P985, DOI 10.1111/j.1600-0587.2010.06953.x; Zuckerberg B, 2011, PREDICTIVE SPECIES AND HABITAT MODELING IN LANDSCAPE ECOLOOGY: CONCEPTS AND APPLICATIONS, P45, DOI 10.1007/978-1-4419-7390-0_4	80	19	20	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129995	10.1371/journal.pone.0129995	http://dx.doi.org/10.1371/journal.pone.0129995			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075902	Green Submitted, Green Published, gold			2022-12-26	WOS:000356329900120
J	Ma, WQ; Li, Y; Wang, M; Li, HX; Su, TF; Li, Y; Wang, SX				Ma, Wenqing; Li, Ya; Wang, Man; Li, Haixia; Su, Tiefen; Li, Yan; Wang, Shixuan			Associations of Polymorphisms in WNT9B and PBX1 with Mayer-Rokitansky-Kuster-Hauser Syndrome in Chinese Han	PLOS ONE			English	Article							MULLERIAN DUCT ABNORMALITIES; INHIBITING SUBSTANCE; CONGENITAL ABSENCE; REPRODUCTIVE-TRACT; BETA-CATENIN; MUTATIONS; HORMONE; WOMEN; GENE; REGRESSION	Background Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome is a rare syndrome that is characterized by congenital aplasia of the uterus and the upper portion (2/3) of the vagina. Previous attempts to identify causal mutations of MRKH syndrome have primarily resulted in negative outcomes. We investigated whether these reported variants are associated with MRKH syndrome (types I and II) in a relatively large sample size of Chinese Han patients, and whether any gene-gene epistatic interactions exist among these variants. Methods This study included 182 unrelated Chinese women with MRKH syndrome (155 with type I and 27 with type II) and 228 randomized female controls. Seventeen candidate loci in the AMH, PBX1, WNT4, WNT7A, WNT9B, HOXA10, HOXA11, LHXA1 and GALT genes were genotyped using the Sequenom MassARRAY iPLEX platform. Single-marker association, additive effects and multifactor interactions were investigated. Results The gene frequency distributions of MRKH type 1 and type 2 were similar. Rs34072914 in WNT9B was found to be associated with MRKH syndrome (P = 0.024, OR = 2.65, 95%CI = 1.14-6.17). The dominant models of rs34072914 and rs2275558 in WNT9B and PBX1, respectively, were significantly associated with MRKH syndrome risk in the Chinese Han patients. Additive gene-gene interaction analyses indicated a significant synergetic interaction between WNT9B and PBX1 (RERI = 1.397, AP = 0.493, SI = 4.204). Multifactor dimensionality reduction (MDR) analysis revealed novel dimensional epistatic four-gene effects (AMH, PBX1, WNT7A and WNT9B) in MRKH syndrome. Conclusions This association study successfully identified two susceptibility SNPs (WNT9B and PBX1) associated with MRKH syndrome risk, both separately and interactively. The discovery of a four-gene epistatic effect (AMH, PBX1, WNT7A and WNT9B) in MRKH syndrome provides novel information for the elucidation of the genetic mechanism underlying the etiology of MRKH syndrome.	[Ma, Wenqing; Li, Ya; Wang, Man; Li, Haixia; Li, Yan; Wang, Shixuan] Huazhong Univ Sci & Technol, Dept Gynecol & Obstet, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China; [Su, Tiefen] Huazhong Univ Sci & Technol, Dept Pathol, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Li, Y (corresponding author), Huazhong Univ Sci & Technol, Dept Gynecol & Obstet, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China.	liyan.christine@gmail.com; sxwang2012@hotmail.com			National Natural Science Foundation of China [81401164]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (Grant No. 81401164), named with "Effects and molecular mechanism of phthalic acid ester (PAEs) in MRKH syndrom". TS received the funding and participated in the study design and data collection.	Allard S, 2000, DEVELOPMENT, V127, P3349; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; [Anonymous], 2013, ISRN OBSTET GYNECOLO, DOI DOI 10.1155/2013/628717; Bergstein I, 1997, GENOMICS, V46, P450, DOI 10.1006/geno.1997.5041; Burell A, 2006, J NEGAT RESULTS BIOM, V5, DOI 10.1186/1477-5751-5-4; Carroll Thomas J., 2005, DEV CELL, V9, P283, DOI [10.1016/j.devcel.2005.05.016, DOI 10.1016/J.DEVCEL.2005.05.016]; Chang XY, 2012, REPROD BIOMED ONLINE, V24, P630, DOI 10.1016/j.rbmo.2012.03.008; Cheng Z, 2011, HUM REPROD, V26, P3197, DOI 10.1093/humrep/der290; Dang YJ, 2012, FERTIL STERIL, V97, P391, DOI 10.1016/j.fertnstert.2011.11.025; Ferretti E, 2011, DEV CELL, V21, P627, DOI 10.1016/j.devcel.2011.08.005; Gervasini C, 2010, GENET MED, V12, P634, DOI 10.1097/GIM.0b013e3181ed6185; GRIFFIN JE, 1976, ANN INTERN MED, V85, P224, DOI 10.7326/0003-4819-85-2-224; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hossain A, 2003, J BIOL CHEM, V278, P26511, DOI 10.1074/jbc.M300804200; Hunt R, 2009, METHODS MOL BIOL, V578, P23, DOI 10.1007/978-1-60327-411-1_2; Klattig J, 2007, SEX DEV, V1, P271, DOI 10.1159/000108929; Kobayashi A, 2003, NAT REV GENET, V4, P969, DOI 10.1038/nrg1225; Lane AH, 1998, J ENDOCRINOL, V158, P1, DOI 10.1677/joe.0.1580001; Ledig S, 2011, FERTIL STERIL, V95, P1589, DOI 10.1016/j.fertnstert.2010.07.1062; Liatsikos SA, 2010, REPROD BIOMED ONLINE, V21, P126, DOI 10.1016/j.rbmo.2010.03.015; Ma JL, 2011, FERTIL STERIL, V95, P2615, DOI 10.1016/j.fertnstert.2011.04.074; Martinez-Frias ML, 1998, AM J MED GENET, V78, P140, DOI 10.1002/(SICI)1096-8628(19980630)78:2<140::AID-AJMG8>3.0.CO;2-S; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Morcel K, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-13; Nodale C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091010; Oppelt P, 2005, HUM REPROD, V20, P149, DOI 10.1093/humrep/deh547; Parr BA, 1998, NATURE, V395, P707, DOI 10.1038/27221; Philibert P, 2008, J CLIN ENDOCR METAB, V93, P895, DOI 10.1210/jc.2007-2023; Philibert P, 2011, FERTIL STERIL, V95, P2683, DOI 10.1016/j.fertnstert.2011.01.152; Raga F, 1997, HUM REPROD, V12, P2277, DOI 10.1093/humrep/12.10.2277; Rall K, 2015, FERTIL STERIL, V103, P494, DOI 10.1016/j.fertnstert.2014.10.053; Ravel C, 2009, FERTIL STERIL, V91, P1604, DOI 10.1016/j.fertnstert.2008.12.006; Resendes BL, 2001, AM J MED GENET, V98, P129, DOI 10.1002/1096-8628(20010115)98:2<129::AID-AJMG1021>3.0.CO;2-3; Schnabel CA, 2003, GENESIS, V37, P123, DOI 10.1002/gene.10235; Simpson JL, 1999, AM J MED GENET, V89, P224, DOI 10.1002/(SICI)1096-8628(19991229)89:4<224::AID-AJMG7>3.0.CO;2-C; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Timmreck L S, 2003, J Pediatr Adolesc Gynecol, V16, P217, DOI 10.1016/S1083-3188(03)00124-4; Troiano RN, 2004, RADIOLOGY, V233, P19, DOI 10.1148/radiol.2331020777; Wang M, 2014, REPROD BIOMED ONLINE, V28, P80, DOI 10.1016/j.rbmo.2013.09.022; Zenteno Juan Carlos, 2004, Archives of Gynecology and Obstetrics, V269, P270, DOI 10.1007/s00404-002-0456-7	40	17	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130202	10.1371/journal.pone.0130202	http://dx.doi.org/10.1371/journal.pone.0130202			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075712	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900155
J	Reddy, NM; Potteti, HR; Vegiraju, S; Chen, HJ; Tamatam, CM; Reddy, SP				Reddy, Narsa M.; Potteti, Haranatha R.; Vegiraju, Suryanarayana; Chen, Hsin-Jou; Tamatam, Chandra Mohan; Reddy, Sekhar P.			PI3K-AKT Signaling via Nrf2 Protects against Hyperoxia-Induced Acute Lung Injury, but Promotes Inflammation Post-Injury Independent of Nrf2 in Mice	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; PULMONARY EPITHELIAL-CELLS; TRANSCRIPTION FACTOR NRF2; OXIDATIVE STRESS; ANTIOXIDANT RESPONSE; CYCLE PROGRESSION; PI3K/AKT PATHWAY; IN-VITRO; APOPTOSIS; IMPAIRS	Lung epithelial and endothelial cell death accompanied by inflammation contributes to hyperoxia-induced acute lung injury (ALI). Impaired resolution of ALI can promote and/or perpetuate lung pathogenesis, including fibrosis. Previously, we have shown that the transcription factor Nrf2 induces cytoprotective gene expression and confers protection against hyperoxic lung injury, and that Nrf2-mediated signaling is also crucial for the restoration of lung homeostasis post-injury. Although we have reported that PI3K/AKT signaling is required for Nrf2 activation in lung epithelial cells, significance of the PI3K/AKT-Nrf2 crosstalk during hyperoxic lung injury and repair remains unclear. Thus, we evaluated this aspect using Nrf2 knockout (Nrf2(-/-)) and wild-type (Nrf2(+/+)) mouse models. Here, we show that pharmacologic inhibition of PI3K/AKT signaling increased lung inflammation and alveolar permeability in Nrf2(+/+) mice, accompanied by decreased expression of Nrf2-target genes such as Nqo1 and Hmox1. PI3K/AKT inhibition dampened hyperoxia-stimulated Nqo1 and Hmox1 expression in lung epithelial cells and alveolar macrophages. Contrasting with its protective effects, PI3K/AKT inhibition suppressed lung inflammation in Nrf2(+/+) mice during post-injury. In Nrf2(-/-) mice exposed to room-air, PI3K/AKT inhibition caused lung injury and inflammation, but it did not exaggerate hyperoxia-induced ALI. During post-injury, PI3K/AKT inhibition did not augment, but rather attenuated, lung inflammation in Nrf2(-/-) mice. These results suggest that PI3K/AKT-Nrf2 signaling is required to dampen hyperoxia-induced lung injury and inflammation. Paradoxically, the PI3K/AKT pathway promotes lung inflammation, independent of Nrf2, during post-injury.	[Reddy, Narsa M.; Potteti, Haranatha R.; Chen, Hsin-Jou; Tamatam, Chandra Mohan; Reddy, Sekhar P.] Univ Illinois, Dept Pediat, Chicago, IL 60612 USA; [Vegiraju, Suryanarayana] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Reddy, SP (corresponding author), Univ Illinois, Dept Pediat, Chicago, IL 60612 USA.	sreddy03@uic.edu	Reddy, Narsa/AHE-5604-2022		National Institutes of Health [HL66109, ES11863]; National Institutes of Environmental Health Sciences training [ES007141]; National Institutes of Environmental Health Sciences Center [P30ES03819]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011863, P30ES003819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Environmental Health Sciences training; National Institutes of Environmental Health Sciences Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health grants HL66109 and ES11863(to SPR) and the National Institutes of Environmental Health Sciences training grant ES007141 (to SV) and by the National Institutes of Environmental Health Sciences Center supported by P30ES03819 (to Johns Hopkins Environmental Health Sciences), for utilizing its facilities and services.	Ahmad A, 2006, FREE RADICAL BIO MED, V40, P1108, DOI 10.1016/j.freeradbiomed.2005.10.045; Altemeier WA, 2007, CURR OPIN CRIT CARE, V13, P73, DOI 10.1097/MCC.0b013e32801162cb; Arisawa T, 2007, INT J MOL MED, V20, P849; Bailey TC, 2003, J APPL PHYSIOL, V94, P975, DOI 10.1152/japplphysiol.00619.2002; Chabot F, 1998, EUR RESPIR J, V11, P745; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Cho HY, 2006, ANTIOXID REDOX SIGN, V8, P76, DOI 10.1089/ars.2006.8.76; Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501; Cho HY, 2002, AM J RESP CELL MOL, V26, P42, DOI 10.1165/ajrcmb.26.1.4536; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Duan W, 2005, INT IMMUNOPHARMACOL, V5, P495, DOI 10.1016/j.intimp.2004.10.015; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Henson PM, 2008, AM J PHYSIOL-LUNG C, V294, pL601, DOI 10.1152/ajplung.00320.2007; Janssen WJ, 2012, TOXICOL PATHOL, V40, P166, DOI 10.1177/0192623311428477; Kim DI, 2012, J CLIN IMMUNOL, V32, P340, DOI 10.1007/s10875-011-9628-1; Kim HJ, 2010, AM J PHYSIOL-RENAL, V298, pF662, DOI 10.1152/ajprenal.00421.2009; Li LF, 2013, BIOMATERIALS, V34, P78, DOI 10.1016/j.biomaterials.2012.09.042; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Lu YB, 2001, J EXP MED, V193, P545, DOI 10.1084/jem.193.4.545; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marzec JM, 2007, FASEB J, V21, P2237, DOI 10.1096/fj.06-7759com; Matthay MA, 2005, AM J RESP CELL MOL, V33, P319, DOI 10.1165/rcmb.F305; Matthay MA, 2002, AM J PHYSIOL-LUNG C, V283, pL678, DOI 10.1152/ajplung.00154.2002; Morito N, 2003, ONCOGENE, V22, P9275, DOI 10.1038/sj.onc.1207024; Ong E, 2005, AM J PHYSIOL-LUNG C, V289, pL1094, DOI 10.1152/ajplung.00179.2005; Pagano A, 2003, ANN NY ACAD SCI, V1010, P405, DOI 10.1196/annals.1299.074; Papaiahgari S, 2006, ANTIOXID REDOX SIGN, V8, P43, DOI 10.1089/ars.2006.8.43; Papaiahgari S, 2004, J BIOL CHEM, V279, P42302, DOI 10.1074/jbc.M408275200; Qi YC, 2001, DEVELOPMENT, V128, P2723; Rahman Irfan, 2002, Current Drug Targets - Inflammation and Allergy, V1, P291, DOI 10.2174/1568010023344607; Reddy NM, 2008, ONCOGENE, V27, P5821, DOI 10.1038/onc.2008.188; Reddy NM, 2007, AM J RESP CELL MOL, V37, P3, DOI 10.1165/rcmb.2007-0004RC; Reddy NM, 2009, J IMMUNOL, V182, P7264, DOI 10.4049/jimmunol.0804248; Reddy SP, 2008, CURR MOL MED, V8, P376, DOI 10.2174/156652408785160925; Rizvi F, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.118; Salazar M, 2006, J BIOL CHEM, V281, P14841, DOI 10.1074/jbc.M513737200; Sun Z, 2009, MOL CELL BIOL, V29, P2658, DOI 10.1128/MCB.01639-08; Tan Y, 2011, DIABETES, V60, P625, DOI 10.2337/db10-1164; Wang Z, 2013, FREE RADICAL BIO MED, V65, P849, DOI 10.1016/j.freeradbiomed.2013.08.169; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010	41	35	40	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129676	10.1371/journal.pone.0129676	http://dx.doi.org/10.1371/journal.pone.0129676			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075390	gold, Green Published, Green Submitted			2022-12-26	WOS:000356329900090
J	Zhao, X; Xue, JF; Zhang, XQ; Kong, FL; Chen, F; Lal, R; Zhang, HL				Zhao, Xin; Xue, Jian-Fu; Zhang, Xiang-Qian; Kong, Fan-Lei; Chen, Fu; Lal, Rattan; Zhang, Hai-Lin			Stratification and Storage of Soil Organic Carbon and Nitrogen as Affected by Tillage Practices in the North China Plain	PLOS ONE			English	Article							LONG-TERM TILLAGE; CLIMATE-CHANGE; RESIDUE MANAGEMENT; QUALITY ASSESSMENT; CROPPING SYSTEM; PADDY SOILS; CLAY LOAM; SEQUESTRATION; RATIO; AGRICULTURE	Tillage practices can redistribute the soil profiles, and thus affects soil organic carbon (SOC), and its storage. The stratification ratio (SR) can be an indicator of soil quality. This study was conducted to determine tillage effects on the profile distribution of certain soil properties in winter wheat (Triticum aestivum L.) and summer maize (Zea mays L.) systems in the North China Plain (NCP). Three tillage treatments, including no till (NT), rotary tillage (RT), and plow tillage (PT), were established in 2001 in Luancheng County, Hebei Province. The concentration, storage, and SR of SOC and soil total nitrogen (TN) were assessed in both the wheat and maize seasons. Compared with RT and PT, the mean SRs for all depth ratios of SOC under NT increased by 7.85% and 30.61% during the maize season, and by 14.67% and 30.91% during the wheat season, respectively. The SR of TN for 0-5:30-50 cm increased by 140%, 161%, and 161% in the maize season, and 266%, 154%, and 122% in the wheat season compared to the SR for 0-5:5-10 cm under NT, RT and PT, respectively. The data indicated that SOC and TN were both concentrated in the surface-soil layers (0-10 cm) under NT but were distributed relatively evenly through the soil profile under PT. Meanwhile, the storage of SOC and TN was higher under NT for the surface soil (0-10 cm) but was higher under PT for the deeper soil (30-50 cm). Furthermore, the storage of SOC and TN was significantly related to SR of SOC and TN along the whole soil profile (P< 0.0001). Therefore, SR could be used to explain and indicate the changes in the storage of SOC and TN. Further, NT stratifies SOC and TN, enhances the topsoil SOC storage, and helps to improve SOC sequestration and soil quality.	[Zhao, Xin; Xue, Jian-Fu; Zhang, Xiang-Qian; Kong, Fan-Lei; Chen, Fu; Zhang, Hai-Lin] China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China; [Zhao, Xin; Xue, Jian-Fu; Zhang, Xiang-Qian; Kong, Fan-Lei; Chen, Fu; Zhang, Hai-Lin] Minist Agr China, Key Lab Farming Syst, Beijing, Peoples R China; [Kong, Fan-Lei] Sichuan Agr Univ, Coll Agron, Chengdu, Peoples R China; [Lal, Rattan] Ohio State Univ, Sch Environm & Nat Resources, Carbon Management & Sequestrat Ctr, Columbus, OH 43210 USA	China Agricultural University; Ministry of Agriculture & Rural Affairs; Sichuan Agricultural University; University System of Ohio; Ohio State University	Zhang, HL (corresponding author), China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China.	hailin@cau.edu.cn	Zhao, Xin/AAH-5629-2019; Lal, Rattan/D-2505-2013; Zhang, Hai-Lin/H-2715-2017	Zhao, Xin/0000-0002-2977-6430; Zhang, Hai-Lin/0000-0002-7426-2885; Zhao, Xu/0000-0001-7875-4863	Chinese Universities Scientific Fund [2014FG055]; Program for New Century Excellent Talents in University of Ministry of Education of China [NCET-13-0567]; Special Fund for Agro-scientific Research in the Public Interest in China [201103001]	Chinese Universities Scientific Fund; Program for New Century Excellent Talents in University of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)); Special Fund for Agro-scientific Research in the Public Interest in China	This work was funded by Chinese Universities Scientific Fund (2014FG055), Program for New Century Excellent Talents in University of Ministry of Education of China (NCET-13-0567) and Special Fund for Agro-scientific Research in the Public Interest in China (201103001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao S.D, 2000, SOIL AGR CHEM ANAL; Blake G. R., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P363; Churka Blum S, 2014, STRATIFICATION RATIO, P427; Corral-Fernandez R, 2013, AGR ECOSYST ENVIRON, V164, P252, DOI 10.1016/j.agee.2012.11.002; Dalal RC, 2011, SOIL TILL RES, V112, P133, DOI 10.1016/j.still.2010.12.006; Dikgwatlhe SB, 2014, SOIL TILL RES, V144, P110, DOI 10.1016/j.still.2014.07.014; Du ZL, 2013, J INTEGR AGR, V12, P2114, DOI 10.1016/S2095-3119(13)60428-1; Du ZL, 2010, SOIL SCI SOC AM J, V74, P196, DOI 10.2136/sssaj2009.0048; Ellert BH, 1995, CAN J SOIL SCI, V75, P529, DOI 10.4141/cjss95-075; Ferreira AD, 2013, SOIL TILL RES, V133, P65, DOI 10.1016/j.still.2013.05.011; Franzluebbers AJ, 2007, SOIL TILL RES, V96, P303, DOI 10.1016/j.still.2007.07.001; Franzluebbers AJ, 2002, SOIL TILL RES, V66, P197, DOI 10.1016/S0167-1987(02)00027-2; Franzluebbers AJ, 2013, SOIL TILL RES, V134, P83, DOI 10.1016/j.still.2013.07.010; Hou RX, 2012, SOIL SCI SOC AM J, V76, P230, DOI 10.2136/sssaj2011.0107; Kong XB, 2014, ADV AGRON, V125, P135, DOI 10.1016/B978-0-12-800137-0.00004-2; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lal R, 2004, ENVIRON MANAGE, V33, P528, DOI 10.1007/s00267-003-9110-9; Liu ZJ, 2014, J INTEGR AGR, V13, P177, DOI 10.1016/S2095-3119(13)60594-8; Lopez-Garrido R, 2011, AGR ECOSYST ENVIRON, V140, P182, DOI 10.1016/j.agee.2010.12.001; Lopez-Garrido R, 2009, SPAN J AGRIC RES, V7, P706; Lou YL, 2012, CATENA, V95, P124, DOI 10.1016/j.catena.2012.02.009; Luo ZK, 2010, AGR ECOSYST ENVIRON, V139, P224, DOI 10.1016/j.agee.2010.08.006; Melero S, 2012, SOIL TILL RES, V119, P7, DOI 10.1016/j.still.2011.11.012; Noellemeyer E, 2006, J ARID ENVIRON, V65, P142, DOI 10.1016/j.jaridenv.2005.07.007; NRCS, SOIL QUAL CONC; Pan GX, 2008, J ENVIRON SCI, V20, P456, DOI 10.1016/S1001-0742(08)62079-3; Peregrina F, 2014, J PLANT NUTR SOIL SC, V177, P548, DOI 10.1002/jpln.201300371; Powlson DS, 2014, NAT CLIM CHANGE, V4, P678, DOI 10.1038/NCLIMATE2292; Reynolds WD, 2007, SOIL TILL RES, V96, P316, DOI 10.1016/j.still.2007.07.003; Sa JCD, 2009, SOIL TILL RES, V103, P46, DOI 10.1016/j.still.2008.09.003; Shi XH, 2012, SOIL TILL RES, V120, P1, DOI [10.1016/j.still.2012.01.003, 10.1016/j.sti1l.2012.01.003]; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stockmann U, 2013, AGR ECOSYST ENVIRON, V164, P80, DOI 10.1016/j.agee.2012.10.001; Ussiri DAN, 2009, SOIL TILL RES, V104, P39, DOI 10.1016/j.still.2008.11.008; Wang Y, 2011, SOIL TILL RES, V117, P8, DOI 10.1016/j.still.2011.08.002; Wei YanHua, 2013, Transactions of the Chinese Society of Agricultural Engineering, V29, P87; West TO, 2002, SOIL SCI SOC AM J, V66, P1930, DOI 10.2136/sssaj2002.1930; Yang XM, 2013, ACTA AGR SCAND B-S P, V63, P523, DOI 10.1080/09064710.2013.816363; Zhang HL, 2015, CLIMATIC CHANGE, V129, P213, DOI 10.1007/s10584-015-1337-y; Zhang HL, 2014, ADV AGRON, V124, P1, DOI 10.1016/B978-0-12-800138-7.00001-2; Zhang MY, 2013, J CLEAN PROD, V54, P101, DOI 10.1016/j.jclepro.2013.04.033	41	35	39	9	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128873	10.1371/journal.pone.0128873	http://dx.doi.org/10.1371/journal.pone.0128873			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075391	gold, Green Published, Green Submitted			2022-12-26	WOS:000356329900036
J	Bosco-Lauth, AM; Han, SS; Hartwig, A; Bowen, RA				Bosco-Lauth, Angela M.; Han, Sushan; Hartwig, Airn; Bowen, Richard A.			Development of a Hamster Model for Chikungunya Virus Infection and Pathogenesis	PLOS ONE			English	Article							MESOCRICETUS-AURATUS; MOUSE MODEL; DISEASE; PERSISTENCE; ARTHRITIS; EPIDEMIC; OUTBREAK	Chikungunya virus is transmitted by mosquitoes and causes severe, debilitating infectious arthritis in humans. The need for an animal model to study the disease process and evaluate potential treatments is imminent as the virus continues its spread into novel geographic locations. Golden hamsters (Mesocricetus auratus) are often used as outbred laboratory animal models for arboviral diseases. Here we demonstrate that hamsters inoculated with chikungunya virus developed viremia and histopathologic lesions in their limbs and joints similar to those seen in human patients. The virus disseminated rapidly and was found in every major organ, including brain, within a few days of infection. Hamsters did not manifest overt clinical signs, and the virus was generally cleared within 4 days, followed by a strong neutralizing antibody response. These results indicate that hamsters are highly susceptible to chikungunya virus infection and develop myositis and tenosynovitis similar to human patients followed by a complete recovery. This animal model may be useful for testing antiviral drugs and vaccines.	[Bosco-Lauth, Angela M.; Hartwig, Airn; Bowen, Richard A.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Han, Sushan] Colorado State Univ, Diagnost Med Lab, Ft Collins, CO 80523 USA; [Han, Sushan] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University; Colorado State University	Bowen, RA (corresponding author), Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA.	Richard.Bowen@colostate.edu			National Institute of Allergy and Infectious Disease (NIAID) [N01-AI25489]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI025489] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported through contract N01-AI25489 from National Institute of Allergy and Infectious Disease (NIAID). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaty BJ, 1995, DIAGNOSTIC PROCEDURE, P189; Bordi L, 2008, CLIN INFECT DIS, V47, P428, DOI 10.1086/589925; Bosco-Lauth A, 2011, AM J TROP MED HYG, V84, P727, DOI 10.4269/ajtmh.2011.11-0012; Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530; Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029; Couderc T, 2009, MICROBES INFECT, V11, P1197, DOI 10.1016/j.micinf.2009.09.002; Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09; Her Z, 2009, MICROBES INFECT, V11, P1165, DOI 10.1016/j.micinf.2009.09.004; Higgs S, 2010, J CLIN INVEST, V120, P657, DOI 10.1172/JCI42392; Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104; LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X; Morrison TE, 2011, AM J PATHOL, V178, P32, DOI 10.1016/j.ajpath.2010.11.018; Ng LC, 2010, INFECT GENET EVOL, V10, P876, DOI 10.1016/j.meegid.2010.07.012; Pesko K, 2009, J MED ENTOMOL, V46, P395, DOI 10.1603/033.046.0228; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0; Renault P, 2007, AM J TROP MED HYG, V77, P727; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; ROBINSON M. C., 1955, TANGANYIKA TERRITORY IN 1952 53 I TRANS ROY SOC TROP MED AND HYG, V49, P28, DOI 10.1016/0035-9203(55)90080-8; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Soumahoro MK, 2009, PLOS ONE, V4, pA221, DOI 10.1371/journal.pone.0007800; Teo TH, 2012, IMMUNOL RES, V53, P136, DOI 10.1007/s12026-012-8266-x; Tesh RB, 2001, J INFECT DIS, V183, P1431, DOI 10.1086/320199; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Xiao SY, 2001, EMERG INFECT DIS, V7, P714; Ziegler SA, 2008, AM J TROP MED HYG, V79, P133, DOI 10.4269/ajtmh.2008.79.133	26	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130150	10.1371/journal.pone.0130150	http://dx.doi.org/10.1371/journal.pone.0130150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070211	Green Submitted, Green Published, gold			2022-12-26	WOS:000356327000143
J	Celdran, D; Lloret, J; Verduin, J; van Keulen, M; Marin, A				Celdran, David; Lloret, Javier; Verduin, Jennifer; van Keulen, Mike; Marin, Arnaldo			Linking Seed Photosynthesis and Evolution of the Australian and Mediterranean Seagrass Genus Posidonia	PLOS ONE			English	Article								Recent findings have shown that photosynthesis in the skin of the seed of Posidonia oceanica enhances seedling growth. The seagrass genus Posidoniais found only in two distant parts of the world, the Mediterranean Sea and southern Australia. This fact led us to question whether the acquisition of this novel mechanism in the evolution of this seagrass was a pre-adaptation prior to geological isolation of the Mediterranean from Tethys Sea in the Eocene. Photosynthetic activity in seeds of Australian species of Posidoniais still unknown. This study shows oxygen production and respiration rates, and maximum PSII photochemical efficiency (Fv : Fm) in seeds of two Australian Posidonia species (P. australis and P. sinuosa), and compares these with previous results for Posidonia oceanica. Results showed relatively high oxygen production and respiratory rates in all three species but with significant differences among them, suggesting the existence of an adaptive mechanism to compensate for the relatively high oxygen demands of the seeds. In all cases maximal photochemical efficiency of photosystem II rates reached similar values. The existence of photosynthetic activity in the seeds of all three species implicates that it was an ability probably acquired from a common ancestor during the Late Eocene, when this adaptive strategy could have helped Posidonia species to survive in nutrient-poor temperate seas. This study sheds new light on some aspects of the evolution of marine plants and represents an important contribution to global knowledge of the paleogeographic patterns of seagrass distribution.	[Celdran, David] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Unidad Acad Sistemas Arrecifales Puerto Morelos, Cancun 77500, Quintana Roo, Mexico; [Lloret, Javier] Marine Biol Lab, Ecosyst Ctr, Woods Hole, MA 02543 USA; [Verduin, Jennifer; van Keulen, Mike] Murdoch Univ, Sch Vet & Life Sci Environm & Conservat Sci, Murdoch, WA 6150, Australia; [Marin, Arnaldo] Univ Murcia, Fac Biol, Dept Ecol & Hidrol, E-30100 Murcia, Spain	Universidad Autonoma del Estado de Morelos; Universidad Nacional Autonoma de Mexico; Marine Biological Laboratory - Woods Hole; Murdoch University; University of Murcia	Celdran, D (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Unidad Acad Sistemas Arrecifales Puerto Morelos, Apto Postal 1152, Cancun 77500, Quintana Roo, Mexico.	davidceldran1@hotmail.com	Atucha, Arnaldo Marín/R-3801-2019; Lloret, Javier/C-1994-2016; Verduin, Jennifer J/B-2102-2014; van Keulen, Mike/Q-9856-2019	Atucha, Arnaldo Marín/0000-0001-8439-4104; Lloret, Javier/0000-0003-3916-884X; Verduin, Jennifer J/0000-0002-1538-7813; van Keulen, Mike/0000-0001-6235-5788	Ministerio de Ciencia e Innovacion Espanol, Programa Nacional de Formacion de Profesorado Universitario, Spain; project "Desarroyo de tecnicas de reimplante con semillas para la recuperacion y expansion de las praderas de Posidonia oceanica", from Ministerio de Innovacion y Ciencia, Spain [116/SGTB/2007/1.3]	Ministerio de Ciencia e Innovacion Espanol, Programa Nacional de Formacion de Profesorado Universitario, Spain; project "Desarroyo de tecnicas de reimplante con semillas para la recuperacion y expansion de las praderas de Posidonia oceanica", from Ministerio de Innovacion y Ciencia, Spain	This research was further facilitated by a grant to D.C. from the Ministerio de Ciencia e Innovacion Espanol, Programa Nacional de Formacion de Profesorado Universitario, Spain; and the project "Desarroyo de tecnicas de reimplante con semillas para la recuperacion y expansion de las praderas de Posidonia oceanica", from the Ministerio de Innovacion y Ciencia (project number 116/SGTB/2007/1.3), Spain.	Aires T, 2011, MAR ECOL PROG SER, V421, P117, DOI 10.3354/meps08879; Boudouresque C.-F, 2004, TRAV SCI PARC NATL P, V20, P97; CAMBRIDGE ML, 1979, AQUAT BOT, V6, P307, DOI 10.1016/0304-3770(79)90071-8; Celdran D, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00104.1; Gessner F, 1970, INT REV GESAMTEN HYD, V56, P141, DOI [10.1002/iroh.19710560139, DOI 10.1002/IROH.19710560139]; KUO J, 1984, AQUAT BOT, V20, P267, DOI 10.1016/0304-3770(84)90092-5; KUO J, 1990, PLANT SYST EVOL, V171, P199, DOI 10.1007/BF00940605; Larkum AW., 2006, SEAGRASSES BIOL ECOL, P691; Roberts A. C., 1998, PREFRONTAL CORTEX EX, P1; Rolletschek H, 2002, J EXP BOT, V53, P1099, DOI 10.1093/jexbot/53.371.1099; SEARLE MP, 1987, GEOL SOC AM BULL, V98, P678, DOI 10.1130/0016-7606(1987)98<678:TCOTAT>2.0.CO;2; Souvermezoglou E, 1988, OCEANOL ACTA, V9, P103; STOCKMANS F., 1932, BULL MUS ROY HIST NAT BELGIQUE, V8, P1; Tschiersch H, 2011, BIOSYSTEMS, V103, P302, DOI 10.1016/j.biosystems.2010.08.007; Vigeolas H, 2003, PLANT PHYSIOL, V133, P2048, DOI 10.1104/pp.103.031963; Waycott M, 1997, HEREDITY, V79, P408, DOI 10.1038/sj.hdy.6881900	16	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130015	10.1371/journal.pone.0130015	http://dx.doi.org/10.1371/journal.pone.0130015			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066515	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000134
J	de Melo, SM; Bittencourt, S; Ferrazoli, EG; da Silva, CS; da Cunha, FF; da Silva, FH; Stilhano, RS; Denapoli, PMA; Zanetti, BF; Martin, PKM; Silva, LM; dos Santos, AA; Baptista, LS; Longo, BM; Han, SW				de Melo, Suely Maymone; Bittencourt, Simone; Ferrazoli, Eneas Galdini; da Silva, Clivandir Severino; da Cunha, Flavia Franco; da Silva, Flavia Helena; Stilhano, Roberta Sessa; Andrade Denapoli, Priscila Martins; Zanetti, Bianca Ferrarini; Matsumoto Martin, Priscila Keiko; Silva, Leonardo Martins; dos Santos, Adara Aurea; Baptista, Leandra Santos; Longo, Beatriz Monteiro; Han, Sang Won			The Anti-Tumor Effects of Adipose Tissue Mesenchymal Stem Cell Transduced with HSV-Tk Gene on U-87-Driven Brain Tumor	PLOS ONE			English	Article							HUMAN BONE-MARROW; THYMIDINE KINASE GENE; SUICIDE-GENE; PROGENITOR CELLS; STROMAL CELLS; MALIGNANT GLIOMA; GAP-JUNCTIONS; PHASE-III; IN-VITRO; THERAPY	Glioblastoma (GBM) is an infiltrative tumor that is difficult to eradicate. Treating GBM with mesenchymal stem cells (MSCs) that have been modified with the HSV-Tk suicide gene has brought significant advances mainly because MSCs are chemoattracted to GBM and kill tumor cells via a bystander effect. To use this strategy, abundantly present adipose-tissue-derived mesenchymal stem cells (AT-MSCs) were evaluated for the treatment of GBM in mice. AT-MSCs were prepared using a mechanical protocol to avoid contamination with animal protein and transduced with HSV-Tk via a lentiviral vector. The U-87 glioblastoma cells cultured with AT-MSC-HSV-Tk died in the presence of 25 or 50 mu M ganciclovir (GCV). U-87 glioblastoma cells injected into the brains of nude mice generated tumors larger than 3.5 mm(2) after 4 weeks, but the injection of AT-MSC-HSV-Tk cells one week after the U-87 injection, combined with GCV treatment, drastically reduced tumors to smaller than 0.5 mm(2). Immunohistochemical analysis of the tumors showed the presence of AT-MSC-HSV-Tk cells only within the tumor and its vicinity, but not in other areas of the brain, showing chemoattraction between them. The abundance of AT-MSCs and the easier to obtain them mechanically are strong advantages when compared to using MSCs from other tissues.	[de Melo, Suely Maymone; da Cunha, Flavia Franco; da Silva, Flavia Helena; Stilhano, Roberta Sessa; Andrade Denapoli, Priscila Martins; Zanetti, Bianca Ferrarini; Matsumoto Martin, Priscila Keiko; Silva, Leonardo Martins; dos Santos, Adara Aurea; Han, Sang Won] Univ Fed Sao Paulo, Res Ctr Gene Therapy CINTERGEN, Sao Paulo, Brazil; [Bittencourt, Simone; Ferrazoli, Eneas Galdini; da Silva, Clivandir Severino; Longo, Beatriz Monteiro] Univ Fed Sao Paulo, Dept Physiol, Sao Paulo, Brazil; [Baptista, Leandra Santos] Univ Fed Rio de Janeiro Xerem, Nucleus Multidisciplinary Res Biol, Numpex Bio, Sao Paulo, Brazil; [Han, Sang Won] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Han, SW (corresponding author), Univ Fed Sao Paulo, Res Ctr Gene Therapy CINTERGEN, Sao Paulo, Brazil.	sang.han@unifesp.br	Bittencourt, Simone/N-9393-2019; Baptista, Leandra/D-4259-2013; Martins, Leonardo/N-9454-2013; STILHANO, roberta/F-6923-2015; Monteiro Longo, Beatriz/D-2216-2012	Bittencourt, Simone/0000-0003-4872-0747; Baptista, Leandra/0000-0001-9998-8044; Martins, Leonardo/0000-0003-3524-4876; STILHANO, roberta/0000-0002-0653-5968; DOS SANTOS, ADARA AUREA/0000-0003-2309-4890; Monteiro Longo, Beatriz/0000-0002-2638-8061	Fundacao de ampara a pesquisa do estado de Sao Paulo (FAPESP) [2012/21861-1]	Fundacao de ampara a pesquisa do estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was funded by the Fundacao de ampara a pesquisa do estado de Sao Paulo (FAPESP): 2012/21861-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Amano S, 2011, CANCER LETT, V306, P99, DOI 10.1016/j.canlet.2011.02.037; [Anonymous], NEUROSURG FOCUS; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Baptista LS, 2009, CYTOTHERAPY, V11, P706, DOI 10.3109/14653240902981144; Benedetti S, 2000, NAT MED, V6, P447, DOI 10.1038/74710; Bexell D, 2009, MOL THER, V17, P183, DOI 10.1038/mt.2008.229; Bourin P, 2013, CYTOTHERAPY, V15, P641, DOI 10.1016/j.jcyt.2013.02.006; Brown AB, 2003, HUM GENE THER, V14, P1777, DOI 10.1089/104303403322611782; Candolfi M, 2007, J NEURO-ONCOL, V85, P133, DOI 10.1007/s11060-007-9400-9; Carvalho PP, 2011, CYTOTHERAPY, V13, P594, DOI 10.3109/14653249.2010.544721; Choi SA, 2011, NEURO-ONCOLOGY, V13, P61, DOI 10.1093/neuonc/noq147; COLOMBO BM, 1995, HUM GENE THER, V6, P763, DOI 10.1089/hum.1995.6.6-763; Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097; Cottin S, 2011, CANCER GENE THER, V18, P674, DOI 10.1038/cgt.2011.38; ELION GB, 1977, P NATL ACAD SCI USA, V74, P5716, DOI 10.1073/pnas.74.12.5716; Elshami AA, 1996, GENE THER, V3, P85; EZZEDDINE ZD, 1991, NEW BIOL, V3, P608; FREEMAN SM, 1993, CANCER RES, V53, P5274; Freeman SM, 1997, LANCET, V349, P2, DOI 10.1016/S0140-6736(97)22001-5; Gagandeep S, 1996, CANCER GENE THER, V3, P83; GOLUMBEK PT, 1992, J IMMUNOTHER, V12, P224, DOI 10.1097/00002371-199211000-00002; Grogan SP, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2719; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Kruse CA, 1997, CANCER GENE THER, V4, P118; Ladd B, 2011, CANCER GENE THER, V18, P751, DOI 10.1038/cgt.2011.51; Li SY, 2007, CANCER LETT, V251, P220, DOI 10.1016/j.canlet.2006.11.024; Li SY, 2012, STEM CELL RES, V9, P270, DOI 10.1016/j.scr.2012.08.002; Miletic H, 2004, HUM GENE THER, V15, P1091, DOI 10.1089/hum.2004.15.1091; Miletic H, 2007, MOL THER, V15, P1373, DOI 10.1038/sj.mt.6300155; Morizono K, 2003, HUM GENE THER, V14, P59, DOI 10.1089/10430340360464714; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Nakamura K, 2004, GENE THER, V11, P1155, DOI 10.1038/sj.gt.3302276; Namba H, 2001, CANCER GENE THER, V8, P414, DOI 10.1038/sj.cgt.7700317; Nestler U, 2004, J NEURO-ONCOL, V67, P177, DOI 10.1023/B:NEON.0000021897.53969.ca; Pachon-Pena G, 2011, J CELL PHYSIOL, V226, P843, DOI 10.1002/jcp.22408; Pendleton C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058198; Rainov NG, 2000, HUM GENE THER, V11, P2389, DOI 10.1089/104303400750038499; Rainov NG, 2001, CANCER GENE THER, V8, P662, DOI 10.1038/sj.cgt.7700355; Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615; Schmidt A, 2006, EUR J CELL BIOL, V85, P1179, DOI 10.1016/j.ejcb.2006.05.015; Studeny M, 2002, CANCER RES, V62, P3603; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Uhl M, 2005, BIOCHEM BIOPH RES CO, V328, P125, DOI 10.1016/j.bbrc.2004.12.164; WILLIAMS SK, 1995, CELL TRANSPLANT, V4, P281, DOI 10.1016/0963-6897(95)00006-J; Yamamoto S, 1997, CANCER GENE THER, V4, P91; Zhang Y, 2012, CANCER RES, V72, P5198, DOI 10.1158/0008-5472.CAN-12-0294; Zimmerlin L, 2010, CYTOM PART A, V77A, P22, DOI 10.1002/cyto.a.20813; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	51	39	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128922	10.1371/journal.pone.0128922	http://dx.doi.org/10.1371/journal.pone.0128922			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26067671	Green Submitted, Green Published, gold			2022-12-26	WOS:000356327000033
J	Kinney, KM; Asner, GP; Cordell, S; Chadwick, OA; Heckman, K; Hotchkiss, S; Jeraj, M; Kennedy-Bowdoin, T; Knapp, DE; Questad, EJ; Thaxton, JM; Trusdell, F; Kellner, JR				Kinney, Kealohanuiopuna M.; Asner, Gregory P.; Cordell, Susan; Chadwick, Oliver A.; Heckman, Katherine; Hotchkiss, Sara; Jeraj, Marjeta; Kennedy-Bowdoin, Ty; Knapp, David E.; Questad, Erin J.; Thaxton, Jarrod M.; Trusdell, Frank; Kellner, James R.			Primary Succession on a Hawaiian Dryland Chronosequence	PLOS ONE			English	Article							SOIL; PHOSPHORUS; DYNAMICS; MATRIX; FIRE	We used measurements from airborne imaging spectroscopy and LiDAR to quantify the biophysical structure and composition of vegetation on a dryland substrate age gradient in Hawaii. Both vertical stature and species composition changed during primary succession, and reveal a progressive increase in vertical stature on younger substrates followed by a collapse on Pleistocene-aged flows. Tall-stature Metrosideros polymorpha woodlands dominated on the youngest substrates (hundreds of years), and were replaced by the tall-stature endemic tree species Myoporum sandwicense and Sophora chrysophylla on intermediate-aged flows (thousands of years). The oldest substrates (tens of thousands of years) were dominated by the short-stature native shrub Dodonaea viscosa and endemic grass Eragrostis atropioides. We excavated 18 macroscopic charcoal fragments from Pleistocene-aged substrates. Mean radiocarbon age was 2,002 years and ranged from < 200 to 7,730. Genus identities from four fragments indicate that Osteomeles spp. or M. polymorpha once occupied the Pleistocene-aged substrates, but neither of these species is found there today. These findings indicate the existence of fires before humans are known to have occupied the Hawaiian archipelago, and demonstrate that a collapse in vertical stature is prevalent on the oldest substrates. This work contributes to our understanding of prehistoric fires in shaping the trajectory of primary succession in Hawaiian drylands.	[Kinney, Kealohanuiopuna M.; Kellner, James R.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Kinney, Kealohanuiopuna M.; Cordell, Susan] US Forest Serv, USDA, Inst Pacific Isl Forestry, Hilo, HI USA; [Asner, Gregory P.; Kennedy-Bowdoin, Ty; Knapp, David E.] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA USA; [Chadwick, Oliver A.] Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA; [Heckman, Katherine] Lawrence Livermore Natl Lab, USDA, Forest Serv, Northern Res Stn,Ctr Accelerator Mass Spectrometr, Livermore, CA USA; [Hotchkiss, Sara; Jeraj, Marjeta] Univ Wisconsin, Dept Bot, Madison, WI USA; [Questad, Erin J.] Calif Polytech Univ, Dept Biol Sci, Pomona, CA 91768 USA; [Thaxton, Jarrod M.] Eastern Kentucky Univ, Dept Biol Sci, Richmond, KY 40475 USA; [Trusdell, Frank] US Geol Survey, Hawaii Volcano Observ, Volcano, HI USA	Brown University; United States Department of Agriculture (USDA); United States Forest Service; Carnegie Institution for Science; University of California System; University of California Santa Barbara; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Wisconsin System; University of Wisconsin Madison; California State University System; California State Polytechnic University Pomona; United States Department of the Interior; United States Geological Survey	Kinney, KM (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	kealohanuiopuna_kinney@brown.edu	Asner, Gregory/G-9268-2013	Asner, Gregory/0000-0001-7893-6421; Hotchkiss, Sara/0000-0002-0383-0144	USDA Forest Service Pacific Southwest Research Station; University of Maryland, College Park; Strategic Environmental Research and Development Program	USDA Forest Service Pacific Southwest Research Station(United States Department of Agriculture (USDA)United States Forest Service); University of Maryland, College Park; Strategic Environmental Research and Development Program	This work was supported by a Joint Venture Agreement between the USDA Forest Service Pacific Southwest Research Station and the University of Maryland, College Park, and by a grant from the Strategic Environmental Research and Development Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth A, 2009, PLANT ECOL, V201, P197, DOI 10.1007/s11258-008-9538-3; APLET GH, 1994, J ECOL, V82, P137, DOI 10.2307/2261393; Asner GP, 2005, REMOTE SENS ENVIRON, V96, P497, DOI 10.1016/j.rse.2005.04.008; Asner GP, 2002, INT J REMOTE SENS, V23, P3939, DOI 10.1080/01431160110115960; Asner GP, 2007, J APPL REMOTE SENS, V1, DOI 10.1117/1.2794018; Austin AT, 1998, OECOLOGIA, V113, P519, DOI 10.1007/s004420050405; Burney Lida Pigott, 2003, Pacific Science, V57, P211, DOI 10.1353/psc.2003.0011; Certini G, 2005, OECOLOGIA, V143, P1, DOI 10.1007/s00442-004-1788-8; CREWS TE, 1995, ECOLOGY, V76, P1407, DOI 10.2307/1938144; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; DAVIS JC, 1990, NUCL INSTRUM METH B, V52, P269, DOI 10.1016/0168-583X(90)90419-U; Jenny H., 1941, FACTORS SOIL FORMATI; Kellner JR, 2011, ECOL APPL, V21, P2094, DOI 10.1890/10-0859.1; Peltzer DA, 2010, ECOL MONOGR, V80, P509, DOI 10.1890/09-1552.1; Porder S, 2007, EARTH PLANET SC LETT, V258, P414, DOI 10.1016/j.epsl.2007.03.047; Rasmussen C, 2010, GEODERMA, V154, P473, DOI 10.1016/j.geoderma.2009.05.019; Rhodes J., 1995, MAUNA LOA REVEALED S; Runyan CW, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001841; Selmants PC, 2010, ECOLOGY, V91, P474, DOI 10.1890/09-0243.1; Shaw R. B., 1997, PLANT COMMUNITIES PO; Sokal R.R., 1994, BIOMETRY PRINCIPLES; STEMMERMANN L, 1993, BIOTROPICA, V25, P36, DOI 10.2307/2388977; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Trusdell FA, 2007, DIGITAL DATABASE GEO; Vitousek, 2004, NUTR CYCLING LIMITAT; VOGEL JS, 1987, NUCL INSTRUM METH B, V29, P50, DOI 10.1016/0168-583X(87)90202-3; Wardle DA, 2004, SCIENCE, V305, P509, DOI 10.1126/science.1098778	27	4	4	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0123995	10.1371/journal.pone.0123995	http://dx.doi.org/10.1371/journal.pone.0123995			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066334	Green Submitted, Green Published, gold			2022-12-26	WOS:000356327000001
J	Miles, LA; Brennen, WN; Rudin, CM; Poirier, JT				Miles, Linde A.; Brennen, W. Nathaniel; Rudin, Charles M.; Poirier, John T.			Seneca Valley Virus 3C(pro) Substrate Optimization Yields Efficient Substrates for Use in Peptide-Prodrug Therapy	PLOS ONE			English	Article							PROSTATE-SPECIFIC ANTIGEN; MALTOSE-BINDING PROTEIN; ONCOLYTIC PICORNAVIRUS; ESCHERICHIA-COLI; EVOLUTIONARY OPTIMIZATION; PROTEOLYTIC CLEAVAGE; 3C PROTEASE; IN-VITRO; POLYPROTEIN; ENZYME	The oncolytic picornavirus Seneca Valley Virus (SVV-001) demonstrates anti-tumor activity in models of small cell lung cancer (SCLC), but may ultimately need to be combined with cytotoxic therapies to improve responses observed in patients. Combining SVV-001 virotherapy with a peptide prodrug activated by the viral protease 3C(pro) is a novel strategy that may increase the therapeutic potential of SVV-001. Using recombinant SVV-001 3C(pro), we measured cleavage kinetics of predicted SVV-001 3C(pro) substrates. An efficient substrate, L/VP4 (k(cat)/K-M = 1932 +/- 183 M(-1)s(-1)), was further optimized by a P2' N -> P substitution yielding L/VP4.1 (k(cat)/KM = 17446 +/- 2203 M(-1)s(-1)). We also determined essential substrate amino acids by sequential N-terminal deletion and substitution of amino acids found in other picornavirus genera. A peptide corresponding to the L/VP4.1 substrate was selectively cleaved by SVV-001 3C(pro) in vitro and was stable in human plasma. These data define an optimized peptide substrate for SVV-001 3C(pro), with direct implications for anti-cancer therapeutic development.	[Miles, Linde A.; Rudin, Charles M.] Johns Hopkins Univ, Dept Pharmacol & Mol Sci, Baltimore, MD USA; [Brennen, W. Nathaniel; Rudin, Charles M.; Poirier, John T.] Johns Hopkins Univ, Dept Oncol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Rudin, CM (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.	rudinc@mskcc.org; poirierj@mskcc.org	Rudin, Charles/R-2530-2019	Rudin, Charles/0000-0001-5204-3465; Poirier, John/0000-0001-9795-5644; Miles, Linde/0000-0003-3578-2842	NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008752] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA008748] Funding Source: Medline; NIGMS NIH HHS [T32 GM008752] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARNOLD E, 1987, P NATL ACAD SCI USA, V84, P21, DOI 10.1073/pnas.84.1.21; BAZAN JF, 1988, P NATL ACAD SCI USA, V85, P7872, DOI 10.1073/pnas.85.21.7872; Birtley JR, 2005, J BIOL CHEM, V280, P11520, DOI 10.1074/jbc.M413254200; Boulware KT, 2006, P NATL ACAD SCI USA, V103, P7583, DOI 10.1073/pnas.0511108103; Boulware KT, 2010, BIOTECHNOL BIOENG, V106, P339, DOI 10.1002/bit.22693; Brennen WN, 2012, JNCI-J NATL CANCER I, V104, P1320, DOI 10.1093/jnci/djs336; Choi KY, 2012, THERANOSTICS, V2, P156, DOI 10.7150/thno.4068; CORDINGLEY MG, 1990, J BIOL CHEM, V265, P9062; DeFeo-Jones D, 2000, NAT MED, V6, P1248, DOI 10.1038/81351; DeFeo-Jones D, 2002, MOL CANCER THER, V1, P451; Denmeade SR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003886; Denmeade SR, 1998, CANCER RES, V58, P2537; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Felber LM, 2004, BIOTECHNIQUES, V36, P878, DOI 10.2144/04365PT04; FREEMAN SM, 1993, CANCER RES, V53, P5274; GORBALENYA AE, 1986, FEBS LETT, V194, P253, DOI 10.1016/0014-5793(86)80095-3; Grove JI, 1999, ANTI-CANCER DRUG DES, V14, P461; Hales LM, 2008, J GEN VIROL, V89, P1265, DOI 10.1099/vir.0.83570-0; Hewitt SN, 2011, ACTA CRYSTALLOGR F, V67, P1006, DOI 10.1107/S1744309111022159; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; Knox Richard J, 1997, Pathol Oncol Res, V3, P309; Liu BL, 1996, J VIROL, V70, P2605, DOI 10.1128/JVI.70.4.2605-2610.1996; Liu TC, 2007, NAT CLIN PRACT ONCOL, V4, P101, DOI 10.1038/ncponc0736; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; McNeish IA, 1998, GENE THER, V5, P1061, DOI 10.1038/sj.gt.3300744; Morton CL, 2010, PEDIATR BLOOD CANCER, V55, P295, DOI 10.1002/pbc.22535; Nallamsetty S, 2005, PROTEIN SCI, V14, P2964, DOI 10.1110/ps.051718605; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; PARKS GD, 1989, J VIROL, V63, P1054, DOI 10.1128/JVI.63.3.1054-1058.1989; Poirier JT, 2012, J GEN VIROL, V93, P2606, DOI 10.1099/vir.0.046011-0; Poirier JT, 2012, J NATL CANC I; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Reddy PS, 2007, J NATL CANCER I, V99, P1623, DOI 10.1093/jnci/djm198; Rudin CM, 2011, CLIN CANCER RES, V17, P888, DOI 10.1158/1078-0432.CCR-10-1706; Tropea J. E., 2007, GENERIC METHOD PRODU; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Venkataraman S, 2008, STRUCTURE, V16, P1555, DOI 10.1016/j.str.2008.07.013; Wadhwa L, 2007, CANCER RES, V67, P10653, DOI 10.1158/0008-5472.CAN-07-2352; YPMAWONG MF, 1988, VIROLOGY, V166, P265, DOI 10.1016/0042-6822(88)90172-9; YPMAWONG MF, 1988, J BIOL CHEM, V263, P17846; Yu LT, 2011, NEURO-ONCOLOGY, V13, P14, DOI 10.1093/neuonc/noq148	42	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129103	10.1371/journal.pone.0129103	http://dx.doi.org/10.1371/journal.pone.0129103			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26069962	gold, Green Published, Green Submitted			2022-12-26	WOS:000356327000046
J	Seys, LJM; Verhamme, FM; Dupont, LL; Desauter, E; Duerr, J; Agircan, AS; Conickx, G; Joos, GF; Brusselle, GG; Mall, MA; Bracke, KR				Seys, Leen J. M.; Verhamme, Fien M.; Dupont, Lisa L.; Desauter, Elke; Duerr, Julia; Agircan, Ayca Seyhan; Conickx, Griet; Joos, Guy F.; Brusselle, Guy G.; Mall, Marcus A.; Bracke, Ken R.			Airway Surface Dehydration Aggravates Cigarette Smoke-Induced Hallmarks of COPD in Mice	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CYSTIC-FIBROSIS; LUNG-DISEASE; CHRONIC-BRONCHITIS; INDUCED EMPHYSEMA; MUCUS CLEARANCE; ANIMAL-MODELS; INFLAMMATION; CONDUCTANCE; HEALTH	Introduction Airway surface dehydration, caused by an imbalance between secretion and absorption of ions and fluid across the epithelium and/or increased epithelial mucin secretion, impairs mucociliary clearance. Recent evidence suggests that this mechanism may be implicated in chronic obstructive pulmonary disease (COPD). However, the role of airway surface dehydration in the pathogenesis of cigarette smoke (CS)-induced COPD remains unknown. Objective We aimed to investigate in vivo the effect of airway surface dehydration on several CS-induced hallmarks of COPD in mice with airway-specific overexpression of the beta-subunit of the epithelial Na+ channel (beta ENaC). Methods beta ENaC-Tg mice and wild-type (WT) littermates were exposed to air or CS for 4 or 8 weeks. Pathological hallmarks of COPD, including goblet cell metaplasia, mucin expression, pulmonary inflammation, lymphoid follicles, emphysema and airway wall remodelling were determined and lung function was measured. Results Airway surface dehydration in beta ENaC-Tg mice aggravated CS-induced airway inflammation, mucin expression and destruction of alveolar walls and accelerated the formation of pulmonary lymphoid follicles. Moreover, lung function measurements demonstrated an increased compliance and total lung capacity and a lower resistance and hysteresis in beta ENaC-Tg mice, compared to WT mice. CS exposure further altered lung function measurements. Conclusions We conclude that airway surface dehydration is a risk factor that aggravates CS-induced hallmarks of COPD.	[Seys, Leen J. M.; Verhamme, Fien M.; Dupont, Lisa L.; Desauter, Elke; Conickx, Griet; Joos, Guy F.; Brusselle, Guy G.; Bracke, Ken R.] Ghent Univ Hosp, Dept Resp Med, Lab Translat Res Obstruct Pulm Dis, Ghent, Belgium; [Duerr, Julia; Agircan, Ayca Seyhan; Mall, Marcus A.] Translat Lung Res Ctr Heidelberg TLRC, Dept Translat Pulmonol, Heidelberg, Germany	Ghent University; Ghent University Hospital	Bracke, KR (corresponding author), Ghent Univ Hosp, Dept Resp Med, Lab Translat Res Obstruct Pulm Dis, Ghent, Belgium.	ken.bracke@UGent.be	Duerr, Julia/J-9133-2015; Bracke, Ken R/GSN-7630-2022; Mall, Marcus A./AAA-1498-2022	Bracke, Ken R/0000-0001-5906-4605; Mall, Marcus A./0000-0002-4057-2199; Verhamme, Anne/0000-0002-2201-1865; Duerr, Julia/0000-0002-4862-9487; Brusselle, Guy/0000-0001-7021-8505; Conickx, Griet/0000-0002-9475-8749	Concerted Research Action of Ghent University (BOF/GOA) [01G02714]; Fund for Scientific Research in Flanders (FWO Vlaanderen) [G.0897.12]; Interuniversity Attraction Poles program (IUAP) [P7/30]; Deutsche Forschungsgemainschaft [MA 2081/3-2, 2081/4-1]	Concerted Research Action of Ghent University (BOF/GOA); Fund for Scientific Research in Flanders (FWO Vlaanderen)(FWO); Interuniversity Attraction Poles program (IUAP)(Belgian Federal Science Policy Office); Deutsche Forschungsgemainschaft(German Research Foundation (DFG))	The research described in this article was supported by the Concerted Research Action of Ghent University (BOF/GOA, 01G02714), by the Fund for Scientific Research in Flanders (FWO Vlaanderen, G.0897.12), by the Interuniversity Attraction Poles program (IUAP, P7/30) and the Deutsche Forschungsgemainschaft (MA 2081/3-2 and 2081/4-1 to MAM). Ken R. Bracke is a postdoctoral researcher of the fund for Scientific Research in Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bracke KR, 2006, J IMMUNOL, V177, P4350, DOI 10.4049/jimmunol.177.7.4350; Bracke KR, 2013, AM J RESP CRIT CARE, V188, P343, DOI 10.1164/rccm.201211-2055OC; Brusselle GG, 2011, LANCET, V378, P1015, DOI 10.1016/S0140-6736(11)60988-4; Button B, 2012, SCIENCE, V337, P937, DOI 10.1126/science.1223012; Cantin AM, 2006, AM J RESP CRIT CARE, V173, P1139, DOI 10.1164/rccm.200508-1330OC; Chrysofakis G, 2004, CHEST, V125, P71, DOI 10.1378/chest.125.1.71; Churg A, 2005, CURR OPIN PULM MED, V11, P153, DOI 10.1097/01.mcp.0000149592.51761.e3; CLARKE LL, 1994, P NATL ACAD SCI USA, V91, P479, DOI 10.1073/pnas.91.2.479; Clunes LA, 2012, FASEB J, V26, P533, DOI 10.1096/fj.11-192377; Davis CW, 2008, ANNU REV PHYSIOL, V70, P487, DOI 10.1146/annurev.physiol.70.113006.100638; Demedts IK, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-53; Demoor T, 2009, EUR RESPIR J, V34, P405, DOI 10.1183/09031936.00101408; Downs CA, 2013, AM J RESP CELL MOL, V49, P251, DOI 10.1165/rcmb.2012-0234OC; Dransfield MT, 2013, CHEST; Ehre C, 2012, P NATL ACAD SCI USA, V109, P16528, DOI 10.1073/pnas.1206552109; Evans CM, 2009, PHARMACOL THERAPEUT, V121, P332, DOI 10.1016/j.pharmthera.2008.11.001; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Gehrig S, 2014, AM J RESP CRIT CARE, V189, P1082, DOI 10.1164/rccm.201311-1932OC; Global initiative for chronic obstructive pulmonary disease, GLOB STRAT DIAGN MAN; Grubb Barbara R., 1999, Physiological Reviews, V79, pS193; GRUBB BR, 1994, AM J PHYSIOL, V267, pC293, DOI 10.1152/ajpcell.1994.267.1.C293; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Henderson AG, 2014, J CLIN INVEST, V124, P3047, DOI 10.1172/JCI73469; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Hunninghake GM, 2009, NEW ENGL J MED, V361, P2599, DOI 10.1056/NEJMoa0904006; Ji XL H.-L., 2014, AM J RESP CRIT CARE, V189, pA3020; Johannesson B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044059; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Lambert JA, 2014, AM J RESP CELL MOL, V50, P549, DOI 10.1165/rcmb.2013-0228OC; Lanckacker EA, 2013, EUR RESPIR J, V41, P1189, DOI 10.1183/09031936.00096612; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Mall MA, 2008, J AEROSOL MED PULM D, V21, P13, DOI 10.1089/jamp.2007.0659; Mall MA, 2008, AM J RESP CRIT CARE, V177, P730, DOI 10.1164/rccm.200708-1233OC; Mall MA, 2014, EUR RESPIR J, V44, P1042, DOI 10.1183/09031936.00228013; McDonough JE, 2011, NEW ENGL J MED, V365, P1567, DOI 10.1056/NEJMoa1106955; Rab A, 2013, AM J PHYSIOL-LUNG C, V305, pL530, DOI 10.1152/ajplung.00039.2013; Randell SH, 2006, AM J RESP CELL MOL, V35, P20, DOI 10.1165/rcmb.2006-0082SF; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Saetta M, 2001, AM J RESP CRIT CARE, V163, P1304, DOI 10.1164/ajrccm.163.6.2009116; Sloane PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039809; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Trojanek JB, 2014, AM J RESP CELL MOL, V51, P709, DOI 10.1165/rcmb.2013-0407OC; van der Strate BWA, 2006, AM J RESP CRIT CARE, V173, P751, DOI 10.1164/rccm.200504-594OC; Vermaelen K, 2004, CYTOM PART A, V61A, P170, DOI 10.1002/cyto.a.20064; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; Wielputz MO, 2011, EUR RESPIR J, V38, P1060, DOI 10.1183/09031936.00149810; Wright JL, 2008, AM J PHYSIOL-LUNG C, V295, pL1, DOI 10.1152/ajplung.90200.2008; Wright JL, 2008, PULM PHARMACOL THER, V21, P696, DOI 10.1016/j.pupt.2008.01.007; Xavier RF, 2013, RESPIRATION, V86, P479, DOI 10.1159/000348398	50	21	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129897	10.1371/journal.pone.0129897	http://dx.doi.org/10.1371/journal.pone.0129897			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066648	gold, Green Published, Green Submitted			2022-12-26	WOS:000356327000121
J	Sun, J; Li, C; Wang, SW				Sun, Jun; Li, Chen; Wang, Suwen			The Up-Regulation of Ribosomal Proteins Further Regulates Protein Expression Profile in Female Schistosoma japonicum after Pairing	PLOS ONE			English	Article							GENE-EXPRESSION; MANSONI; DNA; S3	Background Pairing of Schistosoma males and females leads to and maintains female sexual maturation. However, the mechanism by which pairing facilitates sexual maturation of females is not clear. An increasing body of evidence suggests that ribosomal proteins have regulatory rather than constitutive roles in protein translation. Methodology/Principal Findings To investigate the effect of ribosome regulation on female sex maturation, Solexa and iTRAQ techniques were used to analyze the relationship between ribosomal gene or protein expression and sexual development of Schistosoma females. In the present study, considerably higher number of ribosomal genes or proteins were found to be differentially expressed in paired 23-day-old females. Moreover, mature female-specific proteins associated with egg production, such as ferritin-1 heavy chain and superoxide dismutase, were selectively highly expressed in paired females, rather than higher level of protein synthesis of all transcripts compared with those in unpaired 23-day-old females. Furthermore, other developmental stages were utilized to investigate different expression pattern of ribosomal proteins in females by analysing 18-day-old female schistosomula from single- or double-sex infections to determine the relationship between ribosomal protein expression pattern and development. Results showed that undeveloped 18-day-old females from single-and double-sex infections, as well as 23-day-old unpaired females, possessed similar ribosomal protein expression patterns, which were distinct from those in 23-day-old paired females. Conclusions/Significance Our findings reveal that the pairing of females and males triggers a specialized ribosomal protein expression profile which further regulates the protein profile for sexual maturation in Schistosoma japonicum, based on its gene expression profile.	[Sun, Jun; Li, Chen; Wang, Suwen] Tongji Univ, Sch Med, Inst Infect Dis & Vaccine Dev, Shanghai 200092, Peoples R China	Tongji University	Sun, J (corresponding author), Tongji Univ, Sch Med, Inst Infect Dis & Vaccine Dev, Shanghai 200092, Peoples R China.	swksj@tongji.edu.cn		Sun, Jun/0000-0003-0720-1879	National Natural Science Foundation of China [81071383]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors were supported by the National Natural Science Foundation of China (No. 81071383), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Byrne ME, 2009, TRENDS PLANT SCI, V14, P512, DOI 10.1016/j.tplants.2009.06.009; Chang IF, 2005, PLANT PHYSIOL, V137, P848, DOI 10.1104/pp.104.053637; CLOUGH ER, 1981, J PARASITOL, V67, P535, DOI 10.2307/3280487; Dresios J, 2006, MOL MICROBIOL, V59, P1651, DOI 10.1111/j.1365-2958.2006.05054.x; Fitzpatrick JM, 2006, INT J PARASITOL, V36, P1081, DOI 10.1016/j.ijpara.2006.06.007; Giavalisco P, 2005, PLANT MOL BIOL, V57, P577, DOI 10.1007/s11103-005-0699-3; Gilbert WV, 2011, TRENDS BIOCHEM SCI, V36, P127, DOI 10.1016/j.tibs.2010.12.002; HE YX, 1980, ACTA ZOOL SINICA, V26, P32; Huang SCC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002996; Jang CY, 2012, BIOCHEM BIOPH RES CO, V429, P57, DOI 10.1016/j.bbrc.2012.10.093; Kaberdina AC, 2009, MOL CELL, V33, P227, DOI 10.1016/j.molcel.2008.12.014; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; KIM J, 1995, J BIOL CHEM, V270, P13620, DOI 10.1074/jbc.270.23.13620; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; Lindstrom MS, 2009, BIOCHEM BIOPH RES CO, V379, P167, DOI 10.1016/j.bbrc.2008.12.083; Liu S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003856; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Lopez A, 2007, J MOL EVOL, V65, P687, DOI 10.1007/s00239-007-9047-3; Malygin AA, 2007, NUCLEIC ACIDS RES, V35, P6414, DOI 10.1093/nar/gkm701; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Naora H, 1998, J CELL BIOL, V141, P741, DOI 10.1083/jcb.141.3.741; Neumann F, 1997, EXP CELL RES, V230, P252, DOI 10.1006/excr.1996.3417; Ni JQ, 2006, GENE DEV, V20, P1959, DOI 10.1101/gad.390106; POPIEL I, 1984, J EXP ZOOL, V232, P141, DOI 10.1002/jez.1402320117; Qin W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100796; RAMAGOPAL S, 1981, P NATL ACAD SCI-BIOL, V78, P3083, DOI 10.1073/pnas.78.5.3083; SCHILLER EL, 1975, J PARASITOL, V61, P385, DOI 10.2307/3279308; SHAW JR, 1977, EXP PARASITOL, V41, P54, DOI 10.1016/0014-4894(77)90129-1; Sun J, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-177; Sun J, 2014, PARASITOL RES, V113, P881, DOI 10.1007/s00436-013-3719-2; Sun J, 2013, PARASITOL RES, V112, P2983, DOI 10.1007/s00436-013-3470-8; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Thomas G, 2000, NAT CELL BIOL, V2, pE71, DOI 10.1038/35010581; Uechi T, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000037; VANLIJSEBETTENS M, 1994, EMBO J, V13, P3378, DOI 10.1002/j.1460-2075.1994.tb06640.x; VANOORDT BEP, 1985, MOL BIOCHEM PARASIT, V16, P117, DOI 10.1016/0166-6851(85)90080-5; VANOORDT BEP, 1989, PARASITOLOGY, V98, P409, DOI 10.1017/S0031182000061497; Vermeire JJ, 2006, MOL BIOCHEM PARASIT, V147, P39, DOI 10.1016/j.molbiopara.2006.01.006; Williams DL, 2007, EXP PARASITOL, V117, P246, DOI 10.1016/j.exppara.2007.05.001; WILSON DM, 1994, J BIOL CHEM, V269, P25359; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8	44	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129626	10.1371/journal.pone.0129626	http://dx.doi.org/10.1371/journal.pone.0129626			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070205	Green Published, Green Submitted, gold			2022-12-26	WOS:000356327000098
J	Vijayaratnam, PRS; O'Brien, CC; Reizes, JA; Barber, TJ; Edelman, ER				Vijayaratnam, Pujith R. S.; O'Brien, Caroline C.; Reizes, John A.; Barber, Tracie J.; Edelman, Elazer R.			The Impact of Blood Rheology on Drug Transport in Stented Arteries: Steady Simulations	PLOS ONE			English	Article							BALLOON ANGIOPLASTY; FLOW; DEPOSITION; HEMATOCRIT; VISCOSITY; PROTEINS	Background and Methods It is important to ensure that blood flow is modelled accurately in numerical studies of arteries featuring drug-eluting stents due to the significant proportion of drug transport from the stent into the arterial wall which is flow-mediated. Modelling blood is complicated, however, by variations in blood rheological behaviour between individuals, blood's complex near-wall behaviour, and the large number of rheological models which have been proposed. In this study, a series of steady-state computational fluid dynamics analyses were performed in which the traditional Newtonian model was compared against a range of non-Newtonian models. The impact of these rheological models was elucidated through comparisons of haemodynamic flow details and drug transport behaviour at various blood flow rates. Results Recirculation lengths were found to reduce by as much as 24% with the inclusion of a non-Newtonian rheological model. Another model possessing the viscosity and density of blood plasma was also implemented to account for near-wall red blood cell losses and yielded recirculation length increases of up to 59%. However, the deviation from the average drug concentration in the tissue obtained with the Newtonian model was observed to be less than 5% in all cases except one. Despite the small sensitivity to the effects of viscosity variations, the spatial distribution of drug matter in the tissue was found to be significantly affected by rheological model selection. Conclusions/Significance These results may be used to guide blood rheological model selection in future numerical studies. The clinical significance of these results is that they convey that the magnitude of drug uptake in stent-based drug delivery is relatively insensitive to individual variations in blood rheology. Furthermore, the finding that flow separation regions formed downstream of the stent struts diminish drug uptake may be of interest to device designers.	[Vijayaratnam, Pujith R. S.; Reizes, John A.; Barber, Tracie J.] Univ New S Wales, Sch Mech & Mfg Engn, Sydney, NSW, Australia; [O'Brien, Caroline C.; Edelman, Elazer R.] MIT, Harvard MIT Biomed Engn Ctr, Cambridge, MA 02139 USA	University of New South Wales Sydney; Massachusetts Institute of Technology (MIT)	Vijayaratnam, PRS (corresponding author), Univ New S Wales, Sch Mech & Mfg Engn, Sydney, NSW, Australia.	p.vijayaratnam@unsw.edu.au	Barber, Tracie/AAW-2342-2021	Barber, Tracie/0000-0002-6574-8074; Edelman, Elazer/0000-0002-7832-7156	United States National Institutes of Health [R01 GM49039]; Australian Government Department of Education and Training; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049039] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Government Department of Education and Training(Australian GovernmentDepartment of Industry, Innovation and Science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by a grant from the United States National Institutes of Health (R01 GM49039) to EE. URL: http://www.nih.gov/. PV was supported by an Australian Postgraduate Award scholarship from the Australian Government Department of Education and Training. URL: https://education.gov.au/australian-postgraduate-awards. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARTS PAMM, 1988, ARTERIOSCLEROSIS, V8, P819, DOI 10.1161/01.ATV.8.6.819; Balakrishnan B, 2005, CIRCULATION, V111, P2958, DOI 10.1161/CIRCULATIONAHA.104.512475; BALLYK PD, 1994, BIORHEOLOGY, V31, P565; Berger SA, 2000, ANNU REV FLUID MECH, V32, P347, DOI 10.1146/annurev.fluid.32.1.347; Billett H. H., 1990, CLIN METHODS HIST PH; CHIEN S, 1966, J APPL PHYSIOL, V21, P81, DOI 10.1152/jappl.1966.21.1.81; CHO YI, 1991, BIORHEOLOGY, V28, P241; Cokelet G., 1973, BIOMECHANICS ITS FDN; COKELET GR, 1963, T SOC RHEOL, V7, P303, DOI 10.1122/1.548959; Cokelet GR, 1987, HDB BIOENGINEERING; Creel CJ, 2000, CIRC RES, V86, P879, DOI 10.1161/01.RES.86.8.879; DINTENFASS L, 1966, LANCET, V1, P234; Dintenfass L., 1985, BLOOD VISCOSITY; DORROS G, 1993, CATHETER CARDIO DIAG, V29, P191, DOI 10.1002/ccd.1810290304; Finkelstein A, 2003, CIRCULATION, V107, P777, DOI 10.1161/01.CIR.0000050367.65079.71; Fung Y.C., 1993, BIOMECHANICS MECH PR; Henry FS, 2000, INTRA EXTRA CORPOREA; Huang C, 1973, MATH INTERPRETATIO 2, V10, P17; Khan W, 2012, J CONTROL RELEASE, V161, P703, DOI 10.1016/j.jconrel.2012.02.010; Kolachalama VB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008105; Kolachalama VB, 2009, J CONTROL RELEASE, V133, P24, DOI 10.1016/j.jconrel.2008.09.075; Lovich MA, 2001, J PHARM SCI, V90, P1324, DOI 10.1002/jps.1085; Lovick MA, 1996, AM J PHYSIOL-HEART C, V271, pH2014, DOI 10.1152/ajpheart.1996.271.5.H2014; Mejia J, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004408; MERRILL EW, 1963, BIOPHYS J, V3, P199, DOI 10.1016/S0006-3495(63)86816-2; Mongrain R, 2007, J BIOMECH ENG-T ASME, V129, P733, DOI 10.1115/1.2768381; O'Brien CC, 2013, J CONTROL RELEASE, V168, P115, DOI 10.1016/j.jconrel.2013.03.014; Pedersen L, 2014, ANN CLIN BIOCHEM, V51, P495, DOI 10.1177/0004563213504550; PHILLIPS SJ, 1989, AM J CARDIOL, V64, P940, DOI 10.1016/0002-9149(89)90848-5; RAND PW, 1964, J APPL PHYSIOL, V19, P117, DOI 10.1152/jappl.1964.19.1.117; Razavi A, 2011, J BIOMECH, V44, P2021, DOI 10.1016/j.jbiomech.2011.04.023; Roache PJ, 1997, ANNU REV FLUID MECH, V29, P123, DOI 10.1146/annurev.fluid.29.1.123; Rocha-Singh K, 2005, J AM COLL CARDIOL, V46, P776, DOI 10.1016/j.jacc.2004.11.073; SKALAK R, 1981, J BIOMECH ENG-T ASME, V103, P102, DOI 10.1115/1.3138253; van Jaarsveld BC, 2000, NEW ENGL J MED, V342, P1007, DOI 10.1056/NEJM200004063421403; WALBURN FJ, 1976, BIORHEOLOGY, V13, P201; White CJ, 1997, J AM COLL CARDIOL, V30, P1445, DOI 10.1016/S0735-1097(97)00348-3; Zunino P, 2009, COMPUT METHOD APPL M, V198, P3633, DOI 10.1016/j.cma.2008.07.019	38	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128178	10.1371/journal.pone.0128178	http://dx.doi.org/10.1371/journal.pone.0128178			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066041	Green Submitted, Green Published, gold			2022-12-26	WOS:000356327000016
J	Kerkhofs, J; Geris, L				Kerkhofs, Johan; Geris, Liesbet			A Semiquantitative Framework for Gene Regulatory Networks: Increasing the Time and Quantitative Resolution of Boolean Networks	PLOS ONE			English	Article							CELLULAR SIGNALING NETWORKS; GROWTH-PLATE; QUALITATIVE SIMULATION; TRANSCRIPTION FACTOR; FUNCTIONAL-ANALYSIS; CONTINUOUS MODELS; SYSTEMS BIOLOGY; CYCLE NETWORK; EXPRESSION; TRANSDUCTION	Boolean models have been instrumental in predicting general features of gene networks and more recently also as explorative tools in specific biological applications. In this study we introduce a basic quantitative and a limited time resolution to a discrete ( Boolean) framework. Quantitative resolution is improved through the employ of normalized variables in unison with an additive approach. Increased time resolution stems from the introduction of two distinct priority classes. Through the implementation of a previously published chondrocyte network and T helper cell network, we show that this addition of quantitative and time resolution broadens the scope of biological behaviour that can be captured by the models. Specifically, the quantitative resolution readily allows models to discern qualitative differences in dosage response to growth factors. The limited time resolution, in turn, can influence the reachability of attractors, delineating the likely long term system behaviour. Importantly, the information required for implementation of these features, such as the nature of an interaction, is typically obtainable from the literature. Nonetheless, a trade-off is always present between additional computational cost of this approach and the likelihood of extending the model's scope. Indeed, in some cases the inclusion of these features does not yield additional insight. This framework, incorporating increased and readily available time and semiquantitative resolution, can help in substantiating the litmus test of dynamics for gene networks, firstly by excluding unlikely dynamics and secondly by refining falsifiable predictions on qualitative behaviour.	[Kerkhofs, Johan; Geris, Liesbet] Univ Liege, Biomech Res Unit, Liege, Belgium; [Kerkhofs, Johan; Geris, Liesbet] Katholieke Univ Leuven, Biomech Sect, Leuven, Belgium; [Kerkhofs, Johan; Geris, Liesbet] Katholieke Univ Leuven, Prometheus, Leuven, Belgium	University of Liege; KU Leuven; KU Leuven	Geris, L (corresponding author), Univ Liege, Biomech Res Unit, Liege, Belgium.	liesbet.geris@ulg.ac.be	geris, liesbet/D-2343-2016	geris, liesbet/0000-0002-8180-1445	European Research Council under the European Union [279100]	European Research Council under the European Union(European Research Council (ERC))	Johan Kerkhofs is a PhD fellow of the research Foundation Flanders (FWO-Vlaanderen). This work is part of Prometheus, the KU Leuven R&D division for skeletal tissue engineering (http://www.kuleuven.be/prometheus). The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013) / ERC Grant Agreement n. 279100. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert I, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-16; Aldridge BB, 2006, NAT CELL BIOL, V8, P1195, DOI 10.1038/ncb1497; Aldridge BB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000340; Alexopoulos LG, 2010, MOL CELL PROTEOMICS, V9, P1849, DOI 10.1074/mcp.M110.000406; [Anonymous], 2004, P WORKSH TUT 9 INT C; Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Bornholdt S, 2008, J R SOC INTERFACE, V5, pS85, DOI 10.1098/rsif.2008.0132.focus; Chaouiya C, 2003, LECT NOTES CONTROL I, V294, P830, DOI DOI 10.1007/978-3-540-44928-7; Darabos C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025110; De Jong H, 2004, B MATH BIOL, V66, P301, DOI 10.1016/j.bulm.2003.08.010; de Jong H, 2003, BIOINFORMATICS, V19, P336, DOI 10.1093/bioinformatics/btf851; Di Cara A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-462; Faure A, 2006, BIOINFORMATICS, V22, pE124, DOI 10.1093/bioinformatics/btl210; Faure A, 2009, MOL BIOSYST, V5, P1787, DOI [10.1039/b910101m, 10.1039/B910101m]; Franke R, 2010, J INTEGR BIOINFORMAT, V7, DOI 10.2390/biecoll-jib-2010-151; Garg A, 2008, BIOINFORMATICS, V24, P1917, DOI 10.1093/bioinformatics/btn336; Ghaffarizadeh A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S7-S7; GLASS L, 1973, J THEOR BIOL, V39, P103, DOI 10.1016/0022-5193(73)90208-7; Griffiths AJ, 2007, INTRO GENETIC ANAL; Helikar T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-58; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Kauffman S.A., 1993, ORIGINS ORDER; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kerkhofs J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034729; Kestler HA, 2008, BIOESSAYS, V30, P1110, DOI 10.1002/bies.20834; Klamt S, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-2; Klemm K, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.055101; Klipp E, 2009, SYSTEMS BIOL; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Krumsiek J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-233; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Liao JC, 2003, P NATL ACAD SCI USA, V100, P15522, DOI 10.1073/pnas.2136632100; Liu ZY, 2006, J BIOL CHEM, V281, P17156, DOI 10.1074/jbc.M513812200; Machado D, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-45; Martinez-Sosa P, 2013, BIOSYSTEMS, V113, P96, DOI 10.1016/j.biosystems.2013.05.007; Melas IN, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003204; Mendoza L, 2006, BIOSYSTEMS, V84, P101, DOI 10.1016/j.biosystems.2005.10.004; Mendoza L, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-13; Morris MK, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001099; Morris MK, 2010, BIOCHEMISTRY-US, V49, P3216, DOI 10.1021/bi902202q; Mussel C, 2010, BIOINFORMATICS, V26, P1378, DOI 10.1093/bioinformatics/btq124; Naldi A, 2009, BIOSYSTEMS, V97, P134, DOI 10.1016/j.biosystems.2009.04.008; Nilsson O, 2007, J ENDOCRINOL, V193, P75, DOI 10.1677/joe.1.07099; Oktem H, 2003, CHAOS, V13, P1167, DOI 10.1063/1.1608671; Oshin AO, 2007, VET COMP ORTHOPAED, V20, P185, DOI 10.1160/VCOT-07-07-0061; Ouyang ZQ, 2009, P NATL ACAD SCI USA, V106, P21521, DOI 10.1073/pnas.0904863106; Papin JA, 2005, NAT REV MOL CELL BIO, V6, P99, DOI 10.1038/nrm1570; Park S, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.2; Plahte E, 1998, J MATH BIOL, V36, P321, DOI 10.1007/s002850050103; Remy E, 2003, BIOINFORMATICS, V19, pII172, DOI 10.1093/bioinformatics/btg1075; Ruz GA, 2014, BIOSYSTEMS, V115, P23, DOI 10.1016/j.biosystems.2013.10.007; Saadatpour A, 2013, METHODS, V62, P3, DOI 10.1016/j.ymeth.2012.10.012; Saadatpour A, 2010, J THEOR BIOL, V266, P641, DOI 10.1016/j.jtbi.2010.07.022; Saez-Rodriguez J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.87; Samaga R, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-43; Schivo S, 2014, IEEE J BIOMED HEALTH, V18, P832, DOI 10.1109/JBHI.2013.2292880; Schlatter R, 2012, BRIEF BIOINFORM, V13, P365, DOI 10.1093/bib/bbr065; Schlatter R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000595; Schlitt T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S9; Scholma J, 2014, GENE, V533, P379, DOI 10.1016/j.gene.2013.10.010; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shmulevich I, 2002, BIOINFORMATICS, V18, P261, DOI 10.1093/bioinformatics/18.2.261; Shmulevich I, 2015, PBN MATLAB TOOLBOX; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Stoll G, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-116; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Terfve C, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-133; Thieffry D, 2007, BRIEF BIOINFORM, V8, P220, DOI 10.1093/bib/bbm028; THOMAS R, 1973, J THEOR BIOL, V42, P563, DOI 10.1016/0022-5193(73)90247-6; Tran TD, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0771; Torres-Sosa C, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002669; van der Kraan PM, 2009, OSTEOARTHR CARTILAGE, V17, P1539, DOI 10.1016/j.joca.2009.06.008; Villaverde AF, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0505; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wang RS, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/5/055001; Westerhoff HV, 2004, NAT BIOTECHNOL, V22, P1249, DOI 10.1038/nbt1020; Wittmann DM, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-98; Yoon BS, 2006, DEVELOPMENT, V133, P4667, DOI 10.1242/dev.02680	79	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0130033	10.1371/journal.pone.0130033	http://dx.doi.org/10.1371/journal.pone.0130033			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067297	Green Published, gold, Green Submitted			2022-12-26	WOS:000356100900094
J	Killilea, DW; Westropp, JL; Shiraki, R; Mellema, M; Larsen, J; Kahn, AJ; Kapahi, P; Chi, T; Stoller, ML				Killilea, David W.; Westropp, Jodi L.; Shiraki, Ryoji; Mellema, Matthew; Larsen, Jennifer; Kahn, Arnold J.; Kapahi, Pankaj; Chi, Thomas; Stoller, Marshall L.			Elemental Content of Calcium Oxalate Stones from a Canine Model of Urinary Stone Disease	PLOS ONE			English	Article							DIETARY CALCIUM; TRACE-ELEMENTS; RISK-FACTORS; DOGS; UROLITHIASIS; MAGNESIUM; PHOSPHATE; HEALTHY; CALCULI; ZINC	One of the most common types of urinary stones formed in humans and some other mammals is composed of calcium oxalate in ordered hydrated crystals. Many studies have reported a range of metals other than calcium in human stones, but few have looked at stones from animal models such as the dog. Therefore, we determined the elemental profile of canine calcium oxalate urinary stones and compared it to reported values from human stones. The content of 19 elements spanning 7-orders of magnitude was quantified in calcium oxalate stones from 53 dogs. The elemental profile of the canine stones was highly overlapping with human stones, indicating similar inorganic composition. Correlation and cluster analysis was then performed on the elemental profile from canine stones to evaluate associations between the elements and test for potential subgrouping based on elemental content. No correlations were observed with the most abundant metal calcium. However, magnesium and sulfur content correlated with the mineral hydration form, while phosphorous and zinc content correlated with the neuter status of the dog. Inter-elemental correlation analysis indicated strong associations between barium, phosphorous, and zinc content. Additionally, cluster analysis revealed subgroups within the stones that were also based primarily on barium, phosphorous, and zinc. These data support the use of the dog as a model to study the effects of trace metal homeostasis in urinary stone disease.	[Killilea, David W.] Childrens Hosp Oakland Res Inst, Nutr & Metab Ctr, Oakland, CA USA; [Westropp, Jodi L.; Shiraki, Ryoji] Univ Calif Davis, Sch Vet Med, Med & Epidemiol, Davis, CA USA; [Mellema, Matthew] Univ Calif Davis, Sch Vet Med, Surg & Radiol Sci, Davis, CA USA; [Larsen, Jennifer] Univ Calif Davis, Sch Vet Med, Mol Biosci, Davis, CA USA; [Kahn, Arnold J.; Kapahi, Pankaj] Buck Inst Res Aging, Novato, CA USA; [Killilea, David W.; Kapahi, Pankaj; Chi, Thomas; Stoller, Marshall L.] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Buck Institute for Research on Aging; University of California System; University of California San Francisco	Stoller, ML (corresponding author), Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA.	mstoller@urology.ucsf.edu		Gonzalez, Katty/0000-0001-5197-5703; Killilea, David/0000-0002-8929-6527	National Institute of Health [RFA-DK-12-003]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P20DK100863, K12DK083021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG045835] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding provided by National Institute of Health RFA-DK-12-003, www.nih.gov (MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Gawad M, 2014, J PEDIATR UROL, V10, P1267, DOI 10.1016/j.jpurol.2014.06.022; Adams LG, 2008, JAVMA-J AM VET MED A, V232, P1680, DOI 10.2460/javma.232.11.1680; Arulpragasam SP, 2013, JAVMA-J AM VET MED A, V243, P703, DOI 10.2460/javma.243.5.703; Atakan IH, 2007, INT UROL NEPHROL, V39, P351, DOI 10.1007/s11255-006-9050-4; Atmani F, 1998, UROL RES, V26, P201, DOI 10.1007/s002400050047; Bagga HS, 2013, UROL CLIN N AM, V40, P1, DOI 10.1016/j.ucl.2012.09.006; Blaschko SD, 2013, J UROLOGY, V189, P735, DOI 10.1016/j.juro.2012.08.199; Canales BK, 2010, UROLOGY, V76, DOI 10.1016/j.urology.2010.05.005; CURHAN GC, 1993, NEW ENGL J MED, V328, P833, DOI 10.1056/NEJM199303253281203; Dijcker JC, 2012, VET REC, V171, P46, DOI 10.1136/vr.100293; DRETLER SP, 1988, J UROLOGY, V139, P1124, DOI 10.1016/S0022-5347(17)42801-1; DURAK I, 1988, BRIT J UROL, V62, P203, DOI 10.1111/j.1464-410X.1988.tb04318.x; DURAK I, 1992, UROL RES, V20, P23, DOI 10.1007/BF00294330; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fang X, 2005, LASER MED SCI, V20, P132, DOI 10.1007/s10103-005-0356-8; FLEISCH H, 1978, KIDNEY INT, V13, P361, DOI 10.1038/ki.1978.54; Furrow E, 2015, J VET INTERN MED, V29, P113, DOI 10.1111/jvim.12527; Giannossi ML, 2013, J TRACE ELEM MED BIO, V27, P91, DOI 10.1016/j.jtemb.2012.09.004; Heilberg IP, 2013, ADV CHRONIC KIDNEY D, V20, P165, DOI 10.1053/j.ackd.2012.12.001; Houston DM, 2004, CAN VET J, V45, P225; Keshavarzi B, 2014, ENV GEOCHEM HLTH; Lekcharoensuk C, 2002, AM J VET RES, V63, P163, DOI 10.2460/ajvr.2002.63.163; Lekcharoensuk C, 2002, AM J VET RES, V63, P330, DOI 10.2460/ajvr.2002.63.330; Lekcharoensuk C, 2000, J AM VET MED ASSOC, V217, P515, DOI 10.2460/javma.2000.217.515; Lewandowski S, 2004, CLIN CHIM ACTA, V345, P17, DOI 10.1016/j.cccn.2004.03.009; Ling GV, 2003, J VET INTERN MED, V17, P817, DOI 10.1892/0891-6640(2003)017&lt;0817:CIPOCU&gt;2.3.CO;2; Low WW, 2010, JAVMA-J AM VET MED A, V236, P193, DOI 10.2460/javma.236.2.193; Lulich JP, 2001, J AM VET MED ASSOC, V218, P1583, DOI 10.2460/javma.2001.218.1583; Madaan S, 2007, CURR OPIN UROL, V17, P109, DOI 10.1097/MOU.0b013e32802b70bc; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; NAGY Z, 1963, Z Urol, V56, P186; Osborne CA, 1999, VET CLIN N AM-SMALL, V29, P17, DOI 10.1016/S0195-5616(99)50002-8; Osborne CA, 2009, VET CLIN N AM-SMALL, V39, P127, DOI 10.1016/j.cvsm.2008.10.001; PRIEN EL, 1947, J UROLOGY, V57, P949, DOI 10.1016/S0022-5347(17)69732-5; Ramello A, 2000, J NEPHROL, V13, pS45; Riley JM, 2013, J ENDOUROL, V27, P1487, DOI 10.1089/end.2013.0173; Rodgers A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103602; Romani AMP, 2011, ARCH BIOCHEM BIOPHYS, V512, P1, DOI 10.1016/j.abb.2011.05.010; Slojewski M, 2011, CENT EUR J UROL, V64, P58, DOI 10.5173/ceju.2011.02.art1; Slojewski M, 2010, BIOL TRACE ELEM RES, V137, P301, DOI 10.1007/s12011-009-8584-6; Stevenson AE, 2004, VET THER, V5, P218; Stevenson AE, 2003, RES VET SCI, V75, P33, DOI 10.1016/S0034-5288(03)00042-0; Tang YZ, 2009, BIOMATERIALS, V30, P2864, DOI 10.1016/j.biomaterials.2009.01.043; TISELIUS HG, 1993, UROL RES, V21, P175, DOI 10.1007/BF00590033; Turgut M, 2008, UROL RES, V36, P31, DOI 10.1007/s00240-007-0133-1; Wisener LV, 2010, AM J VET RES, V71, P1045, DOI 10.2460/ajvr.71.9.1045	46	5	5	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128374	10.1371/journal.pone.0128374	http://dx.doi.org/10.1371/journal.pone.0128374			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26066810	Green Published, gold			2022-12-26	WOS:000356100900020
J	Manjarrez, J; Rivas-Gonzalez, E; Venegas-Barrera, CS; Moyaho, A				Manjarrez, Javier; Rivas-Gonzalez, Eric; Venegas-Barrera, Crystian S.; Moyaho, Alejandro			Visual Detection of Speckles in the Fish Xenotoca variata by the Predatory Snake Thamnophis melanogaster in Water of Different Turbidity	PLOS ONE			English	Article							PREY INTERACTIONS; TRAIT	Semi-aquatic snakes integrate visual and chemical stimuli, and prey detection and capture success are therefore linked to the display of visual predatory behavior. The snake Thamnophis melanogaster responds preferentially to individuals of the fish Xenotoca variata with a greater number of bright, colorful spots (lateral speckles) compared with those with a smaller number; however, water turbidity can reduce underwater visibility and effect the vulnerability of fish. In this study, we tested whether the presence of iridescent speckles on the flanks of male X. variata interacted with water turbidity to modify the predatory behavior displayed by the snake T. melanogaster. We predicted that in an experimental laboratory test, the snakes would increase the frequency of their predatory behavior to the extent that the water turbidity decreases. The snakes were tested at six different levels of water turbidity, in combination with three categories of male fish (with few, a median number of, or many speckles). The results showed that in a pool with high or zero turbidity, the number of speckles is not a determining factor in the deployment of the predatory behavior of the snake T. melanogaster toward X. variata. Our findings suggest that snakes can view the fish at intermediate percentages of turbidity, but the number of speckles in male X. variata is irrelevant as an interspecific visual signal in environments with insufficient luminosity. The successful capture of aquatic prey is influenced by integration between chemical and visual signals, according to environmental factors that may influence the recognition of individual traits.	[Manjarrez, Javier; Rivas-Gonzalez, Eric] Univ Autonoma Estado Mexico, Fac Ciencias, Lab Biol Evolut, Toluca, Estado Mexico, Mexico; [Venegas-Barrera, Crystian S.] Inst Tecnol Ciudad Victoria, Div Estudios Posgrad Invest, Tamaulipas, Mexico; [Moyaho, Alejandro] Benemerita Univ Autonoma Puebla, Inst Fisiol, Lab Ecol Conducta, Puebla, Mexico	Universidad Autonoma del Estado de Morelos; Benemerita Universidad Autonoma de Puebla	Manjarrez, J (corresponding author), Univ Autonoma Estado Mexico, Fac Ciencias, Lab Biol Evolut, Toluca, Estado Mexico, Mexico.	jsilva@ecologia.unam.mx	Venegas-Barrera, Crystian Sadiel/H-3215-2017; Manjarrez, Javier/S-3082-2019	Venegas-Barrera, Crystian Sadiel/0000-0002-4290-0838; Manjarrez, Javier/0000-0003-3053-3257; Moyaho, Alejandro/0000-0002-2902-2938	Universidad Autonoma del Estado de Mexico [2865/2010, 2663/2013, 3589/2013SF]	Universidad Autonoma del Estado de Mexico(Universidad Nacional Autonoma de Mexico)	This study was supported by research grants from Universidad Autonoma del Estado de Mexico (2865/2010, 2663/2013, 3589/2013SF).	Abrahams M, 1997, BEHAV ECOL SOCIOBIOL, V40, P169, DOI 10.1007/s002650050330; Alfaro ME, 2002, FUNCT ECOL, V16, P204, DOI 10.1046/j.1365-2435.2002.00620.x; Botero M, 2004, REV COLOMBIANA CIENC, V17, P1; Davies-Colley RJ, 2001, J AM WATER RESOUR AS, V37, P1085, DOI 10.1111/j.1752-1688.2001.tb03624.x; De Robertis A, 2003, CAN J FISH AQUAT SCI, V60, P1517, DOI 10.1139/F03-123; DRUMMOND H, 1989, BEHAVIOUR, V108, P23, DOI 10.1163/156853989X00033; DRUMMOND H, 1983, BEHAVIOUR, V86, P1, DOI 10.1163/156853983X00543; Endler J. A., 1992, AM NAT, V139, pS125; Fiksen O, 2002, HYDROBIOLOGIA, V484, P49, DOI 10.1023/A:1021396719733; GARCIA CM, 1995, ETHOLOGY, V101, P101, DOI 10.1111/j.1439-0310.1995.tb00349.x; Gotelli NJ, 2013, ECOSIMR 1 00; Griffin AS, 2003, BEHAV PROCESS, V61, P87, DOI 10.1016/S0376-6357(02)00169-9; Guillen FC, 1990, ACTA ZOOL MEX, V35, P3; JAMES FC, 1990, ANNU REV ECOL SYST, V21, P129, DOI 10.1146/annurev.es.21.110190.001021; Legendre P., 2012, NUMERICAL ECOLOGY; Manjarrez J, 1996, ETHOLOGY, V102, P146; Manjarrez J, 2013, J HERPETOL, V47, P413, DOI 10.1670/12-174; Moyaho A, 2004, CAN J ZOOL, V82, P1917, DOI 10.1139/Z05-004; Moyaho A, 2004, J ZOOL, V262, P265, DOI 10.1017/S095283690300459X; Moyaho A, 2002, THESIS U NACL AUTONO; O'Steen S, 2002, EVOLUTION, V56, P776, DOI 10.1111/j.0014-3820.2002.tb01388.x; Rossman DA, 1996, THE GARTER SNAKES; Sweka JA, 2003, ENVIRON BIOL FISH, V67, P341, DOI 10.1023/A:1025835031366; Van de Meutter F, 2005, OECOLOGIA, V144, P327, DOI 10.1007/s00442-005-0050-3; Villalobos-Castaneda B, 2010, ENVIRON MONIT ASSESS, V166, P331, DOI 10.1007/s10661-009-1005-7; [No title captured]	26	2	2	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129429	10.1371/journal.pone.0129429	http://dx.doi.org/10.1371/journal.pone.0129429			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061294	Green Published, gold, Green Submitted			2022-12-26	WOS:000355979500142
J	Neff, RA; Spiker, ML; Truant, PL				Neff, Roni A.; Spiker, Marie L.; Truant, Patricia L.			Wasted Food: US Consumers' Reported Awareness, Attitudes, and Behaviors	PLOS ONE			English	Article							ENVIRONMENTAL KNOWLEDGE; DETERMINANTS; IMPACTS; WATER	The U.S. wastes 31 to 40% of its post-harvest food supply, with a substantial portion of this waste occurring at the consumer level. Globally, interventions to address wasted food have proliferated, but efforts are in their infancy in the U.S. To inform these efforts and provide baseline data to track change, we performed a survey of U.S. consumer awareness, attitudes and behaviors related to wasted food. The survey was administered online to members of a nationally representative panel (N=1010), and post-survey weights were applied. The survey found widespread (self-reported) awareness of wasted food as an issue, efforts to reduce it, and knowledge about how to do so, plus moderately frequent performance of waste-reducing behaviors. Three-quarters of respondents said they discard less food than the average American. The leading motivations for waste reduction were saving money and setting an example for children, with environmental concerns ranked last. The most common reasons given for discarding food were concern about foodborne illness and a desire to eat only the freshest food. In some cases there were modest differences based on age, parental status, and income, but no differences were found by race, education, rural/urban residence or other demographic factors. Respondents recommended ways retailers and restaurants could help reduce waste. This is the first nationally representative consumer survey focused on wasted food in the U.S. It provides insight into U.S. consumers' perceptions related to wasted food, and comparisons to existing literature. The findings suggest approaches including recognizing that many consumers perceive themselves as being already-knowledgeable and engaged, framing messages to focus on budgets, and modifying existing messages about food freshness and aesthetics. This research also suggests opportunities to shift retail and restaurant practice, and identifies critical research gaps.	[Neff, Roni A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; [Neff, Roni A.; Spiker, Marie L.; Truant, Patricia L.] Johns Hopkins Univ, Ctr Livable Future, Baltimore, MD USA; [Spiker, Marie L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Program Human Nutr, Baltimore, MD USA; [Neff, Roni A.; Truant, Patricia L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Neff, RA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA.	Rneff1@jhu.edu		Neff, Roni/0000-0002-0010-2635; Spiker, Marie/0000-0002-6348-5960	Johns Hopkins Center for a Livable Future (CLF); CLF-Lerner Fellowship	Johns Hopkins Center for a Livable Future (CLF); CLF-Lerner Fellowship	This research was funded by the Johns Hopkins Center for a Livable Future (CLF) with a gift from the GRACE Communications Foundation (www.gracelinks.org). At the time of writing, two authors were also supported by the CLF-Lerner Fellowship. The Grace Communications Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, INT J FOOD SYST DYN; [Anonymous], 2012, 1203 ESA; Baker D, 2009, WHAT WASTE ANAL HOUS, P6; Bamberg S, 2007, J ENVIRON PSYCHOL, V27, P14, DOI 10.1016/j.jenvp.2006.12.002; Broad Leib M. D., 2013, DATING GAME CONFUSIN; Buzby JC, 2014, EC INFORM B; Eshel G, 2014, P NATL ACAD SCI USA, V111, P11996, DOI 10.1073/pnas.1402183111; European Commission, 2014, FOOD WAST; Evans D, 2011, CRIT PUBLIC HEALTH, V21, P429, DOI 10.1080/09581596.2011.608797; Food and Agriculture Organization of the United Nations, 2014, SAV FOOD GLOB IN FOO; Freidberg S., 2010, FRESH PERISHABLE HIS; GfK, 2013, KNOWL PAN DES SUMM; Hall KD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007940; Hanssen O. J., 2013, FOOD WASTAGE NORWAY; Johnston MW, BIOCYCLE; Koivupuro HK, 2012, INT J CONSUM STUD, V36, P183, DOI 10.1111/j.1470-6431.2011.01080.x; Kollmuss A., 2002, ENVIRON EDUC RES, V8, P239, DOI [10.1080/1350462022014540, DOI 10.1080/1350462022014540, 10.1080/13504620220145401, DOI 10.1080/13504620220145401]; Kummu M, 2012, SCI TOTAL ENVIRON, V438, P477, DOI 10.1016/j.scitotenv.2012.08.092; Lo J., 2011, RACE ETHNICITY MULTI, V5, P61, DOI DOI 10.2979/RACETHMULGLOCON.5.1.61; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; NEDERHOF AJ, 1985, EUR J SOC PSYCHOL, V15, P263, DOI 10.1002/ejsp.2420150303; Newsome R, 2014, COMPR REV FOOD SCI F, V13, P745, DOI 10.1111/1541-4337.12086; NSW, 2011, FOOD WAST AV BENCHM; Parizeau K, 2015, WASTE MANAGE, V35, P207, DOI 10.1016/j.wasman.2014.09.019; Pascaud L, FORBES; Polonsky MJ, 2012, J MARKET MANAG-UK, V28, P238, DOI 10.1080/0267257X.2012.659279; Puhl RM, 2010, AM J PUBLIC HLTH, V24; Quested T., 2013, HOUSEHOLD FOOD DRINK; Quested TE, 2013, RESOUR CONSERV RECY, V79, P43, DOI 10.1016/j.resconrec.2013.04.011; Robelia B, 2012, ENVIRON EDUC RES, V18, P299, DOI 10.1080/13504622.2011.618288; Segre A, 2014, WASTE WATCHER KNOWLE; Silvenius F, 2014, PACKAG TECHNOL SCI, V27, P277, DOI 10.1002/pts.2032; Sonntag V, 2014, FOOD GOOD WAST UNPUB; Stefan V, 2013, FOOD QUAL PREFER, V28, P375, DOI 10.1016/j.foodqual.2012.11.001; Sustainability Victoria, 2011, FOOD WAST AV STUD; Sustainable America, 2013, FOOD FUEL PUBL POLL; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; U.S. Census Bureau, 2015, AM COMM SURV 2013 PO; U.S. Census Bureau, 2013, CURR POP SURV 2012 A; U.S. Department of Agriculture, 2013, FOOD WAST CHALL FREQ; US Census Bureau, 2014, CURR POP SURV 2014 A; US EPA, 2014, MUN SOL WAST GEN REC; USDA Food Safety and Inspection Service, 2013, FOOD SAF INF FOOD PR; Wansink B., 2014, INT J OBESI IN PRESS; Williams H, 2011, J CLEANER PRODUCTION, V19; WRAP, 2014, FOOD WAST RED; WRAP, 2007, FOOD BEH CONS RES	47	244	247	4	221	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0127881	10.1371/journal.pone.0127881	http://dx.doi.org/10.1371/journal.pone.0127881			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK1PO	26062025	gold, Green Submitted, Green Published			2022-12-26	WOS:000355979500065
J	Wang, Q; Eneji, AE; Kong, XQ; Wang, KY; Dong, HZ				Wang, Qi; Eneji, A. Egrinya; Kong, Xiangqiang; Wang, Kaiyun; Dong, Hezhong			Salt Stress Effects on Secondary Metabolites of Cotton in Relation to Gene Expression Responsible for Aphid Development	PLOS ONE			English	Article							RESISTANCE; GOSSYPOL; BOLLWORM; P450S; REPRODUCTION; MECHANISMS; TOLERANCE; EVOLUTION; CULTIVAR; BT	Many secondary metabolites have insecticidal efficacy against pests and may be affected by abiotic stress. However, little is known of how plants may respond to such stress as pertains the growth and development of pests. The objective of this study was to determine if and how salt stress on cotton plants affects the population dynamics of aphids. The NaCl treatment (50mM, 100mM, 150mM and 200mM) increased contents of gossypol in cotton by 26.8-51.4%, flavonoids by 22.5-37.6% and tannic by 15.1-24.3% at 7-28 d after salt stress. Compared with non-stressed plants, the population of aphids on 150 and 200 mM NaCl stressed plants was reduced by 46.4 and 65.4% at 7d and by 97.3 and 100% at 14 days after infestation. Reductions in aphid population were possibly attributed to the elevated secondary metabolism under salt stress. A total of 796 clones for aphids transcriptome, 412 clones in the positive-library (TEST) and 384 clones in the reverse-library (Ck), were obtained from subtracted cDNA libraries and sequenced. Gene ontology (GO) functional classification and KEGG pathway analysis showed more genes related to fatty acid and lipid biosynthesis, and fewer genes related to carbohydrate metabolism, amino acid metabolism, energy metabolism and cell motility pathways in TEST than in Ck library, which might be the reason of aphids population reduction. A comparative analysis with qRT-PCR indicated high expression of transcripts CYP6A14, CYP6A13, CYP303A1, NADH dehydrogenase and fatty acid synthase in the TEST group. However, CYP307A1 and two ecdysone-induced protein genes were down regulated. The results indicate that genes of aphids related to growth and development can express at a higher level in reaction to the enhanced secondary metabolism in cotton under salinity stress. The expression of CYP307A1 was positively correlated with the population dynamics of aphids since it was involved in ecdysone synthesis.	[Wang, Qi; Eneji, A. Egrinya; Kong, Xiangqiang; Dong, Hezhong] Shandong Acad Agr Sci, Shandong Key Lab Cotton Culture & Physiol, Cotton Res Ctr, Jinan 250100, Peoples R China; [Wang, Qi; Wang, Kaiyun] Shandong Agr Univ, Coll Plant Protect, Tai An 271018, Shandong, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Shandong Academy of Agricultural Sciences; Shandong Agricultural University	Dong, HZ (corresponding author), Shandong Acad Agr Sci, Shandong Key Lab Cotton Culture & Physiol, Cotton Res Ctr, Jinan 250100, Peoples R China.	donghz@saas.ac.cn	Egrinya, Eneji Anthony/V-6662-2019					Ajmal S, 2011, AFR J BIOTECHNOL, V10, P18137, DOI 10.5897/AJB11.2502; Andersen JF, 1997, CHEM RES TOXICOL, V10, P156, DOI 10.1021/tx9601162; Bautista MAM, 2015, PEST MANAG SCI, V71, P423, DOI 10.1002/ps.3822; BRATTSTEN LB, 1988, J CHEM ECOL, V14, P1919, DOI 10.1007/BF01013486; Brun-Barale A, 2010, PEST MANAG SCI, V66, P900, DOI 10.1002/ps.1960; Castellanos I, 1997, BIOCHEM SYST ECOL, V25, P591, DOI 10.1016/S0305-1978(97)00045-8; Celorio-Mancera MD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-575; Du L, 2004, J ECON ENTOMOL, V97, P1278, DOI 10.1603/0022-0493-97.4.1278; Feyereisen R., 2005, P1; Folin O, 1915, J BIOL CHEM, V22, P305; Gao F, 2008, ENVIRON ENTOMOL, V37, P29, DOI 10.1603/0046-225X(2008)37[29:IEOECA]2.0.CO;2; Guo JY, 2013, J ECON ENTOMOL, V106, P1379, DOI 10.1603/EC12401; Hagenbucher S, 2013, CRIT REV PLANT SCI, V32, P458, DOI 10.1080/07352689.2013.809293; Hagenbucher S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0042; HEDIN PA, 1992, J CHEM ECOL, V18, P105, DOI 10.1007/BF00993746; HEDIN PA, 1992, J ECON ENTOMOL, V85, P359, DOI 10.1093/jee/85.2.359; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Liu ZJ, 2000, PHYSIOL PLANTARUM, V110, P483, DOI 10.1111/j.1399-3054.2000.1100409.x; Luo Z, 2008, CROP PROT, V27, P1485, DOI 10.1016/j.cropro.2008.06.006; Ma H, 2014, ARTHROPOD-PLANT INTE, V8, P1, DOI 10.1007/s11829-014-9291-6; Mao WF, 2009, COMP BIOCHEM PHYS B, V154, P427, DOI 10.1016/j.cbpb.2009.08.008; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Mao YB, 2011, TRANSGENIC RES, V20, P665, DOI 10.1007/s11248-010-9450-1; Mauney JR, 1986, COTTON PHYSL COTTON; Namiki T, 2005, BIOCHEM BIOPH RES CO, V337, P367, DOI 10.1016/j.bbrc.2005.09.043; Orth RG, 2007, J CHEM ECOL, V33, P1131, DOI 10.1007/s10886-007-9284-3; Rewitz KF, 2007, INSECT BIOCHEM MOLEC, V37, P741, DOI 10.1016/j.ibmb.2007.02.012; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Romeis J., 2008, INTEGRATION INSECT R, P159, DOI 10.1007/978-1-4020-8373-0_1; Schuler MA, 2012, MOL ECOL, V21, P4157, DOI 10.1111/j.1365-294X.2012.05657.x; Schuler MA, 2011, BBA-PROTEINS PROTEOM, V1814, P36, DOI 10.1016/j.bbapap.2010.09.012; SMITH FH, 1967, J AM OIL CHEM SOC, V44, P267, DOI 10.1007/BF02639273; Stewart J.M., 2009, PHYSL COTTON; Stipanovic RD, 2006, J CHEM ECOL, V32, P959, DOI 10.1007/s10886-006-9052-9; Tao XY, 2012, MOL ECOL, V21, P4371, DOI 10.1111/j.1365-294X.2012.05548.x; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Theis N, 2003, INT J PLANT SCI, V164, pS93, DOI 10.1086/374190; Wang X, 2009, ADV FOOD NUTR RES, V58, P215, DOI 10.1016/S1043-4526(09)58006-0; Wee CW, 2008, INSECT MOL BIOL, V17, P351, DOI 10.1111/j.1365-2583.2008.00809.x; Wink M, 2003, PHYTOCHEMISTRY, V64, P3, DOI 10.1016/S0031-9422(03)00300-5; Yang N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061820; Yang YH, 2006, J ECON ENTOMOL, V99, P1784, DOI 10.1603/0022-0493-99.5.1784; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yi F, 2012, MOLECULES, V17, P7533, DOI 10.3390/molecules17067533; Zhao CQ, 2014, PEST MANAG SCI, V70, P130, DOI 10.1002/ps.3538	46	30	32	5	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129541	10.1371/journal.pone.0129541	http://dx.doi.org/10.1371/journal.pone.0129541			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061875	Green Submitted, Green Published, gold			2022-12-26	WOS:000355979500147
J	Chang, L; Monteiro, MJ				Chang, Lydia; Monteiro, Mervyn J.			Defective Proteasome Delivery of Polyubiquitinated Proteins by Ubiquilin-2 Proteins Containing ALS Mutations	PLOS ONE			English	Article							DEGRADATION; UBIQUITINATION; IDENTIFICATION	Ubiquilin proteins facilitate delivery of ubiquitinated proteins to the proteasome for degradation. Interest in the proteins has been heightened by the discovery that gene mutations in UBQLN2 cause dominant inheritance of amyotrophic lateral sclerosis (ALS). However, the mechanisms by which the mutations cause ALS are not known. Here we report on the underlying defect of ubiquilin-2 proteins containing ALS-linked mutations in affecting proteasome-mediated degradation. We found that overexpression of ubiquilin-2 proteins containing any one of five different ALS mutations slow degradation of Myc, a prototypic proteasome substrate. Examination of coprecipitating proteins indicated that the mutant proteins are generally capable of binding polyubiquitinated proteins, but defective in binding the proteasome. GST-pulldown studies revealed that many of the mutants bind weaker to the S5a subunit of the proteasome, compared with wild type (WT) ubiquilin-2 protein. The results suggest the mutant proteins are unable to deliver their captured cargo to the proteasome for degradation, which presumably leads to toxicity. Quantification of cell death is consistent with this idea. Measurement of protein turnover further indicated the mutant proteins have longer half-lives than WT ubiquilin-2. Our studies provide novel insight into the mechanism by which ALS-linked mutations in UBQLN2 interfere with protein degradation.	[Chang, Lydia; Monteiro, Mervyn J.] Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA; [Monteiro, Mervyn J.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Monteiro, MJ (corresponding author), Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA.	monteiro@umaryland.edu						Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Fahed AC, 2014, ANN NEUROL, V75, P793, DOI 10.1002/ana.24164; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Ford DL, 2007, BIOCHEMISTRY-US, V46, P8827, DOI 10.1021/bi700604q; Gellera C, 2013, J NEUROL NEUROSUR PS, V84, P183, DOI 10.1136/jnnp-2012-303433; Gilpin KM, 2015, HUM MOL GENET, V24, P2565, DOI 10.1093/hmg/ddv020; Gorrie GH, 2014, P NATL ACAD SCI USA, V111, P14524, DOI 10.1073/pnas.1405741111; Gregory MA, 2000, MOL CELL BIOL, V20, P2423, DOI 10.1128/MCB.20.7.2423-2435.2000; Kim TY, 2008, BIOCHEM BIOPH RES CO, V369, P741, DOI 10.1016/j.bbrc.2008.02.086; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Ko HS, 2004, FEBS LETT, V566, P110, DOI 10.1016/j.febslet.2004.04.031; Lee DY, 2012, BIOL CHEM, V393, P441, DOI 10.1515/hsz-2012-0120; Liang J, 2006, J CELL SCI, V119, P4011, DOI 10.1242/jcs.03163; Lim PJ, 2009, J CELL BIOL, V187, P201, DOI 10.1083/jcb.200903024; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Mah AL, 2000, J CELL BIOL, V151, P847, DOI 10.1083/jcb.151.4.847; Massey LK, 2004, J ALZHEIMERS DIS, V6, P79; Monteiro MJ, 1996, EXP CELL RES, V223, P443, DOI 10.1006/excr.1996.0100; N'Diaye EN, 2009, EMBO REP, V10, P173, DOI 10.1038/embor.2008.238; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Rothenberg C, 2010, AUTOPHAGY, V6, P979, DOI 10.4161/auto.6.7.13118; Rothenberg C, 2010, HUM MOL GENET, V19, P3219, DOI 10.1093/hmg/ddq231; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Safren N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087513; Synofzik M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.07.002; Ugolino J, 2011, HUM MOL GENET, V20, P3565, DOI 10.1093/hmg/ddr274; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Walters KJ, 2002, BIOCHEMISTRY-US, V41, P1767, DOI 10.1021/bi011892y; Wu AL, 1999, MOL CELL, V4, P619, DOI 10.1016/S1097-2765(00)80212-9; Wu QX, 2015, ACTA NEUROPATHOL, V129, P417, DOI 10.1007/s00401-014-1367-y; Xia YX, 2014, J NEUROCHEM, V129, P99, DOI 10.1111/jnc.12606	32	53	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130162	10.1371/journal.pone.0130162	http://dx.doi.org/10.1371/journal.pone.0130162			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075709	Green Published, Green Submitted, gold			2022-12-26	WOS:000356329900146
J	Kertho, A; Mamidi, S; Bonman, JM; McClean, PE; Acevedo, M				Kertho, Albert; Mamidi, Sujan; Bonman, J. Michael; McClean, Phillip E.; Acevedo, Maricelis			Genome-Wide Association Mapping for Resistance to Leaf and Stripe Rust in Winter-Habit Hexaploid Wheat Landraces	PLOS ONE			English	Article							F-SP TRITICI; TURGIDUM SSP DICOCCOIDES; PUCCINIA-STRIIFORMIS; DISEASE-RESISTANCE; CHROMOSOMAL LOCATION; HIGH-TEMPERATURE; LINKAGE DISEQUILIBRIUM; UNITED-STATES; MODEL; GENE	Leaf rust, caused by Puccinia triticina (Pt), and stripe rust, caused by P. striiformis f. sp. tritici (Pst), are destructive foliar diseases of wheat worldwide. Breeding for disease resistance is the preferred strategy of managing both diseases. The continued emergence of new races of Pt and Pst requires a constant search for new sources of resistance. Here we report a genome-wide association analysis of 567 winter wheat (Triticum aestivum) land-race accessions using the Infinium iSelect 9K wheat SNP array to identify loci associated with seedling resistance to five races of Pt (MDCL, MFPS, THBL, TDBG, and TBDJ) and one race of Pst (PSTv-37) frequently found in the Northern Great Plains of the United States. Mixed linear models identified 65 and eight significant markers associated with leaf rust and stripe rust, respectively. Further, we identified 31 and three QTL associated with resistance to Pt and Pst, respectively. Eleven QTL, identified on chromosomes 3A, 4A, 5A, and 6D, are previously unknown for leaf rust resistance in T. aestivum.	[Kertho, Albert; Acevedo, Maricelis] N Dakota State Univ, Dept Plant Pathol, Fargo, ND 58105 USA; [Mamidi, Sujan; McClean, Phillip E.] N Dakota State Univ, Dept Plant Sci, Fargo, ND 58105 USA; [Bonman, J. Michael] USDA ARS, Small Grains & Potato Germplasm Res Unit, Aberdeen, ID USA	North Dakota State University Fargo; North Dakota State University Fargo; United States Department of Agriculture (USDA)	Acevedo, M (corresponding author), N Dakota State Univ, Dept Plant Pathol, Fargo, ND 58105 USA.	maricelis.acevedo@ndsu.edu	mamidi, sujan/P-7009-2018	mamidi, sujan/0000-0002-3837-6121; Bonman, John/0000-0002-7414-044X	Ducks Unlimited, Inc.; Triticeae CAP; ARS [ARS-0424394] Funding Source: Federal RePORTER	Ducks Unlimited, Inc.; Triticeae CAP; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by Ducks Unlimited, Inc. (http://www.ducks.org/); and Triticeae CAP (http://www.triticeaecap.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 2001, ANN STAT, V29, P1165; Bolton MD, 2008, MOL PLANT PATHOL, V9, P563, DOI [10.1111/j.1364-3703.2008.00487.x, 10.1111/J.1364-3703.2008.00487.X]; Bonman JM, 2007, CROP SCI, V47, P1955, DOI 10.2135/cropsci2007.01.0028; Brueggeman R, 2002, P NATL ACAD SCI USA, V99, P9328, DOI 10.1073/pnas.142284999; Bux H, 2012, CAN J PLANT PATHOL, V34, P68, DOI 10.1080/07060661.2012.662998; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chen XM, 2005, CAN J PLANT PATHOL, V27, P314; Chen XM, 2002, PLANT DIS, V86, P39, DOI 10.1094/PDIS.2002.86.1.39; Chen XM, 1996, PHYTOPATHOLOGY, V86, P1228, DOI 10.1094/Phyto-86-1228; CHEN XM, 1995, PHYTOPATHOLOGY, V85, P375, DOI 10.1094/Phyto-85-375; CHEN XM, 1995, PHYTOPATHOLOGY, V85, P1362, DOI 10.1094/Phyto-85-1362; Dadrezaei S. T., 2013, American Journal of Plant Sciences, V4, P1821, DOI 10.4236/ajps.2013.49224; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Ghavami F, 2011, G3-GENES GENOM GENET, V1, P209, DOI 10.1534/g3.111.000489; Guo YH, 2009, NEW PHYTOL, V183, P62, DOI 10.1111/j.1469-8137.2009.02838.x; Gurung S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108179; Jin Y, 2010, PHYTOPATHOLOGY, V100, P432, DOI 10.1094/PHYTO-100-5-0432; Kollers S, 2014, MOL BREEDING, V34, P363, DOI 10.1007/s11032-014-0039-x; Kolmer JA, 2006, PLANT DIS, V90, P1219, DOI 10.1094/PD-90-1219; Kolmer JA, 2005, CURR OPIN PLANT BIOL, V8, P441, DOI 10.1016/j.pbi.2005.05.001; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Line RF, 2002, ANNU REV PHYTOPATHOL, V40, P75, DOI 10.1146/annurev.phyto.40.020102.111645; LONG DL, 1989, PHYTOPATHOLOGY, V79, P525, DOI 10.1094/Phyto-79-525; Malosetti M, 2007, GENETICS, V175, P879, DOI 10.1534/genetics.105.054932; Mamidi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107469; Mamidi S, 2011, PLANT GENOME-US, V4, P154, DOI 10.3835/plantgenome2011.04.0011; Markell SG, 2008, PHYTOPATHOLOGY, V98, P632, DOI 10.1094/PHYTO-98-6-0632; Martin GB, 2003, ANNU REV PLANT BIOL, V54, P23, DOI 10.1146/annurev.arplant.54.031902.135035; McIntosh R., 2013, CATALOGUE GENE SYMBO; McIntosh RA, 2012, KOMUGI INTEGRATED WH; McIntosh Wellings RC, 1995, WHEAT RUSTS ATLAS RE; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Neumann K, 2011, MOL BREEDING, V27, P37, DOI 10.1007/s11032-010-9411-7; Newcomb M, 2013, PLANT DIS, V97, P882, DOI 10.1094/PDIS-02-12-0200-RE; Newton AC, 2010, TRENDS MICROBIOL, V18, P365, DOI 10.1016/j.tim.2010.06.002; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; QAYOUM A, 1985, PHYTOPATHOLOGY, V75, P1121, DOI 10.1094/Phyto-75-1121; Reif JC, 2005, THEOR APPL GENET, V110, P859, DOI 10.1007/s00122-004-1881-8; Roelfs A. P., 1985, CEREAL RUSTS, V2; Saintenac C, 2013, G3-GENES GENOM GENET, V3, P1105, DOI 10.1534/g3.113.005819; Salamini F, 2002, NAT REV GENET, V3, P429, DOI 10.1038/nrg817; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Sela H, 2014, THEOR APPL GENET, V127, P2453, DOI 10.1007/s00122-014-2389-5; Tameling WIL, 2007, PHYSIOL MOL PLANT P, V71, P126, DOI 10.1016/j.pmpp.2007.12.006; Uauy C, 2005, THEOR APPL GENET, V112, P97, DOI 10.1007/s00122-005-0109-x; Van Ooijen G, 2008, J EXP BOT, V59, P1383, DOI 10.1093/jxb/ern045; Wan A, 2014, PLANT DIS, P1; Wang LF, 2002, EUPHYTICA, V124, P71, DOI 10.1023/A:1015689817857; William M, 2003, PHYTOPATHOLOGY, V93, P153, DOI 10.1094/PHYTO.2003.93.2.153; Yahyaoui A., 2012, P 2 3 4 REG C YELL R; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zegeye H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105593; Zhang DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103747; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310; Zurn JD, 2014, MOL BREEDING, V34, P871, DOI 10.1007/s11032-014-0081-8	58	61	61	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129580	10.1371/journal.pone.0129580	http://dx.doi.org/10.1371/journal.pone.0129580			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076040	Green Submitted, Green Published, gold			2022-12-26	WOS:000356329900085
J	Scharinger, C; Kammerer, Y; Gerjets, P				Scharinger, Christian; Kammerer, Yvonne; Gerjets, Peter			Pupil Dilation and EEG Alpha Frequency Band Power Reveal Load on Executive Functions for Link-Selection Processes during Text Reading	PLOS ONE			English	Article							WORKING-MEMORY; TASK-DIFFICULTY; EYE-MOVEMENTS; COMPREHENSION; BRAIN; SYNCHRONIZATION; OSCILLATIONS; THETA; SIZE; DESYNCHRONIZATION	Executive working memory functions play a central role in reading comprehension. In the present research we were interested in additional load imposed on executive functions by link-selection processes during computer-based reading. For obtaining process measures, we used a methodology of concurrent electroencephalographic (EEG) and eye-tracking data recording that allowed us to compare epochs of pure text reading with epochs of hyperlink-like selection processes in an online reading situation. Furthermore, this methodology allowed us to directly compare the two physiological load-measures EEG alpha frequency band power and pupil dilation. We observed increased load on executive functions during hyperlink-like selection processes on both measures in terms of decreased alpha frequency band power and increased pupil dilation. Surprisingly however, the two measures did not correlate. Two additional experiments were conducted that excluded potential perceptual, motor, or structural confounds. In sum, EEG alpha frequency band power and pupil dilation both turned out to be sensitive measures for increased load during hyperlink-like selection processes in online text reading.	[Scharinger, Christian; Kammerer, Yvonne; Gerjets, Peter] Knowledge Media Res Ctr, Tubingen, Germany	Eberhard Karls University of Tubingen; Leibniz Institut fur Wissensmedien	Scharinger, C (corresponding author), Knowledge Media Res Ctr, Tubingen, Germany.	c.scharinger@iwm-kmrc.de	Gerjets, Peter/AAD-2017-2020		Leibniz ScienceCampus Tuebingen Informational Environments; Leibniz ScienceCampus	Leibniz ScienceCampus Tuebingen Informational Environments; Leibniz ScienceCampus	This research was funded by the Leibniz ScienceCampus Tuebingen Informational Environments (http://www.wissenschaftscampus-tuebingen.de/www/en/index.html). CS was funded as a doctoral student within the Leibniz ScienceCampus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadieu F, 2009, LEARN INSTR, V19, P376, DOI 10.1016/j.learninstruc.2009.02.005; Andreass J. L., 2007, PSYCHOPHYSIOLOGY HUM, P289; [Anonymous], 2006, F SHAPED PATTERN REA; Antonenko P, 2010, EDUC PSYCHOL REV, V22, P425, DOI 10.1007/s10648-010-9130-y; Antonenko PD, 2010, COMPUT HUM BEHAV, V26, P140, DOI 10.1016/j.chb.2009.10.014; Arrington CN, 2014, SCI STUD READ, V18, P325, DOI 10.1080/10888438.2014.902461; Baccino Thierry, 2012, OXFORD HDB EYE MOVEM, DOI [10.1093/oxfordhb/9780199539789.013.0047, DOI 10.1093/OXFORDHB/9780199539789.013.0047]; Baddeley A, 1996, Q J EXP PSYCHOL-A, V49, P5, DOI 10.1080/713755608; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Basar E, 2012, INT J PSYCHOPHYSIOL, V86, P25, DOI 10.1016/j.ijpsycho.2012.07.001; Beatty J., 2000, HDB PSYCHOPHYSIOL, V2, P142; Brouwer AM, 2014, INT J PSYCHOPHYSIOL, V93, P242, DOI 10.1016/j.ijpsycho.2014.05.004; Cangoz B., 2012, CONT ED TECHNOLOGY, V3, P81, DOI 10.30935/cedtech/6070; Carr N., 2010, SHALLOWS WHAT INTERN; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DeStefano D, 2007, COMPUT HUM BEHAV, V23, P1616, DOI 10.1016/j.chb.2005.08.012; Di Stasi LL, 2011, INT J IND ERGONOM, V41, P298, DOI 10.1016/j.ergon.2011.02.008; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dimigen O, 2011, J EXP PSYCHOL GEN, V140, P552, DOI 10.1037/a0023885; Duggan GB, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P1141; Duggan GB, 2009, J EXP PSYCHOL-APPL, V15, P228, DOI 10.1037/a0016995; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Engle RW, 2002, CURR DIR PSYCHOL SCI, V11, P19, DOI 10.1111/1467-8721.00160; ERICSSON KA, 1995, PSYCHOL REV, V102, P211, DOI 10.1037/0033-295X.102.2.211; Erping Zhu, 1999, Journal of Educational Multimedia and Hypermedia, V8, P331; Ewing K., 2010, HUMAN FACTORS SYSTEM, P423; Fisk JE, 2004, J CLIN EXP NEUROPSYC, V26, P874, DOI 10.1080/13803390490510680; Fitzsimmons G, 2013, P 5 ANN ACM WEB SCI, P65, DOI [10.1145/2464464, DOI 10.1145/2464464.2464501]; Frey A, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00039; Gerjets P, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00385; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Gevins A, 2000, CEREB CORTEX, V10, P829, DOI 10.1093/cercor/10.9.829; Gevins A. S., 2003, THEORETICAL ISSUES E, V4, P113, DOI [DOI 10.1080/14639220210159717, 10.1080/14639220210159717]; Granholm E, 2004, INT J PSYCHOPHYSIOL, V52, P1, DOI 10.1016/j.ijpsycho.2003.12.001; Hanslmayr S, 2008, J COGNITIVE NEUROSCI, V20, P215, DOI 10.1162/jocn.2008.20020; HESS EH, 1960, SCIENCE, V132, P349, DOI 10.1126/science.132.3423.349; Hong LB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091321; Iqbal S.T., 2004, P 2004 C HUMAN FACTO, P1477, DOI [10.1145/985921.986094, DOI 10.1145/985921.986094]; KAHNEMAN D, 1966, SCIENCE, V154, P1583, DOI 10.1126/science.154.3756.1583; Kahneman D, 1973, SERIES EXPT PSYCHOL; Kendeou P, 2014, LEARN DISABIL RES PR, V29, P10, DOI 10.1111/ldrp.12025; KIM H, 1995, BEHAV INFORM TECHNOL, V14, P239, DOI 10.1080/01449299508914637; KINTSCH W, 1988, PSYCHOL REV, V95, P163, DOI 10.1037/0033-295X.95.2.163; Kintsch W., 1991, ADV PSYCHOL, V79, P107, DOI [DOI 10.1016/S0166-4115(08)61551-4, 10.1016/S0166-4115(08)61551-4]; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kliegl R, 2012, PSYCHOL RES-PSYCH FO, V76, P145, DOI 10.1007/s00426-011-0376-x; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2006, PROG BRAIN RES, V159, P151, DOI 10.1016/S0079-6123(06)59010-7; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Krause C.M., 2003, EXPT METHODS NEUROPS, VVolume 1, P111, DOI [10.1007/978-1-4615-1163-2, DOI 10.1007/978-1-4615-1163-2]; Kretzschmar F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056178; Kruger J.-L., 2013, P EYE TRACK S AFR, P62, DOI 10.1145/2509315.2509331; Kuipers Jan Rouke, 2011, Front Hum Neurosci, V5, P61, DOI 10.3389/fnhum.2011.00061; Kuipers JR, 2013, CORTEX, V49, P2853, DOI 10.1016/j.cortex.2013.01.012; Laeng B, 2012, PERSPECT PSYCHOL SCI, V7, P18, DOI 10.1177/1745691611427305; Laeng B, 2011, COGN PROCESS, V12, P13, DOI 10.1007/s10339-010-0370-z; McNamara DS, 2009, PSYCHOL LEARN MOTIV, V51, P297, DOI 10.1016/S0079-7421(09)51009-2; Mehta RK, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00889; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Murphy PR, 2011, PSYCHOPHYSIOLOGY, V48, P1531, DOI 10.1111/j.1469-8986.2011.01226.x; Nee DE, 2013, CEREB CORTEX, V23, P264, DOI 10.1093/cercor/bhs007; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Parasuraman R, 2008, HUM FACTORS, V50, P511, DOI 10.1518/001872008X312198; Parasuraman R, 2011, CURR DIR PSYCHOL SCI, V20, P181, DOI 10.1177/0963721411409176; Partala T, 2003, INT J HUM-COMPUT ST, V59, P185, DOI 10.1016/S1071-5819(03)00017-X; Pfurtscheller G, 1998, ELECTROMYOGR MOTOR C, V109, P154, DOI 10.1016/S0924-980X(97)00070-2; Pfurtscheller G, 1996, INT J PSYCHOPHYSIOL, V24, P39, DOI 10.1016/S0167-8760(96)00066-9; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Piquado T, 2010, PSYCHOPHYSIOLOGY, V47, P560, DOI 10.1111/j.1469-8986.2009.00947.x; Reader WR, 2007, HUM-COMPUT INTERACT, V22, P263; Reiter A, 2005, DYSLEXIA, V11, P116, DOI 10.1002/dys.289; Salmeron L, 2015, INFANC APRENDIZ, V38, P435, DOI 10.1080/02103702.2015.1016750; Scheiter K, 2007, EDUC PSYCHOL REV, V19, P285, DOI 10.1007/s10648-007-9046-3; Scheiter K, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00268; Schneider W, 2007, DTSCH SCHULTESTS; Sesma HW, 2009, CHILD NEUROPSYCHOL, V15, P232, DOI 10.1080/09297040802220029; Smith ME, 2001, HUM FACTORS, V43, P366, DOI 10.1518/001872001775898287; Spironelli C, 2010, BIOL PSYCHOL, V85, P258, DOI 10.1016/j.biopsycho.2010.07.011; St John M, 2004, INT J HUM-COMPUT INT, V17, P131, DOI 10.1207/s15327590ijhc1702_2; Stipacek A, 2003, NEUROSCI LETT, V353, P193, DOI 10.1016/j.neulet.2003.09.044; Strauss A, 2014, NEUROIMAGE, V97, P387, DOI 10.1016/j.neuroimage.2014.04.005; Van Gerven PWM, 2004, PSYCHOPHYSIOLOGY, V41, P167, DOI 10.1111/j.1469-8986.2003.00148.x; Verhoeven L, 2008, APPL COGNITIVE PSYCH, V22, P293, DOI 10.1002/acp.1417; Zwaan RA, 1998, PSYCHOL BULL, V123, P162, DOI 10.1037/0033-2909.123.2.162	85	49	49	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130608	10.1371/journal.pone.0130608	http://dx.doi.org/10.1371/journal.pone.0130608			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076026	Green Submitted, gold, Green Published			2022-12-26	WOS:000356329900184
J	Dong, DX; Chen, BL; Chen, P				Dong, Dexian; Chen, Baoling; Chen, P.			Bacterial Acclimation Inside an Aqueous Battery	PLOS ONE			English	Article							DIRECT ELECTRIC-CURRENT; LIFE; INACTIVATION; STRESS; CELLS; ACID	Specific environmental stresses may lead to induced genomic instability in bacteria, generating beneficial mutants and potentially accelerating the breeding of industrial microorganisms. The environmental stresses inside the aqueous battery may be derived from such conditions as ion shuttle, pH gradient, free radical reaction and electric field. In most industrial and medical applications, electric fields and direct currents are used to kill bacteria and yeast. However, the present study focused on increasing bacterial survival inside an operating battery. Using a bacterial acclimation strategy, both Escherichia coli and Bacillus subtilis were acclimated for 10 battery operation cycles and survived in the battery for over 3 days. The acclimated bacteria changed in cell shape, growth rate and colony color. Further analysis indicated that electrolyte concentration could be one of the major factors determining bacterial survival inside an aqueous battery. The acclimation process significantly improved the viability of both bacteria E. coliand B. subtilis. The viability of acclimated strains was not affected under battery cycle conditions of 0.18-0.80 mA cm(-2) and 1.4-2.1 V. Bacterial addition within 1.0x10(10) cells mL(-1) did not significantly affect battery performance. Because the environmental stress inside the aqueous battery is specific, the use of this battery acclimation strategy may be of great potential for the breeding of industrial microorganisms.	[Dong, Dexian; Chen, Baoling; Chen, P.] Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Chen, P (corresponding author), Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada.	p4chen@uwaterloo.ca			Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Natural Sciences and Engineering Research Council of Canada (PC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birbir Y, 2008, J ELECTROSTAT, V66, P355, DOI 10.1016/j.elstat.2008.03.002; Boutte CC, 2013, TRENDS MICROBIOL, V21, P174, DOI 10.1016/j.tim.2013.01.002; Cauet E, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3421542; Drees KP, 2003, WATER RES, V37, P2291, DOI 10.1016/S0043-1354(03)00009-5; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Gigova A, 2006, J POWER SOURCES, V158, P1054, DOI 10.1016/j.jpowsour.2005.11.006; Grahl T, 1996, APPL MICROBIOL BIOT, V45, P148, DOI 10.1007/s002530050663; Harrison JP, 2013, TRENDS MICROBIOL, V21, P204, DOI 10.1016/j.tim.2013.01.006; Liu WK, 1997, J ANTIMICROB CHEMOTH, V39, P687, DOI 10.1093/jac/39.6.687; Luo QS, 2005, APPL ENVIRON MICROB, V71, P423, DOI 10.1128/AEM.71.1.423-427.2005; MIZUNO A, 1988, IEEE T IND APPL, V24, P387, DOI 10.1109/28.2886; Moreno-Garrido I, 2013, METHODS MOL BIOL, V1051, P327, DOI 10.1007/978-1-62703-550-7_22; Nakanishi K, 1998, J FERMENT BIOENG, V85, P250, DOI 10.1016/S0922-338X(97)86778-5; Oren A, 2011, ENVIRON MICROBIOL, V13, P1908, DOI 10.1111/j.1462-2920.2010.02365.x; Petit L, 2008, J PHYS CHEM B, V112, P10603, DOI 10.1021/jp8017106; Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215; Sandvik EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055118; Stancik LM, 2002, J BACTERIOL, V184, P4246, DOI 10.1128/JB.184.15.4246-4258.2002; Toft C, 2010, NAT REV GENET, V11, P465, DOI 10.1038/nrg2798; Wei V, 2011, WATER RES, V45, P5058, DOI 10.1016/j.watres.2011.07.011; Wilks JC, 2009, APPL ENVIRON MICROB, V75, P981, DOI 10.1128/AEM.01652-08; Yan J, 2012, J POWER SOURCES, V216, P222, DOI 10.1016/j.jpowsour.2012.05.063	22	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129130	10.1371/journal.pone.0129130	http://dx.doi.org/10.1371/journal.pone.0129130			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070088	Green Published, Green Submitted, gold			2022-12-26	WOS:000356327000051
J	Gonzalez-Vargas, J; Dosen, S; Amsuess, S; Yu, WW; Farina, D				Gonzalez-Vargas, Jose; Dosen, Strahinja; Amsuess, Sebastian; Yu, Wenwei; Farina, Dario			Human-Machine Interface for the Control of Multi-Function Systems Based on Electrocutaneous Menu: Application to Multi-Grasp Prosthetic Hands	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACES; OF-THE-ART; PATTERN-RECOGNITION; MYOELECTRIC CONTROL; STIMULATION; REHABILITATION; DISCRIMINATE; VIABILITY; DISPLAY; DESIGN	Modern assistive devices are very sophisticated systems with multiple degrees of freedom. However, an effective and user-friendly control of these systems is still an open problem since conventional human-machine interfaces (HMI) cannot easily accommodate the system's complexity. In HMIs, the user is responsible for generating unique patterns of command signals directly triggering the device functions. This approach can be difficult to implement when there are many functions (necessitating many command patterns) and/or the user has a considerable impairment (limited number of available signal sources). In this study, we propose a novel concept for a general-purpose HMI where the controller and the user communicate bidirectionally to select the desired function. The system first presents possible choices to the user via electro-tactile stimulation; the user then acknowledges the desired choice by generating a single command signal. Therefore, the proposed approach simplifies the user communication interface (one signal to generate), decoding (one signal to recognize), and allows selecting from a number of options. To demonstrate the new concept the method was used in one particular application, namely, to implement the control of all the relevant functions in a state of the art commercial prosthetic hand without using any myoelectric channels. We performed experiments in healthy subjects and with one amputee to test the feasibility of the novel approach. The results showed that the performance of the novel HMI concept was comparable or, for some outcome measures, better than the classic myoelectric interfaces. The presented approach has a general applicability and the obtained results point out that it could be used to operate various assistive systems (e.g., prosthesis vs. wheelchair), or it could be integrated into other control schemes (e.g., myoelectric control, brain-machine interfaces) in order to improve the usability of existing low-bandwidth HMIs.	[Gonzalez-Vargas, Jose; Yu, Wenwei] Chiba Univ, Ctr Frontier Med Engn, Chiba, Japan; [Dosen, Strahinja; Amsuess, Sebastian; Farina, Dario] Univ Med Gottingen, Dept Neurorehabil, Gottingen, Germany	Chiba University; University of Gottingen	Farina, D (corresponding author), Univ Med Gottingen, Dept Neurorehabil, Gottingen, Germany.	dario.farina@bccn.uni-goettingen.de	Yu, Wenwei/AAI-1296-2019; Farina, Dario/AAB-2648-2019; Gonzalez, Jose/M-2629-2014	Gonzalez, Jose/0000-0002-3448-7393; Dosen, Strahinja/0000-0003-3035-147X	Japanese Society for Promotion of Science (JSPS) Grant for Researcher Dispatch Program-International Network of Advanced Medical Engineering using Bio-robotics Technology; European Commission under MYOSENS [FP7-PEOPLE-2011-IAPP-286208]; German Ministry for Education and Research (BMBF) via Bernstein Focus Neurotechnology (BFNT) Gottingen [01GQ0810]	Japanese Society for Promotion of Science (JSPS) Grant for Researcher Dispatch Program-International Network of Advanced Medical Engineering using Bio-robotics Technology; European Commission under MYOSENS; German Ministry for Education and Research (BMBF) via Bernstein Focus Neurotechnology (BFNT) Gottingen	This work was supported by the Japanese Society for Promotion of Science (JSPS) Grant for Researcher Dispatch Program-International Network of Advanced Medical Engineering using Bio-robotics Technology (2009-2012), European Commission under the MYOSENS (FP7-PEOPLE-2011-IAPP-286208) project and by the German Ministry for Education and Research (BMBF) via the Bernstein Focus Neurotechnology (BFNT) Gottingen under Grant 01GQ0810.	ANANI AB, 1977, MED BIOL ENG COMPUT, V15, P363, DOI 10.1007/BF02457988; Antfolk C, 2010, J MED BIOL ENG, V30, P355, DOI 10.5405/jmbe.766; Becedas J, 2012, IEEE T SYST MAN CY C, V42, P825, DOI 10.1109/TSMCC.2012.2203301; Belter JT, 2013, J REHABIL RES DEV, V50, P599, DOI 10.1682/JRRD.2011.10.0188; Bradberry TJ, 2010, J NEUROSCI, V30, P3432, DOI 10.1523/JNEUROSCI.6107-09.2010; Brouwer AM, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00019; Buma DG, 2007, IEEE T NEUR SYS REH, V15, P435, DOI 10.1109/TNSRE.2007.903942; Carrozza MC, 2005, INT C REHAB ROBOT, P109; Cipriani C, 2008, IEEE T ROBOT, V24, P170, DOI 10.1109/TRO.2007.910708; Cipriani C, 2012, IEEE T BIO-MED ENG, V59, P400, DOI 10.1109/TBME.2011.2173342; CUTKOSKY MR, 1989, IEEE T ROBOTIC AUTOM, V5, P269, DOI 10.1109/70.34763; D'Alonzo M, 2013, IEEE T HAPTICS, P1; D'Alonzo M, 2014, IEEE T NEUR SYS REH, V22, P290, DOI 10.1109/TNSRE.2013.2266482; Dermitzakis K, 2011, IEEE ENG MED BIO, P4530, DOI 10.1109/IEMBS.2011.6091122; Dosen S, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-138; Nicolas-Alonso LF, 2012, SENSORS-BASEL, V12, P1211, DOI 10.3390/s120201211; Flor H, 2001, LANCET, V357, P1763, DOI 10.1016/S0140-6736(00)04890-X; Ganin IP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077755; Geng B, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-97; Geng YJ, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-74; Gonzalez J, 2011, J MED IMAG HEALTH IN, V1, P325, DOI 10.1166/jmihi.2011.1051; Hahne JM, 2012, IEEE T BIO-MED ENG, V59, P1436, DOI 10.1109/TBME.2012.2188799; Hao YY, 2013, IEEE ROBOT AUTOM MAG, V20, P40, DOI 10.1109/MRA.2012.2229949; Hartmann C, 2014, IEEE T NEUR IN PRESS; Heo P, 2012, INT J PRECIS ENG MAN, V13, P807, DOI 10.1007/s12541-012-0107-2; Iturrate I, 2009, IEEE T ROBOT, V25, P614, DOI 10.1109/TRO.2009.2020347; Jiang Ning, 2010, Critical Reviews in Biomedical Engineering, V38, P381, DOI 10.1615/CritRevBiomedEng.v38.i4.30; Jiang N, 2009, IEEE T BIO-MED ENG, V56, P1070, DOI 10.1109/TBME.2008.2007967; Johansen D., 2012, INT J ENG MANUF, V2, P14; KACZMAREK KA, 1991, IEEE T BIO-MED ENG, V38, P1, DOI 10.1109/10.68204; KACZMAREK KA, 1992, IEEE T BIO-MED ENG, V39, P701, DOI 10.1109/10.142645; Kamavuako E. N., 2013, IEEE T NEUR SYS REH, V21, P1, DOI DOI 10.1109/TNSRE.2012.2211036; Kingdom FAA, 2009, PSYCHOPHYSICS PRACTI; Kubler A, 2005, PROG BRAIN RES, V150, P513, DOI 10.1016/S0079-6123(05)50035-9; Kuiken TA, 2009, JAMA-J AM MED ASSOC, V301, P619, DOI 10.1001/jama.2009.116; Lo HS, 2012, MED ENG PHYS, V34, P261, DOI 10.1016/j.medengphy.2011.10.004; Lundborg G, 1999, J HAND SURG-AM, V24A, P219, DOI 10.1053/jhsu.1999.0219; Mainardi E, 2007, P ANN INT IEEE EMBS, P3035, DOI 10.1109/IEMBS.2007.4352968; Markovic M, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/4/046001; Onose G, 2012, SPINAL CORD, V50, P599, DOI 10.1038/sc.2012.14; Ortiz-Catalan M, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-33; Pedrocchi A, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-66; Ramos-Murguialday A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047048; Raspopovic S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006820; Resnik L, 2014, PROSTHET ORTHOT INT, V38, P492, DOI 10.1177/0309364613506913; Scheme E, 2011, J REHABIL RES DEV, V48, P643, DOI 10.1682/JRRD.2010.09.0177; Schill O, 2011, BIOMED TECH, V56, P35, DOI 10.1515/BMT.2010.056; Simon AM, 2011, IEEE T BIO-MED ENG, V58, DOI 10.1109/TBME.2011.2155063; Smith LH, 2013, IEEE ENG MED BIO, P4223, DOI 10.1109/EMBC.2013.6610477; SZETO AYJ, 1985, ANN BIOMED ENG, V13, P373, DOI 10.1007/BF02407767; SZETO AYJ, 1982, IEEE T BIO-MED ENG, V29, P300, DOI 10.1109/TBME.1982.324948; Witteveen HJB, 2012, IEEE T BIO-MED ENG, V59, P2219, DOI 10.1109/TBME.2012.2200678; Yatsenko D, 2007, P ANN INT IEEE EMBS, P6134	53	12	12	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0127528	10.1371/journal.pone.0127528	http://dx.doi.org/10.1371/journal.pone.0127528			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26069961	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000009
J	Muka, T; Trajanoska, K; Kiefte-de Jong, JC; Oei, L; Uitterlinden, AG; Hofman, A; Dehghan, A; Zillikens, MC; Franco, OH; Rivadeneira, F				Muka, Taulant; Trajanoska, Katerina; Kiefte-de Jong, Jessica C.; Oei, Ling; Uitterlinden, Andre G.; Hofman, Albert; Dehghan, Abbas; Zillikens, M. Carola; Franco, Oscar H.; Rivadeneira, Fernando			The Association between Metabolic Syndrome, Bone Mineral Density, Hip Bone Geometry and Fracture Risk: The Rotterdam Study	PLOS ONE			English	Article							BODY-MASS INDEX; ELDERLY-MEN; OSTEOPOROTIC FRACTURE; FEMORAL-NECK; WOMEN; POPULATION; POSTMENOPAUSAL; COMPONENTS; MORTALITY; ADULTS	The association between metabolic syndrome (MS) and bone health remains unclear. We aimed to study the association between MS and hip bone geometry (HBG), femoral neck bone mineral density (FN-BMD), and the risk of osteoporosis and incident fractures. Data of 2040 women and 1510 men participants in the third visit (1997-1999) of the Rotterdam Study (RSI-3), a prospective population based cohort, were available (mean follow-up 6.7 years). MS was defined according to the recent harmonized definition. HBG parameters were measured at the third round visit whereas FN-BMD was assessed at the third round and 5 years later. Incident fractures were identified from medical registry data. After correcting for age, body mass index (BMI), lifestyle factors and medication use, individuals with MS had lower bone width (beta = -0.054, P = 0.003), lower cortical buckling ratio (beta = -0.81, P = 0.003) and lower odds of having osteoporosis (odds ratio = 0.56, P = 0.007) in women but not in men. Similarly, MS was associated with higher FN-BMD only in women (beta = 0.028, P = 0.001). In the analyses of MS components, the glucose component (unrelated to diabetes status) was positively associated with FN-BMD in both genders (beta = 0.016, P = 0.01 for women and beta = 0.022, P = 0.004 for men). In men, waist circumference was inversely associated with FN-BMD (beta = -0.03, P = 0.004). No association was observed with fracture risk in either sex. In conclusion, women with MS had higher FN-BMD independent of BMI. The glucose component of MS was associated with high FN-BMD in both genders, highlighting the need to preserve glycemic control to prevent skeletal complications.	[Muka, Taulant; Trajanoska, Katerina; Kiefte-de Jong, Jessica C.; Oei, Ling; Uitterlinden, Andre G.; Hofman, Albert; Dehghan, Abbas; Franco, Oscar H.; Rivadeneira, Fernando] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Trajanoska, Katerina; Oei, Ling; Uitterlinden, Andre G.; Zillikens, M. Carola; Rivadeneira, Fernando] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Oei, Ling; Uitterlinden, Andre G.; Hofman, Albert; Dehghan, Abbas; Zillikens, M. Carola; Franco, Oscar H.; Rivadeneira, Fernando] Netherlands Consortium Hlth Ageing, Netherlands Genom Inititiat, The Hague, Netherlands; [Oei, Ling] IJsselland Hosp, Dept Internal Med, Capelle Aan Den Ijssel, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Rivadeneira, F (corresponding author), Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands.	f.rivadeneira@erasmusmc.nl	Franco, Óscar H/ABE-2305-2020; Dehghan, Abbas/ABE-7377-2020; Oei, Ling/E-8163-2013; Rivadeneira, Fernando/O-5385-2015; Kiefte-de Jong, Jessica/GLV-3216-2022; Dehghan, Abbas/B-9896-2008	Franco, Óscar H/0000-0002-4606-4929; Oei, Ling/0000-0003-3523-458X; Rivadeneira, Fernando/0000-0001-9435-9441; Kiefte-de Jong, Jessica/0000-0002-8136-0918; Trajanoska, Katerina/0000-0002-3792-4296; Dehghan, Abbas/0000-0001-6403-016X	Nestle Nutrition (Nestec Ltd.); Metagenics Inc.; AXA; Netherlands Organization for Health Research (NWO) [016.136.367, 916.12.154]; EUR Fellowship	Nestle Nutrition (Nestec Ltd.)(Nestle SA); Metagenics Inc.; AXA; Netherlands Organization for Health Research (NWO); EUR Fellowship	TM, JCK and OHF work in ErasmusAGE, a center for aging research across the life course funded by Nestle Nutrition (Nestec Ltd.); Metagenics Inc.; and AXA. Additional support from the Netherlands Organization for Health Research (NWO) was provided to FR (ZonMw VIDI 016.136.367) and AD (ZonMW VENI 916.12.154) who also received an EUR Fellowship. These funding sources had no role in design and conduct of this manuscript; collection, management, analysis, and interpretation of the data; and preparation, review or approval of this manuscript.	Adami S, 2004, CALCIFIED TISSUE INT, V74, P136, DOI 10.1007/s00223-003-0050-4; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; BarrettConnor E, 1996, DIABETES CARE, V19, P1388, DOI 10.2337/diacare.19.12.1388; Beck TJ, 2000, J BONE MINER RES, V15, P2297, DOI 10.1359/jbmr.2000.15.12.2297; Bliuc D, 2009, JAMA-J AM MED ASSOC, V301, P513, DOI 10.1001/jama.2009.50; Burger H, 1998, AM J EPIDEMIOL, V147, P871, DOI 10.1093/oxfordjournals.aje.a009541; Campos RMS, 2012, ENDOCRINE, V42, P146, DOI 10.1007/s12020-012-9613-3; Cappuccio FP, 1999, LANCET, V354, P971, DOI 10.1016/S0140-6736(99)01437-3; Center JR, 1999, LANCET, V353, P878, DOI 10.1016/S0140-6736(98)09075-8; EDELSTEIN SL, 1993, AM J EPIDEMIOL, V138, P160, DOI 10.1093/oxfordjournals.aje.a116842; Gnudi S, 2009, J BONE MINER METAB, V27, P479, DOI 10.1007/s00774-009-0056-8; Hernandez JL, 2011, MATURITAS, V68, P217, DOI 10.1016/j.maturitas.2010.12.010; Hofbauer LC, 2004, JAMA-J AM MED ASSOC, V292, P490, DOI 10.1001/jama.292.4.490; Hofman A, 2013, EUR J EPIDEMIOL, V28, P889, DOI 10.1007/s10654-013-9866-z; Holmberg AH, 2008, J CLIN ENDOCR METAB, V93, P815, DOI 10.1210/jc.2007-0843; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Jankowska EA, 2001, ANDROLOGIA, V33, P384, DOI 10.1046/j.1439-0272.2001.00469.x; Kim HY, 2010, CALCIFIED TISSUE INT, V86, P350, DOI 10.1007/s00223-010-9347-2; Kim H, 2013, J BONE MINER METAB, V31, P571, DOI 10.1007/s00774-013-0446-9; Kinjo M, 2007, J CLIN ENDOCR METAB, V92, P4161, DOI 10.1210/jc.2007-0757; Klipstein-Grobusch K, 1998, EUR J CLIN NUTR, V52, P588, DOI 10.1038/sj.ejcn.1600611; Krall EA, 1997, J GERONTOL A-BIOL, V52, pM61, DOI 10.1093/gerona/52A.2.M61; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; Ma LL, 2012, EUR J EPIDEMIOL, V27, P319, DOI 10.1007/s10654-012-9674-x; Makovey J, 2005, OSTEOPOROSIS INT, V16, P1495, DOI 10.1007/s00198-005-1841-4; Margolis KL, 2014, J GEN INTERN MED; Nelson LR, 2001, J AM ACAD DERMATOL, V45, pS116, DOI 10.1067/mjd.2001.117432; Oei L, 2013, DIABETES CARE, V36, P1619, DOI 10.2337/dc12-1188; OHTA H, 1993, BONE, V14, P111, DOI 10.1016/8756-3282(93)90236-4; Rivadeneira F, 2007, J BONE MINER RES, V22, P1781, DOI 10.1359/JBMR.070712; Schott AM, 1998, OSTEOPOROSIS INT, V8, P247, DOI 10.1007/s001980050061; Schwartz AV, 2011, JAMA-J AM MED ASSOC, V305, P2184, DOI 10.1001/jama.2011.715; Smith BJ, 2006, BONE, V38, P378, DOI 10.1016/j.bone.2005.09.008; Spaine LA, 1996, INJURY, V27, P687, DOI 10.1016/S0020-1383(96)00136-2; Sun K, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-13; Tsuda K, 2001, AM J HYPERTENS, V14, P704, DOI 10.1016/S0895-7061(01)01303-6; Vestergaard P, 2009, CALCIFIED TISSUE INT, V84, P103, DOI 10.1007/s00223-008-9198-2; Xu SH, 2006, BIOPHYS J, V91, P4221, DOI [10.1529/biophysj.105.075804, 10.1529/biophysj.106.075804]; Xue P, 2012, ENDOCRINE, V42, P546, DOI 10.1007/s12020-012-9684-1; Yamaguchi T, 2002, ENDOCR J, V49, P211, DOI 10.1507/endocrj.49.211; Yamaguchi T, 2009, BONE, V45, P174, DOI 10.1016/j.bone.2009.05.003; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	42	44	46	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129116	10.1371/journal.pone.0129116	http://dx.doi.org/10.1371/journal.pone.0129116			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066649	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000047
J	Ronning, SB; Carlson, CR; Stang, E; Kolset, SO; Hollung, K; Pedersen, ME				Ronning, Sissel B.; Carlson, Cathrine R.; Stang, Espen; Kolset, Svein O.; Hollung, Kristin; Pedersen, Mona E.			Syndecan-4 Regulates Muscle Differentiation and Is Internalized from the Plasma Membrane during Myogenesis	PLOS ONE			English	Article							FIBROBLAST GROWTH-FACTOR; FOCAL ADHESION KINASE; CYTOPLASMIC DOMAIN; SATELLITE CELLS; MYOBLAST FUSION; ALPHA-ACTININ; PROTEOGLYCANS; LOCALIZATION; EXPRESSION; ACTIVATION	The cell surface proteoglycan syndecan-4 has been reported to be crucial for muscle differentiation, but the molecular mechanisms still remain to be fully understood. During in vitro differentiation of bovine muscle cells immunocytochemical analyses showed strong labelling of syndecan-4 intracellularly, in close proximity with Golgi structures, in membranes of intracellular vesicles and finally, in the nuclear area including the nuclear envelope. Chase experiments showed that syndecan-4 was internalized from the plasma membrane during this process. Furthermore, when syndecan-4 was knocked down by siRNA more myotubes were formed, and the expression of myogenic transcription factors, beta 1-integrin and actin was influenced. However, when bovine muscle cells were treated with a cell-penetrating peptide containing the cytoplasmic region of syndecan-4, myoblast fusion and thus myo-tube formation was blocked, both in normal cells and in syndecan-4 knock down cells. Altogether this suggests that the cytoplasmic domain of syndecan-4 is important in regulation of myogenesis. The internalization of syndecan-4 from the plasma membrane during muscle differentiation and the nuclear localization of syndecan-4 in differentiated muscle cells may be part of this regulation, and is a novel aspect of syndecan biology which merits further studies.	[Ronning, Sissel B.; Hollung, Kristin; Pedersen, Mona E.] Nofima AS, NO-1431 As, Norway; [Carlson, Cathrine R.] Oslo Univ Hosp, Expt Med Res Inst, Oslo, Norway; [Carlson, Cathrine R.] Univ Oslo, Oslo, Norway; [Carlson, Cathrine R.] Univ Oslo, KG Jebsen Cardiac Res Ctr, Oslo, Norway; [Carlson, Cathrine R.] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [Stang, Espen] Oslo Univ Hosp, Rikshosp, Dept Pathol, N-0424 Oslo, Norway; [Kolset, Svein O.] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Oslo, Norway	Nofima; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo	Ronning, SB (corresponding author), Nofima AS, Pb 210, NO-1431 As, Norway.	sissel.ronning@nofima.no		Ronning, Sissel Beate/0000-0002-2255-0172	Fund for Research Levy on Agricultural Products in Norway; Norwegian Research Council [203697/O99]; Throne Holst Foundation	Fund for Research Levy on Agricultural Products in Norway; Norwegian Research Council(Research Council of NorwayEuropean Commission); Throne Holst Foundation	This work was supported by grants from the Fund for Research Levy on Agricultural Products in Norway, the Norwegian Research Council (203697/O99) and the Throne Holst Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Brandan E, 2013, MATRIX BIOL, V32, P289, DOI 10.1016/j.matbio.2013.03.007; BRUNETTI A, 1990, J BIOL CHEM, V265, P5960; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Carpenter G, 2009, EXP CELL RES, V315, P1556, DOI 10.1016/j.yexcr.2008.09.027; Carvallo L, 2010, J BIOL CHEM, V285, P29546, DOI 10.1074/jbc.M110.155812; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Choi Y, 2008, EUR J CELL BIOL, V87, P807, DOI 10.1016/j.ejcb.2008.04.005; Cornelison DDW, 2004, GENE DEV, V18, P2231, DOI 10.1101/gad.1214204; Couchman JR, 2012, J HISTOCHEM CYTOCHEM, V60, P885, DOI 10.1369/0022155412464638; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Finsen AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028302; Forterre A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084153; Fuentealba L, 1999, J BIOL CHEM, V274, P37876, DOI 10.1074/jbc.274.53.37876; Gopal S, 2010, J BIOL CHEM, V285, P14247, DOI 10.1074/jbc.M109.056945; GRIFFITHS G, 1984, J ULTRA MOL STRUCT R, V89, P65, DOI 10.1016/S0022-5320(84)80024-6; Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152; Kolset SO, 2004, BIOCHEM J, V379, P217, DOI 10.1042/BJ20031230; Kwon MJ, 2012, FEBS LETT, V586, P2207, DOI 10.1016/j.febslet.2012.05.037; Lee JL, 2009, J CELL BIOL, V185, P949, DOI 10.1083/jcb.200812060; Lendorf ME, 2011, J HISTOCHEM CYTOCHEM, V59, P615, DOI 10.1369/0022155411405057; Letoha T, 2010, BBA-BIOMEMBRANES, V1798, P2258, DOI 10.1016/j.bbamem.2010.01.022; Lim ST, 2003, J BIOL CHEM, V278, P13795, DOI 10.1074/jbc.M208300200; Madaro L, 2011, MOL BIOL CELL, V22, P1409, DOI 10.1091/mbc.E10-10-0821; Multhaupt HAB, 2009, J PHYSIOL PHARMACOL, V60, P31; Pisconti Addolorata, 2012, Muscles Ligaments Tendons J, V2, P1; Pisconti A, 2010, J CELL BIOL, V190, P427, DOI 10.1083/jcb.201003081; Quach NL, 2009, MOL BIOL CELL, V20, P3422, DOI 10.1091/mbc.E09-02-0175; Richardson TP, 2001, J CELL SCI, V114, P1613; Ronning SB, 2013, DIFFERENTIATION, V86, P13, DOI 10.1016/j.diff.2013.06.006; Schaefer L, 2010, CELL TISSUE RES, V339, P237, DOI 10.1007/s00441-009-0821-y; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7; Shin J, 2012, POULTRY SCI, V91, P201, DOI 10.3382/ps.2011-01695; Shin J, 2013, MOL CELL BIOCHEM, V375, P115, DOI 10.1007/s11010-012-1534-1; Shin JH, 2012, MOL CELL BIOCHEM, V363, P437, DOI 10.1007/s11010-011-1198-2; Shin NY, 2014, J CELL BIOL, V207, P73, DOI 10.1083/jcb.201401137; Song Y, 2012, CELL BIOL INT, V36, P433, DOI 10.1042/CBI20110467; Stewart MD, 2014, MATRIX BIOL, V35, P56, DOI 10.1016/j.matbio.2013.10.009; Xian XJ, 2010, CELL TISSUE RES, V339, P31, DOI 10.1007/s00441-009-0829-3; Yoneda A, 2003, MATRIX BIOL, V22, P25, DOI 10.1016/S0945-053X(03)00010-6; Zhang XF, 2008, MATRIX BIOL, V27, P619, DOI 10.1016/j.matbio.2008.06.002; Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011; Zong F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014816; Zong F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007346	45	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129288	10.1371/journal.pone.0129288	http://dx.doi.org/10.1371/journal.pone.0129288			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068620	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000356327000060
J	Sexton, TJ; Van Gelder, RN				Sexton, Timothy J.; Van Gelder, Russell N.			G-Protein Coupled Receptor Kinase 2 Minimally Regulates Melanopsin Activity in Intrinsically Photosensitive Retinal Ganglion Cells	PLOS ONE			English	Article							LIGHT; PHOSPHORYLATION; DESENSITIZATION; ADAPTATION; DIVERSITY; RESPONSES; MICE	Phosphorylation is a primary modulator of mammalian G-protein coupled receptor (GPCR) activity. The GPCR melanopsin is the photopigment of intrinsically photosensitive retinal ganglion cells (ipRGCs) in the mammalian retina. Recent evidence from in vitro experiments suggests that the G-protein coupled receptor kinase 2 (GRK2) phosphorylates melanopsin and reduces its activity following light exposure. Using an ipRGC-specific GRK2 loss-of-function mouse, we show that GRK2 loss alters melanopsin response dynamics and termination time in postnatal day 8 (P8) ipRGCs but not in older animals. However, the alterations are small in comparison to the changes reported for other opsins with loss of their cognate GRK. These results suggest GRK2 contributes to melanopsin deactivation, but that other mechanisms account for most of modulation of melanopsin activity in ipRGCs.	[Sexton, Timothy J.; Van Gelder, Russell N.] Univ Washington, Sch Med, Dept Ophthalmol, Seattle, WA 98195 USA; [Sexton, Timothy J.] Univ Washington, Sch Med, Program Neurobiol & Behav, Seattle, WA 98195 USA; [Van Gelder, Russell N.] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Van Gelder, Russell N.] Univ Washington, Sch Med, Dept Biol Struct, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Van Gelder, RN (corresponding author), Univ Washington, Sch Med, Dept Ophthalmol, Seattle, WA 98195 USA.	russvg@uw.edu	Van Gelder, Russell/ABB-4225-2021	Van Gelder, Russell/0000-0001-5368-3659	National Institute of Health grants [EY009339, T32EY07031, P30EY001730]; Research to Prevent Blindness; Burroughs-Welcome Translational Scientist Award; Richard M. and Maude Ferry Charitable Foundation; NATIONAL EYE INSTITUTE [T32EY007031, P30EY001730, R01EY009339] Funding Source: NIH RePORTER	National Institute of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Burroughs-Welcome Translational Scientist Award; Richard M. and Maude Ferry Charitable Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by National Institute of Health grants [http://www.nih.gov/] EY009339 (RVG, TJS), T32EY07031 (TJS), P30EY001730 (RVG) in addition to support from an unrestricted grant from Research to Prevent Blindness [http://www.rpbusa.org/rpb/], the Burroughs-Welcome Translational Scientist Award [http://www.bwfund.org/grant-programs/translationalresearch/clinical-scientist-awards-translationalresearch](RVG), and the Richard M. and Maude Ferry Charitable Foundation.	Aiyar N, 2000, EUR J PHARMACOL, V403, P1, DOI 10.1016/S0014-2999(00)00419-2; Blasic JR, 2014, BIOCHEMISTRY-US, V53, P2644, DOI 10.1021/bi401724r; Blasic JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045387; Blasic JR, 2012, CELLULAR MOL LIFE SC, V69, P10; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; Chew KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098356; Do MTH, 2013, P NATL ACAD SCI USA, V110, P7470, DOI 10.1073/pnas.1304039110; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Fahrenkrug J, 2014, J BIOL CHEM, V289, P35482, DOI 10.1074/jbc.M114.586529; Holy TE, 2000, SCIENCE, V289, P1569, DOI 10.1126/science.289.5484.1569; Iacovelli L, 1999, FASEB J, V13, P1; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Luo DG, 2008, SENSES COMPREHENSIVE, V1, P32; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Sexton T, 2012, J BIOL CHEM, V287, P1649, DOI 10.1074/jbc.R111.301226; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; Vinge LE, 2007, MOL PHARMACOL, V72, P582, DOI 10.1124/mol.107.035766; Williams JT, 2013, PHARMACOL REV, V65, P223, DOI 10.1124/pr.112.005942; Wong KY, 2005, NEURON, V48, P1001, DOI 10.1016/j.neuron.2005.11.016; Wong WT, 2000, J NEUROSCI, V20, P351, DOI 10.1523/JNEUROSCI.20-01-00351.2000; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029	23	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128690	10.1371/journal.pone.0128690	http://dx.doi.org/10.1371/journal.pone.0128690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26069965	Green Submitted, Green Published, gold			2022-12-26	WOS:000356327000023
J	Tzeng, YL; Chen, SL; Chen, CF; Wang, FC; Kuo, SY				Tzeng, Ya-Ling; Chen, Shu-Ling; Chen, Chuen-Fei; Wang, Fong-Chen; Kuo, Shu-Yu			Sleep Trajectories of Women Undergoing Elective Cesarean Section: Effects on Body Weight and Psychological Well-Being	PLOS ONE			English	Article							RESTLESS LEGS SYNDROME; QUALITY INDEX; PSYCHOMETRIC EVALUATION; POSTNATAL DEPRESSION; CHILDBIRTH FEAR; MATERNAL SLEEP; LATE PREGNANCY; RISK-FACTORS; POSTPARTUM; FATIGUE	Background After cesarean section (CS), women may be at great risk for sleep disturbance, but little is known about temporal changes in their sleep patterns and characteristics. We had two aims: 1) to identify distinct classes of sleep-disturbance trajectories in women considering elective CS from third-trimester pregnancy to 6 months post-CS and 2) to examine associations of sleep trajectories with body mass index (BMI), depressive symptoms, and fatigue scores. Methods We analyzed data from a prospective cohort study of 139 Taiwanese pregnant women who elected CS. Sleep components were assessed using the Pittsburgh Sleep Quality Index in third-trimester pregnancy, 1 day, 1 week, 1 month, and 6 months post-CS. Data were collected on depressive symptoms, fatigue symptoms, and BMI. Sleep-quality trajectories were identified by group-based trajectory modeling. Results We identified three distinct trajectories: stable poor sleep (50 women, 36.0%), progressively worse sleep (67 women, 48.2%), and persistently poor sleep (22 women, 15.8%). Poor sleep was significantly associated with pre-pregnancy BMI and more baseline (third-trimester pregnancy) depressive and fatigue symptoms. At 6 months post-CS, women classified as progressively worse or persistently poor sleepers showed a trend toward higher BMI (p < 0.03), more depressive symptoms (p < 0.001), and higher fatigue scores (p < 0.001) than those with stable poor sleep. Conclusions Women had three distinct sleep-disturbance trajectories before and after elective CS. These poor-sleep courses were associated with BMI and psychological well-being. Our findings suggest a need to continuously assess sleep quality among women considering elective CS and up to 6 months post-CS.	[Tzeng, Ya-Ling; Wang, Fong-Chen] China Med Univ, Sch Nursing, Taichung, Taiwan; [Tzeng, Ya-Ling; Wang, Fong-Chen] China Med Univ Hosp, Taichung, Taiwan; [Chen, Shu-Ling] Hungkuang Univ, Dept Nursing, Taichung, Taiwan; [Chen, Chuen-Fei] Mackay Med Coll, Dept Med, New Taipei City, Taiwan; [Kuo, Shu-Yu] Taipei Med Univ, Coll Nursing, Sch Nursing, Taipei, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Hungkuang University; Mackay Medical College; Taipei Medical University	Kuo, SY (corresponding author), Taipei Med Univ, Coll Nursing, Sch Nursing, Taipei, Taiwan.	sykuo@tmu.edu.tw		Kuo, Shu-Yu/0000-0003-4221-7673	Ministry of Science and Technology [NSC 101-2629-H-038 -001 -MY2]; China Medical University [CMU-DMR-101-100]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); China Medical University(China Medical University)	This study was supported by the Ministry of Science and Technology, grant NSC 101-2629-H-038 -001 -MY2 to SYK, and by China Medical University, CMU-DMR-101-100, to YLT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott SM, 2014, BEST PRACT RES CL OB, V28, P159, DOI 10.1016/j.bpobgyn.2013.09.003; Backhaus J, 2002, J PSYCHOSOM RES, V53, P737, DOI 10.1016/S0022-3999(02)00330-6; Bei B, 2010, SLEEP, V33, P531, DOI 10.1093/sleep/33.4.531; Buysse D J, 1989, Psychiatry Res, V28, P193; Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5; Centers for Disease Control (CDC), 1989, MMWR Morb Mortal Wkly Rep, V38, P400; Chen PH, 2012, SLEEP MED, V13, P1153, DOI 10.1016/j.sleep.2012.06.008; Chen YH, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.023; Cohen J.E., 1988, STAT POWER ANAL BEHA; Coo S, 2014, JOGNN-J OBST GYN NEO, V43, P465, DOI 10.1111/1552-6909.12464; Cote S, 2002, J CHILD PSYCHOL PSYC, V43, P609, DOI 10.1111/1469-7610.00050; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Dorheim SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094674; Dorheim SK, 2009, SLEEP, V32, P847, DOI 10.1093/sleep/32.7.847; Elek SM, 1997, BIRTH-ISS PERINAT C, V24, P49, DOI 10.1111/j.1523-536X.1997.tb00336.x; Gay Caryl L, 2004, Biol Res Nurs, V5, P311, DOI 10.1177/1099800403262142; Germain A, 2008, RISK FACTORS IN DEPRESSION, P91, DOI 10.1016/B978-0-08-045078-0.00005-8; Goyal D, 2007, J PERINAT NEONAT NUR, V21, P123, DOI 10.1097/01.JPN.0000270629.58746.96; Gunderson EP, 2008, AM J EPIDEMIOL, V167, P178, DOI 10.1093/aje/kwm298; Hall WA, 2009, JOGNN-J OBST GYN NEO, V38, P567, DOI 10.1111/j.1552-6909.2009.01054.x; Heh S, 2001, J NURS RES, V9, P1; Huang HC, 2004, BIRTH-ISS PERINAT C, V31, P183, DOI 10.1111/j.0730-7659.2004.00303.x; Hung HM, 2013, MCN-AM J MATERN-CHIL, V38, P95, DOI 10.1097/NMC.0b013e3182659345; Hunter LP, 2009, JOGNN-J OBST GYN NEO, V38, P60, DOI 10.1111/j.1552-6909.2008.00309.x; Hutchison BL, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-144; Jomeen J, 2007, J REPROD INFANT PSYC, V25, P87, DOI 10.1080/02646830601117308; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Jones CR, 2013, CLIN OBSTET GYNECOL, V56, P360, DOI 10.1097/GRF.0b013e31828f2717; Kamysheva E, 2010, J AFFECT DISORDERS, V123, P317, DOI 10.1016/j.jad.2009.09.015; Kao CC, 2008, QUAL LIFE RES, V17, P1073, DOI 10.1007/s11136-008-9383-9; Ko SH, 2010, J NURS SCHOLARSHIP, V42, P23, DOI 10.1111/j.1547-5069.2009.01326.x; Ko Yi-Li, 2008, J Nurs Res, V16, P177; Kuo SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086653; Lavender T, 2012, COCHRANE DATABASE SY, V3; Lee H, 2005, THESIS NATL TAIPEI C; Lee SY, 2007, J PERINAT NEONAT NUR, V21, P109, DOI 10.1097/01.JPN.0000270627.73993.b0; Magee L, 2012, SLEEP MED REV, V16, P231, DOI 10.1016/j.smrv.2011.05.005; Marques M, 2011, PSYCHIAT RES, V186, P272, DOI 10.1016/j.psychres.2010.06.029; Mindell J A, 2000, J Obstet Gynecol Neonatal Nurs, V29, P590; Nagin D. S, 2005, GROUP BASED MODELING, DOI DOI 10.4159/9780674041318; Okun ML, 2011, SLEEP, V34, P1493, DOI 10.5665/sleep.1384; Okun ML, 2009, BEHAV SLEEP MED, V7, P106, DOI 10.1080/15402000902762394; Park EM, 2013, ARCH WOMEN MENT HLTH, V16, P539, DOI 10.1007/s00737-013-0356-9; Pien GW, 2014, THORAX, V69, P371, DOI 10.1136/thoraxjnl-2012-202718; Pien GW, 2004, SLEEP, V27, P1405, DOI 10.1093/sleep/27.7.1405; Posmontier B, 2008, JOGNN-J OBST GYN NEO, V37, P722, DOI 10.1111/j.1552-6909.2008.00298.x; Pugh L C, 1999, J Obstet Gynecol Neonatal Nurs, V28, P74, DOI 10.1111/j.1552-6909.1999.tb01967.x; Raisanen S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004047; Rooney BL, 2002, OBSTET GYNECOL, V100, P245, DOI 10.1016/S0029-7844(02)02125-7; Sahota PK, 2003, CURR OPIN PULM MED, V9, P477, DOI 10.1097/00063198-200311000-00005; Skouteris H, 2009, WOMEN HEALTH ISS, V19, P45, DOI 10.1016/j.whi.2008.10.004; Srivanitchapoom P, 2014, PARKINSONISM RELAT D, V20, P716, DOI 10.1016/j.parkreldis.2014.03.027; Su KP, 2007, GEN HOSP PSYCHIAT, V29, P436, DOI 10.1016/j.genhosppsych.2007.05.005; Taylor J, 2013, MIDWIFERY, V29, P526, DOI 10.1016/j.midw.2012.04.011; Toohill J, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-275; Tribotti S, 1988, J Obstet Gynecol Neonatal Nurs, V17, P410, DOI 10.1111/j.1552-6909.1988.tb00467.x; Troy N W, 1997, Clin Nurs Res, V6, P126, DOI 10.1177/105477389700600202; Tsai PS, 2005, QUAL LIFE RES, V14, P1943, DOI 10.1007/s11136-005-4346-x; Tzeng YL, 2008, J ADV NURS, V63, P240, DOI 10.1111/j.1365-2648.2008.04732.x; Yuan E, 2013, MED SERVICE QUALITY	60	13	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129094	10.1371/journal.pone.0129094	http://dx.doi.org/10.1371/journal.pone.0129094			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6GR	26066326	gold, Green Submitted, Green Published			2022-12-26	WOS:000356327000044
J	Tsai, FC; Ho, HT; Chang, JP; Tsai, FC; Chu, JJ; Lin, PJ				Tsai, Feng-Chun; Ho, Heng-Tsan; Chang, Jen-Ping; Tsai, Feng-Chang; Chu, Jaw-Ji; Lin, Pyng-Jing			The Prognostic Scoring System Establishment and Validation for Chronic Atrial Fibrillation Patients Receiving Modified Cox-Maze IV and Concomitant Cardiac Surgery	PLOS ONE			English	Article							SURGICAL-TREATMENT; LATE RECURRENCE; SINUS RHYTHM; SIZE; PREDICTOR; SUCCESS; REDUCTION; ABLATION; IMPACT	Objectives Traditional Cox maze III is the gold standard for treatment of atrial fibrillation (AF). Because of its invasiveness, it has been replaced by a simplified procedure involving radiofrequency ablation of modified Cox maze IV. Although the modified Cox maze IV has the advantages of simplicity and less morbidity, a lower rate of sinus rhythm conversion has been reported. We try to establish a scoring system to predict the outcome of this procedure. Methods and Results The derivation group consisted of 287 patients with structural heart disease and chronic AF who underwent cardiac surgery and modified Cox-maze IV procedure between August 2005 and March 2013. Demographics, clinical and laboratory variables were retrospectively collected as sinus conversional predictors. Overall sinus conversion rate was 75.8%. The parameters of the Soft Markers Scoring system included AF duration, preoperative left atrial (LA) size, rheumatic pathology and postoperative LA remodeling. We compared 80 patients from another hospital between January 2004 and December 2011 as a validation group to evaluate the power of the scoring system. Soft Markers Score indicated a good discriminative power by using the areas under the receiver operating characteristic curve (AUROC: 0.759 +/- 0.032). The score was further divided into three groups: low (0-2), intermediate (3-5), and high (6-10), with predicted sinus conversion rates of 92.4%, 74.2%, and 47.8%, respectively. Conclusions In patients with chronic AF receiving modified Cox-maze IV procedure, the Soft Markers Score demonstrated good discriminative power of predicting sinus recovery in our patients and applied well to the other validation populations.	[Tsai, Feng-Chun; Chu, Jaw-Ji; Lin, Pyng-Jing] Chang Gung Mem Hosp, Dept Cardiothorac & Vasc Surg, Linkou, Taiwan; [Tsai, Feng-Chun; Chang, Jen-Ping; Chu, Jaw-Ji; Lin, Pyng-Jing] Chang Gung Univ Med, Taoyuan, Taiwan; [Ho, Heng-Tsan] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Tsai, Feng-Chun; Chang, Jen-Ping] Chang Gung Mem Hosp, Dept Cardiothorac & Vasc Surg, Kaohsiung, Taiwan; [Tsai, Feng-Chang] Chang Gung Mem Hosp, Formosa Biomed Technol, Taoyuan, Taiwan; [Tsai, Feng-Chang] Chang Gung Univ, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Tsai, FC (corresponding author), Chang Gung Mem Hosp, Dept Cardiothorac & Vasc Surg, Linkou, Taiwan.	lutony@cgmh.org.tw			national science council in Taiwan [NMRP 99-2314-B-182A-050-MY2, NMRP 102-2314-B-182A-049-MY2]; Formosa Biomedical Technology	national science council in Taiwan(Ministry of Science and Technology, Taiwan); Formosa Biomedical Technology	This study was supported by funds from the national science council in Taiwan (NMRP 99-2314-B-182A-050-MY2 and NMRP 102-2314-B-182A-049-MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Feng-Chang Tsai, an expert in statistical analysis, took part in data analysis and statistical methods verification. He received the salaries from Formosa Biomedical Technology, but this commercial company did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa M, 2009, CIRC J, V73, P269, DOI 10.1253/circj.CJ-08-0281; Basu S, 2012, INTERACT CARDIOV TH, V15, P741, DOI 10.1093/icvts/ivs311; Beukema WP, 2008, EUR J CARDIO-THORAC, V34, P771, DOI 10.1016/j.ejcts.2008.07.026; Chaiyaroj Suchart, 2008, Asian Cardiovasc Thorac Ann, V16, P292; Chen MC, 2004, CHEST, V125, P2129, DOI 10.1378/chest.125.6.2129; Chen MC, 2001, J CARDIOVASC ELECTR, V12, P867, DOI 10.1046/j.1540-8167.2001.00867.x; Cox JL, 1999, J THORAC CARDIOV SUR, V118, P833, DOI 10.1016/S0022-5223(99)70052-8; Damiano Jr RJ, 2004, OPERATIVE TECHNIQUES, V9, P24; Damiano RJ, 2011, J THORAC CARDIOV SUR, V141, P113, DOI 10.1016/j.jtcvs.2010.08.067; Gaynor SL, 2005, J THORAC CARDIOV SUR, V129, P104, DOI 10.1016/j.jtcvs.2004.08.042; HENRY WL, 1976, CIRCULATION, V53, P273, DOI 10.1161/01.CIR.53.2.273; Khargi K, 2005, EUR J CARDIO-THORAC, V27, P258, DOI 10.1016/j.ejcts.2004.11.003; Kim YH, 2007, J THORAC CARDIOV SUR, V134, P448, DOI 10.1016/j.jtcvs.2007.02.031; Lee JW, 2003, ANN THORAC SURG, V75, P57, DOI 10.1016/S0003-4975(02)04319-9; Marui A, 2008, J THORAC CARDIOV SUR, V135, P1297, DOI 10.1016/j.jtcvs.2008.02.026; Polyakova V, 2008, J CELL MOL MED, V12, P189, DOI 10.1111/j.1582-4934.2008.00219.x; Sunderland N, 2011, INTERACT CARDIOV TH, V13, P332, DOI 10.1510/icvts.2011.271999; Tsao HM, 2005, J CARDIOVASC ELECTR, V16, P7, DOI 10.1046/j.1540-8167.2005.04407.x; Wang X, 2013, CARDIOLOGY, V126, P62, DOI 10.1159/000351980	19	1	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0126300	10.1371/journal.pone.0126300	http://dx.doi.org/10.1371/journal.pone.0126300			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067656	Green Published, gold, Green Submitted			2022-12-26	WOS:000356100900008
J	Li, JL; Liang, HW; Bai, M; Ning, T; Wang, C; Fan, Q; Wang, YB; Fu, Z; Wang, N; Liu, R; Zen, K; Zhang, CY; Chen, X; Ba, Y				Li, Jialu; Liang, Hongwei; Bai, Ming; Ning, Tao; Wang, Cheng; Fan, Qian; Wang, Yanbo; Fu, Zheng; Wang, Nan; Liu, Rui; Zen, Ke; Zhang, Chen-Yu; Chen, Xi; Ba, Yi			miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer	PLOS ONE			English	Article							COLON-CANCER; MICROSATELLITE INSTABILITY; MICRORNA EXPRESSION; INACTIVATION; GENE; METHYLATION; OCCURS; CELLS; KRAS	The transforming growth factor beta (TGF-beta) signaling pathway is a tumor-suppressor pathway that is commonly inactivated in colorectal cancer (CRC). The inactivation of TGFBR2 is the most common genetic event affecting the TGF-beta signaling pathway. However, the mechanism by which cancer cells downregulate TGFBR2 is unclear. In this study, we found that the TGFBR2 protein levels were consistently upregulated in CRC tissues, whereas its mRNA levels varied in these tissues, suggesting that a post-transcriptional mechanism is involved in the regulation of TGFBR2. Because microRNAs (miRNAs) are powerful post-transcriptional regulators of gene expression, we performed bioinformatic analyses to search for miRNAs that potentially target TGFBR2. We identified the specific targeting site of miR-135b in the 3'-untranslated region (3'-UTR) of TGFBR2. We further identified an inverse correlation between the levels of miR-135b and TGFBR2 protein, but not mRNA, in CRC tissue samples. By overexpressing or silencing miR-135b in CRC cells, we experimentally validated that miR-135b directly binds to the 3'-UTR of the TGFBR2 transcript and regulates TGFBR2 expression. Furthermore, the biological consequences of the targeting of TGFBR2 by miR-135b were examined using in vitro cell proliferation and apoptosis assays. We demonstrated that miR-135b exerted a tumor-promoting effect by inducing the proliferation and inhibiting the apoptosis of CRC cells via the negative regulation of TGFBR2 expression. Taken together, our findings provide the first evidence supporting the role of miR-135b as an oncogene in CRC via the inhibition of TGFBR2 translation.	[Li, Jialu; Bai, Ming; Ning, Tao; Fan, Qian; Liu, Rui] Tianjin Med Univ, Canc Inst & Hosp, Key Lab Canc Prevent & Therapy, Tianjin 300060, Peoples R China; [Li, Jialu; Liang, Hongwei; Wang, Cheng; Fan, Qian; Wang, Yanbo; Fu, Zheng; Wang, Nan; Zen, Ke; Zhang, Chen-Yu; Chen, Xi; Ba, Yi] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, Nanjing 210093, Jiangsu, Peoples R China; [Wang, Cheng] Nanjing Univ, Clin Sch Med Coll, Jinling Hosp, Dept Clin Lab, Nanjing 210093, Jiangsu, Peoples R China	Tianjin Medical University; Nanjing University; Nanjing University	Zhang, CY (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, Nanjing 210093, Jiangsu, Peoples R China.	cyzhang@nju.edu.cn; xichen@nju.edu.cn; bayi@tjmuch.com	Wang, Cheng/O-7206-2016; li, jia/GVT-7587-2022	Wang, Cheng/0000-0002-1834-2119; 	National Natural Science Foundation of China [81201946, 81372394, 81250044, 81401257]; Ministry of Education Research Fund for doctoral program [2012202120013]; Science Foundation of Medical University of Tianjin [2011KY15]; National Research Platform of Clinical Evaluation Technology for New Anticancer Drugs [2013ZX09303001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education Research Fund for doctoral program; Science Foundation of Medical University of Tianjin; National Research Platform of Clinical Evaluation Technology for New Anticancer Drugs	This work was funded by the National Natural Science Foundation of China (No. 81201946, 81372394, 81250044, 81401257), the Ministry of Education Research Fund for doctoral program (No. 2012202120013), the Science Foundation of Medical University of Tianjin (No. 2011KY15), the National Research Platform of Clinical Evaluation Technology for New Anticancer Drugs (No. 2013ZX09303001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Biswas S, 2004, CANCER RES, V64, P4687, DOI 10.1158/0008-5472.CAN-03-3255; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; de Caestecker MP, 2000, JNCI-J NATL CANCER I, V92, P1388, DOI 10.1093/jnci/92.17.1388; Dong ZM, 2012, AM J MED SCI, V343, P375, DOI 10.1097/MAJ.0b013e3182253430; Engle SJ, 1999, CANCER RES, V59, P3379; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gaedcke J, 2012, CLIN CANCER RES, V18, P4919, DOI 10.1158/1078-0432.CCR-12-0016; Gryfe R, 1997, CURR PROB CANCER, V21, P238, DOI 10.1016/S0147-0272(97)80003-7; Guo W, 2012, MOL BIOL REP, V39, P9453, DOI 10.1007/s11033-012-1810-x; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hougaard S, 1999, BRIT J CANCER, V79, P1005, DOI 10.1038/sj.bjc.6690161; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Kent OA, 2013, ONCOGENE, V32, P2576, DOI 10.1038/onc.2012.266; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; LIU B, 1995, NAT MED, V1, P348, DOI 10.1038/nm0495-348; MacKay SLD, 1998, ANN SURG, V227, P781, DOI 10.1097/00000658-199806000-00001; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Michael MZ, 2003, MOL CANCER RES, V1, P882; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Munoz NM, 2006, CANCER RES, V66, P9837, DOI 10.1158/0008-5472.CAN-06-0890; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Ogino S, 2007, HUM PATHOL, V38, P614, DOI 10.1016/j.humpath.2006.10.005; Pagliuca A, 2013, ONCOGENE, V32, P4806, DOI 10.1038/onc.2012.495; PARSONS R, 1995, CANCER RES, V55, P5548; Rojas A, 2009, BBA-MOL CELL RES, V1793, P1165, DOI 10.1016/j.bbamcr.2009.02.001; Valeri N, 2014, CANCER CELL, V25, P469, DOI 10.1016/j.ccr.2014.03.006; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wu WY, 2014, MOL CELL BIOCHEM, V388, P249, DOI 10.1007/s11010-013-1916-z; Yu M, 2014, ONCOGENE, V33, P1538, DOI 10.1038/onc.2013.102; Zhang Q, 2005, MOL ENDOCRINOL, V19, P2390, DOI 10.1210/me.2005-0096	39	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0130194	10.1371/journal.pone.0130194	http://dx.doi.org/10.1371/journal.pone.0130194			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061281	Green Submitted, Green Published, gold			2022-12-26	WOS:000355979500167
J	McCormick, K; Jiang, Z; Zhu, LC; Lawson, SR; Langenhorst, R; Ransburgh, R; Brunick, C; Tracy, MC; Hurtig, HR; Mabee, LM; Mingo, M; Li, YH; Webby, RJ; Huber, VC; Fang, Y				McCormick, Kara; Jiang, Zhiyong; Zhu, Longchao; Lawson, Steven R.; Langenhorst, Robert; Ransburgh, Russell; Brunick, Colin; Tracy, Miranda C.; Hurtig, Heather R.; Mabee, Leah M.; Mingo, Mark; Li, Yanhua; Webby, Richard J.; Huber, Victor C.; Fang, Ying			Construction and Immunogenicity Evaluation of Recombinant Influenza A Viruses Containing Chimeric Hemagglutinin Genes Derived from Genetically Divergent Influenza A H1N1 Subtype Viruses	PLOS ONE			English	Article							IMMUNIZATION PRACTICES ACIP; DNA VACCINE; NEUTRALIZING ANTIBODY; RESPIRATORY-DISEASE; ADVISORY-COMMITTEE; UNITED-STATES; SWINE; LIVE; EVOLUTION; FAMILY	Background and Objectives Influenza A viruses cause highly contagious diseases in a variety of hosts, including humans and pigs. To develop a vaccine that can be broadly effective against genetically divergent strains of the virus, in this study we employed molecular breeding (DNA shuffling) technology to create a panel of chimeric HA genes. Methods and Results Each chimeric HA gene contained genetic elements from parental swine influenza A viruses that had a history of zoonotic transmission, and also from a 2009 pandemic virus. Each parental virus represents a major phylogenetic clade of influenza A H1N1 viruses. Nine shuffled HA constructs were initially screened for immunogenicity in mice by DNA immunization, and one chimeric HA (HA-129) was expressed on both a A/Puerto Rico/8/34 backbone with mutations associated with a live, attenuated phenotype (PR8(LAIV)-129) and a A/swine/Texas/4199-2/98 backbone (TX98-129). When delivered to mice, the PR8(LAIV)-129 induced antibodies against all four parental viruses, which was similar to the breadth of immunity observed when HA-129 was delivered as a DNA vaccine. This chimeric HA was then tested as a candidate vaccine in a nursery pig model, using inactivated TX98-129 virus as the backbone. The results demonstrate that pigs immunized with HA-129 developed antibodies against all four parental viruses, as well as additional primary swine H1N1 influenza virus field isolates. Conclusion This study established a platform for creating novel genes of influenza viruses using a molecular breeding approach, which will have important applications toward future development of broadly protective influenza virus vaccines.	[McCormick, Kara; Brunick, Colin; Tracy, Miranda C.; Hurtig, Heather R.; Mabee, Leah M.; Mingo, Mark; Huber, Victor C.] Univ S Dakota, Sanford Sch Med, Div Basic Biomed Sci, Vermillion, SD 57069 USA; [Jiang, Zhiyong; Zhu, Longchao; Lawson, Steven R.; Langenhorst, Robert; Ransburgh, Russell; Li, Yanhua; Fang, Ying] S Dakota State Univ, Dept Vet & Biomed Sci, Brookings, SD 57007 USA; [Webby, Richard J.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	University of South Dakota; South Dakota State University; St Jude Children's Research Hospital	Huber, VC (corresponding author), Univ S Dakota, Sanford Sch Med, Div Basic Biomed Sci, Vermillion, SD 57069 USA.	Victor.Huber@usd.edu; yfang@vet.k-state.edu	Zhu, Longchao/GZM-4400-2022; Webby, Richard J/N-5657-2018	li, yanhua/0000-0002-2141-5139	National Institute of Health [1R15AI090582-01]; Division of Basic Biomedical Sciences at USD; Sanford School of Medicine Medical Student Summer Research Program; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH) [P20GM103443]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI090582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103443] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Basic Biomedical Sciences at USD; Sanford School of Medicine Medical Student Summer Research Program; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by National Institute of Health (grant number 1R15AI090582-01) (VCH and YF), start-up funds provided by the Division of Basic Biomedical Sciences at USD (VCH), the Sanford School of Medicine Medical Student Summer Research Program (MCT and MM), and an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH) (P20GM103443) (VCH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almansour I, 2013, HUM VACC IMMUNOTHER, V9, P2049, DOI 10.4161/hv.25735; [Anonymous], 2013, MMWR-MORBID MORTAL W, V62, P356; Apt D, 2006, VACCINE, V24, P335, DOI 10.1016/j.vaccine.2005.07.100; Baumeister E, 2010, MEDICINA-BUENOS AIRE, V70, P518; BLACK SC, 2011, AM POETRY REV, V40, P30, DOI DOI 10.1097/INF.0B013E3182367662; Brown IH, 1997, J GEN VIROL, V78, P553, DOI 10.1099/0022-1317-78-3-553; Burgers WA, 2006, J GEN VIROL, V87, P399, DOI 10.1099/vir.0.81379-0; Cai ZP, 2012, VACCINE, V30, P448, DOI 10.1016/j.vaccine.2011.10.051; Callison S, 2005, VIRUS GENES, V31, P5, DOI 10.1007/s11262-004-2194-3; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Chang CCJ, 1999, NAT BIOTECHNOL, V17, P793, DOI 10.1038/11737; Chaussee MS, 2011, VACCINE, V29, P3773, DOI 10.1016/j.vaccine.2011.03.031; Crameri A, 1998, NATURE, V391, P288, DOI 10.1038/34663; Cwach KT, 2012, INFLUENZA OTHER RESP, V6, P127, DOI 10.1111/j.1750-2659.2011.00283.x; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Fulvini AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020823; Gerdil C, 2003, VACCINE, V21, P1776, DOI 10.1016/S0264-410X(03)00071-9; Hause BM, 2012, CLIN VACCINE IMMUNOL, V19, P1457, DOI 10.1128/CVI.00096-12; Hensley Scott E, 2009, Expert Rev Anti Infect Ther, V7, P763, DOI 10.1586/eri.09.62; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; Huber VC, 2006, J INFECT DIS, V193, P677, DOI 10.1086/500247; Huber VC, 2006, CLIN VACCINE IMMUNOL, V13, P981, DOI 10.1128/CVI.00156-06; Huber VC, 2009, VACCINE, V27, P1192, DOI 10.1016/j.vaccine.2008.12.023; Jin H, 2004, J VIROL, V78, P995, DOI 10.1128/JVI.78.2.995-998.2004; KILBOURN.ED, 1971, J INFECT DIS, V124, P449, DOI 10.1093/infdis/124.5.449; KILBOURN.ED, 1969, B WORLD HEALTH ORGAN, V41, P643; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Klimov A, 1999, VACCINE, V17, pS42, DOI 10.1016/S0264-410X(99)00104-8; Lorusso A, 2011, J GEN VIROL, V92, P919, DOI 10.1099/vir.0.027557-0; MEIKLEJOHN G, 1983, J INFECT DIS, V148, P775, DOI 10.1093/infdis/148.5.775; Ness JE, 2002, NAT BIOTECHNOL, V20, P1251, DOI 10.1038/nbt754; Ness JE, 1999, NAT BIOTECHNOL, V17, P893, DOI 10.1038/12884; Nichol KL, 2008, VACCINE, V26, pD17, DOI 10.1016/j.vaccine.2008.07.048; Osen W, 2001, VACCINE, V19, P4276, DOI 10.1016/S0264-410X(01)00154-2; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Ramanunninair M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065955; REED L. J., 1938, AMER JOUR HYG, V27, P493; Richt JA, 2006, J VIROL, V80, P11009, DOI 10.1128/JVI.00787-06; Robertson JS, 2011, VACCINE, V29, P1836, DOI 10.1016/j.vaccine.2010.12.044; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; SCHOLTISSEK C, 1978, VIROLOGY, V87, P13, DOI 10.1016/0042-6822(78)90153-8; Schurmann N, 2013, NAT STRUCT MOL BIOL, V20, P818, DOI 10.1038/nsmb.2607; Schultz-Cherry S., 2012, CURR TOP MICROBIOL I; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Soong NW, 2000, NAT GENET, V25, P436, DOI 10.1038/78132; Vijaykrishna D, 2010, SCIENCE, V328, P1529, DOI 10.1126/science.1189132; VINCENT AL, 2009, VIRUS GENES; Vincent AL, 2012, J VIROL, V86, P10597, DOI 10.1128/JVI.01439-12; Webby RJ, 2003, SCIENCE, V302, P1519, DOI 10.1126/science.1090350; Webster R, 2002, WHO MANUAL ANIMAL IN, P1; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Yassine HM, 2009, VET MICROBIOL, V139, P132, DOI 10.1016/j.vetmic.2009.04.028; Zhao GY, 1998, GENE, V215, P47, DOI 10.1016/S0378-1119(98)00273-X	56	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0127649	10.1371/journal.pone.0127649	http://dx.doi.org/10.1371/journal.pone.0127649			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061265	Green Submitted, gold, Green Published			2022-12-26	WOS:000355979500047
J	Ho, TH; Park, IY; Zhao, H; Tong, P; Champion, MD; Yan, H; Monzon, FA; Hoang, A; Tamboli, P; Parker, AS; Joseph, RW; Qiao, W; Dykema, K; Tannir, NM; Castle, EP; Nunez-Nateras, R; Teh, BT; Wang, J; Walker, CL; Hung, MC; Jonasch, E				Ho, T. H.; Park, I. Y.; Zhao, H.; Tong, P.; Champion, M. D.; Yan, H.; Monzon, F. A.; Hoang, A.; Tamboli, P.; Parker, A. S.; Joseph, R. W.; Qiao, W.; Dykema, K.; Tannir, N. M.; Castle, E. P.; Nunez-Nateras, R.; Teh, B. T.; Wang, J.; Walker, C. L.; Hung, M-C; Jonasch, E.			High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma	ONCOGENE			English	Article							ANTITUMOR-ACTIVITY; SNP MICROARRAYS; METHYLATION; TARGET; SETD2; HYPB/SETD2; MUTATIONS; EVOLUTION; CANCER; REPAIR	Mutations in SETD2, a histone H3 lysine trimethyltransferase, have been identified in clear cell renal cell carcinoma (ccRCC); however it is unclear if loss of SETD2 function alters the genomic distribution of histone 3 lysine 36 trimethylation (H3K36me3) in ccRCC. Furthermore, published epigenomic profiles are not specific to H3K36me3 or metastatic tumors. To determine if progressive SETD2 and H3K36me3 dysregulation occurs in metastatic tumors, H3K36me3, SETD2 copy number (CN) or SETD2 mRNA abundance was assessed in two independent cohorts: metastatic ccRCC (n = 71) and the Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma data set (n = 413). Although SETD2 CN loss occurs with high frequency (490%), H3K36me3 is not significantly impacted by monoallelic loss of SETD2. H3K36me3-positive nuclei were reduced an average of similar to 20% in primary ccRCC (90% positive nuclei in uninvolved vs 70% positive nuclei in ccRCC) and reduced by similar to 60% in metastases (90% positive in uninvolved kidney vs 30% positive in metastases) (P<0.001). To define a kidney-specific H3K36me3 profile, we generated genome-wide H3K36me3 profiles from four cytoreductive nephrectomies and SETD2 isogenic renal cell carcinoma (RCC) cell lines using chromatin immunoprecipitation coupled with high-throughput DNA sequencing and RNA sequencing. SETD2 loss of methyltransferase activity leads to regional alterations of H3K36me3 associated with aberrant RNA splicing in a SETD2 mutant RCC and SETD2 knockout cell line. These data suggest that during progression of ccRCC, a decline in H3K36me3 is observed in distant metastases, and regional H3K36me3 alterations influence alternative splicing in ccRCC.	[Ho, T. H.] Mayo Clin, Div Hematol & Med Oncol, Scottsdale, AZ USA; [Ho, T. H.; Champion, M. D.; Yan, H.] Mayo Clin, Ctr Individualized Med, Rochester, MN USA; [Park, I. Y.; Walker, C. L.] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Translat Canc Res, Houston, TX USA; [Zhao, H.; Tong, P.; Wang, J.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Champion, M. D.] Mayo Clin, Dept Biomed Stat & Informat, Scottsdale, AZ USA; [Yan, H.] Dept Biomed Stat & Informat, Rochester, MN USA; [Monzon, F. A.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Monzon, F. A.; Hoang, A.; Tannir, N. M.; Jonasch, E.] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, 1515 Holcombe Blvd,Unit 1374, Houston, TX 77030 USA; [Tamboli, P.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Parker, A. S.] Mayo Clin, Dept Hlth Sci Res, Jacksonville, FL 32224 USA; [Joseph, R. W.] Mayo Clin, Div Hematol & Med Oncol, Jacksonville, FL 32224 USA; [Qiao, W.] Univ Texas MD Anderson Canc Ctr, Div Quantitat Sci, Houston, TX 77030 USA; [Dykema, K.; Teh, B. T.] Van Andel Inst, Ctr Canc Genom & Computat Biol, Grand Rapids, MI USA; [Castle, E. P.; Nunez-Nateras, R.] Mayo Clin, Dept Urol, Scottsdale, AZ USA; [Hung, M-C] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Hung, M-C] China Med Univ, Ctr Mol Med, Taichung, Taiwan; [Hung, M-C] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Monzon, F. A.] Invitae, San Francisco, CA USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; UTMD Anderson Cancer Center; Mayo Clinic; Mayo Clinic Phoenix; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Mayo Clinic; Mayo Clinic; University of Texas System; UTMD Anderson Cancer Center; Van Andel Institute; Mayo Clinic; Mayo Clinic Phoenix; University of Texas System; UTMD Anderson Cancer Center; China Medical University Taiwan; China Medical University Taiwan	Jonasch, E (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, 1515 Holcombe Blvd,Unit 1374, Houston, TX 77030 USA.	ejonasch@mdanderson.org	Hung, Mien-Chie/ABD-5911-2021	Hung, Mien-Chie/0000-0003-4317-4740; Joseph, Richard/0000-0001-6102-4661	ASCO Young Investigator Award from the Kidney Cancer Association; Action to Cure Kidney Cancer Organization; MD Anderson Hematology-Oncology Fellowship; NIH grant [K12 CA90628]; Mayo Clinic CR5 grant; Mayo Clinic Center for Individualized Medicine Epigenomics Translational Program; Kathryn H and Roger Penske Career Development Award to Support Medical Research; Mayo Clinic Center for Individualized Medicine; NATIONAL CANCER INSTITUTE [R01CA143811, K12CA090628, R01CA134466, P30CA015083, P30CA016672] Funding Source: NIH RePORTER	ASCO Young Investigator Award from the Kidney Cancer Association; Action to Cure Kidney Cancer Organization; MD Anderson Hematology-Oncology Fellowship; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic CR5 grant; Mayo Clinic Center for Individualized Medicine Epigenomics Translational Program; Kathryn H and Roger Penske Career Development Award to Support Medical Research; Mayo Clinic Center for Individualized Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Ian Davis, W Kimryn Rathmell, Kathryn E Hacker and Jeremy M Simon for helpful discussions and assistance with the genotyping of tissue. THH is supported by funding from the ASCO Young Investigator Award from the Kidney Cancer Association, the Action to Cure Kidney Cancer Organization, the MD Anderson Hematology-Oncology Fellowship, NIH grant K12 CA90628, a Mayo Clinic CR5 grant, the Mayo Clinic Center for Individualized Medicine Epigenomics Translational Program and a Kathryn H and Roger Penske Career Development Award to Support Medical Research. MDC is supported by the Mayo Clinic Center for Individualized Medicine.	Alvarez K, 2010, DIAGN MOL PATHOL, V19, P127, DOI 10.1097/PDM.0b013e3181d527c5; Bai AL, 2010, CANCER RES, V70, P7630, DOI 10.1158/0008-5472.CAN-10-1489; Bonnal S, 2012, NAT REV DRUG DISCOV, V11, P847, DOI 10.1038/nrd3823; Buck MJ, 2013, ONCOGENE; Carvalho S, 2014, ELIFE, V3, DOI 10.7554/eLife.02482; Champion MD, 2014, CHIP RNA SEQPRO STRA; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Finley SD, 2012, AAPS J, V14, P500, DOI 10.1208/s12248-012-9363-4; Fontebasso AM, 2013, ACTA NEUROPATHOL, V125, P659, DOI 10.1007/s00401-013-1095-8; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Hu M, 2010, P NATL ACAD SCI USA, V107, P2956, DOI 10.1073/pnas.0915033107; James LI, 2013, NAT CHEM BIOL, V9, P184, DOI [10.1038/NCHEMBIO.1157, 10.1038/nchembio.1157]; Jonasch E, 2010, CANCER-AM CANCER SOC, V116, P57, DOI 10.1002/cncr.24685; Jonasch E, 2009, J CLIN ONCOL, V27, P4076, DOI 10.1200/JCO.2008.21.3660; Joseph CG, 2014, GENE CHROMOSOME CANC, V53, P15, DOI 10.1002/gcc.22114; Kim HJ, 2009, AM J SURG PATHOL, V33, P1276, DOI 10.1097/PAS.0b013e3181a2aa36; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Li F, 2013, CELL, V153, P590, DOI 10.1016/j.cell.2013.03.025; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Linehan WM, 2010, NAT REV UROL, V7, P277, DOI 10.1038/nrurol.2010.47; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Mar BG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4469; Monzon FA, 2011, MODERN PATHOL, V24, P1470, DOI 10.1038/modpathol.2011.107; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Pfister SX, 2014, CELL REP, V7, P2006, DOI 10.1016/j.celrep.2014.05.026; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Simon JM, 2014, GENOME RES, V24, P241, DOI 10.1101/gr.158253.113; Singh RK, 2012, TRENDS MOL MED, V18, P472, DOI 10.1016/j.molmed.2012.06.006; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Vivas-Mejia PE, 2011, CLIN CANCER RES, V17, P3716, DOI 10.1158/1078-0432.CCR-11-0233; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Xie P, 2008, CELL SIGNAL, V20, P1671, DOI 10.1016/j.cellsig.2008.05.012	42	47	49	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 24	2016	35	12					1565	1574		10.1038/onc.2015.221	http://dx.doi.org/10.1038/onc.2015.221			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DH8RJ	26073078	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000373063600009
J	Huang, JW; Cardamone, MD; Johnson, HE; Neault, M; Chan, M; Floyd, ZE; Mallette, FA; Perissi, V				Huang, Jiawen; Cardamone, M. Dafne; Johnson, Holly E.; Neault, Mathieu; Chan, Michelle; Floyd, Z. Elizabeth; Mallette, Frederick A.; Perissi, Valentina			Exchange Factor TBL1 and Arginine Methyltransferase PRMT6 Cooperate in Protecting G Protein Pathway Suppressor 2 (GPS2) from Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY RESPONSE GENES; TRANSCRIPTIONAL REPRESSION; BETA-CATENIN; TUMOR-SUPPRESSOR; STRUCTURAL BASIS; SUBUNIT GPS2; PPAR-GAMMA; METHYLATION; SUMOYLATION; RECRUITMENT	G protein pathway suppressor 2 (GPS2) is a multifunctional protein involved in the regulation of a number of metabolic organs. First identified as part of the NCoR/SMRT corepressor complex, GPS2 is known to play an important role in the nucleus in the regulation of gene transcription and meiotic recombination. In addition, we recently reported a non-transcriptional role of GPS2 as an inhibitor of the proinflammatory TNF alpha pathway in the cytosol. Although this suggests that the control of GPS2 localization may be an important determinant of its molecular functions, a clear understanding of GPS2 differential targeting to specific cellular locations is still lacking. Here we show that a fine balance between protein stabilization and degradation tightly regulates GPS2 nuclear function. Our findings indicate that GPS2 is degraded upon polyubiquitination by the E3 ubiquitin ligase Siah2. Unexpectedly, interaction with the exchange factor TBL1 is required to protect GPS2 from degradation, with methylation of GPS2 by arginine methyltransferase PRMT6 regulating the interaction with TBL1 and inhibiting proteasome-dependent degradation. Overall, our findings indicate that regulation of GPS2 by posttranslational modifications provides an effective strategy for modulating its molecular function within the nuclear compartment.	[Huang, Jiawen; Cardamone, M. Dafne; Johnson, Holly E.; Chan, Michelle; Perissi, Valentina] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Neault, Mathieu; Mallette, Frederick A.] Hop Maison Neuve Rosemont, Ctr Rech, Chromatin Struct & Cellular Senescence Res Unit, Montreal, PQ H1T 2M4, Canada; [Floyd, Z. Elizabeth] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Mallette, Frederick A.] Univ Montreal, Dept Med, Montreal, PQ H1T 2M4, Canada	Boston University; Universite de Montreal; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Universite de Montreal	Perissi, V (corresponding author), Boston Univ, Sch Med, Dept Biochem, Silvio Conte Bldg, Boston, MA 02118 USA.	vperissi@bu.edu	Regan, Clinton/E-6250-2012; Mallette, Frédérick A./J-6646-2019; Floyd, Elizabeth/W-2758-2019; Floyd, Elizabeth/N-1962-2017	Mallette, Frédérick A./0000-0001-7932-0338; Floyd, Elizabeth/0000-0002-3002-6186; Floyd, Elizabeth/0000-0002-3002-6186; Perissi, Valentina/0000-0002-3716-0003; Cardamone, Maria/0000-0003-4591-3447; Neault, Mathieu/0000-0002-0479-1001	National Institutes of Health [DK078756, DK100422]; Canadian Institutes of Health Research Operating Grant [MOP-133442]; Fonds de Recherche du Quebec-Sante; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK078756, R01DK099625, R01DK100422, K99DK078756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research Operating Grant(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK078756 and DK100422 (to V. P.). This work was also supported by Canadian Institutes of Health Research Operating Grant MOP-133442 (to F. A. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Holder of a Ph.D. studentship from the Fonds de Recherche du Quebec-Sante.	Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bi HL, 2014, MOL BIOL CELL, V25, P2499, DOI 10.1091/mbc.E13-12-0733; Breiding DE, 1997, MOL CELL BIOL, V17, P7208, DOI 10.1128/MCB.17.12.7208; Cardamone MD, 2014, CELL REP, V8, P163, DOI 10.1016/j.celrep.2014.05.041; Cardamone MD, 2012, MOL CELL, V46, P91, DOI 10.1016/j.molcel.2012.01.025; Cheng DH, 2012, METHOD ENZYMOL, V512, P71, DOI 10.1016/B978-0-12-391940-3.00004-4; Choi HK, 2013, J CELL PHYSIOL, V228, P1159, DOI 10.1002/jcp.24269; Choi HK, 2011, MOL CELL, V43, P203, DOI 10.1016/j.molcel.2011.05.027; Chun ACS, 2000, AIDS RES HUM RETROV, V16, P1689, DOI 10.1089/08892220050193155; Di Lorenzo A, 2014, NUCLEIC ACIDS RES, V42, P8297, DOI 10.1093/nar/gku530; Dimitrova YN, 2010, J BIOL CHEM, V285, P13507, DOI 10.1074/jbc.M109.049411; Dong XZ, 1999, GENE DEV, V13, P954, DOI 10.1101/gad.13.8.954; Frankel A, 2002, J BIOL CHEM, V277, P3537, DOI 10.1074/jbc.M108786200; Frew IJ, 2003, MOL CELL BIOL, V23, P9150, DOI 10.1128/MCB.23.24.9150-9161.2003; Guo AL, 2014, MOL CELL PROTEOMICS, V13, P372, DOI 10.1074/mcp.O113.027870; Guo C, 2015, J BIOL CHEM, V290, P3666, DOI 10.1074/jbc.M114.598797; Harrison MJ, 2010, NUCLEIC ACIDS RES, V38, P2201, DOI 10.1093/nar/gkp1203; Huang WD, 2011, NATURE, V470, P414, DOI 10.1038/nature09703; Huang W, 2009, MOL CELL, V35, P48, DOI 10.1016/j.molcel.2009.05.023; Jakobsson T, 2009, MOL CELL, V34, P510, DOI 10.1016/j.molcel.2009.05.006; Jarmalavicius S, 2010, FASEB J, V24, P937, DOI 10.1096/fj.09-136283; Jin DY, 1997, J BIOL CHEM, V272, P25816, DOI 10.1074/jbc.272.41.25816; Kleinschmidt MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041446; Lee TH, 2006, DNA REPAIR, V5, P32, DOI 10.1016/j.dnarep.2005.07.004; Lee YH, 2009, MOL ENDOCRINOL, V23, P425, DOI 10.1210/me.2008-0380; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Migliori V, 2012, EPIGENETICS-US, V7, P815, DOI 10.4161/epi.21140; Neault M, 2012, NUCLEIC ACIDS RES, V40, P9513, DOI 10.1093/nar/gks764; Oberoi J, 2011, NAT STRUCT MOL BIOL, V18, P177, DOI 10.1038/nsmb.1983; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Peng YC, 2000, J VIROL, V74, P5872, DOI 10.1128/JVI.74.13.5872-5879.2000; Peng YC, 2001, MOL CELL BIOL, V21, P5913, DOI 10.1128/MCB.21.17.5913-5924.2001; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Perissi V, 2008, MOL CELL, V29, P755, DOI 10.1016/j.molcel.2008.01.020; Ramadoss S, 2011, MOL CELL BIOL, V31, P924, DOI 10.1128/MCB.00576-10; Rohm M, 2013, CELL METAB, V17, P575, DOI 10.1016/j.cmet.2013.02.010; Sambrook J., 2001, MOL CLONING LAB MANU; Sanyal S, 2007, P NATL ACAD SCI USA, V104, P15665, DOI 10.1073/pnas.0706736104; Spain BH, 1996, MOL CELL BIOL, V16, P6698; Stein C, 2012, NUCLEIC ACIDS RES, V40, P9522, DOI 10.1093/nar/gks767; Toubal A, 2013, J CLIN INVEST, V123, P362, DOI 10.1172/JCI64052; Uhlmann T, 2012, MOL CELL PROTEOMICS, V11, P1489, DOI 10.1074/mcp.M112.020743; Venteclef N, 2010, GENE DEV, V24, P381, DOI 10.1101/gad.545110; Zhang DF, 2008, GENOMICS, V92, P107, DOI 10.1016/j.ygeno.2008.04.008; Zhang DH, 2008, J BIOL CHEM, V283, P8580, DOI 10.1074/jbc.M708209200; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zhang JS, 1998, GENE DEV, V12, P1775, DOI 10.1101/gad.12.12.1775; Zhang XH, 2005, GENE DEV, V19, P827, DOI 10.1101/gad.1286005; Zhao HL, 2010, BIOCHEM BIOPH RES CO, V399, P623, DOI 10.1016/j.bbrc.2010.07.127	49	11	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19044	19054		10.1074/jbc.M115.637660	http://dx.doi.org/10.1074/jbc.M115.637660			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26070566	Green Published, hybrid			2022-12-26	WOS:000358781100022
J	Zeng, JW; Mi, RJ; Wang, YC; Li, YJ; Lin, L; Yao, B; Song, LN; van Die, I; Chapman, AB; Cummings, RD; Jin, P; Ju, TZ				Zeng, Junwei; Mi, Rongjuan; Wang, Yingchun; Li, Yujing; Lin, Li; Yao, Bing; Song, Lina; van Die, Irma; Chapman, Arlene B.; Cummings, Richard D.; Jin, Peng; Ju, Tongzhong			Promoters of Human Cosmc and T-synthase Genes Are Similar in Structure, Yet Different in Epigenetic Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-O-GLYCOSYLATION; MOLECULAR CHAPERONE COSMC; IGA NEPHROPATHY; TRANSCRIPTION FACTORS; FUNCTIONAL-ANALYSIS; EPITHELIAL-CELLS; BINDING-SITES; P-SELECTIN; I GENE; SP1	The T/synthase (core 1 beta 3-galactosyltransferase) and its molecular chaperone Cosmc regulate the biosynthesis of mucin type O-glycans on glycoproteins, and evidence suggests that both T-synthase and Cosmc are transcriptionally suppressed in several human diseases, although the transcriptional regulation of these two genes is not understood. Here, we characterized the promoters essential for human Cosmc and T-synthase transcription. The upstream regions of the genes lack a conventional TATA box but contain CpG islands, cCpG-I and cCpG-II for Cosmc and tCpG for T-synthase. Using luciferase reporter assays, site-directed mutagenesis, ChIP assays, and mithramycin A treatment, we identified the core promoters within cCpG-II and tCpG, which contain two binding sites for Kruppel-like transcription factors, including SP1/SP3, respectively. Methylome analysis of Tn4 B cells, which harbor a silenced Cosmc, confirmed the hypermethylation of the Cosmc core promoter but not for T-synthase. These results demonstrate that Cosmc and T-synthase are transcriptionally regulated at a basal level by the specificity protein/Krupple-like transcription factor family of members, which explains their ubiquitous and coordinated expression, and also indicate that they are differentially epigenetically regulated beyond X chromosome imprinting. These results are important in understanding the regulation of these genes that have roles in human diseases, such as IgA nephropathy and cancer.	[Zeng, Junwei; Mi, Rongjuan; Wang, Yingchun; Song, Lina; Cummings, Richard D.; Ju, Tongzhong] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Li, Yujing; Lin, Li; Yao, Bing; Jin, Peng] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Chapman, Arlene B.] Emory Univ, Sch Med, Dept Med, Atlanta, GA 30322 USA; [van Die, Irma] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands	Emory University; Emory University; Emory University; Vrije Universiteit Amsterdam	Ju, TZ (corresponding author), Emory Univ, Sch Med, 1510 Clifton Rd NE,Rm 4029, Atlanta, GA 30322 USA.	tju@emory.edu	Regan, Clinton/E-6250-2012; Li, Yujing/AAJ-1411-2020; Li, yujing/GQA-4109-2022	Li, Yujing/0000-0002-4363-2484; Yao, Bing/0000-0002-3205-8130; Ju, Tongzhong/0000-0002-4429-1976	National Institutes of Health [RO1DK80876]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1DK80876 (to T. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Berger EG, 1999, BBA-MOL BASIS DIS, V1455, P255, DOI 10.1016/S0925-4439(99)00069-1; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; Chen L, 1998, ONCOGENE, V17, P2087, DOI 10.1038/sj.onc.1202124; Crew VK, 2008, BRIT J HAEMATOL, V142, P657, DOI 10.1111/j.1365-2141.2008.07215.x; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Ellies LG, 1998, IMMUNITY, V9, P881, DOI 10.1016/S1074-7613(00)80653-6; Falkenberg VR, 2007, GLYCOCONJUGATE J, V24, P511, DOI 10.1007/s10719-007-9043-2; Falkenberg VR, 2003, GLYCOBIOLOGY, V13, P411, DOI 10.1093/glycob/cwg039; Fu JX, 2008, J CLIN INVEST, V118, P3725, DOI 10.1172/JCI36077; Gharavi AG, 2008, J AM SOC NEPHROL, V19, P1008, DOI 10.1681/ASN.2007091052; Giannakakis K, 2007, J AM SOC NEPHROL, V18, P3139, DOI 10.1681/ASN.2007030259; GILL G, 1994, P NATL ACAD SCI USA, V91, P192, DOI 10.1073/pnas.91.1.192; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; Herzog BH, 2013, NATURE, V502, P105, DOI 10.1038/nature12501; Higai K, 2006, BIOL PHARM BULL, V29, P2372, DOI 10.1248/bpb.29.2372; Hiki Y, 2009, CLIN EXP NEPHROL, V13, P415, DOI 10.1007/s10157-009-0173-7; HOEY T, 1993, CELL, V72, P247, DOI 10.1016/0092-8674(93)90664-C; Homeister JW, 2001, IMMUNITY, V15, P115, DOI 10.1016/S1074-7613(01)00166-2; Inoue T, 2011, ADV OTO-RHINO-LARYNG, V72, P71, DOI 10.1159/000324610; Inoue T, 2010, CLIN IMMUNOL, V136, P447, DOI 10.1016/j.clim.2010.05.009; ITZKOWITZ S, 1992, APMIS, V100, P173; Izumi H, 2003, BIOCHEM J, V373, P713, DOI 10.1042/BJ20021902; Ju T., 2014, HDB GLYCOSYLTRANSFER, V1, P149; Ju TZ, 2008, J CELL BIOL, V182, P531, DOI 10.1083/jcb.200711151; Ju TZ, 2008, CANCER RES, V68, P1636, DOI 10.1158/0008-5472.CAN-07-2345; Ju TZ, 2011, ANGEW CHEM INT EDIT, V50, P1770, DOI 10.1002/anie.201002313; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; Jung EM, 2011, BIOCHEM BIOPH RES CO, V404, P463, DOI 10.1016/j.bbrc.2010.12.003; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; Kiryluk Krzysztof, 2010, Pediatr Nephrol, V25, P2257, DOI 10.1007/s00467-010-1500-7; Kudo T, 2013, BLOOD, V122, P1649, DOI 10.1182/blood-2012-12-471102; Kwon HY, 2010, EXP MOL MED, V42, P849, DOI 10.3858/emm.2010.42.12.088; Lehoux S, 2014, MOL CELL PROTEOMICS, V13, P3097, DOI 10.1074/mcp.M114.039693; Lehoux S, 2010, GLYCOCONJUGATE J, V27, P99, DOI 10.1007/s10719-009-9260-y; Leppanen A, 1999, J BIOL CHEM, V274, P24838, DOI 10.1074/jbc.274.35.24838; LEVY M, 1988, AM J KIDNEY DIS, V12, P340, DOI 10.1016/S0272-6386(88)80021-0; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Liang YJ, 2010, P NATL ACAD SCI USA, V107, P22564, DOI 10.1073/pnas.1007290108; Liu WL, 2008, MOL CELL, V29, P81, DOI 10.1016/j.molcel.2007.11.003; Lombo F, 2006, APPL MICROBIOL BIOT, V73, P1, DOI 10.1007/s00253-006-0511-6; MCEVER RP, 1995, J BIOL CHEM, V270, P11025, DOI 10.1074/jbc.270.19.11025; Mestecky J, 2008, KIDNEY BLOOD PRESS R, V31, P29, DOI 10.1159/000112922; Mi RJ, 2012, J BIOL CHEM, V287, P41523, DOI 10.1074/jbc.M112.371989; Muller B, 2009, J BIOL CHEM, V284, P30775, DOI 10.1074/jbc.M109.016592; Novak J, 2008, SEMIN NEPHROL, V28, P78, DOI 10.1016/j.semnephrol.2007.10.009; Qin W, 2005, J INTERN MED, V258, P467, DOI 10.1111/j.1365-2796.2005.01558.x; Qin W, 2008, NEPHROL DIAL TRANSPL, V23, P1608, DOI 10.1093/ndt/gfm781; Radhakrishnan P, 2014, P NATL ACAD SCI USA, V111, pE4066, DOI 10.1073/pnas.1406619111; Safe S, 2004, PROG NUCLEIC ACID RE, V77, P1, DOI 10.1016/S0079-6603(04)77001-4; Sato T, 2007, J BIOL CHEM, V282, P27702, DOI 10.1074/jbc.M611862200; Schietinger A, 2006, SCIENCE, V314, P304, DOI 10.1126/science.1129200; SCHMITT FC, 1995, VIRCHOWS ARCH, V427, P251; Sengupta PK, 2010, J BIOL CHEM, V285, P31164, DOI 10.1074/jbc.M110.149195; Shenker N, 2012, BRIT J CANCER, V106, P248, DOI 10.1038/bjc.2011.550; Solomon SS, 2008, LIFE SCI, V83, P305, DOI 10.1016/j.lfs.2008.06.024; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; Suzuki H, 2008, J CLIN INVEST, V118, P629, DOI 10.1172/JCI33189; Suzuki Yusuke, 2008, Nihon Jinzo Gakkai Shi, V50, P456; SVENSSON EC, 1990, J BIOL CHEM, V265, P20863; Takashima S, 2000, J BIOCHEM-TOKYO, V127, P399, DOI 10.1093/oxfordjournals.jbchem.a022621; Tenno M, 2007, MOL CELL BIOL, V27, P8783, DOI 10.1128/MCB.01204-07; Terasawa K, 1996, CANCER RES, V56, P2229; VANDYKE MW, 1983, BIOCHEMISTRY-US, V22, P2373, DOI 10.1021/bi00279a011; Wang YC, 2012, P NATL ACAD SCI USA, V109, P16143, DOI 10.1073/pnas.1208253109; Wang YC, 2010, P NATL ACAD SCI USA, V107, P9228, DOI 10.1073/pnas.0914004107; Wilkins PP, 1996, J BIOL CHEM, V271, P18732, DOI 10.1074/jbc.271.31.18732; Xia LJ, 2004, J CELL BIOL, V164, P451, DOI 10.1083/jcb.200311112; Xie LS, 2010, CLIN INVEST MED, V33, pE5; Xu QS, 2011, J BIOL CHEM, V286, P4310, DOI 10.1074/jbc.M110.182576; Yamada K, 2010, NEPHROL DIAL TRANSPL, V25, P3890, DOI 10.1093/ndt/gfq325; Yao B, 2014, HUM MOL GENET, V23, P1095, DOI 10.1093/hmg/ddt504; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4; Yu HH, 2011, CLIN REV ALLERG IMMU, V41, P198, DOI 10.1007/s12016-010-8232-0	78	16	18	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19018	19033		10.1074/jbc.M115.654244	http://dx.doi.org/10.1074/jbc.M115.654244			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26063800	Green Published, hybrid			2022-12-26	WOS:000358781100020
J	Hoe, E; Boelsen, LK; Toh, ZQ; Sun, GW; Koo, GC; Balloch, A; Marimla, R; Dunne, EM; Tikoduadua, L; Russell, FM; Satzke, C; Mulholland, EK; Licciardi, PV				Hoe, Edwin; Boelsen, Laura K.; Toh, Zheng Quan; Sun, Guang Wen; Koo, Ghee Chong; Balloch, Anne; Marimla, Rachel; Dunne, Eileen M.; Tikoduadua, Lisi; Russell, Fiona M.; Satzke, Catherine; Mulholland, E. Kim; Licciardi, Paul V.			Reduced IL-17A Secretion Is Associated with High Levels of Pneumococcal Nasopharyngeal Carriage in Fijian Children	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; TH17; CELLS; COLONIZATION; SEVERITY; ADULTS	Streptococcus pneumonia (the pneumococcus) is the leading vaccine preventable cause of serious infections in infants under 5 years of age. The major correlate of protection for pneumococcal infections is serotype-specific IgG antibody. More recently, antibody-independent mechanisms of protection have also been identified. Preclinical studies have found that IL-17 secreting CD4+ Th17 cells in reducing pneumococcal colonisation. This study assessed IL-17A levels in children from Fiji with high and low pneumococcal carriage density, as measured by quantitative real-time PCR (qPCR). We studied Th17 responses in 54 children who were designated as high density carriers (N=27, > 8.21x10(5) CFU/ml) or low density carriers (N=27, < 1.67x10(5) CFU/ml). Blood samples were collected, and isolated peripheral blood mononuclear cells (PBMCs) were stimulated for 6 days. Supernatants were harvested for cytokine analysis by multiplex bead array and/or ELISA. Th17 cytokines assayed included IL-17A, IL-21, IL-22 as well as TNF-alpha, IL-10, TGF-beta, IL-6, IL-23 and IFN gamma. Cytokine levels were significantly lower in children with high density pneumococcal carriage compared with children with low density carriage for IL-17A (p=0.002) and IL-23 (p=0.04). There was a trend towards significance for IL-22 (p=0.057) while no difference was observed for the other cytokines. These data provide further support for the role of Th17-mediated protection in humans and suggest that these cytokines may be important in the defence against pneumococcal carriage.	[Hoe, Edwin; Boelsen, Laura K.; Toh, Zheng Quan; Balloch, Anne; Marimla, Rachel; Dunne, Eileen M.; Russell, Fiona M.; Satzke, Catherine; Mulholland, E. Kim; Licciardi, Paul V.] Murdoch Childrens Res Inst, Pneumococcal Res, Melbourne, Vic, Australia; [Boelsen, Laura K.; Satzke, Catherine; Licciardi, Paul V.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Sun, Guang Wen; Koo, Ghee Chong] Republ Polytech, Sch Appl Sci, Singapore, Singapore; [Tikoduadua, Lisi] Minist Hlth, Suva, Fiji; [Russell, Fiona M.] Univ Melbourne, Dept Paediat, Ctr Int Child Hlth, Melbourne, Vic, Australia; [Satzke, Catherine] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Mulholland, E. Kim] London Sch Hyg & Trop Med, London WC1, England	Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; University of Melbourne; University of London; London School of Hygiene & Tropical Medicine	Licciardi, PV (corresponding author), Murdoch Childrens Res Inst, Pneumococcal Res, Melbourne, Vic, Australia.	paul.licciardi@mcri.edu.au	Satzke, Catherine/D-6501-2013; Boelsen, Laura Kate/ABA-7442-2021; Dunne, Eileen M/M-3203-2019	Satzke, Catherine/0000-0003-3164-8849; Boelsen, Laura Kate/0000-0002-2480-0753; Dunne, Eileen M/0000-0001-5542-0780; Koo, Ghee Chong/0000-0001-6569-0098	National Institute of Allergy Infectious Diseases [1R01AI085198-01A1]; Victorian Government; National Health and Medical Research Council (NHMRC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085198] Funding Source: NIH RePORTER	National Institute of Allergy Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Victorian Government; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was funded by National Institute of Allergy Infectious Diseases (Grant number: 1R01AI085198-01A1). This study was supported in part by the Victorian Government's Operational Infrastructure Support Program. Paul V. Licciardi is the recipient of a National Health and Medical Research Council (NHMRC) Early Career Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrich WC, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005953; Alizadeh D, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/957878; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Basset A, 2007, INFECT IMMUN, V75, P5460, DOI 10.1128/IAI.00773-07; Bermejo DA, 2013, NAT IMMUNOL, V14, P514, DOI 10.1038/ni.2569; Bosch AATM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003057; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Chen Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018139; Crome SQ, 2010, J IMMUNOL, V185, P3199, DOI 10.4049/jimmunol.1000557; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Dunne EM, 2012, J CLIN MICROBIOL, V50, P1034, DOI 10.1128/JCM.06589-11; Eyerich S, 2010, TRENDS IMMUNOL, V31, P354, DOI 10.1016/j.it.2010.06.004; Henriques-Normark B, 2013, COLD SPRING HARBOR P, V3; Hoe E, 2015, J IMMUNE RES, V2, P1015; Hsieh YC, 2014, PEDIAT INFECT DIS J; Huong TTV, 2011, PEDIATR INFECT DIS J, V30, P11, DOI 10.1097/INF.0b013e3181f111a2; Jin W, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.58; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Lundgren A, 2012, VACCINE, V30, P3897, DOI 10.1016/j.vaccine.2012.03.082; Malley R, 2010, J MOL MED, V88, P135, DOI 10.1007/s00109-009-0579-4; Moffitt KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043445; Moffitt KL, 2011, CELL HOST MICROBE, V9, P158, DOI 10.1016/j.chom.2011.01.007; Mulholland K, 2012, LANCET, V379, P1387, DOI 10.1016/S0140-6736(12)60588-1; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Pido-Lopez J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002396; Rello J, 2009, CHEST, V136, P832, DOI 10.1378/chest.09-0258; Russell FM, 2009, VACCINE, V27, P5685, DOI 10.1016/j.vaccine.2009.06.098; Satzke C, 2013, VACCINE, V32, P165, DOI 10.1016/j.vaccine.2013.08.062; Shak JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098829; Stritesky GL, 2008, J IMMUNOL, V181, P5948, DOI 10.4049/jimmunol.181.9.5948; van der Linden M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060848; Werno AM, 2012, J MED MICROBIOL, V61, P1129, DOI 10.1099/jmm.0.044107-0; Zhang QB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002175; Zhang Z, 2009, J CLIN INVEST, V119, P1899, DOI 10.1172/JCI36731; Zheng SG, 2013, AM J CLIN EXP IMMUNO, V2, P94	38	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129199	10.1371/journal.pone.0129199	http://dx.doi.org/10.1371/journal.pone.0129199			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26069966	Green Published, gold, Green Accepted			2022-12-26	WOS:000356327000054
J	Kumar, J; Namsechi, R; Sim, VL				Kumar, Jitendra; Namsechi, Risa; Sim, Valerie L.			Structure-Based Peptide Design to Modulate Amyloid Beta Aggregation and Reduce Cytotoxicity	PLOS ONE			English	Article							SOLID-STATE NMR; ALZHEIMERS-DISEASE; FIBRIL FORMATION; CASCADE HYPOTHESIS; PROTEIN; OLIGOMERS; REAPPRAISAL; INHIBITORS; FRAGMENT; NEURONS	The deposition of A beta peptide in the brain is the key event in Alzheimer disease progression. Therefore, the prevention of A beta self assembly into disease-associated oligomers is a logical strategy for treatment. p stacking is known to provide structural stability to many amyloids; two phenylalanine residues within the A beta 14-23 self recognition element are in such an arrangement in many solved structures. Therefore, we targeted this structural stacking by substituting these two phenylalanine residues with their D-enantiomers. The resulting peptides were able to modulate A beta aggregation in vitro and reduce A beta cytotoxicity in primary neuronal cultures. Using kinetic analysis of fibril formation, electron microscopy and dynamic light scattering characterization of oligomer size distributions, we demonstrate that, in addition to altering fibril structural characteristics, these peptides can induce the formation of larger amorphous aggregates which are protective against toxic oligomers, possibly because they are able to sequester the toxic oligomers during co-incubation. Alternatively, they may alter the surface structure of the oligomers such that they can no longer interact with cells to induce toxic pathways.	[Kumar, Jitendra; Namsechi, Risa; Sim, Valerie L.] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada; [Kumar, Jitendra; Namsechi, Risa; Sim, Valerie L.] Univ Alberta, Dept Med Neurol, Edmonton, AB, Canada; [Sim, Valerie L.] Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Sim, VL (corresponding author), Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada.	valerie.sim@ualberta.ca	Sim, Valerie/C-4137-2013	Sim, Valerie/0000-0002-0088-8666	University of Alberta Faculty of Medicine Dentistry	University of Alberta Faculty of Medicine Dentistry	RN received funding from the University of Alberta Faculty of Medicine & Dentistry as a summer studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Amritraj A, 2013, J BIOL CHEM, V288, P3136, DOI 10.1074/jbc.M112.412460; Amritraj A, 2009, AM J PATHOL, V175, P2540, DOI 10.2353/ajpath.2009.081096; Balbach JJ, 2000, BIOCHEMISTRY-US, V39, P13748, DOI 10.1021/bi0011330; Balbach JJ, 2002, BIOPHYS J, V83, P1205, DOI 10.1016/S0006-3495(02)75244-2; Bernstein SL, 2005, J AM CHEM SOC, V127, P2075, DOI 10.1021/ja044531p; Bu ZM, 2007, BIOPHYS J, V92, P594, DOI 10.1529/biophysj.106.091017; Capone R, 2012, BIOCHEMISTRY-US, V51, P776, DOI 10.1021/bi2017427; Chalifour RJ, 2003, J BIOL CHEM, V278, P34874, DOI 10.1074/jbc.M212694200; Chen YR, 2011, BIOCHEM BIOPH RES CO, V405, P91, DOI 10.1016/j.bbrc.2010.12.133; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Cruz M, 2004, J PEPT RES, V63, P324, DOI 10.1111/j.1399-3011.2004.00156.x; Fawzi NL, 2011, NATURE, V480, P268, DOI 10.1038/nature10577; Frydman-Marom A, 2009, ANGEW CHEM INT EDIT, V48, P1981, DOI 10.1002/anie.200802123; Goure WF, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt272; Gupta S, 2012, NAT STRUCT MOL BIOL, V19, P72, DOI 10.1038/nsmb.2175; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2014, J INTERN MED, V275, P296, DOI 10.1111/joim.12192; Hardy J, 2002, NEUROBIOL AGING, V23, P1073, DOI 10.1016/S0197-4580(02)00042-8; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hardy J, 2006, J ALZHEIMERS DIS, V9, P151; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; HILBICH C, 1991, J MOL BIOL, V218, P149, DOI 10.1016/0022-2836(91)90881-6; Inouye H, 2010, PROTEINS, V78, P2306, DOI 10.1002/prot.22743; Lindberg DJ, 2015, BIOCHEM BIOPH RES CO, V458, P418, DOI 10.1016/j.bbrc.2015.01.132; Liu HM, 2010, REJUV RES, V13, P210, DOI 10.1089/rej.2009.0926; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Makarava N, 2006, PROTEIN SCI, V15, P1334, DOI 10.1110/ps.052013106; Makin OS, 2005, P NATL ACAD SCI USA, V102, P315, DOI 10.1073/pnas.0406847102; Nadai M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052994; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Paivio A, 2004, PROTEIN SCI, V13, P1251, DOI 10.1110/ps.03442404; Paravastu AK, 2009, P NATL ACAD SCI USA, V106, P7443, DOI 10.1073/pnas.0812033106; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; Reches M, 2006, NAT NANOTECHNOL, V1, P195, DOI 10.1038/nnano.2006.139; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Serpell LC, 2000, BBA-MOL BASIS DIS, V1502, P16, DOI 10.1016/S0925-4439(00)00029-6; Sievers SA, 2011, NATURE, V475, P96, DOI 10.1038/nature10154; Sikorski P, 2003, STRUCTURE, V11, P915, DOI 10.1016/S0969-2126(03)00149-7; Soto C, 1996, BIOCHEM BIOPH RES CO, V226, P672, DOI 10.1006/bbrc.1996.1413; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Tartaglia GG, 2004, PROTEIN SCI, V13, P1939, DOI 10.1110/ps.04663504; Teplow DB, 2006, METHOD ENZYMOL, V413, P20, DOI 10.1016/S0076-6879(06)13002-5; Tjernberg LO, 1999, J BIOL CHEM, V274, P12619, DOI 10.1074/jbc.274.18.12619; Tomita T, 2009, EXPERT REV NEUROTHER, V9, P661, DOI [10.1586/ern.09.24, 10.1586/ERN.09.24]; Zheng WH, 2002, NEUROSCIENCE, V115, P201, DOI 10.1016/S0306-4522(02)00404-9	50	30	30	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129087	10.1371/journal.pone.0129087	http://dx.doi.org/10.1371/journal.pone.0129087			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070139	Green Published, Green Submitted, gold			2022-12-26	WOS:000356327000043
J	Shuvy, M; Abedat, S; Mustafa, M; Duvdevan, N; Meir, K; Beeri, R; Lotan, C				Shuvy, Mony; Abedat, Suzan; Mustafa, Mahmoud; Duvdevan, Nitsan; Meir, Karen; Beeri, Ronen; Lotan, Chaim			Cellular Changes during Renal Failure-Induced Inflammatory Aortic Valve Disease	PLOS ONE			English	Article							VASCULAR CELLS; MATRIX; CALCIFICATION; STENOSIS; EXPRESSION; GROWTH; DIFFERENTIATION; PROGRESSION	Background Aortic valve calcification (AVC) secondary to renal failure (RF) is an inflammation-regulated process, but its pathogenesis remains unknown. We sought to assess the cellular processes that are involved in the early phases of aortic valve disease using a unique animal model of RF-associated AVC. Methods Aortic valves were obtained from rats that were fed a uremia-inducing diet exclusively for 2, 3, 4, 5, and 6 weeks as well as from controls. Pathological examination of the valves included histological characterization, von Kossa staining, and antigen expression analyses. Results After 2 weeks, we noted a significant increase in urea and creatinine levels, reflecting RF. RF parameters exacerbated until the Week 5 and plateaued. Whereas no histological changes or calcification was observed in the valves of any study group, macrophage accumulation became apparent as early as 2 weeks after the diet was started and rose after 3 weeks. By western blot, osteoblast markers were expressed after 2 weeks on the diet and decreased after 6 weeks. Collagen 3 was up-regulated after 3 weeks, plateauing at 4 weeks, whereas collagen 1 levels peaked at 2 and 4 weeks. Fibronectin levels increased gradually until Week 5 and decreased at 6 weeks. We observed early activation of the ERK pathway, whereas other pathways remained unchanged. Conclusions We concluded that RF induces dramatic changes at the cellular level, including macrophage accumulation, activation of cell signaling pathway and extracellular matrix modification. These changes precede valve calcification and may increase propensity for calcification, and have to be investigated further.	[Shuvy, Mony] Sunnybrook Hlth Sci Ctr, Schulich Heart Ctr, Toronto, ON M4N 3M5, Canada; [Shuvy, Mony; Abedat, Suzan; Mustafa, Mahmoud; Duvdevan, Nitsan; Beeri, Ronen; Lotan, Chaim] Hadassah Hebrew Univ Med Ctr, Cardiovasc Res Ctr, Jerusalem, Israel; [Meir, Karen] Hadassah Hebrew Univ Med Ctr, Dept Pathol, Jerusalem, Israel	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Shuvy, M (corresponding author), Sunnybrook Hlth Sci Ctr, Schulich Heart Ctr, Toronto, ON M4N 3M5, Canada.	monysh@gmail.com	Beeri, Ronen/A-4035-2009	Beeri, Ronen/0000-0002-8014-0702				Agmon Y, 2001, J AM COLL CARDIOL, V38, P827, DOI 10.1016/S0735-1097(01)01422-X; CAREY DJ, 1991, ANNU REV PHYSIOL, V53, P161, DOI 10.1146/annurev.physiol.53.1.161; Chan KL, 2010, CIRCULATION, V121, P306, DOI 10.1161/CIRCULATIONAHA.109.900027; Chen JH, 2011, CIRC RES, V108, P1510, DOI 10.1161/CIRCRESAHA.110.234237; Fondard O, 2005, EUR HEART J, V26, P1333, DOI 10.1093/eurheartj/ehi248; Helske S, 2006, ARTERIOSCL THROM VAS, V26, P1791, DOI 10.1161/01.ATV.0000228824.01604.63; Hjortnaes J, 2010, EUR HEART J, V31, P1975, DOI 10.1093/eurheartj/ehq237; Kume T, 2006, J AM SOC ECHOCARDIOG, V19, P914, DOI 10.1016/j.echo.2006.01.026; Latif N, 2005, J HEART VALVE DIS, V14, P218; LIAN JB, 1992, CRIT REV ORAL BIOL M, V3, P269, DOI 10.1177/10454411920030030501; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Mohler ER, 2001, CIRCULATION, V103, P1522, DOI 10.1161/01.cir.103.11.1522; NAVAB M, 1995, AM J CARDIOL, V76, pC18, DOI 10.1016/S0002-9149(99)80466-4; OTTO CM, 1994, CIRCULATION, V90, P844, DOI 10.1161/01.CIR.90.2.844; Rabkin E, 2001, CIRCULATION, V104, P2525, DOI 10.1161/hc4601.099489; Raines EW, 2000, ANN NY ACAD SCI, V902, P39; Rajamannan NM, 2006, CIRCULATION, V114, P2007, DOI 10.1161/CIRCULATIONAHA.106.657759; Rajamannan NM, 2009, ARTERIOSCL THROM VAS, V29, P162, DOI 10.1161/ATVBAHA.107.156752; Rajamannan NM, 2005, CIRCULATION, V111, P3296, DOI 10.1161/CIRCULATIONAHA.104.473165; Rajamannan NM, 2005, HEART, V91, P806, DOI 10.1136/hrt.2003.029785; Rajamannan NM, 2003, CIRCULATION, V107, P2181, DOI 10.1161/01.CIR.0000070591.21548.69; Rajamannan NM, 2002, CIRCULATION, V105, P2660, DOI 10.1161/01.CIR.0000017435.87463.72; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Satta J, 2003, ANN THORAC SURG, V76, P681, DOI 10.1016/S0003-4975(03)00529-0; Shuvy M, 2011, AM J PHYSIOL-HEART C, V300, pH1829, DOI 10.1152/ajpheart.00240.2010; Shuvy M, 2011, EXP TOXICOL PATHOL, V63, P303, DOI 10.1016/j.etp.2010.02.002; Shuvy M, 2008, CARDIOVASC RES, V79, P492, DOI 10.1093/cvr/cvn088; Watson KE, 1998, ARTERIOSCL THROM VAS, V18, P1964, DOI 10.1161/01.ATV.18.12.1964; Yang XP, 2009, J AM COLL CARDIOL, V53, P491, DOI 10.1016/j.jacc.2008.09.052	29	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129725	10.1371/journal.pone.0129725	http://dx.doi.org/10.1371/journal.pone.0129725			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070132	gold, Green Published, Green Submitted			2022-12-26	WOS:000356327000101
J	Stoffels, RJ				Stoffels, Rick J.			Physiological Trade-Offs Along a Fast-Slow Lifestyle Continuum in Fishes: What Do They Tell Us about Resistance and Resilience to Hypoxia?	PLOS ONE			English	Article							COMMUNITY ECOLOGY; CLIMATE-CHANGE; SWIMMING PERFORMANCE; FUNCTIONAL TRAITS; METABOLIC-RATE; FRESH-WATER; ENVIRONMENTAL HYPOXIA; TROPICAL BIRDS; BODY-MASS; DROUGHT	It has recently been suggested that general rules of change in ecological communities might be found through the development of functional relationships between species traits and performance. The physiological, behavioural and life-history traits of fishes are often organised along a fast-slow lifestyle continuum (FSLC). With respect to resistance (capacity for population to resist change) and resilience (capacity for population to recover from change) to environmental hypoxia, the literature suggests that traits enhancing resilience may come at the expense of traits promoting resistance to hypoxia; a trade-off may exist. Here I test whether three fishes occupying different positions along the FSLC trade-off resistance and resilience to environmental hypoxia. Static respirometry experiments were used to determine resistance, as measured by critical oxygen tension (P-crit), and capacity for (RC) and magnitude of metabolic reduction (RM). Swimming respirometry experiments were used to determine aspects of resilience: critical (U-crit) and optimal swimming speed (U-opt), and optimal cost of transport (COTopt). Results pertaining to metabolic reduction suggest a resistance gradient across species described by the inequality Melanotaenia fluviatilis (fast lifestyle) < Hypseleotris sp. (intermediate lifestyle) < Mogurnda adspersa (slow lifestyle). The U-crit and COTopt data suggest a resilience gradient described by the reverse inequality, and so the experiments generally indicate that three fishes occupying different positions on the FSLC trade-off resistance and resilience to hypoxia. However, the scope of inferences that can be drawn from an individual study is narrow, and so steps towards general, traitbased rules of fish community change along environmental gradients are discussed.	[Stoffels, Rick J.] CSIRO, Murray Darling Freshwater Res Ctr, Land & Water, Wodonga, Vic, Australia; [Stoffels, Rick J.] La Trobe Univ, Dept Ecol Environm & Evolut, Wodonga, Vic, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Murray Darling Basin Authority; La Trobe University	Stoffels, RJ (corresponding author), CSIRO, Murray Darling Freshwater Res Ctr, Land & Water, Wodonga, Vic, Australia.	rick.stoffels@csiro.au	Stoffels, Rick/H-3595-2011	Stoffels, Rick/0000-0003-4888-5875	New South Wales Office of Water; CSIRO Land and Water; Murray-Darling Freshwater Research Centre	New South Wales Office of Water; CSIRO Land and Water(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Murray-Darling Freshwater Research Centre	This work was funded by the New South Wales Office of Water, CSIRO Land and Water and the Murray-Darling Freshwater Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Ankins S, 2012, J FISH BIOL, V80, P195, DOI 10.1111/j.1095-8649.2011.03166.x; Allison G, 2004, ECOL MONOGR, V74, P117, DOI 10.1890/02-0681; Beamish F.W., 1979, FISH PHYSL LOCOMOTIO, P101, DOI DOI 10.1139/cjfas-2015-0209; BELL WH, 1970, FISH RES BD CAN TECH, V195, P1; Bertozzi T, 2000, MAR FRESHWATER RES, V51, P805, DOI 10.1071/MF00039; Bickler PE, 2007, ANNU REV PHYSIOL, V69, P145, DOI 10.1146/annurev.physiol.69.031905.162529; Bond NR, 2008, HYDROBIOLOGIA, V600, P3, DOI 10.1007/s10750-008-9326-z; Bonsall MB, 2004, SCIENCE, V306, P111, DOI 10.1126/science.1100680; BRAND MD, 1990, J THEOR BIOL, V145, P267, DOI 10.1016/S0022-5193(05)80131-6; BRETT JR, 1964, J FISH RES BOARD CAN, V21, P1183, DOI 10.1139/f64-103; Brill RW, 1996, COMP BIOCHEM PHYS A, V113, P3, DOI 10.1016/0300-9629(95)02064-0; Careau V, 2009, FUNCT ECOL, V23, P150, DOI 10.1111/j.1365-2435.2008.01468.x; Careau V, 2012, PHYSIOL BIOCHEM ZOOL, V85, P543, DOI 10.1086/666970; Chapman LJ, 2009, FISH PHYSIOL, V27, P25, DOI 10.1016/S1546-5098(08)00002-2; Chown SL, 2012, PHILOS T R SOC B, V367, P1615, DOI 10.1098/rstb.2011.0422; Claireaux G, 2006, J EXP BIOL, V209, P3420, DOI 10.1242/jeb.02346; Clark TD, 2013, J EXP BIOL, V216, P2771, DOI 10.1242/jeb.084251; Dodds WK, 2004, BIOSCIENCE, V54, P205, DOI 10.1641/0006-3568(2004)054[0205:LOTETE]2.0.CO;2; Downs CJ, 2008, FUNCT ECOL, V22, P239, DOI 10.1111/j.1365-2435.2007.01371.x; Dwyer GK, 2014, FRESHWATER BIOL, V59, P819, DOI 10.1111/fwb.12306; Fausch KD, 2002, BIOSCIENCE, V52, P483, DOI 10.1641/0006-3568(2002)052[0483:LTRBTG]2.0.CO;2; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Fu SJ, 2009, J EXP BIOL, V212, P2296, DOI 10.1242/jeb.027102; Fu SJ, 2009, J COMP PHYSIOL B, V179, P509, DOI 10.1007/s00360-008-0337-x; Garland T, 2005, J EXP BIOL, V208, P3015, DOI 10.1242/jeb.01745; GOOLISH EM, 1991, PHYSIOL ZOOL, V64, P485, DOI 10.1086/physzool.64.2.30158187; Guppy M, 1999, BIOL REV, V74, P1, DOI 10.1017/S0006323198005258; Helmuth B, 2009, J EXP BIOL, V212, P753, DOI 10.1242/jeb.023861; Herbert NA, 2005, MAR BIOL, V147, P1403, DOI 10.1007/s00227-005-0003-8; Herbert NA, 2006, MAR BIOL, V149, P1217, DOI 10.1007/s00227-006-0284-6; Herbert NA, 2006, PHYSIOL BIOCHEM ZOOL, V79, P909, DOI 10.1086/506000; Higham TE, 2005, J EXP BIOL, V208, P2653, DOI 10.1242/jeb.01682; Higham TE, 2006, J EXP BIOL, V209, P2713, DOI 10.1242/jeb.02315; HUEY RB, 1981, ECOLOGY, V62, P991, DOI 10.2307/1936998; Hughes L, 2003, AUSTRAL ECOL, V28, P423, DOI 10.1046/j.1442-9993.2003.01300.x; Humphries MM, 2014, J ANIM ECOL, V83, P7, DOI 10.1111/1365-2656.12124; Johnston IA, 1998, J EXP BIOL, V201, P1; Kearney M, 2010, PHILOS T R SOC B, V365, P3469, DOI 10.1098/rstb.2010.0034; Killen SS, 2010, ECOL LETT, V13, P184, DOI 10.1111/j.1461-0248.2009.01415.x; Kneitel JM, 2004, ECOL LETT, V7, P69, DOI 10.1046/j.1461-0248.2003.00551.x; Korsmeyer KE, 2002, J EXP BIOL, V205, P1253; Lake PS, 2003, FRESHWATER BIOL, V48, P1161, DOI 10.1046/j.1365-2427.2003.01086.x; Langerhans RB, 2008, INTEGR COMP BIOL, V48, P750, DOI 10.1093/icb/icn092; Lawton JH, 1999, OIKOS, V84, P177, DOI 10.2307/3546712; LINDSTROM MJ, 1990, BIOMETRICS, V46, P673, DOI 10.2307/2532087; Litchman E, 2007, ECOL LETT, V10, P1170, DOI 10.1111/j.1461-0248.2007.01117.x; Lowe TE, 2000, MAR BIOL, V136, P1087, DOI 10.1007/s002270000255; MACGILLIVRAY CW, 1995, FUNCT ECOL, V9, P640, DOI 10.2307/2390156; Mandic M, 2009, P ROY SOC B-BIOL SCI, V276, P735, DOI 10.1098/rspb.2008.1235; Matthews W. J., 1998, PATTERNS FRESHWATER; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Mol JH, 2000, ENVIRON BIOL FISH, V59, P429, DOI 10.1023/A:1026529200610; MOYES CD, 1992, CAN J ZOOL, V70, P1246, DOI 10.1139/z92-172; Nilsson GE, 2004, J EXP BIOL, V207, P3131, DOI 10.1242/jeb.00979; Nilsson GE, 2007, J EXP BIOL, V210, P2403, DOI 10.1242/jeb.000281; Ohlberger J, 2006, J COMP PHYSIOL B, V176, P17, DOI 10.1007/s00360-005-0024-0; Palzenberger M., 1992, Reviews in Fish Biology and Fisheries, V2, P187, DOI 10.1007/BF00045037; Perkins SE, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053361; PETERSON CG, 1992, ECOLOGY, V73, P1445, DOI 10.2307/1940689; Pettersson LB, 2000, P ROY SOC B-BIOL SCI, V267, P759, DOI 10.1098/rspb.2000.1068; Pusey B., 2004, FRESHWATER FISHES OF; Reale D, 2010, PHILOS T R SOC B, V365, P4051, DOI 10.1098/rstb.2010.0208; Ricklefs RE, 2002, TRENDS ECOL EVOL, V17, P462, DOI 10.1016/S0169-5347(02)02578-8; SCHOENER TW, 1986, AM ZOOL, V26, P81; Seneviratne SI, 2014, NAT CLIM CHANGE, V4, P161, DOI 10.1038/nclimate2145; Simberloff D, 2004, AM NAT, V163, P787, DOI 10.1086/420777; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Sousa PM, 2011, NAT HAZARD EARTH SYS, V11, P33, DOI 10.5194/nhess-11-33-2011; STEFFENSEN JF, 1989, FISH PHYSIOL BIOCHEM, V6, P49, DOI 10.1007/BF02995809; Steffensen JF, 2007, FISH PHYSIOLOGY TOXI, P239; Svendsen JC, 2012, CAN J ZOOL, V90, P1, DOI [10.1139/z11-095, 10.1139/Z11-095]; Tieleman BI, 2005, P ROY SOC B-BIOL SCI, V272, P1715, DOI 10.1098/rspb.2005.3155; VIDELER JJ, 1990, COMP BIOCHEM PHYS A, V97, P91, DOI 10.1016/0300-9629(90)90155-L; Wainwright PC, 2005, INTEGR COMP BIOL, V45, P256, DOI 10.1093/icb/45.2.256; WEBB PW, 1984, AM ZOOL, V24, P107; Wells RMG, 2005, COMP BIOCHEM PHYS A, V141, P87, DOI 10.1016/j.cbpb.2005.04.005; Wells RMG, 2009, FISH PHYSIOL, V27, P255, DOI 10.1016/S1546-5098(08)00006-X; West J, 2003, COMMENTARY, V115, P17; Whitworth KL, 2012, J HYDROL, V450, P190, DOI 10.1016/j.jhydrol.2012.04.057; Wiersma P, 2007, P NATL ACAD SCI USA, V104, P9340, DOI 10.1073/pnas.0702212104; Winemiller KO, 2005, CAN J FISH AQUAT SCI, V62, P872, DOI 10.1139/F05-040; Yan GJ, 2013, J EVOLUTION BIOL, V26, P1802, DOI 10.1111/jeb.12182; YEAGER DP, 1989, PHYSIOL ZOOL, V62, P888, DOI 10.1086/physzool.62.4.30157935	85	19	20	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130303	10.1371/journal.pone.0130303	http://dx.doi.org/10.1371/journal.pone.0130303			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070078	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000154
J	Sunyer, P; Boixadera, E; Munoz, A; Bonal, R; Espelta, JM				Sunyer, Pau; Boixadera, Ester; Munoz, Alberto; Bonal, Raul; Maria Espelta, Josep			The Interplay among Acorn Abundance and Rodent Behavior Drives the Spatial Pattern of Seedling Recruitment in Mature Mediterranean Oak Forests	PLOS ONE			English	Article							QUERCUS-ILEX RECRUITMENT; BOAR SUS-SCROFA; INTERSPECIFIC DIFFERENCES; CACHE PROTECTION; SMALL MAMMALS; DISPERSAL; PREDATION; SIZE; ESTABLISHMENT; HETEROGENEITY	The patterns of seedling recruitment in animal-dispersed plants result from the interactions among environmental and behavioral variables. However, we know little on the contribution and combined effect of both kinds of variables. We designed a field study to assess the interplay between environment (vegetation structure, seed abundance, rodent abundance) and behavior (seed dispersal and predation by rodents, and rooting by wild boars), and their contribution to the spatial patterns of seedling recruitment in a Mediterranean mixed-oak forest. In a spatially explicit design, we monitored intensively all environmental and behavioral variables in fixed points at a small spatial scale from autumn to spring, as well as seedling emergence and survival. Our results revealed that the spatial patterns of seedling emergence were strongly related to acorn availability on the ground, but not by a facilitationeffect of vegetation cover. Rodents changed seed shadows generated by mother trees by dispersing most seeds from shrubby to open areas, but the spatial patterns of acorn dispersal/predation had no direct effect on recruitment. By contrast, rodents had a strong impact on recruitment as pilferers of cached seeds. Rooting by wild boars also reduced recruitment by reducing seed abundance, but also by changing rodent's behavior towards higher consumption of acorns in situ. Hence, seed abundance and the foraging behavior of scatter-hoarding rodents and wild boars are driving the spatial patterns of seedling recruitment in this mature oak forest, rather than vegetation features. The contribution of vegetation to seedling recruitment (e.g. facilitation by shrubs) may be context dependent, having a little role in closed forests, or being overridden by directed seed dispersal from shrubby to open areas. We warn about the need of using broad approaches that consider the combined action of environment and behavior to improve our knowledge on the dynamics of natural regeneration in forests.	[Sunyer, Pau; Munoz, Alberto; Bonal, Raul; Maria Espelta, Josep] CREAF, Cerdanyola Del Valles, Catalonia, Spain; [Boixadera, Ester] Univ Autonoma Barcelona, Serv Estat Aplicada, Cerdanyola Del Valles, Catalonia, Spain; [Munoz, Alberto] Univ Complutense Madrid, Fac Educ, Dept Didact Ciencias Expt, Madrid, Spain; [Bonal, Raul] Univ Extremadura, Forest Res Grp GIF INDEHESA, Plasencia, Spain; [Bonal, Raul] Univ Castilla La Mancha, DITEG Res Grp, Toledo, Spain	Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Autonomous University of Barcelona; Complutense University of Madrid; Universidad de Extremadura; Universidad de Castilla-La Mancha	Sunyer, P (corresponding author), CREAF, Cerdanyola Del Valles, Catalonia, Spain.	p.sunyer@creaf.uab.cat	Muñoz, Alberto/H-5026-2015; Espelta, Josep M/I-3891-2016	Muñoz, Alberto/0000-0002-1152-7444; Espelta, Josep M/0000-0002-0242-4988; Boixadera Planas, Ester/0000-0002-3995-6750; BONAL, RAUL/0000-0002-6084-1771	project NOVFORESTS [CGL2012-33398]; Generalitat de Catalunya [SGR 913]; Juan de la Cierva contract; Programme Atraccion de Talento Investigador (Government of Extremadura)	project NOVFORESTS; Generalitat de Catalunya(Generalitat de Catalunya); Juan de la Cierva contract; Programme Atraccion de Talento Investigador (Government of Extremadura)	This research was funded by project NOVFORESTS (CGL2012-33398) and project SGR 913 of the Generalitat de Catalunya. AM was funded by a Juan de la Cierva contract. RB was funded by a contract of the Programme Atraccion de Talento Investigador (Government of Extremadura). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, SAS 9 3 SYST OPT REF; Arrieta S, 2005, FOREST ECOL MANAG, V205, P267, DOI 10.1016/j.foreco.2004.10.009; Beckage B, 2003, ECOLOGY, V84, P1849, DOI 10.1890/0012-9658(2003)084[1849:SSAGOT]2.0.CO;2; Bonal R, 2007, OECOLOGIA, V152, P533, DOI 10.1007/s00442-007-0672-8; BRAN D, 1990, VEGETATIO, V87, P45, DOI 10.1007/BF00045654; Cahill S, 2003, WILDLIFE BIOL, V9, P3, DOI 10.2981/wlb.2003.058; Calvino-Cancela M, 2002, J ECOL, V90, P775, DOI 10.1046/j.1365-2745.2002.00711.x; Clark JS, 1999, AM J BOT, V86, P1, DOI 10.2307/2656950; CRAWLEY MJ, 1995, J ECOL, V83, P683, DOI 10.2307/2261636; Dally JM, 2006, ANIM BEHAV, V72, P13, DOI 10.1016/j.anbehav.2005.08.020; ESPELTA JM, 1995, J VEG SCI, V6, P465, DOI 10.2307/3236344; Espelta JM, 2005, ECOSCIENCE, V12, P447, DOI 10.2980/i1195-6860-12-4-447.1; Espelta JM, 2009, J ECOL, V97, P1416, DOI 10.1111/j.1365-2745.2009.01564.x; Espelta JM, 2008, ECOLOGY, V89, P805, DOI 10.1890/07-0217.1; Focardi S, 2000, J ZOOL, V250, P329, DOI 10.1111/j.1469-7998.2000.tb00777.x; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Gomez JM, 2008, FOREST ECOL MANAG, V256, P1384, DOI 10.1016/j.foreco.2008.06.045; Gomez JM, 2008, OECOLOGIA, V155, P529, DOI 10.1007/s00442-007-0928-3; Gomez-Aparicio L, 2005, ECOGRAPHY, V28, P757, DOI 10.1111/j.2005.0906-7590.04337.x; Gomez-Aparicio L, 2008, J VEG SCI, V19, P161, DOI 10.3170/2008-8-18347; Gonzalez-Rodriguez V, 2011, ANN FOREST SCI, V68, P1217, DOI 10.1007/s13595-011-0069-z; Huang ZY, 2011, ANIM BEHAV, V81, P831, DOI 10.1016/j.anbehav.2011.01.018; HUGHES JJ, 1994, ECOLOGY, V75, P1397, DOI 10.2307/1937463; Jurena PN, 2003, ECOLOGY, V84, P907, DOI 10.1890/0012-9658(2003)084[0907:WPEASH]2.0.CO;2; Lookingbill TR, 2000, J VEG SCI, V11, P607, DOI 10.2307/3246590; Manson RH, 1998, OIKOS, V82, P37, DOI 10.2307/3546915; Espelta JM, 2009, OECOLOGIA, V161, P559, DOI 10.1007/s00442-009-1394-x; Munoz A, 2007, OIKOS, V116, P1631, DOI [10.1111/j.2007.0030-1299.15710.x, 10.1111/j.0030-1299.2007.15710.x]; Munoz A, 2014, FOREST ECOL MANAG, V322, P98, DOI 10.1016/j.foreco.2014.02.039; Munoz A, 2011, J ECOL, V99, P1016, DOI 10.1111/j.1365-2745.2011.01818.x; Munoz A, 2009, BASIC APPL ECOL, V10, P151, DOI 10.1016/j.baae.2008.01.003; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Peguero G, 2013, REV CHIL HIST NAT, V86, P161, DOI 10.4067/S0716-078X2013000200005; Perea R, 2014, FOREST ECOL MANAG, V312, P47, DOI 10.1016/j.foreco.2013.10.022; Perea R, 2012, EUR J FOREST RES, V131, P623, DOI 10.1007/s10342-011-0536-y; Perea R, 2011, ANIM BEHAV, V82, P717, DOI 10.1016/j.anbehav.2011.07.001; Perea R, 2011, J ECOL, V99, P194, DOI 10.1111/j.1365-2745.2010.01749.x; Perez-Ramos IM, 2008, OIKOS, V117, P1386, DOI 10.1111/j.0030-1299.2008.16370.x; Perez-Ramos IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077197; Perez-Ramos IM, 2013, PERSPECT PLANT ECOL, V15, P106, DOI 10.1016/j.ppees.2012.12.005; Puerta-Pinero C, 2010, OIKOS, V119, P179, DOI 10.1111/j.1600-0706.2009.17793.x; Pulido FJ, 2005, ECOSCIENCE, V12, P92, DOI 10.2980/i1195-6860-12-1-92.1; Retana J, 1999, ECOL STU AN, V137, P89; Rey PJ, 2000, J ECOL, V88, P622, DOI 10.1046/j.1365-2745.2000.00472.x; Smit C, 2008, J VEG SCI, V19, P193, DOI 10.3170/2007-8-18352; Smit C, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009028; Spiegel O, 2012, J ECOL, V100, P392, DOI 10.1111/j.1365-2745.2011.01886.x; Steele MA, 2014, BEHAV ECOL, V25, P206, DOI 10.1093/beheco/art107; Steele MA, 2011, ACTA OECOL, V37, P554, DOI 10.1016/j.actao.2011.05.002; Sunyer P, 2014, BEHAV ECOL SOCIOBIOL, V68, P1205, DOI 10.1007/s00265-014-1731-x; Sunyer P, 2013, FUNCT ECOL, V27, P1313, DOI 10.1111/1365-2435.12143; Urbieta IR, 2008, CAN J FOREST RES, V38, P2382, DOI 10.1139/X08-089; Vander Wall S. B., 2003, BEHAV ECOL, V84, P487; Vander Wall S. B., 1990, FOOD HOARDING ANIMAL, P3; Vander Wall SB, 2002, ECOLOGY, V83, P3508, DOI 10.2307/3072099; Wang B, 2013, OIKOS, V122, P1027, DOI 10.1111/j.1600-0706.2012.20823.x; Wang B, 2009, ECOLOGY, V90, P3023, DOI 10.1890/08-2188.1; Xiao ZS, 2013, J ECOL, V101, P1256, DOI 10.1111/1365-2745.12113; Xiao ZS, 2013, BEHAV ECOL SOCIOBIOL, V67, P1067, DOI 10.1007/s00265-013-1531-8; Xiao ZS, 2006, FOREST ECOL MANAG, V223, P18, DOI 10.1016/j.foreco.2005.10.054; Yan C, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2797; Zavala MA, 2000, BOT REV, V66, P119, DOI 10.1007/BF02857785; Zavala MA, 2011, CAN J FOREST RES, V41, P1432, DOI [10.1139/X11-050, 10.1139/x11-050]	64	22	22	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129844	10.1371/journal.pone.0129844	http://dx.doi.org/10.1371/journal.pone.0129844			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070129	Green Published, Green Submitted, gold			2022-12-26	WOS:000356327000113
J	Dileepan, T; Kim, HO; Cleary, PP; Skinner, PJ				Dileepan, Thamotharampillai; Kim, Hyeon O.; Cleary, P. Patrick; Skinner, Pamela J.			In Situ Peptide-MHC-II Tetramer Staining of Antigen-Specific CD4(+) T Cells in Tissues	PLOS ONE			English	Article								The invention of peptide-MHC-tetramer technology to label antigen-specific T cells has led to an enhanced understanding of T lymphocyte biology. Here we describe the development of an in situ pMHC-II tetramer staining method to visualize antigen-specific CD4(+) T cells in tissues. This method complements other methods developed that similarly use MHC class II reagents to stain antigen-specific CD4(+) T cells in situ. In this study, we used group A streptococcus (GAS) expressing a surrogate peptide (2W) to inoculate C57BL/6 mice, and used fresh nasal-associated lymphoid tissues (NALT) in optimizing the in situ staining of 2W:I-A(b) specific CD4(+) T cells. The results showed 2W:I-A(b) tetramer-binding CD4(+) T cells in GAS-2W but not GAS infected mice. This method holds promise to be broadly applicable to study the localization, abundance, and phenotype of antigen-specific CD4(+) T cells in undisrupted tissues.	[Dileepan, Thamotharampillai; Cleary, P. Patrick] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; [Kim, Hyeon O.; Skinner, Pamela J.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Skinner, PJ (corresponding author), Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.	skinn002@umn.edu		DILEEPAN, THAMOTHARAMPILLAI/0000-0002-2810-6996; Skinner, Pamela/0000-0003-3388-1687	Venture Research Project grant from the Wisconsin National Primate Research Center; NIH [P30 CA77598]; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000167] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER	Venture Research Project grant from the Wisconsin National Primate Research Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Venture Research Project grant from the Wisconsin National Primate Research Center (PJS) and in part by NIH P30 CA77598 utilizing the Masonic Cancer Center, University of Minnesota shared flow cytometer resource. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischof F, 2004, J IMMUNOL, V172, P2878, DOI 10.4049/jimmunol.172.5.2878; Dileepan T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002252; Dombek PE, 1999, MOL MICROBIOL, V31, P859, DOI 10.1046/j.1365-2958.1999.01223.x; Li Y, 2011, IMMUNOBIOLOGY, V216, P947, DOI 10.1016/j.imbio.2011.01.003; Massilamany C, 2014, JOVE-J VIS EXP, DOI 10.3791/51679; Massilamany C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087519; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Skinner PJ, 2000, J IMMUNOL, V165, P613, DOI 10.4049/jimmunol.165.2.613; Skinner PJ, 2002, J IMMUNOL METHODS, V268, P29, DOI 10.1016/S0022-1759(02)00197-7; Skinner PJ, 2005, CURR PROTOC IMMUNOL; Wang BN, 2010, P NATL ACAD SCI USA, V107, P5937, DOI 10.1073/pnas.0904831107	14	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128862	10.1371/journal.pone.0128862	http://dx.doi.org/10.1371/journal.pone.0128862			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067103	gold, Green Submitted, Green Published			2022-12-26	WOS:000356100900032
J	Tsuchiya, M; Giuliani, A; Hashimoto, M; Erenpreisa, J; Yoshikawa, K				Tsuchiya, Masa; Giuliani, Alessandro; Hashimoto, Midori; Erenpreisa, Jekaterina; Yoshikawa, Kenichi			Emergent Self-Organized Criticality in Gene Expression Dynamics: Temporal Development of Global Phase Transition Revealed in a Cancer Cell Line	PLOS ONE			English	Article							NETWORKS; NORMALIZATION; EPIGENETICS; HYPOTHESIS; RANGE	Background The underlying mechanism of dynamic control of the genome-wide expression is a fundamental issue in bioscience. We addressed it in terms of phase transition by a systemic approach based on both density analysis and characteristics of temporal fluctuation for the time-course mRNA expression in differentiating MCF-7 breast cancer cells. Methodology In a recent work, we suggested criticality as an essential aspect of dynamic control of genome-wide gene expression. Criticality was evident by a unimodal-bimodal transition through flattened unimodal expression profile. The flatness on the transition suggests the existence of a critical transition at which up- and down-regulated expression is balanced. Mean field (averaging) behavior of mRNAs based on the temporal expression changes reveals a sandpile type of transition in the flattened profile. Furthermore, around the transition, a self-similar unimodal-bimodal transition of the whole expression occurs in the density profile of an ensemble of mRNA expression. These singular and scaling behaviors identify the transition as the expression phase transition driven by self-organized criticality (SOC). Principal Findings Emergent properties of SOC through a mean field approach are revealed: i) SOC, as a form of genomic phase transition, consolidates distinct critical states of expression, ii) Coupling of coherent stochastic oscillations between critical states on different time-scales gives rise to SOC, and iii) Specific gene clusters (barcode genes) ranging in size from kbp to Mbp reveal similar SOC to genome-wide mRNA expression and ON-OFF synchronization to critical states. This suggests that the cooperative gene regulation of topological genome sub-units is mediated by the coherent phase transitions of megadomain-scaled conformations between compact and swollen chromatin states. Conclusion and Significance In summary, our study provides not only a systemic method to demonstrate SOC in whole-genome expression, but also introduces novel, physically grounded concepts for a breakthrough in the study of biological regulation.	[Tsuchiya, Masa] Keio Univ, Sch Media & Governance, Syst Biol Program, Fujisawa, Kanagawa, Japan; [Giuliani, Alessandro] Ist Super Sanit, Environm & Hlth Dept, Rome, Italy; [Hashimoto, Midori] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Erenpreisa, Jekaterina] Latvian Biomed Res & Study Ctr, Riga, Latvia; [Yoshikawa, Kenichi] Doshisha Univ, Fac Life & Med Sci, Kyotanabe, Japan	Keio University; Istituto Superiore di Sanita (ISS); University of Tokyo; Latvian Biomedical Research & Study Centre; Doshisha University	Tsuchiya, M (corresponding author), Keio Univ, Sch Media & Governance, Syst Biol Program, Fujisawa, Kanagawa, Japan.	tsuchiya.masa@gmail.com; alessandro.giuliani@iss.it; keyoshik@mail.doshisha.ac.jp	Giuliani, Alessandro/K-7589-2016; Giuliani, Alessandro/AAF-1740-2020; Yoshikawa, Kenichi/N-1867-2019	Giuliani, Alessandro/0000-0002-4640-804X; Giuliani, Alessandro/0000-0002-4640-804X; Yoshikawa, Kenichi/0000-0002-2751-7136	Japan Society for the Promotion of Science (KAKENHI) [15H02121, 2510301]; European Social Fund, Latvia [1DP/1.1.1.2/APIA/VIAA/037]	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); European Social Fund, Latvia	This study was supported in part by Japan Society for the Promotion of Science (Grants-in-Aid, KAKENHI: Nos. 15H02121 and 2510301) and by European Social Fund (grant Nr 1DP/1.1.1.2/APIA/VIAA/037), Latvia.	Alberts B, 2014, MOL BIOL CELL, DOI DOI 10.1201/9780203833445; Bachmann M., 2014, THERMODYNAMICS STAT; BAK P, 1988, PHYS REV A, V38, P364, DOI 10.1103/PhysRevA.38.364; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Barbieri M, 2012, P NATL ACAD SCI USA, V109, P16173, DOI 10.1073/pnas.1204799109; BEEBE KR, 1987, ANAL CHEM, V59, pA1007, DOI 10.1021/ac00144a725; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bornfleth H, 1999, BIOPHYS J, V77, P2871, DOI 10.1016/S0006-3495(99)77119-5; Censi F, 2011, IEEE T BIO-MED ENG, V58, P2943, DOI 10.1109/TBME.2011.2150747; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Csermely P, 2013, PHARMACOL THERAPEUT, V138, P333, DOI 10.1016/j.pharmthera.2013.01.016; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; FITZHUGH R, 1955, B MATH BIOL, V17, P257, DOI DOI 10.1007/BF02477753; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Ginzburg V.L., 1950, J. Exp. Theor. Phys, V20, P1064, DOI DOI 10.1007/978-3-540-68008-6_4; Giuliani A, 2014, ADV SYST BIO, V3, P3; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; IZHIKEVICH E. M., 2006, SCHOLARPEDIA, V1, P1349, DOI 10.4249/scholarpedia.1349; Jensen H.J., 1998, SELF ORG CRITICALITY; Kauffman S.A., 1993, ORIGINS ORDER; Klevecz RR, 2004, P NATL ACAD SCI USA, V101, P1200, DOI 10.1073/pnas.0306490101; Koren A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-164; Laue T, 2011, NAT CHEM BIOL, V7, P331, DOI 10.1038/nchembio.575; Ld L, 1937, ZH EXPER THEOR FIZ, V7, P19, DOI DOI 10.1038/138840A0; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Markovic D, 2014, PHYS REP, V536, P41, DOI 10.1016/j.physrep.2013.11.002; McClintick JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-49; Mirkin SM, 2001, ENCYCLOPEDIA OF LIFE; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Plenz D., 2014, CRITICALITY NEURAL S; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Rosenfeld S, 2011, GENE REGUL SYST BIO, V5, P27, DOI 10.4137/GRSB.S6804; Saeki Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-545; Sexton T, 2009, SEMIN CELL DEV BIOL, V20, P849, DOI 10.1016/j.semcdb.2009.06.004; Shew WL, 2009, J NEUROSCI, V29, P15595, DOI 10.1523/JNEUROSCI.3864-09.2009; Shu GP, 2003, COMP FUNCT GENOM, V4, P287, DOI 10.1002/cfg.290; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Takagi S, 1999, LANGMUIR, V15, P4143, DOI 10.1021/la981158o; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takenaka Y, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.031905; Tompa P, 2011, PROTEIN SCI, V20, P2074, DOI 10.1002/pro.747; Tsuchiya M., 2012, Proceedings of the 2012 ICME International Conference on Complex Medical Engineering (CME), P744, DOI 10.1109/ICCME.2012.6275649; Tsuchiya M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097411; Tsuchiya M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012116; Tsuchiya M, 2009, PHYSICA A, V388, P1738, DOI 10.1016/j.physa.2008.12.030; Tsuchiya M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004905; Van Bortle K, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r82; Waddington C H, 1957, STRATEGY GENES DISCU; WEINBERG AM, 1982, INTERDISCIPL SCI REV, V7, P47, DOI 10.1179/030801882789801322; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yasar F, 2005, INT J MOD PHYS C, V16, P427, DOI 10.1142/S0129183105007224; Yoshikawa K, 1999, CHEM PHYS LETT, V303, P10, DOI 10.1016/S0009-2614(99)00203-1; Yoshikawa K, 2002, J BIOL PHYS, V28, P701, DOI 10.1023/A:1021251125101; Yoshikawa K., 2002, PHARM PROPERTIES NUC, P137; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033; [No title captured]; [No title captured]	64	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0128565	10.1371/journal.pone.0128565	http://dx.doi.org/10.1371/journal.pone.0128565			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067993	Green Submitted, gold, Green Published			2022-12-26	WOS:000356100900025
J	Sartorius, B; Veerman, LJ; Manyema, M; Chola, L; Hofman, K				Sartorius, Benn; Veerman, Lennert J.; Manyema, Mercy; Chola, Lumbwe; Hofman, Karen			Determinants of Obesity and Associated Population Attributability, South Africa: Empirical Evidence from a National Panel Survey, 2008-2012	PLOS ONE			English	Article							BLACK-WOMEN; SOCIOECONOMIC-STATUS; PREVALENCE; OVERWEIGHT; URBAN; CHILDHOOD	Background Obesity is a major risk factor for emerging non-communicable diseases (NCDS) in middle income countries including South Africa (SA). Understanding the multiple and complex determinants of obesity and their true population attributable impact is critical for informing and developing effective prevention efforts using scientific based evidence. This study identified contextualised high impact factors associated with obesity in South Africa. Methods Analysis of three national cross sectional (repeated panel) surveys, using a multilevel logistic regression and population attributable fraction estimation allowed for identification of contextualised high impact factors associated with obesity (BMI>30 kg/m(2)) among adults (15years+). Results Obesity prevalence increased significantly from 23.5% in 2008 to 27.2% in 2012, with a significantly (p-value<0.001) higher prevalence among females (37.9% in 2012) compared to males (13.3% in 2012). Living in formal urban areas, white ethnicity, being married, not exercising and/or in higher socio-economic category were significantly associated with male obesity. Females living in formal or informal urban areas, higher crime areas, African/White ethnicity, married, not exercising, in a higher socio-economic category and/or living in households with proportionate higher spending on food (and unhealthy food options) were significantly more likely to be obese. The identified determinants appeared to account for 75% and 43% of male and female obesity respectively. White males had the highest relative gain in obesity from 2008 to 2012. Conclusions The rising prevalence of obesity in South Africa is significant and over the past 5 years the rising prevalence of Type-2 diabetes has mirrored this pattern, especially among females. Targeting young adolescent girls should be a priority. Addressing determinants of obesity will involve a multifaceted strategy and requires at individual and population levels. With rising costs in the private and public sector to combat obesity related NCDS, this analysis can inform culturally sensitive mass communications and wellness campaigns. Knowledge of social determinants is critical to develop "best buys".	[Sartorius, Benn] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Discipline Publ Hlth Med, Durban, South Africa; [Veerman, Lennert J.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Manyema, Mercy; Chola, Lumbwe; Hofman, Karen] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Manyema, Mercy; Chola, Lumbwe; Hofman, Karen] Univ Witwatersrand, Fac Hlth Sci, Hlth & Hlth Transit Res Unit, PRICELESS SA,Sch Publ Hlth,MRC Wits Rural Publ, Johannesburg, South Africa; [Hofman, Karen] Johns Hopkins Univ, John Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	University of Kwazulu Natal; University of Queensland; University of Witwatersrand; University of Witwatersrand; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Hofman, K (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa.	Karen.Hofman@wits.ac.za	Chola, Lumbwe/AFX-3377-2022; Veerman, Lennert/A-9973-2011	Veerman, Lennert/0000-0002-3206-8232; Chola, Lumbwe/0000-0001-6488-2813; HOFMAN, KAREN/0000-0001-9512-7220; , bennsartorius/0000-0001-6761-2325	International Development Research Centre (IDRC), Canada [PROP020911E]	International Development Research Centre (IDRC), Canada(CGIAR)	This work was supported by the International Development Research Centre (IDRC), Canada, Grant number: PROP020911E (http://www.idrc.ca/EN/Pages/default.aspx). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakari AR, 2008, OBES REV, V9, P297, DOI 10.1111/j.1467-789X.2007.00462.x; Aitsi-Selmi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039507; Alaba OA, 2013, LANCET, V381, P6; [Anonymous], 2009, METHODOLOGY REPORT N; Averett SL, 2008, ECON HUM BIOL, V6, P330, DOI 10.1016/j.ehb.2008.07.003; Bennett GG, 2013, JAMA INTERN MED, V173, P1770, DOI 10.1001/jamainternmed.2013.9263; Case A, 2009, ECON HUM BIOL, V7, P271, DOI 10.1016/j.ehb.2009.07.002; Chaloupka FJ, 2009, PREVENTING CHRONIC D; Chaloupka FJ, 2007, AM J PREV MED, V33, pS147, DOI 10.1016/j.amepre.2007.07.016; Coetzee V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048116; Dalal S, 2011, INT J EPIDEMIOL, V40, P885, DOI 10.1093/ije/dyr050; Darling N., 2007, RES HUM DEV, V4, P203, DOI [https://doi.org/10.1080/15427600701663023, DOI 10.1080/15427600701663023, 10.1080/15427600701663023]; Demographic CE, 2013, HLTH SURV 2011; Drimie S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-911; Fezeu LK, 2008, OBESITY, V16, P1144, DOI 10.1038/oby.2008.44; Foley P, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-305; Freedman Rachel E K, 2007, Eat Behav, V8, P319, DOI 10.1016/j.eatbeh.2006.11.008; Han JC, 2010, LANCET, V375, P1737, DOI 10.1016/S0140-6736(10)60171-7; Hill JO, 2008, OBES REV, V9, P41, DOI 10.1111/j.1467-789X.2007.00437.x; Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR; Kruger A, 2012, J HEALTH POPUL NUTR, V30, P56, DOI 10.3329/jhpn.v30i1.11277; Kruger HS, 2005, PUBLIC HEALTH NUTR, V8, P491, DOI 10.1079/PHN2005785; Kruger HS, 2002, NUTRITION, V18, P422, DOI 10.1016/S0899-9007(01)00751-1; Lakerveld J, 2012, BMC PUBLIC HEALTH, V12, P1, DOI [10.1186/1471-2458-12-1, DOI 10.1186/1471-2458-12-1]; Letamo G, 2011, J BIOSOC SCI, V43, P75, DOI 10.1017/S0021932010000519; Malarcher AM, 2000, AM J EPIDEMIOL, V152, P573, DOI 10.1093/aje/152.6.573; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; MELNYK MG, 1994, J AM DIET ASSOC, V94, P536, DOI 10.1016/0002-8223(94)90218-6; Mfenyana K, 2008, S AFR MED J, V96, P323; Micklesfield LK, 2013, CARDIOVASCULAR J AFR, V24, P1; MIETTINE.OS, 1974, AM J EPIDEMIOL, V99, P325, DOI 10.1093/oxfordjournals.aje.a121617; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; NORTHRIDGE ME, 1995, AM J PUBLIC HEALTH, V85, P1202, DOI 10.2105/AJPH.85.9.1202; Olatunbosun ST, 2011, OBES REV, V12, P233, DOI 10.1111/j.1467-789X.2010.00801.x; Peer N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043336; Puoane T, 2002, OBES RES, V10, P1038, DOI 10.1038/oby.2002.141; Puoane T., 2006, HUM ECOL, V14, P89; Puoane T, 2005, S AFRICAN J CLIN NUT, V18; Razak F, 2007, CIRCULATION, V115, P2111, DOI 10.1161/CIRCULATIONAHA.106.635011; Reed DB, 2011, J NUTR EDUC BEHAV, V43, P401, DOI 10.1016/j.jneb.2010.12.005; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Roskam AJR, 2010, INT J EPIDEMIOL, V39, P392, DOI 10.1093/ije/dyp329; ROYALL RM, 1986, INT STAT REV, V54, P221, DOI 10.2307/1403146; SADHS: Department of Health MRC OrcMacro, 2007, S AFR DEM HLTH SURV; Schlesselman JJ, 1982, J OCCUPATIONAL ENV M, V24, P879; Schmidt LA, 2012, J STUD ALCOHOL DRUGS, V73, P144, DOI 10.15288/jsad.2012.73.144; SOBAL J, 1992, SOC SCI MED, V35, P915, DOI 10.1016/0277-9536(92)90106-Z; Sobngwi E, 2002, INT J OBESITY, V26, P1009, DOI 10.1038/sj.ijo.0802008; Sodjinou R, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-84; StataCorp, 2013, STATA STAT SOFTW REL; Tampubolon G, 2013, HEALTH ECON, V22, P14, DOI 10.1002/hec.1808; Tomita A, 2015, MATERN CHILD HLTH J, P1, DOI [10.1007/s10995-014-1489-9, DOI 10.1007/S10995-014-1489-9]; Tomita A, 2012, J AFFECTIVE DISORDER; Tzotzas T, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-732; University of Cape Town SALaDRU, 2011, NAT INC DYN STUD NID; Wand H, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-159; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Wilson SE, 2012, ECON HUM BIOL, V10, P431, DOI 10.1016/j.ehb.2012.04.012; Witkowski T.H., 2007, J MACROMARKETING, V27, P126, DOI DOI 10.1177/0276146707300076; World Health Organization, 2008, World health statistics 2008; Ziraba AK, 2009, BMC HEALTH SERV RES, V9, DOI [10.1186/1471-2458-9-465, 10.1186/1472-6963-9-46]; ZOCCHETTI C, 1995, INT J EPIDEMIOL, V24, P1064, DOI 10.1093/ije/24.5.1064; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	64	56	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0130218	10.1371/journal.pone.0130218	http://dx.doi.org/10.1371/journal.pone.0130218			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK1PO	26061419	gold, Green Published, Green Submitted			2022-12-26	WOS:000355979500168
J	Billet, A; Jia, YL; Jensen, T; Riordan, JR; Hanrahan, JW				Billet, Arnaud; Jia, Yanlin; Jensen, Tim; Riordan, John R.; Hanrahan, John W.			Regulation of the cystic fibrosis transmembrane conductance regulator anion channel by tyrosine phosphorylation	FASEB JOURNAL			English	Article						Src; Pyk2; R domain	PROTEIN-KINASE-A; NUCLEOTIDE-BINDING DOMAIN; CFTR CHLORIDE CHANNEL; R-DOMAIN; PSEUDOMONAS-AERUGINOSA; ATP HYDROLYSIS; CL-CHANNEL; ACTIVATION; CELLS; SITES	The cystic fibrosis transmembrane conductance regulator (CFTR) channel is activated by PKA phosphorylation of a regulatory domain that interacts dynamically with multiple CFTR domains and with other proteins. The large number of consensus sequences for phosphorylation by PKA has naturally focused most attention on regulation by this kinase. We report here that human CFTR is also phosphorylated by the tyrosine kinases p60c-Src (proto-oncogene tyrosine-protein kinase) and the proline-rich tyrosine kinase 2 (Pyk2), and they can also cause robust activation of quiescent CFTR channels. In excised patch-clamp experiments, CFTR activity during exposure to Src or Pyk2 reached similar to 80% of that stimulated by PKA. Exposure to PKA after Src or Pyk2 caused a further increase to the level induced by PKA alone, implying a common limiting step. Channels became spontaneously active when v-Src or the catalytic domain of Pyk2 was coexpressed with CFTR and were further stimulated by the tyrosine phosphatase inhibitor dephostatin. Exogenous Src also activated 15SA-CFTR, a variant that lacks 15 potential PKA sites and has little response to PKA. PKA-independent activation by tyrosine phosphorylation has implications for the mechanism of regulation by the R domain and for the physiologic functions of CFTR.	[Billet, Arnaud; Jia, Yanlin; Hanrahan, John W.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Billet, Arnaud; Jia, Yanlin; Hanrahan, John W.] McGill Univ, Cyst Fibrosis Translat Res Ctr, Montreal, PQ H3G 1Y6, Canada; [Jensen, Tim; Riordan, John R.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA; [Jensen, Tim; Riordan, John R.] Univ N Carolina, Cyst Fibrosis Res Ctr, Chapel Hill, NC USA; [Hanrahan, John W.] McGill Univ, Ctr Hosp, Res Inst, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; McGill University	Billet, A (corresponding author), McGill Univ, Dept Physiol, 3655 Promenade Sir William Osler, Montreal, PQ H3G 1Y6, Canada.	arnaud.billet@mcgill.ca	Billet, Arnaud/AAZ-3834-2020; billet, arnaud/P-9503-2016; Hanrahan, John/AGG-1926-2022	Hanrahan, John/0000-0001-9080-2039	Groupe d'Etude des Proteines Membranaire; Groupe de Recherche Axe sur la Structure des Proteines; McGill Canadian Institutes of Health Research Program in Chemical Biology; McGill Faculty of Medicine; Respiratory Health Network of Centers of Excellence; Canadian Lung Association/Medical Research Council; Canadian Cystic Fibrosis Foundation; U.S. National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases) [R01-DK051870]; U.S. National Institutes of Health (National Heart, Lung, and Blood Institute) [P01 HL 10873-01]; Canadian Institutes of Health Research [MOP-126156]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051870] Funding Source: NIH RePORTER	Groupe d'Etude des Proteines Membranaire; Groupe de Recherche Axe sur la Structure des Proteines; McGill Canadian Institutes of Health Research Program in Chemical Biology; McGill Faculty of Medicine; Respiratory Health Network of Centers of Excellence; Canadian Lung Association/Medical Research Council; Canadian Cystic Fibrosis Foundation; U.S. National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U.S. National Institutes of Health (National Heart, Lung, and Blood Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	A.B. was supported by fellowships from the Groupe d'Etude des Proteines Membranaire, Groupe de Recherche Axe sur la Structure des Proteines, McGill Canadian Institutes of Health Research Program in Chemical Biology, and McGill Faculty of Medicine. Y.J. was supported by the Respiratory Health Network of Centers of Excellence and fellowships from the Canadian Lung Association/Medical Research Council and Canadian Cystic Fibrosis Foundation. This work was funded by grants from the U.S. National Institutes of Health [R01-DK051870 (National Institute of Diabetes and Digestive and Kidney Diseases) and P01 HL 10873-01 (National Heart, Lung, and Blood Institute) to J.R.R.] and Canadian Institutes of Health Research (MOP-126156; to J.W.H.).	Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Alshafie W, 2014, AM J PHYSIOL-CELL PH, V307, pC107, DOI 10.1152/ajpcell.00296.2013; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Baker MA, 2006, J CELL SCI, V119, P3182, DOI 10.1242/jcs.03055; Basso C, 2003, J GEN PHYSIOL, V122, P333, DOI 10.1085/jgp.200308798; Billet A, 2013, J PHYSIOL-LONDON, V591, P5273, DOI 10.1113/jphysiol.2013.261909; Billet A, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.479360; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bozoky Z, 2013, P NATL ACAD SCI USA, V110, pE4427, DOI 10.1073/pnas.1315104110; Bozoky Z, 2013, FEBS J, V280, P4407, DOI 10.1111/febs.12422; Cesaro L, 2013, AMINO ACIDS, V45, P1423, DOI 10.1007/s00726-013-1613-y; CHANG XB, 1993, J BIOL CHEM, V268, P11304; Chappe V, 2005, EMBO J, V24, P2730, DOI 10.1038/sj.emboj.7600747; Chappe V, 2004, P NATL ACAD SCI USA, V101, P390, DOI 10.1073/pnas.0303411101; Chappe V, 2003, J PHYSIOL-LONDON, V548, P39, DOI 10.1113/jphysiol.2002.035790; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; Csanady L, 2005, J GEN PHYSIOL, V125, P171, DOI 10.1085/jgp.200409076; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; DULHANTY AM, 1994, BIOCHEMISTRY-US, V33, P4072, DOI 10.1021/bi00179a036; Esen M, 2001, INFECT IMMUN, V69, P281, DOI 10.1128/IAI.69.1.281-287.2001; Felsch JS, 1998, P NATL ACAD SCI USA, V95, P5051, DOI 10.1073/pnas.95.9.5051; Fischer H, 1996, BIOPHYS J, V71, P3073, DOI 10.1016/S0006-3495(96)79501-2; Gadsby David C., 1999, Physiological Reviews, V79, pS77; GUNDERSON KL, 1994, J BIOL CHEM, V269, P19349; Hallows KR, 2003, J BIOL CHEM, V278, P998, DOI 10.1074/jbc.M210621200; Hegedus T, 2008, J MOL BIOL, V378, P1052, DOI 10.1016/j.jmb.2008.03.033; Hegedus T, 2009, BBA-BIOMEMBRANES, V1788, P1341, DOI 10.1016/j.bbamem.2009.03.015; HWANG TC, 1994, P NATL ACAD SCI USA, V91, P4698, DOI 10.1073/pnas.91.11.4698; HWANG TC, 1993, J GEN PHYSIOL, V101, P629, DOI 10.1085/jgp.101.5.629; Kannan S, 2006, EUR J IMMUNOL, V36, P1739, DOI 10.1002/eji.200635973; KARTNER N, 1991, CELL, V64, P681, DOI 10.1016/0092-8674(91)90498-N; KARTNER N, 1992, NAT GENET, V1, P321, DOI 10.1038/ng0892-321; Liang LH, 2011, J NANOMATER, V2011, DOI 10.1155/2011/670857; Liang XB, 2012, MOL BIOL CELL, V23, P996, DOI 10.1091/mbc.E11-08-0662; Luo JX, 1998, AM J PHYSIOL-CELL PH, V274, pC1397, DOI 10.1152/ajpcell.1998.274.5.C1397; Luz S, 2014, J BIOL CHEM, V289, P15080, DOI 10.1074/jbc.M114.563742; Luz S, 2011, MOL CELL BIOL, V31, P4392, DOI 10.1128/MCB.05517-11; Marshall WS, 2009, J EXP BIOL, V212, P2365, DOI 10.1242/jeb.030015; Mathews CJ, 1998, J PHYSIOL-LONDON, V508, P365, DOI 10.1111/j.1469-7793.1998.365bq.x; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Reddy MM, 2001, AM J PHYSIOL-CELL PH, V280, pC604, DOI 10.1152/ajpcell.2001.280.3.C604; RIORDAN JR, 1989, SCIENCE, V245, P1066; Seibert FS, 1999, BBA-BIOMEMBRANES, V1461, P275, DOI 10.1016/S0005-2736(99)00163-7; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; TABCHARANI JA, 1991, NATURE, V352, P628, DOI 10.1038/352628a0; Thelin WR, 2005, J BIOL CHEM, V280, P41512, DOI 10.1074/jbc.M507308200; Vais H, 2004, AM J PHYSIOL-CELL PH, V287, pC737, DOI 10.1152/ajpcell.00504.2003; Venerando A, 2014, CELL MOL LIFE SCI, V71, P2193, DOI 10.1007/s00018-014-1581-8; Wang YG, 2006, EMBO J, V25, P5058, DOI 10.1038/sj.emboj.7601384; Wilkinson DJ, 1997, AM J PHYSIOL-LUNG C, V273, pL127, DOI 10.1152/ajplung.1997.273.1.L127; Yamamoto S, 2007, J PHYSIOL SCI, V57, P85, DOI 10.2170/physiolsci.RP011406	52	18	18	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3945	3953		10.1096/fj.15-273151	http://dx.doi.org/10.1096/fj.15-273151			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26062600	Green Published			2022-12-26	WOS:000359915600029
J	Finiguerra, M; Avery, DE; Dam, HG				Finiguerra, Michael; Avery, David E.; Dam, Hans G.			Determining the Advantages, Costs, and Trade-Offs of a Novel Sodium Channel Mutation in the Copepod Acartia hudsonica to Paralytic Shellfish Toxins (PST)	PLOS ONE			English	Article							ALEXANDRIUM-FUNDYENSE; FEEDING-BEHAVIOR; BINDING-PROTEIN; EGG-PRODUCTION; RESISTANCE; ZOOPLANKTON; SELECTION; DINOFLAGELLATE; MECHANISMS; TOLERANCE	The marine copepod Acartia hudsonica was shown to be adapted to dinoflagellate prey, Alexandrium fundyense, which produce paralytic shellfish toxins (PST). Adaptation to PSTs in other organisms is caused by a mutation in the sodium channel. Recently, a mutation in the sodium channel in A. hudsonica was found. In this study, we rigorously tested for advantages, costs, and trade-offs associated with the mutant isoform of A. hudsonica under toxic and non-toxic conditions. We combined fitness with wild-type: mutant isoform ratio measurements on the same individual copepod to test our hypotheses. All A. hudsonica copepods express both the wild-type and mutant sodium channel isoforms, but in different proportions; some individuals express predominantly mutant (PMI) or wild-type isoforms (PWI), while most individuals express relatively equal amounts of each (EI). There was no consistent pattern of improved performance as a function of toxin dose for egg production rate (EPR), ingestion rate (I), and gross growth efficiency (GGE) for individuals in the PMI group relative to individuals in the PWI expression group. Neither was there any evidence to indicate a fitness benefit to the mutant isoform at intermediate toxin doses. No clear advantage under toxic conditions was associated with the mutation. Using a mixed-diet approach, there was also no observed relationship between individual wild-type: mutant isoform ratios and among expression groups, on both toxic and non-toxic diets, for eggs produced over three days. Lastly, expression of the mutant isoform did not mitigate the negative effects of the toxin. That is, the reductions in EPR from a toxic to non-toxic diet for copepods were independent of expression groups. Overall, the results did not support our hypotheses; the mutant sodium channel isoform does not appear to be related to adaptation to PST in A. hudsonica. Other potential mechanisms responsible for the adaptation are discussed.	[Finiguerra, Michael; Avery, David E.; Dam, Hans G.] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA	University of Connecticut	Finiguerra, M (corresponding author), Univ Connecticut, Ecol & Evolutionary Biol, 1080 Shennecosset Rd, Groton, CT 06435 USA.	Michael.finiguerra@uconn.edu	Dam, Hans G/A-9723-2015	Dam, Hans G/0000-0001-6121-5038	National Science Foundation [IOS-0950852]; Direct For Biological Sciences [0950852] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation #IOS-0950852 awarded to HD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agra AR, 2010, ENVIRON TOXICOL CHEM, V29, P939, DOI 10.1002/etc.97; Anderson PAV, 2005, HARMFUL ALGAE, V4, P95, DOI 10.1016/j.hal.2003.12.007; Ashcroft FM, 2006, NATURE, V440, P440, DOI 10.1038/nature04707; Avery DE, 2007, LIMNOL OCEANOGR, V52, P2099, DOI 10.4319/lo.2007.52.5.2099; Bamstedt U., 2000, P297; BANSE K, 1995, ICES J MAR SCI, V52, P265, DOI 10.1016/1054-3139(95)80043-3; Barata C, 2002, ENVIRON TOXICOL CHEM, V21, P1058, DOI [10.1897/1551-5028(2002)021<1058:AAWPVI>2.0.CO;2, 10.1897/1551-5028(2002)021&lt;1058:AAWPVI&gt;2.0.CO;2]; Barreiro A, 2006, MAR ECOL PROG SER, V316, P115, DOI 10.3354/meps316115; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Besiktepe S, 2002, MAR ECOL PROG SER, V229, P151, DOI 10.3354/meps229151; Bricelj VM, 2005, NATURE, V434, P763, DOI 10.1038/nature03415; Cestele S, 2000, BIOCHIMIE, V82, P883, DOI 10.1016/S0300-9084(00)01174-3; Chen L, 2010, MOL APPROACH STUDY S; Chen L, 2015, J EXP MAR BIOL ECOL; Clancy CE, 1999, NATURE, V400, P566, DOI 10.1038/23034; Colin SP, 2007, HARMFUL ALGAE, V6, P875, DOI 10.1016/j.hal.2007.05.003; Colin Sean P., 2002, Harmful Algae, V1, P113, DOI 10.1016/S1568-9883(02)00007-0; Colin SP, 2004, EVOL ECOL, V18, P355, DOI 10.1007/s10682-004-2369-3; Colin SP, 2003, MAR ECOL PROG SER, V248, P55, DOI 10.3354/meps248055; Colin SP, 2002, LIMNOL OCEANOGR, V47, P1430, DOI 10.4319/lo.2002.47.5.1430; Connell LB, 2007, MAR BIOL, V150, P1227, DOI 10.1007/s00227-006-0432-z; Coustau C, 2000, TRENDS ECOL EVOL, V15, P378, DOI 10.1016/S0169-5347(00)01929-7; Dam HG, 2013, ANNU REV MAR SCI, V5, P349, DOI 10.1146/annurev-marine-121211-172229; Dam HG, 2011, HARMFUL ALGAE, V10, P245, DOI 10.1016/j.hal.2010.10.004; Falconer DS, 1996, INTRODUCTION TO QUAN; Fallang A, 2005, DIS AQUAT ORGAN, V65, P129, DOI 10.3354/dao065129; Finiguerra MB, 2013, DETERMINING THE ROLE; Finiguerra M, 2014, ECOL EVOL, V4, P3470, DOI 10.1002/ece3.1197; FROST BW, 1972, LIMNOL OCEANOGR, V17, P805, DOI 10.4319/lo.1972.17.6.0805; Geffeney S, 2002, SCIENCE, V297, P1336, DOI 10.1126/science.1074310; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Gustafsson S, 2004, AQUAT ECOL, V38, P37, DOI 10.1023/B:AECO.0000020985.47348.5e; Hairston NG, 2001, EVOLUTION, V55, P2203, DOI 10.1111/j.0014-3820.2001.tb00736.x; Hattenrath-Lehmann TK, 2011, HARMFUL ALGAE, V11, P106, DOI 10.1016/j.hal.2011.08.005; Hirst AG, 2001, MAR ECOL PROG SER, V223, P179, DOI 10.3354/meps223179; Horn R, 2007, NATURE, V446, P32, DOI 10.1038/446032a; HUMES AG, 1994, HYDROBIOLOGIA, V293, P1, DOI 10.1007/BF00229916; IVES JD, 1987, J EXP MAR BIOL ECOL, V112, P131, DOI 10.1016/0022-0981(87)90113-4; KIORBOE T, 1985, MAR ECOL PROG SER, V26, P85, DOI 10.3354/meps026085; Kwok KWH, 2009, ECOTOX ENVIRON SAFE, V72, P358, DOI 10.1016/j.ecoenv.2008.03.014; Lenarcic B, 2000, J BIOL CHEM, V275, P15572, DOI 10.1074/jbc.M001406200; Lenz PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088589; LERCHE H, 1993, J PHYSIOL-LONDON, V470, P13, DOI 10.1113/jphysiol.1993.sp019843; Liebeskind BJ, 2012, MOL BIOL EVOL, V29, P3613, DOI 10.1093/molbev/mss182; Llewellyn LE, 2009, SODIUM CHANNEL INHIB; Meyer JN, 2003, ECOL APPL, V13, P490, DOI 10.1890/1051-0761(2003)013[0490:HAAFCI]2.0.CO;2; MORABITO MA, 1994, P NATL ACAD SCI USA, V91, P2478, DOI 10.1073/pnas.91.7.2478; Motoike HK, 2004, J GEN PHYSIOL, V123, P155, DOI 10.1085/jgp.200308929; PRIGOGINE I, 1972, PHYS TODAY, V25, P38; Purrington CB, 2000, CURR OPIN PLANT BIOL, V3, P305, DOI 10.1016/S1369-5266(00)00085-6; Raberg L, 2009, PHILOS T R SOC B, V364, P37, DOI 10.1098/rstb.2008.0184; Reinikainen M, 1998, ECOTOX ENVIRON SAFE, V40, P77, DOI 10.1006/eesa.1998.1645; Rigby MC, 2002, TRENDS PARASITOL, V18, P116, DOI 10.1016/S1471-4922(01)02203-6; Schlichting CD, 1998, PHENOTYPIC EVOLUTION; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Senft C, 2011, HARMFUL ALGAE, V10, P804, DOI 10.1016/j.hal.2011.06.014; Senft-Batoh C, 2012, GRAZER INDUCED TOXIN; Senft-Batoh CD, 2015, LIMNOL OCEANOGR, V60, P318, DOI 10.1002/lno.10027; Shirley MDF, 1999, EVOLUTION, V53, P826, DOI 10.1111/j.1558-5646.1999.tb05376.x; SHUMWAY S E, 1990, Journal of the World Aquaculture Society, V21, P65, DOI 10.1111/j.1749-7345.1990.tb00529.x; Sokal RR, 1995, BIOMETRY; Sokolov S, 2007, NATURE, V446, P76, DOI 10.1038/nature05598; Teegarden GJ, 1999, MAR ECOL PROG SER, V181, P163, DOI 10.3354/meps181163; Teegarden GJ, 2001, MAR ECOL PROG SER, V218, P213, DOI 10.3354/meps218213; Teegarden GJ, 2008, HARMFUL ALGAE, V7, P33, DOI 10.1016/j.hal.2007.05.010; Turner JT, 2005, DEEP-SEA RES PT II, V52, P2801, DOI 10.1016/j.dsr2.2005.06.011; Turner JT, 1997, LIMNOL OCEANOGR, V42, P1203, DOI 10.4319/lo.1997.42.5_part_2.1203; Turner JT, 1984, THE FEEDING ECOLOGY; Urbani A, 2000, EUR J NEUROSCI, V12, P3567, DOI 10.1046/j.1460-9568.2000.00242.x; UYE S, 1990, MAR ECOL PROG SER, V59, P97, DOI 10.3354/meps059097; Yotsu-Yamashita M, 2001, EUR J BIOCHEM, V268, P5937, DOI 10.1046/j.0014-2956.2001.02547.x; Zhang H, 2013, J EXP MAR BIOL ECOL, V446, P57, DOI 10.1016/j.jembe.2013.04.021	72	7	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130097	10.1371/journal.pone.0130097	http://dx.doi.org/10.1371/journal.pone.0130097			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075900	Green Submitted, Green Published, gold			2022-12-26	WOS:000356329900138
J	Kotzen, M; Sell, J; Mathes, RW; Dentinger, C; Lee, L; Schiff, C; Weiss, D				Kotzen, Mollie; Sell, Jessica; Mathes, Robert W.; Dentinger, Catherine; Lee, Lillian; Schiff, Corinne; Weiss, Don			Using Syndromic Surveillance to Investigate Tattoo-Related Skin Infections in New leYork City	PLOS ONE			English	Article								In response to two isolated cases of Mycobacterium chelonae infections in tattoo recipients where tap water was used to dilute ink, the New York City (NYC) Department of Health and Mental Hygiene conducted an investigation using Emergency Department (ED) syndromic surveillance to assess whether an outbreak was occuring. ED visits with chief complaints containing the key word "tattoo" from November 1, 2012 to March 18, 2013 were selected for study. NYC laboratories were also contacted and asked to report skin or soft tissue cultures in tattoo recipients that were positive for non-tuberculosis mycobacterial infection (NTM). Thirty-one TREDV were identified and 14 (45%) were interviewed to determine if a NTM was the cause for the visit. One ED visit met the case definition and was referred to a dermatologist. This individual was negative for NTM. No tattoo-associated NTM cases were reported by NYC laboratories. ED syndromic surveillance was utilized to investigate a non-reportable condition for which no other data source existed. The results were reassuring that an outbreak of NTM in tattoo recipients was not occurring. In response to concerns about potential NTM infections, the department sent a letter to all licensed tattoo artists advising them not to dilute tattoo ink with tap water.	[Kotzen, Mollie; Sell, Jessica; Mathes, Robert W.; Dentinger, Catherine; Lee, Lillian; Schiff, Corinne; Weiss, Don] New York City Dept Hlth & Mental Hyg, Queens, NY 11101 USA; [Dentinger, Catherine] Ctr Dis Control & Prevent, Atlanta, GA USA; [Kotzen, Mollie] NYU, New York, NY USA	New York City Department of Health & Mental Hygiene; Centers for Disease Control & Prevention - USA; New York University	Mathes, RW (corresponding author), New York City Dept Hlth & Mental Hyg, Queens, NY 11101 USA.	rmathes@health.nyc.gov						Braverman S, 2012, HARRIS INTERACTICVE, V22, DOI [10.1186/1687-9856-2012-22, DOI 10.1186/1687-9856-2012-22]; (CDC) CfDCaP, 2004, MMWR MORB MORTAL WKL, V53, P95; Kennedy BS, 2012, NEW ENGL J MED, V367, P1020, DOI 10.1056/NEJMoa1205114; Kluger N, 2012, AM J EMERG MED, V30, P2055, DOI 10.1016/j.ajem.2012.06.014; Laumann AE, 2006, J AM ACAD DERMATOL, V55, P413, DOI 10.1016/j.jaad.2006.03.026; Tohme RA, 2012, CLIN INFECT DIS, V54, P1167, DOI 10.1093/cid/cir991; Urdang M, 2011, WEST J EMERG MED, V12, P393, DOI 10.5811/westjem.2011.4.2268	7	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130468	10.1371/journal.pone.0130468	http://dx.doi.org/10.1371/journal.pone.0130468			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076006	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900175
J	Liu, ZL; Shen, F; Zhu, XM; Li, FJ; Tan, MQ				Liu, Ziliang; Shen, Fang; Zhu, Xiaomin; Li, Fengjie; Tan, Mengqi			Formation Conditions and Sedimentary Characteristics of a Triassic Shallow Water Braided Delta in the Yanchang Formation, Southwest Ordos Basin, China	PLOS ONE			English	Article							SEQUENCE STRATIGRAPHY; LACUSTRINE; FACIES; ARCHITECTURE; MARGIN	A large, shallow braided river delta sedimentary system developed in the Yanchang Formation during the Triassic in the southwest of the Ordos basin. In this braided delta system, abundant oil and gas resources have been observed, and the area is a hotspot for oil and gas resource exploration. Through extensive field work on outcrops and cores and analyses of geophysical data, it was determined that developments in the Late Triassic produced favorable geological conditions for the development of shallow water braided river deltas. Such conditions included a large basin, flat terrain, and wide and shallow water areas; wet and dry cyclical climate changes; ancient water turbulence; dramatic depth cycle changes; ancient uplift development; strong weathering of parent rock; and abundant supply. The shallow water braided river delta showed grain sediment granularity, plastic debris, and sediment with mature composition and structure that reflected the strong hydrodynamic environment of large tabular cross-bedding, wedge cross-bedding, and multiple positive rhythms superimposed to form a thick sand body layer. The branch river bifurcation developed underwater, and the thickness of the sand body increased further, indicating that the slope was slow and located in shallow water. The seismic responses of the braided river delta reflected strong shallow water performance, indicated by a progradation seismic reflection phase axis that was relatively flat; in addition, the seismic reflection amplitude was strong and continuous with a low angle and extended over considerable distances (up to 50 km). The sedimentary center was close to the provenance, the width of the river was large, and a shallow sedimentary structure and a sedimentary rhythm were developed. The development of the delta was primarily controlled by tectonic activity and changes in the lake level; as a result, the river delta sedimentary system eventually presented a " small plain, big front" character.	[Liu, Ziliang; Shen, Fang] Chengdu Univ Technol, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Peoples R China; [Liu, Ziliang; Tan, Mengqi] Chengdu Univ Technol, Sch Energy, Chengdu, Peoples R China; [Zhu, Xiaomin] China Univ Petr, State Key Lab Geol Proc & Mineral Resources, Beijing, Peoples R China; [Li, Fengjie] Chengdu Univ Technol, Inst Sedimentary Geol, Chengdu, Peoples R China	Chengdu University of Technology; Chengdu University of Technology; China University of Petroleum; Chengdu University of Technology	Liu, ZL (corresponding author), Chengdu Univ Technol, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Peoples R China.	bugliu2001@163.com; xmzhu@cup.edu.cn		li, feng jie/0000-0001-8900-4064	National Natural Science Foundation of China [41272133]; National Demonstration Project of China [2008ZX05044-1-3-2]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Demonstration Project of China	This research was financially supported jointly by the National Natural Science Foundation of China (grant no. 41272133) and the National Demonstration Project of China (grant no. 2008ZX05044-1-3-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Donaldson A.C., 1974, SPECIAL PAPERS GEOLO, V148, P47, DOI DOI 10.1130/SPE148-P47; Fisk H.N., 1954, J SEDIMENT PETROL, V24, P76, DOI [10.1306/D4269661-2B26-11D7-8648000102C1865D, DOI 10.1306/D4269661-2B26-11D7-8648000102C1865D]; Garcia-Garcia F, 2006, SEDIMENT GEOL, V185, P79, DOI 10.1016/j.sedgeo.2005.10.010; Gong SL, 1986, COAL GEOLOGY EXPLORA, P2; Guo ZM, 1989, TECTONIC CHARACTERIS; Hu JY, 1992, THEORETICAL BASIS NO; [吉利明 JI Liming], 2006, [沉积学报, Acta Sedimentologica Sinica], V24, P426; Keumsuk L., 2007, J SEDIMENT RES, V77, P284; Kostic B, 2005, SEDIMENT GEOL, V181, P147, DOI 10.1016/j.sedgeo.2005.07.004; Lemons DR, 1999, AAPG BULL, V83, P635; [李洁 Li Jie], 2011, [成都理工大学学报. 自然科学版, Journal of Chengdu University of Technology. Science & Technonogy Edition], V38, P132; [李相博 Li Xiangbo], 2011, [地球科学进展, Advance in Earth Sciences], V26, P286; Li Y, 2013, GEOLOGICAL J CHINA U, P23; Li ZX, 1995, COAL GEOLOGY EXPLORA, V2, P7; Liao J, 2013, DIXUE QIANYUAN, V20, P1; [刘柳红 LIU Liu-hong], 2009, [现代地质, Geoscience], V23, P667; Liu Y. P., 2010, J ADV SIGNAL PROCESS, V2010, P1, DOI DOI 10.1038/TPJ.2009.55; Liu ZL, 2005, ACTA SEDIMENTOLOGICA, V24, P248; Longhitano SG, 2008, SEDIMENT GEOL, V210, P87, DOI 10.1016/j.sedgeo.2008.07.004; Lou Z., 1999, ACTA GEOL SIN-ENGL, V73, P83; Lu J, 2010, SCI TECHNOLOGY ENG, V10, P8407; [罗静兰 LUO Jinglan], 2008, [地质通报, Geological Bulletin of China], V27, P101; Olariu C, 2006, J SEDIMENT RES, V76, P212, DOI 10.2110/jsr.2006.026; Postma G, 1990, TERRA NOVA, V2, P124, DOI 10.1111/j.1365-3121.1990.tb00052.x; Su CQ, 1993, J CHANGAN U, V15, P23; Sun Yu, 2010, Dizhi Xuebao, V84, P1502; [王昌勇 WANG Changyong], 2011, [石油天然气学报, Journal of Oil and Gas Technology], V33, P11; Wang J., 2007, LITHOL RESERV CHIN, V19, P28; Wang Jia-hao, 2012, Earth Science - Journal of China University of Geosciences, V37, P556, DOI 10.3799/dqkx.2012.062; [王立武 Wang Liwu], 2012, [沉积学报, Acta Sedimentologica Sinica], V30, P1053; Xiao DS, 2011, SCI TECHNOLOGY ENG, V11, P4986; Ya DJ, 2011, PERIODICAL OCEAN U C, P299; [杨华 Yang Hua], 2013, [地学前缘, Earth Science Frontiers], V20, P10; Zhai GM, 1992, PETROLEUM GEOLOGY CH, V12; Zhang SN, 2000, J MINERALOGY PETROLO, V20, P25; Zhang XM, 2011, J CHONGQING U SCI TE, V13, P47; [赵宝峰 Zhao Baofeng], 2012, [沉积学报, Acta Sedimentologica Sinica], V30, P511; [朱筱敏 Zhu Xiaomin], 2013, [地学前缘, Earth Science Frontiers], V20, P19; [朱筱敏 Zhu Xiaomin], 2012, [地学前缘, Earth Science Frontiers], V19, P89	39	8	8	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0119704	10.1371/journal.pone.0119704	http://dx.doi.org/10.1371/journal.pone.0119704			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075611	Green Published, Green Submitted, gold			2022-12-26	WOS:000356329900001
J	Sakaguchi, M; Kim, K; Yu, LMY; Hashikawa, Y; Sekine, Y; Okumura, Y; Kawano, M; Hayashi, M; Kumar, D; Boyden, ES; McHugh, TJ; Hayashi, Y				Sakaguchi, Masanori; Kim, Karam; Yu, Lily Mae Yee; Hashikawa, Yoshiko; Sekine, Yukiko; Okumura, Yuki; Kawano, Masako; Hayashi, Masanobu; Kumar, Deependra; Boyden, Edward S.; McHugh, Thomas J.; Hayashi, Yasunori			Inhibiting the Activity of CA1 Hippocampal Neurons Prevents the Recall of Contextual Fear Memory in Inducible ArchT Transgenic Mice	PLOS ONE			English	Article							OPTICAL ACTIVATION; PYRAMIDAL CELLS; IN-VIVO; STRATEGIES; CORTEX; CONSOLIDATION; MICROCIRCUIT; EXPRESSION; RETRIEVAL; DYNAMICS	The optogenetic manipulation of light- activated ion- channels/pumps (i.e., opsins) can reversibly activate or suppress neuronal activity with precise temporal control. Therefore, optogenetic techniques hold great potential to establish causal relationships between specific neuronal circuits and their function in freely moving animals. Due to the critical role of the hippocampal CA1 region in memory function, we explored the possibility of targeting an inhibitory opsin, ArchT, to CA1 pyramidal neurons in mice. We established a transgenic mouse line in which tetracycline trans- activator induces ArchT expression. By crossing this line with a CaMKIIa- tTA transgenic line, the delivery of light via an implanted optrode inhibits the activity of excitatory CA1 neurons. We found that light delivery to the hippocampus inhibited the recall of a contextual fear memory. Our results demonstrate that this optogenetic mouse line can be used to investigate the neuronal circuits underlying behavior.	[Sakaguchi, Masanori; Kim, Karam; Yu, Lily Mae Yee; Hashikawa, Yoshiko; Sekine, Yukiko; Okumura, Yuki; Kawano, Masako; McHugh, Thomas J.; Hayashi, Yasunori] RIKEN, Brain Sci Inst, Wako, Saitama, Japan; [Sakaguchi, Masanori; Hayashi, Masanobu; Kumar, Deependra] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki, Japan; [Boyden, Edward S.] MIT, Media Lab, Synthet Neurobiol Grp, Cambridge, MA 02139 USA; [Hayashi, Yasunori] Saitama Univ, Saitama Univ Brain Sci Inst, Saitama 3388570, Japan	RIKEN; University of Tsukuba; Massachusetts Institute of Technology (MIT); Saitama University	Sakaguchi, M (corresponding author), RIKEN, Brain Sci Inst, Wako, Saitama, Japan.	masanori.sakaguchi@gmail.com; yhayashi@brain.riken.jp	Kim, Karam/K-1412-2018; McHugh, Thomas J/A-6693-2010; Hayashi, Yasunori/AAF-1408-2019; Kumar, Deependra/G-3510-2018; McHugh, Thomas/M-6159-2019; Hayashi, Yasunori/C-2249-2008	Kim, Karam/0000-0002-1886-5163; McHugh, Thomas J/0000-0002-1243-5189; Hayashi, Yasunori/0000-0002-7560-3004; McHugh, Thomas/0000-0002-1243-5189; Hayashi, Yasunori/0000-0002-7560-3004; Sakaguchi, Masanori/0000-0002-7211-9452; Kumar, Deependra/0000-0003-1529-7567	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan Society for the Promotion of Science KAKENHI [26115502, 25116530, 24700340]; RIKEN Special Postdoctoral Fellowship; strategic program for R&D (President's discretionary fund) of RIKEN; Uehara Memorial Foundation; Takeda Science Foundation; Brain Science Foundation; Research Foundation for Optoscience and Technology; Japan Foundation for Applied Enzymology; RIKEN, U.S. National Institutes of Health [R01DA17310]; MEXT, Human Frontier Science Program; Takeda Pharmaceutical Co. Ltd.; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017310] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [15K14330, 26115502] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan Society for the Promotion of Science KAKENHI; RIKEN Special Postdoctoral Fellowship; strategic program for R&D (President's discretionary fund) of RIKEN; Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Brain Science Foundation; Research Foundation for Optoscience and Technology; Japan Foundation for Applied Enzymology; RIKEN, U.S. National Institutes of Health; MEXT, Human Frontier Science Program; Takeda Pharmaceutical Co. Ltd.(Takeda Pharmaceutical Company Ltd); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by the World Premier International Research Center Initiative and Grants for Excellent Graduate Schools from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan Society for the Promotion of Science KAKENHI grants (numbers 26115502, 25116530, and 24700340), RIKEN Special Postdoctoral Fellowship, the strategic program for R&D (President's discretionary fund) of RIKEN, Uehara Memorial Foundation, Takeda Science Foundation, Brain Science Foundation, Research Foundation for Optoscience and Technology, and Japan Foundation for Applied Enzymology to MS and by RIKEN, U.S. National Institutes of Health (R01DA17310), Grant-in-Aid for Scientific Research (A), Scientific Research on Innovative Area 'Foundation of Synapse and Neurocircuit Pathology' from MEXT, Human Frontier Science Program, Takeda Pharmaceutical Co. Ltd., and Fujitsu Laboratories to Y. Hayashi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Arruda-Carvalho M, 2011, J NEUROSCI, V31, P15113, DOI 10.1523/JNEUROSCI.3432-11.2011; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Courtin J, 2014, NATURE, V505, P92, DOI 10.1038/nature12755; Denny CA, 2014, NEURON, V83, P189, DOI 10.1016/j.neuron.2014.05.018; Ferenczi E, 2012, NAT NEUROSCI, V15, P1058, DOI 10.1038/nn.3172; Fukaya M, 2005, EUR J NEUROSCI, V21, P1432, DOI 10.1111/j.1460-9568.2005.03957.x; Goshen I, 2011, CELL, V147, P678, DOI 10.1016/j.cell.2011.09.033; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Gu Y, 2012, NAT NEUROSCI, V15, P1700, DOI 10.1038/nn.3260; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Han X, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00018; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Huff ML, 2013, P NATL ACAD SCI USA, V110, P3597, DOI 10.1073/pnas.1219593110; Johansen JP, 2010, P NATL ACAD SCI USA, V107, P12692, DOI 10.1073/pnas.1002418107; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; Nakashiba T, 2009, NEURON, V62, P781, DOI 10.1016/j.neuron.2009.05.013; Raimondo JV, 2012, NAT NEUROSCI, V15, P1102, DOI 10.1038/nn.3143; Sakaguchi M, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-32; Tanaka KZ, 2014, NEURON, V84, P347, DOI 10.1016/j.neuron.2014.09.037; Tanaka KF, 2012, CELL REP, V2, P397, DOI 10.1016/j.celrep.2012.06.011; Tsunematsu T, 2013, BEHAV BRAIN RES, V255, P64, DOI 10.1016/j.bbr.2013.05.021; Van den Oever MC, 2013, J NEUROSCI, V33, P18225, DOI 10.1523/JNEUROSCI.2412-13.2013; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	30	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130163	10.1371/journal.pone.0130163	http://dx.doi.org/10.1371/journal.pone.0130163			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075894	Green Submitted, Green Published, gold			2022-12-26	WOS:000356329900147
J	Flegel, C; Schobel, N; Altmuller, J; Becker, C; Tannapfel, A; Hatt, H; Gisselmann, G				Flegel, Caroline; Schoebel, Nicole; Altmueller, Janine; Becker, Christian; Tannapfel, Andrea; Hatt, Hanns; Gisselmann, Guenter			RNA-Seq Analysis of Human Trigeminal and Dorsal Root Ganglia with a Focus on Chemoreceptors	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; NICOTINIC ACETYLCHOLINE-RECEPTORS; DOMAIN POTASSIUM CHANNELS; LINGUAL NERVE NEUROMAS; POTENTIAL VANILLOID 1; RAT SENSORY NEURONS; TRANSIENT RECEPTOR; OLFACTORY RECEPTOR; CAPSAICIN-RECEPTOR; ION-CHANNEL	The chemosensory capacity of the somatosensory system relies on the appropriate expression of chemoreceptors, which detect chemical stimuli and transduce sensory information into cellular signals. Knowledge of the complete repertoire of the chemoreceptors expressed in human sensory ganglia is lacking. This study employed the next-generation sequencing technique (RNA-Seq) to conduct the first expression analysis of human trigeminal ganglia (TG) and dorsal root ganglia (DRG). We analyzed the data with a focus on G-protein coupled receptors (GPCRs) and ion channels, which are (potentially) involved in chemosensation by somatosensory neurons in the human TG and DRG. For years, transient receptor potential (TRP) channels have been considered the main group of receptors for chemosensation in the trigeminal system. Interestingly, we could show that sensory ganglia also express a panel of different olfactory receptors (ORs) with putative chemosensory function. To characterize OR expression in more detail, we performed microarray, semiquantitative RT-PCR experiments, and immunohistochemical staining. Additionally, we analyzed the expression data to identify further known or putative classes of chemoreceptors in the human TG and DRG. Our results give an overview of the major classes of chemoreceptors expressed in the human TG and DRG and provide the basis for a broader understanding of the reception of chemical cues.	[Flegel, Caroline; Hatt, Hanns; Gisselmann, Guenter] Ruhr Univ Bochum, Dept Cell Physiol, Bochum, Germany; [Schoebel, Nicole] Ruhr Univ Bochum, Dept Anim Physiol, Bochum, Germany; [Altmueller, Janine; Becker, Christian] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Tannapfel, Andrea] Ruhr Univ Bochum, Inst Pathol, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum; University of Cologne; Ruhr University Bochum	Gisselmann, G (corresponding author), Ruhr Univ Bochum, Dept Cell Physiol, Univ Str 150, Bochum, Germany.	Guenter.Gisselmann@rub.de		Altmuller, Janine/0000-0003-4372-1521	Heinrich und Alma Vogelsang Stiftung; DFG-Sonderforschungsbereich [642]	Heinrich und Alma Vogelsang Stiftung; DFG-Sonderforschungsbereich(German Research Foundation (DFG))	Caroline Flegel was funded by Heinrich und Alma Vogelsang Stiftung. Hanns Hatt was funded by DFG-Sonderforschungsbereich 642 "GTP- and ATP dependent membrane processes." The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram SE, 2006, ANESTHESIOLOGY, V105, P146, DOI 10.1097/00000542-200607000-00024; Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Alimohammadi H, 2000, CHEM SENSES, V25, P61, DOI 10.1093/chemse/25.1.61; Ameur A, 2011, NAT STRUCT MOL BIOL, V18, P1435, DOI 10.1038/nsmb.2143; Anand U, 2008, NEUROSCI LETT, V438, P221, DOI 10.1016/j.neulet.2008.04.007; Asai H, 1996, BIOCHEM BIOPH RES CO, V221, P240, DOI 10.1006/bbrc.1996.0580; Axelsson HE, 2009, NEUROSCIENCE, V162, P1322, DOI 10.1016/j.neuroscience.2009.05.052; Bautista DM, 2008, NAT NEUROSCI, V11, P772, DOI 10.1038/nn.2143; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Behrendt HJ, 2004, BRIT J PHARMACOL, V141, P737, DOI 10.1038/sj.bjp.0705652; Beltran LR, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00141; BENARIE N, 1994, HUM MOL GENET, V3, P229, DOI 10.1093/hmg/3.2.229; Biggs JE, 2007, BRAIN RES, V1127, P59, DOI 10.1016/j.brainres.2006.10.014; Bonaventure P, 1998, NEUROREPORT, V9, P641, DOI 10.1097/00001756-199803090-00015; Bonigk W, 1999, J NEUROSCI, V19, P5332; Borowsky B, 2001, P NATL ACAD SCI USA, V98, P8966, DOI 10.1073/pnas.151105198; Braun T, 2007, GASTROENTEROLOGY, V132, P1890, DOI 10.1053/j.gastro.2007.02.036; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Burnstock G, 2009, CURR PHARM DESIGN, V15, P1717, DOI 10.2174/138161209788186335; Busse D, 2014, J INVEST DERMATOL; Martinez-Garcia MC, 2013, HISTOL HISTOPATHOL, V28, P1507, DOI 10.14670/HH-28.1507; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Chen G, 2000, MOL PHARMACOL, V57, P125; Cho H, 2012, NAT NEUROSCI, V15, P1015, DOI 10.1038/nn.3111; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Coughlin SR, 2003, J CLIN INVEST, V111, P25, DOI 10.1172/JCI200317564; Devor M, 1999, PAIN, pS27, DOI 10.1016/S0304-3959(99)00135-9; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Domotor Andras, 2005, Inflammopharmacology, V13, P161, DOI 10.1163/156856005774423737; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; DOTY RL, 1978, PHYSIOL BEHAV, V20, P175, DOI 10.1016/0031-9384(78)90070-7; Duran C, 2012, AM J PHYSIOL-CELL PH, V302, pC482, DOI 10.1152/ajpcell.00140.2011; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Facer P, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-11; Faussone-Pellegrini MS, 2005, HISTOCHEM CELL BIOL, V124, P61, DOI 10.1007/s00418-005-0025-9; Feldmesser E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-121; Ferrero DM, 2011, P NATL ACAD SCI USA, V108, P11235, DOI 10.1073/pnas.1103317108; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Flegel C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055368; Flockerzi V., 2007, V179, P1; Fusi C, 2014, J INVEST DERMATOL, V134, P2408, DOI 10.1038/jid.2014.145; Gabashvili IS, 2007, JARO-J ASSOC RES OTO, V8, P305, DOI 10.1007/s10162-007-0082-y; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; George SR, 2002, NAT REV DRUG DISCOV, V1, P808, DOI 10.1038/nrd913; Gerhold KA, 2009, ANN NY ACAD SCI, V1170, P184, DOI 10.1111/j.1749-6632.2009.03895.x; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Gopinath Preethi, 2005, BMC Womens Health, V5, P2, DOI 10.1186/1472-6874-5-2; Grosser BI, 2000, PSYCHONEUROENDOCRINO, V25, P289, DOI 10.1016/S0306-4530(99)00056-6; Gu X, 2013, AM J RESP CELL MOL B; GU YP, 1994, J NEUROSCI, V14, P4561; Guarino MPL, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2010.01514.x; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Han SK, 2002, P NATL ACAD SCI USA, V99, P14740, DOI 10.1073/pnas.192565799; Hanani M, 2005, BRAIN RES REV, V48, P457, DOI 10.1016/j.brainresrev.2004.09.001; Hartmann C, 2013, CHEMPLUSCHEM, V78, P695, DOI 10.1002/cplu.201300008; Hou MY, 2002, NEUROSCI LETT, V330, P223, DOI 10.1016/S0304-3940(02)00741-3; Hummel T, 2005, CHEM SENSES, V30, pI205, DOI 10.1093/chemse/bjh186; Hummel T, 2011, INT J PSYCHOPHYSIOL, V81, P116, DOI 10.1016/j.ijpsycho.2011.05.002; Ibarra-Soria X, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004593; Ichikawa H, 2000, NEUROSCIENCE, V101, P719, DOI 10.1016/S0306-4522(00)00427-9; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Johnson KW, 1998, PROG DRUG RES, V51, P219; Kanageswaran N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113170; Keydar I, 2013, HUM MUTAT, V34, P32, DOI 10.1002/humu.22212; Kilic G, 2010, PSYCHIAT RES, V175, P43, DOI 10.1016/j.psychres.2008.10.001; KOBAL G, 1988, ELECTROEN CLIN NEURO, V71, P241, DOI 10.1016/0168-5597(88)90023-8; Kunzelmann K, 2012, EXP PHYSIOL, V97, P184, DOI 10.1113/expphysiol.2011.058206; Lafreniere RG, 2010, NAT MED, V16, P1157, DOI 10.1038/nm.2216; Laska M, 1997, CHEM SENSES, V22, P447, DOI 10.1093/chemse/22.4.447; Lembo PMC, 2002, NAT NEUROSCI, V5, P201, DOI 10.1038/nn815; Li WG, 2011, ACS CHEM NEUROSCI, V2, P26, DOI 10.1021/cn100094b; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Liberles SD, 2009, ANN NY ACAD SCI, V1170, P168, DOI 10.1111/j.1749-6632.2009.04014.x; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liibbert M, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00064; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; Liu L, 1998, CHEM SENSES, V23, P125, DOI 10.1093/chemse/23.2.125; Liu L, 1998, BRAIN RES, V809, P238, DOI 10.1016/S0006-8993(98)00862-2; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Lubbert M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077998; Mainland JD, 2014, NAT NEUROSCI, V17, P114, DOI 10.1038/nn.3598; Mandadi S, 2009, PFLUG ARCH EUR J PHY, V458, P1093, DOI 10.1007/s00424-009-0703-x; Manteniotis S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079523; MASON JR, 1983, BRAIN RES, V269, P196; Massberg D, 2015, ARCH BIOCHEM BIOPHYS, V566, P100, DOI 10.1016/j.abb.2014.12.004; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Medhurst AD, 2001, MOL BRAIN RES, V86, P101, DOI 10.1016/S0169-328X(00)00263-1; Mezey E, 2000, P NATL ACAD SCI USA, V97, P3655, DOI 10.1073/pnas.060496197; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; Morgan CR, 2009, NEUROSCI LETT, V465, P189, DOI 10.1016/j.neulet.2009.08.055; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Neuhaus EM, 2009, J BIOL CHEM, V284, P16218, DOI 10.1074/jbc.M109.012096; Ohkawara S, 2010, BIOL PHARM BULL, V33, P1434, DOI 10.1248/bpb.33.1434; Padilla F, 2007, MOL CELL NEUROSCI, V35, P138, DOI 10.1016/j.mcn.2007.02.008; Pan AH, 2012, PURINERG SIGNAL, V8, P245, DOI 10.1007/s11302-011-9277-0; PARMENTIER M, 1992, NATURE, V355, P453, DOI 10.1038/355453a0; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Pecze L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003419; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pifferi S, 2006, P NATL ACAD SCI USA, V103, P12929, DOI 10.1073/pnas.0604505103; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Rasche S, 2010, CHEM SENSES, V35, P239, DOI 10.1093/chemse/bjq007; Rau KK, 2009, J NEUROSCI, V29, P8612, DOI 10.1523/JNEUROSCI.1057-09.2009; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Rodriguez I, 2000, NAT GENET, V26, P18, DOI 10.1038/79124; Rothermel M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026158; Savic I, 2001, NEURON, V31, P661, DOI 10.1016/S0896-6273(01)00390-7; Schobel N, 2014, CHEM SENSES; Schobel N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048005; Schreiner BSP, 2014, EUR J PHARM; Scott K, 2005, NEURON, V48, P455, DOI 10.1016/j.neuron.2005.10.015; Seki N, 2006, RHINOLOGY, V44, P128; Sherkheli MA, 2010, J PHARM PHARM SCI, V13, P242, DOI 10.18433/J3N88N; Shiao MS, 2012, GENOME BIOL EVOL, V4, P703, DOI 10.1093/gbe/evs039; Shinohara T, 2004, J BIOL CHEM, V279, P23559, DOI 10.1074/jbc.M314240200; Shirokova E, 2008, FASEB J, V22, P1416, DOI 10.1096/fj.07-9233com; SILVER WL, 1991, BRAIN RES, V561, P212, DOI 10.1016/0006-8993(91)91597-T; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Solinski HJ, 2012, J BIOL CHEM, V287, P40956, DOI 10.1074/jbc.M112.408617; Sondersorg AC, 2014, J BIOL CHEM; Spehr J, 2004, EUR J NEUROSCI, V19, P2497, DOI 10.1111/j.0953-816X.2004.03329.x; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Stotz SC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002082; Strickland IT, 2008, EUR J PAIN, V12, P564, DOI 10.1016/j.ejpain.2007.09.001; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Subramanian H, 2011, MOL PHARMACOL, V79, P1005, DOI 10.1124/mol.111.071472; Suzuki M, 2003, NEUROSCI LETT, V353, P189, DOI 10.1016/j.neulet.2003.09.041; Szallasi A, 1995, Acta Physiol Scand Suppl, V629, P1; Takeda M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-5; Tatemoto K, 2006, BIOCHEM BIOPH RES CO, V349, P1322, DOI 10.1016/j.bbrc.2006.08.177; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Thuerauf N, 1999, PSYCHOPHARMACOLOGY, V142, P236, DOI 10.1007/s002130050885; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Van Haute C, 2010, THESCIENTIFICWORLDJO, V10, P1597, DOI 10.1100/tsw.2010.149; Vandewauw I, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-21; Veitinger T, 2011, J BIOL CHEM, V286, P17311, DOI 10.1074/jbc.M110.211524; Verbeurgt C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096333; Viana F, 2011, ACS CHEM NEUROSCI, V2, P38, DOI 10.1021/cn100102c; Vogt-Eisele AK, 2007, BRIT J PHARMACOL, V151, P530, DOI 10.1038/sj.bjp.0707245; Vrontou S, 2013, NATURE, V493, P669, DOI 10.1038/nature11810; Wallrabenstein I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054950; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yiangou YG, 2001, EUR J GASTROEN HEPAT, V13, P891, DOI 10.1097/00042737-200108000-00003; Yilmaz Z, 2007, J CLIN NEUROSCI, V14, P864, DOI 10.1016/j.jocn.2006.09.002; Zhang XH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r86; Zhang Y, 2006, PLOS COMPUT BIOL, V2, P88, DOI 10.1371/journal.pcbi.0020013; Zhu JJ, 1998, NEUROSCIENCE, V87, P767, DOI 10.1016/S0306-4522(98)00209-7	155	116	116	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128951	10.1371/journal.pone.0128951	http://dx.doi.org/10.1371/journal.pone.0128951			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070209	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000036
J	Roa, PL; Perez-Granda, MJ; Munoz, P; Catalan, P; Alonso, R; Sanchez-Perez, E; Novoa, E; Bouza, E				Lopez Roa, Paula; Jesus Perez-Granda, Maria; Munoz, Patricia; Catalan, Pilar; Alonso, Roberto; Sanchez-Perez, Eduardo; Novoa, Emma; Bouza, Emilio			A Prospective Monitoring Study of Cytomegalovirus Infection in Non-Immunosuppressed Critical Heart Surgery Patients	PLOS ONE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; SOLID-ORGAN TRANSPLANTATION; INTENSIVE-CARE PATIENTS; ILL SURGICAL-PATIENTS; NOSOCOMIAL INFECTIONS; DIABETES-MELLITUS; CARDIAC-SURGERY; REACTIVATION; MORTALITY; OUTCOMES	Background Reactivation cytomegalovirus (CMV) has been reported occasionally in immnunocompetent patients in the intensive care unit (ICU). The epidemiology and association of CMV infection with adverse outcome is not well defined in this population. Patients undergoing major heart surgery (MHS) are at a particularly high risk of infection. CMV infection has not been systematically monitored in MSH-ICU patients. Methods We assessed CMV plasma viremia weekly using a quantitative polymerase chain reaction assay in a prospective cohort of immunocompetent adults admitted to the MHS-ICU for at least 72 hours between October 2012 and May 2013. Risk factors for CMV infection and its potential association with continued hospitalization or death by day 30 (composited endpoint) were assessed using univariate and multivariate logistic regression analyses. Results CMV viremia at any level was recorded in 16.5% of patients at a median of 17 days (range, 3-54 days) after admission to the MHS-ICU. Diabetes (adjusted OR, 5.6; 95% CI, 1.8-17.4; p=0.003) and transfusion requirement (>10 units) (adjusted OR, 13.7; 95% CI, 3.9-47.8; p<0.001) were independent risk factors associated with CMV reactivation. Reactivation of CMV at any level was independently associated with the composite endpoint (adjusted OR, 12.1; 95% CI, 2.3-64; p= 0.003). Conclusion Reactivation of CMV is relatively frequent in immunocompetent patients undergoing MHS and is associated with prolonged hospitalization or death.	[Lopez Roa, Paula; Munoz, Patricia; Catalan, Pilar; Alonso, Roberto; Bouza, Emilio] Hosp Gen Univ Gregorio Maranon, Dept Clin Microbiol & Infect Dis, Madrid, Spain; [Lopez Roa, Paula; Jesus Perez-Granda, Maria; Munoz, Patricia; Alonso, Roberto; Bouza, Emilio] Inst Invest Biomed Gregorio Maranon, Madrid, Spain; [Jesus Perez-Granda, Maria; Munoz, Patricia; Bouza, Emilio] Univ Complutense, Sch Med, Dept Med, E-28040 Madrid, Spain; [Jesus Perez-Granda, Maria; Sanchez-Perez, Eduardo; Novoa, Emma] Hosp Gen Univ Gregorio Maranon, Dept Anesthesiol, Madrid, Spain	General University Gregorio Maranon Hospital; Complutense University of Madrid; General University Gregorio Maranon Hospital	Roa, PL (corresponding author), Hosp Gen Univ Gregorio Maranon, Dept Clin Microbiol & Infect Dis, Madrid, Spain.	plroa@salud.madrid.org	Roa, Paula Lopez/D-5041-2016; Bouza, Emilio/D-8661-2014; Muñoz, Patricia/E-9431-2017; GRANDA, MARIA JESUS mjpg PEREZ/L-3040-2015	Roa, Paula Lopez/0000-0002-7989-4275; Bouza, Emilio/0000-0001-6967-9267; Muñoz, Patricia/0000-0001-5706-5583; GRANDA, MARIA JESUS mjpg PEREZ/0000-0002-0613-2122				Angele MK, 2002, CRIT CARE, V6, P298, DOI 10.1186/cc1514; Benhammane H, 2012, CASE REP ONCOL MED, V2012, DOI 10.1155/2012/137291; Blyth D, 2012, TRANSPL INFECT DIS, V14, P149, DOI 10.1111/j.1399-3062.2011.00705.x; Boeckh Michael, 2003, Herpes, V10, P12; Bouza E, 2006, J HOSP INFECT, V64, P224, DOI 10.1016/j.jhin.2006.06.019; CAUL EO, 1971, LANCET, V1, P777; Cervia JS, 2007, CLIN INFECT DIS, V45, P1008, DOI 10.1086/521896; Cook CH, 1998, AM J SURG, V176, P357, DOI 10.1016/S0002-9610(98)00205-0; Cook CH, 2003, CRIT CARE MED, V31, P1923, DOI 10.1097/01.CCM.0000070222.11325.C4; De Vlieger G, 2012, CRIT CARE MED, V40, P36, DOI 10.1097/CCM.0b013e31822b50ae; DOMART Y, 1990, CHEST, V97, P18, DOI 10.1378/chest.97.1.18; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Harvala H, 2013, J MED VIROL, V85, P893, DOI 10.1002/jmv.23539; Heininger A, 2001, CRIT CARE MED, V29, P541, DOI 10.1097/00003246-200103000-00012; Heininger A, 2011, CRIT CARE, V15, DOI 10.1186/cc10069; Jaber S, 2005, CHEST, V127, P233, DOI 10.1378/chest.127.1.233; Kalil AC, 2009, CRIT CARE MED, V37, P2350, DOI 10.1097/CCM.0b013e3181a3aa43; Kijpittayarit-Arthurs S, 2007, J HEART LUNG TRANSPL, V26, P1019, DOI 10.1016/j.healun.2007.07.016; KOLLEF MH, 1993, JAMA-J AM MED ASSOC, V270, P1965, DOI 10.1001/jama.270.16.1965; Kollef MH, 1997, CHEST, V112, P666, DOI 10.1378/chest.112.3.666; Kutza AST, 1998, CLIN INFECT DIS, V26, P1076, DOI 10.1086/520307; Limaye AP, 2008, JAMA-J AM MED ASSOC, V300, P413, DOI 10.1001/jama.300.4.413; Limaye AP, 2010, REV MED VIROL, V20, P372, DOI 10.1002/rmv.664; Linares L, 2011, TRANSPL P, V43, P2145, DOI 10.1016/j.transproceed.2011.05.007; Osawa R, 2009, CRIT CARE, V13, DOI 10.1186/cc7875; PUGIN J, 1991, AM REV RESPIR DIS, V143, P1121, DOI 10.1164/ajrccm/143.5_Pt_1.1121; Roberts BW, 2005, SOUTH MED J, V98, P686, DOI 10.1097/01.SMJ.0000163310.12516.2D; Snyder LD, 2010, AM J RESP CRIT CARE, V181, P1391, DOI 10.1164/rccm.200911-1786OC; Sodano L, 2004, Ann Ig, V16, P735; Stephan F, 1996, INTENS CARE MED, V22, P1244, DOI 10.1007/s001340050245; Visseren FLJ, 1997, DIABETES RES CLIN PR, V36, P49, DOI 10.1016/S0168-8227(97)00027-2; Ziemann M, 2008, CRIT CARE MED, V36, P3145, DOI 10.1097/CCM.0b013e31818f3fc4; Ziemann M, 2014, TRANSFUS MED HEMOTH, V41, P40, DOI 10.1159/000357102	33	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129447	10.1371/journal.pone.0129447	http://dx.doi.org/10.1371/journal.pone.0129447			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070136	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000076
J	Mun, PS; Ting, HN; Ong, TA; Wong, CM; Ng, KH; Chong, YB				Mun, Peck Shen; Ting, Hua Nong; Ong, Teng Aik; Wong, Chew Ming; Ng, Kwan Hong; Chong, Yip Boon			A Study of Dielectric Properties of Proteinuria between 0.2 GHz and 50 GHz	PLOS ONE			English	Article							TISSUES; PERMITTIVITY; HEMATOCRIT; BLOOD; WATER; RISK	This paper investigates the dielectric properties of urine in normal subjects and subjects with chronic kidney disease (CKD) at microwave frequency of between 0.2 GHz and 50 GHz. The measurements were conducted using an open-ended coaxial probe at room temperature (25 degrees C), at 30 degrees C and at human body temperature (37 degrees C). There were statistically significant differences in the dielectric properties of the CKD subjects compared to those of the normal subjects. Statistically significant differences in dielectric properties were observed across the temperatures for normal subjects and CKD subjects. Pearson correlation test showed the significant correlation between proteinuria and dielectric properties. The experimental data closely matched the single-pole Debye model. The relaxation dispersion and relaxation time increased with the proteinuria level, while decreasing with the temperature. As for static conductivity, it increased with proteinuria level and temperature.	[Mun, Peck Shen; Ting, Hua Nong] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia; [Ong, Teng Aik] Univ Malaya, Fac Med, Dept Surg, Kuala Lumpur, Malaysia; [Wong, Chew Ming] Univ Malaya, Fac Med, Fac Med, Kuala Lumpur, Malaysia; [Ng, Kwan Hong] Univ Malaya, Fac Med, Dept Biomed Imaging, Kuala Lumpur, Malaysia; [Chong, Yip Boon] Damansara Specialist Hosp, Petaling Jaya, Selangor, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Ting, HN (corresponding author), Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia.	tinghn@um.edu.my	Ng, Kwan Hoong/D-2231-2009; Ong, Teng Aik/B-5321-2010; Ong, Teng Aik/B-2284-2010; TING, HUA NONG/B-5255-2010; Wong, Chew Ming/F-8822-2010	Ong, Teng Aik/0000-0002-0207-8966; Wong, Chew Ming/0000-0003-4406-4850; Ting, Hua Nong/0000-0001-6295-1651	University of Malaya [PG036-2013A]	University of Malaya(Universiti Malaya)	This work was supported by grants from University of Malaya (PG036-2013A). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla S, 2011, AIP ADV, V1, DOI 10.1063/1.3556986; Abdalla S, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3458908; ALISON JM, 1993, PHYS MED BIOL, V38, P971, DOI 10.1088/0031-9155/38/7/007; Boresch S, 2000, J PHYS CHEM B, V104, P8743, DOI 10.1021/jp0008905; Desouky OS, 2009, ROMANIAN J BIOPHYSIC, V19, P239; Ellison WJ, 2007, J PHYS CHEM REF DATA, V36, P1, DOI 10.1063/1.2360986; Ferry JD, 1938, J AM CHEM SOC, V60, P1123, DOI 10.1021/ja01272a036; Gabriel C, 2006, PHYS MED BIOL, V51, P6033, DOI 10.1088/0031-9155/51/23/006; Gabriel C, 1996, PHYS MED BIOL, V41, P2231, DOI 10.1088/0031-9155/41/11/001; Gabriel S, 1996, PHYS MED BIOL, V41, P2251, DOI 10.1088/0031-9155/41/11/002; GRANT EH, 1968, J PHYS CHEM-US, V72, P4373, DOI 10.1021/j100859a004; Ikeda K, 2012, PROTEINS PROTEOMICS, P1; Iseki K, 2004, AM J KIDNEY DIS, V44, P806, DOI 10.1016/S0272-6386(04)01080-7; Ishani A, 2006, J AM SOC NEPHROL, V17, P1444, DOI 10.1681/ASN.2005091012; Jaspard F, 2003, PHYSIOL MEAS, V24, P137, DOI 10.1088/0967-3334/24/1/310; Komarov V, 2005, ENCY RF MICROWAVE EN; Lamb EJ, 2009, ANN CLIN BIOCHEM, V46, P205, DOI 10.1258/acb.2009.009007; Matyushov DV, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/32/325105; Nandi N, 1998, J PHYS CHEM A, V102, P8217, DOI 10.1021/jp983327j; Nortemann K, 1997, J PHYS CHEM A, V101, P6864, DOI 10.1021/jp971623a; Oncley JL, 1938, J AM CHEM SOC, V60, P1115, DOI 10.1021/ja01272a035; PETHIG R, 1987, PHYS MED BIOL, V32, P933, DOI 10.1088/0031-9155/32/8/001; Peyman A, 2012, PHYS MED BIOL, V57, pN339, DOI 10.1088/0031-9155/57/19/N339; Peyman A, 2010, PHYS MED BIOL, V55, pN413, DOI 10.1088/0031-9155/55/15/N02; Remuzzi G, 1998, NEW ENGL J MED, V339, P1448, DOI 10.1056/NEJM199811123392007; Rodriguez-Arteche I, 2012, PHYS CHEM CHEM PHYS, V14, P11352, DOI 10.1039/c2cp41496a; Shim S, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4774304; Smulders PFM, 2013, MICROW OPT TECHN LET, V55, P1916, DOI 10.1002/mop.27672; SUROWIEC A, 1985, PHYS MED BIOL, V30, P1131, DOI 10.1088/0031-9155/30/10/012; Wentholt IME, 2008, DIABETOLOGIA, V51, P183, DOI 10.1007/s00125-007-0842-6; Zhadobov M, 2012, BIOELECTROMAGNETICS, V33, P346, DOI 10.1002/bem.20713	31	6	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130011	10.1371/journal.pone.0130011	http://dx.doi.org/10.1371/journal.pone.0130011			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066351	gold, Green Published, Green Submitted			2022-12-26	WOS:000356327000133
J	Pizzutto, SJ; Upham, JW; Yerkovich, ST; Chang, AB				Pizzutto, Susan J.; Upham, John W.; Yerkovich, Stephanie T.; Chang, Anne B.			High Pulmonary Levels of IL-6 and IL-1 beta in Children with Chronic Suppurative Lung Disease Are Associated with Low Systemic IFN-gamma Production in Response to Non-Typeable Haemophilus influenzae	PLOS ONE			English	Article							INDIGENOUS CHILDREN; BRONCHIECTASIS; IMMUNITY; CELLS	Non-typeable Haemophilus influenzae (NTHi) is commonly associated with chronic suppurative lung disease in children. We have previously shown that children with chronic suppurative lung disease have a reduced capacity to produce IFN-gamma in response to NTHi compared with healthy control children. The aim of this study was to determine if deficient NTHi-specific IFN-gamma production is associated with heightened systemic or airway inflammation. We measured a panel of cytokines (IFN-gamma, IL-1 beta, IL-6, IL-8, IL-12 p70), antimicrobial proteins (LL-37, IP-10) as well as cellular and clinical factors associated with airway and systemic inflammation in 70 children with chronic suppurative lung disease. IFN-gamma was measured in peripheral blood mononuclear cells challenged in vitro with live NTHi. Regression analysis was used to assess the association between the systemic and airway inflammation and the capacity to produce IFN-gamma. On multivariate regression, NTHi-specific IFN-gamma production was significantly negatively associated with the BAL concentrations of the inflammatory cytokines IL-6 (beta=-0.316; 95% CI -0.49, -0.14; p=0.001) and IL-1 beta (beta=-0.023; 95% CI -0.04, -0.01; p=0.001). This association was independent of bacterial or viral infection, BAL cellularity and the severity of bronchiectasis (using modified Bhalla score on chest CT scans). We found limited evidence of systemic inflammation in children with chronic suppurative lung disease. In summary, increased local airway inflammation is associated with a poorer systemic cell-mediated immune response to NTHi in children with chronic suppurative lung disease. These data support the emerging body of evidence that impaired cell-mediated immune responses and dysregulated airway inflammation may be linked and contribute to the pathobiology of chronic suppurative lung disease.	[Pizzutto, Susan J.; Yerkovich, Stephanie T.; Chang, Anne B.] Charles Darwin Univ, Menzies Sch Hlth Res, Child Hlth Div, Casuarina, NT, Australia; [Upham, John W.] Princess Alexandra Hosp, Dept Resp Med, Woolloongabba, Qld 4102, Australia; [Upham, John W.; Yerkovich, Stephanie T.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Yerkovich, Stephanie T.] Prince Charles Hosp, Queensland Lung Transplant Serv, Brisbane, Qld 4032, Australia; [Chang, Anne B.] Queensland Univ Technol, Dept Resp & Sleep Med, Childrens Hlth Queensland, Brisbane, Qld 4001, Australia; [Chang, Anne B.] Queensland Univ Technol, Queensland Childrens Med Res Inst, Brisbane, Qld 4001, Australia	Charles Darwin University; Menzies School of Health Research; University of Queensland; Prince Charles Hospital; Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Pizzutto, SJ (corresponding author), Charles Darwin Univ, Menzies Sch Hlth Res, Child Hlth Div, Casuarina, NT, Australia.	susan.pizzutto@menzies.edu.au	Upham, John/F-4420-2010; Chang, Anne/F-2066-2013	Upham, John/0000-0002-0017-3433; Chang, Anne/0000-0002-1331-3706; Yerkovich, Stephanie/0000-0003-4163-4782	Australian National Health; Medical Research Council [1038415, 545216, 511019]; NHMRC Centre [1040830]	Australian National Health(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHMRC Centre(National Health and Medical Research Council (NHMRC) of Australia)	SP is funded by an Australian National Health and Medical Research Council postgraduate scholarship (1038415). AC receives funding from an Australian National Health and Medical Research Council practitioner fellowship (545216). JU receives funding from an Australian National Health and Medical Research Council practitioner fellowship (511019). This study was supported by the NHMRC Centre for Research Excellence for Lung Health in Aboriginal and Torres Strait Islanders (1040830). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Arsava BE, 2011, TUBERK TORAK, V59, P340, DOI 10.5578/tt.2934; Baines KJ, 2014, CHEST, V146, P1013, DOI 10.1378/chest.14-0131; Burke SJ, 2013, J IMMUNOL, V191, P323, DOI 10.4049/jimmunol.1300344; Chalmers JD, 2012, AM J RESP CRIT CARE, V186, P657, DOI 10.1164/rccm.201203-0487OC; Chang AB, 2011, PAEDIATR RESPIR REV, V12, P97, DOI 10.1016/j.prrv.2010.10.008; Chang AB, 2003, PEDIATR PULM, V35, P477, DOI 10.1002/ppul.10289; Chang AB, 2012, J PEDIATR-US, V161, P621, DOI 10.1016/j.jpeds.2012.03.049; Chang AB, 2010, MED J AUSTRALIA, V193, P356, DOI 10.5694/j.1326-5377.2010.tb03949.x; Chen AC, 2013, AM J RESP CRIT CARE, V187, pA3818; Demedts IK, 2006, AM J RESP CELL MOL, V35, P387, DOI 10.1165/rcmb.2005-0382OC; Dodge IL, 2003, J IMMUNOL, V170, P4457, DOI 10.4049/jimmunol.170.9.4457; Douros K, 2011, CHEST, V140, P317, DOI 10.1378/chest.10-3050; Hales BJ, 2012, THORAX, V67, P321, DOI 10.1136/thoraxjnl-2011-200650; Hare KM, 2010, J PEDIATR-US, V157, P1001, DOI 10.1016/j.jpeds.2010.06.002; Kapur N, 2014, ARCH DIS CHILD, V99, P749, DOI 10.1136/archdischild-2013-305147; King PT, 2008, CLIN EXP IMMUNOL, V152, P542, DOI 10.1111/j.1365-2249.2008.03667.x; King PT, 2003, AM J RESP CRIT CARE, V167, P587, DOI 10.1164/rccm.200207-728OC; Mueller SN, 2009, P NATL ACAD SCI USA, V106, P8623, DOI 10.1073/pnas.0809818106; Pena OM, 2011, J IMMUNOL, V186, P7243, DOI 10.4049/jimmunol.1001952; Pizzutto SJ, 2015, VACCINE, V33, P321, DOI 10.1016/j.vaccine.2014.11.024; Pizzutto SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104236; Pizzutto SJ, 2013, PEDIATR PULM, V48, P67, DOI 10.1002/ppul.22544; Van Eldere J, 2014, LANCET INFECT DIS, V14, P1281, DOI 10.1016/S1473-3099(14)70734-0; Xu W, 2012, J EXP MED, V209, P1813, DOI 10.1084/jem.20112142; Zhu XH, 2009, J IMMUNOL, V182, P3270, DOI 10.4049/jimmunol.0802622	25	19	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129517	10.1371/journal.pone.0129517	http://dx.doi.org/10.1371/journal.pone.0129517			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26066058	Green Submitted, Green Published, gold			2022-12-26	WOS:000356327000084
J	Sunde, RA; Sunde, GR; Sunde, CM; Sunde, ML; Evenson, JK				Sunde, Roger A.; Sunde, Gavin R.; Sunde, Colin M.; Sunde, Milton L.; Evenson, Jacqueline K.			Cloning, Sequencing, and Expression of Selenoprotein Transcripts in the Turkey (Meleagris gallopavo)	PLOS ONE			English	Article							HYDROPEROXIDE GLUTATHIONE-PEROXIDASE; MESSENGER-RNA LEVELS; SELENIUM DEFICIENCY; GENES; SELENOCYSTEINE; EVOLUTION; CHICKS; LIVER; RATS	The minimum Se requirement for male turkey poults is 0.3 mu g Se/g - three times higher than requirements found in rodents - based on liver and gizzard glutathione peroxidase-4 (GPX4) and GPX1 activities. In addition, turkey liver GPX4 activity is 10-fold higher and GPX1 activity is 10-fold lower than in rats, and both GPX1 and GPX4 mRNA levels are dramatically down-regulated by Se deficiency. Currently, the sequences of all annotated turkey selenoprotein transcripts and proteins in the NCBI database are only "predicted." Thus we initiated cloning and sequencing of the full turkey selenoprotein transcriptome to demonstrate expression of selenoprotein transcripts in the turkey, and to develop tools to investigate Se regulation of the full selenoproteome. Total RNA was isolated from six tissues of Se-adequate adult tom turkeys, and used to prepare reverse-transcription cDNA libraries. PCR primers were designed, based initially on chicken, rodent, porcine, bovine and human sequences and later on turkey shotgun cloning sequences. We report here the cloning of full transcript sequences for 9 selenoproteins, and 3'UTR portions for 15 additional selenoproteins, which include SECIS elements in 22 3'UTRs, and in-frame Sec (UGA) codons within coding regions of 19 selenoproteins, including 12 Sec codons in SEPP1. In addition, we sequenced the gap between two contigs from the shotgun cloning of the turkey genome, and found the missing sequence for the turkey Sec-tRNA. RTPCR was used to determine the relative transcript expression in 6 tissues. GPX3 expression was high in all tissues except kidney, GPX1 expression was high in kidney, SEPW1 expression was high in heart, gizzard and muscle, and SELU expression was high in liver. SEPP2, a selenoprotein not found in mammals, was highly expressed in liver but not in other tissues. In summary, transcripts for 24 selenoproteins are expressed in the turkey, not just predicted.	[Sunde, Roger A.; Sunde, Gavin R.; Sunde, Colin M.; Evenson, Jacqueline K.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA; [Sunde, Milton L.] Univ Wisconsin, Dept Anim Sci, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Sunde, RA (corresponding author), Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.	sunde@nutrisci.wisc.edu			National Institute of Food and Agriculture, United States Department of Agriculture; Hatch [0201908, 233618, 1004389]; Wisconsin Alumni Foundation	National Institute of Food and Agriculture, United States Department of Agriculture(United States Department of Agriculture (USDA)); Hatch(United States Department of Agriculture (USDA)); Wisconsin Alumni Foundation	This Research was supported by the National Institute of Food and Agriculture, United States Department of Agriculture (www.csrees.usda.gov), Hatch projects 0201908, 233618, and 1004389, and by the Wisconsin Alumni Foundation (http://www.uwalumni.com) Selenium Nutrition Research Fund.	Ausubel FM, 1988, MOL REPROD DEV; AVISSAR N, 1989, BLOOD, V73, P318; Barnes KM, 2009, J NUTR, V139, P199, DOI 10.3945/jn.108.098624; Castellano S, 2004, EMBO REP, V5, P71, DOI 10.1038/sj.embor.7400036; Dalloul RA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000475; Fischer J, 2008, ARCH ANIM NUTR, V62, P485, DOI 10.1080/17450390802453468; Hadley KB, 1997, TRACE ELEMENTS IN MAN AND ANIMALS - 9, P59; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HATFIELD DL, 1983, P NATL ACAD SCI-BIOL, V80, P4940, DOI 10.1073/pnas.80.16.4940; Hatfield DL, 2012, SELENIUM: ITS MOLECULAR BIOLOGY AND ROLE IN HUMAN HEALTH, THIRD EDITION, P1, DOI 10.1007/978-1-4614-1025-6; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Huang JQ, 2011, J NUTR, V141, P1605, DOI 10.3945/jn.111.145722; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; LEI XG, 1995, J NUTR, V125, P1438; Liu CP, 2014, BIOL TRACE ELEM RES, V159, P192, DOI 10.1007/s12011-014-0005-9; Lobanov AV, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r62; LOWRY OH, 1951, J BIOL CHEM, V193, P265; National Research Council, 1994, NUTR REQ POULTR; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; PESTI GM, 1979, POULTRY SCI, V58, P1541, DOI 10.3382/ps.0581541; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; SUNDE RA, 1987, J BIOL CHEM, V262, P933; Sunde RA, 2010, EXP BIOL MED, V235, P23, DOI 10.1258/ebm.2009.009262; Tamura T, 2004, P NATL ACAD SCI USA, V101, P16162, DOI 10.1073/pnas.0406313101; Yao HD, 2014, BIOL TRACE ELEM RES, V161, P318, DOI 10.1007/s12011-014-0125-2	25	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129801	10.1371/journal.pone.0129801	http://dx.doi.org/10.1371/journal.pone.0129801			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070131	Green Submitted, Green Published, gold			2022-12-26	WOS:000356327000109
J	Kondrikov, D; Fulton, D; Dong, Z; Su, YC				Kondrikov, Dmitry; Fulton, David; Dong, Zheng; Su, Yunchao			Heat Shock Protein 70 Prevents Hyperoxia-Induced Disruption of Lung Endothelial Barrier via Caspase-Dependent and AIF-Dependent Pathways	PLOS ONE			English	Article							OXYGEN-TOXICITY; ACTIVATION; PERMEABILITY; APOPTOSIS; STRESS; INJURY; HSP70; CELLS	Exposure of pulmonary artery endothelial cells (PAECs) to hyperoxia results in a compromise in endothelial monolayer integrity, an increase in caspase-3 activity, and nuclear translocation of apoptosis-inducing factor (AIF), a marker of caspase-independent apoptosis. In an endeavor to identify proteins involved in hyperoxic endothelial injury, we found that the protein expression of heat-shock protein 70 (Hsp70) was increased in hyperoxic PAECs. The hyperoxia-induced Hsp70 protein expression is from hspA1B gene. Neither inhibition nor overexpression of Hsp70 affected the first phase barrier disruption of endothelial monolayer. Nevertheless, inhibition of Hsp70 by using the Hsp70 inhibitor KNK437 or knock down Hsp70 using siRNA exaggerated and overexpression of Hsp70 prevented the second phase disruption of lung endothelial integrity. Moreover, inhibition of Hsp70 exacerbated and overexpression of Hsp70 prevented hyperoxia-induced apoptosis, caspase-3 activation, and increase in nuclear AIF protein level in PAECs. Furthermore, we found that Hsp70 interacted with AIF in the cytosol in hyperoxic PAECs. Inhibition of Hsp70/AIF association by KNK437 correlated with increased nuclear AIF level and apoptosis in KNK437-treated PAECs. Finally, the ROS scavenger NAC prevented the hyperoxia-induced increase in Hsp70 expression and reduced the interaction of Hsp70 with AIF in hyperoxic PAECs. Together, these data indicate that increased expression of Hsp70 plays a protective role against hyperoxia-induced lung endothelial barrier disruption through caspase-dependent and AIF-dependent apoptotic pathways. Association of Hsp70 with AIF prevents AIF nuclear translocation, contributing to the protective effect of Hsp70 on hyperoxia-induced endothelial apoptosis. The hyperoxia-induced increase in Hsp70 expression and Hsp70/AIF interaction is contributed to ROS formation.	[Kondrikov, Dmitry; Fulton, David; Su, Yunchao] Georgia Regents Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; [Su, Yunchao] Georgia Regents Univ, Med Coll Georgia, Dept Med, Augusta, GA 30912 USA; [Dong, Zheng] Georgia Regents Univ, Med Coll Georgia, Dept Cell Biol & Anat, Augusta, GA 30912 USA; [Fulton, David; Su, Yunchao] Georgia Regents Univ, Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA; [Dong, Zheng; Su, Yunchao] Charlie Norwood Vet Affairs Med Ctr, Res Serv, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Su, YC (corresponding author), Georgia Regents Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA.	ysu@gru.edu			National Institutes of Health [HL088261, HL115078]; Flight Attendants Medical Research Institute [113018_CIA]; Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R03HL115078, R01HL088261, P01HL101902] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002035] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendants Medical Research Institute; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health grants HL088261 and HL115078 to YS, Flight Attendants Medical Research Institute grant 113018_CIA to YS, and by the Department of Veterans Affairs.	Alphonse RS, 2011, AM J RESP CELL MOL, V44, P146, DOI 10.1165/rcmb.2009-0182OC; Azad N, 2010, ANN NY ACAD SCI, V1203, P1, DOI 10.1111/j.1749-6632.2010.05608.x; Bhandari V, 2006, FREE RADICAL BIO MED, V41, P4, DOI 10.1016/j.freeradbiomed.2006.01.027; BRASCH RC, 1993, PEDIATR RADIOL, V23, P495, DOI 10.1007/BF02012128; Cande C, 2002, BIOCHIMIE, V84, P215, DOI 10.1016/S0300-9084(02)01374-3; Chen F, 2012, ARTERIOSCL THROM VAS, V32, P2989, DOI 10.1161/ATVBAHA.112.300361; Chen Q, 2011, BIOCHEM BIOPH RES CO, V415, P533, DOI 10.1016/j.bbrc.2011.10.037; Delavallee L, 2011, IUBMB LIFE, V63, P221, DOI 10.1002/iub.432; Gupta SC, 2007, BIOCHIM BIOPHYS ACTA, V1770, P1394; Hu YM, 1999, EMBO J, V18, P3586, DOI 10.1093/emboj/18.13.3586; Kiang JG, 1998, PHARMACOL THERAPEUT, V80, P183, DOI 10.1016/S0163-7258(98)00028-X; Kondrikov D, 2014, J BIOL CHEM, V289, P33355, DOI 10.1074/jbc.M114.585356; Kondrikov D, 2011, FREE RADICAL BIO MED, V50, P1689, DOI 10.1016/j.freeradbiomed.2011.03.020; Kondrikov D, 2010, J BIOL CHEM, V285, P35479, DOI 10.1074/jbc.M110.140269; Mayer MP, 2013, TRENDS BIOCHEM SCI, V38, P507, DOI 10.1016/j.tibs.2013.08.001; McGrath-Morrow SA, 2001, AM J RESP CELL MOL, V25, P150, DOI 10.1165/ajrcmb.25.2.4362; Payne DK, 1996, FREE RADICAL RES, V25, P229, DOI 10.3109/10715769609149048; PHILLIPS PG, 1988, J APPL PHYSIOL, V64, P1196, DOI 10.1152/jappl.1988.64.3.1196; Radomski A, 1998, BRIT J PHARMACOL, V125, P1455, DOI 10.1038/sj.bjp.0702216; Reubold TF, 2009, J BIOL CHEM, V284, P32717, DOI 10.1074/jbc.M109.014027; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Sapozhnikov AM, 2002, CELL PROLIFERAT, V35, P193, DOI 10.1046/j.1365-2184.2002.00239.x; Scieglinska D, 2011, HISTOCHEM CELL BIOL, V135, P337, DOI 10.1007/s00418-011-0791-5; Sevrioukova IF, 2011, ANTIOXID REDOX SIGN, V14, P2545, DOI 10.1089/ars.2010.3445; Usatyuk PV, 2012, J BIOL CHEM, V287, P9360, DOI 10.1074/jbc.M111.294546; Vitiello PF, 2009, FREE RADICAL BIO MED, V46, P33, DOI 10.1016/j.freeradbiomed.2008.09.022; WEIR KLI, 1994, AM J RESP CRIT CARE, V150, P784, DOI 10.1164/ajrccm.150.3.8087353; Yokota S, 2000, CANCER RES, V60, P2942; Zhang Y, 2013, J IMMUNOL, V191, P1393, DOI 10.4049/jimmunol.1300052	29	18	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129343	10.1371/journal.pone.0129343	http://dx.doi.org/10.1371/journal.pone.0129343			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26066050	gold, Green Submitted, Green Published			2022-12-26	WOS:000356100900050
J	Huang, LY; Wang, F; Wang, YQ; Cao, Q; Sang, TT; Liu, F; Chen, SY				Huang, Liya; Wang, Fei; Wang, Yuqiang; Cao, Qing; Sang, Tiantian; Liu, Fang; Chen, Shuyan			Acidic Fibroblast Growth Factor Promotes Endothelial Progenitor Cells Function via Akt/FOXO3a Pathway	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; TRANSCRIPTION FACTORS; RISK-FACTORS; FORKHEAD; FOXO3A; CANCER; TRANSPLANTATION; TRANSLOCATION; EXPRESSION; RATIONALE	Acidic fibroblast growth factor (FGF1) has been suggested to enhance the functional activities of endothelial progenitor cells (EPCs). The Forkhead homeobox type O transcription factors (FOXOs), a key substrate of the survival kinase Akt, play important roles in regulation of various cellular processes. We previously have shown that FOXO3a is the main subtype of FOXOs expressed in EPCs. Here, we aim to determine whether FGF1 promotes EPC function through Akt/FOXO3a pathway. Human peripheral blood derived EPCs were transduced with adenoviral vectors either expressing a non-phosphorylable, constitutively active triple mutant of FOXO3a (Ad-TM-FOXO3a) or a GFP control (Ad-GFP). FGF1 treatment improved functional activities of Ad-GFP transduced EPCs, including cell viability, proliferation, antiapoptosis, migration and tube formation, whereas these beneficial effects disappeared by Akt inhibitor pretreatment. Moreover, EPC function was declined by Ad-TM-FOXO3a transduction and failed to be attenuated even with FGF1 treatment. FGF1 upregulated phosphorylation levels of Akt and FOXO3a in Ad-GFP transduced EPCs, which were repressed by Akt inhibitor pretreatment. However, FGF1 failed to recover Ad-TM-FOXO3a transduced EPCs from dysfunction. These data indicate that FGF1 promoting EPC function is at least in part mediated through Akt/FOXO3a pathway. Our study may provide novel ideas for enhancing EPC angiogenic ability and optimizing EPC transplantation therapy in the future.	[Huang, Liya; Wang, Fei; Wang, Yuqiang; Cao, Qing; Sang, Tiantian; Liu, Fang; Chen, Shuyan] Shanghai Jiao Tong Univ, Dept Geriatr, Xinhua Hosp, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Liu, F (corresponding author), Shanghai Jiao Tong Univ, Dept Geriatr, Xinhua Hosp, Sch Med, Shanghai 200030, Peoples R China.	liufang_sh2008@yeah.net; shuyanchencn@hotmail.com	Sang, Tiantian/GPT-0103-2022		National Natural Science Foundation of China [30973152, 81270205]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 30973152 and 81270205). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arden KC, 2002, ARCH BIOCHEM BIOPHYS, V403, P292, DOI 10.1016/S0003-9861(02)00207-2; Asahara T, 2004, AM J PHYSIOL-CELL PH, V287, pC572, DOI 10.1152/ajpcell.00330.2003; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Assmus B, 2010, CIRC-HEART FAIL, V3, P89, DOI 10.1161/CIRCHEARTFAILURE.108.843243; Borniquel S, 2010, MOL CELL BIOL, V30, P4035, DOI 10.1128/MCB.00175-10; Burger PE, 2002, BLOOD, V100, P3527, DOI 10.1182/blood.V100.10.3527; Chen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012293; Chen SW, 2009, J ELECTRON MATER, V38, P1, DOI 10.1007/s11664-008-0572-7; Deschaseaux F, 2007, EUR J PHARMACOL, V562, P111, DOI 10.1016/j.ejphar.2007.01.045; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Gomez-Gutierrez JG, 2006, CANCER BIOL THER, V5, P875, DOI 10.4161/cbt.5.7.2911; Heiss C, 2005, J AM COLL CARDIOL, V45, P1441, DOI 10.1016/j.jacc.2004.12.074; Huang Haojie, 2006, Future Oncol, V2, P83, DOI 10.2217/14796694.2.1.83; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Ingram DA, 2005, BLOOD, V106, P1525, DOI 10.1182/blood-2005-04-1509; Javerzat S, 2002, TRENDS MOL MED, V8, P483, DOI 10.1016/S1471-4914(02)02394-8; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Mansour S, 2010, J CARDIOVASC TRANSL, V3, P153, DOI 10.1007/s12265-009-9145-2; Martinez-Gac L, 2004, MOL CELL BIOL, V24, P2181, DOI 10.1128/MCB.24.5.2181-2189.2004; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Ornitz DM, 2001, GENOME BIOL, V2; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Sang TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101703; Schachinger V, 2004, J AM COLL CARDIOL, V44, P1690, DOI 10.1016/j.jacc.2004.08.014; Skurk C, 2004, J BIOL CHEM, V279, P1513, DOI 10.1074/jbc.M304736200; Sunters A, 2006, CANCER RES, V66, P212, DOI 10.1158/0008-5472.CAN-05-1997; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; Wang F, 2013, MICROVASC RES, V90, P48, DOI 10.1016/j.mvr.2013.07.009; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P257, DOI 10.1161/01.ATV.0000198239.41189.5d; Yang JY, 2009, CLIN CANCER RES, V15, P752, DOI 10.1158/1078-0432.CCR-08-0124; Zampetaki A, 2008, CARDIOVASC RES, V78, P413, DOI 10.1093/cvr/cvn081	38	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129665	10.1371/journal.pone.0129665	http://dx.doi.org/10.1371/journal.pone.0129665			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061278	Green Submitted, Green Published, gold			2022-12-26	WOS:000355979500155
J	Irwin, MT; Raharison, JL; Raubenheimer, DR; Chapman, CA; Rothman, JM				Irwin, Mitchell T.; Raharison, Jean-Luc; Raubenheimer, David R.; Chapman, Colin A.; Rothman, Jessica M.			The Nutritional Geometry of Resource Scarcity: Effects of Lean Seasons and Habitat Disturbance on Nutrient Intakes and Balancing in Wild Sifakas	PLOS ONE			English	Article							PROPITHECUS-DIADEMA; FRAGMENTED FOREST; ACTIVITY PATTERNS; GORILLA DIETS; PRIMATE; ECOLOGY; FOOD; ENERGY; LEMUR; POPULATION	Animals experience spatial and temporal variation in food and nutrient supply, which may cause deviations from optimal nutrient intakes in both absolute amounts (meeting nutrient requirements) and proportions (nutrient balancing). Recent research has used the geometric framework for nutrition to obtain an improved understanding of how animals respond to these nutritional constraints, among them free-ranging primates including spider monkeys and gorillas. We used this framework to examine macronutrient intakes and nutrient balancing in sifakas (Propithecus diadema) at Tsinjoarivo, Madagascar, in order to quantify how these vary across seasons and across habitats with varying degrees of anthropogenic disturbance. Groups in intact habitat experience lean season decreases in frugivory, amounts of food ingested, and nutrient intakes, yet preserve remarkably constant proportions of dietary macronutrients, with the proportional contribution of protein to the diet being highly consistent. Sifakas in disturbed habitat resemble intact forest groups in the relative contribution of dietary macronutrients, but experience less seasonality: all groups' diets converge in the lean season, but disturbed forest groups largely fail to experience abundant season improvements in food intake or nutritional outcomes. These results suggest that: (1) lemurs experience seasonality by maintaining nutrient balance at the expense of calories ingested, which contrasts with earlier studies of spider monkeys and gorillas, (2) abundant season foods should be the target of habitat management, even though mortality might be concentrated in the lean season, and (3) primates' within-group competitive landscapes, which contribute to variation in social organization, may vary in complex ways across habitats and seasons.	[Irwin, Mitchell T.] No Illinois Univ, Dept Anthropol, De Kalb, IL 60115 USA; [Irwin, Mitchell T.; Raharison, Jean-Luc] SADABE Madagascar, Antananarivo, Madagascar; [Raharison, Jean-Luc] Univ Antananarivo, Dept Anim Biol, Antananarivo, Madagascar; [Raubenheimer, David R.] Univ Sydney, Fac Vet Sci, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Raubenheimer, David R.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Chapman, Colin A.] McGill Univ, Dept Anthropol, Montreal, PQ, Canada; [Chapman, Colin A.] McGill Univ, McGill Sch Environm, Montreal, PQ, Canada; [Chapman, Colin A.] Wildlife Conservat Soc, Bronx, NY USA; [Rothman, Jessica M.] CUNY, Hunter Coll, Dept Anthropol, New York, NY 10021 USA; [Rothman, Jessica M.] NYCEP, York, NY USA	Northern Illinois University; University Antananarivo; University of Sydney; University of Sydney; McGill University; McGill University; Wildlife Conservation Society; City University of New York (CUNY) System; Hunter College (CUNY)	Irwin, MT (corresponding author), No Illinois Univ, Dept Anthropol, De Kalb, IL 60115 USA.	mirwin@niu.edu	Chapman, Colin/S-1911-2019; Irwin, Mitchell Thomas/AAY-1776-2021; Irwin, Mitchell/A-1482-2012	Chapman, Colin/0000-0002-8827-8140; Irwin, Mitchell Thomas/0000-0003-2088-0028; Irwin, Mitchell/0000-0003-2088-0028; Raubenheimer, David/0000-0001-9050-1447	Margot Marsh Biodiversity Foundation; National Geographic Society Committee for Research and Exploration [8637-07]; Natural Sciences and Engineering Research Council (Canada)	Margot Marsh Biodiversity Foundation; National Geographic Society Committee for Research and Exploration(National Geographic Society); Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this study was provided by the Margot Marsh Biodiversity Foundation and the National Geographic Society Committee for Research and Exploration (8637-07). MTI was supported by a Natural Sciences and Engineering Research Council (Canada) postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann SA, 1998, FORAGING SURVIVAL YE; Altmann Stuart A., 2006, P243; Behie AM, 2012, J TROP ECOL, V28, P153, DOI 10.1017/S0266467411000678; Blanco MB, 2013, SCI REP-UK, V3, DOI 10.1038/srep01768; Castanet J, 2004, J ZOOL, V263, P31, DOI 10.1017/S0952836904004844; Chapman CA, 2002, INT J PRIMATOL, V23, P283, DOI 10.1023/A:1013831511405; Chapman CA, 2004, AM J PRIMATOL, V62, P55, DOI 10.1002/ajp.20006; Chapman CA, 2002, COMP BIOCHEM PHYS A, V133, P861, DOI 10.1016/S1095-6433(02)00209-X; Chapman CA, 1999, PRIMATES, V40, P215, DOI 10.1007/BF02557712; Conklin-Brittain Nancy Lou, 2006, P445; Dewar RE, 2007, P NATL ACAD SCI USA, V104, P13723, DOI 10.1073/pnas.0704346104; Donati G, 2011, PLOS ONE, V6; ELEY RM, 1989, AM J PRIMATOL, V18, P209, DOI 10.1002/ajp.1350180304; Felton AM, 2009, BEHAV ECOL, V20, P685, DOI 10.1093/beheco/arp021; Felton AM, 2009, FUNCT ECOL, V23, P70, DOI 10.1111/j.1365-2435.2008.01526.x; FREELAND WJ, 1974, AM NAT, V108, P269, DOI 10.1086/282907; Ganzhorn JU, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008253; GANZHORN JU, 1995, ECOLOGY, V76, P2084, DOI 10.2307/1941683; GANZHORN JU, 1992, OECOLOGIA, V91, P540, DOI 10.1007/BF00650329; Ganzhorn JU, 2002, OECOLOGIA, V131, P427, DOI 10.1007/s00442-002-0891-y; Godfrey LR, 2004, AM J PHYS ANTHROPOL, V123, P250, DOI 10.1002/ajpa.10315; GOLDIZEN AW, 1988, J ANIM ECOL, V57, P893, DOI 10.2307/5099; Gosby AK, 2014, OBES REV, V15, P183, DOI 10.1111/obr.12131; Gosby AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025929; Gould L, 1999, INT J PRIMATOL, V20, P69, DOI 10.1023/A:1020584200807; Harrison ME, 2010, INT J PRIMATOL, V31, P585, DOI 10.1007/s10764-010-9415-5; Hemingway CA, 2005, CAM S BIO EVOL ANTHR, V44, P57, DOI 10.1017/CBO9780511542343.004; Irwin M. T., GPS GIS PRIMATOLOGIS; Irwin MT, 2008, BIOTROPICA, V40, P231, DOI 10.1111/j.1744-7429.2007.00368.x; Irwin MT, 2008, INT J PRIMATOL, V29, P95, DOI 10.1007/s10764-007-9222-9; Irwin MT, 2014, AM J PHYS ANTHROPOL, V153, P78, DOI 10.1002/ajpa.22412; Irwin MT, 2010, AM J PRIMATOL, V72, P1013, DOI 10.1002/ajp.20847; Irwin MT, 2006, ECOLOGICAL IMPACTS F, P410; Janson C, 2005, CAM S BIO EVOL ANTHR, V44, P307, DOI 10.1017/CBO9780511542343.012; Johnson CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070383; KING GJ, 1978, BRIT J NUTR, V40, P55, DOI 10.1079/BJN19780095; King SJ, 2011, AM J PRIMATOL, V73, P155, DOI 10.1002/ajp.20881; Knott CD, 1998, INT J PRIMATOL, V19, P1061, DOI 10.1023/A:1020330404983; Marsh KJ, 2006, J CHEM ECOL, V32, P1247, DOI 10.1007/s10886-006-9082-3; Marshall AJ, 2007, INT J PRIMATOL, V28, P1218, DOI 10.1007/s10764-007-9218-5; Marshall AJ, 2009, AM J PHYS ANTHROPOL, V140, P603, DOI 10.1002/ajpa.21082; National Academy of Science Institute of Medicine, 2005, DIET REF INT EN CARB; National Research Council, 2003, NUTR REQ NONH PRIM; OFTEDAL OT, 1991, PHILOS T R SOC B, V334, P161, DOI 10.1098/rstb.1991.0105; Raubenheimer D, 2012, PHILOS T R SOC B, V367, P1628, DOI 10.1098/rstb.2012.0007; Raubenheimer D, 2011, ECOL MONOGR, V81, P407, DOI 10.1890/10-1707.1; Raubenheimer D, 2009, FUNCT ECOL, V23, P4, DOI 10.1111/j.1365-2435.2009.01522.x; RICHARD AF, 1987, AM J PRIMATOL, V12, P309, DOI 10.1002/ajp.1350120308; Riley EP, 2007, INT J PRIMATOL, V28, P107, DOI 10.1007/s10764-006-9104-6; Rode KD, 2006, BIOTROPICA, V38, P625, DOI 10.1111/j.1744-7429.2006.00183.x; Rothman JM, 2008, AM J PRIMATOL, V70, P690, DOI 10.1002/ajp.20540; Rothman JM, 2008, OECOLOGIA, V155, P111, DOI 10.1007/s00442-007-0901-1; Rothman JM, 2011, BIOL LETTERS, V7, P847, DOI 10.1098/rsbl.2011.0321; Shultz S, 2011, NATURE, V479, P219, DOI 10.1038/nature10601; Simmen B, 2012, J TROP ECOL, V28, P141, DOI 10.1017/S026646741200003X; Simpson S.J., 2012, NATURE NUTR INTEGRAT; STERLING EJ, 1994, FOLIA PRIMATOL, V62, P115, DOI 10.1159/000156768; STRUHSAKER T T, 1976, Biotropica, V8, P211, DOI 10.2307/2989688; STRUM SC, 1991, AM J PRIMATOL, V25, P219, DOI 10.1002/ajp.1350250403; Turkington R, 2009, BOTANY, V87, P723, DOI 10.1139/B09-035; Tutin CEG, 1999, PRIMATES, V40, P249, DOI 10.1007/BF02557714; Vogel ER, 2012, BIOL LETTERS, V8, P333, DOI 10.1098/rsbl.2011.1040; Wallis IR, 2012, OECOLOGIA, V169, P281, DOI 10.1007/s00442-011-2212-9; West BW., 2015, LINEAR MIXED MODELS, V2; Wright PC, 1999, YEARB PHYS ANTHROPOL, V42, P31; YOUNG AL, 1990, AM NAT, V135, P473, DOI 10.1086/285057	66	31	31	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0128046	10.1371/journal.pone.0128046	http://dx.doi.org/10.1371/journal.pone.0128046			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061401	Green Published, gold			2022-12-26	WOS:000355979500072
J	Longo, GO; Morais, RA; Martins, CDL; Mendes, TC; Aued, AW; Candido, DV; de Oliveira, JC; Nunes, LT; Fontoura, L; Sissini, MN; Teschima, MM; Silva, MB; Ramlov, F; Gouvea, LP; Ferreira, CEL; Segal, B; Horta, PA; Floeter, SR				Longo, G. O.; Morais, R. A.; Martins, C. D. L.; Mendes, T. C.; Aued, A. W.; Candido, D. V.; de Oliveira, J. C.; Nunes, L. T.; Fontoura, L.; Sissini, M. N.; Teschima, M. M.; Silva, M. B.; Ramlov, F.; Gouvea, L. P.; Ferreira, C. E. L.; Segal, B.; Horta, P. A.; Floeter, S. R.			Between-Habitat Variation of Benthic Cover, Reef Fish Assemblage and Feeding Pressure on the Benthos at the Only Atoll in South Atlantic: Rocas Atoll, NE Brazil	PLOS ONE			English	Article							EPILITHIC ALGAL MATRIX; DE-NORONHA ARCHIPELAGO; FUNCTIONAL-FORM GROUPS; CORAL-REEFS; HERBIVOROUS FISHES; COMMUNITY STRUCTURE; WESTERN ATLANTIC; CHEMICAL DEFENSE; NUTRIENT-UPTAKE; TROPHIC STATUS	The Southwestern Atlantic harbors unique and relatively understudied reef systems, including the only atoll in South Atlantic: Rocas atoll. Located 230 km off the NE Brazilian coast, Rocas is formed by coralline red algae and vermetid mollusks, and is potentially one of the most "pristine" areas in Southwestern Atlantic. We provide the first comprehensive and integrative description of the fish and benthic communities inhabiting different shallow reef habitats of Rocas. We studied two contrasting tide pool habitats: open pools, which communicate with the open ocean even during low tides, thus more exposed to wave action; and closed pools, which remain isolated during low tide and are comparatively less exposed. Reef fish assemblages, benthic cover, algal turfs and fish feeding pressure on the benthos remarkably varied between open and closed pools. The planktivore Thalassoma noronhanum was the most abundant fish species in both habitats. In terms of biomass, the lemon shark Negaprion brevirostris and the omnivore Melichtys niger were dominant in open pools, while herbivorous fishes (mainly Acanthurus spp.) prevailed in closed pools. Overall benthic cover was dominated by algal turfs, composed of articulated calcareous algae in open pools and non-calcified algae in closed pools. Feeding pressure was dominated by acanthurids and was 10-fold lower in open pools than in closed pools. Besides different wave exposure conditions, such pattern could also be related to the presence of sharks in open pools, prompting herbivorous fish to feed more in closed pools. This might indirectly affect the structure of reef fish assemblages and benthic communities. The macroalgae Digenea simplex, which is uncommon in closed pools and abundant in the reef flat, was highly preferred in herbivory assays, indicating that herbivory by fishes might be shaping this distribution pattern. The variations in benthic and reef fish communities, and feeding pressure on the benthos between open and closed pools suggest that the dynamics in open pools is mostly driven by physical factors and the tolerance of organisms to harsh conditions, while in closed pools direct and indirect effects of species interactions also play an important role. Understanding the mechanisms shaping biological communities and how they scale-up to ecosystem functioning is particularly important on isolated near-pristine systems where natural processes can still be studied under limited human impact.	[Longo, G. O.; Morais, R. A.; Martins, C. D. L.; Aued, A. W.; Nunes, L. T.; Fontoura, L.; Teschima, M. M.; Segal, B.; Horta, P. A.; Floeter, S. R.] Univ Fed Santa Catarina, Programa Posgrad Ecol, Florianopolis, SC, Brazil; [Longo, G. O.; Morais, R. A.; Nunes, L. T.; Fontoura, L.; Floeter, S. R.] Univ Fed Santa Catarina, Dept Ecol & Zool, Lab Biogeog & Macroecol Marinha, Florianopolis, SC, Brazil; [Martins, C. D. L.; Ramlov, F.; Gouvea, L. P.] Univ Fed Santa Catarina, Dept Bot, Lab Ficol, Florianopolis, SC, Brazil; [Mendes, T. C.; Ferreira, C. E. L.] Univ Fed Fluminense, Lab Ecol & Conservacao Ambientes Recifa, Niteroi, RJ, Brazil; [Aued, A. W.; Candido, D. V.; de Oliveira, J. C.; Segal, B.] Univ Fed Santa Catarina, Dept Ecol & Zool, Lab Ecol Ambientes Recifais, Florianopolis, SC, Brazil; [Teschima, M. M.] Univ Fed Santa Catarina, Dept Ecol & Zool, Lab Crustaceos & Plancton, Florianopolis, SC, Brazil; [Silva, M. B.] Reserva Biol Atol das Rocas, Inst Chico Mendes Conservacao Biodiversidade ICMB, Natal, RN, Brazil; [Ferreira, C. E. L.; Segal, B.; Horta, P. A.] Inst Coral Vivo, Arraial DAjuda, Porto Seguro, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC); Universidade Federal Fluminense; Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC)	Floeter, SR (corresponding author), Univ Fed Santa Catarina, Programa Posgrad Ecol, Florianopolis, SC, Brazil.	sergio.floeter@ufsc.br	Longo, Guilherme O/E-3372-2014; Horta, Paulo A/L-3092-2015; Mendes, Thiago/A-1848-2013; Araujo, Renato Morais/AAA-7903-2021; Floeter, S. R./B-1438-2012	Longo, Guilherme O/0000-0003-2033-7439; Horta, Paulo A/0000-0001-7699-7589; Mendes, Thiago/0000-0002-9959-064X; Araujo, Renato Morais/0000-0003-4652-6676; Floeter, S. R./0000-0002-3201-6504; Fontoura, Luisa/0000-0003-3568-8565; Ferreira, Carlos Eduardo/0000-0002-4311-0491; Nasri Sissini, Marina/0000-0002-0378-3157; Nunes Teixeira, Lucas/0000-0001-9543-4589	CNPq [563276/2010-0]; FAPESC [6308/2011-8]; CAPES; Brazilian Ministry Educational Council; CNPq; PROTAX/CNPq; PNADB/CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESC(Fundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Ministry Educational Council; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PROTAX/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PNADB/CAPES	This work was supported by CNPq (www.cnpq.br) and FAPESC (www.fapesc.sc.gov.br) through the grant SISBIOTA-Mar Rede Nacional de Pesquisa em Biodiversidade Marinha (www.sisbiota.ufsc.br; CNPq #563276/2010-0 and FAPESC #6308/2011-8) awarded to SRF. CAPES, Brazilian Ministry Educational Council (www.capes.gov.br) and CNPq (www.cnpq.br) provided scholarships to GOL RAM CDLM, TCM, AWA, DVC, JCdeO, LTN, LF, MNS, MMT, FR and LPG. PAH is also grateful to PROTAX/CNPq, PNADB/CAPES for additional financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G. R., 1991, DAMSELFISHES WORLD; [Anonymous], 2013, MAPTOOLS TOOLS READI; Ballantine B, 2014, BIOL CONSERV, V176, P297, DOI 10.1016/j.biocon.2014.01.014; Barr NG, 2008, AQUAT BIOL, V3, P179, DOI 10.3354/ab00079; Bell JJ, 2001, AQUAT CONSERV, V11, P109, DOI 10.1002/aqc.436; Bellwood DR, 2006, CURR BIOL, V16, P2434, DOI 10.1016/j.cub.2006.10.030; Bellwood DR, 2008, LIMNOL OCEANOGR, V53, P2695, DOI 10.4319/lo.2008.53.6.2695; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bellwood DR, 2001, CORAL REEFS, V20, P139, DOI 10.1007/s003380100156; Bender MG, 2013, GLOBAL ECOL BIOGEOGR, V22, P1173, DOI 10.1111/geb.12099; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown BE, 2002, MAR BIOL, V141, P21, DOI 10.1007/s00227-002-0810-0; Burkepile DE, 2011, CORAL REEFS, V30, P351, DOI 10.1007/s00338-011-0726-6; Burkepile DE, 2006, ECOLOGY, V87, P3128, DOI 10.1890/0012-9658(2006)87[3128:HVNCOM]2.0.CO;2; Castro CB, 2001, B MAR SCI, V69, P357; Castro JB, 2006, IBEROROMANIA, P27; Cheroske AG, 2000, J EXP MAR BIOL ECOL, V248, P1, DOI 10.1016/S0022-0981(00)00153-2; Choat JH, 2004, MAR BIOL, V145, P445, DOI 10.1007/s00227-004-1341-7; Choat JH, 2002, MAR BIOL, V140, P613, DOI 10.1007/s00227-001-0715-3; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Connell SD, 2014, MAR ECOL PROG SER, V495, P299, DOI 10.3354/meps10513; Cronin G, 1997, J CHEM ECOL, V23, P289, DOI 10.1023/B:JOEC.0000006360.36833.13; Crossman DJ, 2005, MAR ECOL PROG SER, V296, P129, DOI 10.3354/meps296129; Depczynski M, 2004, MAR BIOL, V145, P455, DOI 10.1007/s002270004-1342-6; Dollar S.J., 1982, Coral Reefs, V1, P71, DOI 10.1007/BF00301688; Done TJ, 1999, AM ZOOL, V39, P66; Drummond G. M, 2005, LISTA FAUNA BRASILEI; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fabricius KE, 2000, ESTUAR COAST SHELF S, V50, P115, DOI 10.1006/ecss.1999.0538; Feitoza Bertran M., 2003, Aqua (Miradolo Terme), V7, P61; Ferreira BP, 2008, IUCN RED LIST THREAT; Ferreira CEL, 2006, J FISH BIOL, V69, P1533, DOI 10.1111/j.1095-8649.2006.01220.x; Ferreira CEL, 2004, J BIOGEOGR, V31, P1093, DOI 10.1111/j.1365-2699.2004.01044.x; Floeter SR, 2008, J BIOGEOGR, V35, P22, DOI 10.1111/j.1365-2699.2007.01790.x; Floeter SR, 2007, ENVIRON BIOL FISH, V78, P147, DOI 10.1007/s10641-006-9084-6; Floeter SR, 2001, GLOBAL ECOL BIOGEOGR, V10, P423, DOI 10.1046/j.1466-822X.2001.00245.x; Folch J., 1957, Journal of Biological Chemistry., V193, P265; Fonseca AC, 2012, J MAR BIOL, V2012, P1; FOSTER MS, 1991, J EXP MAR BIOL ECOL, V146, P193, DOI 10.1016/0022-0981(91)90025-R; Fox RJ, 2008, CORAL REEFS, V27, P605, DOI 10.1007/s00338-008-0359-6; Froese R., 2014, FISHBASE; Fulton CJ, 2005, LIMNOL OCEANOGR, V50, P255, DOI 10.4319/lo.2005.50.1.0255; Garla RC, 2006, FISH RES, V81, P236, DOI 10.1016/j.fishres.2006.07.003; Gherardi DFM, 2001, CORAL REEFS, V19, P205, DOI 10.1007/s003380000100; Goatley CHR, 2012, BIOL LETTERS, V8, P1016, DOI 10.1098/rsbl.2012.0770; HAY ME, 1984, ECOLOGY, V65, P446, DOI 10.2307/1941407; Hay ME, 1997, CORAL REEFS, V16, pS67, DOI 10.1007/s003380050243; HAY ME, 1988, OECOLOGIA, V75, P233, DOI 10.1007/BF00378604; HAY ME, 1988, MAR ECOL PROG SER, V48, P185, DOI 10.3354/meps048185; HAY ME, 1981, ECOLOGY, V62, P739, DOI 10.2307/1937742; HAY ME, 1984, OECOLOGIA, V64, P396, DOI 10.1007/BF00379139; Hearn CJ, 2001, CORAL REEFS, V20, P347, DOI 10.1007/s00338-001-0185-6; Hoey AS, 2009, ECOSYSTEMS, V12, P1316, DOI 10.1007/s10021-009-9291-z; Hughes T, 1999, LIMNOL OCEANOGR, V44, P1583; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jackson J, 2014, STATUS TRENDS CARIBB, DOI DOI 10.1111/1365-2664.12388; Kavanagh KD, 2006, ENVIRON BIOL FISH, V76, P387, DOI 10.1007/s10641-006-9044-1; Kikuchi RKP, 1997, P 8 INT COR REEF S P, V1, P731; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Kraines SB, 2001, CORAL REEFS, V20, P330, DOI 10.1007/s00338-001-0191-8; Krajewski JP, 2011, J MAR BIOL ASSOC UK, V91, P1359, DOI 10.1017/S0025315410000111; Krajewski JP, 2011, ENVIRON BIOL FISH, V92, P25, DOI 10.1007/s10641-011-9813-3; Kramer MJ, 2014, MAR BIOL, V161, P2183, DOI 10.1007/s00227-014-2495-6; Kramer MJ, 2013, CORAL REEFS, V32, P575, DOI 10.1007/s00338-013-1009-1; Kramer MJ, 2012, CORAL REEFS, V31, P1007, DOI 10.1007/s00338-012-0924-x; Lamb K, 2012, B MAR SCI, V88, P119, DOI 10.5343/bms.2010.1105; Leao ZMAN, 2003, LATIN AMERICAN CORAL REEFS, P9, DOI 10.1016/B978-044451388-5/50003-5; Legendre P., 2012, NUMERICAL ECOLOGY, V24; LEWIS SM, 1987, ECOLOGY, V68, P636, DOI 10.2307/1938468; LEWIS SM, 1986, ECOL MONOGR, V56, P183, DOI 10.2307/2937073; Littler M.M., 1983, Coral Reefs, V2, P111, DOI 10.1007/BF02395281; LITTLER MM, 1984, J EXP MAR BIOL ECOL, V74, P13, DOI 10.1016/0022-0981(84)90035-2; LITTLER MM, 1983, J PHYCOL, V19, P229, DOI 10.1111/j.0022-3646.1983.00229.x; Littler MM, 2011, ENCY MODERN CORAL RE; Longo GO, 2012, J FISH BIOL, V81, P1773, DOI 10.1111/j.1095-8649.2012.03441.x; Longo GO, 2014, ECOL EVOL, V4, P4553, DOI 10.1002/ece3.1310; Luiz OJ, 2015, MAR FRESHWATER RES; Maida Mauro, 1997, P263; Mantyka CS, 2007, MAR ECOL PROG SER, V352, P177, DOI 10.3354/meps07055; Marques LV, 2006, BOT MAR, V49, P379, DOI 10.1515/BOT.2006.049; McClanahan T, 2011, CORAL REEFS, V30, P9, DOI 10.1007/s00338-010-0690-6; McClanahan TR, 2003, MAR ECOL PROG SER, V261, P135, DOI 10.3354/meps261135; MCCREADY RM, 1950, ANAL CHEM, V22, P1156, DOI 10.1021/ac60045a016; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; PADILLA DK, 1989, ECOLOGY, V70, P835, DOI 10.2307/1941352; PAUL VJ, 1986, MAR ECOL PROG SER, V34, P157, DOI 10.3354/meps034157; Pereira NS, 2010, J INTEGR COAST ZONE, V10, P331, DOI DOI 10.5894/RGCI209; Pereira RC, 2000, MAR ECOL PROG SER, V205, P95, DOI 10.3354/meps205095; Pereira GH, 2011, BRAZ J OCEANOGR, V59, P201, DOI 10.1590/S1679-87592011000300001; Pinheiro HT, 2011, J FISH BIOL, V79, P1984, DOI 10.1111/j.1095-8649.2011.03138.x; Pinheiro HT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118180; RANDALL JOHN E., 1967, STUD TROP OCEANOGR INST MAR SCI UNIV MIAMI, V5, P665; RANDI AM, 1988, BOT MAG TOKYO, V101, P529, DOI 10.1007/BF02488094; Rasher DB, 2013, ECOLOGY, V94, P1347, DOI 10.1890/12-0389.1; Riul P, 2008, J MAR BIOL ASSOC UK, V88, P17, DOI 10.1017/S0025315408000258; Rizzari JR, 2014, OIKOS, V123, P829, DOI 10.1111/oik.01318; Rosa M, 2009, PLANT PHYSIOL BIOCH, V47, P300, DOI 10.1016/j.plaphy.2008.12.001; Rosa R.S., 1997, P983; Sampaio CLS, 2006, ILHAS OCEANICAS BRAS, P215; SHANNON JC, 1968, PLANT PHYSIOL, V43, P1215, DOI 10.1104/pp.43.8.1215; Sissini Marina Nasri, 2014, Marine Biodiversity Records, V7, pe104, DOI 10.1017/S1755267214001018; Sluka RD, 2001, CORAL REEFS, V20, P255, DOI 10.1007/s003380100166; Smith JE, 2010, OECOLOGIA, V163, P497, DOI 10.1007/s00442-009-1546-z; Souza AT, 2011, ENVIRON BIOL FISH, V91, P133, DOI 10.1007/s10641-010-9765-z; STENECK RS, 1994, OIKOS, V69, P476, DOI 10.2307/3545860; STEPHENSON TA, 1972, LIFE TIDE MARKS ROCK; STRAUSS RE, 1979, T AM FISH SOC, V108, P344, DOI 10.1577/1548-8659(1979)108<344:REFIEI>2.0.CO;2; Umbreit WW, 1964, MANOMETRIC TECHNIQUE; Williams GJ, 2013, PEERJ, V1, DOI 10.7717/peerj.81; Wilson S, 2004, BIOL CONSERV, V120, P279, DOI 10.1016/j.biocon.2004.03.001; Wilson S, 1997, MAR ECOL PROG SER, V153, P299, DOI 10.3354/meps153299; Wilson SK, 2003, OCEANOGR MAR BIOL, V41, P279; Zemke-White WL, 2002, MAR BIOL, V141, P571, DOI 10.1007/s00227-002-0849-y	116	49	50	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0127176	10.1371/journal.pone.0127176	http://dx.doi.org/10.1371/journal.pone.0127176			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061735	Green Published, Green Submitted, gold			2022-12-26	WOS:000355979500027
J	Recio-Spinoso, A; Rhode, WS				Recio-Spinoso, Alberto; Rhode, William S.			Fast Waves at the Base of the Cochlea	PLOS ONE			English	Article							BASILAR-MEMBRANE RESPONSES; VIBRATION; CLICKS; NOISE	Georg von Bekesy observed that the onset times of responses to brief-duration stimuli vary as a function of distance from the stapes, with basal regions starting to move earlier than apical ones. He noticed that the speed of signal propagation along the cochlea is slow when compared with the speed of sound in water. Fast traveling waves have been recorded in the cochlea, but their existence is interpreted as the result of an experiment artifact. Accounts of the timing of vibration onsets at the base of the cochlea generally agree with Bekesy's results. Some authors, however, have argued that the measured delays are too short for consistency with Bekesy's theory. To investigate the speed of the traveling wave at the base of the cochlea, we analyzed basilar membrane (BM) responses to clicks recorded at several locations in the base of the chinchilla cochlea. The initial component of the BM response matches remarkably well the initial component of the stapes response, after a 4-mu s delay of the latter. A similar conclusion is reached by analyzing onset times of time-domain gain functions, which correspond to BM click responses normalized by middle-ear input. Our results suggest that BM responses to clicks arise from a combination of fast and slow traveling waves.	[Recio-Spinoso, Alberto] Univ Castilla La Mancha, Inst Invest Discapacidades Neurol, Albacete, Spain; [Rhode, William S.] Univ Wisconsin, Dept Neurosci, Madison, WI USA	Universidad de Castilla-La Mancha; University of Wisconsin System; University of Wisconsin Madison	Recio-Spinoso, A (corresponding author), Univ Castilla La Mancha, Inst Invest Discapacidades Neurol, Albacete, Spain.	reci0001@umn.edu	Recio-Spinoso, Alberto/F-7744-2013	Recio-Spinoso, Alberto/0000-0003-1909-832X	National Institute on Deafness and Other Communication Disorders [5R01DC001910-14]; Regional Operational Programme of the European Social Fund, within the framework of Spain's Instituto de Recursos Humanos para la Ciencia y la Tecnologia program of the Fundacion Parque Cientifico y Tecnologico de Castilla-La Mancha in Albacete; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001910] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Regional Operational Programme of the European Social Fund, within the framework of Spain's Instituto de Recursos Humanos para la Ciencia y la Tecnologia program of the Fundacion Parque Cientifico y Tecnologico de Castilla-La Mancha in Albacete; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by the National Institute on Deafness and Other Communication Disorders (5R01DC001910-14; http://www.nidcd.nih.gov/Pages/default.aspx; principal investigator: WSR), and the Regional Operational Programme of the European Social Fund 2007/2013, within the framework of Spain's Instituto de Recursos Humanos para la Ciencia y la Tecnologia program of the Fundacion Parque Cientifico y Tecnologico de Castilla-La Mancha in Albacete (http://www.pcyta.com; principal investigator: ARS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047918; Cooper NP, 1996, AUDIT NEUROSCI, V2, P289; Cooper NP, 1999, J NEUROSCI METH, V88, P93, DOI 10.1016/S0165-0270(99)00017-5; DANCER A, 1992, AUDIOLOGY, V31, P301; Dancer A., 1997, DIVERSITY AUDITORY M, P340; de La Rochefoucauld O, 2007, BIOPHYS J, V93, P3434, DOI 10.1529/biophysj.107.109744; Dong W, 2006, J R SOC INTERFACE, V3, P561, DOI 10.1098/rsif.2006.0117; Goldstein JL, 1971, PHYSL AUDITORY SYSTE, P133; He W, 2013, SCI REP-UK, V3, DOI 10.1038/srep01874; He WX, 2008, P NATL ACAD SCI USA, V105, P2729, DOI 10.1073/pnas.0708103105; Helmholtz H. V., 1954, SENSATION TONE; Huang S, 2011, JARO-J ASSOC RES OTO, V12, P559, DOI 10.1007/s10162-011-0272-5; KOSHIGOE S, 1982, J ACOUST SOC AM, V71, P1194, DOI 10.1121/1.387767; LIGHTHILL J, 1981, J FLUID MECH, V106, P149, DOI 10.1017/S0022112081001560; Muller M, 2010, HEARING RES, V268, P184, DOI 10.1016/j.heares.2010.05.021; Nuttall AL, 2006, AUDITORY MECH PROCES, P535; Olson ES, 2013, POMA, V19, DOI [10.1121/1.4799326, DOI 10.1121/1.4799326]; Papoulis A, 1962, FOURIER INTEGRALS IT; PETERSON LC, 1950, J ACOUST SOC AM, V22, P369, DOI 10.1121/1.1906615; Recio A, 2000, J ACOUST SOC AM, V108, P2281, DOI 10.1121/1.1318898; Recio A, 1998, J ACOUST SOC AM, V103, P1972, DOI 10.1121/1.421377; Recio-Spinoso A, 2011, IEEE T BIO-MED ENG, V58, P1456, DOI 10.1109/TBME.2010.2052254; Ren TY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020149; Ren TY, 2002, P NATL ACAD SCI USA, V99, P17101, DOI 10.1073/pnas.262663699; RHODE WS, 1971, J ACOUST SOC AM, V49, P1218, DOI 10.1121/1.1912485; Rhode WS, 2000, J ACOUST SOC AM, V107, P3317, DOI 10.1121/1.429404; ROBLES L, 1976, J ACOUST SOC AM, V59, P926, DOI 10.1121/1.380953; RUGGERO MA, 1980, J ACOUST SOC AM, V67, P707, DOI 10.1121/1.383900; Ruggero MA, 2007, JARO-J ASSOC RES OTO, V8, P153, DOI 10.1007/s10162-007-0081-z; Steele CR, 2009, CONCEPTS AND CHALLENGES IN THE BIOPHYSICS OF HEARING, P323, DOI 10.1142/9789812833785_0050; Temchin AN, 2005, J NEUROPHYSIOL, V93, P3635, DOI 10.1152/jn.00885.2004; Temchin AN, 2012, J NEUROSCI, V32, P10522, DOI 10.1523/JNEUROSCI.1138-12.2012; VONBEKESY G, 1949, J ACOUST SOC AM, V21, P245; Watts L, 2000, J ACOUST SOC AM, V108, P2266, DOI 10.1121/1.1310194; ZWEIG G, 1975, COLD SPRING HARB SYM, V40, P619, DOI 10.1101/SQB.1976.040.01.058	35	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129556	10.1371/journal.pone.0129556	http://dx.doi.org/10.1371/journal.pone.0129556			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26062000	Green Published, gold, Green Submitted			2022-12-26	WOS:000355979500148
J	Krasner, DS; Daley, JM; Sung, P; Niu, HY				Krasner, Danielle S.; Daley, James M.; Sung, Patrick; Niu, Hengyao			Interplay between Ku and Replication Protein A in the Restriction of Exo1-mediated DNA Break End Resection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAK; REPAIR PATHWAY CHOICE; HOMOLOGOUS RECOMBINATION; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; CHECKPOINT ACTIVATION; JOINING REPAIR; COMPLEX; EXO1; DAMAGE	DNA double-strand breaks can be eliminated via non-homologous end joining or homologous recombination. Non-homologous end joining is initiated by the association of Ku with DNA ends. In contrast, homologous recombination entails nucleolytic resection of the 5'-strands, forming 3'-ssDNA tails that become coated with replication protein A (RPA). Ku restricts end access by the resection nuclease Exo1. It is unclear how partial resection might affect Ku engagement and Exo1 restriction. Here, we addressed these questions in a reconstituted system with yeast proteins. With blunt-ended DNA, Ku protected against Exo1 in a manner that required its DNA end-binding activity. Despite binding poorly to ssDNA, Ku could nonetheless engage a 5'-recessed DNA end with a 40-nucleotide (nt) ssDNA overhang, where it localized to the ssDNA-dsDNA junction and efficiently blocked resection by Exo1. Interestingly, RPA could exclude Ku from a partially resected structure with a 22-nt ssDNA tail and thus restored processing by Exo1. However, at a 40-nt tail, Ku remained stably associated at the ssDNA-dsDNA junction, and RPA simultaneously engaged the ssDNA region. We discuss a model in which the dynamic equilibrium between Ku and RPA binding to a partially resected DNA end influences the timing and efficiency of the resection process.	[Krasner, Danielle S.; Daley, James M.; Sung, Patrick] Yale Univ, Dept Mol Biophys & Biochem, Sch Med, New Haven, CT 06520 USA; [Niu, Hengyao] Indiana Univ, Mol & Cellular Biochem Dept, Bloomington, IN 47405 USA	Yale University; Indiana University System; Indiana University Bloomington	Sung, P (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, Sch Med, New Haven, CT 06520 USA.	patrick.sung@yale.edu; hniu@indiana.edu	Regan, Clinton/E-6250-2012; Niu, Hengyao/AAE-9269-2020		National Institutes of Health [R01 ES007016, R01 ES015632, R01 ES015252, R01 GM057814, K99/R00 ES021441]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES021441, R01ES015632, K99ES021441, R01ES015252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223, R01GM057814] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES007016, R01 ES015632, R01 ES015252, R01 GM057814, and K99/R00 ES021441. The authors declare that they have no conflicts of interest with the contents of this article.	Adkins NL, 2013, NAT STRUCT MOL BIOL, V20, P836, DOI 10.1038/nsmb.2585; Aylon Y, 2004, EMBO J, V23, P4868, DOI 10.1038/sj.emboj.7600469; Bizard AH, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016477; Bressan DA, 1999, MOL CELL BIOL, V19, P7681; Brosey CA, 2013, NUCLEIC ACIDS RES, V41, P2313, DOI 10.1093/nar/gks1332; Cannavo E, 2014, NATURE, V514, P122, DOI 10.1038/nature13771; Cary RB, 1997, P NATL ACAD SCI USA, V94, P4267, DOI 10.1073/pnas.94.9.4267; Chen H, 2013, MOL CELL, V50, P589, DOI 10.1016/j.molcel.2013.04.032; Chiruvella KK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012757; Clerici M, 2008, EMBO REP, V9, P810, DOI 10.1038/embor.2008.121; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; Daley JM, 2005, MOL CELL BIOL, V25, P896, DOI 10.1128/MCB.25.3.896-906.2005; DEVRIES E, 1989, J MOL BIOL, V208, P65, DOI 10.1016/0022-2836(89)90088-0; Dynan WS, 1998, NUCLEIC ACIDS RES, V26, P1551, DOI 10.1093/nar/26.7.1551; FALZON M, 1993, J BIOL CHEM, V268, P10546; Foster SS, 2011, MOL CELL BIOL, V31, P4379, DOI 10.1128/MCB.05854-11; Genschel J, 2003, MOL CELL, V12, P1077, DOI 10.1016/S1097-2765(03)00428-3; Grob P, 2012, DNA REPAIR, V11, P74, DOI 10.1016/j.dnarep.2011.10.023; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Ira G, 2012, NAT CELL BIOL, V14, P448, DOI 10.1038/ncb2494; Kantake N, 2003, J BIOL CHEM, V278, P23410, DOI 10.1074/jbc.M302995200; Karathanasis E, 2002, GENETICS, V161, P1015; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Langerak P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002271; LeBel C, 2009, GENETICS, V182, P671, DOI 10.1534/genetics.109.102939; Lee BI, 1999, J BIOL CHEM, V274, P37763, DOI 10.1074/jbc.274.53.37763; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Lopez CR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002233; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Maringele L, 2002, GENE DEV, V16, P1919, DOI 10.1101/gad.225102; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2010, EMBO J, V29, P3358, DOI 10.1038/emboj.2010.193; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Orans J, 2011, CELL, V145, P212, DOI 10.1016/j.cell.2011.03.005; PAILLARD S, 1991, NUCLEIC ACIDS RES, V19, P5619, DOI 10.1093/nar/19.20.5619; RATHMELL WK, 1994, MOL CELL BIOL, V14, P4741, DOI 10.1128/MCB.14.7.4741; Reynolds P, 2012, NUCLEIC ACIDS RES, V40, P10821, DOI 10.1093/nar/gks879; Shibata A, 2011, EMBO J, V30, P1079, DOI 10.1038/emboj.2011.27; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; Tomimatsu N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4561; Tomita K, 2003, MOL CELL BIOL, V23, P5186, DOI 10.1128/MCB.23.15.5186-5197.2003; Van Komen S, 2006, METHOD ENZYMOL, V408, P445, DOI 10.1016/S0076-6879(06)08028-1; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wasko BM, 2009, DNA REPAIR, V8, P162, DOI 10.1016/j.dnarep.2008.09.010; Wilson TE, 1999, J BIOL CHEM, V274, P23599, DOI 10.1074/jbc.274.33.23599; Wu DL, 2008, GENETICS, V178, P1237, DOI 10.1534/genetics.107.083535; Wu TJ, 2009, J BIOL CHEM, V284, P12801, DOI 10.1074/jbc.M809131200; Wyatt HDM, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a023192; Yang SH, 2013, EMBO J, V32, P126, DOI 10.1038/emboj.2012.314; Zhang Y, 2007, NAT STRUCT MOL BIOL, V14, P639, DOI 10.1038/nsmb1261; Zhou Y, 2013, J BIOL CHEM, V288, P37112, DOI 10.1074/jbc.M113.514398; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	56	28	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18806	18816		10.1074/jbc.M115.660191	http://dx.doi.org/10.1074/jbc.M115.660191			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26067273	Green Published, hybrid			2022-12-26	WOS:000358512100047
J	Chen, J; Fang, M; Zhao, YP; Yi, CH; Ji, J; Cheng, C; Wang, MM; Gu, X; Sun, QS; Chen, XL; Gao, CF				Chen, Jie; Fang, Meng; Zhao, Yun-Peng; Yi, Chang-Hong; Ji, Jun; Cheng, Cheng; Wang, Meng-Meng; Gu, Xing; Sun, Quan-Sheng; Chen, Xiao-Ling; Gao, Chun-Fang			Serum N-Glycans: A New Diagnostic Biomarker for Light Chain Multiple Myeloma	PLOS ONE			English	Article							MONOCLONAL GAMMOPATHY; RHEUMATOID-ARTHRITIS; RISK; GLYCOSYLATION; ASSOCIATION; PROGRESSION; CARCINOMA; SURVIVAL; DIMERS; IGG	The aim of this study was to evaluate the diagnostic and differential diagnostic power of serum N-glycans for light chain multiple myeloma (LCMM). A total of 167 cases of subjects, including 42 LCMM, 42 IgG myeloma, 41 IgA myeloma, and 42 healthy controls were recruited in this study. DNA sequencer-assisted fluorophore-assisted capillary electrophoresis (DSA-FACE) was applied to determine the quantitive abundance of serum N-glycans. The core fucosylated, bisecting and sialylated modifications were analyzed in serum of LCMM patients (n=20) and healthy controls (n=20) randomly selected from the same cohort by lectin blot. Moreover, serum sialic acid (SA) level was measured by enzymatic method. We found two N-glycan structures (NG1A2F, Peak3; NA2FB, Peak7) showed the optimum diagnostic efficacy with area under the ROC curve (AUC) 0.939 and 0.940 between LCMM and healthy control. The sensitivity and specificity of Peak3 were 88.1% and 92.9%, while Peak7 were 92.9% and 97.6%, respectively. The abundance of Peak3 could differentiate LCMM from IgG myeloma with AUC 0.899, sensitivity 100% and specificity 76.2%, and Peak7 could be used to differentiate LCMM from IgA myeloma with AUC 0.922, sensitivity 92.9% and specificity 82.9%. Serum SA level was significantly higher in patients with LCMM than that in healthy controls. Moreover, the decreased core fucosylation, bisecting and increased sialylation characters of serum glycoproteins were observed in patients with LCMM. We concluded that serum N-glycan could provide a simple, reliable and non-invasive biomarker for LCMM diagnosis and abnormal glycosylation might imply a new potential therapeutic target in LCMM.	[Chen, Jie; Fang, Meng; Zhao, Yun-Peng; Yi, Chang-Hong; Ji, Jun; Cheng, Cheng; Wang, Meng-Meng; Gu, Xing; Sun, Quan-Sheng; Gao, Chun-Fang] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Lab Med, Shanghai, Peoples R China; [Chen, Xiao-Ling] Shanghai Zhabei Dist Cent Hosp, Dept Hematol, Shanghai, Peoples R China	Naval Medical University	Gao, CF (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Lab Med, Shanghai, Peoples R China.	gaocf1115@163.com			Natural Science Foundation of China [81101639, 81271925, 81301877]; Science and Technology Commission of Shanghai Municipality [2010-04]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	The study was supported by Natural Science Foundation of China (No, 81101639, 81271925, 81301877); and the Science and Technology Commission of Shanghai Municipality (grants 2010-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CL, 2006, TRENDS IMMUNOL, V27, P343, DOI 10.1016/j.it.2006.05.004; Bradwell AR, 2003, LANCET, V361, P489, DOI 10.1016/S0140-6736(03)12457-9; Callewaert N, 2004, NAT MED, V10, P429, DOI 10.1038/nm1006; Chen NF, 2011, CHINESE LABORATORY D, V15, P1896; Cunningham S, 2010, ANALYST, V135, P2471, DOI 10.1039/c0an00276c; Dispenzieri A, 2009, LEUKEMIA, V23, P215, DOI 10.1038/leu.2008.307; Drayson M, 2001, BLOOD, V97, P2900, DOI 10.1182/blood.V97.9.2900; Drayson M, 2006, BLOOD, V108, P2013, DOI 10.1182/blood-2006-03-008953; Fang M, 2010, INT J CANCER, V127, P148, DOI 10.1002/ijc.25030; Feizi T, 2000, IMMUNOL REV, V173, P79, DOI 10.1034/j.1600-065X.2000.917310.x; Glavey SV, 2014, BLOOD, V124, P1765, DOI 10.1182/blood-2014-03-560862; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Holland M, 2002, CLIN EXP IMMUNOL, V129, P183, DOI 10.1046/j.1365-2249.2002.01864.x; Kaplan B, 2011, THESCIENTIFICWORLDJO, V11, P726, DOI 10.1100/tsw.2011.65; Kyle RA, 2009, LEUKEMIA, V23, P3, DOI 10.1038/leu.2008.291; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Lachmann HJ, 2003, BRIT J HAEMATOL, V122, P78, DOI 10.1046/j.1365-2141.2003.04433.x; Lauc G, 2012, BBA-GEN SUBJECTS, V1820, P1305, DOI 10.1016/j.bbagen.2012.03.001; Li C, 2011, CLIN LAB, V57, P53; Liu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077821; Liu XE, 2007, HEPATOLOGY, V46, P1426, DOI 10.1002/hep.21855; Mead GP, 2004, BRIT J HAEMATOL, V126, P348, DOI 10.1111/j.1365-2141.2004.05045.x; Mead GP, 2009, BLOOD, V114, P1717, DOI 10.1182/blood-2009-06-225854; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; Pilkington C, 1995, AUTOIMMUNITY, V22, P107, DOI 10.3109/08916939508995306; Rajkumar SV, 2004, BRIT J HAEMATOL, V127, P308, DOI 10.1111/j.1365-2141.2004.05169.x; Rajkumar SV, 2005, BLOOD, V106, P812, DOI 10.1182/blood-2005-03-1038; Reinders J, 2007, BIOMOL ENG, V24, P169, DOI 10.1016/j.bioeng.2007.03.002; Saldova R, 2014, J PROTEOME RES, V13, P2314, DOI 10.1021/pr401092y; Shaheen SP, 2009, CLIN CHIM ACTA, V406, P162, DOI 10.1016/j.cca.2009.04.024; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Vanhooren V, 2009, MECH AGEING DEV, V130, P92, DOI 10.1016/j.mad.2008.11.008; Zhao YP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094536; Zhao YP, 2012, CANCER-AM CANCER SOC, V118, P639, DOI 10.1002/cncr.26342	34	16	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0127022	10.1371/journal.pone.0127022	http://dx.doi.org/10.1371/journal.pone.0127022			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075387	Green Published, Green Submitted, gold			2022-12-26	WOS:000356329900009
J	Gadoev, J; Asadov, D; Tillashaykhov, M; Tayler-Smith, K; Isaakidis, P; Dadu, A; De Colombani, P; Hinderaker, SG; Parpieva, N; Ulmasova, D; Jalolov, A; Hamraev, A; Ali, E; van den Boom, M; Hammerich, A; Gozalov, O; Dara, M				Gadoev, Jamshid; Asadov, Damin; Tillashaykhov, Mirzagolib; Tayler-Smith, Katie; Isaakidis, Petros; Dadu, Andrei; De Colombani, Pierpaolo; Hinderaker, Sven Gudmund; Parpieva, Nargiza; Ulmasova, Dilrabo; Jalolov, Avazbek; Hamraev, Atadjan; Ali, Engy; van den Boom, Martin; Hammerich, Asmus; Gozalov, Ogtay; Dara, Masoud			Factors Associated with Unfavorable Treatment Outcomes in New and Previously Treated TB Patients in Uzbekistan: A Five Year Countrywide Study	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS	Background TB is one of the main health priorities in Uzbekistan and relatively high rates of unfavorable treatment outcomes have recently been reported. This requires closer analysis to explain the reasons and recommend interventions to improve the situation. Thus, by using countrywide data this study sought to determine trends in unfavorable outcomes (lost-to-follow-ups, deaths and treatment failures) and describe their associations with socio-demographic and clinical factors. Method A countrywide retrospective cohort study of all new and previously treated TB patients registered in the National Tuberculosis programme between January 2006 and December 2010. Results Among 107,380 registered patients, 67% were adults, with smaller proportions of children (10%), adolescents (4%) and elderly patients (19%). Sixty per cent were male, 66% lived in rural areas, 1% were HIV-infected and 1% had a history of imprisonment. Pulmonary TB (PTB) was present in 77%, of which 43% were smear-positive and 53% were smear-negative. Overall, 83% of patients were successfully treated, 6% died, 6% were lost-to-follow-up, 3% failed treatment and 2% transferred out. Factors associated with death included being above 55 years of age, HIV-positive, sputum smear positive, previously treated, jobless and living in certain provinces. Factors associated with lost-to-follow-up were being male, previously treated, jobless, living in an urban area, and living in certain provinces. Having smear positive PTB, being an adolescent, being urban population, being HIV-negative, previously treated, jobless and residing in particular provinces were associated with treatment failure. Conclusion Overall, 83% treatment success rate was achieved. However, our study findings highlight the need to improve TB services for certain vulnerable groups and in specific areas of the country. They also emphasize the need to develop unified monitoring and evaluation tools for drug-susceptible and drug-resistant TB, and call for better TB surveillance and coordination between provinces and neighbouring countries.	[Gadoev, Jamshid; Ulmasova, Dilrabo; Hammerich, Asmus; Gozalov, Ogtay] World Hlth Org Country Off Tashkent, Tashkent, Uzbekistan; [Asadov, Damin] State Post Grad Inst Med Educ, Tashkent, Uzbekistan; [Tillashaykhov, Mirzagolib] Republican Specialized TB Ctr, Tashkent, Uzbekistan; [Tayler-Smith, Katie; Isaakidis, Petros; Ali, Engy] MSF Luxembourg, Operat Res Unit, Operat Ctr Brussels, MSF, Luxembourg, Luxembourg; [Dadu, Andrei; De Colombani, Pierpaolo; van den Boom, Martin; Dara, Masoud] WHO Reg Off Europe, TBM Dept, Copenhagen, Denmark; [Hinderaker, Sven Gudmund] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Parpieva, Nargiza] Tashkent Med Acad, Tashkent, Uzbekistan; [Jalolov, Avazbek] Republican DOTS Ctr, Tashkent, Uzbekistan; [Hamraev, Atadjan] Tashkent State Pediat Inst, Nukus Branch, Nukus, Karakalpakstan, Uzbekistan	World Health Organization; Doctors Without Borders; World Health Organization; University of Bergen; Tashkent Medical Academy; Tashkent Pediatric Medical Institute	Gadoev, J (corresponding author), World Hlth Org Country Off Tashkent, Tashkent, Uzbekistan.	jag@euro.who.int	Parpieva, Nargiza/ABD-1085-2020; Tillyashaikhov, Mirzagaleb/AAU-8946-2021	Tillyashaikhov, Mirzagaleb/0000-0001-6428-9550; Asadov, Damin/0000-0003-2192-1418; Isaakidis, Petros/0000-0002-7881-1554; Gadoev, Jamshid/0000-0003-3998-5786; DADU, Andrei/0000-0002-3080-8321	International Union Against Tuberculosis and Lung Disease; Department for International Development (DFID); WHO; Medecins Sans Frontieres	International Union Against Tuberculosis and Lung Disease; Department for International Development (DFID); WHO(World Health Organization); Medecins Sans Frontieres	The programme was funded by Medecins Sans Frontieres, International Union Against Tuberculosis and Lung Disease, the Department for International Development (DFID) and WHO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthakrishnan R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067288; Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81; Cox HS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001126; Dara M, 2011, ROADMAP PREVENT COMB; Fenner L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034186; Gaur S. N., 2004, Indian Journal of Tuberculosis, V51, P83; Hamusse SD, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25382; Hasker E, 2010, INT J TUBERC LUNG D, V14, P1132; Hasker E, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-97; Isaakidis P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068869; Kherosheva T, 2003, INT J TUBERC LUNG D, V7, P1045; Kilicaslan Z, 2003, INT J TUBERC LUNG D, V7, P1059; Lalor MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078364; Multidrug and extensively drug-resistant TB (M/XDR-TB), 2010, GLOBAL REPORT SURVEI; Pande JN, 1996, THORAX, V51, P132, DOI 10.1136/thx.51.2.132; Perez-Guzman C, 1999, CHEST, V116, P961, DOI 10.1378/chest.116.4.961; Reed GW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058044; Sanchez Mauro, 2012, PLoS One, V7, pe33129, DOI 10.1371/journal.pone.0033129; Tweya H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056248; Ulmasova DJ, 2013, EUROSURVEILLANCE, V18, P5, DOI 10.2807/1560-7917.ES2013.18.42.20609; van Hest R, 2013, EUR RESPIR J, V41, P635, DOI 10.1183/09031936.00030612; Velayutham BRV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088045; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; World Health Organization, 2013, GLOB TUB CONTR 2013	24	31	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128907	10.1371/journal.pone.0128907	http://dx.doi.org/10.1371/journal.pone.0128907			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075615	gold, Green Submitted, Green Published			2022-12-26	WOS:000356329900037
J	Gritsenko, V; Dailey, E; Kyle, N; Taylor, M; Whittacre, S; Swisher, AK				Gritsenko, Valeriya; Dailey, Eric; Kyle, Nicholas; Taylor, Matt; Whittacre, Sean; Swisher, Anne K.			Feasibility of Using Low-Cost Motion Capture for Automated Screening of Shoulder Motion Limitation after Breast Cancer Surgery	PLOS ONE			English	Article							MICROSOFT KINECT; TERM MORBIDITY; NODE BIOPSY; UPPER-LIMB; REHABILITATION; PHYSIOTHERAPY; DISSECTION; VALIDITY; SYSTEM; CARE	Objective To determine if a low-cost, automated motion analysis system using Microsoft Kinect could accurately measure shoulder motion and detect motion impairments in women following breast cancer surgery. Design Descriptive study of motion measured via 2 methods. Setting Academic cancer center oncology clinic. Participants 20 women (mean age = 60 yrs) were assessed for active and passive shoulder motions during a routine post-operative clinic visit (mean = 18 days after surgery) following mastectomy (n = 4) or lumpectomy (n = 16) for breast cancer. Interventions Participants performed 3 repetitions of active and passive shoulder motions on the side of the breast surgery. Arm motion was recorded using motion capture by Kinect for Windows sensor and on video. Goniometric values were determined from video recordings, while motion capture data were transformed to joint angles using 2 methods (body angle and projection angle). Main Outcome Measure Correlation of motion capture with goniometry and detection of motion limitation. Results Active shoulder motion measured with low-cost motion capture agreed well with goniometry (r = 0.70-0.80), while passive shoulder motion measurements did not correlate well. Using motion capture, it was possible to reliably identify participants whose range of shoulder motion was reduced by 40% or more. Conclusions Low-cost, automated motion analysis may be acceptable to screen for moderate to severe motion impairments in active shoulder motion. Automatic detection of motion limitation may allow quick screening to be performed in an oncologist's office and trigger timely referrals for rehabilitation.	[Gritsenko, Valeriya; Dailey, Eric; Kyle, Nicholas; Taylor, Matt; Whittacre, Sean; Swisher, Anne K.] W Virginia Univ, Div Phys Therapy, Morgantown, WV 26506 USA	West Virginia University	Gritsenko, V (corresponding author), W Virginia Univ, Div Phys Therapy, Morgantown, WV 26506 USA.	vgritsenko@hsc.wvu.edu	Gritsenko, Valeriya/G-9232-2012	Gritsenko, Valeriya/0000-0001-5302-4004; Gritsenko, Valeriya/0000-0002-6408-9433	WVU School of Medicine; WVU; WVU/NSF ADVANCE program [HRD-100797]	WVU School of Medicine; WVU; WVU/NSF ADVANCE program(National Science Foundation (NSF)NSF - Office of the Director (OD))	VG received the following funding: Departmental Start-up Fund from WVU School of Medicine; Research Funding Development Grant from WVU (www.hsc.wvu.edu/ResOff/Pages/Research/Internal-Funding-Sources/Research-Funding-Development-Grants); WVU/NSF ADVANCE program HRD-100797 (advance.wvu.edu).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2012, CANCER TREATMENT SUR; Blomqvist L, 2004, ACTA ONCOL, V43, P280, DOI 10.1080/02841860410026170; Boulos MNK, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-18; Caimmi M, 2008, NEUROREHAB NEURAL RE, V22, P31, DOI 10.1177/1545968307302923; Chang YJ, 2013, RES DEV DISABIL, V34, P3654, DOI 10.1016/j.ridd.2013.08.021; Chang YJ, 2011, RES DEV DISABIL, V32, P2566, DOI 10.1016/j.ridd.2011.07.002; Cismas A, 2011, TIMISOARA PHYS EDU R, V4, P35; Clark RA, 2013, GAIT POSTURE, V38, P1064, DOI 10.1016/j.gaitpost.2013.03.029; Clark RA, 2013, J BIOMECH, V46, P2722, DOI 10.1016/j.jbiomech.2013.08.011; Crane-Okada R, 2008, ANN SURG ONCOL, V15, P1996, DOI 10.1245/s10434-008-9909-y; Karki A, 2005, J REHABIL MED, V37, P180, DOI 10.1080/16501970410024181; Kolber MJ, 2012, INT J SPORTS PHYS TH, V7, P306; Kootstra JJ, 2013, BREAST CANCER RES TR, V139, P125, DOI 10.1007/s10549-013-2509-y; Lange B, 2011, IEEE ENG MED BIO, P1831, DOI 10.1109/IEMBS.2011.6090521; Lauridsen MC, 2005, ACTA ONCOL, V44, P449, DOI 10.1080/02841860510029905; Lauridsen MC, 2000, BREAST, V9, P45, DOI 10.1054/brst.1999.0087; McAnaw Maire B, 2002, Breast Dis, V16, P163; Olesh EV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104487; do Rosario JLP, 2014, J BODYW MOV THER, V18, P368, DOI 10.1016/j.jbmt.2013.11.018; Rietman JS, 2003, CANCER, V98, P690, DOI 10.1002/cncr.11545; Shum HPH, 2013, IEEE T CYBERNETICS, V43, P1357, DOI 10.1109/TCYB.2013.2275945; Stone EE, 2011, IEEE ENG MED BIO, P6491, DOI 10.1109/IEMBS.2011.6091602; Swisher AK, 2010, REHABIL ONCOL, V28, P3, DOI 10.1097/01893697-201028010-00001; Taylor MJD, 2011, J REHABIL RES DEV, V48, P1171, DOI 10.1682/JRRD.2010.09.0171; Thomas-MacLean RL, 2008, ONCOL NURS FORUM, V35, P65, DOI 10.1188/08.ONF.65-71; Verbelen H, 2014, BREAST CANCER RES TR, V144, P21, DOI 10.1007/s10549-014-2846-5; Webster D, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-108; Wise CH, 2009, REHABIL ONCOL, V27, P14, DOI 10.1097/01893697-200927010-00003	28	12	13	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128809	10.1371/journal.pone.0128809	http://dx.doi.org/10.1371/journal.pone.0128809			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26076031	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900031
J	He, JB; Li, JJ; Huang, ZW; Zhao, TJ; Xing, GN; Gai, JY; Guan, RZ				He, Jianbo; Li, Jijie; Huang, Zhongwen; Zhao, Tuanjie; Xing, Guangnan; Gai, Junyi; Guan, Rongzhan			Composite Interval Mapping Based on Lattice Design for Error Control May Increase Power of Quantitative Trait Locus Detection	PLOS ONE			English	Article							BAYESIAN LASSO; GENETIC ARCHITECTURE; ASSOCIATION; RESISTANCE; IMPROVEMENT; STRATEGIES; SEARCH; PLANTS; CROSS; RUST	Experimental error control is very important in quantitative trait locus (QTL) mapping. Although numerous statistical methods have been developed for QTL mapping, a QTL detection model based on an appropriate experimental design that emphasizes error control has not been developed. Lattice design is very suitable for experiments with large sample sizes, which is usually required for accurate mapping of quantitative traits. However, the lack of a QTL mapping method based on lattice design dictates that the arithmetic mean or adjusted mean of each line of observations in the lattice design had to be used as a response variable, resulting in low QTL detection power. As an improvement, we developed a QTL mapping method termed composite interval mapping based on lattice design (CIMLD). In the lattice design, experimental errors are decomposed into random errors and block-within-replication errors. Four levels of block-within-replication errors were simulated to show the power of QTL detection under different error controls. The simulation results showed that the arithmetic mean method, which is equivalent to a method under random complete block design (RCBD), was very sensitive to the size of the block variance and with the increase of block variance, the power of QTL detection decreased from 51.3% to 9.4%. In contrast to the RCBD method, the power of CIMLD and the adjusted mean method did not change for different block variances. The CIMLD method showed 1.2- to 7.6-fold higher power of QTL detection than the arithmetic or adjusted mean methods. Our proposed method was applied to real soybean (Glycine max) data as an example and 10 QTLs for biomass were identified that explained 65.87% of the phenotypic variation, while only three and two QTLs were identified by arithmetic and adjusted mean methods, respectively.	[He, Jianbo; Li, Jijie; Zhao, Tuanjie; Xing, Guangnan; Gai, Junyi; Guan, Rongzhan] Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Modern Crop Prod, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [He, Jianbo; Zhao, Tuanjie; Xing, Guangnan; Gai, Junyi; Guan, Rongzhan] Minist Agr, Natl Ctr Soybean Improvement, Nanjing, Jiangsu, Peoples R China; [He, Jianbo; Zhao, Tuanjie; Xing, Guangnan; Gai, Junyi; Guan, Rongzhan] Minist Agr, Key Lab Biol & Genet Improvement Soybean, Nanjing, Jiangsu, Peoples R China; [Huang, Zhongwen] Henan Inst Sci & Technol, Collaborat Innovat Ctr Modern Biol Breeding, Dept Agron, Xinxiang, Henan, Peoples R China	Nanjing Agricultural University; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs; Henan Institute of Science & Technology	Guan, RZ (corresponding author), Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Modern Crop Prod, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	guanrzh@njau.edu.cn	He, Jianbo/H-4917-2018	He, Jianbo/0000-0002-9685-7564; Guan, Rongzhan/0000-0001-9177-6610	National Basic Research Program of China (973 Program) [2011CB109300]; Fundamental Research Funds for the Central Universities of China in China [KJQN201423, KYZ201202-7]; Open Research Fund of State Key Laboratory of Crop Genetics and Germplasm Enhancement [ZW2011006]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Fundamental Research Funds for the Central Universities of China in China; Open Research Fund of State Key Laboratory of Crop Genetics and Germplasm Enhancement; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Basic Research Program of China (973 Program) (No. 2011CB109300), the Fundamental Research Funds for the Central Universities of China (KJQN201423 and KYZ201202-7) in China, the Open Research Fund of State Key Laboratory of Crop Genetics and Germplasm Enhancement (ZW2011006), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal U, 2014, THEOR APPL GENET, V127, P1441, DOI 10.1007/s00122-014-2311-1; Barriere Y, 2012, THEOR APPL GENET, V125, P531, DOI 10.1007/s00122-012-1851-5; Broman KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9_1; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Broman KW, 2006, USE HIDDEN MARKOV MO, V125; Cai XD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-211; CHURCHILL GA, 1994, GENETICS, V138, P963; Cobb JN, 2013, THEOR APPL GENET, V126, P867, DOI 10.1007/s00122-013-2066-0; Dixit S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109574; Dixit S, 2012, THEOR APPL GENET, V125, P155, DOI 10.1007/s00122-012-1823-9; Doerge RW, 1997, STAT SCI, V12, P195; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Fu WQ, 2013, CURR OPIN GENET DEV, V23, P678, DOI 10.1016/j.gde.2013.10.008; HANSON C. H., 1956, AGRON JOUR, V48, P268; Hinkelmann K., 2007, DESIGN ANAL EXPT INT, V1; Houle D, 2010, NAT REV GENET, V11, P855, DOI 10.1038/nrg2897; Huang ZW, 2014, BRIEF BIOINFORM, V15, P562, DOI 10.1093/bib/bbt019; Hung HY, 2012, HEREDITY, V108, P490, DOI 10.1038/hdy.2011.103; JANSEN RC, 1993, GENETICS, V135, P205; Kempthorne, 2005, DESIGN ANAL EXPT ADV, V2; LANDER ES, 1989, GENETICS, V121, P185; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Li HY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001245; Li HH, 2007, GENETICS, V175, P361, DOI 10.1534/genetics.106.066811; Lin Y, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0250-2; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Mutshinda CM, 2010, GENETICS, V186, P1067, DOI 10.1534/genetics.110.119586; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; SAS Institute Inc, 2011, SAS STAT 9 3 US GUID; Sen S, 2001, GENETICS, V159, P371; Sillanpaa MJ, 1998, GENETICS, V148, P1373; Strigens A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057234; Wang S., WINDOWS QTL CARTOGRA; Wen ZX, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-809; Xu S., 2013, PRINCIPLES STAT GENO, P109; Yates F, 1936, J AGR SCI, V26, P424, DOI 10.1017/S0021859600022760; Yi NJ, 2008, GENETICS, V179, P1045, DOI 10.1534/genetics.107.085589; Yi NJ, 2003, GENETICS, V164, P1129; ZENG ZB, 1994, GENETICS, V136, P1457; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972; Zhang WK, 2004, THEOR APPL GENET, V108, P1131, DOI 10.1007/s00122-003-1527-2	42	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130125	10.1371/journal.pone.0130125	http://dx.doi.org/10.1371/journal.pone.0130125			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076140	Green Submitted, Green Published, gold			2022-12-26	WOS:000356329900140
J	Karisola, P; Lehto, M; Kinaret, P; Ahonen, N; Haapakoski, R; Anthoni, M; Taniguchi, M; Wolff, H; Puustinen, A; Alenius, H				Karisola, Piia; Lehto, Maili; Kinaret, Pia; Ahonen, Niina; Haapakoski, Rita; Anthoni, Minna; Taniguchi, Masaru; Wolff, Henrik; Puustinen, Anne; Alenius, Harri			Invariant Natural Killer T Cells Play a Role in Chemotaxis, Complement Activation and Mucus Production in a Mouse Model of Airway Hyperreactivity and Inflammation	PLOS ONE			English	Article							BRONCHOALVEOLAR LAVAGE FLUID; NKT CELLS; ALPHA-GALACTOSYLCERAMIDE; ASTHMA; PROTEOME; MICE; EXPRESSION; BIOMARKERS; PROTEINS; ALLERGEN	CD1d-restricted invariant natural killer T ( iNKT) cells play a critical role in the induction of airway hyperreactivity (AHR). After intranasal alpha-galactosylceramide (a-GalCer) administration, bronchoalveolar lavage fluid (BALF) proteins from mouse lung were resolved by two-dimensional differential gel electrophoresis (2D-DIGE), and identified by tandem mass spectroscopy. A lack of iNKT cells prevented the development of airway responses including AHR, neutrophilia and the production of the proinflammatory cytokines in lungs. Differentially abundant proteins in the BALF proteome of alpha-GalCer-treated wild type mice included lungkine (CXCL15), pulmonary surfactant-associated protein D (SFTPD), calcium-activated chloride channel regulator 1 (CLCA1), fragments of complement 3, chitinase 3-like proteins 1 (CH3LI) and 3 (CH3L3) and neutrophil gelatinase-associated lipocalin (NGAL). These proteins may contribute to iNKT regulated AHR via several mechanisms: altering leukocyte chemotaxis, increasing airway mucus production and possibly via complement activation.	[Karisola, Piia; Lehto, Maili; Kinaret, Pia; Ahonen, Niina; Haapakoski, Rita; Anthoni, Minna; Wolff, Henrik; Puustinen, Anne; Alenius, Harri] Finnish Inst Occupat Hlth, Unit Syst Toxicol, Helsinki, Finland; [Taniguchi, Masaru] RIKEN, Ctr Integrat Med Sci, Lab Immune Regulat, RCAI Kanagawa, Kanagawa, Japan	Finnish Institute of Occupational Health; RIKEN	Karisola, P (corresponding author), Finnish Inst Occupat Hlth, Unit Syst Toxicol, Helsinki, Finland.	Piia.Karisola@ttl.fi		Alenius, Harri/0000-0003-0106-8923; Puustinen, Anne/0000-0002-0262-9975; Karisola, Piia/0000-0003-0635-2704; Haapakoski, Rita/0000-0001-5263-0870; Kinaret, Pia/0000-0002-3312-5331	Academy of Finland [121025]; Grants-in-Aid for Scientific Research [23229005] Funding Source: KAKEN	Academy of Finland(Academy of Finland); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was funded by the Academy of Finland (decision number 121025, www.aka.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Anderson L, 2014, J PROTEOMICS, V107, P24, DOI 10.1016/j.jprot.2014.03.005; Bargagli E, 2008, INFLAMMATION, V31, P351, DOI 10.1007/s10753-008-9085-z; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; Chen SC, 2001, J IMMUNOL, V166, P3362, DOI 10.4049/jimmunol.166.5.3362; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Gerszten RE, 2011, CIRC RES, V109, P463, DOI 10.1161/CIRCRESAHA.110.225003; Gharib SA, 2011, J ALLERGY CLIN IMMUN, V128, P1176, DOI 10.1016/j.jaci.2011.07.053; Haapakoski R, 2011, AM J RESP CELL MOL, V44, P639, DOI 10.1165/rcmb.2009-0355OC; Hachem P, 2005, EUR J IMMUNOL, V35, P2793, DOI 10.1002/eji.200535268; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Holgate ST, 2008, NAT REV IMMUNOL, V8, P218, DOI 10.1038/nri2262; Hortobagyi L, 2008, J ALLERGY CLIN IMMUN, V122, P521, DOI 10.1016/j.jaci.2008.05.002; Hoshino M, 2002, AM J RESP CRIT CARE, V165, P1132, DOI 10.1164/ajrccm.165.8.2107068; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kang XD, 2010, PROTEOMICS, V10, P520, DOI 10.1002/pmic.200900573; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Kim JO, 2004, J ALLERGY CLIN IMMUN, V114, P1332, DOI 10.1016/j.jaci.2004.09.004; Konradsen JR, 2013, J ALLERGY CLIN IMMUN, V132, P328, DOI 10.1016/j.jaci.2013.03.003; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Leverkoehne I, 2002, J HISTOCHEM CYTOCHEM, V50, P829, DOI 10.1177/002215540205000609; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Matsuda H, 2005, AM J RESP CELL MOL, V33, P22, DOI 10.1165/rcmb.2004-0010OC; Meyer EH, 2006, P NATL ACAD SCI USA, V103, P2782, DOI 10.1073/pnas.0510282103; Nakanishi A, 2001, P NATL ACAD SCI USA, V98, P5175, DOI 10.1073/pnas.081510898; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Rostila A, 2012, LUNG CANCER, V77, P450, DOI 10.1016/j.lungcan.2012.03.024; Rydman EM, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0048-2; Scanlon ST, 2011, J EXP MED, V208, P2113, DOI 10.1084/jem.20110522; Schroll A, 2012, EUR J IMMUNOL, V42, P3346, DOI 10.1002/eji.201142351; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Umetsu DT, 2010, J ALLERGY CLIN IMMUN, V125, P975, DOI 10.1016/j.jaci.2010.02.006; Umetsu DT, 2010, INT J BIOCHEM CELL B, V42, P529, DOI 10.1016/j.biocel.2009.10.022; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wong WSF, 2007, EUR J PHARMACOL, V575, P134, DOI 10.1016/j.ejphar.2007.07.027; Zhang LF, 2009, J PROTEOME RES, V8, P1631, DOI 10.1021/pr800685h; Zhang X, 2010, EXPERT REV CLIN IMMU, V6, P269, DOI 10.1586/ECI.09.84; Zhao J, 2005, PROTEOMICS, V5, P2799, DOI 10.1002/pmic.200401169; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440; Zhou YH, 2001, AM J RESP CELL MOL, V25, P486, DOI 10.1165/ajrcmb.25.4.4578	44	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129446	10.1371/journal.pone.0129446	http://dx.doi.org/10.1371/journal.pone.0129446			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26067998	gold, Green Published, Green Submitted			2022-12-26	WOS:000356327000075
J	La Gerche, A; Inder, WJ; Roberts, TJ; Brosnan, MJ; Heidbuchel, H; Prior, DL				La Gerche, Andre; Inder, Warrick J.; Roberts, Timothy J.; Brosnan, Maria J.; Heidbuchel, Hein; Prior, David L.			Relationship between Inflammatory Cytokines and Indices of Cardiac Dysfunction following Intense Endurance Exercise	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; MUSCLE-DERIVED INTERLEUKIN-6; VENTRICULAR DYSFUNCTION; ATRIAL-FIBRILLATION; PROLONGED EXERCISE; IRONMAN TRIATHLON; TROPONIN-T; HEART; ARRHYTHMIAS; METAANALYSIS	Objectives Pro-inflammatory cytokines have been noted to increase following exercise but their relationship to exercise-induced cardiac dysfunction has not previously been investigated. We sought to evaluate whether exercise-induced cardiac dysfunction was associated with increases in cytokines, particularly the pro-inflammatory cytokines IL-1 beta, IL-12p70 and TNF alpha, which have been most implicated in cardiac pathology. Methods 40 well-trained endurance athletes underwent evaluation prior to and immediately following one of four endurance sporting events ranging from 3 to 11 hours duration. Cytokines (IL-1 beta, IL-6, IL-8, IL-10, IL-12p70 and TNF alpha) were analyzed by flow cytometry from serum samples collected within 50 minutes of race completion. Cardiac troponin (cTnI) and B-type natriuretic peptide were combined with an echocardiographic assessment of cardiac function, and a composite of cTnI > 0.04 mu g/L, BNP increase > 10 ng/L and a decrease in right ventricular ejection (RVEF) > 10% were prospectively defined as evidence of myocardial dysfunction. Results Relative to baseline, IL-6 IL-8 and IL-10 increased 8.5-, 2.9-, and 7.1-fold, respectively, P<0.0001. Thirty-one (78%), 19 (48%) and 18 (45%) of the athletes met the pre-specified criteria for significant cTnI, BNP and RVEF changes, respectively. TNF alpha, IL-12p70 were univariate predictors of Delta RVEF and Delta BNP whilst none of the anti-inflammatory cytokines were significantly associated with these measures. Ten athletes (25%, all athletes competing in the endurance event of longest duration) met criteria for exercise-induced myocardial dysfunction. In these 10 athletes with myocardial dysfunction, as compared to those without, there was significantly greater post-race expression of the pro-inflammatory cytokines IL-12p70 (8.1 +/- 3.8pg/ml vs. 2.5 +/- 2.6pg/ml, P<0.0001) and TNF alpha (6.5 +/- 3.1pg/ml vs. 2.0 +/- 2.5pg/ml, P<0.0001). Conclusion Cardiac dysfunction following intense endurance exercise was associated with increased expression of pro-inflammatory cytokines. This does not prove a causal relationship but provides rationale for further investigations into whether inflammation mediates exercise-induced myocardial dysfunction.	[La Gerche, Andre] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [La Gerche, Andre; Roberts, Timothy J.; Brosnan, Maria J.; Prior, David L.] St Vincents Hosp Melbourne, Fitzroy, Vic, Australia; [La Gerche, Andre] Katholieke Univ Leuven, Univ Hosp Leuven, Louvain, Belgium; [Roberts, Timothy J.; Brosnan, Maria J.; Prior, David L.] Univ Melbourne, St Vincents Dept Med, Fitzroy, Vic 3065, Australia; [Inder, Warrick J.] Univ Queensland, Brisbane, Qld, Australia; [Inder, Warrick J.] Princess Alexandra Hosp, Brisbane, Qld 4102, Australia; [Heidbuchel, Hein] Hasselt Univ & Heart Ctr, Hasselt, Belgium	Baker Heart and Diabetes Institute; St Vincent's Hospital Melbourne; KU Leuven; University Hospital Leuven; University of Melbourne; University of Queensland; Hasselt University	La Gerche, A (corresponding author), Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia.	andre.lagerche@bakeridi.edu.au	La Gerche, Andre/O-4733-2017; Heidbuchel, Hein/AAU-2711-2021; Inder, Warrick/C-7121-2014; Heidbuchel, Hein/C-2331-2019	La Gerche, Andre/0000-0002-3906-3784; Heidbuchel, Hein/0000-0001-9301-8127; Inder, Warrick/0000-0001-5078-4980; Heidbuchel, Hein/0000-0001-9301-8127	Pfizer International; Career Development Fellowship from National Health and Medical Research Council; Future Leader Fellowship from Heart Foundation of Australia	Pfizer International(Pfizer); Career Development Fellowship from National Health and Medical Research Council; Future Leader Fellowship from Heart Foundation of Australia	This study was funded by a competitive and unrestricted CVL Grant sponsored by Pfizer International (http://www.pfizergrants.com.au/Grants/CardiovascularLipid). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. A La Gerche is supported by a Career Development Fellowship from the National Health and Medical Research Council and a Future Leader Fellowship from the Heart Foundation of Australia.	Abdulla J, 2009, EUROPACE, V11, P1156, DOI 10.1093/europace/eup197; Banerjee I, 2009, AM J PHYSIOL-HEART C, V296, pH1694, DOI 10.1152/ajpheart.00908.2008; Benito B, 2011, CIRCULATION, V123, P13, DOI 10.1161/CIRCULATIONAHA.110.938282; Bryant D, 1998, CIRCULATION, V97, P1375, DOI 10.1161/01.CIR.97.14.1375; Chen YJ, 2000, J APPL PHYSIOL, V88, P1749, DOI 10.1152/jappl.2000.88.5.1749; Deswal A, 2001, CIRCULATION, V103, P2055; DOUGLAS PS, 1990, J AM COLL CARDIOL, V15, P64, DOI 10.1016/0735-1097(90)90176-P; Febbraio MA, 2002, FASEB J, V16, P1335, DOI 10.1096/fj.01-0876rev; Fischer CP, 2007, SCAND J MED SCI SPOR, V17, P580, DOI 10.1111/j.1600-0838.2006.00602.x; Foote RS, 2004, J AM COLL CARDIOL, V44, P1980, DOI 10.1016/j.jacc.2004.08.045; Guasch E, 2013, J AM COLL CARDIOL, V62, P68, DOI 10.1016/j.jacc.2013.01.091; Heidbuchel H, 2003, EUR HEART J, V24, P1473, DOI 10.1016/S0195-668X(03)00282-3; Jiang BB, 2010, J CARDIOVASC TRANSL, V3, P410, DOI 10.1007/s12265-010-9193-7; Kapadia SR, 1997, CIRC RES, V81, P187, DOI 10.1161/01.RES.81.2.187; KINUGAWA K, 1994, CIRC RES, V75, P285, DOI 10.1161/01.RES.75.2.285; La Gerche A, 2008, HEART, V94, P860, DOI 10.1136/hrt.2006.101063; La Gerche A, 2010, HEART, V96, P1268, DOI 10.1136/hrt.2009.189621; La Gerche A, 2014, CIRCULATION, V130, P992, DOI 10.1161/CIRCULATIONAHA.114.008141; La Gerche A, 2013, EUR HEART J, V34, P3599, DOI 10.1093/eurheartj/eht265; La Gerche A, 2012, EUR HEART J, V33, P998, DOI 10.1093/eurheartj/ehr397; Marcus GM, 2008, AM HEART J, V155, P303, DOI 10.1016/j.ahj.2007.09.006; Markel TA, 2007, AM J PHYSIOL-REG I, V293, pR1893, DOI 10.1152/ajpregu.00359.2007; Marklund P, 2013, J APPL PHYSIOL, V114, P66, DOI 10.1152/japplphysiol.01538.2011; Melendez GC, 2010, HYPERTENSION, V56, P225, DOI 10.1161/HYPERTENSIONAHA.109.148635; Middleton N, 2006, MED SCI SPORT EXER, V38, P681, DOI 10.1249/01.mss.0000210203.10200.12; Mont L, 2010, HEART, V96, P398, DOI 10.1136/hrt.2008.160903; Mousavi N, 2009, AM J CARDIOL, V103, P1467, DOI 10.1016/j.amjcard.2009.01.294; Neilan TG, 2006, CIRCULATION, V114, P2325, DOI 10.1161/CIRCULATIONAHA.106.647461; Neubauer O, 2008, EUR J APPL PHYSIOL, V104, P417, DOI 10.1007/s00421-008-0787-6; Nielsen HB, 1996, AM J PHYSIOL-REG I, V271, pR222, DOI 10.1152/ajpregu.1996.271.1.R222; Niemann PS, 2007, J AM COLL CARDIOL, V50, P1668, DOI 10.1016/j.jacc.2007.07.031; Ostrowski K, 1999, J PHYSIOL-LONDON, V515, P287, DOI 10.1111/j.1469-7793.1999.287ad.x; Peake JM, 2005, EUR J APPL PHYSIOL, V95, P514, DOI 10.1007/s00421-005-0035-2; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pedersen BK, 2006, ESSAYS BIOCHEM, V42, P105, DOI 10.1042/bse0420105; Rifai N, 1999, AM J CARDIOL, V83, P1085, DOI 10.1016/S0002-9149(99)00020-X; Sabatine MS, 2004, J AM COLL CARDIOL, V44, P1988, DOI 10.1016/j.jacc.2004.07.057; Serrano E, 2010, J SPORT SCI, V28, P1047, DOI 10.1080/02640414.2010.484067; Sun M, 2007, CIRCULATION, V115, P1398, DOI 10.1161/CIRCULATIONAHA.106.643585; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Trivax JE, 2010, J APPL PHYSIOL, V108, P1148, DOI 10.1152/japplphysiol.01151.2009; Wardyn GG, 2008, EXP HEMATOL, V36, P216, DOI 10.1016/j.exphem.2007.10.003	42	40	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130031	10.1371/journal.pone.0130031	http://dx.doi.org/10.1371/journal.pone.0130031			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26070197	Green Published, gold			2022-12-26	WOS:000356327000137
J	Rosche, KL; Aljasham, AT; Kipfer, JN; Piatkowski, BT; Konjufca, V				Rosche, Kristin L.; Aljasham, Alanoud T.; Kipfer, James N.; Piatkowski, Bryan T.; Konjufca, Vjollca			Infection with Salmonella enterica Serovar Typhimurium Leads to Increased Proportions of F4/80(+) Red Pulp Macrophages and Decreased Proportions of B and T Lymphocytes in the Spleen	PLOS ONE			English	Article							MURINE TYPHOID-FEVER; PROTECTIVE IMMUNITY; CUTTING EDGE; SPI-C; MICE; CELLS; ERYTHROPOIETIN; MONOCYTE; SURVIVAL; ALPHA	Infection of mice with Salmonella enterica serovar Typhimurium (Salmonella) causes systemic inflammatory disease and enlargement of the spleen (splenomegaly). Splenomegaly has been attributed to a general increase in the numbers of phagocytes, lymphocytes, as well as to the expansion of immature CD71(+)Ter119(+) reticulocytes. The spleen is important for recycling senescent red blood cells (RBCs) and for the capture and eradication of blood-borne pathogens. Conservation of splenic tissue architecture, comprised of the white pulp (WP), marginal zone (MZ), and red pulp (RP) is essential for initiation of adaptive immune responses to captured pathogens. Using flow cytometry and four color immunofluorescence microscopy (IFM), we show that Salmonella-induced splenomegaly is characterized by drastic alterations of the splenic tissue architecture and cell population proportions, as well as in situ cell distributions. A major cause of splenomegaly appears to be the significant increase in immature RBC precursors and F4/80(+) macrophages that are important for recycling of heme-associated iron. In contrast, the proportions of B220(+), CD4(+) and CD8(+) lymphocytes, as well as MZ MOMA(+) macrophages decrease significantly as infection progresses. Spleen tissue sections show visible tears and significantly altered tissue architecture with F4/80(+) macrophages and RBCs expanding beyond the RP and taking over most of the spleen tissue. Additionally, F4/80(+) macrophages actively phagocytose not only RBCs, but also lymphocytes, indicating that they may contribute to declining lymphocyte proportions during Salmonella infection. Understanding how these alterations of spleen microarchitecture impact the generation of adaptive immune responses to Salmonella has implications for understanding Salmonella pathogenesis and for the design of more effective Salmonella-based vaccines.	[Rosche, Kristin L.; Aljasham, Alanoud T.; Kipfer, James N.; Konjufca, Vjollca] So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA; [Piatkowski, Bryan T.] So Illinois Univ, Dept Plant Biol, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University	Konjufca, V (corresponding author), So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA.	vjollca@micro.siu.edu		Konjufca, Vjollca/0000-0002-7736-5097; Piatkowski, Bryan/0000-0002-1334-8431	Southern Illinois University	Southern Illinois University	This work was funded by start-up funds provided to VK by Southern Illinois University.	Aoshiba K, 2009, CRIT CARE MED, V37, P889, DOI 10.1097/CCM.0b013e31819b8371; Benedict CA, 2006, PLOS PATHOG, V2, P164, DOI 10.1371/journal.ppat.0020016; Brendt P, 2009, ANESTH ANALG, V109, P705, DOI 10.1213/ane.0b013e3181adc80f; Brines M, 2012, MOL MED, V18, P486, DOI 10.2119/molmed.2011.00414; Brown DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009441; Bueno SM, 2007, IMMUNOL LETT, V111, P14, DOI 10.1016/j.imlet.2007.05.003; Cesta MF, 2006, TOXICOL PATHOL, V34, P455, DOI 10.1080/01926230600867743; COLLINS FM, 1972, INFECT IMMUN, V5, P191, DOI 10.1128/IAI.5.2.191-198.1972; Curtiss R, 2010, CRIT REV IMMUNOL, V30, P255, DOI 10.1615/CritRevImmunol.v30.i3.30; den Haan JMM, 2012, J INNATE IMMUN, V4, P437, DOI 10.1159/000335216; Duffield JS, 2003, CLIN SCI, V104, P27, DOI 10.1042/CS20020240; Engwerda CR, 2002, AM J PATHOL, V161, P429, DOI 10.1016/S0002-9440(10)64199-5; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Haldar M, 2014, CELL, V156, P1223, DOI 10.1016/j.cell.2014.01.069; Hess J, 1996, J IMMUNOL, V156, P3321; Hyland L, 2005, EXP HEMATOL, V33, P1477, DOI 10.1016/j.exphem.2005.09.005; Jackson A, 2010, J IMMUNOL, V185, P6198, DOI 10.4049/jimmunol.1001198; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Konjufca V, 2008, INFECT IMMUN, V76, P5745, DOI 10.1128/IAI.00897-08; Konjufca V, 2006, INFECT IMMUN, V74, P6785, DOI 10.1128/IAI.00851-06; Koury MJ, 2002, CURR OPIN HEMATOL, V9, P93, DOI 10.1097/00062752-200203000-00002; Kovtunovych G, 2010, BLOOD, V116, P6054, DOI 10.1182/blood-2010-03-272138; Kullas AL, 2012, CELL HOST MICROBE, V12, P791, DOI 10.1016/j.chom.2012.10.018; Labow RS, 2001, J BIOMED MATER RES, V54, P189, DOI 10.1002/1097-4636(200102)54:2<189::AID-JBM5>3.0.CO;2-8; LACOMBE C, 1991, AM J KIDNEY DIS, V18, P14; LACOMBE C, 1988, J CLIN INVEST, V81, P620, DOI 10.1172/JCI113363; Lang F, 2012, BLOOD PURIFICAT, V33, P125, DOI 10.1159/000334163; Li YH, 2009, P NATL ACAD SCI USA, V106, P593, DOI 10.1073/pnas.0811697106; Lifshitz L, 2010, HAEMATOL-HEMATOL J, V95, P1823, DOI 10.3324/haematol.2010.025015; Luu RA, 2006, J IMMUNOL, V177, P1516, DOI 10.4049/jimmunol.177.3.1516; MATSUI K, 1993, FEMS MICROBIOL LETT, V112, P113; McCoy MW, 2012, INFECT IMMUN, V80, P3642, DOI 10.1128/IAI.00656-12; McLaughlin LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000671; McSorley SJ, 2014, IMMUNOL REV, V260, P168, DOI 10.1111/imr.12184; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Mittrucker HW, 2000, J IMMUNOL, V164, P1648, DOI 10.4049/jimmunol.164.4.1648; Mittrucker HW, 2000, J LEUKOCYTE BIOL, V67, P457, DOI 10.1002/jlb.67.4.457; Nanton MR, 2012, J IMMUNOL, V189, P5503, DOI 10.4049/jimmunol.1201413; NAUCIEL C, 1990, J IMMUNOL, V145, P1265; Nix RN, 2007, PLOS PATHOG, V3, P1982, DOI 10.1371/journal.ppat.0030193; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Perez-Lopez A, 2013, J IMMUNOL, V190, P1201, DOI 10.4049/jimmunol.1200415; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Rabsch W, 2002, INFECT IMMUN, V70, P2249, DOI 10.1128/IAI.70.5.2249-2255.2002; Robinson N, 2012, NAT IMMUNOL, V13, P954, DOI 10.1038/ni.2397; Rosales-Reyes R, 2005, INFECT IMMUN, V73, P3937, DOI 10.1128/IAI.73.7.3937-3944.2005; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593	50	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0130092	10.1371/journal.pone.0130092	http://dx.doi.org/10.1371/journal.pone.0130092			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068006	gold, Green Published, Green Submitted			2022-12-26	WOS:000356327000139
J	Vilar, S; Lorberbaum, T; Hripcsak, G; Tatonetti, NP				Vilar, Santiago; Lorberbaum, Tal; Hripcsak, George; Tatonetti, Nicholas P.			Improving Detection of Arrhythmia Drug-Drug Interactions in Pharmacovigilance Data through the Implementation of Similarity-Based Modeling	PLOS ONE			English	Article							SIGNAL-DETECTION; PREDICTION; INHIBITORS	Identification of Drug-Drug Interactions (DDIs) is a significant challenge during drug development and clinical practice. DDIs are responsible for many adverse drug effects (ADEs), decreasing patient quality of life and causing higher care expenses. DDIs are not systematically evaluated in pre-clinical or clinical trials and so the FDA U.S. Food and Drug Administration relies on post-marketing surveillance to monitor patient safety. However, existing pharmacovigilance algorithms show poor performance for detecting DDIs exhibiting prohibitively high false positive rates. Alternatively, methods based on chemical structure and pharmacological similarity have shown promise in adverse drug event detection. We hypothesize that the use of chemical biology data in a post hoc analysis of pharmacovigilance results will significantly improve the detection of dangerous interactions. Our model integrates a reference standard of DDIs known to cause arrhythmias with drug similarity data. To compare similarity between drugs we used chemical structure (both 2D and 3D molecular structure), adverse drug side effects, chemogenomic targets, drug indication classes, and known drug-drug interactions. We evaluated the method on external reference standards. Our results showed an enhancement of sensitivity, specificity and precision in different top positions with the use of similarity measures to rank the candidates extracted from pharmacovigilance data. For the top 100 DDI candidates, similarity-based modeling yielded close to twofold precision enhancement compared to the proportional reporting ratio (PRR). Moreover, the method helps in the DDI decision making through the identification of the DDI in the reference standard that generated the candidate.	[Vilar, Santiago; Lorberbaum, Tal; Hripcsak, George; Tatonetti, Nicholas P.] Columbia Univ, Dept Biomed Informat, New York, NY 10027 USA; [Vilar, Santiago; Lorberbaum, Tal; Tatonetti, Nicholas P.] Columbia Univ, Dept Syst Biol, New York, NY USA; [Vilar, Santiago; Hripcsak, George; Tatonetti, Nicholas P.] Observat Hlth Data Sci & Informat, New York, NY USA; [Tatonetti, Nicholas P.] Columbia Univ, Dept Med, New York, NY USA	Columbia University; Columbia University; Columbia University	Vilar, S (corresponding author), Columbia Univ, Dept Biomed Informat, New York, NY 10027 USA.	sv2348@cumc.columbia.edu		Tatonetti, Nicholas/0000-0002-2700-2597; Lorberbaum, Tal/0000-0002-4772-7392	National Library of Medicine [R01 LM006910]; Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation Research Starter Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107145, T32GM082797] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM006910] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation Research Starter Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by grant R01 LM006910 (GH) "Discovering and Applying Knowledge in Clinical Databases" from the National Library of Medicine, and Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation Research Starter Award (NPT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzelius L, 2001, MOL PHARMACOL, V59, P909, DOI 10.1124/mol.59.4.909; [Anonymous], 2011, MICR HEALTHC SER; [Anonymous], 2011, SCHROD PACK VERS 9 2; [Anonymous], FDA ADV EV REP SYST; Cheng FX, 2014, J AM MED INFORM ASSN, V21, pE278, DOI 10.1136/amiajnl-2013-002512; Crouch MA, 2003, PHARMACOTHERAPY, V23, P881, DOI 10.1592/phco.23.7.881.32730; De Rienzo F, 2000, J COMPUT AID MOL DES, V14, P93, DOI 10.1023/A:1008187802746; Durant JL, 2002, J CHEM INF COMP SCI, V42, P1273, DOI 10.1021/ci010132r; Gottlieb A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.26; Harpaz R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S9-S7; Korhonen LE, 2005, J MED CHEM, V48, P3808, DOI 10.1021/jm0489713; Krishna G, 2012, EXPERT OPIN DRUG MET, V8, P1, DOI 10.1517/17425255.2012.639360; Olvey EL, 2010, CLIN PHARMACOL THER, V87, P48, DOI 10.1038/clpt.2009.198; Percha B, 2013, TRENDS PHARMACOL SCI, V34, P178, DOI 10.1016/j.tips.2013.01.006; Percha B, 2012, BIOCOMPUT-PAC SYM, P410; Pirmohamed M., 1998, MI O DRUG INTERACTIO; Rahnasto M, 2005, J MED CHEM, V48, P440, DOI 10.1021/jm049536b; Rice PJ, 2003, BRIT DENT J, V194, P411, DOI 10.1038/sj.bdj.4810049; Tari L, 2010, BIOINFORMATICS, V26, pi547, DOI 10.1093/bioinformatics/btq382; Tatonetti NP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003377; Tatonetti NP, 2012, J AM MED INFORM ASSN, V19, P79, DOI 10.1136/amiajnl-2011-000214; Vilar S, 2014, CPT-PHARMACOMET SYST, V3, DOI 10.1038/psp.2014.35; Vilar S, 2014, CURR DRUG METAB, V15, P490, DOI 10.2174/138920021505141126102223; Vilar S, 2014, NAT PROTOC, V9, P2147, DOI 10.1038/nprot.2014.151; Vilar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058321; Vilar S, 2012, J AM MED INFORM ASSN, V19, P1066, DOI 10.1136/amiajnl-2012-000935; Vilar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041471; Vilar S, 2011, J AM MED INFORM ASSN, V18, pI73, DOI 10.1136/amiajnl-2011-000417; Yap CW, 2005, J CHEM INF MODEL, V45, P982, DOI 10.1021/ci0500536	29	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129974	10.1371/journal.pone.0129974	http://dx.doi.org/10.1371/journal.pone.0129974			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068584	gold, Green Submitted, Green Published			2022-12-26	WOS:000356327000129
J	Ceperuelo-Mallafre, V; Ejarque, M; Duran, X; Pachon, G; Vazquez-Carballo, A; Roche, K; Nunez-Roa, C; Garrido-Sanchez, L; Tinahones, FJ; Vendrell, J; Fernandez-Veledo, S				Ceperuelo-Mallafre, Victoria; Ejarque, Miriam; Duran, Xavier; Pachon, Gisela; Vazquez-Carballo, Ana; Roche, Kelly; Nunez-Roa, Catalina; Garrido-Sanchez, Lourdes; Tinahones, Francisco J.; Vendrell, Joan; Fernandez-Veledo, Sonia			Zinc-alpha 2-Glycoprotein Modulates AKT-Dependent Insulin Signaling in Human Adipocytes by Activation of the PP2A Phosphatase	PLOS ONE			English	Article							LIPID MOBILIZING FACTOR; NECROSIS-FACTOR-ALPHA; SKELETAL-MUSCLE; ADIPOSE-TISSUE; GLUCOSE-UPTAKE; ZINC-ALPHA(2)-GLYCOPROTEIN; RESISTANCE; LIPOLYSIS; PATHWAYS; WEIGHT	Objective Evidence from mouse models suggests that zinc-alpha 2-glycoprotein (ZAG) is a novel anti-obesity adipokine. In humans, however, data are controversial and its physiological role in adipose tissue (AT) remains unknown. Here we explored the molecular mechanisms by which ZAG regulates carbohydrate metabolism in human adipocytes. Methods ZAG action on glucose uptake and insulin action was analyzed. beta 1 and beta 2-adrenoreceptor (AR) antagonists and siRNA targeting PP2A phosphatase were used to examine the mechanisms by which ZAG modulates insulin sensitivity. Plasma levels of ZAG were measured in a lean patient cohort stratified for HOMA-IR. Results ZAG treatment increased basal glucose uptake, correlating with an increase in GLUT expression, but induced insulin resistance in adipocytes. Pretreatment of adipocytes with propranolol and a specific beta 1-AR antagonist demonstrated that ZAG effects on basal glucose uptake and GLUT4 expression are mediated via beta 1-AR, whereas inhibition of insulin action is dependent on beta 2-AR activation. ZAG treatment correlated with an increase in PP2A activity. Silencing of the PP2A catalytic subunit abrogated the negative effect of ZAG on insulin-stimulated AKT phosphorylation and glucose uptake but not on GLUT4 expression and basal glucose uptake. ZAG circulating levels were unchanged in a lean patient cohort stratified for HOMA-IR. Neither glucose nor insulin was associated with plasma ZAG. Conclusions ZAG inhibits insulin-induced glucose uptake in human adipocytes by impairing insulin signaling at the level of AKT in a beta 2-AR- and PP2A-dependent manner.	[Ceperuelo-Mallafre, Victoria; Ejarque, Miriam; Pachon, Gisela; Roche, Kelly; Nunez-Roa, Catalina; Vendrell, Joan; Fernandez-Veledo, Sonia] Univ Rovira & Virgili, Hosp Univ Tarragona Joan XXIII, Inst Invest Sanitaria Pere Virgili, E-43007 Tarragona, Spain; [Ceperuelo-Mallafre, Victoria; Ejarque, Miriam; Duran, Xavier; Pachon, Gisela; Roche, Kelly; Nunez-Roa, Catalina; Garrido-Sanchez, Lourdes; Tinahones, Francisco J.; Vendrell, Joan; Fernandez-Veledo, Sonia] Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain; [Vazquez-Carballo, Ana] Univ Complutense, Dept Biochem & Mol Biol 2, Sch Pharm, Inst Invest Sanitaria,Hosp Clin San Carlos, E-28040 Madrid, Spain; [Garrido-Sanchez, Lourdes; Tinahones, Francisco J.] Hosp Univ Virgen de la Victoria, Inst Invest Biomed Malaga, Malaga, Spain; [Garrido-Sanchez, Lourdes; Tinahones, Francisco J.] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain	Universitat Rovira i Virgili; Hospital Universitari De Tarragona Joan XXIII; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Complutense University of Madrid; Hospital Clinico San Carlos; Universidad de Malaga; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Vendrell, J (corresponding author), Univ Rovira & Virgili, Hosp Univ Tarragona Joan XXIII, Inst Invest Sanitaria Pere Virgili, E-43007 Tarragona, Spain.	jvortega2002@gmail.com; sonia.fernandezveledo@gmail.com	Fernández-Veledo, Sonia/V-4625-2018; Vendrell, Joan j/V-4034-2018; Ejarque, Miriam/H-1503-2015; Tinahones, Francisco José/AAB-2882-2020; Ceperuelo-Mallafré, Victòria/A-4615-2017	Fernández-Veledo, Sonia/0000-0003-2906-3788; Vendrell, Joan j/0000-0002-6994-6115; Ejarque, Miriam/0000-0003-0545-9817; Ceperuelo-Mallafré, Victòria/0000-0002-4460-9761; Tinahones, Francisco J/0000-0001-6871-4403	Spanish Ministry of Economy and Competitiveness [SAF2012-36186, CP10/00438, PI11/0085, PI12/02355]; "Miguel Servet" tenure track program from Fondo de Investigacioin Sanitaria (FIS) - European Regional Development Fund (ERDF) [CP10/00438, CP13/00188]	Spanish Ministry of Economy and Competitiveness(Spanish Government); "Miguel Servet" tenure track program from Fondo de Investigacioin Sanitaria (FIS) - European Regional Development Fund (ERDF)	This study was supported by grants from the Spanish Ministry of Economy and Competitiveness (SAF2012-36186 and CP10/00438 to SF-V, PI11/0085 to JV and PI12/02355 to FJT). CIBER de Diabetes y Enfermedades Metabolicas asociadas (CB07708/0012) is an initiative of the Instituto de Salud Carlos III. SF-V and LG-S acknowledge support from the "Miguel Servet" tenure track program (CP10/00438 and CP13/00188 respectively), from the Fondo de Investigacioin Sanitaria (FIS,) co-financed by the European Regional Development Fund (ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aflaki E, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008659; Arch J R, 2001, Rev Endocr Metab Disord, V2, P385, DOI 10.1023/A:1011852500209; Balaz M, 2014, OBESITY, DOI [10.1002/oby.20764, DOI 10.1002/0BY.20764]; Bao Y, 2005, FEBS LETT, V579, P41, DOI 10.1016/j.febslet.2004.11.042; Bing C, 2004, P NATL ACAD SCI USA, V101, P2500, DOI 10.1073/pnas.0308647100; Bing C, 2010, INT J OBESITY, V34, P1559, DOI 10.1038/ijo.2010.105; Blouin CM, 2010, DIABETES, V59, P600, DOI 10.2337/db09-0897; Capel F, 2009, DIABETES, V58, P1558, DOI 10.2337/db09-0033; Ceperuelo-Mallafre V, 2012, HIV MED, V13, P297, DOI 10.1111/j.1468-1293.2011.00976.x; Ceperuelo-Mallafre V, 2009, J CLIN ENDOCR METAB, V94, P5062, DOI 10.1210/jc.2009-0764; Ceperuelo-Mallafre V, 2014, J CLIN ENDOCR METAB, V99, pE908, DOI 10.1210/jc.2013-3350; Chernogubova E, 2004, ENDOCRINOLOGY, V145, P269, DOI 10.1210/en.2003-0857; Deepa SS, 2011, MOL ENDOCRINOL, V25, P1773, DOI 10.1210/me.2011-0082; Fernandez-Veledo S, 2008, J CLIN ENDOCR METAB, V93, P2866, DOI 10.1210/jc.2007-2472; Fernandez-Veledo S, 2009, J CLIN ENDOCR METAB, V94, P3583, DOI 10.1210/jc.2009-0558; Garrido-Sanchez L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033264; Ge S, 2014, METABOLISM, V63, P995, DOI 10.1016/j.metabol.2014.04.013; Gong FY, 2009, INT J OBESITY, V33, P1023, DOI 10.1038/ijo.2009.141; Kazantzis Melissa, 2012, Front Endocrinol (Lausanne), V3, P13, DOI 10.3389/fendo.2012.00013; Lansey MN, 2012, AM J PHYSIOL-ENDOC M, V303, pE1273, DOI 10.1152/ajpendo.00316.2012; Mracek T, 2010, J ENDOCRINOL, V204, P165, DOI 10.1677/JOE-09-0299; Mracek T, 2011, BRIT J CANCER, V104, P441, DOI 10.1038/sj.bjc.6606083; Nevzorova J, 2006, BRIT J PHARMACOL, V147, P446, DOI 10.1038/sj.bjp.0706626; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; Rolli V, 2007, FEBS LETT, V581, P394, DOI 10.1016/j.febslet.2006.12.047; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Russell ST, 2004, BBA-MOL CELL BIOL L, V1636, P59, DOI 10.1016/j.bbalip.2003.12.004; Russell ST, 2002, BRIT J CANCER, V86, P424, DOI 10.1038/sj.bjc.6600086; Russell ST, 2010, ENDOCRINOLOGY, V151, P4696, DOI 10.1210/en.2010-0532; Russell ST, 2010, ENDOCRINOLOGY, V151, P948, DOI 10.1210/en.2009-0827; Russell ST, 2012, BBA-MOL CELL BIOL L, V1821, P590, DOI 10.1016/j.bbalip.2011.12.003; Ryden M, 2012, J INTERN MED, V271, P414, DOI 10.1111/j.1365-2796.2011.02441.x; Sanders PM, 2004, CANCER LETT, V212, P71, DOI 10.1016/j.canlet.2004.03.021; Selva DM, 2009, J CLIN ENDOCR METAB, V94, P4499, DOI 10.1210/jc.2009-0758; Tedeschi S, 2012, METABOLISM, V61, P37, DOI 10.1016/j.metabol.2011.05.011; Usui I, 2005, MOL ENDOCRINOL, V19, P2760, DOI 10.1210/me.2004-0429; Vazquez-Carballo A, 2013, AM J PHYSIOL-ENDOC M, V305, pE101, DOI 10.1152/ajpendo.00589.2012; Wargent ET, 2013, J ENDOCRINOL, V216, P157, DOI 10.1530/JOE-12-0402; Yang ML, 2013, DIABETES CARE, V36, P1074, DOI 10.2337/dc12-0940; Yeung DCY, 2009, J CLIN ENDOCR METAB, V94, P2531, DOI 10.1210/jc.2009-0058; Zhu CH, 2007, AGING CELL, V6, P515, DOI 10.1111/j.1474-9726.2007.00306.x	41	13	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129644	10.1371/journal.pone.0129644	http://dx.doi.org/10.1371/journal.pone.0129644			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068931	Green Published, Green Submitted, gold			2022-12-26	WOS:000356100900066
J	Field, J; Shahijanian, F; Schibeci, S; Johnson, L; Gresle, M; Laverick, L; Parnell, G; Stewart, G; McKay, F; Kilpatrick, T; Butzkueven, H; Booth, D				Field, Judith; Shahijanian, Fernando; Schibeci, Stephen; Johnson, Laura; Gresle, Melissa; Laverick, Louise; Parnell, Grant; Stewart, Graeme; McKay, Fiona; Kilpatrick, Trevor; Butzkueven, Helmut; Booth, David		Australia New Zealand MS Genetics	The MS Risk Allele of CD40 Is Associated with Reduced Cell-Membrane Bound Expression in Antigen Presenting Cells: Implications for Gene Function	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; REGULATORY T-CELLS; MESSENGER-RNA; MULTIPLE-SCLEROSIS; GRAVES-DISEASE; PATHWAYS; TISSUE; PROMOTES; ANTIBODY	Human genetic and animal studies have implicated the costimulatory molecule CD40 in the development of multiple sclerosis (MS). We investigated the cell specific gene and protein expression variation controlled by the CD40 genetic variant(s) associated with MS, i.e. the T-allele at rs1883832. Previously we had shown that the risk allele is expressed at a lower level in whole blood, especially in people with MS. Here, we have defined the immune cell subsets responsible for genotype and disease effects on CD40 expression at the mRNA and protein level. In cell subsets in which CD40 is most highly expressed, B lymphocytes and dendritic cells, the MS-associated risk variant is associated with reduced CD40 cell-surface protein expression. In monocytes and dendritic cells, the risk allele additionally reduces the ratio of expression of full-length versus truncated CD40 mRNA, the latter encoding secreted CD40. We additionally show that MS patients, regardless of genotype, express significantly lower levels of CD40 cell-surface protein compared to unaffected controls in B lymphocytes. Thus, both genotype-dependent and independent down-regulation of cell-surface CD40 is a feature of MS. Lower expression of a co-stimulator of T cell activation, CD40, is therefore associated with increased MS risk despite the same CD40 variant being associated with reduced risk of other inflammatory autoimmune diseases. Our results highlight the complexity and likely individuality of autoimmune pathogenesis, and could be consistent with antiviral and/or immunoregulatory functions of CD40 playing an important role in protection from MS.	[Field, Judith; Johnson, Laura; Kilpatrick, Trevor] Univ Melbourne, Multiple Sclerosis Div, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Shahijanian, Fernando; Schibeci, Stephen; Parnell, Grant; Stewart, Graeme; McKay, Fiona; Booth, David] Univ Sydney, Westmead Millennium Inst, Ctr Immunol & Allergy Res, Sydney, NSW 2006, Australia; [Gresle, Melissa; Laverick, Louise; Kilpatrick, Trevor; Butzkueven, Helmut] Univ Melbourne, Royal Melbourne Hosp, Melbourne Brain Ctr, Parkville, Vic, Australia; [Gresle, Melissa; Laverick, Louise; Butzkueven, Helmut] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Kilpatrick, Trevor] Univ Melbourne, Melbourne Neurosci Inst, Melbourne, Vic, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Sydney; Westmead Institute for Medical Research; Royal Melbourne Hospital; University of Melbourne; University of Melbourne; University of Melbourne	Field, J (corresponding author), Univ Melbourne, Multiple Sclerosis Div, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia.	judith.field@florey.edu.au	Baxter, Alan G/A-1412-2010; Charlesworth, Jac/J-7661-2014; Brown, Matthew A/E-5749-2010; Kermode, Allan/G-3568-2019; Parnell, Grant/AAB-8155-2021; Scott, Rodney/B-2827-2013; Slee, Mark/J-4731-2015	Baxter, Alan G/0000-0002-6960-9821; Charlesworth, Jac/0000-0001-6201-3518; Brown, Matthew A/0000-0003-0538-8211; Kermode, Allan/0000-0002-4476-4016; Griffiths, Lyn/0000-0002-6774-5475; Kilpatrick, Trevor/0000-0003-3999-085X; Lechner-Scott, Jeannette/0000-0002-3850-447X; Booth, David/0000-0001-8580-2384; McKay, Fiona Catherine/0000-0002-9610-0668; Butzkueven, Helmut/0000-0003-3940-8727; Moscato, Pablo/0000-0003-2570-5966; Parnell, Grant/0000-0002-2898-0253; Scott, Rodney/0000-0001-7724-3404; Vucic, Steve/0000-0002-8323-873X; Wiley, James/0000-0001-9421-4154; Slee, Mark/0000-0003-4323-2453	National Health and Medical Research Council of Australia (NHMRC) [633275, 1065157]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia (NHMRC) (grant numbers 633275 and 1065157).	Adorini L, 2003, J CELL BIOCHEM, V88, P227, DOI 10.1002/jcb.10340; Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Barbe-Tuana FM, 2006, DIABETES, V55, P2437, DOI 10.2337/db05-1673; Becher B, 2001, J EXP MED, V193, P967, DOI 10.1084/jem.193.8.967; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Blanco-Kelly F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011520; Boon L, 2001, J IMMUNOL, V167, P2942, DOI 10.4049/jimmunol.167.5.2942; Buck D, 2006, TISSUE ANTIGENS, V68, P335, DOI 10.1111/j.1399-0039.2006.00672.x; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Duddy ME, 2004, J IMMUNOL, V172, P3422, DOI 10.4049/jimmunol.172.6.3422; Flores-Borja F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005407; GALY AHM, 1992, J IMMUNOL, V149, P775; Gandhi KS, 2010, HUM MOL GENET, V19, P2134, DOI 10.1093/hmg/ddq090; Gerritse K, 1996, P NATL ACAD SCI USA, V93, P2499, DOI 10.1073/pnas.93.6.2499; Graham JP, 2010, IMMUNOL REV, V237, P226, DOI 10.1111/j.1600-065X.2010.00932.x; Griffin MD, 2001, P NATL ACAD SCI USA, V98, P6800, DOI 10.1073/pnas.121172198; Hoe E, 2010, J IMMUNOL, V184, P2512, DOI 10.4049/jimmunol.0902900; Huang WX, 2000, MULT SCLER, V6, P61, DOI 10.1177/135245850000600201; Huber AK, 2012, J IMMUNOL, V189, P3043, DOI 10.4049/jimmunol.1200311; Jacobson EM, 2007, GENES IMMUN, V8, P205, DOI 10.1038/sj.gene.6364375; Jacobson EM, 2005, ENDOCRINOLOGY, V146, P2684, DOI 10.1210/en.2004-1617; Kim DY, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-25; Li G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003487; Li M, 2012, ENDOCR J, V59, P1041, DOI 10.1507/endocrj.EJ12-0126; Lundstrom W, 2013, P NATL ACAD SCI USA, V110, pE1761, DOI 10.1073/pnas.1222303110; Orozco G, 2010, ANN RHEUM DIS, V69, P813, DOI 10.1136/ard.2009.109579; Parnell G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023162; Parnell GP, 2014, MULT SCLER J, V20, P675, DOI 10.1177/1352458513507819; Pender MP, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/189096; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Reichardt P, 2007, BLOOD, V110, P1519, DOI 10.1182/blood-2006-10-053793; Rubicz R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003147; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Shahijanian F, 2014, HUM MOL GENET, V23, P1425, DOI 10.1093/hmg/ddt529; Smith TJ, 1999, THYROID, V9, P749, DOI 10.1089/thy.1999.9.749; Sokolova EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061032; van der Linden MPM, 2009, ARTHRITIS RHEUM, V60, P2242, DOI 10.1002/art.24721; Vazgiourakis VM, 2011, ANN RHEUM DIS, V70, P2184, DOI 10.1136/ard.2010.146530; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Witten JT, 2011, TRENDS GENET, V27, P89, DOI 10.1016/j.tig.2010.12.001; Yang J, 2012, ENDOCRINE, V41, P111, DOI 10.1007/s12020-011-9510-1	43	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0127080	10.1371/journal.pone.0127080	http://dx.doi.org/10.1371/journal.pone.0127080			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068105	Green Published, Green Accepted, gold			2022-12-26	WOS:000356100900011
J	Park, IS; Chung, PS; Ahn, JC				Park, In-Su; Chung, Phil-Sang; Ahn, Jin Chul			Enhancement of Ischemic Wound Healing by Spheroid Grafting of Human Adipose-Derived Stem Cells Treated with Low-Level Light Irradiation	PLOS ONE			English	Article							LASER IRRADIATION; 3-DIMENSIONAL GROWTH; IN-VITRO; DIFFERENTIATION; PROLIFERATION; ANGIOGENESIS; THERAPY; MATRIX; MODEL	We investigated whether low-level light irradiation prior to transplantation of adipose-derived stromal cell (ASC) spheroids in an animal skin wound model stimulated angiogenesis and tissue regeneration to improve functional recovery of skin tissue. The spheroid, composed of hASCs, was irradiated with low-level light and expressed angiogenic factors, including vascular endothelial growth factor (VEGF), basic fibroblast growth factor (FGF), and hepatocyte growth factor (HGF). Immunochemical staining analysis revealed that the spheroid of the hASCs was CD31(+), KDR+, and CD34(+). On the other hand, monolayer-cultured hASCs were negative for these markers. PBS, human adipose tissue-derived stromal cells, and the ASC spheroid were transplanted into a wound bed in athymic mice to evaluate the therapeutic effects of the ASC spheroid in vivo. The ASC spheroid transplanted into the wound bed differentiated into endothelial cells and remained differentiated. The density of vascular formations increased as a result of the angiogenic factors released by the wound bed and enhanced tissue regeneration at the lesion site. These results indicate that the transplantation of the ASC spheroid significantly improved functional recovery relative to both ASC transplantation and PBS treatment. These findings suggest that transplantation of an ASC spheroid treated with low-level light may be an effective form of stem cell therapy for treatment of a wound bed.	[Park, In-Su; Chung, Phil-Sang; Ahn, Jin Chul] Dankook Univ, Beckman Laser Inst Korea, Cheonan 330714, Chungnam, South Korea; [Chung, Phil-Sang] Dankook Univ, Dept Otolaryngol Head & Neck Surg, Coll Med, Cheonan 330714, Chungnam, South Korea; [Ahn, Jin Chul] Dankook Univ, Dept Biomed Sci, Cheonan 330714, Chungnam, South Korea; [Ahn, Jin Chul] Dankook Univ, Biomed Translat Res Inst, Cheonan 330714, Chungnam, South Korea	Dankook University; Dankook University; Dankook University; Dankook University	Ahn, JC (corresponding author), Dankook Univ, Beckman Laser Inst Korea, 119 Dandae Ro, Cheonan 330714, Chungnam, South Korea.	jcahn@dankook.ac.kr			Ministry of Science, ICT and Future Planning grant - Korea government [2012K1A4A3053142, NRF-2014R1A1A1038199]	Ministry of Science, ICT and Future Planning grant - Korea government	This study was supported by a grant of the Ministry of Science, ICT and Future Planning grant funded by the Korea government (2012K1A4A3053142, NRF-2014R1A1A1038199). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alev C, 2011, ANTIOXID REDOX SIGN, V15, P949, DOI 10.1089/ars.2010.3872; Amos PJ, 2010, TISSUE ENG PT A, V16, P1595, DOI [10.1089/ten.tea.2009.0616, 10.1089/ten.TEA.2009.0616]; Bhang SH, 2011, BIOMATERIALS, V32, P2734, DOI 10.1016/j.biomaterials.2010.12.035; Calvani M, 2006, BLOOD, V107, P2705, DOI 10.1182/blood-2005-09-3541; Cao Y, 2005, BIOCHEM BIOPH RES CO, V332, P370, DOI 10.1016/j.bbrc.2005.04.135; de Sousa APC, 2013, LASER MED SCI, V28, P981, DOI 10.1007/s10103-012-1187-z; Choi K, 2013, J BIOMED MATER RES B, V101B, P919, DOI 10.1002/jbm.b.32897; Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026; Glicklis R, 2004, BIOTECHNOL BIOENG, V86, P672, DOI 10.1002/bit.20086; Heydarkhan-Hagvall S, 2008, CELLS TISSUES ORGANS, V187, P263, DOI 10.1159/000113407; Hou JF, 2008, LASER SURG MED, V40, P726, DOI 10.1002/lsm.20709; Hu WP, 2007, J INVEST DERMATOL, V127, P2048, DOI 10.1038/sj.jid.5700826; Huang JI, 2004, PLAST RECONSTR SURG, V113, P585, DOI 10.1097/01.PRS.0000101063.27008.E1; Joggerst SJ, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001124; Kapur SK, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/2/025004; Kim WS, 2007, J DERMATOL SCI, V48, P15, DOI 10.1016/j.jdermsci.2007.05.018; Kyriakides TR, 2009, J CELL COMMUN SIGNAL, V3, P215, DOI 10.1007/s12079-009-0077-z; Lee EJ, 2013, REGEN MED, V8, P283, DOI [10.2217/RME.13.17, 10.2217/rme.13.17]; Li HH, 2006, CELL TISSUE RES, V326, P725, DOI 10.1007/s00441-006-0270-9; Metcalfe AD, 2007, BIOMATERIALS, V28, P5100, DOI 10.1016/j.biomaterials.2007.07.031; Mvula B, 2008, LASER MED SCI, V23, P277, DOI 10.1007/s10103-007-0479-1; Mvula B, 2010, LASER MED SCI, V25, P33, DOI 10.1007/s10103-008-0636-1; Nie CL, 2011, CELL TRANSPLANT, V20, P205, DOI 10.3727/096368910X520065; Nie CL, 2009, MED HYPOTHESES, V72, P679, DOI 10.1016/j.mehy.2008.10.033; Park IS, 2013, ANAT REC, V296, P168, DOI 10.1002/ar.22606; Park IS, 2013, CYTOTHERAPY, V13, P00681; Peplow PV, 2011, PHOTOMED LASER SURG, V29, P285, DOI 10.1089/pho.2010.2846; Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104; Santini MT, 2000, CRIT REV ONCOL HEMAT, V36, P75, DOI 10.1016/S1040-8428(00)00078-0; Smith AN, 2010, EXP CELL RES, V316, P48, DOI 10.1016/j.yexcr.2009.08.001; Traktuev DO, 2009, CIRC RES, V104, P1410, DOI 10.1161/CIRCRESAHA.108.190926; Valcarcel M, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-57; Wang XS, 2013, NAT PROTOC, V8, P302, DOI 10.1038/nprot.2013.002; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226	34	46	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0122776	10.1371/journal.pone.0122776	http://dx.doi.org/10.1371/journal.pone.0122776			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26065900	gold, Green Submitted, Green Published			2022-12-26	WOS:000356100900001
J	Tommasino, F; Friedrich, T; Jakob, B; Meyer, B; Durante, M; Scholz, M				Tommasino, Francesco; Friedrich, Thomas; Jakob, Burkhard; Meyer, Barbara; Durante, Marco; Scholz, Michael			Induction and Processing of the Radiation-Induced Gamma-H2AX Signal and Its Link to the Underlying Pattern of DSB: A Combined Experimental and Modelling Study	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; PHOSPHORYLATED HISTONE H2AX; STRUCTURE-DEPENDENT REPAIR; DNA-DAMAGE; IONIZING-RADIATION; DOSE-DISTRIBUTION; X-RAYS; CELL-SURVIVAL; HIGH-LET; CHROMATIN	We present here an analysis of DSB induction and processing after irradiation with X-rays in an extended dose range based on the use of the gamma H2AX assay. The study was performed by quantitative flow cytometry measurements, since the use of foci counting would result in reasonable accuracy only in a limited dose range of a few Gy. The experimental data are complemented by a theoretical analysis based on the GLOBLE model. In fact, original aim of the study was to test GLOBLE predictions against new experimental data, in order to contribute to the validation of the model. Specifically, the gamma H2AX signal kinetics has been investigated up to 24 h after exposure to increasing photon doses between 2 and 500 Gy. The prolonged persistence of the signal at high doses strongly suggests dose dependence in DSB processing after low LET irradiation. Importantly, in the framework of our modelling analysis, this is related to a gradually increased fraction of DSB clustering at the micrometre scale. The parallel study of gamma H2AX dose response curves shows the onset of a pronounced saturation in two cell lines at a dose of about 20 Gy. This dose is much lower than expected according to model predictions based on the values usually adopted for the DSB induction yield (approximate to 30 DSB/Gy) and for the gamma H2AX foci extension of approximately 2 Mbp around the DSB. We show and discuss how theoretical predictions and experimental findings can be in principle reconciled by combining an increased DSB induction yield with the assumption of a larger genomic extension for the single phosphorylated regions. As an alternative approach, we also considered in our model the possibility of a 3D spreading-mechanism of the H2AX phosphorylation around the induced DSB, and applied it to the analysis of both the aspects considered. Our results are found to be supportive for the basic assumptions on which GLOBLE is built. Apart from giving new insights into the H2AX phosphorylation process, experiments performed at high doses are of relevance in the context of radiation therapy, where hypo-fractionated schemes become increasingly popular.	[Tommasino, Francesco; Friedrich, Thomas; Jakob, Burkhard; Meyer, Barbara; Durante, Marco; Scholz, Michael] GSI Helmholtzzentrum Schwerionenforsch, Dept Biophys, Darmstadt, Germany; [Meyer, Barbara] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO USA; [Durante, Marco] Tech Univ Darmstadt, Inst Festkorperphys, Darmstadt, Germany	Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research; Washington University (WUSTL); Technical University of Darmstadt	Tommasino, F (corresponding author), GSI Helmholtzzentrum Schwerionenforsch, Dept Biophys, Darmstadt, Germany.	f.tommasino@gsi.de	Friedrich, Thomas/K-6748-2013; Durante, Marco/L-4795-2017; Jakob, Burkhard/D-2047-2013	Friedrich, Thomas/0000-0003-0074-6390; Durante, Marco/0000-0002-4615-553X; Jakob, Burkhard/0000-0003-2404-377X; Scholz, Michael/0000-0002-6382-6737; Tommasino, Francesco/0000-0002-8684-9261	DFG [GRK 1657]; GSI	DFG(German Research Foundation (DFG)); GSI	This work was supported by a DFG-funded Graduiertenkolleg (GRK 1657) and by GSI. The work is part of HGS-HIRe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banath JP, 2004, CANCER RES, V64, P7144, DOI 10.1158/0008-5472.CAN-04-1433; Barnard S, 2014, RAD PROT DOSIMETRY; Belli M, 2002, INT J RADIAT BIOL, V78, P475, DOI 10.1080/09553000210123676; Belov OV, 2014, J THEOR BIOL; Bijlani A, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00077; BLOCHER D, 1982, INT J RADIAT BIOL, V42, P329, DOI 10.1080/09553008214551241; Botchway SW, 1997, RADIAT RES, V148, P317, DOI 10.2307/3579516; Chappell LJ, 2010, RADIAT RES, V174, P691, DOI 10.1667/RR2204.1; Costes SV, 2010, MUTAT RES-REV MUTAT, V704, P78, DOI 10.1016/j.mrrev.2009.12.006; Costes SV, 2006, RADIAT RES, V165, P505, DOI 10.1667/RR3538.1; Cucinotta FA, 2000, INT J RADIAT BIOL, V76, P1463, DOI 10.1080/09553000050176225; Cucinotta FA, 2008, RADIAT RES, V169, P214, DOI 10.1667/RR1035.1; DahmDaphi J, 1996, INT J RADIAT BIOL, V69, P615, DOI 10.1080/095530096145625; Elsasser T, 2010, INT J RADIAT ONCOL, V78, P1177, DOI 10.1016/j.ijrobp.2010.05.014; Friedland W, 2006, RADIAT PROT DOSIM, V122, P116, DOI 10.1093/rpd/ncl451; Friedrich T, 2012, RADIAT RES, V178, P385, DOI 10.1667/RR2964.1; Friedrich T, 2012, INT J RADIAT BIOL, V88, P103, DOI 10.3109/09553002.2011.611213; Gauter B, 2002, RADIAT RES, V157, P721, DOI 10.1667/0033-7587(2002)157[0721:RORIDD]2.0.CO;2; Georgakilas AG, 2013, RADIAT RES, V180, P100, DOI 10.1667/RR3041.1; Goodarzi AA, 2010, DNA REPAIR, V9, P1273, DOI 10.1016/j.dnarep.2010.09.013; Grun R, 2012, PHYS MED BIOL, V57, P7261, DOI 10.1088/0031-9155/57/22/7261; Grun R, 2013, MED PHYS, V40, DOI 10.1118/1.4824321; Hill MA, 2004, RADIAT PROT DOSIM, V112, P471, DOI 10.1093/rpd/nch091; Horn S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025113; Hufnagl A, 2015, DNA REPAIR, V27, P28, DOI 10.1016/j.dnarep.2015.01.002; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Jakob B, 2003, RADIAT RES, V159, P676, DOI 10.1667/0033-7587(2003)159[0676:BIOHCT]2.0.CO;2; Jakob B, 2009, RADIAT RES, V171, P405, DOI 10.1667/RR1520.1; Johnston PJ, 1998, RADIAT RES, V149, P533, DOI 10.2307/3579899; JOHNSTON PJ, 1994, INT J RADIAT BIOL, V66, P531, DOI 10.1080/09553009414551571; Johnston PJ, 1998, RADIAT RES, V149, P455, DOI 10.2307/3579785; Kataoka Y, 2006, J RADIAT RES, V47, P245, DOI 10.1269/jrr.0628; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Kuhne M, 2004, CANCER RES, V64, P500, DOI 10.1158/0008-5472.CAN-03-2384; Lobrich M, 1995, P NATL ACAD SCI USA, V92, P12050, DOI 10.1073/pnas.92.26.12050; MacPhail SH, 2003, INT J RADIAT BIOL, V79, P351, DOI 10.1080/0955300032000093128; MacPhail SH, 2003, RADIAT RES, V159, P759, DOI 10.1667/RR3003; Mirzayans R, 2006, INT J RADIAT ONCOL, V66, P1498, DOI 10.1016/j.ijrobp.2006.08.064; Munoz DP, 2013, NUCLEIC ACIDS RES, V41, P2894, DOI 10.1093/nar/gks1478; Neumaier T, 2012, P NATL ACAD SCI USA, V109, P443, DOI 10.1073/pnas.1117849108; Nikjoo H, 2001, RADIAT RES, V156, P577, DOI 10.1667/0033-7587(2001)156[0577:CAFDTS]2.0.CO;2; Olive PL, 2004, CANCER RES, V64, P5363, DOI 10.1158/0008-5472.CAN-04-0729; OTTOLENGHI A, 1995, RADIAT ENVIRON BIOPH, V34, P239, DOI 10.1007/BF01209749; Ponomarev AL, 2008, INT J RADIAT BIOL, V84, P916, DOI 10.1080/09553000802499212; Prise KM, 2001, RADIAT RES, V156, P572, DOI 10.1667/0033-7587(2001)156[0572:AROSOI]2.0.CO;2; Radulescu I, 2004, RADIAT RES, V161, P1, DOI 10.1667/RR3094; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Rothkamm K, 2009, ANN I SUPER SANITA, V45, P265; Sak A, 2007, INT J RADIAT BIOL, V83, P639, DOI 10.1080/09553000701596118; Savic Velibor, 2013, Frontiers in Genetics, V4, P139, DOI 10.3389/fgene.2013.00139; Schipler A, 2013, NUCLEIC ACIDS RES, V41, P7589, DOI 10.1093/nar/gkt556; Schmid TE, 2012, FRONT ONCOL, V2, P15, DOI 10.3389/fonc.2012.00080; Shibata A, 2011, EMBO J, V30, P1079, DOI 10.1038/emboj.2011.27; Singh SK, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-77; Singh SK, 2011, NUCLEIC ACIDS RES, V39, P8416, DOI 10.1093/nar/gkr463; Solovjeva L, 1998, CHROMOSOME RES, V6, P595, DOI 10.1023/A:1009293108736; Splinter J, 2010, MUTAGENESIS, V25, P289, DOI 10.1093/mutage/geq005; Stenerlow B, 2003, RADIAT RES, V159, P502, DOI 10.1667/0033-7587(2003)159[0502:MOPDDS]2.0.CO;2; Sutherland BM, 2000, P NATL ACAD SCI USA, V97, P103, DOI 10.1073/pnas.97.1.103; Tommasino F, 2013, RADIAT RES, V180, P524, DOI 10.1667/RR13389.1; Tommasino F, 2014, RAD PROT DOSIM UNPUB; Vadhavkar N, 2014, RADIAT RES, V182, P273, DOI 10.1667/RR13792.1; Wada S, 2005, J VET MED SCI, V67, P1089, DOI 10.1292/jvms.67.1089; WARD JF, 1994, INT J RADIAT BIOL, V66, P427, DOI 10.1080/09553009414551401; Whalen MK, 2008, RADIAT RES, V170, P353, DOI 10.1667/RR1354.1; YOKOTA H, 1995, J CELL BIOL, V130, P1239, DOI 10.1083/jcb.130.6.1239; Zwicker F, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-62	68	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129416	10.1371/journal.pone.0129416	http://dx.doi.org/10.1371/journal.pone.0129416			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067661	Green Submitted, gold, Green Published			2022-12-26	WOS:000356100900054
J	Towers, S; Afzal, S; Bernal, G; Bliss, N; Brown, S; Espinoza, B; Jackson, J; Judson-Garcia, J; Khan, M; Lin, M; Mamada, R; Moreno, VM; Nazari, F; Okuneye, K; Ross, ML; Rodriguez, C; Medlock, J; Ebert, D; Castillo-Chavez, C				Towers, Sherry; Afzal, Shehzad; Bernal, Gilbert; Bliss, Nadya; Brown, Shala; Espinoza, Baltazar; Jackson, Jasmine; Judson-Garcia, Julia; Khan, Maryam; Lin, Michael; Mamada, Robert; Moreno, Victor M.; Nazari, Fereshteh; Okuneye, Kamaldeen; Ross, Mary L.; Rodriguez, Claudia; Medlock, Jan; Ebert, David; Castillo-Chavez, Carlos			Mass Media and the Contagion of Fear: The Case of Ebola in America	PLOS ONE			English	Article							WEB	Background In the weeks following the first imported case of Ebola in the U.S. on September 29, 2014, coverage of the very limited outbreak dominated the news media, in a manner quite disproportionate to the actual threat to national public health; by the end of October, 2014, there were only four laboratory confirmed cases of Ebola in the entire nation. Public interest in these events was high, as reflected in the millions of Ebola-related Internet searches and tweets performed in the month following the first confirmed case. Use of trending Internet searches and tweets has been proposed in the past for real-time prediction of outbreaks (a field referred to as "digital epidemiology"), but accounting for the biases of public panic has been problematic. In the case of the limited U.S. Ebola outbreak, we know that the Ebola-related searches and tweets originating the U.S. during the outbreak were due only to public interest or panic, providing an unprecedented means to determine how these dynamics affect such data, and how news media may be driving these trends. Methodology We examine daily Ebola-related Internet search and Twitter data in the U.S. during the six week period ending Oct 31, 2014. TV news coverage data were obtained from the daily number of Ebola-related news videos appearing on two major news networks. We fit the parameters of a mathematical contagion model to the data to determine if the news coverage was a significant factor in the temporal patterns in Ebola-related Internet and Twitter data. Conclusions We find significant evidence of contagion, with each Ebola-related news video inspiring tens of thousands of Ebola-related tweets and Internet searches. Between 65% to 76% of the variance in all samples is described by the news media contagion model.	[Towers, Sherry; Bernal, Gilbert; Bliss, Nadya; Brown, Shala; Espinoza, Baltazar; Jackson, Jasmine; Judson-Garcia, Julia; Khan, Maryam; Lin, Michael; Mamada, Robert; Moreno, Victor M.; Nazari, Fereshteh; Okuneye, Kamaldeen; Ross, Mary L.; Rodriguez, Claudia; Castillo-Chavez, Carlos] Arizona State Univ, Tempe, AZ 85281 USA; [Afzal, Shehzad; Ebert, David] Purdue Univ, W Lafayette, IN 47907 USA; [Medlock, Jan] Oregon State Univ, Corvallis, OR 97331 USA	Arizona State University; Arizona State University-Tempe; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Oregon State University	Towers, S (corresponding author), Arizona State Univ, Tempe, AZ 85281 USA.	smtowers@asu.edu	Afzal, Shehzad/AAI-5276-2021; Castillo-Chavez, Carlos/E-1412-2014	Castillo-Chavez, Carlos/0000-0002-1046-3901; Espinoza, Baltazar/0000-0002-6280-3277; Afzal, Shehzad/0000-0002-9712-3618; Ebert, David/0000-0001-6177-1296	Western Alliance to Expand Student Opportunities (WAESO) Louis Stokes Alliance for Minority Participation (LSAMP) Bridge [HRD-1401190]; Offices of the President and Provost of Arizona State University; U.S. Department of Homeland Security (DHS) VACCINE Center award [2009-ST-061-CI0001-06]; National Institute of General Medical Sciences (NIGMS) at the National Institutes of Health [1R01GM100471-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100471] Funding Source: NIH RePORTER	Western Alliance to Expand Student Opportunities (WAESO) Louis Stokes Alliance for Minority Participation (LSAMP) Bridge; Offices of the President and Provost of Arizona State University; U.S. Department of Homeland Security (DHS) VACCINE Center award(United States Department of Homeland Security (DHS)); National Institute of General Medical Sciences (NIGMS) at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The parameter optimization portion of the analysis was made possible with education allocation #DMS140043 of super-computing resources from National Science Foundation Extreme Science and Engineering Discovery Environment (XSEDE) high-performance computing initiative (ST GB NB SB BE JJ JJG MK ML RM VMM FN KO MLR CR CCC). This research was also partially supported by the Western Alliance to Expand Student Opportunities (WAESO) Louis Stokes Alliance for Minority Participation (LSAMP) Bridge to the Doctorate (BD) National Science Foundation (NSF) "Multidisciplinary STEM Solutions LSAMP Bridge to the Doctorate" grant #HRD-1401190 (GB SB JJ JJG MLR CR), and the Offices of the President and Provost of Arizona State University. This work was funded in part by the U.S. Department of Homeland Security (DHS) VACCINE Center award #2009-ST-061-CI0001-06 (SA DE), and was also made possible by grant #1R01GM100471-01 from the National Institute of General Medical Sciences (NIGMS) at the National Institutes of Health (CCC). The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmaseda A, 2010, J INFECT DIS, V201, P5, DOI 10.1086/648592; Bettencourt LMA, 2006, PHYSICA A, V364, P513, DOI 10.1016/j.physa.2005.08.083; Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Cha M, 2012, IEEE T SYST MAN CY A, V42, P991, DOI 10.1109/TSMCA.2012.2183359; Chan EH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001206; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x; Chunara R, 2012, AM J TROP MED HYG, V86, P39, DOI 10.4269/ajtmh.2012.11-0597; Cook S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023610, 10.1371/journal.pone.0025407]; Cowan G, 1998, STAT DATA ANAL; DICKERSIN K, 1990, JAMA-J AM MED ASSOC, V263, P1385, DOI 10.1001/jama.263.10.1385; Eysenbach Gunther, 2006, AMIA Annu Symp Proc, P244; Eysenbach G, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1157; Gallup, 2013, TV IS AM MAIN SOURC; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Goel S, 2010, P NATL ACAD SCI USA, V107, P17486, DOI 10.1073/pnas.1005962107; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hay SI, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001413; McCullagh P, 1989, GEN LINEAR MODELS; Metaxas P., 2011, 2011 IEEE 3 INT C PR, P165, DOI [10.1109/PASSAT/SocialCom.2011.98, DOI 10.1109/PASSAT/SOCIALCOM.2011.98]; MOSEGAARD K, 1995, J GEOPHYS RES-SOL EA, V100, P12431, DOI 10.1029/94JB03097; Olson DR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003256; Pew Research Center, 2014, KEY IND MED NEWS; Polgreen PM, 2008, CLIN INFECT DIS, V47, P1443, DOI 10.1086/593098; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Salathe M, 2013, EPJ DATA SCI, V2, DOI 10.1140/epjds16; Salathe M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002616; Salathe M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002199; Schmidt CW, 2012, ENVIRON HEALTH PERSP, V120, pA30, DOI 10.1289/ehp.120-a30; Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467; Tausczik Y, 2012, HEALTH COMMUN, V27, P179, DOI 10.1080/10410236.2011.571759; Wilson K, 2009, CAN MED ASSOC J, V180, P829, DOI [10.1503/cmaj.090215, 10.1503/cmaj.1090215]; Zhou XC, 2011, IEEE T BIO-MED ENG, V58, DOI 10.1109/TBME.2011.2132132	33	155	158	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129179	10.1371/journal.pone.0129179	http://dx.doi.org/10.1371/journal.pone.0129179			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067433	Green Published, gold			2022-12-26	WOS:000356100900044
J	Hedrick, BP; Zanno, LE; Wolfe, DG; Dodson, P				Hedrick, Brandon P.; Zanno, Lindsay E.; Wolfe, Douglas G.; Dodson, Peter			The Slothful Claw: Osteology and Taphonomy of Nothronychus mckinleyi and N-graffami (Dinosauria: Theropoda) and Anatomical Considerations for Derived Therizinosaurids	PLOS ONE			English	Article							PECTORAL GIRDLE; BRAINCASE; MANIRAPTORA; AFFINITIES; FORELIMB; YUNNAN	Nothronychus was the first definitive therizinosaurian discovered in North America and currently represents the most specialized North American therizinosaurian genus. It is known from two species, No. mckinleyi from the Moreno Hill Formation (middle Turonian) in west-central New Mexico, and No. graffami from the Tropic Shale (early Turonian) in south-central Utah. Both species are represented by partial to nearly complete skeletons that have helped elucidate evolutionary trends in Therizinosauria. In spite of the biogeographical and evolutionary importance of these two taxa, neither has received a detailed description. Here, we present comprehensive descriptions of No. mckinleyi and No. graffami, the latter of which represents the most complete therizinosaurid skeleton known to date. We amend previous preliminary descriptions of No. mckinleyi and No. graffami based on these new data and modify previous character states based on an in-depth morphological analysis. Additionally, we review the depositional history of both specimens of Nothronychus and compare their taphonomic modes. We demonstrate that the species were not only separated geographically, but also temporally. Based on ammonoid biozones, the species appear to have been separated by at least 1.5 million years and up to 3 million years. We then discuss the impacts of diagenetic deformation on morphology and reevaluate potentially diagnostic characters in light of these new data. For example, the ulna of No. mckinleyi is curved whereas the ulna of No. graffami was considered straight, a character originally separating the two species. However, here we present the difference as much more likely related to diagenetic compression in No. graffami rather than as a true biologic difference. Finally, we include copies of three-dimensional surface scans of all major bones for both taxa for reference.	[Hedrick, Brandon P.; Dodson, Peter] Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA; [Zanno, Lindsay E.] North Carolina Museum Nat Sci, Raleigh, NC USA; [Zanno, Lindsay E.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Wolfe, Douglas G.] White Mt Dinosaur Explorat Ctr, Springerville, AZ USA; [Dodson, Peter] Univ Penn, Dept Anim Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of North Carolina; North Carolina State University; University of Pennsylvania	Hedrick, BP (corresponding author), Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA.	bphedrick1@gmail.com		Zanno, Lindsay/0000-0002-1654-1990	NSF [EAR 1024671]; University of Pennsylvania Research Foundation; EES Paleobiology Summer Research Stipend	NSF(National Science Foundation (NSF)); University of Pennsylvania Research Foundation; EES Paleobiology Summer Research Stipend	The authors would like to thank NSF EAR 1024671, University of Pennsylvania Research Foundation, and the EES Paleobiology Summer Research Stipend. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright LB, 2007, J VERTEBR PALEONTOL, V27, P31, DOI 10.1671/0272-4634(2007)27[31:PFTUCC]2.0.CO;2; Albright LB, 2007, J VERTEBR PALEONTOL, V27, P41, DOI 10.1671/0272-4634(2007)27[41:PFTUCC]2.0.CO;2; [Anonymous], 1983, MESOZOIC PALEOGEOGRA; [Anonymous], 1954, PRIRODA; Barrett PM, 2009, PALAEONTOLOGY, V52, P681, DOI 10.1111/j.1475-4983.2009.00887.x; Barsbold R., 1976, T JOINT SOVIET MONGO, V3, P76; Carrano MT, 2002, J MORPHOL, V253, P207, DOI 10.1002/jmor.10018; Clark James M., 1994, American Museum Novitates, V3115, P1; Cobban WA, 1984, GEOLOGICAL ASS CANAD, V27, P257; Dong Z, 1979, DINOSAURS CRETACEOUS, P342; Dong Zhiming, 1997, P90; Dyman TS, 1994, SPECIAL PUBLICATION, P365; Everhart Michael J., 2005, Transactions of the Kansas Academy of Science, V108, P15, DOI 10.1660/0022-8443(2005)108[0015:ANNSDN]2.0.CO;2; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Hedrick BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069265; Hook S.C., 1983, New Mexico Bureau of Mines & Mineral Resources Circular, P7; Jasinoski SC, 2006, ZOOL J LINN SOC-LOND, V146, P301, DOI 10.1111/j.1096-3642.2006.00200.x; Kirkland JI, 2005, NATURE, V435, P84, DOI 10.1038/nature03468; Kirkland JI, 2005, LIFE O PAST, P87; Kirkland JI, 2001, J VERTEBR PALEONTOL, V21, P410, DOI 10.1671/0272-4634(2001)021[0410:FDTDTF]2.0.CO;2; Kirkland JI, 1991, STRATIGRAPHY DEPOSIT, P80; Lautenschlager S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052289; Lautenschlager S, 2013, J ANAT, V222, P260, DOI 10.1111/joa.12000; Li DQ, 2008, CAN J EARTH SCI, V45, P769, DOI 10.1139/E08-021; Li DQ, 2007, ACTA GEOL SIN-ENGL, V81, P539; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Mcdonald AT, 2010, J VERTEBR PALEONTOL, V30, P799, DOI 10.1080/02724631003763516; McLellan MW, 1983, NEW MEXICO BUREAU MI, V185, P41; NICHOLLS EL, 1985, PALAEONTOLOGY, V28, P643; Osmolska H, 2004, DINOSAURIA, 2ND EDITION, P165; Owen R., 1842, REPORTS BRIT ASS ADV, V11, P60; PERLE A, 1982, PROBLEMS GEOLOGY MON, V5, P94; Perle A., 1981, JOINT SOVIET MONGOLI, V8, P45; Perle A., 1979, T JOINT SOVIET MONGO, V15, P28, DOI DOI 10.1126/SCIENCE.1144066; Pu HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063423; ROSS CA, 1978, J PALEONTOL, V52, P943; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2107, DOI 10.1139/e93-183; Russell DA, 1987, ENCY DINOSAURS, P729; Sageman B. B, 1994, EARLY TURONIAN PALEO, P457; Senter P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043911; Shimada K, 2006, J PALEONTOL, V80, P589, DOI 10.1666/0022-3360(2006)80[589:CORSFT]2.0.CO;2; Smith DK, 2014, J VERTEBR PALEONTOL, V34, P635, DOI 10.1080/02724634.2013.812097; Smith DK, 2011, J VERTEBR PALEONTOL, V31, P387, DOI 10.1080/02724634.2011.549442; Sweeney IJ, 2009, INT J COAL GEOL, V79, P1, DOI 10.1016/j.coal.2009.04.001; Tschopp E, 2013, PALAEONTOL ELECTRON, V16; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wolfe DG, 2000, MESA SW MUSEUM B, V7, P89; Wolfe DG, 1989, STRATIGRAPHY PALEOEN, P1; Wolfe DG, 1998, B NEW MEXICO MUSEUM, V17, P303; Wolfe Douglas G., 2010, P91; Xu X, 1999, NATURE, V399, P350, DOI 10.1038/20670; Xu X, 2003, ACTA GEOL SIN-ENGL, V77, P294; Xu X, 2001, J VERTEBR PALEONTOL, V21, P477, DOI 10.1671/0272-4634(2001)021[0477:ANTFTL]2.0.CO;2; Xu Xing, 2002, Vertebrata Palasiatica, V40, P228; Xu X, 2009, P NATL ACAD SCI USA, V106, P832, DOI 10.1073/pnas.0810055106; Zanno LE, 2006, J VERTEBR PALEONTOL, V26, P636, DOI 10.1671/0272-4634(2006)26[636:TPGAFO]2.0.CO;2; Zanno LE, 2010, J SYST PALAEONTOL, V8, P503, DOI 10.1080/14772019.2010.488045; Zanno LE, 2010, ZOOL J LINN SOC-LOND, V158, P196, DOI 10.1111/j.1096-3642.2009.00464.x; Zanno LE, 2009, P ROY SOC B-BIOL SCI, V276, P3505, DOI 10.1098/rspb.2009.1029; Zhang Xiao-Hong, 2001, Vertebrata Palasiatica, V39, P282; Zhao XJ, 1998, NATURE, V394, P234, DOI 10.1038/28300	61	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129449	10.1371/journal.pone.0129449	http://dx.doi.org/10.1371/journal.pone.0129449			49	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061728	Green Published, gold, Green Submitted			2022-12-26	WOS:000355979500146
J	Xu, QL; Qi, H; Sun, ML; Zuo, DY; Jiang, XW; Wen, ZY; Wang, ZW; Wu, YL; Zhang, WG				Xu, Qile; Qi, Huan; Sun, Maolin; Zuo, Daiying; Jiang, Xuewei; Wen, Zhiyong; Wang, Zhiwei; Wu, Yingliang; Zhang, Weige			Synthesis and Biological Evaluation of 3-Alkyl-1,5-Diaryl-1H-Pyrazoles as Rigid Analogues of Combretastatin A-4 with Potent Antiproliferative Activity	PLOS ONE			English	Article							ANTINEOPLASTIC AGENTS; PYRAZOLE DERIVATIVES; INHIBITORS; ANTITUMOR; CYTOTOXICITY; WATER; A4	A series of novel 3-alkyl-1,5-diaryl-1H-pyrazoles were synthesized as combretastatin A-4 (CA-4) analogues and evaluated for antiproliferative activity against three human cancer cell lines (SGC-7901, A549 and HT-1080). Most of the target compounds displayed moderate to potent antiproliferative activity, and 7k was found to be the most potent compound. Structure-activity relationships indicated that compounds with a trimethoxyphenyl A-ring at the N-1 position of the pyrazole skeleton were more potent than those with the A-ring at the C-5 position. Tubulin polymerization and immunostaining experiments revealed that 7k potently inhibited tubulin polymerization and disrupted tubulin microtubule dynamics in a manner similar to CA-4. Computational modelling demonstrated that the binding of 7k to the colchicine binding site on microtubules may involve a similar mode as CA-4.	[Xu, Qile; Sun, Maolin; Wen, Zhiyong; Wang, Zhiwei; Zhang, Weige] Shenyang Pharmaceut Univ, Minist Educ, Dept Key Lab Struct Based Drug Design & Discovery, Shenyang, Peoples R China; [Qi, Huan; Zuo, Daiying; Jiang, Xuewei; Wu, Yingliang] Shenyang Pharmaceut Univ, Dept Pharmacol, Shenyang, Peoples R China	Shenyang Pharmaceutical University; Shenyang Pharmaceutical University	Wu, YL (corresponding author), Shenyang Pharmaceut Univ, Dept Pharmacol, Shenyang, Peoples R China.	yingliang_1016@163.com; zhangweige2000@sina.com		Zhang, Weige/0000-0002-4492-3072	Programme for Innovative Research Team of the Ministry of Education; Programme for Liaoning Innovative Research Team in University; National Science and Technology Major Project of the Ministry of Science and Technology of China [1.2012ZX09103101-060]; National Natural Science Foundation of China [2.30973614]	Programme for Innovative Research Team of the Ministry of Education; Programme for Liaoning Innovative Research Team in University; National Science and Technology Major Project of the Ministry of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Programme for Innovative Research Team of the Ministry of Education and the Programme for Liaoning Innovative Research Team in University, the National Science and Technology Major Project of the Ministry of Science and Technology of China (1.2012ZX09103101-060, http://www.nmp.gov.cn/zxjs/WZ, YW), and the National Natural Science Foundation of China (2.30973614, http://www.nsfc.gov.cn/WZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos LA, 2004, ORG BIOMOL CHEM, V2, P2153, DOI 10.1039/b403634d; Biersack B, 2010, EUR J MED CHEM, V45, P4890, DOI 10.1016/j.ejmech.2010.07.061; Blanch NM, 2012, EUR J MED CHEM, V54, P22, DOI 10.1016/j.ejmech.2012.04.017; Burja B, 2010, BIOORGAN MED CHEM, V18, P2375, DOI 10.1016/j.bmc.2010.03.006; CLIVE DLJ, 1987, J ORG CHEM, V52, P1339, DOI 10.1021/jo00383a032; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; FEHNEL EA, 1958, J ORG CHEM, V23, P432, DOI 10.1021/jo01097a029; Ferlin MG, 2005, BIOORGAN MED CHEM, V13, P4733, DOI 10.1016/j.bmc.2005.04.080; Frey RR, 2008, J MED CHEM, V51, P3777, DOI 10.1021/jm701397k; Genin MJ, 2000, J MED CHEM, V43, P1034, DOI 10.1021/jm990383f; Gong JX, 2009, BIOORGAN MED CHEM, V17, P3414, DOI 10.1016/j.bmc.2009.03.032; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; KADAM SM, 1992, TETRAHEDRON LETT, V33, P5129, DOI 10.1016/S0040-4039(00)61209-1; Kaffy J, 2006, BIOORGAN MED CHEM, V14, P4067, DOI 10.1016/j.bmc.2006.02.001; Kanthou C, 2009, INT J EXP PATHOL, V90, P284, DOI 10.1111/j.1365-2613.2009.00651.x; Kumar V, 2013, EUR J MED CHEM, V69, P735, DOI 10.1016/j.ejmech.2013.08.053; Lee L, 2008, EUR J MED CHEM, V43, P2011, DOI 10.1016/j.ejmech.2007.11.030; Li M, 2014, EUR J MED CHEM, V85, P311, DOI 10.1016/j.ejmech.2014.07.102; Liu JJ, 2013, MINI-REV MED CHEM, V13, P1957, DOI 10.2174/13895575113139990078; Lu Y, 2012, PHARM RES-DORDR, V29, P2943, DOI 10.1007/s11095-012-0828-z; MCGOWN AT, 1990, CANCER CHEMOTH PHARM, V26, P79, DOI 10.1007/BF02940301; Pettit GR, 1999, J MED CHEM, V42, P1459, DOI 10.1021/jm9807149; PETTIT GR, 1989, EXPERIENTIA, V45, P209, DOI 10.1007/BF01954881; SERRETTE AG, 1994, CHEM MATER, V6, P2252, DOI 10.1021/cm00048a012; Tron GC, 2006, J MED CHEM, V49, P3033, DOI 10.1021/jm0512903; Tron GC, 2005, J MED CHEM, V48, P3260, DOI 10.1021/jm049096o; Tsyganov DV, 2013, J NAT PROD, V76, P1485, DOI 10.1021/np400310m; Wang L, 2002, J MED CHEM, V45, P1697, DOI 10.1021/jm010523x; Zhang Q, 2007, J MED CHEM, V50, P749, DOI 10.1021/jm061142s; Zhao ZG, 2007, SYNTHETIC COMMUN, V37, P137, DOI 10.1080/00397910600978549	30	18	19	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0128710	10.1371/journal.pone.0128710	http://dx.doi.org/10.1371/journal.pone.0128710			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061410	Green Published, Green Submitted, gold			2022-12-26	WOS:000355979500095
J	Michalska, K; Steen, AD; Chhor, G; Endres, M; Webber, AT; Bird, J; Lloyd, KG; Joachimiak, A				Michalska, Karolina; Steen, Andrew D.; Chhor, Gekleng; Endres, Michael; Webber, Austen T.; Bird, Jordan; Lloyd, Karen G.; Joachimiak, Andrzej			New aminopeptidase from "microbial dark matter" archaeon	FASEB JOURNAL			English	Article						carbon cycle; marine sediments; single-cell genomics; detrital proteins	ACID ESTER HYDROLASE; LIGATION-INDEPENDENT CLONING; HIGH-THROUGHPUT; CRYSTAL-STRUCTURE; GENE-EXPRESSION; LIC VECTORS; PROTEINS; MODEL; CRYSTALLOGRAPHY; PURIFICATION	Marine sediments host a large population of diverse, heterotrophic, uncultured microorganisms with unknown physiologies that control carbon flow through organic matter decomposition. Recently, single-cell genomics uncovered new key players in these processes, such as the miscellaneous crenarchaeotal group. These widespread archaea encode putative intra- and extracellular proteases for the degradation of detrital proteins present in sediments. Here, we show that one of these enzymes is a self-compartmentalizing tetrameric aminopeptidase with a preference for cysteine and hydrophobic residues at the N terminus of the hydrolyzed peptide. The ability to perform detailed characterizations of enzymes from native subsurface microorganisms, without requiring that those organisms first be grown in pure culture, holds great promise for understanding key carbon transformations in the environment as well as identifying new enzymes for biomedical and biotechnological applications.	[Michalska, Karolina; Chhor, Gekleng; Endres, Michael; Joachimiak, Andrzej] Argonne Natl Lab, Biosci Div, Midwest Ctr Struct Genom, Argonne, IL 60439 USA; [Michalska, Karolina; Joachimiak, Andrzej] Argonne Natl Lab, Biosci Div, Struct Biol Ctr, Argonne, IL 60439 USA; [Steen, Andrew D.; Bird, Jordan; Lloyd, Karen G.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Steen, Andrew D.; Webber, Austen T.] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN USA; [Joachimiak, Andrzej] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; University of Chicago	Joachimiak, A (corresponding author), Argonne Natl Lab, Biosci Div, Struct Biol Ctr, 9700 South Cass Ave,Bldg 446, Argonne, IL 60439 USA.	andrzejj@anl.gov		Joachimiak, Andrzej/0000-0003-2535-6209; Bird, Jordan/0000-0001-5753-6058	U.S. National Institutes of Health, National Institute of General Medical Sciences [GM094585]; U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; Center for Dark Energy Biosphere Investigations [157595, 36202823]; U.S. Department of Energy Office of Science laboratory [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094585] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Center for Dark Energy Biosphere Investigations; U.S. Department of Energy Office of Science laboratory(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Robert Jedrzejczak (Argonne National Laboratory) for discussion of cloning strategy, Dr. Gyorgy Babnigg (Argonne National Laboratory) for help in designing the cloning construct, Katlyn Fayman (Argonne National Laboratory) for help with protein purification, members of the Structural Biology Center at Argonne National Laboratory for their help with data collection at the 19-Insertion Device Beamline, Dr. Steven Wilhelm (University of Tennessee Department of Microbiology) for provision of lab space to A.D.S., and Dr. B. B. Jorgensen and the staff of the Center for Geomicrobiology at Aarhus University (Aarhus, Denmark) for providing amplified genomic deoxyribonucleic acid. This work was supported by the following funds: U.S. National Institutes of Health, National Institute of General Medical Sciences Grant GM094585 (to A.J.); the U.S. Department of Energy, Office of Biological and Environmental Research, under contract DE-AC02-06CH11357 (to A.J.); and Center for Dark Energy Biosphere Investigations Grants 157595 (to K.G.L.) and 36202823 (to A.D.S.). This work is Center for Dark Energy Biosphere Investigation Contribution 268. The submitted manuscript has been created by UChicago Argonne, Limited Liability Company, Operator of Argonne National Laboratory ("Argonne"). Argonne, a U.S. Department of Energy Office of Science laboratory, is operated under Contract No. DE-AC02-06CH11357. The U.S. Government retains for itself, and others acting on its behalf, a paid-up nonexclusive, irrevocable worldwide license in said article to reproduce, prepare derivative works, distribute copies to the public, and perform publicly and display publicly, by or on behalf of the Government.	ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Barends TRM, 2006, J BIOL CHEM, V281, P5804, DOI 10.1074/jbc.M511187200; Barends TRM, 2003, ACTA CRYSTALLOGR D, V59, P2237, DOI 10.1107/S0907444903020729; Barends TRM, 2003, J BIOL CHEM, V278, P23076, DOI 10.1074/jbc.M302246200; Bricogne G., 2011, BUSTER VERSION 2 10; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eschenfeldt William H., 2013, Journal of Structural and Functional Genomics, V14, P135, DOI 10.1007/s10969-013-9163-9; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Feller G, 2003, NAT REV MICROBIOL, V1, P200, DOI 10.1038/nrmicro773; Hartmann EM, 2014, MAR GENOM, V17, P35, DOI 10.1016/j.margen.2014.04.003; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kim Youngchang, 2004, Journal of Structural and Functional Genomics, V5, P111, DOI 10.1023/B:JSFG.0000029206.07778.fc; Kim Y, 2011, METHODS, V55, P12, DOI 10.1016/j.ymeth.2011.07.010; Krest'ianova I N, 1990, Biokhimiia, V55, P2226; Kurochkina VB, 2013, APPL BIOCHEM MICRO+, V49, P672, DOI 10.1134/S0003683813080036; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larsen NA, 2002, NAT STRUCT BIOL, V9, P17, DOI 10.1038/nsb742; Lloyd KG, 2013, NATURE, V496, P215, DOI 10.1038/nature12033; Lupas A, 1997, TRENDS BIOCHEM SCI, V22, P399, DOI 10.1016/S0968-0004(97)01117-1; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; Meng J, 2014, ISME J, V8, P650, DOI 10.1038/ismej.2013.174; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Orsi WD, 2013, NATURE, V499, P205, DOI 10.1038/nature12230; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; Rigolet P, 2002, STRUCTURE, V10, P1383, DOI 10.1016/S0969-2126(02)00851-1; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Rosenbaum G, 2006, J SYNCHROTRON RADIAT, V13, P30, DOI 10.1107/S0909049505036721; Stepanauskas R, 2007, P NATL ACAD SCI USA, V104, P9052, DOI 10.1073/pnas.0700496104; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Stols Lucy, 2004, Journal of Structural and Functional Genomics, V5, P95, DOI 10.1023/B:JSFG.0000029196.87615.6e; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; WALLIS M, 1973, BIOCHIM BIOPHYS ACTA, V310, P388, DOI 10.1016/0005-2795(73)90120-7; Wilson K., 1978, ACTA CRYSTALLOGR A, V34, P517, DOI DOI 10.1107/S0567739478001114; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wrighton KC, 2012, SCIENCE, V337, P1661, DOI 10.1126/science.1224041; Zarubina SA, 2013, ACTA NATURAE, V5, P62, DOI 10.32607/20758251-2013-5-4-62-70	41	11	11	1	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					4071	4079		10.1096/fj.15-272906	http://dx.doi.org/10.1096/fj.15-272906			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26062601	Green Published, Bronze			2022-12-26	WOS:000359915600040
J	Caetano, SM; Menezes, R; Amaral, C; Rodrigues-Pousada, C; Pimentel, C				Caetano, Soraia M.; Menezes, Regina; Amaral, Catarina; Rodrigues-Pousada, Claudina; Pimentel, Catarina			Repression of the Low Affinity Iron Transporter Gene FET4 A NOVEL MECHANISM AGAINST CADMIUM TOXICITY ORCHESTRATED BY YAP1 VIA ROX1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CADMIUM TOLERANCE; ABC TRANSPORTER; HYPOXIC GENES; YEAST; EXPRESSION; PROTEIN; TRANSCRIPTION; TOXICITY; ROX1	Cadmiumis a well known mutagenic metal that can enter cells via nonspecific metal transporters, causing several cellular damages and eventually leading to death. In the yeast Saccharomyces cerevisiae, the transcription factor Yap1 plays a key role in the regulation of several genes involved in metal stress response. We have previously shown that Yap1 represses the expression of FET4, a gene encoding a low affinity iron transporter able to transport metals other than iron. Here, we have studied the relevance of this repression in cell tolerance to cadmium. Our results indicate that genomic deletion of Yap1 increases FET4 transcript and protein levels. In addition, the cadmium toxicity exhibited by this strain is completely reversed by co-deletion of FET4 gene. These data correlate well with the increased intracellular levels of cadmium observed in the mutant yap1. Rox1, a well known aerobic repressor of hypoxic genes, conveys the Yap1-mediated repression of FET4. We further show that, in a scenario where the activity of Yap1 or Rox1 is compromised, cells activate post-transcriptional mechanisms, involving the exoribonuclease Xrn1, to compensate the derepression of FET4. Our data thus reveal a novel protection mechanism against cadmium toxicity mediated by Yap1 that relies on the aerobic repression of FET4 and results in the impairment of cadmium uptake.	[Caetano, Soraia M.; Menezes, Regina; Amaral, Catarina; Rodrigues-Pousada, Claudina; Pimentel, Catarina] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, P-2781901 Oeiras, Portugal; [Menezes, Regina] Inst Biol Expt & Tecnol, P-2781901 Oeiras, Portugal	Universidade Nova de Lisboa	Rodrigues-Pousada, C (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Ave Republ,EAN, P-2781901 Oeiras, Portugal.	claudina@itqb.unl.pt; pimentel@itqb.unl.pt	Echaniz, Regina Menezes/AAE-8041-2020; Menezes Echaniz, Regina/L-3792-2014	Menezes Echaniz, Regina/0000-0003-0552-8480; Rodrigues-Pousada, Claudina/0000-0002-5075-3639; Caetano, Soraia/0000-0001-7427-5670; Pimentel, Catarina/0000-0002-5158-6414; Amaral, Catarina/0000-0002-9442-2225	Fundacao para Ciencia e Tecnologia [EXPL/BIA-MIC/2525/2013, Pest-OE/EQB/LA0004/2011, SFRH/BD/91077/2012, SFRH/BPD/74294/2010, SFRH/BPD/90823/2012]	Fundacao para Ciencia e Tecnologia(Portuguese Foundation for Science and Technology)	This work was supported by the Fundacao para Ciencia e Tecnologia through Grants EXPL/BIA-MIC/2525/2013 (to C. P.) and Pest-OE/EQB/LA0004/2011 (to Instituto de Tecnologia Quimica e Biologica) and Fellowships SFRH/BD/91077/2012 (to S. M. C.), SFRH/BPD/74294/2010 (to C. A.), and SFRH/BPD/90823/2012 (to C. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Adle DJ, 2007, J BIOL CHEM, V282, P947, DOI 10.1074/jbc.M609535200; Azevedo D, 2003, FREE RADICAL BIO MED, V35, P889, DOI 10.1016/S0891-5849(03)00434-9; Batista-Nascimento L, 2013, BBA-MOL CELL RES, V1833, P997, DOI 10.1016/j.bbamcr.2012.12.018; Chanfreau C, 2000, P NATL ACAD SCI USA, V97, P3142, DOI 10.1073/pnas.070043997; CHOLLET A, 1983, Toxicological European Research, V5, P71; Clemens S, 1998, P NATL ACAD SCI USA, V95, P12043, DOI 10.1073/pnas.95.20.12043; Clemens S, 2006, BIOCHIMIE, V88, P1707, DOI 10.1016/j.biochi.2006.07.003; DECKERT J, 1995, GENETICS, V139, P1149; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; DIX DR, 1994, J BIOL CHEM, V269, P26092; Fernandes L, 1997, MOL CELL BIOL, V17, P6982, DOI 10.1128/MCB.17.12.6982; Gardarin A, 2010, MOL MICROBIOL, V76, P1034, DOI 10.1111/j.1365-2958.2010.07166.x; Gitan RS, 2003, J BIOL CHEM, V278, P39558, DOI 10.1074/jbc.M302760200; Gomes DS, 2002, BBA-GEN SUBJECTS, V1573, P21, DOI 10.1016/S0304-4165(02)00324-0; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Heo DH, 2010, BIOCHEM J, V431, P257, DOI 10.1042/BJ20100638; Himeno S, 2002, TOHOKU J EXP MED, V196, P43, DOI 10.1620/tjem.196.43; Huang YH, 2006, J CELL BIOCHEM, V98, P577, DOI 10.1002/jcb.20772; Huff J, 2007, INT J OCCUP ENV HEAL, V13, P202, DOI 10.1179/oeh.2007.13.2.202; Jensen LT, 2002, J MOL BIOL, V318, P251, DOI 10.1016/S0022-2836(02)00093-1; JEYAPRAKASH A, 1991, MOL GEN GENET, V225, P363, DOI 10.1007/BF00261675; Jin YH, 2003, NAT GENET, V34, P326, DOI 10.1038/ng1172; Johri N, 2010, BIOMETALS, V23, P783, DOI 10.1007/s10534-010-9328-y; Jones CI, 2012, WIRES RNA, V3, P455, DOI 10.1002/wrna.1109; Kaplan CD, 2009, CHEM REV, V109, P4536, DOI 10.1021/cr9001676; KENG T, 1992, MOL CELL BIOL, V12, P2616, DOI 10.1128/MCB.12.6.2616; Kern AL, 2005, BIOMETALS, V18, P31, DOI 10.1007/s10534-004-5772-x; Lauer CM, 2008, FEMS MICROBIOL LETT, V285, P79, DOI 10.1111/j.1574-6968.2008.01214.x; Lee A, 2005, MOL CELL, V19, P39, DOI 10.1016/j.molcel.2005.05.021; Li LT, 1998, J BIOL CHEM, V273, P22181, DOI 10.1074/jbc.273.35.22181; Li ZS, 1997, P NATL ACAD SCI USA, V94, P42, DOI 10.1073/pnas.94.1.42; Liu JJ, 2013, ANTIOXID REDOX SIGN, V19, P1916, DOI 10.1089/ars.2012.4589; Liu XF, 1997, J BIOL CHEM, V272, P11763, DOI 10.1074/jbc.272.18.11763; LOWRY CV, 1988, MOL CELL BIOL, V8, P4651, DOI 10.1128/MCB.8.11.4651; Mielniczki-Pereira AA, 2011, TOXICOL LETT, V207, P104, DOI 10.1016/j.toxlet.2011.08.023; Nagy Z, 2006, BIOCHIMIE, V88, P1665, DOI 10.1016/j.biochi.2006.05.014; Newbury SF, 2006, BIOCHEM SOC T, V34, P30, DOI 10.1042/BST0340030; Pimentel C, 2014, BBA-GEN SUBJECTS, V1840, P1977, DOI 10.1016/j.bbagen.2014.01.032; Pimentel C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037434; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Puig S, 2008, CELL METAB, V7, P555, DOI 10.1016/j.cmet.2008.04.010; RHODES ML, 1976, LAB INVEST, V35, P496; Rodrigues-Pousada C, 2010, YEAST, V27, P245, DOI 10.1002/yea.1752; Ruotolo R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r67; Sharma KG, 2002, EUKARYOT CELL, V1, P391, DOI 10.1128/EC.1.3.391-400.2002; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; TELLMANN G, 2006, NAT METHODS, V3, P3; Thorsen M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-105; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Waters BM, 2002, J BIOL CHEM, V277, P33749, DOI 10.1074/jbc.M206214200; Wawrzycka D, 2010, FEMS YEAST RES, V10, P828, DOI 10.1111/j.1567-1364.2010.00673.x; WEMMIE JA, 1994, J BIOL CHEM, V269, P32592; ZITOMER RS, 1992, MICROBIOL REV, V56, P1	53	17	18	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18584	18595		10.1074/jbc.M114.600742	http://dx.doi.org/10.1074/jbc.M114.600742			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26063801	Green Published, hybrid			2022-12-26	WOS:000358512100029
J	Adachi, M; So, M; Sakurai, K; Kardos, J; Goto, Y				Adachi, Masayuki; So, Masatomo; Sakurai, Kazumasa; Kardos, Jozsef; Goto, Yuji			Supersaturation-limited and Unlimited Phase Transitions Compete to Produce the Pathway Complexity in Amyloid Fibrillation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; BETA(2)-MICROGLOBULIN; MECHANISM; AGGREGATION; KINETICS; FIBRILS; CRYSTALLIZATION; ACCELERATION; NUCLEATION; MORPHOLOGY	Although amyloid fibrils and amorphous aggregates are two types of aggregates formed by denatured proteins, their relationship currently remains unclear. We used beta(2)-microglobulin (beta 2m), a protein responsible for dialysis-related amyloidosis, to clarify the mechanism by which proteins form either amyloid fibrils or amorphous aggregates. Whenultrasonication was used to accelerate the spontaneous fibrillation of beta 2m at pH 2.0, the effects observed depended on ultrasonic power; although stronger ultrasonic power effectively accelerated fibrillation, excessively strong ultrasonic power decreased the amount of fibrils formed, as monitored by thioflavin T fluorescence. An analysis of the products formed indicated that excessively strong ultrasonic power generated fibrillar aggregates that retained beta-structures but without high efficiency as seeds. On the other hand, when the spontaneous fibrillation of beta 2m was induced at higher concentrations of NaCl at pH 2.0 with stirring, amorphous aggregates became more dominant than amyloid fibrils. These apparent complexities in fibrillation were explained comprehensively by a competitive mechanism in which supersaturation-limited reactions competed with supersaturation-unlimited reactions. We link the kinetics of protein aggregation and a conformational phase diagram, in which supersaturation played important roles.	[Adachi, Masayuki; So, Masatomo; Goto, Yuji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Sakurai, Kazumasa] Kinki Univ, Inst Adv Technol, High Pressure Prot Res Ctr, Wakayama 6496493, Japan; [Kardos, Jozsef] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary; [Kardos, Jozsef] Eotvos Lorand Univ, MTA ELTE NAP B Neuroimmunol Res Grp, H-1117 Budapest, Hungary	Osaka University; Kindai University (Kinki University); Eotvos Lorand University; Eotvos Lorand University	Goto, Y (corresponding author), Osaka Univ, Inst Prot Res, Yamadaoka 3-2, Suita, Osaka 5650871, Japan.	ygoto@protein.osaka-u.ac.jp	Kardos, József/J-1035-2017	Kardos, József/0000-0002-2135-2932; So, Masatomo/0000-0002-4815-4995	Japanese Ministry of Education, Culture, Sports, Science, and Technology; Hungarian National Research, Development and Innovation Office [KTIA_NAP_13-2-2014-0017]; Grants-in-Aid for Scientific Research [15K14458] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hungarian National Research, Development and Innovation Office; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japanese Ministry of Education, Culture, Sports, Science, and Technology and performed under the International Collaborative Research Program of Institute for Protein Research, Osaka University. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Hungarian National Research, Development and Innovation Office (KTIA_NAP_13-2-2014-0017).	Arosio P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033372; Bemporad F, 2012, CHEM BIOL, V19, P315, DOI 10.1016/j.chembiol.2012.02.003; Bouchard M, 2000, PROTEIN SCI, V9, P1960, DOI 10.1110/ps.9.10.1960; Bramanti E, 2013, J PHYS CHEM B, V117, P13816, DOI 10.1021/jp4079986; Chatani E, 2009, P NATL ACAD SCI USA, V106, P11119, DOI 10.1073/pnas.0901422106; Chiba T, 2003, J BIOL CHEM, V278, P47016, DOI 10.1074/jbc.M304473200; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Ciryam P, 2013, CELL REP, V5, P781, DOI 10.1016/j.celrep.2013.09.043; Dusa A, 2006, BIOCHEMISTRY-US, V45, P2752, DOI 10.1021/bi051426z; EATON WA, 1987, BLOOD, V70, P1245; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Giehm L, 2010, ANAL BIOCHEM, V400, P270, DOI 10.1016/j.ab.2010.02.001; Gosal WS, 2005, J MOL BIOL, V351, P850, DOI 10.1016/j.jmb.2005.06.040; GOTO Y, 1989, BIOCHEMISTRY-US, V28, P945, DOI 10.1021/bi00429a004; Hall D, 2015, FEBS LETT, V589, P672, DOI 10.1016/j.febslet.2015.01.032; HOFRICHTER J, 1976, P NATL ACAD SCI USA, V73, P3035, DOI 10.1073/pnas.73.9.3035; Hong DP, 2006, BIOCHEMISTRY-US, V45, P9342, DOI 10.1021/bi0604936; Ikenoue T, 2014, P NATL ACAD SCI USA, V111, P6654, DOI 10.1073/pnas.1322602111; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kardos J, 2005, BBA-PROTEINS PROTEOM, V1753, P108, DOI 10.1016/j.bbapap.2005.08.013; Kardos J, 2004, J BIOL CHEM, V279, P55308, DOI 10.1074/jbc.M409677200; Kitayama H, 2013, BBA-PROTEINS PROTEOM, V1834, P2640, DOI 10.1016/j.bbapap.2013.09.016; Korevaar PA, 2012, NATURE, V481, P492, DOI 10.1038/nature10720; Lin YX, 2014, LANGMUIR, V30, P1845, DOI 10.1021/la403100h; Miti T, 2015, BIOMACROMOLECULES, V16, P326, DOI 10.1021/bm501521r; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Muta H, 2014, J BIOL CHEM, V289, P18228, DOI 10.1074/jbc.M114.566950; Nymeyer H, 1998, P NATL ACAD SCI USA, V95, P5921, DOI 10.1073/pnas.95.11.5921; Ohhashi Y, 2005, J BIOL CHEM, V280, P32843, DOI 10.1074/jbc.M506501200; Platt GW, 2008, J MOL BIOL, V378, P251, DOI 10.1016/j.jmb.2008.01.092; Raman B, 2005, BIOCHEMISTRY-US, V44, P1288, DOI 10.1021/bi048029t; Sasahara K, 2008, BIOCHEMISTRY-US, V47, P2650, DOI 10.1021/bi701968g; Sasahara K, 2007, J MOL BIOL, V372, P981, DOI 10.1016/j.jmb.2007.06.088; Sipe JD, 2014, AMYLOID, V21, P221, DOI 10.3109/13506129.2014.964858; So M, 2011, J MOL BIOL, V412, P568, DOI 10.1016/j.jmb.2011.07.069; Souillac PO, 2002, J BIOL CHEM, V277, P12666, DOI 10.1074/jbc.M109229200; Tycko R, 2013, ACCOUNTS CHEM RES, V46, P1487, DOI 10.1021/ar300282r; Umemoto A, 2014, J BIOL CHEM, V289, P27290, DOI 10.1074/jbc.M114.569814; Uversky VN, 2009, CURR PROTEIN PEPT SC, V10, P483, DOI 10.2174/138920309789351921; Wetzel R, 2006, ACCOUNTS CHEM RES, V39, P671, DOI 10.1021/ar050069h; Wolynes PG, 2005, PHILOS T R SOC A, V363, P453, DOI 10.1098/rsta.2004.1502; Yagi H, 2015, BBA-PROTEINS PROTEOM, V1854, P209, DOI 10.1016/j.bbapap.2014.12.014; Yagi H, 2013, BBA-PROTEINS PROTEOM, V1834, P2480, DOI 10.1016/j.bbapap.2013.08.013; Yamaguchi K, 2012, PROTEIN SCI, V21, P38, DOI 10.1002/pro.755; Yoshimura Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.07HA01; Yoshimura Y, 2012, P NATL ACAD SCI USA, V109, P14446, DOI 10.1073/pnas.1208228109	46	47	47	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					18134	18145		10.1074/jbc.M115.648139	http://dx.doi.org/10.1074/jbc.M115.648139			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26063798	Green Published, hybrid			2022-12-26	WOS:000358511700044
J	Almeida, I; Soares, SC; Castelo-Branco, M				Almeida, Ines; Soares, Sandra C.; Castelo-Branco, Miguel			The Distinct Role of the Amygdala, Superior Colliculus and Pulvinar in Processing of Central and Peripheral Snakes	PLOS ONE			English	Article							RIGHT-HEMISPHERE DOMINANCE; RAPID DETECTION; FACIAL EXPRESSIONS; EMOTIONAL STIMULI; EVOLVED MODULE; NEURAL SYSTEMS; BASAL GANGLIA; EYE-MOVEMENT; ATTENTION; FEAR	Introduction Visual processing of ecologically relevant stimuli involves a central bias for stimuli demanding detailed processing (e.g., faces), whereas peripheral object processing is based on coarse identification. Fast detection of animal shapes holding a significant phylogenetic value, such as snakes, may benefit from peripheral vision. The amygdala together with the pulvinar and the superior colliculus are implicated in an ongoing debate regarding their role in automatic and deliberate spatial processing of threat signals. Methods Here we tested twenty healthy participants in an fMRI task, and investigated the role of spatial demands (the main effect of central vs. peripheral vision) in the processing of fear-relevant ecological features. We controlled for stimulus dependence using true or false snakes; snake shapes or snake faces and for task constraints (implicit or explicit). The main idea justifying this double task is that amygdala and superior colliculus are involved in both automatic and controlled processes. Moreover the explicit/implicit instruction in the task with respect to emotion is not necessarily equivalent to explicit vs. implicit in the sense of endogenous vs. exogenous attention, or controlled vs. automatic processes. Results We found that stimulus-driven processing led to increased amygdala responses specifically to true snake shapes presented in the centre or in the peripheral left hemifield (right hemisphere). Importantly, the superior colliculus showed significantly biased and explicit central responses to snake-related stimuli. Moreover, the pulvinar, which also contains foveal representations, also showed strong central responses, extending the results of a recent single cell pulvinar study in monkeys. Similar hemispheric specialization was found across structures: increased amygdala responses occurred to true snake shapes presented to the right hemisphere, with this pattern being closely followed by the superior colliculus and the pulvinar. Conclusion These results show that subcortical structures containing foveal representations such as the amygdala, pulvinar and superior colliculus play distinct roles in the central and peripheral processing of snake shapes. Our findings suggest multiple phylogenetic fingerprints in the responses of subcortical structures to fear-relevant stimuli.	[Almeida, Ines; Soares, Sandra C.; Castelo-Branco, Miguel] Univ Coimbra, Fac Med, IBILI, Coimbra, Portugal; [Soares, Sandra C.] Univ Aveiro, Dept Educ, P-3800 Aveiro, Portugal	Universidade de Coimbra; Universidade de Aveiro	Castelo-Branco, M (corresponding author), Univ Coimbra, Fac Med, IBILI, Coimbra, Portugal.	mcbranco@fmed.uc.pt	Castelo-Branco, Miguel/F-3866-2019; Almeida, Ines A. T./U-9150-2017; Soares, Sandra C./K-5576-2013	Castelo-Branco, Miguel/0000-0003-4364-6373; Almeida, Ines A. T./0000-0003-0230-3075; Soares, Sandra C./0000-0002-0346-7840	Portuguese Foundation for Science and Technology (FCT) [PEst-C/SAU/UI3282/2013, CENTRO-07-ST24-FEDER-00205, FP7-HEALTH-2013-INNOVATION-1-602186, SFRH/BD/35973/2007]; Bial Foundation [132/133-2013]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); Bial Foundation(Bial Foundation)	This work was supported by grants of the Portuguese Foundation for Science and Technology (FCT) [PEst-C/SAU/UI3282/2013, CENTRO-07-ST24-FEDER-00205, FP7-HEALTH-2013-INNOVATION-1-602186, SFRH/BD/35973/2007 to I.A.] and the Bial Foundation [132/133-2013]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Almeida I, 2013, NEUROPSYCHOLOGIA, V51, P2120, DOI 10.1016/j.neuropsychologia.2013.07.007; Andrew R. J., 2002, COMP LATERALIZATION, P95; Arend I, 2008, PROG BRAIN RES, V171, P475, DOI 10.1016/S0079-6123(08)00669-9; Atkinson AP, 2013, EMOT REV, V5, P30, DOI 10.1177/1754073912457226; Baas D, 2004, BRAIN RES REV, V45, P96, DOI 10.1016/j.brainresrev.2004.02.004; Balderston NL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063220; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Bisazza A, 1998, NEUROSCI BIOBEHAV R, V22, P411, DOI 10.1016/S0149-7634(97)00050-X; Bishop SJ, 2004, J NEUROSCI, V24, P10364, DOI 10.1523/JNEUROSCI.2550-04.2004; Calvo MG, 2005, J EXP PSYCHOL HUMAN, V31, P502, DOI 10.1037/0096-1523.31.3.502; Canli T, 1998, NEUROREPORT, V9, P3233, DOI 10.1097/00001756-199810050-00019; Carretie L, 2014, COGN AFFECT BEHAV NE, V14, P1228, DOI 10.3758/s13415-014-0270-2; Carretie L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037082; Chica AB, 2013, BEHAV BRAIN RES, V237, P107, DOI 10.1016/j.bbr.2012.09.027; COOK M, 1989, J ABNORM PSYCHOL, V98, P448, DOI 10.1037/0021-843X.98.4.448; Corbetta M, 2002, J COGNITIVE NEUROSCI, V14, P508, DOI 10.1162/089892902317362029; Courtney CG, 2010, INT J PSYCHOPHYSIOL, V78, P107, DOI 10.1016/j.ijpsycho.2010.06.028; Critchley H, 2000, HUM BRAIN MAPP, V9, P93, DOI 10.1002/(SICI)1097-0193(200002)9:2<93::AID-HBM4>3.3.CO;2-Q; Davidson RJ, 2000, BIOL PSYCHIAT, V47, P85, DOI 10.1016/S0006-3223(99)00222-X; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Fischer J, 2009, HUM BRAIN MAPP, V30, P101, DOI 10.1002/hbm.20485; FREDRIKSON M, 1993, PSYCHOPHYSIOLOGY, V30, P126; Grieve KL, 2000, TRENDS NEUROSCI, V23, P35, DOI 10.1016/S0166-2236(99)01482-4; Grosbras MN, 2005, HUM BRAIN MAPP, V25, P140, DOI 10.1002/hbm.20145; Habel U, 2007, NEUROPSYCHOLOGIA, V45, P2369, DOI 10.1016/j.neuropsychologia.2007.01.023; Hamame CM, 2014, NEUROIMAGE, V95, P276, DOI 10.1016/j.neuroimage.2014.03.025; HEILMAN KM, 1980, NEUROLOGY, V30, P327, DOI 10.1212/WNL.30.3.327; Huijding J, 2011, EMOTION, V11, P666, DOI 10.1037/a0022996; Isbell L. A., 2009, FRUIT TREE SERPENT W; Isbell LA, 2006, J HUM EVOL, V51, P1, DOI 10.1016/j.jhevol.2005.12.012; Juttner M, 2000, EUR J NEUROSCI, V12, P353, DOI 10.1046/j.1460-9568.2000.00907.x; Kanwisher N, 2001, NAT NEUROSCI, V4, P455, DOI 10.1038/87399; Kennedy DP, 2010, NEUROPSYCHOLOGIA, V48, P3392, DOI 10.1016/j.neuropsychologia.2010.06.025; Killgore WDS, 2007, SOC COGN AFFECT NEUR, V2, P240, DOI 10.1093/scan/nsm020; KLORMAN R, 1974, BEHAV THER, V5, P401, DOI 10.1016/S0005-7894(74)80008-0; LeDoux J.E., 2008, HDB EMOTIONS, P159; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lerner Y, 2006, NEUROIMAGE, V33, P169, DOI 10.1016/j.neuroimage.2006.06.026; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; Liddell BJ, 2005, NEUROIMAGE, V24, P235, DOI 10.1016/j.neuroimage.2004.08.016; Liu LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009790; Lobue V, 2014, EMOTION, V14, P816, DOI 10.1037/a0035869; Lori NF, 2002, NMR BIOMED, V15, P493, DOI 10.1002/nbm.779; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; MERCKELBACH H, 1989, ACTA PSYCHOL, V70, P147, DOI 10.1016/0001-6918(89)90017-6; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; Morawetz C, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00226; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Morris JS, 2002, NEUROIMAGE, V17, P214, DOI 10.1006/nimg.2002.1220; MUNOZ DP, 1992, J NEUROPHYSIOL, V67, P1000, DOI 10.1152/jn.1992.67.4.1000; Ohman A, 2005, PSYCHONEUROENDOCRINO, V30, P953, DOI 10.1016/j.psyneuen.2005.03.019; Ohman A, 2003, CURR DIR PSYCHOL SCI, V12, P5, DOI 10.1111/1467-8721.01211; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Ohman A, 2007, PHYSIOL BEHAV, V92, P180, DOI 10.1016/j.physbeh.2007.05.057; Ohman A, 2012, J COGN PSYCHOL, V24, P17, DOI 10.1080/20445911.2011.629603; Padmala S, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00064; Palermo R, 2007, NEUROPSYCHOLOGIA, V45, P75, DOI 10.1016/j.neuropsychologia.2006.04.025; Peelen MV, 2007, SOC COGN AFFECT NEUR, V2, P274, DOI 10.1093/scan/nsm023; Penkunas MJ, 2013, J EXP CHILD PSYCHOL, V114, P522, DOI 10.1016/j.jecp.2012.10.001; Pessoa L, 2003, J NEUROSCI, V23, P3990; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Pierrot-Deseilligny C, 2004, CURR OPIN NEUROL, V17, P17, DOI 10.1097/00019052-200402000-00005; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Provost F., 1997, Proceedings of the Third International Conference on Knowledge Discovery and Data Mining, P43; Rigoulot S, 2008, BRAIN TOPOGR, V20, P216, DOI 10.1007/s10548-008-0050-9; Rinck M, 2006, J ABNORM PSYCHOL, V115, P231, DOI 10.1037/0021-843X.115.2.231; Rohner JC, 2002, COGNITION EMOTION, V16, P837, DOI 10.1080/02699930143000572; Rolls ET, 2007, NEUROPSYCHOLOGIA, V45, P124, DOI 10.1016/j.neuropsychologia.2006.04.019; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Sayette MA, 2010, NICOTINE TOB RES, V12, P1068, DOI 10.1093/ntr/ntq159; Schneider KA, 2005, J NEUROPHYSIOL, V94, P2491, DOI 10.1152/jn.00288.2005; Shipp S, 2003, PHILOS T R SOC B, V358, P1605, DOI 10.1098/rstb.2002.1213; Shulman GL, 2010, J NEUROSCI, V30, P3640, DOI 10.1523/JNEUROSCI.4085-09.2010; Siman-Tov T, 2007, J NEUROSCI, V27, P11271, DOI 10.1523/JNEUROSCI.0599-07.2007; Siman-Tov T, 2009, J COGNITIVE NEUROSCI, V21, P1782, DOI 10.1162/jocn.2009.21120; Siniscalchi M, 2010, BEHAV BRAIN RES, V208, P516, DOI 10.1016/j.bbr.2009.12.042; Soares SC, 2013, PSYCH J, V2, P11, DOI 10.1002/pchj.18; Soares SC, 2012, EVOL PSYCHOL-US, V10, P187, DOI 10.1177/147470491201000202; Spence S, 1996, PSYCHOPHYSIOLOGY, V33, P112, DOI 10.1111/j.1469-8986.1996.tb02115.x; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Stefanacci L, 2002, J COMP NEUROL, V451, P301, DOI 10.1002/cne.10339; Strasburger H, 2011, J VISION, V11, DOI 10.1167/11.5.13; Tamietto M, 2012, CURR BIOL, V22, P1449, DOI 10.1016/j.cub.2012.06.006; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; Thorpe SJ, 2001, EUR J NEUROSCI, V14, P869, DOI 10.1046/j.0953-816x.2001.01717.x; Vallortigara G, 1998, NEUROREPORT, V9, P3341, DOI 10.1097/00001756-199810050-00035; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105; van Asselen M, 2012, J INT NEUROPSYCH SOC, V18, P689, DOI 10.1017/S1355617712000288; van Asselen M, 2009, NEUROPSYCHOLOGIA, V47, P1269, DOI 10.1016/j.neuropsychologia.2009.01.008; van Asselen M, 2009, ATTEN PERCEPT PSYCHO, V71, P76, DOI 10.3758/APP.71.1.76; Van Le Q, 2013, P NATL ACAD SCI USA, V110, P19000, DOI 10.1073/pnas.1312648110; Villeneuve MY, 2012, EUR J NEUROSCI, V36, P2849, DOI 10.1111/j.1460-9568.2012.08205.x; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Ward R, 2007, NEUROPSYCHOLOGIA, V45, P1973, DOI 10.1016/j.neuropsychologia.2006.09.017; Whalen PJ, 2004, SCIENCE, V306, P2061, DOI 10.1126/science.1103617; White B.J., 2011, OXFORD HDB EYE MOVEM, P195, DOI [10.1093/oxfordhb/9780199539789.013.0011, DOI 10.1093/OXFORDHB/9780199539789.013.0011]	98	43	43	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129949	10.1371/journal.pone.0129949	http://dx.doi.org/10.1371/journal.pone.0129949			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26075614	gold, Green Published, Green Submitted			2022-12-26	WOS:000356329900118
J	Hinriksdottir, G; Tryggvadottir, A; Olafsdottir, AS; Arngrimsson, SA				Hinriksdottir, Gunnhildur; Tryggvadottir, Agusta; Olafsdottir, Anna Sigriour; Arngrimsson, Sigurbjoern Arni			Fatness but Not Fitness Relative to the Fat-Free Mass Is Related to C-Reactive Protein in 18 Year-Old Adolescents	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE RISK; LOW-GRADE INFLAMMATION; PHYSICAL-ACTIVITY; AEROBIC POWER; WEIGHT-LOSS; TRENDS; INTERVENTION; CHILDHOOD; EXERCISE; MARKER	Introduction The interaction between fatness, fitness, and C-reactive protein (CRP) in adolescents is not well characterized but may be important to prevent low grade inflammation. The purpose of this study was to assess the relationship between adiposity, different expressions of fitness, and CRP in late adolescence using direct measures of fitness and fatness. Methods Anthropometric measurements were taken on 245 eighteen-year-old participants (116 girls). Fasting CRP, glucose, and insulin were measured and homeostatic model assessment (HOMA) calculated. Body composition was estimated via dual energy X-ray absorptiometry. Fitness was assessed with maximal oxygen uptake (VO(2)max) during a treadmill test and also expressed relative to the fat-free mass (VO(2)max(FFM)). Results Prevalence of overweight/obesity based on body mass index (BMI) was 20.7% and 25.6% among girls and boys, respectively (p = 0.407), but 42.5% and 58.1% when based on body fat percentage (%fat, p = 0.015). Higher proportion of boys (81.3%) than girls (54.5%) were highly fit (p<0.001), but the percentage of girls with high levels of CRP was greater (12.1% vs 6.2%, p = 0.028). Adiposity, indicated with BMI, waist circumference, fat mass, android fat mass (aFM), or %fat, was positively associated with CRP independent of VO(2)max (r = 0.13-0.18, p<0.05) and VO(2)max(FFM) (r = 0.24-0.32, p<0.001). VO(2)max, was negatively associated with CRP independent only of BMI and waist circumference (r = -0.21, p = 0.001), but not % fat, fat mass or aFM (r = -0.08 to -0.12, p>0.05). VO(2)max(FFM) was unrelated to CRP with (r = -0.07 to -0.11, p>0.05) or without (r = -0.10, p = 0.142) adjustment for adiposity. Additional adjustment for HOMA did not change any of the relationships, although the coefficients were attenuated. Conclusions Fatness has a greater association with CRP than fitness in late adolescence. However, VO(2)max(FFM), which is truly independent of adiposity, is unrelated to CRP, indicating that the effects of fitness might be mediated via the fatness component embedded in fitness expressed relative to body mass.	[Hinriksdottir, Gunnhildur; Tryggvadottir, Agusta; Olafsdottir, Anna Sigriour; Arngrimsson, Sigurbjoern Arni] Univ Iceland, Ctr Sport & Hlth Sci, Laugarvatn, Iceland	University of Iceland	Hinriksdottir, G (corresponding author), Univ Iceland, Ctr Sport & Hlth Sci, Laugarvatn, Iceland.	ghinriks@hi.is	Olafsdottir, Anna/A-8804-2013	Olafsdottir, Anna/0000-0002-7258-1727	Ministry of Education Sports Fund; University of Iceland Research Fund	Ministry of Education Sports Fund; University of Iceland Research Fund	This work was supported by the Ministry of Education Sports Fund (no grant number) to SAA ASO, (http://en.rannis.is/funding/youth-sport/theicelandic-sport-fund/) and the University of Iceland Research Fund (no grant number) to SAA ASO. (http://sjodir.hi.is/node/16131) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdellaoui A, 2007, EUR J VASC ENDOVASC, V34, P18, DOI 10.1016/j.ejvs.2006.10.040; Arikawa AY, 2011, MED SCI SPORT EXER, V43, P1002, DOI 10.1249/MSS.0b013e3182059eda; Arsenault BJ, 2009, AM J CARDIOL, V104, P240, DOI 10.1016/j.amjcard.2009.03.027; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Barlow CE, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001354; Belalcazar LM, 2010, DIABETES CARE, V33, P2297, DOI 10.2337/dc10-0728; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Campbell KL, 2008, CANCER EPIDEM BIOMAR, V17, P1714, DOI 10.1158/1055-9965.EPI-08-0088; Church TS, 2010, MED SCI SPORT EXER, V42, P708, DOI 10.1249/MSS.0b013e3181c03a43; Duncan GE, 1997, MED SCI SPORT EXER, V29, P273, DOI 10.1097/00005768-199702000-00017; Dyrstad SM, 2012, SCAND J MED SCI SPOR, V22, P822, DOI 10.1111/j.1600-0838.2011.01315.x; Eisenmann JC, 2005, AM HEART J, V149, P46, DOI 10.1016/j.ahj.2004.07.016; Ekblom OB, 2011, ACTA PAEDIATR, V100, P565, DOI 10.1111/j.1651-2227.2010.02135.x; Friedenreich CM, 2012, CANCER PREV RES, V5, P98, DOI 10.1158/1940-6207.CAPR-11-0369; Gutin B, 2011, INT J PEDIAT, V2011, DOI 10.1155/2011/219268; Hamer M, 2007, PREV MED, V44, P3, DOI 10.1016/j.ypmed.2006.09.005; Hamer M, 2009, AM J CLIN NUTR, V89, P85, DOI 10.3945/ajcn.2008.26779; Huotan PRT, 2010, BRIT J SPORT MED, V44, P968, DOI 10.1136/bjsm.2008.055913; Isasi CR, 2003, PEDIATRICS, V111, P332, DOI 10.1542/peds.111.2.332; Johannsson E, 2006, INT J OBESITY, V30, P1265, DOI 10.1038/sj.ijo.0803253; LOHMAN TG, 1997, ACSMS HEALTH FIT J, V1, P30; Lucia A, 2006, INT J SPORTS MED, V27, P984, DOI 10.1055/s-2006-923833; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Martinez-Gomez D, 2010, INT J OBESITY, V34, P1501, DOI 10.1038/ijo.2010.114; Martinez-Gomez D, 2012, ATHEROSCLEROSIS, V221, P260, DOI 10.1016/j.atherosclerosis.2011.12.032; MCCONNELL TR, 1988, SPORTS MED, V5, P57, DOI 10.2165/00007256-198805010-00005; McMurray RG, 2011, ANN HUM BIOL, V38, P647, DOI 10.3109/03014460.2011.598561; McVean JJF, 2009, J PEDIATR ENDOCR MET, V22, P153; Nemet D, 2013, HORM RES PAEDIAT, V79, P325, DOI 10.1159/000348732; Ondrak KS, 2007, J ADOLESCENT HEALTH, V41, P146, DOI 10.1016/j.jadohealth.2007.03.008; Ortega FB, 2008, INT J OBESITY, V32, P1, DOI 10.1038/sj.ijo.0803774; Parrett AL, 2010, MED SCI SPORT EXER, V42, P1981, DOI 10.1249/MSS.0b013e3181e0355e; Puder JJ, 2011, INT J PEDIATR OBES, V6, pE297, DOI 10.3109/17477166.2010.533774; Radak Z, 2004, FASEB J, V18, P749, DOI 10.1096/fj.03-0509fje; Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C; Rietzschel E, 2012, BIOMARK MED, V6, P19, DOI [10.2217/BMM.11.108, 10.2217/bmm.11.108]; Ruiz JR, 2007, INT J OBESITY, V31, P1545, DOI 10.1038/sj.ijo.0803693; Skinner JS, 2003, MED SCI SPORT EXER, V35, P1908, DOI 10.1249/01.MSS.0000093607.57995.E3; Steingrimsdottir L, 2014, LAEKNABLADID, V100, P659, DOI 10.17992/lbl.2014.12.571; Stewart LK, 2010, MED SCI SPORT EXER, V42, P701, DOI 10.1249/MSS.0b013e3181c03a2b; Thompson W. R., 2009, ACSMS GUIDELINES EXE; Thorsson B, 2009, LAEKNABLADID, V95, P259; Tripathy D, 2003, DIABETES, V52, P2882, DOI 10.2337/diabetes.52.12.2882; Valentine RJ, 2009, MENOPAUSE, V16, P84, DOI 10.1097/gme.0b013e31817fcb8f; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3	46	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130597	10.1371/journal.pone.0130597	http://dx.doi.org/10.1371/journal.pone.0130597			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075745	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900182
J	Ligtenberg, MA; Cinar, O; Holmdahl, R; Mougiakakos, D; Kiessling, R				Ligtenberg, Maarten A.; Cinar, Ozcan; Holmdahl, Rikard; Mougiakakos, Dimitrios; Kiessling, Rolf			Methylcholanthrene-Induced Sarcomas Develop Independently from NOX2-Derived ROS	PLOS ONE			English	Article							REGULATORY T-CELLS; OXIDATIVE STRESS; SUPPRESSOR-CELLS; HYDROGEN-PEROXIDE; TUMOR-GROWTH; CANCER; INHIBITION; INFLAMMATION; APOPTOSIS; MODEL	Reactive oxygen species (ROS) produced by the inducible NADPH oxidase type 2 (NOX2) complex are essential for clearing certain infectious organisms but may also have a role in regulating inflammation and immune response. For example, ROS is involved in myeloid derived suppressor cell (MDSC)- and regulatory T cell (T-reg) mediated T- and NK-cell suppression. However, abundant ROS produced within the tumor microenvironment, or by the tumor itself may also yield oxidative stress, which can blunt anti-tumor immune responses as well as eventually leading to tumor toxicity. In this study we aimed to decipher the role of NOX2-derived ROS in a chemically (by methylcholanthrene (MCA)) induced sarcoma model. Superoxide production by NOX2 requires the p47(phox) (NCF1) subunit to organize the formation of the NOX2 complex on the cell membrane. Homozygous mutant mice (NCF1*(/)*) have a functional loss of their super oxide burst while heterozygous mice (NCF1*(/+)) retain this key function. Mice harboring either a homo- or a heterozygous mutation were injected intramuscularly with MCA to induce sarcoma formation. We found that NOX2 functionality does not determine tumor incidence in the tested MCA model. Comprehensive immune monitoring in tumor bearing mice showed that infiltrating immune cells experienced an increase in their oxidative state regardless of the NOX2 functionality. While MCA-induced sarcomas where characterized by a T-reg and MDSC accumulation, no significant differences could be found between NCF1*(/)* and NCF1*(/+) mice. Furthermore, infiltrating T cells showed an increase in effector-memory cell phenotype markers in both NCF1*(/)* and NCF1*(/+) mice. Tumors established from both NCF1*(/)* and NCF1*(/+) mice were tested for their in vitro proliferative capacity as well as their resistance to cisplatin and radiation therapy, with no differences being recorded. Overall our findings indicate that NOX2 activity does not play a key role in tumor development or immune cell infiltration in the chemically induced MCA sarcoma model.	[Ligtenberg, Maarten A.; Cinar, Ozcan; Kiessling, Rolf] Karolinska Inst, Canc Ctr Karolinska, Dept Pathol & Oncol, Stockholm, Sweden; [Holmdahl, Rikard] Karolinska Inst, Dept Med Biochem & Biophys, Div Med Inflammat Res, Stockholm, Sweden; [Mougiakakos, Dimitrios] Univ Erlangen Nurnberg, Dept Internal Med 5, Haematol & Oncol, Nurnberg, Germany	Karolinska Institutet; Karolinska Institutet; University of Erlangen Nuremberg	Kiessling, R (corresponding author), Karolinska Inst, Canc Ctr Karolinska, Dept Pathol & Oncol, Stockholm, Sweden.	rolf.kiessling@ki.se	Holmdahl, Rikard/AAI-7682-2020	ligtenberg, maarten/0000-0002-0020-1043; Cinar, Ozcan/0000-0001-5297-127X	Swedish Medical Research Council [K2011-66X-15387-07-3]; Swedish Cancer Society [12 0598]; Cancer Society of Stockholm [121103]; ALF-Project grant from Stockholm City Council [20110070]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Cancer Society(Swedish Cancer Society); Cancer Society of Stockholm; ALF-Project grant from Stockholm City Council	Research described here have been supported by grants to R.K. from The Swedish Medical Research Council (K2011-66X-15387-07-3 VR), The Swedish Cancer Society (12 0598 Cancerfonden), The Cancer Society of Stockholm (121103 Cancerforeningen, Radiumhemmets Forskningsfonder), ALF-Project grant from Stockholm City Council (20110070 ALF Medicin 2012).	ALFRED LJ, 1983, IMMUNOLOGY, V50, P207; Brandes RP, 2014, FREE RADICAL BIO MED, V76, P208, DOI 10.1016/j.freeradbiomed.2014.07.046; Corzo CA, 2009, J IMMUNOL, V182, P5693, DOI 10.4049/jimmunol.0900092; Delano MJ, 2007, J EXP MED, V204, P1463, DOI 10.1084/jem.20062602; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; DuPage M, 2015, EXPRESSION TUMOUR SP, V482, P405; FOLEY EJ, 1953, CANCER RES, V13, P835; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Highfill SL, 2014, SCI TRANSL MED, V6, DOI [10.1126/scitranslmed.3008639, DOI 10.1126/SCITRANSLMED.3008639]; Holmdahl R, 2013, ANTIOXID REDOX SIGN, V18, P1463, DOI 10.1089/ars.2012.4734; Horiguchi S, 1999, CANCER RES, V59, P2950; Hultqvist M, 2004, P NATL ACAD SCI USA, V101, P12646, DOI 10.1073/pnas.0403831101; INDROVA M, 1979, NEOPLASMA, V26, P405; Jitschin R, 2014, BLOOD, V123, P2663, DOI 10.1182/blood-2013-10-532200; Kelkka T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084148; Khong HT, 2002, NAT IMMUNOL, V3, P999, DOI 10.1038/ni1102-999; Kiessling R, 1999, CANCER IMMUNOL IMMUN, V48, P353, DOI 10.1007/s002620050586; Klaunig JE, 2010, TOXICOL PATHOL, V38, P96, DOI 10.1177/0192623309356453; KLEIN G, 1960, CANCER RES, V20, P1561; KONO K, 1995, CANCER RES, V55, P5648; Kono K, 1996, EUR J IMMUNOL, V26, P1308, DOI 10.1002/eji.1830260620; Kusmartsev S, 2004, J IMMUNOL, V172, P989, DOI 10.4049/jimmunol.172.2.989; Liu-Smith F, 2015, EXP DERMATOL, V24, P171, DOI 10.1111/exd.12559; Lu JP, 2010, PROSTATE CANCER P D, V13, P39, DOI 10.1038/pcan.2009.24; Mailloux AW, 2010, INT J CANCER, V127, P2598, DOI 10.1002/ijc.25281; Mak IWY, 2014, AM J TRANSL RES, V6, P114; Mao Y, 2014, J INTERN MED, V276, P154, DOI 10.1111/joim.12229; Maraldi T, 2009, FREE RADICAL RES, V43, P1111, DOI 10.1080/10715760903186132; Matsushita H, 2014, CANC EXOME ANAL REVE, V482, P400; Mehrotra S, 2009, ADV CANCER RES, V102, P197, DOI 10.1016/S0065-230X(09)02006-5; Milkovic L, 2014, CURR PHARM DESIGN, V20, P6529, DOI 10.2174/1381612820666140826152822; Mishra SK, 2013, MOL CELLS, V36, P219, DOI 10.1007/s10059-013-0050-9; Mittal D, 2014, CURR OPIN IMMUNOL, V27, P16, DOI 10.1016/j.coi.2014.01.004; Mougiakakos D, 2010, REGULATORY T CELLS C, P1; Mougiakakos D, 2009, BLOOD, V113, P3542, DOI 10.1182/blood-2008-09-181040; Ngiow SF, 2014, ONCOIMMUNOLOGY, V2; Nishigori C, 2004, ANTIOXID REDOX SIGN, V6, P561, DOI 10.1089/152308604773934314; Pagano G, 2014, OXIDATIVE MED CELLUL, V2014, P1; PREHN RT, 1957, J NATL CANCER I, V18, P769; Rao, 2010, INT J ONCOL, V37; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; ROSENAU W, 1966, J NATL CANCER I, V36, P825; Sareila O, 2011, ANTIOXID REDOX SIGNA; Sareila O, 2013, J LEUKOCYTE BIOL, V93, P427, DOI 10.1189/jlb.1211588; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Swann JB, 2008, P NATL ACAD SCI USA, V105, P652, DOI 10.1073/pnas.0708594105; Tawara I, 2002, JPN J CANCER RES, V93, P911, DOI 10.1111/j.1349-7006.2002.tb01337.x; Ushmorov A, 1999, CANCER RES, V59, P3527; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Zhang H, 2013, BLOOD, V122, P1105, DOI 10.1182/blood-2012-08-449413	50	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129786	10.1371/journal.pone.0129786	http://dx.doi.org/10.1371/journal.pone.0129786			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076008	Green Published, Green Submitted, gold			2022-12-26	WOS:000356329900103
J	Xu, LH; Mu, FF; Zhao, JH; He, Q; Cao, CL; Yang, H; Liu, Q; Liu, XH; Sun, SJ				Xu, Li-Hui; Mu, Fang-Fang; Zhao, Jian-Hong; He, Qiang; Cao, Cui-Li; Yang, Hui; Liu, Qi; Liu, Xue-Hui; Sun, Su-Ju			Lead Induces Apoptosis and Histone Hyperacetylation in Rat Cardiovascular Tissues	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; DEACETYLASE INHIBITOR; BLOOD-PRESSURE; NITRIC-OXIDE; INDUCED HYPERTENSION; DEPENDENT APOPTOSIS; LEUKEMIA-CELLS; MELANOMA-CELLS; VALPROIC ACID; EXPOSURE	Acute and chronic lead (Pb) exposure might cause hypertension and cardiovascular diseases. The purpose of this study was to evaluate the effects of early acute exposure to Pb on the cellular morphology, apoptosis, and proliferation in rats and to elucidate the early mechanisms involved in the development of Pb-induced hypertension. Very young Sprague-Dawley rats were allowed to drink 1% Pb acetate for 12 and 40 days. Western blot analysis indicated that the expression of proliferating cell nuclear antigen (PCNA) decreased in the tissues of the abdominal and thoracic aortas and increased in the cardiac tissue after 12 and 40 days of Pb exposure, respectively. Bax was upregulated and Bcl-2 was downregulated in vascular and cardiac tissues after 40 days of Pb exposure. In addition, an increase in caspase-3 activity was observed after 40 days of exposure to Pb. In terms of morphology, we found that the internal elastic lamina (IEL) of aorta lost the original curve and the diameter of cardiac cell was enlarged after 40 days. Furthermore, the exposure led to a marked increase in acetylated histone H3 levels in the aortas and cardiac tissue after 12 and 40 days, than that in the control group. These findings indicate that Pb might increase the level of histone acetylation and induce apoptosis in vascular and cardiac tissues. However, the mechanism involved need to be further investigated.	[Xu, Li-Hui] Hebei Med Univ, Dept Biochem & Mol Biol, Shijiazhuang 050017, Peoples R China; [Mu, Fang-Fang; Yang, Hui; Liu, Qi; Liu, Xue-Hui; Sun, Su-Ju] Hebei Med Univ, Coll Publ Hlth, Shijiazhuang 050017, Peoples R China; [Zhao, Jian-Hong; He, Qiang] Hebei Med Univ, Hosp 2, Shijiazhuang 050000, Peoples R China; [Cao, Cui-Li] Hebei Med Univ, Inst Basic Med, Neurobiol Lab, Shijiazhuang 050017, Peoples R China	Hebei Medical University; Hebei Medical University; Hebei Medical University; Hebei Medical University	Sun, SJ (corresponding author), Hebei Med Univ, Coll Publ Hlth, Shijiazhuang 050017, Peoples R China.	Sun_suju@163.com						Alghasham AA, 2011, INT J HEALTH SCI-IJH, V5, P19; Bagchi D, 2005, J INORG BIOCHEM, V99, P1155, DOI 10.1016/j.jinorgbio.2005.02.011; Ballew C, 1999, J PEDIATR-US, V134, P623, DOI 10.1016/S0022-3476(99)70250-7; Cao XBX, 2001, AM J RESP CELL MOL, V25, P562, DOI 10.1165/ajrcmb.25.5.4539; CARSIA RV, 1995, P SOC EXP BIOL MED, V210, P180; Doi S, 2004, MOL CANCER THER, V3, P1397; Duan H, 2005, MOL CELL BIOL, V25, P1608, DOI 10.1128/MCB.25.5.1608-1619.2005; Dursun N, 2005, BIOL TRACE ELEM RES, V104, P141, DOI 10.1385/BTER:104:2:141; Ethier AA, 2012, NEUROTOXICOLOGY, V33, P1075, DOI 10.1016/j.neuro.2012.05.010; Eum KD, 2014, ENVIRON HEALTH PERSP, V122, P229, DOI 10.1289/ehp.1206399; FUJIWARA Y, 1995, TOXICOLOGY, V98, P105, DOI 10.1016/0300-483X(94)02984-3; Gonick HC, 1997, HYPERTENSION, V30, P1487, DOI 10.1161/01.HYP.30.6.1487; Herold C, 2002, J HEPATOL, V36, P233, DOI 10.1016/S0168-8278(01)00257-4; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Hsieh J, 2005, CURR OPIN CELL BIOL, V17, P664, DOI 10.1016/j.ceb.2005.09.002; Huang PC, 2012, ENVIRON INT, V40, P88, DOI 10.1016/j.envint.2011.10.011; Kasten-Jolly J, 2011, J BIOCHEM MOL TOXIC, V25, P41, DOI 10.1002/jbt.20358; Krepela E, 2001, NEOPLASMA, V48, P332; Kwon SH, 2002, J BIOL CHEM, V277, P2073, DOI 10.1074/jbc.M106699200; Lockshin Richard A., 2005, Journal de la Societe de Biologie, V199, P169, DOI 10.1051/jbio:2005017; Martin D, 2006, AM J EPIDEMIOL, V163, P467, DOI 10.1093/aje/kwj060; Nash D, 2003, JAMA-J AM MED ASSOC, V289, P1523, DOI 10.1001/jama.289.12.1523; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Prozialeck WC, 2008, TOXICOL SCI, V102, P207, DOI 10.1093/toxsci/kfm263; Pulido MD, 2003, MUTAT RES-FUND MOL M, V533, P227, DOI 10.1016/j.mrfmmm.2003.07.015; Rossi-George A, 2011, NEUROTOXICOLOGY, V32, P83, DOI 10.1016/j.neuro.2010.09.004; Ryu JK, 2006, CANCER LETT, V237, P143, DOI 10.1016/j.canlet.2005.05.040; Sandow SL, 2009, J ANAT, V214, P258, DOI 10.1111/j.1469-7580.2008.01020.x; Shirsath N, 2013, LUNG CANCER, V82, P214, DOI 10.1016/j.lungcan.2013.08.010; Tang R, 2004, LEUKEMIA, V18, P1246, DOI 10.1038/sj.leu.2403390; Telisman S, 2004, AM J IND MED, V45, P446, DOI 10.1002/ajim.20006; Robles HV, 2007, HUM EXP TOXICOL, V26, P499, DOI 10.1177/0960327106077597; Vaziri ND, 1999, KIDNEY INT, V56, P1492, DOI 10.1046/j.1523-1755.1999.00670.x; Venza I, 2014, INT IMMUNOPHARMACOL, V21, P439, DOI 10.1016/j.intimp.2014.05.024; Venza M, 2015, TOXICOL IN VITRO, V29, P242, DOI 10.1016/j.tiv.2014.10.020; Venza M, 2014, CURR GENOMICS, V15, P420, DOI 10.2174/138920291506150106145932; Walsh K, 2000, CIRC RES, V87, P184, DOI 10.1161/01.RES.87.3.184; WEILER E, 1990, CLIN SCI, V79, P185, DOI 10.1042/cs0790185; Zeller I, 2010, ARTERIOSCL THROM VAS, V30, P1733, DOI 10.1161/ATVBAHA.110.211011; Zhang XD, 2004, MOL CANCER THER, V3, P425; Zuscik MJ, 2007, ENVIRON HEALTH PERSP, V115, P1276, DOI 10.1289/ehp.10028	41	17	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129091	10.1371/journal.pone.0129091	http://dx.doi.org/10.1371/journal.pone.0129091			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26075388	gold, Green Published, Green Submitted			2022-12-26	WOS:000356329900045
J	Yamasaki, T; Fujinaga, M; Yui, J; Wakizaka, H; Ohya, T; Nengaki, N; Ogawa, M; Ikoma, Y; Hatori, A; Xie, L; Kawamura, K; Zhang, MR				Yamasaki, Tomoteru; Fujinaga, Masayuki; Yui, Joji; Wakizaka, Hidekatsu; Ohya, Tomoyuki; Nengaki, Nobuki; Ogawa, Masanao; Ikoma, Yoko; Hatori, Akiko; Xie, Lin; Kawamura, Kazunori; Zhang, Ming-Rong			Improved Visualization and Specific Binding for Metabotropic Glutamate Receptor Subtype 1 (mGluR1) Using [C-11]ITMM with Ultra-High Specific Activity in Small-Animal PET	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; RAT-BRAIN; SIGNAL-TRANSDUCTION; IN-VITRO; LIGAND; TYPE-1; QUANTIFICATION; KINETICS; AFFINITY; DENSITY	Metabotropic glutamate receptor subtype 1 (mGluR1) is a crucial target in the development of new medications to treat central nervous system(CNS) disorders. Recently, we developed N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-4-[C-11]methoxy-N-methyl-benzamide ([C-11]ITMM) as a useful positron emission tomography (PET) probe for mGluR1 in clinical studies. Here, we aimed to improve visualization and threshold of specific binding for mGluR1 using [C-11] ITMM with ultra-high specific activity (SA) of > 3,500 GBq/mu mol in rat brains. A two-tissue compartment model indicated large differences between the two SAs in the constants k(3) and k(4), representing binding ability for mGluR1, while constants K-1 and k(2) showed no differences. The total distribution volume (V-T) values of conventional and ultra-high SA were 9.1 and 11.2 in the thalamus, 7.7 and 9.7 in the striatum, and 6.4 and 8.5 mL/cm(3) in the substantia nigra, respectively. The specific binding of [C-11] ITMM with ultra-high SA was significantly higher than the conventional SA, especially in the basal ganglia. Parametric PET images scaled with VT of the ultra-high SA clearly identified regional differences in the rat brain. In conclusion, PET studies using [C-11] ITMM with ultra-high SA could sufficiently improve visualization and specific binding for mGluR1, which could help further understanding for mGluR1 functions in CNS disorders.	[Yamasaki, Tomoteru; Fujinaga, Masayuki; Yui, Joji; Wakizaka, Hidekatsu; Ohya, Tomoyuki; Nengaki, Nobuki; Ogawa, Masanao; Ikoma, Yoko; Hatori, Akiko; Xie, Lin; Kawamura, Kazunori; Zhang, Ming-Rong] Natl Inst Radiol Sci, Mol Probe Program, Mol Imaging Ctr, Chiba 260, Japan	National Institutes for Quantum Science & Technology	Yamasaki, T (corresponding author), Natl Inst Radiol Sci, Mol Probe Program, Mol Imaging Ctr, Chiba 260, Japan.	yamato@nirs.go.jp		, Lin/0000-0002-6472-322X	National Institute of Radiological Sciences; cyclotron operation; radioisotope production; radiosynthesis	National Institute of Radiological Sciences; cyclotron operation; radioisotope production; radiosynthesis	We thank the staff at the National Institute of Radiological Sciences for their support with the cyclotron operation, radioisotope production, radiosynthesis, and animal experiments.	Akaike H., 1974, IEEE T AUTOMAT CONTR, V19, P8; ARAMORI I, 1992, NEURON, V8, P757, DOI 10.1016/0896-6273(92)90096-V; Cha JHJ, 1998, P NATL ACAD SCI USA, V95, P6480, DOI 10.1073/pnas.95.11.6480; De Vry J, 2001, EUR J PHARMACOL, V428, P203, DOI 10.1016/S0014-2999(01)01296-1; Di Matteo V, 2001, TRENDS PHARMACOL SCI, V22, P229, DOI 10.1016/S0165-6147(00)01688-6; Ferraguti F, 2008, PHARMACOL REV, V60, P536, DOI 10.1124/pr.108.000166; Francesconi A, 1998, J BIOL CHEM, V273, P5615, DOI 10.1074/jbc.273.10.5615; Fujimura Y, 2010, NUCL MED BIOL, V37, P831, DOI 10.1016/j.nucmedbio.2010.04.138; Fujinaga M, 2012, J NEUROCHEM, V121, P115, DOI 10.1111/j.1471-4159.2011.07348.x; Fujinaga M, 2012, J MED CHEM, V55, P2342, DOI 10.1021/jm201590g; Ginovart N, 2006, J CEREBR BLOOD F MET, V26, P330, DOI 10.1038/sj.jcbfm.9600197; Hermans E, 1998, NEUROPHARMACOLOGY, V37, P1645, DOI 10.1016/S0028-3908(98)00132-4; Hermans E, 2001, BIOCHEM J, V359, P465, DOI 10.1042/0264-6021:3590465; Hostetler ED, 2011, SYNAPSE, V65, P125, DOI 10.1002/syn.20826; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Kaneda K, 2005, EUR J NEUROSCI, V22, P3241, DOI 10.1111/j.1460-9568.2005.04488.x; Kawamura K, 2012, NUCL MED BIOL, V39, P199, DOI 10.1016/j.nucmedbio.2011.07.008; KEYES JW, 1995, J NUCL MED, V36, P1836; KOEPPE RA, 1991, J CEREBR BLOOD F MET, V11, P735, DOI 10.1038/jcbfm.1991.130; Kohara A, 2008, BRAIN RES, V1191, P168, DOI 10.1016/j.brainres.2007.11.035; Lesage A, 2010, EUR J PHARMACOL, V639, P2, DOI 10.1016/j.ejphar.2009.12.043; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Makarewicz D, 2006, NEUROCHEM INT, V48, P485, DOI 10.1016/j.neuint.2005.12.022; MINTUN MA, 1984, ANN NEUROL, V15, P217, DOI 10.1002/ana.410150302; Noguchi J, 2003, NUCL MED BIOL, V30, P335, DOI 10.1016/S0969-8051(02)00422-5; Noguchi J, 2008, NUCL MED BIOL, V35, P19, DOI 10.1016/j.nucmedbio.2007.09.009; Prabhakaran J, 2010, BIOORG MED CHEM LETT, V20, P3499, DOI 10.1016/j.bmcl.2010.04.146; Satoh A, 2009, BIOORG MED CHEM LETT, V19, P5464, DOI 10.1016/j.bmcl.2009.07.097; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Suhara T, 1999, INT J NEUROPSYCHOP, V2, P73, DOI 10.1017/S1461145799001431; SUZUKI K, 1985, INT J APPL RADIAT IS, V36, P971, DOI 10.1016/0020-708X(85)90258-3; Takei M, 2001, APPL RADIAT ISOTOPES, V55, P229, DOI 10.1016/S0969-8043(00)00392-4; Toyohara J, 2013, J NUCL MED, V54, P1302, DOI 10.2967/jnumed.113.119891; Toyohara J, 2013, NUCL MED BIOL, V40, P214, DOI 10.1016/j.nucmedbio.2012.11.008; Yamasaki T, 2014, AM J NUCL MED MOLEC, V4, P260; Yamasaki T, 2012, J NUCL MED, V53, P1601, DOI 10.2967/jnumed.112.105908; Yamasaki T, 2011, BIOORG MED CHEM LETT, V21, P2998, DOI 10.1016/j.bmcl.2011.03.046; Yanamoto K, 2010, NUCL MED BIOL, V37, P615, DOI 10.1016/j.nucmedbio.2010.03.002; Yui J, 2013, STROKE, V44, P2567, DOI 10.1161/STROKEAHA.113.001178; Yui J, 2011, NEUROIMAGE, V54, P123, DOI 10.1016/j.neuroimage.2010.08.010	40	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130006	10.1371/journal.pone.0130006	http://dx.doi.org/10.1371/journal.pone.0130006			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076143	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900122
J	Blondel, M; Onogi, A; Iwata, H; Ueda, N				Blondel, Mathieu; Onogi, Akio; Iwata, Hiroyoshi; Ueda, Naonori			A Ranking Approach to Genomic Selection	PLOS ONE			English	Article							QUANTITATIVE TRAITS; RIDGE-REGRESSION; GENOMEWIDE SELECTION; VARIABLE SELECTION; BAYESIAN LASSO; COMPLEX TRAITS; PREDICTION; ASSOCIATION; EFFICIENCY; INFERENCE	Background Genomic selection (GS) is a recent selective breeding method which uses predictive models based on whole-genome molecular markers. Until now, existing studies formulated GS as the problem of modeling an individual's breeding value for a particular trait of interest, i.e., as a regression problem. To assess predictive accuracy of the model, the Pearson correlation between observed and predicted trait values was used. Contributions In this paper, we propose to formulate GS as the problem of ranking individuals according to their breeding value. Our proposed framework allows us to employ machine learning methods for ranking which had previously not been considered in the GS literature. To assess ranking accuracy of a model, we introduce a new measure originating from the information retrieval literature called normalized discounted cumulative gain (NDCG). NDCG rewards more strongly models which assign a high rank to individuals with high breeding value. Therefore, NDCG reflects a prerequisite objective in selective breeding: accurate selection of individuals with high breeding value. Results We conducted a comparison of 10 existing regression methods and 3 new ranking methods on 6 datasets, consisting of 4 plant species and 25 traits. Our experimental results suggest that tree-based ensemble methods including McRank, Random Forests and Gradient Boosting Regression Trees achieve excellent ranking accuracy. RKHS regression and RankSVM also achieve good accuracy when used with an RBF kernel. Traditional regression methods such as Bayesian lasso, wBSR and BayesC were found less suitable for ranking. Pearson correlation was found to correlate poorly with NDCG. Our study suggests two important messages. First, ranking methods are a promising research direction in GS. Second, NDCG can be a useful evaluation measure for GS.	[Blondel, Mathieu; Ueda, Naonori] NTT Commun Sci Labs, Kyoto, Japan; [Onogi, Akio; Iwata, Hiroyoshi] Univ Tokyo, Tokyo, Japan	Nippon Telegraph & Telephone Corporation; University of Tokyo	Iwata, H (corresponding author), Univ Tokyo, Tokyo, Japan.	aiwata@mail.ecc.u-tokyo.ac.jp			FIRST (funding program for world-leading R&D on science and technology) program; NTT Communication Science Laboratories;  [26.10661]; Grants-in-Aid for Scientific Research [25252002] Funding Source: KAKEN	FIRST (funding program for world-leading R&D on science and technology) program; NTT Communication Science Laboratories; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	MB was funded by the FIRST (funding program for world-leading R&D on science and technology) program (http://www.jst.go.jp/first/english/en-about-us/). AO received grant-in-aid for Japan Society for the Promotion of Science (JSPS) (http://www.jsps.go.jp/english/index.html, grant 26.10661). HI and NU did not receive specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NTT Communication Science Laboratories provided support in the form of salaries for authors MB and NU, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Bernardo R, 2007, CROP SCI, V47, P1082, DOI 10.2135/cropsci2006.11.0690; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Buitinck L., 2013, ECML PKDD WORKSH LAN, DOI DOI 10.48550/ARXIV.1309.0238; Burges C.J., 2005, P ICML, DOI DOI 10.1145/1102351.1102363; Burges C. J. C, 2010, MSRTR201082; Carbonetto P, 2012, BAYESIAN ANAL, V7, P73, DOI 10.1214/12-BA703; Chapelle O., 2011, JMLR P TRACK, P1; Cossock D, 2008, IEEE T INFORM THEORY, V54, P5140, DOI 10.1109/TIT.2008.929939; Crossa J, 2010, GENETICS, V186, P713, DOI 10.1534/genetics.110.118521; de los Campos G, 2009, GENETICS, V182, P375, DOI 10.1534/genetics.109.101501; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Falconer DS, 1981, INTRODUCTION TO QUAN; Freund Y, 2004, J MACH LEARN RES, V4, P933, DOI 10.1162/1532443041827916; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; GEORGE EI, 1993, J AM STAT ASSOC, V88, P881, DOI 10.2307/2290777; Gianola D, 2008, GENETICS, V178, P2289, DOI 10.1534/genetics.107.084285; Goddard ME, 2007, J ANIM BREED GENET, V124, P323, DOI 10.1111/j.1439-0388.2007.00702.x; Gonzalez-Recio O, 2008, GENETICS, V178, P2305, DOI 10.1534/genetics.107.084293; Gupta PK, 2005, PLANT MOL BIOL, V57, P461, DOI 10.1007/s11103-005-0257-z; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hayashi Takeshi, 2010, BMC Genet, V11, P3, DOI 10.1186/1471-2156-11-3; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Hayes BJ, 2013, TRENDS GENET, V29, P206, DOI 10.1016/j.tig.2012.11.009; Herbrich R, 2000, ADV NEUR IN, P115; Heslot N, 2012, CROP SCI, V52, P146, DOI 10.2135/cropsci2011.06.0297; Hofheinz N, 2014, G3-GENES GENOM GENET, V4, P539, DOI 10.1534/g3.113.010025; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Jarvelin K, 2000, P 23 ANN INT ACM SIG, P41; Kendall M. G., 1938, NEW MEASURE RANK COR; Kumar GR, 2010, BIOTECHNOL ADV, V28, P451, DOI 10.1016/j.biotechadv.2010.02.007; Kuo TM, 2014, PROCEEDINGS OF SIAM; Lee CP, 2014, NEURAL COMPUT, V26, P781, DOI 10.1162/NECO_a_00571; Li H, 2011, IEICE T INF SYST, VE94D, P1854, DOI 10.1587/transinf.E94.D.1854; LI P, 2008, ADV NEURAL INFORM PR, V20, P897; Li ZT, 2012, GENETICS, V190, P231, DOI 10.1534/genetics.111.134866; LIU DC, 1989, MATH PROGRAM, V45, P503, DOI 10.1007/BF01589116; Liu T.-Y., 2009, FOUND TRENDS INF RET, V3, P225, DOI [DOI 10.1561/1500000016, DOI 10.1007/978-3-642-14267-3]; Lorenzana RE, 2009, THEOR APPL GENET, V120, P151, DOI 10.1007/s00122-009-1166-3; Loudet O, 2002, THEOR APPL GENET, V104, P1173, DOI 10.1007/s00122-001-0825-9; Louppe G., 2014, ARXIV; Luan T, 2009, GENETICS, V183, P1119, DOI 10.1534/genetics.109.107391; Meuwissen THE, 2001, GENETICS, V157, P1819; Mutshinda CM, 2010, GENETICS, V186, P1067, DOI 10.1534/genetics.110.119586; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Perez-Rodriguez P, 2012, G3-GENES GENOM GENET, V2, P1595, DOI 10.1534/g3.112.003665; Piepho HP, 2009, CROP SCI, V49, P1165, DOI 10.2135/cropsci2008.10.0595; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Scholkopf B, 2001, LECT NOTES ARTIF INT, V2111, P416, DOI 10.1007/3-540-44581-1_27; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wahba G, 1990, SPLINE MODELS FOR OB, V59; Wu Q., 2008, MSRTR2008109; Yi NJ, 2008, GENETICS, V179, P1045, DOI 10.1534/genetics.107.085589; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhao KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010780	58	25	25	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128570	10.1371/journal.pone.0128570	http://dx.doi.org/10.1371/journal.pone.0128570			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068103	Green Submitted, Green Published, gold			2022-12-26	WOS:000356327000019
J	Han, P; Liu, SB; Zhang, MT; Zhao, J; Wang, YQ; Wu, GC; Mi, WL				Han, Ping; Liu, Shenbin; Zhang, Mengting; Zhao, Jing; Wang, Yanqing; Wu, Gencheng; Mi, Wenli			Inhibition of Spinal Interlukin-33/ST2 Signaling and Downstream ERK and JNK Pathways in Electroacupuncture Analgesia in Formalin Mice	PLOS ONE			English	Article							INDUCED INFLAMMATORY PAIN; ADJUNCTIVE THERAPY; ANTI-HYPERALGESIA; CONTROLLED-TRIAL; ACUPUNCTURE; RATS; INTERLEUKIN-33; MODEL; IL-33; INVOLVEMENT	Although acupuncture is widely used to manage pain, it remains highly controversial, largely due to the lack of a clear mechanism for its benefits. Here, we investigated the role of IL-33, a novel interleukin (IL)-1 family member, and its receptor ST2 in the analgesic effects of electroacupuncture (EA) on formalin-induced inflammatory pain. The results showed that 1) EA stimulation of ipsilateral Zusanli (ST 36) and Yanglingquan (GB 34) acupoints for 30 min remarkably suppressed the two phases of formalin-induced spontaneous pain; 2) subcutaneous or intrathecal administration of recombinant IL-33 (rIL-33) significantly inhibited the analgesic effect of EA, whereas the ST2 antibody potentiated EA analgesia in formalin mice; 3) EA treatment decreased the up-regulation of IL-33 and ST2 protein following formalin injection; and 4) the suppression of the formalin-induced expression of spinal phosphorylated ERK and JNK induced by EA treatment was significantly attenuated following subcutaneous rIL-33 delivery, and was further decreased by the ST2 antibody. These data suggest that EA alleviates formalin-induced inflammatory pain, at least partially, by inhibiting of spinal IL-33/ST2 signaling and the downstream ERK and JNK pathways.	[Han, Ping; Liu, Shenbin; Zhang, Mengting; Zhao, Jing; Wang, Yanqing; Wu, Gencheng; Mi, Wenli] Fudan Univ, Dept Integrat Med & Neurobiol, Collaborat Innovat Ctr Brain Sci, Sch Basic Med Sci,State Key Lab Med Neurobiol,Ins, Shanghai 200433, Peoples R China; [Han, Ping] Shanghai Jiao Tong Univ, Med X Res Inst, Neurosci & Neuroengn Ctr, Shanghai 200030, Peoples R China	Fudan University; Shanghai Jiao Tong University	Mi, WL (corresponding author), Fudan Univ, Dept Integrat Med & Neurobiol, Collaborat Innovat Ctr Brain Sci, Sch Basic Med Sci,State Key Lab Med Neurobiol,Ins, Shanghai 200433, Peoples R China.	wenlimi@fudan.edu.cn	Mi, Wenli/P-5541-2019; Han, Ping/GYD-5588-2022	Han, Ping/0000-0001-7945-2613	National Key Basic Research Program of China [2013CB531906]; National Natural Science Foundation of China [31000495, 81171045, 81371247, 81473749]; National Natural Science Foundation of Shanghai [15ZR1402800]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Shanghai	This work was supported by the National Key Basic Research Program of China (2013CB531906), the National Natural Science Foundation of China (31000495, 81171045, 81371247, and 81473749) and the National Natural Science Foundation of Shanghai (15ZR1402800).	Andre R, 2005, J NEUROCHEM, V95, P324, DOI 10.1111/j.1471-4159.2005.03364.x; Berman BM, 2004, ANN INTERN MED, V141, P901, DOI 10.7326/0003-4819-141-12-200412210-00006; Chang KH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/324039; Chen XY, 2013, J PAIN, V14, P1310, DOI 10.1016/j.jpain.2013.05.011; Choi SS, 2006, BRAIN RES, V1108, P28, DOI 10.1016/j.brainres.2006.06.048; Crown ED, 2012, EXP NEUROL, V234, P330, DOI 10.1016/j.expneurol.2011.10.019; Du Jing, 2008, Zhen Ci Yan Jiu, V33, P37; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; Fang JQ, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-13; Funakoshi-Tago M, 2011, CELL SIGNAL, V23, P363, DOI 10.1016/j.cellsig.2010.10.006; Goldman N, 2010, NAT NEUROSCI, V13, P883, DOI 10.1038/nn.2562; Han JS, 2003, TRENDS NEUROSCI, V26, P17, DOI 10.1016/S0166-2236(02)00006-1; Han P, 2013, NEUROSCIENCE, V241, P59, DOI 10.1016/j.neuroscience.2013.03.019; Han P, 2011, NEUROSCI BULL, V27, P351, DOI 10.1007/s12264-011-1025-5; Ji RR, 2009, BRAIN RES REV, V60, P135, DOI 10.1016/j.brainresrev.2008.12.011; Jiang HR, 2012, EUR J IMMUNOL, V42, P1804, DOI 10.1002/eji.201141947; Kakkar R, 2008, NAT REV DRUG DISCOV, V7, P827, DOI 10.1038/nrd2660; Lee JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073948; Leung L, 2012, J ACUPUNCT MERIDIAN, V5, P261, DOI 10.1016/j.jams.2012.07.017; Magro DAC, 2013, BRAZ J MED BIOL RES, V46, P601, DOI 10.1590/1414-431X20132894; Mao-Ying QL, 2006, EUR J PAIN, V10, P689, DOI 10.1016/j.ejpain.2005.11.001; Martin MU, 2013, SEMIN IMMUNOL, V25, P449, DOI 10.1016/j.smim.2013.10.006; Mavrommatis CI, 2012, PAIN, V153, P1720, DOI 10.1016/j.pain.2012.05.005; Mi WL, 2008, BRAIN RES BULL, V77, P98, DOI 10.1016/j.brainresbull.2008.04.008; Mi WL, 2011, J PAIN, V12, P974, DOI 10.1016/j.jpain.2011.03.002; Miller AM, 2011, PHARMACOL THERAPEUT, V131, P179, DOI 10.1016/j.pharmthera.2011.02.005; Park JY, 2014, J PAIN; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Song MJ, 2009, BRAIN RES BULL, V78, P335, DOI 10.1016/j.brainresbull.2008.10.009; Su TF, 2012, EUR J PAIN, V16, P624, DOI 10.1002/j.1532-2149.2011.00055.x; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Vas J, 2012, PAIN, V153, P1883, DOI 10.1016/j.pain.2012.05.033; Verri WA, 2008, P NATL ACAD SCI USA, V105, P2723, DOI 10.1073/pnas.0712116105; Vickers AJ, 2012, ARCH INTERN MED, V172, P1444, DOI 10.1001/archinternmed.2012.3654; Villarreal DO, 2014, CURR OPIN IMMUNOL, V28, P102, DOI 10.1016/j.coi.2014.03.004; Yasuoka S, 2011, BRAIN RES, V1385, P8, DOI 10.1016/j.brainres.2011.02.045; Yi M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-61; Zarpelon AC, 2013, BRIT J PHARMACOL, V169, P90, DOI 10.1111/bph.12110; Zhang RX, 2014, ANESTHESIOLOGY, V120, P482, DOI 10.1097/ALN.0000000000000101; Zhao J, 2013, NEUROSCIENCE, V253, P172, DOI 10.1016/j.neuroscience.2013.08.026; Zhao ZQ, 2008, PROG NEUROBIOL, V85, P355, DOI 10.1016/j.pneurobio.2008.05.004; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	42	24	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129576	10.1371/journal.pone.0129576	http://dx.doi.org/10.1371/journal.pone.0129576			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26067287	Green Published, gold, Green Submitted			2022-12-26	WOS:000356327000092
J	Lopez-Panades, E; Gavis, ER; Casacuberta, E				Lopez-Panades, Elisenda; Gavis, Elizabeth R.; Casacuberta, Elena			Specific Localization of the Drosophila Telomere Transposon Proteins and RNAs, Give Insight in Their Behavior, Control and Telomere Biology in This Organism	PLOS ONE			English	Article							HET-A; GAG PROTEINS; RETROTRANSPOSONS; ELEMENTS; MELANOGASTER; CHROMOSOME; EXPRESSION; PATHWAY; MAINTENANCE; ELONGATION	Drosophila telomeres constitute a remarkable exception to the telomerase mechanism. Although maintaining the same cytological and functional properties as telomerase maintain telomeres, Drosophila telomeres embed the telomere retrotransposons whose specific and highly regulated terminal transposition maintains the appropriate telomere length in this organism. Nevertheless, our current understanding of how the mechanism of the retrotransposon telomere works and which features are shared with the telomerase system is very limited. We report for the first time a detailed study of the localization of the main components that constitute the telomeres in Drosophila, HeT-A and TART RNAs and proteins. Our results in wild type and mutant strains reveal localizations of HeT-A Gag and TART Pol that give insight in the behavior of the telomere retrotransposons and their control. We find that TART Pol and HeT-A Gag only co-localize at the telomeres during the interphase of cells undergoing mitotic cycles. In addition, unexpected protein and RNA localizations with a well-defined pattern in cells such as the ovarian border cells and nurse cells, suggest possible strategies for the telomere transposons to reach the oocyte, and/or additional functions that might be important for the correct development of the organism. Finally, we have been able to visualize the telomere RNAs at different ovarian stages of development in wild type and mutant lines, demonstrating their presence in spite of being tightly regulated by the piRNA mechanism.	[Lopez-Panades, Elisenda; Casacuberta, Elena] CSIC, UPF, Inst Evolutionary Biol, Dept Comparat Genom, Barcelona, Spain; [Gavis, Elizabeth R.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Princeton University	Casacuberta, E (corresponding author), CSIC, UPF, Inst Evolutionary Biol, Dept Comparat Genom, Barcelona, Spain.	elena.casacuberta@ibe.upf-csic.es		Casacuberta, Elena/0000-0002-8203-8357; Gavis, Elizabeth/0000-0003-0251-0760	Spanish Ministry of Science and Innovation [BFU2009-08318/BMC]; National Institutes of Health [R01GM067758]; Ruth Lee Kennedy (Fulbright) Fellowship; EMBO short term Fellowship; Journal Cell Science traveling Fellowship; Spanish Society of Genetics traveling fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061107, R01GM067758] Funding Source: NIH RePORTER	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth Lee Kennedy (Fulbright) Fellowship; EMBO short term Fellowship(European Molecular Biology Organization (EMBO)); Journal Cell Science traveling Fellowship; Spanish Society of Genetics traveling fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the Spanish Ministry of Science and Innovation BFU2009-08318/BMC to EC. A National Institutes of Health grant R01GM067758 to ERG. EL-P acknowledges the following short term Fellowships: Ruth Lee Kennedy (Fulbright), EMBO short term, Journal Cell Science traveling Fellowship, and the Spanish Society of Genetics traveling fellowship.	Arbouzova NI, 2006, CURR BIOL, V16, P80, DOI 10.1016/j.cub.2005.11.033; Becalska AN, 2009, DEVELOPMENT, V136, P2493, DOI 10.1242/dev.032391; Bilder D, 2012, DEV CELL, V22, P12, DOI 10.1016/j.devcel.2011.12.003; Casacuberta E, 2005, CYTOGENET GENOME RES, V110, P152, DOI 10.1159/000084947; Casacuberta E, 2003, P NATL ACAD SCI USA, V100, P14091, DOI 10.1073/pnas.1936193100; Casacuberta E, 2003, P NATL ACAD SCI USA, V100, P3363, DOI 10.1073/pnas.0230353100; Casacuberta E, 2002, GENETICS, V161, P1113; Casacuberta E, 2007, P NATL ACAD SCI USA, V104, P8391, DOI 10.1073/pnas.0702566104; Cenci G, 2003, NAT CELL BIOL, V5, P82, DOI 10.1038/ncb902; Chambeyron S, 2008, P NATL ACAD SCI USA, V105, P14964, DOI 10.1073/pnas.0805943105; Choi JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040010; Danilevskaya ON, 1999, MOL CELL BIOL, V19, P873; Dufourt J, 2014, NUCLEIC ACIDS RES, V42, P2512, DOI 10.1093/nar/gkt1184; George JA, 2003, GENETICS, V163, P625; George JA, 2006, GENOME RES, V16, P1231, DOI 10.1101/gr.5348806; Gonzalez J, 2012, METHODS MOL BIOL, V855, P361, DOI 10.1007/978-1-61779-582-4_13; Guzzardo PM, 2013, CURR OPIN GENET DEV, V23, P44, DOI 10.1016/j.gde.2012.12.003; Homem CCF, 2012, DEVELOPMENT, V139, P4297, DOI 10.1242/dev.080515; Hrdlickova R, 2012, MOL CELL BIOL, V32, P4283, DOI 10.1128/MCB.00550-12; Montell DJ, 2012, NAT REV MOL CELL BIO, V13, P631, DOI 10.1038/nrm3433; Ovando-Roche P, 2014, STEM CELLS, V32, P2111, DOI 10.1002/stem.1725; Pardue ML, 2008, FLY, V2, P101, DOI 10.4161/fly.6393; Petit N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037405; Pickett HA, 2012, CELL CYCLE, V11, P1309, DOI 10.4161/cc.19632; Pineyro D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-573; Rashkova S, 2003, J VIROL, V77, P6376, DOI 10.1128/JVI.77.11.6376-6384.2003; Rashkova S, 2002, J CELL BIOL, V159, P397, DOI 10.1083/jcb.200205039; Sahara K, 1999, CHROMOSOME RES, V7, P449, DOI 10.1023/A:1009297729547; Savitsky M, 2006, GENE DEV, V20, P345, DOI 10.1101/gad.370206; SCHUPBACH T, 1991, GENETICS, V129, P1119; Shpiz Sergey, 2011, Mob Genet Elements, V1, P274; Shpiz S, 2011, NUCLEIC ACIDS RES, V39, P8703, DOI 10.1093/nar/gkr552; Shpiz S, 2009, NUCLEIC ACIDS RES, V37, P268, DOI 10.1093/nar/gkn960; Silva-Sousa R, 2012, GENOME DYNAM, V7, P46, DOI 10.1159/000337127; Silva-Sousa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081543; Silva-Sousa R, 2013, MOBILE DNA-UK, V4, DOI 10.1186/1759-8753-4-18; Silva-Sousa R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003153; Siriaco GM, 2002, GENETICS, V160, P235; Veraksa A, 2005, DEV DYNAM, V232, P827, DOI 10.1002/dvdy.20272; Villasante A, 2007, GENOME RES, V17, P1909, DOI 10.1101/gr.6365107; Wesolowska N, 2013, GENETICS, V195, P381, DOI 10.1534/genetics.113.155408; Wong LH, 2010, EPIGENOMICS-UK, V2, P639, DOI [10.2217/epi.10.49, 10.2217/EPI.10.49]; Wu XD, 2008, SEMIN CELL DEV BIOL, V19, P271, DOI 10.1016/j.semcdb.2008.01.004; Ye J, 2014, NAT REV GENET, V15, P491, DOI 10.1038/nrg3743; Zhang L, 2014, EMBO J, V33, P1148, DOI 10.1002/embj.201386940; Zhao ZR, 2014, J CELL PHYSIOL, V229, P1323, DOI 10.1002/jcp.24537	46	7	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0128573	10.1371/journal.pone.0128573	http://dx.doi.org/10.1371/journal.pone.0128573			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26068215	Green Submitted, Green Published, gold			2022-12-26	WOS:000356327000020
J	Taniguti, LM; Schaker, PDC; Benevenuto, J; Peters, LP; Carvalho, G; Palhares, A; Quecine, MC; Nunes, FRS; Kmit, MCP; Wai, A; Hausner, G; Aitken, KS; Berkman, PJ; Fraser, JA; Moolhuijzen, PM; Coutinho, LL; Creste, S; Vieira, MLC; Kitajima, JP; Monteiro-Vitorello, CB				Taniguti, Lucas M.; Schaker, Patricia D. C.; Benevenuto, Juliana; Peters, Leila P.; Carvalho, Giselle; Palhares, Alessandra; Quecine, Maria C.; Nunes, Filipe R. S.; Kmit, Maria C. P.; Wai, Alvan; Hausner, Georg; Aitken, Karen S.; Berkman, Paul J.; Fraser, James A.; Moolhuijzen, Paula M.; Coutinho, Luiz L.; Creste, Silvana; Vieira, Maria L. C.; Kitajima, Joao P.; Monteiro-Vitorello, Claudia B.			Complete Genome Sequence of Sporisorium scitamineum and Biotrophic Interaction Transcriptome with Sugarcane	PLOS ONE			English	Article							RICE BLAST FUNGUS; MATING-TYPE LOCUS; BOTRYTIS-CINEREA; SMUT FUNGI; MITOCHONDRIAL GENOME; MOLECULAR PHYLOGENY; FILAMENTOUS GROWTH; SECRETOME ANALYSIS; VIRULENCE FACTORS; CELL-WALL	Sporisorium scitamineum is a biotrophic fungus responsible for the sugarcane smut, a worldwide spread disease. This study provides the complete sequence of individual chromosomes of Sporisorium scitamineum from telomere to telomere achieved by a combination of PacBio long reads and Illumina short reads sequence data, as well as a draft sequence of a second fungal strain. Comparative analysis to previous available sequences of another strain detected few polymorphisms among the three genomes. The novel complete sequence described herein allowed us to identify and annotate extended subtelomeric regions, repetitive elements and the mitochondrial DNA sequence. The genome comprises 19,979,571 bases, 6,677 genes encoding proteins, 111 tRNAs and 3 assembled copies of rDNA, out of our estimated number of copies as 130. Chromosomal reorganizations were detected when comparing to sequences of S. reilianum, the closest smut relative, potentially influenced by repeats of transposable elements. Repetitive elements may have also directed the linkage of the two mating-type loci. The fungal transcriptome profiling from in vitro and from interaction with sugarcane at two time points (early infection and whip emergence) revealed that 13.5% of the genes were differentially expressed in planta and particular to each developmental stage. Among them are plant cell wall degrading enzymes, proteases, lipases, chitin modification and lignin degradation enzymes, sugar transporters and transcriptional factors. The fungus also modulates transcription of genes related to surviving against reactive oxygen species and other toxic metabolites produced by the plant. Previously described effectors in smut/plant interactions were detected but some new candidates are proposed. Ten genomic islands harboring some of the candidate genes unique to Sporisorium scitamineum were expressed only in planta. RNAseq data was also used to reassure gene predictions.	[Taniguti, Lucas M.; Schaker, Patricia D. C.; Benevenuto, Juliana; Peters, Leila P.; Carvalho, Giselle; Palhares, Alessandra; Quecine, Maria C.; Nunes, Filipe R. S.; Kmit, Maria C. P.; Coutinho, Luiz L.; Vieira, Maria L. C.; Monteiro-Vitorello, Claudia B.] Univ Sao Paulo, Coll Agr Luiz de Queiroz, BR-13400970 Sao Paulo, Brazil; [Wai, Alvan; Hausner, Georg] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada; [Aitken, Karen S.; Berkman, Paul J.] CSIRO Agr, Flagship, Queensland Biosci Precinct, St Lucia, Qld 4067, Australia; [Fraser, James A.] Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia; [Moolhuijzen, Paula M.] Murdoch Univ, Ctr Comparat Genom, Perth, WA, Australia; [Creste, Silvana] Ctr Avancado Pesquisa Tecnol Agronegocio Cana IAC, Sao Paulo, Brazil; [Kitajima, Joao P.] Mendel Anal Genom, BR-04013000 Sao Paulo, SP, Brazil	Universidade de Sao Paulo; University of Manitoba; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; Murdoch University	Monteiro-Vitorello, CB (corresponding author), Univ Sao Paulo, Coll Agr Luiz de Queiroz, Av Padua Dias 11,POB 9, BR-13400970 Sao Paulo, Brazil.	cbmontei@usp.br	Fraser, James A/B-4918-2012; Quecine, Maria C/B-8261-2016; Dayane Carvalho Schaker, Patricia/G-4268-2012; Hausner, Georg/X-5517-2019; aitken, karen/I-5817-2012; Carvalho, Giselle/AAO-9818-2020; Berkman, Paul/G-8678-2011; Coutinho, Luiz/P-5233-2019; Monteiro-Vitorello, Claudia B/F-2436-2012; Vieira, Maria Lucia Carneiro/D-1628-2012; Coutinho, Luiz L/C-8455-2012; Quecine, Maria/N-4478-2016	Fraser, James A/0000-0001-5724-5285; Dayane Carvalho Schaker, Patricia/0000-0002-1215-9735; aitken, karen/0000-0003-4372-0721; Carvalho, Giselle/0000-0001-5161-7340; Berkman, Paul/0000-0002-6523-4356; Coutinho, Luiz/0000-0002-7266-8881; Monteiro-Vitorello, Claudia B/0000-0002-1238-9354; Vieira, Maria Lucia Carneiro/0000-0003-0341-5714; Coutinho, Luiz L/0000-0002-7266-8881; Creste, Silvana/0000-0002-3315-3332; Taniguti, Lucas Mitsuo/0000-0002-2682-7343; Moolhuijzen, Paula/0000-0002-3502-7612; Peters, Leila Priscila/0000-0002-9469-5290; Quecine, Maria/0000-0002-9781-8479; Benevenuto, Juliana/0000-0002-4698-2738; Verdi, Maria/0000-0002-9524-941X	Brazilian institution FAPESP [2008/52074-0, 2010/05591-9, 2014/17034-8, 2013/25599-2, 2013/15014-7, 2014/21802-0, 2012/09524-0]; NSERC Discovery Grant	Brazilian institution FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	The authors acknowledge the support of the Brazilian institution FAPESP: grant numbers 2008/52074-0 and 2010/05591-9 (C.B.M.-V.); fellowships to L.M.T (2014/17034-8); P.D.C.S (2013/25599-2); L.P.P (2013/15014-7); J.B. (2014/21802-0); A.C.P. (2012/09524-0); and NSERC Discovery Grant (G.H.). Mendelics Analise Genomica also provided support in the form of a salary for author JPK. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander K, 1980, P C INT SOC SUG CAN; Arora DS, 2010, APPL BIOCHEM BIOTECH, V160, P1760, DOI 10.1007/s12010-009-8676-y; BAKKEREN G, 1994, P NATL ACAD SCI USA, V91, P7085, DOI 10.1073/pnas.91.15.7085; Bakkeren G, 2008, FUNGAL GENET BIOL, V45, pS15, DOI 10.1016/j.fgb.2008.04.005; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Bao ZR, 2002, GENOME RES, V12, P1269, DOI 10.1101/gr.88502; Barry JD, 1997, PARASITOL TODAY, V13, P212, DOI 10.1016/S0169-4758(97)01039-9; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BOLKER M, 1992, CELL, V68, P441, DOI 10.1016/0092-8674(92)90182-C; Brown NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033731; Bueno CRNC, 2010, INFECCAO SPORISORIUM; Cafarchia C, 2004, J CLIN MICROBIOL, V42, P4868, DOI 10.1128/JCM.42.10.4868-4869.2004; CALDWELL GA, 1995, MICROBIOL REV, V59, P406, DOI 10.1128/MMBR.59.3.406-422.1995; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; CLUTTERBUCK AJ, 1972, J GEN MICROBIOL, V70, P423, DOI 10.1099/00221287-70-3-423; Co O., 2008, Sugar Tech, V10, P341, DOI 10.1007/s12355-008-0060-7; Coleman JJ, 2011, MOL PLANT MICROBE IN, V24, P1482, DOI 10.1094/MPMI-05-11-0119; Comstock J.C., 2005, SUGARCANE SMUT DIS; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; de Oliveira JFNC, 2013, CARACTERIZACAO FISIO; Djamei A, 2011, NATURE, V478, P395, DOI 10.1038/nature10454; Doehlemann G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000290; Doidy J, 2012, TRENDS PLANT SCI, V17, P413, DOI 10.1016/j.tplants.2012.03.009; Donaldson ME, 2013, FUNGAL GENET BIOL, V58-59, P91, DOI 10.1016/j.fgb.2013.08.006; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Espino JJ, 2010, PROTEOMICS, V10, P3020, DOI 10.1002/pmic.201000037; Farman ML, 2007, FEMS MICROBIOL LETT, V273, P125, DOI 10.1111/j.1574-6968.2007.00812.x; Feldbrugge M, 2013, APPL MICROBIOL BIOT, V97, P3253, DOI 10.1007/s00253-013-4777-1; Fernandes I, 2014, FUNGAL BIOL-UK, V118, P516, DOI 10.1016/j.funbio.2014.04.006; Garnica DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067150; Gasic K., 2004, Plant Molecular Biology Reporter, V22, P437, DOI 10.1007/BF02772687; Gelfand Y, 2007, NUCLEIC ACIDS RES, V35, pD80, DOI 10.1093/nar/gkl1013; Goddard MR, 1999, P NATL ACAD SCI USA, V96, P13880, DOI 10.1073/pnas.96.24.13880; GOLD S, 1994, GENE DEV, V8, P2805, DOI 10.1101/gad.8.23.2805; Greenfield P, 2014, BIOINFORMATICS, V30, P2723, DOI 10.1093/bioinformatics/btu368; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hartmann HA, 1996, EMBO J, V15, P1632, DOI 10.1002/j.1460-2075.1996.tb00508.x; Harwood CS, 1996, ANNU REV MICROBIOL, V50, P553, DOI 10.1146/annurev.micro.50.1.553; Hausner G, 2012, ORGANELLE GENETICS: EVOLUTION OF ORGANELLE GENOMES AND GENE EXPRESSION, P329, DOI 10.1007/978-3-642-22380-8_13; Hegedusova E, 2014, CURR GENET, V60, P49, DOI 10.1007/s00294-013-0410-1; Hemetsberger C, 2015, NEW PHYTOL, V206, P1116, DOI 10.1111/nph.13304; Hemetsberger C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002684; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kang SC, 1995, MOL PLANT MICROBE IN, V8, P939, DOI 10.1094/MPMI-8-0939; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kawahara Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049423; Kellner R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002436; Klose J, 2004, MOL MICROBIOL, V52, P823, DOI 10.1111/j.1365-2958.2004.04019.x; Koeck M, 2011, CELL MICROBIOL, V13, P1849, DOI 10.1111/j.1462-5822.2011.01665.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lang BF, 2007, TRENDS GENET, V23, P119, DOI 10.1016/j.tig.2007.01.006; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lao M, 2008, PLANT CELL REP, V27, P1103, DOI 10.1007/s00299-008-0524-y; Laurie JD, 2012, PLANT CELL, V24, P1733, DOI 10.1105/tpc.112.097261; LEATHAM GF, 1981, J GEN MICROBIOL, V125, P147; Leroch M, 2013, EUKARYOT CELL, V12, P614, DOI 10.1128/EC.00295-12; Levdansky Emma, 2008, Fungal Biology Reviews, V22, P85, DOI 10.1016/j.fbr.2008.08.001; Levis C, 1997, FEMS MICROBIOL LETT, V157, P267, DOI 10.1111/j.1574-6968.1997.tb12783.x; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Losada L, 2014, FEMS MICROBIOL LETT, V352, P165, DOI 10.1111/1574-6968.12387; Madhavi V, 2009, BIORESOURCES, V4, P1694; Mayer AM, 2002, PHYTOCHEMISTRY, V60, P551, DOI 10.1016/S0031-9422(02)00171-1; MCCLUSKEY K, 1990, MOL PLANT MICROBE IN, V3, P366, DOI 10.1094/MPMI-3-366; Meinhardt LW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-164; Mewes HW, 2011, NUCLEIC ACIDS RES, V39, pD220, DOI 10.1093/nar/gkq1157; Mueller O, 2008, FUNGAL GENET BIOL, V45, pS63, DOI 10.1016/j.fgb.2008.03.012; Nampally M, 2012, APPL ENVIRON MICROB, V78, P3114, DOI 10.1128/AEM.07506-11; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Connell RJ, 2012, NAT GENET, V44, P1060, DOI 10.1038/ng.2372; Okmen B, 2014, CURR OPIN PLANT BIOL, V20, P19, DOI 10.1016/j.pbi.2014.03.011; Padovan ACB, 2009, MED MYCOL, V47, P824, DOI 10.3109/13693780802669574; PAQUIN B, 1994, P NATL ACAD SCI USA, V91, P11807, DOI 10.1073/pnas.91.25.11807; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Peterson DG, 2000, J AGR GENOMICS; Pierleoni A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-392; Podobnik B, 2008, J MED CHEM, V51, P3480, DOI 10.1021/jm800030e; Que YA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080140; Que YX, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/160934; Que YX, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-996; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rabe F, 2013, MOL MICROBIOL, V89, P179, DOI 10.1111/mmi.12269; Raffaele S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-637; Ramesh Sundar E.L.B., 2012, BOTANY, P107; Rehmeyer C, 2006, NUCLEIC ACIDS RES, V34, P4685, DOI 10.1093/nar/gkl588; Roetzer A, 2011, FEMS MICROBIOL LETT, V314, P1, DOI 10.1111/j.1574-6968.2010.02102.x; Ruiz-Duenas FJ, 2009, MICROB BIOTECHNOL, V2, P164, DOI 10.1111/j.1751-7915.2008.00078.x; Salavirta H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097141; Santiago R, 2010, PAK J BOT, V42, P2867; Santos ASS, 2003, IX REUNIAO ITINERANT, P11; Saunders CW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002701; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schirawski J, 2005, EUKARYOT CELL, V4, P1317, DOI 10.1128/EC.4.8.1317-1327.2005; Schirawski J, 2010, SCIENCE, V330, P1546, DOI 10.1126/science.1195330; Schmidt SM, 2011, CURR OPIN PLANT BIOL, V14, P392, DOI 10.1016/j.pbi.2011.03.006; Sethuraman J, 2009, J MOL EVOL, V69, P372, DOI 10.1007/s00239-009-9291-9; Sharma R, 2014, GENOME BIOL EVOL, V6, P2034, DOI 10.1093/gbe/evu148; Singh N, 2005, PLANT CELL TISS ORG, V80, P259, DOI 10.1007/s11240-004-1017-5; Smit A, 1996, REPEATMASKER OPEN 30; Soanes DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002514; Soyer JL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004227; Stanke M, 2005, NUCLEIC ACIDS RES, V33, pW465, DOI 10.1093/nar/gki458; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; Stoll M, 2005, MYCOL RES, V109, P342, DOI 10.1017/S0953756204002229; Stoll M, 2003, CAN J BOT, V81, P976, DOI [10.1139/b03-094, 10.1139/B03-094]; SWEIGARD JA, 1995, PLANT CELL, V7, P1221, DOI 10.1105/tpc.7.8.1221; Thokoane L. N., 2001, Proceedings of the Annual Congress - South African Sugar Technologists' Association, P104; THURSTON CF, 1994, MICROBIOL-SGM, V140, P19, DOI 10.1099/13500872-140-1-19; Tian MY, 2007, PLANT PHYSIOL, V143, P364, DOI 10.1104/pp.106.090050; Tian MY, 2004, J BIOL CHEM, V279, P26370, DOI 10.1074/jbc.M400941200; Urban M, 1996, MOL GEN GENET, V250, P414; Verheye W, 2010, LAND USE LAND COVER; Verstrepen KJ, 2004, NAT REV MICROBIOL, V2, P533, DOI 10.1038/nrmicro927; Voigt CA, 2005, PLANT J, V42, P364, DOI 10.1111/j.1365-313X.2005.02377.x; Waclawovsky AJ, 2010, PLANT BIOTECHNOL J, V8, P263, DOI 10.1111/j.1467-7652.2009.00491.x; Wahl R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000303; Wessling R, 2012, FUNGAL GENET BIOL, V49, P470, DOI 10.1016/j.fgb.2012.04.001; Winnenburg R, 2008, NUCLEIC ACIDS RES, V36, pD572, DOI 10.1093/nar/gkm858; Wollenberg T, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004218; Wu C, 2009, GENETICS, V181, P1129, DOI 10.1534/genetics.107.084392; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhao ZT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-274	126	69	72	6	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2015	10	6							e0129318	10.1371/journal.pone.0129318	http://dx.doi.org/10.1371/journal.pone.0129318			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6GR	26065709	Green Submitted, Green Published, gold			2022-12-26	WOS:000356327000063
J	Je, IG; Kim, DS; Kim, SW; Lee, S; Lee, HS; Park, EK; Khang, D; Kim, SH				Je, In-Gyu; Kim, Duk-Sil; Kim, Sung-Wan; Lee, Soyoung; Lee, Hyun-Shik; Park, Eui Kyun; Khang, Dongwoo; Kim, Sang-Hyun			Tyrosol Suppresses Allergic Inflammation by Inhibiting the Activation of Phosphoinositide 3-Kinase in Mast Cells	PLOS ONE			English	Article							HISTAMINE-RELEASE; EFFECTOR; CALCIUM; ANAPHYLAXIS; MECHANISMS; IGE	Allergic diseases such as atopic dermatitis, rhinitis, asthma, and anaphylaxis are attractive research areas. Tyrosol (2-(4-hydroxyphenyl)ethanol) is a polyphenolic compound with diverse biological activities. In this study, we investigated whether tyrosol has anti-allergic inflammatory effects. Ovalbumin-induced active systemic anaphylaxis and immunoglobulin E-mediated passive cutaneous anaphylaxis models were used for the immediate-type allergic responses. Oral administration of tyrosol reduced the allergic symptoms of hypothermia and pigmentation in both animal models. Mast cells that secrete allergic mediators are key regulators on allergic inflammation. Tyrosol dose-dependently decreased mast cell degranulation and expression of inflammatory cytokines. Intracellular calcium levels and activation of inhibitor of kappa B kinase (IKK) regulate cytokine expression and degranulation. Tyrosol blocked calcium influx and phosphorylation of the IKK complex. To define the molecular target for tyrosol, various signaling proteins involved in mast cell activation such as Lyn, Syk, phosphoinositide 3-kinase (PI3K), and Akt were examined. Our results showed that PI3K could be a molecular target for tyrosol in mast cells. Taken together, these findings indicated that tyrosol has anti-allergic inflammatory effects by inhibiting the degranulation of mast cells and expression of inflammatory cytokines; these effects are mediated via PI3K. Therefore, we expect tyrosol become a potential therapeutic candidate for allergic inflammatory disorders.	[Je, In-Gyu; Lee, Soyoung; Kim, Sang-Hyun] Kyungpook Natl Univ, Sch Med, Dept Pharmacol, Daegu 700422, South Korea; [Kim, Duk-Sil; Kim, Sung-Wan] CHA Univ, CHA Gumi Med Ctr, Dept Thorac & Cardiovasc Surg, Gumi 730040, South Korea; [Lee, Hyun-Shik] Kyungpook Natl Univ, Sch Life Sci, Daegu 702701, South Korea; [Park, Eui Kyun] Kyungpook Natl Univ, Sch Dent, Dept Oral Pathol & Regenerat Med, Daegu 700412, South Korea; [Khang, Dongwoo] Gachon Univ, Sch Med, Dept Mol Med, Inchon 406840, South Korea	Kyungpook National University; Pochon Cha University; Kyungpook National University; Kyungpook National University; Gachon University	Kim, SH (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Pharmacol, Daegu 700422, South Korea.	shkim72@knu.ac.kr		Khang, Dongwoo/0000-0003-2353-8017	National Research Foundation of Korea - Korea government [2014R1A5A2009242, 2013R1A1A3009525]	National Research Foundation of Korea - Korea government(National Research Foundation of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea grant funded by the Korea government (2014R1A5A2009242 and 2013R1A1A3009525). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba Y, 2008, NAT IMMUNOL, V9, P81, DOI 10.1038/ni1546; Bae Y, 2011, TOXICOL APPL PHARM, V254, P56, DOI 10.1016/j.taap.2011.04.008; Beghdadi W, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00037; Bertelli AAE, 2002, ANN NY ACAD SCI, V957, P295, DOI 10.1111/j.1749-6632.2002.tb02929.x; Blank U, 2002, MOL IMMUNOL, V38, P1341, DOI 10.1016/S0161-5890(02)00085-8; Brandt Eric B, 2011, J Clin Cell Immunol, V2; Choi JK, 2014, AM J CHINESE MED, V42, P967, DOI 10.1142/S0192415X1450061X; Finkelman FD, 2005, J ALLERGY CLIN IMMUN, V115, P449, DOI 10.1016/j.jaci.2004.12.1125; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Galli SJ, 2010, EUR J IMMUNOL, V40, P1843, DOI 10.1002/eji.201040559; Ishikawa R, 2010, BIOCHEM BIOPH RES CO, V402, P742, DOI 10.1016/j.bbrc.2010.10.098; Je IG, 2015, EXP BIOL MED, V240, P631, DOI 10.1177/1535370214555663; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kambayashi T, 2007, J ALLERGY CLIN IMMUN, V119, P544, DOI 10.1016/j.jaci.2007.01.017; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Kim HH, 2014, TOXICOL APPL PHARM, V274, P455, DOI 10.1016/j.taap.2013.12.006; Kim HH, 2013, FOOD CHEM TOXICOL, V57, P209, DOI 10.1016/j.fct.2013.03.015; Kim SH, 2006, TOXICOL SCI, V91, P123, DOI 10.1093/toxsci/kfj063; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Krause K, 2012, CURR OPIN ALLERGY CL, V12, P477, DOI 10.1097/ACI.0b013e3283574d0c; Lecci RM, 2014, ANTI-CANCER AGENT ME, V14, P1363, DOI 10.2174/1871520614666140922121014; Li JX, 2013, ADV IMMUNOL, V119, P135, DOI 10.1016/B978-0-12-407707-2.00005-9; Lu J, 2013, FOOD CHEM TOXICOL, V62, P172, DOI 10.1016/j.fct.2013.08.031; Manikandan J, 2012, CELL MOL LIFE SCI, V69, P1917, DOI 10.1007/s00018-011-0886-0; Palmieri D, 2012, MICROVASC RES, V83, P281, DOI 10.1016/j.mvr.2012.02.010; Ribeiro J, 2014, J ETHNOPHARMACOL, V155, P1118, DOI 10.1016/j.jep.2014.06.041; Seo BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095588; Sismanopoulos N, 2012, CURR PHARM DESIGN, V18, P2261, DOI 10.2174/138161212800165997; Suzuki K, 2008, CELL, V134, P485, DOI 10.1016/j.cell.2008.05.050; Tanaka S, 2005, EUR J IMMUNOL, V35, P460, DOI 10.1002/eji.200425622; Tuck KL, 2002, J NUTR BIOCHEM, V13, P636, DOI 10.1016/S0955-2863(02)00229-2; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; WERSHIL BK, 1995, J IMMUNOL, V154, P1391	36	28	29	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129829	10.1371/journal.pone.0129829	http://dx.doi.org/10.1371/journal.pone.0129829			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068872	gold, Green Submitted, Green Published			2022-12-26	WOS:000356100900081
J	Kimura, T; Takahashi, S; Takahashi, I; Nishibuchi, I; Doi, Y; Kenjo, M; Murakami, Y; Honda, Y; Aikata, H; Chayama, K; Nagata, Y				Kimura, Tomoki; Takahashi, Shigeo; Takahashi, Ippei; Nishibuchi, Ikuno; Doi, Yoshiko; Kenjo, Masahiro; Murakami, Yuji; Honda, Yohji; Aikata, Hiroshi; Chayama, Kazuaki; Nagata, Yasushi			The Time Course of Dynamic Computed Tomographic Appearance of Radiation Injury to the Cirrhotic Liver Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma	PLOS ONE			English	Article							GD-EOB-DTPA; RADIOTHERAPY; CT; HEPATITIS; DISEASE	This study aimed to evaluate the dynamic computed tomographic (CT) appearance of focal radiation injury to cirrhotic liver tissue around the tumor following stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma (HCC). Seventy-seven patients with 92 HCCs were observed for >6 months. Sixty-four and 13 patients belonged to Child-Pugh class A and B, respectively. The median SBRT dose was 48 Gy/4fr. Dynamic CT scans were performed in non-enhanced, arterial, portal, and venous phases. The median follow-up period was 18 months. Dynamic CT appearances were classified into 3 types: type 1, hyperdensity in all enhanced phases; type 2, hypodensity in arterial and portal phases; type 3, isodensity in all enhanced phases. Half of the type 2 or 3 appearances significantly changed to type 1, particularly in patients belonging to Child-Pugh class A. After 3-6 months, Child-Pugh class B was a significant factor in type 3 patients. Thus, dynamic CT appearances were classified into 3 patterns and significantly changed over time into the enhancement group (type 1) in most patients belonging to Child-Pugh class A. Child-Pugh class B was a significant factor in the non-enhancement group (type 3).	[Kimura, Tomoki; Takahashi, Ippei; Nishibuchi, Ikuno; Doi, Yoshiko; Kenjo, Masahiro; Murakami, Yuji; Nagata, Yasushi] Hiroshima Univ, Grad Sch Biomed Sci, Dept Radiat Oncol, Hiroshima, Japan; [Takahashi, Shigeo] Kagawa Univ Hosp, Dept Radiat Oncol, Takamatsu, Kagawa, Japan; [Honda, Yohji; Aikata, Hiroshi; Chayama, Kazuaki] Hiroshima Univ, Grad Sch Biomed Sci, Div Frontier Med Sci, Dept Med & Mol Sci, Hiroshima, Japan	Hiroshima University; Kagawa University; Hiroshima University	Kimura, T (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Radiat Oncol, Hiroshima, Japan.	tkkimura@hiroshima-u.ac.jp	Chayama, Kazuaki/B-2493-2016	Chayama, Kazuaki/0000-0002-5530-5341; Takahashi, Shigeo/0000-0002-1043-3171	Ministry of Education, Culture, Sports, Science and Technology of Japan [22591385]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant no. 22591385).	Andolino DL, 2011, INT J RADIAT ONCOL, V81, pE447, DOI 10.1016/j.ijrobp.2011.04.011; Fukumitsu N, 2009, INT J RADIAT ONCOL, V74, P831, DOI 10.1016/j.ijrobp.2008.10.073; Guha C, 2011, SEMINARS RAD ONCOLOG, V21, P236; Hashimoto K, 2006, ONCOL REP, V16, P677; Herfarth KK, 2003, INT J RADIAT ONCOL, V57, P444, DOI 10.1016/S0360-3016(03)00586-8; Kato H, 2004, INT J RADIAT ONCOL, V59, P1468, DOI 10.1016/j.ijrobp.2004.01.032; Kimura T, 2004, INT J RADIAT ONCOL, V60, P1307, DOI 10.1016/j.ijrobp.2004.07.718; Kimura T, 2013, HEPATOL RES, V43, P717, DOI 10.1111/hepr.12007; LEEN E, 1993, GUT, V34, P554, DOI 10.1136/gut.34.4.554; Motosugi U, 2009, J MAGN RESON IMAGING, V30, P1042, DOI 10.1002/jmri.21956; OKUMURA T, 1994, J COMPUT ASSIST TOMO, V18, P821, DOI 10.1097/00004728-199409000-00025; Olsen CC, 2009, INT J RADIAT ONCOL, V73, P1414, DOI 10.1016/j.ijrobp.2008.07.032; REICHEN J, 1988, J CLIN INVEST, V82, P2069, DOI 10.1172/JCI113828; Sanuki N, 2014, INT J RADIAT ONCOL, V88, P306, DOI 10.1016/j.ijrobp.2013.10.045; Sanuki-Fujimoto N, 2010, BRIT J RADIOL, V83, P1063, DOI 10.1259/bjr/74105551; Sempoux C, 1997, HEPATOLOGY, V26, P128; Takeda A, 2008, HEPATOL RES, V38, P60, DOI 10.1111/j.1872-034X.2007.00084.x; UNGER EC, 1987, J COMPUT ASSIST TOMO, V11, P264, DOI 10.1097/00004728-198703000-00013; Willemart S, 2000, BRIT J RADIOL, V73, P544, DOI 10.1259/bjr.73.869.10884753; Wulf J, 2005, STEROTACTIC BODY RADIATION THERAPY, P39	20	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0125231	10.1371/journal.pone.0125231	http://dx.doi.org/10.1371/journal.pone.0125231			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067065	gold, Green Submitted, Green Published			2022-12-26	WOS:000356100900005
J	Maurya, DK; Henriques, T; Marini, M; Pedemonte, N; Galietta, LJV; Rock, JR; Harfe, BD; Menini, A				Maurya, Devendra Kumar; Henriques, Tiago; Marini, Monica; Pedemonte, Nicoletta; Galietta, Luis J. V.; Rock, Jason R.; Harfe, Brian D.; Menini, Anna			Development of the Olfactory Epithelium and Nasal Glands in TMEM16A(-/-) and TMEM16A(+/+) Mice	PLOS ONE			English	Article							ACTIVATED CHLORIDE CHANNEL; CA2+-ACTIVATED CL-CHANNEL; GLOBOSE BASAL-CELLS; ANOCTAMIN 1; TRANSMEMBRANE PROTEIN; MOUSE; EXPRESSION; ANO1; CANCER; MARKER	TMEM16A/ANO1 is a calcium-activated chloride channel expressed in several types of epithelia and involved in various physiological processes, including proliferation and development. During mouse embryonic development, the expression of TMEM16A in the olfactory epithelium is dynamic. TMEM16A is expressed at the apical surface of the entire olfactory epithelium at embryonic day E12.5 while from E16.5 its expression is restricted to a region near the transition zone with the respiratory epithelium. To investigate whether TMEM16A plays a role in the development of the mouse olfactory epithelium, we obtained the first immunohistochemistry study comparing the morphological properties of the olfactory epithelium and nasal glands in TMEM16A(-/-) and TMEM16A(+/+) littermate mice. A comparison between the expression of the olfactory marker protein and adenylyl cyclase III shows that genetic ablation of TMEM16A did not seem to affect the maturation of olfactory sensory neurons and their ciliary layer. As TMEM16A is expressed at the apical part of supporting cells and in their microvilli, we used ezrin and cytokeratin 8 as markers of microvilli and cell body of supporting cells, respectively, and found that morphology and development of supporting cells were similar in TMEM16A(-/-) and TMEM16A(+/+) littermate mice. The average number of supporting cells, olfactory sensory neurons, horizontal and globose basal cells were not significantly different in the two types of mice. Moreover, we also observed that the morphology of Bowman's glands, nasal septal glands and lateral nasal glands did not change in the absence of TMEM16A. Our results indicate that the development of mouse olfactory epithelium and nasal glands does not seem to be affected by the genetic ablation of TMEM16A.	[Maurya, Devendra Kumar; Henriques, Tiago; Menini, Anna] Scuola Int Super Studi Avanzati, SISSA, Lab Olfactory Transduct, Trieste, Italy; [Marini, Monica; Pedemonte, Nicoletta; Galietta, Luis J. V.] Ist Giannina Gaslini, I-16148 Genoa, Italy; [Rock, Jason R.] UCSF Sch Med, Dept Anat, San Francisco, CA USA; [Harfe, Brian D.] Univ Florida, Coll Med, Dept Mol Genet, Gainesville, FL USA; [Harfe, Brian D.] Univ Florida, Coll Med, Microbiol Genet Inst, Gainesville, FL USA	International School for Advanced Studies (SISSA); University of Genoa; IRCCS Istituto Giannina Gaslini; University of California System; University of California San Francisco; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Menini, A (corresponding author), Scuola Int Super Studi Avanzati, SISSA, Lab Olfactory Transduct, Trieste, Italy.	menini@sissa.it	Galietta, Luis JV/HCG-8692-2022; Henriques, Tiago/AAE-2951-2019; Maurya, Devendra Kumar/GZL-1112-2022; Pedemonte, Nicoletta/B-3607-2010	Henriques, Tiago/0000-0001-6075-2368; Maurya, Devendra Kumar/0000-0001-6052-4314; Pedemonte, Nicoletta/0000-0002-5161-1720; Menini, Anna/0000-0001-9304-0412; Galietta, Luis/0000-0001-8686-3461	Italian Ministry of Education, Universities, and Research (MIUR)	Italian Ministry of Education, Universities, and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This study was supported by a grant (to AM) from the Italian Ministry of Education, Universities, and Research (MIUR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablimit A, 2006, ARCH HISTOL CYTOL, V69, P1, DOI 10.1679/aohc.69.1; Ayoub C, 2010, BRIT J CANCER, V103, P715, DOI 10.1038/sj.bjc.6605823; Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; Britschgi A, 2013, P NATL ACAD SCI USA, V110, pE1026, DOI 10.1073/pnas.1217072110; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; CASANOVA L, 1995, J CELL SCI, V108, P811; Chen MF, 2014, J NEUROSCI, V34, P8268, DOI 10.1523/JNEUROSCI.0240-14.2014; Cho H, 2012, NAT NEUROSCI, V15, P1015, DOI 10.1038/nn.3111; Coulombe PA, 1993, CURR OPIN CELL BIOL, V5, P17, DOI 10.1016/S0955-0674(05)80004-3; CUSCHIERI A, 1975, J ANAT, V119, P277; Dal Col JA, 2007, DEVELOPMENT, V134, P2481, DOI 10.1242/dev.006346; Dauner K, 2012, CELL TISSUE RES, V347, P327, DOI 10.1007/s00441-012-1324-9; Dibattista M, 2012, J GEN PHYSIOL, V140, P3, DOI 10.1085/jgp.201210780; DRENCKHAHN D, 1988, J CELL BIOL, V107, P1037, DOI 10.1083/jcb.107.3.1037; Duran C, 2011, ACTA PHARMACOL SIN, V32, P685, DOI 10.1038/aps.2011.48; Espinosa I, 2008, AM J SURG PATHOL, V32, P210, DOI 10.1097/PAS.0b013e3181238cec; Farbman Albert I., 1994, Seminars in Cell Biology, V5, P3; Fletcher RB, 2011, NEURON, V72, P748, DOI 10.1016/j.neuron.2011.09.009; FRANKE WW, 1982, DIFFERENTIATION, V23, P43, DOI 10.1111/j.1432-0436.1982.tb01266.x; FRISCH D, 1967, AM J ANAT, V121, P87, DOI 10.1002/aja.1001210107; Galindo BE, 2005, INT J MOL MED, V16, P919; GETCHELL TV, 1984, PROG NEUROBIOL, V23, P317, DOI 10.1016/0301-0082(84)90008-X; Gokoffski KK, 2011, DEVELOPMENT, V138, P4131, DOI 10.1242/dev.065870; Gritli-Linde A, 2009, GENE EXPR PATTERNS, V9, P178, DOI 10.1016/j.gep.2008.11.002; Guo Z, 2010, J COMP NEUROL, V518, P4395, DOI 10.1002/cne.22463; HOLBROOK EH, 1995, J COMP NEUROL, V363, P129, DOI 10.1002/cne.903630111; Huang F, 2012, PHARMACOL REV, V64, P1, DOI 10.1124/pr.111.005009; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Huang X, 2006, GENE CHROMOSOME CANC, V45, P1058, DOI 10.1002/gcc.20371; Jang W, 2014, J COMP NEUROL, V522, P731, DOI 10.1002/cne.23470; Jang Y, 2014, CELL CALCIUM, V55, P355, DOI 10.1016/j.ceca.2014.02.006; Jeon JH, 2013, PLOS ONE, V6, P1, DOI DOI 10.1371/J0UR-NAL.P0NE.0067989; Jeon JH, 2011, CELL TISSUE RES, V345, P223, DOI 10.1007/s00441-011-1206-6; Kashyap MK, 2009, CANCER BIOL THER, V8, P36, DOI 10.4161/cbt.8.1.7090; KELLER A, 1975, J NEUROCHEM, V24, P1101, DOI 10.1111/j.1471-4159.1975.tb03883.x; Krolewski RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051737; Leung CT, 2007, NAT NEUROSCI, V10, P720, DOI 10.1038/nn1882; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; Maurya DK, 2014, DEV NEUROBIOL, V74, P657, DOI 10.1002/dneu.22159; Mazzone A, 2011, J BIOL CHEM, V286, P13393, DOI 10.1074/jbc.M110.196089; Mercer AJ, 2011, J NEUROPHYSIOL, V105, P321, DOI 10.1152/jn.00332.2010; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Ohta Y, 2000, ANN OTO RHINOL LARYN, V109, P1046, DOI 10.1177/000348940010901110; Ousingsawat J, 2009, J BIOL CHEM, V284, P28698, DOI 10.1074/jbc.M109.012120; Pedemonte N, 2014, PHYSIOL REV, V94, P419, DOI 10.1152/physrev.00039.2011; Perez-Cornejo P, 2012, P NATL ACAD SCI USA, V109, P10376, DOI 10.1073/pnas.1200174109; Qu ZQ, 2014, CANCER MED-US, V3, P453, DOI 10.1002/cam4.232; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Romanenko VG, 2010, J BIOL CHEM, V285, P12990, DOI 10.1074/jbc.M109.068544; Ruiz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043265; Ruppersburg CC, 2014, MOL BIOL CELL, V25, P1793, DOI 10.1091/mbc.E13-10-0599; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; SMART IHM, 1971, J ANAT, V109, P243; Solbu TT, 2012, CHEM SENSES, V37, P35, DOI 10.1093/chemse/bjr063; Stanich JE, 2011, AM J PHYSIOL-GASTR L, V301, pG1044, DOI 10.1152/ajpgi.00196.2011; Taniguchi K, 2008, J VET MED SCI, V70, P57, DOI 10.1292/jvms.70.57; Tsutsumi S, 2004, AM J HUM GENET, V74, P1255, DOI 10.1086/421527; Wanitchakool P, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0096; West RB, 2004, AM J PATHOL, V165, P107, DOI 10.1016/S0002-9440(10)63279-8; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yi Eunyoung, 2013, Exp Neurobiol, V22, P322, DOI 10.5607/en.2013.22.4.322; Zou DJ, 2007, J NEUROSCI, V27, P6675, DOI 10.1523/JNEUROSCI.0699-07.2007	64	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129171	10.1371/journal.pone.0129171	http://dx.doi.org/10.1371/journal.pone.0129171			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26067252	Green Published, gold, Green Submitted			2022-12-26	WOS:000356100900043
J	Verschueren, E; Spiess, M; Gkourtsa, A; Avula, T; Landgraf, C; Mancilla, VT; Huber, A; Volkmer, R; Winsor, B; Serrano, L; Hochstenbach, F; Distel, B				Verschueren, Erik; Spiess, Matthias; Gkourtsa, Areti; Avula, Teja; Landgraf, Christiane; Mancilla, Victor Tapia; Huber, Aline; Volkmer, Rudolf; Winsor, Barbara; Serrano, Luis; Hochstenbach, Frans; Distel, Ben			Evolution of the SH3 Domain Specificity Landscape in Yeasts	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; MYOSIN-I; ACTIN CYTOSKELETON; GENOME SEQUENCE; ARP2/3 COMPLEX; BAR; FISSION; BINDING; RVS167P; ENDOCYTOSIS	To explore the conservation of Src homology 3 (SH3) domain-mediated networks in evolution, we compared the specificity landscape of these domains among four yeast species, Saccharomyces cerevisiae, Ashbya gossypii, Candida albicans, and Schizosaccharomyces pombe, encompassing 400 million years of evolution. We first aligned and catalogued the families of SH3-containing proteins in these four species to determine the relationships between homologous domains. Then, we tagged and purified all soluble SH3 domains (82 in total) to perform a quantitative peptide assay (SPOT) for each SH3 domain. All SPOT read-outs were hierarchically clustered and we observed that the organization of the SH3 specificity landscape in three distinct profile classes remains conserved across these four yeast species. We also produced a specificity profile for each SH3 domain from manually aligned top SPOT hits and compared the within-family binding motif consensus. This analysis revealed a striking example of binding motif divergence in a C. albicans Rvs167 paralog, which cannot be explained by overall SH3 sequence or interface residue divergence, and we validated this specificity change with a yeast two-hybrid (Y2H) assay. In addition, we show that position-weighted matrices (PWM) compiled from SPOT assays can be used for binding motif screening in potential binding partners and present cases where motifs are either conserved or lost among homologous SH3 interacting proteins. Finally, by comparing pairwise SH3 sequence identity to binding profile correlation we show that for similar to 75% of all analyzed families the SH3 specificity profile was remarkably conserved over a large evolutionary distance. Thus, a high sequence identity within an SH3 domain family predicts conserved binding specificity, whereas divergence in sequence identity often coincided with a change in binding specificity within this family. As such, our results are important for future studies aimed at unraveling complex specificity networks of peptide recognition domains in higher eukaryotes, including mammals.	[Verschueren, Erik; Serrano, Luis] Ctr Genom Regulat CRG, EMBL CRG Syst Biol Res Unit, Barcelona, Spain; [Spiess, Matthias; Mancilla, Victor Tapia; Huber, Aline; Winsor, Barbara] Univ Strasbourg, Dept Mol & Cellular Genet, UMR7156, Strasbourg, France; [Spiess, Matthias; Mancilla, Victor Tapia; Huber, Aline; Winsor, Barbara] CNRS, Strasbourg, France; [Gkourtsa, Areti; Avula, Teja; Hochstenbach, Frans; Distel, Ben] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Landgraf, Christiane; Mancilla, Victor Tapia; Volkmer, Rudolf] Humboldt Univ, Inst Med Immunol, D-10099 Berlin, Germany	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Amsterdam; Academic Medical Center Amsterdam; Humboldt University of Berlin	Distel, B (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	b.distel@amc.uva.nl	Serrano, Luis/B-3355-2013	Serrano, Luis/0000-0002-5276-1392; Volkmer, Rudolf/0000-0003-4710-1143	European Union (Marie Curie Research Training Network Penelope) [MRTN-CT-2006-036076]	European Union (Marie Curie Research Training Network Penelope)	LS, BW, FH and BD received funding from the European Union (Marie Curie Research Training Network Penelope; MRTN-CT-2006-036076). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson BL, 1998, J CELL BIOL, V141, P1357, DOI 10.1083/jcb.141.6.1357; Bon E, 2000, YEAST, V16, P1229, DOI 10.1002/1097-0061(20000930)16:13<1229::AID-YEA618>3.0.CO;2-Q; Borth N, 2010, MICROBIOL-SGM, V156, P2962, DOI 10.1099/mic.0.041707-0; Chae M, 2013, J BIOL CHEM, V288, P6427, DOI 10.1074/jbc.M112.449629; Chae M, 2012, J BIOL CHEM, V287, P40186, DOI 10.1074/jbc.M112.421776; Colwill K, 1999, GENETICS, V152, P881; Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781; Dislich B, 2011, BIOCHEM J, V433, P75, DOI 10.1042/BJ20100709; Douangamath A, 2002, MOL CELL, V10, P1007, DOI 10.1016/S1097-2765(02)00749-9; Douglas LM, 2009, INFECT IMMUN, V77, P4150, DOI 10.1128/IAI.00683-09; Fernandez-Ballester G, 2004, J MOL BIOL, V335, P619, DOI 10.1016/j.jmb.2003.10.060; Fernandez-Ballester G, 2009, J MOL BIOL, V388, P902, DOI 10.1016/j.jmb.2009.03.038; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Friesen H, 2006, MOL BIOL CELL, V17, P1306, DOI 10.1091/mbc.e05-06-0476; Friesen H, 2005, GENETICS, V170, P555, DOI 10.1534/genetics.104.040063; Geli MI, 1996, SCIENCE, V272, P533, DOI 10.1126/science.272.5261.533; Geli MI, 2000, EMBO J, V19, P4281, DOI 10.1093/emboj/19.16.4281; Gfeller D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.18; Giblin J, 2011, BIOCHEM SOC T, V39, P1185, DOI 10.1042/BST0391185; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gkourtsa A, 2015, EUKARYOT CELL, V14, P182, DOI 10.1128/EC.00282-14; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Grotsch H, 2010, EMBO J, V29, P2899, DOI 10.1038/emboj.2010.159; Huang TY, 2005, J CELL SCI, V118, P199, DOI 10.1242/jcs.01608; Huerta-Cepas J, 2011, NUCLEIC ACIDS RES, V39, pD556, DOI 10.1093/nar/gkq1109; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Jia CYH, 2005, MOL CELL PROTEOMICS, V4, P1155, DOI 10.1074/mcp.M500108-MCP200; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kim JM, 2008, J MOL BIOL, V377, P889, DOI 10.1016/j.jmb.2008.01.063; Kim SV, 2008, CELL MOL LIFE SCI, V65, P2128, DOI 10.1007/s00018-008-7435-5; Kramer A, 1998, METH MOL B, V87, P25; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Landgraf C, 2004, PLOS BIOL, V2, P94, DOI 10.1371/journal.pbio.0020014; Lechler T, 2000, J CELL BIOL, V148, P363, DOI 10.1083/jcb.148.2.363; Lee WL, 2000, J CELL BIOL, V151, P789, DOI 10.1083/jcb.151.4.789; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Lila T, 1997, MOL BIOL CELL, V8, P367, DOI 10.1091/mbc.8.2.367; Madania A, 1999, MOL BIOL CELL, V10, P3521, DOI 10.1091/mbc.10.10.3521; Mayer BJ, 2001, J CELL SCI, V114, P1253; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oberholzer U, 2004, EUKARYOT CELL, V3, P1272, DOI 10.1128/EC.3.5.1272-1286.2004; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; POLLARD TD, 1991, ANNU REV PHYSIOL, V53, P653, DOI 10.1146/annurev.ph.53.030191.003253; Prigent M, 2011, TRAFFIC, V12, P1084, DOI 10.1111/j.1600-0854.2011.01218.x; Pryszcz LP, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq953; Reijnst P, 2010, FEMS YEAST RES, V10, P452, DOI 10.1111/j.1567-1364.2010.00624.x; Ren G, 2006, MICROBIOL MOL BIOL R, V70, P37, DOI 10.1128/MMBR.70.1.37-120.2006; Ren LP, 2015, MOL BIOL CELL, V26, P256, DOI 10.1091/mbc.E14-10-1451; Routhier EL, 2003, ONCOGENE, V22, P637, DOI 10.1038/sj.onc.1206162; SIMON JA, 1995, CHEM BIOL, V2, P53, DOI 10.1016/1074-5521(95)90080-2; Sipiczki M, 2000, GENOME BIOL, V1, DOI [10.1186/gb-2000-1-2-reviews1011, DOI 10.1186/GB-2000-1-2-REVIEWS1011]; Sirotkin V, 2005, J CELL BIOL, V170, P637, DOI 10.1083/jcb.200502053; SPARKS AB, 1994, J BIOL CHEM, V269, P23853; Talarek N, 2005, CELL BIOCHEM FUNCT, V23, P253, DOI 10.1002/cbf.1146; Tian LJ, 2006, FASEB J, V20, P2588, DOI 10.1096/fj.06-6152fje; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Tonikian R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000218; Walther A, 2004, J CELL SCI, V117, P4947, DOI 10.1242/jcs.01377; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Xin XF, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.9; Youn JY, 2010, MOL BIOL CELL, V21, P3054, DOI 10.1091/mbc.E10-03-0181; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8	66	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129229	10.1371/journal.pone.0129229	http://dx.doi.org/10.1371/journal.pone.0129229			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	26068101	Green Published, Green Submitted, gold			2022-12-26	WOS:000356100900047
J	Frieboes, HB; Smith, BR; Wang, ZH; Kotsuma, M; Ito, K; Day, A; Cahill, B; Flinders, C; Mumenthaler, SM; Mallick, P; Simbawa, E; Al-Fhaid, AS; Mahmoud, SR; Gambhir, SS; Cristini, V				Frieboes, Hermann B.; Smith, Bryan R.; Wang, Zhihui; Kotsuma, Masakatsu; Ito, Ken; Day, Armin; Cahill, Benjamin; Flinders, Colin; Mumenthaler, Shannon M.; Mallick, Parag; Simbawa, Eman; Al-Fhaid, A. S.; Mahmoud, S. R.; Gambhir, Sanjiv S.; Cristini, Vittorio			Predictive Modeling of Drug Response in Non-Hodgkin's Lymphoma	PLOS ONE			English	Article							LUNG-CANCER MODEL; MATHEMATICAL-MODEL; BREAST-CANCER; TUMOR-GROWTH; SENSITIVITY-ANALYSIS; CELL MALIGNANCIES; SOLID TUMORS; CROSS-SCALE; IN-VIVO; ANGIOGENESIS	We combine mathematical modeling with experiments in living mice to quantify the relative roles of intrinsic cellular vs. tissue-scale physiological contributors to chemotherapy drug resistance, which are difficult to understand solely through experimentation. Experiments in cell culture and in mice with drug-sensitive (E mu-myc/Arf-/-) and drug-resistant (E mu-myc/p53-/-) lymphoma cell lines were conducted to calibrate and validate a mechanistic mathematical model. Inputs to inform the model include tumor drug transport characteristics, such as blood volume fraction, average geometric mean blood vessel radius, drug diffusion penetration distance, and drug response incell culture. Model results show that the drug response in mice, represented by the fraction of dead tumor volume, can be reliably predicted from these inputs. Hence, a proof-of principle for predictive quantification of lymphoma drug therapy was established based on both cellular and tissue-scale physiological contributions. We further demonstrate that, if the in vitro cytotoxic response of a specific cancer cell line under chemotherapy is known, the model is then able to predict the treatment efficacy in vivo. Lastly, tissue blood volume fraction was determined to be the most sensitive model parameter and a primary contributor to drug resistance.	[Frieboes, Hermann B.; Cahill, Benjamin] Univ Louisville, Dept Bioengn, Louisville, KY 40202 USA; [Frieboes, Hermann B.] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40202 USA; [Frieboes, Hermann B.; Wang, Zhihui; Day, Armin; Cristini, Vittorio] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA; [Smith, Bryan R.; Kotsuma, Masakatsu; Ito, Ken; Mallick, Parag; Gambhir, Sanjiv S.] Stanford Univ, Dept Radiol, MIPS, Stanford, CA 94305 USA; [Flinders, Colin] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Flinders, Colin; Mumenthaler, Shannon M.] Univ So Calif, Ctr Appl Mol Med, Los Angeles, CA 90033 USA; [Al-Fhaid, A. S.; Cristini, Vittorio] King Abdulaziz Univ, Fac Sci, Dept Math, Jeddah 21589, Saudi Arabia; [Gambhir, Sanjiv S.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Gambhir, Sanjiv S.] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA; [Gambhir, Sanjiv S.] Stanford Univ, Biox, Stanford, CA 94305 USA; [Cristini, Vittorio] Univ New Mexico, Dept Chem Engn, Albuquerque, NM 87131 USA; [Cristini, Vittorio] Univ New Mexico, Ctr Biomed Engn, Albuquerque, NM 87131 USA	University of Louisville; University of Louisville; University of New Mexico; Stanford University; University of California System; University of California Los Angeles; University of Southern California; King Abdulaziz University; Stanford University; Stanford University; Stanford University; University of New Mexico; University of New Mexico	Frieboes, HB (corresponding author), Univ Louisville, Dept Bioengn, Louisville, KY 40202 USA.	hbfrie01@louisville.edu; sgambhir@stanford.edu; VCristini@salud.unm.edu	Wang, Zhihui/B-2464-2009; Mumenthaler, Shannon M/AGY-8535-2022; Smith, Bryan/AAS-1108-2021; Cristini, Vittorio/N-3540-2013; Mahmoud, Samy Refahy/I-1875-2012; Simbawa, Eman/F-4443-2015	Wang, Zhihui/0000-0001-6262-700X; Smith, Bryan/0000-0002-5990-2901; Mahmoud, Samy Refahy/0000-0002-7008-1366; Cristini, Vittorio/0000-0002-7909-4278; Simbawa, Eman/0000-0003-4831-1249	NCI [PSOC MC-START U54CA143907, ICMIC P50CA114747, RO1 CA082214, CCNE-TR U54 CA119367, CCNE-T U54 U54CA151459]; NSF [DMS-1263742, ICBP-1U54CA149196]; NIGMS [STMC P50GM085273]; Victor and Ruby Hansen Surface Professorship in Molecular Modeling of Cancer; Methodist Hospital Research Institute; Canary Foundation; Deanship of Scientific Research (DSR), King Abdulaziz University [HiCi/54-130-35]; King Abdulaziz University;  [K99 CA160764]; NATIONAL CANCER INSTITUTE [R01CA082214, U54CA119367, P50CA114747, U54CA143907, U54CA151459, U01CA188383, K99CA160764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085273] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NSF(National Science Foundation (NSF)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Victor and Ruby Hansen Surface Professorship in Molecular Modeling of Cancer; Methodist Hospital Research Institute; Canary Foundation; Deanship of Scientific Research (DSR), King Abdulaziz University; King Abdulaziz University; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by NCI PSOC MC-START U54CA143907 (HBF, ZW, PM, SSG, VC); NSF Grant DMS-1263742, ICBP-1U54CA149196 (ZW, VC); NIGMS STMC P50GM085273 (VC); the Victor and Ruby Hansen Surface Professorship in Molecular Modeling of Cancer (VC); the Methodist Hospital Research Institute (VC); NCI ICMIC P50CA114747, NCI Powered by RO1 CA082214, NCI CCNE-TR U54 CA119367, CCNE-T U54 U54CA151459, Canary Foundation (SSG); K99 CA160764 (BRS). This work was also funded in part by the Deanship of Scientific Research (DSR), King Abdulaziz University, under Grant no. (HiCi/54-130-35) (ES, ASA, SRM, VC). The authors, therefore, acknowledge technical and financial support of King Abdulaziz University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon T, 2006, J THEOR BIOL, V240, P54, DOI 10.1016/j.jtbi.2005.08.028; Bello L, 2004, CLIN CANCER RES, V10, P4527, DOI 10.1158/1078-0432.CCR-04-0194; Byrne HM, 2006, MATH MOD METH APPL S, V16, P1219, DOI 10.1142/S0218202506001522; Chrobak JM, 2012, J MATH ANAL APPL, V386, P813, DOI 10.1016/j.jmaa.2011.08.043; Cristini V, 2005, CLIN CANCER RES, V11, P6772, DOI 10.1158/1078-0432.CCR-05-0852; Das H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061398; Edgerton ME, 2011, ANAL CELL PATHOL, V34, P247, DOI [10.1155/2011/803816, 10.3233/ACP-2011-0019]; Enderling H, 2007, J THEOR BIOL, V246, P245, DOI 10.1016/j.jtbi.2006.12.010; Frieboes HB, 2006, CANCER RES, V66, P1597, DOI 10.1158/0008-5472.CAN-05-3166; Frieboes HB, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003008; Frieboes HB, 2010, J THEOR BIOL, V264, P1254, DOI 10.1016/j.jtbi.2010.02.036; Frieboes HB, 2009, CANCER RES, V69, P4484, DOI 10.1158/0008-5472.CAN-08-3740; Gangatharan S, 2013, TRANSFUS APHER SCI, V49, P72, DOI 10.1016/j.transci.2013.05.029; Gevertz JL, 2011, COMPUT MATH METHOD M, V2011, DOI 10.1155/2011/830515; Goldie JH, 1996, CHEMOTHERAPY SOURCE, P63; Hinow P, 2009, MATH BIOSCI ENG, V6, P521, DOI 10.3934/mbe.2009.6.521; Ito K, 2012, CANCER RES, V72, P6111, DOI 10.1158/0008-5472.CAN-12-2579; Koay EJ, 2014, J CLIN INVEST, V124, P1525, DOI 10.1172/JCI73455; Kunkel P, 2001, CANCER RES, V61, P6624; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Meyer-Hermann ME, 2007, J THEOR BIOL, V244, P656, DOI 10.1016/j.jtbi.2006.09.006; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; O'Connor OA, 2011, J CLIN ONCOL, V29, P1182, DOI 10.1200/JCO.2010.29.9024; O'Connor OA, 2009, J CLIN ONCOL, V27, P4357, DOI 10.1200/JCO.2008.20.8470; Ogura M, 2012, CANCER SCI, V103, P1290, DOI 10.1111/j.1349-7006.2012.02287.x; Paoluzzi L, 2008, HEMATOL ONCOL CLIN N, V22, P1007, DOI 10.1016/j.hoc.2008.07.006; Pascal J, 2013, ACS NANO, V7, P11174, DOI 10.1021/nn4048974; Pascal J, 2013, P NATL ACAD SCI USA, V110, P14266, DOI 10.1073/pnas.1300619110; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Pham K, 2011, J R SOC INTERFACE, V8, P16, DOI 10.1098/rsif.2010.0194; Primeau AJ, 2005, CLIN CANCER RES, V11, P8782, DOI 10.1158/1078-0432.CCR-05-1664; Rapisarda A, 2012, NAT REV CLIN ONCOL, V9, P378, DOI 10.1038/nrclinonc.2012.64; Ribba B, 2005, B MATH BIOL, V67, P79, DOI 10.1016/j.bulm.2004.06.007; Ribba B, 2006, J THEOR BIOL, V243, P532, DOI 10.1016/j.jtbi.2006.07.013; Roeder I, 2008, J MOL MED, V86, P17, DOI 10.1007/s00109-007-0241-y; Roesch K, 2014, B MATH BIOL, V76, P401, DOI 10.1007/s11538-013-9925-3; SALMON SE, 1989, J NATL CANCER I, V81, P696, DOI 10.1093/jnci/81.9.696; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Sinek JP, 2009, J MATH BIOL, V58, P485, DOI 10.1007/s00285-008-0214-y; Smith BR, 2013, NANO TODAY, V8, P126, DOI 10.1016/j.nantod.2013.02.004; Stamatakos GS, 2006, IEEE T BIO-MED ENG, V53, P1467, DOI 10.1109/TBME.2006.873761; Toner LE, 2006, CLIN CANCER RES, V12, P924, DOI 10.1158/1078-0432.CCR-05-0331; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Ungersma SE, 2010, MAGN RESON MED, V63, P1637, DOI 10.1002/mrm.22442; Wang ZH, 2008, BIOSYSTEMS, V92, P249, DOI 10.1016/j.biosystems.2008.03.002; Wang ZH, 2014, IET SYST BIOL, V8, P191, DOI 10.1049/iet-syb.2013.0026; Wang ZH, 2009, BIOINFORMATICS, V25, P2389, DOI 10.1093/bioinformatics/btp416; Wolfram Research, MATH VERS 8 0 MATH A; Wu M, 2013, J THEOR BIOL, V320, P131, DOI 10.1016/j.jtbi.2012.11.031; Yustein JT, 2007, CURR OPIN HEMATOL, V14, P375, DOI 10.1097/MOH.0b013e3281bccdee	50	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129433	10.1371/journal.pone.0129433	http://dx.doi.org/10.1371/journal.pone.0129433			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061425	gold, Green Submitted, Green Published			2022-12-26	WOS:000355979500143
J	Sandak, B; Huss, E; Sarid, O; Harel, D				Sandak, Billie; Huss, Ephrat; Sarid, Orly; Harel, David			Computational Paradigm to Elucidate the Effects of Arts-Based Approaches and Interventions: Individual and Collective Emerging Behaviors in Artwork Construction	PLOS ONE			English	Article							MUSIC-THERAPY; CANCER; DANCE; STATECHARTS; SYMPTOMS; DISEASE; QUALITY; PEOPLE; HEALTH; PAIN	Art therapy, as well as other arts-based therapies and interventions, is used to reduce pain, stress, depression, breathlessness and other symptoms in a wide variety of serious and chronic diseases, such as cancer, Alzheimer and schizophrenia. Arts-based approaches are also known to contribute to one's well-being and quality of life. However, much research is required, since the mechanisms by which these non-pharmacological treatments exert their therapeutic and psychosocial effects are not adequately understood. A typical clinical setting utilizing the arts consists of the creation work itself, such as the artwork, as well as the therapist and the patient, all of which constitute a rich and dynamic environment of occurrences. The underlying complex, simultaneous and interwoven processes of this setting are often considered intractable to human observers, and as a consequence are usually interpreted subjectively and described verbally, which affect their subsequent analyses and understanding. We introduce a computational research method for elucidating and analyzing emergent expressive and social behaviors, aiming to understand how arts-based approaches operate. Our methodology, which centers on the visual language of Statecharts and tools for its execution, enables rigorous qualitative and quantitative tracking, analysis and documentation of the underlying creation and interaction processes. Also, it enables one to carry out exploratory, hypotheses-generating and knowledge discovery investigations, which are empirical-based. Furthermore, we illustrate our method's use in a proof-of-principle study, applying it to a real-world artwork investigation with human participants. We explore individual and collective emergent behaviors impacted by diverse drawing tasks, yielding significant gender and age hypotheses, which may account for variation factors in response to art use. We also discuss how to gear our research method to systematic and mechanistic investigations, as we wish to provide a broad empirical evidence for the uptake of arts-based approaches, also aiming to ameliorate their use in clinical settings.	[Sandak, Billie; Harel, David] Weizmann Inst Sci, Fac Math & Comp Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Huss, Ephrat; Sarid, Orly] Ben Gurion Univ Negev, Fac Humanities & Social Sci, Spitzer Dept Social Work, IL-84105 Beer Sheva, Israel	Weizmann Institute of Science; Ben Gurion University	Sandak, B (corresponding author), Weizmann Inst Sci, Fac Math & Comp Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	billie.sandak@alumni.weizmann.ac.il		Sarid, Orly/0000-0002-6967-8755; Huss, Ephrat/0000-0003-3121-977X	Braginsky Center for the Interface between Science and the Humanities, at the Weizmann Institute of Science	Braginsky Center for the Interface between Science and the Humanities, at the Weizmann Institute of Science	The authors thank the Braginsky Center for the Interface between Science and the Humanities, at the Weizmann Institute of Science (http://www.weizmann.ac.il/pages/research-institutes-institute-wide), for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen P. B., 1995, ART IS WAY KNOWING G; Ball B, 2002, ART PSYCHOTHER, V29, P79, DOI 10.1016/S0197-4556(02)00138-7; Bar-Sela G, 2007, PSYCHO-ONCOLOGY, V16, P980, DOI 10.1002/pon.1175; Batson G, 2014, PHYS OCCUP THER GERI, V32, P188, DOI 10.3109/02703181.2014.927946; Belkofer CM, 2014, ART THER, V31, P61, DOI 10.1080/07421656.2014.903821; Benesh Rudolf, 1983, READING DANCE BIRTH; Bergstrom-Nielsen C., 2009, MUSIC THERAPY SPECIA, V1, P72, DOI [10.3389/fpsyg.2014.00706, DOI 10.3389/FPSYG.2014.00706]; Bittman BB, 2001, ALTERN THER HEALTH M, V7, P38; Bolwerk A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101035; Burns SJI, 2001, ALTERN THER HEALTH M, V7, P48; Chanda ML, 2013, TRENDS COGN SCI, V17, P179, DOI 10.1016/j.tics.2013.02.007; Chapman L., 2001, ART THER, V18, P100, DOI [10.1080/07421656.2001.10129750, DOI 10.1080/07421656.2001.10129750]; COHEN BM, 1988, ART PSYCHOTHER, V15, P11, DOI 10.1016/0197-4556(88)90048-2; Cruz RF, 2013, ART SCI EVALUATION A; Czamanski-Cohen J, 2014, ART PSYCHOTHER, V41, P320, DOI 10.1016/j.aip.2014.05.002; Dalley T, 2009, ART THERAPY INTRO US; Dassa A, 2014, J MUSIC THER, V51, P131, DOI 10.1093/jmt/thu007; Devlin B, 2006, INT J PALLIAT NURS, V12, P16, DOI 10.12968/ijpn.2006.12.1.20391; Dileo Cheryl, 2006, J Soc Integr Oncol, V4, P67, DOI 10.2310/7200.2006.002; Douglass B. P., 1998, Lectures on Embedded Systems. European Educational Forum School on Embedded Systems, P368; Drusinsky D, 1987, P IEEE CAD C SANT CL; Ekman P., 1999, HDB COGNITION EMOTIO, P301, DOI [10.1002/0470013494.ch16, DOI 10.1002/0470013494.CH16]; Eshkol N, 1958, MOVEMENT NOTATION; Everingham M, 2014, INT J COMPUT VISION, P1; Fridin M., 2009, P S MENT STAT EM THE; Gantt LM, 2001, ART THER, V18, P51, DOI DOI 10.1080/07421656.2001.10129453; Gilboa A, 2007, MUSIC THER PERSPECT, V25, P32, DOI 10.1093/mtp/25.1.32; Gold C, 2009, CLIN PSYCHOL REV, V29, P193, DOI 10.1016/j.cpr.2009.01.001; Graham JE, 2008, J BEHAV MED, V31, P201, DOI 10.1007/s10865-008-9149-4; Greenberg LS, 1994, REASSESSING PSYCHOTH, P114; GUZZETTA CE, 1989, HEART LUNG, V18, P609; HAREL D, 1988, COMMUN ACM, V31, P514, DOI 10.1145/42411.42414; HAREL D, 1987, SCI COMPUT PROGRAM, V8, P231, DOI 10.1016/0167-6423(87)90035-9; Harel D, 2004, LECT NOTES COMPUT SC, V3147, P325; Harel D., 1985, LOGICS MODELS CONCUR, P477, DOI [10.1007/978-3-642-82453-1_17, DOI 10.1007/978-3-642-82453-1_17]; Hilliard RE, 2003, J MUSIC THER, V40, P113, DOI 10.1093/jmt/40.2.113; Huss E, 2014, ART PSYCHOTHER, V41, P409, DOI 10.1016/j.aip.2014.07.004; Huss E, 2009, ART PSYCHOTHER, V36, P154, DOI 10.1016/j.aip.2009.01.003; Hutchinson A, 1987, LABANOTATION SYSTEM, P528; Italia S, 2008, PSYCHO-ONCOLOGY, V17, P676, DOI 10.1002/pon.1293; Jones P., 2005, ARTS THERAPIES REVOL; Junge MB, 1994, HIST THERAPY US; Kam N, 2001, P VIS LANG FORM METH; Kiepe MS, 2012, ART PSYCHOTHER, V39, P404, DOI 10.1016/j.aip.2012.06.001; Kim SI, 2010, ART PSYCHOTHER, V37, P378, DOI 10.1016/j.aip.2010.09.002; Koch S, 2014, ART PSYCHOTHER, V41, P46, DOI 10.1016/j.aip.2013.10.004; Kruk KA, 2014, ART THER, V31, P52, DOI 10.1080/07421656.2014.903826; Kumar AM, 1999, ALTERN THER HEALTH M, V5, P49; Lindblad F, 2007, STRESS HEALTH, V23, P9, DOI 10.1002/smi.1109; Malchiodi C., 2012, ART THERAPY HEALTHCA; Marsella S, 2014, COMMUN ACM, V57, P56, DOI 10.1145/2631912; Mason J., 2002, QUALITATIVE RES; McLean C. L., 2014, CREATIVE ARTS HUMANE; McNiff S., 1992, ART MED; Monti DA, 2006, PSYCHO-ONCOL, V15, P363, DOI 10.1002/pon.988; Nainis N, 2006, J PAIN SYMPTOM MANAG, V31, P162, DOI 10.1016/j.jpainsymman.2005.07.006; Orr P, 2012, ART PSYCHOTHER, V39, P234, DOI 10.1016/j.aip.2012.03.010; Pacchetti C, 2000, PSYCHOSOM MED, V62, P386, DOI 10.1097/00006842-200005000-00012; Park H., 2011, SCI SOCIAL VISION, P75, DOI 10.1093/acprof:oso/9780195333176.003.0004; Perruzza N, 2010, BRIT J OCCUP THER, V73, P261, DOI 10.4276/030802210X12759925468943; Reuderink B, 2008, LECT NOTES COMPUT SC, V5237, P137, DOI 10.1007/978-3-540-85853-9_13; Richardson P., 2007, J MENT HEALTH, V16, P483, DOI [DOI 10.1080/09638230701483111, https://doi.org/10.1080/09638230701483111]; Sandak B, 1998, PROTEINS, V32, P159, DOI 10.1002/(SICI)1097-0134(19980801)32:2<159::AID-PROT3>3.3.CO;2-U; Sandak B, 1998, J COMPUT BIOL, V5, P631, DOI 10.1089/cmb.1998.5.631; Sandel SL, 2005, CANCER NURS, V28, P301; Sarid O, 2011, ART PSYCHOTHER, V38, P252, DOI 10.1016/j.aip.2011.07.001; Silver R. A., 2005, AGGRESSION DEPRESSIO; Smolen D, 2002, APPL NURS RES, V15, P126, DOI 10.1053/apnr.2002.34140; Sobolev B, 2008, HEALTH CARE MANAG SC, V11, P79, DOI 10.1007/s10729-007-9026-7; Stuckey HL, 2010, AM J PUBLIC HEALTH, V100, P254, DOI 10.2105/AJPH.2008.156497; Swerdlin N, 2008, P IEEE COMP SYST BIO; Thyme Karin Egberg, 2009, Palliat Support Care, V7, P87, DOI 10.1017/S147895150900011X; Tusek D L, 1999, J Cardiovasc Manag, V10, P22; Ullman S., 1996, HIGH LEVEL VISION OB	74	4	4	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0126467	10.1371/journal.pone.0126467	http://dx.doi.org/10.1371/journal.pone.0126467			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CK1PO	26061736	gold, Green Published, Green Submitted			2022-12-26	WOS:000355979500015
